{"meta":{"query_hash":"93b59fb0cd5d","filters":{"topic":"Ovarian cancer diagnosis and treatment"},"cohort_total":2301,"direct_labels_cover":7,"predictions_cover":2301,"exported":2301,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/93b59fb0cd5d","api":"https://metacan.xera.ac/api/v1/cohort?topic=Ovarian+cancer+diagnosis+and+treatment"},"results":[{"id":"W1154672498","doi":"10.1016/j.jpag.2015.08.002","title":"The Relationship between Intraoperative Rupture and Recurrence of Pediatric Ovarian Neoplasms: Preliminary Observations","year":2015,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Laparotomy; Laparoscopy; Surgery; Univariate analysis; Ovarian tumor; Retrospective cohort study; Cystectomy; Multivariate analysis; Ovarian cancer; Cancer; Bladder cancer; Internal medicine","score_opus":0.07671077051076687,"score_gpt":0.30836518608959873,"score_spread":0.23165441557883187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1154672498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97832906,0.01302577,0.00014055418,0.007731747,0.0004175114,0.00027711492,0.000015429338,0.0000047972158,0.000058009424],"genre_scores_gemma":[0.9902902,0.0071352907,0.00092056877,0.0001492745,0.0014232066,0.000005991898,0.000005143553,0.000008707849,0.00006159292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987956,0.00013536305,0.00055398804,0.00014171533,0.0002041382,0.00016915421],"domain_scores_gemma":[0.99706095,0.0017180588,0.0005077562,0.00011876819,0.0003480996,0.00024634454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052067195,0.00012969201,0.0003465588,0.00014502171,0.00013385907,0.000019078096,0.00007694694,0.00012987893,0.000005454798],"category_scores_gemma":[0.0014262036,0.00008259823,0.000061770384,0.0002798854,0.00009109773,0.000116184194,0.00004680642,0.0003829818,0.0000014399427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015348889,0.00020207452,0.9864019,0.0000724246,0.000057719502,0.000026383894,0.00040707714,0.0000068121476,7.116606e-7,0.0006124347,0.009484792,0.0025741372],"study_design_scores_gemma":[0.0022034547,0.0018225919,0.9926503,0.00003057712,0.0009912081,0.00008087831,0.00032941127,0.000011589138,0.0000048811644,0.00073020393,0.0010739514,0.00007098589],"about_ca_topic_score_codex":0.000004521199,"about_ca_topic_score_gemma":0.0000055131495,"teacher_disagreement_score":0.0119611565,"about_ca_system_score_codex":0.00008068262,"about_ca_system_score_gemma":0.00056229625,"threshold_uncertainty_score":0.33682582},"labels":[],"label_agreement":null},{"id":"W1423334311","doi":"10.1097/01.npr.0000450742.00077.a2","title":"Ovarian cancer","year":2015,"lang":"en","type":"article","venue":"The Nurse Practitioner","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.051960672991760076,"score_gpt":0.3473904399883095,"score_spread":0.29542976699654944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1423334311","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08829439,0.0027331929,0.00027418634,0.511243,0.0024036244,0.0010647894,0.000046221554,0.00020076468,0.39373988],"genre_scores_gemma":[0.98664546,0.00010260963,0.00039947484,0.0039879456,0.00070020405,0.0002222658,0.000018605437,0.0000169572,0.00790647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943125,0.0000350746,0.00008949935,0.00012520411,0.00019653172,0.00012244318],"domain_scores_gemma":[0.9994254,0.000037536058,0.000051668423,0.0002645677,0.000096787866,0.0001240153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014193484,0.0000762745,0.00010387623,0.000023870332,0.00006313265,0.000021328924,0.00004044084,0.000033112035,0.0012124946],"category_scores_gemma":[0.000042923846,0.000043421514,0.00004326239,0.00010471655,0.00003422771,0.00010326237,0.0000056481936,0.00010828559,0.0005718589],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009781659,0.0018670164,0.05676542,0.000027738746,0.00086913037,0.00020096907,0.0038233506,0.00017104628,0.00041192566,0.040215198,0.84523493,0.04943513],"study_design_scores_gemma":[0.0035591677,0.00019980918,0.115826815,0.00007750666,0.0005364709,0.00017581809,0.00079844636,0.000072787014,0.0014997277,0.0016847241,0.8754366,0.00013212796],"about_ca_topic_score_codex":0.0005395735,"about_ca_topic_score_gemma":0.000033484484,"teacher_disagreement_score":0.8983511,"about_ca_system_score_codex":0.00017866929,"about_ca_system_score_gemma":0.00022104022,"threshold_uncertainty_score":0.99970055},"labels":[],"label_agreement":null},{"id":"W1490550714","doi":"10.1002/cncr.28406","title":"Intravenous aflibercept in patients with platinum‐resistant, advanced ovarian cancer: Results of a randomized, double‐blind, phase 2, parallel‐arm study","year":2013,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Aflibercept; Clinical endpoint; Internal medicine; Topotecan; Ovarian cancer; Cohort; Surgery; Randomized controlled trial; Phases of clinical research; Cancer; Progression-free survival; Clinical trial; Chemotherapy; Bevacizumab; Gastroenterology","score_opus":0.01861937080668284,"score_gpt":0.30442749613359266,"score_spread":0.2858081253269098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490550714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873943,0.0012578348,0.000018729104,0.00082456233,0.00023265464,0.008386215,0.00018489019,0.000038445036,0.0016624207],"genre_scores_gemma":[0.9924745,0.00047597554,0.0004847633,0.00017956528,0.00011935928,0.005721431,0.000079824335,0.000056081823,0.0004085296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973711,0.00010358473,0.0009278358,0.00062574464,0.0005207405,0.0004509953],"domain_scores_gemma":[0.99825,0.00013600566,0.00046260707,0.0005622801,0.00036366004,0.00022542017],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002509105,0.00037031597,0.0014084785,0.0002018808,0.000059759866,0.000029540042,0.00013709826,0.00009879582,0.001049033],"category_scores_gemma":[0.00004046855,0.0002572184,0.00012129371,0.00046148314,0.00014295282,0.00017434348,0.00003719691,0.00022795018,0.000014976681],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8485773,0.011227743,0.07800839,0.0001224535,0.0012845705,0.000056072786,0.0044015367,0.00062801974,0.00004606132,0.00007211901,0.00063734927,0.054938357],"study_design_scores_gemma":[0.85471207,0.0035537325,0.13919744,0.0005736024,0.00059782265,7.8567354e-7,0.00035937715,0.00004754605,0.00022025299,0.000040640032,0.00042514704,0.00027157235],"about_ca_topic_score_codex":0.010267649,"about_ca_topic_score_gemma":0.0030314855,"teacher_disagreement_score":0.061189044,"about_ca_system_score_codex":0.00051644543,"about_ca_system_score_gemma":0.00039803702,"threshold_uncertainty_score":0.999988},"labels":[],"label_agreement":null},{"id":"W1508250292","doi":"10.3109/0284186x.2015.1054950","title":"Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer – a population-based study","year":2015,"lang":"en","type":"article","venue":"Acta Oncologica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Rio Tinto; Conquer Cancer Foundation; Cancer Australia; QIMR Berghofer Medical Research Institute; National Health and Medical Research Council","keywords":"Medicine; Hazard ratio; Carboplatin; Proportional hazards model; Chemotherapy; Internal medicine; Confidence interval; Oncology; Stage (stratigraphy); Ovarian cancer; Epithelial ovarian cancer; Cohort; Population; Cancer; Gynecology; Cisplatin","score_opus":0.03325361560438226,"score_gpt":0.31877702184965306,"score_spread":0.2855234062452708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508250292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908319,0.00006410322,0.000009203987,0.0074842633,0.000079895704,0.0009803278,0.000015845282,0.000023826215,0.00051063753],"genre_scores_gemma":[0.99759316,0.000033255128,0.0006858691,0.0008089929,0.000074487245,0.00074339303,0.000010762778,0.000013461144,0.00003660549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989946,0.00009760524,0.0002081141,0.00028651726,0.00019343852,0.00021971572],"domain_scores_gemma":[0.9994581,0.000114990034,0.00007383708,0.0001710386,0.00004646204,0.00013560383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034444814,0.00013566166,0.00037562623,0.00011108017,0.000030401196,0.000017326422,0.000045770343,0.0000670666,0.0001524723],"category_scores_gemma":[0.00004799181,0.00009164468,0.00001285328,0.0002911571,0.00001720097,0.000052084783,0.000013884345,0.000110746565,0.0000017957152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001429809,0.0022903404,0.9833415,0.0000058865066,0.000058669317,0.000101106525,0.0019263426,0.00008156773,0.000018515133,0.00004128911,0.00003866416,0.010666314],"study_design_scores_gemma":[0.017120052,0.002779765,0.97822195,0.000044773886,0.000037500038,0.0000019213614,0.0006466268,0.0001460786,0.000007665794,0.00012775557,0.0007594456,0.00010644593],"about_ca_topic_score_codex":0.0052128667,"about_ca_topic_score_gemma":0.0074167373,"teacher_disagreement_score":0.015690245,"about_ca_system_score_codex":0.0009629357,"about_ca_system_score_gemma":0.00043231284,"threshold_uncertainty_score":0.788033},"labels":[],"label_agreement":null},{"id":"W151291288","doi":"","title":"Medical therapy of advanced malignant epithelial tumours of the ovary.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Taxane; Medicine; Regimen; Oncology; Internal medicine; Cisplatin; Paclitaxel; Chemotherapy; Ovarian cancer; Progression-free survival; Clinical trial; Gemcitabine; Ovarian carcinoma; Cancer; Breast cancer","score_opus":0.020192063085086167,"score_gpt":0.25375205313228666,"score_spread":0.2335599900472005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W151291288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827251,0.0017056263,0.0000062796794,0.009623911,0.00033048372,0.0008879355,0.000014671441,0.000014043546,0.004691941],"genre_scores_gemma":[0.99593776,0.002444474,0.00006265625,0.00051609805,0.00012550899,0.0004962522,0.0000023982545,0.000012558713,0.00040229617],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988983,0.00003555242,0.00025422906,0.00014643592,0.00045399953,0.0002114427],"domain_scores_gemma":[0.99932605,0.000061568884,0.00011760134,0.00031332462,0.00005755075,0.00012389898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022977933,0.00009244683,0.00026808796,0.00003477655,0.00002047312,0.0000019653303,0.00012323148,0.000053744367,0.0002969953],"category_scores_gemma":[0.00009049475,0.000049827962,0.00014218518,0.00018038545,0.00011029149,0.000022452718,0.0000274149,0.00007507567,0.000002745017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057218113,0.0009019029,0.31093416,0.000025412408,0.00014888788,0.000053680047,0.00013660363,0.000003255707,0.00032957774,0.00060965744,0.0007810925,0.6855036],"study_design_scores_gemma":[0.0034672471,0.00010613082,0.95113,0.00006669042,0.000043279797,0.00003874405,0.000021271564,0.0000039123265,0.03203884,0.00010669848,0.012929716,0.000047479236],"about_ca_topic_score_codex":0.00007262128,"about_ca_topic_score_gemma":0.000011638695,"teacher_disagreement_score":0.6854561,"about_ca_system_score_codex":0.000042000996,"about_ca_system_score_gemma":0.00010260598,"threshold_uncertainty_score":0.32518902},"labels":[],"label_agreement":null},{"id":"W1514503818","doi":"10.1007/s10269-008-0849-8","title":"Recommandations pour la pratique clinique: Standards, Options: Recommandations 2007 pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l’ovaire. Traitement chirurgical (rapport abrégé)","year":2008,"lang":"fr","type":"article","venue":"ONCOLOGIE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Gynecology; Medicine; Clinical Practice; Family medicine","score_opus":0.061961765539017735,"score_gpt":0.3597508519835687,"score_spread":0.297789086444551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514503818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7147352,0.028239746,0.027964551,0.1626113,0.002697726,0.005099372,0.0041278345,0.0007851761,0.05373909],"genre_scores_gemma":[0.5630065,0.19203976,0.19033079,0.0026216374,0.003709512,0.004482936,0.001302115,0.00027318904,0.042233564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99467164,0.0018974975,0.0011788917,0.0007418994,0.00047107818,0.0010389616],"domain_scores_gemma":[0.9941494,0.0036353588,0.00047359522,0.0005399723,0.0006128264,0.00058884686],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032073907,0.0005991845,0.0008728237,0.0002572685,0.00068927725,0.0001285815,0.00030682413,0.00061573676,0.005231429],"category_scores_gemma":[0.0022455808,0.0005475085,0.00042776452,0.00034846994,0.0007026624,0.0003443576,0.00013630345,0.00071175024,0.0002112329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042057835,0.010495808,0.35968572,0.00040048631,0.0010532158,0.0014826229,0.004068209,0.00013075906,0.00021214048,0.013989833,0.45517856,0.15288207],"study_design_scores_gemma":[0.0056041875,0.0019323841,0.2126782,0.0020386681,0.0009878585,0.00095244264,0.0016412461,0.0005275927,0.00180404,0.002137533,0.76903903,0.0006567906],"about_ca_topic_score_codex":0.000520679,"about_ca_topic_score_gemma":0.00040160003,"teacher_disagreement_score":0.3138605,"about_ca_system_score_codex":0.0036098277,"about_ca_system_score_gemma":0.0085912,"threshold_uncertainty_score":0.9996976},"labels":[],"label_agreement":null},{"id":"W1518120855","doi":"10.1002/cncr.29030","title":"Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Clinical endpoint; Randomized controlled trial; Clinical trial; Sample size determination; Population; Internal medicine; Oncology; Outcome (game theory); Cohort; Surrogate endpoint; Statistics","score_opus":0.04837735680435675,"score_gpt":0.41292237477880006,"score_spread":0.36454501797444333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518120855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98614454,0.010020177,0.00043249267,0.001283164,0.00042200938,0.0013707387,0.00018497453,0.000014375456,0.00012754866],"genre_scores_gemma":[0.98778784,0.010230844,0.00030407874,0.00012231222,0.00008259113,0.0014149516,0.000009282647,0.000016679123,0.000031427786],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998617,0.00015186978,0.00059041474,0.00023084163,0.00024884567,0.00016104634],"domain_scores_gemma":[0.99860424,0.00064602186,0.00032172757,0.00020775848,0.0001771762,0.00004306907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041521917,0.00017077678,0.0013702427,0.00018837569,0.00001553429,0.0000036245744,0.000056074514,0.000060063165,0.00017298707],"category_scores_gemma":[0.00056742004,0.000115574076,0.00013482159,0.00023578823,0.00018842611,0.000092498325,0.000015527332,0.000088007735,4.8013607e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22799675,0.0026266386,0.29934642,0.00070154236,0.0032070542,0.000025466292,0.027844742,0.005755537,0.0018076426,0.00092557713,0.00038109854,0.42938155],"study_design_scores_gemma":[0.82077235,0.0011366418,0.10795404,0.0027846573,0.00047540214,0.0000011124358,0.0008654399,0.0050965156,0.059255976,0.0010985183,0.0003095888,0.0002497794],"about_ca_topic_score_codex":0.0017141834,"about_ca_topic_score_gemma":0.0004153036,"teacher_disagreement_score":0.5927756,"about_ca_system_score_codex":0.00040694448,"about_ca_system_score_gemma":0.0003012373,"threshold_uncertainty_score":0.4712974},"labels":[],"label_agreement":null},{"id":"W1518256842","doi":"","title":"Randomised Trial of Two Intravenous Schedules of the Liposomal Topoisomerase I Inhibitor, OSI-211, in Women With Relapsed Epithelial Ovarian Cancer. A Trial of the National Cancer Institute of Canada Clinical Trials Group","year":2005,"lang":"en","type":"article","venue":"Research Explorer (The University of Manchester)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Clinical trial; Ovarian cancer; Oncology; Internal medicine; Epithelial ovarian cancer; Gynecology","score_opus":0.1078150361225854,"score_gpt":0.36960682231513275,"score_spread":0.26179178619254734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1518256842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988452,0.00016612172,0.000007816016,0.0073730825,0.00051596964,0.0032537736,0.00016138275,0.0000031997959,0.000066658264],"genre_scores_gemma":[0.99843025,0.0006835015,0.0001714448,0.00006160609,0.0005328486,0.00006734731,0.0000037800094,0.000014306118,0.000034895933],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949394,0.0016977618,0.0010953934,0.00031483607,0.0016026199,0.00035002505],"domain_scores_gemma":[0.996278,0.0015971547,0.00090485765,0.0005123093,0.00057316426,0.00013454646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00520935,0.00018333785,0.0011692349,0.0001737419,0.00013378434,0.0000056054746,0.00054887583,0.00012011801,0.00012843177],"category_scores_gemma":[0.0010272642,0.00010445378,0.00032327033,0.00060253224,0.001147185,0.00012858228,0.00019254682,0.0004747177,3.367455e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9607246,0.0035278639,0.0065807225,0.00030826134,0.0015082569,0.000015016956,0.01110484,0.0007457156,0.002509882,0.00073970726,0.0006479263,0.0115872035],"study_design_scores_gemma":[0.9278822,0.0033639076,0.04086178,0.0015439033,0.00044244705,0.0000024756935,0.0033874551,0.00010823694,0.019010812,0.00018665219,0.0030442318,0.00016587207],"about_ca_topic_score_codex":0.032265015,"about_ca_topic_score_gemma":0.048102394,"teacher_disagreement_score":0.03428106,"about_ca_system_score_codex":0.00094005896,"about_ca_system_score_gemma":0.005596926,"threshold_uncertainty_score":0.9928707},"labels":[],"label_agreement":null},{"id":"W1522554466","doi":"10.1002/1097-0142(20001115)89:10<2068::aid-cncr6>3.0.co;2-z","title":"Ovarian carcinoma diagnosis","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":505,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian carcinoma; Stage (stratigraphy); Disease; Carcinoma; Ovarian cancer; Pelvic pain; Depression (economics); Abdominal pain; Gynecology; Obstetrics and gynaecology; Internal medicine; Cancer; Obstetrics; Surgery; Pregnancy","score_opus":0.021427874175089852,"score_gpt":0.28973099628181176,"score_spread":0.2683031221067219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522554466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9278645,0.006243871,0.0000032036464,0.011790116,0.00027645135,0.0003457747,0.00004074806,0.00007235805,0.053362977],"genre_scores_gemma":[0.9859874,0.0026414937,0.00018864207,0.0028128505,0.0005492564,0.0007103841,0.0000120851655,0.000023260045,0.0070746196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926585,0.000010704371,0.00012431838,0.00024873493,0.00013538501,0.00021498147],"domain_scores_gemma":[0.9994955,0.000021483986,0.000019708077,0.00027376882,0.000031696876,0.00015782758],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000029487444,0.0001181536,0.00019733305,0.00003279323,0.000053265718,0.000014807551,0.00004516859,0.000053287604,0.04157569],"category_scores_gemma":[0.0000045380075,0.00009569995,0.00009140085,0.00013957686,0.000032382366,0.000043098313,0.0000073311376,0.00007437192,0.00044162796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007351364,0.00018922734,0.584982,0.000025225472,0.000096210686,0.000116041614,0.00013366448,0.000008961745,0.000018028208,0.00021330039,0.036585916,0.37755796],"study_design_scores_gemma":[0.0014831634,0.00011120447,0.57748044,0.000069953116,0.00014794925,0.000013828107,0.0000083423065,0.000017992372,0.0019090767,0.00004796393,0.41861838,0.000091734946],"about_ca_topic_score_codex":0.0006818024,"about_ca_topic_score_gemma":0.00004729541,"teacher_disagreement_score":0.38203245,"about_ca_system_score_codex":0.00020928355,"about_ca_system_score_gemma":0.0001230806,"threshold_uncertainty_score":0.95930046},"labels":[],"label_agreement":null},{"id":"W1526094093","doi":"10.1038/modpathol.2015.77","title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","year":2015,"lang":"en","type":"review","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Serous carcinoma; Cancer; Ovarian cancer; Gynecology; Family medicine; Internal medicine","score_opus":0.3025764608946879,"score_gpt":0.4550846515028896,"score_spread":0.1525081906082017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526094093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033604116,0.9753452,0.0002446546,0.0070298384,0.0012054155,0.0019375915,0.010411373,0.00002729521,0.00043820872],"genre_scores_gemma":[0.0029480355,0.96008533,0.0042908653,0.0005792655,0.0010163032,0.00096930796,0.029869687,0.00006950831,0.00017171033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996361,0.00011517182,0.0023830917,0.00074354594,0.00022362883,0.0001735205],"domain_scores_gemma":[0.99324673,0.00032460017,0.0051253918,0.000927027,0.00030924045,0.000067003864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013927349,0.0002576816,0.0014108468,0.000079694866,0.00009797064,0.000032782435,0.00022331323,0.00021786493,0.000024829269],"category_scores_gemma":[0.0012062787,0.00017696458,0.00013170301,0.00009757654,0.00006471737,0.000074639116,0.0002430915,0.00023748407,8.3726945e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074376025,0.00017308896,0.012023995,0.0015128131,0.0005700501,0.00022479071,0.00079970004,0.0000038044725,0.000009226122,0.000064446984,0.0163255,0.9682182],"study_design_scores_gemma":[0.001052593,0.00022078076,0.0039808145,0.0033424979,0.0021284285,0.00037009094,0.00012458352,0.0005887403,0.0000059362173,0.00017123643,0.98781157,0.00020275876],"about_ca_topic_score_codex":0.0003909742,"about_ca_topic_score_gemma":0.00046891684,"teacher_disagreement_score":0.97148603,"about_ca_system_score_codex":0.0003912019,"about_ca_system_score_gemma":0.0013772963,"threshold_uncertainty_score":0.7216406},"labels":[],"label_agreement":null},{"id":"W1527338770","doi":"10.1002/ijc.29386","title":"Factors influencing ovulation and the risk of ovarian cancer in <scp><i>BRCA1</i></scp> and <scp><i>BRCA2</i></scp> mutation carriers","year":2014,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Women's College Hospital","funders":"Canadian Cancer Society Research Institute; National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Ovarian cancer; Medicine; BRCA mutation; Context (archaeology); Gynecology; Ovulation; Quartile; Obstetrics; Case-control study; Internal medicine; Cancer; Confidence interval; Biology; Hormone","score_opus":0.011367686281143465,"score_gpt":0.28695132712332955,"score_spread":0.27558364084218606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527338770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913001,0.0057690227,0.00027139278,0.0012300764,0.00077537255,0.00022375732,0.000047429305,0.0000060298626,0.00037678579],"genre_scores_gemma":[0.9942004,0.004729813,0.00014259625,0.0003661375,0.00046211635,0.00002653272,0.0000050025465,0.00001996824,0.000047408823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982813,0.00012688078,0.00061465666,0.00019195923,0.0006153183,0.00016990057],"domain_scores_gemma":[0.9973251,0.0010320519,0.0008720993,0.000113477996,0.00052798766,0.00012926482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006054526,0.00018219497,0.00042362724,0.0002731304,0.00005835047,0.000056601257,0.00012686723,0.000088258115,0.000024134899],"category_scores_gemma":[0.00084770756,0.000118912416,0.0001209539,0.00015642338,0.00017102323,0.000259877,0.000037154154,0.0002850348,3.8818905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114402435,0.00006367407,0.9590475,0.000041203275,0.0011930178,0.000017550814,0.0066720247,0.0036667828,0.0005264667,0.0007971904,0.00027583083,0.027584359],"study_design_scores_gemma":[0.008535397,0.00015899404,0.97859067,0.0005301285,0.00050749705,0.000039068113,0.0012850992,0.0013400061,0.0037970778,0.0016538065,0.0035276494,0.000034590226],"about_ca_topic_score_codex":0.0026943297,"about_ca_topic_score_gemma":0.0010379663,"teacher_disagreement_score":0.027549768,"about_ca_system_score_codex":0.00034131465,"about_ca_system_score_gemma":0.00024584864,"threshold_uncertainty_score":0.48491076},"labels":[],"label_agreement":null},{"id":"W1534818217","doi":"10.21236/ada554207","title":"Elucidation of Molecular Alterations in Precursor Lesions of Ovarian Serous Carcinoma","year":2011,"lang":"en","type":"report","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian carcinoma; Serous fluid; Serous carcinoma; Cancer research; Pathology; Chemistry; Medicine; Internal medicine; Ovarian cancer; Cancer","score_opus":0.058321972113876616,"score_gpt":0.3193756807111238,"score_spread":0.2610537085972472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1534818217","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29790354,0.0046637775,0.0017526826,0.0011240463,0.00093140645,0.0048932815,0.00041924193,0.000054507953,0.6882575],"genre_scores_gemma":[0.9922806,0.00068989437,0.0027881644,0.000032312942,0.000067644665,0.00023516205,0.00046617456,0.000034814497,0.0034052185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835324,0.000043643027,0.0007046447,0.00031474585,0.0004343254,0.00014938028],"domain_scores_gemma":[0.9984907,0.000038401962,0.00036574109,0.00055496074,0.00047066255,0.00007952434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021117339,0.00020270035,0.0006797676,0.00033632023,0.000014417688,0.0000040458863,0.00006783874,0.00024236676,0.0007383202],"category_scores_gemma":[0.00008503256,0.00016929775,0.00018598861,0.00022120618,0.000038862818,0.000037538426,0.000032496548,0.00015755215,0.00000770541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00106947,0.017821265,0.7401761,0.009580311,0.004760908,0.0017088823,0.004904821,0.00012318642,0.0136170285,0.023726922,0.054956026,0.12755512],"study_design_scores_gemma":[0.0042006574,0.0016770185,0.83585984,0.0026868568,0.0021802366,0.00015789211,0.00012134054,0.000050167288,0.14121155,0.00033323807,0.01107807,0.0004431052],"about_ca_topic_score_codex":0.007891352,"about_ca_topic_score_gemma":0.00081965287,"teacher_disagreement_score":0.69437706,"about_ca_system_score_codex":0.00026053528,"about_ca_system_score_gemma":0.001610309,"threshold_uncertainty_score":0.99871516},"labels":[],"label_agreement":null},{"id":"W1551799872","doi":"10.1002/ijc.28741","title":"17β‐estradiol upregulates GREB1 and accelerates ovarian tumor progression <i>in vivo</i>","year":2014,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Institute of Gender and Health; Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Ovarian cancer; Downregulation and upregulation; Gene knockdown; Cancer research; Tumor progression; Biology; Ovarian tumor; Microarray analysis techniques; Estrogen; In vivo; Cancer; Internal medicine; Medicine; Cell culture; Endocrinology; Gene expression; Gene","score_opus":0.011054332529476662,"score_gpt":0.32708836843561023,"score_spread":0.31603403590613355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551799872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810223,0.0035572117,0.00005958374,0.01309203,0.0009310002,0.00014591479,0.000011504034,0.000008123368,0.001172319],"genre_scores_gemma":[0.9966168,0.00080231385,0.0008244416,0.0007774931,0.0008605988,0.000015647454,0.000001452955,0.0000125186725,0.000088777946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905187,0.000023787317,0.00032776585,0.000126294,0.00035439598,0.00011588569],"domain_scores_gemma":[0.99929655,0.000060185987,0.000227292,0.000067591754,0.00024189323,0.00010650857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016560503,0.00010568636,0.00023268275,0.00013543009,0.000018278788,0.000051712603,0.00010135034,0.000034073124,0.0003172551],"category_scores_gemma":[0.000029088598,0.00007516956,0.00006677469,0.000059059403,0.000039867657,0.00015123218,0.000020789299,0.00012631324,0.0000017623819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086467597,0.00041666464,0.8417152,0.00003864023,0.0005565831,0.00041942144,0.0002649036,0.00011997022,0.0057849274,0.001349053,0.002737991,0.14573197],"study_design_scores_gemma":[0.0092894845,0.0007125353,0.89583486,0.0023123724,0.00019142756,0.00093918375,0.000044050077,0.00072324695,0.040151842,0.0015847562,0.04803254,0.00018369361],"about_ca_topic_score_codex":0.0000837274,"about_ca_topic_score_gemma":0.000041791467,"teacher_disagreement_score":0.14554828,"about_ca_system_score_codex":0.0001690408,"about_ca_system_score_gemma":0.00012616772,"threshold_uncertainty_score":0.34737208},"labels":[],"label_agreement":null},{"id":"W1558773828","doi":"10.1002/ijc.28064","title":"Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin","year":2013,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Ovarian cancer; Serous fluid; Medicine; Tubal ligation; Fallopian tube; Population; Oncology; Internal medicine; Ovary; Case-control study; Logistic regression; Gynecology; Pathology; Cancer; Family planning","score_opus":0.013795060317339855,"score_gpt":0.3174445559659699,"score_spread":0.30364949564863003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558773828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874536,0.0057347855,0.0004150495,0.0031629386,0.0019225716,0.00038515608,0.0005646971,0.0000053265007,0.00035588254],"genre_scores_gemma":[0.9934691,0.003946759,0.0008053331,0.00030181912,0.00060320005,0.00012908003,0.000008503343,0.00002295044,0.00071321713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986961,0.000019162473,0.00051975535,0.00014294036,0.000456661,0.00016540734],"domain_scores_gemma":[0.9977194,0.0001254366,0.00083571696,0.000099884004,0.001089328,0.00013020476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011786449,0.00014704157,0.0003773616,0.00012995349,0.000025155201,0.000027772518,0.00018330387,0.000043167103,0.0015159313],"category_scores_gemma":[0.000039173636,0.00010479518,0.00025444923,0.00007769207,0.000044873796,0.00017642301,0.00001661201,0.00013719097,0.0000048770244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001167664,0.00091366045,0.8745946,0.00008852122,0.0024630246,0.000036095935,0.00042759025,0.00024349694,0.007730571,0.00017003334,0.07717213,0.034992594],"study_design_scores_gemma":[0.025041401,0.001322004,0.5203158,0.001431999,0.0013880845,0.000046391582,0.00022750658,0.0004045401,0.17626673,0.0009692714,0.2722082,0.00037801272],"about_ca_topic_score_codex":0.0045622415,"about_ca_topic_score_gemma":0.00010268778,"teacher_disagreement_score":0.35427877,"about_ca_system_score_codex":0.00041305713,"about_ca_system_score_gemma":0.00041178532,"threshold_uncertainty_score":0.9993968},"labels":[],"label_agreement":null},{"id":"W1564356745","doi":"10.1111/j.1399-0004.2012.01906.x","title":"Estimating survival rates after ovarian cancer among women tested for <scp>BRCA1</scp> and <scp>BRCA2</scp> mutations","year":2012,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Medicine; Survival rate; Oncology; Cohort; Internal medicine; Cancer; Survival analysis; Overall survival; Stage (stratigraphy); Chemotherapy; Gynecology; Biology","score_opus":0.05922702322410079,"score_gpt":0.3810337619311347,"score_spread":0.3218067387070339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564356745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916395,0.0036737283,0.0010231612,0.0003631274,0.00142648,0.0010530575,0.00012223629,0.00007145532,0.000627245],"genre_scores_gemma":[0.9698134,0.00058931456,0.024340019,0.0007627351,0.001998369,0.0012115305,0.000069814014,0.00008406585,0.0011307516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747545,0.000115982235,0.000831071,0.0005246364,0.000258351,0.0007945163],"domain_scores_gemma":[0.9943989,0.003896887,0.00026549317,0.00042673058,0.00023284904,0.0007791374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007860071,0.00032152326,0.00066828704,0.000076590244,0.00017044834,0.00008225433,0.00010483626,0.0002829563,0.000055862896],"category_scores_gemma":[0.0022312142,0.00027569904,0.00017794242,0.00022256437,0.00030455907,0.00010119041,0.000096180614,0.00026918828,0.000029916619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015341915,0.0006519581,0.9825401,0.00013173436,0.00042908094,0.000011232422,0.0016157393,0.0000780535,0.000032413365,0.000054155174,0.001634399,0.012805827],"study_design_scores_gemma":[0.0038334478,0.00063026825,0.97619617,0.00016151207,0.0006591099,0.000007367267,0.0005369021,0.0030553418,0.0003674809,0.00031436258,0.014161615,0.0000764342],"about_ca_topic_score_codex":0.000045563305,"about_ca_topic_score_gemma":0.000051608236,"teacher_disagreement_score":0.023316858,"about_ca_system_score_codex":0.00014025724,"about_ca_system_score_gemma":0.00021476496,"threshold_uncertainty_score":0.99996954},"labels":[],"label_agreement":null},{"id":"W1565050438","doi":"","title":"The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Liter; Medicine; Internal medicine; Gastroenterology; Cancer; Biomarker; Hazard ratio; Stage (stratigraphy); Serous cystadenocarcinoma; Debulking; Oncology; Confidence interval; Biology","score_opus":0.0674270622762505,"score_gpt":0.30990700646239305,"score_spread":0.24247994418614255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565050438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557156,0.0077401362,0.00009966783,0.01928349,0.00056993973,0.011029621,0.0002954338,0.000060993116,0.0052051498],"genre_scores_gemma":[0.96736455,0.0007091657,0.0001709928,0.00018087195,0.000063823994,0.030747633,0.000014942398,0.000019754441,0.0007282718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988892,0.00003461909,0.00028345126,0.0002934369,0.00017652153,0.0003227786],"domain_scores_gemma":[0.9991792,0.00017859114,0.00014410661,0.00023813681,0.00012749908,0.0001324567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003431876,0.00013176705,0.00023133497,0.000028768016,0.0001580384,0.000038940234,0.00005150698,0.0000647282,0.00006517336],"category_scores_gemma":[0.00019797657,0.00008930276,0.00008244929,0.00013462837,0.00009833833,0.00005933952,0.000015894035,0.00004344935,5.280271e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017413321,0.000676896,0.8552722,0.00012295731,0.00061152095,0.000002966143,0.00010936195,8.300618e-7,0.0002041506,0.0050039175,0.0074843843,0.13033669],"study_design_scores_gemma":[0.004183793,0.00009998379,0.9358497,0.000050757775,0.00030177226,0.0000032850542,0.000029563085,0.000022760729,0.016042914,0.00017438734,0.043149415,0.00009165007],"about_ca_topic_score_codex":0.00016711568,"about_ca_topic_score_gemma":0.00013467242,"teacher_disagreement_score":0.13024503,"about_ca_system_score_codex":0.000097418604,"about_ca_system_score_gemma":0.000059877515,"threshold_uncertainty_score":0.36416608},"labels":[],"label_agreement":null},{"id":"W1570210889","doi":"10.1111/j.1442-2042.2006.01575.x","title":"Intratesticular borderline serous tumor","year":2006,"lang":"en","type":"article","venue":"International Journal of Urology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Serous fluid; General surgery; Internal medicine","score_opus":0.007147200472079221,"score_gpt":0.2745798770873588,"score_spread":0.2674326766152796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1570210889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95344263,0.0018368865,0.0016926298,0.03878527,0.0015322005,0.000081327235,0.000008410844,0.0000126322275,0.0026079915],"genre_scores_gemma":[0.9949456,0.00006845916,0.0016193032,0.0020684318,0.001192796,0.0000022707864,0.000008896919,0.000008248188,0.00008598075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926513,0.000018759696,0.00031422195,0.000077035846,0.00023031996,0.000094505405],"domain_scores_gemma":[0.9991984,0.000057312096,0.00019239286,0.00006117956,0.00044019267,0.000050516526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094692325,0.0000691348,0.00017233664,0.000120075325,0.000011003765,0.000012496379,0.00009440385,0.00003163973,0.0002853704],"category_scores_gemma":[0.000056460052,0.000052410764,0.000088832545,0.000041487034,0.000034813962,0.000044391192,0.000014447617,0.00012219512,0.000023439932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039357,0.0063151177,0.7739872,0.00003158364,0.0034077237,0.055051684,0.00014526585,0.0049403273,0.010293593,0.03256397,0.053419482,0.05590837],"study_design_scores_gemma":[0.011380906,0.0035556783,0.66951895,0.00007546267,0.00057044195,0.033195287,0.000023700288,0.0007313704,0.0044817957,0.008840194,0.26743942,0.0001867808],"about_ca_topic_score_codex":0.00005423954,"about_ca_topic_score_gemma":0.0000127417325,"teacher_disagreement_score":0.21401994,"about_ca_system_score_codex":0.00008146111,"about_ca_system_score_gemma":0.000116284566,"threshold_uncertainty_score":0.31246057},"labels":[],"label_agreement":null},{"id":"W1571075157","doi":"10.1002/cncr.26618","title":"Reclassification of serous ovarian carcinoma by a 2‐tier system","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Serous carcinoma; Hazard ratio; Serous fluid; Ovarian carcinoma; Stage (stratigraphy); Internal medicine; Gynecologic oncology; Confidence interval; Oncology; Multivariate analysis; Gynecology; Ovarian cancer; Cancer","score_opus":0.05355123337613995,"score_gpt":0.2650168739257673,"score_spread":0.21146564054962733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1571075157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370355,0.0066288784,0.0003267518,0.0011116874,0.0007655122,0.00079919177,0.00014496408,0.00008876474,0.05309876],"genre_scores_gemma":[0.99795055,0.00011796256,0.00041004532,0.00012354962,0.000097629,0.00022731918,0.000015857626,0.000017787714,0.0010392662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993626,0.00001696049,0.00018296999,0.00019318443,0.000117838616,0.00012645799],"domain_scores_gemma":[0.99942815,0.000008532875,0.000098106306,0.00028898867,0.000090041074,0.00008620367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005229287,0.000091202615,0.00021061832,0.000036410693,0.00002415883,0.0000032185822,0.000045551868,0.00006107493,0.00041915313],"category_scores_gemma":[0.0000042403794,0.00007329616,0.000055534267,0.000112407906,0.000032337248,0.00003326557,0.000008845259,0.0000486655,0.000022465625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005903528,0.0008955388,0.86226606,0.0009474743,0.0005837333,0.00006835683,0.0030035065,0.0000010360475,0.007450257,0.007401904,0.052700404,0.06409139],"study_design_scores_gemma":[0.0036725823,0.0005531403,0.8682268,0.0005561559,0.00063583144,0.00003578097,0.00056550937,0.00012358917,0.094824545,0.00003604059,0.030554807,0.00021520964],"about_ca_topic_score_codex":0.001395113,"about_ca_topic_score_gemma":0.00001997792,"teacher_disagreement_score":0.08737429,"about_ca_system_score_codex":0.00030352743,"about_ca_system_score_gemma":0.00012763198,"threshold_uncertainty_score":0.45894328},"labels":[],"label_agreement":null},{"id":"W1593071362","doi":"10.1155/2015/183243","title":"Primary Fallopian Tube Clear Cell Adenocarcinoma in Pregnancy: Case Presentation and Review of the Literature","year":2015,"lang":"en","type":"article","venue":"Case Reports in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"King Abdulaziz University","keywords":"Medicine; Pregnancy; Fallopian tube; Laparotomy; Adnexal mass; Fallopian tube cancer; Pelvic pain; Presentation (obstetrics); Histopathology; Clear-cell adenocarcinoma; Obstetrics; Adenocarcinoma; Uterus; Gynecology; Surgery; Cancer; Pathology; Ovarian cancer; Internal medicine","score_opus":0.02142638416849081,"score_gpt":0.27326196752590637,"score_spread":0.25183558335741557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593071362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6774849,0.32008356,2.8057238e-7,0.0004866754,0.00032143373,0.00065260875,0.0000059009076,0.0000031612437,0.0009614635],"genre_scores_gemma":[0.96010584,0.03911544,0.00013643998,0.00038354375,0.00001454896,0.000054046464,0.000013176223,0.000009912899,0.00016702959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989132,0.00009331497,0.00046058028,0.00028039113,0.00011175339,0.00014076072],"domain_scores_gemma":[0.9986133,0.0006645094,0.00020273343,0.000306919,0.00010925933,0.00010329345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002653169,0.00010865546,0.00035190352,0.00013445222,0.000024134095,0.000010064684,0.000016540738,0.00012252,0.0000075371477],"category_scores_gemma":[0.0020570487,0.00007792501,0.00003754937,0.00047305712,0.000060586848,0.0000510579,0.000069211404,0.00017281527,1.6511011e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010935351,0.00024622702,0.49718896,0.0033953448,0.000016238733,0.47796878,0.0009136431,0.0000027933097,0.0000023097443,0.000058967278,0.00027725668,0.019918537],"study_design_scores_gemma":[0.0055883233,0.0011843613,0.51271373,0.010564997,0.00040766137,0.45298156,0.0007063319,0.00008025245,0.0001812756,0.00033756564,0.0149660455,0.00028788572],"about_ca_topic_score_codex":0.00012352706,"about_ca_topic_score_gemma":0.00011577967,"teacher_disagreement_score":0.28262094,"about_ca_system_score_codex":0.00018443381,"about_ca_system_score_gemma":0.00019752068,"threshold_uncertainty_score":0.317769},"labels":[],"label_agreement":null},{"id":"W1594350035","doi":"10.1002/path.4516","title":"Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden","year":2015,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"Canadian Cancer Society Research Institute; BC Cancer Foundation; VGH and UBC Hospital Foundation","keywords":"Endometriosis; Malignant transformation; ARID1A; Cancer research; Carcinoma; Somatic cell; Mutation; Clear cell carcinoma; Biology; Cancer; Pathology; Medicine; Gene; Genetics","score_opus":0.040606367406022206,"score_gpt":0.30295750629312834,"score_spread":0.26235113888710615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594350035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898332,0.0028203854,0.00010970186,0.0068620713,0.00018393285,0.00012147611,0.000016488324,0.000004963864,0.000047782232],"genre_scores_gemma":[0.99888164,0.00029832992,0.0002627639,0.00024523522,0.00022224513,0.0000053833674,0.000003241409,0.000009637395,0.00007153686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927163,0.0001513247,0.00018723214,0.000069178146,0.0002019299,0.000118726566],"domain_scores_gemma":[0.99897844,0.00026992286,0.0002830215,0.00007794387,0.00026789872,0.0001227802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000413765,0.00007978092,0.00027538193,0.00009826993,0.00004369263,0.0000059633935,0.000040429375,0.0000556535,0.000027306247],"category_scores_gemma":[0.000286804,0.00004112343,0.000031624386,0.00013206614,0.00009272288,0.0000346269,0.00001155375,0.00018471504,0.000001915706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066969553,0.001873418,0.85809255,0.000084496394,0.0033096,0.029564183,0.020937905,0.0045163804,0.004445467,0.00037561613,0.007188196,0.06291526],"study_design_scores_gemma":[0.0123229,0.0029093227,0.97144526,0.00033650702,0.0014849724,0.008543173,0.0017340755,0.00011988731,0.00055095274,0.00020242993,0.00025700027,0.00009350363],"about_ca_topic_score_codex":0.00021595061,"about_ca_topic_score_gemma":0.0001738065,"teacher_disagreement_score":0.11335275,"about_ca_system_score_codex":0.00017707654,"about_ca_system_score_gemma":0.00020764404,"threshold_uncertainty_score":0.16769648},"labels":[],"label_agreement":null},{"id":"W1608269846","doi":"10.1002/cncr.29082","title":"Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials","year":2014,"lang":"en","type":"review","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical endpoint; Ovarian cancer; Oncology; Clinical trial; Internal medicine; Progression-free survival; Cancer; Disease; Chemotherapy","score_opus":0.24179199521495473,"score_gpt":0.5021888484501298,"score_spread":0.26039685323517503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608269846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041500336,0.98858714,0.000017576205,0.0012978519,0.0041936673,0.003180651,0.001494984,0.000059210317,0.0007539091],"genre_scores_gemma":[0.00074845017,0.98825055,0.000099159886,0.00025065625,0.007169159,0.002566593,0.00032059746,0.0001697568,0.00042508982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925764,0.001699354,0.0029078263,0.0014179524,0.0006491061,0.00074933626],"domain_scores_gemma":[0.9943478,0.0024442254,0.0013512626,0.001109338,0.00012427437,0.0006230839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004275648,0.00092461397,0.0087056365,0.00031506055,0.000066581226,0.0000909178,0.00040715456,0.0008557844,0.0008372554],"category_scores_gemma":[0.001263743,0.0006365485,0.0011507535,0.00033246464,0.0002526239,0.00009773962,0.00035199334,0.0011462073,0.00003719546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017554093,0.0002273433,0.048981793,0.008343586,0.001624868,0.00013117722,0.000044119406,9.372871e-8,7.182224e-8,0.00013892514,0.0061579645,0.93417454],"study_design_scores_gemma":[0.008272223,0.00033091486,0.07898993,0.04604124,0.004793284,0.000008863559,0.0000039349216,0.000001627747,0.0000012802232,0.0000822843,0.8609168,0.0005575972],"about_ca_topic_score_codex":0.00096148165,"about_ca_topic_score_gemma":0.0009801028,"teacher_disagreement_score":0.93361694,"about_ca_system_score_codex":0.00093628967,"about_ca_system_score_gemma":0.0019468652,"threshold_uncertainty_score":0.9996086},"labels":[],"label_agreement":null},{"id":"W1608658514","doi":"10.1186/s12885-015-1511-7","title":"Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers","year":2015,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Sherbrooke","keywords":"Medicine; Serous fluid; Ascites; Internal medicine; Oncology; Serous carcinoma; SuPAR; Surgical oncology; Ovarian cancer; Biomarker; Gastroenterology; Cancer; Plasminogen activator; Urokinase receptor","score_opus":0.02578966665713712,"score_gpt":0.3048801611258162,"score_spread":0.27909049446867906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608658514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940258,0.0022754825,0.000013153821,0.0010817089,0.00030787836,0.00078311894,0.000098134406,0.000024221641,0.0013904991],"genre_scores_gemma":[0.99780613,0.00016548927,0.0013071488,0.000021970764,0.0001377508,0.0002523871,0.000019252266,0.000024767283,0.0002650879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984112,0.000097279386,0.00042327517,0.00036320213,0.0004440405,0.00026099768],"domain_scores_gemma":[0.99900955,0.00019990049,0.00021263113,0.00028748845,0.00012668574,0.00016375334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039472198,0.00019748449,0.00041905636,0.00020108177,0.00003250197,0.000017557391,0.00009081305,0.0000840582,0.00004084982],"category_scores_gemma":[0.00032506324,0.00016275894,0.000047636833,0.00042723297,0.00012482832,0.00015140856,0.000059731916,0.00011418776,7.589779e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015381168,0.00007323424,0.9898208,0.00017350838,0.00010302533,0.000016288332,0.0038297407,0.0003177271,0.00025196848,0.00018702282,0.00026857248,0.00341999],"study_design_scores_gemma":[0.008269752,0.00015641934,0.9797548,0.001691045,0.000077976954,0.0000017908064,0.0018444341,0.00042395532,0.006491598,0.0005850084,0.0005186596,0.00018453044],"about_ca_topic_score_codex":0.015623555,"about_ca_topic_score_gemma":0.072655685,"teacher_disagreement_score":0.057032127,"about_ca_system_score_codex":0.0010040903,"about_ca_system_score_gemma":0.001129751,"threshold_uncertainty_score":0.9909315},"labels":[],"label_agreement":null},{"id":"W161468253","doi":"10.1016/s1701-2163(15)30996-8","title":"Are Too Many Imaging Tests Being Performed in Women With an Adnexal Mass?","year":2013,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Adnexal mass; Adnexal Diseases; Laparotomy; Radiology; Obstetrics; Referral; Logistic regression; Body mass index; Obstetrics and gynaecology; Pelvic examination; Work-up; Gynecology; Pregnancy; Laparoscopy; Internal medicine; Family medicine","score_opus":0.008083137779321365,"score_gpt":0.2212788907099937,"score_spread":0.21319575293067233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W161468253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953547,0.0011911541,0.000003179953,0.0016534753,0.0009960291,0.00015776395,0.0000028122945,0.0000023624718,0.00063851144],"genre_scores_gemma":[0.99768436,0.0000980043,0.00061704015,0.001474767,0.000032568445,0.000016318321,9.0612644e-7,0.000012743758,0.000063315376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898887,0.000025520914,0.0003087462,0.00013690458,0.00023014848,0.00030983522],"domain_scores_gemma":[0.9986261,0.0004343315,0.00030022993,0.000105892905,0.00021200938,0.0003214523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012915344,0.00012302383,0.00036456692,0.00023158905,0.00005570501,0.000032933076,0.00006296957,0.000047417067,0.0004777517],"category_scores_gemma":[0.00041482446,0.000087033,0.000018357676,0.00023353018,0.00003359016,0.00016155536,0.00001390445,0.0002554171,7.293396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013517105,0.00010171258,0.9239745,0.000024701329,0.00006937416,0.0047987537,0.000120336736,0.000014719425,0.0000068475456,0.000013087388,0.00054794207,0.07031452],"study_design_scores_gemma":[0.0037754455,0.00077764376,0.9921881,0.0000265136,0.0000504149,0.00015462075,0.0012124376,0.00013098605,0.000019068351,0.00010039854,0.0014718984,0.00009245281],"about_ca_topic_score_codex":0.010193072,"about_ca_topic_score_gemma":0.015908169,"teacher_disagreement_score":0.070222065,"about_ca_system_score_codex":0.0020749979,"about_ca_system_score_gemma":0.0010457686,"threshold_uncertainty_score":0.99639815},"labels":[],"label_agreement":null},{"id":"W165611170","doi":"10.1007/978-1-4419-9751-7_17","title":"Fallopian Tube and Peritoneum","year":2011,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Peritoneum; Fallopian tube; Tube (container); Medicine; Anatomy; Engineering; Mechanical engineering","score_opus":0.030780331631012018,"score_gpt":0.2405231483709752,"score_spread":0.20974281673996317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W165611170","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012323608,0.0023996453,0.0000038352364,0.001240826,0.00015952758,0.000290593,0.000015543794,0.000047803744,0.995719],"genre_scores_gemma":[0.01398318,0.0038086635,0.0004097033,0.00094015675,0.0002689975,0.00001850685,0.000033339908,0.000052045016,0.9804854],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931973,0.0000016927717,0.00014188999,0.00030268673,0.00011522075,0.00011879211],"domain_scores_gemma":[0.9994878,0.000011724816,0.000037147856,0.0002725427,0.000034500375,0.00015624972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000022007644,0.00022001928,0.00035899322,0.00006034194,0.000027097645,0.0000115531875,0.000027761103,0.00019508043,0.007836195],"category_scores_gemma":[0.0000018010755,0.00016175138,0.0000937281,0.000004958667,0.000059628608,0.000017252074,0.000035426274,0.00013750879,0.00021589153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086552456,0.00013337092,0.004387106,0.00023854109,0.0009399331,0.00063610077,0.00020880652,1.0640233e-8,0.000008412003,0.8889881,0.026949385,0.07742373],"study_design_scores_gemma":[0.00079122995,0.00043903658,0.005814947,0.00029844357,0.00045979375,0.000120448036,0.0000047350677,6.434659e-7,0.00006954087,0.0041642333,0.98763406,0.0002028762],"about_ca_topic_score_codex":0.00009105259,"about_ca_topic_score_gemma":0.000050833685,"teacher_disagreement_score":0.9606847,"about_ca_system_score_codex":0.00005343575,"about_ca_system_score_gemma":0.00006389505,"threshold_uncertainty_score":0.9930708},"labels":[],"label_agreement":null},{"id":"W1664711560","doi":"","title":"AAGL Stump the Professors Score: Experts 1, Presenters 2","year":2014,"lang":"en","type":"article","venue":"Contemporary OB/GYN Special Delivery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Session (web analytics); Medicine; Medical education; Business; Advertising","score_opus":0.059388033086175,"score_gpt":0.2822281197403662,"score_spread":0.22284008665419122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1664711560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72600967,0.0058365893,0.000090896945,0.02763748,0.004901359,0.0028247505,0.000045246223,0.00022467709,0.23242933],"genre_scores_gemma":[0.98629206,0.000252055,0.00006275211,0.0027306331,0.0057505174,0.00012729588,0.000048632373,0.000047739693,0.004688323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793047,0.00020859369,0.00045100017,0.00053732336,0.0005005429,0.00037209014],"domain_scores_gemma":[0.9984739,0.00020013956,0.00016027232,0.00079355476,0.0001329103,0.00023925737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031478825,0.00031747157,0.0005030132,0.00009383603,0.0002611156,0.00007167515,0.00025848244,0.000120395685,0.00051089015],"category_scores_gemma":[0.00008608742,0.00020852074,0.00027272807,0.00019406049,0.00020190571,0.00022576938,0.00013523208,0.00021767289,0.00021109947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011864902,0.0010548319,0.19429591,0.000106496045,0.00059105246,0.00038646758,0.0017983523,0.0000044050494,0.0001765196,0.0035821942,0.7544268,0.042390473],"study_design_scores_gemma":[0.004718504,0.00074726413,0.1411625,0.00033525063,0.00015655985,0.000031126696,0.001035036,0.00010918693,0.0012352932,0.00026795926,0.8498504,0.00035088445],"about_ca_topic_score_codex":0.0001819552,"about_ca_topic_score_gemma":0.00004890265,"teacher_disagreement_score":0.26028237,"about_ca_system_score_codex":0.0001630252,"about_ca_system_score_gemma":0.00026591693,"threshold_uncertainty_score":0.8503229},"labels":[],"label_agreement":null},{"id":"W1718276241","doi":"10.1016/j.ygyno.2015.06.019","title":"Why have ovarian cancer mortality rates declined? Part III. Prospects for the future","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Debulking; Case fatality rate; Oncology; Mortality rate; Disease; Cancer; Incidence (geometry); Population; Stage (stratigraphy); Gynecology; Internal medicine; Epidemiology; Environmental health; Biology","score_opus":0.13828505688273204,"score_gpt":0.44958799449292913,"score_spread":0.3113029376101971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1718276241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012030353,0.9685408,0.000019969824,0.01413084,0.005626836,0.008497651,0.00041084705,0.00010163483,0.0026593902],"genre_scores_gemma":[0.00002596602,0.96873623,0.00047228325,0.005551174,0.005474976,0.01742315,0.00048064947,0.00008037314,0.0017552064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996583,0.00031921064,0.0010027136,0.0010215347,0.00028987505,0.0007836772],"domain_scores_gemma":[0.9954321,0.0019924804,0.00087632705,0.00096926535,0.000407463,0.0003224093],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011267199,0.0007546171,0.0037474348,0.000103517836,0.00026581818,0.000045094628,0.00040951147,0.0012825843,0.0016408007],"category_scores_gemma":[0.00033018825,0.00039273532,0.0008897413,0.00027992667,0.000245525,0.000046830333,0.00015537327,0.0007127163,0.000064745334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069693764,0.0006573341,0.00089720055,0.0024632625,0.0019654061,0.00019123561,0.000050623647,0.0000015282093,1.6785242e-8,0.0006910486,0.27324286,0.7197698],"study_design_scores_gemma":[0.0032914332,0.0020149176,0.000994964,0.00095399265,0.010861804,0.00009670576,0.00009710576,0.000009415248,7.4272447e-7,0.00040629358,0.98089755,0.00037508807],"about_ca_topic_score_codex":0.00030401844,"about_ca_topic_score_gemma":0.0057641217,"teacher_disagreement_score":0.7193947,"about_ca_system_score_codex":0.0026600074,"about_ca_system_score_gemma":0.004892289,"threshold_uncertainty_score":0.9998525},"labels":[],"label_agreement":null},{"id":"W1722111647","doi":"","title":"Steroid cell tumor.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; hirsutism; Leydig Cell Tumor; Testosterone (patch); Ovary; Leydig cell; Pathology; Urology; Internal medicine; Hormone; Luteinizing hormone","score_opus":0.03201694062695316,"score_gpt":0.2109016200846496,"score_spread":0.17888467945769645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1722111647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.925843,0.0012172555,0.000005880747,0.0017775836,0.00020352626,0.000637408,0.000005026529,0.000059660568,0.07025067],"genre_scores_gemma":[0.9922302,0.00018153607,0.00014088178,0.0011081108,0.00016954151,0.0011022813,0.000005196384,0.000012247749,0.005050053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940914,0.000008247727,0.00009839548,0.0001465613,0.00012854597,0.00020913381],"domain_scores_gemma":[0.9996059,0.000016504488,0.000028227092,0.00018215607,0.000020157513,0.0001470371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043166725,0.000071050425,0.00013733223,0.000023971363,0.000038397375,0.0000046785663,0.000029469677,0.000018441659,0.00010517971],"category_scores_gemma":[0.000010147517,0.000055693294,0.0000569113,0.000067856345,0.000025084411,0.000026840187,0.000012854674,0.00004923288,0.00010898233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016586881,0.0013983531,0.83234185,0.00008245242,0.00013243593,0.0013230598,0.0002221072,0.0000021980206,0.0000638177,0.000094991956,0.07404145,0.09013144],"study_design_scores_gemma":[0.0017578012,0.000042323096,0.94481987,0.0000031783627,0.000039129824,0.000083509425,0.000006796379,0.0000014618611,0.00421003,0.000012136907,0.048970018,0.000053751784],"about_ca_topic_score_codex":0.00002355306,"about_ca_topic_score_gemma":0.0000024938886,"teacher_disagreement_score":0.11247803,"about_ca_system_score_codex":0.00007600818,"about_ca_system_score_gemma":0.000029134084,"threshold_uncertainty_score":0.22711065},"labels":[],"label_agreement":null},{"id":"W1750153791","doi":"10.14740/jcgo.v4i3.345","title":"Effectiveness and Safety of Cytoreduction Surgery in Advanced Ovarian Cancer: Initial Experience at a University General Hospital","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Surgery; Stage (stratigraphy); Referral; Ovarian carcinoma; Cytoreductive surgery; Cancer; General surgery; Internal medicine","score_opus":0.04891741309517386,"score_gpt":0.3659703418220997,"score_spread":0.3170529287269258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1750153791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494916,0.0021595303,0.000021941823,0.000506799,0.0021601936,0.0001416687,0.000006718796,0.0000023541568,0.0000516559],"genre_scores_gemma":[0.99306357,0.006399466,0.0003475804,0.000043199838,0.00012222065,0.000001617853,0.0000012630696,0.000004568073,0.000016518754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987627,0.00024036014,0.00058508274,0.00015872598,0.0001337066,0.00011938449],"domain_scores_gemma":[0.9946685,0.0043791,0.00044097498,0.000069708236,0.00022690733,0.00021483385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081811857,0.00008482879,0.0006639958,0.00015835142,0.000032387135,0.0000028260959,0.00003514647,0.00016964354,0.000013971304],"category_scores_gemma":[0.00391716,0.00007034516,0.000101808444,0.00023523561,0.0002022055,0.0001202407,0.000043968586,0.00021585151,2.4106635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026228107,0.0005186183,0.9426137,0.000039366423,0.00009521609,0.0004267832,0.00027420558,0.000035246503,0.000014137126,0.00006944475,0.000056792243,0.053233653],"study_design_scores_gemma":[0.008342083,0.0017983146,0.9869012,0.0001087237,0.000116616065,0.00006825392,0.00027410654,0.000023151228,0.00027087782,0.000052432253,0.0019798437,0.000064358006],"about_ca_topic_score_codex":0.000035829155,"about_ca_topic_score_gemma":0.000018776529,"teacher_disagreement_score":0.053169295,"about_ca_system_score_codex":0.00026329496,"about_ca_system_score_gemma":0.00042279836,"threshold_uncertainty_score":0.46894893},"labels":[],"label_agreement":null},{"id":"W17628674","doi":"10.1016/s1701-2163(16)34294-3","title":"Intermittent Right Lower Quadrant Pain and a Simple Cyst","year":2009,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cyst; Quadrant (abdomen); Surgery; Ovarian cyst; Emergency department; Nursing","score_opus":0.007848479361902944,"score_gpt":0.22939784778314706,"score_spread":0.22154936842124412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W17628674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762743,0.012137265,0.000047871006,0.0073397416,0.0031056334,0.00016152316,0.0000150656715,0.000003344399,0.0009152689],"genre_scores_gemma":[0.99621964,0.00035645976,0.0002016236,0.0030953567,0.000040692463,0.000001240336,0.000002080238,0.000005547593,0.00007733781],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99915516,0.000041012034,0.00032622594,0.00011771387,0.00018000774,0.00017986381],"domain_scores_gemma":[0.99857306,0.000757308,0.00018547989,0.00008955494,0.00013762074,0.00025698935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022769351,0.00010992451,0.0003539974,0.00012793952,0.00005926447,0.000017677978,0.000042020038,0.00006372447,0.00029607804],"category_scores_gemma":[0.000720465,0.00007671974,0.000050496496,0.00012870689,0.000030327308,0.000034705816,0.000012521197,0.00017516149,2.8179397e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028470764,0.00040755875,0.18154944,0.00003823644,0.00028197467,0.025250707,0.00009333129,0.000005116073,0.000015854042,0.0002851073,0.01875378,0.7732904],"study_design_scores_gemma":[0.003598927,0.003083222,0.8926889,0.000018190518,0.00018069701,0.0004583414,0.000100208046,0.00006917818,0.000024496769,0.00028679834,0.09939198,0.000099068406],"about_ca_topic_score_codex":0.003443085,"about_ca_topic_score_gemma":0.00893467,"teacher_disagreement_score":0.77319133,"about_ca_system_score_codex":0.0005898868,"about_ca_system_score_gemma":0.00063878216,"threshold_uncertainty_score":0.52049375},"labels":[],"label_agreement":null},{"id":"W1767210701","doi":"","title":"SOX11 but not SOX4 is a prognostic marker for improved recurrence free survival in epithelial ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Lund University Publications (Lund University)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Epithelial ovarian cancer; Internal medicine; Cancer research; SOX4; Cancer; Overall survival; Gene; Gene expression","score_opus":0.024304522060855677,"score_gpt":0.250047941781568,"score_spread":0.2257434197207123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1767210701","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11655382,0.00019610891,0.009183536,0.18902479,0.00094183907,0.0065280143,0.0052781478,0.0005424071,0.6717513],"genre_scores_gemma":[0.12841396,0.0015298502,0.010538665,0.0022770471,0.0004193032,0.000021234546,0.00052933226,0.000062119456,0.8562085],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983508,0.00007416725,0.00019510648,0.00069182797,0.00020501783,0.00048306736],"domain_scores_gemma":[0.9982032,0.00022755323,0.00015914784,0.0006958055,0.00040179945,0.00031246993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015885313,0.0002608207,0.0003873895,0.00084356003,0.00041656563,0.00006270121,0.0004931676,0.0001958484,0.00041434861],"category_scores_gemma":[0.00013379897,0.00027904808,0.0001961611,0.001590091,0.000120791905,0.00054628827,0.00011720912,0.00023647885,0.00001077406],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058549107,0.003948402,0.052053608,0.00015605628,0.00084991014,0.00024104324,0.0012678104,0.000019830315,0.0006394387,0.8831701,0.017033502,0.03476535],"study_design_scores_gemma":[0.007947015,0.00042381443,0.14108315,0.00009968367,0.00048579823,0.0000069151997,0.00063743023,0.0005689656,0.00011504169,0.00025940168,0.8480657,0.00030712332],"about_ca_topic_score_codex":0.0012870751,"about_ca_topic_score_gemma":0.0025900302,"teacher_disagreement_score":0.8829107,"about_ca_system_score_codex":0.0010885895,"about_ca_system_score_gemma":0.0010658487,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W1775707152","doi":"10.5430/jst.v3n3p9","title":"Prolonged response to trabectedin in a patient with carcinosarcoma of the ovary refractory to adjuvant platinum-taxane","year":2013,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Trabectedin; Medicine; Taxane; Carcinosarcoma; Refractory (planetary science); Carboplatin; Debulking; Tumor Debulking; Oncology; Internal medicine; Paclitaxel; Surgery; Chemotherapy; Sarcoma; Ovarian cancer; Cisplatin; Cancer; Soft tissue sarcoma; Pathology; Carcinoma; Breast cancer","score_opus":0.010234844596616072,"score_gpt":0.2494681665752239,"score_spread":0.2392333219786078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1775707152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897942,0.0001969364,0.0000041365706,0.008878042,0.00011135823,0.00091665017,0.000012023599,0.000004398635,0.00008226762],"genre_scores_gemma":[0.9982132,0.000008372729,0.0008046693,0.0007607945,0.000077152814,0.000059620535,4.613393e-7,0.000020318197,0.00005546643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837154,0.00012710299,0.0006224546,0.00014752815,0.0004999502,0.00023144786],"domain_scores_gemma":[0.9986752,0.00013027694,0.00039913694,0.0002719995,0.00026360663,0.00025977366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003058448,0.00015182183,0.00050780457,0.00026729426,0.000027671664,0.000008641515,0.00012460403,0.000039968134,0.00007817605],"category_scores_gemma":[0.00021660519,0.000081151906,0.00010321727,0.00039917376,0.000034974284,0.00007970134,0.00003790615,0.00028180788,0.000008477595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03726638,0.0046206373,0.76620835,0.00019337684,0.00056054187,0.005865497,0.026258582,0.0011847753,0.10962601,0.00001693025,0.013669343,0.034529593],"study_design_scores_gemma":[0.0028468326,0.007859548,0.9619654,0.001328867,0.00007216216,0.0007700824,0.0007559227,0.000010969276,0.023796719,0.000011305551,0.00049176347,0.00009045771],"about_ca_topic_score_codex":0.00018636331,"about_ca_topic_score_gemma":0.000082384904,"teacher_disagreement_score":0.19575705,"about_ca_system_score_codex":0.0003058465,"about_ca_system_score_gemma":0.00041016654,"threshold_uncertainty_score":0.33092788},"labels":[],"label_agreement":null},{"id":"W1788215754","doi":"10.3791/52721","title":"&lt;em&gt;In Vivo&lt;/em&gt; and &lt;em&gt;Ex Vivo&lt;/em&gt; Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose","year":2015,"lang":"en","type":"article","venue":"Journal of Visualized Experiments","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Elsa U. Pardee Foundation; U.S. Department of Defense","keywords":"Ovarian cancer; Ex vivo; Metastasis; Adipose tissue; Serous fluid; Peritoneal cavity; Pathology; Biology; Cancer; Cancer research; In vivo; Medicine; Internal medicine; Endocrinology; Anatomy","score_opus":0.07362853005894157,"score_gpt":0.37789288426237433,"score_spread":0.3042643542034328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1788215754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840867,0.011597928,0.00014791593,0.0004581923,0.0008917935,0.002446999,0.000106293235,0.000028559114,0.00023563752],"genre_scores_gemma":[0.99137396,0.0005392558,0.0066463924,0.00035613336,0.00041740283,0.00029011123,0.000028003346,0.00013260121,0.00021613033],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9935484,0.000669371,0.0021861815,0.0008543154,0.0019363539,0.000805378],"domain_scores_gemma":[0.9965817,0.00016328199,0.001211811,0.000608097,0.00052677817,0.00090834976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014740514,0.00080935925,0.002174298,0.0010574672,0.00013913674,0.00018893584,0.00040301698,0.00024530423,0.00069148006],"category_scores_gemma":[0.0002844025,0.0006760369,0.00027765462,0.001010699,0.00011527457,0.0004753459,0.00020109038,0.00040762816,0.0000075935995],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03904074,0.047385886,0.20439643,0.0014107716,0.014069356,0.0054400656,0.35243574,0.003617074,0.28911865,0.0028334889,0.015003659,0.025248125],"study_design_scores_gemma":[0.16681004,0.025411345,0.38677,0.003971207,0.005695911,0.0009363682,0.049145754,0.0036163437,0.34074023,0.00094937475,0.012770248,0.0031831805],"about_ca_topic_score_codex":0.0004025315,"about_ca_topic_score_gemma":0.0013890632,"teacher_disagreement_score":0.30328998,"about_ca_system_score_codex":0.0012594451,"about_ca_system_score_gemma":0.0007565141,"threshold_uncertainty_score":0.99956906},"labels":[],"label_agreement":null},{"id":"W1790943099","doi":"10.25011/cim.v31i4.4817","title":"GENOMIC AND TRANSCRIPTOME PROFILING OF EPITHELIAL OVARIAN CANCER","year":2008,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Serous fluid; Biology; Disease; Malignancy; SNP; Clear cell; Oncology; Cancer; SNP array; Transcriptome; Epithelial ovarian cancer; Internal medicine; Single-nucleotide polymorphism; Bioinformatics; Gene; Medicine; Carcinoma; Genetics; Genotype; Gene expression","score_opus":0.18617098868287385,"score_gpt":0.3628687379374329,"score_spread":0.17669774925455906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1790943099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96665674,0.0046906765,0.000028760136,0.027417755,0.00026531983,0.0003593678,0.00002458334,0.00001652937,0.0005402338],"genre_scores_gemma":[0.9885069,0.006897863,0.0016479458,0.00207909,0.0006055129,0.000035086545,0.000011616025,0.000013968642,0.00020201052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873215,0.00006454988,0.00056450866,0.00033319546,0.0001539385,0.00015168602],"domain_scores_gemma":[0.99915034,0.00012398844,0.00012530884,0.00014175235,0.00009130139,0.00036730155],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00028302582,0.00015557381,0.00068261306,0.000055846147,0.000069956666,0.0000016794544,0.000035596622,0.00008755391,0.00011586252],"category_scores_gemma":[0.00024272916,0.00009895086,0.000059308502,0.00011495198,0.0068261437,0.000045906843,0.000021620388,0.00020420286,0.0000019801112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013343914,0.00014386064,0.9675149,0.00013766729,0.0002164481,0.0000476997,0.0010614884,2.723259e-7,0.019806474,0.0033738802,0.00045932934,0.0071045915],"study_design_scores_gemma":[0.0061932234,0.0016314843,0.98038435,0.00047915932,0.00031877958,0.00005164742,0.000114734314,0.00005431072,0.0055305883,0.0030521164,0.0020917982,0.00009778477],"about_ca_topic_score_codex":0.00027659597,"about_ca_topic_score_gemma":0.000010344201,"teacher_disagreement_score":0.025338665,"about_ca_system_score_codex":0.000017540653,"about_ca_system_score_gemma":0.00016006819,"threshold_uncertainty_score":0.9958767},"labels":[],"label_agreement":null},{"id":"W1798828893","doi":"10.1007/s10528-015-9690-0","title":"Association Between Genetic Variants of Akt1 and Endometrial Cancer","year":2015,"lang":"en","type":"article","venue":"Biochemical Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Human genetics; Endometrial cancer; AKT1; Genetics; Computational biology; Genome-wide association study; Genetic association; Evolutionary biology; Cancer; Cancer research; Gene; Genotype; Single-nucleotide polymorphism; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.04697443274591353,"score_gpt":0.31228028923696843,"score_spread":0.2653058564910549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1798828893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914317,0.007138782,0.000038105485,0.0006606756,0.00015772035,0.00021261218,0.00006752234,0.000010345359,0.0002825164],"genre_scores_gemma":[0.99422246,0.0012596023,0.003707912,0.00006979032,0.00057326455,0.000019038649,0.000017539698,0.0000123171,0.000118064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991685,0.000017631093,0.00021541474,0.00018022534,0.0002720937,0.00014611073],"domain_scores_gemma":[0.99934757,0.00007486128,0.00010260619,0.0001397247,0.00013143504,0.00020378432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010010516,0.00009209815,0.0002548922,0.00004763003,0.000010224964,0.000007651537,0.000037585545,0.00012748163,0.00003463479],"category_scores_gemma":[0.00018897302,0.000080162405,0.00004244364,0.00015249506,0.000029823666,0.000007777706,0.000037607628,0.000056989447,0.0000049964874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006747676,0.00012483256,0.9694916,0.000037757924,0.00035365325,0.0000036000858,0.00006992086,0.0000018882117,0.012928692,0.000006849649,0.005268348,0.011645355],"study_design_scores_gemma":[0.005103311,0.00042396554,0.7932047,0.00005611131,0.0008234854,0.0000033247702,0.000012494045,0.00003452557,0.19519526,0.00013614715,0.0048933867,0.000113246504],"about_ca_topic_score_codex":0.00006801591,"about_ca_topic_score_gemma":0.000001544421,"teacher_disagreement_score":0.18226658,"about_ca_system_score_codex":0.00017351758,"about_ca_system_score_gemma":0.00013254072,"threshold_uncertainty_score":0.3268928},"labels":[],"label_agreement":null},{"id":"W1806756686","doi":"10.1200/jco.2010.28.15_suppl.5018","title":"Breast cancer protein expression as a prognostic marker in sporadic epithelial ovarian cancer (EOC): An NCIC CTG OV.16 correlative study.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Topotecan; Carboplatin; Internal medicine; Oncology; Ovarian cancer; Paclitaxel; Breast cancer; Immunohistochemistry; Tissue microarray; Debulking; Cisplatin; Progression-free survival; Cancer; Chemotherapy","score_opus":0.062083655998273916,"score_gpt":0.45545814546020036,"score_spread":0.39337448946192644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1806756686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833037,0.00032106874,0.0000122220235,0.010792455,0.0028342393,0.0016428434,0.000037624814,0.000014425566,0.0010414184],"genre_scores_gemma":[0.99449164,0.0002717663,0.00076501316,0.00071149203,0.0028485404,0.00029861418,0.0000039242855,0.000042664553,0.00056636427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954435,0.0007823125,0.002281462,0.0004789702,0.00059842225,0.00041532496],"domain_scores_gemma":[0.9956258,0.00096488814,0.0018141231,0.00035293648,0.00051434035,0.00072794664],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029565925,0.00029529087,0.0017577447,0.00022867147,0.000070821676,0.000022154267,0.00023294217,0.0005564633,0.0037685235],"category_scores_gemma":[0.0011226031,0.0001946126,0.00035125043,0.00028186146,0.00023480676,0.0002630043,0.000068886555,0.002328361,0.000027948734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0112312725,0.012406257,0.8188377,0.000024913084,0.00040864144,0.0017703685,0.00051231694,0.000011054345,0.00068656163,0.000051317264,0.00079504144,0.15326454],"study_design_scores_gemma":[0.020676317,0.012230452,0.95681876,0.00073063176,0.0006458698,0.0005715338,0.00032725645,0.00005422329,0.00015293446,0.00035494356,0.0072485507,0.00018852191],"about_ca_topic_score_codex":0.0023731159,"about_ca_topic_score_gemma":0.0064353966,"teacher_disagreement_score":0.15307602,"about_ca_system_score_codex":0.00058434554,"about_ca_system_score_gemma":0.004858306,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W1807036088","doi":"10.3109/01443615.2015.1004524","title":"Clinical risk factors for ovarian torsion","year":2015,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Ovarian torsion; Medicine; Odds ratio; Asymptomatic; Population; Odds; Obstetrics; Gynecology; Surgery; Internal medicine; Logistic regression","score_opus":0.12498815665014296,"score_gpt":0.4154608316516352,"score_spread":0.29047267500149226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1807036088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002723546,0.98720044,0.00005650082,0.000059583228,0.01135062,0.0007142995,0.00009069637,0.0000045508978,0.0002509385],"genre_scores_gemma":[0.00033995268,0.9971548,0.001817761,0.000042424446,0.0004399453,0.000015700056,0.000030905805,0.000036561887,0.00012199307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767125,0.00019169501,0.0014029222,0.0002566909,0.00021881347,0.0002586067],"domain_scores_gemma":[0.99074453,0.0062244516,0.0018589131,0.00020778016,0.0005294046,0.00043493754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011900673,0.00028637203,0.0029423102,0.00043779195,0.00007625599,0.000024386853,0.000116804076,0.00065835426,0.00012564515],"category_scores_gemma":[0.0076865708,0.00017138934,0.00097284396,0.00025209563,0.000056560482,0.000041840514,0.000056293684,0.0006377397,0.0000045784523],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010363001,0.00040653293,0.011192311,0.0014189848,0.00090889935,0.00023072319,0.000030930012,1.3404112e-7,7.704126e-10,0.00007267903,0.0039987774,0.9817297],"study_design_scores_gemma":[0.0032225421,0.0043271473,0.008834823,0.00036035568,0.006936169,0.00011966824,0.000034887715,0.0000024953222,4.7534897e-8,0.00009996484,0.9759264,0.00013549285],"about_ca_topic_score_codex":0.0000042692645,"about_ca_topic_score_gemma":9.0736546e-7,"teacher_disagreement_score":0.98159415,"about_ca_system_score_codex":0.00066006096,"about_ca_system_score_gemma":0.0012315251,"threshold_uncertainty_score":0.9202099},"labels":[],"label_agreement":null},{"id":"W1821275256","doi":"10.18632/oncotarget.3985","title":"Tumorigenesis and peritoneal colonization from fallopian tube epithelium","year":2015,"lang":"en","type":"article","venue":"Oncotarget","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; American Cancer Society; U.S. Department of Defense","keywords":"PTEN; Cancer research; KRAS; Carcinogenesis; Gene silencing; Biology; Ovarian cancer; Metastasis; Cancer; Medicine; Pathology; PI3K/AKT/mTOR pathway; Signal transduction; Cell biology; Genetics; Colorectal cancer","score_opus":0.02763677438634553,"score_gpt":0.2732839469577859,"score_spread":0.24564717257144036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1821275256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852205,0.0017319905,0.00008020601,0.005724662,0.000383131,0.00022567532,0.000055761186,0.000049590435,0.0032269214],"genre_scores_gemma":[0.9929336,0.00023648841,0.004687799,0.00076327036,0.00047705023,0.000036974143,0.0001553444,0.000021015421,0.0006884852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931145,0.00002331149,0.00012894187,0.00022716021,0.00016874618,0.00014040417],"domain_scores_gemma":[0.99945456,0.000024631692,0.00003486028,0.00016794328,0.00007818459,0.00023980872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006853244,0.00010886603,0.00021138239,0.000033220636,0.000042597538,0.000023203387,0.00003027835,0.00005601626,0.00016861335],"category_scores_gemma":[0.00003079036,0.000090264875,0.00003116786,0.00008292086,0.00003292885,0.000055055618,0.000022889015,0.000049509235,0.00007040374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001280693,0.00025251397,0.9847821,0.000013674615,0.00009509032,0.00010701572,0.00075896597,0.00000562258,0.00034239385,0.00034366138,0.010396358,0.0027745117],"study_design_scores_gemma":[0.0028471637,0.00051997066,0.8126968,0.00004761249,0.00016094597,0.000021102645,0.00017440882,0.00019923129,0.0021998181,0.00038818215,0.18060826,0.00013647464],"about_ca_topic_score_codex":0.00093329366,"about_ca_topic_score_gemma":0.0001134498,"teacher_disagreement_score":0.17208529,"about_ca_system_score_codex":0.00014365322,"about_ca_system_score_gemma":0.00015290942,"threshold_uncertainty_score":0.3680895},"labels":[],"label_agreement":null},{"id":"W1843076150","doi":"10.1016/j.ygyno.2015.06.017","title":"Why have ovarian cancer mortality rates declined? Part I. Incidence","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Incidence (geometry); Demography; Epidemiology; Mortality rate; Cancer; Case fatality rate; Gynecology; Parity (physics); Obstetrics; Internal medicine","score_opus":0.19984933680186442,"score_gpt":0.47631370600326356,"score_spread":0.27646436920139916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1843076150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008144698,0.98140585,0.000008044466,0.0037671153,0.0028868667,0.002841333,0.00026163578,0.00014591233,0.00860179],"genre_scores_gemma":[0.000053699274,0.9861762,0.0006177146,0.0052173925,0.0013654474,0.0041384767,0.0004884946,0.000080192534,0.0018624044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953424,0.0007197662,0.0013619836,0.0012866895,0.00042241113,0.0008667607],"domain_scores_gemma":[0.99572504,0.0012059492,0.0010265944,0.0010474825,0.00039937516,0.0005955904],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011876072,0.0008644338,0.005044525,0.00022341055,0.00013886673,0.000039237824,0.00041588783,0.0015449256,0.0050199884],"category_scores_gemma":[0.00076025847,0.0005977543,0.000744747,0.0004085478,0.00031913648,0.000083850595,0.00028584752,0.000910723,0.0004622172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002969625,0.00091119396,0.006140729,0.0028190725,0.0012871163,0.0016997451,0.000041173935,0.0000016699421,4.1091226e-8,0.00012293567,0.16092774,0.82601887],"study_design_scores_gemma":[0.0017387209,0.0018261602,0.0022162423,0.0026556514,0.007270748,0.00024952999,0.000032456315,0.000005032481,9.3011613e-7,0.0002809704,0.98321855,0.0005049894],"about_ca_topic_score_codex":0.0012218201,"about_ca_topic_score_gemma":0.0044283797,"teacher_disagreement_score":0.8255139,"about_ca_system_score_codex":0.0041779056,"about_ca_system_score_gemma":0.005711339,"threshold_uncertainty_score":0.9999254},"labels":[],"label_agreement":null},{"id":"W1850035702","doi":"10.1016/s1470-2045(15)00311-3","title":"Discordance between the results and conclusions of ICON7 – Authors' reply","year":2015,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Bevacizumab; Medicine; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Population; Overall survival; Cancer","score_opus":0.1103282341605306,"score_gpt":0.37946278162361025,"score_spread":0.26913454746307963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1850035702","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004537482,0.001974329,0.0000063048847,0.97711724,0.0005770014,0.0007634006,0.00063512113,0.00002950498,0.014359625],"genre_scores_gemma":[0.07448849,0.0021824285,0.00057732925,0.8942769,0.021063913,0.00025000103,0.0005742528,0.00006735936,0.006519297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980463,0.0004537971,0.00046632928,0.000388444,0.0002865567,0.0003586025],"domain_scores_gemma":[0.99664813,0.0015454447,0.0004650455,0.0011457932,0.00012254511,0.0000730657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001181442,0.00023862644,0.0012302805,0.000042422103,0.00012450933,0.000012495175,0.00032654888,0.00037992,0.00003384576],"category_scores_gemma":[0.00029840914,0.0001102203,0.00010348629,0.00012221509,0.00059609354,0.000018919254,0.00025443613,0.0013314349,0.00001970775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025934904,0.000038693004,0.0034831397,0.000077957346,0.00034865635,0.00021387551,0.0006480962,3.7814576e-7,0.000005093424,0.00016325532,0.98930854,0.0054529635],"study_design_scores_gemma":[0.00351029,0.0010266963,0.020324659,0.0001989915,0.0008311746,0.000104390405,0.000057583013,0.000003066063,0.000027408294,0.0011346812,0.97267383,0.00010720842],"about_ca_topic_score_codex":0.0003611723,"about_ca_topic_score_gemma":0.00005067762,"teacher_disagreement_score":0.0828403,"about_ca_system_score_codex":0.0002121746,"about_ca_system_score_gemma":0.0004889741,"threshold_uncertainty_score":0.5784496},"labels":[],"label_agreement":null},{"id":"W1852968667","doi":"10.1016/j.ygyno.2015.06.005","title":"Long-term mortality among women with epithelial ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Cause of death; Cancer; Stage (stratigraphy); Epidemiology; Disease; Internal medicine; Epithelial ovarian cancer; Gynecology; Oncology","score_opus":0.05131269534732253,"score_gpt":0.3451073308555909,"score_spread":0.2937946355082684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1852968667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799484,0.00023371703,0.000038084152,0.0032792275,0.0007921603,0.0008181309,0.000031131927,0.00011810485,0.014741041],"genre_scores_gemma":[0.9946777,0.00015206811,0.00049731456,0.0018836983,0.00042891764,0.0012879317,0.000026309912,0.000026453537,0.001019581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981636,0.00013510788,0.00030604567,0.00051552727,0.00025948402,0.000620244],"domain_scores_gemma":[0.9985074,0.00014743822,0.00018654922,0.00042203383,0.00017654971,0.0005600228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042949454,0.0002551504,0.0006955713,0.00007996057,0.000077381424,0.000018704215,0.00013053833,0.0002808586,0.0023456025],"category_scores_gemma":[0.00010270283,0.00017078241,0.000060861905,0.0002057936,0.00028688402,0.00008449798,0.00007382986,0.00025007804,0.00012149041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058481836,0.0011312308,0.96035117,0.000028686152,0.0005343894,0.0018121083,0.0006336427,0.0000274959,0.00003010808,0.00014950804,0.0014408942,0.03327592],"study_design_scores_gemma":[0.00794266,0.0063996986,0.9760516,0.000027965069,0.0003468671,0.00008100075,0.00020341433,0.000010322019,0.00016161434,0.000207734,0.008369474,0.00019763986],"about_ca_topic_score_codex":0.00064630277,"about_ca_topic_score_gemma":0.0029700254,"teacher_disagreement_score":0.033078283,"about_ca_system_score_codex":0.0025237997,"about_ca_system_score_gemma":0.0014066129,"threshold_uncertainty_score":0.9985664},"labels":[],"label_agreement":null},{"id":"W1867443899","doi":"10.3747/co.22.2482","title":"The Optimal Organization of Gynecologic Oncology Services: A Systematic Review","year":2015,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Mount Sinai Hospital; Cancer Care Ontario; University of Ottawa","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Gynecologic oncology; Ovarian cancer; MEDLINE; Guideline; Multidisciplinary approach; Surgical oncology; Internal medicine; Oncology; Endometrial cancer; Family medicine; Gynecology; Cancer; Pathology","score_opus":0.16778703538502962,"score_gpt":0.47183454428621885,"score_spread":0.30404750890118926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1867443899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014264954,0.99039084,0.000008163313,0.00049548835,0.0016903233,0.006447529,0.00004409559,0.000043440734,0.000878675],"genre_scores_gemma":[0.0000030195565,0.9971098,0.00009747755,0.00019314383,0.00022955237,0.0015852045,0.000608998,0.00005410508,0.00011872823],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604046,0.0010533558,0.0017635553,0.00046654345,0.0003229205,0.00035315714],"domain_scores_gemma":[0.994904,0.0011640434,0.0020725734,0.0008315629,0.0008281759,0.00019965338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013289026,0.00046639805,0.005920352,0.0001194647,0.00009178181,0.000013085447,0.0004253961,0.00048085756,0.00014017556],"category_scores_gemma":[0.0005534323,0.00024104449,0.00048036568,0.0006941782,0.0001413968,0.000031093525,0.00019047646,0.0004746327,0.00029282836],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003783055,0.00058520015,0.000012675385,0.6374783,0.0004886165,0.00003006584,0.000046612477,8.48037e-8,5.2462963e-9,0.00014932289,0.0029337502,0.3582716],"study_design_scores_gemma":[0.0004829707,0.00083308923,0.0000018227067,0.34193045,0.014959805,0.0002564894,0.000036256144,0.0000018137267,7.1010945e-8,0.000005405621,0.6413801,0.00011176705],"about_ca_topic_score_codex":0.0000047848343,"about_ca_topic_score_gemma":0.000012626084,"teacher_disagreement_score":0.63844633,"about_ca_system_score_codex":0.0024316672,"about_ca_system_score_gemma":0.003495182,"threshold_uncertainty_score":0.98295087},"labels":[],"label_agreement":null},{"id":"W1882737284","doi":"10.1111/his.12784","title":"Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non‐neoplastic remnants?","year":2015,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Sertoli cell; Pathology; Differential diagnosis; Biology; Immunohistochemistry; Medicine; Spermatogenesis; Endocrinology","score_opus":0.05056746819515919,"score_gpt":0.3072175443366826,"score_spread":0.2566500761415234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1882737284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97766227,0.001521307,0.0014287683,0.0059481133,0.002213199,0.0010930912,0.000041609444,0.00017543878,0.009916214],"genre_scores_gemma":[0.98156327,0.000095242045,0.0087237675,0.0011301566,0.00043163312,0.00022278477,0.00007349934,0.000057812893,0.007701825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981966,0.00009786473,0.00041624872,0.00056705886,0.00023458005,0.00048763066],"domain_scores_gemma":[0.9986049,0.000093298906,0.00014127523,0.0005677806,0.00020600732,0.00038675347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024173205,0.00027003605,0.00053454185,0.00023686187,0.00017177046,0.000033732897,0.00012598762,0.00019841213,0.00019088821],"category_scores_gemma":[0.00021038865,0.00021486323,0.00009122634,0.0002925516,0.00011575378,0.00009535948,0.00006114448,0.0002692046,0.0005171971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004183434,0.00558459,0.7361525,0.0007503938,0.00007769275,0.022969365,0.012040025,0.00032307665,0.060103707,0.0014172146,0.15415505,0.0022429156],"study_design_scores_gemma":[0.0349786,0.010883486,0.65162146,0.0009023834,0.001980802,0.011075086,0.0011740194,0.0015245385,0.03308184,0.0006210275,0.25061867,0.0015380608],"about_ca_topic_score_codex":0.00011807227,"about_ca_topic_score_gemma":0.00025358322,"teacher_disagreement_score":0.09646362,"about_ca_system_score_codex":0.00048454467,"about_ca_system_score_gemma":0.0010206612,"threshold_uncertainty_score":0.87618685},"labels":[],"label_agreement":null},{"id":"W1896865931","doi":"10.1186/s40661-015-0014-1","title":"Opportunistic salpingectomy for ovarian cancer prevention","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology Research and Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Salpingectomy; Medicine; Hysterectomy; Tubal ligation; Ovarian cancer; Oophorectomy; Sterilization (economics); Fallopian tube; Perioperative; Gynecology; Obstetrics; Population; Gynecologic oncology; Surgery; Pregnancy; Family planning; Cancer; Internal medicine","score_opus":0.6057722516616034,"score_gpt":0.6270119524882953,"score_spread":0.02123970082669191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896865931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028488112,0.95873284,0.000040146482,0.005181464,0.0004369428,0.005311419,0.00015806928,0.000046031582,0.030090252],"genre_scores_gemma":[0.000011444714,0.9799684,0.004878238,0.0002743667,0.0006256474,0.007791178,0.00040135253,0.000054658158,0.0059947087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99545765,0.0018700451,0.0005970787,0.00083949877,0.00041668603,0.0008190244],"domain_scores_gemma":[0.98295075,0.014223081,0.00046344646,0.00043388922,0.0013053964,0.0006234545],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007513107,0.0003668035,0.0020039212,0.0003482796,0.00039769674,0.00007984984,0.000177086,0.00085121277,0.000542783],"category_scores_gemma":[0.010511872,0.00026455568,0.00023906544,0.00048292178,0.0005090931,0.00018153896,0.00019118458,0.0010833549,0.00009158308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055129593,0.0014170044,0.000022596661,0.008051976,0.0010489031,0.0005436958,0.0000626648,3.1909888e-8,1.4527784e-7,0.0014474842,0.028908886,0.9579453],"study_design_scores_gemma":[0.0024844855,0.011584378,0.0000439927,0.0024983808,0.0040532355,0.00096688943,0.00017151337,0.00000217673,1.12884436e-7,0.0024180312,0.9755643,0.0002125043],"about_ca_topic_score_codex":0.0001287379,"about_ca_topic_score_gemma":0.00013128784,"teacher_disagreement_score":0.9577328,"about_ca_system_score_codex":0.0024603738,"about_ca_system_score_gemma":0.009957062,"threshold_uncertainty_score":0.9999807},"labels":[],"label_agreement":null},{"id":"W1912909478","doi":"10.25011/cim.v30i4.2865","title":"Characterization of low grade serous carcinoma of the ovary and its precursorss","year":2007,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Serous fluid; Carcinogenesis; Ovarian tumor; Ovarian carcinoma; Serous carcinoma; Malignant transformation; Cancer research; Pathology; Biology; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.12929893716386553,"score_gpt":0.3425676447434133,"score_spread":0.21326870757954774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1912909478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838685,0.0009383598,0.000014883053,0.014346664,0.00022446827,0.00038950282,0.000012324223,0.000005682709,0.00019961766],"genre_scores_gemma":[0.9979052,0.00046172334,0.00007018089,0.0011677042,0.00024186197,0.0000058464343,0.000015728825,0.000007944145,0.00012380097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988953,0.000068395115,0.0005542556,0.00020186233,0.00017330283,0.00010690146],"domain_scores_gemma":[0.99910265,0.00018743447,0.0002485472,0.0001506109,0.000121837205,0.00018890442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048798657,0.00010994191,0.00044642217,0.00003806109,0.000031659674,0.0000011427818,0.00004242677,0.00007759751,0.000021586386],"category_scores_gemma":[0.0004888101,0.00005862136,0.0000461548,0.00017162238,0.0026965248,0.000043012737,0.000041234296,0.00014425792,4.3118868e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009909963,0.00023444876,0.96094424,0.0002917056,0.00008962147,0.000008575956,0.0008767062,3.9408945e-8,0.029270945,0.0029874598,0.000098033786,0.0050991494],"study_design_scores_gemma":[0.0022693116,0.0011681403,0.9250144,0.0007861711,0.00017133473,0.000012216575,0.00007719449,0.00003204985,0.069131985,0.0010712431,0.0002202974,0.00004568541],"about_ca_topic_score_codex":0.000032646378,"about_ca_topic_score_gemma":0.0000073899723,"teacher_disagreement_score":0.039861042,"about_ca_system_score_codex":0.000009667437,"about_ca_system_score_gemma":0.000056139088,"threshold_uncertainty_score":0.9935458},"labels":[],"label_agreement":null},{"id":"W1916168367","doi":"10.1016/j.ygyno.2015.06.014","title":"Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecology; Surrogate endpoint; Cancer; Oncology; Population; Oophorectomy; Internal medicine; Surgery; Hysterectomy; Environmental health","score_opus":0.05103400292627381,"score_gpt":0.3894994561347671,"score_spread":0.3384654532084933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1916168367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872393,0.0006640554,0.00002366991,0.0074795657,0.00023885226,0.0023231395,0.000028170458,0.0000075141643,0.000511083],"genre_scores_gemma":[0.9976856,0.00022190761,0.0006705981,0.00019164206,0.000052506017,0.0008417535,0.00005266022,0.000008492818,0.0002748452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987707,0.0003489721,0.00034072442,0.00021055438,0.00015622687,0.0001727901],"domain_scores_gemma":[0.99830276,0.00097161136,0.00035872817,0.00019663737,0.00012795828,0.000042334927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082288444,0.00010919248,0.0003605933,0.000057705092,0.00006275143,0.00000583682,0.00007831576,0.0001209369,0.00018121957],"category_scores_gemma":[0.0003461239,0.000058391925,0.00007878935,0.0001344343,0.000099973564,0.000046210265,0.000056781475,0.000099203695,0.0000023793923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027335468,0.00408927,0.70095855,0.00038566373,0.00047800608,0.000038604594,0.0019828682,0.00047677773,0.0025316896,0.00069235417,0.005135989,0.28049666],"study_design_scores_gemma":[0.003999949,0.0034569239,0.98780626,0.000044050856,0.0004032548,0.00002025215,0.00023987523,0.00051144353,0.00026974143,0.0010009713,0.002186648,0.000060605485],"about_ca_topic_score_codex":0.00029354874,"about_ca_topic_score_gemma":0.00076417625,"teacher_disagreement_score":0.2868477,"about_ca_system_score_codex":0.0006109297,"about_ca_system_score_gemma":0.00042641157,"threshold_uncertainty_score":0.23811536},"labels":[],"label_agreement":null},{"id":"W1925407809","doi":"10.1016/j.ygyno.2015.05.011","title":"Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Chemotherapy; Surgery; Histopathology; Disease; Internal medicine; Pathology","score_opus":0.05518377647312948,"score_gpt":0.3300759917503429,"score_spread":0.2748922152772134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1925407809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8565885,0.0006939062,0.0000530621,0.003829989,0.0015225478,0.0014371818,0.00009321276,0.00009016288,0.13569143],"genre_scores_gemma":[0.9840315,0.00041952936,0.0018240835,0.00087140047,0.00010499845,0.00022160048,0.00012236065,0.000021757953,0.012382746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979547,0.00016308205,0.00059399125,0.0005221315,0.00029005972,0.00047598244],"domain_scores_gemma":[0.9982735,0.0003297217,0.00035635766,0.000541703,0.00017803129,0.00032066746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005920685,0.0002518663,0.00078136905,0.0001290649,0.000047269335,0.000010452383,0.00018086862,0.00023619592,0.0004045122],"category_scores_gemma":[0.00014382954,0.00019868961,0.00017699585,0.00021677522,0.00016823657,0.00004965444,0.00014488013,0.00018327736,0.00020988983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006258858,0.010299929,0.77105,0.00070212723,0.0008566701,0.014051599,0.001757653,0.000066403416,0.0002137842,0.0021358381,0.08350678,0.1091004],"study_design_scores_gemma":[0.061749164,0.018661879,0.82886875,0.00011691191,0.0012248328,0.00011793602,0.0012350532,0.000023418956,0.004119177,0.00041726447,0.0830575,0.00040810314],"about_ca_topic_score_codex":0.000088948844,"about_ca_topic_score_gemma":0.00027863326,"teacher_disagreement_score":0.12744302,"about_ca_system_score_codex":0.00082210754,"about_ca_system_score_gemma":0.0004085847,"threshold_uncertainty_score":0.8102327},"labels":[],"label_agreement":null},{"id":"W1928826206","doi":"10.1002/cncr.29481","title":"Ovarian cancer treatment: The end of empiricism?","year":2015,"lang":"en","type":"review","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Clinical trial; Intensive care medicine; Cancer therapy; Cancer; Internal medicine","score_opus":0.1617073479542435,"score_gpt":0.43955625986112173,"score_spread":0.2778489119068782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1928826206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010860634,0.9895021,0.0000011328708,0.0012254689,0.0009607373,0.0017237307,0.00084644253,0.000029161612,0.0057004075],"genre_scores_gemma":[0.00008211313,0.98997045,0.000032504657,0.00024668768,0.001235036,0.0032470278,0.000111652356,0.000091971175,0.004982555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981482,0.00009149267,0.00057105895,0.00049468654,0.0003564998,0.00033808],"domain_scores_gemma":[0.9981831,0.000118302785,0.0004616334,0.0008606759,0.00017012913,0.00020615791],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013824365,0.0005319278,0.002325782,0.00011429712,0.00006145241,0.000018496763,0.00019432826,0.0002620592,0.0022310484],"category_scores_gemma":[0.000013184658,0.00026244592,0.00071675004,0.0004190664,0.00017178737,0.000032261956,0.0000452535,0.00021186726,0.00006580906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021516606,0.00019917997,0.00023284061,0.003444008,0.0019862857,0.000037469374,0.00019615654,0.0000014114228,7.9662314e-8,0.00011323515,0.014465795,0.97930205],"study_design_scores_gemma":[0.0013054352,0.00025991193,0.00017802957,0.010285159,0.009516926,0.000029061941,0.000014456688,0.0000011525276,0.000009068803,0.000021668615,0.9781664,0.00021273349],"about_ca_topic_score_codex":0.0023981384,"about_ca_topic_score_gemma":0.0003235136,"teacher_disagreement_score":0.97908926,"about_ca_system_score_codex":0.0020160484,"about_ca_system_score_gemma":0.0039223055,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W1929713882","doi":"10.1155/2015/808531","title":"Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma","year":2015,"lang":"en","type":"article","venue":"BioMed Research International","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Fonds de Recherche du Québec - Santé; Institut Du Cancer de Montréal; Université de Montréal","keywords":"Serous fluid; Stem cell; CD44; Fallopian tube; Stem cell marker; CD117; Pathology; Ovarian carcinoma; Biology; Clear cell; CD24; Cancer stem cell; Carcinoma; Cell; Medicine; Ovarian cancer; Cancer; CD34; Cell biology; Anatomy; Genetics","score_opus":0.1381998916880678,"score_gpt":0.387232816407246,"score_spread":0.2490329247191782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929713882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819433,0.00031647497,0.000029029385,0.001929894,0.00036111686,0.0004432188,0.00009721542,0.000006028474,0.014873693],"genre_scores_gemma":[0.99779886,0.00006311841,0.00081815664,0.000011388452,0.000107106316,0.000066671804,0.00004980957,0.000010268189,0.0010746089],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981785,0.00013126356,0.00030030182,0.00021147361,0.0009814303,0.0001970255],"domain_scores_gemma":[0.9987624,0.00018042234,0.00007938742,0.0002183165,0.00057173107,0.0001877109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066985446,0.00007674722,0.00018672686,0.0005805534,0.000016714064,0.000007551045,0.00017347716,0.00006998244,0.0002116869],"category_scores_gemma":[0.00008655396,0.00006071597,0.00006332151,0.00032824028,0.00013965099,0.00005945172,0.00013060044,0.00014435753,0.000013207018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041426104,0.0045067077,0.7351894,0.00037516703,0.00022263732,0.0004727352,0.0026310377,0.000027963697,0.18116084,0.002036901,0.04933917,0.019894887],"study_design_scores_gemma":[0.0077308137,0.001141703,0.47618333,0.00058762863,0.000017643295,0.000014631563,0.0017705322,0.00026298864,0.5067329,0.00024146764,0.0052248565,0.0000915348],"about_ca_topic_score_codex":0.00056596193,"about_ca_topic_score_gemma":0.000021914968,"teacher_disagreement_score":0.32557204,"about_ca_system_score_codex":0.00038087278,"about_ca_system_score_gemma":0.00057897915,"threshold_uncertainty_score":0.24759255},"labels":[],"label_agreement":null},{"id":"W1933854096","doi":"10.1016/j.ygyno.2015.11.005","title":"A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Carboplatin; Medicine; Tolerability; Cisplatin; Internal medicine; Oncology; Ovarian cancer; Chemotherapy; Toxicity; Neutropenia; Nausea; Cancer; Adverse effect","score_opus":0.07092967197632274,"score_gpt":0.4184938203996043,"score_spread":0.34756414842328154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933854096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864279,0.0006156419,0.00009804549,0.009752036,0.00055556477,0.0013771931,0.00013704886,0.00001658758,0.0010199763],"genre_scores_gemma":[0.9937612,0.00011601134,0.0047449474,0.0008083445,0.000103580765,0.00031921975,0.0000060602147,0.000011082426,0.00012958501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987619,0.00011994787,0.0004508094,0.00029941052,0.00013394588,0.00023401731],"domain_scores_gemma":[0.99855715,0.00045587154,0.00035791687,0.00031539967,0.0001978675,0.000115821706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040563426,0.00015048511,0.00084303704,0.000031350588,0.00005282924,0.0000030137946,0.000108299806,0.0001597328,0.000134338],"category_scores_gemma":[0.00023036498,0.000096444564,0.00011504933,0.00011671991,0.0003646688,0.000029261646,0.000056437886,0.00013175269,5.218632e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029115784,0.005312419,0.8003262,0.00023895976,0.00040547512,0.000007343434,0.0029767323,0.00028467516,0.015459954,0.0035481127,0.0018013634,0.16672717],"study_design_scores_gemma":[0.046510875,0.018484931,0.67019856,0.000105462124,0.00061963906,0.000023556053,0.001575595,0.0011066411,0.16994782,0.0031397971,0.08795447,0.0003326752],"about_ca_topic_score_codex":0.00031661757,"about_ca_topic_score_gemma":0.0010199704,"teacher_disagreement_score":0.1663945,"about_ca_system_score_codex":0.00044587307,"about_ca_system_score_gemma":0.00063156046,"threshold_uncertainty_score":0.3932895},"labels":[],"label_agreement":null},{"id":"W1942558153","doi":"10.1200/jco.2000.18.6.1193","title":"Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; World Health Organization","keywords":"Medicine; Oxaliplatin; Carboplatin; Ovarian cancer; Paclitaxel; Internal medicine; Neutropenia; Population; Cisplatin; Chemotherapy; Progression-free survival; Gynecologic oncology; Febrile neutropenia; Oncology; Cancer; Surgery; Colorectal cancer","score_opus":0.10580411642949675,"score_gpt":0.4781313047964457,"score_spread":0.372327188366949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1942558153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950384,0.00027146627,0.0000045655875,0.0015977544,0.00018658534,0.002664213,0.00003652006,0.0000031168206,0.00019739299],"genre_scores_gemma":[0.99732226,0.0016976442,0.0005096157,0.00007435174,0.00013449471,0.00008113348,0.000008115061,0.000026829177,0.00014554612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578977,0.0015292757,0.0019341893,0.00024005501,0.00030316907,0.00020355583],"domain_scores_gemma":[0.9938448,0.0036860162,0.0013474042,0.00020845723,0.0007760664,0.00013722556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021277654,0.00015145626,0.0019039558,0.00013191719,0.00008690757,0.0000043263462,0.00010450319,0.00012959643,0.00038770546],"category_scores_gemma":[0.0015708694,0.00007198748,0.0001327291,0.00041937616,0.0002842644,0.000058347403,0.000030805375,0.00023969961,2.500195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22754717,0.02525916,0.40326473,0.000018432027,0.0009480933,0.000035340363,0.0010851054,0.00006589813,0.000010269025,0.000011950218,0.000043991065,0.34170985],"study_design_scores_gemma":[0.42378664,0.098621294,0.47600693,0.00014135586,0.0006055902,0.0000037472246,0.00016000113,0.000021262484,0.00003639781,0.000024362707,0.00055145967,0.00004094821],"about_ca_topic_score_codex":0.00055514084,"about_ca_topic_score_gemma":0.0024603852,"teacher_disagreement_score":0.3416689,"about_ca_system_score_codex":0.0003619153,"about_ca_system_score_gemma":0.00069035625,"threshold_uncertainty_score":0.42451027},"labels":[],"label_agreement":null},{"id":"W194705011","doi":"","title":"Cancer de l'ovaire: deux témoignages","year":2010,"lang":"fr","type":"article","venue":"Canadian women's studies","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.020020088180512728,"score_gpt":0.2962829355855134,"score_spread":0.2762628474050007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W194705011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79397166,0.13919982,0.0000012662746,0.03918529,0.013284035,0.0006163908,0.00049021275,0.000058848047,0.013192475],"genre_scores_gemma":[0.92882925,0.020020181,0.00028162886,0.008075842,0.003952095,0.0011533045,0.000010075899,0.00008292468,0.037594702],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968523,0.000056942183,0.00032855623,0.0005666095,0.00023284773,0.0019627446],"domain_scores_gemma":[0.99707115,0.00020152377,0.00009755501,0.00052573293,0.00023980139,0.0018642329],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003508939,0.00045353765,0.00071626407,0.0002448065,0.00046397524,0.00006503234,0.00018764303,0.00025255966,0.0049717086],"category_scores_gemma":[0.00029438952,0.0004348997,0.00014070226,0.00039220834,0.00057949015,0.00011223303,0.00006173319,0.00055979844,0.0005375094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079669786,0.0005948251,0.48201567,0.001755304,0.011134684,0.005671989,0.04290618,0.00003798221,0.000506891,0.053893533,0.24257913,0.15882415],"study_design_scores_gemma":[0.002601113,0.0004679936,0.07507139,0.0010901423,0.0010339789,0.00010670008,0.025896953,0.0000238638,0.0006521679,0.0037188262,0.8885779,0.0007589896],"about_ca_topic_score_codex":0.03361443,"about_ca_topic_score_gemma":0.4719774,"teacher_disagreement_score":0.6459988,"about_ca_system_score_codex":0.0059527834,"about_ca_system_score_gemma":0.003899022,"threshold_uncertainty_score":0.9998103},"labels":[],"label_agreement":null},{"id":"W1951785345","doi":"10.1111/j.1742-4658.2008.06679.x","title":"Gonadotropin‐releasing hormone and ovarian cancer: a functional and mechanistic overview","year":2008,"lang":"en","type":"review","venue":"FEBS Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Autocrine signalling; Biology; Gonadotropin-releasing hormone; Gonadotropic cell; Internal medicine; Cancer research; Endocrinology; Cancer cell; Receptor; Cancer; Hormone; Luteinizing hormone; Medicine; Biochemistry","score_opus":0.09294838726533666,"score_gpt":0.3453434374041571,"score_spread":0.25239505013882046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951785345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034425702,0.9980391,0.00012471809,0.0005377781,0.00051055313,0.00047065452,0.00007170278,0.00001934814,0.00019171719],"genre_scores_gemma":[0.00006266178,0.9969724,0.0007464284,0.00022437426,0.0015748254,0.00007935028,0.000033073986,0.00006465393,0.00024223202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982651,0.00009604062,0.00055616687,0.0003985292,0.0003596659,0.00032452215],"domain_scores_gemma":[0.9987872,0.0000990794,0.00039607115,0.00018521574,0.000095371586,0.00043703947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000087766944,0.00044160133,0.0015905071,0.00021186842,0.0003391522,0.00010924797,0.000055364537,0.00021891456,0.00036137228],"category_scores_gemma":[0.000036687747,0.00031733233,0.00032398294,0.00017680724,0.0000697989,0.0000789159,0.000056164237,0.00069114973,0.000017334361],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039985534,0.00009760201,0.000070406415,0.003124837,0.0009602085,0.00076869776,0.000022419516,1.7055025e-7,4.1698235e-7,0.0005425331,0.0049348213,0.9894379],"study_design_scores_gemma":[0.001732967,0.00033453573,0.0053353505,0.0185517,0.003129089,0.036619406,0.0000049069918,0.0000063608177,1.12707056e-7,0.00014702289,0.9338712,0.00026735966],"about_ca_topic_score_codex":0.00007192514,"about_ca_topic_score_gemma":0.000006756451,"teacher_disagreement_score":0.98917055,"about_ca_system_score_codex":0.0005093346,"about_ca_system_score_gemma":0.000985667,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W1956465683","doi":"10.1016/j.ygyno.2015.06.016","title":"Why have ovarian cancer mortality rates declined? Part II. Case-fatality","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Medicine; Case fatality rate; Ovarian cancer; Mortality rate; Epidemiology; Cancer; Incidence (geometry); Demography; Chemotherapy; Internal medicine; Oncology","score_opus":0.2341247714256782,"score_gpt":0.48056356958166,"score_spread":0.24643879815598183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1956465683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044915458,0.9781248,0.0000038957132,0.003185332,0.0032667755,0.003555771,0.0010177899,0.00018855654,0.010207933],"genre_scores_gemma":[0.00016728546,0.9870529,0.0004934084,0.003953593,0.0015722775,0.0040528453,0.0010715015,0.00009649541,0.0015396611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944888,0.00095561065,0.0016304762,0.0015226841,0.0003961323,0.0010063244],"domain_scores_gemma":[0.99530965,0.0010748677,0.0011247896,0.0013418439,0.0004220975,0.0007267686],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015332857,0.0010367779,0.005748255,0.00021871319,0.00032160297,0.00003978216,0.00033823392,0.0018454189,0.0056397915],"category_scores_gemma":[0.00062387856,0.0007255373,0.0009714685,0.0004175118,0.0003804088,0.00008828107,0.0004329608,0.0010316398,0.00022782931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039141523,0.0018190377,0.002651368,0.0030734898,0.0023159515,0.020394942,0.00006778612,0.0000013187924,2.1597295e-8,0.0002666111,0.1483137,0.82105666],"study_design_scores_gemma":[0.0024130405,0.0023829257,0.00058009825,0.0014959291,0.010431832,0.0036156934,0.000063399755,0.0000049737505,8.9780207e-7,0.00020934646,0.9781924,0.0006094508],"about_ca_topic_score_codex":0.0031530678,"about_ca_topic_score_gemma":0.009700207,"teacher_disagreement_score":0.8298787,"about_ca_system_score_codex":0.0045506004,"about_ca_system_score_gemma":0.0054833377,"threshold_uncertainty_score":0.9995196},"labels":[],"label_agreement":null},{"id":"W1963713422","doi":"10.1097/00013644-200406000-00004","title":"Sonographic Diagnosis of Primary Malignant Tumors of the Fallopian Tube","year":2004,"lang":"en","type":"review","venue":"Ultrasound Quarterly","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Toronto General Hospital","funders":"","keywords":"Medicine; Fallopian tube; Adnexal mass; Fallopian tube cancer; Adnexal Diseases; Radiology; Gynecology; Ovarian cancer; Laparoscopy; Cancer; Internal medicine","score_opus":0.023540384092058386,"score_gpt":0.2766055817499959,"score_spread":0.2530651976579375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963713422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018850872,0.9941022,0.0000043754744,0.0001035086,0.00035544127,0.0018828767,0.0003495747,0.000028473221,0.0012884863],"genre_scores_gemma":[0.009442873,0.98925424,0.00021328875,0.00006965428,0.00013458445,0.00052094506,0.0001438299,0.0000806506,0.00013996058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972257,0.0001408364,0.0012079928,0.00052423985,0.0005265394,0.0003746828],"domain_scores_gemma":[0.9972539,0.000506072,0.0008437541,0.0011366968,0.000107830754,0.0001517653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020038862,0.0005634233,0.0027137408,0.00025130884,0.0000658206,0.000020410947,0.00036422772,0.00029197452,0.00021017066],"category_scores_gemma":[0.000034170713,0.00032787383,0.001812345,0.00070640777,0.00028435464,0.000053399373,0.000019954468,0.00034380553,0.000021706039],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027248998,0.0020789045,0.013462996,0.07627491,0.0023869663,0.00006894151,0.0009526269,6.723659e-7,0.0000055728265,0.001867078,0.0006368267,0.90223724],"study_design_scores_gemma":[0.0023938688,0.0034674841,0.0272186,0.16744247,0.0106091015,0.00055120897,0.00019723142,6.805696e-8,0.000077724406,0.00038139016,0.78694224,0.00071862363],"about_ca_topic_score_codex":0.00036190546,"about_ca_topic_score_gemma":0.00005177365,"teacher_disagreement_score":0.90151864,"about_ca_system_score_codex":0.00033775665,"about_ca_system_score_gemma":0.0011346611,"threshold_uncertainty_score":0.9999173},"labels":[],"label_agreement":null},{"id":"W1963718242","doi":"10.1016/j.ygyno.2012.12.009","title":"Low-grade and high-grade serous Mullerian carcinoma: Review and analysis of publicly available gene expression profiles","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Serous carcinoma; Serous fluid; Gene; Oncology; Cancer research; Internal medicine; Bioinformatics; Cancer; Biology; Genetics; Ovarian cancer","score_opus":0.0727199607080715,"score_gpt":0.3424772886158243,"score_spread":0.2697573279077528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963718242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018309986,0.9934144,0.0000026451783,0.000853673,0.0002860866,0.0027817818,0.0002705551,0.000046272125,0.0005135668],"genre_scores_gemma":[0.002155109,0.9921187,0.0023853448,0.0005048235,0.00014719668,0.0012708565,0.00089218485,0.00004890996,0.0004768696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644536,0.00058578816,0.0011405642,0.0010043936,0.00021714739,0.0006067583],"domain_scores_gemma":[0.9967752,0.00082500966,0.0010769181,0.0007984386,0.0001249502,0.00039948066],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007121547,0.0006418695,0.0062846965,0.0005584471,0.00010920195,0.000019504485,0.00018875115,0.0008658951,0.0023644473],"category_scores_gemma":[0.0001920084,0.0004254443,0.0005128818,0.00090567966,0.00025711377,0.00008652593,0.00029012456,0.00041956358,0.000042638836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021473517,0.0022431493,0.0138955945,0.061180737,0.0046650046,0.00025933504,0.0000582677,1.7683386e-7,0.00001502128,0.000082766324,0.007800764,0.9097777],"study_design_scores_gemma":[0.0013845833,0.0014144147,0.010383367,0.003751592,0.076725945,0.00020317986,0.000018632356,0.0000019541292,0.000047568923,0.000008428687,0.90567625,0.00038407455],"about_ca_topic_score_codex":0.00023402869,"about_ca_topic_score_gemma":0.00013384757,"teacher_disagreement_score":0.9093936,"about_ca_system_score_codex":0.0005552815,"about_ca_system_score_gemma":0.0006424077,"threshold_uncertainty_score":0.99981976},"labels":[],"label_agreement":null},{"id":"W1964065802","doi":"10.3747/co.v18i0.939","title":"Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective","year":2011,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hamilton Health Sciences; Hôtel-Dieu de Québec; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Ottawa Hospital; BC Cancer Agency; London Health Sciences Centre; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Cancer; Library science; Family medicine; Gynecology; Gerontology; Internal medicine","score_opus":0.23339315143269324,"score_gpt":0.4886407089730963,"score_spread":0.25524755754040307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964065802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014878432,0.9862686,5.816663e-7,0.0036485847,0.0016501661,0.0038111021,0.00022784743,0.00002911888,0.0043625245],"genre_scores_gemma":[0.0000069917196,0.994073,0.00022272157,0.00038001366,0.00037259303,0.0046740575,0.00013240262,0.00006617983,0.00007204173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972791,0.0003168974,0.0006862119,0.0009205147,0.00017634737,0.000620909],"domain_scores_gemma":[0.9979804,0.00015316388,0.00035705895,0.0006977205,0.0001804089,0.00063121726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032485815,0.00058147096,0.003410658,0.00036192965,0.00007063043,0.000010918983,0.00026096636,0.0003804746,0.00066003494],"category_scores_gemma":[0.00022837394,0.0004274132,0.00029542955,0.0004153936,0.00013724709,0.00005178538,0.00013595526,0.0007395946,0.0000293209],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019962592,0.00046979293,0.0005286272,0.018632835,0.00024814942,0.0002130195,0.00031478505,3.910815e-9,6.1120997e-9,0.0009058291,0.0049519083,0.97371507],"study_design_scores_gemma":[0.0018465264,0.0004219395,0.0005966945,0.08971861,0.0021268688,0.000121603676,0.00007159796,2.1649188e-7,5.0891423e-8,0.00006608433,0.9047029,0.00032692988],"about_ca_topic_score_codex":0.029366743,"about_ca_topic_score_gemma":0.1068879,"teacher_disagreement_score":0.97338814,"about_ca_system_score_codex":0.004663388,"about_ca_system_score_gemma":0.0054392084,"threshold_uncertainty_score":0.9998178},"labels":[],"label_agreement":null},{"id":"W1964163461","doi":"10.1016/s0306-9877(02)00204-9","title":"Human breast cancer and lymphomas may share a common aetiology involving Mouse Mammary Tumour Virus (MMTV)","year":2002,"lang":"en","type":"article","venue":"Medical Hypotheses","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Breast cancer; Lymphoma; Etiology; Cancer; Mouse mammary tumor virus; Medicine; Virus; Cancer research; Oncology; Pathology; Immunology; Internal medicine","score_opus":0.04152496781402372,"score_gpt":0.2915196790583246,"score_spread":0.2499947112443009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964163461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95734864,0.013628954,0.00000488861,0.02515328,0.0001474632,0.0003534263,0.0001634845,0.00014711401,0.003052759],"genre_scores_gemma":[0.98873633,0.0051460257,0.000102007296,0.004125306,0.000406735,0.00017286013,0.000019337536,0.000038733204,0.0012526884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998401,0.000075629505,0.00030116213,0.00042175467,0.00042195307,0.00037850332],"domain_scores_gemma":[0.99891156,0.00017738594,0.00007613128,0.00030716768,0.0000448188,0.00048294154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014499831,0.00023606652,0.0004945959,0.00009771089,0.00015378608,0.00003489442,0.00014918142,0.00019515377,0.009005592],"category_scores_gemma":[0.00011048229,0.00017715618,0.000085719344,0.00011606834,0.00022952101,0.00008276918,0.00012164964,0.00021830396,0.00006503897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011080262,0.0021999425,0.7627268,0.00036473555,0.0005563075,0.0026644566,0.0007491009,0.0000010322835,0.0019855972,0.0031091077,0.047726445,0.17780569],"study_design_scores_gemma":[0.0054138238,0.00049206865,0.9647554,0.0010462538,0.00022383798,0.0014430062,0.00012284459,0.0004735939,0.0019185108,0.00043519694,0.023245981,0.00042943782],"about_ca_topic_score_codex":0.0015041649,"about_ca_topic_score_gemma":0.00070570945,"teacher_disagreement_score":0.20202866,"about_ca_system_score_codex":0.00017955384,"about_ca_system_score_gemma":0.000076957345,"threshold_uncertainty_score":0.9919003},"labels":[],"label_agreement":null},{"id":"W1964628278","doi":"10.1016/j.jconrel.2011.11.025","title":"An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels","year":2011,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Ovarian Cancer Canada","keywords":"Ovarian cancer; Ascites; Medicine; Chemotherapy; Distribution (mathematics); Pharmacokinetics; Docetaxel; Pharmacology; Cancer; Internal medicine; Cancer research","score_opus":0.01436166426252772,"score_gpt":0.2710255815573861,"score_spread":0.2566639172948584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964628278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913634,0.0022995698,0.00020160893,0.004156414,0.00025684692,0.0013217526,0.00026828624,0.000009829307,0.0001222947],"genre_scores_gemma":[0.9986587,0.0002735493,0.00030684005,0.00011126408,0.00032067482,0.000113632974,0.000022977418,0.000023356966,0.00016897917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99810934,0.00015957965,0.0009439467,0.00021072372,0.000271097,0.00030529656],"domain_scores_gemma":[0.9982528,0.00016022545,0.0007006232,0.00023871996,0.0004310302,0.00021661991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092239963,0.0002036107,0.000928619,0.00010225728,0.00012368037,0.000033623965,0.000110472385,0.00009510228,0.00003016402],"category_scores_gemma":[0.00011588808,0.00012387226,0.00019742892,0.0001684198,0.0001031222,0.0001780724,0.000015391017,0.00022206009,3.2373063e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7161239,0.00925011,0.107172914,0.0022088955,0.005219064,0.0019070689,0.016929558,0.0006866381,0.08365413,0.0057763825,0.010057351,0.041014023],"study_design_scores_gemma":[0.4963624,0.012445546,0.32796484,0.0028006325,0.0031028236,0.0012895112,0.013052734,0.012570578,0.1253564,0.00050524034,0.0037287858,0.0008205111],"about_ca_topic_score_codex":0.0010196109,"about_ca_topic_score_gemma":0.0003106837,"teacher_disagreement_score":0.22079192,"about_ca_system_score_codex":0.0005292551,"about_ca_system_score_gemma":0.0005911416,"threshold_uncertainty_score":0.50513643},"labels":[],"label_agreement":null},{"id":"W1964740590","doi":"10.1016/j.ygyno.2011.04.005","title":"Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Concordance; Response Evaluation Criteria in Solid Tumors; Radiological weapon; Internal medicine; Ovarian cancer; Predictive value; Oncology; Nuclear medicine; Cancer; Phases of clinical research; Chemotherapy; Radiology","score_opus":0.10797616294569438,"score_gpt":0.3847583790814949,"score_spread":0.2767822161358005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964740590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991023,0.0007013325,0.00005450791,0.0033213806,0.0007603183,0.0018479051,0.0001881623,0.00004025326,0.0020631189],"genre_scores_gemma":[0.9969087,0.0003040638,0.00041025566,0.00051699363,0.00007288588,0.00074526167,0.000049520906,0.000018161492,0.0009741217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782485,0.00052710745,0.0005419172,0.00056943647,0.00014631498,0.0003903645],"domain_scores_gemma":[0.99851614,0.0007171019,0.00021842324,0.00027900055,0.000072146155,0.00019721105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009963433,0.00023664997,0.00073172513,0.00018276343,0.00010253131,0.000009475877,0.000075316384,0.00028289173,0.0015163895],"category_scores_gemma":[0.0002820932,0.00019532732,0.000050262886,0.00028613408,0.00010851456,0.000068331945,0.00008032687,0.00032803343,0.000034206576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004985165,0.0059475,0.73636985,0.000011207753,0.00020370743,0.00060188264,0.0038649782,0.000001037286,0.000041655952,0.000027047176,0.005517482,0.2424285],"study_design_scores_gemma":[0.027672634,0.015621642,0.9302407,0.000036920737,0.00035583606,0.000024733912,0.0008872998,0.00004902365,0.000057288857,0.00011994287,0.024751997,0.0001820049],"about_ca_topic_score_codex":0.002316236,"about_ca_topic_score_gemma":0.0045194854,"teacher_disagreement_score":0.2422465,"about_ca_system_score_codex":0.0013917935,"about_ca_system_score_gemma":0.0004704295,"threshold_uncertainty_score":0.9993964},"labels":[],"label_agreement":null},{"id":"W1965189676","doi":"10.1111/his.12651","title":"Assessment of a new system for primary site assignment in high‐grade serous carcinoma of the fallopian tube, ovary, and peritoneum","year":2015,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Fallopian tube; Peritoneum; Ovary; Serous carcinoma; Serous fluid; Serous membrane; Medicine; Pathology; Carcinoma; Gynecology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.02614586435552394,"score_gpt":0.27457633704766704,"score_spread":0.2484304726921431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965189676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945801,0.001477393,0.0002270044,0.0015593759,0.0004133147,0.0007943877,0.00003610315,0.000009663718,0.0009026474],"genre_scores_gemma":[0.99662405,0.000021138287,0.0026662492,0.00015297502,0.000061315026,0.000115338386,0.000015399846,0.000015090218,0.00032844912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999028,0.000078573525,0.00032454604,0.00024328644,0.00016461176,0.00016096815],"domain_scores_gemma":[0.9993384,0.000041670475,0.0001495776,0.00031911436,0.00005303522,0.00009820467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020839533,0.00012216713,0.00048784754,0.00007826124,0.00002090501,0.0000024642184,0.00006463774,0.000082694845,0.0000042977226],"category_scores_gemma":[0.0000132315645,0.00008751988,0.00006788636,0.00008526603,0.00008374995,0.000020554235,0.00005727373,0.00007784608,4.6403866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012225311,0.0003816237,0.9876584,0.00047757555,0.000014879634,0.00011061154,0.0010126285,0.000022317618,0.00618467,0.0023869795,0.0007583335,0.0008697624],"study_design_scores_gemma":[0.0041593313,0.0009680507,0.99114627,0.00014453518,0.00015055951,0.00019482331,0.00016149155,0.000054060987,0.0008868954,0.00004822591,0.002018571,0.00006719649],"about_ca_topic_score_codex":0.0008314731,"about_ca_topic_score_gemma":0.0001230102,"teacher_disagreement_score":0.0052977744,"about_ca_system_score_codex":0.0006485045,"about_ca_system_score_gemma":0.0004472313,"threshold_uncertainty_score":0.35689571},"labels":[],"label_agreement":null},{"id":"W1965232242","doi":"10.1158/1078-0432.ovca13-a53","title":"Abstract A53: Biomarkers of chemotherapy resistance in serous epithelial ovarian cancer identified by integrative genomic and transcriptomic analysis","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Queen's University","funders":"","keywords":"Ovarian cancer; Chemotherapy; Gene expression profiling; Oncology; Microarray; Serous fluid; Microarray analysis techniques; Biology; Cancer research; Internal medicine; Cancer; Medicine; Gene expression; Bioinformatics; Gene; Genetics","score_opus":0.08205332957718654,"score_gpt":0.4533780097143822,"score_spread":0.37132468013719566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965232242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97764236,0.009351745,0.000015588677,0.010605082,0.0001500568,0.0012018672,0.0002610552,0.000014446989,0.00075782905],"genre_scores_gemma":[0.9799351,0.017788084,0.00022854404,0.00031038182,0.00014382403,0.00069079275,0.000026534854,0.000034987006,0.0008417157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691576,0.00029010052,0.00096414227,0.00077364134,0.0005379864,0.00051839533],"domain_scores_gemma":[0.99804735,0.000644975,0.00017809591,0.00047530234,0.00034171427,0.00031255954],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015509931,0.00023029518,0.0009567231,0.0004094695,0.00007525747,0.000059149905,0.00021801799,0.00022073096,0.002407438],"category_scores_gemma":[0.00012018479,0.00017795502,0.00029072788,0.0011706783,0.0006312148,0.0001054573,0.000038711823,0.0006443244,0.000018096353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042327014,0.0013536351,0.87601125,0.00031056872,0.005492902,0.000042273157,0.0013885667,0.000006306545,0.034241732,0.000107700325,0.019584812,0.057227574],"study_design_scores_gemma":[0.0057251686,0.00022304054,0.98603547,0.00031347421,0.0003176367,4.1570112e-7,0.0002678217,0.000078868,0.004229504,0.00033958623,0.0023075687,0.00016143182],"about_ca_topic_score_codex":0.031859957,"about_ca_topic_score_gemma":0.022205219,"teacher_disagreement_score":0.11002426,"about_ca_system_score_codex":0.0005442539,"about_ca_system_score_gemma":0.0005698965,"threshold_uncertainty_score":0.9985045},"labels":[],"label_agreement":null},{"id":"W1965669900","doi":"10.1002/pon.1562","title":"It's a choice to move forward: women's perceptions about treatment decision making in recurrent ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Psycho-Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Hamilton Health Sciences","funders":"McMaster University","keywords":"Perception; Ovarian cancer; Medicine; Psychology; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.029823318660041315,"score_gpt":0.41374898331953913,"score_spread":0.38392566465949785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965669900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91316324,0.0013877184,0.00064295466,0.06260741,0.0016736657,0.0020920113,0.00006539192,0.00008337513,0.018284248],"genre_scores_gemma":[0.9774845,0.0025554153,0.005664171,0.01137446,0.00065737497,0.001851091,0.000017602313,0.000030786847,0.00036457888],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99773806,0.00008414037,0.0005272296,0.000715245,0.00025205998,0.0006832905],"domain_scores_gemma":[0.9986626,0.00024082545,0.000122042395,0.0004977609,0.000083798965,0.00039296935],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020346654,0.00032380738,0.0007045462,0.00037510533,0.00010352905,0.000029107418,0.00012484513,0.00021836851,0.0022994438],"category_scores_gemma":[0.00006521034,0.00026501963,0.00016028593,0.000508601,0.000031397,0.00007356866,0.000025481026,0.00021419856,0.00022348738],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013500598,0.003629223,0.024452824,0.000011735473,0.00013976786,0.00014313038,0.016988229,0.00008814946,0.0001910468,0.00012877671,0.007629042,0.945248],"study_design_scores_gemma":[0.00775062,0.005714457,0.606775,0.00044662427,0.00013830917,0.00004150743,0.0015179515,0.00007377851,0.000028761577,0.00047819887,0.37680307,0.00023174776],"about_ca_topic_score_codex":0.0002898367,"about_ca_topic_score_gemma":0.0018446546,"teacher_disagreement_score":0.94501626,"about_ca_system_score_codex":0.0070914947,"about_ca_system_score_gemma":0.00041988736,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W1966258320","doi":"10.1016/j.ygyno.2014.05.020","title":"Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Hysterectomy; Endometrial cancer; Gynecology; Tamoxifen; Complement (music); Oophorectomy; Oncology; Obstetrics; Cancer; Internal medicine; Surgery; Breast cancer; Gene; Genetics","score_opus":0.04107096430846765,"score_gpt":0.3344632035953647,"score_spread":0.29339223928689706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966258320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800266,0.0003675823,0.000071726514,0.007053586,0.00047269496,0.0012964804,0.0000060421494,0.000068527326,0.010636781],"genre_scores_gemma":[0.99504286,0.00007310077,0.0018091137,0.0023512067,0.0001283912,0.00045206829,0.000034682827,0.00001939269,0.00008916398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825454,0.0002581999,0.00039877603,0.00051456224,0.00016110473,0.0004127981],"domain_scores_gemma":[0.9987192,0.0006354001,0.00015981545,0.00024818158,0.00006941274,0.00016796139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048946147,0.00021862637,0.0006241193,0.00018279237,0.00008267264,0.000020842379,0.000071141105,0.00021174748,0.00047808717],"category_scores_gemma":[0.00031185988,0.00017553837,0.000060149458,0.00020537635,0.00012519334,0.000056048357,0.00006491427,0.0002479344,0.000047960526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004967881,0.0018780372,0.5681954,0.0003368112,0.00027366512,0.0008708883,0.0018245141,0.000046900066,0.0009439518,0.0027830277,0.0015358938,0.42081413],"study_design_scores_gemma":[0.010345551,0.0073641413,0.91195965,0.000049213693,0.00021000144,0.00021300116,0.0004566791,0.00055359723,0.00061832124,0.0010328039,0.066952154,0.0002449133],"about_ca_topic_score_codex":0.00026405175,"about_ca_topic_score_gemma":0.0010497359,"teacher_disagreement_score":0.4205692,"about_ca_system_score_codex":0.001004188,"about_ca_system_score_gemma":0.00022705852,"threshold_uncertainty_score":0.71582466},"labels":[],"label_agreement":null},{"id":"W1966367059","doi":"10.1016/j.jgyn.2012.10.011","title":"Vers un dépistage possible du cancer de l’ovaire ?","year":2012,"lang":"fr","type":"review","venue":"Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Gynecology; Ovarian cancer; Ovary; Cancer; Internal medicine","score_opus":0.042293027959486924,"score_gpt":0.357447475843651,"score_spread":0.3151544478841641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966367059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050242238,0.8555788,0.005923822,0.05348163,0.025793895,0.005359411,0.0006224676,0.0013799403,0.001617826],"genre_scores_gemma":[0.043387588,0.89567214,0.024079718,0.0033793529,0.025785267,0.0026993277,0.0005316572,0.0006113378,0.003853588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9454183,0.033226997,0.006142599,0.005666044,0.0015611633,0.007984884],"domain_scores_gemma":[0.96664906,0.015001178,0.008065879,0.0045261914,0.0024311582,0.003326549],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.067481555,0.0044145486,0.0066111446,0.0025515822,0.00307008,0.0022455107,0.0035751679,0.00945562,0.0028514143],"category_scores_gemma":[0.06874091,0.0036372084,0.0044043823,0.0035624108,0.003512121,0.0021131716,0.0014677347,0.020169597,0.0002781226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0030518745,0.008317421,0.14634922,0.004308681,0.007909546,0.015434643,0.0023803464,0.011688908,0.0088432925,0.001537496,0.067107044,0.7230715],"study_design_scores_gemma":[0.00603768,0.004459,0.07133226,0.0047507896,0.0064994125,0.10826305,0.0024106763,0.000082380044,0.007922515,0.008253488,0.7767878,0.0032009215],"about_ca_topic_score_codex":0.0011616258,"about_ca_topic_score_gemma":0.00009020662,"teacher_disagreement_score":0.7198706,"about_ca_system_score_codex":0.0761136,"about_ca_system_score_gemma":0.029375834,"threshold_uncertainty_score":0.99919975},"labels":[],"label_agreement":null},{"id":"W1966868760","doi":"10.1054/bjoc.2000.1538","title":"Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Apoptosis; Programmed cell death; Biology; Cancer cell; Chinese hamster ovary cell; Cancer research; Transfection; Cell culture; Cancer; Ovarian cancer; Immunology; Genetics","score_opus":0.02986125080838409,"score_gpt":0.30980188662445707,"score_spread":0.279940635816073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966868760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94771063,0.048545368,0.00019011088,0.0017566531,0.00048135954,0.00085172703,0.000063706706,0.000012719544,0.00038774655],"genre_scores_gemma":[0.8772284,0.115951255,0.0038916953,0.00031282377,0.0008948213,0.0002826862,0.000003922947,0.000053144788,0.0013812887],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981081,0.0000378578,0.0005907315,0.00042240025,0.00050289533,0.0003380321],"domain_scores_gemma":[0.9980263,0.000110684436,0.00062770455,0.00024781298,0.0007820237,0.00020543784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019013303,0.0002603721,0.00084491115,0.000121990895,0.00010967809,0.000048681206,0.00011243783,0.000079979676,0.00011635832],"category_scores_gemma":[0.000046013996,0.00021518939,0.00047561363,0.00022852486,0.00004036599,0.00025545424,0.000014319298,0.00011297992,0.0000015504512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010303142,0.010873312,0.2554563,0.0016253268,0.008914987,0.0039680977,0.004295375,0.0008643209,0.16706662,0.0001495199,0.0036360733,0.5328469],"study_design_scores_gemma":[0.015460417,0.004618551,0.009417269,0.007213266,0.0033565082,0.0003848403,0.0005637167,0.000024519095,0.954463,0.00016060287,0.003988171,0.00034915135],"about_ca_topic_score_codex":0.002078745,"about_ca_topic_score_gemma":0.00022122041,"teacher_disagreement_score":0.7873964,"about_ca_system_score_codex":0.0005549013,"about_ca_system_score_gemma":0.000732594,"threshold_uncertainty_score":0.87751687},"labels":[],"label_agreement":null},{"id":"W1966945481","doi":"10.1054/bjoc.2001.2196","title":"The surgical management of women with ovarian cancer in the south west of England","year":2001,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Cancer; Stage (stratigraphy); Gynecology; Epithelial ovarian cancer; Multivariate analysis; Surgery; Internal medicine","score_opus":0.010527599922157781,"score_gpt":0.26899921502353485,"score_spread":0.25847161510137706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966945481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744158,0.020831011,0.000006075905,0.0027817327,0.0001290873,0.00023784577,0.000025305719,0.0000016509345,0.001571514],"genre_scores_gemma":[0.9587213,0.040645998,0.000053693824,0.000099076795,0.00022651438,0.00006589531,4.7618457e-7,0.000010805304,0.00017626927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987428,0.00006182891,0.00040786708,0.00009669833,0.00045667784,0.00023413113],"domain_scores_gemma":[0.9992401,0.0000747069,0.0003152397,0.00013806079,0.00015331573,0.00007857707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057656487,0.00008844589,0.00032928135,0.000042050153,0.000047849066,0.000025031977,0.00014561648,0.000030224099,0.00037150414],"category_scores_gemma":[0.000006253119,0.00004913488,0.00007017996,0.00023902293,0.00010073074,0.00004584854,0.000015166672,0.0001744404,3.6312298e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027807585,0.00053526834,0.4966723,0.00014471839,0.0012426798,0.005646397,0.0026272123,0.0002526318,0.000005993927,0.00025385627,0.00042591864,0.48941225],"study_design_scores_gemma":[0.008793916,0.00049703394,0.9300837,0.0018644339,0.0002467782,0.0013230371,0.0015353706,0.000003670777,0.00005526839,0.000045200464,0.055488203,0.00006342065],"about_ca_topic_score_codex":0.0014980168,"about_ca_topic_score_gemma":0.0025505372,"teacher_disagreement_score":0.48934883,"about_ca_system_score_codex":0.00024310088,"about_ca_system_score_gemma":0.00019359279,"threshold_uncertainty_score":0.40677097},"labels":[],"label_agreement":null},{"id":"W1966969455","doi":"10.1038/sj.onc.1204804","title":"Microarray analysis of gene expression mirrors the biology of an ovarian cancer model","year":2001,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill Genome Centre; Hôpital Notre-Dame; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Biology; Ovarian cancer; DNA microarray; Gene expression profiling; Gene expression; Microarray; Tissue microarray; Cancer research; Microarray analysis techniques; Cell culture; Cancer; Gene; Pathology; Genetics; Medicine","score_opus":0.04657252168646347,"score_gpt":0.34606447741929836,"score_spread":0.2994919557328349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966969455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944601,0.0020855793,0.0010583119,0.0011971132,0.000063329404,0.0001924146,0.00012287662,0.00000942727,0.00081083755],"genre_scores_gemma":[0.9908101,0.0010746949,0.0075233863,0.00021840337,0.000048205686,0.00005289152,0.00008816154,0.000012971124,0.00017118255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991555,0.000047647714,0.0002790233,0.00023927173,0.00012400046,0.00015450925],"domain_scores_gemma":[0.9991224,0.000030972915,0.00016641081,0.0004974217,0.00010143746,0.000081382765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012878694,0.00011518814,0.0004348753,0.0001526132,0.000038057446,0.0000024268506,0.0001063574,0.00008092569,0.00047253486],"category_scores_gemma":[0.000008129361,0.00006927815,0.00018773008,0.00049556745,0.00007649349,0.000025423098,0.000019836802,0.000054847496,0.0000016623441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020860779,0.00052780315,0.08361197,0.000012056885,0.0014019702,0.000009329201,0.00041092196,0.0022946573,0.8972031,0.000083504805,0.00009164813,0.014144449],"study_design_scores_gemma":[0.0017570794,0.00031718067,0.04988881,0.000050447085,0.0037038405,0.0000067782717,0.00008801926,0.007918828,0.93441,0.00007695072,0.0016733084,0.00010881056],"about_ca_topic_score_codex":0.0017706326,"about_ca_topic_score_gemma":0.00048355656,"teacher_disagreement_score":0.037206866,"about_ca_system_score_codex":0.00006776278,"about_ca_system_score_gemma":0.00013576631,"threshold_uncertainty_score":0.5173925},"labels":[],"label_agreement":null},{"id":"W1967147743","doi":"10.1097/igc.0b013e31829a5527","title":"Risk Factors for Ovarian Cancers With and Without Microsatellite Instability","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Microsatellite instability; Oncology; Ovarian cancer; Gynecology; Internal medicine; Microsatellite; Cancer; Genetics; Gene","score_opus":0.023801167257815867,"score_gpt":0.311596328579462,"score_spread":0.2877951613216461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967147743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384344,0.00063656684,0.00031887577,0.0039825006,0.00046676505,0.00044410359,0.00007399697,0.000008177055,0.00022555485],"genre_scores_gemma":[0.9944023,0.0012150357,0.0033136029,0.0006279038,0.00024314139,0.00009316585,0.0000053818367,0.00001087241,0.00008862641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904245,0.000027296872,0.0003196048,0.00018059621,0.00027292478,0.00015715271],"domain_scores_gemma":[0.9983982,0.0002696366,0.00032865256,0.00007602685,0.0007519007,0.00017559524],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014406128,0.00013555658,0.0003151304,0.00006666837,0.000047698817,0.0000554047,0.00010318093,0.00006970666,0.0009857438],"category_scores_gemma":[0.00019456142,0.00007534785,0.00010769456,0.00004879349,0.00011749744,0.0001518188,0.000022127339,0.00016984207,0.0000019086413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006634382,0.00017391566,0.9694263,0.000011784324,0.0006978197,0.000012258029,0.00015525731,0.000066543376,0.00022256133,0.00009127588,0.00038744407,0.02809141],"study_design_scores_gemma":[0.0037256605,0.0012632441,0.98331463,0.000073042866,0.00019795036,0.00004992591,0.00011481222,0.000061862534,0.00096510863,0.00048465157,0.009656066,0.00009301868],"about_ca_topic_score_codex":0.0009599978,"about_ca_topic_score_gemma":0.0002801589,"teacher_disagreement_score":0.027998392,"about_ca_system_score_codex":0.00066596403,"about_ca_system_score_gemma":0.000279295,"threshold_uncertainty_score":0.99992746},"labels":[],"label_agreement":null},{"id":"W1967958724","doi":"10.1016/j.jpag.2008.12.008","title":"Management of Ovarian Dermoid Cysts in the Pediatric and Adolescent Population","year":2009,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Laparotomy; Dermoid cyst; Cystectomy; Surgery; Laparoscopy; Cyst; Population; Ovarian Teratoma; Ovarian cyst; General surgery; Teratoma; Bladder cancer; Internal medicine","score_opus":0.01274493852174111,"score_gpt":0.27018359152053445,"score_spread":0.2574386529987933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967958724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601156,0.008262844,0.000070706395,0.004837442,0.00022908936,0.00041558893,0.0000026111138,0.0000041715857,0.0001660039],"genre_scores_gemma":[0.97263336,0.02534255,0.0004902003,0.0008805796,0.00062356197,0.000002965025,0.000002767661,0.0000072019975,0.000016832484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986283,0.00009672062,0.0006211219,0.00017381828,0.00026151916,0.00021848745],"domain_scores_gemma":[0.9991524,0.00009442183,0.00043433014,0.00013267383,0.00007032364,0.00011583026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043707367,0.0001526093,0.00040865422,0.00030150355,0.000046309626,0.000013612727,0.00008219387,0.000096680335,0.000016466987],"category_scores_gemma":[0.000032244443,0.00010158614,0.000088802386,0.00028247875,0.000022446196,0.00006712224,0.000025324227,0.0002502967,0.0000010550616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020149864,0.0013281417,0.96971023,0.000363965,0.000042366846,0.0004967984,0.000115030896,0.0000108842005,0.000004868882,0.0003914161,0.0021092189,0.025225576],"study_design_scores_gemma":[0.0040440103,0.0009389072,0.99300694,0.00008144772,0.0008167055,0.0002666652,0.00015388784,0.000013881676,0.000004398113,0.00033323225,0.00025729765,0.00008259579],"about_ca_topic_score_codex":0.00000452634,"about_ca_topic_score_gemma":0.0000026191758,"teacher_disagreement_score":0.02514298,"about_ca_system_score_codex":0.00009418146,"about_ca_system_score_gemma":0.00005636897,"threshold_uncertainty_score":0.41425624},"labels":[],"label_agreement":null},{"id":"W1968045430","doi":"10.1016/s0301-5629(03)00618-5","title":"Sonographic diagnosis of primary malignant tumors of the fallopian tube","year":2003,"lang":"en","type":"article","venue":"Ultrasound in Medicine & Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Fallopian tube; Medicine; Adnexal mass; Malignancy; Radiology; Uterus; Fallopian tube cancer; Incidence (geometry); Ovary; Lumen (anatomy); Gynecology; Surgery; Pathology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.0193474372813004,"score_gpt":0.27064804018414135,"score_spread":0.25130060290284095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968045430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793986,0.004601345,0.000014100576,0.002327938,0.00038091763,0.00055942585,0.000020307221,0.000010984072,0.012686349],"genre_scores_gemma":[0.99497086,0.0033950398,0.00028885642,0.0010640402,0.00007002588,0.00010164706,0.000027089829,0.000015283846,0.00006716115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840236,0.00019303714,0.00063692126,0.00029880146,0.00017884417,0.0002900616],"domain_scores_gemma":[0.9983902,0.0007412548,0.00022437693,0.00047975755,0.00008065456,0.000083731735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046909205,0.0001919637,0.0007854229,0.00019894198,0.000031270327,0.000001207314,0.00015015273,0.0001141838,0.00052892166],"category_scores_gemma":[0.0007480904,0.000105632986,0.00014661004,0.000573201,0.00070570013,0.00002057399,0.000020300684,0.00020165922,0.000002453651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043220356,0.0004220713,0.9817203,0.000120672805,0.00010716957,0.000009494121,0.0003449196,0.0000020622576,0.0053241877,0.00831758,0.0008004024,0.0027878738],"study_design_scores_gemma":[0.003113699,0.0014130062,0.9620918,0.00080062705,0.00019712273,0.00007871521,0.00025943224,6.678565e-7,0.009688822,0.0016151303,0.020633612,0.00010736221],"about_ca_topic_score_codex":0.00058138586,"about_ca_topic_score_gemma":0.00014280333,"teacher_disagreement_score":0.019833209,"about_ca_system_score_codex":0.00008771915,"about_ca_system_score_gemma":0.000187631,"threshold_uncertainty_score":0.57913214},"labels":[],"label_agreement":null},{"id":"W1968047515","doi":"10.1007/s10552-014-0357-7","title":"The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics","year":2014,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Minority Health and Health Disparities; National Institutes of Health","keywords":"Debulking; Medicine; Ovarian cancer; Socioeconomic status; Cancer; Oncology; Logistic regression; Stage (stratigraphy); Epidemiology; Internal medicine; Confidence interval; Disease; Demography; Population; Environmental health; Biology","score_opus":0.009929986771856266,"score_gpt":0.26586456873023756,"score_spread":0.2559345819583813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968047515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963452,0.006476941,0.00016620338,0.025807155,0.0013021522,0.0011006845,0.00075471966,0.0000935426,0.00084661506],"genre_scores_gemma":[0.9905197,0.003581929,0.000011803474,0.0030680285,0.0018244683,0.0005624042,0.000022617363,0.000038098817,0.00037097474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985881,0.00008354246,0.00033053337,0.00033095505,0.00017998552,0.00048686887],"domain_scores_gemma":[0.99846345,0.0005758309,0.00032255863,0.00027246497,0.00013586396,0.00022983296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027405508,0.00021434674,0.0005081689,0.00003477144,0.00025814667,0.000118951044,0.00006943349,0.00009642973,0.00018777327],"category_scores_gemma":[0.00011636085,0.00015494914,0.000093953,0.000049155824,0.00006150893,0.000079624995,0.000021880744,0.0002084685,0.000030589865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091359034,0.000029139426,0.94243795,0.000027640912,0.00091002235,0.0000025909178,0.000120923854,0.0000019429783,0.000062098596,0.0009122942,0.0010487476,0.054355275],"study_design_scores_gemma":[0.0049270983,0.0001429869,0.91164565,0.00006407813,0.0011417575,9.191792e-7,0.00002855911,0.00018815408,0.00010264744,0.0001746864,0.08142849,0.00015498168],"about_ca_topic_score_codex":0.000773695,"about_ca_topic_score_gemma":0.0003512381,"teacher_disagreement_score":0.08037974,"about_ca_system_score_codex":0.0011802944,"about_ca_system_score_gemma":0.00036871358,"threshold_uncertainty_score":0.6318643},"labels":[],"label_agreement":null},{"id":"W1968901807","doi":"10.1016/s0959-8049(11)70152-6","title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer","year":2011,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Surgery; Chemotherapy; Stage (stratigraphy); Cancer; Oncology; Internal medicine","score_opus":0.07258835780814786,"score_gpt":0.3448472579200515,"score_spread":0.2722589001119036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968901807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005231108,0.99393487,0.000026113992,0.0007231312,0.0028407592,0.00062552356,0.00008728671,0.000028078732,0.0012111368],"genre_scores_gemma":[0.00042060943,0.9948211,0.00028776794,0.0011675886,0.0014474974,0.00009640506,0.000040647225,0.00032303965,0.0013953452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495584,0.00071221543,0.0025522849,0.0005827595,0.0005450499,0.00065184914],"domain_scores_gemma":[0.99558645,0.00071040046,0.0025385476,0.0005015167,0.00024808172,0.00041502572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017207653,0.0008108419,0.0047158953,0.0007008871,0.00005631508,0.00005992772,0.00034277703,0.00014967429,0.0018295106],"category_scores_gemma":[0.00015670716,0.0005355001,0.0018158655,0.0006116547,0.0000791222,0.00022672956,0.00007102774,0.0009379371,0.000025087813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094233,0.00037356632,0.0024651922,0.004698827,0.001478751,0.004506579,0.0001599227,0.0000010278054,0.0000036283316,0.0000010981456,0.0544948,0.9308743],"study_design_scores_gemma":[0.0022772863,0.00022146225,0.00417062,0.094419904,0.0015067515,0.00037888312,0.000011417377,2.4677067e-7,0.000018684837,9.262221e-7,0.89652115,0.00047269682],"about_ca_topic_score_codex":0.0001536883,"about_ca_topic_score_gemma":0.00010733807,"teacher_disagreement_score":0.93040156,"about_ca_system_score_codex":0.0016184825,"about_ca_system_score_gemma":0.0039128894,"threshold_uncertainty_score":0.99970967},"labels":[],"label_agreement":null},{"id":"W1969023321","doi":"10.1097/igc.0b013e3182798188","title":"BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Immunohistochemistry; Tissue microarray; Serous fluid; Medicine; Staining; Pathology; Serous carcinoma; Ovarian carcinoma; Carcinoma; Ovarian cancer; Cancer; Internal medicine","score_opus":0.025554933832673286,"score_gpt":0.3614962488458423,"score_spread":0.33594131501316904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969023321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906433,0.0027925004,0.000021215932,0.0044056145,0.0010452394,0.0001816271,0.00001068083,0.000009044962,0.0008907794],"genre_scores_gemma":[0.99677277,0.0003480615,0.0005862482,0.0013207872,0.0007978184,0.00006634567,0.000005751172,0.000012554693,0.000089639834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985755,0.000039361432,0.00049652305,0.00013343207,0.0004816629,0.0002735041],"domain_scores_gemma":[0.9989819,0.00020399544,0.00028578777,0.000082516315,0.00022749558,0.00021833454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026457058,0.00013481332,0.00033378723,0.0001735112,0.000019798514,0.000020237401,0.00018708824,0.000099642435,0.0024260024],"category_scores_gemma":[0.00038630544,0.000096800395,0.00013933382,0.00009697849,0.000059883754,0.00014752151,0.000070737064,0.0003325499,0.000027493503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060810737,0.0010103234,0.9802439,0.000013195355,0.00024468315,0.00092728774,0.00026536535,0.000010005688,0.000987635,0.00025304843,0.00050630316,0.014930139],"study_design_scores_gemma":[0.0031673186,0.00074971933,0.98166776,0.0001278055,0.000076478864,0.0007420215,0.00007022131,0.000013043233,0.0013614243,0.00011090815,0.011814773,0.00009850549],"about_ca_topic_score_codex":0.000089258996,"about_ca_topic_score_gemma":0.000009129201,"teacher_disagreement_score":0.014831633,"about_ca_system_score_codex":0.0013095441,"about_ca_system_score_gemma":0.00031891282,"threshold_uncertainty_score":0.9984859},"labels":[],"label_agreement":null},{"id":"W1969187198","doi":"10.3747/co.2007.106","title":"A Tale of Two Time Periods: Ovarian Cancer Trends in Ontario","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.08074736437602757,"score_gpt":0.42256310351786275,"score_spread":0.34181573914183516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969187198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96940756,0.0023615255,0.000037683796,0.0014746876,0.0010620503,0.00026644795,0.0000162304,0.000020708267,0.025353108],"genre_scores_gemma":[0.9972184,0.00009683341,0.0004149879,0.00011925535,0.00019685738,0.000071123686,0.000049689254,0.000013638233,0.0018192453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989282,0.00002782732,0.00035592963,0.00025626307,0.00013371487,0.00029808152],"domain_scores_gemma":[0.9994546,0.000054580483,0.00011407833,0.00019808448,0.000055418404,0.00012324672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023201645,0.00013378105,0.00046292364,0.00026695378,0.00001964399,0.0000032804567,0.000060396993,0.00008307234,0.005466624],"category_scores_gemma":[0.000009415182,0.000114707276,0.00010190101,0.00025123902,0.00007803194,0.00003129902,0.000031807474,0.00022999039,0.000036774843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023850582,0.001625775,0.58592826,0.00001645154,0.00006791875,0.000106109605,0.0012624818,0.0000031872662,0.00020661742,0.00022040276,0.0020047415,0.40831953],"study_design_scores_gemma":[0.0064130714,0.0006876519,0.76245064,0.00012532581,0.00013314931,0.000026190575,0.000036410584,0.000025658754,0.00057224097,0.00003761698,0.22939968,0.00009239262],"about_ca_topic_score_codex":0.02582643,"about_ca_topic_score_gemma":0.28114468,"teacher_disagreement_score":0.40822715,"about_ca_system_score_codex":0.0016475403,"about_ca_system_score_gemma":0.00057600637,"threshold_uncertainty_score":0.9954425},"labels":[],"label_agreement":null},{"id":"W1969785272","doi":"10.1097/00013644-200303000-00003","title":"Low-Malignant-Potential Tumor of the Ovary: Sonographic Features With Clinicopathologic Correlation in 41 Patients","year":2003,"lang":"en","type":"article","venue":"Ultrasound Quarterly","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ovary; Malignancy; Parenchyma; Presentation (obstetrics); Pathology; Cyst; Radiology; Internal medicine","score_opus":0.005512062465089256,"score_gpt":0.21990981815198152,"score_spread":0.21439775568689226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969785272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979658,0.00019307222,0.000075566764,0.00011460757,0.00033274532,0.0006352137,0.000020999329,0.000017606157,0.0006443617],"genre_scores_gemma":[0.9992385,0.000022199712,0.00032935131,0.00023726934,0.000031038395,0.000049474398,0.000027244356,0.000016692798,0.00004820925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987701,0.0001295057,0.0003256736,0.00028194877,0.00026922446,0.00022351317],"domain_scores_gemma":[0.99919677,0.00011662125,0.0001992368,0.00034303227,0.000084280866,0.00006006482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016071192,0.00016998017,0.0002875755,0.00009475451,0.0000630638,0.00001750876,0.00007177337,0.000075703196,0.0000654783],"category_scores_gemma":[0.000049815382,0.000098639146,0.00012937533,0.00034033446,0.00011287458,0.0000718717,0.0000029714927,0.0001776027,0.000008570947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021973555,0.0012212018,0.9953868,0.000036866175,0.000049871556,0.000033764423,0.0007470661,0.000033716613,0.00026720137,0.0004267827,0.0001910509,0.0013859773],"study_design_scores_gemma":[0.003993709,0.0025851512,0.99128604,0.0002496965,0.0001511272,0.000076402364,0.00035041742,0.0000049081764,0.0007290553,0.00035803657,0.00010144999,0.00011400468],"about_ca_topic_score_codex":0.000057990554,"about_ca_topic_score_gemma":0.000102499645,"teacher_disagreement_score":0.004100724,"about_ca_system_score_codex":0.000052478368,"about_ca_system_score_gemma":0.00009655193,"threshold_uncertainty_score":0.40223876},"labels":[],"label_agreement":null},{"id":"W1969993915","doi":"10.1097/01.pgp.0000159935.38913.57","title":"Aggressive Behavior of Stage I Ovarian Mucinous Tumors Lacking Extensive Infiltrative Invasion: A Report of Four Cases and Review of the Literature","year":2005,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Pathology; Mucinous carcinoma; Medicine; Stage (stratigraphy); Ovary; Occult; Carcinoma; Mucinous Tumor; Gross examination; Ovarian carcinoma; Adenocarcinoma; Ovarian cancer; Cancer; Biology; Internal medicine; Pancreas","score_opus":0.07572518933257091,"score_gpt":0.38872029265306,"score_spread":0.3129951033204891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969993915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01624861,0.98121786,0.0000031837974,0.00071587483,0.0005435529,0.0008253384,0.00027374932,0.0000026182313,0.00016921261],"genre_scores_gemma":[0.045238853,0.95333534,0.00070468325,0.00038408677,0.00019042446,0.000042460873,0.000037010497,0.000015409494,0.000051732368],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9965252,0.00043722818,0.0020668,0.00028272386,0.00054402923,0.00014399021],"domain_scores_gemma":[0.98896486,0.0014229647,0.0071502267,0.00028713947,0.0020826138,0.0000922053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006150955,0.0003005776,0.0025423917,0.0002382754,0.000025126285,0.000008457547,0.00031909646,0.0003050102,0.00023917253],"category_scores_gemma":[0.0057803225,0.00015672976,0.0008456702,0.00021005933,0.00033668286,0.00006679309,0.00017966915,0.00063717517,5.5024697e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019311506,0.0015667089,0.0061659846,0.01524288,0.0016090085,0.24764134,0.00031811383,0.0000014836389,0.000025939042,0.0005595397,0.00043313415,0.7262428],"study_design_scores_gemma":[0.002289319,0.004116554,0.055360485,0.3842773,0.0057477513,0.4745868,0.000117256255,2.916491e-7,0.00010943939,0.00014067967,0.07295043,0.0003036593],"about_ca_topic_score_codex":0.000009505359,"about_ca_topic_score_gemma":0.000008421002,"teacher_disagreement_score":0.7259391,"about_ca_system_score_codex":0.00021141359,"about_ca_system_score_gemma":0.00081324455,"threshold_uncertainty_score":0.6920003},"labels":[],"label_agreement":null},{"id":"W1970078959","doi":"10.1016/j.ygyno.2006.02.034","title":"Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: A report of 3 cases with radiological evidence of response","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Radiological weapon; Ovary; Radiation therapy; Granulosa cell; Oncology; General surgery; Gynecology; Internal medicine; Radiology","score_opus":0.0448117563078234,"score_gpt":0.34726503545006393,"score_spread":0.3024532791422405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970078959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906638,0.0037104257,0.00012426793,0.0032494478,0.00020092691,0.0017352505,0.00006768665,0.000013258309,0.00023492011],"genre_scores_gemma":[0.9924768,0.0003135673,0.0064608487,0.00023703875,0.000051583047,0.0003375995,0.000011372744,0.000009127393,0.00010202992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816704,0.00039709764,0.0006720014,0.00034221268,0.00018718526,0.00023446989],"domain_scores_gemma":[0.99302423,0.0052630017,0.0009794313,0.00041345748,0.00027243438,0.000047473724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008136271,0.00017749173,0.00090575375,0.00006999616,0.00004404952,0.0000015377598,0.00014055132,0.00013873675,0.00011650453],"category_scores_gemma":[0.0009886066,0.000092361435,0.00022980722,0.00023343327,0.0005077244,0.000022820572,0.00003120668,0.00011851738,4.6106874e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08118844,0.010863157,0.85268456,0.000828134,0.00072900177,0.0041015674,0.00072392356,0.0002817965,0.026553018,0.0010923707,0.014300281,0.0066537326],"study_design_scores_gemma":[0.006835843,0.05790594,0.89183867,0.00030795153,0.0005343519,0.0008785228,0.00015454953,0.000025073794,0.034688286,0.0003788544,0.0063091884,0.0001427904],"about_ca_topic_score_codex":0.00016528403,"about_ca_topic_score_gemma":0.00019756233,"teacher_disagreement_score":0.07435259,"about_ca_system_score_codex":0.00037288747,"about_ca_system_score_gemma":0.0008253096,"threshold_uncertainty_score":0.37663898},"labels":[],"label_agreement":null},{"id":"W1970115049","doi":"10.1097/igc.0b013e31821bb700","title":"Clinical Trials and Treatment of the Elderly Diagnosed With Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Medicine; Ovarian cancer; Clinical trial; Cancer; Oncology; Internal medicine","score_opus":0.27931149285886586,"score_gpt":0.4963706761450325,"score_spread":0.21705918328616663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970115049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032697383,0.9915637,0.000007773472,0.0013140102,0.0023286233,0.001003484,0.00020150878,0.000005324056,0.00030583917],"genre_scores_gemma":[0.0048361407,0.9926596,0.00026027122,0.00019949998,0.0014680914,0.00028763583,0.0000060656766,0.000027530908,0.00025511856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963592,0.0006242671,0.002026533,0.00031415705,0.00049348705,0.00018231114],"domain_scores_gemma":[0.99366283,0.002317496,0.0029873636,0.00023027406,0.0005938123,0.00020821023],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009301409,0.00036709453,0.0033644678,0.00013539984,0.000036050857,0.000028732862,0.0003317454,0.00032992248,0.0019393788],"category_scores_gemma":[0.00062200247,0.00014512912,0.0013907552,0.00013088973,0.00024257111,0.00005442329,0.00005699521,0.0003749751,0.0000023955276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004942954,0.001154043,0.020669784,0.00024108005,0.006511574,0.00032359286,0.000050033475,0.0000010231724,1.398151e-7,0.00015867842,0.0005532944,0.96984243],"study_design_scores_gemma":[0.005484613,0.0052517364,0.039797504,0.008255453,0.007531582,0.00025691453,0.000012850141,5.724071e-7,0.0000044163617,0.000049458453,0.9332026,0.00015225717],"about_ca_topic_score_codex":0.00029975455,"about_ca_topic_score_gemma":0.00029712744,"teacher_disagreement_score":0.9696902,"about_ca_system_score_codex":0.0007963738,"about_ca_system_score_gemma":0.0017436186,"threshold_uncertainty_score":0.998973},"labels":[],"label_agreement":null},{"id":"W1970360031","doi":"10.1016/j.mce.2010.05.015","title":"Chronology and complexities of ovarian tumorigenesis in FORKO mice: Age-dependent gene alterations and progressive dysregulation of Major Histocompatibility Complex (MHC) Class I and II profiles","year":2010,"lang":"en","type":"review","venue":"Molecular and Cellular Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute","keywords":"Biology; Ovarian cancer; Carcinogenesis; Immune system; Knockout mouse; Ovary; Cancer research; Internal medicine; Cancer; Gene; Immunology; Endocrinology; Medicine; Genetics","score_opus":0.034828881412668815,"score_gpt":0.3108152874212336,"score_spread":0.2759864060085648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970360031","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19744562,0.79989463,0.0001253405,0.00020851365,0.000066185676,0.002034268,0.00012527315,0.000012363628,0.00008777781],"genre_scores_gemma":[0.5686719,0.42764866,0.0024413432,0.000030186475,0.0000512363,0.000491406,0.0005850462,0.00004402629,0.000036228674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793637,0.0002215113,0.0007701003,0.00064177363,0.00012935534,0.00030088107],"domain_scores_gemma":[0.99894714,0.00009039454,0.00041813875,0.00035948848,0.000083213876,0.00010165037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010654112,0.00038233434,0.0017922932,0.0003064234,0.00010126553,0.000014615322,0.000069943024,0.00025856035,0.000040420215],"category_scores_gemma":[0.000022139528,0.0003309351,0.000109653265,0.00009999311,0.00078284007,0.00003200152,0.00019888426,0.0002612814,2.572408e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033423924,0.0020406025,0.011153931,0.04037243,0.0021613364,0.002084814,0.0013285122,0.0000030307956,0.040522825,0.04575668,0.000042996722,0.8541986],"study_design_scores_gemma":[0.05697019,0.020080255,0.20021954,0.02344398,0.032876395,0.017286122,0.0012627317,0.0012537176,0.18311486,0.015947383,0.44132495,0.0062198783],"about_ca_topic_score_codex":0.00024852244,"about_ca_topic_score_gemma":0.00018653895,"teacher_disagreement_score":0.8479787,"about_ca_system_score_codex":0.00007671745,"about_ca_system_score_gemma":0.00015323017,"threshold_uncertainty_score":0.9999143},"labels":[],"label_agreement":null},{"id":"W1970401133","doi":"10.1016/j.ijrobp.2004.09.010","title":"Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Radiation therapy; Chemotherapy; Paclitaxel; Ovarian cancer; Surgery; Oncology; Neutropenia; Internal medicine; Cancer; Cisplatin","score_opus":0.020954889814387475,"score_gpt":0.3445236446620732,"score_spread":0.3235687548476857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970401133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9376895,0.006223968,0.00955253,0.042646587,0.0025180061,0.00070658047,0.00042095108,0.000029671328,0.00021219734],"genre_scores_gemma":[0.9720402,0.0068193907,0.009295962,0.0053763236,0.006184578,0.00012686726,0.00004680001,0.000040412626,0.00006950227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856645,0.00010822767,0.00065577566,0.00025648394,0.00018449705,0.00022855148],"domain_scores_gemma":[0.9976052,0.00080193445,0.0007590278,0.000119647804,0.0005654147,0.00014875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042390326,0.00022286942,0.00064837426,0.00015500124,0.000055723434,0.000031484484,0.000118016724,0.00019709379,0.00022352285],"category_scores_gemma":[0.000106433814,0.0001837817,0.00027856347,0.00008490494,0.00017334158,0.00021848039,0.000015485271,0.00022046054,0.0000048948627],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030810204,0.0006339889,0.31406897,0.000014373136,0.0022538335,0.000027347185,0.0010777684,0.000102454294,0.0022827585,0.002304261,0.0026474395,0.6715058],"study_design_scores_gemma":[0.05569374,0.0032146643,0.39772567,0.00037179483,0.0009196186,0.00055103394,0.00015765509,0.0043875985,0.02177887,0.0069058198,0.5075445,0.0007490484],"about_ca_topic_score_codex":0.000041272135,"about_ca_topic_score_gemma":0.000015363827,"teacher_disagreement_score":0.67075676,"about_ca_system_score_codex":0.00096984283,"about_ca_system_score_gemma":0.0007364442,"threshold_uncertainty_score":0.74943995},"labels":[],"label_agreement":null},{"id":"W1971083266","doi":"10.1038/modpathol.2013.55","title":"The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors","year":2013,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; University of Toronto; University of Calgary; Sunnybrook Health Science Centre; Calgary Laboratory Services; University of Manitoba","funders":"Calgary Laboratory Services","keywords":"Serous fluid; CDKN2A; Serous carcinoma; Pathology; Tissue microarray; Medicine; Immunohistochemistry; Clear cell; Cancer; Internal medicine; Ovarian cancer","score_opus":0.015165910551057246,"score_gpt":0.24298512462973768,"score_spread":0.22781921407868044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971083266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537976,0.0010230441,0.0009370276,0.010323152,0.0004095598,0.0013208068,0.00023147123,0.00007507524,0.00030009233],"genre_scores_gemma":[0.9960112,0.000077244535,0.0017312557,0.0011774664,0.00030710513,0.00042966963,0.00008872486,0.000056719404,0.000120608005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744165,0.0002280679,0.0005879869,0.0008267817,0.00028613498,0.00062939257],"domain_scores_gemma":[0.9972026,0.0009824127,0.00019751773,0.0010444734,0.00019102971,0.0003819641],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024565676,0.00037659105,0.0007643722,0.00008532189,0.00023037163,0.000058473044,0.00023368343,0.00020260258,0.00014986459],"category_scores_gemma":[0.000723737,0.0002748402,0.00011780783,0.00017577161,0.00029220968,0.000062611216,0.00020698889,0.0002873473,0.000055142034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002614227,0.0013276817,0.9407213,0.00014795312,0.00029301515,0.00197033,0.003879007,0.000028650318,0.0026168372,0.0009825424,0.003068941,0.044702347],"study_design_scores_gemma":[0.0024756426,0.00055424665,0.98663116,0.0001303341,0.00025649933,0.00020012725,0.00015168192,0.0009582396,0.0014738976,0.0066804606,0.0002497587,0.00023793637],"about_ca_topic_score_codex":0.012432994,"about_ca_topic_score_gemma":0.0011994453,"teacher_disagreement_score":0.045909904,"about_ca_system_score_codex":0.00010607522,"about_ca_system_score_gemma":0.00012474286,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W1971554308","doi":"10.1097/01.aog.0000119226.39514.1d","title":"Assisted Reproductive Technology and the Incidence of Ovarian Cancer: A Meta-Analysis","year":2004,"lang":"en","type":"review","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Population; Infertility; Odds ratio; Ovarian cancer; Gynecology; Cohort study; Cohort; Obstetrics; Assisted reproductive technology; Cancer; Oncology; Internal medicine; Pregnancy; Environmental health","score_opus":0.07114665551169942,"score_gpt":0.3515015033919516,"score_spread":0.28035484788025217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971554308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033698143,0.99490625,0.000015533364,0.0031885575,0.00023574589,0.001259964,0.0001026661,0.000016768863,0.00024083174],"genre_scores_gemma":[0.00393871,0.99415416,0.000519303,0.00009664353,0.000029208335,0.0008648084,0.00002661218,0.00002380854,0.0003467238],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977906,0.00019532308,0.00075341156,0.000829957,0.00018119735,0.00024954806],"domain_scores_gemma":[0.99351925,0.004498568,0.00082185515,0.00084408233,0.00023038097,0.000085872016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004930731,0.0003758025,0.0056167613,0.0012761793,0.00009859968,0.000017614113,0.00015311541,0.00049684447,0.00015700818],"category_scores_gemma":[0.0034558729,0.00019866074,0.0010923127,0.003877765,0.0006673218,0.000023840124,0.00018043742,0.00039324374,0.0000021984777],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016537027,0.00019032211,0.000441379,0.003408131,0.19583093,0.00013445572,0.00007980424,0.000001674088,4.7576005e-8,0.014613308,0.000030431114,0.785253],"study_design_scores_gemma":[0.0015009755,0.0002204614,0.00066372467,0.00024699094,0.60180295,0.000113685295,0.000023967266,0.0000020793345,0.0000012084896,0.0007216541,0.39454445,0.0001578477],"about_ca_topic_score_codex":0.00039309112,"about_ca_topic_score_gemma":0.00011417046,"teacher_disagreement_score":0.78509516,"about_ca_system_score_codex":0.00027540463,"about_ca_system_score_gemma":0.00057994167,"threshold_uncertainty_score":0.810115},"labels":[],"label_agreement":null},{"id":"W1971744627","doi":"10.1158/1538-7445.am10-2054","title":"Abstract 2054: A microRNA hypothesis for the precursor lesions of ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Fallopian tube; Serous fluid; Stromal cell; Laser capture microdissection; Biology; Cancer research; Pathology; Ovary; Epithelium; Cancer; Medicine; Internal medicine; Gene; Gene expression; Endocrinology","score_opus":0.14515863496322948,"score_gpt":0.43244220748167295,"score_spread":0.2872835725184435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971744627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9319744,0.007452092,0.000028218123,0.05207663,0.0008895441,0.003370267,0.0007177919,0.000033569333,0.003457449],"genre_scores_gemma":[0.9900328,0.0027507094,0.00066359993,0.0002057173,0.0007589292,0.0034839858,0.000005781671,0.000043671393,0.0020548068],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984469,0.000031847136,0.00024189477,0.00034106942,0.00046042,0.0004778852],"domain_scores_gemma":[0.9974668,0.001162484,0.00007705497,0.0006023724,0.0005083026,0.00018300593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000679433,0.00013699092,0.00027762554,0.00012704932,0.0002509315,0.00003371658,0.00026254077,0.00011411577,0.0033302573],"category_scores_gemma":[0.00027043954,0.00008460605,0.00017048785,0.00032547038,0.0002941559,0.000046566172,0.000054348304,0.00050237647,0.000028707056],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013490935,0.0009345819,0.019159378,0.0005915593,0.0010023954,0.000020516525,0.0008942753,0.000017151771,0.32475317,0.0018463032,0.15116291,0.49826866],"study_design_scores_gemma":[0.003552085,0.0003151637,0.3994889,0.00045875818,0.00029035073,0.000007521623,0.00019405053,0.000035706886,0.296201,0.0005733037,0.29871,0.00017316855],"about_ca_topic_score_codex":0.004182289,"about_ca_topic_score_gemma":0.0034702544,"teacher_disagreement_score":0.49809548,"about_ca_system_score_codex":0.00018592102,"about_ca_system_score_gemma":0.0010808668,"threshold_uncertainty_score":0.9975808},"labels":[],"label_agreement":null},{"id":"W1972182149","doi":"10.1038/modpathol.2010.215","title":"Calculator for ovarian carcinoma subtype prediction","year":2010,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; Centre for Health Evaluation and Outcome Sciences; Vancouver General Hospital; Calgary Laboratory Services; BC Cancer Agency","funders":"BC Cancer Agency; Eli Lilly Canada; Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Ovarian carcinoma; Serous carcinoma; Ovarian cancer; Oncology; Serous fluid; Medicine; Tissue microarray; Logistic regression; Internal medicine; Cohort; Anatomical pathology; Pathology; Immunohistochemistry; Cancer","score_opus":0.018039823172582667,"score_gpt":0.2712445993056805,"score_spread":0.25320477613309783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972182149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98744076,0.00013314508,0.007111323,0.0023075563,0.001013096,0.00058338634,0.00009632629,0.00007316569,0.0012412617],"genre_scores_gemma":[0.9941984,0.0000067191963,0.0039832257,0.0005238717,0.00046661406,0.00025314494,0.000095306794,0.000026362439,0.0004463978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921656,0.00001399155,0.00015251519,0.00031725309,0.00007787359,0.0002218238],"domain_scores_gemma":[0.999395,0.00003317898,0.000042568478,0.00034420376,0.000076275624,0.00010873907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109168854,0.00011155582,0.00021307492,0.00005835112,0.0000662733,0.000007597168,0.00004105618,0.00017727855,0.00012150982],"category_scores_gemma":[0.000043091764,0.00009414035,0.000092197486,0.000043258555,0.000048183574,0.000029061399,0.000016422522,0.00014321771,0.000028936334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005192977,0.0007675646,0.86586934,0.00009156713,0.00013487037,0.00044538852,0.0007228734,0.000012278316,0.07529135,0.0091914125,0.003649651,0.043304387],"study_design_scores_gemma":[0.0046591754,0.00086878816,0.96250385,0.000010764767,0.00027950355,0.00059443543,0.000010827654,0.0053189043,0.007084271,0.0027149422,0.015821993,0.00013251675],"about_ca_topic_score_codex":0.000037014364,"about_ca_topic_score_gemma":0.00006945736,"teacher_disagreement_score":0.09663452,"about_ca_system_score_codex":0.00004327326,"about_ca_system_score_gemma":0.000093963004,"threshold_uncertainty_score":0.3838932},"labels":[],"label_agreement":null},{"id":"W1972275697","doi":"10.1158/1078-0432.ovca13-a18","title":"Abstract A18: Defining ovarian mucinous tumors: Cancer genes and heterogeneity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"KRAS; CDKN2A; PTEN; Cancer research; Neuroblastoma RAS viral oncogene homolog; Ovarian cancer; Biology; Mucinous carcinoma; Genetic heterogeneity; Cancer; Mutation; Pathology; Gene; Adenocarcinoma; Medicine; Genetics; Phenotype; PI3K/AKT/mTOR pathway","score_opus":0.24405499687169965,"score_gpt":0.5141800381400699,"score_spread":0.2701250412683702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972275697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96594244,0.01928276,0.000003017126,0.011148196,0.00032852084,0.00098941,0.000050973664,0.000055477667,0.0021991942],"genre_scores_gemma":[0.98192745,0.013948492,0.0003834754,0.0010240455,0.00094888033,0.0013463304,0.000013323808,0.000051153806,0.00035682734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967933,0.00019856133,0.0006801695,0.0008438269,0.0006929857,0.0007911355],"domain_scores_gemma":[0.9972441,0.00082668423,0.00010864201,0.0005859739,0.0004923451,0.0007422323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013731574,0.00023158538,0.00062057166,0.00013829822,0.00025715513,0.00013910174,0.00017770902,0.00021339093,0.0034729403],"category_scores_gemma":[0.00030022193,0.00017820491,0.00017650519,0.00031348818,0.0004593751,0.0001412733,0.00019773435,0.00084521895,0.0003508507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020339587,0.00045564483,0.7251924,0.00016330688,0.0002635835,0.00011348002,0.00007376722,0.0000052116807,0.00035688412,0.00016005176,0.0077913003,0.26522094],"study_design_scores_gemma":[0.002685733,0.00055696483,0.9818806,0.00045274378,0.0000739717,0.000016528642,0.00007650349,0.00008130326,0.0016003891,0.0002667907,0.012117538,0.00019091503],"about_ca_topic_score_codex":0.018112777,"about_ca_topic_score_gemma":0.001455727,"teacher_disagreement_score":0.26503003,"about_ca_system_score_codex":0.0003138549,"about_ca_system_score_gemma":0.000835971,"threshold_uncertainty_score":0.997438},"labels":[],"label_agreement":null},{"id":"W1972505996","doi":"10.1002/cyto.a.10001","title":"Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: Pilot study","year":2002,"lang":"en","type":"article","venue":"Cytometry Part A","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Ovarian cancer; Repopulation; Oncology; Chemotherapy; Medicine; Cancer; Cancer research; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.04362329792012913,"score_gpt":0.34591913234746097,"score_spread":0.3022958344273318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972505996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940208,0.0009157006,0.00035662952,0.00064418715,0.00031858374,0.0021279417,0.000051107767,0.000040459217,0.0015245831],"genre_scores_gemma":[0.99344754,0.00014925214,0.00340265,0.0003522365,0.00021265139,0.001595485,0.000015806883,0.000035831006,0.0007885326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875814,0.000024920455,0.0003811112,0.00035836903,0.00026347165,0.00021400927],"domain_scores_gemma":[0.99912864,0.000055655346,0.00019158027,0.00041162563,0.00011198633,0.00010049651],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014465365,0.00016921504,0.00042001318,0.0001517639,0.00004605747,0.000013076707,0.000051495186,0.000024896464,0.0011496978],"category_scores_gemma":[0.000015350879,0.00014353405,0.00009307315,0.00036417713,0.000020562802,0.00006428569,0.000013973093,0.000068918984,0.000006867363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057009805,0.007287412,0.97881544,0.00018720303,0.00025620105,0.000037275142,0.00020239258,0.00003160004,0.0021036481,0.000024377092,0.0013064981,0.009177845],"study_design_scores_gemma":[0.012552145,0.0070124543,0.9672796,0.00012331072,0.0003028399,0.0000048218035,0.000106638836,0.0004647949,0.0056655584,0.000015254585,0.006307725,0.00016482593],"about_ca_topic_score_codex":0.000053162563,"about_ca_topic_score_gemma":0.00002054973,"teacher_disagreement_score":0.011982047,"about_ca_system_score_codex":0.00023507334,"about_ca_system_score_gemma":0.000046738372,"threshold_uncertainty_score":0.99976337},"labels":[],"label_agreement":null},{"id":"W1972807527","doi":"10.1097/pgp.0b013e3181f45f3e","title":"The Origin of Ovarian Carcinomas","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre of Excellence for Women's Health; Child and Family Research Institute; University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Mesothelium; Epithelium; Biology; Fimbria; Oviduct; Transitional epithelium; Pathology; Ampulla; Neoplastic transformation; Malignant transformation; Anatomy; Cancer research; Carcinogenesis; Endocrinology; Cancer; Medicine; Genetics","score_opus":0.022175069448905908,"score_gpt":0.3191133405148342,"score_spread":0.2969382710659283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972807527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97813064,0.00017910583,0.00009532414,0.015109599,0.0029265068,0.00008238672,0.0000064795136,0.0000043725277,0.003465581],"genre_scores_gemma":[0.9968992,0.00016233812,0.0018856362,0.0004897443,0.00045336768,0.000005128862,0.0000018937686,0.0000048045276,0.00009787747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904376,0.000051242554,0.0004311604,0.00009194916,0.00026355957,0.00011830745],"domain_scores_gemma":[0.9983454,0.0005890853,0.00033485465,0.00012327886,0.00052789965,0.00007950774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043824114,0.00007415994,0.00023654476,0.000071642084,0.000035059395,0.00001174654,0.00025020962,0.00010300381,0.00051454623],"category_scores_gemma":[0.00076260575,0.000038566104,0.0001665035,0.0000471792,0.0001967141,0.00003373889,0.000044750715,0.00034893132,0.00001205046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010703976,0.0014206107,0.81402737,0.000006156764,0.0006699585,0.0061820475,0.00015507663,0.0000107450805,0.029218992,0.07465372,0.0030872624,0.06949764],"study_design_scores_gemma":[0.0020418984,0.0011664635,0.946323,0.000012085756,0.000075156204,0.0028356202,0.00003396105,0.000010735745,0.0023209339,0.004548309,0.04058848,0.00004340197],"about_ca_topic_score_codex":0.0000100329735,"about_ca_topic_score_gemma":0.000034413846,"teacher_disagreement_score":0.13229556,"about_ca_system_score_codex":0.00005909646,"about_ca_system_score_gemma":0.00015243441,"threshold_uncertainty_score":0.56339204},"labels":[],"label_agreement":null},{"id":"W1972943130","doi":"10.1016/j.ygyno.2009.12.024","title":"Pure dysgerminoma of the ovary 35 years on: A single institutional experience","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"American Physicians Fellowship for Medicine in Israel","keywords":"Medicine; Ovary; Dysgerminoma; Gynecology; Internal medicine","score_opus":0.02949583117848758,"score_gpt":0.30659673162726364,"score_spread":0.27710090044877606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972943130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729921,0.000058142337,0.0000024523906,0.0033417463,0.0015691315,0.00035374513,0.000009495669,0.000023252314,0.021649897],"genre_scores_gemma":[0.99689215,0.000014622426,0.0005779791,0.0019744644,0.00016221816,0.00013937168,0.000004962502,0.000006152209,0.00022806569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991718,0.00004241366,0.00020196658,0.00023662715,0.0001544132,0.00019278577],"domain_scores_gemma":[0.9992362,0.0002008803,0.00009548006,0.0003466917,0.00004704687,0.00007367967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009664481,0.00010457093,0.00026105967,0.000045135992,0.00007891775,0.0000040981304,0.00014965411,0.00020637897,0.0012421913],"category_scores_gemma":[0.0002523497,0.00006573975,0.000103826,0.00014544181,0.0003548556,0.0000271102,0.00007388189,0.00026785696,0.000050221715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007983736,0.017055761,0.49992004,0.00009769748,0.0004242371,0.0035472794,0.004150676,0.00014342488,0.056139693,0.064507045,0.011066926,0.34214884],"study_design_scores_gemma":[0.0023140553,0.0031650425,0.88763463,0.000030012865,0.000075293734,0.0003850091,0.00019187061,0.000032946915,0.004732673,0.0005838765,0.100742884,0.00011169245],"about_ca_topic_score_codex":0.000022060749,"about_ca_topic_score_gemma":0.00013860237,"teacher_disagreement_score":0.3877146,"about_ca_system_score_codex":0.00020923813,"about_ca_system_score_gemma":0.00045744763,"threshold_uncertainty_score":0.9996708},"labels":[],"label_agreement":null},{"id":"W1973865817","doi":"10.1097/00004347-200101000-00006","title":"Immunohistochemical Analysis Of Gynecologic Tumors","year":2001,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytokeratin; Immunohistochemistry; Pathology; Biology; Immunophenotyping; Stromal cell; Ovary; Cervix; Vimentin; Medicine; Cancer; Antigen; Immunology","score_opus":0.05667024058194423,"score_gpt":0.4010800060073227,"score_spread":0.34440976542537843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973865817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040136143,0.9921749,0.000087729495,0.00036567115,0.0011551991,0.00033151792,0.0000905341,0.000012772944,0.001768012],"genre_scores_gemma":[0.0101369405,0.98798007,0.0010042184,0.00024980603,0.0003042675,0.000037696875,0.00015319105,0.000021693359,0.00011213903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644077,0.00026023987,0.0021125444,0.00036242008,0.0005566302,0.000267415],"domain_scores_gemma":[0.9948361,0.0015047853,0.0024096856,0.00029317386,0.00078673864,0.0001695352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055778015,0.00037350613,0.004264954,0.0013400136,0.000022652546,0.000013623468,0.0006375366,0.00062411214,0.0030463939],"category_scores_gemma":[0.0013704953,0.00023710959,0.0028629838,0.00076811016,0.00026904006,0.000044474065,0.00015836053,0.00073732436,0.000029258339],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024188233,0.00291098,0.0042477483,0.00047863068,0.022886474,0.021838464,0.00003171771,0.000019756964,0.000017944601,0.00064640964,0.0009725426,0.94570744],"study_design_scores_gemma":[0.0023342879,0.0035535889,0.019686058,0.0027631598,0.041662924,0.009586024,0.000025162179,0.000009557236,0.0000113636015,0.00041136937,0.9195589,0.00039760844],"about_ca_topic_score_codex":0.000006699362,"about_ca_topic_score_gemma":0.0000035514392,"teacher_disagreement_score":0.9453098,"about_ca_system_score_codex":0.000929063,"about_ca_system_score_gemma":0.0005382722,"threshold_uncertainty_score":0.99786496},"labels":[],"label_agreement":null},{"id":"W1974929173","doi":"10.1046/j.1525-1438.2000.99509.x","title":"New cytotoxics and non-cytotoxics in epithelial ovarian cancer","year":2000,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Topotecan; Medicine; Ovarian cancer; Gemcitabine; Paclitaxel; Epirubicin; Matrix metalloproteinase inhibitor; Oncology; Pharmacology; Cancer research; Cancer; Chemotherapy; Internal medicine; Matrix metalloproteinase; Breast cancer","score_opus":0.017505400216172314,"score_gpt":0.323875507917991,"score_spread":0.3063701077018187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974929173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765439,0.0015037319,0.00008823287,0.018584749,0.0009446308,0.00021743738,0.000043766126,0.0000080250975,0.0020655468],"genre_scores_gemma":[0.9831544,0.010346445,0.0015883209,0.0025794883,0.0012773938,0.00003269188,0.0000025375912,0.000013799965,0.0010049206],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861264,0.00002941693,0.000496233,0.0002000733,0.00045496604,0.0002066706],"domain_scores_gemma":[0.9991454,0.00013827052,0.00018481168,0.000082912054,0.00020381424,0.00024481828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017810303,0.00015721637,0.00038655603,0.00013729016,0.00002636689,0.000042848285,0.00017231925,0.0001305392,0.013030257],"category_scores_gemma":[0.000072912284,0.000112282636,0.00012810451,0.00012191937,0.000052927848,0.00013402854,0.00003139333,0.0003173608,0.00001495701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017986197,0.0006328177,0.41660735,0.000014533463,0.00056733214,0.0015996192,0.00029441324,0.000619408,0.0013287768,0.00026036322,0.0040356154,0.5722412],"study_design_scores_gemma":[0.007440857,0.0006936897,0.949898,0.0002795094,0.00011064128,0.00021578153,0.000024354613,0.00014626549,0.0017720897,0.0007400832,0.038531803,0.00014689795],"about_ca_topic_score_codex":0.00059187127,"about_ca_topic_score_gemma":0.00048440424,"teacher_disagreement_score":0.57209426,"about_ca_system_score_codex":0.0006866376,"about_ca_system_score_gemma":0.0005564941,"threshold_uncertainty_score":0.98787194},"labels":[],"label_agreement":null},{"id":"W1975095453","doi":"10.1016/j.jsbmb.2012.05.006","title":"Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells","year":2012,"lang":"en","type":"article","venue":"The Journal of Steroid Biochemistry and Molecular Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montpellier; Institut National Du Cancer; Ligue Contre le Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Fulvestrant; Estrogen; Estrogen receptor; Cancer research; Aromatase; Internal medicine; Cell growth; Ovarian cancer; DNA methylation; Endocrinology; Biology; Chemistry; Cancer; Breast cancer; Medicine; Gene expression; Gene; Biochemistry","score_opus":0.012265207975720852,"score_gpt":0.2702628997806244,"score_spread":0.25799769180490356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975095453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97547036,0.020247797,0.00021943088,0.0037047246,0.0000589803,0.00024559008,0.000017928525,0.0000037661146,0.000031446085],"genre_scores_gemma":[0.9967563,0.0024353028,0.00019396315,0.00034545764,0.00020757546,0.00001479432,0.000008791402,0.000015861657,0.000021958938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903405,0.00009855731,0.00028327553,0.00014902503,0.00011502141,0.00032006679],"domain_scores_gemma":[0.9992641,0.000045859786,0.00023983822,0.00023732301,0.000058239868,0.00015463257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025870526,0.00022035414,0.0003529225,0.000033495206,0.00007599817,0.000015416834,0.00012236598,0.00011140383,0.000020623507],"category_scores_gemma":[0.0000032166276,0.000100118115,0.00009953084,0.00008399582,0.00017201985,0.000035302997,0.000025720832,0.00019612329,6.9229407e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047990936,0.00030348267,0.084862985,0.000038817758,0.00061989395,0.00017170007,0.00033893643,0.000040998006,0.91073066,0.000022913991,0.000010935385,0.0023787562],"study_design_scores_gemma":[0.0028094277,0.0009765829,0.010830236,0.00020171965,0.0007839582,0.0016250194,0.0001745939,0.0000046972013,0.9823343,0.000015377913,0.00012170219,0.0001223965],"about_ca_topic_score_codex":0.00004552193,"about_ca_topic_score_gemma":0.0000057176644,"teacher_disagreement_score":0.074032746,"about_ca_system_score_codex":0.000113604816,"about_ca_system_score_gemma":0.00015519801,"threshold_uncertainty_score":0.40826982},"labels":[],"label_agreement":null},{"id":"W1975628280","doi":"10.1007/s13187-012-0344-1","title":"Knowledge of Reproductive System Cancers, Their Treatments and Side Effects","year":2012,"lang":"en","type":"article","venue":"Journal of Cancer Education","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Breast cancer; Cancer; Gynecology; Family medicine; Oncology; Internal medicine","score_opus":0.016101695814102028,"score_gpt":0.3657582254965226,"score_spread":0.34965652968242056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975628280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.893054,0.1015923,0.000009090559,0.0006833075,0.0020688863,0.00029348474,0.0000050459776,0.0000043071323,0.002289572],"genre_scores_gemma":[0.995472,0.0022696625,0.0002817925,0.000040733805,0.0016302847,0.000056956822,0.0000017333789,0.000012255311,0.00023454608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993643,0.000043096305,0.00026668742,0.00010204562,0.00010526887,0.000118608295],"domain_scores_gemma":[0.9989636,0.00006104362,0.00039814416,0.0001473066,0.00028874623,0.00014115185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017082374,0.00010234533,0.00031906128,0.000101664315,0.000027692324,0.0000055322957,0.000027914552,0.000035886358,0.000010028417],"category_scores_gemma":[0.000029267121,0.000068730005,0.00007297949,0.0001078289,0.000028906972,0.00014747988,0.0000073111314,0.00006867677,0.0000015761941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033211062,0.0014384199,0.5361602,0.0009674397,0.001241487,0.0000021940202,0.0076788473,0.00000448166,0.0018530564,0.00036478767,0.0021303245,0.4478267],"study_design_scores_gemma":[0.001755345,0.00059516146,0.9472683,0.0018560889,0.0011197992,0.00014883265,0.0017085094,0.0000033749263,0.039937336,0.000029309515,0.0055039814,0.00007394619],"about_ca_topic_score_codex":0.00038616624,"about_ca_topic_score_gemma":0.000013552919,"teacher_disagreement_score":0.44775274,"about_ca_system_score_codex":0.0012017669,"about_ca_system_score_gemma":0.0009692254,"threshold_uncertainty_score":0.31425786},"labels":[],"label_agreement":null},{"id":"W1975833718","doi":"10.5737/1181912x173133136","title":"Effectiveness of a nursing support program for patients with recurrent ovarian cancer receiving pegylated liposomal doxorubicin (Caelyx®/Doxil®)","year":2007,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Royal Victoria Regional Health Centre; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Ovarian cancer; Mucositis; Chemotherapy; Internal medicine; Oncology; Cancer; Adverse effect","score_opus":0.019316460938865097,"score_gpt":0.35562093912101606,"score_spread":0.336304478182151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975833718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98538536,0.0011955502,0.0008462627,0.003438338,0.0028863677,0.0030571623,0.000088216984,0.00004693108,0.0030557988],"genre_scores_gemma":[0.99370384,0.00006937462,0.0054202313,0.000120552264,0.0003994698,0.000108834385,0.00008354649,0.00006503337,0.000029105959],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976146,0.00014750834,0.0005665306,0.00039094238,0.00029726847,0.0009831554],"domain_scores_gemma":[0.9972604,0.00027713875,0.00040071443,0.00021030301,0.0007328446,0.0011185913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000919912,0.0002963234,0.000707934,0.00056468195,0.00035083268,0.000039942828,0.00012112957,0.00027483166,0.0001304101],"category_scores_gemma":[0.0000998458,0.00024872643,0.00017172575,0.000415991,0.00026968593,0.000119335964,0.0000045060156,0.0004850759,0.0000018661723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0044106063,0.0027932993,0.1797738,0.00013370132,0.00050743663,0.00029984833,0.0011869657,0.000014239501,0.00019158793,0.00013472057,0.001711842,0.80884194],"study_design_scores_gemma":[0.013604345,0.014841762,0.9508579,0.012356736,0.0011782672,0.0006544121,0.000283684,0.00006022407,0.0011346362,0.00015167812,0.0045681037,0.0003082752],"about_ca_topic_score_codex":0.0016652199,"about_ca_topic_score_gemma":0.007946314,"teacher_disagreement_score":0.80853367,"about_ca_system_score_codex":0.011593679,"about_ca_system_score_gemma":0.006012903,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W1975877336","doi":"10.1016/j.gore.2015.03.007","title":"Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Serous fluid; Peritoneum; Serous carcinoma; Serous membrane; Carcinoma; Oncology; Pathology; Internal medicine; Radiology; Cancer; Ovarian cancer","score_opus":0.025359063235798996,"score_gpt":0.2700174237737601,"score_spread":0.24465836053796108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975877336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991933,0.0006849586,0.000002158078,0.002011735,0.0020883053,0.0024625629,0.000060528546,0.00008713165,0.00066961115],"genre_scores_gemma":[0.99745214,0.00016016308,0.00022927213,0.0006963833,0.00035299544,0.0008587235,0.000051066836,0.00007163432,0.00012764052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950134,0.000778154,0.0013777628,0.0011781378,0.00066087046,0.0009916512],"domain_scores_gemma":[0.99534667,0.0013327734,0.0012569798,0.0013032034,0.0002718975,0.00048851024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015347794,0.00060079707,0.0018091911,0.00027151225,0.00017759834,0.000025773115,0.00021071888,0.0005722195,0.00006590267],"category_scores_gemma":[0.001912516,0.00038591443,0.0003634372,0.000647696,0.00050621055,0.00009356313,0.00014799788,0.00086516456,0.00000641577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052645826,0.004485094,0.95246327,0.000158432,0.00024403268,0.031428646,0.00295683,0.0004120613,0.00017764361,0.000009666246,0.0019336126,0.0052042366],"study_design_scores_gemma":[0.0057082316,0.0056978185,0.975777,0.00042625034,0.00073999306,0.0048889183,0.00093056867,0.00006262587,0.0044119684,0.00011984155,0.00086833996,0.00036845854],"about_ca_topic_score_codex":0.0059173936,"about_ca_topic_score_gemma":0.004389765,"teacher_disagreement_score":0.026539728,"about_ca_system_score_codex":0.0021894139,"about_ca_system_score_gemma":0.0037893166,"threshold_uncertainty_score":0.9998593},"labels":[],"label_agreement":null},{"id":"W1976191662","doi":"10.1007/s00280-004-0762-9","title":"A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study","year":2004,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Docetaxel; Medicine; Debulking; Neutropenia; Ovarian cancer; Cisplatin; Progressive disease; Chemotherapy; Phases of clinical research; Internal medicine; Oncology; Surgery; Cancer; Tumor Debulking","score_opus":0.03240721167240346,"score_gpt":0.3838513191967099,"score_spread":0.35144410752430644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976191662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553425,0.0056264605,0.000004470339,0.005410615,0.00016211244,0.0031756845,0.000053086835,0.000009007188,0.000024298208],"genre_scores_gemma":[0.98750013,0.009896912,0.00006443683,0.001052846,0.00012292957,0.0013150305,0.00000379363,0.000019492005,0.000024452174],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988375,0.000048183345,0.0004004368,0.00037028824,0.00012984854,0.0002137591],"domain_scores_gemma":[0.99941766,0.000078876976,0.00018460202,0.00019257594,0.000053513497,0.000072796014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107266904,0.00024361785,0.0006315833,0.00010038992,0.00008083026,0.000005180593,0.00007098327,0.000052156607,0.00026627403],"category_scores_gemma":[0.0000022090478,0.00015894647,0.000052957985,0.00020205336,0.00009116781,0.000046265734,0.000019379328,0.00009378654,1.6664956e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020420209,0.10416668,0.37821624,0.00032594678,0.0031528652,0.0002521424,0.09958049,0.00066242827,0.014359541,0.000018539315,0.00010992742,0.37873498],"study_design_scores_gemma":[0.5109944,0.09537109,0.3210844,0.00026380425,0.0022008312,0.000027499389,0.005536553,0.00026465708,0.05686472,0.000050028197,0.006957004,0.0003850355],"about_ca_topic_score_codex":0.0023702178,"about_ca_topic_score_gemma":0.0022294598,"teacher_disagreement_score":0.49057415,"about_ca_system_score_codex":0.00017408625,"about_ca_system_score_gemma":0.000098896126,"threshold_uncertainty_score":0.64816487},"labels":[],"label_agreement":null},{"id":"W1976214612","doi":"10.1590/s0004-27302011000700010","title":"Incidental finding of ovarian teratoma on post-therapy scan for papillary thyroid cancer and impact of SPECT/CT imaging","year":2011,"lang":"en","type":"article","venue":"Arquivos Brasileiros de Endocrinologia & Metabologia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Radiology; Papillary thyroid cancer; Thyroid cancer; Thyroid carcinoma; Abdomen; Thyroid; Lymph node; Malignancy; Nuclear medicine; Pathology; Internal medicine","score_opus":0.047200642166668,"score_gpt":0.33235913548270646,"score_spread":0.2851584933160385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976214612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902879,0.0074035744,0.000030136787,0.0001473572,0.0002096382,0.0011327612,0.000312904,0.000075731645,0.00039997243],"genre_scores_gemma":[0.99451673,0.0023141964,0.0023489767,0.00033248647,0.00010845503,0.00026181972,0.000034664416,0.00005321484,0.00002943502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978719,0.00008983052,0.00056452904,0.0005801745,0.00022004597,0.00067353575],"domain_scores_gemma":[0.9985244,0.00025322495,0.00039864736,0.000500391,0.00014472872,0.00017858438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019367982,0.00042691172,0.00093083817,0.00033092898,0.00010128851,0.000019103487,0.00020733532,0.000049665607,0.00034368213],"category_scores_gemma":[0.00015343736,0.0003136063,0.00039910348,0.0002417545,0.00030053352,0.00013942081,0.00009355919,0.00022836417,0.0000034455818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013308447,0.00063573633,0.90820503,0.00006451821,0.0008576566,0.00033211475,0.00037657953,0.0000038983962,0.066926695,0.0009641531,0.00019095447,0.020111846],"study_design_scores_gemma":[0.0038742826,0.0022424045,0.72616637,0.00010703917,0.0002382422,0.0004247221,0.00019413044,0.000020397603,0.26637024,0.00014752874,0.000023294058,0.00019134741],"about_ca_topic_score_codex":0.0025357094,"about_ca_topic_score_gemma":0.000054666525,"teacher_disagreement_score":0.19944355,"about_ca_system_score_codex":0.0002517257,"about_ca_system_score_gemma":0.00028475048,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W1976301747","doi":"10.1038/bjc.2012.307","title":"Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada)","funders":"","keywords":"Carboplatin; Medicine; Hazard ratio; Paclitaxel; Internal medicine; Confidence interval; Ovarian cancer; Chemotherapy; Clinical endpoint; Oncology; Urology; Surgery; Gastroenterology; Randomized controlled trial; Cancer; Cisplatin","score_opus":0.022326826636536557,"score_gpt":0.30727154723815603,"score_spread":0.28494472060161946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976301747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064755,0.0064025074,0.00000433237,0.0003180338,0.000687349,0.0006502421,0.0008728078,0.000004923445,0.00041226397],"genre_scores_gemma":[0.99662215,0.0023111207,0.00019697857,0.000059649028,0.0006460215,0.000024084375,0.00003541697,0.000031764634,0.000072846575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971253,0.00017261117,0.0014222161,0.00026957202,0.0006135187,0.00039674403],"domain_scores_gemma":[0.9977332,0.00025357786,0.0011323863,0.00013309717,0.00047137274,0.00027641095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005752022,0.0002582094,0.0011595293,0.0001972575,0.00005022873,0.000024952726,0.000059668262,0.00017678269,0.000054897173],"category_scores_gemma":[0.00019185501,0.00025272506,0.00014492388,0.0002147844,0.0001593128,0.00024085703,0.000044543995,0.00038374742,1.3242985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24856254,0.007013604,0.5525373,0.00047047302,0.0018609542,0.0009308916,0.0047029704,0.00018572803,0.005729949,0.00009040163,0.0017591424,0.17615604],"study_design_scores_gemma":[0.26666164,0.0027916748,0.7220309,0.002225284,0.0005772695,0.00014800706,0.00012346622,0.00012211976,0.004792516,0.000020585894,0.00028822833,0.00021831246],"about_ca_topic_score_codex":0.03216758,"about_ca_topic_score_gemma":0.0060045817,"teacher_disagreement_score":0.17593773,"about_ca_system_score_codex":0.0002777331,"about_ca_system_score_gemma":0.00039087833,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W1976435116","doi":"10.1158/1538-7445.am2014-lb-312","title":"Abstract LB-312: The somatic mutational landscape of ovarian clear cell carcinoma and its precursor lesions","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"","keywords":"ARID1A; KRAS; Biology; Serous fluid; Cancer research; Endometriosis; Clear cell carcinoma; Mutation; Somatic cell; Gene; Genetics; Oncology; Carcinoma; Internal medicine; Medicine","score_opus":0.0689584520663348,"score_gpt":0.3711548639577383,"score_spread":0.30219641189140345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976435116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196644,0.002894391,0.000004409142,0.0061508166,0.000067338624,0.0005613904,0.00004055252,0.000009885342,0.008304806],"genre_scores_gemma":[0.99842,0.00033215637,0.00006688219,0.00008812535,0.0002080761,0.0002075988,0.000012204472,0.000019423998,0.0006455054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987157,0.000100180725,0.00018496974,0.00023316979,0.000496838,0.0002691556],"domain_scores_gemma":[0.9988267,0.00048281832,0.000053707325,0.00026043426,0.00022863023,0.00014774346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055429176,0.000094688476,0.0001907399,0.000102273836,0.00016467241,0.000026815667,0.00010665007,0.000056366527,0.00091747585],"category_scores_gemma":[0.00010091625,0.000060411603,0.000049945873,0.00020464764,0.00010499303,0.000045520243,0.000052118827,0.00024211734,0.0000529266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038140947,0.0047795223,0.6132833,0.008845052,0.001209509,0.00031703652,0.01681646,0.00047410806,0.06628714,0.03550431,0.098692834,0.14997667],"study_design_scores_gemma":[0.0026055353,0.0005255676,0.9684369,0.00023325207,0.00008072743,0.000012691136,0.00034820652,0.0006621707,0.022158518,0.00045445078,0.004390336,0.00009165046],"about_ca_topic_score_codex":0.0002813107,"about_ca_topic_score_gemma":0.00006419621,"teacher_disagreement_score":0.35515362,"about_ca_system_score_codex":0.000076223885,"about_ca_system_score_gemma":0.0003372446,"threshold_uncertainty_score":0.9999958},"labels":[],"label_agreement":null},{"id":"W1976446230","doi":"10.1016/j.ygyno.2004.12.059","title":"Development of ovarian cancer surgery quality indicators using a modified Delphi approach","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Cancer Care Ontario","funders":"","keywords":"Medicine; Delphi method; Multidisciplinary approach; Delphi; Radiation oncologist; Psychological intervention; Ovarian cancer; Quality (philosophy); Medical physics; Family medicine; Surgery; Cancer; Radiation therapy; Nursing; Internal medicine","score_opus":0.1513645134398713,"score_gpt":0.3984230757904187,"score_spread":0.24705856235054738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976446230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845243,0.00056457956,0.0007741831,0.0015963307,0.0003011644,0.00060550513,0.000014608488,0.000057004112,0.0076341997],"genre_scores_gemma":[0.9220343,0.00012917032,0.076379575,0.00087407115,0.0001664472,0.00029935784,0.000033258126,0.000017982833,0.00006579242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99781466,0.00017430395,0.0008736388,0.00045033885,0.00024692543,0.00044015134],"domain_scores_gemma":[0.99843055,0.0004990145,0.00048465913,0.0003010795,0.00009166856,0.00019302184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095781917,0.0002231353,0.0009619549,0.00028443566,0.000118650714,0.0000058816786,0.00010765083,0.0003375055,0.0007606207],"category_scores_gemma":[0.00017410822,0.0001788769,0.00016371738,0.00038696744,0.00014150733,0.000052995638,0.00007974347,0.00019184973,0.000013648319],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050809816,0.0063369256,0.26318198,0.0002738685,0.0010786561,0.000073744624,0.0034150868,0.00084253476,0.001229936,0.0019881641,0.0014915343,0.71957946],"study_design_scores_gemma":[0.0051720873,0.00035509685,0.9187515,0.00007460366,0.0005358454,0.00006327915,0.0010163953,0.0008733316,0.0039096307,0.000087756525,0.06868061,0.00047990863],"about_ca_topic_score_codex":0.00019683168,"about_ca_topic_score_gemma":0.00027185507,"teacher_disagreement_score":0.7190996,"about_ca_system_score_codex":0.0014737478,"about_ca_system_score_gemma":0.0025216313,"threshold_uncertainty_score":0.8328263},"labels":[],"label_agreement":null},{"id":"W1976748828","doi":"10.1158/1538-7445.am2011-3193","title":"Abstract 3193: Valosin containing protein (VCP) is a potential novel serum marker for ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Hyacinthe","funders":"","keywords":"Ovarian cancer; Medicine; Biology; Cancer research; Cancer; Pathology; Internal medicine","score_opus":0.17529859857631414,"score_gpt":0.4159299085706017,"score_spread":0.24063130999428756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976748828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96261305,0.003357997,0.00051446474,0.014003744,0.00071038137,0.0063239564,0.0010739447,0.00011100229,0.011291488],"genre_scores_gemma":[0.9865731,0.0003109781,0.00167653,0.00065277907,0.0008545915,0.006174038,0.00002188291,0.000095471754,0.0036406305],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99705094,0.000049811108,0.00037492497,0.00074218825,0.00076198805,0.0010201288],"domain_scores_gemma":[0.9981951,0.00007899266,0.00010198884,0.0005431852,0.0006801313,0.00040060788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008590456,0.0002714247,0.00044493066,0.00023947062,0.00030402598,0.00007507724,0.00023062748,0.00019394093,0.009426037],"category_scores_gemma":[0.00006890873,0.00022954603,0.00021315311,0.0003707898,0.00017599482,0.00014907373,0.00010009284,0.00050788664,0.00006326075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032823104,0.007453977,0.20253669,0.004597547,0.007267438,0.0012408617,0.0121626,0.000029312097,0.3039379,0.008667399,0.113765955,0.3055172],"study_design_scores_gemma":[0.017441273,0.0018146471,0.76243764,0.0023329118,0.00037202632,0.000028088825,0.0006495458,0.00025716302,0.14757904,0.0009098187,0.0655158,0.00066200725],"about_ca_topic_score_codex":0.009565785,"about_ca_topic_score_gemma":0.0006675128,"teacher_disagreement_score":0.559901,"about_ca_system_score_codex":0.0008741118,"about_ca_system_score_gemma":0.0014363476,"threshold_uncertainty_score":0.9970296},"labels":[],"label_agreement":null},{"id":"W197851819","doi":"10.1007/978-1-4419-9751-7_18","title":"Familial Cancer and Prophylactic Surgery","year":2011,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Serous fluid; Lynch syndrome; Prophylactic Surgery; Lesion; Genetic testing; Cancer; Gynecology; Oncology; Pathology; Internal medicine; Colorectal cancer; DNA mismatch repair","score_opus":0.0551652232358898,"score_gpt":0.26332236809699294,"score_spread":0.20815714486110315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W197851819","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073616166,0.0076097827,0.000002687086,0.0011072243,0.00051840674,0.00050679705,0.000036443125,0.000054236392,0.9894283],"genre_scores_gemma":[0.058998898,0.0113719115,0.00008978363,0.00080004224,0.0005975962,0.00008454312,0.000025411488,0.00006834385,0.9279635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991658,0.0000026462976,0.00019211137,0.00033969447,0.00015522854,0.00014454091],"domain_scores_gemma":[0.9994179,0.0000521617,0.0000857998,0.00024096157,0.000058001613,0.00014514613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000040529205,0.00024594783,0.0005096351,0.00009348661,0.000028129907,0.0000100638845,0.000019999967,0.00019525326,0.005797559],"category_scores_gemma":[0.0000054469483,0.00017410402,0.0001355582,0.000009491109,0.00006779903,0.000024569617,0.000025508318,0.00015201066,0.00012682776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072875316,0.00036249784,0.030495696,0.0017765542,0.0024501395,0.0015069351,0.00020893155,5.576205e-8,0.000015985388,0.11972401,0.091472216,0.7512582],"study_design_scores_gemma":[0.0015710692,0.00047639137,0.028531034,0.0012883522,0.0023410865,0.00012253216,0.000005377835,0.0000012658679,0.00029139145,0.005789449,0.958934,0.0006480557],"about_ca_topic_score_codex":0.00060439983,"about_ca_topic_score_gemma":0.00011401585,"teacher_disagreement_score":0.8674618,"about_ca_system_score_codex":0.00011523842,"about_ca_system_score_gemma":0.00029050428,"threshold_uncertainty_score":0.9951113},"labels":[],"label_agreement":null},{"id":"W1979045512","doi":"10.1158/0008-5472.can-09-2669","title":"Adult-Type Granulosa Cell Tumors and FOXL2 Mutation","year":2009,"lang":"en","type":"review","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Somatic cell; Granulosa cell; Pathogenesis; Stromal cell; Biology; Germline mutation; Mutation; Cancer research; Cell type; Cell; Ovary; Genetics; Gene; Immunology","score_opus":0.1457025029729518,"score_gpt":0.48234876590819875,"score_spread":0.33664626293524696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979045512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003048556,0.9938241,7.5747613e-7,0.0006195743,0.00015237581,0.0017233544,0.000053642605,0.000031827916,0.0032894963],"genre_scores_gemma":[0.0006714487,0.9958034,0.00008440405,0.00010312396,0.0005300373,0.0006288747,0.00017124183,0.00006513193,0.001942318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760544,0.0002019393,0.00037791254,0.00065043615,0.00064841565,0.0005158601],"domain_scores_gemma":[0.998448,0.0002147845,0.00010883147,0.00046010825,0.0004570086,0.00031122888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837536,0.00031350972,0.0011737406,0.00037696847,0.00013963607,0.00006666405,0.00012989047,0.00023097175,0.00030106714],"category_scores_gemma":[0.00007878077,0.00023134254,0.00018931384,0.0007467856,0.00012882547,0.00004877521,0.00005790284,0.0007531887,0.00016679426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041563708,0.0001450245,0.00005387222,0.013914563,0.00011741646,0.000377021,0.000067112625,1.15816924e-7,0.0000012539285,0.000112602094,0.010146695,0.97502273],"study_design_scores_gemma":[0.0009811952,0.0007349939,0.00020722474,0.019872013,0.0006746185,0.00008570886,0.000024879386,0.0000014065806,0.000046494344,0.000106334315,0.97704995,0.00021521217],"about_ca_topic_score_codex":0.00043497645,"about_ca_topic_score_gemma":0.000047501275,"teacher_disagreement_score":0.97480756,"about_ca_system_score_codex":0.0007600302,"about_ca_system_score_gemma":0.0014794494,"threshold_uncertainty_score":0.9433875},"labels":[],"label_agreement":null},{"id":"W1979055263","doi":"10.1097/igc.0000000000000230","title":"Early-Stage Endometrioid Ovarian Carcinoma","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Univariate analysis; Multivariate analysis; Oncology; Population; Adjuvant therapy; Adjuvant; Cancer; Gynecology; Surgery","score_opus":0.02579384745949379,"score_gpt":0.3204834208071613,"score_spread":0.2946895733476675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979055263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950125,0.0006063151,0.000593875,0.0094614,0.002101327,0.000126895,0.000020871646,0.000013440578,0.0075746253],"genre_scores_gemma":[0.9942724,0.0003822462,0.0011416252,0.0021047473,0.0012967793,0.000018892346,0.0000032304017,0.000011530208,0.00076852244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985897,0.00005192174,0.00042927937,0.00016007303,0.000592184,0.00017687467],"domain_scores_gemma":[0.9984382,0.00036051124,0.00031537007,0.00011165585,0.00057454844,0.00019971623],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030081018,0.00012632579,0.00034020207,0.00020733848,0.000031900683,0.000043448996,0.00022770301,0.00008690984,0.0046815756],"category_scores_gemma":[0.00054236443,0.000084857085,0.00024081262,0.00012515941,0.000055001812,0.00010033136,0.00004722475,0.00024243101,0.000034611203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077290257,0.0006826208,0.89525545,0.000012170016,0.0006805661,0.0008597862,0.00009156767,0.000089163645,0.0005123162,0.0042412407,0.0026651006,0.09413711],"study_design_scores_gemma":[0.0042407606,0.0012132453,0.8695388,0.00004913373,0.000101907106,0.00013275495,0.000014332999,0.000055899178,0.0013626876,0.0003139721,0.12289328,0.00008324478],"about_ca_topic_score_codex":0.00012598292,"about_ca_topic_score_gemma":0.00001913949,"teacher_disagreement_score":0.12022818,"about_ca_system_score_codex":0.00049538154,"about_ca_system_score_gemma":0.00017073602,"threshold_uncertainty_score":0.9962283},"labels":[],"label_agreement":null},{"id":"W1979114632","doi":"10.1016/s0140-6736(05)73293-1","title":"Ovarian cancer not so silent after all","year":2000,"lang":"en","type":"article","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Medicine; Pathological; Ovarian carcinoma; Cancer; Quarter (Canadian coin); Gynecology; Oncology; Gerontology; Internal medicine; History","score_opus":0.035503941934228345,"score_gpt":0.30838510719907647,"score_spread":0.2728811652648481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979114632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7997732,0.0032812376,0.000004132962,0.1746092,0.00027742135,0.00048783474,0.00011542097,0.000090538786,0.021360984],"genre_scores_gemma":[0.9618436,0.0023321782,0.00018375763,0.02929677,0.0018226269,0.0002989205,0.000010388202,0.000018352895,0.004193393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992359,0.000025867635,0.000117984484,0.0001845499,0.00016571005,0.00026995144],"domain_scores_gemma":[0.9993433,0.00002830724,0.00002300512,0.0005114853,0.000017118899,0.00007679859],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000974839,0.00011513057,0.0002809795,0.000013576538,0.000042280222,0.000031843378,0.000098527606,0.00003893685,0.012642618],"category_scores_gemma":[0.0000037808154,0.00006534134,0.00007243927,0.000063496125,0.000048838505,0.000026839429,0.000015210998,0.00011728196,0.00058507215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004990444,0.00087088684,0.14212534,0.00015218063,0.001342837,0.0005060411,0.004708215,0.00010686271,0.00037267312,0.0016841114,0.31025255,0.5328879],"study_design_scores_gemma":[0.0022619253,0.00007296364,0.3462892,0.00007706413,0.00016234051,0.00001297469,0.0000072873845,0.00002906847,0.0006288582,0.0000916279,0.65029585,0.0000708305],"about_ca_topic_score_codex":0.0006182753,"about_ca_topic_score_gemma":0.00013160054,"teacher_disagreement_score":0.53281707,"about_ca_system_score_codex":0.000092119066,"about_ca_system_score_gemma":0.000060410264,"threshold_uncertainty_score":0.98826},"labels":[],"label_agreement":null},{"id":"W1979309900","doi":"10.1186/1471-2407-13-549","title":"Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer","year":2013,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University","funders":"Ontario Institute for Cancer Research; Ottawa Hospital Research Institute","keywords":"Gene expression profiling; Chemotherapy; Microarray; Serous fluid; Ovarian cancer; Oncology; Gene signature; Cancer research; Significance analysis of microarrays; Transcriptome; Biology; Microarray analysis techniques; PI3K/AKT/mTOR pathway; DNA microarray; Gene expression; Medicine; Cancer; Gene; Internal medicine; Signal transduction; Genetics","score_opus":0.016778409892442128,"score_gpt":0.2594759275998905,"score_spread":0.2426975177074484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979309900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896841,0.003694783,0.00021475044,0.004719952,0.0001878258,0.0013656935,0.00009132004,0.000025415931,0.000016140037],"genre_scores_gemma":[0.99403054,0.002508217,0.00027851202,0.00032362316,0.00019161697,0.0012372916,0.000012854591,0.000045033055,0.0013723429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843067,0.000171698,0.00040545707,0.0004188323,0.00027449869,0.00029884212],"domain_scores_gemma":[0.9988861,0.00018737194,0.0003307098,0.00037168627,0.00013357819,0.00009052752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025188428,0.00024171502,0.00042730002,0.00007094089,0.0000957277,0.000037863905,0.000091055845,0.000119595556,0.00013311746],"category_scores_gemma":[0.000027118866,0.0001530667,0.000077156394,0.00039427358,0.00010421856,0.00007744358,0.000015806414,0.00011509043,0.000001546382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104576945,0.00165973,0.88891834,0.00012090576,0.0014841967,0.00003078214,0.0025810113,0.016244868,0.05959328,0.00016700191,0.0009065182,0.017835682],"study_design_scores_gemma":[0.0075001107,0.00027331986,0.9525134,0.00062327436,0.00025356392,0.0000023100558,0.00005070897,0.0012506444,0.037032317,0.00006174716,0.00026533645,0.00017328827],"about_ca_topic_score_codex":0.0074151168,"about_ca_topic_score_gemma":0.014849034,"teacher_disagreement_score":0.06359505,"about_ca_system_score_codex":0.0011562277,"about_ca_system_score_gemma":0.00042163834,"threshold_uncertainty_score":0.99919456},"labels":[],"label_agreement":null},{"id":"W1979709020","doi":"10.1016/j.ijrobp.2012.07.1216","title":"Integration of CT-planned Interstitial Brachytherapy Boost in Advanced Gynecologic Malignancies","year":2012,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Cancer Care Ontario; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Brachytherapy; Nuclear medicine; Rectum; Radiation treatment planning; Radiation therapy; Cumulative dose; Dose rate; Dosimetry; External beam radiotherapy; Radiology; Surgery; Medical physics","score_opus":0.024880029863107955,"score_gpt":0.34137985284211886,"score_spread":0.3164998229790109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979709020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836386,0.0014292471,0.00303344,0.002824145,0.0031436258,0.0002792668,0.000050826955,0.000016886037,0.00085868186],"genre_scores_gemma":[0.9933241,0.0012642137,0.0031534997,0.0008757454,0.0012184107,0.000023856308,0.00009425606,0.00001736836,0.000028521798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845284,0.00015373221,0.0007966885,0.00015410373,0.00021056135,0.00023204398],"domain_scores_gemma":[0.9979807,0.0003835037,0.000977297,0.000117593074,0.00043906164,0.00010182302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046643158,0.00017698441,0.00052841037,0.00022566068,0.00002746398,0.000010210793,0.00018529127,0.0001261193,0.0001507986],"category_scores_gemma":[0.00027316858,0.00014358624,0.00019841107,0.00015808678,0.00012615978,0.00038363735,0.000029145378,0.00029687225,0.000015436222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013433043,0.0017046604,0.71755683,0.000011092608,0.00046861373,0.00005601027,0.0008605946,0.00025157782,0.015202035,0.012140731,0.0005470521,0.2498575],"study_design_scores_gemma":[0.023610631,0.00833868,0.8622093,0.00043597157,0.00028847414,0.0006241451,0.0007043611,0.0006722569,0.061043527,0.0070484765,0.03463821,0.00038593874],"about_ca_topic_score_codex":0.000026466189,"about_ca_topic_score_gemma":0.000021534068,"teacher_disagreement_score":0.24947156,"about_ca_system_score_codex":0.00096602424,"about_ca_system_score_gemma":0.00031425926,"threshold_uncertainty_score":0.5855277},"labels":[],"label_agreement":null},{"id":"W1979803519","doi":"10.1016/j.prp.2005.12.004","title":"Chemotherapy-induced alterations in ovarian sex cord tumor with annular tubules (SCTAT): A diagnostic challenge","year":2006,"lang":"en","type":"article","venue":"Pathology - Research and Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Chemotherapy; Ovarian carcinoma; Medicine; Adjuvant chemotherapy; Oncology; Ovarian cancer; Pathology; Internal medicine; Cancer","score_opus":0.06240211757214884,"score_gpt":0.38734898703840037,"score_spread":0.3249468694662515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979803519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9033255,0.0027666276,0.000096757816,0.07150192,0.00006261847,0.0013873648,0.000020157024,0.000036832345,0.02080223],"genre_scores_gemma":[0.99466306,0.0014795586,0.0020964008,0.00068654295,0.00021244453,0.00039878642,0.000036216334,0.000028652967,0.00039834465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790114,0.00056500576,0.00022379123,0.0004856708,0.0003317764,0.0004925988],"domain_scores_gemma":[0.9957537,0.0034499601,0.00006771103,0.00033894082,0.00023410894,0.00015554881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012504385,0.00016320667,0.00029406563,0.0002368221,0.00018967566,0.000063814165,0.0000657619,0.00007974288,0.00011388589],"category_scores_gemma":[0.0012076213,0.000115085495,0.000023545672,0.00032537768,0.0001913035,0.0002197104,0.000038185335,0.00051899184,0.0000329169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028534813,0.031748272,0.60286635,0.00079520483,0.0010296127,0.16809191,0.008962371,0.000020638463,0.01669822,0.05647266,0.006315419,0.07846455],"study_design_scores_gemma":[0.02100241,0.022401864,0.87614405,0.0005385834,0.00029070774,0.010927182,0.0039849146,0.00013633234,0.007716737,0.0071498253,0.04903918,0.00066821254],"about_ca_topic_score_codex":0.0015381748,"about_ca_topic_score_gemma":0.0012704163,"teacher_disagreement_score":0.27327773,"about_ca_system_score_codex":0.000101087186,"about_ca_system_score_gemma":0.00029312487,"threshold_uncertainty_score":0.46930504},"labels":[],"label_agreement":null},{"id":"W1979901429","doi":"10.1097/01.pgp.0000130049.19643.f6","title":"Early Recurrence of Ovarian Serous Borderline Tumor as High-grade Carcinoma: A Report of Two Cases","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Serous fluid; Medicine; Serous carcinoma; Stage (stratigraphy); Clear cell carcinoma; Carcinoma; Ovarian carcinoma; Lymph node; Pathology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.027721893313729134,"score_gpt":0.3328979535969804,"score_spread":0.3051760602832512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979901429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921528,0.00040402147,0.0003220012,0.0055383453,0.0010229785,0.00016342736,0.000036476937,0.000007250075,0.0003526789],"genre_scores_gemma":[0.99190617,0.0000999186,0.0072673527,0.0004151531,0.0002536366,0.000009667275,0.000013777543,0.000009528429,0.000024821995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998049,0.00008125452,0.0010207171,0.00021663061,0.00045955714,0.0001728491],"domain_scores_gemma":[0.9973313,0.0003677824,0.0010702849,0.00017508127,0.00092794135,0.0001275887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037248342,0.0001484101,0.0006275813,0.00020314782,0.000020300933,0.0000072029857,0.00022846316,0.00009512401,0.00030057057],"category_scores_gemma":[0.0013536684,0.00010659033,0.00022881605,0.00012304197,0.0002072363,0.00007378769,0.00006733695,0.00026811718,0.0000065960403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018554227,0.0066867904,0.5983776,0.000043067455,0.0007979495,0.35913098,0.00037489558,0.00040799193,0.0077750254,0.017586982,0.00021381033,0.006749516],"study_design_scores_gemma":[0.0079962155,0.0072717047,0.89359,0.00015510664,0.00022012352,0.07177532,0.000048774968,0.00000291606,0.008645444,0.009909456,0.00028373464,0.000101244914],"about_ca_topic_score_codex":0.00060367637,"about_ca_topic_score_gemma":0.000051579307,"teacher_disagreement_score":0.2952124,"about_ca_system_score_codex":0.00023471336,"about_ca_system_score_gemma":0.00045184704,"threshold_uncertainty_score":0.43466273},"labels":[],"label_agreement":null},{"id":"W1979909956","doi":"10.1046/j.1525-1438.2001.11(suppl.1)sup1068.x","title":"Impact of new non-cytotoxics in the treatment of ovarian cancer","year":2001,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Carboplatin; Oncology; Ovarian carcinoma; Clinical trial; Paclitaxel; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.11746670883883477,"score_gpt":0.4685798291412507,"score_spread":0.3511131203024159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979909956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01025546,0.9864369,0.000013572847,0.0009320577,0.00089761906,0.0007363085,0.00020119819,0.0000023411167,0.0005245542],"genre_scores_gemma":[0.017524492,0.9807341,0.00014724192,0.00009844102,0.0011349444,0.000118742275,0.000017564716,0.000020847807,0.0002035976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744385,0.000105045365,0.0013336663,0.00021279069,0.000689744,0.00021488272],"domain_scores_gemma":[0.9970688,0.0005523555,0.0015939546,0.00021248379,0.00043126364,0.0001410935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022642492,0.0003466738,0.002049773,0.00032307254,0.000013768112,0.000018161563,0.00045915946,0.00025432897,0.0030584554],"category_scores_gemma":[0.00009068722,0.00015974288,0.0016008453,0.0003489358,0.00007656682,0.000056941677,0.000025308975,0.00030870442,0.0000032613082],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032956182,0.0025876535,0.022778135,0.0002776794,0.003651154,0.00068849744,0.0002253399,0.00009313545,0.0000014458544,0.000035341924,0.0016849623,0.9676471],"study_design_scores_gemma":[0.00577591,0.006763219,0.13208629,0.008979254,0.002942082,0.00044150077,0.000028925626,0.000006566019,0.000013458814,0.000109799985,0.8426454,0.00020759045],"about_ca_topic_score_codex":0.0019633404,"about_ca_topic_score_gemma":0.00033827126,"teacher_disagreement_score":0.96743953,"about_ca_system_score_codex":0.0030629684,"about_ca_system_score_gemma":0.002864018,"threshold_uncertainty_score":0.99785286},"labels":[],"label_agreement":null},{"id":"W1980747736","doi":"10.1111/j.1525-1438.2006.00305.x","title":"Primary malignant mesodermal ovarian sarcomas","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Stage (stratigraphy); Adjuvant chemotherapy; Surgery; Disease; Adjuvant; Oncology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.01619722178816822,"score_gpt":0.29752697941472117,"score_spread":0.28132975762655293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980747736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92215294,0.005311691,0.0005599008,0.04241262,0.0031027836,0.00027102797,0.00005288464,0.00003258233,0.026103599],"genre_scores_gemma":[0.9920082,0.00053284207,0.0020461492,0.0030178695,0.0015841444,0.000020225536,0.000013136738,0.000011813073,0.00076558394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985039,0.000034150275,0.000504426,0.00015628102,0.00061603193,0.00018516507],"domain_scores_gemma":[0.9988587,0.00013635526,0.0003038835,0.000088651774,0.0004977969,0.000114628776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018038998,0.0001317661,0.00032855073,0.00011747353,0.000033073055,0.000037667112,0.00019186022,0.00008784434,0.0030690124],"category_scores_gemma":[0.000053919623,0.000086440654,0.00024294121,0.00007442542,0.00006117057,0.000110599234,0.00004776379,0.00019941057,0.000020010753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017259457,0.0031754947,0.81062984,0.000032735185,0.001460933,0.0082273055,0.00005954437,0.0005012925,0.0049311253,0.010134121,0.045239884,0.113881774],"study_design_scores_gemma":[0.003463373,0.00049136375,0.9049864,0.000100982936,0.00015057718,0.00063683203,0.000009458923,0.000024852206,0.0018316454,0.0013384233,0.08686634,0.00009976],"about_ca_topic_score_codex":0.00012553895,"about_ca_topic_score_gemma":0.000036035,"teacher_disagreement_score":0.11378202,"about_ca_system_score_codex":0.00075137324,"about_ca_system_score_gemma":0.00031141998,"threshold_uncertainty_score":0.9978423},"labels":[],"label_agreement":null},{"id":"W1980752656","doi":"10.1016/j.ygyno.2009.09.029","title":"Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"BC Cancer Agency; Eli Lilly Canada; Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Ovarian cancer; Stage (stratigraphy); Oncology; Clear cell carcinoma; Internal medicine; Clear cell; Carcinoma; Univariate analysis; Population; Cohort; Cancer; Multivariate analysis; Biology","score_opus":0.026131896738301286,"score_gpt":0.3016891471119304,"score_spread":0.2755572503736291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980752656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98136264,0.0022520998,0.0000035784724,0.009203194,0.00013480989,0.00060119526,0.000017312566,0.000034782992,0.0063904044],"genre_scores_gemma":[0.9967656,0.001110267,0.00052458665,0.0012029167,0.00005602668,0.000056565746,0.000023106682,0.000007945303,0.00025297108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989508,0.00008344462,0.00023747578,0.0004083652,0.00006221871,0.00025772367],"domain_scores_gemma":[0.9992159,0.00028576862,0.000076174816,0.00019349271,0.000054926797,0.00017375215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017374012,0.00015760036,0.00043596287,0.00012013476,0.00013021119,0.000013027468,0.000041014053,0.00015093769,0.00009276444],"category_scores_gemma":[0.00013783113,0.0001247815,0.000016809385,0.00020071185,0.00013550499,0.000056362376,0.00006530463,0.00016455876,0.0000027171975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019919554,0.0010095611,0.9516688,0.000034325563,0.000048071317,0.00061948504,0.0008282356,0.0000012659907,0.0005246766,0.015114783,0.00045649955,0.029495103],"study_design_scores_gemma":[0.0037487233,0.0050605224,0.9714731,0.000009756741,0.00008362941,0.00010025714,0.00019012328,0.000036999616,0.00004374207,0.001002422,0.018144453,0.00010627786],"about_ca_topic_score_codex":0.00011344241,"about_ca_topic_score_gemma":0.0008222452,"teacher_disagreement_score":0.029388826,"about_ca_system_score_codex":0.0002051738,"about_ca_system_score_gemma":0.00021593439,"threshold_uncertainty_score":0.5088442},"labels":[],"label_agreement":null},{"id":"W1981858001","doi":"10.1111/j.1525-1438.2007.01108.x","title":"Future opportunities of the Gynecological Cancer Intergroup","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Cancer Research Institute","keywords":"Medicine; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.07982529874400798,"score_gpt":0.3351600051317568,"score_spread":0.2553347063877488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981858001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94433177,0.003800792,0.000021110005,0.04493234,0.0046299207,0.000181356,0.000049640545,0.000010272881,0.0020428023],"genre_scores_gemma":[0.9799449,0.013617681,0.00022034053,0.0037550493,0.001557691,0.00004784726,0.000002461196,0.000010787153,0.0008432681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982418,0.00007150141,0.0006209956,0.00015994316,0.00072196854,0.00018378628],"domain_scores_gemma":[0.99801755,0.00023153686,0.0005858987,0.00013978842,0.00088486494,0.00014036558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017120947,0.00016480772,0.00045454793,0.000093885435,0.0000684266,0.000012243081,0.0004263812,0.00014267699,0.006430919],"category_scores_gemma":[0.00019974008,0.00008477978,0.00042406685,0.00011038072,0.0002787271,0.00010366054,0.00011657953,0.00036417795,0.000003588063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012168722,0.0018418088,0.85795176,0.00003382507,0.0019806286,0.0018127224,0.00049701775,0.00022061069,0.0007590712,0.0027076346,0.037916858,0.09306117],"study_design_scores_gemma":[0.0022950228,0.0007821772,0.8868641,0.00017352783,0.00017987755,0.00054115814,0.00021114998,0.000016887374,0.001761839,0.00026067876,0.106809765,0.000103812505],"about_ca_topic_score_codex":0.000077896795,"about_ca_topic_score_gemma":0.000080122634,"teacher_disagreement_score":0.09295736,"about_ca_system_score_codex":0.0006125806,"about_ca_system_score_gemma":0.00060461654,"threshold_uncertainty_score":0.99447733},"labels":[],"label_agreement":null},{"id":"W1982051964","doi":"10.2350/14-11-1576-let.1","title":"Neurogenic Ovarian Cyst—A Rare, Monodermal Teratoma","year":2015,"lang":"en","type":"letter","venue":"Pediatric and Developmental Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Ovarian Teratoma; Medicine; Pathology; Ovarian cyst; Teratoma; Anatomy; Cyst; Biology","score_opus":0.021727877289459005,"score_gpt":0.24473285758551544,"score_spread":0.22300498029605642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982051964","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37977448,0.022887222,0.00009957276,0.56695783,0.0041997726,0.0030263509,0.00086375,0.0005429145,0.021648109],"genre_scores_gemma":[0.07679065,0.0045803655,0.0082887,0.8868595,0.012969594,0.00058521953,0.003635428,0.00027844447,0.0060121305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975094,0.00010075439,0.000512925,0.0008877023,0.00037371585,0.00061545474],"domain_scores_gemma":[0.9990752,0.00009616889,0.00017663158,0.00028963128,0.00009918391,0.0002632052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014449243,0.00054210966,0.0008246687,0.0003334986,0.000117253854,0.000046962992,0.00012247864,0.00087299896,0.0002478229],"category_scores_gemma":[0.000042904812,0.00046837697,0.00013710969,0.00023125274,0.000093094946,0.000070343296,0.00019818956,0.0009835738,0.00035778864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006661448,0.00010948483,0.07264253,0.00016491991,0.00015325304,0.034214865,0.0001956539,7.170217e-8,0.000005812232,0.0000076278084,0.8896278,0.0028113862],"study_design_scores_gemma":[0.0054394603,0.00061063335,0.095495075,0.00003214507,0.0012931615,0.026416583,0.000045403114,0.000005678105,0.000034197103,0.00019866388,0.869616,0.00081301853],"about_ca_topic_score_codex":0.000032353662,"about_ca_topic_score_gemma":0.0000031518007,"teacher_disagreement_score":0.31990165,"about_ca_system_score_codex":0.00025968827,"about_ca_system_score_gemma":0.0008930849,"threshold_uncertainty_score":0.9997768},"labels":[],"label_agreement":null},{"id":"W1982570340","doi":"10.1200/edbook_am.2013.33.e205","title":"Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Radiation therapy; Oncology; Chemotherapy; Cancer; Disease; Internal medicine; Serous ovarian cancer; Clear cell; Stage (stratigraphy); Carcinoma; Biology","score_opus":0.042238208908425265,"score_gpt":0.4209099409121961,"score_spread":0.3786717320037708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982570340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83205384,0.0027243933,0.000116482945,0.16001591,0.00034206736,0.001870633,0.00011700159,0.000008261272,0.0027514328],"genre_scores_gemma":[0.9816313,0.0033733246,0.009467932,0.0026444655,0.0012358953,0.00066302647,0.000041757787,0.000013601473,0.0009287431],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986082,0.000079529695,0.0008235036,0.0002057004,0.00014615738,0.00013696418],"domain_scores_gemma":[0.9951519,0.0031365175,0.0010498753,0.00021081649,0.00036678696,0.0000841308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035138335,0.000107033906,0.00073043373,0.000016261447,0.000049209557,0.000002304144,0.000080730824,0.000082378094,0.00045901493],"category_scores_gemma":[0.00017608644,0.00007044187,0.000530055,0.00009810391,0.00060636975,0.000041180894,0.000013923877,0.00008183676,0.0000052973955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014864557,0.000888088,0.24574947,0.000033012933,0.0006740729,4.2689358e-8,0.0007389522,0.000011059497,0.00048536024,0.0007154612,0.0030446404,0.7475112],"study_design_scores_gemma":[0.0025758606,0.0024362272,0.89048564,0.000071479735,0.00052960764,0.0000014912962,0.0011784245,0.00023684061,0.003756683,0.00059067004,0.098067455,0.00006959342],"about_ca_topic_score_codex":0.0029013557,"about_ca_topic_score_gemma":0.000010608859,"teacher_disagreement_score":0.7474416,"about_ca_system_score_codex":0.0002262095,"about_ca_system_score_gemma":0.002117132,"threshold_uncertainty_score":0.50258917},"labels":[],"label_agreement":null},{"id":"W1983102462","doi":"10.1210/en.2008-0148","title":"GATA-4 Regulates Bcl-2 Expression in Ovarian Granulosa Cell Tumors","year":2008,"lang":"en","type":"article","venue":"Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Cyclin D2; Biology; Cyclin; Cancer research; Transactivation; Cyclin D; Cyclin A; Cell cycle; Cyclin E1; Cyclin B1; Transcription factor; Cyclin D3; Cyclin A2; Internal medicine; Apoptosis; Endocrinology; Gene; Medicine; Cyclin-dependent kinase 1; Genetics","score_opus":0.020445642180136555,"score_gpt":0.25685291621953255,"score_spread":0.236407274039396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983102462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818486,0.0019287149,0.00002046991,0.0031555989,0.00026013007,0.00037302604,0.000008642727,0.00007287957,0.012331914],"genre_scores_gemma":[0.99582636,0.00089651026,0.0012149405,0.00036035903,0.00013474122,0.000097983335,0.00003539351,0.000022627768,0.0014110637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987172,0.000057526468,0.0002730373,0.00037539424,0.00012971605,0.0004471658],"domain_scores_gemma":[0.9993436,0.00006670731,0.000062071325,0.00039117667,0.000026058902,0.00011043956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003348635,0.00017230047,0.0003743824,0.00017879451,0.00007107208,0.0000037667453,0.000080589176,0.00007422597,0.0005223352],"category_scores_gemma":[0.000021971342,0.00014079903,0.00007705859,0.00015825953,0.00010385194,0.000049694707,0.00005354981,0.00019414102,0.00017648103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005197901,0.002142038,0.9182086,0.000120650904,0.000079313235,0.01592946,0.0012526441,0.00003176293,0.035329826,0.0018103338,0.019200264,0.005375299],"study_design_scores_gemma":[0.005884018,0.00041998428,0.7079542,0.00010717312,0.000036133744,0.0012476831,0.00008278382,0.00001131517,0.2634245,0.00031137787,0.020347241,0.00017358342],"about_ca_topic_score_codex":0.00021756049,"about_ca_topic_score_gemma":0.000031379626,"teacher_disagreement_score":0.22809465,"about_ca_system_score_codex":0.0001076269,"about_ca_system_score_gemma":0.00008674906,"threshold_uncertainty_score":0.57416177},"labels":[],"label_agreement":null},{"id":"W1983150990","doi":"10.1016/j.ygyno.2013.04.011","title":"A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Onyx Pharmaceuticals; Bayer HealthCare","keywords":"Medicine; Sorafenib; Front line; Oncology; Ovarian carcinoma; Internal medicine; Randomized controlled trial; Ovarian cancer; Gynecology; Hepatocellular carcinoma; Cancer","score_opus":0.03282044406175986,"score_gpt":0.32112195465424237,"score_spread":0.2883015105924825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983150990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97364473,0.00054919557,0.00010834358,0.011528989,0.0003977241,0.005732759,0.000010007849,0.000036405134,0.007991865],"genre_scores_gemma":[0.9909604,0.0005442535,0.0032451907,0.001343538,0.00015311074,0.0028557056,0.000028513772,0.000020873444,0.00084839406],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784917,0.00038330955,0.00071144354,0.00043457784,0.00017080702,0.00045071472],"domain_scores_gemma":[0.99801904,0.00091979635,0.00037210982,0.00038237675,0.00016809544,0.00013859251],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071003917,0.0002608952,0.001770517,0.00017159045,0.000055447326,0.0000071590575,0.00012689536,0.0002603004,0.0031270103],"category_scores_gemma":[0.00033469519,0.00015261282,0.00019882816,0.00015783886,0.00033059096,0.00006618576,0.000045440924,0.00023467474,0.000043148804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8917067,0.016375769,0.004319241,0.000025516547,0.00042614152,0.0004798183,0.0007814815,0.000013947837,0.0002833534,0.00071979687,0.0019284,0.082939796],"study_design_scores_gemma":[0.93679494,0.046047665,0.010058678,0.00003445189,0.00017331899,0.00003806407,0.00014473025,0.00023341537,0.00043773532,0.00084418955,0.005043533,0.00014925464],"about_ca_topic_score_codex":0.0010955295,"about_ca_topic_score_gemma":0.0005298915,"teacher_disagreement_score":0.082790546,"about_ca_system_score_codex":0.00041395883,"about_ca_system_score_gemma":0.00062727946,"threshold_uncertainty_score":0.99778426},"labels":[],"label_agreement":null},{"id":"W1983248140","doi":"10.1016/s1535-6108(02)00021-1","title":"Of mice and women","year":2002,"lang":"en","type":"letter","venue":"Cancer Cell","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Cell biology; Medicine","score_opus":0.01772017759213309,"score_gpt":0.24262088357783987,"score_spread":0.22490070598570677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983248140","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03037194,0.08381999,0.0000019558404,0.8284194,0.00091630575,0.00085114315,0.0003836712,0.000043068598,0.055192567],"genre_scores_gemma":[0.05710601,0.037706703,0.00026491555,0.83631974,0.0048492495,0.00064800336,0.000114200346,0.00013045355,0.06286071],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991657,0.00001168465,0.00016396107,0.00027776405,0.00015676783,0.00022411681],"domain_scores_gemma":[0.99949306,0.000036439855,0.000112796246,0.00024556165,0.0000443764,0.000067738896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023820743,0.00017641886,0.00043732853,0.000037478505,0.000013951212,0.00000655494,0.000047032558,0.00025499417,0.0032888593],"category_scores_gemma":[0.0000018911378,0.00014617483,0.000063943524,0.000048298967,0.000051675423,0.000018170676,0.000020823481,0.000293726,0.00001583047],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014794401,0.0000607686,0.0022531156,0.0011263677,0.0001589318,0.00018538152,0.0003288418,1.7798821e-7,0.000049604067,0.0000018018807,0.99121743,0.004602802],"study_design_scores_gemma":[0.0012003913,0.00020527166,0.0012975448,0.00021619137,0.0002744634,0.000008721474,0.00002266783,0.0000023896714,0.0012213137,0.000011688632,0.99541426,0.00012510715],"about_ca_topic_score_codex":0.00028776884,"about_ca_topic_score_gemma":0.000007041267,"teacher_disagreement_score":0.046113286,"about_ca_system_score_codex":0.0003913888,"about_ca_system_score_gemma":0.00008567735,"threshold_uncertainty_score":0.99762225},"labels":[],"label_agreement":null},{"id":"W1983367203","doi":"10.1097/igc.0b013e31821bb446","title":"The Global Impact of the Gynecologic Cancer InterGroup in Enhancing Clinical Trials in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Gynecologic oncology; Gynecologic cancer; Clinical trial; Ovarian cancer; Cervical cancer; Oncology; Cancer; Epithelial ovarian cancer; Gynecology; Cervix; Internal medicine; Family medicine","score_opus":0.18222419082206012,"score_gpt":0.5015021597815861,"score_spread":0.319277968959526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983367203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239225,0.0041030613,0.000031125794,0.007332107,0.0046602264,0.0005048005,0.00007529465,0.0000046825185,0.00089646043],"genre_scores_gemma":[0.9895696,0.008575673,0.00012019958,0.0009024403,0.0006079015,0.00015686771,8.310623e-7,0.000010466503,0.000056007928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99553764,0.0008826125,0.0024055988,0.0002613631,0.0005750703,0.00033772824],"domain_scores_gemma":[0.9950678,0.002354633,0.0016642867,0.00020467733,0.00056035205,0.00014827863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043740585,0.00022217711,0.0010674789,0.00011184185,0.00004543829,0.000029874192,0.0006846771,0.00021611164,0.0032800224],"category_scores_gemma":[0.004473541,0.00009873518,0.00097200944,0.00034498572,0.00023417146,0.0001206837,0.00015865892,0.00063258316,0.000002607067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020108966,0.0008878667,0.9417061,0.000007194165,0.0009600707,0.00017280334,0.00017111687,0.00024118435,0.00011549513,0.00043643883,0.00062367617,0.05266713],"study_design_scores_gemma":[0.004777627,0.0008469882,0.99054325,0.00048029618,0.00017580355,0.00003369571,0.00009535735,0.00005787696,0.0005107542,0.0015784121,0.0008011111,0.000098811994],"about_ca_topic_score_codex":0.0051625995,"about_ca_topic_score_gemma":0.024339912,"teacher_disagreement_score":0.052568316,"about_ca_system_score_codex":0.003398886,"about_ca_system_score_gemma":0.0015601335,"threshold_uncertainty_score":0.99763113},"labels":[],"label_agreement":null},{"id":"W1983692373","doi":"10.1016/j.ygyno.2008.05.019","title":"Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Topotecan; Ovarian cancer; Paclitaxel; Cisplatin; Gemcitabine; Oncology; Chemotherapy; Internal medicine; In vivo; Primary tumor; Cancer; Tumor heterogeneity; Drug resistance; Pathology; Cancer research; Metastasis; Biology","score_opus":0.027707289952550503,"score_gpt":0.3197382537485896,"score_spread":0.2920309637960391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983692373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98059696,0.0017134459,0.0000065320914,0.0061889007,0.00036984877,0.00077286066,0.000037423866,0.00005002863,0.0102640055],"genre_scores_gemma":[0.9931348,0.0009712141,0.000923443,0.0036957283,0.00006501972,0.00079154497,0.000053997057,0.000021336886,0.00034289737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789965,0.00019141764,0.0005084382,0.0006089696,0.00017292252,0.0006185809],"domain_scores_gemma":[0.9989855,0.00032134276,0.00016407047,0.00028533893,0.000058898968,0.000184798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002902682,0.00026374104,0.0008166462,0.00015317074,0.000076254866,0.0000061569,0.00013500167,0.00029985476,0.0008321137],"category_scores_gemma":[0.00020660018,0.00022991568,0.00009309771,0.00046866635,0.00020214648,0.000059667294,0.000048040274,0.0003850523,0.000082076156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014898304,0.004363234,0.92957294,0.000048735063,0.00014373088,0.011502885,0.00020608392,0.00004035273,0.028919887,0.00012663174,0.010065726,0.013519969],"study_design_scores_gemma":[0.009619946,0.0012047848,0.9257618,0.000039082846,0.00006478786,0.00036841142,0.00007382999,0.00007845976,0.046817414,0.0001772884,0.015524962,0.00026923564],"about_ca_topic_score_codex":0.0016244537,"about_ca_topic_score_gemma":0.004733167,"teacher_disagreement_score":0.017897528,"about_ca_system_score_codex":0.0022241736,"about_ca_system_score_gemma":0.0010679136,"threshold_uncertainty_score":0.93756896},"labels":[],"label_agreement":null},{"id":"W1983848828","doi":"","title":"Giant Ovarian Cyst Presenting With Colon Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Current Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Concomitant; Surgery; Ovarian cyst; Ovarian cancer; Hysterectomy; Abdominal hysterectomy; Colorectal cancer; Cyst; Right hemicolectomy; General surgery; Radiology; Cancer; Internal medicine","score_opus":0.043899758004082044,"score_gpt":0.313055894625024,"score_spread":0.26915613662094195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983848828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832143,0.006994279,0.000110911955,0.007166285,0.0017233458,0.00030548824,0.000007620215,0.00001334812,0.00046440202],"genre_scores_gemma":[0.99690855,0.0016008687,0.0002263429,0.0001445461,0.0009332424,0.000041130086,0.0000042223473,0.00002045605,0.00012061934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868107,0.000040380386,0.0004817876,0.00012649968,0.0004227858,0.00024746833],"domain_scores_gemma":[0.9985738,0.00017512323,0.00050918746,0.00014477878,0.00036242924,0.00023473063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025257835,0.00013953916,0.00048359035,0.00017509206,0.00004996428,0.000048107002,0.000048360256,0.000035956855,0.00084698875],"category_scores_gemma":[0.000057003428,0.000085862164,0.00020604242,0.00017273767,0.000034256074,0.00021480831,0.0000151801405,0.00023044492,0.000024679863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001998885,0.0007762951,0.84666276,0.00020013582,0.0005061935,0.000347023,0.00014047073,0.000022402404,0.0003931496,0.00004706783,0.08145056,0.06925404],"study_design_scores_gemma":[0.0020152996,0.0002521714,0.9221134,0.0021500313,0.00051315594,0.00074922113,0.000058407746,0.0000754253,0.0015996875,0.00005952627,0.07022739,0.00018628537],"about_ca_topic_score_codex":0.00008831669,"about_ca_topic_score_gemma":0.000009403416,"teacher_disagreement_score":0.07545062,"about_ca_system_score_codex":0.00015692222,"about_ca_system_score_gemma":0.0004765973,"threshold_uncertainty_score":0.92739326},"labels":[],"label_agreement":null},{"id":"W1983896663","doi":"10.1188/09.cjon.443-445","title":"Are Serum Protein Biomarkers Effective in Detecting Ovarian Cancer in Its Early Stages?","year":2009,"lang":"en","type":"article","venue":"Clinical journal of oncology nursing","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.056797376145326046,"score_gpt":0.44722216374070006,"score_spread":0.390424787595374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983896663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97504413,0.001690432,0.000027035685,0.021269051,0.0007391792,0.0007149959,0.0000030871201,0.000008500031,0.00050357735],"genre_scores_gemma":[0.99761873,0.00017113377,0.000905446,0.0007994664,0.00045754833,0.000017644652,2.1110762e-7,0.00001463437,0.000015164515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975597,0.00051294675,0.0011170064,0.0002640789,0.00019379989,0.00035244372],"domain_scores_gemma":[0.9979458,0.0005742293,0.0009688627,0.00012493983,0.0001621061,0.00022405674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001680059,0.0001626675,0.00089539273,0.00031437483,0.000041472264,0.0000151915165,0.00009561421,0.00030602101,0.000044807864],"category_scores_gemma":[0.000826401,0.00013349408,0.00020782468,0.00037487652,0.00009783978,0.000133127,0.000010137105,0.0009893657,0.000003503154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015967999,0.0014577142,0.50705725,0.00001380514,0.00011193854,0.0021037525,0.00028053642,0.000020807667,0.0003914463,0.000010148364,0.000052832795,0.48690295],"study_design_scores_gemma":[0.011553707,0.005824229,0.9752359,0.005037132,0.0001573816,0.00015071168,0.0002638334,0.000050201645,0.0010921736,0.0003183731,0.00020886715,0.000107496264],"about_ca_topic_score_codex":0.000025167217,"about_ca_topic_score_gemma":0.000111149195,"teacher_disagreement_score":0.48679546,"about_ca_system_score_codex":0.0016117848,"about_ca_system_score_gemma":0.00052963523,"threshold_uncertainty_score":0.54437304},"labels":[],"label_agreement":null},{"id":"W1984136243","doi":"10.1371/journal.pone.0097997","title":"Glucocorticoid-Induced Reversal of Interleukin-1β-Stimulated Inflammatory Gene Expression in Human Oviductal Cells","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chemokine; Biology; Interleukin 8; Glucocorticoid; Cytokine; Tumor necrosis factor alpha; Endocrinology; Gene expression; Internal medicine; Interleukin; Gene expression profiling; Proinflammatory cytokine; Inflammation; Cancer research; Immunology; Gene; Medicine; Genetics","score_opus":0.03435015653242369,"score_gpt":0.25310157092271823,"score_spread":0.21875141439029455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984136243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984408,0.00008187208,0.000008022401,0.00017987157,0.000066487315,0.0005672381,0.000004412784,0.000037644506,0.00061365793],"genre_scores_gemma":[0.9983637,0.000023264953,0.001142531,0.00010966401,0.00011999335,0.000040975825,0.000024377192,0.000030018013,0.00014550929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870145,0.000058802918,0.0004198829,0.00029368888,0.00031715992,0.00020900453],"domain_scores_gemma":[0.999188,0.000065451524,0.00014992083,0.00041458954,0.00007548125,0.00010657771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001312196,0.00015783489,0.0004687393,0.00014836428,0.00002319067,0.000007485603,0.00008022726,0.000106771244,0.00021674391],"category_scores_gemma":[0.000049344864,0.00014085807,0.00007039139,0.000121719786,0.000030081635,0.00006276195,0.000056298486,0.00014143038,0.000039159928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015355795,0.0022916014,0.07469666,0.00024800014,0.00017735227,0.00003708038,0.0002991201,0.000018125944,0.9217412,0.000029173492,0.00006040733,0.00024772412],"study_design_scores_gemma":[0.0040450045,0.0007196803,0.06670403,0.0012345833,0.0002226822,0.0000015883529,0.000020187472,0.00029012785,0.92658776,0.00003234824,0.000024145373,0.000117879856],"about_ca_topic_score_codex":0.00006424757,"about_ca_topic_score_gemma":0.00001809741,"teacher_disagreement_score":0.007992636,"about_ca_system_score_codex":0.00016199404,"about_ca_system_score_gemma":0.00006111539,"threshold_uncertainty_score":0.5744026},"labels":[],"label_agreement":null},{"id":"W1984240217","doi":"10.1038/modpathol.2008.206","title":"IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype","year":2009,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital; Royal Alexandra Hospital; BC Cancer Agency","funders":"National Cancer Institute; Eli Lilly Canada; Michael Smith Health Research BC; Sanofi; BC Cancer Agency; Eli Lilly and Company","keywords":"Immunohistochemistry; Medicine; Biomarker; Serous carcinoma; Ovarian carcinoma; Oncology; Serous fluid; Carcinoma; Confidence interval; Pathology; Clear cell; Internal medicine; Tissue microarray; Ovarian cancer; Cancer; Biology","score_opus":0.01592418245725394,"score_gpt":0.2552796615832286,"score_spread":0.23935547912597469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984240217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920629,0.0010239114,0.00013114732,0.001227728,0.000056681583,0.0004251009,0.000024342677,0.000012405024,0.005035777],"genre_scores_gemma":[0.9970015,0.000099307836,0.0022861091,0.0003642699,0.00002639348,0.000032709893,0.0000119915485,0.000018789377,0.00015890712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987525,0.000082693805,0.0003838272,0.00035495957,0.00016264307,0.0002633797],"domain_scores_gemma":[0.9992593,0.000034958157,0.00016242405,0.00037568578,0.00007559259,0.000092036506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001768951,0.0001546748,0.0005061735,0.00016757818,0.000018567576,0.000002769995,0.000079551246,0.00017622668,0.00025915547],"category_scores_gemma":[0.000022845654,0.00013096734,0.00010364377,0.00017334729,0.000055483317,0.000031454678,0.000032648913,0.00013100078,0.000009012815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011346503,0.0027637887,0.85044014,0.00020946992,0.00002703134,0.0006110866,0.0024383347,0.000047458303,0.13367628,0.00016629651,0.00083843694,0.0076470305],"study_design_scores_gemma":[0.003374965,0.0015808298,0.74409145,0.00016493753,0.000088003435,0.000049060753,0.000060035472,0.0009292632,0.2487745,0.00067543995,0.00009948007,0.00011203807],"about_ca_topic_score_codex":0.00014561883,"about_ca_topic_score_gemma":0.000011328795,"teacher_disagreement_score":0.11509822,"about_ca_system_score_codex":0.000069661895,"about_ca_system_score_gemma":0.00013016883,"threshold_uncertainty_score":0.5340693},"labels":[],"label_agreement":null},{"id":"W1984325076","doi":"10.1097/aog.0000000000000630","title":"Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy","year":2015,"lang":"en","type":"article","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Salpingectomy; Medicine; Hysterectomy; Tubal ligation; Gynecology; Obstetrics; Ovarian cancer; Confidence interval; Population; Surgery; Family planning; Cancer; Internal medicine; Pregnancy; Environmental health","score_opus":0.06910611674192428,"score_gpt":0.3306991226468808,"score_spread":0.2615930059049565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984325076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870366,0.007856335,0.000011502846,0.00059757236,0.00035830124,0.00032111528,0.0000331322,0.000013466935,0.0037720003],"genre_scores_gemma":[0.9958024,0.0033257825,0.00021336392,0.00016925886,0.00004317981,0.00004182894,0.00004215702,0.0000121639405,0.00034983628],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99925697,0.000037630005,0.00019246558,0.00024228988,0.000112075264,0.00015857928],"domain_scores_gemma":[0.99891895,0.00038938774,0.0001051523,0.00014606958,0.00015558407,0.00028488063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013169867,0.00010808145,0.00028828878,0.00011975775,0.000035069283,0.000015284188,0.000029575098,0.00011386434,0.00009454692],"category_scores_gemma":[0.000555889,0.00009378601,0.000021984275,0.00016593262,0.00005946772,0.000057816167,0.000029199093,0.000068616784,0.000002301472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009487685,0.0008063657,0.26468608,0.00011733132,0.00022214159,0.00012925245,0.00030609447,0.000020135856,0.000045313194,0.040061124,0.0004460942,0.6930652],"study_design_scores_gemma":[0.010182825,0.0076290197,0.9610088,0.00013729898,0.0006833616,0.00010793022,0.0004824121,0.00047970822,0.00027660772,0.0045084413,0.014236789,0.0002668007],"about_ca_topic_score_codex":0.00039686591,"about_ca_topic_score_gemma":0.00022578264,"teacher_disagreement_score":0.69632274,"about_ca_system_score_codex":0.00013002381,"about_ca_system_score_gemma":0.00030891685,"threshold_uncertainty_score":0.38244826},"labels":[],"label_agreement":null},{"id":"W1984389614","doi":"10.1097/00004347-200304000-00001","title":"Challenges in the Early Diagnosis and Staging of Fallopian-Tube Carcinomas Associated with BRCA Mutations","year":2003,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Fallopian tube; Medicine; BRCA mutation; Stage (stratigraphy); Carcinoma in situ; Carcinoma; Dysplasia; Pathology; Occult; Gynecology; Cancer; Ovarian cancer; Biology; Internal medicine","score_opus":0.13599921959345634,"score_gpt":0.367351015848654,"score_spread":0.23135179625519764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984389614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036634374,0.9594581,0.000006446762,0.0020018893,0.00026999658,0.00043030223,0.000041646774,0.000003799034,0.0011534144],"genre_scores_gemma":[0.18013331,0.8193535,0.00016885786,0.0001580598,0.00006404858,0.00008330787,0.000016583746,0.0000122907695,0.000009996332],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99794346,0.00050575624,0.00078042207,0.0002263428,0.00037522972,0.00016877234],"domain_scores_gemma":[0.9964022,0.0022063353,0.00086390023,0.00012429935,0.00033991205,0.00006337676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067897176,0.00021819456,0.0012305668,0.0003092704,0.00002470337,0.000018174758,0.00024123155,0.00023974311,0.00007034461],"category_scores_gemma":[0.00073270407,0.000113836686,0.00024732293,0.00013953133,0.00017041733,0.0000526027,0.00003653864,0.00051397935,0.0000014265572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007464758,0.0023844156,0.14522164,0.00054642506,0.0019763247,0.013693486,0.0009085848,0.0000075217527,3.211821e-7,0.003423628,0.000091050475,0.83167195],"study_design_scores_gemma":[0.0039764238,0.0054951967,0.8378325,0.008309232,0.002590638,0.0050748377,0.00038127173,0.0000014052306,0.0000015501178,0.0009209219,0.13513617,0.00027983676],"about_ca_topic_score_codex":0.000010207743,"about_ca_topic_score_gemma":0.0000748705,"teacher_disagreement_score":0.8313921,"about_ca_system_score_codex":0.00027097712,"about_ca_system_score_gemma":0.0002503802,"threshold_uncertainty_score":0.46421254},"labels":[],"label_agreement":null},{"id":"W1984401610","doi":"10.1097/cco.0b013e328348846a","title":"Which is the better surgical strategy for newly diagnosed epithelial ovarian cancer","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Debulking; Medicine; Ovarian cancer; Epithelial ovarian cancer; Chemotherapy; Stage (stratigraphy); Surgery; Cancer; Oncology; Internal medicine","score_opus":0.20829813910009345,"score_gpt":0.46950232987938784,"score_spread":0.26120419077929435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984401610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000064565706,0.97699803,0.000018773735,0.004961332,0.012461522,0.003985932,0.00064570777,0.000028823786,0.0008934077],"genre_scores_gemma":[0.000025771118,0.9853009,0.00008447046,0.00019425056,0.0052996976,0.008348741,0.00056235073,0.000076361626,0.000107476866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698764,0.00035032388,0.0010202162,0.00083437987,0.00019835109,0.0006091057],"domain_scores_gemma":[0.9974565,0.0010986844,0.00048382216,0.00060192327,0.0001601878,0.00019888794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044105895,0.00057576655,0.0022926019,0.00021325308,0.00009657217,0.000028959235,0.00032511452,0.000669029,0.0014577362],"category_scores_gemma":[0.00006260524,0.00034470408,0.0006757931,0.00040850032,0.00011974552,0.000043510423,0.000097408185,0.00084406364,0.000111996924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010136437,0.0008820967,0.0003872739,0.006462722,0.0003372263,0.000013670634,0.00016397859,4.880048e-7,6.363631e-9,0.0015391951,0.0447513,0.94536066],"study_design_scores_gemma":[0.0052849217,0.00083066063,0.0005915369,0.0107402,0.00103958,0.00007057011,0.000012965979,0.000007250918,2.8326485e-7,0.00017353118,0.9809351,0.00031343094],"about_ca_topic_score_codex":0.0002932144,"about_ca_topic_score_gemma":0.00017586623,"teacher_disagreement_score":0.94504726,"about_ca_system_score_codex":0.0009454388,"about_ca_system_score_gemma":0.0025560549,"threshold_uncertainty_score":0.9999005},"labels":[],"label_agreement":null},{"id":"W1984491982","doi":"10.1097/01.pgp.0000228142.52054.0f","title":"Mixed Ovarian Germ Cell Tumor in a BRCA2 Mutation Carrier","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Dysgerminoma; Loss of heterozygosity; Ovarian cancer; Biology; Immature teratoma; Germline mutation; Breast cancer; Cancer research; Teratoma; Germ cell; Germ cell tumors; Mutation; Choriocarcinoma; Cancer; Oncology; Pathology; Ovary; Allele; Genetics; Medicine; Chemotherapy; Gene","score_opus":0.02167746026937373,"score_gpt":0.3040256371132218,"score_spread":0.28234817684384805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984491982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016976,0.00021058042,0.00096786587,0.0033305532,0.0015081107,0.00014272664,0.000009530039,0.0000086195405,0.0036522378],"genre_scores_gemma":[0.9943598,0.00004463513,0.0033476732,0.0017977349,0.00035775363,0.000006715103,0.000009373198,0.000008985295,0.00006731739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851924,0.00008632954,0.0006728147,0.00017368032,0.00033120273,0.00021674078],"domain_scores_gemma":[0.9985379,0.0004732002,0.0004021174,0.000084616884,0.00036559402,0.00013659935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008811772,0.00011765535,0.0003374786,0.00031319307,0.000018943589,0.000014533011,0.00015224959,0.00012413178,0.0006115779],"category_scores_gemma":[0.0006175238,0.00008626845,0.00015566769,0.00011124673,0.00007086221,0.00007337164,0.000036853304,0.00031041206,0.000022856011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002114312,0.0033999262,0.769805,0.000016334856,0.00026296277,0.16425608,0.00054425106,0.00013600137,0.0072417567,0.0033653888,0.0010727482,0.047785237],"study_design_scores_gemma":[0.0049747652,0.0013118086,0.9806446,0.000034302677,0.000052738716,0.004695894,0.00014730223,0.000023230723,0.003467118,0.0016758586,0.0028905207,0.00008186614],"about_ca_topic_score_codex":0.000023873998,"about_ca_topic_score_gemma":0.00009586522,"teacher_disagreement_score":0.2108396,"about_ca_system_score_codex":0.00045042552,"about_ca_system_score_gemma":0.00016218568,"threshold_uncertainty_score":0.6696349},"labels":[],"label_agreement":null},{"id":"W1984542528","doi":"10.4161/cc.9.1.10264","title":"Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment","year":2010,"lang":"en","type":"article","venue":"Cell Cycle","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Ovarian carcinoma; Biology; Ovarian cancer; Ovary; Cancer research; Carcinoma; Pathology; Cellular differentiation; Cancer; Endocrinology; Gene; Medicine","score_opus":0.010330941541853655,"score_gpt":0.23604466865072962,"score_spread":0.22571372710887597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984542528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989205,0.00018424274,0.000003875328,0.00010259327,0.00020970083,0.00038048447,0.000014474643,0.0000060764955,0.00017805933],"genre_scores_gemma":[0.9968024,0.00006827933,0.0029415668,0.000033831813,0.00007371687,0.000006370807,0.000012739424,0.000019879433,0.00004122214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991696,0.000027241505,0.00026072896,0.00024053808,0.00012539458,0.00017651312],"domain_scores_gemma":[0.99958014,0.000010075366,0.00008839749,0.00022059768,0.000012370629,0.00008840404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008259377,0.00012235812,0.00021596543,0.000049162696,0.000055262055,0.000008857383,0.000037380905,0.00007666704,0.00015405485],"category_scores_gemma":[0.0000013195006,0.00011929161,0.000036082427,0.000057149853,0.0000721748,0.000029388168,0.000040767103,0.00013393605,0.000003935124],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032930537,0.00038628708,0.2925535,0.000049749153,0.000013296327,0.000024923074,0.00020561717,0.00006282903,0.7061847,0.000007091641,0.00001105019,0.00046801113],"study_design_scores_gemma":[0.0024249966,0.00023345838,0.54006255,0.000018122333,0.000058966172,0.0000079839565,0.00006365438,0.00029311416,0.45663625,0.000030191139,0.0000999843,0.00007073422],"about_ca_topic_score_codex":0.00092546124,"about_ca_topic_score_gemma":0.00007154163,"teacher_disagreement_score":0.24954845,"about_ca_system_score_codex":0.00007959592,"about_ca_system_score_gemma":0.000035881352,"threshold_uncertainty_score":0.48645708},"labels":[],"label_agreement":null},{"id":"W1984568232","doi":"10.1007/s00439-013-1383-3","title":"Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA","year":2013,"lang":"en","type":"article","venue":"Human Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of British Columbia; University of Calgary; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"National Center for Research Resources; Cancer Council Victoria; Cancer Council South Australia; National Cancer Institute; Helse Vest; Cancer Council Tasmania; National Institutes of Health; Cancer Council NSW; Cancer Research UK; Rutgers Cancer Institute of New Jersey; WorkSafeBC; Bundesministerium für Bildung und Forschung; Lon V. Smith Foundation; Deutsches Krebsforschungszentrum; Helsingin ja Uudenmaan Sairaanhoitopiiri; Canadian Institutes of Health Research; Cancer Council Queensland; Fred C. and Katherine B. Andersen Foundation","keywords":"Genome-wide association study; Serous fluid; Biology; Odds ratio; Genotype; Ovarian cancer; Allele; Genetic association; Oncology; Epithelial ovarian cancer; Case-control study; Genetics; Internal medicine; Cancer; Gene; Single-nucleotide polymorphism; Medicine","score_opus":0.034109280320359966,"score_gpt":0.2855128605479704,"score_spread":0.25140358022761045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984568232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676085,0.0014262036,0.000035715322,0.00019981267,0.00018140922,0.0010513541,0.000035357985,0.000024031793,0.00028528782],"genre_scores_gemma":[0.9974456,0.0009788369,0.00062616233,0.00008592866,0.00041129754,0.00008758934,0.00001971995,0.000039596875,0.000305275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860334,0.00008979789,0.00039752078,0.00029307618,0.00035883446,0.00025740234],"domain_scores_gemma":[0.9988507,0.00007239434,0.0003545763,0.00036947502,0.00024814997,0.000104707695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014907804,0.00017673412,0.0003674559,0.00009450029,0.00013881555,0.00003608247,0.00008778649,0.00009411181,0.0011412778],"category_scores_gemma":[0.00002494795,0.00015892931,0.00008563287,0.00012694205,0.000024660609,0.000032574822,0.00004184129,0.00012285051,0.00004199464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025416168,0.0010731849,0.9838422,0.000021060918,0.0006424945,0.0000075449225,0.0015714366,0.0003496053,0.010305555,0.0000124625285,0.0004791391,0.0016699053],"study_design_scores_gemma":[0.0033717845,0.00060745823,0.99026823,0.00003133823,0.0006627281,5.530962e-7,0.00040078213,0.00007955196,0.0027577851,0.000119000295,0.0015579355,0.00014286044],"about_ca_topic_score_codex":0.0018143994,"about_ca_topic_score_gemma":0.00061312865,"teacher_disagreement_score":0.007547769,"about_ca_system_score_codex":0.00047456275,"about_ca_system_score_gemma":0.00008626966,"threshold_uncertainty_score":0.99977183},"labels":[],"label_agreement":null},{"id":"W1984877106","doi":"10.1016/j.ygyno.2007.02.018","title":"UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Topotecan; Medicine; Neutropenia; Ovarian cancer; Internal medicine; Oncology; Phases of clinical research; Chemotherapy; Carboplatin; Progressive disease; Cancer; Febrile neutropenia; Surgery; Cisplatin","score_opus":0.010832574774115058,"score_gpt":0.305409538293352,"score_spread":0.29457696351923696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984877106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931786,0.00007081545,0.000007479495,0.0018057767,0.00040426943,0.0037226414,0.000012926776,0.000016878696,0.00078063086],"genre_scores_gemma":[0.9990037,0.000031043917,0.00022903051,0.00018175178,0.000016229385,0.0004854146,0.00001701099,0.000013502683,0.000022330916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835926,0.00013570125,0.00047070996,0.0004037978,0.00027136586,0.00035917357],"domain_scores_gemma":[0.99891126,0.00019181304,0.0003702032,0.0003004374,0.00014863383,0.000077632314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034997147,0.00019396808,0.00056172995,0.00015529511,0.000072489616,0.000004007577,0.00013776627,0.00012176606,0.00010792502],"category_scores_gemma":[0.00008475454,0.00011547933,0.000030649033,0.0005397014,0.00013727313,0.00006017626,0.00008029637,0.00027490914,6.470994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027704174,0.035637762,0.8642124,0.000021291866,0.00008445628,0.00012423321,0.0014148562,0.000052438496,0.0000031194133,0.0001240997,0.000024719553,0.09553019],"study_design_scores_gemma":[0.05441102,0.074736975,0.8687559,0.00010179586,0.00010732827,0.000002086678,0.0010079304,0.000009430344,0.000089915964,0.0000338788,0.0006223877,0.000121357276],"about_ca_topic_score_codex":0.00050653337,"about_ca_topic_score_gemma":0.025452003,"teacher_disagreement_score":0.095408835,"about_ca_system_score_codex":0.0013326599,"about_ca_system_score_gemma":0.00043071306,"threshold_uncertainty_score":0.99233097},"labels":[],"label_agreement":null},{"id":"W1984952272","doi":"10.1089/lap.2008.0191.supp","title":"Laparoscopic Approach to Ovarian Mass in Children and Adolescents: Already a Standard in Therapy","year":2009,"lang":"en","type":"article","venue":"Journal of Laparoendoscopic & Advanced Surgical Techniques","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Laparoscopy; Ovarian torsion; Surgery; Cyst; Ovarian cyst; Magnetic resonance imaging; Endometriosis; Adnexal mass; Dissection (medical); Laparoscopic surgery; Radiology; General surgery; Gynecology","score_opus":0.010255047326439684,"score_gpt":0.2949038694922922,"score_spread":0.2846488221658525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984952272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920632,0.0029723677,0.00044386258,0.0020206005,0.000056742178,0.001208172,0.000009348578,0.00004920854,0.0011764754],"genre_scores_gemma":[0.95875204,0.0053230613,0.035041004,0.0006785076,0.00011686209,0.00004358597,0.00000438239,0.000019351179,0.00002122743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806035,0.000098494624,0.0007431912,0.0003356889,0.00038432423,0.0003779354],"domain_scores_gemma":[0.99915713,0.00004067129,0.0002003886,0.0002408535,0.00009194881,0.00026898185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033735772,0.0002652346,0.0009619488,0.00042992597,0.00002755535,0.000033280776,0.00013803864,0.000106436884,0.000015705333],"category_scores_gemma":[0.000040172723,0.00019953332,0.00010873158,0.00042087265,0.00004402048,0.0001886702,0.000020548427,0.00045254827,7.210995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004778915,0.0026859487,0.76246184,0.000057636313,0.00011005288,0.00085133786,0.00025767903,0.0000314139,0.0028196776,0.0008352138,0.00024720313,0.22486305],"study_design_scores_gemma":[0.023064634,0.0065521984,0.93173456,0.002759645,0.00005477924,0.00075103587,0.00005712897,0.00000560889,0.027001087,0.0022357008,0.0054357033,0.00034793263],"about_ca_topic_score_codex":0.000022475078,"about_ca_topic_score_gemma":0.000004106679,"teacher_disagreement_score":0.22451513,"about_ca_system_score_codex":0.0003338464,"about_ca_system_score_gemma":0.00009470675,"threshold_uncertainty_score":0.8136732},"labels":[],"label_agreement":null},{"id":"W1985530449","doi":"10.1158/1535-7163.mct-15-0039","title":"Enhanced <i>GAB2</i> Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition","year":2015,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Serous fluid; Serous carcinoma; Ovarian carcinoma; Cancer research; Cancer; Oncology; PI3K/AKT/mTOR pathway; Biology; Comparative genomic hybridization; Internal medicine; Medicine; Gene; Genetics; Signal transduction; Genome","score_opus":0.02712509881237877,"score_gpt":0.2853249266071337,"score_spread":0.2581998277947549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985530449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670584,0.0013200878,0.0024606478,0.00812201,0.00023132197,0.00087857334,0.000113791844,0.00005988056,0.000107840984],"genre_scores_gemma":[0.99135387,0.00039368,0.0005646879,0.0070785154,0.000089236935,0.00032523062,0.000041026567,0.00006657546,0.00008720532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826026,0.00013730633,0.00024503347,0.00054239697,0.000410543,0.00040447843],"domain_scores_gemma":[0.9990271,0.000041422023,0.00012012671,0.00031634528,0.00021488695,0.00028016733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002363332,0.00031046593,0.0004930757,0.000102791426,0.000055776578,0.000043138556,0.00003365541,0.00016452093,0.000017484257],"category_scores_gemma":[0.000014290109,0.00025639747,0.000050356226,0.00040930457,0.000053461466,0.00007847051,0.000047312365,0.00021801193,0.000002315375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001928392,0.0010839851,0.032916903,0.00007427225,0.0008701835,0.0007676613,0.0038581642,0.0005616177,0.9335906,0.00009265233,0.00020683503,0.024048733],"study_design_scores_gemma":[0.014008837,0.00096711365,0.061852455,0.0009314456,0.0004989204,0.000017532699,0.00020377497,0.00051051093,0.91940516,0.0001390891,0.00095673907,0.0005084132],"about_ca_topic_score_codex":0.003190171,"about_ca_topic_score_gemma":0.003340912,"teacher_disagreement_score":0.028935552,"about_ca_system_score_codex":0.0007598416,"about_ca_system_score_gemma":0.00035081292,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W1985742486","doi":"10.1038/ng.666","title":"Common variants at 19p13 are associated with susceptibility to ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Alberta Health Services; BC Cancer Agency; Coalition for Research in Women's Health","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK; Wellcome Trust","keywords":"Ovarian cancer; Biology; Single-nucleotide polymorphism; Genome-wide association study; Locus (genetics); Serous fluid; Epithelial ovarian cancer; Malignancy; Gene; Candidate gene; Genetic association; Oncology; Cancer; Internal medicine; Genetics; Genotype; Medicine","score_opus":0.012029095205191322,"score_gpt":0.2917239398868368,"score_spread":0.2796948446816455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985742486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896356,0.00069354154,0.0000065836593,0.006285845,0.0008441419,0.0007181373,0.00022367873,0.000067135355,0.0015253403],"genre_scores_gemma":[0.99376345,0.0000797214,0.0015977402,0.0031081806,0.0003974188,0.000077553595,0.00007815019,0.000045960263,0.0008518512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848974,0.000033226577,0.00020183844,0.00049703836,0.00041153815,0.00036662418],"domain_scores_gemma":[0.99851364,0.00006410595,0.00011853211,0.0006961066,0.00026213125,0.0003454695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015300662,0.00024472785,0.0003889679,0.00006252199,0.00012430831,0.000028177274,0.00013052068,0.0004996067,0.00070317136],"category_scores_gemma":[0.0000991824,0.00018213148,0.000072896524,0.00032588793,0.0000543249,0.000020324125,0.00007728514,0.00078200107,0.000037578284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021550346,0.0004648696,0.9835829,0.000023699367,0.00026817186,0.000100354875,0.00016222948,0.000022265463,0.0021222322,0.000041104868,0.008900025,0.0040966477],"study_design_scores_gemma":[0.002210567,0.0003867451,0.9732884,0.00013073628,0.00031085266,0.000017987462,0.000015787853,0.000037158665,0.0057747248,0.00004582656,0.01757545,0.00020575679],"about_ca_topic_score_codex":0.00014883738,"about_ca_topic_score_gemma":0.024914164,"teacher_disagreement_score":0.024765326,"about_ca_system_score_codex":0.0003741858,"about_ca_system_score_gemma":0.00018616607,"threshold_uncertainty_score":0.9928786},"labels":[],"label_agreement":null},{"id":"W1985822486","doi":"10.1007/s10334-003-0027-3","title":"Magnetic resonance diffusion imaging of ovarian masses: a first experience with 12 cases","year":2004,"lang":"en","type":"article","venue":"Magnetic Resonance Materials in Physics Biology and Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Effective diffusion coefficient; Magnetic resonance imaging; Malignancy; Medicine; Artifact (error); Radiology; Nuclear medicine; Pathology; Biology","score_opus":0.013724862828756464,"score_gpt":0.2767456000188326,"score_spread":0.2630207371900761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985822486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96044403,0.03520528,0.000059222537,0.0027251192,0.00024569198,0.00064447033,0.000039122864,0.00002526716,0.0006117747],"genre_scores_gemma":[0.9904433,0.0070838314,0.0013465412,0.00047497763,0.00029462102,0.0002096049,0.000029354145,0.00002486587,0.000092925045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834996,0.000057739362,0.0004964539,0.00054261426,0.00017432346,0.00037889156],"domain_scores_gemma":[0.9991372,0.00013431998,0.00014368865,0.00041201836,0.00006456348,0.00010820503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017489087,0.00029683637,0.0007568721,0.00008787673,0.00008508366,0.000009326346,0.00010654559,0.000091087844,0.00025441626],"category_scores_gemma":[0.00008126205,0.00020026215,0.000027511102,0.0002327158,0.0009005238,0.000060569444,0.000070007496,0.00010567299,0.0000027862234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003112179,0.0011755532,0.72588634,0.0006143778,0.000023096376,0.0011930716,0.004923198,0.000005388361,0.0685279,0.014929892,0.00012711853,0.17948186],"study_design_scores_gemma":[0.015646135,0.0054128375,0.92891634,0.004146384,0.00015966145,0.00045452913,0.00058306125,0.000016613378,0.026670018,0.0047274027,0.012900189,0.0003668512],"about_ca_topic_score_codex":0.0015917898,"about_ca_topic_score_gemma":0.00019249413,"teacher_disagreement_score":0.20302996,"about_ca_system_score_codex":0.000070717426,"about_ca_system_score_gemma":0.00009011837,"threshold_uncertainty_score":0.8166454},"labels":[],"label_agreement":null},{"id":"W1986151536","doi":"10.1155/2010/740968","title":"Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Ovarian cancer; Serous fluid; Medicine; Serous carcinoma; Ovarian carcinoma; Oncology; Carcinogenesis; Clear cell carcinoma; Cancer; Internal medicine; Clear cell; Pathology; Carcinoma; Cancer research","score_opus":0.02103828670944343,"score_gpt":0.31561314861911643,"score_spread":0.294574861909673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986151536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652354,0.0032032032,0.000024710871,0.028655214,0.0004005731,0.0001363169,0.0000054766215,0.000005333694,0.002333782],"genre_scores_gemma":[0.9950723,0.00039924867,0.00076413626,0.0031734796,0.0004168648,0.00000811089,0.0000011550351,0.000013147184,0.00015157924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989717,0.00008585394,0.00040299376,0.00011927174,0.00018462745,0.00023553625],"domain_scores_gemma":[0.99935097,0.00004926038,0.00024643395,0.00013011479,0.00009796803,0.0001252346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021054481,0.00012646188,0.00050336245,0.00019150409,0.000020967169,0.000009645897,0.000081667495,0.00012403597,0.00022016128],"category_scores_gemma":[0.000017992677,0.00009454699,0.00011821574,0.00013351525,0.000035793546,0.000069705085,0.000009052562,0.0002452062,0.0000049788036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016528737,0.002882024,0.91600156,0.000057846606,0.0005761017,0.01402848,0.0023061351,0.00047693032,0.0066789496,0.006979266,0.003990599,0.044369217],"study_design_scores_gemma":[0.0067917006,0.0041890964,0.96006626,0.00013209358,0.0002384053,0.0009945749,0.00018550259,0.000009945829,0.008519096,0.000962933,0.0178029,0.0001075189],"about_ca_topic_score_codex":0.0012775579,"about_ca_topic_score_gemma":0.00047600633,"teacher_disagreement_score":0.044261698,"about_ca_system_score_codex":0.00060007477,"about_ca_system_score_gemma":0.00051898503,"threshold_uncertainty_score":0.38555142},"labels":[],"label_agreement":null},{"id":"W1986958762","doi":"10.1016/j.ygyno.2013.06.029","title":"Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Arthritis Research Centre of Canada; Simon Fraser University; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research; NCMIC Foundation","keywords":"Medicine; Asymptomatic; Relative risk; Meta-analysis; Ovarian cancer; Odds ratio; Confidence interval; Randomized controlled trial; Gynecology; MEDLINE; Obstetrics; Internal medicine; Cancer","score_opus":0.22172006333392388,"score_gpt":0.4224848015814642,"score_spread":0.2007647382475403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986958762","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020241367,0.985991,0.000034723605,0.0009962836,0.00005238948,0.012337959,0.00039427096,0.00002973794,0.00014338027],"genre_scores_gemma":[0.00007552459,0.9591488,0.003406575,0.00090497546,0.000031675303,0.035940576,0.00008569443,0.000040466246,0.00036566166],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962619,0.0005751305,0.0017367891,0.0007642846,0.00018432157,0.0004775595],"domain_scores_gemma":[0.99379,0.0030991652,0.002000578,0.0006309214,0.00021258558,0.0002667524],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013334773,0.0006278622,0.01921248,0.00039450865,0.00008899486,0.000022622786,0.00017236969,0.00054870354,0.001182555],"category_scores_gemma":[0.0006452626,0.00036280352,0.001629269,0.0005688975,0.00012769755,0.0000460782,0.00013387787,0.0002299332,0.000007639233],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037410878,0.0001573517,0.000027824108,0.6571058,0.22646755,0.000008399723,0.000046533307,0.0000010276933,5.1460725e-9,0.00011692562,0.0001728516,0.11589199],"study_design_scores_gemma":[0.0007717673,0.0013600859,0.00014161548,0.020288598,0.9348375,0.000075471195,0.00003322719,0.0000080646805,8.497898e-8,0.000039521343,0.04217852,0.00026550976],"about_ca_topic_score_codex":0.0001501248,"about_ca_topic_score_gemma":0.00008816143,"teacher_disagreement_score":0.70837,"about_ca_system_score_codex":0.00056036015,"about_ca_system_score_gemma":0.00040630414,"threshold_uncertainty_score":0.9998824},"labels":[],"label_agreement":null},{"id":"W1987029726","doi":"10.1097/pas.0b013e3181758831","title":"Endocervical Adenocarcinomas With Ovarian Metastases","year":2008,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Johns Hopkins Bloomberg School of Public Health","keywords":"Medicine; Cervix; Metastasis; Ovary; Adenocarcinoma; Occult; Ovarian tumor; Pathology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.022982552053637296,"score_gpt":0.27046968815045547,"score_spread":0.24748713609681816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987029726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983134,0.0011961852,0.00015900019,0.014152367,0.00006958219,0.0001086339,0.00000619821,0.000011532705,0.0011625565],"genre_scores_gemma":[0.9948419,0.0010931503,0.0025879256,0.0011231354,0.00026844264,0.000006702586,0.0000019291447,0.000017826716,0.000058984577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862564,0.0002778428,0.00036438293,0.00015803623,0.00031168273,0.00026240488],"domain_scores_gemma":[0.9986438,0.00034032794,0.00038223554,0.0002631405,0.00014609532,0.00022441219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031560851,0.00015428055,0.00075882155,0.000094979085,0.00009378623,0.0000058670835,0.00013946781,0.000024134675,0.00024250496],"category_scores_gemma":[0.000023331791,0.00007193713,0.00020291204,0.0002939899,0.0009773836,0.000042352724,0.000029967123,0.00032972367,0.000022136324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016536316,0.0026774548,0.562495,0.000025061932,0.0021058384,0.31836882,0.0014774187,0.0000926117,0.00039411013,0.0034467145,0.0034513187,0.08892933],"study_design_scores_gemma":[0.0063855117,0.01138628,0.6088827,0.000047802405,0.0007330179,0.3444994,0.00035092546,0.000005784925,0.00050283276,0.00014248259,0.02691311,0.00015010482],"about_ca_topic_score_codex":0.000042216576,"about_ca_topic_score_gemma":0.0000022838933,"teacher_disagreement_score":0.088779226,"about_ca_system_score_codex":0.000056155717,"about_ca_system_score_gemma":0.00019076018,"threshold_uncertainty_score":0.36012104},"labels":[],"label_agreement":null},{"id":"W1987367854","doi":"10.2147/ott.s30373","title":"Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Erlotinib; Ovarian carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Ovarian cancer; Cancer research; Cancer; Epidermal growth factor receptor","score_opus":0.015431443605721327,"score_gpt":0.2651156672300822,"score_spread":0.24968422362436085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987367854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98056406,0.016175894,9.130329e-7,0.0015233879,0.000045997745,0.0009865214,0.000014249623,0.0000037188952,0.000685271],"genre_scores_gemma":[0.98854494,0.010739425,0.0003084181,0.00009522595,0.000044998236,0.00015237331,0.000008260664,0.000008788394,0.00009757965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994299,0.000029480883,0.00017457001,0.00015111802,0.000097759665,0.000117192096],"domain_scores_gemma":[0.99967617,0.000034087763,0.00006795879,0.00013615267,0.000041756914,0.000043848035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047770944,0.00010837345,0.00027214186,0.00004057644,0.000025344645,0.0000066627726,0.000027281374,0.00003552171,0.00018387094],"category_scores_gemma":[0.0000019824267,0.00005792642,0.000045306235,0.00006307792,0.000037615762,0.000041578067,0.0000044435883,0.000028219114,0.0000015207772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009957522,0.0049624797,0.380622,0.00012299133,0.00036961256,0.00006300272,0.009066525,0.0000045300785,0.022767458,0.0019105371,0.00020565717,0.57890946],"study_design_scores_gemma":[0.00826445,0.0040313257,0.9703493,0.00003935044,0.000039784678,0.000013018507,0.0003215411,0.000100051286,0.01285811,0.00019181345,0.0037251837,0.000066075205],"about_ca_topic_score_codex":0.0004934678,"about_ca_topic_score_gemma":0.000016487007,"teacher_disagreement_score":0.5897273,"about_ca_system_score_codex":0.000017794533,"about_ca_system_score_gemma":0.00003058947,"threshold_uncertainty_score":0.23621708},"labels":[],"label_agreement":null},{"id":"W1987573988","doi":"10.1002/ijc.21486","title":"Altered patterns of transcription of the septin gene, <i>SEPT9</i>, in ovarian tumorigenesis","year":2005,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Pathological Society of Great Britain and Ireland","keywords":"Serous fluid; Pathology; Carcinogenesis; Biology; Cystadenocarcinoma; Serous carcinoma; Malignancy; Ovarian carcinoma; Ovarian cancer; Cancer research; Medicine; Cancer; Genetics","score_opus":0.01559203598715522,"score_gpt":0.3097390682926535,"score_spread":0.2941470323054983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987573988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880197,0.0016526263,0.00022975694,0.008587249,0.0010153457,0.000117631076,0.00007353826,0.0000014606454,0.00030267437],"genre_scores_gemma":[0.99718875,0.0011832735,0.00037621832,0.00043629625,0.0006706685,0.000008576954,0.000002218066,0.000009880122,0.00012409966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874395,0.000030424759,0.00056528277,0.00008115111,0.0004958015,0.000083371],"domain_scores_gemma":[0.9990456,0.000025143074,0.00043537133,0.000103375925,0.00034918863,0.000041290805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014385224,0.00008102553,0.00023812636,0.00013827169,0.000007831571,0.0000057478073,0.00017894877,0.000033859043,0.0005831455],"category_scores_gemma":[0.000013257017,0.000054291115,0.00021208721,0.00008465374,0.000024884426,0.000088430956,0.000013077428,0.0001021992,8.920156e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080419774,0.00083440414,0.8467382,0.00005274005,0.0009475745,0.000036882677,0.0009467592,0.001958178,0.093954064,0.00027856373,0.0007270041,0.052721407],"study_design_scores_gemma":[0.0032100866,0.000096450916,0.78505224,0.00058353523,0.00013647012,0.000051525425,0.00003805008,0.000038063645,0.20513308,0.000051733492,0.0055668936,0.000041868803],"about_ca_topic_score_codex":0.00044115994,"about_ca_topic_score_gemma":0.00050886185,"teacher_disagreement_score":0.11117901,"about_ca_system_score_codex":0.00029449916,"about_ca_system_score_gemma":0.00021454686,"threshold_uncertainty_score":0.6385034},"labels":[],"label_agreement":null},{"id":"W1987593512","doi":"10.1111/j.1525-1438.2006.00594.x","title":"Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Hazard ratio; Chemotherapy; Proportional hazards model; Neoadjuvant therapy; Internal medicine; Oncology; Stage (stratigraphy); Surgery; Cancer; Confidence interval; Breast cancer","score_opus":0.01255594879096513,"score_gpt":0.28171305097797655,"score_spread":0.26915710218701144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987593512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957059,0.00079531345,0.000021725054,0.0026398532,0.00021432224,0.00033395353,0.00003922865,0.0000064451924,0.0002432722],"genre_scores_gemma":[0.9983171,0.00054852036,0.00043455002,0.0003213364,0.0002184873,0.000082292485,0.00000738579,0.00001584623,0.000054445067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842954,0.00004658425,0.00061795977,0.0002306053,0.00047652543,0.00019877],"domain_scores_gemma":[0.9985416,0.00024181207,0.00048197436,0.00006667674,0.00057060306,0.000097346456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014672769,0.00017775994,0.0005117711,0.00015840503,0.000020487392,0.00002730057,0.00013157823,0.00006892382,0.00055223366],"category_scores_gemma":[0.000059921673,0.0001118291,0.00010641409,0.00016319808,0.00012438188,0.00010426955,0.000026998372,0.00019974713,5.458016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021957888,0.0013936838,0.97948784,0.00002175963,0.00027381277,0.00067391427,0.00005823036,0.000140342,0.0004596901,0.00008250698,0.00013077733,0.015081647],"study_design_scores_gemma":[0.009650681,0.0015929856,0.98304015,0.000627174,0.000119138764,0.000087132394,0.00001542714,0.00007986286,0.0036872155,0.00009539834,0.0008888836,0.000115940515],"about_ca_topic_score_codex":0.0014211348,"about_ca_topic_score_gemma":0.0005113457,"teacher_disagreement_score":0.0149657065,"about_ca_system_score_codex":0.0005358619,"about_ca_system_score_gemma":0.00021011173,"threshold_uncertainty_score":0.6046571},"labels":[],"label_agreement":null},{"id":"W1987674332","doi":"10.1038/modpathol.2012.226","title":"FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines","year":2013,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Pathology; Medicine; Medical physics","score_opus":0.03884751651708298,"score_gpt":0.28354271846242735,"score_spread":0.24469520194534436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987674332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380405,0.0016356095,0.0040390417,0.0071812393,0.00006671199,0.00091158826,0.0000042718616,0.000050322742,0.0023071885],"genre_scores_gemma":[0.96131986,0.00006029803,0.035029106,0.0028189686,0.00006843127,0.00059328345,0.000018322768,0.000028690254,0.000063008985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987637,0.000045273908,0.00031112554,0.00045081647,0.000106714586,0.00032238793],"domain_scores_gemma":[0.99927074,0.00018319942,0.000059786096,0.0002448254,0.00012628599,0.00011515424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012475037,0.00018272625,0.00034218346,0.00010654331,0.000036731784,0.000021996311,0.00005274648,0.00012072081,0.00002524641],"category_scores_gemma":[0.000877861,0.000149665,0.000034370096,0.00013999395,0.00006773653,0.00006696868,0.000060005284,0.00013918552,0.0000248198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048917726,0.0009349754,0.87429106,0.0002969737,0.000099035664,0.0024467355,0.0013514474,0.0007177321,0.014327654,0.0010836271,0.001684264,0.10271756],"study_design_scores_gemma":[0.0058071204,0.0007649485,0.93070406,0.00029324304,0.00020537368,0.002987344,0.00017612874,0.04819286,0.0014244912,0.008812001,0.00020677118,0.0004256624],"about_ca_topic_score_codex":0.00036748263,"about_ca_topic_score_gemma":0.00002446276,"teacher_disagreement_score":0.102291904,"about_ca_system_score_codex":0.000053321626,"about_ca_system_score_gemma":0.00007671017,"threshold_uncertainty_score":0.61031616},"labels":[],"label_agreement":null},{"id":"W1987942446","doi":"10.1016/s1470-2045(12)70127-4","title":"Screening of symptomatic women for ovarian cancer – Authors' reply","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ovarian cancer; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.08046158177394504,"score_gpt":0.38738397600514635,"score_spread":0.3069223942312013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987942446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88906646,0.0031753727,0.0020335817,0.09076509,0.0014882799,0.0019731058,0.00010679104,0.000112004585,0.011279334],"genre_scores_gemma":[0.9846841,0.00017442007,0.0076031107,0.0042005256,0.001644411,0.0010211089,0.000008749093,0.000020213149,0.0006433495],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900943,0.000082683946,0.00023064729,0.00012823577,0.00010224547,0.00044676664],"domain_scores_gemma":[0.99899507,0.0003270142,0.00016134024,0.00035440314,0.000048214046,0.00011398675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008900248,0.00010077589,0.0005424131,0.00003695717,0.000061526356,0.000003962422,0.00010025211,0.00007067862,0.00033546836],"category_scores_gemma":[0.00008198864,0.00006191076,0.000072024544,0.000102963146,0.000070539165,0.000038484195,0.000033459826,0.000099694975,0.0000083302875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035936171,0.0018846926,0.52106315,0.0010715902,0.002800944,0.00001883786,0.020366445,0.00005187057,0.0020729261,0.030115627,0.09464474,0.32231557],"study_design_scores_gemma":[0.009631652,0.0015944307,0.3865691,0.00022666602,0.0006131466,0.0000646443,0.0006688288,0.00027836984,0.0017710644,0.0009544661,0.59746796,0.00015966677],"about_ca_topic_score_codex":0.00014227003,"about_ca_topic_score_gemma":0.000016417736,"teacher_disagreement_score":0.50282323,"about_ca_system_score_codex":0.00028232665,"about_ca_system_score_gemma":0.00013566711,"threshold_uncertainty_score":0.36731434},"labels":[],"label_agreement":null},{"id":"W1988082213","doi":"10.1593/tlo.10103","title":"Effect of Ovarian Cancer Ascites on Cell Migration and Gene Expression in an Epithelial Ovarian Cancer In Vitro Model","year":2010,"lang":"en","type":"article","venue":"Translational Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Cancer Research Society","keywords":"Ovarian cancer; Ascites; Cancer research; Biology; CD44; Cancer; Cell; Andrology; Internal medicine; Medicine","score_opus":0.016125086392735143,"score_gpt":0.32882980238767673,"score_spread":0.3127047159949416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988082213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946345,0.00027319937,0.00013152958,0.0037254032,0.00017445612,0.00056618586,0.00016562878,0.0000090455005,0.00032004595],"genre_scores_gemma":[0.9952829,0.00015098821,0.0038201783,0.00017543227,0.0001552105,0.00029381123,0.000081635684,0.000016042464,0.000023839042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989684,0.00011336613,0.0002875749,0.00029867704,0.00016858712,0.00016336331],"domain_scores_gemma":[0.9994325,0.00022954513,0.00008334985,0.00012786724,0.000040714018,0.000086017586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026829343,0.00014817977,0.00036699398,0.00018492999,0.000027665748,0.0000052185924,0.000042594078,0.00020043213,0.00017378964],"category_scores_gemma":[0.000008973581,0.000118651835,0.000044551405,0.00011900537,0.000054482163,0.000092344126,0.000005384877,0.00023494114,0.0000012301056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004205722,0.0006797853,0.124030896,0.00006231258,0.000018983723,0.00001799542,0.0008426664,0.006385121,0.8128808,0.000176635,0.000009016054,0.05069006],"study_design_scores_gemma":[0.012154247,0.0013893362,0.37455025,0.00009009792,0.00009699172,0.0000036196705,0.0000059855333,0.030579371,0.58050317,0.00028272124,0.00021750147,0.0001267467],"about_ca_topic_score_codex":0.0011162718,"about_ca_topic_score_gemma":0.0095575405,"teacher_disagreement_score":0.25051937,"about_ca_system_score_codex":0.0001121615,"about_ca_system_score_gemma":0.0003377644,"threshold_uncertainty_score":0.5333332},"labels":[],"label_agreement":null},{"id":"W1988368041","doi":"10.1158/1538-7445.am2014-3283","title":"Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Biology; SNP; Locus (genetics); Genotype; Genetic association; Minor allele frequency; 1000 Genomes Project; Imputation (statistics); Genetics; Allele; Ovarian cancer; Oncology; Gene; Cancer; Medicine","score_opus":0.09044935625200771,"score_gpt":0.41160121404870936,"score_spread":0.32115185779670163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988368041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795922,0.0018924504,0.00033950995,0.0051150536,0.00080100854,0.0018943963,0.00023547732,0.00008147007,0.0100484025],"genre_scores_gemma":[0.99357224,0.00069808913,0.0004235361,0.00020470496,0.0013472422,0.0013860301,0.00004341982,0.00006614347,0.0022585774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973204,0.00013255095,0.00033059006,0.0006759152,0.00071056007,0.0008299917],"domain_scores_gemma":[0.99763525,0.00057468796,0.00009436337,0.0007690884,0.0005534723,0.00037312144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015125867,0.00021500792,0.00042178424,0.00026824832,0.00043365455,0.00012661295,0.00022664621,0.00014683689,0.0011092925],"category_scores_gemma":[0.00045043157,0.0001786571,0.0001807871,0.0003494071,0.00016685973,0.00011278923,0.000081217724,0.0004580657,0.00019890246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032975113,0.0022023963,0.51151234,0.0021145511,0.0015805383,0.00035416073,0.0025956878,0.000111107984,0.0220623,0.009291901,0.18939409,0.25548342],"study_design_scores_gemma":[0.005820588,0.0007022631,0.91638803,0.00028797783,0.0002047437,0.000017178923,0.00015631922,0.00021506367,0.01723895,0.0024191346,0.05629257,0.00025716203],"about_ca_topic_score_codex":0.005388616,"about_ca_topic_score_gemma":0.0005531985,"teacher_disagreement_score":0.4048757,"about_ca_system_score_codex":0.00051607564,"about_ca_system_score_gemma":0.00055821514,"threshold_uncertainty_score":0.99980384},"labels":[],"label_agreement":null},{"id":"W1988536568","doi":"10.1016/j.ygyno.2004.01.047","title":"Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Michael Smith Health Research BC","keywords":"Serous fluid; Pathology; Serous Cystadenoma; Immunohistochemistry; Oviduct; Ovary; Epithelium; Serous carcinoma; Medicine; Biology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.013756043613473289,"score_gpt":0.28388539161525517,"score_spread":0.2701293480017819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988536568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97210515,0.00027752394,0.00029934014,0.02506424,0.0003483877,0.00132394,0.0000147195615,0.000062475236,0.0005042497],"genre_scores_gemma":[0.99460983,0.000052607655,0.0034143634,0.0013033631,0.00026547472,0.0002390937,0.000041822215,0.000019300242,0.000054127555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817854,0.00014776294,0.0004364816,0.000535249,0.00025913672,0.00044281592],"domain_scores_gemma":[0.99884295,0.00035008322,0.00015487074,0.0002514679,0.00003666901,0.00036395574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021981083,0.00023746032,0.0005660824,0.00021215476,0.00018292638,0.000020437596,0.000105943735,0.00039225593,0.00047721685],"category_scores_gemma":[0.00027640763,0.0001879605,0.00008158152,0.0002056602,0.00014920908,0.00005765328,0.0002528838,0.00036880386,0.00006374997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034078243,0.007997865,0.8789409,0.00012842349,0.0003013542,0.0038484053,0.0036629122,0.000201873,0.004453939,0.00473383,0.00057108246,0.09175162],"study_design_scores_gemma":[0.018143848,0.0064862473,0.96753395,0.00005762687,0.00015614905,0.00007859712,0.000045580175,0.000105714345,0.0013243227,0.0028769637,0.0030114013,0.00017959361],"about_ca_topic_score_codex":0.0010616079,"about_ca_topic_score_gemma":0.0010730365,"teacher_disagreement_score":0.091572024,"about_ca_system_score_codex":0.0011232038,"about_ca_system_score_gemma":0.0014334902,"threshold_uncertainty_score":0.7664807},"labels":[],"label_agreement":null},{"id":"W1988820699","doi":"10.1007/s004040100244","title":"Adenocarcinoma arising from respiratory ciliated epithelium in mature ovarian cystic teratoma","year":2002,"lang":"en","type":"review","venue":"Archives of Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Carcinoembryonic antigen; Ovary; Medicine; Mature Cystic Teratoma; Adenocarcinoma; Pathology; Malignant transformation; Teratoma; Papillary adenocarcinoma; Mature teratoma; Cancer; Internal medicine","score_opus":0.03900121514079121,"score_gpt":0.2949019431184277,"score_spread":0.2559007279776365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988820699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001965098,0.9952523,0.000012476142,0.00008080023,0.0005444846,0.0008510665,0.00022731366,0.000025586489,0.0010408798],"genre_scores_gemma":[0.011173953,0.9870708,0.0010629118,0.00017027321,0.00010442579,0.00007969145,0.0001729024,0.00005357596,0.00011149134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758047,0.00034563994,0.0008672804,0.0006736553,0.00015378611,0.00037915164],"domain_scores_gemma":[0.9904986,0.00833806,0.00042692447,0.00053470326,0.000028494838,0.00017324177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011437015,0.00045871586,0.0022192658,0.00091585715,0.00006701252,0.000017531269,0.0001713638,0.0005970081,0.00012468809],"category_scores_gemma":[0.0011776417,0.0003698952,0.00030287215,0.00060121843,0.00020645237,0.000040247833,0.00012022525,0.0007720483,0.000021550075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035418227,0.00045037275,0.030775033,0.0049793664,0.0005882833,0.001426936,0.0003867098,5.1879624e-7,0.0000011183944,0.00023128357,0.0001316052,0.96099335],"study_design_scores_gemma":[0.0045445166,0.001065238,0.25107256,0.014050486,0.004043143,0.00010914502,0.00006560125,0.000041552954,0.000008233418,0.0008471878,0.72356015,0.0005921949],"about_ca_topic_score_codex":0.000046067093,"about_ca_topic_score_gemma":0.000028887105,"teacher_disagreement_score":0.9604012,"about_ca_system_score_codex":0.00013457924,"about_ca_system_score_gemma":0.0003046006,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W1988849455","doi":"10.1007/s00404-005-0017-y","title":"An unusual case of uterine tube cancer (transitional cell carcinoma) co-existing with appendicitis: a case report","year":2005,"lang":"en","type":"article","venue":"Archives of Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Medicine; Omentectomy; Hysterectomy; Carcinoma; Surgery; Uterine cancer; Radical surgery; Cancer; General surgery; Pathology; Internal medicine","score_opus":0.020059899697670382,"score_gpt":0.3128359364098439,"score_spread":0.29277603671217356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988849455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420834,0.0018149805,0.00020157137,0.0002604546,0.00007337572,0.00026142257,0.00023796187,0.000012083712,0.002929792],"genre_scores_gemma":[0.99385864,0.000211109,0.0055164,0.00011891329,0.00006953859,0.000032810723,0.00006609024,0.000015299865,0.00011119019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999016,0.000045519002,0.00034391682,0.00029277802,0.0001008002,0.0002009701],"domain_scores_gemma":[0.998298,0.0010750369,0.00019087936,0.00021640128,0.00006297203,0.000156734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007717192,0.00014545441,0.0003718966,0.00020521763,0.00009651063,0.000004429215,0.00003544402,0.0000624938,0.00011255742],"category_scores_gemma":[0.00007852776,0.000120524885,0.000052798183,0.00014167099,0.00029234958,0.000065506545,0.000017718823,0.00012808159,5.4036605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038453788,0.0014954306,0.5138064,0.0005773407,0.0002233408,0.40920857,0.0022910454,0.0001914039,0.0005645197,0.0005620704,0.00004283176,0.07065249],"study_design_scores_gemma":[0.014559548,0.006912348,0.48767102,0.00018490247,0.0010492572,0.45235378,0.0021322167,0.002201487,0.029141687,0.00012710952,0.0032043585,0.0004622786],"about_ca_topic_score_codex":0.0005334254,"about_ca_topic_score_gemma":0.0005062273,"teacher_disagreement_score":0.07019021,"about_ca_system_score_codex":0.000036891735,"about_ca_system_score_gemma":0.0001899582,"threshold_uncertainty_score":0.49148622},"labels":[],"label_agreement":null},{"id":"W1989187633","doi":"10.1016/s0242-6498(04)93914-4","title":"Tumeurs ovariennes mucineuses de type endocervical (müllérien) : analyse clinico-pathologique de 17 cas","year":2004,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Gynecology; Medicine","score_opus":0.0651922319443348,"score_gpt":0.3699472889524287,"score_spread":0.3047550570080939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989187633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91299933,0.05950816,0.0016260893,0.020517655,0.0013353332,0.000540043,0.00011514636,0.00028279316,0.0030754379],"genre_scores_gemma":[0.9465459,0.027292084,0.016242262,0.0070335316,0.0014104112,0.00015228507,0.00008514888,0.0000906932,0.0011476858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99530464,0.0006127286,0.00080007117,0.0010253338,0.00030302236,0.001954199],"domain_scores_gemma":[0.99690336,0.0007672194,0.00028544693,0.0010005011,0.00024254042,0.000800949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015128613,0.00065459387,0.000981696,0.00023626757,0.0002287591,0.00010206692,0.00044204656,0.0008254369,0.0007483363],"category_scores_gemma":[0.002425361,0.00059258245,0.0005192494,0.0006672454,0.0006512368,0.00021249885,0.0002139466,0.0009686018,0.0007573465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072544697,0.0041461056,0.82185423,0.00032371946,0.0006297127,0.061167415,0.0065719895,0.001652985,0.0022581497,0.00694535,0.0046532014,0.08907169],"study_design_scores_gemma":[0.005450658,0.0054592015,0.8975545,0.0010819606,0.0024829933,0.008334551,0.004010869,0.0002170064,0.017950045,0.0284538,0.027977956,0.0010264642],"about_ca_topic_score_codex":0.0012362293,"about_ca_topic_score_gemma":0.00074716215,"teacher_disagreement_score":0.088045225,"about_ca_system_score_codex":0.0017196977,"about_ca_system_score_gemma":0.0026623958,"threshold_uncertainty_score":0.99965256},"labels":[],"label_agreement":null},{"id":"W1989331814","doi":"10.5489/cuaj.2010","title":"New paradigms in the treatment of genitourinary malignancies: GU-ASCO Update 2014","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Genitourinary system; Medicine; Oncology; Internal medicine","score_opus":0.013076835741439129,"score_gpt":0.23701169829255225,"score_spread":0.2239348625511131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989331814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8843585,0.0019731517,0.00010530852,0.108430706,0.00040054249,0.0004153921,0.000029755609,0.000011240866,0.00427541],"genre_scores_gemma":[0.993946,0.001187818,0.0003306747,0.0035711809,0.00065414206,0.000016782009,0.000014432049,0.000007607018,0.0002713741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870396,0.00020257484,0.00032278238,0.00014977007,0.0002642065,0.0003567376],"domain_scores_gemma":[0.9989851,0.00018694246,0.00020554347,0.00015704728,0.00006716443,0.0003981777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044519707,0.00012876111,0.00030378602,0.00012291409,0.00010040386,0.000038321294,0.000105984705,0.00013061445,0.0006526209],"category_scores_gemma":[0.00009581143,0.000075978496,0.00015942105,0.0001505733,0.000017869608,0.00004278161,0.000003312647,0.0001649189,0.00007054849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050187708,0.00027624302,0.93521464,0.0000027289886,0.00012827259,0.00015662299,0.0003685989,0.000046492634,0.000009086941,0.0012807029,0.04484025,0.01762616],"study_design_scores_gemma":[0.0016060236,0.0013780122,0.65684825,0.000010109826,0.000088627276,0.000103619655,0.000037768477,0.000024993218,0.000021565906,0.00082868163,0.33899674,0.00005558684],"about_ca_topic_score_codex":0.0034739804,"about_ca_topic_score_gemma":0.002670787,"teacher_disagreement_score":0.2941565,"about_ca_system_score_codex":0.0011258364,"about_ca_system_score_gemma":0.00045521487,"threshold_uncertainty_score":0.71457416},"labels":[],"label_agreement":null},{"id":"W1989354370","doi":"10.1038/modpathol.2009.89","title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers","year":2009,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University Health Network; Canary Foundation","keywords":"BRCA mutation; Serous carcinoma; Serous fluid; Fallopian tube; Fallopian tube cancer; Medicine; Pathology; Ovarian cancer; Cancer; Lynch syndrome; Carcinoma; Immunostaining; Malignancy; Germline mutation; Oncology; Internal medicine; Mutation; Immunohistochemistry; Biology; Gynecology; Colorectal cancer","score_opus":0.012606111060079337,"score_gpt":0.2885385424456439,"score_spread":0.27593243138556456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989354370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933184,0.00131924,0.00026924853,0.0033911213,0.0001622316,0.00036729994,0.000055785345,0.000024344352,0.0010923365],"genre_scores_gemma":[0.9981775,0.00033306092,0.00034545446,0.0008081292,0.00004812661,0.00007235037,0.00003495433,0.000014426618,0.00016598821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901533,0.000055366145,0.0002580339,0.00030139578,0.00011975197,0.0002500938],"domain_scores_gemma":[0.999522,0.000019008952,0.00008538762,0.00023820075,0.000054708915,0.000080741775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009839754,0.00013517751,0.0003572606,0.00013079587,0.000021425869,0.000003791096,0.000053088184,0.0001159144,0.000060736205],"category_scores_gemma":[0.000019505775,0.00011904791,0.0000580152,0.00012939378,0.000051058047,0.000041521893,0.000010053189,0.00011322316,0.000004470442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001106058,0.0014628266,0.5596379,0.0002024596,0.00027292542,0.00413606,0.026320597,0.0069303093,0.015226656,0.0014619426,0.0004073268,0.3828349],"study_design_scores_gemma":[0.0063389014,0.0014150441,0.9690739,0.0002070574,0.00022335794,0.00024135539,0.00018833677,0.0032332547,0.015916001,0.0024957794,0.0004298529,0.00023714775],"about_ca_topic_score_codex":0.001287715,"about_ca_topic_score_gemma":0.002626924,"teacher_disagreement_score":0.409436,"about_ca_system_score_codex":0.00019493609,"about_ca_system_score_gemma":0.00014978652,"threshold_uncertainty_score":0.48546326},"labels":[],"label_agreement":null},{"id":"W1989524135","doi":"10.1046/j.1469-0705.2000.00004-1-8.x","title":"P08Case report: transvaginal ultrasonographic aspiration in the management of an ovarian cyst detected at the seventh gestational week","year":2000,"lang":"en","type":"article","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network","keywords":"Medicine; Cyst; Gestation; Ovarian cyst; Obstetrics; Cystectomy; Pregnancy; Corpus luteum; Gestational age; Color doppler; Gynecology; Radiology; Ultrasonography; Ovary; Internal medicine; Bladder cancer; Cancer","score_opus":0.014953523573425529,"score_gpt":0.26136595943405655,"score_spread":0.24641243586063102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989524135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544185,0.0009469611,0.000012588391,0.0012187804,0.00013840132,0.0007009317,0.00003570854,0.000008405627,0.0014963849],"genre_scores_gemma":[0.996502,0.0022040878,0.0004376524,0.0003381616,0.00001969842,0.00014115033,0.00021191263,0.000010439807,0.0001349083],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862725,0.00016097639,0.00044125368,0.00030814574,0.00023532758,0.00022705673],"domain_scores_gemma":[0.9947635,0.004718603,0.000106273495,0.00031479046,0.000042731444,0.000054104145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049137353,0.00013852004,0.00021891737,0.00017951487,0.00010657987,0.000023771872,0.00009174279,0.00009347034,0.0004929243],"category_scores_gemma":[0.00036815924,0.00009200645,0.00005433957,0.00077098113,0.00013284625,0.000070633076,0.0000066940956,0.00016883506,0.000003701323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058240094,0.005566345,0.42744228,0.00026450655,0.0005076013,0.0073635713,0.0053110654,0.0009283636,0.00043161798,0.0054679187,0.00015150197,0.54598284],"study_design_scores_gemma":[0.0031679894,0.0011406868,0.97868955,0.000033874207,0.00016123058,0.0009922084,0.0005718483,0.000103362785,0.00006306105,0.0004824338,0.01448746,0.00010630298],"about_ca_topic_score_codex":0.00020586715,"about_ca_topic_score_gemma":0.0011638532,"teacher_disagreement_score":0.55124724,"about_ca_system_score_codex":0.00013224845,"about_ca_system_score_gemma":0.000049528702,"threshold_uncertainty_score":0.53971756},"labels":[],"label_agreement":null},{"id":"W1989951698","doi":"10.1016/j.molonc.2009.02.002","title":"Thematic issue on the molecular biology of hereditary ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Molecular Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Disease; Oncology; Context (archaeology); Breast cancer; Gynecology; Cancer; Internal medicine; Biology","score_opus":0.018303768001668108,"score_gpt":0.3431388483042977,"score_spread":0.3248350803026296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989951698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72812325,0.006889532,0.0015398696,0.20330372,0.0005887758,0.0015022414,0.00003136729,0.00006261551,0.05795863],"genre_scores_gemma":[0.98277736,0.00015400507,0.0011496275,0.015475231,0.00015717212,0.00012719785,0.000015073208,0.000018574212,0.00012576122],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988504,0.00016192309,0.00028443642,0.00028780111,0.00015012649,0.00026532414],"domain_scores_gemma":[0.99907285,0.00012535883,0.00012715034,0.00051123556,0.000074660384,0.000088743545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017249965,0.00018062361,0.00047400297,0.000080401995,0.00003954745,0.0000039691804,0.00014239672,0.00016759353,0.0007512352],"category_scores_gemma":[0.00007067765,0.000113087124,0.00016258282,0.00018545322,0.000111431174,0.0000110308065,0.000025172285,0.00018317284,0.00005091078],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068280863,0.0041712,0.0017128871,0.000130714,0.0018201006,0.0042037265,0.00085334963,0.0002202556,0.21273777,0.33051738,0.018670617,0.42427918],"study_design_scores_gemma":[0.011113739,0.021666141,0.01861064,0.00069951185,0.001972973,0.00048267923,0.00047960135,0.0003245268,0.7268851,0.037927072,0.17913145,0.0007065878],"about_ca_topic_score_codex":0.000123912,"about_ca_topic_score_gemma":0.000008004277,"teacher_disagreement_score":0.5141473,"about_ca_system_score_codex":0.00017850637,"about_ca_system_score_gemma":0.00022203855,"threshold_uncertainty_score":0.8225498},"labels":[],"label_agreement":null},{"id":"W1990281292","doi":"10.1002/ijc.22562","title":"Second primary malignancies in females with primary fallopian tube cancer","year":2007,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute; Suomen Kulttuurirahasto; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Etiology; Breast cancer; Incidence (geometry); Cancer; Colorectal cancer; Gastroenterology; Lung cancer; Gynecology; Oncology","score_opus":0.017948327362286933,"score_gpt":0.31753014205699576,"score_spread":0.29958181469470885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990281292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96888465,0.015538572,0.00009439485,0.0070321895,0.00097145926,0.00015634252,0.000036276244,0.000007782694,0.007278307],"genre_scores_gemma":[0.9901832,0.0034754393,0.00092898036,0.0035221742,0.0010207343,0.000023402159,0.000007709227,0.000022746517,0.0008156289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984854,0.000012539616,0.00046872674,0.0001517915,0.0006768962,0.00020464476],"domain_scores_gemma":[0.9989187,0.000065720385,0.00029419927,0.00009205852,0.00050699123,0.00012229646],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024560862,0.00014510933,0.00032887317,0.0002767546,0.000018208913,0.000028954373,0.00015843716,0.000055047163,0.00093904615],"category_scores_gemma":[0.0000098493365,0.0001027288,0.00010378877,0.000127749,0.000061763516,0.00020005979,0.000025390253,0.00021019786,0.0000028995019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018582335,0.00033581862,0.9282624,0.00006826042,0.0009267569,0.0014821393,0.00035312964,0.00020256272,0.0012961727,0.00036743912,0.0013305974,0.06351645],"study_design_scores_gemma":[0.004147506,0.00024432407,0.94698477,0.0012540258,0.00010511934,0.00030396198,0.000063014646,0.000002378424,0.0044567175,0.000043848235,0.04228464,0.00010968213],"about_ca_topic_score_codex":0.00024408789,"about_ca_topic_score_gemma":0.0031037577,"teacher_disagreement_score":0.06340677,"about_ca_system_score_codex":0.0013893653,"about_ca_system_score_gemma":0.0008098574,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W1990608952","doi":"10.3802/jgo.2011.22.4.222","title":"ASGO's Second Biennial Meeting, November 3-5 2011","year":2011,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE","score_opus":0.05096692995109468,"score_gpt":0.3059223805317175,"score_spread":0.2549554505806228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990608952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7848535,0.0013225084,0.000033882032,0.0029545675,0.003182857,0.00029043763,0.000004177707,0.000023099486,0.20733494],"genre_scores_gemma":[0.9865686,0.00035767877,0.0085982615,0.002378557,0.00066822063,0.000016254622,0.0000011654313,0.000019573563,0.0013916496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984128,0.00011823745,0.00068389234,0.0001962667,0.00025644447,0.00033236068],"domain_scores_gemma":[0.99810845,0.00025615955,0.0007297702,0.00019658134,0.00044468886,0.00026434383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088922767,0.00017658572,0.00072869426,0.00019013278,0.000059660433,0.000007578976,0.00015393324,0.00027469333,0.025588294],"category_scores_gemma":[0.00030536254,0.00011927549,0.0002688928,0.000093309434,0.0001227868,0.00010269383,0.00005416859,0.00039538398,0.000265571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032532518,0.012542562,0.48535636,0.00013638954,0.002428226,0.014712765,0.0024776654,0.000006213779,0.0029189491,0.0021412892,0.3364865,0.13753985],"study_design_scores_gemma":[0.0066448883,0.016002836,0.58167684,0.000054257664,0.0005674683,0.002346465,0.00022938041,0.000004102103,0.0019174136,0.001070774,0.3893279,0.00015767022],"about_ca_topic_score_codex":0.00003142394,"about_ca_topic_score_gemma":0.00021442374,"teacher_disagreement_score":0.20594329,"about_ca_system_score_codex":0.00068478857,"about_ca_system_score_gemma":0.00075449474,"threshold_uncertainty_score":0.97530246},"labels":[],"label_agreement":null},{"id":"W1991059053","doi":"10.1503/cjs.013311","title":"Pediatric ovarian torsion: case series and review of the literature","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Ovarian torsion; Pyuria; Abdominal pain; Leukocytosis; Vomiting; Urinalysis; Appendicitis; Surgery; Pelvic pain; Ovarian cyst; Cyst; Urinary system; Internal medicine","score_opus":0.01727984424631761,"score_gpt":0.22499005650191203,"score_spread":0.2077102122555944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991059053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7086942,0.26636603,3.1248996e-7,0.02366673,0.0007148699,0.00021641518,0.00002473105,0.0000015141547,0.00031519533],"genre_scores_gemma":[0.9613146,0.03632018,0.00008568611,0.001720265,0.00040209584,0.000004859911,0.000001758914,0.000008996781,0.00014155709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993162,0.000043007003,0.00032486644,0.00006576837,0.00010633641,0.00014378296],"domain_scores_gemma":[0.9988092,0.000075918746,0.00020496105,0.0001567739,0.0003191256,0.0004340316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002529309,0.00008182652,0.00031736316,0.00014020767,0.00007545051,0.000025309422,0.000035422374,0.000044038778,0.00054239057],"category_scores_gemma":[0.00019802531,0.00004724923,0.00015659753,0.00028441078,0.00004202606,0.00013758727,0.000006402613,0.00013443865,0.0000018164131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012204776,0.00003156745,0.7456168,0.003478422,0.00012453525,0.010484907,0.0004057525,1.2932067e-7,0.0000050356116,0.00011894948,0.22929184,0.010429856],"study_design_scores_gemma":[0.00076671963,0.00024455914,0.728173,0.026662247,0.0009567284,0.13797016,0.00032292068,5.7580894e-7,0.00017420818,0.0001656676,0.10433902,0.00022414514],"about_ca_topic_score_codex":0.0015978889,"about_ca_topic_score_gemma":0.0008831253,"teacher_disagreement_score":0.2526204,"about_ca_system_score_codex":0.000080168946,"about_ca_system_score_gemma":0.0012903106,"threshold_uncertainty_score":0.59387964},"labels":[],"label_agreement":null},{"id":"W1991152196","doi":"10.1111/igc.0b013e318199009c","title":"The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; BC Cancer Agency; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Fallopian tube; Tubal ligation; Pelvic inflammatory disease; Serous carcinoma; Ovarian carcinoma; Salpingectomy; Gynecology; Endometriosis; Hysterectomy; Ovarian cancer; Oncology; Pregnancy; Ectopic pregnancy; Internal medicine; Cancer; Pathology; Population; Family planning","score_opus":0.04235860833698081,"score_gpt":0.35590021485305035,"score_spread":0.31354160651606955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991152196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018335991,0.9906965,0.0000065912914,0.0037902426,0.0019958531,0.0004776893,0.00014561627,0.0000095964115,0.001044346],"genre_scores_gemma":[0.0076039727,0.98915344,0.00024028291,0.0008523646,0.001368323,0.000055647975,0.000056375917,0.00002787409,0.0006417359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969944,0.00014801335,0.0013342102,0.0002728817,0.0009785836,0.00027193408],"domain_scores_gemma":[0.99643975,0.00088518916,0.0014676064,0.0002433153,0.00077478733,0.0001893317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000349926,0.00036386235,0.0017421661,0.00018476318,0.000066205044,0.000055784,0.00054607,0.00028449454,0.000647345],"category_scores_gemma":[0.00020800374,0.00018724341,0.0008819193,0.00020665354,0.00013621637,0.000074329146,0.000096351425,0.0007030243,0.000016196795],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015132896,0.0005525374,0.0018313193,0.00057373726,0.0019186111,0.0009822646,0.000023259301,0.0000149552625,0.0000018685815,0.00044995296,0.004890673,0.9886095],"study_design_scores_gemma":[0.0015607624,0.001022034,0.041319635,0.004464882,0.0017237482,0.0005916508,0.000006772906,0.0000016680452,0.0000061119385,0.00013739709,0.9489984,0.00016694835],"about_ca_topic_score_codex":0.000108879416,"about_ca_topic_score_gemma":0.00009547555,"teacher_disagreement_score":0.98844254,"about_ca_system_score_codex":0.0018100311,"about_ca_system_score_gemma":0.0014326419,"threshold_uncertainty_score":0.7635565},"labels":[],"label_agreement":null},{"id":"W1991447704","doi":"10.1016/j.jpedsurg.2007.11.007","title":"A laparoscopic approach to treating torsion of a nonpregnant uterus accompanied by a large ovarian cyst in a premenarchal girl","year":2008,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Surgery; Cyst; Uterus; Oophorectomy; Abdominal pain; Vomiting; Labrador Retriever; Radiology; Hysterectomy; Internal medicine","score_opus":0.03384589918170141,"score_gpt":0.27262109747708185,"score_spread":0.23877519829538044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991447704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959109,0.0025465917,0.00017819174,0.0003363722,0.00026266804,0.00032957568,0.00002625447,0.000009088212,0.0004004034],"genre_scores_gemma":[0.99521244,0.0012367687,0.0022124927,0.00013484526,0.0010760258,0.000027603397,0.000013377001,0.000024197307,0.00006225115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777496,0.00010332124,0.0009934629,0.00022534216,0.0005354584,0.000367459],"domain_scores_gemma":[0.99851006,0.0003033903,0.0005591588,0.00020988987,0.00014490838,0.00027258095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006643759,0.00019513544,0.0009213987,0.0006660351,0.000051751416,0.000009738002,0.00009475043,0.00008871358,0.00003700694],"category_scores_gemma":[0.00017772114,0.0001484965,0.00028626292,0.00071473577,0.000017961369,0.00012052557,0.000040600502,0.00021395042,0.0000045239613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006187802,0.0037802104,0.9661354,0.00023034557,0.00014254826,0.0008209745,0.0018571665,0.000020600215,0.00041484585,0.000009419799,0.02500254,0.00096716563],"study_design_scores_gemma":[0.016737195,0.0019583502,0.9697001,0.0013043392,0.00089782506,0.0018259183,0.0006628978,0.00025478264,0.0026252433,0.000018450366,0.0034641756,0.00055072474],"about_ca_topic_score_codex":0.00012804144,"about_ca_topic_score_gemma":0.0000058613905,"teacher_disagreement_score":0.021538364,"about_ca_system_score_codex":0.00025529135,"about_ca_system_score_gemma":0.0005031439,"threshold_uncertainty_score":0.6055512},"labels":[],"label_agreement":null},{"id":"W1991654042","doi":"10.1046/j.1525-1438.2002.01067.x","title":"Postoperative chemotherapy in advanced ovarian granulosa cell tumors","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Univariate analysis; Stage (stratigraphy); Chemotherapy; Hysterectomy; Radiation therapy; Surgery; Retrospective cohort study; Population; Disease; Internal medicine; Multivariate analysis","score_opus":0.020721134848475244,"score_gpt":0.3043143164714355,"score_spread":0.2835931816229602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991654042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579582,0.0020962448,0.000036903013,0.033891007,0.0007702827,0.00020251842,0.000013522262,0.000008805012,0.005022488],"genre_scores_gemma":[0.9912415,0.002377668,0.00091042224,0.0047066887,0.00026754264,0.000029482202,0.0000019566858,0.000010956073,0.00045376417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998793,0.000037819565,0.00044013813,0.00016419114,0.0003977115,0.00016712546],"domain_scores_gemma":[0.9991248,0.00010312904,0.00023006264,0.00007568,0.00034841217,0.0001179146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001215285,0.0001332642,0.00033355813,0.00014881756,0.000021470667,0.000023299652,0.0001670081,0.00007156761,0.0069835573],"category_scores_gemma":[0.000082780716,0.0000917591,0.00015511212,0.00012128722,0.00004656638,0.00012742075,0.000019633582,0.00026341726,0.000022422406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028197228,0.00633656,0.66251135,0.000026378426,0.00073124067,0.006601582,0.0015535756,0.0011360548,0.005021937,0.0010917372,0.007919707,0.30425018],"study_design_scores_gemma":[0.015606657,0.0021732207,0.9458051,0.0002943772,0.000055461234,0.0002710041,0.00014397434,0.00027671302,0.006680863,0.00041524845,0.028081207,0.00019617836],"about_ca_topic_score_codex":0.000036546873,"about_ca_topic_score_gemma":0.00004179497,"teacher_disagreement_score":0.304054,"about_ca_system_score_codex":0.0006677096,"about_ca_system_score_gemma":0.00008739284,"threshold_uncertainty_score":0.9939242},"labels":[],"label_agreement":null},{"id":"W1991700067","doi":"10.1016/j.ygyno.2007.03.029","title":"Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Internal medicine; Ovarian cancer; Oncology; Proportional hazards model; Stage (stratigraphy); Prognostic variable; Hazard ratio; Cancer; Pathology; Surgery; Confidence interval","score_opus":0.008749230358979529,"score_gpt":0.3023285964595628,"score_spread":0.29357936610058327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991700067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288344,0.0005676841,0.00009277942,0.0011846484,0.00018947056,0.0014682342,0.0000135291275,0.000048697908,0.0035515418],"genre_scores_gemma":[0.9919939,0.0010156188,0.0049471264,0.0015921441,0.00007602037,0.00023132419,0.0000421597,0.000031289426,0.0000704411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979671,0.00015683025,0.0005422791,0.00057777565,0.0002316068,0.0005243773],"domain_scores_gemma":[0.9983248,0.00083759264,0.0003234366,0.00023674307,0.00011446145,0.00016296016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061204005,0.00031642633,0.0010577458,0.00021030779,0.00006112041,0.000006660197,0.000088954286,0.000357228,0.00019140248],"category_scores_gemma":[0.000038588867,0.00021483772,0.00008365068,0.0002944394,0.00022395588,0.00004645418,0.000037534388,0.00027962038,0.0000014409121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020139269,0.0029588223,0.7956388,0.00007189174,0.00015388722,0.0014664548,0.00021152086,0.0000077525665,0.0009938609,0.00012612353,0.00003761841,0.19631937],"study_design_scores_gemma":[0.02856482,0.012369427,0.9542988,0.000095096046,0.00016196878,0.0000893498,0.000027797038,0.000045641667,0.0012821953,0.000053990676,0.0028068242,0.0002040666],"about_ca_topic_score_codex":0.00037077753,"about_ca_topic_score_gemma":0.00046478517,"teacher_disagreement_score":0.1961153,"about_ca_system_score_codex":0.0017618889,"about_ca_system_score_gemma":0.00039664222,"threshold_uncertainty_score":0.87608284},"labels":[],"label_agreement":null},{"id":"W1992492119","doi":"10.1097/00002142-200308000-00001","title":"Magnetic Resonance Imaging in Gynecologic Disease","year":2003,"lang":"en","type":"letter","venue":"Topics in Magnetic Resonance Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Magnetic resonance imaging; Medicine; Radiology; Female pelvis; Adnexal Diseases; Laparotomy; Laparoscopy; Pelvis","score_opus":0.013857111411618802,"score_gpt":0.265655601028856,"score_spread":0.25179848961723716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992492119","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034310354,0.4349403,0.0000070317797,0.545053,0.0010533648,0.0017025104,0.000062628416,0.000092653885,0.013657489],"genre_scores_gemma":[0.015790213,0.016221546,0.005128322,0.9248114,0.0035237402,0.001959121,0.00025907563,0.0003690932,0.03193746],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948113,0.00027805552,0.0010873072,0.0016134086,0.0007628546,0.0014470632],"domain_scores_gemma":[0.9977438,0.00030373925,0.00020831364,0.0014169886,0.00011324455,0.00021390588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040488155,0.0008370564,0.0011284967,0.0006267118,0.00009219263,0.00013699463,0.00045540827,0.00031351263,0.0015850727],"category_scores_gemma":[0.00038535314,0.00083197607,0.0002580606,0.00070504186,0.0003128612,0.00014886845,0.0001626298,0.0022213547,0.000108668915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004433002,0.00019048843,0.4364753,0.00021592889,0.0000019469512,0.017404767,0.00006918437,0.0000028952263,0.0000014651008,0.000092417016,0.20928398,0.3362173],"study_design_scores_gemma":[0.0023281723,0.0000821259,0.4188687,0.0010573848,0.00007963042,0.00006543022,0.000020397783,0.00041185884,0.000003857046,0.0013347324,0.57529247,0.00045527084],"about_ca_topic_score_codex":0.00039212202,"about_ca_topic_score_gemma":0.00010849347,"teacher_disagreement_score":0.41871876,"about_ca_system_score_codex":0.001187031,"about_ca_system_score_gemma":0.0005654427,"threshold_uncertainty_score":0.99941313},"labels":[],"label_agreement":null},{"id":"W1992984772","doi":"10.1016/j.ygyno.2008.06.021","title":"SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"Serous fluid; Motility; Vimentin; Cancer research; Antigen; Cadherin; Biology; Pathology; Cell; Medicine; Molecular biology; Immunohistochemistry; Immunology; Cell biology","score_opus":0.043517144906768154,"score_gpt":0.2747318047830496,"score_spread":0.23121465987628143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992984772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891758,0.0011284963,0.0000119727965,0.0033950494,0.00085242523,0.0009548721,0.000010827166,0.00010646667,0.0043640975],"genre_scores_gemma":[0.99352705,0.0005768786,0.0019217853,0.002119678,0.00023788631,0.0004352477,0.000015176227,0.00003088241,0.0011353978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980085,0.00016385275,0.00049974245,0.0005440223,0.00018500969,0.00059891155],"domain_scores_gemma":[0.9988703,0.00034540743,0.00015431544,0.0003330248,0.000106447835,0.00019047935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019654808,0.00029012287,0.0007851835,0.00019726697,0.00013624111,0.000011026341,0.0001429893,0.00028067167,0.00072901807],"category_scores_gemma":[0.00019184378,0.0002169669,0.00009786243,0.00032820847,0.00021231273,0.00007614191,0.000087271466,0.00035322466,0.00031296242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012459559,0.009975414,0.8748016,0.00018654275,0.0004039656,0.023861816,0.0027027617,0.00045418605,0.010204809,0.00034872277,0.005429533,0.07038474],"study_design_scores_gemma":[0.0072605107,0.007759921,0.92783266,0.000057775425,0.0001593849,0.0009399195,0.00021490302,0.00014538535,0.005372857,0.00010171602,0.049827486,0.0003274856],"about_ca_topic_score_codex":0.00062413135,"about_ca_topic_score_gemma":0.0009361573,"teacher_disagreement_score":0.07005725,"about_ca_system_score_codex":0.00070472376,"about_ca_system_score_gemma":0.0009299416,"threshold_uncertainty_score":0.8847653},"labels":[],"label_agreement":null},{"id":"W1993286491","doi":"10.1097/igc.0000000000000282","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Ovarian cancer; Gynecologic cancer; Gynecology; Gynecologic oncology; Oncology; Statement (logic); Consensus conference; Obstetrics and gynaecology; Internal medicine; Cancer; Pregnancy","score_opus":0.04385770882175851,"score_gpt":0.388409190163566,"score_spread":0.3445514813418075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993286491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017825211,0.9810968,0.00045848117,0.009325595,0.0053330553,0.002387249,0.0009397557,0.000027503427,0.00025328537],"genre_scores_gemma":[0.00392737,0.9856043,0.0016597871,0.0042605055,0.002926841,0.0009444569,0.00017343252,0.000094957584,0.00040834278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99346167,0.00037066708,0.0036731944,0.0007545233,0.0011336682,0.0006063027],"domain_scores_gemma":[0.9891637,0.0014392505,0.0047818436,0.00042909224,0.003760906,0.00042520338],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013168833,0.00085453875,0.0053281924,0.0004724352,0.00008077012,0.00005861604,0.0009989258,0.0005479079,0.0060345875],"category_scores_gemma":[0.0024275344,0.00054678466,0.0026195915,0.00033613265,0.00027554447,0.00008470699,0.00021368996,0.00089457165,0.000017935492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080321636,0.0017366734,0.0003360245,0.028258868,0.006207922,0.0018812597,0.000019116016,0.00007076956,0.0000103794455,0.000900148,0.028800901,0.9309747],"study_design_scores_gemma":[0.004813262,0.0025040107,0.001293717,0.121826604,0.006293225,0.0013229656,0.000013904089,0.000056318462,0.00002444249,0.00025938769,0.8610065,0.0005856558],"about_ca_topic_score_codex":0.00013495222,"about_ca_topic_score_gemma":0.00009722748,"teacher_disagreement_score":0.93038905,"about_ca_system_score_codex":0.0019079825,"about_ca_system_score_gemma":0.0028073536,"threshold_uncertainty_score":0.99969834},"labels":[],"label_agreement":null},{"id":"W1993490337","doi":"10.1111/his.12580","title":"Microscopic extraovarian sex cord proliferations: an undescribed phenomenon","year":2014,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pathology; Cord; Anatomy; Calretinin; Medicine; Fallopian tube; Immunohistochemistry; Surgery","score_opus":0.025942386749933873,"score_gpt":0.29902446131047633,"score_spread":0.27308207456054245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993490337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94616675,0.0011134797,0.008166872,0.0056228065,0.0012150813,0.0010827576,0.000017255943,0.00028110316,0.036333915],"genre_scores_gemma":[0.98704875,0.00004028219,0.0066274623,0.0024591268,0.00036818942,0.00013233404,0.000089831905,0.000030644595,0.0032033771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988912,0.00011719157,0.00023434435,0.00040182337,0.00009851379,0.00025693618],"domain_scores_gemma":[0.9992023,0.000030217014,0.000067427216,0.0004893731,0.000054996664,0.00015566451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018399014,0.00015664593,0.00032207597,0.00009939376,0.00012543489,0.00001814018,0.00007148564,0.00010669482,0.00034608398],"category_scores_gemma":[0.00003259399,0.00014213836,0.0000505686,0.00008791168,0.0001004241,0.000061190905,0.000018142573,0.00012128012,0.0001398192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012087779,0.0069950926,0.48472825,0.00038837688,0.00010098303,0.0010987704,0.005908652,0.000026769094,0.15117027,0.17634042,0.009553798,0.16247985],"study_design_scores_gemma":[0.006187312,0.006335982,0.69720596,0.00007168947,0.00035730138,0.0007801465,0.00012939799,0.0002970029,0.0025273983,0.0027967812,0.28289798,0.00041307352],"about_ca_topic_score_codex":0.00006102612,"about_ca_topic_score_gemma":0.00009819089,"teacher_disagreement_score":0.2733442,"about_ca_system_score_codex":0.00022551963,"about_ca_system_score_gemma":0.0001509341,"threshold_uncertainty_score":0.5796234},"labels":[],"label_agreement":null},{"id":"W1993590751","doi":"10.1111/aogs.12642","title":"Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study","year":2015,"lang":"en","type":"article","venue":"Acta Obstetricia Et Gynecologica Scandinavica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Ben-Gurion University of the Negev; American Physicians Fellowship for Medicine in Israel; Israel Cancer Association; Israel Cancer Research Fund","keywords":"Medicine; Doxorubicin; Toxicity; Cumulative dose; Internal medicine; Surgery; Liposome; Oncology; Chemotherapy; Gastroenterology","score_opus":0.1618477658016329,"score_gpt":0.3929924240981204,"score_spread":0.2311446582964875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993590751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97847,0.0019870996,0.000005855688,0.0048334585,0.0012731199,0.0103236,0.00013927411,0.00025842024,0.0027091552],"genre_scores_gemma":[0.99432176,0.0002601022,0.00061129703,0.0005119001,0.00017733412,0.0032802527,0.00018815008,0.000057663103,0.0005915119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962884,0.0003129379,0.0007250647,0.0012358613,0.00058484945,0.00085289445],"domain_scores_gemma":[0.9962353,0.0013076654,0.00035688395,0.0009057875,0.0005004056,0.00069396617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006108024,0.00061348267,0.001194289,0.0002957713,0.0002367863,0.00009574608,0.00024034845,0.0002928234,0.00022725925],"category_scores_gemma":[0.0018299265,0.0004255424,0.00035599177,0.0009892511,0.00009419903,0.00015894423,0.00010318913,0.0002961244,0.000043783773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00872574,0.02898381,0.90366894,0.00010450455,0.0017065258,0.00059837295,0.0049758726,0.00003541474,0.0001948363,0.00012748173,0.01005784,0.04082065],"study_design_scores_gemma":[0.039068554,0.09330154,0.8355452,0.000119799166,0.0018266495,0.000053153304,0.002750008,0.000260479,0.0005999592,0.00022552646,0.025570164,0.0006790146],"about_ca_topic_score_codex":0.0005996451,"about_ca_topic_score_gemma":0.0014680207,"teacher_disagreement_score":0.068123795,"about_ca_system_score_codex":0.0063476786,"about_ca_system_score_gemma":0.0013746051,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W1994052710","doi":"10.1097/pas.0b013e3181e1a3bb","title":"Diagnosis of Ovarian Carcinoma Cell Type is Highly Reproducible","year":2010,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbotsford Veterinary Clinic; Memorial University of Newfoundland; University of Calgary; McGill University; University of Manitoba; Vancouver General Hospital; University of Alberta","funders":"","keywords":"Concordance; Medicine; Clear cell carcinoma; Serous fluid; Subtyping; Kappa; Clear cell; Ovarian carcinoma; Reproducibility; Ovarian cancer; Serous carcinoma; Carcinoma; Pathology; Germ cell tumors; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.01626748508860054,"score_gpt":0.2782578848019575,"score_spread":0.26199039971335697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994052710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97796035,0.00073356606,0.0000038212556,0.019113213,0.00048350176,0.000112070935,0.000008612873,0.0000062839626,0.0015786113],"genre_scores_gemma":[0.996312,0.0011865657,0.0011858364,0.0006979147,0.00046163172,0.000006458535,0.0000012912574,0.000018609537,0.00012968987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986577,0.00014121068,0.00050698605,0.0002275068,0.00024163422,0.00022495221],"domain_scores_gemma":[0.99790865,0.0003374487,0.0006859003,0.00060287706,0.00029812395,0.0001670126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006703995,0.0001384774,0.0007108331,0.000113894515,0.00004441871,0.0000064382066,0.00019427968,0.00005279537,0.0005032886],"category_scores_gemma":[0.000077673416,0.000079203055,0.000233431,0.0003776489,0.0005536404,0.00003408694,0.000047513422,0.0004659303,0.000025372672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026353337,0.0017557776,0.91423225,0.00004144043,0.00026801456,0.0055229645,0.0011597631,0.000007106704,0.01207414,0.0006428299,0.007796091,0.053864285],"study_design_scores_gemma":[0.0047676424,0.009040728,0.8383692,0.00006939437,0.00079599087,0.009633353,0.00033010292,0.000005919425,0.067090966,0.0005619036,0.069117874,0.00021695417],"about_ca_topic_score_codex":0.0001244829,"about_ca_topic_score_gemma":0.0000029938842,"teacher_disagreement_score":0.07586308,"about_ca_system_score_codex":0.00002854139,"about_ca_system_score_gemma":0.00017467645,"threshold_uncertainty_score":0.55106574},"labels":[],"label_agreement":null},{"id":"W1994498878","doi":"10.1111/j.1525-1438.2003.13356.x","title":"Systemic treatment policies in ovarian cancer: the next 10 years","year":2003,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Carboplatin; Randomized controlled trial; Ovarian cancer; Paclitaxel; Front line; Intensive care medicine; Oncology; Cancer; Internal medicine; Chemotherapy","score_opus":0.12375707875798199,"score_gpt":0.420059247060314,"score_spread":0.296302168302332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994498878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011299645,0.9926375,0.0000017249216,0.0024692754,0.0023258345,0.00067831855,0.000105563544,0.0000065485724,0.0006452456],"genre_scores_gemma":[0.0042823395,0.9923187,0.000044247743,0.00060309406,0.0011870558,0.0004703956,0.0000127517005,0.00003152229,0.0010498993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754864,0.00021223916,0.001098205,0.00027247678,0.0005844696,0.00028394468],"domain_scores_gemma":[0.99785244,0.0005141988,0.0009687383,0.00020641684,0.00031304747,0.00014513767],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029117818,0.00036358743,0.0016358512,0.00029782995,0.000034527002,0.00008500262,0.00043205777,0.0002694934,0.004034913],"category_scores_gemma":[0.00011347396,0.0001835285,0.00082894124,0.0002461118,0.00008816722,0.00007647878,0.00004850756,0.00044637755,0.000040475938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009672204,0.0005074289,0.0023038862,0.00031193782,0.0021840793,0.001226451,0.00009771114,0.000042056872,6.3919776e-7,0.0002615916,0.0023843828,0.9905831],"study_design_scores_gemma":[0.0018968675,0.0005634388,0.0052194567,0.0075995396,0.001394599,0.0009559156,0.00004057101,0.00000149487,0.0000016359068,0.000035779485,0.98213035,0.00016036692],"about_ca_topic_score_codex":0.000611152,"about_ca_topic_score_gemma":0.00028814655,"teacher_disagreement_score":0.9904227,"about_ca_system_score_codex":0.005519687,"about_ca_system_score_gemma":0.0019358121,"threshold_uncertainty_score":0.9982979},"labels":[],"label_agreement":null},{"id":"W1994689333","doi":"10.1016/j.ygyno.2003.11.034","title":"Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Topotecan; Chemotherapy; Etoposide; Internal medicine; Ovarian cancer; Oncology; Cancer; Quality of life (healthcare); Surgery","score_opus":0.040131013655083536,"score_gpt":0.3713003744710657,"score_spread":0.33116936081598214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994689333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913316,0.00017026332,0.000010387482,0.0055947015,0.00012525587,0.0011173629,0.000025717643,0.000024145571,0.0016005652],"genre_scores_gemma":[0.9970332,0.0002507832,0.0014061901,0.00060726656,0.00004414011,0.00055053056,0.000027491526,0.000013196947,0.00006720704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987721,0.00009443497,0.00040144633,0.00030335426,0.00017572202,0.00025297026],"domain_scores_gemma":[0.99916816,0.00014274329,0.0002128873,0.00024735334,0.000119080185,0.000109784916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016189595,0.00016085581,0.0006123347,0.00010597447,0.000047183326,0.0000030688907,0.000050445153,0.00013927513,0.0008042035],"category_scores_gemma":[0.00008655795,0.00010872662,0.00007115395,0.0002140608,0.00008393299,0.00003630669,0.000013753526,0.00008152304,0.000010394562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010931714,0.0057871123,0.9707723,0.000028288016,0.00027318194,0.00001641088,0.00043746934,0.00061807816,0.000071571885,0.00030296922,0.000012661415,0.020586748],"study_design_scores_gemma":[0.040925656,0.0052704886,0.9524407,0.0000312449,0.00009201651,0.000001044515,0.00006643003,0.0000018284702,0.0004862773,0.00017970306,0.0004080372,0.000096579526],"about_ca_topic_score_codex":0.0013241731,"about_ca_topic_score_gemma":0.0033386888,"teacher_disagreement_score":0.039832484,"about_ca_system_score_codex":0.0027390055,"about_ca_system_score_gemma":0.0011773906,"threshold_uncertainty_score":0.88054645},"labels":[],"label_agreement":null},{"id":"W1995993811","doi":"10.3747/co.v18i1.680","title":"Weekly Paclitaxel in Ovarian Cancer—The Latest Success Story","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Paclitaxel; Medicine; Ovarian cancer; Oncology; Cancer; Internal medicine; Bioinformatics; Gynecology; Biology","score_opus":0.17304150293311085,"score_gpt":0.41158923235274675,"score_spread":0.2385477294196359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995993811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8523292,0.03411344,0.000052178246,0.064044654,0.008706553,0.0019553876,0.00007381151,0.00010743328,0.038617373],"genre_scores_gemma":[0.9961077,0.0019964566,0.000102514314,0.00059719756,0.00038290853,0.0004810851,0.000014839348,0.000018900926,0.00029842366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888116,0.00013314986,0.00023979311,0.00029932157,0.00012316296,0.0003234387],"domain_scores_gemma":[0.9992664,0.00012669172,0.00010083308,0.000311698,0.0000637727,0.0001306092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027747266,0.00015383099,0.00034286123,0.00009633066,0.00006888109,0.000005929045,0.00013567362,0.00010291804,0.0010097491],"category_scores_gemma":[0.000042588144,0.00010439399,0.00007865951,0.00019654221,0.00013482122,0.000062884115,0.00005007832,0.00037684245,0.00009653788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021196213,0.0022704653,0.8447099,0.00007802966,0.000105323066,0.00017600694,0.00213897,0.0000022045635,0.000021677182,0.0025124091,0.019711038,0.12806204],"study_design_scores_gemma":[0.002696844,0.00049174717,0.68107575,0.000121888515,0.00012758478,0.000019587509,0.00015102117,0.000016700133,0.000100711535,0.00023234403,0.3148712,0.0000946181],"about_ca_topic_score_codex":0.0009785466,"about_ca_topic_score_gemma":0.0015504361,"teacher_disagreement_score":0.29516017,"about_ca_system_score_codex":0.00066589063,"about_ca_system_score_gemma":0.00045270837,"threshold_uncertainty_score":0.99990344},"labels":[],"label_agreement":null},{"id":"W1996122527","doi":"10.1097/pgp.0b013e318273fd07","title":"HNF-1β in Ovarian Carcinomas With Serous and Clear Cell Change","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Alberta; Health Sciences Centre; Vancouver General Hospital; Royal Alexandra Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Serous fluid; Clear cell carcinoma; Clear cell; Immunohistochemistry; Serous carcinoma; Pathology; Ovarian cancer; Clear-cell adenocarcinoma; Ovary; Medicine; Carcinoma; Cancer; Biology; Internal medicine","score_opus":0.023058753407835926,"score_gpt":0.26283502793109254,"score_spread":0.23977627452325662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996122527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853938,0.00040870087,0.000035953653,0.011937595,0.0002852435,0.00022310363,0.000003406832,0.0000049534274,0.0017071959],"genre_scores_gemma":[0.99525565,0.00028767623,0.001955085,0.0021747726,0.00022861108,0.000033081764,0.0000029658893,0.000008271782,0.000053910644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991334,0.000062358704,0.0002982968,0.00015516303,0.00019238808,0.000158413],"domain_scores_gemma":[0.999244,0.00015494609,0.00017572167,0.00007080909,0.0002357148,0.000118810494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015281336,0.00010514554,0.0002938413,0.00015633489,0.000015850674,0.000019732073,0.000102402104,0.000105355364,0.00067586085],"category_scores_gemma":[0.00006864283,0.00006547602,0.000051411567,0.000055923934,0.000084150815,0.00011195621,0.000046062014,0.00023776363,0.000028729635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048608135,0.00091377046,0.9729353,0.000009677788,0.000095042604,0.0109510645,0.00035439606,0.000006290227,0.00090874924,0.0004918191,0.00031886087,0.012528914],"study_design_scores_gemma":[0.0037675833,0.0031327275,0.98845863,0.00003851089,0.000038180173,0.0027858086,0.00010787685,0.000019299743,0.00021518662,0.0005655665,0.0008050798,0.00006555899],"about_ca_topic_score_codex":0.000111575806,"about_ca_topic_score_gemma":0.000053493826,"teacher_disagreement_score":0.0155232875,"about_ca_system_score_codex":0.00014484095,"about_ca_system_score_gemma":0.00004970223,"threshold_uncertainty_score":0.7400202},"labels":[],"label_agreement":null},{"id":"W1996463727","doi":"10.1007/s10637-012-9832-8","title":"Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; BC Cancer Agency; University of British Columbia","funders":"University of British Columbia; British Columbia Innovation Council","keywords":"Topotecan; Pharmacokinetics; Pharmacology; Liposome; Camptothecin; In vivo; Ovarian cancer; Irinotecan; Bioavailability; Drug; Chemistry; Medicine; Doxorubicin; Pharmacodynamics; Chemotherapy; Cancer; Internal medicine; Biochemistry; Biology","score_opus":0.046230400316462986,"score_gpt":0.32016301409947817,"score_spread":0.2739326137830152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996463727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251086,0.00097627967,0.00008444284,0.005135467,0.00016220106,0.00062044675,0.000082628874,0.000013276255,0.00041438208],"genre_scores_gemma":[0.9912241,0.000042297397,0.007490996,0.00016293982,0.00042841234,0.00016285166,0.000069677,0.0000134604115,0.000405278],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992179,0.000010966819,0.0002847425,0.00012272462,0.00019447437,0.00016918675],"domain_scores_gemma":[0.9993213,0.00008417373,0.0001404661,0.00013989164,0.00010952559,0.00020465258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056541416,0.00010388164,0.00024086694,0.000053870106,0.000033807064,0.0000036523822,0.000027416581,0.000049258266,0.00015075007],"category_scores_gemma":[0.000026528662,0.00008578679,0.00010943154,0.0001231795,0.000045708075,0.00010060131,0.000006686289,0.00001371572,0.0000029533307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007301545,0.0022168488,0.715907,0.00027302132,0.0007543269,0.0000018153656,0.009027082,0.0003045997,0.077962294,0.114975,0.00201802,0.07582988],"study_design_scores_gemma":[0.006135793,0.0009506316,0.3584128,0.00014680014,0.0004085656,0.0000100692905,0.00009377348,0.0004342309,0.62080055,0.00491541,0.00756733,0.00012403275],"about_ca_topic_score_codex":0.0008966507,"about_ca_topic_score_gemma":0.00002588156,"teacher_disagreement_score":0.5428383,"about_ca_system_score_codex":0.00018858947,"about_ca_system_score_gemma":0.00039712715,"threshold_uncertainty_score":0.3498284},"labels":[],"label_agreement":null},{"id":"W1996465736","doi":"10.1093/jnci/96.2.96","title":"For Ovarian Cancer, An Optimal Treatment Remains To Be Found","year":2004,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Oncology; Medicine; Cancer; Internal medicine; Biology","score_opus":0.1344047919052976,"score_gpt":0.41367537661834053,"score_spread":0.2792705847130429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996465736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81690544,0.001566263,0.0017119946,0.16970508,0.0063701025,0.0016748536,0.000716662,0.00002261647,0.0013270114],"genre_scores_gemma":[0.9709877,0.00057377754,0.01330451,0.009143921,0.004905828,0.00036085484,0.00001537253,0.000031580443,0.000676478],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848515,0.000017094299,0.0004068833,0.0002008166,0.00067167066,0.00021840088],"domain_scores_gemma":[0.99849546,0.000035219167,0.0002810016,0.0001543324,0.0007754654,0.00025852284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021924118,0.00018152862,0.0003287708,0.00013856492,0.00021403171,0.000042752366,0.00018577055,0.00006382671,0.00009025021],"category_scores_gemma":[0.00009048101,0.00011228289,0.00028853305,0.00023696358,0.00005717752,0.00027751562,0.000021246904,0.00011647787,0.0000023289083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010187739,0.0063245064,0.016294582,0.00020405634,0.0063656904,0.00022839972,0.005083425,0.776971,0.0054299845,0.050319366,0.044196215,0.07839507],"study_design_scores_gemma":[0.02374552,0.0039923163,0.080044635,0.0007700522,0.0013395135,0.0004989235,0.000101145415,0.00022163175,0.016749267,0.002364242,0.8698042,0.00036858098],"about_ca_topic_score_codex":0.0005336212,"about_ca_topic_score_gemma":0.0024774277,"teacher_disagreement_score":0.82560796,"about_ca_system_score_codex":0.004570034,"about_ca_system_score_gemma":0.003277022,"threshold_uncertainty_score":0.99925125},"labels":[],"label_agreement":null},{"id":"W1996632091","doi":"10.1080/10937400701876095","title":"Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors","year":2008,"lang":"en","type":"review","venue":"Journal of Toxicology and Environmental Health Part B","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Risk factor; Gynecology; Oncology; Infertility; Menopause; Breast cancer; Physiology; Internal medicine; Pregnancy; Biology","score_opus":0.11483779415931115,"score_gpt":0.39432870560473005,"score_spread":0.2794909114454189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996632091","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02263265,0.974425,0.000005681161,0.0004283014,0.00039303498,0.0011259544,0.0009714039,0.0000063207544,0.000011622774],"genre_scores_gemma":[0.0028583328,0.9955188,0.00021248573,0.0005450874,0.00042186337,0.000101739184,0.00022523013,0.000057229172,0.00005923772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977997,0.00023833891,0.0008832957,0.00038403066,0.00028009858,0.00041452775],"domain_scores_gemma":[0.99736214,0.00034363725,0.0014177436,0.00022165403,0.000010195041,0.0006446571],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021416583,0.00049298856,0.0023527297,0.00017364926,0.00031872623,0.000009881814,0.00009666268,0.00034107023,0.00020770943],"category_scores_gemma":[0.000012494946,0.00029263503,0.00045772697,0.00006521902,0.00015727096,0.00008592412,0.000021541442,0.00058095116,0.000002581416],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044904093,0.0018829518,0.02277728,0.0027067505,0.0016780077,0.00010857862,0.00031415184,0.000008017512,1.0368148e-7,0.000019405952,0.0028229733,0.96723276],"study_design_scores_gemma":[0.0021858404,0.015648741,0.035261337,0.0037999211,0.0016168803,0.0006698744,0.00009477223,0.0000013036786,0.0000027511405,0.000005052485,0.9404875,0.00022603931],"about_ca_topic_score_codex":0.000073657684,"about_ca_topic_score_gemma":0.00004890445,"teacher_disagreement_score":0.9670067,"about_ca_system_score_codex":0.0011158088,"about_ca_system_score_gemma":0.0006457348,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W1996695999","doi":"10.1186/1471-2407-12-379","title":"Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer","year":2012,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Fonds de Recherche du Québec - Santé; McGill University Health Centre; Canadian Institutes of Health Research; Université de Montréal; McGill University","keywords":"Surgical oncology; Ovarian cancer; Serous ovarian cancer; Medicine; Oncology; Internal medicine; Serous fluid; Gynecology; Cancer; Pathology","score_opus":0.0270288973638968,"score_gpt":0.2776767744866708,"score_spread":0.250647877122774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996695999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927987,0.0087892795,0.0001954442,0.00075673225,0.00036972042,0.00033434553,0.00015738605,0.000016019214,0.00010119085],"genre_scores_gemma":[0.99074984,0.0069541903,0.00090372894,0.00032158988,0.00058308506,0.00017593562,0.00015741335,0.000018078132,0.00013616505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938583,0.000018184735,0.00017973915,0.00017141229,0.00011278943,0.00013202768],"domain_scores_gemma":[0.99957263,0.000027238482,0.00012862141,0.00011859888,0.000057995083,0.00009490782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048579815,0.000112509035,0.00023540446,0.000037292284,0.000028089447,0.0000106137895,0.000017369915,0.00005965478,0.00019818463],"category_scores_gemma":[0.000004633733,0.00009417092,0.000023325018,0.00007462091,0.000026825033,0.000118672564,0.00002302404,0.00004479079,0.000001382505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021693872,0.00020480258,0.8757757,0.00033501568,0.00006561379,5.7704835e-7,0.00086117967,9.263507e-7,0.066254005,0.000027971113,0.00014686826,0.05611043],"study_design_scores_gemma":[0.0017453859,0.000055241566,0.9647241,0.00023851708,0.00022556214,0.0000014853758,0.000025131723,0.000054552198,0.030286733,0.000010031824,0.0025443295,0.00008889531],"about_ca_topic_score_codex":0.0013369145,"about_ca_topic_score_gemma":0.00017602174,"teacher_disagreement_score":0.088948466,"about_ca_system_score_codex":0.00011756075,"about_ca_system_score_gemma":0.000100720725,"threshold_uncertainty_score":0.38401788},"labels":[],"label_agreement":null},{"id":"W1996703519","doi":"10.1016/s0015-0282(02)03796-2","title":"Induction of ovulation and ovarian cancer: A meta-analysis","year":2002,"lang":"en","type":"article","venue":"Fertility and Sterility","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Inclusion and exclusion criteria; Ovulation induction; Meta-analysis; MEDLINE; Ovarian cancer; Gynecology; CINAHL; Population; Oncology; Ovulation; Internal medicine; Cancer; Psychological intervention; Pathology; Alternative medicine; Biology","score_opus":0.1469474608400779,"score_gpt":0.31893018316749483,"score_spread":0.17198272232741693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996703519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99270785,0.004415023,0.00011849502,0.0020779194,0.000028198674,0.00016663423,0.00006710005,0.000012834197,0.00040593254],"genre_scores_gemma":[0.99934304,0.00017598712,0.00019681393,0.00008128048,0.000012028517,0.00003813904,0.00001008132,0.000002845366,0.00013978478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992323,0.00006115162,0.00023331697,0.00026951593,0.000119624216,0.00008411353],"domain_scores_gemma":[0.9995195,0.00002937826,0.00006942605,0.0002444091,0.000059622926,0.00007765993],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018059363,0.00009364672,0.00055427186,0.00005954022,0.000049013623,0.000011278042,0.000014352459,0.000058352325,0.0012255837],"category_scores_gemma":[0.00001836683,0.000069385795,0.0001964977,0.00020064342,0.00007435323,0.0000768297,0.000018329132,0.000051961793,7.112908e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039826096,0.001078405,0.8426351,0.00044647037,0.07307311,0.000005551897,0.0018230992,0.000019182033,0.00035687626,0.00006593567,0.000055459608,0.07645819],"study_design_scores_gemma":[0.00046000542,0.00009451903,0.94950944,0.000003079218,0.04828828,0.0000012912274,0.000021383346,0.00095614506,0.00026517647,0.00010475363,0.00025060243,0.00004530634],"about_ca_topic_score_codex":0.001385805,"about_ca_topic_score_gemma":0.00039714828,"teacher_disagreement_score":0.10687436,"about_ca_system_score_codex":0.000032717355,"about_ca_system_score_gemma":0.0000087487815,"threshold_uncertainty_score":0.99968743},"labels":[],"label_agreement":null},{"id":"W1996737831","doi":"10.1016/j.humpath.2009.04.017","title":"Ovarian carcinoma pathology and genetics: recent advances","year":2009,"lang":"en","type":"review","venue":"Human Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Ovarian carcinoma; Molecular pathology; Pathology; Carcinoma; Anatomical pathology; Medicine; Ovarian cancer; Biology; Internal medicine; Cancer; Gene; Immunohistochemistry; Genetics","score_opus":0.06612446557829361,"score_gpt":0.3670373268290499,"score_spread":0.3009128612507563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996737831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025418296,0.9933261,0.000008294207,0.00027469653,0.00036300745,0.0011044376,0.00005618797,0.000062843195,0.004550228],"genre_scores_gemma":[0.00015128659,0.9968082,0.00085261575,0.0005420961,0.0005759331,0.00028409468,0.00034364845,0.00007456436,0.00036760722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973361,0.00029242787,0.0007042677,0.0010140885,0.00014405376,0.00050909125],"domain_scores_gemma":[0.99849683,0.000079689424,0.00034962775,0.0007764504,0.00007439017,0.0002230055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020066995,0.00059034856,0.0025398957,0.00028917714,0.00013767717,0.000021556352,0.0001435073,0.0006143653,0.0003864298],"category_scores_gemma":[0.000027339709,0.00046386875,0.00029245229,0.00015307905,0.00023631702,0.000029775063,0.00009931431,0.00046449638,0.00009475602],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010156474,0.00021878327,0.00040782278,0.0027105552,0.000087030516,0.008119329,0.000073742915,3.1943017e-8,9.946087e-7,0.0008715249,0.00055534183,0.9869447],"study_design_scores_gemma":[0.0012285622,0.0013909916,0.0033953458,0.0017591879,0.0021617066,0.008396036,0.000009257368,1.5457927e-7,0.0000018161659,0.00051928277,0.9807936,0.00034409095],"about_ca_topic_score_codex":0.0000036698111,"about_ca_topic_score_gemma":0.000022944821,"teacher_disagreement_score":0.9866006,"about_ca_system_score_codex":0.00019482218,"about_ca_system_score_gemma":0.00022243752,"threshold_uncertainty_score":0.9997813},"labels":[],"label_agreement":null},{"id":"W1997144017","doi":"10.1111/his.12033","title":"Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates","year":2012,"lang":"en","type":"review","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Pathological; Serous fluid; Ovarian carcinoma; Clear cell carcinoma; Carcinogenesis; Clear cell; Pathology; Carcinoma; Serous carcinoma; Ovarian cancer; Mucinous carcinoma; Cystadenocarcinoma; Biology; Medicine; Oncology; Cancer; Internal medicine; Adenocarcinoma","score_opus":0.10820964790416716,"score_gpt":0.37274820379230494,"score_spread":0.2645385558881378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997144017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003385981,0.9933622,0.000010586213,0.00017633902,0.00072684657,0.0007724185,0.000022386559,0.00003065366,0.001512625],"genre_scores_gemma":[0.034913804,0.96347713,0.00020928765,0.0005278752,0.00019249068,0.00030452484,0.00008295512,0.000054346096,0.00023760746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997361,0.0005692921,0.0008915881,0.000615388,0.00011382527,0.000448877],"domain_scores_gemma":[0.99869734,0.0002960765,0.00027013014,0.0005160269,0.000028841709,0.00019155614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000572309,0.00043687416,0.002487335,0.00022815898,0.000043811517,0.00000985422,0.00010829268,0.0007985479,0.00021616786],"category_scores_gemma":[0.000045150897,0.00031741077,0.00040107194,0.0001474882,0.0003902749,0.000022237225,0.00009625869,0.00072479906,0.00010505473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006424628,0.0011765736,0.11813919,0.005768134,0.00010716247,0.015960956,0.0002471692,1.5631193e-7,0.0000014077144,0.005239701,0.00020358215,0.8530917],"study_design_scores_gemma":[0.0012700497,0.00056637055,0.08646459,0.0012523483,0.0031678057,0.006320737,0.000015648568,0.0000010507886,2.665562e-7,0.00011648294,0.90050894,0.0003157145],"about_ca_topic_score_codex":0.00004886823,"about_ca_topic_score_gemma":0.000007388923,"teacher_disagreement_score":0.90030533,"about_ca_system_score_codex":0.0002558861,"about_ca_system_score_gemma":0.00023642855,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W1997162001","doi":"10.1097/ruq.0b013e3182814d9b","title":"ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass","year":2013,"lang":"en","type":"article","venue":"Ultrasound Quarterly","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiology; Guideline; Adnexal mass; Medical physics; Pathology","score_opus":0.014562417183840413,"score_gpt":0.28592068610589294,"score_spread":0.2713582689220525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997162001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98446673,0.00017135488,0.0010274495,0.0028475896,0.0008230851,0.0011034446,0.000032791206,0.0002484211,0.009279161],"genre_scores_gemma":[0.9925117,0.00004955981,0.0042079655,0.0009364289,0.0006702088,0.00030814824,0.00011532478,0.000050640683,0.0011500568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796194,0.00008193972,0.0005864901,0.00054646045,0.00033364072,0.00048950245],"domain_scores_gemma":[0.9983039,0.00034065143,0.00013007454,0.0006301888,0.00024379216,0.00035139202],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017965038,0.00029167454,0.0005058357,0.00008078859,0.00010000016,0.00017780848,0.00014589488,0.00018074212,0.0054296763],"category_scores_gemma":[0.00008360859,0.0002265481,0.00020908998,0.00020208876,0.00010344639,0.00020782555,0.0000072456046,0.00022545579,0.0018020037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017077442,0.0089916745,0.4339378,0.000713965,0.0032060752,0.0011479612,0.011442476,0.000004935792,0.2115962,0.005639694,0.08819183,0.23341964],"study_design_scores_gemma":[0.011364784,0.009203918,0.95093185,0.0002899755,0.0006648262,0.0005094995,0.0028612746,0.00014582508,0.0023724611,0.007745004,0.012944819,0.0009657952],"about_ca_topic_score_codex":0.00035096408,"about_ca_topic_score_gemma":0.000019003059,"teacher_disagreement_score":0.516994,"about_ca_system_score_codex":0.00012708943,"about_ca_system_score_gemma":0.00013054094,"threshold_uncertainty_score":0.9989752},"labels":[],"label_agreement":null},{"id":"W1998198982","doi":"10.1016/j.ygyno.2006.10.006","title":"Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel—ANZGOG 02-01","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Health Canada; Pfizer Canada; Pfizer","keywords":"Medicine; Docetaxel; Paclitaxel; Neutropenia; Internal medicine; Chemotherapy; Ovarian cancer; Oncology; Toxicity; Cancer; Surgery","score_opus":0.022469635385142107,"score_gpt":0.3245821224454167,"score_spread":0.30211248706027455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998198982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722339,0.00047892774,0.000088488785,0.007811774,0.0009520365,0.0069400063,0.00032888286,0.00007939315,0.011086599],"genre_scores_gemma":[0.98821443,0.00031109483,0.0037407896,0.00078931364,0.0005238092,0.0032469688,0.0003554209,0.00005249082,0.002765652],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971815,0.00018754324,0.0008826225,0.0007316927,0.00030967387,0.00070702226],"domain_scores_gemma":[0.99729776,0.00081004295,0.0007501473,0.0005137111,0.00042918918,0.0001991442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043435622,0.00039695864,0.001406,0.00016204441,0.00021925921,0.000013069196,0.00017079488,0.0004615452,0.0010539208],"category_scores_gemma":[0.00037287382,0.00028183742,0.00027337283,0.00022168575,0.00024521534,0.00009088618,0.00006510998,0.00024155006,0.000009303396],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26309028,0.1218746,0.20128068,0.0005096028,0.0025127765,0.00029166986,0.0010474522,0.00011544091,0.00024009062,0.002257216,0.1286844,0.2780958],"study_design_scores_gemma":[0.5480865,0.17373274,0.13731442,0.00016009662,0.00173371,0.000008599528,0.00010206789,0.000066233966,0.00043785555,0.0008358319,0.13711199,0.00040991823],"about_ca_topic_score_codex":0.00061610225,"about_ca_topic_score_gemma":0.0012733288,"teacher_disagreement_score":0.28499624,"about_ca_system_score_codex":0.0010465388,"about_ca_system_score_gemma":0.0009583784,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W1998222704","doi":"10.4021//jmc.v4i3.1085","title":"Laparoscopic Management With Detorsion Suture of an Ovarian Torsion During Early Pregnancy","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Laparoscopy; Surgery; Gestation; Ovarian torsion; Pregnancy; Fibrous joint; Ovary; Ovarian cyst; Laparoscopic surgery; Quadrant (abdomen); Gestational sac; Cyst; Internal medicine","score_opus":0.011885590296839273,"score_gpt":0.27181088753858124,"score_spread":0.25992529724174196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998222704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575454,0.001217689,0.00002478287,0.0023058483,0.00019590749,0.00026808193,0.0000017282349,0.0000080305435,0.00022339229],"genre_scores_gemma":[0.9970887,0.0007040412,0.0016766479,0.0001090209,0.0002926018,0.000011650255,0.0000021925664,0.00001381923,0.000101351696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981868,0.00004253847,0.00038664634,0.00012771568,0.0010781806,0.00017809961],"domain_scores_gemma":[0.9989436,0.00004306166,0.00024775224,0.00018547522,0.00016134177,0.00041876332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015244035,0.00011891448,0.00035495474,0.000117011085,0.0000506313,0.000017788963,0.00011054191,0.00009450467,0.0010999822],"category_scores_gemma":[0.000054201046,0.000068364745,0.000083652834,0.000116955045,0.000049857234,0.00018194257,0.000035253615,0.00019988944,0.0000061882906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033527925,0.009673852,0.73158544,0.0037649893,0.002305176,0.05463832,0.0024681417,0.000020816959,0.0024125737,0.0010118784,0.005706394,0.1830596],"study_design_scores_gemma":[0.00951016,0.006321666,0.9603636,0.009054137,0.0005356625,0.0025862472,0.0006134722,0.00001729458,0.010207471,0.000044117707,0.0006211315,0.00012504074],"about_ca_topic_score_codex":0.00019856109,"about_ca_topic_score_gemma":0.000024888965,"teacher_disagreement_score":0.22877814,"about_ca_system_score_codex":0.000095340496,"about_ca_system_score_gemma":0.00011148854,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W1998415551","doi":"10.1016/j.jpedsurg.2004.01.037","title":"Asynchronous bilateral ovarian torsion","year":2004,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Ovarian torsion; Torsion (gastropod); Asynchronous communication; Surgery; Computer network; Computer science","score_opus":0.01998632934517009,"score_gpt":0.2604694962013181,"score_spread":0.240483166856148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998415551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909132,0.0026122136,0.00054460095,0.0033961546,0.0020263297,0.00010109138,0.0000029174778,0.000016241262,0.00038723648],"genre_scores_gemma":[0.9884946,0.0018906174,0.0028780564,0.00034272464,0.0063453186,0.0000025769498,0.0000028394593,0.000018134162,0.000025182444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874765,0.000024126399,0.00052556617,0.00011538241,0.00035449272,0.00023279384],"domain_scores_gemma":[0.9989719,0.000135893,0.00034926584,0.00014279525,0.00016875558,0.00023139031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042374022,0.00012397688,0.00041635855,0.00036211687,0.000055308155,0.000020908894,0.000044587257,0.00007574435,0.0002542315],"category_scores_gemma":[0.000111933616,0.00008848481,0.0003624826,0.00028649985,0.00001335806,0.00013189182,0.000015033603,0.00016978045,0.00004309572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045403728,0.0015809538,0.9388311,0.000107203094,0.00032243007,0.004795706,0.0002616811,0.00012666071,0.000116136645,0.00025467778,0.04050808,0.012641363],"study_design_scores_gemma":[0.006131666,0.0011722003,0.97951686,0.00020116472,0.0014091235,0.0018543893,0.00008039741,0.0000029440105,0.0015522722,0.001343361,0.0064302315,0.0003053955],"about_ca_topic_score_codex":0.000047703743,"about_ca_topic_score_gemma":0.0000021175285,"teacher_disagreement_score":0.040685784,"about_ca_system_score_codex":0.00039084206,"about_ca_system_score_gemma":0.0008174927,"threshold_uncertainty_score":0.3608306},"labels":[],"label_agreement":null},{"id":"W1998435018","doi":"10.1158/1538-7445.am2014-2167","title":"Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Infertility; Endometrial cancer; Odds ratio; Gynecology; Obstetrics; Confidence interval; Epidemiology; Cohort study; Cancer; Demography; Pregnancy; Internal medicine","score_opus":0.11625777657610123,"score_gpt":0.42674801396735434,"score_spread":0.31049023739125314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998435018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753452,0.021049414,0.000054682398,0.001506383,0.00025123806,0.000856219,0.00075355027,0.000008731218,0.00017457682],"genre_scores_gemma":[0.9915138,0.0072434684,0.00008327088,0.00007456291,0.00063370913,0.00038264785,0.00003162753,0.000016497788,0.000020455911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960588,0.0012939344,0.0008967235,0.0005699201,0.0006956893,0.00048489126],"domain_scores_gemma":[0.9841089,0.013753386,0.00047814476,0.00078761374,0.0006237312,0.0002482075],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053441194,0.00019256516,0.001339972,0.00064469187,0.00012314948,0.000010342345,0.00023123813,0.00015895747,0.0011943479],"category_scores_gemma":[0.009941854,0.00012168755,0.00036443045,0.0018947495,0.0007555627,0.00004689638,0.0001707257,0.00054312195,0.0000036733613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024453665,0.00022558108,0.97825485,0.0000729052,0.0042670956,0.0000047133126,0.000255458,0.000067724584,0.0011902838,0.00010436493,0.00039828176,0.012713362],"study_design_scores_gemma":[0.007447495,0.00042313518,0.9785454,0.00007913762,0.0031980996,5.461663e-7,0.000086063614,0.00010818823,0.00918319,0.00034472335,0.0004983058,0.00008568072],"about_ca_topic_score_codex":0.1943886,"about_ca_topic_score_gemma":0.008241111,"teacher_disagreement_score":0.18614748,"about_ca_system_score_codex":0.00036670803,"about_ca_system_score_gemma":0.00063577003,"threshold_uncertainty_score":0.99971867},"labels":[],"label_agreement":null},{"id":"W1998617484","doi":"10.1006/gyno.2001.6199","title":"Quality of Life in Ovarian Cancer Patients Receiving Chemotherapy","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Carboplatin; Quality of life (healthcare); Chemotherapy; Nausea; Ovarian cancer; Cancer; Disease; Internal medicine; Cisplatin","score_opus":0.0471843192948267,"score_gpt":0.365827130510649,"score_spread":0.31864281121582233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998617484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717479,0.00036127042,0.000010479591,0.007865778,0.0004234286,0.0005652395,0.000008703889,0.000022605085,0.018994626],"genre_scores_gemma":[0.9935768,0.0017092032,0.0006702055,0.0034984362,0.000089744026,0.00020484836,0.000014473112,0.000012836562,0.00022343053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985073,0.00016810106,0.0005599401,0.0003125766,0.00014557508,0.0003064683],"domain_scores_gemma":[0.99884146,0.00044239956,0.0002653591,0.00022347913,0.000106579246,0.00012069863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041101477,0.00014184025,0.000715758,0.0001086036,0.000029276525,0.000003083415,0.00008478023,0.00022820459,0.0024854562],"category_scores_gemma":[0.00044753178,0.00011425308,0.00009060708,0.00027856408,0.000076920514,0.00003786478,0.000032381402,0.00015732617,0.00001946812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041591184,0.0025356545,0.9027545,0.000029937557,0.00008760708,0.000029063774,0.0002174632,0.000011017386,0.00015394948,0.00017185831,0.00089486927,0.09269819],"study_design_scores_gemma":[0.00958213,0.0014788976,0.97405565,0.00002932458,0.000027679424,0.000002101657,0.00006785454,0.000009060841,0.00012700404,0.00022942471,0.014292663,0.00009820552],"about_ca_topic_score_codex":0.0012576923,"about_ca_topic_score_gemma":0.0029720843,"teacher_disagreement_score":0.09259999,"about_ca_system_score_codex":0.0008161104,"about_ca_system_score_gemma":0.00045308654,"threshold_uncertainty_score":0.9984264},"labels":[],"label_agreement":null},{"id":"W1998764910","doi":"10.1007/s12022-011-9175-6","title":"Is Adrenal Ovarian Thecal Metaplasia a Misnomer? Report of Three Cases of Radial Scar-Like Spindle Cell Myofibroblastic Nodule of the Adrenal Gland","year":2011,"lang":"en","type":"article","venue":"Endocrine Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Memorial University of Newfoundland; Health Sciences Centre; University Health Network","funders":"","keywords":"Pathology; Adrenal gland; Medicine; Nodule (geology); Anatomy; Hamartoma; Biology","score_opus":0.03484331171716488,"score_gpt":0.2619349178812026,"score_spread":0.22709160616403773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998764910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403495,0.00077192765,0.00014197052,0.00031202988,0.00046686854,0.00046585136,0.00019031133,0.000014089061,0.0036019972],"genre_scores_gemma":[0.99665445,0.00004560259,0.002764708,0.000073611845,0.00013253109,0.0000405371,0.000022986282,0.000028012451,0.00023758442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981305,0.00009593893,0.00075372093,0.00039956337,0.00029010914,0.00033019128],"domain_scores_gemma":[0.9982759,0.00013407393,0.00054324133,0.0007767188,0.00015692959,0.00011318021],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001588443,0.00024519605,0.00080639817,0.0001384963,0.000040088755,0.0000024225405,0.00018485902,0.000081554725,0.0011256348],"category_scores_gemma":[0.000101191115,0.00016091406,0.00035455878,0.00022075184,0.00037417628,0.000036551577,0.00012895279,0.00016854907,0.000008997735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019643335,0.0032327103,0.95487946,0.0005394593,0.0009787171,0.011877949,0.0015005497,0.000016799957,0.019523678,0.0009651246,0.0017409471,0.0027802824],"study_design_scores_gemma":[0.00534225,0.0025399528,0.7027632,0.00017045741,0.0011479668,0.0145981945,0.00007620144,0.000028688513,0.27220327,0.00024266087,0.0007239662,0.00016322314],"about_ca_topic_score_codex":0.0010692601,"about_ca_topic_score_gemma":0.00024102055,"teacher_disagreement_score":0.2526796,"about_ca_system_score_codex":0.000036258076,"about_ca_system_score_gemma":0.00022817552,"threshold_uncertainty_score":0.99978745},"labels":[],"label_agreement":null},{"id":"W1998901985","doi":"10.1002/path.2927","title":"Identification of abrogated pathways in fallopian tube epithelium from <i>BRCA1</i> mutation carriers","year":2011,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University Health Network","keywords":"Serous fluid; Fallopian tube; Epithelium; Carcinogenesis; Biology; Heterozygote advantage; Pathology; Ovarian cancer; Immunohistochemistry; Cancer research; Cancer; Genetics; Gene; Medicine; Immunology; Allele","score_opus":0.02763567744900417,"score_gpt":0.2611602502844471,"score_spread":0.23352457283544295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998901985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976132,0.0006425308,0.0003064559,0.00060518074,0.00028961053,0.00014083681,0.00002129256,0.0000041318294,0.00037678136],"genre_scores_gemma":[0.9990669,0.00033571158,0.00034874535,0.00014575405,0.00006356787,0.0000040110926,0.0000064116584,0.0000092544615,0.000019662912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998963,0.00017396268,0.00054497574,0.00007952224,0.00013423074,0.00010428749],"domain_scores_gemma":[0.9990707,0.0000786794,0.0004664166,0.00018845896,0.00014671523,0.00004902909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000558234,0.0000766885,0.00026576215,0.00011592491,0.000020150756,0.0000022896238,0.00009647433,0.00006846656,0.00010088485],"category_scores_gemma":[0.00006984393,0.000049222,0.00007018361,0.000121444034,0.00008337688,0.000056026318,0.00001189388,0.00014899377,0.000007685246],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033103044,0.0021202387,0.24543115,0.00009555224,0.00083703484,0.004782294,0.08218112,0.00017515982,0.63051593,0.0017552299,0.0006948838,0.028101115],"study_design_scores_gemma":[0.003605419,0.0009926127,0.8184692,0.00012433986,0.00044954865,0.00072965806,0.0019395571,0.00007646026,0.17040055,0.0030687167,0.00007481959,0.00006910651],"about_ca_topic_score_codex":0.00021749623,"about_ca_topic_score_gemma":0.00009911817,"teacher_disagreement_score":0.57303804,"about_ca_system_score_codex":0.000072344184,"about_ca_system_score_gemma":0.000092167094,"threshold_uncertainty_score":0.20072147},"labels":[],"label_agreement":null},{"id":"W1998939264","doi":"10.1097/igc.0b013e3182028d09","title":"Summary of Gynecologic Pathology Papers With Significant Clinical Implications From the Last United States and Canadian Academy of Pathology, Boston, March 2009","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pathology; General surgery; Pathology; Family medicine","score_opus":0.07339199764521417,"score_gpt":0.40077837324148363,"score_spread":0.3273863755962695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998939264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04453684,0.9207176,0.0000069061753,0.028822051,0.00076936506,0.0010259842,0.0037942056,0.000008606333,0.00031841977],"genre_scores_gemma":[0.022464346,0.9737722,0.00046132336,0.0025032824,0.00037201104,0.00011455633,0.0002557261,0.000024654388,0.000031861273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997001,0.00042865047,0.0015451265,0.00037972696,0.00035995743,0.00028554795],"domain_scores_gemma":[0.9927128,0.004345784,0.0017573467,0.00020627948,0.00065205566,0.00032576488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008264885,0.00032220522,0.0017359719,0.0003209396,0.000059780024,0.000017842405,0.0005902235,0.0006785392,0.0007725728],"category_scores_gemma":[0.0006827278,0.00016280159,0.00042291483,0.0002547869,0.00088016526,0.000041682095,0.000107620406,0.0014507762,0.0000025565055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003017935,0.0007360491,0.12054703,0.00024669318,0.0025848926,0.0010100615,0.000055157343,0.000013163526,0.000015457794,0.0006633633,0.0056723277,0.868154],"study_design_scores_gemma":[0.0011164072,0.0010587869,0.3152015,0.0012999305,0.001470901,0.00040134965,0.00003725872,0.0000013114812,0.0000038190965,0.00023319693,0.6790453,0.00013020173],"about_ca_topic_score_codex":0.0021543961,"about_ca_topic_score_gemma":0.008958578,"teacher_disagreement_score":0.8680238,"about_ca_system_score_codex":0.0003895585,"about_ca_system_score_gemma":0.0017485418,"threshold_uncertainty_score":0.84591305},"labels":[],"label_agreement":null},{"id":"W1999009260","doi":"10.3802/jgo.2009.20.4.213","title":"KGOG's &amp; KSGOC's Symposium, Nov. 12-13, 2009","year":2009,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecologic oncology; Clinical trial; Session (web analytics); Gynecology; Oncology; Family medicine; Internal medicine","score_opus":0.03169229107742382,"score_gpt":0.33523989956274053,"score_spread":0.3035476084853167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999009260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77453977,0.0029667236,0.00018661915,0.12852716,0.0026340133,0.00064638857,0.000010649776,0.000060702532,0.09042799],"genre_scores_gemma":[0.9773944,0.0024988248,0.0062782415,0.010389875,0.0010705924,0.000011091232,0.0000071374475,0.000016551821,0.002333285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795973,0.0001440129,0.0008842997,0.00025101184,0.00031844372,0.00044251874],"domain_scores_gemma":[0.99779975,0.0004840608,0.00076268153,0.0002913942,0.00031051022,0.00035160026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069522666,0.00023956002,0.001061243,0.000262302,0.00009032805,0.00002132449,0.00017976855,0.00034674935,0.0016693017],"category_scores_gemma":[0.0003597047,0.00016562256,0.00036537868,0.00018753858,0.0000912737,0.00011558651,0.00003103169,0.000531833,0.00017765898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027798535,0.019915767,0.11238462,0.00007359855,0.0014074546,0.011081188,0.00082715834,0.00033899114,0.010143264,0.0018416203,0.43593308,0.4032734],"study_design_scores_gemma":[0.007125836,0.02482299,0.36182925,0.00007454256,0.00062975695,0.0030943106,0.00007541124,0.000008100273,0.00039001074,0.0013981895,0.6003741,0.00017747538],"about_ca_topic_score_codex":0.000012957911,"about_ca_topic_score_gemma":0.00009259317,"teacher_disagreement_score":0.40309593,"about_ca_system_score_codex":0.0010159945,"about_ca_system_score_gemma":0.0007686577,"threshold_uncertainty_score":0.9992433},"labels":[],"label_agreement":null},{"id":"W1999127438","doi":"10.1016/j.jconrel.2005.02.008","title":"In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel","year":2005,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"In vivo; Paclitaxel; Chitosan; Pharmacology; In vitro; Drug delivery; Chemistry; Biocompatibility; Controlled release; Implant; Medicine; Chemotherapy; Biology; Surgery; Biochemistry; Biotechnology","score_opus":0.009180503262052386,"score_gpt":0.24805528126971174,"score_spread":0.23887477800765936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999127438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193263,0.0027027675,0.00036466628,0.003892214,0.000103185994,0.00091285456,0.000072138246,0.0000016633227,0.000017877566],"genre_scores_gemma":[0.9989891,0.00042115734,0.00017722971,0.00013842886,0.00018530437,0.000037272326,0.000002400729,0.000008890498,0.000040218983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988142,0.000041528627,0.0007802385,0.00007706334,0.00016133486,0.00012560432],"domain_scores_gemma":[0.9986421,0.00034070684,0.00065913185,0.00009913343,0.00019352538,0.00006542159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040069944,0.00009773511,0.0007218783,0.00024873947,0.000017502181,0.0000066416505,0.00004537685,0.000046327055,0.000007030152],"category_scores_gemma":[0.000064204025,0.00005673534,0.00015100515,0.00012095929,0.000025251555,0.00008638947,0.000007818159,0.000080394304,7.84076e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05703084,0.001748698,0.0040195254,0.00049092644,0.00056840596,0.0000663873,0.0004417654,0.0000975037,0.92868286,0.00028520037,0.000115248906,0.0064526377],"study_design_scores_gemma":[0.32632494,0.002795309,0.03398182,0.002558031,0.001601068,0.0005037464,0.0018639502,0.03369438,0.5955224,0.000007973038,0.0009228284,0.00022353743],"about_ca_topic_score_codex":0.00007889742,"about_ca_topic_score_gemma":0.00001646898,"teacher_disagreement_score":0.33316046,"about_ca_system_score_codex":0.00013546438,"about_ca_system_score_gemma":0.00020253815,"threshold_uncertainty_score":0.23136},"labels":[],"label_agreement":null},{"id":"W1999331462","doi":"10.1111/his.12219","title":"Accelerating type‐specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (<scp>COSP</scp>) is a reliable high‐throughput tool for case review","year":2013,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"","keywords":"Concordance; Medicine; Ovarian carcinoma; Biomarker; Ovarian cancer; Oncology; Internal medicine; Bioinformatics; Cancer; Biology; Genetics","score_opus":0.11117387517121616,"score_gpt":0.3410558597619158,"score_spread":0.22988198459069967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999331462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84869796,0.081408665,0.004793618,0.02476807,0.007286893,0.025913306,0.00081021746,0.0005021896,0.0058190865],"genre_scores_gemma":[0.90492994,0.0052782777,0.059248127,0.0058801277,0.0024799067,0.0096917385,0.00072517135,0.00024952012,0.011517181],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970585,0.00013543188,0.0007090785,0.0009696455,0.0002990755,0.0008282601],"domain_scores_gemma":[0.9970151,0.0004619837,0.00021321133,0.00094847794,0.00111381,0.00024737965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010853984,0.00032839944,0.00078747404,0.00020411568,0.0005495003,0.00005832746,0.00014637555,0.0003207397,0.0005026547],"category_scores_gemma":[0.0006554861,0.00029465568,0.0002319054,0.00043611557,0.00014860985,0.0001863224,0.00007585468,0.0003480005,0.00023909521],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015827213,0.0006260502,0.01869566,0.0024068162,0.000073232564,0.0015983627,0.0009246773,0.0000030970925,0.0023587989,0.010986398,0.9555878,0.0065808548],"study_design_scores_gemma":[0.0061199144,0.0036314835,0.08339838,0.0008874828,0.000615927,0.0041929595,0.00017354036,0.0005961003,0.00096080685,0.0015057332,0.8976774,0.0002402548],"about_ca_topic_score_codex":0.00077552366,"about_ca_topic_score_gemma":0.000032102318,"teacher_disagreement_score":0.07613039,"about_ca_system_score_codex":0.00078782596,"about_ca_system_score_gemma":0.00043947354,"threshold_uncertainty_score":0.9999505},"labels":[],"label_agreement":null},{"id":"W2000158821","doi":"10.1097/pas.0b013e318164edf7","title":"Mixed Ovarian Epithelial Carcinomas With Clear Cell and Serous Components are Variants of High-grade Serous Carcinoma","year":2008,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian carcinomas; Clear cell; Carcinoma; Ovarian carcinoma; Pathology; Clear cell carcinoma; Medicine; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.025660802092240337,"score_gpt":0.23268677980822494,"score_spread":0.2070259777159846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000158821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538726,0.00060278666,0.00004462859,0.0034613826,0.00014779369,0.0001918761,0.000036843412,0.000009303206,0.00011813816],"genre_scores_gemma":[0.99719673,0.00074165827,0.001498983,0.00026540682,0.00022002122,0.0000047676226,0.0000038867415,0.00003269173,0.00003584868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810004,0.00039720372,0.0005518853,0.00025468963,0.0003627674,0.00033342087],"domain_scores_gemma":[0.9979891,0.00026557175,0.000955129,0.00033732102,0.00018378314,0.00026905877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030205914,0.00023947649,0.0011702845,0.00013194593,0.000117514726,0.000006761332,0.00016893902,0.000061746854,0.00003159705],"category_scores_gemma":[0.000012835617,0.00013641041,0.00014850368,0.00025596295,0.0010567043,0.000049604845,0.000060173763,0.0003821098,0.000005147687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013111683,0.0021315673,0.9101228,0.000071342365,0.0005549454,0.062278304,0.0018485893,0.00010624361,0.0043687248,0.0002311313,0.00025052793,0.004924108],"study_design_scores_gemma":[0.007844415,0.0071407417,0.9399091,0.000070715374,0.00038133076,0.04235392,0.00043694145,0.000014946836,0.0013707989,0.00005220435,0.00029142175,0.00013344444],"about_ca_topic_score_codex":0.0006016351,"about_ca_topic_score_gemma":0.000010388147,"teacher_disagreement_score":0.029786287,"about_ca_system_score_codex":0.000069511814,"about_ca_system_score_gemma":0.0001355145,"threshold_uncertainty_score":0.55626553},"labels":[],"label_agreement":null},{"id":"W2000211955","doi":"10.1158/1538-7445.am10-2536","title":"Abstract 2536: Therapeutic testing of a novel PKC inhibitor GAP-107B8 on ovarian cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micropharma (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cancer research; Ovarian cancer; Cell growth; Cancer; Cell culture; Oncogene; Biology; Kinase; Protein kinase C; Cell; Cancer cell; Cell cycle; Medicine; Internal medicine; Cell biology; Biochemistry","score_opus":0.1942330286169569,"score_gpt":0.43643164251929395,"score_spread":0.24219861390233705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000211955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813814,0.0010276946,0.000008264287,0.004941374,0.00090352976,0.0010626846,0.00016380988,0.0000463064,0.0104649225],"genre_scores_gemma":[0.9960747,0.00033280783,0.0006344144,0.00036434125,0.001222819,0.00065549236,0.000006517695,0.00006487392,0.00064403296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974677,0.000039251125,0.00035119453,0.000541163,0.0009396305,0.0006610843],"domain_scores_gemma":[0.99781543,0.00052776077,0.00011604729,0.0006362653,0.00059773354,0.00030674905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006888938,0.00022335348,0.0003966832,0.0002684326,0.00016170293,0.00004806118,0.00021207346,0.00017057887,0.0019702064],"category_scores_gemma":[0.00013092725,0.00017477597,0.0001129824,0.00067475653,0.00025178638,0.000069206166,0.00006777751,0.0010678978,0.000059679973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000395123,0.0012380652,0.016029606,0.00029198185,0.0002245246,0.00005186405,0.00030772766,0.000047135203,0.915673,0.00073494436,0.0029870025,0.06201901],"study_design_scores_gemma":[0.0054420405,0.00084481295,0.16145526,0.0012880483,0.00010912799,0.000009671347,0.000111614485,0.00012600647,0.8123072,0.00013832258,0.017900953,0.00026699566],"about_ca_topic_score_codex":0.0059305457,"about_ca_topic_score_gemma":0.00070383976,"teacher_disagreement_score":0.14542565,"about_ca_system_score_codex":0.00040700738,"about_ca_system_score_gemma":0.0013429918,"threshold_uncertainty_score":0.99894214},"labels":[],"label_agreement":null},{"id":"W2000441479","doi":"10.1097/01.ogx.0000371715.57006.04","title":"Tumor Type and Substage Predict Survival in Stage I and II Ovarian Carcinoma: Insights and Implications","year":2010,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Serous fluid; Grading (engineering); Oncology; Serous carcinoma; Ovarian cancer; Internal medicine; Stage (stratigraphy); Univariate analysis; Ovarian carcinoma; Disease; Population; Clear cell; Adjuvant therapy; Multivariate analysis; Carcinoma; Cancer","score_opus":0.03542141383427776,"score_gpt":0.2837575503344095,"score_spread":0.24833613650013175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000441479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534553,0.001782438,0.000004596939,0.00089541415,0.00026338833,0.0005548886,0.000085461244,0.000039727147,0.001028537],"genre_scores_gemma":[0.9986359,0.0004112895,0.00034404837,0.00022540065,0.00004493141,0.000053661464,0.00006556682,0.000015826643,0.00020340722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984072,0.00018105464,0.0003211501,0.00058704143,0.00017012034,0.0003334375],"domain_scores_gemma":[0.99637324,0.0027203113,0.00006759037,0.00027498193,0.00012111413,0.00044278783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034082736,0.0002190283,0.0004948999,0.00013338609,0.00017077886,0.000048644593,0.00007043491,0.00020744118,0.00021933463],"category_scores_gemma":[0.0032488166,0.00015510258,0.000028801516,0.000691226,0.00022198251,0.00007271356,0.0001773972,0.0004320741,0.0000054038433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088955174,0.0005973013,0.9915385,0.000020420066,0.000025546167,0.00014388336,0.00007772058,1.716813e-7,0.00027496216,0.0027088714,0.00007447349,0.0044491477],"study_design_scores_gemma":[0.0026133587,0.0009786119,0.9914133,0.0000071482395,0.000040979114,0.000021535288,0.00003168049,0.000062007864,0.00003559573,0.00015257591,0.0044801915,0.00016303186],"about_ca_topic_score_codex":0.00066542963,"about_ca_topic_score_gemma":0.0020110304,"teacher_disagreement_score":0.0044057183,"about_ca_system_score_codex":0.00007719079,"about_ca_system_score_gemma":0.000092108996,"threshold_uncertainty_score":0.63249},"labels":[],"label_agreement":null},{"id":"W2000449009","doi":"10.1038/mt.2012.187","title":"Targeting Gonadotropin-releasing Hormone Receptor Inhibits the Early Step of Ovarian Cancer Metastasis by Modulating Tumor-mesothelial Adhesion","year":2012,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Research Grants Council, University Grants Committee; Croucher Foundation","keywords":"Ovarian cancer; Mesothelium; Cancer research; Metastasis; GNRHR; Small interfering RNA; Biology; Downregulation and upregulation; Internal medicine; Tumor progression; Cancer; Endocrinology; Medicine; Pathology; Gonadotropin-releasing hormone; Peritoneum; Hormone; Cell culture; Transfection","score_opus":0.016536629192473718,"score_gpt":0.2691408481823798,"score_spread":0.2526042189899061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000449009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544328,0.041587144,0.001228559,0.0016549929,0.00021162252,0.0006795032,0.00005658867,0.000038053193,0.0001107297],"genre_scores_gemma":[0.9929476,0.0018296293,0.0037558896,0.0008972618,0.00028566565,0.00012621043,0.000033631703,0.00007443122,0.000049692586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825305,0.00017268486,0.00039248815,0.00028651842,0.00044467274,0.00045058868],"domain_scores_gemma":[0.9990776,0.00005444829,0.00025083646,0.00035538114,0.00010825248,0.00015347551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025474228,0.0002643963,0.0004035455,0.00006128383,0.00015158257,0.000030013274,0.00011206256,0.000072372284,0.00019963566],"category_scores_gemma":[0.00003296889,0.00017782561,0.00019708213,0.00025471635,0.00006411983,0.000110209316,0.000035572382,0.0001879899,0.000015020845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003927963,0.00041751613,0.010281088,0.00002511772,0.000564335,0.000007674044,0.00076569954,0.00003455564,0.9119324,0.00023688721,0.0011489064,0.074193016],"study_design_scores_gemma":[0.006620477,0.0008270102,0.06138678,0.0003074804,0.00032049877,0.000012973128,0.00020537846,0.00025572034,0.9036484,0.000029888752,0.025970777,0.00041464128],"about_ca_topic_score_codex":0.0011233267,"about_ca_topic_score_gemma":0.0000014190772,"teacher_disagreement_score":0.073778376,"about_ca_system_score_codex":0.00015659413,"about_ca_system_score_gemma":0.00007553946,"threshold_uncertainty_score":0.72515184},"labels":[],"label_agreement":null},{"id":"W2000820980","doi":"10.1006/gyno.2000.6095","title":"A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Fallopian tube; Medicine; Ovarian cancer; Fallopian tube cancer; Family history; Breast cancer; Lynch syndrome; Gynecology; Cancer; Epidemiology; Population; Obstetrics; Relative risk; Cancer registry; Internal medicine; Oncology; Confidence interval; Colorectal cancer; DNA mismatch repair","score_opus":0.04815611408765114,"score_gpt":0.3317254101505687,"score_spread":0.2835692960629176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000820980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872985,0.00034720186,0.000005245105,0.0028290309,0.00041436302,0.0011856668,0.0000034693842,0.000015823063,0.007900687],"genre_scores_gemma":[0.9980431,0.00013662619,0.00046313545,0.0008087594,0.00007004679,0.00016479044,0.000001424078,0.000007953176,0.00030415723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982738,0.00042569585,0.00056308636,0.0003091067,0.00015418207,0.00027414365],"domain_scores_gemma":[0.9982062,0.00084082555,0.00027573516,0.0004948843,0.00009832333,0.00008404585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003487166,0.00015701336,0.000834991,0.000055867,0.000052875985,0.0000013006838,0.00019441043,0.0002011155,0.00088209123],"category_scores_gemma":[0.00055008265,0.0000831303,0.00017533333,0.0002534069,0.0002061434,0.0000110402825,0.0001296896,0.00017325224,0.000012958401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014031307,0.0046434957,0.98078996,0.000016762275,0.00014554839,0.000238744,0.00028843983,0.000058523987,0.00009764438,0.00032445675,0.0006845193,0.012571579],"study_design_scores_gemma":[0.0036650081,0.013587782,0.97468376,0.000010929444,0.00029605068,0.00012233213,0.00062404934,0.000032758002,0.0000901757,0.00030964744,0.00651273,0.00006475926],"about_ca_topic_score_codex":0.0002959139,"about_ca_topic_score_gemma":0.00062001264,"teacher_disagreement_score":0.012506819,"about_ca_system_score_codex":0.00023763628,"about_ca_system_score_gemma":0.00023459776,"threshold_uncertainty_score":0.96582806},"labels":[],"label_agreement":null},{"id":"W2000953087","doi":"10.1503/cmaj.111863","title":"Severe edema and elevated CA 125 in a 56-year-old woman","year":2012,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Vomiting; Abdominal pain; Nausea; Rash; Edema; Diarrhea; Ascites; Surgery; Internal medicine","score_opus":0.008539951723092833,"score_gpt":0.2445420312641565,"score_spread":0.23600207954106367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000953087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9169212,0.0017133247,0.0000052440205,0.07588569,0.0006670421,0.00021025792,0.00002717478,0.000013269631,0.0045568226],"genre_scores_gemma":[0.9862228,0.0005262855,0.00008894494,0.010938997,0.0014042272,0.000011102281,0.0000123811915,0.000013563231,0.00078168773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983651,0.00008444772,0.00028322925,0.00011284974,0.0006317124,0.0005226861],"domain_scores_gemma":[0.9975062,0.00008866723,0.00009944797,0.00007369535,0.00010448878,0.0021274893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009193538,0.00010417876,0.00023552301,0.00017119438,0.00009945675,0.000037320508,0.000047710397,0.00026131995,0.0045099347],"category_scores_gemma":[0.0005948983,0.000089322464,0.00006182654,0.00021521891,0.000019354833,0.000111586196,0.000008730766,0.00052881823,0.000111788024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012940737,0.000075777,0.9085788,0.00000842968,0.00012027366,0.00029959803,0.00032823073,2.7670444e-7,0.0000026643886,0.00016967003,0.08256907,0.00783426],"study_design_scores_gemma":[0.0027841034,0.00008193124,0.79917204,0.00014860748,0.000058931266,0.00067410746,0.00026748734,0.00002810828,0.0000066885573,0.000039533184,0.19663696,0.00010147773],"about_ca_topic_score_codex":0.004066559,"about_ca_topic_score_gemma":0.031581875,"teacher_disagreement_score":0.11406789,"about_ca_system_score_codex":0.0017735973,"about_ca_system_score_gemma":0.0012546355,"threshold_uncertainty_score":0.99640006},"labels":[],"label_agreement":null},{"id":"W2001150727","doi":"10.1016/j.ygyno.2011.07.098","title":"Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992–2005: A population-based study","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Relative survival; Medicine; Serous fluid; Ovarian cancer; Population; Relative risk; Cancer; Internal medicine; Survival analysis; Survival rate; Oncology; Demography; Cancer registry; Confidence interval","score_opus":0.03347564626544584,"score_gpt":0.2909303209861102,"score_spread":0.25745467472066436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001150727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296474,0.000035526013,0.0000017059331,0.0013885656,0.00030271552,0.0014145226,0.00004169606,0.00001579826,0.0038347382],"genre_scores_gemma":[0.9975013,0.000006188789,0.00015778052,0.0007767895,0.000034352794,0.0013583452,0.00010456465,0.00001743867,0.000043235937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977757,0.00056002825,0.00044928718,0.0004533221,0.00029948226,0.00046219653],"domain_scores_gemma":[0.99859166,0.00071186194,0.00023232718,0.00030576278,0.000051816183,0.00010659523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040268787,0.00024395804,0.0006012522,0.00022145605,0.00007432033,0.0000064840783,0.00015091005,0.00013020451,0.0012537388],"category_scores_gemma":[0.00009550193,0.00014747582,0.000047534006,0.00058095413,0.00005273047,0.00007101955,0.000025114465,0.00033858287,0.0000026037847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041941024,0.004035097,0.9827827,0.000005153646,0.000104982995,0.0015576635,0.001958426,0.00009994863,4.6286694e-8,0.000046146804,0.00020194732,0.008788483],"study_design_scores_gemma":[0.011956415,0.0038175927,0.98186904,0.00002744715,0.000154194,0.0000011798483,0.0015796976,0.000058138754,9.006951e-7,0.00003335795,0.00034097402,0.00016106277],"about_ca_topic_score_codex":0.9734242,"about_ca_topic_score_gemma":0.99941057,"teacher_disagreement_score":0.025986338,"about_ca_system_score_codex":0.003980164,"about_ca_system_score_gemma":0.001597143,"threshold_uncertainty_score":0.99984336},"labels":[],"label_agreement":null},{"id":"W2001771665","doi":"10.1111/j.1525-1438.2007.01171.x","title":"Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"Ministry of Fisheries, New Zealand","keywords":"Serous fluid; Serous carcinoma; Phenotype; Cancer research; Biology; Ovarian carcinoma; Ovarian cancer; Ovary; Cell culture; Genotype; Pathology; Cancer; Medicine; Gene; Genetics","score_opus":0.026658766446911442,"score_gpt":0.2954835696897994,"score_spread":0.26882480324288793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001771665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902075,0.0034483594,0.00028279374,0.004469863,0.0009752573,0.00022691506,0.00004659629,0.000012326188,0.00033040257],"genre_scores_gemma":[0.9936495,0.0029619618,0.0009198874,0.0012473814,0.0010150922,0.00003201084,0.000045068595,0.0000148438185,0.00011428196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845725,0.000063234285,0.00056882686,0.00027589465,0.00043595865,0.00019881933],"domain_scores_gemma":[0.9986664,0.00019428156,0.00034764656,0.00010588464,0.0004993563,0.00018639803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011859338,0.00019451618,0.00044336906,0.00014817693,0.00007235734,0.000030311927,0.0001626193,0.00013305462,0.0013454995],"category_scores_gemma":[0.00028282532,0.00013988624,0.000121977944,0.00012900357,0.0001102425,0.00015621528,0.00006076154,0.00035803003,0.000007397223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001001267,0.00058971584,0.97684765,0.000012296156,0.00039674167,0.0041590747,0.00043723595,0.00007092546,0.00036098022,0.00014493884,0.00032303535,0.015656147],"study_design_scores_gemma":[0.005280939,0.0006515913,0.9913122,0.00018951687,0.00012797989,0.0006703831,0.000043665885,0.000032064345,0.00044360905,0.0003981725,0.0007180384,0.00013180908],"about_ca_topic_score_codex":0.0006918776,"about_ca_topic_score_gemma":0.0016574052,"teacher_disagreement_score":0.015524338,"about_ca_system_score_codex":0.0007735669,"about_ca_system_score_gemma":0.00031690407,"threshold_uncertainty_score":0.9995674},"labels":[],"label_agreement":null},{"id":"W2001962377","doi":"10.1038/modpathol.2008.108","title":"Immunophenotyping of serous carcinoma of the female genital tract","year":2008,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cytokeratin; Serous fluid; Mesothelioma; Pathology; Endometrium; Serous carcinoma; Carcinoma; Ovary; Immunohistochemistry; Medicine; Biology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.030849163167968385,"score_gpt":0.25025144537175553,"score_spread":0.21940228220378716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001962377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960882,0.0018109586,0.00015798178,0.00027293485,0.00012983772,0.00019113511,0.00001742873,0.000007958967,0.0013235437],"genre_scores_gemma":[0.9992028,0.000054491586,0.0003934733,0.00010912107,0.000035426874,0.000016165068,0.000003848218,0.000012774803,0.000171902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993654,0.000039353843,0.00020813792,0.00015050864,0.00010356955,0.00013302932],"domain_scores_gemma":[0.99942166,0.00003209583,0.0001012758,0.00036516247,0.00005372371,0.000026094967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005337876,0.00008406843,0.00027722432,0.00003325806,0.00004437228,6.8627975e-7,0.000071376075,0.000066699366,0.000039465285],"category_scores_gemma":[0.000017081244,0.00005652187,0.00012175308,0.00006560212,0.00013946508,0.000017587481,0.00003720557,0.00008408521,0.0000046725454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010967079,0.0007243705,0.9588431,0.000063937645,0.00007053087,0.00046570244,0.004031174,0.000052478495,0.028473018,0.00015505399,0.00003816127,0.0069728033],"study_design_scores_gemma":[0.0012636842,0.00032049304,0.96723586,0.000025220892,0.000091260874,0.0010494178,0.000050871866,0.00011293699,0.029632369,0.00013062729,0.00004019319,0.00004705262],"about_ca_topic_score_codex":0.0001039446,"about_ca_topic_score_gemma":0.0000073627,"teacher_disagreement_score":0.008392774,"about_ca_system_score_codex":0.000037120328,"about_ca_system_score_gemma":0.00009299799,"threshold_uncertainty_score":0.23048949},"labels":[],"label_agreement":null},{"id":"W2002056332","doi":"10.3747/co.20.1548","title":"Fallopian Tube Removal: “stic-Ing” it to Ovarian Cancer: What Is the Utility of Prophylactic Tubal Removal?","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Ovarian cancer; Gynecology; Surgery; Cancer; Internal medicine","score_opus":0.09304735966219656,"score_gpt":0.3960964864922555,"score_spread":0.3030491268300589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002056332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6857733,0.017007718,0.00022693811,0.26661405,0.00796933,0.0058085327,0.00006336209,0.00011801126,0.016418738],"genre_scores_gemma":[0.99126136,0.0025070643,0.00089250336,0.003503278,0.00056131545,0.00064844725,0.000015985632,0.000033796376,0.00057626155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977976,0.00017265182,0.0005748113,0.0005814173,0.00037367115,0.00049982406],"domain_scores_gemma":[0.99804795,0.00022695959,0.0002140272,0.00080774457,0.0003842029,0.00031910528],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032406487,0.0002853156,0.0006807113,0.00010484294,0.00011897568,0.000055994806,0.00025714858,0.00015608208,0.0033428438],"category_scores_gemma":[0.00015186096,0.00018641604,0.00020231731,0.00037027156,0.00019467,0.00018064634,0.00014136538,0.00034733364,0.00022037777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029340867,0.0015628026,0.030328335,0.0003630408,0.00028376348,0.00010316957,0.0025002402,0.0000029332073,0.00019909245,0.0006891988,0.063294776,0.90037924],"study_design_scores_gemma":[0.0029618533,0.0013861129,0.1554895,0.0004915298,0.00060166913,0.00022197563,0.00089035166,0.00070458825,0.0011205948,0.00055352564,0.8353301,0.00024817328],"about_ca_topic_score_codex":0.0013968917,"about_ca_topic_score_gemma":0.00027522145,"teacher_disagreement_score":0.90013105,"about_ca_system_score_codex":0.00044841482,"about_ca_system_score_gemma":0.00070732436,"threshold_uncertainty_score":0.99756825},"labels":[],"label_agreement":null},{"id":"W2002330524","doi":"10.1111/1471-0528.12359","title":"Authors' response to: Lymphadenectomy in ovarian cancer–an overrated procedure?","year":2013,"lang":"en","type":"letter","venue":"BJOG An International Journal of Obstetrics & Gynaecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphadenectomy; Ovarian cancer; Prospective cohort study; Cancer; Gynecology; Surgery; General surgery; Internal medicine","score_opus":0.028956480453412623,"score_gpt":0.33806682817193223,"score_spread":0.3091103477185196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002330524","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38593903,0.0017184584,0.000077061726,0.57936335,0.030263312,0.0013854564,0.00023674722,0.000044330936,0.000972258],"genre_scores_gemma":[0.6679412,0.00056400354,0.0021848816,0.31946492,0.005822464,0.00032728663,0.00034583377,0.00019199844,0.0031573956],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9955453,0.0005286878,0.0014133404,0.0006507768,0.0012618516,0.00059999677],"domain_scores_gemma":[0.9946179,0.0012873106,0.001112818,0.00046224508,0.0020406218,0.00047911415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069904025,0.00050380395,0.0011200069,0.0029910074,0.0000543112,0.00017134771,0.000964068,0.0011496646,0.004046112],"category_scores_gemma":[0.0030856,0.00044508983,0.0002777712,0.000797353,0.0000702614,0.0004536565,0.0001031563,0.0017098684,0.00007425667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003162796,0.0031447425,0.23309238,0.00014283141,0.0029032584,0.060008105,0.0015259797,0.0006432628,0.00032347665,0.00015727432,0.65384114,0.041054748],"study_design_scores_gemma":[0.0075847623,0.0029824283,0.68776196,0.00018087772,0.0003134359,0.0010191144,0.00006702907,0.00010541238,0.00014663767,0.00016459166,0.29927212,0.0004016265],"about_ca_topic_score_codex":0.00039340413,"about_ca_topic_score_gemma":0.00007478687,"teacher_disagreement_score":0.4546696,"about_ca_system_score_codex":0.0054904893,"about_ca_system_score_gemma":0.0032129937,"threshold_uncertainty_score":0.9998001},"labels":[],"label_agreement":null},{"id":"W2002604331","doi":"10.1111/his.12349","title":"Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry","year":2013,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Immunohistochemistry; Pathology; Carcinoma; Medicine; Ovarian carcinoma; Internal medicine; Ovarian cancer; Cancer","score_opus":0.03458622741824152,"score_gpt":0.2705943796240718,"score_spread":0.23600815220583027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002604331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784653,0.0045086034,0.0001441581,0.013674352,0.00035407956,0.00070319144,0.000025562884,0.000032365206,0.0020923503],"genre_scores_gemma":[0.988771,0.00020534819,0.0044640554,0.0023561965,0.00008022209,0.00015467421,0.000016756647,0.000022821478,0.003928922],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988693,0.000040287538,0.0003163584,0.00048209034,0.00010582892,0.00018615859],"domain_scores_gemma":[0.9986,0.000063279316,0.00019178772,0.000915233,0.00017928373,0.000050429604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088059634,0.00016186773,0.00031998247,0.000044971304,0.00009638866,0.000012574504,0.00007728674,0.00013182714,0.0004358327],"category_scores_gemma":[0.00007960375,0.00011878824,0.000080371865,0.00010073265,0.0002727931,0.000112084905,0.00005133622,0.00013462034,0.00002237336],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005087285,0.0010071724,0.1100461,0.00061358785,0.000090927744,0.0002656268,0.0174535,7.180499e-7,0.703702,0.0011049184,0.10313177,0.062074956],"study_design_scores_gemma":[0.0024851593,0.0008518128,0.83651936,0.000065088236,0.00046707847,0.0007417739,0.00009955469,0.00020463164,0.046558287,0.0004729546,0.11126753,0.00026677092],"about_ca_topic_score_codex":0.0016541107,"about_ca_topic_score_gemma":0.0000045617385,"teacher_disagreement_score":0.7264733,"about_ca_system_score_codex":0.00021056931,"about_ca_system_score_gemma":0.00009326647,"threshold_uncertainty_score":0.48440436},"labels":[],"label_agreement":null},{"id":"W2002710053","doi":"10.1097/igc.0b013e3182070f17","title":"Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":619,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Clinical trial; Response Evaluation Criteria in Solid Tumors; Cancer; Gynecologic cancer; Disease; Oncology; Ovarian cancer; Consistency (knowledge bases); Internal medicine; Medical physics; Phases of clinical research; Artificial intelligence","score_opus":0.2990942419300802,"score_gpt":0.4831261344702777,"score_spread":0.18403189254019747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002710053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584372,0.0069338446,0.00025680626,0.030822339,0.0018466881,0.0010408543,0.0003200846,0.000012135823,0.00033001913],"genre_scores_gemma":[0.98296005,0.010957275,0.002159865,0.0023657796,0.00061892736,0.00080711645,0.00001132809,0.000017887678,0.000101802114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662614,0.0008024593,0.0015345067,0.0003749243,0.00039891517,0.00026306362],"domain_scores_gemma":[0.992751,0.005214386,0.0011079127,0.00012100628,0.00056466705,0.0002410474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045152544,0.00023502213,0.00085056905,0.00014141781,0.00012391503,0.00006991594,0.00024101864,0.00026196905,0.0013009964],"category_scores_gemma":[0.00515878,0.00012868138,0.0002564709,0.00014386565,0.00035489362,0.000154506,0.00012423503,0.00053933606,0.0000012749844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01950826,0.0016103982,0.70652163,0.00002966938,0.0010636703,0.00034952382,0.00044902615,0.000010063589,0.0010850411,0.001340053,0.008351944,0.25968072],"study_design_scores_gemma":[0.010987529,0.0031844184,0.97040683,0.00069131365,0.00045316402,0.00014604384,0.0002702904,0.00018352417,0.00055733696,0.0035900637,0.009312978,0.00021652489],"about_ca_topic_score_codex":0.00050959195,"about_ca_topic_score_gemma":0.0012542815,"teacher_disagreement_score":0.2638852,"about_ca_system_score_codex":0.0005879047,"about_ca_system_score_gemma":0.00050773844,"threshold_uncertainty_score":0.999612},"labels":[],"label_agreement":null},{"id":"W2002831182","doi":"10.1016/j.clon.2014.10.001","title":"Dose-dense Paclitaxel in Advanced Ovarian Cancer","year":2014,"lang":"en","type":"review","venue":"Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Paclitaxel; Carboplatin; Medicine; Oncology; Ovarian cancer; Chemotherapy; Internal medicine; Angiogenesis; Cancer; Pharmacology; Cisplatin","score_opus":0.2143458826993593,"score_gpt":0.5538725846298677,"score_spread":0.3395267019305084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002831182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060515722,0.98444927,0.000004661535,0.0031631398,0.0028905752,0.0017967417,0.000044131764,0.00005756203,0.0075334315],"genre_scores_gemma":[0.00012823298,0.9914198,0.0009440928,0.0023229038,0.0020368022,0.0014447934,0.000101466474,0.00009814409,0.0015037479],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948066,0.0008843427,0.0024655228,0.0010766804,0.00020509747,0.0005617538],"domain_scores_gemma":[0.99437195,0.003306839,0.00088582473,0.0008783508,0.00009018009,0.00046685306],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013505021,0.0005307163,0.0066395774,0.0001994427,0.000035856112,0.000010941151,0.00023083373,0.001579434,0.0008850415],"category_scores_gemma":[0.001019186,0.0003779548,0.0012738961,0.00034924338,0.00023340291,0.000031358817,0.0001240756,0.0014365605,0.00069581944],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001587881,0.0014740995,0.0015811485,0.0035984318,0.0005003997,0.00074016507,0.000012743907,3.570862e-7,1.2616215e-8,0.00034941465,0.005144994,0.98643947],"study_design_scores_gemma":[0.006632898,0.002499915,0.0059372145,0.011573963,0.0025673676,0.00006690582,0.000005112724,0.000002395477,3.9974186e-8,0.000094408744,0.97031164,0.00030812446],"about_ca_topic_score_codex":0.00015679435,"about_ca_topic_score_gemma":0.00051340606,"teacher_disagreement_score":0.9861313,"about_ca_system_score_codex":0.0013173829,"about_ca_system_score_gemma":0.0031943894,"threshold_uncertainty_score":0.99986726},"labels":[],"label_agreement":null},{"id":"W2003305754","doi":"10.1016/j.ygyno.2008.02.009","title":"Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortia","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Fallopian tube cancer; Gastrointestinal perforation; Ovarian cancer; Internal medicine; Tolerability; Clinical endpoint; Nausea; Erlotinib; Perforation; Surgery; Vomiting; Gastroenterology; Phases of clinical research; Cancer; Chemotherapy; Adverse effect; Clinical trial; Peritonitis; Epidermal growth factor receptor","score_opus":0.02357263650907375,"score_gpt":0.30406097685637823,"score_spread":0.28048834034730447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003305754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138325,0.0010436401,0.000005961576,0.0023278384,0.00029223226,0.0041742916,0.00049234426,0.0000135682485,0.00026684313],"genre_scores_gemma":[0.9960609,0.0021445765,0.00084809173,0.00030029292,0.00006937243,0.00046141175,0.00005934304,0.000015399553,0.000040599472],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985469,0.000115673196,0.00051157596,0.00040309076,0.00016073238,0.00026200846],"domain_scores_gemma":[0.9984857,0.0006376466,0.00036227616,0.00022895748,0.00014530543,0.00014013759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018216838,0.0002148505,0.0008857982,0.00005606836,0.0002455541,0.000003661951,0.000069920025,0.00018912848,0.00006413279],"category_scores_gemma":[0.00023258265,0.00012890135,0.000065671265,0.00010756612,0.0006834026,0.000029107781,0.00011702078,0.00015542253,1.9395306e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35422257,0.018742444,0.32869053,0.0007765744,0.0015287577,0.00006436816,0.0029792495,0.000012957415,0.00020061145,0.0005876461,0.0018692404,0.29032505],"study_design_scores_gemma":[0.3227789,0.04948718,0.60387766,0.000109613924,0.00076648814,0.00005526563,0.000053066244,0.0000408717,0.000094964234,0.000030471792,0.02254887,0.00015661785],"about_ca_topic_score_codex":0.00008965943,"about_ca_topic_score_gemma":0.00020726956,"teacher_disagreement_score":0.29016843,"about_ca_system_score_codex":0.00027770712,"about_ca_system_score_gemma":0.00082427595,"threshold_uncertainty_score":0.5256444},"labels":[],"label_agreement":null},{"id":"W2003391982","doi":"10.1016/j.ygyno.2012.10.013","title":"Quantification of ER/PR expression in ovarian low-grade serous carcinoma","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Serous fluid; Immunohistochemistry; Oncology; Internal medicine; Tissue microarray; Serous carcinoma; Ovarian cancer; Cancer; Gynecology","score_opus":0.04633466633727685,"score_gpt":0.331653398810315,"score_spread":0.2853187324730382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003391982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897758,0.00090356555,0.00009667756,0.0025373616,0.000722015,0.00065794884,0.000008474727,0.000028211358,0.005269957],"genre_scores_gemma":[0.9964232,0.00013671322,0.0024810103,0.00039827242,0.0001475675,0.00021399265,0.000042782238,0.000013850463,0.0001426528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985987,0.0001760831,0.00042342494,0.00027138833,0.00013176928,0.00039866203],"domain_scores_gemma":[0.99887127,0.00037790393,0.00021107154,0.00034275054,0.000055298453,0.00014172657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041544653,0.00014979955,0.0005050583,0.00015572426,0.000039272993,0.0000031928653,0.00008799256,0.00029781865,0.000607802],"category_scores_gemma":[0.00017250946,0.000117177224,0.00008036187,0.0002204932,0.00008345024,0.00007851657,0.00004960681,0.00017576983,0.000076242504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018235983,0.0040979446,0.95063424,0.000085477914,0.000035794692,0.00009004309,0.0006671814,0.000017303733,0.027399046,0.0012834049,0.0014010143,0.014106163],"study_design_scores_gemma":[0.003053871,0.0011747567,0.9536824,0.000040454524,0.00008041049,0.00004297865,0.0002544583,0.000027826583,0.034382805,0.00013707645,0.0070220944,0.000100862664],"about_ca_topic_score_codex":0.00013570664,"about_ca_topic_score_gemma":0.00011039504,"teacher_disagreement_score":0.0140053,"about_ca_system_score_codex":0.0005619271,"about_ca_system_score_gemma":0.00020411145,"threshold_uncertainty_score":0.6655006},"labels":[],"label_agreement":null},{"id":"W2003626142","doi":"10.1016/j.ygyno.2011.03.011","title":"Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian carcinoma; Palliative treatment; Oncology; Clear cell carcinoma; Gynecology; General surgery; Carcinoma; Internal medicine; Ovarian cancer; Cancer","score_opus":0.1629775661451262,"score_gpt":0.32336680301499643,"score_spread":0.16038923686987022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003626142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835087,0.00014028016,0.0000057032253,0.0010301303,0.00041223475,0.0012763636,0.000012949868,0.00006791961,0.013545715],"genre_scores_gemma":[0.9889545,0.0009123926,0.005415633,0.0005545726,0.000044999575,0.0036143945,0.000008524492,0.00003070551,0.00046428616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980691,0.00013494636,0.00039398175,0.00059119595,0.00013777749,0.0006730008],"domain_scores_gemma":[0.99877584,0.00036997546,0.00018416552,0.00036503133,0.000058888843,0.00024607035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015076014,0.0003422425,0.0009222545,0.00017358991,0.000071443086,0.000006647355,0.00010496506,0.00014400046,0.001561779],"category_scores_gemma":[0.000059904465,0.00019847296,0.00007361101,0.0002510104,0.00009131129,0.00011096149,0.00005187145,0.00019317289,0.00009743468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010861488,0.0090812445,0.7312729,0.000052103165,0.00027295033,0.0038801932,0.013002955,0.00001062182,0.000027879278,0.00021494566,0.00004530227,0.23127745],"study_design_scores_gemma":[0.014259546,0.060138103,0.91317385,0.000029776184,0.00013434024,0.000017709368,0.0038000331,0.000005586623,0.0006793554,0.00007337841,0.007469392,0.00021893262],"about_ca_topic_score_codex":0.000256725,"about_ca_topic_score_gemma":0.0009940793,"teacher_disagreement_score":0.23105851,"about_ca_system_score_codex":0.0038625128,"about_ca_system_score_gemma":0.00055034953,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W2004073507","doi":"10.1016/s0090-8258(03)00473-6","title":"Workshop: options for therapy in ovarian cancer","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Topotecan; Medicine; Carboplatin; Tolerability; Ovarian cancer; Oncology; Internal medicine; Paclitaxel; Chemotherapy; Gemcitabine; Surgery; Cisplatin; Cancer; Adverse effect","score_opus":0.17746734570266418,"score_gpt":0.4648333417566929,"score_spread":0.2873659960540287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004073507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008684552,0.98547,0.000027046639,0.0022837745,0.001641353,0.0053188154,0.00010900765,0.000041237803,0.005100087],"genre_scores_gemma":[0.000012433774,0.974946,0.0027086386,0.0014479326,0.0003576421,0.017671177,0.00021182105,0.00006561531,0.0025787007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974304,0.00030843233,0.0007733834,0.0007601418,0.0001066133,0.0006210218],"domain_scores_gemma":[0.99723774,0.0016707721,0.00037829578,0.00046606173,0.00008579273,0.0001613393],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046544152,0.0004961836,0.003006347,0.00032388416,0.00008615047,0.000015596244,0.0001756304,0.0011944982,0.0024401515],"category_scores_gemma":[0.00018622445,0.00034908712,0.00066488865,0.00048057604,0.00009437955,0.000028857145,0.000035968627,0.00052196794,0.000078596466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004198313,0.0013203587,0.00017174202,0.0013391206,0.0005189806,0.00016969927,0.000029570187,0.0000030486578,8.5041435e-8,0.0015022837,0.008745816,0.9861573],"study_design_scores_gemma":[0.003921851,0.0017542762,0.00035164415,0.0016834058,0.0011748015,0.00007542936,0.000022068962,0.0000013096471,3.2169092e-7,0.00028439236,0.9904409,0.00028956556],"about_ca_topic_score_codex":0.000050336832,"about_ca_topic_score_gemma":0.0005536749,"teacher_disagreement_score":0.98586774,"about_ca_system_score_codex":0.002839977,"about_ca_system_score_gemma":0.0027826363,"threshold_uncertainty_score":0.9998961},"labels":[],"label_agreement":null},{"id":"W2004207618","doi":"10.1006/gyno.2002.6834","title":"Outcomes in Surgery for Ovarian Cancer","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Gynecologic oncology; Ovarian cancer; Specialty; Comorbidity; Surgery; Population; Cohort; Relative survival; Retrospective cohort study; Relative risk; Cancer; Internal medicine; Confidence interval; Cancer registry","score_opus":0.08444831637244556,"score_gpt":0.35628955968532955,"score_spread":0.271841243312884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004207618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8582387,0.0021435393,0.000053592714,0.1153608,0.002501143,0.0021416633,0.00006259541,0.0001281901,0.01936976],"genre_scores_gemma":[0.9877807,0.00094908575,0.0014313525,0.005510841,0.00015047459,0.0019326562,0.000013965581,0.000017063065,0.002213847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877965,0.000057544978,0.00033735106,0.00033189784,0.00008104787,0.00041249135],"domain_scores_gemma":[0.99770856,0.0018366837,0.00010029032,0.00020176327,0.000048800764,0.00010391352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024751647,0.00015347327,0.0007309619,0.00015510978,0.00004891099,0.0000061876694,0.000057552166,0.0002262269,0.004415664],"category_scores_gemma":[0.00041241638,0.00011509932,0.00017200297,0.00015968145,0.00005520018,0.00003510401,0.000023364877,0.00012019838,0.00008738543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006342419,0.0015034236,0.8253088,0.00003143717,0.00012333003,0.00024447875,0.00009607657,0.000008464025,0.000012702605,0.0005131479,0.028679976,0.14341472],"study_design_scores_gemma":[0.0036472771,0.00083893334,0.8176483,0.000018090763,0.000108816945,0.00001885364,0.00004128898,0.0001481143,0.000052416595,0.00039609402,0.17696148,0.00012036113],"about_ca_topic_score_codex":0.00016850574,"about_ca_topic_score_gemma":0.0010508588,"teacher_disagreement_score":0.1482815,"about_ca_system_score_codex":0.00081348786,"about_ca_system_score_gemma":0.0001683918,"threshold_uncertainty_score":0.9964944},"labels":[],"label_agreement":null},{"id":"W2004976275","doi":"10.1007/s10585-012-9562-5","title":"Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression","year":2012,"lang":"en","type":"article","venue":"Clinical & Experimental Metastasis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Focal adhesion; Ovarian cancer; PTK2; Proto-oncogene tyrosine-protein kinase Src; Ovarian carcinoma; Tyrosine kinase; Ovarian tumor; Biology; Tumor progression; Internal medicine; Kinase; Medicine; Signal transduction; Cell biology; Cancer; Protein kinase A","score_opus":0.05208273264125095,"score_gpt":0.378540095495448,"score_spread":0.326457362854197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004976275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941563,0.0036443882,0.000037102047,0.0001964224,0.00041019276,0.0010018811,0.00004894212,0.000032440126,0.00047233835],"genre_scores_gemma":[0.99618214,0.00012431513,0.0029789926,0.00015909129,0.0002906329,0.00017552022,0.000033287884,0.00003727349,0.000018719915],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976027,0.0003232371,0.0006653556,0.0005407424,0.0004735074,0.00039445632],"domain_scores_gemma":[0.99850404,0.00016049856,0.0003392036,0.0003703782,0.00004737869,0.0005784755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000580679,0.0002958589,0.0007045451,0.000089942914,0.000097895885,0.000018867931,0.000061467494,0.00014166607,0.00021142862],"category_scores_gemma":[0.00007866426,0.00023279845,0.00030337783,0.00014924245,0.00017331172,0.00028322169,0.00018435699,0.0002496217,0.000016477705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023805178,0.023942046,0.6881475,0.00035681418,0.0002513971,0.00018347742,0.00048074604,1.3260855e-7,0.23846948,0.00015753906,0.00036303847,0.045267344],"study_design_scores_gemma":[0.0042982567,0.0021881673,0.31677687,0.00017013296,0.00031173462,0.000025341704,0.00018264016,0.000009933622,0.67578,0.000015524733,0.00009384764,0.0001475414],"about_ca_topic_score_codex":0.00007517385,"about_ca_topic_score_gemma":0.000001093236,"teacher_disagreement_score":0.43731055,"about_ca_system_score_codex":0.00013906052,"about_ca_system_score_gemma":0.00007344555,"threshold_uncertainty_score":0.94932455},"labels":[],"label_agreement":null},{"id":"W2005113853","doi":"10.1111/j.1525-1438.2006.00465.x","title":"Irregularly shaped inclusion cysts display increased expression of Ki67, Fas, Fas ligand, and procaspase-3 but relatively little active caspase-3","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fas ligand; Apoptosis; Carcinogenesis; Cancer research; Fas receptor; Cell; Pathology; Caspase 3; Caspase; Cell biology; Programmed cell death; Biology; Medicine; Internal medicine; Cancer; Biochemistry","score_opus":0.014441140371477949,"score_gpt":0.2935255677960767,"score_spread":0.27908442742459877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005113853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935243,0.0017193584,0.0002489823,0.003128278,0.0003368786,0.00029057203,0.00013964203,0.0000107351325,0.0006012387],"genre_scores_gemma":[0.9975662,0.0004643196,0.0009984678,0.00031318387,0.00038458794,0.00004127291,0.000025751977,0.000015305983,0.00019086998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816155,0.00008341754,0.0006056375,0.00024439066,0.00072805973,0.00017693189],"domain_scores_gemma":[0.9978208,0.00046825726,0.0006617328,0.00009772098,0.0007878769,0.00016363672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022842154,0.0001952491,0.00047086467,0.00016796832,0.00011047245,0.000026076668,0.0001684459,0.00015920734,0.00041407117],"category_scores_gemma":[0.00031976873,0.00012828954,0.0001728082,0.0001103266,0.00013800057,0.00022496501,0.00022428758,0.00027961284,0.0000026928722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008230976,0.005042608,0.46339834,0.00012958134,0.0012599734,0.0029060622,0.0012507812,0.00014922902,0.47181433,0.002487565,0.0025518402,0.040778738],"study_design_scores_gemma":[0.006301797,0.0012581113,0.8670411,0.000742936,0.00025037336,0.00019808783,0.0001143699,0.00015460845,0.12042221,0.0016588598,0.0016937221,0.0001638352],"about_ca_topic_score_codex":0.0005195873,"about_ca_topic_score_gemma":0.00013084893,"teacher_disagreement_score":0.40364277,"about_ca_system_score_codex":0.0005598889,"about_ca_system_score_gemma":0.00026300608,"threshold_uncertainty_score":0.52314955},"labels":[],"label_agreement":null},{"id":"W2005700965","doi":"10.1007/s10552-015-0547-y","title":"Ovarian cancer survival by tumor dominance, a surrogate for site of origin","year":2015,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Women's College Hospital","funders":"National Institutes of Health; Canada Research Chairs; National Cancer Institute; Cancer Care Ontario","keywords":"Serous fluid; Fallopian tube; Hazard ratio; Medicine; Ovarian cancer; Ovary; Oncology; Internal medicine; Serous carcinoma; Proportional hazards model; Gynecology; Dominance (genetics); Pathology; Confidence interval; Cancer; Biology; Genetics","score_opus":0.053584881604666165,"score_gpt":0.3419748884791957,"score_spread":0.28839000687452954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005700965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90370166,0.06220932,0.0019710544,0.013141223,0.004372079,0.0050517726,0.007678831,0.00017163492,0.0017023941],"genre_scores_gemma":[0.992546,0.0010180131,0.00022506017,0.0015140376,0.00072633283,0.0025067278,0.00004803794,0.00006463908,0.0013511317],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981856,0.000049533002,0.0004473813,0.0004797029,0.00034905376,0.0004887548],"domain_scores_gemma":[0.9982485,0.00017540388,0.0002815547,0.0004094753,0.0005238297,0.0003612455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002653694,0.00030592128,0.00092756166,0.00007949677,0.0000549091,0.000024483978,0.00010498133,0.00008563899,0.00023271286],"category_scores_gemma":[0.00008328241,0.000251958,0.00022172276,0.00022347222,0.000107749314,0.00010919168,0.000019318551,0.00011317627,0.0000142375475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009598482,0.0011671017,0.7979754,0.00062721653,0.0028108484,0.00014243527,0.0008909271,0.00028526993,0.010676062,0.0019918515,0.15019023,0.023644162],"study_design_scores_gemma":[0.090735145,0.0017894171,0.061466552,0.0010741043,0.003354777,0.000020142234,0.00018397861,0.00086694694,0.017314112,0.00022454574,0.8221849,0.00078536954],"about_ca_topic_score_codex":0.0049181534,"about_ca_topic_score_gemma":0.00154221,"teacher_disagreement_score":0.73650885,"about_ca_system_score_codex":0.0005699656,"about_ca_system_score_gemma":0.0011482687,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2005959958","doi":"10.1016/j.ajog.2011.03.008","title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","year":2011,"lang":"en","type":"review","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":430,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Gynecologic cancer; Cancer; Cancer recurrence; Vaginal cancer; Gynecologic oncology; Intensive care medicine; Gynecology; Ovarian cancer; Oncology; Cervical cancer; Internal medicine","score_opus":0.04604020942294241,"score_gpt":0.3217219598228944,"score_spread":0.275681750399952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005959958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085698515,0.9125621,0.0000066990337,0.00038552625,0.00035146126,0.00078054576,0.00012325926,0.0000048304164,0.00008710377],"genre_scores_gemma":[0.0761707,0.9199392,0.0034846119,0.00012859893,0.00001615787,0.00021072735,0.0000123617965,0.00002455765,0.000013068567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714416,0.00036158226,0.0014594763,0.00042339572,0.00018397401,0.00042743207],"domain_scores_gemma":[0.9830382,0.012784547,0.003272384,0.00028738816,0.00039405172,0.0002234371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007433581,0.0004331463,0.0038409173,0.0005094242,0.00004845609,0.00000959526,0.00018701516,0.0002507119,0.00011114768],"category_scores_gemma":[0.0019150821,0.0002817044,0.0002774294,0.0011642952,0.0008192191,0.00006224945,0.00010926638,0.00043442988,7.3392505e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006594936,0.0012207564,0.10521978,0.0017092681,0.0008515563,0.00013503032,0.00046072286,8.065703e-7,1.392525e-7,0.000039898026,0.00018202477,0.89011407],"study_design_scores_gemma":[0.0064148433,0.06844615,0.30058905,0.007913149,0.002460658,0.00074297475,0.0025235335,0.0000024372282,0.000007060747,0.00014646784,0.6100377,0.00071599445],"about_ca_topic_score_codex":0.000081601975,"about_ca_topic_score_gemma":0.000041245385,"teacher_disagreement_score":0.8893981,"about_ca_system_score_codex":0.0009991953,"about_ca_system_score_gemma":0.0010233698,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W2007026065","doi":"10.1111/j.1471-0528.2000.tb11106.x","title":"Patterns in the incidence of age‐related ovarian cancer in South East England 1967–1996","year":2000,"lang":"en","type":"article","venue":"BJOG An International Journal of Obstetrics & Gynaecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Incidence (geometry); Ovarian cancer; Medicine; Demography; Cancer registry; Cancer; South east; Population; Gynecology; Internal medicine; Geography; Environmental health","score_opus":0.021302008586802552,"score_gpt":0.29875419854120017,"score_spread":0.27745218995439763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007026065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948493,0.00091391796,0.00001525398,0.0012745981,0.001619632,0.00018775895,0.00004840539,0.00000334863,0.001087767],"genre_scores_gemma":[0.998553,0.0006527567,0.0001279728,0.0004172311,0.00013898716,0.00001654999,0.000013865617,0.000012312607,0.00006736182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981523,0.00017132785,0.00078921777,0.00017641444,0.00051168364,0.00019904009],"domain_scores_gemma":[0.9985574,0.0005276942,0.00039008597,0.00017089111,0.00027096365,0.00008299037],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048063212,0.00013469454,0.0003766978,0.00061810866,0.000019626405,0.000024007872,0.0004166405,0.00012426189,0.0032674572],"category_scores_gemma":[0.000389327,0.00009657424,0.00010951588,0.00043520425,0.000055324334,0.00015350399,0.000023908993,0.00040807688,0.0000072192993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014779757,0.0007726534,0.8987998,0.000009334824,0.0001700538,0.0037619502,0.00515074,0.00085212576,0.00000849275,0.00022738778,0.000013045136,0.09008663],"study_design_scores_gemma":[0.006798713,0.000605324,0.99055946,0.00007356834,0.000072058545,0.00023795702,0.0003907383,0.00016551558,0.000028952883,0.00022178299,0.0007692782,0.00007664387],"about_ca_topic_score_codex":0.0003560533,"about_ca_topic_score_gemma":0.0005858668,"teacher_disagreement_score":0.09175968,"about_ca_system_score_codex":0.0005567734,"about_ca_system_score_gemma":0.0003062431,"threshold_uncertainty_score":0.9976437},"labels":[],"label_agreement":null},{"id":"W2007074431","doi":"10.3747/co.20.1196","title":"Conservative Management for an Entero-Adnexal Fistula at Initial Presentation of Advanced Ovarian Carcinoma","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Conservative management; Presentation (obstetrics); General surgery; Ovarian carcinoma; Fistula; Ovarian cancer; Gynecology; Surgery; Internal medicine; Cancer","score_opus":0.12806276458318602,"score_gpt":0.4321309420493664,"score_spread":0.3040681774661804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007074431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893119,0.0003289095,0.00045928633,0.0018388109,0.0010836021,0.002854972,0.00008175577,0.000024507033,0.0040162806],"genre_scores_gemma":[0.9948011,0.00007817119,0.002461216,0.00021352293,0.00018143139,0.0015956211,0.00040552724,0.000016174949,0.00024722258],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99895144,0.00007146321,0.00032004205,0.00030415988,0.00013294448,0.00021997718],"domain_scores_gemma":[0.99915946,0.00011431482,0.00017249066,0.00022721432,0.0001992396,0.00012729557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000757674,0.00014138475,0.0003420249,0.000082587976,0.0000554015,0.000006996775,0.00006380593,0.000062539744,0.0003451035],"category_scores_gemma":[0.000020668489,0.00012372488,0.00009037154,0.00007308816,0.00009048142,0.00010466037,0.000058642905,0.00006406062,0.00002369719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00253771,0.005809339,0.3841763,0.00093420455,0.0005923523,0.000043037562,0.0026262125,0.000015084978,0.0011484615,0.0048959493,0.036818862,0.56040245],"study_design_scores_gemma":[0.017341018,0.0057310597,0.8766419,0.00012215956,0.00044894102,0.00001935299,0.00078593695,0.00050895486,0.0047928076,0.00062901655,0.09281031,0.00016849059],"about_ca_topic_score_codex":0.00007860548,"about_ca_topic_score_gemma":0.00008039426,"teacher_disagreement_score":0.56023395,"about_ca_system_score_codex":0.0003936182,"about_ca_system_score_gemma":0.00008012642,"threshold_uncertainty_score":0.5045354},"labels":[],"label_agreement":null},{"id":"W2007089900","doi":"10.1111/j.1525-1438.2007.01109.x","title":"Addressing unanswered questions in ovarian cancer trial methodology: follow-up of the 2004 Baden–Baden Gynecologic Cancer Intergroup meeting","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Gynecologic cancer; Ovarian cancer; Cancer; Gynecology; Oncology; Internal medicine","score_opus":0.19537251337842815,"score_gpt":0.41808144920652285,"score_spread":0.2227089358280947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007089900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96348214,0.007385582,0.00018164839,0.018994888,0.0083146915,0.000692259,0.00008874554,0.00001639575,0.0008436272],"genre_scores_gemma":[0.9896573,0.005174694,0.0015560964,0.001547604,0.001200332,0.0003027147,0.000004045299,0.000024841165,0.0005324162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966064,0.00051460596,0.0013041703,0.00036148282,0.0008296838,0.000383656],"domain_scores_gemma":[0.9962319,0.0012648372,0.0012142451,0.00021533846,0.0009075411,0.00016610348],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089499104,0.00028639205,0.0009189239,0.00029118636,0.00012897966,0.000027281098,0.00061197195,0.0002982047,0.004421998],"category_scores_gemma":[0.0021404265,0.00017712943,0.0005431503,0.00039812725,0.00031584798,0.00018499632,0.00016446732,0.000751164,0.0000027412393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026562355,0.0024264255,0.9072057,0.0000709339,0.002951206,0.0012338483,0.0018717091,0.005624269,0.0069886837,0.000625201,0.009283325,0.035156343],"study_design_scores_gemma":[0.062461987,0.0013042368,0.92056966,0.0017881517,0.0006296271,0.0002842764,0.0002906029,0.00013755473,0.006319804,0.0009663846,0.00493753,0.00031020353],"about_ca_topic_score_codex":0.0024935848,"about_ca_topic_score_gemma":0.0030579255,"teacher_disagreement_score":0.03589963,"about_ca_system_score_codex":0.0021167588,"about_ca_system_score_gemma":0.0014994085,"threshold_uncertainty_score":0.9964881},"labels":[],"label_agreement":null},{"id":"W2007398903","doi":"10.1016/j.ygyno.2010.10.022","title":"Successful management of medulloblastoma arising in an immature ovarian teratoma in pregnancy","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Medulloblastoma; Regimen; Malignancy; Ovarian Teratoma; Surgery; Oncology; Teratoma; Internal medicine; Pathology","score_opus":0.014081955150006141,"score_gpt":0.323446040364004,"score_spread":0.30936408521399783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007398903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984067,0.00026843493,0.0000075378534,0.0022762155,0.0006676633,0.00094708824,0.0000066294806,0.00003697956,0.011722421],"genre_scores_gemma":[0.9920501,0.00014957805,0.0070555075,0.0002677347,0.000052764604,0.00029630476,0.000023342991,0.000017666158,0.00008699442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830574,0.00011962917,0.0005247297,0.00047698987,0.00015175986,0.00042117503],"domain_scores_gemma":[0.99903744,0.00016934355,0.00017934806,0.00043639634,0.000055118704,0.00012236518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030776506,0.00020659823,0.0006306189,0.0002867333,0.000032228243,0.000011768757,0.00017773705,0.00041975445,0.00072711695],"category_scores_gemma":[0.000043458775,0.00017020565,0.00006988156,0.00040963024,0.000107823114,0.000108275206,0.00008871402,0.0005001525,0.000016932301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043108378,0.004142294,0.8262298,0.00018665337,0.00010014745,0.0046670437,0.0005201431,0.000019437768,0.0015069449,0.004633357,0.000088858156,0.15747423],"study_design_scores_gemma":[0.005856577,0.002248517,0.98676085,0.00028630573,0.00008618694,0.000075935335,0.00044021072,0.0000824775,0.0010359744,0.00095861935,0.0020203604,0.00014800076],"about_ca_topic_score_codex":0.0001299779,"about_ca_topic_score_gemma":0.006251607,"teacher_disagreement_score":0.16053103,"about_ca_system_score_codex":0.000350471,"about_ca_system_score_gemma":0.00019581248,"threshold_uncertainty_score":0.79614204},"labels":[],"label_agreement":null},{"id":"W2007824384","doi":"10.1046/j.1469-0705.2000.00004-1-142.x","title":"P143Primary bilateral fallopian tube cancer – case report","year":2000,"lang":"en","type":"article","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network","keywords":"Medicine; Fallopian tube; Fallopian tube cancer; Pelvic examination; Laparotomy; Abdomen; Pelvis; Uterus; Ovarian cancer; Physical examination; Cancer; Surgery","score_opus":0.013137288930394266,"score_gpt":0.27613339230722095,"score_spread":0.26299610337682666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007824384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98360634,0.004834411,0.0000012341638,0.0011781107,0.0006999827,0.00033574543,0.000028135859,0.000027413356,0.009288642],"genre_scores_gemma":[0.98304856,0.011910976,0.000294444,0.0014456969,0.00008658506,0.000099811536,0.00004711359,0.000020759897,0.0030460763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986992,0.000035540477,0.00036735923,0.00043072476,0.00011516399,0.00035202608],"domain_scores_gemma":[0.99512005,0.00432501,0.000056408542,0.00028192092,0.00004758607,0.00016903252],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012891727,0.00017199185,0.00038025773,0.0001738593,0.00008027582,0.000028508308,0.000041023388,0.0001742908,0.002870839],"category_scores_gemma":[0.0016484108,0.00015014433,0.000062899264,0.00038516987,0.0000858143,0.00006581495,0.000016125132,0.00019498728,0.00002121324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003992574,0.0005455252,0.5579176,0.000051086558,0.0001245509,0.15121646,0.00033571885,0.000032123437,0.000048958555,0.00024135082,0.0011027593,0.28834394],"study_design_scores_gemma":[0.0039835665,0.00052688975,0.5116299,0.000042287473,0.00016022212,0.057103276,0.000084604835,0.00005019257,0.00011295275,0.00026776321,0.4257546,0.0002837735],"about_ca_topic_score_codex":0.0011151122,"about_ca_topic_score_gemma":0.000597293,"teacher_disagreement_score":0.42465186,"about_ca_system_score_codex":0.00032902186,"about_ca_system_score_gemma":0.00014707838,"threshold_uncertainty_score":0.9980407},"labels":[],"label_agreement":null},{"id":"W2008583417","doi":"10.1097/01.ogx.0000251480.69322.50","title":"Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women with a BRCA1 or BRCA2 Mutation","year":2006,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Oophorectomy; Hazard ratio; Gynecology; Fallopian tube; Incidence (geometry); Fallopian tube cancer; Confidence interval; Obstetrics; Cancer registry; Cancer; Internal medicine; Hysterectomy; Surgery","score_opus":0.014084994296685135,"score_gpt":0.24711148025270221,"score_spread":0.23302648595601708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008583417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962744,0.0016026918,0.00002231497,0.0006674571,0.00006525368,0.00074878434,0.000048588205,0.00002098549,0.00054953276],"genre_scores_gemma":[0.99813145,0.00073503796,0.00051198824,0.0002374685,0.00003563044,0.00020691472,0.000018232851,0.000013864704,0.00010942553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981201,0.00047294755,0.00038159752,0.000415529,0.00026243995,0.00034733635],"domain_scores_gemma":[0.9944556,0.0049866675,0.00014071338,0.00017224283,0.00009227166,0.00015255007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062014477,0.00020369345,0.00063995534,0.00010058309,0.000087310036,0.000036643774,0.00006627941,0.00014595521,0.00015866637],"category_scores_gemma":[0.0018510307,0.000098161894,0.00003881277,0.00081289484,0.00040033422,0.000045012577,0.00004949804,0.00024894983,0.0000016422027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042703506,0.0004059511,0.9741454,0.000034888442,0.00014016168,0.00019480824,0.0002715095,0.000068075424,0.0000071714167,0.00026898502,0.00008700099,0.020105658],"study_design_scores_gemma":[0.011718499,0.0016379298,0.98510593,0.00003561763,0.000081421924,0.000029589635,0.00014862092,0.000302125,0.000019505414,0.00015532479,0.00063470786,0.00013070402],"about_ca_topic_score_codex":0.012703422,"about_ca_topic_score_gemma":0.0062310593,"teacher_disagreement_score":0.019974953,"about_ca_system_score_codex":0.00046838212,"about_ca_system_score_gemma":0.00016278597,"threshold_uncertainty_score":0.9938711},"labels":[],"label_agreement":null},{"id":"W2008681283","doi":"10.1016/j.annepidem.2015.03.021","title":"The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois","year":2015,"lang":"en","type":"article","venue":"Annals of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Institute of Circulatory and Respiratory Health; National Institute on Minority Health and Health Disparities; American Cancer Society","keywords":"Medicine; Hazard ratio; Socioeconomic status; Demography; Confidence interval; Proportional hazards model; Health equity; Survival analysis; Ovarian cancer; Gerontology; Cancer; Population; Environmental health; Internal medicine; Public health; Pathology","score_opus":0.09069561546277309,"score_gpt":0.38531840052824745,"score_spread":0.29462278506547435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008681283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845995,0.004317769,0.000032417265,0.010102365,0.0000758101,0.00018176991,0.00058663223,0.000005169027,0.00009857296],"genre_scores_gemma":[0.9943292,0.0036772247,0.00015206762,0.0016204502,0.000039328515,0.00002437558,0.00014025673,0.000008496538,0.0000085746415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827075,0.0003508428,0.0007601556,0.00026328448,0.000108421016,0.00024651628],"domain_scores_gemma":[0.99396825,0.0044292253,0.0007487866,0.0003975005,0.00029984146,0.00015639218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013321263,0.00013326998,0.001114314,0.00012248913,0.000033087705,0.0000019722413,0.00007955773,0.000109533015,0.000053153417],"category_scores_gemma":[0.0012518751,0.00009217679,0.00017284804,0.00015663539,0.00021082872,0.000030825682,0.000020704363,0.00008398652,0.0000013093506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005207937,0.00012135848,0.96856713,0.000016539945,0.0019488698,8.0340453e-7,0.00010662699,0.022548128,0.000017070197,0.003950738,0.000395092,0.0018068331],"study_design_scores_gemma":[0.0011873583,0.0004576883,0.9914858,0.000051566163,0.0008284219,1.0595733e-7,0.00005104634,0.0024590744,0.00018644374,0.0025937671,0.0006331337,0.00006560548],"about_ca_topic_score_codex":0.037114173,"about_ca_topic_score_gemma":0.0018452939,"teacher_disagreement_score":0.035268877,"about_ca_system_score_codex":0.000065279135,"about_ca_system_score_gemma":0.00028540945,"threshold_uncertainty_score":0.96929777},"labels":[],"label_agreement":null},{"id":"W2009014192","doi":"10.2741/s401","title":"The origin of ovarian cancers - hypotheses and controversies","year":2012,"lang":"en","type":"review","venue":"Frontiers in Bioscience-Scholar","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Fimbria; Ovarian cancer; Biology; Ampulla; Epithelium; Fallopian tube; Malignant transformation; Epithelial ovarian cancer; Neoplastic transformation; Cancer research; Cancer; Pathology; Medicine; Carcinogenesis; Anatomy; Gene; Genetics","score_opus":0.05378249718637612,"score_gpt":0.32048724426188807,"score_spread":0.26670474707551195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009014192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010674888,0.99546224,0.000020684602,0.0002625535,0.0020203497,0.0009767752,0.00008915768,0.0000135085065,0.0010479849],"genre_scores_gemma":[0.00031072088,0.99548787,0.0034252647,0.00011374727,0.00016301549,0.00012498477,0.000008404205,0.000026850355,0.00033916545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797297,0.00014620519,0.0005208759,0.00046670923,0.00039666877,0.000496568],"domain_scores_gemma":[0.9985985,0.00028780883,0.00034923188,0.0005133017,0.000051341536,0.00019982053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010730865,0.00035000435,0.0014126076,0.00026444986,0.00028771278,0.00008508786,0.0003119635,0.0002122639,0.000020437657],"category_scores_gemma":[0.00038051317,0.00020344811,0.00024233914,0.0006240191,0.0006401566,0.00021539032,0.00007930522,0.00054319005,0.0000044433327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028622537,0.00007574345,0.0059857853,0.0015264088,0.0002278918,0.000013996784,0.00013394766,1.8162825e-7,5.429449e-7,0.00036737876,0.0038402777,0.9877992],"study_design_scores_gemma":[0.0006940153,0.00012992458,0.0015636579,0.0033405407,0.0009629785,0.000020446018,0.00021462343,0.0000045204492,0.000005942948,0.00006061619,0.992815,0.00018774178],"about_ca_topic_score_codex":0.0002188136,"about_ca_topic_score_gemma":0.000024867859,"teacher_disagreement_score":0.9889747,"about_ca_system_score_codex":0.0007680898,"about_ca_system_score_gemma":0.0008658297,"threshold_uncertainty_score":0.8296373},"labels":[],"label_agreement":null},{"id":"W2009136967","doi":"10.1016/j.ygyno.2015.01.103","title":"The acceptability and perception of the morbidity and mortality of complex surgical procedures in primary debulking of ovarian cancer: A survey of American and Canadian gynecologic oncologists","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Debulking; Gynecologic cancer; Ovarian cancer; Gynecologic surgical procedures; Gynecology; General surgery; Surgery; Cancer; Internal medicine; Laparoscopy","score_opus":0.0781444801695139,"score_gpt":0.3662620790847306,"score_spread":0.28811759891521665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009136967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953167,0.0007331133,5.488784e-7,0.0017190583,0.000113001464,0.00092541013,0.00012324216,0.0000053627773,0.0010635842],"genre_scores_gemma":[0.99799293,0.0014754257,0.00026610444,0.00013684748,0.000014297525,0.00009084165,0.000011524079,0.0000063150733,0.000005704633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773914,0.00080566504,0.00065277895,0.00033703158,0.00018115368,0.0002842337],"domain_scores_gemma":[0.996703,0.0019410437,0.0006046817,0.0002943588,0.0002828262,0.00017406481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059966,0.00016533825,0.0009948781,0.0000805218,0.00007418565,0.0000046034816,0.00014354466,0.00018832642,0.00006860079],"category_scores_gemma":[0.0016816349,0.00009646234,0.000054912623,0.000330485,0.0019603102,0.00003435657,0.00016882432,0.00018762727,7.431573e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029461965,0.0005047486,0.9541409,0.00015428137,0.0000888635,0.000012486188,0.00047668893,0.0000132636505,0.00009608646,0.00008868992,0.000080130805,0.04404922],"study_design_scores_gemma":[0.002272171,0.0021629906,0.99391055,0.000020769083,0.0001305686,0.000024971234,0.00081273273,0.00007932662,0.000051413488,0.00019168289,0.00026534425,0.000077502955],"about_ca_topic_score_codex":0.3729168,"about_ca_topic_score_gemma":0.79573286,"teacher_disagreement_score":0.42281607,"about_ca_system_score_codex":0.00081132574,"about_ca_system_score_gemma":0.0023549318,"threshold_uncertainty_score":0.72228444},"labels":[],"label_agreement":null},{"id":"W2009205448","doi":"10.1097/pgp.0b013e31820d20ba","title":"Biomarker Expression in Pelvic High-grade Serous Carcinoma","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Foothills Medical Centre; University of Calgary; BC Cancer Agency; Calgary Laboratory Services","funders":"","keywords":"PDGFRB; Ovarian carcinoma; Pathology; Serous fluid; Serous carcinoma; Tissue microarray; Biomarker; Ovarian cancer; Biology; Carcinoma; Medicine; Cancer; Oncology; Immunohistochemistry; Internal medicine","score_opus":0.05720289650563004,"score_gpt":0.3071224773792963,"score_spread":0.24991958087366628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009205448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385124,0.00033519792,0.00014268752,0.0022546793,0.0012385948,0.000108962486,0.0000058996566,0.0000083560535,0.0020544035],"genre_scores_gemma":[0.9947293,0.00015291055,0.004064665,0.0008241089,0.00015857798,0.000011863155,0.000005548743,0.00000856754,0.000044474815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879855,0.0001112583,0.00048799056,0.00017465474,0.00025322172,0.00017434367],"domain_scores_gemma":[0.99914724,0.00016956007,0.000254993,0.00010446535,0.00021418308,0.00010953942],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002556876,0.00011710616,0.00033409722,0.00024926424,0.000015670894,0.000007292829,0.00019645625,0.00015128907,0.0015341714],"category_scores_gemma":[0.00022467668,0.00007771261,0.00013428568,0.00007587691,0.00007989444,0.00007667031,0.00006680942,0.00024046202,0.000032352018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009896419,0.0025080747,0.93870735,0.0000058808982,0.00011865452,0.033874832,0.0003376598,0.0000045377296,0.008503241,0.00063966884,0.0010014115,0.013309065],"study_design_scores_gemma":[0.0037932245,0.0012381944,0.9855937,0.000050032108,0.00003917664,0.002445652,0.000057826415,0.0000087320095,0.0041284245,0.0019212405,0.0006552404,0.000068586676],"about_ca_topic_score_codex":0.000038016075,"about_ca_topic_score_gemma":0.000022266087,"teacher_disagreement_score":0.04688634,"about_ca_system_score_codex":0.00024048566,"about_ca_system_score_gemma":0.0000792312,"threshold_uncertainty_score":0.99937856},"labels":[],"label_agreement":null},{"id":"W2009279284","doi":"10.1016/s0899-7071(03)00116-5","title":"MRI of gynecological neoplasm","year":2004,"lang":"en","type":"article","venue":"Clinical Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Pelvis; Radiology; Magnetic resonance imaging; Radiation therapy; Lymph; Peritoneum; Surgery; Pathology","score_opus":0.04316362505335919,"score_gpt":0.3960904481229758,"score_spread":0.3529268230696166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009279284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511923,0.0006958976,0.000962193,0.027516685,0.0006569921,0.0003116555,0.0000051160905,0.00007389331,0.018585246],"genre_scores_gemma":[0.99097776,0.00022276008,0.0064248377,0.0020928332,0.0001768589,0.000010209541,0.000004268825,0.000008810912,0.00008164909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909204,0.000021094711,0.00040701672,0.00022015962,0.00010948339,0.00015021076],"domain_scores_gemma":[0.99922425,0.00029151046,0.0000798848,0.00021782599,0.000052846786,0.00013370116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022229708,0.00007792105,0.0003204358,0.000025547573,0.0000225164,0.0000060686634,0.00004843286,0.00004739955,0.0002003437],"category_scores_gemma":[0.00030647378,0.00005668129,0.00018452197,0.000077771256,0.00014852676,0.00003208457,0.000036439887,0.00015004695,0.00009820885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005518644,0.0013678751,0.9203611,0.000024617026,0.00008681305,0.0002750613,0.000033886416,0.00001992847,0.00005708604,0.0020898846,0.0013649288,0.074263625],"study_design_scores_gemma":[0.005424418,0.00039207685,0.98007125,0.00013694928,0.00016956276,0.00004353429,0.000035688623,0.00005794112,0.0010103603,0.0020974895,0.010477369,0.00008333734],"about_ca_topic_score_codex":0.00002111581,"about_ca_topic_score_gemma":0.000003056726,"teacher_disagreement_score":0.07418029,"about_ca_system_score_codex":0.000054255277,"about_ca_system_score_gemma":0.00011595231,"threshold_uncertainty_score":0.23113959},"labels":[],"label_agreement":null},{"id":"W2009333542","doi":"10.1007/s12020-007-0041-8","title":"Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion","year":2007,"lang":"en","type":"article","venue":"Endocrine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"GNRHR; Ovarian cancer; Gonadotropin-releasing hormone; Biology; Ovarian carcinoma; Internal medicine; Endocrinology; Cancer research; Cancer; Hormone; Medicine; Luteinizing hormone","score_opus":0.021206555906885007,"score_gpt":0.3068841731733376,"score_spread":0.2856776172664526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009333542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896092,0.0013076563,0.00007470992,0.00042770134,0.00024936607,0.00034223826,0.00003960285,0.000041250605,0.007908283],"genre_scores_gemma":[0.99749035,0.0007222036,0.0003079934,0.00014669096,0.0007145296,0.000024179073,0.000045215453,0.000035351786,0.00051346817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869835,0.00001985226,0.0003321732,0.00029444037,0.00031041983,0.00034478595],"domain_scores_gemma":[0.99929523,0.00004682533,0.00012408948,0.00031230217,0.00005931131,0.00016222293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000037072186,0.00019656651,0.0003515748,0.00009192276,0.00008435607,0.000009465534,0.00007205218,0.000045029836,0.0010910712],"category_scores_gemma":[0.000010232072,0.00015902042,0.0001319295,0.00010323662,0.000042808817,0.00004130202,0.00004175663,0.00014560975,0.000023538085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009830144,0.0018230362,0.016389197,0.00007322443,0.00017071617,0.00017961269,0.00021825523,0.000006550845,0.9321388,0.002430373,0.0005451183,0.04504212],"study_design_scores_gemma":[0.0049049393,0.0009890078,0.43685886,0.00013436016,0.00016009148,0.000012199816,0.000053873093,0.000009583052,0.5503705,0.000100539364,0.006280108,0.00012591701],"about_ca_topic_score_codex":0.0032242585,"about_ca_topic_score_gemma":0.0002495301,"teacher_disagreement_score":0.42046964,"about_ca_system_score_codex":0.00026059974,"about_ca_system_score_gemma":0.00005573,"threshold_uncertainty_score":0.9998221},"labels":[],"label_agreement":null},{"id":"W2009390349","doi":"10.1016/j.jpedsurg.2005.05.022","title":"Müllerian agenesis and ovarian torsion. A case report and review of literature","year":2005,"lang":"en","type":"review","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ovarian torsion; Müllerian mimicry; Torsion (gastropod); Gynecology; Renal agenesis; Agenesis; Anatomy; Surgery; Internal medicine; Pathology","score_opus":0.046475950470375775,"score_gpt":0.33804003411723516,"score_spread":0.2915640836468594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009390349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020157603,0.99813235,0.0000012334659,0.00043833652,0.0006556877,0.00043359425,0.000047813908,0.000005279571,0.00008411923],"genre_scores_gemma":[0.000040972944,0.99273574,0.0006705364,0.00015500728,0.006198683,0.000017103806,0.00003036855,0.00004289199,0.000108673295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968278,0.0001856265,0.00208744,0.0002980272,0.00038792007,0.00021318215],"domain_scores_gemma":[0.99539274,0.0007194142,0.002785326,0.00035437313,0.00038317614,0.00036499178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017212918,0.00038135014,0.0035687813,0.0006927441,0.000052717354,0.000030960666,0.000048983195,0.0002757173,0.00015197303],"category_scores_gemma":[0.0007328533,0.0002466269,0.0010158281,0.000673447,0.000029818078,0.000111721245,0.00004961394,0.00037500224,0.000001299473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016790538,0.00015564167,0.0008363064,0.10605471,0.00047839442,0.18146393,0.000028908595,5.755355e-9,1.0378797e-8,0.0000019094575,0.050536513,0.66042686],"study_design_scores_gemma":[0.00024156964,0.000084023144,0.00017147303,0.076393045,0.009527056,0.27563462,0.000005419402,3.513773e-8,9.1094996e-8,0.0000011053544,0.6378027,0.00013883384],"about_ca_topic_score_codex":0.000014626246,"about_ca_topic_score_gemma":0.0000014229294,"teacher_disagreement_score":0.66028804,"about_ca_system_score_codex":0.00015199282,"about_ca_system_score_gemma":0.00127684,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W2009850733","doi":"10.1038/onc.2010.486","title":"Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin","year":2010,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Biology; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; Serous fluid; Downregulation and upregulation; Cadherin; Gene knockdown; Ovarian cancer; Ovarian tumor; Tumor progression; LY294002; Cell; Cell culture; Internal medicine; Cancer; Signal transduction; Cell biology; Medicine","score_opus":0.015937655273803614,"score_gpt":0.27139662242158547,"score_spread":0.2554589671477818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009850733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776727,0.00027266712,0.000026861435,0.00033421064,0.0002870115,0.00044344855,0.00024217519,0.00001928379,0.0006070814],"genre_scores_gemma":[0.9964941,0.00017377437,0.0027177609,0.00007792016,0.000100042234,0.000024991596,0.0003377413,0.000029362875,0.000044297263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985105,0.00004657607,0.00062404346,0.00026636798,0.00036559455,0.00018695624],"domain_scores_gemma":[0.99866754,0.00011595083,0.00053390005,0.0003380995,0.0002233496,0.000121171506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002366653,0.00017618778,0.00050454726,0.00011029365,0.00003222953,0.0000051127986,0.00007758421,0.00014276107,0.0005225624],"category_scores_gemma":[0.000114798204,0.00014425161,0.00009792794,0.00027816775,0.000076730925,0.000081079124,0.00006357389,0.00018232738,0.000006660924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020288992,0.0011933612,0.008310533,0.00022977575,0.00007163583,0.000014870541,0.00027920713,0.0000046138975,0.9776382,0.000014396696,0.0008752833,0.011165226],"study_design_scores_gemma":[0.003486115,0.00086260994,0.0074234195,0.0004841388,0.000143084,0.000009299992,0.00012156231,0.00006103112,0.9865057,0.000020633099,0.0007776245,0.00010481179],"about_ca_topic_score_codex":0.0005850952,"about_ca_topic_score_gemma":0.00007177998,"teacher_disagreement_score":0.011060414,"about_ca_system_score_codex":0.0000416587,"about_ca_system_score_gemma":0.00017250012,"threshold_uncertainty_score":0.588241},"labels":[],"label_agreement":null},{"id":"W2010201867","doi":"10.1038/bjc.2011.593","title":"CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Tumor progression; Carboplatin; Hazard ratio; Progression-free survival; Confidence interval; Internal medicine; Radiological weapon; Response Evaluation Criteria in Solid Tumors; Ovarian cancer; Chemotherapy; Cancer; Oncology; Surgery; Phases of clinical research; Cisplatin","score_opus":0.10808988722431266,"score_gpt":0.4141243571881464,"score_spread":0.3060344699638337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010201867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677667,0.022242265,0.000003877726,0.004376588,0.0040708906,0.0010341232,0.00020744464,0.0000017926088,0.00029632336],"genre_scores_gemma":[0.995427,0.0020319067,0.00004339391,0.00035262544,0.0017585562,0.00023975462,0.0000023056323,0.000018279792,0.0001261711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671835,0.0006369539,0.0012593473,0.00014560093,0.0009648958,0.0002748462],"domain_scores_gemma":[0.99774975,0.00015307532,0.001253606,0.0002426817,0.00048736823,0.00011352753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023783075,0.0001457302,0.00077425153,0.00006695229,0.00006988969,0.000025196847,0.00022063623,0.00008866347,0.0014107861],"category_scores_gemma":[0.00072965526,0.00009453225,0.00037862547,0.00035369545,0.00014189207,0.00015340287,0.00004177638,0.00025208667,1.9098862e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018738579,0.0040792674,0.6294596,0.00039188386,0.0016327811,0.000095035066,0.0107852155,0.00073208305,0.021290114,0.00020963539,0.06580913,0.24677667],"study_design_scores_gemma":[0.053287238,0.00028155095,0.88242304,0.0037514206,0.0014340956,0.00019802955,0.0005345824,0.000045179055,0.042016517,0.000087513596,0.015772937,0.00016788873],"about_ca_topic_score_codex":0.021758994,"about_ca_topic_score_gemma":0.013645267,"teacher_disagreement_score":0.25296345,"about_ca_system_score_codex":0.0006113769,"about_ca_system_score_gemma":0.001475427,"threshold_uncertainty_score":0.99950206},"labels":[],"label_agreement":null},{"id":"W2010224550","doi":"10.1158/1538-7445.am2013-4765","title":"Abstract 4765: The role of estrogen receptor signalling in serous ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Serous carcinoma; Serous fluid; Ovarian cancer; Fallopian tube; Estrogen receptor; Tissue microarray; Cancer; Estrogen; Cancer research; Progesterone receptor; Biology; Oncology; Internal medicine; Medicine; Pathology; Breast cancer; Gynecology","score_opus":0.06389084324985113,"score_gpt":0.3843240378293947,"score_spread":0.3204331945795436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010224550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975714,0.012312327,0.0000012931952,0.007490053,0.00013494647,0.0012253522,0.000036216417,0.000016013815,0.0030697412],"genre_scores_gemma":[0.99433196,0.0027884482,0.00010841584,0.00009956693,0.00041413703,0.0018875126,0.000008097715,0.000031995776,0.00032984893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813926,0.00008881512,0.00030475846,0.00032666564,0.00060932816,0.00053117634],"domain_scores_gemma":[0.9988126,0.00022787083,0.00006923568,0.00037640668,0.0003461462,0.00016775395],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055359356,0.00013562116,0.00028946705,0.00014873619,0.000099689845,0.000041331565,0.00022727222,0.000090159316,0.0060891868],"category_scores_gemma":[0.000051270967,0.00009039217,0.0000811233,0.0005363426,0.00015533026,0.00009073353,0.000066273984,0.00048867625,0.00013291759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046991714,0.0008111168,0.47948176,0.00031142432,0.00051932974,0.000044874443,0.0021106869,0.0004378577,0.19968551,0.0015257883,0.010744666,0.3038571],"study_design_scores_gemma":[0.0044858744,0.00059534615,0.6093115,0.0017505662,0.000092113136,0.000007800028,0.0024057317,0.00033117767,0.33195415,0.0021277575,0.046599206,0.00033876815],"about_ca_topic_score_codex":0.048224702,"about_ca_topic_score_gemma":0.0010849921,"teacher_disagreement_score":0.30351833,"about_ca_system_score_codex":0.00061201566,"about_ca_system_score_gemma":0.00076405605,"threshold_uncertainty_score":0.9948194},"labels":[],"label_agreement":null},{"id":"W2010261386","doi":"10.1111/j.1048-891x.2004.014304.x","title":"Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"National Science Council","keywords":"Immunostaining; Ovary; Gonadotropin-releasing hormone receptor; Immunohistochemistry; Western blot; Ovarian cancer; Endocrinology; Internal medicine; Messenger RNA; Blot; Receptor; Monoclonal antibody; Biology; Medicine; Antibody; Cancer; Hormone receptor; Breast cancer; Immunology; Gene","score_opus":0.020891714403831075,"score_gpt":0.3015512834694513,"score_spread":0.28065956906562023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010261386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921381,0.0030341803,0.00006875383,0.003600483,0.0006864779,0.00016513723,0.000025535861,0.000005733095,0.0002756051],"genre_scores_gemma":[0.9943179,0.004194373,0.00047006927,0.00050581986,0.00045468708,0.000018177996,0.0000034352738,0.000010020411,0.000025546025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987667,0.00003229552,0.0005118727,0.00015531151,0.00039127175,0.00014251396],"domain_scores_gemma":[0.9990531,0.000071960734,0.0003703432,0.000052028503,0.0003465933,0.00010596695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013453,0.00011821418,0.0003462013,0.00018449638,0.000031615713,0.000014767129,0.000104975334,0.00009534652,0.00022961969],"category_scores_gemma":[0.00011033283,0.0000902752,0.000107014785,0.00010617786,0.00006136398,0.00012570871,0.000032885237,0.00024422084,0.0000018678508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470949,0.001633135,0.0699528,0.000090359004,0.001271544,0.0008118895,0.00056491914,0.0021705523,0.75990784,0.0019641633,0.00014795618,0.15677534],"study_design_scores_gemma":[0.007831664,0.001533162,0.96628183,0.00032714833,0.00008282959,0.00011030269,0.00003298414,0.000014383917,0.021829844,0.00050712546,0.0013503848,0.00009835248],"about_ca_topic_score_codex":0.0005839743,"about_ca_topic_score_gemma":0.00015673671,"teacher_disagreement_score":0.89632905,"about_ca_system_score_codex":0.0023871202,"about_ca_system_score_gemma":0.00037548432,"threshold_uncertainty_score":0.6242236},"labels":[],"label_agreement":null},{"id":"W2010326641","doi":"10.4161/cc.22226","title":"Hereditary ovarian cancer and two-compartment tumor metabolism","year":2012,"lang":"en","type":"article","venue":"Cell Cycle","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Biology; Cancer research; Ovarian cancer; Stromal cell; Tumor microenvironment; Cancer cell; Tumor suppressor gene; Cancer; Carcinogenesis; Genetics; Tumor cells","score_opus":0.015307053897409688,"score_gpt":0.27652128955261446,"score_spread":0.2612142356552048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010326641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567321,0.02533156,0.0000093987765,0.0018876081,0.00081785716,0.00035328805,0.000026888614,0.000046595553,0.014794695],"genre_scores_gemma":[0.9958489,0.00030180372,0.00090374175,0.0011550152,0.0010699407,0.00014147145,0.000014578147,0.000023249928,0.0005413061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999185,0.000017368375,0.00013999843,0.00019613343,0.00014379362,0.00031765166],"domain_scores_gemma":[0.9993856,0.000023770068,0.000043275566,0.0002196838,0.000021859101,0.00030579793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008660647,0.00014337851,0.00025375164,0.00003663201,0.000066196604,0.00001382882,0.000033331424,0.00002613191,0.0008209577],"category_scores_gemma":[0.0000029328153,0.00011313825,0.00005684441,0.00006960508,0.000035161538,0.00009292039,0.000034328437,0.00008184055,0.00010335154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004143722,0.005332204,0.85197407,0.00045281966,0.0009972721,0.00043503207,0.0033462388,0.00006417452,0.005002282,0.0051347655,0.06542302,0.06142374],"study_design_scores_gemma":[0.0059296554,0.00009811422,0.8039505,0.000066189896,0.0006738758,0.00007360565,0.00015406539,0.00009150961,0.028454604,0.00015685553,0.16010936,0.00024168992],"about_ca_topic_score_codex":0.0005229374,"about_ca_topic_score_gemma":0.000020304646,"teacher_disagreement_score":0.09468634,"about_ca_system_score_codex":0.00008479077,"about_ca_system_score_gemma":0.00004815738,"threshold_uncertainty_score":0.8988911},"labels":[],"label_agreement":null},{"id":"W2010403722","doi":"10.1097/pgp.0b013e318264ae09","title":"Do Deeper Sections Increase the Frequency of Detection of Serous Tubal Intraepithelial Carcinoma (STIC) in the “Sectioning and Extensively Examining the FIMbriated End” (SEE-FIM) Protocol?","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University Medical Centre; McMaster University","funders":"","keywords":"Serous carcinoma; Fallopian tube; Serous fluid; Medicine; Pathology; Carcinoma; Ovarian carcinoma; H&E stain; Gynecology; Ovarian cancer; Cancer; Staining; Internal medicine","score_opus":0.02729051195641936,"score_gpt":0.2925243372380859,"score_spread":0.26523382528166656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010403722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930278,0.00009910336,0.00025488436,0.002155115,0.00035857686,0.0038102395,0.0000069113285,0.000004036004,0.000283357],"genre_scores_gemma":[0.99703103,0.000032522246,0.00028919952,0.00043657375,0.00025474437,0.0019408724,0.0000013530308,0.0000063217185,0.0000074004815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831444,0.00047061878,0.00064263464,0.00014741329,0.00028486358,0.00014004289],"domain_scores_gemma":[0.99746937,0.0012367568,0.0005223327,0.00013283685,0.0005958485,0.000042867687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087024225,0.00011967951,0.00029066947,0.00013581107,0.00008836021,0.000027497426,0.00020992201,0.00011134644,0.00022779574],"category_scores_gemma":[0.0014802304,0.00005362217,0.000098723955,0.00014801041,0.00027964657,0.00009022475,0.000053661992,0.00041970875,0.0000028238076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012073107,0.0019260488,0.8616322,0.00003890246,0.00054821715,0.0011835508,0.0046559754,0.000333283,0.06970849,0.0019396862,0.00020877448,0.056617558],"study_design_scores_gemma":[0.0020553372,0.0019475966,0.9883904,0.000048389047,0.00009071412,0.0029362007,0.00089462067,0.00008891897,0.001339577,0.0020799905,0.00008007362,0.000048205595],"about_ca_topic_score_codex":0.00077843963,"about_ca_topic_score_gemma":0.000244981,"teacher_disagreement_score":0.12675817,"about_ca_system_score_codex":0.00012696369,"about_ca_system_score_gemma":0.00009414563,"threshold_uncertainty_score":0.24942036},"labels":[],"label_agreement":null},{"id":"W2011065238","doi":"10.1016/j.humpath.2008.01.003","title":"Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma","year":2008,"lang":"en","type":"article","venue":"Human Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Serous fluid; Grading (engineering); Medicine; Serous carcinoma; Stage (stratigraphy); Clear cell; Oncology; Internal medicine; Multivariate analysis; Disease; Clear cell carcinoma; Carcinoma; Ovarian cancer; Pathology; Cancer; Gastroenterology; Gynecology; Biology","score_opus":0.02188176427768925,"score_gpt":0.23597146189067975,"score_spread":0.2140896976129905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011065238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977624,0.00024490457,0.0000015235577,0.00035542698,0.000056792385,0.0009962369,0.000033453347,0.000018718076,0.0005305591],"genre_scores_gemma":[0.99866384,0.000040142946,0.00047439482,0.00047695736,0.000032652202,0.00011464905,0.000050813174,0.000031774143,0.0001147669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844134,0.000069849535,0.00033525506,0.0006507418,0.00021636809,0.00028644956],"domain_scores_gemma":[0.9990125,0.000051031133,0.00016931444,0.00050802715,0.00014569404,0.00011343512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117202515,0.00020178194,0.0004677883,0.00017814248,0.000066544315,0.0000046001473,0.000072971074,0.00007922667,0.0000976613],"category_scores_gemma":[0.000051791532,0.00016593967,0.000032785614,0.00021200012,0.00020488397,0.00003183649,0.000042725304,0.00016146657,0.0000038735097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039065216,0.0012892539,0.992367,0.0000945483,0.00002799961,0.0027378225,0.0020206245,0.000001315221,0.000635461,0.000045642195,0.00016839206,0.00022125263],"study_design_scores_gemma":[0.0070712077,0.0035972996,0.98453844,0.00006691934,0.00010154788,0.00010127465,0.000051115665,0.0000013246103,0.0042047137,0.000026160533,0.00008964322,0.00015035292],"about_ca_topic_score_codex":0.00060189015,"about_ca_topic_score_gemma":0.00040031507,"teacher_disagreement_score":0.007828596,"about_ca_system_score_codex":0.00009448922,"about_ca_system_score_gemma":0.00018405412,"threshold_uncertainty_score":0.6766823},"labels":[],"label_agreement":null},{"id":"W2011661083","doi":"10.1158/1078-0432.ovca13-ia8","title":"Abstract IA8: Discovering drivers in rare ovarian cancer subtypes","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian cancer; Clear cell carcinoma; Context (archaeology); Clear cell; Cancer; Cancer research; Biology; Ovarian carcinoma; ARID1A; Mutation; Carcinoma; Medicine; Oncology; Bioinformatics; Internal medicine; Gene; Genetics","score_opus":0.20641064351636376,"score_gpt":0.514709670638262,"score_spread":0.3082990271218983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011661083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703818,0.002319853,0.0000022197928,0.01994247,0.0005075237,0.0011058816,0.00003538212,0.000034546334,0.0056703044],"genre_scores_gemma":[0.9889631,0.007370008,0.00010689195,0.0005505747,0.0007945483,0.001154003,0.000012902362,0.000039830542,0.0010081436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971737,0.00014466912,0.00059288717,0.0006668867,0.0006904371,0.0007313695],"domain_scores_gemma":[0.99804854,0.0006467848,0.00007447847,0.0005096236,0.0002816182,0.00043895197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000987214,0.00018182366,0.0005061187,0.0001945687,0.00010907076,0.00009143435,0.00021998014,0.0001959653,0.009467244],"category_scores_gemma":[0.0002955584,0.00014211376,0.00017933095,0.0005247158,0.0002992686,0.00021498345,0.00014312164,0.001048311,0.00046987392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002640198,0.00052820775,0.8910533,0.00012501067,0.0001483603,0.00017403826,0.00017476799,0.00003602675,0.00018707814,0.0002347931,0.0134130465,0.09366135],"study_design_scores_gemma":[0.0032754466,0.00024194979,0.97551125,0.00060860807,0.000029851984,0.0000017025357,0.00021191208,0.00007260616,0.0004715347,0.00026091022,0.01916638,0.0001478588],"about_ca_topic_score_codex":0.03891009,"about_ca_topic_score_gemma":0.0052971817,"teacher_disagreement_score":0.093513496,"about_ca_system_score_codex":0.0010197468,"about_ca_system_score_gemma":0.0009590146,"threshold_uncertainty_score":0.9914382},"labels":[],"label_agreement":null},{"id":"W2011749889","doi":"10.3747/co.v17i6.676","title":"Endometrioid Ovarian Carcinoma Benefits from Aromatase Inhibitors: Case Report and Literature Review","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Aromatase; Medicine; Ovarian carcinoma; Gynecology; Bioinformatics; Oncology; Internal medicine; Cancer research; Ovarian cancer; Cancer; Biology; Breast cancer","score_opus":0.05016996328558877,"score_gpt":0.3662670351837215,"score_spread":0.31609707189813274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011749889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.687167,0.30385697,0.0000023721323,0.0046444447,0.0026626918,0.00076110935,0.00037249515,0.000042457217,0.0004905001],"genre_scores_gemma":[0.9469066,0.047372356,0.0012772321,0.0008009425,0.0019231049,0.00027815514,0.0013611785,0.0000325307,0.00004787137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984525,0.00006261146,0.00047785603,0.0005739796,0.00016888481,0.0002641993],"domain_scores_gemma":[0.9984311,0.00022633249,0.00021606532,0.0006037194,0.00014988848,0.0003728863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027385386,0.00024364298,0.0006413303,0.0001517198,0.000082747865,0.00003074616,0.000056834433,0.00019805273,0.0003255631],"category_scores_gemma":[0.00043044597,0.00019016067,0.00011983325,0.00033188582,0.00008128541,0.00008194111,0.00008282998,0.00057853287,0.000028801902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010405063,0.0016441981,0.11738488,0.0012092126,0.00017458295,0.37176615,0.00037395366,3.4070762e-8,0.00022819568,0.00043797496,0.0478386,0.45883816],"study_design_scores_gemma":[0.0051649134,0.0007555837,0.05614964,0.003418623,0.0009907135,0.26178086,0.000030510968,0.0000070195842,0.0005788345,0.00009584824,0.6707454,0.0002820733],"about_ca_topic_score_codex":0.0001312964,"about_ca_topic_score_gemma":0.00015885591,"teacher_disagreement_score":0.62290674,"about_ca_system_score_codex":0.00012053988,"about_ca_system_score_gemma":0.00022038721,"threshold_uncertainty_score":0.7754527},"labels":[],"label_agreement":null},{"id":"W2011841619","doi":"10.1016/j.ygyno.2008.11.021","title":"Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Chemotherapy; Nausea; Surgery; Chemotherapy regimen; Vomiting; Gynecologic oncology; Internal medicine","score_opus":0.02041710507123097,"score_gpt":0.342952700631732,"score_spread":0.32253559556050104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011841619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98546535,0.000054617652,0.000015344716,0.00719511,0.00024096161,0.0062554334,0.00007433313,0.000041038977,0.0006578289],"genre_scores_gemma":[0.9935451,0.000016255286,0.0036884507,0.0007546933,0.00013933524,0.0014735251,0.00034935586,0.000015190278,0.000018097195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983435,0.00019353886,0.00032623665,0.00037644044,0.0004168618,0.00034341888],"domain_scores_gemma":[0.9985552,0.00016579386,0.00026507094,0.00032828815,0.0005899681,0.000095710355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075250777,0.00018871996,0.00040910416,0.00004755436,0.00013530115,0.000010719946,0.00012613375,0.0001510852,0.00051224447],"category_scores_gemma":[0.000096425756,0.00010821844,0.00008445611,0.00013070101,0.00013731839,0.000056367557,0.000022629016,0.00008942396,0.000002342927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013774752,0.0071504246,0.20184836,0.00001380018,0.00023747119,0.000008497214,0.0003981007,0.0000086335185,0.00006291743,0.00017772874,0.00036619822,0.7883504],"study_design_scores_gemma":[0.01903615,0.062247895,0.9074124,0.000008519662,0.00063930266,0.0000065789945,0.00010756686,0.0003186696,0.00094620587,0.0003062993,0.008851507,0.000118916396],"about_ca_topic_score_codex":0.000043687083,"about_ca_topic_score_gemma":0.00032975196,"teacher_disagreement_score":0.7882315,"about_ca_system_score_codex":0.000928714,"about_ca_system_score_gemma":0.0005281832,"threshold_uncertainty_score":0.5608717},"labels":[],"label_agreement":null},{"id":"W2011978684","doi":"10.1007/s00261-011-9722-0","title":"Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT","year":2011,"lang":"en","type":"article","venue":"Abdominal Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brandon Regional Health Authority; McGill University Health Centre","funders":"","keywords":"Medicine; Hepatology; Radiology; Carcinoma; Positron emission tomography; Internal medicine; Nuclear medicine","score_opus":0.019699259379054916,"score_gpt":0.23354709443358862,"score_spread":0.2138478350545337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011978684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238636,0.0011809976,0.00058001635,0.0018692558,0.00023941325,0.0005354739,0.0000123663085,0.00013611882,0.071582794],"genre_scores_gemma":[0.97787386,0.00003321391,0.02031682,0.0009455022,0.0002155192,0.000077399905,0.000023205203,0.00006397035,0.00045052156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983426,0.00003517255,0.00027568542,0.00051956985,0.00031796843,0.0005090299],"domain_scores_gemma":[0.9990401,0.000041122963,0.000103907056,0.00046299936,0.00009371865,0.00025813762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017257841,0.00029858566,0.00041794442,0.00014116733,0.00016612142,0.00005199989,0.00011421101,0.000005915424,0.00064753334],"category_scores_gemma":[0.000008720154,0.00023609288,0.000120212266,0.00017712728,0.00014955885,0.00024143737,0.000057588048,0.0002351096,0.00008330773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089219835,0.0007104914,0.90913767,0.00019048502,0.00024238124,0.044247612,0.0010504287,0.0000010230608,0.00088989706,0.0006084743,0.0010093612,0.041020002],"study_design_scores_gemma":[0.007573853,0.00057229365,0.9559498,0.00048349952,0.0010669762,0.019309731,0.0015113938,0.00043040008,0.008470499,0.000112030684,0.003917144,0.00060238224],"about_ca_topic_score_codex":0.0012102303,"about_ca_topic_score_gemma":0.000022495005,"teacher_disagreement_score":0.07113227,"about_ca_system_score_codex":0.00028187424,"about_ca_system_score_gemma":0.00026946486,"threshold_uncertainty_score":0.96275884},"labels":[],"label_agreement":null},{"id":"W2012229186","doi":"10.1097/01.pgp.0000130446.84670.93","title":"Subclassification of Ovarian Surface Epithelial Tumors Based on Correlation of Histologic and Molecular Pathologic Data","year":2004,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Serous fluid; Pathology; Clear cell; Ovarian carcinomas; Medicine; Epithelium; Immunohistochemistry; Serous carcinoma; Carcinoma; Ovarian carcinoma; Internal medicine; Cancer; Ovarian cancer","score_opus":0.07109296919576356,"score_gpt":0.36369830252164653,"score_spread":0.29260533332588295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012229186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017814528,0.97153693,0.0044706278,0.0019766167,0.0017533989,0.0010922118,0.00073890854,0.000020625957,0.0005961254],"genre_scores_gemma":[0.3560206,0.6369825,0.0062511736,0.00019000802,0.00009893623,0.000011713548,0.00041126725,0.00002397806,0.000009808554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691564,0.0004311459,0.0015319447,0.00044582866,0.00050796545,0.00016746359],"domain_scores_gemma":[0.9953135,0.0009842893,0.002622331,0.00046271118,0.0005131873,0.00010393629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008914647,0.00031020868,0.0018525376,0.0003618919,0.00002252094,0.000009576992,0.00056920754,0.0005057043,0.00015456787],"category_scores_gemma":[0.0015001013,0.00020644051,0.00038574205,0.00015575551,0.0003269134,0.000063344414,0.00013871024,0.000526131,0.000006380523],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018702865,0.008350518,0.010411883,0.0048651453,0.0018225309,0.028506314,0.00010067549,0.0019523817,0.00073287863,0.0121624,0.00024695188,0.928978],"study_design_scores_gemma":[0.060415052,0.08601701,0.27764028,0.10491229,0.031186523,0.056488715,0.00024491016,0.0039867377,0.0013605071,0.021949954,0.3516615,0.0041364916],"about_ca_topic_score_codex":0.000008754727,"about_ca_topic_score_gemma":0.0000012606795,"teacher_disagreement_score":0.9248415,"about_ca_system_score_codex":0.0004562993,"about_ca_system_score_gemma":0.00072423316,"threshold_uncertainty_score":0.84183997},"labels":[],"label_agreement":null},{"id":"W2012350639","doi":"10.1158/1538-7445.am2012-3645","title":"Abstract 3645: Integrative molecular profiling in serous epithelial ovarian cancer for identification of biomarkers of chemoresistance","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; microRNA; Ovarian cancer; Serous fluid; Epigenetics; Cancer research; Gene expression profiling; Carboplatin; Pharmacogenomics; Cancer; Gene; Oncology; Bioinformatics; Gene expression; Genetics; Medicine; Cisplatin; Chemotherapy","score_opus":0.07255284684015388,"score_gpt":0.4325871401235289,"score_spread":0.360034293283375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012350639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000597,0.0060774935,0.00021315168,0.0012178465,0.0001843789,0.001564917,0.00030190567,0.0000075622365,0.00042677097],"genre_scores_gemma":[0.9964757,0.0007839965,0.0008007049,0.000020184174,0.00013135979,0.0016303593,0.000028419938,0.000027055132,0.00010220154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983571,0.000060590774,0.00044808123,0.00027404682,0.00044752305,0.00041262343],"domain_scores_gemma":[0.9986881,0.00015897164,0.00017241524,0.00029782535,0.00056932797,0.00011336919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010650482,0.00012551867,0.00034438577,0.00025187974,0.00003910784,0.000009092681,0.00012014333,0.00008790108,0.00010762076],"category_scores_gemma":[0.00017634242,0.00010261859,0.00009863031,0.0005340263,0.00017298767,0.000104715546,0.000026476962,0.0001817001,0.0000022002607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001726818,0.0006540158,0.0834893,0.001176102,0.00037234227,0.0000074298628,0.0013184506,0.000036921283,0.88871485,0.001803253,0.00034507367,0.020355437],"study_design_scores_gemma":[0.0018428206,0.000092086935,0.16603021,0.00058779423,0.000049220373,6.4097503e-7,0.0004047891,0.000043864507,0.8304708,0.00016585203,0.0002388475,0.00007306902],"about_ca_topic_score_codex":0.0021566541,"about_ca_topic_score_gemma":0.0003087596,"teacher_disagreement_score":0.082540914,"about_ca_system_score_codex":0.0006468626,"about_ca_system_score_gemma":0.0005630989,"threshold_uncertainty_score":0.41846648},"labels":[],"label_agreement":null},{"id":"W2012697894","doi":"10.1002/cncr.22466","title":"Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer","year":2007,"lang":"en","type":"review","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; London Health Sciences Centre; McMaster University; Sunnybrook Health Science Centre; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Chemotherapy; Randomized controlled trial; Oncology; Ovarian cancer; Internal medicine; Adverse effect; Cisplatin; Stage (stratigraphy); Cochrane Library; Clinical trial; Surgery; Cancer","score_opus":0.054936419630249506,"score_gpt":0.3734571849316796,"score_spread":0.31852076530143014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012697894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028152296,0.9920009,0.000008067914,0.0011444949,0.00029052433,0.0027804568,0.000447558,0.000021710997,0.0004911032],"genre_scores_gemma":[0.001259283,0.9906311,0.00006951509,0.0006725827,0.0011476625,0.005390251,0.000061578365,0.00010040303,0.00066761463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762654,0.000057980895,0.00069429225,0.0005787717,0.00039823618,0.00064420426],"domain_scores_gemma":[0.9985326,0.00014016127,0.00040054592,0.0006892852,0.000072671384,0.00016474549],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000238162,0.00063399196,0.0024159532,0.00020586632,0.000060046095,0.000021530353,0.00020013595,0.0002704593,0.0013764478],"category_scores_gemma":[0.0000032227406,0.00031978174,0.000302806,0.00061505975,0.00015249262,0.000036737987,0.000013666203,0.00025103404,0.0000075571475],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007102489,0.0010808437,0.0006696682,0.0039244387,0.0014786691,0.00021512849,0.002547422,0.000007186895,4.206994e-7,0.000049883067,0.00014194372,0.9891741],"study_design_scores_gemma":[0.007199625,0.0018131805,0.001452706,0.007875882,0.0011694417,0.000027065595,0.00010499863,0.0000016181986,0.000033289234,0.000003003699,0.9800243,0.00029490402],"about_ca_topic_score_codex":0.0040395753,"about_ca_topic_score_gemma":0.00262763,"teacher_disagreement_score":0.98887926,"about_ca_system_score_codex":0.004308958,"about_ca_system_score_gemma":0.0015702862,"threshold_uncertainty_score":0.99992543},"labels":[],"label_agreement":null},{"id":"W2013049627","doi":"10.1016/j.clinbiochem.2008.11.008","title":"Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays","year":2008,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Ovarian cancer; Autoantibody; DNA microarray; Computational biology; Cancer; Biology; Cancer research; Genetics; Gene; Antibody; Gene expression","score_opus":0.08765390135250159,"score_gpt":0.38590673905202116,"score_spread":0.2982528376995196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013049627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644226,0.0011122745,0.00020993984,0.0011484029,0.00033269826,0.00040990015,0.000031801486,0.00004699263,0.000265745],"genre_scores_gemma":[0.9901968,0.00022075005,0.0077978754,0.0005085344,0.0006444771,0.000040742045,0.00003415596,0.000030445493,0.00052621955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980285,0.000030569106,0.0006486418,0.0006925128,0.0002501424,0.00034964603],"domain_scores_gemma":[0.9989228,0.00008871477,0.00018245867,0.00047802785,0.000097314914,0.00023066647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000269908,0.00023795803,0.0005586353,0.000048767793,0.00010735533,0.00001909967,0.0001258175,0.00039545164,0.00025607742],"category_scores_gemma":[0.00022305781,0.00021430332,0.00022023106,0.00023152419,0.000218537,0.000046299447,0.000085538224,0.0005602576,0.000012272461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002259098,0.0015026086,0.18192369,0.00019464402,0.00019048183,0.0005990799,0.00005335295,0.000013459309,0.81379783,0.00003653848,0.0009045113,0.00055790925],"study_design_scores_gemma":[0.0044633523,0.00007565902,0.30685437,0.0008157097,0.00013247783,0.000057171565,0.000024054416,0.00013207944,0.6868777,0.000034213055,0.00027614448,0.0002570512],"about_ca_topic_score_codex":0.0009833965,"about_ca_topic_score_gemma":0.000025978354,"teacher_disagreement_score":0.1269201,"about_ca_system_score_codex":0.00028289837,"about_ca_system_score_gemma":0.00054324686,"threshold_uncertainty_score":0.8739036},"labels":[],"label_agreement":null},{"id":"W2013149435","doi":"10.1111/igc.0b013e3181ee1c01","title":"Current Academic Clinical Trials in Ovarian Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Clinical trial; Ovarian cancer; Gynecologic oncology; Cancer; Family medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.42165541544232316,"score_gpt":0.6135878610745493,"score_spread":0.19193244563222617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013149435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003854677,0.97708756,0.000018092267,0.004022306,0.017222553,0.00085879804,0.00019986185,0.000009331076,0.00019601359],"genre_scores_gemma":[0.00056104345,0.98957896,0.00018951931,0.0006503934,0.00847343,0.0003740594,0.000028269054,0.000039621842,0.0001046981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99216396,0.0011057688,0.004984532,0.000476131,0.0009298565,0.00033973117],"domain_scores_gemma":[0.99048716,0.0043144217,0.0039274674,0.00021224986,0.0006659058,0.00039276932],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0062294053,0.00045992952,0.0050941934,0.0005388216,0.00002485193,0.000048483977,0.00071845704,0.0010711966,0.0052563767],"category_scores_gemma":[0.005970054,0.000269114,0.0024586804,0.0002490638,0.00013484193,0.00011288872,0.00013453253,0.0045604813,0.000039302715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023008604,0.0007267795,0.014144724,0.0004757135,0.0012614365,0.0005959756,0.000012235607,0.0000025051509,5.4910595e-7,0.00017469598,0.004492125,0.97788316],"study_design_scores_gemma":[0.0033196723,0.00032645243,0.016488703,0.017328767,0.0023371459,0.00019928445,0.0000029494859,0.0000025684924,0.0000016953786,0.00018762947,0.9595802,0.00022495785],"about_ca_topic_score_codex":0.000054384265,"about_ca_topic_score_gemma":0.000116830364,"teacher_disagreement_score":0.9776582,"about_ca_system_score_codex":0.0017454509,"about_ca_system_score_gemma":0.0036047238,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W2013378021","doi":"10.1097/01.rlu.0000255018.37567.fd","title":"Artifact on PET/CT Secondary to FDG Accumulation in a Vaginal Tampon","year":2007,"lang":"en","type":"article","venue":"Clinical Nuclear Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Artifact (error); PET-CT; Nuclear medicine; Radiology; Positron Emission Tomography-Computed Tomography; Positron emission tomography","score_opus":0.10656954837899199,"score_gpt":0.4495086441358946,"score_spread":0.3429390957569026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013378021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94400513,0.00008367167,0.000029833765,0.036979508,0.0007301775,0.00055585924,0.000003109609,0.0000669948,0.017545687],"genre_scores_gemma":[0.97681093,0.000090530724,0.0005949943,0.021259166,0.00093526306,0.0000072468124,0.000023180735,0.00003881497,0.0002398459],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978843,0.00006579115,0.0008375145,0.00048761268,0.00037770806,0.00034707523],"domain_scores_gemma":[0.9982104,0.0006925237,0.000105884086,0.00043008054,0.00005674192,0.0005043939],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014982792,0.00019175759,0.00058689195,0.00022887887,0.000043546595,0.000007856343,0.00008700635,0.000035659024,0.0027417038],"category_scores_gemma":[0.0008032248,0.00014167123,0.00011354006,0.0003158935,0.00011590792,0.000049042363,0.000035678084,0.00051911024,0.00083641213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068235383,0.00392651,0.37810972,0.00013894105,0.00024293664,0.013002857,0.0006964679,0.000037648366,0.00042197,0.0020028115,0.08543217,0.5091644],"study_design_scores_gemma":[0.0061834613,0.004137916,0.8289874,0.00059912296,0.00008434292,0.00012930087,0.00014858585,0.000093710805,0.00004566806,0.0001254822,0.15934423,0.000120791905],"about_ca_topic_score_codex":0.00012503014,"about_ca_topic_score_gemma":0.000081826955,"teacher_disagreement_score":0.50904363,"about_ca_system_score_codex":0.00020378602,"about_ca_system_score_gemma":0.000069148715,"threshold_uncertainty_score":0.9999415},"labels":[],"label_agreement":null},{"id":"W2013560682","doi":"10.1016/j.jgyn.2013.09.027","title":"Épidémiologie des tumeurs ovariennes présumées bénignes","year":2013,"lang":"fr","type":"review","venue":"Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Gynecology; Asymptomatic; Medicine; Incidence (geometry); Obstetrics; Pregnancy; Ovary; Epidemiology; Endometriosis; Menopause; Internal medicine","score_opus":0.05483821414287604,"score_gpt":0.37661294692760083,"score_spread":0.3217747327847248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013560682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07462408,0.8490304,0.007954746,0.03241222,0.024147697,0.0076281507,0.00042694886,0.0019693493,0.0018064228],"genre_scores_gemma":[0.026820406,0.8915639,0.05199066,0.0022237226,0.018227242,0.0036211673,0.00062619196,0.0006541418,0.004272561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9311699,0.04404539,0.0077466452,0.0071607893,0.0016099663,0.008267262],"domain_scores_gemma":[0.9478415,0.029497983,0.009681054,0.005717537,0.0039358158,0.0033260873],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.06860797,0.005371448,0.008424158,0.0032414696,0.0036686615,0.0035216894,0.004465701,0.010865649,0.0022372368],"category_scores_gemma":[0.16106802,0.0041866186,0.00517794,0.003933954,0.0072767236,0.002770126,0.0019881264,0.021166835,0.0005401079],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0024047138,0.0085098455,0.075940736,0.0055286395,0.007351235,0.01412492,0.0021836488,0.011019367,0.012104624,0.0023417983,0.097467855,0.7610226],"study_design_scores_gemma":[0.0054549086,0.00881734,0.06691097,0.006141483,0.0048637176,0.13424481,0.004684598,0.00010395496,0.008180293,0.04190187,0.71468765,0.0040084072],"about_ca_topic_score_codex":0.0008064538,"about_ca_topic_score_gemma":0.00006877047,"teacher_disagreement_score":0.7570142,"about_ca_system_score_codex":0.046404067,"about_ca_system_score_gemma":0.021610016,"threshold_uncertainty_score":0.99867487},"labels":[],"label_agreement":null},{"id":"W2013878239","doi":"10.1158/1538-7445.am10-897","title":"Abstract 897: Association of inherited variants in HGF and ovarian cancer survival time","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Single-nucleotide polymorphism; Hazard ratio; Internal medicine; Serous fluid; Ovarian cancer; Oncology; SNP; Medicine; Proportional hazards model; Genome-wide association study; Cancer; Confidence interval; Biology; Gene; Genotype; Genetics","score_opus":0.07599708435192871,"score_gpt":0.4178503120534894,"score_spread":0.3418532277015607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013878239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878456,0.00056516536,5.046771e-7,0.00642947,0.00027426356,0.0005083422,0.000101049925,0.000014294686,0.0042613274],"genre_scores_gemma":[0.9968445,0.0011399803,0.00007927659,0.00007482008,0.00029685104,0.00024622443,0.000014672448,0.000025268324,0.001278439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998288,0.00008590327,0.00026598145,0.00032794147,0.0006218108,0.00041039093],"domain_scores_gemma":[0.99886864,0.00027222556,0.00008784182,0.00025890823,0.00034665925,0.00016573591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001264,0.00011624467,0.0003390737,0.00023259298,0.000059234673,0.000030984855,0.00008825035,0.00017853187,0.0027491206],"category_scores_gemma":[0.00022245923,0.00010292581,0.00004016282,0.00051160454,0.00008699936,0.00008819165,0.000054147,0.0006346702,0.000028440549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038635943,0.0004746459,0.78003216,0.000189633,0.00022978101,0.00006661886,0.00047973535,0.000004584037,0.19018494,0.00033287267,0.004159826,0.023458868],"study_design_scores_gemma":[0.0029606707,0.000096259835,0.98523,0.00022848764,0.000030762345,0.0000017667162,0.00003491123,0.00005147439,0.006668719,0.0001304317,0.0044780695,0.00008843563],"about_ca_topic_score_codex":0.010886781,"about_ca_topic_score_gemma":0.005242689,"teacher_disagreement_score":0.20519787,"about_ca_system_score_codex":0.00053476566,"about_ca_system_score_gemma":0.0006499075,"threshold_uncertainty_score":0.9981625},"labels":[],"label_agreement":null},{"id":"W2014627554","doi":"10.1002/cncr.11064","title":"A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors","year":2003,"lang":"en","type":"review","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Oncology; Stage (stratigraphy); Internal medicine; Confidence interval; Clinical significance; Ovarian carcinoma; Ovarian tumor; Pathology; Ovarian cancer; Gynecology; Cancer; Biology","score_opus":0.03202026608492645,"score_gpt":0.3437758750134073,"score_spread":0.3117556089284808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014627554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045986733,0.9972912,0.0000038152216,0.00012046684,0.00013159706,0.0017337679,0.0001305956,0.000007030794,0.000121659075],"genre_scores_gemma":[0.00036895298,0.998051,0.00015792418,0.0003803717,0.00012330376,0.0006749188,0.0001257319,0.00004202968,0.00007578363],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998374,0.00011979594,0.0006636343,0.00048002918,0.00017362116,0.00018892785],"domain_scores_gemma":[0.9990072,0.000049497525,0.00045098615,0.00027060456,0.00009866874,0.00012300356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019515282,0.00032426606,0.001714001,0.00015732017,0.000041447292,0.000012762328,0.00005012287,0.00016102982,0.00022157845],"category_scores_gemma":[0.000049845567,0.00023266702,0.00016669776,0.00019682018,0.0000758085,0.000050767063,0.000037208298,0.00017701993,0.0000019422787],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015757068,0.0002330682,0.000114008646,0.34740555,0.0002227116,0.0003985746,0.0001332054,4.6521055e-7,0.00011712866,0.00011386358,0.0013669917,0.6498787],"study_design_scores_gemma":[0.0016959264,0.0002294776,0.00029032794,0.75451595,0.0020373263,0.00017207918,0.000022428663,5.783056e-7,0.0002648661,0.000044109915,0.2404494,0.00027753395],"about_ca_topic_score_codex":0.0002259559,"about_ca_topic_score_gemma":0.00004729058,"teacher_disagreement_score":0.6496011,"about_ca_system_score_codex":0.00022276439,"about_ca_system_score_gemma":0.0005134122,"threshold_uncertainty_score":0.9487886},"labels":[],"label_agreement":null},{"id":"W2014705446","doi":"10.5858/arpa.2010-0640-rs","title":"Squamous Lesions of the Ovary","year":2011,"lang":"en","type":"review","venue":"Archives of Pathology & Laboratory Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Hamilton General Hospital","funders":"","keywords":"Ovary; Histogenesis; Pathology; Differential diagnosis; Medicine; Biology; Immunohistochemistry; Internal medicine","score_opus":0.053517136292758616,"score_gpt":0.3376658048349488,"score_spread":0.2841486685421902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014705446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023749997,0.99167925,0.000009887232,0.0003532969,0.00057325466,0.0009567444,0.00027487995,0.000021574459,0.0058935867],"genre_scores_gemma":[0.0018156568,0.9967654,0.00043322743,0.000249969,0.00026854684,0.00012025493,0.00007024988,0.0000574459,0.00021927114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975911,0.00047923822,0.001002889,0.00044352852,0.00021741938,0.0002658395],"domain_scores_gemma":[0.9967726,0.00082654,0.0008744761,0.0012784294,0.00009796074,0.0001499974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026418956,0.0004128025,0.0027109927,0.0003077065,0.000056577384,6.823066e-7,0.00036957773,0.0002453357,0.00026845414],"category_scores_gemma":[0.00036489667,0.00021294541,0.0004932025,0.00046902185,0.0017477943,0.000017542738,0.00016336363,0.0005021299,0.000011451395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008196598,0.0009340018,0.0017832139,0.019660706,0.00085030636,0.0006950038,0.0015888525,8.6555744e-8,0.00010441255,0.00535796,0.0030682185,0.96587527],"study_design_scores_gemma":[0.0015718495,0.0012444818,0.0074154735,0.027366564,0.006580217,0.0003184984,0.00007698713,1.9176196e-7,0.00008403997,0.00027473335,0.95488495,0.00018200852],"about_ca_topic_score_codex":0.000033377986,"about_ca_topic_score_gemma":0.000010217191,"teacher_disagreement_score":0.96569324,"about_ca_system_score_codex":0.000037099184,"about_ca_system_score_gemma":0.0010882698,"threshold_uncertainty_score":0.8683662},"labels":[],"label_agreement":null},{"id":"W2015224186","doi":"10.1002/gcc.20549","title":"Amplification of 11q13 in ovarian carcinoma","year":2008,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Amplicon; Serous fluid; Biology; Ovarian cancer; Fluorescence in situ hybridization; Tissue microarray; Histology; Gene duplication; Ovarian carcinoma; Gene; Serous carcinoma; Pathology; Cancer research; Cancer; Medicine; Genetics; Chromosome; Polymerase chain reaction","score_opus":0.031507328501579716,"score_gpt":0.27769673716534854,"score_spread":0.24618940866376882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015224186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97605735,0.022020381,0.000011667373,0.00105493,0.000085852844,0.00019115336,0.000019306182,0.0000069127327,0.00055242144],"genre_scores_gemma":[0.9840311,0.015123909,0.00023955439,0.00014456696,0.0001108118,0.00010207615,0.000011421169,0.000009612965,0.00022699013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994354,0.000008941447,0.000158723,0.00018136363,0.00009753748,0.00011800404],"domain_scores_gemma":[0.99969304,0.000011827267,0.00004862563,0.00015331066,0.000035318968,0.000057906702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028022343,0.00008309383,0.00021156963,0.000057465,0.000030434268,0.0000027341994,0.0000248662,0.000041750776,0.00021575316],"category_scores_gemma":[0.0000022998056,0.00006806765,0.000036413738,0.00013175124,0.000054723296,0.00003167511,0.000012651419,0.000035092522,0.000002620334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004949167,0.00013850589,0.9577598,0.00009148313,0.00004074696,0.000038658156,0.0004957695,0.000008845033,0.0059843753,0.00030379565,0.0002759903,0.03481252],"study_design_scores_gemma":[0.0015660756,0.00011556364,0.9710518,0.0000699178,0.000041151485,0.000045720866,0.000059070342,0.000027180693,0.02080963,0.000031035284,0.0061148517,0.000067988694],"about_ca_topic_score_codex":0.0010977801,"about_ca_topic_score_gemma":0.000094409785,"teacher_disagreement_score":0.03474453,"about_ca_system_score_codex":0.00007433338,"about_ca_system_score_gemma":0.00012039347,"threshold_uncertainty_score":0.27757183},"labels":[],"label_agreement":null},{"id":"W2016917919","doi":"10.1016/j.ygyno.2012.03.048","title":"Preoperative identification of a suspicious adnexal mass: A systematic review and meta-analysis","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Meta-analysis; Adnexal mass; Confidence interval; MEDLINE; Bivariate analysis; Systematic review; Radiology; Receiver operating characteristic; Medical physics; Pathology; Internal medicine; Machine learning; Computer science","score_opus":0.1443210536215035,"score_gpt":0.4172580017863185,"score_spread":0.272936948164815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016917919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011988335,0.99061036,0.000028691655,0.00060845725,0.000087013395,0.0078482665,0.00016830594,0.000027087879,0.000620642],"genre_scores_gemma":[0.00062594883,0.98978066,0.00039594935,0.00052671693,0.000031392876,0.0071435473,0.00020936917,0.000026809557,0.0012595943],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954224,0.0013325312,0.0020818526,0.0006210516,0.00022286589,0.00031927874],"domain_scores_gemma":[0.9952296,0.0013752128,0.0021675217,0.0008171835,0.00024271122,0.00016775251],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015018537,0.0005172508,0.015506159,0.00035195053,0.00005454219,0.00001322058,0.00017547431,0.0005256869,0.0015716644],"category_scores_gemma":[0.0005665013,0.0002886528,0.0024566886,0.0007448791,0.00014042298,0.00005184688,0.00007785775,0.00028933265,0.00009605279],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028643165,0.0005070051,0.000018533165,0.7445482,0.2484868,0.00004417173,0.00005481636,1.3510996e-7,8.494835e-8,0.00023276605,0.0001245347,0.0059800725],"study_design_scores_gemma":[0.00023697797,0.00072515756,0.00004537817,0.0047860737,0.95130235,0.000104500345,0.000022548002,6.717916e-7,5.942141e-7,0.00001640988,0.042570237,0.00018910873],"about_ca_topic_score_codex":0.000016729035,"about_ca_topic_score_gemma":0.000042086973,"teacher_disagreement_score":0.7397621,"about_ca_system_score_codex":0.00063857343,"about_ca_system_score_gemma":0.00048773896,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W2017055023","doi":"10.1016/j.ygyno.2005.03.040","title":"Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Chemotherapy; Ovarian cancer; Oncology; Internal medicine; Disease; Adjuvant; Cancer; Stage (stratigraphy); Adjuvant therapy","score_opus":0.035496408626650953,"score_gpt":0.3949745626083521,"score_spread":0.3594781539817012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017055023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97736394,0.0014527517,0.00033824152,0.017297192,0.00035362135,0.0013317167,0.00020382158,0.00004761447,0.0016110963],"genre_scores_gemma":[0.9722878,0.0023570284,0.02094032,0.0026189166,0.00039121494,0.00071900885,0.000017123735,0.00002280092,0.000645787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984099,0.000104565304,0.00054365245,0.00043417644,0.00014585706,0.00036184798],"domain_scores_gemma":[0.9985199,0.0005728867,0.00035205044,0.00026837192,0.00010822313,0.00017857601],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004661599,0.00020199579,0.0008627943,0.000065585315,0.00009363895,0.0000067331634,0.00007954241,0.00019467401,0.0009588389],"category_scores_gemma":[0.00016994012,0.00016063561,0.00012250834,0.000082046034,0.00013335908,0.000064898326,0.000045315675,0.00014716413,0.000003417123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027769117,0.0038235425,0.5125955,0.00073710945,0.0008864574,0.000047780664,0.0006624109,0.0002491906,0.035113793,0.0058434196,0.00091022806,0.4363537],"study_design_scores_gemma":[0.015920164,0.0019780812,0.912913,0.00002769402,0.00010027087,0.000005442928,0.00014647347,0.000108307,0.0046666465,0.00013754141,0.063829936,0.00016640578],"about_ca_topic_score_codex":0.0001375426,"about_ca_topic_score_gemma":0.00066448876,"teacher_disagreement_score":0.4361873,"about_ca_system_score_codex":0.0007639039,"about_ca_system_score_gemma":0.00060014334,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W2017261407","doi":"10.1007/s003830000413","title":"Unilateral ovarian agenesis and fallopian tube maldescent","year":2001,"lang":"en","type":"article","venue":"Pediatric Surgery International","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Fallopian tube; Medicine; Laparotomy; Ovarian cyst; Cyst; Agenesis; Ovary; Surgery; Gynecology; Anatomy; Internal medicine","score_opus":0.023623448966695212,"score_gpt":0.26320258127780716,"score_spread":0.23957913231111194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017261407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98521215,0.0005192175,0.000064247084,0.0071400846,0.001297882,0.00014729002,0.000020161424,0.000058391583,0.0055405768],"genre_scores_gemma":[0.9908127,0.004539105,0.000277428,0.00085036457,0.0017513781,0.00003650526,0.00008953286,0.000018770657,0.0016242084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989417,0.000020770689,0.0002618918,0.00027815113,0.0002939908,0.00020349583],"domain_scores_gemma":[0.9993824,0.00015533646,0.00006772198,0.00014084754,0.00008778826,0.00016594463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014292101,0.00014113443,0.00021349754,0.0002552626,0.00004959556,0.000041376494,0.000052408977,0.00005828537,0.0011981105],"category_scores_gemma":[0.000055513017,0.00012459149,0.00011564777,0.000176853,0.000020554828,0.00009391045,0.000038168575,0.00007297197,0.000042089323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009495024,0.00022659158,0.97991246,0.000015043567,0.00011967179,0.0003874666,0.000040929794,0.0000032838805,0.000008391998,0.00035878946,0.0068245092,0.01200793],"study_design_scores_gemma":[0.00075293815,0.000031268144,0.9484897,0.000018357208,0.00012748265,0.00023854102,0.000011137992,0.00011901232,0.00004686051,0.000056879642,0.0499853,0.00012251928],"about_ca_topic_score_codex":0.00016974674,"about_ca_topic_score_gemma":0.000014766387,"teacher_disagreement_score":0.043160792,"about_ca_system_score_codex":0.00015414789,"about_ca_system_score_gemma":0.00010756394,"threshold_uncertainty_score":0.9997149},"labels":[],"label_agreement":null},{"id":"W2017800162","doi":"10.1016/j.ygyno.2015.01.010","title":"A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal; McGill University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Conjugate; Internal medicine; Paclitaxel; Cancer; Oncology; Nuclear medicine","score_opus":0.14478755348117509,"score_gpt":0.3979734417184835,"score_spread":0.25318588823730837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017800162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553,0.00065000553,0.00001372028,0.0027552748,0.0009108184,0.005734799,0.000010212319,0.000081144404,0.0043140296],"genre_scores_gemma":[0.9956946,0.00020170571,0.00041157386,0.0002725449,0.00016836087,0.0030404134,0.000076302385,0.00003779309,0.00009672102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996276,0.00041402073,0.0012226095,0.00081988715,0.00038208737,0.0008853735],"domain_scores_gemma":[0.99734104,0.0011722617,0.0005435684,0.00029156718,0.0002061398,0.00044543087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017131397,0.0004656064,0.0022996608,0.00046510628,0.000102191705,0.00005405387,0.00014697568,0.00044756584,0.00027046198],"category_scores_gemma":[0.00048800005,0.00035073666,0.00009662794,0.00063308567,0.00031968873,0.00018283806,0.000108616056,0.00053560425,0.000017105054],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.966589,0.005278917,0.019738639,0.00004591147,0.00052802835,0.0009704265,0.0020785988,0.0002682349,0.00016101699,0.001002317,0.00013328905,0.0032056745],"study_design_scores_gemma":[0.9636626,0.016183805,0.013755918,0.00016164436,0.00085698284,0.000029233657,0.00088708644,0.0028782631,0.0004525918,0.00026321484,0.0005110064,0.0003576098],"about_ca_topic_score_codex":0.0041378993,"about_ca_topic_score_gemma":0.028201854,"teacher_disagreement_score":0.024063954,"about_ca_system_score_codex":0.00203759,"about_ca_system_score_gemma":0.00145141,"threshold_uncertainty_score":0.99989444},"labels":[],"label_agreement":null},{"id":"W2017858235","doi":"10.1158/1078-0432.ovca13-a27","title":"Abstract A27: The ovarian tumor tissue analysis (OTTA) consortium","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Calgary","funders":"","keywords":"Serous fluid; Tissue microarray; Ovarian cancer; Serous carcinoma; Immunohistochemistry; Pathology; Biology; Clear cell; Cancer; Oncology; Molecular pathology; Cancer research; Internal medicine; Medicine; Gene; Genetics","score_opus":0.22185382597507952,"score_gpt":0.5372881851395189,"score_spread":0.3154343591644394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017858235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86795187,0.0030521401,0.000026203783,0.10069292,0.00055416184,0.002320754,0.000059749,0.00007642905,0.025265785],"genre_scores_gemma":[0.99145865,0.001060472,0.0001511503,0.0020676532,0.0010706465,0.0011232934,0.000020398304,0.000030669245,0.0030170674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996556,0.0003470695,0.0007529721,0.0006693261,0.00097506883,0.00069959485],"domain_scores_gemma":[0.99560755,0.0019688217,0.00012372763,0.0010923964,0.0006649636,0.00054255675],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025636759,0.00018167464,0.0006415717,0.00020580455,0.00027196313,0.00015055279,0.00034625753,0.00013702744,0.023027914],"category_scores_gemma":[0.00070538855,0.00010686926,0.000385555,0.0013048655,0.0006688558,0.00008964826,0.00014452887,0.0010707573,0.001979261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033978402,0.0012786102,0.71780574,0.000085974076,0.003351275,0.00026527813,0.00012049265,0.000021277845,0.00018777895,0.00084948394,0.1714436,0.104250714],"study_design_scores_gemma":[0.0015036827,0.00036373254,0.9006543,0.000057610752,0.00057955587,0.0000044713447,0.000111802765,0.000101850055,0.00047666306,0.00032005087,0.09571297,0.000113300775],"about_ca_topic_score_codex":0.0083988225,"about_ca_topic_score_gemma":0.00088625844,"teacher_disagreement_score":0.18284857,"about_ca_system_score_codex":0.00025012955,"about_ca_system_score_gemma":0.00072875695,"threshold_uncertainty_score":0.99879783},"labels":[],"label_agreement":null},{"id":"W2017894589","doi":"10.1038/modpathol.3800475","title":"Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation","year":2005,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"BC Cancer Agency; Eli Lilly and Company","keywords":"CD99; Calretinin; Pathology; Cytokeratin; Biology; Immunohistochemistry; Vimentin; Medicine","score_opus":0.022119074987084996,"score_gpt":0.27985088475236364,"score_spread":0.25773180976527865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017894589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765234,0.0002797119,0.01689843,0.004398949,0.00017506492,0.0005881663,0.000035127272,0.0001687643,0.0009323808],"genre_scores_gemma":[0.99187815,0.000060747865,0.0034949658,0.0010610236,0.00045507896,0.000116627605,0.0001300914,0.000079767124,0.002723572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978848,0.000105682906,0.00043021646,0.00072946417,0.00029495652,0.0005548725],"domain_scores_gemma":[0.9987073,0.00008544601,0.00024916543,0.0006487061,0.00008537605,0.00022400371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001436219,0.0003681536,0.00069746264,0.00022284157,0.00015161194,0.00003913303,0.00012781427,0.00016019659,0.00025590966],"category_scores_gemma":[0.00003394096,0.00029478848,0.000101405865,0.0001904962,0.000097061005,0.00010754521,0.00007407424,0.000299165,0.000068984045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042145187,0.0019530971,0.78435063,0.0002409908,0.00044493112,0.004424704,0.0020915521,0.0019952548,0.0034625016,0.0011869812,0.00040273715,0.19523212],"study_design_scores_gemma":[0.00923738,0.003552938,0.9544002,0.0003370739,0.00036640983,0.0016301658,0.0002462988,0.019816734,0.007039735,0.0005666931,0.0022200313,0.0005863718],"about_ca_topic_score_codex":0.00020544334,"about_ca_topic_score_gemma":0.0008719943,"teacher_disagreement_score":0.19464575,"about_ca_system_score_codex":0.00025392944,"about_ca_system_score_gemma":0.00017755834,"threshold_uncertainty_score":0.9999504},"labels":[],"label_agreement":null},{"id":"W2017958518","doi":"10.1097/igc.0000000000000289","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital","funders":"Cancer Research UK","keywords":"Medicine; Carboplatin; Serous carcinoma; Oncology; Ovary; Clear cell carcinoma; Internal medicine; Serous fluid; Stage (stratigraphy); Ovarian cancer; Irinotecan; PI3K/AKT/mTOR pathway; Paclitaxel; Cisplatin; Chemotherapy; Gynecologic oncology; BRCA mutation; Clinical trial; Gynecology; Cancer; Colorectal cancer","score_opus":0.06846054688510105,"score_gpt":0.4027854182400701,"score_spread":0.334324871354969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017958518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005377331,0.98688716,0.000015610754,0.005438702,0.0045107487,0.0015983758,0.0003461133,0.000008019852,0.00065753516],"genre_scores_gemma":[0.008466867,0.9855557,0.00031201527,0.0033612899,0.0012073223,0.0005220041,0.000019770618,0.000046197878,0.0005088521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964296,0.00027464342,0.0018850089,0.0003837017,0.0007206376,0.0003063801],"domain_scores_gemma":[0.99335504,0.0017521877,0.0030413577,0.00033549484,0.0013416824,0.00017421905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006800455,0.00045512285,0.0028316793,0.00016030075,0.00005453655,0.00002216624,0.000877339,0.0003601883,0.002537677],"category_scores_gemma":[0.00088139303,0.00023308359,0.0023007675,0.00020032052,0.00020039928,0.000035942066,0.00019432146,0.0006822294,0.000009483855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031751517,0.000841877,0.00232868,0.022388062,0.0020795434,0.00017430847,0.00001765062,0.000010150593,0.0000024617461,0.00020721655,0.06868966,0.9029429],"study_design_scores_gemma":[0.0018766297,0.0013079968,0.0031443387,0.035257343,0.0045563728,0.00022803097,0.0000060387815,0.00000508316,0.000025134146,0.00007623098,0.9533005,0.00021634312],"about_ca_topic_score_codex":0.00005275077,"about_ca_topic_score_gemma":0.000041716306,"teacher_disagreement_score":0.90272653,"about_ca_system_score_codex":0.0014980058,"about_ca_system_score_gemma":0.0016220062,"threshold_uncertainty_score":0.99837416},"labels":[],"label_agreement":null},{"id":"W2018100760","doi":"10.1016/j.ygyno.2014.04.003","title":"Dynamic modeling in ovarian cancer: An original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Oncology; Receiver operating characteristic; Ovarian cancer; Predictive value; Internal medicine; Parametric statistics; Predictive marker; Cancer; Statistics; Mathematics","score_opus":0.05433801386473591,"score_gpt":0.3277328218629944,"score_spread":0.2733948079982585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018100760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922432,0.00027228595,0.003297016,0.0022492714,0.0003085703,0.0010215568,0.000007536565,0.000029161061,0.00057140394],"genre_scores_gemma":[0.96469826,0.00040071452,0.033606935,0.00032830262,0.00007584956,0.0007768839,0.00003641344,0.000029181327,0.000047471814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728614,0.00028160284,0.0005964564,0.0008561917,0.00025116443,0.00072845974],"domain_scores_gemma":[0.9988076,0.0004381878,0.000106643,0.00029205135,0.00008368325,0.00027182358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010339959,0.00032510434,0.00090961496,0.0006437193,0.00007995985,0.000033981578,0.00018394135,0.000310767,0.000038861945],"category_scores_gemma":[0.00014526531,0.00028991018,0.000035275054,0.0005752949,0.000054114575,0.00008466977,0.00015002837,0.00045577914,0.0000095336945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041543486,0.0018296749,0.85208005,0.000039235223,0.00004795987,0.0002789007,0.0038715098,0.033324372,0.00013099256,0.00038461684,0.0000056016365,0.10759163],"study_design_scores_gemma":[0.0055731665,0.0018846593,0.8483159,0.0001899178,0.000052763095,0.000019259845,0.00033213655,0.14238971,0.000028021212,0.0004285067,0.00047908467,0.00030685504],"about_ca_topic_score_codex":0.004543412,"about_ca_topic_score_gemma":0.18193439,"teacher_disagreement_score":0.17739098,"about_ca_system_score_codex":0.0021519626,"about_ca_system_score_gemma":0.00049733976,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2018514314","doi":"10.1159/000226541","title":"The Value of a Monoclonal Anti-Epithelial Antibody (mAB lu-5) in the Differential Diagnosis of Tumors","year":2009,"lang":"en","type":"article","venue":"Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Universität Basel","keywords":"Monoclonal antibody; Immunohistochemistry; Immunostaining; Pathology; Differential diagnosis; Epithelium; Biology; Antibody; Monoclonal; Medicine; Immunology","score_opus":0.015307711695733812,"score_gpt":0.33172885694838145,"score_spread":0.31642114525264764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018514314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397535,0.0005006455,0.000009672069,0.012800694,0.00020018221,0.00043193868,0.000024118437,0.0000061105106,0.0020512957],"genre_scores_gemma":[0.99814975,0.0010163664,0.00011164025,0.00045049508,0.00017026966,0.00006278838,0.000014329975,0.000007120352,0.000017213415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882424,0.00017318128,0.00038255425,0.00017514621,0.00021984585,0.00022501059],"domain_scores_gemma":[0.99891883,0.00052552007,0.00017540182,0.00029180647,0.000048535247,0.000039878632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026583884,0.00012192684,0.0004591661,0.0000660107,0.00005385794,0.0000058248916,0.00017243698,0.000087849796,0.00009781975],"category_scores_gemma":[0.00007032455,0.00006314132,0.00014457779,0.00017502008,0.0001623806,0.000019492278,0.00002488014,0.00015333763,0.0000040400605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013207134,0.013579889,0.75855744,0.000072180505,0.00043985297,0.00049152964,0.002957115,0.00005657773,0.011858738,0.04370182,0.0034324024,0.1635317],"study_design_scores_gemma":[0.0033049928,0.003793403,0.9794752,0.000086557586,0.00018548839,0.00004676691,0.0002831037,0.00008049917,0.008286059,0.0009914893,0.0034039957,0.00006243932],"about_ca_topic_score_codex":0.0003072116,"about_ca_topic_score_gemma":0.00007576764,"teacher_disagreement_score":0.22091773,"about_ca_system_score_codex":0.000089525,"about_ca_system_score_gemma":0.00020691613,"threshold_uncertainty_score":0.25748283},"labels":[],"label_agreement":null},{"id":"W2018929154","doi":"10.1200/jco.2007.12.1939","title":"Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":549,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Internal medicine; Cyclophosphamide; Vascular endothelial growth factor; Regimen; Adverse effect; Ovarian cancer; Clinical endpoint; Oncology; Chemotherapy; Gastroenterology; Phases of clinical research; Cancer; Surgery; Clinical trial","score_opus":0.08053328566653827,"score_gpt":0.47261857151957426,"score_spread":0.392085285853036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018929154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984698,0.0015152101,0.000020012982,0.0076500806,0.004261062,0.0016373788,0.0000937994,0.0000042726883,0.00012021173],"genre_scores_gemma":[0.99264264,0.004770748,0.0007760521,0.00034741595,0.0013924788,0.00002536072,0.0000048826755,0.000020773858,0.000019658317],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921169,0.000712449,0.005915262,0.00042732464,0.00045510943,0.0003729317],"domain_scores_gemma":[0.99178517,0.0028208331,0.0042265314,0.00035157322,0.0002732395,0.00054262695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008533396,0.0002713726,0.003002232,0.00017403475,0.0000835547,0.0000085730335,0.00023700998,0.00052300264,0.00011181227],"category_scores_gemma":[0.0038283283,0.00017309409,0.00073255267,0.00023536051,0.00087532826,0.000091508475,0.0002281943,0.0012319012,5.7981856e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51248485,0.0433751,0.04882451,0.0000395832,0.00072252215,0.00018261177,0.0001412791,0.0000016140395,0.000011626919,0.00008232317,0.0003375409,0.39379644],"study_design_scores_gemma":[0.7095241,0.17561595,0.101542704,0.00030457805,0.0012011895,0.000042907755,0.00007159534,0.00005120429,0.00013817775,0.00015545763,0.011219053,0.00013309406],"about_ca_topic_score_codex":0.00022459222,"about_ca_topic_score_gemma":0.00054161745,"teacher_disagreement_score":0.39366335,"about_ca_system_score_codex":0.00030062866,"about_ca_system_score_gemma":0.0029045902,"threshold_uncertainty_score":0.70585716},"labels":[],"label_agreement":null},{"id":"W2019026643","doi":"10.1158/1538-7445.am2011-2835","title":"Abstract 2835: BRCA1 signature in high-risk fallopian tube epithelium","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Fallopian tube; Serous fluid; Carcinogenesis; Epithelium; Ovarian cancer; BRCA mutation; Cancer; Biology; Pathology; Cancer research; Oncology; Medicine; Internal medicine; Gynecology","score_opus":0.08298439581336467,"score_gpt":0.3729413838780354,"score_spread":0.28995698806467074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019026643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791738,0.003953341,0.000003687585,0.0027337405,0.00029359895,0.00080897246,0.00008489633,0.000043113247,0.012904899],"genre_scores_gemma":[0.99329764,0.0041649207,0.00023481864,0.0002332109,0.00039154786,0.00048285787,0.000016962747,0.000045659115,0.0011323744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779224,0.00010567342,0.000261604,0.00052209897,0.0006261492,0.00069224054],"domain_scores_gemma":[0.9987613,0.00012869274,0.00004906519,0.0005390818,0.0002312995,0.00029059293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006952199,0.00018074371,0.0003315693,0.00032414863,0.00010563992,0.000027430628,0.00020848146,0.00019141615,0.004440856],"category_scores_gemma":[0.000090746464,0.00014185879,0.00008852113,0.0005789382,0.00014970316,0.0000954348,0.00007611793,0.0010655741,0.00026662354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014845345,0.0018914301,0.8319312,0.00039436418,0.00047701848,0.0018892199,0.004145816,0.000024027186,0.0048069875,0.0028486254,0.02334126,0.12676553],"study_design_scores_gemma":[0.0031312588,0.00042915903,0.96082765,0.0004070796,0.000041502328,0.000006065997,0.0001687909,0.00000532486,0.01774308,0.0013681103,0.015705967,0.00016600385],"about_ca_topic_score_codex":0.02187621,"about_ca_topic_score_gemma":0.0035664416,"teacher_disagreement_score":0.12889647,"about_ca_system_score_codex":0.0006668012,"about_ca_system_score_gemma":0.00054465875,"threshold_uncertainty_score":0.9964692},"labels":[],"label_agreement":null},{"id":"W2019067804","doi":"10.1016/j.ygyno.2010.05.012","title":"Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Fallopian tube; BRCA mutation; Mutation; Gynecology; Oncology; Internal medicine; Genetics; Ovarian cancer; Cancer; Gene; Biology","score_opus":0.018958541067977567,"score_gpt":0.3053359126236823,"score_spread":0.28637737155570475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019067804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216473,0.000020018984,0.000020766438,0.0027977014,0.0011381842,0.001314214,0.000074157106,0.000013650007,0.0024565596],"genre_scores_gemma":[0.99794775,0.00006396002,0.001058723,0.00035874933,0.000061184626,0.0003164135,0.000025302475,0.0000106317575,0.00015725788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907416,0.00007449572,0.00028190453,0.00024318989,0.00008715206,0.00023911885],"domain_scores_gemma":[0.9976947,0.0016704162,0.00020421458,0.00025837068,0.00009232593,0.00007999715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021436904,0.0001253983,0.00037475143,0.00008183025,0.000099273144,0.0000033975123,0.0001097537,0.00027452793,0.00025240774],"category_scores_gemma":[0.0016456898,0.00007642542,0.00015102242,0.00016593139,0.0001623294,0.00002683035,0.000036734382,0.00027513778,0.000005506107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008427117,0.0006792202,0.9783043,0.000034530887,0.00012544026,0.000033158114,0.0014639051,0.000091798545,0.0019429906,0.00086954783,0.0010702034,0.01530059],"study_design_scores_gemma":[0.0033237126,0.0018782015,0.9794786,0.000015365624,0.00020617503,0.000009840709,0.001032007,0.00007399313,0.006146595,0.0007789308,0.006980279,0.00007627859],"about_ca_topic_score_codex":0.00051173836,"about_ca_topic_score_gemma":0.013321254,"teacher_disagreement_score":0.0152243115,"about_ca_system_score_codex":0.00030210722,"about_ca_system_score_gemma":0.0006929545,"threshold_uncertainty_score":0.74335724},"labels":[],"label_agreement":null},{"id":"W2020713814","doi":"10.3747/co.2007.148","title":"Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; McMaster University; Ottawa Regional Cancer Foundation; Kingston General Hospital; Princess Margaret Cancer Centre; Ottawa Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Gynecology; Bioinformatics; Cancer; Cancer research; Biology","score_opus":0.09351944156578035,"score_gpt":0.4260427977140308,"score_spread":0.33252335614825046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020713814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97676444,0.0051304772,0.0026765857,0.0077815177,0.0019579164,0.002706366,0.00009383204,0.00010494868,0.0027838924],"genre_scores_gemma":[0.97967654,0.004653237,0.007316658,0.000679735,0.0020080155,0.004314419,0.000109116765,0.000086110645,0.0011561594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984806,0.00001960524,0.00028318667,0.0004468183,0.00015150504,0.00061829615],"domain_scores_gemma":[0.9990351,0.00012100221,0.00013095258,0.0002611906,0.00013305737,0.00031868264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021030847,0.00026514,0.000531619,0.00010721369,0.00008350284,0.0000117226955,0.00006295834,0.00010446686,0.00048289433],"category_scores_gemma":[0.000008569084,0.00017860786,0.00010020339,0.00015152895,0.00007994141,0.000034549637,0.000011964798,0.00010857474,0.000014440187],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066224695,0.0040120087,0.032278474,0.00008040441,0.00053777534,0.000045852095,0.0015643351,0.000010309963,0.00007373528,0.0003228348,0.0025437647,0.95190805],"study_design_scores_gemma":[0.019973932,0.014108439,0.081375815,0.0001104736,0.00024165634,0.000042422256,0.00026182493,0.00005462396,0.0012074545,0.000039774906,0.88238233,0.00020125102],"about_ca_topic_score_codex":0.00003511137,"about_ca_topic_score_gemma":0.00016554288,"teacher_disagreement_score":0.95170677,"about_ca_system_score_codex":0.0032678158,"about_ca_system_score_gemma":0.00058242976,"threshold_uncertainty_score":0.85452247},"labels":[],"label_agreement":null},{"id":"W2020974878","doi":"10.1007/s10456-014-9422-9","title":"Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Angiogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; National Research Council Canada; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Topotecan; Pazopanib; Medicine; Ovarian cancer; Chemotherapy; Pharmacology; Sunitinib; Cancer; Oncology; Paclitaxel; Internal medicine","score_opus":0.019313904476841556,"score_gpt":0.3181504694778853,"score_spread":0.2988365650010437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020974878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160784,0.0016378368,0.00040894595,0.00516671,0.00012263736,0.0008624783,0.00007517964,0.000030004647,0.000088364824],"genre_scores_gemma":[0.9944358,0.000241447,0.002814646,0.0011699225,0.000084381696,0.0008640849,0.000027527436,0.000043413904,0.00031878593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783105,0.00019652376,0.0006169556,0.0006806176,0.00028233218,0.00039250994],"domain_scores_gemma":[0.9985402,0.00018455624,0.00017546545,0.00073769514,0.00014932298,0.00021274583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051676633,0.00026289685,0.0010992491,0.0006165473,0.000036183534,0.000014041213,0.00015846977,0.000134128,0.00027072086],"category_scores_gemma":[0.00010380906,0.00023694702,0.00048271596,0.0015041924,0.000059306763,0.00006169314,0.000046373803,0.00004112019,0.000008219621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020757562,0.000770495,0.87698156,0.00009999534,0.004187927,0.000053006097,0.00079730235,0.00285631,0.004545893,0.00008114921,0.00014511035,0.08872368],"study_design_scores_gemma":[0.0040733246,0.00038249945,0.97688943,0.00016655913,0.0019326954,6.6935957e-7,0.00004160633,0.00028897592,0.012979526,0.000020829702,0.0029939783,0.00022987906],"about_ca_topic_score_codex":0.0008085888,"about_ca_topic_score_gemma":0.006500317,"teacher_disagreement_score":0.09990788,"about_ca_system_score_codex":0.0006148034,"about_ca_system_score_gemma":0.00025237992,"threshold_uncertainty_score":0.9662419},"labels":[],"label_agreement":null},{"id":"W2021017228","doi":"10.1136/bcr-2012-007744","title":"Detection and differential diagnosis of suspected malignant transformation of an endometrioma during pregnancy","year":2013,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Vascularity; Differential diagnosis; Radiology; Malignancy; Endometriosis; Asymptomatic; Pregnancy; Nodule (geology); Adnexal mass; Gynecology; Pathology","score_opus":0.01551156766218082,"score_gpt":0.2712607629958709,"score_spread":0.25574919533369006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021017228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979369,0.00038931784,0.000061989995,0.00006250323,0.00009408246,0.0012932867,0.0000059837803,0.000022811491,0.0001331005],"genre_scores_gemma":[0.99916214,0.000231648,0.00012373697,0.0000016572277,0.000036388778,0.00040785628,0.000012391174,0.000012120596,0.000012036607],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989404,0.000026790347,0.0005404821,0.00018737015,0.00018864564,0.00011627592],"domain_scores_gemma":[0.99919754,0.00003787728,0.00029955982,0.00024040115,0.00012590231,0.00009873315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052745276,0.00010611266,0.00029325945,0.00019009842,0.000037974976,0.000009989469,0.000007914455,0.00005811798,0.00020753987],"category_scores_gemma":[0.000056313274,0.00008455547,0.00007238442,0.00017849589,0.00002947616,0.00016412753,0.000009129083,0.000038573715,6.51561e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034504785,0.0030257346,0.28095835,0.003282915,0.0007832323,0.17442246,0.0024411576,0.000006889156,0.15831152,0.000052791427,0.0000109255925,0.376359],"study_design_scores_gemma":[0.001411995,0.00048647914,0.3975336,0.00048632632,0.0002341096,0.100812964,0.00010099344,0.0000663798,0.49876267,0.000028788534,0.0000045155484,0.000071204035],"about_ca_topic_score_codex":0.0011713399,"about_ca_topic_score_gemma":0.0001112938,"teacher_disagreement_score":0.37628776,"about_ca_system_score_codex":0.000050364895,"about_ca_system_score_gemma":0.000028086239,"threshold_uncertainty_score":0.34480718},"labels":[],"label_agreement":null},{"id":"W2021145375","doi":"10.1038/modpathol.2011.94","title":"Letter to the editor regarding ‘Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression‘","year":2011,"lang":"en","type":"letter","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University Health Network; Vancouver General Hospital","funders":"","keywords":"PTEN; P53 expression; Cancer research; Biology; Immunohistochemistry; Pathology; Medicine; Apoptosis; Genetics","score_opus":0.025608893746863745,"score_gpt":0.2528406039920003,"score_spread":0.22723171024513655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021145375","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007806347,0.0014931216,0.00092834455,0.98137313,0.00576215,0.0012885275,0.0007684973,0.00010686737,0.00047299865],"genre_scores_gemma":[0.049362667,0.00024760273,0.0010403815,0.92441756,0.019157046,0.0007756665,0.00079862523,0.00019591235,0.004004567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962592,0.00057695905,0.00051174,0.0014015238,0.00046630317,0.0007842753],"domain_scores_gemma":[0.99771273,0.00025869405,0.00034906916,0.001368929,0.00009351141,0.00021707607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036462117,0.000701476,0.001154869,0.00020950043,0.00020738141,0.00008582732,0.00032925644,0.0011182089,0.0001899167],"category_scores_gemma":[0.00007714539,0.00046972965,0.00020988742,0.00010220889,0.00017920836,0.0000733002,0.0003050215,0.0017479489,0.00006992337],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015809396,0.00013800945,0.0015943251,0.00008319085,0.0001725844,0.0034327225,0.00087827124,0.0000015757196,0.0015640785,0.000014238078,0.9910889,0.00087397284],"study_design_scores_gemma":[0.0029440667,0.00033835977,0.007301886,0.00038940416,0.00047196596,0.00025649532,0.000018896668,0.00001711019,0.0008080242,0.00017225095,0.9868124,0.00046913934],"about_ca_topic_score_codex":0.00050028996,"about_ca_topic_score_gemma":0.0001096078,"teacher_disagreement_score":0.056955613,"about_ca_system_score_codex":0.0002095054,"about_ca_system_score_gemma":0.00011419481,"threshold_uncertainty_score":0.99977547},"labels":[],"label_agreement":null},{"id":"W2021334860","doi":"10.1111/igc.0b013e3181e0a353","title":"Ovarian Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Clinical trial; Gynecologic cancer; Cancer; End point; Cancer imaging; Medical physics; Gynaecological cancer; Oncology; Gynecology; Pathology; Internal medicine","score_opus":0.08208195182534754,"score_gpt":0.44220837634441995,"score_spread":0.3601264245190724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021334860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007975553,0.98628366,0.00001331523,0.0037200074,0.007686053,0.0003772368,0.00016800246,0.000014702723,0.001657255],"genre_scores_gemma":[0.00025911658,0.99274015,0.0005351562,0.00095188536,0.0044399276,0.000208322,0.000023235612,0.000041279367,0.00080090313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754083,0.00006978034,0.0010627764,0.00030076876,0.0007744519,0.00025141926],"domain_scores_gemma":[0.99704635,0.00036735798,0.0012491511,0.00019119393,0.0008648221,0.00028112103],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026159076,0.00036809576,0.001822202,0.00029049168,0.0000368106,0.00006704867,0.00052447553,0.00053203484,0.012054594],"category_scores_gemma":[0.0002596519,0.00021804786,0.001176282,0.00015734923,0.00009249785,0.000089948604,0.000093742674,0.0012525499,0.000052781437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007386197,0.00040722286,0.0007348108,0.00044300727,0.002023246,0.0011764833,0.000011649327,0.0000018107492,9.980711e-7,0.0002548653,0.0051559834,0.98971605],"study_design_scores_gemma":[0.0012915732,0.00031021863,0.0017406268,0.006964989,0.002359101,0.0007109644,0.0000027948404,0.0000010694231,0.0000047097224,0.00009033092,0.9863311,0.00019250833],"about_ca_topic_score_codex":0.00006860661,"about_ca_topic_score_gemma":0.000071773306,"teacher_disagreement_score":0.98952353,"about_ca_system_score_codex":0.0013393842,"about_ca_system_score_gemma":0.0020174528,"threshold_uncertainty_score":0.9888485},"labels":[],"label_agreement":null},{"id":"W2021449942","doi":"10.1111/j.1525-1438.2007.01177.x","title":"cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation","year":2008,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"CREB; Ovarian cancer; Cell growth; Cancer research; Carcinogenesis; Ovarian tumor; Biology; Cell culture; Apoptosis; Internal medicine; Endocrinology; Medicine; Transcription factor; Cancer; Gene","score_opus":0.036331901931240376,"score_gpt":0.3021647604758049,"score_spread":0.26583285854456457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021449942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027,0.0004289005,0.000020465219,0.008303266,0.00025050945,0.00051188393,0.000056536053,0.000010722433,0.00014770377],"genre_scores_gemma":[0.9965452,0.00010870658,0.001055985,0.00078444264,0.00032239404,0.00011926628,0.000009873193,0.000017617871,0.0010365344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806464,0.00014828925,0.00066722155,0.00029673352,0.000587493,0.00023564497],"domain_scores_gemma":[0.9987487,0.00017158264,0.0004454975,0.00012134366,0.00034691475,0.00016595394],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004535355,0.00019192926,0.00039015483,0.0002706647,0.00012281413,0.00004278715,0.00016191782,0.00010624532,0.0025471444],"category_scores_gemma":[0.00016470904,0.00014573273,0.000103244696,0.00011683244,0.00008649205,0.00018352567,0.000083612904,0.00025737472,0.0000070958436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005561333,0.0010286692,0.8020844,0.000035400597,0.00034904672,0.0035656814,0.0009420558,0.00006277388,0.18331753,0.00040483338,0.0017247942,0.00092349114],"study_design_scores_gemma":[0.006865912,0.0010845576,0.8546228,0.00020608559,0.00005288987,0.00034577496,0.000046871384,0.000033248707,0.1352383,0.00031975485,0.0010468784,0.00013694612],"about_ca_topic_score_codex":0.00010925027,"about_ca_topic_score_gemma":0.000068753856,"teacher_disagreement_score":0.05253839,"about_ca_system_score_codex":0.0013065601,"about_ca_system_score_gemma":0.00029924317,"threshold_uncertainty_score":0.9983647},"labels":[],"label_agreement":null},{"id":"W2021822156","doi":"10.1016/j.ygyno.2014.03.221","title":"The usefulness of ovarian cancer risk scoring in the discrimination of an isolated pelvic mass","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Hamilton Health Sciences; Mount Sinai Hospital; Juravinski Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Body mass index; Cohort; Malignancy; Referral; Prospective cohort study; Oncology; Gynecology; Cancer; Population; Disease; Internal medicine","score_opus":0.03214734786407029,"score_gpt":0.31793091596228823,"score_spread":0.2857835680982179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021822156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105746,0.00024660354,0.00020613572,0.0046414556,0.00043214086,0.0005701524,0.000010538053,0.000012454333,0.0028230746],"genre_scores_gemma":[0.9985525,0.00047096834,0.00033081582,0.00023754034,0.00007928066,0.0002741585,0.000009348145,0.000008646082,0.00003672032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984553,0.0005775559,0.00037578325,0.0002151854,0.00014882616,0.00022733818],"domain_scores_gemma":[0.9977547,0.0014080169,0.0003367977,0.00036293126,0.00009879234,0.00003875891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011896557,0.000114075716,0.00037048088,0.00006945537,0.00010407495,0.0000073894557,0.00019114817,0.00013952258,0.0001064079],"category_scores_gemma":[0.00040149374,0.000058301885,0.00006373472,0.00023460088,0.00015979016,0.000047297443,0.000028509377,0.00019883936,0.0000031309103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005495012,0.0017607245,0.508795,0.00011292968,0.00020784533,0.000046015044,0.0032801514,0.0005392519,0.0007559109,0.010424947,0.0001904262,0.4733373],"study_design_scores_gemma":[0.0026266892,0.0030235061,0.98469335,0.00004456848,0.0002683139,0.000008916414,0.0012907314,0.0019240531,0.00094630907,0.002308987,0.0027958911,0.00006869803],"about_ca_topic_score_codex":0.001117577,"about_ca_topic_score_gemma":0.005525746,"teacher_disagreement_score":0.47589836,"about_ca_system_score_codex":0.00025122808,"about_ca_system_score_gemma":0.00018087367,"threshold_uncertainty_score":0.30834958},"labels":[],"label_agreement":null},{"id":"W2021853462","doi":"10.1016/j.ygyno.2014.03.043","title":"External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Family history; Ovarian cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Disease; Gynecology; Cohort","score_opus":0.04117889233257345,"score_gpt":0.336828700878626,"score_spread":0.29564980854605255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021853462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208934,0.0008988095,0.00051537296,0.0023906443,0.0013182398,0.0008731832,0.00015984569,0.00009324713,0.01166129],"genre_scores_gemma":[0.99008685,0.0005553756,0.0034299304,0.004046608,0.0003063867,0.00041822088,0.00012512246,0.000030972667,0.0010005359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792105,0.00024582277,0.0004641419,0.0005771207,0.00028366304,0.00050819706],"domain_scores_gemma":[0.9983161,0.00028470697,0.0004114911,0.00047334377,0.0002072346,0.00030708683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036531838,0.00026174262,0.00070036435,0.00015027211,0.00005778578,0.000008395145,0.00015524957,0.00033901416,0.0028315885],"category_scores_gemma":[0.00012536296,0.00021663663,0.00014659802,0.00011555643,0.00023160435,0.00012076799,0.00006288986,0.00024070538,0.000031176558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019894538,0.007002879,0.6793507,0.00023676717,0.0014188752,0.00042296376,0.007546414,0.00053476286,0.0083754165,0.0021712305,0.016193137,0.27475742],"study_design_scores_gemma":[0.005156912,0.008771637,0.7558344,0.000040278315,0.0005588724,0.000015706411,0.00035398564,0.00087925734,0.002438228,0.00024759411,0.2255056,0.00019752541],"about_ca_topic_score_codex":0.0023362797,"about_ca_topic_score_gemma":0.00039960872,"teacher_disagreement_score":0.2745599,"about_ca_system_score_codex":0.0026376417,"about_ca_system_score_gemma":0.00083678914,"threshold_uncertainty_score":0.99807996},"labels":[],"label_agreement":null},{"id":"W2022157561","doi":"10.1016/j.ygyno.2012.03.027","title":"Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Ovarian cancer; Gynecologic oncology; Fallopian tube; Cisplatin; Neutropenia; Paclitaxel; Chemotherapy; Surgery; Fallopian tube cancer; Ovarian carcinoma; Internal medicine; Ovary; Gastroenterology; Oncology; Gynecology; Cancer","score_opus":0.02659873446706569,"score_gpt":0.30471148131131137,"score_spread":0.2781127468442457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022157561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623127,0.0064976146,0.000009335621,0.0026271895,0.000434855,0.001398218,0.0000986575,0.00002297756,0.0026798674],"genre_scores_gemma":[0.9898476,0.0035716665,0.00542422,0.00049012614,0.00017324022,0.00037644428,0.000047457223,0.000029742294,0.000039503244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742794,0.00027904424,0.00080795045,0.00054119295,0.00031520752,0.00062864064],"domain_scores_gemma":[0.9981574,0.0006836879,0.00036404075,0.000360499,0.000103499646,0.00033087848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069388153,0.00035411894,0.0014058272,0.0001944481,0.000077935285,0.000012266988,0.00011837961,0.00048529598,0.000087865235],"category_scores_gemma":[0.00016583636,0.0002877644,0.00007018062,0.00016188277,0.00065021584,0.00014898219,0.00030680795,0.0003826364,4.130529e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023724306,0.0039758035,0.8468976,0.0010058304,0.0003606601,0.0001386509,0.004689325,0.000006097302,0.007230513,0.0027526505,0.00020606839,0.13036437],"study_design_scores_gemma":[0.009251432,0.0057813963,0.9817447,0.00019589943,0.00025346037,0.0001288995,0.00040340188,0.000069914204,0.00065655087,0.0002818225,0.0009742982,0.00025820266],"about_ca_topic_score_codex":0.0007270814,"about_ca_topic_score_gemma":0.00046690868,"teacher_disagreement_score":0.13484713,"about_ca_system_score_codex":0.0005613736,"about_ca_system_score_gemma":0.00050639256,"threshold_uncertainty_score":0.99995744},"labels":[],"label_agreement":null},{"id":"W2022449942","doi":"10.1016/s0301-5629(02)00486-6","title":"Ovarian stroma flow intensity decreases by age: a three-dimensional power doppler ultrasonographic study","year":2002,"lang":"en","type":"article","venue":"Ultrasound in Medicine & Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé","keywords":"Stroma; Medicine; Ovary; Polycystic ovary; Blood flow; Ultrasound; Menstrual cycle; Gynecology; Prospective cohort study; Pathology; Internal medicine; Hormone; Radiology","score_opus":0.026440990268410406,"score_gpt":0.2833271495811463,"score_spread":0.2568861593127359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022449942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851794,0.0036120287,0.00007009549,0.004078731,0.00064848625,0.0011795949,0.000059062757,0.00010215758,0.0017318805],"genre_scores_gemma":[0.9947215,0.00040724472,0.00075902947,0.0031077769,0.00030453358,0.00015773153,0.00036627293,0.000040409093,0.00013554606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722654,0.00017592518,0.00069941545,0.00088020775,0.0003514532,0.00066644413],"domain_scores_gemma":[0.99777937,0.0008918954,0.00014947672,0.0006596178,0.00013720061,0.00038243397],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044906372,0.00047468563,0.0011214754,0.00035586394,0.00012590364,0.000015387055,0.0001862629,0.00021951216,0.0062672016],"category_scores_gemma":[0.0007374149,0.00033297416,0.00014780373,0.0006061132,0.00058094144,0.000068975496,0.000043212913,0.0005576467,0.00007323234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033077828,0.003719394,0.93813944,0.0000137688485,0.00046459204,0.0005814747,0.0006895525,0.0000026886305,0.0028071809,0.00011122818,0.04923738,0.0039025296],"study_design_scores_gemma":[0.012933832,0.008748682,0.9597567,0.00024010059,0.00047456374,0.0009121813,0.0005867232,0.0000909096,0.000096484015,0.0005692669,0.015166878,0.00042372732],"about_ca_topic_score_codex":0.0021771088,"about_ca_topic_score_gemma":0.00120975,"teacher_disagreement_score":0.034070503,"about_ca_system_score_codex":0.00016968373,"about_ca_system_score_gemma":0.00005139407,"threshold_uncertainty_score":0.9999122},"labels":[],"label_agreement":null},{"id":"W2023067558","doi":"10.1111/j.1525-1438.2007.00990.x","title":"Decreased dose density of standard chemotherapy does not compromise survival for ovarian cancer patients","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Carboplatin; Chemotherapy; Ovarian cancer; Taxane; Internal medicine; Debulking; Proportional hazards model; Survival analysis; Surgery; Oncology; Paclitaxel; Cancer; Cisplatin; Prospective cohort study; Breast cancer","score_opus":0.02723114690335802,"score_gpt":0.35085182466723447,"score_spread":0.32362067776387643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023067558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899919,0.00017452301,0.0012320671,0.0054916325,0.0022294624,0.0004189996,0.00029929698,0.000008148737,0.00015398563],"genre_scores_gemma":[0.99491405,0.0005699686,0.00219903,0.001498186,0.0006741427,0.000029548122,0.000013223268,0.00001509144,0.00008677854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821365,0.000028517585,0.00065379654,0.0001843594,0.00071164843,0.00020804154],"domain_scores_gemma":[0.99682945,0.00048311465,0.0005975627,0.0000915627,0.0017985577,0.00019973585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005077215,0.0001556053,0.000514623,0.00011267973,0.00003830899,0.000018386118,0.00018835317,0.00010660925,0.0014339708],"category_scores_gemma":[0.00028211495,0.000094529394,0.00029119375,0.00006969094,0.00008675325,0.00007662104,0.000027464219,0.00014959727,7.8318925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01828092,0.0020959522,0.88910145,0.000036607424,0.0013768834,0.000104696184,0.000117846146,0.000047878908,0.0023273327,0.0003201663,0.00093774404,0.08525252],"study_design_scores_gemma":[0.016085098,0.0014222373,0.93468475,0.00014521228,0.00019125488,0.0000070905944,0.000028519311,0.00002416592,0.039879866,0.00032355994,0.007099206,0.00010905666],"about_ca_topic_score_codex":0.00022271478,"about_ca_topic_score_gemma":0.00041999156,"teacher_disagreement_score":0.08514347,"about_ca_system_score_codex":0.00087201793,"about_ca_system_score_gemma":0.0003443095,"threshold_uncertainty_score":0.9994789},"labels":[],"label_agreement":null},{"id":"W2024384404","doi":"10.1210/endo.142.6.8144","title":"Estradiol Up-Regulates Antiapoptotic Bcl-2 Messenger Ribonucleic Acid and Protein in Tumorigenic Ovarian Surface Epithelium Cells*","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre of Excellence for Women's Health; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Biology; Estrogen; Cell culture; Tamoxifen; Epithelium; Apoptosis; Endocrinology; Internal medicine; Neoplastic transformation; Carcinogenesis; Cell growth; Malignant transformation; Thymidine; Cancer research; Cell biology; DNA; Cancer; Medicine; Biochemistry; Gene; Genetics","score_opus":0.013943997279509976,"score_gpt":0.2535360295648992,"score_spread":0.2395920322853892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024384404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985016,0.002834283,0.000009442558,0.005151443,0.00036089742,0.0008514213,0.000009823198,0.000087869244,0.00084465765],"genre_scores_gemma":[0.99562424,0.0013343485,0.0008814828,0.0001478893,0.00012616457,0.00007960154,0.0000148204945,0.000042970503,0.0017484615],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981275,0.00010051964,0.00035796704,0.0005710856,0.00014482244,0.00069811253],"domain_scores_gemma":[0.99922323,0.000056960824,0.000085497035,0.00042834447,0.0000374993,0.00016844507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000092960036,0.0002903681,0.0005581198,0.00016051553,0.00006994066,0.00002123425,0.00010061651,0.00011170696,0.00049994315],"category_scores_gemma":[0.000022688371,0.00025089324,0.00008093886,0.00025172555,0.00015787694,0.000079030586,0.000060195856,0.00028269994,0.00010832899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009968894,0.00200088,0.4225758,0.0003505161,0.00083278614,0.00881408,0.0011432141,0.0000678951,0.533197,0.0072508706,0.0011628672,0.021607226],"study_design_scores_gemma":[0.009958225,0.0011354346,0.55348545,0.00023281875,0.00026579178,0.0024876727,0.00022082351,0.0002202216,0.4152898,0.0006120833,0.015548326,0.00054334407],"about_ca_topic_score_codex":0.00035124057,"about_ca_topic_score_gemma":0.00010960082,"teacher_disagreement_score":0.13090967,"about_ca_system_score_codex":0.00013806627,"about_ca_system_score_gemma":0.00010207221,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W2024583612","doi":"10.1055/s-2001-17859","title":"Ovarian Cyst in a Premature Infant Treated with Spironolactone","year":2001,"lang":"en","type":"article","venue":"American Journal of Perinatology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Spironolactone; hirsutism; Hyperandrogenism; Ovarian cyst; Gynecomastia; Polycystic ovarian disease; Cyst; Internal medicine; Endocrinology; Surgery; Polycystic ovary; Aldosterone","score_opus":0.006847991529450587,"score_gpt":0.2613575048509983,"score_spread":0.2545095133215477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024583612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939634,0.0004604319,0.00002998796,0.004143284,0.000039738414,0.00014081353,0.0000027493704,0.0000085614765,0.0012110072],"genre_scores_gemma":[0.9974284,0.00030547127,0.0016912692,0.00040462296,0.000067195855,0.000008277788,0.000002880727,0.000018863504,0.00007300324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902487,0.00006305426,0.0003459019,0.00016205249,0.00015078227,0.00025333514],"domain_scores_gemma":[0.9991785,0.00004781125,0.00032281142,0.00018284984,0.000105780266,0.00016223364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009813363,0.00015612705,0.0006964382,0.00026196716,0.000018498866,0.000008505394,0.00007863506,0.000051996096,0.00018333983],"category_scores_gemma":[0.000021382697,0.00010139064,0.00008267254,0.0003649059,0.0001977501,0.00006317979,0.000012848556,0.00029449246,0.000007956892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029819554,0.00065406284,0.88965917,0.000016677795,0.00030901987,0.012948495,0.00044394057,0.000014029987,0.00006161726,0.000081671365,0.00008805687,0.09274129],"study_design_scores_gemma":[0.0070857443,0.007981564,0.8629589,0.0002938787,0.00021968897,0.030574407,0.0007361838,0.000019067984,0.000477172,0.000027185499,0.08945329,0.00017293205],"about_ca_topic_score_codex":0.0005938289,"about_ca_topic_score_gemma":0.00016619693,"teacher_disagreement_score":0.09256836,"about_ca_system_score_codex":0.00017238238,"about_ca_system_score_gemma":0.00021315199,"threshold_uncertainty_score":0.413459},"labels":[],"label_agreement":null},{"id":"W2025029496","doi":"10.1038/sj.onc.1209773","title":"Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression","year":2006,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; University Health Network; U.S. Department of Defense","keywords":"Biology; Ovarian cancer; Androgen; Carcinogenesis; Cancer research; Microarray analysis techniques; Cancer; Endocrinology; Internal medicine; Gene; Gene expression; Genetics; Medicine","score_opus":0.008290453073364385,"score_gpt":0.2520700200993058,"score_spread":0.24377956702594142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025029496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336046,0.0027032215,0.00016684148,0.0007167724,0.00041519591,0.0010275239,0.0015312954,0.000030969004,0.00004771375],"genre_scores_gemma":[0.99807715,0.00041119248,0.00022919015,0.000084014,0.00035011454,0.00016600138,0.0006123386,0.000035820285,0.000034151468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848354,0.000097783675,0.00033039256,0.0005060287,0.0003094939,0.00027278526],"domain_scores_gemma":[0.9991995,0.000051259718,0.00012730245,0.00019049503,0.0000809024,0.0003505311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077747674,0.0002491557,0.0003914722,0.00009412471,0.00009217396,0.00004777666,0.00003982658,0.00011327074,0.00008302744],"category_scores_gemma":[0.000018207293,0.00020465584,0.000054971977,0.00011534125,0.00007188739,0.000079961515,0.000029125944,0.00008157125,0.000001733713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015107329,0.000746485,0.9206813,0.000054658954,0.00023357828,0.00021257298,0.00013397679,0.000070432056,0.031121913,0.000024912917,0.000054834214,0.04515463],"study_design_scores_gemma":[0.01975464,0.00028307855,0.9612756,0.00019428249,0.000579934,0.0000018749633,0.000015285797,0.0011663587,0.015939293,0.0002005279,0.00038219595,0.00020696603],"about_ca_topic_score_codex":0.00448557,"about_ca_topic_score_gemma":0.001195573,"teacher_disagreement_score":0.044947665,"about_ca_system_score_codex":0.00016771615,"about_ca_system_score_gemma":0.00020423857,"threshold_uncertainty_score":0.8345623},"labels":[],"label_agreement":null},{"id":"W2025455201","doi":"10.1097/00004347-200301000-00008","title":"Advanced-Stage Serous Borderline Tumors of the Ovary: A Clinicopathological Study of 49 Cases","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria General Hospital; BC Cancer Agency","funders":"","keywords":"Serous fluid; Stage (stratigraphy); Pathological; Medicine; Pathology; Cancer; Clear cell; Disease; Ovary; Surgical pathology; Clinical significance; Ovarian cancer; Internal medicine; Serous cystadenocarcinoma; Oncology; Immunohistochemistry; Biology","score_opus":0.03928780346303631,"score_gpt":0.3557919894087496,"score_spread":0.31650418594571333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025455201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626285,0.0004270013,0.000054321426,0.0011049673,0.0009818542,0.00035921956,0.00002798373,0.000006578406,0.00077521644],"genre_scores_gemma":[0.9978048,0.00017811202,0.0012748028,0.0005578307,0.00008399524,0.000015827653,0.0000020620798,0.000009561639,0.00007300899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758637,0.00042001682,0.0011150786,0.00021868247,0.00048475454,0.00017511251],"domain_scores_gemma":[0.99704057,0.0008953943,0.0010451073,0.00023094869,0.00070086704,0.000087126245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006870835,0.00016131019,0.00071432913,0.00012501929,0.00003423541,0.0000054156476,0.00032426935,0.00012708594,0.0004754435],"category_scores_gemma":[0.0030767408,0.000088249755,0.00029927603,0.00015556402,0.00023042658,0.000051191928,0.00009728556,0.00036049174,0.0000033391007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012525199,0.012174609,0.9623145,0.000016130001,0.00031401246,0.013667039,0.00029683523,0.00048518617,0.001775703,0.001882326,0.00013140854,0.00568976],"study_design_scores_gemma":[0.0071281358,0.015010901,0.96736014,0.000087187924,0.00020619066,0.005198016,0.0009022798,0.0000069801404,0.0018461202,0.0007276418,0.0014325556,0.000093843344],"about_ca_topic_score_codex":0.000010961737,"about_ca_topic_score_gemma":0.000030888063,"teacher_disagreement_score":0.008469023,"about_ca_system_score_codex":0.00011725603,"about_ca_system_score_gemma":0.00020050717,"threshold_uncertainty_score":0.5205773},"labels":[],"label_agreement":null},{"id":"W2026063421","doi":"10.1097/gme.0b013e3181fca1b6","title":"Induction of a menopausal state alters the growth and histology of ovarian tumors in a mouse model of ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Menopause The Journal of The North American Menopause Society","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Ottawa; Ottawa Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canadian Institutes of Health Research","keywords":"Ovarian cancer; Follicle-stimulating hormone; Medicine; Endocrinology; Stromal cell; Internal medicine; Ovary; Luteinizing hormone; Carcinogenesis; Gonadotropin; Cancer; Hormone; Biology","score_opus":0.02262070944614194,"score_gpt":0.2526227511500278,"score_spread":0.23000204170388586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026063421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954987,0.00066891307,0.00016388908,0.0026894954,0.00016271306,0.0006372022,0.00009946465,0.000007206302,0.000072380084],"genre_scores_gemma":[0.99431866,0.0031957899,0.0017119871,0.00057578157,0.00006111669,0.00002809805,0.0000014637496,0.000045382047,0.000061738094],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99705404,0.00044033615,0.0012472942,0.00024053892,0.00062072935,0.0003970848],"domain_scores_gemma":[0.99614084,0.00019404605,0.0024800973,0.0006381567,0.0003930602,0.0001538093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011286691,0.00033000094,0.0010733481,0.00013346452,0.00013421765,0.0000065912614,0.000527482,0.00005881103,0.00002010575],"category_scores_gemma":[0.00008492023,0.0001694174,0.00014592598,0.0007515158,0.0014438621,0.00014340662,0.00016868555,0.0006007888,2.3901964e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009216587,0.003999094,0.35846737,0.0008303752,0.0075954306,0.00004493834,0.1635791,0.0061770803,0.44130856,0.0005902019,0.0013972936,0.006793992],"study_design_scores_gemma":[0.017117718,0.015721017,0.72061455,0.0010493542,0.007141645,0.00054015353,0.014021701,0.0014285443,0.2197868,0.0016155717,0.00010616988,0.00085676083],"about_ca_topic_score_codex":0.007472252,"about_ca_topic_score_gemma":0.0009755048,"teacher_disagreement_score":0.3621472,"about_ca_system_score_codex":0.00030632492,"about_ca_system_score_gemma":0.00063074054,"threshold_uncertainty_score":0.9991371},"labels":[],"label_agreement":null},{"id":"W2026106407","doi":"10.1016/j.ygyno.2011.02.016","title":"Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Internal medicine; Ovarian cancer; Oncology; Proportional hazards model; Serous fluid; Paclitaxel; Surgery; Cancer","score_opus":0.015773558917520792,"score_gpt":0.2746366058048993,"score_spread":0.2588630468873785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026106407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057246,0.00033582738,0.000025065277,0.008231757,0.002178071,0.0014781533,0.00010465792,0.00016334651,0.0069106757],"genre_scores_gemma":[0.97385454,0.0018780316,0.008546265,0.012714256,0.0005513258,0.0014753623,0.00004691653,0.0000729087,0.00086041365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975079,0.000080033366,0.00058286195,0.0007947549,0.00025397306,0.00078042794],"domain_scores_gemma":[0.99857765,0.00014590203,0.0002557984,0.00047314924,0.00022190883,0.00032556432],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019213262,0.00046422635,0.00092942733,0.00013506225,0.00012467717,0.00002081449,0.00022986768,0.00053476036,0.017458899],"category_scores_gemma":[0.000041654173,0.00027595335,0.0002530394,0.0001932337,0.00024478187,0.00010445729,0.000075235395,0.00032058894,0.00014974848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043698964,0.0065840203,0.54587436,0.000053927546,0.0008614989,0.00048505113,0.0024135069,0.0000031227116,0.00048090308,0.0002887479,0.0010315344,0.4375534],"study_design_scores_gemma":[0.012865129,0.0060257954,0.91750425,0.000048694874,0.00028271897,0.000014922422,0.000076547745,0.000026647514,0.0042227786,0.00059305126,0.057958916,0.0003805235],"about_ca_topic_score_codex":0.00058721955,"about_ca_topic_score_gemma":0.0007470699,"teacher_disagreement_score":0.4371729,"about_ca_system_score_codex":0.0009523523,"about_ca_system_score_gemma":0.0004308146,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W2026361533","doi":"10.1016/j.ygyno.2009.04.037","title":"Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; Hôpital Notre-Dame; University of British Columbia; Jewish General Hospital; Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Internal medicine; Neutropenia; Chemotherapy; Taxane; Paclitaxel; Oncology; Phases of clinical research; Gastroenterology; Surgery; Cancer; Cisplatin; Breast cancer","score_opus":0.02413970923359803,"score_gpt":0.3525937397668985,"score_spread":0.32845403053330047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026361533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873741,0.00025853,0.0000028282068,0.0041661886,0.0006402008,0.0047271787,0.0000489041,0.000058169047,0.0027238978],"genre_scores_gemma":[0.99667984,0.000045234076,0.0005715648,0.0017144937,0.00013184949,0.000561255,0.000045477715,0.000027393473,0.00022289588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968002,0.000317855,0.0010784623,0.00082447473,0.00034428973,0.00063475675],"domain_scores_gemma":[0.9980827,0.00044327948,0.0004342796,0.00049752434,0.00022449356,0.0003177405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004470183,0.00040574174,0.001447785,0.000378846,0.000113961796,0.000010608869,0.00021621773,0.00036738455,0.0005155823],"category_scores_gemma":[0.00066235854,0.00032903074,0.0001361973,0.000804332,0.00007129239,0.00006831617,0.000121956306,0.0004116299,0.000021362905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018499035,0.11965813,0.5741322,0.000072522766,0.0012645765,0.0025844304,0.037658654,0.0030549068,0.0022837794,0.00028124577,0.003790636,0.23671988],"study_design_scores_gemma":[0.060075514,0.09784867,0.838048,0.00014324092,0.00049664994,0.000007685272,0.000600357,0.00020735475,0.0011180034,0.000056029505,0.001106308,0.00029219597],"about_ca_topic_score_codex":0.002281464,"about_ca_topic_score_gemma":0.0067234016,"teacher_disagreement_score":0.26391578,"about_ca_system_score_codex":0.0019364958,"about_ca_system_score_gemma":0.00078122655,"threshold_uncertainty_score":0.9999162},"labels":[],"label_agreement":null},{"id":"W2026646322","doi":"10.1111/his.12253","title":"A current perspective on the pathological assessment of <i><scp>FOXL</scp>2</i> in adult‐type granulosa cell tumours of the ovary","year":2013,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pathology; Immunohistochemistry; Biology; Granulosa cell; Ovary; Sanger sequencing; Mutation; Immunostaining; Pathological; Mutation testing; Medicine; Genetics; Gene","score_opus":0.017588977472278073,"score_gpt":0.28678142897244746,"score_spread":0.2691924515001694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026646322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97830826,0.0014578355,0.000010264042,0.0038739,0.0005218849,0.00091581204,0.000020710491,0.000012878781,0.01487848],"genre_scores_gemma":[0.9981553,0.0004057555,0.00022346432,0.0007885176,0.000054611093,0.00020842263,0.0000053870845,0.000015059854,0.00014349174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984478,0.0003226346,0.0003629331,0.00034883272,0.0002606627,0.0002571661],"domain_scores_gemma":[0.99855214,0.00034779822,0.00024219904,0.0005434959,0.00025673903,0.000057605623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025672044,0.00018823025,0.00045341425,0.00009694292,0.00005273932,0.000003667188,0.00018981948,0.00010071871,0.00009961293],"category_scores_gemma":[0.00021093996,0.00009824293,0.00017509972,0.0002796898,0.00035058364,0.000023222961,0.000082380786,0.00040335604,0.000024468402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007322047,0.0049875244,0.9286369,0.00013366752,0.000012732675,0.00020566769,0.003920477,0.00002993881,0.010836109,0.038417976,0.011429716,0.0013160813],"study_design_scores_gemma":[0.0013175718,0.0011057034,0.9917713,0.00012859952,0.00009703978,0.000052246625,0.0008969259,0.000033988134,0.0024893377,0.0010425998,0.0010181831,0.00004650827],"about_ca_topic_score_codex":0.00022242551,"about_ca_topic_score_gemma":0.0000244782,"teacher_disagreement_score":0.06313441,"about_ca_system_score_codex":0.00036348475,"about_ca_system_score_gemma":0.00018491135,"threshold_uncertainty_score":0.40062302},"labels":[],"label_agreement":null},{"id":"W2026697154","doi":"10.1038/bjc.2011.334","title":"Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"Cancer Research UK","keywords":"Medicine; Carboplatin; Internal medicine; Placebo; Chemotherapy; Ovarian cancer; Adverse effect; Oncology; Toxicity; Surgery; Cancer; Gastroenterology; Cisplatin; Pathology","score_opus":0.035242061252903516,"score_gpt":0.3413820964353197,"score_spread":0.30614003518241617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026697154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154073,0.0021916064,0.0001625601,0.00044199373,0.000906475,0.0011219099,0.00013131219,0.0000060957736,0.003497325],"genre_scores_gemma":[0.991957,0.0056171617,0.0013302708,0.00031423222,0.0006062826,0.00008972565,0.000003569003,0.00003174677,0.0000500157],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975546,0.00015120363,0.001256325,0.00021496412,0.0005736513,0.0002492848],"domain_scores_gemma":[0.99791956,0.00014382943,0.0011183935,0.00015512912,0.0005091711,0.00015394432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006507101,0.00019024283,0.0012455021,0.00017810984,0.00002992116,0.000012853824,0.000110525674,0.00014810628,0.001326306],"category_scores_gemma":[0.0000884008,0.00018417489,0.0003682028,0.00023671085,0.00013030396,0.00013705788,0.000017385324,0.00037509316,2.4223883e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64317566,0.0062769107,0.036166932,0.00046971065,0.004852588,0.0036010419,0.0056264265,0.00020898279,0.007819843,0.00026756164,0.0017390405,0.2897953],"study_design_scores_gemma":[0.6650608,0.0025272043,0.28207794,0.0034745825,0.00063823676,0.00028638676,0.00022441712,0.00008842227,0.0449724,0.00011407748,0.00032703643,0.00020848995],"about_ca_topic_score_codex":0.006044148,"about_ca_topic_score_gemma":0.00194544,"teacher_disagreement_score":0.2895868,"about_ca_system_score_codex":0.0005749147,"about_ca_system_score_gemma":0.0016894875,"threshold_uncertainty_score":0.99958664},"labels":[],"label_agreement":null},{"id":"W2027589610","doi":"10.1016/j.ejca.2014.11.017","title":"Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial","year":2014,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Carboplatin; Medicine; Internal medicine; Neutropenia; Paclitaxel; Gastroenterology; Nausea; Ovarian cancer; Clinical endpoint; Progression-free survival; Phases of clinical research; Chemotherapy; Oncology; Urology; Randomized controlled trial; Cisplatin; Cancer","score_opus":0.018460881832693014,"score_gpt":0.28701299381109685,"score_spread":0.26855211197840384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027589610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514115,0.0014569168,0.000010084309,0.00078088,0.0006770493,0.00039694775,0.00071948115,0.000005890653,0.00081161107],"genre_scores_gemma":[0.99878484,0.00036743656,0.000092544615,0.00012038883,0.0005049404,0.0000068040936,0.000049559716,0.00003206299,0.000041395906],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99719167,0.00058939087,0.0011436148,0.00034699676,0.00048703252,0.00024130163],"domain_scores_gemma":[0.9976634,0.0004953894,0.0010748004,0.00028065604,0.00030851155,0.00017724307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068431767,0.0002650393,0.00091408397,0.00030023258,0.00006851995,0.00003357017,0.00009890856,0.00006320126,0.000042861382],"category_scores_gemma":[0.0003274692,0.0001800506,0.00021496708,0.00061264634,0.00014341432,0.00009867216,0.00006184718,0.00035437697,3.8449286e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4515864,0.00256271,0.34490657,0.000081842416,0.015049167,0.0007796627,0.01585293,0.0037973986,0.0057639214,0.00006581074,0.0020704,0.15748319],"study_design_scores_gemma":[0.23197167,0.001940824,0.75756735,0.0005259092,0.0041700834,0.0000033364058,0.00016736158,0.0017087944,0.0012355876,0.0000048438,0.00052862655,0.00017562963],"about_ca_topic_score_codex":0.007225976,"about_ca_topic_score_gemma":0.0037736949,"teacher_disagreement_score":0.41266075,"about_ca_system_score_codex":0.00023777968,"about_ca_system_score_gemma":0.00019200185,"threshold_uncertainty_score":0.999385},"labels":[],"label_agreement":null},{"id":"W2027651351","doi":"10.1016/j.jpag.2008.01.047","title":"Ovarian Epithelial Tumors of Low Malignant Potential: A Case Series of 5 Adolescent Patients","year":2008,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Series (stratigraphy); Epithelial ovarian cancer; Ovary; Oncology; Internal medicine; Pathology; Gynecology; Ovarian cancer; Cancer; Biology","score_opus":0.012086961417608483,"score_gpt":0.2320608538892822,"score_spread":0.2199738924716737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027651351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691427,0.0014583791,0.00008674391,0.00054891314,0.00059409975,0.0003127843,0.000049944407,0.000005007669,0.000029857032],"genre_scores_gemma":[0.9925208,0.0060801134,0.00057838834,0.0001819865,0.0005685379,0.0000028279437,0.0000041581457,0.000019162391,0.000043998683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981369,0.00008957452,0.0010046446,0.0001878531,0.00031722244,0.00026382742],"domain_scores_gemma":[0.99805015,0.0000699328,0.0010095225,0.00016181296,0.00045801897,0.00025055956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019874003,0.00019937614,0.0007938742,0.00029394258,0.00007006747,0.0000038875287,0.00007601299,0.00012465619,0.00008560045],"category_scores_gemma":[0.00013131263,0.00014918865,0.00024473786,0.00018596723,0.00015783843,0.00009122931,0.0000542398,0.00022707014,0.000002045325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011317669,0.00470308,0.9763192,0.0008418877,0.00021088068,0.010190063,0.00027283,0.000025891519,0.00026382442,0.00004688843,0.002975147,0.0030185236],"study_design_scores_gemma":[0.008790382,0.0037348927,0.9720582,0.0002480265,0.0008881187,0.012105395,0.00016786765,0.000011292974,0.001531656,0.0000315023,0.00028361776,0.00014909545],"about_ca_topic_score_codex":0.000017535322,"about_ca_topic_score_gemma":0.0000047403632,"teacher_disagreement_score":0.0076586157,"about_ca_system_score_codex":0.0000957804,"about_ca_system_score_gemma":0.00040350846,"threshold_uncertainty_score":0.6083737},"labels":[],"label_agreement":null},{"id":"W2027720922","doi":"10.1054/ebog.2002.0030","title":"Oral contraceptive use did not protect against ovarian cancer in BRCA1 and BRCA2 mutation carriers","year":2002,"lang":"en","type":"article","venue":"Evidence-based obstetrics and gynecology/Evidence-based obstetrics & gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ovarian cancer; Medicine; BRCA mutation; Mutation; Cancer; Oncology; Gynecology; Genetics; Internal medicine; Biology; Gene","score_opus":0.07783744973049656,"score_gpt":0.2998904364785416,"score_spread":0.22205298674804502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027720922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84680974,0.121125646,0.0005034411,0.020563575,0.0040136594,0.0063698334,0.00024424796,0.00025272372,0.000117139636],"genre_scores_gemma":[0.9491611,0.03844761,0.0021675562,0.007626117,0.00015749937,0.0019648722,0.00004936575,0.00014407763,0.0002817626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99083877,0.0013834274,0.0019709624,0.0026565585,0.0011817213,0.0019685882],"domain_scores_gemma":[0.8921394,0.10347238,0.0010555573,0.0011451446,0.0011348699,0.0010526621],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018875229,0.00128726,0.0023164232,0.0027963019,0.000655075,0.00042185467,0.0005114629,0.0013897729,0.0009284422],"category_scores_gemma":[0.13661647,0.0012169398,0.00043281965,0.004611233,0.0011286456,0.0017332763,0.00021969143,0.0016174617,0.00006297646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092939596,0.0016494378,0.6131955,0.0009151975,0.00056737324,0.0050400784,0.0011049707,0.0034471017,0.00083481864,0.0003548187,0.0010349693,0.37092632],"study_design_scores_gemma":[0.028342962,0.0094222585,0.88963485,0.0057821083,0.0020627105,0.000081590166,0.00094279594,0.0471496,0.0036195007,0.0001532287,0.010310038,0.0024983615],"about_ca_topic_score_codex":0.0012366029,"about_ca_topic_score_gemma":0.00110257,"teacher_disagreement_score":0.36842796,"about_ca_system_score_codex":0.004406487,"about_ca_system_score_gemma":0.0019252084,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W2028366722","doi":"10.1038/oncsis.2012.25","title":"Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity","year":2012,"lang":"en","type":"article","venue":"Oncogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Terry Fox Research Institute; McGill University Health Centre; Cancer Research Society; McGill University","keywords":"CCL2; Immunohistochemistry; Biology; Cancer research; Chemokine; Ovarian cancer; Cell culture; Transcriptome; Cell; Gene; Cancer; Gene expression; Immunology; Immune system","score_opus":0.03226192986578952,"score_gpt":0.3104675533251376,"score_spread":0.2782056234593481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028366722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994173,0.0022896756,0.0000024647347,0.0011399761,0.00016183275,0.0004026353,0.00012847815,0.000009960246,0.0016919822],"genre_scores_gemma":[0.9980904,0.00075306924,0.00037008466,0.00017987374,0.00034137705,0.000095905874,0.000013245875,0.000026277086,0.00012977088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984625,0.00011104632,0.00053467986,0.00028076203,0.00022882444,0.00038218754],"domain_scores_gemma":[0.99919206,0.000096730015,0.00016082369,0.00039428746,0.000044920675,0.00011119128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054746895,0.00018150349,0.00042103438,0.00011427553,0.000027641667,0.00000833172,0.00011567745,0.00011248922,0.00023298267],"category_scores_gemma":[0.00003799464,0.00012816316,0.000074493226,0.00038112482,0.000040290575,0.00015707119,0.00004298811,0.00013458593,0.0000030969234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094521925,0.00276927,0.8953006,0.00008312258,0.000027837077,0.000041779113,0.0026179436,0.00020516955,0.08808779,0.000029730727,0.00009436766,0.009797111],"study_design_scores_gemma":[0.005057742,0.0001342774,0.67839134,0.0002768395,0.00005933386,0.0000026793887,0.00012743169,0.00014102025,0.31513822,0.000014306902,0.00054526073,0.00011155464],"about_ca_topic_score_codex":0.022079129,"about_ca_topic_score_gemma":0.01445067,"teacher_disagreement_score":0.22705044,"about_ca_system_score_codex":0.00045489287,"about_ca_system_score_gemma":0.00018623099,"threshold_uncertainty_score":0.98443294},"labels":[],"label_agreement":null},{"id":"W2029044351","doi":"10.1503/cmaj.070179","title":"Health care use and risk of ovarian cancer: Is there a link?","year":2007,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Cancer Care Ontario","funders":"McMaster University; Cancer Care Ontario","keywords":"CD44; Synovitis; Hyaluronic acid; Cell adhesion molecule; Cancer research; Cell adhesion; Rheumatoid arthritis; Medicine; Synovial membrane; Inflammation; Cell biology; Immunology; Biology; Cell; Anatomy; Biochemistry","score_opus":0.013983414154088984,"score_gpt":0.27890743417596764,"score_spread":0.26492402002187865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029044351","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063353647,0.01576871,0.000008967829,0.9749492,0.0008763422,0.00032984908,0.0013609641,0.000010520561,0.00036011156],"genre_scores_gemma":[0.006354545,0.03574791,0.00026897088,0.94466794,0.012005665,0.000016566264,0.00016029619,0.000062250125,0.0007158655],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963888,0.00024009756,0.0007170208,0.00030530768,0.0016646634,0.00068409066],"domain_scores_gemma":[0.99602836,0.00030568568,0.0009468075,0.0002117614,0.0007188315,0.0017885553],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00091179094,0.00027213508,0.00083909405,0.0003558628,0.00024021712,0.00008828676,0.00012411657,0.0015358061,0.0027883237],"category_scores_gemma":[0.0005540935,0.00022681133,0.00023636728,0.00020836979,0.00006067356,0.00006736212,0.000014255899,0.0038285146,0.00001447599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000007315631,0.000009604702,0.31029198,0.000103787315,0.00081495324,0.0011080166,0.0005585847,9.7999006e-8,1.4244494e-8,0.0000029960372,0.6345085,0.052594133],"study_design_scores_gemma":[0.0016314333,0.00017364015,0.17781997,0.00092212827,0.00041315923,0.00022407273,0.00011784174,0.0000041790236,0.000001693188,0.000009254532,0.81854445,0.00013816361],"about_ca_topic_score_codex":0.14133918,"about_ca_topic_score_gemma":0.1874788,"teacher_disagreement_score":0.18403597,"about_ca_system_score_codex":0.0046695843,"about_ca_system_score_gemma":0.013064424,"threshold_uncertainty_score":0.9997604},"labels":[],"label_agreement":null},{"id":"W2029046676","doi":"10.1016/j.ygyno.2012.05.038","title":"Height, weight, BMI and ovarian cancer survival","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Body mass index; Hazard ratio; Overweight; Obesity; Proportional hazards model; Oncology; Cancer; Internal medicine; Population; Confidence interval; Cancer registry; Gynecology; Environmental health","score_opus":0.05848969438925701,"score_gpt":0.3565522598982975,"score_spread":0.2980625655090405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029046676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8476968,0.008867645,0.000043940727,0.026786188,0.0041546794,0.000896369,0.00003294375,0.00015232948,0.11136915],"genre_scores_gemma":[0.9901518,0.002489703,0.0017283316,0.0028083816,0.0009811519,0.0003502062,0.000018682122,0.000021522157,0.0014501843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855775,0.0001267353,0.00025522776,0.0003302479,0.00013538286,0.00059467327],"domain_scores_gemma":[0.99880356,0.00042291757,0.00010528778,0.00024466027,0.00005746015,0.00036613224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034692598,0.00020980225,0.0005645213,0.00007754923,0.000118836324,0.000010056185,0.000065879496,0.00028468046,0.0044534747],"category_scores_gemma":[0.00008959186,0.00015127088,0.00007930057,0.00013542388,0.0001439234,0.00008955003,0.000084604726,0.0002091987,0.00014950256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014132337,0.0014302232,0.85353,0.00003838556,0.0003289126,0.00015634704,0.0002773519,7.3785344e-7,0.000153784,0.010024292,0.010621124,0.12329752],"study_design_scores_gemma":[0.0026906126,0.0008187635,0.5931282,0.000010357167,0.0002497484,0.000084205945,0.00006146561,0.000007263047,0.00018030856,0.00022762845,0.40242216,0.00011928637],"about_ca_topic_score_codex":0.00018041332,"about_ca_topic_score_gemma":0.0002607541,"teacher_disagreement_score":0.39180103,"about_ca_system_score_codex":0.00055659283,"about_ca_system_score_gemma":0.00026272432,"threshold_uncertainty_score":0.99645656},"labels":[],"label_agreement":null},{"id":"W2029274663","doi":"10.1002/ijc.21521","title":"From gene profiling to diagnostic markers: IL‐18 and FGF‐2 complement CA125 as serum‐based markers in epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Ovarian cancer; Epithelial ovarian cancer; Cancer; Ovarian tumor; Biology; Pathology; Medicine; Cancer research; Internal medicine","score_opus":0.022580890849562267,"score_gpt":0.3507662077645486,"score_spread":0.3281853169149863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029274663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460445,0.0041160127,0.00019733133,0.046828374,0.0013699576,0.00044694118,0.00069448125,0.000008767135,0.00029364406],"genre_scores_gemma":[0.9856884,0.0019337386,0.0052118674,0.004602014,0.0023258824,0.00011646125,0.000021166397,0.000026735885,0.00007373705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981905,0.00005216004,0.00058385654,0.0002600622,0.0006811911,0.00023219878],"domain_scores_gemma":[0.9986972,0.000284909,0.00027257303,0.000121512974,0.00037192347,0.0002518581],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000257216,0.00019261657,0.0003519329,0.00028010612,0.000031316267,0.000058906022,0.00017256342,0.000060864797,0.00338452],"category_scores_gemma":[0.00013159068,0.00016440055,0.000110310575,0.00011412872,0.000034388766,0.0001414265,0.00004896828,0.00021162747,0.000012983579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00480838,0.0006663222,0.64343786,0.000033030257,0.002151636,0.00082419586,0.0006653281,0.00867998,0.0023738984,0.00012309774,0.0056134313,0.33062285],"study_design_scores_gemma":[0.015140681,0.0005631696,0.89962566,0.0021693415,0.00044482204,0.00006811475,0.00021649248,0.0011387705,0.024493841,0.00014511948,0.05570769,0.00028632127],"about_ca_topic_score_codex":0.0046785744,"about_ca_topic_score_gemma":0.002200551,"teacher_disagreement_score":0.33033654,"about_ca_system_score_codex":0.0013355777,"about_ca_system_score_gemma":0.00063908973,"threshold_uncertainty_score":0.9975265},"labels":[],"label_agreement":null},{"id":"W2029358923","doi":"10.3747/co.20.1560","title":"Examining the Use of Salpingectomy with Hysterectomy in Canada","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Toronto; Vancouver General Hospital; University of British Columbia; University of Ottawa; Canadian Partnership Against Cancer","funders":"","keywords":"Medicine; Salpingectomy; Hysterectomy; Ovarian cancer; Gynecology; Cancer; General surgery; Obstetrics; Internal medicine; Surgery; Pregnancy","score_opus":0.21889046740724957,"score_gpt":0.34572558759594363,"score_spread":0.12683512018869406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029358923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962924,0.0006573947,0.000009792816,0.0016604118,0.00030119842,0.0005177704,0.0000035726007,0.0000054011434,0.00055204774],"genre_scores_gemma":[0.99918497,0.00008715964,0.00021792298,0.00021927839,0.000047058915,0.00020242415,0.000006236351,0.000008189831,0.000026733856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993305,0.000056422785,0.00018423887,0.0001442715,0.000113595204,0.00017095776],"domain_scores_gemma":[0.999318,0.00028284325,0.000087144,0.0001912332,0.00006432438,0.000056467376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045271026,0.00008630207,0.00026360166,0.000041289644,0.000015613237,0.0000053787935,0.000048043865,0.000022778504,0.00018196915],"category_scores_gemma":[0.000023410055,0.000047427413,0.000015999552,0.0001298624,0.000044599434,0.00004208106,0.00002211906,0.00012732658,0.0000064179108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031989483,0.00018407337,0.85378927,0.000039759583,0.00004466937,0.00002584495,0.00017895107,0.0000147740875,0.00001801534,0.000030910527,0.0044011725,0.14124055],"study_design_scores_gemma":[0.002010866,0.0004471559,0.87728995,0.00020072507,0.000057171168,0.000023030603,0.00021617855,0.0001333214,0.00013358552,0.000003903362,0.119430654,0.000053473523],"about_ca_topic_score_codex":0.53109485,"about_ca_topic_score_gemma":0.70736736,"teacher_disagreement_score":0.17627248,"about_ca_system_score_codex":0.0007098183,"about_ca_system_score_gemma":0.0012553722,"threshold_uncertainty_score":0.47202763},"labels":[],"label_agreement":null},{"id":"W2029583286","doi":"10.1097/00004347-200304000-00012","title":"Brenner Tumor of the Ovary with Striking Microcystic Change","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Pathology; Atypia; Stroma; Nuclear atypia; Metaplasia; Ovary; Epithelium; Biology; Medicine; Immunohistochemistry","score_opus":0.030064928379863316,"score_gpt":0.2825278782423138,"score_spread":0.2524629498624505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029583286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936225,0.00047944562,0.00013942934,0.003456252,0.0007965569,0.00014549194,0.00000854907,0.0000035477515,0.0013482589],"genre_scores_gemma":[0.9963137,0.00006123701,0.0016572635,0.0017627942,0.00015913545,0.000009711165,0.0000010579589,0.000006179056,0.000028951887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991021,0.00009733346,0.00032399094,0.000103555765,0.00025605707,0.00011693132],"domain_scores_gemma":[0.9989484,0.0002298637,0.0003738188,0.000095223186,0.00029883083,0.000053840886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021419031,0.00008715494,0.00026407084,0.00007676223,0.00002230511,0.0000059154045,0.00015932861,0.00005424681,0.00048659477],"category_scores_gemma":[0.00026848403,0.00004235018,0.00013043723,0.0000585611,0.00011965585,0.00004042915,0.00003099234,0.0001935254,0.0000038097612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096272223,0.002153945,0.9598763,0.000022754983,0.0007716925,0.009385509,0.0002745787,0.000048622827,0.0076880082,0.0071771904,0.00071533216,0.0109233335],"study_design_scores_gemma":[0.0034712255,0.0019465839,0.9702598,0.00013194606,0.00018424616,0.010318746,0.00006799637,0.000004321153,0.005745011,0.001055465,0.006744684,0.00006997815],"about_ca_topic_score_codex":0.000003975303,"about_ca_topic_score_gemma":0.000007021941,"teacher_disagreement_score":0.010853355,"about_ca_system_score_codex":0.0001229505,"about_ca_system_score_gemma":0.00011488084,"threshold_uncertainty_score":0.53278714},"labels":[],"label_agreement":null},{"id":"W2029882269","doi":"10.1210/jc.2011-2751","title":"Epidermal Growth Factor Induces Human Oviductal Epithelial Cell Invasion by Down-Regulating E-Cadherin Expression","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; University of Hong Kong","keywords":"Epidermal growth factor; Biology; Cell biology; Protein kinase B; Cadherin; Small interfering RNA; Slug; Cell culture; Cancer research; Cell; Signal transduction; Transfection","score_opus":0.07475730342925178,"score_gpt":0.3756306017829594,"score_spread":0.3008732983537076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029882269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825621,0.008687178,0.0000403662,0.0062214173,0.0017956296,0.0002502567,0.000017170785,0.000022819308,0.00040304408],"genre_scores_gemma":[0.99013215,0.0032693176,0.0008886545,0.0011179175,0.004379555,0.000007648305,0.0000062245863,0.000036070192,0.00016246729],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959149,0.0009423617,0.0017616644,0.00022651031,0.0004961464,0.00065842364],"domain_scores_gemma":[0.9965329,0.0011389415,0.0012989885,0.00037820006,0.00019410277,0.0004568475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013157717,0.00030360816,0.0012106118,0.00011388283,0.00021657263,0.000016897782,0.00033122752,0.00022718679,0.00048382737],"category_scores_gemma":[0.00052668777,0.00016747392,0.00050652324,0.000116105555,0.00030661887,0.0003243793,0.00016456649,0.0012044705,0.000047128793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022485119,0.0051620873,0.23393854,0.00009389758,0.0010784655,0.00014599178,0.001835604,0.000007304414,0.69164526,0.000998006,0.018435435,0.04441086],"study_design_scores_gemma":[0.00909245,0.00084869907,0.5845471,0.00012817413,0.0010311024,0.00061805773,0.00021909949,0.0000018738442,0.37425905,0.00034567824,0.028684853,0.00022386436],"about_ca_topic_score_codex":0.000096330405,"about_ca_topic_score_gemma":0.0000022583138,"teacher_disagreement_score":0.35060853,"about_ca_system_score_codex":0.000040098595,"about_ca_system_score_gemma":0.00012337306,"threshold_uncertainty_score":0.6829388},"labels":[],"label_agreement":null},{"id":"W2029924265","doi":"10.1097/gco.0b013e3280115f40","title":"Cytoreductive surgery for recurrent ovarian cancer","year":2007,"lang":"en","type":"review","venue":"Current Opinion in Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; Confounding; Disease; Randomized controlled trial; Intensive care medicine; Prospective cohort study; Surgery; Cancer; Oncology; General surgery; Internal medicine","score_opus":0.24271717105689902,"score_gpt":0.4671505245170314,"score_spread":0.22443335346013235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029924265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000042356082,0.90916514,0.00010064806,0.00022379278,0.08561409,0.004189848,0.0005436254,0.000054455057,0.00010412889],"genre_scores_gemma":[0.000015359341,0.9900078,0.0002478913,0.000036506553,0.0023969074,0.0051294863,0.001967379,0.00012904659,0.0000696068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539745,0.00021930377,0.0017285341,0.0012718206,0.00038155253,0.001001359],"domain_scores_gemma":[0.98292994,0.0148201715,0.0009056896,0.0006580431,0.0003420091,0.00034413912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071898254,0.0007850222,0.0037386536,0.002133177,0.00009810862,0.00003278753,0.0002454277,0.0008410021,0.00024400145],"category_scores_gemma":[0.0041070497,0.00070295687,0.0012469741,0.0019959866,0.00012294142,0.00007003114,0.00011729587,0.00093875563,0.0000640064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053245483,0.0012809992,0.0008680971,0.028917655,0.0003716692,0.00001584027,0.000052454485,6.3866537e-7,4.0777497e-9,0.0008118917,0.019965414,0.9476621],"study_design_scores_gemma":[0.0016841374,0.00039659967,0.0009053661,0.020519461,0.0010123391,0.00003121489,0.00001577796,0.000006086363,3.0583965e-7,0.000084629624,0.9747959,0.000548207],"about_ca_topic_score_codex":0.000026239348,"about_ca_topic_score_gemma":0.000015162816,"teacher_disagreement_score":0.95483047,"about_ca_system_score_codex":0.0041744076,"about_ca_system_score_gemma":0.0028730494,"threshold_uncertainty_score":0.9996484},"labels":[],"label_agreement":null},{"id":"W2030454750","doi":"10.1016/s0242-6498(05)86202-9","title":"Identification de facteurs de chimiorésistance du cancer de l’ovaire","year":2005,"lang":"fr","type":"article","venue":"Annales de Pathologie","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Gynecology","score_opus":0.03863884056285647,"score_gpt":0.3335347927256592,"score_spread":0.29489595216280273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030454750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7909992,0.12755623,0.0036675793,0.07488266,0.0008364571,0.00038162686,0.00016980125,0.00013633788,0.0013701499],"genre_scores_gemma":[0.8962868,0.08948778,0.0032371166,0.0045573865,0.0019095921,0.00034522085,0.000032405762,0.000050805284,0.004092928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974346,0.00025539714,0.00041493063,0.0005299005,0.00020875323,0.0011563904],"domain_scores_gemma":[0.9986057,0.00017398207,0.00021093225,0.0005050306,0.00012943892,0.00037491054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081721874,0.00032383457,0.00037837753,0.00008839999,0.0001900334,0.000081244514,0.00024231419,0.00032313957,0.00065085327],"category_scores_gemma":[0.00034454055,0.00032721905,0.00021856099,0.0002147191,0.00023709788,0.00018360493,0.00005110776,0.0003475606,0.00044766968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105460815,0.00089522754,0.6072632,0.00024813533,0.00019996513,0.0012768762,0.002644505,0.0012019237,0.0059423465,0.0013500543,0.023570059,0.35530227],"study_design_scores_gemma":[0.0012360123,0.0001849115,0.88132805,0.00076322193,0.00060826354,0.0003839901,0.0004289525,0.0014956509,0.026135646,0.0008741698,0.08623144,0.00032967507],"about_ca_topic_score_codex":0.00051223487,"about_ca_topic_score_gemma":0.0008163229,"teacher_disagreement_score":0.3549726,"about_ca_system_score_codex":0.0030124802,"about_ca_system_score_gemma":0.0011505923,"threshold_uncertainty_score":0.999918},"labels":[],"label_agreement":null},{"id":"W2030464267","doi":"10.1016/j.jpag.2011.01.034","title":"Pediatric Synchronous Bilateral Ovarian Torsion: A Case Report and Review of the Literature","year":2011,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ovarian torsion; Medicine; Torsion (gastropod); Gynecology; Surgery; General surgery","score_opus":0.015374698743535186,"score_gpt":0.25573581643141763,"score_spread":0.24036111768788243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030464267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8364681,0.16003199,0.000017687284,0.0020199148,0.0008532853,0.00041749605,0.000008858998,0.0000048119336,0.00017784875],"genre_scores_gemma":[0.85454744,0.1429037,0.0006578334,0.0009636181,0.000859768,0.0000036105978,0.0000012620657,0.000009950877,0.00005284385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872094,0.00008750584,0.0006740222,0.00017177852,0.00016407571,0.00018167486],"domain_scores_gemma":[0.99855065,0.00007235882,0.00074092986,0.00020018627,0.00025284017,0.00018300205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041682116,0.0001496041,0.00050394546,0.00013540628,0.00007541545,0.000007828572,0.000060439583,0.000116650626,0.00012752465],"category_scores_gemma":[0.00022064819,0.000083872445,0.00016455355,0.00026473514,0.00004760798,0.000066926645,0.00006879009,0.00029557178,7.926408e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012057335,0.00085902045,0.9062697,0.005864768,0.00012423175,0.0705047,0.00047659737,9.595506e-8,0.0000038196627,0.00007500656,0.01275718,0.0029442452],"study_design_scores_gemma":[0.0022235871,0.0011375507,0.787837,0.0012559367,0.0025463104,0.20359722,0.000056155586,0.0000012487345,0.000021112928,0.000084225074,0.0011240885,0.00011555574],"about_ca_topic_score_codex":0.000010425984,"about_ca_topic_score_gemma":0.0000032819773,"teacher_disagreement_score":0.13309252,"about_ca_system_score_codex":0.00006820599,"about_ca_system_score_gemma":0.0002950331,"threshold_uncertainty_score":0.3420219},"labels":[],"label_agreement":null},{"id":"W2030586486","doi":"10.1371/journal.pone.0028250","title":"Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Ovarian Cancer Canada; McGill University Health Centre; McGill University","keywords":"Serous fluid; KRAS; Biology; Ovarian cancer; Cancer research; Pathology; Mutation; Cancer; Genetics; Gene; Medicine","score_opus":0.03820721047225995,"score_gpt":0.21939482163462265,"score_spread":0.1811876111623627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030586486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967236,0.0013380772,0.00002713345,0.00092389464,0.000028013568,0.0004558301,0.00027554808,0.00005441025,0.0001734861],"genre_scores_gemma":[0.99676806,0.0005526339,0.0016482209,0.00033162846,0.000056910947,0.00006251764,0.00033957406,0.00003784052,0.00020259319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831164,0.000056839483,0.00043032152,0.0004678615,0.00039481666,0.00033855165],"domain_scores_gemma":[0.9988575,0.00003369307,0.00020547443,0.00043818154,0.00014117808,0.0003239716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011381574,0.00026190697,0.00088256836,0.00030101716,0.000070118265,0.000021484282,0.0001042568,0.00011174398,0.00043209427],"category_scores_gemma":[0.00003710786,0.00022603983,0.00013611051,0.0006606374,0.00019894236,0.000095588795,0.000055497116,0.00011582179,0.000012631814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027032336,0.00882265,0.6829403,0.0005198691,0.017578159,0.00053065206,0.0017112376,0.000013722226,0.28714654,0.00015074415,0.00018683128,0.000128935],"study_design_scores_gemma":[0.0023712048,0.0008866833,0.7670019,0.00036365452,0.013545785,0.000014348007,0.00010056323,0.0005920407,0.21472335,0.00010869142,0.000011853846,0.0002798956],"about_ca_topic_score_codex":0.00085011206,"about_ca_topic_score_gemma":0.00007884259,"teacher_disagreement_score":0.0840616,"about_ca_system_score_codex":0.0000896381,"about_ca_system_score_gemma":0.0000953885,"threshold_uncertainty_score":0.92176366},"labels":[],"label_agreement":null},{"id":"W2031409388","doi":"10.1097/ruq.0b013e31819032f","title":"Adnexal Masses in the Pregnant Patient","year":2008,"lang":"en","type":"review","venue":"Ultrasound Quarterly","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Natural history; Adnexal mass; Pregnancy; Adnexal Diseases; Conservative management; Psychological intervention; Risk stratification; Radiology; Obstetrics; Surgery; Laparoscopy","score_opus":0.036645990217056224,"score_gpt":0.31739268498942197,"score_spread":0.28074669477236575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031409388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012111199,0.99388844,0.0000028734883,0.000113549955,0.00029443429,0.0018517768,0.000076805474,0.000031767748,0.0036192234],"genre_scores_gemma":[0.00074567535,0.99735296,0.00012553325,0.00021483304,0.0002713384,0.00087399204,0.00024678776,0.000049801412,0.00011908148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786407,0.00020540967,0.000645265,0.00048795188,0.0004161209,0.00038118009],"domain_scores_gemma":[0.9981688,0.0007449453,0.00022395725,0.0007289078,0.000032089454,0.00010127924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000089108,0.00046697925,0.0013451548,0.00015398746,0.000077277924,0.00005658359,0.0001928485,0.00021884507,0.00020225573],"category_scores_gemma":[0.00002951644,0.00024605266,0.00057589967,0.0003247262,0.00007129139,0.000052136813,0.0000058122287,0.00042820434,0.0002454574],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070152832,0.0007294784,0.00012012068,0.0021249028,0.00020478212,0.00057247555,0.0019465847,3.725558e-8,5.0264887e-8,0.000101553385,0.0047941743,0.98939884],"study_design_scores_gemma":[0.00051787525,0.0018029748,0.00037805433,0.013570364,0.00069301104,0.0021073113,0.00032297024,8.7070454e-8,2.2529234e-7,0.000025832454,0.9803432,0.00023804582],"about_ca_topic_score_codex":0.00011046676,"about_ca_topic_score_gemma":0.000051667612,"teacher_disagreement_score":0.9891608,"about_ca_system_score_codex":0.00027135355,"about_ca_system_score_gemma":0.00041364794,"threshold_uncertainty_score":0.99999917},"labels":[],"label_agreement":null},{"id":"W2031666275","doi":"10.1158/1538-7445.am2013-810","title":"Abstract 810: Integrative genomic and transcriptomic analysis in idenfitication of biomarkers of chemoresistance in serous epithelial ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; Queen's University","funders":"","keywords":"Ovarian cancer; Serous fluid; Gene expression profiling; Chemotherapy; Microarray; Oncology; Microarray analysis techniques; Cancer research; Biology; Copy-number variation; Transcriptome; Internal medicine; Medicine; Cancer; Gene; Gene expression; Genetics; Genome","score_opus":0.04237829536080324,"score_gpt":0.37955481067024355,"score_spread":0.3371765153094403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031666275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923656,0.004164952,0.000010522838,0.002036099,0.000032092572,0.00083536416,0.00009827624,0.000004325537,0.0004527819],"genre_scores_gemma":[0.9950959,0.003971678,0.00014445501,0.000025502017,0.000030340963,0.00064761145,0.000013668832,0.000015598329,0.000055208046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984363,0.00009080642,0.0004631502,0.00036437166,0.00033128657,0.00031409736],"domain_scores_gemma":[0.99907684,0.00015844077,0.00010116429,0.00027489083,0.00028188457,0.00010678444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050334854,0.00013346616,0.0005351207,0.00076253235,0.000024359133,0.000013638996,0.0001160245,0.000085962536,0.0006849418],"category_scores_gemma":[0.000049977945,0.00011107307,0.00008605886,0.0013728675,0.00028059207,0.00010006379,0.000021277028,0.00023924447,0.0000031798718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007996568,0.00035630655,0.6101457,0.00044796328,0.00091163313,0.000017809749,0.0025302481,0.000075096985,0.36287332,0.00024764924,0.00014632284,0.021448288],"study_design_scores_gemma":[0.0021272895,0.000093861934,0.9209544,0.0004357067,0.00013328748,5.7849275e-7,0.0006685588,0.00019872024,0.07505826,0.00023329853,0.000019575686,0.00007648543],"about_ca_topic_score_codex":0.08114511,"about_ca_topic_score_gemma":0.03470712,"teacher_disagreement_score":0.3108087,"about_ca_system_score_codex":0.0008089306,"about_ca_system_score_gemma":0.0004975724,"threshold_uncertainty_score":0.98290694},"labels":[],"label_agreement":null},{"id":"W2031674672","doi":"10.1172/jci65833","title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":591,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"National Human Genome Research Institute; National Institute of General Medical Sciences; Duke-NUS Medical School; Medical Research Council; National Health and Medical Research Council; National Cancer Institute; Foundation Medicine; National Institutes of Health","keywords":"Oncology; Ovarian cancer; Internal medicine; Medicine; Serous carcinoma; Serous fluid; Context (archaeology); Ovarian carcinoma; Disease; Prognostic variable; Cancer; Bioinformatics; Biology","score_opus":0.0778061322023824,"score_gpt":0.36296631908472043,"score_spread":0.285160186882338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031674672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851484,0.0012929348,0.00026896704,0.00862043,0.0009238082,0.0002442313,0.0000068306517,0.000009091241,0.000118848795],"genre_scores_gemma":[0.9672782,0.00021210393,0.029646099,0.0009717908,0.0018252442,0.0000048659444,0.000011725577,0.000017921453,0.00003207094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974035,0.0001937342,0.001569121,0.00013312302,0.00049386994,0.00020662342],"domain_scores_gemma":[0.9970459,0.00073833944,0.0010572039,0.00020341504,0.0004054565,0.0005497021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013920343,0.00013358184,0.0006703021,0.00009724341,0.000029476461,0.000011304111,0.000085177206,0.00021095196,0.00005904299],"category_scores_gemma":[0.0020365377,0.00009225575,0.00027371492,0.00016088822,0.00017502416,0.00018059129,0.000021710317,0.0004460083,0.000008636217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042942754,0.0014518346,0.97726846,0.00009481628,0.0003858607,0.000087380766,0.00019681307,0.000030544474,0.0034834463,0.0041765156,0.0026211326,0.009773767],"study_design_scores_gemma":[0.0032148447,0.0018657591,0.9678418,0.00026285974,0.0007039351,0.00013175132,0.00001929626,0.000057252015,0.022622833,0.002336429,0.00086034794,0.00008287684],"about_ca_topic_score_codex":0.00003766349,"about_ca_topic_score_gemma":0.0000025125005,"teacher_disagreement_score":0.02937713,"about_ca_system_score_codex":0.00006341952,"about_ca_system_score_gemma":0.00040153597,"threshold_uncertainty_score":0.37620804},"labels":[],"label_agreement":null},{"id":"W2032519623","doi":"10.1002/1096-9098(200011)75:3<186::aid-jso6>3.0.co;2-s","title":"Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma","year":2000,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Nova Scotia Community College","funders":"","keywords":"Medicine; Debulking; Colorectal cancer; Ovarian cancer; Stage (stratigraphy); Malignancy; Surgery; Adenocarcinoma; Cancer; Oncology; Internal medicine","score_opus":0.02980121826554796,"score_gpt":0.3322303988000133,"score_spread":0.3024291805344654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032519623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97957563,0.0014251418,0.0000049285377,0.007451195,0.00030832898,0.0002381148,0.000007695269,0.000007003649,0.010981972],"genre_scores_gemma":[0.99649185,0.00036817705,0.0018168961,0.0005315677,0.0002925713,0.000032903914,0.0000021895294,0.00001773516,0.00044613314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979214,0.00023144572,0.0009985542,0.00019301461,0.00032579177,0.00032977472],"domain_scores_gemma":[0.9988919,0.0003683785,0.00020967759,0.00013177874,0.00010115185,0.000297151],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063213514,0.00018527365,0.0011056863,0.0002409221,0.00002156156,0.000013300773,0.000090744696,0.00012386292,0.008954195],"category_scores_gemma":[0.000025780188,0.00012487816,0.00036538302,0.00027883,0.000091289825,0.00010880271,0.000019520281,0.00048905076,0.00010382181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013549637,0.0043747467,0.69961643,0.00007237727,0.00070928544,0.12752084,0.0004142817,0.000062763655,0.00006816683,0.0002796269,0.00074523396,0.15258662],"study_design_scores_gemma":[0.021908283,0.005570619,0.60100895,0.00006229556,0.0007833983,0.013864435,0.00006790577,0.00004506305,0.00019022587,0.00015037582,0.35618237,0.00016609847],"about_ca_topic_score_codex":0.000055700326,"about_ca_topic_score_gemma":0.000041364732,"teacher_disagreement_score":0.35543713,"about_ca_system_score_codex":0.00057238847,"about_ca_system_score_gemma":0.00040267062,"threshold_uncertainty_score":0.99195176},"labels":[],"label_agreement":null},{"id":"W2033703555","doi":"10.1111/igc.0b013e3181990127","title":"Ovarian Epithelial Dysplasia and Prophylactic Oophorectomy for Genetic Risk","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Dysplasia; Ovarian cancer; Gynecology; Oophorectomy; Retrospective cohort study; Ovary; Cohort; Internal medicine; Oncology; Gastroenterology; Cancer; Pathology; Hysterectomy","score_opus":0.016156019650142347,"score_gpt":0.3183983369512164,"score_spread":0.30224231730107404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033703555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833623,0.0016462471,0.0007355676,0.012501614,0.0010143452,0.00034552606,0.000050519055,0.000009074504,0.00033480028],"genre_scores_gemma":[0.98765045,0.001679174,0.008261298,0.0012857239,0.0009978788,0.000032202206,0.0000020341315,0.000007360221,0.00008387167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99902785,0.000028888691,0.00034891663,0.00015775155,0.00029344676,0.0001431539],"domain_scores_gemma":[0.9988337,0.00021115695,0.00031021473,0.000061877516,0.00044073188,0.00014227838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155133,0.000114914175,0.0002705244,0.00009133267,0.000042813255,0.000038758142,0.0001069967,0.00007623286,0.00044995133],"category_scores_gemma":[0.00031250992,0.00007478306,0.00014070417,0.000049621325,0.000043588407,0.00006319502,0.00001333802,0.00016930138,0.0000031653042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004214018,0.0012222738,0.23514913,0.00002409496,0.0009811338,0.00078028796,0.00015397795,0.00014757183,0.0020476698,0.0009501838,0.0016976998,0.75263196],"study_design_scores_gemma":[0.0053401543,0.003481048,0.971654,0.00005772061,0.00031924303,0.00035046975,0.000012843656,0.0001355882,0.0011880317,0.0034788337,0.013891993,0.00009005956],"about_ca_topic_score_codex":0.000020039854,"about_ca_topic_score_gemma":0.000011016229,"teacher_disagreement_score":0.7525419,"about_ca_system_score_codex":0.00028770036,"about_ca_system_score_gemma":0.00018441636,"threshold_uncertainty_score":0.49266517},"labels":[],"label_agreement":null},{"id":"W2034119142","doi":"10.1007/s10585-011-9446-0","title":"The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma","year":2012,"lang":"en","type":"article","venue":"Clinical & Experimental Metastasis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Calgary; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Podocalyxin; Serous fluid; Pathology; Clear cell carcinoma; Cancer research; Basement membrane; Ovarian cancer; Cell adhesion; Integrin; Metastasis; Cell; Biology; Chemistry; Medicine; Carcinoma; Internal medicine; Cancer; Biochemistry; Kidney","score_opus":0.09207766250969145,"score_gpt":0.3899417853601498,"score_spread":0.2978641228504583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034119142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738451,0.015334277,0.000052217427,0.007148337,0.0015077612,0.0012907772,0.0002954973,0.000057976336,0.0004680426],"genre_scores_gemma":[0.9944217,0.000990535,0.0018551307,0.0013807379,0.00077540695,0.00033044087,0.000064671105,0.000083999,0.000097336255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99520856,0.00095233467,0.001548682,0.000645746,0.0007481455,0.00089656],"domain_scores_gemma":[0.99622434,0.0014261979,0.00045218386,0.0011978524,0.00012245117,0.0005769512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016242238,0.0005349077,0.0013269057,0.00008528066,0.00044010679,0.00006495554,0.0004449181,0.00019221212,0.0005285253],"category_scores_gemma":[0.0001708439,0.00029619163,0.0010633403,0.00044471642,0.0009245353,0.00021590639,0.00016348691,0.00051833515,0.00010085449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063732783,0.041608203,0.6143561,0.0004106221,0.020900693,0.00089512113,0.010969057,0.000020545598,0.028968465,0.04816622,0.014006282,0.21332544],"study_design_scores_gemma":[0.0079277465,0.002351928,0.49827933,0.00010941377,0.0031715487,0.00019083724,0.0046455865,0.000013905136,0.46886986,0.00018181013,0.013764391,0.00049364567],"about_ca_topic_score_codex":0.0010906688,"about_ca_topic_score_gemma":0.00002709423,"teacher_disagreement_score":0.4399014,"about_ca_system_score_codex":0.00017757913,"about_ca_system_score_gemma":0.00015872522,"threshold_uncertainty_score":0.99994904},"labels":[],"label_agreement":null},{"id":"W2034572897","doi":"10.1111/j.1525-1438.2007.01041.x","title":"Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Topotecan; Medicine; Regimen; Internal medicine; Gastroenterology; Chemotherapy; Ovarian cancer; Prospective cohort study; Surgery; Progressive disease; Cancer","score_opus":0.04654194982179452,"score_gpt":0.3886737131277309,"score_spread":0.3421317633059364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034572897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824114,0.0018977133,0.00009675984,0.00514048,0.0018826067,0.00045143435,0.00006665278,0.0000054717266,0.0022177263],"genre_scores_gemma":[0.99779403,0.0005941928,0.0005374177,0.00024913173,0.0006970255,0.000060616432,0.000004115202,0.00000982007,0.00005364341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974776,0.000075094016,0.000809359,0.00019650198,0.0012440985,0.00019734321],"domain_scores_gemma":[0.99725026,0.00024197667,0.0006061632,0.00008909662,0.0016962686,0.00011621343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014799604,0.00013696,0.00039605697,0.0002525841,0.00002141399,0.0000141237415,0.00016742997,0.00010656745,0.002713402],"category_scores_gemma":[0.0004944024,0.00009925083,0.00014759725,0.00018852412,0.00007059246,0.000097870994,0.000033948214,0.0002847342,0.0000023508323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067712143,0.0021112391,0.5772219,0.000027288708,0.0009968816,0.00044927065,0.00064576336,0.001061576,0.0065089418,0.0017053843,0.0005325769,0.40196797],"study_design_scores_gemma":[0.007284467,0.001304582,0.9797282,0.00039398368,0.00023975574,0.000029325814,0.00012418508,0.00016272678,0.007533367,0.0015677328,0.0015344061,0.00009723145],"about_ca_topic_score_codex":0.00047312584,"about_ca_topic_score_gemma":0.00219182,"teacher_disagreement_score":0.40250635,"about_ca_system_score_codex":0.0027775704,"about_ca_system_score_gemma":0.00079093105,"threshold_uncertainty_score":0.9981983},"labels":[],"label_agreement":null},{"id":"W2034874445","doi":"10.1002/pbc.21877","title":"3q27 aberrations in a childhood ovary teratoma with associated malignant germ cell component","year":2008,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Loss of heterozygosity; Ovary; Teratoma; Germ cell; Karyotype; Biology; Ovarian Teratoma; Pathology; Immature teratoma; Ovarian cancer; Cytogenetics; Dysgerminoma; Medicine; Germ cell tumors; Cancer research; Cancer; Genetics; Gene; Chromosome; Allele; Chemotherapy","score_opus":0.011947613922786015,"score_gpt":0.23020599709150238,"score_spread":0.21825838316871637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034874445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749804,0.008056216,0.000005603259,0.0012864254,0.00018265624,0.0007605854,0.0000997544,0.00008494452,0.0020257607],"genre_scores_gemma":[0.99134004,0.0059704017,0.0003416895,0.00062965864,0.00058641384,0.0005718181,0.000070981056,0.000047600686,0.0004413933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982343,0.00004914445,0.00039411138,0.00046806375,0.00041470246,0.00043971004],"domain_scores_gemma":[0.9991215,0.00006618285,0.00019250937,0.00030932954,0.00010359742,0.00020687009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089360765,0.00028020257,0.00047722613,0.00021876655,0.00013935509,0.0000184852,0.000082489874,0.0001102727,0.0003263717],"category_scores_gemma":[0.000012431192,0.00021649765,0.00010899081,0.0007211185,0.000038059745,0.000086472035,0.000029241686,0.00025753633,0.000031522875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074287105,0.004623744,0.98799515,0.0000660084,0.00024144426,0.0008984919,0.0009973384,0.000064789805,0.000047478483,0.000014184335,0.004718251,0.000258854],"study_design_scores_gemma":[0.009142839,0.0005483561,0.9872552,0.00011276011,0.0010949755,0.0001218419,0.000028895683,0.000031633605,0.0007343241,0.000008459914,0.0006503655,0.00027031766],"about_ca_topic_score_codex":0.0013518975,"about_ca_topic_score_gemma":0.00059533713,"teacher_disagreement_score":0.009068552,"about_ca_system_score_codex":0.00024123986,"about_ca_system_score_gemma":0.0008197615,"threshold_uncertainty_score":0.8828518},"labels":[],"label_agreement":null},{"id":"W2034930875","doi":"10.1111/j.1525-1438.2007.01030.x","title":"Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series","year":2007,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Lynch syndrome; Internal medicine; Cancer; Radiation therapy; Population; Disease; Germline mutation; Serous fluid; Germline; Serous carcinoma; Stage (stratigraphy); Gynecology; BRCA mutation; Carcinoma; Mutation; Ovarian cancer; DNA mismatch repair; Colorectal cancer; Gene; Genetics","score_opus":0.019066215872749804,"score_gpt":0.3309937737192156,"score_spread":0.3119275578464658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034930875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931518,0.0010661366,0.0001458393,0.00394908,0.0010323051,0.00029647193,0.000058731657,0.000015205878,0.00028443965],"genre_scores_gemma":[0.9960976,0.0011386172,0.0012933525,0.0003396247,0.0008203332,0.00011038137,0.0000044492126,0.000014567195,0.00018107993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851334,0.000036998514,0.00048172497,0.0002005689,0.0005091886,0.00025815656],"domain_scores_gemma":[0.9980299,0.0004559961,0.00039838668,0.00007307653,0.00077355275,0.00026911925],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044730736,0.0001621231,0.00041196018,0.00022012621,0.000071768685,0.000043273372,0.00009602694,0.00008088989,0.0010574035],"category_scores_gemma":[0.0003137933,0.00010410569,0.00007449283,0.00020235988,0.00018497252,0.00023503185,0.000035359877,0.00025772414,9.889868e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014444317,0.0008276509,0.7623561,0.0000289905,0.0020591996,0.032010134,0.0008168974,0.0003815234,0.00051686825,0.00025639214,0.00013094195,0.18617097],"study_design_scores_gemma":[0.01449057,0.003988646,0.96590763,0.00017179594,0.00027526394,0.0073132617,0.00070934417,0.000017159915,0.0010810016,0.00017055465,0.0056868894,0.00018790059],"about_ca_topic_score_codex":0.0001328158,"about_ca_topic_score_gemma":0.001637007,"teacher_disagreement_score":0.20355149,"about_ca_system_score_codex":0.0008516384,"about_ca_system_score_gemma":0.00029899078,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W2035458641","doi":"10.1111/igc.0b013e3181bf7fb8","title":"Symptom Control in Patients With Recurrent Ovarian Cancer","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Quality of life (healthcare); Refractory (planetary science); Chemotherapy; Cancer; Oncology; Intensive care medicine; Clinical trial; Gynecologic cancer; Internal medicine","score_opus":0.0300218634020791,"score_gpt":0.3639423750675774,"score_spread":0.3339205116654983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035458641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010158406,0.99364406,0.000014496357,0.0020625475,0.0018521098,0.00085021293,0.00020802181,0.000009154563,0.00034356068],"genre_scores_gemma":[0.010330614,0.9872129,0.000133887,0.0010799018,0.00090931763,0.00019184941,0.000039214352,0.000028363855,0.00007397076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729484,0.00011611196,0.0010793019,0.00033027917,0.00089782994,0.0002816071],"domain_scores_gemma":[0.9973883,0.0002864749,0.0011608765,0.00014627152,0.0008090819,0.00020901208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021073753,0.00039086692,0.0019159126,0.0003653811,0.000022187181,0.000046791785,0.00035671575,0.0002685917,0.001981215],"category_scores_gemma":[0.000111524365,0.00021783379,0.0005180749,0.00020745167,0.000053894677,0.000101271864,0.00003160121,0.0007219258,0.000010698312],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007372593,0.0013826578,0.044439074,0.00026866316,0.0017038053,0.00049785257,0.000012480177,0.000018505107,1.735862e-8,0.000060803326,0.0012488315,0.94963],"study_design_scores_gemma":[0.008620221,0.0018528261,0.21114156,0.016418656,0.0016391233,0.00004528034,0.0000018031631,0.0000025879076,1.3917551e-7,0.00003128619,0.7600236,0.00022290924],"about_ca_topic_score_codex":0.000051590938,"about_ca_topic_score_gemma":0.00009579725,"teacher_disagreement_score":0.94940716,"about_ca_system_score_codex":0.0030431782,"about_ca_system_score_gemma":0.001271618,"threshold_uncertainty_score":0.9989311},"labels":[],"label_agreement":null},{"id":"W2035973935","doi":"10.1097/igc.0b013e31821bb717","title":"Survivorship as an Element of Clinical Trials in Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Survivorship curve; Ovarian cancer; Oncology; Clinical trial; Cancer survivorship; Cancer; Internal medicine","score_opus":0.5089301195320578,"score_gpt":0.5964039336662992,"score_spread":0.08747381413424138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035973935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022853673,0.98908013,0.000018022418,0.0009916048,0.0053903335,0.00089376327,0.00021050186,0.0000064342257,0.0011238119],"genre_scores_gemma":[0.008812807,0.98746026,0.00036982173,0.0004938999,0.0023808484,0.00023967454,0.000032002208,0.000035444,0.00017524298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909175,0.0019360175,0.0056182817,0.0004318743,0.0008142003,0.00028210727],"domain_scores_gemma":[0.9903891,0.0030573634,0.0050259945,0.00025921484,0.000908363,0.0003599373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008496972,0.0004119981,0.0056313663,0.0004664063,0.000016509772,0.00002840674,0.00064773735,0.0005813936,0.013637803],"category_scores_gemma":[0.003935828,0.0002397005,0.0020463434,0.0002134019,0.00011843284,0.00012512502,0.00009825078,0.00097205455,0.000016677925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008818337,0.002257914,0.02521927,0.00068257464,0.0028474266,0.00069270603,0.00005191079,0.0000041630065,4.13854e-7,0.0011917681,0.0006760207,0.965494],"study_design_scores_gemma":[0.004815971,0.0023635714,0.031795803,0.012830617,0.003031131,0.00013502922,0.000023497889,0.000002387668,0.000011634194,0.0005973812,0.9441294,0.00026357893],"about_ca_topic_score_codex":0.001614506,"about_ca_topic_score_gemma":0.0012385695,"teacher_disagreement_score":0.9652304,"about_ca_system_score_codex":0.0010576635,"about_ca_system_score_gemma":0.0030752183,"threshold_uncertainty_score":0.98726386},"labels":[],"label_agreement":null},{"id":"W2036319230","doi":"10.1038/sj.bjc.6603020","title":"Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Ovarian cancer; Relative risk; Cohort study; Prospective cohort study; Body mass index; Cohort; Internal medicine; Proportional hazards model; Oncology; Cancer; Physiology; Confidence interval","score_opus":0.01753804341093503,"score_gpt":0.3200312903753389,"score_spread":0.3024932469644039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036319230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8318597,0.16616619,0.00001838276,0.0009606119,0.00019432373,0.00017766,0.00018757927,0.0000059979975,0.00042952885],"genre_scores_gemma":[0.91434795,0.08412221,0.00034128787,0.00016524168,0.00040677018,0.000043310556,0.0000062809627,0.000016940143,0.0005500214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984772,0.000053691405,0.0006654023,0.00020356946,0.00040708054,0.0001930326],"domain_scores_gemma":[0.99834394,0.000076853095,0.0006714587,0.00012708233,0.00066131016,0.000119370074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032547227,0.0001458048,0.0009810479,0.00025984485,0.00007100224,0.000033356322,0.000062918356,0.00006335409,0.0009292446],"category_scores_gemma":[0.00006463671,0.00013278428,0.00030202864,0.0005266734,0.00012318903,0.00009648099,0.000024463397,0.00018023237,6.43679e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023162618,0.00024472934,0.85707766,0.00006126301,0.025696423,0.00041850095,0.00010377732,0.00040117957,0.00012608044,0.000021625734,0.0074920035,0.10812515],"study_design_scores_gemma":[0.0034821827,0.00019093086,0.9578837,0.0007943806,0.029328285,0.0001906199,0.00009409204,0.000054380303,0.0007347137,0.0000746609,0.007057188,0.00011486981],"about_ca_topic_score_codex":0.016477138,"about_ca_topic_score_gemma":0.015684672,"teacher_disagreement_score":0.10801028,"about_ca_system_score_codex":0.0002815798,"about_ca_system_score_gemma":0.00023774442,"threshold_uncertainty_score":0.999984},"labels":[],"label_agreement":null},{"id":"W2036395582","doi":"10.1016/j.mce.2005.03.019","title":"Models of ovarian cancer—Are we there yet?","year":2005,"lang":"en","type":"review","venue":"Molecular and Cellular Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Ovarian cancer; Disease; Cancer; Biology; Cancer research; Bioinformatics; Medicine; Immunology; Oncology; Internal medicine; Genetics","score_opus":0.054799140219957965,"score_gpt":0.32709763803197806,"score_spread":0.2722984978120201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036395582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006928171,0.9951011,0.00029300802,0.00087524654,0.00019247535,0.00083915005,0.00010394261,0.000035711044,0.00249007],"genre_scores_gemma":[0.0037736876,0.9946833,0.00027620725,0.00013142267,0.00012727085,0.00032406204,0.00009965098,0.00008905787,0.0004952962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802095,0.0001309657,0.000550969,0.00063429185,0.00019466966,0.0004681733],"domain_scores_gemma":[0.99876237,0.000042884356,0.00033829207,0.0006314635,0.000063340085,0.00016166398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000043992655,0.00050258,0.0022127705,0.00020657144,0.00004283097,0.000011888262,0.00015312467,0.00033054434,0.0002855006],"category_scores_gemma":[0.0000061803985,0.00039214673,0.00056692614,0.00017184114,0.00012829743,0.000026925005,0.00011748047,0.00035952992,0.00001544957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017135122,0.00024011191,0.000027677275,0.00706162,0.0013689812,0.0017637474,0.000034774373,0.000008643734,0.000018253611,0.007193105,0.00026975464,0.9819962],"study_design_scores_gemma":[0.0011917027,0.00020027599,0.0000061193937,0.0065336335,0.004237064,0.00039008018,0.000020966976,0.000016902964,0.00052067597,0.00031825528,0.9862561,0.00030821082],"about_ca_topic_score_codex":0.00016620124,"about_ca_topic_score_gemma":0.000019688274,"teacher_disagreement_score":0.98598635,"about_ca_system_score_codex":0.00012982568,"about_ca_system_score_gemma":0.00029286073,"threshold_uncertainty_score":0.999853},"labels":[],"label_agreement":null},{"id":"W2036927649","doi":"10.1006/gyno.2001.6552","title":"Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer","year":2002,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University; Cancer Care Ontario; Western University; University of Toronto","funders":"National Cancer Institute; Cancer Care Ontario","keywords":"Carboplatin; Medicine; Paclitaxel; Regimen; Cisplatin; Oncology; Chemotherapy; Internal medicine; Adverse effect; Randomized controlled trial; Ovarian cancer; Surgery; Cancer","score_opus":0.043612416413509325,"score_gpt":0.3548521566997152,"score_spread":0.3112397402862059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036927649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006324307,0.96887606,0.000034884742,0.0021165125,0.00060001336,0.02625754,0.001497051,0.000058324236,0.00049636356],"genre_scores_gemma":[0.000030878633,0.97190785,0.0012466549,0.003676719,0.00021501492,0.018353742,0.00062001107,0.00011413317,0.0038349624],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954574,0.00038836626,0.0021316002,0.00097577926,0.0003898143,0.0006570212],"domain_scores_gemma":[0.99299973,0.0028020141,0.0023835746,0.0008798967,0.0006868058,0.0002479564],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005609981,0.00096637994,0.009170757,0.00021333044,0.00020929307,0.000013669547,0.00036744808,0.00076605525,0.0057752444],"category_scores_gemma":[0.0009918694,0.0005039924,0.00085923076,0.00051706325,0.00018709146,0.000064014144,0.00009330367,0.0004077631,0.00002327495],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044773126,0.0038997175,0.00012891673,0.746469,0.003639201,0.00019797558,0.0001881098,0.0000013855556,2.7941084e-8,0.000038776365,0.005523592,0.23946552],"study_design_scores_gemma":[0.012401639,0.01471052,0.00006713849,0.34604117,0.010659298,0.00002281478,0.0000168535,0.000004613739,8.384478e-7,0.000002868802,0.615673,0.00039923575],"about_ca_topic_score_codex":0.000110542416,"about_ca_topic_score_gemma":0.0005857379,"teacher_disagreement_score":0.61014944,"about_ca_system_score_codex":0.0021572255,"about_ca_system_score_gemma":0.0017444103,"threshold_uncertainty_score":0.9997412},"labels":[],"label_agreement":null},{"id":"W2036952999","doi":"10.1186/1755-8794-1-34","title":"Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines","year":2008,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Canadian Institutes of Health Research; McGill University Health Centre; McGill University","keywords":"Biology; Ovarian cancer; Spheroid; Cancer research; Gene expression; Gene; Human genetics; Chromosome; Cell; Cell growth; DNA microarray; Cancer; Cell biology; Cell culture; Genetics","score_opus":0.018163512320369977,"score_gpt":0.26666167107944433,"score_spread":0.24849815875907436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036952999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969861,0.0018539224,0.00004255922,0.00029575522,0.00013067601,0.00042225936,0.00009082888,0.000019628178,0.00015829141],"genre_scores_gemma":[0.9900116,0.007046291,0.0018435846,0.000530288,0.0003350592,0.00013708226,0.000022232061,0.000027367301,0.000046496727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984871,0.00005436445,0.00045641686,0.00037470114,0.00036983076,0.00025754637],"domain_scores_gemma":[0.99897736,0.00019802363,0.00013790217,0.0002679925,0.00006859272,0.00035009862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013882437,0.00019514555,0.00043866312,0.00006801621,0.00006952471,0.0000047113667,0.00011088761,0.00011956702,0.00032335875],"category_scores_gemma":[0.00014321477,0.0001582395,0.0000721602,0.00013347686,0.00014161335,0.000056097895,0.00005742298,0.0001892439,0.00001539962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00099049,0.0036175123,0.5609946,0.0008523323,0.0001466826,0.0015057421,0.0017651165,0.0031400034,0.42453974,0.00031758426,0.0010178379,0.0011123022],"study_design_scores_gemma":[0.0073974077,0.00056259596,0.6188979,0.0006361921,0.000089290814,0.00017026727,0.00006109553,0.00047308046,0.3710223,0.000104233404,0.00035143484,0.00023417607],"about_ca_topic_score_codex":0.00091927935,"about_ca_topic_score_gemma":0.00036984836,"teacher_disagreement_score":0.057903275,"about_ca_system_score_codex":0.00023951007,"about_ca_system_score_gemma":0.0010254818,"threshold_uncertainty_score":0.645282},"labels":[],"label_agreement":null},{"id":"W2038083644","doi":"10.1097/pgp.0b013e3181c042b6","title":"Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Calgary; BC Cancer Agency; Foothills Medical Centre","funders":"","keywords":"Stage (stratigraphy); Ovarian carcinomas; Pathology; Biology; Ovary; Ovarian cancer; Medicine; Oncology; Cancer research; Ovarian carcinoma; Cancer; Internal medicine; Endocrinology","score_opus":0.0330537442337692,"score_gpt":0.3126107838281396,"score_spread":0.2795570395943704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038083644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904608,0.000075627584,0.000012963434,0.004046295,0.0039993557,0.00012878598,0.000015393107,0.000006828576,0.0012539515],"genre_scores_gemma":[0.9979378,0.00007449414,0.0010064327,0.00053811644,0.00030100823,0.000010237667,0.000007869908,0.000008087669,0.00011596429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986694,0.00009094508,0.00054116204,0.00020704008,0.00027615318,0.00021528981],"domain_scores_gemma":[0.9987899,0.0005044932,0.00025664558,0.00011845342,0.0002203158,0.00011018202],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036196355,0.00013501712,0.00043191845,0.00031069096,0.000015236644,0.000018838477,0.00025120107,0.00015196206,0.0021381134],"category_scores_gemma":[0.00093023764,0.0000954165,0.00009377261,0.00013046143,0.00011354379,0.00007708303,0.00006610149,0.0006575873,0.000027531152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019110107,0.0013118694,0.9570526,0.000007446803,0.00008414192,0.028400399,0.000116935626,0.000023656468,0.0026511073,0.0066836136,0.000052548385,0.0017046751],"study_design_scores_gemma":[0.0069984375,0.0016263,0.9891517,0.000039075632,0.000021276586,0.00031882734,0.00007810365,0.000041947344,0.00040031664,0.0004536845,0.00078619714,0.00008410361],"about_ca_topic_score_codex":0.000115017916,"about_ca_topic_score_gemma":0.0010189441,"teacher_disagreement_score":0.03209913,"about_ca_system_score_codex":0.00022804634,"about_ca_system_score_gemma":0.00019893475,"threshold_uncertainty_score":0.99877405},"labels":[],"label_agreement":null},{"id":"W2038535093","doi":"10.1097/igc.0000000000000066","title":"Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Epithelial ovarian cancer; Adjuvant; Oncology; Chemotherapy; Interval (graph theory); Ovarian cancer; Cancer; Modality (human–computer interaction); Internal medicine","score_opus":0.012538050743310937,"score_gpt":0.3185599847289857,"score_spread":0.3060219339856748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038535093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96887416,0.0004764302,0.00014261196,0.028046047,0.0017365452,0.00015597229,0.000052940595,0.0000061425385,0.0005091819],"genre_scores_gemma":[0.99506617,0.00089778786,0.00050096377,0.0022892337,0.0010378882,0.000064005464,0.0000027399599,0.000015304831,0.0001259027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981173,0.000103945145,0.00078539725,0.00022831715,0.0005479577,0.00021708467],"domain_scores_gemma":[0.99865276,0.0002568738,0.00042599053,0.00012360037,0.00041045455,0.00013032883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043829324,0.00017647185,0.00061579316,0.00015720069,0.000014460844,0.000023808925,0.00023780209,0.00012802678,0.008329847],"category_scores_gemma":[0.00008331461,0.00009434198,0.0002927745,0.00009123864,0.00010460199,0.00011171011,0.000058087415,0.00029700136,0.000007516753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029699684,0.00078375114,0.91698885,0.000030571635,0.00042865385,0.00043716704,0.0001894765,0.00013682625,0.00034921835,0.00018353084,0.00021037624,0.077291586],"study_design_scores_gemma":[0.0063835448,0.0004561626,0.97715884,0.00047664143,0.00008399296,0.000072540985,0.000021688636,0.00018694632,0.0029335734,0.0010540768,0.011050023,0.000121992096],"about_ca_topic_score_codex":0.00048327225,"about_ca_topic_score_gemma":0.0003447882,"teacher_disagreement_score":0.0771696,"about_ca_system_score_codex":0.0006283018,"about_ca_system_score_gemma":0.00017712374,"threshold_uncertainty_score":0.99257666},"labels":[],"label_agreement":null},{"id":"W2039198739","doi":"10.1210/jcem.86.10.8100","title":"Expression and Antiproliferative Effect of a Second Form of Gonadotropin-Releasing Hormone in Normal and Neoplastic Ovarian Surface Epithelial Cells","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovary; Biology; Ovarian cancer; Epithelium; Endocrinology; Carcinogenesis; Internal medicine; Ovarian carcinomas; Gonadotropin-releasing hormone; Hormone; Cell growth; Cell culture; Gonadotropin; Cancer research; Ovarian carcinoma; Cancer; Luteinizing hormone; Medicine","score_opus":0.019825747143384496,"score_gpt":0.32508139333346653,"score_spread":0.30525564619008205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039198739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039894,0.008087023,0.00007352654,0.0007933345,0.00027031256,0.00028616117,0.000011760332,0.0000028625025,0.00007608595],"genre_scores_gemma":[0.981105,0.017867984,0.0006380342,0.00010839555,0.00024411427,0.0000019016423,6.1982803e-7,0.000012346842,0.000021569529],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99758774,0.0005671252,0.0012271745,0.00015589714,0.00020103964,0.00026103665],"domain_scores_gemma":[0.9966999,0.0020859535,0.0007782296,0.0001771642,0.000120486,0.00013822896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077994034,0.00017983769,0.0013545884,0.000113225215,0.000041172767,0.0000052745604,0.00009677188,0.00011149085,0.000039695504],"category_scores_gemma":[0.0003317992,0.00010018149,0.00015731915,0.000113762486,0.0003785838,0.00010800284,0.00007295979,0.00053552515,8.577362e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049112324,0.0019523668,0.41488266,0.00034910132,0.0017508009,0.0009303642,0.002797086,0.00015692918,0.4551461,0.00082158425,0.0002349636,0.0718657],"study_design_scores_gemma":[0.01765274,0.0034067016,0.9035673,0.00020266607,0.00074574066,0.000948084,0.00007483655,0.00007018125,0.07229165,0.00022982687,0.00072909327,0.00008114729],"about_ca_topic_score_codex":0.00006273564,"about_ca_topic_score_gemma":0.000015579573,"teacher_disagreement_score":0.48868465,"about_ca_system_score_codex":0.000012970961,"about_ca_system_score_gemma":0.00011072272,"threshold_uncertainty_score":0.40852824},"labels":[],"label_agreement":null},{"id":"W2039612621","doi":"10.1097/pgp.0b013e31815c24fe","title":"A Practical Approach to Intraoperative Consultation in Gynecological Pathology","year":2008,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Frozen section procedure; Malignancy; Cervix; Biopsy; Germ cell tumors; Pathology; Radiology; Carcinoma; Gynecology; Surgery; Cancer; Internal medicine","score_opus":0.1140524491445354,"score_gpt":0.43234282939047897,"score_spread":0.3182903802459436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039612621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064172954,0.96818876,0.0023399538,0.007939204,0.0037704613,0.0031847185,0.00014120761,0.000053452604,0.007964939],"genre_scores_gemma":[0.007920689,0.96912694,0.019978058,0.0018440458,0.0006068934,0.00031955325,0.00011167578,0.00003514231,0.000056984118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952634,0.0010245377,0.0019871267,0.0006846129,0.00058159255,0.0004587237],"domain_scores_gemma":[0.994358,0.003160636,0.0010569326,0.0002261254,0.00085483707,0.00034345128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070501975,0.0005181635,0.003012632,0.00084829354,0.00004892431,0.00003542771,0.00043313054,0.0010415268,0.00042512643],"category_scores_gemma":[0.0074513745,0.00033481946,0.0007177904,0.00038613187,0.00031753894,0.00011638006,0.00020595253,0.0016213589,0.00016047289],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008941426,0.011630268,0.0017850779,0.00039407334,0.0015301615,0.12079728,0.000681016,0.0000491096,0.000007975781,0.0064083515,0.008283529,0.847539],"study_design_scores_gemma":[0.0057377317,0.006611082,0.013325757,0.0016703095,0.0008563241,0.12699187,0.000157611,0.000018276298,0.000004670703,0.0004969874,0.8435792,0.000550193],"about_ca_topic_score_codex":0.000006025683,"about_ca_topic_score_gemma":0.000011067798,"teacher_disagreement_score":0.8469888,"about_ca_system_score_codex":0.0013730024,"about_ca_system_score_gemma":0.0012377427,"threshold_uncertainty_score":0.99991035},"labels":[],"label_agreement":null},{"id":"W2039704180","doi":"10.1016/j.ejca.2013.01.035","title":"Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group","year":2013,"lang":"de","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Retrospective cohort study; Stage (stratigraphy); Prospective cohort study; Ovarian cancer; Cohort; Internal medicine; Oncology; Cancer; Multivariate analysis; Cohort study; Gynecology","score_opus":0.024531381608693975,"score_gpt":0.2950203833766818,"score_spread":0.27048900176798785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039704180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512736,0.03338687,0.000009233805,0.0062671513,0.004319838,0.0033693262,0.000029057039,0.000009982558,0.0013349184],"genre_scores_gemma":[0.99412376,0.0032865833,0.000062716346,0.0005018284,0.0013770696,0.00005728474,9.5275766e-7,0.00008584664,0.00050398643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99317527,0.0024587621,0.001993768,0.00043682416,0.0014600724,0.00047529835],"domain_scores_gemma":[0.99420536,0.00025448963,0.002998658,0.0013088473,0.0010231821,0.00020948322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026601013,0.0004879223,0.0012964505,0.00015237587,0.00018764821,0.000045140914,0.0012600303,0.00005795477,0.000905608],"category_scores_gemma":[0.00044827882,0.00023771591,0.00055451674,0.00067246624,0.0003828508,0.00014442741,0.0004974189,0.0010034648,0.00003594186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003734796,0.008710083,0.96086377,0.000063100146,0.0046101273,0.00023709494,0.0031222834,0.0003558099,0.00014948145,0.000017852579,0.009539196,0.011957731],"study_design_scores_gemma":[0.00928001,0.008697624,0.9635856,0.0007685225,0.0063047367,0.000016053198,0.004586127,0.000016278307,0.00033883934,0.000013092326,0.006194017,0.00019906674],"about_ca_topic_score_codex":0.001227247,"about_ca_topic_score_gemma":0.0002910013,"teacher_disagreement_score":0.042850107,"about_ca_system_score_codex":0.00025330193,"about_ca_system_score_gemma":0.0005218071,"threshold_uncertainty_score":0.9915772},"labels":[],"label_agreement":null},{"id":"W2040434769","doi":"10.3747/co.v18i6.998","title":"Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective","year":2011,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Université Laval; Ottawa Hospital; Princess Margaret Cancer Centre; London Health Sciences Centre; Dalhousie University; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Colorectal cancer; Clinical endpoint; Progression-free survival; Randomized controlled trial; Oncology; Overall survival; Confounding; Ovarian cancer; Clinical trial; Internal medicine; Intensive care medicine; Cancer","score_opus":0.27519082017665064,"score_gpt":0.4811720943517004,"score_spread":0.20598127417504974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040434769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015107785,0.98508894,7.0565017e-7,0.0024893202,0.0034052022,0.004149501,0.00030667995,0.000032884847,0.004525266],"genre_scores_gemma":[0.000007898225,0.99395347,0.00017201644,0.00037542588,0.00040074374,0.0046680938,0.00017664461,0.00007460644,0.00017108936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997032,0.00033851218,0.0007518893,0.0009997407,0.0001906604,0.00068718987],"domain_scores_gemma":[0.9978099,0.000109122455,0.00041520808,0.0007522828,0.00020513886,0.0007083578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032192923,0.0006404366,0.0035869202,0.00038608842,0.00008389932,0.000012160184,0.00029158493,0.00041888334,0.000849604],"category_scores_gemma":[0.00020628021,0.00047547274,0.0003172388,0.00045228587,0.00015067616,0.00005529876,0.00014300575,0.0008106816,0.000036108388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000023399813,0.0005058607,0.0007136556,0.016492257,0.00026436054,0.00026361342,0.00035835322,3.4194858e-9,6.8660073e-9,0.0008870657,0.010510733,0.9699807],"study_design_scores_gemma":[0.0018877368,0.00047008527,0.00066866697,0.07952608,0.0022777147,0.00015153729,0.00009089941,3.1802045e-7,5.4874686e-8,0.00006010775,0.91449755,0.00036925648],"about_ca_topic_score_codex":0.034559224,"about_ca_topic_score_gemma":0.12222317,"teacher_disagreement_score":0.9696114,"about_ca_system_score_codex":0.0050700335,"about_ca_system_score_gemma":0.006195114,"threshold_uncertainty_score":0.9997697},"labels":[],"label_agreement":null},{"id":"W2041065068","doi":"10.1016/j.ygyno.2012.04.018","title":"Surgical management of a suspicious adnexal mass: A systematic review","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Context (archaeology); Laparotomy; Systematic review; Adnexal mass; Laparoscopy; MEDLINE; Malignancy; Stage (stratigraphy); Lymphadenectomy; Meta-analysis; Surgery; General surgery; Cancer; Pathology; Internal medicine","score_opus":0.08333958322107564,"score_gpt":0.408514775181626,"score_spread":0.32517519196055034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041065068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010415579,0.9681077,0.0000032026978,0.00033423965,0.0006367023,0.009080489,0.00003872265,0.00006547886,0.021732394],"genre_scores_gemma":[0.000046613124,0.9914888,0.00091560587,0.00034531776,0.00015868085,0.0052568135,0.00016072024,0.000054856366,0.001572573],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955536,0.0008139804,0.0020042183,0.000616537,0.00036114725,0.0006505106],"domain_scores_gemma":[0.9960304,0.0011640865,0.0014357519,0.000979655,0.00010794981,0.00028219324],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012044131,0.0006426136,0.009129649,0.00019274512,0.00004506726,0.0000059948507,0.0003246763,0.0007451989,0.0018989058],"category_scores_gemma":[0.00010643713,0.0003934154,0.0013434482,0.00044031718,0.00013357121,0.000027885128,0.00017475495,0.00045074653,0.00067849737],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009616139,0.0009804318,0.000013364712,0.76669794,0.0019978883,0.002664357,0.000006885122,1.816475e-8,2.8697442e-9,0.0010204667,0.0008672676,0.22574176],"study_design_scores_gemma":[0.00085059326,0.0011531231,0.000010294205,0.3441618,0.047523014,0.000928406,0.00001398611,1.1391924e-7,4.605577e-8,0.000016396407,0.6051467,0.00019551578],"about_ca_topic_score_codex":0.000005928709,"about_ca_topic_score_gemma":0.0000037048408,"teacher_disagreement_score":0.60427946,"about_ca_system_score_codex":0.0016327881,"about_ca_system_score_gemma":0.0005626443,"threshold_uncertainty_score":0.99985176},"labels":[],"label_agreement":null},{"id":"W2041376332","doi":"10.1016/j.path.2010.12.004","title":"High-Grade Serous Carcinoma Involving Fallopian Tube, Ovary and Peritoneum","year":2011,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Fallopian tube; Serous carcinoma; Peritoneum; Ovary; Serous fluid; Differential diagnosis; Ovarian carcinoma; Pathology; Gynecology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.08189870940757119,"score_gpt":0.3562924533321634,"score_spread":0.27439374392459226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041376332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053759185,0.9908298,0.0000011179203,0.00023265042,0.001366511,0.0009733419,0.000121629986,0.00010003385,0.0009989846],"genre_scores_gemma":[0.0015863369,0.9951645,0.00079141284,0.00032438964,0.0008167649,0.00023427361,0.00035045142,0.000120512515,0.0006113334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963672,0.00045495018,0.0012286147,0.0011610903,0.00019121642,0.00059690414],"domain_scores_gemma":[0.99750525,0.00072676124,0.00039228122,0.0008529296,0.00007644241,0.00044631274],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005138835,0.0007130742,0.003705442,0.00020382118,0.0001239909,0.000024849125,0.00019201942,0.0013462603,0.00023263512],"category_scores_gemma":[0.000103590435,0.00052744756,0.000777349,0.00022546427,0.00038131463,0.000047337777,0.00025699515,0.0012142939,0.00012582888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086303655,0.0009985454,0.012081825,0.008773428,0.0006035499,0.027649919,0.0001400775,6.1770656e-8,6.721908e-8,0.0038794049,0.00059524016,0.94519156],"study_design_scores_gemma":[0.001981189,0.00089107006,0.003611554,0.0033189338,0.002912016,0.0053518936,0.000012603525,0.0000015693367,3.408153e-7,0.00023089003,0.98122996,0.00045799802],"about_ca_topic_score_codex":0.000067997455,"about_ca_topic_score_gemma":0.000022956903,"teacher_disagreement_score":0.9806347,"about_ca_system_score_codex":0.00015420541,"about_ca_system_score_gemma":0.0004505237,"threshold_uncertainty_score":0.99995023},"labels":[],"label_agreement":null},{"id":"W2042093910","doi":"10.1016/j.ygyno.2005.09.032","title":"A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Regimen; Tirapazamine; Ovarian cancer; Cisplatin; Gynecologic oncology; Internal medicine; Chemotherapy; Oncology; Progressive disease; Chemotherapy regimen; Surgery; Adverse effect; Phases of clinical research; Ovarian carcinoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cancer","score_opus":0.09526104529368758,"score_gpt":0.4222465381856592,"score_spread":0.32698549289197165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042093910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98096937,0.0013268107,0.000008601806,0.004706752,0.0006037942,0.007165845,0.000117951495,0.00003435918,0.0050665424],"genre_scores_gemma":[0.99167365,0.0013241788,0.0015464389,0.0006894227,0.00032171913,0.0041579017,0.00015834412,0.00002460925,0.00010373757],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99480563,0.00176733,0.0013866306,0.00078131165,0.00066495675,0.0005941388],"domain_scores_gemma":[0.99519163,0.0027748605,0.00092453405,0.0005769736,0.00040115774,0.00013086108],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002260264,0.00046578672,0.001893609,0.0003451976,0.00017376563,0.0000075274183,0.00022377109,0.00044230075,0.0014886984],"category_scores_gemma":[0.00045002397,0.00027974957,0.0002408871,0.00063802116,0.0003337129,0.00008263558,0.00009107762,0.00032004408,0.0000109491075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006877163,0.11036751,0.011970546,0.000055257042,0.0007460172,0.00062667456,0.02182391,0.00042781286,0.00052506244,0.00012249398,0.0004220777,0.8460355],"study_design_scores_gemma":[0.11923405,0.43978584,0.39609808,0.00009163832,0.003677349,0.00021115351,0.009933181,0.004651232,0.0005412772,0.00009489368,0.025283579,0.0003977547],"about_ca_topic_score_codex":0.000654157,"about_ca_topic_score_gemma":0.017434372,"teacher_disagreement_score":0.84563774,"about_ca_system_score_codex":0.00846713,"about_ca_system_score_gemma":0.0025257028,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W2042177108","doi":"10.1016/j.ygyno.2005.06.065","title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Occult; Prophylactic Surgery; Oophorectomy; Ovarian cancer; Fallopian tube; Malignancy; Histopathology; Gynecology; Cancer; Carcinoma; Surgery; Internal medicine; Pathology; Hysterectomy","score_opus":0.02890545074826593,"score_gpt":0.35181832090032567,"score_spread":0.3229128701520597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042177108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889309,0.0020914597,0.0000019903985,0.0056302478,0.00021366858,0.000617229,0.000006765451,0.000028165068,0.002479566],"genre_scores_gemma":[0.9933294,0.0021713646,0.0029098657,0.0013038495,0.00009487473,0.000077811186,0.000004355503,0.000011665163,0.00009680918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983473,0.00019734321,0.00056142785,0.0004793356,0.00009591106,0.00031869573],"domain_scores_gemma":[0.99854285,0.00090271054,0.0001579297,0.00019278967,0.000051025032,0.00015271227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071270234,0.00018125819,0.0008319471,0.00015262254,0.000044529996,0.000008118302,0.0000626671,0.00037098327,0.00019439623],"category_scores_gemma":[0.0007819991,0.00013644775,0.000071750655,0.00015883482,0.00059504417,0.00005278241,0.00009472843,0.00030818002,0.000012290165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024472745,0.00068454345,0.8753826,0.00007009181,0.000062020954,0.0003848839,0.00041557883,0.0000027647252,0.00020522592,0.0003137367,0.00026497897,0.121968836],"study_design_scores_gemma":[0.0053207385,0.0055006174,0.9793933,0.000031065887,0.00015225053,0.00022081217,0.000266982,0.00004320137,0.00030551403,0.0004111199,0.008227538,0.00012684513],"about_ca_topic_score_codex":0.000053684,"about_ca_topic_score_gemma":0.00029301838,"teacher_disagreement_score":0.12184199,"about_ca_system_score_codex":0.0002803852,"about_ca_system_score_gemma":0.00025149834,"threshold_uncertainty_score":0.5564178},"labels":[],"label_agreement":null},{"id":"W2042227848","doi":"10.1038/modpathol.2011.211","title":"BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma","year":2012,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; University of British Columbia","funders":"","keywords":"Serous fluid; Germline mutation; Ovarian carcinoma; BRCA2 Protein; Medicine; Germline; Somatic cell; Serous carcinoma; Pathology; Ovarian cancer; Methylation; Cancer research; Biology; Internal medicine; Mutation; Cancer; Gene; Genetics","score_opus":0.012253407425656697,"score_gpt":0.23060295134803702,"score_spread":0.21834954392238032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042227848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934651,0.004975792,0.00025603783,0.0005249789,0.000060023896,0.00029676172,0.000031783547,0.000012585128,0.00037689263],"genre_scores_gemma":[0.99819624,0.00022560415,0.0012450982,0.00007486399,0.000026394604,0.000065191096,0.000026689271,0.00001675225,0.00012318566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914485,0.00006840569,0.00023349094,0.00020902827,0.00008315585,0.0002610844],"domain_scores_gemma":[0.9994668,0.00011244401,0.000091218375,0.00020499804,0.000035309542,0.000089251225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012732435,0.00013917587,0.00032665144,0.00010026513,0.00004086375,0.000008092402,0.000033189397,0.00009164379,0.00001660497],"category_scores_gemma":[0.000011980918,0.000110608366,0.000019180165,0.00008149801,0.00020672799,0.00011746878,0.000036260157,0.00012417343,0.0000017656022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115057475,0.00035179005,0.9854482,0.00013014782,0.000037087164,0.00022032268,0.008293375,0.000074354546,0.0036300328,0.0009455383,0.000008171176,0.00074595923],"study_design_scores_gemma":[0.002912838,0.000491666,0.9879527,0.00007136095,0.0001261486,0.0007569978,0.00044026016,0.00029468807,0.0063456115,0.0004893552,0.000014099247,0.00010429071],"about_ca_topic_score_codex":0.0012575936,"about_ca_topic_score_gemma":0.00016229691,"teacher_disagreement_score":0.007853115,"about_ca_system_score_codex":0.00003080083,"about_ca_system_score_gemma":0.00004926187,"threshold_uncertainty_score":0.45104784},"labels":[],"label_agreement":null},{"id":"W2042493664","doi":"10.1002/ijc.21902","title":"Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research","keywords":"Serous fluid; Tissue microarray; Immunohistochemistry; Ovarian cancer; Biology; Oncology; Pathology; Serous Cystadenoma; Microarray; Internal medicine; Cancer; Cancer research; Medicine; Gene expression; Gene; Genetics","score_opus":0.011002084521069712,"score_gpt":0.31193156568857644,"score_spread":0.30092948116750673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042493664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326456,0.0032777844,0.000084926105,0.0025086137,0.00040803946,0.00011993977,0.0002441038,0.000004392635,0.00008765903],"genre_scores_gemma":[0.99857175,0.0005423086,0.00023238997,0.00016401641,0.00021054728,0.000021839463,0.000023952753,0.000014597161,0.00021858673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985274,0.00004281014,0.00059086335,0.00016539679,0.00053232396,0.000141195],"domain_scores_gemma":[0.9987285,0.00008771746,0.0006394442,0.00008381844,0.00039319904,0.000067303605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019243006,0.00014264,0.00051288714,0.0005205707,0.000021813397,0.000036071386,0.00011264914,0.00004599048,0.00030779516],"category_scores_gemma":[0.000032647236,0.00010035578,0.00011449521,0.00029937955,0.00006940539,0.00013611243,0.00001511389,0.00013648554,3.2060444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081686646,0.00026782017,0.9614259,0.000015693868,0.0032075706,0.00020188151,0.00020216209,0.0013410153,0.030448265,0.000016592621,0.00032854953,0.0017276595],"study_design_scores_gemma":[0.0037326808,0.000119358454,0.9085366,0.0007520896,0.0014455683,0.000026442525,0.00006588792,0.000035529956,0.08466945,0.000039055256,0.00048192497,0.00009542311],"about_ca_topic_score_codex":0.007861655,"about_ca_topic_score_gemma":0.010504478,"teacher_disagreement_score":0.05422118,"about_ca_system_score_codex":0.00047722633,"about_ca_system_score_gemma":0.00018190574,"threshold_uncertainty_score":0.9987451},"labels":[],"label_agreement":null},{"id":"W2042668744","doi":"10.1016/j.ygyno.2012.06.033","title":"Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; CancerCare Manitoba; BC Cancer Agency; University of Toronto","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Benchmarking; Ovarian cancer; General partnership; Oncology; Stage (stratigraphy); Cancer; Gynecology; Internal medicine; Management","score_opus":0.17369846699064362,"score_gpt":0.40524954504904376,"score_spread":0.23155107805840014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042668744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131137,0.019692989,0.0000080667005,0.059540298,0.003352711,0.0006232027,0.00010504186,0.000049020106,0.0035149374],"genre_scores_gemma":[0.963492,0.025499271,0.0004106708,0.0061388537,0.00170557,0.001841155,0.000035156198,0.000018941959,0.00085837726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832934,0.00021141561,0.0002857886,0.0004241572,0.00026120682,0.00048811708],"domain_scores_gemma":[0.9954562,0.0037426942,0.00020095572,0.00029369333,0.00008087899,0.0002255373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063983636,0.00021562993,0.00041940802,0.00003184808,0.00020431737,0.000029928768,0.00019463283,0.00020653609,0.014201326],"category_scores_gemma":[0.00044356272,0.00013761064,0.00008763986,0.00011806319,0.00017721833,0.00014677602,0.00026973567,0.00023183496,0.000045958353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013830385,0.00028297008,0.91729736,0.000012730259,0.00036381028,0.00004508983,0.00085228076,0.000011317681,0.00008333481,0.00031467728,0.017377803,0.06322033],"study_design_scores_gemma":[0.0010677362,0.00025011075,0.7109824,0.00008615556,0.00028844297,0.000005909358,0.00016579675,0.00003617489,0.00027604387,0.000036656184,0.28669384,0.00011073141],"about_ca_topic_score_codex":0.0053270254,"about_ca_topic_score_gemma":0.013486943,"teacher_disagreement_score":0.26931605,"about_ca_system_score_codex":0.0017232543,"about_ca_system_score_gemma":0.00029610726,"threshold_uncertainty_score":0.9866998},"labels":[],"label_agreement":null},{"id":"W2042826018","doi":"10.1002/cam4.343","title":"The transcriptomic profile of ovarian cancer grading","year":2014,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Ovarian cancer; Grading (engineering); Transcriptome; Oncology; Internal medicine; Medicine; Biology; Gynecology; Cancer; Gene; Genetics; Gene expression; Ecology","score_opus":0.024004818055035165,"score_gpt":0.31192030283296107,"score_spread":0.2879154847779259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042826018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4312129,0.110940814,0.001491113,0.3857804,0.009023358,0.0036216967,0.0001405818,0.00026831118,0.057520814],"genre_scores_gemma":[0.9890372,0.0056203706,0.000110836074,0.0019155617,0.0013063313,0.0004703313,0.000011013684,0.000032516564,0.0014958117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986795,0.000044373537,0.00036712343,0.00027939564,0.00033032184,0.00029927463],"domain_scores_gemma":[0.99893105,0.00020790969,0.00014589778,0.00041299866,0.00013186116,0.0001702901],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033291033,0.00017934445,0.00047009476,0.00006422085,0.0001306096,0.000006166415,0.00012802891,0.000060062168,0.0011105647],"category_scores_gemma":[0.00009074775,0.00009839376,0.00009252049,0.0002543466,0.000280124,0.000035242883,0.000012166618,0.0001557927,0.0000073031406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091307744,0.00028674965,0.14794132,0.00077215984,0.0012348054,0.000022669974,0.003148053,0.000028716642,0.020013483,0.020467335,0.13718475,0.66798687],"study_design_scores_gemma":[0.01395096,0.0014162654,0.26800838,0.003084127,0.0016239738,0.000027000704,0.00045754347,0.0009946189,0.028804278,0.00084833894,0.680468,0.00031649676],"about_ca_topic_score_codex":0.0016436162,"about_ca_topic_score_gemma":0.0003263252,"teacher_disagreement_score":0.66767037,"about_ca_system_score_codex":0.0002100869,"about_ca_system_score_gemma":0.0002061276,"threshold_uncertainty_score":0.99980253},"labels":[],"label_agreement":null},{"id":"W2042835441","doi":"10.1111/j.1525-1438.2005.00134.x","title":"Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa","funders":"","keywords":"Debulking; Medicine; Perioperative; Chemotherapy; Surgery; Ovarian cancer; Stage (stratigraphy); Proportional hazards model; Confidence interval; Oncology; Tumor Debulking; Internal medicine; Cancer","score_opus":0.017705690702063532,"score_gpt":0.3242937361125526,"score_spread":0.30658804541048906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042835441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97312635,0.003798626,0.000045473553,0.020869186,0.0004284314,0.0002756218,0.000027883187,0.0000043355726,0.0014240822],"genre_scores_gemma":[0.98169947,0.0100418655,0.0026547955,0.0049750786,0.0004180734,0.000064696695,0.0000019045161,0.000009206485,0.0001349236],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99871945,0.000034640394,0.0004619058,0.00014973918,0.00048563242,0.00014859939],"domain_scores_gemma":[0.9992193,0.00012623059,0.00033390528,0.000087363405,0.00017401515,0.000059195077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029806956,0.00012248484,0.0003145759,0.000092154754,0.000022776383,0.000018094603,0.00021162216,0.000036057452,0.0008301846],"category_scores_gemma":[0.000016095859,0.00007111175,0.0001077938,0.000086783,0.00006607541,0.00010536618,0.00003956187,0.00018944393,0.0000010940287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014554824,0.0011431426,0.13145453,0.00006651966,0.00086973666,0.00089011475,0.00050227734,0.0010196877,0.0008449169,0.0011380729,0.00030773468,0.8603078],"study_design_scores_gemma":[0.0058008838,0.00037311466,0.95276535,0.00041732483,0.00011073752,0.00008568564,0.0001567846,0.00006106289,0.0010519722,0.00014261667,0.038953472,0.0000809881],"about_ca_topic_score_codex":0.00006353115,"about_ca_topic_score_gemma":0.00011312916,"teacher_disagreement_score":0.8602268,"about_ca_system_score_codex":0.00052981044,"about_ca_system_score_gemma":0.00011681562,"threshold_uncertainty_score":0.90899396},"labels":[],"label_agreement":null},{"id":"W2042844054","doi":"10.1016/s1470-2045(15)70157-9","title":"Targeting the microenvironment in ovarian cancer","year":2015,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Cancer; Tumor microenvironment; Cancer research; Oncology; Medicine; Biology; Computational biology; Internal medicine","score_opus":0.059247390125151386,"score_gpt":0.3343081014540412,"score_spread":0.2750607113288898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042844054","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009785983,0.00731255,0.000004085391,0.9816325,0.0010112867,0.0009547261,0.00007938879,0.00002111996,0.008005772],"genre_scores_gemma":[0.0062438287,0.005156254,0.00023690403,0.9661969,0.017517876,0.001030819,0.00017273723,0.000062324456,0.0033823627],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979578,0.00041338394,0.00034045143,0.00039204446,0.0002884346,0.00060787506],"domain_scores_gemma":[0.9986609,0.0003054091,0.00022382285,0.0007304388,0.000030928164,0.000048487105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008390102,0.00028573195,0.0008954164,0.000051568994,0.00008127832,0.000017895076,0.0003650864,0.00047975074,0.0008179081],"category_scores_gemma":[0.000038445072,0.00013967342,0.00010363153,0.0001122125,0.00020009466,0.00001639371,0.00013637965,0.0019603346,0.00016580638],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121232195,0.00009414416,0.004116165,0.000063034066,0.00024212089,0.00095736305,0.00054623384,0.00003273094,0.00004561765,0.000027046084,0.9895703,0.004183997],"study_design_scores_gemma":[0.0030322385,0.00023770842,0.006354143,0.0001281777,0.00033693522,0.00007973205,0.00006543313,0.00001491779,0.000034722543,0.00018617869,0.9893902,0.00013959248],"about_ca_topic_score_codex":0.0010892515,"about_ca_topic_score_gemma":0.00025008037,"teacher_disagreement_score":0.016506588,"about_ca_system_score_codex":0.0017693246,"about_ca_system_score_gemma":0.0005255249,"threshold_uncertainty_score":0.895552},"labels":[],"label_agreement":null},{"id":"W2042930098","doi":"10.1097/pas.0b013e31815c186f","title":"Granulosa Cell Tumors of the Ovary With a Pseudopapillary Pattern: A Study of 14 Cases of an Unusual Morphologic Variant Emphasizing Their Distinction From Transitional Cell Neoplasms and Other Papillary Ovarian Tumors","year":2008,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Jubilee Hospital","funders":"","keywords":"Granulosa cell; Pathology; Ovary; Clear cell; Psammoma body; Germ cell tumors; Biology; Papillary tumor; Immunohistochemistry; Medicine; Endocrinology","score_opus":0.017736561946618438,"score_gpt":0.23767313743965984,"score_spread":0.2199365754930414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042930098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825424,0.0004531722,0.000119887976,0.0005268447,0.00006603413,0.0003435164,0.00015920866,0.000006459667,0.00007062477],"genre_scores_gemma":[0.9990314,0.00020738889,0.00034103583,0.00026113284,0.00011316328,0.000009821842,0.0000065517634,0.000026501342,0.0000029897958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974981,0.0008145633,0.00079609733,0.00026979187,0.00040625897,0.00021517464],"domain_scores_gemma":[0.9974325,0.00061689795,0.001266509,0.00036354287,0.00018972844,0.00013085564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043189424,0.00025510567,0.0010678684,0.00011706938,0.000113720875,0.000004194467,0.0001868574,0.0000492094,0.0000533339],"category_scores_gemma":[0.000016395372,0.00012307458,0.000196409,0.0003203047,0.0011505211,0.000056535642,0.000046834786,0.00031626615,2.9191946e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0153002255,0.012374494,0.88770515,0.0001156453,0.0008294727,0.046797752,0.014103243,0.00067745964,0.015098198,0.000025362127,0.000041020994,0.006931993],"study_design_scores_gemma":[0.008979743,0.021285547,0.8983348,0.0002393708,0.0007264269,0.055110842,0.00781737,0.00005824644,0.007139401,0.000098083925,0.000020148567,0.00018999373],"about_ca_topic_score_codex":0.0009117051,"about_ca_topic_score_gemma":0.000030579635,"teacher_disagreement_score":0.010629693,"about_ca_system_score_codex":0.000034380322,"about_ca_system_score_gemma":0.00017312756,"threshold_uncertainty_score":0.50188357},"labels":[],"label_agreement":null},{"id":"W2043178214","doi":"10.1016/j.ygyno.2005.03.022","title":"Identifying patients unlikely to benefit from further chemotherapy: A descriptive study of outcome at each relapse in ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Retrospective cohort study; Internal medicine; Cancer; Surgery; Oncology","score_opus":0.053480507698290915,"score_gpt":0.3516750492072854,"score_spread":0.29819454150899444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043178214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095005,0.00026795975,0.000008099228,0.0049320976,0.00056812,0.0020231076,0.000052132433,0.000031350046,0.0011671045],"genre_scores_gemma":[0.9937236,0.00008592556,0.00185854,0.002771369,0.00012537513,0.0007589549,0.00002399573,0.00003386075,0.0006183977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978357,0.00013131883,0.0007234332,0.00062683335,0.00025295038,0.0004297921],"domain_scores_gemma":[0.9987523,0.00027831245,0.0002748083,0.00039389677,0.00012894702,0.00017176059],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024678188,0.00026755026,0.000919932,0.00022401988,0.00006063693,0.000008399761,0.00016637689,0.00024779324,0.0025920898],"category_scores_gemma":[0.000110013214,0.00021863916,0.000103069855,0.0003277135,0.000038373273,0.000070667935,0.00015054297,0.00022422282,0.00011658578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007960033,0.007749892,0.9347854,0.000010767906,0.00031702084,0.000087414846,0.014010201,0.0000976529,0.00022478419,0.00002795657,0.00050319894,0.0413897],"study_design_scores_gemma":[0.015873697,0.0048996788,0.97159904,0.00004231383,0.00022959632,0.000001772656,0.001970451,0.000014280757,0.00033177037,0.000093710776,0.0047632465,0.00018041204],"about_ca_topic_score_codex":0.0043494795,"about_ca_topic_score_gemma":0.054828133,"teacher_disagreement_score":0.050478656,"about_ca_system_score_codex":0.0039562616,"about_ca_system_score_gemma":0.0001327805,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W2043559279","doi":"10.1006/gyno.2001.6280","title":"Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"Neoplastic transformation; Biology; Cancer research; Kinase; P70-S6 Kinase 1; Protein kinase A; Carcinogenesis; Cyclin-dependent kinase 4; Protein kinase B; Cyclin-dependent kinase 2; Cell biology; Signal transduction; Cancer; Genetics","score_opus":0.03587211772932169,"score_gpt":0.32660949037437703,"score_spread":0.29073737264505534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043559279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984838,0.00016225645,0.00006695496,0.0034999133,0.000079485995,0.001409696,0.000010112469,0.000014471342,0.009919103],"genre_scores_gemma":[0.99849355,0.00007677575,0.0009922374,0.00017704356,0.000029409919,0.00015755303,0.00002493552,0.0000066426755,0.000041862593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988221,0.00020189043,0.00046499295,0.00016099062,0.00014072571,0.00020929571],"domain_scores_gemma":[0.9990632,0.0004388084,0.00020127665,0.00019394892,0.00007094143,0.000031851356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256748,0.0001131346,0.00042819526,0.00008425412,0.00004261041,0.0000029235423,0.000102533704,0.00014202249,0.00024320121],"category_scores_gemma":[0.00013751141,0.00007163396,0.00007412571,0.00026617572,0.000110334,0.000043421984,0.000012772075,0.00014400147,0.00000699039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016473455,0.013683716,0.7559923,0.0010974979,0.00038442222,0.0009782346,0.008622413,0.0013370613,0.107781634,0.04621117,0.00026585223,0.06199838],"study_design_scores_gemma":[0.009413534,0.016240263,0.9176108,0.00022034907,0.00033508375,0.00015294563,0.0032033615,0.0002535911,0.04685999,0.002310603,0.0031988018,0.00020067536],"about_ca_topic_score_codex":0.00022380626,"about_ca_topic_score_gemma":0.0005063724,"teacher_disagreement_score":0.16161852,"about_ca_system_score_codex":0.00017085926,"about_ca_system_score_gemma":0.00020038987,"threshold_uncertainty_score":0.2921148},"labels":[],"label_agreement":null},{"id":"W2043825191","doi":"10.1007/s10552-005-1724-1","title":"Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2005,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Sunnybrook Health Science Centre; McGill University; BC Cancer Agency; Women's College Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Menarche; Breast cancer; Medicine; Population; Gynecology; Epidemiology; Age of onset; Family history; Case-control study; Demography; Internal medicine; Cancer; Oncology; Disease; Environmental health","score_opus":0.010000953397306318,"score_gpt":0.2749497484384839,"score_spread":0.2649487950411776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043825191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483388,0.036249656,0.0000114926015,0.01382047,0.000091834874,0.000818385,0.00046284604,0.000012817783,0.00019368948],"genre_scores_gemma":[0.9848047,0.013322285,0.000022278204,0.001047199,0.00019567383,0.0004536686,0.0000040945147,0.000017356086,0.00013275024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990515,0.00008765341,0.00023956018,0.000257986,0.00016172284,0.00020159222],"domain_scores_gemma":[0.99930716,0.0002015329,0.00013650718,0.00018453923,0.00006249753,0.000107792075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019721659,0.00015042305,0.0004128323,0.000058431946,0.00006773164,0.000014802724,0.00003874994,0.00005624464,0.0002012084],"category_scores_gemma":[0.000030085912,0.00009530203,0.00005888757,0.000103442275,0.00028281534,0.00006496573,0.00002167771,0.00011929746,0.0000011518725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025655183,0.00009211562,0.8716624,0.000104011335,0.0010570148,0.00005911812,0.0038745974,0.0006206757,0.00064282934,0.0003006266,0.0006112934,0.1184098],"study_design_scores_gemma":[0.02708471,0.00008682408,0.966166,0.00020347071,0.0010612552,0.00003274471,0.0002458953,0.0010786069,0.0006650949,0.00006973792,0.0031856035,0.00012002833],"about_ca_topic_score_codex":0.006419602,"about_ca_topic_score_gemma":0.01658495,"teacher_disagreement_score":0.11828977,"about_ca_system_score_codex":0.00044054404,"about_ca_system_score_gemma":0.00014105454,"threshold_uncertainty_score":0.97045606},"labels":[],"label_agreement":null},{"id":"W2043990322","doi":"10.1016/j.ijrobp.2009.12.005","title":"Role of Adjuvant Radiotherapy in Granulosa Cell Tumors of the Ovary","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Princess Margaret Cancer Centre; Juravinski Cancer Centre; McMaster University; University of Toronto; Hamilton Health Sciences; University Health Network; Health Sciences Centre","funders":"","keywords":"Medicine; Ovary; Adjuvant; Adjuvant radiotherapy; Radiation therapy; Oncology; Granulosa cell; Gynecology; Internal medicine","score_opus":0.009491366919139762,"score_gpt":0.3004154319017665,"score_spread":0.29092406498262674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043990322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935299,0.0010263171,0.00018426533,0.0028199437,0.0014209336,0.00020836262,0.000049350216,0.0000050994745,0.0007558149],"genre_scores_gemma":[0.9962414,0.0006753789,0.0018255411,0.00039916576,0.00080599455,0.000007689692,0.000013672846,0.000014870722,0.000016284643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869645,0.00011184108,0.00070275937,0.00012992542,0.00023345902,0.00012556555],"domain_scores_gemma":[0.99806875,0.0002423961,0.0010789885,0.00017310334,0.0003777631,0.000058983358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035666832,0.00012450566,0.0004609275,0.00013553281,0.000019600691,0.000004311679,0.00029581436,0.00014507657,0.000092653645],"category_scores_gemma":[0.00008336149,0.00008598959,0.00025199438,0.00015328576,0.00018027672,0.000089582376,0.000029851259,0.0004207045,0.000002201138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003405218,0.0012040556,0.8067392,0.00001016135,0.0002825161,0.000014247892,0.0005549007,0.00020856035,0.10450279,0.005290265,0.00023950386,0.08061326],"study_design_scores_gemma":[0.011070892,0.0014429162,0.84022224,0.00013482141,0.00014452501,0.00016004422,0.00011376845,0.00084799033,0.12342654,0.009714502,0.012594455,0.00012728258],"about_ca_topic_score_codex":0.00007430604,"about_ca_topic_score_gemma":0.000022338603,"teacher_disagreement_score":0.08048598,"about_ca_system_score_codex":0.0002651707,"about_ca_system_score_gemma":0.0005781867,"threshold_uncertainty_score":0.35065535},"labels":[],"label_agreement":null},{"id":"W2044111165","doi":"10.1503/cmaj.1041601","title":"Ovarian cancer screening","year":2005,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Fallopian tube cancer; Gynecology; Medicine; Cancer; Significant difference; Oncology; Obstetrics; Internal medicine","score_opus":0.015444040962701447,"score_gpt":0.270295854484916,"score_spread":0.25485181352221453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044111165","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014240011,0.002058034,0.000029822626,0.9867883,0.002082524,0.00023632147,0.00017738884,0.000030547304,0.008454685],"genre_scores_gemma":[0.0009264697,0.001720326,0.0004486912,0.91403896,0.0738379,0.000050293074,0.00017372785,0.00007673681,0.008726927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951474,0.00015268226,0.00064875983,0.00035984672,0.002692093,0.0009992182],"domain_scores_gemma":[0.9964461,0.0001680862,0.00045417927,0.00022411063,0.0005457435,0.0021618265],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008343723,0.00033892086,0.00067918637,0.0004190355,0.00030903198,0.00017441402,0.00023566639,0.0023972965,0.04443845],"category_scores_gemma":[0.00051652227,0.00029823574,0.00037874025,0.00024826292,0.00003561206,0.00009273421,0.00001667586,0.006149732,0.0003918782],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000045473153,0.00001840747,0.020973932,0.000020542437,0.00085013243,0.00837585,0.00004284274,0.0000013516178,8.606721e-8,0.00000750342,0.85651076,0.113194026],"study_design_scores_gemma":[0.0019269069,0.000059817645,0.01781223,0.0007237709,0.0004434852,0.0012199689,0.000017731081,0.000039426603,0.0000017211371,0.000012167091,0.9774831,0.00025969592],"about_ca_topic_score_codex":0.013526474,"about_ca_topic_score_gemma":0.037777726,"teacher_disagreement_score":0.1209723,"about_ca_system_score_codex":0.0060042357,"about_ca_system_score_gemma":0.011658743,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W2044537567","doi":"10.1002/cncr.25242","title":"Regional variation in cancer‐directed surgery and mortality among women with epithelial ovarian cancer in the medicare population","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Cancer; Ovarian cancer; Odds ratio; Referral; Internal medicine; Population; Cohort; Epidemiology; Confidence interval; Gynecology; Oncology; Family medicine; Environmental health","score_opus":0.022630969958014044,"score_gpt":0.29590940100681284,"score_spread":0.2732784310487988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044537567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923752,0.00063975196,0.0000029469745,0.005813109,0.00042658532,0.0005391151,0.00008387239,0.000028496968,0.00009092521],"genre_scores_gemma":[0.99551994,0.0011290271,0.000034660894,0.00073626,0.0005475811,0.0019391178,0.000036235146,0.000020323969,0.000036832185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986478,0.00008110811,0.0002741985,0.00035925567,0.0003512175,0.0002864065],"domain_scores_gemma":[0.9993022,0.00013292381,0.00013720899,0.00024255767,0.00007597264,0.00010913942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041783825,0.00016840806,0.00033605046,0.00012707252,0.00006163227,0.000025769064,0.00005844739,0.00012400464,0.0006074005],"category_scores_gemma":[0.00003975702,0.000109927445,0.000029127179,0.00042544614,0.00009035605,0.00012759483,0.000011771271,0.00030745796,5.587544e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020942537,0.000112431706,0.9780716,0.000053381802,0.000092646,0.000037758953,0.0025901624,0.000053118514,0.00017246345,0.000089780544,0.00026557065,0.018251682],"study_design_scores_gemma":[0.0017084144,0.000038268834,0.9964528,0.00031645343,0.00008971745,0.000005552178,0.00013175368,0.00026385646,0.000040991876,0.00011923091,0.0007016739,0.0001312798],"about_ca_topic_score_codex":0.08173745,"about_ca_topic_score_gemma":0.1613834,"teacher_disagreement_score":0.079645954,"about_ca_system_score_codex":0.0005475119,"about_ca_system_score_gemma":0.00046895942,"threshold_uncertainty_score":0.9243773},"labels":[],"label_agreement":null},{"id":"W2045438979","doi":"10.1158/1055-9965.epi-14-1128","title":"Population Distribution of Lifetime Risk of Ovarian Cancer in the United States","year":2015,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Center for Research Resources; National Institute of Environmental Health Sciences; National Cancer Institute; Cancer Research UK; National Institute on Aging; Francis Crick Institute","keywords":"Ovarian cancer; Tubal ligation; Medicine; Population; Gynecology; Risk factor; Relative risk; Family history; Obstetrics; Endometriosis; Confidence interval; Cancer; Demography; Family planning; Internal medicine; Environmental health","score_opus":0.06173626028478753,"score_gpt":0.38064059357464436,"score_spread":0.31890433328985685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045438979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099935,0.008020558,0.0013711718,0.0081101,0.00035284788,0.0007856689,0.00029711542,0.00001627672,0.000046938298],"genre_scores_gemma":[0.9927475,0.004529032,0.00037602917,0.00019739564,0.00008303034,0.00024836708,0.0017789076,0.000010328285,0.000029413879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755204,0.0010994207,0.0007248674,0.00026157367,0.0001448884,0.00021720788],"domain_scores_gemma":[0.9983502,0.00043338936,0.00067898753,0.00028604956,0.00017216959,0.00007920768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025224017,0.00014402924,0.0005122524,0.00013878485,0.000031424956,0.0000019957179,0.00008714672,0.00015263475,0.000072446215],"category_scores_gemma":[0.00052344875,0.00009986426,0.0001477276,0.0004994503,0.00012953616,0.00006216791,0.000020017962,0.00012540314,0.000001769641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066291925,0.00025150643,0.9792581,0.000071316856,0.00047730762,0.0000018260165,0.00024400567,0.0015419085,0.000022389982,0.0005497316,0.0043342016,0.012584738],"study_design_scores_gemma":[0.0024046104,0.0003341254,0.98648524,0.00042812637,0.0005695812,0.000002875925,0.00019194103,0.0022708194,0.00015874236,0.0056203455,0.0014534225,0.00008017954],"about_ca_topic_score_codex":0.03276917,"about_ca_topic_score_gemma":0.0010544208,"teacher_disagreement_score":0.03171475,"about_ca_system_score_codex":0.00039468927,"about_ca_system_score_gemma":0.00016073337,"threshold_uncertainty_score":0.9736717},"labels":[],"label_agreement":null},{"id":"W2045828467","doi":"10.1007/s13139-011-0089-5","title":"Bilateral Tubo-Ovarian Abscess Mimics Ovarian Cancer on MRI and 18F-FDG PET/CT","year":2011,"lang":"en","type":"article","venue":"Nuclear Medicine and Molecular Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Brandon University; Brandon Regional Health Authority; Royal Victoria Hospital","funders":"","keywords":"Medicine; Malignancy; Magnetic resonance imaging; Abscess; Radiology; Ovarian cancer; Positron emission tomography; Ovary; Nuclear medicine; Cancer; Pathology; Surgery; Internal medicine","score_opus":0.0212090330282665,"score_gpt":0.2752701377197887,"score_spread":0.2540611046915222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045828467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88745356,0.0058608754,0.00019499313,0.05684582,0.0006203828,0.0008569419,0.000017998336,0.0001732427,0.047976177],"genre_scores_gemma":[0.97839856,0.0015511374,0.0027452905,0.016952638,0.00017313434,0.000023444225,0.000011584473,0.00007631848,0.0000678925],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99853873,0.00003677708,0.00026418167,0.00053495466,0.00026636472,0.00035896408],"domain_scores_gemma":[0.99918765,0.00002349381,0.00008384438,0.00030595664,0.000064563035,0.00033449862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015071232,0.00029272973,0.00043152907,0.0001782808,0.00013322318,0.000033614204,0.00007640827,0.000015884962,0.00072535424],"category_scores_gemma":[0.00002682534,0.00022421937,0.00006258678,0.00013637422,0.00021259958,0.00008619229,0.00006220279,0.00024253824,0.0000158777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003735059,0.0029827629,0.3052957,0.0021140364,0.004177279,0.1537854,0.025517736,0.000015398311,0.046903256,0.070761144,0.06329242,0.3214198],"study_design_scores_gemma":[0.049795035,0.003934628,0.5826502,0.0073851077,0.0056525506,0.01894419,0.0051078554,0.007599657,0.008094496,0.0042575467,0.30393377,0.0026449997],"about_ca_topic_score_codex":0.0017783423,"about_ca_topic_score_gemma":0.000022920542,"teacher_disagreement_score":0.3187748,"about_ca_system_score_codex":0.00007018098,"about_ca_system_score_gemma":0.000047869697,"threshold_uncertainty_score":0.91434},"labels":[],"label_agreement":null},{"id":"W2045883387","doi":"10.1016/j.jpedsurg.2012.06.011","title":"Ovarian torsion: diagnosis of inclusion mandates earlier intervention","year":2012,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Testicular torsion; Ovarian torsion; Incidence (geometry); Lower abdominal pain; Retrospective cohort study; Pediatrics; Surgery","score_opus":0.025009834834838356,"score_gpt":0.2877492571783758,"score_spread":0.2627394223435374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045883387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147506,0.015163302,0.000059119302,0.0010176959,0.0019717896,0.00010436247,0.0000062453237,0.000006800789,0.0001956251],"genre_scores_gemma":[0.9870107,0.006791771,0.00063038367,0.0000883269,0.0053983964,0.000008308662,0.000006202333,0.000015482601,0.000050401075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984203,0.0000778577,0.00074760115,0.00008409815,0.0004470444,0.00022311251],"domain_scores_gemma":[0.99822503,0.00044869527,0.00072284165,0.0001447825,0.0002400568,0.00021861448],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012775094,0.0001176382,0.0004763567,0.00042151986,0.00007635465,0.000008150917,0.000055887926,0.00008282386,0.000975219],"category_scores_gemma":[0.00028277305,0.00008521235,0.00050388963,0.00024772706,0.000016853615,0.000261715,0.00012077058,0.0001376766,0.000013539701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017874995,0.0013539286,0.9273808,0.0001247885,0.00014237071,0.000052983312,0.00034316062,7.9689494e-7,0.000016228574,0.00001535782,0.045039676,0.025351178],"study_design_scores_gemma":[0.0016957743,0.00042911578,0.97721976,0.0002851886,0.0012242064,0.0001116674,0.000106818225,0.0000024937758,0.0032765055,0.00006043231,0.015462936,0.00012512848],"about_ca_topic_score_codex":0.000046367153,"about_ca_topic_score_gemma":0.0000016082832,"teacher_disagreement_score":0.049838953,"about_ca_system_score_codex":0.0001446825,"about_ca_system_score_gemma":0.00011584718,"threshold_uncertainty_score":0.999938},"labels":[],"label_agreement":null},{"id":"W2046425487","doi":"10.1016/j.path.2010.12.009","title":"Molecular Pathology of Ovarian Carcinomas","year":2011,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Foothills Medical Centre; BC Cancer Agency; Calgary Laboratory Services","funders":"","keywords":"Serous fluid; Clear cell; Molecular pathology; Medicine; Pathology; Ovarian carcinomas; Clear cell carcinoma; Ovarian cancer; Cancer research; Gene mutation; Mutation; Carcinoma; Cancer; Gene; Ovarian carcinoma; Internal medicine; Biology","score_opus":0.08353510993408209,"score_gpt":0.3833199365053596,"score_spread":0.29978482657127753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046425487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048755825,0.9871525,0.000018613597,0.00009101437,0.0009176527,0.0010114147,0.00016544515,0.00005398916,0.010101776],"genre_scores_gemma":[0.00070632645,0.99711126,0.0008686017,0.00016986174,0.0002490569,0.0002107973,0.0003217989,0.00010611027,0.00025617587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958562,0.0007009126,0.0017237972,0.0009925517,0.00019383064,0.00053267746],"domain_scores_gemma":[0.996797,0.00062190025,0.00083196344,0.0012980708,0.00015551667,0.00029552178],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007382428,0.00062170136,0.004825139,0.00026895566,0.000038447874,0.000004683116,0.0002712597,0.0016630194,0.00058697106],"category_scores_gemma":[0.00019388099,0.00045948182,0.0017994886,0.00032402674,0.00048019658,0.000019251442,0.00019813185,0.00095486786,0.000263439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102842525,0.0011574329,0.000987242,0.006002277,0.00065776176,0.049630523,0.00005351749,1.1692436e-7,2.4645306e-7,0.010798505,0.00014183314,0.9304677],"study_design_scores_gemma":[0.0020086623,0.0012025313,0.00045577003,0.0025942263,0.0048371814,0.0055176145,0.000004522727,4.624418e-7,0.000002974331,0.00043228653,0.9826122,0.00033157534],"about_ca_topic_score_codex":0.000009940155,"about_ca_topic_score_gemma":0.000002344238,"teacher_disagreement_score":0.98247033,"about_ca_system_score_codex":0.000104873434,"about_ca_system_score_gemma":0.00071748975,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W2046938002","doi":"10.1159/000089982","title":"New Aspects in Gynecologic Oncology","year":2006,"lang":"de","type":"article","venue":"Gyn�kologisch-geburtshilfliche Rundschau","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gynecologic oncology; Medicine; Gynecology; Oncology; Medical physics; Internal medicine","score_opus":0.021030203035323717,"score_gpt":0.29179527728068977,"score_spread":0.27076507424536606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046938002","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20534185,0.33940586,0.0008009556,0.10147756,0.020896096,0.00764979,0.0002741475,0.0012337976,0.32291993],"genre_scores_gemma":[0.9579485,0.013596246,0.0061892453,0.00336956,0.008409802,0.00048249224,0.0004894458,0.0002327839,0.00928191],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905786,0.0008372893,0.0021981478,0.0025144904,0.00096497155,0.0029065008],"domain_scores_gemma":[0.9941204,0.0018204413,0.00092341675,0.0019112343,0.00022983726,0.0009946803],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0015934967,0.0015358996,0.002800319,0.0009863138,0.0003575642,0.00021430202,0.0008871856,0.0020839267,0.0057192254],"category_scores_gemma":[0.0008200403,0.0013825916,0.00073407707,0.0017796883,0.0005461179,0.00034665357,0.00054036407,0.0020435434,0.005295046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001334734,0.011853543,0.43630594,0.00043355714,0.0022993311,0.015864609,0.0012127975,0.0010557885,0.0006589263,0.075593516,0.35563123,0.097756036],"study_design_scores_gemma":[0.01645674,0.006062239,0.4176509,0.00046091626,0.0021458569,0.00012288666,0.00037672571,0.00017713614,0.0016902235,0.015762405,0.53756654,0.0015273825],"about_ca_topic_score_codex":0.01705373,"about_ca_topic_score_gemma":0.0077800592,"teacher_disagreement_score":0.7526067,"about_ca_system_score_codex":0.004077476,"about_ca_system_score_gemma":0.003584481,"threshold_uncertainty_score":0.99974567},"labels":[],"label_agreement":null},{"id":"W2047119337","doi":"10.1111/j.1447-0756.2007.00478.x","title":"Role of endocrine and growth factors on the ovarian surface epithelium","year":2007,"lang":"en","type":"review","venue":"Journal of obstetrics and gynaecology research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Ovary; Ovulation; Malignant transformation; Hormone; Ovarian cancer; Epithelium; Medicine; Neoplastic transformation; Endocrine system; Cancer research; Biology; Endocrinology; Internal medicine; Pathology; Cancer; Carcinogenesis","score_opus":0.13608567454819495,"score_gpt":0.41101030832701924,"score_spread":0.27492463377882426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047119337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00968415,0.986532,8.647885e-7,0.00052019645,0.00058362813,0.00062452606,0.000031400188,0.0000021101337,0.0020211502],"genre_scores_gemma":[0.045387454,0.9542028,0.000083917905,0.000027265713,0.00007985708,0.0000060799534,0.0000044037706,0.000029240375,0.00017901695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741215,0.00042108403,0.0007992507,0.0002500071,0.000697417,0.0004201219],"domain_scores_gemma":[0.9805743,0.017628314,0.0005326706,0.00026708803,0.000728209,0.0002693845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021252178,0.00025655373,0.0016071964,0.0009195053,0.00013375674,0.00003441108,0.0002133397,0.0002847267,0.00026355922],"category_scores_gemma":[0.004409408,0.0001293396,0.00028246696,0.000880228,0.00029882058,0.000034562843,0.00013745285,0.0014873439,0.0000040825316],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029202798,0.00059452996,0.021146301,0.0026736944,0.0011243126,0.00085137587,0.00014332881,1.9677803e-7,0.0000011769868,0.0029958747,0.00048686544,0.9699531],"study_design_scores_gemma":[0.0024114733,0.0056799026,0.098548785,0.0015311516,0.0013430298,0.0004927168,0.00037372977,0.0000024652447,0.000063832245,0.0006382686,0.88870645,0.00020819837],"about_ca_topic_score_codex":0.000024862982,"about_ca_topic_score_gemma":0.0000017770107,"teacher_disagreement_score":0.9697449,"about_ca_system_score_codex":0.00037375945,"about_ca_system_score_gemma":0.0006458269,"threshold_uncertainty_score":0.6461852},"labels":[],"label_agreement":null},{"id":"W2047187032","doi":"10.1111/igc.0b013e3181c7fccf","title":"Malignant Transformation Within Ovarian Dermoid Cysts: An Audit of Treatment Received and Patient Outcomes. An Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) Study","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Debulking; Radiation therapy; Stage (stratigraphy); Surgery; Chemotherapy; Disease; Radical surgery; Ovarian cancer; Cancer; Internal medicine","score_opus":0.04252812577289607,"score_gpt":0.36851969982256144,"score_spread":0.3259915740496654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047187032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898432,0.00017786476,0.000029129298,0.005947085,0.0028429665,0.0009778941,0.00007737209,0.000020085488,0.000084390515],"genre_scores_gemma":[0.9963883,0.00077047467,0.0014963703,0.0007378313,0.00026088176,0.00019328838,0.000021121368,0.000018172203,0.000113526934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997357,0.00021824281,0.0011791411,0.000449881,0.00049053767,0.000305178],"domain_scores_gemma":[0.99762315,0.0002878427,0.0008941997,0.00018690953,0.0004655992,0.0005422934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004234342,0.00036137216,0.00095285435,0.00022448291,0.00008263183,0.00006762934,0.00024472974,0.00031863424,0.0031678535],"category_scores_gemma":[0.00017261303,0.00021942491,0.00016653555,0.000102490805,0.00020208897,0.0003917236,0.0000617376,0.00047512772,0.000001747154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020427501,0.00616652,0.7837944,0.000013141687,0.0014385051,0.00076376303,0.0040571042,0.000106723004,0.002245521,0.00041702407,0.00024728666,0.19870725],"study_design_scores_gemma":[0.010773692,0.033661406,0.9493069,0.000041157702,0.00053651904,0.00031332675,0.0009298192,0.000110927496,0.00045992603,0.00046297308,0.0031871994,0.00021614673],"about_ca_topic_score_codex":0.0023195203,"about_ca_topic_score_gemma":0.0134265805,"teacher_disagreement_score":0.19849111,"about_ca_system_score_codex":0.0012809552,"about_ca_system_score_gemma":0.00050464866,"threshold_uncertainty_score":0.99774337},"labels":[],"label_agreement":null},{"id":"W2047458509","doi":"10.1158/1538-7445.am2014-3285","title":"Abstract 3285: Functional analysis of the 9p22 locus implicates the transcriptional regulation of <i>BNC2</i> as a mechanism in ovarian cancer predisposition","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Single-nucleotide polymorphism; Biology; Genetics; Locus (genetics); DNA methylation; Allele; Genome-wide association study; Minor allele frequency; Expression quantitative trait loci; Gene; Regulation of gene expression; Gene expression; Genotype","score_opus":0.052239728658023836,"score_gpt":0.364721173259026,"score_spread":0.31248144460100213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047458509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809956,0.00090427167,0.00025799227,0.015405697,0.0001588034,0.0008494762,0.00018950844,0.000007893211,0.0012307583],"genre_scores_gemma":[0.9984362,0.00032355817,0.000016911908,0.00015626819,0.00016352072,0.00067122397,0.000049324106,0.000013666385,0.00016930715],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980879,0.00015345571,0.00034704796,0.00029229352,0.0008778563,0.0002414617],"domain_scores_gemma":[0.998808,0.00019798595,0.00012373351,0.00041142543,0.00039400725,0.000064823886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085766346,0.00010885654,0.00028749413,0.00028641577,0.000121930345,0.000014792208,0.00015353973,0.00008529295,0.001183673],"category_scores_gemma":[0.000042779782,0.00006475176,0.00020942374,0.0014023953,0.00016611173,0.00006522461,0.000031255477,0.00026292674,0.0000034830157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019454783,0.0010251693,0.16020717,0.00032519063,0.002844553,0.0000027017602,0.0012918003,0.008325966,0.71468735,0.09323782,0.0016868005,0.014420027],"study_design_scores_gemma":[0.0011584056,0.00011374317,0.9258355,0.00019154894,0.00048792022,0.0000016070146,0.00007876545,0.0006242753,0.06649128,0.0044300305,0.00053237035,0.00005454364],"about_ca_topic_score_codex":0.0058232094,"about_ca_topic_score_gemma":0.0015271599,"teacher_disagreement_score":0.76562834,"about_ca_system_score_codex":0.0004077883,"about_ca_system_score_gemma":0.0004438245,"threshold_uncertainty_score":0.9997294},"labels":[],"label_agreement":null},{"id":"W2048063355","doi":"10.1097/pas.0b013e31820a406c","title":"FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary","year":2011,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Immunostaining; Stromal cell; Biology; Pathology; Ovary; Granulosa cell; Immunohistochemistry; Cancer research; Medicine; Endocrinology","score_opus":0.030432964376431938,"score_gpt":0.2726880845902637,"score_spread":0.24225512021383178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048063355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448746,0.00028223294,0.00006796806,0.003934421,0.0001024077,0.00019076526,0.000017957398,0.0000026332655,0.0009141424],"genre_scores_gemma":[0.9974435,0.0004738355,0.0011756959,0.0006723751,0.00014150784,0.0000045192487,4.406661e-7,0.000012314903,0.00007580141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990543,0.00017826812,0.00033249392,0.00012538576,0.00013844935,0.00017107849],"domain_scores_gemma":[0.99876326,0.00034866726,0.00048320793,0.00019781064,0.00011982268,0.000087235174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036126634,0.0001102968,0.0005372643,0.000044353008,0.000048750473,0.0000029240505,0.00008968186,0.000025323374,0.00007548085],"category_scores_gemma":[0.000018394836,0.000052206717,0.00021875105,0.000115619914,0.00087314093,0.000019731191,0.000043707332,0.00017729487,0.0000013878819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041041676,0.002274812,0.6586822,0.00008574924,0.0021025562,0.011387557,0.0122355195,0.0000027699314,0.0052131973,0.0037325625,0.0058223037,0.25741908],"study_design_scores_gemma":[0.0030153184,0.0062634684,0.9643966,0.00010601822,0.000334769,0.016006518,0.0016752715,0.000008440299,0.0036731367,0.0005498031,0.0038799634,0.000090718546],"about_ca_topic_score_codex":0.000027023249,"about_ca_topic_score_gemma":7.5297106e-7,"teacher_disagreement_score":0.30571434,"about_ca_system_score_codex":0.000027206883,"about_ca_system_score_gemma":0.0000752105,"threshold_uncertainty_score":0.32171243},"labels":[],"label_agreement":null},{"id":"W2048298425","doi":"10.1369/0022155414538821","title":"Immunohistological Insight into the Correlation between Neuropilin-1 and Epithelial-Mesenchymal Transition Markers in Epithelial Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Journal of Histochemistry & Cytochemistry","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Vimentin; Epithelial–mesenchymal transition; Immunohistochemistry; Ovarian cancer; Serous fluid; Pathology; Slug; Tissue microarray; Epithelium; Cancer; Cadherin; Adenocarcinoma; Biology; Cancer research; Medicine; Internal medicine; Cell; Metastasis","score_opus":0.009618080120054022,"score_gpt":0.25635380779220773,"score_spread":0.2467357276721537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048298425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891898,0.002268144,0.0005310123,0.00585489,0.0001880871,0.00022258503,0.000020624591,0.000015078123,0.0017098045],"genre_scores_gemma":[0.9974988,0.0004676046,0.00056593143,0.0002890923,0.0009180487,0.000032008174,0.000025664374,0.000025116451,0.00017770802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810475,0.0000857585,0.0007967969,0.0003336687,0.00041765018,0.00026135996],"domain_scores_gemma":[0.99856794,0.00023548327,0.00048260685,0.00031561585,0.00018285839,0.00021550334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046745766,0.00028353056,0.00058642676,0.00006799577,0.00013993979,0.00003060649,0.00015321221,0.00026406994,0.00013871613],"category_scores_gemma":[0.0001917156,0.00020435324,0.00021664487,0.00017684214,0.0002742497,0.000094224226,0.00003528633,0.00077061745,0.0000025677032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022635027,0.00055314426,0.046688262,0.0005033697,0.00040192445,0.000433221,0.0028316907,0.00019729779,0.9029517,0.000033253684,0.00088107714,0.04226152],"study_design_scores_gemma":[0.023197668,0.0017993768,0.4569428,0.0025146015,0.0024019321,0.0030597912,0.0007909609,0.0013951401,0.46651873,0.00081937725,0.03934858,0.0012110426],"about_ca_topic_score_codex":0.00011051123,"about_ca_topic_score_gemma":0.000004524801,"teacher_disagreement_score":0.43643302,"about_ca_system_score_codex":0.0005974231,"about_ca_system_score_gemma":0.00030837895,"threshold_uncertainty_score":0.8333283},"labels":[],"label_agreement":null},{"id":"W2048880738","doi":"10.1593/neo.07472","title":"Characterization of Ovarian Cancer Ascites on Cell Invasion, Proliferation, Spheroid Formation, Gene Expression in an In Vitro Model of Epithelial Ovarian Cancer","year":2007,"lang":"en","type":"article","venue":"Neoplasia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Ascites; Ovarian cancer; Biology; Cancer research; Cancer; Gene expression; Internal medicine; Gene; Medicine; Genetics","score_opus":0.019829857132316275,"score_gpt":0.2690812751345723,"score_spread":0.24925141800225603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048880738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955739,0.00008478458,0.0024343685,0.0004911429,0.00014182153,0.00088495866,0.00016284414,0.000016306385,0.00020991384],"genre_scores_gemma":[0.9955511,0.0002405467,0.003215515,0.00027076394,0.00015197172,0.00019508554,0.0002826227,0.000029052606,0.000063333384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983124,0.000053462885,0.0007187427,0.00031419567,0.00034918354,0.0002520271],"domain_scores_gemma":[0.99901706,0.00003621873,0.00033131187,0.00029725532,0.00020810596,0.0001100513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029474936,0.00019774938,0.000402643,0.00029191168,0.00003909261,0.000012458213,0.00008269428,0.00015891099,0.00014508724],"category_scores_gemma":[0.000021719687,0.00017181711,0.000051703646,0.00037315043,0.000028608267,0.00033287855,0.000019193232,0.00013985981,0.000002891921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015602501,0.00087578833,0.10053699,0.00014218541,0.000012031635,0.0000072809653,0.0020709988,0.002611909,0.88705075,0.000051668845,0.000026502536,0.0050536543],"study_design_scores_gemma":[0.0037255832,0.00020372844,0.19795872,0.00034591297,0.00003106917,0.0000017527169,0.000052102492,0.005927718,0.7915642,0.000047973786,0.000034543602,0.00010667684],"about_ca_topic_score_codex":0.00046602354,"about_ca_topic_score_gemma":0.0017142135,"teacher_disagreement_score":0.097421736,"about_ca_system_score_codex":0.00031226725,"about_ca_system_score_gemma":0.0003495419,"threshold_uncertainty_score":0.70064986},"labels":[],"label_agreement":null},{"id":"W2049111529","doi":"10.1016/s0020-7292(00)00232-0","title":"Progress in gynecologic cancer detection and treatment","year":2000,"lang":"en","type":"review","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cervical cancer; Intensive care medicine; Disease; Radiation therapy; Etiology; Cancer; Quality of life (healthcare); Developed country; Developing country; Chemotherapy; Surgery; Internal medicine; Population","score_opus":0.04757552324896129,"score_gpt":0.37773206535783277,"score_spread":0.33015654210887146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049111529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041296566,0.99146205,0.00000151363,0.00046333898,0.0031571044,0.00054935575,0.000034099492,0.000008529161,0.00019432433],"genre_scores_gemma":[0.007664296,0.9913156,0.00015168,0.00009902771,0.00040309704,0.00017076072,0.000015121408,0.000029522658,0.000150883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980866,0.000119119526,0.0009702495,0.00028240803,0.00031938762,0.00022225421],"domain_scores_gemma":[0.9970147,0.0016174279,0.0008336801,0.00012882303,0.0002725741,0.00013281923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015917078,0.00032297912,0.0015200557,0.0011936384,0.00002811904,0.00003630062,0.00017829434,0.00038920002,0.0003687648],"category_scores_gemma":[0.00034409732,0.0002221555,0.00040398235,0.00035777382,0.0000879412,0.00008054411,0.000035313817,0.00040212777,0.000013462991],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055620767,0.0007675796,0.012926772,0.00026086456,0.0012908677,0.002489491,0.000042023523,0.000002620821,4.2568136e-8,0.000010299938,0.00004750823,0.9821063],"study_design_scores_gemma":[0.0029884994,0.0016358184,0.010849863,0.0024247793,0.0016894481,0.0012798181,0.000012541547,0.0000064345254,0.0000029549672,0.00002358353,0.9789315,0.00015478459],"about_ca_topic_score_codex":0.000022147882,"about_ca_topic_score_gemma":0.00010259845,"teacher_disagreement_score":0.98195153,"about_ca_system_score_codex":0.0035612464,"about_ca_system_score_gemma":0.00084938545,"threshold_uncertainty_score":0.93125355},"labels":[],"label_agreement":null},{"id":"W2049441520","doi":"10.1016/j.jconrel.2006.10.007","title":"Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors","year":2006,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Paclitaxel; In vivo; Pharmacology; Ovarian cancer; P-glycoprotein; Drug delivery; Intraperitoneal injection; Medicine; Dosing; Ovarian carcinoma; Chemotherapy; Drug resistance; Multiple drug resistance; Chemistry; Biology; Internal medicine; Cancer","score_opus":0.007531524495932024,"score_gpt":0.26164860179938565,"score_spread":0.2541170773034536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049441520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952469,0.0018116412,0.000027905777,0.0016200395,0.0000533513,0.0007523594,0.000017696733,0.000002071984,0.00046807475],"genre_scores_gemma":[0.9993549,0.0001818261,0.00017754226,0.000054326072,0.00015080458,0.000017856973,0.0000018588041,0.000015480924,0.000045378023],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781096,0.0001996773,0.0012337809,0.0001083024,0.00046218783,0.00018511845],"domain_scores_gemma":[0.99729633,0.00048554217,0.0013050071,0.00027035968,0.0005432971,0.0000994441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005971874,0.00017107898,0.0011352136,0.00031153808,0.000022685674,0.0000059056792,0.00011004255,0.00008298643,0.00017153834],"category_scores_gemma":[0.00041549653,0.0000870745,0.0006388659,0.00023068821,0.00008844249,0.000064231266,0.000013836335,0.00025096457,5.405681e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19729546,0.016203145,0.13846058,0.00054834515,0.002157682,0.002073116,0.0007856703,0.0046381024,0.62097985,0.0028584148,0.0076336167,0.006366023],"study_design_scores_gemma":[0.16378996,0.0182849,0.5704409,0.0057070814,0.0010485784,0.00017092063,0.0011336489,0.00058627734,0.23718719,0.0012817413,0.0000893563,0.00027947986],"about_ca_topic_score_codex":0.00071117684,"about_ca_topic_score_gemma":0.000011531204,"teacher_disagreement_score":0.4319803,"about_ca_system_score_codex":0.00019337561,"about_ca_system_score_gemma":0.0005874035,"threshold_uncertainty_score":0.3550795},"labels":[],"label_agreement":null},{"id":"W2049476028","doi":"10.1016/j.ygyno.2010.03.009","title":"Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; American Physicians Fellowship for Medicine in Israel","keywords":"Medicine; Germline; Germline mutation; Gynecology; BRCA mutation; Fallopian tube; Carcinoma; Oncology; Mutation; Internal medicine; Obstetrics; Genetics; Cancer; Gene; Ovarian cancer; Biology","score_opus":0.013273603694827519,"score_gpt":0.28273718075381127,"score_spread":0.26946357705898377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049476028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963767,0.000035742858,0.000011591006,0.0017247016,0.00020165039,0.0010322353,0.000026740732,0.000010702084,0.0005799462],"genre_scores_gemma":[0.9979423,0.000025835732,0.0012167112,0.00029791275,0.000038145616,0.00036920077,0.0000066155258,0.000010056911,0.00009321449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992306,0.000056708,0.00020188757,0.00022247739,0.00007002243,0.00021829535],"domain_scores_gemma":[0.9990798,0.00044585735,0.0001629096,0.00018134239,0.00006156073,0.000068477355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021446662,0.00011488548,0.00036474498,0.000059863985,0.000052846965,0.000003900674,0.00005638155,0.00015471605,0.00010722693],"category_scores_gemma":[0.00028102423,0.00006131028,0.00003247734,0.00010851363,0.00015807826,0.000024727546,0.000026538968,0.0001904621,7.8600436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000385773,0.00040146708,0.9810436,0.000027793641,0.00006395602,0.000011888259,0.0012696907,0.000009200572,0.00029335692,0.0001974322,0.000041412306,0.016254423],"study_design_scores_gemma":[0.0056320033,0.00457892,0.9848791,0.000009956943,0.0001133982,0.000029911922,0.00054930086,0.0000796079,0.00065863837,0.00031961134,0.0030843073,0.00006525166],"about_ca_topic_score_codex":0.00027344792,"about_ca_topic_score_gemma":0.004042418,"teacher_disagreement_score":0.016189171,"about_ca_system_score_codex":0.00021241889,"about_ca_system_score_gemma":0.00026492728,"threshold_uncertainty_score":0.25001606},"labels":[],"label_agreement":null},{"id":"W2049536840","doi":"10.5430/jst.v3n5p12","title":"Comparison of clinical staging of benign and malignant ovarian tissues with DNA flow cytometry","year":2013,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"King's College London","keywords":"Ovarian cancer; Aneuploidy; DAPI; Flow cytometry; Cancer; Pathology; Malignancy; Cancer research; Nuclear DNA; Oncology; Medicine; DNA; Biology; Internal medicine; Molecular biology; Staining; Genetics","score_opus":0.04548970000424765,"score_gpt":0.3891520543391774,"score_spread":0.34366235433492975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049536840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718076,0.0009491577,0.00024953004,0.0010143325,0.00012229962,0.00018432754,0.000009795587,0.0000038721346,0.00028593896],"genre_scores_gemma":[0.9899496,0.00023025619,0.009504919,0.00006228137,0.00019423205,0.00000268382,0.0000013966425,0.000016118816,0.00003851127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810815,0.000052585558,0.0011572147,0.00013312441,0.00039031057,0.0001585882],"domain_scores_gemma":[0.99814826,0.00015315402,0.0009804808,0.00017525439,0.0003220813,0.00022076459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045353762,0.00012876956,0.0010881502,0.00018487482,0.000024240951,0.000011851258,0.00007209582,0.000052077223,0.0001697746],"category_scores_gemma":[0.00007468176,0.00008049603,0.00012643504,0.00015479937,0.00012577446,0.0001160636,0.000025149544,0.00020681554,0.0000025869933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032589043,0.00085938704,0.98257846,0.00016476105,0.0004914974,0.00017503618,0.00061591156,0.000050501963,0.0008071942,0.000056097088,0.0009529854,0.012922281],"study_design_scores_gemma":[0.0039188922,0.004199397,0.96418875,0.0014626805,0.0004235626,0.00027132494,0.0011337424,0.0004982297,0.023486724,0.00007485209,0.00024634635,0.00009550637],"about_ca_topic_score_codex":0.00006935819,"about_ca_topic_score_gemma":0.0000040387195,"teacher_disagreement_score":0.02267953,"about_ca_system_score_codex":0.00003315344,"about_ca_system_score_gemma":0.0001692116,"threshold_uncertainty_score":0.3282533},"labels":[],"label_agreement":null},{"id":"W2049549481","doi":"10.1002/ijc.21298","title":"An inverse association between ovarian cysts and breast cancer in the breast cancer family registry","year":2005,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"Cancer Care Ontario; National Health and Medical Research Council; National Cancer Institute; National Institutes of Health; University of Melbourne; Medical Research Council","keywords":"Breast cancer; Medicine; Ovarian cancer; Odds ratio; Family history; Gynecology; Cancer registry; Population; Case-control study; Oncology; Obstetrics; Internal medicine; Cancer","score_opus":0.014297584066431088,"score_gpt":0.33040025504739756,"score_spread":0.31610267098096645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049549481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.880793,0.0027296918,0.00001858838,0.11428394,0.0007707779,0.00016631554,0.0008173127,0.000007825547,0.00041255617],"genre_scores_gemma":[0.9863322,0.0054995595,0.00010535112,0.0035362972,0.0043249303,0.000046091976,0.000009000282,0.000017422763,0.00012915363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983044,0.0000712852,0.00044462061,0.00018229069,0.0008057501,0.00019165606],"domain_scores_gemma":[0.998576,0.00007822687,0.0005121989,0.0001335649,0.00056504767,0.00013499155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003929245,0.00015264262,0.00028621597,0.00016040925,0.000042104704,0.00008920299,0.00024427203,0.000098260105,0.0004029171],"category_scores_gemma":[0.000014805751,0.00010576718,0.00009739798,0.00013696426,0.00003900183,0.00038697463,0.000020471974,0.0003214753,0.0000029683144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032029735,0.00019766012,0.8755286,0.000010240939,0.0008663792,0.00008160651,0.00058260775,0.00032533432,0.00026937004,0.00005803243,0.005954088,0.115805805],"study_design_scores_gemma":[0.0035285302,0.000059263657,0.98351246,0.00047794037,0.00035054993,0.00027880524,0.00016576433,0.00011847775,0.00007562086,0.0000781522,0.011250779,0.00010366089],"about_ca_topic_score_codex":0.0039715,"about_ca_topic_score_gemma":0.0035088758,"teacher_disagreement_score":0.11570214,"about_ca_system_score_codex":0.001973391,"about_ca_system_score_gemma":0.0005468453,"threshold_uncertainty_score":0.60037464},"labels":[],"label_agreement":null},{"id":"W2049732945","doi":"10.1016/j.gynor.2013.07.008","title":"Patterns of spread of clear cell ovarian cancer: Case report and case series","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Serous fluid; Cancer; Radiation therapy; Clear cell; Ovarian carcinoma; Serous carcinoma; Clear cell carcinoma; Pathology; Oncology; Internal medicine; Carcinoma","score_opus":0.018930435067457185,"score_gpt":0.2960802511227826,"score_spread":0.2771498160553254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049732945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294496,0.00094052526,0.000007804303,0.0012165466,0.00058947277,0.0013225315,0.000057589164,0.00004618292,0.0028744002],"genre_scores_gemma":[0.99660057,0.0004252738,0.0015604998,0.00019419657,0.00008599246,0.00042136657,0.000021940856,0.000028667566,0.00066147454],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9974702,0.00012492467,0.0012256592,0.00063533,0.00016569723,0.00037820166],"domain_scores_gemma":[0.9970302,0.00035888873,0.0012145952,0.0007360713,0.00035955073,0.00030071876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005092694,0.00028943937,0.0010452296,0.0001421881,0.00012184117,0.000011408015,0.000025749972,0.00036633798,0.0018131615],"category_scores_gemma":[0.00025139854,0.00023052635,0.00015585218,0.0001485596,0.000219254,0.00013129659,0.000119218195,0.00022157007,0.0000041529447],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053148684,0.00073633384,0.27832517,0.00025384928,0.00019928766,0.7091026,0.00028720876,0.0000054117504,0.00014094185,0.000019921614,0.0006856852,0.010190466],"study_design_scores_gemma":[0.0014180709,0.0029835948,0.044723216,0.000057521756,0.0007582393,0.9425396,0.0013783189,0.000010135982,0.0035559712,0.00009200213,0.0023062108,0.00017715024],"about_ca_topic_score_codex":0.019991174,"about_ca_topic_score_gemma":0.004634377,"teacher_disagreement_score":0.23360194,"about_ca_system_score_codex":0.0003262255,"about_ca_system_score_gemma":0.00059998257,"threshold_uncertainty_score":0.9990993},"labels":[],"label_agreement":null},{"id":"W2049897958","doi":"10.1006/gyno.2002.6638","title":"Peritoneal Lavage Cytology: An Assessment of Its Value during Prophylactic Oophorectomy","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Occult; Cytology; Malignancy; Carcinoma; BRCA mutation; Ovarian carcinoma; Gynecology; Pathology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.04060428712800371,"score_gpt":0.3742508951052551,"score_spread":0.33364660797725143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049897958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96495014,0.0007139733,0.0000071916734,0.0029682198,0.00056574185,0.0009419607,0.000013781772,0.00009063796,0.029748358],"genre_scores_gemma":[0.9936945,0.0005466585,0.004113138,0.0004731269,0.00018988397,0.00033789064,0.000015249078,0.000025248655,0.0006043385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980352,0.0002793,0.00046419993,0.00052928214,0.00021291093,0.00047910627],"domain_scores_gemma":[0.99869823,0.0002844003,0.00025549572,0.00041318074,0.0001298522,0.00021886261],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023570163,0.00024278698,0.0008279214,0.0001578218,0.00012414019,0.000009352003,0.00014552203,0.00033785473,0.0037473415],"category_scores_gemma":[0.00014903418,0.00019302688,0.00013471067,0.00022205997,0.00016887537,0.000089727706,0.000078595476,0.00033132365,0.00008869742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007645828,0.03085715,0.7909337,0.0014189058,0.0013730406,0.009459135,0.002040844,0.00029868956,0.06017657,0.008662798,0.0019255666,0.09208901],"study_design_scores_gemma":[0.0062250057,0.013949473,0.963334,0.000030222298,0.00042100344,0.0005292877,0.00020036697,0.0011408547,0.006657211,0.00009637736,0.0071734567,0.00024271567],"about_ca_topic_score_codex":0.000031183205,"about_ca_topic_score_gemma":0.000048639453,"teacher_disagreement_score":0.17240033,"about_ca_system_score_codex":0.00089833327,"about_ca_system_score_gemma":0.00026831048,"threshold_uncertainty_score":0.99716336},"labels":[],"label_agreement":null},{"id":"W2050126505","doi":"10.1016/s1470-2045(06)70983-4","title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","year":2006,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Coalition for Research in Women's Health; Hôtel-Dieu de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; Cancer Research Institute","keywords":"Ovarian cancer; BRCA mutation; Medicine; Gynecology; Odds ratio; Breast cancer; Tubal ligation; Family history; Cancer; Population; Oncology; Obstetrics; Case-control study; Internal medicine; Family planning; Environmental health","score_opus":0.04654725572640173,"score_gpt":0.3675856329846427,"score_spread":0.32103837725824097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050126505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98785317,0.00055166654,0.000104216284,0.006854351,0.0003163081,0.0030653372,0.0007154382,0.000024561285,0.000514922],"genre_scores_gemma":[0.99722123,0.00007211763,0.00040995548,0.00017857432,0.0006425674,0.0012340684,0.00001017565,0.000018799828,0.00021252311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986739,0.00026001688,0.00034985883,0.0003450967,0.00010217577,0.00026895103],"domain_scores_gemma":[0.9982837,0.0008925653,0.00024367051,0.00042912827,0.00011307653,0.00003786625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065677543,0.00014077537,0.0007036581,0.00008268379,0.000087158944,0.0000056717354,0.00008072313,0.00007604414,0.00017131068],"category_scores_gemma":[0.00030939656,0.00008140045,0.000077551034,0.0002318248,0.00010719063,0.00003269274,0.000014606727,0.00015923259,0.0000012760875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004181399,0.001914609,0.96258706,0.000055983463,0.0010435135,0.00080640515,0.008656402,0.0016604722,0.000064771615,0.00054186885,0.0019968755,0.016490642],"study_design_scores_gemma":[0.024308523,0.0031777758,0.9583552,0.000035697663,0.0013145449,0.00015716215,0.0074177794,0.00021109937,0.00031340617,0.00079602416,0.0037912258,0.000121543366],"about_ca_topic_score_codex":0.020566056,"about_ca_topic_score_gemma":0.03260537,"teacher_disagreement_score":0.020127123,"about_ca_system_score_codex":0.00040686494,"about_ca_system_score_gemma":0.0003875869,"threshold_uncertainty_score":0.9859561},"labels":[],"label_agreement":null},{"id":"W2050216612","doi":"10.1371/journal.pone.0028561","title":"Copy Number Variation Analysis of Matched Ovarian Primary Tumors and Peritoneal Metastasis","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; Qatar National Research Fund; Fonds National de la Recherche Luxembourg","keywords":"Ovarian cancer; Copy-number variation; Metastasis; Biology; Primary tumor; Cancer research; Carcinogenesis; Cancer; Oncology; Medicine; Internal medicine; Gene; Genome; Genetics","score_opus":0.05973313478702283,"score_gpt":0.2531991560302469,"score_spread":0.19346602124322407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050216612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932813,0.00014345841,0.00009642992,0.00042318905,0.000014954455,0.00027853233,0.000060413946,0.000027806338,0.005673882],"genre_scores_gemma":[0.9738896,0.00014644722,0.025503,0.00015110802,0.000036105113,0.00005225442,0.000077813704,0.000015112483,0.00012857617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906075,0.00003576104,0.00026416627,0.00023575535,0.00027071306,0.00013285909],"domain_scores_gemma":[0.9993598,0.000038938924,0.00012311217,0.0002699456,0.00010149617,0.00010670784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001355287,0.000116799056,0.00061914243,0.00014369475,0.000030776446,0.000008291525,0.000035874058,0.000050830404,0.0017415485],"category_scores_gemma":[0.000019955765,0.00010112499,0.00010121634,0.00042074668,0.000042062296,0.00006482997,0.000025504738,0.000060923536,0.000016975913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003107201,0.005084947,0.96811026,0.00020861585,0.017552389,0.00003729139,0.0024256434,5.3681185e-7,0.0042138156,0.0008963537,0.00004557162,0.0011138261],"study_design_scores_gemma":[0.0011815802,0.00019791584,0.9540226,0.000087983004,0.01833724,0.000003459063,0.00006313032,0.000102812155,0.02581228,0.0000906511,0.000009981827,0.00009036107],"about_ca_topic_score_codex":0.0007426698,"about_ca_topic_score_gemma":0.000026410607,"teacher_disagreement_score":0.025406571,"about_ca_system_score_codex":0.00007372017,"about_ca_system_score_gemma":0.000055113964,"threshold_uncertainty_score":0.999171},"labels":[],"label_agreement":null},{"id":"W2050573111","doi":"10.1016/j.ygyno.2012.08.038","title":"Five-year trends in mortality indices among gynecological cancer patients in Canada","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Mortality rate; Cervical cancer; Cancer; Cause of death; Ovarian cancer; Demography; Population; Epithelial ovarian cancer; Gynecology; Obstetrics; Internal medicine; Disease; Environmental health","score_opus":0.028050574929171665,"score_gpt":0.32555667076780054,"score_spread":0.29750609583862886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050573111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841957,0.0003132032,1.0332548e-7,0.0012014967,0.0010796849,0.00047737075,0.000044450033,0.00002173925,0.012666265],"genre_scores_gemma":[0.9972171,0.00026200814,0.000081001046,0.0014308045,0.00012059442,0.00059931853,0.00007857891,0.00001367695,0.00019689891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772274,0.00022836705,0.0005306493,0.00041795304,0.0002458929,0.0008544138],"domain_scores_gemma":[0.9987604,0.0004851296,0.00019950025,0.00022185135,0.000046711157,0.00028640698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036004122,0.0002424297,0.00075768324,0.00023508834,0.000045733083,0.0000057026837,0.0001328924,0.00031333556,0.005051165],"category_scores_gemma":[0.00021757363,0.00018793948,0.00007449463,0.0005023671,0.00010645786,0.00011666634,0.00009546119,0.00040312318,0.000023129152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006701524,0.0022260244,0.964284,0.000014524609,0.000069607435,0.00024214757,0.00021006624,0.000031285344,0.0000012769136,0.0000718986,0.0029053062,0.029876847],"study_design_scores_gemma":[0.004590433,0.0008759559,0.9883362,0.000019074692,0.00008592144,0.0000024302865,0.00029333358,0.00002014005,0.000027330012,0.000029110328,0.0055387057,0.0001813866],"about_ca_topic_score_codex":0.79043514,"about_ca_topic_score_gemma":0.9887664,"teacher_disagreement_score":0.19833122,"about_ca_system_score_codex":0.0074314517,"about_ca_system_score_gemma":0.0012571434,"threshold_uncertainty_score":0.99637884},"labels":[],"label_agreement":null},{"id":"W2050719655","doi":"10.3747/co.20.1492","title":"Opportunistic Salpingectomy: The Way Forward—Response to Steven Narod","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Ovarian carcinoma; Cancer; Law; Internal medicine; Political science","score_opus":0.11039658139036065,"score_gpt":0.4041995463541869,"score_spread":0.2938029649638263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050719655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8730042,0.0015702804,0.00026827314,0.11691268,0.0025191286,0.0022919644,0.00003585575,0.00009497197,0.0033026512],"genre_scores_gemma":[0.99528027,0.00015596516,0.00021302103,0.0020220676,0.0004006793,0.00096921274,0.000022751467,0.00002298244,0.000913062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987375,0.00017419277,0.00025540058,0.00030354058,0.00017912724,0.00035020837],"domain_scores_gemma":[0.99859613,0.00043949825,0.000076485194,0.00043821635,0.00013084032,0.00031884306],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032451996,0.00016687078,0.00034956867,0.00008765892,0.000101732665,0.000023672968,0.00014011703,0.00007422603,0.0013076907],"category_scores_gemma":[0.00024016773,0.000102306214,0.00010849229,0.00015383697,0.000074635405,0.000037442056,0.00008915901,0.00019142668,0.0013835776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010641213,0.001821663,0.034115046,0.00007535788,0.0002716895,0.00012762382,0.0014679736,0.0000031756308,0.00069437455,0.0019149242,0.1842592,0.7741848],"study_design_scores_gemma":[0.0023762954,0.0016757881,0.16652466,0.000073225165,0.00018247664,0.000056222703,0.00017993568,0.00005581143,0.000121608726,0.00021245872,0.82843,0.00011151651],"about_ca_topic_score_codex":0.000050362712,"about_ca_topic_score_gemma":0.000018311399,"teacher_disagreement_score":0.77407336,"about_ca_system_score_codex":0.0007075335,"about_ca_system_score_gemma":0.0004145057,"threshold_uncertainty_score":0.99960524},"labels":[],"label_agreement":null},{"id":"W2050940496","doi":"10.1097/00002142-200308000-00004","title":"Magnetic Resonance Imaging of Benign Adnexal Disease","year":2003,"lang":"en","type":"review","venue":"Topics in Magnetic Resonance Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Magnetic resonance imaging; Medicine; Adnexal Diseases; Malignancy; Radiology; Ovary; Ovarian Teratoma; Adnexal mass; Fibroma; Teratoma; Pathology; Laparoscopy","score_opus":0.026242548761189654,"score_gpt":0.31905467615739264,"score_spread":0.292812127396203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050940496","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003423556,0.9893,0.000011615537,0.0006302886,0.000538319,0.001747715,0.00011390238,0.00004994708,0.0075739883],"genre_scores_gemma":[0.00017650428,0.9915385,0.002617304,0.00038667256,0.00037935926,0.00051642145,0.000060901024,0.00014390261,0.0041804085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953562,0.00025964514,0.001544712,0.0012505873,0.0007002254,0.0008885983],"domain_scores_gemma":[0.9973621,0.00022823126,0.00040414595,0.0015110389,0.0001486108,0.00034590182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041816165,0.00084429816,0.0024400656,0.00048023983,0.000080518475,0.00006883431,0.00044087032,0.00015033744,0.0007709081],"category_scores_gemma":[0.0002214551,0.00076963013,0.00054252817,0.0008214144,0.00032647297,0.00011913477,0.00016249467,0.00074117194,0.000049506274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003271986,0.0003108804,0.02545332,0.005749805,0.000008602312,0.0011660479,0.00005371922,5.25464e-7,1.6637057e-7,0.0010916699,0.0012733077,0.96485925],"study_design_scores_gemma":[0.0017066976,0.00013405002,0.024676958,0.027981095,0.00090107473,0.00012464126,0.000017863804,0.000113825845,0.0000012083289,0.00050090277,0.9432713,0.00057041395],"about_ca_topic_score_codex":0.00012321075,"about_ca_topic_score_gemma":0.000014211343,"teacher_disagreement_score":0.96428883,"about_ca_system_score_codex":0.00055884494,"about_ca_system_score_gemma":0.0009943689,"threshold_uncertainty_score":0.9994755},"labels":[],"label_agreement":null},{"id":"W2051222694","doi":"10.1159/000184639","title":"Central Precocious Puberty following Feminizing Right Ovarian Granulosa Cell Tumor","year":2008,"lang":"en","type":"article","venue":"Hormone Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill-Queen's University Press","funders":"","keywords":"Precocious puberty; Endocrinology; Luteinizing hormone; Internal medicine; Medicine; Agonist; Hormone; Receptor","score_opus":0.06629772949310928,"score_gpt":0.33794813945480623,"score_spread":0.271650409961697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051222694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92489636,0.007377966,0.000046861962,0.0029349122,0.00023380411,0.0011014654,0.000017828634,0.00011486161,0.06327592],"genre_scores_gemma":[0.9927424,0.0015135375,0.0011315477,0.0001321151,0.00045153068,0.00018346778,0.000044408695,0.00005745556,0.0037435282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963562,0.00016458776,0.000336058,0.0005917348,0.0011417958,0.0014096516],"domain_scores_gemma":[0.9983828,0.00024988907,0.000050383063,0.0005866508,0.00015341028,0.0005768889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073705445,0.00023153426,0.00043330612,0.00025792178,0.0006080942,0.000052536365,0.0001875222,0.00011400177,0.00014093111],"category_scores_gemma":[0.00011029946,0.00018329211,0.00027662085,0.0005899245,0.00014846069,0.00013705101,0.000119519,0.00070508884,0.00021663522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020209611,0.008073509,0.5185419,0.00036159993,0.0015295196,0.040424585,0.008250571,0.00001429858,0.017924061,0.0014093401,0.38430953,0.017140152],"study_design_scores_gemma":[0.015051314,0.0025408117,0.8590458,0.0002454059,0.00029432893,0.0009454845,0.0007189323,0.00033826192,0.042043477,0.00064147863,0.07740417,0.0007305155],"about_ca_topic_score_codex":0.0009705458,"about_ca_topic_score_gemma":0.000045751374,"teacher_disagreement_score":0.34050393,"about_ca_system_score_codex":0.00066173874,"about_ca_system_score_gemma":0.00064691,"threshold_uncertainty_score":0.74744356},"labels":[],"label_agreement":null},{"id":"W2051861143","doi":"10.1016/j.path.2010.12.012","title":"Nonserous Ovarian Epithelial Tumors","year":2011,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Medicine; Serous fluid; Clear cell; Ovary; Pathology; Optimal distinctiveness theory; Internal medicine; Immunohistochemistry","score_opus":0.09142489826524777,"score_gpt":0.39060047574052204,"score_spread":0.29917557747527423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051861143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006719034,0.9843382,0.0000070976344,0.00015596724,0.0015948559,0.0011436167,0.00025571362,0.0001301572,0.012307185],"genre_scores_gemma":[0.00004510685,0.99524003,0.0007475534,0.00032126022,0.0011551527,0.00031666676,0.00035915375,0.00012851525,0.0016865372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611384,0.0005102436,0.0014841645,0.0010605383,0.00020472611,0.0006264648],"domain_scores_gemma":[0.9969574,0.0008429978,0.00057486806,0.0011006279,0.00009400141,0.0004300594],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007600442,0.00069609255,0.0042166333,0.00020456807,0.000091066475,0.000015325002,0.00026164114,0.0013581164,0.0014137045],"category_scores_gemma":[0.00019748507,0.00048403483,0.0016997271,0.0002938335,0.0003213947,0.000027078497,0.00016059505,0.0012413287,0.0025893187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104478284,0.00086402183,0.00020837334,0.002438596,0.00041380056,0.024135489,0.000027711074,2.2746969e-8,5.5714726e-9,0.0025850898,0.0004490829,0.9687733],"study_design_scores_gemma":[0.002051256,0.00090255606,0.00015834655,0.004548559,0.0034384327,0.006805391,0.000002584077,3.9156401e-7,1.6484341e-7,0.00027588438,0.9814214,0.00039502178],"about_ca_topic_score_codex":0.000016392683,"about_ca_topic_score_gemma":0.0000062534577,"teacher_disagreement_score":0.98097235,"about_ca_system_score_codex":0.00017137725,"about_ca_system_score_gemma":0.00093473925,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W2051950694","doi":"10.1016/j.ygyno.2014.03.121","title":"Evaluation of CA-125 response in the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Paclitaxel; Placebo; Clinical endpoint; Ovarian cancer; Oncology; Internal medicine; Post-hoc analysis; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical trial; Phases of clinical research; Pathology","score_opus":0.06933795730224084,"score_gpt":0.38087967814575274,"score_spread":0.3115417208435119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051950694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999155,0.00023089435,0.000003409023,0.004561266,0.00019736114,0.0032739362,0.0000140305965,0.000008587581,0.0017189777],"genre_scores_gemma":[0.9961496,0.00009902606,0.000111310874,0.00038042734,0.000039311686,0.003126467,0.0000044481044,0.00001177851,0.00007765327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99512166,0.002969072,0.00065070513,0.00039507385,0.0005054676,0.00035801597],"domain_scores_gemma":[0.9964445,0.0024245642,0.0003761371,0.00044156576,0.0002491621,0.00006405326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077939657,0.00019409164,0.00084881467,0.00028758988,0.000034684774,0.000004639285,0.00016941996,0.00016263762,0.0007699132],"category_scores_gemma":[0.0013255869,0.000106120315,0.00003631609,0.0006711092,0.00010850836,0.00003640993,0.0000388931,0.00023699108,0.0000042758456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17274785,0.02817477,0.26344076,0.0001648505,0.00081962126,0.00043003235,0.04728324,0.002924675,0.00018690091,0.000323019,0.0015627039,0.48194158],"study_design_scores_gemma":[0.04547073,0.053008612,0.8863174,0.00008242586,0.00044635354,0.00001447321,0.012153435,0.00046315667,0.000026434409,0.00014093984,0.0017697491,0.00010631218],"about_ca_topic_score_codex":0.0016509102,"about_ca_topic_score_gemma":0.03439103,"teacher_disagreement_score":0.6228766,"about_ca_system_score_codex":0.0031085203,"about_ca_system_score_gemma":0.0022325863,"threshold_uncertainty_score":0.9832288},"labels":[],"label_agreement":null},{"id":"W2051960191","doi":"10.1016/j.ygyno.2014.02.038","title":"“Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?","year":2014,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Clinical trial; Chemotherapy; Intensive care medicine; Oncology; Disease; Cancer; Internal medicine","score_opus":0.07161383321883226,"score_gpt":0.37289602804582245,"score_spread":0.3012821948269902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051960191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010965733,0.90457207,0.000013199302,0.08237842,0.001136512,0.004116209,0.00021025754,0.000080957485,0.007382733],"genre_scores_gemma":[0.00016838245,0.97146326,0.0012987686,0.013838617,0.000847946,0.0034346636,0.00009615073,0.00010704655,0.008745185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588746,0.0003663499,0.0007561747,0.0016528371,0.00038431433,0.00095285394],"domain_scores_gemma":[0.99593496,0.0013660371,0.00049289776,0.0010197321,0.00024535775,0.0009410213],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067556155,0.0009779888,0.005245146,0.00044657107,0.00022548965,0.00022268116,0.00033970678,0.0013668485,0.0014754841],"category_scores_gemma":[0.00040502026,0.00070271495,0.0004460518,0.00061160786,0.000106543026,0.00013841307,0.0002871439,0.00056357053,0.00031214554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012229249,0.00023179875,0.000098123644,0.00356903,0.0005256387,0.00033623134,0.0002584666,7.314334e-7,0.0000011061069,0.00024476208,0.10629075,0.8883211],"study_design_scores_gemma":[0.0018796637,0.0066387453,0.00071733486,0.009802141,0.004251507,0.00013853582,0.00017397957,0.000001103815,0.0000037473471,0.000047149708,0.9757359,0.0006101601],"about_ca_topic_score_codex":0.00018440072,"about_ca_topic_score_gemma":0.0018338518,"teacher_disagreement_score":0.8877109,"about_ca_system_score_codex":0.0028712628,"about_ca_system_score_gemma":0.0012640991,"threshold_uncertainty_score":0.9999296},"labels":[],"label_agreement":null},{"id":"W2052266277","doi":"10.1016/j.ygyno.2009.01.012","title":"A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"AstraZeneca","keywords":"Fulvestrant; Medicine; Ovarian cancer; Clinical endpoint; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cancer; Oncology; Progressive disease; Phases of clinical research; Gastroenterology; Breast cancer; Toxicity; Disease; Estrogen receptor; Clinical trial","score_opus":0.05204197889891651,"score_gpt":0.39162367403128223,"score_spread":0.3395816951323657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052266277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906016,0.00092089776,0.000002441509,0.0047730412,0.00034442035,0.0023776272,0.000051988336,0.000013930742,0.0009140526],"genre_scores_gemma":[0.9975826,0.0011050011,0.00023293516,0.00033877714,0.00010974088,0.0005751,0.000012152267,0.0000065400004,0.000037166734],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835503,0.00023876177,0.00058543595,0.0003316335,0.00019218975,0.0002969186],"domain_scores_gemma":[0.99887127,0.00037046257,0.0002584562,0.00035968376,0.000069797214,0.000070340626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025390415,0.0002109502,0.0008324403,0.00013406617,0.00006186442,0.0000028044979,0.00013139549,0.00013396515,0.0003085511],"category_scores_gemma":[0.00004821309,0.000118571166,0.00014137174,0.00026283436,0.00008724794,0.000022596618,0.000013885821,0.000114286304,0.0000031913303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018930165,0.22766937,0.027398292,0.000017987863,0.0003032371,0.0005327417,0.014647461,0.000052812902,0.0010862005,0.00022436981,0.0001564828,0.726018],"study_design_scores_gemma":[0.06429524,0.4039449,0.51422524,0.00003806773,0.0007407916,0.000025184141,0.003043641,0.00008076678,0.0012806106,0.00016596058,0.012027694,0.00013189531],"about_ca_topic_score_codex":0.0007873612,"about_ca_topic_score_gemma":0.0024705497,"teacher_disagreement_score":0.7258861,"about_ca_system_score_codex":0.0005709423,"about_ca_system_score_gemma":0.00034094186,"threshold_uncertainty_score":0.4835192},"labels":[],"label_agreement":null},{"id":"W2052289427","doi":"10.1097/ruq.0b013e3181fdd604","title":"ACR Appropriateness Criteria© Ovarian Cancer Screening","year":2010,"lang":"en","type":"review","venue":"Ultrasound Quarterly","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Disease; Oncology; Stage (stratigraphy); Gynecology; Cancer; Clinical trial; Internal medicine","score_opus":0.04994008398073509,"score_gpt":0.36859013695827636,"score_spread":0.3186500529775413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052289427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007658386,0.993326,0.00031938864,0.00023656832,0.0019600918,0.0018126032,0.0004368087,0.00018149524,0.0016504617],"genre_scores_gemma":[0.00018665334,0.99062127,0.0029606828,0.000207762,0.002569984,0.0014552773,0.00074800267,0.00021529102,0.0010350591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667966,0.00014078448,0.0009140892,0.0010719462,0.00047444223,0.00071906386],"domain_scores_gemma":[0.9974318,0.00036377748,0.0004634437,0.0011577574,0.000151841,0.000431346],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002877358,0.0009166663,0.0028147933,0.00026891936,0.0001951047,0.00024864287,0.0003169188,0.0008626852,0.0021945608],"category_scores_gemma":[0.000040762614,0.0006774284,0.0009850402,0.00041582304,0.00011793446,0.00014467264,0.000019498777,0.0010492291,0.00029895155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024564117,0.00028834306,0.00006842333,0.0064219986,0.00088499155,0.00019057318,0.00035079353,3.6410967e-8,0.00000916684,0.0001705124,0.001093774,0.9904968],"study_design_scores_gemma":[0.0012257071,0.00049179525,0.00029902122,0.013644423,0.0046281926,0.00077909965,0.00007253934,0.0000010821578,0.0000038131366,0.000053292762,0.9781527,0.0006483346],"about_ca_topic_score_codex":0.00059235515,"about_ca_topic_score_gemma":0.00013114118,"teacher_disagreement_score":0.9898485,"about_ca_system_score_codex":0.00026327698,"about_ca_system_score_gemma":0.00072567764,"threshold_uncertainty_score":0.9995677},"labels":[],"label_agreement":null},{"id":"W2052357722","doi":"10.1593/neo.04760","title":"High-Resolution Mapping of Genomic Imbalance and Identification of Gene Expression Profiles Associated with Differential Chemotherapy Response in Serous Epithelial Ovarian Cancer","year":2005,"lang":"en","type":"article","venue":"Neoplasia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Women's College Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"Government of Ontario; Genome Canada","keywords":"Biology; Comparative genomic hybridization; Ovarian cancer; Gene; Cancer research; Microarray; Gene expression profiling; Gene expression; Serous fluid; Molecular biology; Microarray analysis techniques; Genetics; Cancer; Genome","score_opus":0.009964928491161604,"score_gpt":0.24349862129729874,"score_spread":0.23353369280613714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052357722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788237,0.00033428273,0.000349834,0.0008179748,0.000058939655,0.0004480419,0.00008711427,0.000014412962,0.000007006242],"genre_scores_gemma":[0.99797475,0.00022974075,0.0014856285,0.000028365066,0.00008111812,0.00008155238,0.00003740012,0.000017554852,0.000063880456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990563,0.00007516783,0.0003299179,0.00022744313,0.0001723357,0.00013887667],"domain_scores_gemma":[0.9994,0.000053087322,0.00027612672,0.00016527658,0.00006498242,0.000040504277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016039451,0.00011810105,0.00029953624,0.000111798596,0.00002884987,0.00000722633,0.000038982067,0.00008465046,0.000049320217],"category_scores_gemma":[0.000020254674,0.00009504826,0.000028772487,0.000120205645,0.00004916852,0.000055343004,0.000010185616,0.000070422255,9.71307e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037325297,0.0003606756,0.15805477,0.000045513883,0.00008650906,0.000004543046,0.0009013362,0.00022375125,0.83269113,0.000015917434,0.000024942168,0.0038583777],"study_design_scores_gemma":[0.0039146626,0.00016880468,0.659571,0.0002691104,0.000038041137,0.0000038158914,0.000027148057,0.00045622975,0.33547577,0.000005638954,0.000017712042,0.000052085146],"about_ca_topic_score_codex":0.00023493773,"about_ca_topic_score_gemma":0.00012078137,"teacher_disagreement_score":0.5015162,"about_ca_system_score_codex":0.00022365294,"about_ca_system_score_gemma":0.000109591136,"threshold_uncertainty_score":0.38759556},"labels":[],"label_agreement":null},{"id":"W2052562237","doi":"10.1158/0008-5472.can-05-1785","title":"Gonadotropins Activate Proteolysis and Increase Invasion through Protein Kinase A and Phosphatidylinositol 3-Kinase Pathways in Human Epithelial Ovarian Cancer Cells","year":2006,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Proteolysis; Phosphatidylinositol; Kinase; Ovarian cancer; Cancer research; Cancer; Biology; Protein kinase A; Cell biology; Internal medicine; Medicine; Enzyme; Biochemistry","score_opus":0.05080814047093385,"score_gpt":0.3478654305532728,"score_spread":0.29705729008233894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052562237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98762494,0.0043194736,0.000010458535,0.0037774672,0.000054473407,0.0034713617,0.00020072011,0.00003815074,0.0005029705],"genre_scores_gemma":[0.9921168,0.0017512362,0.0004214775,0.00014804647,0.00043208955,0.004594219,0.000034231423,0.000060234037,0.00044164347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970838,0.00025693027,0.00039481593,0.0008630438,0.0006581249,0.00074331043],"domain_scores_gemma":[0.9988573,0.0000863584,0.00010133682,0.00044899574,0.00020974867,0.00029626084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044432018,0.00031550342,0.0005209404,0.0002857802,0.00036851023,0.00011368394,0.00012306604,0.00017409363,0.00030995696],"category_scores_gemma":[0.00004335943,0.00026452227,0.00006874092,0.00065250404,0.00033133038,0.00023027304,0.0001873141,0.0005801973,0.0000071154677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012658555,0.0011757173,0.049725052,0.0007651842,0.0001224301,0.0010464817,0.00090599945,0.000016822234,0.9231139,0.0016896863,0.0007521764,0.019420717],"study_design_scores_gemma":[0.008000584,0.0006540985,0.11258568,0.001627555,0.000086250904,0.00001069404,0.00013711663,0.000058708705,0.8714222,0.0012629934,0.0038286415,0.0003254949],"about_ca_topic_score_codex":0.10669816,"about_ca_topic_score_gemma":0.005025832,"teacher_disagreement_score":0.10167233,"about_ca_system_score_codex":0.0008874799,"about_ca_system_score_gemma":0.000668551,"threshold_uncertainty_score":0.9999807},"labels":[],"label_agreement":null},{"id":"W2053358503","doi":"10.1097/igc.0b013e31821bb8aa","title":"Clinical Trials in Recurrent Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Transplant Association","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Medicine; Ovarian cancer; Gynecologic cancer; Clinical trial; Consensus conference; Oncology; Gynecology; Epithelial ovarian cancer; Randomized controlled trial; Cancer; Internal medicine","score_opus":0.4619277207717376,"score_gpt":0.5798671776175781,"score_spread":0.1179394568458405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053358503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001284361,0.98580235,0.000015326923,0.0016781753,0.010381108,0.0007872008,0.00016947131,0.000009858305,0.0010280664],"genre_scores_gemma":[0.00043126728,0.9938451,0.00041902813,0.00066109607,0.003986211,0.00034861936,0.000022502567,0.00003645643,0.00024972289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927614,0.0013185162,0.0045472845,0.0004432095,0.00062887045,0.00030076565],"domain_scores_gemma":[0.99237674,0.0028290465,0.0035778796,0.00020984828,0.0006763085,0.00033017556],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005131267,0.00042732785,0.0051265983,0.0004866295,0.000020310428,0.000045645967,0.0005770733,0.00061751105,0.010954848],"category_scores_gemma":[0.0035359953,0.00024760957,0.0026041728,0.00022432898,0.00010411799,0.000094502444,0.000117716634,0.0013853667,0.00004260642],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044315468,0.0013203233,0.006750164,0.000509354,0.0028673697,0.0011595748,0.000021615882,0.0000011895778,4.1514493e-8,0.00030738235,0.005689683,0.98093015],"study_design_scores_gemma":[0.003168995,0.00084155716,0.013189427,0.01781348,0.0026381372,0.00018926263,0.000005257436,0.0000017153262,5.222561e-7,0.00019156375,0.96174634,0.00021372593],"about_ca_topic_score_codex":0.00014398989,"about_ca_topic_score_gemma":0.00019188806,"teacher_disagreement_score":0.9807164,"about_ca_system_score_codex":0.0020339277,"about_ca_system_score_gemma":0.002515606,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W2053483138","doi":"10.1593/neo.07238","title":"Early Alterations in Ovarian Surface Epithelial Cells and Induction of Ovarian Epithelial Tumors Triggered by Loss of FSH Receptor","year":2007,"lang":"en","type":"article","venue":"Neoplasia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Ludwig Institute for Cancer Research","keywords":"Biology; Ovary; Endocrinology; Internal medicine; Follicle-stimulating hormone receptor; Ovulation; Follicle-stimulating hormone; Hormone; Luteinizing hormone; Medicine","score_opus":0.010273481422397347,"score_gpt":0.2500176229975508,"score_spread":0.23974414157515347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053483138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970611,0.00015129993,0.00023596059,0.00070219743,0.00036375408,0.0005549637,0.00032497078,0.000014895461,0.00059085514],"genre_scores_gemma":[0.9970442,0.00011718334,0.0022998159,0.000046887257,0.00014984226,0.000011275481,0.00005113283,0.000024542407,0.00025510084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984947,0.00006133899,0.00059977116,0.00031131122,0.0002748473,0.00025801742],"domain_scores_gemma":[0.99915683,0.00012941935,0.00022257282,0.00024805544,0.00009762552,0.00014547538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004197514,0.00018118118,0.00047273107,0.00015593063,0.00006184028,0.000011978802,0.00006121962,0.0001549228,0.0001620972],"category_scores_gemma":[0.00003842022,0.00016628922,0.000075718424,0.00033715038,0.00010963159,0.00010699572,0.00003528385,0.00017548788,0.00001075972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002772329,0.0019425498,0.10898113,0.000207015,0.00030422583,0.000088471534,0.006660566,0.000052827156,0.8631336,0.0016091455,0.001257266,0.01299084],"study_design_scores_gemma":[0.007878176,0.001054696,0.2756188,0.00024079667,0.00014983186,0.00003601788,0.00027487066,0.000022230315,0.71242684,0.00014548696,0.0019666879,0.00018559155],"about_ca_topic_score_codex":0.0019329268,"about_ca_topic_score_gemma":0.00021115164,"teacher_disagreement_score":0.16663767,"about_ca_system_score_codex":0.000104905375,"about_ca_system_score_gemma":0.00015832501,"threshold_uncertainty_score":0.67810774},"labels":[],"label_agreement":null},{"id":"W2053496544","doi":"10.1097/00004347-200210000-00011","title":"Histopathologic Features of Genetically Determined Ovarian Cancer","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Serous fluid; Ovarian cancer; Germline; Germline mutation; Ovarian carcinoma; Pathology; Grading (engineering); Oncology; Serous carcinoma; Medicine; Histology; Internal medicine; Biology; Cancer; Mutation; Gene; Genetics","score_opus":0.031033855493776595,"score_gpt":0.3088986220463099,"score_spread":0.27786476655253334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053496544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753015,0.0031462177,0.00026808304,0.013901399,0.0016654882,0.00015874926,0.000025028945,0.000013474224,0.0055200765],"genre_scores_gemma":[0.9905022,0.0015089171,0.0055476977,0.0017627139,0.00036659985,0.000014852555,0.0000027767305,0.000009251837,0.00028503776],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857515,0.00009776337,0.00060959125,0.00018592,0.0003514343,0.00018012445],"domain_scores_gemma":[0.9984561,0.00025963326,0.00045625205,0.00013183734,0.00057048065,0.00012567971],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021442259,0.00013833694,0.0004892842,0.00017851887,0.000022081647,0.000009463837,0.00025999977,0.00017433245,0.0035378432],"category_scores_gemma":[0.0005632811,0.00009240565,0.00025420717,0.000075856406,0.00019041378,0.000044804863,0.000060655708,0.00025271764,0.000015421188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015604423,0.0059781866,0.43011898,0.00004236885,0.0010721828,0.041965637,0.00055169634,0.00014476157,0.045335427,0.0053162896,0.011916699,0.45599735],"study_design_scores_gemma":[0.0036545056,0.0028765283,0.9787775,0.00006570156,0.00021495784,0.0055041434,0.000018903944,0.000043429874,0.0024578916,0.0012769556,0.004999635,0.00010982829],"about_ca_topic_score_codex":0.000008956498,"about_ca_topic_score_gemma":0.000009093742,"teacher_disagreement_score":0.54865855,"about_ca_system_score_codex":0.00021212037,"about_ca_system_score_gemma":0.00006176431,"threshold_uncertainty_score":0.99737304},"labels":[],"label_agreement":null},{"id":"W2053974737","doi":"10.1006/gyno.2000.5926","title":"A Critique of Surgical Cytoreduction in Advanced Ovarian Cancer","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Perioperative; Disease; Quality of life (healthcare); Randomized controlled trial; Surgery; General surgery; Retrospective cohort study; Intensive care medicine; Cancer; Internal medicine","score_opus":0.016943024848871165,"score_gpt":0.35198174616733596,"score_spread":0.3350387213184648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053974737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95192873,0.00082654867,0.0000018439499,0.013052528,0.00032483827,0.0005092297,0.000012732942,0.00003383937,0.033309694],"genre_scores_gemma":[0.9928387,0.0039694654,0.0010871931,0.00054313295,0.000133615,0.0004432784,0.000014367768,0.000010645091,0.0009596249],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988567,0.000111573376,0.0003518848,0.00030686124,0.00009690481,0.00027605536],"domain_scores_gemma":[0.99938333,0.00021714934,0.00007449645,0.00017895938,0.000055910074,0.00009015921],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001791536,0.00012678133,0.0005247113,0.000097626886,0.000026313819,0.0000023971218,0.00005631083,0.00023421929,0.011103647],"category_scores_gemma":[0.000040245814,0.000103678045,0.00008576247,0.00023796984,0.000106200314,0.000047372396,0.00001356883,0.00017812608,0.000037367096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013747548,0.0031671168,0.12315182,0.000065016335,0.00011234943,0.0014730812,0.00031377288,0.00035377132,0.0005682072,0.002031701,0.0017606975,0.8656277],"study_design_scores_gemma":[0.012293712,0.0042389478,0.68462795,0.000091878195,0.00013171669,0.00027460977,0.00016902834,0.00006209817,0.001763803,0.0008734325,0.29529804,0.000174768],"about_ca_topic_score_codex":0.00048263802,"about_ca_topic_score_gemma":0.00061537436,"teacher_disagreement_score":0.86545295,"about_ca_system_score_codex":0.0006855001,"about_ca_system_score_gemma":0.00040175227,"threshold_uncertainty_score":0.98980033},"labels":[],"label_agreement":null},{"id":"W2054009413","doi":"10.1016/j.ygyno.2014.06.011","title":"Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Intraperitoneal chemotherapy; Ovarian cancer; Oncology; Chemotherapy; Gynecology; Cancer; Internal medicine","score_opus":0.01047705733791128,"score_gpt":0.2887194723815612,"score_spread":0.27824241504364994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054009413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96998626,0.00006673002,0.00002280194,0.023709908,0.00029962944,0.0006983431,0.0000062267754,0.000040029896,0.0051700626],"genre_scores_gemma":[0.99073035,0.00016874414,0.00041677116,0.006939335,0.00043241476,0.0011695913,0.000029385394,0.000016361557,0.000097064505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984865,0.0002617404,0.000252586,0.00032806146,0.0002072553,0.00046385967],"domain_scores_gemma":[0.99903715,0.00041048904,0.00012291917,0.0002671069,0.00004161636,0.00012074291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000712311,0.00017087368,0.0004670215,0.000079173675,0.0000845975,0.000013821258,0.00013315736,0.0002232261,0.0012372498],"category_scores_gemma":[0.000102242564,0.000093492745,0.000045463552,0.00022635006,0.0001522082,0.000044848643,0.000017068642,0.0002601953,0.000012338352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033289773,0.000611704,0.79746073,0.000019689862,0.00010313077,0.00012114526,0.0026348054,0.00003203076,0.00003452099,0.00056300126,0.00050093967,0.19758542],"study_design_scores_gemma":[0.005544676,0.0032748186,0.9591412,0.000026775491,0.00006338065,0.000034713776,0.000668599,0.00011420924,0.000034526987,0.0004391008,0.030549262,0.00010875469],"about_ca_topic_score_codex":0.001271246,"about_ca_topic_score_gemma":0.0043469435,"teacher_disagreement_score":0.19747667,"about_ca_system_score_codex":0.001041286,"about_ca_system_score_gemma":0.00022466495,"threshold_uncertainty_score":0.99967575},"labels":[],"label_agreement":null},{"id":"W2054057449","doi":"10.1148/rg.326125511","title":"Ovarian Carcinomatosis: How the Radiologist Can Help Plan the Surgical Approach","year":2012,"lang":"en","type":"review","venue":"Radiographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Radiology; Ovarian carcinoma; Malignancy; Peritoneal cavity; Abdomen; Surgery; Pathology; Cancer; Internal medicine","score_opus":0.11832271374286912,"score_gpt":0.30715599284247025,"score_spread":0.18883327909960113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054057449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012528812,0.9887017,0.000015596423,0.0051176553,0.0006584254,0.002633493,0.00026221797,0.0001029899,0.00249538],"genre_scores_gemma":[0.0053264117,0.98935014,0.0001442882,0.0002671055,0.0024228152,0.0014397554,0.0006923995,0.00012002518,0.00023706697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662817,0.00069919624,0.0005652206,0.0007090621,0.0005730636,0.00082526566],"domain_scores_gemma":[0.9966062,0.00071773253,0.00042646052,0.0018179755,0.00006230697,0.00036932892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009954943,0.0008333048,0.0023115803,0.00030324876,0.00047596853,0.00016417103,0.00068623485,0.000659343,0.000034824945],"category_scores_gemma":[0.0000292614,0.00035346832,0.001971027,0.0013681096,0.00067698746,0.000040589428,0.000108085136,0.001318459,0.000012863185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005264942,0.0010523819,0.019398764,0.012728295,0.008494369,0.00054459483,0.0006026698,9.113968e-7,1.6417479e-8,0.022601856,0.025494425,0.90902907],"study_design_scores_gemma":[0.0007381491,0.00012989122,0.001443357,0.0015890489,0.010198967,0.0034485755,0.00011217935,0.000005637857,1.1154456e-7,0.00001605184,0.9819433,0.00037473135],"about_ca_topic_score_codex":0.00024917218,"about_ca_topic_score_gemma":0.00003774951,"teacher_disagreement_score":0.95644885,"about_ca_system_score_codex":0.00023615139,"about_ca_system_score_gemma":0.00045186156,"threshold_uncertainty_score":0.99989176},"labels":[],"label_agreement":null},{"id":"W2054058496","doi":"10.1055/s-2006-921345","title":"Diagnostik und Therapie maligner Ovarialtumoren 2005: Die Empfehlungen der Kommission Ovar der AGO","year":2006,"lang":"de","type":"article","venue":"Zentralblatt für Gynäkologie","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; General surgery; Family medicine","score_opus":0.02055372463452821,"score_gpt":0.31137940582163415,"score_spread":0.29082568118710594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054058496","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099358834,0.7955019,0.0006292732,0.062330823,0.014586325,0.0051982864,0.0008444837,0.00094686094,0.020603225],"genre_scores_gemma":[0.9239632,0.04565843,0.0032119795,0.004731885,0.009380381,0.0005708553,0.0016829518,0.0004692038,0.010331123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99170446,0.0004367592,0.0016957732,0.0020446277,0.0011793249,0.0029390717],"domain_scores_gemma":[0.9950577,0.0010672123,0.0007018446,0.0019099882,0.0002928008,0.00097046216],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00077629543,0.001521127,0.0018087766,0.00034871622,0.00062296103,0.0003251116,0.0007161947,0.0010549516,0.011802849],"category_scores_gemma":[0.00033932595,0.0012055929,0.0008283324,0.0005044028,0.0005332023,0.00033956175,0.0003714945,0.0008599265,0.004511569],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014251315,0.0051583536,0.29194817,0.0003279915,0.009470423,0.007760168,0.0004689254,0.00036169862,0.00065656094,0.003619364,0.6332171,0.04558613],"study_design_scores_gemma":[0.009014181,0.0013283119,0.31437972,0.0007228383,0.009636884,0.00003756691,0.00006305661,0.00010233069,0.011972045,0.0035795935,0.64775527,0.0014082069],"about_ca_topic_score_codex":0.0027123936,"about_ca_topic_score_gemma":0.00026375917,"teacher_disagreement_score":0.82460433,"about_ca_system_score_codex":0.0013192964,"about_ca_system_score_gemma":0.0009095522,"threshold_uncertainty_score":0.9997538},"labels":[],"label_agreement":null},{"id":"W2054139086","doi":"10.1111/igc.0b013e31819c54db","title":"Cardiac Arrest During Laparotomy With Argon Beam Coagulation of Metastatic Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Laparotomy; Ovarian cancer; Coagulation; Internal medicine; Oncology; Cancer; Radiology","score_opus":0.022258698417812074,"score_gpt":0.32643685038215126,"score_spread":0.30417815196433917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054139086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030095,0.0012560219,0.00009103288,0.006489122,0.00096827943,0.00029160627,0.000048554208,0.000009808969,0.0005446218],"genre_scores_gemma":[0.99673575,0.0010988944,0.00093368534,0.0004733291,0.0006004272,0.000044515025,0.000007163022,0.0000096084905,0.000096642645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984943,0.00003743101,0.0004959895,0.00016363747,0.000645243,0.00016335286],"domain_scores_gemma":[0.99840355,0.00011483057,0.000535829,0.00009882878,0.0007149538,0.00013202784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016002599,0.0001489179,0.0004863474,0.00013942299,0.00003247981,0.00002241498,0.00014080957,0.00005498868,0.0007667991],"category_scores_gemma":[0.00007311485,0.000094912066,0.00018780337,0.00013301242,0.00005800716,0.0001440194,0.000015572423,0.00018855724,0.000002322275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066342186,0.0027118106,0.89866126,0.000104162435,0.0054441243,0.0013844218,0.0004190792,0.01578675,0.014701393,0.0013712194,0.0014827037,0.05129883],"study_design_scores_gemma":[0.003966317,0.0011473058,0.9739926,0.00039751912,0.00045041696,0.000050210507,0.000039204002,0.00003318223,0.017395604,0.00021587875,0.0022037635,0.000107987624],"about_ca_topic_score_codex":0.00011799243,"about_ca_topic_score_gemma":0.000043137476,"teacher_disagreement_score":0.07533132,"about_ca_system_score_codex":0.00056789117,"about_ca_system_score_gemma":0.00030439947,"threshold_uncertainty_score":0.8395912},"labels":[],"label_agreement":null},{"id":"W2054146518","doi":"10.1186/1471-2407-11-210","title":"Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients","year":2011,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Cancer Research Society","keywords":"Surgical oncology; Medicine; Ascites; Ovarian cancer; Oncology; Internal medicine; Cancer; Gynecology; General surgery","score_opus":0.06031674189053925,"score_gpt":0.2935587730519888,"score_spread":0.23324203116144954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054146518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993929,0.002808001,0.000036562957,0.0002004791,0.00028353912,0.0010189367,0.0003425427,0.000018353916,0.0013625412],"genre_scores_gemma":[0.9967756,0.0006764305,0.0011853249,0.00018567825,0.000095570525,0.0008023583,0.000007864379,0.0000272619,0.00024386852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877226,0.000033498367,0.0003240825,0.0003745846,0.00022162448,0.00027393005],"domain_scores_gemma":[0.9993047,0.00007739082,0.0001431739,0.00021749703,0.00012965078,0.00012755394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091723734,0.00018553116,0.000384481,0.000110822904,0.000028396335,0.000008113959,0.00006709692,0.00007640451,0.0008133964],"category_scores_gemma":[0.00005616027,0.00015347324,0.000057673213,0.00025083637,0.00010113561,0.00008687872,0.00003477594,0.0000968062,0.000005537318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017412222,0.0005511201,0.9870569,0.00023682162,0.00008621711,0.000009048761,0.00091580895,0.0000051831767,0.0004020924,0.0001824007,0.0002907452,0.010089536],"study_design_scores_gemma":[0.0031505714,0.0003092522,0.98566675,0.000572114,0.00016324299,0.0000011273997,0.00004968346,0.000024620867,0.008845497,0.00013578503,0.00092824566,0.00015312262],"about_ca_topic_score_codex":0.0061379233,"about_ca_topic_score_gemma":0.0031422875,"teacher_disagreement_score":0.009936414,"about_ca_system_score_codex":0.00020110332,"about_ca_system_score_gemma":0.0003637809,"threshold_uncertainty_score":0.9278745},"labels":[],"label_agreement":null},{"id":"W2054451866","doi":"10.1159/000292725","title":"Postmenopausal Hyperandrogenism of Ovarian Origin","year":2010,"lang":"en","type":"article","venue":"Gynecologic and Obstetric Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Virilization; Hyperandrogenism; hirsutism; Medicine; Hyperplasia; Polycystic ovarian disease; Stromal cell; Androstenedione; Endometrial hyperplasia; Pathology; Gynecology; Androgen; Internal medicine; Polycystic ovary; Hormone","score_opus":0.01845161620753861,"score_gpt":0.25280337898961136,"score_spread":0.23435176278207276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054451866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445844,0.0003731428,0.000018750743,0.001063112,0.00046539743,0.0003333812,0.0000071440973,0.00003170707,0.0032489214],"genre_scores_gemma":[0.99466825,0.00009724744,0.004427594,0.0005003249,0.00007052119,0.00003133702,0.000031814096,0.000007852168,0.00016509302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930507,0.000020729642,0.00020715798,0.0002026217,0.00012781566,0.00013660532],"domain_scores_gemma":[0.9992905,0.00023448784,0.00009229609,0.00016552955,0.00008166943,0.00013549232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001333692,0.000105827836,0.00021567514,0.00011791204,0.00006412162,0.000010766072,0.00003311139,0.00012880829,0.00019373505],"category_scores_gemma":[0.00038455712,0.00007997247,0.00003359655,0.00027844383,0.00013025837,0.00005560275,0.000016785852,0.00014056524,0.000013395148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005005411,0.00031725533,0.896911,0.00010461672,0.000109723645,0.00007041323,0.00036545313,0.0000068889476,0.02843814,0.032179553,0.0004307433,0.04101614],"study_design_scores_gemma":[0.0027635593,0.0009489208,0.97789204,0.000018993165,0.00021241017,0.00008278399,0.000049716375,0.0005184971,0.010635795,0.004164471,0.0025876113,0.00012520154],"about_ca_topic_score_codex":0.000047706126,"about_ca_topic_score_gemma":0.000009012874,"teacher_disagreement_score":0.08098102,"about_ca_system_score_codex":0.00003388247,"about_ca_system_score_gemma":0.00012355129,"threshold_uncertainty_score":0.32611826},"labels":[],"label_agreement":null},{"id":"W2055272681","doi":"10.1111/j.1525-1438.2003.13357.x","title":"Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Paclitaxel; Cisplatin; Regimen; Oncology; Cyclophosphamide; Chemotherapy; Internal medicine; Ovarian cancer; Randomized controlled trial; Cancer","score_opus":0.021486651551304473,"score_gpt":0.3305047550723723,"score_spread":0.30901810352106784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055272681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841762,0.0021034058,0.000073552415,0.0074436218,0.0038389412,0.000575061,0.00005574008,0.000006788379,0.0017266596],"genre_scores_gemma":[0.99626184,0.0017524633,0.00013126424,0.00096979394,0.00016372307,0.00010745045,0.0000056715517,0.000019507122,0.0005882791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741477,0.0002240298,0.0008853872,0.00025331342,0.000954476,0.00026801566],"domain_scores_gemma":[0.997406,0.00071611593,0.0009344358,0.00023892046,0.0005993653,0.000105180574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066372834,0.00022924948,0.0005308494,0.00011249307,0.00006994844,0.00003441093,0.00040421332,0.00013535914,0.0025646626],"category_scores_gemma":[0.00066987437,0.00012294204,0.000321351,0.0002834656,0.0001628435,0.00017131407,0.00006860309,0.0004660701,0.000002914616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010719824,0.00065319607,0.9730106,0.000022213288,0.0005349871,0.00018146467,0.0002821642,0.00035382912,0.0006430847,0.005654917,0.00036453197,0.017227024],"study_design_scores_gemma":[0.010873986,0.0004431976,0.98177105,0.00046068232,0.0001729895,0.0000541737,0.0001311501,0.000036485126,0.0025708866,0.0010205414,0.0023335882,0.00013124332],"about_ca_topic_score_codex":0.00022579319,"about_ca_topic_score_gemma":0.0010437103,"teacher_disagreement_score":0.01709578,"about_ca_system_score_codex":0.0009590904,"about_ca_system_score_gemma":0.00050091126,"threshold_uncertainty_score":0.9983471},"labels":[],"label_agreement":null},{"id":"W2055638608","doi":"10.1111/j.1525-1438.2005.15355.x","title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Gemcitabine; Ovarian cancer; Internal medicine; Oncology; Hazard ratio; Regimen; Chemotherapy; Cancer; Surgery; Confidence interval; Cisplatin","score_opus":0.02572366799496827,"score_gpt":0.3329184474933183,"score_spread":0.30719477949835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055638608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555634,0.0045048194,0.000026652204,0.038739074,0.000421489,0.0001907955,0.000011332809,0.0000059288714,0.00053646],"genre_scores_gemma":[0.988745,0.008562139,0.0007279498,0.0013687009,0.00042987886,0.000059084912,0.0000033939357,0.000008570531,0.000095293086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998987,0.000031501786,0.00033158864,0.00014480708,0.00037961148,0.00012549404],"domain_scores_gemma":[0.9991644,0.00010752395,0.00022407579,0.00005138185,0.00035887834,0.000093728006],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016223501,0.000114034054,0.0002595942,0.0001402842,0.000018810302,0.00002590336,0.00008509457,0.000059507744,0.001173662],"category_scores_gemma":[0.000044420794,0.0000702587,0.000051646577,0.00009549799,0.00004792814,0.00012672367,0.000017851187,0.00020680879,0.0000014526543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018204417,0.0011442328,0.50130624,0.0000066505786,0.00037307973,0.00023999144,0.00023518347,0.0003446982,0.00026082897,0.00081956503,0.00046795126,0.49298117],"study_design_scores_gemma":[0.009794781,0.0013694006,0.9708331,0.00021232245,0.000046698955,0.00009928877,0.000026937158,0.00026412425,0.0006934869,0.00016934311,0.016400615,0.00008990498],"about_ca_topic_score_codex":0.00014979846,"about_ca_topic_score_gemma":0.00072487065,"teacher_disagreement_score":0.49289125,"about_ca_system_score_codex":0.00068599544,"about_ca_system_score_gemma":0.00019283016,"threshold_uncertainty_score":0.9997394},"labels":[],"label_agreement":null},{"id":"W2056312147","doi":"10.1016/j.jpedsurg.2004.01.034","title":"Ovarian torsion in children: is oophorectomy necessary?","year":2004,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Oophorectomy; Ovarian torsion; Ovary; Surgery; Follicular phase; Gynecology; Internal medicine; Hysterectomy","score_opus":0.015258275954345797,"score_gpt":0.2583343835609814,"score_spread":0.2430761076066356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056312147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010295,0.0053091766,0.000018504596,0.0034047586,0.00076272595,0.00013522364,0.000004559097,0.000008733051,0.00025335446],"genre_scores_gemma":[0.98793066,0.0065523805,0.0005650382,0.00062490173,0.004279817,0.0000040558134,0.000003900342,0.000019065208,0.00002020379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985286,0.000032384152,0.00062834483,0.00015448226,0.00039839503,0.00025781404],"domain_scores_gemma":[0.9990214,0.00013834269,0.0003619949,0.00015819,0.00012232337,0.00019776667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005201557,0.00014482753,0.00049776764,0.00063224457,0.000038239927,0.00001861166,0.000061215775,0.00009482454,0.0002858855],"category_scores_gemma":[0.0001146912,0.00011070434,0.00031875906,0.00063788256,0.000013088312,0.0001473285,0.000018635648,0.00025063832,0.00002741021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013774165,0.00065643276,0.9683884,0.000019958112,0.0000930271,0.00053304655,0.00013396406,0.00001866361,0.000010018477,0.000011934707,0.02711386,0.0028829766],"study_design_scores_gemma":[0.003310228,0.00022196365,0.99377346,0.000096807125,0.00030285827,0.00040832517,0.000039997125,8.0699675e-7,0.00062807405,0.00015998918,0.00093744945,0.00012004145],"about_ca_topic_score_codex":0.00017710481,"about_ca_topic_score_gemma":0.0000033961953,"teacher_disagreement_score":0.026176412,"about_ca_system_score_codex":0.00035571854,"about_ca_system_score_gemma":0.0007052134,"threshold_uncertainty_score":0.4514392},"labels":[],"label_agreement":null},{"id":"W2056564024","doi":"10.1097/pas.0b013e3181ff400e","title":"Morphologic Spectrum of Immunohistochemically Characterized Clear Cell Carcinoma of the Ovary","year":2010,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pathology; Immunohistochemistry; Nuclear atypia; Pleomorphism (cytology); Biology; Clear cell; Carcinoma; Cuboidal Cell; Medicine","score_opus":0.008078531914494353,"score_gpt":0.2416950205581666,"score_spread":0.23361648864367227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056564024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112046,0.00030834757,0.0000051878283,0.00733454,0.00029298052,0.00014154114,0.000011231458,0.0000035059572,0.0007822201],"genre_scores_gemma":[0.9987213,0.00024174416,0.000468638,0.00033882578,0.00016636215,0.0000034405846,0.0000011742945,0.000014339906,0.000044183114],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986071,0.00020367048,0.0006158108,0.00013094992,0.00023937233,0.0002030814],"domain_scores_gemma":[0.99782914,0.00026963095,0.0012088424,0.00047893418,0.00012674973,0.00008670472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004887334,0.0001367538,0.0007884829,0.000063934516,0.000037545688,0.0000027058759,0.0003376464,0.000058677273,0.00026536683],"category_scores_gemma":[0.000044423206,0.00006481585,0.00040750077,0.00022286958,0.001287383,0.000021146494,0.00008619,0.0006200247,0.000004885854],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039967825,0.00094029313,0.07307265,0.000023482893,0.00011632702,0.0012315385,0.00032699824,0.0000018251868,0.91582716,0.00022741989,0.00019152502,0.004043992],"study_design_scores_gemma":[0.0038896988,0.004735926,0.8491239,0.00004663345,0.00035959744,0.009256985,0.00015494082,0.0000041195017,0.13046871,0.0002850252,0.0015669501,0.000107537446],"about_ca_topic_score_codex":0.000042981665,"about_ca_topic_score_gemma":6.4349854e-7,"teacher_disagreement_score":0.7853584,"about_ca_system_score_codex":0.000034420755,"about_ca_system_score_gemma":0.00014364508,"threshold_uncertainty_score":0.47434166},"labels":[],"label_agreement":null},{"id":"W2056823481","doi":"10.1186/1471-2407-8-346","title":"Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Sherbrooke; Université de Montréal; Université Laval; McGill University; Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Serous fluid; Immunohistochemistry; Surgical oncology; Medicine; Pathology; Ovarian cancer; Oncology; Cancer; Internal medicine","score_opus":0.018622096815997875,"score_gpt":0.2663168716354013,"score_spread":0.2476947748194034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056823481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948961,0.0033588577,0.0001989021,0.00042231582,0.000316553,0.00053639075,0.0000970135,0.00003418078,0.00013968012],"genre_scores_gemma":[0.9955557,0.0005881737,0.0027285714,0.00018170528,0.0004509677,0.00015953137,0.000024952298,0.000034192788,0.00027619212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986913,0.000025044183,0.00034299833,0.00037025046,0.0002839967,0.0002863687],"domain_scores_gemma":[0.999306,0.00002683699,0.0001290151,0.00028010696,0.000107962434,0.00015002588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068708105,0.00020031758,0.0004388715,0.00006651231,0.00008985421,0.0000078300545,0.00006685817,0.000096532945,0.00014056677],"category_scores_gemma":[0.000022843635,0.00016530528,0.00013733958,0.00012203359,0.00017143041,0.000049094804,0.00004269041,0.00013125852,0.000006187129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025959238,0.0020855658,0.26789668,0.001484558,0.00074402895,0.0011359361,0.0015249795,0.00030858244,0.71387833,0.00093781186,0.0025173984,0.0048902105],"study_design_scores_gemma":[0.010505778,0.00062429043,0.27080515,0.0012087096,0.0005155397,0.0008779795,0.00013782144,0.00089781586,0.7134182,0.00012720223,0.00040260173,0.00047891337],"about_ca_topic_score_codex":0.0010022217,"about_ca_topic_score_gemma":0.000033210385,"teacher_disagreement_score":0.007909854,"about_ca_system_score_codex":0.00020577355,"about_ca_system_score_gemma":0.00045793105,"threshold_uncertainty_score":0.67409533},"labels":[],"label_agreement":null},{"id":"W2056941427","doi":"10.1186/1897-4287-10-s2-a83","title":"Benign serous ovarian tumour: a redefining moment?","year":2012,"lang":"en","type":"article","venue":"Hereditary Cancer in Clinical Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous carcinoma; KRAS; Pathology; Serous Cystadenoma; Medicine; Cystadenocarcinoma; Ovary; Ovarian carcinoma; Ovarian cancer; Cancer research; Biology; Cancer; Internal medicine; Colorectal cancer","score_opus":0.09535101933719978,"score_gpt":0.4364301360810729,"score_spread":0.34107911674387315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056941427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4535968,0.059699193,0.00030256103,0.16944553,0.018990614,0.0031538287,0.00026076706,0.000479964,0.29407075],"genre_scores_gemma":[0.9731971,0.00359697,0.008297998,0.009420094,0.0047675623,0.00027096478,0.000021890437,0.000058628866,0.00036877888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967728,0.00034502798,0.0011016433,0.0005657327,0.0005288966,0.000685877],"domain_scores_gemma":[0.9958457,0.0025871224,0.0003458982,0.00054919353,0.0001345869,0.00053753325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023015114,0.00027316675,0.0006455229,0.00009382199,0.00009271771,0.000030133502,0.00012813888,0.00024986992,0.0017985823],"category_scores_gemma":[0.001897976,0.0002430109,0.00020904587,0.00037057354,0.000089631976,0.000740028,0.0000914324,0.0009486355,0.0002624373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003218553,0.008050004,0.7686203,0.00017446997,0.001128841,0.002211298,0.0009975911,0.00008573829,0.00003625163,0.003443496,0.069022164,0.1430113],"study_design_scores_gemma":[0.004817431,0.00077001785,0.6282222,0.0004722305,0.0008008007,0.00037893557,0.0008927053,0.000065706445,0.000049750186,0.00010346821,0.3630988,0.00032790942],"about_ca_topic_score_codex":0.0019810959,"about_ca_topic_score_gemma":0.00017422094,"teacher_disagreement_score":0.51960033,"about_ca_system_score_codex":0.00058864016,"about_ca_system_score_gemma":0.00049282797,"threshold_uncertainty_score":0.9991139},"labels":[],"label_agreement":null},{"id":"W2058783279","doi":"10.1007/s10637-012-9837-3","title":"Investigational agents in development for the treatment of ovarian cancer","year":2012,"lang":"en","type":"review","venue":"Investigational New Drugs","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Ovarian cancer; PI3K/AKT/mTOR pathway; Cancer research; Epidermal growth factor receptor; Cancer; Protein kinase B; Receptor tyrosine kinase; Biology; Tyrosine kinase; Medicine; Signal transduction; Pharmacology; Internal medicine; Receptor; Cell biology","score_opus":0.21656059714362874,"score_gpt":0.398267042823047,"score_spread":0.18170644567941824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058783279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012423318,0.993072,0.000019486886,0.0028417513,0.0004595026,0.0030449682,0.00022752263,0.000016171458,0.00019438092],"genre_scores_gemma":[0.0001229668,0.9850487,0.006367621,0.0004399646,0.0010276947,0.0040469053,0.0012089355,0.00006353916,0.0016736635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775183,0.000058353668,0.0009553228,0.0004138411,0.0004909219,0.0003297076],"domain_scores_gemma":[0.99806666,0.00067386683,0.00048361038,0.0003222461,0.0001113305,0.0003423043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020270344,0.00045910478,0.0011917478,0.00022063384,0.00009675659,0.000019059464,0.00015486174,0.00021162757,0.0003426292],"category_scores_gemma":[0.000042348882,0.00028652605,0.0004011815,0.0003789864,0.0001592111,0.00006549694,0.000023400911,0.00012280862,0.000036233945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020615598,0.0005620996,0.0024754703,0.0028010807,0.0012479819,0.0000033329254,0.0011256472,0.000023079516,2.597744e-7,0.003344608,0.0030324461,0.98536336],"study_design_scores_gemma":[0.0020110335,0.0000997887,0.0070611895,0.0065224012,0.0019946601,0.00001090774,0.0000110811525,0.00001467946,0.00003882807,0.0004923929,0.9815146,0.00022844985],"about_ca_topic_score_codex":0.0005559302,"about_ca_topic_score_gemma":0.00012937619,"teacher_disagreement_score":0.9851349,"about_ca_system_score_codex":0.0014297765,"about_ca_system_score_gemma":0.0067299595,"threshold_uncertainty_score":0.9999587},"labels":[],"label_agreement":null},{"id":"W2059000312","doi":"10.1002/cncr.11310","title":"Improved survival in women with <i>BRCA</i>‐associated ovarian carcinoma","year":2003,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":433,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"Cedars-Sinai Medical Center","keywords":"Medicine; Oncology; BRCA mutation; Gynecology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.01409746319491444,"score_gpt":0.25109978046498127,"score_spread":0.23700231727006682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059000312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877224,0.0009880412,0.000011162393,0.0011219456,0.000287367,0.00042872902,0.000024032735,0.000036005502,0.00938033],"genre_scores_gemma":[0.99718064,0.00013399805,0.00010703397,0.00091018254,0.000075253585,0.0005295714,0.00000717314,0.000033056687,0.0010230679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889773,0.000046975467,0.00017004213,0.00031049942,0.00015977467,0.00041500587],"domain_scores_gemma":[0.9994248,0.000031729694,0.000062284795,0.00024359729,0.0000684776,0.0001690713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015298963,0.00016675681,0.0003422664,0.00006271893,0.00003697949,0.000015817746,0.000042791162,0.000076792,0.0007345341],"category_scores_gemma":[0.000030965268,0.00012683659,0.000033429085,0.0003291036,0.000036974216,0.000047250276,0.000008469539,0.00013969759,0.0000090494805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000633747,0.0005730391,0.9886756,0.000046229725,0.0003059173,0.00021619853,0.0009862158,0.000014951999,0.0006267153,0.0005234006,0.0008352301,0.006562749],"study_design_scores_gemma":[0.011336941,0.00061689375,0.97087324,0.00014676107,0.00009768292,0.000008606486,0.00029749822,0.000032590036,0.0022339663,0.000060675306,0.014074331,0.00022083776],"about_ca_topic_score_codex":0.00094621384,"about_ca_topic_score_gemma":0.0010012918,"teacher_disagreement_score":0.01780239,"about_ca_system_score_codex":0.0012327719,"about_ca_system_score_gemma":0.0005065401,"threshold_uncertainty_score":0.80426335},"labels":[],"label_agreement":null},{"id":"W2059643491","doi":"10.1016/j.yexcr.2006.09.026","title":"Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes","year":2006,"lang":"en","type":"article","venue":"Experimental Cell Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Biology; Cancer research; Germline; Epithelium; Ovarian cancer; DNA damage; Tumor suppressor gene; Somatic cell; Germline mutation; Apoptosis; Malignant transformation; Cell biology; DNA repair; Neoplastic transformation; Mutation; Cancer; Gene; Genetics; Carcinogenesis; DNA","score_opus":0.055637585630042355,"score_gpt":0.3713350074016593,"score_spread":0.31569742177161697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059643491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930046,0.00039963057,0.0000012308187,0.0010385602,0.00001714386,0.0007912288,0.000062303756,0.00000567264,0.004679637],"genre_scores_gemma":[0.99897814,0.000033142456,0.00011379881,0.000043332107,0.00006429475,0.00018953622,0.0003675487,0.000013945433,0.0001962368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980881,0.00042381903,0.0002887891,0.00030371157,0.00059393427,0.00030164476],"domain_scores_gemma":[0.99917084,0.00040221075,0.000049753515,0.00026077346,0.000059247388,0.00005719905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097583135,0.00010983292,0.00018822661,0.00032146982,0.000040367362,0.000021593441,0.00011484054,0.00006956997,0.00010636454],"category_scores_gemma":[0.00004686276,0.000085382424,0.000022354618,0.0005223607,0.000090424044,0.000100785815,0.00004307371,0.00026142807,0.000010182346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005912839,0.018939534,0.17979316,0.00014059729,0.000018502105,0.0005498947,0.008294527,0.0011049986,0.7804886,0.0030323146,0.0014160376,0.0003089735],"study_design_scores_gemma":[0.0058403024,0.0010387646,0.3808646,0.00008003379,0.0000025765005,0.000004456373,0.0025703504,0.0003765019,0.6089057,0.000108105436,0.00013665229,0.000072002484],"about_ca_topic_score_codex":0.016069623,"about_ca_topic_score_gemma":0.0048787636,"teacher_disagreement_score":0.20107141,"about_ca_system_score_codex":0.0005448072,"about_ca_system_score_gemma":0.00015339469,"threshold_uncertainty_score":0.99048245},"labels":[],"label_agreement":null},{"id":"W2059729942","doi":"10.1097/pgp.0b013e318223118a","title":"P16INK4a Expression in Undifferentiated Carcinoma of the Uterus Does Not Exclude Its Endometrial Origin","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Uterus; Carcinoma; Pathology; Endometrium; Immunohistochemistry; Biology; Medicine; Internal medicine","score_opus":0.07435367591653985,"score_gpt":0.3190462050483338,"score_spread":0.24469252913179396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059729942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951761,0.0001503866,0.00005885072,0.0011761942,0.0025971797,0.00017599847,0.000022056447,0.0000042652023,0.00063896424],"genre_scores_gemma":[0.9986081,0.0001468292,0.00061509194,0.00033013275,0.00022069416,0.000010421646,0.000002642498,0.0000067196574,0.000059348997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850583,0.0001928596,0.000640718,0.00015512423,0.00035255883,0.0001529285],"domain_scores_gemma":[0.99864763,0.0003687411,0.0004935824,0.00012504552,0.00029452264,0.00007045853],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030359917,0.00011703427,0.00040211645,0.00025856143,0.000018680403,0.000006263746,0.00032896746,0.00014469461,0.0012574102],"category_scores_gemma":[0.000752763,0.000055359204,0.00021932148,0.000119249984,0.00009588871,0.000060970164,0.00011705085,0.0002808033,0.000006593957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002100669,0.0019942604,0.94470954,0.000010121908,0.00016955772,0.0030168358,0.00038814958,0.000004947922,0.04281392,0.0009398557,0.00011455279,0.0037375793],"study_design_scores_gemma":[0.005092722,0.00093420065,0.8859555,0.00007658897,0.00005600586,0.0003427253,0.000032191543,0.0000068103977,0.106439486,0.00081658753,0.00019694476,0.00005021675],"about_ca_topic_score_codex":0.000022452861,"about_ca_topic_score_gemma":0.000025178586,"teacher_disagreement_score":0.06362556,"about_ca_system_score_codex":0.00018851325,"about_ca_system_score_gemma":0.0001018629,"threshold_uncertainty_score":0.9996556},"labels":[],"label_agreement":null},{"id":"W2060045463","doi":"10.1158/1078-0432.ovca13-a9","title":"Abstract A9: A whole-locus sequencing approach to identify polymorphisms associated with juvenile-onset granulosa cell tumor susceptibility in SWR mice","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Biology; Locus (genetics); Congenic; Carcinogenesis; Allele; Genetics; Epigenetics; Gene; Quantitative trait locus; Cancer research","score_opus":0.16583900280883065,"score_gpt":0.4523502060969039,"score_spread":0.2865112032880732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060045463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871722,0.0007101961,0.000009637983,0.0058212196,0.00016912518,0.0027682518,0.0001129633,0.000061656516,0.0031747739],"genre_scores_gemma":[0.995652,0.00010481074,0.00035590905,0.00093854027,0.00029460355,0.0016488782,0.00008153954,0.000069517366,0.00085416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944406,0.0005959952,0.0011203189,0.0013029723,0.0013371892,0.0012029103],"domain_scores_gemma":[0.99581325,0.0014473192,0.00019788237,0.00091161777,0.0007070249,0.0009229143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042040157,0.0003325704,0.00095365784,0.00032513,0.00017530721,0.00015706732,0.00039137303,0.00025895648,0.0009467088],"category_scores_gemma":[0.001123711,0.00025414588,0.0002329646,0.0012927921,0.00045090483,0.00019232073,0.00018668454,0.0017194183,0.00051236595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010998577,0.004211149,0.9626586,0.00022012951,0.00024188892,0.00039362468,0.0006037921,0.000063604835,0.0041518514,0.000010965721,0.020820973,0.005523576],"study_design_scores_gemma":[0.0056991386,0.0012097885,0.98872906,0.0007314559,0.00009536963,0.000011158197,0.00051297585,0.00011209338,0.0019171026,0.00015101225,0.0005268854,0.00030395566],"about_ca_topic_score_codex":0.026946573,"about_ca_topic_score_gemma":0.006971957,"teacher_disagreement_score":0.026070476,"about_ca_system_score_codex":0.0021872725,"about_ca_system_score_gemma":0.002003934,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2060142689","doi":"10.1006/gyno.2002.6636","title":"The Benefits of Comprehensive Surgical Staging in the Management of Early-Stage Epithelial Ovarian Carcinoma","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Serous fluid; Laparotomy; Serous carcinoma; Population; Ovarian cancer; Logistic regression; Cancer; Surgery; Internal medicine","score_opus":0.05198782285814984,"score_gpt":0.3053745793490813,"score_spread":0.25338675649093145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060142689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971428,0.0014656036,0.0000021242527,0.0056943432,0.00025030872,0.0008343837,0.000029793333,0.000010424764,0.020285042],"genre_scores_gemma":[0.9970076,0.0017333587,0.0003617662,0.00029725442,0.0000562897,0.00014326235,0.0000054780658,0.000008777211,0.00038617887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998474,0.00025141082,0.0004624587,0.00024909934,0.00022953551,0.00033352253],"domain_scores_gemma":[0.99802667,0.001225336,0.00021780455,0.00040342772,0.00007797653,0.000048788068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003984896,0.00014881407,0.0004742376,0.000069008594,0.000092685674,0.0000070699666,0.00022748776,0.00012065364,0.000371639],"category_scores_gemma":[0.000016434125,0.00008003771,0.000121731566,0.00024651378,0.000237956,0.000021852387,0.00009647854,0.00019764295,0.000018122186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000962961,0.004892315,0.5844033,0.00034141535,0.0009766531,0.004435438,0.0041766306,0.00040447435,0.00005813552,0.097767375,0.0017061777,0.2998751],"study_design_scores_gemma":[0.004935917,0.0025638475,0.94454014,0.00003765161,0.00017806709,0.000038538412,0.0018240398,0.00008561669,0.00013385489,0.00014223847,0.045442894,0.000077166995],"about_ca_topic_score_codex":0.00023877378,"about_ca_topic_score_gemma":0.00010983391,"teacher_disagreement_score":0.36013687,"about_ca_system_score_codex":0.00019540667,"about_ca_system_score_gemma":0.000043649394,"threshold_uncertainty_score":0.40691864},"labels":[],"label_agreement":null},{"id":"W2060196381","doi":"10.4103/2230-8210.107870","title":"Juvenile granulosa cell tumor presenting as isosexual precocious puberty: A case report and review of literature","year":2013,"lang":"en","type":"article","venue":"Indian Journal of Endocrinology and Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Precocious puberty; Exploratory laparotomy; Ovary; Pediatrics; Internal medicine; Surgery; Hormone","score_opus":0.010131608521435654,"score_gpt":0.27332012054137,"score_spread":0.2631885120199344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060196381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7238295,0.2721986,0.0000014829905,0.0026679507,0.00027296811,0.00032159447,0.00001119332,0.000004556553,0.0006921718],"genre_scores_gemma":[0.9481609,0.049246464,0.0008602928,0.0009641262,0.00029297918,0.000027379336,0.0000062351473,0.000015068167,0.00042656888],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99859256,0.00010122827,0.00069102796,0.00020146379,0.000144256,0.0002694705],"domain_scores_gemma":[0.99849284,0.000097098135,0.00066243846,0.00020069303,0.0003007241,0.00024618398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000213057,0.00017090504,0.0007743692,0.00018268137,0.00006469863,0.000023116232,0.000053707583,0.000068313595,0.00019716193],"category_scores_gemma":[0.00023118574,0.000119967124,0.00012680257,0.00011717297,0.00012020012,0.00018660344,0.00004336338,0.0003688599,0.0000039533084],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012725676,0.0007835661,0.045894325,0.0060834866,0.0010791773,0.85656774,0.004318094,2.2395982e-7,0.0006612518,0.00048732868,0.009924157,0.07407342],"study_design_scores_gemma":[0.0028864343,0.00039237438,0.02857464,0.0021707134,0.0009106297,0.93092835,0.00028930572,5.9665075e-7,0.0031786158,0.0005474549,0.029991003,0.00012986755],"about_ca_topic_score_codex":0.00010552411,"about_ca_topic_score_gemma":0.0000050704953,"teacher_disagreement_score":0.22433138,"about_ca_system_score_codex":0.000013483881,"about_ca_system_score_gemma":0.00016129407,"threshold_uncertainty_score":0.48921174},"labels":[],"label_agreement":null},{"id":"W2060451225","doi":"10.4161/cbt.87","title":"Effect of Reproductive Hormones on Ovarian Epithelial Tumors: II. Effect on Angiogenic Activity","year":2002,"lang":"en","type":"article","venue":"Cancer Biology & Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; University of Toronto; National Ovarian Cancer Coalition; National Cancer Coalition","keywords":"Angiogenesis; Internal medicine; Endocrinology; Secretion; Hormone; Biology; Vascular endothelial growth factor; Antibody; Western blot; Menstrual cycle; Cancer research; Medicine; VEGF receptors; Immunology","score_opus":0.021857469513528634,"score_gpt":0.3122226243139893,"score_spread":0.29036515480046066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060451225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851955,0.005882383,0.0000021296319,0.002892465,0.0005591196,0.0012061415,0.00009162611,0.00005817683,0.0007884111],"genre_scores_gemma":[0.99518216,0.0026618512,0.000012017186,0.00051123387,0.0008472263,0.00054973783,0.000014080807,0.0000356422,0.0001860488],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982895,0.0003806829,0.00019245203,0.00068934367,0.00012980656,0.00031817416],"domain_scores_gemma":[0.9986794,0.000360521,0.00016158115,0.0006603021,0.000046687994,0.00009149563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034412934,0.0003303449,0.00075345836,0.00012702403,0.00010651514,0.0000044019735,0.000103913975,0.00016951832,0.0004992386],"category_scores_gemma":[0.000052052448,0.00020719685,0.00030814306,0.00020913822,0.00018151598,0.000030282663,0.000020072212,0.00019788175,0.0000446875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014993821,0.0011715039,0.051674504,0.000057739817,0.0017151991,0.000043041546,0.0004667492,0.000010197001,0.189002,0.00019539884,0.0013508453,0.739319],"study_design_scores_gemma":[0.008311829,0.05892533,0.0895398,0.00018581207,0.00019955092,0.000013434403,0.0000024535761,0.00000879352,0.8378003,0.000045535242,0.004771811,0.00019534398],"about_ca_topic_score_codex":0.00026744264,"about_ca_topic_score_gemma":0.0000057002226,"teacher_disagreement_score":0.73912364,"about_ca_system_score_codex":0.00023207902,"about_ca_system_score_gemma":0.000037400834,"threshold_uncertainty_score":0.8449242},"labels":[],"label_agreement":null},{"id":"W2060978013","doi":"10.1046/j.1525-1438.2003.13320.x","title":"A comparison of the incidence, duration, and degree of the neurologic toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC)","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Carboplatin; Cisplatin; Paclitaxel; Toxicity; Incidence (geometry); Neurotoxicity; Cyclophosphamide; Chemotherapy; Internal medicine; Oncology","score_opus":0.04396429752159475,"score_gpt":0.3429296773506782,"score_spread":0.29896537982908344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060978013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925193,0.003028817,0.00007928759,0.0031270192,0.0005015028,0.00025591336,0.00003504898,0.000001436522,0.00045165198],"genre_scores_gemma":[0.9981193,0.00067662954,0.0006342861,0.00044220625,0.000052858853,0.000015878482,5.012718e-7,0.000004754656,0.000053584507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985804,0.00008364492,0.0007370037,0.0001093547,0.00039998683,0.00008958618],"domain_scores_gemma":[0.9974193,0.00080855377,0.0010202677,0.00009997407,0.0006076444,0.00004423554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030947648,0.00010176697,0.0003850725,0.00004934296,0.000043877364,0.0000088739935,0.0001612743,0.00006955383,0.00015061538],"category_scores_gemma":[0.0012897248,0.000050321556,0.00013729888,0.000094956806,0.0002820377,0.000055115215,0.000054764554,0.0001500925,7.270336e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034078833,0.00024370766,0.9891764,0.00003822156,0.00019753329,0.0000049700093,0.00025044018,0.00019082223,0.0017864933,0.0039176587,0.00031203666,0.0035409497],"study_design_scores_gemma":[0.0017520319,0.00090490823,0.9769965,0.00016693992,0.00014359583,0.00006401297,0.0001419453,0.000099383156,0.016722249,0.0022031344,0.00076024944,0.000045083965],"about_ca_topic_score_codex":0.00003745881,"about_ca_topic_score_gemma":0.000098820565,"teacher_disagreement_score":0.014935756,"about_ca_system_score_codex":0.0000798391,"about_ca_system_score_gemma":0.00018849496,"threshold_uncertainty_score":0.20520535},"labels":[],"label_agreement":null},{"id":"W2061153684","doi":"10.1016/j.ygyno.2011.04.006","title":"Surgical staging of early stage epithelial ovarian cancer","year":2011,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Ovarian cancer; Ovarian carcinoma; Lymph node; Chemotherapy; Oncology; Cancer; Carcinoma; Disease; Gynecology; Internal medicine; General surgery","score_opus":0.052228813079906886,"score_gpt":0.33312647866378425,"score_spread":0.28089766558387735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061153684","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12402844,0.0020744822,0.000020043231,0.76595974,0.006019486,0.0028653983,0.0014581828,0.0002465588,0.097327664],"genre_scores_gemma":[0.20442681,0.0069686086,0.0039426223,0.70579636,0.014333701,0.0026332294,0.0009606335,0.00035612888,0.060581874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967315,0.00033604482,0.0008228202,0.00086857984,0.00038325152,0.0008577977],"domain_scores_gemma":[0.99734944,0.00083592825,0.0007144889,0.00069840706,0.00022705915,0.00017468003],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003726426,0.0005389171,0.0019284564,0.00028903398,0.0000809972,0.0000129186665,0.0003068476,0.0021016481,0.014400586],"category_scores_gemma":[0.00008700977,0.00041593154,0.0004470936,0.00021132805,0.00036715137,0.00004902229,0.00016707547,0.0018597491,0.00017429217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076340046,0.0014765761,0.0945827,0.00068379403,0.00209899,0.0361778,0.0005869852,0.0000037029833,0.000040594405,0.00073148514,0.80864555,0.0542084],"study_design_scores_gemma":[0.0046728584,0.004510388,0.05442986,0.00012254265,0.0009499005,0.00008890207,0.000025024074,0.0000024598571,0.00022515633,0.0001931562,0.9344392,0.00034055283],"about_ca_topic_score_codex":0.0028291377,"about_ca_topic_score_gemma":0.00015585235,"teacher_disagreement_score":0.12579364,"about_ca_system_score_codex":0.0012069135,"about_ca_system_score_gemma":0.0018007229,"threshold_uncertainty_score":0.99982923},"labels":[],"label_agreement":null},{"id":"W2061461769","doi":"10.1097/00004347-200201000-00004","title":"Ovarian Teratomas with Florid Benign Vascular Proliferation: A Distinctive Finding Associated with the Neural Component of Teratomas that may be Confused with a Vascular Neoplasm","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Immature teratoma; Pathology; Ovarian Teratoma; Teratoma; Neoplasm; Biology; Neuroepithelial cell; Ovary; Immunohistochemistry; Angiogenesis; Germ cell tumors; Medicine; Neural stem cell; Cancer research; Stem cell; Cell biology; Endocrinology","score_opus":0.03264238567416626,"score_gpt":0.25809085134957926,"score_spread":0.225448465675413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061461769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440766,0.00017214277,0.0012725759,0.012874524,0.0002356466,0.00054016773,0.00003208351,0.000019134586,0.0004460766],"genre_scores_gemma":[0.99740225,0.00004322791,0.0010087974,0.001212659,0.00017466607,0.000067589535,0.0000324925,0.000021721049,0.000036572106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978137,0.00029757665,0.0004702496,0.00030053913,0.00085529755,0.00026262083],"domain_scores_gemma":[0.99757385,0.0005858906,0.0006913102,0.00019898661,0.0008138926,0.00013605179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038614444,0.0002716716,0.0006609394,0.00014903543,0.00011866566,0.000060658807,0.0002490945,0.00013245773,0.00038112636],"category_scores_gemma":[0.00016809754,0.0001291017,0.00019425627,0.00017190384,0.0003178434,0.0001409542,0.000045454814,0.0004382497,0.0000025413526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038081857,0.0048380094,0.94944024,0.000028255865,0.008984637,0.02140399,0.0028571147,0.0021014246,0.0007223602,0.0024285147,0.0006072433,0.0027800463],"study_design_scores_gemma":[0.016719753,0.0099882865,0.9623523,0.00031217057,0.0010505563,0.0045926864,0.00037978066,0.0012344455,0.001172372,0.000063309504,0.001865958,0.00026841759],"about_ca_topic_score_codex":0.000010949874,"about_ca_topic_score_gemma":0.000090697904,"teacher_disagreement_score":0.016811304,"about_ca_system_score_codex":0.00028185826,"about_ca_system_score_gemma":0.000119248056,"threshold_uncertainty_score":0.5264615},"labels":[],"label_agreement":null},{"id":"W2061881330","doi":"10.1016/j.jpedsurg.2009.06.027","title":"Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients","year":2009,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Series (stratigraphy); Oncology; Pathology; Internal medicine","score_opus":0.013828206816834327,"score_gpt":0.2389939948192928,"score_spread":0.22516578800245846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061881330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971483,0.001129889,0.000036705304,0.00061544793,0.00081279565,0.00016588341,0.00004865663,0.000005574876,0.00003679371],"genre_scores_gemma":[0.99629116,0.0015221148,0.00040148577,0.00010704199,0.0016369151,0.000001435253,0.0000047850554,0.000015428695,0.000019625506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978644,0.000070601105,0.0011764519,0.00013455375,0.0005324928,0.00022148954],"domain_scores_gemma":[0.9977116,0.00011650562,0.0012426202,0.00019489834,0.0005261546,0.0002082218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045619629,0.00016808156,0.00079216104,0.00045606605,0.00003022373,0.000008187482,0.000058498685,0.00007261142,0.00008823022],"category_scores_gemma":[0.00017678528,0.0001241122,0.00050992216,0.00033891754,0.000033426033,0.00013178239,0.00001526771,0.00014511301,0.0000021114643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001929224,0.005381636,0.94076526,0.0005207513,0.00029090216,0.01771129,0.00024112148,0.000051452353,0.00037317618,0.000026358917,0.013141437,0.01956736],"study_design_scores_gemma":[0.0041821143,0.0021214676,0.9796915,0.0006444069,0.0014121088,0.0046610124,0.00014638597,0.0000066259554,0.0066413525,0.00009068146,0.0001930192,0.00020931834],"about_ca_topic_score_codex":0.000031135627,"about_ca_topic_score_gemma":0.0000013753621,"teacher_disagreement_score":0.038926214,"about_ca_system_score_codex":0.00009548707,"about_ca_system_score_gemma":0.0004822389,"threshold_uncertainty_score":0.50611484},"labels":[],"label_agreement":null},{"id":"W2061937504","doi":"10.5009/gnl.2011.5.4.543","title":"Metastasis of Hepatocellular Carcinoma to the Ovary: A Case Report and Review of the Literature","year":2011,"lang":"en","type":"article","venue":"Gut and Liver","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Ovary; Metastasis; Hepatocellular carcinoma; Exploratory laparotomy; Hepatectomy; Laparotomy; Radiology; Surgery; Internal medicine; Cancer; Resection","score_opus":0.034300552427142104,"score_gpt":0.25450512275260556,"score_spread":0.22020457032546345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061937504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8317611,0.16545878,0.0000020654318,0.001377462,0.00004215011,0.0004899404,0.000029849652,0.00000221597,0.00083643384],"genre_scores_gemma":[0.99041396,0.008398488,0.00025098657,0.0006775737,0.000026487722,0.000021229042,0.0000028614174,0.000004438224,0.00020395145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995676,0.000030517082,0.00014609848,0.00011487562,0.00008329915,0.000057573434],"domain_scores_gemma":[0.99950105,0.000016559015,0.00007108281,0.00029913837,0.000066106106,0.000046056135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016301405,0.0000666372,0.00019423847,0.000016227932,0.000029435725,0.0000029352907,0.000027236569,0.000020928197,0.000098235134],"category_scores_gemma":[0.000023840566,0.000029626784,0.00006212878,0.000111941685,0.00003988106,0.00001676872,0.00004240056,0.000045148005,6.9092914e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019930776,0.00049076416,0.8540598,0.009579855,0.0008853948,0.052950963,0.017236842,2.8652297e-8,0.0001976761,0.0015919256,0.023850068,0.038957354],"study_design_scores_gemma":[0.0014212477,0.00074288173,0.8616953,0.010490544,0.0032577063,0.048962194,0.00032043553,0.000013243587,0.007979408,0.000081427475,0.064854234,0.00018141192],"about_ca_topic_score_codex":0.00052419485,"about_ca_topic_score_gemma":0.000017716995,"teacher_disagreement_score":0.15865287,"about_ca_system_score_codex":0.000006591944,"about_ca_system_score_gemma":0.000026076921,"threshold_uncertainty_score":0.120814525},"labels":[],"label_agreement":null},{"id":"W2061945206","doi":"10.1097/pgp.0b013e31822ea955","title":"Frequency of Serous Tubal Intraepithelial Carcinoma in Various Gynecologic Malignancies","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Serous carcinoma; Medicine; Serous fluid; Pathology; Fallopian tube; Carcinoma; Ovarian carcinoma; Gynecology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.021889122227814438,"score_gpt":0.2937841574317159,"score_spread":0.27189503520390146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061945206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928904,0.001065791,0.0001370897,0.0022671367,0.0020106765,0.00016510193,0.000020827363,0.000008361384,0.0014345883],"genre_scores_gemma":[0.9949825,0.00021708282,0.0035116985,0.0007861038,0.00045331687,0.000015447173,0.0000063269886,0.0000096861695,0.000017884386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981845,0.00015894261,0.0008284245,0.00015562397,0.00034609038,0.00032639934],"domain_scores_gemma":[0.9983521,0.00048883446,0.00047655025,0.000119920725,0.00041478736,0.00014777557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006107063,0.00015978547,0.00058890803,0.00027847453,0.000018178589,0.000007569939,0.00025224886,0.00022375569,0.0009151915],"category_scores_gemma":[0.0008892667,0.0001115548,0.00021057876,0.00012013573,0.00016967524,0.00013252362,0.000076716344,0.00033302396,0.000021349957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022497056,0.0021079958,0.97642237,0.000010559486,0.00014243773,0.0043380065,0.00030680755,0.000022149801,0.004887573,0.0042328034,0.00014982348,0.0071544815],"study_design_scores_gemma":[0.0029502637,0.0018466568,0.98605955,0.000038664464,0.00008517805,0.0033999502,0.000095891955,0.0000069887715,0.002129912,0.0030344238,0.00026068033,0.00009181982],"about_ca_topic_score_codex":0.000055554912,"about_ca_topic_score_gemma":0.00004103272,"teacher_disagreement_score":0.009637179,"about_ca_system_score_codex":0.0004293259,"about_ca_system_score_gemma":0.00018679223,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2062696104","doi":"10.1097/pas.0b013e3181666a5f","title":"Luteinized Thecomas (Thecomatosis) of the Type Typically Associated With Sclerosing Peritonitis","year":2008,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Pathology; Progesterone receptor; Ascites; Calretinin; Lesion; Peritonitis; Estrogen receptor; Immunohistochemistry; Internal medicine; Breast cancer","score_opus":0.02197055569426854,"score_gpt":0.2560557811679434,"score_spread":0.23408522547367488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062696104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240655,0.00036558427,0.0000122065885,0.0062873927,0.00012722543,0.00011771529,0.0000046643613,0.0000082861125,0.00067035935],"genre_scores_gemma":[0.99819237,0.0008013126,0.0003706849,0.0004622024,0.00009778639,0.0000028154036,8.968231e-7,0.000018242317,0.00005366995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985792,0.0003859909,0.00041580453,0.00011373669,0.0002991768,0.000206114],"domain_scores_gemma":[0.9981692,0.0004456686,0.0007496855,0.00027197064,0.00027279113,0.000090696536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034072355,0.00013070181,0.0006929907,0.00004928639,0.00012341817,0.000005050035,0.00019496461,0.000037878563,0.00009199137],"category_scores_gemma":[0.00009584047,0.00005578727,0.00022241316,0.0004160364,0.0011437264,0.000029702966,0.000041628973,0.0003098481,0.000004502674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068848976,0.0020411492,0.9584969,0.0000148639765,0.0015121753,0.0053006583,0.0019096655,0.00007251026,0.004393161,0.00067121343,0.00074954383,0.017953224],"study_design_scores_gemma":[0.0037487315,0.0038859255,0.97578686,0.00024877797,0.00036293984,0.01355726,0.00025511536,0.0000096645535,0.0008773525,0.000086201944,0.0010873218,0.00009384648],"about_ca_topic_score_codex":0.000017651242,"about_ca_topic_score_gemma":0.0000027616297,"teacher_disagreement_score":0.017859377,"about_ca_system_score_codex":0.00007006429,"about_ca_system_score_gemma":0.0002188371,"threshold_uncertainty_score":0.42141077},"labels":[],"label_agreement":null},{"id":"W2062762146","doi":"10.1097/00001703-200302000-00005","title":"Update on granulosa cell tumours of the ovary","year":2003,"lang":"en","type":"review","venue":"Current Opinion in Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Calgary; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Granulosa cell; Ovary; Disease; Stage (stratigraphy); Atypia; Pathology; Oncology; Gynecology; Bioinformatics; Internal medicine; Biology","score_opus":0.08915318711404972,"score_gpt":0.37867087957435636,"score_spread":0.2895176924603066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062762146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030148358,0.9648168,0.0000024067426,0.00016487551,0.03191393,0.0018649382,0.00014769041,0.000015882155,0.0010433164],"genre_scores_gemma":[0.0002163987,0.998699,0.000043395357,0.00008041489,0.0001910789,0.00035331966,0.00027933868,0.000059634553,0.000077437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969492,0.00045065125,0.0010972946,0.0006597173,0.0003853915,0.0004577472],"domain_scores_gemma":[0.9949631,0.0030847273,0.00078701286,0.0009307238,0.00009970669,0.00013473582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027147282,0.0005047944,0.0020580788,0.0007267811,0.00005586096,0.000010364336,0.0003589233,0.0004387213,0.00019287471],"category_scores_gemma":[0.00093292637,0.00034245857,0.0007548962,0.0016366217,0.00012173423,0.000023643674,0.0001251478,0.00096750434,0.0001351758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008352265,0.002016858,0.003197225,0.018590579,0.000059914863,0.0000126246205,0.000025711022,0.0000027175859,1.3727101e-8,0.0015961842,0.012389787,0.9621],"study_design_scores_gemma":[0.0016425294,0.00033830007,0.0017905511,0.009528019,0.0005786646,0.000019331565,0.0000060447665,0.000001255999,0.0000023231612,0.00008538975,0.9857628,0.0002447885],"about_ca_topic_score_codex":0.0000046839295,"about_ca_topic_score_gemma":0.0000011580507,"teacher_disagreement_score":0.973373,"about_ca_system_score_codex":0.00088030205,"about_ca_system_score_gemma":0.0009014613,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W2062794120","doi":"10.1006/gyno.2001.6484","title":"Peritoneal Implantation of Squamous Cell Carcinoma Following Rupture of a Dermoid Cyst during Laparoscopic Removal","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Laparotomy; Dermoid cyst; Laparoscopy; Malignancy; Stage (stratigraphy); Cyst; Surgery; General surgery; Pathology","score_opus":0.01921274295539734,"score_gpt":0.2748010690353021,"score_spread":0.2555883260799048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062794120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986692,0.001706974,0.0000027714777,0.0005539033,0.00048353532,0.00047097955,0.000024627316,0.000029548231,0.010035646],"genre_scores_gemma":[0.99797666,0.000090324625,0.0012557361,0.000161627,0.00009466403,0.000063296626,0.000025032383,0.000015864594,0.00031679528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986932,0.0000911019,0.00044439555,0.00029822314,0.00016586336,0.00030719617],"domain_scores_gemma":[0.9990486,0.00028935575,0.0002595963,0.0002442751,0.000064016494,0.00009419369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010052846,0.00016939895,0.00068244437,0.00011708429,0.00006854161,0.0000035407406,0.00008570407,0.00025886198,0.000583017],"category_scores_gemma":[0.00008313477,0.00014275477,0.0001871848,0.0001617618,0.00007721374,0.000040208877,0.00004312324,0.00015744193,0.00001949481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005722354,0.0052479235,0.8470626,0.0015231343,0.00021102061,0.009533425,0.0035063026,0.0000721779,0.118714035,0.00019547385,0.0012569559,0.012104709],"study_design_scores_gemma":[0.015773194,0.006131898,0.9106902,0.00004680207,0.00063994183,0.00086249935,0.00064734876,0.00007277535,0.06357456,0.00004456861,0.0013208825,0.00019532531],"about_ca_topic_score_codex":0.00009895507,"about_ca_topic_score_gemma":0.00007743646,"teacher_disagreement_score":0.0636276,"about_ca_system_score_codex":0.00037256983,"about_ca_system_score_gemma":0.00012016668,"threshold_uncertainty_score":0.63836277},"labels":[],"label_agreement":null},{"id":"W2063107188","doi":"10.1245/s10434-006-9125-6","title":"Prognostic Significance of Postoperative Morbidities in Patients With Advanced Epithelial Ovarian Cancer Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking","year":2006,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Debulking; Perioperative; Confidence interval; Surgery; Chemotherapy; Surgical oncology; Neoadjuvant therapy; Odds ratio; Proportional hazards model; Retrospective cohort study; Taxane; Internal medicine; Oncology; Ovarian cancer; Cancer; Breast cancer","score_opus":0.017184967867897336,"score_gpt":0.2939992533135658,"score_spread":0.27681428544566844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063107188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150497,0.0010104635,0.0000040903915,0.004834535,0.000022846856,0.0009687587,0.00009968768,0.00001574457,0.0015389066],"genre_scores_gemma":[0.9967289,0.0021082598,0.0005236694,0.00025464143,0.00004295285,0.00017687524,0.00008007389,0.000025955185,0.000058689602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845207,0.00010403158,0.0004725253,0.00038265757,0.00027047427,0.0003182696],"domain_scores_gemma":[0.99878114,0.000370751,0.00026175007,0.0001515904,0.00033203143,0.000102755206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013105075,0.00024050096,0.0009354611,0.00011336316,0.00003370318,0.0000056438703,0.00005197418,0.00013024181,0.0000823751],"category_scores_gemma":[0.0000055807413,0.00015271622,0.000060008173,0.00026006906,0.00035341375,0.00008662537,0.00001762542,0.00014642104,4.5309565e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026364796,0.0036137523,0.8952581,0.00008917652,0.000383324,0.0009698828,0.00035291017,0.00021093953,0.0002704566,0.00034694822,0.000103563536,0.07203614],"study_design_scores_gemma":[0.026212202,0.012440792,0.9438456,0.00045267848,0.00012862864,0.000044833952,0.00005117686,0.000026891465,0.0069359336,0.000039260227,0.00960348,0.0002185115],"about_ca_topic_score_codex":0.0015643846,"about_ca_topic_score_gemma":0.00029212743,"teacher_disagreement_score":0.07181763,"about_ca_system_score_codex":0.00011065321,"about_ca_system_score_gemma":0.00032596753,"threshold_uncertainty_score":0.6227587},"labels":[],"label_agreement":null},{"id":"W2063560014","doi":"10.1016/j.jmig.2012.11.010","title":"Surgical Implications of the Potential New Tubal Pathway for Ovarian Carcinogenesis","year":2013,"lang":"en","type":"review","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Salpingectomy; Ovarian cancer; Fallopian tube; Serous fluid; BRCA mutation; Gynecology; Population; Serous Cystadenoma; Surgical Menopause; Oncology; Obstetrics; Menopause; Surgery; Internal medicine; Cancer; Pregnancy","score_opus":0.054880544578957614,"score_gpt":0.3265607007680676,"score_spread":0.27168015618910996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063560014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019310347,0.98992276,0.00003822264,0.0040523554,0.0011815693,0.0022337728,0.00022542766,0.0000051192374,0.00040972652],"genre_scores_gemma":[0.0017835452,0.99399763,0.0019901793,0.0001950361,0.0012940414,0.0002217768,0.000035905847,0.000060126815,0.0004217686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997178,0.00023245746,0.0016485982,0.00031445897,0.0002696684,0.00035681727],"domain_scores_gemma":[0.9940292,0.0020846487,0.002293689,0.0005088611,0.00077995023,0.00030364344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027500448,0.00038782513,0.0026457927,0.00024704364,0.000089296846,0.00001764542,0.0004768605,0.00051958713,0.0006448658],"category_scores_gemma":[0.00070576,0.00022193255,0.0022684985,0.0002449781,0.00014445189,0.00005040008,0.00011435181,0.00038926266,0.000017052742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013695228,0.0008833156,0.0009477341,0.0044964277,0.0036593957,0.00025866926,0.00006669808,0.0000027002525,0.00008867624,0.0011314285,0.022294575,0.9660334],"study_design_scores_gemma":[0.0034141229,0.002355697,0.010258082,0.0027044995,0.008136069,0.0039629624,0.000030525138,3.2147597e-7,0.00013070882,0.00029311323,0.968511,0.00020289313],"about_ca_topic_score_codex":0.000032975586,"about_ca_topic_score_gemma":0.000059042017,"teacher_disagreement_score":0.9658305,"about_ca_system_score_codex":0.00044611812,"about_ca_system_score_gemma":0.0076983306,"threshold_uncertainty_score":0.99792707},"labels":[],"label_agreement":null},{"id":"W2063684969","doi":"10.1245/s10434-015-4475-6","title":"Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; Northern Cancer Care and Research Society; Cancer Research Society","keywords":"Medicine; Machine learning; Logistic regression; Artificial intelligence; Artificial neural network; Surgical oncology; Predictive modelling; Oncology; Data mining; Computer science","score_opus":0.21439368046654145,"score_gpt":0.42770338764542354,"score_spread":0.2133097071788821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063684969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8902066,0.011526212,0.00009816126,0.06526327,0.0008187434,0.0018091528,0.000099964906,0.000033105734,0.030144809],"genre_scores_gemma":[0.99457484,0.0045935293,0.000056319826,0.00025756177,0.00020232757,0.00022263532,0.000011876395,0.000008999255,0.0000718796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987857,0.00011198388,0.00041768252,0.00025825523,0.0001899047,0.00023651536],"domain_scores_gemma":[0.99888533,0.000415916,0.00011232856,0.00012081973,0.00021195566,0.000253632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043065383,0.000115866154,0.00052274426,0.00009613229,0.000014778597,0.000011410938,0.00004694073,0.00015332505,0.0000763893],"category_scores_gemma":[0.00011356812,0.000089729314,0.000047518388,0.000194508,0.00015209564,0.00006935481,0.00003912335,0.00013895684,0.000016981881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009116701,0.0059413225,0.2655711,0.0003359914,0.00080870907,0.0066988696,0.003264876,0.0012771987,0.000083965104,0.06846807,0.0051385895,0.63329464],"study_design_scores_gemma":[0.007913084,0.039114416,0.2516693,0.0026012915,0.00083284895,0.0015831323,0.004289071,0.004240148,0.009876381,0.021011427,0.6559425,0.00092642335],"about_ca_topic_score_codex":0.0008998458,"about_ca_topic_score_gemma":0.00007533445,"teacher_disagreement_score":0.6508039,"about_ca_system_score_codex":0.00010311476,"about_ca_system_score_gemma":0.00048170367,"threshold_uncertainty_score":0.36590552},"labels":[],"label_agreement":null},{"id":"W2064295135","doi":"10.1097/igc.0b013e3182158640","title":"Comparative Study of Grade 3/4 Toxicity Associated With Intraperitoneal Chemotherapy Administered After Primary Versus Interval Surgical Debulking in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Toxicity; Chemotherapy; Oncology; Intraperitoneal chemotherapy; Surgery; Internal medicine; Cancer","score_opus":0.09030698841717472,"score_gpt":0.365542067431809,"score_spread":0.2752350790146343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064295135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682635,0.00036355815,0.000008905609,0.0009641575,0.0007604414,0.0003702253,0.000029400278,0.0000073990645,0.00066953414],"genre_scores_gemma":[0.99877894,0.0002441673,0.00024506144,0.00034815195,0.00021713294,0.00012320041,0.0000044969847,0.000013702552,0.000025172318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980832,0.00013412202,0.0007042905,0.00023836143,0.000628518,0.00021154045],"domain_scores_gemma":[0.9984355,0.00029938272,0.0005444949,0.00009828564,0.0004893228,0.00013301626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002404571,0.00020562139,0.00076639396,0.00016613315,0.00002030328,0.000017483366,0.00022526033,0.00009952461,0.0018040633],"category_scores_gemma":[0.000046747093,0.00013558747,0.00015173545,0.000177142,0.000121538695,0.0001303656,0.00005042515,0.00035905564,7.774571e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040249977,0.011928058,0.92813116,0.0000137919515,0.0034322473,0.0034473564,0.005162222,0.000047896585,0.00021186587,0.000029682016,0.00007502554,0.0072707026],"study_design_scores_gemma":[0.02189223,0.0075017055,0.96734434,0.00035892817,0.00021462952,0.00005557414,0.0004990684,0.00002259672,0.0017848335,0.00002180832,0.00016849469,0.00013577046],"about_ca_topic_score_codex":0.00040444688,"about_ca_topic_score_gemma":0.0026464784,"teacher_disagreement_score":0.039213188,"about_ca_system_score_codex":0.0011324357,"about_ca_system_score_gemma":0.00033495278,"threshold_uncertainty_score":0.99910843},"labels":[],"label_agreement":null},{"id":"W2064330422","doi":"10.1016/j.ygyno.2011.01.005","title":"Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010","year":2011,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; Calgary Laboratory Services; University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Ovarian cancer; Clear cell carcinoma; Medicine; Serous fluid; Serous carcinoma; Clear cell; Ovarian carcinoma; Endometriosis; Disease; Ovary; Stage (stratigraphy); Pathological; Oncology; Clinical trial; Internal medicine; Carcinoma; Cancer; Bioinformatics; Biology","score_opus":0.04655003216528951,"score_gpt":0.29563951158551477,"score_spread":0.24908947942022525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064330422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008100509,0.9255724,0.0000019555594,0.0061398027,0.006295759,0.004319821,0.00026335844,0.00007553601,0.05652133],"genre_scores_gemma":[0.006306994,0.98294824,0.00054877705,0.0015946418,0.0008615208,0.00083820027,0.00023602489,0.00013818119,0.006527418],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515885,0.0007469494,0.001705327,0.0012475312,0.00036612962,0.0007752323],"domain_scores_gemma":[0.99249315,0.0021763213,0.0022272638,0.0026838165,0.00018489626,0.00023455548],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008714602,0.0008570031,0.0036075437,0.0001263994,0.0003336237,0.00002511257,0.001106715,0.0016131937,0.0030705966],"category_scores_gemma":[0.00021816227,0.00043523248,0.0014868795,0.00050710514,0.0005508899,0.00004493346,0.000681147,0.001441526,0.00053843553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000764097,0.011055939,0.020669036,0.01135742,0.0029466115,0.009299426,0.0018513061,0.000003466744,0.000007839692,0.0007158546,0.58310986,0.35821918],"study_design_scores_gemma":[0.001990207,0.0024890874,0.015201172,0.00092472386,0.006990093,0.0005385586,0.00007936618,0.0000012526531,0.00002602047,0.00009941662,0.9712829,0.0003771936],"about_ca_topic_score_codex":0.0020354844,"about_ca_topic_score_gemma":0.0010133847,"teacher_disagreement_score":0.38817307,"about_ca_system_score_codex":0.0011465378,"about_ca_system_score_gemma":0.0026300135,"threshold_uncertainty_score":0.9998099},"labels":[],"label_agreement":null},{"id":"W2064354484","doi":"10.1016/j.ygyno.2010.05.011","title":"Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Fallopian tube; Ovarian cancer; Gynecology; Fallopian tube cancer; Breast cancer; Family history; Cancer; Obstetrics; Lynch syndrome; Internal medicine; Oncology; Colorectal cancer; DNA mismatch repair","score_opus":0.010903220087383403,"score_gpt":0.2638797722191378,"score_spread":0.25297655213175435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064354484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930917,0.000104125924,0.000003705034,0.0019447901,0.00019508753,0.00058753823,0.000024362895,0.000012088031,0.004036623],"genre_scores_gemma":[0.99819857,0.000064604465,0.00079506706,0.00022403504,0.000042363292,0.00017388198,0.0000025815737,0.000008661993,0.00049024716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991326,0.00005971506,0.00025501312,0.00023191409,0.00011414562,0.00020666118],"domain_scores_gemma":[0.99886847,0.00037779656,0.00021782782,0.0003204405,0.00012221906,0.00009327768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018780852,0.000114661314,0.0003595733,0.000050173785,0.0000563323,0.0000029791522,0.0001070256,0.00015043972,0.0006417037],"category_scores_gemma":[0.00017713248,0.00006526561,0.000038695027,0.00014113488,0.0005917905,0.00003165681,0.000063056235,0.00020534021,0.0000021373808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089387715,0.0005829088,0.9868081,0.00015071053,0.00010320708,0.000043826778,0.0010112739,0.000009355823,0.0014097326,0.00063880853,0.000056181594,0.00909648],"study_design_scores_gemma":[0.002173905,0.0039411397,0.99008656,0.00002582928,0.00020048753,0.00007921602,0.00024411512,0.000036524343,0.0021537854,0.00017578818,0.00082076236,0.0000618662],"about_ca_topic_score_codex":0.00010665576,"about_ca_topic_score_gemma":0.0006423785,"teacher_disagreement_score":0.009034613,"about_ca_system_score_codex":0.00013020719,"about_ca_system_score_gemma":0.0003820881,"threshold_uncertainty_score":0.70262057},"labels":[],"label_agreement":null},{"id":"W2064967799","doi":"10.1111/aji.12200","title":"Authors’ reply: Human papillomavirus vaccine and primary ovarian failure","year":2014,"lang":"en","type":"letter","venue":"American Journal of Reproductive Immunology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Center (category theory); Family medicine; Internal medicine; Rheumatology; Library science","score_opus":0.012113584309405007,"score_gpt":0.26852396780870785,"score_spread":0.25641038349930284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064967799","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061002824,0.006973409,0.000050506747,0.9299216,0.00090083736,0.00047769124,0.00001576361,0.000039988325,0.0006173483],"genre_scores_gemma":[0.16453612,0.004276683,0.009701896,0.7891371,0.027835676,0.00009651292,0.00028421817,0.00040425998,0.0037275353],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963626,0.0005467266,0.0010863971,0.0010492939,0.00041250774,0.00054245495],"domain_scores_gemma":[0.9951789,0.00019907835,0.002410464,0.0014115524,0.0006617316,0.0001382671],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00073055766,0.000577661,0.0024548206,0.0005832812,0.00014947577,0.00003753034,0.00028282922,0.00037482983,0.00014992942],"category_scores_gemma":[0.00026591698,0.00045039586,0.0003817912,0.00033484513,0.0007646385,0.000116672854,0.00013207045,0.0030530202,0.000016035408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010347727,0.00031944594,0.014263988,0.0001548302,0.006493963,0.004861609,0.00051749626,4.0719715e-7,0.0042185658,0.00008262513,0.914366,0.053686284],"study_design_scores_gemma":[0.0027394344,0.008584276,0.07552913,0.00041271313,0.001443687,0.014335586,0.00014760283,8.6842455e-8,0.00072694354,0.0004073228,0.89529514,0.0003780985],"about_ca_topic_score_codex":0.0003101211,"about_ca_topic_score_gemma":0.0000030342553,"teacher_disagreement_score":0.14078453,"about_ca_system_score_codex":0.00048668415,"about_ca_system_score_gemma":0.00035009853,"threshold_uncertainty_score":0.9997948},"labels":[],"label_agreement":null},{"id":"W2065071195","doi":"10.1016/s0090-8258(03)00472-4","title":"First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Topotecan; Taxane; Oncology; Ovarian cancer; Chemotherapy; Clinical trial; Radiation therapy; Salvage therapy; Regimen; Internal medicine; Intensive care medicine; Cancer; Breast cancer","score_opus":0.05232850364174327,"score_gpt":0.3771091044721546,"score_spread":0.3247806008304114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065071195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005587456,0.9889609,0.0000012741003,0.0016902062,0.00029689024,0.0038332385,0.000049137823,0.000016443464,0.004593124],"genre_scores_gemma":[0.002201866,0.9926592,0.0003148944,0.00030836434,0.000075839176,0.0040197247,0.000065082626,0.000029103785,0.00032591174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787337,0.0004781215,0.0007286042,0.000502258,0.000104682265,0.0003129893],"domain_scores_gemma":[0.99723685,0.0015774674,0.0006246017,0.0004153785,0.00006594997,0.00007974731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035592992,0.00040659963,0.0027782454,0.00015790986,0.00006697762,0.0000069374173,0.000093381575,0.0004814055,0.00051939784],"category_scores_gemma":[0.00009876044,0.00021066073,0.0002836375,0.0002662419,0.00028675844,0.000024105088,0.000031586846,0.00022956789,0.000009573044],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026602438,0.0009554391,0.0007338026,0.00046376226,0.000603758,0.00005845531,0.00016591727,0.000008617343,2.498246e-7,0.0018726734,0.00004795134,0.99482334],"study_design_scores_gemma":[0.013857985,0.0038113678,0.0006660141,0.0009781256,0.0012987201,0.00007145272,0.000059662594,0.000008039165,0.000007101297,0.0006123281,0.97847074,0.00015843414],"about_ca_topic_score_codex":0.00036503634,"about_ca_topic_score_gemma":0.0010666291,"teacher_disagreement_score":0.9946649,"about_ca_system_score_codex":0.001473409,"about_ca_system_score_gemma":0.0011026345,"threshold_uncertainty_score":0.8590495},"labels":[],"label_agreement":null},{"id":"W2066801022","doi":"10.1056/nejmoa0902542","title":"Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":771,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Centre Hospitalier de l’Université de Montréal; University of Ottawa; Vancouver General Hospital; University of Toronto; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Missense mutation; Transcriptome; Germline mutation; Mutation; Cancer research; Genetics; Gene; Gene expression","score_opus":0.011342569618585705,"score_gpt":0.26033760580571463,"score_spread":0.24899503618712893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066801022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97174966,0.0035216676,0.000050129333,0.021426016,0.00026726606,0.00016979432,0.000001953399,0.000002109552,0.002811406],"genre_scores_gemma":[0.9978382,0.00051582366,0.00027925,0.00065014855,0.00062727294,4.6332252e-7,0.0000019039645,0.000005630298,0.00008128421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987368,0.00005656857,0.00062393077,0.00007085686,0.00041256944,0.00009925959],"domain_scores_gemma":[0.99903584,0.00012359618,0.00046669057,0.0001464128,0.00012722166,0.0001002587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004623094,0.00009247053,0.00046574324,0.00014758129,0.000011074675,0.0000010978652,0.00008231896,0.000034606903,0.00007241635],"category_scores_gemma":[0.00011903056,0.000047489215,0.0000903188,0.00025365493,0.000059817237,0.000039747236,0.000005585275,0.00018917251,3.9825602e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042776735,0.0025625667,0.3739808,0.000392355,0.000278706,0.0014512045,0.008367238,0.00043902974,0.039703254,0.0009085332,0.02011427,0.5475244],"study_design_scores_gemma":[0.101272404,0.00669211,0.8439035,0.0031468852,0.0005348947,0.0010515761,0.00031263346,0.00002731095,0.0370428,0.0025483929,0.0033858425,0.0000816877],"about_ca_topic_score_codex":0.00017199223,"about_ca_topic_score_gemma":0.000023225588,"teacher_disagreement_score":0.5474427,"about_ca_system_score_codex":0.000046017965,"about_ca_system_score_gemma":0.0001981172,"threshold_uncertainty_score":0.19365539},"labels":[],"label_agreement":null},{"id":"W2067337257","doi":"10.3747/co.v18i2.725","title":"Phase II/III Study of Intraperitoneal Chemotherapy after Neoadjuvant Chemotherapy for Ovarian Cancer: NCIC CTG OV.21","year":2011,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Oncology; Intraperitoneal chemotherapy; Internal medicine; Cancer; Gynecology","score_opus":0.09639886097071619,"score_gpt":0.417933450831704,"score_spread":0.3215345898609878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067337257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887287,0.0037685172,0.00019053735,0.0018896213,0.0018475187,0.0029760934,0.00007788204,0.000053290772,0.0004678358],"genre_scores_gemma":[0.99303645,0.0018977069,0.0008339125,0.0006457758,0.0007206935,0.0026536873,0.00003306773,0.000056532586,0.00012220324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981191,0.000058513902,0.0005980353,0.00056072394,0.00021126814,0.0004523499],"domain_scores_gemma":[0.9987768,0.00006107669,0.00026792355,0.0004767047,0.00020087193,0.00021663876],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019851344,0.00033143198,0.0009459727,0.00014708475,0.00009214405,0.000006714747,0.00015502844,0.00016212242,0.0020224596],"category_scores_gemma":[0.000010338209,0.00026941983,0.00021548473,0.00019194931,0.00012887888,0.00005970822,0.00004085507,0.0002047612,0.000005114331],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012700246,0.066881396,0.035846185,0.00013619014,0.0009581801,0.00005480568,0.016916083,4.103443e-7,0.00062289444,0.00009606624,0.004427977,0.86135954],"study_design_scores_gemma":[0.26913002,0.106884494,0.13291804,0.00042788315,0.0018450014,0.00006219352,0.0021392552,0.00022236128,0.017165205,0.00030662937,0.46808577,0.00081313663],"about_ca_topic_score_codex":0.00038122627,"about_ca_topic_score_gemma":0.00026629135,"teacher_disagreement_score":0.8605464,"about_ca_system_score_codex":0.00041048878,"about_ca_system_score_gemma":0.00041114033,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W2067351953","doi":"10.1002/gcc.21990","title":"<i>E2F3b</i> over‐expression in ovarian carcinomas and in <i>BRCA1</i> Haploinsufficient fallopian tube epithelium","year":2012,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Haploinsufficiency; Carcinogenesis; Cancer research; Biology; Fallopian tube; Oncogene; Mutation; Context (archaeology); Wild type; Germline mutation; Cell cycle; Cancer; Gene; Genetics; Phenotype","score_opus":0.01498714921222447,"score_gpt":0.26497686638813145,"score_spread":0.24998971717590698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067351953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9093377,0.08773751,0.0000052506703,0.0015397188,0.00032914686,0.00041805877,0.00004044076,0.000016457821,0.0005757079],"genre_scores_gemma":[0.97586066,0.022234818,0.00017990154,0.000950124,0.00033131582,0.00021641936,0.000014359966,0.000029601342,0.00018282578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860704,0.00003731082,0.00027879016,0.00039603343,0.00019528181,0.0004855319],"domain_scores_gemma":[0.9993949,0.000032555236,0.000060080674,0.00023706847,0.000021024187,0.00025435878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014085445,0.00023987236,0.00040780264,0.00013126821,0.000061280196,0.000027172902,0.000048188424,0.00011288139,0.00019307864],"category_scores_gemma":[0.0000048171732,0.00018920373,0.00004975981,0.00021214987,0.000068791465,0.0001406115,0.00008406623,0.000136049,0.0000030293427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117428346,0.00043800197,0.9692866,0.00015678059,0.00003397052,0.00004647629,0.0010867667,0.000022763026,0.010130256,0.00014024676,0.00035051687,0.018190177],"study_design_scores_gemma":[0.003928063,0.00015082798,0.93508303,0.00045511764,0.00006577507,0.000040588257,0.00020420297,0.000075667944,0.0148502225,0.000020760444,0.04489317,0.00023256832],"about_ca_topic_score_codex":0.0011454368,"about_ca_topic_score_gemma":0.00082181813,"teacher_disagreement_score":0.066522926,"about_ca_system_score_codex":0.00021676847,"about_ca_system_score_gemma":0.00010064119,"threshold_uncertainty_score":0.7715504},"labels":[],"label_agreement":null},{"id":"W2067363820","doi":"10.1016/j.ygyno.2005.11.047","title":"Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Nausea; Radiation therapy; Vomiting; Palliative care; Internal medicine; Ovarian cancer; Cancer; Surgery; Gastroenterology","score_opus":0.030211697689914843,"score_gpt":0.37092783493773945,"score_spread":0.3407161372478246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067363820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87127775,0.011320655,0.0033138015,0.072276354,0.0055245645,0.020080274,0.00046011168,0.00057586865,0.01517065],"genre_scores_gemma":[0.9539643,0.0015397511,0.020476649,0.0039873286,0.0019430222,0.015026251,0.00015645604,0.00007006344,0.002836163],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982087,0.00018722186,0.00040819758,0.00053417595,0.00015168235,0.0005100409],"domain_scores_gemma":[0.99710906,0.0021310097,0.00024355961,0.00025006995,0.00014958264,0.00011673467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030286633,0.00028178527,0.0008087061,0.00011280174,0.0001495271,0.000016432698,0.00010023607,0.000296567,0.0014703713],"category_scores_gemma":[0.00021258403,0.00018642623,0.00016491661,0.00020646417,0.00012623052,0.00004178708,0.000026291415,0.0001694763,0.000027398464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007089575,0.007328655,0.14501311,0.0005001824,0.0024736163,0.000818749,0.000977976,0.00022665669,0.00069192273,0.011096016,0.12753467,0.6962489],"study_design_scores_gemma":[0.019948063,0.02090175,0.7315135,0.00014368,0.0008245994,0.000055200544,0.00012087736,0.00045547448,0.0011092162,0.0027133906,0.22185683,0.0003574165],"about_ca_topic_score_codex":0.00027002863,"about_ca_topic_score_gemma":0.0012905769,"teacher_disagreement_score":0.69589144,"about_ca_system_score_codex":0.0024849502,"about_ca_system_score_gemma":0.00068164984,"threshold_uncertainty_score":0.9994424},"labels":[],"label_agreement":null},{"id":"W2067545495","doi":"10.1016/j.jpag.2010.01.003","title":"Juvenile Granulosa and Theca Cell Tumor of the Ovary as a Rare Cause of Precocious Puberty: Case Report and Review of Literature","year":2010,"lang":"en","type":"review","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Theca; Medicine; Ovary; Precocious puberty; Juvenile; Granulosa cell; Endocrinology; Internal medicine; Biology; Hormone; Genetics","score_opus":0.016838250166847746,"score_gpt":0.3001414856991314,"score_spread":0.28330323553228365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067545495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014084174,0.98389643,5.721768e-7,0.00039563837,0.0004282247,0.0009945253,0.00011874291,0.0000020421942,0.000079660604],"genre_scores_gemma":[0.006439631,0.99263173,0.00012449274,0.00022803893,0.00042213517,0.000013031655,0.000011748711,0.00002631568,0.00010288901],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.9973932,0.00023018624,0.0016730747,0.00027224343,0.00024731073,0.00018399143],"domain_scores_gemma":[0.9948903,0.00045726312,0.0037266267,0.00036171006,0.00036566457,0.00019846276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006367254,0.0003327743,0.0027119059,0.00021911398,0.000045082106,0.000008291134,0.00010647826,0.00032031164,0.000050577262],"category_scores_gemma":[0.00048793442,0.00017943398,0.0005029545,0.00027259893,0.00015416503,0.00004969688,0.000115829396,0.0008354843,2.430942e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013073477,0.0021042104,0.033133868,0.52192545,0.0009003728,0.06365346,0.00033868302,5.2100127e-8,0.0000025646088,0.000024226005,0.01783772,0.35994864],"study_design_scores_gemma":[0.003927325,0.0023585574,0.008467089,0.103179835,0.03400563,0.42589062,0.000059602553,4.1746503e-7,0.000021367572,0.00006370335,0.42166492,0.00036091343],"about_ca_topic_score_codex":0.000010832743,"about_ca_topic_score_gemma":0.0000073087986,"teacher_disagreement_score":0.41874564,"about_ca_system_score_codex":0.000052373573,"about_ca_system_score_gemma":0.0010003869,"threshold_uncertainty_score":0.73171055},"labels":[],"label_agreement":null},{"id":"W2067771393","doi":"10.5737/1181912x2111620","title":"Survivors Teaching Students: Increasing awareness about ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Canadian Oncology Nursing Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ovarian Cancer Canada; Sunnybrook Health Science Centre","funders":"","keywords":"Ovarian cancer; Session (web analytics); Medicine; Medical education; Disease; Oncology; Cancer; Family medicine; Psychology; Internal medicine; Computer science","score_opus":0.04947812911004317,"score_gpt":0.37237725784153297,"score_spread":0.3228991287314898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067771393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370705,0.00417829,0.00030152034,0.0092199445,0.004560077,0.0003835074,0.00002822389,0.000050554456,0.044207405],"genre_scores_gemma":[0.99320436,0.00048879604,0.0027339426,0.0022215794,0.0010355662,0.000028075869,0.000009544033,0.00005344229,0.00022467722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783033,0.00034568997,0.00042592268,0.0003262169,0.00029011632,0.0007816952],"domain_scores_gemma":[0.9977284,0.00008166111,0.00021295248,0.00025964348,0.00017717917,0.0015401503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001000904,0.00024949203,0.00051114126,0.0004894906,0.0008390629,0.00009178065,0.00024821286,0.00024527145,0.0011911304],"category_scores_gemma":[0.000115288785,0.00022732397,0.00014492834,0.00017107186,0.00017085909,0.00016844065,0.000014665863,0.00087483524,0.000027513499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021026353,0.00054588035,0.77871794,0.000012158675,0.0004048175,0.0023536573,0.0051753474,0.0000034106909,0.000031759377,0.0006489275,0.0050690095,0.20682684],"study_design_scores_gemma":[0.0032509898,0.00061011297,0.95099497,0.0023061298,0.0006469724,0.0038849465,0.0012748658,0.000031832376,0.000080520156,0.0003025431,0.036345154,0.0002709895],"about_ca_topic_score_codex":0.22563829,"about_ca_topic_score_gemma":0.17521738,"teacher_disagreement_score":0.20655584,"about_ca_system_score_codex":0.009935698,"about_ca_system_score_gemma":0.008034945,"threshold_uncertainty_score":0.99972194},"labels":[],"label_agreement":null},{"id":"W2067841857","doi":"10.1158/1078-0432.ccr-10-3314","title":"IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sunitinib; Medicine; Ovarian cancer; Cancer research; Cancer; Serous fluid; Angiogenesis; Internal medicine; Pathology","score_opus":0.34325376796023427,"score_gpt":0.49524241971514615,"score_spread":0.15198865175491189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067841857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96906286,0.0066504986,0.0000070586757,0.021780847,0.0003013708,0.0012994795,0.00005940906,0.00002318812,0.00081527355],"genre_scores_gemma":[0.9917691,0.002984637,0.00022691675,0.0026207422,0.00065568683,0.0009236659,0.0000026907212,0.000058696212,0.00075788697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960397,0.0012799905,0.0006200588,0.0006987535,0.00063876185,0.0007227676],"domain_scores_gemma":[0.99655384,0.0019518938,0.00007405194,0.00060645415,0.0003187819,0.0004949521],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052619693,0.00020749996,0.0004657629,0.0002674182,0.00023954712,0.000053497086,0.0002550503,0.00018489257,0.0014583452],"category_scores_gemma":[0.00036066616,0.00014002078,0.00015292865,0.000943752,0.00035021757,0.000047595193,0.00019520361,0.0007486724,0.00009380618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054673795,0.0027837337,0.76151425,0.0002664205,0.00058459095,0.00092695886,0.0095591815,0.00003728296,0.0066683968,0.0003544179,0.009825973,0.15280503],"study_design_scores_gemma":[0.0056093787,0.0030532393,0.9203479,0.00054132135,0.00016763755,0.000007947129,0.0012955184,0.000043339158,0.015744641,0.00022332181,0.052679684,0.00028602302],"about_ca_topic_score_codex":0.006355895,"about_ca_topic_score_gemma":0.0021158012,"teacher_disagreement_score":0.15883373,"about_ca_system_score_codex":0.00034094366,"about_ca_system_score_gemma":0.00096607517,"threshold_uncertainty_score":0.99945444},"labels":[],"label_agreement":null},{"id":"W2068368161","doi":"10.1097/01.pgp.0000152024.37482.63","title":"Mucinous Ovarian Tumors of Mullerian-type: An Analysis of 17 Cases Including Borderline Tumors and Intraepithelial, Microinvasive, and Invasive Carcinomas","year":2005,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Serous fluid; Medicine; Pathology; Stage (stratigraphy); Mucinous carcinoma; Ovary; Adenocarcinoma; Internal medicine; Cancer; Biology","score_opus":0.0759277467051882,"score_gpt":0.3790688278506194,"score_spread":0.3031410811454312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068368161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33667243,0.6618292,0.000017871245,0.00044498465,0.00032763046,0.00037158385,0.000255235,0.00000661789,0.00007448466],"genre_scores_gemma":[0.30433136,0.6933452,0.0017034579,0.0002059778,0.00026835938,0.000009162369,0.000101974365,0.00002059788,0.000013911954],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99679697,0.0003406815,0.0018118925,0.00044793406,0.00036417288,0.00023834006],"domain_scores_gemma":[0.99448913,0.0017202207,0.002238058,0.00023224103,0.0010818527,0.00023849586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055912527,0.00040137235,0.0033884689,0.0012356254,0.0000455359,0.00002189352,0.00030734585,0.00035891758,0.00036317453],"category_scores_gemma":[0.0018751653,0.0002814341,0.000571904,0.0003777529,0.000414694,0.00010012973,0.00020328045,0.0004572337,0.0000010160794],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012375523,0.004190832,0.060016185,0.0023106975,0.018591493,0.043386467,0.00087104546,0.00012501971,0.00046875738,0.0008382698,0.00032497037,0.8676387],"study_design_scores_gemma":[0.015762882,0.035885394,0.6241027,0.019437429,0.07674195,0.10038441,0.0013571329,0.00014327375,0.000561112,0.000549471,0.12311989,0.0019543322],"about_ca_topic_score_codex":0.00012053096,"about_ca_topic_score_gemma":0.0002595941,"teacher_disagreement_score":0.8656844,"about_ca_system_score_codex":0.0002877948,"about_ca_system_score_gemma":0.0006698524,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W2068958034","doi":"10.3747/co.21.2325","title":"Erratum: Salpingectomy to Prevent Ovarian Cancer","year":2014,"lang":"en","type":"erratum","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Salpingectomy; Bioinformatics; Gynecology; Internal medicine; Cancer; Biology; Pregnancy; Genetics","score_opus":0.08728298227514768,"score_gpt":0.4207801902704367,"score_spread":0.33349720799528904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068958034","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010578091,0.09762495,0.00036273184,0.08294893,0.48450902,0.006890141,0.0005535872,0.0005025567,0.3255503],"genre_scores_gemma":[0.017432695,0.06786669,0.0025250844,0.018120026,0.108032316,0.017516835,0.006713335,0.0010175791,0.76077545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996727,0.00018253518,0.00066505565,0.0011440538,0.0004839832,0.0007973547],"domain_scores_gemma":[0.9976233,0.00009483022,0.00037099395,0.0009109635,0.00029153354,0.00070836034],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027110023,0.0006655942,0.0016744052,0.00037203435,0.00011081508,0.00003733627,0.00029980717,0.0008412229,0.0017816226],"category_scores_gemma":[0.000120531404,0.000566099,0.00039970764,0.00034630293,0.00008470746,0.00003262108,0.00021145589,0.001503187,0.0006550435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001037091,0.0017670335,0.0013943601,0.0005818201,0.00045864342,0.0000862934,0.0002021253,0.000002008652,0.000004096101,0.00023107848,0.81056434,0.18460448],"study_design_scores_gemma":[0.0022914056,0.0017135135,0.010752551,0.002281238,0.0013968437,0.000047859703,0.000012814804,0.00002363606,0.000023244753,0.00015185356,0.98082256,0.00048248065],"about_ca_topic_score_codex":0.00020462122,"about_ca_topic_score_gemma":0.00063378474,"teacher_disagreement_score":0.43522516,"about_ca_system_score_codex":0.0026850335,"about_ca_system_score_gemma":0.00284584,"threshold_uncertainty_score":0.999679},"labels":[],"label_agreement":null},{"id":"W2069079549","doi":"10.1006/gyno.2002.6683","title":"Specific Keynote: Experimental Models of Epithelial Ovarian Carcinogenesis","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Carcinogenesis; Cancer research; Oncology; Internal medicine; Cancer","score_opus":0.12722476769499189,"score_gpt":0.3793157282476406,"score_spread":0.2520909605526487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069079549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013608679,0.9652896,0.00003709271,0.00011742108,0.0016110585,0.002261379,0.00017737923,0.000054347285,0.03031563],"genre_scores_gemma":[0.0019511988,0.9927108,0.002886035,0.00023244867,0.00036348004,0.0010134197,0.0001804863,0.00009205227,0.00057002215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963281,0.00052129047,0.0012574227,0.0009611738,0.00030240437,0.00062958396],"domain_scores_gemma":[0.99733776,0.0006476323,0.0007735534,0.0008523543,0.00011433402,0.0002743663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038726258,0.00071656733,0.0045944382,0.0003342783,0.000090067995,0.0000113588985,0.00028027306,0.001239736,0.0032051266],"category_scores_gemma":[0.000047186113,0.00053131126,0.0011316412,0.00038598938,0.00025885817,0.000046886038,0.0001300407,0.00043774498,0.000228965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008188161,0.0028022393,0.000039647002,0.0025125158,0.000869293,0.0008434961,0.00009038489,0.0000044514336,0.000011386089,0.0031096828,0.0027415934,0.9868934],"study_design_scores_gemma":[0.0025576008,0.0034965104,0.000084501895,0.00095874845,0.0024165027,0.00045634987,0.00005256599,0.000002612259,0.0001284384,0.00022132107,0.9892295,0.00039532303],"about_ca_topic_score_codex":0.00004323175,"about_ca_topic_score_gemma":0.000007379432,"teacher_disagreement_score":0.9864981,"about_ca_system_score_codex":0.002200693,"about_ca_system_score_gemma":0.0018927935,"threshold_uncertainty_score":0.99971384},"labels":[],"label_agreement":null},{"id":"W2069180403","doi":"10.1097/pgp.0b013e318224e089","title":"Immunohistochemical Characterization of Primary and Recurrent Adult Granulosa Cell Tumors","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Toronto Public Health","funders":"","keywords":"Immunohistochemistry; Pathology; Primary (astronomy); Biology; Medicine","score_opus":0.019832271484033718,"score_gpt":0.25239047588735125,"score_spread":0.23255820440331754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069180403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644375,0.0002345565,0.00020865092,0.0007096413,0.000536621,0.00010284251,0.000017380107,0.0000049753294,0.0017415938],"genre_scores_gemma":[0.9968675,0.00066475576,0.0018120942,0.00049552723,0.000102839,0.0000066785506,0.000024747505,0.0000057651905,0.000020090183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990343,0.000050098337,0.0004978193,0.00012406925,0.00019824709,0.00009548667],"domain_scores_gemma":[0.99885625,0.00008530813,0.00043461638,0.00006931293,0.00047685654,0.00007765526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014446964,0.00009235744,0.0003372643,0.0001100343,0.000012792265,0.0000036998179,0.000111190966,0.000094430776,0.00030382557],"category_scores_gemma":[0.00014832665,0.00006578105,0.000109460285,0.000037569727,0.00013129179,0.000056716508,0.000049855607,0.00017080244,0.000003916268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038845832,0.0055998084,0.30672517,0.00008527702,0.0003769476,0.0043234574,0.0009977161,3.457049e-7,0.6164373,0.0028218105,0.00024429278,0.058503255],"study_design_scores_gemma":[0.0024679715,0.0023814216,0.96504325,0.00008339168,0.00009666932,0.0013028003,0.000022754815,0.0000049161413,0.027692063,0.00061847985,0.0002196994,0.00006655691],"about_ca_topic_score_codex":0.0000042508427,"about_ca_topic_score_gemma":5.147588e-7,"teacher_disagreement_score":0.6583181,"about_ca_system_score_codex":0.00012805799,"about_ca_system_score_gemma":0.00007130157,"threshold_uncertainty_score":0.3326677},"labels":[],"label_agreement":null},{"id":"W2069694588","doi":"10.1038/modpathol.2008.80","title":"Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas","year":2008,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"Cancer Research Society","keywords":"Immunohistochemistry; Serous fluid; Tissue microarray; Serous carcinoma; Medicine; Oncology; Ovarian cancer; Ovarian carcinoma; Pathology; Proportional hazards model; Internal medicine; Cancer; Cancer research","score_opus":0.01613132663670727,"score_gpt":0.2546286507459101,"score_spread":0.23849732410920285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069694588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930455,0.001855317,0.0011314456,0.0006795765,0.00011102602,0.0002577503,0.00012988692,0.00003855354,0.0027509485],"genre_scores_gemma":[0.9958894,0.0001750251,0.001453071,0.00046472432,0.000030513054,0.00006413997,0.0002567806,0.00002950139,0.0016367933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983986,0.000058930018,0.00040904476,0.00056989834,0.00023713526,0.00032636835],"domain_scores_gemma":[0.9988316,0.00006304517,0.00016822714,0.0007243073,0.0000941323,0.000118638935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012214128,0.00022582462,0.00077418506,0.00024968735,0.0000887874,0.000005697926,0.00013132958,0.0001855074,0.00018373059],"category_scores_gemma":[0.000030009198,0.00020877844,0.00031137207,0.00042257342,0.00021842761,0.000029676075,0.000035636942,0.00016943469,0.0000181422],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022985742,0.0018365744,0.2714115,0.00009533741,0.0030171743,0.0021392952,0.0016541533,0.000115430536,0.7036435,0.00012954045,0.012248104,0.0014107828],"study_design_scores_gemma":[0.0051713423,0.0006857924,0.80945885,0.00006326212,0.0032866504,0.00036520028,0.000057735604,0.00088475674,0.1790842,0.00015970407,0.00040340755,0.00037908068],"about_ca_topic_score_codex":0.00018973337,"about_ca_topic_score_gemma":0.00002387742,"teacher_disagreement_score":0.5380474,"about_ca_system_score_codex":0.00025662247,"about_ca_system_score_gemma":0.00009752668,"threshold_uncertainty_score":0.8513738},"labels":[],"label_agreement":null},{"id":"W2070026312","doi":"10.1158/1535-7163.targ-13-b181","title":"Abstract B181: TP53 mutation screening in patients with recurrent platinum-sensitive ovarian cancer.","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Missense mutation; Exon; Nonsense mutation; Mutation; Medicine; Cancer; Population; Genetics; Olaparib; Gene mutation; Cancer research; Molecular biology; Oncology; Biology; Internal medicine; Gene","score_opus":0.020973451297443265,"score_gpt":0.2818688197757348,"score_spread":0.26089536847829153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070026312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255204,0.0013800322,0.00081928965,0.0027608408,0.00020211164,0.0014416781,0.000057278645,0.000044621032,0.00074210175],"genre_scores_gemma":[0.9955165,0.0002316411,0.0014110914,0.0020930555,0.00007598045,0.00048803995,0.00009568068,0.000059935584,0.000028113076],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984602,0.00003955052,0.0003008143,0.00040559005,0.00042392744,0.00036993466],"domain_scores_gemma":[0.9991558,0.000032080232,0.00016307572,0.00027925498,0.0002463239,0.00012342882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060957278,0.00027651814,0.0003331539,0.00011821251,0.00006249242,0.00004872312,0.00006534075,0.00010293041,0.00031294706],"category_scores_gemma":[0.000004447709,0.00022352696,0.000075712145,0.0002887422,0.00005320251,0.00010148918,0.000019076215,0.00024806,0.000018179147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077224924,0.00080724666,0.48946592,0.000086488915,0.0010854682,0.00016550143,0.0011049025,0.0014814788,0.0011710057,0.00012607097,0.00010801157,0.5036257],"study_design_scores_gemma":[0.0063517103,0.0004368039,0.98515266,0.0006161177,0.00028122417,0.0000026244022,0.00009732508,0.000635739,0.0052475864,0.00005505711,0.00084803934,0.0002751097],"about_ca_topic_score_codex":0.0025434382,"about_ca_topic_score_gemma":0.00035289626,"teacher_disagreement_score":0.50335056,"about_ca_system_score_codex":0.00039211407,"about_ca_system_score_gemma":0.00018416067,"threshold_uncertainty_score":0.91151655},"labels":[],"label_agreement":null},{"id":"W2070531269","doi":"10.1586/17474108.3.1.21","title":"PEGylated liposomal doxorubicin: present and future role in the treatment of ovarian cancer","year":2007,"lang":"en","type":"article","venue":"Expert Review of Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Carboplatin; Ovarian cancer; Oncology; Doxorubicin; Internal medicine; Adverse effect; Paclitaxel; Gemcitabine; Chemotherapy; Population; Pharmacology; Cancer; Cisplatin","score_opus":0.017144021159816503,"score_gpt":0.3309503297597861,"score_spread":0.3138063085999696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070531269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12029181,0.86432374,0.0000029977602,0.011403647,0.0007056833,0.0014512057,0.000012404444,0.0000085233505,0.0018000209],"genre_scores_gemma":[0.3851927,0.6126894,0.0004117913,0.0011335654,0.00031923497,0.00017487525,0.000017599848,0.000013411064,0.000047436235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984538,0.000108299486,0.0006266746,0.00028268583,0.00024233366,0.0002862375],"domain_scores_gemma":[0.99789953,0.0012247612,0.00024140665,0.0004137542,0.00012996614,0.00009056011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028944088,0.00020468155,0.000809464,0.00017414922,0.000031884436,0.0000038065618,0.00010506462,0.00013295,0.00030033677],"category_scores_gemma":[0.00014655685,0.00011889068,0.0001497799,0.0006645502,0.00007968673,0.00003023256,0.000021352478,0.00009620319,0.0000023570503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100192665,0.0033978107,0.10605775,0.0013873756,0.0003618705,0.00032161962,0.0039052295,9.539689e-7,0.00029057058,0.0007839261,0.001881354,0.88151133],"study_design_scores_gemma":[0.0033031462,0.002224892,0.32547343,0.00082674844,0.00027022755,0.00004060974,0.00046926356,0.00000848548,0.0018363235,0.000017820154,0.66541594,0.000113094],"about_ca_topic_score_codex":0.00049995293,"about_ca_topic_score_gemma":0.00010343381,"teacher_disagreement_score":0.88139826,"about_ca_system_score_codex":0.00030704107,"about_ca_system_score_gemma":0.00013495017,"threshold_uncertainty_score":0.48482212},"labels":[],"label_agreement":null},{"id":"W2071014344","doi":"10.1073/pnas.1017300108","title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","year":2011,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Fallopian tube; Telomerase reverse transcriptase; Serous fluid; Cancer research; Serous carcinoma; Carcinogenesis; Ovarian cancer; Ovarian carcinoma; Ovary; Biology; Epithelium; Antigen; Malignant transformation; Cancer; Pathology; Immunology; Medicine; Telomerase; Endocrinology; Genetics","score_opus":0.09542314635186334,"score_gpt":0.2975721462772123,"score_spread":0.20214899992534896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071014344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836504,0.00036397186,0.000003046771,0.011630143,0.000035565903,0.00025053127,0.000029787734,0.000012101925,0.0040244497],"genre_scores_gemma":[0.9957609,0.000084942454,0.0030455396,0.0008753473,0.00015694833,0.000022769615,3.3906184e-7,0.000005920405,0.000047304915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841475,0.000005790999,0.00027415412,0.00025604715,0.0009003695,0.00014886519],"domain_scores_gemma":[0.9994974,0.000070863665,0.00016996705,0.000016567026,0.00019730844,0.000047867765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005142134,0.00010481759,0.0001834047,0.000063998974,0.00020122684,0.00001511694,0.0004999552,0.00006959762,0.000060343977],"category_scores_gemma":[0.000119653916,0.000053513035,0.00009871147,0.00043289686,0.00033406637,0.00017414396,0.00009136839,0.000120067096,0.0000023000123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019821784,0.00079053297,0.63554025,0.00012864881,0.0005590116,2.1842561e-7,0.005148463,0.00077139866,0.06145961,0.2906238,0.0016103444,0.0031695028],"study_design_scores_gemma":[0.0006931615,0.000106496285,0.8165967,0.0002020414,0.0001791477,0.00001075801,0.00047450064,0.0045420188,0.13148081,0.045510568,0.00010473981,0.000099085955],"about_ca_topic_score_codex":0.00092637487,"about_ca_topic_score_gemma":0.0000016924071,"teacher_disagreement_score":0.24511324,"about_ca_system_score_codex":0.000055301258,"about_ca_system_score_gemma":0.00006257096,"threshold_uncertainty_score":0.21821982},"labels":[],"label_agreement":null},{"id":"W2071733983","doi":"10.1007/s00335-012-9439-6","title":"Fine map of the Gct1 spontaneous ovarian granulosa cell tumor locus","year":2012,"lang":"en","type":"article","venue":"Mammalian Genome","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Cancer Institute; Canadian Institutes of Health Research; Memorial University of Newfoundland; Canada Research Chairs","keywords":"Congenic; Biology; Locus (genetics); Allele; Genetics; Carcinogenesis; Inbred strain; Endocrinology; Molecular biology; Gene","score_opus":0.01025565353010692,"score_gpt":0.21907758237416855,"score_spread":0.20882192884406164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071733983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800061,0.0024535432,0.000021224389,0.0059002745,0.00079210097,0.00078929897,0.00012293005,0.00004006711,0.00987444],"genre_scores_gemma":[0.99208295,0.000010260334,0.00046040607,0.0004798076,0.00050425023,0.000040949108,0.00002343986,0.000037169728,0.0063607683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987025,0.000047739326,0.00030093,0.00022307837,0.0002812565,0.00044447527],"domain_scores_gemma":[0.99889547,0.000031338972,0.0001402446,0.00067164516,0.00005064604,0.00021064888],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016924481,0.00020668213,0.0003422354,0.000061774954,0.000076048615,0.000011701648,0.00016164967,0.00006148212,0.0017260651],"category_scores_gemma":[0.00000905652,0.0001365854,0.00020093781,0.00015749631,0.00007655917,0.000041752624,0.000072329574,0.00013929688,0.00042583336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017765494,0.009125875,0.8472315,0.0025226832,0.0011432723,0.0067223418,0.0065884246,0.00006763717,0.07682661,0.006604551,0.026940295,0.014450266],"study_design_scores_gemma":[0.003508882,0.00051945547,0.7170267,0.00010374626,0.00060391106,0.0013538771,0.00010688505,0.000004955849,0.032450173,0.0001331146,0.2438583,0.00033000627],"about_ca_topic_score_codex":0.0001846636,"about_ca_topic_score_gemma":0.0000469475,"teacher_disagreement_score":0.21691799,"about_ca_system_score_codex":0.00015760462,"about_ca_system_score_gemma":0.000086406195,"threshold_uncertainty_score":0.9991865},"labels":[],"label_agreement":null},{"id":"W2071842647","doi":"10.1002/ijc.23987","title":"The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer","year":2008,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medical Council of Canada; Ottawa Hospital","funders":"Cancer Care Ontario","keywords":"ERCC1; Carboplatin; Cisplatin; Chemotherapy; DNA repair; Internal medicine; Ovarian cancer; Medicine; Cancer research; Oncology; Biology; Cancer; Nucleotide excision repair; DNA; Genetics","score_opus":0.01335565791840473,"score_gpt":0.30523589216234986,"score_spread":0.29188023424394516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071842647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494148,0.020126324,0.000020741481,0.026956603,0.0012934251,0.00038929228,0.00003773349,0.000013038866,0.0017480756],"genre_scores_gemma":[0.9730853,0.024508512,0.00016312917,0.0008167717,0.0008122127,0.00009396977,0.0000015592007,0.000015166077,0.000503425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986992,0.000035547775,0.00038773927,0.00015136425,0.00057589746,0.00015026332],"domain_scores_gemma":[0.99904716,0.000082890896,0.0002694937,0.00010238905,0.00037817456,0.000119875695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022657192,0.00011746406,0.00021630588,0.00013475798,0.00006778813,0.000022612492,0.00013046716,0.000049597333,0.00027941342],"category_scores_gemma":[0.000072190225,0.00007596506,0.000121553094,0.00010353222,0.00012842382,0.00014179465,0.000027663737,0.00022969749,0.0000025509119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076182913,0.0004180576,0.88837504,0.000022881739,0.0031954926,0.0024034674,0.0011895511,0.00028249147,0.00014793416,0.0009795793,0.010741389,0.084625795],"study_design_scores_gemma":[0.0045987335,0.00056149426,0.9444975,0.00069748075,0.00013660431,0.0008123706,0.00012688924,0.00014187247,0.00060357683,0.0002758259,0.04746172,0.00008592105],"about_ca_topic_score_codex":0.0017134558,"about_ca_topic_score_gemma":0.00067203876,"teacher_disagreement_score":0.084539875,"about_ca_system_score_codex":0.0007472361,"about_ca_system_score_gemma":0.0008120626,"threshold_uncertainty_score":0.3097765},"labels":[],"label_agreement":null},{"id":"W2071855640","doi":"10.1038/nprot.2012.097","title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","year":2012,"lang":"en","type":"article","venue":"Nature Protocols","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Fallopian tube; Cell culture; Immortalised cell line; Cell biology; Epithelium; Biology; In vitro; Primary culture; Immunology; Anatomy; Genetics","score_opus":0.014076210538741358,"score_gpt":0.32342903659787997,"score_spread":0.3093528260591386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071855640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59311926,0.006193549,0.00014142864,0.0010804938,0.00074350013,0.34169495,0.0003146479,0.0002691726,0.056442976],"genre_scores_gemma":[0.96596396,0.000031546504,0.001079758,0.00066911936,0.0006256951,0.03066828,0.00010265718,0.00002980357,0.0008292008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991753,0.000030891948,0.00019734,0.00017795787,0.00023527886,0.0001832216],"domain_scores_gemma":[0.9994511,0.0000117898,0.00010609307,0.00021250307,0.000086837725,0.00013166822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012773761,0.00014428751,0.00027427648,0.0000495326,0.00005194583,0.0000111602485,0.00004604271,0.00030016204,0.00009350798],"category_scores_gemma":[0.000011602501,0.00010496334,0.00006566062,0.00009643009,0.00004757037,0.00010548778,0.000028204819,0.00026124433,0.0000041537155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041107298,0.0018979051,0.6594595,0.0024599659,0.00038693435,0.000027888314,0.0023084767,0.0000010461478,0.30230206,0.0140344715,0.009454552,0.007256157],"study_design_scores_gemma":[0.004641942,0.0009633108,0.5226077,0.0006399948,0.00021367866,0.000027662814,0.00004330936,0.0000029979376,0.3072766,0.00019699727,0.163154,0.00023182001],"about_ca_topic_score_codex":0.000013245466,"about_ca_topic_score_gemma":0.000004026853,"teacher_disagreement_score":0.37284464,"about_ca_system_score_codex":0.000076151126,"about_ca_system_score_gemma":0.000051160154,"threshold_uncertainty_score":0.4280281},"labels":[],"label_agreement":null},{"id":"W2072213112","doi":"10.1016/j.clinbiochem.2009.10.012","title":"Nidogen-2: A new serum biomarker for ovarian cancer","year":2009,"lang":"es","type":"article","venue":"Clinical Biochemistry","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Ovarian cancer; Biomarker; Medicine; Internal medicine; Oncology; Immunoassay; Ovarian carcinoma; Gastroenterology; Serous fluid; Stage (stratigraphy); Area under the curve; Cancer; Pathology; Chemistry; Immunology; Biology","score_opus":0.0757247828634422,"score_gpt":0.4227755404462271,"score_spread":0.3470507575827849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072213112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6477675,0.06590724,0.0004586979,0.26025006,0.006255248,0.0033228644,0.0025380165,0.00033593335,0.013164451],"genre_scores_gemma":[0.96650016,0.006037202,0.0019173538,0.007720518,0.007555776,0.00009955857,0.00017316751,0.000058816062,0.009937419],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966172,0.00004322006,0.0011367158,0.0011907049,0.00029376603,0.00071841327],"domain_scores_gemma":[0.9969629,0.00048879645,0.0003487111,0.0009931182,0.00017308591,0.0010333897],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046097432,0.0004966648,0.0009468061,0.00003978479,0.00011895893,0.00010112983,0.00028234936,0.00082623225,0.0016712599],"category_scores_gemma":[0.0006227335,0.0004341295,0.0008542994,0.0002504564,0.00016962294,0.000045041248,0.000058318237,0.0003721158,0.00014166196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013001638,0.0025369069,0.12773706,0.00043580314,0.0014571161,0.000101712336,0.00003060561,9.309136e-7,0.0066535687,0.00026580275,0.30169907,0.5577813],"study_design_scores_gemma":[0.020302514,0.0018807494,0.5250747,0.0024751627,0.003019343,0.0000252759,0.000049020327,0.00015581961,0.09739029,0.0007800326,0.34788924,0.00095784385],"about_ca_topic_score_codex":0.00007917682,"about_ca_topic_score_gemma":0.0000034633822,"teacher_disagreement_score":0.55682343,"about_ca_system_score_codex":0.00027420247,"about_ca_system_score_gemma":0.0015813517,"threshold_uncertainty_score":0.99981105},"labels":[],"label_agreement":null},{"id":"W2072273059","doi":"10.5146/tjpath.2012.01128","title":"Expression of p16, p53, CD24, EpCAM and Calretinin in Serous Borderline Tumors of the Ovary","year":2012,"lang":"en","type":"article","venue":"Turkish Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agricultural Research Development Agency; Egg Farmers of Canada; World Health Organization","keywords":"Calretinin; CD24; Immunohistochemistry; Pathology; Serous fluid; Serous carcinoma; Tumor progression; Cancer research; Biology; Ovarian cancer; Medicine; Cancer; Internal medicine; Cancer stem cell","score_opus":0.016006736613159028,"score_gpt":0.2836152598028211,"score_spread":0.26760852318966205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072273059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924279,0.0057819765,0.000018108003,0.0011430724,0.000246061,0.00012385592,0.000008843671,0.0000018217589,0.00024834953],"genre_scores_gemma":[0.9980166,0.00044403673,0.0011708153,0.00017971071,0.00014757666,0.000003018802,0.0000014011713,0.000010194573,0.00002662343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989236,0.00013817384,0.00051951193,0.00008290888,0.00016645259,0.00016935551],"domain_scores_gemma":[0.9990952,0.00009974212,0.0004613256,0.00016077387,0.000096523865,0.00008645337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048444874,0.000097298354,0.0004612254,0.00010554856,0.000016028753,0.0000015457314,0.00007489706,0.00008465516,0.00006166045],"category_scores_gemma":[0.00011960578,0.00005717693,0.00008698968,0.00011453107,0.00012077664,0.00005635092,0.000051845545,0.00023257639,6.2618915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003516352,0.0008328769,0.9591878,0.00008909729,0.00003983372,0.00046007393,0.0016964152,0.000011688653,0.030205272,0.00009046798,0.0007270702,0.00630776],"study_design_scores_gemma":[0.0028650363,0.0007065839,0.94570816,0.0005349763,0.000119656805,0.0030448532,0.00027806163,0.0000036390102,0.04612004,0.00010320663,0.00046447208,0.0000513383],"about_ca_topic_score_codex":0.000025073785,"about_ca_topic_score_gemma":0.000007372302,"teacher_disagreement_score":0.015914766,"about_ca_system_score_codex":0.00003403443,"about_ca_system_score_gemma":0.00008031515,"threshold_uncertainty_score":0.23316075},"labels":[],"label_agreement":null},{"id":"W2072317433","doi":"10.1210/endo.141.1.7250","title":"Role of Gonadotropin-Releasing Hormone as an Autocrine Growth Factor in Human Ovarian Surface Epithelium1","year":2000,"lang":"en","type":"article","venue":"Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Medical Research Council Canada","keywords":"GNRHR; Endocrinology; Internal medicine; Gonadotropin-releasing hormone; Autocrine signalling; Gonadotropin-releasing hormone receptor; Agonist; Biology; Receptor; Messenger RNA; Hormone; Luteinizing hormone; Medicine; Gene","score_opus":0.01425761478838241,"score_gpt":0.2856425373376753,"score_spread":0.2713849225492929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072317433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889512,0.001246016,0.0000031379798,0.0014800745,0.0000553817,0.00039781007,0.000026413903,0.00007381355,0.007766171],"genre_scores_gemma":[0.99743384,0.0008036764,0.00076336693,0.00021163735,0.00010625675,0.00002931694,0.00004090283,0.000036559435,0.00057443534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837464,0.00009489925,0.00040811332,0.0004298664,0.00016709189,0.0005253608],"domain_scores_gemma":[0.999238,0.00004607784,0.000081972335,0.00042908193,0.000054463733,0.00015041139],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000027834389,0.00022643851,0.00054351985,0.00014603099,0.000058304504,0.000009092096,0.00012981535,0.00008560634,0.002519727],"category_scores_gemma":[0.000019429994,0.00020715104,0.00009139984,0.0001924029,0.000108824526,0.00008899515,0.000032488275,0.00023016705,0.00011098083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016361027,0.005912888,0.5257037,0.00013544285,0.00071563595,0.0019664096,0.0025020414,0.00014176109,0.24656165,0.06240029,0.00031633742,0.15200771],"study_design_scores_gemma":[0.004694768,0.0018302042,0.960467,0.00004910572,0.00006847392,0.0002347125,0.000093649236,0.000044276625,0.026047248,0.0017093441,0.0045767473,0.00018451479],"about_ca_topic_score_codex":0.0059790686,"about_ca_topic_score_gemma":0.0001571018,"teacher_disagreement_score":0.43476322,"about_ca_system_score_codex":0.00016342827,"about_ca_system_score_gemma":0.00010069583,"threshold_uncertainty_score":0.9983921},"labels":[],"label_agreement":null},{"id":"W2072468007","doi":"10.1016/j.ygyno.2010.12.333","title":"Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: A promising step towards screening and early detection","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Autofluorescence; Fallopian tube; Occult; Epithelium; Pathology; Narrow-band imaging; Radiology; Gynecology; Endoscopy; Optics","score_opus":0.07394357259399684,"score_gpt":0.34897690703052553,"score_spread":0.27503333443652866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072468007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923782,0.00024477908,0.00089312054,0.002153696,0.00038877316,0.0013397095,0.000010166041,0.00011391179,0.0024776643],"genre_scores_gemma":[0.9798908,0.00037271736,0.018299328,0.0008659607,0.00008778211,0.00030483832,0.0000052047585,0.000024481877,0.00014886167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766314,0.00027212437,0.0006779719,0.0006836959,0.0001690857,0.00053401134],"domain_scores_gemma":[0.99859357,0.00047509684,0.00025772443,0.00028952345,0.00013761906,0.00024644888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066800683,0.0002581256,0.0006537531,0.0002204734,0.00016988392,0.000031820153,0.00013499938,0.00028037187,0.00022701915],"category_scores_gemma":[0.0009883511,0.00019374656,0.00010499309,0.0002759625,0.000236649,0.00012986804,0.00015496057,0.00044442865,0.000012860377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056591176,0.00055020995,0.5174568,0.00004270247,0.000086586515,0.0014338421,0.001608578,0.0000017641366,0.0005575351,0.000046292756,0.00003901822,0.4776107],"study_design_scores_gemma":[0.004446241,0.0040826327,0.98754877,0.00019852062,0.00022485564,0.00025211758,0.0007309757,0.00028001936,0.0010933641,0.00019258662,0.00074135355,0.00020858513],"about_ca_topic_score_codex":0.0023662727,"about_ca_topic_score_gemma":0.0060806405,"teacher_disagreement_score":0.47740212,"about_ca_system_score_codex":0.0005687894,"about_ca_system_score_gemma":0.00063550787,"threshold_uncertainty_score":0.79007554},"labels":[],"label_agreement":null},{"id":"W2072490215","doi":"10.1097/pgp.0b013e31827630eb","title":"Stage II to IV Low-grade Serous Carcinoma of the Ovary Is Associated With a Poor Prognosis","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous carcinoma; Medicine; Ovary; Stage (stratigraphy); Ovarian cancer; Immunostaining; Population; Ovarian carcinoma; Cancer; Internal medicine; Pathology; Carcinoma; Oncology; Gynecology; Gastroenterology; Immunohistochemistry; Biology","score_opus":0.02067726723991664,"score_gpt":0.27460914829771915,"score_spread":0.2539318810578025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072490215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643867,0.000065037355,0.000030728756,0.03417049,0.0004105198,0.00041846043,0.000038051552,0.0000073187553,0.0004727214],"genre_scores_gemma":[0.9929904,0.000021145266,0.00075131655,0.005784835,0.00011120144,0.000052000025,0.0000039903744,0.000010891143,0.0002742726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857974,0.00010781603,0.0004797142,0.0001748836,0.00046405615,0.0001938037],"domain_scores_gemma":[0.99822724,0.00026447806,0.0004641941,0.0001184404,0.000793767,0.00013186339],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020188648,0.00013706289,0.0004078043,0.00009386419,0.00004782546,0.0000142528,0.00030124592,0.0001230252,0.001452286],"category_scores_gemma":[0.0004788869,0.00007046158,0.00019171908,0.00014602295,0.000117039155,0.00006669099,0.00013196035,0.000251746,0.000014271501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003532059,0.003064919,0.97960997,0.000009402617,0.0007949876,0.0020516878,0.0004929776,0.00004168479,0.004792302,0.00025156146,0.0046365866,0.0039007268],"study_design_scores_gemma":[0.0025993132,0.004110412,0.986212,0.00010665689,0.00012043985,0.0005950636,0.000070600116,0.000025734878,0.005292774,0.0002412669,0.0005516047,0.00007412441],"about_ca_topic_score_codex":0.00005157349,"about_ca_topic_score_gemma":0.000027282567,"teacher_disagreement_score":0.028603677,"about_ca_system_score_codex":0.00027048483,"about_ca_system_score_gemma":0.00016048063,"threshold_uncertainty_score":0.9994605},"labels":[],"label_agreement":null},{"id":"W2072622889","doi":"10.1016/j.ygyno.2008.05.010","title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; BC Cancer Agency; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Fallopian tube; Serous carcinoma; Serous fluid; Salpingectomy; Pathology; Medicine; Mucinous carcinoma; Cystadenocarcinoma; Ovarian carcinoma; Carcinoma; Ovarian cancer; Gynecology; Adenocarcinoma; Biology; Internal medicine; Cancer; Pregnancy","score_opus":0.03237494038853245,"score_gpt":0.28247338832374574,"score_spread":0.2500984479352133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072622889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203587,0.0017202953,0.000010361036,0.001974595,0.00025893006,0.0016134206,0.00014277997,0.000041706127,0.0022020214],"genre_scores_gemma":[0.99628997,0.0005565907,0.0024445204,0.00028033665,0.00007148902,0.00023007921,0.000049760503,0.000027698552,0.00004954108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682796,0.0004250164,0.0010075194,0.0008655863,0.00025942407,0.00061452313],"domain_scores_gemma":[0.99786705,0.00068045367,0.00033747507,0.0005822513,0.00018822747,0.00034452617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045878196,0.00041398473,0.0015060626,0.0002118492,0.00014413007,0.000006948814,0.00017217548,0.0005395484,0.00020701886],"category_scores_gemma":[0.00030223656,0.00035708724,0.00014729067,0.00030700944,0.0009027988,0.00010651521,0.00023044465,0.00040489517,0.0000032109103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044829163,0.0027869523,0.9805564,0.0003650211,0.00015178163,0.0011749945,0.0017148944,0.000018284156,0.0006195079,0.0008908091,0.000058436086,0.01121461],"study_design_scores_gemma":[0.007374398,0.007266237,0.9812845,0.000054678305,0.00023654188,0.00086790713,0.00036297366,0.0002018222,0.0011477362,0.00031389948,0.0006284433,0.00026088383],"about_ca_topic_score_codex":0.0053548245,"about_ca_topic_score_gemma":0.0073793577,"teacher_disagreement_score":0.010953726,"about_ca_system_score_codex":0.001032501,"about_ca_system_score_gemma":0.0013169689,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W2073078104","doi":"10.1158/1538-7445.am2011-lb-271","title":"Abstract LB-271: Benign ovarian serous tumors: A redefining moment","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous Cystadenoma; Ovarian cancer; Cystadenocarcinoma; Pathology; Ovary; Serous carcinoma; Biology; Clear cell; Medicine; Cancer research; Cancer; Internal medicine; Carcinoma","score_opus":0.2230265689919213,"score_gpt":0.41272523664993144,"score_spread":0.18969866765801013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073078104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86195606,0.0030162963,0.000026678603,0.0042472235,0.0003303651,0.0012144484,0.000053937707,0.00012261281,0.12903236],"genre_scores_gemma":[0.99509925,0.00074751495,0.00077416206,0.00029562492,0.0004396362,0.00092501106,0.000017117365,0.000057165344,0.0016445112],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99736744,0.00007200389,0.00032518018,0.0005891074,0.0008387587,0.0008075118],"domain_scores_gemma":[0.99847203,0.0000893749,0.000064170636,0.00065453345,0.00029030748,0.00042956416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078437437,0.00020321843,0.00036104987,0.00026422922,0.00021919067,0.000053469015,0.00019985525,0.00010721122,0.006385396],"category_scores_gemma":[0.000052941818,0.00016861678,0.00011479554,0.00048050872,0.00015006764,0.00009616138,0.00010901443,0.000553523,0.0003802609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006415352,0.007780637,0.34287727,0.0019853294,0.0032427358,0.010713098,0.027070355,0.000046383197,0.023777591,0.03734876,0.13861084,0.40013167],"study_design_scores_gemma":[0.007914117,0.0024104377,0.85069627,0.0024096156,0.00018940287,0.00011746479,0.0017805763,0.000028796812,0.055673905,0.0020506154,0.07610098,0.0006278085],"about_ca_topic_score_codex":0.005959148,"about_ca_topic_score_gemma":0.00019380504,"teacher_disagreement_score":0.507819,"about_ca_system_score_codex":0.000887639,"about_ca_system_score_gemma":0.0007659598,"threshold_uncertainty_score":0.9945229},"labels":[],"label_agreement":null},{"id":"W2073175689","doi":"10.7326/0003-4819-155-6-201109200-02008","title":"Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality","year":2011,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ovarian cancer; Incidence (geometry); Gynecology; Colorectal cancer; Internal medicine; Randomized controlled trial; Transvaginal ultrasonography; Oncology; Cancer; Cancer screening; Prostate cancer; Ultrasonography; Obstetrics; Surgery","score_opus":0.09207359541258908,"score_gpt":0.3677317249467239,"score_spread":0.2756581295341348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073175689","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15490407,0.008917263,0.0006909593,0.8296872,0.0007867359,0.0012961521,0.0018424388,0.00007800359,0.0017972116],"genre_scores_gemma":[0.49897137,0.008233494,0.0008624956,0.48457932,0.0051377355,0.00023214128,0.00018214653,0.0001274182,0.0016738833],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965489,0.00010027873,0.00087582815,0.0008671856,0.0010078725,0.0005999485],"domain_scores_gemma":[0.99749184,0.00024791597,0.00063395005,0.0006326938,0.00064329157,0.00035030209],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004220729,0.00068373844,0.0016137786,0.000434496,0.00006777965,0.000013908484,0.00031098945,0.0004082669,0.0012916445],"category_scores_gemma":[0.00010073703,0.00041130837,0.00021489711,0.00034121683,0.00071296905,0.00018115634,0.000044653923,0.0013964793,0.0000031104612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005167441,0.00033611292,0.17718633,0.0019195986,0.0060795373,0.007635576,0.003272067,0.0000011933969,0.00017913106,0.000032517553,0.76914555,0.029044954],"study_design_scores_gemma":[0.010171661,0.014085356,0.5235088,0.04190556,0.004927281,0.0020077247,0.00077132403,0.000012802867,0.008476302,0.00006907894,0.39294955,0.0011145733],"about_ca_topic_score_codex":0.027636945,"about_ca_topic_score_gemma":0.0007821137,"teacher_disagreement_score":0.376196,"about_ca_system_score_codex":0.00004445813,"about_ca_system_score_gemma":0.0003115937,"threshold_uncertainty_score":0.9998339},"labels":[],"label_agreement":null},{"id":"W2074059416","doi":"10.1111/igc.0b013e3181dd0110","title":"Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Histology; Stage (stratigraphy); Ovarian cancer; Epithelial ovarian cancer; Gynecology; Oncology; Internal medicine; Cancer; Pathology","score_opus":0.03717033442550096,"score_gpt":0.35891985178083596,"score_spread":0.321749517355335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074059416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018870128,0.9733527,0.000045234014,0.0023980783,0.0031616369,0.0010974099,0.00039364674,0.00001528027,0.00066593284],"genre_scores_gemma":[0.027532268,0.9689789,0.00093090587,0.00042212993,0.0009674403,0.0006447609,0.000020302003,0.000055232875,0.0004480703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641246,0.00018020252,0.0016530827,0.0004633331,0.00084191747,0.00044898648],"domain_scores_gemma":[0.99544233,0.0009750298,0.0022196171,0.00027897593,0.0008186325,0.00026544122],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005298772,0.00049172743,0.0027093866,0.00050182774,0.000032753076,0.000028597082,0.0006215056,0.00055003,0.0031111152],"category_scores_gemma":[0.0004745036,0.000302735,0.0003972174,0.00033099623,0.0002532733,0.00011819571,0.00009954722,0.001488655,0.0000073576416],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021846143,0.0011964669,0.011286533,0.0011872199,0.001853794,0.002548192,0.00016223514,0.000058617286,0.0000086810005,0.00034779712,0.00028662762,0.9788792],"study_design_scores_gemma":[0.0057129296,0.0019856358,0.028759394,0.011289917,0.0010424271,0.00042563365,0.000026498223,0.00000646027,0.0000110722685,0.00014581162,0.95027447,0.0003197652],"about_ca_topic_score_codex":0.0004947337,"about_ca_topic_score_gemma":0.001394447,"teacher_disagreement_score":0.97855943,"about_ca_system_score_codex":0.0032896304,"about_ca_system_score_gemma":0.0029609678,"threshold_uncertainty_score":0.9999425},"labels":[],"label_agreement":null},{"id":"W2074157782","doi":"10.3389/fonc.2014.00005","title":"BRCA and Early Events in the Development of Serous Ovarian Cancer","year":2014,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Congressionally Directed Medical Research Programs; Princess Margaret Hospital Foundation; U.S. Department of Defense","keywords":"Serous carcinoma; Ovarian cancer; Serous fluid; Biology; Fallopian tube; BRCA mutation; Ovulation; Germline; Germline mutation; Cancer research; Cancer; Internal medicine; Oncology; Medicine; Mutation; Hormone; Genetics; Gene; Gynecology","score_opus":0.04367900450268094,"score_gpt":0.3735518114843658,"score_spread":0.32987280698168486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074157782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072295166,0.99557215,0.000053739535,0.00041285538,0.0008911348,0.0012916801,0.00000863471,0.0000048035945,0.0010420234],"genre_scores_gemma":[0.00095068396,0.9915741,0.0060994127,0.0001530306,0.0001167164,0.0009197141,0.000020817872,0.000026262884,0.00013922475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822164,0.00029659248,0.0007232599,0.0003409501,0.0001586812,0.00025886012],"domain_scores_gemma":[0.99920386,0.00014402499,0.00030716564,0.00026395428,0.00002324567,0.000057729198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005949458,0.00025024664,0.0019918191,0.00028403333,0.000025422598,0.0000031980317,0.00016628136,0.00035461542,0.00002242048],"category_scores_gemma":[0.000031171287,0.00015967802,0.00011121016,0.0002588508,0.000064009786,0.00001735438,0.000049198232,0.0003423439,0.0000034054983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030298836,0.0002725049,0.052911136,0.0032234218,0.00022719247,0.00004480911,0.0011826422,2.3050946e-7,1.0872085e-8,0.000031157226,0.0020988695,0.9399777],"study_design_scores_gemma":[0.0016713507,0.00026820452,0.04926576,0.004908324,0.0005046828,0.000026397081,0.000054873064,0.0000010247903,2.2449231e-7,0.000054088327,0.94312227,0.00012281968],"about_ca_topic_score_codex":0.00035401457,"about_ca_topic_score_gemma":0.00080342934,"teacher_disagreement_score":0.9410234,"about_ca_system_score_codex":0.0010263588,"about_ca_system_score_gemma":0.0012914395,"threshold_uncertainty_score":0.6511481},"labels":[],"label_agreement":null},{"id":"W2074525098","doi":"10.1038/sj.onc.1208214","title":"Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling","year":2005,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University Health Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Biology; Serous fluid; Gene expression profiling; Candidate gene; Computational biology; Gene; Ovarian cancer; Microarray analysis techniques; Gene expression; Immunohistochemistry; Cancer research; Cancer; Genetics; Immunology","score_opus":0.02088142066997719,"score_gpt":0.2799766621168945,"score_spread":0.2590952414469173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074525098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947283,0.00049028324,0.00210847,0.0018019368,0.00008993402,0.00047875708,0.000051037696,0.000029653753,0.00022161931],"genre_scores_gemma":[0.98357785,0.00007733441,0.015128226,0.00031452102,0.00071094383,0.000024551435,0.00008634618,0.00003251555,0.000047729143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989241,0.000036857786,0.00023906812,0.00032914052,0.00022993454,0.00024093808],"domain_scores_gemma":[0.99945813,0.00001969573,0.00009297841,0.000183687,0.00008873485,0.00015679417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011288583,0.00016988159,0.00027850358,0.00008511091,0.000093867995,0.00003295358,0.00004157734,0.0000747274,0.000038295828],"category_scores_gemma":[0.000028636325,0.00014559121,0.000073208335,0.00009910705,0.00004038956,0.000089594316,0.00004343254,0.00007972061,0.00001331936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016788303,0.0005188075,0.03687775,0.00023989621,0.0004671682,0.0011842446,0.00057197065,0.00063712115,0.85387164,0.0005310131,0.00003383829,0.10489868],"study_design_scores_gemma":[0.0033838397,0.00036607546,0.030461539,0.00040207861,0.0008280717,0.00023447162,0.00013370179,0.0010141332,0.96263117,0.00013926289,0.00015841839,0.00024724856],"about_ca_topic_score_codex":0.00014080244,"about_ca_topic_score_gemma":0.000019569425,"teacher_disagreement_score":0.10875953,"about_ca_system_score_codex":0.00021768894,"about_ca_system_score_gemma":0.0001782436,"threshold_uncertainty_score":0.5937037},"labels":[],"label_agreement":null},{"id":"W2074525163","doi":"10.1016/j.ejso.2006.03.021","title":"Malignancies following bilateral salpingo-oophorectomy (BSO)","year":2006,"lang":"en","type":"article","venue":"European Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Breast cancer; Ovarian cancer; Gynecology; Cancer; Incidence (geometry); Population; Cancer registry; Obstetrics; Surgery; Internal medicine","score_opus":0.018264436243181838,"score_gpt":0.282479853388118,"score_spread":0.2642154171449361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074525163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88084215,0.00207673,0.00004352239,0.0073334933,0.0009581571,0.000110524816,0.0000021798296,0.000024209938,0.108609036],"genre_scores_gemma":[0.9952104,0.00044976926,0.0017514129,0.00038570442,0.0013858498,0.0000015231944,0.0000041904827,0.00003171092,0.00077945733],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982896,0.00031992784,0.00068593665,0.00016558639,0.00025733598,0.0002816363],"domain_scores_gemma":[0.9990998,0.00016100655,0.0003058951,0.00013052541,0.00011390091,0.00018887738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007642582,0.00015818355,0.00058391073,0.00014271429,0.00005862056,0.000023775152,0.00010453997,0.000045496905,0.0003088093],"category_scores_gemma":[0.000017970362,0.00010791189,0.00044148823,0.00015908222,0.000069425485,0.00007335963,0.000038687533,0.0002686741,0.00010045691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030583953,0.0044617043,0.19337954,0.00008723137,0.0014990696,0.49451673,0.00057345256,0.00017804213,0.0070382827,0.0025394664,0.06624841,0.22641967],"study_design_scores_gemma":[0.0073409886,0.0026931015,0.11029311,0.00017685197,0.00023988137,0.005069176,0.000027461794,0.000003873851,0.0006845212,0.000061476334,0.87329674,0.00011280813],"about_ca_topic_score_codex":0.000014348366,"about_ca_topic_score_gemma":0.0000021498201,"teacher_disagreement_score":0.8070483,"about_ca_system_score_codex":0.00023722998,"about_ca_system_score_gemma":0.00016575209,"threshold_uncertainty_score":0.4400519},"labels":[],"label_agreement":null},{"id":"W2075021378","doi":"10.1006/gyno.2000.6097","title":"Recurrent Metastatic Fallopian Tube Carcinoma in Pregnancy","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Fallopian tube; Fallopian tube cancer; Carboplatin; Pregnancy; Laparotomy; Chemotherapy; Surgery; Carcinoma; Asymptomatic; Gynecology; Ovarian cancer; Cancer; Cisplatin; Internal medicine","score_opus":0.05266140451056141,"score_gpt":0.34107674936985305,"score_spread":0.28841534485929166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075021378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274632,0.003763771,0.000020846897,0.009985072,0.00082827045,0.0012299359,0.000007979258,0.00007027838,0.056630675],"genre_scores_gemma":[0.994311,0.0015115415,0.0014275453,0.0012356214,0.000073892086,0.0005826697,0.000031508014,0.000016535432,0.0008097061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983325,0.0001629883,0.00040991325,0.00045250868,0.00013866351,0.00050342386],"domain_scores_gemma":[0.99901587,0.00034255785,0.00010495924,0.00031230348,0.000054372955,0.00016993014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019185831,0.00020708071,0.00062766095,0.00017770137,0.00004948764,0.000008288195,0.00010590677,0.00015234547,0.0019518111],"category_scores_gemma":[0.00018809234,0.00016124816,0.00011259747,0.00032685837,0.000080530444,0.00004990503,0.000058052472,0.0002497332,0.00019906483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016766634,0.0025746033,0.6749032,0.000048632435,0.00008937295,0.0059849643,0.00026249868,0.000016187121,0.000020476115,0.0013957672,0.0014290704,0.31310752],"study_design_scores_gemma":[0.0063438867,0.0056590885,0.87495404,0.00010276467,0.00019051098,0.0003609569,0.00019326882,0.000115646304,0.000071386225,0.0008488384,0.11098809,0.0001715343],"about_ca_topic_score_codex":0.0001325801,"about_ca_topic_score_gemma":0.0015378809,"teacher_disagreement_score":0.31293598,"about_ca_system_score_codex":0.0010864593,"about_ca_system_score_gemma":0.00040575152,"threshold_uncertainty_score":0.99896055},"labels":[],"label_agreement":null},{"id":"W2075711878","doi":"10.1038/nrc3144","title":"Rethinking ovarian cancer: recommendations for improving outcomes","year":2011,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1507,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Ovarian Cancer Action; National Institute of General Medical Sciences; Cancer Research UK","keywords":"Ovarian cancer; Cancer; Medicine; Outcome (game theory); Gynecology; Oncology; Internal medicine","score_opus":0.14126058002732167,"score_gpt":0.4431636237029608,"score_spread":0.30190304367563914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075711878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.498834e-8,0.9822631,0.00006329667,0.0040068603,0.0038668446,0.0077719972,0.0009918978,0.0001117428,0.00092421164],"genre_scores_gemma":[0.0000014604356,0.96788603,0.0072927647,0.0029013427,0.0018072821,0.016806846,0.0006715248,0.0002212439,0.0024115015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617004,0.00018519658,0.0014983611,0.001198502,0.00028061168,0.0006672705],"domain_scores_gemma":[0.9964704,0.00036082033,0.0014606136,0.0011353709,0.00027830753,0.00029449063],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007523438,0.0010330091,0.0051226066,0.00029696632,0.0002539239,0.00006857611,0.00039058906,0.0014180787,0.0016322689],"category_scores_gemma":[0.0003374813,0.0006763497,0.00230567,0.0005821263,0.00004946739,0.00013374425,0.000105450454,0.0019069618,0.00005861037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001145527,0.00010993754,0.00009876511,0.049503636,0.0009934206,0.0000064963165,0.00010448358,2.021703e-8,4.9031694e-8,0.0010661645,0.03801244,0.9100931],"study_design_scores_gemma":[0.000910232,0.000086410866,0.000031910422,0.0706275,0.012421275,0.000022073336,0.0000028256693,8.6502627e-7,0.0000012839774,0.00014305393,0.91518635,0.0005662016],"about_ca_topic_score_codex":0.00058683,"about_ca_topic_score_gemma":0.00043362268,"teacher_disagreement_score":0.90952694,"about_ca_system_score_codex":0.0017846652,"about_ca_system_score_gemma":0.0016909769,"threshold_uncertainty_score":0.9998783},"labels":[],"label_agreement":null},{"id":"W2075853386","doi":"10.1593/tlo.13136","title":"Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell Tumor","year":2013,"lang":"en","type":"article","venue":"Translational Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Hyacinthe; McGill University; Université de Montréal","funders":"Canadian Institutes of Health Research; Genentech","keywords":"Vascular endothelial growth factor A; Angiogenesis; Cancer research; PTEN; Cell growth; MAPK/ERK pathway; Kinase insert domain receptor; Apoptosis; Vascular endothelial growth factor; Adjuvant therapy; Medicine; Internal medicine; Biology; Endocrinology; Kinase; Cancer; PI3K/AKT/mTOR pathway; Cell biology; VEGF receptors","score_opus":0.030162516009897278,"score_gpt":0.2901945666499952,"score_spread":0.26003205064009793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075853386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98338664,0.00078394264,0.00011697875,0.008612621,0.000078146826,0.00054221554,0.00004101713,0.000015638618,0.0064228144],"genre_scores_gemma":[0.993951,0.0003131823,0.0050711897,0.00036612593,0.00007587351,0.00011975995,0.000036763922,0.000017787814,0.000048296282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989084,0.00006130709,0.00036799873,0.00027822264,0.00018568004,0.0001983987],"domain_scores_gemma":[0.9994482,0.00016197936,0.00009757778,0.00011121701,0.000081637205,0.000099423276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013857543,0.00015405225,0.00048768937,0.00015139129,0.000028715162,0.00000619685,0.00005298682,0.00006499984,0.00026806086],"category_scores_gemma":[0.000007121557,0.00012513234,0.00007188622,0.00014408304,0.00011256703,0.000092957234,0.0000076667475,0.00012161597,0.0000055776927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029407793,0.012175078,0.6960758,0.0005441535,0.000560567,0.00040518635,0.004258264,0.0014990919,0.19898576,0.029413236,0.0004757749,0.052666333],"study_design_scores_gemma":[0.012957535,0.0011712417,0.96079373,0.00005757366,0.00008208449,0.00004534434,0.000065914595,0.005822108,0.01341382,0.0050899033,0.00031898258,0.0001817332],"about_ca_topic_score_codex":0.00041157534,"about_ca_topic_score_gemma":0.00006801432,"teacher_disagreement_score":0.26471797,"about_ca_system_score_codex":0.000041153366,"about_ca_system_score_gemma":0.00032378576,"threshold_uncertainty_score":0.5102749},"labels":[],"label_agreement":null},{"id":"W2076229749","doi":"10.1097/pgp.0b013e3181d90bca","title":"Ovarian Adenosarcoma Arising from Benign Cystadenoma and Associated Intraoperative Consultation Pitfalls","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Cystadenoma; Serous Cystadenoma; Pathology; Medicine; Mucinous cystadenoma; Stromal cell; Immunohistochemistry; Frozen section procedure; Gross examination; Cyst; Ovary; Internal medicine","score_opus":0.011947601670505124,"score_gpt":0.2882335764332225,"score_spread":0.2762859747627174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076229749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880799,0.0001691211,0.000378086,0.009247993,0.0012782448,0.000140803,0.000052469753,0.00001312897,0.00064027193],"genre_scores_gemma":[0.9931591,0.00012909375,0.0049730116,0.0012609886,0.00039495758,0.000006818368,0.000041085976,0.000009065294,0.000025873129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875,0.0001257155,0.0004934961,0.00020619038,0.00027473152,0.00014990353],"domain_scores_gemma":[0.99780047,0.0009512469,0.00038278507,0.000078819576,0.0006440622,0.0001426432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031604903,0.00013298259,0.00037487777,0.00012960982,0.000054610337,0.000054241587,0.00013347746,0.00023206363,0.0007103065],"category_scores_gemma":[0.0020239677,0.000097144664,0.000091357084,0.000058421596,0.00016694149,0.00011813315,0.000050162387,0.0005398859,0.000012044074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013745659,0.0031240408,0.7579808,0.000005399967,0.0021406284,0.019484812,0.0024522566,0.000020780091,0.14179087,0.011905832,0.0011255015,0.05859451],"study_design_scores_gemma":[0.005058789,0.0012194433,0.9833634,0.00003880692,0.00015554273,0.0014587103,0.00016245406,0.000070913055,0.0018138663,0.0056945872,0.0008623783,0.00010113119],"about_ca_topic_score_codex":0.000039987775,"about_ca_topic_score_gemma":0.00009868971,"teacher_disagreement_score":0.22538257,"about_ca_system_score_codex":0.00014010145,"about_ca_system_score_gemma":0.00012357478,"threshold_uncertainty_score":0.7777358},"labels":[],"label_agreement":null},{"id":"W2076864282","doi":"10.1016/s1083-3188(00)00027-9","title":"Isolated tubal torsion at menarche— a case report","year":2000,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Menarche; Ovarian torsion; Torsion (gastropod); General surgery; Surgery; Internal medicine","score_opus":0.013371218784490447,"score_gpt":0.272417437170937,"score_spread":0.2590462183864466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076864282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346036,0.0030626708,0.000018920102,0.0024385462,0.0003400855,0.00016606934,0.000003494696,0.00000915638,0.0005007192],"genre_scores_gemma":[0.99012464,0.0065558827,0.00032580394,0.00057503197,0.0010396339,0.0000024007113,0.0000037575821,0.0000122650845,0.0013605525],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9988642,0.000052356027,0.0005253552,0.000174072,0.000163978,0.00022005427],"domain_scores_gemma":[0.9991205,0.000089708476,0.00027210245,0.00012443955,0.000105316576,0.0002879337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024025912,0.00013152613,0.0003789149,0.00012512929,0.00008967075,0.000008415509,0.000033616343,0.00011910738,0.0016051084],"category_scores_gemma":[0.00006551175,0.000095017065,0.00012846965,0.00012640067,0.000035957062,0.000053954245,0.000026498325,0.00022283754,0.000023699635],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011572258,0.0016577129,0.5148353,0.00012827208,0.00021070991,0.38221404,0.00018235609,0.0000062481495,0.000060663002,0.000010612077,0.058344647,0.041192215],"study_design_scores_gemma":[0.008927724,0.004209686,0.3781373,0.00006605125,0.0017649933,0.5615789,0.00008686226,0.00011445482,0.000085474996,0.00004702025,0.0447629,0.00021860283],"about_ca_topic_score_codex":0.0000092967275,"about_ca_topic_score_gemma":0.0000073598335,"teacher_disagreement_score":0.17936489,"about_ca_system_score_codex":0.00024221375,"about_ca_system_score_gemma":0.00016428638,"threshold_uncertainty_score":0.9993076},"labels":[],"label_agreement":null},{"id":"W2077255241","doi":"10.1038/nrc3432","title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","year":2013,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":567,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust; Cancer Research UK; Wellcome Trust","keywords":"Ascites; Ovarian cancer; Ascitic fluid; Translational research; Context (archaeology); Medicine; Cancer; Bioinformatics; Internal medicine; Pathology; Biology","score_opus":0.2531028857580959,"score_gpt":0.50477975650963,"score_spread":0.2516768707515341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077255241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003521864,0.98430914,5.8269404e-7,0.006527557,0.0003657063,0.008187596,0.00011301618,0.000008188544,0.00048472104],"genre_scores_gemma":[0.000017568736,0.98880905,0.0003513582,0.00026308972,0.0015796206,0.00835732,0.00003443867,0.00008184959,0.00050570635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971542,0.00040884624,0.0008636425,0.0006742192,0.0004305014,0.00046860805],"domain_scores_gemma":[0.9974309,0.00094735116,0.0005554817,0.0006730857,0.00024578345,0.00014736931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728044,0.0004693205,0.0028832543,0.00024622973,0.000096546835,0.000039860992,0.00029630814,0.00065226684,0.00025393095],"category_scores_gemma":[0.00033879565,0.00023966804,0.0005394446,0.0006917713,0.0001157441,0.000057033005,0.0000745013,0.0014814606,0.000006618168],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019070265,0.00008180549,0.00008500886,0.025581755,0.00033188993,0.000002917887,0.00024062769,7.2426985e-8,5.270302e-7,0.00045084363,0.01815132,0.95505416],"study_design_scores_gemma":[0.0008933884,0.00015272782,0.000091140864,0.095477946,0.00059725175,0.0000043254236,0.0000095192745,8.168268e-7,0.0000071759296,0.00019933947,0.90239245,0.00017393794],"about_ca_topic_score_codex":0.001789131,"about_ca_topic_score_gemma":0.000727977,"teacher_disagreement_score":0.95488024,"about_ca_system_score_codex":0.0004650828,"about_ca_system_score_gemma":0.0012030224,"threshold_uncertainty_score":0.9773379},"labels":[],"label_agreement":null},{"id":"W2077260544","doi":"10.14740/jcgo.v3i3.232","title":"A Rare Case of Histologic Benign Struma Ovarii With Distant Metastasis","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Struma ovarii; Metastasis; Thyroglobulin; Pathology; Scintigraphy; Thyroid; Ovarian tumor; Ovarian Teratoma; Ovary; Teratoma; Radiology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.04936567930632403,"score_gpt":0.35676810970782297,"score_spread":0.30740243040149895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077260544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928886,0.0035845735,0.0005827084,0.001432682,0.0007951789,0.00014257923,0.000010836961,0.000004952558,0.000557869],"genre_scores_gemma":[0.9921714,0.0012214532,0.005955849,0.00048394868,0.000106500745,0.0000025555623,0.0000018051802,0.000009605306,0.000046890807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980743,0.00023472965,0.0011533203,0.00019008416,0.00017767645,0.00016989438],"domain_scores_gemma":[0.9894791,0.008719212,0.0009829906,0.00021032356,0.0003440408,0.0002642829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010828607,0.00013541362,0.0011021548,0.00015709609,0.00005644277,0.0000071390623,0.00006850509,0.00020619718,0.00012807877],"category_scores_gemma":[0.0075847125,0.00007969703,0.00022791149,0.0002351467,0.00024757665,0.00005255407,0.000029911404,0.00041515438,0.0000015048403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012052855,0.0017367911,0.7390734,0.00012394965,0.00093611714,0.011832084,0.000098071054,0.000017729486,0.0000036868355,0.0027955712,0.0008012881,0.24137603],"study_design_scores_gemma":[0.030153807,0.04725368,0.82110655,0.0002682624,0.005744361,0.018951537,0.00054512976,0.0002493611,0.00028830825,0.0022632745,0.072824344,0.0003513515],"about_ca_topic_score_codex":0.000008672998,"about_ca_topic_score_gemma":0.00002450671,"teacher_disagreement_score":0.24102467,"about_ca_system_score_codex":0.00005727274,"about_ca_system_score_gemma":0.00021341717,"threshold_uncertainty_score":0.9080157},"labels":[],"label_agreement":null},{"id":"W2077422669","doi":"10.1016/j.ygyno.2010.05.005","title":"A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Carboplatin; Erlotinib; Medicine; Ovarian cancer; Internal medicine; Oncology; Progressive disease; Chemotherapy; Epidermal growth factor receptor; Cancer; Cisplatin","score_opus":0.016665746575817732,"score_gpt":0.31674435591680217,"score_spread":0.30007860934098446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077422669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410504,0.00003199049,0.0000022741037,0.0011065617,0.0005274997,0.003370464,0.000043862263,0.000024843024,0.00078749243],"genre_scores_gemma":[0.9980149,0.000016095779,0.00047256763,0.00016553474,0.000051325922,0.0011604716,0.00005792142,0.00002384634,0.00003729752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797016,0.00019655796,0.0005628195,0.00053340854,0.0003060012,0.00043104507],"domain_scores_gemma":[0.9987141,0.00024766283,0.00039475426,0.0003244029,0.00019840186,0.00012066054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040063908,0.00027013774,0.000830949,0.00032743218,0.000072993294,0.000006120288,0.00012833964,0.00024360215,0.00035836425],"category_scores_gemma":[0.0001310237,0.0001871617,0.000036919086,0.00050345855,0.00012480121,0.00007293828,0.000076419834,0.00056380045,0.000003738873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045101075,0.06184781,0.8382408,0.00003188193,0.00015218346,0.0001809321,0.0028414573,0.000040500006,0.000100512465,0.00010237228,0.00007549646,0.09187596],"study_design_scores_gemma":[0.087224275,0.09968347,0.81147885,0.00007591653,0.00018911387,0.000004103481,0.00040929765,0.000051307663,0.000113303635,0.000057962923,0.0005495017,0.00016291327],"about_ca_topic_score_codex":0.001822634,"about_ca_topic_score_gemma":0.050836593,"teacher_disagreement_score":0.09171305,"about_ca_system_score_codex":0.00074650516,"about_ca_system_score_gemma":0.000672931,"threshold_uncertainty_score":0.9664832},"labels":[],"label_agreement":null},{"id":"W2077515066","doi":"10.1016/j.ygyno.2010.11.015","title":"Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health","keywords":"Medicine; Oncology; Ovarian cancer; Prostate; Internal medicine; Colorectal cancer; Prostate cancer; Gynecology; Cancer","score_opus":0.02926786420893145,"score_gpt":0.35645225734779407,"score_spread":0.3271843931388626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077515066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759673,0.0007814209,0.00023222563,0.013920544,0.0017558604,0.0059204735,0.00018426795,0.00008862862,0.0011492993],"genre_scores_gemma":[0.9796243,0.00020802717,0.009485418,0.0026775529,0.0005738297,0.00718241,0.000072483344,0.00004438355,0.00013164904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970319,0.000304251,0.0006049229,0.00089642976,0.00026205598,0.0009004008],"domain_scores_gemma":[0.99649054,0.0026136066,0.0002753574,0.00030003808,0.00013393952,0.00018651082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017159521,0.00042909884,0.00096585124,0.00021829175,0.00046374748,0.00008602827,0.00024353083,0.0006199912,0.0002727724],"category_scores_gemma":[0.0009790636,0.00029337424,0.00024935298,0.0004260148,0.00024228063,0.00015158876,0.000121899815,0.00086413376,0.000002865272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016972756,0.0017000381,0.75954086,0.00009286393,0.0008031338,0.0022077793,0.0053163692,0.00006293448,0.0041785063,0.0014800703,0.0021465898,0.20549808],"study_design_scores_gemma":[0.07421592,0.0063690017,0.90869576,0.00016062625,0.00087612594,0.00018532047,0.00094292325,0.0005684269,0.000414515,0.00047659222,0.006651004,0.0004437624],"about_ca_topic_score_codex":0.0011101022,"about_ca_topic_score_gemma":0.0066213575,"teacher_disagreement_score":0.20505433,"about_ca_system_score_codex":0.000434459,"about_ca_system_score_gemma":0.0005949494,"threshold_uncertainty_score":0.99995184},"labels":[],"label_agreement":null},{"id":"W2077520295","doi":"10.1016/j.ygyno.2013.03.021","title":"Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis?","year":2013,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Serous fluid; Ovary; Pathology; Metaplasia; Stroma; Epithelium; Biology; Serous carcinoma; Ovarian carcinoma; Mesothelium; Malignant transformation; Ovarian cancer; Medicine; Mesothelial Cell; Immunohistochemistry; Cancer; Endocrinology; Genetics","score_opus":0.1768499433057926,"score_gpt":0.39191442066935583,"score_spread":0.21506447736356324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077520295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000592982,0.9855461,0.00020356184,0.0029680901,0.0011381388,0.006225643,0.00006420242,0.00017369373,0.003087602],"genre_scores_gemma":[0.0020854706,0.98260194,0.00966524,0.0010431269,0.0004289363,0.0012021562,0.00013196935,0.00013252441,0.0027086285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945246,0.0011677815,0.00173957,0.0012404864,0.00049679633,0.0008307718],"domain_scores_gemma":[0.9895286,0.0066188895,0.0018953406,0.0011881599,0.00038428043,0.00038473532],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009234627,0.000950079,0.005077654,0.00040745246,0.00014340231,0.000038748578,0.00046826617,0.0015995223,0.011388246],"category_scores_gemma":[0.0022079276,0.00062246056,0.0010018009,0.00093647966,0.0003469358,0.00013142539,0.0001241633,0.00069849263,0.0009082021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004597388,0.0010912912,0.00033779835,0.008405955,0.0014712268,0.0005592113,0.00009785861,0.000101205595,0.0000103245775,0.00015613074,0.002476026,0.98483324],"study_design_scores_gemma":[0.0034605379,0.0064591644,0.0012426447,0.014170381,0.00656882,0.00028003694,0.00008064482,0.00008555811,0.000045084384,0.00011030579,0.9668891,0.00060776155],"about_ca_topic_score_codex":0.002190663,"about_ca_topic_score_gemma":0.00039778292,"teacher_disagreement_score":0.98422545,"about_ca_system_score_codex":0.0046210173,"about_ca_system_score_gemma":0.0105763255,"threshold_uncertainty_score":0.9998697},"labels":[],"label_agreement":null},{"id":"W2077796933","doi":"10.1158/1055-9965.epi-07-2524","title":"Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies","year":2008,"lang":"en","type":"review","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Body mass index; Confidence interval; Relative risk; Multivariate analysis; Cohort study; Ovarian cancer; Anthropometry; Prospective cohort study; Internal medicine; Population; Proportional hazards model; Gynecology; Multivariate statistics; Demography; Cancer; Obstetrics; Oncology; Statistics","score_opus":0.10792406471002941,"score_gpt":0.4377777055323646,"score_spread":0.3298536408223352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077796933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023858335,0.9950808,0.0001839894,0.00095213513,0.00076178455,0.0023099044,0.00028690026,0.000051889958,0.00013398453],"genre_scores_gemma":[0.0005824863,0.99363387,0.0008258854,0.00020015522,0.0002839716,0.0030298345,0.0007959986,0.00006693404,0.0005808658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943655,0.001286781,0.002145457,0.0013579683,0.00024281481,0.00060146325],"domain_scores_gemma":[0.9954324,0.0011833606,0.002093882,0.00079024315,0.00022422757,0.00027588493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012701529,0.0008089807,0.007807488,0.0010635906,0.00014425273,0.0000060343655,0.00017992215,0.00081029884,0.0003237526],"category_scores_gemma":[0.0003220077,0.000611576,0.0019584089,0.0011514114,0.00057888223,0.00008173146,0.00010726937,0.00037973167,0.0000042778847],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015173685,0.00015861173,0.3160695,0.005173804,0.18592155,0.00003880901,0.000030655516,0.0000051809443,7.0725287e-7,0.00009101114,0.0049227164,0.48743573],"study_design_scores_gemma":[0.0022533692,0.00040645644,0.25012442,0.02225959,0.24585573,0.000060853712,0.000033913475,0.000128298,0.0000025837087,0.00040299253,0.4777808,0.0006910194],"about_ca_topic_score_codex":0.0014113347,"about_ca_topic_score_gemma":0.0006955442,"teacher_disagreement_score":0.4867447,"about_ca_system_score_codex":0.0012722922,"about_ca_system_score_gemma":0.000913538,"threshold_uncertainty_score":0.99963355},"labels":[],"label_agreement":null},{"id":"W2077980077","doi":"10.1038/oby.2011.394","title":"Anthropometric Measures and Risk of Ovarian Cancer Among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers","year":2012,"lang":"en","type":"article","venue":"Obesity","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université de Montréal; McGill University; BC Cancer Agency; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Ovarian cancer; Medicine; Anthropometry; Logistic regression; Body mass index; Demography; Cancer; Population; Body weight; Conditional logistic regression; Gynecology; Risk factor; Oncology; Internal medicine; Case-control study; Environmental health","score_opus":0.014000586591758625,"score_gpt":0.2659492509994728,"score_spread":0.2519486644077142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077980077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857162,0.0126789715,0.0000883192,0.00018329933,0.00017573316,0.00027817432,0.00005626025,0.000019398,0.00080364913],"genre_scores_gemma":[0.9924292,0.006924354,0.00038203434,0.000056095927,0.00012027367,0.000026707852,0.0000067403585,0.0000132452105,0.00004133107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991858,0.00005261116,0.00015927097,0.00019495872,0.00020570951,0.00020162472],"domain_scores_gemma":[0.99934524,0.000066447654,0.000121633995,0.00016574672,0.00007365893,0.00022724477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025688348,0.00012644065,0.00027888306,0.00011349477,0.000104673665,0.000011891812,0.000023455626,0.00007444496,0.00007216571],"category_scores_gemma":[0.00007776039,0.00010279252,0.00004381726,0.00027995475,0.00017195885,0.00013981349,0.000025403704,0.00009543452,0.0000016933391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039739436,0.00023597863,0.97838575,0.000075611875,0.00028147813,0.000005777314,0.0008209506,0.0000017097759,0.00010680452,0.000085312655,0.00029303654,0.019667845],"study_design_scores_gemma":[0.0016166405,0.00015862151,0.98941,0.00006371135,0.00070579926,0.0000137103225,0.00013498883,0.00001800976,0.0066375597,0.000029451345,0.0011167381,0.00009480244],"about_ca_topic_score_codex":0.0054548965,"about_ca_topic_score_gemma":0.00033812708,"teacher_disagreement_score":0.019573042,"about_ca_system_score_codex":0.00009118729,"about_ca_system_score_gemma":0.000047617883,"threshold_uncertainty_score":0.8246208},"labels":[],"label_agreement":null},{"id":"W2078220975","doi":"10.1097/pas.0b013e31828e4f55","title":"Ovarian Cellular Fibromas Lack FOXL2 Mutations","year":2013,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Fibroma; Mutation; Granulosa cell; Pathology; Stromal cell; Biology; Ovarian tumor; Ovary; Stroma; Cancer research; Medicine; Immunohistochemistry; Endocrinology; Ovarian cancer; Cancer; Genetics","score_opus":0.020268546993825354,"score_gpt":0.2865716803896461,"score_spread":0.26630313339582073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078220975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95914274,0.00043796978,0.00020681127,0.037629385,0.000198522,0.00016565736,0.0000033871622,0.00001099175,0.0022045053],"genre_scores_gemma":[0.9963695,0.00027008395,0.0017169233,0.0009363675,0.00044919824,0.000014409757,0.0000033382519,0.000015674643,0.00022452985],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988428,0.00020823358,0.00039718344,0.00012550777,0.00019701837,0.00022929639],"domain_scores_gemma":[0.998668,0.0003308279,0.00039525592,0.00024248366,0.00017255433,0.00019087411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002672768,0.00012052511,0.00050122937,0.00008359566,0.00006932784,0.000017058359,0.00012590102,0.00003246758,0.0008833285],"category_scores_gemma":[0.00003352215,0.000066072695,0.00021747674,0.00023271887,0.00048998185,0.000059557642,0.000028326771,0.00026271516,0.00019585487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003987727,0.005973059,0.25837624,0.00010746,0.0037239708,0.06167574,0.0060635405,0.00046287078,0.029807424,0.019637255,0.05777236,0.55241233],"study_design_scores_gemma":[0.011505302,0.014873982,0.81784004,0.00022287737,0.0014032264,0.042497505,0.0023865069,0.00012854341,0.0032536038,0.008944716,0.09643655,0.0005071194],"about_ca_topic_score_codex":0.00008210768,"about_ca_topic_score_gemma":9.3352344e-7,"teacher_disagreement_score":0.5594638,"about_ca_system_score_codex":0.000055878376,"about_ca_system_score_gemma":0.00009257071,"threshold_uncertainty_score":0.96718276},"labels":[],"label_agreement":null},{"id":"W2078311993","doi":"10.1158/1538-7445.am2011-3059","title":"Abstract 3059: CCL2 overexpression in an epithelial ovarian cancer cell line results in reduced tumorigenic potential","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Biology; Cancer research; Cell culture; Ovarian cancer; Gene; Cell; Molecular biology; Chromosome; Cancer; Genetics","score_opus":0.12338130120418801,"score_gpt":0.41174985492027466,"score_spread":0.28836855371608666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078311993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944604,0.0017012572,0.0000012896644,0.0012587475,0.00037003966,0.0010893,0.00023128065,0.00003340397,0.005868655],"genre_scores_gemma":[0.99433345,0.0029291608,0.00018027984,0.00009545767,0.0008840243,0.0007874767,0.00006221314,0.00006275912,0.000665155],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965365,0.00021378664,0.00061701605,0.0008847281,0.0008119096,0.0009360846],"domain_scores_gemma":[0.99841005,0.000073309915,0.00011135695,0.00072650996,0.00025950425,0.00041924827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010272147,0.0002625685,0.0004477757,0.0003869951,0.000108138316,0.000042713466,0.00029155388,0.00021953796,0.0030260542],"category_scores_gemma":[0.00006387824,0.00022117398,0.000098462864,0.00061771163,0.00012479219,0.00027591232,0.00011688578,0.000856657,0.000058151345],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021622505,0.006768798,0.039603494,0.0005164835,0.00012863627,0.0028290804,0.0070271585,0.00030173134,0.8753007,0.00014093409,0.00411507,0.04164539],"study_design_scores_gemma":[0.012832736,0.0009004887,0.6186711,0.0017687272,0.000030595253,0.0000068572344,0.0003787382,0.00013547011,0.36382228,0.00023587447,0.0009209278,0.00029617577],"about_ca_topic_score_codex":0.06814341,"about_ca_topic_score_gemma":0.010346604,"teacher_disagreement_score":0.57906765,"about_ca_system_score_codex":0.0016602887,"about_ca_system_score_gemma":0.00136979,"threshold_uncertainty_score":0.9978853},"labels":[],"label_agreement":null},{"id":"W2078873145","doi":"10.1016/j.ygyno.2011.06.037","title":"Ovarian immature teratoma: Treatment and outcome in a single institutional cohort","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Oophorectomy; Immature teratoma; Surgery; Cystectomy; Teratoma; Hysterectomy; Chemotherapy; Cohort; Adjuvant therapy; Cancer; Internal medicine; Germ cell tumors","score_opus":0.07308704056774572,"score_gpt":0.31479253301895777,"score_spread":0.24170549245121203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078873145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94868916,0.00049062946,0.000010818978,0.0022746958,0.0004012032,0.0008037851,0.000013745473,0.000052456868,0.047263525],"genre_scores_gemma":[0.99427384,0.00016341334,0.0037262198,0.0009995475,0.000072674295,0.0003784158,0.000029239975,0.00000966069,0.00034698614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885994,0.00006867657,0.00031912437,0.0003863323,0.000070487156,0.0002954503],"domain_scores_gemma":[0.9994249,0.00013184379,0.000079165045,0.00019376623,0.000033567132,0.00013677588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015262676,0.0001910995,0.0005290513,0.00013044926,0.00006926171,0.000008154448,0.000046444577,0.00027363363,0.0008467072],"category_scores_gemma":[0.00007369482,0.00013454567,0.00006703762,0.00013162551,0.00014937908,0.000052812,0.00004072945,0.00013983285,0.000053146563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029492367,0.0032736224,0.9662601,0.000014235964,0.00015118926,0.0017854782,0.00043348115,9.3302725e-7,0.00009310496,0.0032184266,0.00014892622,0.0243256],"study_design_scores_gemma":[0.0053232363,0.0046442165,0.962751,0.000014189305,0.00016790025,0.0003899222,0.000074478616,0.000009087042,0.00020827181,0.00047063056,0.025830304,0.00011679237],"about_ca_topic_score_codex":0.00029182914,"about_ca_topic_score_gemma":0.00074876717,"teacher_disagreement_score":0.046916537,"about_ca_system_score_codex":0.0013500538,"about_ca_system_score_gemma":0.00028868072,"threshold_uncertainty_score":0.92708504},"labels":[],"label_agreement":null},{"id":"W2079036144","doi":"10.1016/j.ygyno.2010.06.002","title":"Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cytology; Histology; Chemotherapy; Biopsy; Radiology; Debulking; Medical diagnosis; Surgical pathology; Ovarian cancer; Cancer; Pathology; Internal medicine","score_opus":0.01719130201086838,"score_gpt":0.30666990075511763,"score_spread":0.28947859874424925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079036144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96193326,0.00009455724,0.000021222244,0.027781306,0.001423467,0.0011609835,0.000041283765,0.000059807495,0.0074840914],"genre_scores_gemma":[0.9822178,0.00014022722,0.011300711,0.004923473,0.00039832527,0.0006442786,0.000013643918,0.000027942628,0.00033362364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99839914,0.00006678189,0.0004436787,0.0004720905,0.00017979837,0.00043851664],"domain_scores_gemma":[0.9982812,0.0005567553,0.00017719003,0.0005247708,0.00015010199,0.00031000908],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032342685,0.0002309236,0.0007775743,0.00015998862,0.00007561639,0.000008092554,0.000183828,0.00036550543,0.004530845],"category_scores_gemma":[0.00036642005,0.00017694673,0.00018277459,0.00024503504,0.00014341995,0.000032674223,0.000077185505,0.00031353376,0.00019780132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004768066,0.0026016145,0.48465768,0.0000383808,0.00017314049,0.00034292022,0.00057256425,0.0000031272925,0.01136924,0.0014979569,0.005943953,0.49232262],"study_design_scores_gemma":[0.0050721033,0.004808101,0.76961863,0.0000140373895,0.0001512205,0.00007129369,0.00006269125,0.0000088447105,0.024683243,0.000266349,0.19509456,0.00014893158],"about_ca_topic_score_codex":0.0002544202,"about_ca_topic_score_gemma":0.000550061,"teacher_disagreement_score":0.49217367,"about_ca_system_score_codex":0.0002703273,"about_ca_system_score_gemma":0.0005246666,"threshold_uncertainty_score":0.99637914},"labels":[],"label_agreement":null},{"id":"W2079114151","doi":"10.1159/000108654","title":"Malignant Struma Ovarii – A Case Report and Review of the Literature","year":2007,"lang":"en","type":"review","venue":"Gynecologic and Obstetric Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Struma ovarii; Medicine; Gynecology; General surgery; Ovary; Pathology; Internal medicine","score_opus":0.05658685562764238,"score_gpt":0.3263629015309512,"score_spread":0.26977604590330884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079114151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005318196,0.9964293,0.0000012861806,0.00030355222,0.00034350087,0.0018650981,0.000040480292,0.000015839909,0.00046909292],"genre_scores_gemma":[0.00038770933,0.9976825,0.00042169937,0.0007660419,0.000073504736,0.00011448109,0.00015741354,0.000017310456,0.00037930036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821347,0.00014400354,0.0008049454,0.0004345247,0.00022169977,0.00018137462],"domain_scores_gemma":[0.997814,0.0006514283,0.00079647516,0.00044348193,0.00015235857,0.00014226507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005541374,0.00031040775,0.0012704933,0.0001772109,0.00010732759,0.000022290511,0.00005617749,0.0003599347,0.000035470453],"category_scores_gemma":[0.0016247239,0.0001596876,0.00022909213,0.0010445841,0.00017359664,0.000042590254,0.0000801995,0.00031525092,0.0000017644203],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000015754949,0.000048800277,0.00071221346,0.12964705,0.00016760506,0.01703031,0.00006460403,1.2235639e-8,6.432127e-8,0.00045151342,0.0009151773,0.8509611],"study_design_scores_gemma":[0.00054704637,0.00032064092,0.0020459786,0.21220402,0.0045143575,0.10976468,0.000024392933,0.0000012755376,0.0000057205975,0.0002222478,0.67008656,0.0002630646],"about_ca_topic_score_codex":0.000023097698,"about_ca_topic_score_gemma":0.0000038535436,"teacher_disagreement_score":0.850698,"about_ca_system_score_codex":0.00018233195,"about_ca_system_score_gemma":0.0003875196,"threshold_uncertainty_score":0.6511871},"labels":[],"label_agreement":null},{"id":"W2079242442","doi":"10.1007/s10549-007-9634-4","title":"Ovarian cysts and breast cancer: results from the Women’s Contraceptive and Reproductive Experiences Study","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Centers for Disease Control and Prevention","keywords":"Medicine; Breast cancer; Odds ratio; Ovarian cancer; Gynecology; Confidence interval; Population; Epidemiology; Case-control study; Obstetrics; Cancer; Demography; Oncology; Internal medicine","score_opus":0.04891227199401871,"score_gpt":0.37506724685075754,"score_spread":0.32615497485673883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079242442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96732426,0.0077347546,0.0000011753318,0.020808091,0.0001178368,0.0021671923,0.0015437013,0.00002953298,0.00027343398],"genre_scores_gemma":[0.9891436,0.0067452653,0.00003022492,0.00011779123,0.000765817,0.0027808195,0.000019177869,0.000026661366,0.0003706466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696636,0.00016944224,0.00033634022,0.0011816995,0.0005929341,0.0007531938],"domain_scores_gemma":[0.9979943,0.00051434484,0.000097771735,0.0005329874,0.00030399693,0.0005566142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087807834,0.00033052586,0.00049155974,0.00011321731,0.00057992927,0.0001501124,0.0000852656,0.00007325994,0.00017807832],"category_scores_gemma":[0.000035071633,0.00018857853,0.0000387643,0.0003027108,0.0006531067,0.00014090433,0.000119169825,0.00022294093,0.0000034931286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015813174,0.0025106913,0.50670534,0.000014231035,0.0017154982,0.00051625754,0.08912957,5.2041105e-7,0.00008297576,0.00011575593,0.00033908503,0.38305688],"study_design_scores_gemma":[0.0121054575,0.0023420393,0.91555583,0.00015754426,0.00015575648,0.00023198241,0.06796833,0.000004176701,0.00029015343,0.00016181722,0.0008626894,0.00016420886],"about_ca_topic_score_codex":0.0711235,"about_ca_topic_score_gemma":0.009570184,"teacher_disagreement_score":0.4088505,"about_ca_system_score_codex":0.0011941612,"about_ca_system_score_gemma":0.00035145628,"threshold_uncertainty_score":0.935062},"labels":[],"label_agreement":null},{"id":"W2079647316","doi":"10.1186/1471-2164-9-99","title":"Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids","year":2008,"lang":"en","type":"article","venue":"BMC Genomics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôtel-Dieu de Québec; Université de Montréal; Centre hospitalier universitaire de Québec; Université Laval","funders":"Cancer Research Society","keywords":"Biology; Cisplatin; Gene expression; Gene expression profiling; DNA repair; Cell cycle; Microarray analysis techniques; Signal transduction; Topotecan; DNA damage; Cell biology; Paclitaxel; Cell growth; Ovarian cancer; Cancer research; Gene; Genetics; Cancer; DNA; Chemotherapy","score_opus":0.03166413186808024,"score_gpt":0.3051854700058922,"score_spread":0.27352133813781193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079647316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975246,0.00077162776,0.000439269,0.00031759418,0.00006489667,0.0006274813,0.00013322901,0.000012555187,0.000108699904],"genre_scores_gemma":[0.9854864,0.0008123599,0.012880433,0.00020425396,0.000076431126,0.0002122519,0.000018366496,0.000018356579,0.00029117503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890786,0.000058629492,0.00031000248,0.00034670846,0.00015953564,0.0002172484],"domain_scores_gemma":[0.99921674,0.00004413364,0.00008438659,0.00044739386,0.00004636999,0.00016099753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010014121,0.00017481402,0.00052577216,0.00017869099,0.00003473786,0.0000060099665,0.00006920795,0.00007870842,0.00019238092],"category_scores_gemma":[0.000008852513,0.00014497107,0.00020728278,0.00078262034,0.000027267735,0.000022220063,0.00002039615,0.000027922648,0.000008798437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061553526,0.00075541984,0.9454831,0.000007300182,0.00071114686,0.00006308078,0.001991791,0.005767521,0.036030844,0.000005712367,0.000104528146,0.00292423],"study_design_scores_gemma":[0.004151593,0.0008726178,0.9332438,0.000026091544,0.00050146866,0.0000048979327,0.000061665945,0.000102837,0.059424553,0.000004609473,0.0014904091,0.000115419796],"about_ca_topic_score_codex":0.0036664358,"about_ca_topic_score_gemma":0.0021954088,"teacher_disagreement_score":0.02339371,"about_ca_system_score_codex":0.0015189911,"about_ca_system_score_gemma":0.000506812,"threshold_uncertainty_score":0.59117484},"labels":[],"label_agreement":null},{"id":"W2080156752","doi":"10.1111/j.1525-1438.2005.00483.x","title":"A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"University of Pittsburgh","keywords":"Medicine; Concomitant; Ovarian cancer; Internal medicine; Adjuvant; Chemotherapy; Adverse effect; Monoclonal antibody; Immune system; Antibody; Oncology; Immunotherapy; Phases of clinical research; Cancer; Gastroenterology; Immunology","score_opus":0.07371906642979087,"score_gpt":0.4565962377889497,"score_spread":0.38287717135915883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080156752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845817,0.0017063472,0.00025992835,0.010625762,0.0015655219,0.0010183731,0.00012987414,0.000011458503,0.00010100157],"genre_scores_gemma":[0.99359477,0.0008426803,0.0014359257,0.0023601127,0.0012571933,0.00031758432,0.00001616444,0.000023546456,0.00015201935],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978562,0.00006596507,0.00082554255,0.00029637734,0.00070919207,0.00024674076],"domain_scores_gemma":[0.99788404,0.00018442812,0.0005054234,0.0001711769,0.001020949,0.00023401706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030537977,0.00021998146,0.00055496296,0.00022136112,0.00005283327,0.000035665853,0.00033223056,0.000051900464,0.0029729751],"category_scores_gemma":[0.00011725584,0.00015519101,0.000211935,0.0001352603,0.00004101855,0.00014223982,0.000053984153,0.00020003977,0.0000063896327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04094687,0.061373156,0.068161145,0.000055702312,0.0060319956,0.00053940236,0.0020264024,0.002253592,0.011177801,0.00065662485,0.0027056877,0.8040716],"study_design_scores_gemma":[0.07644964,0.13174337,0.67442006,0.0007142419,0.0014969675,0.00028487862,0.0005911387,0.0008307307,0.009254738,0.00034688573,0.10332809,0.0005392564],"about_ca_topic_score_codex":0.0005406723,"about_ca_topic_score_gemma":0.00082410395,"teacher_disagreement_score":0.80353236,"about_ca_system_score_codex":0.0010838202,"about_ca_system_score_gemma":0.0004887481,"threshold_uncertainty_score":0.99793845},"labels":[],"label_agreement":null},{"id":"W2080317223","doi":"10.1155/2012/281745","title":"Retroperitoneal Extraovarian Fibrothecoma Mimicking a Malignant Epithelial Ovarian Carcinoma","year":2012,"lang":"en","type":"article","venue":"Case Reports in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ovary; Pathology; Renal cell carcinoma; Ovarian carcinoma; Sigmoid colon; Ovarian cancer; Uterus; Clear cell carcinoma; Debulking; Carcinoma; Cancer; Surgery; Internal medicine; Rectum","score_opus":0.023793770122488556,"score_gpt":0.2714453196992419,"score_spread":0.24765154957675334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080317223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98638177,0.006874365,0.000033897424,0.00056530343,0.0026198728,0.0005980976,0.0000150595815,0.00003261856,0.0028790152],"genre_scores_gemma":[0.9968859,0.0003681766,0.0017302172,0.00031578823,0.00027947774,0.00009667972,0.000018560198,0.000039614122,0.00026559585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792355,0.00008439366,0.00067801395,0.0004925735,0.0001662758,0.00065517146],"domain_scores_gemma":[0.9976148,0.0012179695,0.0002230319,0.000498283,0.00007240869,0.00037349598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052871986,0.00024506307,0.00055905647,0.0003416569,0.0001272002,0.000031652,0.000029728488,0.00027313773,0.00022414982],"category_scores_gemma":[0.0020217595,0.00021519647,0.00010398391,0.00040578074,0.00009618835,0.00010980787,0.00008435152,0.00025800863,0.0000070816973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031872165,0.0005750702,0.665587,0.00008630898,0.00007990678,0.2817205,0.00064098067,0.0000025366812,0.00020363863,0.0014840973,0.00010773683,0.049480353],"study_design_scores_gemma":[0.0032746517,0.0007283637,0.6379137,0.000094387535,0.0002926125,0.27822122,0.00039018164,0.00019970557,0.001038944,0.00017001567,0.077246055,0.00043013445],"about_ca_topic_score_codex":0.00045025555,"about_ca_topic_score_gemma":0.00006464651,"teacher_disagreement_score":0.07713832,"about_ca_system_score_codex":0.00042610973,"about_ca_system_score_gemma":0.0001766671,"threshold_uncertainty_score":0.8775458},"labels":[],"label_agreement":null},{"id":"W2080407657","doi":"10.1016/j.ygyno.2014.12.017","title":"Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; University of Calgary; Alberta Health Services","funders":"National Institutes of Health; Cancer Research UK; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Francis Crick Institute","keywords":"Genome-wide association study; Ovarian cancer; Oncology; Single-nucleotide polymorphism; Medicine; Genetic association; Breast cancer; Biology; Gene; Genetics; Cancer; Internal medicine; Bioinformatics; Genotype","score_opus":0.09765061622820562,"score_gpt":0.4051553375416975,"score_spread":0.30750472131349194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080407657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705351,0.00053738564,0.000037411315,0.020255,0.0008691449,0.001814746,0.000011855604,0.00008499803,0.005854338],"genre_scores_gemma":[0.98853165,0.00020201268,0.0021974682,0.005714056,0.0005398942,0.0020334541,0.000006975291,0.000026340836,0.0007481379],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99763846,0.0006782514,0.0003966622,0.0005341072,0.00026417262,0.00048831746],"domain_scores_gemma":[0.997685,0.0012561686,0.00021366139,0.0005836726,0.000115899406,0.00014556212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011016086,0.00023977688,0.00060914096,0.00007178777,0.00029371298,0.000024842526,0.00020777254,0.00015533797,0.0017358289],"category_scores_gemma":[0.0006889077,0.00013905285,0.00011473571,0.00021610661,0.00011618367,0.00003098054,0.000105090214,0.0002642968,0.00016192398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045909703,0.0032678582,0.2404521,0.000026685579,0.0009287532,0.0002236623,0.0013121364,0.00026606416,0.00091950595,0.0005347509,0.0027363985,0.748873],"study_design_scores_gemma":[0.007633153,0.014981761,0.9320883,0.000020447376,0.0010615208,0.00006721578,0.00044269155,0.00078381953,0.00024055231,0.0006579075,0.041821674,0.0002009618],"about_ca_topic_score_codex":0.0011370167,"about_ca_topic_score_gemma":0.0021455972,"teacher_disagreement_score":0.748672,"about_ca_system_score_codex":0.00086124014,"about_ca_system_score_gemma":0.00054684025,"threshold_uncertainty_score":0.99917674},"labels":[],"label_agreement":null},{"id":"W2080655842","doi":"10.1111/his.12314","title":"Adult granulosa cell tumour‐like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of <i><scp>FOXL</scp>2</i> mutation status","year":2013,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Pathology; Mucinous cystadenoma; Stromal cell; Biology; Hematopathology; Molecular pathology; Ovary; Endometriosis; Clear cell; Immunohistochemistry; Cystadenoma; Mutation; Medicine; Chromosome; Cytogenetics; Gene; Genetics","score_opus":0.007924189908149673,"score_gpt":0.21652322575459737,"score_spread":0.2085990358464477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080655842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974075,0.00024854945,0.00012195636,0.00023845647,0.00020569934,0.00065937696,0.000053632695,0.000024292829,0.0010405671],"genre_scores_gemma":[0.9934547,0.000035049543,0.0058064945,0.00020021721,0.00004209305,0.00020366703,0.00010501502,0.000026354792,0.00012643234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840313,0.00010593311,0.0006324881,0.00037376684,0.00019821225,0.00028648227],"domain_scores_gemma":[0.9985681,0.00010744082,0.00051113626,0.0003374533,0.00033248076,0.00014334556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017744213,0.0002004169,0.00051087956,0.00025379105,0.000042408592,0.0000065309187,0.000042325748,0.00011932788,0.000027602993],"category_scores_gemma":[0.0001445382,0.00017331523,0.000063414045,0.00026971335,0.00025357035,0.00016436704,0.000022661325,0.00015308656,0.000009603197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019083956,0.0004918362,0.9025894,0.00055441074,0.000024972307,0.041897364,0.008947668,0.00011094813,0.043750446,0.00031982915,0.0006343234,0.00048797787],"study_design_scores_gemma":[0.0069490364,0.0025014747,0.8271796,0.00041421095,0.00042463772,0.061403926,0.0024120526,0.000078535355,0.09728271,0.00058884145,0.0005953494,0.00016963617],"about_ca_topic_score_codex":0.0041412944,"about_ca_topic_score_gemma":0.0012558725,"teacher_disagreement_score":0.0754098,"about_ca_system_score_codex":0.00018172186,"about_ca_system_score_gemma":0.00031773245,"threshold_uncertainty_score":0.706759},"labels":[],"label_agreement":null},{"id":"W2080767500","doi":"10.1016/s0959-8049(03)00195-3","title":"Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study","year":2003,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Serous fluid; Ovarian cancer; Relative risk; Cohort; Internal medicine; Prospective cohort study; Cohort study; Oncology; Epithelial ovarian cancer; Proportional hazards model; Cancer; Confidence interval; Gynecology","score_opus":0.011286685008375258,"score_gpt":0.2678493100703497,"score_spread":0.2565626250619744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080767500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847424,0.0088217445,0.000015101432,0.001071989,0.00034444605,0.0008239882,0.000021379274,0.0000030684305,0.004155862],"genre_scores_gemma":[0.9939846,0.005366874,0.000050374067,0.000191531,0.0002445847,0.000036069934,1.419708e-7,0.000026588583,0.000099265046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980596,0.0007145324,0.0005199661,0.00017953261,0.00037282126,0.00015358497],"domain_scores_gemma":[0.9987427,0.00014708817,0.0005905409,0.00017591304,0.0002578803,0.00008586374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019209468,0.00014547324,0.0005005854,0.000103969745,0.000056181376,0.000019514557,0.00008390244,0.000016298938,0.00019338673],"category_scores_gemma":[0.00026313082,0.00008343212,0.00010892228,0.00020047558,0.00013167327,0.00006486049,0.000023850538,0.00035689553,6.0784913e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008144889,0.00025370027,0.98384345,0.000015012386,0.0017978742,0.00034565004,0.004322787,0.00013035831,0.000031325508,0.00013764134,0.00011347522,0.00819426],"study_design_scores_gemma":[0.016617674,0.00061492843,0.978312,0.00044364142,0.0014859309,0.000044000204,0.000658883,0.0000036096058,0.0009078564,0.000076628865,0.00075691566,0.000077922756],"about_ca_topic_score_codex":0.0005163774,"about_ca_topic_score_gemma":0.00050953927,"teacher_disagreement_score":0.015803184,"about_ca_system_score_codex":0.00022210393,"about_ca_system_score_gemma":0.00030944252,"threshold_uncertainty_score":0.3402263},"labels":[],"label_agreement":null},{"id":"W2080781649","doi":"10.1097/01.ogx.0000228777.15365.32","title":"Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer","year":2006,"lang":"en","type":"review","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Intraperitoneal chemotherapy; Chemotherapy; Epithelial ovarian cancer; Oncology; Cancer; Internal medicine","score_opus":0.1095878879564255,"score_gpt":0.394981708929804,"score_spread":0.2853938209733785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080781649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004036742,0.99090344,0.00010208929,0.00044061482,0.001604665,0.0038783816,0.0021428908,0.0001416021,0.00074594066],"genre_scores_gemma":[0.00020583425,0.99005646,0.0014101894,0.00063817756,0.0011976076,0.0030200775,0.0018987008,0.00013744769,0.0014355355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956517,0.0004785612,0.001185419,0.0012713629,0.00046998844,0.0009429339],"domain_scores_gemma":[0.9900192,0.0082647465,0.00041935765,0.0005749357,0.0002378478,0.00048389833],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004970637,0.0008932189,0.0041195205,0.00022487009,0.00017117051,0.000091399255,0.00034235328,0.0013455246,0.0018785836],"category_scores_gemma":[0.0018888288,0.0005664993,0.0015118718,0.0011380863,0.00016216426,0.000039669198,0.000083759856,0.00069474295,0.00013070798],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012019603,0.0015880705,0.001735141,0.002325709,0.0006872161,0.0001079573,0.000003836725,5.338492e-7,2.1326288e-7,0.00013374354,0.009204727,0.98409265],"study_design_scores_gemma":[0.003124146,0.0010694335,0.047521092,0.0009750953,0.001400386,0.000018854866,9.508608e-7,0.000007021626,0.0000018146574,0.00003914787,0.9452662,0.0005758506],"about_ca_topic_score_codex":0.00072910654,"about_ca_topic_score_gemma":0.00014522989,"teacher_disagreement_score":0.9835168,"about_ca_system_score_codex":0.0014058751,"about_ca_system_score_gemma":0.000765629,"threshold_uncertainty_score":0.99995095},"labels":[],"label_agreement":null},{"id":"W2080894104","doi":"10.1016/j.ygyno.2006.03.052","title":"Outcomes for systemic therapy in women with ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; York University; McMaster University; Institute for Clinical Evaluative Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Systemic therapy; Internal medicine; Cancer; Population; Ovarian cancer; Comorbidity; Cohort; Multivariate analysis; Surgery; Oncology; Breast cancer","score_opus":0.02278868901704574,"score_gpt":0.31802419259884995,"score_spread":0.2952355035818042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080894104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920334,0.00071948685,0.000041279778,0.015009009,0.00024539017,0.0017585517,0.000014756276,0.000059622227,0.0029485857],"genre_scores_gemma":[0.9880998,0.00034912903,0.0011662635,0.003452759,0.00013845744,0.0058970745,0.000013180025,0.000021353379,0.00086194975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873984,0.00005692805,0.00029190982,0.00034798568,0.00009438594,0.0004689539],"domain_scores_gemma":[0.9990977,0.0004298737,0.0001243305,0.00020334267,0.00007305496,0.00007171142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022722152,0.00018335738,0.0006574936,0.00010871084,0.000050662842,0.000008642598,0.00007330322,0.00018996245,0.00047629757],"category_scores_gemma":[0.000025804344,0.00011330873,0.00005420943,0.0001579966,0.000061463805,0.000031334384,0.000011525254,0.00010523893,0.000013766703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014432672,0.0015441014,0.92125106,0.00005327944,0.00022998994,0.0003760829,0.00023805219,0.00012971972,0.00016181776,0.0012633904,0.0027135548,0.07059569],"study_design_scores_gemma":[0.015146629,0.00577059,0.93157685,0.000036956397,0.000052404153,0.00007640213,0.00020160493,0.000015178647,0.0000852913,0.00061231613,0.046288915,0.00013685161],"about_ca_topic_score_codex":0.00067369145,"about_ca_topic_score_gemma":0.0013597298,"teacher_disagreement_score":0.07045884,"about_ca_system_score_codex":0.0018725022,"about_ca_system_score_gemma":0.00050076697,"threshold_uncertainty_score":0.52151245},"labels":[],"label_agreement":null},{"id":"W2081275953","doi":"10.1002/ijc.24952","title":"Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition","year":2009,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"Instituto de Salud Carlos III; National Health and Medical Research Council; Medical Research Council; Institut Gustave-Roussy; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul Cancro; Stavros Niarchos Foundation; Compagnia di San Paolo; Fondation pour la Recherche Médicale; Cancerfonden; Ligue Contre le Cancer; Bundesministerium für Bildung und Forschung; European Commission; Stroke Association; British Heart Foundation; Wellcome Trust; Deutsches Krebsforschungszentrum","keywords":"Medicine; European Prospective Investigation into Cancer and Nutrition; Prospective cohort study; Body mass index; Hazard ratio; Waist; Risk factor; Internal medicine; Anthropometry; Cancer; Waist–hip ratio; Gynecology; Obesity; Confounding; Proportional hazards model; Confidence interval; Obstetrics; Oncology","score_opus":0.017035695433234226,"score_gpt":0.3245442659113156,"score_spread":0.30750857047808133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081275953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396752,0.025642607,0.00007459015,0.033375725,0.0005444792,0.00031204364,0.00005325097,0.000005749293,0.00031632866],"genre_scores_gemma":[0.94803095,0.049427193,0.00025262902,0.0008988033,0.0013233068,0.000039246774,0.0000021957526,0.000009168358,0.000016496018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881405,0.00011409622,0.00031539574,0.00015970904,0.00049372506,0.00010302582],"domain_scores_gemma":[0.9990765,0.000059410715,0.00030355775,0.00006465405,0.0004173151,0.00007857514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045162826,0.00011709202,0.00019638636,0.00031338946,0.00005914544,0.00007133651,0.00010140782,0.000034608824,0.000045014745],"category_scores_gemma":[0.00008072731,0.000076701326,0.000051333256,0.00024744953,0.00009178088,0.00019867282,0.000012980191,0.00023325907,5.856469e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054542854,0.0003203013,0.5625766,0.000018157543,0.00039950208,0.00012137231,0.0028981983,0.00004790593,0.0009519586,0.0003321474,0.00067904766,0.4311094],"study_design_scores_gemma":[0.0047934847,0.00043317844,0.9856322,0.0006345307,0.00022522995,0.00008095087,0.00020283346,0.000041638654,0.0015494858,0.0030919418,0.0032317862,0.00008276635],"about_ca_topic_score_codex":0.003127224,"about_ca_topic_score_gemma":0.0012010782,"teacher_disagreement_score":0.4310266,"about_ca_system_score_codex":0.0004426778,"about_ca_system_score_gemma":0.00016891948,"threshold_uncertainty_score":0.47274482},"labels":[],"label_agreement":null},{"id":"W2081370824","doi":"10.1158/1078-0432.ovca13-a13","title":"Abstract A13: Molecular profiling of low grade serous ovarian tumors","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Loss of heterozygosity; Pathology; Cystadenocarcinoma; Medicine; Ovarian tumor; Oncology; Clear cell; Ovary; Ovarian cancer; Cancer research; Biology; Internal medicine; Carcinoma; Cancer; Gene; Genetics","score_opus":0.1915692505941295,"score_gpt":0.5080251463816321,"score_spread":0.3164558957875026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081370824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832726,0.0013791629,0.000017021177,0.00983319,0.00023924733,0.0014805952,0.000023025532,0.00003560989,0.0037195405],"genre_scores_gemma":[0.99636364,0.00069150655,0.0010359013,0.0005358085,0.00044669452,0.0006093848,0.000016738488,0.000043981014,0.00025632227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969464,0.00018717263,0.00079996226,0.0005614372,0.000901932,0.0006031122],"domain_scores_gemma":[0.99731034,0.00059458875,0.00013021531,0.0006688621,0.00082221767,0.0004737776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014220102,0.00016734953,0.0005767114,0.00014480988,0.00007760185,0.000039734303,0.00022647763,0.00017965354,0.0019820514],"category_scores_gemma":[0.000653869,0.00013007427,0.00025502263,0.00044900828,0.0003838003,0.00008341009,0.00011559299,0.0008685766,0.00027199363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010970087,0.006380023,0.7867855,0.0020787935,0.0012297608,0.0011793666,0.00023784433,0.0000912667,0.027912747,0.0031906045,0.024718368,0.14509876],"study_design_scores_gemma":[0.0047909208,0.0013181681,0.91664106,0.0010713778,0.00008313976,0.000012040306,0.00016311216,0.00017138135,0.07251815,0.0015561782,0.0014489515,0.00022553973],"about_ca_topic_score_codex":0.002736654,"about_ca_topic_score_gemma":0.000040948296,"teacher_disagreement_score":0.14487322,"about_ca_system_score_codex":0.00021390826,"about_ca_system_score_gemma":0.0008573651,"threshold_uncertainty_score":0.9989303},"labels":[],"label_agreement":null},{"id":"W2082216559","doi":"10.1016/j.ygyno.2007.05.037","title":"Incidental MRI detection of BRCA1-related solitary peritoneal carcinoma during breast screening—A case report","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; University Health Network; Health Sciences Centre","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Radiology; Carcinoma; Breast carcinoma; Breast MRI; General surgery; Mammography; Gynecology; Oncology; Pathology; Breast cancer; Internal medicine; Cancer","score_opus":0.013712456771947606,"score_gpt":0.2933257482801208,"score_spread":0.2796132915081732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082216559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299186,0.00038583725,0.00011560444,0.00075612165,0.0007540823,0.0006074908,0.000018845327,0.00009255474,0.004277581],"genre_scores_gemma":[0.99818313,0.000028643657,0.0010514933,0.00013141423,0.00021951222,0.00005197314,0.000034859462,0.000024017936,0.000274963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979449,0.00008779158,0.0007889731,0.0004893627,0.0001997629,0.0004892321],"domain_scores_gemma":[0.9986081,0.00028059699,0.0003713588,0.0003529197,0.00015489152,0.0002321135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006670898,0.0002216837,0.0006157136,0.00022501011,0.00017711557,0.000005215915,0.00006833571,0.00041059512,0.000523193],"category_scores_gemma":[0.000102667094,0.00019591842,0.00019715,0.00026206777,0.00020343265,0.000074176736,0.00010014742,0.00032454196,0.000022510096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078031386,0.0012707025,0.47561866,0.00007347543,0.00034127757,0.46716434,0.000424948,0.000021778495,0.0066561145,0.000039357918,0.000085905725,0.047523122],"study_design_scores_gemma":[0.003164807,0.0017712611,0.65594774,0.000016384407,0.00024088795,0.32955468,0.00074175326,0.000047523725,0.008031631,0.000021356835,0.00034661387,0.00011536412],"about_ca_topic_score_codex":0.0018473935,"about_ca_topic_score_gemma":0.002215651,"teacher_disagreement_score":0.18032907,"about_ca_system_score_codex":0.0011454177,"about_ca_system_score_gemma":0.00023437849,"threshold_uncertainty_score":0.79893214},"labels":[],"label_agreement":null},{"id":"W2082224235","doi":"10.1007/s11912-013-0310-z","title":"Follow-Up of Epithelial Ovarian Cancer: Overdue For A Major Rethink","year":2013,"lang":"en","type":"article","venue":"Current Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Epithelial ovarian cancer; Cancer; Oncology; Internal medicine; Gynecology","score_opus":0.051700962821053506,"score_gpt":0.370034131581174,"score_spread":0.31833316876012047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082224235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96546483,0.005912344,0.0002611192,0.010082723,0.011464821,0.0039524226,0.00010394862,0.00008942121,0.0026683942],"genre_scores_gemma":[0.99274784,0.0006295471,0.001648686,0.00026779104,0.00084316626,0.0025017236,0.00009803601,0.000037375445,0.0012258048],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998251,0.000038792852,0.00069402007,0.00046354657,0.00021549691,0.00033713045],"domain_scores_gemma":[0.9982994,0.00013995642,0.0005347573,0.0004697832,0.0003549524,0.0002011242],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027723063,0.0002046521,0.00070272014,0.0000945797,0.000068490095,0.000010171153,0.00005933933,0.00019075687,0.000966193],"category_scores_gemma":[0.00017631939,0.00016264996,0.00028755714,0.00012325349,0.00010385626,0.00007331944,0.000044847726,0.00017550288,0.00001859528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048772444,0.0027025118,0.43378824,0.0007241213,0.0010670818,0.00033488314,0.001085907,0.0000032345272,0.0036500534,0.0014202355,0.13761128,0.41712475],"study_design_scores_gemma":[0.012959285,0.002666788,0.44092858,0.0006395437,0.0017182819,0.0007347828,0.000081347345,0.000072758485,0.010457814,0.0051748035,0.52424544,0.00032058946],"about_ca_topic_score_codex":0.00060751545,"about_ca_topic_score_gemma":0.00008704534,"teacher_disagreement_score":0.41680413,"about_ca_system_score_codex":0.00039048333,"about_ca_system_score_gemma":0.0010778497,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W2082810850","doi":"10.1111/j.1525-1438.2006.00472.x","title":"A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Carboplatin; Ovarian cancer; Surgery; Stage (stratigraphy); Retrospective cohort study; Internal medicine; Oncology; Cancer; Cisplatin","score_opus":0.02393308602563269,"score_gpt":0.33291612833109313,"score_spread":0.3089830423054604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082810850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893527,0.0013751542,0.00020691204,0.006288112,0.0017511131,0.00018524424,0.000118653596,0.0000092490245,0.0007128723],"genre_scores_gemma":[0.9973993,0.00084499735,0.00066529773,0.0005628223,0.00033385036,0.00006058176,0.000022740043,0.000013358624,0.000097108124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797356,0.00005103076,0.0008300071,0.00024348895,0.00068998145,0.00021193927],"domain_scores_gemma":[0.9978065,0.00047819392,0.0007580497,0.00012522556,0.0007446673,0.00008737522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028011546,0.00017885983,0.00088065385,0.0005942615,0.00001964479,0.00001716122,0.00015978001,0.00011189691,0.0041958624],"category_scores_gemma":[0.0001936049,0.00013190559,0.0005348457,0.00047028836,0.00007374401,0.00009474648,0.000018125693,0.00022556144,0.0000014529257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005323487,0.0009618891,0.94256556,0.0000092900345,0.0030236004,0.0003314993,0.00007337581,0.014879247,0.00055554433,0.00018812681,0.0009143463,0.031174056],"study_design_scores_gemma":[0.009369658,0.00048206572,0.9846714,0.0001787295,0.00068386726,0.0000045867423,0.000035605495,0.0009192468,0.0019394231,0.00011417467,0.0014806696,0.000120586155],"about_ca_topic_score_codex":0.001179893,"about_ca_topic_score_gemma":0.0029694345,"teacher_disagreement_score":0.04210585,"about_ca_system_score_codex":0.0020358488,"about_ca_system_score_gemma":0.00056717696,"threshold_uncertainty_score":0.9967144},"labels":[],"label_agreement":null},{"id":"W2083016284","doi":"10.1016/s0090-8258(03)00331-7","title":"Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; London Health Sciences Centre","funders":"","keywords":"Medicine; Serous fluid; Surgery; Omentectomy; Laparotomy; Dissection (medical); Stage (stratigraphy); Carboplatin; Radiation therapy; Chemotherapy; Lymph node; Debulking; Radiology; Ovarian cancer; Cancer; Internal medicine; Cisplatin","score_opus":0.03745914480063468,"score_gpt":0.3143284644674656,"score_spread":0.2768693196668309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083016284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842794,0.000520384,0.00003117014,0.0035744496,0.00047415844,0.0018547156,0.000063157895,0.000033803353,0.009168767],"genre_scores_gemma":[0.99472964,0.00027169092,0.001630283,0.0013692058,0.000062120285,0.00078902516,0.000036525023,0.000022672179,0.0010888644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986666,0.00013170608,0.0003428696,0.00034313466,0.00012289679,0.00039281882],"domain_scores_gemma":[0.99749196,0.0016436664,0.00027010535,0.0003578441,0.00013010998,0.000106322084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021945432,0.00022242489,0.00077264855,0.00006516487,0.00011627131,0.0000044101544,0.00007137635,0.0001618242,0.00028680675],"category_scores_gemma":[0.00028219537,0.0001160515,0.00021193974,0.0001722595,0.00014601942,0.000023299748,0.000019386976,0.00008411323,0.000014965324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002553598,0.010782385,0.8856345,0.00022183996,0.0022994983,0.002172789,0.00076085795,0.00016672625,0.00055897987,0.004492618,0.016934717,0.0734215],"study_design_scores_gemma":[0.027330387,0.05647932,0.51892346,0.00026724962,0.002458346,0.004905386,0.0013912108,0.000027540074,0.072328776,0.0020778785,0.313156,0.00065442215],"about_ca_topic_score_codex":0.00013461465,"about_ca_topic_score_gemma":0.0006040534,"teacher_disagreement_score":0.36671102,"about_ca_system_score_codex":0.00061368773,"about_ca_system_score_gemma":0.0018497602,"threshold_uncertainty_score":0.47324428},"labels":[],"label_agreement":null},{"id":"W2083210974","doi":"10.1046/j.1365-2508.2002.00526.x","title":"Laparoscopic management of cystic adnexal masses","year":2002,"lang":"en","type":"article","venue":"Gynaecological Endoscopy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Enucleation; Adnexal mass; Laparoscopy; Laparotomy; Surgery; General surgery; Cyst; Ovarian cyst; Adnexal Diseases; Malignancy","score_opus":0.034789419072510895,"score_gpt":0.2842496720940821,"score_spread":0.24946025302157118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083210974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8557372,0.0023282317,0.000163115,0.0015758885,0.0006734004,0.00093698245,0.000024046009,0.00013505778,0.1384261],"genre_scores_gemma":[0.9854834,0.00075135543,0.011755129,0.0003649991,0.000047498954,0.00014792755,0.00000939107,0.0000118080225,0.0014284976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988839,0.000032104366,0.00027433355,0.00029408766,0.00023326385,0.00028232395],"domain_scores_gemma":[0.99934053,0.00013507901,0.00007450409,0.00027793474,0.000032781176,0.00013917091],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006494192,0.00015531716,0.00039398554,0.000050423045,0.000043433123,0.000009591743,0.00009081328,0.00008640803,0.016110105],"category_scores_gemma":[0.000035667377,0.00011113967,0.00011088596,0.00017254273,0.00008718129,0.000030963827,0.00005519183,0.000101622565,0.00032527657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005948593,0.01589863,0.7071562,0.00219117,0.002727283,0.0064842748,0.0003140772,0.00010923893,0.0014935934,0.055160966,0.029036885,0.17883286],"study_design_scores_gemma":[0.012146393,0.004095296,0.95113575,0.0001999846,0.0008371916,0.000037286805,0.00013223052,0.00028067615,0.00883252,0.00090478436,0.021103488,0.00029439043],"about_ca_topic_score_codex":0.0000076246,"about_ca_topic_score_gemma":0.0000012055731,"teacher_disagreement_score":0.24397959,"about_ca_system_score_codex":0.00012528278,"about_ca_system_score_gemma":0.0000118286225,"threshold_uncertainty_score":0.9847893},"labels":[],"label_agreement":null},{"id":"W2083489552","doi":"10.1016/j.suronc.2004.08.010","title":"Poorer survival of elderly patients with ovarian cancer: a population-based study","year":2004,"lang":"en","type":"article","venue":"Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Ovarian cancer; Proportional hazards model; Hazard ratio; Stage (stratigraphy); Cancer; Disease; Internal medicine; Logistic regression; Cancer registry; Oncology; Population; Gynecology; Confidence interval","score_opus":0.01659645458796991,"score_gpt":0.31445752184500336,"score_spread":0.29786106725703343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083489552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360466,0.00005923387,0.000011309891,0.0017836601,0.00021608852,0.00081572734,0.000028213772,0.000025283365,0.0034557972],"genre_scores_gemma":[0.99918026,0.000009024732,0.0003288462,0.00014765986,0.000086542044,0.00013380287,0.00006535723,0.000017140346,0.00003135766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988514,0.000076999844,0.00029193555,0.00027335374,0.00030140617,0.00020486515],"domain_scores_gemma":[0.9992485,0.00012401157,0.00012695102,0.00020956334,0.00015360543,0.00013736365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010782762,0.00013956065,0.0005303022,0.00007306666,0.000040732903,0.0000041690746,0.000048933496,0.00009224902,0.00045967702],"category_scores_gemma":[0.000011353845,0.00009340367,0.00007620841,0.00020931398,0.000040683146,0.000025062685,0.000013235624,0.00011028452,0.0000078648445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014296437,0.0068693594,0.9555892,0.000017010127,0.00022413429,0.00026182987,0.00009626202,0.00029020366,7.5723955e-7,0.0006086292,0.0000073364004,0.03460568],"study_design_scores_gemma":[0.025173482,0.009975899,0.9567462,0.00005236966,0.00027104572,0.0000026767566,0.000039190312,0.0000026512873,0.00002090549,0.000050007602,0.007572489,0.000093083676],"about_ca_topic_score_codex":0.004739603,"about_ca_topic_score_gemma":0.0013498294,"teacher_disagreement_score":0.034512594,"about_ca_system_score_codex":0.000476747,"about_ca_system_score_gemma":0.00051435037,"threshold_uncertainty_score":0.7164894},"labels":[],"label_agreement":null},{"id":"W2083824552","doi":"10.1158/1538-7445.am2013-4050","title":"Abstract 4050: Progesterone receptor signaling induces cellular senescence in ovarian cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer research; Cancer; Downregulation and upregulation; Senescence; Biology; Estrogen; Progesterone receptor; Estrogen receptor; Endocrinology; Internal medicine; Medicine; Breast cancer; Gene","score_opus":0.09061545127984535,"score_gpt":0.3816497879168134,"score_spread":0.2910343366369681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083824552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391366,0.00460726,0.0000069536304,0.008521285,0.00036456596,0.0018061552,0.000033169625,0.00003698176,0.00070997427],"genre_scores_gemma":[0.9923963,0.0023430705,0.00029820928,0.00022673132,0.0006109941,0.0032266339,0.000019887313,0.000059073493,0.0008191071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702734,0.00012112727,0.00039798178,0.0006930093,0.00085069844,0.0009098436],"domain_scores_gemma":[0.99851036,0.00014626446,0.00008058329,0.00046764204,0.0004125487,0.00038259584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063861936,0.00024498408,0.00040003096,0.00032044595,0.00014414112,0.000130103,0.00023553341,0.00018046577,0.007099322],"category_scores_gemma":[0.000037170455,0.00020406295,0.00007771578,0.0007762837,0.00017222205,0.00023820713,0.00009416079,0.00077309314,0.00044098447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011059179,0.00044077905,0.03801669,0.0003171855,0.00009449597,0.00010566698,0.0007713254,0.000035828907,0.93380564,0.000034542376,0.0062338626,0.0200334],"study_design_scores_gemma":[0.0020611123,0.00020335968,0.08929563,0.0014158017,0.000026543434,0.0000021693209,0.00036024264,0.000021988915,0.90116423,0.00006504981,0.005140399,0.00024346323],"about_ca_topic_score_codex":0.023937048,"about_ca_topic_score_gemma":0.00048069877,"teacher_disagreement_score":0.05127894,"about_ca_system_score_codex":0.0011721683,"about_ca_system_score_gemma":0.0009439422,"threshold_uncertainty_score":0.9938083},"labels":[],"label_agreement":null},{"id":"W2083882897","doi":"10.3791/51655","title":"Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time","year":2014,"lang":"en","type":"article","venue":"Journal of Visualized Experiments","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council; State Government of Victoria","keywords":"Spheroid; Ovarian cancer; Mesothelial Cell; Cancer cell; Metastasis; Extracellular matrix; Mesothelium; Cancer; Pathology; Cell culture; Biology; Cell; Cancer research; Cell biology; Chemistry; Medicine","score_opus":0.028878557099643834,"score_gpt":0.4382567880999854,"score_spread":0.4093782310003416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083882897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970422,0.0007077354,0.00009349373,0.00016673848,0.00021178559,0.00027484706,0.000009426899,0.0000033190238,0.0014904747],"genre_scores_gemma":[0.99226385,0.0013411065,0.006086688,0.000090166584,0.00011146285,0.000013940866,0.0000021962278,0.000018566505,0.0000720075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998299,0.000121245284,0.00079263444,0.00015537576,0.00047730192,0.00015446737],"domain_scores_gemma":[0.99886096,0.00006754969,0.00065706717,0.00016195202,0.00012296198,0.0001295015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046269217,0.00015139845,0.0007221506,0.00015297988,0.000017027523,0.000008269485,0.00007180081,0.00006936026,0.00035667937],"category_scores_gemma":[0.000013582915,0.0001146999,0.00011924178,0.000106722626,0.00004796704,0.00007607885,0.000040560008,0.00009866098,0.0000012726476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008229435,0.0021495959,0.11185357,0.00011912264,0.00038467167,0.000029125154,0.0008084471,0.000025851217,0.8798305,0.00028149126,0.00044999935,0.003244693],"study_design_scores_gemma":[0.016715607,0.0025240176,0.17731912,0.0010596657,0.00021279436,0.000017111011,0.0001450243,0.00032172387,0.80056655,0.00004760082,0.000954163,0.00011661481],"about_ca_topic_score_codex":0.00036927607,"about_ca_topic_score_gemma":0.0000059114054,"teacher_disagreement_score":0.07926393,"about_ca_system_score_codex":0.00025310557,"about_ca_system_score_gemma":0.00020074916,"threshold_uncertainty_score":0.4677326},"labels":[],"label_agreement":null},{"id":"W2084148547","doi":"10.1097/pgp.0b013e31823b8831","title":"Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Algorithm; Serous fluid; Serous carcinoma; Medical diagnosis; Fallopian tube; Serous Cystadenoma; Gynecologic oncology; Pathology; Gynecology; Radiology; Oncology; Internal medicine; Ovarian cancer; Cancer; Computer science","score_opus":0.03613024821645671,"score_gpt":0.3316103950693447,"score_spread":0.295480146852888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084148547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917147,0.0004754384,0.0037093798,0.002205541,0.0014978081,0.0002340112,0.0000825871,0.000003424786,0.00007711223],"genre_scores_gemma":[0.98934734,0.00019129249,0.009307983,0.0002881367,0.0007942314,0.00004125869,0.000014698806,0.0000074170084,0.000007650709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885505,0.00009489047,0.00053721044,0.00009104246,0.00027567608,0.00014609692],"domain_scores_gemma":[0.9977078,0.0009681717,0.00049881166,0.000103629056,0.0006361942,0.000085402884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058989064,0.000091406735,0.00033306915,0.00009479121,0.000023891005,0.000005386788,0.00019898887,0.000106416934,0.0002653342],"category_scores_gemma":[0.00046147604,0.00005274665,0.00020486001,0.000050722756,0.00012582034,0.00010890674,0.0000357527,0.00012354598,0.0000018222215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070007384,0.0036465644,0.56742555,0.000015862319,0.00061670755,0.00020441579,0.00047820434,0.0000758742,0.002139046,0.0011870549,0.0004722593,0.42303836],"study_design_scores_gemma":[0.0036145535,0.004722599,0.9401925,0.00002895732,0.00039215884,0.0009922065,0.00015841948,0.0002224732,0.04757311,0.00069611374,0.0013385232,0.00006835457],"about_ca_topic_score_codex":0.000018630863,"about_ca_topic_score_gemma":0.0000026210178,"teacher_disagreement_score":0.42297003,"about_ca_system_score_codex":0.00010646463,"about_ca_system_score_gemma":0.00007573983,"threshold_uncertainty_score":0.29052234},"labels":[],"label_agreement":null},{"id":"W2084281139","doi":"10.4137/cmt.s4456","title":"Pegylated Liposomal Doxorubicin in the Management of Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Doxorubicin; Paclitaxel; Drug; Oncology; Pharmacology; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.08930760328561985,"score_gpt":0.4170289362062235,"score_spread":0.3277213329206037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084281139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9432202,0.0024940264,0.00002847158,0.038811874,0.0017759181,0.0010432743,0.00000426474,0.00003560578,0.012586392],"genre_scores_gemma":[0.9866125,0.0051094466,0.00057198596,0.0065552485,0.00083335483,0.000086632084,0.00001252218,0.000026607055,0.0001916953],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99773175,0.00013412458,0.0010189374,0.00037299102,0.0004740974,0.0002680857],"domain_scores_gemma":[0.9981964,0.0005427193,0.00022682133,0.00077774253,0.00012471015,0.00013160825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006595929,0.00023066433,0.0006532323,0.00011260758,0.000051995623,0.000007794372,0.00027533225,0.00021812532,0.00039541852],"category_scores_gemma":[0.000027975406,0.00011720523,0.00014882915,0.00049486716,0.0004874389,0.00003645724,0.000040103183,0.0007644237,0.000015238452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017865939,0.007841141,0.3646468,0.00060683786,0.0040455614,0.001415723,0.0068637915,0.000007864273,0.0047434787,0.06277757,0.0020646688,0.54319996],"study_design_scores_gemma":[0.011559384,0.0018560059,0.8854603,0.00093959866,0.0016802764,0.000038356244,0.0006639452,0.00017608554,0.0010412767,0.0023764246,0.094011545,0.00019675592],"about_ca_topic_score_codex":0.00019481852,"about_ca_topic_score_gemma":0.00021610007,"teacher_disagreement_score":0.5430032,"about_ca_system_score_codex":0.000034836565,"about_ca_system_score_gemma":0.000101015816,"threshold_uncertainty_score":0.47794905},"labels":[],"label_agreement":null},{"id":"W2084425477","doi":"10.1016/s0015-0282(00)00735-4","title":"Endocrine Influences on Normal and Neoplastic Ovarian Surface Epithelium (OSE) Cell Growth","year":2000,"lang":"en","type":"article","venue":"Fertility and Sterility","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epithelium; Endocrine system; Biology; Ovary; Endocrinology; Hormone; Genetics","score_opus":0.01121454957212748,"score_gpt":0.23835196535318554,"score_spread":0.22713741578105806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084425477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117494,0.00048047092,0.0000075617586,0.0013540584,0.00007737794,0.00025043284,0.000082135564,0.000044124077,0.0065289303],"genre_scores_gemma":[0.99835426,0.00024298603,0.00016941945,0.0005204707,0.00003764423,0.000014761745,0.000014723894,0.000008807883,0.0006369373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987144,0.00008353654,0.00026309452,0.00047832108,0.00017984885,0.00028080493],"domain_scores_gemma":[0.9992388,0.00013460846,0.0000353394,0.0003049875,0.000043030665,0.00024326536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017284308,0.00020972866,0.0003452444,0.000023658438,0.00013887168,0.00004477378,0.0000463557,0.00006594091,0.0009931095],"category_scores_gemma":[0.000028996306,0.00016261321,0.00005348494,0.00008405756,0.00016265614,0.000115392664,0.000034176635,0.00014799954,0.000039752264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026692508,0.0014162696,0.9223421,0.0006414986,0.00010806333,0.000111577385,0.0008091298,0.000011731138,0.00039468368,0.00003630723,0.00009898503,0.047337137],"study_design_scores_gemma":[0.0019190817,0.000772751,0.9924566,0.000056563647,0.000088471475,0.000017735078,0.000030318211,0.00012780403,0.0019366773,0.00017114352,0.002292473,0.0001303655],"about_ca_topic_score_codex":0.0008552319,"about_ca_topic_score_gemma":0.00010509095,"teacher_disagreement_score":0.07011451,"about_ca_system_score_codex":0.00004502883,"about_ca_system_score_gemma":0.000049264087,"threshold_uncertainty_score":0.9999201},"labels":[],"label_agreement":null},{"id":"W2085177991","doi":"10.1586/17474108.2.5.587","title":"Novel drug-delivery strategies for the treatment of ovarian cancer","year":2007,"lang":"en","type":"article","venue":"Expert Review of Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Disease; Drug; Chemotherapy; Drug resistance; Internal medicine; Cancer; Intensive care medicine; Pharmacology","score_opus":0.04040846684574545,"score_gpt":0.35861659515728483,"score_spread":0.3182081283115394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085177991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011092663,0.97701645,0.0012582198,0.0046376847,0.002082581,0.0025500755,0.000071754584,0.000017642635,0.0012729479],"genre_scores_gemma":[0.20524317,0.78631294,0.005234623,0.0019494187,0.00022694268,0.0007407122,0.000029095052,0.00002900504,0.0002341097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985256,0.000024896393,0.00065765856,0.00026740023,0.00019967042,0.00032477715],"domain_scores_gemma":[0.9944248,0.004327136,0.0003431361,0.00046339014,0.0003503182,0.00009121525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031685398,0.00020952181,0.000835146,0.00011935385,0.000059543836,0.0000050692843,0.00012931436,0.00008578173,0.00031902725],"category_scores_gemma":[0.0003578505,0.0001227083,0.00036185514,0.000416385,0.00011529334,0.00004145013,0.000018036508,0.000053217944,0.0000031898683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015980176,0.0045927847,0.008768963,0.0038719606,0.0015459814,0.000044291333,0.0017487794,0.000008467318,0.0013088337,0.005784606,0.010930064,0.96123546],"study_design_scores_gemma":[0.0058562513,0.002470944,0.03411431,0.0017061331,0.0010779813,0.0000150965425,0.0007645419,0.000028341039,0.005747784,0.000061593135,0.9479606,0.00019643818],"about_ca_topic_score_codex":0.0005976397,"about_ca_topic_score_gemma":0.00017360841,"teacher_disagreement_score":0.961039,"about_ca_system_score_codex":0.0004878361,"about_ca_system_score_gemma":0.00049488497,"threshold_uncertainty_score":0.50038993},"labels":[],"label_agreement":null},{"id":"W2085225919","doi":"10.1038/onc.2015.62","title":"Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis","year":2015,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Congressionally Directed Medical Research Programs; Hospital for Sick Children","keywords":"Biology; Carcinogenesis; Cancer research; Serous fluid; Cell biology; Molecular biology; Cancer; Genetics","score_opus":0.02295939106141521,"score_gpt":0.27586394193353236,"score_spread":0.25290455087211716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085225919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324775,0.0023459278,0.00003708053,0.0033119186,0.00023859266,0.0002969435,0.000065034925,0.000022113574,0.00043462458],"genre_scores_gemma":[0.99531245,0.0005335838,0.0027877446,0.00052977185,0.00033510514,0.000036205023,0.000014369902,0.000027480033,0.00042325837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905205,0.000027739112,0.00020570877,0.00030102735,0.00021124673,0.00020220282],"domain_scores_gemma":[0.99921,0.000036683414,0.000051917552,0.00024449642,0.0000889932,0.00036791025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011395082,0.00016501988,0.00038814644,0.000070810114,0.000032962933,0.000014473154,0.00004712876,0.000059042322,0.000039659626],"category_scores_gemma":[0.000028705035,0.00012870542,0.0000373008,0.000119520024,0.000062599385,0.000038546932,0.00005792014,0.000043764612,0.000018309467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032404175,0.0030327465,0.60547465,0.000743353,0.002000443,0.0015399477,0.0059016,0.00012581526,0.09934382,0.0054244613,0.008070386,0.26510236],"study_design_scores_gemma":[0.020037219,0.0073014903,0.44844362,0.00056739734,0.001615921,0.0003807359,0.0004820456,0.00008256969,0.43984005,0.0011539197,0.07920608,0.0008889579],"about_ca_topic_score_codex":0.00093585614,"about_ca_topic_score_gemma":0.00018489391,"teacher_disagreement_score":0.3404962,"about_ca_system_score_codex":0.00008218729,"about_ca_system_score_gemma":0.000110985835,"threshold_uncertainty_score":0.5248454},"labels":[],"label_agreement":null},{"id":"W2085422244","doi":"10.3892/ijo.29.4.919","title":"Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy","year":2006,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Hotel Dieu Hospital; Hôtel-Dieu de Québec","funders":"Cancer Research Society","keywords":"Serous fluid; Serous ovarian cancer; Cancer research; Biology; Ovarian cancer; Gene expression profiling; Oncology; Cancer; Gene expression; Internal medicine; Gene; Medicine; Genetics","score_opus":0.010302438258177175,"score_gpt":0.3021997793899166,"score_spread":0.29189734113173943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085422244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139965,0.000054215572,0.0007197302,0.0070357537,0.00018742168,0.00021415987,0.00007503247,0.0000039188412,0.00031010032],"genre_scores_gemma":[0.99357015,0.000045476158,0.0053273174,0.0005491621,0.00043270647,0.000009889747,0.0000077907225,0.000015522572,0.000041998825],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99877226,0.000103316495,0.000461616,0.00016350571,0.0003670693,0.00013224476],"domain_scores_gemma":[0.99875236,0.00018735591,0.00035187576,0.00007847701,0.00053395075,0.00009598261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034022704,0.0001239963,0.00039812113,0.0002914939,0.000015322852,0.000010646839,0.00008582542,0.00007888856,0.000037722602],"category_scores_gemma":[0.00006936989,0.00009174053,0.000057633606,0.00008285242,0.000057678044,0.00007265374,0.00003096536,0.00015648286,6.89605e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21467265,0.0051464722,0.25193447,0.000041181396,0.0009764469,0.017020022,0.0047497614,0.0012895595,0.48118734,0.00025226263,0.00040994893,0.022319898],"study_design_scores_gemma":[0.012060804,0.0054295887,0.63828754,0.00051688263,0.000053718086,0.0021480676,0.00026484337,0.00003602616,0.34066287,0.0001418426,0.0003206016,0.000077221724],"about_ca_topic_score_codex":0.0003227001,"about_ca_topic_score_gemma":0.00005891518,"teacher_disagreement_score":0.38635308,"about_ca_system_score_codex":0.00053599535,"about_ca_system_score_gemma":0.0004641138,"threshold_uncertainty_score":0.374107},"labels":[],"label_agreement":null},{"id":"W2085491990","doi":"10.1038/sj.bjc.6602239","title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations","year":2004,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"Cancer Council Tasmania; Medical Research Council; National Cancer Institute; National Institutes of Health; Wellcome Trust; National Breast Cancer Foundation; University of Melbourne; Huntsman Cancer Institute; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Ovarian cancer; Medicine; Odds ratio; Gynecology; Confidence interval; Cancer; BRCA mutation; Obstetrics; Population; Demography; Oncology; Internal medicine; Environmental health","score_opus":0.019340837229207666,"score_gpt":0.3000147470173663,"score_spread":0.28067390978815865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085491990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826692,0.01481912,0.00018931479,0.0011170299,0.00034114192,0.0003047262,0.0004607546,0.000007677035,0.0000910617],"genre_scores_gemma":[0.97405016,0.02368006,0.001518248,0.00023036082,0.00026252342,0.000038599464,0.0000036859078,0.000025460826,0.00019091435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987777,0.00004696312,0.00048015534,0.00017371448,0.00031182024,0.00020964537],"domain_scores_gemma":[0.99848664,0.00008128105,0.00052217604,0.00009711945,0.00054212473,0.00027063527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016041483,0.0001364772,0.0005103812,0.00009367574,0.00009725369,0.00006801266,0.000056581008,0.00008098567,0.00062832853],"category_scores_gemma":[0.00016437213,0.00012115607,0.00014378945,0.0001838901,0.00023058525,0.000338799,0.000013657838,0.00027022947,5.2486797e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010129214,0.00041505866,0.766815,0.00008898431,0.002294277,0.0021675818,0.0015568691,0.0015994424,0.00015928451,0.00009563356,0.0018061916,0.22198874],"study_design_scores_gemma":[0.011277237,0.0005141249,0.97868246,0.0019418424,0.0013108111,0.0007688097,0.00046662687,0.0000121533685,0.0013490188,0.00015395155,0.0033873417,0.00013562762],"about_ca_topic_score_codex":0.037132215,"about_ca_topic_score_gemma":0.035188057,"teacher_disagreement_score":0.2218531,"about_ca_system_score_codex":0.00034716056,"about_ca_system_score_gemma":0.0009246927,"threshold_uncertainty_score":0.9824172},"labels":[],"label_agreement":null},{"id":"W2085556398","doi":"10.1016/j.path.2010.03.003","title":"Hereditary Carcinomas of the Ovary, Fallopian Tube, and Peritoneum","year":2011,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fallopian tube; Serous fluid; Serous carcinoma; Pathology; Lynch syndrome; Ovarian cancer; Ovary; Cancer; Adenocarcinoma; Colorectal cancer; Gynecology; Internal medicine; DNA mismatch repair","score_opus":0.07205527427225064,"score_gpt":0.3549401914902647,"score_spread":0.282884917218014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085556398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016849054,0.9917179,2.740778e-7,0.0002264596,0.0012407493,0.00080494006,0.00013790542,0.000021388867,0.0041654943],"genre_scores_gemma":[0.001066429,0.9974472,0.00013260845,0.00013558514,0.00042286413,0.00009446517,0.00006554845,0.00005017064,0.0005851328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976774,0.00036568384,0.0009309631,0.0005820618,0.00015410995,0.00028978274],"domain_scores_gemma":[0.9980704,0.0005065839,0.00036515595,0.000822059,0.00006636713,0.00016940283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038342338,0.0003889565,0.0024131746,0.00007408954,0.00006183706,0.0000045747556,0.00019624106,0.0007665771,0.0001809588],"category_scores_gemma":[0.000086130734,0.0002163517,0.0008875913,0.00016908391,0.0005427233,0.000017752907,0.00024386926,0.00073420646,0.00002262168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007096642,0.0007047078,0.02036172,0.007771637,0.00056761975,0.004614713,0.00010356567,3.1271405e-8,2.60357e-8,0.001535319,0.00085559726,0.9634141],"study_design_scores_gemma":[0.0009322221,0.00048475288,0.008449629,0.0031077408,0.0024029342,0.0032358833,0.000008175007,4.8681704e-7,3.5797086e-7,0.000120679455,0.98107934,0.00017779345],"about_ca_topic_score_codex":0.00002372828,"about_ca_topic_score_gemma":0.000011744539,"teacher_disagreement_score":0.9802238,"about_ca_system_score_codex":0.000052759588,"about_ca_system_score_gemma":0.00043633842,"threshold_uncertainty_score":0.8822567},"labels":[],"label_agreement":null},{"id":"W2085597974","doi":"10.1016/j.jmig.2012.08.596","title":"Incidental Adnexal Malignancies during Routine Laparoscopic Surgery","year":2012,"lang":"en","type":"article","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Adnexal mass; Serous fluid; Laparoscopic surgery; Incidence (geometry); Surgery; Hysterectomy; Cohort; Retrospective cohort study; Laparoscopy; Gynecology; General surgery; Internal medicine","score_opus":0.023969840108961325,"score_gpt":0.27030823884668415,"score_spread":0.2463383987377228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085597974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931935,0.0028564334,0.0000023733528,0.0016966345,0.0014873246,0.00016380737,0.000007978687,0.000011832387,0.0005800929],"genre_scores_gemma":[0.9961995,0.0008734476,0.0007265727,0.00085205265,0.0010984174,0.000015823525,0.000005806979,0.00002527522,0.00020311406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819946,0.00010005206,0.0007542117,0.00014524398,0.00029333416,0.00050768803],"domain_scores_gemma":[0.99746954,0.001138041,0.0006133071,0.00016715168,0.00026564187,0.00034631797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039983305,0.00020028075,0.0008001443,0.00027580519,0.00007885089,0.00001445545,0.00009771608,0.0001434102,0.0009563886],"category_scores_gemma":[0.0012209866,0.00015944736,0.0003237236,0.00013923,0.00010329663,0.00025209025,0.00006656312,0.0002540055,0.00008116522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035049627,0.0008378169,0.97559917,0.000106436644,0.0004505145,0.0011240577,0.00046891856,0.0000014363051,0.016285352,0.0000775958,0.0042791907,0.0004190194],"study_design_scores_gemma":[0.0029075078,0.00087682717,0.93937534,0.00021502923,0.00034419197,0.0030926412,0.00034113295,2.1527022e-7,0.051226817,0.000020416748,0.0014764904,0.00012336535],"about_ca_topic_score_codex":0.000013376512,"about_ca_topic_score_gemma":0.00005209867,"teacher_disagreement_score":0.0362238,"about_ca_system_score_codex":0.00045890085,"about_ca_system_score_gemma":0.0006218618,"threshold_uncertainty_score":0.99995685},"labels":[],"label_agreement":null},{"id":"W2086037490","doi":"10.1111/j.1048-891x.2004.14065.x","title":"Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Stage (stratigraphy); Ascites; Multivariate analysis; Univariate analysis; Internal medicine; Epithelial ovarian cancer; Disease; Oncology; Gynecology; Surgery; Cancer","score_opus":0.028714013377175718,"score_gpt":0.3555106594136239,"score_spread":0.3267966460364482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086037490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208087,0.0021794739,0.000054098924,0.0038272194,0.0011611644,0.00038170238,0.000058093916,0.000007419593,0.00024993808],"genre_scores_gemma":[0.9894148,0.007142337,0.0021811016,0.000342765,0.0007491668,0.000111982714,0.000004321448,0.000014983401,0.00003851109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972275,0.00012125329,0.0012343716,0.00029378373,0.0008839711,0.00023911452],"domain_scores_gemma":[0.99731547,0.00045181517,0.0008975309,0.00012956084,0.0010162408,0.00018937745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324793,0.0001979396,0.00085825863,0.00018703047,0.00002018007,0.000011549191,0.0002495275,0.00015576096,0.00063048815],"category_scores_gemma":[0.00024557728,0.00012788846,0.00019183088,0.00022096896,0.00032912873,0.00033264834,0.00006223483,0.0004310318,9.777734e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045067117,0.00391945,0.8801696,0.00014044899,0.0017543095,0.0010992268,0.0009329356,0.01657805,0.003244209,0.00022829497,0.00008810071,0.046778288],"study_design_scores_gemma":[0.012034805,0.0060608257,0.9758062,0.0016935444,0.00015814805,0.00015505166,0.00011737672,0.0000065984327,0.0032537247,0.00010660964,0.00048404417,0.0001230882],"about_ca_topic_score_codex":0.00016634229,"about_ca_topic_score_gemma":0.00007358856,"teacher_disagreement_score":0.09563661,"about_ca_system_score_codex":0.0024295182,"about_ca_system_score_gemma":0.0020151997,"threshold_uncertainty_score":0.6903403},"labels":[],"label_agreement":null},{"id":"W2086055140","doi":"10.1038/sj.bjc.6604088","title":"A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens","year":2007,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Trabectedin; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer; Phases of clinical research; Chemotherapy; Pathology; Sarcoma; Soft tissue sarcoma","score_opus":0.01891746772662693,"score_gpt":0.2959323091599805,"score_spread":0.27701484143335353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086055140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944233,0.003829237,0.000034121247,0.00017475875,0.00013020565,0.0012273944,0.000061665036,0.000010479307,0.00010886809],"genre_scores_gemma":[0.99891645,0.0002912937,0.00038640734,0.00009735814,0.0001321105,0.00007398122,0.000012379763,0.00004086276,0.00004918652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781543,0.00005836497,0.0007725406,0.00027365726,0.00072582957,0.00035418416],"domain_scores_gemma":[0.99821067,0.000043170094,0.0007377413,0.00016921839,0.00059497484,0.00024421597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002744167,0.00022458614,0.00070492586,0.00023120258,0.00006582835,0.000023391121,0.00008714299,0.000061237486,0.00022338255],"category_scores_gemma":[0.000021191197,0.00017723354,0.00008404155,0.00051800394,0.000057417852,0.00011017749,0.000011358401,0.00026807774,1.853751e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014110228,0.031175958,0.6202849,0.000088127184,0.00088321697,0.0017764873,0.0011659698,0.00026595176,0.000088168075,7.158045e-7,0.00047654816,0.32968372],"study_design_scores_gemma":[0.109631896,0.055166222,0.8246694,0.0065170843,0.0010496025,0.00009296277,0.00025026102,0.000010648349,0.0015141361,0.0000011899469,0.00087778614,0.0002188048],"about_ca_topic_score_codex":0.0036589655,"about_ca_topic_score_gemma":0.022712214,"teacher_disagreement_score":0.3294649,"about_ca_system_score_codex":0.00088969443,"about_ca_system_score_gemma":0.0005140111,"threshold_uncertainty_score":0.99512076},"labels":[],"label_agreement":null},{"id":"W2086139141","doi":"10.1016/j.ygyno.2015.01.258","title":"The effect of time on racial differences in ovarian cancer stage at diagnosis among cases identified through the National Cancer Database","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Cancer; Epithelial ovarian cancer; Gynecology; Cancer stage; Oncology; Demography; Internal medicine","score_opus":0.08072550410260793,"score_gpt":0.3842631669295571,"score_spread":0.30353766282694916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086139141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831696,0.0019195987,0.0000010461039,0.008186291,0.001204622,0.0012905515,0.00029887754,0.000019183948,0.0039102254],"genre_scores_gemma":[0.99157786,0.0012364313,0.000016346652,0.0008126872,0.00028418592,0.00402888,0.000041390773,0.000013863378,0.0019883781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978077,0.00059406046,0.00039909175,0.0003973092,0.00043229767,0.00036954653],"domain_scores_gemma":[0.9925543,0.006640362,0.00029815178,0.00027729856,0.00013057547,0.000099301],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086736726,0.00022728926,0.00057935546,0.00006191806,0.00021580243,0.000019580031,0.00022354978,0.00017033011,0.0019504855],"category_scores_gemma":[0.0013243752,0.00010984719,0.000106302396,0.00024807893,0.00043971674,0.000078855555,0.00014890864,0.0002396567,0.000057725934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014036761,0.0005776066,0.9612066,0.000029761752,0.00035264497,0.00032139028,0.00088666065,0.0001392257,0.00005132888,0.00047218704,0.026550824,0.008008065],"study_design_scores_gemma":[0.00610631,0.004623423,0.95956117,0.00009791292,0.00032473484,0.0000123364425,0.00022780843,0.00006913536,0.0026597197,0.00012639546,0.026030662,0.00016041784],"about_ca_topic_score_codex":0.0063548516,"about_ca_topic_score_gemma":0.027388686,"teacher_disagreement_score":0.021033835,"about_ca_system_score_codex":0.0017898559,"about_ca_system_score_gemma":0.0005560376,"threshold_uncertainty_score":0.99896187},"labels":[],"label_agreement":null},{"id":"W2086566101","doi":"10.1002/uog.598","title":"P133: Maternal adnexal masses: a diagnostic challenge","year":2003,"lang":"en","type":"article","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital","funders":"","keywords":"Medicine; Serous Cystadenoma; Cystadenoma; Cyst; Mucinous cystadenoma; Pathological; Pregnancy; Dermoid cyst; Serous fluid; Radiology; Ovarian cyst; Adnexal mass; Ovary; Surgery; Pathology; Internal medicine","score_opus":0.014721408585991835,"score_gpt":0.2572657508916837,"score_spread":0.24254434230569186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086566101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742131,0.011105563,0.00002290059,0.00062646146,0.0011311697,0.0004190457,0.000017116407,0.00002497539,0.012439619],"genre_scores_gemma":[0.97687626,0.021455418,0.00067680253,0.0005016572,0.00004163314,0.00010301376,0.000013008173,0.000020873607,0.00031130473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875766,0.000069723224,0.00028556527,0.0003653671,0.00013935305,0.00038232675],"domain_scores_gemma":[0.97361386,0.025892058,0.00006430339,0.00021859622,0.00004763377,0.00016354684],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00016551565,0.00017555128,0.00036820865,0.00020779112,0.000057131034,0.00003061098,0.000051887553,0.00016731571,0.0006632551],"category_scores_gemma":[0.025550783,0.00015696933,0.00005573212,0.0002911205,0.00007632039,0.000054190234,0.000017422262,0.00019332425,0.00004936289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014849649,0.00092576054,0.9505178,0.000080522936,0.00009433985,0.0007761596,0.00025943285,0.000004787325,0.000053244235,0.018522132,0.00038211743,0.0283689],"study_design_scores_gemma":[0.0051487405,0.0011981771,0.7274051,0.00006103304,0.00012399965,0.0003040381,0.00023992141,0.000010537579,0.00023765405,0.0029436783,0.2620844,0.00024273798],"about_ca_topic_score_codex":0.000059963655,"about_ca_topic_score_gemma":0.00007906463,"teacher_disagreement_score":0.26170227,"about_ca_system_score_codex":0.00022093808,"about_ca_system_score_gemma":0.00010948273,"threshold_uncertainty_score":0.98265743},"labels":[],"label_agreement":null},{"id":"W2086879010","doi":"10.1016/j.ygyno.2014.09.017","title":"Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Chemotherapy; Ovarian cancer; Cytoreductive surgery; Internal medicine; Multivariate analysis; Oncology; Observational study; Surgery; Cancer; Confidence interval","score_opus":0.020351057303024167,"score_gpt":0.31312800113464356,"score_spread":0.2927769438316194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086879010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571264,0.000017942659,0.000004170048,0.00039954123,0.0007339267,0.00095009577,0.00026893744,0.000008021629,0.001904712],"genre_scores_gemma":[0.9995363,0.0000138920805,0.00004702694,0.000069953836,0.000089826375,0.00010302289,0.000111824025,0.000011365443,0.000016828735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979405,0.0005939097,0.0005452067,0.00037220822,0.00026447495,0.00028371453],"domain_scores_gemma":[0.9966472,0.0020848056,0.0006235164,0.00034332418,0.00022949916,0.000071651535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052734,0.00021173034,0.0014064834,0.0003447172,0.00003923922,0.0000028869924,0.00007598394,0.00018879157,0.00026751426],"category_scores_gemma":[0.00037364123,0.00011647664,0.0004269211,0.0008506665,0.00020578338,0.000027296543,0.000041078576,0.0002492818,0.0000011874603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022671444,0.0034171154,0.9397632,0.0000146948705,0.0026086615,0.000013414138,0.00021010285,0.0008529589,0.000008172711,0.0000895312,0.00031499943,0.030035743],"study_design_scores_gemma":[0.026060339,0.010758222,0.9611229,0.000045792018,0.0015694561,6.5071345e-7,0.00005080737,0.00007938645,0.0001042231,0.000026230371,0.0000790849,0.00010293257],"about_ca_topic_score_codex":0.002247707,"about_ca_topic_score_gemma":0.003476664,"teacher_disagreement_score":0.02993281,"about_ca_system_score_codex":0.0013084343,"about_ca_system_score_gemma":0.0010470416,"threshold_uncertainty_score":0.47497797},"labels":[],"label_agreement":null},{"id":"W2087016156","doi":"10.1111/j.1525-1438.2006.00713.x","title":"Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Intraperitoneal chemotherapy; Epithelial ovarian cancer; Catheter; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.014201608342584682,"score_gpt":0.3331052177308427,"score_spread":0.318903609388258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087016156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8244774,0.0040787263,0.00046073398,0.16114548,0.0044173994,0.00084977667,0.0005734638,0.000026468919,0.003970598],"genre_scores_gemma":[0.9889052,0.0013013126,0.0025105905,0.003911632,0.0028478052,0.00019011048,0.000012045678,0.000021233314,0.00030005784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868727,0.000020852682,0.0004182414,0.0002213236,0.00036611967,0.00028621772],"domain_scores_gemma":[0.9979914,0.0001457106,0.00027081362,0.000080362675,0.0012806862,0.00023105119],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014000312,0.0001683006,0.0003755172,0.00018116669,0.00006940044,0.000043728232,0.00020351009,0.00011748214,0.0022457303],"category_scores_gemma":[0.00010053854,0.0001243591,0.00028351115,0.00009888007,0.000074662705,0.000108532964,0.000012073791,0.00019717599,0.0000037528885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014678345,0.004108523,0.29278743,0.00005933604,0.006484381,0.0024914534,0.001178425,0.0035153273,0.015387046,0.053587724,0.04579594,0.55992603],"study_design_scores_gemma":[0.022155777,0.0023742602,0.66266423,0.00025861055,0.00038300062,0.0002879394,0.000331446,0.00021006711,0.009666924,0.008909079,0.29236472,0.0003939334],"about_ca_topic_score_codex":0.044059835,"about_ca_topic_score_gemma":0.050112307,"teacher_disagreement_score":0.5595321,"about_ca_system_score_codex":0.0031515951,"about_ca_system_score_gemma":0.0013587371,"threshold_uncertainty_score":0.99866635},"labels":[],"label_agreement":null},{"id":"W2087058916","doi":"10.1371/journal.pone.0002633","title":"Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer","year":2008,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Canary Foundation; Howard Hughes Medical Institute","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Bioinformatics; Computational biology; Biology; Internal medicine","score_opus":0.08949018760013971,"score_gpt":0.2999495032416423,"score_spread":0.2104593156415026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087058916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945326,0.0019291238,0.000025745063,0.00039668314,0.00004824569,0.0025127295,0.000029905885,0.000021821128,0.00050313433],"genre_scores_gemma":[0.9958629,0.0002252759,0.0020330928,0.000057342142,0.000099145174,0.0015454357,0.000011775711,0.0000189308,0.00014611999],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988656,0.000054133016,0.00028956943,0.0001666367,0.00048422857,0.00013983109],"domain_scores_gemma":[0.9990809,0.00011956536,0.0001699556,0.00022263914,0.00034529227,0.000061668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004523106,0.00009156139,0.00040208048,0.00006454689,0.00006659083,0.0000039618153,0.000032440483,0.00004015581,0.00014329475],"category_scores_gemma":[0.00029209856,0.00007551234,0.000070560156,0.00010782652,0.000018777146,0.000032442807,0.000007745711,0.000040117848,0.0000035118053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023920333,0.025464827,0.5668164,0.21642867,0.05598725,0.000114995,0.006878871,0.00023834432,0.1161222,0.00034399665,0.0007938187,0.008418598],"study_design_scores_gemma":[0.0369705,0.0025105828,0.16601275,0.06560801,0.06808004,0.00007548604,0.00042893045,0.019391133,0.64017874,0.0001977323,0.000010349168,0.0005357381],"about_ca_topic_score_codex":0.00036931905,"about_ca_topic_score_gemma":0.00009841635,"teacher_disagreement_score":0.52405655,"about_ca_system_score_codex":0.00017250283,"about_ca_system_score_gemma":0.00024156227,"threshold_uncertainty_score":0.30793038},"labels":[],"label_agreement":null},{"id":"W2087223809","doi":"10.1371/journal.pone.0038945","title":"NuMA Overexpression in Epithelial Ovarian Cancer","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Oncolytics Biotech; University of Leeds; Wellbeing of Women; Breast Cancer Campaign; Cancer Research UK","keywords":"Aneuploidy; Immunohistochemistry; Biology; Serous fluid; Ovarian cancer; Tissue microarray; Pathology; Cancer research; Andrology; Cancer; Medicine; Immunology; Gene; Genetics; Chromosome","score_opus":0.06095957570481675,"score_gpt":0.28895426833728155,"score_spread":0.2279946926324648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087223809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987037,0.0011316895,0.0000021696121,0.0027271085,0.00007293394,0.0003444364,0.00002673419,0.000030244457,0.0057943296],"genre_scores_gemma":[0.99643755,0.00036750187,0.001132022,0.00049895066,0.0007122681,0.0001920349,0.0000119503065,0.000019258887,0.0006284643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991972,0.000020799735,0.0001387453,0.00014471292,0.00023321895,0.00026534777],"domain_scores_gemma":[0.9995614,0.00002825011,0.000037350736,0.00019992077,0.00002477155,0.0001482765],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007485563,0.00009775518,0.00022686309,0.000056007462,0.000025490564,0.0000067025203,0.00003332259,0.00006315479,0.0018190627],"category_scores_gemma":[0.000024145307,0.00007755731,0.000036254976,0.00009734544,0.000014427822,0.00008948023,0.000023772116,0.00010734804,0.0001402937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020338382,0.00814599,0.9197817,0.00014839233,0.0002496694,0.0000176031,0.00059930084,8.492227e-7,0.06513465,0.0005671532,0.00077141187,0.0043799104],"study_design_scores_gemma":[0.0037721486,0.00013999935,0.79277515,0.0023615956,0.00021033581,0.0000025136064,0.000027263768,0.000030584943,0.19895712,0.000085907464,0.0015066491,0.0001307581],"about_ca_topic_score_codex":0.0005032376,"about_ca_topic_score_gemma":0.000025128831,"teacher_disagreement_score":0.13382246,"about_ca_system_score_codex":0.00019997197,"about_ca_system_score_gemma":0.000053551645,"threshold_uncertainty_score":0.9990934},"labels":[],"label_agreement":null},{"id":"W2088050133","doi":"10.1016/j.ygyno.2013.05.013","title":"The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study)","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Proportional hazards model; Internal medicine; Oncology; Progression-free survival; Population; Confidence interval; Multivariate analysis; Chemotherapy; Paclitaxel; Urology; Cancer; Cisplatin","score_opus":0.07237740890737773,"score_gpt":0.3571437969437789,"score_spread":0.2847663880364012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088050133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526466,0.00079833966,0.000444936,0.0059962124,0.0009911124,0.005193913,0.0006834781,0.00003540646,0.00059195136],"genre_scores_gemma":[0.990804,0.0001137788,0.0050307,0.00055429933,0.00031188672,0.0024827966,0.00059771526,0.000032743286,0.00007204735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967795,0.00049458677,0.00096432195,0.0008534899,0.00032601028,0.0005821066],"domain_scores_gemma":[0.99249774,0.0053951824,0.00041653417,0.0013871936,0.00014453146,0.00015881864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044248987,0.0003472606,0.0010722737,0.00010747036,0.00009352697,0.00003955767,0.0006095396,0.00034277295,0.0010355895],"category_scores_gemma":[0.0010142379,0.0002273639,0.00011503675,0.00025749853,0.00022721541,0.00008032097,0.00028081934,0.00039617007,0.00004780712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010872934,0.024956204,0.860756,0.00004880044,0.0017335253,0.0004887689,0.0005669776,0.015491509,0.00047638582,0.0001942034,0.016360313,0.068054415],"study_design_scores_gemma":[0.07732876,0.009690967,0.7701076,0.00006451548,0.0014013139,0.0000012320072,0.00032328843,0.13620867,0.0001255938,0.0014293488,0.0030218328,0.00029684408],"about_ca_topic_score_codex":0.035723526,"about_ca_topic_score_gemma":0.028115617,"teacher_disagreement_score":0.12071715,"about_ca_system_score_codex":0.00076790137,"about_ca_system_score_gemma":0.0010284104,"threshold_uncertainty_score":0.9998776},"labels":[],"label_agreement":null},{"id":"W2088534306","doi":"10.1210/jc.2013-1782","title":"Coexistence of Malignant Struma Ovarii and Cervical Papillary Thyroid Carcinoma","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Society of Endocrinology and Metabolism; Society for Endocrinology","keywords":"Medicine; Thyroid; Struma ovarii; Pathology; Thyroid carcinoma; Cytokeratin; Thyroglobulin; Thyroidectomy; Internal medicine; Immunohistochemistry","score_opus":0.04664350366377237,"score_gpt":0.34332990047883954,"score_spread":0.29668639681506714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088534306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623294,0.017641231,0.00001670924,0.018392056,0.00056592416,0.00028299593,0.0000058690603,0.0000075572802,0.0007582526],"genre_scores_gemma":[0.9800085,0.016135056,0.0011228096,0.0019202584,0.0006738221,0.000007196968,9.687059e-7,0.000016545373,0.00011486778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711585,0.00044619179,0.0015629194,0.00019181418,0.0003372999,0.00034590188],"domain_scores_gemma":[0.9969922,0.0010832404,0.0008298732,0.00043784213,0.00037950397,0.0002773505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007672645,0.0001924539,0.0012634676,0.00008992467,0.00006129959,0.000010302446,0.00025706724,0.00013188335,0.00034038234],"category_scores_gemma":[0.00037726233,0.00010142613,0.0003283376,0.000112982154,0.00062349427,0.00009868842,0.00013291501,0.0006330436,0.000022095248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003401933,0.0027068427,0.69495815,0.00021302394,0.0033930296,0.0010436975,0.0010214879,0.000010810531,0.0047183963,0.015097366,0.007917191,0.26551807],"study_design_scores_gemma":[0.0049970928,0.0014921807,0.978732,0.00007353537,0.0011162309,0.0020953743,0.00021709873,0.000023484266,0.0020880902,0.0016177358,0.0074581965,0.00008900581],"about_ca_topic_score_codex":0.00015917714,"about_ca_topic_score_gemma":0.000004811272,"teacher_disagreement_score":0.2837738,"about_ca_system_score_codex":0.000015017837,"about_ca_system_score_gemma":0.00019633117,"threshold_uncertainty_score":0.41360375},"labels":[],"label_agreement":null},{"id":"W2088989339","doi":"10.1038/modpathol.2011.183","title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma","year":2011,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Pathology; Germline mutation; Germline; Serous fluid; Biology; Serous carcinoma; Cancer; Pleomorphism (cytology); Carcinoma; Ovarian cancer; Medicine; Cancer research; Oncology; Mutation; Internal medicine; Immunohistochemistry; Genetics","score_opus":0.037954615774464184,"score_gpt":0.23596507041623332,"score_spread":0.19801045464176914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088989339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632883,0.00044649374,0.0005077999,0.00042265252,0.00006110826,0.00030877677,0.000025026146,0.000034358258,0.0018649324],"genre_scores_gemma":[0.99830425,0.000058548936,0.00060005335,0.00077531894,0.000025435278,0.00007521867,0.00003615502,0.000025984253,0.00009904839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891317,0.00008037343,0.00017799978,0.0004285359,0.00008945068,0.0003104588],"domain_scores_gemma":[0.99948287,0.000031055115,0.00006809021,0.0002830299,0.000039142924,0.00009578398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013850481,0.00016850249,0.00035801606,0.00010689704,0.000033952623,0.0000059200393,0.00005284773,0.00016065007,0.00020239658],"category_scores_gemma":[0.000024044166,0.00012683537,0.00003085933,0.00009107094,0.000079343714,0.00003415016,0.00004170856,0.00016291137,0.00001397691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017066399,0.00044636318,0.987782,0.000013006659,0.000058715148,0.0061899303,0.0020232887,0.0000015705106,0.0004838449,0.00015483728,0.00001936733,0.002656401],"study_design_scores_gemma":[0.0035580634,0.0010425375,0.993162,0.00004351478,0.000111186564,0.00051733793,0.000055508513,0.00012995038,0.00058636116,0.00065264077,0.000011778238,0.00012915365],"about_ca_topic_score_codex":0.0005669422,"about_ca_topic_score_gemma":0.00077693426,"teacher_disagreement_score":0.005672592,"about_ca_system_score_codex":0.00011330647,"about_ca_system_score_gemma":0.000054836877,"threshold_uncertainty_score":0.5172196},"labels":[],"label_agreement":null},{"id":"W2089159125","doi":"10.1371/journal.pone.0008534","title":"Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas","year":2009,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Biology; Cre recombinase; Tumor suppressor gene; Ovarian cancer; Somatic cell; Malignant transformation; Molecular biology; Carcinogenesis; Gene; Cancer; Transgene; Genetics","score_opus":0.059435244612310506,"score_gpt":0.26953497871159016,"score_spread":0.21009973409927965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089159125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995048,0.00013738112,0.000007591304,0.0036777598,0.000002515681,0.00026255168,0.000018991117,0.0000032276664,0.00084201514],"genre_scores_gemma":[0.9967879,0.000052623946,0.0029004032,0.00012197854,0.000011985565,0.000024603782,0.00006608172,0.000002508249,0.000031898257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999317,0.000024337327,0.00028926527,0.00009402922,0.00020981449,0.0000655475],"domain_scores_gemma":[0.9996586,0.00010839334,0.00008235853,0.000092302806,0.00004322696,0.00001511259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019503717,0.00005423558,0.00020755555,0.00009698267,0.000013773206,0.0000031645654,0.000025126768,0.000027734515,0.000010258109],"category_scores_gemma":[0.000079256075,0.00003824608,0.000011730469,0.00012141546,0.000030784355,0.000040462946,0.000006501965,0.000053470885,6.2394497e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004467038,0.051755663,0.6406827,0.0010487748,0.0011221138,0.000083092345,0.044041973,0.000021916363,0.20212816,0.026567923,0.00050171016,0.027578957],"study_design_scores_gemma":[0.0021227961,0.00021823477,0.8188751,0.00027691553,0.000027518328,7.9017906e-7,0.00018154489,0.000013772959,0.1777538,0.00047023795,0.000029462612,0.000029823337],"about_ca_topic_score_codex":0.00004210288,"about_ca_topic_score_gemma":0.00009804946,"teacher_disagreement_score":0.17819242,"about_ca_system_score_codex":0.000065308224,"about_ca_system_score_gemma":0.00008268085,"threshold_uncertainty_score":0.15596299},"labels":[],"label_agreement":null},{"id":"W2089662123","doi":"10.1046/j.1525-1438.2002.01152.x","title":"Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches","year":2002,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Carcinogenesis; Ovarian cancer; Epithelial ovarian cancer; Malignancy; Bioinformatics; Oncology; Cancer; Pathology; Internal medicine; Biology","score_opus":0.1385814274880016,"score_gpt":0.37229298023828117,"score_spread":0.23371155275027958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089662123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030685231,0.9671544,0.000001365795,0.00053257705,0.0006535456,0.0007898609,0.000030940133,0.00000415934,0.00014794662],"genre_scores_gemma":[0.20914477,0.7897847,0.0001289327,0.00005537303,0.0004088209,0.00040422892,0.0000078801195,0.000022370075,0.00004287354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977594,0.00014694424,0.0009924462,0.00033309497,0.0005254254,0.00024266278],"domain_scores_gemma":[0.9989251,0.00013918846,0.0005891665,0.00009733725,0.0001054528,0.00014378704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029178275,0.0003107311,0.0013416816,0.00042250764,0.000015999189,0.000027604989,0.00025387388,0.00027269518,0.0004109259],"category_scores_gemma":[0.00005064872,0.00020409717,0.0003189114,0.00016754318,0.00007807835,0.00010376637,0.000089506306,0.00047382724,0.0000052073065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014154661,0.0021881342,0.15848373,0.000774099,0.0007884275,0.0011760984,0.0002640673,0.000011423115,0.0000013300696,0.0000891803,0.000033572986,0.83604836],"study_design_scores_gemma":[0.01457951,0.003190795,0.6556508,0.038843192,0.0013095676,0.0015851445,0.00009928992,0.000032306067,0.00003790513,0.0002187346,0.28361735,0.0008354093],"about_ca_topic_score_codex":0.00011806304,"about_ca_topic_score_gemma":0.00006966536,"teacher_disagreement_score":0.835213,"about_ca_system_score_codex":0.0014547717,"about_ca_system_score_gemma":0.00029600787,"threshold_uncertainty_score":0.8322841},"labels":[],"label_agreement":null},{"id":"W2090091233","doi":"10.1002/cncr.20595","title":"Systematic review of adjuvant care for women with Stage I ovarian carcinoma","year":2004,"lang":"en","type":"review","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Stage (stratigraphy); Ovarian carcinoma; Oncology; Adjuvant; Gynecology; Carcinoma; Internal medicine; Ovarian cancer; Cancer","score_opus":0.031577774016540876,"score_gpt":0.34469501280937775,"score_spread":0.31311723879283687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090091233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016833734,0.987327,0.000012109647,0.000072114104,0.00016977472,0.010723098,0.0011970341,0.000022115026,0.00047506692],"genre_scores_gemma":[0.00004105604,0.9784984,0.00018341409,0.00022305235,0.0001511548,0.019431176,0.00021292863,0.00010647229,0.0011523374],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99791723,0.000056643312,0.0008912256,0.00048077037,0.0003062892,0.00034785204],"domain_scores_gemma":[0.99778235,0.00008550549,0.0008069668,0.00082680414,0.00030688208,0.0001914861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015685945,0.00048557468,0.0052858726,0.00010133801,0.000038236307,0.000010237841,0.00015090092,0.00015087318,0.00028287643],"category_scores_gemma":[0.00004131897,0.00028023057,0.0004992528,0.0002694963,0.00004556613,0.000027330023,0.000024097284,0.00014862919,0.000011564141],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022859289,0.000060711125,0.000010247908,0.9402441,0.0012858922,0.000050077637,0.00023217415,2.3687102e-7,1.1590695e-8,0.00008309257,0.0001434333,0.0578672],"study_design_scores_gemma":[0.0009401294,0.00043053323,0.000008502569,0.64985955,0.009937896,0.000021866314,0.00007988009,5.7253995e-8,0.0000011147276,0.0000013333354,0.33854413,0.00017500408],"about_ca_topic_score_codex":0.00009532922,"about_ca_topic_score_gemma":0.000023758603,"teacher_disagreement_score":0.3384007,"about_ca_system_score_codex":0.0029217876,"about_ca_system_score_gemma":0.0031602248,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W2090170616","doi":"10.1016/s1074-3804(05)60152-1","title":"Lateral Distribution of Ovarian Dermoid Cyst","year":2003,"lang":"en","type":"article","venue":"The Journal of the American Association of Gynecologic Laparoscopists","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Dermoid cyst; Ovary; Confidence interval; Odds ratio; Cyst; Cohort; Anatomy; Radiology; Gynecology; Internal medicine","score_opus":0.008126988828574142,"score_gpt":0.25857987918217,"score_spread":0.25045289035359586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090170616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921877,0.00013555493,0.000051251125,0.0063919234,0.0003575822,0.00020889628,0.000034015266,0.000004457475,0.0006286602],"genre_scores_gemma":[0.9987826,0.0002565122,0.00021421551,0.00039648547,0.000047898855,0.0000032786359,0.000003772938,0.000007095333,0.0002881876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832207,0.00047471348,0.0005505449,0.00007059342,0.00041169793,0.00017039779],"domain_scores_gemma":[0.9959524,0.0005893293,0.0028385548,0.00023030605,0.00033662078,0.00005278258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001119056,0.00010627722,0.00052017195,0.000032904598,0.00007781693,0.000006805117,0.00017429277,0.000045049557,0.000065328524],"category_scores_gemma":[0.0013073358,0.00005392894,0.00021682517,0.0003193997,0.00015584448,0.00004262734,0.000025248224,0.00017701407,0.0000027998756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029416967,0.0007266698,0.9826777,0.000037875987,0.000711795,0.0000074973377,0.00032113618,0.0001189428,0.0068134847,0.00087745686,0.006565476,0.000847811],"study_design_scores_gemma":[0.0015034776,0.0010111462,0.9800363,0.000082393824,0.00047644452,0.000051619496,0.00011253656,0.000008179287,0.0142510785,0.00049886067,0.0019135912,0.000054372653],"about_ca_topic_score_codex":0.00007390642,"about_ca_topic_score_gemma":0.000019232488,"teacher_disagreement_score":0.0074375933,"about_ca_system_score_codex":0.0007084623,"about_ca_system_score_gemma":0.00025636036,"threshold_uncertainty_score":0.21991582},"labels":[],"label_agreement":null},{"id":"W2090208401","doi":"10.1016/j.cdip.2004.03.005","title":"BRCA mutations and pathology in the female genital tract","year":2004,"lang":"en","type":"article","venue":"Current Diagnostic Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Germline mutation; Genital tract; Pathology; Medicine; Lynch syndrome; Germline; Genetic testing; Female circumcision; Sex organ; Gynecology; Biology; Mutation; Cancer; Gene; Internal medicine; DNA mismatch repair; Physiology; Genetics","score_opus":0.035860255135795376,"score_gpt":0.3264291361804541,"score_spread":0.2905688810446587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090208401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842617,0.00862428,0.00020783987,0.0052518984,0.00048219593,0.00063398504,0.000048403326,0.000026519489,0.00046317972],"genre_scores_gemma":[0.99670285,0.0017171921,0.0002787643,0.000635397,0.00015302814,0.00040245513,0.000091267866,0.000013813178,0.0000052269174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988384,0.00011080573,0.000260631,0.0003592704,0.00011965227,0.00031120435],"domain_scores_gemma":[0.9986401,0.00090163184,0.000060428814,0.00027619142,0.000033575812,0.00008807674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020457295,0.00016905334,0.00028882766,0.00012599542,0.00007960533,0.000015804957,0.00008012156,0.00009121417,0.000044539807],"category_scores_gemma":[0.0006946053,0.00011915215,0.00006729054,0.00018031453,0.00021946806,0.000049543592,0.00003052205,0.00027038407,0.00007676198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003820513,0.004604314,0.8827506,0.00010106185,0.000036064805,0.015258252,0.007360212,0.000062304105,0.000120911536,0.00961692,0.00031355926,0.07973761],"study_design_scores_gemma":[0.0036125996,0.0005842752,0.98669773,0.00009988767,0.00018642246,0.0035171234,0.00038983807,0.000004349214,0.00008239835,0.0033552705,0.0013470773,0.00012302228],"about_ca_topic_score_codex":0.000023834948,"about_ca_topic_score_gemma":0.000053864595,"teacher_disagreement_score":0.103947155,"about_ca_system_score_codex":0.00008537795,"about_ca_system_score_gemma":0.000119079705,"threshold_uncertainty_score":0.4858884},"labels":[],"label_agreement":null},{"id":"W2090372541","doi":"10.1210/jcem.87.5.8506","title":"Follicle-Stimulating Hormone Activates Mitogen-Activated Protein Kinase in Preneoplastic and Neoplastic Ovarian Surface Epithelial Cells","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of California, Los Angeles","keywords":"MAPK/ERK pathway; Follicle-stimulating hormone; Follicle-stimulating hormone receptor; Cell growth; Kinase; Internal medicine; Protein kinase A; Biology; Endocrinology; Cell culture; Cell biology; Mitogen-activated protein kinase; Cancer research; Hormone; Medicine; Luteinizing hormone; Biochemistry","score_opus":0.04577578276641091,"score_gpt":0.3220890350344025,"score_spread":0.2763132522679916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090372541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881193,0.006016059,0.000099429264,0.0043647955,0.0007552619,0.0005332414,0.000012169162,0.00001992721,0.00007981783],"genre_scores_gemma":[0.99401486,0.0034688967,0.0013319406,0.0002838359,0.0006912685,0.000009693392,0.0000010092945,0.000034901233,0.00016360982],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99665296,0.0006771083,0.0015227221,0.00029617234,0.00032493155,0.0005261251],"domain_scores_gemma":[0.9958789,0.0025745484,0.0007716076,0.00032849758,0.00015954973,0.000286939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074295624,0.0003019463,0.0012656773,0.00014640827,0.000105545,0.000022878576,0.00019846034,0.00017450105,0.00013138853],"category_scores_gemma":[0.0012150251,0.00018805778,0.00023585792,0.000274044,0.00028668376,0.00014778668,0.000091154456,0.0010490182,0.000023235298],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014309371,0.005275787,0.03844446,0.00013857156,0.003198231,0.0025160436,0.0025560963,0.0044290726,0.8296711,0.00096714054,0.00083697966,0.097657144],"study_design_scores_gemma":[0.06558148,0.0072418083,0.63171875,0.00068497553,0.0036410727,0.0021348032,0.0004023132,0.0047629485,0.26918876,0.0012602137,0.01262699,0.0007559007],"about_ca_topic_score_codex":0.00011473841,"about_ca_topic_score_gemma":0.000015130456,"teacher_disagreement_score":0.5932743,"about_ca_system_score_codex":0.000044982484,"about_ca_system_score_gemma":0.000115293624,"threshold_uncertainty_score":0.76687735},"labels":[],"label_agreement":null},{"id":"W2090453433","doi":"10.1016/j.ygyno.2010.10.011","title":"An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"GlaxoSmithKline","keywords":"Topotecan; Medicine; Carboplatin; Platinum; Phases of clinical research; Oncology; Internal medicine; Surgery; Chemotherapy; Cisplatin","score_opus":0.025037199839799518,"score_gpt":0.3150109359607031,"score_spread":0.2899737361209036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090453433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937188,0.000032061667,0.0000037344155,0.00081432605,0.0002387677,0.0039672493,0.000046822377,0.000025821642,0.0011523959],"genre_scores_gemma":[0.9980492,0.000028388018,0.00071740075,0.00051517354,0.0000375266,0.000477671,0.000094778545,0.000035444144,0.000044447188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997814,0.00033421948,0.00056006317,0.0006699911,0.00023778035,0.00038394402],"domain_scores_gemma":[0.99836195,0.00043564045,0.00041858814,0.00037637373,0.000254807,0.00015266557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005369947,0.0003194062,0.00095908146,0.00027529543,0.00011944288,0.000023263518,0.00015685907,0.00030187174,0.0003992792],"category_scores_gemma":[0.000096893804,0.00023430435,0.000013626153,0.0004118038,0.00018872923,0.0001879503,0.00008318643,0.00055974425,0.0000011024531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015369957,0.20289819,0.5029514,0.000031440046,0.00045015727,0.00091051846,0.014161635,0.000073298615,0.005154169,0.0002775929,0.00003788089,0.25768375],"study_design_scores_gemma":[0.10038648,0.29991537,0.59677696,0.000053579937,0.000101984035,0.000015684429,0.0012134583,0.00010430866,0.0010128979,0.00011373912,0.000099517325,0.00020603863],"about_ca_topic_score_codex":0.002505771,"about_ca_topic_score_gemma":0.050321467,"teacher_disagreement_score":0.25747773,"about_ca_system_score_codex":0.0005882377,"about_ca_system_score_gemma":0.0006224126,"threshold_uncertainty_score":0.9670077},"labels":[],"label_agreement":null},{"id":"W2090512174","doi":"10.1038/onc.2015.101","title":"Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance","year":2015,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Antibody; Ovarian carcinoma; Ascites; Peritoneum; Ovarian cancer; In vivo; Immunohistochemistry; Immunology; Cancer; Internal medicine; Medicine","score_opus":0.014568577305046399,"score_gpt":0.2270500662932688,"score_spread":0.2124814889882224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090512174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931144,0.0033177568,0.00003207139,0.0017119974,0.00009133168,0.0006789587,0.00006949608,0.00004669963,0.00093729317],"genre_scores_gemma":[0.9972412,0.00008695465,0.001616221,0.00040449,0.00009452265,0.00007434072,0.00017940826,0.000030889638,0.00027200137],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986883,0.00004914717,0.00040217795,0.00032618025,0.0002890811,0.00024514945],"domain_scores_gemma":[0.9990636,0.000036583315,0.00021372491,0.00019026367,0.00014630039,0.00034950787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022158877,0.00020304321,0.00029712755,0.000042769985,0.00008042075,0.000045716406,0.000039309052,0.00006989677,0.000034362503],"category_scores_gemma":[0.00006004092,0.00016911296,0.00003316504,0.00012335274,0.00003930456,0.00015438547,0.00003657964,0.00009150344,0.000016743053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007375683,0.0013662998,0.82165235,0.0009967258,0.00008176413,0.00018032631,0.0063301655,0.0000066183366,0.13116775,0.000019848927,0.029201299,0.008259297],"study_design_scores_gemma":[0.011942022,0.0028383539,0.084857255,0.00014985584,0.00042030655,0.000089009875,0.0013166717,0.003172387,0.88253295,0.00004554799,0.012190127,0.00044552924],"about_ca_topic_score_codex":0.0001673817,"about_ca_topic_score_gemma":0.00009581912,"teacher_disagreement_score":0.7513652,"about_ca_system_score_codex":0.00017863131,"about_ca_system_score_gemma":0.000091863956,"threshold_uncertainty_score":0.6896226},"labels":[],"label_agreement":null},{"id":"W2090716605","doi":"10.5402/2012/878635","title":"The Multifaceted Granulosa Cell Tumours—Myths and Realities: A Review","year":2012,"lang":"en","type":"review","venue":"ISRN Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Pathological; Medicine; Context (archaeology); Abdomen; Retrospective cohort study; Pathology; General surgery; Radiology; Biology","score_opus":0.046003215838706965,"score_gpt":0.32708189307432234,"score_spread":0.28107867723561536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090716605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012802906,0.99369025,9.74572e-7,0.0009632091,0.0011568255,0.0020204748,0.000117877804,0.000029839799,0.0020077296],"genre_scores_gemma":[0.00011229895,0.996589,0.00008301081,0.00069570396,0.00014205666,0.00048035395,0.00013526075,0.00005937087,0.0017029624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772877,0.0002545578,0.00070722715,0.00052759785,0.00019548445,0.0005863416],"domain_scores_gemma":[0.98830783,0.010246901,0.00042982516,0.000584819,0.00010777402,0.00032287094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004944534,0.000502286,0.0021738054,0.0001620169,0.0002428423,0.000047644666,0.00013019578,0.0003995339,0.00008551642],"category_scores_gemma":[0.0016430438,0.00028883555,0.0003084055,0.00042451476,0.00019849924,0.00003533942,0.00014178766,0.0004850181,0.00005879638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022461804,0.00013552721,0.00023620854,0.03267197,0.00016327402,0.0000819139,0.000056917692,2.8383236e-9,1.1615949e-8,0.00026744313,0.0031713177,0.96321315],"study_design_scores_gemma":[0.0008549754,0.00027908626,0.0003011423,0.007516504,0.0054141167,0.00018268275,0.000048119306,8.9938584e-7,1.988723e-7,0.000025010593,0.9851161,0.0002611656],"about_ca_topic_score_codex":0.00003709732,"about_ca_topic_score_gemma":0.000029541645,"teacher_disagreement_score":0.9819448,"about_ca_system_score_codex":0.00024030042,"about_ca_system_score_gemma":0.000285718,"threshold_uncertainty_score":0.99995637},"labels":[],"label_agreement":null},{"id":"W2090853702","doi":"10.1097/pas.0b013e3181788546","title":"A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary","year":2008,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Royal Alexandra Hospital; BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Serous fluid; Medicine; Immunophenotyping; Ovarian carcinoma; Pathology; Internal medicine; Oncology; Ovarian cancer; Cancer; Flow cytometry; Immunology","score_opus":0.025773547861326074,"score_gpt":0.24347049107604546,"score_spread":0.21769694321471939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090853702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381614,0.001041372,0.0000033667877,0.0046319477,0.000091803035,0.00013433969,0.000030708514,0.0000040787427,0.00024624885],"genre_scores_gemma":[0.9981255,0.001156079,0.00033137808,0.00019093748,0.00013831473,0.0000023180523,0.0000021649953,0.00001803996,0.000035277637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984477,0.0003529203,0.00059090153,0.00014328033,0.000253178,0.00021200479],"domain_scores_gemma":[0.9978854,0.0005512662,0.0009661831,0.00032856394,0.00015189059,0.00011671935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035987914,0.00014621326,0.0008383752,0.00007343775,0.000081426595,0.0000026201233,0.00019297484,0.000045144083,0.000014319889],"category_scores_gemma":[0.0000615807,0.0000762806,0.00021438957,0.0002932967,0.0013483544,0.000016709713,0.00007807576,0.0003381836,4.98393e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015209521,0.00038022615,0.98641604,0.000033953558,0.0002548335,0.002228877,0.0012128316,0.000012566022,0.0011090833,0.000032403328,0.00034769226,0.006450511],"study_design_scores_gemma":[0.0025423684,0.0032275745,0.98707217,0.00008051901,0.00038183798,0.004452797,0.00039678195,0.0000034152683,0.0012661426,0.000054059296,0.00045227318,0.00007008627],"about_ca_topic_score_codex":0.0007654534,"about_ca_topic_score_gemma":0.0000030887672,"teacher_disagreement_score":0.006380425,"about_ca_system_score_codex":0.000052919855,"about_ca_system_score_gemma":0.00015371357,"threshold_uncertainty_score":0.4968068},"labels":[],"label_agreement":null},{"id":"W2091145066","doi":"10.1111/j.1525-1438.2003.13363.x","title":"First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Medicine; Carboplatin; Epirubicin; Paclitaxel; TEC; Internal medicine; Regimen; Oncology; Ovarian cancer; Chemotherapy; Urology; Gastroenterology; Cancer; Cisplatin; Cyclophosphamide","score_opus":0.052322890997252625,"score_gpt":0.34923049353517804,"score_spread":0.2969076025379254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091145066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97362554,0.007072028,0.0002076246,0.012211124,0.0023086965,0.0006121885,0.0002982727,0.000026001822,0.003638518],"genre_scores_gemma":[0.98922735,0.0067376783,0.0022388354,0.00041901783,0.00065976166,0.00015416261,0.000015457774,0.000034359124,0.0005133994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972354,0.00011233944,0.00095835637,0.00037541217,0.00094843406,0.00037003853],"domain_scores_gemma":[0.99671304,0.0008470444,0.00091668015,0.00024838498,0.0009702229,0.00030464493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025863727,0.00037993226,0.0009047404,0.00021438698,0.0000725256,0.00003944833,0.00021197803,0.00017879238,0.006202935],"category_scores_gemma":[0.0003751715,0.00023554615,0.00037694187,0.00023327497,0.00016237887,0.00015209246,0.000027904485,0.00025103174,0.0000074525788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01844987,0.0075949896,0.8537511,0.00012702915,0.011086345,0.003263432,0.001198247,0.009120127,0.0009883373,0.0056951493,0.002497515,0.08622784],"study_design_scores_gemma":[0.067988664,0.03063297,0.773168,0.0012541323,0.0023335903,0.00032848012,0.0005167629,0.00026315227,0.015767882,0.0009345206,0.10603493,0.0007768702],"about_ca_topic_score_codex":0.00065671233,"about_ca_topic_score_gemma":0.0012803447,"teacher_disagreement_score":0.10353741,"about_ca_system_score_codex":0.0020264413,"about_ca_system_score_gemma":0.0008416323,"threshold_uncertainty_score":0.99470556},"labels":[],"label_agreement":null},{"id":"W2091320648","doi":"10.1016/j.jpag.2016.06.008","title":"Evolution in the Management of Pediatric and Adolescent Ovarian Torsion as a Result of Quality Improvement Measures","year":2016,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children","keywords":"Medicine; Ovarian torsion; Psychological intervention; Cohort; Retrospective cohort study; Quality management; Cohort study; Pediatrics; Surgery; Internal medicine; Nursing","score_opus":0.021683118282340513,"score_gpt":0.29193293792489466,"score_spread":0.2702498196425541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091320648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806965,0.0062535848,0.00034608136,0.004290665,0.00031664682,0.0005881654,0.000011855859,0.0000034372226,0.00011988047],"genre_scores_gemma":[0.9687523,0.030226814,0.00022149303,0.0002595396,0.0004909305,0.000008685852,8.623004e-7,0.0000085328065,0.000030798285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979048,0.000191819,0.00097557064,0.00021897239,0.00045945775,0.0002494161],"domain_scores_gemma":[0.9984147,0.00019226095,0.0008493888,0.00019924299,0.00021980797,0.00012458136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013631985,0.00016548262,0.0005006263,0.00028903794,0.000047776466,0.00000642175,0.00010794783,0.00011002513,0.000023129625],"category_scores_gemma":[0.0001330499,0.0000901328,0.00012339525,0.0002421808,0.0000667447,0.000069553076,0.0000741451,0.0001733238,0.0000012140922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012662769,0.0026977537,0.9544424,0.0012749061,0.0001792642,0.00011185251,0.0002689141,0.0000031896557,0.00050238613,0.0012249019,0.0027487748,0.035279382],"study_design_scores_gemma":[0.0077002957,0.0019319495,0.9876399,0.00020654623,0.00094150344,0.00003536991,0.0005240511,0.0000020778666,0.00016028021,0.00036564862,0.0004002878,0.00009209367],"about_ca_topic_score_codex":0.00003510542,"about_ca_topic_score_gemma":0.000014139402,"teacher_disagreement_score":0.03518729,"about_ca_system_score_codex":0.00024312231,"about_ca_system_score_gemma":0.00017356961,"threshold_uncertainty_score":0.3675509},"labels":[],"label_agreement":null},{"id":"W2091938246","doi":"10.1016/j.ygyno.2004.03.020","title":"A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temozolomide; Medicine; Toxicity; Ovarian cancer; Chemotherapy; Internal medicine; Ovarian carcinoma; Oncology; Phases of clinical research; Gastroenterology; Cancer; Surgery; Urology","score_opus":0.036127711828768824,"score_gpt":0.36129383086308176,"score_spread":0.3251661190343129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091938246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252725,0.0002690295,0.000009246202,0.0032825824,0.00043333234,0.001616834,0.00005006692,0.000018401135,0.0017932337],"genre_scores_gemma":[0.9976773,0.00008996881,0.0010386811,0.00038234063,0.00006537596,0.0006557645,0.00006113868,0.000011804747,0.00001761943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985262,0.00013660405,0.00038049152,0.00033844096,0.00034127888,0.00027698342],"domain_scores_gemma":[0.99905807,0.00009592821,0.00023532564,0.00021748945,0.0003024132,0.00009080509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051791605,0.00015951296,0.00051089196,0.0001472072,0.000052372343,0.0000025811648,0.00006611563,0.00016603731,0.00080544164],"category_scores_gemma":[0.00019368956,0.00011191419,0.0000567051,0.00024950336,0.000097148375,0.000047305875,0.000037975286,0.00015499553,0.000011220656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00352757,0.03353081,0.29550347,0.00004321125,0.00028993833,0.00006758306,0.00081005995,0.0008294267,0.00017199505,0.0005561228,0.0002230089,0.66444683],"study_design_scores_gemma":[0.10270404,0.040415723,0.85229623,0.00011565376,0.0005949196,0.000004316362,0.00005788274,0.00005565095,0.0006793319,0.0007240327,0.0022185403,0.00013366208],"about_ca_topic_score_codex":0.00033447237,"about_ca_topic_score_gemma":0.0016991467,"teacher_disagreement_score":0.66431314,"about_ca_system_score_codex":0.0023973593,"about_ca_system_score_gemma":0.0014873791,"threshold_uncertainty_score":0.88190216},"labels":[],"label_agreement":null},{"id":"W2092148144","doi":"10.1016/j.ygyno.2005.11.025","title":"Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Regimen; Internal medicine; Paclitaxel; Ovarian cancer; Prospective cohort study; Gastroenterology; Chemotherapy; Surgery; Toxicity; Oncology; Cancer","score_opus":0.030082444865835615,"score_gpt":0.35884730214217925,"score_spread":0.32876485727634364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092148144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93736666,0.0021254744,0.00002439332,0.02878192,0.00071672496,0.002685967,0.00018757585,0.00006350531,0.028047768],"genre_scores_gemma":[0.99353707,0.0004718664,0.0029902987,0.0005457822,0.00024670706,0.0012681854,0.000028204837,0.00001899466,0.0008929045],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979351,0.00022404226,0.00067314715,0.00049267244,0.00024843944,0.00042659263],"domain_scores_gemma":[0.998392,0.0005705032,0.00035708892,0.00032157855,0.00023060401,0.00012822347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000594841,0.00022376506,0.0008334153,0.00018518564,0.00006701121,0.0000070827477,0.00011253173,0.00026155246,0.0041043707],"category_scores_gemma":[0.0004603206,0.00017935569,0.00011299621,0.00030683284,0.00016841893,0.000062150284,0.00005672327,0.0002812656,0.000082425904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038333,0.012071829,0.40096235,0.0001359468,0.0009537994,0.00042752124,0.0043423595,0.00038895372,0.0066603264,0.013212653,0.011722353,0.5452886],"study_design_scores_gemma":[0.012002812,0.007998617,0.9357345,0.00012205156,0.00038136973,0.00002107097,0.0004961739,0.00013901034,0.0015871306,0.0014703934,0.03983817,0.00020868587],"about_ca_topic_score_codex":0.0004897238,"about_ca_topic_score_gemma":0.005275372,"teacher_disagreement_score":0.54507995,"about_ca_system_score_codex":0.0023942462,"about_ca_system_score_gemma":0.0010994409,"threshold_uncertainty_score":0.996806},"labels":[],"label_agreement":null},{"id":"W2092437373","doi":"10.1007/s10555-012-9383-7","title":"Ovarian cancer molecular pathology","year":2012,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Biomarker; Cancer; Oncology; Medicine; Breast cancer; Population; Internal medicine; Stage (stratigraphy); Biomarker discovery; Bioinformatics; Proteomics; Biology; Gene; Genetics","score_opus":0.14426596655371923,"score_gpt":0.4225085611250292,"score_spread":0.27824259457130995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092437373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032491405,0.9940562,0.000033220203,0.00040432494,0.00090227363,0.0030024867,0.00041664307,0.000035709374,0.0011458435],"genre_scores_gemma":[0.000004441347,0.9891302,0.0008672193,0.0010971831,0.0007879228,0.0070910393,0.00017617586,0.00012180979,0.0007240245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689806,0.00032836522,0.001052083,0.0008769946,0.00021934831,0.000625182],"domain_scores_gemma":[0.9979022,0.00005806746,0.0005971288,0.0008419156,0.000071952134,0.00052872545],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005351739,0.00084792404,0.0052197697,0.00020547606,0.00008448984,0.000036233792,0.00015258865,0.00033661863,0.0019628364],"category_scores_gemma":[0.000035029105,0.00054334896,0.001180332,0.0004318156,0.000106922904,0.000071975664,0.00010659789,0.00045388,0.00016275854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006446988,0.000120100565,0.00006119441,0.030355627,0.0010604057,0.000120904195,0.000032308948,2.191984e-8,0.0000011186482,0.00028241734,0.0027174077,0.965242],"study_design_scores_gemma":[0.00062383665,0.00008778336,0.000049600156,0.018163444,0.029802494,0.00021867204,0.0000024914084,8.019052e-8,0.000007504475,0.000009418975,0.95059603,0.00043866978],"about_ca_topic_score_codex":0.00013139962,"about_ca_topic_score_gemma":0.000030393743,"teacher_disagreement_score":0.9648034,"about_ca_system_score_codex":0.00041431974,"about_ca_system_score_gemma":0.0005539991,"threshold_uncertainty_score":0.9997018},"labels":[],"label_agreement":null},{"id":"W2093322198","doi":"10.1016/j.ogc.2012.02.003","title":"Trends in Gynecologic Cancer Care in North America","year":2012,"lang":"en","type":"review","venue":"Obstetrics and Gynecology Clinics of North America","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"Health Canada","keywords":"Medicine; Subspecialty; Gynecologic cancer; Gynecologic oncology; Cancer; Cervical cancer; Population; Health care; Family medicine; Ovarian cancer; Intensive care medicine; Oncology; Internal medicine; Environmental health","score_opus":0.053956368244658756,"score_gpt":0.363121367477703,"score_spread":0.30916499923304425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093322198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006340618,0.9899069,6.3371107e-7,0.00013443215,0.0012899402,0.00093932374,0.0005457706,0.000021384874,0.0008209859],"genre_scores_gemma":[0.012852637,0.9843497,0.0003424532,0.00043207774,0.00010171706,0.00063280266,0.0010615804,0.00007380464,0.00015318835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99592793,0.000257955,0.0017685859,0.00094018533,0.00027147584,0.00083387573],"domain_scores_gemma":[0.9902308,0.0072609494,0.0013151909,0.00069264974,0.00016012014,0.00034030387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001432948,0.0007055795,0.004508515,0.0017126426,0.00005523598,0.000012918742,0.00028040976,0.00058243703,0.00038490625],"category_scores_gemma":[0.0013293051,0.0005748416,0.00060277525,0.00396445,0.00038675533,0.00006948229,0.00021028814,0.0010226509,0.000031650507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013404673,0.00069933047,0.33919215,0.0021790946,0.00019388433,0.00017666441,0.00015567361,0.000010043475,4.9324134e-10,0.000001780347,0.00010085762,0.6572771],"study_design_scores_gemma":[0.0013847372,0.0013356449,0.25622505,0.0005558166,0.0014655489,0.0000052728606,0.00006259168,0.0000057811294,7.468931e-9,0.0000012227017,0.7386149,0.00034340913],"about_ca_topic_score_codex":0.00036796005,"about_ca_topic_score_gemma":0.008277384,"teacher_disagreement_score":0.73851407,"about_ca_system_score_codex":0.00089451636,"about_ca_system_score_gemma":0.00084872515,"threshold_uncertainty_score":0.9996703},"labels":[],"label_agreement":null},{"id":"W2093544818","doi":"10.2147/ott.s30238","title":"Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ovarian cancer; Olaparib; Oncology; Internal medicine; Chemotherapy; Systemic therapy; Bevacizumab; Clinical trial; Cancer; Polymerase; Breast cancer; Poly ADP ribose polymerase","score_opus":0.027344287524817407,"score_gpt":0.30800633036633196,"score_spread":0.2806620428415145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093544818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91917783,0.07195792,0.00019249291,0.0044363923,0.0005246282,0.0032644514,0.00017372768,0.000058814385,0.00021373683],"genre_scores_gemma":[0.8468859,0.14539923,0.0006683791,0.00039615907,0.00048759204,0.005850371,0.000032641325,0.000041180858,0.00023854314],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878436,0.000036308746,0.00022879051,0.00039525115,0.00017727652,0.00037801554],"domain_scores_gemma":[0.9991586,0.0000625076,0.00012344409,0.00022698566,0.00019365935,0.00023480336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010808248,0.00026437914,0.00042930915,0.000063261694,0.00016578636,0.00006045929,0.000059786318,0.00005852099,0.00048688427],"category_scores_gemma":[0.0000032426067,0.00015793595,0.00007378697,0.00010412115,0.0000618192,0.0000913519,0.000009276966,0.00011459394,0.000013347212],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016247589,0.0011406159,0.044879198,0.000110020155,0.0008768361,0.0000041922144,0.0027716581,0.000006017317,0.0011346331,0.0012354682,0.0014559777,0.9447606],"study_design_scores_gemma":[0.03411679,0.009426905,0.5048835,0.0010089746,0.00011759781,0.00002613863,0.00062604266,0.00027788477,0.0014201785,0.0025384903,0.44486737,0.0006900901],"about_ca_topic_score_codex":0.00023446945,"about_ca_topic_score_gemma":0.000019536923,"teacher_disagreement_score":0.9440705,"about_ca_system_score_codex":0.00024576517,"about_ca_system_score_gemma":0.0001912493,"threshold_uncertainty_score":0.64404416},"labels":[],"label_agreement":null},{"id":"W2094093912","doi":"10.1016/s1074-3804(05)60052-7","title":"Frozen Section in Laparoscopic Management of Macroscopically Suspicious Ovarian Masses","year":2004,"lang":"en","type":"article","venue":"The Journal of the American Association of Gynecologic Laparoscopists","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Frozen section procedure; Adnexal mass; Malignancy; Laparoscopy; Adnexal Diseases; Radiology; Biopsy; Surgery; General surgery; Pathology","score_opus":0.007626215793076689,"score_gpt":0.27087533770908345,"score_spread":0.26324912191600675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094093912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879176,0.00016834613,0.00004561458,0.009176012,0.0005890146,0.00044987106,0.000008535936,0.000007781554,0.0007630711],"genre_scores_gemma":[0.99672866,0.0009134435,0.0015035522,0.00047242717,0.00007713726,0.0000111346035,0.0000012475834,0.00001240889,0.00027997803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801946,0.00026513287,0.00079550216,0.00012311357,0.0005570739,0.00023974362],"domain_scores_gemma":[0.9965456,0.00035539627,0.0025158862,0.00030991915,0.00021750112,0.000055677563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092779327,0.000151935,0.00071203895,0.00010665089,0.00006818618,0.00001066568,0.00030408343,0.00006628161,0.000041987783],"category_scores_gemma":[0.00026861884,0.00008603047,0.00019230935,0.00057714357,0.00017358486,0.000060162165,0.000077799035,0.0002725566,0.0000028622464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054093456,0.0012756746,0.98836786,0.00015624624,0.000817862,0.00002871338,0.00055022567,0.0015398556,0.0042492757,0.0005897721,0.0006454443,0.0012381122],"study_design_scores_gemma":[0.0041213576,0.0014627355,0.9791481,0.00043747458,0.00043927773,0.000017407343,0.0003892774,0.0000035975727,0.012571552,0.0010957752,0.00024196865,0.00007151189],"about_ca_topic_score_codex":0.00036741106,"about_ca_topic_score_gemma":0.00024869357,"teacher_disagreement_score":0.009219819,"about_ca_system_score_codex":0.0014470558,"about_ca_system_score_gemma":0.00024575595,"threshold_uncertainty_score":0.3784001},"labels":[],"label_agreement":null},{"id":"W2094305394","doi":"10.1016/j.ygyno.2007.02.022","title":"The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Oncology; Stage (stratigraphy); Internal medicine; Proportional hazards model; Neoadjuvant therapy; Hazard ratio; Surgery; Cancer; Confidence interval; Breast cancer","score_opus":0.019977366058998372,"score_gpt":0.3154018376649635,"score_spread":0.29542447160596513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094305394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953352,0.0005958528,0.000009028014,0.002049825,0.000092872266,0.0009119558,0.00002762461,0.00001341346,0.00096420443],"genre_scores_gemma":[0.9979152,0.00097048585,0.00047298003,0.00038387606,0.000033974124,0.0001062267,0.000009830487,0.000015458696,0.000091972775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842334,0.00021852358,0.0005191697,0.0003116183,0.0001762489,0.00035109423],"domain_scores_gemma":[0.9967622,0.00246617,0.0003209757,0.00021074146,0.00014770594,0.000092215654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009877702,0.00017233889,0.0006308541,0.000098579156,0.00005968887,0.000003832194,0.00008501434,0.00019520396,0.000070927366],"category_scores_gemma":[0.00012837393,0.00009928052,0.000052485622,0.00026561716,0.00035059144,0.000025418709,0.000030217383,0.00016414857,8.452091e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043960806,0.001669713,0.8216502,0.000035544275,0.00023044471,0.00043705167,0.0005020405,0.000017753175,0.0017848006,0.00011379842,0.00006442502,0.12953341],"study_design_scores_gemma":[0.014400454,0.009951739,0.9654609,0.00005879119,0.00010185829,0.000022445201,0.00010623007,0.000016502727,0.004260497,0.00003179866,0.005489718,0.00009906872],"about_ca_topic_score_codex":0.0007717605,"about_ca_topic_score_gemma":0.0015589749,"teacher_disagreement_score":0.14381069,"about_ca_system_score_codex":0.0006133543,"about_ca_system_score_gemma":0.00050144317,"threshold_uncertainty_score":0.4048542},"labels":[],"label_agreement":null},{"id":"W2094601634","doi":"10.5858/arpa.2011-0312-cr","title":"Papillary Syncytial Metaplasia of Fallopian Tube Endometriosis: A Potential Pitfall in the Diagnosis of Serous Tubal Intraepithelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Fallopian tube; Endometriosis; Metaplasia; Medicine; Serous fluid; Squamous metaplasia; Gynecology; Pathology; Epithelium","score_opus":0.014645180247587422,"score_gpt":0.2649277170786213,"score_spread":0.25028253683103385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094601634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98308784,0.012866597,0.000046493697,0.0019497997,0.00044121806,0.0006733598,0.00020652403,0.000013678724,0.0007144731],"genre_scores_gemma":[0.9955143,0.0025173791,0.00075088174,0.0005101422,0.0004803301,0.00014670427,0.00004472581,0.00002978735,0.0000057752195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971022,0.00061639206,0.0009760469,0.00033651618,0.0004959288,0.00047294388],"domain_scores_gemma":[0.9973974,0.0012345315,0.00042590598,0.0006317811,0.00012919711,0.00018117635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008163135,0.00030893736,0.0012159682,0.0005874804,0.000040480674,0.0000018280443,0.000297139,0.00014667066,0.00012404799],"category_scores_gemma":[0.00067730277,0.00019977553,0.00019619962,0.0007209944,0.001120124,0.000088234585,0.000084564716,0.00032832002,0.000002500819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090799475,0.0020406963,0.9458558,0.00042075926,0.00044186364,0.00077918015,0.010995834,0.000006284407,0.02960764,0.0016832863,0.00021457282,0.0070460956],"study_design_scores_gemma":[0.006999093,0.0034318154,0.9595888,0.0004305114,0.00117705,0.00024234998,0.0018999269,0.0000102584,0.025360731,0.00011426978,0.00059917424,0.00014599158],"about_ca_topic_score_codex":0.00027834554,"about_ca_topic_score_gemma":0.00008051307,"teacher_disagreement_score":0.013733035,"about_ca_system_score_codex":0.0000413838,"about_ca_system_score_gemma":0.00026542434,"threshold_uncertainty_score":0.81466097},"labels":[],"label_agreement":null},{"id":"W2094698614","doi":"10.1097/igc.0000000000000257","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian and Primary Peritoneal Low-Grade Serous Carcinomas","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Serous fluid; Ovarian cancer; Clear cell; Serous ovarian cancer; Oncology; Clinical trial; Serous carcinoma; Ovary; Internal medicine; Cancer; Pathology; Carcinoma","score_opus":0.06329750467361535,"score_gpt":0.40411303949501637,"score_spread":0.34081553482140103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094698614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058977614,0.98457515,0.00003595373,0.008482007,0.0037378103,0.0018434793,0.00039740102,0.00002441536,0.00031400617],"genre_scores_gemma":[0.0014134018,0.98792666,0.00096165965,0.0057680532,0.0023407503,0.0010681921,0.00009829602,0.00006771717,0.00035526234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996123,0.00024819263,0.001848675,0.00063103455,0.0006976268,0.00045147265],"domain_scores_gemma":[0.9946582,0.0017280777,0.0019269788,0.00026254592,0.001029137,0.00039507955],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072512234,0.0006576464,0.0037319595,0.00026136043,0.00008674149,0.000078269615,0.00051860994,0.00050043693,0.0014130147],"category_scores_gemma":[0.0007179834,0.0004209416,0.0013119014,0.00016051212,0.00022510895,0.00007213002,0.000180661,0.000808911,0.000009143979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025992413,0.0005957221,0.0012847157,0.022576481,0.0031938616,0.000837839,0.000021797181,0.0000027350463,0.0000022178033,0.0002048305,0.018987285,0.95203257],"study_design_scores_gemma":[0.0028880888,0.0013602377,0.0043266183,0.045606673,0.0049003223,0.0014631549,0.0000066022953,0.000007809405,0.0000028106965,0.00008694498,0.9389559,0.00039481162],"about_ca_topic_score_codex":0.00007781298,"about_ca_topic_score_gemma":0.000083134764,"teacher_disagreement_score":0.9516378,"about_ca_system_score_codex":0.0024864494,"about_ca_system_score_gemma":0.0016249415,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W2094835237","doi":"10.1148/radiol.2242911110","title":"Echogenic Ovarian Foci without Shadowing: Are They Caused by Psammomatous Calcifications?","year":2002,"lang":"en","type":"article","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Echogenicity; Medicine; Pathology; Ultrasound; Ovary; Cyst; Radiology","score_opus":0.03406515176108735,"score_gpt":0.2746163500478626,"score_spread":0.24055119828677526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094835237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9172052,0.015153321,0.00083886407,0.046876084,0.0008983369,0.0017049563,0.00019585672,0.0004819608,0.016645413],"genre_scores_gemma":[0.9954423,0.00063532573,0.00046047036,0.0013856468,0.00022570332,0.00017643928,0.00007209139,0.00003552737,0.0015665173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877393,0.000082857274,0.00026761327,0.00041519452,0.000114294686,0.0003461133],"domain_scores_gemma":[0.9990432,0.00008685776,0.00011002891,0.0005305311,0.00004580572,0.00018356738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008881444,0.0001910878,0.00044116256,0.000078099,0.00012872682,0.00001390004,0.00010441613,0.00017868397,0.00086515245],"category_scores_gemma":[0.00005224655,0.00015650586,0.00012190192,0.000114185445,0.00007015958,0.000036987232,0.00001725254,0.00016033875,0.00038346543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010297003,0.0014770699,0.7246596,0.00006485674,0.0012833595,0.0004223597,0.0013163696,0.000016838014,0.004916737,0.0037913432,0.25038525,0.011563191],"study_design_scores_gemma":[0.013450896,0.0013376769,0.7223339,0.00017090837,0.0011604755,0.0019807655,0.00033574514,0.0014676782,0.002911483,0.00086616195,0.25316232,0.00082200655],"about_ca_topic_score_codex":0.00011510091,"about_ca_topic_score_gemma":0.000047457874,"teacher_disagreement_score":0.07823707,"about_ca_system_score_codex":0.00021392111,"about_ca_system_score_gemma":0.000034921806,"threshold_uncertainty_score":0.94728124},"labels":[],"label_agreement":null},{"id":"W2094856888","doi":"10.1097/pap.0b013e3180ca8a5b","title":"Ovarian Spindle Cell Lesions","year":2007,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Pathology; Stromal cell; Mesenchymal stem cell; Biology; Medicine","score_opus":0.050453031108818484,"score_gpt":0.41131198565663296,"score_spread":0.36085895454781447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094856888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002225644,0.97657096,0.00011423526,0.00006397998,0.0008187581,0.0009095171,0.000055046763,0.000047344838,0.021397877],"genre_scores_gemma":[0.00016442602,0.99607456,0.0023427666,0.0002937775,0.00022764954,0.00023242872,0.00016071134,0.00006836388,0.00043534633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976693,0.00012732952,0.00075979566,0.00075386924,0.00015111335,0.00053858943],"domain_scores_gemma":[0.99862283,0.00022823854,0.0003040783,0.0006555882,0.000030091654,0.00015914452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029763227,0.0004594111,0.002136942,0.0005756099,0.000047205525,0.0000072741586,0.00019458753,0.00053017715,0.00021230563],"category_scores_gemma":[0.000042525833,0.00036548646,0.00040597422,0.0004971216,0.00014149662,0.000075910124,0.000081067345,0.0006372501,0.0003377885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001197165,0.0003506929,0.00028366613,0.0035732123,0.000034453882,0.0038953358,0.000023779989,6.100385e-7,1.9664319e-7,0.0012047513,0.000165455,0.99045587],"study_design_scores_gemma":[0.0011457194,0.00018488166,0.00013989767,0.0050568446,0.00055997993,0.0008068233,0.000016755608,0.0000012226336,0.0000050994313,0.0002675425,0.9915344,0.00028079675],"about_ca_topic_score_codex":0.00002229535,"about_ca_topic_score_gemma":0.00008269769,"teacher_disagreement_score":0.991369,"about_ca_system_score_codex":0.0005413298,"about_ca_system_score_gemma":0.0004451518,"threshold_uncertainty_score":0.9998797},"labels":[],"label_agreement":null},{"id":"W2095085832","doi":"10.1016/j.ajog.2014.01.003","title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","year":2014,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Child and Family Research Institute; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Tubal ligation; Salpingectomy; Hysterectomy; Perioperative; Odds ratio; Laparotomy; Sterilization (economics); Gynecology; Obstetrics; Retrospective cohort study; Confidence interval; Population; Surgery; Pregnancy; Family planning; Internal medicine; Research methodology","score_opus":0.0943138277105313,"score_gpt":0.35573599688129914,"score_spread":0.2614221691707678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095085832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690705,0.0040487414,0.014029977,0.011210538,0.00048586243,0.0005744572,0.00010141679,0.0000068878276,0.00047163558],"genre_scores_gemma":[0.9899091,0.0028099515,0.006577899,0.0005848327,0.00005114136,0.000031267664,0.000010304109,0.000009069727,0.000016404303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992763,0.000052748965,0.00034882384,0.000121323894,0.00008861518,0.00011222444],"domain_scores_gemma":[0.99626964,0.0025113872,0.00066008035,0.000084074556,0.00034364354,0.00013117323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019766302,0.00008288091,0.0004229303,0.00017978654,0.00005412945,0.0000067343426,0.000036184818,0.0000330451,0.000015254906],"category_scores_gemma":[0.0011360528,0.00006774963,0.000068271685,0.00019153417,0.00020748342,0.000034357843,0.000013376231,0.00008263344,1.5077543e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013404961,0.00048881257,0.12937659,0.00008074129,0.00058877957,0.000012292998,0.00038003107,0.000009336188,0.00009607545,0.011287924,0.00070209027,0.8568433],"study_design_scores_gemma":[0.003918259,0.005948558,0.95266265,0.000121428566,0.000619946,0.00009744481,0.00032762965,0.00030199307,0.0000281509,0.0023429722,0.033543903,0.0000870387],"about_ca_topic_score_codex":0.000043485685,"about_ca_topic_score_gemma":0.000013030109,"teacher_disagreement_score":0.8567562,"about_ca_system_score_codex":0.000077505036,"about_ca_system_score_gemma":0.00023746291,"threshold_uncertainty_score":0.27627498},"labels":[],"label_agreement":null},{"id":"W2095340292","doi":"10.1097/pgp.0b013e31824c2372","title":"Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Calgary Laboratory Services; University of Calgary; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Psammoma body; Debulking; Serous fluid; Nuclear atypia; Pathology; Chemotherapy; Medicine; Serous carcinoma; Ovarian carcinoma; Ovarian cancer; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.024528468208078025,"score_gpt":0.29876785027931807,"score_spread":0.27423938207124005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095340292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913537,0.0004421279,0.00056626514,0.0050098775,0.002074395,0.00012150456,0.000034065913,0.000008895142,0.00038918672],"genre_scores_gemma":[0.99561644,0.000076712204,0.0024478002,0.00093317305,0.0008449384,0.000008194666,0.0000152030125,0.000011225452,0.000046322697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984975,0.00012641095,0.000598819,0.00013463046,0.00037911162,0.00026351516],"domain_scores_gemma":[0.9984681,0.00036502132,0.00045286014,0.00013010357,0.00039731455,0.00018658536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030989468,0.00014537199,0.00047557187,0.00019174421,0.000020350806,0.000008104251,0.00022442281,0.00013819987,0.00095281756],"category_scores_gemma":[0.00033328144,0.0000969297,0.00022050756,0.00007116285,0.00008633274,0.000084379,0.00007838172,0.00029800125,0.000019356807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037942533,0.0014712923,0.97656274,0.000013003811,0.00034210645,0.002247733,0.00023980167,0.0000240464,0.0022363763,0.0021975471,0.00023309066,0.0140528325],"study_design_scores_gemma":[0.0032116058,0.0015326208,0.9843713,0.000038846818,0.00014647946,0.0064173983,0.000051242037,0.00000544169,0.0027737836,0.0005718073,0.00080005964,0.00007941938],"about_ca_topic_score_codex":0.000054391963,"about_ca_topic_score_gemma":0.000009554291,"teacher_disagreement_score":0.013973413,"about_ca_system_score_codex":0.00020294634,"about_ca_system_score_gemma":0.00008609235,"threshold_uncertainty_score":0.9999604},"labels":[],"label_agreement":null},{"id":"W2095420209","doi":"10.1111/j.1525-1438.2006.00274.x","title":"Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Northern Cancer Care and Research Society; Cancer Research Society","keywords":"Cell culture; Programmed cell death; Luteinizing hormone; DNA synthesis; Cell growth; Follicle-stimulating hormone; Biology; Immortalised cell line; Cell; Epithelium; Internal medicine; Hormone; Endocrinology; In vitro; Cell biology; Medicine; Apoptosis; Biochemistry; Genetics","score_opus":0.019403038388312185,"score_gpt":0.27699915445766043,"score_spread":0.25759611606934824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095420209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914438,0.00071578915,0.00007575421,0.00612542,0.0005132787,0.00020249945,0.000058011738,0.000010063895,0.0008553913],"genre_scores_gemma":[0.9975028,0.00063085504,0.00075439416,0.00032061816,0.00061454537,0.000031175452,0.000006143508,0.000012337961,0.00012712149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875474,0.000065353444,0.0004492373,0.0001979009,0.00037519974,0.00015754894],"domain_scores_gemma":[0.9991171,0.00023619854,0.00027898705,0.000071220544,0.00020316063,0.00009335297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015730932,0.0001392737,0.00032830736,0.000107890424,0.000036734073,0.00003644262,0.00011610208,0.00010787554,0.0011928438],"category_scores_gemma":[0.00008605816,0.000100894045,0.0000999938,0.00006161595,0.00004273106,0.00008069479,0.000031684092,0.00022931445,0.000005167334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022880586,0.0033358452,0.8919691,0.00004411949,0.00073611096,0.017810948,0.0002016034,0.002066481,0.05579057,0.0009484493,0.00066093414,0.02414779],"study_design_scores_gemma":[0.0024907626,0.0004491077,0.9820682,0.00015863446,0.00011902508,0.00031678955,0.00001795308,0.000110830035,0.010205481,0.001317439,0.0026340336,0.000111744695],"about_ca_topic_score_codex":0.0026566552,"about_ca_topic_score_gemma":0.0012973804,"teacher_disagreement_score":0.09009911,"about_ca_system_score_codex":0.0007824977,"about_ca_system_score_gemma":0.00012268839,"threshold_uncertainty_score":0.9997202},"labels":[],"label_agreement":null},{"id":"W2095459904","doi":"10.1016/j.ygyno.2005.07.008","title":"Who should operate on patients with ovarian cancer? An evidence-based review","year":2005,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cochrane Library; Specialty; MEDLINE; Ovarian cancer; Gynecologic oncology; Disease; Stage (stratigraphy); Evidence-based medicine; Internal medicine; Confounding; Oncology; Intensive care medicine; Surgery; Gynecology; General surgery; Cancer; Family medicine; Meta-analysis; Alternative medicine; Pathology","score_opus":0.19397694325257508,"score_gpt":0.4469568336005771,"score_spread":0.252979890348002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095459904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047774327,0.98227215,0.000002167009,0.0069621494,0.00064717967,0.0066317027,0.00016978089,0.00012375436,0.0031433587],"genre_scores_gemma":[0.00006546402,0.9696793,0.0007491298,0.022582639,0.0005850439,0.005125523,0.00059651735,0.000115396826,0.0005009883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517155,0.00093346246,0.0011089526,0.0014710343,0.0005220435,0.0007929637],"domain_scores_gemma":[0.99574,0.0012839667,0.00088013906,0.0012365029,0.00035115224,0.0005082609],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006613354,0.001014519,0.0052039535,0.0002672394,0.00016998751,0.00003604431,0.00044206594,0.00097009016,0.0051736],"category_scores_gemma":[0.00040199843,0.00059134094,0.0005375711,0.0006045997,0.00017465922,0.00014674819,0.00007757716,0.0009888975,0.00037805492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015254878,0.00244891,0.0011296393,0.014176826,0.0005296893,0.0003646694,0.000009065223,0.000008846921,6.534968e-9,0.00010182977,0.00954004,0.97153795],"study_design_scores_gemma":[0.002762713,0.014092507,0.003505145,0.11010232,0.00689556,0.000021704473,0.0000025370134,0.000003014801,2.416633e-7,0.000001942852,0.8620944,0.0005178883],"about_ca_topic_score_codex":0.00009727593,"about_ca_topic_score_gemma":0.00034310494,"teacher_disagreement_score":0.97102004,"about_ca_system_score_codex":0.004347961,"about_ca_system_score_gemma":0.0051409677,"threshold_uncertainty_score":0.9996538},"labels":[],"label_agreement":null},{"id":"W2095762335","doi":"10.1007/s12022-007-0022-8","title":"Follicular Variant Papillary Thyroid Carcinoma Arising in Struma Ovarii","year":2007,"lang":"en","type":"article","venue":"Endocrine Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Struma ovarii; Pathology; Thyroid carcinoma; Thyroid; Immunohistochemistry; PAX8; Malignancy; Medicine; Malignant transformation; Ovarian Teratoma; V600E; Biology; Teratoma; Mutation; Internal medicine; Gene","score_opus":0.013547286130819139,"score_gpt":0.2831642782974174,"score_spread":0.2696169921665983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095762335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832423,0.0033328922,0.0007721242,0.002413881,0.00043010083,0.00045824764,0.0000098515675,0.00006711733,0.009273506],"genre_scores_gemma":[0.9941975,0.00021794318,0.0038801264,0.0010569603,0.0003087729,0.000039654216,0.0000479021,0.000036764028,0.00021436188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981273,0.00007124312,0.00044925182,0.00050236273,0.00019291771,0.00065691443],"domain_scores_gemma":[0.9990886,0.00011767522,0.000086568776,0.0004892294,0.000047758578,0.00017017432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034945185,0.00023822938,0.0004918571,0.0002791825,0.000060187325,0.000011645434,0.00008567084,0.00009780316,0.00025673772],"category_scores_gemma":[0.00007354103,0.00020739205,0.00012590355,0.00029610094,0.00006542,0.00005172937,0.00008321081,0.00029302418,0.00006976328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041103232,0.0009692165,0.8010622,0.00007045933,0.00012305164,0.15411016,0.00053908466,0.000017850965,0.0077182427,0.007380018,0.00087401253,0.02672462],"study_design_scores_gemma":[0.005926385,0.00093102606,0.9631692,0.000064108404,0.00012797429,0.007852258,0.00016059364,0.000042811545,0.011061679,0.0006585725,0.009767092,0.00023828824],"about_ca_topic_score_codex":0.00048067738,"about_ca_topic_score_gemma":0.00021787382,"teacher_disagreement_score":0.16210696,"about_ca_system_score_codex":0.00023433284,"about_ca_system_score_gemma":0.00009725551,"threshold_uncertainty_score":0.84572023},"labels":[],"label_agreement":null},{"id":"W2095936660","doi":"10.1038/ng.3185","title":"Identification of six new susceptibility loci for invasive epithelial ovarian cancer","year":2015,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University Health Network; University of Toronto; Université Laval; BC Cancer Agency; McGill University; Simon Fraser University; Women's College Hospital; Centre hospitalier universitaire de Québec","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Francis Crick Institute; Cancer Research UK; Wellcome Trust","keywords":"Biology; Identification (biology); Epithelial ovarian cancer; Ovarian cancer; Genetics; Computational biology; Cancer","score_opus":0.05529373860324408,"score_gpt":0.38667156070573094,"score_spread":0.33137782210248684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095936660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007768779,0.9936934,0.00008526185,0.00033239147,0.0011699876,0.0030729326,0.0014727163,0.00001860361,0.0000770173],"genre_scores_gemma":[0.0007392353,0.9936528,0.0016945455,0.00010020959,0.0018069303,0.00030474458,0.00077881076,0.000071905495,0.0008507891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793774,0.000058237907,0.000787792,0.0005891898,0.00038694305,0.00024009212],"domain_scores_gemma":[0.99754083,0.00014089256,0.00066620944,0.00080064597,0.00062214053,0.00022930112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030826326,0.00037452762,0.0015607225,0.0001201964,0.000032896252,0.000019712263,0.00020443343,0.0010611701,0.000089722496],"category_scores_gemma":[0.00023708203,0.0002879579,0.00054659054,0.00027627914,0.000057325055,0.00001918839,0.00004824254,0.00046843762,0.000015537957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048778147,0.0002027238,0.00030449976,0.014346107,0.0007047684,0.0000043991026,0.00008850576,0.0000028463146,0.000012070235,0.0000809064,0.024014931,0.96018946],"study_design_scores_gemma":[0.0014032864,0.00028076902,0.00050580694,0.003272408,0.0057016253,0.000009030691,0.000008506489,0.0000029851635,0.0005877105,0.00029229687,0.98770964,0.000225912],"about_ca_topic_score_codex":0.00007136474,"about_ca_topic_score_gemma":0.0002790521,"teacher_disagreement_score":0.96369475,"about_ca_system_score_codex":0.00060236425,"about_ca_system_score_gemma":0.0039200834,"threshold_uncertainty_score":0.99995726},"labels":[],"label_agreement":null},{"id":"W2097105130","doi":"10.1093/jnci/92.9.699","title":"Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results","year":2000,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1023,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Regimen; Medicine; Cyclophosphamide; Paclitaxel; Internal medicine; Oncology; Randomized controlled trial; Cisplatin; Proportional hazards model; Chemotherapy; Clinical endpoint; Chemotherapy regimen; Gynecologic oncology; Surgery","score_opus":0.029400078032254407,"score_gpt":0.32156454280446495,"score_spread":0.29216446477221053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097105130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512113,0.00072216056,0.00002027905,0.0053069033,0.0029825598,0.0012224694,0.00028174522,0.000008706918,0.0043340363],"genre_scores_gemma":[0.9944788,0.0020998665,0.0011829926,0.00039254403,0.0012461997,0.00025729273,0.0000065104346,0.000025625584,0.00031012073],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967441,0.00011826136,0.0012908764,0.0002711859,0.0012743706,0.0003012194],"domain_scores_gemma":[0.9976115,0.00040233578,0.0010358328,0.00022276555,0.0005729524,0.00015461583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001140376,0.00026647202,0.0010243508,0.00020868985,0.000088776396,0.000023598946,0.00028443275,0.00010457454,0.00044415393],"category_scores_gemma":[0.00050993677,0.00016010013,0.00029802916,0.000535173,0.00026432227,0.0003293517,0.00003217704,0.00043602116,0.0000036839458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9564976,0.00045338928,0.00083322683,0.00003695288,0.0009675906,0.00003595282,0.0005617787,0.010894191,0.000105642495,0.0005520335,0.0004740654,0.02858757],"study_design_scores_gemma":[0.96279925,0.0017720372,0.021544764,0.0014217843,0.00039519332,0.000035616165,0.000044218363,0.00013716314,0.00088519766,0.0007286122,0.010038762,0.00019741568],"about_ca_topic_score_codex":0.0007643176,"about_ca_topic_score_gemma":0.0012768545,"teacher_disagreement_score":0.028390156,"about_ca_system_score_codex":0.0017262836,"about_ca_system_score_gemma":0.0018771825,"threshold_uncertainty_score":0.6528694},"labels":[],"label_agreement":null},{"id":"W2097327234","doi":"10.1158/1541-7786.mcr-12-0395","title":"Microenvironmental Regulation of <i>BRCA1</i> Gene Expression by c-Jun and Fra2 in Premalignant Human Ovarian Surface Epithelial Cells","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Biology; Cancer research; AP-1 transcription factor; Ovarian cancer; Ovarian carcinoma; Transcription factor; Promoter; Metastasis; Gene expression; Gene; Regulation of gene expression; Cell culture; Transcription (linguistics); Cancer; Genetics","score_opus":0.02046637980987152,"score_gpt":0.3102767822908207,"score_spread":0.28981040248094914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097327234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943947,0.002718371,0.00006433655,0.0012220814,0.00003466706,0.001178084,0.000058212,0.000007734652,0.00032179581],"genre_scores_gemma":[0.99784935,0.0006266727,0.00076251366,0.00008201085,0.000032349908,0.0002065718,0.000045196175,0.00003402088,0.00036131215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981589,0.00017556184,0.0002806193,0.0004393868,0.0005770204,0.00036854955],"domain_scores_gemma":[0.99933463,0.000026322903,0.000063913256,0.00035362484,0.00006562772,0.00015585434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003068255,0.00014702539,0.0002699852,0.0001071729,0.00007821057,0.000028056838,0.00008919434,0.00010310688,0.00056020974],"category_scores_gemma":[0.000006876171,0.00012686758,0.00005044442,0.00018349565,0.00016651597,0.00007383789,0.000113142865,0.00020408857,0.000017405711],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006917634,0.00034566983,0.0135053005,0.00007997543,0.000040623152,0.00003094134,0.00023175673,0.00005997172,0.98288655,0.000037704423,0.001730734,0.0009816035],"study_design_scores_gemma":[0.0023141021,0.0002770699,0.06586322,0.00021480242,0.000019884239,0.0000036457839,0.000059274204,0.00006826217,0.93021333,0.00013046675,0.00073711824,0.00009883199],"about_ca_topic_score_codex":0.0045789126,"about_ca_topic_score_gemma":0.000050770464,"teacher_disagreement_score":0.05267322,"about_ca_system_score_codex":0.00029952516,"about_ca_system_score_gemma":0.000073748844,"threshold_uncertainty_score":0.6921977},"labels":[],"label_agreement":null},{"id":"W2097672752","doi":"10.1016/j.ygyno.2009.03.035","title":"Sentinel lymph node biopsy in patients with gynecologic cancers","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Université Laval","funders":"","keywords":"Medicine; Sentinel lymph node; Sentinel node; Biopsy; Gynecologic oncology; General surgery; Radiology; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.012429742027722025,"score_gpt":0.27515708508095515,"score_spread":0.26272734305323314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097672752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654345,0.00016085691,0.000008242,0.0070916796,0.000357209,0.0007782007,0.000011322273,0.00010461982,0.02605338],"genre_scores_gemma":[0.9895945,0.00010210958,0.0018626384,0.007776203,0.000085717795,0.0001832213,0.00007419812,0.000017838813,0.00030357204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790424,0.00010957686,0.00042639257,0.0006334636,0.0002256155,0.00070070295],"domain_scores_gemma":[0.998797,0.00028606062,0.00020613894,0.00038043613,0.00012677757,0.00020360072],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020939062,0.0003144534,0.00077828806,0.00021875519,0.00008713099,0.000013643644,0.00014216897,0.00034243183,0.0010438006],"category_scores_gemma":[0.00016853536,0.00022009642,0.000097041324,0.0004567851,0.00013297642,0.00007175072,0.000040626222,0.0002455418,0.00013189255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005273481,0.0027014455,0.96089363,0.000014645489,0.00008686454,0.00068142277,0.0000611287,0.00010386649,0.000019396093,0.00023580312,0.00084406964,0.0338304],"study_design_scores_gemma":[0.014212601,0.0029444324,0.9784349,0.000034637324,0.00015098874,0.00003155593,0.00006385048,0.000040190273,0.000025910653,0.00021712892,0.003606542,0.00023721371],"about_ca_topic_score_codex":0.000115095696,"about_ca_topic_score_gemma":0.00007515498,"teacher_disagreement_score":0.03359319,"about_ca_system_score_codex":0.003082355,"about_ca_system_score_gemma":0.000755684,"threshold_uncertainty_score":0.9998694},"labels":[],"label_agreement":null},{"id":"W2097783842","doi":"10.1155/2014/367103","title":"Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites","year":2014,"lang":"en","type":"article","venue":"BioMed Research International","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Hospital for Sick Children; Princess Margaret Cancer Centre; SickKids Foundation; University of Toronto; University Health Network; Trillium Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Ascites; Ovarian cancer; Serous fluid; Medicine; Immune system; Downregulation and upregulation; Tissue microarray; Cancer; Oncology; Pathology; Immunohistochemistry; Cancer research; Internal medicine; Gastroenterology; Biology; Immunology; Gene","score_opus":0.08267920702224267,"score_gpt":0.4355120337656084,"score_spread":0.3528328267433657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097783842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880422,0.00015362386,0.00025444283,0.009679054,0.0008441735,0.0004582016,0.000056513076,0.000024281677,0.00048751003],"genre_scores_gemma":[0.9936066,0.00013454948,0.005014574,0.000059026934,0.0006154562,0.00010944466,0.000074578784,0.00002577262,0.00035997256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763805,0.00016363457,0.00040677353,0.0004283937,0.0010338424,0.00032931042],"domain_scores_gemma":[0.99848336,0.00041891017,0.00012136926,0.0002665094,0.00049666397,0.00021317003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096824707,0.00013335922,0.00031346313,0.00029105213,0.00007203396,0.00005615981,0.0001784431,0.0000934956,0.00015733307],"category_scores_gemma":[0.00048615132,0.00009869538,0.00007141561,0.0002656282,0.00032329865,0.0000805066,0.00015177978,0.00029134136,0.000010860963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010775957,0.0007036229,0.9792176,0.00015328178,0.0012046843,0.00011139981,0.000042195923,0.00003090432,0.0018824146,0.0074338256,0.00044459853,0.0076979115],"study_design_scores_gemma":[0.013232001,0.0013410433,0.96051896,0.00031492134,0.00014723546,0.000015494332,0.000056052453,0.0036105537,0.016751653,0.0003218752,0.003507584,0.00018263672],"about_ca_topic_score_codex":0.0017857956,"about_ca_topic_score_gemma":0.000092908376,"teacher_disagreement_score":0.018698616,"about_ca_system_score_codex":0.0001770216,"about_ca_system_score_gemma":0.00016412188,"threshold_uncertainty_score":0.4024681},"labels":[],"label_agreement":null},{"id":"W2098099565","doi":"10.1200/jco.2005.02.028","title":"Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women With Relapsed Epithelial Ovarian Cancer: A Trial of the National Cancer Institute of Canada Clinical Trials Group","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Clinical trial; Randomized controlled trial; Epithelial ovarian cancer; Cancer; Oncology; Internal medicine; Gynecology","score_opus":0.09511183689925354,"score_gpt":0.44645178394527024,"score_spread":0.3513399470460167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098099565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683469,0.00039020582,0.000010965153,0.022028184,0.006530418,0.0023565441,0.00013569892,0.0000019170095,0.00019918926],"genre_scores_gemma":[0.99161136,0.0013358431,0.0009827134,0.0008618142,0.004999808,0.00014757652,0.000001292548,0.000018771821,0.000040808973],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9847327,0.0042985454,0.009091266,0.00028136445,0.0012890279,0.00030708683],"domain_scores_gemma":[0.97946924,0.009046,0.0100126825,0.00032618837,0.0008749012,0.00027097878],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020415192,0.0002466246,0.0055717183,0.00015110166,0.000046243345,0.000004686945,0.0003996005,0.00039264682,0.00015729229],"category_scores_gemma":[0.017070932,0.00011937697,0.0012146733,0.0003927593,0.0011186864,0.00009954643,0.00008017086,0.001079094,1.2639734e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.937385,0.0068219574,0.004100505,0.000055229073,0.0024498445,0.000022881426,0.00020698464,0.0006260816,0.0001673723,0.00084207504,0.0002995582,0.047022466],"study_design_scores_gemma":[0.95974493,0.0138695305,0.017795876,0.0007456915,0.0013678658,0.000018055673,0.00006339891,0.000059766102,0.0011669458,0.00036012658,0.004702288,0.000105524465],"about_ca_topic_score_codex":0.034757797,"about_ca_topic_score_gemma":0.16201998,"teacher_disagreement_score":0.12726219,"about_ca_system_score_codex":0.00097514485,"about_ca_system_score_gemma":0.027955823,"threshold_uncertainty_score":0.9912087},"labels":[],"label_agreement":null},{"id":"W2098427446","doi":"10.1093/annonc/mdq383","title":"Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"BC Cancer Agency; Eli Lilly Canada","keywords":"Medicine; Serous fluid; Ovarian cancer; Radiation therapy; Stage (stratigraphy); Oncology; Cohort; Internal medicine; Population; Disease; Adjuvant therapy; Debulking; Adjuvant; Chemotherapy; Cancer; Surgery","score_opus":0.05624276589817073,"score_gpt":0.3594123704605975,"score_spread":0.30316960456242675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098427446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9145411,0.0027861602,0.00015622935,0.06907822,0.0011342068,0.00088631635,0.0000822675,0.000011584664,0.011323881],"genre_scores_gemma":[0.9970976,0.00093459786,0.0004158525,0.0011853899,0.00017763296,0.000036585297,0.0000061313895,0.000010196477,0.00013598563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917233,0.000087324406,0.0002961242,0.00013554166,0.00016491223,0.00014378643],"domain_scores_gemma":[0.9987828,0.00024096483,0.00031559347,0.00037542506,0.00023887442,0.000046313366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033609572,0.000090251866,0.0003701258,0.000040732608,0.000041534473,0.0000016252767,0.00014478032,0.00009608313,0.00044687852],"category_scores_gemma":[0.00005619278,0.00004719697,0.000125348,0.00012140037,0.0004705141,0.000025640818,0.00002062147,0.00016510532,0.000001188451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068752426,0.0045424304,0.042375647,0.0003141093,0.0065737856,0.000112359085,0.022815384,0.00041673472,0.13957755,0.0694999,0.17181085,0.535086],"study_design_scores_gemma":[0.005154053,0.009913027,0.285098,0.00007895094,0.00047712287,0.000065163826,0.00041417437,0.00020236381,0.053997956,0.0011805937,0.64329785,0.000120753604],"about_ca_topic_score_codex":0.0057853106,"about_ca_topic_score_gemma":0.00079772447,"teacher_disagreement_score":0.5349652,"about_ca_system_score_codex":0.00004448806,"about_ca_system_score_gemma":0.0006502577,"threshold_uncertainty_score":0.8745697},"labels":[],"label_agreement":null},{"id":"W2098739456","doi":"10.1158/1078-0432.ccr-08-1291","title":"Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Loss of heterozygosity; Uniparental disomy; Serous fluid; Biology; Ovarian cancer; Genome instability; Genetics; Gene duplication; Cancer research; Allele; Cancer; Chromosome; Gene; DNA damage; DNA; Karyotype","score_opus":0.21731051445294747,"score_gpt":0.46542768542570057,"score_spread":0.2481171709727531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098739456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331385,0.0021102116,0.0000020125476,0.0029154632,0.000115146286,0.0006203181,0.000061001225,0.000014715923,0.0008472804],"genre_scores_gemma":[0.9941372,0.005030723,0.000043903976,0.00017346471,0.00014571825,0.00011545994,0.00003143321,0.000023620276,0.0002984436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973369,0.0003842425,0.0006592059,0.0005289092,0.00058943836,0.00050126406],"domain_scores_gemma":[0.99807787,0.0008440379,0.000097231896,0.00038712847,0.00023909667,0.0003546088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012501079,0.0001477524,0.00064767955,0.00017823577,0.00011955616,0.000010976171,0.00014186883,0.00017829312,0.00026005082],"category_scores_gemma":[0.0005079419,0.00012544406,0.00013880494,0.00051894126,0.0008097266,0.000060337927,0.00018648728,0.00067794515,0.00001286399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058166013,0.0013083917,0.9954553,0.00006859717,0.00014654375,0.00046800563,0.00034317534,0.0000024546998,0.00005770745,0.00003791635,0.00033627314,0.0011939502],"study_design_scores_gemma":[0.0059874216,0.0008835883,0.9911651,0.00017255738,0.000038248476,0.000014116166,0.000052196916,0.000020472839,0.00021564492,0.00009540375,0.0012524828,0.00010279347],"about_ca_topic_score_codex":0.005266155,"about_ca_topic_score_gemma":0.0022317052,"teacher_disagreement_score":0.005405762,"about_ca_system_score_codex":0.0005035269,"about_ca_system_score_gemma":0.0006143722,"threshold_uncertainty_score":0.79608864},"labels":[],"label_agreement":null},{"id":"W2099331063","doi":"10.1093/aje/kwn318","title":"Cancer Risk After Exposure to Treatments for Ovulation Induction","year":2008,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mailman School of Public Health, Columbia University; National Human Genome Research Institute; National Institute of Mental Health; National Cancer Institute; School of Medicine, New York University; National Institutes of Health; Department of Psychiatry, Columbia University; Hebrew University of Jerusalem; York University","keywords":"Medicine; Hazard ratio; Ovulation; Cancer; Ovulation induction; Confidence interval; Gynecology; Population; Obstetrics; Proportional hazards model; Breast cancer; Cohort; Cohort study; Internal medicine; Oncology; Hormone","score_opus":0.05358387543495107,"score_gpt":0.36987065675020714,"score_spread":0.31628678131525606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099331063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849662,0.0014993676,0.004203813,0.008602027,0.00038421756,0.0002809779,0.0000297983,0.0000062249346,0.00002732989],"genre_scores_gemma":[0.97177935,0.0025407437,0.022551559,0.0022204726,0.000662133,0.00013663717,0.000006247576,0.000015090002,0.00008778036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881256,0.00019354296,0.0005248716,0.00017332962,0.00007799254,0.00021769975],"domain_scores_gemma":[0.99833727,0.0005028797,0.0006250251,0.00014220715,0.00018327324,0.00020931973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004221863,0.00011906152,0.0006535676,0.00013848997,0.000055608023,0.0000011403823,0.000035979192,0.000046124456,0.000089556765],"category_scores_gemma":[0.0005684311,0.0000822452,0.00020051327,0.00014335898,0.00010214908,0.000051455547,0.0000069326775,0.00011433716,0.0000067587216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012943004,0.00015821368,0.87966347,0.0000033941021,0.0005493076,0.000029844317,0.0002789898,0.00043705362,0.00004918629,0.000019310635,0.0031461152,0.11437084],"study_design_scores_gemma":[0.0016969172,0.007285888,0.97945476,0.00005709139,0.00050083915,0.00032837782,0.000063498395,0.000017622797,0.00010751189,0.00017944194,0.010238275,0.0000697928],"about_ca_topic_score_codex":0.0004844118,"about_ca_topic_score_gemma":0.000025402434,"teacher_disagreement_score":0.11430105,"about_ca_system_score_codex":0.0002862091,"about_ca_system_score_gemma":0.00012687719,"threshold_uncertainty_score":0.3353862},"labels":[],"label_agreement":null},{"id":"W2100674628","doi":"10.1371/journal.pone.0022469","title":"Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôtel-Dieu de Québec","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian cancer; Oncology; Gene signature; Internal medicine; Cancer research; Medicine; Ovarian carcinoma; Tissue microarray; Biology; Gene expression profiling; Cancer; Gene; Gene expression","score_opus":0.06805918831649078,"score_gpt":0.23368578912301605,"score_spread":0.16562660080652525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100674628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935082,0.0012877891,0.000015424208,0.0005084601,0.00006132675,0.0009823242,0.000025177325,0.00008066729,0.0035306236],"genre_scores_gemma":[0.97242373,0.00007243324,0.026233682,0.0006375084,0.00009864776,0.00028158812,0.000057433746,0.00004789861,0.00014709808],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985974,0.000044553843,0.00031582397,0.00042253375,0.00025711686,0.0003625642],"domain_scores_gemma":[0.99915594,0.000037895246,0.00008612502,0.00047029887,0.0000822386,0.00016751498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001205467,0.00020971731,0.0004437663,0.00013472616,0.000045142016,0.000008560877,0.00008524831,0.00010624415,0.0002807714],"category_scores_gemma":[0.000034453093,0.0001902497,0.00009255575,0.00023112213,0.000033990207,0.0000615726,0.000025685293,0.00019011956,0.00009182276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007607968,0.007967664,0.8260162,0.0004013166,0.00033388677,0.00090032,0.0006665486,0.0000024050214,0.15819794,0.00012311546,0.00001835112,0.0046114745],"study_design_scores_gemma":[0.005935792,0.00093304575,0.25516778,0.00058591046,0.00027208624,0.000008776359,0.00008727775,0.00010537837,0.7365425,0.00007127659,0.00007329971,0.00021687763],"about_ca_topic_score_codex":0.00023675847,"about_ca_topic_score_gemma":0.00007350242,"teacher_disagreement_score":0.5783446,"about_ca_system_score_codex":0.00027466196,"about_ca_system_score_gemma":0.0003085767,"threshold_uncertainty_score":0.7758158},"labels":[],"label_agreement":null},{"id":"W2101016194","doi":"10.1016/j.jpag.2008.06.002","title":"Virilizing Luteinized Thecoma of the Ovary in a 15-Year-Old Female: A Case Report","year":2009,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital","funders":"","keywords":"Medicine; Virilization; hirsutism; Hyperandrogenism; Amenorrhea; Polycystic ovary; Gynecology; Androgen Excess; Ovary; Androgen; Testosterone (patch); Polycystic ovarian disease; Internal medicine; Obesity; Pregnancy; Hormone","score_opus":0.017053653728303014,"score_gpt":0.2813014034924913,"score_spread":0.26424774976418824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101016194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922832,0.0030112884,0.0000128247275,0.003815357,0.00036560357,0.00024290771,0.000002394962,0.0000036483443,0.00026274135],"genre_scores_gemma":[0.9963896,0.0017765509,0.00038912965,0.0008503613,0.00049555406,0.000001837772,5.2452214e-7,0.000007425294,0.00008901516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998703,0.00008477827,0.0007037674,0.00014567324,0.00017331928,0.000189484],"domain_scores_gemma":[0.9988326,0.00016286247,0.0006073104,0.00018464754,0.00010185247,0.000110735826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044763435,0.000121120596,0.00047900615,0.00018133162,0.000039823342,0.0000063351727,0.00006550443,0.00010044317,0.000058208785],"category_scores_gemma":[0.0002787568,0.00007460578,0.00016696409,0.00025385397,0.00003899591,0.000048698206,0.000031435844,0.0003059603,9.3384693e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003241481,0.0012425625,0.94857574,0.00008468589,0.00006402084,0.04132877,0.00017106962,0.000006307089,0.00007954158,0.000088815505,0.0031369152,0.0048974156],"study_design_scores_gemma":[0.005208694,0.0008755677,0.9596913,0.00009936497,0.00043790662,0.032678362,0.00021209447,0.000010716368,0.00010508365,0.00012715645,0.00048236173,0.00007137954],"about_ca_topic_score_codex":0.000012649706,"about_ca_topic_score_gemma":0.000016249498,"teacher_disagreement_score":0.011115564,"about_ca_system_score_codex":0.00010127884,"about_ca_system_score_gemma":0.0002515046,"threshold_uncertainty_score":0.30423355},"labels":[],"label_agreement":null},{"id":"W2101034600","doi":"10.1158/1940-6207.capr-11-0547","title":"Allelic Transcripts Dosage Effect in Morphologically Normal Ovarian Cells from Heterozygous Carriers of a <i>BRCA1</i> / <i>2</i> French Canadian Founder Mutation","year":2012,"lang":"en","type":"article","venue":"Cancer Prevention Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Biology; Allele; Carcinogenesis; Penetrance; Transcriptome; BRCA2 Protein; Cancer research; Mutation; Genetics; Cancer; Gene; Phenotype; Germline mutation; Gene expression","score_opus":0.05817017273541116,"score_gpt":0.3710362515853643,"score_spread":0.31286607884995316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101034600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896926,0.0034080073,0.00019376328,0.001165863,0.00045425267,0.0015919656,0.00015984253,0.000020161047,0.0033135093],"genre_scores_gemma":[0.9973899,0.0004274375,0.00035454234,0.00028027888,0.00021452131,0.0007831308,0.00014503821,0.00002956111,0.0003755566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717385,0.0005539007,0.00041698135,0.00040613854,0.00063469855,0.0008144074],"domain_scores_gemma":[0.9986349,0.00017758064,0.000078605146,0.0003652218,0.00016983903,0.0005738845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011691405,0.00019941175,0.00042172294,0.00038593463,0.00010982656,0.000031300606,0.00015003381,0.00020827517,0.0025784706],"category_scores_gemma":[0.0000450859,0.0001752447,0.00017542188,0.00056411827,0.00013650488,0.00019423514,0.00002817332,0.00044235215,0.00003887572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019713545,0.0028349012,0.6781711,0.0009716952,0.0014798667,0.0011010919,0.008081503,0.00045949238,0.0771369,0.00026941823,0.015529808,0.21199287],"study_design_scores_gemma":[0.008387402,0.0014642134,0.9462472,0.00058802095,0.00020567668,0.0000177367,0.00023390546,0.00010810031,0.03517438,0.00030101507,0.00698281,0.0002895116],"about_ca_topic_score_codex":0.25963297,"about_ca_topic_score_gemma":0.15033597,"teacher_disagreement_score":0.26807612,"about_ca_system_score_codex":0.00090234017,"about_ca_system_score_gemma":0.0007344488,"threshold_uncertainty_score":0.99833333},"labels":[],"label_agreement":null},{"id":"W2102306754","doi":"10.1016/s1470-2045(15)00086-8","title":"Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":867,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; University of British Columbia; Princess Margaret Cancer Centre","funders":"Wellbeing of Women; Medical Research Council; National Institute for Health and Care Research","keywords":"Bevacizumab; Medicine; Ovarian cancer; Oncology; Chemotherapy; Internal medicine; Cancer","score_opus":0.08231778117429578,"score_gpt":0.3864691238198101,"score_spread":0.3041513426455143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102306754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96464825,0.00018324978,0.0007150588,0.023824433,0.00040416745,0.0064759543,0.00059827924,0.00006933617,0.003081274],"genre_scores_gemma":[0.98685056,0.00043159223,0.003946378,0.0018277022,0.0017178293,0.0038669913,0.00005451642,0.000069693415,0.0012347641],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997938,0.00023823275,0.0004793565,0.00041424355,0.0003900033,0.0005401879],"domain_scores_gemma":[0.9975942,0.00079025864,0.0004503272,0.0005981666,0.0003165652,0.00025052848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013527706,0.00029336056,0.0017584144,0.000058297337,0.00006833569,0.000021324262,0.00018874106,0.00013159386,0.00015281478],"category_scores_gemma":[0.00017852095,0.00013847806,0.00008155473,0.0001774238,0.00022706871,0.000057956164,0.000020778718,0.00017807362,0.0000018224742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.958147,0.001396635,0.001035584,0.00007005001,0.0013762014,0.00009597093,0.0042691543,0.000055326702,0.00006125376,0.000111190646,0.0075567067,0.02582494],"study_design_scores_gemma":[0.8280505,0.049055815,0.0005853222,0.000118692384,0.00044042157,0.00002956269,0.00048148562,0.00008705429,0.00059206743,0.0001229064,0.12026391,0.00017224833],"about_ca_topic_score_codex":0.0005599897,"about_ca_topic_score_gemma":0.001761647,"teacher_disagreement_score":0.13009648,"about_ca_system_score_codex":0.00085661904,"about_ca_system_score_gemma":0.002682829,"threshold_uncertainty_score":0.56469715},"labels":[],"label_agreement":null},{"id":"W2102682078","doi":"10.1158/1541-7786.mcr-12-0353","title":"Revisiting the Complexity of the Ovarian Cancer Microenvironment—Clinical Implications for Treatment Strategies","year":2012,"lang":"en","type":"review","venue":"Molecular Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Tumor microenvironment; Stromal cell; Cancer research; Angiogenesis; Ovarian cancer; Cancer; Medicine; Disease; Stroma; Immune system; Tumor progression; Immunotherapy; Bioinformatics; Immunology; Biology; Internal medicine; Immunohistochemistry","score_opus":0.4894605195602622,"score_gpt":0.5494639959794337,"score_spread":0.06000347641917153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102682078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009809946,0.9731735,0.000072517,0.019414775,0.00019877603,0.0056861015,0.0009106909,0.000011341972,0.00043419577],"genre_scores_gemma":[0.0052723465,0.98304385,0.0002348453,0.00011514929,0.0009514331,0.009882217,0.00010305118,0.0000882512,0.0003088782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965716,0.00081080437,0.0008351879,0.0006210895,0.00048649957,0.00067479693],"domain_scores_gemma":[0.9971264,0.0005184539,0.00041578215,0.0015452153,0.00021126479,0.0001828617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010984805,0.00038746127,0.001457659,0.00009127216,0.00041868965,0.00006870255,0.0005245218,0.00022419135,0.00019819455],"category_scores_gemma":[0.000054094195,0.0001909745,0.0012574877,0.0004733507,0.0010532067,0.000035380774,0.00022847157,0.0004667008,0.000010836208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033069344,0.00030798535,0.0010429788,0.0048003206,0.0018334956,0.000003367906,0.000059678234,0.00000267229,0.000039067636,0.008172015,0.0004027029,0.98330265],"study_design_scores_gemma":[0.00088842766,0.00015877788,0.005186842,0.005575668,0.0038200016,0.000012993036,0.00003574683,0.0000018882056,0.000117120486,0.00041594304,0.98362386,0.00016272241],"about_ca_topic_score_codex":0.0016959404,"about_ca_topic_score_gemma":0.00017213084,"teacher_disagreement_score":0.9832212,"about_ca_system_score_codex":0.0014732592,"about_ca_system_score_gemma":0.0024087478,"threshold_uncertainty_score":0.7787714},"labels":[],"label_agreement":null},{"id":"W2102763015","doi":"10.1093/annonc/mdl268","title":"New targets and non-cytotoxics in ovarian cancer","year":2006,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Cancer; Internal medicine","score_opus":0.1266691729296048,"score_gpt":0.4571530828931772,"score_spread":0.33048390996357235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102763015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019113271,0.9882794,0.0000086154205,0.0026560156,0.00024381986,0.00086198514,0.00006584934,0.0000065826407,0.007858596],"genre_scores_gemma":[0.000118515505,0.997096,0.00071636477,0.00053555664,0.00040821676,0.00019482973,0.000072006995,0.000036416517,0.00082210125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984985,0.00006943415,0.0006319007,0.00037571968,0.0001211115,0.00030334978],"domain_scores_gemma":[0.99899906,0.0001562281,0.00035850948,0.0002598027,0.00006291384,0.0001634631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001853562,0.00029364665,0.002433903,0.00025261237,0.000015629907,0.000005262321,0.00008152546,0.00048191534,0.00022098038],"category_scores_gemma":[0.000024386882,0.00022835794,0.00024834168,0.00023818167,0.000055023636,0.00002707983,0.00005225099,0.00027014257,0.000012899025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025766314,0.00032355625,0.0006219967,0.00393963,0.0002946838,0.00025759902,0.00003629666,4.4123198e-7,3.513896e-7,0.00011560402,0.040258106,0.95412594],"study_design_scores_gemma":[0.0014580595,0.0010312169,0.0027082358,0.0059985244,0.0006741429,0.000049921553,0.0000027570873,6.0755025e-7,0.000013160342,0.000093317205,0.98781514,0.00015492717],"about_ca_topic_score_codex":0.0029660035,"about_ca_topic_score_gemma":0.0010248882,"teacher_disagreement_score":0.953971,"about_ca_system_score_codex":0.00018294848,"about_ca_system_score_gemma":0.002083432,"threshold_uncertainty_score":0.9312166},"labels":[],"label_agreement":null},{"id":"W2102925061","doi":"10.1158/1078-0432.ccr-10-3405","title":"The Role of <i>KRAS</i> rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute; Cancer Research UK; Peter MacCallum Cancer Centre; Wellcome Trust; Friedrich-Schiller-Universität Jena; Moffitt Cancer Center; University of South Florida; Deutsches Krebsforschungszentrum; Helsingin ja Uudenmaan Sairaanhoitopiiri; University College London; Helsingin Yliopisto","keywords":"KRAS; Ovarian cancer; Epithelial ovarian cancer; Medicine; Cancer; Oncology; Internal medicine; Pathology; Gynecology; Cancer research; Biology; Colorectal cancer","score_opus":0.5335970556706076,"score_gpt":0.5682043515900453,"score_spread":0.034607295919437786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102925061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931926,0.016190378,0.000036847603,0.028961454,0.0011864124,0.0058688647,0.0006724126,0.0000655132,0.015092113],"genre_scores_gemma":[0.9748582,0.018622575,0.0013510707,0.00043388116,0.0011365415,0.0033458197,0.00000998907,0.000043649314,0.00019824336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641365,0.0004770512,0.0014144945,0.0006525352,0.0003741494,0.00066810206],"domain_scores_gemma":[0.986845,0.010641215,0.0002704729,0.0008003343,0.0010951837,0.00034780073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005163414,0.00016344605,0.00062947633,0.00010507088,0.00026692761,0.000024787185,0.0004317353,0.00022970355,0.00013278985],"category_scores_gemma":[0.0054896306,0.00011090415,0.00030576534,0.0006732004,0.000838039,0.000059759426,0.0001804945,0.0008333286,0.000016860062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009641406,0.0008261034,0.7336421,0.000043017644,0.00015806819,0.0000043276655,0.00012137724,8.5739197e-7,0.0001604729,0.0024880837,0.0022548742,0.25933656],"study_design_scores_gemma":[0.0042377524,0.0015319588,0.9474366,0.00036804072,0.00012178193,0.000002481754,0.00018989092,0.000046280104,0.0021462059,0.009664137,0.034135114,0.00011977086],"about_ca_topic_score_codex":0.005743074,"about_ca_topic_score_gemma":0.0047822306,"teacher_disagreement_score":0.2592168,"about_ca_system_score_codex":0.0002556987,"about_ca_system_score_gemma":0.0027287358,"threshold_uncertainty_score":0.86818486},"labels":[],"label_agreement":null},{"id":"W2103354988","doi":"10.1038/modpathol.2010.171","title":"The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls","year":2010,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Cancer Institute; Brigham and Women's Hospital","keywords":"Serous fluid; Biology; Block (permutation group theory); Pathology; BRCA mutation; Serous carcinoma; Medicine; Ovarian cancer; Cancer; Genetics; Mathematics","score_opus":0.015016697900275192,"score_gpt":0.29150280902197717,"score_spread":0.27648611112170196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103354988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830097,0.0002439967,0.00020827373,0.0006831553,0.000040881114,0.00039868534,0.000048477916,0.0000067840274,0.00006875354],"genre_scores_gemma":[0.99956995,0.00004702234,0.00013082268,0.00006436147,0.000037006932,0.00011579221,0.0000035364985,0.000010439752,0.000021054433],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99942243,0.000054386055,0.00015435534,0.0001540622,0.00007708741,0.0001376856],"domain_scores_gemma":[0.9990641,0.00057626015,0.00006373918,0.00021693297,0.000044733868,0.00003426397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012774201,0.0000946727,0.00023041449,0.00004752696,0.000058852816,0.000008095163,0.00004557862,0.0000809471,0.000033662203],"category_scores_gemma":[0.0000906509,0.000040951873,0.000023451134,0.00006195831,0.00013469376,0.000016101243,0.000011739593,0.00018289968,5.595025e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033866577,0.00069045916,0.12928902,0.000026688642,0.0005456664,0.000100868325,0.0106085865,0.0022484004,0.7921755,0.0004209787,0.000014624844,0.060492553],"study_design_scores_gemma":[0.0032620442,0.0030677654,0.96216226,0.000057754216,0.000089189554,0.000042683743,0.0003755604,0.0014677868,0.027265256,0.00206502,0.00006805738,0.00007663278],"about_ca_topic_score_codex":0.0006281355,"about_ca_topic_score_gemma":0.0025476336,"teacher_disagreement_score":0.8328732,"about_ca_system_score_codex":0.000040775005,"about_ca_system_score_gemma":0.0000637567,"threshold_uncertainty_score":0.16699688},"labels":[],"label_agreement":null},{"id":"W2103455702","doi":"10.1093/annonc/mdv071","title":"Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Trabectedin; Medicine; Oncology; Ovarian cancer; Internal medicine; Phases of clinical research; Chemotherapy; Cancer; BRCA mutation; Clinical trial; Pathology; Sarcoma","score_opus":0.046515431706351196,"score_gpt":0.40140119112359324,"score_spread":0.35488575941724204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103455702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662954,0.00026407387,7.1971505e-7,0.0014240782,0.000040511695,0.0014717969,0.0001188576,0.0000052468604,0.00004520827],"genre_scores_gemma":[0.9995165,0.00006930231,0.00003965361,0.00010340847,0.0000076316965,0.00022624352,0.000015280923,0.000010666552,0.000011298558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985298,0.0004986769,0.00035849228,0.00026387334,0.0002029555,0.00014621373],"domain_scores_gemma":[0.99869126,0.00045840762,0.00022948172,0.00026170255,0.00022368996,0.00013543315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041453962,0.0001625498,0.00082633155,0.00039709755,0.000023784802,0.0000024225674,0.00004457319,0.00005828567,0.000013454652],"category_scores_gemma":[0.00015034337,0.000093976574,0.00006228703,0.00081699423,0.00009551615,0.00003963227,0.00002137184,0.00005872648,2.1742864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057416163,0.008995933,0.8124234,0.000027282116,0.0026211333,0.000036582886,0.009351276,0.00066903816,0.00069324975,0.0000058419796,0.000035407353,0.1077247],"study_design_scores_gemma":[0.033848293,0.12815532,0.8236333,0.000084728475,0.0017698348,7.647552e-7,0.0005680533,0.000036856098,0.011727677,0.0000022029326,0.00010923733,0.00006370889],"about_ca_topic_score_codex":0.00064899906,"about_ca_topic_score_gemma":0.0014313597,"teacher_disagreement_score":0.11915939,"about_ca_system_score_codex":0.00016617164,"about_ca_system_score_gemma":0.00026789284,"threshold_uncertainty_score":0.38322535},"labels":[],"label_agreement":null},{"id":"W2103663755","doi":"","title":"Place du paclitaxel en traitement de première ligne des cancers de l’ovaire ?","year":2003,"lang":"fr","type":"article","venue":"Bulletin du Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Paclitaxel; Gynecology; Chemotherapy; Internal medicine","score_opus":0.011173464212447866,"score_gpt":0.259785183497814,"score_spread":0.24861171928536613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103663755","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3788188,0.44777158,0.00084722997,0.121809065,0.0049589765,0.0023730947,0.0005528582,0.0001935727,0.04267481],"genre_scores_gemma":[0.8203729,0.12254314,0.0056942794,0.004556905,0.004058586,0.0020971827,0.0000224363,0.00018847626,0.040466093],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962259,0.00045989806,0.0005619141,0.00077950815,0.0004523924,0.0015204136],"domain_scores_gemma":[0.99793977,0.00039245692,0.00020850207,0.0005090358,0.00018350167,0.0007667378],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009783529,0.0005940955,0.00067921594,0.000090789836,0.00030377292,0.00008991797,0.00021644495,0.00035635434,0.029829027],"category_scores_gemma":[0.0003616392,0.0005841016,0.00030247326,0.0002800419,0.0003420384,0.000068329944,0.000053006064,0.0003914695,0.00035730522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041246956,0.0013284513,0.37243542,0.0014336682,0.0015709134,0.00096107763,0.0074557033,0.0040051187,0.0001971157,0.00773719,0.5149726,0.08749022],"study_design_scores_gemma":[0.005684868,0.0006209038,0.04296778,0.003299838,0.0011392577,0.00023445548,0.0017129772,0.00016927347,0.003101434,0.00017569374,0.94034624,0.00054725015],"about_ca_topic_score_codex":0.012036038,"about_ca_topic_score_gemma":0.0019879753,"teacher_disagreement_score":0.44155407,"about_ca_system_score_codex":0.011537409,"about_ca_system_score_gemma":0.002834709,"threshold_uncertainty_score":0.999661},"labels":[],"label_agreement":null},{"id":"W2103812354","doi":"10.1158/1078-0432.ccr-11-2080","title":"Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Serous Cystadenoma; Pathology; Biology; Carcinogenesis; Cystadenocarcinoma; Ovary; Ovarian cancer; Cancer research; Medicine; Cancer; Genetics","score_opus":0.5835839815901704,"score_gpt":0.5824806149641291,"score_spread":0.00110336662604138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103812354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911807,0.00073351845,0.0004540047,0.034981016,0.0009045406,0.006109096,0.0002629911,0.000114216644,0.044633638],"genre_scores_gemma":[0.9896819,0.0004074462,0.0035868927,0.00055790815,0.00058768847,0.0033077113,0.000028047432,0.000037660546,0.0018047217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754477,0.00028665672,0.00071661815,0.00060971663,0.00034423615,0.000497981],"domain_scores_gemma":[0.9973249,0.00094054826,0.00008309434,0.00060466566,0.0006959911,0.00035083533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021654193,0.00013504397,0.00040312984,0.00013140346,0.00018416399,0.00003357416,0.00013620657,0.00018004024,0.0021441325],"category_scores_gemma":[0.00086170906,0.00011445178,0.00015510658,0.00054930407,0.00024921892,0.00008871789,0.000051655617,0.0005789871,0.00017066262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022955611,0.003941971,0.8710011,0.00017108713,0.0002558956,0.00227951,0.0013802145,0.000002264853,0.000019682524,0.011565245,0.07236801,0.034719445],"study_design_scores_gemma":[0.023071574,0.003930762,0.8647472,0.0009943441,0.00033200558,0.00083214743,0.0020785583,0.0006852065,0.0016343618,0.0126864165,0.08837361,0.0006338102],"about_ca_topic_score_codex":0.0045616757,"about_ca_topic_score_gemma":0.004747355,"teacher_disagreement_score":0.07787494,"about_ca_system_score_codex":0.0004205325,"about_ca_system_score_gemma":0.0010567536,"threshold_uncertainty_score":0.99876803},"labels":[],"label_agreement":null},{"id":"W2104072698","doi":"10.1016/j.ygyno.2012.09.003","title":"Human epididymis protein 4 (HE4) and ovarian cancer prognosis","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University Health Network; Hôpital du Saint-Sacrement; Toronto General Hospital; Hôtel-Dieu de Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Terry Fox Foundation; Cancer Research Institute","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Confidence interval; Ovarian cancer; Cohort; Oncology; Cancer; Stage (stratigraphy); Clinical endpoint; Gynecology; Gastroenterology; Clinical trial","score_opus":0.04536125832236143,"score_gpt":0.35622402951637144,"score_spread":0.31086277119401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104072698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562733,0.00304832,0.000011362443,0.018660884,0.00046834993,0.0017956342,0.000016013224,0.00012412717,0.019602021],"genre_scores_gemma":[0.9908667,0.00023914457,0.0024408342,0.0020993545,0.0005106412,0.0023969682,0.000014918143,0.000024525336,0.001406919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984107,0.00014363989,0.0003069938,0.00037556828,0.00013257618,0.0006305178],"domain_scores_gemma":[0.9990585,0.00013548836,0.00014965892,0.00023519814,0.000065177395,0.00035596307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041746488,0.00022677818,0.00058528566,0.000092685295,0.00018627352,0.00001385174,0.000071826515,0.00030777865,0.0023103913],"category_scores_gemma":[0.000115823794,0.00017144758,0.00008763537,0.00015397694,0.00016790749,0.00009345331,0.0000894504,0.00022647493,0.000090451766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069390066,0.0025353516,0.84712577,0.000109823835,0.00035695027,0.00012871462,0.0004166099,5.5527875e-7,0.0022520416,0.00795239,0.0057298974,0.13332254],"study_design_scores_gemma":[0.0030931218,0.0024252003,0.8238855,0.000046089575,0.00037811862,0.00007551905,0.000109188644,0.0000039897864,0.0021329932,0.00052942714,0.16712494,0.00019589001],"about_ca_topic_score_codex":0.00030413718,"about_ca_topic_score_gemma":0.00020097032,"teacher_disagreement_score":0.16139504,"about_ca_system_score_codex":0.0006231404,"about_ca_system_score_gemma":0.0002093797,"threshold_uncertainty_score":0.9986016},"labels":[],"label_agreement":null},{"id":"W2104355916","doi":"10.1503/cmaj.1031298","title":"Ovarian cancer screening","year":2004,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Stage (stratigraphy); Medicine; Cancer; Oncology; Population; Disease; Internal medicine; Survival rate; Gynecology; Biology; Environmental health","score_opus":0.03354539010897506,"score_gpt":0.3367989770328369,"score_spread":0.30325358692386184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104355916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010963331,0.9779988,0.000027928876,0.017471818,0.0015035578,0.0004144271,0.0001360948,0.000023569031,0.0024227316],"genre_scores_gemma":[0.0000123129485,0.9889529,0.0003060291,0.0042637535,0.005229202,0.00009443045,0.000081646576,0.00007167172,0.0009880983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961719,0.00016287324,0.0008722638,0.0003339171,0.0017086635,0.00075036497],"domain_scores_gemma":[0.9951276,0.00015131364,0.0006099665,0.00020032791,0.00032646416,0.0035843141],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010080058,0.00037690104,0.0015848341,0.00043932363,0.0002869528,0.0001394487,0.00022250206,0.0012451024,0.014630891],"category_scores_gemma":[0.0006229885,0.00029361932,0.0007751524,0.00045417168,0.000029671675,0.00007182061,0.000018534742,0.0022451258,0.00036392754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000001671828,0.000038272396,0.0007558448,0.0011186154,0.0013359627,0.0024228978,0.00002648122,4.86122e-7,9.844162e-10,0.00011277064,0.036653202,0.9575338],"study_design_scores_gemma":[0.0012853541,0.000053163712,0.00047520606,0.03611903,0.0017848214,0.0018286365,0.000013406471,0.0000017011433,3.5243826e-8,0.000016657055,0.958186,0.00023600276],"about_ca_topic_score_codex":0.010073339,"about_ca_topic_score_gemma":0.020584619,"teacher_disagreement_score":0.9572978,"about_ca_system_score_codex":0.010115147,"about_ca_system_score_gemma":0.03702594,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W2104730351","doi":"10.1016/s0140-6736(00)03590-x","title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","year":2001,"lang":"en","type":"article","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":627,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Ascites; Ovarian cancer; Ovarian carcinoma; Multivariate analysis; Oncology; Internal medicine; Pathological; Hazard ratio; Univariate analysis; Retrospective cohort study; Prognostic variable; Carcinoma; Disease; Gynecology; Cancer; Pathology; Biology","score_opus":0.041058778783968554,"score_gpt":0.27185184290021447,"score_spread":0.23079306411624592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104730351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956266,0.0007774051,0.000014004929,0.0022755796,0.000040232455,0.00040606625,0.00009398898,0.0000064152287,0.00075968384],"genre_scores_gemma":[0.99904066,0.00040670062,0.00014125418,0.00014446766,0.00015010912,0.00002996818,0.000026310337,0.000007983042,0.00005252269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939626,0.00003352296,0.00019698977,0.00012522955,0.00012036375,0.00012761698],"domain_scores_gemma":[0.9994301,0.00010099759,0.00013259352,0.00026906718,0.000037509846,0.000029685669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011242074,0.000083533894,0.00034792197,0.000038296086,0.000015679778,0.0000045209144,0.00006144753,0.00003927493,0.000056985435],"category_scores_gemma":[0.00006865384,0.000051833616,0.000030015679,0.00011881037,0.00005350078,0.000027560165,0.000022060693,0.00007910662,9.68636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025764204,0.00014661551,0.99475163,0.000145104,0.000047175225,0.00005896881,0.0006298448,0.0000027875783,0.001625413,0.0010810216,0.00009152808,0.0011622679],"study_design_scores_gemma":[0.0031144086,0.00022198084,0.99364316,0.00017518384,0.00008969793,0.00002019063,0.000102039034,0.00004067274,0.00208949,0.00033763095,0.00012134498,0.00004420512],"about_ca_topic_score_codex":0.00023935131,"about_ca_topic_score_gemma":0.00087667024,"teacher_disagreement_score":0.0034140607,"about_ca_system_score_codex":0.000031717693,"about_ca_system_score_gemma":0.000053054504,"threshold_uncertainty_score":0.21137136},"labels":[],"label_agreement":null},{"id":"W2104979074","doi":"10.1186/1477-7819-5-118","title":"Collision tumor of the colon – colonic adenocarcinoma and ovarian granulosa cell tumor","year":2007,"lang":"en","type":"article","venue":"World Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Surgical oncology; Mucinous Tumor; Ovarian tumor; Adenocarcinoma; Stromal tumor; Sigmoid colon; Granulosa cell; Ovary; Pathological; Pathology; Hysterectomy; Oncology; Internal medicine; Stromal cell; Ovarian cancer; Rectum; Cancer","score_opus":0.013249205735690968,"score_gpt":0.28585420381791204,"score_spread":0.27260499808222105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104979074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737971,0.0042135287,0.000008301527,0.010951843,0.0006245018,0.00035847325,0.0000073075425,0.0000050477597,0.010033885],"genre_scores_gemma":[0.9975247,0.0005283321,0.0006035118,0.0006291913,0.0002967687,0.000003958412,8.920914e-7,0.000014159829,0.000398487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982791,0.0001450873,0.0007783621,0.00016794736,0.00034699342,0.0002825149],"domain_scores_gemma":[0.9978565,0.00076338643,0.0007159735,0.00018063032,0.00021114943,0.00027238193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00103072,0.00015107768,0.0007309629,0.00020312551,0.0000830249,0.000008252531,0.00013005783,0.00007509301,0.00021147159],"category_scores_gemma":[0.00003474134,0.00008990299,0.00023952957,0.00041585293,0.00024979794,0.000043678312,0.000068022724,0.00041461244,0.0000041536264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016264606,0.0062215817,0.89671427,0.00029620287,0.0005806528,0.031899974,0.00075014395,0.000033319484,0.0035378113,0.00880788,0.013024394,0.021869175],"study_design_scores_gemma":[0.012699154,0.0047074715,0.58990455,0.00026531055,0.0005534408,0.006133956,0.00014719604,0.000009433474,0.008985023,0.00026521643,0.37621555,0.00011366593],"about_ca_topic_score_codex":0.000043070453,"about_ca_topic_score_gemma":0.00017038068,"teacher_disagreement_score":0.36319116,"about_ca_system_score_codex":0.00036181932,"about_ca_system_score_gemma":0.00050126476,"threshold_uncertainty_score":0.36661378},"labels":[],"label_agreement":null},{"id":"W2105096699","doi":"10.1038/ng.3336","title":"Genome-wide significant risk associations for mucinous ovarian carcinoma","year":2015,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Simon Fraser University; BC Cancer Agency; University of Toronto; Canada's Michael Smith Genome Sciences Centre; Public Health Ontario; University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; European Commission; Wellcome Trust; Francis Crick Institute; National Cancer Institute; Cancer Research UK; Roswell Park Cancer Institute; Ovarian Cancer Research Fund","keywords":"Biology; Genome-wide association study; Ovarian cancer; Single-nucleotide polymorphism; Expression quantitative trait loci; Ovarian carcinoma; Genetic association; Colorectal cancer; Genetics; Cancer research; Gene; Cancer; Genotype","score_opus":0.025563677635819394,"score_gpt":0.2864805752735155,"score_spread":0.2609168976376961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105096699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737628,0.010271862,0.0013670066,0.006576789,0.0012420631,0.0018352965,0.00084175065,0.00009599587,0.0040064356],"genre_scores_gemma":[0.983318,0.00021519653,0.013606977,0.0011733697,0.0007790866,0.00011554025,0.0002639192,0.000040632644,0.000487293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987876,0.000033560947,0.0002309453,0.00033110342,0.0003005715,0.00031622662],"domain_scores_gemma":[0.9986212,0.00014171982,0.0001366244,0.00040442238,0.00038867095,0.0003073666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023324726,0.00017428747,0.0002895168,0.00007757155,0.00009974087,0.0000293991,0.000093467796,0.00033610596,0.000025199522],"category_scores_gemma":[0.00036727602,0.00014915873,0.0001394955,0.00017138067,0.000023550894,0.000018067794,0.00002662625,0.0003301063,0.000027511067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090435016,0.0003764193,0.98087627,0.00002461945,0.00030005298,0.000036330308,0.0004845837,0.00010454381,0.00007735577,0.00019951332,0.014103644,0.0033262605],"study_design_scores_gemma":[0.003323814,0.00056726084,0.8972607,0.000009123553,0.0006160757,0.000006874478,0.00007707497,0.00016278183,0.001463106,0.0007491322,0.09560971,0.0001543059],"about_ca_topic_score_codex":0.00007045481,"about_ca_topic_score_gemma":0.000052416555,"teacher_disagreement_score":0.083615504,"about_ca_system_score_codex":0.00041797495,"about_ca_system_score_gemma":0.00043477258,"threshold_uncertainty_score":0.6082517},"labels":[],"label_agreement":null},{"id":"W2105259646","doi":"10.1158/1055-9965.epi-05-0218","title":"Fruits and Vegetables and Ovarian Cancer Risk in a Pooled Analysis of 12 Cohort Studies","year":2005,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Quartile; Medicine; Relative risk; Confidence interval; Ovarian cancer; Cancer; Proportional hazards model; Prospective cohort study; Cohort study; Internal medicine","score_opus":0.052609549905049666,"score_gpt":0.38936891274382185,"score_spread":0.33675936283877217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105259646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79234314,0.20109165,0.000096463795,0.00566202,0.00012581453,0.0005441994,0.000048275077,0.000015097378,0.00007336036],"genre_scores_gemma":[0.8762679,0.12102835,0.0016433483,0.00034347476,0.00008025089,0.00045181066,0.000035304543,0.000011726301,0.00013781202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979692,0.0004331282,0.00067925645,0.0005429327,0.00008601696,0.0002894645],"domain_scores_gemma":[0.9986385,0.00051817205,0.00042207626,0.00022998605,0.00007908479,0.00011219119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001499687,0.00020742955,0.0011927736,0.00040616706,0.000060231523,0.0000033887343,0.000040833336,0.0001593781,0.000113489856],"category_scores_gemma":[0.0002949633,0.00016949154,0.00016497723,0.0004181438,0.0002534415,0.00009181954,0.000048277238,0.00011556706,7.1696746e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025701,0.00012100668,0.88919955,0.00009565232,0.020153485,0.000003519953,0.00022433104,0.00014918059,0.000089042944,0.00012823333,0.00050960766,0.089069396],"study_design_scores_gemma":[0.0022807296,0.00013781119,0.9791442,0.00044566847,0.014741695,0.0000029235298,0.000098845536,0.0014258985,0.00014753733,0.0007102587,0.00073485135,0.00012959144],"about_ca_topic_score_codex":0.0036894074,"about_ca_topic_score_gemma":0.016461663,"teacher_disagreement_score":0.08994466,"about_ca_system_score_codex":0.000319629,"about_ca_system_score_gemma":0.00009886748,"threshold_uncertainty_score":0.9185994},"labels":[],"label_agreement":null},{"id":"W2105869142","doi":"10.1016/s1701-2163(16)32914-0","title":"The Importance of CA125 Normalization During Neoadjuvant Chemotherapy Followed by Planned Delayed Surgical Debulking in Patients With Epithelial Ovarian Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Proportional hazards model; Hazard ratio; Ovarian cancer; Internal medicine; Oncology; Surgery; Cancer; Confidence interval","score_opus":0.00524141161888991,"score_gpt":0.20976905217397165,"score_spread":0.20452764055508174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105869142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948397,0.0033268954,0.00000514251,0.00066244905,0.0009110498,0.00017692917,0.00003124802,0.0000013132238,0.00004526563],"genre_scores_gemma":[0.9982732,0.0014538427,0.000058510304,0.00014009772,0.000019133406,0.000005799978,0.0000069513794,0.000011290579,0.00003120923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890286,0.00002986451,0.00045361905,0.00010981298,0.00030259864,0.0002012743],"domain_scores_gemma":[0.9987524,0.00040558784,0.00043535393,0.000088054614,0.00020909436,0.00010952064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010028666,0.000111496614,0.00034878223,0.00008595429,0.00011603925,0.000005920212,0.00006104131,0.000058718248,0.00004791316],"category_scores_gemma":[0.00012994735,0.00006834275,0.000036150923,0.00025656508,0.000048294816,0.000044534037,0.000010032588,0.00014987061,2.7919851e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003012671,0.00014550773,0.99312365,0.000011196659,0.00018269938,0.0011533655,0.000085580876,0.00007108099,0.0000049475357,0.0000071229774,0.0003314772,0.004582113],"study_design_scores_gemma":[0.014076854,0.00070683035,0.9831065,0.000018785138,0.00006013006,0.000044795604,0.000028064214,0.000028601691,0.00021563415,0.000002723818,0.0016409908,0.00007011861],"about_ca_topic_score_codex":0.011573361,"about_ca_topic_score_gemma":0.048306488,"teacher_disagreement_score":0.036733124,"about_ca_system_score_codex":0.0007930734,"about_ca_system_score_gemma":0.0010115015,"threshold_uncertainty_score":0.99500865},"labels":[],"label_agreement":null},{"id":"W2106183217","doi":"10.1093/humupd/dml002","title":"Endocrine signaling in ovarian surface epithelium and cancer","year":2006,"lang":"en","type":"review","venue":"Human Reproduction Update","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer; Endocrine system; Biology; Cancer research; Internal medicine; Hormone; Endocrinology; Oncology; Medicine","score_opus":0.0624361298356149,"score_gpt":0.3725293230075402,"score_spread":0.3100931931719253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106183217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008174967,0.9960493,0.0000018194542,0.00082959846,0.0004486595,0.0011929346,0.000048697922,0.00006234446,0.00054919097],"genre_scores_gemma":[0.0005262388,0.9936995,0.00023225884,0.000052725736,0.001235184,0.00023348325,0.00035763858,0.00008380615,0.0035791744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974321,0.000108438595,0.0007086002,0.0012221131,0.00020677489,0.00032195108],"domain_scores_gemma":[0.99871045,0.000021885573,0.000324951,0.0007791578,0.00006790532,0.00009561995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033151486,0.00042638037,0.0014711466,0.00023880557,0.00010091295,0.000046266723,0.00006860973,0.00013900847,0.00049298623],"category_scores_gemma":[0.000016324177,0.00035063972,0.00019911391,0.00033908512,0.00006557183,0.000060537393,0.000055450786,0.00038736456,0.000056589237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002490614,0.00044471765,0.0013219411,0.012546428,0.00047806514,0.00032208808,0.00005094525,0.000033732435,0.000042212585,0.00060803985,0.0039835814,0.98014337],"study_design_scores_gemma":[0.0008323614,0.000063783154,0.00044522906,0.0065010674,0.0012222786,0.0002086099,0.0000035009418,6.933652e-7,0.00013321044,0.000059081976,0.9902402,0.000289997],"about_ca_topic_score_codex":0.0011226422,"about_ca_topic_score_gemma":0.0001066356,"teacher_disagreement_score":0.9862566,"about_ca_system_score_codex":0.00038550587,"about_ca_system_score_gemma":0.00017217462,"threshold_uncertainty_score":0.99989456},"labels":[],"label_agreement":null},{"id":"W2106371203","doi":"10.1097/01.pas.0000194743.33540.e6","title":"Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors)","year":2006,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ECW Press (Canada)","funders":"","keywords":"Medicine; Lymph node; Serous fluid; Lymph; Pathology; Biopsy","score_opus":0.009101418980340269,"score_gpt":0.2523230558420106,"score_spread":0.2432216368616703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106371203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912875,0.00062212645,0.0002310588,0.0072587854,0.00013273685,0.00016788895,0.000013300086,0.0000063518637,0.0002802217],"genre_scores_gemma":[0.9977367,0.0003634365,0.0009923782,0.0004980891,0.0003283069,0.000009298138,0.000007510231,0.000022371114,0.000041931216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977636,0.0002893114,0.0010074514,0.00020994425,0.000370148,0.00035959203],"domain_scores_gemma":[0.99839133,0.00014186674,0.0008886937,0.00029025917,0.00016335964,0.00012450316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070953416,0.00020060445,0.001021959,0.00021426895,0.000038149035,0.000007869729,0.0001887295,0.00004299474,0.00011574801],"category_scores_gemma":[0.000019216888,0.00012058002,0.0002587274,0.00040234788,0.0005168681,0.000039387618,0.000056195306,0.00025536853,0.0000065024487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011245251,0.010063735,0.77554893,0.00020600637,0.00063418783,0.123740226,0.0009756521,0.008550194,0.023269238,0.003567259,0.00060344674,0.041595846],"study_design_scores_gemma":[0.0110023795,0.0034873085,0.963515,0.0005687905,0.00028815324,0.014954487,0.000700049,0.00016309184,0.0036257494,0.0009884073,0.00046955282,0.00023702429],"about_ca_topic_score_codex":0.000768157,"about_ca_topic_score_gemma":0.000020275056,"teacher_disagreement_score":0.18796605,"about_ca_system_score_codex":0.00015877683,"about_ca_system_score_gemma":0.00022782282,"threshold_uncertainty_score":0.49171108},"labels":[],"label_agreement":null},{"id":"W2106439593","doi":"10.1016/j.ygyno.2012.04.029","title":"Ovarian low-grade serous carcinoma: A comprehensive update","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Serous fluid; Ovarian carcinoma; Serous carcinoma; Oncology; Internal medicine; Disease; Clinical trial; Chemotherapy; Pathogenesis; Ovarian cancer; Cancer","score_opus":0.11391346383685244,"score_gpt":0.38393609334286577,"score_spread":0.2700226295060133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106439593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016816767,0.9849401,0.0000062287286,0.0013250462,0.0026847732,0.0032020325,0.00014193825,0.00018082655,0.0073508937],"genre_scores_gemma":[0.0016017217,0.99036086,0.001437739,0.0021090836,0.0011891193,0.0016825328,0.0008083167,0.00012017291,0.00069045014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957363,0.00064260286,0.0011016681,0.0010551059,0.00027298366,0.0011913475],"domain_scores_gemma":[0.99627566,0.0011579795,0.0007973197,0.0010290979,0.00015762936,0.00058232486],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028902793,0.00097047054,0.00521009,0.00034040483,0.00017055502,0.000026776856,0.0003548966,0.0016872651,0.0028558623],"category_scores_gemma":[0.00008094282,0.0006923069,0.0010393059,0.00046449868,0.00024963988,0.00006549624,0.00030362644,0.0010886921,0.0030071302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034577333,0.0021490622,0.0005101552,0.007721001,0.0011907544,0.002805293,0.000059481008,2.917261e-7,2.1774069e-7,0.0007308024,0.007319939,0.97747844],"study_design_scores_gemma":[0.0026404331,0.0018549768,0.0029899403,0.0011396826,0.00939362,0.0019160995,0.000031821575,0.0000011608221,8.7295865e-7,0.00006637016,0.97942096,0.00054403447],"about_ca_topic_score_codex":0.00008429146,"about_ca_topic_score_gemma":0.00006810797,"teacher_disagreement_score":0.9769344,"about_ca_system_score_codex":0.0028653014,"about_ca_system_score_gemma":0.0020218052,"threshold_uncertainty_score":0.99960876},"labels":[],"label_agreement":null},{"id":"W2106767659","doi":"10.1056/nejmoa0908806","title":"Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2523,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Chemotherapy; Stage (stratigraphy); Oncology; Internal medicine; Neoadjuvant therapy; Surgery; Cancer; Gynecology; Breast cancer","score_opus":0.03204506985650066,"score_gpt":0.3159492098826625,"score_spread":0.2839041400261618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106767659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9103486,0.0028177376,0.000073568124,0.08252577,0.0026905527,0.00034987868,0.000009052269,0.000017923297,0.0011669296],"genre_scores_gemma":[0.964534,0.011552421,0.0012807995,0.0066243936,0.010912088,0.000013946632,0.00001135435,0.00005501614,0.0050159665],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980635,0.000056274286,0.000807134,0.00020513106,0.0005539683,0.00031397666],"domain_scores_gemma":[0.9981431,0.0005634324,0.0004053452,0.00026780803,0.00014638997,0.00047397355],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010886255,0.00023529884,0.0010297191,0.0003570913,0.000034882163,0.0000121528155,0.00011301999,0.0001174871,0.0071162037],"category_scores_gemma":[0.0003261191,0.00011719558,0.000113436545,0.00034590095,0.00008929858,0.00010541944,0.000013385472,0.0006750998,0.0000041871012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010993733,0.0005350479,0.21510461,0.00015373035,0.0003498521,0.0055694343,0.0012837679,0.000007829963,0.004601801,0.00004735004,0.037740666,0.7236122],"study_design_scores_gemma":[0.10720763,0.0019578536,0.50098,0.001810768,0.000279069,0.002088001,0.00012064409,0.000019599,0.0008241095,0.00007346162,0.38445628,0.00018255756],"about_ca_topic_score_codex":0.0010592947,"about_ca_topic_score_gemma":0.0020232017,"teacher_disagreement_score":0.7234296,"about_ca_system_score_codex":0.00018775342,"about_ca_system_score_gemma":0.0017390382,"threshold_uncertainty_score":0.9937914},"labels":[],"label_agreement":null},{"id":"W2106921303","doi":"10.1111/j.1471-0528.2009.02213.x","title":"Defining the surgical management of suspected early‐stage ovarian cancer by estimating patient numbers through alternative management strategies","year":2009,"lang":"en","type":"article","venue":"BJOG An International Journal of Obstetrics & Gynaecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Dissection (medical); Ovarian cancer; Lymph node; General surgery; Cancer; Surgery; Internal medicine","score_opus":0.01668824354203264,"score_gpt":0.3278903054802273,"score_spread":0.31120206193819466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106921303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94733435,0.0040442054,0.003274542,0.0028840739,0.006772565,0.00070909836,0.00010696527,0.000030190131,0.03484402],"genre_scores_gemma":[0.98549336,0.0012084331,0.012707175,0.00029019619,0.00011300824,0.000022410093,0.000026759062,0.00001693118,0.000121731035],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99772954,0.00010122876,0.0008168251,0.00025463031,0.0008275001,0.00027025136],"domain_scores_gemma":[0.9978788,0.0003811258,0.00087913615,0.00020944467,0.0005454392,0.0001060665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022185524,0.00020943856,0.00040123597,0.00022491188,0.00008228276,0.00007876652,0.00040618624,0.00007528048,0.0006155348],"category_scores_gemma":[0.000057920563,0.00015191696,0.00017470386,0.0003202403,0.0000879743,0.00031312095,0.00007415797,0.0002779424,0.0000042670636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096504367,0.004639738,0.115350574,0.00012031861,0.008872912,0.016931787,0.0051033073,0.015354062,0.000015379801,0.40402022,0.0019084627,0.4267182],"study_design_scores_gemma":[0.015881227,0.004602267,0.9526383,0.0003441646,0.0011461315,0.00039132894,0.006077934,0.0014339767,0.0007908802,0.0057555716,0.010501017,0.00043717847],"about_ca_topic_score_codex":0.00017739041,"about_ca_topic_score_gemma":0.0000065713984,"teacher_disagreement_score":0.8372877,"about_ca_system_score_codex":0.0007984447,"about_ca_system_score_gemma":0.000120947356,"threshold_uncertainty_score":0.67396736},"labels":[],"label_agreement":null},{"id":"W2107100377","doi":"10.1210/er.2006-0036","title":"Gonadotropins and Ovarian Cancer","year":2007,"lang":"en","type":"review","venue":"Endocrine Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Ovarian cancer; Cancer; Metastasis; Biology; Oncology; Gonadotropin; Cancer research; Internal medicine; Medicine; Bioinformatics; Hormone","score_opus":0.16237955249536556,"score_gpt":0.46116638705322344,"score_spread":0.29878683455785787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107100377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.5489472e-7,0.9899271,0.000012352368,0.00058361096,0.00041160168,0.003010203,0.00006675525,0.000047697402,0.0059404853],"genre_scores_gemma":[2.7741413e-7,0.99197936,0.0011233526,0.00056177966,0.0011890088,0.0012527708,0.00013753533,0.00009363871,0.0036622647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751645,0.00011292237,0.0010177495,0.00068132294,0.0002032982,0.00046826934],"domain_scores_gemma":[0.9984354,0.00009334684,0.00039811013,0.0006946069,0.00004007643,0.00033848357],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021883064,0.00065041025,0.00393419,0.0002163716,0.00006269002,0.000030843243,0.00011337008,0.00012880047,0.001135532],"category_scores_gemma":[0.00006309809,0.00041298455,0.0007886265,0.00038126702,0.000057284884,0.000040485713,0.000092302704,0.00043678322,0.00035754425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040614577,0.00009716914,0.000048051937,0.03616566,0.00030924316,0.00025298458,0.000007409528,3.3491558e-9,1.5706314e-8,0.00032830687,0.009188485,0.9535986],"study_design_scores_gemma":[0.00060712884,0.00010308513,0.00009144494,0.046018254,0.0041781603,0.00070086017,8.871471e-7,1.3760597e-7,3.9615463e-7,0.000004922724,0.9479884,0.00030632984],"about_ca_topic_score_codex":0.00019413307,"about_ca_topic_score_gemma":0.0000500402,"teacher_disagreement_score":0.9532923,"about_ca_system_score_codex":0.00037318876,"about_ca_system_score_gemma":0.00032462506,"threshold_uncertainty_score":0.9998322},"labels":[],"label_agreement":null},{"id":"W2107197750","doi":"10.1016/s0015-0282(00)00729-9","title":"Prostaglandin F2α Activates Mitogen-Activated Protein Kinase in Human Granulosa-Luteal Cells","year":2000,"lang":"en","type":"article","venue":"Fertility and Sterility","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Protein kinase A; Luteal phase; Prostaglandin; Internal medicine; Mitogen-activated protein kinase; Endocrinology; Cell biology; Chemistry; Kinase; Biology; Medicine; Hormone","score_opus":0.01842369154387775,"score_gpt":0.26783211189094314,"score_spread":0.2494084203470654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107197750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967251,0.00019895664,0.0000019383294,0.0010800477,0.000054980344,0.0010707792,0.00010608031,0.00006185121,0.00070026406],"genre_scores_gemma":[0.9982333,0.000024703424,0.00006940365,0.00009659281,0.000035856367,0.0002021393,0.000077661694,0.000014772347,0.0012455242],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844325,0.00013867489,0.00030027993,0.00057643495,0.00019155984,0.0003498158],"domain_scores_gemma":[0.99925077,0.000029696119,0.000048524733,0.00043348136,0.000037500504,0.00020001468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022665017,0.00024692365,0.0004497049,0.000057004087,0.00013111622,0.000053552187,0.00005926002,0.00013652322,0.0007908007],"category_scores_gemma":[0.000017822726,0.00020102822,0.00008510399,0.00017176778,0.00013851577,0.00015788873,0.000031448806,0.00021750282,0.000009914973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06373722,0.004989444,0.3434683,0.0011843984,0.00021715362,0.00024510312,0.002632821,0.0000015157076,0.48053828,0.000014047838,0.00027893067,0.10269275],"study_design_scores_gemma":[0.0027117643,0.00038057976,0.77355266,0.00012174651,0.000027483002,0.000002390965,0.000043359803,0.000015386531,0.22038853,0.00013928636,0.0024798801,0.00013694307],"about_ca_topic_score_codex":0.0009745842,"about_ca_topic_score_gemma":0.00031533805,"teacher_disagreement_score":0.43008432,"about_ca_system_score_codex":0.0001716818,"about_ca_system_score_gemma":0.000054752825,"threshold_uncertainty_score":0.8658713},"labels":[],"label_agreement":null},{"id":"W2107792561","doi":"10.1200/jco.2006.08.2933","title":"Does Ovarian Cancer Treatment and Survival Differ by the Specialty Providing Chemotherapy?","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; Centers for Medicare and Medicaid Services; National Science Foundation","keywords":"Medicine; Chemotherapy; Internal medicine; Specialty; Ovarian cancer; Adverse effect; Epidemiology; Oncology; Epithelial ovarian cancer; Propensity score matching; Gynecologic oncology; Surgery; Cancer; Pathology","score_opus":0.09024954363195509,"score_gpt":0.4601325704176186,"score_spread":0.36988302678566354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107792561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89721286,0.0013998357,0.00009785528,0.096306905,0.00249907,0.00032266023,0.000008921491,0.0000063685548,0.0021455477],"genre_scores_gemma":[0.98186845,0.008378312,0.0005389988,0.0035706914,0.0044694715,0.000008980065,0.0000012214776,0.00001738878,0.0011464637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980552,0.00016337159,0.0011586135,0.00017939715,0.00021666726,0.00022672805],"domain_scores_gemma":[0.9967567,0.0019005884,0.0007606258,0.00014944754,0.0001295954,0.00030305798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021651115,0.00014362688,0.0009808512,0.000037669008,0.00006942281,0.000015016842,0.00007515918,0.00019790619,0.00027229008],"category_scores_gemma":[0.00025502435,0.000053654378,0.00028288466,0.00006843158,0.00017285217,0.000046538127,0.000018091587,0.0003461352,0.0000023732487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023003875,0.0017640897,0.43829697,0.000007987651,0.0008285353,0.0001771163,0.00019875138,3.2395837e-7,0.000090697045,0.00014190414,0.0045191227,0.55167407],"study_design_scores_gemma":[0.009790817,0.005230199,0.5847188,0.00004153137,0.0004280031,0.0000633489,0.000116553725,0.0000036737517,0.0006573975,0.00014449366,0.39874768,0.000057485515],"about_ca_topic_score_codex":0.00019071219,"about_ca_topic_score_gemma":0.0007004581,"teacher_disagreement_score":0.5516166,"about_ca_system_score_codex":0.00041074574,"about_ca_system_score_gemma":0.0006456739,"threshold_uncertainty_score":0.29813853},"labels":[],"label_agreement":null},{"id":"W2108052323","doi":"10.1158/1535-7163.mct-11-0058","title":"Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ovarian Cancer Canada; Government of Ontario","keywords":"Docetaxel; Dosing; Chemotherapy; Pharmacology; Ovarian cancer; Drug resistance; Medicine; Cancer; Downregulation and upregulation; Efflux; Internal medicine; Oncology; Biology; Gene","score_opus":0.04093129730218682,"score_gpt":0.3039166700605155,"score_spread":0.2629853727583287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108052323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95783204,0.030843938,0.00065182085,0.0058479514,0.00036391662,0.0008272851,0.000010203886,0.00007616522,0.0035467055],"genre_scores_gemma":[0.97681415,0.0028677848,0.011956386,0.0070833284,0.00007145698,0.0005486366,0.0000062048457,0.00007014414,0.00058190373],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823123,0.000051594187,0.00040067302,0.00049068587,0.0003612818,0.00046454085],"domain_scores_gemma":[0.9992052,0.000015566404,0.00013392024,0.00040392193,0.0001109472,0.00013049447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016288926,0.00030834757,0.0003947207,0.00014390271,0.00009093173,0.00003030813,0.00016914101,0.0001085843,0.0004700107],"category_scores_gemma":[0.0000031636175,0.0002737361,0.00009728663,0.0004323103,0.00009044992,0.00007975882,0.000029668045,0.00021908655,0.000012794491],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016879303,0.0019225143,0.77485347,0.0003974726,0.0024572741,0.0006350594,0.02027937,0.00008548053,0.056464408,0.002954054,0.00028602255,0.13797696],"study_design_scores_gemma":[0.0053366697,0.00006414733,0.3208118,0.0010012973,0.00025515232,0.000005595003,0.00015486055,0.00003307893,0.5975176,0.0004921996,0.07379211,0.0005354738],"about_ca_topic_score_codex":0.00076170365,"about_ca_topic_score_gemma":0.0015534195,"teacher_disagreement_score":0.54105324,"about_ca_system_score_codex":0.0006485569,"about_ca_system_score_gemma":0.0006654721,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W2108090432","doi":"10.1093/jnci/djr282","title":"Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Ovarian cancer; Carboplatin; Confidence interval; Oncology; Progression-free survival; Proportional hazards model; Univariate analysis; Cancer; Chemotherapy; Multivariate analysis","score_opus":0.12614464931403235,"score_gpt":0.40639493036760227,"score_spread":0.2802502810535699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108090432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584275,0.007988935,0.00002640793,0.023956364,0.0068369824,0.001211931,0.00033648638,0.000010419282,0.0012050063],"genre_scores_gemma":[0.990633,0.0045844684,0.0012095183,0.0013217982,0.0014942742,0.00053262827,0.000005328459,0.000028766515,0.00019022773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755436,0.00006683427,0.00077115314,0.00026166392,0.0010253919,0.00032060806],"domain_scores_gemma":[0.9981639,0.00008583619,0.0005793326,0.00018853121,0.00082994974,0.00015246072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081664947,0.00022092716,0.00048859953,0.0002930689,0.000092037306,0.000026047339,0.00041009826,0.00011213206,0.00027047747],"category_scores_gemma":[0.00033938527,0.00014487293,0.00024346093,0.0005209742,0.0001009223,0.00031322226,0.000102007645,0.00038604854,0.0000022974614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004544581,0.0015012155,0.9382666,0.00014266282,0.0006074974,0.000115994575,0.0014346017,0.0007807453,0.0002243698,0.0024452326,0.0044597755,0.04547676],"study_design_scores_gemma":[0.011276859,0.00041337582,0.9480385,0.0026045563,0.00016616908,0.00003599398,0.000025051388,0.00010371136,0.0019127734,0.0035723373,0.031659,0.00019163103],"about_ca_topic_score_codex":0.007426391,"about_ca_topic_score_gemma":0.025159685,"teacher_disagreement_score":0.045285128,"about_ca_system_score_codex":0.0016629437,"about_ca_system_score_gemma":0.0030901514,"threshold_uncertainty_score":0.99918324},"labels":[],"label_agreement":null},{"id":"W2108856543","doi":"10.1093/carcin/bgi305","title":"Aberrant expression of PDGF ligands and receptors in the tumor prone ovary of follitropin receptor knockout (FORKO) mouse","year":2005,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Ludwig Institute for Cancer Research","keywords":"Endocrinology; Platelet-derived growth factor receptor; Internal medicine; Biology; Receptor; Ovary; Growth factor; Medicine","score_opus":0.018702664986070854,"score_gpt":0.2558630418686795,"score_spread":0.23716037688260863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108856543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903229,0.007321562,0.0000069128314,0.001342037,0.00007227431,0.0006174888,0.00003097984,0.000012137909,0.00027374178],"genre_scores_gemma":[0.9970678,0.0010273843,0.0012368234,0.00017995184,0.00013312139,0.00013385525,0.000018701545,0.000023065557,0.0001793038],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988103,0.000055508277,0.00040608546,0.0002642833,0.00026543625,0.00019842082],"domain_scores_gemma":[0.99923414,0.00009063927,0.0001467487,0.000382166,0.00006741378,0.000078920384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002155444,0.00016698538,0.00043602937,0.00012166302,0.000035759153,0.0000055541504,0.00009572394,0.000068274974,0.00012201458],"category_scores_gemma":[0.00003977939,0.000105984196,0.00010816916,0.00022083274,0.00008642892,0.000053838765,0.000037887425,0.000079223624,0.0000041294093],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085860706,0.0014139935,0.6100058,0.0005217062,0.00014620034,0.000021102709,0.0046143406,0.000018646175,0.33633777,0.000114430215,0.004860384,0.04108703],"study_design_scores_gemma":[0.002124347,0.00041172619,0.18823734,0.00032991398,0.00014228937,0.000012045636,0.00037730305,0.000014151245,0.8056419,0.0000078672,0.0026039076,0.00009722868],"about_ca_topic_score_codex":0.00013831799,"about_ca_topic_score_gemma":0.000027678901,"teacher_disagreement_score":0.4693041,"about_ca_system_score_codex":0.00008297352,"about_ca_system_score_gemma":0.00008551961,"threshold_uncertainty_score":0.432191},"labels":[],"label_agreement":null},{"id":"W2109242104","doi":"10.1093/jnci/djq387","title":"Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer","year":2010,"lang":"en","type":"letter","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Topotecan; Taxane; Medicine; Oncology; Gemcitabine; Ovarian cancer; Internal medicine; Paclitaxel; Ovarian carcinoma; Gynecology; Cancer; Chemotherapy; Breast cancer","score_opus":0.0530572568758695,"score_gpt":0.337114920862775,"score_spread":0.2840576639869055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109242104","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07570508,0.0010909812,0.00002564963,0.9109126,0.007910885,0.00078801124,0.0005987521,0.0000033266065,0.0029647162],"genre_scores_gemma":[0.8696866,0.00059510843,0.00016535902,0.1235831,0.005164945,0.00006345597,0.000009878267,0.00003229096,0.00069925457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756736,0.0000974552,0.0007476031,0.00014961037,0.0012864089,0.00015155567],"domain_scores_gemma":[0.99690497,0.00009615651,0.0017702862,0.00024827,0.00095082895,0.000029489687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033396576,0.00019803458,0.00059563736,0.00022101635,0.000057258545,0.000011684072,0.00038207846,0.00047938104,0.00031054186],"category_scores_gemma":[0.00016970531,0.00011169152,0.00037264923,0.00036495912,0.00023713073,0.00016814232,0.000054406537,0.0020738433,6.3337427e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075166195,0.0007862153,0.078915834,0.0011035823,0.0022058354,0.00006724473,0.000935443,0.0027853248,0.010076183,0.0011797098,0.89125437,0.009938602],"study_design_scores_gemma":[0.0033441642,0.00009621866,0.24177334,0.0024388204,0.0005387889,0.00010092081,0.000008308057,0.000026652251,0.026582351,0.00072306657,0.72420746,0.00015988851],"about_ca_topic_score_codex":0.0027983908,"about_ca_topic_score_gemma":0.0024509788,"teacher_disagreement_score":0.79398155,"about_ca_system_score_codex":0.0012289527,"about_ca_system_score_gemma":0.003216222,"threshold_uncertainty_score":0.9009932},"labels":[],"label_agreement":null},{"id":"W2109430398","doi":"10.1016/j.ygyno.2014.01.012","title":"Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary","year":2014,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Endometriosis; Medicine; Clear cell carcinoma; Stage (stratigraphy); Ovarian cancer; Ovary; Internal medicine; Serous fluid; Clear cell; Carcinoma; Oncology; Serous carcinoma; Gastroenterology; Endometrial cancer; Gynecology; Cancer; Survival rate","score_opus":0.07607395729341869,"score_gpt":0.4071033568216074,"score_spread":0.3310293995281887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109430398","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44222325,0.5509377,0.00000387103,0.00022958805,0.0006224754,0.0045096017,0.00049681147,0.000020519712,0.0009561329],"genre_scores_gemma":[0.5761304,0.42255238,0.0006254784,0.0002224269,0.00003915831,0.00026277124,0.0000612592,0.000047706555,0.000058443224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540716,0.00095608854,0.0020591558,0.00065894536,0.0005111791,0.00040746806],"domain_scores_gemma":[0.9854598,0.009869158,0.003292108,0.00070245966,0.00045640557,0.00022004845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082631974,0.00052535796,0.0076342393,0.00044064887,0.000060900653,0.000004726989,0.00032918752,0.0007658808,0.00015671599],"category_scores_gemma":[0.0022747878,0.0002610469,0.0005737061,0.0012493741,0.0004074429,0.000023073797,0.00025527872,0.000565816,0.0000026048374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031549012,0.002857652,0.7157244,0.0022403372,0.0016632634,0.000012747308,0.00006174436,0.0000020818288,9.383702e-8,0.000008930899,0.00025683505,0.27685642],"study_design_scores_gemma":[0.0076347846,0.019756392,0.8315806,0.0016965541,0.0065357075,0.0000032800963,0.00003419416,9.25903e-7,0.0000113230835,0.000001782145,0.13252765,0.00021682579],"about_ca_topic_score_codex":0.00035512148,"about_ca_topic_score_gemma":0.00043185492,"teacher_disagreement_score":0.2766396,"about_ca_system_score_codex":0.0005140097,"about_ca_system_score_gemma":0.0013404167,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W2109925286","doi":"10.1093/annonc/mdt237","title":"Quality indicators in ovarian cancer surgery: Report from the French Society of Gynecologic Oncology (Société Française d'Oncologie Gynécologique, SFOG)","year":2013,"lang":"fr","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ovarian cancer; Gynecologic oncology; Mindset; General partnership; Multidisciplinary approach; Quality (philosophy); Cancer; Family medicine; Gynecology; General surgery; Oncology; Internal medicine; Finance","score_opus":0.12709067241690333,"score_gpt":0.4293995267101241,"score_spread":0.30230885429322074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109925286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6922979,0.051272284,0.0000336904,0.2304937,0.0070403605,0.002926583,0.0005570993,0.000046693604,0.015331689],"genre_scores_gemma":[0.9291263,0.049979407,0.0019538132,0.013780335,0.0013858554,0.0020909829,0.00017145074,0.000058213554,0.0014536455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99044895,0.002872679,0.0034131743,0.001167417,0.0006035572,0.0014942085],"domain_scores_gemma":[0.971315,0.022699721,0.0034431277,0.001286301,0.00082008494,0.00043575282],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059846956,0.0006804555,0.0036665648,0.0003279384,0.0001625309,0.000018770523,0.00069083273,0.0024867314,0.014184593],"category_scores_gemma":[0.0037847564,0.0005093098,0.0012134941,0.0015195864,0.0022737712,0.00023712136,0.00041441614,0.001400042,0.00009878724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013926649,0.0041735265,0.39635134,0.00015071378,0.0012107214,0.00037774304,0.0013901357,0.000023347604,0.0001350946,0.0003967245,0.2595062,0.33614522],"study_design_scores_gemma":[0.0027163415,0.0022994657,0.64186823,0.00024798722,0.0003693078,0.000029381414,0.0013515997,0.000021461803,0.0012416707,0.0020110074,0.34755424,0.00028928058],"about_ca_topic_score_codex":0.14828202,"about_ca_topic_score_gemma":0.017861312,"teacher_disagreement_score":0.33585593,"about_ca_system_score_codex":0.0021077697,"about_ca_system_score_gemma":0.009941199,"threshold_uncertainty_score":0.99973583},"labels":[],"label_agreement":null},{"id":"W2110103048","doi":"10.1097/igc.0b013e31821b2669","title":"Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Transplant Association","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Clinical trial; Targeted therapy; Dysfunctional family; Bioinformatics; Computational biology; Oncology; Internal medicine","score_opus":0.22499213156271886,"score_gpt":0.48894391317644026,"score_spread":0.2639517816137214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110103048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024326108,0.97300625,0.00001865029,0.00044563066,0.00066209526,0.0011960808,0.0002052732,0.0000036577023,0.00013626079],"genre_scores_gemma":[0.022837969,0.97493166,0.000598482,0.00040197367,0.00045787156,0.0006912125,0.000010001707,0.000028800821,0.000042058156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968359,0.0003723377,0.0019380128,0.00028691924,0.00035582166,0.0002110489],"domain_scores_gemma":[0.9959981,0.0010345685,0.0020837502,0.0001177667,0.00057686353,0.0001889621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018454064,0.0002767118,0.002796883,0.00023933257,0.000012157285,0.000018107958,0.00025225306,0.0003028151,0.0014571674],"category_scores_gemma":[0.00063536235,0.00014997885,0.00056103786,0.000113947164,0.00009742584,0.000054217395,0.00003879523,0.0003757098,6.926114e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020720568,0.0007992653,0.009319406,0.00037524366,0.0044523953,0.00012000236,0.00007887322,0.0000035612,0.0000042208544,0.00015888088,0.00016096937,0.98245513],"study_design_scores_gemma":[0.010735379,0.0046007256,0.0693815,0.006468584,0.0011992973,0.00007463909,0.000029063533,0.0000043171976,0.0000311169,0.0006866623,0.9065652,0.000223504],"about_ca_topic_score_codex":0.00008683509,"about_ca_topic_score_gemma":0.00004243372,"teacher_disagreement_score":0.9822316,"about_ca_system_score_codex":0.0006453607,"about_ca_system_score_gemma":0.0009982984,"threshold_uncertainty_score":0.99945563},"labels":[],"label_agreement":null},{"id":"W2110240387","doi":"10.1016/j.jogc.2018.01.017","title":"Archivée: N° 230-Prise en charge des masses pelviennes / ovariennes : Évaluation initiale et lignes directrices quant à l'orientation des patientes","year":2018,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.0281105656735249,"score_gpt":0.28482614786117433,"score_spread":0.25671558218764945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110240387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86800563,0.107254714,0.00018423707,0.0017269473,0.02118218,0.00031355873,0.00009686781,0.0000071965455,0.0012286663],"genre_scores_gemma":[0.9756436,0.02002092,0.0031817271,0.00033556813,0.0004667276,0.000019766776,0.000025098183,0.000029628894,0.00027701553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728394,0.00045868105,0.00087718945,0.00030856155,0.0005111404,0.0005604685],"domain_scores_gemma":[0.9915383,0.0059257774,0.0008206565,0.0001643142,0.0011537425,0.00039721106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008738476,0.00031296368,0.0006309633,0.000471842,0.00038738365,0.000107770415,0.00013736579,0.00016570704,0.00094279443],"category_scores_gemma":[0.00680485,0.00026226914,0.00011735962,0.0006915304,0.0004940868,0.00039730055,0.000059643033,0.00028807123,0.0000065198137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043014283,0.00060988596,0.50533277,0.00030033162,0.0004746546,0.001040108,0.005920648,0.000016336387,0.00003368292,0.0015553021,0.0012285578,0.48344472],"study_design_scores_gemma":[0.0038109638,0.004787355,0.9567114,0.00024896336,0.0010605066,0.00017743646,0.003317195,0.0003642133,0.001179104,0.0022235562,0.025823481,0.0002958102],"about_ca_topic_score_codex":0.046898518,"about_ca_topic_score_gemma":0.106170245,"teacher_disagreement_score":0.4831489,"about_ca_system_score_codex":0.0018106175,"about_ca_system_score_gemma":0.0029509652,"threshold_uncertainty_score":0.99998295},"labels":[],"label_agreement":null},{"id":"W2110956488","doi":"10.1200/jco.2011.40.1646","title":"Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carboplatin; Stage (stratigraphy); Population; Internal medicine; Oncology; Paclitaxel; Clear cell carcinoma; Ovarian carcinoma; Carcinoma; Surgery; Gynecology; Ovarian cancer; Cancer; Chemotherapy; Cisplatin; Biology","score_opus":0.09942625205044944,"score_gpt":0.40801463886365813,"score_spread":0.30858838681320866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110956488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943453,0.00029558165,0.000021697806,0.0039811623,0.000693579,0.00043961426,0.000044948993,0.0000023140456,0.00017581868],"genre_scores_gemma":[0.9959906,0.000049759183,0.0022334515,0.0009962585,0.00036427344,0.000017353337,0.000010486158,0.000016469618,0.00032140312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734986,0.00017715215,0.001673526,0.00015866528,0.00039335404,0.00024744243],"domain_scores_gemma":[0.9939523,0.003789246,0.0014086213,0.00016189799,0.00037231838,0.00031561282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018703989,0.00008878118,0.0011720092,0.000056625406,0.000033474993,0.000014435209,0.000086889086,0.00018821108,0.00011410901],"category_scores_gemma":[0.002170534,0.00009097761,0.00021831706,0.00012403875,0.000041925454,0.00012731693,0.000010773828,0.00029751047,8.016285e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022165983,0.0019879336,0.98828214,0.00008817933,0.000096818636,0.00017635041,0.00003255841,0.00011965673,0.0000028276634,0.000023276947,0.00052298926,0.0064506466],"study_design_scores_gemma":[0.013986115,0.007440497,0.97610646,0.00024875233,0.00030077266,0.000023708679,0.00007981712,0.00006620063,0.0000127882695,0.000020662272,0.0016333875,0.000080830534],"about_ca_topic_score_codex":0.74525857,"about_ca_topic_score_gemma":0.9509222,"teacher_disagreement_score":0.20566365,"about_ca_system_score_codex":0.00068921474,"about_ca_system_score_gemma":0.004424778,"threshold_uncertainty_score":0.78493655},"labels":[],"label_agreement":null},{"id":"W2111513937","doi":"10.1016/j.ygyno.2011.08.027","title":"Defining the limits of radical cytoreductive surgery for ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Comorbidity; Surgery; Complication; Ovarian cancer; Cancer; Radical surgery; Charlson comorbidity index; Retrospective cohort study; Internal medicine","score_opus":0.08564184217394964,"score_gpt":0.34832800996823465,"score_spread":0.262686167794285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111513937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91135377,0.0073329764,0.0004021642,0.030959673,0.004480065,0.0032379325,0.00015798397,0.00012592504,0.041949518],"genre_scores_gemma":[0.9924334,0.0004642525,0.004194754,0.0014432147,0.00019029579,0.0011059411,0.000015182098,0.00001618635,0.00013673413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988344,0.00010995887,0.000343307,0.00028568465,0.000097876255,0.00032882503],"domain_scores_gemma":[0.9970609,0.0022470395,0.000226719,0.0002379528,0.0001311016,0.00009626926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004745661,0.0001417011,0.0005883692,0.00007141027,0.000097354015,0.0000027911567,0.00009994188,0.00021211617,0.0011118237],"category_scores_gemma":[0.0005961365,0.00008525571,0.00020795589,0.0001438134,0.00030399044,0.00002897377,0.000030855463,0.00014178733,0.000015815225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021609103,0.0037933756,0.4572207,0.0001518133,0.0016884971,0.00024572344,0.0033720762,0.000008262385,0.00023548253,0.08995447,0.040003166,0.40116552],"study_design_scores_gemma":[0.003324714,0.003798422,0.9096893,0.000060166454,0.0008928539,0.000090472415,0.00067464594,0.000028384226,0.0061638057,0.0030999025,0.0720012,0.00017616081],"about_ca_topic_score_codex":0.00023527093,"about_ca_topic_score_gemma":0.00016066979,"teacher_disagreement_score":0.45246857,"about_ca_system_score_codex":0.0003495995,"about_ca_system_score_gemma":0.0009190502,"threshold_uncertainty_score":0.9998013},"labels":[],"label_agreement":null},{"id":"W2111658171","doi":"10.1016/j.ygyno.2015.04.009","title":"A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Fallopian tube; Internal medicine; Gastroenterology; Clinical endpoint; Fallopian tube cancer; Phases of clinical research; Progression-free survival; Chemotherapy; Gynecology; Urology; Surgery; Cancer; Randomized controlled trial","score_opus":0.09231435434348424,"score_gpt":0.39577697519004246,"score_spread":0.30346262084655823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111658171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964083,0.00049653027,0.0000011999824,0.0039123646,0.0010249494,0.004181247,0.00017425328,0.000018480412,0.00055015116],"genre_scores_gemma":[0.99797064,0.00034420233,0.00016081925,0.00027564997,0.00013611653,0.000932312,0.000013189073,0.000015723468,0.00015133926],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99749666,0.00043986583,0.0008696756,0.00050397735,0.00032451126,0.00036533322],"domain_scores_gemma":[0.99836224,0.00037306355,0.00045196363,0.00039702153,0.00017827368,0.00023740837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063566223,0.00026431165,0.0011608053,0.00012565701,0.00009710189,0.000007273183,0.00020141063,0.00022654129,0.00047775853],"category_scores_gemma":[0.00062995736,0.00014240788,0.00013460446,0.00036414547,0.00031093313,0.00003546812,0.00021890897,0.0002950488,0.0000013148706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.423502,0.22361894,0.15001142,0.0003933917,0.0018864804,0.0015181362,0.018888136,0.0000583204,0.00019653172,0.00021254492,0.0023644618,0.17734964],"study_design_scores_gemma":[0.63976467,0.2906587,0.026706703,0.00016701664,0.0015117141,0.00013292413,0.007651937,0.00038382786,0.00018118239,0.00003280614,0.03253994,0.00026859198],"about_ca_topic_score_codex":0.0009801167,"about_ca_topic_score_gemma":0.0118310675,"teacher_disagreement_score":0.21626265,"about_ca_system_score_codex":0.00082206045,"about_ca_system_score_gemma":0.0021323129,"threshold_uncertainty_score":0.6602013},"labels":[],"label_agreement":null},{"id":"W2111684784","doi":"10.1177/1535370213508216","title":"Altered expression of inflammation-associated genes in oviductal cells following follicular fluid exposure: Implications for ovarian carcinogenesis","year":2013,"lang":"en","type":"article","venue":"Experimental Biology and Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Guelph; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Biology; Carcinogenesis; Follicular fluid; Inflammation; Epithelium; Endocrinology; Internal medicine; Andrology; Cancer research; Immunology; Cell biology; Medicine; Gene; Oocyte; Embryo","score_opus":0.02119412345350543,"score_gpt":0.31486243672868414,"score_spread":0.2936683132751787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111684784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617965,0.009804649,0.000051297127,0.002513854,0.00025060133,0.0010739056,0.000018850124,0.000016666694,0.000090537724],"genre_scores_gemma":[0.99771786,0.00024884028,0.00067711336,0.00017111162,0.00017071943,0.00074054115,0.00023098977,0.00001310534,0.000029736679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990542,0.000046680238,0.00037004097,0.00027501784,0.000060955008,0.00019311346],"domain_scores_gemma":[0.999453,0.00010844161,0.00010597856,0.00017903479,0.00005002975,0.000103494574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001260034,0.0001502754,0.0004118112,0.00010946469,0.00007459245,0.0000031449301,0.000046976238,0.000125647,0.00009808329],"category_scores_gemma":[0.000040722443,0.00011010547,0.00008032726,0.00010746065,0.000096669966,0.000056325596,0.0000275634,0.000041356994,0.0000018023845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005079031,0.0001740719,0.14446977,0.000018014929,0.00008640148,0.0000013709168,0.0006776303,7.5864676e-7,0.8526653,0.00027247478,0.00024841388,0.0013350025],"study_design_scores_gemma":[0.0054029874,0.0009613736,0.20788522,0.00014377249,0.00008321027,0.0000052743185,0.0005793026,0.000016872818,0.78442544,0.00017069298,0.00023741822,0.00008844428],"about_ca_topic_score_codex":0.00038198076,"about_ca_topic_score_gemma":0.000011035721,"teacher_disagreement_score":0.06823987,"about_ca_system_score_codex":0.000073437644,"about_ca_system_score_gemma":0.000036211393,"threshold_uncertainty_score":0.44899708},"labels":[],"label_agreement":null},{"id":"W2111743676","doi":"10.1017/thg.2012.38","title":"Genome-Wide Association Study for Ovarian Cancer Susceptibility Using Pooled DNA","year":2012,"lang":"en","type":"article","venue":"Twin Research and Human Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Simon Fraser University; BC Cancer Agency","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Genome-wide association study; Genotyping; Single-nucleotide polymorphism; Ovarian cancer; Biology; Genetics; Genetic association; Penetrance; Genotype; Cancer; Phenotype; Gene","score_opus":0.15441857352024996,"score_gpt":0.4382563874050688,"score_spread":0.2838378138848188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111743676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951247,0.0018559597,0.000028340193,0.0007057462,0.00008883153,0.001869909,0.0000352485,0.000016039938,0.00027521446],"genre_scores_gemma":[0.99738556,0.00015634787,0.00047377552,0.00009525233,0.0007276219,0.00021316933,0.000023634388,0.000026109343,0.0008985536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982805,0.00012540129,0.00021999967,0.0002845313,0.00047216946,0.0006173758],"domain_scores_gemma":[0.99874395,0.00024952262,0.000058706577,0.00029176875,0.00035976307,0.00029627408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014634763,0.0001215052,0.00024656934,0.00011665782,0.00037945202,0.000064262706,0.000063456086,0.000078737896,0.00029217632],"category_scores_gemma":[0.00012942584,0.00010691112,0.000049922633,0.00013805236,0.000059425623,0.000045756686,0.00007346349,0.00017007005,0.0000078581115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008486518,0.0013581773,0.9928717,0.00007116399,0.00027876341,0.0000027034143,0.0011210573,0.0000029866708,0.003021199,0.00007172391,0.00050293957,0.00061272446],"study_design_scores_gemma":[0.0027524263,0.0013224621,0.99053687,0.000023455768,0.0002150992,5.1367954e-7,0.00049316214,0.000024654952,0.0011109223,0.00031454596,0.0031059615,0.00009992024],"about_ca_topic_score_codex":0.0004439218,"about_ca_topic_score_gemma":0.00059048174,"teacher_disagreement_score":0.0026675612,"about_ca_system_score_codex":0.00078793464,"about_ca_system_score_gemma":0.00015407044,"threshold_uncertainty_score":0.43597087},"labels":[],"label_agreement":null},{"id":"W2111900617","doi":"10.1038/nrc4019","title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","year":2015,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1425,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Women's College Hospital; University of Toronto; University of British Columbia","funders":"National Cancer Institute; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Ovarian cancer; Serous fluid; Incidence (geometry); Medicine; Disease; Oncology; Cancer; Serous ovarian cancer; Internal medicine; Gynecology","score_opus":0.11562458749610163,"score_gpt":0.4217960661403027,"score_spread":0.306171478644201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111900617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007929876,0.97519404,0.000008488329,0.0035562227,0.009246156,0.0067940177,0.0039848844,0.0002815502,0.0008553703],"genre_scores_gemma":[0.00018506534,0.9704183,0.0016566552,0.0030567923,0.0112759685,0.009368476,0.0018033634,0.0004978926,0.0017375071],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897083,0.0008809057,0.0028816187,0.0031976325,0.001815021,0.0015165366],"domain_scores_gemma":[0.9921947,0.00025879047,0.0027220154,0.0030485874,0.000665116,0.0011107755],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001616704,0.0024478652,0.010288983,0.00042095015,0.00051225023,0.00019835882,0.0009998245,0.0034753885,0.004470122],"category_scores_gemma":[0.00028861256,0.001761533,0.0022786167,0.0019369727,0.00019346122,0.0003209058,0.00045121548,0.0057242904,0.00012288203],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004503098,0.00034620054,0.0004454749,0.022938361,0.004480418,0.00027725863,0.00051403296,0.000007654909,0.0000016662948,0.00022706969,0.061549664,0.9091672],"study_design_scores_gemma":[0.0019342145,0.00010819226,0.00059398025,0.14369556,0.022795834,0.000047523154,0.0000069082434,0.0000049274504,0.000011043473,0.0002761175,0.8291731,0.001352624],"about_ca_topic_score_codex":0.057033043,"about_ca_topic_score_gemma":0.0071359994,"teacher_disagreement_score":0.90781456,"about_ca_system_score_codex":0.008086883,"about_ca_system_score_gemma":0.0070737065,"threshold_uncertainty_score":0.99882585},"labels":[],"label_agreement":null},{"id":"W2112303498","doi":"10.1016/s1701-2163(15)30659-9","title":"The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift","year":2014,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia; University of Toronto","funders":"","keywords":"Fallopian tube; Medicine; Salpingectomy; Ovarian cancer; Serous carcinoma; BRCA mutation; Serous fluid; Gynecology; Fallopian tube cancer; Oncology; Population; Ovarian carcinoma; Cancer; Bioinformatics; Internal medicine; Pregnancy; Genetics; Biology; Ectopic pregnancy","score_opus":0.02583938316465253,"score_gpt":0.3037218945527535,"score_spread":0.277882511388101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112303498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085559936,0.9862225,0.0000018715051,0.0066206064,0.005977638,0.0007614441,0.00009021365,0.0000015741523,0.00023860559],"genre_scores_gemma":[0.003976404,0.9947096,0.000034239285,0.0009665614,0.00012041029,0.00004783728,0.000010204055,0.000030345582,0.000104411156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694437,0.00030771742,0.0016330054,0.00021906018,0.0005784337,0.00031739144],"domain_scores_gemma":[0.9912473,0.00523239,0.0025463782,0.0004887589,0.00024663564,0.00023855484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007497143,0.00035185652,0.0029204069,0.00015313074,0.00012739396,0.000015353353,0.00041722157,0.00021432985,0.00027921994],"category_scores_gemma":[0.0014467211,0.00016645923,0.0004638743,0.0006151846,0.00016293391,0.000023940907,0.000056765664,0.00066670665,7.077727e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000038111225,0.00009090732,0.0006910319,0.023491468,0.0017602807,0.0005835657,0.00002073901,0.0000013065658,3.2516208e-9,0.004530406,0.0056196884,0.96320677],"study_design_scores_gemma":[0.0011237831,0.0005798413,0.0049903216,0.0095414985,0.004692274,0.00024360119,0.000008493836,5.6488165e-7,3.6351645e-7,0.00021487263,0.97847277,0.0001316089],"about_ca_topic_score_codex":0.058968425,"about_ca_topic_score_gemma":0.031207407,"teacher_disagreement_score":0.97285306,"about_ca_system_score_codex":0.0013009021,"about_ca_system_score_gemma":0.009445781,"threshold_uncertainty_score":0.99616975},"labels":[],"label_agreement":null},{"id":"W2112741722","doi":"10.1038/modpathol.2010.202","title":"Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary","year":2010,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Institutes of Health; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Serous fluid; Minichromosome maintenance; Tissue microarray; Biology; Pathology; Ovarian cancer; Concordance; Ovary; Immunohistochemistry; Cancer; Cancer research; Medicine; Bioinformatics; Internal medicine; Proliferating cell nuclear antigen","score_opus":0.016308564708718637,"score_gpt":0.27364259374895067,"score_spread":0.25733402904023206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112741722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907427,0.00023887324,0.0002250461,0.004833599,0.00065668,0.0030007788,0.00020434725,0.000029975841,0.00006804321],"genre_scores_gemma":[0.9944554,0.000005543653,0.0037278705,0.00013598798,0.00015844732,0.0011971258,0.000020607577,0.000039599112,0.00025943268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841356,0.00009392003,0.00036294764,0.00046381017,0.00025627474,0.00040945743],"domain_scores_gemma":[0.99875665,0.00009938625,0.000178802,0.0007681549,0.00010837,0.000088617104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018740707,0.000211782,0.0004757961,0.00007500986,0.000057393983,0.000008354608,0.00025658787,0.00022088202,0.00005007538],"category_scores_gemma":[0.00033381558,0.00013497083,0.00015256727,0.000121237616,0.00019560587,0.000038588292,0.00014150696,0.00031186215,0.0000042498305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012874701,0.0036952172,0.6653565,0.0005529345,0.00018161954,0.0017971355,0.0016652929,0.00002011729,0.29825214,0.002652967,0.0002425415,0.024296064],"study_design_scores_gemma":[0.008358452,0.001420577,0.9500657,0.00026752168,0.0001458185,0.00039017,0.000035104706,0.000385531,0.031020947,0.0075236238,0.00018787444,0.00019869866],"about_ca_topic_score_codex":0.00014215558,"about_ca_topic_score_gemma":0.00046083838,"teacher_disagreement_score":0.28470916,"about_ca_system_score_codex":0.00006083262,"about_ca_system_score_gemma":0.0002761351,"threshold_uncertainty_score":0.55039513},"labels":[],"label_agreement":null},{"id":"W2112788544","doi":"10.1186/1471-2407-8-17","title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Biological and Environmental Research; National Institutes of Health; National Cancer Institute; Office of Science; Michael Smith Health Research BC; U.S. Department of Energy","keywords":"Serous fluid; Loss of heterozygosity; Epigenetics; PTEN; Cancer research; Biology; DNA methylation; Germline mutation; Germline; Somatic cell; Mutation; Medicine; Pathology; Genetics; Gene; Gene expression; PI3K/AKT/mTOR pathway","score_opus":0.02202225993340322,"score_gpt":0.25352175151617196,"score_spread":0.23149949158276872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112788544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830506,0.01305849,0.00064500445,0.00059482956,0.0000827204,0.00044706385,0.000041169245,0.0000350578,0.0020450752],"genre_scores_gemma":[0.99469143,0.0009492443,0.002185847,0.0003657053,0.00019933045,0.00028302375,0.000012319533,0.00004128786,0.0012718261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884874,0.000029696936,0.00018609445,0.00038249724,0.00024753972,0.00030543067],"domain_scores_gemma":[0.9992912,0.000031628857,0.00006179948,0.00033613906,0.00007218842,0.00020707911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003426417,0.00021819424,0.0003147779,0.000056616147,0.00011319166,0.000018531033,0.000050186773,0.00005726187,0.0003157348],"category_scores_gemma":[0.0000071857335,0.00016593302,0.00006244294,0.00009202402,0.00021450594,0.000033742468,0.000030046078,0.00008329396,0.000009569278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017022422,0.0000931337,0.99561715,0.00012699766,0.00015117876,0.0009897937,0.0004864781,0.00009888506,0.00006121646,0.00009455489,0.00025632326,0.0018540543],"study_design_scores_gemma":[0.0029083525,0.00036486503,0.9888273,0.0001381283,0.00030893442,0.00065137696,0.000057565776,0.000076458615,0.0029854695,0.000039097897,0.0034330424,0.00020941418],"about_ca_topic_score_codex":0.0028019582,"about_ca_topic_score_gemma":0.0011831087,"teacher_disagreement_score":0.012109246,"about_ca_system_score_codex":0.00016311028,"about_ca_system_score_gemma":0.000379845,"threshold_uncertainty_score":0.6766552},"labels":[],"label_agreement":null},{"id":"W2112948882","doi":"10.1186/1757-2215-4-10","title":"On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research","year":2011,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Translational research; Disease; Face (sociological concept); Alternative medicine; Cancer; Medical education; Family medicine; Pathology; Internal medicine; Sociology; Social science","score_opus":0.36321323580695797,"score_gpt":0.4242074519189652,"score_spread":0.06099421611200723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112948882","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23308028,0.0008012309,0.00005629903,0.6979727,0.0012231799,0.002016088,0.00019315768,0.000012588862,0.06464448],"genre_scores_gemma":[0.99442875,0.0005948295,0.00049071806,0.0021793817,0.0011612574,0.0001123519,0.000004471751,0.000034873465,0.0009933542],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951739,0.0010137925,0.00046784827,0.0003598001,0.002179477,0.0008052167],"domain_scores_gemma":[0.99488944,0.0018529093,0.00010417559,0.0008527657,0.0014061452,0.0008945623],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049240896,0.00019350491,0.00034309752,0.00056230393,0.0007636984,0.00017898469,0.0007533578,0.00015772521,0.007261733],"category_scores_gemma":[0.00041423374,0.0000945528,0.0001505991,0.0009580962,0.00023808151,0.000091732734,0.000046869947,0.0019847397,0.00035023002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006427763,0.0015361732,0.01011528,0.000037971193,0.0014515701,0.0031563677,0.022157636,0.000017146522,0.001180104,0.33491823,0.58115023,0.037851516],"study_design_scores_gemma":[0.0053183036,0.006697253,0.7538718,0.0025158713,0.0001894721,0.00009631607,0.002265743,0.00008759853,0.005158969,0.028872956,0.19457749,0.00034822527],"about_ca_topic_score_codex":0.17081247,"about_ca_topic_score_gemma":0.068020046,"teacher_disagreement_score":0.7613485,"about_ca_system_score_codex":0.0008139982,"about_ca_system_score_gemma":0.0033818274,"threshold_uncertainty_score":0.9936458},"labels":[],"label_agreement":null},{"id":"W2113122060","doi":"10.1056/nejmoa1103799","title":"A Phase 3 Trial of Bevacizumab in Ovarian Cancer","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"Medicine; Bevacizumab; Hazard ratio; Ovarian cancer; Internal medicine; Carboplatin; Regimen; Oncology; Progression-free survival; Interim analysis; Cancer; Confidence interval; Surgery; Randomized controlled trial; Chemotherapy; Cisplatin","score_opus":0.06633579281492227,"score_gpt":0.35108734056102425,"score_spread":0.284751547746102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113122060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980076,0.0037912484,0.0001483494,0.009294876,0.0013515522,0.00039850298,0.0000055491128,0.0000044169665,0.0049294694],"genre_scores_gemma":[0.9941274,0.0016666312,0.0006351187,0.0002549292,0.003150656,0.0000060423945,0.0000019641893,0.000012588839,0.0001446763],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856603,0.000056431683,0.0007336898,0.00010895916,0.00037886392,0.00015602654],"domain_scores_gemma":[0.998944,0.00008897787,0.00040390395,0.00016110823,0.0001441157,0.0002579],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006091137,0.00012586372,0.0006973301,0.00027638648,0.000011279792,0.0000015887099,0.00008079522,0.00005780042,0.0015127085],"category_scores_gemma":[0.00017651092,0.0000762613,0.00009341658,0.00020981404,0.000064145504,0.00005742416,0.000009178519,0.00022650194,0.0000014445777],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2792886,0.005305926,0.022352407,0.00011383589,0.0007237417,0.0021429337,0.009302395,0.0000035439225,0.0021119644,0.0006166024,0.006824992,0.6712131],"study_design_scores_gemma":[0.9490697,0.019889284,0.013379504,0.0011968166,0.000597269,0.0003880059,0.00015059803,0.000006631022,0.002802627,0.0005544437,0.011895087,0.000070029535],"about_ca_topic_score_codex":0.0015333763,"about_ca_topic_score_gemma":0.00019323063,"teacher_disagreement_score":0.67114305,"about_ca_system_score_codex":0.0001042854,"about_ca_system_score_gemma":0.00045860207,"threshold_uncertainty_score":0.9994},"labels":[],"label_agreement":null},{"id":"W2113586104","doi":"10.1093/carcin/bgr241","title":"Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids","year":2011,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Spheroid; Metastasis; Cancer research; Protein kinase B; Ovarian cancer; Cell growth; Cell; Cell culture; Ascites; Biology; Cell biology; Chemistry; Pathology; Cancer; Medicine; Internal medicine; Signal transduction","score_opus":0.04375976713885234,"score_gpt":0.2601655146120414,"score_spread":0.21640574747318908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113586104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759126,0.00035232757,0.00006895467,0.0002563944,0.000100533165,0.00042111918,0.000083699386,0.000025766236,0.0010999595],"genre_scores_gemma":[0.99890316,0.00017168433,0.00045624492,0.00011662596,0.00005175223,0.000085837004,0.000015392869,0.000028972187,0.00017032353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989376,0.00005311531,0.0002102733,0.00031646495,0.0002421855,0.00024032558],"domain_scores_gemma":[0.99925244,0.000032812906,0.00016162443,0.00030688095,0.00014934955,0.00009687125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001214137,0.00017884564,0.00042193153,0.00013072226,0.000040782706,0.000005031413,0.000063653715,0.0001114435,0.00070704345],"category_scores_gemma":[0.000021251022,0.0001467875,0.00009745253,0.0004710072,0.000053411564,0.0001129989,0.000022837554,0.00007635692,0.0000065950303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005468766,0.00053981977,0.9476489,0.000058570105,0.00032718966,0.000050356728,0.0012557772,0.000024591489,0.0397678,0.00001827997,0.000086899614,0.0096749775],"study_design_scores_gemma":[0.0027684509,0.00027054502,0.74753815,0.00020354257,0.00024082561,0.0000024881463,0.00003919974,0.00014035024,0.24864487,0.000022089465,0.000018562394,0.00011089283],"about_ca_topic_score_codex":0.0056649926,"about_ca_topic_score_gemma":0.0009941974,"teacher_disagreement_score":0.20887707,"about_ca_system_score_codex":0.00034822067,"about_ca_system_score_gemma":0.00022871395,"threshold_uncertainty_score":0.8563812},"labels":[],"label_agreement":null},{"id":"W2113679067","doi":"10.1158/1078-0432.ccr-12-2155","title":"Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Congressionally Directed Medical Research Programs","keywords":"Fallopian tube; Serous fluid; Ovarian cancer; Germline mutation; Biology; Serous Cystadenoma; Population; Pathology; BRCA mutation; Cancer; Cancer research; Medicine; Internal medicine; Gynecology; Mutation; Genetics","score_opus":0.28016628688970757,"score_gpt":0.5606441821127327,"score_spread":0.28047789522302513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113679067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97403085,0.0015884158,0.000009635216,0.021438587,0.00023068128,0.0013262259,0.00003963165,0.0000052526043,0.0013306945],"genre_scores_gemma":[0.9959307,0.0009388659,0.00006343735,0.001740833,0.0005633379,0.0005529818,0.000013101077,0.000012314939,0.00018444368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973235,0.0006322848,0.00048088995,0.000215235,0.0009040574,0.00044401715],"domain_scores_gemma":[0.99837214,0.0007072925,0.000093511626,0.00044426802,0.00024990822,0.00013287393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003262828,0.00008809926,0.00023564343,0.00006498816,0.00010605428,0.000022891214,0.00015174651,0.00009683734,0.00032214195],"category_scores_gemma":[0.0005290651,0.0000458902,0.00014873265,0.0004995837,0.0002099683,0.00010279546,0.00005746663,0.0005268799,0.000022055749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013101614,0.0027122805,0.91487426,0.00010690633,0.00013561288,0.000015428182,0.002517545,0.000008413611,0.00014612514,0.00067033427,0.010250128,0.06725283],"study_design_scores_gemma":[0.006208186,0.00086111797,0.9542314,0.00016554983,0.00009044477,0.0000054798406,0.00025475884,0.0002022644,0.005117214,0.00009988395,0.032698467,0.000065229084],"about_ca_topic_score_codex":0.00090585585,"about_ca_topic_score_gemma":0.00036427955,"teacher_disagreement_score":0.0671876,"about_ca_system_score_codex":0.00020501483,"about_ca_system_score_gemma":0.0005628267,"threshold_uncertainty_score":0.35272282},"labels":[],"label_agreement":null},{"id":"W2113964935","doi":"10.1093/annonc/mdt473","title":"Targeted therapies and clinical trials in ovarian cancer","year":2013,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Impact; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Ovarian cancer; Druggability; Clinical trial; Targeted therapy; Oncology; Olaparib; Bioinformatics; Cancer; Cancer research; Computational biology; Internal medicine; Gene; Biology; Genetics","score_opus":0.5412878740202864,"score_gpt":0.6029907062384672,"score_spread":0.061702832218180736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113964935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013259989,0.98980093,8.477262e-7,0.006623746,0.0004758052,0.0017552377,0.00007674112,0.000008467178,0.0011256202],"genre_scores_gemma":[0.00013186442,0.9972432,0.00032105364,0.00088686956,0.00047493278,0.000642589,0.000045911893,0.000031977786,0.00022156103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953021,0.0017978199,0.0021114943,0.00041192924,0.00011614951,0.00026051188],"domain_scores_gemma":[0.9953024,0.0029885555,0.0011271377,0.0003009966,0.00012311958,0.00015779144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003623512,0.0002934118,0.006486086,0.0002343644,0.000015500944,0.000008236441,0.00009162708,0.00070712034,0.000938494],"category_scores_gemma":[0.00085409643,0.00018427343,0.0007460872,0.00017932481,0.00016144654,0.0000320386,0.000049096605,0.0003815446,0.000024240806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063896376,0.0006648496,0.001205178,0.0024403255,0.0018228759,0.00006181894,0.000053449676,2.0973197e-8,2.2148735e-7,0.00018328664,0.01195761,0.98154646],"study_design_scores_gemma":[0.0022008396,0.0019209986,0.0034364783,0.0054251826,0.0015624526,0.000019861685,0.000014463591,4.9174565e-7,0.000002296095,0.00012228994,0.9851617,0.00013292086],"about_ca_topic_score_codex":0.00070365897,"about_ca_topic_score_gemma":0.00016687864,"teacher_disagreement_score":0.98141354,"about_ca_system_score_codex":0.0000829232,"about_ca_system_score_gemma":0.0012679017,"threshold_uncertainty_score":0.9999748},"labels":[],"label_agreement":null},{"id":"W2114005635","doi":"10.1210/endo.142.8.8320","title":"Ovarian Pathology and High Incidence of Sex Cord Tumors in Follitropin Receptor Knockout (FORKO) Mice","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Ovary; Follicle-stimulating hormone receptor; Internal medicine; Endocrinology; Biology; Knockout mouse; Stromal cell; Hypergonadotropic hypogonadism; Receptor; Follicle-stimulating hormone; Medicine; Hormone; Luteinizing hormone","score_opus":0.01559113991141172,"score_gpt":0.27795653035794576,"score_spread":0.26236539044653406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114005635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252033,0.0014871408,0.000052484473,0.0039598495,0.00023633831,0.00032608802,0.000010802788,0.000029747682,0.0013772064],"genre_scores_gemma":[0.9950159,0.0020597,0.0017746026,0.00046589502,0.00009368129,0.00006627481,0.000017843782,0.000016979442,0.00048913097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986678,0.00009260626,0.00035953394,0.00038160823,0.0000938111,0.0004046715],"domain_scores_gemma":[0.999346,0.00014150995,0.000106856736,0.0002775706,0.00004086824,0.00008715373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006552772,0.00016266602,0.00052675116,0.00018603925,0.000028297885,0.0000038621556,0.000080838625,0.00009210164,0.00034174856],"category_scores_gemma":[0.00007869236,0.000146135,0.00004627173,0.00018850491,0.00017011211,0.00004128322,0.000078645775,0.00018686087,0.000031776286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006652203,0.00043276232,0.9064635,0.000057427886,0.00009162648,0.003704267,0.00044325888,0.0000030368037,0.00356612,0.010529655,0.00033162485,0.07371152],"study_design_scores_gemma":[0.00535235,0.0018750852,0.9681512,0.00012763815,0.000072584386,0.0025430436,0.00024031129,0.00001619668,0.009287131,0.00088903174,0.011273643,0.00017180173],"about_ca_topic_score_codex":0.0014284694,"about_ca_topic_score_gemma":0.00043780557,"teacher_disagreement_score":0.07353972,"about_ca_system_score_codex":0.00010444296,"about_ca_system_score_gemma":0.00010781067,"threshold_uncertainty_score":0.5959213},"labels":[],"label_agreement":null},{"id":"W2115198702","doi":"10.1186/s13048-014-0123-1","title":"The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells","year":2014,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Serous fluid; In vivo; Gene knockdown; Ovarian cancer; In vitro; Medicine; Cancer research; Cell growth; Ovary; Cancer; Oncology; Cell culture; Internal medicine; Biology; Pathology; Biotechnology","score_opus":0.025606291329124953,"score_gpt":0.3365678987801932,"score_spread":0.31096160745106827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115198702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98505574,0.0038626713,0.000027827067,0.007939774,0.0003124741,0.000545764,0.000025010273,0.000004410245,0.0022263317],"genre_scores_gemma":[0.9963057,0.001905467,0.0012416494,0.00011923282,0.00029304967,0.00002636448,0.0000027745202,0.00002484628,0.00008089105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968062,0.00048149945,0.00085774367,0.0001960772,0.0012266746,0.0004318096],"domain_scores_gemma":[0.9975678,0.0005746072,0.00049511634,0.000412598,0.00073929376,0.000210602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001738379,0.00015408732,0.0006151834,0.00033223495,0.00010477221,0.00003446565,0.00031242752,0.00012482893,0.00012027224],"category_scores_gemma":[0.0002103852,0.00009235581,0.0001792518,0.00052158674,0.00021783369,0.000096050804,0.000096832664,0.00066038663,0.0000034329232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006211241,0.004980066,0.08238332,0.00066025864,0.0019221464,0.0005389811,0.0063389945,0.0006383159,0.60676074,0.010558063,0.013373341,0.26563454],"study_design_scores_gemma":[0.010036717,0.0041484176,0.46149743,0.0013216193,0.00021388559,0.00012929956,0.0015263088,0.00011289766,0.48237783,0.0054296395,0.033001482,0.00020448082],"about_ca_topic_score_codex":0.002092946,"about_ca_topic_score_gemma":0.00021768993,"teacher_disagreement_score":0.37911412,"about_ca_system_score_codex":0.00034297683,"about_ca_system_score_gemma":0.00068626844,"threshold_uncertainty_score":0.37661606},"labels":[],"label_agreement":null},{"id":"W2115421008","doi":"10.1158/1541-7786.mcr-08-0193","title":"Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health","keywords":"Serous fluid; KRAS; Cancer research; Neuroblastoma RAS viral oncogene homolog; Ovarian cancer; MAPK/ERK pathway; Serous carcinoma; Carcinogenesis; Biology; HMGA2; Cancer; Medicine; Internal medicine; Signal transduction; Colorectal cancer; Gene; Genetics; microRNA","score_opus":0.06228791382504891,"score_gpt":0.364613128376661,"score_spread":0.3023252145516121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115421008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611943,0.00029367633,0.032831263,0.0027866985,0.000089023786,0.0026673428,0.000060336934,0.000007126408,0.00007027344],"genre_scores_gemma":[0.9971964,0.00018909328,0.001039192,0.00009618632,0.00007651996,0.0012928358,0.000020759548,0.00002965865,0.000059385184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982319,0.00009147788,0.00032400445,0.0003044206,0.0007452723,0.00030292317],"domain_scores_gemma":[0.998688,0.00016436583,0.00014142289,0.000277792,0.0006700308,0.00005841091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044393452,0.0001232056,0.00028040484,0.00024623648,0.00009054199,0.000010048065,0.00013735401,0.00006344598,0.000025378964],"category_scores_gemma":[0.00016973905,0.0000898415,0.0001072048,0.00042522882,0.000132745,0.00006266961,0.000048621518,0.00017396885,8.452528e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001714423,0.0010013126,0.00086995994,0.00047369616,0.00042077905,0.00035885125,0.0021694987,0.0031887465,0.9768326,0.007975755,0.000085017906,0.0049093477],"study_design_scores_gemma":[0.004139432,0.00079562876,0.009329782,0.00055408006,0.000055971854,0.000031251966,0.00030205812,0.004467354,0.97895855,0.0012672427,0.00001855523,0.00008011995],"about_ca_topic_score_codex":0.009447502,"about_ca_topic_score_gemma":0.00019803293,"teacher_disagreement_score":0.03600211,"about_ca_system_score_codex":0.00037214853,"about_ca_system_score_gemma":0.0006847667,"threshold_uncertainty_score":0.9971487},"labels":[],"label_agreement":null},{"id":"W2115533722","doi":"10.1053/hupa.2001.20900","title":"Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: A case report","year":2001,"lang":"en","type":"article","venue":"Human Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Cytokeratin; Endometrium; Pathology; Immunostaining; Carcinoma; Clear cell carcinoma; Immunohistochemistry; Ovary; Medicine; Biology; Internal medicine","score_opus":0.021336461749364544,"score_gpt":0.2518469042250313,"score_spread":0.23051044247566677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115533722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903062,0.00014182678,0.00004659088,0.00077631517,0.0000869115,0.00036235177,0.000058217676,0.000020573172,0.008200997],"genre_scores_gemma":[0.9984929,0.000002334299,0.0001370086,0.0003911854,0.00008438657,0.00006858395,0.00006913911,0.000021595031,0.0007328415],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99885815,0.000105211715,0.00030663592,0.00030131364,0.00019721115,0.00023146947],"domain_scores_gemma":[0.99911743,0.00007693795,0.0002020838,0.0004087455,0.00011561533,0.00007921146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020886431,0.00014599926,0.00034667176,0.000117907286,0.0001218104,0.0000054355114,0.00005561562,0.000078566874,0.00058343407],"category_scores_gemma":[0.00003055794,0.000093585106,0.00013468493,0.00023184947,0.00015430436,0.000022708451,0.000018123068,0.0001569055,0.0000055649407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001738503,0.0016195724,0.42027995,0.000029177318,0.0001329373,0.5732349,0.00076402375,0.00000795501,0.0021061855,0.0007541666,0.0007102767,0.00018700349],"study_design_scores_gemma":[0.006517876,0.0010653232,0.73749745,0.0000423534,0.00049702195,0.2511023,0.00011713317,0.000007282283,0.00247451,0.00013716488,0.00041699805,0.0001245885],"about_ca_topic_score_codex":0.00020598917,"about_ca_topic_score_gemma":0.0003967347,"teacher_disagreement_score":0.32213262,"about_ca_system_score_codex":0.00010840439,"about_ca_system_score_gemma":0.00014007291,"threshold_uncertainty_score":0.6388194},"labels":[],"label_agreement":null},{"id":"W2116145684","doi":"10.1158/1078-0432.ccr-07-4959","title":"Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from <i>BRCA</i> Mutation Carriers Resemble High-Grade Serous Carcinoma","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University Health Network","keywords":"Luteal phase; Biology; Serous carcinoma; Cancer research; Follicular phase; Pathology; Ovarian cancer; Internal medicine; Endocrinology; Genetics; Medicine; Cancer","score_opus":0.1903665756927608,"score_gpt":0.47073682850195914,"score_spread":0.28037025280919836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116145684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004626,0.0032410224,0.00003343015,0.004013187,0.0005092078,0.0011925017,0.00054236193,0.000046563742,0.0003754586],"genre_scores_gemma":[0.99206614,0.0032834874,0.0016724317,0.00024029904,0.0012468101,0.00053256715,0.0002585186,0.000059603415,0.00064014335],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566007,0.0005951289,0.00093043543,0.0008601764,0.00130595,0.0006482566],"domain_scores_gemma":[0.9968447,0.0008920353,0.00018863156,0.00083597575,0.00062536635,0.0006133085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009915067,0.00024108854,0.0007755364,0.00019370379,0.00027468003,0.000020490628,0.00027527087,0.00029352534,0.0005366869],"category_scores_gemma":[0.00041355225,0.00019149823,0.00025682274,0.00051017967,0.00065440615,0.00012205421,0.00015416696,0.00081202906,0.000040171923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008463865,0.005972096,0.8170025,0.00035773334,0.00070745713,0.0025650302,0.0019963619,0.00007193226,0.07144038,0.00010222757,0.06241592,0.028904503],"study_design_scores_gemma":[0.022128569,0.0039643566,0.3403264,0.0005034934,0.00019277364,0.000030764608,0.00033337303,0.00018568824,0.62573475,0.00031790955,0.005985234,0.00029672042],"about_ca_topic_score_codex":0.011972283,"about_ca_topic_score_gemma":0.00032986168,"teacher_disagreement_score":0.55429435,"about_ca_system_score_codex":0.0004156101,"about_ca_system_score_gemma":0.0014517843,"threshold_uncertainty_score":0.9946071},"labels":[],"label_agreement":null},{"id":"W2116183806","doi":"10.1016/s1470-2045(12)70567-3","title":"Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; McMaster University","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Bevacizumab; Medicine; Ovarian cancer; Carboplatin; Clinical endpoint; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Oncology; Chemotherapy; Endometrial cancer; Gynecologic oncology; Cancer; Clinical trial; Surgery","score_opus":0.07110357242492646,"score_gpt":0.4109774263119079,"score_spread":0.33987385388698144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116183806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8564069,0.00009550038,0.00013336012,0.1375898,0.0007460686,0.0034949165,0.0002293524,0.00003281807,0.0012712801],"genre_scores_gemma":[0.9855762,0.0004913788,0.0014914894,0.009533488,0.00078090245,0.0018163198,0.0000807273,0.000029547211,0.00019993905],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979135,0.0004194882,0.0006295534,0.0003417157,0.00042277586,0.0002730028],"domain_scores_gemma":[0.9970587,0.0016255195,0.0004875196,0.0005433433,0.00019761627,0.0000873093],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077353796,0.00023985465,0.0012398786,0.00005989023,0.000085859225,0.0000459859,0.00029079756,0.00012152229,0.0017350399],"category_scores_gemma":[0.0003343799,0.000108690634,0.000089639536,0.00023661731,0.0001441922,0.00009872023,0.000026360245,0.00026296815,0.000013766548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8768721,0.0012429716,0.060469843,0.00001681976,0.0011285681,0.000014152576,0.0027122344,0.0001110754,0.00038020912,0.000952729,0.0034079489,0.052691318],"study_design_scores_gemma":[0.9028552,0.0049492763,0.06551111,0.00013169264,0.00017429437,0.0000033320828,0.0009459048,0.00022697712,0.0009621893,0.00033103165,0.023731368,0.00017758149],"about_ca_topic_score_codex":0.002945672,"about_ca_topic_score_gemma":0.007036828,"teacher_disagreement_score":0.1291693,"about_ca_system_score_codex":0.0005912221,"about_ca_system_score_gemma":0.0012831581,"threshold_uncertainty_score":0.9991775},"labels":[],"label_agreement":null},{"id":"W2116330399","doi":"10.1017/s1368980007696360","title":"Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study","year":2007,"lang":"en","type":"article","venue":"Public Health Nutrition","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Prospective cohort study; Quartile; Internal medicine; Cohort; Proportional hazards model; Cohort study; Ovarian cancer; Cancer; Glycemic index; Breast cancer; Gynecology; Confidence interval; Insulin","score_opus":0.023034076922285623,"score_gpt":0.33071598494990706,"score_spread":0.3076819080276214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116330399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665497,0.005098063,0.0005277569,0.02012556,0.00031427518,0.0061833365,0.00007078248,0.00015021597,0.0009803309],"genre_scores_gemma":[0.991878,0.0043168114,0.00033389975,0.0013147291,0.00053700345,0.0014743601,0.000046620476,0.000033385084,0.00006523573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975284,0.00011695596,0.00050829846,0.00063194096,0.0005559489,0.00065849815],"domain_scores_gemma":[0.9983826,0.00009488844,0.00025184892,0.00033305737,0.0003011583,0.00063641724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018528908,0.00023037041,0.00051230536,0.00024028722,0.0002786193,0.000061146166,0.000057563044,0.000121105535,0.00012649858],"category_scores_gemma":[0.00012014838,0.00020834096,0.00006022837,0.00054923235,0.00006562407,0.00018909074,0.000034328026,0.00036743542,0.0000136923645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035667792,0.0032909133,0.9459154,0.00019294677,0.00023124846,0.00003874185,0.0011821191,1.6259611e-7,0.0000045824618,0.00015167483,0.0017384464,0.04689708],"study_design_scores_gemma":[0.010773792,0.0014189625,0.9742875,0.00019724118,0.00011221084,0.00005898677,0.00082597067,0.000035735444,0.000024050476,0.00019261993,0.011913932,0.00015897633],"about_ca_topic_score_codex":0.010945144,"about_ca_topic_score_gemma":0.0033414064,"teacher_disagreement_score":0.046738103,"about_ca_system_score_codex":0.0029734035,"about_ca_system_score_gemma":0.0010459202,"threshold_uncertainty_score":0.99564105},"labels":[],"label_agreement":null},{"id":"W2116411136","doi":"10.1002/path.2659","title":"Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma","year":2009,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; Université de Montréal; Vancouver General Hospital; Hôtel-Dieu de Montréal; University of British Columbia; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; University of Michigan","keywords":"Ovarian carcinoma; Carcinoma; Serous carcinoma; Serous fluid; Ovary; Medicine; Internal medicine; Oncology; Pathology; Ovarian cancer; Cancer","score_opus":0.017790209649733806,"score_gpt":0.24877125271037487,"score_spread":0.23098104306064107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116411136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909326,0.0007674346,0.00042650432,0.0073498315,0.0001541258,0.00021563275,0.000015049311,0.0000032392022,0.00013559469],"genre_scores_gemma":[0.998994,0.0001721951,0.00016941085,0.00044272278,0.000187213,0.0000015610723,0.0000029968444,0.000008126078,0.000021756308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988849,0.00025591764,0.00039592432,0.0001002099,0.00020934502,0.00015371176],"domain_scores_gemma":[0.99897826,0.000117555566,0.00045139028,0.00025663502,0.000121763536,0.000074412594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040167331,0.00012342002,0.00042693602,0.0001276785,0.0000687224,0.000009235147,0.0001571266,0.0000787495,0.000021228609],"category_scores_gemma":[0.00007280966,0.00006192577,0.000100414625,0.00022176457,0.00010886826,0.000043701817,0.000033121774,0.00020572779,7.5429085e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002049882,0.0001591863,0.8056906,0.000020312425,0.000115818395,0.00035935635,0.0012434094,8.645385e-7,0.17939657,0.00067518145,0.000010692073,0.012123039],"study_design_scores_gemma":[0.0017921176,0.0013911799,0.9642754,0.000047387795,0.0005411726,0.0016553337,0.00005957249,0.0000044354765,0.029686196,0.0004473604,0.00005007885,0.000049736234],"about_ca_topic_score_codex":0.000030317176,"about_ca_topic_score_gemma":0.0000023440668,"teacher_disagreement_score":0.15858485,"about_ca_system_score_codex":0.000041566655,"about_ca_system_score_gemma":0.000093456525,"threshold_uncertainty_score":0.25252596},"labels":[],"label_agreement":null},{"id":"W2116430774","doi":"10.1016/j.jpag.2013.11.006","title":"The Recurrence Rate of Ovarian Dermoid Cysts in Pediatric and Adolescent Girls","year":2014,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Pediatrics; Demography","score_opus":0.011948607457758971,"score_gpt":0.2580573291738095,"score_spread":0.24610872171605055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116430774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772286,0.016078489,0.00014145445,0.0052968427,0.0007597028,0.00034973343,0.000004247792,0.0000051530637,0.00013579096],"genre_scores_gemma":[0.9362316,0.06192557,0.00020330286,0.0005589509,0.0010292585,0.00000533648,0.0000010083427,0.000012814046,0.000032153068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982244,0.00024103757,0.0007934042,0.00022614164,0.00018992534,0.00032509342],"domain_scores_gemma":[0.9980516,0.00068621646,0.00067317847,0.00017342117,0.0001784736,0.00023712683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010498029,0.0001910261,0.0005643035,0.00026703015,0.0000865014,0.000023896499,0.00011422854,0.00013085351,0.00001485039],"category_scores_gemma":[0.00053063355,0.00012425309,0.00010220261,0.0002789038,0.000095459895,0.00006813009,0.00006499434,0.000412851,0.0000027302406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030138076,0.0006297984,0.96815276,0.00037824802,0.000037042722,0.00008388723,0.0000709402,0.000006272556,0.00002086934,0.00025331107,0.0056329714,0.024432538],"study_design_scores_gemma":[0.0047291988,0.0010233535,0.98977876,0.00009576389,0.00048190958,0.00014888482,0.000040015806,0.000051388914,0.000039717077,0.00029253197,0.0032077301,0.0001107239],"about_ca_topic_score_codex":0.000005621457,"about_ca_topic_score_gemma":0.000014925001,"teacher_disagreement_score":0.04584708,"about_ca_system_score_codex":0.00009314887,"about_ca_system_score_gemma":0.00026190485,"threshold_uncertainty_score":0.50668937},"labels":[],"label_agreement":null},{"id":"W2117769291","doi":"10.1016/j.ijrobp.2014.05.1544","title":"Transvaginal Ultrasound-Guided Interstitial Brachytherapy for Vaginal Tumors: A Fixed Template Technique","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brachytherapy; Nuclear medicine; Vagina; External beam radiotherapy; Implant; Magnetic resonance imaging; Radiation therapy; Perineum; Radiology; Surgery","score_opus":0.02479059876047698,"score_gpt":0.3522486759620596,"score_spread":0.32745807720158265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117769291","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23039277,0.00044501034,0.744603,0.017297182,0.0040620896,0.0013222572,0.00021530596,0.00010900371,0.0015534147],"genre_scores_gemma":[0.97280306,0.0002962143,0.020347653,0.002066282,0.0041262177,0.00012868726,0.00014711618,0.000041119536,0.00004365325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820846,0.00017110811,0.00081160263,0.00028463046,0.000254492,0.00026972927],"domain_scores_gemma":[0.9974214,0.00065739494,0.0008154019,0.00016598297,0.0007775981,0.00016225026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069170573,0.00025102668,0.00060683873,0.00019508135,0.0000817013,0.0000398363,0.00030272396,0.00021183718,0.00011823161],"category_scores_gemma":[0.00023244029,0.00021467307,0.00037987815,0.00011688498,0.00016618053,0.00022675877,0.000016203767,0.00037310738,0.000013379684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006345495,0.0037756155,0.364263,0.00010076947,0.0047861063,0.00019254332,0.0015961801,0.0007723235,0.0675857,0.08120876,0.022172032,0.4472015],"study_design_scores_gemma":[0.0797664,0.03086588,0.08274295,0.0011010326,0.0016082125,0.010806027,0.0001831385,0.003942853,0.11541898,0.10066609,0.57156986,0.0013285883],"about_ca_topic_score_codex":0.0000255486,"about_ca_topic_score_gemma":0.000005118898,"teacher_disagreement_score":0.7424103,"about_ca_system_score_codex":0.00079817814,"about_ca_system_score_gemma":0.0005470357,"threshold_uncertainty_score":0.8754114},"labels":[],"label_agreement":null},{"id":"W2118060163","doi":"10.1016/j.ygyno.2014.07.004","title":"The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Ovarian cancer; Oncology; Neoadjuvant therapy; Internal medicine; General surgery; Gynecology; Surgery; Cancer; Breast cancer","score_opus":0.020369816799317087,"score_gpt":0.3127163489134138,"score_spread":0.2923465321140967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118060163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986673,0.0013192251,0.000016039772,0.008657752,0.00074258697,0.0003438889,0.000024392832,0.000016786606,0.0022063323],"genre_scores_gemma":[0.9941325,0.0041269306,0.00044972976,0.0010284481,0.00012544206,0.000072485214,0.000008670792,0.000014377718,0.000041424453],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987987,0.00016280814,0.00037437078,0.000258907,0.00014102385,0.00026414922],"domain_scores_gemma":[0.99437964,0.0048186807,0.00033817734,0.00028738775,0.000081639344,0.00009447491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050695054,0.00015205482,0.0007299329,0.000053992742,0.000072461386,0.000004855898,0.000073578376,0.00015206821,0.00020925976],"category_scores_gemma":[0.00046285443,0.00009068742,0.000100590245,0.00010148188,0.00018474103,0.000021725218,0.000030766794,0.00012068437,0.0000027155234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089637114,0.00048179794,0.33802822,0.000030217752,0.00030329628,0.00001851462,0.00019192412,0.000016841106,0.0023325572,0.0009505321,0.0006321152,0.6561176],"study_design_scores_gemma":[0.0037019206,0.0023351272,0.95845276,0.000096687414,0.00012331989,0.000004023582,0.00009534774,0.00005255668,0.007759776,0.00084379484,0.026442738,0.0000919274],"about_ca_topic_score_codex":0.0008197637,"about_ca_topic_score_gemma":0.0011764292,"teacher_disagreement_score":0.6560257,"about_ca_system_score_codex":0.00019658603,"about_ca_system_score_gemma":0.00027416612,"threshold_uncertainty_score":0.36981258},"labels":[],"label_agreement":null},{"id":"W2118228232","doi":"10.1186/s12885-015-1421-8","title":"Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms","year":2015,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation; VGH and UBC Hospital Foundation","keywords":"KRAS; CDKN2A; PTEN; Cancer research; STK11; Biology; Ovarian cancer; Mucinous carcinoma; Massive parallel sequencing; Genetic heterogeneity; Exome sequencing; Cancer; Adenocarcinoma; Mutation; DNA sequencing; Gene; Colorectal cancer; Genetics; PI3K/AKT/mTOR pathway; Phenotype; Signal transduction","score_opus":0.045508922290677184,"score_gpt":0.29582748717758145,"score_spread":0.2503185648869043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118228232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936888,0.0035735143,0.0006631233,0.00047432544,0.00023030434,0.00074606226,0.000065839704,0.000045898458,0.0005121052],"genre_scores_gemma":[0.98985773,0.0001263873,0.009062861,0.0002546955,0.00019414953,0.0002926681,0.000039543324,0.000038834503,0.00013312811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840516,0.000063144325,0.00050674286,0.00040166735,0.00027774088,0.0003455456],"domain_scores_gemma":[0.9988097,0.00022049046,0.00026521494,0.00025114536,0.0002389349,0.00021451808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002635058,0.00021927117,0.0005423268,0.00018227159,0.000064956046,0.000018829951,0.000057116657,0.00008880957,0.00005989023],"category_scores_gemma":[0.00048572704,0.00020378477,0.00006079133,0.0004494204,0.000053545566,0.0001415097,0.00003921454,0.00017157069,0.0000017604385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045249844,0.00025574627,0.9376005,0.00043611258,0.00017769472,0.00011618684,0.008530105,0.013594251,0.01512277,0.00014711352,0.0001789524,0.023388105],"study_design_scores_gemma":[0.024630494,0.00085723266,0.89118373,0.0034148118,0.00028841733,0.00016023267,0.008706397,0.035554416,0.032579124,0.00040815922,0.001397219,0.0008197529],"about_ca_topic_score_codex":0.02400666,"about_ca_topic_score_gemma":0.021294141,"teacher_disagreement_score":0.046416722,"about_ca_system_score_codex":0.0014444026,"about_ca_system_score_gemma":0.0013071989,"threshold_uncertainty_score":0.9965647},"labels":[],"label_agreement":null},{"id":"W2118275137","doi":"10.1136/jcp.2010.079319","title":"<i>Diagnostic Pathology: Genitourinary</i>","year":2010,"lang":"he","type":"article","venue":"Journal of Clinical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Genitourinary system; Pathology; Medicine; Bioinformatics; Biology; Internal medicine","score_opus":0.051426645753074846,"score_gpt":0.41266411873655995,"score_spread":0.3612374729834851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118275137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9331685,0.007763833,0.00010195817,0.023121633,0.031543586,0.00042776423,0.000052135525,0.000020166008,0.0038004396],"genre_scores_gemma":[0.9572306,0.015216264,0.004567117,0.004849835,0.017424058,0.000013172202,0.0000072399926,0.000074191295,0.0006175128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925861,0.0011237526,0.0042929715,0.00063966395,0.0005702491,0.000787292],"domain_scores_gemma":[0.98515767,0.009188932,0.00279094,0.0009448596,0.00083151326,0.0010860894],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.005624592,0.00048675653,0.0026566866,0.00026977863,0.00013007523,0.00003804914,0.0005201153,0.0014033777,0.0029197077],"category_scores_gemma":[0.016443186,0.00036667899,0.0014660622,0.000245691,0.0009825045,0.00014643208,0.00018508852,0.0046004537,0.0011098171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013575273,0.007199956,0.69651216,0.00012754297,0.00082604686,0.13565443,0.0002545697,0.000005271591,0.0011730399,0.0008480277,0.045717657,0.11032377],"study_design_scores_gemma":[0.013158143,0.013460069,0.8015244,0.0003735954,0.0028272632,0.029350009,0.00010657201,0.000011190923,0.00031295515,0.0017625825,0.13675533,0.00035787967],"about_ca_topic_score_codex":0.000009732153,"about_ca_topic_score_gemma":0.000039316583,"teacher_disagreement_score":0.10996589,"about_ca_system_score_codex":0.000065434404,"about_ca_system_score_gemma":0.0013264449,"threshold_uncertainty_score":0.999893},"labels":[],"label_agreement":null},{"id":"W2118514776","doi":"10.1016/j.ygyno.2007.02.015","title":"Intraperitoneal chemotherapy for patients with advanced ovarian cancer: A review of the evidence and standards for the delivery of care","year":2007,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; McMaster University; Cancer Care Ontario; Ottawa Hospital; University of British Columbia; University of Toronto; Université de Montréal; University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Context (archaeology); Regimen; Randomized controlled trial; Oncology; Chemotherapy regimen; Intensive care medicine; Cochrane Library; Adverse effect; Clinical trial; Ovarian cancer; Cancer; Internal medicine","score_opus":0.042317622743555335,"score_gpt":0.40803425185382597,"score_spread":0.36571662911027064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118514776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014430967,0.98572046,0.000029174755,0.0013204416,0.00040539386,0.011373047,0.00092494756,0.000008049363,0.00007417801],"genre_scores_gemma":[0.00037730744,0.99267125,0.001723931,0.0011201119,0.00009469678,0.0039213384,0.000041996478,0.000033519027,0.000015838415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816024,0.00012051575,0.0007021317,0.00041018554,0.000321468,0.00028545718],"domain_scores_gemma":[0.9936395,0.0036178997,0.00097002863,0.00046884618,0.0012434024,0.000060290986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007055101,0.00032845332,0.002328362,0.000049923274,0.00010597641,0.000003823633,0.00024121767,0.0002933568,0.00008433616],"category_scores_gemma":[0.0006213137,0.0001424892,0.0004434931,0.00023112648,0.00031027792,0.000027548727,0.000056958575,0.00018946678,1.1045216e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046792687,0.0002425717,0.000650983,0.096214734,0.0005859287,0.0000015990768,0.00007612735,2.9204617e-7,8.336175e-8,0.00005408058,0.0008687529,0.90083694],"study_design_scores_gemma":[0.0032359366,0.0077605457,0.0022205438,0.07116944,0.004614625,0.000007279556,0.000040933737,5.097121e-7,0.000004759098,0.0000071459353,0.9108091,0.00012916775],"about_ca_topic_score_codex":0.000036723628,"about_ca_topic_score_gemma":0.00018432815,"teacher_disagreement_score":0.90994036,"about_ca_system_score_codex":0.0012817662,"about_ca_system_score_gemma":0.0035847551,"threshold_uncertainty_score":0.63592017},"labels":[],"label_agreement":null},{"id":"W2118522664","doi":"10.1016/s1701-2163(16)32970-x","title":"Variations in Ultrasound Reporting on Patients Referred for Investigation of Ovarian Masses","year":2008,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Ultrasound; Audit; Malignancy; Descriptive statistics; Radiology; Internal medicine","score_opus":0.03699101027603634,"score_gpt":0.26454137779810777,"score_spread":0.22755036752207142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118522664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968325,0.0002715507,0.000023944891,0.00048070386,0.0019446189,0.00017830211,0.000017883991,9.751607e-7,0.00024953266],"genre_scores_gemma":[0.99787605,0.000092528295,0.001769381,0.00019759822,0.000018002338,0.0000065145473,0.000013131832,0.000006121125,0.00002065152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880177,0.000023244293,0.00079997943,0.000089794274,0.000179055,0.00010615434],"domain_scores_gemma":[0.99608773,0.0022139263,0.001190994,0.00007424045,0.00033998652,0.00009312385],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00019689389,0.00006774921,0.00030361046,0.00020383927,0.00005231908,0.0000033810406,0.00002746197,0.00005951659,0.000029357212],"category_scores_gemma":[0.010240862,0.00005584442,0.000039225033,0.00022954185,0.000024614197,0.00003710661,0.00000493712,0.0001029692,4.1259796e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011255259,0.00013071402,0.99532676,0.000026248768,0.00007170657,0.00024241883,0.0001061301,0.000034626162,0.000013789105,0.00017824146,0.00078689057,0.0030712227],"study_design_scores_gemma":[0.0033856095,0.0007719804,0.99443287,0.000017614937,0.00006941019,0.000033161123,0.000040618954,0.000017461194,0.0001925214,0.00017934613,0.0008175074,0.000041926378],"about_ca_topic_score_codex":0.005713069,"about_ca_topic_score_gemma":0.0071897726,"teacher_disagreement_score":0.010043968,"about_ca_system_score_codex":0.00071777985,"about_ca_system_score_gemma":0.0014471707,"threshold_uncertainty_score":0.9980963},"labels":[],"label_agreement":null},{"id":"W2118851499","doi":"10.2165/00019053-200422060-00004","title":"Measuring Treatment Preferences and Willingness to Pay for Docetaxel in Advanced Ovarian Cancer","year":2004,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Sunnybrook Health Science Centre; Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Health economics; Willingness to pay; Quality of Life Research; Ovarian cancer; Health administration; Medicine; Public health; Oncology; Internal medicine; Economics; Intensive care medicine; Cancer; Nursing; Microeconomics","score_opus":0.06984964040290455,"score_gpt":0.3547769810316263,"score_spread":0.28492734062872177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118851499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896937,0.0011555593,0.00018204702,0.0069858283,0.0003209156,0.0012946394,0.00007936936,0.000025580968,0.00026233136],"genre_scores_gemma":[0.9908097,0.0032794422,0.0034365081,0.0008388234,0.00018635967,0.0013436599,0.000011016723,0.00002391183,0.00007058134],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991128,0.000006817466,0.0002275447,0.00036280474,0.00004263413,0.00024744164],"domain_scores_gemma":[0.99957216,0.000040583993,0.000054306776,0.0001196515,0.000028945773,0.0001843585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007642539,0.00017479766,0.00032080268,0.000071183356,0.000050289804,0.000026180309,0.000044293985,0.000033258515,0.000040215953],"category_scores_gemma":[0.000007005705,0.00013217243,0.000053898013,0.000058015456,0.000013231492,0.00009878772,0.000015892294,0.0000493576,0.0000070117653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017977873,0.0011974251,0.28413,0.0002193589,0.0007278583,0.00003118478,0.002449334,0.019654917,0.0034876966,0.0011405098,0.0000874892,0.6850764],"study_design_scores_gemma":[0.09949784,0.002770293,0.50284266,0.00087999075,0.0012811072,0.00004047439,0.00042924713,0.0015388129,0.2748681,0.0039883526,0.110576816,0.0012862863],"about_ca_topic_score_codex":0.000729042,"about_ca_topic_score_gemma":0.000868506,"teacher_disagreement_score":0.68379015,"about_ca_system_score_codex":0.0007872037,"about_ca_system_score_gemma":0.00020289632,"threshold_uncertainty_score":0.53898346},"labels":[],"label_agreement":null},{"id":"W2119255622","doi":"10.1677/erc.1.01057","title":"Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells","year":2006,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"GNRHR; Autocrine signalling; Paracrine signalling; Endocrinology; Internal medicine; Gonadotropin-releasing hormone; Luteinizing hormone; Gonadotropin-releasing hormone receptor; Biology; Gonadotropin; Receptor; Hormone; Follicle-stimulating hormone; Ovary; Ovarian cancer; Cancer; Medicine","score_opus":0.007084500605257545,"score_gpt":0.2710778418676892,"score_spread":0.2639933412624316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119255622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536056,0.011718035,0.000066994915,0.0010140162,0.00023812144,0.00081201043,0.00027401387,0.000046265937,0.00046995957],"genre_scores_gemma":[0.994178,0.004385826,0.00030643592,0.000029208994,0.0001176061,0.00009035024,0.00020509191,0.000079845944,0.00060760824],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974714,0.0000792619,0.0009845598,0.00055208645,0.00040413806,0.00050856406],"domain_scores_gemma":[0.9987806,0.00003800542,0.00050365884,0.00040034496,0.00014224878,0.0001351253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060445753,0.00039453528,0.0009286718,0.00020264993,0.00008430501,0.000018787921,0.000098804616,0.00013764891,0.00094574335],"category_scores_gemma":[0.0000066439225,0.0003414348,0.00017135845,0.00046146294,0.00017132127,0.00015413582,0.00005768152,0.00029936837,0.0000017507024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043043695,0.00062217086,0.042048495,0.00019672884,0.0005033207,0.00003809495,0.00014933659,0.0007747219,0.9495923,0.0026356739,0.000724557,0.0022841962],"study_design_scores_gemma":[0.016874695,0.00029322974,0.59563,0.0006097099,0.00061643624,0.000020191823,0.00002149105,0.0007089632,0.38353932,0.0005177751,0.00082395744,0.0003442207],"about_ca_topic_score_codex":0.031123815,"about_ca_topic_score_gemma":0.001107539,"teacher_disagreement_score":0.566053,"about_ca_system_score_codex":0.0004666587,"about_ca_system_score_gemma":0.0001647136,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2119648337","doi":"10.1002/gcc.10108","title":"Evidence of a role for the INK4 family of cyclin‐dependent kinase inhibitors in ovarian granulosa cell tumors","year":2002,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Cyclin-dependent kinase; Cancer research; Exon; Loss of heterozygosity; Cyclin D; DNA methylation; Cyclin-dependent kinase 4; Tumor suppressor gene; Gene; Molecular biology; Gene expression; Genetics; Carcinogenesis; Cell cycle; Cyclin-dependent kinase 2; Allele","score_opus":0.033250296951063456,"score_gpt":0.2757835941166847,"score_spread":0.24253329716562122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119648337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75611824,0.24158101,0.000011385242,0.0012419332,0.00015504737,0.000671383,0.00006434426,0.000005426898,0.00015124823],"genre_scores_gemma":[0.94859684,0.050405566,0.000119049444,0.00018644203,0.00015985375,0.0003602382,0.0000025363786,0.000016278114,0.00015319759],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989499,0.000021676804,0.00035547683,0.00026156378,0.00020896434,0.0002024142],"domain_scores_gemma":[0.99929255,0.00015420455,0.00015275365,0.00025942145,0.0000697337,0.000071359136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012893562,0.00015244973,0.00037313876,0.00007003385,0.000044200253,0.000008932189,0.00008129687,0.000059851198,0.00014990529],"category_scores_gemma":[0.000013220656,0.00010109631,0.00011320399,0.00017873697,0.00009084441,0.00005641282,0.000037594007,0.00006825433,0.0000011760816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006495458,0.0013958726,0.36383864,0.0020384467,0.00034591684,0.000063383704,0.0038505767,0.0004645844,0.118320204,0.00021346893,0.0014988161,0.5073206],"study_design_scores_gemma":[0.01177492,0.0022839063,0.3989444,0.0045499424,0.00097200024,0.000025131745,0.0024841551,0.0015913466,0.56710136,0.00029124177,0.0094738025,0.0005077587],"about_ca_topic_score_codex":0.0015622537,"about_ca_topic_score_gemma":0.00028236845,"teacher_disagreement_score":0.5068128,"about_ca_system_score_codex":0.00007632864,"about_ca_system_score_gemma":0.00007904411,"threshold_uncertainty_score":0.4122588},"labels":[],"label_agreement":null},{"id":"W2120734014","doi":"10.1097/pas.0b013e31818479c3","title":"Microcystic Stromal Tumor of the Ovary","year":2009,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Jubilee Hospital","funders":"","keywords":"Hyaline; Pathology; Eosinophilic; Stromal cell; Ovary; Biology; Gross examination; Anatomy; Medicine","score_opus":0.010477937498215613,"score_gpt":0.2718362511999592,"score_spread":0.26135831370174356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120734014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98174846,0.0007767078,0.000019451854,0.016610363,0.00012222983,0.00008635993,0.0000044713775,0.0000034582872,0.00062849314],"genre_scores_gemma":[0.9977542,0.00018503395,0.00041062682,0.0014025404,0.00020830547,0.000001113501,2.9334845e-7,0.000006148132,0.00003172173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989708,0.00019259888,0.00038067764,0.00008876704,0.00019765245,0.00016946802],"domain_scores_gemma":[0.99881935,0.00020730178,0.0005545395,0.00024442724,0.00009283221,0.00008152822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003009074,0.00009672417,0.00051074644,0.00004588195,0.00004095066,0.00000346492,0.00018178187,0.000016845177,0.000061409104],"category_scores_gemma":[0.00003372894,0.00004201832,0.0002627672,0.0002056319,0.00048296928,0.000017983984,0.00002503817,0.00025772135,0.000004452014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020187808,0.007260049,0.3571938,0.000077127064,0.0016457281,0.044934854,0.0025361069,0.00033496696,0.08165278,0.006665771,0.00894572,0.4685653],"study_design_scores_gemma":[0.002970854,0.007258092,0.94753104,0.00013600725,0.00045155804,0.033491984,0.0002551594,0.0000072237585,0.0029210763,0.0007804707,0.0041128243,0.000083684085],"about_ca_topic_score_codex":0.000008940106,"about_ca_topic_score_gemma":3.5846097e-7,"teacher_disagreement_score":0.5903373,"about_ca_system_score_codex":0.000043766766,"about_ca_system_score_gemma":0.00011184092,"threshold_uncertainty_score":0.17795205},"labels":[],"label_agreement":null},{"id":"W2120788872","doi":"10.1158/0008-5472.can-08-4652","title":"Biological Significance of Prolactin in Gynecologic Cancers","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute","keywords":"Cancer research; Autocrine signalling; Prolactin; Biology; Internal medicine; Endocrinology; MAPK/ERK pathway; Endometrial cancer; Ovarian cancer; Carcinogenesis; Oncogene; Kinase; Cancer; Medicine; Receptor; Cell cycle; Hormone; Cell biology","score_opus":0.16394448193465957,"score_gpt":0.4511173490119096,"score_spread":0.28717286707725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120788872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844101,0.0025580593,0.0000030290457,0.0066587366,0.0000739447,0.0010305563,0.00001337335,0.000020352893,0.005231816],"genre_scores_gemma":[0.9964402,0.0022112466,0.00015976929,0.00031034584,0.00010919369,0.0004924905,0.0000047239578,0.000008017193,0.00026401872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837416,0.00013348785,0.0002567981,0.0003787701,0.0003767655,0.00048003905],"domain_scores_gemma":[0.99912816,0.00022301075,0.000051287752,0.00027447278,0.00018863402,0.00013444388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063919777,0.00011080442,0.0003496546,0.00021095577,0.000044277425,0.0000091313,0.00013221781,0.000108968394,0.00073824404],"category_scores_gemma":[0.00019803116,0.000080571765,0.000063856445,0.00074892474,0.00018225977,0.000039074304,0.000025511332,0.00038355507,0.000017800245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003949989,0.001949319,0.68695027,0.0002092573,0.00012544019,0.00048506574,0.00077230675,0.00020641145,0.08917334,0.002782571,0.008435694,0.20496033],"study_design_scores_gemma":[0.002339687,0.0023639305,0.9409594,0.00022858141,0.000012923057,0.0000044566737,0.00019569744,0.000026585798,0.04693709,0.00084686466,0.0059709144,0.00011389761],"about_ca_topic_score_codex":0.0008927323,"about_ca_topic_score_gemma":0.00025991298,"teacher_disagreement_score":0.2540091,"about_ca_system_score_codex":0.0012499715,"about_ca_system_score_gemma":0.00089405914,"threshold_uncertainty_score":0.80832547},"labels":[],"label_agreement":null},{"id":"W2121019919","doi":"10.1016/j.ygyno.2004.09.025","title":"Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; VGH and UBC Hospital Foundation","keywords":"Pathology; Medicine; Serous fluid; Immunohistochemistry; Immunostaining; H&E stain; Ovary; Ovarian tumor; Ovarian cancer; Clear cell; Cancer; Internal medicine","score_opus":0.025283072494958616,"score_gpt":0.291341168002541,"score_spread":0.2660580955075824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121019919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837496,0.0004694701,0.000106489715,0.0024953787,0.0003565067,0.0008541427,0.000034426095,0.000028983339,0.011904981],"genre_scores_gemma":[0.99441457,0.00012617043,0.0043841116,0.0006709515,0.000099695535,0.00013027606,0.000099756355,0.00001762317,0.000056873792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797916,0.00010472746,0.0007849367,0.0004220186,0.00027250615,0.00043667265],"domain_scores_gemma":[0.99892014,0.000081322345,0.00036008746,0.00032544107,0.00017371796,0.00013930812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044879818,0.0002171126,0.0009768932,0.00031811013,0.000053974287,0.000005614216,0.00016975559,0.00026869142,0.00051290944],"category_scores_gemma":[0.00006018964,0.00018458009,0.00016634668,0.00033964627,0.0002733382,0.00011139874,0.0001110904,0.00023538213,0.000011409633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068077277,0.11489664,0.17378817,0.003404861,0.0033462055,0.018485155,0.009590248,0.0869825,0.36140367,0.119866475,0.009344672,0.09208366],"study_design_scores_gemma":[0.035457447,0.01978329,0.8912993,0.00037126205,0.0006287085,0.00029029872,0.00061099784,0.0001062555,0.029596731,0.020248376,0.0011372595,0.00047007448],"about_ca_topic_score_codex":0.0011592406,"about_ca_topic_score_gemma":0.00070823915,"teacher_disagreement_score":0.7175111,"about_ca_system_score_codex":0.0013852841,"about_ca_system_score_gemma":0.0011067853,"threshold_uncertainty_score":0.75269574},"labels":[],"label_agreement":null},{"id":"W2121322385","doi":"10.1038/bjc.2011.364","title":"Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer","year":2011,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Dalhousie University; Juravinski Cancer Centre; Hôtel-Dieu de Québec","funders":"","keywords":"Nomogram; Medicine; Oncology; Concordance; Ovarian cancer; Cohort; Internal medicine; Chemotherapy; Progression-free survival; Confidence interval; Cancer; Surgery","score_opus":0.016965124006928674,"score_gpt":0.27703905316030875,"score_spread":0.26007392915338007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121322385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294823,0.002931804,0.00004337947,0.00073445984,0.0009640132,0.001263121,0.00023057657,0.000017671846,0.00086674455],"genre_scores_gemma":[0.995793,0.00074637355,0.002457276,0.0002594427,0.00041939606,0.00023066366,0.000010518007,0.000043645152,0.000039724757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792814,0.00006914994,0.00055865804,0.00029321882,0.0007685169,0.00038233917],"domain_scores_gemma":[0.9983014,0.000049954207,0.0003630229,0.00019456612,0.00071328634,0.00037779065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023351415,0.00021083704,0.00054665015,0.00016340864,0.000057583744,0.0000420679,0.00014997838,0.00007970125,0.00037867253],"category_scores_gemma":[0.00013469167,0.00017469602,0.00010425436,0.00035046728,0.000065020606,0.00016136994,0.000052776086,0.0003588196,0.0000027980648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001988385,0.001130189,0.7011298,0.000042136988,0.00028566548,0.0008460919,0.0004263762,0.000011335878,0.0000015359658,0.000007458039,0.0011977362,0.29293332],"study_design_scores_gemma":[0.009922588,0.0029130925,0.9770755,0.0076330644,0.00033131495,0.00012288433,0.000063572435,0.0000064154196,0.00015670455,0.00002711252,0.0015562354,0.00019152008],"about_ca_topic_score_codex":0.001743203,"about_ca_topic_score_gemma":0.005624971,"teacher_disagreement_score":0.29274178,"about_ca_system_score_codex":0.0004694906,"about_ca_system_score_gemma":0.0005627713,"threshold_uncertainty_score":0.7123897},"labels":[],"label_agreement":null},{"id":"W2121537891","doi":"10.1046/j.1525-1438.2002.01055.x","title":"Use of CA-125 and ultrasound in high-risk women","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ultrasound; Ovarian cancer; Gynecology; BRCA mutation; Stage (stratigraphy); Population; Obstetrics; Retrospective cohort study; Cancer; Radiology; Internal medicine","score_opus":0.03750988866655887,"score_gpt":0.2948254529117063,"score_spread":0.25731556424514745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121537891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563146,0.0011687559,0.000010136119,0.0024807432,0.00039527603,0.000078285964,0.00004672043,0.0000023958605,0.00018624838],"genre_scores_gemma":[0.98764783,0.010990808,0.0004353096,0.0005547485,0.00016552504,0.000014994416,0.0000012450265,0.0000050873987,0.00018442818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990642,0.00003746219,0.00037498595,0.0001041589,0.00030038194,0.000118813776],"domain_scores_gemma":[0.9987088,0.0006210045,0.00027860375,0.000055848992,0.00023616172,0.00009959763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014458432,0.00008084947,0.00028351697,0.00012130103,0.000011552378,0.000018299388,0.00007684249,0.000060242844,0.0049425387],"category_scores_gemma":[0.0005316702,0.000054658816,0.00006251247,0.00007779308,0.00006626517,0.000112430804,0.00002180493,0.00017414872,0.0000037738798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002100862,0.0006521214,0.94317687,0.0000074349928,0.00036010362,0.0003396046,0.0002606395,0.00017611585,0.00021254308,0.00016663794,0.0015054147,0.052932423],"study_design_scores_gemma":[0.00277762,0.0008069492,0.9860401,0.000088840185,0.00005513168,0.00011213106,0.000046522066,0.000058694124,0.00026770317,0.00035030986,0.009341686,0.00005432006],"about_ca_topic_score_codex":0.00032068777,"about_ca_topic_score_gemma":0.00014812849,"teacher_disagreement_score":0.052878104,"about_ca_system_score_codex":0.0005135603,"about_ca_system_score_gemma":0.00004487914,"threshold_uncertainty_score":0.9959671},"labels":[],"label_agreement":null},{"id":"W2122866336","doi":"10.1136/bcr-2014-204287","title":"Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary","year":2014,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Anastrozole; Aromatase; Serous fluid; Ovary; Internal medicine; Chemotherapy; Aromatase inhibitor; Oncology; Disease; Positron emission tomography; Pathology; Radiology; Breast cancer; Cancer","score_opus":0.01212785847312199,"score_gpt":0.26922207816368293,"score_spread":0.25709421969056095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122866336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972448,0.00014796859,0.000049616076,0.0010297043,0.00038173923,0.00061447057,0.0000073590427,0.000017791132,0.0005065897],"genre_scores_gemma":[0.9993104,0.000013611477,0.00022866922,0.00017119109,0.00012897469,0.00004924955,0.000029146064,0.000016302378,0.0000524998],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987882,0.00006688506,0.00049547135,0.00024600953,0.00024420267,0.00015925239],"domain_scores_gemma":[0.9990478,0.00002576133,0.00030573155,0.00050480204,0.00004443802,0.000071461414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044172452,0.000111807894,0.00024688986,0.00006736097,0.0000473336,0.000009187152,0.00001012204,0.000060782484,0.000041491006],"category_scores_gemma":[0.00009581162,0.000075637945,0.00011225885,0.0001476734,0.000041225725,0.000047528945,0.000036329577,0.000092665796,0.0000037692562],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101569385,0.00067599927,0.054599017,0.00020313976,0.00003875097,0.9345095,0.00016690734,0.00022546033,0.0031271528,0.000098519326,0.0016006097,0.004653354],"study_design_scores_gemma":[0.0016199031,0.00019230509,0.13102888,0.0019382748,0.00024629536,0.8260867,0.000092491544,0.00031610424,0.03766496,0.00043959776,0.00022884637,0.00014564686],"about_ca_topic_score_codex":0.0006195636,"about_ca_topic_score_gemma":0.0000910024,"teacher_disagreement_score":0.108422816,"about_ca_system_score_codex":0.00010831385,"about_ca_system_score_gemma":0.00012575868,"threshold_uncertainty_score":0.3084426},"labels":[],"label_agreement":null},{"id":"W2124051475","doi":"10.1016/j.ygyno.2015.04.037","title":"Risk stratification and outcomes of women undergoing surgery for ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; National Cancer Institute, Cairo University; American College of Surgeons","keywords":"Medicine; Perioperative; Ovarian cancer; Logistic regression; Complication; Surgery; Cancer; Internal medicine","score_opus":0.05989864775738174,"score_gpt":0.3495221570306768,"score_spread":0.28962350927329505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124051475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071544,0.00051335344,0.0001966191,0.006266151,0.00047061683,0.0006368078,0.000036527428,0.000027794616,0.0011366626],"genre_scores_gemma":[0.9952739,0.00083084556,0.0024371915,0.00045996747,0.00006537051,0.00072956574,0.000017939936,0.00000956194,0.0001756732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905884,0.000080958525,0.00029101598,0.00023115458,0.000079277306,0.00025876067],"domain_scores_gemma":[0.9967036,0.0025991153,0.0002484344,0.00015609995,0.00012309056,0.00016962546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006981262,0.00010582243,0.00055239134,0.00007614761,0.000045190332,0.000005851938,0.000032633,0.00014041598,0.0001165169],"category_scores_gemma":[0.0013758332,0.000078773395,0.0000608458,0.00007943658,0.000077810146,0.000038187303,0.000019390985,0.00006149287,0.0000033230913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001811531,0.00045042826,0.9184938,0.00006726626,0.00030340898,0.000009757998,0.0005735339,0.000017308797,0.000028203642,0.0016109542,0.0021108303,0.07615336],"study_design_scores_gemma":[0.0033557606,0.0018521859,0.9796334,0.000015138554,0.00023985491,0.0000073358674,0.0008681014,0.000054480308,0.00016448274,0.0040168483,0.009705073,0.00008732062],"about_ca_topic_score_codex":0.00022744732,"about_ca_topic_score_gemma":0.00082685106,"teacher_disagreement_score":0.07606604,"about_ca_system_score_codex":0.0010096313,"about_ca_system_score_gemma":0.0012954703,"threshold_uncertainty_score":0.32122856},"labels":[],"label_agreement":null},{"id":"W2124060053","doi":"10.4021/wjon362w","title":"The Management Dilemma of Leiomyosarcoma of the Ovary","year":2011,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Presentation (obstetrics); Dilemma; Ovary; Stage (stratigraphy); Leiomyosarcoma; Disease; Ovarian cancer; General surgery; Gynecology; Surgery; Cancer; Pathology; Internal medicine","score_opus":0.037947839497776824,"score_gpt":0.29760449983032167,"score_spread":0.25965666033254486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124060053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7303203,0.006109956,0.000060124377,0.0300626,0.0028180988,0.00082962273,0.000007825118,0.000007134791,0.22978438],"genre_scores_gemma":[0.9963425,0.0006345366,0.0017802952,0.00028877734,0.000105632134,0.0000059853423,1.5575156e-7,0.0000070657106,0.0008350555],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905777,0.00008016892,0.0004802749,0.00006039563,0.00019998329,0.00012143182],"domain_scores_gemma":[0.9988701,0.00012741653,0.00057264336,0.000247531,0.000132114,0.000050231247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039534213,0.00007037928,0.00030553478,0.00009298379,0.00004419048,0.0000018546806,0.00019870179,0.000027088226,0.00021529972],"category_scores_gemma":[0.000013456895,0.00003245926,0.00019703878,0.00018249701,0.00016409738,0.000023058858,0.00006657884,0.0001466679,0.0000025271352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025905438,0.0037186232,0.31000584,0.0001781422,0.00392524,0.00088961347,0.0014187691,0.000008201964,0.00049990695,0.06782298,0.03827395,0.5706682],"study_design_scores_gemma":[0.0025944167,0.0014498712,0.7037072,0.00018063643,0.0005576318,0.00023145461,0.00014446166,0.0000014894971,0.0025629876,0.0012706432,0.28726703,0.000032184613],"about_ca_topic_score_codex":0.00003020479,"about_ca_topic_score_gemma":0.00008531454,"teacher_disagreement_score":0.57063603,"about_ca_system_score_codex":0.000114375325,"about_ca_system_score_gemma":0.00013900243,"threshold_uncertainty_score":0.2357381},"labels":[],"label_agreement":null},{"id":"W2124074422","doi":"10.1186/1757-2215-5-40","title":"Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel","year":2012,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sudbury Regional Hospital; Northeast Cancer Centre; Laurentian University","funders":"","keywords":"Carboplatin; Docetaxel; Ovarian cancer; Drug resistance; Cancer research; Taxane; Microarray; Medicine; Cell culture; Oncology; Microarray analysis techniques; Pharmacology; Chemotherapy; Biology; Cancer; Internal medicine; Gene expression; Gene; Cisplatin; Genetics; Breast cancer","score_opus":0.056009212939951716,"score_gpt":0.37281697337411196,"score_spread":0.31680776043416026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124074422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847941,0.0014564997,0.0010566186,0.009594496,0.00031153264,0.0016807438,0.00007566075,0.000008645512,0.0010217377],"genre_scores_gemma":[0.9791598,0.000047224432,0.01956018,0.00015797283,0.0005034735,0.00010087851,0.000007183947,0.000028069102,0.00043521656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781114,0.00021072669,0.00059960206,0.00021726827,0.00056255644,0.0005987103],"domain_scores_gemma":[0.9978212,0.0005448879,0.00014822166,0.00025056305,0.00067716214,0.0005579764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015898232,0.00015200261,0.00043884324,0.0005367461,0.0001511726,0.00008406702,0.00012264642,0.00006419657,0.00009150402],"category_scores_gemma":[0.000623975,0.00012447713,0.000073725285,0.00084386655,0.00005615351,0.00012871253,0.000045280416,0.0004109849,0.000008491739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01082231,0.0054709567,0.83651364,0.0009404482,0.00092497224,0.0012938431,0.005674382,0.00006621396,0.05489625,0.005827475,0.072493926,0.0050755613],"study_design_scores_gemma":[0.006822238,0.0013887315,0.976022,0.00038190154,0.00010045432,0.0001387178,0.000127863,0.00010618005,0.006267579,0.00034974795,0.008152884,0.00014170998],"about_ca_topic_score_codex":0.00007466926,"about_ca_topic_score_gemma":0.0002111185,"teacher_disagreement_score":0.13950834,"about_ca_system_score_codex":0.0003511516,"about_ca_system_score_gemma":0.0005276322,"threshold_uncertainty_score":0.507603},"labels":[],"label_agreement":null},{"id":"W2124597710","doi":"10.3410/m3-22","title":"The new face of ovarian cancer modeling: better prospects for detection and treatment","year":2011,"lang":"en","type":"article","venue":"F1000 Medicine Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; Ovarian Cancer Research Fund; Mary Kay Foundation","keywords":"Serous carcinoma; Fallopian tube; Ovarian cancer; Ovary; Serous fluid; Medicine; Stage (stratigraphy); Carcinogenesis; Disease; Ovarian carcinoma; Bioinformatics; Ex vivo; Cancer; Oncology; Cancer research; Pathology; Biology; Internal medicine; Gynecology; In vivo","score_opus":0.05064806957003399,"score_gpt":0.30044852697608454,"score_spread":0.24980045740605056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124597710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9328969,0.01655122,0.008953037,0.028543528,0.0018280947,0.0054443087,0.00001093253,0.00011954881,0.0056523997],"genre_scores_gemma":[0.9955791,0.0013921921,0.0006433782,0.0001676632,0.0005372201,0.00037692487,0.000005706319,0.000024641207,0.0012731267],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988763,0.00001070505,0.00041529356,0.00030523815,0.00019511125,0.00019738181],"domain_scores_gemma":[0.999111,0.00004740292,0.00020822971,0.00036122304,0.000103811326,0.00016836604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017306877,0.00016584565,0.0003560211,0.000050535677,0.000095058764,0.0000048306865,0.00002372168,0.000061023988,0.0000719082],"category_scores_gemma":[0.000055968732,0.000087544955,0.00007112894,0.000086939,0.00007082978,0.000033847784,0.00001128385,0.000050547013,4.745685e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014356979,0.0006606571,0.13688251,0.00023399215,0.0017131439,0.0005111271,0.008768774,0.00004332986,0.0041482337,0.0005284337,0.005263331,0.8398108],"study_design_scores_gemma":[0.035628706,0.02503008,0.43192515,0.0030461499,0.009712245,0.0034551057,0.0019845665,0.011451475,0.23183878,0.015440385,0.22933173,0.001155641],"about_ca_topic_score_codex":0.004208351,"about_ca_topic_score_gemma":0.00044946378,"teacher_disagreement_score":0.8386551,"about_ca_system_score_codex":0.0001554654,"about_ca_system_score_gemma":0.00018910796,"threshold_uncertainty_score":0.6361796},"labels":[],"label_agreement":null},{"id":"W2124932273","doi":"10.1186/s13550-014-0060-4","title":"Immuno-PET of epithelial ovarian cancer: harnessing the potential of CA125 for non-invasive imaging","year":2014,"lang":"en","type":"article","venue":"EJNMMI Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cardiac imaging; Ovarian cancer; Epithelial ovarian cancer; Medical physics; Pathology; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.035454694242361987,"score_gpt":0.37100340617995364,"score_spread":0.33554871193759167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124932273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95217335,0.0021829715,0.0026716902,0.03368266,0.00093399634,0.0028609408,0.00027596214,0.000028102395,0.00519035],"genre_scores_gemma":[0.99744254,0.00030803733,0.00091137516,0.00008901303,0.0005453311,0.0002491544,0.000018013507,0.00003019564,0.000406342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982155,0.00016777797,0.00029615744,0.00028243987,0.0006074227,0.0004307297],"domain_scores_gemma":[0.99796635,0.00063595135,0.00012599413,0.0005145112,0.00066662644,0.00009054339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015430673,0.00012563054,0.00036442062,0.00016534279,0.00022770216,0.00003167447,0.00022394383,0.00003869788,0.0001586121],"category_scores_gemma":[0.00032207373,0.0000830711,0.0001744629,0.0002800416,0.00033111824,0.000060127222,0.00009823777,0.00023661733,0.000008235344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035354348,0.0016565251,0.087024316,0.002419946,0.0015391706,0.00014356255,0.0033728993,0.00022717324,0.50967413,0.0069042076,0.022268089,0.36123452],"study_design_scores_gemma":[0.017330341,0.0018358215,0.2843767,0.0025889333,0.0006291256,0.00007971505,0.0021866877,0.0074667186,0.6577688,0.0025133672,0.022842523,0.00038126597],"about_ca_topic_score_codex":0.002976157,"about_ca_topic_score_gemma":0.00011700697,"teacher_disagreement_score":0.36085325,"about_ca_system_score_codex":0.00014136833,"about_ca_system_score_gemma":0.0006730329,"threshold_uncertainty_score":0.44990793},"labels":[],"label_agreement":null},{"id":"W2124957996","doi":"10.1634/theoncologist.2011-0164","title":"Revisiting the Role of Antiandrogen Strategies in Ovarian Cancer","year":2011,"lang":"en","type":"review","venue":"The Oncologist","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Antiandrogen; Ovarian cancer; Oncology; Prostate cancer; Cancer; Internal medicine","score_opus":0.08430796692686533,"score_gpt":0.388245100507742,"score_spread":0.3039371335808767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124957996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025624531,0.96800005,0.0000010361971,0.00065179146,0.00011476481,0.001066355,0.00004142443,0.000012201869,0.030086767],"genre_scores_gemma":[0.0034882955,0.9953134,0.000052229647,0.00006725165,0.00045951767,0.00043358514,0.00001750193,0.000028046943,0.0001401752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865234,0.00022223839,0.00052020926,0.00024673645,0.00012556455,0.00023288668],"domain_scores_gemma":[0.99862015,0.00027200856,0.00046450782,0.00056518207,0.0000413664,0.00003679838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053786125,0.00025402525,0.0013036075,0.000056821842,0.00006946054,0.000022350705,0.00030356305,0.00017133214,0.00033160034],"category_scores_gemma":[0.000034561086,0.0001073793,0.0003121367,0.00027678226,0.00022349105,0.000027161841,0.000084501444,0.00035715886,0.000024939804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017157221,0.00007531666,0.0007436545,0.002107237,0.00034234172,0.000033609085,0.00019185014,8.189509e-7,3.9406683e-7,0.0068696574,0.00009830789,0.98951966],"study_design_scores_gemma":[0.0003567369,0.00010962963,0.001361018,0.010744231,0.0019523569,0.000046319346,0.00034743437,0.0000011276181,0.000007631336,0.00036793345,0.9845945,0.00011103702],"about_ca_topic_score_codex":0.003349622,"about_ca_topic_score_gemma":0.0003438994,"teacher_disagreement_score":0.9894086,"about_ca_system_score_codex":0.00027515652,"about_ca_system_score_gemma":0.0010638763,"threshold_uncertainty_score":0.5063649},"labels":[],"label_agreement":null},{"id":"W2125370994","doi":"10.1093/carcin/bgt003","title":"Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial–stromal interaction","year":2013,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Illinois at Urbana-Champaign","keywords":"Protein kinase B; PTEN; Downregulation and upregulation; Cancer research; Oxidative stress; Stromal cell; Biology; Malignant transformation; Tensin; Cell growth; DNA damage; Cell biology; PI3K/AKT/mTOR pathway; Chemistry; Endocrinology; Signal transduction; Biochemistry","score_opus":0.0162999006769426,"score_gpt":0.24939483424905717,"score_spread":0.23309493357211458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125370994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362415,0.00026613133,0.00005865161,0.0040993574,0.00014948087,0.0010561685,0.0002760891,0.000042008007,0.00042794552],"genre_scores_gemma":[0.99881434,0.00012322527,0.00024449383,0.00020859008,0.00010421226,0.00019724884,0.0001374219,0.000036964117,0.00013348482],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854803,0.00013049132,0.00032998133,0.00040592725,0.00023594844,0.00034964175],"domain_scores_gemma":[0.9991508,0.00009223157,0.0001327745,0.0002638795,0.00016228516,0.0001980348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013290565,0.0002842692,0.00041360743,0.00014644374,0.00010395686,0.00006412007,0.00007643671,0.00014831638,0.00031847807],"category_scores_gemma":[0.000018100822,0.0002497938,0.000065973356,0.00026063013,0.00007108623,0.00066728913,0.000032805357,0.00015106073,0.00003143658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043603274,0.000560996,0.41001233,0.00022445459,0.00037028463,0.000036447727,0.0129963495,0.000029541388,0.5473957,0.00014440533,0.0002844944,0.027508918],"study_design_scores_gemma":[0.0019630403,0.0004348329,0.6597021,0.00014783052,0.000099282865,0.000008008629,0.0011453805,0.00015126726,0.33604988,0.000024202813,0.00010347759,0.00017068986],"about_ca_topic_score_codex":0.0036593238,"about_ca_topic_score_gemma":0.00042303093,"teacher_disagreement_score":0.24968976,"about_ca_system_score_codex":0.00022566464,"about_ca_system_score_gemma":0.00006207376,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2125483466","doi":"10.3747/co.20.1613","title":"Preventing Ovarian Cancer by Salpingectomy","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Salpingectomy; Ovarian cancer; Serous fluid; Ovarian carcinoma; Gynecology; Oncology; Ovary; Internal medicine; General surgery; Cancer; Pregnancy; Biology","score_opus":0.07615453757165407,"score_gpt":0.41022365386876913,"score_spread":0.33406911629711505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125483466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90388864,0.033780906,0.00027074714,0.03434205,0.0046240524,0.0023477317,0.000043638196,0.00021324708,0.020488959],"genre_scores_gemma":[0.9939689,0.0017304709,0.000541931,0.0006803788,0.0006807759,0.0012832241,0.000061771665,0.000027944365,0.0010245858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989866,0.00004697926,0.0002293718,0.00029611998,0.00012309846,0.00031784616],"domain_scores_gemma":[0.9993772,0.000060112256,0.000100275305,0.00019563343,0.00009168529,0.00017511233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007891624,0.00014176343,0.00031495732,0.000051959556,0.000060516046,0.000018108098,0.00006512443,0.000084634434,0.0038456118],"category_scores_gemma":[0.000027616723,0.000114980394,0.00008694024,0.00011676907,0.00004559596,0.00006781744,0.00004295034,0.00018367205,0.00033450255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017001998,0.0009852684,0.1803416,0.00008017192,0.00013505579,0.000009178583,0.0001534078,5.127798e-7,0.0005419642,0.00019092935,0.19860236,0.61894256],"study_design_scores_gemma":[0.003149025,0.00035867427,0.12022586,0.00017406017,0.00020652002,0.000018838513,0.00004032743,0.0001035447,0.00089419086,0.00017462778,0.8745177,0.00013667459],"about_ca_topic_score_codex":0.00032793748,"about_ca_topic_score_gemma":0.000028826205,"teacher_disagreement_score":0.6759153,"about_ca_system_score_codex":0.0004327475,"about_ca_system_score_gemma":0.0002094178,"threshold_uncertainty_score":0.997065},"labels":[],"label_agreement":null},{"id":"W2125679005","doi":"10.1097/aog.0b013e318269b8b1","title":"New Insights Into the Pathogenesis of Ovarian Carcinoma","year":2012,"lang":"en","type":"article","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Serous fluid; Serous carcinoma; Pathogenesis; Fallopian tube; Disease; Biomarker; Endometriosis; Cancer; Oncology; Ovarian carcinoma; Clear cell carcinoma; Clear cell; Carcinoma; Bioinformatics; Pathology; Internal medicine; Gynecology; Biology","score_opus":0.017359315290024678,"score_gpt":0.24961000251650442,"score_spread":0.23225068722647974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125679005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599808,0.034232114,0.000069354566,0.0017888605,0.0009495932,0.00022723418,0.0000019146232,0.000008142611,0.002741994],"genre_scores_gemma":[0.99667776,0.0013969725,0.0009941108,0.00043285187,0.000121590434,0.00001688336,0.0000050894578,0.0000098275395,0.00034491692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939924,0.000034321074,0.00016297119,0.00012905226,0.00009318131,0.0001812331],"domain_scores_gemma":[0.9981342,0.0013596907,0.00006784007,0.00022840277,0.00004788525,0.00016198456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007792115,0.00009294441,0.00022698239,0.00009170458,0.00006414242,0.0000054010643,0.000047041915,0.00009136042,0.00014387007],"category_scores_gemma":[0.0005070635,0.000056175224,0.00005194536,0.000270341,0.000044694592,0.00003200593,0.00004649535,0.0000623809,0.000011588747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013977546,0.0002243268,0.72613716,0.000033233497,0.000100877885,0.000025600379,0.0023785473,3.934369e-7,0.00036527865,0.012535398,0.0010621658,0.25712302],"study_design_scores_gemma":[0.0011343685,0.00027688828,0.8785166,0.000005213263,0.00017484334,0.000011279643,0.00013817294,0.000009033171,0.00070571067,0.0002906409,0.11868246,0.000054782577],"about_ca_topic_score_codex":0.00024215311,"about_ca_topic_score_gemma":0.000031389183,"teacher_disagreement_score":0.25706825,"about_ca_system_score_codex":0.00006376359,"about_ca_system_score_gemma":0.00010067092,"threshold_uncertainty_score":0.22907592},"labels":[],"label_agreement":null},{"id":"W2126087169","doi":"10.1038/onc.2010.245","title":"Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma","year":2010,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cambridge University Hospitals; National Institute for Health and Care Research; University of Cambridge; Cancer Research UK","keywords":"Biology; Loss of heterozygosity; Ovarian carcinoma; Genetics; Ovarian cancer; Serous fluid; clone (Java method); Single-nucleotide polymorphism; Cancer research; Genotype; Cancer; Gene; Allele","score_opus":0.01246357386897763,"score_gpt":0.25996881620942586,"score_spread":0.24750524234044824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126087169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980981,0.0010156333,0.000075061325,0.00031872734,0.000115347684,0.00023444711,0.00004323281,0.000010906552,0.000088572844],"genre_scores_gemma":[0.99653023,0.00010736125,0.0031221241,0.0000627296,0.000081384336,0.000029614052,0.000035116147,0.0000143478,0.0000171046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907523,0.000030379879,0.0002756603,0.0003055407,0.00013432253,0.00017886498],"domain_scores_gemma":[0.9993614,0.000026246458,0.00008908095,0.00036418502,0.000039289684,0.0001197789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010552659,0.00012846284,0.00042436153,0.00031357296,0.000027725611,0.0000075153375,0.000049835016,0.00009873329,0.00006699759],"category_scores_gemma":[0.000010633409,0.00011611373,0.00010472174,0.00046526082,0.000053286847,0.00002209564,0.000032743097,0.00010102092,0.0000044541202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044682736,0.00027026152,0.9053906,0.00002009789,0.00047541835,0.00005055519,0.00006428142,0.00007730692,0.090669215,0.00013606978,0.0000065386917,0.0027949805],"study_design_scores_gemma":[0.0018727815,0.00018826213,0.9840398,0.0000094517145,0.0016165494,0.000027535623,0.000010983174,0.0006302152,0.011386081,0.00005040767,0.00007736843,0.00009055384],"about_ca_topic_score_codex":0.0034254843,"about_ca_topic_score_gemma":0.0075476714,"teacher_disagreement_score":0.07928313,"about_ca_system_score_codex":0.00014779458,"about_ca_system_score_gemma":0.00009501354,"threshold_uncertainty_score":0.517833},"labels":[],"label_agreement":null},{"id":"W2126795725","doi":"10.1038/modpathol.2008.191","title":"Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss","year":2008,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Institutes of Health; National Cancer Institute; Sanofi; BC Cancer Agency; Eli Lilly and Company","keywords":"Tissue microarray; Serous fluid; Ovarian cancer; Medicine; Pathology; CD8; Oncology; Ovarian carcinoma; Immunohistochemistry; Internal medicine; Cancer research; Cancer; Immune system; Immunology","score_opus":0.024004751381416545,"score_gpt":0.24780703574396093,"score_spread":0.22380228436254437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126795725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973492,0.00033272294,0.00025339006,0.0011732636,0.000060120987,0.00040037814,0.00010894972,0.000018894469,0.00030305132],"genre_scores_gemma":[0.9966287,0.00014608802,0.002510384,0.00035665644,0.00005613678,0.000069325564,0.000021530072,0.000021360012,0.00018978813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912906,0.000032001753,0.00016476582,0.00034421013,0.0001001817,0.0002298068],"domain_scores_gemma":[0.99958783,0.000048514587,0.00006358537,0.00013819992,0.00007155156,0.000090329086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008834886,0.00013792167,0.0003113969,0.000091001784,0.00007348265,0.000008858194,0.000027502681,0.000081989056,0.000014290242],"category_scores_gemma":[0.000022220469,0.000110969566,0.000015209176,0.00013861038,0.0001377692,0.00004380503,0.000030696225,0.00013819274,0.0000048660904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013616,0.0005414502,0.99181455,0.000026584308,0.000044950182,0.0023606538,0.0015251782,0.000012280981,0.002697156,0.00018277613,0.00005280334,0.0006054648],"study_design_scores_gemma":[0.0046406323,0.0006794818,0.99097294,0.000022823602,0.000087867396,0.00096066645,0.000034671113,0.0002994838,0.0019833976,0.000055719505,0.00014434286,0.000117957214],"about_ca_topic_score_codex":0.00027181298,"about_ca_topic_score_gemma":0.00031156206,"teacher_disagreement_score":0.004504472,"about_ca_system_score_codex":0.0000814836,"about_ca_system_score_gemma":0.00014235047,"threshold_uncertainty_score":0.45252076},"labels":[],"label_agreement":null},{"id":"W2126987398","doi":"10.7150/thno.6413","title":"Biologically-Targeted Detection of Primary and Micro-Metastatic Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Theranostics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Princess Margaret Hospital Foundation; U.S. Department of Defense","keywords":"Debulking; Ovarian cancer; Medicine; In vivo; Primary tumor; Ex vivo; Cancer; Tumor Debulking; Cancer research; Metastasis; Malignancy; Pathology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.019347973983414677,"score_gpt":0.25388848282173915,"score_spread":0.23454050883832447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126987398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936746,0.0036332249,0.000591754,0.0011654772,0.000115522635,0.0004995916,0.000018240837,0.00006891725,0.00023271225],"genre_scores_gemma":[0.99484026,0.00158193,0.0026946266,0.0006807478,0.00005382276,0.000063862964,0.000009009997,0.000023616023,0.00005210086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99947035,0.000027395874,0.00016664552,0.00013717613,0.00007664067,0.00012177757],"domain_scores_gemma":[0.9995606,0.000094394534,0.00006573061,0.00013068608,0.000083061015,0.00006555834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047782185,0.000097968375,0.00023937259,0.000037652386,0.000018607814,0.000008085184,0.000025213894,0.000044114702,0.00015741611],"category_scores_gemma":[0.000028590224,0.00006700832,0.000035221154,0.00008071217,0.00006675028,0.000025585074,0.000013950074,0.000060168335,0.000007837096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001544517,0.0003484104,0.056631755,0.00016691077,0.0003587813,0.000011047311,0.00023642411,0.0000043258888,0.8134185,0.0001407557,0.00020446641,0.1283242],"study_design_scores_gemma":[0.0022008792,0.0005257507,0.90213645,0.00009655713,0.00026961116,0.000015924064,0.00003316434,0.0000854939,0.092732236,0.00045944995,0.0013457206,0.00009875236],"about_ca_topic_score_codex":0.0005348486,"about_ca_topic_score_gemma":0.000011202753,"teacher_disagreement_score":0.8455047,"about_ca_system_score_codex":0.00005447123,"about_ca_system_score_gemma":0.00004390754,"threshold_uncertainty_score":0.27325198},"labels":[],"label_agreement":null},{"id":"W2127143084","doi":"10.1093/annonc/mds060","title":"First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Epirubicin; Carboplatin; Hazard ratio; Paclitaxel; Internal medicine; Oncology; Ovarian cancer; Chemotherapy; Gynecologic oncology; TEC; Cancer; Gynecology; Urology; Confidence interval; Breast cancer; Cisplatin","score_opus":0.11730253074379335,"score_gpt":0.41085849000406627,"score_spread":0.2935559592602729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127143084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889249,0.0036567976,0.0000062739564,0.0042961626,0.0003106665,0.0019205876,0.00007043098,0.000014882574,0.0007992816],"genre_scores_gemma":[0.99516606,0.0029531752,0.000389689,0.00028930645,0.00011873417,0.00082503154,0.000005537341,0.00003417158,0.00021829113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982259,0.0001441443,0.00055524934,0.00037311472,0.00028172773,0.0004198397],"domain_scores_gemma":[0.99791574,0.00045847136,0.0006759883,0.0005120826,0.00027144866,0.0001662537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019830614,0.00033548335,0.001248327,0.000105393876,0.00006968595,0.0000033646163,0.00011389912,0.000132245,0.00031957473],"category_scores_gemma":[0.00005438208,0.00016294932,0.00009330276,0.0003305831,0.0003108141,0.000087943736,0.000058941318,0.00012064522,7.2139966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021419942,0.0097020455,0.8700432,0.00017292131,0.0026089386,0.00004428052,0.0054796585,0.0002665918,0.00020899842,0.00008419059,0.00016272355,0.08980648],"study_design_scores_gemma":[0.0446109,0.13730364,0.79379046,0.0005659155,0.0023171408,0.00003563156,0.0046441453,0.00004364061,0.009066302,0.000014548054,0.007323286,0.00028442204],"about_ca_topic_score_codex":0.0042535346,"about_ca_topic_score_gemma":0.035644434,"teacher_disagreement_score":0.1276016,"about_ca_system_score_codex":0.00030097333,"about_ca_system_score_gemma":0.00045240007,"threshold_uncertainty_score":0.98195255},"labels":[],"label_agreement":null},{"id":"W2127580939","doi":"10.1158/1535-7163.mct-08-0200","title":"Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using β-human choriogonadotropin secreting tumor cell lines","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Toyota Research Institute, North America","keywords":"Metastasis; Medicine; Cancer research; Cancer; Trastuzumab; Antibody; Oncology; Internal medicine; Breast cancer; Immunology","score_opus":0.0419588195616885,"score_gpt":0.3378455719101534,"score_spread":0.2958867523484649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127580939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297244,0.015273569,0.00022890634,0.00042478886,0.00007215563,0.00095691206,0.000038167604,0.000026448948,0.000006579164],"genre_scores_gemma":[0.9967495,0.0012521191,0.0011477435,0.0004848235,0.00007014944,0.00014147203,0.000018556853,0.00008235685,0.000053240823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815273,0.00019086886,0.00046242782,0.0004379438,0.00038677032,0.00036923971],"domain_scores_gemma":[0.99898773,0.00005786176,0.00024061462,0.00037604736,0.00013018817,0.00020757277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014370609,0.00033789975,0.0005293048,0.00021770183,0.00012292789,0.000020875812,0.00010110068,0.000048280264,0.000018733077],"category_scores_gemma":[0.00000955113,0.00028662354,0.00013936449,0.00026468138,0.00018627114,0.00005168939,0.000054830107,0.00018899838,7.233389e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002701439,0.00087048433,0.5236641,0.0004543362,0.0003116406,0.0018192121,0.0006492779,0.00028767312,0.46720713,0.000006315167,0.000001205302,0.0020271835],"study_design_scores_gemma":[0.006114752,0.0006961624,0.6413365,0.0007741764,0.00066733814,0.000059644124,0.000045414028,0.0015824243,0.34835514,0.000022450702,0.00003092958,0.00031506922],"about_ca_topic_score_codex":0.00017201097,"about_ca_topic_score_gemma":0.000015393916,"teacher_disagreement_score":0.118851975,"about_ca_system_score_codex":0.0002701194,"about_ca_system_score_gemma":0.00042234545,"threshold_uncertainty_score":0.9999586},"labels":[],"label_agreement":null},{"id":"W2127705485","doi":"10.1016/s1701-2163(16)34254-2","title":"Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses","year":2009,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Fredericton; Ontario Neurotrauma Foundation; Manitoba Beekeepers' Association; Medicine Hat College; Saskatoon Medical Imaging; Congress of Aboriginal Peoples","funders":"Royal College of Obstetricians and Gynaecologists","keywords":"Medicine; Referral; General surgery; Gynecology; Obstetrics; Family medicine","score_opus":0.07806599597443756,"score_gpt":0.3640315062637718,"score_spread":0.28596551028933426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127705485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495038,0.022960389,0.00021264078,0.017557831,0.005687086,0.0008559282,0.000041502215,0.0000033321576,0.003177528],"genre_scores_gemma":[0.99160707,0.0007659836,0.006730652,0.0007848477,0.000049630988,0.00000513252,0.0000057338452,0.0000046566543,0.00004627977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99907136,0.000020505338,0.0004325936,0.00009847441,0.00026165968,0.000115400675],"domain_scores_gemma":[0.99836695,0.00033316508,0.00027919683,0.00007264488,0.00084467564,0.000103376995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032196697,0.00008290478,0.00029108138,0.00012757082,0.00004106906,0.000008890003,0.000034123626,0.000052627827,0.00009293324],"category_scores_gemma":[0.0007624162,0.00006397388,0.000039524908,0.000117100535,0.000018830591,0.000037940565,0.000009991924,0.00006346364,3.658081e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054552478,0.00020117525,0.032938875,0.00014506729,0.0005174906,0.00063957745,0.000049081696,0.00004784222,0.000009583116,0.0017679103,0.009846966,0.9537819],"study_design_scores_gemma":[0.00988398,0.0021507535,0.9648837,0.000044692253,0.0011053773,0.0000800952,0.0003175481,0.00032816044,0.000112658745,0.0012656456,0.019735288,0.00009210208],"about_ca_topic_score_codex":0.0010965487,"about_ca_topic_score_gemma":0.0019113391,"teacher_disagreement_score":0.95368975,"about_ca_system_score_codex":0.0003816337,"about_ca_system_score_gemma":0.0006901321,"threshold_uncertainty_score":0.2608779},"labels":[],"label_agreement":null},{"id":"W2128868545","doi":"10.1093/jnci/djh081","title":"Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)","year":2004,"lang":"en","type":"letter","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Ovarian cancer; Oncology; Medicine; Solid tumor; Cancer; Internal medicine","score_opus":0.1463469272282162,"score_gpt":0.4341297608905745,"score_spread":0.28778283366235824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128868545","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009330381,0.0022689542,0.000028213113,0.98085356,0.0053502554,0.0015087869,0.00029722363,0.00001049486,0.00035213085],"genre_scores_gemma":[0.023365507,0.0011967338,0.0014051731,0.93808126,0.02730502,0.0005761671,0.00002172328,0.000085935855,0.007962484],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953032,0.00021071779,0.001338996,0.00043546467,0.002260722,0.0004508738],"domain_scores_gemma":[0.99681324,0.00022130774,0.0006280837,0.00044681906,0.0016086416,0.00028191693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011630785,0.0005046807,0.0009131626,0.0005539502,0.00019139587,0.0000896892,0.00066983816,0.0002660615,0.00031811156],"category_scores_gemma":[0.00104548,0.00026218154,0.0005349977,0.0008683878,0.00007625379,0.00014904582,0.00010224637,0.001024823,0.000034806817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002333817,0.00012473103,0.0006658668,0.00003427451,0.0008296746,0.00055939343,0.00066155364,0.050399106,0.00011115399,0.00004318807,0.9372826,0.0069546327],"study_design_scores_gemma":[0.0051128194,0.000672678,0.01908493,0.003320279,0.0007073067,0.00024095696,0.00002217254,0.00001611027,0.0008181836,0.0006346931,0.9690992,0.0002706722],"about_ca_topic_score_codex":0.007567182,"about_ca_topic_score_gemma":0.008155178,"teacher_disagreement_score":0.050382994,"about_ca_system_score_codex":0.012971639,"about_ca_system_score_gemma":0.019583292,"threshold_uncertainty_score":0.999983},"labels":[],"label_agreement":null},{"id":"W2128904109","doi":"10.1002/path.4088","title":"Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with <scp>HER2</scp> targeting in 19% of carcinomas","year":2012,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; Toronto General Hospital; University Health Network; University of Toronto; Alberta Health Services; University of British Columbia","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council Victoria; Peter MacCallum Cancer Centre; Cancer Council South Australia; Medical Research Council; Cancer Council NSW; National Health and Medical Research Council; Alberta Health Services","keywords":"KRAS; Medicine; CISH; Immunohistochemistry; Internal medicine; Oncology; Concordance; Stage (stratigraphy); Ovarian cancer; Pathology; Cancer; Biology; Gene","score_opus":0.015985301162487513,"score_gpt":0.2486619037406503,"score_spread":0.2326766025781628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128904109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732345,0.00083722826,0.00073160307,0.00025222963,0.0000799577,0.0003362708,0.000010876199,0.0000030889787,0.00042531505],"genre_scores_gemma":[0.99821377,0.00014971984,0.0014122415,0.00005638691,0.000094069226,0.000010731972,0.000024058389,0.000017833552,0.000021180476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870986,0.00023536514,0.00052847096,0.00009586867,0.00019306841,0.00023735002],"domain_scores_gemma":[0.99879056,0.00008456645,0.000710514,0.00019573483,0.000111844725,0.00010678077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063294184,0.00014548145,0.0005287239,0.00015364148,0.000021937958,0.0000028221816,0.000068092515,0.000070324604,0.000014501474],"category_scores_gemma":[0.000043116313,0.00008240818,0.00008487309,0.00015728966,0.00008121442,0.00006647621,0.000012936226,0.00012912849,5.644149e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035391128,0.0026105933,0.74886423,0.00010673323,0.0002822701,0.0010167443,0.01282698,0.00016286713,0.23255792,0.00034914055,0.000027698647,0.00084090384],"study_design_scores_gemma":[0.0035716211,0.0031279237,0.8894076,0.00009038136,0.00067491585,0.0029035427,0.0014671766,0.00003054252,0.09861122,0.000025513911,0.000046654724,0.00004290473],"about_ca_topic_score_codex":0.000098154065,"about_ca_topic_score_gemma":0.000005897854,"teacher_disagreement_score":0.14054337,"about_ca_system_score_codex":0.000113860544,"about_ca_system_score_gemma":0.00020120185,"threshold_uncertainty_score":0.3360508},"labels":[],"label_agreement":null},{"id":"W2129355295","doi":"10.1371/journal.pmed.0050232","title":"Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies","year":2008,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":820,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research; Eli Lilly Canada; Michael Smith Health Research BC; Canary Foundation; Sanofi; Eli Lilly and Company","keywords":"Biomarker; Serous fluid; Oncology; Serous carcinoma; Ovarian cancer; Clear cell; Internal medicine; Medicine; Population; Ovarian carcinoma; Clear cell carcinoma; Cohort; Cancer; Carcinoma; Pathology; Biology","score_opus":0.13978494339329314,"score_gpt":0.3475216397840144,"score_spread":0.20773669639072126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129355295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8731381,0.022032587,0.00015716018,0.10148509,0.00038660236,0.0017911784,0.00020202433,0.00014089615,0.0006663529],"genre_scores_gemma":[0.9939337,0.0021299792,0.00018989129,0.0012533944,0.00067641103,0.001008277,0.00016426886,0.000035420493,0.00060869585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877363,0.000023061495,0.00031849125,0.00039297968,0.00021242943,0.0002794212],"domain_scores_gemma":[0.9985366,0.0003187791,0.0001235194,0.00048425785,0.0002615511,0.0002752774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004569577,0.00023478206,0.0006473898,0.00012534986,0.00022016586,0.0000036025376,0.000077132114,0.000051829076,0.00013527322],"category_scores_gemma":[0.00032124636,0.00014581445,0.0001236279,0.00017445482,0.00023575436,0.000036546033,0.000031058582,0.000064885666,0.000013887453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023639559,0.0010664703,0.9409553,0.00033923262,0.0011211797,0.00008757135,0.0007209903,1.7116655e-7,0.00053684117,0.0007913197,0.05222423,0.0019203228],"study_design_scores_gemma":[0.0049677114,0.0006234718,0.9874491,0.00040340776,0.0014304171,0.00007404316,0.00037720273,0.000027408041,0.00036637846,0.0005171182,0.003628416,0.00013534482],"about_ca_topic_score_codex":0.000030004505,"about_ca_topic_score_gemma":0.000016433534,"teacher_disagreement_score":0.12079555,"about_ca_system_score_codex":0.00019886774,"about_ca_system_score_gemma":0.0000757455,"threshold_uncertainty_score":0.5946141},"labels":[],"label_agreement":null},{"id":"W2129699144","doi":"10.1093/jnci/dju029","title":"Better Therapeutic Trials in Ovarian Cancer","year":2014,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre; University of British Columbia; Ontario Institute for Cancer Research","funders":"","keywords":"Clinical trial; Randomized controlled trial; Medicine; Government (linguistics); Alternative medicine; Task force; Translational research; Family medicine; Political science; Internal medicine; Pathology; Public administration","score_opus":0.268705701978992,"score_gpt":0.483486889873344,"score_spread":0.21478118789435197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129699144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002295142,0.98325646,0.000024241694,0.008755575,0.006110682,0.00089835696,0.00016461908,0.0000045486713,0.00076254696],"genre_scores_gemma":[0.0006644781,0.9880842,0.00015747747,0.0035975983,0.006766037,0.0002897387,0.000011968892,0.00004359575,0.0003849151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957892,0.0004933115,0.002046204,0.00026244964,0.00116458,0.0002442911],"domain_scores_gemma":[0.99619716,0.00049125066,0.0024541318,0.00022320444,0.00051096483,0.00012330609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025538278,0.00039001423,0.003176042,0.00044288917,0.000081151586,0.000050408613,0.00041581728,0.00027508065,0.0004355611],"category_scores_gemma":[0.0005323804,0.00020152231,0.0016435557,0.00053279265,0.000094769384,0.00015688843,0.000051013685,0.0008636571,0.000013662159],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001188986,0.00023170724,0.00074669416,0.0031989294,0.0032187442,0.000042004798,0.00004748403,0.00014190727,0.0000024702538,0.00086574553,0.01607616,0.97530925],"study_design_scores_gemma":[0.0022893776,0.000066867746,0.0015783869,0.024255628,0.004084982,0.00020373621,9.621031e-7,0.000003220209,0.000010775114,0.00042672534,0.96690005,0.0001792851],"about_ca_topic_score_codex":0.00019012693,"about_ca_topic_score_gemma":0.00025645315,"teacher_disagreement_score":0.97512996,"about_ca_system_score_codex":0.0028851677,"about_ca_system_score_gemma":0.005279246,"threshold_uncertainty_score":0.93651557},"labels":[],"label_agreement":null},{"id":"W2130021659","doi":"10.1016/j.carj.2009.07.001","title":"Imaging of Ovarian Teratomas in Children: A 9-Year Review","year":2009,"lang":"en","type":"review","venue":"Canadian Association of Radiologists Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Ovarian Teratoma; Teratoma; Immature teratoma; Germ cell tumors; Mature Cystic Teratoma; Endodermal sinus tumor; Pathology; Histology; Stage (stratigraphy); Internal medicine; Biology; Chemotherapy","score_opus":0.018527027092174506,"score_gpt":0.30918239415123866,"score_spread":0.29065536705906414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130021659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018611587,0.9957635,0.0000019273584,0.0016970001,0.0001586867,0.00078305404,0.00016628235,0.0000054557813,0.0014054927],"genre_scores_gemma":[0.0006323607,0.99794245,0.00032693922,0.0005263082,0.00026575796,0.000018303706,0.0001508174,0.00002516397,0.000111895744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974315,0.00034353527,0.0012920488,0.0002477867,0.00028933692,0.0003957602],"domain_scores_gemma":[0.9971374,0.00010939573,0.0018926363,0.00026894623,0.00021892182,0.00037269812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012425643,0.00029117404,0.0025232285,0.00068418676,0.000043421074,0.00001929733,0.00018528654,0.00027224305,0.00018327565],"category_scores_gemma":[0.0006334858,0.00023697985,0.0006745763,0.00049641944,0.000036601286,0.000057916648,0.000008523093,0.0006436702,0.00001042982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004317189,0.000094438234,0.16013081,0.004574822,0.0008039226,0.00020098919,0.00001996695,4.5175312e-7,3.1241534e-8,0.00017845327,0.034201942,0.79978985],"study_design_scores_gemma":[0.001453566,0.00016530609,0.089226514,0.08424267,0.0021527738,0.0016564431,0.000004270787,6.063799e-7,2.5137982e-7,0.000038148126,0.82081234,0.00024711975],"about_ca_topic_score_codex":0.0022499384,"about_ca_topic_score_gemma":0.0023189106,"teacher_disagreement_score":0.7995427,"about_ca_system_score_codex":0.0046617733,"about_ca_system_score_gemma":0.0038704718,"threshold_uncertainty_score":0.99915916},"labels":[],"label_agreement":null},{"id":"W2130307611","doi":"10.1503/cmaj.060697","title":"Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider","year":2007,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Relation (database); Medicine; Ovarian cancer; Type (biology); Gynecology; Health care; Family medicine; Computer science; Cancer; Data science; Internal medicine; Data mining","score_opus":0.01256735817551935,"score_gpt":0.31257874919980927,"score_spread":0.3000113910242899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130307611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83654463,0.006312611,0.0002717647,0.1537551,0.0009032614,0.000597967,0.000053313157,0.00001361583,0.0015477361],"genre_scores_gemma":[0.99113655,0.0012555349,0.00033226222,0.00669051,0.00047748856,0.000008759709,0.000016395426,0.0000127459625,0.00006977904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760264,0.00014924146,0.0005816204,0.00016476704,0.0011481352,0.00035360534],"domain_scores_gemma":[0.9970673,0.00019855594,0.00025199613,0.00008057997,0.00039637022,0.002005234],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026124797,0.000094462004,0.00028619115,0.00035730767,0.00013827582,0.000017850825,0.00005961351,0.00026915167,0.0016285549],"category_scores_gemma":[0.0029745225,0.0000840496,0.000038865972,0.00045438236,0.000018687744,0.00006150098,0.000010361656,0.00058191747,0.000010352776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015582937,0.000042815245,0.74980134,0.000023539253,0.00006466991,0.00011339407,0.0018911753,0.0000029248615,7.125953e-7,0.00017005969,0.00559801,0.24227576],"study_design_scores_gemma":[0.001769861,0.0001926116,0.9617347,0.00041405138,0.000037787122,0.000058775644,0.00080283755,0.00004890241,0.000005408146,0.000022715734,0.034845855,0.0000664688],"about_ca_topic_score_codex":0.031629562,"about_ca_topic_score_gemma":0.3481442,"teacher_disagreement_score":0.31651464,"about_ca_system_score_codex":0.0029574658,"about_ca_system_score_gemma":0.007950781,"threshold_uncertainty_score":0.9992841},"labels":[],"label_agreement":null},{"id":"W2131451291","doi":"10.1093/annonc/mdi966","title":"The Gynecologic Cancer Intergroup (GCIG): history and current status","year":2005,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Surrogate endpoint; Randomized controlled trial; Clinical endpoint; Gynecologic cancer; Cancer; Intensive care medicine; Oncology; Internal medicine; Ovarian cancer","score_opus":0.2685363916126825,"score_gpt":0.49650688316372366,"score_spread":0.22797049155104115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131451291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021194823,0.9907375,4.8943616e-7,0.0026742725,0.0015286694,0.0007698728,0.000052075226,0.000015085943,0.0042008287],"genre_scores_gemma":[0.00005517118,0.99740404,0.000034496657,0.0006290034,0.00046864455,0.00062394387,0.000033674925,0.000028305427,0.00072273763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982895,0.00018473189,0.00062211434,0.0003619415,0.00013977193,0.00040189558],"domain_scores_gemma":[0.99802434,0.00075019005,0.0005793759,0.00034280962,0.00012785273,0.00017540483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029568333,0.0003024505,0.0017439399,0.000110128014,0.000050385697,0.0000055097007,0.00012806166,0.00026845303,0.00046121064],"category_scores_gemma":[0.00010300454,0.00017105676,0.00036688976,0.000079010664,0.00029075527,0.000025215142,0.00010333887,0.0003945257,0.000024632069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028531149,0.0003839836,0.00007386351,0.0020420966,0.0004962528,0.000026011612,0.000060203325,5.5771064e-8,2.0413307e-8,0.0003417657,0.09202868,0.90451854],"study_design_scores_gemma":[0.00056891097,0.0016822106,0.00044969405,0.0028484743,0.0012351614,0.000031349187,0.000010391696,5.815229e-7,2.6321482e-7,0.000025274578,0.9930167,0.00013097697],"about_ca_topic_score_codex":0.000110473346,"about_ca_topic_score_gemma":0.0003181422,"teacher_disagreement_score":0.90438753,"about_ca_system_score_codex":0.0011851458,"about_ca_system_score_gemma":0.0019777024,"threshold_uncertainty_score":0.6975492},"labels":[],"label_agreement":null},{"id":"W2131593373","doi":"10.1158/1078-0432.ccr-08-0196","title":"Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1511,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Serous fluid; Serous ovarian cancer; Ovarian cancer; Cancer; Medicine; Oncology; Ovary; Internal medicine; Biology; Cancer research; Pathology","score_opus":0.4324944750005766,"score_gpt":0.571834478133757,"score_spread":0.1393400031331804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131593373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783769,0.0050913896,0.00014173942,0.013580197,0.000665146,0.0012507336,0.00011228773,0.00003491781,0.00074668153],"genre_scores_gemma":[0.98179877,0.011789291,0.0023644632,0.0018680712,0.00088890747,0.00038407533,0.000007947798,0.000054077213,0.0008443767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955547,0.00033861317,0.0014871827,0.0009188719,0.001040998,0.0006596665],"domain_scores_gemma":[0.99508536,0.0022007194,0.0001666467,0.00076995254,0.0008211695,0.0009561336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089142,0.00023319843,0.001191708,0.00034545758,0.00014168171,0.000021458907,0.00026610645,0.00032663322,0.00052732445],"category_scores_gemma":[0.002909845,0.000185897,0.00034466994,0.0010977971,0.00077555317,0.00005477591,0.0002976453,0.0010795342,0.000055455046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015857668,0.0014475946,0.95139426,0.00012716895,0.00046089594,0.00027133187,0.0001047839,0.000009527462,0.00069324765,0.00023160453,0.0027098139,0.040963985],"study_design_scores_gemma":[0.0083612725,0.0023948555,0.9657253,0.00023223906,0.00015441986,0.00003129343,0.000029585655,0.000030356023,0.00088833494,0.000048451213,0.0219179,0.00018601098],"about_ca_topic_score_codex":0.0037528651,"about_ca_topic_score_gemma":0.0003720825,"teacher_disagreement_score":0.040777978,"about_ca_system_score_codex":0.00024108107,"about_ca_system_score_gemma":0.0012133018,"threshold_uncertainty_score":0.758066},"labels":[],"label_agreement":null},{"id":"W2132193955","doi":"10.1093/annonc/mdq357","title":"A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Ovarian cancer; Dosing; Oncology; Tyrosine-kinase inhibitor; Adverse effect; Gastroenterology; Progressive disease; Phases of clinical research; Cancer; Clinical trial; Chemotherapy","score_opus":0.18159103005263225,"score_gpt":0.485284439144716,"score_spread":0.30369340909208375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132193955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958665,0.00006671372,3.9614278e-7,0.0005157342,0.00038453625,0.0029083916,0.000082253326,0.000008409352,0.00016710581],"genre_scores_gemma":[0.99914867,0.000036220146,0.00018884342,0.00017963185,0.00021503436,0.00015414874,0.00005429544,0.000018654082,0.0000045087595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656683,0.0011518333,0.0013013931,0.0004475453,0.0002932859,0.00023910566],"domain_scores_gemma":[0.9979806,0.0005341372,0.00057270005,0.00041793683,0.00027659867,0.00021805895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033386743,0.00019723408,0.0015916707,0.00019113992,0.00005350416,0.000005485129,0.00010036733,0.00015340405,0.000061149934],"category_scores_gemma":[0.0003359447,0.00014049202,0.0000896349,0.00016098408,0.00017670913,0.00007954162,0.00008676394,0.00036782844,5.676227e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012461096,0.1715663,0.638114,0.000025604148,0.0002726198,0.00009354858,0.002823839,7.8483524e-8,0.00006720842,0.000020842286,0.00005418167,0.17450069],"study_design_scores_gemma":[0.06912021,0.28038827,0.6487996,0.000022700708,0.00031214044,0.0000037759628,0.0009026822,0.0000024586786,0.000035364228,0.000009313281,0.0003276234,0.00007585104],"about_ca_topic_score_codex":0.0006731362,"about_ca_topic_score_gemma":0.0021841505,"teacher_disagreement_score":0.17442483,"about_ca_system_score_codex":0.000030577434,"about_ca_system_score_gemma":0.00033500078,"threshold_uncertainty_score":0.57290983},"labels":[],"label_agreement":null},{"id":"W2133354033","doi":"10.1200/jco.2011.36.4950","title":"American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer","year":2011,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Systemic therapy; Tamoxifen; Oncology; Breast cancer; Internal medicine; Cancer; Hormonal therapy; Adjuvant therapy; Gynecology; Clinical trial; Intensive care medicine; Hormone therapy; Stage (stratigraphy); Pathology","score_opus":0.21755191730877613,"score_gpt":0.5159748102747106,"score_spread":0.2984228929659345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133354033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13890564,0.8237088,0.000019873867,0.019660825,0.003868917,0.008619952,0.0010108014,0.000010717697,0.0041945125],"genre_scores_gemma":[0.030748198,0.9637299,0.0022536744,0.0016344475,0.0010992984,0.00035643709,0.000016473008,0.000047093366,0.0001144875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9872733,0.0028293214,0.008080486,0.00054934376,0.0008560187,0.0004115762],"domain_scores_gemma":[0.9717965,0.0064452644,0.01919875,0.0007863189,0.0014899527,0.00028320443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048791366,0.0005225502,0.007963447,0.00013885467,0.000046961115,0.0000061039586,0.00053600234,0.00067609455,0.00041475697],"category_scores_gemma":[0.000634535,0.00023251247,0.001603018,0.00042200516,0.0008065284,0.00008935427,0.0000845286,0.0016260598,0.0000014730738],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009480983,0.013552754,0.056845833,0.0010069129,0.0073537542,0.0001734717,0.0060594007,0.000045980498,5.2092264e-7,0.000043810298,0.0010516832,0.9043849],"study_design_scores_gemma":[0.010102889,0.0763298,0.16080284,0.0046333745,0.008449429,0.00009818425,0.0017901869,0.0000010665262,0.0000039942165,0.00000516254,0.7376355,0.00014760702],"about_ca_topic_score_codex":0.056439977,"about_ca_topic_score_gemma":0.07469551,"teacher_disagreement_score":0.9042373,"about_ca_system_score_codex":0.005194443,"about_ca_system_score_gemma":0.030721534,"threshold_uncertainty_score":0.99862444},"labels":[],"label_agreement":null},{"id":"W2134021845","doi":"10.1016/s1470-2045(11)70338-2","title":"Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Juravinski Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Aflibercept; Paracentesis; Ascites; Placebo; Surgery; Population; Clinical endpoint; Internal medicine; Ovarian cancer; Chemotherapy; Bevacizumab; Gastroenterology; Randomized controlled trial; Cancer","score_opus":0.06439106428427824,"score_gpt":0.35626371206261853,"score_spread":0.2918726477783403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134021845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798348,0.00052863656,0.000048446145,0.0007050807,0.00026717523,0.017912993,0.00006733073,0.000031079013,0.00060446584],"genre_scores_gemma":[0.9842626,0.00044855048,0.0010730996,0.00011338174,0.00015096067,0.01382263,0.000040531326,0.00003478335,0.000053462958],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99805087,0.00023199047,0.0006533118,0.00039982382,0.00020617535,0.00045781708],"domain_scores_gemma":[0.9983747,0.00041897665,0.00043766972,0.00051741156,0.00014356681,0.00010768207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045145443,0.0003173487,0.0019872237,0.00013982807,0.000071676746,0.000008071747,0.0001523135,0.00008454267,0.00016528102],"category_scores_gemma":[0.000023863233,0.00016412219,0.00015808031,0.00019749926,0.00009571074,0.00004631126,0.000020795123,0.000078851386,0.000004015928],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79693866,0.028030645,0.042424075,0.000081252445,0.0017175005,0.000039535724,0.009726483,0.000020270607,0.000013593121,0.00011925814,0.000042168675,0.12084656],"study_design_scores_gemma":[0.88933736,0.05391699,0.053094074,0.00018319851,0.00183,0.000005439174,0.0005373101,0.00006966141,0.00041062792,0.000054071275,0.00040171985,0.00015956134],"about_ca_topic_score_codex":0.0004601215,"about_ca_topic_score_gemma":0.0012665632,"teacher_disagreement_score":0.120687,"about_ca_system_score_codex":0.0006724789,"about_ca_system_score_gemma":0.00034991113,"threshold_uncertainty_score":0.6692709},"labels":[],"label_agreement":null},{"id":"W2134559385","doi":"10.2174/156652309790031148","title":"Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy","year":2009,"lang":"en","type":"review","venue":"Current Gene Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Ovarian cancer; Cancer therapy; Medicine; Current (fluid); Oncology; Cancer; Internal medicine; Engineering","score_opus":0.24333650949710753,"score_gpt":0.4492741907744034,"score_spread":0.20593768127729586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134559385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059024693,0.9905561,0.0000023597115,0.0037727237,0.002840611,0.0024880744,0.00007950933,0.000050737126,0.00015081768],"genre_scores_gemma":[0.000037313333,0.9931434,0.000021491345,0.00012889226,0.004913205,0.0015150068,0.00013117133,0.00008112717,0.0000283882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975933,0.00026641067,0.0005995961,0.0007696973,0.00032055078,0.00045047663],"domain_scores_gemma":[0.99863577,0.00009056008,0.0003178074,0.000716064,0.00006827763,0.00017154618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002629788,0.0007023933,0.001616162,0.0002561908,0.0002138839,0.00008347586,0.00020440492,0.00022315636,0.0002538133],"category_scores_gemma":[0.000004087233,0.00038761893,0.00047095667,0.0005280126,0.00008194844,0.000058000074,0.000031169024,0.0009346768,0.000010204098],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004349524,0.0008703481,0.00006435939,0.0009882991,0.0003204853,0.000009099032,0.00047167277,1.5944549e-7,3.863434e-7,0.00007899568,0.00094852346,0.9962042],"study_design_scores_gemma":[0.0022615925,0.00020677967,0.0015557292,0.010640835,0.0003983475,0.000031255593,0.000012090156,0.0000015478238,0.0000042719753,0.0000707506,0.9844647,0.00035209247],"about_ca_topic_score_codex":0.000041499115,"about_ca_topic_score_gemma":0.000037557173,"teacher_disagreement_score":0.9958521,"about_ca_system_score_codex":0.00039640436,"about_ca_system_score_gemma":0.0006051703,"threshold_uncertainty_score":0.99985754},"labels":[],"label_agreement":null},{"id":"W2134970255","doi":"10.1158/1078-0432.ccr-12-0199","title":"Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Proinflammatory cytokine; Biology; Luteal phase; Transfection; Inflammation; Gene expression; Small interfering RNA; Luciferase; Molecular biology; Tumor necrosis factor alpha; Signal transduction; Cancer research; Cell biology; Follicular phase; Immunology; Gene; Endocrinology; Genetics","score_opus":0.280077492417682,"score_gpt":0.5072895510402354,"score_spread":0.22721205862255345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134970255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500675,0.0068457685,0.0000023938644,0.03672964,0.00045700299,0.002464313,0.00003898821,0.00005881229,0.0033355646],"genre_scores_gemma":[0.99190074,0.0013301758,0.0001834786,0.0035405806,0.0014347559,0.0011288165,0.000033926804,0.00006118008,0.00038632916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943547,0.0014331727,0.0009323201,0.000642869,0.0014159036,0.0012210308],"domain_scores_gemma":[0.9957889,0.002437986,0.00012705194,0.0008863701,0.00032777476,0.00043192555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008185978,0.0002685774,0.0006368555,0.00016218463,0.00022148177,0.000053136402,0.00041576682,0.00032681943,0.0009911717],"category_scores_gemma":[0.001310359,0.00017022865,0.00025783537,0.000777963,0.00059756776,0.00022635392,0.00015852088,0.0018233372,0.00023669955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009603493,0.0020732319,0.9732343,0.00023089623,0.00030812153,0.00024047049,0.004642553,0.000005406666,0.00046882036,0.0009814863,0.010101032,0.006753351],"study_design_scores_gemma":[0.005645249,0.0011457377,0.8526141,0.0005064296,0.0001300118,0.000022594751,0.0011796816,0.000035804263,0.0012981434,0.00021442656,0.13692367,0.00028416963],"about_ca_topic_score_codex":0.001070046,"about_ca_topic_score_gemma":0.0005457765,"teacher_disagreement_score":0.12682265,"about_ca_system_score_codex":0.00053432584,"about_ca_system_score_gemma":0.001163179,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W2135936215","doi":"10.3390/ijms141122655","title":"HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival","year":2013,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institute for Theoretical Astrophysics","keywords":"Serous fluid; Endometrial cancer; Epididymis; Biology; Messenger RNA; Biomarker; Cancer; Internal medicine; Medicine; Gene; Genetics","score_opus":0.018399554384534708,"score_gpt":0.2763164034346819,"score_spread":0.25791684905014717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135936215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916891,0.0034729866,0.0013015872,0.0026547788,0.00047193532,0.00014711639,0.0000029050257,0.0000018757488,0.00025772562],"genre_scores_gemma":[0.9958149,0.0015961289,0.002369423,0.00012377748,0.00007542871,0.000010246045,8.671672e-7,0.0000035348912,0.000005694907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900806,0.000029846613,0.00021835112,0.00013291674,0.0005334656,0.00007738979],"domain_scores_gemma":[0.9995038,0.000059599202,0.00014156636,0.000034735433,0.00019106836,0.0000692564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017999134,0.00006745907,0.00012982648,0.00023136829,0.000029880362,0.000060455164,0.00006298092,0.000023732075,0.00007797833],"category_scores_gemma":[0.00002180037,0.000043708555,0.000025365365,0.00014229515,0.00008820461,0.0002550574,0.000012885377,0.00007698792,8.0912724e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013830737,0.000863022,0.54949915,0.00002262681,0.00034180738,0.0007194889,0.0029048666,0.0019322225,0.19307348,0.0019458553,0.00032508554,0.24698932],"study_design_scores_gemma":[0.010868363,0.0021440117,0.9554655,0.0010285876,0.000075703516,0.0006325547,0.001081585,0.0009899423,0.025284674,0.0007074347,0.0015233548,0.00019830285],"about_ca_topic_score_codex":0.00015031776,"about_ca_topic_score_gemma":0.000015914637,"teacher_disagreement_score":0.40596634,"about_ca_system_score_codex":0.00006470824,"about_ca_system_score_gemma":0.00007878537,"threshold_uncertainty_score":0.1782383},"labels":[],"label_agreement":null},{"id":"W2136091069","doi":"10.1186/1471-2407-10-237","title":"Expression signatures of TP53 mutations in serous ovarian cancers","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; University of Alabama; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Ovarian cancer; Serous fluid; Mutation; Biology; Missense mutation; Breast cancer; Context (archaeology); Cancer; Surgical oncology; Gene; Cancer research; Genetics; Oncology; Medicine","score_opus":0.018778457891285776,"score_gpt":0.31215418177521403,"score_spread":0.29337572388392824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136091069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993679,0.0012213333,0.000056113477,0.0007730264,0.00067566027,0.00044432204,0.000062080435,0.000026442642,0.0030620468],"genre_scores_gemma":[0.9962461,0.00012681891,0.0025319776,0.00020314171,0.00020654993,0.0002840725,0.00001718726,0.00001798643,0.00036617258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992228,0.000016242595,0.00020105172,0.00021854276,0.00017465904,0.000166714],"domain_scores_gemma":[0.99946105,0.00005961274,0.00008254413,0.0002450294,0.00006586353,0.00008587737],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000064004234,0.00010924697,0.00022427013,0.00010357365,0.000029529183,0.0000069214193,0.00005630621,0.00010015957,0.0010723699],"category_scores_gemma":[0.00003315744,0.00008842573,0.00006553603,0.00020244457,0.000052271636,0.000051386414,0.000016469477,0.00019812804,0.000005357477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045989262,0.0005301462,0.84487885,0.00026013106,0.00010356802,0.00005301313,0.0015193105,0.0017770237,0.12075742,0.0012351652,0.0059896302,0.022435855],"study_design_scores_gemma":[0.003755342,0.00012761465,0.90151966,0.0004418831,0.00012660831,0.0000065930417,0.00014927365,0.00023319955,0.08483255,0.00020830176,0.0084429905,0.0001559752],"about_ca_topic_score_codex":0.006090538,"about_ca_topic_score_gemma":0.01856978,"teacher_disagreement_score":0.056640826,"about_ca_system_score_codex":0.00019571777,"about_ca_system_score_gemma":0.00059266476,"threshold_uncertainty_score":0.9998408},"labels":[],"label_agreement":null},{"id":"W2136416459","doi":"10.1016/j.ijrobp.2011.06.768","title":"Image Guided Salvage High Dose Rate (HDR) Interstitial Gynecological Brachytherapy","year":2011,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Brachytherapy; Dose rate; Medical physics; Radiology; Nuclear medicine; Radiation therapy","score_opus":0.040018655713819865,"score_gpt":0.3435775023578488,"score_spread":0.30355884664402893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136416459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663981,0.0005038899,0.011595556,0.008914586,0.0066230255,0.000496522,0.000096563956,0.00008685918,0.0052848924],"genre_scores_gemma":[0.9786942,0.0011503423,0.0130349845,0.003788499,0.0031077145,0.00002798275,0.00009298683,0.000034426288,0.000068841386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798554,0.0002853038,0.00089756434,0.0003064854,0.00024000533,0.00028512487],"domain_scores_gemma":[0.9974209,0.00038797522,0.0010083353,0.00020119794,0.0007782912,0.00020327712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058346754,0.00026273422,0.0006285767,0.00017159338,0.0000699517,0.000031421077,0.00036116716,0.00027636092,0.0013196896],"category_scores_gemma":[0.00030328927,0.00020674775,0.00035707734,0.0001356951,0.00025598635,0.0003143147,0.000067793975,0.00047208383,0.00012711201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057527698,0.006864573,0.4614115,0.000026906182,0.0053736656,0.002388194,0.0022301024,0.00007957824,0.015999764,0.06259387,0.02337533,0.41390374],"study_design_scores_gemma":[0.043230962,0.013751036,0.7935644,0.00018338977,0.0008923806,0.0013963869,0.0001835543,0.0009536489,0.01919377,0.048881963,0.07705809,0.0007104368],"about_ca_topic_score_codex":0.000062871855,"about_ca_topic_score_gemma":0.00000736317,"teacher_disagreement_score":0.4131933,"about_ca_system_score_codex":0.00100716,"about_ca_system_score_gemma":0.00052362215,"threshold_uncertainty_score":0.99959326},"labels":[],"label_agreement":null},{"id":"W2136580161","doi":"","title":"Oviduct-specific glycoprotein (OVGP1), a new serum biomarker for the detection of ovarian cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Immunohistochemistry; Oviduct; Biology; Cystadenocarcinoma; Ovarian cancer; Glycoprotein; Clear cell; Polyclonal antibodies; Antibody; Monoclonal antibody; Pathology; Serous carcinoma; Monoclonal; Cancer; Ovary; Endometrium; Cancer research; Medicine; Immunology; Molecular biology; Endocrinology","score_opus":0.1933657799724145,"score_gpt":0.4175337521712154,"score_spread":0.2241679721988009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136580161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.788223,0.12562172,0.003707474,0.067786776,0.0021408396,0.010158261,0.0004233993,0.00012594985,0.0018125786],"genre_scores_gemma":[0.9794584,0.0122434255,0.00024582713,0.00014403508,0.0010619021,0.0025082338,0.000005737469,0.000048079914,0.0042843516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979948,0.000076355216,0.00028103663,0.0004367449,0.0006774905,0.00053361856],"domain_scores_gemma":[0.9983553,0.00028289188,0.000078353034,0.0005882452,0.0004784668,0.00021669315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005032442,0.00016371494,0.00030627224,0.00019094998,0.00038148585,0.000023462913,0.00019039056,0.00010903436,0.0014118261],"category_scores_gemma":[0.00007046487,0.000108805005,0.00016481735,0.0007929867,0.00026823021,0.00007099324,0.00005901012,0.00028308737,0.00002205632],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044488558,0.000451121,0.017879955,0.00037831676,0.0010651895,0.00006683434,0.0013983853,0.000039215425,0.14179085,0.0006081835,0.095905475,0.73596764],"study_design_scores_gemma":[0.0060841297,0.000678452,0.20147856,0.00034635075,0.00011664015,0.000039319402,0.00016738253,0.00011330579,0.25302598,0.0002573449,0.5375171,0.0001754351],"about_ca_topic_score_codex":0.010022827,"about_ca_topic_score_gemma":0.0013607938,"teacher_disagreement_score":0.73579216,"about_ca_system_score_codex":0.000701522,"about_ca_system_score_gemma":0.0013015838,"threshold_uncertainty_score":0.999501},"labels":[],"label_agreement":null},{"id":"W2136609875","doi":"10.1093/jnci/dju049","title":"Comparative Meta-analysis of Prognostic Gene Signatures for Late-Stage Ovarian Cancer","year":2014,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Ovarian cancer; Meta-analysis; Oncology; Serous fluid; Stage (stratigraphy); Internal medicine; Medicine; Cancer; Bioinformatics; Biology","score_opus":0.33766344917865443,"score_gpt":0.47869238855009333,"score_spread":0.1410289393714389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136609875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047478537,0.9918827,0.0001979147,0.0012316626,0.001423433,0.0015152544,0.0034611132,0.000005264602,0.00023520332],"genre_scores_gemma":[0.004483047,0.9899276,0.0012682735,0.00068609614,0.0014774232,0.0008454866,0.00014985102,0.00003945274,0.0011227904],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660057,0.0001614247,0.0014686211,0.00032395107,0.0012272703,0.0002181837],"domain_scores_gemma":[0.99385476,0.0005705876,0.0032037569,0.0002594362,0.001972689,0.00013877256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007228657,0.0004478491,0.0052354545,0.00064067845,0.0001246365,0.00003351238,0.0004415893,0.00023471264,0.00042857026],"category_scores_gemma":[0.00023762956,0.00023169792,0.005637938,0.0010711538,0.00014731775,0.00012677792,0.000052704152,0.0004896201,0.000001506618],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026177338,0.00057022256,0.00012979789,0.00704844,0.9006111,0.00001782709,0.00018333718,0.054988217,0.0000084682,0.002383353,0.010735192,0.023062285],"study_design_scores_gemma":[0.00067665556,0.00009744872,0.00026919367,0.0011477013,0.41128367,0.000007828547,0.0000015043147,0.0001168996,0.000045779972,0.00004352606,0.5861746,0.00013518662],"about_ca_topic_score_codex":0.00015890469,"about_ca_topic_score_gemma":0.00041964234,"teacher_disagreement_score":0.5754394,"about_ca_system_score_codex":0.0010653535,"about_ca_system_score_gemma":0.0036854523,"threshold_uncertainty_score":0.94483674},"labels":[],"label_agreement":null},{"id":"W2137186819","doi":"10.1038/ng.424","title":"A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2","year":2009,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Ovarian cancer; Odds ratio; Biology; Locus (genetics); SNP; Genetic association; Genetics; Oncology; Cancer; Genotype; Internal medicine; Medicine; Gene","score_opus":0.013790097655723612,"score_gpt":0.30670213357997694,"score_spread":0.29291203592425336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137186819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750591,0.004847678,0.000014241291,0.01695271,0.00062163576,0.0011169319,0.00002590362,0.00006916152,0.0012926572],"genre_scores_gemma":[0.99018145,0.0004928357,0.0002526165,0.0041504987,0.00089617714,0.000029988338,0.000025150423,0.000021251066,0.0039500464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982574,0.00005705821,0.00027957637,0.00049519556,0.00059677986,0.00031401918],"domain_scores_gemma":[0.99884856,0.00009455058,0.00014292402,0.0005288666,0.0001901615,0.00019491528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022167982,0.00022784076,0.00034786027,0.00009369981,0.000088469475,0.000057810295,0.00010826845,0.00032561953,0.00025922802],"category_scores_gemma":[0.00016966744,0.00019186873,0.00012176079,0.00028801803,0.000010848451,0.00003040709,0.000022234244,0.00051416847,0.00004714386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021864807,0.0018363734,0.9632732,0.000020187283,0.0004061141,0.00007281506,0.0010432706,0.00007133675,0.00047394703,0.00001646407,0.012626929,0.01994066],"study_design_scores_gemma":[0.0030025458,0.0013879108,0.9801902,0.000043879754,0.00045542693,0.0000011999741,0.000102802034,0.0000059047425,0.0016586335,0.00049093657,0.012495384,0.00016515533],"about_ca_topic_score_codex":0.0002726506,"about_ca_topic_score_gemma":0.001166976,"teacher_disagreement_score":0.019775504,"about_ca_system_score_codex":0.0009979733,"about_ca_system_score_gemma":0.0002887182,"threshold_uncertainty_score":0.78241795},"labels":[],"label_agreement":null},{"id":"W2137268781","doi":"10.1158/1535-7163.mct-09-0960","title":"Potent Preclinical Impact of Metronomic Low-Dose Oral Topotecan Combined with the Antiangiogenic Drug Pazopanib for the Treatment of Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canada Research Chairs; GlaxoSmithKline","keywords":"Topotecan; Medicine; Pazopanib; Ovarian cancer; Pharmacology; Paclitaxel; Irinotecan; Chemotherapy; Cyclophosphamide; Ovarian carcinoma; Cancer; Oncology; Internal medicine; Sunitinib; Colorectal cancer","score_opus":0.030211782874553963,"score_gpt":0.3444115221306979,"score_spread":0.314199739256144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137268781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794526,0.008053376,0.0005244734,0.009130679,0.00032098612,0.0022229059,0.0002467112,0.00001714293,0.000031105545],"genre_scores_gemma":[0.9956879,0.0022731365,0.00050049403,0.00048373395,0.00014189712,0.0007339494,0.000020060874,0.0000626979,0.0000961152],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986321,0.000064681124,0.00037501767,0.00032805695,0.00026085414,0.00033930677],"domain_scores_gemma":[0.9983798,0.00020868043,0.0002862392,0.0008256201,0.00019592092,0.00010368702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018475212,0.00030748322,0.0005926796,0.00005443079,0.00009901575,0.000020395959,0.00022237666,0.00009263603,0.00014753232],"category_scores_gemma":[0.0000044705703,0.00014440333,0.0006789199,0.00021611367,0.00027704047,0.00002450362,0.000019983603,0.00015004697,8.78189e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020756079,0.010055606,0.20576908,0.0002756833,0.050351683,0.000057176796,0.004490484,0.0060804924,0.13068089,0.0016737639,0.0006726686,0.5691364],"study_design_scores_gemma":[0.036685478,0.015777603,0.5422763,0.0002585466,0.016199414,0.00002424104,0.00031513124,0.004667925,0.364939,0.00023343385,0.017934881,0.00068800064],"about_ca_topic_score_codex":0.0035547945,"about_ca_topic_score_gemma":0.0022829748,"teacher_disagreement_score":0.56844836,"about_ca_system_score_codex":0.00034222662,"about_ca_system_score_gemma":0.0008044917,"threshold_uncertainty_score":0.5888597},"labels":[],"label_agreement":null},{"id":"W2137349242","doi":"10.1158/0008-5472.can-14-0108","title":"Emergence, Involution, and Progression to Carcinoma of Mutant Clones in Normal Endometrial Tissues","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"PTEN; Carcinogenesis; Endometrial cancer; Biology; Carcinoma; Cancer research; Pathology; Oncology; Cancer; Internal medicine; Medicine; Genetics","score_opus":0.07596648738764479,"score_gpt":0.4356516464816572,"score_spread":0.35968515909401244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137349242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279594,0.0034300284,0.000013022997,0.0021882446,0.00015208796,0.000698046,0.0000116808205,0.0000072902303,0.0007036355],"genre_scores_gemma":[0.99793303,0.000996937,0.00028841014,0.00003072739,0.0002916537,0.00035058052,0.0000045014303,0.000011553997,0.000092630304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986074,0.00011320235,0.0002250894,0.00026667342,0.0004801949,0.00030744507],"domain_scores_gemma":[0.99925107,0.0001160098,0.00003134047,0.00019791858,0.00022078892,0.00018286583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000704957,0.00008222479,0.00025288798,0.00045636776,0.00005544317,0.000010278544,0.00006915703,0.000052037332,0.00026690034],"category_scores_gemma":[0.0002458969,0.00006326658,0.000026344684,0.00083450216,0.000107299056,0.00004546237,0.00008903384,0.00014188782,0.000009440538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085834536,0.00024996532,0.89226234,0.00020165967,0.000027785443,0.000026472217,0.00078982033,0.000005421228,0.015103754,0.0006226966,0.00222186,0.08762985],"study_design_scores_gemma":[0.004800455,0.0024093748,0.80232245,0.00066087814,0.00002661191,0.0000076086094,0.00026484253,0.00009972479,0.17446487,0.00015541313,0.014665898,0.00012186547],"about_ca_topic_score_codex":0.0023109883,"about_ca_topic_score_gemma":0.0005618883,"teacher_disagreement_score":0.15936111,"about_ca_system_score_codex":0.00011805657,"about_ca_system_score_gemma":0.00018089516,"threshold_uncertainty_score":0.34935385},"labels":[],"label_agreement":null},{"id":"W2138124620","doi":"10.1158/1535-7163.mct-10-0249","title":"Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Docetaxel; Ovarian cancer; Chemotherapy; Medicine; Debulking; Oncology; Internal medicine; Cancer; Angiogenesis; Tumor microenvironment; Cancer research; Pharmacology","score_opus":0.021881203073399767,"score_gpt":0.3033659557191305,"score_spread":0.28148475264573075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138124620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97630274,0.012392961,0.0006274383,0.007553885,0.0005658061,0.0012666004,0.000048714708,0.0000680279,0.0011738269],"genre_scores_gemma":[0.9890623,0.004178531,0.0010829305,0.004824184,0.00016680133,0.00035875497,0.000012441219,0.00010910336,0.00020493392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979916,0.000048269052,0.00052370207,0.00052969053,0.00040598473,0.0005007079],"domain_scores_gemma":[0.99865276,0.00005159012,0.00022163604,0.0007402984,0.00018816833,0.00014553546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016917985,0.000394303,0.0007414999,0.00018194306,0.00004364165,0.00002902821,0.00022765202,0.0002328191,0.00033647584],"category_scores_gemma":[0.000004782797,0.0003323233,0.00025545727,0.00041856852,0.00016762907,0.00008043429,0.00003578484,0.0004766212,0.0000035857897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079171656,0.0023330068,0.023299228,0.0001548884,0.0015538625,0.00009268907,0.0010847985,0.000420657,0.65844333,0.0037523243,0.00003244845,0.30804107],"study_design_scores_gemma":[0.030035377,0.0010246743,0.2276109,0.00056181033,0.0014913074,0.00004464283,0.00012191048,0.0053404286,0.7068953,0.003620723,0.022221448,0.0010315119],"about_ca_topic_score_codex":0.0015094398,"about_ca_topic_score_gemma":0.00047920342,"teacher_disagreement_score":0.30700955,"about_ca_system_score_codex":0.00016902224,"about_ca_system_score_gemma":0.00042039537,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2138202356","doi":"10.1210/edrv.22.2.0422","title":"Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*","year":2001,"lang":"en","type":"review","venue":"Endocrine Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":997,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre of Excellence for Women's Health; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Epithelium; Pathology; Biology; Endocrinology; Internal medicine; Medicine","score_opus":0.08952469654848703,"score_gpt":0.39473102488269024,"score_spread":0.3052063283342032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138202356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005174798,0.9873625,0.000020983609,0.0011919884,0.0005621867,0.0039191106,0.00014542027,0.00012346993,0.0066691726],"genre_scores_gemma":[0.000003928249,0.99211735,0.00284818,0.0004218651,0.00068297854,0.00080253277,0.0004792223,0.00012497696,0.0025189691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99536204,0.00070618093,0.0015405169,0.0013272368,0.00012745209,0.0009365469],"domain_scores_gemma":[0.99721974,0.00030223635,0.00069322094,0.0013510165,0.00006031459,0.00037344376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004331402,0.0010845347,0.0062851855,0.00025451678,0.00011687896,0.000032355376,0.00026345902,0.0003266878,0.0008808455],"category_scores_gemma":[0.0002137393,0.00071238045,0.0010739621,0.00053857506,0.00028338685,0.000055323762,0.00028133002,0.0008483727,0.0010564276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000082067,0.00021273029,0.00032408268,0.011978063,0.00041545057,0.0013932909,0.000010751075,1.35628735e-8,5.026277e-7,0.0012180947,0.004755766,0.97968304],"study_design_scores_gemma":[0.0011176821,0.00038578254,0.00006524068,0.011805098,0.0043248637,0.012134227,0.000003999559,2.7908408e-7,0.0000016274001,0.00008807851,0.96957415,0.0004989952],"about_ca_topic_score_codex":0.00010865392,"about_ca_topic_score_gemma":0.00001567564,"teacher_disagreement_score":0.97918403,"about_ca_system_score_codex":0.00023766098,"about_ca_system_score_gemma":0.0002535886,"threshold_uncertainty_score":0.99972135},"labels":[],"label_agreement":null},{"id":"W2138366068","doi":"10.1095/biolreprod.113.111336","title":"Estrogen Responsiveness of the TFIID Subunit TAF4B in the Normal Mouse Ovary and in Ovarian Tumors1","year":2013,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canadian Institutes of Health Research; National Institutes of Health; National Center for Research Resources; National Institute of General Medical Sciences; British Heart Foundation; Society for the Study of Reproduction","keywords":"Estrogen; Biology; Diethylstilbestrol; Ovary; Endocrinology; Internal medicine; Estrogen receptor; Estrogen receptor alpha; Estrogen receptor beta; Cancer; Medicine; Breast cancer","score_opus":0.017088130812199325,"score_gpt":0.2602059588731812,"score_spread":0.2431178280609819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138366068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896558,0.0016103628,0.0000019503314,0.007993578,0.00010902853,0.0005249287,0.000003902247,0.0000033632848,0.0000971209],"genre_scores_gemma":[0.9993584,0.00022732248,0.00013520534,0.00005912186,0.000072647985,0.000071132046,0.0000074429395,0.0000044855574,0.00006424829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992214,0.00019402697,0.00020841161,0.00022140365,0.000056574565,0.00009819057],"domain_scores_gemma":[0.99935937,0.000055064575,0.00010007209,0.00041484108,0.00005693686,0.00001368662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044741182,0.00006726859,0.00017301763,0.00008158674,0.000022272094,0.000002056035,0.00006217676,0.0000594452,0.00002605752],"category_scores_gemma":[0.00014278358,0.00003734141,0.000031075644,0.00019949186,0.00016565487,0.000039616512,0.00002868478,0.00009584165,0.0000017833781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003419105,0.00027726946,0.9564054,0.000035954956,0.000033727385,0.0000037895081,0.000527511,0.000009689887,0.033884875,0.00067653,0.00011828653,0.007685048],"study_design_scores_gemma":[0.0007258971,0.00023777649,0.9212492,0.00003443476,0.000020723113,0.00006493435,0.00024728104,0.0000035921153,0.07613947,0.00023575051,0.0010095722,0.000031346783],"about_ca_topic_score_codex":0.0015387981,"about_ca_topic_score_gemma":0.00006916397,"teacher_disagreement_score":0.042254593,"about_ca_system_score_codex":0.000028121367,"about_ca_system_score_gemma":0.00005745463,"threshold_uncertainty_score":0.23262127},"labels":[],"label_agreement":null},{"id":"W2138368669","doi":"10.2217/fon.15.251","title":"Current State of Biomarkers in Ovarian Cancer Prognosis","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Carboplatin; Paclitaxel; Tumor microenvironment; Disease; Drug resistance; Oncology; Chemotherapy; Cancer; Serous fluid; Internal medicine; Bioinformatics; Cisplatin; Biology","score_opus":0.07496433028108566,"score_gpt":0.43021415235169136,"score_spread":0.3552498220706057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138368669","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000133382355,0.99215144,0.0000010146575,0.0012675648,0.0024869482,0.0021890313,0.0002844228,0.000017910448,0.0015883495],"genre_scores_gemma":[0.000017045031,0.9965738,0.00034977793,0.000059050686,0.0009489468,0.0017017297,0.00023227339,0.000055520264,0.00006185438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977921,0.00024014927,0.0008316871,0.00052465603,0.00024471042,0.00036668684],"domain_scores_gemma":[0.99860156,0.00009201274,0.0005747785,0.0003665265,0.00014637479,0.00021874839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035876204,0.00041694497,0.0029877576,0.00040440712,0.000014994115,0.000005470462,0.0001485093,0.00034445943,0.00019871525],"category_scores_gemma":[0.000021040669,0.00028981105,0.00039400885,0.0006160852,0.000082273924,0.000025999401,0.000068828274,0.00047456118,0.00003295451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008324492,0.0009469806,0.0007486064,0.012004341,0.0010786754,0.00017334615,0.00011587569,1.5780518e-7,8.0362355e-8,0.000041303152,0.015489007,0.9693184],"study_design_scores_gemma":[0.0020535074,0.00066740834,0.001051424,0.0130878035,0.0024118545,0.000048632886,0.000011124025,4.650679e-7,0.0000014617563,0.000025370624,0.98043656,0.00020439186],"about_ca_topic_score_codex":0.00020483218,"about_ca_topic_score_gemma":0.0006241944,"teacher_disagreement_score":0.969114,"about_ca_system_score_codex":0.0019678113,"about_ca_system_score_gemma":0.0044969167,"threshold_uncertainty_score":0.9999554},"labels":[],"label_agreement":null},{"id":"W2138740802","doi":"10.1007/s12094-012-0756-8","title":"Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls","year":2012,"lang":"en","type":"review","venue":"Clinical & Translational Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Oncology; Biomarker; Chemotherapy; Epithelial ovarian cancer; Internal medicine; Perioperative; Ovarian cancer; Adjuvant; Stage (stratigraphy); Clinical trial; Clinical significance; Cytoreductive surgery; Disease; Cancer; Surgery","score_opus":0.11711359335822245,"score_gpt":0.4451432596071883,"score_spread":0.32802966624896585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138740802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021905862,0.9916167,0.00003118797,0.0016936089,0.00028131262,0.0027139536,0.00104673,0.000004481991,0.00042140466],"genre_scores_gemma":[0.021162806,0.97663105,0.0007055034,0.000121069424,0.00050154596,0.00052168843,0.00031590683,0.000022032373,0.00001842346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969447,0.00071586494,0.0014856155,0.00040477046,0.00023906688,0.00020993887],"domain_scores_gemma":[0.9946686,0.0043446785,0.000567221,0.0002134555,0.000076939265,0.00012908067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075470656,0.0002954412,0.0026117123,0.000114092305,0.000029833229,0.000004043321,0.00008091573,0.0004939074,0.00007501807],"category_scores_gemma":[0.000060340062,0.00017271779,0.0004214766,0.00015775123,0.00045843684,0.00003618933,0.00001639443,0.00024197043,0.0000019875592],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035305237,0.0033367912,0.033605687,0.0028999874,0.0012827516,0.00003572473,0.00035458637,0.0000024544129,5.137867e-7,0.00092121493,0.000018081286,0.95718914],"study_design_scores_gemma":[0.006230321,0.0054424643,0.4682443,0.0032209097,0.014094405,0.00010598672,0.0000141065375,0.000013876744,6.3548345e-7,0.00033654697,0.50213796,0.0001584988],"about_ca_topic_score_codex":0.00016667464,"about_ca_topic_score_gemma":0.00008173723,"teacher_disagreement_score":0.95703065,"about_ca_system_score_codex":0.00016946759,"about_ca_system_score_gemma":0.0015672973,"threshold_uncertainty_score":0.7043227},"labels":[],"label_agreement":null},{"id":"W2138820856","doi":"10.1093/jnci/djq362","title":"Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel","year":2010,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Carboplatin; Topotecan; Paclitaxel; Cisplatin; Ovarian cancer; Medicine; Oncology; Internal medicine; Chemotherapy; Cancer","score_opus":0.033467745382938334,"score_gpt":0.3712773288904837,"score_spread":0.33780958350754536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138820856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671275,0.0012549371,0.00004847238,0.0042256135,0.0045969347,0.0016743918,0.00024218063,0.000015110137,0.0012296155],"genre_scores_gemma":[0.9959991,0.00049782504,0.0009895314,0.00045956386,0.0016006884,0.00019589157,0.000008689537,0.00003428218,0.00021440633],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961946,0.00016443442,0.0014450148,0.00036103328,0.0015329515,0.00030198495],"domain_scores_gemma":[0.996138,0.00029466604,0.0016557121,0.0003099388,0.0013258591,0.00027585903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011866356,0.00036104166,0.0013757128,0.0002969775,0.0002660326,0.000049523227,0.00029867396,0.000159825,0.00023633611],"category_scores_gemma":[0.00062905374,0.00024214029,0.00042064837,0.00043911242,0.00041025455,0.00039881156,0.000100168356,0.00082681514,7.5532523e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48439968,0.017912077,0.103885084,0.00114418,0.025000697,0.00066865253,0.023029514,0.021150673,0.14866112,0.021642294,0.008473142,0.1440329],"study_design_scores_gemma":[0.9079922,0.0024976064,0.052964445,0.0012419762,0.005088808,0.0006416533,0.0005950793,0.0020324646,0.015104828,0.0020858035,0.009020784,0.0007343617],"about_ca_topic_score_codex":0.002643197,"about_ca_topic_score_gemma":0.003072416,"teacher_disagreement_score":0.4235925,"about_ca_system_score_codex":0.000525273,"about_ca_system_score_gemma":0.0019053658,"threshold_uncertainty_score":0.9874195},"labels":[],"label_agreement":null},{"id":"W2139580868","doi":"10.1016/j.ygyno.2008.03.011","title":"Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Michael Smith Health Research BC; VGH and UBC Hospital Foundation; National Cancer Institute; BC Cancer Foundation; Sanofi","keywords":"Carboplatin; Cancer research; Ovarian cancer; Medicine; Transplantation; Pathology; Cancer; Chemotherapy; Internal medicine; Cisplatin","score_opus":0.032534502283381464,"score_gpt":0.28370729887957197,"score_spread":0.2511727965961905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139580868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499136,0.00018610497,0.000028436443,0.0027682616,0.00014462505,0.0012475741,0.000040331935,0.000029225255,0.0005640768],"genre_scores_gemma":[0.99629295,0.0004092362,0.0017849108,0.0011241047,0.00011150602,0.00017831111,0.000027454473,0.00001615836,0.000055387856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806404,0.00031468517,0.00059843966,0.0004576357,0.00022181706,0.00034339662],"domain_scores_gemma":[0.99863356,0.00056725665,0.00024291634,0.00030720577,0.00010853794,0.0001405247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041926085,0.00021981962,0.0007499045,0.000110907305,0.00019409983,0.0000047239546,0.00014471731,0.00024439834,0.00084906287],"category_scores_gemma":[0.00007891026,0.00014849007,0.00011785355,0.00023262261,0.0005235294,0.00004567404,0.000053131538,0.00019215555,0.0000049222153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003549418,0.0027472414,0.09273613,0.0003327263,0.0003009817,0.00052727497,0.0033069914,0.00013812535,0.8936887,0.00015482446,0.00036858712,0.002149029],"study_design_scores_gemma":[0.0053252634,0.00574912,0.90992683,0.00002509986,0.0001505721,0.00028557863,0.00021171398,0.0000032200837,0.07787062,0.00017576227,0.00015260205,0.00012361469],"about_ca_topic_score_codex":0.00008715199,"about_ca_topic_score_gemma":0.0003508378,"teacher_disagreement_score":0.8171907,"about_ca_system_score_codex":0.0004757441,"about_ca_system_score_gemma":0.00035024656,"threshold_uncertainty_score":0.9296643},"labels":[],"label_agreement":null},{"id":"W2139702772","doi":"10.1016/j.jvir.2011.01.237","title":"Abstract No. 215: Prognostic value of visualization of ovarian arteries on pre-UAE MRA","year":2011,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Adenomyosis; Radiology; Magnetic resonance imaging; Surgery; Internal medicine; Uterus","score_opus":0.023477940816368625,"score_gpt":0.29697269955986866,"score_spread":0.27349475874350004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139702772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448055,0.002624835,0.0012670341,0.00011770211,0.0003294653,0.00017949758,0.000012681455,0.0000030894284,0.0009851232],"genre_scores_gemma":[0.99829656,0.00062823796,0.0008611437,0.000041292595,0.00012412335,0.000004920287,0.000012096804,0.000008261558,0.000023374485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897385,0.00006900608,0.0005958003,0.00009997436,0.00017625191,0.00008509763],"domain_scores_gemma":[0.9990723,0.00006800721,0.0004575109,0.00009549597,0.00024281396,0.00006383213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033261403,0.000092379465,0.00039869227,0.00014497987,0.000016893971,0.0000032283363,0.00004955207,0.00007082751,0.00047057634],"category_scores_gemma":[0.00015703478,0.00006707969,0.00037777817,0.000048403625,0.00009844998,0.000070342285,0.000011903809,0.00008597868,0.000002353903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006666171,0.013073027,0.8461946,0.0024979732,0.010582678,0.0002967547,0.0021980961,0.00010283161,0.0074905246,0.089452356,0.0031808035,0.01826418],"study_design_scores_gemma":[0.0022562293,0.006781016,0.98530805,0.00089520175,0.00034991157,0.00028976687,0.000027220358,0.000032021937,0.0022417388,0.0009935056,0.0007741788,0.00005112945],"about_ca_topic_score_codex":0.000030325586,"about_ca_topic_score_gemma":0.0000022687445,"teacher_disagreement_score":0.13911347,"about_ca_system_score_codex":0.000027082933,"about_ca_system_score_gemma":0.000068764464,"threshold_uncertainty_score":0.5152481},"labels":[],"label_agreement":null},{"id":"W2140049927","doi":"10.1586/eog.12.72","title":"Differential diagnosis and clinical relevance of ovarian carcinoma subtypes","year":2012,"lang":"en","type":"article","venue":"Expert Review of Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Serous carcinoma; Ovarian carcinoma; Serous fluid; Clear cell carcinoma; Differential diagnosis; Carcinoma; Ovarian cancer; Clear cell; Carcinogenesis; Pathology; Oncology; Molecular pathology; Internal medicine; Bioinformatics; Cancer; Gene; Biology; Genetics","score_opus":0.03950000557953906,"score_gpt":0.3593789064687912,"score_spread":0.3198789008892522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140049927","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3787402,0.6164827,0.000029567562,0.0014939151,0.001971932,0.0006628302,0.000015315665,0.000011953733,0.00059161655],"genre_scores_gemma":[0.61410826,0.38359973,0.0013329629,0.0006779324,0.00014167004,0.00008473281,0.000012223697,0.000013508389,0.000028964774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981408,0.00017265827,0.00088783685,0.0002838792,0.00021287205,0.0003019275],"domain_scores_gemma":[0.9946783,0.0040715486,0.00039363286,0.0004544598,0.00017587692,0.00022613916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030857473,0.00018878684,0.0011637047,0.00011069665,0.000029673338,0.0000026647406,0.00009990629,0.00016189092,0.00077995047],"category_scores_gemma":[0.005491044,0.00014327593,0.00026007215,0.00031509376,0.0001750639,0.0000633421,0.00009070951,0.00015310258,0.000012380511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019574733,0.0012878181,0.84896183,0.0018632174,0.00017793986,0.000016266387,0.000092887334,8.801698e-9,0.000024284689,0.0007987041,0.0038054662,0.142952],"study_design_scores_gemma":[0.0018019039,0.00093506085,0.8741886,0.0013765898,0.0004927272,0.000020495247,0.000020367746,0.0000031544473,0.0010453408,0.000014818224,0.11997208,0.00012883828],"about_ca_topic_score_codex":0.00004515284,"about_ca_topic_score_gemma":0.000003392385,"teacher_disagreement_score":0.23536809,"about_ca_system_score_codex":0.00009684664,"about_ca_system_score_gemma":0.000100649246,"threshold_uncertainty_score":0.8539911},"labels":[],"label_agreement":null},{"id":"W2140180407","doi":"10.1186/1471-2407-14-982","title":"Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; National Cancer Institute; BC Cancer Foundation","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; Serous fluid; Oncology; Internal medicine; Ovarian cancer; Sanger sequencing; Surgical oncology; Ovarian carcinoma; V600E; Mutation; Cancer; Colorectal cancer; Genetics; Biology","score_opus":0.02954157855875827,"score_gpt":0.29806447064144403,"score_spread":0.26852289208268576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140180407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963258,0.00105325,0.000057893296,0.00054253655,0.00026306996,0.0003481223,0.000029576708,0.000020269403,0.0013595185],"genre_scores_gemma":[0.998298,0.00007183558,0.0007716499,0.00027779728,0.00029583432,0.00014220538,0.000010771105,0.000014966291,0.00011695786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892604,0.000058170637,0.00027420284,0.00029993392,0.00018824454,0.00025337999],"domain_scores_gemma":[0.9993514,0.000040438408,0.00008814098,0.00034625884,0.00004953998,0.000124244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013414863,0.0001523688,0.0004043653,0.00007847264,0.000021118352,0.000008460207,0.000069106965,0.00007688341,0.00013721852],"category_scores_gemma":[0.000024187006,0.00013137754,0.000108034015,0.00019463671,0.000055396777,0.00004034716,0.000028477962,0.00011445334,0.000008143372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017555186,0.0004272561,0.9934251,0.00026142263,0.00004586885,0.00002066534,0.00013424644,0.000045481796,0.00064895523,0.0004937386,0.000451149,0.0038705843],"study_design_scores_gemma":[0.0034459815,0.00022715113,0.9800724,0.00017578497,0.00009943359,0.000013248096,0.000015986863,0.0003500415,0.014017262,0.00007458125,0.0013889291,0.0001192461],"about_ca_topic_score_codex":0.0071711857,"about_ca_topic_score_gemma":0.012894607,"teacher_disagreement_score":0.013368307,"about_ca_system_score_codex":0.0002723568,"about_ca_system_score_gemma":0.00023845538,"threshold_uncertainty_score":0.99944013},"labels":[],"label_agreement":null},{"id":"W2140241493","doi":"10.1016/j.ygyno.2015.08.020","title":"A model for estimating ovarian cancer risk: Application for preventive oophorectomy","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Ovarian cancer; Medicine; Population; Gynecology; Tubal ligation; Obstetrics; Family history; Oophorectomy; BRCA mutation; Cancer; Oncology; Internal medicine; Family planning; Hysterectomy; Surgery; Environmental health","score_opus":0.07346968011477237,"score_gpt":0.3876878041320141,"score_spread":0.3142181240172417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140241493","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13666226,0.0009095848,0.832647,0.011486592,0.0015186393,0.011943848,0.00046871416,0.00021881612,0.004144518],"genre_scores_gemma":[0.6310523,0.000060330174,0.34810388,0.0007709382,0.0003925932,0.018807964,0.00011007964,0.000026572643,0.00067532546],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987532,0.00005269131,0.00030331925,0.00044622086,0.00009306611,0.00035149005],"domain_scores_gemma":[0.9983275,0.00066585303,0.00029084733,0.00022176206,0.00031166754,0.00018235204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053252256,0.00016999835,0.0004793825,0.00006223588,0.00012308372,0.00000897922,0.00008652532,0.00022736492,0.000039369923],"category_scores_gemma":[0.0007180048,0.00013715809,0.00013936784,0.00010426891,0.000054415115,0.000044242883,0.000034701847,0.00010940709,0.000012931584],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00203468,0.0027776284,0.04880782,0.00022771563,0.00084069977,0.000014470835,0.0019328895,0.021921923,0.00023026837,0.004744774,0.043099858,0.87336725],"study_design_scores_gemma":[0.013746463,0.004293595,0.010231449,0.000030600582,0.001052389,0.000012917444,0.00016675968,0.90393865,0.00027593994,0.021907702,0.044123437,0.00022009482],"about_ca_topic_score_codex":0.00014997153,"about_ca_topic_score_gemma":0.00046380467,"teacher_disagreement_score":0.8820167,"about_ca_system_score_codex":0.0012189762,"about_ca_system_score_gemma":0.0011322724,"threshold_uncertainty_score":0.5593145},"labels":[],"label_agreement":null},{"id":"W2140949677","doi":"10.1093/annonc/mdl400","title":"Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens","year":2006,"lang":"fr","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Chemotherapy; Paclitaxel; Cyclophosphamide; Oncology; Population; Cancer; Gynecology; Surgery; Cisplatin","score_opus":0.07145167684246971,"score_gpt":0.37961758614551344,"score_spread":0.3081659093030437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140949677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95832235,0.022908904,0.00007631792,0.010024484,0.00087708124,0.0017720461,0.0043778606,0.000018546381,0.0016223852],"genre_scores_gemma":[0.9896013,0.0043786773,0.0032354495,0.0011912414,0.00033383764,0.0004520929,0.0005195826,0.00005709314,0.00023073798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941963,0.001238106,0.0021541293,0.00084187044,0.000689063,0.00088053837],"domain_scores_gemma":[0.98967505,0.0060686385,0.002153524,0.0006018322,0.0012372072,0.00026376327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013311099,0.00060264935,0.0029887876,0.00046898742,0.00014476731,0.000022539736,0.00030979153,0.00035873978,0.0007554509],"category_scores_gemma":[0.0012293303,0.00041674834,0.00046261246,0.0023770698,0.0013902343,0.00020493988,0.00007192654,0.0004038092,0.0000033082704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00522377,0.0020546126,0.85783035,0.00009774501,0.010743539,0.00018633682,0.0045975135,0.026472492,0.00018954054,0.003695836,0.0013014467,0.08760683],"study_design_scores_gemma":[0.019962445,0.004868281,0.9565716,0.0011147062,0.0077188076,0.000002703375,0.0014877236,0.0006381371,0.0024752547,0.002723811,0.0020367184,0.0003998084],"about_ca_topic_score_codex":0.31196198,"about_ca_topic_score_gemma":0.25316134,"teacher_disagreement_score":0.09874126,"about_ca_system_score_codex":0.0014055669,"about_ca_system_score_gemma":0.00482266,"threshold_uncertainty_score":0.99982846},"labels":[],"label_agreement":null},{"id":"W2140963269","doi":"10.1093/ije/dyt042","title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","year":2013,"lang":"en","type":"article","venue":"International Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; National Cancer Institute; National Institutes of Health; State of Connecticut Department of Public Health; Medical Research Council; Ovarian Cancer Research Fund; U.S. Department of Defense","keywords":"Ovarian cancer; Tubal ligation; Medicine; Case-control study; Oncology; Gynecology; Obstetrics; Internal medicine; Cancer; Environmental health; Family planning; Research methodology; Population","score_opus":0.04091496754116889,"score_gpt":0.3819170249048327,"score_spread":0.3410020573636638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140963269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979642,0.010658812,0.001059446,0.008056891,0.00032854843,0.00012471814,0.00008474266,0.0000020357518,0.00004282857],"genre_scores_gemma":[0.9899718,0.007450866,0.001916993,0.00042776437,0.00019229556,0.0000139372405,0.000004544248,0.000004784715,0.000016969196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984429,0.0002570342,0.00093457726,0.00012027453,0.00014564332,0.0000995574],"domain_scores_gemma":[0.9953365,0.0019980567,0.0012845915,0.00009426391,0.0012114932,0.000075109754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010350075,0.000091850736,0.00089840614,0.00038920765,0.000015158846,0.0000026264088,0.00006728734,0.00006426333,0.0002732085],"category_scores_gemma":[0.0021668554,0.00006192199,0.00025561656,0.00013730838,0.00012487547,0.00007762278,0.000019035713,0.00011495408,9.672565e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027945684,0.0001297343,0.92946404,0.000016375625,0.04831491,0.00011691796,0.00029743023,0.0009505442,0.00021980179,0.00080331916,0.0005329456,0.018874532],"study_design_scores_gemma":[0.0025782958,0.00043747833,0.9795881,0.0001398412,0.01187091,0.0004467839,0.00022238007,0.0024350458,0.00025076795,0.0018773105,0.00010634565,0.00004673203],"about_ca_topic_score_codex":0.002692808,"about_ca_topic_score_gemma":0.00029192737,"teacher_disagreement_score":0.050124075,"about_ca_system_score_codex":0.00011720522,"about_ca_system_score_gemma":0.00007956901,"threshold_uncertainty_score":0.4070738},"labels":[],"label_agreement":null},{"id":"W2140998546","doi":"","title":"The influence of intraoperative tumor rupture on recurrence risk in Stage Ic epithelial ovarian cancer.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Oncology; Internal medicine; Epithelial ovarian cancer; Cancer; Hazard ratio; Cohort; Ovarian carcinoma; Proportional hazards model; Carcinoma; Adjuvant therapy; Retrospective cohort study; Demographics; Confidence interval","score_opus":0.014130746146751286,"score_gpt":0.2653475417202666,"score_spread":0.2512167955735153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140998546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990223,0.00087781204,0.000002049493,0.006262569,0.00015343196,0.0012415377,0.00012751759,0.000015483962,0.0010966158],"genre_scores_gemma":[0.9960608,0.0015463902,0.000039392962,0.0008863804,0.00011599314,0.0011674871,0.0000033046672,0.000007837406,0.00017240507],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988143,0.00008391355,0.00026990118,0.00026101843,0.00025021133,0.0003206493],"domain_scores_gemma":[0.9992156,0.00014552179,0.00014685243,0.00030863952,0.000074318654,0.000109079694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003415898,0.00014641497,0.00025806294,0.000059448404,0.000076231816,0.000022915998,0.00012883799,0.00004458746,0.000020166166],"category_scores_gemma":[0.0002519503,0.00008868836,0.000053637134,0.0002781891,0.00008040784,0.0000613627,0.000014111143,0.00027331494,0.000004497347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012594962,0.00087186106,0.1792125,0.00003625935,0.0001477449,0.0001409995,0.0013549408,0.0011684955,0.00013461283,0.0038814317,0.00055504375,0.8112366],"study_design_scores_gemma":[0.0017696217,0.0002756353,0.98954535,0.000114163915,0.000046597124,0.000002554016,0.000051190258,0.00001635172,0.0044679116,0.00022663767,0.0033990215,0.00008497718],"about_ca_topic_score_codex":0.000726866,"about_ca_topic_score_gemma":0.00041603125,"teacher_disagreement_score":0.8111516,"about_ca_system_score_codex":0.00023927492,"about_ca_system_score_gemma":0.00013309278,"threshold_uncertainty_score":0.3616606},"labels":[],"label_agreement":null},{"id":"W2141306616","doi":"10.14740/jcgo.v4i2.334","title":"Subtle Presentation of Bilateral Ovarian Dermoid Cysts With Unilateral Torsion: A Case Report","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dermoid cyst; Medicine; Presentation (obstetrics); Ovarian torsion; Third trimester; Case presentation; Cystectomy; Surgery; Pregnancy; Mature Cystic Teratoma; Elective cesarean section; Gynecology; General surgery; Teratoma; Fetus; Internal medicine","score_opus":0.08294524701572054,"score_gpt":0.3906017712317281,"score_spread":0.3076565242160076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141306616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957871,0.0005496598,0.00015868273,0.001601924,0.0013035972,0.00016055003,0.0000028484037,0.0000045635325,0.00043108914],"genre_scores_gemma":[0.9944392,0.00019054813,0.0046487655,0.00026903147,0.0001961691,0.0000021530846,0.0000046701216,0.000009136252,0.0002403348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981886,0.00013718523,0.0011247109,0.0001559203,0.0002587708,0.0001347809],"domain_scores_gemma":[0.99634206,0.0016904158,0.0008735057,0.00016228188,0.00058317435,0.00034857192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009885158,0.00010373749,0.00062511966,0.00014404119,0.000031147665,0.000011112805,0.0000450866,0.00019164785,0.000037992613],"category_scores_gemma":[0.0034934853,0.00006496038,0.0001211325,0.0002217976,0.00012302937,0.00010912067,0.000028116092,0.00028332035,0.0000014416042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008829988,0.00076890306,0.8486029,0.000036561018,0.000299303,0.14154553,0.00017448164,0.000019010058,0.000003870109,0.00012241742,0.000953619,0.006590405],"study_design_scores_gemma":[0.013865334,0.008774426,0.84388,0.00009872085,0.0007728959,0.12545371,0.00023229227,0.00010586291,0.00019389349,0.00040517835,0.0061075157,0.0001101892],"about_ca_topic_score_codex":0.000024602974,"about_ca_topic_score_gemma":0.000017347764,"teacher_disagreement_score":0.016091824,"about_ca_system_score_codex":0.0000613734,"about_ca_system_score_gemma":0.0004992436,"threshold_uncertainty_score":0.41822806},"labels":[],"label_agreement":null},{"id":"W2142007136","doi":"10.1016/s1701-2163(16)32253-8","title":"Short-Term Morbidity and Long-TermRecurrence Rate of Ovarian Dermoid CystsTreated by Laparoscopy Versus Laparotomy","year":2006,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski; Université Laval","funders":"","keywords":"Medicine; Laparotomy; Laparoscopy; Oophorectomy; Surgery; Retrospective cohort study; Dermoid cyst; Medical record; General surgery; Hysterectomy","score_opus":0.014494932506777292,"score_gpt":0.25633613548825385,"score_spread":0.24184120298147654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142007136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924786,0.007086987,0.000010770965,0.00037668043,0.0026646117,0.0001971887,0.00008420935,0.0000031329384,0.00032857317],"genre_scores_gemma":[0.9989243,0.00074400246,0.00013817786,0.00007245219,0.00003547766,0.0000061688916,0.000020947975,0.000010911807,0.00004756891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884593,0.000052067608,0.0004878092,0.00018282807,0.00019846282,0.00023290575],"domain_scores_gemma":[0.99822545,0.0008619082,0.00032021495,0.00013159835,0.0002416456,0.00021915745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013749636,0.0001703755,0.0005352755,0.00013499822,0.00006506512,0.000019044855,0.00007174491,0.00010973081,0.00011465244],"category_scores_gemma":[0.00028954932,0.0001390879,0.00005324048,0.0002296173,0.00010285668,0.000060459766,0.00002805751,0.00019989864,2.001899e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067390356,0.00024318833,0.9779508,0.00007616329,0.0002498903,0.0023391438,0.000016472746,0.000006369584,0.000183169,0.000051199677,0.0044113295,0.014404894],"study_design_scores_gemma":[0.005184225,0.00085417763,0.9890678,0.000025359614,0.00037507046,0.00009531696,0.000022217768,0.000022026477,0.0027263165,0.000026125965,0.0014835274,0.000117820135],"about_ca_topic_score_codex":0.018068206,"about_ca_topic_score_gemma":0.017868519,"teacher_disagreement_score":0.014287074,"about_ca_system_score_codex":0.0005159155,"about_ca_system_score_gemma":0.00078137225,"threshold_uncertainty_score":0.9971053},"labels":[],"label_agreement":null},{"id":"W2142353844","doi":"10.1093/annonc/mdr583","title":"Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); Carboplatin; Ovarian cancer; Internal medicine; Paclitaxel; Chemotherapy; Cancer; Physical therapy; Surgery; Cisplatin","score_opus":0.22290881291297554,"score_gpt":0.4564747042049889,"score_spread":0.23356589129201338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142353844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9242003,0.0038433275,0.0000047006674,0.06743236,0.0008663527,0.00083110307,0.00068940147,0.000008869587,0.0021236087],"genre_scores_gemma":[0.9967919,0.0007782362,0.00010083773,0.0016614802,0.00042474974,0.000059716247,0.00014848067,0.000009959722,0.00002462359],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972978,0.0006430526,0.0013043752,0.00021713538,0.00021377695,0.00032381306],"domain_scores_gemma":[0.99694824,0.0015355698,0.0009126777,0.0002925699,0.00015274866,0.0001581717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015380408,0.00013535176,0.0010082152,0.000057921352,0.000031935655,0.000001960802,0.000070325674,0.00016830605,0.00007898595],"category_scores_gemma":[0.0006725953,0.000092533264,0.00014799027,0.00019896677,0.00012899177,0.000039277787,0.00003659713,0.00021746363,0.000006024915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2212353,0.013953855,0.2456944,0.0001525975,0.0022525347,0.000046073572,0.019560369,0.00010863578,0.00015933524,0.0061621536,0.07378285,0.4168919],"study_design_scores_gemma":[0.069168694,0.003528898,0.9187995,0.00022300314,0.00008313159,0.0000023522034,0.0003483064,0.000023896137,0.00056251924,0.00027238022,0.006890364,0.000096952295],"about_ca_topic_score_codex":0.0957111,"about_ca_topic_score_gemma":0.0083935,"teacher_disagreement_score":0.6731051,"about_ca_system_score_codex":0.00016995863,"about_ca_system_score_gemma":0.00083159277,"threshold_uncertainty_score":0.9103106},"labels":[],"label_agreement":null},{"id":"W2142399539","doi":"10.1016/s0936-6555(03)00194-8","title":"A Late Relapse of Primary Krukenberg Tumour with Bone Metastases","year":2003,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Krukenberg tumor; Medicine; Ovary; Malignancy; Pathology; Metastasis; Cancer; Internal medicine","score_opus":0.0742709579696654,"score_gpt":0.3869968455343895,"score_spread":0.3127258875647241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142399539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551482,0.0019240086,0.000060504757,0.00478453,0.00037650063,0.00045757196,0.000017211949,0.000034021763,0.03719742],"genre_scores_gemma":[0.9844197,0.0008481511,0.010728195,0.0025092897,0.00012422586,0.00005076416,0.000019026613,0.00002119626,0.0012794462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834085,0.0003140002,0.0006834125,0.000308432,0.00014761859,0.00020566271],"domain_scores_gemma":[0.9979854,0.0011191325,0.00027457622,0.0003056563,0.000103317805,0.00021188386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089423376,0.00012977018,0.000994964,0.000048061527,0.000023315215,0.0000024104324,0.000044011198,0.00015604222,0.00037635927],"category_scores_gemma":[0.00045429362,0.000084916326,0.00018675298,0.00014460327,0.00025258368,0.000028969544,0.000022610784,0.00024383643,0.00006180686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063473014,0.0232661,0.7407134,0.00031864224,0.0028982216,0.0067753997,0.0001762589,0.000021391279,0.0008986733,0.011769369,0.037246116,0.16956913],"study_design_scores_gemma":[0.020852916,0.019787852,0.57309216,0.00018983807,0.0019704215,0.00037880155,0.000053197993,0.000006970357,0.0015675059,0.00048774472,0.38140637,0.00020626218],"about_ca_topic_score_codex":0.000026181924,"about_ca_topic_score_gemma":0.000035339654,"teacher_disagreement_score":0.34416023,"about_ca_system_score_codex":0.00013692967,"about_ca_system_score_gemma":0.00086187787,"threshold_uncertainty_score":0.41208702},"labels":[],"label_agreement":null},{"id":"W2143144742","doi":"10.1158/1055-9965.epi-13-0962","title":"Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institute of General Medical Sciences; Cancer Research UK","keywords":"Variation (astronomy); Ovarian cancer; Epithelial ovarian cancer; Biology; Signal transduction; NF-κB; Cancer research; Cancer; Oncology; Medicine; Genetics","score_opus":0.05528018342729558,"score_gpt":0.33888847527260535,"score_spread":0.2836082918453098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143144742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97970474,0.0061101047,0.0020473672,0.009638174,0.0011125985,0.0009975431,0.000034849116,0.00004178074,0.0003128507],"genre_scores_gemma":[0.99233836,0.0037147957,0.0019219521,0.00079476816,0.00035962026,0.0007150962,0.00006976028,0.000027658869,0.000057971167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692416,0.0010390623,0.0007645005,0.000693941,0.00011807853,0.00046028005],"domain_scores_gemma":[0.99826175,0.0009505442,0.0003318488,0.00024677912,0.000063597094,0.00014550272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027183802,0.00025772088,0.0007577203,0.00028009003,0.00006414141,0.000009155745,0.000074076685,0.00029769287,0.00020915519],"category_scores_gemma":[0.00065343955,0.00023717979,0.00011856415,0.00029135565,0.00010855325,0.00013423132,0.000045026958,0.00022484286,0.0000071208865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005335779,0.0001997556,0.9357083,0.00013837041,0.00029276643,0.0000162497,0.00037831758,0.0002113388,0.006624432,0.0021729772,0.00014305465,0.053580884],"study_design_scores_gemma":[0.005304137,0.00026029043,0.97865254,0.0010367503,0.00019175344,0.000005714023,0.00006201671,0.001270491,0.0010391333,0.011452505,0.0005054673,0.00021923472],"about_ca_topic_score_codex":0.006225739,"about_ca_topic_score_gemma":0.00873294,"teacher_disagreement_score":0.05336165,"about_ca_system_score_codex":0.00066473713,"about_ca_system_score_gemma":0.00031136547,"threshold_uncertainty_score":0.96719116},"labels":[],"label_agreement":null},{"id":"W2143541838","doi":"10.1677/erc.1.00896","title":"Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells","year":2005,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Epidermal growth factor; Endocrinology; Biology; Kinase; Internal medicine; Epidermal growth factor receptor; Cell culture; LY294002; Protein kinase A; Growth factor; Luteinizing hormone; Receptor; Cell biology; Cancer research; Hormone; Phosphatidylinositol; Medicine","score_opus":0.015184780583373232,"score_gpt":0.2784467402773903,"score_spread":0.26326195969401706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143541838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851539,0.0020214631,0.000012493756,0.010614781,0.00023249447,0.0015437034,0.00015299463,0.00006315736,0.00020502595],"genre_scores_gemma":[0.9965638,0.001342434,0.00053257233,0.00018937101,0.00020676565,0.0001920183,0.000060414943,0.000058602407,0.00085404876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979739,0.00014479384,0.0006133795,0.00050068804,0.00032061498,0.00044658154],"domain_scores_gemma":[0.9989624,0.000102564685,0.00031746938,0.00036553305,0.00013429564,0.00011772972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007399074,0.00035606252,0.0005418016,0.00008170392,0.00014610282,0.000024816709,0.00011502708,0.00012310613,0.00081043283],"category_scores_gemma":[0.000038559545,0.0002608861,0.00012086394,0.00044119015,0.00015161124,0.00029272103,0.000057265588,0.00037182786,0.000009469981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007214567,0.0007379614,0.021005735,0.00019696465,0.0005797294,0.00003932837,0.0015420433,0.00055268174,0.96354795,0.0014448088,0.001031879,0.008599454],"study_design_scores_gemma":[0.005546248,0.0002900687,0.060341228,0.00053738937,0.0001217356,0.000009806881,0.000055390512,0.00008698939,0.92372185,0.0000943732,0.008957184,0.00023770808],"about_ca_topic_score_codex":0.007972294,"about_ca_topic_score_gemma":0.00019013182,"teacher_disagreement_score":0.03982608,"about_ca_system_score_codex":0.00048200134,"about_ca_system_score_gemma":0.0001779753,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W2144024213","doi":"10.1016/j.ygyno.2005.06.040","title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Epithelial ovarian cancer; Ovarian cancer; Complement (music); Expression (computer science); Oncology; Cancer research; Internal medicine; Cancer; Biology; Gene; Genetics; Phenotype","score_opus":0.030160175818020666,"score_gpt":0.3323007867348419,"score_spread":0.30214061091682126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144024213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715158,0.00063412555,0.000069919945,0.017144725,0.00077018474,0.0009821127,0.00006793078,0.000034570447,0.00878066],"genre_scores_gemma":[0.992718,0.00064853387,0.004454132,0.001302075,0.00023695687,0.00031834317,0.000030049412,0.000013813239,0.00027809961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984835,0.00014909326,0.00042164914,0.00035813777,0.00019779732,0.00038982352],"domain_scores_gemma":[0.99918157,0.00019344929,0.00020722805,0.00024488827,0.00005395786,0.000118890464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031306758,0.00017744368,0.00058948685,0.00014681983,0.000048365106,0.0000045535808,0.00010966373,0.00021214111,0.0066347485],"category_scores_gemma":[0.0000433059,0.00013679343,0.00011552834,0.00012591736,0.00010527351,0.000049125163,0.00008852812,0.00018230539,0.00003349916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021326798,0.005311869,0.55070585,0.00011673184,0.00027274128,0.0007373944,0.00071351085,0.0010134707,0.017924778,0.0006701314,0.014547238,0.4058536],"study_design_scores_gemma":[0.010733599,0.002109437,0.8721383,0.000092270886,0.00017733198,0.000032841657,0.00029867014,0.00018812939,0.016276779,0.00013247077,0.097657025,0.00016312531],"about_ca_topic_score_codex":0.00062045123,"about_ca_topic_score_gemma":0.0019464021,"teacher_disagreement_score":0.40569046,"about_ca_system_score_codex":0.001092627,"about_ca_system_score_gemma":0.0004072081,"threshold_uncertainty_score":0.9942733},"labels":[],"label_agreement":null},{"id":"W2144420447","doi":"10.1002/sim.1099","title":"Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data","year":2002,"lang":"en","type":"article","venue":"Statistics in Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":694,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Receiver operating characteristic; Diagnostic odds ratio; Area under the curve; Statistics; Homogeneous; Meta-analysis; Odds ratio; Area under curve; Coverage probability; Standard error; Mathematics; Medicine; Confidence interval; Internal medicine; Combinatorics","score_opus":0.08867909890496116,"score_gpt":0.31968617351874695,"score_spread":0.23100707461378578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144420447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5195694,0.11445716,0.033029243,0.20725618,0.015806224,0.040327094,0.046832643,0.0004269275,0.022295108],"genre_scores_gemma":[0.9895924,0.0025977711,0.0052238908,0.0007785183,0.00041029087,0.00014879649,0.00032116706,0.000032926477,0.0008942402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998605,0.000047119043,0.0005081047,0.00031588235,0.00029877838,0.0002250972],"domain_scores_gemma":[0.99670506,0.0021828413,0.00015582639,0.0007278759,0.00015608409,0.00007230721],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00033833281,0.00016540455,0.00045013265,0.00006071466,0.00007632808,0.000008002486,0.00024216017,0.000047890524,0.00029769936],"category_scores_gemma":[0.013522811,0.000095382624,0.000022613965,0.00018129262,0.00026106733,0.000051322557,0.00010041579,0.00016532883,0.0000066959233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001621128,0.002443464,0.56978947,0.0033962235,0.00040124843,0.00028936262,0.004857919,0.000019070152,0.003415035,0.0029635609,0.33279082,0.07947169],"study_design_scores_gemma":[0.021245426,0.004456701,0.849469,0.021426799,0.0024991687,0.00014617987,0.0013164639,0.04372391,0.0025967632,0.0011495723,0.051187307,0.00078271865],"about_ca_topic_score_codex":0.00021609473,"about_ca_topic_score_gemma":0.00013831857,"teacher_disagreement_score":0.47002298,"about_ca_system_score_codex":0.000095071824,"about_ca_system_score_gemma":0.00006965039,"threshold_uncertainty_score":0.9947867},"labels":[],"label_agreement":null},{"id":"W2145149859","doi":"10.1021/mp400345h","title":"Continuous Intraperitoneal Carboplatin Delivery for the Treatment of Late-Stage Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Molecular Pharmaceutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Carboplatin; Chemotherapy; Angiogenesis; Ovarian cancer; Medicine; Context (archaeology); Apoptosis; TUNEL assay; Cancer; Immunostaining; Cancer research; Internal medicine; Pharmacology; Oncology; Biology; Cisplatin; Immunohistochemistry","score_opus":0.036164594679626724,"score_gpt":0.3371954084549445,"score_spread":0.30103081377531776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145149859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756458,0.0134172235,0.0007130138,0.005741214,0.0004439114,0.0031171266,0.00016684775,0.000040372463,0.0007145212],"genre_scores_gemma":[0.99168086,0.0042109014,0.0010644699,0.0011255074,0.0001422225,0.0011239795,0.000028921431,0.000039485054,0.00058363547],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990339,0.000027951446,0.0002592241,0.00022617832,0.00017624402,0.0002765003],"domain_scores_gemma":[0.9991971,0.00011529103,0.0000983356,0.00030341747,0.0001576956,0.00012814013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005155191,0.00019956655,0.00032889718,0.000040468814,0.00007011641,0.000023695518,0.00007470207,0.00006814217,0.0004291792],"category_scores_gemma":[0.000006990949,0.00013071015,0.00020529165,0.00010483049,0.00007564611,0.000028897937,0.000014050975,0.000067488094,0.000010065382],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091774296,0.004244869,0.031948764,0.00043851702,0.0068664895,0.00033373124,0.0029305825,0.004338778,0.22906506,0.001573476,0.002272941,0.71506906],"study_design_scores_gemma":[0.012728036,0.0015341509,0.008592017,0.000080169775,0.0026730034,0.00001017154,0.00020857572,0.026313188,0.7623451,0.000059081616,0.18515487,0.00030164534],"about_ca_topic_score_codex":0.0011940938,"about_ca_topic_score_gemma":0.000027655813,"teacher_disagreement_score":0.7147674,"about_ca_system_score_codex":0.00018238295,"about_ca_system_score_gemma":0.00012421714,"threshold_uncertainty_score":0.5330205},"labels":[],"label_agreement":null},{"id":"W2145162195","doi":"10.1148/rg.231025048","title":"Transvaginal US and Hysterosonography in Postmenopausal Women with Breast Cancer Receiving Tamoxifen: Correlation with Hysteroscopy and Pathologic Study","year":2003,"lang":"en","type":"article","venue":"Radiographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Adenomyosis; Hysteroscopy; Endometrial Polyp; Endometrium; Tamoxifen; Endometrial hyperplasia; Endometrial cancer; Endometrial biopsy; Gynecology; Radiology; Carcinoma; Polypectomy; Obstetrics; Endometriosis; Cancer; Breast cancer; Pathology; Internal medicine; Colonoscopy","score_opus":0.00683155445084784,"score_gpt":0.23483454750480356,"score_spread":0.22800299305395572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145162195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996955,0.0014705493,0.00005571381,0.00028817257,0.00005123196,0.0009978337,0.00002876336,0.000033712317,0.00011905151],"genre_scores_gemma":[0.99793047,0.0009045712,0.0005815242,0.00017413442,0.000018204319,0.0003495521,0.0000051005877,0.000029693469,0.00000675167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986858,0.00010873333,0.00020209969,0.000456039,0.00022227755,0.00032509805],"domain_scores_gemma":[0.9994449,0.0000448042,0.000082711624,0.00020195855,0.00005195063,0.00017368274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022320174,0.0002558957,0.00040162145,0.00034496762,0.00009511643,0.000052615887,0.000029800476,0.00007167775,0.000012878812],"category_scores_gemma":[0.0000025142588,0.00017505868,0.000018715888,0.0007893751,0.00016077147,0.00014126746,0.0000057685334,0.00020412172,1.8687204e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007332578,0.0007098758,0.9937193,0.00007215349,0.00022874984,0.00028404788,0.0028477104,0.00001918251,0.00008514734,0.000056817462,0.0000035094527,0.0012402426],"study_design_scores_gemma":[0.0072970847,0.005791921,0.98402786,0.0003026162,0.00026326222,0.00064618076,0.001377609,0.00001934452,0.000014819187,0.000023080285,0.000036089634,0.00020011654],"about_ca_topic_score_codex":0.00018660144,"about_ca_topic_score_gemma":0.00046104824,"teacher_disagreement_score":0.009691429,"about_ca_system_score_codex":0.00008189411,"about_ca_system_score_gemma":0.000060938728,"threshold_uncertainty_score":0.7138686},"labels":[],"label_agreement":null},{"id":"W2145763794","doi":"10.4021/wjon2010.06.213w","title":"Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients","year":2010,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Immunohistochemistry; Stage (stratigraphy); Serous fluid; Ovarian carcinoma; Progesterone receptor; Ovarian cancer; Estrogen receptor; Ascites; Serous carcinoma; Oncology; Internal medicine; Cancer; Pathology; Gynecology; Breast cancer; Biology","score_opus":0.014104694604013611,"score_gpt":0.29374562830415696,"score_spread":0.27964093370014337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145763794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961356,0.00024621096,0.000017724282,0.0016009342,0.00032105937,0.00021691306,0.0000040384366,0.000002378003,0.001455168],"genre_scores_gemma":[0.99648255,0.000035157274,0.0032905599,0.000039986546,0.000105842955,0.000006772662,0.000008959248,0.000008846223,0.000021299975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905115,0.000054436976,0.00051450013,0.000108589964,0.00015164685,0.000119700264],"domain_scores_gemma":[0.99908704,0.00015799292,0.00041385554,0.000097341195,0.0001263181,0.00011747286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025428264,0.00008836726,0.00040206825,0.00031904547,0.000022167502,0.0000037075652,0.000045139484,0.000109567285,0.00007242457],"category_scores_gemma":[0.00007280245,0.00006917658,0.0000676077,0.00016584437,0.00009582909,0.00006229382,0.000026591128,0.00032508664,7.500082e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041878366,0.00054397614,0.9465221,0.000020261532,0.00007764535,0.000046774803,0.0002444877,4.2607022e-7,0.012584226,0.000042456988,0.00044546273,0.039053354],"study_design_scores_gemma":[0.0059645497,0.0012147955,0.9828676,0.00018327164,0.00016075475,0.000049418046,0.000031407788,0.000009140036,0.004803851,0.00007034234,0.004592469,0.000052380485],"about_ca_topic_score_codex":0.000050324394,"about_ca_topic_score_gemma":0.000058829366,"teacher_disagreement_score":0.039000973,"about_ca_system_score_codex":0.00017643748,"about_ca_system_score_gemma":0.00017122686,"threshold_uncertainty_score":0.2820939},"labels":[],"label_agreement":null},{"id":"W2146239695","doi":"10.1093/aje/155.3.217","title":"Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies","year":2002,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":436,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Infertility; Odds ratio; Gynecology; Fertility; Ovarian cancer; Obstetrics; Confidence interval; Endometriosis; Case-control study; Tubal ligation; Cancer; Population; Pregnancy; Family planning; Internal medicine","score_opus":0.05778027006645714,"score_gpt":0.37340471994209895,"score_spread":0.3156244498756418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146239695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205793,0.06239474,0.00028671487,0.016354026,0.00010680619,0.00015324265,0.000049301005,0.0000066916923,0.000069156995],"genre_scores_gemma":[0.9876005,0.008349911,0.0016881855,0.0022437137,0.000079082645,0.000014811191,0.000001139935,0.000009097122,0.000013556701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972448,0.00082392816,0.0012450594,0.0002659701,0.00012545398,0.00029481566],"domain_scores_gemma":[0.99452174,0.003292037,0.0012428148,0.0003089858,0.00037730706,0.00025710135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018453334,0.00018651213,0.002637031,0.0003781908,0.000050579536,0.0000025258912,0.00007114728,0.000054663673,0.00027343756],"category_scores_gemma":[0.002142464,0.00012689848,0.00043241898,0.00062891806,0.00072046014,0.000053750733,0.00003085351,0.00022009807,9.092816e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004843121,0.00028212433,0.88577074,0.000032461252,0.024387097,0.000387782,0.00092596636,0.00017499243,0.000022788787,0.00011597495,0.00043295242,0.08698283],"study_design_scores_gemma":[0.0024080244,0.0018354215,0.9715728,0.00008095465,0.020545386,0.00058874977,0.0008681223,0.0013585304,0.000017401602,0.00033815223,0.00028950244,0.000096953736],"about_ca_topic_score_codex":0.0019751538,"about_ca_topic_score_gemma":0.0002947485,"teacher_disagreement_score":0.08688588,"about_ca_system_score_codex":0.00018160554,"about_ca_system_score_gemma":0.00006315327,"threshold_uncertainty_score":0.517477},"labels":[],"label_agreement":null},{"id":"W2147808471","doi":"10.1016/j.ygyno.2006.03.017","title":"Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Sanofi; Eli Lilly and Company","keywords":"Medicine; Oxaliplatin; Gemcitabine; Carboplatin; Internal medicine; Ovarian cancer; Regimen; Neutropenia; Chemotherapy; Phases of clinical research; Nausea; Gastroenterology; Debulking; Urology; Paclitaxel; Oncology; Surgery; Cancer; Cisplatin; Colorectal cancer","score_opus":0.015944914509582388,"score_gpt":0.313273242588668,"score_spread":0.2973283280790856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147808471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837757,0.00080952636,0.00003475633,0.0058202404,0.0004268417,0.008399141,0.00039018362,0.000041281088,0.00030236976],"genre_scores_gemma":[0.994566,0.0005546242,0.0010418156,0.00033357806,0.00023870516,0.0028376135,0.00017864413,0.000041639043,0.00020734439],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977971,0.00013507713,0.0006778329,0.00065789826,0.0002681382,0.0004639589],"domain_scores_gemma":[0.99780923,0.0010188363,0.00050342694,0.00033148512,0.00020298769,0.00013401918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043359937,0.00039423272,0.0010030695,0.00008157052,0.00042866133,0.000024091889,0.0001222274,0.00022692235,0.00014879162],"category_scores_gemma":[0.0001542277,0.0002371311,0.0001085465,0.00018786312,0.00028944475,0.00007730655,0.00008327541,0.00018518615,8.952357e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4677642,0.07847199,0.30074787,0.00018117053,0.0026764376,0.00020143484,0.0029344582,0.00025900535,0.001432483,0.0005364794,0.003587198,0.1412073],"study_design_scores_gemma":[0.647134,0.22935127,0.094826244,0.00004824257,0.0010605123,0.000013153038,0.00022770342,0.00012273222,0.00046963198,0.00020796373,0.02617118,0.00036738112],"about_ca_topic_score_codex":0.0015123024,"about_ca_topic_score_gemma":0.0064508943,"teacher_disagreement_score":0.20592162,"about_ca_system_score_codex":0.00030240437,"about_ca_system_score_gemma":0.0003297309,"threshold_uncertainty_score":0.96699256},"labels":[],"label_agreement":null},{"id":"W2148004875","doi":"10.1016/s1470-2045(11)70058-4","title":"Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma","year":2011,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Ovary; Mucinous Tumor; Mucinous carcinoma; Mucin; Pathology; Adenocarcinoma; Carcinoma; Rectum; Medicine; Biology; Cancer; Internal medicine; Pancreas","score_opus":0.13044719982098338,"score_gpt":0.35886265752626,"score_spread":0.22841545770527663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148004875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048781796,0.9865648,6.295128e-7,0.0020953966,0.00066723884,0.0016232373,0.00009204963,0.000025933967,0.0040525286],"genre_scores_gemma":[0.008535823,0.989285,0.000051448726,0.0005864124,0.0007496874,0.00031557318,0.000027247104,0.000046819172,0.00040201188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822825,0.0004589309,0.00047585473,0.00035715633,0.00013685538,0.00034292982],"domain_scores_gemma":[0.9979279,0.0005329379,0.0004650583,0.00092939206,0.00005679498,0.0000879071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002760528,0.00036673248,0.0029125863,0.000055178043,0.000084281004,0.000006903273,0.00034766705,0.00031585494,0.0002527977],"category_scores_gemma":[0.000056078155,0.0001496345,0.00032864636,0.00016329889,0.00034584754,0.000010881397,0.00027623,0.0005161299,0.000021582244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001715796,0.0005771928,0.00647763,0.007773266,0.0012947281,0.000089070934,0.00062145933,3.7743714e-8,0.0000013895451,0.003184382,0.009919902,0.96988934],"study_design_scores_gemma":[0.0014433985,0.0009364801,0.02131284,0.0024970924,0.003938099,0.00052773487,0.000015651383,3.8703948e-7,0.0000104251885,0.00018085106,0.9690009,0.00013617544],"about_ca_topic_score_codex":0.00025606918,"about_ca_topic_score_gemma":0.0001890886,"teacher_disagreement_score":0.9697532,"about_ca_system_score_codex":0.00035241223,"about_ca_system_score_gemma":0.0005144821,"threshold_uncertainty_score":0.6101918},"labels":[],"label_agreement":null},{"id":"W2148259196","doi":"10.1016/j.ygyno.2015.11.008","title":"Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Calgary; Foothills Medical Centre; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Oncology; Ovarian cancer; Internal medicine; Chemotherapy; Association (psychology); Gynecology; Cancer","score_opus":0.0604292466459228,"score_gpt":0.3440498561880175,"score_spread":0.28362060954209467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148259196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91155887,0.0012543106,0.000035353405,0.07668075,0.0011527962,0.00055492396,0.00006468988,0.00006522958,0.008633051],"genre_scores_gemma":[0.99359983,0.00075566483,0.00048504482,0.0035204452,0.0008631543,0.00018743961,0.000048198002,0.00001815647,0.00052204484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985862,0.00022854886,0.00026124722,0.00034849005,0.00023852967,0.0003370121],"domain_scores_gemma":[0.9981201,0.0011382584,0.00022471647,0.00022865595,0.00011380209,0.00017444161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007271558,0.00017365202,0.0005422571,0.00003923201,0.000111147514,0.000027271868,0.00009947887,0.00034109192,0.00042536762],"category_scores_gemma":[0.0002511962,0.00010955949,0.000065778506,0.000119597906,0.000071287635,0.000044384637,0.00006170719,0.0002731293,0.000025973235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077152916,0.00015897033,0.8818188,0.0000035808785,0.00056851556,0.000040252275,0.0006506702,0.000008963488,0.000022667931,0.00025673426,0.004841055,0.11155268],"study_design_scores_gemma":[0.0055098548,0.0007876931,0.8375543,0.000012311669,0.0004357025,0.0000035666988,0.00026518194,0.00003905969,0.00012397472,0.0012790839,0.15388463,0.000104661274],"about_ca_topic_score_codex":0.00250845,"about_ca_topic_score_gemma":0.00086864387,"teacher_disagreement_score":0.14904357,"about_ca_system_score_codex":0.0019169141,"about_ca_system_score_gemma":0.00044185255,"threshold_uncertainty_score":0.50126636},"labels":[],"label_agreement":null},{"id":"W2148264387","doi":"10.1200/jco.2007.14.3420","title":"Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Imatinib mesylate; Internal medicine; Tolerability; Imatinib; Gynecologic oncology; Vascular endothelial growth factor; Platelet-derived growth factor receptor; Oncology; Ovarian carcinoma; Carcinoma; Gastroenterology; Pathology; Ovarian cancer; Cancer; Growth factor; Receptor; Adverse effect","score_opus":0.3437575897750259,"score_gpt":0.5152730711735055,"score_spread":0.1715154813984796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148264387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003536,0.0012042383,0.000003589208,0.0046697957,0.001220098,0.0020627102,0.000022677532,0.0000038658086,0.00077766017],"genre_scores_gemma":[0.99453765,0.0026616573,0.0015537462,0.0003656301,0.0006541382,0.00015526224,0.000010660058,0.00001450879,0.00004675124],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99198014,0.0028159556,0.0036693185,0.00032671975,0.0009190241,0.0002888703],"domain_scores_gemma":[0.9921452,0.0038173224,0.0027688502,0.00036049134,0.0006984358,0.0002097414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068262387,0.00025043436,0.002659635,0.00022028075,0.000098867386,0.0000034110758,0.00022168817,0.00032223665,0.00047996896],"category_scores_gemma":[0.0016669501,0.00011857569,0.0008471726,0.00028573046,0.0003431111,0.00007260824,0.0000467889,0.00047364517,0.000002663183],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05196578,0.3104579,0.063684955,0.000049808186,0.0016054767,0.0036242842,0.010796999,0.000037226462,0.00006845822,0.000018442366,0.00041961728,0.55727106],"study_design_scores_gemma":[0.088585176,0.49791795,0.40096706,0.00005180928,0.0030334026,0.0008196865,0.002215537,0.00024850495,0.000028788283,0.000023250546,0.0060293553,0.00007948877],"about_ca_topic_score_codex":0.00013737114,"about_ca_topic_score_gemma":0.0005538935,"teacher_disagreement_score":0.55719155,"about_ca_system_score_codex":0.0016670376,"about_ca_system_score_gemma":0.005873441,"threshold_uncertainty_score":0.99976236},"labels":[],"label_agreement":null},{"id":"W2148496724","doi":"10.1016/s1701-2163(16)34142-1","title":"Cancer of the Ovary: There Is Reason for Optimism!","year":2009,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Optimism; Cancer; Ovary; Gynecology; Oncology; Internal medicine; Psychotherapist","score_opus":0.014964982601361717,"score_gpt":0.26058438069905976,"score_spread":0.24561939809769803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148496724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9046829,0.053452097,0.000020389218,0.033128712,0.0065279766,0.0004417039,0.00009712566,0.0000019378513,0.0016471937],"genre_scores_gemma":[0.995784,0.001258468,0.00044900883,0.002233879,0.00003956951,0.0000038024207,5.690348e-7,0.000005473647,0.00022525496],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993485,0.000013775363,0.00025830735,0.00007836876,0.00017329174,0.00012772567],"domain_scores_gemma":[0.9987634,0.00047540962,0.00030449213,0.000110412395,0.00025203172,0.00009424405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000863978,0.00007798588,0.00029070166,0.000051027204,0.000051153707,0.0000049584023,0.00007266719,0.00006140983,0.00024498624],"category_scores_gemma":[0.00037039837,0.000045509663,0.00008920157,0.00015889789,0.000025021875,0.00001968299,0.000008815158,0.00011265203,3.7267426e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005042187,0.00036875316,0.38500965,0.00008777316,0.0007034189,0.0004078633,0.00020105578,0.00009931367,0.000035718796,0.00070082024,0.0778386,0.5344966],"study_design_scores_gemma":[0.0033038156,0.00088768697,0.9360503,0.000030029763,0.00036282698,0.000033089065,0.00007305118,0.000048373644,0.0007710735,0.00026424942,0.058117297,0.000058223242],"about_ca_topic_score_codex":0.0064844564,"about_ca_topic_score_gemma":0.005149774,"teacher_disagreement_score":0.55104065,"about_ca_system_score_codex":0.00053406914,"about_ca_system_score_gemma":0.0015691521,"threshold_uncertainty_score":0.9802602},"labels":[],"label_agreement":null},{"id":"W2148512375","doi":"10.1038/ng.668","title":"A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24","year":2010,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":353,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Alberta Health Services; Cancer Care Ontario; BC Cancer Agency; Simon Fraser University; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK; Wellcome Trust","keywords":"Biology; Genome-wide association study; Single-nucleotide polymorphism; Ovarian cancer; Genetics; Locus (genetics); Candidate gene; Genetic association; Cancer; Gene; Genotype","score_opus":0.011487030395675082,"score_gpt":0.30316804794095464,"score_spread":0.2916810175452796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148512375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123496,0.0030136236,0.0000122366455,0.0030609332,0.00086955685,0.0015134597,0.00011278195,0.000030216643,0.00015223361],"genre_scores_gemma":[0.99551195,0.00039429974,0.0009019737,0.000684391,0.000573888,0.00021404172,0.000058848524,0.000026468453,0.0016341262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882734,0.000023469263,0.00020909606,0.00041214155,0.00028635038,0.00024159948],"domain_scores_gemma":[0.998964,0.00017761938,0.000117818396,0.0003499531,0.00026791534,0.00012270403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031354275,0.00016316939,0.00027047834,0.000048558206,0.00014186853,0.00004784768,0.000062925705,0.00034429558,0.00017722583],"category_scores_gemma":[0.00026095446,0.00013827618,0.00007710034,0.000101402715,0.000029842806,0.00002669318,0.0000600241,0.00037489942,0.0000059387316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094695475,0.00039511695,0.9914656,0.000059480633,0.00029846778,0.0000060638736,0.00061615324,0.0000026051641,0.0017906232,0.000007566711,0.003463077,0.0018005277],"study_design_scores_gemma":[0.0027072967,0.00033680093,0.9598933,0.000009608498,0.00052824774,0.0000016316495,0.00010441987,0.000014570005,0.0031080034,0.0001826233,0.03298982,0.00012369409],"about_ca_topic_score_codex":0.00006831062,"about_ca_topic_score_gemma":0.0066727395,"teacher_disagreement_score":0.03157234,"about_ca_system_score_codex":0.0003782293,"about_ca_system_score_gemma":0.000106632724,"threshold_uncertainty_score":0.5638739},"labels":[],"label_agreement":null},{"id":"W2148653481","doi":"10.1016/s1701-2163(16)34453-x","title":"Intraperitoneal Chemotherapy for Advanced Ovarian and Peritoneal Cancers in Patients Following Interval Debulking Surgery or Primary Cytoreductive Surgery: Tom Baker Cancer Centre Experience From 2006 to 2009","year":2010,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Ovarian cancer; Surgery; Cancer; Cisplatin; Oncology; Internal medicine","score_opus":0.010154087224764689,"score_gpt":0.25203689297919035,"score_spread":0.24188280575442567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148653481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842736,0.0019705473,0.000009370911,0.0016677955,0.011521954,0.00040345165,0.00013721714,0.0000034810455,0.00001259784],"genre_scores_gemma":[0.9964972,0.00039757584,0.0013480703,0.0015023932,0.0001407431,0.00004801486,0.000016580212,0.000026519992,0.000022909697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984202,0.000032000236,0.0005695599,0.00031436686,0.00027339533,0.00039047957],"domain_scores_gemma":[0.9966837,0.0022743405,0.00034717575,0.000118365286,0.00022217428,0.00035425244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016239447,0.00021974083,0.0008046912,0.00025497828,0.00009500842,0.00003354074,0.000070465016,0.00012877732,0.00018847574],"category_scores_gemma":[0.0012206461,0.00017796483,0.00011151607,0.0003038073,0.000051237526,0.00014223484,0.00002680335,0.00027436012,5.8019047e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030684756,0.00013017771,0.7877473,0.000028392727,0.00020485466,0.000568019,0.0007689411,0.000009841348,0.00010195092,0.0000014801581,0.001565579,0.20856659],"study_design_scores_gemma":[0.0041912035,0.00025738272,0.98646146,0.000086516986,0.000093574665,0.000010282182,0.0005487529,0.0000145513795,0.00042127355,0.0000063500675,0.007715279,0.00019338386],"about_ca_topic_score_codex":0.050116215,"about_ca_topic_score_gemma":0.17453352,"teacher_disagreement_score":0.2083732,"about_ca_system_score_codex":0.0019593255,"about_ca_system_score_gemma":0.0035912315,"threshold_uncertainty_score":0.9562091},"labels":[],"label_agreement":null},{"id":"W2149050841","doi":"10.1016/j.ijrobp.2009.07.841","title":"Procedural Impact of Laparoscopic Guidance for Gynecologic Interstitial Brachytherapy","year":2009,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Brachytherapy; Surgery; Gynecologic oncology; Hysterectomy; Perforation; Laparoscopy; Radiation therapy","score_opus":0.024944580040225123,"score_gpt":0.3819795402835336,"score_spread":0.3570349602433085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149050841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807265,0.0009979518,0.0076758983,0.0076428484,0.0018618584,0.0005021591,0.00010934172,0.000024325649,0.00045915841],"genre_scores_gemma":[0.99181044,0.0005077695,0.004154604,0.0015325738,0.0018715415,0.000019967554,0.000060942795,0.000013847303,0.000028340932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986996,0.00006764319,0.00069063075,0.00018092067,0.00016575411,0.00019546018],"domain_scores_gemma":[0.9976308,0.00029543156,0.0010484395,0.000113937676,0.0008129598,0.00009846335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698119,0.00017455874,0.0005628002,0.0001242603,0.000037081987,0.000014292067,0.00022393656,0.00016535926,0.00008674303],"category_scores_gemma":[0.0002748285,0.00013203842,0.0004439995,0.00010519089,0.000101281825,0.00017766294,0.000013554245,0.00019467529,0.000004959613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036252472,0.0027716774,0.58010674,0.000025824158,0.0022447708,0.000046137116,0.0005528496,0.0010811184,0.011653109,0.013135239,0.008199869,0.3765574],"study_design_scores_gemma":[0.040131606,0.045163225,0.83754045,0.00034070408,0.0005432138,0.00044701953,0.0000688696,0.0023572943,0.019754874,0.037166364,0.016092721,0.00039366347],"about_ca_topic_score_codex":0.000011026907,"about_ca_topic_score_gemma":0.0000026000112,"teacher_disagreement_score":0.37616372,"about_ca_system_score_codex":0.001054904,"about_ca_system_score_gemma":0.00081705715,"threshold_uncertainty_score":0.53843707},"labels":[],"label_agreement":null},{"id":"W2149486768","doi":"10.2214/ajr.180.3.1800765","title":"MR Imaging Findings and Patterns of Spread in Secondary Tumor Involvement of the Uterine Body and Cervix","year":2003,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Cervix; Uterine cervix; Gynecology; Radiology; Pathology; Cancer; Internal medicine; Carcinoma","score_opus":0.007509815404715039,"score_gpt":0.2537372339580589,"score_spread":0.24622741855334387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149486768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962993,0.0012641381,0.00002323527,0.0021161942,0.0000885001,0.000109840934,0.000010841501,0.0000010587684,0.00008684851],"genre_scores_gemma":[0.9982035,0.0008672559,0.00040052427,0.0004913253,0.000015546677,0.0000029041719,5.075816e-7,0.000008533629,0.000009863126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991525,0.00007540547,0.00040689443,0.0001096009,0.000110259374,0.00014538736],"domain_scores_gemma":[0.9992849,0.000049587165,0.0004101615,0.00013168238,0.000059765687,0.00006388695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016669605,0.000094155344,0.00044328623,0.0001413443,0.000014997973,0.0000030404558,0.00005913137,0.0000116485535,0.000081338054],"category_scores_gemma":[0.000027649174,0.00006345496,0.000056356912,0.00010569945,0.0002176653,0.000036250214,0.00004378361,0.00013721186,1.2922477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089790345,0.00017709131,0.98142,0.00006802559,0.00013423678,0.00009724673,0.00054549053,0.0000013865955,0.003917739,0.00012801122,0.000032858734,0.013388123],"study_design_scores_gemma":[0.002596451,0.001525406,0.9759873,0.00022319824,0.00011220904,0.0008707518,0.0014807136,0.00000402288,0.016091138,0.00008996191,0.00097063574,0.00004820935],"about_ca_topic_score_codex":0.00031200133,"about_ca_topic_score_gemma":0.00005289862,"teacher_disagreement_score":0.013339913,"about_ca_system_score_codex":0.00005574573,"about_ca_system_score_gemma":0.000095194475,"threshold_uncertainty_score":0.2587618},"labels":[],"label_agreement":null},{"id":"W2149951063","doi":"10.1200/jco.2004.99.042","title":"A Recent Illustration of Some Essentials of Circadian Chronotherapy Study Design","year":2004,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Chronotherapy (sleep phase); Medicine; Circadian rhythm; Intensive care medicine; Internal medicine","score_opus":0.2496642569734486,"score_gpt":0.48006366982699133,"score_spread":0.23039941285354273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149951063","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05605049,0.005229615,0.00047510225,0.931671,0.0041476404,0.0019790882,0.000021438127,0.0000075171956,0.00041811058],"genre_scores_gemma":[0.41303992,0.06073131,0.009895329,0.48201936,0.033560947,0.00007121891,0.00004851755,0.00015969669,0.000473696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934205,0.00097461115,0.004448044,0.0002719619,0.00065788045,0.00022704102],"domain_scores_gemma":[0.9906357,0.0019517704,0.0061172666,0.00034852512,0.0007718336,0.00017492418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030559248,0.00024444133,0.003443106,0.0002727541,0.000018616915,0.0000060196653,0.00019954143,0.0012216195,0.000588997],"category_scores_gemma":[0.00075392926,0.00017438605,0.0008063279,0.00013882869,0.00022642722,0.00007533439,0.000018349003,0.0017620738,0.00000681288],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058745723,0.025754286,0.012780203,0.00041931428,0.010837161,0.007142532,0.00059002475,0.00025438468,0.000108012246,0.000075208685,0.57064015,0.36552417],"study_design_scores_gemma":[0.037945587,0.11773827,0.07684676,0.001130547,0.005112695,0.00026954577,0.00011429502,0.0000053444487,0.000601173,0.000946715,0.7590347,0.00025439306],"about_ca_topic_score_codex":0.000057788457,"about_ca_topic_score_gemma":0.000019781452,"teacher_disagreement_score":0.44965166,"about_ca_system_score_codex":0.00056078465,"about_ca_system_score_gemma":0.0071299314,"threshold_uncertainty_score":0.99849874},"labels":[],"label_agreement":null},{"id":"W2151801952","doi":"10.2214/ajr.183.3.1830737","title":"Sonography of the Abnormal Fallopian Tube","year":2004,"lang":"en","type":"article","venue":"American Journal of Roentgenology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Fallopian tube; Transvaginal sonography; Radiology; Gynecology; Pregnancy","score_opus":0.00657669062831381,"score_gpt":0.24195216380348647,"score_spread":0.23537547317517266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151801952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866954,0.0006656296,0.00016033257,0.011470056,0.00027959442,0.00009271372,0.000003838756,0.000003981708,0.0006284364],"genre_scores_gemma":[0.9967434,0.0004460138,0.0017360892,0.00094037584,0.000107603264,0.0000023262562,5.074818e-7,0.000009606051,0.00001410685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991279,0.00004396714,0.00036621973,0.000086919106,0.0001846425,0.00019032798],"domain_scores_gemma":[0.9990445,0.000024410021,0.00048556627,0.00021267451,0.00013433222,0.00009856808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009386477,0.000094604904,0.00041963294,0.00013715443,0.000034042034,0.0000030225647,0.00014936746,0.000026618518,0.000051281993],"category_scores_gemma":[0.000020472451,0.000056066354,0.0002893057,0.00030984747,0.00041621507,0.00003312134,0.000028153854,0.00017722558,0.0000029890405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054333656,0.0010014357,0.9346119,0.00002352279,0.0014902778,0.00023483584,0.0010713816,0.00048554555,0.0013509799,0.002741701,0.00044488587,0.05600019],"study_design_scores_gemma":[0.0043740612,0.007344153,0.96751904,0.00015393623,0.0004997326,0.0021897324,0.00096257805,0.0000011594939,0.007868062,0.00053751975,0.008462913,0.0000870804],"about_ca_topic_score_codex":0.00016017414,"about_ca_topic_score_gemma":0.00003095278,"teacher_disagreement_score":0.055913113,"about_ca_system_score_codex":0.00008787289,"about_ca_system_score_gemma":0.00024684065,"threshold_uncertainty_score":0.22863196},"labels":[],"label_agreement":null},{"id":"W2151937382","doi":"10.1016/j.ogc.2011.02.001","title":"PET/CT in Gynecologic Cancer: Present Applications and Future Prospects—A Clinician’s Perspective","year":2011,"lang":"en","type":"review","venue":"Obstetrics and Gynecology Clinics of North America","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Gynecologic cancer; Intensive care medicine; Perspective (graphical); Clinical Practice; Modalities; Medical physics; Treatment modality; Cancer; Ovarian cancer; Surgery; Family medicine; Internal medicine","score_opus":0.03994022561129055,"score_gpt":0.3583238348432305,"score_spread":0.3183836092319399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151937382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058777444,0.99288917,0.0000016892061,0.00052898563,0.000825138,0.0033736306,0.0003208544,0.000026112964,0.0014466449],"genre_scores_gemma":[0.0008222674,0.9956468,0.0006226753,0.0002623851,0.0002658331,0.0020031394,0.00011086972,0.000056292472,0.0002097725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684674,0.00016170602,0.0012875025,0.0010834555,0.00016580253,0.00045478804],"domain_scores_gemma":[0.991827,0.005726103,0.0012608394,0.0006342503,0.00027337702,0.00027840308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020531354,0.0005452639,0.0031420363,0.0005229731,0.000097365984,0.000016306754,0.00021102649,0.00015765143,0.00012709586],"category_scores_gemma":[0.0010318671,0.000431208,0.00039469355,0.0011496174,0.00049361173,0.000048679347,0.0002054883,0.0008452201,0.000014644145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014172927,0.0011435486,0.0601432,0.0026372655,0.0005057915,0.00034362832,0.00006159413,3.679082e-7,6.3788935e-10,0.0005289392,0.00020293747,0.93441856],"study_design_scores_gemma":[0.0013193766,0.001479987,0.04224119,0.00049985736,0.0020835497,0.00008180272,0.00013369088,0.0000059893246,1.926849e-8,0.00014543234,0.9516841,0.00032500908],"about_ca_topic_score_codex":0.0002232795,"about_ca_topic_score_gemma":0.00046174278,"teacher_disagreement_score":0.95148116,"about_ca_system_score_codex":0.0004844156,"about_ca_system_score_gemma":0.0010030685,"threshold_uncertainty_score":0.999814},"labels":[],"label_agreement":null},{"id":"W2152197423","doi":"10.3892/ijo.2012.1533","title":"Cytokine gene expression signature in ovarian clear cell carcinoma","year":2012,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare","keywords":"Biology; Cytokine; Autocrine signalling; Cancer research; Cytotoxic T cell; Oncogene; Ovarian cancer; SOCS3; Tumor microenvironment; Immunology; Cancer; Signal transduction; STAT3; Cell cycle; Cell culture; Cell biology; Genetics","score_opus":0.02052995670864294,"score_gpt":0.32114379764414,"score_spread":0.3006138409354971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152197423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982133,0.0015026794,0.00017693802,0.0075234966,0.0021971625,0.00010597409,0.0000097863585,0.0000037326704,0.006347233],"genre_scores_gemma":[0.99284756,0.00017039054,0.0042531323,0.00090679387,0.0016741413,0.0000047095878,0.000008468332,0.00001188447,0.00012290193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901813,0.000058285757,0.0003679294,0.00008667454,0.0003014358,0.00016752422],"domain_scores_gemma":[0.9992041,0.00008520634,0.00026310823,0.000080671976,0.00021994935,0.0001469605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026501107,0.00009035215,0.0002542994,0.0002327146,0.000012723652,0.0000075163352,0.00013205266,0.00012721188,0.00049932324],"category_scores_gemma":[0.00004117972,0.00006815685,0.0001040245,0.00006309634,0.000022194317,0.00013521145,0.00003990613,0.00030076457,0.000021513346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033597816,0.0049584517,0.74415934,0.000019222884,0.00023120499,0.003964694,0.0014546438,0.00007872355,0.20982553,0.0004830099,0.0118415,0.019623918],"study_design_scores_gemma":[0.011503657,0.0021435055,0.65241694,0.00011983959,0.00010703526,0.0023759282,0.00016518166,0.000013131518,0.21424685,0.00012707232,0.11666508,0.00011574238],"about_ca_topic_score_codex":0.000023957533,"about_ca_topic_score_gemma":0.000005063425,"teacher_disagreement_score":0.104823574,"about_ca_system_score_codex":0.0006362195,"about_ca_system_score_gemma":0.00021184619,"threshold_uncertainty_score":0.5467239},"labels":[],"label_agreement":null},{"id":"W2152492190","doi":"10.1016/j.ejca.2010.08.008","title":"Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?","year":2010,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Quality (philosophy); Ovarian cancer; Cancer; Pathology; Oncology; Internal medicine","score_opus":0.025589521434968045,"score_gpt":0.3503520536766089,"score_spread":0.3247625322416408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152492190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943192,0.005939655,0.0047784145,0.035342533,0.0057580476,0.0006474533,0.00014134319,0.000025729352,0.0041748295],"genre_scores_gemma":[0.9914924,0.0011416834,0.005859054,0.00047439977,0.000872611,0.000014017419,0.000005686892,0.000023609944,0.00011657325],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998281,0.000091585236,0.0010456152,0.00012386893,0.00028437117,0.00017352782],"domain_scores_gemma":[0.99687934,0.00006109261,0.0019092802,0.00024833233,0.0007454513,0.00015649658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008778401,0.00013266425,0.00046777885,0.00011040062,0.00006168346,0.000021501846,0.00008349192,0.00003567715,0.00029458193],"category_scores_gemma":[0.00020481314,0.00010322357,0.00021569555,0.000097542405,0.00006938444,0.00024311144,0.000020904978,0.00024216862,0.0000013798177],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020950944,0.00042944477,0.09463117,0.0006374541,0.0007232637,0.0012698876,0.0018171079,0.00037039616,0.040202945,0.0004075157,0.010708427,0.8467073],"study_design_scores_gemma":[0.010582585,0.00073315296,0.54175,0.001130189,0.0005526141,0.00088378054,0.0002750311,0.000021433929,0.03033707,0.00024897588,0.41321635,0.00026879093],"about_ca_topic_score_codex":0.000029302179,"about_ca_topic_score_gemma":0.000055672757,"teacher_disagreement_score":0.8464385,"about_ca_system_score_codex":0.00007959838,"about_ca_system_score_gemma":0.00039476078,"threshold_uncertainty_score":0.4209335},"labels":[],"label_agreement":null},{"id":"W2152961124","doi":"10.1093/annonc/mdr001","title":"Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Gastroenterology; Neutropenia; myalgia; Leukopenia; Taxane; Ovarian cancer; Paclitaxel; Cancer; Surgery; Chemotherapy; Breast cancer; Cisplatin","score_opus":0.07139436111871882,"score_gpt":0.3530403629742522,"score_spread":0.28164600185553335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152961124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922085,0.003057246,3.2887633e-7,0.0014248888,0.00044271088,0.0012427982,0.00006846463,0.000022248218,0.001532826],"genre_scores_gemma":[0.9973017,0.0017284242,0.000083443505,0.00028870162,0.00005269272,0.00044532763,0.000018452736,0.000031681964,0.000049551556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976557,0.0002541164,0.00078160205,0.0006161869,0.00018501238,0.0005073721],"domain_scores_gemma":[0.99876046,0.00032111036,0.00031806823,0.00026289307,0.00016789013,0.00016957834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036145424,0.00032584634,0.000970385,0.0003582034,0.00004318501,0.000009746065,0.00008989474,0.00032121784,0.00015554714],"category_scores_gemma":[0.00013570067,0.00028155863,0.00006617587,0.00040682236,0.00016975118,0.00011513216,0.00011181503,0.00037417462,0.0000019333986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030965086,0.0030755203,0.910862,0.00007110772,0.00034165566,0.00044644094,0.0057039573,0.000020293777,0.00039932554,0.00007000231,0.00021478438,0.07569835],"study_design_scores_gemma":[0.01984483,0.014496303,0.96336216,0.00021988347,0.00022194402,0.0000039058964,0.00048315173,0.00013204789,0.00065066625,0.00011932382,0.00023213297,0.00023368036],"about_ca_topic_score_codex":0.053526975,"about_ca_topic_score_gemma":0.12073913,"teacher_disagreement_score":0.07546467,"about_ca_system_score_codex":0.0003131984,"about_ca_system_score_gemma":0.0002862639,"threshold_uncertainty_score":0.99996364},"labels":[],"label_agreement":null},{"id":"W2153682492","doi":"10.1371/journal.pone.0057799","title":"Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute; National Institutes of Health; Barr Foundation","keywords":"Ovarian cancer; Cancer stem cell; Serous fluid; Stem cell; Biology; Gene signature; Cancer; Cancer research; Oncology; Internal medicine; Pathology; Medicine; Gene expression; Gene; Genetics","score_opus":0.040032737865591174,"score_gpt":0.23921039423014265,"score_spread":0.19917765636455148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153682492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991289,0.0041647097,0.0000013865854,0.0022868759,0.000080054306,0.0010590967,0.000012165215,0.000039378105,0.001067321],"genre_scores_gemma":[0.9933687,0.002503156,0.0016938597,0.00032872817,0.00014553269,0.0006388842,0.000017841125,0.000029045483,0.0012742444],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897534,0.000025493726,0.00019250298,0.0003181748,0.00025000417,0.00023851628],"domain_scores_gemma":[0.99941045,0.000026492546,0.00006433078,0.00022680424,0.000099848374,0.00017204911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054934157,0.00014711608,0.00029733992,0.0000772723,0.000060280854,0.000020793948,0.000046252968,0.00009458739,0.000660568],"category_scores_gemma":[0.000005752509,0.00011671446,0.000022843566,0.0001711144,0.000026035932,0.00009526252,0.000063258674,0.00011853607,0.0000517319],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014445471,0.0059228316,0.8161545,0.00037487186,0.00024743052,0.000040269893,0.0008117181,0.000001970419,0.16799657,0.000011923333,0.0029407206,0.0053527295],"study_design_scores_gemma":[0.0027997175,0.00080820336,0.48258263,0.0011028909,0.00033016867,0.0000025764837,0.000050860788,0.00014530419,0.51165146,0.000020963322,0.00033971044,0.0001655363],"about_ca_topic_score_codex":0.00048765662,"about_ca_topic_score_gemma":0.000045254434,"teacher_disagreement_score":0.34365487,"about_ca_system_score_codex":0.0001142137,"about_ca_system_score_gemma":0.00009779251,"threshold_uncertainty_score":0.72327566},"labels":[],"label_agreement":null},{"id":"W2153734611","doi":"10.1093/annonc/mdt406","title":"Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data","year":2013,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research UK","keywords":"Medicine; Chemotherapy; Internal medicine; Oncology; Ovarian cancer; Meta-analysis; Randomized controlled trial; Carboplatin; Cancer; Paclitaxel; Cisplatin; Surgery","score_opus":0.5102139847643494,"score_gpt":0.49961723618323384,"score_spread":0.01059674858111559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153734611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009384852,0.9902837,0.000018105606,0.0015226223,0.0005980098,0.0030079414,0.0026951993,0.000025084219,0.00091081584],"genre_scores_gemma":[0.0029665024,0.9892405,0.00232131,0.00041046142,0.00019550486,0.000634708,0.0041155755,0.00008111559,0.000034278695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949833,0.0006689782,0.0019303947,0.0011846914,0.0006621453,0.0005704729],"domain_scores_gemma":[0.99465764,0.0011036249,0.0023352357,0.0012958472,0.0004063713,0.0002013005],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008329591,0.00075366674,0.0070365565,0.001072502,0.000069655856,0.000034202523,0.00042232007,0.0007138486,0.001143297],"category_scores_gemma":[0.00018040359,0.00058155105,0.0016121177,0.0014182368,0.00013267428,0.00018793072,0.00030074254,0.00063812255,0.000019160787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002527674,0.0013870326,0.000046910318,0.0009240712,0.16665551,0.00009128359,0.0006793836,0.000029499,3.016697e-7,0.000089167355,0.001886027,0.82795805],"study_design_scores_gemma":[0.0058241813,0.004135863,0.00033954118,0.0015378826,0.4133338,0.00003349333,0.00018628112,0.00046607933,0.000029343295,0.000046936602,0.57341015,0.00065643346],"about_ca_topic_score_codex":0.0020163818,"about_ca_topic_score_gemma":0.00081744633,"teacher_disagreement_score":0.8273016,"about_ca_system_score_codex":0.0006052158,"about_ca_system_score_gemma":0.00161149,"threshold_uncertainty_score":0.9997698},"labels":[],"label_agreement":null},{"id":"W2153954237","doi":"10.1016/s1470-2045(13)70253-5","title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency; University of Toronto; University of Calgary","funders":"National Institutes of Health; Cancer Research UK; National Cancer Institute; Kræftens Bekæmpelse","keywords":"Ovarian cancer; Ovarian tissue cryopreservation; Oncology; Hormone receptor; Internal medicine; Medicine; Gynecology; Biology; Cancer research; Cancer; Breast cancer; Fertility; Fertility preservation","score_opus":0.05828470196006116,"score_gpt":0.37146549834479403,"score_spread":0.3131807963847329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153954237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97685486,0.00092749594,0.00006373697,0.017828694,0.00039364622,0.0015796083,0.000050638908,0.0000933892,0.0022079318],"genre_scores_gemma":[0.9945417,0.00040062246,0.000969401,0.0016270914,0.0009192531,0.001009038,0.00004113677,0.000030256688,0.00046151297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797344,0.000487514,0.00034941727,0.0005172425,0.00023722455,0.00043513792],"domain_scores_gemma":[0.9984553,0.00021154604,0.00018472578,0.00076978456,0.00012352115,0.00025510901],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005608004,0.00024499145,0.001040472,0.000121070494,0.00018493089,0.000058208643,0.00019474764,0.00010513266,0.0023614184],"category_scores_gemma":[0.000038989758,0.00014889993,0.0000754941,0.0003939135,0.00014583845,0.00011952244,0.0001032105,0.00024801758,0.00008955296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012848191,0.0037384783,0.90663916,0.000046531935,0.003961376,0.00020812663,0.0049649426,0.000045339733,0.017523084,0.000714741,0.024492,0.0363814],"study_design_scores_gemma":[0.0071969437,0.0022757149,0.9505436,0.000018938103,0.002117627,0.000018879397,0.00141892,0.00015516087,0.00078819116,0.00009937796,0.035166536,0.00020015429],"about_ca_topic_score_codex":0.0067529436,"about_ca_topic_score_gemma":0.0019119116,"teacher_disagreement_score":0.043904398,"about_ca_system_score_codex":0.0002017684,"about_ca_system_score_gemma":0.00016143905,"threshold_uncertainty_score":0.9998612},"labels":[],"label_agreement":null},{"id":"W2154233175","doi":"10.1136/jech-2013-202386.10","title":"IS RACE A PROGNOSTIC FACTOR IN DETERMINING OVARIAN CANCER SURVIVAL OUTCOMES? THE ANSWER IS NOT JUST <i>BLACK AND WHITE</i>","year":2013,"lang":"en","type":"article","venue":"Journal of Epidemiology & Community Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Oncology; Relative survival; Epidemiology; Disease; Incidence (geometry); Gynecology; Internal medicine; Cervical cancer; Survival analysis; Survival rate; Race (biology); Stage (stratigraphy); Cause of death; Cancer registry","score_opus":0.21158419053807875,"score_gpt":0.43848457736643864,"score_spread":0.2269003868283599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154233175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7442188,0.0010787107,0.00006338389,0.25369892,0.0002904307,0.0004985099,0.00002595685,0.000006665731,0.000118639786],"genre_scores_gemma":[0.92475826,0.0042518647,0.0015606829,0.069156915,0.0001419919,0.0000347426,0.0000030306617,0.000021500158,0.00007103198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99507755,0.0026619227,0.0013208153,0.00020434709,0.00018178533,0.00055359135],"domain_scores_gemma":[0.9912709,0.006428421,0.0010312807,0.0006485274,0.00021800495,0.00040286913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004289173,0.00025487435,0.0014853362,0.00014799302,0.00028979452,0.000019061394,0.00025934554,0.00016350171,0.0003776969],"category_scores_gemma":[0.0020403718,0.00015011041,0.00018376774,0.00018054154,0.0002358429,0.00014741629,0.00011351004,0.0017706602,0.000011317187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076962184,0.0003168272,0.97569215,0.000132012,0.00021273668,0.000009867523,0.0055295397,0.000008259273,0.0000046638124,0.00003167997,0.008040293,0.009945004],"study_design_scores_gemma":[0.002526776,0.00095999794,0.99069333,0.00055927195,0.00010518079,0.00008565138,0.0013860147,0.00016434725,0.0000067842857,0.00020661183,0.0032021273,0.000103914914],"about_ca_topic_score_codex":0.017859045,"about_ca_topic_score_gemma":0.004897091,"teacher_disagreement_score":0.18454199,"about_ca_system_score_codex":0.00044975203,"about_ca_system_score_gemma":0.0006772177,"threshold_uncertainty_score":0.98868114},"labels":[],"label_agreement":null},{"id":"W2155191323","doi":"10.1148/rg.313105066","title":"Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment","year":2011,"lang":"en","type":"review","venue":"Radiographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Serous fluid; Clear cell; Pathology; Medicine; Serous carcinoma; Malignancy; Ovarian cancer; Carcinogenesis; Disease; Ovarian carcinoma; Histopathology; Stage (stratigraphy); Cancer research; Cancer; Carcinoma; Biology; Internal medicine","score_opus":0.09147691355386725,"score_gpt":0.3544954006904796,"score_spread":0.26301848713661236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155191323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106129344,0.99589753,0.000041630785,0.0003087021,0.00008089153,0.0026798465,0.00060898525,0.000023272736,0.00025301392],"genre_scores_gemma":[0.0010561318,0.9914478,0.0028067757,0.00006139389,0.00006484858,0.0042850194,0.00019282204,0.000055006076,0.000030197365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870914,0.00004668824,0.0003967231,0.00054453855,0.00006820957,0.00023472303],"domain_scores_gemma":[0.998696,0.0002388979,0.00029078926,0.0005046216,0.00007491357,0.00019475346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006878906,0.0004186845,0.0015964904,0.0003856128,0.00007917251,0.000015566524,0.0000760624,0.00030723796,0.0000093514345],"category_scores_gemma":[0.00002208116,0.00030222567,0.0005754418,0.00033487723,0.0002064543,0.000016954538,0.00002506488,0.00009828423,2.3386633e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019164572,0.00025002254,0.006927913,0.004406357,0.0018450749,0.000009631047,0.000061995255,5.0227065e-8,3.633557e-7,0.0075031337,0.00043118658,0.9785451],"study_design_scores_gemma":[0.0012857099,0.0014768195,0.012276509,0.0030862496,0.012551722,0.00018791859,0.000006003447,2.0910983e-7,0.000012783067,0.00041590896,0.96842664,0.00027351142],"about_ca_topic_score_codex":0.00036532863,"about_ca_topic_score_gemma":0.000129033,"teacher_disagreement_score":0.9782716,"about_ca_system_score_codex":0.00023910249,"about_ca_system_score_gemma":0.00030299142,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W2155481602","doi":"10.1200/jco.2005.01.2757","title":"Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cisplatin; Hazard ratio; Internal medicine; Chemotherapy; Cyclophosphamide; Oncology; Ovarian cancer; Tumor progression; Paclitaxel; Progression-free survival; Ovarian carcinoma; Cancer; Urology; Gastroenterology; Confidence interval","score_opus":0.17813556036093378,"score_gpt":0.5249395145190848,"score_spread":0.346803954158151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155481602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906683,0.003935035,0.000022002967,0.004104774,0.00029226707,0.0003478128,0.000054895074,8.53288e-7,0.00057407434],"genre_scores_gemma":[0.9898109,0.006357114,0.003578111,0.000067698435,0.00016627293,0.000009428848,0.0000018645688,0.000006099031,0.0000025547567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691486,0.00029707316,0.0022623031,0.00012666883,0.00029068423,0.0001084138],"domain_scores_gemma":[0.9940246,0.0034550598,0.00208185,0.00012277807,0.00021115714,0.00010458097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018681143,0.000103954415,0.0014785011,0.000100090074,0.000018627368,0.0000030401382,0.00006278898,0.00019139651,0.000052055588],"category_scores_gemma":[0.0010762367,0.00006314997,0.00013962822,0.000118360964,0.0004091685,0.000054902637,0.000039663606,0.0003600054,6.949222e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116302006,0.0040341914,0.50620353,0.0001853676,0.00055629516,0.000036097335,0.0015017346,0.000022157792,0.00019125435,0.0012205159,0.0005318683,0.36921495],"study_design_scores_gemma":[0.1455122,0.047294874,0.8007967,0.0011384145,0.0010679457,0.000032997777,0.00086112134,0.00012929467,0.0007201607,0.00043899714,0.0019359816,0.00007135011],"about_ca_topic_score_codex":0.0001144231,"about_ca_topic_score_gemma":0.000577507,"teacher_disagreement_score":0.3691436,"about_ca_system_score_codex":0.000059075814,"about_ca_system_score_gemma":0.00050126313,"threshold_uncertainty_score":0.2575181},"labels":[],"label_agreement":null},{"id":"W2155587446","doi":"10.1158/1940-6207.capr-10-0195","title":"Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens","year":2011,"lang":"en","type":"article","venue":"Cancer Prevention Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Ovarian cancer; Biomarker; Oncology; Internal medicine; Medicine; Cancer; Prostate cancer; Population; Colorectal cancer; Prostate; Asymptomatic; Pathology; Biology","score_opus":0.15685146426521343,"score_gpt":0.4237008069469277,"score_spread":0.26684934268171423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155587446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785209,0.0075669894,0.000037893577,0.0023629558,0.000645592,0.0042847553,0.00009110206,0.000057877074,0.006431941],"genre_scores_gemma":[0.9740815,0.013535254,0.0006382095,0.0001039475,0.00044786747,0.0063183955,0.000033147888,0.00006608568,0.0047755595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660176,0.00031985508,0.0005653382,0.0008586809,0.00075708784,0.00089726364],"domain_scores_gemma":[0.9986398,0.0000842363,0.00015247561,0.00040327208,0.00036647535,0.00035373992],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001401548,0.00030598766,0.0005268083,0.00055677386,0.000280401,0.00008043652,0.00017182114,0.00017745815,0.0061772987],"category_scores_gemma":[0.00004902078,0.00026998777,0.000120242184,0.0010701884,0.00027224206,0.0003180001,0.00016208329,0.0005975165,0.000016957225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037091304,0.0012557739,0.79515713,0.0005644052,0.0007902878,0.00016478093,0.0020403336,0.000016238211,0.0009086387,0.0003714455,0.005372208,0.15626748],"study_design_scores_gemma":[0.047073092,0.001120262,0.9353248,0.001696909,0.0001707264,0.000013011043,0.0001981329,0.00084189663,0.0032929296,0.000120561126,0.00983053,0.00031715946],"about_ca_topic_score_codex":0.008807072,"about_ca_topic_score_gemma":0.0037241168,"teacher_disagreement_score":0.15595032,"about_ca_system_score_codex":0.0009978871,"about_ca_system_score_gemma":0.0011307389,"threshold_uncertainty_score":0.9999752},"labels":[],"label_agreement":null},{"id":"W2155866473","doi":"10.1016/j.ygyno.2003.11.044","title":"Ovarian cancer patients and hormone replacement therapy: a systematic review","year":2004,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Agence Nationale pour la Gestion des Déchets Radioactifs","keywords":"Medicine; Hormone replacement therapy (female-to-male); Observational study; Ovarian cancer; Randomized controlled trial; Internal medicine; Oncology; Meta-analysis; Cancer; Systematic review; Gynecology; Cohort study; Clinical trial; MEDLINE","score_opus":0.0489746827743853,"score_gpt":0.3759801187576179,"score_spread":0.3270054359832326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155866473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010622495,0.9835423,0.0000010543073,0.0012577904,0.0005084515,0.013278618,0.00008075587,0.000073753996,0.001246654],"genre_scores_gemma":[0.000027282693,0.98349077,0.00020113516,0.0034679347,0.00010254194,0.011936734,0.00023462051,0.00006549453,0.0004734978],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630207,0.00052642386,0.0014410377,0.00091449113,0.00029697592,0.0005189808],"domain_scores_gemma":[0.99712956,0.00058293587,0.0011883802,0.00067179545,0.00015555328,0.0002717824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006218862,0.0007162704,0.0065481756,0.00016813351,0.00011101236,0.00002116144,0.0001892425,0.00066706905,0.0006703024],"category_scores_gemma":[0.00037510513,0.00043102415,0.00054161536,0.0003219804,0.00011093863,0.000037279253,0.00013452588,0.0004556487,0.0001395171],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032029166,0.0012542896,0.00004826309,0.6691328,0.0015429824,0.00015858402,0.000028431159,2.6549206e-8,1.3588482e-8,0.000082712904,0.002870288,0.32484952],"study_design_scores_gemma":[0.0039314847,0.0048484746,0.00020044601,0.35183075,0.011385528,0.00011957875,0.0000049992736,1.1149295e-7,6.689463e-8,0.000026074433,0.62734944,0.0003030612],"about_ca_topic_score_codex":0.000074862444,"about_ca_topic_score_gemma":0.00002446015,"teacher_disagreement_score":0.6244791,"about_ca_system_score_codex":0.0035698672,"about_ca_system_score_gemma":0.0018858847,"threshold_uncertainty_score":0.99981415},"labels":[],"label_agreement":null},{"id":"W2156205902","doi":"10.1186/s13048-015-0124-8","title":"A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population","year":2015,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill Genome Centre; Montreal General Hospital; Jewish General Hospital; Université de Montréal; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal; Cancer Research Society; McGill University Health Centre; Ovarian Cancer Canada; McGill University","keywords":"Ovarian cancer; Mutation; Serous fluid; Population; BRCA mutation; Mutation frequency; Founder effect; Mutation testing; Fallopian tube; Medicine; Cancer; Fallopian tube cancer; Oncology; Genetics; Internal medicine; Biology; Gynecology; Gene; Genotype; Haplotype","score_opus":0.055287307316786626,"score_gpt":0.36860544733745526,"score_spread":0.31331814002066866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156205902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955698,0.0010970862,0.00024320763,0.0025693453,0.000088005465,0.0002933748,0.000036704118,0.000004168807,0.00009826109],"genre_scores_gemma":[0.9969687,0.00014103211,0.0025818,0.000045002424,0.0001403909,0.000042483563,0.000022424932,0.000017560638,0.000040644925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975021,0.00027253598,0.00058146904,0.00024516517,0.0010958628,0.0003028923],"domain_scores_gemma":[0.9980464,0.00015576046,0.00033005752,0.00022907989,0.00090071943,0.00033799704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015453834,0.00012963591,0.0005977743,0.0012153173,0.000053554126,0.00007326581,0.00009486941,0.00009824212,0.00024571494],"category_scores_gemma":[0.00023136578,0.00009625213,0.000067048095,0.0016196478,0.000103046994,0.00028940334,0.000027261978,0.00034606876,9.2156677e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003117925,0.00040073207,0.974037,0.00007247682,0.004520553,0.00083873136,0.009779872,0.0007131271,0.0010300449,0.00038212843,0.00017360583,0.0049337843],"study_design_scores_gemma":[0.006788667,0.00076601777,0.9836873,0.00025389082,0.0005785362,0.00003484914,0.002861871,0.00022031792,0.0002999634,0.0044009644,0.000020910673,0.00008674622],"about_ca_topic_score_codex":0.04300477,"about_ca_topic_score_gemma":0.004484145,"teacher_disagreement_score":0.038520627,"about_ca_system_score_codex":0.0011863845,"about_ca_system_score_gemma":0.00086800073,"threshold_uncertainty_score":0.96336794},"labels":[],"label_agreement":null},{"id":"W2156753629","doi":"10.1093/annonc/dkg022","title":"Dietary glycemic index, glycemic load and ovarian cancer risk:a case–control study in Italy","year":2002,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Glycemic load; Hyperinsulinemia; Quartile; Odds ratio; Glycemic index; Ovarian cancer; Internal medicine; Glycemic; Insulin; Case-control study; Confidence interval; Cancer; Insulin resistance; Logistic regression; Endocrinology; Oncology","score_opus":0.06809387408262906,"score_gpt":0.36554379176686813,"score_spread":0.29744991768423906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156753629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97955596,0.009369073,0.0000023232578,0.0071459212,0.00017218576,0.0008786177,0.000091085654,0.000018138668,0.0027666953],"genre_scores_gemma":[0.99367946,0.0044721765,0.000043309326,0.0013573365,0.00013573207,0.00018699876,0.0000019521187,0.000019913701,0.000103146594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984822,0.00013852325,0.000452363,0.0003980458,0.00018340554,0.0003454427],"domain_scores_gemma":[0.998952,0.00025109065,0.00021031516,0.00030254078,0.00012540232,0.0001586706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002444448,0.00020127432,0.0007285234,0.00016579902,0.000050610688,0.0000067570763,0.000065695625,0.00016612573,0.00060687884],"category_scores_gemma":[0.00008066573,0.0001718619,0.0000869587,0.00021492153,0.00010884601,0.000074254705,0.00004057284,0.00027356498,0.000015625084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004203658,0.0031940436,0.6976704,0.000039274753,0.0007863246,0.0065820958,0.0019599453,0.000039456707,0.000036740003,0.000011726838,0.0018100885,0.28366625],"study_design_scores_gemma":[0.04211099,0.021946095,0.9264742,0.00011676893,0.00077416,0.0011319563,0.00084902486,0.0007595773,0.00007284488,0.00015525744,0.0053493367,0.0002597916],"about_ca_topic_score_codex":0.0098192515,"about_ca_topic_score_gemma":0.008708303,"teacher_disagreement_score":0.28340644,"about_ca_system_score_codex":0.00020242725,"about_ca_system_score_gemma":0.0001780713,"threshold_uncertainty_score":0.99677444},"labels":[],"label_agreement":null},{"id":"W2157191370","doi":"10.1200/jco.2012.47.7927","title":"Clinical Trials of Palliative Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: Time to Think Differently?","year":2013,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Chemotherapy; Oncology; Palliative chemotherapy; Ovarian cancer; Internal medicine; Cancer; Clinical trial","score_opus":0.26245118894999153,"score_gpt":0.5288915851924206,"score_spread":0.2664403962424291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157191370","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06900549,0.001511326,0.000029574123,0.9217019,0.004018769,0.0021447076,0.00021355176,0.000014372268,0.0013603083],"genre_scores_gemma":[0.016089324,0.021319013,0.00825604,0.9058583,0.038777232,0.00018286864,0.000081361046,0.00021105382,0.009224811],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9797367,0.004398431,0.013678032,0.0006684472,0.00097573554,0.0005426851],"domain_scores_gemma":[0.9545935,0.03083719,0.0124550145,0.0006370042,0.0008365234,0.00064078445],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.012936209,0.00057938905,0.0116643915,0.0004487212,0.000028362387,0.00002243954,0.00051811937,0.0033539718,0.012264675],"category_scores_gemma":[0.014140538,0.00033236854,0.0022137032,0.0002742487,0.00029426173,0.00008765639,0.00009131316,0.0057289894,0.00015615817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018278807,0.0039979015,0.017704252,0.00015662824,0.0038344008,0.0022904337,0.00016113934,0.0000021850135,0.000028756234,0.000006213233,0.7297609,0.22377841],"study_design_scores_gemma":[0.02542614,0.028397137,0.257184,0.0019249325,0.0014967815,0.000018065313,0.000020881265,0.00001486939,0.00001732271,0.00016910458,0.6850828,0.00024798364],"about_ca_topic_score_codex":0.00027494718,"about_ca_topic_score_gemma":0.00013382072,"teacher_disagreement_score":0.23947975,"about_ca_system_score_codex":0.0009914379,"about_ca_system_score_gemma":0.007153478,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2157267683","doi":"10.1016/j.ijgo.2009.05.017","title":"Papillary serous carcinoma in situ in ovarian endometriosis in an MSH2 mutation carrier","year":2009,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Tel Aviv University","keywords":"Medicine; Gynecologic oncology; Obstetrics and gynaecology; Serous carcinoma; Gynecology; General surgery; Ovarian cancer; Internal medicine; Cancer; Pregnancy","score_opus":0.018142992434539304,"score_gpt":0.30347512670832283,"score_spread":0.2853321342737835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157267683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919271,0.0017963335,0.000024128529,0.0039787153,0.0013861657,0.00021011483,0.000008371192,0.0000045997162,0.0006644782],"genre_scores_gemma":[0.9973518,0.0005896469,0.00062027655,0.0012233551,0.00015700533,0.000008201259,0.000020525793,0.000011953236,0.000017216347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981125,0.0001269016,0.0008431537,0.00021493014,0.00046031404,0.00024220654],"domain_scores_gemma":[0.99764186,0.0013671251,0.0003307801,0.00013307377,0.00039785833,0.00012929575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042579736,0.00015188256,0.00044216585,0.002496232,0.000014766403,0.000027913751,0.00021417026,0.00017683246,0.00008616769],"category_scores_gemma":[0.0026578098,0.00014252591,0.00010259043,0.0009892443,0.000026899394,0.0002903695,0.000022216236,0.00042067375,0.0000045785896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027828797,0.0013906397,0.91929454,0.0000057662373,0.00007225678,0.0146235125,0.0008205419,0.00060434354,0.00065718056,0.00021955968,0.000054611286,0.061978783],"study_design_scores_gemma":[0.008919246,0.0014988083,0.9862722,0.00008344404,0.000042578362,0.00053849677,0.00028115025,0.00013746491,0.0011633263,0.00048087284,0.00047900714,0.00010340208],"about_ca_topic_score_codex":0.000120015706,"about_ca_topic_score_gemma":0.00073407305,"teacher_disagreement_score":0.06697769,"about_ca_system_score_codex":0.001855278,"about_ca_system_score_gemma":0.00035426687,"threshold_uncertainty_score":0.58120376},"labels":[],"label_agreement":null},{"id":"W2157429957","doi":"10.1002/dc.20257","title":"Clear-cell adenocarcinoma of the female genital tract: Presence of Hyaline stroma and tigroid background in various types of cytologic specimens","year":2005,"lang":"en","type":"article","venue":"Diagnostic Cytopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Cytology; Pathology; Hyaline; Cytopathology; Medicine; Biology","score_opus":0.017069739987159858,"score_gpt":0.25644937063510814,"score_spread":0.2393796306479483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157429957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921369,0.0054042987,0.000014774029,0.0006930344,0.000088350505,0.00045540291,0.000074373245,0.0000065023455,0.0011263796],"genre_scores_gemma":[0.99815315,0.0005491024,0.0010332107,0.00007797433,0.00006595407,0.000025708907,0.000008649871,0.000014248371,0.0000719729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987377,0.000102702295,0.0004866981,0.00028565672,0.00016448923,0.0002227459],"domain_scores_gemma":[0.9981653,0.0010828881,0.00023540502,0.00038507246,0.00007270184,0.000058611316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017929892,0.00015524642,0.00055411475,0.00010172472,0.000020811973,0.0000029457926,0.00012526278,0.00012242932,0.00015923133],"category_scores_gemma":[0.00032983275,0.00011281075,0.000088344466,0.00017986516,0.00035644835,0.000037707134,0.0000945627,0.00015985082,0.0000067601927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016510172,0.0016075526,0.9878407,0.0001585332,0.00002650452,0.00029560467,0.00079392357,0.00004992022,0.0064768754,0.0008070759,0.000056768262,0.0017214151],"study_design_scores_gemma":[0.0022786604,0.0014459371,0.97298056,0.00012303045,0.00019033287,0.00032326474,0.00023860183,0.00004258641,0.022099335,0.0001148324,0.00008299459,0.00007986099],"about_ca_topic_score_codex":0.00014040503,"about_ca_topic_score_gemma":0.00016386707,"teacher_disagreement_score":0.015622459,"about_ca_system_score_codex":0.0000494974,"about_ca_system_score_gemma":0.00009418425,"threshold_uncertainty_score":0.46002886},"labels":[],"label_agreement":null},{"id":"W2157582563","doi":"10.1148/rg.324115180","title":"T2-Hypointense Adnexal Lesions: An Imaging Algorithm","year":2012,"lang":"en","type":"article","venue":"Radiographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Lesion; Calcification; Magnetic resonance imaging; Adnexal Diseases; Radiology; Pathology","score_opus":0.024666534882916754,"score_gpt":0.30109897169988076,"score_spread":0.276432436816964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157582563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8631223,0.08448241,0.01157034,0.018427318,0.005224623,0.002559127,0.00023770572,0.0012590775,0.013117113],"genre_scores_gemma":[0.9770335,0.0019829732,0.017911252,0.0018443684,0.0009556685,0.000056492972,0.00007282755,0.000046353227,0.00009656657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880755,0.00004420106,0.00020061125,0.00024616002,0.00025563114,0.0004458308],"domain_scores_gemma":[0.99887383,0.000056705532,0.00005374137,0.00044631952,0.0000877474,0.00048166385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025040758,0.00018325259,0.00025983117,0.00027541528,0.00012004459,0.00002739031,0.00006484729,0.00006643328,0.0001350049],"category_scores_gemma":[0.000026175892,0.00015104389,0.00020988606,0.00044210698,0.000095232084,0.00024339883,0.000021781267,0.00018574821,0.000037345362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041822303,0.001393991,0.74278605,0.00002860392,0.00024302972,0.00015512975,0.00047925964,6.677663e-7,0.00011491037,0.0024902043,0.007914853,0.2443515],"study_design_scores_gemma":[0.0036977362,0.00047089581,0.8834982,0.00020897124,0.0008266457,0.0010566834,0.00059624726,0.0013910966,0.0007189983,0.00043181502,0.106657095,0.00044562612],"about_ca_topic_score_codex":0.00012172264,"about_ca_topic_score_gemma":0.0000057274965,"teacher_disagreement_score":0.24390587,"about_ca_system_score_codex":0.00006954117,"about_ca_system_score_gemma":0.00005277129,"threshold_uncertainty_score":0.61593914},"labels":[],"label_agreement":null},{"id":"W2157717773","doi":"10.1158/1055-9965.epi-13-0028","title":"Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome","year":2013,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Cancer Research UK","keywords":"Ovarian cancer; Single-nucleotide polymorphism; Oncology; Medicine; Cancer; Internal medicine; Genotype; SNP; Proportional hazards model; ERCC1; Survival analysis; Disease; Genetic association; Bioinformatics; Genome-wide association study; Biology; Genetics; DNA repair; Gene; Nucleotide excision repair","score_opus":0.062379926364643075,"score_gpt":0.38070974129619456,"score_spread":0.3183298149315515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157717773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98221993,0.00919993,0.00016501296,0.0061816545,0.0004446669,0.0011645578,0.00029331874,0.00005581209,0.00027508577],"genre_scores_gemma":[0.99008024,0.0030637775,0.0005991784,0.0006172946,0.00023400124,0.00081865984,0.00068874937,0.000030459652,0.0038676285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966677,0.00049666135,0.0014000692,0.0007030958,0.00021548285,0.00051701436],"domain_scores_gemma":[0.9965304,0.00085381727,0.0015709184,0.00048158356,0.00030456105,0.00025873166],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015100661,0.00031362416,0.0015044996,0.00041489227,0.000099770754,0.00001380054,0.00008518359,0.00038006713,0.0052014263],"category_scores_gemma":[0.00086528645,0.00026483313,0.0004604404,0.0006416614,0.00012460005,0.00017854662,0.000055126202,0.00015528323,0.000020449615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015180255,0.000106606574,0.95416826,0.000084244144,0.017901322,0.000010847313,0.000049985654,0.000012177959,0.00016813162,0.00001406852,0.0101862075,0.017146366],"study_design_scores_gemma":[0.0018568523,0.00027776623,0.98009676,0.0002404191,0.014825725,0.000005088185,0.000010544349,0.00039924067,0.00014450395,0.00014691796,0.0017799344,0.00021623894],"about_ca_topic_score_codex":0.035377823,"about_ca_topic_score_gemma":0.0021476627,"teacher_disagreement_score":0.033230163,"about_ca_system_score_codex":0.0010042705,"about_ca_system_score_gemma":0.00021122166,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W2158238655","doi":"10.1016/s1701-2163(15)30894-x","title":"Risk-Reducing Salpingectomy in Canada: A Survey of Obstetrician-Gynaecologists","year":2013,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; Vancouver General Hospital; Ottawa Hospital; University of British Columbia; University of Toronto","funders":"Ovarian Cancer Canada","keywords":"Medicine; Salpingectomy; Obstetrics and gynaecology; Gynecology; Tubal ligation; Gynecologic oncology; Fallopian tube; Population; Obstetrics; Family medicine; Hysterectomy; Family planning; Pregnancy; Surgery; Research methodology; Environmental health; Ectopic pregnancy","score_opus":0.01624834380205672,"score_gpt":0.2317942068453727,"score_spread":0.21554586304331597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158238655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98272705,0.01090239,0.000003025138,0.00043556865,0.0051808003,0.00027479712,0.000045908597,0.0000014483909,0.00042901715],"genre_scores_gemma":[0.99860865,0.00079739926,0.0002606179,0.00026611122,0.000014192233,0.000008496562,0.000004721603,0.000013756034,0.000026081574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980296,0.0001530758,0.0008864987,0.00018884488,0.00039198773,0.00034997554],"domain_scores_gemma":[0.99222255,0.0057454547,0.00087582966,0.00017549872,0.00068957754,0.00029111345],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00038012827,0.0001732777,0.00080520916,0.000376557,0.00004741603,0.000011812462,0.00012506872,0.00010115704,0.00057339447],"category_scores_gemma":[0.0094004,0.00013953728,0.000053395714,0.00085830287,0.000047060865,0.00006526866,0.00003956459,0.00040335127,5.3503913e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000049535724,0.000116111456,0.91260105,0.000038574515,0.00017329765,0.001322952,0.00002940571,0.00013908476,0.0000020394414,0.0000062748622,0.0024397727,0.0831265],"study_design_scores_gemma":[0.0031657482,0.00042287697,0.995194,0.000018326376,0.000104918356,0.000036791214,0.00017270283,0.00013993111,0.00006030067,0.000017553599,0.00055540056,0.000111430745],"about_ca_topic_score_codex":0.9984169,"about_ca_topic_score_gemma":0.99833316,"teacher_disagreement_score":0.08301507,"about_ca_system_score_codex":0.006396443,"about_ca_system_score_gemma":0.01665581,"threshold_uncertainty_score":0.99894387},"labels":[],"label_agreement":null},{"id":"W2158401328","doi":"10.1017/s146239940800077x","title":"Critical molecular abnormalities in high-grade serous carcinoma of the ovary","year":2008,"lang":"en","type":"review","venue":"Expert Reviews in Molecular Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Eli Lilly Canada; Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"CDKN2A; Serous fluid; Serous carcinoma; Ovarian carcinoma; Carcinogenesis; Biology; Ovarian cancer; Cancer research; Ovary; Serous ovarian cancer; Pathology; Carcinoma; Clear cell carcinoma; Oncology; Gene; Cancer; Medicine; Genetics","score_opus":0.050765824291170644,"score_gpt":0.36997787570658464,"score_spread":0.319212051415414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158401328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001382963,0.9924925,0.00005011756,0.0024930337,0.000616919,0.0032669117,0.00001449751,0.000016593982,0.0009111508],"genre_scores_gemma":[0.0011288407,0.99362946,0.0010319143,0.0023626671,0.00028416404,0.0012882992,0.00009093006,0.00011685488,0.00006690128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99405664,0.0011792203,0.002457471,0.00084594224,0.0008451845,0.00061555405],"domain_scores_gemma":[0.997112,0.00033380074,0.00048363238,0.0017505483,0.00009537006,0.00022465936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006223068,0.00089974364,0.0057848245,0.00048746407,0.00004284965,0.0000069422667,0.0005286117,0.0004488692,0.00019226177],"category_scores_gemma":[0.0010261238,0.0005099971,0.0010591258,0.0012292375,0.0005967547,0.000049870938,0.00018809442,0.00094615883,0.000017922597],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041041607,0.0016657128,0.0008829817,0.053180218,0.00046247788,0.014912851,0.0015522895,0.0000017645145,0.000078280114,0.0054177945,0.008788964,0.9130156],"study_design_scores_gemma":[0.0017922933,0.00034343166,0.00043390514,0.114194885,0.0007339529,0.0011499497,0.00004445421,0.0000016191838,0.00011761166,0.000076353215,0.8807241,0.00038746579],"about_ca_topic_score_codex":0.001146342,"about_ca_topic_score_gemma":0.000028330844,"teacher_disagreement_score":0.9126282,"about_ca_system_score_codex":0.0006050993,"about_ca_system_score_gemma":0.0005475357,"threshold_uncertainty_score":0.9997352},"labels":[],"label_agreement":null},{"id":"W2158435543","doi":"10.1530/erc-10-0235","title":"Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma","year":2011,"lang":"en","type":"article","venue":"Endocrine Related Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Institute of Gender and Health; Canadian Institutes of Health Research; University Health Network; U.S. Department of Defense","keywords":"Luteal phase; Follicular phase; Progesterone receptor; Serous carcinoma; Fallopian tube; Biology; Immunohistochemistry; Internal medicine; Andrology; Endocrinology; Molecular biology; Medicine; Estrogen receptor; Cancer; Ovarian cancer","score_opus":0.02399009151892472,"score_gpt":0.2851806287602314,"score_spread":0.2611905372413067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158435543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072665,0.0052436753,0.000007634246,0.001727768,0.00035093894,0.00095831294,0.00006659721,0.000098238204,0.00082018226],"genre_scores_gemma":[0.9946701,0.002276608,0.0011283006,0.00022144869,0.00013067768,0.0005518302,0.00009043786,0.00006058058,0.0008700219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982379,0.000055638673,0.00043236907,0.0005366492,0.00022714962,0.0005102686],"domain_scores_gemma":[0.99909526,0.00003066545,0.00011924036,0.0003597018,0.00005285824,0.00034228148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007508708,0.00031416802,0.0004824359,0.00017446766,0.000065753055,0.0000143394755,0.00008116014,0.00011620902,0.0012464299],"category_scores_gemma":[0.000017596934,0.00024900975,0.000073498166,0.0002530418,0.00007337876,0.00015093469,0.00005620927,0.0003248757,0.000028015962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029487985,0.004960883,0.86040044,0.00037630586,0.00056600594,0.0022173868,0.0036589347,0.0000076906235,0.020008393,0.0005778427,0.003302576,0.10097476],"study_design_scores_gemma":[0.053579643,0.0027033538,0.7065565,0.0014329669,0.00054647384,0.00040445026,0.00025448648,0.00018359863,0.21725251,0.00020649015,0.016179483,0.00070004445],"about_ca_topic_score_codex":0.005688839,"about_ca_topic_score_gemma":0.0003852336,"teacher_disagreement_score":0.19724411,"about_ca_system_score_codex":0.0003969846,"about_ca_system_score_gemma":0.0001753243,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W2159079082","doi":"10.1006/gyno.2001.6367","title":"Bone Metastasis from a Granulosa Cell Tumor of the Ovary","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Ovary; Bone metastasis; Metastasis; Bone scintigraphy; Radiation therapy; Lesion; Radiology; Megestrol acetate; Surgery; Cancer; Internal medicine","score_opus":0.02425748036796751,"score_gpt":0.28445227119358746,"score_spread":0.26019479082561997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159079082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95927286,0.0017302617,0.000016382079,0.00943701,0.0006478718,0.00063572626,0.00006709164,0.000039215236,0.02815356],"genre_scores_gemma":[0.9928962,0.00042568485,0.0023342676,0.003475227,0.00012656489,0.00014461839,0.000021330494,0.000013721864,0.00056237355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867404,0.00017175848,0.00036747273,0.00032234943,0.0001704507,0.00029395468],"domain_scores_gemma":[0.9984995,0.0006028495,0.00024849587,0.00047740777,0.00006967043,0.000102082144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020326275,0.00016787433,0.00062613894,0.000059329243,0.000074917334,0.000004175999,0.00014581563,0.00013652217,0.0031625386],"category_scores_gemma":[0.000142818,0.00009922873,0.00023945948,0.00025835264,0.00016825384,0.000026745758,0.000106430416,0.0001923131,0.000099291574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010140816,0.01000635,0.7986661,0.000093724535,0.0009244887,0.0039172377,0.0005982225,0.000029754945,0.007930166,0.00092836673,0.040466562,0.1354249],"study_design_scores_gemma":[0.005763446,0.0026316678,0.75084025,0.00002831057,0.0010489044,0.00019004992,0.00024409189,0.00002095439,0.0096806185,0.0017263483,0.22767672,0.00014861228],"about_ca_topic_score_codex":0.00041725655,"about_ca_topic_score_gemma":0.00030910812,"teacher_disagreement_score":0.18721016,"about_ca_system_score_codex":0.0003079179,"about_ca_system_score_gemma":0.0003353809,"threshold_uncertainty_score":0.99774873},"labels":[],"label_agreement":null},{"id":"W2160139566","doi":"10.1093/annonc/mdr467","title":"Optimal assessment of response in ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Clinical endpoint; Oncology; Ovarian cancer; Clinical trial; Response Evaluation Criteria in Solid Tumors; Surrogate endpoint; Progression-free survival; Internal medicine; Cancer; Randomized controlled trial; Tumor progression; Phases of clinical research; Overall survival","score_opus":0.16914206435670756,"score_gpt":0.45985911768495225,"score_spread":0.2907170533282447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160139566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97299004,0.0004091832,0.000026129957,0.006927093,0.00011924757,0.0002289027,0.000019110892,0.000004580005,0.019275717],"genre_scores_gemma":[0.9935513,0.00062847906,0.004978696,0.00062123366,0.000028047361,0.00007469673,0.000002508825,0.000008136613,0.000106911124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991611,0.00011411261,0.0003137089,0.00014709044,0.00010239203,0.00016159045],"domain_scores_gemma":[0.9993557,0.00011750184,0.00015034829,0.00019089768,0.0001203926,0.00006521545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004692846,0.00007653263,0.00040622836,0.00013821929,0.0000076219803,6.3557314e-7,0.000055520944,0.00009104749,0.0009254747],"category_scores_gemma":[0.00004025424,0.00006411904,0.000073299554,0.00013289129,0.00007681111,0.000027417647,0.000026556148,0.0000821184,0.0000027262072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01465564,0.0081811305,0.8845695,0.00014745277,0.00071560754,0.00070181466,0.0033307583,0.000104568266,0.0070138145,0.00565086,0.004648083,0.070280775],"study_design_scores_gemma":[0.0027385114,0.006734486,0.96476114,0.00009422097,0.00005658912,0.000009798414,0.00010321703,0.000028256783,0.018132294,0.00008206837,0.007210001,0.000049422993],"about_ca_topic_score_codex":0.0011744179,"about_ca_topic_score_gemma":0.00012011816,"teacher_disagreement_score":0.080191635,"about_ca_system_score_codex":0.00008305509,"about_ca_system_score_gemma":0.00072177756,"threshold_uncertainty_score":0.99998784},"labels":[],"label_agreement":null},{"id":"W2160627578","doi":"10.3747/co.19.980","title":"Management of a Suspicious Adnexal Mass: A Clinical Practice Guideline","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Adnexal mass; Malignancy; Cancer; Guideline; Disease; Stage (stratigraphy); Bloating; Gynecology; Abdominal pain; Internal medicine; Pathology","score_opus":0.18708996226721036,"score_gpt":0.5334517642765464,"score_spread":0.34636180200933603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160627578","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3228455,0.1506617,0.014230011,0.09865997,0.038369153,0.007141971,0.00011868211,0.00040133184,0.3675717],"genre_scores_gemma":[0.92966205,0.0060567423,0.06065306,0.0013830005,0.0017083231,0.00017198948,0.000068175774,0.000028033872,0.00026860286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830806,0.00015805285,0.0007589736,0.0002280648,0.0002248046,0.00032204558],"domain_scores_gemma":[0.9986988,0.0002525368,0.0002883949,0.00033091416,0.00019311921,0.00023625579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010238052,0.00013388747,0.00046496774,0.000060057497,0.00002375857,0.0000029602984,0.00007369401,0.00010479878,0.00035482328],"category_scores_gemma":[0.0001616411,0.00010653939,0.0001591526,0.00012562503,0.000084095256,0.00007433294,0.00006984443,0.00020440866,0.00013613292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006351704,0.011457549,0.17267738,0.00023457523,0.00071327854,0.00020882122,0.00018950182,0.000001119196,0.000010736116,0.0093934005,0.08289432,0.72158414],"study_design_scores_gemma":[0.0044146474,0.0013361963,0.04180154,0.000098885415,0.0012049858,0.000075396936,0.00031345597,0.000023651706,0.000042947966,0.000063353145,0.9505403,0.00008462049],"about_ca_topic_score_codex":0.000009482157,"about_ca_topic_score_gemma":0.000001415896,"teacher_disagreement_score":0.867646,"about_ca_system_score_codex":0.0002504043,"about_ca_system_score_gemma":0.00012826113,"threshold_uncertainty_score":0.43445504},"labels":[],"label_agreement":null},{"id":"W2160720356","doi":"10.5812/iranjradiol.21260","title":"Decidualized Ovarian Endometrioma in a Pregnant Woman Mimicking Ovarian Malignancy: Magnetic Resonance Imaging and Ultrasonographic Findings","year":2015,"lang":"en","type":"article","venue":"Iranian Journal of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"Universiti Malaya","keywords":"Medicine; Magnetic resonance imaging; Malignancy; Ultrasonography; Endometriosis; Pregnancy; Radiology; Ovary; Gestation; Obstetrics; Gynecology; Pathology; Internal medicine","score_opus":0.021380370519600442,"score_gpt":0.2677863849861905,"score_spread":0.24640601446659005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160720356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8980166,0.09644998,0.00019016361,0.0040559433,0.0004782938,0.00038434486,0.000009546865,0.000017460761,0.00039767034],"genre_scores_gemma":[0.9892394,0.002427618,0.007430573,0.0005956795,0.00021988196,0.000017093269,0.0000031153918,0.0000366102,0.00003006227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775934,0.00025004864,0.0008353289,0.00035964482,0.00027940964,0.00051620684],"domain_scores_gemma":[0.9985482,0.00029039982,0.00030636752,0.00025818948,0.00016129017,0.00043553283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010292159,0.00027484092,0.00090582937,0.0010868515,0.000057983696,0.000046789635,0.0001743939,0.00012634975,0.0000630194],"category_scores_gemma":[0.00043561673,0.00022517164,0.00015887221,0.0007229698,0.00019478818,0.00017656013,0.000032832424,0.0003643126,0.0000036849285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011008893,0.00027366314,0.94364285,0.00004226482,0.00010517082,0.005946144,0.002520203,0.000003924131,0.0012088976,0.000589636,0.000760213,0.043806113],"study_design_scores_gemma":[0.025946895,0.0023907872,0.92291814,0.0016512633,0.00027695537,0.035935022,0.0004996333,0.00006726954,0.00037906735,0.0010419633,0.008621949,0.0002710575],"about_ca_topic_score_codex":0.00007698301,"about_ca_topic_score_gemma":0.000036551242,"teacher_disagreement_score":0.09402236,"about_ca_system_score_codex":0.00023123507,"about_ca_system_score_gemma":0.0003045517,"threshold_uncertainty_score":0.9182233},"labels":[],"label_agreement":null},{"id":"W2161701941","doi":"10.1002/path.2744","title":"The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomas","year":2010,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Calgary Laboratory Services; University of Calgary; Alberta Health Services","funders":"","keywords":"Serous fluid; Immunohistochemistry; Tissue microarray; Clear cell; Population; Serous carcinoma; Pathology; Carcinoma; P53 expression; Stage (stratigraphy); Proportional hazards model; Medicine; Oncology; Biology; Cancer; Ovarian cancer; Internal medicine","score_opus":0.03558695500464818,"score_gpt":0.33885982973606055,"score_spread":0.30327287473141235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161701941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922861,0.0015483126,0.000013581077,0.0055196285,0.00046005566,0.00010977031,0.0000018780285,0.0000015118977,0.00005916948],"genre_scores_gemma":[0.99639565,0.0024904553,0.00072019175,0.00014187898,0.00023167727,0.0000016440129,4.1548213e-7,0.0000049783334,0.00001311639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989153,0.00031413973,0.0004636208,0.000080182814,0.00010004924,0.00012669989],"domain_scores_gemma":[0.99855727,0.0008507318,0.00027909543,0.00019438863,0.000054315504,0.000064223896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014116709,0.000073420066,0.0003213474,0.000038039194,0.000045149744,0.0000032529108,0.000109780034,0.00012092609,0.000024225103],"category_scores_gemma":[0.00022729515,0.00002900403,0.000075568634,0.000049687067,0.00031647284,0.00001653752,0.000048734986,0.00050466345,0.0000018390939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005889393,0.00061234826,0.93364877,0.000007649019,0.00005336504,0.00070307753,0.00051671336,0.0000033257077,0.0540038,0.00061888533,0.00021444888,0.009028663],"study_design_scores_gemma":[0.0021822506,0.001619119,0.9885309,0.000038536335,0.000101668214,0.0021481707,0.0001713891,0.000008516515,0.003731442,0.0010097721,0.0004291673,0.000029097198],"about_ca_topic_score_codex":0.000023654602,"about_ca_topic_score_gemma":0.000049734743,"teacher_disagreement_score":0.054882087,"about_ca_system_score_codex":0.000014087493,"about_ca_system_score_gemma":0.000059282404,"threshold_uncertainty_score":0.21925397},"labels":[],"label_agreement":null},{"id":"W2161704600","doi":"10.1210/jc.2004-0044","title":"Overexpression of Follicle-Stimulating Hormone Receptor Activates Oncogenic Pathways in Preneoplastic Ovarian Surface Epithelial Cells","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transfection; Follicle-stimulating hormone receptor; Biology; Cell culture; Ovarian cancer; MAPK/ERK pathway; Kinase; Cell growth; Cancer research; Receptor; Cell biology; Molecular biology; Endocrinology; Cancer; Follicle-stimulating hormone; Hormone; Luteinizing hormone","score_opus":0.04638500866609964,"score_gpt":0.34245403074090736,"score_spread":0.29606902207480773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161704600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929438,0.0031630844,0.00019812559,0.0024384372,0.0008039056,0.00032385974,0.000025845453,0.000012366184,0.00009053436],"genre_scores_gemma":[0.9894954,0.0053329947,0.004147651,0.0002404841,0.0007257088,0.000003662246,0.0000022068666,0.00002869184,0.000023226099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644953,0.0005127078,0.0019729186,0.00023480976,0.00040756102,0.0004224645],"domain_scores_gemma":[0.99582404,0.002118446,0.0012621965,0.0003893336,0.0002034688,0.00020251777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011230897,0.00024401078,0.0013850786,0.000121769444,0.00006311988,0.000007531476,0.00028016797,0.00018676964,0.000083058636],"category_scores_gemma":[0.0008869738,0.000145781,0.0004522353,0.00022874365,0.00022876686,0.00012365126,0.00010354662,0.0009010204,0.000017970486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008433682,0.0031475644,0.011599251,0.00004795408,0.0010468377,0.00018852392,0.0009518059,0.01647631,0.93852484,0.0014346564,0.00019833825,0.01795023],"study_design_scores_gemma":[0.039946694,0.0042549097,0.3032114,0.00076522055,0.0014355569,0.0003653855,0.00025528946,0.00013481271,0.6435645,0.0032524269,0.0025431428,0.00027063763],"about_ca_topic_score_codex":0.00016268626,"about_ca_topic_score_gemma":0.0000073248434,"teacher_disagreement_score":0.29496032,"about_ca_system_score_codex":0.00007976288,"about_ca_system_score_gemma":0.0004915597,"threshold_uncertainty_score":0.59447765},"labels":[],"label_agreement":null},{"id":"W2162318396","doi":"10.1093/annonc/mdr441","title":"Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Neutropenia; Hazard ratio; Gastroenterology; Paclitaxel; Ovarian cancer; Oncology; Chemotherapy; Clinical endpoint; Surgery; Confidence interval; Randomized controlled trial; Cancer; Cisplatin","score_opus":0.09745928418949434,"score_gpt":0.37125514234528034,"score_spread":0.273795858155786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162318396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494463,0.0003604762,0.0000015967395,0.00095026963,0.00026775597,0.0008402928,0.0015388898,0.000008279728,0.001087836],"genre_scores_gemma":[0.99910975,0.00022332897,0.00012090246,0.00015709003,0.00008143093,0.00005774527,0.00022186174,0.000014527379,0.000013392353],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99779993,0.00028114897,0.00094774686,0.0004526282,0.00023678453,0.000281744],"domain_scores_gemma":[0.9979439,0.0006915483,0.0006603815,0.00032389033,0.00025671898,0.00012358521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033597494,0.00022658566,0.0011013354,0.00019953953,0.000045270568,0.000005680151,0.0000698536,0.00024135655,0.000057003635],"category_scores_gemma":[0.0002985386,0.00016632199,0.0001635813,0.00059717445,0.00025863957,0.00005707331,0.00007337643,0.00018978762,3.1988426e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53812885,0.00869859,0.330412,0.00005113624,0.011334214,0.00032886752,0.026823478,0.00014108198,0.0024394488,0.0002920492,0.0007293969,0.0806209],"study_design_scores_gemma":[0.19657846,0.007383585,0.783942,0.0001117698,0.002902448,0.0000011702165,0.00034604143,0.00096050656,0.00744744,0.000043163764,0.00012943955,0.00015396583],"about_ca_topic_score_codex":0.067695536,"about_ca_topic_score_gemma":0.047401696,"teacher_disagreement_score":0.45353,"about_ca_system_score_codex":0.00008707545,"about_ca_system_score_gemma":0.0002620188,"threshold_uncertainty_score":0.9699807},"labels":[],"label_agreement":null},{"id":"W2162472136","doi":"10.1111/his.12419","title":"Assignment of primary site in high‐grade serous tubal, ovarian and peritoneal carcinoma: a proposal","year":2014,"lang":"en","type":"review","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Fallopian tube; Serous carcinoma; Peritoneum; Serous fluid; Medicine; Ovary; Ovarian cancer; Stage (stratigraphy); Serous membrane; Ovarian carcinoma; Carcinoma; Pathology; Gynecology; Oncology; Cancer; Internal medicine; Biology","score_opus":0.026370162442007385,"score_gpt":0.29015374804386934,"score_spread":0.26378358560186194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162472136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038097221,0.99312806,0.000018803465,0.00037724175,0.00043206394,0.001387697,0.000084655265,0.000025035408,0.0007367067],"genre_scores_gemma":[0.0121115055,0.984464,0.0018167465,0.00014996316,0.0002571884,0.00047633972,0.00031538305,0.00007502369,0.00033384448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975901,0.0003385953,0.0007954286,0.0007106965,0.00021013583,0.00035501772],"domain_scores_gemma":[0.9987805,0.00009996887,0.0003847737,0.0005502591,0.00003685637,0.00014764396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031642558,0.0004476113,0.0031242108,0.00033439317,0.00003856196,0.0000073172137,0.00010038987,0.00045480987,0.000053714622],"category_scores_gemma":[0.000023380468,0.00035582308,0.00024374445,0.0001690454,0.00023440048,0.000024237168,0.00010819388,0.0004079804,0.000021750051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001870406,0.0025132676,0.03414693,0.06896517,0.00012316408,0.007932129,0.00090545043,4.983656e-7,0.00005506684,0.0027646816,0.0017889203,0.8806177],"study_design_scores_gemma":[0.00329904,0.0017320215,0.0993434,0.0051494665,0.002321019,0.0030701126,0.000008031068,0.0000020520097,0.0000032994485,0.00004952755,0.88461727,0.00040474944],"about_ca_topic_score_codex":0.0003892093,"about_ca_topic_score_gemma":0.000074727766,"teacher_disagreement_score":0.88282835,"about_ca_system_score_codex":0.0009770342,"about_ca_system_score_gemma":0.000781382,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W2162832987","doi":"10.1158/1055-9965.epi-13-0391","title":"Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium","year":2013,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Alberta Health Services","funders":"National Center for Research Resources; National Cancer Institute; Mayo Clinic","keywords":"Medicine; Tissue microarray; Serous carcinoma; Ovarian carcinoma; Concordance; Immunohistochemistry; Oncology; Serous fluid; Carcinoma; Biomarker; Pathology; Internal medicine; Ovarian cancer; Cancer; Biology","score_opus":0.08399486586195487,"score_gpt":0.35850813211239885,"score_spread":0.274513266250444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162832987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8909306,0.010460272,0.00481963,0.08845913,0.00073462067,0.003518743,0.000031504384,0.00012491886,0.00092056656],"genre_scores_gemma":[0.9872617,0.00011344177,0.0038814698,0.0056943297,0.000113918104,0.0023090336,0.00042695785,0.000025049438,0.00017409085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555063,0.0017714807,0.0010505652,0.00085284875,0.00016806481,0.0006064176],"domain_scores_gemma":[0.9974347,0.00084216584,0.00060892926,0.00075451855,0.00014548156,0.00021422213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022497019,0.0003666805,0.0009447212,0.0006201123,0.00016268947,0.000025782547,0.00023618348,0.00028236766,0.0013629392],"category_scores_gemma":[0.0005071289,0.00026459666,0.00040866953,0.0014268887,0.00039900193,0.0001501003,0.000034991866,0.00025655382,0.00007693601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021618982,0.00026259126,0.97494364,0.00007840345,0.0012890566,0.00004137508,0.00012271061,0.000060247843,0.0005618036,0.0006708767,0.008920033,0.0128330765],"study_design_scores_gemma":[0.0023736241,0.00030275376,0.9833705,0.00014815986,0.0021103271,0.00002479205,0.000121353194,0.004662708,0.00024997152,0.003518136,0.0028693553,0.00024833903],"about_ca_topic_score_codex":0.0080927955,"about_ca_topic_score_gemma":0.0014829066,"teacher_disagreement_score":0.0963311,"about_ca_system_score_codex":0.00073609815,"about_ca_system_score_gemma":0.00043849277,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W2163214112","doi":"10.1634/theoncologist.2009-0331","title":"Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review","year":2010,"lang":"en","type":"review","venue":"The Oncologist","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Tolerability; Carboplatin; Regimen; Medicine; Gemcitabine; Internal medicine; Oncology; Chemotherapy; Adverse effect; Cisplatin","score_opus":0.05658101786179498,"score_gpt":0.3669097908403569,"score_spread":0.31032877297856193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163214112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013474728,0.97509485,0.0000070618985,0.0012213766,0.0003260307,0.021420494,0.00035688354,0.000018919533,0.00020688045],"genre_scores_gemma":[0.019285139,0.976534,0.00017405547,0.000026125219,0.000083643106,0.0036393488,0.00017531062,0.000046165766,0.00003621897],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99672806,0.0005293468,0.0016068061,0.00050452224,0.00034374595,0.00028751654],"domain_scores_gemma":[0.991509,0.0055951974,0.0017009089,0.0008555801,0.00026285884,0.00007645672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009534991,0.0005740497,0.0044136764,0.000106522435,0.00010872302,0.000014545734,0.00018638081,0.0002801016,0.000017381728],"category_scores_gemma":[0.00039853726,0.0002528804,0.0003889121,0.00046683336,0.0004081573,0.000025497282,0.00004613905,0.00035710627,9.597177e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032559107,0.002514226,0.00011499642,0.42294547,0.0027084246,0.000028234306,0.00094177487,0.000012456069,0.0000025248444,0.0005894467,0.000034013072,0.5668525],"study_design_scores_gemma":[0.03395355,0.024424449,0.002988609,0.849458,0.060603723,0.00013965736,0.00027683316,0.0003276665,0.000058077636,0.000022532991,0.027052468,0.00069446553],"about_ca_topic_score_codex":0.0012146459,"about_ca_topic_score_gemma":0.0026310016,"teacher_disagreement_score":0.56615806,"about_ca_system_score_codex":0.0011064054,"about_ca_system_score_gemma":0.000782883,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W2164678107","doi":"10.1016/j.cancergencyto.2008.11.013","title":"Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Genetics and Cytogenetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Jewish General Hospital","funders":"","keywords":"Comparative genomic hybridization; Biology; Hazard ratio; Ovarian cancer; Ovarian carcinoma; Epithelial ovarian cancer; Internal medicine; Stage (stratigraphy); Oncology; Cancer; Carcinoma; Gene; Cancer research; Genetics; Medicine; Genome; Confidence interval","score_opus":0.026565605945110128,"score_gpt":0.2899979269045208,"score_spread":0.26343232095941066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164678107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97195256,0.025493681,0.00065772305,0.0009687521,0.00010691498,0.000593053,0.00013544768,0.000013693085,0.0000781652],"genre_scores_gemma":[0.97489905,0.022310184,0.0019959926,0.00047601326,0.00013356999,0.000072228926,0.000043701042,0.000017338923,0.00005194692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998778,0.000058561,0.0003335749,0.00044422172,0.00011666397,0.00026898974],"domain_scores_gemma":[0.9993706,0.000029354378,0.0000905848,0.00021569384,0.000098712546,0.00019508183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005997695,0.00022973875,0.000313308,0.00009092787,0.00010436348,0.000062681174,0.000054646098,0.00008168791,0.000025328525],"category_scores_gemma":[0.0000070161204,0.0002257866,0.000029865174,0.00018887523,0.0000860407,0.00002331273,0.000026521111,0.00011007828,0.0000019764727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020624527,0.0003798731,0.77315235,0.00007449372,0.000118847405,0.000052905933,0.001793655,0.001335356,0.1049753,0.00017528873,0.00074088626,0.1169948],"study_design_scores_gemma":[0.0023896964,0.00066935987,0.94670784,0.000067278226,0.00015991669,0.00002217664,0.000036939808,0.0052937698,0.041473463,0.00024164257,0.0026996662,0.00023821737],"about_ca_topic_score_codex":0.00007062555,"about_ca_topic_score_gemma":0.00019082654,"teacher_disagreement_score":0.17355552,"about_ca_system_score_codex":0.00011791005,"about_ca_system_score_gemma":0.00017248641,"threshold_uncertainty_score":0.920731},"labels":[],"label_agreement":null},{"id":"W2165076873","doi":"10.1016/j.jpag.2005.11.005","title":"Anaplastic Carcinoma Arising in an Ovarian Mucinous Cystadenocarcinoma in a 17-Year-Old Female","year":2006,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Mucinous cystadenocarcinoma; Medicine; Mucinous carcinoma; Anaplastic carcinoma; Ovarian carcinoma; Oncology; Cystadenocarcinoma; Carcinoma; Ovary; Internal medicine; Gynecology; Ovarian cancer; Adenocarcinoma; Cancer","score_opus":0.014860700178286081,"score_gpt":0.25548919469197057,"score_spread":0.24062849451368448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165076873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953136,0.0030291707,0.000044399556,0.0008118101,0.00031229178,0.0002572293,0.0000045256565,0.0000066652133,0.00022033718],"genre_scores_gemma":[0.99742264,0.00047383714,0.0005651149,0.00031904952,0.001122654,0.0000051080706,0.0000052852906,0.000020086776,0.000066208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982686,0.000105160776,0.0007480499,0.0002760381,0.00020234303,0.00039982662],"domain_scores_gemma":[0.9990583,0.00017599452,0.0003228682,0.0001514104,0.00008964886,0.00020180034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003178837,0.0001971821,0.00060297654,0.000677445,0.00004248416,0.000026624182,0.000080573445,0.00016977914,0.000069482434],"category_scores_gemma":[0.00007107226,0.00016825927,0.00009187494,0.0003631693,0.00004190424,0.00013263448,0.000031922256,0.00043391043,0.0000035707096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004089246,0.0015975675,0.9922819,0.000102456586,0.000014740346,0.0032590355,0.00014783637,0.00011100177,0.000038977643,0.00012358137,0.0008377811,0.0010761687],"study_design_scores_gemma":[0.008176036,0.0019944082,0.9882906,0.00006579496,0.00022557564,0.00043637733,0.0002395348,0.000119946475,0.00002046939,0.0001319363,0.0001604003,0.00013891101],"about_ca_topic_score_codex":0.00018233477,"about_ca_topic_score_gemma":0.0006206215,"teacher_disagreement_score":0.007767112,"about_ca_system_score_codex":0.00037059243,"about_ca_system_score_gemma":0.0003031456,"threshold_uncertainty_score":0.6861414},"labels":[],"label_agreement":null},{"id":"W2167614636","doi":"10.1016/j.ijgo.2005.08.014","title":"Gasless laparoscopic management of ovarian cysts during pregnancy","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cyst; Pregnancy; Surgery; Cystectomy; Laparoscopy; Cyst; Bladder cancer","score_opus":0.014992461399078621,"score_gpt":0.29550050587092414,"score_spread":0.2805080444718455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167614636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847359,0.0042439583,0.00013174128,0.003787949,0.002822021,0.00019701013,0.000011708789,0.000009738988,0.0040599825],"genre_scores_gemma":[0.99201864,0.0022812632,0.0046938714,0.00013648266,0.00023329606,0.000008526034,0.000004245866,0.000013721189,0.00060993654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985531,0.000027584985,0.00063132774,0.00013887738,0.0004830184,0.00016607105],"domain_scores_gemma":[0.9984307,0.00029219527,0.00051149674,0.00015267383,0.0005121615,0.000100737794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091526395,0.00011906078,0.0003393799,0.00039792195,0.00002626203,0.00001342943,0.00024604797,0.00008000296,0.00031495138],"category_scores_gemma":[0.00018033046,0.00010206833,0.00016221414,0.00019155168,0.000043853655,0.00011968125,0.000068013396,0.00016524729,0.000018541183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006226314,0.0051557473,0.7056948,0.00044548383,0.006294539,0.012249285,0.00073753926,0.00075635687,0.0011178862,0.008327829,0.0010879993,0.25750992],"study_design_scores_gemma":[0.014382826,0.0006940677,0.9575055,0.0012212652,0.0005820254,0.0010584674,0.00015919907,0.000042208594,0.012460185,0.00020058543,0.011548524,0.00014514329],"about_ca_topic_score_codex":0.0000034217153,"about_ca_topic_score_gemma":0.000003727999,"teacher_disagreement_score":0.25736478,"about_ca_system_score_codex":0.00057688897,"about_ca_system_score_gemma":0.0001008642,"threshold_uncertainty_score":0.41622257},"labels":[],"label_agreement":null},{"id":"W2168152495","doi":"10.1016/s1701-2163(16)32460-4","title":"The Prevalence of Incidental Simple Ovarian Cysts ≥ 3 cm Detected by Transvaginal Sonography in Early Pregnancy","year":2007,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; Mount Sinai Hospital; Health Sciences Centre; London Health Sciences Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Asymptomatic; Pregnancy; Cyst; Population; Gestation; Ovarian cyst; Gestational age; Gynecology; Obstetrics; Surgery","score_opus":0.007309960730388815,"score_gpt":0.23322358782312677,"score_spread":0.22591362709273796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168152495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970166,0.027859936,0.000037520284,0.000324217,0.0012274558,0.00019525496,0.00003246586,0.0000015521132,0.00015557575],"genre_scores_gemma":[0.9983407,0.0013904511,0.00014822492,0.00006297222,0.000012360101,0.000003351878,0.0000012885025,0.000008177006,0.000032438053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986888,0.000041621268,0.0005676665,0.00011912262,0.00031139416,0.00027136898],"domain_scores_gemma":[0.9978519,0.0013323168,0.00033719634,0.00011989748,0.00018329237,0.00017537747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030601714,0.00011265186,0.00029374927,0.00020363987,0.00007341563,0.000011413939,0.00011628921,0.0000817454,0.000062184525],"category_scores_gemma":[0.0004318561,0.000078718076,0.00006821417,0.00045813175,0.000082930805,0.000052188156,0.000014602531,0.00025790854,8.564814e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031168078,0.00014580828,0.92293143,0.000082683335,0.00012724978,0.0013947913,0.00013580114,0.0000016759917,0.000039456092,0.000034771394,0.00028190078,0.07479325],"study_design_scores_gemma":[0.0034272152,0.0009895159,0.9926888,0.000042510314,0.00013612879,0.00007247456,0.00010936434,0.000005601539,0.0005061953,0.00006973384,0.0018868783,0.000065611275],"about_ca_topic_score_codex":0.016613914,"about_ca_topic_score_gemma":0.06390905,"teacher_disagreement_score":0.07472763,"about_ca_system_score_codex":0.0005359305,"about_ca_system_score_gemma":0.0007780006,"threshold_uncertainty_score":0.98993456},"labels":[],"label_agreement":null},{"id":"W2168681897","doi":"10.1016/j.mehy.2011.07.043","title":"Src inhibitors are promising therapy molecules for human cervical carcinomas","year":2011,"lang":"en","type":"article","venue":"Medical Hypotheses","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Cervical cancer; Cancer; Medicine; Proto-oncogene tyrosine-protein kinase Src; Oncology; Src family kinase; Cervical carcinoma; Internal medicine; Cancer research; Bioinformatics; Biology; Receptor","score_opus":0.11418297286919914,"score_gpt":0.3110565723143109,"score_spread":0.19687359944511174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168681897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98729044,0.0019796202,0.00022056312,0.0033561836,0.00023267514,0.0009618826,0.000015102334,0.00011719046,0.0058263605],"genre_scores_gemma":[0.9957432,0.00012409811,0.0014409863,0.0015913525,0.0005774292,0.00027108134,0.000011630832,0.000046292018,0.00019393525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852026,0.000040561557,0.000286824,0.0003525403,0.0004701313,0.0003297091],"domain_scores_gemma":[0.99903435,0.00015296847,0.0000801027,0.00027961234,0.00007482482,0.000378158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019844585,0.00019733905,0.00038489417,0.000070656126,0.00012087122,0.000016190203,0.00011908278,0.00016320836,0.0013891378],"category_scores_gemma":[0.00018760128,0.00013458043,0.00018726607,0.00009133028,0.00015981028,0.000037032656,0.000031471238,0.00014595482,0.000023223456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014236589,0.0075749243,0.72253394,0.0006488231,0.0011014082,0.0014326923,0.0047859843,2.6361693e-7,0.0022236586,0.010923515,0.014823837,0.23252732],"study_design_scores_gemma":[0.013230729,0.0037005595,0.8157751,0.0014680106,0.0003644558,0.0001419231,0.00087292586,0.00007151434,0.10423398,0.007895966,0.051606566,0.00063829444],"about_ca_topic_score_codex":0.00022255555,"about_ca_topic_score_gemma":0.00005520995,"teacher_disagreement_score":0.23188902,"about_ca_system_score_codex":0.000075556185,"about_ca_system_score_gemma":0.0001361402,"threshold_uncertainty_score":0.9995237},"labels":[],"label_agreement":null},{"id":"W2168814113","doi":"10.1016/j.critrevonc.2006.11.009","title":"Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Paclitaxel; Regimen; Chemotherapy; Oncology; Internal medicine; Randomized controlled trial; Stage (stratigraphy); Cancer; Cisplatin","score_opus":0.19755678368570986,"score_gpt":0.5193243633535761,"score_spread":0.3217675796678663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168814113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063197534,0.9706904,0.00005464987,0.017345496,0.0010481625,0.0072846166,0.00026605686,0.00007595247,0.0031714474],"genre_scores_gemma":[0.0001349033,0.98334837,0.003675889,0.004711923,0.00032998342,0.0071367323,0.00022797646,0.00016865724,0.0002655417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99171025,0.00091209245,0.0036260665,0.0017999329,0.0003965886,0.0015550536],"domain_scores_gemma":[0.99332315,0.0040679886,0.00059180235,0.0012003895,0.00016854769,0.00064812624],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012840055,0.0014362168,0.012295552,0.0007308415,0.00010849655,0.000029393812,0.00034703102,0.0020260527,0.0031660662],"category_scores_gemma":[0.0019093922,0.0010737715,0.0010993769,0.0009410751,0.00078827795,0.00008843064,0.00011397479,0.0015239558,0.00014459112],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056661316,0.0026131263,0.00046358112,0.015872182,0.00036982098,0.0076284697,0.00017886079,5.1177625e-7,2.9581278e-7,0.015693722,0.001009381,0.9556034],"study_design_scores_gemma":[0.0078338785,0.0036863624,0.000031297033,0.036803238,0.0013540945,0.001434082,0.00005508573,0.000003760412,0.000026084024,0.00038911976,0.94768894,0.00069404213],"about_ca_topic_score_codex":0.00039657252,"about_ca_topic_score_gemma":0.0048163915,"teacher_disagreement_score":0.9549094,"about_ca_system_score_codex":0.0067246747,"about_ca_system_score_gemma":0.0037766572,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W2168932004","doi":"10.1093/annonc/mdu300.1","title":"Emerging Molecular Targets in Gynaecological Cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Gynaecological cancer; Cancer; Oncology; Internal medicine","score_opus":0.056015479729446586,"score_gpt":0.40925738928241695,"score_spread":0.35324190955297036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168932004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9137861,0.0022986874,0.00008989105,0.04634322,0.00026901398,0.00024342228,0.000004136656,0.000016271744,0.036949273],"genre_scores_gemma":[0.99342513,0.0008170632,0.0004921082,0.005046022,0.00006337076,0.00008287423,0.0000045501397,0.0000076853,0.00006119831],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99923027,0.00006952509,0.000217731,0.00017731996,0.000090213616,0.00021496402],"domain_scores_gemma":[0.9995472,0.00009903053,0.00007604743,0.00013144706,0.00007056402,0.00007573543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022172579,0.00008069992,0.00036951396,0.000080578175,0.000012140319,0.0000014499132,0.00004778256,0.0001037389,0.00078700203],"category_scores_gemma":[0.000103972,0.0000645169,0.00007411038,0.00010775356,0.000049287628,0.000017784443,0.000026391323,0.00009289466,0.0000145414815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018728436,0.0016434318,0.19150919,0.000059589456,0.0001771156,0.00040295027,0.00024067007,0.00019820224,0.0017609653,0.006329806,0.0066826926,0.7908081],"study_design_scores_gemma":[0.0034303304,0.0040913126,0.6710009,0.000054536296,0.000065243774,0.000012042111,0.000038803948,0.00022282901,0.019598532,0.0016177145,0.2997483,0.000119439566],"about_ca_topic_score_codex":0.0001964302,"about_ca_topic_score_gemma":0.00012063077,"teacher_disagreement_score":0.79068863,"about_ca_system_score_codex":0.00006422591,"about_ca_system_score_gemma":0.00011533236,"threshold_uncertainty_score":0.86171204},"labels":[],"label_agreement":null},{"id":"W2169044620","doi":"10.3802/jgo.2012.23.2.75","title":"Three ongoing intraperitoneal chemotherapy trials in ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intraperitoneal chemotherapy; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.08828688899847667,"score_gpt":0.41027198192904546,"score_spread":0.32198509293056876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169044620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573415,0.005260262,0.00017722664,0.031074055,0.0026784996,0.00054938695,0.0000042115503,0.000010988081,0.0029038521],"genre_scores_gemma":[0.98609275,0.002967943,0.0057375557,0.0031323072,0.0019502834,0.00006227254,0.0000013096777,0.000017823802,0.000037755057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977416,0.00029929134,0.0011693441,0.00014051487,0.000205228,0.00044406534],"domain_scores_gemma":[0.99710506,0.0014959819,0.0008873751,0.00014294674,0.00012294143,0.00024567064],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038403585,0.00017372394,0.001512651,0.00025041038,0.000040468076,0.000011059247,0.00011105651,0.0002830606,0.00259286],"category_scores_gemma":[0.000885895,0.00011494507,0.0002999666,0.0002137522,0.00006943209,0.0001424178,0.000023280843,0.0004372208,0.000014517039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011300994,0.002791332,0.7337403,0.000028356018,0.0005469073,0.0004563201,0.0005953145,0.000016470327,0.0023684246,0.0005135615,0.0052489517,0.25256392],"study_design_scores_gemma":[0.011271977,0.0034853886,0.9087938,0.00009182535,0.0003329186,0.0005230305,0.00017259081,0.000010983643,0.0014518511,0.00042719423,0.07332058,0.00011785843],"about_ca_topic_score_codex":0.00010529912,"about_ca_topic_score_gemma":0.00042748087,"teacher_disagreement_score":0.2524461,"about_ca_system_score_codex":0.0014420756,"about_ca_system_score_gemma":0.0007729617,"threshold_uncertainty_score":0.9983189},"labels":[],"label_agreement":null},{"id":"W2169405034","doi":"10.1186/1479-5876-10-121","title":"Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis","year":2012,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Qatar National Research Fund; Fonds National de la Recherche Luxembourg","keywords":"Ovarian cancer; Metastasis; Peritoneal cavity; Cancer research; Primary tumor; Gene expression profiling; Gene expression; Cancer; Medicine; Transcriptome; Gene; Biology; Internal medicine; Genetics","score_opus":0.028835071185929994,"score_gpt":0.30293277756874054,"score_spread":0.27409770638281056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169405034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97121423,0.013876136,0.0023507234,0.011624074,0.00021045883,0.00016530046,0.00003818664,0.0000054545153,0.0005154222],"genre_scores_gemma":[0.9808595,0.00043621013,0.017819623,0.00022740223,0.00057886576,0.0000031531285,0.000044743556,0.000010687196,0.000019805992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984009,0.000051706334,0.0006779723,0.0001005401,0.000626023,0.00014283413],"domain_scores_gemma":[0.99888253,0.00017415754,0.0003709323,0.00011788507,0.00019143205,0.00026304598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005898522,0.00012764378,0.0008126589,0.00049126364,0.000033527114,0.0000030928184,0.00004488001,0.00005082671,0.0005375837],"category_scores_gemma":[0.000036079142,0.00008197314,0.00020393546,0.00040829848,0.00009641645,0.00015301855,0.0000066751927,0.00012831276,4.839226e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015596214,0.0011792886,0.86397684,0.00022659895,0.0076367618,0.000091296075,0.003975873,0.00015088162,0.09801849,0.0004164342,0.000777545,0.021990376],"study_design_scores_gemma":[0.003748603,0.0004783752,0.9750903,0.00030972477,0.008285608,0.00021826806,0.0001586549,0.000050050123,0.0109148845,0.000070511196,0.0006048799,0.00007009207],"about_ca_topic_score_codex":0.000023283217,"about_ca_topic_score_gemma":0.0000017551364,"teacher_disagreement_score":0.11111351,"about_ca_system_score_codex":0.000047400375,"about_ca_system_score_gemma":0.00009549852,"threshold_uncertainty_score":0.5886165},"labels":[],"label_agreement":null},{"id":"W2169429264","doi":"10.1016/s1470-2045(11)70333-3","title":"Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada); Université de Montréal; McGill University Health Centre","funders":"Biotechnology and Biological Sciences Research Council; Canadian Institutes of Health Research; Fondation Cancer","keywords":"Dove; Ovarian cancer; Prospective cohort study; Medicine; Gynecology; Oncology; Cancer; Internal medicine; Political science","score_opus":0.07418821961832656,"score_gpt":0.3901691244541551,"score_spread":0.3159809048358285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169429264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743012,0.0007363832,0.00005744057,0.01586321,0.00043701107,0.0031071203,0.0010401509,0.00002554029,0.004431905],"genre_scores_gemma":[0.99062955,0.00057447713,0.0017499708,0.0007674707,0.0010272792,0.0051424582,0.00002577755,0.00002048075,0.0000625081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852145,0.00021046514,0.00043033846,0.00021616239,0.00020662628,0.00041495528],"domain_scores_gemma":[0.9966796,0.0021181717,0.00044501384,0.0005667204,0.000130213,0.000060264494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010429863,0.00015537074,0.00078782707,0.000033997683,0.000072233925,0.0000071057707,0.00021148194,0.00007011735,0.00007806643],"category_scores_gemma":[0.00017433416,0.00007869298,0.00009201317,0.00018005112,0.00016395382,0.00005068846,0.00006430794,0.00015269789,0.000002619439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002781564,0.0020480535,0.95770705,0.00013728604,0.0015784325,0.0000024760698,0.013163928,0.000006900021,0.00021529473,0.006876151,0.005947998,0.009534858],"study_design_scores_gemma":[0.011095243,0.004268272,0.9730181,0.00016299036,0.00053843093,0.000003323837,0.00061519846,0.000039159426,0.0013755824,0.0009853549,0.007815467,0.00008289755],"about_ca_topic_score_codex":0.0036719984,"about_ca_topic_score_gemma":0.00029000055,"teacher_disagreement_score":0.016328339,"about_ca_system_score_codex":0.00071751466,"about_ca_system_score_gemma":0.00041841337,"threshold_uncertainty_score":0.5550988},"labels":[],"label_agreement":null},{"id":"W2169894506","doi":"10.7326/0003-4819-133-7-200010030-00009","title":"High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Ovarian Cancer: An Autologous Blood and Marrow Transplant Registry Report","year":2000,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Internal medicine; Transplantation; Surgery; Oncology; Chemotherapy; Hematopoietic stem cell transplantation; Ovarian cancer; Proportional hazards model; Cohort; Autotransplantation; Cancer","score_opus":0.025345699254505777,"score_gpt":0.31426755076782215,"score_spread":0.2889218515133164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169894506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97701293,0.004813317,0.00013652095,0.016430462,0.00015365124,0.00059120863,0.0001475806,0.000041001604,0.00067332387],"genre_scores_gemma":[0.9742196,0.02156457,0.0006171871,0.0020828308,0.0002498681,0.00009499356,0.0000883878,0.000030544135,0.0010520071],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99846286,0.000035484696,0.00057313376,0.0004479029,0.00022389206,0.00025673272],"domain_scores_gemma":[0.9990321,0.00010353641,0.00022892101,0.0002781286,0.00011267756,0.00024462843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027998321,0.000247336,0.0006670776,0.00009722234,0.000053440028,0.000009919296,0.00007934582,0.00013091939,0.00032009342],"category_scores_gemma":[0.0000075641406,0.00018359559,0.00007159979,0.000070370974,0.00020386575,0.0000816259,0.0000033840308,0.00013002801,5.82457e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015687233,0.0018665505,0.10747606,0.0026951318,0.0019676983,0.0068730954,0.005752863,0.000017829565,0.019682107,0.000655629,0.003766607,0.8335592],"study_design_scores_gemma":[0.037872,0.01756143,0.7682847,0.0050975597,0.0031512321,0.015149572,0.00031968224,0.00026645345,0.14118557,0.00076194544,0.009710659,0.0006392417],"about_ca_topic_score_codex":0.0029966338,"about_ca_topic_score_gemma":0.00013409452,"teacher_disagreement_score":0.83291996,"about_ca_system_score_codex":0.000015880445,"about_ca_system_score_gemma":0.000081795355,"threshold_uncertainty_score":0.74868107},"labels":[],"label_agreement":null},{"id":"W2169927269","doi":"10.1002/ijc.20242","title":"Association of cigarette smoking with the risk of ovarian cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Medicine; Odds ratio; Confidence interval; Ovarian cancer; Internal medicine; Case-control study; Population; Gynecology; Cancer; Gastroenterology; Environmental health","score_opus":0.009387575069821574,"score_gpt":0.2964246652002969,"score_spread":0.28703709013047535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169927269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501545,0.0043005203,0.00033905363,0.043690734,0.000818787,0.000116448864,0.000098239114,0.0000029769333,0.00047877338],"genre_scores_gemma":[0.99568444,0.0030384713,0.00017393114,0.00044082446,0.00055076095,0.00001168344,0.0000013848714,0.000009742995,0.00008873028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986885,0.000023013266,0.00032525026,0.00006954349,0.0008121604,0.00008154242],"domain_scores_gemma":[0.9976164,0.00007812066,0.0011343091,0.00007968165,0.0010534475,0.00003802319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026213168,0.00007534932,0.00021951654,0.000085294414,0.000019801806,0.000010526572,0.00012936637,0.00003979138,0.00025378924],"category_scores_gemma":[0.000045472287,0.000042571224,0.00013002504,0.00009737165,0.00003499351,0.00008102079,0.000012641587,0.00017213938,2.6779878e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007507927,0.00022132223,0.95118463,0.000016842601,0.008449474,0.000032169373,0.00073073135,0.009574976,0.00028129507,0.0006905497,0.0015600168,0.026507182],"study_design_scores_gemma":[0.0067500523,0.00032457814,0.9628021,0.0011242972,0.0016543929,0.00003111893,0.00009467654,0.000013063901,0.019873992,0.0002863729,0.0069836522,0.00006167217],"about_ca_topic_score_codex":0.0014699308,"about_ca_topic_score_gemma":0.0006172822,"teacher_disagreement_score":0.045530003,"about_ca_system_score_codex":0.0008043639,"about_ca_system_score_gemma":0.0004867575,"threshold_uncertainty_score":0.2778814},"labels":[],"label_agreement":null},{"id":"W2169962529","doi":"10.1093/annonc/mds538","title":"A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hôtel-Dieu de Québec","funders":"Medical Research Council","keywords":"Nomogram; Medicine; Confidence interval; Oncology; Ovarian cancer; Internal medicine; Chemotherapy; Multivariate analysis; Multivariate statistics; Metastasis; Cancer; Statistics","score_opus":0.051415355228568674,"score_gpt":0.3561148298264661,"score_spread":0.3046994745978974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169962529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905166,0.00019194158,0.000013216276,0.0043527014,0.00041490173,0.0011701116,0.000100230376,0.000015561802,0.0032247363],"genre_scores_gemma":[0.99773866,0.000076489836,0.00055181916,0.0010884806,0.00019350187,0.00024465736,0.000052918662,0.00001901806,0.00003447655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987079,0.000087502434,0.00029667802,0.00023464626,0.00023773448,0.00043551924],"domain_scores_gemma":[0.9990203,0.00015983204,0.00013801496,0.00017778973,0.00025179994,0.00025229043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021560933,0.00016245361,0.00049689505,0.00013304921,0.000020530342,0.000003857563,0.000046165795,0.00009856787,0.000105155996],"category_scores_gemma":[0.00009444507,0.00012225226,0.000056851375,0.00020262004,0.000050228755,0.00007138833,0.000038204456,0.00013520973,0.000013856309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019188863,0.0035365399,0.9100466,0.000034801607,0.00023308682,0.00002401299,0.00093947345,0.000015256329,0.0000047321514,0.00021283144,0.0016333256,0.08140045],"study_design_scores_gemma":[0.0050124354,0.009215334,0.97430146,0.0002868817,0.00011263487,0.0000030416259,0.000043154752,0.000008126818,0.0001839913,0.000013297388,0.010706155,0.00011348812],"about_ca_topic_score_codex":0.00055438303,"about_ca_topic_score_gemma":0.00048753776,"teacher_disagreement_score":0.08128696,"about_ca_system_score_codex":0.00017452813,"about_ca_system_score_gemma":0.00025196775,"threshold_uncertainty_score":0.49853024},"labels":[],"label_agreement":null},{"id":"W2170115437","doi":"10.3747/co.2007.144","title":"Cancer Antigen 125 in Ovarian Cancer Surveillance: A Decision Analysis Model","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Cancer antigen; Oncology; Gynecology; Internal medicine","score_opus":0.09929037168489387,"score_gpt":0.4657019151391671,"score_spread":0.36641154345427324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170115437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96178126,0.021367442,0.009833614,0.0027115145,0.0014981414,0.0006197744,0.00009510551,0.00004026222,0.0020528943],"genre_scores_gemma":[0.9844358,0.013532002,0.0010125461,0.0003184654,0.00032917166,0.00019896058,0.000053182906,0.000020533587,0.000099366465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813306,0.00004874366,0.0005027663,0.0005277646,0.00027813637,0.000509542],"domain_scores_gemma":[0.9989421,0.00018618707,0.00014793215,0.0003445434,0.00015426312,0.00022500895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005735986,0.0002136037,0.0007590801,0.000542503,0.000053659332,0.000010628777,0.00010802506,0.00017292197,0.0005841146],"category_scores_gemma":[0.00004672695,0.00017729576,0.00021308367,0.0011896436,0.00005992277,0.000047995516,0.000052185955,0.00025938483,0.00001805511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032264538,0.00074334047,0.69749415,0.00001769644,0.00031450434,0.00006995681,0.00024088586,0.0020064414,0.000055868288,0.000110381174,0.0012906435,0.2973335],"study_design_scores_gemma":[0.0041034436,0.00015639179,0.9369413,0.00011444042,0.0005081618,0.0000046183313,0.000037640788,0.0109337745,0.00015482277,0.00015204797,0.046713322,0.00018000901],"about_ca_topic_score_codex":0.0011557714,"about_ca_topic_score_gemma":0.0214402,"teacher_disagreement_score":0.2971535,"about_ca_system_score_codex":0.001552766,"about_ca_system_score_gemma":0.00064971455,"threshold_uncertainty_score":0.996416},"labels":[],"label_agreement":null},{"id":"W2170133015","doi":"10.1186/1471-2407-8-152","title":"Characterization of three new serous epithelial ovarian cancer cell lines","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Institute of Cancer Research; Institut Du Cancer de Montréal; Université de Montréal; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Biology; Ovarian cancer; Somatic cell; Serous fluid; Cancer research; Cell culture; Pathology; Stromal cell; Population; Germline mutation; Germline; Cancer; Medicine; Mutation; Genetics; Gene","score_opus":0.04573630255713032,"score_gpt":0.2821631486496458,"score_spread":0.2364268460925155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170133015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925837,0.0027181187,0.00079962856,0.0013962804,0.000787124,0.0005120879,0.00019413297,0.000046485526,0.00096246845],"genre_scores_gemma":[0.9845796,0.006723975,0.0010518775,0.0005369995,0.0019489262,0.0001991806,0.000058519498,0.000043197037,0.0048577315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990107,0.000013073762,0.0002715945,0.00026971972,0.00023137325,0.00020353902],"domain_scores_gemma":[0.9992711,0.000019435969,0.0001613992,0.00027268118,0.00013163297,0.00014373373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000033677457,0.00016708071,0.00034164512,0.000042874835,0.00005610292,0.000007003091,0.00006608217,0.00008617478,0.002029358],"category_scores_gemma":[0.000007650713,0.00013752347,0.00011193352,0.00016302985,0.000041240222,0.00009798719,0.000021835072,0.00006572926,0.000021365497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007042063,0.00060063874,0.8318266,0.0003104498,0.00024202684,0.000040599458,0.0009908187,0.00010018881,0.12707648,0.00012524784,0.0037396022,0.03424311],"study_design_scores_gemma":[0.003850785,0.00018092453,0.8404699,0.00022077298,0.00025851003,0.000015237848,0.000009765334,0.00011181146,0.13542305,0.000020607822,0.019273618,0.00016502738],"about_ca_topic_score_codex":0.014950617,"about_ca_topic_score_gemma":0.0067023886,"teacher_disagreement_score":0.03407808,"about_ca_system_score_codex":0.00023984139,"about_ca_system_score_gemma":0.0009752243,"threshold_uncertainty_score":0.99888295},"labels":[],"label_agreement":null},{"id":"W2170220266","doi":"10.1158/1535-7163.mct-07-2117","title":"Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paclitaxel; Clonogenic assay; In vivo; Ovarian cancer; Chemotherapy; Medicine; Apoptosis; Cancer; Cancer research; Internal medicine; Oncology; Biology","score_opus":0.026150746924365,"score_gpt":0.30451623315443827,"score_spread":0.2783654862300733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170220266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820547,0.014260135,0.00011935503,0.002439324,0.00015017878,0.00083359407,0.000007657487,0.00001718756,0.000117885495],"genre_scores_gemma":[0.98841655,0.007888886,0.00015038485,0.0030789226,0.000053326123,0.00030145652,0.000005766785,0.00003726901,0.000067453686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888796,0.00006553372,0.00028236868,0.00030626435,0.00023913232,0.00021876374],"domain_scores_gemma":[0.99941754,0.000047826208,0.0001280483,0.00025570559,0.00007914289,0.00007175211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066079134,0.00019824812,0.00036338106,0.00013081745,0.000038749673,0.00000680935,0.000048144866,0.000067253466,0.000024282526],"category_scores_gemma":[0.000009145238,0.00016088483,0.00008884485,0.0002063694,0.000073661446,0.000029558301,0.000016118904,0.0001302601,6.746692e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027723133,0.002132518,0.67288387,0.00056956563,0.0013942113,0.002318347,0.003942305,0.00024043836,0.157705,0.0016586573,0.0000950443,0.15428773],"study_design_scores_gemma":[0.007626223,0.000891673,0.7669569,0.00047705718,0.00016593363,0.000025397523,0.000047350743,0.00018490483,0.22189339,0.00020774674,0.0013336192,0.00018978793],"about_ca_topic_score_codex":0.00097092235,"about_ca_topic_score_gemma":0.00005446817,"teacher_disagreement_score":0.15409794,"about_ca_system_score_codex":0.00029001475,"about_ca_system_score_gemma":0.00015887577,"threshold_uncertainty_score":0.6560693},"labels":[],"label_agreement":null},{"id":"W2170845869","doi":"10.1016/s0959-8049(01)00188-5","title":"A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer","year":2002,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Neutropenia; Internal medicine; Tolerability; Gastroenterology; Toxicity; Regimen; Febrile neutropenia; Surgery; Chemotherapy; Adverse effect","score_opus":0.022079824404099866,"score_gpt":0.2601823772802902,"score_spread":0.23810255287619034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170845869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912361,0.0012207344,0.000020240434,0.0017270668,0.0013020175,0.00069963414,0.00003138874,0.000007003446,0.0037558295],"genre_scores_gemma":[0.997789,0.0008938539,0.00038555168,0.00013804814,0.00054356694,0.000015572547,0.000001894458,0.000043390923,0.00018910498],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99815524,0.00023530102,0.000704302,0.00017314941,0.0004987341,0.00023327426],"domain_scores_gemma":[0.99870515,0.000058629605,0.0005849251,0.00019793272,0.00028140153,0.00017195201],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004130054,0.00018155534,0.00062566006,0.00017347939,0.000029943125,0.000014692495,0.00012180962,0.000031410902,0.0011058584],"category_scores_gemma":[0.0000749257,0.00012551951,0.00016361434,0.00022742724,0.00007009471,0.00008457241,0.000015488917,0.00027587317,0.0000060585417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68093675,0.0021934493,0.026223332,0.000044775672,0.001128226,0.00059361564,0.0014408729,0.00029649702,0.00007867732,0.000018716673,0.0014861318,0.28555897],"study_design_scores_gemma":[0.8179703,0.009884748,0.16177286,0.00059452606,0.0006054549,0.000006488124,0.000032747143,0.0000165742,0.00041852213,0.0000030028493,0.00854354,0.00015129549],"about_ca_topic_score_codex":0.00018795472,"about_ca_topic_score_gemma":0.000112605994,"teacher_disagreement_score":0.2854077,"about_ca_system_score_codex":0.00031952313,"about_ca_system_score_gemma":0.00019285208,"threshold_uncertainty_score":0.99980724},"labels":[],"label_agreement":null},{"id":"W2171614210","doi":"","title":"Surgical outcomes in women with ovarian cancer.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Specialty; Perioperative; Ovarian cancer; Stage (stratigraphy); Cancer registry; Disease; Population; Cancer; General surgery; Surgery; Internal medicine; Family medicine","score_opus":0.027076062275140658,"score_gpt":0.25199722650012074,"score_spread":0.2249211642249801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171614210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415506,0.00032225667,9.1837285e-7,0.00771048,0.0000854612,0.0006670155,0.000007900766,0.000036898065,0.0070140157],"genre_scores_gemma":[0.9901541,0.00038523212,0.00006537514,0.00056373415,0.00008993053,0.0069085294,0.000002480959,0.000015261847,0.0018153454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990552,0.000015496327,0.00013895586,0.00021297314,0.00018683315,0.00039051307],"domain_scores_gemma":[0.9995282,0.00003804297,0.000030314382,0.00017959594,0.000020231857,0.000203568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008410797,0.00011176944,0.00030958306,0.00007054487,0.00003206649,0.0000062016406,0.000038791688,0.000040759867,0.00017131744],"category_scores_gemma":[0.000010336728,0.00007227958,0.000030060351,0.00018472601,0.00004749618,0.000042098844,0.000012911803,0.000088455155,0.000009140337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004479081,0.0003977519,0.9362005,0.000010906343,0.00012853529,0.0014955972,0.000250742,0.000004629257,1.702889e-7,0.000076491495,0.00037139672,0.060615372],"study_design_scores_gemma":[0.0059945663,0.00008265721,0.9754735,0.000014727564,0.000023407627,0.000109755674,0.000025608964,0.000001379852,0.000043779917,0.0000130694325,0.018133707,0.00008379798],"about_ca_topic_score_codex":0.00050310366,"about_ca_topic_score_gemma":0.00012210022,"teacher_disagreement_score":0.060531575,"about_ca_system_score_codex":0.00042749298,"about_ca_system_score_gemma":0.000094426236,"threshold_uncertainty_score":0.2947476},"labels":[],"label_agreement":null},{"id":"W2174752725","doi":"10.1097/pgp.0000000000000251","title":"Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Centre Hospitalier de l’Université de Montréal; University of Calgary; Université de Montréal","funders":"","keywords":"Immunohistochemistry; Staining; Tissue microarray; Pathology; Ovarian carcinoma; Biology; Carcinoma; clone (Java method); Medicine; Cancer; Ovarian cancer; Internal medicine; Gene; Genetics","score_opus":0.03738511758811537,"score_gpt":0.3178282610876944,"score_spread":0.28044314349957905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174752725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98514766,0.0020311333,0.010008237,0.0021240744,0.0003117632,0.00015658751,0.000022888587,0.000003328597,0.00019435506],"genre_scores_gemma":[0.97640455,0.00015196462,0.023156712,0.00015406385,0.000088840236,0.00000725458,0.000017603154,0.000005378853,0.000013625741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992022,0.000035979436,0.00042623858,0.00011174916,0.00015328889,0.00007053305],"domain_scores_gemma":[0.9986129,0.00022124121,0.00041470706,0.000060579936,0.00061400735,0.00007656272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029028428,0.00007476347,0.00029476866,0.000088471854,0.000014054524,0.0000053268714,0.00006883578,0.00010787638,0.00002435529],"category_scores_gemma":[0.00079711294,0.00005867962,0.00005800297,0.000034506895,0.00012151198,0.000064341744,0.000037414407,0.000074808886,5.4029307e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008614198,0.0031225139,0.7873184,0.00037598363,0.0011424237,0.0018112467,0.002041756,0.005443048,0.14731246,0.004853061,0.0030645793,0.034900337],"study_design_scores_gemma":[0.026657203,0.012318563,0.9099795,0.0004401746,0.00074269756,0.007751314,0.000520578,0.012910306,0.021991115,0.0050847726,0.0012484868,0.0003552579],"about_ca_topic_score_codex":0.000009894681,"about_ca_topic_score_gemma":0.0000016040815,"teacher_disagreement_score":0.12532134,"about_ca_system_score_codex":0.00014969845,"about_ca_system_score_gemma":0.00016752272,"threshold_uncertainty_score":0.23928855},"labels":[],"label_agreement":null},{"id":"W2181062692","doi":"10.1158/1055-9965.1521.13.9","title":"A Case-Control Study of Diet and the Risk of Ovarian Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Quartile; Medicine; Odds ratio; Ovarian cancer; Case-control study; Confidence interval; Cruciferous vegetables; Polyunsaturated fatty acid; Population; Vitamin E; Gynecology; Cancer; Internal medicine; Physiology; Biology; Environmental health; Fatty acid","score_opus":0.039163118834153784,"score_gpt":0.3535212207823937,"score_spread":0.3143581019482399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181062692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668104,0.023767242,0.00076496706,0.0060115336,0.00033202217,0.0021304407,0.00010627606,0.000016004396,0.00006110863],"genre_scores_gemma":[0.993433,0.0048218137,0.00053646846,0.00023768142,0.00009651088,0.00082324946,0.000004994785,0.000015099956,0.000031166128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976536,0.00091595534,0.0007262282,0.00037637394,0.00009862704,0.00022923244],"domain_scores_gemma":[0.9979371,0.00078349706,0.00071411463,0.00037464083,0.000104390056,0.000086284745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020523893,0.00018463147,0.00088406645,0.00008604439,0.00009494891,0.0000022222443,0.00006591912,0.00012348511,0.00011415874],"category_scores_gemma":[0.00032940798,0.000113689435,0.00022153421,0.00017135865,0.00039831284,0.00004586649,0.000032699358,0.00013959507,7.496546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059460644,0.00077672006,0.95525837,0.00010954693,0.005958847,0.00006437468,0.0008513443,0.00030862069,0.00004089201,0.0008030919,0.00022177407,0.02966035],"study_design_scores_gemma":[0.034071706,0.0019673544,0.9521515,0.00034661096,0.0047894833,0.00010207494,0.00056108553,0.00017340641,0.0001032541,0.0055529852,0.00007243081,0.00010810548],"about_ca_topic_score_codex":0.018123655,"about_ca_topic_score_gemma":0.004166458,"teacher_disagreement_score":0.029552246,"about_ca_system_score_codex":0.00017118594,"about_ca_system_score_gemma":0.0001677736,"threshold_uncertainty_score":0.98841476},"labels":[],"label_agreement":null},{"id":"W2181733035","doi":"10.1016/s1701-2163(16)35425-1","title":"Serous Cystadenofibroma of the Ovary","year":2012,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ovary; Serous fluid; Gynecology; Pathology; Internal medicine","score_opus":0.012563076631849947,"score_gpt":0.22850023962354793,"score_spread":0.215937162991698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181733035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97238195,0.01803714,0.000003064389,0.0014799543,0.0068324753,0.00008953626,0.000010063558,8.7905386e-7,0.0011649496],"genre_scores_gemma":[0.9990044,0.00016950333,0.00022333169,0.0004387152,0.00004865865,0.0000010224113,4.2527623e-7,0.0000060884745,0.000107851556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926454,0.000029327022,0.0002795639,0.00004743152,0.00021993405,0.00015923133],"domain_scores_gemma":[0.99870974,0.000601849,0.00028231126,0.00011276471,0.00013756793,0.00015573925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012102162,0.00006938303,0.00025780997,0.000064518856,0.00004178069,0.0000032231292,0.00006194709,0.000055232507,0.00019531698],"category_scores_gemma":[0.0005027754,0.000040603987,0.00006222395,0.0001927099,0.00003872219,0.000037387144,0.000027868507,0.00013718655,2.393679e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004830871,0.00015149434,0.97169226,0.000038516355,0.00020699213,0.0002822645,0.000081749524,0.0000035708042,0.000022653443,0.00023538333,0.0048193717,0.022460938],"study_design_scores_gemma":[0.0013843018,0.00027386262,0.977038,0.000009613402,0.00019600743,0.000237205,0.00009398407,0.00000200348,0.00037070416,0.000029697008,0.020328164,0.000036402627],"about_ca_topic_score_codex":0.005394045,"about_ca_topic_score_gemma":0.0024272033,"teacher_disagreement_score":0.026622467,"about_ca_system_score_codex":0.00051027513,"about_ca_system_score_gemma":0.0010020308,"threshold_uncertainty_score":0.8154218},"labels":[],"label_agreement":null},{"id":"W2183485722","doi":"10.1016/s1701-2163(15)31050-1","title":"Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative","year":2013,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Carboplatin; Taxane; Regimen; Ovarian cancer; Neutropenia; Paclitaxel; Oncology; Internal medicine; Chemotherapy; Febrile neutropenia; Population; Cancer; Surgery; Urology; Cisplatin; Breast cancer","score_opus":0.01738115585109725,"score_gpt":0.26169696392845704,"score_spread":0.24431580807735978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183485722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981402,0.009007106,0.000048828624,0.0048387004,0.002970062,0.0010097225,0.00007992245,0.0000048831125,0.0006387735],"genre_scores_gemma":[0.9951831,0.0009259722,0.002750482,0.00048530285,0.0000669662,0.00016975058,0.0000048735533,0.000021431288,0.00039210622],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989392,0.000024581856,0.00034696542,0.00019044621,0.00021885664,0.0002799588],"domain_scores_gemma":[0.9976232,0.0010625824,0.00037715508,0.00012973312,0.00049246347,0.00031488654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006261275,0.00018834812,0.0005320998,0.00014556065,0.000091445225,0.000024764104,0.00005459544,0.00006654301,0.00033097962],"category_scores_gemma":[0.00028324142,0.00012070452,0.00007381181,0.00018807483,0.00004095733,0.00007751768,0.000010636408,0.00011710579,5.1858365e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020438759,0.00069635134,0.36536422,0.000103442144,0.0024094556,0.0029491666,0.0004438831,0.00041676927,0.00006647367,0.00042553133,0.0038482992,0.623072],"study_design_scores_gemma":[0.041423317,0.011831538,0.9126189,0.000070471695,0.0010980214,0.00023244745,0.00078041333,0.00035487962,0.0009145286,0.00037581255,0.029970547,0.00032916272],"about_ca_topic_score_codex":0.09277786,"about_ca_topic_score_gemma":0.07356239,"teacher_disagreement_score":0.62274283,"about_ca_system_score_codex":0.0026008454,"about_ca_system_score_gemma":0.0025586078,"threshold_uncertainty_score":0.9433427},"labels":[],"label_agreement":null},{"id":"W2184564633","doi":"10.1016/s1701-2163(16)34101-9","title":"The Significance of Duration of Chemotherapy Interruptions Due to Interval Surgery in Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy","year":2009,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Surgery; Ovarian cancer; Retrospective cohort study; Stage (stratigraphy); Cancer; Internal medicine; Oncology","score_opus":0.01184664759154364,"score_gpt":0.24797461315465924,"score_spread":0.2361279655631156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184564633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326384,0.0009432539,0.0000268157,0.0047546937,0.00065629446,0.00027805357,0.0000168279,9.620617e-7,0.00005928115],"genre_scores_gemma":[0.99861735,0.0006071271,0.000122005746,0.00059551845,0.000014821985,0.0000090080175,0.0000025745696,0.000007507673,0.000024115032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989198,0.000037207472,0.0005827196,0.00010697216,0.00020769995,0.00014563369],"domain_scores_gemma":[0.9982384,0.00069771806,0.0004915659,0.00010547977,0.00036828287,0.00009858137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016211961,0.00010596719,0.00046309739,0.00019167285,0.00003354716,0.0000072174334,0.000061701525,0.000049633814,0.0000645674],"category_scores_gemma":[0.00027178932,0.000064965316,0.000052902145,0.00041962418,0.000039718445,0.00003727649,0.0000046079062,0.00011626402,3.8895095e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020599029,0.00044053554,0.7791161,0.000018213324,0.0001908102,0.00016438303,0.00023173155,0.000042803007,0.00010178829,0.000026604725,0.0006353597,0.2188257],"study_design_scores_gemma":[0.0032694577,0.0015210933,0.9923527,0.00006251687,0.0000516484,0.000009932533,0.00008941254,0.000020418336,0.0016855042,0.000015000637,0.0008649209,0.000057351834],"about_ca_topic_score_codex":0.013519423,"about_ca_topic_score_gemma":0.043652497,"teacher_disagreement_score":0.21876834,"about_ca_system_score_codex":0.000730509,"about_ca_system_score_gemma":0.0009755521,"threshold_uncertainty_score":0.9930496},"labels":[],"label_agreement":null},{"id":"W2184669274","doi":"10.1016/s1701-2163(16)34175-5","title":"Risk of Malignancy Index in the Evaluation of Patients With Adnexal Masses","year":2009,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Malignancy; Adnexal mass; Referral; Population; Adnexal Diseases; Gynecology; Radiology; Internal medicine; Laparoscopy","score_opus":0.013613658709215742,"score_gpt":0.2511055240373742,"score_spread":0.23749186532815844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184669274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960802,0.0026202216,0.0000036257668,0.00031942056,0.00044435865,0.00017825249,0.000014979587,2.3632163e-7,0.00033869495],"genre_scores_gemma":[0.9995732,0.0001758009,0.00010216075,0.00013326948,0.000006960834,0.00000168277,0.0000021826063,0.00000238004,0.0000023821933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895096,0.000083987696,0.00031924088,0.000058083995,0.0005043147,0.00008339508],"domain_scores_gemma":[0.99829966,0.0005909556,0.00047289414,0.00008280985,0.0005121892,0.000041501262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038567669,0.000060169587,0.00024612065,0.00013623996,0.00001747858,0.0000027192082,0.00004824901,0.000039404687,0.00007694311],"category_scores_gemma":[0.00088229054,0.000033533805,0.000026085072,0.0002599635,0.000022480655,0.000028635506,0.000003949511,0.000115785035,2.1065965e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017407152,0.00029122745,0.9198833,0.000010142118,0.00007614708,0.00007721212,0.00007540907,0.00010995272,2.94894e-7,0.000029781719,0.00016229504,0.0792668],"study_design_scores_gemma":[0.005414743,0.0015135516,0.99213374,0.000016907743,0.00036065353,0.000004815821,0.00013862191,0.00003840238,0.00002243884,0.00013969876,0.00018770227,0.00002874084],"about_ca_topic_score_codex":0.0045232316,"about_ca_topic_score_gemma":0.012757627,"teacher_disagreement_score":0.07923806,"about_ca_system_score_codex":0.00035204177,"about_ca_system_score_gemma":0.0012081054,"threshold_uncertainty_score":0.71190554},"labels":[],"label_agreement":null},{"id":"W2185886254","doi":"10.1016/s1701-2163(15)30790-8","title":"Endometrioid Ovarian Carcinoma During Pregnancy Presenting With Acute Rupture","year":2013,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Gynecology; Pregnancy; Gestation; Ovarian carcinoma; Obstetrics; Abdominal pain; Uterine rupture; Ovarian cancer; Cancer; Surgery; Uterus; Internal medicine","score_opus":0.008459888580360016,"score_gpt":0.21324190624569747,"score_spread":0.20478201766533746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185886254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985889,0.009491131,0.000007886528,0.001272291,0.0018563914,0.0003029948,0.000008576801,0.000003883791,0.0011678351],"genre_scores_gemma":[0.9981568,0.00035785703,0.0008700462,0.0001516359,0.0000490134,0.000014735791,0.0000018141128,0.000016976259,0.00038111716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883485,0.000025785115,0.0003570914,0.00016502605,0.0003174602,0.0002998037],"domain_scores_gemma":[0.99825275,0.00059625314,0.00034160688,0.00014996187,0.00035218548,0.00030726148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004334687,0.00015448038,0.0004263127,0.00027499723,0.00010849239,0.000035682184,0.00008114125,0.00008587442,0.0005023102],"category_scores_gemma":[0.00036360364,0.00010442487,0.00005816455,0.00042472922,0.000035896348,0.0001136683,0.000034894456,0.00029806368,8.3507854e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008759464,0.00012166502,0.9594958,0.00008040234,0.00070015027,0.019436676,0.000088624016,0.0000069088746,0.000033183747,0.000041836876,0.0007202152,0.019265782],"study_design_scores_gemma":[0.005497356,0.0006116678,0.9899795,0.00003109857,0.0004029899,0.0013729627,0.000110559326,0.000014539285,0.00042999815,0.000023621733,0.001420162,0.00010553206],"about_ca_topic_score_codex":0.019110737,"about_ca_topic_score_gemma":0.0058554728,"teacher_disagreement_score":0.030483715,"about_ca_system_score_codex":0.000746392,"about_ca_system_score_gemma":0.0012089506,"threshold_uncertainty_score":0.9874211},"labels":[],"label_agreement":null},{"id":"W2186120210","doi":"10.1016/s1701-2163(16)35322-1","title":"Type-Specific Response to Neoadjuvant Chemotherapy: Ovarian High-Grade Serous Carcinoma Versus Colorectal Mucinous Carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Oncology; Ovarian carcinoma; Mucinous carcinoma; Chemotherapy; Internal medicine; Serous fluid; Carcinoma; Colorectal cancer; Serous carcinoma; Adenocarcinoma; Ovarian cancer; Cancer","score_opus":0.019571951376360672,"score_gpt":0.24309223793004983,"score_spread":0.22352028655368916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186120210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722164,0.008719303,0.000006207996,0.0036938044,0.014807935,0.00029767258,0.000026061467,0.000006595448,0.00022597169],"genre_scores_gemma":[0.9976176,0.00017340561,0.00089970446,0.00091096334,0.00023905766,0.000007637873,0.000005363049,0.000034513752,0.00011176489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823916,0.00011145251,0.00048517433,0.00021945394,0.0004022325,0.0005425088],"domain_scores_gemma":[0.9967565,0.0016269217,0.000269807,0.00023240387,0.00032140967,0.00079297373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035372734,0.00024218111,0.0006164735,0.00032377327,0.00012664768,0.00002511436,0.00012452844,0.0001612918,0.0004940194],"category_scores_gemma":[0.00075604906,0.00019898081,0.000087966546,0.0005414474,0.000047367615,0.000072935356,0.00004223908,0.00032770156,0.000005702681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031911298,0.00085093826,0.90339553,0.000040270148,0.00059859187,0.009517712,0.0011103387,0.000026876067,0.0004791962,0.00024994512,0.017165357,0.06337411],"study_design_scores_gemma":[0.010984749,0.0037692985,0.9297923,0.0000075685057,0.00017229457,0.0003503236,0.00027217774,0.000005698799,0.00074057514,0.000006122399,0.05372225,0.00017666821],"about_ca_topic_score_codex":0.013855988,"about_ca_topic_score_gemma":0.005317434,"teacher_disagreement_score":0.06319744,"about_ca_system_score_codex":0.0029808742,"about_ca_system_score_gemma":0.0019738576,"threshold_uncertainty_score":0.9927108},"labels":[],"label_agreement":null},{"id":"W2186871651","doi":"10.1016/s1701-2163(16)35019-8","title":"Characteristics and Management of Adnexal Masses in a Canadian Pediatric and Adolescent Population","year":2011,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Adnexal mass; Laparotomy; Cystectomy; Presentation (obstetrics); Adnexal Diseases; Surgery; Laparoscopy; Population; Oophorectomy; Hysterectomy; Cancer; Internal medicine","score_opus":0.017635808497452037,"score_gpt":0.22821163396544641,"score_spread":0.2105758254679944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186871651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351877,0.004932092,0.0000010783174,0.00021679305,0.0008924957,0.00012084018,0.000014134614,5.12216e-7,0.0003032768],"genre_scores_gemma":[0.9934492,0.00597995,0.00040110727,0.00013604599,0.000013517038,0.0000016489631,0.0000024014948,0.000004886633,0.000011212874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935544,0.000015067384,0.00029745654,0.000084098,0.0001043835,0.00014356898],"domain_scores_gemma":[0.9993583,0.000097788696,0.0001841612,0.000049486214,0.000068737725,0.00024152642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103811166,0.00007250843,0.0002483306,0.0002754369,0.000023733275,0.000004950169,0.000022910664,0.000049231974,0.000059675083],"category_scores_gemma":[0.00010439959,0.00006150263,0.0000135855225,0.0001468369,0.000016732285,0.000028012277,0.000014714544,0.00009282665,3.8826762e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000061616106,0.00006254349,0.9677046,0.00018865267,0.000047865557,0.0017203715,0.000044780347,2.4322034e-7,1.2822998e-7,0.00014498418,0.00011438968,0.02996528],"study_design_scores_gemma":[0.001431909,0.00025288644,0.9971855,0.00002270043,0.00019539558,0.00004072148,0.00007374348,0.00001139899,0.0000025261265,0.000029421224,0.0007061489,0.000047626203],"about_ca_topic_score_codex":0.34583104,"about_ca_topic_score_gemma":0.48923886,"teacher_disagreement_score":0.1434078,"about_ca_system_score_codex":0.0005391464,"about_ca_system_score_gemma":0.0005021991,"threshold_uncertainty_score":0.6585251},"labels":[],"label_agreement":null},{"id":"W2186978816","doi":"10.1016/s1701-2163(15)31048-3","title":"Optimal Cytoreduction With Neutral Argon Plasma Energy in Selected Patients With Ovarian and Primitive Peritoneal Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Oncology; Internal medicine","score_opus":0.004533136365211079,"score_gpt":0.1913509268460908,"score_spread":0.18681779048087974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186978816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746764,0.00074412045,0.000004917159,0.00072655047,0.00078142056,0.00017045418,0.000011073779,0.0000018535758,0.000091955495],"genre_scores_gemma":[0.99890333,0.00019638854,0.0006378289,0.00015629316,0.00003246178,0.000022257778,0.0000066565613,0.000012128546,0.000032647717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992132,0.000026683414,0.00022527373,0.00015223099,0.00017373284,0.00020887161],"domain_scores_gemma":[0.9989349,0.00019163135,0.00019907561,0.000051453568,0.00042371376,0.0001992161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029383984,0.0001306969,0.00031585246,0.00016955394,0.000052960433,0.00002103067,0.000027509315,0.00007121212,0.00008463589],"category_scores_gemma":[0.00007075507,0.000086063534,0.000012798776,0.00029599576,0.000056372537,0.00010288187,0.000009661295,0.00018617562,5.3920314e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098433076,0.00022913734,0.97287583,0.000017697417,0.0002486389,0.0005541973,0.00012069859,0.0003183093,0.0000058301143,0.000038691906,0.00031168605,0.02518086],"study_design_scores_gemma":[0.0072136503,0.0021244555,0.9892804,0.0000225978,0.0001354492,0.000082482664,0.00014684553,0.00011133277,0.00017453538,0.0000026285043,0.00061116175,0.00009448373],"about_ca_topic_score_codex":0.07888528,"about_ca_topic_score_gemma":0.0936573,"teacher_disagreement_score":0.025086375,"about_ca_system_score_codex":0.0010282396,"about_ca_system_score_gemma":0.0015465239,"threshold_uncertainty_score":0.9272485},"labels":[],"label_agreement":null},{"id":"W2188374514","doi":"10.1017/s1481803500013622","title":"Ovarian torsion in a 20-year-old patient","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Emergency Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University","funders":"","keywords":"Medicine; Ovarian torsion; Presentation (obstetrics); Abdominal pain; Acute abdominal pain; Emergency department; Surgical emergency; General surgery; Lower abdominal pain; Population; Pediatrics; Physical therapy; Surgery; Nursing","score_opus":0.037027461921368215,"score_gpt":0.2958246167810398,"score_spread":0.2587971548596716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188374514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9180638,0.0098796245,0.000033504693,0.027669067,0.008757624,0.0004686579,0.00002063514,0.000008478832,0.035098597],"genre_scores_gemma":[0.99659306,0.00032658462,0.00020486579,0.00030445744,0.0014710256,0.000006522594,0.00001662709,0.000020772977,0.0010560848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830914,0.000036527857,0.0008235677,0.00015650086,0.0002970211,0.00037723995],"domain_scores_gemma":[0.9986253,0.000017462495,0.0002340939,0.0001989532,0.000250055,0.0006741661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002807343,0.0001572772,0.00041429597,0.0005105309,0.00006382163,0.0000030573658,0.000084860236,0.00007695594,0.0074695204],"category_scores_gemma":[0.00012770652,0.000116251395,0.00011446248,0.00044505158,0.00004473724,0.00006978342,0.000005429383,0.00022426003,0.000018108114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011032423,0.00020019911,0.6770001,0.00004933988,0.00008659145,0.0017982468,0.0009934282,0.000044787117,0.00035027575,0.001796136,0.31480297,0.002767566],"study_design_scores_gemma":[0.0062286113,0.0029458178,0.581313,0.001266584,0.0003019164,0.00015658946,0.00092443405,0.000027001339,0.00028786328,0.0010626467,0.40524763,0.00023792229],"about_ca_topic_score_codex":0.06019808,"about_ca_topic_score_gemma":0.11009614,"teacher_disagreement_score":0.095687136,"about_ca_system_score_codex":0.00051745505,"about_ca_system_score_gemma":0.00073995104,"threshold_uncertainty_score":0.99343777},"labels":[],"label_agreement":null},{"id":"W2188377804","doi":"10.1016/s1701-2163(16)35272-0","title":"Optimal Debulking Targets in Women With Advanced Stage Ovarian Cancer: A Retrospective Study of Immediate Versus Interval Debulking Surgery","year":2012,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; University of Manitoba; CancerCare Manitoba; Health Sciences Centre","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Surgery; Stage (stratigraphy); Retrospective cohort study; Fallopian tube cancer; Disease; Survival rate; Cancer; Internal medicine","score_opus":0.01571922998471187,"score_gpt":0.2582214751840241,"score_spread":0.24250224519931224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188377804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885589,0.006270654,0.0000067609503,0.00017510913,0.0046394877,0.00025818674,0.000015356265,0.0000024303336,0.00007314103],"genre_scores_gemma":[0.99903685,0.00046212788,0.00030527683,0.00008361654,0.000052516858,0.000029369101,0.0000010843905,0.000019031993,0.000010129031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983687,0.000066002816,0.0005750769,0.00016713775,0.00037195627,0.0004511402],"domain_scores_gemma":[0.9975725,0.0011473097,0.0006241411,0.00012225844,0.00024709306,0.00028673984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004084478,0.00017610594,0.00080684264,0.00036476532,0.000052666917,0.000009648854,0.00006841105,0.00006733441,0.00016646009],"category_scores_gemma":[0.0007958433,0.00013513178,0.00004231504,0.00047322272,0.00003828823,0.00013942872,0.000038549566,0.00032277472,7.108019e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006002664,0.00073248136,0.9569025,0.00004345105,0.0006606987,0.0020428551,0.0019408889,0.00026395617,0.00000635053,0.000008269347,0.000049941114,0.03674831],"study_design_scores_gemma":[0.011269761,0.0028663569,0.9804847,0.00004737868,0.00017099273,0.000021115755,0.0044363714,0.000018383656,0.000066424735,0.0000018000383,0.00049586827,0.00012082311],"about_ca_topic_score_codex":0.023294847,"about_ca_topic_score_gemma":0.05418809,"teacher_disagreement_score":0.036627486,"about_ca_system_score_codex":0.0040934226,"about_ca_system_score_gemma":0.0016245007,"threshold_uncertainty_score":0.9997297},"labels":[],"label_agreement":null},{"id":"W2190395287","doi":"10.3747/co.20.1471","title":"Salpingectomy to Prevent Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Salpingectomy; Alternative medicine; Family medicine; Cancer; Gynecology; Pathology; Internal medicine; Pregnancy","score_opus":0.10188108667324762,"score_gpt":0.4307352231037321,"score_spread":0.32885413643048444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190395287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8749576,0.008176633,0.0002774582,0.09229094,0.0054291263,0.0035836466,0.000027203225,0.00016757802,0.015089813],"genre_scores_gemma":[0.9912115,0.0008239395,0.0011242311,0.0021249312,0.0009790899,0.00286633,0.000022256181,0.0000277956,0.00081996416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989705,0.00004083323,0.00021619422,0.0003199843,0.00013591374,0.00031654653],"domain_scores_gemma":[0.99919826,0.000046929228,0.000057098332,0.0002566123,0.00011847745,0.000322616],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006908514,0.00014528786,0.00032871266,0.000090338624,0.000044373952,0.000014799484,0.000074170224,0.0000716174,0.0041869287],"category_scores_gemma":[0.000030462788,0.000114299946,0.00008431804,0.0001626436,0.00002814503,0.000043393346,0.00005839597,0.00014497897,0.0011265471],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004140422,0.0021932344,0.07347481,0.000070668146,0.00014970492,0.00002122432,0.0003994957,0.0000049203995,0.0002794014,0.00063082983,0.13867639,0.7840579],"study_design_scores_gemma":[0.0015872398,0.0006590275,0.25328848,0.00014234817,0.00013692483,0.00001591549,0.000029696925,0.000031966003,0.0006831793,0.00016396941,0.7431477,0.00011358229],"about_ca_topic_score_codex":0.00032560356,"about_ca_topic_score_gemma":0.00008814272,"teacher_disagreement_score":0.7839443,"about_ca_system_score_codex":0.0006742481,"about_ca_system_score_gemma":0.0003020232,"threshold_uncertainty_score":0.9996512},"labels":[],"label_agreement":null},{"id":"W2199916845","doi":"10.1016/j.fertnstert.2015.11.034","title":"Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation","year":2015,"lang":"en","type":"article","venue":"Fertility and Sterility","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CReATe Fertility Centre; Women's College Hospital; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Infertility; Medicine; Odds ratio; Confidence interval; BRCA mutation; Gynecology; Ovarian cancer; Fertility; Obstetrics; Oncology; Logistic regression; Cancer; Internal medicine; Pregnancy; Population; Biology; Genetics","score_opus":0.03080354871652963,"score_gpt":0.28477976834282775,"score_spread":0.2539762196262981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199916845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975616,0.00026213218,0.0000359736,0.0006327373,0.000059312846,0.0007210551,0.000471046,0.00002096825,0.00023521538],"genre_scores_gemma":[0.99921376,0.00010153902,0.00012049326,0.00005048458,0.00002557669,0.0003128932,0.00001483978,0.000009270517,0.00015115406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998424,0.00025830712,0.00043807275,0.00037471368,0.00028872845,0.00021616617],"domain_scores_gemma":[0.99845797,0.00018150845,0.00023556344,0.0006249183,0.00024613098,0.00025392618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048903795,0.00021020256,0.0005843076,0.000033966797,0.00007571965,0.000016068427,0.00005878873,0.0000784101,0.00016074923],"category_scores_gemma":[0.00015272567,0.000090703455,0.000069408205,0.0001539614,0.00043158585,0.000113088034,0.00003541989,0.000074517004,6.506131e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08692902,0.0012935562,0.87835455,0.00019621004,0.0004598935,0.000014744169,0.0072483537,0.0000057965235,0.000040759347,0.0000025553197,0.0000035895164,0.02545099],"study_design_scores_gemma":[0.005353714,0.0026625134,0.98684114,0.00006157473,0.00043518294,0.0000046652276,0.00085911225,0.00018759914,0.0032004486,0.00012942156,0.00017491027,0.00008973308],"about_ca_topic_score_codex":0.028366743,"about_ca_topic_score_gemma":0.008180062,"teacher_disagreement_score":0.10848659,"about_ca_system_score_codex":0.00036598288,"about_ca_system_score_gemma":0.0004030472,"threshold_uncertainty_score":0.97810346},"labels":[],"label_agreement":null},{"id":"W2200047700","doi":"10.1097/igc.0b013e31821ce75d","title":"First-Line Therapy in Ovarian Cancer Trials","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Transplant Association","funders":"","keywords":"Medicine; Gynecologic cancer; Ovarian cancer; Clinical trial; Oncology; Randomized controlled trial; Gynecologic oncology; Schedule; Cancer; Epithelial ovarian cancer; Gynecology; Internal medicine; Family medicine","score_opus":0.28905253002962966,"score_gpt":0.4770028652430502,"score_spread":0.18795033521342053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200047700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015819549,0.9911509,0.0000221701,0.0029067392,0.0040854537,0.00084150454,0.0001642735,0.000009075524,0.0006616971],"genre_scores_gemma":[0.0012081705,0.9940759,0.00023800661,0.0008551149,0.002742075,0.00050615775,0.000019957504,0.00004230533,0.00031230165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627435,0.0003022616,0.0021976633,0.00035505407,0.0005836826,0.0002869639],"domain_scores_gemma":[0.9958217,0.0011075644,0.0020559835,0.00018878448,0.00061541237,0.00021054638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001210697,0.00043839548,0.0034647977,0.0004948821,0.000027769125,0.00004451765,0.0005247963,0.00044927746,0.01629802],"category_scores_gemma":[0.0007144177,0.00024629713,0.0014342292,0.00024078102,0.000070290575,0.000101584796,0.000070083996,0.0007761766,0.000026964144],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055587105,0.0009914623,0.0020181495,0.0003890542,0.0029704543,0.0010398331,0.000048066973,0.000012778557,3.2625508e-7,0.00023553275,0.0018571637,0.98988134],"study_design_scores_gemma":[0.0045473967,0.00095976883,0.005336882,0.011225612,0.0011032677,0.0001967859,0.0000036355843,0.0000015116149,0.0000072304583,0.0003102859,0.9760889,0.00021873217],"about_ca_topic_score_codex":0.0002901583,"about_ca_topic_score_gemma":0.00031119175,"teacher_disagreement_score":0.9896626,"about_ca_system_score_codex":0.001990358,"about_ca_system_score_gemma":0.0015675564,"threshold_uncertainty_score":0.9999989},"labels":[],"label_agreement":null},{"id":"W2221484896","doi":"10.1097/igc.0000000000000147","title":"Symptom Burden and Outcomes of Patients With Platinum Resistant/Refractory Recurrent Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Chemotherapy; Internal medicine; Ovarian cancer; Refractory (planetary science); Clinical trial; Cancer; Physical therapy; Intensive care medicine","score_opus":0.013711501300392094,"score_gpt":0.2984781835728649,"score_spread":0.28476668227247276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221484896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156237,0.00072688796,0.000046127516,0.006046568,0.0008062466,0.00015968339,0.000081328086,0.000005938218,0.00056484394],"genre_scores_gemma":[0.9978178,0.00066817837,0.0005352504,0.00045027575,0.00039562996,0.000023449069,0.0000070415454,0.000011032006,0.00009132105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859875,0.000043932327,0.00045076682,0.00016353498,0.0006086308,0.00013439737],"domain_scores_gemma":[0.99816,0.00031819002,0.00053268997,0.000090350004,0.00076308456,0.00013570317],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015609647,0.00014228947,0.00043718683,0.00010674117,0.000027013064,0.000019157518,0.00013418411,0.00007201509,0.0011281883],"category_scores_gemma":[0.0002010503,0.000082096,0.00008581648,0.00005748727,0.00008845002,0.00009319998,0.000040872765,0.00017941704,0.0000012188602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014969801,0.0003877325,0.90750873,0.000019314211,0.00087466615,0.000027519689,0.00010240583,0.00004419617,0.000058414764,0.00036139393,0.00042853036,0.088690124],"study_design_scores_gemma":[0.005285551,0.0019906021,0.97514707,0.00024851374,0.00021471916,0.0000049485784,0.000019339279,0.000021172767,0.00009830791,0.00014821938,0.016733607,0.0000879574],"about_ca_topic_score_codex":0.00012640572,"about_ca_topic_score_gemma":0.00010590605,"teacher_disagreement_score":0.08860217,"about_ca_system_score_codex":0.00036258783,"about_ca_system_score_gemma":0.00016715201,"threshold_uncertainty_score":0.9997849},"labels":[],"label_agreement":null},{"id":"W2222499720","doi":"10.1200/jco.2012.30.15_suppl.5005","title":"Outcome of patients with borderline ovarian tumors: Results of the multicenter AGO ROBOT study.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Debulking; Serous fluid; Surgery; Stage (stratigraphy); Overdiagnosis; Retrospective cohort study; Internal medicine; Ovarian cancer; Cancer","score_opus":0.10897268076587172,"score_gpt":0.4540927503844166,"score_spread":0.3451200696185449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2222499720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920009,0.00010503974,0.000021473232,0.0056354865,0.001118479,0.00050011073,0.00001766559,0.0000022081945,0.00059867435],"genre_scores_gemma":[0.9960395,0.000027514556,0.0024498417,0.00083991565,0.00054577616,0.000003851902,0.0000020184336,0.000013009393,0.00007858163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958963,0.00039127914,0.0029160294,0.00012260962,0.00047986006,0.00019393208],"domain_scores_gemma":[0.99445814,0.0011961414,0.0029957471,0.0003335521,0.0007826463,0.0002337524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022115952,0.00012615291,0.001387368,0.000062969324,0.000021567868,0.00000219777,0.00016091233,0.00013096047,0.00006394551],"category_scores_gemma":[0.0025892637,0.000058358575,0.000358244,0.00013250553,0.00015608138,0.00008251468,0.00006483742,0.00047362846,0.000002819177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008586649,0.022881586,0.95494026,0.000022478953,0.00069945276,0.000029053064,0.0002846686,0.000015149341,0.0000024402455,0.000015807742,0.00065322936,0.011869236],"study_design_scores_gemma":[0.0371653,0.01759214,0.9381597,0.00014619468,0.00089868065,0.000009931913,0.00017169103,0.0000045886463,0.0000441778,0.000005414724,0.0057541234,0.000048031026],"about_ca_topic_score_codex":0.000067900335,"about_ca_topic_score_gemma":0.000078564,"teacher_disagreement_score":0.02857865,"about_ca_system_score_codex":0.000095603566,"about_ca_system_score_gemma":0.0003907827,"threshold_uncertainty_score":0.30997774},"labels":[],"label_agreement":null},{"id":"W2225304791","doi":"10.1200/jco.2006.24.18_suppl.5066","title":"The prognostic effects of performance status (PS) and quality of life (QoL) scores on progression-free survival (PFS) and overall survival (OS) in advanced ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Quality of life (healthcare); Performance status; Ovarian cancer; Chemotherapy; Proportional hazards model; Progression-free survival; Prognostic variable; Cancer","score_opus":0.06749624071936033,"score_gpt":0.4418462204754326,"score_spread":0.37434997975607226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2225304791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891564,0.005321602,0.0000067540655,0.0036538728,0.00088876206,0.0005204428,0.000010736678,0.0000035745927,0.0004378008],"genre_scores_gemma":[0.9884989,0.010275854,0.0006218488,0.00016694596,0.00037077413,0.000026141272,0.0000014010384,0.000013178952,0.000024900708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627656,0.00069149834,0.0020247223,0.00021990227,0.0005119874,0.0002753319],"domain_scores_gemma":[0.98752,0.009973931,0.0017525869,0.00023786779,0.00027655077,0.00023906397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002965348,0.00016426931,0.0015051025,0.000079339916,0.000047495476,0.0000087021335,0.00011978561,0.00019279936,0.000010803712],"category_scores_gemma":[0.005309775,0.00009317971,0.00015624728,0.00011564804,0.00038259028,0.00008374185,0.000073452924,0.0005090377,2.7731727e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089247655,0.0018053715,0.8686017,0.0003200589,0.00020181865,0.000047789126,0.000048184305,0.00004489614,0.00006665832,0.0011003081,0.000101638754,0.118736856],"study_design_scores_gemma":[0.020652344,0.011368829,0.9647858,0.00090052286,0.00017774345,0.0000060366206,0.000030933694,0.000047299203,0.0001822011,0.00037879637,0.0013901702,0.000079282974],"about_ca_topic_score_codex":0.0004117016,"about_ca_topic_score_gemma":0.0013014626,"teacher_disagreement_score":0.11865757,"about_ca_system_score_codex":0.000114554714,"about_ca_system_score_gemma":0.0011322416,"threshold_uncertainty_score":0.635668},"labels":[],"label_agreement":null},{"id":"W2226333405","doi":"10.6000/1929-2279.2015.04.04.8","title":"Molecular Technologies in Gynecologic Oncology","year":2015,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer; Ovarian cancer; Medicine; Molecular pathology; Molecular diagnostics; Oncology; Internal medicine; Gene; Biology; Pathology; Bioinformatics; Genetics","score_opus":0.12814925915384834,"score_gpt":0.48376611601464026,"score_spread":0.3556168568607919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226333405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90537924,0.027535181,0.0000070865162,0.06322895,0.00020484219,0.00027162983,0.000003175828,0.00001793556,0.003351965],"genre_scores_gemma":[0.99246866,0.0063363663,0.00078121043,0.00018284992,0.0000943985,0.000062503095,0.0000010568479,0.0000113054975,0.00006162666],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983899,0.00014476498,0.00034950225,0.00014166652,0.00062311697,0.0003510749],"domain_scores_gemma":[0.9986128,0.00018687831,0.0001322815,0.0001792723,0.0007237232,0.00016505075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015447529,0.000089028494,0.00038913835,0.000567699,0.000024049114,0.000022104427,0.0001945295,0.00012488167,0.00011568672],"category_scores_gemma":[0.0008172616,0.000059625767,0.000073217,0.00054231903,0.0001768026,0.000098470904,0.00008917276,0.00065270805,0.000019224033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002355619,0.0024351373,0.5562547,0.00011176238,0.00065390597,0.014145712,0.00066333014,0.0005214259,0.008333907,0.0027292063,0.07111998,0.34067535],"study_design_scores_gemma":[0.019883545,0.01753674,0.0820783,0.0009755371,0.00021687555,0.00074581534,0.008533738,0.00011214558,0.19000553,0.025407385,0.65417,0.0003344278],"about_ca_topic_score_codex":0.00016027829,"about_ca_topic_score_gemma":0.00017771704,"teacher_disagreement_score":0.58304995,"about_ca_system_score_codex":0.0015303671,"about_ca_system_score_gemma":0.0017326546,"threshold_uncertainty_score":0.40018567},"labels":[],"label_agreement":null},{"id":"W2231504001","doi":"10.1097/00008571-200110000-00010","title":"Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives","year":2001,"lang":"en","type":"article","venue":"Pharmacogenetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Centre Hospitalier de l’Université de Montréal; McGill Genome Centre; Coalition for Research in Women's Health; Toronto General Hospital; University of Toronto","funders":"","keywords":"Ovarian cancer; Breast cancer; Progesterone receptor; Medicine; Allele; Progestin; Cancer; Odds ratio; Oncology; Internal medicine; Gynecology; Biology; Genetics; Hormone; Estrogen receptor; Gene","score_opus":0.024719324310688923,"score_gpt":0.3170980235512851,"score_spread":0.2923786992405962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231504001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068934,0.003943856,0.00016623532,0.0031785064,0.00021950585,0.0013629707,0.00024646882,0.000041798914,0.00015130366],"genre_scores_gemma":[0.98782563,0.00755364,0.0021655394,0.0014939851,0.00026452617,0.0003812206,0.000044958117,0.00004776933,0.00022270203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983948,0.00013715743,0.00034851112,0.00048350688,0.0002488818,0.00038714375],"domain_scores_gemma":[0.9990746,0.00007665687,0.00011540836,0.00020034285,0.00010628713,0.00042671053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001809054,0.00027054996,0.0004122316,0.00014703967,0.00008488668,0.000047267076,0.00006879758,0.00008511989,0.00074829074],"category_scores_gemma":[0.000052693955,0.0002472385,0.000054392905,0.00028090653,0.00006531572,0.00012288347,0.00004238049,0.00016485373,0.000018285644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018181583,0.0009714701,0.7884562,0.000087338,0.00074884837,0.0006729842,0.003024761,0.00045732412,0.016553905,0.000048280093,0.002654986,0.18450573],"study_design_scores_gemma":[0.01795414,0.0009379492,0.8973023,0.00037455861,0.0010203205,0.0001365331,0.0005107627,0.001146667,0.03658281,0.000044990917,0.043462243,0.00052671565],"about_ca_topic_score_codex":0.0020976125,"about_ca_topic_score_gemma":0.0006063986,"teacher_disagreement_score":0.183979,"about_ca_system_score_codex":0.00028728604,"about_ca_system_score_gemma":0.00018578554,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W2238704542","doi":"10.4103/1658-600x.173843","title":"The clinical implications of new insights into the origins of epithelial ovarian cancer with emphasis on the British Columbia Ovarian Cancer Prevention Initiative","year":2016,"lang":"en","type":"article","venue":"Journal of Health Specialties","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Epithelial ovarian cancer; Cancer; Medicine; Political science; Cancer prevention; Oncology; Gynecology; Internal medicine","score_opus":0.0697367486500972,"score_gpt":0.38654858514329904,"score_spread":0.3168118364932018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238704542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70997095,0.0075937496,0.00030778715,0.279108,0.0011543974,0.0012710638,0.00009156714,0.0000076051497,0.0004948976],"genre_scores_gemma":[0.9532416,0.042240083,0.00026826598,0.0015358978,0.0020168386,0.000082871076,0.0000012158607,0.000020780944,0.0005924616],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975191,0.00039162856,0.0012286599,0.00016825071,0.00047271032,0.00021965883],"domain_scores_gemma":[0.99620366,0.00094784977,0.0017987355,0.00034626323,0.0005516691,0.000151847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010396566,0.00012229396,0.0005745161,0.000041115167,0.00065579725,0.000085572414,0.00022733626,0.00006635316,0.00028788557],"category_scores_gemma":[0.00017166104,0.000057252208,0.00021736392,0.000249455,0.0003764514,0.00010633828,0.00002605574,0.00025660425,0.0000015524566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010537319,0.0007654645,0.14417872,0.00006641709,0.00129928,0.0000084755775,0.0038776565,0.0000061964706,0.000028458862,0.00848546,0.051394768,0.78883535],"study_design_scores_gemma":[0.0034933432,0.0022672764,0.82394826,0.0019266825,0.00026148304,0.000023059914,0.00065706513,7.571021e-7,0.00020607286,0.0050457623,0.16210148,0.00006877085],"about_ca_topic_score_codex":0.05033264,"about_ca_topic_score_gemma":0.24332783,"teacher_disagreement_score":0.7887666,"about_ca_system_score_codex":0.00071677484,"about_ca_system_score_gemma":0.0049117845,"threshold_uncertainty_score":0.95599127},"labels":[],"label_agreement":null},{"id":"W2243168506","doi":"10.1200/jco.2009.27.15_suppl.5576","title":"A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the PMH Phase II Consortium","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Regimen; Phases of clinical research; Endometrial cancer; Oncology; Gastroenterology; Clinical endpoint; Urology; Cancer; Surgery; Chemotherapy; Clinical trial","score_opus":0.2843529791827545,"score_gpt":0.5407086601337543,"score_spread":0.2563556809509998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243168506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010533,0.00036825734,0.000004642806,0.005317597,0.0022189403,0.0016648818,0.000025098769,0.0000025253253,0.0002927451],"genre_scores_gemma":[0.99805,0.00026651358,0.00033725487,0.00040404045,0.0008591243,0.000020529615,0.0000017149438,0.00000915462,0.000051665724],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930427,0.0013072708,0.0046165367,0.00021271239,0.000590677,0.00023007783],"domain_scores_gemma":[0.991222,0.0041899225,0.0035928555,0.00032784665,0.0004154755,0.00025189613],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004305975,0.00017820465,0.0027989675,0.00032724824,0.000052449035,0.0000035892049,0.00022148989,0.00014840788,0.00023549199],"category_scores_gemma":[0.009925148,0.00009357289,0.00070796075,0.00057630165,0.00018375799,0.000059434184,0.000070601694,0.00077148573,6.732863e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42677167,0.31115606,0.0032631743,0.000020526246,0.0007590329,0.0010357609,0.0008385635,0.0000033364072,0.00006622807,0.000054819866,0.0010617771,0.25496906],"study_design_scores_gemma":[0.51333076,0.47042885,0.010085682,0.0001019353,0.0016572444,0.0000825437,0.00043554814,0.000011388949,0.00017092709,0.00007067301,0.0035742405,0.000050216204],"about_ca_topic_score_codex":0.000051943534,"about_ca_topic_score_gemma":0.0001302053,"teacher_disagreement_score":0.25491884,"about_ca_system_score_codex":0.00017573139,"about_ca_system_score_gemma":0.002843056,"threshold_uncertainty_score":0.9984147},"labels":[],"label_agreement":null},{"id":"W2243255469","doi":"10.1158/1538-7445.am2015-854","title":"Abstract 854: Ovarian cancer risk factors by histologic subtypes: evidence for etiologic heterogeneity","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Toronto","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Clear cell; Oncology; Endometrial cancer; Cancer; Internal medicine; Cohort; Risk factor; Gynecology; Serous carcinoma; Clear cell carcinoma; Carcinoma","score_opus":0.3916433470307197,"score_gpt":0.49597247247097176,"score_spread":0.10432912544025208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243255469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95228297,0.03963677,0.0000672191,0.0048940214,0.00055513345,0.001582692,0.00049992895,0.00007414058,0.0004071205],"genre_scores_gemma":[0.98532605,0.010767611,0.0001760636,0.00022940036,0.0004096899,0.0023022394,0.00006214228,0.000041258158,0.0006855199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971588,0.00019759874,0.00032874607,0.0007867167,0.00070896314,0.0008191695],"domain_scores_gemma":[0.99723136,0.00075115904,0.00013956697,0.00058017165,0.0007140411,0.0005836725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013703271,0.00026213942,0.0004859997,0.00014760587,0.00026279906,0.000059204107,0.00028519737,0.00022520308,0.0007141247],"category_scores_gemma":[0.0010070897,0.00018835625,0.0001764386,0.00036395612,0.00028155962,0.00014221978,0.00008377995,0.0005300724,0.00006422539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012454872,0.00040032036,0.8397304,0.00020468075,0.0003434033,0.00003530721,0.00036957048,0.000084402505,0.0028576837,0.00007341058,0.14515789,0.009497484],"study_design_scores_gemma":[0.006653279,0.0028306185,0.7654347,0.000831221,0.0004059192,0.0000113646975,0.0004872656,0.00009659709,0.050798588,0.000962368,0.17085753,0.0006305597],"about_ca_topic_score_codex":0.017544331,"about_ca_topic_score_gemma":0.0012824069,"teacher_disagreement_score":0.07429568,"about_ca_system_score_codex":0.0024767483,"about_ca_system_score_gemma":0.0013382981,"threshold_uncertainty_score":0.98899794},"labels":[],"label_agreement":null},{"id":"W2244807134","doi":"10.1200/jco.2006.24.18_suppl.5018","title":"Bevacizumab (B) plus erlotinib (E) for patients (pts) with recurrent ovarian (OC) and fallopian tube (FT) cancer: Preliminary results of a multi-center phase II trial","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Gastroenterology; Ovarian cancer; Erlotinib; Refractory (planetary science); Phases of clinical research; Vascular endothelial growth factor; Cancer; Urology; Chemotherapy; Surgery; Epidermal growth factor receptor; VEGF receptors","score_opus":0.1005680349449474,"score_gpt":0.4501131593538547,"score_spread":0.3495451244089073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2244807134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735565,0.00067531475,0.00010082434,0.007439536,0.001869261,0.0019104771,0.00027260868,0.000008097034,0.00036822679],"genre_scores_gemma":[0.99017215,0.0008374955,0.0066442774,0.0003928054,0.0015734356,0.000090901085,0.00005540416,0.000027622344,0.00020593053],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959159,0.00021694551,0.0028508306,0.00035206036,0.00036943445,0.00029483697],"domain_scores_gemma":[0.9952201,0.001148594,0.0023720218,0.0002205881,0.00070330134,0.00033536565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011588075,0.00022792646,0.0017401741,0.00012760455,0.00007602032,0.000009135553,0.00011732583,0.00030243077,0.000025000432],"category_scores_gemma":[0.00092537206,0.00014712976,0.00041660195,0.00010131867,0.00019068542,0.00009661132,0.000056027777,0.00044539844,6.784112e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66855204,0.052776847,0.013522608,0.00008660061,0.0007391935,0.00015572362,0.0002389321,0.000018652036,0.0000032359378,0.0000521725,0.006603029,0.25725093],"study_design_scores_gemma":[0.60144776,0.26951545,0.04815945,0.00042915196,0.001020966,0.000051426334,0.000027465752,0.0002374551,0.000026377942,0.000026034608,0.0789462,0.00011223931],"about_ca_topic_score_codex":0.00018263662,"about_ca_topic_score_gemma":0.00040670947,"teacher_disagreement_score":0.2571387,"about_ca_system_score_codex":0.00036151794,"about_ca_system_score_gemma":0.0016947397,"threshold_uncertainty_score":0.59997773},"labels":[],"label_agreement":null},{"id":"W2246147839","doi":"10.1200/jco.2007.25.18_suppl.5508","title":"VEGF-Trap for patients (pts) with recurrent platinum-resistant epithelial ovarian cancer (EOC): Preliminary results of a randomized, multicenter phase II study","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Vascular endothelial growth factor; Proteinuria; Gastroenterology; Adverse effect; Oncology; Urology; Kidney; VEGF receptors","score_opus":0.07443637575174555,"score_gpt":0.46063096622025007,"score_spread":0.3861945904685045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246147839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077433,0.00045999515,0.00028803886,0.0029613147,0.001876097,0.0031267686,0.00016596244,0.0000068744116,0.00034060064],"genre_scores_gemma":[0.99215114,0.00038098064,0.0057535605,0.00036254257,0.0011176956,0.00010553194,0.00001507508,0.000028292943,0.00008516967],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9937414,0.00046169703,0.004496916,0.00034754135,0.00060669077,0.00034575156],"domain_scores_gemma":[0.9883257,0.0058115567,0.0039977552,0.00027224128,0.0011758532,0.00041689366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006732468,0.00024917323,0.0029375034,0.00018006569,0.00007747269,0.0000068360177,0.00015261816,0.00024231127,0.00005485219],"category_scores_gemma":[0.0034864729,0.00014509333,0.0007289988,0.00013490937,0.00023247814,0.000085702566,0.000050731927,0.0005257321,0.0000012160967],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7146103,0.052830596,0.012393914,0.00005067038,0.0022429489,0.00028944563,0.0007329241,0.0000060539223,0.000019847881,0.000016390168,0.0011217194,0.21568519],"study_design_scores_gemma":[0.6102799,0.2994413,0.07749893,0.00047254193,0.0030727312,0.000012236647,0.0001971758,0.00004802907,0.00010640194,0.000026188274,0.008740719,0.00010382346],"about_ca_topic_score_codex":0.0001139663,"about_ca_topic_score_gemma":0.00030311677,"teacher_disagreement_score":0.2466107,"about_ca_system_score_codex":0.0003072784,"about_ca_system_score_gemma":0.0010826727,"threshold_uncertainty_score":0.59167343},"labels":[],"label_agreement":null},{"id":"W2248813510","doi":"10.1200/jco.2004.22.90140.5053","title":"Epithelial ovarian cancer (EOC) without macroscopic residual tumour: Long-term, population-based outcomes","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Epithelial ovarian cancer; Radiation therapy; Incidence (geometry); Internal medicine; Chemotherapy; Population; Oncology; Ovarian cancer; Disease; Gynecology; Surgery; Cancer","score_opus":0.09649344784847107,"score_gpt":0.48111578164589974,"score_spread":0.38462233379742866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248813510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94381183,0.00040518647,0.00020915273,0.05227623,0.0026900084,0.00029505367,0.000022903281,0.000017136665,0.00027247937],"genre_scores_gemma":[0.98564684,0.00030390816,0.0053280876,0.0061198007,0.0023597728,0.000017798453,0.00001147662,0.00003025559,0.00018207886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649346,0.00022851951,0.002186893,0.00027569674,0.00050161796,0.0003137893],"domain_scores_gemma":[0.99654096,0.00087069365,0.0015363209,0.00025273152,0.0003193799,0.00047990412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012001469,0.00021792957,0.0017603283,0.00014088019,0.0000748228,0.000021179074,0.00015988656,0.00036237674,0.0004782835],"category_scores_gemma":[0.0009897898,0.00014521775,0.0005958663,0.0001206436,0.00012619713,0.0001008491,0.000028622122,0.0007427089,0.000034444445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016472318,0.0021833193,0.9682707,0.00003301669,0.0005661675,0.0011403448,0.000033195505,0.0002659213,0.000051154326,0.00015471944,0.00029083915,0.025363376],"study_design_scores_gemma":[0.02656056,0.005355563,0.9645245,0.00032602914,0.00092906377,0.000103960396,0.000007759963,0.0000056353647,0.00035567372,0.00035247378,0.0013527826,0.00012599297],"about_ca_topic_score_codex":0.0006692632,"about_ca_topic_score_gemma":0.0011101923,"teacher_disagreement_score":0.04615643,"about_ca_system_score_codex":0.0007157301,"about_ca_system_score_gemma":0.0038990113,"threshold_uncertainty_score":0.69166785},"labels":[],"label_agreement":null},{"id":"W2250508233","doi":"10.1016/s1701-2163(15)30951-8","title":"Torsion tubaire isolée chez une adolescente pubère","year":2013,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.008525457789691122,"score_gpt":0.21800982691917895,"score_spread":0.2094843691294878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2250508233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53238285,0.32380328,0.0000190501,0.046820074,0.093353294,0.0005647065,0.00005543657,0.0000055981927,0.0029956945],"genre_scores_gemma":[0.97946644,0.015002518,0.00026561393,0.0018733467,0.0004064481,0.0000070652645,0.000005391977,0.000027759648,0.0029454331],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997883,0.000100352256,0.0007568703,0.00023643236,0.00043935212,0.0005839895],"domain_scores_gemma":[0.9968863,0.0009718902,0.0005690002,0.00020131585,0.00060247234,0.0007690242],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002161337,0.00027579846,0.0007110333,0.0003465164,0.00014137702,0.000054826076,0.00014732164,0.00028448668,0.0050123273],"category_scores_gemma":[0.0011862677,0.00022700212,0.00014289943,0.00075767154,0.000137031,0.00017411192,0.00006278484,0.0006204876,0.000023323486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006589992,0.0005236674,0.36524436,0.00024954305,0.00051894883,0.005729475,0.00013431322,0.000021726695,0.0000102018685,0.00035662678,0.20503683,0.42216772],"study_design_scores_gemma":[0.00432005,0.0012132798,0.7488661,0.00015939036,0.0005251237,0.00023871845,0.0005598676,0.00013323105,0.000076125216,0.000101969934,0.2436208,0.00018535723],"about_ca_topic_score_codex":0.17553064,"about_ca_topic_score_gemma":0.0541711,"teacher_disagreement_score":0.44708356,"about_ca_system_score_codex":0.0028220057,"about_ca_system_score_gemma":0.0030221455,"threshold_uncertainty_score":0.99589723},"labels":[],"label_agreement":null},{"id":"W2250938575","doi":"10.1016/s1701-2163(16)35456-1","title":"It Sounded Like a Good Idea at the Time","year":2012,"lang":"en","type":"letter","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tubal ligation; Gynecology; Gynecologic oncology; Obstetrics and gynaecology; Salpingectomy; Fallopian tube; Population; Family medicine; Demographics; Obstetrics; Oncology; Pregnancy; Demography; Family planning; Research methodology; Environmental health","score_opus":0.013747237068951127,"score_gpt":0.23076131547917497,"score_spread":0.21701407841022385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2250938575","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060428334,0.04207043,0.0000013637296,0.92398995,0.020156944,0.00037129028,0.00011516699,0.0000042848787,0.007247718],"genre_scores_gemma":[0.05189694,0.0013066978,0.000102448146,0.9236311,0.0016484896,0.000017616132,0.00007387085,0.0000665099,0.021256348],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980902,0.00009081871,0.00057733787,0.00019536534,0.0005949972,0.0004512876],"domain_scores_gemma":[0.99502826,0.0034275001,0.0007407373,0.0002990906,0.00027677751,0.000227659],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024583083,0.00028263533,0.00079026696,0.00018723938,0.00016088891,0.00003116438,0.00017185259,0.00050299725,0.0043365033],"category_scores_gemma":[0.0005989743,0.00016956044,0.0001915334,0.00021131188,0.000091532034,0.000036651658,0.00008406253,0.0013934361,0.000020651556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004216673,0.000052247386,0.013529144,0.00005894999,0.00081678067,0.009485572,0.000040319323,9.0122734e-7,5.045721e-7,0.000004561072,0.96812725,0.007879548],"study_design_scores_gemma":[0.0019690488,0.0003966902,0.041462433,0.000019120675,0.0012077377,0.00078912097,0.000017957864,0.0000020474713,0.000004323361,0.000026272579,0.95395833,0.00014690614],"about_ca_topic_score_codex":0.007420723,"about_ca_topic_score_gemma":0.016299287,"teacher_disagreement_score":0.045854107,"about_ca_system_score_codex":0.0036618952,"about_ca_system_score_gemma":0.0028712705,"threshold_uncertainty_score":0.99918896},"labels":[],"label_agreement":null},{"id":"W2251495032","doi":"10.1016/s1701-2163(15)30176-6","title":"Hyperreactio Luteinalis: Maternal and Fetal Effects","year":2015,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hyperandrogenism; Pregnancy; Virilization; Malignancy; Breastfeeding; Fertility; Obstetrics; Miscarriage; Pediatrics; Gynecology; Androgen; Population; Endocrinology; Pathology; Hormone; Diabetes mellitus","score_opus":0.02573102971301248,"score_gpt":0.2876604263923418,"score_spread":0.2619293966793293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2251495032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016042745,0.98888135,9.0725916e-7,0.00010911838,0.008632808,0.00028728574,0.000028143844,0.0000024827355,0.0004536099],"genre_scores_gemma":[0.0033561068,0.99597746,0.00017691375,0.00013925468,0.00013157331,0.000010881491,0.0000070081965,0.000027989112,0.0001728325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985611,0.0000782638,0.0005875832,0.00019780794,0.00034358128,0.00023170578],"domain_scores_gemma":[0.99712706,0.0013491848,0.0006882175,0.00013422995,0.00022559553,0.00047573415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020832825,0.00028979208,0.0018879218,0.00028751662,0.000050624934,0.00003289667,0.00007907333,0.00024239346,0.000076902805],"category_scores_gemma":[0.00074245286,0.00019501123,0.00015663676,0.00019888373,0.000049387625,0.000045743323,0.000047300513,0.00048649593,0.0000012772944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002321244,0.000050057613,0.003210786,0.0035240331,0.0007545374,0.011579443,0.0000073143983,8.924085e-8,1.0993337e-8,0.000018901836,0.0032708757,0.9775816],"study_design_scores_gemma":[0.0020023037,0.0007370318,0.012052605,0.00076483015,0.0036412308,0.0032867773,0.000009952177,9.798656e-7,5.0231733e-7,0.000016087059,0.97733957,0.00014811213],"about_ca_topic_score_codex":0.007311822,"about_ca_topic_score_gemma":0.0032146175,"teacher_disagreement_score":0.9774335,"about_ca_system_score_codex":0.0023050066,"about_ca_system_score_gemma":0.0048851497,"threshold_uncertainty_score":0.9992986},"labels":[],"label_agreement":null},{"id":"W2257850486","doi":"10.1016/j.jogc.2015.10.010","title":"Luteinized Thecomas (“Thecomatosis”) with Sclerosing Peritonitis (LTSP): Report of 2 Cases and Review of an Enigmatic Syndrome Associated with a Peritoneal Proliferation of Specialized (vimentin+/keratin+/CD34+) Submesothelial Fibroblasts","year":2016,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Medicine; Vimentin; Pathology; Peritonitis; Bowel obstruction; Abdominal pain; Keratin; Internal medicine; Immunohistochemistry; Surgery","score_opus":0.020309831448222154,"score_gpt":0.27228054712717126,"score_spread":0.25197071567894913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257850486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11290121,0.8848744,0.0000030992205,0.00011441377,0.0005922422,0.0012053214,0.00022380133,0.0000034741918,0.00008201414],"genre_scores_gemma":[0.1047543,0.8941221,0.00085729605,0.000041118637,0.0000385084,0.000039892468,0.000058378984,0.000051163304,0.000037245132],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963129,0.00033696485,0.0021133295,0.00030515244,0.00066596584,0.00026568168],"domain_scores_gemma":[0.99196625,0.0020677953,0.004587856,0.0002995564,0.00084082026,0.00023770468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006101185,0.0004145583,0.0038766793,0.0003380292,0.00008180911,0.000022052616,0.00011203772,0.00021157907,0.00019953457],"category_scores_gemma":[0.001974458,0.00024425186,0.00021941165,0.00043214744,0.00020117789,0.00011112501,0.000034973757,0.00025614465,5.9343986e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026738658,0.0023077922,0.027263224,0.15141073,0.012348864,0.04910497,0.00036024337,0.0000013196372,0.000013837294,0.0001237146,0.00047587042,0.756322],"study_design_scores_gemma":[0.04396518,0.035275944,0.14382827,0.5553722,0.04093772,0.11224868,0.00034277944,0.000019017756,0.00046990666,0.000037273527,0.0653477,0.0021553366],"about_ca_topic_score_codex":0.0015091859,"about_ca_topic_score_gemma":0.004484975,"teacher_disagreement_score":0.7541667,"about_ca_system_score_codex":0.00083187985,"about_ca_system_score_gemma":0.005837826,"threshold_uncertainty_score":0.9997982},"labels":[],"label_agreement":null},{"id":"W2262351582","doi":"10.1200/jco.2005.23.16_suppl.5005","title":"Prognostic value of clinical and molecular markers in advanced ovarian cancer (AOC): importance of residual (Rs) disease. Translational study using tumor specimens from EORTC 55931/NCIC OV10 Phase III Randomized Clinical Trial (RCT)","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Randomized controlled trial; Population; Concordance; Ovarian cancer; Context (archaeology); Breast cancer; Univariate analysis; Cancer; Multivariate analysis","score_opus":0.11169151791978289,"score_gpt":0.5102172237063687,"score_spread":0.3985257057865858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262351582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868779,0.003169185,0.00022456789,0.0048571234,0.0015621544,0.003109985,0.000092001545,0.0000074089803,0.00009964774],"genre_scores_gemma":[0.98209,0.0015295859,0.012920285,0.00084099994,0.0024897016,0.00006404739,0.0000151571785,0.00003917051,0.000011070144],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9814922,0.004159117,0.012313545,0.0007039824,0.00095648697,0.00037467392],"domain_scores_gemma":[0.9775048,0.01486903,0.00589344,0.00042121753,0.0005020665,0.00080944004],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.016258074,0.0003602713,0.006311685,0.00022299869,0.000040689552,0.000010361821,0.0002269504,0.00040451658,0.0003931444],"category_scores_gemma":[0.011482968,0.00027117832,0.001507016,0.00025494045,0.0009235045,0.00018054967,0.000066193,0.001322463,0.0000010498208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5174274,0.016685273,0.43363538,0.000023700728,0.0018462978,0.0010819435,0.0000841032,0.00022188353,0.000019649058,0.00008592005,0.00007234499,0.028816106],"study_design_scores_gemma":[0.5364348,0.009490114,0.4479048,0.0003324663,0.0035787753,0.00001559414,0.00008729441,0.001346132,0.000012040998,0.00034122035,0.00032245947,0.00013426214],"about_ca_topic_score_codex":0.0001550005,"about_ca_topic_score_gemma":0.0002936665,"teacher_disagreement_score":0.028681844,"about_ca_system_score_codex":0.00016041723,"about_ca_system_score_gemma":0.005426344,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W2263949224","doi":"10.1093/carcin/bgv138","title":"Common variants at the<i>CHEK2</i>gene locus and risk of epithelial ovarian cancer","year":2015,"lang":"en","type":"review","venue":"Carcinogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Simon Fraser University; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Medical Research Council; U.S. Department of Defense; European Commission; National Health and Medical Research Council; Minnesota Ovarian Cancer Alliance; Cancer Research UK; Fred C. and Katherine B. Andersen Foundation; Mayo Foundation for Medical Education and Research; Francis Crick Institute; Rutgers Cancer Institute of New Jersey; National Institutes of Health; Ovarian Cancer Research Fund; National Center for Research Resources; Roswell Park Cancer Institute; Lon V. Smith Foundation","keywords":"CHEK2; Single-nucleotide polymorphism; Genome-wide association study; Biology; Genetics; Locus (genetics); SNP; Odds ratio; Genotype; Ovarian cancer; Gene; Cancer; Internal medicine; Medicine; Mutation","score_opus":0.05619067970592979,"score_gpt":0.33441484449377584,"score_spread":0.27822416478784606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263949224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004661658,0.9897535,0.0000034259924,0.00018035946,0.0005303727,0.0015168446,0.002782647,0.000026313259,0.0005448774],"genre_scores_gemma":[0.0016641378,0.9960111,0.00008994454,0.000074829404,0.00060443894,0.0005304173,0.00018104297,0.00011910292,0.00072498276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973174,0.00035186016,0.00076290243,0.0006978633,0.00046695012,0.00040305126],"domain_scores_gemma":[0.99736303,0.00026163663,0.00068505737,0.0011431457,0.00020082938,0.00034632214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005493977,0.00062137534,0.0027896643,0.0001495237,0.00015884028,0.000022194401,0.0002252741,0.00038936222,0.00030437636],"category_scores_gemma":[0.000049590493,0.00037280703,0.0006136658,0.00037390343,0.00022262255,0.000030923416,0.00024887148,0.00026294508,0.000051101593],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087611064,0.00016130622,0.015516437,0.0051013906,0.0025519219,0.000112896494,0.00012710677,0.0000015598573,0.000011085294,0.000030995794,0.0022777645,0.97401994],"study_design_scores_gemma":[0.0019945935,0.0002405056,0.008440629,0.004537639,0.026418842,0.00025150756,0.000014457235,0.0000027400954,0.00046890738,0.000027102547,0.95718783,0.0004152665],"about_ca_topic_score_codex":0.003454802,"about_ca_topic_score_gemma":0.00045484427,"teacher_disagreement_score":0.9736047,"about_ca_system_score_codex":0.00066802045,"about_ca_system_score_gemma":0.0009344195,"threshold_uncertainty_score":0.9998724},"labels":[],"label_agreement":null},{"id":"W2265590678","doi":"10.1111/his.12937","title":"Differential expression of E‐cadherin and catenins in ovarian sex cord stromal tumours","year":2016,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; Royal Jubilee Hospital; University of British Columbia","funders":"Imperial College London","keywords":"Cadherin; Catenin; Stromal cell; Adherens junction; Immunohistochemistry; Biology; Pathology; Beta-catenin; Cancer research; Medicine; Cell biology; Cell; Wnt signaling pathway; Genetics; Signal transduction","score_opus":0.015169818189935893,"score_gpt":0.25912944592078274,"score_spread":0.24395962773084684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265590678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765,0.00023190933,0.00020708822,0.00087660784,0.00017631396,0.0001467876,0.000014471737,0.000011900832,0.0006848832],"genre_scores_gemma":[0.99868214,0.00009774353,0.00044839256,0.000041602452,0.00005482669,0.000025161695,0.00000501538,0.000011897629,0.00063319586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992835,0.00004880383,0.00019335956,0.00023623809,0.00007464901,0.00016342913],"domain_scores_gemma":[0.9996294,0.000036668494,0.0000686779,0.0001759026,0.00001763017,0.00007173034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048641614,0.00010067617,0.00030101987,0.00009368334,0.000017220227,0.0000015456433,0.00003523626,0.000079863115,0.00028234973],"category_scores_gemma":[0.000019356547,0.00006553669,0.000034979003,0.0000392748,0.00011871418,0.000024152117,0.000037110465,0.000057604033,0.000006035573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029989117,0.00022090664,0.64032805,0.000020603284,0.0000020712262,0.00031106698,0.00019638948,5.9194207e-8,0.35353613,0.00040481082,0.00012245191,0.004557568],"study_design_scores_gemma":[0.0032762084,0.0007778874,0.9559665,0.000113595794,0.000036866535,0.00015031468,0.000024916853,0.0000014789349,0.03885587,0.000080299455,0.0006518647,0.00006421019],"about_ca_topic_score_codex":0.000115602605,"about_ca_topic_score_gemma":0.000059029757,"teacher_disagreement_score":0.31563845,"about_ca_system_score_codex":0.00009431964,"about_ca_system_score_gemma":0.000054984266,"threshold_uncertainty_score":0.30915317},"labels":[],"label_agreement":null},{"id":"W2266079976","doi":"10.1093/annonc/mdu338.35","title":"Etoposide Benefit in 2Nd Line and Beyond Relapsed Epithelial Ovarian Cancer (Eoc): a Population Based Analysis","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Ovarian cancer; Oncology; Etoposide; Internal medicine; Population; Gynecology; Cancer; Chemotherapy; Environmental health","score_opus":0.038298457132991334,"score_gpt":0.36425134458623293,"score_spread":0.3259528874532416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266079976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662444,0.0005056936,0.0001250527,0.031509873,0.00010467748,0.00026092088,0.000043366927,0.000018662673,0.0011873387],"genre_scores_gemma":[0.9946917,0.00041249505,0.001204711,0.0033301755,0.0001266793,0.000063124135,0.00008529074,0.000016055792,0.00006973473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890846,0.000083613624,0.000382695,0.00028660984,0.00013629602,0.00020233759],"domain_scores_gemma":[0.99916,0.0002101447,0.0001853808,0.00022436891,0.00011092106,0.00010919929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037658022,0.0001282928,0.00064247893,0.00036183075,0.000024817738,0.000005679245,0.00004111159,0.00016148154,0.00017317744],"category_scores_gemma":[0.00008038851,0.000110342706,0.00012546222,0.00041948567,0.00004082945,0.000042542208,0.000018405339,0.00010464521,0.0000016174466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073375815,0.0008406489,0.80663896,0.00005619499,0.0007230006,0.00003537317,0.00021737379,0.0015289418,0.00045502212,0.0017937255,0.00026455222,0.18671249],"study_design_scores_gemma":[0.0045995545,0.0020080982,0.9785046,0.000056431894,0.0008377605,0.0000030990227,0.000014274826,0.0035364535,0.0024343715,0.0009691163,0.0069341823,0.00010206114],"about_ca_topic_score_codex":0.0066679716,"about_ca_topic_score_gemma":0.010912804,"teacher_disagreement_score":0.18661042,"about_ca_system_score_codex":0.00008701044,"about_ca_system_score_gemma":0.00010994564,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W2268238083","doi":"10.1016/j.ygyno.2015.10.022","title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Statement (logic); Serous fluid; Ovarian carcinoma; Carcinoma; Gynecology; Serous carcinoma; Oncology; General surgery; Internal medicine; Ovarian cancer; Cancer; Linguistics","score_opus":0.02116955579973446,"score_gpt":0.33138953222195067,"score_spread":0.3102199764222162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268238083","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02266099,0.0017145599,0.000037592174,0.06956898,0.866095,0.00576827,0.0010956208,0.00028341403,0.032775547],"genre_scores_gemma":[0.33560902,0.0051296116,0.009484694,0.012776988,0.61762995,0.0046148472,0.0037442732,0.0004386778,0.010571956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271524,0.0013615291,0.0015796525,0.0017772273,0.0011885662,0.0013777798],"domain_scores_gemma":[0.9803857,0.016410885,0.0013003977,0.0010908309,0.00037033734,0.0004418014],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019371673,0.0009904793,0.0023795664,0.00060232315,0.00018470018,0.000053477357,0.00033117324,0.0020394288,0.00084346096],"category_scores_gemma":[0.0030202523,0.0007433978,0.00026175755,0.0003568965,0.00025859562,0.00008756258,0.0003118039,0.0019945414,0.00055965455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002616168,0.005533619,0.0048100813,0.00031469905,0.0007931081,0.020644069,0.0002290063,0.000050969593,0.00009010974,0.0003493866,0.94610524,0.01846355],"study_design_scores_gemma":[0.020008372,0.010541175,0.028042084,0.0005373029,0.001105524,0.000085184474,0.00015830885,0.0000030743051,0.000077225755,0.00023389109,0.9385373,0.0006705797],"about_ca_topic_score_codex":0.0013318713,"about_ca_topic_score_gemma":0.0013782638,"teacher_disagreement_score":0.31294802,"about_ca_system_score_codex":0.020196965,"about_ca_system_score_gemma":0.0053487453,"threshold_uncertainty_score":0.9995017},"labels":[],"label_agreement":null},{"id":"W2269087069","doi":"10.1038/nrclinonc.2015.224","title":"Can advanced-stage ovarian cancer be cured?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.19827072950754132,"score_gpt":0.5608637098340041,"score_spread":0.3625929803264628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269087069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.1885174e-7,0.95643604,0.0000047518297,0.020582546,0.00565914,0.0054393047,0.0007713271,0.000092696384,0.011013976],"genre_scores_gemma":[0.0000014622476,0.9689215,0.0016812435,0.011894155,0.004910096,0.0029605173,0.00034956535,0.0001767283,0.009104728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99097705,0.0016774194,0.004110759,0.0018837086,0.0004627078,0.00088833034],"domain_scores_gemma":[0.9914303,0.0027574487,0.0028132505,0.001815211,0.00024200155,0.0009417787],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0024192545,0.001193196,0.012949674,0.00022126925,0.00010537106,0.000021679758,0.00058725505,0.005223753,0.003726963],"category_scores_gemma":[0.0023463673,0.0006425045,0.0041169673,0.0005940022,0.00031748923,0.000065848944,0.00022951172,0.0048801904,0.0006296742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005879872,0.0007629114,0.000082886196,0.012972096,0.0010958563,0.00045100483,0.000005476938,1.2346756e-8,2.975733e-8,0.0016911711,0.063371435,0.91950834],"study_design_scores_gemma":[0.0029746278,0.0013103695,0.00006963136,0.057263747,0.006838508,0.000113970935,0.0000014170906,1.1222642e-7,1.4879964e-7,0.000040895335,0.93081594,0.00057064823],"about_ca_topic_score_codex":0.000045243796,"about_ca_topic_score_gemma":0.00033196076,"teacher_disagreement_score":0.9189377,"about_ca_system_score_codex":0.0022348326,"about_ca_system_score_gemma":0.0070688887,"threshold_uncertainty_score":0.9996026},"labels":[],"label_agreement":null},{"id":"W2269230994","doi":"10.1200/jco.2005.23.16_suppl.5136","title":"Efficacy of third-line chemotherapy for recurrent ovarian, peritoneal and fallopian tube carcinoma","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Topotecan; Fallopian tube; Fallopian tube cancer; Chemotherapy; Ovarian cancer; Ovarian carcinoma; Regimen; Clinical endpoint; Internal medicine; Surgery; Chemotherapy regimen; Oncology; Gynecology; Gastroenterology; Cancer; Randomized controlled trial","score_opus":0.11460759853702733,"score_gpt":0.462665828266809,"score_spread":0.3480582297297817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269230994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327137,0.0021112887,0.000194165,0.06283543,0.0008269402,0.00042507923,0.000009650506,0.000005448505,0.00087832694],"genre_scores_gemma":[0.9730302,0.0021620996,0.019154957,0.0024677531,0.0030109196,0.000008804423,0.0000032479718,0.00001723538,0.00014478972],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975128,0.00010837787,0.0017995312,0.00018890976,0.000205641,0.0001847259],"domain_scores_gemma":[0.99668956,0.0014995818,0.0009984892,0.00016307265,0.00033430933,0.00031499824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013711822,0.00013434154,0.0013726867,0.00007792297,0.000028673641,0.000005744632,0.00008908244,0.0002614826,0.0000957659],"category_scores_gemma":[0.00076274085,0.00009181637,0.00047617158,0.00006474535,0.00014955483,0.00005468568,0.000021155765,0.00038250012,0.0000020367027],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015178053,0.0054467213,0.08125991,0.000066074324,0.0006645346,0.00007748112,0.00024214917,0.000009270436,0.00008089269,0.0007051406,0.005812192,0.8904576],"study_design_scores_gemma":[0.038303632,0.03274923,0.61524606,0.00012225134,0.00055851083,0.00022862945,0.00003772473,0.00021615003,0.0006070413,0.00012864608,0.31171632,0.00008581795],"about_ca_topic_score_codex":0.000011108289,"about_ca_topic_score_gemma":0.000032109925,"teacher_disagreement_score":0.8903718,"about_ca_system_score_codex":0.00013105513,"about_ca_system_score_gemma":0.00086431066,"threshold_uncertainty_score":0.3744163},"labels":[],"label_agreement":null},{"id":"W2269947569","doi":"10.1200/jco.2012.30.15_suppl.5020","title":"Randomized trial of oral cyclophosphamide (C) with or without veliparib (V), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent BRCA-positive ovarian, or primary peritoneal or high-grade serous ovarian carcinoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Veliparib; PARP inhibitor; Ovarian cancer; Surgery; Randomized controlled trial; Cancer; Poly ADP ribose polymerase","score_opus":0.06851753896149007,"score_gpt":0.3946114848879246,"score_spread":0.3260939459264345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269947569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899785,0.0004735072,0.00009006242,0.0033692713,0.0029306267,0.0029136187,0.000077930286,0.000020275875,0.00014620456],"genre_scores_gemma":[0.9782995,0.0002556097,0.017139403,0.001447339,0.0024139616,0.00012068464,0.00008217208,0.00008841804,0.0001529121],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9909077,0.0022444278,0.004264405,0.00059810985,0.0011409112,0.0008444188],"domain_scores_gemma":[0.99139786,0.0025946533,0.0035468077,0.00052801153,0.0006912774,0.001241368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041012065,0.0006259845,0.0060381535,0.00033747675,0.00009473606,0.000033346998,0.00028688757,0.00064996857,0.00029537617],"category_scores_gemma":[0.0012669727,0.0003087862,0.00051770714,0.0005501157,0.00068851025,0.0005778605,0.00009552009,0.0013839558,0.0000046558703],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67151195,0.0224498,0.26920974,0.00005386128,0.0013566238,0.0009874178,0.0004978886,0.0000031390398,0.0000047270046,0.000038911985,0.00027817578,0.033607762],"study_design_scores_gemma":[0.55300987,0.07774992,0.36523443,0.00036457376,0.0020252035,0.00024318135,0.00010172256,0.000012540374,0.000110433204,0.0000073916844,0.0008870938,0.00025363266],"about_ca_topic_score_codex":0.0019786395,"about_ca_topic_score_gemma":0.0014144923,"teacher_disagreement_score":0.11850207,"about_ca_system_score_codex":0.0008669597,"about_ca_system_score_gemma":0.007040646,"threshold_uncertainty_score":0.9999364},"labels":[],"label_agreement":null},{"id":"W2270912873","doi":"","title":"Low BRCA1 and ERCC1 mRNA expression correlates with improved survival in ovarian cancer patients","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ERCC1; Ovarian cancer; Oncology; Chemotherapy; Internal medicine; Stage (stratigraphy); Medicine; Biology; Cisplatin; Cancer; Survival analysis; Cancer research; Nucleotide excision repair; DNA repair; Gene","score_opus":0.012970336250718879,"score_gpt":0.2731652375159512,"score_spread":0.2601949012652323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270912873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141526,0.0052830023,0.0008662525,0.0009404404,0.00034279973,0.00071279146,0.000027637983,0.00002914536,0.00038264817],"genre_scores_gemma":[0.99595696,0.0016055618,0.00046076044,0.0016214502,0.00007339399,0.00012157005,0.000021336109,0.000060097464,0.000078844954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985851,0.00003467386,0.00026556605,0.00041495598,0.00029593482,0.00040373913],"domain_scores_gemma":[0.9993071,0.00003969406,0.00010728469,0.00027209954,0.00011757644,0.00015625448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013466831,0.00026323803,0.000339317,0.00010280886,0.000058545873,0.000027493463,0.00006867443,0.00013713482,0.000071781455],"category_scores_gemma":[0.0000039849933,0.0001982703,0.000052388845,0.00024165321,0.00007250514,0.000057231067,0.000033473996,0.00022491776,0.0000017285611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012517498,0.000810156,0.86421674,0.000092809554,0.00041771313,0.00017347987,0.000783595,0.0000492208,0.07109612,0.00006865558,0.000019230483,0.06102051],"study_design_scores_gemma":[0.012071599,0.0007926026,0.6852244,0.00078796444,0.00039822297,0.0000064653045,0.00011131781,0.00020090964,0.297885,0.00006073023,0.0020710935,0.00038971336],"about_ca_topic_score_codex":0.00079588295,"about_ca_topic_score_gemma":0.0009405267,"teacher_disagreement_score":0.22678886,"about_ca_system_score_codex":0.00033740947,"about_ca_system_score_gemma":0.00016107297,"threshold_uncertainty_score":0.8085228},"labels":[],"label_agreement":null},{"id":"W2272680342","doi":"10.1200/jco.2000.18.24.4038","title":"Phase II Feasibility Study of Sequential Couplets of Cisplatin/Topotecan Followed by Paclitaxel/Cisplatin as Primary Treatment for Advanced Epithelial Ovarian Cancer: A National Cancer Institute of Canada Clinical Trials Group Study","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Topotecan; Medicine; Cisplatin; Debulking; Paclitaxel; Ovarian cancer; Oncology; Chemotherapy; Regimen; Internal medicine; Surgery; Cancer; Urology","score_opus":0.2597301339149043,"score_gpt":0.5603606752653596,"score_spread":0.3006305413504553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272680342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879478,0.00064344204,0.000030470199,0.002532016,0.002711017,0.0044575366,0.001405279,0.00000606189,0.0002663336],"genre_scores_gemma":[0.99556714,0.0011264632,0.001119698,0.00042656265,0.0011504759,0.0002938851,0.000045807457,0.00003148819,0.00023847606],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9863505,0.0018125226,0.009493202,0.00061779324,0.0013444404,0.00038156047],"domain_scores_gemma":[0.9852433,0.005679476,0.0067808507,0.00042947623,0.0013103597,0.00055653625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011101879,0.00038671592,0.0058247163,0.00013271467,0.00012333537,0.000006325307,0.00027350226,0.0003742,0.0007889494],"category_scores_gemma":[0.0045888205,0.00027888265,0.001221485,0.00026270148,0.0003119804,0.00015645481,0.000053398508,0.00053125975,3.6564734e-7],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13254781,0.20224674,0.16049436,0.00013456159,0.010225438,0.0003114763,0.0007096341,0.00049965805,0.0011138313,0.000046695273,0.004729493,0.4869403],"study_design_scores_gemma":[0.3753598,0.39155936,0.19654049,0.00037386082,0.007494104,0.000034238998,0.00057131593,0.00015639793,0.00074703444,0.00018598096,0.026638966,0.00033845322],"about_ca_topic_score_codex":0.0714855,"about_ca_topic_score_gemma":0.17584208,"teacher_disagreement_score":0.48660186,"about_ca_system_score_codex":0.0019247837,"about_ca_system_score_gemma":0.019667625,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W2278274289","doi":"10.1016/s1701-2163(15)30991-9","title":"Demande de tests, report du traitement","year":2013,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Medicine; Philosophy","score_opus":0.010864719538972742,"score_gpt":0.23483889671074082,"score_spread":0.22397417717176807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278274289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69866693,0.21194567,0.000092461436,0.03629181,0.048514634,0.00044606766,0.000026171969,0.000003936855,0.0040123165],"genre_scores_gemma":[0.9890238,0.0057797343,0.0010672068,0.0018810699,0.00037722007,0.00001429015,0.000003492394,0.000019661347,0.001833502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800414,0.00008010095,0.0008497877,0.00018787457,0.00036263303,0.0005154574],"domain_scores_gemma":[0.9958138,0.002159314,0.00065441057,0.00017027564,0.0005028259,0.0006993926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004367777,0.00020428699,0.0005760371,0.00017029949,0.00010462456,0.000045064287,0.00010186045,0.0001839507,0.006034248],"category_scores_gemma":[0.003121928,0.00016989814,0.00010605932,0.00025397833,0.00008919294,0.000103875434,0.00003579111,0.000366295,0.0000065660083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000018882279,0.0003561461,0.582701,0.00010510652,0.00059962156,0.04373373,0.00009073148,0.00005411212,0.000005497288,0.00030866393,0.05828627,0.3137572],"study_design_scores_gemma":[0.0027708067,0.0007870987,0.8048021,0.000046880992,0.00055997935,0.0028434282,0.0002463136,0.00011353478,0.000029880719,0.00022080178,0.18745823,0.00012090045],"about_ca_topic_score_codex":0.13627663,"about_ca_topic_score_gemma":0.04462653,"teacher_disagreement_score":0.3136363,"about_ca_system_score_codex":0.0046312604,"about_ca_system_score_gemma":0.0056990073,"threshold_uncertainty_score":0.9999378},"labels":[],"label_agreement":null},{"id":"W2280596730","doi":"10.1016/j.ygyno.2016.02.020","title":"Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Ovarian cancer; Life expectancy; Cancer; Population; Randomized controlled trial; Oncology; Gynecology; Internal medicine; Environmental health","score_opus":0.053290030864508085,"score_gpt":0.38803444125866254,"score_spread":0.3347444103941545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280596730","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064890104,0.0025068123,0.0003597144,0.21330398,0.72591466,0.041943174,0.011155951,0.0001231305,0.004043678],"genre_scores_gemma":[0.005818558,0.01551481,0.0022594437,0.009331834,0.8892442,0.0734613,0.0016055459,0.00023648894,0.0025278423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9916618,0.00234604,0.0021550604,0.0014979218,0.0012004324,0.0011387612],"domain_scores_gemma":[0.95000774,0.044838127,0.002616162,0.0010971832,0.0011057971,0.00033498838],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042010183,0.0011597546,0.005874549,0.00039591428,0.00047704516,0.000060058283,0.0007740195,0.002851826,0.004120252],"category_scores_gemma":[0.0063293893,0.000639819,0.0014051643,0.0005117639,0.0009384167,0.0000751114,0.000257316,0.0014451911,0.000015685955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48980314,0.001101233,0.00001390611,0.000067632835,0.0035797716,0.000045233923,0.00015603052,0.00000785553,0.000004592322,0.0005365353,0.48893678,0.01574729],"study_design_scores_gemma":[0.50435245,0.01467348,0.00001011797,0.00049561675,0.0031825667,8.180185e-7,0.00009472283,0.000014002692,0.000053829634,0.00044642642,0.47635132,0.00032462119],"about_ca_topic_score_codex":0.0037431868,"about_ca_topic_score_gemma":0.0041556624,"teacher_disagreement_score":0.20397215,"about_ca_system_score_codex":0.003155316,"about_ca_system_score_gemma":0.006487684,"threshold_uncertainty_score":0.9996053},"labels":[],"label_agreement":null},{"id":"W2281851327","doi":"10.1200/jco.2006.24.18_suppl.5026","title":"Phase II study of exemestane (E) in refractory ovarian cancer (ROC)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; Chemotherapy; Clinical endpoint; Taxane; Phases of clinical research; Gastroenterology; Surgery; Cancer; Oncology; Breast cancer; Clinical trial","score_opus":0.13074082257249003,"score_gpt":0.5139407353670817,"score_spread":0.3831999127945917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281851327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989902,0.0012130612,0.000008616587,0.0051420797,0.00094659283,0.00030767065,0.0000041251396,0.0000037961834,0.0024720372],"genre_scores_gemma":[0.9965573,0.00088143896,0.00058550714,0.00052242633,0.0011152123,0.000013187382,0.0000014131779,0.000013204721,0.0003102968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963501,0.0002813535,0.0026713994,0.00017951765,0.0003362642,0.00018133504],"domain_scores_gemma":[0.9968875,0.0007761406,0.001664852,0.00019717755,0.00029626212,0.00017803731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001675688,0.00012126209,0.0015600497,0.00016591212,0.000024477697,0.0000027069182,0.000103258935,0.0002185532,0.00036690762],"category_scores_gemma":[0.0004389888,0.00008419356,0.0002595851,0.00018143297,0.00008478283,0.00006775932,0.00003557885,0.0006137301,0.0000024199526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009106567,0.17013988,0.45880657,0.000031645428,0.00063679554,0.003968423,0.00038385598,0.00005033117,0.00021186742,0.00016254172,0.007913462,0.34858805],"study_design_scores_gemma":[0.08241572,0.12423926,0.71679074,0.00017004143,0.0006766905,0.00007979407,0.0002833453,0.000018876923,0.00007062456,0.00019689996,0.074976176,0.000081830134],"about_ca_topic_score_codex":0.0009528833,"about_ca_topic_score_gemma":0.0016220602,"teacher_disagreement_score":0.34850624,"about_ca_system_score_codex":0.00033358333,"about_ca_system_score_gemma":0.0015159731,"threshold_uncertainty_score":0.4017381},"labels":[],"label_agreement":null},{"id":"W2290497264","doi":"10.1016/s1701-2163(16)34712-0","title":"Ovarian Cancer in the Elderly Patient: Are We Doing Enough?","year":2010,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Intensive care medicine; Oncology; Internal medicine","score_opus":0.011667549596247846,"score_gpt":0.24416090538729918,"score_spread":0.23249335579105132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290497264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95774287,0.010431683,0.0000027043702,0.021590205,0.00876269,0.00018131944,0.00002084743,0.0000015711339,0.0012661327],"genre_scores_gemma":[0.99753547,0.0010023543,0.00023880949,0.0011097608,0.00006992,0.000008965443,7.1541916e-7,0.000007649306,0.000026378511],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990794,0.0000364376,0.00032574,0.00010694556,0.00025427356,0.00019721405],"domain_scores_gemma":[0.9983525,0.00095860584,0.00029246794,0.00012552307,0.00014635912,0.00012452928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015673274,0.000101043406,0.0002812258,0.0001432216,0.0000752629,0.000021599255,0.00008884004,0.0000868458,0.00048153978],"category_scores_gemma":[0.0004008231,0.00006222914,0.000045174518,0.00028218766,0.000032291435,0.000040980143,0.000014836669,0.0005147691,2.799359e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007487171,0.00019682891,0.42239553,0.000030390982,0.00012296869,0.005876672,0.0004924081,0.00002644098,0.000013067524,0.0003147041,0.0035421061,0.5669814],"study_design_scores_gemma":[0.0025550171,0.0006309002,0.78284496,0.000022634045,0.00012137233,0.00017046292,0.0007011689,0.000013941894,0.000039822477,0.00007335111,0.21274988,0.00007648071],"about_ca_topic_score_codex":0.024746852,"about_ca_topic_score_gemma":0.27731764,"teacher_disagreement_score":0.5669049,"about_ca_system_score_codex":0.0004388174,"about_ca_system_score_gemma":0.0013300056,"threshold_uncertainty_score":0.98174745},"labels":[],"label_agreement":null},{"id":"W2293618284","doi":"10.1016/s0140-6736(15)01167-8","title":"Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; Juravinski Cancer Centre","funders":"Medical Research Council; Canadian Cancer Society Research Institute; AstraZeneca; University College London; Cancer Research UK; Cancer Australia","keywords":"Medicine; Double blind; Placebo; Ovarian cancer; Internal medicine; Oncology; Cancer; Pathology; Alternative medicine","score_opus":0.03579664388086664,"score_gpt":0.30764359791146967,"score_spread":0.27184695403060305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293618284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761494,0.000116342955,0.00005569099,0.011291381,0.0004393336,0.007824452,0.00013830129,0.000057805802,0.003927302],"genre_scores_gemma":[0.99506956,0.00009375355,0.000078251716,0.0008669245,0.0013257021,0.0019459096,0.000031999985,0.0000392248,0.0005486418],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99812675,0.00016611333,0.0004543503,0.00040019027,0.00039721598,0.0004553847],"domain_scores_gemma":[0.99837637,0.00054243184,0.00024968394,0.00058284437,0.00012204686,0.0001266044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055369764,0.00028616388,0.0012600431,0.00009390126,0.00008610296,0.00003207804,0.00013290858,0.00010381093,0.0004129888],"category_scores_gemma":[0.00009739135,0.00012272518,0.00014777482,0.0001983619,0.000098960394,0.0000944581,0.000025142783,0.00020628238,0.00003809059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9807693,0.0010267659,0.009528477,0.0000145470785,0.00079498085,0.000057314992,0.0004465698,0.0000071632644,0.0000527944,0.00023704852,0.002014531,0.005050515],"study_design_scores_gemma":[0.9865808,0.0017842699,0.008804507,0.00044956195,0.000590777,0.0000031750199,0.000027544067,0.000025591697,0.0005376949,0.00004768521,0.00096049777,0.00018788617],"about_ca_topic_score_codex":0.00023872865,"about_ca_topic_score_gemma":0.00023055173,"teacher_disagreement_score":0.018920202,"about_ca_system_score_codex":0.00027758526,"about_ca_system_score_gemma":0.0002257814,"threshold_uncertainty_score":0.5004588},"labels":[],"label_agreement":null},{"id":"W2299201707","doi":"10.1097/pgp.0000000000000274","title":"An Immunohistochemical Algorithm for Ovarian Carcinoma Typing","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Calgary; Université de Montréal; University of Alberta; University of British Columbia; Alberta Health Services; University of Ottawa; Calgary Laboratory Services; Foothills Medical Centre","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; University Health Network; Terry Fox Research Institute; Ontario Institute for Cancer Research; BC Cancer Agency; Calgary Laboratory Services","keywords":"Immunohistochemistry; Pathology; Typing; Carcinoma; Ovarian carcinoma; Medicine; Biology; Internal medicine; Ovarian cancer; Cancer; Genetics","score_opus":0.021938032361887908,"score_gpt":0.32770847165295053,"score_spread":0.3057704392910626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299201707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90984315,0.00034059904,0.07269365,0.014131471,0.0021400794,0.00025806398,0.00005682236,0.00002050685,0.00051563885],"genre_scores_gemma":[0.96196467,0.00006949963,0.036055557,0.0010279274,0.0007742621,0.000025453295,0.000009316476,0.0000107379765,0.00006256831],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998996,0.00005034893,0.00042623497,0.00018219704,0.00016975001,0.00017547395],"domain_scores_gemma":[0.9985624,0.00039211346,0.00024116992,0.00012039518,0.0005475875,0.00013635526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002844331,0.000107501655,0.0003073249,0.00011306395,0.000029669229,0.000012073776,0.00021927993,0.000141291,0.00051324716],"category_scores_gemma":[0.00036954772,0.000060758983,0.00020414,0.000031110845,0.00010100492,0.00009337751,0.000030569376,0.00011294649,0.000013821852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011815089,0.0018159023,0.05441117,0.000005288578,0.00045351803,0.003247276,0.00008514778,0.0000017875514,0.09107549,0.0036021837,0.0016490268,0.8424717],"study_design_scores_gemma":[0.02376759,0.012944652,0.8891517,0.00018178365,0.00038658915,0.011365385,0.000085214226,0.00030525526,0.020197202,0.013118988,0.028128278,0.00036735833],"about_ca_topic_score_codex":0.0000028877166,"about_ca_topic_score_gemma":9.098042e-7,"teacher_disagreement_score":0.8421043,"about_ca_system_score_codex":0.00036361883,"about_ca_system_score_gemma":0.0001277012,"threshold_uncertainty_score":0.5619697},"labels":[],"label_agreement":null},{"id":"W2302903621","doi":"10.5430/jst.v6n2p1","title":"Efficacy of a modified regimen of gemcitabine and cisplatin among women with recurrent epithelial ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; Regimen; Cisplatin; Neutropenia; Chemotherapy; Internal medicine; Nausea; Gastroenterology; Ovarian cancer; Vomiting; Combination chemotherapy; Chemotherapy regimen; Oncology; Cancer; Surgery","score_opus":0.014189373626942156,"score_gpt":0.27469093289876706,"score_spread":0.2605015592718249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302903621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736756,0.00043988094,0.00007518759,0.0015234388,0.00010391402,0.00022854646,0.00004543365,0.0000037628151,0.00021224924],"genre_scores_gemma":[0.9986143,0.0005611549,0.00045056661,0.00002773404,0.00019673724,0.000016183376,4.6603924e-7,0.000019376906,0.00011344193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865776,0.000033998596,0.00060668954,0.00014330886,0.00035109444,0.000207154],"domain_scores_gemma":[0.99840516,0.00011205719,0.00085020997,0.00017557139,0.00023832697,0.00021867818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027095445,0.00014922445,0.00067372655,0.00016223404,0.000021508236,0.000004587571,0.00007145958,0.000041814834,0.00012232123],"category_scores_gemma":[0.000061730134,0.00007806581,0.00007790287,0.0001340435,0.00015462993,0.00009660051,0.000023132112,0.00010993717,5.6250377e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045819048,0.0046983305,0.6432472,0.0010327117,0.0054270485,0.0012524802,0.0109847095,0.0003276245,0.04858033,0.0011006034,0.0018615862,0.23566833],"study_design_scores_gemma":[0.020113854,0.00476079,0.95126086,0.0037140497,0.00040745395,0.00018747924,0.00018860651,0.000026016394,0.018888226,0.0001684953,0.00015148046,0.00013271379],"about_ca_topic_score_codex":0.00007158969,"about_ca_topic_score_gemma":0.00001214482,"teacher_disagreement_score":0.30801365,"about_ca_system_score_codex":0.00018825446,"about_ca_system_score_gemma":0.00026095283,"threshold_uncertainty_score":0.31834313},"labels":[],"label_agreement":null},{"id":"W2305245841","doi":"10.1200/jco.2005.23.16_suppl.5137","title":"Weekly paclitaxel treatment of patients with progressive platinum resistant epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health","funders":"","keywords":"Medicine; Paclitaxel; Taxane; Chemotherapy; Internal medicine; Ovarian cancer; Quality of life (healthcare); Oncology; Cancer; Progression-free survival; Surgery; Gastroenterology; Breast cancer","score_opus":0.07164226877409904,"score_gpt":0.4345814840692362,"score_spread":0.3629392152951372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305245841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97738326,0.0014017321,0.000014527888,0.018711878,0.0005712321,0.00050879637,0.00008439301,0.00000636579,0.0013177969],"genre_scores_gemma":[0.98789084,0.00089250365,0.00856305,0.00057645224,0.0017431787,0.00003203007,0.000007172721,0.000021919132,0.0002728816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969357,0.00019539625,0.001958132,0.00021891457,0.0004496354,0.00024219506],"domain_scores_gemma":[0.9955936,0.00076494314,0.0023753678,0.00022376646,0.0006774119,0.0003648878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005065073,0.00018955352,0.0016174132,0.0000938688,0.0000361191,0.0000062168947,0.00008635787,0.00023510553,0.00046363167],"category_scores_gemma":[0.00028408927,0.00010278552,0.00036115618,0.00011214974,0.00020089422,0.00008889493,0.000015708236,0.00026269414,0.00000791936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020871954,0.013468727,0.5244365,0.00002273131,0.001757056,0.00041317422,0.0002257606,0.000022657789,0.00002099896,0.000119005395,0.0012726774,0.43736878],"study_design_scores_gemma":[0.03264956,0.07433349,0.7845809,0.00022407238,0.0011689402,0.000024370534,0.000051185816,0.000008573528,0.00024857937,0.000045884426,0.1065761,0.00008836563],"about_ca_topic_score_codex":0.000066499335,"about_ca_topic_score_gemma":0.00015144494,"teacher_disagreement_score":0.43728042,"about_ca_system_score_codex":0.00061704,"about_ca_system_score_gemma":0.0020874483,"threshold_uncertainty_score":0.5076442},"labels":[],"label_agreement":null},{"id":"W2309664335","doi":"10.1634/theoncologist.2015-0239","title":"Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer","year":2016,"lang":"en","type":"review","venue":"The Oncologist","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Randomized controlled trial; Clinical trial; Oncology; Internal medicine; Cancer; Serous fluid; Surgery","score_opus":0.0784323802967087,"score_gpt":0.382023392231853,"score_spread":0.3035910119351443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309664335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013756056,0.97132164,0.000049362327,0.001247736,0.0018728136,0.009310424,0.0022912067,0.000030873336,0.000119858254],"genre_scores_gemma":[0.03780784,0.9571972,0.00051450374,0.00028027577,0.00024193976,0.0035450142,0.00022837336,0.00009485999,0.00008998703],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9908787,0.0025374219,0.004691564,0.0009124768,0.0003656978,0.0006141203],"domain_scores_gemma":[0.9616855,0.030518502,0.0064266967,0.0007999102,0.00044804005,0.00012136573],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0076082707,0.00084920507,0.012712884,0.0004051344,0.0001437351,0.000024641768,0.00041900334,0.00039895915,0.000032542004],"category_scores_gemma":[0.0084813535,0.0003850994,0.0016605627,0.0005495604,0.0014019985,0.00014044667,0.00043372097,0.000409086,2.6077456e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06547386,0.00042256105,0.004197675,0.018139731,0.0020534908,0.000014001708,0.00039295442,0.0000015776549,0.000013017273,0.00008495103,0.000317396,0.90888876],"study_design_scores_gemma":[0.28276753,0.0023559975,0.030507535,0.33128768,0.021279326,0.00009412443,0.00029349627,0.00001727558,0.0007152346,0.0010538409,0.32763794,0.001990012],"about_ca_topic_score_codex":0.0025057162,"about_ca_topic_score_gemma":0.0013647192,"teacher_disagreement_score":0.9068988,"about_ca_system_score_codex":0.0010657441,"about_ca_system_score_gemma":0.0031839495,"threshold_uncertainty_score":0.99987066},"labels":[],"label_agreement":null},{"id":"W2312658559","doi":"10.1097/pgp.0000000000000240","title":"Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Biology; Stromal cell; Pathology; Somatic cell; Missense mutation; Mutation; Cancer research; Medicine; Gene; Genetics","score_opus":0.04362804355819849,"score_gpt":0.33091599219704054,"score_spread":0.28728794863884205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312658559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866771,0.0002630193,0.00086922606,0.009673383,0.00046854897,0.00030356474,0.00005978676,0.000023935874,0.0016614257],"genre_scores_gemma":[0.99196273,0.00011870227,0.0052162455,0.002099191,0.00028578195,0.000020444417,0.000025592357,0.000021295105,0.00024999495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998096,0.00024008122,0.0005663407,0.00035242332,0.00045728812,0.0002878892],"domain_scores_gemma":[0.99756056,0.00081500434,0.00046772443,0.0001452709,0.0006020642,0.00040934753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006939531,0.0002434652,0.0006119581,0.00023011964,0.0000944309,0.000078393896,0.00016785576,0.000107713866,0.000118963304],"category_scores_gemma":[0.0006092515,0.00017239094,0.00008998603,0.00010547066,0.00035040086,0.00018614942,0.00016144261,0.00044166145,0.0000056963113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008589094,0.0016549879,0.92002785,0.00003746323,0.0009024623,0.041651867,0.0003366597,0.00004617231,0.0018652319,0.0015156902,0.0012963293,0.02207619],"study_design_scores_gemma":[0.010261706,0.01166196,0.9444798,0.00015353222,0.00026209294,0.027144218,0.0005184041,0.00023612777,0.0005247734,0.0015491097,0.002975467,0.00023275812],"about_ca_topic_score_codex":0.00012877015,"about_ca_topic_score_gemma":0.00015161668,"teacher_disagreement_score":0.024451999,"about_ca_system_score_codex":0.00028298842,"about_ca_system_score_gemma":0.0003325099,"threshold_uncertainty_score":0.7029899},"labels":[],"label_agreement":null},{"id":"W2312762606","doi":"10.1097/00001703-200102000-00008","title":"Developments in the pathology of ovarian tumours","year":2001,"lang":"en","type":"review","venue":"Current Opinion in Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Grading (engineering); Serous fluid; Ovarian cancer; Ovarian carcinomas; Pathology; Endometriosis; Molecular pathology; Serous carcinoma; Ovarian carcinoma; Oncology; Bioinformatics; Cancer; Internal medicine; Biology","score_opus":0.14295897006314054,"score_gpt":0.415675555625093,"score_spread":0.27271658556195244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312762606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056267054,0.9846778,0.0000067202354,0.00017038666,0.012173995,0.0019273838,0.00004420467,0.000012373421,0.00093088497],"genre_scores_gemma":[0.00053417153,0.997678,0.00015659323,0.0000496717,0.00018479748,0.00082649256,0.0005076256,0.00004048265,0.000022178041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638426,0.0006079748,0.0014703008,0.00065343553,0.00032675805,0.00055725774],"domain_scores_gemma":[0.9936725,0.0048891716,0.0006437711,0.00061089895,0.00009259742,0.000091067035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068697956,0.0004519737,0.0022866684,0.0014256776,0.00003537336,0.000011658921,0.00043547348,0.0005277258,0.000090994654],"category_scores_gemma":[0.0021411513,0.00032601703,0.00033077085,0.0026777652,0.000115276336,0.000033616736,0.00013418624,0.00091673754,0.000064181455],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071199884,0.0014231809,0.016889581,0.0071760337,0.000059939233,0.00016753493,0.00020923423,6.897906e-7,6.298812e-9,0.0016545618,0.0009208421,0.9714913],"study_design_scores_gemma":[0.0019490807,0.00026577353,0.03643942,0.0072763106,0.0002466455,0.00019284677,0.00004692883,9.0324806e-7,7.090149e-8,0.000074730655,0.9532822,0.0002251381],"about_ca_topic_score_codex":0.0000176777,"about_ca_topic_score_gemma":0.000014482527,"teacher_disagreement_score":0.97126615,"about_ca_system_score_codex":0.0009635002,"about_ca_system_score_gemma":0.0011221606,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W2313406363","doi":"10.1097/pgp.0b013e31824d7445","title":"Transitional Cell Carcinoma of the Ovary is Related to High-grade Serous Carcinoma and is Distinct From Malignant Brenner Tumor","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Pathology; Ovary; Carcinoma; Serous carcinoma; Clear cell carcinoma; Serous fluid; Medicine; Biology; Cancer; Internal medicine; Ovarian cancer","score_opus":0.016123889129526992,"score_gpt":0.26009108057126895,"score_spread":0.24396719144174195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313406363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797755,0.00080308336,0.00004349323,0.017592607,0.0010803561,0.00016664606,0.0002817667,0.000004277715,0.00025227733],"genre_scores_gemma":[0.99428225,0.000029678637,0.001037232,0.0042978455,0.00025503457,0.000009781434,0.000014852884,0.000011226185,0.000062132676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985517,0.000121333345,0.0005555103,0.00019136093,0.00037201273,0.00020805147],"domain_scores_gemma":[0.9988103,0.00031595642,0.0003171259,0.00013711287,0.00022626547,0.00019325214],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002094914,0.00015385571,0.00039616227,0.00009485223,0.000041720643,0.000009003816,0.00019668174,0.00012061279,0.0015231927],"category_scores_gemma":[0.00006832868,0.000090256915,0.00020244055,0.000065017455,0.00013185831,0.00006692187,0.000087151486,0.00025321153,0.000018320627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037014968,0.0011974308,0.985716,0.000008615425,0.00018106881,0.0013307612,0.0008711766,0.000004996933,0.006617279,0.00045228953,0.0020346786,0.0012155682],"study_design_scores_gemma":[0.002649402,0.000798693,0.98172164,0.000034851644,0.0002036268,0.001755626,0.00006584443,0.000009740098,0.010717698,0.0013066472,0.00065017806,0.000086044834],"about_ca_topic_score_codex":0.00009477094,"about_ca_topic_score_gemma":0.0000069324637,"teacher_disagreement_score":0.014506724,"about_ca_system_score_codex":0.00015976574,"about_ca_system_score_gemma":0.00008788923,"threshold_uncertainty_score":0.9993895},"labels":[],"label_agreement":null},{"id":"W2314135891","doi":"10.1097/igc.0000000000000167","title":"Development of the Measure of Ovarian Symptoms and Treatment Concerns","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bloating; Nausea; Ovarian cancer; Prom; Sleep disorder; Patient-reported outcome; Flatulence; Physical therapy; Rating scale; Quality of life (healthcare); Internal medicine; Cancer; Insomnia; Psychiatry; Obstetrics","score_opus":0.03688508592569373,"score_gpt":0.32033568369517484,"score_spread":0.2834505977694811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314135891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937752,0.00057527935,0.00013128565,0.0036429728,0.00060245144,0.00013479122,0.000012005013,0.0000023715565,0.0011236466],"genre_scores_gemma":[0.9978385,0.0002475619,0.0013634501,0.00025895843,0.0001982674,0.000013117436,8.6280335e-7,0.000004733764,0.000074548276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998957,0.00003771641,0.00042974873,0.0000909265,0.0004059557,0.00007868954],"domain_scores_gemma":[0.9988609,0.00015113057,0.0004210278,0.00007784145,0.000420641,0.000068472946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018442901,0.00008974745,0.00029921372,0.000045355697,0.000023455514,0.000006485886,0.00012726337,0.00005229893,0.00038824914],"category_scores_gemma":[0.00012043986,0.00004486519,0.00012535659,0.00004654648,0.00008994713,0.000029841163,0.00003636985,0.000072264134,6.4190664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005946453,0.00092567585,0.53971416,0.000020547017,0.0019124576,0.000022509914,0.0007536781,0.0000712859,0.0029508655,0.002999475,0.00022523076,0.4498095],"study_design_scores_gemma":[0.0039924183,0.00088335335,0.94899416,0.000257243,0.00019994914,0.00004595142,0.000049762886,0.000031737367,0.01587217,0.0001629165,0.02945399,0.00005635729],"about_ca_topic_score_codex":0.000031411808,"about_ca_topic_score_gemma":0.00007789259,"teacher_disagreement_score":0.44975314,"about_ca_system_score_codex":0.0003678824,"about_ca_system_score_gemma":0.00032151895,"threshold_uncertainty_score":0.4251056},"labels":[],"label_agreement":null},{"id":"W2314493298","doi":"10.1097/01.cot.0000292954.13777.d3","title":"Ovarian Cancer","year":2004,"lang":"en","type":"article","venue":"Oncology Times","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Paclitaxel; Debulking; Internal medicine; Oncology; Cancer; Chemotherapy; Cisplatin; Gynecology","score_opus":0.0210936638660766,"score_gpt":0.33449598065611497,"score_spread":0.3134023167900384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314493298","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13752721,0.0045931092,0.00012653218,0.19438905,0.0011390303,0.00070327666,0.000024829393,0.0001999858,0.66129696],"genre_scores_gemma":[0.9801997,0.0005537232,0.004081357,0.0043818476,0.00040018145,0.00018101482,0.00001261187,0.000017300003,0.0101722665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947244,0.0000109339735,0.000103667364,0.00017317141,0.000073818075,0.00016594038],"domain_scores_gemma":[0.9996602,0.000023425642,0.000034033987,0.00015192802,0.000032357384,0.00009807448],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000046088437,0.00008303014,0.00021069951,0.00003934996,0.00004404468,0.000004761666,0.000033734348,0.00009093376,0.0030553394],"category_scores_gemma":[0.000010055206,0.000064046064,0.000057794125,0.000079704674,0.00005167746,0.000025729434,0.000015354653,0.00008226828,0.00038409486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076272094,0.0054831523,0.18548246,0.00010616489,0.0019439677,0.0030625707,0.0018677209,0.00029671742,0.002093317,0.08805052,0.20638932,0.50446135],"study_design_scores_gemma":[0.00867563,0.0013144795,0.1799183,0.00009672504,0.00037589166,0.00016207935,0.000058941925,0.000005601648,0.005112946,0.0025199975,0.8016201,0.00013930009],"about_ca_topic_score_codex":0.00043144246,"about_ca_topic_score_gemma":0.000112041846,"teacher_disagreement_score":0.84267247,"about_ca_system_score_codex":0.0004881585,"about_ca_system_score_gemma":0.0005403357,"threshold_uncertainty_score":0.997856},"labels":[],"label_agreement":null},{"id":"W2314742590","doi":"10.1055/s-0034-1388355","title":"Diagnostik adulter Granulosazelltumoren unter Berücksichtigung aktueller Forschungsergebnisse","year":2014,"lang":"de","type":"article","venue":"Geburtshilfe und Frauenheilkunde","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gynecology; Medicine","score_opus":0.010121379132414001,"score_gpt":0.26499626392163733,"score_spread":0.2548748847892233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314742590","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32751456,0.4293568,0.00963338,0.07182736,0.040779654,0.011991782,0.0013064066,0.0018950023,0.105695054],"genre_scores_gemma":[0.9569318,0.014169755,0.0017139987,0.00985091,0.009766549,0.00061079644,0.00086072984,0.00047849162,0.0056169312],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913618,0.00050086656,0.0017783588,0.0023867828,0.0014665123,0.0025057038],"domain_scores_gemma":[0.9932167,0.0012539149,0.0006834993,0.0026666585,0.00047526514,0.0017039437],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0009938277,0.0017787848,0.0021115264,0.0005673518,0.0006915854,0.00048588726,0.0008320454,0.00091096485,0.0046948143],"category_scores_gemma":[0.0005293969,0.0015796187,0.0011098802,0.00087195827,0.0006303017,0.00050342653,0.000428896,0.001293968,0.011189583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018023971,0.0074246307,0.49756742,0.0018557048,0.013590906,0.0016680667,0.0045512314,0.00030225966,0.00023358526,0.027793167,0.34594965,0.09726099],"study_design_scores_gemma":[0.011804325,0.00234119,0.10509874,0.002309114,0.008831277,0.000033789966,0.0002280491,0.0010806246,0.0031444614,0.0041029006,0.85896575,0.0020597756],"about_ca_topic_score_codex":0.0010802114,"about_ca_topic_score_gemma":0.0003623827,"teacher_disagreement_score":0.6294173,"about_ca_system_score_codex":0.00074934354,"about_ca_system_score_gemma":0.00042520007,"threshold_uncertainty_score":0.99949574},"labels":[],"label_agreement":null},{"id":"W2314751956","doi":"10.1097/pat.0000000000000291","title":"The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters","year":2015,"lang":"en","type":"review","venue":"Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian cancer; Clear cell carcinoma; Biology; Ovarian carcinoma; Fimbria; Carcinoma; Gynecology; Medicine; Pathology; Cancer; Genetics; Gene","score_opus":0.03896621840323807,"score_gpt":0.2876415838882577,"score_spread":0.24867536548501964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314751956","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01055723,0.98400503,0.000082526974,0.0017730349,0.0008716053,0.0019657316,0.00024969873,0.000014075534,0.00048109237],"genre_scores_gemma":[0.5016656,0.49716818,0.000241252,0.0002917819,0.000219296,0.00019400285,0.00006423816,0.00007832331,0.00007734255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976572,0.0006475261,0.0007353424,0.00041316607,0.00026930316,0.0002774705],"domain_scores_gemma":[0.9978375,0.0006863998,0.0007145147,0.00060339883,0.000054070188,0.00010415396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008059913,0.00037016696,0.0021188818,0.00011743115,0.00009977149,0.000017455086,0.00016116584,0.00029284804,0.0000101019],"category_scores_gemma":[0.000047774374,0.00020394153,0.00023306439,0.00014804836,0.00017527175,0.00003288064,0.00020387353,0.0003375412,8.8037217e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080324226,0.0007514998,0.08354134,0.30203333,0.006116701,0.0020296657,0.0031771571,0.0000033751853,0.00049442623,0.006268788,0.028963536,0.56581694],"study_design_scores_gemma":[0.04879408,0.023701776,0.16620187,0.21978197,0.05928765,0.022369996,0.0072231623,0.00009751897,0.0013123532,0.0009441711,0.44656572,0.003719728],"about_ca_topic_score_codex":0.00042552745,"about_ca_topic_score_gemma":0.00005674547,"teacher_disagreement_score":0.5620972,"about_ca_system_score_codex":0.00056137634,"about_ca_system_score_gemma":0.00038462455,"threshold_uncertainty_score":0.8316494},"labels":[],"label_agreement":null},{"id":"W2315722463","doi":"10.1093/annonc/mdw147","title":"Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Kyowa Hakko Kirin; National Comprehensive Cancer Network; Sanofi; PharmaMar; AstraZeneca; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Paclitaxel; Placebo; Oncology; Ovarian cancer; Gynecology; Internal medicine; Cancer; Alternative medicine; Pathology","score_opus":0.13738594973953594,"score_gpt":0.4197746250834984,"score_spread":0.28238867534396245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315722463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91762847,0.0023702683,0.000014544288,0.07694956,0.00019956265,0.0007453695,0.000096624535,0.00002029068,0.0019753405],"genre_scores_gemma":[0.99234664,0.005209959,0.00024505364,0.0014800788,0.00005945176,0.00025565564,0.0000050193235,0.000021486758,0.0003766516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997448,0.00033313566,0.0011157511,0.00036651795,0.00024595647,0.00049059064],"domain_scores_gemma":[0.9977288,0.00062630547,0.0007984151,0.00034851098,0.00021514016,0.00028277814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012035647,0.00018990293,0.001381458,0.00019711803,0.000028173561,0.0000024689134,0.000098173325,0.00015988463,0.00077909447],"category_scores_gemma":[0.00034714912,0.00010882267,0.00007238437,0.00038585023,0.00015377898,0.000065636676,0.00003742887,0.00014395487,0.000006334669],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050450854,0.0025385115,0.1389904,0.0006565929,0.0011373957,0.00009701415,0.00533183,0.00002305698,0.00025659677,0.0012618614,0.0071808877,0.792075],"study_design_scores_gemma":[0.03309798,0.017579246,0.92936224,0.0021523307,0.000055865687,0.000019433171,0.0007185926,0.0000064059886,0.00054046884,0.00025497001,0.015976146,0.00023633504],"about_ca_topic_score_codex":0.008045148,"about_ca_topic_score_gemma":0.008088328,"teacher_disagreement_score":0.79183865,"about_ca_system_score_codex":0.0010674611,"about_ca_system_score_gemma":0.0033921283,"threshold_uncertainty_score":0.99856037},"labels":[],"label_agreement":null},{"id":"W2316030169","doi":"10.1097/igc.0000000000000442","title":"Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University Medical Centre; McMaster University; Mount Sinai Hospital; Ontario Clinical Oncology Group; University Health Network; University of Toronto","funders":"Abbott Diagnostics","keywords":"Medicine; Malignancy; Ovarian cancer; Stage (stratigraphy); Histology; Cancer; Serous fluid; Internal medicine; Gynecology; Oncology; Gastroenterology; Biology","score_opus":0.011277928443958108,"score_gpt":0.28021973130373035,"score_spread":0.26894180285977226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316030169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951369,0.0023718718,0.00032614285,0.0007433482,0.00041972694,0.00057500903,0.00019904265,0.0000018786192,0.0002260875],"genre_scores_gemma":[0.99629474,0.0029373073,0.00045653275,0.000061609106,0.000088427434,0.00013117351,0.0000010529023,0.000011459353,0.000017672199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975755,0.0004883113,0.0007886715,0.00017930345,0.00078681635,0.00018137414],"domain_scores_gemma":[0.9960913,0.00088105496,0.001599093,0.00018675035,0.0011336821,0.000108140324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001891115,0.00016629268,0.00084815535,0.0001327688,0.000021083002,0.0000072346834,0.0003011773,0.00010434512,0.00020808495],"category_scores_gemma":[0.0005386523,0.000076580975,0.00016913628,0.0002644714,0.00043940343,0.00007833944,0.00009295437,0.00029723614,1.4060784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006196047,0.0006065373,0.97479254,0.000078555764,0.0023364455,0.000045532648,0.0006561854,0.0012681731,0.00009844426,0.0006010436,0.000020697116,0.013299779],"study_design_scores_gemma":[0.014865835,0.0011629384,0.9769609,0.0012314103,0.0005121827,0.00004407815,0.00020152342,0.0001836876,0.0026652883,0.002026,0.00007286138,0.00007331765],"about_ca_topic_score_codex":0.0047756108,"about_ca_topic_score_gemma":0.00038180273,"teacher_disagreement_score":0.013226462,"about_ca_system_score_codex":0.00067734666,"about_ca_system_score_gemma":0.00075920497,"threshold_uncertainty_score":0.7219327},"labels":[],"label_agreement":null},{"id":"W2316696396","doi":"10.1097/00000478-200110000-00009","title":"Occult Carcinoma in Prophylactic Oophorectomy Specimens","year":2001,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto Public Health","funders":"","keywords":"Medicine; Occult; Ovarian carcinoma; Carcinoma; Malignancy; Ovarian cancer; Gynecology; Cancer; Internal medicine; Pathology","score_opus":0.01788178416218663,"score_gpt":0.28828664064403076,"score_spread":0.27040485648184415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316696396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844319,0.000783411,0.0000067666783,0.012048172,0.00013219516,0.00013248167,0.0000013381698,0.0000051603784,0.0024585628],"genre_scores_gemma":[0.9979162,0.00087794627,0.00023016348,0.0005602314,0.00032909334,0.0000066467733,6.771299e-7,0.000012489794,0.000066553075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987694,0.0002211797,0.00040259436,0.00014272521,0.0002029725,0.00026113493],"domain_scores_gemma":[0.999002,0.00022097075,0.00033981132,0.00020850837,0.00009215605,0.00013656526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038394134,0.00012478116,0.00059442944,0.00013763204,0.000031009473,0.000007421565,0.000113357695,0.000028818578,0.00020584786],"category_scores_gemma":[0.000032328946,0.000067106885,0.00016291633,0.0004150029,0.00036311353,0.000032994038,0.000025140715,0.00035936572,0.00003195904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004768042,0.0011443434,0.84103453,0.000010745062,0.000116210336,0.089353636,0.0006582489,0.000042653894,0.00078863115,0.00026243526,0.00036199306,0.061458506],"study_design_scores_gemma":[0.004120798,0.0044417623,0.93398476,0.000039769377,0.00014197954,0.042115204,0.00040011283,0.000011850453,0.00022150413,0.00020296923,0.014220191,0.000099120094],"about_ca_topic_score_codex":0.00006161807,"about_ca_topic_score_gemma":0.000006392963,"teacher_disagreement_score":0.09295018,"about_ca_system_score_codex":0.0001478286,"about_ca_system_score_gemma":0.00012859251,"threshold_uncertainty_score":0.27365392},"labels":[],"label_agreement":null},{"id":"W2317206393","doi":"10.1097/pgp.0b013e3182800ad5","title":"The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Biology; Stem cell marker; Pathology; Epithelium; Homeobox protein NANOG; Stem cell; Clear cell; Ovarian cancer; Malignant transformation; Cuboidal Cell; Ovarian carcinoma; Immunohistochemistry; Cancer research; Cancer; Induced pluripotent stem cell; Embryonic stem cell; Immunology; Cell biology; Medicine; Genetics; Biochemistry","score_opus":0.012162100433678819,"score_gpt":0.24381098765981635,"score_spread":0.23164888722613752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317206393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861493,0.00029371254,0.0000120024215,0.011357748,0.00041290082,0.0007280651,0.000037416976,0.00000309908,0.001005718],"genre_scores_gemma":[0.9985891,0.00011077315,0.00022467117,0.0006840315,0.000074119205,0.000034427783,0.000004239989,0.000010577943,0.00026807035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997358,0.0006977924,0.0008662329,0.00027192282,0.00056704885,0.00023900706],"domain_scores_gemma":[0.99686754,0.0013309245,0.00083622034,0.00039059223,0.00051202305,0.00006269769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014155855,0.00017728395,0.000482719,0.00007187635,0.00005193432,0.000025431984,0.0005314869,0.00012687639,0.00026969533],"category_scores_gemma":[0.00020509819,0.00007522378,0.00018777137,0.00018277453,0.00031847192,0.00008264947,0.00012845072,0.000435771,0.000007745261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015199455,0.0025393676,0.98117673,0.00003058939,0.00017263555,0.0008997743,0.0007652412,0.00007888116,0.009209828,0.0002999473,0.0014927908,0.0018142718],"study_design_scores_gemma":[0.0036510543,0.0011120542,0.98161626,0.000091673486,0.00007479454,0.00048620722,0.00058850355,0.000057425645,0.0116844,0.00030571572,0.0002524939,0.00007942476],"about_ca_topic_score_codex":0.0003308843,"about_ca_topic_score_gemma":0.00023828655,"teacher_disagreement_score":0.012439752,"about_ca_system_score_codex":0.00016580008,"about_ca_system_score_gemma":0.00025149208,"threshold_uncertainty_score":0.3067537},"labels":[],"label_agreement":null},{"id":"W2317375977","doi":"10.1111/igc.0b013e3181f6bde3","title":"Intraperitoneal Chemotherapy","year":2010,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Chemotherapy; Intraperitoneal chemotherapy; Peritoneal cavity; Gynecologic oncology; Oncology; Randomized controlled trial; Internal medicine; Intensive care medicine; Surgery; Cancer; Ovarian cancer","score_opus":0.05825613593496491,"score_gpt":0.43704614987625223,"score_spread":0.3787900139412873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317375977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018700324,0.99090767,0.000010930672,0.0029832986,0.0044662813,0.00029384627,0.000050544488,0.000011807465,0.0010886131],"genre_scores_gemma":[0.00021335097,0.9938966,0.0007510264,0.0011456559,0.0035836196,0.00007382966,0.000017907361,0.00003251014,0.00028552546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811983,0.000045407272,0.00084495574,0.00021897382,0.00058872066,0.00018210532],"domain_scores_gemma":[0.9979797,0.00028695614,0.00085163134,0.00014364033,0.0005417379,0.00019636344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019690613,0.00028715777,0.0015071988,0.00020528841,0.000023447461,0.000050591883,0.00039991594,0.00043677428,0.0064462414],"category_scores_gemma":[0.00014335674,0.00016824793,0.0009977687,0.00010418005,0.00008919322,0.00006226575,0.000044931952,0.0009900182,0.00003655005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008504066,0.00045347714,0.00023592079,0.00028027524,0.0013745788,0.0007822124,0.000011664474,3.156535e-7,0.000001552972,0.00011701041,0.0028633866,0.99379456],"study_design_scores_gemma":[0.0012451411,0.00047887804,0.00084135425,0.003357496,0.00093310606,0.0011146963,0.0000025759232,6.371109e-7,0.00000862991,0.000060995244,0.9918144,0.00014214485],"about_ca_topic_score_codex":0.0000096687945,"about_ca_topic_score_gemma":0.000010001838,"teacher_disagreement_score":0.9936524,"about_ca_system_score_codex":0.0007561609,"about_ca_system_score_gemma":0.0010267905,"threshold_uncertainty_score":0.994462},"labels":[],"label_agreement":null},{"id":"W2318409487","doi":"10.1111/igc.0b013e3181e273a8","title":"Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Sorafenib; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Ovarian cancer; Adverse effect; Toxicity; Clinical endpoint; Chemotherapy; Phases of clinical research; Cancer; Clinical trial; Gastroenterology; Hepatocellular carcinoma","score_opus":0.01911840457621101,"score_gpt":0.32815200818142676,"score_spread":0.30903360360521576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318409487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97260666,0.00038599098,0.000034917568,0.023871932,0.0021597089,0.00024269897,0.000025716085,0.0000064377023,0.0006659472],"genre_scores_gemma":[0.99696934,0.00087995874,0.0007198929,0.00072936784,0.0005146298,0.00009783348,0.0000068380405,0.000011120965,0.00007099844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985823,0.000038994145,0.00049415743,0.00018659943,0.00050945836,0.00018850784],"domain_scores_gemma":[0.99888945,0.0001475949,0.00029110114,0.000081947466,0.00047875856,0.000111172754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030874342,0.00013831098,0.0003409514,0.00028451663,0.000016334347,0.000027892333,0.00017952682,0.00010892123,0.0024122454],"category_scores_gemma":[0.00016328164,0.00009027352,0.00008521457,0.0001915414,0.0000658128,0.00014273348,0.000029350262,0.0005903654,0.0000048736642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023543537,0.0021633056,0.87243485,0.000012129444,0.00020654657,0.0011747606,0.0001581506,0.00026438496,0.0015146077,0.0020209812,0.00032205225,0.11737387],"study_design_scores_gemma":[0.011077466,0.0009609927,0.9764825,0.00026227869,0.000050290848,0.00009820343,0.00002766565,0.00015081043,0.0010164807,0.0006453022,0.009120322,0.00010768913],"about_ca_topic_score_codex":0.00051152514,"about_ca_topic_score_gemma":0.0071736625,"teacher_disagreement_score":0.117266186,"about_ca_system_score_codex":0.00074362586,"about_ca_system_score_gemma":0.0005265714,"threshold_uncertainty_score":0.9984997},"labels":[],"label_agreement":null},{"id":"W2318970924","doi":"10.1016/j.ygyno.2015.01.257","title":"Access to high quality food and survival from ovarian cancer: An analysis of Cook County, Illinois","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ovarian cancer; Environmental health; Overall survival; Consumption (sociology); Gerontology; Survival analysis; Demography; Cancer; Oncology; Internal medicine","score_opus":0.11633630079080964,"score_gpt":0.4119605093691766,"score_spread":0.29562420857836696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318970924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806053,0.00044859314,0.00011358226,0.007466449,0.0006860957,0.0005575935,0.0008590146,0.000045372217,0.0017627921],"genre_scores_gemma":[0.99509907,0.00027893062,0.0014032761,0.0025393178,0.00017045016,0.0002038135,0.00024186118,0.000013519045,0.00004978098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979661,0.00033719972,0.0005147495,0.0005898724,0.00027779784,0.00031424194],"domain_scores_gemma":[0.99771476,0.00071372476,0.00026913267,0.00047537655,0.00033425976,0.0004927385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006799856,0.00020986355,0.0013175722,0.00023091928,0.000053755804,0.000025768182,0.00020150456,0.00027446734,0.00093414873],"category_scores_gemma":[0.00029301603,0.00016772245,0.00010775228,0.0005981918,0.00013504576,0.00010194737,0.00016068816,0.00013067551,0.0000078858475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005863017,0.001368494,0.9687122,0.000016477463,0.0028278115,0.000062403655,0.0005650202,0.0004024119,0.00009827238,0.0017306089,0.0012124231,0.022417558],"study_design_scores_gemma":[0.0040372624,0.004945035,0.9770194,0.000008766507,0.0030693852,0.0000017132578,0.00040871557,0.00009955814,0.00034287677,0.00076210307,0.009133891,0.00017123563],"about_ca_topic_score_codex":0.022971984,"about_ca_topic_score_gemma":0.05473546,"teacher_disagreement_score":0.031763475,"about_ca_system_score_codex":0.0008611511,"about_ca_system_score_gemma":0.0006844392,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W2319325812","doi":"10.1097/01.ogx.0000446909.04052.1e","title":"A 2-Stage, Single-Arm, Phase 2 Study of Epigallocatechin Gallate–Enriched Green Tea Drink as a Maintenance Therapy in Women With Advanced-Stage Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; Hôtel-Dieu de Québec; Hôpital du Saint-Sacrement; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Taxane; Debulking; Ovarian cancer; Stage (stratigraphy); Serous fluid; Oncology; Internal medicine; Cancer; Chemotherapy; Clinical trial; Surgery; Gynecology; Breast cancer","score_opus":0.04332187523270023,"score_gpt":0.3211670897195394,"score_spread":0.2778452144868392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319325812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949937,0.0005667673,0.00010175828,0.0005931438,0.0001608143,0.0022335884,0.00005372576,0.000099984274,0.0011965117],"genre_scores_gemma":[0.9963608,0.00042152422,0.00035685877,0.0008284424,0.000042530784,0.00090029516,0.00002494304,0.000058292844,0.0010063245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99556345,0.0008487865,0.00086750294,0.001059088,0.0007014549,0.00095973787],"domain_scores_gemma":[0.99527824,0.0028235577,0.00037998718,0.0007032329,0.0002966421,0.0005183287],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010047994,0.00053298456,0.0014647613,0.000228141,0.00009367853,0.00003863093,0.00033908815,0.00026880662,0.0015159249],"category_scores_gemma":[0.0022394753,0.00033797725,0.00010989218,0.0019262675,0.0001754086,0.000108048196,0.00011966328,0.0005617075,0.000025113239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008753888,0.04440524,0.69423574,0.00006330858,0.00046732888,0.0007202611,0.0009402713,0.00040382496,0.0005979646,0.00021029823,0.0000481798,0.2491537],"study_design_scores_gemma":[0.035176586,0.04518789,0.9141802,0.00007359406,0.000047547244,0.000004490234,0.00045461673,0.00022212579,0.00015655765,0.00007351483,0.0040165517,0.0004062997],"about_ca_topic_score_codex":0.005897166,"about_ca_topic_score_gemma":0.0028220005,"teacher_disagreement_score":0.24874741,"about_ca_system_score_codex":0.0011455739,"about_ca_system_score_gemma":0.00021621528,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W2319987028","doi":"10.4172/2375-4508.1000169","title":"Synchrotron Imaging of Ovaries Ex Vivo","year":2016,"lang":"en","type":"article","venue":"Journal of Fertilization In Vitro - IVF-Worldwide Reproductive Medicine Genetics & Stem Cell Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ex vivo; Synchrotron; Materials science; Physics; Optics; In vivo; Biology","score_opus":0.019170575628993124,"score_gpt":0.28803008593481016,"score_spread":0.26885951030581706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319987028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94258624,0.03229841,0.0064103724,0.01486772,0.0015677146,0.00074837316,0.00002002154,0.000019705805,0.0014814629],"genre_scores_gemma":[0.99330264,0.003921847,0.0013708181,0.00019153897,0.0008219275,0.000014366805,0.000007792922,0.000035874597,0.0003331716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701375,0.00026536023,0.0014793201,0.00053268904,0.00036120167,0.0003476725],"domain_scores_gemma":[0.99684304,0.0003199632,0.0011441769,0.000576146,0.0009588102,0.00015786914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009121559,0.00028935872,0.0010344104,0.00064562086,0.00003954678,0.0000053575463,0.00017279068,0.00009911592,0.00019928391],"category_scores_gemma":[0.0002937518,0.00017269136,0.00015022326,0.00049833476,0.00047246108,0.000091612834,0.00005879565,0.00018923092,0.000004333934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023691943,0.00042018323,0.18204355,0.00015768786,0.00018548223,0.00006294205,0.00068330567,0.000079270445,0.7670831,0.00013559239,0.00066540675,0.046114285],"study_design_scores_gemma":[0.0065659704,0.0017502042,0.101768926,0.0009229713,0.000467695,0.00018441361,0.00052655756,0.000060709237,0.87982935,0.0011311873,0.006587204,0.00020481994],"about_ca_topic_score_codex":0.000034988978,"about_ca_topic_score_gemma":0.0000063467132,"teacher_disagreement_score":0.112746246,"about_ca_system_score_codex":0.00036541725,"about_ca_system_score_gemma":0.0002818953,"threshold_uncertainty_score":0.70421493},"labels":[],"label_agreement":null},{"id":"W2320681944","doi":"10.1016/j.ygyno.2013.04.377","title":"Nonascites-forming advanced-stage serous ovarian cancer is related to a superior epithelial antigen presentation and enhanced infiltrating T-cell response","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University Health Network; University of Toronto; Toronto General Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Ascites; Serous fluid; Medicine; Ovarian cancer; Antigen; Ovary; Stage (stratigraphy); Cancer antigen; Cancer research; Cancer; Serous ovarian cancer; Differential diagnosis; Pathology; Immunology; Oncology; Internal medicine; Biology","score_opus":0.015505561126462597,"score_gpt":0.32162907924634443,"score_spread":0.3061235181198818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320681944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859173,0.00037643337,0.0000709615,0.007846847,0.00046843756,0.00229955,0.000050007795,0.00009840039,0.0028720591],"genre_scores_gemma":[0.9845284,0.00044301225,0.006671378,0.0037040436,0.000079689824,0.0013806247,0.000020510057,0.00003374193,0.0031385648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99789083,0.00021482771,0.00051749626,0.00063691917,0.00018516483,0.0005547428],"domain_scores_gemma":[0.9982491,0.00076823734,0.00020407254,0.0002992095,0.0001802478,0.000299093],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037761367,0.0002827464,0.00058767153,0.00017274551,0.00021162623,0.00004508325,0.00010277412,0.00029711085,0.0031578718],"category_scores_gemma":[0.00036655276,0.00023591291,0.0000827374,0.00032787953,0.00009676051,0.00022761809,0.00009949752,0.00024946273,0.00020263347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022345933,0.000926667,0.16878352,0.00013132655,0.00028836838,0.0003389729,0.0082442155,0.0003786115,0.59288675,0.000082986764,0.0012199713,0.224484],"study_design_scores_gemma":[0.009053193,0.0068968316,0.88339674,0.00010481096,0.0001678002,0.00006181312,0.0019635982,0.00044910755,0.0804513,0.00014403107,0.01688,0.00043076003],"about_ca_topic_score_codex":0.00095123926,"about_ca_topic_score_gemma":0.00031122167,"teacher_disagreement_score":0.71461326,"about_ca_system_score_codex":0.00065012154,"about_ca_system_score_gemma":0.0005075542,"threshold_uncertainty_score":0.9977534},"labels":[],"label_agreement":null},{"id":"W2321190300","doi":"10.1158/1538-7445.am2013-3564","title":"Abstract 3564: ARID1A promotes endocrine resistance in ER+ breast cancer cells.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"ARID1A; Cancer research; Gene silencing; Estrogen; Biology; Estrogen receptor; Cancer cell; Estrogen receptor alpha; Breast cancer; Cell growth; Chromatin; Cancer; Internal medicine; Endocrinology; Medicine; Gene; Mutation; Genetics","score_opus":0.05636248359988951,"score_gpt":0.3898862271509738,"score_spread":0.33352374355108433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321190300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93708366,0.010180115,0.0000011019152,0.039403778,0.0003064002,0.0021374954,0.00018576103,0.00006132651,0.0106403725],"genre_scores_gemma":[0.98525,0.0053897393,0.00015595414,0.00027690118,0.0005479027,0.0037558023,0.000014029447,0.000058408423,0.004551285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970603,0.00007749787,0.00036766665,0.0006721203,0.0008331013,0.0009892967],"domain_scores_gemma":[0.998298,0.00016468165,0.000065300876,0.0005918547,0.00051352254,0.0003666472],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036823325,0.00024027823,0.000420803,0.00031136937,0.0001280725,0.00010117696,0.00022863,0.00009564699,0.010228465],"category_scores_gemma":[0.000035421763,0.00019351346,0.00009208285,0.00075751846,0.0002079335,0.00020335277,0.00009591068,0.00071102177,0.0004458083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015312964,0.003260749,0.41284156,0.0024666858,0.00062425755,0.0015319512,0.001550623,0.000059641578,0.17757563,0.0011289938,0.2778431,0.11958551],"study_design_scores_gemma":[0.0034073663,0.00012790973,0.9008234,0.0014686841,0.000033899276,0.000013487939,0.00013349432,0.000017533692,0.067198336,0.00050478627,0.025995566,0.00027550707],"about_ca_topic_score_codex":0.02266924,"about_ca_topic_score_gemma":0.009182715,"teacher_disagreement_score":0.48798186,"about_ca_system_score_codex":0.0013777971,"about_ca_system_score_gemma":0.0008782383,"threshold_uncertainty_score":0.99067634},"labels":[],"label_agreement":null},{"id":"W2322260142","doi":"10.1097/pas.0b013e31825793e1","title":"Ovarian Serous Tumors of Low Malignant Potential With Nodal Low-grade Serous Carcinoma","year":2012,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Psammoma body; Medicine; Serous fluid; Lymph node; Serous carcinoma; NODAL; Pathology; Lymph; Ovarian carcinoma; Ovarian cancer; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.010364294369774762,"score_gpt":0.248440317746362,"score_spread":0.23807602337658723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322260142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420965,0.00070908276,0.00017836023,0.0042549702,0.0002291635,0.00017688198,0.000014112627,0.000009605338,0.00021816714],"genre_scores_gemma":[0.99777013,0.00018621517,0.0009417674,0.00040445253,0.00061628217,0.0000072419175,0.0000032375083,0.000032393407,0.000038290367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798906,0.0003161281,0.00060066266,0.00017676792,0.00041263728,0.00050473283],"domain_scores_gemma":[0.99812335,0.00015832049,0.0008533543,0.00034545705,0.00017495046,0.00034455064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055124494,0.00023008311,0.0010079804,0.00012784664,0.0000657678,0.000008402726,0.00019176683,0.000051580184,0.00012182239],"category_scores_gemma":[0.000015544329,0.00011985619,0.00026421846,0.0003035636,0.0007633764,0.000077302735,0.00005069156,0.00037439534,0.000012160869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013881959,0.0053825984,0.8817164,0.00015306544,0.0012534147,0.05201163,0.0028929214,0.00038046556,0.007576347,0.0009826714,0.00041739817,0.03335118],"study_design_scores_gemma":[0.0069151493,0.008865059,0.87882984,0.00027134048,0.00078022113,0.09843853,0.0010181029,0.000023178902,0.0040796464,0.00006229728,0.0004784486,0.00023821065],"about_ca_topic_score_codex":0.0001260943,"about_ca_topic_score_gemma":0.0000026372772,"teacher_disagreement_score":0.046426903,"about_ca_system_score_codex":0.00009547045,"about_ca_system_score_gemma":0.0001840247,"threshold_uncertainty_score":0.48875934},"labels":[],"label_agreement":null},{"id":"W2322691303","doi":"10.1097/igc.0b013e31822925c0","title":"Identification and Quantification of Peritoneal Metastases in Patients With Ovarian Cancer With Multidetector Computed Tomography","year":2011,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Radiology; Multidetector computed tomography; Stage (stratigraphy); Metastasis; Computed tomography; Retrospective cohort study; Cancer; Nuclear medicine; Surgery; Internal medicine","score_opus":0.027438616178764065,"score_gpt":0.28938462997752934,"score_spread":0.26194601379876525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322691303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800175,0.00044399744,0.00039558584,0.0005624407,0.00023855567,0.00025485613,0.00006636912,0.0000050562126,0.00003141127],"genre_scores_gemma":[0.99753624,0.00018221291,0.0020630076,0.00009347826,0.000055046105,0.000044142467,0.000010626955,0.000008393614,0.0000068231134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888074,0.000040822215,0.00042405957,0.00016553054,0.00039134486,0.000097515],"domain_scores_gemma":[0.9984284,0.00007463433,0.00049245375,0.000079843114,0.00084853586,0.00007610743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013680963,0.00010954546,0.0002846687,0.00022340122,0.000018633484,0.000015108548,0.000099864534,0.000045898832,0.00033347396],"category_scores_gemma":[0.000036470276,0.00006618117,0.00005375236,0.00016671569,0.00010914842,0.00014249903,0.000015935539,0.000115255076,3.9325622e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026918412,0.001090487,0.9784123,0.000019110745,0.0005456488,0.00004006687,0.00020350859,0.000077902165,0.00038321942,0.00013498773,0.000025338386,0.016375639],"study_design_scores_gemma":[0.0047987932,0.0012074804,0.98786706,0.00021199515,0.00017592443,0.000011291506,0.000046881592,0.00005816687,0.0054263105,0.000028148017,0.00009498188,0.000072955394],"about_ca_topic_score_codex":0.000402574,"about_ca_topic_score_gemma":0.00039672598,"teacher_disagreement_score":0.016302682,"about_ca_system_score_codex":0.0001656285,"about_ca_system_score_gemma":0.000119132834,"threshold_uncertainty_score":0.3651306},"labels":[],"label_agreement":null},{"id":"W2323089456","doi":"10.1097/pgp.0000000000000270","title":"Adopting a Uniform Approach to Site Assignment in Tubo-Ovarian High-Grade Serous Carcinoma","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Terminology; Serous carcinoma; Serous fluid; Ovarian carcinoma; Fallopian tube; Disease; Computer science; Protocol (science); Medicine; Ovarian cancer; Gynecology; Pathology; Internal medicine; Cancer; Linguistics","score_opus":0.027029408885880946,"score_gpt":0.2849359329485306,"score_spread":0.25790652406264963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323089456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724021,0.00006534482,0.0063614245,0.018846044,0.0006541396,0.00024038994,0.000021280972,0.000011469245,0.0013978097],"genre_scores_gemma":[0.98066115,0.000052958378,0.01689046,0.0018875225,0.00036307794,0.000032727825,0.000006214106,0.000012108243,0.00009380422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832094,0.00010911383,0.0006240367,0.0002646723,0.0004002228,0.0002810133],"domain_scores_gemma":[0.9988099,0.00033882554,0.00026667136,0.0001354823,0.00024205417,0.00020710971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047737258,0.00015988751,0.00043662504,0.0003015047,0.000024007031,0.000017703442,0.00023339607,0.00014787324,0.00027002394],"category_scores_gemma":[0.00043040433,0.00009153917,0.0001377981,0.00010377973,0.000059393773,0.00008779096,0.00010687,0.00022404501,0.000045871853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013608367,0.00478078,0.8652075,0.00001516169,0.00037690156,0.01886992,0.00053478376,0.0004846594,0.008868062,0.009280055,0.001309386,0.08891194],"study_design_scores_gemma":[0.0062087816,0.002097966,0.98419595,0.00011793546,0.00005191499,0.0025475186,0.000063815714,0.00001990593,0.0005588564,0.00071524933,0.0032987983,0.00012331457],"about_ca_topic_score_codex":0.000038229893,"about_ca_topic_score_gemma":0.00002102179,"teacher_disagreement_score":0.11898843,"about_ca_system_score_codex":0.00091934134,"about_ca_system_score_gemma":0.00012578371,"threshold_uncertainty_score":0.3732859},"labels":[],"label_agreement":null},{"id":"W2324113074","doi":"10.1097/igc.0000000000000639","title":"Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Royal Jubilee Hospital; University of British Columbia; University of Calgary; University of Alberta; BC Cancer Agency; Calgary Laboratory Services; Royal Alexandra Hospital","funders":"","keywords":"Medicine; BRCA mutation; Serous carcinoma; Fallopian tube; Ovarian cancer; Serous fluid; Gynecology; Ovarian carcinoma; Genetic testing; Breast cancer; Cancer; Oncology; Obstetrics; Internal medicine","score_opus":0.009978530736780355,"score_gpt":0.2639358044063036,"score_spread":0.25395727366952325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324113074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180114,0.0011621364,0.0000069856965,0.00526724,0.00082493643,0.00021025586,0.0006987698,0.0000049949776,0.000023512279],"genre_scores_gemma":[0.996975,0.002038878,0.00014489425,0.00034078298,0.00036864623,0.000043194566,0.0000032152066,0.000016561997,0.000068851106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807775,0.00009380636,0.0007506667,0.0002665413,0.0005489795,0.00026226288],"domain_scores_gemma":[0.9984054,0.0003619249,0.0005506495,0.000113918926,0.0003391778,0.00022894626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002619936,0.00022045382,0.00072454277,0.00019958254,0.000030413003,0.000012213378,0.000185751,0.00014261922,0.0007922035],"category_scores_gemma":[0.00011804317,0.00013132925,0.00011181731,0.000087674875,0.0002369344,0.0001594134,0.00015113852,0.0002051116,8.394493e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00203916,0.00049135194,0.9647378,0.000037371356,0.00072220684,0.0007003521,0.00045069057,0.000030140845,0.0013237663,0.000084580824,0.00011221559,0.029270409],"study_design_scores_gemma":[0.01041096,0.0011270259,0.98516387,0.00025655766,0.00016061288,0.0006060967,0.00014489863,0.000025328483,0.0016763507,0.00022867465,0.00006985186,0.0001297753],"about_ca_topic_score_codex":0.005076351,"about_ca_topic_score_gemma":0.002371202,"teacher_disagreement_score":0.029140633,"about_ca_system_score_codex":0.0014691782,"about_ca_system_score_gemma":0.00027270522,"threshold_uncertainty_score":0.86740726},"labels":[],"label_agreement":null},{"id":"W2324134517","doi":"10.1111/igc.0b013e3181bf830d","title":"Other New Targets","year":2009,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Clinical trial; Precision medicine; Ovarian cancer; Personalized medicine; Targeted therapy; Cancer; Intensive care medicine; Medical physics; Bioinformatics; Internal medicine; Pathology","score_opus":0.09738799521216375,"score_gpt":0.4397810619632007,"score_spread":0.342393066751037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324134517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067361834,0.9912738,0.000055503988,0.0033957816,0.0021759206,0.00026779732,0.00003911282,0.000011548571,0.002773774],"genre_scores_gemma":[0.000062358195,0.9914146,0.0008477214,0.0020508748,0.0036035408,0.000021059841,0.00001161047,0.000025446847,0.0019627574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806213,0.00005440017,0.00085111277,0.00021995764,0.0006220817,0.00019031703],"domain_scores_gemma":[0.9980969,0.00022881778,0.00090124295,0.00012749374,0.0003764566,0.00026908427],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016027098,0.00028885162,0.0015105548,0.00021691671,0.000018075032,0.00004301857,0.00036227016,0.00027518277,0.008527138],"category_scores_gemma":[0.00018393771,0.00016708253,0.0010172733,0.00010783301,0.000033741388,0.00006657602,0.000040000425,0.00049675984,0.000081597675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062605046,0.00033162834,0.00014129946,0.00016546027,0.0014851182,0.00090139144,0.0000090197145,0.0000023277391,1.2802425e-7,0.0002238777,0.0352215,0.96145564],"study_design_scores_gemma":[0.0011625867,0.00063028437,0.0007965653,0.006050427,0.0013663381,0.0005452451,0.0000016117676,4.1527164e-7,0.0000017703503,0.0003945419,0.9889081,0.00014211604],"about_ca_topic_score_codex":0.000031160413,"about_ca_topic_score_gemma":0.000013046888,"teacher_disagreement_score":0.96131355,"about_ca_system_score_codex":0.0012148413,"about_ca_system_score_gemma":0.0014749792,"threshold_uncertainty_score":0.9923792},"labels":[],"label_agreement":null},{"id":"W2324164945","doi":"10.1097/igc.0000000000000196","title":"DNA Damage Signaling and Apoptosis in Preinvasive Tubal Lesions of Ovarian Carcinoma","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Serous fluid; Immunohistochemistry; Medicine; Cancer research; Apoptosis; Ovarian cancer; Fallopian tube; DNA damage; Genome instability; Serous carcinoma; Malignancy; Tissue microarray; Cancer; Pathology; Oncology; Internal medicine; Biology; DNA; Genetics; Gynecology","score_opus":0.026236640482513455,"score_gpt":0.3063069944518052,"score_spread":0.28007035396929175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324164945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327064,0.00032190394,0.00012661623,0.0048871506,0.00038986866,0.00010950865,0.000014833388,0.0000031681602,0.00087628776],"genre_scores_gemma":[0.99788076,0.00029628037,0.0009486525,0.00054138585,0.00027571226,0.000014269736,0.0000025854206,0.00000683408,0.0000335302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989109,0.000061108956,0.00044182304,0.00013581238,0.00033015577,0.000120172],"domain_scores_gemma":[0.9987867,0.00041294133,0.00027785308,0.000067369,0.00034427567,0.00011088572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025789512,0.00009911431,0.00033477455,0.0001574595,0.000018958895,0.000014799523,0.00012377577,0.00007542124,0.0006575582],"category_scores_gemma":[0.0003590245,0.000069937494,0.00010844033,0.00007960338,0.00007095226,0.00007928782,0.00004810099,0.00017248689,0.0000012321389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006534503,0.000729462,0.95050174,0.00003553727,0.0003912818,0.00020208,0.0003111491,0.00032684364,0.0119410865,0.002472538,0.000359934,0.032074872],"study_design_scores_gemma":[0.003671072,0.0009751929,0.97188205,0.00026173066,0.000116114934,0.000054090262,0.00008727944,0.00014176735,0.021079188,0.000750456,0.00090570754,0.000075364755],"about_ca_topic_score_codex":0.00012324483,"about_ca_topic_score_gemma":0.00006397769,"teacher_disagreement_score":0.03199951,"about_ca_system_score_codex":0.00025449027,"about_ca_system_score_gemma":0.00015197045,"threshold_uncertainty_score":0.7199801},"labels":[],"label_agreement":null},{"id":"W2324289595","doi":"10.1158/1538-7445.am2013-1352","title":"Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Single-nucleotide polymorphism; Serous fluid; Ovarian cancer; Population; SNP; Biology; Oncology; Genotype; Cancer; Ancestry-informative marker; Case-control study; Internal medicine; Genetics; Medicine; Gene","score_opus":0.04161216823740239,"score_gpt":0.3453912623959014,"score_spread":0.303779094158499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324289595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889697,0.0015021106,0.000010297438,0.0048213834,0.00013198303,0.0012424253,0.00046335856,0.00002676656,0.0029046822],"genre_scores_gemma":[0.98936355,0.008436232,0.00023140422,0.00018371738,0.000437474,0.0011500382,0.000011450527,0.00005708919,0.00012903212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99669355,0.00036098668,0.0005701641,0.0007069726,0.0007515586,0.0009167685],"domain_scores_gemma":[0.9982359,0.00015692708,0.00017667456,0.0005094541,0.00044243856,0.00047859756],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012227728,0.0002761415,0.0005477732,0.0003956771,0.00015929055,0.00007626692,0.00022599475,0.00012978897,0.0016798213],"category_scores_gemma":[0.00013443484,0.00023593607,0.00007251894,0.00078782695,0.0004055056,0.0003107791,0.000080067795,0.0006941612,0.00006431502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027880238,0.0017954145,0.18328837,0.0012041965,0.00083079323,0.00079245894,0.02176764,0.00093098363,0.311931,0.00021509465,0.001147841,0.47330818],"study_design_scores_gemma":[0.0040044705,0.00045561726,0.9798731,0.0006483386,0.000045859702,0.000011948457,0.0007254891,0.000063802814,0.012406055,0.00033435994,0.0012125109,0.00021842092],"about_ca_topic_score_codex":0.029592171,"about_ca_topic_score_gemma":0.00073058193,"teacher_disagreement_score":0.7965848,"about_ca_system_score_codex":0.0008050235,"about_ca_system_score_gemma":0.000776239,"threshold_uncertainty_score":0.99923277},"labels":[],"label_agreement":null},{"id":"W2324927921","doi":"10.1097/00152193-200606000-00003","title":"Surviving ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Nursing","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Suite; Phone; Computer science; Library science; History; Linguistics; Archaeology; Philosophy","score_opus":0.01841315646935113,"score_gpt":0.3123573692705895,"score_spread":0.29394421280123834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324927921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72674096,0.0054626875,0.0008699908,0.025100918,0.0016476905,0.00045354862,0.000014459864,0.0002045095,0.23950526],"genre_scores_gemma":[0.99686354,0.000030051582,0.0011465189,0.00022244129,0.0006264998,0.000020716168,0.00001022775,0.00001665265,0.0010633182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943286,0.000010241939,0.00010135981,0.00015672007,0.00012265939,0.00017614056],"domain_scores_gemma":[0.9997404,0.00001824341,0.00002755661,0.00013451275,0.00002948263,0.00004979484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004613311,0.00007687841,0.00013201474,0.000040836512,0.00006358021,0.000018501234,0.000020407568,0.00003616357,0.00037165938],"category_scores_gemma":[0.000004085551,0.000066547516,0.0000479301,0.000104428975,0.000025493002,0.000035677134,0.0000031511568,0.000056315515,0.000023782844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008171618,0.0009586947,0.5793601,0.00004795762,0.000096575415,0.00012560032,0.00036109253,0.000082414845,0.0028280825,0.008803972,0.027024636,0.38022912],"study_design_scores_gemma":[0.0014453345,0.00006389659,0.9776415,0.00068740314,0.0001643098,0.000030218649,0.00004269247,0.0001595283,0.0048208474,0.0007349297,0.014102276,0.000107036176],"about_ca_topic_score_codex":0.0014776445,"about_ca_topic_score_gemma":0.00010326944,"teacher_disagreement_score":0.3982814,"about_ca_system_score_codex":0.00028939612,"about_ca_system_score_gemma":0.000064620304,"threshold_uncertainty_score":0.40694097},"labels":[],"label_agreement":null},{"id":"W2325489337","doi":"10.1055/s-0034-1396961","title":"Major Bleeding after Percutaneous Image-Guided Biopsies: Frequency, Predictors, and Periprocedural Management","year":2015,"lang":"en","type":"review","venue":"Seminars in Interventional Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Tufts University School of Medicine","keywords":"Medicine; Percutaneous; Complication; Percutaneous biopsy; Biopsy; Radiology; Surgery; Major bleeding; Interventional radiology; Internal medicine","score_opus":0.031413870151065004,"score_gpt":0.3444772216182574,"score_spread":0.3130633514671924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325489337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019344266,0.9932059,0.0000065097734,0.00023913156,0.00075359375,0.0012676046,0.0002322856,0.00004386608,0.0023166845],"genre_scores_gemma":[0.0010711468,0.9913482,0.0034974345,0.00008095431,0.00033966405,0.0010598982,0.00055411225,0.00007214008,0.001976438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972536,0.00014687676,0.0010140446,0.00084276375,0.0002787971,0.00046391657],"domain_scores_gemma":[0.9989639,0.000117181226,0.00026384878,0.00034165088,0.000099685756,0.00021375464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043484423,0.00056143745,0.0018229168,0.0005348659,0.000044609656,0.000036583402,0.00018646993,0.000410054,0.0009083876],"category_scores_gemma":[0.00005945258,0.00045255542,0.0006070612,0.0002280131,0.00029313352,0.00007705411,0.0001539276,0.0004301062,0.000060915543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003806923,0.0015532873,0.011251138,0.082844324,0.006168719,0.025990989,0.00079398014,7.162017e-7,0.0000032012763,0.0022003243,0.045266025,0.8235466],"study_design_scores_gemma":[0.0020627175,0.0016801651,0.001762759,0.08483912,0.004431031,0.0540903,0.00023766757,0.000011151898,5.9764767e-7,0.00096199824,0.8492045,0.00071801856],"about_ca_topic_score_codex":0.000033296867,"about_ca_topic_score_gemma":0.0000150819915,"teacher_disagreement_score":0.8228286,"about_ca_system_score_codex":0.0012594971,"about_ca_system_score_gemma":0.00019071021,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W2325724207","doi":"10.1158/1538-7445.am10-5190","title":"Abstract 5190: GnRH promotes peritoneal adhesion and dissemination of ovarian cancer cells","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Mesothelium; Metastasis; Cancer research; Medicine; Endocrinology; Cancer; Internal medicine; Biology; Pathology; Peritoneum","score_opus":0.04657831388753839,"score_gpt":0.42053473651446877,"score_spread":0.37395642262693035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325724207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141073,0.0015098482,0.000001178243,0.0045228065,0.0002801394,0.0006628728,0.00008152501,0.000016919255,0.0015139761],"genre_scores_gemma":[0.9964581,0.0019481444,0.00020917656,0.000024033638,0.0003859562,0.00038326255,0.000010787959,0.000026168778,0.00055436854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985691,0.000031766096,0.00020383294,0.00034390576,0.0005320562,0.0003193415],"domain_scores_gemma":[0.99885553,0.00022633991,0.00006079797,0.00029063728,0.00035944476,0.00020723796],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045201118,0.00012116741,0.0002399034,0.00015380574,0.000117504045,0.00003536061,0.00008520846,0.00012081367,0.0019270112],"category_scores_gemma":[0.000105083374,0.00009554621,0.000048588845,0.0002462745,0.00021587244,0.000087136155,0.000054182914,0.00044908904,0.00001126467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020881374,0.00032935818,0.040057804,0.00041276083,0.00006962126,0.000028951254,0.00067286013,6.479972e-7,0.87695354,0.00024207727,0.0032970686,0.0777265],"study_design_scores_gemma":[0.0006223389,0.00021996134,0.3866243,0.00062508613,0.000039863186,0.0000045176957,0.00009785054,0.000027002836,0.60879165,0.00006079139,0.0028025613,0.00008406656],"about_ca_topic_score_codex":0.0029743423,"about_ca_topic_score_gemma":0.00073705864,"teacher_disagreement_score":0.3465665,"about_ca_system_score_codex":0.00014847085,"about_ca_system_score_gemma":0.00039079555,"threshold_uncertainty_score":0.99898535},"labels":[],"label_agreement":null},{"id":"W2326402536","doi":"10.1097/pgp.0000000000000209","title":"A Sex Cord-stromal Tumor, Specifically a Fibroma, Arising From the Uterine Corpus","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Pathology; Stromal cell; Fibroma; Medicine; Context (archaeology); Biology","score_opus":0.053679131340464314,"score_gpt":0.3303252181159935,"score_spread":0.2766460867755292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326402536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97816545,0.0004332851,0.0007582561,0.016681919,0.0020270837,0.00013139297,0.00003928125,0.000016272517,0.001747062],"genre_scores_gemma":[0.9895228,0.00009499193,0.0055276,0.003398311,0.001287936,0.000006417175,0.000016485636,0.0000112060325,0.0001342091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839723,0.00015371597,0.000564028,0.00020469115,0.00048757353,0.00019273104],"domain_scores_gemma":[0.99804616,0.0007111881,0.00039363684,0.00016461452,0.00047091852,0.00021348521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041010467,0.00014909674,0.00042325206,0.00006608805,0.000034858327,0.000046950412,0.00034084282,0.0000968529,0.00078449387],"category_scores_gemma":[0.000876229,0.00008355148,0.00019650917,0.00006169774,0.00016168915,0.00007044038,0.00012178297,0.00037069054,0.00006009568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046761385,0.002576565,0.8407951,0.000004563108,0.0011256145,0.07299821,0.00047675215,0.00007800722,0.0058808904,0.0031785553,0.016406221,0.051803377],"study_design_scores_gemma":[0.0053387377,0.00476848,0.92901945,0.00006059597,0.00012402708,0.009229673,0.00018458987,0.00006569823,0.0005433675,0.004258108,0.046293918,0.00011333851],"about_ca_topic_score_codex":0.000050968287,"about_ca_topic_score_gemma":0.000023386487,"teacher_disagreement_score":0.08822436,"about_ca_system_score_codex":0.0003086449,"about_ca_system_score_gemma":0.00026653914,"threshold_uncertainty_score":0.85896575},"labels":[],"label_agreement":null},{"id":"W2327610860","doi":"10.1097/pas.0b013e31822f58bc","title":"Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features","year":2011,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Serous fluid; Serous carcinoma; Immunohistochemistry; Confidence interval; Pathology; Serous Cystadenoma; Clinical significance; Carcinoma; Radiology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.01810733384456237,"score_gpt":0.25790018507467183,"score_spread":0.23979285123010946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327610860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995154,0.0010015151,0.000011393656,0.0029048594,0.0001127601,0.000118428536,0.000013156664,0.000006308552,0.00067753496],"genre_scores_gemma":[0.99752986,0.0005968031,0.0010038015,0.000698547,0.00013149991,0.000013566234,0.0000014814967,0.000013578056,0.0000108770755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988105,0.00022188797,0.000393564,0.000166696,0.00020251704,0.00020481549],"domain_scores_gemma":[0.99862367,0.00043339178,0.00045160475,0.00024809432,0.00010639883,0.00013682226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003397238,0.00015895937,0.00070889137,0.000104264705,0.000038478913,0.0000034875893,0.00014173088,0.000059654663,0.00014532819],"category_scores_gemma":[0.00006008812,0.000086348635,0.0002014188,0.0001490276,0.0010188163,0.000018955496,0.000034395296,0.00035542788,0.0000029775633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025794048,0.0040382,0.7378867,0.000059248843,0.00048450351,0.023360694,0.0019148982,0.000024607789,0.0050732056,0.00085437694,0.0015694585,0.19894001],"study_design_scores_gemma":[0.004653811,0.015167116,0.9560292,0.0001080241,0.0004633457,0.0113907065,0.00021634136,0.000015761074,0.011092782,0.00036241973,0.00035347271,0.00014706339],"about_ca_topic_score_codex":0.000082616374,"about_ca_topic_score_gemma":6.7033307e-7,"teacher_disagreement_score":0.2181424,"about_ca_system_score_codex":0.000059487786,"about_ca_system_score_gemma":0.00007531911,"threshold_uncertainty_score":0.3753871},"labels":[],"label_agreement":null},{"id":"W2327938475","doi":"10.1016/s1701-2163(16)32550-6","title":"Epithelial Ovarian Cancer Surgical Staging by Ontario Gynaecologic Surgeons: Is There a Gap Between Current Practice and the Canadian Clinical Practice Guidelines?","year":2007,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Clinical Practice; General surgery; Gynecology; Cancer; Family medicine; Internal medicine","score_opus":0.058390257738342374,"score_gpt":0.37001066579619596,"score_spread":0.31162040805785357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327938475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63427985,0.14070207,0.000054541284,0.19364592,0.022732528,0.0012924614,0.00035703206,0.000011361839,0.006924222],"genre_scores_gemma":[0.9787548,0.009986582,0.0010311026,0.009635508,0.00030035156,0.000011490996,0.000010168169,0.00002342264,0.00024658244],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966844,0.00031518532,0.0014464787,0.00033693697,0.000639019,0.00057803147],"domain_scores_gemma":[0.97738355,0.018481143,0.0011487502,0.00023176245,0.0017811557,0.0009736181],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0046526836,0.0002654113,0.0008751725,0.00019186261,0.0003738472,0.00008798905,0.00015971535,0.00025604764,0.00070946646],"category_scores_gemma":[0.016149668,0.00016862492,0.00014404142,0.0003422486,0.00023275486,0.00016606007,0.00006134861,0.0012532851,0.0000010553828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001228327,0.00017732053,0.7023775,0.000019227671,0.000926172,0.0064399154,0.00024037843,0.000002407235,6.0981556e-8,0.00027297848,0.034513768,0.25490743],"study_design_scores_gemma":[0.006461378,0.00028478508,0.42794243,0.000013621574,0.00089518976,0.00019419959,0.00031042317,0.0000071292566,0.0000018637262,0.000044866043,0.56373125,0.000112855916],"about_ca_topic_score_codex":0.95880955,"about_ca_topic_score_gemma":0.9737458,"teacher_disagreement_score":0.5292175,"about_ca_system_score_codex":0.0045326343,"about_ca_system_score_gemma":0.015317892,"threshold_uncertainty_score":0.9992888},"labels":[],"label_agreement":null},{"id":"W2328069724","doi":"10.1158/1538-7445.am10-1832","title":"Abstract 1832: Associations between ovarian cancer and other malignant neoplasms in an international population-based study","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Germ cell tumors; Serous fluid; Population; Oncology; Internal medicine; Stomach cancer; Incidence (geometry); Ovary; Epidemiology; Cancer registry; Cumulative incidence; Gynecology; Pathology; Cohort","score_opus":0.1115620759545287,"score_gpt":0.4590718012458812,"score_spread":0.3475097252913525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328069724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934477,0.000069669426,9.840941e-7,0.00442659,0.00027806425,0.0008729092,0.00036071806,0.000021839904,0.0005214843],"genre_scores_gemma":[0.99821365,0.000026579588,0.00010756192,0.00016652718,0.0005768238,0.0006541893,0.00009373792,0.000030653322,0.0001302707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983124,0.000068711044,0.0002662382,0.0004123959,0.00061556324,0.0003247066],"domain_scores_gemma":[0.99901354,0.0002088041,0.00006473855,0.00029431086,0.00021936077,0.00019921572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073186785,0.00012299916,0.00023989324,0.0003092078,0.00013514383,0.00009918534,0.00013388181,0.00010032234,0.0013047551],"category_scores_gemma":[0.0000862233,0.00010552789,0.000033893713,0.00029943383,0.000042489857,0.00013355217,0.00003453739,0.00051179534,0.0000112226035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006865245,0.0005982075,0.9880814,0.000012416276,0.00011305265,0.000025168592,0.00038764486,0.000024547291,0.00064775633,0.00021480893,0.00010015982,0.009726216],"study_design_scores_gemma":[0.002793768,0.00016192703,0.99484384,0.00008226841,0.00003699437,4.0024494e-7,0.000106668085,0.00005271054,0.00039259056,0.00009902039,0.0013299646,0.00009985585],"about_ca_topic_score_codex":0.04340789,"about_ca_topic_score_gemma":0.056787964,"teacher_disagreement_score":0.013380073,"about_ca_system_score_codex":0.0005674965,"about_ca_system_score_gemma":0.00045788477,"threshold_uncertainty_score":0.99960816},"labels":[],"label_agreement":null},{"id":"W2328480975","doi":"10.1093/annonc/mdu338.4","title":"Beneficial Effect of Adjuvant Chemotherapy and Whole Abdominal or Pelvic Radiotherapy (Waprt) on Progression Free and Overall Survival Following Primary Surgery in Patients with Ovarian Clear Cell Carcinoma (Occc)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Clear cell carcinoma; Radiation therapy; Overall survival; Chemotherapy; Internal medicine; Adjuvant; Carcinoma","score_opus":0.0171053854701012,"score_gpt":0.29827104399901005,"score_spread":0.28116565852890885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328480975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677366,0.0006385659,0.000003924905,0.001415641,0.00013564005,0.00064222544,0.000014797918,0.000007704796,0.00036784634],"genre_scores_gemma":[0.9986076,0.0002513543,0.00040134572,0.00055689627,0.00008853365,0.00002752139,0.000023272529,0.000030932937,0.000012551961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860597,0.00021863088,0.00034249653,0.00032197539,0.00025775944,0.00025314625],"domain_scores_gemma":[0.9986834,0.0006800206,0.00023133591,0.0002475186,0.000053511976,0.00010424864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005974654,0.00021025843,0.0010190116,0.00015794717,0.000033342298,0.000006452757,0.00005579613,0.00014239596,0.000019372988],"category_scores_gemma":[0.000044087585,0.00013638026,0.00009635531,0.00009599567,0.000086962755,0.000054963537,0.000026018373,0.000117097334,3.750081e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022882983,0.0012759103,0.78619707,0.00026803254,0.00011014305,0.000045631215,0.00023478243,0.000002434244,0.00037756597,0.000012878349,0.00033182238,0.18826073],"study_design_scores_gemma":[0.022509633,0.036396727,0.935628,0.00031919638,0.0000807075,0.0000033975784,0.000010049805,0.000030672796,0.0036738105,0.000014896759,0.0012104453,0.00012248592],"about_ca_topic_score_codex":0.000147717,"about_ca_topic_score_gemma":0.000046963163,"teacher_disagreement_score":0.18813825,"about_ca_system_score_codex":0.00006696957,"about_ca_system_score_gemma":0.00014355157,"threshold_uncertainty_score":0.55614257},"labels":[],"label_agreement":null},{"id":"W2328839522","doi":"10.1136/archdischild-2012-302724.1593","title":"1593 Antenatally Diagnosed Ovarian Cysts: Management and Follow-Up Protocol","year":2012,"lang":"en","type":"article","venue":"Archives of Disease in Childhood","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Fetus; Parenchyma; Retrospective cohort study; Cyst; Pregnancy; Ovary; Ovarian torsion; Surgery; Pathology; Internal medicine","score_opus":0.009745635075254791,"score_gpt":0.26518053106187595,"score_spread":0.25543489598662117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328839522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88028353,0.0017022669,0.00007586441,0.0027617293,0.00024365126,0.09364772,0.00021921196,0.00010381284,0.02096222],"genre_scores_gemma":[0.9710041,0.00016057912,0.0016949257,0.00025743613,0.000108560984,0.026593525,0.000038228325,0.000027975795,0.0001146642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874645,0.000048303893,0.00031346604,0.00030662722,0.00022442431,0.00036073505],"domain_scores_gemma":[0.998941,0.00011444534,0.000088782675,0.00040070244,0.000010524648,0.00044455775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007921385,0.00020447312,0.0003087968,0.00019705431,0.000042382035,0.000013346199,0.00009443951,0.000025820173,0.00006673941],"category_scores_gemma":[0.000041919753,0.00016621305,0.00012775378,0.00013068657,0.00009289204,0.00012255037,0.00011899565,0.00009625093,0.0000086054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010888984,0.0044542346,0.95348734,0.0006495236,0.00034463507,0.00021242627,0.0016337464,0.000002060528,0.000018125513,0.0034463545,0.0002118827,0.03445078],"study_design_scores_gemma":[0.012645738,0.00024200152,0.9826555,0.0009737083,0.00022281831,0.000005956772,0.00012431294,0.000014233083,0.00013727137,0.0012524115,0.0015716212,0.00015440956],"about_ca_topic_score_codex":0.000045395707,"about_ca_topic_score_gemma":0.000009212811,"teacher_disagreement_score":0.09072058,"about_ca_system_score_codex":0.000028345956,"about_ca_system_score_gemma":0.000065167966,"threshold_uncertainty_score":0.67779714},"labels":[],"label_agreement":null},{"id":"W2329400486","doi":"10.1158/1078-0432.ccr-16-0316","title":"A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; National Institutes of Health; Institut Gustave-Roussy; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul Cancro; NordForsk; Hellenic Health Foundation; Stavros Niarchos Foundation; Institut National de la Santé et de la Recherche Médicale; World Health Organization; European Commission; Bundesministerium für Bildung und Forschung; Ligue Contre le Cancer; National Institute for Health and Care Research; Cancer Research UK; Cancerfonden; Fujirebio US; Deutsches Krebsforschungszentrum","keywords":"European Prospective Investigation into Cancer and Nutrition; EPIC; Prospective cohort study; Ovarian cancer; Cohort; Medicine; Cancer; Oncology; Cohort study; Gynecology; Internal medicine","score_opus":0.2989766636547487,"score_gpt":0.5522878446054476,"score_spread":0.2533111809506989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329400486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408663,0.0009568324,0.00009644518,0.006607099,0.00030625396,0.004347849,0.00007049544,0.000012199853,0.0035162142],"genre_scores_gemma":[0.99492383,0.00086836313,0.00003780441,0.00007661412,0.00053208775,0.0034193157,0.0000022674978,0.000023447641,0.000116242336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961855,0.0015709961,0.0004955962,0.00045626482,0.0009745615,0.0003170951],"domain_scores_gemma":[0.997099,0.0012992981,0.00011099042,0.00040218592,0.000994029,0.000094517374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015843226,0.000099406076,0.0002767276,0.00014255631,0.00008282897,0.000019189583,0.00015260982,0.000078019366,0.0003133885],"category_scores_gemma":[0.0013639417,0.000052381693,0.00014396009,0.00049121137,0.00024561147,0.000061974075,0.000037040503,0.00023108305,0.000014417597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009787771,0.00027844973,0.55240023,0.000027890579,0.00021953942,0.0000039479214,0.00019379327,0.0000013735216,0.0003315835,0.000068659,0.0004410742,0.44505465],"study_design_scores_gemma":[0.0075054765,0.0012094228,0.98731816,0.0003613744,0.00022162891,0.0000011579544,0.00009361104,0.00007604903,0.0013296286,0.0009822702,0.0008383244,0.000062881954],"about_ca_topic_score_codex":0.0017151496,"about_ca_topic_score_gemma":0.003080983,"teacher_disagreement_score":0.44499177,"about_ca_system_score_codex":0.0007575882,"about_ca_system_score_gemma":0.00071814697,"threshold_uncertainty_score":0.5490978},"labels":[],"label_agreement":null},{"id":"W2329874989","doi":"10.1097/pas.0000000000000353","title":"Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases","year":2014,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Calgary Laboratory Services; Vancouver General Hospital; Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Serous carcinoma; Fallopian tube; Serous fluid; Pathology; Medicine; Serous Cystadenoma; Ovarian cancer; Gynecology; Cancer; Internal medicine","score_opus":0.016563859647146982,"score_gpt":0.2789636309460449,"score_spread":0.26239977129889797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329874989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98139346,0.00034199524,0.000013956721,0.017723063,0.00013520884,0.0001572753,0.0000051767574,0.0000046612768,0.00022522428],"genre_scores_gemma":[0.9970213,0.0005293622,0.0001813752,0.0019075029,0.0003143252,0.000014365924,0.0000034861644,0.000014068181,0.000014215111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981436,0.00063359656,0.00051057374,0.00016683091,0.0002529334,0.00029243212],"domain_scores_gemma":[0.99855286,0.0007035132,0.00030699425,0.00028847708,0.00004400476,0.00010416357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083865825,0.00016119092,0.0006686851,0.00014990571,0.00004244,0.0000144772175,0.00023630311,0.000038161645,0.000047461734],"category_scores_gemma":[0.0000674523,0.00008051222,0.00012077643,0.0003989411,0.0004097093,0.000044011915,0.000051941854,0.00047565735,0.000009360686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019369107,0.001483865,0.87568265,0.000016926137,0.00009395657,0.0786991,0.0020573682,0.00021919247,0.00041079978,0.0013149029,0.00032890428,0.0377554],"study_design_scores_gemma":[0.003957292,0.0036810907,0.9488101,0.00006535212,0.000086746746,0.037513465,0.000896621,0.000036083868,0.000076146775,0.00019977972,0.0045803585,0.000096935175],"about_ca_topic_score_codex":0.001762328,"about_ca_topic_score_gemma":0.00035555728,"teacher_disagreement_score":0.07312745,"about_ca_system_score_codex":0.00016757408,"about_ca_system_score_gemma":0.00007260425,"threshold_uncertainty_score":0.3283193},"labels":[],"label_agreement":null},{"id":"W2329904653","doi":"10.1097/igc.0b013e31821bb8be","title":"Patient-Reported Outcomes","year":2011,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"World Health Organization","keywords":"Medicine; Ovarian cancer; Clinical trial; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.11240224310641674,"score_gpt":0.41666635818909503,"score_spread":0.3042641150826783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329904653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002562194,0.9923713,0.000007152969,0.0006356421,0.0039037205,0.00035183845,0.000049792467,0.000013694344,0.0024106328],"genre_scores_gemma":[0.00080195104,0.9970049,0.000352361,0.000695664,0.00058157847,0.00009592324,0.000017749784,0.000028571067,0.0004213009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976534,0.00006581762,0.0012904704,0.00023617543,0.0005667342,0.00018737688],"domain_scores_gemma":[0.9968777,0.00030271662,0.0017098688,0.00017061336,0.0007364202,0.00020270732],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015326068,0.00031422416,0.0017938017,0.00025711628,0.000021832124,0.000029204091,0.00028369317,0.0002715224,0.0063649477],"category_scores_gemma":[0.00036014576,0.00017118605,0.0012782387,0.00010264643,0.000059014503,0.00007237485,0.00008516233,0.0004892513,0.00004877835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006790793,0.0006356888,0.0050472524,0.00026913747,0.004696111,0.0021628758,0.000021585516,3.640649e-7,5.129484e-8,0.00014862581,0.0034420267,0.98350835],"study_design_scores_gemma":[0.0010207503,0.0006372223,0.0070079826,0.004137426,0.0025641185,0.0009084383,0.000005109217,1.4150628e-7,0.0000015556058,0.0000938655,0.98347306,0.0001503442],"about_ca_topic_score_codex":0.000031611085,"about_ca_topic_score_gemma":0.000008082278,"teacher_disagreement_score":0.983358,"about_ca_system_score_codex":0.0009925514,"about_ca_system_score_gemma":0.0008685541,"threshold_uncertainty_score":0.9945434},"labels":[],"label_agreement":null},{"id":"W2329997776","doi":"10.4137/cmo.s32813","title":"Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations","year":2016,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Ovarian cancer; Tamoxifen; Medicine; Hormone; Estrogen receptor; Ovarian carcinoma; Hormone receptor; Oncology; Internal medicine; Serous fluid; Cancer; Breast cancer; Estrogen; Gynecology; Bioinformatics; Biology","score_opus":0.1605716960928768,"score_gpt":0.4398224549734831,"score_spread":0.2792507588806063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329997776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053660694,0.98166496,0.0000062333593,0.009657523,0.0017296453,0.003862879,0.0000407564,0.00007222022,0.0024291852],"genre_scores_gemma":[0.0022808162,0.99087596,0.0006047769,0.00093021913,0.0026987963,0.001952319,0.00020925322,0.00010253485,0.00034534134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935806,0.001171782,0.00293273,0.001460185,0.00028407745,0.0005706563],"domain_scores_gemma":[0.99196064,0.0054973303,0.00081990263,0.00078792893,0.00016970333,0.0007645005],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006711126,0.00088810065,0.006455648,0.00054468715,0.00012926804,0.000015122151,0.00011964921,0.0014190483,0.0005059665],"category_scores_gemma":[0.0010025026,0.0004656102,0.0005310193,0.0003757685,0.0011745369,0.000060722286,0.000100288555,0.00063401554,0.00011094546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010554708,0.0021473637,0.0027259118,0.00087929843,0.0007580435,0.002837541,0.00020051179,1.010729e-8,6.5383836e-7,0.0010199624,0.0049593886,0.98436576],"study_design_scores_gemma":[0.011064985,0.013115394,0.005366792,0.008147533,0.0044761887,0.0008053045,0.000042826417,7.95819e-7,8.647966e-7,0.00030027505,0.95628333,0.00039572633],"about_ca_topic_score_codex":0.00020841266,"about_ca_topic_score_gemma":0.00042524392,"teacher_disagreement_score":0.98397005,"about_ca_system_score_codex":0.0015104099,"about_ca_system_score_gemma":0.0027489867,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W2330129993","doi":"10.1097/00024382-200406002-00217","title":"BRUTONʼS TYROSINE KINASE (BTK) INHIBITS CONSTITUTIVE NEUTROPHIL (PMN) APOPTOSIS AND PROLONGS PMN SURVIVAL IN SEPSIS.","year":2004,"lang":"en","type":"article","venue":"Shock","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Bruton's tyrosine kinase; Sepsis; Tyrosine kinase; Cancer research; Apoptosis; Immunology; Medicine; Chemistry; Internal medicine; Receptor","score_opus":0.0154042563703905,"score_gpt":0.2629742751625525,"score_spread":0.247570018792162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330129993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98310727,0.0013751264,0.000022179998,0.009975312,0.00023526752,0.000751351,0.000057900736,0.000057185258,0.0044183815],"genre_scores_gemma":[0.9974959,0.00045395055,0.00067658577,0.0009526798,0.00014737766,0.00007702332,0.000045318673,0.000024723513,0.00012646022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868006,0.000030692943,0.00027210973,0.00045632588,0.00021667451,0.00034414424],"domain_scores_gemma":[0.9993589,0.00004612258,0.000065170556,0.000257633,0.000070244285,0.000201936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111213645,0.00023994975,0.00044109218,0.00013219264,0.000069306036,0.000031114698,0.000050015125,0.00011493396,0.000085309046],"category_scores_gemma":[0.000049052473,0.00020416088,0.0000724489,0.0002891778,0.00017128077,0.00010142929,0.000060551607,0.00019497512,0.000053222986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024301826,0.0057306453,0.90506524,0.00076837157,0.0009362137,0.0019069473,0.0038092954,0.0004289393,0.007868336,0.041058205,0.004015131,0.025982508],"study_design_scores_gemma":[0.038078118,0.0030362266,0.7984108,0.0018331895,0.00072662416,0.00019827388,0.0005062429,0.000048654587,0.14345062,0.002742349,0.009977887,0.0009910217],"about_ca_topic_score_codex":0.00094393565,"about_ca_topic_score_gemma":0.00047573558,"teacher_disagreement_score":0.13558228,"about_ca_system_score_codex":0.00031656635,"about_ca_system_score_gemma":0.00026567615,"threshold_uncertainty_score":0.8325439},"labels":[],"label_agreement":null},{"id":"W2331413035","doi":"10.1111/igc.0b013e3181bcc96d","title":"Oviductal Glycoprotein (OVGP1, MUC9): A Differentiation-Based Mucin Present in Serum of Women With Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Serous fluid; Medicine; Immunohistochemistry; Pathology; Mucinous cystadenocarcinoma; Clear cell; Cystadenocarcinoma; Antibody; Ovarian cancer; Polyclonal antibodies; Serous carcinoma; Ovary; Cancer; Internal medicine; Immunology","score_opus":0.012686015767089822,"score_gpt":0.30133244785299385,"score_spread":0.288646432085904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331413035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255163,0.00023477332,0.000081308564,0.015506786,0.0010010261,0.0003350548,0.00006603354,0.000007862254,0.00021553846],"genre_scores_gemma":[0.9974664,0.0001304497,0.00091217924,0.00057485537,0.0005894661,0.00021881805,0.000004992756,0.000015414,0.00008743742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981431,0.00004764559,0.0005807822,0.00021596695,0.000734677,0.00027784912],"domain_scores_gemma":[0.99827135,0.00020409809,0.0005189678,0.00013784032,0.00066149095,0.00020626612],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027938109,0.00017309976,0.00046567677,0.00023458141,0.000022814407,0.00002933086,0.00024080576,0.00012059864,0.006963865],"category_scores_gemma":[0.00016998338,0.00011052579,0.000117460855,0.0001722064,0.00009853789,0.0001189064,0.000037244285,0.00047399095,0.0000021682463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034535972,0.001981618,0.95355636,0.000046261757,0.00080222206,0.0005048027,0.00035815116,0.0011565002,0.005543116,0.0004442264,0.0002764477,0.031876676],"study_design_scores_gemma":[0.008151341,0.0012562549,0.97788906,0.00025764655,0.00008772275,0.00004371536,0.00006414573,0.00031491625,0.008446321,0.00025497138,0.0031113736,0.00012253573],"about_ca_topic_score_codex":0.0008515896,"about_ca_topic_score_gemma":0.0018586003,"teacher_disagreement_score":0.03175414,"about_ca_system_score_codex":0.0011025525,"about_ca_system_score_gemma":0.0009791575,"threshold_uncertainty_score":0.9939439},"labels":[],"label_agreement":null},{"id":"W2331727214","doi":"10.1097/igc.0000000000000235","title":"Pelvic Inflammation and the Pathogenesis of Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Odds ratio; Ovarian cancer; Confidence interval; Cancer; Cohort; Population; Internal medicine; Cohort study; Gynecology; Oncology","score_opus":0.016100145827477853,"score_gpt":0.30308465884688957,"score_spread":0.2869845130194117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331727214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600011,0.0019458784,0.00023844207,0.03575886,0.00084498,0.00016094728,0.000014487122,0.000004212939,0.0010310777],"genre_scores_gemma":[0.99471444,0.003296812,0.00038719483,0.00075037417,0.0007333548,0.000035723006,0.0000014113374,0.000005658493,0.00007500635],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898785,0.00007627629,0.00039035227,0.00009242951,0.0003706283,0.00008243673],"domain_scores_gemma":[0.99851644,0.00039961128,0.00040845832,0.000070778515,0.00054011197,0.000064615706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040675112,0.00008221353,0.00028661574,0.0000668364,0.000027208309,0.000018072436,0.00012104074,0.000054242675,0.00088606036],"category_scores_gemma":[0.00032107587,0.000042506606,0.00012620863,0.000058996317,0.00012648109,0.00006295967,0.000034021785,0.00011212921,0.0000015719467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036954079,0.0003858949,0.33997223,0.00006120912,0.0018763731,0.00009135207,0.00059233035,0.0008683484,0.0045686974,0.022044053,0.0011706458,0.6246734],"study_design_scores_gemma":[0.0077396403,0.00036054896,0.9731547,0.00015722537,0.00031732573,0.000073074916,0.00003854046,0.0005048566,0.0019072908,0.001825043,0.013857679,0.000064067324],"about_ca_topic_score_codex":0.0001283729,"about_ca_topic_score_gemma":0.0000707674,"teacher_disagreement_score":0.63318247,"about_ca_system_score_codex":0.00015815806,"about_ca_system_score_gemma":0.00012260844,"threshold_uncertainty_score":0.97017395},"labels":[],"label_agreement":null},{"id":"W2331897577","doi":"10.1097/coc.0000000000000281","title":"Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Serous fluid; Hazard ratio; Internal medicine; Proportional hazards model; Chemotherapy; Progression-free survival; Population; Univariate analysis; Oncology; Ovarian cancer; Surgery; Multivariate analysis; Confidence interval; Cancer","score_opus":0.03879162495960458,"score_gpt":0.40089231286677424,"score_spread":0.36210068790716965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331897577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91691566,0.0005267314,0.00008241292,0.08137906,0.0005728314,0.00016671921,0.000040241786,0.0000040617388,0.00031230843],"genre_scores_gemma":[0.9768486,0.008557216,0.0052428516,0.008352577,0.00075429183,0.000008957873,6.7367733e-7,0.000023732744,0.00021111155],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99733895,0.00030365237,0.0016380007,0.00025674765,0.0002262631,0.00023639396],"domain_scores_gemma":[0.99616927,0.001599618,0.0015187613,0.00021112016,0.00019857041,0.0003026818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001063918,0.00016313698,0.0017235148,0.00014372199,0.000015846805,0.0000033586596,0.000113613314,0.00016308049,0.0006961521],"category_scores_gemma":[0.00027083757,0.00009635033,0.0002466688,0.00020734165,0.00063148345,0.000065115746,0.00002665277,0.00037006117,0.000004243992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004056511,0.001580076,0.18885872,0.000015357851,0.00063303305,0.00025477595,0.00028345053,0.0000026322207,0.00084117946,0.00021683998,0.0011187375,0.8021387],"study_design_scores_gemma":[0.0443817,0.035063975,0.85946035,0.0003886776,0.00045347988,0.0002764802,0.00017163026,0.000014414607,0.0040221876,0.0012871923,0.054290954,0.00018897495],"about_ca_topic_score_codex":0.0004423935,"about_ca_topic_score_gemma":0.00015044227,"teacher_disagreement_score":0.8019497,"about_ca_system_score_codex":0.00018894505,"about_ca_system_score_gemma":0.0009483881,"threshold_uncertainty_score":0.7622377},"labels":[],"label_agreement":null},{"id":"W2332150043","doi":"10.1097/pgp.0b013e31827f3fa8","title":"Precursor Lesions and Prognostic Factors in Primary Peritoneal Serous Carcinoma","year":2013,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Immunohistochemistry; Biomarker; Serous carcinoma; Serous fluid; Pathology; Biology; Ovarian carcinoma; Ovarian cancer; Medicine; Cancer; Internal medicine","score_opus":0.021352302947206872,"score_gpt":0.27891067882255893,"score_spread":0.2575583758753521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332150043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925631,0.000394243,0.000020230651,0.0053977496,0.0004907758,0.00025521353,0.0000066432453,0.00000680028,0.0008651887],"genre_scores_gemma":[0.9978149,0.0001664244,0.0011220566,0.00067140115,0.0001293115,0.000027896793,0.000008571529,0.0000069038992,0.00005253821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990274,0.000074625175,0.00038491897,0.00015422623,0.00020143397,0.00015744996],"domain_scores_gemma":[0.99898994,0.0004213253,0.00016385241,0.000060490576,0.00023754533,0.0001268436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012366327,0.00010908543,0.00032062538,0.000159191,0.000020563677,0.000020797217,0.00010862506,0.00011675531,0.00046234642],"category_scores_gemma":[0.00039984036,0.00007091532,0.000081409824,0.000048866164,0.00010230755,0.00009889834,0.00006209933,0.00024824112,0.000015596184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008385539,0.000679807,0.9844854,0.0000068522745,0.000057376623,0.002406904,0.00016776184,0.0000041971266,0.0009566904,0.0001174367,0.0003430187,0.010690705],"study_design_scores_gemma":[0.0018283672,0.0014737959,0.9937594,0.00003870749,0.000039778533,0.001717975,0.000086514534,0.000015496085,0.00014722974,0.0005123037,0.00032082835,0.000059628495],"about_ca_topic_score_codex":0.00003563193,"about_ca_topic_score_gemma":0.00001583734,"teacher_disagreement_score":0.010631076,"about_ca_system_score_codex":0.00022941885,"about_ca_system_score_gemma":0.0001049849,"threshold_uncertainty_score":0.5062369},"labels":[],"label_agreement":null},{"id":"W2332152864","doi":"10.1038/sj.onc.1203463","title":"Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers","year":2000,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Hôpital Notre-Dame; Université du Québec à Montréal; Montreal General Hospital","funders":"","keywords":"Loss of heterozygosity; Biology; Serous fluid; Carcinogenesis; Ovarian cancer; Malignancy; Cancer research; Tumor suppressor gene; Ovarian tumor; Clear cell; Pathology; Cancer; Allele; Carcinoma; Gene; Genetics; Medicine","score_opus":0.014150958077113864,"score_gpt":0.2556255234968605,"score_spread":0.24147456541974666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332152864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821151,0.0014631207,0.000009295296,0.003488211,0.00024420815,0.00045774406,0.000026731472,0.00005004826,0.012145559],"genre_scores_gemma":[0.991711,0.0022651784,0.0011174252,0.00090753665,0.00066409394,0.00015554842,0.000053777974,0.00004593182,0.0030795091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984348,0.0000328518,0.00033523096,0.000509285,0.00023015354,0.00045768885],"domain_scores_gemma":[0.99929047,0.000038773444,0.0000788955,0.00037841225,0.00003584089,0.00017762247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008889911,0.0002545328,0.00044610412,0.0000828867,0.0000956715,0.00001663571,0.00010041331,0.00013286038,0.0010653182],"category_scores_gemma":[0.000011601896,0.00023016536,0.00012302426,0.00024974043,0.0000611449,0.000068613685,0.00003274993,0.00012479002,0.00026753888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005993107,0.0015935905,0.54097867,0.000265609,0.00061125116,0.0065377187,0.00189196,0.0008922356,0.030865751,0.0001806957,0.010497142,0.39969224],"study_design_scores_gemma":[0.016689785,0.0014566546,0.8491665,0.00090190285,0.00028323816,0.0009296112,0.00006314136,0.0006848049,0.024534518,0.00006457899,0.10453416,0.00069110293],"about_ca_topic_score_codex":0.0019531378,"about_ca_topic_score_gemma":0.0018702152,"teacher_disagreement_score":0.39900115,"about_ca_system_score_codex":0.0011735664,"about_ca_system_score_gemma":0.00025714334,"threshold_uncertainty_score":0.9998478},"labels":[],"label_agreement":null},{"id":"W2332596163","doi":"10.1097/01.ogx.0000445778.98285.93","title":"Introduction of Staging Laparoscopy in the Management of Advanced Epithelial Ovarian, Tubal and Peritoneal Cancer","year":2014,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Laparoscopy; Surgery; Epithelial ovarian cancer; Chemotherapy; Stage (stratigraphy); Disease; Oncology; Cancer; Internal medicine","score_opus":0.02208419984119886,"score_gpt":0.29959010153179716,"score_spread":0.2775059016905983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332596163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567395,0.00070475356,0.000059336227,0.002099431,0.000310511,0.0004815151,0.000035552646,0.000011042038,0.00062388973],"genre_scores_gemma":[0.99757093,0.0006908237,0.0013124599,0.0001465493,0.00010139837,0.000086744076,0.000022990047,0.0000075484545,0.000060530976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984324,0.00033513724,0.00037812567,0.00033185145,0.0002941617,0.0002283171],"domain_scores_gemma":[0.99830115,0.0012022916,0.00011658388,0.00022885829,0.00007868135,0.00007240866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006789638,0.00013660705,0.000451976,0.00007058625,0.000038784798,0.000009988104,0.0000984667,0.00008533236,0.00024825844],"category_scores_gemma":[0.00055893965,0.00008209133,0.000059755042,0.0005404073,0.0001276778,0.000037462807,0.000059122645,0.00016048893,0.0000027033539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006548311,0.0016210704,0.80450857,0.00022040775,0.0001713357,0.000034001154,0.00019722321,0.0001399725,0.00076334877,0.0035447376,0.00032635336,0.18781817],"study_design_scores_gemma":[0.0020765034,0.00083042285,0.9925688,0.000036515165,0.000082997016,0.0000019294712,0.000120770485,0.00010420146,0.0007839415,0.000095540316,0.0032186392,0.00007975609],"about_ca_topic_score_codex":0.00036760585,"about_ca_topic_score_gemma":0.000060288858,"teacher_disagreement_score":0.18806022,"about_ca_system_score_codex":0.00011629183,"about_ca_system_score_gemma":0.00002199332,"threshold_uncertainty_score":0.33475873},"labels":[],"label_agreement":null},{"id":"W2332621463","doi":"10.1097/cej.0000000000000191","title":"Prophylactic bilateral salpingectomy for the prevention of ovarian cancers: What is happening in Italy?","year":2015,"lang":"en","type":"article","venue":"European Journal of Cancer Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Salpingectomy; Tubal ligation; Population; Gynecology; Hysterectomy; Incidence (geometry); Family medicine; Demographics; Obstetrics and gynaecology; Obstetrics; Family planning; Surgery; Demography; Environmental health; Pregnancy; Research methodology","score_opus":0.05658072255038625,"score_gpt":0.3433455636014198,"score_spread":0.28676484105103356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332621463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93235445,0.041572504,0.009893162,0.010262145,0.0026079433,0.0022933786,0.00001171683,0.000018040331,0.0009866679],"genre_scores_gemma":[0.99604225,0.0011836773,0.0016811509,0.00013746503,0.0004862184,0.00003504798,0.000003619596,0.000031378826,0.00039917533],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99846715,0.00021822086,0.0006585168,0.00016148027,0.000324011,0.00017061207],"domain_scores_gemma":[0.9985927,0.000043932054,0.0007512159,0.00018156259,0.0003308087,0.00009978874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013655429,0.00013367539,0.00031705428,0.00015042498,0.000038326503,0.000062722385,0.000120062396,0.000024830162,0.00009088462],"category_scores_gemma":[0.000045909117,0.00009016032,0.00024342802,0.00021038443,0.000037420174,0.00052192964,0.000023755863,0.00016112026,0.0000028958855],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044229897,0.0007875983,0.031657327,0.000605017,0.0011182446,0.00013844013,0.007275831,0.00137524,0.0017264702,0.00012826675,0.002028935,0.94873565],"study_design_scores_gemma":[0.08904333,0.026045633,0.72778195,0.027399015,0.006709537,0.00064693374,0.0062164245,0.0030013502,0.039759714,0.0068639447,0.06543512,0.0010970496],"about_ca_topic_score_codex":0.000098649296,"about_ca_topic_score_gemma":0.00007221997,"teacher_disagreement_score":0.9476386,"about_ca_system_score_codex":0.0004649544,"about_ca_system_score_gemma":0.00053671683,"threshold_uncertainty_score":0.36766312},"labels":[],"label_agreement":null},{"id":"W2333131025","doi":"10.1097/igc.0000000000000249","title":"Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Sex Cord Stromal Tumors","year":2014,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Stage (stratigraphy); Natural history; Ovarian cancer; Stromal cell; Oncology; Chemotherapy; Adjuvant; Disease; Internal medicine; Cancer","score_opus":0.08887842818525894,"score_gpt":0.4453858892253338,"score_spread":0.35650746104007486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333131025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011942393,0.98481196,0.00010949083,0.0068262117,0.004932431,0.0019911136,0.0004714511,0.000032658907,0.0007052436],"genre_scores_gemma":[0.0008009706,0.98796207,0.0010760337,0.0048410646,0.0029578703,0.0011375045,0.00010574314,0.00007829338,0.0010404561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521065,0.00028686065,0.0024330665,0.0006498218,0.0008876422,0.00053197396],"domain_scores_gemma":[0.99268425,0.00216864,0.0029584598,0.0003249843,0.0014484571,0.0004152009],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095466484,0.0007314733,0.0043557566,0.00031857064,0.00008027705,0.00007588294,0.00082927715,0.00049209484,0.006095153],"category_scores_gemma":[0.0014960478,0.00046188,0.002218158,0.00021711059,0.00018632784,0.000068667345,0.0001650391,0.0009301258,0.000033253255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034349813,0.0005705718,0.00063726987,0.009591509,0.0037933942,0.0008096613,0.0000076776405,0.000005470257,5.551845e-7,0.00044426363,0.03726326,0.94653285],"study_design_scores_gemma":[0.0025747977,0.0025462075,0.0010090743,0.057220552,0.0049719447,0.0009482192,0.0000076105857,0.000009606377,0.0000026559296,0.00012540114,0.93018425,0.0003996752],"about_ca_topic_score_codex":0.00007354831,"about_ca_topic_score_gemma":0.00010057596,"teacher_disagreement_score":0.9461332,"about_ca_system_score_codex":0.0028281412,"about_ca_system_score_gemma":0.0026517364,"threshold_uncertainty_score":0.9997833},"labels":[],"label_agreement":null},{"id":"W2334362062","doi":"10.1055/s-0029-1245923","title":"Increasing Constipation and Abdominal Fullness","year":2011,"lang":"de","type":"article","venue":"RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Constipation; Medicine; Disease; Stage (stratigraphy); Intensive care medicine; Internal medicine; Surgery; Biology","score_opus":0.04274677182541784,"score_gpt":0.2774670290990258,"score_spread":0.23472025727360799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334362062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75478846,0.22113778,0.0016085333,0.0013843995,0.004415939,0.0034436544,0.0005810168,0.000411051,0.0122291595],"genre_scores_gemma":[0.9818421,0.007981365,0.005932382,0.0010423436,0.0020065221,0.00022179983,0.0004068935,0.00027487977,0.00029171206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921954,0.00047539393,0.0018414515,0.0022413484,0.0012773118,0.001969062],"domain_scores_gemma":[0.9953065,0.00047692785,0.0008204969,0.0015006551,0.00045358154,0.0014418276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0011821307,0.001556389,0.0018165804,0.00060298364,0.0008263857,0.00039873514,0.00047879823,0.0010315492,0.001994925],"category_scores_gemma":[0.00017772082,0.0015149344,0.00055206893,0.00068712153,0.0009199206,0.00083744025,0.00041776846,0.0010305793,0.0009432155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042768572,0.003194505,0.6622261,0.001390211,0.02120127,0.0044096853,0.005512958,0.000015593867,0.00046641123,0.006055603,0.0070053777,0.28424543],"study_design_scores_gemma":[0.029281864,0.0040403837,0.78608316,0.004305565,0.061753415,0.003332438,0.0017108626,0.0017048856,0.01576091,0.0051313913,0.081550114,0.0053449823],"about_ca_topic_score_codex":0.003737378,"about_ca_topic_score_gemma":0.00037446147,"teacher_disagreement_score":0.27890047,"about_ca_system_score_codex":0.00048557064,"about_ca_system_score_gemma":0.0011539521,"threshold_uncertainty_score":0.99983466},"labels":[],"label_agreement":null},{"id":"W2334383563","doi":"10.5114/pm.2013.39021","title":"Biochemical markers for screening of ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Menopausal Review","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Menopause; Medicine; Cancer; Gynecology; Internal medicine","score_opus":0.03450397944208479,"score_gpt":0.3370661157712731,"score_spread":0.3025621363291883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334383563","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022235965,0.9066646,0.0014659772,0.052045673,0.00036098328,0.008938188,0.00012355835,0.00008328059,0.008081786],"genre_scores_gemma":[0.60422355,0.3197543,0.05287409,0.013007473,0.00059418,0.0071851215,0.00018598081,0.000118407144,0.0020568916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999139,0.000017591787,0.00030406236,0.00020327771,0.00014906471,0.00018700238],"domain_scores_gemma":[0.9993476,0.000067190784,0.00010431142,0.00023268313,0.00012345817,0.00012471955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016408032,0.00012309018,0.00047211486,0.000025621797,0.000021894477,0.0000057925477,0.000057171303,0.000038717953,0.0018820893],"category_scores_gemma":[0.00007856347,0.00008848321,0.00007681113,0.00012511079,0.000030867843,0.000036833302,0.000020450256,0.00005244542,0.000027690212],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013741099,0.0004048709,0.006134218,0.015791874,0.00079412735,0.000008695109,0.000025875783,4.8811e-7,0.014242173,0.0010544679,0.26078868,0.70061713],"study_design_scores_gemma":[0.006425028,0.0024128952,0.06692931,0.048453964,0.003641164,0.000038528782,0.000022492224,0.00009283752,0.022777548,0.00027067843,0.8484177,0.000517876],"about_ca_topic_score_codex":0.0002427539,"about_ca_topic_score_gemma":0.0000020459424,"teacher_disagreement_score":0.70009923,"about_ca_system_score_codex":0.00006049095,"about_ca_system_score_gemma":0.00007329134,"threshold_uncertainty_score":0.99903035},"labels":[],"label_agreement":null},{"id":"W2334855903","doi":"10.1097/igc.0000000000000055","title":"The Significance of Combination Chemotherapy in Epithelial Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Debulking; Oncology; Internal medicine; Chemotherapy; Ovarian cancer; Population; Proportional hazards model; Combination chemotherapy; Cancer; Surgery; Cisplatin","score_opus":0.018265196115459733,"score_gpt":0.3240976720827991,"score_spread":0.30583247596733937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334855903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9456885,0.001041519,0.00028099105,0.04958513,0.0018738791,0.00027513658,0.000018193175,0.000005687623,0.0012309758],"genre_scores_gemma":[0.99476993,0.0030981784,0.00022503683,0.0012067215,0.00047649993,0.00006272794,0.0000014154641,0.000008421296,0.00015104262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986707,0.00007553962,0.0005162627,0.000119885866,0.0004802443,0.00013739073],"domain_scores_gemma":[0.99831855,0.0004964402,0.00045956887,0.00009144703,0.00056963036,0.000064371154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004965841,0.0000991338,0.00028831008,0.000086567125,0.000030984454,0.00002083454,0.0002370734,0.00006954456,0.00066444144],"category_scores_gemma":[0.00026571268,0.00005742989,0.00013575437,0.00011251945,0.00010269532,0.00006717276,0.000020126467,0.00019257989,0.0000022112738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002182156,0.0012981154,0.50811005,0.000020451158,0.00063165976,0.00006553327,0.00024101327,0.000502476,0.0037351174,0.010166143,0.0016497998,0.47139746],"study_design_scores_gemma":[0.0060004704,0.00070995797,0.9461872,0.00015166024,0.000049441187,0.000016089985,0.000032444717,0.00032728858,0.0064724004,0.00251625,0.03746536,0.00007146011],"about_ca_topic_score_codex":0.0002329451,"about_ca_topic_score_gemma":0.00024997993,"teacher_disagreement_score":0.47132602,"about_ca_system_score_codex":0.0004942474,"about_ca_system_score_gemma":0.00024057495,"threshold_uncertainty_score":0.7275168},"labels":[],"label_agreement":null},{"id":"W2335450077","doi":"10.1097/pgp.0b013e31828bb4c5","title":"Recurrent Intestinal Mucinous Borderline Tumors of the Ovary","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pseudomyxoma peritonei; Appendix; Mucinous Tumor; Cystectomy; Ovary; Mucinous carcinoma; Vagina; Carcinoma; Adenocarcinoma; Surgery; Pathology; Internal medicine; Cancer; Bladder cancer","score_opus":0.018350381279103538,"score_gpt":0.29876302490904444,"score_spread":0.2804126436299409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335450077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821796,0.0002763133,0.0007051031,0.012974369,0.0017584377,0.000117947246,0.000006640095,0.000006996243,0.001974601],"genre_scores_gemma":[0.9956879,0.00008254055,0.0024268231,0.0013680189,0.00038142508,0.0000051089296,0.0000030940246,0.000006236791,0.00003883713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986788,0.0001449657,0.00057756365,0.00012880599,0.00034167405,0.00012818843],"domain_scores_gemma":[0.9982231,0.0004636405,0.00052573055,0.00013538836,0.0005748522,0.00007725163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043040045,0.00010355164,0.00034970438,0.000094333045,0.000024466943,0.000006271475,0.00029336973,0.00007453159,0.00036965447],"category_scores_gemma":[0.0017330602,0.00005570947,0.00023376371,0.000077081124,0.00016663212,0.00003137139,0.00009631722,0.00029720756,0.000007821134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015494851,0.0046738633,0.7642887,0.000033234097,0.0005484249,0.0026956939,0.00024630237,0.00019733665,0.0045853513,0.011678985,0.0036781882,0.20582442],"study_design_scores_gemma":[0.0025082605,0.0037139093,0.97802323,0.00016784652,0.00010918602,0.0045900494,0.000028205035,0.000114181246,0.0015986082,0.0035549304,0.0055264835,0.000065091546],"about_ca_topic_score_codex":0.0000063242232,"about_ca_topic_score_gemma":0.000007286786,"teacher_disagreement_score":0.21373454,"about_ca_system_score_codex":0.00012663947,"about_ca_system_score_gemma":0.00012478737,"threshold_uncertainty_score":0.40474573},"labels":[],"label_agreement":null},{"id":"W2335534400","doi":"10.1016/s1701-2163(16)34052-x","title":"Can Surgical Debulking Reverse Platinum Resistance in Patients With Metastatic Epithelial Ovarian Cancer?","year":2009,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Internal medicine; Oncology; Stage (stratigraphy); Surgery; Cancer","score_opus":0.009349582795338273,"score_gpt":0.23114217933796116,"score_spread":0.2217925965426229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335534400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990996,0.002809672,0.0000026538887,0.0040874663,0.0013891117,0.00020252034,0.00004497621,0.0000021003927,0.00046551295],"genre_scores_gemma":[0.99821067,0.0001752468,0.00083368336,0.00066378264,0.000026737694,0.0000032495361,0.00000438417,0.000008546117,0.000073674055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988007,0.0000441858,0.00041422437,0.00015314367,0.00033850805,0.00024924186],"domain_scores_gemma":[0.99863404,0.00052726234,0.00031525156,0.00009995261,0.00021093001,0.00021255638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013300945,0.00013655722,0.00047402008,0.00018630522,0.000056683763,0.000012996346,0.00005737145,0.00005166396,0.00014715112],"category_scores_gemma":[0.0003368312,0.00009743721,0.000037063397,0.00035571266,0.00002917226,0.000046121848,0.000008245512,0.00025383715,1.04189205e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015355025,0.00031187493,0.94724894,0.000029174464,0.00018897194,0.010489309,0.00011637688,0.00007312958,7.425194e-7,0.00021021285,0.00075908995,0.040418647],"study_design_scores_gemma":[0.012471908,0.0008362265,0.97929543,0.000052659252,0.00018579434,0.00002421772,0.00004219733,0.0000065604145,0.000011728581,0.00009956642,0.0068725557,0.00010117124],"about_ca_topic_score_codex":0.0150637515,"about_ca_topic_score_gemma":0.23075913,"teacher_disagreement_score":0.21569538,"about_ca_system_score_codex":0.0016929696,"about_ca_system_score_gemma":0.001876442,"threshold_uncertainty_score":0.991495},"labels":[],"label_agreement":null},{"id":"W2337786508","doi":"10.1093/jnci/djv428","title":"Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality","year":2015,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Ovary; Carcinoma; Ovarian carcinoma; Stage (stratigraphy); Endometrium; Oncology; Endometrial cancer; Metastasis; Ovarian cancer; Biology; Internal medicine; Cancer research; Medicine; Cancer","score_opus":0.16801908227631523,"score_gpt":0.3894075092056204,"score_spread":0.22138842692930516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337786508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96958846,0.013928977,0.000107328786,0.011457266,0.0034797075,0.00032444633,0.00005800516,0.000004679077,0.0010511565],"genre_scores_gemma":[0.996525,0.00052686705,0.0008791543,0.00047687933,0.0015122178,0.000009162055,8.3708744e-7,0.00000597975,0.000063890424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832475,0.000044197393,0.00044490822,0.000110762274,0.0009752797,0.00010007198],"domain_scores_gemma":[0.99801505,0.0001469756,0.00046993562,0.000103916056,0.001108494,0.00015562054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008295844,0.000097765675,0.00031220188,0.00012913703,0.000050074046,0.0000141626115,0.00013713459,0.000048646187,0.000035760222],"category_scores_gemma":[0.0010988829,0.000060127808,0.00014444655,0.0002841123,0.00015018533,0.00024925335,0.000048772963,0.00016989888,0.0000010537673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075116805,0.0011694005,0.91056657,0.0005045067,0.002435775,0.0001621215,0.0014136774,0.0032126468,0.002885232,0.017567962,0.029078519,0.02349194],"study_design_scores_gemma":[0.017140308,0.0015699735,0.92173696,0.0022106234,0.0011689089,0.0013548033,0.00006651546,0.00013154777,0.009965656,0.0049954974,0.03942804,0.00023118782],"about_ca_topic_score_codex":0.00038325955,"about_ca_topic_score_gemma":0.000076408716,"teacher_disagreement_score":0.026936578,"about_ca_system_score_codex":0.0008058147,"about_ca_system_score_gemma":0.0024193928,"threshold_uncertainty_score":0.42918992},"labels":[],"label_agreement":null},{"id":"W2338520375","doi":"10.1158/1557-3265.ovcasymp14-poster-tech-1130","title":"Abstract POSTER-TECH-1130: Identification of putative genes involved in early steps of epithelial ovarian cancer pathogenesis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ovarian cancer; Transcription factor; Disease; Biology; Pathogenesis; Gene; Cancer; Chromatin immunoprecipitation; Biomarker; Cancer research; Bioinformatics; Medicine; Promoter; Gene expression; Immunology; Genetics; Internal medicine","score_opus":0.30147284438947997,"score_gpt":0.511912477007406,"score_spread":0.2104396326179261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338520375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915466,0.0037210973,0.000012200815,0.0025148944,0.00038610637,0.0010368489,0.0004483661,0.000013559787,0.00032036213],"genre_scores_gemma":[0.99492115,0.0038143012,0.0001419297,0.00005165285,0.0003499056,0.0005136192,0.000029074945,0.00003528389,0.00014306429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962307,0.00042118417,0.0013538765,0.0005657566,0.0010214638,0.00040698587],"domain_scores_gemma":[0.99684054,0.00069931085,0.0003683547,0.0005435983,0.0012156242,0.00033256854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037288987,0.0001690157,0.0006988164,0.00031763458,0.00003867011,0.000021514159,0.000243754,0.00022849516,0.00017360182],"category_scores_gemma":[0.0006335862,0.000140997,0.0001932606,0.0007445761,0.00047211442,0.00011907645,0.0001167967,0.0004406102,0.000025200568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022001027,0.0018386568,0.83125156,0.00027078664,0.00026172065,0.000043337037,0.00095341617,0.000051789313,0.011909351,0.00008469161,0.00023222037,0.15090239],"study_design_scores_gemma":[0.004510626,0.0010847726,0.9430868,0.00033496742,0.00008522313,5.7778584e-7,0.00033165904,0.000041907417,0.04948105,0.0004898261,0.0004397334,0.000112879454],"about_ca_topic_score_codex":0.013555102,"about_ca_topic_score_gemma":0.0024066642,"teacher_disagreement_score":0.15078951,"about_ca_system_score_codex":0.0004692441,"about_ca_system_score_gemma":0.0017901,"threshold_uncertainty_score":0.99301374},"labels":[],"label_agreement":null},{"id":"W2340223341","doi":"10.1007/s00439-016-1663-9","title":"Assessing the genetic architecture of epithelial ovarian cancer histological subtypes","year":2016,"lang":"en","type":"article","venue":"Human Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Public Health Ontario; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"Medical Research and Materiel Command; National Center for Research Resources; Canadian Institutes of Health Research; Francis Crick Institute; National Cancer Institute; Cancer Research UK; California Breast Cancer Research Program; National Center for Advancing Translational Sciences; Foundation for the National Institutes of Health","keywords":"Biology; Serous fluid; Heritability; Genetic architecture; Ovarian cancer; Single-nucleotide polymorphism; Genetics; Cancer; Genetic association; Clear cell; Disease; Oncology; Quantitative trait locus; Genotype; Internal medicine; Gene; Carcinoma; Medicine","score_opus":0.04269218883226275,"score_gpt":0.3301255520728228,"score_spread":0.28743336324056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340223341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964703,0.0038435252,0.00078973314,0.004145007,0.00017975314,0.0002576054,0.000020038688,0.000021654107,0.0010956811],"genre_scores_gemma":[0.9961542,0.00047395466,0.0021609834,0.00028827848,0.00037093958,0.000041640124,0.000002247033,0.000019828325,0.00048792202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908686,0.00005514666,0.00023048959,0.0002252033,0.00020245713,0.000199826],"domain_scores_gemma":[0.99929315,0.00008285771,0.00011049664,0.0003719148,0.000067455534,0.000074109346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000741684,0.0001334894,0.0002303315,0.000039216302,0.00009834129,0.000016926286,0.000115438714,0.00007614203,0.00066394074],"category_scores_gemma":[0.000019419234,0.000061821294,0.00009726842,0.00006707135,0.00021193647,0.000012149009,0.000041043797,0.00008158529,0.000010795986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007025136,0.00044776307,0.49157846,0.00009072445,0.00038209607,0.00008585186,0.00053314347,0.000077238394,0.11456035,0.0015803378,0.0015140824,0.38907972],"study_design_scores_gemma":[0.0013593312,0.00029444476,0.96507263,0.00014263092,0.0002858131,0.000028975264,0.000019524537,0.0000075520256,0.019150004,0.0010629934,0.012473361,0.00010272359],"about_ca_topic_score_codex":0.000060736038,"about_ca_topic_score_gemma":0.00006378105,"teacher_disagreement_score":0.4734942,"about_ca_system_score_codex":0.000091157584,"about_ca_system_score_gemma":0.000104366765,"threshold_uncertainty_score":0.7269686},"labels":[],"label_agreement":null},{"id":"W2340927445","doi":"","title":"The Chr X-linked Gct6 locus: A granulosa cell tumor suppressor in mice","year":2015,"lang":"en","type":"dissertation","venue":"Memorial University Research Repository (Memorial University)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Memorial University of Newfoundland","keywords":"Biology; Congenic; Genetics; Locus (genetics); Gene; Allele; Sanger sequencing; Candidate gene; DNA sequencing","score_opus":0.025916840967616584,"score_gpt":0.2835094769261149,"score_spread":0.2575926359584983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340927445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7434792,0.0008581151,0.0000020084979,0.00071094197,0.01701096,0.003644916,0.0001994037,0.00018394187,0.23391053],"genre_scores_gemma":[0.6897527,0.0013040585,0.000113205555,0.000022774928,0.009473829,0.000009884377,0.0011338339,0.00016899314,0.29802072],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99300754,0.0014711932,0.00052726635,0.0014477603,0.0022323942,0.0013138561],"domain_scores_gemma":[0.9948391,0.00086125056,0.0004281818,0.0011797792,0.0018090467,0.0008826433],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001391479,0.0006795698,0.0011220364,0.0016784611,0.0016488574,0.0002546073,0.0014763202,0.0008136245,0.00007712052],"category_scores_gemma":[0.00032107727,0.0006527924,0.0005650032,0.002333349,0.00052484445,0.00046162782,0.00039494835,0.0023481993,0.0001468707],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.2684844,0.01101783,0.005153359,0.003949357,0.0044494728,0.18536599,0.014534883,0.00018549727,0.08136424,0.009053697,0.41141224,0.0050290357],"study_design_scores_gemma":[0.03362401,0.002698859,0.0028951522,0.0011528017,0.0016794362,0.00009405091,0.028123643,0.00007803834,0.02518286,0.00031171326,0.90281576,0.0013436818],"about_ca_topic_score_codex":0.008649454,"about_ca_topic_score_gemma":0.005300511,"teacher_disagreement_score":0.49140352,"about_ca_system_score_codex":0.0051476993,"about_ca_system_score_gemma":0.005883704,"threshold_uncertainty_score":0.99995345},"labels":[],"label_agreement":null},{"id":"W2341020060","doi":"10.1097/aog.0000000000001396","title":"Hormone Use After Nonserous Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; The Society of Obstetricians and Gynaecologists of Canada; Victoria General Hospital; CancerCare Manitoba; Medical Council of Canada","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Proportional hazards model; Gynecology; Cancer; Ovarian cancer; Fallopian tube; Cohort; Cancer registry; Retrospective cohort study; Fallopian tube cancer; Hormone therapy; Cohort study; Oncology; Breast cancer","score_opus":0.01861941329272299,"score_gpt":0.2590261127905991,"score_spread":0.24040669949787613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341020060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832529,0.0061423173,0.000080645616,0.0085070925,0.0010886735,0.00030540323,0.00013479344,0.00003125535,0.00045691826],"genre_scores_gemma":[0.9859102,0.009275995,0.0004016652,0.0014966056,0.00012608035,0.00018817134,0.0000038427133,0.00002124534,0.0025762396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907756,0.000027654587,0.00017797903,0.00031551288,0.00010743152,0.00029384685],"domain_scores_gemma":[0.9975847,0.0018561427,0.000054503547,0.00023715361,0.00008337749,0.00018411652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006056538,0.00014533423,0.00028234115,0.00012502726,0.000051984847,0.000021309821,0.00003620076,0.0001449561,0.0005847002],"category_scores_gemma":[0.000871177,0.000088020395,0.0000590416,0.00017310365,0.00008115004,0.00007249941,0.000046959627,0.000070629314,0.00006930393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024009304,0.00041821384,0.5583949,0.000020914957,0.00026515193,0.0009246339,0.00011804643,2.5448165e-7,0.0013748902,0.0011022757,0.0032759397,0.43386468],"study_design_scores_gemma":[0.004603183,0.00057576597,0.7962411,0.00002705235,0.00017101903,0.000030934723,0.0000065088993,0.0000048063525,0.00036815152,0.00013584322,0.19770859,0.00012702287],"about_ca_topic_score_codex":0.00017956363,"about_ca_topic_score_gemma":0.00009822559,"teacher_disagreement_score":0.43373764,"about_ca_system_score_codex":0.00019352716,"about_ca_system_score_gemma":0.000105681094,"threshold_uncertainty_score":0.64020574},"labels":[],"label_agreement":null},{"id":"W2341475099","doi":"10.1200/jco.2005.23.16_suppl.3127","title":"A phase II study of UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A Princess Margaret Phase II Consortium Trial","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Neutropenia; Ovarian cancer; Internal medicine; Febrile neutropenia; Chemotherapy; Phases of clinical research; Oncology; Anemia; Toxicity; Surgery; Cancer; Gastroenterology","score_opus":0.06667616169456882,"score_gpt":0.4599364877177345,"score_spread":0.3932603260231657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341475099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193776,0.00014458923,0.000014963583,0.0052247792,0.00055442867,0.0019414984,0.000012821101,0.0000047634708,0.00016437196],"genre_scores_gemma":[0.99821705,0.00022127466,0.00086715934,0.0002799774,0.00027429248,0.00009784041,0.00000788073,0.000016380429,0.000018121787],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99600834,0.00040458582,0.0025061972,0.00029701888,0.00053795363,0.00024591017],"domain_scores_gemma":[0.99642897,0.00043718814,0.0022545732,0.00021402499,0.00041987997,0.00024535824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013831917,0.00019045742,0.0017295198,0.00026038048,0.00004495165,0.000005137565,0.00012981352,0.00016627392,0.00011413238],"category_scores_gemma":[0.0004071225,0.00012465128,0.00012033866,0.0003384106,0.00011700477,0.00016636642,0.000046353533,0.00069719297,3.7875702e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27209204,0.19272268,0.15614691,0.000014622548,0.00027950527,0.00018324044,0.0005735951,0.00007485985,0.0000013334991,0.000022958668,0.000069413734,0.37781882],"study_design_scores_gemma":[0.46811995,0.35037038,0.17775266,0.00028817743,0.00029238063,0.0000058866267,0.00014392931,0.000041951585,0.000017466667,0.000012078681,0.0028796396,0.00007550381],"about_ca_topic_score_codex":0.00013787713,"about_ca_topic_score_gemma":0.003731952,"teacher_disagreement_score":0.37774333,"about_ca_system_score_codex":0.0006527339,"about_ca_system_score_gemma":0.0017727294,"threshold_uncertainty_score":0.5083132},"labels":[],"label_agreement":null},{"id":"W2341800003","doi":"10.1016/s1701-2163(16)31078-7","title":"Early Ovarian Cancer: What Is the Staging Impact of Retroperitoneal Node Sampling?","year":2003,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Ottawa; University of Alberta","funders":"","keywords":"Medicine; Stage (stratigraphy); Serous fluid; Dissection (medical); Lymph node; Ovarian cancer; Retroperitoneal lymph node dissection; Cancer; Radiology; Ovary; Surgery; Pathology; Internal medicine; Testicular cancer","score_opus":0.01904898806970226,"score_gpt":0.2802370453571099,"score_spread":0.2611880572874077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341800003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654142,0.02766101,0.000014376786,0.0023068194,0.0041246507,0.00013316136,0.000030343064,0.0000013600998,0.00031402902],"genre_scores_gemma":[0.9947595,0.0040345252,0.00035736052,0.00074443576,0.000037003425,0.0000032381784,7.5511156e-7,0.000012796874,0.000050397564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886745,0.000053532258,0.00042138368,0.00012399214,0.00029511773,0.00023849837],"domain_scores_gemma":[0.9980893,0.00080801785,0.00039682412,0.0001703044,0.0003358003,0.00019974483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022607797,0.0001326367,0.00043558006,0.00012244051,0.000096887285,0.000041368574,0.0000856515,0.00007304919,0.0006716314],"category_scores_gemma":[0.00050736766,0.00007857301,0.00013149253,0.00030932477,0.000060616847,0.000097745804,0.000015869085,0.0002763699,1.9665262e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014830331,0.00009950365,0.9433509,0.000028470424,0.00073515036,0.00055052416,0.000321301,0.00008780788,0.000021729953,0.00013082226,0.0015377918,0.05312113],"study_design_scores_gemma":[0.002609222,0.00073884527,0.98609966,0.000036496866,0.000293285,0.00007256516,0.00036862222,0.000018738518,0.00020236548,0.00005555609,0.009422167,0.00008249832],"about_ca_topic_score_codex":0.07536556,"about_ca_topic_score_gemma":0.0056530265,"teacher_disagreement_score":0.069712535,"about_ca_system_score_codex":0.0015196775,"about_ca_system_score_gemma":0.003321417,"threshold_uncertainty_score":0.9307917},"labels":[],"label_agreement":null},{"id":"W2343275026","doi":"10.1016/j.jval.2015.03.1168","title":"Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse: a Cost Effective option for Canadian Patients","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Fallopian tube cancer; Oncology; Internal medicine; Fallopian tube; Debulking; Population; Chemotherapy; Carboplatin; Randomized controlled trial; Gynecology; Surgery; Cancer","score_opus":0.030159287082776955,"score_gpt":0.29893055403457947,"score_spread":0.26877126695180253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343275026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779024,0.00042805067,0.00018854259,0.0009097557,0.00045964573,0.013210233,0.006870016,0.00001151242,0.000019856558],"genre_scores_gemma":[0.9875707,0.00042849386,0.0063410043,0.00014370034,0.00016738057,0.004213216,0.0010239172,0.00004994136,0.00006164812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816257,0.00013244203,0.0005864963,0.0003956203,0.00029099008,0.00043190512],"domain_scores_gemma":[0.99817413,0.00022313288,0.00040603775,0.0002645789,0.0004813669,0.00045075413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025995803,0.00024649067,0.0007945926,0.00020730156,0.00008732848,0.0000058287646,0.000056351822,0.00011438547,0.000011856293],"category_scores_gemma":[0.00010463069,0.00017037768,0.00009846317,0.00015789884,0.000051752802,0.00006593701,0.00000864639,0.000071561466,8.8180445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017981343,0.0043352786,0.87503284,0.0009451626,0.0005417581,0.0000051765337,0.0029104503,0.0029618104,0.0000016012132,0.00019311787,0.00029910012,0.09479239],"study_design_scores_gemma":[0.06586495,0.043057222,0.88318235,0.0008843252,0.00041396864,0.0000011637701,0.000077410856,0.0011889024,0.00028767055,0.000081953454,0.0047671986,0.00019288054],"about_ca_topic_score_codex":0.5840001,"about_ca_topic_score_gemma":0.15285987,"teacher_disagreement_score":0.43114024,"about_ca_system_score_codex":0.005348049,"about_ca_system_score_gemma":0.0032277019,"threshold_uncertainty_score":0.99847025},"labels":[],"label_agreement":null},{"id":"W2343487664","doi":"","title":"The Kisspeptin and GPR54 ligand-receptor pair are associated with favorable prognosis and clear cell subtype in human ovarian carcinoma","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Kisspeptin; Biology; Ovarian carcinoma; Immunohistochemistry; Ovary; Tissue microarray; Cancer research; Internal medicine; Receptor; Ovarian cancer; Endocrinology; Oncology; Cancer; Medicine; Immunology; Genetics","score_opus":0.1264533606682524,"score_gpt":0.4374532210557041,"score_spread":0.3109998603874517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343487664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859325,0.0033076722,7.8044525e-7,0.008331977,0.000072355724,0.0010239771,0.000017853314,0.000026704683,0.0012861446],"genre_scores_gemma":[0.9965063,0.0014962113,0.000059673384,0.00023330726,0.0002583158,0.00017380908,0.000011295573,0.000041112846,0.0012199833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972442,0.00032404912,0.0005173053,0.0006036121,0.00058018946,0.0007306549],"domain_scores_gemma":[0.99707645,0.0017277487,0.00013361221,0.00033013485,0.00031637299,0.0004156581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048709763,0.00018001121,0.00045565647,0.0001210119,0.00041193422,0.00010782965,0.00012894846,0.00020868852,0.000093095725],"category_scores_gemma":[0.00046314686,0.00011325267,0.000060740793,0.00055750384,0.00062903506,0.000056723096,0.00012032021,0.0009438797,0.000011504866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012050649,0.00068405876,0.9855776,0.000064877466,0.00009023958,0.00012632784,0.00019543659,3.4309215e-7,0.00011076267,0.00009010481,0.0042090104,0.007646202],"study_design_scores_gemma":[0.0051250733,0.0024523162,0.9806046,0.0003987023,0.00005637771,0.0000025368463,0.00059362117,0.000017886803,0.0019923905,0.00006595808,0.008556017,0.00013454867],"about_ca_topic_score_codex":0.0020124884,"about_ca_topic_score_gemma":0.007635926,"teacher_disagreement_score":0.010573756,"about_ca_system_score_codex":0.00032264172,"about_ca_system_score_gemma":0.00035092726,"threshold_uncertainty_score":0.46183094},"labels":[],"label_agreement":null},{"id":"W2345440189","doi":"10.1093/annonc/mdu338.1","title":"Quality of Life in a Randomised Double-Blind Phase III Trial of Cediranib (Azd2171) in Relapsed Platinum Sensitive Ovarian Cancer (Icon6)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Internal medicine; Oncology; Quality of life (healthcare); Double blind; Cancer; Clinical trial; Platinum; Alternative medicine; Pathology","score_opus":0.17128800009953832,"score_gpt":0.45360664158874164,"score_spread":0.2823186414892033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345440189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858524,0.00022813519,0.000027941287,0.005446293,0.00031283256,0.0019701133,0.000057974277,0.000006849902,0.00609744],"genre_scores_gemma":[0.9983874,0.00030283604,0.00012386714,0.0006868996,0.0002026983,0.00020827832,0.000026945714,0.000015706964,0.000045389308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99703074,0.00052054017,0.0015733677,0.0003265803,0.00026815644,0.00028063866],"domain_scores_gemma":[0.99715096,0.0011659114,0.00092768867,0.0003216679,0.00029648034,0.00013728287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021843526,0.00018645498,0.0019560626,0.00029941063,0.000013932566,0.0000020218808,0.000080215475,0.00027687373,0.00018211483],"category_scores_gemma":[0.00057012995,0.00016089491,0.00023486312,0.00032569742,0.0001794112,0.00004225067,0.000030738258,0.00021287017,0.0000015132453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9578522,0.00665931,0.006955539,0.00017765282,0.00050280057,0.000037470738,0.0021556267,0.0000872956,0.002752406,0.0012456534,0.0004990301,0.021075044],"study_design_scores_gemma":[0.9573412,0.007391361,0.017432367,0.00025040933,0.00013272994,0.0000020692923,0.00022025462,0.00013683333,0.016077952,0.0001770712,0.00071387267,0.0001238886],"about_ca_topic_score_codex":0.006857255,"about_ca_topic_score_gemma":0.0030986753,"teacher_disagreement_score":0.020951156,"about_ca_system_score_codex":0.000100703306,"about_ca_system_score_gemma":0.00087164575,"threshold_uncertainty_score":0.99975616},"labels":[],"label_agreement":null},{"id":"W2346080675","doi":"10.1016/j.jogc.2016.04.084","title":"Opportunistic Salpingectomy: We Chose to Act, Not Wait","year":2016,"lang":"en","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Scopus; Civility; Gynecology; Humanities; MEDLINE; Law; Political science; Politics; Art","score_opus":0.016327410553109097,"score_gpt":0.269373476742749,"score_spread":0.2530460661896399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346080675","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014980782,0.00664327,0.0000095946825,0.008143733,0.9820156,0.00029415256,0.0004686035,0.0000057679135,0.000921175],"genre_scores_gemma":[0.26156163,0.02700459,0.0010256189,0.0045861187,0.69535506,0.00007030409,0.00015298538,0.0002672508,0.009976438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974252,0.000053059364,0.00080010126,0.0003428001,0.0009332636,0.00044559457],"domain_scores_gemma":[0.990509,0.006592335,0.000791266,0.00030089493,0.0008812944,0.00092525344],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002885108,0.00035910177,0.0012289493,0.0004911569,0.00009535167,0.00004014403,0.00021314828,0.00056630094,0.0009153383],"category_scores_gemma":[0.009822303,0.00024978683,0.00015948598,0.00026086537,0.000050329734,0.000044192122,0.000084233274,0.00080177776,0.000006339223],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002994157,0.00010214018,0.0017689344,0.00012728745,0.0005573136,0.010451083,0.000023920953,5.2431784e-7,0.000002343754,0.00002766752,0.8848278,0.10208107],"study_design_scores_gemma":[0.004091637,0.0014972668,0.011660629,0.00015914957,0.00078681624,0.000050098395,0.000017820512,7.8373205e-7,0.000014753133,0.000030936044,0.98145425,0.00023585383],"about_ca_topic_score_codex":0.007276945,"about_ca_topic_score_gemma":0.017872369,"teacher_disagreement_score":0.28666055,"about_ca_system_score_codex":0.004826319,"about_ca_system_score_gemma":0.015632952,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W2346236028","doi":"10.1200/jco.2015.33.15_suppl.5503","title":"Impact of trebananib plus weekly paclitaxel on overall survival (OS) in patients (pts) with recurrent ovarian cancer and ascites: Results from the phase III TRINOVA-1 study.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Ascites; Internal medicine; Clinical endpoint; Progression-free survival; Gastroenterology; Placebo; Paclitaxel; Randomized controlled trial; Toxicity; Ovarian cancer; Overall survival; Cancer; Pathology","score_opus":0.17850757050419325,"score_gpt":0.48757933274483095,"score_spread":0.3090717622406377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346236028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904504,0.00038693467,0.000003088354,0.006970154,0.00086590427,0.00066420913,0.00017036207,0.0000032443627,0.0004857471],"genre_scores_gemma":[0.99830353,0.0005035597,0.00011097311,0.00042820486,0.0005780772,0.000012075739,0.000015282858,0.000013548785,0.000034735982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959916,0.0006248925,0.0022148641,0.00031415463,0.00061769434,0.00023681622],"domain_scores_gemma":[0.9938597,0.0029798925,0.0018994756,0.0003193826,0.0004953199,0.00044620814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028306441,0.00021602583,0.0017781493,0.00011030946,0.000026983595,0.000013712248,0.00015029463,0.000178071,0.000046912264],"category_scores_gemma":[0.0017998995,0.0001045755,0.0002752992,0.00018100724,0.00014127743,0.00009220441,0.000043561944,0.0007273332,0.0000022282725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12755911,0.019746302,0.7335923,0.000004111592,0.0013523216,0.00026986815,0.0011845458,0.000062537285,5.923712e-7,0.000017971015,0.00604088,0.11016951],"study_design_scores_gemma":[0.19281372,0.09953171,0.70491046,0.00021767468,0.00049288914,0.000004825291,0.00027920198,0.00002348829,0.00000108359,0.00005425554,0.001598115,0.00007259205],"about_ca_topic_score_codex":0.0048428667,"about_ca_topic_score_gemma":0.0029849142,"teacher_disagreement_score":0.11009692,"about_ca_system_score_codex":0.0008284566,"about_ca_system_score_gemma":0.0026791827,"threshold_uncertainty_score":0.73209983},"labels":[],"label_agreement":null},{"id":"W2356857789","doi":"","title":"A Clinical Analysis of 24 Borderline Ovarian Tumors","year":2012,"lang":"en","type":"article","venue":"Inner Mongolia Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Serous fluid; Stage (stratigraphy); Conservative management; Ovary; Surgery; Chemotherapy; Conservative treatment; Ovarian tumor; Ovarian cancer; Internal medicine; Cancer","score_opus":0.03697911746079595,"score_gpt":0.3705361443188449,"score_spread":0.33355702685804894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2356857789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96212184,0.0027427766,0.0017852801,0.02836705,0.0019618121,0.00021482851,0.000022528402,0.000037884565,0.0027460116],"genre_scores_gemma":[0.99180466,0.0008714401,0.0017499456,0.002715884,0.0026227443,0.00001095917,0.000022745191,0.000023168655,0.00017845786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658495,0.00018855993,0.0012798596,0.00021919482,0.001221656,0.0005057877],"domain_scores_gemma":[0.9970459,0.00026623797,0.00037197254,0.00036471576,0.00029106243,0.0016601078],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019883567,0.00019669766,0.0010345355,0.00043699399,0.00006938472,0.000018632212,0.00018394478,0.00024422802,0.005245192],"category_scores_gemma":[0.0011045291,0.00013216393,0.00073495327,0.0009679904,0.0002150025,0.00011896638,0.00006272738,0.0008222648,0.000029601257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019066209,0.0023681878,0.9053331,0.00002100379,0.00516298,0.00043884976,0.0002156895,0.0000071954464,0.0000110943965,0.0005888372,0.017919397,0.067743],"study_design_scores_gemma":[0.00353706,0.00041507583,0.9545899,0.00022044199,0.0050357603,0.0005940268,0.000103042,0.0009165067,0.00007472933,0.000050008774,0.03432343,0.00013999647],"about_ca_topic_score_codex":0.000092061484,"about_ca_topic_score_gemma":0.000027696064,"teacher_disagreement_score":0.06760301,"about_ca_system_score_codex":0.00010466058,"about_ca_system_score_gemma":0.00047517763,"threshold_uncertainty_score":0.9956641},"labels":[],"label_agreement":null},{"id":"W2375203420","doi":"10.1200/jco.2006.24.18_suppl.5084","title":"Phase II study of sorafenib (BAY 43–9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A PMH phase II consortium trial","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Sorafenib; Clinical endpoint; Internal medicine; Phases of clinical research; Refractory (planetary science); Ovarian cancer; Oncology; Gastroenterology; Cancer; Clinical trial; Surgery; Hepatocellular carcinoma","score_opus":0.09325489722830269,"score_gpt":0.4701086753564609,"score_spread":0.37685377812815823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2375203420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869114,0.00042545723,0.000027002226,0.008965702,0.001666015,0.0015910402,0.000029308885,0.000006734903,0.00037730258],"genre_scores_gemma":[0.9976004,0.00037190443,0.0004059018,0.00023974598,0.0011755221,0.00009644577,0.0000131485485,0.00002058986,0.000076343065],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941955,0.0006896261,0.003918274,0.00033796768,0.000549195,0.00030941874],"domain_scores_gemma":[0.99555016,0.00095792743,0.002588376,0.00023661529,0.00044134448,0.00022555182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002968968,0.00023296534,0.0023293856,0.00040508906,0.00005780856,0.000007447823,0.0001462458,0.00027412514,0.00019299604],"category_scores_gemma":[0.00068921276,0.00016211918,0.00027311422,0.0004323897,0.00017209518,0.00012491948,0.00005491813,0.0008969902,0.0000014220069],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32887927,0.39238352,0.07474184,0.000032068114,0.00051660626,0.0018403415,0.0005515731,0.00009989496,0.00008908641,0.0002699302,0.001015202,0.19958068],"study_design_scores_gemma":[0.5810528,0.33888096,0.07169667,0.00024214768,0.0006397579,0.000041438685,0.0001789124,0.00011217033,0.00009590895,0.00018329325,0.0067655877,0.000110373985],"about_ca_topic_score_codex":0.0011405635,"about_ca_topic_score_gemma":0.006793523,"teacher_disagreement_score":0.25217354,"about_ca_system_score_codex":0.00056493777,"about_ca_system_score_gemma":0.0027040327,"threshold_uncertainty_score":0.66110283},"labels":[],"label_agreement":null},{"id":"W2395498402","doi":"10.1158/1940-6207.capr-15-0384","title":"Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence","year":2016,"lang":"en","type":"review","venue":"Cancer Prevention Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Pathogenesis; Serous carcinoma; Serous fluid; Disease; Medicine; Ovarian cancer; Cancer; Bioinformatics; Pathology; Intensive care medicine; Oncology; Gynecology; Biology; Internal medicine","score_opus":0.3961668275558421,"score_gpt":0.5247675754868558,"score_spread":0.12860074793101373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395498402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045633462,0.9750146,0.00010492357,0.0056937034,0.0001928583,0.01832754,0.0001811801,0.000005236357,0.000023598826],"genre_scores_gemma":[0.0013381311,0.9797317,0.0003159553,0.00010026457,0.00027568144,0.016875276,0.000015299991,0.00003965374,0.0013080314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960485,0.0011628002,0.0009028845,0.0005247978,0.0010539481,0.0003070367],"domain_scores_gemma":[0.99619204,0.0012224402,0.0004633841,0.0010086659,0.001035752,0.000077698714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029751535,0.00024287538,0.0012989898,0.00015987671,0.00017062269,0.000014626766,0.0005309089,0.0000847994,0.00031583343],"category_scores_gemma":[0.00066565257,0.00011276682,0.0005825928,0.0010390003,0.00009447056,0.000043862598,0.0002639347,0.00019776882,0.000011295503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043890534,0.00034336362,0.00037258322,0.08776079,0.00068906613,0.0000034367674,0.00012736734,1.5946267e-7,0.000007144242,0.00031281426,0.0046737236,0.90566564],"study_design_scores_gemma":[0.0010272163,0.0006579082,0.011414641,0.44889286,0.0021347674,0.000009822318,0.00006786027,2.105038e-7,0.00015200715,0.00016108378,0.5353202,0.00016138321],"about_ca_topic_score_codex":0.00020393205,"about_ca_topic_score_gemma":0.00011544447,"teacher_disagreement_score":0.9055043,"about_ca_system_score_codex":0.0008824518,"about_ca_system_score_gemma":0.003491816,"threshold_uncertainty_score":0.61943316},"labels":[],"label_agreement":null},{"id":"W2395520820","doi":"10.1016/s0849-5831(16)30861-8","title":"The Role of Aggressive Surgery in Advanced Epithelial Ovarian Cancer","year":2001,"lang":"en","type":"article","venue":"Journal SOGC","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre; Hamilton Regional Laboratory Medicine Program; Western University","funders":"","keywords":"Medicine; Debulking; Gynecology; Epithelial ovarian cancer; Ovarian cancer; Overall survival; Retrospective cohort study; Cohort; Internal medicine; Cancer; Surgery; Oncology","score_opus":0.011862018002968766,"score_gpt":0.2859228805078478,"score_spread":0.27406086250487904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395520820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744382,0.014812647,0.00000701932,0.007648323,0.0005532583,0.0001647415,0.000008461225,0.00000632167,0.0023610282],"genre_scores_gemma":[0.9716427,0.027345493,0.00009158844,0.00017635021,0.0004667394,0.000030700612,9.84351e-7,0.000012571735,0.00023289502],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990744,0.000044037883,0.00032812607,0.00010099054,0.00022593097,0.00022654422],"domain_scores_gemma":[0.99900955,0.00021397782,0.00043706983,0.0001413036,0.000092717804,0.00010539905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002609927,0.000091863585,0.00026787727,0.000076983175,0.00009721499,0.00001858321,0.000059026243,0.000043049436,0.00021267857],"category_scores_gemma":[0.00014460785,0.000053528238,0.0001392473,0.00017619437,0.000037675632,0.0000613117,0.000013356075,0.00020093065,0.0000068941463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005307134,0.00020615695,0.47943282,0.000006140308,0.00012793847,0.0004820251,0.00018417464,0.000054087788,0.00072253967,0.0001274995,0.0006139231,0.51751196],"study_design_scores_gemma":[0.0028332511,0.0001757547,0.8560281,0.00081833976,0.00010605456,0.0005540732,0.00039111188,0.000055891625,0.0065245135,0.0020408256,0.13036028,0.00011184213],"about_ca_topic_score_codex":0.0002487577,"about_ca_topic_score_gemma":0.00024933988,"teacher_disagreement_score":0.51740015,"about_ca_system_score_codex":0.00019115287,"about_ca_system_score_gemma":0.00027325546,"threshold_uncertainty_score":0.23286812},"labels":[],"label_agreement":null},{"id":"W2396634817","doi":"","title":"Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum--a systematic review of the evidence from randomized trials.","year":2002,"lang":"en","type":"review","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Association of Academic Professionals in Obstetrics and Gynaecology; University of Ottawa","funders":"","keywords":"Medicine; Topotecan; Regimen; Oncology; Internal medicine; Ovarian cancer; Randomized controlled trial; Chemotherapy; Cisplatin; Cochrane Library; Paclitaxel; Doxorubicin; Cancer","score_opus":0.1250586864345756,"score_gpt":0.35374696642603654,"score_spread":0.22868827999146094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396634817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031279155,0.9101955,0.000027361788,0.0010732189,0.0003905387,0.08751188,0.00069413224,0.000037658978,0.00006656447],"genre_scores_gemma":[0.000016631182,0.8220483,0.00017329566,0.00028830263,0.00041235515,0.1763674,0.00009364033,0.00009902904,0.0005010557],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926266,0.0022732145,0.0031839574,0.0007626505,0.0006693137,0.0004842684],"domain_scores_gemma":[0.9874619,0.00647118,0.0042302557,0.0013375084,0.00029528563,0.0002038603],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0045015602,0.0008166338,0.016505037,0.00010872391,0.00006828649,0.000040114322,0.00041259217,0.00026291478,0.0002609152],"category_scores_gemma":[0.005261471,0.00033783872,0.0033985558,0.0005153206,0.0001291126,0.000057756097,0.00003482366,0.00027718127,0.000005142767],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038949759,0.0001546762,0.0000048590205,0.5695773,0.0051570837,0.00000300601,0.000040722327,4.777876e-8,8.56972e-9,0.000006600987,0.0008707061,0.42029005],"study_design_scores_gemma":[0.05440417,0.00011339712,0.000026558033,0.814764,0.0884826,0.00001613815,0.0000014055889,0.000003464526,0.0000071563745,0.000006944693,0.041898124,0.000276032],"about_ca_topic_score_codex":0.0002672543,"about_ca_topic_score_gemma":0.000029253704,"teacher_disagreement_score":0.42001402,"about_ca_system_score_codex":0.0007072589,"about_ca_system_score_gemma":0.00050484214,"threshold_uncertainty_score":0.9999074},"labels":[],"label_agreement":null},{"id":"W2398467218","doi":"10.1158/1557-3265.ovca15-b27","title":"Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Biology; Single-nucleotide polymorphism; Small GTPase; Ovarian cancer; Gene; GTPase; Cancer; Cancer research; Rab; Ras superfamily; Odds ratio; Carcinogenesis; Genetics; Bioinformatics; Internal medicine; Oncology; Signal transduction; Genotype; Medicine; GTP'","score_opus":0.32991778770584873,"score_gpt":0.5111181086346965,"score_spread":0.1812003209288478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398467218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709115,0.0024718924,0.000008583097,0.024718367,0.00034500187,0.00067944947,0.00013029473,0.000018499988,0.0007164259],"genre_scores_gemma":[0.9857414,0.011798715,0.0002627195,0.00029388416,0.000908173,0.0005006159,0.0000070431893,0.000029687286,0.00045779021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732655,0.00025932063,0.00082398,0.0005410045,0.0005727123,0.00047644056],"domain_scores_gemma":[0.99736553,0.0012229162,0.0001445633,0.00048115297,0.0004145774,0.00037125935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002268116,0.00014631613,0.0005030701,0.00021366977,0.000052321026,0.0000141774335,0.0001837961,0.0002025817,0.0015089202],"category_scores_gemma":[0.00057076715,0.000093768394,0.00015502301,0.00045106988,0.0005453702,0.000072076444,0.000086484644,0.00041334584,0.000065458735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087655487,0.0003403778,0.738581,0.00013630145,0.00009872597,0.00007310157,0.00007497546,0.0000037400437,0.0076518655,0.00026990724,0.0013600508,0.25053343],"study_design_scores_gemma":[0.0058632987,0.0005242587,0.95832556,0.0012103479,0.000041774532,0.0000013914567,0.000024290493,0.000012909893,0.026958328,0.00089149154,0.0060357493,0.000110623805],"about_ca_topic_score_codex":0.0082817,"about_ca_topic_score_gemma":0.0045660282,"teacher_disagreement_score":0.2504228,"about_ca_system_score_codex":0.000476726,"about_ca_system_score_gemma":0.0016903515,"threshold_uncertainty_score":0.99940383},"labels":[],"label_agreement":null},{"id":"W2398536625","doi":"10.1158/1557-3265.ovca15-a27","title":"Abstract A27: Transcriptome analyses of human ampulla and fimbriae highlight similarities and differences.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transcriptome; Fallopian tube; Biology; Ampulla; Serous fluid; Andrology; Oviduct; Genetics; Gene; Gene expression; Medicine; Endocrinology; Anatomy","score_opus":0.4691759364194461,"score_gpt":0.5744284520348472,"score_spread":0.10525251561540105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398536625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98049015,0.00687047,0.000002881944,0.010960418,0.00009638933,0.00030918114,0.00008235061,0.000016004733,0.0011721762],"genre_scores_gemma":[0.97871566,0.019987186,0.00003759123,0.00012512438,0.00026129276,0.00007768761,0.0000033092238,0.000016650547,0.0007754705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802434,0.00013933035,0.0005371296,0.00046780318,0.00049691735,0.00033447944],"domain_scores_gemma":[0.99786866,0.0012034692,0.00007440217,0.00030742225,0.00023250534,0.00031355955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008747209,0.0001402041,0.00059718615,0.0001449773,0.0001112372,0.000031143252,0.000099213925,0.00014022904,0.0009395365],"category_scores_gemma":[0.00019365642,0.00007951048,0.000116695046,0.000154778,0.001077159,0.00006876803,0.000064254935,0.0002700595,0.0000047360504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005412473,0.00061393145,0.9209769,0.00051927456,0.00049855054,0.0000654715,0.00016191747,3.427235e-8,0.02126765,0.0010304967,0.004597027,0.049727492],"study_design_scores_gemma":[0.0034075729,0.0010208016,0.98567766,0.0007064678,0.00012234125,0.0000024775118,0.00006318186,0.0000013658845,0.005641479,0.00077814836,0.0024812014,0.00009732378],"about_ca_topic_score_codex":0.0010415982,"about_ca_topic_score_gemma":0.00030438698,"teacher_disagreement_score":0.06470073,"about_ca_system_score_codex":0.00006908596,"about_ca_system_score_gemma":0.00018214491,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W2398537820","doi":"10.1158/1557-3265.ovca15-b20","title":"Abstract B20: Uptake and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Tubal ligation; Hysterectomy; Fallopian tube; Perioperative; Ovarian cancer; Odds ratio; Obstetrics; Gynecology; Blood transfusion; Surgery; Cancer; Population; Family planning; Internal medicine; Pregnancy","score_opus":0.24702994200356687,"score_gpt":0.5268873059424586,"score_spread":0.2798573639388917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398537820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655293,0.0012305258,0.000043656335,0.031000197,0.00015967623,0.0016401409,0.0001567804,0.000010362062,0.00022934176],"genre_scores_gemma":[0.9836231,0.014383973,0.00012020582,0.0003770963,0.0003068084,0.00083588564,0.000030421093,0.00001989079,0.0003026374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799246,0.00022209022,0.0006322796,0.00037655132,0.00040036853,0.00037622981],"domain_scores_gemma":[0.99739164,0.0017971118,0.00010683141,0.00032829904,0.00024539552,0.00013071545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003076196,0.00011261776,0.0003514876,0.00016602047,0.000074651434,0.000020074984,0.00013601723,0.000118794625,0.00038902232],"category_scores_gemma":[0.00033966292,0.000057394056,0.000116848016,0.0003945995,0.0002997452,0.00006012152,0.000046294026,0.00029215074,0.0000039542197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00669869,0.0010265436,0.5865796,0.0004058998,0.00038478948,0.000035729245,0.0005771472,0.000014108212,0.00029797349,0.0008674954,0.0070379185,0.39607406],"study_design_scores_gemma":[0.008769164,0.00087129045,0.9215968,0.0010368865,0.00006006209,0.0000016435583,0.000086396816,0.000057665442,0.0002620132,0.0012446686,0.0659381,0.00007530822],"about_ca_topic_score_codex":0.0034004017,"about_ca_topic_score_gemma":0.0016855916,"teacher_disagreement_score":0.39599875,"about_ca_system_score_codex":0.0002876748,"about_ca_system_score_gemma":0.0005697339,"threshold_uncertainty_score":0.5140413},"labels":[],"label_agreement":null},{"id":"W2399514156","doi":"10.1158/1538-7445.compsysbio-b2-06","title":"Abstract B2-06: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Serous fluid; Oncology; Ovarian cancer; Ovarian carcinoma; Internal medicine; Serous carcinoma; Stage (stratigraphy); Cancer; Adjuvant; Surgery; Biology","score_opus":0.2731987781954914,"score_gpt":0.45766126075695973,"score_spread":0.18446248256146835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399514156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665028,0.0047668577,0.015108238,0.011507083,0.00004007731,0.0011084647,0.00025866562,0.00001946079,0.0006883479],"genre_scores_gemma":[0.994231,0.00031636326,0.004597931,0.00007522875,0.00014196365,0.0004461595,0.000116379226,0.00002205527,0.000052925257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990526,0.000023112809,0.00018427841,0.0002452952,0.00026219033,0.00023251201],"domain_scores_gemma":[0.9986826,0.00015829367,0.000039018712,0.0001879551,0.0007452123,0.00018687271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043416405,0.0000821634,0.00018448663,0.00012831503,0.00010762045,0.000025244566,0.00006794807,0.000050576953,0.00001834065],"category_scores_gemma":[0.00003683565,0.000071124465,0.000044021377,0.00016839038,0.00007604036,0.000056743334,0.000028941826,0.0001277456,0.0000014453335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019295115,0.00084592536,0.6185726,0.00046794472,0.0007428874,0.00001549177,0.0021028302,0.06519177,0.0012560835,0.017723924,0.004889409,0.28626162],"study_design_scores_gemma":[0.013718175,0.0010271211,0.61187595,0.00035113547,0.0000802414,0.000029091661,0.00096201425,0.355209,0.00058690493,0.014344466,0.0015597091,0.00025622846],"about_ca_topic_score_codex":0.0015688976,"about_ca_topic_score_gemma":0.000093728086,"teacher_disagreement_score":0.29001722,"about_ca_system_score_codex":0.0002589216,"about_ca_system_score_gemma":0.00057391485,"threshold_uncertainty_score":0.29003716},"labels":[],"label_agreement":null},{"id":"W2399825327","doi":"10.1016/s0849-5831(16)31528-2","title":"Primary Surgery for Early and Advanced Epithelial Ovarian Cancer","year":2000,"lang":"en","type":"article","venue":"Journal SOGC","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Gynecology; Ovarian cancer; Pathological; Stage (stratigraphy); Epithelial ovarian cancer; Cancer; Surgery; Internal medicine","score_opus":0.016454899615170607,"score_gpt":0.2797248802951075,"score_spread":0.2632699806799369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399825327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98378646,0.003261173,0.000068099886,0.009952975,0.00044024986,0.00033024425,0.00004526028,0.000020252652,0.0020953056],"genre_scores_gemma":[0.9744706,0.013932774,0.0029993618,0.0025724126,0.0020118288,0.00013023536,0.00000940124,0.00004282765,0.0038305398],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992109,0.000016715941,0.0002296409,0.00015637938,0.00015522982,0.00023115177],"domain_scores_gemma":[0.9994354,0.00011701707,0.00007682211,0.00010038727,0.000059683436,0.00021065625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016986419,0.00011406024,0.00030546056,0.0000550867,0.0001359312,0.000044867375,0.000028050086,0.000053573694,0.00091092713],"category_scores_gemma":[0.000018249333,0.00008478362,0.00014215936,0.000063854466,0.000025842628,0.0001150325,0.0000056090025,0.00013044453,0.0000122121055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091988995,0.00018182781,0.050360855,0.000051749066,0.00022191058,0.00011557152,0.0001422808,0.000008137163,0.00041352276,0.00003572826,0.0053652823,0.94218326],"study_design_scores_gemma":[0.0038838077,0.00031952534,0.7571983,0.0002660004,0.0002244182,0.0002868607,0.00000996115,0.000013020437,0.00054841215,0.00041514912,0.23670521,0.00012934668],"about_ca_topic_score_codex":0.00006425114,"about_ca_topic_score_gemma":0.000009636375,"teacher_disagreement_score":0.9420539,"about_ca_system_score_codex":0.00015579138,"about_ca_system_score_gemma":0.0002052182,"threshold_uncertainty_score":0.99740136},"labels":[],"label_agreement":null},{"id":"W2400789541","doi":"10.1158/1557-3265.ovca15-b21","title":"Abstract B21: <i>BRCA</i> mutation status is not associated with better long-term survival from epithelial ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; BRCA mutation; Oncology; Cancer registry; Population; Mutation; Internal medicine; Disease; Cohort; Medical record; Gynecology; Genetics; Biology; Gene","score_opus":0.18987173276025182,"score_gpt":0.4788354603427074,"score_spread":0.2889637275824556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400789541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957836,0.00070335105,0.00003251891,0.03666318,0.0008179009,0.0008993614,0.0021304225,0.000071085,0.0008462338],"genre_scores_gemma":[0.98970574,0.0040486655,0.00007896461,0.0022405887,0.0020941966,0.00055622385,0.00013519362,0.00008830903,0.0010521165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949939,0.00040894706,0.0008130045,0.0010773242,0.0016280648,0.0010787126],"domain_scores_gemma":[0.9945856,0.0029173284,0.0002489672,0.0007181331,0.00081022026,0.00071977347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015116353,0.00031462865,0.000775578,0.00012877559,0.00020749666,0.000096411306,0.00024530475,0.0003434318,0.007797742],"category_scores_gemma":[0.00058912236,0.00019105701,0.00023887637,0.00041387184,0.0005653706,0.00018506224,0.00010728255,0.00085456646,0.00029655537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028393539,0.0007950535,0.8089692,0.000034319808,0.0010629377,0.0004498244,0.00012885605,8.1304796e-7,0.0008561022,0.000016206683,0.004885875,0.17996144],"study_design_scores_gemma":[0.0135198105,0.0009756467,0.973251,0.0012213971,0.0002604224,0.0000014411438,0.000018976998,0.000005467769,0.006243765,0.00012730637,0.0041114218,0.00026333545],"about_ca_topic_score_codex":0.010795351,"about_ca_topic_score_gemma":0.0076195067,"teacher_disagreement_score":0.1796981,"about_ca_system_score_codex":0.0012632575,"about_ca_system_score_gemma":0.0018168605,"threshold_uncertainty_score":0.99579185},"labels":[],"label_agreement":null},{"id":"W2403652567","doi":"10.1158/1557-3265.ovca15-ia15","title":"Abstract IA15: Rarer, yet both interesting and relevant: Other ovarian cancers.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation","funders":"","keywords":"Ovarian cancer; Serous fluid; Medicine; Cancer; Germ cell tumors; Serous carcinoma; Oncology; Ovarian carcinoma; Gynecology; Pathology; Internal medicine; Cancer research; Chemotherapy","score_opus":0.3079086064732586,"score_gpt":0.5336703794071166,"score_spread":0.22576177293385802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403652567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.897036,0.0034153094,0.000027875727,0.072360754,0.0009586761,0.0011359829,0.00013842431,0.000104262734,0.024822721],"genre_scores_gemma":[0.98919874,0.005176323,0.00024698878,0.002192588,0.0008708876,0.0002263237,0.0000019381441,0.000056386372,0.002029795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973027,0.00018221785,0.0005428785,0.00074984954,0.0006072109,0.0006151233],"domain_scores_gemma":[0.9953117,0.0033100403,0.00009639092,0.0005758977,0.00020118803,0.0005048291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018287657,0.00018832281,0.0004520095,0.00013993279,0.00014974651,0.00005147154,0.00016296687,0.00018060322,0.0027390239],"category_scores_gemma":[0.0015923796,0.00011116407,0.00013372477,0.0002263767,0.00041840243,0.000079521546,0.00012077967,0.0006366752,0.00022771921],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002548766,0.000462143,0.3272792,0.0001320305,0.0003344464,0.00026617822,0.00010868426,7.3363645e-7,0.0004282777,0.0015976116,0.065257184,0.60158473],"study_design_scores_gemma":[0.009376866,0.0029624728,0.70871335,0.0039655236,0.000079077814,0.000014876669,0.00007234404,0.000021496793,0.0016551175,0.0013142958,0.27153766,0.0002868953],"about_ca_topic_score_codex":0.0020540385,"about_ca_topic_score_gemma":0.00061935163,"teacher_disagreement_score":0.60129786,"about_ca_system_score_codex":0.00058506825,"about_ca_system_score_gemma":0.0007362475,"threshold_uncertainty_score":0.9981726},"labels":[],"label_agreement":null},{"id":"W2404061968","doi":"10.1097/pgp.0000000000000202","title":"Article by Natalie Banet and Robert J. Kurman","year":2015,"lang":"en","type":"letter","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Johns Hopkins University","keywords":"Calretinin; Biology; PAX8; Serous fluid; Epithelium; Fimbria; Pathology; Columnar Cell; Ovary; Cell biology; Gene; Immunohistochemistry; Medicine; Immunology; Genetics; Transcription factor","score_opus":0.020164109906730315,"score_gpt":0.29741163444477736,"score_spread":0.277247524538047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404061968","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1048283,0.0031559544,0.000041996147,0.8867923,0.001955852,0.00016824632,0.00012473443,0.000013061866,0.0029195691],"genre_scores_gemma":[0.28979927,0.0011620912,0.0010297119,0.70210874,0.0040681413,0.000017936845,0.00026228014,0.00003208186,0.0015197524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984144,0.00011350678,0.00051730557,0.00023742231,0.0005038826,0.00021349362],"domain_scores_gemma":[0.9984891,0.00033271682,0.0004073821,0.00012072312,0.000505621,0.00014448154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000298064,0.00019430705,0.00055920007,0.00013786904,0.000019716721,0.000033702978,0.00021415328,0.00055804185,0.0010741246],"category_scores_gemma":[0.00039333038,0.0001329004,0.00014367735,0.000035712066,0.00015905018,0.00006361261,0.00009330368,0.0010494856,0.00005688582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012241003,0.0002565665,0.006268925,0.000009094877,0.00036753592,0.034106504,0.000027684722,0.0000012533363,0.00012327348,0.00003716766,0.9535645,0.0051150355],"study_design_scores_gemma":[0.002855458,0.001839728,0.013304178,0.00006238998,0.00023473654,0.011686258,0.00000965192,0.0000082736,0.00011631474,0.0015092153,0.9682378,0.00013600374],"about_ca_topic_score_codex":0.000011206118,"about_ca_topic_score_gemma":0.0000031360887,"teacher_disagreement_score":0.18497097,"about_ca_system_score_codex":0.00030766038,"about_ca_system_score_gemma":0.00014458808,"threshold_uncertainty_score":0.999839},"labels":[],"label_agreement":null},{"id":"W2405845947","doi":"","title":"The role of topotecan as second-line therapy in patients with recurrent ovarian cancer.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Topotecan; Medicine; Ovarian cancer; Chemotherapy; Internal medicine; Oncology; Stage (stratigraphy); Progressive disease; Surgery; Cancer","score_opus":0.016236504319271056,"score_gpt":0.22735731179584476,"score_spread":0.2111208074765737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405845947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834497,0.0052081216,2.542623e-7,0.002845732,0.00014749952,0.0013651104,0.000023374358,0.00001298229,0.0069472245],"genre_scores_gemma":[0.9960922,0.0013537349,0.000015279891,0.00021796706,0.00007112986,0.0017963732,0.0000068559266,0.000014593335,0.0004318457],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991376,0.000026118181,0.00019245646,0.00017689937,0.00021154617,0.000255378],"domain_scores_gemma":[0.999462,0.000038579357,0.000088349756,0.00025489775,0.00006315595,0.00009303689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095130905,0.00010754162,0.00019499335,0.00004476588,0.00003976967,0.000011407798,0.000069648624,0.0000350395,0.0003692282],"category_scores_gemma":[0.000014773696,0.00006135006,0.000040577586,0.00017551,0.000042108877,0.000033381075,0.00001186006,0.00009607153,0.0000041101534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035774586,0.00052919175,0.3231442,0.000005573482,0.00009281895,0.0000024106403,0.00014248895,0.0000013993355,8.2351977e-7,0.00012839222,0.00019622102,0.6753987],"study_design_scores_gemma":[0.0049321386,0.00052165706,0.9603519,0.000031787727,0.000027649909,7.5828626e-7,0.000027595719,0.000013575461,0.0009213617,0.000112707516,0.032991603,0.000067306784],"about_ca_topic_score_codex":0.00028565098,"about_ca_topic_score_gemma":0.00047045966,"teacher_disagreement_score":0.6753314,"about_ca_system_score_codex":0.00015107934,"about_ca_system_score_gemma":0.000028742428,"threshold_uncertainty_score":0.40427896},"labels":[],"label_agreement":null},{"id":"W2405899382","doi":"","title":"Physicians' attitudes, beliefs and knowledge concerning ovarian cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Specialty; Referral; Debulking; Family medicine; Ovarian cancer; Cancer; Internal medicine","score_opus":0.02486381169500717,"score_gpt":0.2689653870651272,"score_spread":0.24410157537012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405899382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7910186,0.059503376,0.00008670592,0.017756978,0.0012802705,0.0032965613,0.000103188606,0.00035899685,0.12659532],"genre_scores_gemma":[0.992327,0.00042329048,0.00014544018,0.000392661,0.0010581732,0.0020285787,0.000021698568,0.00002426907,0.003578892],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99908555,0.000018069682,0.00015619955,0.0002948577,0.00011785099,0.00032746862],"domain_scores_gemma":[0.99957967,0.00003983824,0.000057096273,0.00017076402,0.000046041565,0.000106564185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009035069,0.00014213967,0.00025661077,0.00004654892,0.00008509767,0.000033482786,0.00003930569,0.000052356514,0.000049857328],"category_scores_gemma":[0.000009157788,0.00012447554,0.00005407513,0.00013476262,0.000066454755,0.00005996775,0.000031215553,0.00009072451,0.000013339322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038930728,0.00044880257,0.4662274,0.000096150194,0.00018480813,0.000041879946,0.00013587384,0.000006329744,0.00003812022,0.002451752,0.011007768,0.51932216],"study_design_scores_gemma":[0.002107215,0.00003013263,0.91132206,0.00007471921,0.00014785823,0.000009181382,0.000009931981,0.000012691459,0.0006868845,0.000073115654,0.085411616,0.000114606926],"about_ca_topic_score_codex":0.0013741446,"about_ca_topic_score_gemma":0.00048900605,"teacher_disagreement_score":0.51920754,"about_ca_system_score_codex":0.00019325149,"about_ca_system_score_gemma":0.00006181526,"threshold_uncertainty_score":0.50759655},"labels":[],"label_agreement":null},{"id":"W2406086009","doi":"","title":"[Surgical treatment of advanced epithelial ovarian cancer].","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Debulking; Medicine; Randomized controlled trial; Ovarian cancer; Clinical trial; Surgery; Chemotherapy; Stage (stratigraphy); Cancer; Epithelial ovarian cancer; Oncology; Internal medicine","score_opus":0.024042684353643356,"score_gpt":0.27402678519970974,"score_spread":0.2499841008460664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406086009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97711104,0.0032382929,0.000013167911,0.008656581,0.000503549,0.0018172635,0.00010216409,0.00006749805,0.008490444],"genre_scores_gemma":[0.99268955,0.0018528062,0.0004962746,0.00009126881,0.0003367024,0.0038652434,0.000015211218,0.00001965265,0.00063328474],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990053,0.000012144639,0.00022856337,0.00025767589,0.00018957662,0.00030674023],"domain_scores_gemma":[0.99937844,0.000026165784,0.00007599254,0.00026001522,0.000045782555,0.00021363037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045338616,0.00015211885,0.00037656116,0.000060536015,0.000031940057,0.0000062572217,0.00004049873,0.00005894286,0.00011215271],"category_scores_gemma":[0.000009776976,0.00010943535,0.00015807115,0.00014759981,0.000052343577,0.00003937414,0.0000097933635,0.00003637014,0.000011935001],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000732722,0.0021653683,0.018101268,0.000035160847,0.00042228724,0.00032853166,0.00021761346,0.00019343781,0.00008328573,0.0021035704,0.00004095235,0.9755758],"study_design_scores_gemma":[0.02725983,0.00081370515,0.8514653,0.000058667854,0.000407739,0.00006929416,0.00003160383,0.0000017642071,0.04020174,0.00036899743,0.07916023,0.00016115817],"about_ca_topic_score_codex":0.0005817944,"about_ca_topic_score_gemma":0.000057160833,"teacher_disagreement_score":0.97541463,"about_ca_system_score_codex":0.0006086701,"about_ca_system_score_gemma":0.0001336252,"threshold_uncertainty_score":0.44626442},"labels":[],"label_agreement":null},{"id":"W2406182563","doi":"","title":"Answer to case of the month #117. Follicular cyst in surgically transposed ovary of young woman with Hodgkin's disease.","year":2007,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Follicular Cyst; Ovary; Follicular phase; Disease; Gynecology; Cyst; General surgery; Radiology; Pathology; Internal medicine","score_opus":0.011568446401436627,"score_gpt":0.22652067994074904,"score_spread":0.21495223353931242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406182563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481773,0.00040574343,0.000066564564,0.0016933808,0.00007217854,0.0017084073,0.000057417932,0.00001161757,0.0011669655],"genre_scores_gemma":[0.99893093,0.000019454199,0.00015608281,0.00025861314,0.00003911317,0.00046277966,0.000008033492,0.000018594292,0.00010639468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998853,0.00003288523,0.000293581,0.00022420383,0.00029133906,0.00030493535],"domain_scores_gemma":[0.99914926,0.000060978487,0.00007397831,0.00038789047,0.00006429336,0.00026360515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003359399,0.00013249376,0.00031375396,0.00009914,0.000021907648,0.0000048022803,0.00008226246,0.00004035833,0.000018884943],"category_scores_gemma":[0.000025378547,0.00007804357,0.00012357622,0.0004113472,0.000061451516,0.00003278602,0.000014557722,0.000075812204,4.7583387e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032328302,0.0013546345,0.9647803,0.00014788378,0.0002628973,0.011840639,0.0006794802,0.000067712295,0.00006796989,0.00019500744,0.00014192298,0.01722875],"study_design_scores_gemma":[0.0037460066,0.00013476268,0.9930195,0.00011859149,0.00023143952,0.00015805406,0.00010441814,0.000005053528,0.0017513796,0.000010089838,0.0006364695,0.000084238476],"about_ca_topic_score_codex":0.0007945034,"about_ca_topic_score_gemma":0.002125427,"teacher_disagreement_score":0.028239226,"about_ca_system_score_codex":0.000107279295,"about_ca_system_score_gemma":0.00006375857,"threshold_uncertainty_score":0.31825247},"labels":[],"label_agreement":null},{"id":"W2406222198","doi":"10.1016/s0849-5831(16)31440-9","title":"Implementation of Ovarian Cancer Surgery Guidelines","year":2001,"lang":"en","type":"article","venue":"Journal SOGC","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Respondent; Ovarian cancer; Stage (stratigraphy); Lymphadenectomy; Disease; General surgery; Population; Surgery; Cancer; Internal medicine","score_opus":0.09565520108729565,"score_gpt":0.4252419423561299,"score_spread":0.32958674126883425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406222198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95414245,0.0029881708,0.00038402624,0.04021605,0.000825833,0.00017892955,0.000013400197,0.000015116279,0.0012360341],"genre_scores_gemma":[0.98565614,0.010830353,0.0010471906,0.0010380223,0.0010819545,0.000016097842,0.0000053908147,0.0000131852075,0.0003116863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991241,0.000017686905,0.00041829803,0.00008222969,0.00021761245,0.00014003419],"domain_scores_gemma":[0.99930346,0.000038963233,0.00020599333,0.00009328755,0.00025300038,0.00010529555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024355765,0.000073533956,0.0002258535,0.0000933366,0.00004993043,0.000014175202,0.000026413369,0.000028650818,0.0026189447],"category_scores_gemma":[0.000027337914,0.00005348036,0.0001391885,0.00013381164,0.000011434067,0.000091286376,0.0000075078306,0.000071233284,0.000007924356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058457,0.00008701377,0.7069876,0.000014196688,0.00017824167,0.00011754044,0.00006676636,0.000008855092,0.00027486263,0.000060239774,0.044816766,0.24732941],"study_design_scores_gemma":[0.0016886656,0.00010547187,0.8733418,0.00021195516,0.00024554267,0.0005037447,0.00026989786,0.00001375508,0.0030164593,0.00024646486,0.1202789,0.000077365665],"about_ca_topic_score_codex":0.00094864314,"about_ca_topic_score_gemma":0.00018113323,"teacher_disagreement_score":0.24725205,"about_ca_system_score_codex":0.00013023893,"about_ca_system_score_gemma":0.00027817787,"threshold_uncertainty_score":0.9982928},"labels":[],"label_agreement":null},{"id":"W2407048108","doi":"10.1158/1557-3265.ovca15-a35","title":"Abstract A35: Elucidating mechanisms involved in long-term response to platinum-based chemotherapy in high-grade serous ovarian cancer.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Ovarian cancer; Chemotherapy; Cancer; Medicine; Pathology; Oncology; Internal medicine","score_opus":0.16630467607272914,"score_gpt":0.49017947605795675,"score_spread":0.3238747999852276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407048108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9302948,0.00040149983,0.00015984887,0.06681316,0.00034217918,0.001772969,0.000084834566,0.000052021664,0.000078667515],"genre_scores_gemma":[0.9931137,0.0010804003,0.0010038174,0.002249566,0.00046833424,0.0016636391,0.000013809108,0.00008963766,0.00031708632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948335,0.00072150124,0.0011659835,0.0011419471,0.0010354654,0.00110155],"domain_scores_gemma":[0.9947454,0.0033493945,0.0001590932,0.00085777236,0.0002648906,0.00062350015],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005575369,0.00031809445,0.00085784326,0.0005665227,0.000099893005,0.00005897702,0.00037725468,0.00035177727,0.00215158],"category_scores_gemma":[0.0012213007,0.00022911724,0.00016816393,0.0011276768,0.00020330449,0.00011609442,0.000119397664,0.0009359838,0.00010987557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019175539,0.0017708367,0.7990264,0.00015194008,0.00012160975,0.0008615569,0.00020228032,0.000048535006,0.01755836,0.00012343684,0.0009864483,0.15997304],"study_design_scores_gemma":[0.02104326,0.0013197104,0.9542441,0.0028485146,0.000019101684,0.0000014053168,0.000039525698,0.00003245433,0.019276,0.00035036128,0.000562585,0.00026301233],"about_ca_topic_score_codex":0.0072369953,"about_ca_topic_score_gemma":0.0175124,"teacher_disagreement_score":0.15971003,"about_ca_system_score_codex":0.0022464718,"about_ca_system_score_gemma":0.0021811966,"threshold_uncertainty_score":0.9993739},"labels":[],"label_agreement":null},{"id":"W2407112162","doi":"10.1097/igc.0000000000000541","title":"Pure Immature Teratoma of the Ovary in Adults","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Etoposide; Immature teratoma; Cystectomy; Fertility preservation; Stage (stratigraphy); Hysterectomy; Chemotherapy; Surgery; Oophorectomy; Gynecology; Fertility; Cancer; Internal medicine; Germ cell tumors; Population","score_opus":0.02475905282875507,"score_gpt":0.32274308205781277,"score_spread":0.2979840292290577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407112162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770029,0.0018402645,0.000003774389,0.018552452,0.0014526299,0.000121100195,0.000017450477,0.0000026619127,0.0010067202],"genre_scores_gemma":[0.9979448,0.00028893605,0.00018402416,0.0011063742,0.0003675537,0.00001207368,0.0000013695573,0.000004718122,0.00009017537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895227,0.00003811191,0.00035489706,0.000084530286,0.00048200483,0.00008815698],"domain_scores_gemma":[0.99893284,0.000083601255,0.0002694599,0.00008006953,0.00055174495,0.00008231543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016874622,0.0000757286,0.00022106644,0.00006976259,0.0000078430585,0.000008873328,0.00020988341,0.0000785903,0.00041413226],"category_scores_gemma":[0.00025396355,0.000038473805,0.00013815853,0.00010738836,0.000048055113,0.00006410616,0.00004917188,0.00023540342,0.0000023327977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031213823,0.0010309254,0.9557827,0.000023565413,0.00038236377,0.0010373233,0.00054644083,0.00026570412,0.00018910244,0.0005854469,0.011894012,0.02514105],"study_design_scores_gemma":[0.004517394,0.0005211874,0.98454154,0.0005234739,0.000040387044,0.00023603793,0.0001162902,0.000025328172,0.0014442278,0.00076010433,0.0072267465,0.00004727169],"about_ca_topic_score_codex":0.00004330258,"about_ca_topic_score_gemma":0.00009735661,"teacher_disagreement_score":0.028758865,"about_ca_system_score_codex":0.00042502253,"about_ca_system_score_gemma":0.00034322252,"threshold_uncertainty_score":0.45344576},"labels":[],"label_agreement":null},{"id":"W2407450722","doi":"10.1158/1557-3265.ovca15-b08","title":"Abstract B08: Genomics analyses of less common epithelial ovarian cancer subtypes.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; University of British Columbia","funders":"","keywords":"KRAS; Serous fluid; Neuroblastoma RAS viral oncogene homolog; CDKN2A; Serous carcinoma; Exome sequencing; Ovarian carcinoma; Mucinous carcinoma; Massive parallel sequencing; Ovarian cancer; Cancer; Exome; Carcinoma; Oncology; Biology; Internal medicine; Medicine; Adenocarcinoma; Mutation; Genetics; Colorectal cancer; DNA sequencing; Gene","score_opus":0.4500648755636732,"score_gpt":0.5782385353566344,"score_spread":0.1281736597929612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407450722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765947,0.003824368,0.000016481177,0.0154083455,0.0005399976,0.0005940053,0.00037345037,0.00002756771,0.0026210719],"genre_scores_gemma":[0.9790782,0.018112345,0.00011945637,0.000283571,0.0012692215,0.00022638877,0.000009906895,0.000045532888,0.0008553874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685466,0.00024078782,0.0009085426,0.00062079023,0.0007853384,0.0005899071],"domain_scores_gemma":[0.9965087,0.0014874776,0.00020888851,0.0007779486,0.0005865486,0.0004303928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018496272,0.00019377316,0.00081347313,0.0001815265,0.00010872957,0.000024277355,0.00030719175,0.00023449273,0.0026259765],"category_scores_gemma":[0.00033764605,0.00011767021,0.00033903628,0.00039367395,0.0006951844,0.00007643836,0.00014880617,0.0005191043,0.000110587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002374179,0.0011660521,0.5586483,0.00018639554,0.000901889,0.00011291393,0.00007118782,0.000008148941,0.018529827,0.00039597027,0.008590591,0.40901458],"study_design_scores_gemma":[0.005418023,0.0006119196,0.9234381,0.00068221876,0.00022137223,0.000002574792,0.00004588852,0.000011372913,0.04230686,0.00044514015,0.026650734,0.00016582494],"about_ca_topic_score_codex":0.009529179,"about_ca_topic_score_gemma":0.002003468,"teacher_disagreement_score":0.40884873,"about_ca_system_score_codex":0.0006512,"about_ca_system_score_gemma":0.0016167148,"threshold_uncertainty_score":0.9982858},"labels":[],"label_agreement":null},{"id":"W2408324580","doi":"10.1158/1557-3265.ovca15-pr07","title":"Abstract PR07: Synchronous ovarian and endometrial carcinomas: The case for pseudo-metastasis.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Metastasis; Massive parallel sequencing; Ovary; Ovarian cancer; Biology; Cancer; Endometrial cancer; Carcinoma; Ovarian carcinoma; Primary tumor; Endometrium; Cancer research; Oncology; Pathology; Medicine; Internal medicine; Gene; DNA sequencing; Genetics","score_opus":0.264980268446836,"score_gpt":0.5113102394665525,"score_spread":0.24632997101971654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408324580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9323552,0.005960675,0.00010645934,0.05583308,0.00086506887,0.003297652,0.000407931,0.000041744584,0.0011321874],"genre_scores_gemma":[0.99157506,0.0034862645,0.0004133226,0.00036801252,0.002348009,0.0013212317,0.0000051280317,0.00003996467,0.00044300745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99729025,0.000278869,0.00062642084,0.000687185,0.0004558682,0.00066138594],"domain_scores_gemma":[0.98996663,0.008393492,0.00010443271,0.0006743734,0.00040054164,0.0004605393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00439568,0.00018255804,0.0005257206,0.00015494328,0.00034260427,0.00007799842,0.00017382923,0.00016157061,0.0008175408],"category_scores_gemma":[0.0026626447,0.00008774924,0.00025852624,0.0003374517,0.00069790304,0.000078399346,0.00013685037,0.00043584235,0.000047379344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036529547,0.0008005688,0.069922976,0.00020682646,0.000735595,0.0020677047,0.00009669831,3.41716e-7,0.00019447229,0.0015303228,0.030654881,0.89013666],"study_design_scores_gemma":[0.06003808,0.008699008,0.60328096,0.0008727497,0.001046362,0.001394306,0.0004759013,0.00006284542,0.0022032154,0.0024777448,0.31884983,0.0005989818],"about_ca_topic_score_codex":0.0014641411,"about_ca_topic_score_gemma":0.0005937788,"teacher_disagreement_score":0.8895377,"about_ca_system_score_codex":0.00033906396,"about_ca_system_score_gemma":0.00084128877,"threshold_uncertainty_score":0.8951498},"labels":[],"label_agreement":null},{"id":"W2408568328","doi":"10.1158/1557-3265.ovca15-pr16","title":"Abstract PR16: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy.","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Serous fluid; Ovarian carcinoma; Oncology; Internal medicine; Serous carcinoma; Stage (stratigraphy); Cancer; Adjuvant; Surgery; Biology","score_opus":0.3802367171197038,"score_gpt":0.5335727253135414,"score_spread":0.15333600819383758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408568328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378839,0.002372688,0.019022774,0.038487993,0.0000796096,0.0012987556,0.000390899,0.000022535916,0.00044080472],"genre_scores_gemma":[0.99347043,0.0015416387,0.004070539,0.00013754921,0.00026308617,0.00039239723,0.000028099104,0.000023336306,0.00007292948],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857974,0.000058622976,0.00046114158,0.00037826295,0.00025092618,0.0002713279],"domain_scores_gemma":[0.99725074,0.0015837188,0.000076639735,0.0002612232,0.0006370171,0.00019065375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010465176,0.00009193586,0.00029125193,0.00009255122,0.00012388802,0.000016932281,0.0000918682,0.00009552023,0.00007854181],"category_scores_gemma":[0.00020658383,0.000060527334,0.00011526217,0.00013181509,0.00020879055,0.000055558874,0.00004750845,0.000166678,0.000002334515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008681601,0.00034154317,0.49500048,0.00007816521,0.00019253093,0.0000025028937,0.00004020305,0.00026491043,0.000097374184,0.0030412404,0.00045522366,0.49961767],"study_design_scores_gemma":[0.006542251,0.00072410854,0.9635111,0.00028417955,0.000038530212,0.0000044365943,0.000038346654,0.021931656,0.000057467627,0.006176299,0.000599821,0.00009179201],"about_ca_topic_score_codex":0.0004831143,"about_ca_topic_score_gemma":0.00009540857,"teacher_disagreement_score":0.49952587,"about_ca_system_score_codex":0.00013293292,"about_ca_system_score_gemma":0.00045212285,"threshold_uncertainty_score":0.24682331},"labels":[],"label_agreement":null},{"id":"W2411434284","doi":"10.1097/pgp.0000000000000205","title":"Intact PTEN Expression by Immunohistochemistry is Associated With Decreased Survival in Advanced Stage Ovarian/Primary Peritoneal High-grade Serous Carcinoma","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute","keywords":"PTEN; Immunohistochemistry; Medicine; Serous fluid; Debulking; Serous carcinoma; Pathology; Cancer research; Carcinoma; Oncology; Cancer; Internal medicine; Ovarian cancer; PI3K/AKT/mTOR pathway; Biology; Apoptosis","score_opus":0.020660594774628702,"score_gpt":0.29200013299838085,"score_spread":0.2713395382237521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411434284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946305,0.0005423925,0.0001337997,0.002802305,0.00064049015,0.00017015541,0.00009794866,0.000016597707,0.0009658191],"genre_scores_gemma":[0.9969573,0.00007488773,0.0014699808,0.0009959189,0.00013291863,0.00002576591,0.00015396597,0.000019286435,0.0001699706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804324,0.00018189348,0.0005983196,0.00029609338,0.0006142232,0.0002662199],"domain_scores_gemma":[0.99820054,0.00035521682,0.000507564,0.0001606649,0.0005175461,0.0002584898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004332872,0.00021837922,0.00063251634,0.00012777765,0.000030107985,0.000022459002,0.00027313735,0.0002454255,0.00030040575],"category_scores_gemma":[0.0005878527,0.00015395276,0.00012342224,0.00010742585,0.000119550794,0.00012705116,0.000082440914,0.00048735295,0.0000053949607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009345985,0.006601665,0.7864126,0.00002068723,0.00077567494,0.04032486,0.00060078234,0.00014996105,0.14520904,0.00008406463,0.004751771,0.0057229144],"study_design_scores_gemma":[0.022990694,0.0033380163,0.95455533,0.00019322039,0.00013047179,0.0013027963,0.0003103426,0.000032201897,0.01570874,0.00022477093,0.0009586654,0.00025474397],"about_ca_topic_score_codex":0.00009564705,"about_ca_topic_score_gemma":0.000014226987,"teacher_disagreement_score":0.16814275,"about_ca_system_score_codex":0.0015106348,"about_ca_system_score_gemma":0.00042762197,"threshold_uncertainty_score":0.6278011},"labels":[],"label_agreement":null},{"id":"W2412253798","doi":"10.17140/goroj-2-108","title":"Low-Grade Serous Carcinoma – The Clinical Challenge","year":2015,"lang":"en","type":"article","venue":"Gynecology and Obstetrics Research - Open Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Serous carcinoma; Internal medicine; Cancer; Ovarian cancer","score_opus":0.35578092446597653,"score_gpt":0.4906170270703697,"score_spread":0.13483610260439316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412253798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89673823,0.016785596,0.000013517855,0.0680817,0.0021461719,0.0013192727,0.000008672582,0.000011898697,0.014894941],"genre_scores_gemma":[0.98947346,0.007633413,0.0003064284,0.00079053774,0.00050489174,0.00006108744,0.000004200541,0.000019246785,0.001206739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678993,0.001105946,0.00046916673,0.00034783344,0.00065530546,0.0006318016],"domain_scores_gemma":[0.99233574,0.0055040936,0.00011661492,0.00041467935,0.0007023372,0.0009265266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006722435,0.00014183468,0.0004387878,0.00024187325,0.00062316074,0.00028004206,0.00054026674,0.00022820542,0.00026020437],"category_scores_gemma":[0.007848161,0.00008299729,0.00009793867,0.0005370859,0.00043884062,0.00016854903,0.0005724675,0.0018098337,0.00012697578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055485324,0.0026992024,0.6260515,0.00004103879,0.00051824213,0.007095656,0.0012441763,0.0000047530725,0.0000033178146,0.0039033222,0.11558479,0.24229917],"study_design_scores_gemma":[0.014879256,0.008305493,0.6352088,0.000072350136,0.00014901641,0.0020350926,0.0023257781,0.00013042655,0.000060819595,0.0039219945,0.33271825,0.00019273604],"about_ca_topic_score_codex":0.00007137298,"about_ca_topic_score_gemma":0.00009416047,"teacher_disagreement_score":0.24210644,"about_ca_system_score_codex":0.00035070823,"about_ca_system_score_gemma":0.0015341317,"threshold_uncertainty_score":0.9395549},"labels":[],"label_agreement":null},{"id":"W2412469771","doi":"10.18632/genesandcancer.76","title":"Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease","year":2015,"lang":"en","type":"article","venue":"Genes & Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; McGill University Health Centre; Canadian Institutes of Health Research; Université de Montréal; Institute of Cancer Research; Institut Du Cancer de Montréal; McGill University","keywords":"Serous fluid; Cancer research; Germline mutation; Somatic cell; Ovarian cancer; Biology; Loss of heterozygosity; KRAS; Cell of origin; Cell culture; Mutation; Microsatellite instability; Germline; BRCA2 Protein; Cancer; Genetics; Medicine; Pathology; Gene; Allele; Microsatellite","score_opus":0.04666201033718483,"score_gpt":0.28522961563833926,"score_spread":0.23856760530115442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412469771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89012843,0.09306872,0.000075654214,0.014570106,0.0008885172,0.00061763305,0.00048711387,0.000026156751,0.00013767713],"genre_scores_gemma":[0.9888011,0.008060583,0.00019677758,0.0017704549,0.00075800164,0.00013538013,0.000019864603,0.000029104027,0.00022873594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987716,0.00005126064,0.00016560187,0.00033687538,0.00041612418,0.00025852467],"domain_scores_gemma":[0.9989908,0.000045983947,0.00013184705,0.00047659423,0.0001001581,0.00025464446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015786193,0.00022005854,0.00030101923,0.000026132155,0.00018149367,0.00001862134,0.00018154012,0.000060477723,0.00010757495],"category_scores_gemma":[0.000008110007,0.000121256686,0.00010747857,0.00014154734,0.00017955936,0.00006874639,0.00018935399,0.000109759814,0.0000022060894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030194384,0.0016478895,0.89294356,0.00061327545,0.0022355674,0.00082678633,0.0061145313,0.002696447,0.010435376,0.0010121829,0.018772133,0.059682798],"study_design_scores_gemma":[0.009330154,0.00043399696,0.9157368,0.0003167357,0.0034076867,0.000046003865,0.0008330035,0.00025762196,0.027415272,0.00042502646,0.04133372,0.000463956],"about_ca_topic_score_codex":0.043148324,"about_ca_topic_score_gemma":0.003048167,"teacher_disagreement_score":0.09867267,"about_ca_system_score_codex":0.00018994087,"about_ca_system_score_gemma":0.00047380163,"threshold_uncertainty_score":0.96322346},"labels":[],"label_agreement":null},{"id":"W2413051288","doi":"10.1016/j.jogc.2016.04.090","title":"La salpingectomie opportuniste : Nous choisissons d'agir, pas d'attendre","year":2016,"lang":"fr","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Humanities; Scopus; Medicine; Philosophy; MEDLINE; Political science","score_opus":0.015148445549248915,"score_gpt":0.2561437769567606,"score_spread":0.2409953314075117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413051288","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004754613,0.08581617,0.000018379073,0.007286432,0.89493084,0.0003611609,0.00096718455,0.000007669268,0.0058575743],"genre_scores_gemma":[0.58308643,0.09458456,0.0005600851,0.0022167466,0.30955365,0.00005589842,0.00016191117,0.000304358,0.009476387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99509996,0.0003662404,0.0016255586,0.0005896926,0.0012797657,0.0010387871],"domain_scores_gemma":[0.9719172,0.022827245,0.0020924087,0.00047610802,0.001249167,0.0014378692],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088232406,0.00073629833,0.0021207952,0.00060353096,0.0002812756,0.000097380536,0.00042861598,0.0014711188,0.0033313313],"category_scores_gemma":[0.01233095,0.0005568698,0.00039632112,0.00043772653,0.0003329327,0.00012531673,0.00015651292,0.0019699247,0.000012785714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000026871026,0.00038953274,0.02281724,0.00032520108,0.0021600805,0.048165858,0.000080389545,0.000003628916,0.0000024996484,0.00032279844,0.6594136,0.26629233],"study_design_scores_gemma":[0.009268491,0.0018297398,0.05988961,0.00042029753,0.0023809597,0.0005109519,0.00020892562,0.0000047499448,0.000012244961,0.00006803025,0.92493504,0.0004709823],"about_ca_topic_score_codex":0.022602499,"about_ca_topic_score_gemma":0.063976705,"teacher_disagreement_score":0.58537716,"about_ca_system_score_codex":0.011442672,"about_ca_system_score_gemma":0.029019846,"threshold_uncertainty_score":0.9998252},"labels":[],"label_agreement":null},{"id":"W2416203426","doi":"","title":"Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance","year":2016,"lang":"en","type":"article","venue":"eScholarship (California Digital Library)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Antibody; Ascites; Ovarian carcinoma; Biology; In vivo; Immunohistochemistry; Ovarian cancer; Medicine; Immunology; Internal medicine; Cancer","score_opus":0.0075678953771707936,"score_gpt":0.1890905670235642,"score_spread":0.1815226716463934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416203426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037147,0.0010935471,0.000036376616,0.0039939913,0.000052168576,0.0007898243,0.0019398541,0.00016191514,0.0015608728],"genre_scores_gemma":[0.9973164,0.00006936615,0.00060115475,0.0006857721,0.000079901205,0.00007679488,0.0005539056,0.0000757731,0.0005409309],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980002,0.000061752115,0.0006366516,0.0005333319,0.00035359812,0.00041446826],"domain_scores_gemma":[0.99875146,0.0001440579,0.00028099565,0.0002755508,0.00006274803,0.00048518894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013709768,0.00034746315,0.00037547603,0.00008435905,0.00013409581,0.00042916276,0.00009496927,0.000116569754,0.00018444241],"category_scores_gemma":[0.0001525987,0.00024017808,0.000077657074,0.00019419676,0.00008746596,0.0022326421,0.000103809776,0.00018228644,0.00015866538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035961333,0.00044861622,0.9795341,0.0004230187,0.000029443381,0.000060995833,0.00012937233,8.8001435e-8,0.008280815,0.000033978067,0.005149162,0.005550824],"study_design_scores_gemma":[0.010887035,0.0019530859,0.37804428,0.0006656492,0.00024064885,0.00008168784,0.00020819734,0.00026292706,0.5522896,0.0006200227,0.053833034,0.0009138276],"about_ca_topic_score_codex":0.000007195299,"about_ca_topic_score_gemma":0.0000036816625,"teacher_disagreement_score":0.6014898,"about_ca_system_score_codex":0.00008792051,"about_ca_system_score_gemma":0.00007392185,"threshold_uncertainty_score":0.9794178},"labels":[],"label_agreement":null},{"id":"W2416729954","doi":"10.1503/cjs.014315","title":"The optimal time for surgery in women with serous ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Serous ovarian cancer; Ovarian cancer; Serous fluid; Gynecology; General surgery; Oncology; Cancer; Obstetrics; Surgery; Internal medicine","score_opus":0.025113027203552633,"score_gpt":0.24153037570481306,"score_spread":0.21641734850126043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416729954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646084,0.0021535414,0.000033381522,0.03229397,0.0005269318,0.0002079201,0.00005786585,0.0000041637236,0.00011384564],"genre_scores_gemma":[0.9973938,0.0006283837,0.00009061884,0.0006741189,0.00041857213,0.00009136285,0.000001268817,0.000031549484,0.0006703561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987195,0.000037797683,0.00041043683,0.00012991845,0.00015430115,0.000548017],"domain_scores_gemma":[0.9973799,0.0013537006,0.00021402218,0.00016932531,0.00020337124,0.000679709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008751083,0.00013243686,0.000462177,0.00030641473,0.00010538446,0.000038309932,0.00006741296,0.00005556624,0.0003344469],"category_scores_gemma":[0.00018876085,0.000064983855,0.00013488314,0.00019871935,0.000094412964,0.00011495329,0.0000031181562,0.0000909688,0.0000062635168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017563533,0.00006754532,0.6695873,0.000039417566,0.00060826563,0.0020227109,0.00031145997,0.000021449081,0.00006451157,0.00005124851,0.08512512,0.24034463],"study_design_scores_gemma":[0.0023881528,0.00027602547,0.7562479,0.0018436451,0.000119734475,0.0005943685,0.00016474309,0.000005652586,0.00034883534,0.00009036445,0.23768485,0.0002357403],"about_ca_topic_score_codex":0.0020808082,"about_ca_topic_score_gemma":0.008402488,"teacher_disagreement_score":0.24010889,"about_ca_system_score_codex":0.0010611236,"about_ca_system_score_gemma":0.006204991,"threshold_uncertainty_score":0.9994289},"labels":[],"label_agreement":null},{"id":"W2417752581","doi":"10.1097/gco.0000000000000206","title":"Dermoid cysts in adolescents","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; General surgery","score_opus":0.16357015939776756,"score_gpt":0.43711211323958393,"score_spread":0.27354195384181634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417752581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020903828,0.9696462,0.0000032179337,0.000074819276,0.027612766,0.0022784404,0.00005422028,0.000036427886,0.00027300918],"genre_scores_gemma":[0.0003885126,0.99763125,0.000040887306,0.0000312036,0.00045020017,0.0007883213,0.0005618484,0.0000761881,0.000031575455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630415,0.00034816287,0.001331736,0.0009075465,0.000410844,0.00069757097],"domain_scores_gemma":[0.99726194,0.0011451263,0.00046925485,0.0006593689,0.00014519878,0.00031909475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040934223,0.0005875171,0.0028391872,0.0017769188,0.000026242149,0.000022122813,0.00029501348,0.000710429,0.000068969355],"category_scores_gemma":[0.0022978438,0.00052981626,0.00038076448,0.0020198205,0.00006784939,0.000055509656,0.00019886417,0.0011288194,0.0003926189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008718247,0.0017103116,0.014499955,0.026228208,0.000051511408,0.00009198321,0.0000444794,9.116473e-7,2.1799715e-9,0.00012018045,0.0037295672,0.95351416],"study_design_scores_gemma":[0.0035109546,0.00026757724,0.0051884493,0.03998361,0.00024340341,0.000055166718,0.000010187093,0.0000065850313,3.1213027e-8,0.00005113434,0.9503208,0.00036210907],"about_ca_topic_score_codex":0.000019826237,"about_ca_topic_score_gemma":0.000016631617,"teacher_disagreement_score":0.95315206,"about_ca_system_score_codex":0.0036574127,"about_ca_system_score_gemma":0.0016773456,"threshold_uncertainty_score":0.9997153},"labels":[],"label_agreement":null},{"id":"W2418251519","doi":"10.1097/pgp.0000000000000199","title":"Diagnosis of Ovarian Carcinoma Histotype Based on Limited Sampling","year":2015,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta Hospital; Vancouver General Hospital; University of Calgary; University of Alberta; University of British Columbia; Calgary Laboratory Services; BC Cancer Agency","funders":"","keywords":"Medicine; Biopsy; Serous fluid; Ovarian carcinoma; Ovarian cancer; Pathology; Sampling (signal processing); Serous carcinoma; Clear cell carcinoma; Carcinoma; Anatomical pathology; Radiology; Cancer; Immunohistochemistry; Internal medicine","score_opus":0.08481149705125585,"score_gpt":0.33722069560198786,"score_spread":0.252409198550732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418251519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98323846,0.0003099071,0.00071451475,0.011491824,0.0015743268,0.00012942366,0.000020611122,0.000010260564,0.0025106596],"genre_scores_gemma":[0.99174476,0.000058501682,0.00576795,0.0020873118,0.00028498934,0.000014016088,0.000012834117,0.000009769349,0.000019878053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861974,0.00010587113,0.000536818,0.00016065204,0.00043575538,0.00014115986],"domain_scores_gemma":[0.99774545,0.00067680166,0.00041161323,0.00013491405,0.0008458857,0.00018530923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041679983,0.00012050453,0.000420466,0.0002643203,0.000015741376,0.000008187453,0.00019223084,0.00013847291,0.00047190048],"category_scores_gemma":[0.0015789561,0.00008492085,0.00020169713,0.000093253744,0.00009351135,0.000039879935,0.000034304947,0.00022582889,0.000016712887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024356681,0.003053868,0.96218574,0.000010751918,0.00023937484,0.0054675564,0.00012868317,0.0010305443,0.00035826347,0.0015927809,0.002488636,0.02100812],"study_design_scores_gemma":[0.0066507854,0.0067198398,0.9746685,0.000100760626,0.00016288877,0.0005986899,0.000044657823,0.00025149205,0.0013782511,0.0012316076,0.008093148,0.00009938668],"about_ca_topic_score_codex":0.000016453158,"about_ca_topic_score_gemma":0.0000050447943,"teacher_disagreement_score":0.020908734,"about_ca_system_score_codex":0.000430131,"about_ca_system_score_gemma":0.00026851453,"threshold_uncertainty_score":0.51669794},"labels":[],"label_agreement":null},{"id":"W2418429870","doi":"10.1016/s1701-2163(16)32207-1","title":"Ovarian Cancer in an Infertile Woman","year":2006,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Hysterosalpingography; Uterus; Infertility; Ovary; Laparoscopy; Gynecology; Serous fluid; Uterine fibroids; Stage (stratigraphy); Radiology; Pathology; Pregnancy; Internal medicine","score_opus":0.01119938866615846,"score_gpt":0.25167347206342466,"score_spread":0.2404740833972662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418429870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987843,0.0063429507,0.0000032464327,0.0018070196,0.002775687,0.00009399993,0.000013592651,0.0000019649221,0.0011185439],"genre_scores_gemma":[0.9988333,0.00017763194,0.00017949285,0.0006371291,0.00006079567,0.000005748617,0.0000026832868,0.000008724207,0.00009451662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991514,0.000025636846,0.00034953275,0.00010876108,0.00017605099,0.00018861773],"domain_scores_gemma":[0.99914277,0.00029450934,0.0001719744,0.00008925968,0.00014640614,0.00015506589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009413377,0.00009251262,0.0003073511,0.00020501533,0.000035522706,0.00001416656,0.000049277558,0.0000718393,0.0006332658],"category_scores_gemma":[0.00016769822,0.00007356745,0.00003103548,0.00025377388,0.000023762343,0.000062177285,0.0000117313375,0.00017833513,2.4885614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007123659,0.0002051357,0.9493769,0.000013989516,0.000042122465,0.003510417,0.000026086564,0.00011660578,0.000010493197,0.00019733053,0.0016819247,0.044811904],"study_design_scores_gemma":[0.0032167293,0.0003930119,0.98434,0.000009451942,0.000070486705,0.000040651415,0.000048684764,0.000054591856,0.00005390244,0.00013133972,0.011574272,0.000066879504],"about_ca_topic_score_codex":0.1418172,"about_ca_topic_score_gemma":0.48941708,"teacher_disagreement_score":0.34759986,"about_ca_system_score_codex":0.0013615504,"about_ca_system_score_gemma":0.0017501435,"threshold_uncertainty_score":0.8638975},"labels":[],"label_agreement":null},{"id":"W2418827502","doi":"10.1385/1-59259-071-3:169","title":"Culture and Characterization of Human Ovarian Surface Epithelium","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Ovary; Epithelium; Ovarian carcinomas; Mesothelium; Pathology; Biology; Medicine; Ovarian carcinoma; Ovarian cancer; Internal medicine; Mesothelial Cell; Cancer","score_opus":0.037634292824439836,"score_gpt":0.2822680002531001,"score_spread":0.24463370742866028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418827502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89429283,0.0014494946,0.000054287397,0.00005918011,0.00010269615,0.0006022802,0.000028999642,0.00004606901,0.10336416],"genre_scores_gemma":[0.9922754,0.00020650652,0.00023815059,0.00009978095,0.000047293142,0.00001932785,0.000028736922,0.000017385686,0.0070673786],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993676,0.000036347832,0.00017061789,0.00019103549,0.000114700124,0.000119722696],"domain_scores_gemma":[0.99955666,0.0000073419187,0.00008652431,0.00022315216,0.000055675526,0.000070640875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006849703,0.00011277201,0.00021638747,0.00002396208,0.00006976682,0.00001661134,0.000030273945,0.00006210134,0.00006105746],"category_scores_gemma":[0.0000049501577,0.00009165021,0.000039880557,0.000011569236,0.000053442076,0.000028941646,0.000014207308,0.00006406274,0.0000014495919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015601564,0.0008880563,0.013335058,0.00095415424,0.0008697235,0.00010703037,0.008888281,0.0000028224742,0.4126749,0.539791,0.0008622214,0.021470755],"study_design_scores_gemma":[0.0067055374,0.0010212449,0.1828629,0.00048795354,0.00073627534,0.000051381165,0.000101875885,0.000020373554,0.5879678,0.0008829854,0.21874183,0.00041982706],"about_ca_topic_score_codex":0.000086837244,"about_ca_topic_score_gemma":0.000008777762,"teacher_disagreement_score":0.538908,"about_ca_system_score_codex":0.000021014814,"about_ca_system_score_gemma":0.000018424964,"threshold_uncertainty_score":0.3737387},"labels":[],"label_agreement":null},{"id":"W2419491156","doi":"10.1111/1471-0528.13742","title":"Opportunistic salpingectomy at benign gynaecological surgery for ovarian cancer prevention should be performed within a clinical trial","year":2016,"lang":"en","type":"article","venue":"BJOG An International Journal of Obstetrics & Gynaecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Salpingectomy; Hazard ratio; Ovarian cancer; Gynecology; Serous fluid; Randomized controlled trial; Obstetrics; Fallopian tube; Clinical trial; Confidence interval; Serous carcinoma; Cancer; Surgery; Pregnancy; Internal medicine","score_opus":0.25091639066249993,"score_gpt":0.44271131839916683,"score_spread":0.1917949277366669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419491156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566132,0.00035903518,0.002059014,0.008843285,0.030506762,0.0010455287,0.00015477471,0.00003020464,0.00038821908],"genre_scores_gemma":[0.99308616,0.0009536658,0.002118683,0.001169378,0.0016376731,0.00020481978,0.00007563758,0.000038806327,0.00071519945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962861,0.0002788679,0.0018713512,0.00044905854,0.0007286711,0.00038594037],"domain_scores_gemma":[0.9891198,0.007322088,0.0015098415,0.00025587593,0.001337964,0.0004543933],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018972938,0.00026027887,0.00094112306,0.0005753862,0.000113086404,0.00004668062,0.0003536655,0.00040161316,0.004646712],"category_scores_gemma":[0.0104882885,0.00017067086,0.0007398229,0.00018586192,0.0001634149,0.00028117816,0.000086173124,0.00029830384,0.000009687945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024049357,0.0043449923,0.6118587,0.00003305054,0.0022665083,0.0012501699,0.00010635391,0.000016315273,0.00005227929,0.0024775043,0.0056810393,0.34786373],"study_design_scores_gemma":[0.10127697,0.011097055,0.8581915,0.00007989991,0.0010031174,0.00036541265,0.000053434454,0.00013301327,0.00019854098,0.0010556392,0.026230566,0.00031484402],"about_ca_topic_score_codex":0.000009998346,"about_ca_topic_score_gemma":0.000049094644,"teacher_disagreement_score":0.3475489,"about_ca_system_score_codex":0.0022907518,"about_ca_system_score_gemma":0.0019399154,"threshold_uncertainty_score":0.9978468},"labels":[],"label_agreement":null},{"id":"W2423304561","doi":"10.1093/jnci/djw134","title":"Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype","year":2016,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Population; Disease; Pathology; Molecular pathology; Phenotype; Internal medicine; Cohort; Medicine; Oncology; Biology; Genetics","score_opus":0.04987159982151522,"score_gpt":0.34468323728459743,"score_spread":0.2948116374630822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423304561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8434768,0.002532015,0.00028962345,0.14010158,0.007703121,0.000725488,0.0002124775,0.000009576337,0.004949315],"genre_scores_gemma":[0.99218816,0.00044549393,0.0003716555,0.0053937235,0.0012324278,0.000017618553,6.632638e-7,0.000012327429,0.000337906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796486,0.00011314972,0.0006375104,0.00013039162,0.0010161587,0.00013794692],"domain_scores_gemma":[0.9975755,0.0002177086,0.00076641067,0.00025219022,0.0011113953,0.00007677272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005469104,0.00012878628,0.00028149516,0.000044452736,0.00013403581,0.000013581788,0.00041678123,0.00005235366,0.00009250853],"category_scores_gemma":[0.00058339845,0.000044192515,0.00048494863,0.00024329696,0.00028243635,0.00012098248,0.0000707251,0.00027084458,0.0000072991406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055589788,0.0037422397,0.6240873,0.00028029497,0.0042755324,0.00014251612,0.0007323889,0.001074361,0.023569915,0.0609517,0.22753409,0.04805069],"study_design_scores_gemma":[0.011197241,0.0005308779,0.83084136,0.0012914332,0.0011729035,0.00023724425,0.000022098362,0.000034218036,0.028837902,0.0062196553,0.1194244,0.00019063776],"about_ca_topic_score_codex":0.00009329873,"about_ca_topic_score_gemma":0.00010637747,"teacher_disagreement_score":0.20675407,"about_ca_system_score_codex":0.00033532197,"about_ca_system_score_gemma":0.0016892548,"threshold_uncertainty_score":0.29966655},"labels":[],"label_agreement":null},{"id":"W2426126796","doi":"10.1093/biolreprod/85.s1.55","title":"Stem Cell Antigen-1 Expression Marks a Population of Mouse Ovarian Surface Epithelial Cells with Enhanced Stem/Progenitor Cell Characteristics.","year":2011,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Stem cell; Biology; Stem cell marker; Progenitor cell; Cell biology; Adult stem cell; Population; Endothelial stem cell; Side population; Cancer stem cell; Immunology; Molecular biology; In vitro; Genetics","score_opus":0.01972248150593123,"score_gpt":0.2318707806929012,"score_spread":0.21214829918696998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426126796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742347,0.0005291658,0.0004563796,0.000041826876,0.0005697762,0.00068152434,0.00006720347,0.00003412056,0.00019655323],"genre_scores_gemma":[0.9943561,0.00045395803,0.0041729035,0.0000049385144,0.00019316227,0.000023181676,0.000089110064,0.000024993486,0.0006816618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998602,0.00009964957,0.00042956675,0.0005701329,0.00012108981,0.00017758143],"domain_scores_gemma":[0.99856067,0.000017311986,0.0005598995,0.0006021935,0.00019483104,0.000065108514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021716827,0.0001806246,0.00044000897,0.00007798684,0.000044775315,0.000002727931,0.00006224293,0.00016618297,0.000075074124],"category_scores_gemma":[0.0000037115442,0.00013617185,0.00007700161,0.00011275575,0.000083455285,0.00006315681,0.000024567174,0.00009217467,0.000009795669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013740935,0.0007840191,0.08627467,0.00020128266,0.00006085359,0.000003144115,0.0005000306,0.0000036778915,0.9009049,0.000010271649,0.000035034212,0.009848052],"study_design_scores_gemma":[0.0012986241,0.0012328426,0.08479581,0.00006797763,0.00010203506,0.000006675083,0.00012205803,0.0000055439177,0.91201955,0.000005785192,0.00023168408,0.0001114145],"about_ca_topic_score_codex":0.0002901122,"about_ca_topic_score_gemma":0.000003250174,"teacher_disagreement_score":0.011114677,"about_ca_system_score_codex":0.00005561369,"about_ca_system_score_gemma":0.00005933515,"threshold_uncertainty_score":0.5552927},"labels":[],"label_agreement":null},{"id":"W2438866487","doi":"10.1016/s0140-6736(18)32552-2","title":"Epithelial ovarian cancer","year":2019,"lang":"en","type":"review","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1940,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Cancer Research UK","keywords":"Medicine; Ovarian cancer; Oncology; Disease; Population; Precision medicine; Clinical trial; Breast cancer; Internal medicine; Cancer; Bioinformatics; Intensive care medicine; Pathology; Biology","score_opus":0.13696531554179053,"score_gpt":0.3983659008348641,"score_spread":0.2614005852930736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438866487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015093121,0.9821391,0.0000019350082,0.00445916,0.0009916642,0.0012147414,0.00043889112,0.000051405423,0.010701577],"genre_scores_gemma":[0.00000897331,0.9875249,0.00007989401,0.0011140188,0.0062413453,0.00048661995,0.00009559595,0.000062569765,0.004386075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987638,0.000084030034,0.00028356744,0.00033194016,0.00020683622,0.00032984157],"domain_scores_gemma":[0.9984444,0.00012804655,0.00018658221,0.0011402227,0.000028464832,0.00007229115],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018502897,0.00031423275,0.002479,0.000045580673,0.000052201292,0.00003381393,0.00028541335,0.00016963838,0.0011116919],"category_scores_gemma":[0.000017209193,0.00015060074,0.00045557495,0.0001678607,0.00004180433,0.000017552371,0.00006386803,0.0003909334,0.0013344723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002252494,0.000050876926,0.00005175707,0.008488593,0.0007751424,0.000029403976,0.00002890876,2.0666455e-7,6.281384e-8,0.00076669024,0.051811505,0.93797433],"study_design_scores_gemma":[0.0011493608,0.00006314149,0.00019387412,0.012588153,0.0041436083,0.00005129325,0.0000018149749,9.0499447e-7,9.1382316e-7,0.000034212688,0.98161584,0.00015687032],"about_ca_topic_score_codex":0.00017584197,"about_ca_topic_score_gemma":0.000017247037,"teacher_disagreement_score":0.93781745,"about_ca_system_score_codex":0.00024085685,"about_ca_system_score_gemma":0.0005273569,"threshold_uncertainty_score":0.99980146},"labels":[],"label_agreement":null},{"id":"W245005344","doi":"10.21236/ada542288","title":"A Fresh Approach to Identification and Characterization of Early Changes of Disease Associated with Ovarian Cancer","year":2011,"lang":"en","type":"report","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Identification (biology); Disease; Medicine; Oncology; Biology; Computational biology; Cancer; Internal medicine; Ecology","score_opus":0.05293929168081653,"score_gpt":0.28897363075082516,"score_spread":0.23603433907000865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W245005344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97456545,0.0010104597,0.000582665,0.0010542945,0.00033365315,0.0045267916,0.0021836886,0.00005945275,0.015683567],"genre_scores_gemma":[0.9898082,0.0020477124,0.00014749354,0.00005078226,0.00011446916,0.0008057682,0.0013606222,0.00004137286,0.0056235725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987292,0.000024361636,0.0003156863,0.00034993445,0.00046124746,0.00011957082],"domain_scores_gemma":[0.998328,0.000012943178,0.00054349547,0.00031140217,0.00063893595,0.00016526488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017863432,0.00018342723,0.0005405155,0.00018643869,0.000018870296,0.000011126634,0.000044817727,0.00012725341,0.00012298956],"category_scores_gemma":[0.000042856427,0.00013294238,0.00004742386,0.00020839093,0.000042012154,0.000038804374,0.000023120805,0.00006627068,7.0321454e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012406112,0.0031841074,0.95608723,0.0034892373,0.003433425,0.000017451855,0.0019382507,7.718797e-7,0.004308218,0.0004080396,0.0018791263,0.02401353],"study_design_scores_gemma":[0.0007257508,0.00035379868,0.99324256,0.0012228361,0.0014464763,0.0000014928335,0.000015185918,0.0000048556158,0.002018398,0.000004375851,0.0008415284,0.00012274753],"about_ca_topic_score_codex":0.0023725426,"about_ca_topic_score_gemma":0.00036111663,"teacher_disagreement_score":0.037155323,"about_ca_system_score_codex":0.00017491575,"about_ca_system_score_gemma":0.00063977373,"threshold_uncertainty_score":0.5421233},"labels":[],"label_agreement":null},{"id":"W2460194638","doi":"10.1097/pgp.0000000000000307","title":"The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Academy of Medical Sciences; National Institute for Health and Care Research","keywords":"Medicine; Concordance; Debulking; Chemotherapy; Serous carcinoma; Reproducibility; Radiology; Serous fluid; Response Evaluation Criteria in Solid Tumors; Stage (stratigraphy); Internal medicine; Oncology; Cancer; Progressive disease; Ovarian cancer","score_opus":0.03915864888086324,"score_gpt":0.321887656237144,"score_spread":0.28272900735628076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460194638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83786225,0.0002702597,0.00037178674,0.15997688,0.000506809,0.0009776644,0.000012808036,0.0000133975755,0.0000081229155],"genre_scores_gemma":[0.9958229,0.0000981546,0.00165818,0.0020062388,0.00015821897,0.00018306666,0.0000015138608,0.00001912935,0.000052581003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959578,0.00092107826,0.001759596,0.0006875658,0.00031124227,0.000362696],"domain_scores_gemma":[0.99156564,0.006239848,0.0010425444,0.00057254796,0.00045252315,0.00012691741],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011097932,0.00020958418,0.0006280841,0.00017531026,0.00008359093,0.000038360293,0.000370893,0.00017062205,0.00002451858],"category_scores_gemma":[0.026477955,0.00009225605,0.00016997363,0.0001441301,0.00024393802,0.00006327591,0.00010910369,0.0002967535,0.000002160489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10147659,0.0011239192,0.794828,0.000024778816,0.0001956123,0.008746322,0.00087734795,0.000027411697,0.028551847,0.00091166224,0.00048578053,0.06275074],"study_design_scores_gemma":[0.0073010563,0.004286006,0.9795236,0.00022440408,0.000029853054,0.0026425635,0.00019312465,0.00003286544,0.0014662835,0.0015924295,0.0026017113,0.000106103194],"about_ca_topic_score_codex":0.000051895313,"about_ca_topic_score_gemma":0.000191209,"teacher_disagreement_score":0.18469562,"about_ca_system_score_codex":0.0012073048,"about_ca_system_score_gemma":0.00027960475,"threshold_uncertainty_score":0.9817224},"labels":[],"label_agreement":null},{"id":"W2461010563","doi":"10.1016/j.diii.2016.05.009","title":"Ruptured benign serous ovarian cystadenoma mimicking ovarian malignancy with peritoneal carcinomatosis","year":2016,"lang":"en","type":"letter","venue":"Diagnostic and Interventional Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Peritoneal carcinomatosis; Serous Cystadenoma; Malignancy; Ovary; Serous fluid; Ovarian cancer; Cystadenoma; Radiology; Pathology; General surgery; Gynecology; Internal medicine; Cancer; Pancreas","score_opus":0.01193024897857295,"score_gpt":0.2440416948079823,"score_spread":0.23211144582940935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461010563","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014382929,0.014253864,0.0029610835,0.9593997,0.0013427786,0.0018256059,0.0011072136,0.00024070671,0.004486119],"genre_scores_gemma":[0.80045736,0.0004461621,0.0025455877,0.18412744,0.0067258896,0.000752559,0.0018695208,0.00029358262,0.00278189],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966015,0.00011956284,0.00071055465,0.0011355713,0.0006435562,0.00078926154],"domain_scores_gemma":[0.9979099,0.0006573109,0.0003745845,0.0005564949,0.00026214586,0.00023957396],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001731041,0.00074733247,0.0009445977,0.0003473994,0.00025605035,0.00025754995,0.00019979171,0.0003412572,0.0009884743],"category_scores_gemma":[0.00012369367,0.0005523431,0.0004729085,0.00015040641,0.00024881077,0.00025654476,0.00014123063,0.0008369946,0.00006435156],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024260487,0.00055436126,0.3512607,0.0018325376,0.0023350602,0.02045119,0.0004045656,0.0000010437152,0.000042675034,0.00143382,0.60065114,0.020790296],"study_design_scores_gemma":[0.011904662,0.001450204,0.38337007,0.029445313,0.004150598,0.009071,0.00021374262,0.0000977645,0.00032341597,0.0011076764,0.55690724,0.001958317],"about_ca_topic_score_codex":0.0004794796,"about_ca_topic_score_gemma":0.000017544047,"teacher_disagreement_score":0.78607446,"about_ca_system_score_codex":0.00038198027,"about_ca_system_score_gemma":0.00024694184,"threshold_uncertainty_score":0.9999248},"labels":[],"label_agreement":null},{"id":"W2463520830","doi":"10.1097/pas.0000000000000692","title":"Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome","year":2016,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Medicine; Pathology; Internal medicine; Oncology; Radiology","score_opus":0.02283427584595005,"score_gpt":0.3094041028215442,"score_spread":0.28656982697559413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463520830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408525,0.000022706594,0.00048166254,0.00491237,0.00011587901,0.0002640761,0.000045066226,0.0000049411974,0.00006807054],"genre_scores_gemma":[0.998793,0.00006796335,0.00076455105,0.0002529103,0.00007773882,0.0000061582646,0.000006140168,0.000022257935,0.000009265702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699414,0.000552938,0.001492378,0.0002476362,0.00043886036,0.0002740499],"domain_scores_gemma":[0.9967614,0.0005680821,0.001806079,0.00041907426,0.00027810573,0.00016727387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011743562,0.00019341834,0.0012033508,0.00023276843,0.000024701494,0.0000033692102,0.00019567575,0.000063276275,0.00006687001],"category_scores_gemma":[0.000106699634,0.000087542096,0.00022919364,0.0003140314,0.0006725039,0.000042364907,0.000022880595,0.00026233538,0.0000035518347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010826194,0.0024466028,0.9499483,0.000019655687,0.00010516985,0.001529539,0.000041177937,0.00007288669,0.00027210588,0.00016523476,0.0000134132115,0.034559716],"study_design_scores_gemma":[0.0114874365,0.011789165,0.97523665,0.00048814793,0.00014179395,0.00043095212,0.000063617736,0.00004153375,0.00014316583,0.000047895144,0.00003397798,0.00009565742],"about_ca_topic_score_codex":0.000038712482,"about_ca_topic_score_gemma":0.0000060621005,"teacher_disagreement_score":0.034464058,"about_ca_system_score_codex":0.00008813468,"about_ca_system_score_gemma":0.0002204511,"threshold_uncertainty_score":0.35698628},"labels":[],"label_agreement":null},{"id":"W2465476556","doi":"10.1016/s0140-6736(16)30848-0","title":"Ovarian cancer screening: UKCTOCS trial","year":2016,"lang":"en","type":"letter","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Scopus; Cancer; Oncology; Internal medicine; Gynecology; Stage (stratigraphy); Ovarian carcinoma; Randomized controlled trial; Biomarker; MEDLINE; Biology","score_opus":0.08586936914331562,"score_gpt":0.3359210905377286,"score_spread":0.250051721394413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465476556","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015398051,0.0015262406,0.000056584024,0.97986007,0.0017421783,0.0013796964,0.00045875995,0.000111759975,0.014710757],"genre_scores_gemma":[0.0009042535,0.001360951,0.00027846752,0.8254109,0.14929807,0.00086064165,0.00017192004,0.000093928924,0.021620855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979989,0.00010875314,0.0003000544,0.0004696092,0.0004911095,0.00063156034],"domain_scores_gemma":[0.9980514,0.00022424411,0.0002122524,0.001369732,0.00006807743,0.0000742725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024570737,0.00036558206,0.0010892237,0.00006426109,0.000109252156,0.00005978997,0.00038116428,0.00046791235,0.0025332526],"category_scores_gemma":[0.000037749673,0.00017672236,0.00028591353,0.00011142053,0.00010707485,0.000032985135,0.00007330154,0.0010627562,0.0002636437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00581392,0.000029826126,0.00051666267,0.000082937775,0.0007615124,0.00036733452,0.000041596802,2.3514171e-7,0.000003057971,0.00008876279,0.9733877,0.018906439],"study_design_scores_gemma":[0.061334588,0.00028224045,0.0014027383,0.00068209355,0.00072328205,0.000026366848,0.0000021318565,0.0000017038845,0.00004183857,0.00022142664,0.93506753,0.00021405208],"about_ca_topic_score_codex":0.00037889092,"about_ca_topic_score_gemma":0.000024022067,"teacher_disagreement_score":0.15444914,"about_ca_system_score_codex":0.00020138336,"about_ca_system_score_gemma":0.00025163917,"threshold_uncertainty_score":0.9983786},"labels":[],"label_agreement":null},{"id":"W2468525182","doi":"10.1097/coc.0000000000000310","title":"Secondary Surgery Versus Chemotherapy for Recurrent Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Hazard ratio; Chemotherapy; Ovarian cancer; Surgery; Proportional hazards model; Confidence interval; Survival analysis; Cancer; Internal medicine","score_opus":0.13024568978278558,"score_gpt":0.4824705152351497,"score_spread":0.3522248254523641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468525182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7434495,0.0016268359,0.0010276644,0.24207771,0.009501109,0.0004562228,0.00005851238,0.000020502204,0.0017819111],"genre_scores_gemma":[0.97076446,0.012461216,0.0063784844,0.006270713,0.0038312536,0.000055946344,0.0000024541969,0.00003596824,0.00019950196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772686,0.000193901,0.001381201,0.00022959833,0.00019161493,0.00027680356],"domain_scores_gemma":[0.9903384,0.0072236205,0.0015008958,0.00019672565,0.0003426401,0.0003977129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013880433,0.00014496071,0.0015347047,0.00009836363,0.000030433623,0.000005102268,0.00010069235,0.000106940526,0.00078211894],"category_scores_gemma":[0.00096660515,0.00008155351,0.0007756759,0.0001259212,0.00038501894,0.00006269801,0.0000144733995,0.0002541776,0.000011295705],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020433614,0.0008807757,0.04232699,0.000009249551,0.0009816139,0.00008172371,0.00002854012,1.6308023e-7,0.000020300105,0.00008236675,0.027544174,0.9076105],"study_design_scores_gemma":[0.021966346,0.028612262,0.20102826,0.00022473602,0.00047776196,0.00008010487,0.00005772144,0.0000018924967,0.00016076185,0.00014751409,0.7471222,0.00012038769],"about_ca_topic_score_codex":0.000029413093,"about_ca_topic_score_gemma":0.000037151396,"teacher_disagreement_score":0.9074901,"about_ca_system_score_codex":0.00033841757,"about_ca_system_score_gemma":0.0028462843,"threshold_uncertainty_score":0.8563654},"labels":[],"label_agreement":null},{"id":"W2469448132","doi":"10.1093/ije/dyw158","title":"Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study","year":2016,"lang":"en","type":"article","venue":"International Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; Public Health Ontario; University of British Columbia; University of Toronto","funders":"Medical Research and Materiel Command; National Center for Research Resources; National Cancer Institute; Cancer Council Tasmania; Cancer Council Queensland; Cancer Council NSW; Cancer Council Victoria; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Norges Forskningsråd; Amgen; Rutgers Cancer Institute of New Jersey; Radboud Universiteit; Ovarian Cancer Research Fund; Cancer Australia; Helse Vest; Cancer Research UK; University College London; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; U.S. Public Health Service; U.S. Department of Defense; Lon V. Smith Foundation; Fred C. and Katherine B. Andersen Foundation; Helsingin ja Uudenmaan Sairaanhoitopiiri; Cancer Council South Australia; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Francis Crick Institute; Mayo Foundation for Medical Education and Research; European Commission; University of Cambridge; Breast Cancer Research Foundation; Oregon Health and Science University; Celgene; Minnesota Ovarian Cancer Alliance","keywords":"Mendelian randomization; Body mass index; Ovarian cancer; Medicine; Randomization; Oncology; Index (typography); Cancer; Internal medicine; Mendelian inheritance; Gynecology; Bioinformatics; Genetics; Biology; Randomized controlled trial; Genotype; Gene; Genetic variants","score_opus":0.02072926686341466,"score_gpt":0.3477167102269559,"score_spread":0.32698744336354124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469448132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96234316,0.0017693299,0.012664481,0.021677505,0.00093483843,0.0003059374,0.00012604904,0.0000058347846,0.00017283933],"genre_scores_gemma":[0.9894623,0.008956235,0.0007232488,0.00042829616,0.0003017523,0.000016824913,0.000004654791,0.000009812287,0.000096879325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833983,0.00036465804,0.0008094154,0.00015813559,0.00020421241,0.00012374042],"domain_scores_gemma":[0.9970778,0.0010474698,0.0009744526,0.00010168449,0.000689126,0.00010945197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011766718,0.000107022606,0.0005524038,0.00016328864,0.000017522192,0.0000035510643,0.00010534348,0.000072918585,0.0002687261],"category_scores_gemma":[0.002074391,0.00006021951,0.0001065815,0.00004923517,0.000074336174,0.00008231715,0.000021957649,0.00011189234,0.0000019187494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003093154,0.0003471161,0.96825045,0.0000047355397,0.0020848976,0.000032852553,0.000065936256,0.000020527308,0.000767899,0.00052246003,0.0033552744,0.021454694],"study_design_scores_gemma":[0.037399303,0.0012740277,0.95355916,0.00028364247,0.0006014794,0.00012704615,0.00008978946,0.0002030471,0.00073182187,0.0026897516,0.002947886,0.00009306975],"about_ca_topic_score_codex":0.0007412009,"about_ca_topic_score_gemma":0.000076382035,"teacher_disagreement_score":0.03430615,"about_ca_system_score_codex":0.0001558231,"about_ca_system_score_gemma":0.0001101874,"threshold_uncertainty_score":0.2942362},"labels":[],"label_agreement":null},{"id":"W2469511355","doi":"10.1093/hmg/ddw196","title":"Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk","year":2016,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"Medical Research and Materiel Command; National Center for Research Resources; Medical Research Council; National Institutes of Health; Ministry of Health, Labour and Welfare; National Cancer Institute; University College London; Lon V. Smith Foundation; National Institute for Health and Care Research; National Health and Medical Research Council; Minnesota Ovarian Cancer Alliance; University of Cambridge; Cancer Research UK; Mayo Foundation for Medical Education and Research; Francis Crick Institute; Rutgers Cancer Institute of New Jersey; U.S. Department of Defense; Oregon Health and Science University; Pomorski Uniwersytet Medyczny W Szczecinie; Oak Foundation","keywords":"Biology; Genotyping; Exome; Missense mutation; Exome sequencing; Linkage disequilibrium; Genetics; Ovarian cancer; Minor allele frequency; Germline mutation; Germline; Allele frequency; Gene; Cancer; Allele; Mutation; Genotype; Single-nucleotide polymorphism","score_opus":0.01632855070384859,"score_gpt":0.2860799035568496,"score_spread":0.269751352853001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469511355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902316,0.0013932533,0.0061245025,0.00083671126,0.00013070281,0.0006693741,0.00019938548,0.000053858104,0.00036064954],"genre_scores_gemma":[0.9959191,0.000561608,0.002395019,0.00058049307,0.00016320434,0.00012667142,0.000022394663,0.00007676284,0.00015473473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983223,0.00008813672,0.0002736829,0.0005555139,0.0003440308,0.00041634036],"domain_scores_gemma":[0.99884796,0.000034801025,0.00014516522,0.00048064275,0.00017033794,0.00032108065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014340498,0.00027684786,0.00035663665,0.00011770713,0.00017882904,0.000057631987,0.000107446904,0.00012586633,0.0002950455],"category_scores_gemma":[0.00006551655,0.00019511118,0.0000727986,0.0001831169,0.000076108445,0.00003860267,0.000059209407,0.00011703427,0.00003113634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014608593,0.00050523836,0.29979688,0.00007982217,0.0018113287,0.0012422727,0.0011279917,0.000087076216,0.6703495,0.0009915212,0.00034162146,0.023520702],"study_design_scores_gemma":[0.004453634,0.0006215735,0.97047514,0.0007967994,0.0006609987,0.000020693564,0.000015757283,0.000014515183,0.02099656,0.0014042453,0.00020546137,0.00033460947],"about_ca_topic_score_codex":0.00024371297,"about_ca_topic_score_gemma":0.00030554834,"teacher_disagreement_score":0.67067826,"about_ca_system_score_codex":0.00024836697,"about_ca_system_score_gemma":0.00015378176,"threshold_uncertainty_score":0.7956403},"labels":[],"label_agreement":null},{"id":"W2474011408","doi":"10.1111/vcp.12380","title":"What's Your Diagnosis? Multiple hepatic masses in a cat","year":2016,"lang":"en","type":"article","venue":"Veterinary Clinical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Veterinary medicine; Medicine; Library science; Computer science","score_opus":0.15561295539888645,"score_gpt":0.42700069843952304,"score_spread":0.2713877430406366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474011408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831848,0.00083161617,0.00003371299,0.01374753,0.0014941366,0.00044736982,0.00001527432,0.00005580709,0.00018971515],"genre_scores_gemma":[0.98534316,0.010195658,0.0014663257,0.0019753682,0.0002924884,0.00048029562,0.000009600838,0.000029584173,0.0002075022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786603,0.00032765255,0.00071269,0.00059323426,0.00012295613,0.00037740366],"domain_scores_gemma":[0.99739456,0.0017114269,0.00012204705,0.00053378846,0.00004016681,0.00019801778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043267553,0.00019936041,0.000645327,0.00011004167,0.000029430528,0.00001754344,0.000109022156,0.0002328739,0.0004666275],"category_scores_gemma":[0.00082611485,0.00012677729,0.00020611481,0.00012078631,0.00020355305,0.00019312844,0.000119417185,0.00013823797,0.00036786014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043240294,0.0015654007,0.8843269,0.000034538625,0.000042723048,0.0074299993,0.000074203585,2.0763464e-7,0.00085030444,0.00002796694,0.00045715747,0.104758225],"study_design_scores_gemma":[0.0069294954,0.0067282435,0.9673655,0.0005485113,0.00007747411,0.00056366005,0.00007076809,0.0000140138145,0.00020514161,0.0002654655,0.017054966,0.00017676337],"about_ca_topic_score_codex":0.000043159016,"about_ca_topic_score_gemma":0.000059096707,"teacher_disagreement_score":0.10458146,"about_ca_system_score_codex":0.00012888177,"about_ca_system_score_gemma":0.00007582213,"threshold_uncertainty_score":0.5169828},"labels":[],"label_agreement":null},{"id":"W2476437009","doi":"10.1016/j.ygyno.2016.04.144","title":"Examining selection for resistant clones in high-grade serous ovarian cancer after neoadjuvant chemotherapy","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nonsynonymous substitution; Exome sequencing; Medicine; Ovarian cancer; Exome; COLD-PCR; Serous fluid; Oncology; Chemotherapy; Somatic cell; Cancer; Internal medicine; Mutation; Cancer research; Genetics; Biology; Point mutation; Genome; Gene","score_opus":0.03604255268885277,"score_gpt":0.32108556795464277,"score_spread":0.28504301526579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476437009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96573627,0.0006537477,0.00028210695,0.030679254,0.000805369,0.0012936336,0.000039710776,0.000085223495,0.00042469963],"genre_scores_gemma":[0.98686534,0.0010035234,0.004776314,0.0027707953,0.00037380503,0.003235596,0.000010126327,0.00003443881,0.0009300892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830717,0.00010609868,0.00039476718,0.0005503611,0.00011488235,0.0005266973],"domain_scores_gemma":[0.99875313,0.00067932304,0.00015726415,0.00020891783,0.00008722724,0.00011414226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003266055,0.00022829304,0.00061689725,0.00015597184,0.000067185,0.000009881006,0.000075220516,0.00032881484,0.0011121767],"category_scores_gemma":[0.00012496888,0.00014384266,0.00008272163,0.0002034706,0.0000799807,0.00006338702,0.000025383162,0.000120148296,0.000021975902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036020211,0.0015073803,0.6023473,0.00006750655,0.00026808467,0.0002786758,0.00030767402,0.000011711942,0.01057541,0.00081208284,0.00284547,0.37737668],"study_design_scores_gemma":[0.014603501,0.0056370837,0.90969014,0.000119276956,0.00014044807,0.000033438602,0.0000709038,0.000022785604,0.002851108,0.0009581153,0.06567005,0.00020315997],"about_ca_topic_score_codex":0.00056948967,"about_ca_topic_score_gemma":0.0055577783,"teacher_disagreement_score":0.3771735,"about_ca_system_score_codex":0.0019051731,"about_ca_system_score_gemma":0.00042476156,"threshold_uncertainty_score":0.9998009},"labels":[],"label_agreement":null},{"id":"W2483614610","doi":"10.1158/1538-7445.am2016-lb-324","title":"Abstract LB-324: Genomic consequences of aberrant DNA repair stratify ovarian cancer histotypes","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Serous fluid; Ovarian cancer; Comparative genomic hybridization; Serous carcinoma; Loss of heterozygosity; Clear cell; Copy-number variation; Genetics; Indel; Cancer; Cancer research; Single-nucleotide polymorphism; Carcinoma; Genome; Gene; Genotype; Allele","score_opus":0.11047790301248933,"score_gpt":0.40950232723534824,"score_spread":0.2990244242228589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483614610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635219,0.010898211,0.000005548979,0.018058209,0.0003674125,0.0008164386,0.00026855076,0.00006841317,0.005995293],"genre_scores_gemma":[0.9881487,0.008089147,0.00017438937,0.00013752759,0.0004001582,0.00058983377,0.0000060054604,0.00003915946,0.0024151022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997548,0.000095991185,0.00044280378,0.0005706521,0.0007355439,0.0006070115],"domain_scores_gemma":[0.9982333,0.00028550113,0.00012553082,0.00060509366,0.00046370094,0.0002868793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066027907,0.00020261314,0.00046397676,0.00021850821,0.00013550067,0.00002068708,0.00020503135,0.00013393952,0.0068813697],"category_scores_gemma":[0.00008747431,0.00012786474,0.00018067153,0.00030031742,0.0007615226,0.000104141676,0.000054669606,0.00026527274,0.00009586887],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011083967,0.00047227088,0.088179976,0.0005654558,0.00089240196,0.00028724846,0.00059797673,0.0000074687573,0.8070613,0.0030081887,0.026810484,0.07100882],"study_design_scores_gemma":[0.004516496,0.00074609387,0.6130842,0.0020973017,0.00018427845,0.000018432911,0.0001798045,0.0000038675466,0.32005277,0.00093720265,0.05786252,0.00031702218],"about_ca_topic_score_codex":0.010783183,"about_ca_topic_score_gemma":0.0018173297,"teacher_disagreement_score":0.52490425,"about_ca_system_score_codex":0.0013299246,"about_ca_system_score_gemma":0.0025390987,"threshold_uncertainty_score":0.9958041},"labels":[],"label_agreement":null},{"id":"W2485724366","doi":"10.1016/j.ejca.2016.06.014","title":"Corrigendum to “Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group” [Eur J Cancer 49 (2013) 1905–1914]","year":2016,"lang":"de","type":"erratum","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Regret; Cohort; Medicine; Ovary; Gynecology; Cohort study; General surgery; University hospital; Surgery; Internal medicine","score_opus":0.0381080573998257,"score_gpt":0.31478450691716864,"score_spread":0.27667644951734294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485724366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7127463,0.11671725,0.000038406335,0.018588925,0.13364565,0.011118497,0.000995167,0.00004625903,0.0061035138],"genre_scores_gemma":[0.94112414,0.025025172,0.000044561784,0.001284136,0.00869589,0.00026743702,0.000009143802,0.00033831393,0.023211217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9864486,0.0039225067,0.0038872778,0.001283183,0.0032797658,0.0011786519],"domain_scores_gemma":[0.9868903,0.000287567,0.007067521,0.0027918152,0.0023500465,0.00061271316],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004395789,0.0014360438,0.0034519692,0.00052067277,0.0004403319,0.00007357705,0.0032521628,0.0002479576,0.0015431495],"category_scores_gemma":[0.00078817684,0.0006996956,0.0012642158,0.0013411333,0.00063558255,0.00016858173,0.0012423885,0.0027566,0.000077530145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014401954,0.0061688703,0.65757304,0.00016853816,0.007817895,0.00072649185,0.002897102,0.0002840772,0.00009293878,0.000009253359,0.31266928,0.0101523185],"study_design_scores_gemma":[0.009211323,0.009452664,0.7103628,0.0040112697,0.0101498775,0.000029316541,0.0019408911,0.0000047793446,0.00013870434,0.0000058280502,0.2541649,0.0005276561],"about_ca_topic_score_codex":0.0030687281,"about_ca_topic_score_gemma":0.0055921585,"teacher_disagreement_score":0.22837779,"about_ca_system_score_codex":0.0011640473,"about_ca_system_score_gemma":0.0028091143,"threshold_uncertainty_score":0.99983895},"labels":[],"label_agreement":null},{"id":"W2492043181","doi":"10.1158/1538-7445.am2016-441","title":"Abstract 441: Association of interferon inducible genes with tumor immune microenvironment and chemotherapy resistance in high-grade serous epithelial ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Centre Hospitalier de l’Université de Montréal; Queen's University","funders":"","keywords":"Ovarian cancer; Tumor microenvironment; CD8; Medicine; Immune system; Chemotherapy; Cancer research; Biomarker; Immunotherapy; Oncology; Immunohistochemistry; Cancer; Immunology; Internal medicine; Biology","score_opus":0.030738922161102807,"score_gpt":0.3265439540054483,"score_spread":0.2958050318443455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492043181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603077,0.0059498386,0.000005070593,0.017009843,0.000082421684,0.0006762651,0.00011238957,0.000010348575,0.0001230821],"genre_scores_gemma":[0.9839518,0.013503882,0.00020142591,0.00010452756,0.00016153423,0.0005296538,0.0000043891164,0.00003888454,0.0015039106],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815154,0.00008329893,0.0003084636,0.00044741653,0.00055691606,0.00045238313],"domain_scores_gemma":[0.9991395,0.00014553395,0.00015254911,0.00033268027,0.00011673623,0.0001130371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060046115,0.00016594307,0.0003898749,0.00017612505,0.000060106784,0.000019890269,0.00010502765,0.00008763293,0.0004684593],"category_scores_gemma":[0.000021341873,0.00010757041,0.000037347072,0.0002543769,0.00015111985,0.00009290751,0.000042137308,0.00023243576,0.0000067080405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032631261,0.00058285816,0.47733238,0.00028832647,0.0003548213,0.00006777064,0.0005859389,0.0000058502064,0.49135253,0.00010150584,0.0011368485,0.024928046],"study_design_scores_gemma":[0.006286001,0.00035406757,0.6954974,0.0013038713,0.000027738413,0.0000018038296,0.00005772517,5.189889e-7,0.29266027,0.00007706495,0.0036291627,0.00010437999],"about_ca_topic_score_codex":0.005872514,"about_ca_topic_score_gemma":0.0053108525,"teacher_disagreement_score":0.21816503,"about_ca_system_score_codex":0.0021699835,"about_ca_system_score_gemma":0.00034911124,"threshold_uncertainty_score":0.88775235},"labels":[],"label_agreement":null},{"id":"W2492144485","doi":"10.5539/cco.v5n2p1","title":"Cardiovascular Toxicity of Bevacizumab in Long-term Survival of Recurrent Ovarian Cancer: A Case Report","year":2016,"lang":"en","type":"article","venue":"Cancer and Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Surgery; Ovarian cancer; Coronary artery disease; Internal medicine; Angioplasty; Myocardial infarction; Debulking; Chemotherapy; Cancer; Oncology","score_opus":0.07966237273204335,"score_gpt":0.4295754078087101,"score_spread":0.34991303507666677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492144485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364806,0.011249784,0.00006514046,0.0028804382,0.0010623253,0.00045375965,0.00009014534,0.000009074739,0.0005412945],"genre_scores_gemma":[0.97685534,0.022394622,0.00008210246,0.00010183085,0.00031790862,0.0001376237,0.00000462787,0.000013649647,0.00009230273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977994,0.00018152122,0.0011022798,0.00048306907,0.00019992795,0.00023383369],"domain_scores_gemma":[0.9983336,0.00048845704,0.00034410128,0.00045231925,0.00017149189,0.00021008261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009217429,0.00015554878,0.0013944581,0.00006714744,0.000019784078,0.0000019057652,0.00006088282,0.00024497687,0.00025731281],"category_scores_gemma":[0.00023431152,0.00010140318,0.0004115908,0.00014356515,0.00031421648,0.000035815083,0.00006559351,0.0001700836,0.0000010433766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007011181,0.0007385202,0.52760667,0.000110875735,0.0008549556,0.011315157,0.00004418083,8.430778e-7,0.000026236108,0.00006161573,0.000058964968,0.45848086],"study_design_scores_gemma":[0.014615086,0.0023774449,0.9740308,0.00066609756,0.0012766952,0.0020908862,0.000028263743,0.0000033666647,0.0007345128,0.000050900457,0.0039848904,0.00014105038],"about_ca_topic_score_codex":0.001715456,"about_ca_topic_score_gemma":0.0059839957,"teacher_disagreement_score":0.4583398,"about_ca_system_score_codex":0.00041752495,"about_ca_system_score_gemma":0.0009918164,"threshold_uncertainty_score":0.41351017},"labels":[],"label_agreement":null},{"id":"W2498661651","doi":"10.1089/gyn.2016.0009","title":"Should We Manage Large Ovarian Cysts Laparoscopically?","year":2016,"lang":"en","type":"article","venue":"Journal of Gynecologic Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Laparoscopy; Surgery; General surgery; Ovarian tissue; Ovary; Gynecology; Internal medicine","score_opus":0.054587261557545876,"score_gpt":0.30316615887996534,"score_spread":0.24857889732241947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498661651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9187741,0.0029822174,0.0004782603,0.06940742,0.0029199414,0.0002940388,0.00002239006,0.000050217866,0.005071391],"genre_scores_gemma":[0.99128675,0.004279641,0.00062823517,0.0020516862,0.000528161,0.000013632889,0.0000013572316,0.000019609459,0.0011909393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826807,0.00010135114,0.0006717406,0.00019562899,0.0003751351,0.00038809195],"domain_scores_gemma":[0.99700665,0.0018509809,0.00043783733,0.0002635155,0.00016787692,0.00027314175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009230116,0.00017948097,0.00074136467,0.00023767713,0.00005989328,0.000020458712,0.00010127146,0.00015671615,0.0031216273],"category_scores_gemma":[0.0008577506,0.00009198123,0.00043450476,0.00017720251,0.000049522976,0.00013848035,0.000041609426,0.00017666702,0.00011182647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045030974,0.001692476,0.7729707,0.00007905702,0.00067138945,0.005772867,0.000055228487,8.8023876e-7,0.0008528082,0.00062184146,0.1165075,0.10032497],"study_design_scores_gemma":[0.0032830564,0.0007265045,0.76269835,0.00074266543,0.00029331696,0.0005165083,0.000045192588,0.0000012203084,0.0013674718,0.001091143,0.22906807,0.00016648868],"about_ca_topic_score_codex":0.0000028200232,"about_ca_topic_score_gemma":0.000008285238,"teacher_disagreement_score":0.11256056,"about_ca_system_score_codex":0.00029336277,"about_ca_system_score_gemma":0.00024304657,"threshold_uncertainty_score":0.9977897},"labels":[],"label_agreement":null},{"id":"W2501982710","doi":"10.1017/cbo9781107784772.021","title":"Consensus views arising from the 60th Study Group: Gynaecological Cancers: Biology and therapeutics","year":2011,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Ovarian cancer; Clinical trial; Serous fluid; Pathological; Medicine; Disease; Serous carcinoma; Gynaecological cancer; Cancer; Oncology; Internal medicine; Ovarian carcinoma; Pathology; Gynecology; Bioinformatics; Biology","score_opus":0.0908344694357833,"score_gpt":0.2742596887123479,"score_spread":0.1834252192765646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501982710","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01997046,0.0034789988,0.00004110402,0.00017252647,0.00042877736,0.0019327876,0.0005239488,0.00008133606,0.9733701],"genre_scores_gemma":[0.41593477,0.0033449673,0.00025805208,0.0015523413,0.00052268076,0.000013894249,0.00017375936,0.00009672124,0.5781028],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986615,0.000110392364,0.00021913183,0.0006280909,0.00013368536,0.0002471925],"domain_scores_gemma":[0.9986286,0.0003333718,0.00022677882,0.0005808867,0.00008657781,0.00014375467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000109099165,0.00039182307,0.00067494175,0.000057234734,0.00022141323,0.000025580091,0.00019825032,0.00035464406,0.00003723225],"category_scores_gemma":[0.000006195965,0.00027898332,0.00015841254,0.000007125555,0.00047868653,0.000014039815,0.00025119525,0.0004866048,0.000006164674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002025277,0.0007212096,0.031324998,0.00010687781,0.01084985,0.0045677894,0.002440977,5.037857e-7,0.00004633481,0.84018457,0.018813793,0.0889178],"study_design_scores_gemma":[0.0037456793,0.00129496,0.031541802,0.00013549808,0.0038373948,0.000026243866,0.00035967721,0.000007031928,0.000023586002,0.0000690347,0.958585,0.00037407395],"about_ca_topic_score_codex":0.0029061968,"about_ca_topic_score_gemma":0.0001649331,"teacher_disagreement_score":0.93977123,"about_ca_system_score_codex":0.00040958257,"about_ca_system_score_gemma":0.00015022638,"threshold_uncertainty_score":0.9999662},"labels":[],"label_agreement":null},{"id":"W25023396","doi":"10.1016/s1701-2163(16)30643-0","title":"Screening Postmenopausal Women for Ovarian Cancer: A Systematic Review","year":2004,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Cancer Care Ontario; University of Ottawa","funders":"","keywords":"Medicine; Ovarian cancer; Postmenopausal women; Gynecology; Obstetrics; Oncology; Cancer; Internal medicine","score_opus":0.028631970943782132,"score_gpt":0.3074444412859078,"score_spread":0.2788124703421257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W25023396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003881071,0.9924823,0.000019108327,0.00045276442,0.0041497606,0.0026348222,0.00020160472,0.0000037600776,0.000051991698],"genre_scores_gemma":[0.00007716928,0.9974734,0.00061923976,0.0009940894,0.0000811549,0.0005334682,0.000024011475,0.000051475945,0.00014594349],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971832,0.00010487846,0.0016119735,0.00027362167,0.00039066924,0.00043564237],"domain_scores_gemma":[0.9943144,0.0025266076,0.002036156,0.00025971734,0.00040300057,0.00046014937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054701074,0.00041353842,0.0050550923,0.00032427022,0.00009958524,0.000027593333,0.00018171218,0.00024391465,0.00023203],"category_scores_gemma":[0.002602049,0.0002757408,0.00036654895,0.00046319238,0.00003135786,0.000040363335,0.00003766368,0.0004451253,5.20669e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000019491135,0.00007100858,0.000024906776,0.69079554,0.002156558,0.0017307801,0.000013223087,6.332333e-7,2.1665403e-9,0.00005563091,0.0008367188,0.30431306],"study_design_scores_gemma":[0.0029255636,0.0014549753,0.00010163862,0.36981162,0.020857742,0.0008453509,0.0000309815,8.490632e-7,5.6426114e-8,0.000023951907,0.6036537,0.00029356],"about_ca_topic_score_codex":0.0046437415,"about_ca_topic_score_gemma":0.0023328913,"teacher_disagreement_score":0.602817,"about_ca_system_score_codex":0.007876802,"about_ca_system_score_gemma":0.013450708,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W2511058727","doi":"10.1002/path.4783","title":"Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse","year":2016,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Biology; Ovarian carcinoma; Oviduct; Epithelium; Ovary; Cancer research; Ovarian cancer; Metastasis; Phenotype; Gene; Endocrinology; Cancer","score_opus":0.033236398000871546,"score_gpt":0.31147376269329125,"score_spread":0.2782373646924197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511058727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962526,0.00038241342,0.000056332043,0.0018304469,0.00032380136,0.00021892646,0.00006192952,0.000002276726,0.00087128533],"genre_scores_gemma":[0.9990535,0.00030287018,0.00021754479,0.00007501023,0.00029269457,0.000002988291,0.0000013364196,0.000015373995,0.00003873158],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984225,0.00040954893,0.00052992103,0.000110443754,0.0002998755,0.00022773052],"domain_scores_gemma":[0.9978344,0.0010098398,0.0005426564,0.0004086308,0.00013527095,0.00006919951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011064981,0.00015304549,0.00050429476,0.00029095405,0.000027221626,0.0000033224862,0.0002630634,0.000084718464,0.00022663789],"category_scores_gemma":[0.00024934163,0.000060043563,0.0002477006,0.00027140309,0.00016216376,0.0000449477,0.000027019849,0.00023630133,0.00001111221],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040645428,0.005371222,0.34247884,0.00008679417,0.0009892271,0.0030890978,0.008775543,0.00011701035,0.5724959,0.0030515683,0.0014921828,0.021407187],"study_design_scores_gemma":[0.0301366,0.019922929,0.8970019,0.00011052561,0.0006672805,0.001084369,0.00034913974,0.0000034458124,0.049878757,0.00037838428,0.0003409426,0.00012570596],"about_ca_topic_score_codex":0.00027270164,"about_ca_topic_score_gemma":0.000022237416,"teacher_disagreement_score":0.5545231,"about_ca_system_score_codex":0.00019143119,"about_ca_system_score_gemma":0.0003090349,"threshold_uncertainty_score":0.2481526},"labels":[],"label_agreement":null},{"id":"W2511225630","doi":"10.1016/s0246-1064(19)30073-8","title":"10.1016/s0246-1064(19)30073-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.009286647824082802,"score_gpt":0.21267754092371666,"score_spread":0.20339089309963385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511225630","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043892505,0.000363154,3.5460786e-7,0.003707895,0.0000024687183,0.00035322524,0.00002120493,0.00011129422,0.9950015],"genre_scores_gemma":[0.0007503185,0.0000036708898,0.00022913463,0.00034602982,0.00028514286,0.00007721357,0.000032686312,0.000029659579,0.99824613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909455,0.000016874412,0.00016262014,0.00027298846,0.00019465522,0.0002583187],"domain_scores_gemma":[0.99922454,0.000038421644,0.000020419113,0.00036389558,0.000034730176,0.00031796386],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000714934,0.00014981299,0.00024234566,0.00006228982,0.000053096053,0.000021320035,0.00007178674,0.00005786324,0.99878246],"category_scores_gemma":[0.000018806628,0.00012512952,0.0000904225,0.00017156677,0.00002298934,0.00003932332,0.00001814264,0.00008151233,0.9950351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012797,0.00019333953,0.0000033635063,0.000009139473,0.00006195213,0.000052002313,0.000014925182,0.0000076133315,0.0000068671343,7.3126444e-7,0.6307996,0.3687225],"study_design_scores_gemma":[0.0012658191,0.0005450941,0.0008542848,0.00006303941,0.00012899158,0.000035273333,0.0000010824332,0.000024279474,0.00017389911,0.0000064085634,0.9967735,0.00012835478],"about_ca_topic_score_codex":0.00007019131,"about_ca_topic_score_gemma":3.4342986e-7,"teacher_disagreement_score":0.36859414,"about_ca_system_score_codex":0.00013049762,"about_ca_system_score_gemma":0.000074055155,"threshold_uncertainty_score":0.5102634},"labels":[],"label_agreement":null},{"id":"W2511267411","doi":"10.1007/s10552-016-0806-6","title":"The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database","year":2016,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Eye Institute; University of Illinois at Chicago; American Cancer Society","keywords":"Medicine; Stage (stratigraphy); Cancer; Odds ratio; Cancer registry; Ovarian cancer; Confidence interval; Epithelial ovarian cancer; Logistic regression; Demography; Internal medicine; Oncology; Gynecology; Biology","score_opus":0.0193455539495372,"score_gpt":0.30080896577017313,"score_spread":0.28146341182063594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511267411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289895,0.0077567026,0.0000021749954,0.0047295787,0.0003910263,0.0017414924,0.0024071983,0.000010926941,0.000061936764],"genre_scores_gemma":[0.9916479,0.0041113845,0.0000010075971,0.00042668876,0.00019906119,0.003117887,0.0000032841663,0.000019407807,0.00047336542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981082,0.00029717336,0.00039148057,0.00040572518,0.00052309904,0.00027429793],"domain_scores_gemma":[0.9976847,0.0014881584,0.0003212136,0.00029651442,0.00013034236,0.00007905653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030994366,0.00025604726,0.0006387568,0.00006680553,0.0001184531,0.000015122803,0.00018294455,0.00007140537,0.00040484895],"category_scores_gemma":[0.00024141154,0.000110864654,0.0000966185,0.00014792419,0.00023740127,0.000070576025,0.000048325393,0.00013397694,0.000001956238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026139575,0.0004997034,0.97828776,0.00005921685,0.0006296074,0.00000731551,0.00033168317,0.000017849003,0.0038589428,0.000074163436,0.002243095,0.011376694],"study_design_scores_gemma":[0.025390223,0.0023393882,0.9575632,0.00084143865,0.0007649817,0.0000010954664,0.000042256015,0.00006003461,0.0086501725,0.00002467309,0.004115288,0.00020722159],"about_ca_topic_score_codex":0.009116675,"about_ca_topic_score_gemma":0.008901422,"teacher_disagreement_score":0.022776267,"about_ca_system_score_codex":0.00054344133,"about_ca_system_score_gemma":0.0003405621,"threshold_uncertainty_score":0.9974817},"labels":[],"label_agreement":null},{"id":"W2511461890","doi":"10.1016/j.ygyno.2016.08.321","title":"Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Research Foundation of Korea; Ministry of Education","keywords":"Medicine; Lymphadenectomy; Lymph node; Debulking; Metastasis; Stage (stratigraphy); Survival rate; Ovarian cancer; Oncology; Lymph; Surgery; Internal medicine; Cancer; Urology; Pathology","score_opus":0.016224325617222868,"score_gpt":0.32148957413282053,"score_spread":0.30526524851559766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511461890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995354,0.00018075916,0.000018711984,0.0011986648,0.00035608522,0.0008930804,0.00018079951,0.000038957867,0.0017789307],"genre_scores_gemma":[0.9977311,0.00026776656,0.00091519085,0.00025240527,0.00004739095,0.00066676957,0.00002101049,0.000029651843,0.0000687264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978734,0.00022856862,0.0004447438,0.00061268185,0.00029047806,0.00055009854],"domain_scores_gemma":[0.9982455,0.0005716811,0.0003008143,0.0004431003,0.0002563723,0.0001825346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019195043,0.00033537537,0.0009971663,0.00023696345,0.000032463213,0.000005373419,0.00013113103,0.0002037478,0.0020315219],"category_scores_gemma":[0.00024844593,0.00017493861,0.00014800298,0.0004069713,0.00017552244,0.0000942238,0.000051211082,0.00010705614,0.000031517797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005826148,0.0026081128,0.86097205,0.000019709407,0.00040368046,0.00011588588,0.000057729183,0.000036410154,0.000053756507,0.000047881458,0.000042255604,0.12981638],"study_design_scores_gemma":[0.025904983,0.007880773,0.96487623,0.0002484212,0.00023203052,0.0000044970175,0.000013888445,0.0000027016094,0.00025028308,0.00004507175,0.00032978738,0.00021134049],"about_ca_topic_score_codex":0.00041393045,"about_ca_topic_score_gemma":0.0006811932,"teacher_disagreement_score":0.12960504,"about_ca_system_score_codex":0.0030263679,"about_ca_system_score_gemma":0.0009866983,"threshold_uncertainty_score":0.99888074},"labels":[],"label_agreement":null},{"id":"W2511827811","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1349","title":"Abstract POSTER-BIOL-1349: The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; microRNA; Cancer research; Germline mutation; Somatic cell; Germline; Genetics; Gene; Mutation","score_opus":0.19655783500639704,"score_gpt":0.49370869882028373,"score_spread":0.29715086381388667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511827811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96696657,0.003390901,0.0000020820044,0.011842058,0.0002227689,0.001152516,0.00009898335,0.00001750845,0.016306624],"genre_scores_gemma":[0.9975624,0.0006647876,0.00014119846,0.000357027,0.0004734553,0.0003899843,0.00003603037,0.00003823603,0.00033688114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964763,0.00046011456,0.0009793642,0.00053437805,0.0009467388,0.00060308765],"domain_scores_gemma":[0.9965843,0.0014175624,0.0001797298,0.0007619996,0.0004885409,0.0005678541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034706676,0.00018782268,0.00055908266,0.00019648563,0.00011076054,0.000040328905,0.00035613374,0.00018130486,0.00066335197],"category_scores_gemma":[0.0005327085,0.00012560334,0.0002359236,0.00075226073,0.00051865954,0.00008655909,0.00016856639,0.0010221577,0.00015397365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064756474,0.009603513,0.8729704,0.00040032374,0.00061931065,0.0012867667,0.005600227,0.00014961735,0.005070286,0.0012668106,0.015635608,0.08092147],"study_design_scores_gemma":[0.015582783,0.002522969,0.93522525,0.0007010661,0.00015836771,0.000026519292,0.004522474,0.00007912066,0.013099438,0.004804201,0.022965211,0.00031258087],"about_ca_topic_score_codex":0.005978152,"about_ca_topic_score_gemma":0.0018248582,"teacher_disagreement_score":0.08060889,"about_ca_system_score_codex":0.00058353523,"about_ca_system_score_gemma":0.0025699418,"threshold_uncertainty_score":0.9037218},"labels":[],"label_agreement":null},{"id":"W2515153451","doi":"10.1016/j.ygyno.2016.08.320","title":"Low-grade serous ovarian cancer: A review","year":2016,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Serous fluid; KRAS; Medicine; Ovarian cancer; Grading (engineering); Oncology; Serous ovarian cancer; Internal medicine; Serous carcinoma; Cancer research; Cancer; Colorectal cancer; Biology","score_opus":0.07623875466264035,"score_gpt":0.42072772285630766,"score_spread":0.3444889681936673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515153451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.15997e-7,0.97028387,0.0000052236282,0.010702645,0.0020443492,0.0046147862,0.00023080189,0.00018520564,0.01193232],"genre_scores_gemma":[0.0000025982517,0.9815407,0.0003930393,0.006736322,0.0009977465,0.006572012,0.00019743213,0.000107074295,0.0034531192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99564993,0.00060038787,0.0013230282,0.00121322,0.00029524878,0.0009181517],"domain_scores_gemma":[0.9960466,0.0012887776,0.0010074966,0.0010729299,0.0001442262,0.00043998339],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005723303,0.0008909663,0.006420588,0.00022384124,0.00012226455,0.000015554118,0.0004097314,0.0012556837,0.010110503],"category_scores_gemma":[0.00039005448,0.00051262457,0.0012601139,0.00049567455,0.00019230356,0.000047667963,0.00020528198,0.0007246737,0.0023005058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010913123,0.0008356223,0.000028829969,0.047986895,0.0010080028,0.0014933987,0.000006722049,1.8904258e-8,9.017385e-8,0.0002533859,0.056867823,0.8915083],"study_design_scores_gemma":[0.001648015,0.0016049015,0.00006463463,0.10184604,0.006939782,0.0007611257,0.000001998755,9.52432e-8,6.197086e-7,0.00006527387,0.88662404,0.00044345233],"about_ca_topic_score_codex":0.000059165617,"about_ca_topic_score_gemma":0.0000803257,"teacher_disagreement_score":0.8910648,"about_ca_system_score_codex":0.0041191895,"about_ca_system_score_gemma":0.0044514835,"threshold_uncertainty_score":0.99973255},"labels":[],"label_agreement":null},{"id":"W2515679040","doi":"10.1158/1078-0432.ccr-16-1433","title":"Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Montréal; University Health Network; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; U.S. Department of Defense","keywords":"Immunotherapy; Chemotherapy; Cancer; Ovarian cancer; Medicine; Lymphocyte; Tumor-infiltrating lymphocytes; Oncology; Immunology; Pathology; Cancer research; Internal medicine","score_opus":0.1628242435155388,"score_gpt":0.48815544820918283,"score_spread":0.325331204693644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515679040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631433,0.0011272748,0.00059436867,0.03200662,0.00007679683,0.0017635934,0.0011435333,0.000016059037,0.0001284935],"genre_scores_gemma":[0.9937647,0.003216429,0.0006740498,0.00021368483,0.00021828484,0.0016482001,0.000010945067,0.000051699335,0.00020203608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970667,0.00028273102,0.0011373525,0.00059332757,0.00042889046,0.0004910093],"domain_scores_gemma":[0.9940073,0.0039422587,0.00035753503,0.0008343977,0.00068771036,0.00017077981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031250168,0.00018327254,0.00071217434,0.00018400834,0.000073893745,0.000011896202,0.00025085142,0.00011026172,0.00018506481],"category_scores_gemma":[0.00067570846,0.0001087509,0.00018380456,0.00044243515,0.00038279995,0.0000619787,0.000042099666,0.00021778862,0.0000016530239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06699656,0.0006707832,0.70027655,0.00010414927,0.00023071984,0.000008458319,0.00013796004,0.000004153593,0.006823818,0.0002761024,0.00021858433,0.22425215],"study_design_scores_gemma":[0.028180664,0.002906021,0.9516205,0.0018991674,0.00003484927,0.000003777928,0.0000390975,0.00002492592,0.012249066,0.00040611014,0.0025099218,0.0001258796],"about_ca_topic_score_codex":0.0037577462,"about_ca_topic_score_gemma":0.004071179,"teacher_disagreement_score":0.25134397,"about_ca_system_score_codex":0.00060787186,"about_ca_system_score_gemma":0.0020955317,"threshold_uncertainty_score":0.56806135},"labels":[],"label_agreement":null},{"id":"W2516496845","doi":"10.1097/igc.0000000000000767","title":"European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Documentation; Quality management; Quality (philosophy); Multidisciplinary approach; Audit; Medical physics; Performance indicator; Operations management; Management system","score_opus":0.07202843200884235,"score_gpt":0.4079634512288954,"score_spread":0.33593501922005303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516496845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94018286,0.0016715202,0.0014548951,0.051390152,0.0030078064,0.00043891114,0.00028252715,0.000022406939,0.001548936],"genre_scores_gemma":[0.988114,0.0057920353,0.0024602346,0.0024899512,0.0007301157,0.000106903295,0.00000584822,0.000018487091,0.00028242858],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99787253,0.00016309238,0.0009926234,0.00024919194,0.00047008356,0.0002525065],"domain_scores_gemma":[0.9952016,0.0022927094,0.0012740914,0.00012618201,0.00092202617,0.00018342755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010970576,0.00017141021,0.00070531765,0.00014868833,0.00004201592,0.000010281671,0.00026638375,0.00014246079,0.0034883374],"category_scores_gemma":[0.00083878555,0.000095514384,0.0007111852,0.0001301133,0.00018708446,0.00012055534,0.00006678826,0.00016179644,0.0000045953025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013488104,0.0009701552,0.37977353,0.00004001552,0.0013723841,0.00008991717,0.0000901881,0.000028310693,0.002809917,0.0005487478,0.013016553,0.59991145],"study_design_scores_gemma":[0.0061353752,0.00099249,0.87166524,0.0002001189,0.000193463,0.000030500636,0.00005831951,0.0000034913048,0.00411757,0.00045621025,0.11601065,0.00013659324],"about_ca_topic_score_codex":0.000036548503,"about_ca_topic_score_gemma":0.00003986324,"teacher_disagreement_score":0.5997749,"about_ca_system_score_codex":0.0015190073,"about_ca_system_score_gemma":0.00090040517,"threshold_uncertainty_score":0.99742264},"labels":[],"label_agreement":null},{"id":"W2518044343","doi":"10.1111/his.13071","title":"Molecular alterations in indolent, aggressive and recurrent ovarian low‐grade serous carcinoma","year":2016,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Health Services; University of Calgary","funders":"Calgary Laboratory Services","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Oncology; Internal medicine; Pathology; Carcinoma; Ovarian cancer; Cancer","score_opus":0.01454445156529974,"score_gpt":0.2656246292582888,"score_spread":0.251080177692989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518044343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820686,0.0035000278,0.00025639235,0.006641488,0.00029328794,0.00031940598,0.00002133799,0.000021147986,0.00074004586],"genre_scores_gemma":[0.99838656,0.00030529257,0.00036916437,0.0005563851,0.000065550186,0.00014322446,0.0000123695445,0.000015426443,0.00014600925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908084,0.000080521924,0.00020126409,0.00034053685,0.00008151798,0.00021530801],"domain_scores_gemma":[0.99947315,0.000040133833,0.00009269476,0.00025466,0.000034052828,0.00010533207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006926641,0.0001309469,0.000252964,0.0001457304,0.000039163224,0.000005589001,0.00003827539,0.00008415254,0.000061326486],"category_scores_gemma":[0.000054760236,0.0000936047,0.00004189802,0.00008339985,0.00009988572,0.00003567993,0.000032787822,0.000088836976,0.000025322382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004608115,0.0015197847,0.82660013,0.00012397398,0.000029559447,0.01908946,0.0030688634,0.0000032862106,0.04406745,0.011869813,0.0014608082,0.09170606],"study_design_scores_gemma":[0.0047532674,0.0006451912,0.9860383,0.0002881198,0.00007616886,0.0009699893,0.000024410467,0.000013621276,0.0034222417,0.00042028064,0.0032032132,0.00014516522],"about_ca_topic_score_codex":0.000060658083,"about_ca_topic_score_gemma":0.00009531161,"teacher_disagreement_score":0.1594382,"about_ca_system_score_codex":0.0002441136,"about_ca_system_score_gemma":0.000083596955,"threshold_uncertainty_score":0.38170886},"labels":[],"label_agreement":null},{"id":"W2519636597","doi":"10.1038/bjc.2016.273","title":"Ovarian carcinoma diagnosis: the clinical impact of 15 years of change","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Carcinoma; Ovarian carcinoma; Medicine; Pathology; Oncology; Gynecology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.0846219215148308,"score_gpt":0.3866383915693564,"score_spread":0.3020164700545256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519636597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639632,0.032227896,0.000007273662,0.002893561,0.00042967402,0.00021707712,0.00013145023,0.0000026138857,0.00012723099],"genre_scores_gemma":[0.9672782,0.031264447,0.000086884545,0.00022146793,0.0010463742,0.000037362955,5.5468433e-7,0.000017250308,0.00004747076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998618,0.0000840148,0.00068115944,0.00011400208,0.00033523823,0.00016757524],"domain_scores_gemma":[0.9984849,0.00024933156,0.0006067394,0.00018682206,0.00032110407,0.00015106615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004611436,0.000088480534,0.0005253022,0.000057714573,0.000018923065,0.0000097380225,0.00013591528,0.00007098373,0.0008917215],"category_scores_gemma":[0.00015696525,0.00005312957,0.00053538,0.000121997284,0.0001501981,0.0000996909,0.00002546949,0.00014365539,0.0000025422946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016678934,0.0002432628,0.5583408,0.00001642221,0.00041264377,0.00022865899,0.00006857524,4.5545434e-7,0.00003473626,0.00001045734,0.00581886,0.43465838],"study_design_scores_gemma":[0.0041905735,0.0011976247,0.9841457,0.0019673968,0.00041360286,0.00045222449,0.000021644271,6.820291e-7,0.00052973133,0.000055619403,0.0069682747,0.000056916702],"about_ca_topic_score_codex":0.002906614,"about_ca_topic_score_gemma":0.0003902202,"teacher_disagreement_score":0.43460146,"about_ca_system_score_codex":0.00015495394,"about_ca_system_score_gemma":0.00044183334,"threshold_uncertainty_score":0.97637254},"labels":[],"label_agreement":null},{"id":"W2520413912","doi":"10.1016/j.ygyno.2016.09.006","title":"The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Adjuvant; Stage (stratigraphy); Internal medicine; Log-rank test; Cohort; Radiation therapy; Adjuvant therapy; Oncology; Survival analysis; Gastroenterology; Carcinoma; Chemotherapy","score_opus":0.012463813828159573,"score_gpt":0.2811367931030361,"score_spread":0.2686729792748765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520413912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816129,0.0002220866,0.000005532141,0.0042684865,0.00068477425,0.0008053996,0.00001710373,0.000020838886,0.012362841],"genre_scores_gemma":[0.99843776,0.0003102492,0.000037196573,0.00015368017,0.000090431524,0.00015852782,0.000004529361,0.000013880188,0.00079371466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984052,0.0004924374,0.0003240554,0.00029025093,0.00015728344,0.00033077432],"domain_scores_gemma":[0.995888,0.0034869157,0.0001816659,0.0003276686,0.000032753534,0.00008303113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007865467,0.00015500408,0.00049402897,0.00008818113,0.00006271437,0.0000054221723,0.00010859089,0.0001948996,0.00025451416],"category_scores_gemma":[0.00034101866,0.00007271479,0.00009906916,0.00012978417,0.00011674919,0.000029109755,0.000037733298,0.0001416791,0.00011359319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016018599,0.00037923947,0.82808477,0.000025489675,0.000045417473,0.00022395617,0.000109258624,0.0000062933314,0.00054282905,0.0009660086,0.00042305441,0.1675918],"study_design_scores_gemma":[0.009304215,0.025642997,0.93582517,0.000020352938,0.00006769935,0.0000031758216,0.000035938865,0.000010216245,0.0071944166,0.00005723736,0.021763047,0.000075555494],"about_ca_topic_score_codex":0.00024401436,"about_ca_topic_score_gemma":0.00033292262,"teacher_disagreement_score":0.16751625,"about_ca_system_score_codex":0.0007327912,"about_ca_system_score_gemma":0.00018214744,"threshold_uncertainty_score":0.29652232},"labels":[],"label_agreement":null},{"id":"W2520956883","doi":"10.1111/cge.12865","title":"The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania","year":2016,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Ovarian cancer; Medicine; Incidence (geometry); Genetic testing; Gynecology; Oophorectomy; Population; Cancer; Occult; Internal medicine; Oncology; Hysterectomy; Surgery; Pathology; Environmental health","score_opus":0.06843647439484174,"score_gpt":0.42433000063892623,"score_spread":0.3558935262440845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520956883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722683,0.0012178738,0.0000042190986,0.00058801053,0.000067916684,0.0007356414,0.000019270667,0.000007958641,0.00013226659],"genre_scores_gemma":[0.99607986,0.0024519502,0.0011388134,0.000058738533,0.0001283275,0.00011619983,5.287233e-7,0.000015056831,0.000010517499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987386,0.00017063764,0.0004911141,0.0002230281,0.0001603242,0.00021633324],"domain_scores_gemma":[0.99708456,0.0020981012,0.00020165698,0.0003391715,0.00015451908,0.00012201215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048123242,0.00012513186,0.0003044687,0.000028371001,0.000044282096,0.000009551763,0.000104758496,0.000077950855,0.000020301257],"category_scores_gemma":[0.0007573892,0.000051143892,0.00008097744,0.00023947867,0.0003093068,0.000015347776,0.000037911435,0.00012956513,0.0000011865146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017614679,0.00048145273,0.6880854,0.000006343009,0.00008298798,0.00000327792,0.000096733515,0.000014740732,0.0006422658,0.0000124256285,0.000021051394,0.31037718],"study_design_scores_gemma":[0.0017279825,0.004451597,0.9905986,0.0002803808,0.000074336196,0.0000069554653,0.000029452402,0.00035216296,0.002187891,0.00019388998,0.000034183722,0.00006257372],"about_ca_topic_score_codex":0.00039160077,"about_ca_topic_score_gemma":0.00020262087,"teacher_disagreement_score":0.31031463,"about_ca_system_score_codex":0.00007519525,"about_ca_system_score_gemma":0.00030086693,"threshold_uncertainty_score":0.20855875},"labels":[],"label_agreement":null},{"id":"W2521608626","doi":"10.1002/j.2205-0140.2012.tb00011.x","title":"Key findings from the International Ovarian Tumor Analysis (IOTA) study: an approach to the optimal ultrasound based characterisation of adnexal pathology","year":2012,"lang":"en","type":"review","venue":"Australasian Journal of Ultrasound in Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vlaamse regering; Università di Bologna; Università Cattolica del Sacro Cuore; Università degli Studi di Udine; Fonds Wetenschappelijk Onderzoek; Università degli Studi di Milano; iMinds; General Hospital of People’s Liberation Army; Belgian Federal Science Policy Office; Malmö Högskola; Lunds Universitet; Univerzita Karlova v Praze; McMaster University; King's College London; Università degli Studi di Cagliari","keywords":"Medicine; Ultrasound; Transvaginal ultrasound; Principal (computer security); Key (lock); Radiology; Pathology; Medical physics; Computer science","score_opus":0.0635664562449935,"score_gpt":0.34807157603423255,"score_spread":0.28450511978923904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521608626","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4206218,0.55810916,0.0014605277,0.008990973,0.0035722975,0.0057223653,0.0008117474,0.00002762546,0.00068346463],"genre_scores_gemma":[0.7520186,0.24040557,0.0026214384,0.0006154995,0.0031980895,0.00014138443,0.00087257556,0.00007999779,0.000046888494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99487317,0.0007701403,0.0022216747,0.00052092964,0.0011777255,0.0004363862],"domain_scores_gemma":[0.99474937,0.0020274448,0.0016899764,0.00085928786,0.00030703563,0.00036690725],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032541223,0.0005921908,0.0029846851,0.00086059154,0.00009855517,0.00006312743,0.0010026572,0.00023016329,0.0009152419],"category_scores_gemma":[0.0009306258,0.00029695246,0.0007075064,0.0013643815,0.00026046805,0.00016979073,0.000038965085,0.001189394,0.000008552422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015732177,0.01480811,0.71883726,0.0018965378,0.033325676,0.0011500752,0.037365947,0.00046775345,0.0003337924,0.00023860525,0.004674306,0.1853287],"study_design_scores_gemma":[0.0047744876,0.0030050094,0.77132195,0.005038157,0.039808616,0.0019548205,0.00603438,0.000014827999,0.000010699968,0.000011238264,0.16760735,0.00041847327],"about_ca_topic_score_codex":0.00028985756,"about_ca_topic_score_gemma":0.00007983988,"teacher_disagreement_score":0.33139673,"about_ca_system_score_codex":0.00048540387,"about_ca_system_score_gemma":0.00048027566,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W2524074132","doi":"10.1016/s0246-1064(15)54727-0","title":"10.1016/s0246-1064(15)54727-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Physics","score_opus":0.00782004639148082,"score_gpt":0.2046269469439872,"score_spread":0.19680690055250638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524074132","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004859595,0.00035425636,2.7798586e-7,0.003085746,0.000002439188,0.00034501666,0.000020234238,0.00010581985,0.9956002],"genre_scores_gemma":[0.0008860214,0.0000032420892,0.00021326863,0.0002658453,0.00028479626,0.00007539916,0.000031546977,0.00003046363,0.9982094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990968,0.000016051543,0.00016465235,0.0002706349,0.0001935275,0.00025829705],"domain_scores_gemma":[0.9992935,0.00003351888,0.00002051691,0.00036436727,0.00003676593,0.0002513208],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006523058,0.00015087832,0.0002459516,0.00005993778,0.00004927017,0.000021690857,0.000071536524,0.000057434714,0.99894255],"category_scores_gemma":[0.0000139787,0.00012593395,0.00009111406,0.00016568277,0.000022132775,0.000040860945,0.000018056113,0.000082214116,0.9957522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011719324,0.00019597354,0.000002805005,0.000008023198,0.00006274118,0.000045007015,0.000013176369,0.0000063834104,0.000008287844,6.0753837e-7,0.6094962,0.3900436],"study_design_scores_gemma":[0.0012074726,0.00057485985,0.0010171622,0.000072998395,0.00013418552,0.00002936618,9.513117e-7,0.000025856627,0.00026154268,0.0000050994818,0.9965415,0.00012899155],"about_ca_topic_score_codex":0.000052119416,"about_ca_topic_score_gemma":3.6776808e-7,"teacher_disagreement_score":0.3899146,"about_ca_system_score_codex":0.000106941385,"about_ca_system_score_gemma":0.00006005762,"threshold_uncertainty_score":0.5135437},"labels":[],"label_agreement":null},{"id":"W2529965714","doi":"10.1200/jop.2016.016998","title":"Ovarian Sex Cord-Stromal Tumors: The Challenge of Rare Gynecologic Malignancies","year":2016,"lang":"en","type":"letter","venue":"Journal of Oncology Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; MEDLINE; Stromal cell; Gynecology; Oncology; Pathology","score_opus":0.04518685818516028,"score_gpt":0.3395744450644941,"score_spread":0.2943875868793338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529965714","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009475132,0.0035218159,0.000027658132,0.96240026,0.0015510008,0.0005109203,0.00004274106,0.0000118307335,0.030986274],"genre_scores_gemma":[0.06432478,0.012020971,0.00524635,0.8884008,0.02318838,0.00009115786,0.000028573104,0.00013369176,0.006565299],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963883,0.0008955671,0.0012263233,0.0003197896,0.0007048423,0.00046513433],"domain_scores_gemma":[0.9877373,0.006266014,0.004336052,0.0005844556,0.0009564673,0.0001197341],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001764149,0.00037653145,0.0015198338,0.00022582253,0.00010918148,0.000024138373,0.00043406498,0.0009465824,0.0011419579],"category_scores_gemma":[0.0021716969,0.00019285685,0.0004946939,0.00013461141,0.0003122582,0.00028367966,0.00010840209,0.0026906093,0.000052179683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014308589,0.00094537105,0.00094517355,0.00021465006,0.0025601548,0.03166622,0.0003807277,7.538753e-7,0.00004380509,0.00030757408,0.93324536,0.028259344],"study_design_scores_gemma":[0.0038567465,0.014530115,0.0034092295,0.0006140231,0.0027973757,0.011701492,0.00044544105,4.6057835e-7,0.00008442016,0.00026341114,0.962134,0.0001633116],"about_ca_topic_score_codex":0.00003667672,"about_ca_topic_score_gemma":0.000009349649,"teacher_disagreement_score":0.07399945,"about_ca_system_score_codex":0.0008747818,"about_ca_system_score_gemma":0.00290417,"threshold_uncertainty_score":0.9997711},"labels":[],"label_agreement":null},{"id":"W2531058993","doi":"10.1055/s-0036-1592680","title":"Internet based second opinion pathology in a large chemotherapy trial for ovarian cancer – results of a standardized review process","year":2016,"lang":"en","type":"review","venue":"Geburtshilfe und Frauenheilkunde","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Clinical trial; Randomization; Ovarian cancer; The Internet; Cancer; Medical diagnosis; Chemotherapy; Medical physics; Second opinion; Pathology; Oncology; Internal medicine; Computer science","score_opus":0.0653276862780295,"score_gpt":0.41394525423355544,"score_spread":0.34861756795552595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531058993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013123055,0.9787364,0.0006379698,0.0021536562,0.001015935,0.011100332,0.005648891,0.000049670023,0.0006440485],"genre_scores_gemma":[0.000114018156,0.98955935,0.00047209027,0.0012590582,0.0007515123,0.006031917,0.0011116678,0.00016194534,0.00053843134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950089,0.00033117936,0.0022263387,0.001236754,0.00045850157,0.00073835417],"domain_scores_gemma":[0.99631655,0.0006497885,0.0014839311,0.0010081226,0.0003203966,0.00022123332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016293155,0.00082804594,0.0051440434,0.00044836788,0.00004309348,0.000025096497,0.00034485158,0.0007087791,0.0013075181],"category_scores_gemma":[0.0003889145,0.00056063954,0.0012066949,0.0005494036,0.00011424776,0.000078917394,0.000050071565,0.00042776292,0.000013405548],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02828869,0.0016208143,0.000027765525,0.15094896,0.0017204408,0.00008219486,0.00016389224,1.9083328e-7,4.8163207e-7,0.00042499002,0.015371688,0.8013499],"study_design_scores_gemma":[0.122589655,0.0011865833,0.000020134668,0.15093347,0.0013802581,0.000014136791,0.0000034780433,0.0000032085834,0.000016730794,0.00013385917,0.7233437,0.0003747945],"about_ca_topic_score_codex":0.000053296386,"about_ca_topic_score_gemma":0.00018044664,"teacher_disagreement_score":0.8009751,"about_ca_system_score_codex":0.00083127315,"about_ca_system_score_gemma":0.0028811397,"threshold_uncertainty_score":0.9996845},"labels":[],"label_agreement":null},{"id":"W2534490732","doi":"10.1200/jco.2009.27.15_suppl.5511","title":"What is the optimal strategy to confirm the diagnosis of epithelial ovarian carcinoma (EOC) prior to neoadjuvant chemotherapy (NAC)?","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cytology; Histology; Biopsy; Radiology; Serous fluid; Chemotherapy; Internal medicine; Pathology","score_opus":0.09716349933024788,"score_gpt":0.4434798229453422,"score_spread":0.34631632361509435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534490732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65543073,0.00089641404,0.000058125886,0.34132907,0.0011181966,0.000637241,0.000012094108,0.000004402511,0.00051373814],"genre_scores_gemma":[0.9351473,0.0027491292,0.0018002412,0.058143716,0.0019258694,0.000027320497,8.757119e-7,0.000018407385,0.00018717156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99641997,0.000346364,0.0020860708,0.00028612846,0.0005180167,0.0003434353],"domain_scores_gemma":[0.9950286,0.002356574,0.0010977404,0.0005064699,0.0004862072,0.00052439247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025165146,0.00022628257,0.0015079224,0.00009367937,0.000086815286,0.00004924955,0.000426251,0.0002758712,0.00058117637],"category_scores_gemma":[0.00059319887,0.00010875178,0.00073389907,0.00024077001,0.00016957571,0.00011856405,0.00004560093,0.0006891376,0.00003457547],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060450705,0.00330263,0.025291303,0.000009603224,0.00059820624,0.0003914463,0.0016968773,0.00012100319,0.00015688773,0.00053651497,0.022654377,0.9391961],"study_design_scores_gemma":[0.0090438705,0.04772858,0.72713214,0.00018292354,0.0006038623,0.00020166353,0.0007384036,0.00002885813,0.0021685897,0.00027101798,0.21177651,0.00012357136],"about_ca_topic_score_codex":0.00010708473,"about_ca_topic_score_gemma":0.00005266684,"teacher_disagreement_score":0.9390725,"about_ca_system_score_codex":0.00018725405,"about_ca_system_score_gemma":0.0014385647,"threshold_uncertainty_score":0.63634735},"labels":[],"label_agreement":null},{"id":"W2536270877","doi":"10.1097/pas.0000000000000757","title":"Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma","year":2016,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fallopian tube; Serous carcinoma; Carcinosarcoma; Serous fluid; Medicine; Pathology; Lymphovascular invasion; Carcinoma; Gynecology; Cancer; Internal medicine; Ovarian cancer; Metastasis","score_opus":0.015064973378665945,"score_gpt":0.2709382721011389,"score_spread":0.25587329872247294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536270877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9025376,0.0006424147,0.00008968904,0.09599366,0.00028106768,0.00026020876,0.00006864789,0.000011667004,0.00011507085],"genre_scores_gemma":[0.995152,0.00077673054,0.00049473916,0.0026935756,0.0006766495,0.000019871826,0.0000012678987,0.000029990784,0.00015517006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979813,0.0004415882,0.0005352887,0.0002864722,0.00030505104,0.0004503052],"domain_scores_gemma":[0.9982622,0.00041123634,0.00034714266,0.0004393818,0.00015726774,0.00038276843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060860615,0.00025928605,0.0008318501,0.00010728914,0.00011806206,0.000023299954,0.00028145328,0.00004341488,0.00012286255],"category_scores_gemma":[0.000057246798,0.000104681385,0.00020812111,0.0002401974,0.0006828787,0.000045263358,0.00011512676,0.00029303101,0.000019199577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007847488,0.00076594856,0.38487047,0.000043512453,0.0013111035,0.034202978,0.0034987633,0.000029443703,0.011749927,0.0015385927,0.0022129067,0.5519289],"study_design_scores_gemma":[0.007241985,0.011225208,0.8580588,0.00011909999,0.0007626016,0.06601603,0.0006106383,0.000005630843,0.0017879108,0.00028490557,0.053572048,0.0003151555],"about_ca_topic_score_codex":0.00038356427,"about_ca_topic_score_gemma":0.00010255015,"teacher_disagreement_score":0.5516137,"about_ca_system_score_codex":0.00016788984,"about_ca_system_score_gemma":0.00016912063,"threshold_uncertainty_score":0.4268783},"labels":[],"label_agreement":null},{"id":"W2536294504","doi":"10.1093/biolreprod/85.s1.15","title":"Lessons Learned from Mouse Models of Ovarian Cancer.","year":2011,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Biology; Cre recombinase; Ovarian cancer; Transgene; Oncogene; Cancer; Ovulation; Cancer research; Ovary; Genetically modified mouse; Recombinase; Hormone; Gene; Genetics; Endocrinology; Cell cycle","score_opus":0.18234438620591017,"score_gpt":0.3431229938300276,"score_spread":0.16077860762411741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536294504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879014,0.0049574687,0.00044977115,0.0044719935,0.0004168451,0.00022769046,0.000074437194,0.00003109861,0.0014693335],"genre_scores_gemma":[0.99259263,0.0032961313,0.0035451355,0.000018655484,0.00017991904,0.000033722747,0.000040283758,0.00000907619,0.00028443424],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925315,0.000033477576,0.0002031676,0.00036920575,0.000049094928,0.000091924696],"domain_scores_gemma":[0.9992329,0.000011355554,0.00016019195,0.0004622904,0.00010025967,0.000033003747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011483693,0.00007638609,0.0002653765,0.000054938373,0.000018541907,5.99435e-7,0.000040194423,0.00009124106,0.00024102457],"category_scores_gemma":[0.000033318815,0.000061994935,0.00006399819,0.000076356075,0.00011171378,0.000036795445,0.000016581962,0.000055252363,0.0000039199203],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017384489,0.001985841,0.17128664,0.000111621484,0.001403246,0.00000658511,0.0027915223,0.000080385325,0.17791255,0.017654048,0.001199925,0.6238292],"study_design_scores_gemma":[0.0017371526,0.0006979727,0.11590166,0.00006834623,0.000279458,0.000006428103,0.00012970352,0.000052298892,0.86510026,0.012267574,0.0036576567,0.00010149631],"about_ca_topic_score_codex":0.0077656657,"about_ca_topic_score_gemma":0.000056180073,"teacher_disagreement_score":0.68718773,"about_ca_system_score_codex":0.00003775287,"about_ca_system_score_gemma":0.00007078919,"threshold_uncertainty_score":0.9988417},"labels":[],"label_agreement":null},{"id":"W2538173625","doi":"10.1097/igc.0000000000000836","title":"Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca España; Sanofi; PharmaMar; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Bevacizumab; Neutropenia; Gastrointestinal perforation; Surgery; Ovarian cancer; Adverse effect; Perforation; Carboplatin; Clinical endpoint; Internal medicine; Febrile neutropenia; Chemotherapy; Cancer; Peritonitis; Randomized controlled trial","score_opus":0.04761933129659347,"score_gpt":0.3667722720665962,"score_spread":0.3191529407700027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538173625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804784,0.002343268,0.000068457826,0.008086729,0.0006950744,0.00052295247,0.000047084162,0.000008295537,0.00018031542],"genre_scores_gemma":[0.9924691,0.0062951003,0.00018712993,0.00054098095,0.00038174374,0.00007380668,0.0000017478502,0.00001496368,0.00003544993],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998149,0.00009961705,0.00078534364,0.00024804188,0.0005123437,0.00020567856],"domain_scores_gemma":[0.9979471,0.00082984555,0.0005096125,0.00011363708,0.00044329083,0.0001565339],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036858264,0.00018381426,0.0005739948,0.00019844095,0.000030497431,0.000024317667,0.00019940858,0.0000867186,0.0016888657],"category_scores_gemma":[0.00033560058,0.000105212755,0.00012591004,0.00012409555,0.000093466464,0.00014749114,0.000050722505,0.0001832252,0.0000013123782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011051608,0.008107911,0.45705244,0.000005101114,0.00079835864,0.00079933373,0.0005775605,0.000043201737,0.002924977,0.00012477368,0.00010494419,0.5184098],"study_design_scores_gemma":[0.07796419,0.013611398,0.9022247,0.00054071314,0.00012633622,0.000048455,0.0001806528,0.000012037393,0.0018600054,0.00013362122,0.0031678504,0.00013000389],"about_ca_topic_score_codex":0.00038008965,"about_ca_topic_score_gemma":0.0004735507,"teacher_disagreement_score":0.5182798,"about_ca_system_score_codex":0.0009113002,"about_ca_system_score_gemma":0.0003023964,"threshold_uncertainty_score":0.9992237},"labels":[],"label_agreement":null},{"id":"W2539504752","doi":"10.17816/pavlovj20133130-136","title":"IMPORTANCE OF MARKERS OF THE PROLIFERATION AND APOPTOSIS FOR OVARIAN BODERLINE TUMOURS","year":2013,"lang":"en","type":"article","venue":"I P Pavlov Russian Medical Biological Herald","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pacific Insight Electronics (Canada)","funders":"","keywords":"Survivin; Cyclin D1; Ovary; Disease; Apoptosis; Cancer research; Oncology; Medicine; Cyclin; Internal medicine; Pathology; Biology; Gynecology; Cell cycle; Cancer","score_opus":0.019473277023883635,"score_gpt":0.2724121620864405,"score_spread":0.25293888506255685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539504752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9375574,0.00042878833,0.00024966695,0.059305064,0.00011828696,0.0014820911,0.000031274467,0.000020185005,0.0008072509],"genre_scores_gemma":[0.99432135,0.00024481272,0.002606252,0.0023524337,0.00013071332,0.00024095933,0.00002663398,0.000009475168,0.000067358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865556,0.00007043257,0.00047911526,0.00028035263,0.00029095897,0.00022356145],"domain_scores_gemma":[0.9990831,0.00019965127,0.0001754682,0.00024036677,0.0000617958,0.00023959654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030072258,0.00015022518,0.00042896325,0.000027507973,0.000051568033,0.000007870802,0.00011319657,0.0001936741,0.0007202218],"category_scores_gemma":[0.00037315104,0.00007235301,0.0001509894,0.00012772642,0.00028548343,0.00003528903,0.000044052464,0.00014333431,0.0000024538774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005836462,0.0009662182,0.92585105,0.0002789853,0.00023404109,0.0000046332566,0.00008699975,6.5561807e-7,0.0019713682,0.015328402,0.0041661067,0.050527878],"study_design_scores_gemma":[0.0027530144,0.0015598469,0.9844102,0.00028780344,0.00009252481,0.000017035914,0.000041749554,0.00037244151,0.0064181467,0.002813091,0.0011146871,0.00011942291],"about_ca_topic_score_codex":0.000077806006,"about_ca_topic_score_gemma":0.000015738804,"teacher_disagreement_score":0.058559168,"about_ca_system_score_codex":0.000032453478,"about_ca_system_score_gemma":0.00011156957,"threshold_uncertainty_score":0.78859234},"labels":[],"label_agreement":null},{"id":"W2543677770","doi":"10.3747/co.23.3139","title":"The Cost-Effectiveness of Bevacizumab for the Treatment of Advanced Ovarian Cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Roche (Canada)","funders":"","keywords":"Medicine; Bevacizumab; Oncology; Ovarian cancer; Internal medicine; Quality-adjusted life year; Incremental cost-effectiveness ratio; Cost effectiveness; Population; Randomized controlled trial; Progression-free survival; Cost-effectiveness analysis; Chemotherapy; Quality of life (healthcare); Cancer","score_opus":0.08156632930246596,"score_gpt":0.41396331593107516,"score_spread":0.33239698662860917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543677770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350903,0.040025804,0.00032415736,0.013042767,0.0036781828,0.0069803675,0.000582164,0.000008243852,0.0002680074],"genre_scores_gemma":[0.9840301,0.012645151,0.000020073732,0.000013783408,0.00007053662,0.0031734717,0.0000046882114,0.000009167291,0.000033012486],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991732,0.00009464198,0.0002542668,0.00016719416,0.0001047506,0.0002059351],"domain_scores_gemma":[0.9969129,0.002524603,0.00014413122,0.0002545712,0.00011796493,0.00004584765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015664237,0.00010945184,0.00037553615,0.000024940307,0.000044763434,0.0000012003694,0.00007881524,0.000031071137,0.000038366314],"category_scores_gemma":[0.000051238512,0.000043835524,0.00008239741,0.00008922506,0.000090474,0.000013928911,0.00001097032,0.000031926105,4.3307656e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015554776,0.0006192897,0.082780465,0.00006891427,0.00019223672,0.0000035781493,0.00009752886,0.00004080575,0.00023210842,0.00073339656,0.00016856822,0.91350764],"study_design_scores_gemma":[0.018173719,0.002293203,0.53699833,0.00038679922,0.00028436308,0.0000034886118,0.00016333292,0.00005769474,0.009995359,0.00014444433,0.43142745,0.00007181043],"about_ca_topic_score_codex":0.1219016,"about_ca_topic_score_gemma":0.6978464,"teacher_disagreement_score":0.9134358,"about_ca_system_score_codex":0.0033933283,"about_ca_system_score_gemma":0.0023506626,"threshold_uncertainty_score":0.8873435},"labels":[],"label_agreement":null},{"id":"W2546059200","doi":"10.3747/co.23.3042","title":"Follow-Up of Patients Who Are Clinically Disease-Free after Primary Treatment for Fallopian Tube, Primary Peritoneal, or Epithelial Ovarian Cancer: A Program in Evidence-Based Care Guideline Adaptation","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; University of Toronto; McMaster University; Cancer Care Ontario; Ottawa Hospital","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Guideline; Context (archaeology); Randomized controlled trial; Fallopian tube; Hazard ratio; Ovarian cancer; Cancer; MEDLINE; Cochrane Library; Asymptomatic; Gynecology; Health care; Confidence interval; Internal medicine; Family medicine; Intensive care medicine; Pathology","score_opus":0.12075747283521152,"score_gpt":0.4138754967821763,"score_spread":0.29311802394696473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546059200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494306,0.015448417,0.00060548284,0.016111817,0.0030817753,0.011033182,0.0041006217,0.00011093195,0.00007719493],"genre_scores_gemma":[0.9646957,0.007531825,0.007640472,0.0010416602,0.0009178715,0.016874129,0.001016267,0.000086908,0.00019517576],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99704957,0.00017930445,0.0012017619,0.0007326888,0.00037200522,0.0004646586],"domain_scores_gemma":[0.9973043,0.0005263766,0.00049051637,0.000626507,0.0007188971,0.00033335696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019861604,0.00037131348,0.001070251,0.00018309172,0.00005280365,0.000012892245,0.00018478323,0.00018786351,0.00014904965],"category_scores_gemma":[0.00045930402,0.0002269019,0.00037773512,0.00019053883,0.00015404983,0.00013594661,0.000072912815,0.00010289933,0.000003857386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020476023,0.003863317,0.4508436,0.00058776233,0.00010939889,0.000038338454,0.00031205633,0.000006700384,0.0000067657575,0.0000067457277,0.0011552843,0.522594],"study_design_scores_gemma":[0.057417974,0.013344811,0.80398226,0.00456212,0.0008881941,7.557048e-7,0.0000881897,0.0001517012,0.000057117006,0.00003087752,0.11919911,0.0002768812],"about_ca_topic_score_codex":0.00016373214,"about_ca_topic_score_gemma":0.0018287682,"teacher_disagreement_score":0.5223171,"about_ca_system_score_codex":0.003236732,"about_ca_system_score_gemma":0.0034060413,"threshold_uncertainty_score":0.92527914},"labels":[],"label_agreement":null},{"id":"W2547328490","doi":"10.1016/j.ajog.2016.10.035","title":"The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States","year":2016,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Hysterectomy; Fallopian tube; Perioperative; Sterilization (economics); Ovarian cancer; Tubal ligation; Obstetrics; Odds ratio; Gynecology; Surgery; Population; Cancer; Family planning; Pregnancy; Internal medicine","score_opus":0.014612243833875762,"score_gpt":0.28638997791435966,"score_spread":0.2717777340804839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547328490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882556,0.0015423514,0.00010288955,0.009104281,0.00019455554,0.00020712269,0.0000089040495,9.45595e-7,0.000013361254],"genre_scores_gemma":[0.9738968,0.02552594,0.00023993256,0.00025901847,0.000026513038,0.000017817572,0.0000013499633,0.0000049963705,0.000027604912],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993534,0.000068731795,0.0002920953,0.00007296415,0.00008243463,0.00013035911],"domain_scores_gemma":[0.9954388,0.003986533,0.00032622335,0.00007505564,0.00013393536,0.000039438008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038514336,0.000064817075,0.00023247444,0.00013594919,0.000061323495,0.000008367476,0.00005378353,0.000020885045,0.000006178491],"category_scores_gemma":[0.00041420548,0.000026738138,0.000038750153,0.00028446905,0.00019173301,0.000037369253,0.000012096962,0.00006552992,6.7139865e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027513274,0.000098963515,0.42433167,0.000022870472,0.0001426547,0.000009696736,0.00051820494,0.000012636033,0.00004071665,0.0002889698,0.00011186673,0.5741466],"study_design_scores_gemma":[0.004815648,0.0045929407,0.9504598,0.0001408913,0.0001443126,0.00005534204,0.0005940396,0.0001470733,0.000104882514,0.00024393278,0.038649406,0.000051768628],"about_ca_topic_score_codex":0.000058382087,"about_ca_topic_score_gemma":0.000028538945,"teacher_disagreement_score":0.57409483,"about_ca_system_score_codex":0.000074741365,"about_ca_system_score_gemma":0.000087499895,"threshold_uncertainty_score":0.10903496},"labels":[],"label_agreement":null},{"id":"W2547620199","doi":"10.1097/pgp.0000000000000336","title":"The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians","year":2016,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Fallopian tube; Serous carcinoma; Serous fluid; Medicine; Ovarian cancer; Gynecology; Carcinoma; Pathology; Cancer; Internal medicine","score_opus":0.04136147398769818,"score_gpt":0.31471280288195114,"score_spread":0.27335132889425295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547620199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310946,0.00061001605,0.00014209545,0.005511453,0.0003533506,0.00014371652,0.000066569235,0.0000025627835,0.00006074787],"genre_scores_gemma":[0.99676895,0.0022845878,0.00058239774,0.0002648124,0.00004639475,0.0000066497923,0.0000049582,0.0000060941884,0.00003516803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845755,0.0002448539,0.0007299034,0.00017902373,0.00023505963,0.00015360718],"domain_scores_gemma":[0.9974826,0.0017070203,0.00039768056,0.00010127358,0.00023945994,0.00007197669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001056198,0.00011645227,0.0004883026,0.000115755836,0.000018360295,0.000007701722,0.00013883649,0.000119689044,0.000044007316],"category_scores_gemma":[0.00066382973,0.000058010828,0.000066167726,0.00005820158,0.00034798522,0.00004939478,0.000100153695,0.00015359418,9.210128e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006208944,0.0005051139,0.9767724,0.000010765296,0.00008816725,0.0016976082,0.00007305632,0.0000020546256,0.0053211744,0.00046897426,0.00006893769,0.014370849],"study_design_scores_gemma":[0.0040561124,0.0023360886,0.9912049,0.000084385734,0.00003826355,0.00076818874,0.000014706799,0.000003206947,0.00060261664,0.00054143585,0.00029590016,0.000054180942],"about_ca_topic_score_codex":0.00013176256,"about_ca_topic_score_gemma":0.00033629153,"teacher_disagreement_score":0.014432509,"about_ca_system_score_codex":0.00016571228,"about_ca_system_score_gemma":0.00009388026,"threshold_uncertainty_score":0.2365613},"labels":[],"label_agreement":null},{"id":"W2549490887","doi":"10.1016/j.jpag.2016.11.006","title":"Rates and Technique for Oophoropexy in Pediatric Ovarian Torsion: A Single-Institution Case Series","year":2016,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Ovarian torsion; Torsion (gastropod); Series (stratigraphy); Institution; Pediatrics; Radiology; Surgery; Geology; Political science; Law; Paleontology","score_opus":0.019586718921249666,"score_gpt":0.2756236792058062,"score_spread":0.2560369602845565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549490887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98604333,0.0054103797,0.0017385327,0.005503068,0.0005051894,0.0007280899,0.000013002267,0.000008913631,0.00004948857],"genre_scores_gemma":[0.980547,0.015685085,0.0022330447,0.00017646908,0.0012640274,0.00003102484,8.268046e-7,0.000011399933,0.00005108462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990183,0.00004893827,0.00043813096,0.0001828258,0.000086381006,0.00022543759],"domain_scores_gemma":[0.999135,0.00021207178,0.00026299577,0.00007824728,0.00014717248,0.00016448533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034226113,0.0001409553,0.00036842126,0.00030249768,0.000079868485,0.000013347071,0.000031545642,0.000137422,0.000024236073],"category_scores_gemma":[0.00027125762,0.0000870461,0.000067723595,0.00015246373,0.000052883497,0.00015104853,0.000031597203,0.00011799833,9.825171e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007977865,0.00096760713,0.9770931,0.00042561002,0.000042118194,0.004158755,0.00009817163,7.1872194e-7,0.00082862255,0.00036730323,0.0033831445,0.0118370885],"study_design_scores_gemma":[0.026605431,0.012055007,0.8972779,0.00038762408,0.0021434801,0.04484109,0.0003647036,0.000008048089,0.0034463434,0.0009757964,0.011353629,0.0005409797],"about_ca_topic_score_codex":0.0000054826264,"about_ca_topic_score_gemma":0.000033765275,"teacher_disagreement_score":0.0798152,"about_ca_system_score_codex":0.0001821426,"about_ca_system_score_gemma":0.00021956205,"threshold_uncertainty_score":0.3549637},"labels":[],"label_agreement":null},{"id":"W2550250491","doi":"10.1097/01.ogx.0000503538.17538.ae","title":"The Investigations Required Before Referring a Patient to a Gynaecologic Oncologist","year":2016,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Toronto; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Referral; Gynecologic cancer; Gynecologic oncology; Obstetrics and gynaecology; General surgery; Gynecologic surgical procedures; Gynecology; Family medicine; Surgery; Internal medicine; Cancer; Laparoscopy; Pregnancy","score_opus":0.06320140566073679,"score_gpt":0.31129633548812696,"score_spread":0.24809492982739018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550250491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643349,0.0005829948,0.00014329475,0.026877102,0.0010490852,0.0017317014,0.000098731434,0.0002228051,0.00495936],"genre_scores_gemma":[0.9940733,0.00011470062,0.0012923145,0.0026777217,0.00007420452,0.0006738063,0.000023438542,0.000020767375,0.0010497841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703646,0.0005199526,0.00060735387,0.0006565147,0.00045454717,0.00072519376],"domain_scores_gemma":[0.987228,0.011067353,0.00015198617,0.0005720145,0.00026830277,0.00071238464],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00061431545,0.0002796773,0.0005120023,0.00009733416,0.000462288,0.00006655617,0.00026462853,0.00025975687,0.0006550033],"category_scores_gemma":[0.03452388,0.000117669864,0.00018568129,0.0010337078,0.00031161832,0.00006218222,0.00026817253,0.000221162,0.00059278484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018673582,0.0009592081,0.6080343,0.0000061820306,0.00012234677,0.00022789612,0.00006682365,0.000005303536,0.00011129287,0.0021719858,0.007886136,0.38022175],"study_design_scores_gemma":[0.001325596,0.004541922,0.924964,0.000026313139,0.000049899918,0.000009185913,0.000034116216,0.000007908546,0.000119367854,0.00078797265,0.06796605,0.0001676352],"about_ca_topic_score_codex":0.0001328635,"about_ca_topic_score_gemma":0.0008404763,"teacher_disagreement_score":0.38005412,"about_ca_system_score_codex":0.0015119937,"about_ca_system_score_gemma":0.00021316082,"threshold_uncertainty_score":0.97360873},"labels":[],"label_agreement":null},{"id":"W2554872990","doi":"10.3390/ijms17111855","title":"Bidirectional Estrogen-Like Effects of Genistein on Murine Experimental Autoimmune Ovarian Disease","year":2016,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Niagara College","funders":"National Key Research and Development Program of China; Program for New Century Excellent Talents in University; National Natural Science Foundation of China","keywords":"Genistein; Endocrinology; Internal medicine; Ovary; Estrous cycle; Estrogen; Radioimmunoassay; Biology; Medicine","score_opus":0.011044126638785401,"score_gpt":0.29637005034283825,"score_spread":0.28532592370405285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554872990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898619,0.0025669478,0.0006760377,0.005077412,0.0013302803,0.00010162867,0.000007632271,0.000006297078,0.00037183313],"genre_scores_gemma":[0.9980686,0.00010965258,0.0012564717,0.00030476635,0.00015023626,0.0000070275564,0.0000010196526,0.000006446897,0.00009581991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985069,0.000036488116,0.0002859157,0.00014909406,0.0009166437,0.000104965824],"domain_scores_gemma":[0.9992554,0.00008931168,0.00023662308,0.0000936442,0.00019709869,0.00012793137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001627789,0.00009552167,0.00016368752,0.0002131643,0.000034714372,0.000021218388,0.00021537667,0.00002014852,0.00014480311],"category_scores_gemma":[0.000082411716,0.00005710847,0.00018938008,0.00009559219,0.0001674604,0.00012301198,0.000034903172,0.000045663215,0.000006500054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016817221,0.0039300816,0.03406652,0.000031397463,0.0013034897,0.0040851445,0.00015220388,0.00016231321,0.8932113,0.024630506,0.00045504016,0.036290266],"study_design_scores_gemma":[0.004975933,0.0024917484,0.108178034,0.00093432027,0.000109288594,0.00035420887,0.000025469137,0.000036123067,0.8796712,0.00061985647,0.0024863307,0.00011745],"about_ca_topic_score_codex":0.000011192353,"about_ca_topic_score_gemma":2.442592e-7,"teacher_disagreement_score":0.074111514,"about_ca_system_score_codex":0.00015293734,"about_ca_system_score_gemma":0.0002794966,"threshold_uncertainty_score":0.23288158},"labels":[],"label_agreement":null},{"id":"W2555058267","doi":"10.1038/nrc.2016.113","title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","year":2016,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Serous carcinoma; Serous fluid; Ovary; Ovarian carcinoma; Clear cell carcinoma; Clear cell; Stromal cell; Biology; Cancer; Cancer research; Pathology; Carcinoma; Oncology; Medicine; Internal medicine","score_opus":0.045233654165997575,"score_gpt":0.41380513752910564,"score_spread":0.3685714833631081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555058267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028550066,0.99503,0.00002836421,0.00041429902,0.00079568045,0.0028757255,0.00030639287,0.00001982284,0.00052689],"genre_scores_gemma":[0.000038478272,0.99594176,0.00017019825,0.000083600506,0.0007633736,0.0021562716,0.000053729516,0.00006613732,0.0007264533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749666,0.00027245661,0.00094114715,0.0006177717,0.00031926742,0.00035268327],"domain_scores_gemma":[0.99767864,0.00024174862,0.0010241072,0.00075700117,0.00014705551,0.00015144271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049926806,0.0005851284,0.0026840162,0.000093806295,0.00013157145,0.00006163535,0.00020004288,0.0005832537,0.00019131455],"category_scores_gemma":[0.00006867904,0.00026036197,0.0007862358,0.0003959079,0.00018498191,0.00010543239,0.000056768353,0.0005375746,0.000022099328],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020685602,0.000030516901,0.00003352445,0.022168813,0.00068405946,0.000008963134,0.00001428554,4.976895e-8,7.643092e-7,0.005002616,0.0021536632,0.9698821],"study_design_scores_gemma":[0.00047600607,0.000113535825,0.00012045709,0.08390753,0.003914965,0.000027009952,0.000006050919,1.6544836e-7,0.0000030843285,0.00012549182,0.91107106,0.00023465257],"about_ca_topic_score_codex":0.00014583387,"about_ca_topic_score_gemma":0.0003080225,"teacher_disagreement_score":0.9696474,"about_ca_system_score_codex":0.0013196351,"about_ca_system_score_gemma":0.0021003466,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W2555271219","doi":"10.1016/j.gore.2016.11.005","title":"Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Adjuvant; Chemotherapy; Oncology; Stage (stratigraphy); Ovarian cancer; Internal medicine; Adjuvant chemotherapy; Cisplatin; Cancer; Breast cancer; Biology","score_opus":0.021811293834528612,"score_gpt":0.32296509435217857,"score_spread":0.30115380051764995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555271219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482664,0.0009669079,0.00010273349,0.03199906,0.0020195867,0.0014313025,0.000040732888,0.00013768421,0.015035624],"genre_scores_gemma":[0.98266655,0.0020139157,0.0015296107,0.002657705,0.0003630678,0.0007320753,0.00001802951,0.000043289725,0.009975764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971348,0.00015155089,0.0008204554,0.0008581071,0.00028727532,0.00074779784],"domain_scores_gemma":[0.9981999,0.00030483602,0.00045787127,0.00065671036,0.00013862265,0.00024207956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008353664,0.00031225153,0.00092027214,0.00020210593,0.00010162208,0.00001595122,0.00011036543,0.000440544,0.008209493],"category_scores_gemma":[0.00031874757,0.0001933788,0.00017669056,0.00028075775,0.00017758145,0.0001119401,0.00008008674,0.00024354507,0.00005973383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005595056,0.0019584058,0.7012903,0.000039439088,0.00031930258,0.02667484,0.00018219616,0.000021114876,0.010490146,0.00022127875,0.0046913372,0.2535521],"study_design_scores_gemma":[0.008286423,0.0020702991,0.7593079,0.0001308219,0.00014105772,0.00070958846,0.000048672973,0.0000063868993,0.0048060482,0.00085212593,0.22340716,0.00023347518],"about_ca_topic_score_codex":0.0012387972,"about_ca_topic_score_gemma":0.002806728,"teacher_disagreement_score":0.25331864,"about_ca_system_score_codex":0.0018267666,"about_ca_system_score_gemma":0.0016137587,"threshold_uncertainty_score":0.9926971},"labels":[],"label_agreement":null},{"id":"W2556773157","doi":"10.1016/j.ygyno.2016.11.039","title":"Of mice and women - Non-ovarian origins of “ovarian” cancer","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Scopus; Ovarian cancer; Medicine; Gynecology; Cancer; Web of science; Oncology; Internal medicine; Cancer research; MEDLINE; Biology; Meta-analysis","score_opus":0.012250475429220746,"score_gpt":0.32566534320490953,"score_spread":0.3134148677756888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556773157","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048860084,0.0025626111,0.000047104153,0.006693464,0.9237126,0.0021826918,0.0023907789,0.000067524525,0.013483149],"genre_scores_gemma":[0.27311078,0.018393168,0.004183411,0.0007624123,0.6939461,0.0027549043,0.00035937078,0.00019507043,0.0062947255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971846,0.0001618015,0.0008613969,0.0007583809,0.0004153578,0.00061848445],"domain_scores_gemma":[0.9949025,0.0028462077,0.0009836383,0.00052056304,0.0004820317,0.00026504483],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063064316,0.00045696128,0.0022530404,0.0002577092,0.000054386754,0.000007026977,0.000243682,0.0018563255,0.0024606572],"category_scores_gemma":[0.00063898973,0.0003174173,0.00017922538,0.00020531383,0.000441159,0.0000493708,0.00018267531,0.00052011653,0.000022562816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011412712,0.0016040297,0.006754066,0.0010544744,0.002065838,0.0003193596,0.0005530719,0.0000011834333,0.00081139023,0.0013730985,0.9206319,0.06369036],"study_design_scores_gemma":[0.009054412,0.0062329364,0.013308318,0.00028757032,0.0009012477,0.000012191457,0.00007895519,0.0000018127309,0.0004295028,0.0004242321,0.96900034,0.00026849186],"about_ca_topic_score_codex":0.0011653485,"about_ca_topic_score_gemma":0.00031933424,"teacher_disagreement_score":0.22976644,"about_ca_system_score_codex":0.0036629566,"about_ca_system_score_gemma":0.004024945,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W2558822568","doi":"10.1016/j.ygyno.2016.11.019","title":"Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; Partenariat Canadien Contre Le Cancer; Cancer Research UK; Cancer Institute NSW; Cancer Focus Northern Ireland; University of Kentucky","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.08238341664024396,"score_gpt":0.37450130669773174,"score_spread":0.2921178900574878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558822568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96643245,0.0038811883,0.00007359964,0.019984407,0.0010363053,0.0007908868,0.000102086924,0.00009303233,0.0076060263],"genre_scores_gemma":[0.99142516,0.0035290904,0.0011679581,0.00095484836,0.00012680232,0.0007843612,0.000014103628,0.000023408866,0.0019742828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997813,0.00024949992,0.0006161718,0.000624255,0.00020711595,0.00048997113],"domain_scores_gemma":[0.9963841,0.0024794159,0.0004143566,0.0003645186,0.00008795366,0.000269663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035767112,0.00027983336,0.0012418163,0.000119841316,0.00011275801,0.0000057431744,0.00013374444,0.0003641692,0.006600555],"category_scores_gemma":[0.00039915106,0.00016688638,0.00014437451,0.00016812782,0.0005071971,0.00005401467,0.00021313083,0.00016188005,0.000046337107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042707252,0.0012888775,0.8307424,0.00004990698,0.00022333361,0.0001759973,0.000107237305,0.0000014058344,0.0009055282,0.0023859644,0.005191292,0.15850098],"study_design_scores_gemma":[0.0053383275,0.003785186,0.7310376,0.00006079088,0.00030569982,0.000016606908,0.00008537323,0.0000078174035,0.0011333023,0.00020409685,0.25785285,0.00017230982],"about_ca_topic_score_codex":0.0005302729,"about_ca_topic_score_gemma":0.0054968833,"teacher_disagreement_score":0.25266156,"about_ca_system_score_codex":0.0015768491,"about_ca_system_score_gemma":0.00021379864,"threshold_uncertainty_score":0.9943075},"labels":[],"label_agreement":null},{"id":"W2560073692","doi":"10.1080/21678707.2017.1264300","title":"Rare tumors in gynaecological cancers and the lack of therapeutic options and clinical trials","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Orphan Drugs","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Biobank; Clinical trial; Intensive care medicine; Expert opinion; Incidence (geometry); Cancer; Pathology; Internal medicine; Bioinformatics","score_opus":0.15673021908089185,"score_gpt":0.4498017616627763,"score_spread":0.29307154258188445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560073692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85954833,0.02825053,0.000036301728,0.106239125,0.0012776484,0.0024034227,0.000051316132,0.000046827154,0.0021464678],"genre_scores_gemma":[0.9630728,0.034750294,0.00008027924,0.0016508813,0.0001921666,0.00014330551,0.0000032454436,0.000009995937,0.00009705844],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983847,0.0005284213,0.00053552137,0.0002672368,0.00014522646,0.00013885948],"domain_scores_gemma":[0.9971124,0.0024082523,0.00014906777,0.00020446374,0.000028144264,0.00009767206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013569682,0.0001227747,0.0006030479,0.000057169455,0.000040743038,0.000009135162,0.000050358183,0.0000851324,0.00033585235],"category_scores_gemma":[0.00039357864,0.000052539533,0.00011735248,0.0000785516,0.00035440986,0.00003232544,0.000030173609,0.00008600663,0.000005747122],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005497708,0.0012045075,0.16777112,0.00003635671,0.0005071778,0.000025483001,0.0028423895,0.000002209704,0.00017090661,0.035659336,0.0073709497,0.7789119],"study_design_scores_gemma":[0.05692434,0.0025280414,0.8971023,0.0008322202,0.000062560466,0.000021457821,0.0011796335,0.00007728237,0.0011357397,0.0017351164,0.03814336,0.0002579447],"about_ca_topic_score_codex":0.00009944119,"about_ca_topic_score_gemma":0.000012654296,"teacher_disagreement_score":0.7786539,"about_ca_system_score_codex":0.000111901856,"about_ca_system_score_gemma":0.0001058048,"threshold_uncertainty_score":0.36773476},"labels":[],"label_agreement":null},{"id":"W2560636362","doi":"10.1016/j.ygyno.2016.10.019","title":"The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; Partenariat Canadien Contre Le Cancer; Swiss Cancer Research Foundation; Swiss Re; National Cancer Institute; Cancer Research UK; Cancer Institute NSW; Cancer Focus Northern Ireland; University of Kentucky","keywords":"Medicine; Histology; Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.04423721256409234,"score_gpt":0.35947431701505994,"score_spread":0.3152371044509676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560636362","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2681374,0.002917022,0.021055564,0.6889674,0.0067520034,0.0032699322,0.0019061702,0.000110741006,0.0068838075],"genre_scores_gemma":[0.99442476,0.0018904778,0.0010938952,0.00033317393,0.00017250607,0.0014430566,0.00007242096,0.000007646288,0.0005620749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909115,0.00006859496,0.00031990363,0.00024372418,0.00005467423,0.0002219766],"domain_scores_gemma":[0.99686867,0.0023662404,0.00022778127,0.00019978646,0.00026186812,0.000075665484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026951593,0.00010076164,0.00033848695,0.000032530777,0.00015423176,0.0000053611166,0.00011472412,0.000118762786,0.00012300009],"category_scores_gemma":[0.0005885862,0.000055053784,0.000074222,0.00006695151,0.00033365245,0.000026160162,0.00005547271,0.000060598704,0.0000037884458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031287785,0.0003260224,0.53373384,0.000009022198,0.00025190966,0.0000025762179,0.000018216402,0.0000010490727,0.00047448426,0.05972844,0.02454365,0.3805979],"study_design_scores_gemma":[0.0021980193,0.00058261276,0.5597619,0.000008846484,0.00011188902,0.000010885333,0.000024681458,0.00001428411,0.00008473949,0.0014460734,0.43571532,0.000040761595],"about_ca_topic_score_codex":0.00011602004,"about_ca_topic_score_gemma":0.0017308148,"teacher_disagreement_score":0.72628736,"about_ca_system_score_codex":0.0006925465,"about_ca_system_score_gemma":0.00031980046,"threshold_uncertainty_score":0.22450282},"labels":[],"label_agreement":null},{"id":"W2560683138","doi":"10.1016/j.jogc.2016.10.006","title":"Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up","year":2016,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University Health Network; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Hazard ratio; Ovarian cancer; Stage (stratigraphy); Internal medicine; Oncology; Cystadenocarcinoma; Cancer; Histology; Proportional hazards model; Carcinoma; Gynecology; Confidence interval","score_opus":0.014224589716797569,"score_gpt":0.23094152082609906,"score_spread":0.21671693110930149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560683138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905355,0.0034653642,0.0000038190465,0.0014621945,0.0040568467,0.00023898167,0.000080589554,0.0000010134625,0.00015567247],"genre_scores_gemma":[0.99896866,0.000057445515,0.00017982577,0.00038216775,0.00001980603,0.000008942143,5.178784e-7,0.0000117139725,0.0003709336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868685,0.000047467027,0.00053959986,0.0001293831,0.00039271323,0.00020398751],"domain_scores_gemma":[0.99704033,0.0017401287,0.0004050484,0.0002463017,0.00036059067,0.00020758547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014272591,0.00012469037,0.00064746325,0.00028712084,0.000026424976,0.0000044170074,0.00014228384,0.0000697299,0.00045451114],"category_scores_gemma":[0.0016651554,0.00006929486,0.00015716771,0.0004529745,0.000063605214,0.000029915735,0.00006551565,0.000101570375,7.2871615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054214102,0.00009648396,0.96358466,0.0000273768,0.00023538979,0.0006133845,0.0000830944,0.0000014905396,0.00003741962,0.000020096913,0.002092774,0.03315362],"study_design_scores_gemma":[0.006413858,0.0006931956,0.9840426,0.000021009066,0.00024958304,0.00003938275,0.00007093033,8.2552333e-7,0.0007091228,0.000017052444,0.0076750997,0.000067347006],"about_ca_topic_score_codex":0.011750595,"about_ca_topic_score_gemma":0.0139058,"teacher_disagreement_score":0.03308627,"about_ca_system_score_codex":0.0007364839,"about_ca_system_score_gemma":0.0013087193,"threshold_uncertainty_score":0.99483025},"labels":[],"label_agreement":null},{"id":"W2560763414","doi":"10.1016/j.jogc.2016.09.075","title":"Care Delivery Patterns, Processes, and Outcomes for Primary Ovarian Cancer Surgery: A Population-Based Review Using a National Administrative Database","year":2016,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; National database; Ovarian cancer; Primary care; Cancer; Population; Database; Gynecology; Family medicine; Internal medicine; Environmental health","score_opus":0.0702909388409048,"score_gpt":0.3560852280830086,"score_spread":0.28579428924210376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560763414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025284314,0.99302477,0.000017587598,0.00057321,0.0017828948,0.00092800945,0.0034071875,0.000002134453,0.000011337469],"genre_scores_gemma":[0.002541867,0.99513054,0.0004681154,0.001181884,0.00007993689,0.000109394496,0.00044535327,0.000030252966,0.0000126773575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811697,0.00008310084,0.00090202614,0.00028049975,0.00040465486,0.0002127403],"domain_scores_gemma":[0.99105227,0.006223968,0.0013069522,0.00011888019,0.0010671066,0.0002308032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025108844,0.0003149551,0.0020604518,0.00029652944,0.00010503953,0.000021817987,0.000069740956,0.00015118897,0.00012448651],"category_scores_gemma":[0.002656974,0.00020224566,0.00021901782,0.0002515863,0.000025156478,0.00007436248,0.000024014149,0.0001943194,5.6658095e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000058089267,0.00006777058,0.12395642,0.09576049,0.000791867,0.0006085525,0.000005249841,3.2125197e-7,5.0122697e-9,0.000009890813,0.0013065375,0.7774871],"study_design_scores_gemma":[0.00304467,0.0002679836,0.070604175,0.049356177,0.007007484,0.00019949573,0.000028130919,0.000003118711,2.1320584e-7,0.000007371355,0.86900187,0.00047932388],"about_ca_topic_score_codex":0.007904702,"about_ca_topic_score_gemma":0.01627488,"teacher_disagreement_score":0.86769533,"about_ca_system_score_codex":0.003840392,"about_ca_system_score_gemma":0.034389213,"threshold_uncertainty_score":0.99998367},"labels":[],"label_agreement":null},{"id":"W2560862072","doi":"10.1093/annonc/mdw663","title":"Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Eisai; Clovis Oncology; F. Hoffmann-La Roche; Eisai Canada; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Gynecologic cancer; Cancer; Ovarian cancer; Gynecology; Oncology; Disease; Internal medicine","score_opus":0.14624053974814977,"score_gpt":0.40663889857462115,"score_spread":0.2603983588264714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560862072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80298865,0.0039539803,0.00001142567,0.18875766,0.0010774313,0.00056550355,0.00037790692,0.000014624851,0.0022528027],"genre_scores_gemma":[0.9917838,0.005217985,0.000052588508,0.002058615,0.000106201296,0.00022066338,0.0000027189396,0.000010397401,0.00054702285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988289,0.00012580222,0.0003737276,0.00025873986,0.00016280978,0.00025001625],"domain_scores_gemma":[0.99839866,0.00033073063,0.0003458937,0.00036502612,0.00039872917,0.00016097858],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015559333,0.00014351441,0.00047347095,0.000049970586,0.000033143773,0.0000025735603,0.00015177506,0.00009301405,0.0018240223],"category_scores_gemma":[0.0002474369,0.000071011134,0.00017598677,0.0001165801,0.00036773112,0.000021690073,0.00008757106,0.0000869536,0.0000075108405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017001935,0.0018374851,0.31942332,0.00018222751,0.0006954136,0.00007432808,0.00043060238,0.000006063112,0.0017985954,0.0063589825,0.034000415,0.6334924],"study_design_scores_gemma":[0.0037109072,0.0022384687,0.82522744,0.000909542,0.00035534764,0.000006792064,0.000046316036,0.00001608782,0.0073583354,0.0013514714,0.15864806,0.00013123485],"about_ca_topic_score_codex":0.0006191766,"about_ca_topic_score_gemma":0.00092596136,"teacher_disagreement_score":0.63336116,"about_ca_system_score_codex":0.00015139962,"about_ca_system_score_gemma":0.0012157355,"threshold_uncertainty_score":0.99908847},"labels":[],"label_agreement":null},{"id":"W2560928882","doi":"10.1093/annonc/mdw662","title":"Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Eisai Canada; Cancer Research UK; F. Hoffmann-La Roche; Pfizer","keywords":"Medicine; Ovarian cancer; Clinical trial; Oncology; Germ cell tumors; Serous fluid; Randomized controlled trial; Internal medicine; Consensus conference; Gynecology; Cancer; Chemotherapy","score_opus":0.35440996851121664,"score_gpt":0.47570331080435985,"score_spread":0.1212933422931432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560928882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75431657,0.0017548178,0.0015392259,0.22889368,0.0052543627,0.005316892,0.00075768825,0.000044695527,0.002122074],"genre_scores_gemma":[0.9921562,0.0018274729,0.0013117582,0.0027084053,0.0005158817,0.00087875954,0.0000046716605,0.000024092125,0.0005727752],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974647,0.00048475334,0.0009928079,0.00044881945,0.00019806196,0.00041085505],"domain_scores_gemma":[0.9950665,0.0027790638,0.00081536075,0.00047809852,0.0006943233,0.00016664062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010761725,0.0002274641,0.0010818528,0.00007203108,0.000066067354,0.0000063904995,0.00027663112,0.0003335284,0.001008824],"category_scores_gemma":[0.0012389737,0.00012074111,0.00044085216,0.0001454611,0.0005664675,0.000035482695,0.00008879734,0.00016410097,0.0000046208424],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13359052,0.0055748234,0.08949239,0.00023275333,0.002811516,0.00010366025,0.0007102401,0.000031992266,0.0016745506,0.013327729,0.122578956,0.6298709],"study_design_scores_gemma":[0.25671884,0.062758006,0.42587608,0.0017830362,0.0021867682,0.00005298686,0.0002826326,0.00014524,0.025244338,0.007386262,0.21691635,0.0006494488],"about_ca_topic_score_codex":0.00054599013,"about_ca_topic_score_gemma":0.00071843265,"teacher_disagreement_score":0.62922144,"about_ca_system_score_codex":0.00015926272,"about_ca_system_score_gemma":0.0025947832,"threshold_uncertainty_score":0.9999044},"labels":[],"label_agreement":null},{"id":"W2561042881","doi":"10.1016/j.ygyno.2016.11.046","title":"Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?","year":2016,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Disease; Stage (stratigraphy); Internal medicine; Ovarian cancer; Neoadjuvant therapy; Gynecology; Cancer; Breast cancer","score_opus":0.03723581706763498,"score_gpt":0.34770176101994227,"score_spread":0.3104659439523073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561042881","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007636737,0.0030756115,0.0002462217,0.9860922,0.0025978722,0.0033692906,0.0012379554,0.00010913724,0.0025080366],"genre_scores_gemma":[0.0027395296,0.019292004,0.002802242,0.9483571,0.0051186606,0.006846936,0.00054549443,0.00012255949,0.014175438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731624,0.00020406331,0.0005613259,0.0009274648,0.00018416363,0.0008067341],"domain_scores_gemma":[0.9958902,0.0024141956,0.0006703848,0.0006937093,0.00020680027,0.00012473558],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037424054,0.0005399185,0.0012670243,0.0001404597,0.00036870438,0.000034799887,0.00027183298,0.001200315,0.0026797561],"category_scores_gemma":[0.000192974,0.00030182008,0.00028565974,0.00013299366,0.00030405403,0.00006294392,0.000086376414,0.0009672851,0.000038784176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016552913,0.00014228687,0.0015939426,0.00012541623,0.0005259084,0.00022721024,0.00010143907,8.9503766e-7,0.000025002679,0.00012192839,0.67399347,0.32297698],"study_design_scores_gemma":[0.008428203,0.0021756424,0.0046031377,0.00024112433,0.00057845155,0.00007771201,0.00016878531,0.000014676227,0.000078330275,0.00065100833,0.98264146,0.0003414772],"about_ca_topic_score_codex":0.00009880294,"about_ca_topic_score_gemma":0.00045453446,"teacher_disagreement_score":0.3226355,"about_ca_system_score_codex":0.0013365246,"about_ca_system_score_gemma":0.0006637354,"threshold_uncertainty_score":0.9999434},"labels":[],"label_agreement":null},{"id":"W2561451097","doi":"10.1158/1538-7445.am2015-605","title":"Abstract 605: The clinical outcome of patients with FOXL2 402C-&amp;gt;G mutation positive adult-type Granulosa Cell Tumor of the ovary - a population based study with analysis of tissue and plasma ctDNA","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Population; Medicine; Internal medicine; Pathology; Ovary; Histopathology; Oncology","score_opus":0.1027224151146792,"score_gpt":0.43939191514479875,"score_spread":0.33666950003011953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561451097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977145,0.00009628437,0.0000064425326,0.00037756196,0.000037753554,0.001533312,0.00014568318,0.0000035742341,0.00008487801],"genre_scores_gemma":[0.99961305,0.000009547174,0.0001212197,0.000033550154,0.00002229373,0.000080828875,0.000078171666,0.000015102761,0.000026251544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787605,0.00027638688,0.0004452333,0.000263914,0.0009794843,0.0001589451],"domain_scores_gemma":[0.9974336,0.0004242568,0.0003067756,0.00041880968,0.0013179659,0.00009857965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074693956,0.00011470305,0.00044865056,0.00018265762,0.00006052738,0.000009313149,0.00010367717,0.000039272483,0.00004254898],"category_scores_gemma":[0.00015080319,0.000055118075,0.00006364906,0.0010014743,0.00018566947,0.000050821785,0.000036620786,0.00020124053,7.563324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038431424,0.0013824361,0.9914561,0.00009244782,0.0007053926,0.0000072897715,0.0007453209,0.00034647292,0.00003603575,0.0000065911127,0.000045669825,0.0013331086],"study_design_scores_gemma":[0.0051560313,0.0030680902,0.9884381,0.0001482942,0.0012480734,3.3916496e-7,0.0004458666,0.00010409578,0.0013211002,0.0000058679443,0.000009182738,0.00005494282],"about_ca_topic_score_codex":0.0050160014,"about_ca_topic_score_gemma":0.0032947634,"teacher_disagreement_score":0.0030179764,"about_ca_system_score_codex":0.00013796143,"about_ca_system_score_gemma":0.00031687293,"threshold_uncertainty_score":0.7582727},"labels":[],"label_agreement":null},{"id":"W2562511882","doi":"10.3747/co.23.3243","title":"Effect of Chemotherapy on Health-Related Quality of Life among Early-Stage Ovarian Cancer Survivors: A Study from the Population-Based Profiles Registry","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Quality of life (healthcare); Cancer registry; Cancer; Internal medicine; Chemotherapy; Population; Oncology; Adjuvant; Adjuvant chemotherapy; Breast cancer","score_opus":0.08041931551570465,"score_gpt":0.42379602756149526,"score_spread":0.3433767120457906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562511882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859465,0.0011123101,0.000017657163,0.007313789,0.00061999884,0.0020063126,0.00026781182,0.00002673913,0.00004075062],"genre_scores_gemma":[0.9990686,0.00017899403,0.000013026854,0.00012944579,0.00013775645,0.00036495383,0.000052514864,0.00002042307,0.00003427205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997324,0.0011062025,0.00073326385,0.0003466518,0.0002899518,0.00019996749],"domain_scores_gemma":[0.9965349,0.0018900608,0.00082228763,0.0005477075,0.00008848401,0.00011660155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009544341,0.00019064081,0.0008703308,0.000052892658,0.00005328709,0.000003842222,0.00012038952,0.000107912594,0.00035433815],"category_scores_gemma":[0.00029235228,0.00009662688,0.00013773059,0.00015786536,0.00012374696,0.000024032744,0.000017979508,0.0001539836,0.0000038172807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019258938,0.0020915624,0.92410004,0.00015202996,0.00032077119,0.0000021629708,0.0005112937,0.0000046906516,0.00003977414,0.00007848769,0.00027485445,0.07049843],"study_design_scores_gemma":[0.012009325,0.004906201,0.98099136,0.0005467327,0.00010987327,8.856639e-8,0.000060484068,0.0000106866355,0.00077200256,0.00002000327,0.0004918302,0.000081412596],"about_ca_topic_score_codex":0.065170355,"about_ca_topic_score_gemma":0.006374268,"teacher_disagreement_score":0.07041702,"about_ca_system_score_codex":0.00042707234,"about_ca_system_score_gemma":0.000455069,"threshold_uncertainty_score":0.94105476},"labels":[],"label_agreement":null},{"id":"W2563017322","doi":"10.1158/1557-3265.ovcasymp14-as18","title":"Abstract AS18: The somatic mutational landscape of endometriosis associated ovarian cancers and precursor lesions","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Université de Montréal; BC Cancer Agency; University of British Columbia","funders":"","keywords":"ARID1A; Biology; Endometriosis; Somatic cell; Cancer research; Mutation; Somatic evolution in cancer; Ovarian cancer; Genetics; Gene; Cancer; Pathology; Medicine","score_opus":0.34112812295943756,"score_gpt":0.5212013930610312,"score_spread":0.18007327010159363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563017322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97127134,0.005140775,0.0000037013526,0.015636606,0.00029153065,0.000883289,0.00013938005,0.00002142065,0.006611935],"genre_scores_gemma":[0.9967319,0.0019651656,0.00012069726,0.00021990227,0.00026312267,0.00028950916,0.000024863622,0.00001920086,0.00036563183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975247,0.00030511583,0.00054485246,0.00032817313,0.00095974177,0.00033746194],"domain_scores_gemma":[0.9938163,0.0046651782,0.00015526621,0.00031561838,0.00066063757,0.0003869937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032477973,0.00011547296,0.00041904312,0.00015629276,0.00012878007,0.000035602185,0.00014828486,0.00013238766,0.00048487567],"category_scores_gemma":[0.0054736077,0.00007236745,0.00012446559,0.0006840842,0.00040526694,0.00005818889,0.00008522703,0.0005284729,0.000026792188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011934167,0.0014547785,0.8552476,0.00018720714,0.0013226264,0.00007872116,0.0010044005,0.00007331462,0.00005400678,0.0007818973,0.05822134,0.080380686],"study_design_scores_gemma":[0.0059358226,0.0008758757,0.98627716,0.0003566362,0.00017602126,0.000005560577,0.00049289863,0.00019406964,0.00019727893,0.0009759831,0.004423245,0.00008945249],"about_ca_topic_score_codex":0.0018947239,"about_ca_topic_score_gemma":0.0006995353,"teacher_disagreement_score":0.13102955,"about_ca_system_score_codex":0.00037982184,"about_ca_system_score_gemma":0.0021116952,"threshold_uncertainty_score":0.6552815},"labels":[],"label_agreement":null},{"id":"W2563713980","doi":"10.1111/his.13080","title":"The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century","year":2016,"lang":"en","type":"review","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Vulva; Gynaecological cancer; Cancer; Cervix; Surgical pathology; Clinical Practice; Pathology; Molecular pathology; Ovarian cancer; Ovary; General surgery; Gynecology; Biology; Internal medicine; Family medicine","score_opus":0.058153871949670706,"score_gpt":0.3846295813767765,"score_spread":0.3264757094271058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563713980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013762183,0.9812599,0.000017246271,0.012075023,0.00076498423,0.002529371,0.00032548545,0.00002428276,0.0029899525],"genre_scores_gemma":[0.0004629563,0.9710006,0.00019575976,0.00081807916,0.00037652242,0.026897533,0.000073515774,0.00003490534,0.00014009165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974153,0.00057293667,0.00076697546,0.0005746933,0.00014761234,0.00052250066],"domain_scores_gemma":[0.9927416,0.0056106322,0.0006751962,0.00076210994,0.00014464167,0.00006583686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011959899,0.00034639167,0.001392557,0.00019404791,0.000255282,0.000013697935,0.0004127242,0.00041267648,0.00011858841],"category_scores_gemma":[0.0013129484,0.00014779634,0.0005307176,0.0003458001,0.00030308648,0.000034911765,0.00009362247,0.00037413024,0.000017926875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038812716,0.0005468687,0.0010102958,0.0009456342,0.00003113724,0.0001171629,0.00030955582,5.8538973e-8,2.8846205e-7,0.014842184,0.003258725,0.9788993],"study_design_scores_gemma":[0.00069859286,0.00042410896,0.009800835,0.0013251777,0.0013995633,0.00058218575,0.00019907259,1.2263226e-7,1.4941274e-7,0.00013533935,0.9852809,0.00015399615],"about_ca_topic_score_codex":0.000008691579,"about_ca_topic_score_gemma":0.000027110242,"teacher_disagreement_score":0.9820221,"about_ca_system_score_codex":0.0005722285,"about_ca_system_score_gemma":0.00041130776,"threshold_uncertainty_score":0.602696},"labels":[],"label_agreement":null},{"id":"W2564624504","doi":"10.1158/1557-3265.ovcasymp14-poster-biol-1312","title":"Abstract POSTER-BIOL-1312: The role of BRCA and CEBPD in serous ovarian cancer carcinogenesis","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Cancer research; Carcinogenesis; Fallopian tube; Tissue microarray; Ovarian carcinoma; Serous fluid; Serous carcinoma; Biology; Medicine; Cancer; Pathology; Immunohistochemistry; Internal medicine; Gynecology","score_opus":0.2830037735646006,"score_gpt":0.5131848304737923,"score_spread":0.23018105690919166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564624504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960046,0.021326141,2.6693021e-7,0.013230538,0.00022402103,0.0007782887,0.00007666685,0.000011897054,0.004306209],"genre_scores_gemma":[0.9924335,0.006080113,0.000032612435,0.00036323201,0.0005138886,0.00036396465,0.000006448505,0.000029437311,0.00017679922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739856,0.00028816925,0.000623033,0.0005023244,0.0006961843,0.00049175473],"domain_scores_gemma":[0.9976621,0.0007988131,0.00010344766,0.0005530065,0.00046431425,0.00041831404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002539274,0.00015808582,0.0005220327,0.00012977289,0.00007219154,0.000032246277,0.00021576232,0.00017771628,0.0003881278],"category_scores_gemma":[0.0003571861,0.000101193626,0.00011188288,0.00046325685,0.00045505882,0.00006039133,0.0001794958,0.0006275708,0.000020090978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009918307,0.00045309565,0.86318886,0.00007174792,0.00012927967,0.000060040475,0.0004759116,0.000007628655,0.00028341444,0.0001264797,0.0014719155,0.1327398],"study_design_scores_gemma":[0.003951745,0.0006532707,0.97736275,0.00030095343,0.000072024384,0.000007238829,0.00058836804,0.000034569144,0.0029369548,0.0004901114,0.013494986,0.000107027954],"about_ca_topic_score_codex":0.026173308,"about_ca_topic_score_gemma":0.0058883466,"teacher_disagreement_score":0.13263278,"about_ca_system_score_codex":0.00035992597,"about_ca_system_score_gemma":0.0013909717,"threshold_uncertainty_score":0.9803115},"labels":[],"label_agreement":null},{"id":"W2565574808","doi":"10.1038/bjc.2016.400","title":"Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; University of Calgary; University of Alberta; Canadian Centre for Applied Research in Cancer Control; The King's University; Alberta Health Services","funders":"National Cancer Institute; WorkSafe Victoria","keywords":"Medicine; Odds ratio; Gynecology; Case-control study; Obstetrics; Ovarian cancer; Pregnancy; Population; Tubal ligation; Confidence interval; Family planning; Cancer; Internal medicine; Environmental health","score_opus":0.012046660517742693,"score_gpt":0.2637765782554249,"score_spread":0.2517299177376822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565574808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95726955,0.011907314,0.00007471425,0.028748209,0.00075339316,0.000381823,0.00078693836,0.000012356267,0.000065702916],"genre_scores_gemma":[0.95992863,0.03699928,0.00014863261,0.0012294427,0.00088018284,0.000056925117,8.7060727e-7,0.000029204617,0.0007268458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988072,0.00006109849,0.00037489494,0.00018286226,0.0003156176,0.00025833986],"domain_scores_gemma":[0.9987953,0.00013115766,0.00039440562,0.00013628205,0.00034483473,0.00019806842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024799898,0.00015406366,0.00042351545,0.000047697995,0.00018837852,0.00010043762,0.00009407139,0.00007134318,0.0008103352],"category_scores_gemma":[0.00011146758,0.00008727996,0.00015537582,0.00009934569,0.00020319615,0.00024484037,0.000028160195,0.00023215057,0.0000036727429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006726408,0.00014085273,0.5209038,0.000017102719,0.00075603387,0.00042901927,0.00025809518,0.000004196904,0.000039953782,0.00008768462,0.007486257,0.46920434],"study_design_scores_gemma":[0.010213791,0.00060303113,0.84804565,0.0014040454,0.00055097125,0.00051310606,0.00004648098,0.0000068797845,0.00029167507,0.00021780924,0.13800934,0.00009718787],"about_ca_topic_score_codex":0.007837997,"about_ca_topic_score_gemma":0.025238955,"teacher_disagreement_score":0.46910715,"about_ca_system_score_codex":0.00027371914,"about_ca_system_score_gemma":0.000259357,"threshold_uncertainty_score":0.99876887},"labels":[],"label_agreement":null},{"id":"W2565634272","doi":"10.1158/1538-7445.am2015-4246","title":"Abstract 4246: Comparison of pathology versus IHC-based ovarian carcinoma histology assignment using gene expression, DNA methylation, and clinical outcome data","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Serous fluid; Histology; Clear cell; DNA methylation; Medicine; Hematopathology; Pathology; Not Otherwise Specified; Immunohistochemistry; Methylation; Oncology; Carcinoma; Exact test; CDKN2A; Clear cell carcinoma; Cancer; Internal medicine; Biology; Gene; Gene expression; Genetics; Cytogenetics","score_opus":0.6418373939969689,"score_gpt":0.5769529930669741,"score_spread":0.06488440092999481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565634272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907998,0.004445549,0.00063492253,0.0024492827,0.0007068622,0.00058098655,0.00012056951,0.000016114196,0.00024593595],"genre_scores_gemma":[0.99549615,0.00010157563,0.0037922536,0.00007390882,0.0002856282,0.00005868593,0.00013906974,0.000027116628,0.00002558887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970577,0.00043880288,0.000753603,0.00067654025,0.0006647546,0.00040861347],"domain_scores_gemma":[0.9971192,0.000716261,0.00021850264,0.0010655584,0.00046637488,0.00041409943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022752383,0.00016309472,0.0006819874,0.00020081617,0.000106338586,0.00001753559,0.0002648777,0.00021526817,0.00020430873],"category_scores_gemma":[0.00063119736,0.00013484435,0.000060109032,0.00021294066,0.00043643697,0.00008228519,0.00027719617,0.0004544861,0.000008248495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021984663,0.000782017,0.97379786,0.000107335065,0.0001526394,0.00022382475,0.00023335895,0.00008988038,0.010469709,0.00007283831,0.0043378407,0.0075342115],"study_design_scores_gemma":[0.022109257,0.002247819,0.9131618,0.00016969419,0.00045384487,0.000021988373,0.0005017747,0.002197491,0.04985877,0.0001202536,0.0088672815,0.00029003338],"about_ca_topic_score_codex":0.0012374667,"about_ca_topic_score_gemma":0.00019862603,"teacher_disagreement_score":0.06063609,"about_ca_system_score_codex":0.0006914603,"about_ca_system_score_gemma":0.0013737708,"threshold_uncertainty_score":0.54987925},"labels":[],"label_agreement":null},{"id":"W2565911184","doi":"10.1158/1538-7445.am2015-2080","title":"Abstract 2080: Differential transcription profile of epithelia in fimbria versus the ampulla of the fallopian tube","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fallopian tube; Biology; Oviduct; Ampulla; Andrology; Transcriptome; Serous carcinoma; Serous fluid; Fimbria; Ovarian cancer; Pathology; Endocrinology; Gene expression; Gene; Genetics; Medicine; Anatomy; Cancer","score_opus":0.15886252703050416,"score_gpt":0.4115752757942397,"score_spread":0.2527127487637355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565911184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894448,0.0010268159,0.0000013698703,0.004877132,0.00045656526,0.00084403256,0.0000633492,0.000004819662,0.003281116],"genre_scores_gemma":[0.9986755,0.00033290815,0.000012072411,0.000018652203,0.00015785953,0.00022147562,0.000007504879,0.000013826544,0.00056017283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985019,0.00012877406,0.00024188633,0.00018532306,0.00068540656,0.00025670757],"domain_scores_gemma":[0.99909467,0.00011758824,0.0000561021,0.00040039665,0.0002452446,0.00008601892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987303,0.00008896699,0.00021457512,0.00007872144,0.000043935037,0.000010966638,0.00020292867,0.00006326392,0.0006104676],"category_scores_gemma":[0.00008617353,0.00004686325,0.00009413611,0.0003516895,0.00023095941,0.000034403096,0.0000427083,0.00030537124,0.000010949431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024022141,0.0048031355,0.3952065,0.0020869873,0.0014710503,0.00008548762,0.019470591,0.00031618972,0.33803344,0.0070772525,0.06468011,0.14274712],"study_design_scores_gemma":[0.0073371227,0.00048563146,0.8914347,0.0004943644,0.00006565947,0.000001455396,0.0006980346,0.00005341563,0.092989765,0.00015343135,0.006213982,0.000072398005],"about_ca_topic_score_codex":0.004805906,"about_ca_topic_score_gemma":0.0019507251,"teacher_disagreement_score":0.49622825,"about_ca_system_score_codex":0.00030798762,"about_ca_system_score_gemma":0.00059370056,"threshold_uncertainty_score":0.72651243},"labels":[],"label_agreement":null},{"id":"W2566120061","doi":"10.1016/j.ygyno.2016.12.017","title":"Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Osler Library of the History of Medicine, McGill University; McGill University","keywords":"Medicine; Chemotherapy; Oncology; Ovarian cancer; Outcome (game theory); Internal medicine; Cancer; Gynecology","score_opus":0.0735478139779941,"score_gpt":0.44395206691797207,"score_spread":0.370404252939978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566120061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88767254,0.0009789008,0.0017631141,0.09796489,0.0030478775,0.0026667877,0.00014981354,0.00011194949,0.0056441333],"genre_scores_gemma":[0.97686064,0.001927564,0.013450863,0.004779489,0.00033097027,0.0008413061,0.000007666443,0.000026101607,0.0017754248],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982773,0.0000790157,0.0007465562,0.00043061163,0.00010433529,0.0003621487],"domain_scores_gemma":[0.9973729,0.0016141107,0.0003450318,0.00034661088,0.0001674665,0.00015383803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048692987,0.00017664763,0.00096556376,0.00006134944,0.000041183142,0.0000021542544,0.000117531155,0.00031022436,0.0018112928],"category_scores_gemma":[0.00047551337,0.000098794735,0.0003008411,0.00008855104,0.00019421516,0.00003679013,0.000033811873,0.00009415153,0.000030739902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071725214,0.00090399676,0.40449357,0.000028132248,0.00020800969,0.000023804798,0.000022334589,0.0000010848956,0.0008048098,0.0010516031,0.0025265927,0.5892188],"study_design_scores_gemma":[0.024749968,0.008021639,0.6565363,0.000057802892,0.0002415853,0.000012278745,0.000029471115,0.000008290449,0.0018004754,0.0009996494,0.30740085,0.00014169804],"about_ca_topic_score_codex":0.000029959703,"about_ca_topic_score_gemma":0.00012638477,"teacher_disagreement_score":0.5890771,"about_ca_system_score_codex":0.00047015157,"about_ca_system_score_gemma":0.00040208627,"threshold_uncertainty_score":0.99910116},"labels":[],"label_agreement":null},{"id":"W2566926207","doi":"10.1007/s10552-016-0841-3","title":"Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Foothills Medical Centre; University of Calgary","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; Minnesota Ovarian Cancer Alliance; American Cancer Society; Cancer Research UK; National Health and Medical Research Council; Medical Research Council; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Fred C. and Katherine B. Andersen Foundation; Kræftens Bekæmpelse; Mayo Foundation for Medical Education and Research","keywords":"Ovarian cancer; Medicine; Epidemiology; Oncology; Internal medicine; Hematology; Cancer; Gynecology","score_opus":0.01862811536132654,"score_gpt":0.3064411274749739,"score_spread":0.28781301211364735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566926207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363404,0.021364998,0.00002979214,0.033628337,0.0013667655,0.0031479932,0.0029622056,0.00006155661,0.0010979853],"genre_scores_gemma":[0.97386664,0.009312586,0.000017727307,0.001821115,0.0006476571,0.013338112,0.000052941094,0.00004645714,0.0008967804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967137,0.00023724894,0.00079076557,0.0007518371,0.0008227488,0.000683724],"domain_scores_gemma":[0.9964415,0.00042697936,0.0012063856,0.0013264532,0.00037161508,0.00022710292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051494886,0.00046804728,0.001356094,0.00027939468,0.00040041548,0.00012968788,0.00040785884,0.00025751776,0.0018557748],"category_scores_gemma":[0.00026091796,0.00032877526,0.0005602152,0.00050296594,0.0001573428,0.0002042472,0.00007077678,0.00026920257,0.000008889885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059281074,0.00062677515,0.97227174,0.000078325946,0.016802646,0.00009408076,0.0012184011,0.0005271037,0.00013171248,0.000120498655,0.0041531404,0.003382745],"study_design_scores_gemma":[0.012497706,0.00023584071,0.9515555,0.00038601382,0.025045346,0.000002274527,0.000104932944,0.00032371894,0.0015402301,0.000017863274,0.008013984,0.00027657172],"about_ca_topic_score_codex":0.059353884,"about_ca_topic_score_gemma":0.0915721,"teacher_disagreement_score":0.037526257,"about_ca_system_score_codex":0.004035384,"about_ca_system_score_gemma":0.00087315455,"threshold_uncertainty_score":0.99991643},"labels":[],"label_agreement":null},{"id":"W2567323329","doi":"","title":"Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Western University; University of British Columbia","funders":"","keywords":"Trametinib; MEK inhibitor; KRAS; Neuroblastoma RAS viral oncogene homolog; Selumetinib; Medicine; Cancer research; MAPK/ERK pathway; Serous fluid; Oncology; Internal medicine; Kinase; Cancer; Biology; Genetics; Colorectal cancer","score_opus":0.02480194118235795,"score_gpt":0.24111836901810035,"score_spread":0.2163164278357424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567323329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819035,0.0010231376,0.000011113636,0.008411487,0.00041302646,0.0014889425,0.00003372945,0.000043117503,0.00038508742],"genre_scores_gemma":[0.9929362,0.0010987411,0.000062139625,0.0005064787,0.00029164585,0.0045155124,0.000009674958,0.0000328202,0.00054680393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829173,0.000069392634,0.00038816847,0.00045739923,0.00024882914,0.0005444894],"domain_scores_gemma":[0.99923754,0.000107296204,0.000102698556,0.00029658485,0.00003592776,0.00021994859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016216509,0.00023438227,0.0004947358,0.00014248733,0.000020347175,0.000030217372,0.0001061963,0.00011919647,0.00013038261],"category_scores_gemma":[0.00005828489,0.00014966488,0.00009088844,0.0002596697,0.00004305588,0.00012981481,0.000038543374,0.000121780206,0.000017652264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068933814,0.003453472,0.7245561,0.00013285874,0.00013202196,0.00060998875,0.00053928915,4.4441546e-7,0.010515954,0.00005315142,0.00018174118,0.25913563],"study_design_scores_gemma":[0.012380281,0.000062929495,0.9639197,0.00026420684,0.00005358779,0.000003987707,0.000014811059,0.0000047662834,0.022541765,0.000015292324,0.00055793393,0.00018072604],"about_ca_topic_score_codex":0.0014751026,"about_ca_topic_score_gemma":0.00080309436,"teacher_disagreement_score":0.2589549,"about_ca_system_score_codex":0.0005090673,"about_ca_system_score_gemma":0.00010917569,"threshold_uncertainty_score":0.6103157},"labels":[],"label_agreement":null},{"id":"W2567395185","doi":"10.1200/jco.2016.69.9538","title":"Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Takeda Oncology; Genentech; National Cancer Institute; Onyx Pharmaceuticals; Incyte; Regeneron Pharmaceuticals; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ovarian cancer; Internal medicine; Fallopian tube; Adverse effect; Gastroenterology; Fallopian tube cancer; Response Evaluation Criteria in Solid Tumors; Population; Nausea; Phases of clinical research; Folate receptor; Oncology; Cancer; Surgery; Chemotherapy; Cancer cell","score_opus":0.08803792109366386,"score_gpt":0.47507233083841643,"score_spread":0.38703440974475256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567395185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831475,0.0009521262,0.00003520773,0.008361102,0.0010426019,0.00085194677,0.00007486308,0.000008485305,0.00035894103],"genre_scores_gemma":[0.99146914,0.004810836,0.0025399383,0.000326804,0.0006725379,0.0000136947065,0.000008247813,0.00003172661,0.0001270583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950939,0.00066966907,0.002914726,0.0004606125,0.00049709785,0.00036402303],"domain_scores_gemma":[0.993843,0.0015054578,0.0033688904,0.00042093187,0.00043474376,0.00042694734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041718916,0.00030095258,0.0030185806,0.00016537601,0.0001982842,0.00003699555,0.0002370891,0.00030177555,0.00017560797],"category_scores_gemma":[0.0019315397,0.00020451903,0.00029952047,0.00012365983,0.00033539423,0.00032501615,0.00016083132,0.000994596,0.0000013508115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16197023,0.027796235,0.48426947,0.00026677488,0.0017318925,0.0043067983,0.0012457779,0.000009855173,0.017016042,0.00002953638,0.00084092905,0.30051646],"study_design_scores_gemma":[0.07905639,0.034786154,0.87533766,0.0008980281,0.00077880436,0.000106443564,0.0003261355,0.0001987863,0.0005817953,0.000025595546,0.00769026,0.00021394012],"about_ca_topic_score_codex":0.0014021442,"about_ca_topic_score_gemma":0.0020486051,"teacher_disagreement_score":0.3910682,"about_ca_system_score_codex":0.00042424133,"about_ca_system_score_gemma":0.002627015,"threshold_uncertainty_score":0.8340044},"labels":[],"label_agreement":null},{"id":"W2567860926","doi":"10.1016/j.ygyno.2016.12.002","title":"Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto; University Health Network","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; MEK inhibitor; PTEN; Oncology; Internal medicine; Selumetinib; Targeted therapy; CDKN2A; Genotype; Cancer; Cancer research; MAPK/ERK pathway; PI3K/AKT/mTOR pathway; Colorectal cancer; Biology","score_opus":0.03371571033672363,"score_gpt":0.3466888840597135,"score_spread":0.31297317372298983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567860926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818088,0.00027717045,0.000037826907,0.0075503276,0.0016663361,0.0028134568,0.00017483476,0.00007433069,0.0055969204],"genre_scores_gemma":[0.9878746,0.0005599534,0.007382736,0.00079705537,0.0003116394,0.0015956592,0.000120552206,0.00003719262,0.0013205677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859333,0.000038074417,0.00024847066,0.0005180252,0.00012855387,0.0004735251],"domain_scores_gemma":[0.9983071,0.00025654634,0.00032612946,0.00064787176,0.00027950274,0.0001828127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009538091,0.00027693436,0.00071075116,0.00005256172,0.00041535782,0.000029578503,0.00016176506,0.00023367172,0.00074618805],"category_scores_gemma":[0.00019940903,0.00017598315,0.000116150775,0.000050032595,0.00014743891,0.000080422586,0.00004824604,0.000091309565,0.00006998334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048190686,0.0039698854,0.49339578,0.000042451524,0.00088373205,0.00012724257,0.00023922721,0.000032490454,0.00019927521,0.0005344276,0.0011156021,0.49464083],"study_design_scores_gemma":[0.023535777,0.024105486,0.77331245,0.000029821127,0.00063542713,0.000005256631,0.000030595787,0.000019115387,0.0005408977,0.00023821766,0.17734148,0.00020549145],"about_ca_topic_score_codex":0.00028407743,"about_ca_topic_score_gemma":0.0011051077,"teacher_disagreement_score":0.49443534,"about_ca_system_score_codex":0.0013628765,"about_ca_system_score_gemma":0.0007474638,"threshold_uncertainty_score":0.8170236},"labels":[],"label_agreement":null},{"id":"W2568326653","doi":"10.4143/crt.2016.322","title":"Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies","year":2017,"lang":"en","type":"article","venue":"Cancer Research and Treatment","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Korea Health Industry Development Institute; National Research Foundation of Korea; Ministry of Education; Ministry of Health and Welfare; National Research Foundation","keywords":"Medicine; Epithelial ovarian cancer; Ovarian cancer; Preclinical research; Cancer; Oncology; Cancer research; Bioinformatics; Internal medicine; Medical physics","score_opus":0.3600012172570376,"score_gpt":0.5157097600120288,"score_spread":0.15570854275499124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568326653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95559126,0.029989226,0.000015185388,0.010372492,0.00029268855,0.0024858767,0.00072725164,0.000018347051,0.0005076454],"genre_scores_gemma":[0.94261616,0.051466156,0.0006026631,0.000050817915,0.00030023305,0.0043779314,0.00001533952,0.000027048549,0.00054364855],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983514,0.000047184156,0.00030668775,0.0004917349,0.00033828567,0.00046474102],"domain_scores_gemma":[0.9981639,0.00026517487,0.00014922215,0.0006027511,0.0005403849,0.00027857305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020744819,0.00020487346,0.0006026804,0.00009197432,0.0005294521,0.000052957377,0.00009697223,0.00008172454,0.00005988805],"category_scores_gemma":[0.000096394695,0.00013534156,0.0001529224,0.000053655287,0.000543476,0.000114224684,0.0001035769,0.00010095247,0.0000020934126],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072378595,0.003551959,0.070578024,0.00059437053,0.0073654093,0.0001155095,0.003941259,0.000049234488,0.0032452403,0.0030211727,0.0024144466,0.8978855],"study_design_scores_gemma":[0.11044331,0.06780297,0.23745738,0.005557832,0.003938174,0.000033940898,0.003348003,0.0014940532,0.4527564,0.03035155,0.08545906,0.0013573313],"about_ca_topic_score_codex":0.0031362742,"about_ca_topic_score_gemma":0.0010680752,"teacher_disagreement_score":0.8965282,"about_ca_system_score_codex":0.00049216254,"about_ca_system_score_gemma":0.00050295604,"threshold_uncertainty_score":0.5519068},"labels":[],"label_agreement":null},{"id":"W2573772160","doi":"10.1186/s12942-016-0076-2","title":"Ovarian cancer: density equalizing mapping of the global research architecture","year":2017,"lang":"en","type":"article","venue":"International Journal of Health Geographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"China; Ovarian cancer; Science Citation Index; Per capita; Gross domestic product; Citation; Demography; Cancer; Geography; Index (typography); Regional science; Medicine; Political science; Economic growth; Environmental health; Population; Sociology; Internal medicine; Economics","score_opus":0.1308070520510529,"score_gpt":0.4668970839929022,"score_spread":0.3360900319418493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573772160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78393066,0.0043557337,0.00068231486,0.20707195,0.0027048131,0.0002986348,0.00006246207,0.0000054349757,0.00088797987],"genre_scores_gemma":[0.9950782,0.0024114028,0.0009838584,0.00097128504,0.00052948756,0.000003877906,0.000001438649,0.000006896458,0.0000135752925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784917,0.00017094753,0.0005633378,0.00012640422,0.0010619428,0.0002282248],"domain_scores_gemma":[0.9970583,0.00010322631,0.0010142061,0.00034858554,0.0013403272,0.00013540986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018227642,0.00008871871,0.0002958233,0.00021080994,0.00039492705,0.000066259956,0.00059100304,0.000059170765,0.000026229454],"category_scores_gemma":[0.00034644347,0.000057502268,0.00024488356,0.00017226524,0.00022443876,0.000071933035,0.00016209141,0.00048157346,6.9355536e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014708395,0.00018020262,0.9198457,0.000062492945,0.00048379521,0.000058535596,0.00031407646,0.000028271943,0.000020960675,0.006631205,0.00048697827,0.07174071],"study_design_scores_gemma":[0.001523316,0.00017893943,0.97750497,0.0013705329,0.000033538974,0.0002472162,0.000121549936,0.000016429833,0.00012625505,0.007739016,0.011096267,0.00004197087],"about_ca_topic_score_codex":0.0035767078,"about_ca_topic_score_gemma":0.0007598614,"teacher_disagreement_score":0.21114749,"about_ca_system_score_codex":0.00039849614,"about_ca_system_score_gemma":0.0011011002,"threshold_uncertainty_score":0.5406936},"labels":[],"label_agreement":null},{"id":"W2578257868","doi":"10.1007/s10552-016-0848-9","title":"Hormonal and reproductive factors and the risk of ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Jewish General Hospital; McGill University Health Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec-Société et Culture; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Medicine; Odds ratio; Ovarian cancer; Case-control study; Population; Cancer; Logistic regression; Gynecology; Oncology; Epidemiology; Internal medicine; Obstetrics","score_opus":0.02129938412432561,"score_gpt":0.2984652435075228,"score_spread":0.27716585938319716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578257868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541604,0.03133266,0.000022015314,0.012483026,0.0003387418,0.000811736,0.00034808597,0.000013438958,0.00048990414],"genre_scores_gemma":[0.98501974,0.013778986,0.000021193384,0.00029546622,0.00041342794,0.00028939283,0.0000017339307,0.000016530737,0.00016354382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990658,0.000050564584,0.00018523133,0.00036438453,0.00015786974,0.00017615924],"domain_scores_gemma":[0.9986896,0.00017226422,0.00031448298,0.0005929175,0.00012815159,0.000102572056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001963738,0.00017123847,0.0004993219,0.00002860715,0.0002898943,0.00005032282,0.00008197866,0.000053140546,0.000095948955],"category_scores_gemma":[0.00021860049,0.00009256419,0.000086757216,0.000027771224,0.0006029575,0.000094166164,0.000041874096,0.00013497022,5.818439e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011154573,0.00004669453,0.97960323,0.000034392855,0.0014370981,0.000008301649,0.0007563686,0.0000042257498,0.0001960548,0.0011086188,0.00044847882,0.015241091],"study_design_scores_gemma":[0.012263891,0.00012701639,0.9805851,0.00010515371,0.0017731399,0.0000054314273,0.000102926875,0.00005265399,0.0013643194,0.00031430752,0.0032103297,0.00009572522],"about_ca_topic_score_codex":0.013402029,"about_ca_topic_score_gemma":0.0010834355,"teacher_disagreement_score":0.030859333,"about_ca_system_score_codex":0.000079698984,"about_ca_system_score_gemma":0.00016122266,"threshold_uncertainty_score":0.9931678},"labels":[],"label_agreement":null},{"id":"W2580610212","doi":"10.1097/pas.0000000000000812","title":"Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary","year":2017,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pathology; Immunophenotyping; KRAS; Serous carcinoma; HRAS; Serous fluid; Clear cell carcinoma; Cystadenocarcinoma; Immunohistochemistry; Medicine; Sebaceous carcinoma; Carcinoma; Anatomical pathology; Biology; Ovarian cancer; Cancer; Internal medicine; Colorectal cancer; Genetics","score_opus":0.029489031193342508,"score_gpt":0.30362395978116846,"score_spread":0.27413492858782595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580610212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295914,0.0012743586,0.00000550466,0.0049798577,0.00015674577,0.00022682753,0.000010127165,0.000003228692,0.00038420982],"genre_scores_gemma":[0.99878126,0.00042152035,0.00045515678,0.00017710519,0.0001213703,0.000005955471,9.928733e-7,0.000012470334,0.000024192668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983158,0.00024197242,0.000660238,0.00033369462,0.000242578,0.00020569467],"domain_scores_gemma":[0.9964168,0.00019696118,0.0016164241,0.0014645432,0.00022062456,0.0000846307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001689521,0.00014466298,0.00085279986,0.000051220937,0.00012538067,0.000008058438,0.00037739822,0.000056901998,0.00003730458],"category_scores_gemma":[0.0003109198,0.00007202397,0.00025707547,0.00008015483,0.0022335502,0.000037770034,0.00023588966,0.00038066332,9.3233695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031723743,0.00062559237,0.889901,0.00007976293,0.0002480584,0.0018953569,0.0008979278,0.000005254258,0.08422602,0.0003248384,0.00010858633,0.018515231],"study_design_scores_gemma":[0.0017281129,0.0024508734,0.94429713,0.00006407472,0.0003363957,0.011372355,0.00021787875,0.0000043991145,0.038950197,0.00040599657,0.00009492864,0.000077646095],"about_ca_topic_score_codex":0.00015925437,"about_ca_topic_score_gemma":9.493287e-7,"teacher_disagreement_score":0.05439614,"about_ca_system_score_codex":0.00006253738,"about_ca_system_score_gemma":0.00021287486,"threshold_uncertainty_score":0.82296085},"labels":[],"label_agreement":null},{"id":"W2580802759","doi":"10.1093/annonc/mdx010","title":"Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai; Clovis Oncology; F. Hoffmann-La Roche; Eisai Canada; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Consensus conference; Ovarian cancer; Deliberation; Family medicine; Epithelial ovarian cancer; Clinical trial; Disease; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.22618192601324963,"score_gpt":0.4375265894691654,"score_spread":0.21134466345591577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580802759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544903,0.0019726984,7.1022487e-7,0.0360968,0.00024548586,0.00033956143,0.00009877534,0.000010555008,0.0067450893],"genre_scores_gemma":[0.99221224,0.005638728,0.00024182291,0.0017004512,0.000047316025,0.000051375755,0.000010182104,0.000010263071,0.000087613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991946,0.000050944025,0.00022278457,0.00021131514,0.00012667567,0.00019364044],"domain_scores_gemma":[0.9989376,0.00010963886,0.0003102256,0.00032788783,0.000181314,0.00013331126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009565289,0.00012996863,0.00046872723,0.000050808965,0.0001248723,0.000020569063,0.00007467065,0.00012645667,0.00051326014],"category_scores_gemma":[0.00007284454,0.00009291445,0.00006745204,0.000021760397,0.00026289772,0.000028981696,0.000045704972,0.00008831709,0.0000026282805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058170594,0.0007139079,0.37463465,0.000026187125,0.00069756736,0.000088520326,0.0033050582,4.3170536e-7,0.00027347042,0.0019865264,0.0076959473,0.609996],"study_design_scores_gemma":[0.0045603137,0.0031519816,0.7537132,0.000066254324,0.00006571168,0.000011277828,0.00020778355,0.000004309118,0.0057431804,0.0004219293,0.23196405,0.00009001532],"about_ca_topic_score_codex":0.0017080004,"about_ca_topic_score_gemma":0.0001632342,"teacher_disagreement_score":0.609906,"about_ca_system_score_codex":0.000025503137,"about_ca_system_score_gemma":0.00037593432,"threshold_uncertainty_score":0.5619839},"labels":[],"label_agreement":null},{"id":"W2586176547","doi":"10.9778/cmajo.20160100","title":"Diagnostic and referral intervals for Manitoba women with epithelial ovarian cancer - the Manitoba Ovarian Cancer Outcomes (MOCO) study group: a retrospective cross-sectional study","year":2017,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Medicine; Emergency department; Referral; Retrospective cohort study; Ovarian cancer; Medical record; Odds ratio; Confidence interval; Cancer; Stage (stratigraphy); Cohort; Internal medicine; Pediatrics; Gynecology; Family medicine","score_opus":0.06788204354513773,"score_gpt":0.38037599666605293,"score_spread":0.3124939531209152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586176547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982158,0.0001234842,0.00001898564,0.0027001295,0.0010353213,0.012664301,0.00052709493,0.00004145938,0.00073122],"genre_scores_gemma":[0.97560847,0.00006463916,0.00013072522,0.00056683924,0.0008650437,0.021723025,0.000016854068,0.00008521299,0.0009391794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721014,0.00013267499,0.00050944276,0.0010363816,0.00052247674,0.0005888565],"domain_scores_gemma":[0.99744016,0.00035003797,0.00043066166,0.0012334901,0.000298243,0.0002473825],"candidate_categories":["metaepi_narrow","sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.00094110885,0.00047464325,0.0009069133,0.00007857861,0.0015632635,0.0014579409,0.00079136767,0.00009887464,0.00041610273],"category_scores_gemma":[0.00028528293,0.000281176,0.0001008558,0.00010189238,0.0002668676,0.00050334795,0.00063673535,0.00032238037,0.000012427647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002518685,0.0023486658,0.9825821,0.00003870623,0.0027894417,0.00014496206,0.0040959036,0.000004109196,0.0000065008026,0.00024048921,0.0003065476,0.0049238703],"study_design_scores_gemma":[0.021070931,0.005155502,0.96571815,0.00015677094,0.0007084465,0.000022808063,0.005777928,0.000008094882,0.000015442629,0.00037595053,0.00064693857,0.00034306562],"about_ca_topic_score_codex":0.1581498,"about_ca_topic_score_gemma":0.2719738,"teacher_disagreement_score":0.113824,"about_ca_system_score_codex":0.0013382284,"about_ca_system_score_gemma":0.0002737453,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W2587556669","doi":"10.1007/s10552-017-0855-5","title":"Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles","year":2017,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Royal Alexandra Hospital; Calgary Laboratory Services; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Oncology; Internal medicine; Proportional hazards model; Ovarian cancer; Hazard ratio; Endometriosis; Tissue microarray; Endometrial cancer; PTEN; Ovarian carcinoma; Odds ratio; Carcinoma; Gynecology; Cancer; Confidence interval; Biology; Apoptosis","score_opus":0.01555881976230114,"score_gpt":0.26948860256444473,"score_spread":0.2539297828021436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587556669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991061,0.006332975,0.000060715363,0.00041474676,0.000255985,0.0008048151,0.00087577733,0.000019280385,0.00017475667],"genre_scores_gemma":[0.9977209,0.0014402777,0.0001492677,0.000033121334,0.00040122823,0.00020712671,0.0000092867695,0.000020220079,0.000018569002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990477,0.00005522218,0.00020096241,0.00031290247,0.00019550274,0.0001877019],"domain_scores_gemma":[0.998762,0.00031571926,0.00035521627,0.0002923998,0.00010813225,0.0001665271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015408805,0.00016889063,0.0005228285,0.000077209006,0.00027561927,0.00006949948,0.000047130805,0.000058155016,0.000025886253],"category_scores_gemma":[0.0003090464,0.00011888741,0.000035513796,0.00004140775,0.00021820488,0.00012503217,0.000037232945,0.00010290928,2.247215e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005972314,0.00008060163,0.994276,0.000063844294,0.00042674586,0.000026653084,0.00030161673,0.0000016903367,0.00069953885,0.00009269056,0.000068507936,0.003364906],"study_design_scores_gemma":[0.016445564,0.0005469256,0.9790542,0.0002445464,0.0011377597,0.000010441354,0.000117965494,0.00003673416,0.0019923788,0.000020992129,0.00028008327,0.00011241802],"about_ca_topic_score_codex":0.0021061716,"about_ca_topic_score_gemma":0.0006128254,"teacher_disagreement_score":0.015848333,"about_ca_system_score_codex":0.00009367548,"about_ca_system_score_gemma":0.00019224733,"threshold_uncertainty_score":0.48480877},"labels":[],"label_agreement":null},{"id":"W2588578960","doi":"10.1038/bjc.2017.35","title":"Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer","year":2017,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Women's College Hospital","funders":"National Institutes of Health; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Ovarian cancer; National Death Index; Hazard ratio; Internal medicine; Proportional hazards model; Epidemiology; Cancer; Cancer registry; Confidence interval; Oncology; Gynecology","score_opus":0.06172330484195055,"score_gpt":0.3526062796316627,"score_spread":0.29088297478971215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588578960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96414596,0.029030591,0.00005576939,0.0021075252,0.0036985462,0.00032125087,0.00030744862,0.000012958809,0.0003199434],"genre_scores_gemma":[0.9538062,0.044478346,0.00016869903,0.00017651888,0.0010820258,0.000083992156,0.000006552396,0.00003931036,0.00015831598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977994,0.00011735502,0.00076085306,0.000297101,0.00061730936,0.00040796684],"domain_scores_gemma":[0.99739385,0.00026630407,0.0013719178,0.0003813519,0.0002620571,0.00032453542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006414847,0.0002519118,0.0011976906,0.00009724446,0.00026707415,0.00010965554,0.000372837,0.0001656583,0.00095534953],"category_scores_gemma":[0.00050585734,0.00021527811,0.00077888026,0.000069491405,0.0001679787,0.0003494908,0.00007735515,0.0003705732,0.0000015794484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017923815,0.0002774627,0.8809871,0.0000965038,0.0014051155,0.0013273276,0.0000850151,0.000015945167,0.00008584416,0.0000104965575,0.0006707097,0.114859246],"study_design_scores_gemma":[0.0047919755,0.00038016486,0.9842288,0.004206348,0.0012359503,0.00014901362,0.000037028076,0.0000031699321,0.0031880029,0.00006549764,0.0015306612,0.00018342698],"about_ca_topic_score_codex":0.0113261035,"about_ca_topic_score_gemma":0.0046181194,"teacher_disagreement_score":0.11467582,"about_ca_system_score_codex":0.00036233463,"about_ca_system_score_gemma":0.00051122723,"threshold_uncertainty_score":0.9999579},"labels":[],"label_agreement":null},{"id":"W2588998411","doi":"10.1200/jco.2009.27.15_suppl.5577","title":"Phase II study of MKC-1 in patients with metastatic or resistant epithelial ovarian cancer or advanced endometrial cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Credit Valley Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Clinical endpoint; Ovarian cancer; Cancer; Adverse effect; Oncology; Phases of clinical research; PTEN; Gastroenterology; Toxicity; Urology; Clinical trial; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.13055940009060127,"score_gpt":0.5050653213768045,"score_spread":0.3745059212862032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588998411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339753,0.0003565792,0.00001088262,0.003850087,0.0010970723,0.0011156985,0.00005915922,0.0000047001713,0.0001082688],"genre_scores_gemma":[0.9951505,0.00086211634,0.0022939853,0.0008595905,0.00062991737,0.00004618811,0.000002386844,0.00001843578,0.00013688182],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953518,0.0004536956,0.002934698,0.00029666745,0.0006682714,0.00029488237],"domain_scores_gemma":[0.99486893,0.0015820287,0.0023997093,0.0002454734,0.00056993036,0.0003339195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015146523,0.0002188894,0.0025234108,0.00032576662,0.000045781082,0.0000062324193,0.0001597404,0.00013715241,0.000671074],"category_scores_gemma":[0.0020883307,0.000110769106,0.0002362972,0.0005923488,0.00009202799,0.00012950628,0.000028811117,0.00058120233,9.872338e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3435781,0.0854365,0.08915438,0.000023952025,0.0013887949,0.0015146696,0.0003948821,0.00009230042,0.000036829784,0.000012535773,0.00034616265,0.4780209],"study_design_scores_gemma":[0.24585962,0.3368673,0.4102484,0.0002998568,0.0013887442,0.000009842411,0.00018466666,0.0000061577207,0.00006276568,0.0000235667,0.0049538915,0.0000952081],"about_ca_topic_score_codex":0.0003270192,"about_ca_topic_score_gemma":0.002766828,"teacher_disagreement_score":0.4779257,"about_ca_system_score_codex":0.0005094079,"about_ca_system_score_gemma":0.0034724684,"threshold_uncertainty_score":0.734779},"labels":[],"label_agreement":null},{"id":"W2590203295","doi":"10.1093/annonc/mdx011","title":"Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Kitasato University; Eisai; Clovis Oncology; F. Hoffmann-La Roche; Eisai Canada; Jikei University School of Medicine; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Gynecologic cancer; Ovarian cancer; Cancer; Consensus conference; Oncology; Gynecology; Internal medicine","score_opus":0.29648010047028445,"score_gpt":0.46893896384838774,"score_spread":0.1724588633781033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590203295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7960707,0.0026540726,0.000025152816,0.19035347,0.0013525578,0.00063066406,0.0002666241,0.000014118888,0.008632654],"genre_scores_gemma":[0.9938883,0.003517253,0.00013142524,0.00114515,0.00011432296,0.00019731198,0.000005008303,0.000010786052,0.0009904506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988778,0.0000719995,0.00046296456,0.000233101,0.00012886582,0.00022522509],"domain_scores_gemma":[0.997851,0.00019618773,0.00075423747,0.000648145,0.00046735266,0.00008305332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022404802,0.00014063029,0.0005767311,0.000052869076,0.00016268797,0.00001152222,0.0003132867,0.0001396177,0.0017702522],"category_scores_gemma":[0.00037048664,0.00009132747,0.0003304838,0.00006127479,0.0005205543,0.000035520752,0.0001852342,0.00015994944,0.000005758704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092382205,0.004340284,0.5958798,0.0008708961,0.0024801174,0.00012388651,0.0013621809,0.00011532543,0.0006995999,0.010642623,0.03573482,0.34682667],"study_design_scores_gemma":[0.0035435755,0.0027861828,0.9091693,0.0012337733,0.00046155357,0.000017473132,0.000082759005,0.00008628967,0.006108015,0.0011575271,0.07523516,0.00011839902],"about_ca_topic_score_codex":0.0050771465,"about_ca_topic_score_gemma":0.017258205,"teacher_disagreement_score":0.34670827,"about_ca_system_score_codex":0.00009816395,"about_ca_system_score_gemma":0.00054509327,"threshold_uncertainty_score":0.9991423},"labels":[],"label_agreement":null},{"id":"W2592158565","doi":"10.1093/biolreprod/85.s1.391","title":"Overexpression of Wild-type FOXL2 but Not C134W Mutant FOXL2 Enhances GnRH-induced Cell Apoptosis by Increasing GnRH Receptor Expression in Human Granulosa Tumor Cells.","year":2011,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Receptor; Apoptosis; Mutant; Endocrinology; Internal medicine; Mutation; Gonadotropin-releasing hormone; Cancer research; Cell biology; Gene; Hormone; Genetics","score_opus":0.029811712243979806,"score_gpt":0.27268669559453784,"score_spread":0.24287498335055804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592158565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969072,0.0010969983,0.000014287169,0.00016040138,0.000756734,0.000613334,0.000038297523,0.000039891725,0.0003728943],"genre_scores_gemma":[0.99657965,0.0007584839,0.0021324868,0.000026518246,0.00022194622,0.000053459804,0.00012403468,0.000028369637,0.00007507932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977237,0.00024538694,0.00067903794,0.0008752932,0.00018923692,0.00028732864],"domain_scores_gemma":[0.99837434,0.00006429019,0.00061026483,0.0006916399,0.00017000159,0.000089459856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005310476,0.0002624159,0.00063840474,0.00020182933,0.00008688021,0.0000038162743,0.00011914307,0.000223767,0.00021419565],"category_scores_gemma":[0.00013588073,0.00021176596,0.000121170255,0.00024909576,0.000164905,0.00012225242,0.0000665872,0.00019498824,0.00000862567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012715997,0.0012266337,0.023395715,0.0001467012,0.00004567886,0.0000017803856,0.00050357543,3.8373898e-7,0.96907216,0.000017254226,0.00059455493,0.0037239639],"study_design_scores_gemma":[0.0017763184,0.0017362335,0.013737128,0.0005912696,0.000084069834,0.000008839099,0.00023293571,0.0000017897173,0.98083866,0.00007713963,0.0007361225,0.00017949933],"about_ca_topic_score_codex":0.002532012,"about_ca_topic_score_gemma":0.00001025682,"teacher_disagreement_score":0.011766496,"about_ca_system_score_codex":0.00011875548,"about_ca_system_score_gemma":0.0000732828,"threshold_uncertainty_score":0.8635565},"labels":[],"label_agreement":null},{"id":"W2592342141","doi":"10.1016/j.ygyno.2017.02.021","title":"Corrigendum to “The sooner the better: Genetic testing following ovarian cancer diagnosis” [Gynecol. Oncol. 137 (2015) 423–429]","year":2017,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Regret; Genetic testing; Medicine; Ovarian cancer; Preference; Oncology; Serous fluid; Gynecology; Serous ovarian cancer; Internal medicine; Cancer; Statistics","score_opus":0.07262877616096257,"score_gpt":0.3563011263377028,"score_spread":0.2836723501767402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592342141","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009859876,0.03441946,0.000082887644,0.37078327,0.3993228,0.016660739,0.00090696017,0.0006282113,0.1673358],"genre_scores_gemma":[0.08970508,0.015256026,0.010857664,0.13186988,0.05378894,0.11370519,0.0010809898,0.0010126502,0.58272356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927086,0.00073326746,0.00138829,0.0020711946,0.000976855,0.002121764],"domain_scores_gemma":[0.99139416,0.0026748765,0.0014817688,0.003227858,0.00050787925,0.00071346236],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0015465171,0.0013514925,0.0026731843,0.000312942,0.0022092415,0.00032319425,0.0021032258,0.0021138017,0.0037554684],"category_scores_gemma":[0.0044503463,0.00079462957,0.00096394605,0.0005869937,0.00046557622,0.00011235994,0.0010708148,0.002984721,0.0011623837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000056706504,0.00065836404,0.04490459,0.00009868536,0.0012197839,0.0021598223,0.00027618147,0.000027146776,0.0000050644135,0.0000242486,0.7347179,0.21585147],"study_design_scores_gemma":[0.0024562953,0.0028884914,0.23067543,0.00048423358,0.0027498794,0.00013615687,0.00011824921,0.000080517886,0.000013973618,0.00016222405,0.7595286,0.0007059981],"about_ca_topic_score_codex":0.0036927485,"about_ca_topic_score_gemma":0.017110026,"teacher_disagreement_score":0.41538778,"about_ca_system_score_codex":0.0045587835,"about_ca_system_score_gemma":0.0058760117,"threshold_uncertainty_score":0.9999236},"labels":[],"label_agreement":null},{"id":"W2593027991","doi":"10.1002/cncr.30657","title":"Quality of life with cediranib in relapsed ovarian cancer: The <scp>ICON</scp>6 phase 3 randomized clinical trial","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; AstraZeneca","keywords":"Medicine; Internal medicine; Chemotherapy; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Randomization; Clinical trial; Oncology; Cancer; Surgery","score_opus":0.11669124922708206,"score_gpt":0.4506985208661173,"score_spread":0.3340072716390352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593027991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98061347,0.0032528082,0.0000463265,0.0075199497,0.0015372215,0.0029002402,0.000108022745,0.000025054542,0.0039969217],"genre_scores_gemma":[0.9921045,0.0032290167,0.00011210496,0.0011063565,0.0013207403,0.0014460074,0.000009656958,0.000032701664,0.0006389284],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997174,0.00051887555,0.0011014955,0.0004699373,0.00041123282,0.00032442846],"domain_scores_gemma":[0.99570656,0.0017988381,0.0009796153,0.0011054215,0.0001709747,0.00023860653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027651882,0.00024529133,0.0016666019,0.000053664124,0.00016585947,0.000047006783,0.0002840186,0.0001687442,0.00026694767],"category_scores_gemma":[0.0027920324,0.00013483365,0.0003861986,0.00011155703,0.00064082886,0.00007560088,0.000049616643,0.00036792384,0.0000067364535],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7209093,0.002841872,0.21706848,0.00018821853,0.0022077905,0.00006717996,0.0011888783,0.000024450086,0.00006979584,0.0022320354,0.007550743,0.045651257],"study_design_scores_gemma":[0.9042488,0.00070183934,0.08685276,0.0003391548,0.00059688336,0.0000012085637,0.00011040808,0.000096145006,0.00027657652,0.000119609125,0.0065861186,0.0000705219],"about_ca_topic_score_codex":0.0065602646,"about_ca_topic_score_gemma":0.002323724,"teacher_disagreement_score":0.18333948,"about_ca_system_score_codex":0.00018609008,"about_ca_system_score_gemma":0.0013855771,"threshold_uncertainty_score":0.99172014},"labels":[],"label_agreement":null},{"id":"W2593905043","doi":"10.3390/ijms18030515","title":"Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications","year":2017,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Hazard ratio; Ovarian cancer; Tissue microarray; Oncology; Ovarian carcinoma; Estrogen receptor; Internal medicine; Medicine; Cancer; Confidence interval; Hormone receptor; Stage (stratigraphy); Gynecology; Biology; Breast cancer","score_opus":0.05431905473335001,"score_gpt":0.37017015161431455,"score_spread":0.3158510968809645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593905043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888729,0.0003226873,0.0006947282,0.009433678,0.00023487315,0.000089148954,0.000008027647,0.0000013753566,0.00034257388],"genre_scores_gemma":[0.99439925,0.00064409187,0.0048107156,0.000039392617,0.00008983754,0.0000029829723,0.000003148657,0.0000025090733,0.00000808868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988782,0.00007349582,0.0003733202,0.00013636735,0.00046242445,0.00007619021],"domain_scores_gemma":[0.998537,0.00018696394,0.0007488837,0.000099864585,0.00036723915,0.00006005078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010746984,0.000057820547,0.00019645895,0.00017606934,0.000060924074,0.000061407125,0.00021595416,0.000052011164,0.000010473441],"category_scores_gemma":[0.0007250923,0.000037420745,0.00006404917,0.000085035164,0.00014322934,0.00016948051,0.000045720473,0.00009719008,5.7085884e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016565311,0.00024033722,0.9707106,0.0000011520767,0.00008476094,0.000021038573,0.000028869747,0.0000070516307,0.025385287,0.00052550057,0.000044656426,0.0027851057],"study_design_scores_gemma":[0.0025688882,0.0008312574,0.9729255,0.000062165025,0.00003635754,0.00003425755,0.000047042424,0.00001170843,0.023085533,0.00027139115,0.00008797588,0.000037960675],"about_ca_topic_score_codex":0.00006055417,"about_ca_topic_score_gemma":0.000008122332,"teacher_disagreement_score":0.009394286,"about_ca_system_score_codex":0.000098845616,"about_ca_system_score_gemma":0.00014218624,"threshold_uncertainty_score":0.15259737},"labels":[],"label_agreement":null},{"id":"W2594241928","doi":"10.1016/j.jogc.2016.10.001","title":"No. 341-Diagnosis and Management of Adnexal Torsion in Children, Adolescents, and Adults","year":2017,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ontario Neurotrauma Foundation","funders":"","keywords":"Medicine; Guideline; MEDLINE; Ovarian torsion; Observational study; Systematic review; Family medicine; Randomized controlled trial; Specialty; CINAHL; Gynecology; Psychological intervention; Nursing; Surgery; Pathology","score_opus":0.008970834478463875,"score_gpt":0.23490541479041263,"score_spread":0.22593458031194877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594241928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98724157,0.0104464665,4.6126888e-7,0.0004454637,0.0013635845,0.00020805068,0.000013372424,6.9848824e-7,0.0002803174],"genre_scores_gemma":[0.9833944,0.016163375,0.00024741,0.00013131025,0.000021771408,0.0000044467474,0.0000012773867,0.000006252251,0.000029791709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992201,0.00001659521,0.00030722033,0.0001389761,0.00017543204,0.00014172384],"domain_scores_gemma":[0.9991071,0.0001272884,0.0003436739,0.0001361658,0.00011919202,0.00016655568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011506287,0.00010144857,0.00034013877,0.00013086571,0.00007789851,0.000017365232,0.00006520354,0.00006579861,0.00004100106],"category_scores_gemma":[0.0002913349,0.000080985985,0.000026430214,0.00005505237,0.00006319659,0.00005741903,0.00007045607,0.00013154447,1.4268511e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002106975,0.000155846,0.89709175,0.00015941724,0.000130254,0.00074402365,0.000018055707,5.763473e-7,4.3057352e-7,0.00003518322,0.00055979984,0.10108359],"study_design_scores_gemma":[0.0064719813,0.0005781378,0.9907383,0.00022710506,0.00016423583,0.000044782795,0.000048400005,0.000011671784,0.00002806243,0.000011894537,0.0016119669,0.00006350601],"about_ca_topic_score_codex":0.016469847,"about_ca_topic_score_gemma":0.011370715,"teacher_disagreement_score":0.10102009,"about_ca_system_score_codex":0.0002798771,"about_ca_system_score_gemma":0.00018130385,"threshold_uncertainty_score":0.9900796},"labels":[],"label_agreement":null},{"id":"W2594507218","doi":"10.1093/biolreprod/85.s1.343","title":"Reproductive Steroid Hormones Alter Ovarian Cancer Progression in Mouse Models.","year":2011,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; Ottawa Regional Cancer Foundation","funders":"","keywords":"Ovarian cancer; Menopause; Estrogen; Biology; Internal medicine; Endocrinology; Hormone; Cancer; Ovary; Cancer research; Medicine","score_opus":0.06289436773078384,"score_gpt":0.3215504271528871,"score_spread":0.2586560594221033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594507218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850423,0.009723303,0.000107102984,0.0027567542,0.00054934714,0.0007288495,0.000011381334,0.00004892862,0.0010320545],"genre_scores_gemma":[0.993198,0.0021613373,0.00360145,0.000034828387,0.00035522494,0.00023427363,0.000023020742,0.000016879027,0.0003750279],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858826,0.00006485998,0.00030337015,0.00077844446,0.000081413185,0.00018364008],"domain_scores_gemma":[0.9990012,0.000006514701,0.00017259752,0.00064231193,0.00013303125,0.000044355314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002960395,0.00013703239,0.0003118642,0.0001546663,0.00002886898,0.0000019576164,0.000049543418,0.00011751351,0.00007704906],"category_scores_gemma":[0.00004302968,0.00010417902,0.000058921407,0.00016413575,0.00013547666,0.000118575896,0.00003263752,0.00011192944,0.0000053600693],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032244213,0.0028187307,0.42565256,0.00016584438,0.0004224303,0.000028714307,0.0048861783,0.000040403156,0.08254766,0.0024614881,0.00072821917,0.47702333],"study_design_scores_gemma":[0.0023151257,0.0014366199,0.24112405,0.00015730063,0.00010682615,0.00005545664,0.0001828676,0.00005125217,0.7493313,0.003165675,0.0018797354,0.00019377515],"about_ca_topic_score_codex":0.0012226937,"about_ca_topic_score_gemma":0.00004837057,"teacher_disagreement_score":0.66678363,"about_ca_system_score_codex":0.000108476765,"about_ca_system_score_gemma":0.00006592415,"threshold_uncertainty_score":0.4248297},"labels":[],"label_agreement":null},{"id":"W2594531299","doi":"10.1016/j.jogc.2016.12.009","title":"N° 341-Diagnostic et prise en charge de la torsion annexielle chez les filles, les adolescentes et les femmes adultes","year":2017,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine; Humanities; Philosophy","score_opus":0.01812748300461229,"score_gpt":0.2784972286681074,"score_spread":0.2603697456634951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594531299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66887665,0.30061364,0.000021634933,0.019279957,0.00924615,0.0002729166,0.00020802874,0.0000060650345,0.0014749819],"genre_scores_gemma":[0.9237686,0.07365874,0.00048352624,0.0006232579,0.00028649557,0.0000095835885,0.000012056864,0.000036144105,0.0011216007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762183,0.0005485356,0.0006186663,0.00029029854,0.0003715441,0.00054913043],"domain_scores_gemma":[0.98662657,0.011326839,0.00091036246,0.00030599866,0.00032321812,0.00050704426],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010313094,0.0003496474,0.00073634257,0.0002076347,0.0005801408,0.00017752606,0.00031050245,0.00046965756,0.0012606926],"category_scores_gemma":[0.017812891,0.00029390855,0.00016742844,0.000104709914,0.00033518832,0.00016736917,0.00014122711,0.0009321484,0.0000029839687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001782637,0.00065307977,0.78991634,0.00026317892,0.00039362922,0.005274329,0.00050911045,0.000034305052,0.000011777021,0.0016058299,0.030585187,0.17073539],"study_design_scores_gemma":[0.0042638355,0.00081147644,0.84749085,0.0005634841,0.00054550706,0.00017637931,0.00097120856,0.00006533711,0.00035510326,0.00007731817,0.14444558,0.00023389581],"about_ca_topic_score_codex":0.121486835,"about_ca_topic_score_gemma":0.056154333,"teacher_disagreement_score":0.25489196,"about_ca_system_score_codex":0.001526265,"about_ca_system_score_gemma":0.0028586884,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W2596087002","doi":"10.1093/biolreprod/87.s1.548","title":"Mechanisms by Which Estrogen Accelerates Ovarian Tumor Initiation.","year":2012,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Biology; Estrogen; Ovary; Cancer research; Stromal cell; Cancer; Ovarian cancer; Epithelium; Endocrinology; Internal medicine; Medicine; Genetics","score_opus":0.02710485332908992,"score_gpt":0.2909358033498565,"score_spread":0.2638309500207666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596087002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795255,0.0100733265,0.0009306187,0.0062930216,0.0012073321,0.0004738268,0.000030651634,0.000073303585,0.0013923987],"genre_scores_gemma":[0.99510074,0.00023647811,0.003829565,0.00009106503,0.0003979461,0.000058676396,0.00016700663,0.000010413344,0.00010814024],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992774,0.00004086765,0.00018509249,0.00026935394,0.00006058301,0.00016671224],"domain_scores_gemma":[0.99938715,0.000016111517,0.0001208564,0.00029085908,0.00012303828,0.00006199294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025262698,0.00009042484,0.0001896793,0.000052727424,0.000043388467,0.0000031645989,0.00002941377,0.00007007224,0.00023280314],"category_scores_gemma":[0.000108386674,0.00007361161,0.000039082322,0.00014365435,0.000034191573,0.000086994274,0.000014236435,0.000058482587,0.000035048775],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035085407,0.0021501922,0.5497058,0.00010916802,0.000669376,0.0000028025393,0.00044160945,0.000002588417,0.33943376,0.03903855,0.012983138,0.05511215],"study_design_scores_gemma":[0.0011238971,0.0006657831,0.13511387,0.000024068337,0.000168435,0.0001247091,0.00008263746,0.0000040552077,0.8141128,0.0012216112,0.04723776,0.000120385],"about_ca_topic_score_codex":0.00006597414,"about_ca_topic_score_gemma":0.0000014307644,"teacher_disagreement_score":0.47467902,"about_ca_system_score_codex":0.000053925654,"about_ca_system_score_gemma":0.000045283028,"threshold_uncertainty_score":0.30017945},"labels":[],"label_agreement":null},{"id":"W2596235567","doi":"10.1007/s00261-017-1089-4","title":"Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI","year":2017,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Endometriosis; Differential diagnosis; Radiology; Ovarian cancer; Peritoneal cavity; Adnexal Diseases; Ovary; Medical diagnosis; Peritoneum; Hepatology; Pathology; Laparoscopy; Cancer; Surgery; Internal medicine","score_opus":0.07760784966588649,"score_gpt":0.3536900222995735,"score_spread":0.27608217263368706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596235567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015411422,0.99498266,0.0000054438597,0.00052678474,0.0001651802,0.0014359453,0.00011098639,0.000041324365,0.0011905459],"genre_scores_gemma":[0.0027450235,0.9938162,0.0005002458,0.00016577968,0.0003562184,0.0015303403,0.00039376414,0.000092791175,0.00039965205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774754,0.0002011628,0.0004503755,0.0008372511,0.00023770051,0.00052594504],"domain_scores_gemma":[0.9977435,0.0006068984,0.00062539603,0.0006581768,0.0000849738,0.00028106503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002504097,0.0006700285,0.003209247,0.0001789039,0.00022839589,0.00006162462,0.00019108327,0.0002252554,0.00017454737],"category_scores_gemma":[0.00010728657,0.00039499192,0.00024521517,0.000115563555,0.0005304479,0.000070339614,0.00007168324,0.00046130264,0.000021761718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032128778,0.0005905705,0.039967023,0.0050341296,0.005985719,0.006857151,0.00008623929,2.9334197e-7,5.354379e-8,0.00017331007,0.0035673652,0.93741685],"study_design_scores_gemma":[0.003396022,0.004058466,0.0054152543,0.017720357,0.009955172,0.004824744,0.000037099933,0.0000020094303,0.000001952149,0.000009927836,0.9541023,0.0004767162],"about_ca_topic_score_codex":0.00022803634,"about_ca_topic_score_gemma":0.00033846108,"teacher_disagreement_score":0.95053494,"about_ca_system_score_codex":0.0004087492,"about_ca_system_score_gemma":0.0007285208,"threshold_uncertainty_score":0.9998502},"labels":[],"label_agreement":null},{"id":"W2596394717","doi":"10.1002/uog.16059","title":"OC07.04: Two‐step strategy to preoperatively assess adnexal lesions not classifiable by <scp>EDs</scp>, using <scp>RMI</scp>, <scp>IOTA ADNEX</scp> or simple rules risk model","year":2016,"lang":"en","type":"article","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università di Bologna; Università Cattolica del Sacro Cuore; Lunds Universitet; School of Medicine, New York University; York University","keywords":"Medicine; Receiver operating characteristic; Gold standard (test); Malignancy; Gynecology; Internal medicine","score_opus":0.053180619944123736,"score_gpt":0.31303947512343655,"score_spread":0.25985885517931284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596394717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833032,0.0046124775,0.003335134,0.0002300959,0.0009577728,0.0017773022,0.0020431546,0.00010943606,0.0036314372],"genre_scores_gemma":[0.96997,0.013845066,0.00675195,0.0012116508,0.00023434793,0.0003776701,0.00018869097,0.000167767,0.0072528813],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941298,0.00043085383,0.0012515766,0.0016988821,0.0006827302,0.0018061958],"domain_scores_gemma":[0.91564274,0.08149317,0.0005152018,0.0008865547,0.000471414,0.0009908926],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075473764,0.00092021015,0.0015432303,0.0007470046,0.0006146166,0.00029820905,0.00044674275,0.00076809176,0.000108605],"category_scores_gemma":[0.060354773,0.0006782864,0.00024264469,0.0013074084,0.0003474126,0.00042438635,0.00025699558,0.00075074745,0.00011644991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013612186,0.010801805,0.5850223,0.00061042875,0.0026779377,0.0012380556,0.0056460006,0.012242665,0.0711739,0.010532104,0.17864749,0.121271245],"study_design_scores_gemma":[0.036720067,0.010983989,0.15687792,0.000787342,0.0020536922,0.00051580096,0.010002234,0.03373151,0.018259807,0.0046897596,0.7245168,0.0008610478],"about_ca_topic_score_codex":0.0007853105,"about_ca_topic_score_gemma":0.0008495844,"teacher_disagreement_score":0.54586935,"about_ca_system_score_codex":0.0010955913,"about_ca_system_score_gemma":0.0011635647,"threshold_uncertainty_score":0.99956685},"labels":[],"label_agreement":null},{"id":"W2596887331","doi":"10.1093/biolreprod/81.s1.562","title":"Hyaluronidase-1 (Hyal-1) Is Differentially Expressed in Epithelial Ovarian Cancer of Distinct Histopathological Subtypes.","year":2009,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Serous fluid; Ovarian cancer; Metastasis; Cancer research; Perineural invasion; Cancer; Pathology; Internal medicine; Oncology; Medicine","score_opus":0.024449485086466143,"score_gpt":0.294016824056982,"score_spread":0.2695673389705158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596887331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902646,0.0024233626,0.00009369931,0.0061602583,0.0003908163,0.00028295748,0.00005025924,0.000020698888,0.0003133559],"genre_scores_gemma":[0.99843395,0.00051152497,0.00048015395,0.00008046881,0.00025745668,0.000027390402,0.00003662433,0.0000063678494,0.00016608865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988444,0.00006739396,0.00034610892,0.0005010943,0.000085594744,0.0001554342],"domain_scores_gemma":[0.99924827,0.000019307625,0.00018084153,0.00040895154,0.000103802995,0.000038804843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018935389,0.00012234565,0.00040752869,0.00009865732,0.000020097905,0.0000015648399,0.000054652442,0.00013054053,0.00029787692],"category_scores_gemma":[0.0001184675,0.00009337474,0.00008967503,0.00012229243,0.00014117821,0.000024118857,0.000014764203,0.000097391494,0.0000033014885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012738474,0.0015242681,0.5061811,0.00007559983,0.00007272141,0.000025260988,0.0003933775,0.0000051649204,0.2383731,0.0010346683,0.0005114608,0.2505294],"study_design_scores_gemma":[0.0015517487,0.0010818728,0.8432061,0.00006544312,0.000073963725,0.000012774324,0.000011503537,0.000006100258,0.14985694,0.000742061,0.0033187438,0.00007275464],"about_ca_topic_score_codex":0.00036376552,"about_ca_topic_score_gemma":0.00002074366,"teacher_disagreement_score":0.33702496,"about_ca_system_score_codex":0.0000948777,"about_ca_system_score_gemma":0.00007528349,"threshold_uncertainty_score":0.38077116},"labels":[],"label_agreement":null},{"id":"W2597067106","doi":"10.1200/jco.2013.31.15_suppl.5547","title":"Benefit in progression-free survival (PFS) to expect based on CA125 reduction at week 6 in recurrent ovarian cancer (ROC) patients: CALYPSO phase III trial data (a GINECO-GCIG study).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Progression-free survival; Oncology; Ovarian cancer; Internal medicine; Receiver operating characteristic; Clinical trial; Cancer; Overall survival","score_opus":0.20946949223040787,"score_gpt":0.514383490258674,"score_spread":0.30491399802826613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597067106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713457,0.00020802753,0.000008655768,0.019371698,0.005886118,0.0028024674,0.000059681264,0.000009275546,0.00030836105],"genre_scores_gemma":[0.99535155,0.00020112829,0.0008672246,0.0006507698,0.0023766875,0.00035746075,0.00007191203,0.000030414589,0.00009286615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941508,0.00069156446,0.0032881622,0.0006385677,0.0008328265,0.0003980506],"domain_scores_gemma":[0.9954087,0.0013566458,0.0014497704,0.0008686153,0.00039525828,0.00052101334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030591853,0.00027439155,0.001884006,0.00039832477,0.000052303734,0.000022111486,0.00044651647,0.00030214046,0.0008236534],"category_scores_gemma":[0.0025550872,0.00019142083,0.00023979366,0.00037967498,0.00006866117,0.00019547627,0.00022967104,0.00087780063,0.000021105818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17204294,0.08678107,0.2513741,0.000020973726,0.00026806197,0.00045733378,0.00022011522,0.00022254536,0.0000065950335,0.000009974974,0.038113557,0.45048276],"study_design_scores_gemma":[0.39135858,0.07903156,0.51165956,0.0005132664,0.00033518352,0.000007427494,0.00016958467,0.0005856283,0.000011257814,0.000047020072,0.016093785,0.00018715659],"about_ca_topic_score_codex":0.0018724157,"about_ca_topic_score_gemma":0.0060738507,"teacher_disagreement_score":0.4502956,"about_ca_system_score_codex":0.001707723,"about_ca_system_score_gemma":0.0014310082,"threshold_uncertainty_score":0.9018427},"labels":[],"label_agreement":null},{"id":"W2597070782","doi":"10.1200/jco.2013.31.15_suppl.5561","title":"Does aggressive primary debulking surgery influence survival in ovarian cancer?","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Debulking; Surgery; Ovarian cancer; Stage (stratigraphy); Serous fluid; Retrospective cohort study; Medical record; Cancer; Internal medicine","score_opus":0.08658466243258553,"score_gpt":0.4361711961414098,"score_spread":0.3495865337088243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597070782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617116,0.001019991,0.000011512689,0.032797523,0.0029843375,0.00023574334,0.0000025515994,0.0000062480167,0.0012305053],"genre_scores_gemma":[0.9872418,0.0053980793,0.00110388,0.004635507,0.0014609476,0.00003478921,0.0000015054159,0.000016214695,0.00010727672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964533,0.0003862378,0.0022974939,0.0002188918,0.00034912355,0.00029496473],"domain_scores_gemma":[0.9915792,0.004990449,0.0023966648,0.00018999074,0.0004687179,0.0003750079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021309562,0.0001486506,0.0017769234,0.00017400914,0.0000284991,0.00001664843,0.00012548687,0.000307721,0.00047827497],"category_scores_gemma":[0.0031298723,0.00007843201,0.00041861672,0.00018314864,0.00014606239,0.00022688894,0.000049641265,0.0007894707,0.000026410964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005679763,0.000984054,0.76083624,0.000033099095,0.0002512719,0.001670884,0.0000517869,0.000022898155,0.000057500467,0.000028861248,0.0018067885,0.23368862],"study_design_scores_gemma":[0.004236459,0.0012558337,0.9818421,0.00066528417,0.00017399294,0.00010630162,0.000048097954,0.000010162855,0.00007373948,0.00045647717,0.011039079,0.00009245587],"about_ca_topic_score_codex":0.0009027916,"about_ca_topic_score_gemma":0.0003511706,"teacher_disagreement_score":0.23359616,"about_ca_system_score_codex":0.00047945406,"about_ca_system_score_gemma":0.0031229637,"threshold_uncertainty_score":0.5540003},"labels":[],"label_agreement":null},{"id":"W2597747698","doi":"10.1200/jco.2015.33.15_suppl.5564","title":"Baseline predictors of early treatment failure in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive (PPS ≥ 3) recurrent ovarian cancer (ROC) receiving ≥ 3 lines of chemotherapy: The Gynaecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Proportional hazards model; Ascites; Performance status; Cancer; Ovarian cancer; Progression-free survival; Thrombocytosis; Gastroenterology; Chemotherapy; Univariate analysis; Oncology; Surgery; Confidence interval; Multivariate analysis; Platelet","score_opus":0.045707615327933604,"score_gpt":0.36437930156863124,"score_spread":0.31867168624069764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597747698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358994,0.00061418983,0.000016973758,0.0035004176,0.0010381704,0.0010770858,0.00008695814,0.000006774653,0.00006947027],"genre_scores_gemma":[0.9971162,0.0012041539,0.00073323183,0.0002252902,0.00058395456,0.000047612884,0.00000802484,0.00003094827,0.000050592356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957109,0.000604165,0.00243602,0.00037428088,0.00059683766,0.00027779583],"domain_scores_gemma":[0.9935835,0.0018608988,0.0028429483,0.00027562655,0.0011352912,0.00030171432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019332431,0.00031626978,0.0019669938,0.00018326764,0.000042771597,0.000012122846,0.00014800264,0.00028886687,0.00009666324],"category_scores_gemma":[0.0007343745,0.00016929701,0.0002107344,0.0002463346,0.00024103171,0.0001238377,0.000063987594,0.00058511645,4.1550777e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018580973,0.007858455,0.8541248,0.000029555535,0.002060613,0.00011585345,0.0025162292,0.00013447525,0.000016623777,0.000004944011,0.000236918,0.11432056],"study_design_scores_gemma":[0.031593107,0.07207073,0.8924869,0.00053724484,0.001129158,0.000007261803,0.0010244816,0.00004342022,0.000041838826,0.000020748239,0.00091898633,0.00012614856],"about_ca_topic_score_codex":0.00095332606,"about_ca_topic_score_gemma":0.009502738,"teacher_disagreement_score":0.11419441,"about_ca_system_score_codex":0.00085331604,"about_ca_system_score_gemma":0.0017526848,"threshold_uncertainty_score":0.6903732},"labels":[],"label_agreement":null},{"id":"W2598181800","doi":"10.1200/jco.2012.30.15_suppl.5019","title":"A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Toronto; University Health Network; Cancer Care Ontario; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Progression-free survival; Cancer; Oncology; Progressive disease; Adverse effect; Serous fluid; Chemotherapy; Gastroenterology","score_opus":0.09066157760645395,"score_gpt":0.46517900892513414,"score_spread":0.3745174313186802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598181800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271744,0.0019983025,0.0000041989474,0.0024220347,0.00088057306,0.0017308587,0.00010635503,0.000005545282,0.00013469718],"genre_scores_gemma":[0.99821913,0.00036550636,0.00026150505,0.0004290947,0.0005653872,0.00009143872,0.000002393261,0.000026945017,0.000038607603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99382025,0.00090773625,0.0038880315,0.00033443025,0.00064444,0.0004051116],"domain_scores_gemma":[0.9942217,0.001274272,0.00316417,0.00045931686,0.00035648423,0.0005240507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030285616,0.00029412194,0.0025359273,0.00019850151,0.00012498733,0.000005856429,0.00020359262,0.00025829024,0.00022253409],"category_scores_gemma":[0.0016361156,0.00017637001,0.00033635745,0.00036594959,0.00027310516,0.00012888586,0.00021814376,0.00097590155,9.395673e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035839994,0.30216333,0.5563003,0.00008671115,0.0020015598,0.00058110495,0.0067966296,0.000027791237,0.0014453222,0.00004416063,0.0007465038,0.093966596],"study_design_scores_gemma":[0.2903851,0.27239302,0.41688064,0.00056652975,0.003151222,0.000115417366,0.0055642175,0.00006663529,0.00052233454,0.0000532508,0.010074591,0.00022704838],"about_ca_topic_score_codex":0.00061469997,"about_ca_topic_score_gemma":0.0027983093,"teacher_disagreement_score":0.2545451,"about_ca_system_score_codex":0.00026365666,"about_ca_system_score_gemma":0.0014609719,"threshold_uncertainty_score":0.71921605},"labels":[],"label_agreement":null},{"id":"W2598367752","doi":"10.1200/jco.2015.33.15_suppl.5536","title":"Is it time to change the primary endpoint in clinical trials in recurrent ovarian cancer (ROC)?: Symptom burden and outcomes in patients with platinum resistant/refractory (PRR) and potentially platinum sensitive ROC receiving ≥ 3 lines of chemotherapy (PPS ≥ 3)—The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Chemotherapy; Adverse effect; Clinical trial; Progression-free survival; Anorexia; Surgery","score_opus":0.13420773932320723,"score_gpt":0.4486649365407507,"score_spread":0.31445719721754345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598367752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95071566,0.0009964869,0.0000035622622,0.04528025,0.0007300382,0.002150843,0.000050973722,0.000004348481,0.0000678528],"genre_scores_gemma":[0.9915564,0.0025373271,0.0003439798,0.0045213625,0.0007949241,0.00013057081,0.000004233818,0.000030255867,0.00008092369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99156356,0.0022975157,0.004693781,0.0005102403,0.00058271835,0.00035216677],"domain_scores_gemma":[0.9854559,0.010463478,0.0029650433,0.00029894925,0.0004988621,0.00031777794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014093219,0.0003354523,0.0034998711,0.00026900202,0.000041852956,0.000026409953,0.00021279439,0.00037335826,0.00012998718],"category_scores_gemma":[0.0047817286,0.00017220151,0.00024300355,0.00029280028,0.00021431009,0.00014420651,0.00017312932,0.0010390589,0.0000017594301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016914003,0.0029671276,0.7552511,0.000024029563,0.0007595216,0.00011386799,0.0044380245,0.00002257048,0.000004297695,0.0000017880304,0.0004781851,0.2190255],"study_design_scores_gemma":[0.031916454,0.021338204,0.94189894,0.0009105844,0.0004662811,0.000006378513,0.0010978839,0.000060951792,0.0000036729502,0.000038708113,0.0020980968,0.00016381484],"about_ca_topic_score_codex":0.0007637854,"about_ca_topic_score_gemma":0.009534254,"teacher_disagreement_score":0.21886168,"about_ca_system_score_codex":0.00075446913,"about_ca_system_score_gemma":0.0010843534,"threshold_uncertainty_score":0.7022174},"labels":[],"label_agreement":null},{"id":"W2598922717","doi":"10.1200/jco.2013.31.15_suppl.tps5613","title":"A randomized double-blind phase III trial comparing vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD plus placebo in patients with platinum-resistant ovarian cancer (PROCEED).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ovarian cancer; Placebo; Internal medicine; Chemotherapy; Gastroenterology; Cancer; Oncology; Performance status; Phases of clinical research; Urology; Pathology","score_opus":0.13559782063363848,"score_gpt":0.444828116016042,"score_spread":0.30923029538240354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598922717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581463,0.00036274397,0.00004254339,0.00394084,0.0026053586,0.004606994,0.000007950414,0.000022842843,0.00259611],"genre_scores_gemma":[0.99612933,0.00021778134,0.0009799205,0.0005309776,0.0015730232,0.0003575922,0.00002106466,0.000051260962,0.00013903272],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928373,0.0005916731,0.0045937262,0.00051205856,0.0008492405,0.0006160027],"domain_scores_gemma":[0.99108243,0.0036316197,0.0033732767,0.00031491928,0.0008136605,0.00078411156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026589055,0.00044818252,0.005129446,0.00036140112,0.0000923727,0.00006380689,0.00026489986,0.00057194475,0.0008887175],"category_scores_gemma":[0.0011055657,0.00028494842,0.00062724797,0.00035798558,0.00031814023,0.00030946732,0.00008638092,0.001540537,0.000028281418],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9706035,0.0064799828,0.008995839,0.000037193808,0.003114246,0.00045035727,0.00037278005,0.00037088554,0.000011699197,0.00010316446,0.0009464355,0.008513869],"study_design_scores_gemma":[0.94257015,0.03210939,0.019571925,0.0005333566,0.0024891526,0.000023479708,0.00012475063,0.001240969,0.00004599797,0.000038316728,0.0009793222,0.00027320985],"about_ca_topic_score_codex":0.0023370993,"about_ca_topic_score_gemma":0.0014291994,"teacher_disagreement_score":0.028033419,"about_ca_system_score_codex":0.0016119684,"about_ca_system_score_gemma":0.0041636294,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2599032975","doi":"10.1097/igc.0000000000000934","title":"The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care South East; University of British Columbia","funders":"","keywords":"Medicine; Gynecologic cancer; Clinical trial; Proxy (statistics); Citation; Impact factor; Gynecologic oncology; Cancer; Demography; Gerontology; Oncology; Statistics; Library science; Internal medicine; Ovarian cancer","score_opus":0.6701508049921997,"score_gpt":0.6895927536888642,"score_spread":0.01944194869666449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599032975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524609,0.0015978424,0.00030938114,0.022754123,0.018721264,0.0020371284,0.0013474929,0.000018325878,0.0007535384],"genre_scores_gemma":[0.9685294,0.017038468,0.0017455512,0.0011514213,0.010138354,0.0011585993,0.000024274852,0.000029479954,0.0001844516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929852,0.0012940433,0.003125368,0.0006871712,0.0011790327,0.00072919164],"domain_scores_gemma":[0.972432,0.017853959,0.003705651,0.00061171333,0.0049100886,0.00048658063],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.018173583,0.00037923388,0.0017441093,0.00012406944,0.00058548193,0.00030797345,0.0021410915,0.0005604783,0.0014627654],"category_scores_gemma":[0.030994562,0.00020230122,0.002346508,0.00011937695,0.0010018157,0.00033795947,0.00028828086,0.0009937289,0.0000048020183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014939094,0.0024847132,0.60850847,0.000015533024,0.00503595,0.00006317193,0.00001996539,0.0013593878,0.00001579903,0.0022357046,0.032858666,0.33246353],"study_design_scores_gemma":[0.011551868,0.012322861,0.92529255,0.000296457,0.00044391688,0.00002384371,0.000040968756,0.0012259184,0.000066883804,0.0074150893,0.04111306,0.00020657909],"about_ca_topic_score_codex":0.000710496,"about_ca_topic_score_gemma":0.0020307428,"teacher_disagreement_score":0.33225694,"about_ca_system_score_codex":0.0030157974,"about_ca_system_score_gemma":0.0018524496,"threshold_uncertainty_score":0.99945},"labels":[],"label_agreement":null},{"id":"W2599055371","doi":"10.1200/jco.2013.31.15_suppl.5541","title":"Feasibility and safety of front-line bevacizumab (BEV)-containing therapy after neoadjuvant (NA) chemotherapy (CT) for ovarian cancer (OC): The ROSiA experience.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Carboplatin; Surgery; Debulking; Internal medicine; Ovarian carcinoma; Perforation; Chemotherapy; Oncology; Cancer; Cisplatin","score_opus":0.11580552362747036,"score_gpt":0.45036663206945615,"score_spread":0.3345611084419858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599055371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95345974,0.007915923,0.00043500809,0.035995234,0.00081252435,0.0011958978,0.000017454118,0.0000060812463,0.00016216512],"genre_scores_gemma":[0.9814237,0.009133085,0.003252684,0.0049274974,0.00093496795,0.00020405518,0.0000017227378,0.000022943448,0.00009937711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99696934,0.00023561437,0.0019563334,0.00028585608,0.00027433137,0.00027851044],"domain_scores_gemma":[0.9958189,0.001712178,0.0013562206,0.0003257279,0.0005025658,0.00028438595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001770532,0.00020054592,0.0015229101,0.000047880083,0.000070619564,0.000017067974,0.00016346911,0.00019071708,0.0011039678],"category_scores_gemma":[0.00045659774,0.00010624417,0.00051143096,0.000067007364,0.0003509151,0.00013849167,0.000032865224,0.00045047826,0.0000022364502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018673642,0.0014913382,0.40411294,0.000023214661,0.00066667114,0.00004298743,0.0010997849,0.000005956114,0.00012068432,0.000082383645,0.0010064746,0.5726739],"study_design_scores_gemma":[0.031866413,0.011536072,0.91281897,0.00015912579,0.00024190759,0.00009582673,0.00048401245,0.0001897148,0.00038758465,0.0005880598,0.041521415,0.00011092536],"about_ca_topic_score_codex":0.00038324125,"about_ca_topic_score_gemma":0.00016998351,"teacher_disagreement_score":0.572563,"about_ca_system_score_codex":0.00027293214,"about_ca_system_score_gemma":0.00096234673,"threshold_uncertainty_score":0.99980915},"labels":[],"label_agreement":null},{"id":"W2600464340","doi":"10.1016/j.gore.2017.03.018","title":"18F FDG positron-emission tomography findings of gliomatosis peritonei: A case report and review of the literature","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Université de Sherbrooke; BC Cancer Agency","funders":"","keywords":"Medicine; Positron emission tomography; Complication; Magnetic resonance imaging; Computed tomography; Radiology; Pseudomyxoma peritonei; Internal medicine; Appendix","score_opus":0.013045032221286279,"score_gpt":0.31805664729679206,"score_spread":0.3050116150755058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600464340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96037877,0.027075378,4.300917e-7,0.005700143,0.00057418563,0.0009894649,0.000014869377,0.00001796892,0.005248776],"genre_scores_gemma":[0.9920284,0.0065358533,0.00055372505,0.00043688167,0.000040203136,0.000093196555,0.000020034198,0.000011670564,0.0002800502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821204,0.000108074346,0.0008107469,0.00044844075,0.00021120903,0.00020948322],"domain_scores_gemma":[0.99675065,0.00019907605,0.0014120921,0.0012444063,0.00026465877,0.00012909707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009921464,0.00019619822,0.00088377006,0.000085210275,0.00025844024,0.000017236038,0.00010459746,0.00023708222,0.000114462826],"category_scores_gemma":[0.001460361,0.00011462651,0.00030022344,0.00017799358,0.00036217456,0.000073112016,0.00019917738,0.00020284229,3.4752827e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039496983,0.0005593797,0.72650915,0.0029061912,0.00023810398,0.26112267,0.00012500786,5.46282e-8,0.0008854239,0.000034992536,0.004587269,0.0029922936],"study_design_scores_gemma":[0.000710771,0.0009712828,0.5665161,0.006643278,0.0008535568,0.40845895,0.000031156083,7.1921454e-7,0.0076381136,0.00018141975,0.007896237,0.0000984468],"about_ca_topic_score_codex":0.00011508758,"about_ca_topic_score_gemma":0.000022205768,"teacher_disagreement_score":0.15999304,"about_ca_system_score_codex":0.00012543554,"about_ca_system_score_gemma":0.00035270597,"threshold_uncertainty_score":0.46743333},"labels":[],"label_agreement":null},{"id":"W2600875503","doi":"","title":"What Women and Their Physicians Need to Know About the UKCTOCS Study and Ovarian Cancer Screening.","year":2016,"lang":"en","type":"editorial","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ovarian Cancer Canada","funders":"","keywords":"Medicine; Ovarian cancer; Family medicine; Gynecology; Obstetrics; Cancer; Oncology; Internal medicine","score_opus":0.014547266219354933,"score_gpt":0.26998389277651275,"score_spread":0.2554366265571578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600875503","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03572909,0.027633123,0.000023679917,0.043041583,0.8774772,0.0143046165,0.00089435506,0.00015720051,0.0007391168],"genre_scores_gemma":[0.11922273,0.015986025,0.000019346699,0.0014100921,0.81170523,0.042730764,0.000047135916,0.00016925987,0.008709417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759275,0.00010224044,0.0003049206,0.000775393,0.00049896876,0.0007257209],"domain_scores_gemma":[0.99803483,0.00057997083,0.000179133,0.00065288757,0.00016941589,0.00038375313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005020411,0.0005007963,0.0008518653,0.00012566084,0.00019087153,0.0003505069,0.00018962598,0.0002677684,0.00003543746],"category_scores_gemma":[0.00014964366,0.00026297205,0.00008629365,0.00019691906,0.00011359739,0.0001682309,0.00019580605,0.0003823638,0.0000048135093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027111525,0.00020798533,0.0017859327,0.000043276705,0.00087239,0.000014891496,0.0036372475,1.7114196e-7,7.490189e-7,0.0000031104769,0.5059363,0.48722678],"study_design_scores_gemma":[0.0041557048,0.00034258657,0.12779061,0.0004960141,0.00036390717,0.0000017082797,0.002044811,8.8341676e-7,0.000012020117,0.000030578558,0.8644812,0.00027995405],"about_ca_topic_score_codex":0.0005732033,"about_ca_topic_score_gemma":0.00052260695,"teacher_disagreement_score":0.48694685,"about_ca_system_score_codex":0.0004107907,"about_ca_system_score_gemma":0.00015721032,"threshold_uncertainty_score":0.99998224},"labels":[],"label_agreement":null},{"id":"W2602048901","doi":"10.1200/jco.2015.33.15_suppl.5553","title":"Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer (ROC).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Trabectedin; Medicine; Tolerability; Internal medicine; Context (archaeology); Progression-free survival; Oncology; Surgery; Chemotherapy; Gastroenterology; Adverse effect; Soft tissue sarcoma","score_opus":0.1860550349905799,"score_gpt":0.45382723773127653,"score_spread":0.26777220274069663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602048901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98529506,0.0009675288,0.00001558485,0.0097543895,0.0017141158,0.00036259167,0.000009570037,0.000008943782,0.0018722333],"genre_scores_gemma":[0.99620384,0.00043970149,0.0014484407,0.0011179377,0.0006440031,0.000018599892,0.0000075608737,0.000019759003,0.00010017205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971426,0.00028695332,0.0016325511,0.00022370917,0.00046059207,0.00025357548],"domain_scores_gemma":[0.99708664,0.0004040024,0.0010544833,0.00015911178,0.00066172844,0.0006340528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010722288,0.00015992102,0.0012356496,0.00014026304,0.000015619791,0.000009270708,0.00009341013,0.00024422686,0.00014829531],"category_scores_gemma":[0.0008582019,0.00009777548,0.00019339721,0.00024568228,0.00009005941,0.00009090885,0.00002229673,0.00061998423,0.000009881203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007711973,0.010011001,0.771706,0.000012681471,0.00035483137,0.00054693327,0.00018565821,0.000025274065,0.0000032410724,0.000014463723,0.007053321,0.20237464],"study_design_scores_gemma":[0.032719962,0.03728638,0.8729027,0.0003969712,0.00042261963,0.000039002083,0.000048931728,0.000019425235,0.00003244235,0.0000547222,0.05598091,0.00009593037],"about_ca_topic_score_codex":0.00015164493,"about_ca_topic_score_gemma":0.0006521695,"teacher_disagreement_score":0.2022787,"about_ca_system_score_codex":0.0010912528,"about_ca_system_score_gemma":0.0023024708,"threshold_uncertainty_score":0.40844846},"labels":[],"label_agreement":null},{"id":"W2603323257","doi":"10.14740/jcgo417w","title":"Tubal Serous Borderline Tumor With Strongly Positive p53 Which Developed in a 50-Year-Old Woman","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Serous fluid; Gynecology; Internal medicine; Gastroenterology; Pathology","score_opus":0.04318094294051864,"score_gpt":0.3680642748186408,"score_spread":0.32488333187812213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603323257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034065,0.0010221546,0.000038493712,0.0060984725,0.0008629552,0.00023711708,0.00000851789,0.0000051907596,0.001386459],"genre_scores_gemma":[0.99356943,0.0014085708,0.0035684698,0.000940686,0.0002490919,0.0000055216487,0.0000029408673,0.000016370455,0.0002389071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806094,0.00012768283,0.0010205397,0.0002579544,0.0002470249,0.0002858338],"domain_scores_gemma":[0.9945324,0.003415455,0.00094829494,0.00027573213,0.00052128604,0.00030680784],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0009341601,0.00017463442,0.0009570439,0.00017098211,0.00013848547,0.00004753148,0.0001640146,0.00019217293,0.0000610566],"category_scores_gemma":[0.009938923,0.00011742015,0.00010691936,0.00018396771,0.00018242959,0.00015237243,0.000068911104,0.00080387725,0.000006540456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013182334,0.0011155718,0.973302,0.000023617074,0.00031026616,0.0030016818,0.00006812515,0.000010275495,0.0000010860994,0.00018426334,0.00030487275,0.02035998],"study_design_scores_gemma":[0.014923015,0.0061700656,0.9734808,0.00017724522,0.00030107616,0.00040134683,0.00011862989,0.000043018874,0.00002468046,0.0000808231,0.00415969,0.00011960785],"about_ca_topic_score_codex":0.000023579065,"about_ca_topic_score_gemma":0.00037667807,"teacher_disagreement_score":0.020240372,"about_ca_system_score_codex":0.00011786558,"about_ca_system_score_gemma":0.00070638256,"threshold_uncertainty_score":0.9984008},"labels":[],"label_agreement":null},{"id":"W2604499605","doi":"10.1200/jco.2004.22.90140.5043","title":"Is neoadjuvant chemotherapy a realistic alternative to primary surgery for women with advanced ovarian cancer?","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Carboplatin; Chemotherapy; Ovarian cancer; Stage (stratigraphy); Oncology; Internal medicine; Paclitaxel; Cancer; Surgery; Cisplatin","score_opus":0.10342443646081402,"score_gpt":0.46166550706924525,"score_spread":0.35824107060843124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604499605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8055684,0.00051267206,0.0030238098,0.1873137,0.0014412729,0.0008965619,0.000051404146,0.000013893157,0.0011783033],"genre_scores_gemma":[0.93329954,0.0028409977,0.021743754,0.039677773,0.0019495933,0.00019603547,0.0000037513364,0.00004141246,0.00024711533],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976055,0.00007245163,0.0014120921,0.00027092657,0.0003077225,0.0003313284],"domain_scores_gemma":[0.9959622,0.0015645371,0.0011813863,0.00019807299,0.000500516,0.0005932728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013005651,0.00017293134,0.0017667343,0.00012151332,0.000037620706,0.000009550434,0.00010677884,0.00015940511,0.00012558317],"category_scores_gemma":[0.00057010335,0.00011028655,0.00032044345,0.00015717495,0.0000870257,0.0000784745,0.000016285583,0.00032493024,0.000004841091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041704047,0.003334652,0.022122668,0.00009020779,0.0019728139,0.0010116189,0.0009978879,0.00046351142,0.000063558335,0.00022209357,0.006963057,0.9210539],"study_design_scores_gemma":[0.04929297,0.053313326,0.66582596,0.00096190505,0.000528234,0.00034051406,0.00018921492,0.000012396613,0.0004848657,0.0029996224,0.22579582,0.0002551545],"about_ca_topic_score_codex":0.00010868209,"about_ca_topic_score_gemma":0.000069186564,"teacher_disagreement_score":0.9207987,"about_ca_system_score_codex":0.0014471109,"about_ca_system_score_gemma":0.0042901537,"threshold_uncertainty_score":0.7610549},"labels":[],"label_agreement":null},{"id":"W2604592578","doi":"10.1016/j.jpag.2017.03.017","title":"Impact of Introducing an Evidence Based Multidisciplinary Algorithm On the Management of Adnexal Masses in the Pediatric Population","year":2017,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Adnexal mass; Population; Algorithm; General surgery; Retrospective cohort study; Radiology; Surgery","score_opus":0.046265745269410435,"score_gpt":0.35696835394066084,"score_spread":0.31070260867125044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604592578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955339,0.0013384441,0.00008800512,0.002454347,0.00021247279,0.00034366015,0.000005701614,0.0000014879649,0.000021979098],"genre_scores_gemma":[0.9925709,0.005496511,0.0011585429,0.00007907963,0.0006774115,0.000005371593,0.0000015310947,0.0000070646033,0.000003585778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878573,0.00015384125,0.00048387356,0.00014929206,0.0002744402,0.00015284131],"domain_scores_gemma":[0.99813014,0.0004710481,0.0008910702,0.00034016924,0.00010416074,0.00006342246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009290603,0.00012130413,0.00033151786,0.0001944522,0.0001106319,0.00001769894,0.0002043393,0.000051335857,0.000031290445],"category_scores_gemma":[0.00017786297,0.000060899427,0.00014057108,0.000122183,0.00004527992,0.00014141058,0.00004727277,0.00021832273,5.0421187e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024794127,0.0011723475,0.98197347,0.00019064582,0.000062403706,0.00009730376,0.00009917254,0.00023655382,0.0000070905003,0.00003186255,0.0003093448,0.015571851],"study_design_scores_gemma":[0.0018608465,0.0023922822,0.9942032,0.0001668655,0.0006363554,0.000021664891,0.00016825944,0.00042220915,0.000010325451,0.000064873086,0.000002437473,0.000050661816],"about_ca_topic_score_codex":0.000047187372,"about_ca_topic_score_gemma":0.0000042846036,"teacher_disagreement_score":0.015521189,"about_ca_system_score_codex":0.00011191813,"about_ca_system_score_gemma":0.00012461665,"threshold_uncertainty_score":0.24834065},"labels":[],"label_agreement":null},{"id":"W2604605776","doi":"10.1371/journal.pgen.1006707","title":"The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples","year":2017,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; University of Manitoba; CancerCare Manitoba Foundation; Strong; Research Manitoba","keywords":"Biology; Chromosome instability; Ovarian cancer; Drug resistance; Cancer; Genome instability; Chromosome; Disease; Internal medicine; Oncology; Cancer research; Genetics; Gene; Medicine; DNA; DNA damage","score_opus":0.02915311224104055,"score_gpt":0.27012419222094186,"score_spread":0.2409710799799013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604605776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122274,0.005336908,0.0000022096337,0.0019743778,0.00011093828,0.000431875,0.00011591707,0.0000048912457,0.0008001632],"genre_scores_gemma":[0.99392575,0.005103112,0.0007216754,0.000067853995,0.00005992406,0.00006105587,0.000020863203,0.000013238018,0.000026498616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992421,0.0000218809,0.00024628383,0.00018598471,0.00015803525,0.00014566153],"domain_scores_gemma":[0.9991074,0.00006525618,0.0001594983,0.0005313731,0.00007285971,0.00006361616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006921595,0.000107322725,0.00022879822,0.000015012237,0.0001222639,0.000028062555,0.000093315175,0.000052837284,0.00002588604],"category_scores_gemma":[0.000033142645,0.00007219361,0.000034389377,0.000026197693,0.00015950047,0.000029055022,0.00009946733,0.0000683246,4.64284e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006872564,0.00054805714,0.97840554,0.00019661244,0.00005720689,0.000007391321,0.00033015647,0.000007834564,0.0011141069,0.000070577145,0.00003616134,0.019157656],"study_design_scores_gemma":[0.0015506006,0.0003777842,0.9677543,0.00015201168,0.00012408492,0.0000019312358,0.00012372342,0.0011595051,0.027376868,0.00021671371,0.0010591728,0.00010327151],"about_ca_topic_score_codex":0.00093867345,"about_ca_topic_score_gemma":0.008500903,"teacher_disagreement_score":0.026262762,"about_ca_system_score_codex":0.00019804099,"about_ca_system_score_gemma":0.00016418839,"threshold_uncertainty_score":0.47437036},"labels":[],"label_agreement":null},{"id":"W2604899890","doi":"10.1158/1557-3125.dnarepair16-b41","title":"Abstract B41: REV7 is a possible prognostic predictor and a potential therapeutic target in human malignancy","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cell cycle; Gene knockdown; Cancer research; Biology; Carcinogenesis; Malignancy; Cancer; Cisplatin; Cell; Cell growth; Lymphoma; DNA damage; Diffuse large B-cell lymphoma; Cell cycle checkpoint; Ovarian cancer; Pathology; Medicine; Apoptosis; Chemotherapy; Immunology; DNA","score_opus":0.06395816630927577,"score_gpt":0.409517345393631,"score_spread":0.34555917908435524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604899890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97748226,0.010293236,0.000019932255,0.008192518,0.00009687508,0.0013270957,0.000045706332,0.000020868212,0.0025215351],"genre_scores_gemma":[0.99724185,0.0009549969,0.0001345522,0.0002632699,0.00014339418,0.0007074524,0.000012336193,0.000044283,0.00049785967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978427,0.00007292043,0.00023417996,0.00055616285,0.00070361246,0.0005903979],"domain_scores_gemma":[0.99877274,0.00002639218,0.00007512679,0.0007360099,0.00016839568,0.00022135045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045569937,0.00017925816,0.00030594136,0.00020451235,0.00037833507,0.00022322606,0.0002249426,0.00011447983,0.0006138897],"category_scores_gemma":[0.000061465085,0.00015249208,0.000083716535,0.00013890033,0.00024193243,0.000104894236,0.00014664378,0.00040923007,0.000018300272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047924742,0.0011619994,0.8549573,0.0008103432,0.00053603196,0.0056198873,0.00092987006,0.000008689911,0.112470366,0.0009401179,0.0020106914,0.020075504],"study_design_scores_gemma":[0.0037392643,0.0005436606,0.9615417,0.0009911716,0.000080552076,0.000018793857,0.000038363305,0.00008097542,0.028836595,0.0025098992,0.0014464904,0.00017254408],"about_ca_topic_score_codex":0.0023810077,"about_ca_topic_score_gemma":0.00012522639,"teacher_disagreement_score":0.10658444,"about_ca_system_score_codex":0.00024540714,"about_ca_system_score_gemma":0.00038074722,"threshold_uncertainty_score":0.67216617},"labels":[],"label_agreement":null},{"id":"W2605058147","doi":"10.1158/1557-3125.dnarepair16-b02","title":"Abstract B02: DNA repair landscape in High Grade Ovarian Cancer (HGOC) and evolution with neo-adjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; DNA repair; Cancer research; Chemotherapy; Biomarker; Homologous recombination; Oncology; Medicine; Immunohistochemistry; Cisplatin; Poly ADP ribose polymerase; PARP inhibitor; Cancer; Internal medicine; Biology; DNA; Polymerase; Genetics","score_opus":0.03785180247201479,"score_gpt":0.36847752171071557,"score_spread":0.33062571923870077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605058147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96979487,0.0069393273,0.000022645552,0.02064095,0.00010194312,0.0009469339,0.00003442044,0.00004331931,0.001475618],"genre_scores_gemma":[0.9948541,0.0032344335,0.00028226073,0.00028014666,0.00020433826,0.000749373,0.000013459918,0.000058661626,0.000323218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997672,0.00007116841,0.00021923376,0.0006603718,0.0007579376,0.0006192893],"domain_scores_gemma":[0.99855614,0.000037441812,0.00009587842,0.000872954,0.0001879926,0.0002495738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050329365,0.00022533593,0.00039975013,0.0002322619,0.00030597733,0.00012798703,0.00018531822,0.00013131928,0.00033401357],"category_scores_gemma":[0.000041301802,0.00017357309,0.00007582958,0.00022675566,0.00023695282,0.00013056003,0.00008075955,0.00045895402,0.000009468588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015001587,0.00061097345,0.9507288,0.00030479225,0.0005310209,0.0020115757,0.00041388193,0.00006989941,0.013587701,0.0011318831,0.0028424591,0.026266899],"study_design_scores_gemma":[0.0073269703,0.0003856178,0.9768891,0.00069001893,0.000060498,0.000019149331,0.000065214226,0.0001521509,0.010823255,0.00027672356,0.0031138887,0.00019742381],"about_ca_topic_score_codex":0.033896964,"about_ca_topic_score_gemma":0.006095337,"teacher_disagreement_score":0.027801625,"about_ca_system_score_codex":0.00069464796,"about_ca_system_score_gemma":0.0006633513,"threshold_uncertainty_score":0.9725364},"labels":[],"label_agreement":null},{"id":"W2605337228","doi":"10.1200/jco.2014.32.15_suppl.5519","title":"A phase II randomized open-label study of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with weekly paclitaxel versus weekly paclitaxel in patients with platinum-resistant/refractory ovarian cancers.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Paclitaxel; Medicine; Hazard ratio; Internal medicine; Ovarian cancer; Progression-free survival; Monoclonal antibody; Oncology; Refractory (planetary science); Chemotherapy; Gastroenterology; Cancer; Urology; Confidence interval; Antibody; Immunology","score_opus":0.07753090838274025,"score_gpt":0.4464672778584613,"score_spread":0.36893636947572106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605337228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939503,0.00012890887,0.00005682262,0.0020400262,0.0004934827,0.0023179948,0.000017886105,0.0000078619605,0.0009867186],"genre_scores_gemma":[0.9958828,0.000060034694,0.003346137,0.0002627441,0.00023319948,0.00008618642,0.000040646195,0.00004251675,0.00004575297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924562,0.0018392473,0.003917052,0.0005081942,0.00085125485,0.0004280305],"domain_scores_gemma":[0.9906052,0.003737434,0.004144413,0.0003524981,0.000802408,0.0003580432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067200395,0.00036559152,0.0038789099,0.0004060559,0.00012028623,0.000030306956,0.00033453963,0.00031342654,0.00007380708],"category_scores_gemma":[0.0023923086,0.00024110707,0.0001807929,0.0004281267,0.0003110881,0.000351472,0.00012275681,0.0011351338,0.0000014232787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6106844,0.12155531,0.25212166,0.000054368753,0.0015267576,0.0003865306,0.0010717881,0.000038578706,0.00009263913,0.00028684162,0.00026997505,0.0119111445],"study_design_scores_gemma":[0.5385044,0.18878654,0.2704478,0.0004036166,0.00060614845,0.0000035059618,0.00054246094,0.00010172628,0.0000053347394,0.0000863079,0.000366887,0.00014525445],"about_ca_topic_score_codex":0.0014725206,"about_ca_topic_score_gemma":0.0025626216,"teacher_disagreement_score":0.072179966,"about_ca_system_score_codex":0.0008746399,"about_ca_system_score_gemma":0.0018579067,"threshold_uncertainty_score":0.9832061},"labels":[],"label_agreement":null},{"id":"W2606256841","doi":"10.71781/30169","title":"Développement d'un nouveau modèle in vitro du cancer épithélial de l'ovaire","year":2004,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.0350809161558165,"score_gpt":0.33271823808127143,"score_spread":0.29763732192545495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606256841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96107453,0.008213701,0.000050669256,0.013017168,0.0035187996,0.0033254076,0.00045013745,0.0000035079968,0.010346081],"genre_scores_gemma":[0.9649583,0.005711898,0.013976697,0.00039345116,0.0012869175,0.0017625665,0.0025430238,0.000119410965,0.009247754],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968989,0.00009624188,0.00074454956,0.0009614632,0.00044547766,0.00085339457],"domain_scores_gemma":[0.9986558,0.00006618882,0.0003316116,0.00044909155,0.00013561739,0.00036166594],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003847099,0.000609455,0.0009653074,0.00019230107,0.00018709802,0.00017865618,0.00045991887,0.00046812315,0.013014376],"category_scores_gemma":[0.000041768508,0.00059861585,0.00020082606,0.00036267997,0.00005944451,0.00017667134,0.00012008545,0.00046101754,0.001093353],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029137048,0.004493429,0.06490239,0.00044259286,0.0013568497,0.002406153,0.024923583,0.0014618348,0.009356523,0.00015686029,0.0008960311,0.88669],"study_design_scores_gemma":[0.02666004,0.0009005328,0.3294613,0.010415333,0.0025699611,0.000057884743,0.0060748053,0.0006924782,0.5624805,0.00025155416,0.058951136,0.0014844222],"about_ca_topic_score_codex":0.015922265,"about_ca_topic_score_gemma":0.016905725,"teacher_disagreement_score":0.8852056,"about_ca_system_score_codex":0.0051336144,"about_ca_system_score_gemma":0.004467642,"threshold_uncertainty_score":0.9996844},"labels":[],"label_agreement":null},{"id":"W2608251600","doi":"10.1097/igc.0000000000000946","title":"A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; Women's College Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Surgery; Stage (stratigraphy); Oncology; Internal medicine; Cancer","score_opus":0.0554060840473489,"score_gpt":0.38358083397277015,"score_spread":0.3281747499254213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608251600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342984,0.00045620123,0.000011625033,0.0037572763,0.0015467673,0.0002278933,0.000039861345,0.0000074439117,0.00052307465],"genre_scores_gemma":[0.9981327,0.000939749,0.0003346445,0.0003054506,0.00015858268,0.000045720957,0.000010813618,0.000018075665,0.00005425851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998146,0.00004408547,0.0006961855,0.00020976471,0.00068861013,0.00021536287],"domain_scores_gemma":[0.9973482,0.0004892901,0.0011755095,0.00017434212,0.0006995243,0.000113135124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018958285,0.00019744634,0.0009887681,0.00015775838,0.000058140322,0.00004004421,0.00028197456,0.00009585885,0.00044065525],"category_scores_gemma":[0.00025015205,0.00012496856,0.00020027267,0.00006600763,0.00010123314,0.00019264144,0.000046457895,0.0002321051,9.876934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006951118,0.001659861,0.8981569,0.000016346774,0.000868553,0.00019733323,0.00009712581,0.00018866594,0.000093455856,0.00001610065,0.00009265001,0.09166189],"study_design_scores_gemma":[0.015292383,0.0011652552,0.9810386,0.00042643546,0.00013005153,0.0000052625687,0.000031513267,0.000028805782,0.0011025273,0.000012317698,0.0006428619,0.00012398834],"about_ca_topic_score_codex":0.00069729204,"about_ca_topic_score_gemma":0.0010447735,"teacher_disagreement_score":0.09153791,"about_ca_system_score_codex":0.0010270185,"about_ca_system_score_gemma":0.00038222614,"threshold_uncertainty_score":0.509607},"labels":[],"label_agreement":null},{"id":"W2608835133","doi":"10.1038/ng.3849","title":"Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes","year":2017,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":290,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Université de Montréal; Child and Family Research Institute; Centre Hospitalier de l’Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Jikei University School of Medicine; University of British Columbia","keywords":"Biology; Microsatellite instability; Ovarian cancer; Cell of origin; Point mutation; DNA mismatch repair; Genome instability; Serous fluid; Genetics; Cancer research; Mutation; Cancer; Germline mutation; DNA repair; DNA damage; Microsatellite; Gene; DNA; Allele","score_opus":0.022051652814411453,"score_gpt":0.3069829118030615,"score_spread":0.28493125898865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608835133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95613766,0.026487686,0.00007208213,0.006922376,0.0016097302,0.00071107585,0.00018771367,0.00006923272,0.007802462],"genre_scores_gemma":[0.9857689,0.0022652447,0.010689595,0.0004563723,0.00023018452,0.000034356664,0.000011686867,0.000022333086,0.0005213356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989786,0.000017458846,0.00024207398,0.00031190712,0.0002512123,0.00019875407],"domain_scores_gemma":[0.9987292,0.000021067071,0.00023967099,0.0007592109,0.00014111986,0.00010969416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010615942,0.00016842461,0.00033659252,0.000046817328,0.00015614348,0.000025496385,0.0001844026,0.00029666806,0.0002865788],"category_scores_gemma":[0.000035629146,0.00013436456,0.00014240333,0.00003594882,0.00018268637,0.000026488111,0.00004041802,0.00025811474,0.000007612821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009917009,0.0014123585,0.46863395,0.0010434942,0.0038300648,0.0008663857,0.0015251854,0.00011401306,0.3776813,0.044131495,0.022853568,0.076916486],"study_design_scores_gemma":[0.0020921312,0.000530674,0.7205062,0.0002311143,0.0007029039,0.00003720292,0.000043035227,0.00008430585,0.25627017,0.002860102,0.016417272,0.0002248786],"about_ca_topic_score_codex":0.0003248138,"about_ca_topic_score_gemma":0.00038656828,"teacher_disagreement_score":0.25187224,"about_ca_system_score_codex":0.00014205188,"about_ca_system_score_gemma":0.0004358694,"threshold_uncertainty_score":0.5479228},"labels":[],"label_agreement":null},{"id":"W2608920382","doi":"10.1038/ng.3841","title":"Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk","year":2017,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":646,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institute on Aging; Medical Research Council; National Institute for Health and Care Research; Wellcome Trust; Francis Crick Institute; British Heart Foundation; National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Biology; Menarche; Genetics; Cancer; Bioinformatics; Oncology; Computational biology; Endocrinology","score_opus":0.05620437079251206,"score_gpt":0.3844773673354305,"score_spread":0.3282729965429184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608920382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942043,0.004211774,0.000009903404,0.00031924606,0.00009104063,0.0004772016,0.00023889473,0.0000064364576,0.00044124605],"genre_scores_gemma":[0.996306,0.0016332762,0.0013612028,0.00009086074,0.00006869431,0.00006744251,0.00005718617,0.000024894363,0.00039044835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910396,0.000023480277,0.00019587117,0.00028028258,0.00017842777,0.00021800453],"domain_scores_gemma":[0.99910915,0.000068187896,0.00027959843,0.00036206213,0.0000971149,0.000083916435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001897302,0.00013738849,0.00036140066,0.0000785315,0.00013439108,0.000030712006,0.00010129112,0.00021826108,0.000038047918],"category_scores_gemma":[0.00010235832,0.00010468249,0.00005863156,0.00006122705,0.00007800261,0.000030800875,0.00009208618,0.00020055339,5.16405e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021281284,0.00018734664,0.9866296,0.00005562287,0.0007051094,0.00007924464,0.000585579,0.000049349324,0.0026212207,0.0000033751421,0.00042589474,0.0084448205],"study_design_scores_gemma":[0.0035187984,0.0003287794,0.9870539,0.00013893883,0.00091225177,0.000007692886,0.000028520517,0.00029624373,0.0069553796,0.0001222047,0.00053180795,0.00010552221],"about_ca_topic_score_codex":0.00032399414,"about_ca_topic_score_gemma":0.0049430756,"teacher_disagreement_score":0.008339299,"about_ca_system_score_codex":0.00024329855,"about_ca_system_score_gemma":0.00014100234,"threshold_uncertainty_score":0.4268828},"labels":[],"label_agreement":null},{"id":"W2610391635","doi":"10.1111/his.13248","title":"High‐grade serous carcinoma of tubo‐ovarian origin: recent developments","year":2017,"lang":"en","type":"review","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Serous fluid; Serous carcinoma; Ovarian carcinoma; Carcinoma; Medicine; Serous membrane; Ovary; Gynecology; Pathology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.16848256946664747,"score_gpt":0.38816624136404426,"score_spread":0.2196836718973968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610391635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012380676,0.99175805,0.000008866314,0.00034967708,0.0026311744,0.0011305067,0.0001225163,0.000040607953,0.0038347882],"genre_scores_gemma":[0.00039843892,0.9927413,0.002657024,0.00012082422,0.00035211942,0.00037656262,0.0004731174,0.00009595273,0.0027847018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973109,0.00017728243,0.0009643916,0.0008044674,0.00027703942,0.0004659534],"domain_scores_gemma":[0.997218,0.00007042081,0.00096603495,0.0013846228,0.00014744645,0.00021346925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026734435,0.00058568333,0.003488552,0.00033828858,0.00013871006,0.000012727881,0.00036019724,0.00058246835,0.00036668076],"category_scores_gemma":[0.00008936492,0.00046731855,0.00045247847,0.00015961101,0.00020727345,0.00003460182,0.00013363436,0.00042409342,0.000249026],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002833273,0.00048778407,0.0021593254,0.007710556,0.00013816489,0.0031119138,0.00009742529,3.8023366e-8,9.087559e-7,0.0009938434,0.0034442379,0.9818275],"study_design_scores_gemma":[0.0013812046,0.0003527355,0.015111203,0.0042770416,0.0023788882,0.001648928,0.0000026132818,5.5992487e-8,0.00000492514,0.0000364715,0.9744881,0.0003178811],"about_ca_topic_score_codex":0.00020159183,"about_ca_topic_score_gemma":0.000034910267,"teacher_disagreement_score":0.98150957,"about_ca_system_score_codex":0.0011883036,"about_ca_system_score_gemma":0.0018184722,"threshold_uncertainty_score":0.99977785},"labels":[],"label_agreement":null},{"id":"W2610692166","doi":"10.5114/pm.2017.67370","title":"Reply to comment of Prof. Artur Czekierdowski","year":2017,"lang":"pl","type":"letter","venue":"Menopausal Review","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Menopause; Medicine; Internal medicine","score_opus":0.049441498517393025,"score_gpt":0.3527194850308343,"score_spread":0.30327798651344123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610692166","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008161781,0.32434654,0.000012625796,0.6583928,0.001418043,0.005731845,0.00031313888,0.000027771715,0.009749074],"genre_scores_gemma":[0.00016984392,0.26640272,0.00068292156,0.70946306,0.002499519,0.0014836093,0.00052196224,0.00013851638,0.018637843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938339,0.00038623542,0.0019981253,0.0014341631,0.0013451288,0.0010024414],"domain_scores_gemma":[0.99273056,0.0003016456,0.0017372016,0.0042159557,0.00043698904,0.0005776542],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014486029,0.0011247527,0.0041659325,0.0001879278,0.00021639072,0.00007763773,0.00093164627,0.00040558138,0.00458844],"category_scores_gemma":[0.00065983116,0.0008570796,0.00041336456,0.00020368029,0.00016548674,0.00009020467,0.00042526665,0.0011984603,0.0028496166],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044796376,0.0005742692,0.00025030834,0.043821715,0.0011603952,0.00097647554,0.00012404585,8.0192585e-8,0.00002637556,0.0001118379,0.8866165,0.06629318],"study_design_scores_gemma":[0.0012923572,0.0033554188,0.00068955513,0.14470302,0.005225422,0.00007190752,0.0000030302779,4.071627e-7,0.00022530837,0.0000449615,0.84382004,0.000568574],"about_ca_topic_score_codex":0.00057439925,"about_ca_topic_score_gemma":0.000010178382,"teacher_disagreement_score":0.1008813,"about_ca_system_score_codex":0.0008201783,"about_ca_system_score_gemma":0.0006737846,"threshold_uncertainty_score":0.999388},"labels":[],"label_agreement":null},{"id":"W2610787638","doi":"10.5114/pm.2017.67368","title":"Comment on: Case report of ovarian torsion mimicking ovarian cancer as an uncommon late complication of laparoscopic supracervical hysterectomy","year":2017,"lang":"en","type":"letter","venue":"Menopausal Review","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian torsion; Complication; Ovarian cancer; Menopause; Hysterectomy; General surgery; Gynecology; Surgery; Cancer; Internal medicine","score_opus":0.06452584109242779,"score_gpt":0.3800355342313167,"score_spread":0.3155096931388889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610787638","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0123704,0.03468416,0.000011406906,0.9431814,0.0009625752,0.0042723184,0.0003737986,0.00006010023,0.0040838416],"genre_scores_gemma":[0.16645555,0.054105468,0.0017696271,0.7660973,0.0029626712,0.0018163263,0.005385693,0.00032159587,0.00108573],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961162,0.0003770995,0.0014503889,0.00087187515,0.00075215334,0.00043224392],"domain_scores_gemma":[0.99468553,0.00015942432,0.0020529903,0.002528034,0.00037253898,0.00020147448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008092538,0.00058463105,0.0023630266,0.00013967452,0.00017860038,0.000036069785,0.00033383843,0.00044321682,0.0007697038],"category_scores_gemma":[0.000107991546,0.00046300227,0.0002018896,0.00015977898,0.00010679505,0.00010230706,0.00013617825,0.0008634466,0.000034093493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029857244,0.001842094,0.002517017,0.05021428,0.0017133667,0.09081967,0.00023782528,0.000001885823,0.0002839276,0.00056557154,0.8210009,0.030504897],"study_design_scores_gemma":[0.0020467958,0.0022092862,0.0011916235,0.046810087,0.003031337,0.006262328,0.000004423805,0.000007199078,0.0009675415,0.000058170277,0.9370273,0.00038396218],"about_ca_topic_score_codex":0.007753553,"about_ca_topic_score_gemma":0.00018500262,"teacher_disagreement_score":0.17708407,"about_ca_system_score_codex":0.00060362474,"about_ca_system_score_gemma":0.00042731425,"threshold_uncertainty_score":0.99978215},"labels":[],"label_agreement":null},{"id":"W2611245105","doi":"10.1007/s10552-017-0899-6","title":"Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES)","year":2017,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; AGE-WELL","keywords":"Medicine; Odds ratio; Epidemiology; Logistic regression; Serous fluid; Confidence interval; Ovarian cancer; Population; Internal medicine; Cancer; Demography; Gynecology; Environmental health","score_opus":0.02238536137255492,"score_gpt":0.3253095880877823,"score_spread":0.3029242267152274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611245105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113545,0.005159972,0.00002604139,0.07973818,0.00053292856,0.0024454563,0.00025753438,0.000070362476,0.00041502694],"genre_scores_gemma":[0.981117,0.0029123288,0.00002402796,0.0061343783,0.00073197443,0.008694312,0.000004362876,0.00008042952,0.0003011478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961237,0.00060679467,0.0006482656,0.00098367,0.000510804,0.0011268174],"domain_scores_gemma":[0.9957084,0.000990914,0.0016708784,0.0010266493,0.00024714452,0.00035600594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013252997,0.00052996207,0.0020141208,0.00016684002,0.0005615785,0.0001457493,0.00036185724,0.000094196344,0.00015581294],"category_scores_gemma":[0.0004060773,0.00034262252,0.00012758975,0.00038986708,0.0010556302,0.00018157242,0.00009754721,0.0005986311,0.0000019895506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028386803,0.0002738941,0.93030787,0.000028037452,0.0031513895,0.00008985143,0.0053433473,0.00023279496,0.000010767533,0.00012592212,0.00033173253,0.057265706],"study_design_scores_gemma":[0.021478735,0.0010913482,0.96272975,0.00021196288,0.001739787,0.0000060413754,0.0048262556,0.00025287815,0.00001526952,0.00004501617,0.007207514,0.00039544894],"about_ca_topic_score_codex":0.16590874,"about_ca_topic_score_gemma":0.10546743,"teacher_disagreement_score":0.0736038,"about_ca_system_score_codex":0.0036570346,"about_ca_system_score_gemma":0.00066114607,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W2611362917","doi":"10.3747/co.24.3312","title":"Ovarian Cancer in ManitobA: Trends in Incidence and Survival, 1992–2011","year":2017,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Ovarian cancer; Relative survival; Cancer registry; Incidence (geometry); Cancer; Internal medicine; Stage (stratigraphy); Oncology; Retrospective cohort study; Demography; Gynecology","score_opus":0.14780694195634853,"score_gpt":0.4378698481766307,"score_spread":0.2900629062202822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611362917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709213,0.006538706,0.000003899151,0.012852962,0.0020239812,0.0002801701,0.000024792704,0.000015848309,0.0073383595],"genre_scores_gemma":[0.99456865,0.0047293874,0.000062896,0.00008469692,0.00025795487,0.0001880764,0.000010609655,0.000011758471,0.0000859444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989557,0.000059096867,0.00024090624,0.00035542098,0.000111834284,0.00027703383],"domain_scores_gemma":[0.9993079,0.000060741466,0.00012707709,0.00036428147,0.000026605183,0.000113443944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022727757,0.00014364276,0.00042817765,0.00020684484,0.00007413929,0.000023270779,0.0001185317,0.00010702487,0.00042155065],"category_scores_gemma":[0.00004248164,0.00012431642,0.000037799156,0.00007192595,0.00012857081,0.00009336889,0.0001050289,0.00024263594,0.000019391282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070214555,0.00038126076,0.63316303,0.000023532933,0.000014868436,0.00015958189,0.0001640365,5.3383013e-7,0.000011107471,0.00036977621,0.0007536517,0.36488837],"study_design_scores_gemma":[0.0045140404,0.0002642252,0.9470684,0.00019208928,0.00005242654,0.000016645005,0.00006325678,0.00006165189,0.000026100968,0.00015720104,0.047480155,0.00010382434],"about_ca_topic_score_codex":0.008768516,"about_ca_topic_score_gemma":0.108158916,"teacher_disagreement_score":0.36478454,"about_ca_system_score_codex":0.00059905427,"about_ca_system_score_gemma":0.00017031572,"threshold_uncertainty_score":0.9978322},"labels":[],"label_agreement":null},{"id":"W2611610769","doi":"10.26443/mjm.v3i1.585","title":"CA 125: History, Current Status, and Future Prospects","year":2020,"lang":"en","type":"article","venue":"McGill Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Current (fluid); Oceanography; Geology","score_opus":0.039162181206524746,"score_gpt":0.2880090448663681,"score_spread":0.24884686365984332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611610769","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.075540096,0.3364495,0.00003345303,0.57381386,0.0048442124,0.0007276405,0.00003933727,0.000044545704,0.008507355],"genre_scores_gemma":[0.9150734,0.057709746,0.00061113405,0.017610442,0.008801328,0.0000071207105,0.000011549246,0.000040679064,0.00013457758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878645,0.000026379254,0.000398199,0.00016039063,0.00044019916,0.00018835645],"domain_scores_gemma":[0.9987792,0.00003201821,0.0002627213,0.00010705143,0.00017831592,0.00064072566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014850571,0.00015303036,0.00051690196,0.0000846744,0.00004024768,0.000002515723,0.0000513161,0.000041792562,0.0008200824],"category_scores_gemma":[0.00008548853,0.00009435018,0.000069028494,0.000110140936,0.00008145622,0.00006211728,0.000019404459,0.00032033195,0.000008000703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010227036,0.0004734946,0.033163115,0.00057392713,0.00046690376,0.0014401919,0.0019821813,0.0000012507492,0.0009383324,0.0020814114,0.6673159,0.2905406],"study_design_scores_gemma":[0.0071560396,0.0029782888,0.037232623,0.0004187214,0.00042825728,0.00031335073,0.00017621627,0.000009785668,0.00011627877,0.000042969015,0.951053,0.00007442024],"about_ca_topic_score_codex":0.000015347103,"about_ca_topic_score_gemma":0.0000021086053,"teacher_disagreement_score":0.8395333,"about_ca_system_score_codex":0.00037780523,"about_ca_system_score_gemma":0.00012842537,"threshold_uncertainty_score":0.89793265},"labels":[],"label_agreement":null},{"id":"W2612460126","doi":"10.1200/jco.2016.34.18_suppl.lba5503","title":"OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC).","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal; McGill University; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Carboplatin; Debulking; Clinical endpoint; Ovarian cancer; Randomized controlled trial; Gynecologic oncology; Chemotherapy; Surgery; Cisplatin; Internal medicine; Oncology; Urology; Cancer","score_opus":0.07684005521383697,"score_gpt":0.44211323446607603,"score_spread":0.36527317925223907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612460126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802769,0.002104575,0.0001293854,0.012624377,0.003738098,0.0010356678,0.000011960602,0.000014740641,0.00006433615],"genre_scores_gemma":[0.98141277,0.014577017,0.0012090196,0.0011456495,0.0014197581,0.00015454483,0.0000011844243,0.000048301197,0.000031758504],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939735,0.000878495,0.003661109,0.00049627735,0.00047684574,0.0005137827],"domain_scores_gemma":[0.9887296,0.008067486,0.0023003304,0.00026262025,0.00025381098,0.0003861834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004839964,0.0003840041,0.004811422,0.00034846345,0.00008271842,0.00001690185,0.00020190007,0.00044796133,0.0005880329],"category_scores_gemma":[0.0018280635,0.00022750467,0.0009843053,0.0002484213,0.00034610156,0.00017935804,0.00007470858,0.00070478796,9.959517e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28626418,0.012928543,0.045443878,0.000025013458,0.003481246,0.0010826989,0.0014670717,0.000013091434,0.00096055696,0.000013392808,0.000132768,0.6481876],"study_design_scores_gemma":[0.8427707,0.051653627,0.09835342,0.0008989779,0.0016344615,0.00010023878,0.00059789506,0.00015924062,0.0008415475,0.0000778894,0.0025859524,0.00032608403],"about_ca_topic_score_codex":0.0007755677,"about_ca_topic_score_gemma":0.00085931324,"teacher_disagreement_score":0.6478615,"about_ca_system_score_codex":0.00077114947,"about_ca_system_score_gemma":0.0018969883,"threshold_uncertainty_score":0.9277371},"labels":[],"label_agreement":null},{"id":"W2614222513","doi":"10.1016/j.jogc.2016.12.005","title":"No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population","year":2017,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Salpingectomy; Fallopian tube; Ovarian cancer; Gynecology; Obstetrics; Fallopian tube cancer; Population; Oncology; Cancer; Internal medicine; Pregnancy; Environmental health; Genetics","score_opus":0.03337702006682625,"score_gpt":0.3429919160081131,"score_spread":0.3096148959412868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614222513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987233,0.0036491163,0.000110722336,0.0016326554,0.006593462,0.000345521,0.00011887273,0.0000011696932,0.0003154802],"genre_scores_gemma":[0.9940345,0.0006531133,0.004933199,0.00016298243,0.00014658492,0.000014519956,0.0000036437095,0.00000901135,0.00004243045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992014,0.00008542505,0.00034079657,0.00011134772,0.00013244056,0.00012859203],"domain_scores_gemma":[0.9983617,0.0006829326,0.0005577264,0.00014170729,0.00017518744,0.00008072269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049478264,0.00008830865,0.00032542847,0.00010787935,0.00014906372,0.000024636573,0.00007102826,0.00007596018,0.00005711151],"category_scores_gemma":[0.00164103,0.000059778064,0.00004356602,0.0000630424,0.000052619678,0.000047787744,0.000013250684,0.0001501963,2.0514825e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039278286,0.000091482856,0.81126344,0.00006518857,0.00019653788,0.00011818008,0.0001924406,0.00003249143,0.000027977081,0.00065121194,0.0004937595,0.186828],"study_design_scores_gemma":[0.0026917714,0.0003364991,0.9850947,0.000017980838,0.00029813664,0.000049725633,0.00010057223,0.0003876155,0.000025456422,0.0002414302,0.010698653,0.0000574353],"about_ca_topic_score_codex":0.11531487,"about_ca_topic_score_gemma":0.053986147,"teacher_disagreement_score":0.18677057,"about_ca_system_score_codex":0.00038893585,"about_ca_system_score_gemma":0.00059553905,"threshold_uncertainty_score":0.96327615},"labels":[],"label_agreement":null},{"id":"W2615456282","doi":"10.1016/j.jogc.2017.03.121","title":"No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale","year":2017,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Gynecology; Medicine; Humanities; Philosophy","score_opus":0.018471624585663843,"score_gpt":0.2986591238318374,"score_spread":0.2801874992461736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615456282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9269766,0.025207162,0.0005380706,0.030889992,0.0071933754,0.00024159976,0.00026245014,0.000010661361,0.008680038],"genre_scores_gemma":[0.97497493,0.01599505,0.0050289133,0.0016111349,0.00038003034,0.000021895858,0.00001644639,0.000049969483,0.0019216442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973365,0.00083091285,0.0005995334,0.0002654532,0.00028545532,0.0006821091],"domain_scores_gemma":[0.9943374,0.0034783,0.0009243215,0.00028318385,0.00028916117,0.00068763935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017128794,0.00029593692,0.0007098861,0.00019105559,0.00045628037,0.0001910959,0.0002807009,0.00039223908,0.0004545564],"category_scores_gemma":[0.0049026976,0.00029279126,0.00015733606,0.00012251401,0.00020608681,0.00023070269,0.00008581271,0.0006907506,8.9826483e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004276949,0.0004936374,0.9245765,0.00019482385,0.00066461606,0.016073307,0.00045761565,0.0010042036,0.00008074987,0.0055660857,0.013453221,0.037392452],"study_design_scores_gemma":[0.0053139073,0.00047977155,0.92969066,0.00023243892,0.0007001972,0.0009809099,0.00038218583,0.002242523,0.00010592883,0.0009412523,0.058687042,0.0002432114],"about_ca_topic_score_codex":0.39048243,"about_ca_topic_score_gemma":0.43348467,"teacher_disagreement_score":0.047998264,"about_ca_system_score_codex":0.0074933395,"about_ca_system_score_gemma":0.017893989,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W2616131888","doi":"10.1101/mcs.a001628","title":"Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline<i>CHEK2</i>:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma","year":2017,"lang":"en","type":"article","venue":"Molecular Case Studies","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbotsford Veterinary Clinic; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"BC Cancer Foundation; Canadian Institutes of Health Research; Terry Fox Foundation; BC Cancer Agency; Canada Research Chairs; Michael Smith Health Research BC","keywords":"Concomitant; CHEK2; Germline; Germline mutation; Sex organ; Invasive ductal carcinoma; Carcinoma; Biology; Pathology; Cancer research; Medicine; Oncology; Breast cancer; Internal medicine; Mutation; Gene; Cancer; Genetics","score_opus":0.029438092180414613,"score_gpt":0.3015962004609867,"score_spread":0.2721581082805721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616131888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898934,0.008686355,0.000010986147,0.00043055005,0.000035587545,0.0008007615,0.00008084094,0.000006711003,0.000054850974],"genre_scores_gemma":[0.9972372,0.00026838735,0.002210404,0.000040790066,0.000017050472,0.00018338687,0.000012860243,0.000025659529,0.0000042306247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989159,0.000053130865,0.0003478558,0.00031314354,0.00017741659,0.0001925527],"domain_scores_gemma":[0.9989023,0.00011480562,0.00029684257,0.00034714528,0.000268111,0.00007077624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012270022,0.00021376405,0.0006454944,0.00014432264,0.00010059694,0.000016381575,0.000052967873,0.000030205145,0.000004532295],"category_scores_gemma":[0.00014987672,0.00016557073,0.00007633231,0.00010992896,0.00031885417,0.00007149796,0.00010196595,0.000082770996,8.207858e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005974786,0.00046538952,0.8956949,0.0009288934,0.0017400817,0.085819654,0.0035364153,0.000017245531,0.009839406,0.0001678137,0.000009547439,0.001183149],"study_design_scores_gemma":[0.01341069,0.0033861217,0.8262057,0.0010279021,0.0028644039,0.03171013,0.00825253,0.00020922635,0.11235256,0.00015357023,0.0000034590032,0.0004237542],"about_ca_topic_score_codex":0.0006466571,"about_ca_topic_score_gemma":0.0006661809,"teacher_disagreement_score":0.10251315,"about_ca_system_score_codex":0.00010270266,"about_ca_system_score_gemma":0.00017317742,"threshold_uncertainty_score":0.6751778},"labels":[],"label_agreement":null},{"id":"W2617296499","doi":"10.1007/s41669-017-0030-7","title":"Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Programs for Assessment of Technology in Health Research Institute; Impact","funders":"","keywords":"Bevacizumab; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.10839309429298337,"score_gpt":0.43427039666966477,"score_spread":0.3258773023766814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617296499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988376,0.00084802957,0.000001439477,0.0026416194,0.00060937845,0.003107551,0.0015783127,0.0000018305777,0.0028358002],"genre_scores_gemma":[0.9973195,0.0010061942,0.00023608649,0.000057715122,0.0000991513,0.0011443036,0.000059100224,0.000020645048,0.00005726535],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998836,0.00003039003,0.0005429609,0.00031254638,0.0000925074,0.00018559664],"domain_scores_gemma":[0.9986935,0.00007441921,0.00059061515,0.00045965565,0.000086212975,0.000095554096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000354205,0.00016071087,0.0006103609,0.000056225523,0.00007263136,0.000034118628,0.0002596756,0.000028898346,0.00089482556],"category_scores_gemma":[0.000015742922,0.00015051581,0.00007628076,0.000012734359,0.000026541653,0.00014980067,0.00006115,0.000025416406,0.0000023060813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006421968,0.0012299465,0.23459576,0.00025770685,0.002055895,0.000010135122,0.0006650558,0.007985532,0.0014195711,0.0012792323,0.0033503894,0.7407288],"study_design_scores_gemma":[0.09535861,0.0017322632,0.68840504,0.00049998023,0.0028179768,0.0000047103767,0.00024453385,0.07582735,0.105901726,0.000807295,0.02782882,0.0005716948],"about_ca_topic_score_codex":0.8744409,"about_ca_topic_score_gemma":0.9341331,"teacher_disagreement_score":0.7401571,"about_ca_system_score_codex":0.0061898576,"about_ca_system_score_gemma":0.005767173,"threshold_uncertainty_score":0.9998692},"labels":[],"label_agreement":null},{"id":"W2619672834","doi":"10.1186/s13044-017-0038-1","title":"Malignant Struma ovarii in a 30-year old nulliparous patient","year":2017,"lang":"en","type":"article","venue":"Thyroid Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Struma ovarii; Medicine; Thyroid; Thyroid nodules; Malignancy; Thyroid carcinoma; Nodule (geology); Teratoma; Radiology; Gynecology; Pathology; Internal medicine","score_opus":0.08385616524969806,"score_gpt":0.39307212110532724,"score_spread":0.30921595585562917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619672834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585342,0.00082804525,0.0000016673222,0.0061718025,0.00013540497,0.00088912656,0.000020807194,0.000025084048,0.03339387],"genre_scores_gemma":[0.9969634,0.0006349669,0.00022850979,0.00011553176,0.00018722798,0.00021294672,0.000009983014,0.0000310313,0.0016164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763983,0.00011883918,0.0002547581,0.0004547522,0.0008442574,0.0006875591],"domain_scores_gemma":[0.9981637,0.000092901304,0.00006557384,0.0012606473,0.00016524331,0.00025191944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075814617,0.00014722555,0.00030899135,0.00022157711,0.000356499,0.00013556285,0.0002819828,0.00010261304,0.00085348944],"category_scores_gemma":[0.00022482633,0.00011260368,0.00007714108,0.00014109424,0.00020384973,0.00008322654,0.00027153373,0.00047502734,0.0008370815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021157914,0.0052260268,0.7941756,0.00031895065,0.0005313818,0.0070513245,0.0037744942,0.00001621029,0.0070503773,0.019474125,0.05574435,0.104521364],"study_design_scores_gemma":[0.009848247,0.0043413155,0.94021297,0.00073330937,0.000049892926,0.000063903084,0.0007890492,0.00017009943,0.019278085,0.002057715,0.022116648,0.0003387428],"about_ca_topic_score_codex":0.0030629956,"about_ca_topic_score_gemma":0.00021133022,"teacher_disagreement_score":0.14603738,"about_ca_system_score_codex":0.0003819384,"about_ca_system_score_gemma":0.00024384628,"threshold_uncertainty_score":0.9999409},"labels":[],"label_agreement":null},{"id":"W2621232858","doi":"10.1111/his.13272","title":"A comparison of p53 and <scp>WT</scp>1 immunohistochemical expression patterns in tubo‐ovarian high‐grade serous carcinoma before and after neoadjuvant chemotherapy","year":2017,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Calgary","funders":"Cancer Research UK","keywords":"Immunohistochemistry; Chemotherapy; Serous carcinoma; Pathology; Ovarian carcinoma; Serous fluid; Medicine; Biopsy; Biology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.01473724417309697,"score_gpt":0.2979025004244863,"score_spread":0.28316525625138933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621232858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548584,0.0026309344,0.00003645791,0.0011005626,0.00017230616,0.0003632956,0.000030781182,0.000015668324,0.00016412936],"genre_scores_gemma":[0.9983549,0.00014837294,0.00089498766,0.0002089048,0.00008301799,0.00011613832,0.000024104886,0.000029481702,0.00014005997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874526,0.00004836948,0.0003559579,0.00044758987,0.00012813677,0.00027467185],"domain_scores_gemma":[0.9989622,0.000049225942,0.00022614609,0.00060579064,0.00003567682,0.00012093369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010702628,0.00022131333,0.0006972646,0.000110001645,0.00009602135,0.000016225302,0.0001073416,0.000213717,0.000028603716],"category_scores_gemma":[0.000044955894,0.00018820891,0.000057922334,0.000028510416,0.0002906357,0.00006124902,0.000105120045,0.00022109947,0.0000023630932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014986763,0.00043973394,0.9590412,0.00012003593,0.000008407375,0.00049250154,0.0036229037,1.5287094e-7,0.03142629,0.000059281007,0.00018420188,0.004455435],"study_design_scores_gemma":[0.004907603,0.00070603896,0.9807274,0.0002517972,0.000070044596,0.00024856447,0.00012679138,0.000030547006,0.011887629,0.00011256645,0.0008609592,0.00007009379],"about_ca_topic_score_codex":0.0005898651,"about_ca_topic_score_gemma":0.00021537497,"teacher_disagreement_score":0.021686176,"about_ca_system_score_codex":0.00015263884,"about_ca_system_score_gemma":0.000043674514,"threshold_uncertainty_score":0.76749367},"labels":[],"label_agreement":null},{"id":"W2622400237","doi":"10.1158/1557-3265.ovcasymp16-ntoc-083","title":"Abstract NTOC-083: TARGETED APPROACH WITH MOMELOTINIB TREATMENT ATTENUATES PACLITAXEL–INDUCED ENRICHMENT OF CANCER STEM CELLS (CSC)–LIKE AND SUPPRESSES OVARIAN CANCER TUMORIGENESIS AND RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Paclitaxel; Ovarian cancer; Medicine; In vivo; Cancer; Immunohistochemistry; Chemotherapy; Internal medicine; Oncology; Cancer research; Biology","score_opus":0.24230385602564472,"score_gpt":0.48325985584467324,"score_spread":0.24095599981902852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622400237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97327393,0.017587198,0.0000028797822,0.005175929,0.00045521578,0.0022331763,0.0007078217,0.000030267309,0.0005335742],"genre_scores_gemma":[0.93932027,0.056612823,0.00030797248,0.000082526305,0.00048297763,0.0024839665,0.000023100945,0.0000637319,0.0006226546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956149,0.00026209553,0.0008779164,0.0013884719,0.0009779757,0.00087864115],"domain_scores_gemma":[0.9960422,0.0007984555,0.00050946925,0.0012205995,0.0006790092,0.0007502671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012086577,0.00047642086,0.0012708857,0.0001737672,0.0005668681,0.00019268111,0.00035510233,0.00024926855,0.00034499395],"category_scores_gemma":[0.0000909563,0.00032034708,0.00016164237,0.00025343083,0.0011954635,0.00019744522,0.00024096016,0.00056843105,0.000007482974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025444673,0.001884117,0.8231603,0.0008244614,0.0013907792,0.00010635653,0.000540394,0.000016899334,0.0023846484,0.000046317848,0.0015926567,0.16550863],"study_design_scores_gemma":[0.008316139,0.0029344081,0.9520142,0.0011252589,0.0005441733,0.000006211529,0.00040380794,0.000090734684,0.029323235,0.00003010904,0.0048246626,0.00038704879],"about_ca_topic_score_codex":0.032918666,"about_ca_topic_score_gemma":0.0037432136,"teacher_disagreement_score":0.16512157,"about_ca_system_score_codex":0.0005534326,"about_ca_system_score_gemma":0.0014951827,"threshold_uncertainty_score":0.99992484},"labels":[],"label_agreement":null},{"id":"W2622683216","doi":"10.1371/journal.pone.0178989","title":"Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C&gt;G FOXL2 mutation","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Jikei University School of Medicine; Terry Fox Research Institute","keywords":"Mutation; Biology; Ovary; Immunohistochemistry; Cancer research; Allele; Pathology; Internal medicine; Medicine; Genetics; Gene","score_opus":0.07289517440735635,"score_gpt":0.304152049676788,"score_spread":0.23125687526943164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622683216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978446,0.00079501356,0.0000061746414,0.00065604737,0.000056947574,0.0004607051,0.000044751258,0.000003855376,0.00013192676],"genre_scores_gemma":[0.99800074,0.0007641668,0.0010766635,0.000038134338,0.000034153047,0.00001837992,0.000023023944,0.00000830602,0.000036404814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883974,0.0000651662,0.00047135047,0.00020057714,0.000337156,0.000086005304],"domain_scores_gemma":[0.99829715,0.00008013156,0.00059258315,0.00060693617,0.00036924743,0.000053973403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001240001,0.000090583715,0.00050076836,0.000075739685,0.0000522717,0.0000071288305,0.00010634148,0.000043606888,0.000025358051],"category_scores_gemma":[0.00021173994,0.00006335997,0.00023483981,0.00014035599,0.0001511141,0.000043184034,0.000055418346,0.000065135,7.214087e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032135472,0.0034640676,0.987272,0.0004878731,0.0029706198,0.000004943851,0.0003071099,0.00002284288,0.003164792,0.000018412999,0.000034274075,0.0019316665],"study_design_scores_gemma":[0.0016365626,0.0012325385,0.9631292,0.00037726448,0.009539643,9.872758e-7,0.000030914493,0.0033977835,0.020570507,0.000029256591,0.000005177478,0.000050169514],"about_ca_topic_score_codex":0.00022677261,"about_ca_topic_score_gemma":0.00008805216,"teacher_disagreement_score":0.024142846,"about_ca_system_score_codex":0.00002331424,"about_ca_system_score_gemma":0.00004973377,"threshold_uncertainty_score":0.25837445},"labels":[],"label_agreement":null},{"id":"W2623437396","doi":"10.1158/1557-3265.ovcasymp16-tmem-036","title":"Abstract TMEM-036: INTERFERON INDUCED STAT1 ASSOCIATES WITH DIFFERENTIAL CHEMOTHERAPY RESPONSE IN HIGH-GRADE SEROUS OVARIAN CANCER","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"STAT1; Ovarian cancer; Tumor microenvironment; Cancer research; Biology; Immune system; Gene signature; Gene knockdown; Chemotherapy; Small hairpin RNA; Cancer; Immunology; Interferon; Gene expression; Cell culture; Gene","score_opus":0.22922710584305234,"score_gpt":0.5245707499841041,"score_spread":0.2953436441410518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623437396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648205,0.0002679128,0.0000014163554,0.0325197,0.0008016535,0.0011225301,0.00011017475,0.00003729681,0.00031878866],"genre_scores_gemma":[0.99545556,0.001305115,0.0000710736,0.00046062758,0.000819892,0.0006373231,0.000012787741,0.00008663064,0.0011509841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957929,0.0005221622,0.00071740546,0.00095873844,0.0010814447,0.0009273114],"domain_scores_gemma":[0.9967743,0.0007784695,0.00032942725,0.0012972946,0.00034666274,0.0004738459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00191004,0.0003213068,0.0008971903,0.00020020627,0.00037020553,0.00022207969,0.00057920837,0.00040261264,0.0014452036],"category_scores_gemma":[0.0006709762,0.00023563534,0.00020865879,0.0002623263,0.00045077782,0.00017381574,0.00024173233,0.0017315223,0.0000352293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031204835,0.002414664,0.9249935,0.00010725468,0.0005636569,0.00030624116,0.00034129588,0.0000051925854,0.0027404015,0.000044429424,0.0017608018,0.035517707],"study_design_scores_gemma":[0.017042104,0.0022901339,0.97189945,0.0013025276,0.00006823322,0.0000023149835,0.000047420228,0.000018395129,0.00543604,0.0001305168,0.0015202868,0.00024258818],"about_ca_topic_score_codex":0.02370837,"about_ca_topic_score_gemma":0.012884241,"teacher_disagreement_score":0.046905924,"about_ca_system_score_codex":0.0021409146,"about_ca_system_score_gemma":0.0024004905,"threshold_uncertainty_score":0.9994676},"labels":[],"label_agreement":null},{"id":"W2623439833","doi":"10.7439/ijbar.v8i5.4000","title":"Role of USG and CT scan in evaluating ovarian lesions","year":2017,"lang":"en","type":"article","venue":"International Journal of Biomedical and Advance Research - International Journal of Biomedical and Advance Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiology; Abdomen; Ultrasonography; Pelvis; Ultrasound; Lesion; Computed tomography; Tomography; Pathology","score_opus":0.09926730824198352,"score_gpt":0.5167067555794033,"score_spread":0.4174394473374198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623439833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350693,0.011205981,0.00040398486,0.05153008,0.0009228081,0.00028039608,0.00008581858,0.0000037453235,0.0004978711],"genre_scores_gemma":[0.9608372,0.032045707,0.005407477,0.000084625244,0.0014618302,0.000009008147,0.000009457811,0.000019623185,0.0001250934],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9915887,0.00034803394,0.0014180951,0.0003664275,0.005719749,0.0005590011],"domain_scores_gemma":[0.9926449,0.0014129824,0.0008321111,0.0002330225,0.003868667,0.0010082822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068141944,0.00021026243,0.0006886297,0.0018836957,0.00026247563,0.00022692923,0.0010337613,0.0001229122,0.00016483905],"category_scores_gemma":[0.005890705,0.00014870429,0.00016900356,0.0003259336,0.002690424,0.000778032,0.0007033278,0.0016236958,0.0000025159518],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002437211,0.0017172403,0.0317006,0.00011012619,0.00065637217,0.0032266784,0.00033578835,0.0000037449179,0.02761233,0.0023621174,0.0005109138,0.9293269],"study_design_scores_gemma":[0.034268163,0.011862999,0.65024704,0.017228348,0.00015482432,0.015592581,0.004563042,0.0027009158,0.008915247,0.06789243,0.1859746,0.00059978897],"about_ca_topic_score_codex":0.00015878289,"about_ca_topic_score_gemma":0.00002721514,"teacher_disagreement_score":0.9287271,"about_ca_system_score_codex":0.00039839724,"about_ca_system_score_gemma":0.00088525907,"threshold_uncertainty_score":0.9912979},"labels":[],"label_agreement":null},{"id":"W2624530626","doi":"10.1634/theoncologist.2017-0047","title":"Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"UCLH Biomedical Research Centre; Medical Research Council; National Health and Medical Research Council; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Cancer Research UK; American Society of Clinical Oncology","keywords":"Medicine; Chemotherapy; Internal medicine; Oncology; Proportional hazards model; Quality of life (healthcare); Carboplatin; Cancer; Logistic regression; Cisplatin","score_opus":0.031498484669945155,"score_gpt":0.3183567643721904,"score_spread":0.28685827970224526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624530626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98890907,0.0005043303,0.000001188462,0.0065927273,0.00030512045,0.0012116636,0.000044142733,0.00002751382,0.002404246],"genre_scores_gemma":[0.9984382,0.00034359872,0.000031149426,0.00012256618,0.00028354747,0.00015269886,0.0000057947263,0.000027681217,0.00059476163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848765,0.00012319694,0.00040492398,0.0003751016,0.00031525278,0.00029387954],"domain_scores_gemma":[0.99814725,0.00037204617,0.0003911649,0.0009329515,0.0000767386,0.00007986041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009509816,0.00021916258,0.00057250034,0.000059365426,0.00042957847,0.00007594623,0.0003410864,0.0000981963,0.0000967833],"category_scores_gemma":[0.000116957264,0.00012570011,0.000063548614,0.00010567728,0.0004192068,0.00008059559,0.00011443258,0.00025352262,0.000002836309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019046399,0.0011436419,0.9594512,0.0000414761,0.00084443105,0.000083757404,0.0066377083,0.0001576284,0.0024255735,0.00020371114,0.00027039569,0.026835816],"study_design_scores_gemma":[0.004437987,0.0016587739,0.99127823,0.00026064852,0.00027480483,0.0000033727247,0.00089119596,0.00014761658,0.00015081318,0.00007748391,0.0006954739,0.00012357067],"about_ca_topic_score_codex":0.02074672,"about_ca_topic_score_gemma":0.0062575717,"teacher_disagreement_score":0.03182704,"about_ca_system_score_codex":0.00044246536,"about_ca_system_score_gemma":0.00025258953,"threshold_uncertainty_score":0.9857742},"labels":[],"label_agreement":null},{"id":"W2624770203","doi":"10.1200/jco.2014.32.15_suppl.tps5620","title":"Phase II study of oral ENMD-2076 administered to patients with ovarian clear cell carcinoma: A trial of the Princess Margaret Phase II Consortium.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Phases of clinical research; Ovarian carcinoma; Oncology; Internal medicine; Ovarian cancer; Phase (matter); Clinical trial; Cancer","score_opus":0.09546610559454094,"score_gpt":0.44151368234750143,"score_spread":0.3460475767529605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624770203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324566,0.000017236865,0.000019179353,0.003057126,0.001181545,0.0015599304,0.000024422234,0.000003679662,0.0008911928],"genre_scores_gemma":[0.99791545,0.000010321857,0.00073829235,0.0007515469,0.00043721346,0.000021547932,0.0000027510748,0.000021731303,0.00010116588],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99527943,0.00079459196,0.0027582836,0.00028104943,0.00064910983,0.00023754478],"domain_scores_gemma":[0.994561,0.0008698581,0.0029877264,0.00049768004,0.00064801506,0.0004356978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019615155,0.00020195027,0.0020010888,0.00010945182,0.00009034299,0.0000055310647,0.00029782703,0.00020376545,0.00015212291],"category_scores_gemma":[0.0011447512,0.00010985811,0.00039302188,0.00020497577,0.00019911541,0.00005939957,0.00017163022,0.000514763,0.0000018077552],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39657784,0.25429124,0.28775188,0.000048231916,0.00075116934,0.00014144905,0.0010877904,0.000006703418,0.000026838694,0.00005101416,0.0013825428,0.057883326],"study_design_scores_gemma":[0.37927854,0.4387956,0.16771854,0.000064257845,0.0010875963,0.000009919549,0.00013721146,0.000007278726,0.00019798841,0.000010602834,0.012623595,0.00006884251],"about_ca_topic_score_codex":0.00008284627,"about_ca_topic_score_gemma":0.00012620927,"teacher_disagreement_score":0.18450437,"about_ca_system_score_codex":0.00011743095,"about_ca_system_score_gemma":0.0013491738,"threshold_uncertainty_score":0.44798836},"labels":[],"label_agreement":null},{"id":"W26755573","doi":"10.1016/s1701-2163(16)34143-3","title":"Cancer de l’ovaire : La lumière au bout du tunnel!","year":2009,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Gynecology; Cancer; Humanities; Internal medicine","score_opus":0.008627678686328112,"score_gpt":0.24484244579979783,"score_spread":0.23621476711346973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W26755573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54296374,0.33773735,0.000024526815,0.06569586,0.0467172,0.00022112145,0.00009371227,0.000005064297,0.006541444],"genre_scores_gemma":[0.9752133,0.018965099,0.00021213788,0.003266571,0.00072391314,0.00000427512,0.0000022064053,0.00001833583,0.0015941837],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99808633,0.00013142408,0.0005929626,0.00020400633,0.00034304688,0.00064225635],"domain_scores_gemma":[0.99643564,0.0019011488,0.00046476503,0.00015150945,0.0003419169,0.0007050424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004054903,0.00024872413,0.00066713075,0.00019370994,0.00016481645,0.000039652146,0.00013954277,0.00028766596,0.0015366956],"category_scores_gemma":[0.0016164087,0.00021674366,0.00013534495,0.0003681586,0.00011837419,0.00008977273,0.000025816393,0.00056706194,0.0000019431861],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000010483844,0.00036038936,0.44729403,0.00007754048,0.00048389696,0.020144662,0.00028981408,0.00015739628,0.0000038521334,0.0011282756,0.03673974,0.49330992],"study_design_scores_gemma":[0.0035309186,0.00092132285,0.72257155,0.00009715299,0.0007097026,0.0005077114,0.0002531656,0.00007836481,0.000029711235,0.00019449854,0.2709601,0.00014580075],"about_ca_topic_score_codex":0.12921624,"about_ca_topic_score_gemma":0.16506512,"teacher_disagreement_score":0.49316412,"about_ca_system_score_codex":0.008756909,"about_ca_system_score_gemma":0.014386624,"threshold_uncertainty_score":0.99937606},"labels":[],"label_agreement":null},{"id":"W26991058","doi":"10.1111/tpj.13162","title":"Renal amyloidosis and gastrogastric intussusception in a West Highland White Terrier","year":2011,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Australian Research Council; Natural Sciences and Engineering Research Council of Canada","keywords":"Intussusception (medical disorder); Medicine; Amyloidosis; White (mutation); Pathology; General surgery; Biology","score_opus":0.02304398554923231,"score_gpt":0.2359728548055428,"score_spread":0.2129288692563105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W26991058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397475,0.00010939256,0.000115389,0.00095916336,0.000050665556,0.00023023246,0.0000042800543,0.000028169588,0.014527927],"genre_scores_gemma":[0.99577963,0.00014913156,0.0030908452,0.000225942,0.00006240851,0.00004947943,0.000008927993,0.000009146171,0.0006244882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939823,0.000013871025,0.00014251319,0.00019991725,0.000085617176,0.00015982661],"domain_scores_gemma":[0.9997094,0.000008523334,0.000027849424,0.00012620278,0.000018137589,0.00010985922],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006144031,0.00009798748,0.000158511,0.00012917921,0.00001875133,0.000010186116,0.000019942654,0.000042134,0.0020728845],"category_scores_gemma":[0.000005665582,0.00007104741,0.000028274504,0.00013219003,0.000030162511,0.000060156657,0.000019766463,0.000068038236,0.000038144666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011828066,0.00025525317,0.9868655,0.000012613184,0.000030431891,0.000049541723,0.00049178966,2.338673e-7,0.00011566488,0.00017493051,0.0005606139,0.011325138],"study_design_scores_gemma":[0.002463098,0.0005776466,0.99522465,0.00007591806,0.00006564804,0.000041824576,0.00010427915,0.000023116414,0.00044480708,0.000051866376,0.0008681562,0.000058963287],"about_ca_topic_score_codex":0.0005167654,"about_ca_topic_score_gemma":0.00055500894,"teacher_disagreement_score":0.013903439,"about_ca_system_score_codex":0.00006636033,"about_ca_system_score_gemma":0.000023967108,"threshold_uncertainty_score":0.9988394},"labels":[],"label_agreement":null},{"id":"W2724223456","doi":"10.14740/jcgo.v6i2.439","title":"Hyperreactio Luteinalis in the Third Trimester Complicating Fetal Hydrops and Mirror Syndrome","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Polyhydramnios; Gestation; Pleural effusion; Fetus; Pregnancy; Ascites; Obstetrics; Presentation (obstetrics); Surgery; Effusion; Gynecology","score_opus":0.10326024285010718,"score_gpt":0.41215273597860896,"score_spread":0.30889249312850175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724223456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839411,0.0023572447,0.0000049800315,0.01121185,0.000741415,0.00016751575,0.0000018446711,0.0000024391086,0.0015716148],"genre_scores_gemma":[0.9952546,0.002175524,0.0008596008,0.0015112775,0.00009256391,0.0000044781714,7.2349104e-7,0.000006526317,0.00009471759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985591,0.00015761254,0.0007999848,0.00016516515,0.00016180098,0.00015634674],"domain_scores_gemma":[0.99168736,0.0070519866,0.0007506513,0.00028140916,0.00008836813,0.00014021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014814828,0.00010631157,0.0006331132,0.000092377784,0.00017956663,0.00005602425,0.00015745951,0.0001866858,0.00001494143],"category_scores_gemma":[0.007360404,0.00006156944,0.00014444813,0.00007052632,0.00024559433,0.0001252042,0.000055052893,0.00063355186,0.0000041731396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011857189,0.00055875734,0.93990606,0.000025182708,0.00012921175,0.0015066699,0.000116480835,1.461908e-7,0.0000045932334,0.00014142001,0.00026959588,0.057223286],"study_design_scores_gemma":[0.004847646,0.0016001351,0.9780357,0.00006910551,0.0002750369,0.0023380418,0.00010853635,0.000042660475,0.000005863036,0.00028947953,0.01232855,0.000059231585],"about_ca_topic_score_codex":0.000027407947,"about_ca_topic_score_gemma":0.00002078633,"teacher_disagreement_score":0.057164054,"about_ca_system_score_codex":0.00003137515,"about_ca_system_score_gemma":0.00011455372,"threshold_uncertainty_score":0.8811622},"labels":[],"label_agreement":null},{"id":"W2727227103","doi":"10.4158/ep161685.cr","title":"Malignant Ovarian Steroid Cell Tumor Causing Severe Hyperandrogenism: Case Report And Review Of The Literature","year":2017,"lang":"en","type":"article","venue":"AACE Clinical Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hyperandrogenism; Dehydroepiandrosterone sulfate; Androgen Excess; Testosterone (patch); Androgen; Histopathology; Ovarian tumor; Dehydroepiandrosterone; Internal medicine; Pathology; Hormone; Ovarian cancer; Cancer; Polycystic ovary","score_opus":0.042188867212417075,"score_gpt":0.35930373497727885,"score_spread":0.31711486776486175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727227103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94386286,0.048100714,0.000001910169,0.004705764,0.0008056406,0.0010320471,0.00003178156,0.000018214514,0.0014410436],"genre_scores_gemma":[0.9889302,0.007853605,0.00048464575,0.0016697488,0.00024990318,0.000033048615,0.00001287855,0.000030008721,0.0007359181],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99722946,0.00013429218,0.0014458331,0.0006629886,0.00029596785,0.00023146308],"domain_scores_gemma":[0.9952739,0.00017623318,0.0016326592,0.0023418549,0.00028311802,0.00029226785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016044467,0.00024190049,0.00085044117,0.00002355748,0.00036651222,0.00007785013,0.000043704313,0.00014288924,0.00006799797],"category_scores_gemma":[0.0010490265,0.00014517235,0.00040745412,0.000081779384,0.00020739023,0.0001078888,0.00019193495,0.0003433979,0.0000014950438],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034898836,0.00027349757,0.07533458,0.0020289838,0.00011472451,0.9192642,0.000060812756,1.142166e-7,0.000019232435,0.000008265261,0.0013529157,0.0015077738],"study_design_scores_gemma":[0.0011119745,0.00018561281,0.014363805,0.008596336,0.0011755024,0.96812135,0.000027782342,0.0000031731988,0.0006597656,0.0000295609,0.005573878,0.00015128283],"about_ca_topic_score_codex":0.00035388663,"about_ca_topic_score_gemma":0.00007137498,"teacher_disagreement_score":0.060970772,"about_ca_system_score_codex":0.000050560746,"about_ca_system_score_gemma":0.00036246792,"threshold_uncertainty_score":0.59199566},"labels":[],"label_agreement":null},{"id":"W2728485935","doi":"10.1097/pec.0000000000001237","title":"Ovarian Torsion in a Pediatric Patient","year":2017,"lang":"en","type":"article","venue":"Pediatric Emergency Care","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ovarian torsion; Abdominal pain; Emergency department; White blood cell; Surgery; Fallopian tube; Ultrasound; Ovary; Pelvic pain; Radiology; Internal medicine; Nursing","score_opus":0.01566030840161942,"score_gpt":0.29117065001463305,"score_spread":0.27551034161301363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728485935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965857,0.012678783,0.0000047153953,0.0009008881,0.002470225,0.0006583494,0.000025678084,0.000047750516,0.017356599],"genre_scores_gemma":[0.98143244,0.01592634,0.00026727305,0.000049599956,0.001950332,0.00014521918,0.00003668845,0.000030095587,0.00016203332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983711,0.000025714166,0.00040749056,0.00044721033,0.0003477096,0.00040075686],"domain_scores_gemma":[0.9986151,0.000012498466,0.00021631492,0.00078855973,0.00016325434,0.00020427519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000803144,0.0002141582,0.00029677406,0.00021868505,0.00030324346,0.000023031354,0.00016992091,0.00011938514,0.00069485186],"category_scores_gemma":[0.00013405806,0.00018697923,0.00017215584,0.0002232719,0.000010793601,0.000123128,0.000121527926,0.00017020719,0.000119854034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000377231,0.00025956627,0.9851761,0.00020742216,0.0000126899195,0.00016687684,0.0013029358,0.000003175715,0.0000019351885,0.00008587206,0.0062885997,0.0064571444],"study_design_scores_gemma":[0.0016154731,0.00035293057,0.99292487,0.000011544944,0.00033679747,0.000005120657,0.00027997736,0.000008182753,0.000040924522,0.00004804738,0.0041715303,0.00020459326],"about_ca_topic_score_codex":0.00067801913,"about_ca_topic_score_gemma":0.0003684756,"teacher_disagreement_score":0.017194565,"about_ca_system_score_codex":0.0002584801,"about_ca_system_score_gemma":0.00019189302,"threshold_uncertainty_score":0.7624792},"labels":[],"label_agreement":null},{"id":"W2733126121","doi":"10.1097/pas.0000000000000895","title":"DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors","year":2017,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"","keywords":"Biology; Mutation; Cellular differentiation; Pathology; Sexual differentiation; Mutation frequency; Germline mutation; Somatic cell; Cancer research; Genetics; Medicine; Gene","score_opus":0.02562322291702494,"score_gpt":0.2989996694921113,"score_spread":0.27337644657508636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733126121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128384,0.0006944159,0.000014113977,0.016976824,0.000084992884,0.00014743618,0.00001095949,0.000005276752,0.00078216166],"genre_scores_gemma":[0.99861485,0.00082384056,0.00011461915,0.00023617834,0.00009583856,0.000009456227,0.0000022599372,0.000013181856,0.00008977233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988305,0.00020396733,0.00040124013,0.00016603006,0.00017432826,0.00022391399],"domain_scores_gemma":[0.9983907,0.00022585198,0.00080914615,0.00028774628,0.000115859584,0.00017074386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022271025,0.00013960466,0.00065174315,0.00009862787,0.00016210086,0.000048141002,0.00014590753,0.00003178694,0.000037700895],"category_scores_gemma":[0.00004170546,0.00008157225,0.00011718743,0.000071805414,0.000727258,0.00006642399,0.00006086796,0.00029403626,0.0000047278672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036589215,0.0019247828,0.92285687,0.000054568703,0.0003704651,0.035691496,0.001532647,0.00017020086,0.0007933084,0.00030067528,0.0003430894,0.032302957],"study_design_scores_gemma":[0.0039873817,0.0010698914,0.98867905,0.00012236326,0.00019328625,0.0041593644,0.00062149856,0.00014104325,0.00028464387,0.00038031486,0.00027200792,0.00008916379],"about_ca_topic_score_codex":0.0001550583,"about_ca_topic_score_gemma":0.000024960544,"teacher_disagreement_score":0.065822154,"about_ca_system_score_codex":0.00005230678,"about_ca_system_score_gemma":0.00008453213,"threshold_uncertainty_score":0.332642},"labels":[],"label_agreement":null},{"id":"W2733225411","doi":"10.1002/path.4934","title":"Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?","year":2017,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; BC Cancer Foundation; Canada Research Chairs; Cancer Research Institute","keywords":"Cell; Clear cell; Cancer research; Pathology; Biology; Carcinoma; Medicine; Genetics","score_opus":0.04241909929608316,"score_gpt":0.28560852003458476,"score_spread":0.24318942073850158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733225411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502647,0.002029693,0.00006510799,0.0019749575,0.00025966682,0.00014318671,0.000037673075,0.000002145421,0.0004610763],"genre_scores_gemma":[0.9984117,0.0009449575,0.00023577154,0.00009640034,0.00015588797,0.0000020623263,3.870522e-7,0.000008306752,0.0001445295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992677,0.000087161236,0.00026716953,0.00009214378,0.00012758144,0.00015823108],"domain_scores_gemma":[0.9986125,0.00026588875,0.00054815924,0.00033381084,0.00012523656,0.000114365954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044686286,0.000104970146,0.0004989604,0.00008964739,0.00012582501,0.000016023414,0.00019572843,0.00004529832,0.000055630844],"category_scores_gemma":[0.000118447344,0.00005280644,0.00007392286,0.000050345912,0.00014082603,0.000039175437,0.00007766838,0.0001492673,0.0000058272044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006535547,0.0003354725,0.9744277,0.00007177548,0.000106842905,0.00055017794,0.001140703,0.0000031926625,0.018385516,0.000038503335,0.00084357546,0.0034430071],"study_design_scores_gemma":[0.0020103015,0.0024124482,0.95575106,0.000105996805,0.00028152342,0.0005670519,0.00045550385,0.0000032037321,0.036687493,0.00013259408,0.0015352224,0.000057614616],"about_ca_topic_score_codex":0.00006919524,"about_ca_topic_score_gemma":0.00002310669,"teacher_disagreement_score":0.018676633,"about_ca_system_score_codex":0.00003498141,"about_ca_system_score_gemma":0.000055336022,"threshold_uncertainty_score":0.21533841},"labels":[],"label_agreement":null},{"id":"W2733704888","doi":"10.14740/jcgo.v6i2.442","title":"Bilateral Thyroid-Type Struma Ovarii in a Postmenopausal Patient: A Case Report and Review of Literature","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Struma ovarii; Medicine; Thyroid; Malignancy; Differential diagnosis; Gynecology; Pathology; Radiology; Internal medicine","score_opus":0.045775837073617785,"score_gpt":0.3957845296058822,"score_spread":0.3500086925322644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733704888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8998701,0.09599059,6.7622443e-7,0.0026083384,0.0010513572,0.00020410106,0.0000078506455,0.0000015566471,0.0002654583],"genre_scores_gemma":[0.90099984,0.09707956,0.00070518494,0.001067265,0.000095122996,0.0000016782009,0.0000031743245,0.000006656285,0.00004149598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793714,0.00012437934,0.0014571309,0.00018896574,0.00015345142,0.00013891155],"domain_scores_gemma":[0.9955188,0.0020777043,0.0015023376,0.00030307393,0.00040345074,0.00019465871],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010635504,0.000119583536,0.00095291,0.00013859541,0.00006656527,0.000022688637,0.00006283853,0.00023699964,0.00003467865],"category_scores_gemma":[0.01794093,0.00007875403,0.0001159566,0.0001434642,0.00015165187,0.00011940347,0.00007138887,0.0005155063,5.192303e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038771273,0.0007304935,0.6731147,0.00077007624,0.00021773366,0.2408356,0.00011761659,1.8125021e-7,0.0000035329135,0.00009734538,0.00053965853,0.08318532],"study_design_scores_gemma":[0.006217498,0.01165983,0.8823121,0.0041409037,0.00059469906,0.08725161,0.000031418767,0.000009497997,0.00001977247,0.00032979343,0.0073243384,0.000108523665],"about_ca_topic_score_codex":0.000011647426,"about_ca_topic_score_gemma":0.000011033532,"teacher_disagreement_score":0.20919739,"about_ca_system_score_codex":0.00003522261,"about_ca_system_score_gemma":0.00023920201,"threshold_uncertainty_score":0.99033135},"labels":[],"label_agreement":null},{"id":"W2735026933","doi":"10.1200/jco.2017.35.15_suppl.5575","title":"Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Proportional hazards model; Carboplatin; Ovarian cancer; Logistic regression; Cancer; Surgery; Oncology; Cisplatin","score_opus":0.05070146682993377,"score_gpt":0.394004814131398,"score_spread":0.3433033473014642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735026933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935631,0.00017304745,0.000024229774,0.0043952083,0.00072173413,0.0009329332,0.000024686433,0.0000029917646,0.00016205144],"genre_scores_gemma":[0.9976911,0.0010559614,0.0003440376,0.0002497727,0.000573618,0.000011844011,0.0000016849264,0.00002667526,0.000045289464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968737,0.00023461525,0.0018113945,0.0002889077,0.0005692928,0.00022209734],"domain_scores_gemma":[0.995509,0.00076288346,0.0023881483,0.00037595702,0.000783881,0.00018012867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017461837,0.0002237495,0.001806607,0.000104162806,0.0000903051,0.00002124151,0.00020967769,0.00021858008,0.00002528447],"category_scores_gemma":[0.00036503226,0.00012798248,0.00022951493,0.00006770171,0.00034415812,0.00012183123,0.000063709536,0.0005600679,1.5940475e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00914675,0.0037151743,0.8267477,0.000022847576,0.0017827121,0.0000500364,0.0014448123,0.000016143771,0.000009976686,0.00001176352,0.0000325271,0.15701951],"study_design_scores_gemma":[0.02463591,0.020326626,0.9528825,0.00061416376,0.0006299901,0.000006818748,0.00030139377,0.000045872486,0.000090084286,0.000017360058,0.00034652828,0.00010273885],"about_ca_topic_score_codex":0.00047868822,"about_ca_topic_score_gemma":0.0014814566,"teacher_disagreement_score":0.15691677,"about_ca_system_score_codex":0.00015632126,"about_ca_system_score_gemma":0.000748852,"threshold_uncertainty_score":0.5218974},"labels":[],"label_agreement":null},{"id":"W2735772884","doi":"10.1136/bmj.j3277","title":"Why does the ovarian cancer screening fact box exist?","year":2017,"lang":"en","type":"letter","venue":"BMJ","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Computer science; Cancer; Data science; Ovarian cancer; Medicine; Gynecology; Bioinformatics; Internal medicine; Biology","score_opus":0.05435084122831126,"score_gpt":0.34846457683039617,"score_spread":0.2941137356020849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735772884","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057946087,0.0018909175,0.000044129025,0.96964866,0.0017789654,0.001170112,0.00024832544,0.000060079677,0.02510086],"genre_scores_gemma":[0.0020305119,0.0005694142,0.00068735937,0.93444103,0.027779445,0.0010392201,0.00027751506,0.000108806315,0.033066705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981083,0.00006914649,0.00031037576,0.00053882034,0.0005234503,0.0004498855],"domain_scores_gemma":[0.99780124,0.0001381054,0.00037156593,0.0015129879,0.000089400455,0.000086706175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001944712,0.00039364328,0.00059669925,0.00007143978,0.00034300186,0.00018055795,0.00034708207,0.00046810435,0.0016671133],"category_scores_gemma":[0.00006412401,0.00019373039,0.00032406513,0.000047826037,0.00012355871,0.00006240535,0.000092663104,0.0010788466,0.0000757305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035006393,0.000029119366,0.004263585,0.000120083576,0.00082722865,0.0016922366,0.0000895153,7.991384e-7,0.0000019342483,0.000020665339,0.97562134,0.017298486],"study_design_scores_gemma":[0.001125274,0.00007103405,0.018253714,0.0010512264,0.00080211787,0.00007197139,0.000014215158,0.0000033822666,0.000077997836,0.0001087034,0.9781618,0.0002585575],"about_ca_topic_score_codex":0.0073290765,"about_ca_topic_score_gemma":0.0004641344,"teacher_disagreement_score":0.035207644,"about_ca_system_score_codex":0.00019565766,"about_ca_system_score_gemma":0.0002724416,"threshold_uncertainty_score":0.9992812},"labels":[],"label_agreement":null},{"id":"W2736297642","doi":"10.1097/igc.0000000000001074","title":"Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Medicine; Hazard ratio; Stage (stratigraphy); Internal medicine; Proportional hazards model; Retrospective cohort study; Confidence interval; Confounding; Cohort; Cancer; Ovarian cancer; Population; Cohort study; Oncology; Environmental health","score_opus":0.01872574061172092,"score_gpt":0.31438678397740977,"score_spread":0.2956610433656888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736297642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925939,0.0004164184,0.000011467167,0.0047448785,0.0016268084,0.00027758465,0.000024803037,0.000003675509,0.00030047641],"genre_scores_gemma":[0.997015,0.0013876163,0.000036487738,0.0007592801,0.00059177313,0.00011579239,7.8365366e-7,0.0000098710525,0.00008338587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.00007407301,0.0003723543,0.0001704448,0.0004740177,0.00014136423],"domain_scores_gemma":[0.9983081,0.0008089906,0.00043211266,0.00013597382,0.00020772794,0.000107062486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003293517,0.00013018868,0.00034583235,0.00013039012,0.00007726106,0.000056977133,0.00026203366,0.00008052165,0.0005242617],"category_scores_gemma":[0.00092212704,0.000079354155,0.00008484095,0.00004138922,0.0000833406,0.00011609416,0.000113845585,0.00023912419,0.0000063612365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092172826,0.0003194951,0.84333146,0.000019265557,0.000362704,0.0002685456,0.00012098001,0.00011175661,0.0020926138,0.00006866849,0.00011116047,0.15227161],"study_design_scores_gemma":[0.0036506339,0.0016360485,0.98514134,0.0006459405,0.000087948225,0.000027474378,0.000010020377,0.00003420416,0.0076151663,0.00010450376,0.0009708065,0.00007588962],"about_ca_topic_score_codex":0.0008965176,"about_ca_topic_score_gemma":0.00073290383,"teacher_disagreement_score":0.15219572,"about_ca_system_score_codex":0.0006133155,"about_ca_system_score_gemma":0.000113571194,"threshold_uncertainty_score":0.57402974},"labels":[],"label_agreement":null},{"id":"W2736512149","doi":"10.1016/j.ygyno.2017.07.123","title":"Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Trabectedin; Medicine; Ovarian cancer; Oncology; Internal medicine; Cancer; Surgery; Soft tissue sarcoma","score_opus":0.040261372306119106,"score_gpt":0.3261250879985722,"score_spread":0.2858637156924531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736512149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769005,0.0003065299,0.00000342916,0.007061676,0.00092970463,0.0012783592,0.000041696156,0.00005611679,0.0134219965],"genre_scores_gemma":[0.99734974,0.00023978994,0.00062031456,0.00064295245,0.000108065135,0.0006182757,0.00006208269,0.000023280334,0.00033550154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833435,0.00009647107,0.00033377914,0.00054172124,0.00019530517,0.0004983793],"domain_scores_gemma":[0.99867594,0.00014141107,0.00030523495,0.00054385996,0.00014004449,0.00019349538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015343228,0.00025132904,0.0006298048,0.00011858806,0.00019787946,0.000036415306,0.00017846416,0.00025130497,0.001106504],"category_scores_gemma":[0.00021605766,0.0001745075,0.0000711739,0.00011972043,0.00016738009,0.00009211683,0.000072489136,0.00025963163,0.000040768606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006951048,0.0044541187,0.817487,0.000024301586,0.00014493796,0.0003880057,0.00017100207,0.00000676969,0.00003913414,0.00006218393,0.0014306349,0.17509682],"study_design_scores_gemma":[0.0120093245,0.008739318,0.9543131,0.00013125266,0.00020135357,0.000008249294,0.00003002566,0.000018824067,0.00019226958,0.000057549165,0.024118956,0.00017975313],"about_ca_topic_score_codex":0.0008136627,"about_ca_topic_score_gemma":0.0070579457,"teacher_disagreement_score":0.17491707,"about_ca_system_score_codex":0.0020439962,"about_ca_system_score_gemma":0.0004337349,"threshold_uncertainty_score":0.99980664},"labels":[],"label_agreement":null},{"id":"W2737717270","doi":"10.1016/j.cpet.2017.05.007","title":"Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers","year":2017,"lang":"en","type":"review","venue":"PET Clinics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Malignancy; Ovarian cancer; Gynecologic cancer; Computed tomography; Radiology; Molecular imaging; PET-CT; Precision medicine; Cancer; Pathology; Internal medicine","score_opus":0.08697271700508367,"score_gpt":0.46060734538898745,"score_spread":0.37363462838390377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737717270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010414931,0.99568945,0.000013943145,0.0014724762,0.00041901667,0.000818146,0.000038811406,0.000016767814,0.0014272431],"genre_scores_gemma":[0.0003493626,0.9981203,0.0005594645,0.0002807163,0.00028396066,0.00010882781,0.000075948374,0.00005306911,0.000168334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981984,0.00007208285,0.00068870996,0.00061273493,0.0001953406,0.00023272538],"domain_scores_gemma":[0.9984409,0.00027506272,0.00038866335,0.0006567436,0.00004074171,0.00019787226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005284652,0.00035972433,0.001982258,0.00019476649,0.000055903085,0.000037406302,0.000108705,0.000116084295,0.00006454383],"category_scores_gemma":[0.00030723045,0.00025740557,0.00012693685,0.00008523623,0.00015879972,0.00004972608,0.00014180574,0.00035595836,0.0000052121527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019284584,0.000051218376,0.0011309782,0.0051984754,0.000130856,0.001318577,0.000038236012,1.2083176e-7,5.340628e-8,0.00007160957,0.00034222388,0.9916984],"study_design_scores_gemma":[0.0021175514,0.00023968963,0.001382177,0.031666126,0.0012025246,0.00042724586,0.000008828436,0.000061669554,1.2227326e-7,0.00010372539,0.96259516,0.00019520578],"about_ca_topic_score_codex":0.00044276667,"about_ca_topic_score_gemma":0.000100671205,"teacher_disagreement_score":0.9915032,"about_ca_system_score_codex":0.00022676452,"about_ca_system_score_gemma":0.00035302562,"threshold_uncertainty_score":0.99998784},"labels":[],"label_agreement":null},{"id":"W2738993267","doi":"10.1097/grf.0000000000000312","title":"Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention","year":2017,"lang":"en","type":"review","venue":"Clinical Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Pathogenesis; Bioinformatics; Cancer; Cancer prevention; Immunology; Internal medicine; Biology","score_opus":0.42655417797512596,"score_gpt":0.51846656473196,"score_spread":0.091912386756834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738993267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002501276,0.9905504,0.0006229205,0.0008739361,0.0016020327,0.0052278726,0.0007901893,0.00003193861,0.00027568176],"genre_scores_gemma":[0.0002791445,0.99044317,0.004072306,0.000106587366,0.00037750273,0.0036428988,0.00044667043,0.000080919825,0.0005508141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953739,0.00031341612,0.0026945227,0.0010773859,0.00013890037,0.00040187966],"domain_scores_gemma":[0.98004425,0.015661836,0.0022758325,0.0012429962,0.0004327306,0.00034233063],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010945809,0.00043454985,0.0040794583,0.00023713226,0.00015788342,0.000027860107,0.0003411784,0.0013971486,0.000037957576],"category_scores_gemma":[0.008253333,0.00034634888,0.0013522815,0.00023250117,0.0003275479,0.000069796275,0.00019696502,0.00046977485,0.0000065874196],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022500742,0.0013561101,0.0036525012,0.009307999,0.0010335176,0.000004751382,0.0000072958474,0.000001349666,6.223563e-8,0.0020139406,0.0005613148,0.9820387],"study_design_scores_gemma":[0.0030851301,0.002229003,0.012781434,0.004134993,0.009559676,0.000024142133,0.0000014068738,0.00003227618,1.1845339e-7,0.0038926075,0.9639814,0.00027779432],"about_ca_topic_score_codex":0.000022942138,"about_ca_topic_score_gemma":0.00005040993,"teacher_disagreement_score":0.98176086,"about_ca_system_score_codex":0.00024288909,"about_ca_system_score_gemma":0.0015930345,"threshold_uncertainty_score":0.99989927},"labels":[],"label_agreement":null},{"id":"W2739737030","doi":"","title":"Laparoscopy versus laparotomy for FIGO stage 1 ovarian cancer (Review)","year":2005,"lang":"en","type":"article","venue":"Lume (Universidade Federal do Rio Grande do Sul)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Laparotomy; Laparoscopy; Ovarian cancer; Medicine; Stage (stratigraphy); General surgery; Gynecology; Cancer; Surgery; Internal medicine; Biology","score_opus":0.0275912306854202,"score_gpt":0.3168323402880292,"score_spread":0.289241109602609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739737030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56852466,0.14677355,0.0009316768,0.15249966,0.004960823,0.018993858,0.0032140887,0.0011242551,0.10297743],"genre_scores_gemma":[0.8894536,0.05498626,0.0066065495,0.0073475097,0.0019235407,0.0013128162,0.00070088974,0.00021531107,0.037453536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977458,0.000054950287,0.0003440614,0.00072752265,0.00042517282,0.00070248137],"domain_scores_gemma":[0.9985144,0.00012394635,0.00018754578,0.00056205905,0.00018048672,0.00043154988],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017433031,0.00043871757,0.0008028871,0.00016441765,0.00041587962,0.00011867239,0.00022720206,0.0001953339,0.0054919715],"category_scores_gemma":[0.000036041423,0.00041387943,0.0004635292,0.00034924006,0.000092721886,0.00035337504,0.00006291503,0.0002722415,0.00017632126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015768358,0.0029992117,0.05763284,0.0059035537,0.005029178,0.00066247355,0.0024109099,0.00025273755,0.0011165214,0.018344956,0.66448176,0.22539751],"study_design_scores_gemma":[0.025083272,0.0007988229,0.01241855,0.0015274567,0.00094250933,0.000014859518,0.0002750495,0.00015368986,0.0010077338,0.000066095,0.9571398,0.00057215383],"about_ca_topic_score_codex":0.00076930504,"about_ca_topic_score_gemma":0.0008009354,"teacher_disagreement_score":0.32092893,"about_ca_system_score_codex":0.0007195892,"about_ca_system_score_gemma":0.000301586,"threshold_uncertainty_score":0.9998313},"labels":[],"label_agreement":null},{"id":"W2740464630","doi":"10.1016/j.ygyno.2017.07.128","title":"Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Univariate analysis; Chemotherapy; Adjuvant; Internal medicine; Oncology; Adjuvant therapy; Ovarian cancer; Clear cell carcinoma; Cancer; Adjuvant chemotherapy; Surgery; Multivariate analysis; Breast cancer","score_opus":0.04769284563547669,"score_gpt":0.3550731215602443,"score_spread":0.3073802759247676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740464630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92350787,0.0004376749,0.000032682718,0.027556937,0.0011508343,0.0015228438,0.00014654733,0.00006763854,0.04557694],"genre_scores_gemma":[0.98859715,0.00030150122,0.0022810192,0.0032975972,0.000726978,0.0003441067,0.0000423509,0.000038496135,0.00437081],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982396,0.000053497624,0.00035982783,0.00060735235,0.00015806862,0.000581678],"domain_scores_gemma":[0.9981678,0.00038564976,0.0003218167,0.0007736047,0.00011720621,0.0002338956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034324994,0.00026466782,0.0007961424,0.00006704814,0.0004938432,0.00004869712,0.00027605455,0.00044746746,0.003504506],"category_scores_gemma":[0.00010483705,0.00020828741,0.0002962148,0.000040369767,0.00018413833,0.00006281703,0.00009487355,0.00021346979,0.00013623008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007585474,0.009102341,0.57161355,0.00039913875,0.0005973105,0.004233837,0.0012711359,0.000013330138,0.0005052701,0.00906421,0.061029803,0.3345846],"study_design_scores_gemma":[0.018458232,0.007400337,0.41634542,0.000007734848,0.00018955291,0.0000397928,0.00009723904,0.0001087378,0.0020958784,0.00034088801,0.55472296,0.00019321458],"about_ca_topic_score_codex":0.00021315877,"about_ca_topic_score_gemma":0.00014226134,"teacher_disagreement_score":0.49369317,"about_ca_system_score_codex":0.0005435381,"about_ca_system_score_gemma":0.0005021901,"threshold_uncertainty_score":0.9974064},"labels":[],"label_agreement":null},{"id":"W2740976433","doi":"10.1097/gco.0000000000000400","title":"Management of benign ovarian lesions in girls: a trend toward fewer oophorectomies","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multidisciplinary approach; Oophorectomy; Risk stratification; Multidisciplinary team; Disease; Epidemiology; General surgery; Gynecology; Intensive care medicine; Surgery; Pathology; Hysterectomy; Internal medicine; Nursing","score_opus":0.25313575173089164,"score_gpt":0.4520558177687139,"score_spread":0.19892006603782225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740976433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033521257,0.9783964,0.000007907766,0.00019220683,0.016883222,0.0023644236,0.00017917229,0.000024632864,0.0019184725],"genre_scores_gemma":[0.0009013464,0.9964755,0.00031894128,0.0000073710494,0.00020052269,0.0012268282,0.0006296756,0.000066796034,0.00017297643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610597,0.00027260068,0.0016470344,0.00096049893,0.00038400097,0.0006298744],"domain_scores_gemma":[0.9953717,0.0022622887,0.0009626379,0.0011336716,0.00008151702,0.00018817402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004451439,0.0006242645,0.0033082685,0.0020859502,0.000069040805,0.000033380114,0.0005098492,0.0005823055,0.00023201326],"category_scores_gemma":[0.0009678054,0.000548082,0.0006410909,0.0012186765,0.00015398461,0.00006701751,0.0003447224,0.00077678123,0.000060617556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019277983,0.0016425196,0.0020539097,0.029427469,0.00035107357,0.00014306128,0.00012790092,0.0000015788333,4.4823834e-9,0.0022730222,0.0020494305,0.9619107],"study_design_scores_gemma":[0.003367207,0.00032528173,0.013727889,0.029858995,0.00076904934,0.0000195438,0.00004850312,0.0000049731225,1.646492e-7,0.000117057105,0.95139444,0.0003668727],"about_ca_topic_score_codex":0.000047206664,"about_ca_topic_score_gemma":0.000032159693,"teacher_disagreement_score":0.96154386,"about_ca_system_score_codex":0.0014504646,"about_ca_system_score_gemma":0.00057918805,"threshold_uncertainty_score":0.9996971},"labels":[],"label_agreement":null},{"id":"W2741169533","doi":"10.1158/1538-7445.am2017-1454","title":"Abstract 1454: Estrogen receptor signaling in FTE of BRCA mutation carriers","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Estrogen receptor; Biology; Carcinogenesis; Estrogen; Cancer research; Ovarian cancer; Fulvestrant; Estrogen receptor alpha; Cancer; Genetics; Breast cancer","score_opus":0.1244530271342358,"score_gpt":0.4584024839307533,"score_spread":0.3339494567965175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741169533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265003,0.0014159294,0.0000012832089,0.0027220757,0.00013202973,0.00044261856,0.000037930768,0.000007525042,0.002590575],"genre_scores_gemma":[0.99859303,0.0005899278,0.00015490898,0.000024486946,0.00018485518,0.0002123713,0.000012838836,0.000018519739,0.00020906114],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987215,0.000038226823,0.00020565414,0.0002516791,0.0004741236,0.00030881818],"domain_scores_gemma":[0.9990102,0.000091349466,0.00009254585,0.0004353443,0.00023220814,0.00013832733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059452676,0.00008260159,0.0002199213,0.00015651979,0.00014917798,0.000042060296,0.00015287029,0.000068325244,0.00080059917],"category_scores_gemma":[0.00020061554,0.00007282034,0.00005985409,0.00012022556,0.00017251872,0.00010005397,0.000042453597,0.00025568358,0.000028948192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010817228,0.00046138495,0.6337185,0.0006527984,0.0003414804,0.00040671678,0.002208945,0.000214572,0.21824345,0.00069550314,0.004026061,0.13794887],"study_design_scores_gemma":[0.004525966,0.00040629078,0.48704353,0.0012704877,0.000045298777,0.00000415313,0.0005943876,0.00003007514,0.50021183,0.0002881203,0.00543252,0.00014733308],"about_ca_topic_score_codex":0.0050609023,"about_ca_topic_score_gemma":0.0002911574,"teacher_disagreement_score":0.28196838,"about_ca_system_score_codex":0.0005040355,"about_ca_system_score_gemma":0.0006065908,"threshold_uncertainty_score":0.87659997},"labels":[],"label_agreement":null},{"id":"W2741852062","doi":"10.1158/1538-7445.am2017-3381","title":"Abstract 3381: TERT promoter mutation in granulosa cell tumours of the ovary: Prevalence and prognostic significance","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; BC Cancer Agency; McGill University; University of British Columbia","funders":"","keywords":"Missense mutation; Mutation; Biology; Cancer research; Somatic cell; Germline mutation; Mutation rate; Gene; Ovarian cancer; Cancer; Genetics; Medicine; Internal medicine; Oncology","score_opus":0.06707070759494381,"score_gpt":0.3901435211171679,"score_spread":0.32307281352222406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741852062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160963,0.0016018057,8.5854623e-7,0.0038752141,0.00008334867,0.0014870239,0.00002655829,0.0000058815635,0.0013096547],"genre_scores_gemma":[0.99818355,0.0007433125,0.0000442565,0.000025469628,0.00007527935,0.0005357101,0.000001979182,0.000015325713,0.00037514797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998668,0.00006949979,0.00018644893,0.00031959813,0.00046767094,0.00028876844],"domain_scores_gemma":[0.99897087,0.00012858429,0.00010913107,0.0005408414,0.00016443511,0.000086155356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052967365,0.00010009072,0.00018147017,0.00007876332,0.00017821505,0.00005428963,0.000217005,0.000051166484,0.00009709257],"category_scores_gemma":[0.00017154955,0.00006608822,0.000039744074,0.00012135535,0.00037500198,0.00010926782,0.000086696855,0.00029348774,0.0000054413968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014075889,0.00028084437,0.9803438,0.0010757779,0.000012314994,0.00008825503,0.0005244948,0.0000035634396,0.0104993265,0.000027364686,0.00025368892,0.006749788],"study_design_scores_gemma":[0.0012158058,0.00017410456,0.92866117,0.0011098493,0.000029625713,0.0000056668227,0.000035624726,0.000015000077,0.06838202,0.00022760702,0.00008557933,0.000057933168],"about_ca_topic_score_codex":0.0016356352,"about_ca_topic_score_gemma":0.00026265616,"teacher_disagreement_score":0.05788269,"about_ca_system_score_codex":0.00017166063,"about_ca_system_score_gemma":0.00037986462,"threshold_uncertainty_score":0.26949996},"labels":[],"label_agreement":null},{"id":"W2741986277","doi":"10.1158/1538-7445.am2017-1979","title":"Abstract 1979: Cell lines that genomically resemble high-grade serous ovarian carcinomas display differences in growth and invasive capacities in an orthometastatic nude mouse model","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Serous fluid; Peritoneal cavity; Cancer research; Ovary; Fallopian tube; In vivo; Disease; Pathology; Medicine; Cancer; Biology; Internal medicine; Genetics","score_opus":0.1639494731255377,"score_gpt":0.3763137029339241,"score_spread":0.21236422980838637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741986277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442273,0.0012017848,0.00000481922,0.0026582088,0.00006829039,0.00092435814,0.00018216172,0.000015810358,0.0005218451],"genre_scores_gemma":[0.9936564,0.0044807727,0.00046019777,0.000072805175,0.00012590078,0.000637437,0.000031519015,0.00004780433,0.0004871589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974796,0.00014979119,0.00033910127,0.00069250044,0.00060010934,0.0007388513],"domain_scores_gemma":[0.99833167,0.00031121526,0.00011722388,0.00073119183,0.00014722902,0.00036149196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052159553,0.00027079752,0.00059385656,0.00045763078,0.00031472876,0.00028089454,0.00038136216,0.00013627975,0.00005857421],"category_scores_gemma":[0.00013937897,0.00021514547,0.000051948355,0.00015828488,0.00053342833,0.0003927044,0.0001787074,0.0006284485,0.0000065352096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058472744,0.0007533668,0.9562651,0.00075581815,0.00007357676,0.00048419432,0.0042288983,0.00013522599,0.0352235,0.0006415974,0.00014855944,0.0007054606],"study_design_scores_gemma":[0.004002068,0.00038067903,0.9405553,0.00037678293,0.000038158534,0.000004285082,0.0011323945,0.00053388055,0.051600754,0.0011310147,0.000008326845,0.00023637882],"about_ca_topic_score_codex":0.045277998,"about_ca_topic_score_gemma":0.05112458,"teacher_disagreement_score":0.016377253,"about_ca_system_score_codex":0.00042428903,"about_ca_system_score_gemma":0.0007921375,"threshold_uncertainty_score":0.9661899},"labels":[],"label_agreement":null},{"id":"W2743146382","doi":"10.1016/j.jogc.2017.05.008","title":"Poor Prognostic Factors in Patients Undergoing Surgery After Neoadjuvant Chemotherapy for Ovarian, Tubal, or Peritoneal Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Lymphadenectomy; Stage (stratigraphy); Proportional hazards model; Chemotherapy; Hazard ratio; Surgery; Logistic regression; Univariate analysis; Oncology; Internal medicine; Cancer; Multivariate analysis; Confidence interval","score_opus":0.021807787137225747,"score_gpt":0.26895034919024896,"score_spread":0.2471425620530232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743146382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890453,0.0018426953,0.0000042633924,0.002448676,0.0062069446,0.00036446057,0.000052693686,0.0000017005719,0.000033256754],"genre_scores_gemma":[0.9982184,0.00079316495,0.00016449796,0.0006119339,0.000064439926,0.000035461857,0.0000049619907,0.000019984223,0.00008713888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885434,0.000019955929,0.0004418044,0.00016994726,0.00022273163,0.0002912398],"domain_scores_gemma":[0.99646693,0.002480345,0.0004630904,0.00014495829,0.00024519616,0.00019946032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001290104,0.00015910824,0.000551713,0.00017545765,0.00014073736,0.000050146213,0.00008311715,0.00010300273,0.00029558057],"category_scores_gemma":[0.0031116349,0.00010910194,0.000090618494,0.00008555245,0.000044975193,0.00009496894,0.000021665675,0.00015408846,1.0336777e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000128044,0.0002324651,0.95663077,0.00009011253,0.00019208214,0.00082560466,0.000056726713,0.0000033286221,5.025742e-7,0.0000042415572,0.0016568246,0.040179275],"study_design_scores_gemma":[0.007086242,0.000757266,0.9877791,0.00007513737,0.00013897326,0.0000084708345,0.000057184698,0.00001628335,0.000039636405,0.000014608828,0.0039150217,0.00011209652],"about_ca_topic_score_codex":0.015898893,"about_ca_topic_score_gemma":0.14328708,"teacher_disagreement_score":0.12738818,"about_ca_system_score_codex":0.001326013,"about_ca_system_score_gemma":0.0039561847,"threshold_uncertainty_score":0.99065435},"labels":[],"label_agreement":null},{"id":"W2743499784","doi":"10.1155/2017/2873030","title":"Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum‐Sensitive, Platinum‐Resistant, and Platinum‐Refractory Epithelial Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"Oxidative Medicine and Cellular Longevity","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Platinum; Oxidative stress; Inflammation; Refractory (planetary science); Ovarian cancer; Epithelial ovarian cancer; Internal medicine; Ascites; Medicine; Cancer; Cancer research; Chemistry; Biology; Biochemistry","score_opus":0.013831680664346292,"score_gpt":0.2524049521119589,"score_spread":0.23857327144761262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743499784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664783,0.0007641604,0.000028281689,0.0007311036,0.000048106696,0.0009224529,0.00016434069,0.000007952199,0.00068576547],"genre_scores_gemma":[0.9984344,0.00080603,0.00043793948,0.00003444961,0.0000797668,0.000044078584,0.000094078,0.000023558938,0.00004564829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822164,0.0001429152,0.00044800434,0.0005718109,0.00034891695,0.00026671155],"domain_scores_gemma":[0.9984906,0.00037806563,0.000499684,0.0002957589,0.00014500006,0.00019089354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003902968,0.00034957865,0.00080503843,0.00023520552,0.00016720127,0.00003654361,0.000057159203,0.00013312827,0.00005281151],"category_scores_gemma":[0.00028120854,0.0002554266,0.00001946935,0.000118588156,0.000837644,0.00035097144,0.00010225606,0.0002750359,3.16042e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026155089,0.00019697416,0.9587932,0.0003285963,0.00020499337,0.00009596468,0.0033017138,0.0000022541274,0.006043461,0.00014065627,0.00001247831,0.028264148],"study_design_scores_gemma":[0.01436252,0.0016616919,0.96512437,0.0023024355,0.00022005582,0.0000033231831,0.0011096902,0.00017053375,0.01469083,0.000069476155,0.00005259769,0.00023245912],"about_ca_topic_score_codex":0.0022767568,"about_ca_topic_score_gemma":0.003616547,"teacher_disagreement_score":0.028031688,"about_ca_system_score_codex":0.00009445692,"about_ca_system_score_gemma":0.000079255755,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W2744054571","doi":"10.1016/j.ygyno.2017.08.006","title":"Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; University of Toronto; University Health Network; University of Manitoba; Princess Margaret Cancer Centre; Western University","funders":"Partenariat Canadien Contre Le Cancer","keywords":"Medicine; Chemotherapy; Regimen; Internal medicine; Oncology; Ovarian cancer; Serous fluid; Chemotherapy regimen; Ovarian carcinoma; Stage (stratigraphy); Retrospective cohort study; Surgery; Cancer","score_opus":0.02901957411004339,"score_gpt":0.3794712618092702,"score_spread":0.3504516876992268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744054571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94463545,0.000107531036,0.000004828341,0.026290558,0.00036388173,0.001240816,0.000009362437,0.00005985428,0.027287746],"genre_scores_gemma":[0.99193674,0.00055674353,0.0015241526,0.0047105076,0.00023801666,0.00022145885,0.0000075939906,0.00002092784,0.0007838613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987057,0.00006636441,0.00024775107,0.00045949922,0.00021088758,0.0003097902],"domain_scores_gemma":[0.99883676,0.00025477982,0.00022551145,0.00040296483,0.00012482042,0.00015517867],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031364054,0.00020216897,0.00051570364,0.00004094157,0.000364482,0.000051901894,0.00015174007,0.00017860679,0.0017595228],"category_scores_gemma":[0.00021955486,0.00015524207,0.00007629124,0.00003732892,0.00017458187,0.00007950097,0.00007391952,0.00016560785,0.00013415434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034961762,0.0047348524,0.79089314,0.000012472166,0.0003618318,0.00029833333,0.0009849523,0.0000019201077,0.00005058694,0.00024736492,0.0029796285,0.19908528],"study_design_scores_gemma":[0.017933646,0.0025179742,0.91738653,0.000011463971,0.000103658305,0.000086282846,0.00041457338,0.00014528878,0.00007651195,0.0006290205,0.060553525,0.0001415347],"about_ca_topic_score_codex":0.00015302721,"about_ca_topic_score_gemma":0.0003111043,"teacher_disagreement_score":0.19894373,"about_ca_system_score_codex":0.00045893897,"about_ca_system_score_gemma":0.00023403067,"threshold_uncertainty_score":0.999153},"labels":[],"label_agreement":null},{"id":"W2744737400","doi":"10.1002/uog.18836","title":"Sonographers' self‐reported visualization of normal postmenopausal ovaries on transvaginal ultrasound is not reliable: results of expert review of archived images from UKCTOCS","year":2017,"lang":"en","type":"article","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; University College London; James Cook University; National Institute for Health and Care Research; Medical Research Council Canada; Cancer Research UK","keywords":"Medicine; Transvaginal ultrasound; Ultrasound; Visualization; Medical physics; Postmenopausal women; Transvaginal sonography; Radiology; Gynecology; Obstetrics; Artificial intelligence; Internal medicine; Pregnancy","score_opus":0.019937764463084484,"score_gpt":0.3129870118364477,"score_spread":0.29304924737336324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744737400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97293586,0.020409672,0.00005318701,0.00096643745,0.0006287805,0.0009734675,0.0008798447,0.000019072259,0.0031337126],"genre_scores_gemma":[0.84618014,0.15135492,0.0016221792,0.0004968824,0.0000279747,0.000030685853,0.00023198617,0.00001826082,0.000036956204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978883,0.00008510407,0.0010261041,0.0004258712,0.0003189621,0.000255635],"domain_scores_gemma":[0.9874526,0.010583386,0.00091437774,0.0006641258,0.00028871212,0.000096776996],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00033833034,0.00023409352,0.0009029,0.0002536473,0.00009379407,0.000019461058,0.00015782594,0.00016361618,0.00014881766],"category_scores_gemma":[0.010218348,0.0002064627,0.00011038015,0.0002426025,0.00035070654,0.000113718306,0.00002614994,0.00015011869,8.9800443e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005071852,0.010577373,0.8408504,0.0073242965,0.0036552052,0.00033707175,0.012458086,0.000021410991,0.063957445,0.0027062218,0.0074370005,0.045603625],"study_design_scores_gemma":[0.009866574,0.0042389953,0.90595317,0.0026937064,0.0007304943,0.00003466326,0.00021889669,0.00001530677,0.06091128,0.00028613687,0.0147605715,0.00029022852],"about_ca_topic_score_codex":0.0012974889,"about_ca_topic_score_gemma":0.00007350101,"teacher_disagreement_score":0.13094525,"about_ca_system_score_codex":0.00006562452,"about_ca_system_score_gemma":0.00019255729,"threshold_uncertainty_score":0.998119},"labels":[],"label_agreement":null},{"id":"W2745149700","doi":"10.1200/jco.2013.31.15_suppl.5502","title":"Final results of OV16, a phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel (CP) versus CP in first-line chemotherapy for advanced epithelial ovarian cancer (EOC): A GCIG study of NCIC CTG, EORTC-GCG, and GEICO.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University; Hôpital Notre-Dame; Vancouver Coastal Health; Baker Hughes (Canada); BC Cancer Agency","funders":"","keywords":"Medicine; Topotecan; Carboplatin; Internal medicine; Regimen; Hazard ratio; Clinical endpoint; Paclitaxel; Chemotherapy; Progression-free survival; Adverse effect; Cisplatin; Oncology; Randomized controlled trial; Surgery; Confidence interval","score_opus":0.12307816601852095,"score_gpt":0.47724778680149776,"score_spread":0.3541696207829768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745149700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195236,0.0006084224,0.000059685597,0.002470046,0.0007133657,0.004033646,0.0000723536,0.0000040935975,0.00008604825],"genre_scores_gemma":[0.99622434,0.0014403665,0.0015122337,0.00012029917,0.00043367824,0.0002017669,0.000004632592,0.000026874024,0.00003582997],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936082,0.000605987,0.004639118,0.00040982637,0.00045574643,0.0002811518],"domain_scores_gemma":[0.9894395,0.0053788815,0.0039320486,0.00030084426,0.0006713115,0.0002774087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035105068,0.00028481317,0.004190777,0.00025853142,0.000043730517,0.000008113754,0.00013561062,0.00027470742,0.00008272315],"category_scores_gemma":[0.0023126896,0.00020416315,0.000387761,0.00020370459,0.0003244177,0.00011862522,0.00005934656,0.0004985729,1.7094224e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81493086,0.029430272,0.020874651,0.00014421875,0.003039101,0.00014714098,0.0043112272,0.00017207018,0.0007384068,0.000020931275,0.000110537105,0.12608057],"study_design_scores_gemma":[0.84240645,0.0944778,0.05769719,0.00030157168,0.0018688106,0.000023019466,0.0016184418,0.0006401119,0.00043009213,0.00015417063,0.00024142719,0.0001409327],"about_ca_topic_score_codex":0.0030225785,"about_ca_topic_score_gemma":0.0038466905,"teacher_disagreement_score":0.12593964,"about_ca_system_score_codex":0.0001608523,"about_ca_system_score_gemma":0.00084081304,"threshold_uncertainty_score":0.8325532},"labels":[],"label_agreement":null},{"id":"W2745433486","doi":"10.1016/j.humimm.2006.08.246","title":"164-P","year":2006,"lang":"en","type":"article","venue":"Human Immunology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Business","score_opus":0.012082586135176819,"score_gpt":0.2694364451512119,"score_spread":0.2573538590160351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745433486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92043656,0.0025431586,0.000013337026,0.001737765,0.000165096,0.00014437964,0.0000021012822,0.00008363921,0.07487396],"genre_scores_gemma":[0.99403095,0.000033658824,0.00018096257,0.00024345137,0.0001709048,0.000034466648,0.000035977646,0.000011332219,0.0052583013],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9995431,0.000011568206,0.0001139046,0.00013499532,0.000045176814,0.00015126544],"domain_scores_gemma":[0.9997062,0.000011438103,0.000027551263,0.00021612164,0.00002234862,0.00001635946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000023387332,0.00006977868,0.00014744517,0.000052066505,0.000062425825,0.0000058500577,0.000032810527,0.00005538145,0.0010540743],"category_scores_gemma":[0.000002508352,0.000058861253,0.00005169404,0.00004435395,0.000064552005,0.000015154494,0.00001653463,0.00006792248,0.00034930502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021595598,0.0029866458,0.30784616,0.00005790444,0.0008670123,0.0008759724,0.00021724308,0.0000042651923,0.110554464,0.4515715,0.09788512,0.026917752],"study_design_scores_gemma":[0.0020108281,0.00041778042,0.8556832,0.000018025912,0.00006513969,0.00008720724,0.000013411475,7.856938e-7,0.0069837393,0.002365939,0.13228531,0.00006863205],"about_ca_topic_score_codex":0.00035977244,"about_ca_topic_score_gemma":0.000049012036,"teacher_disagreement_score":0.547837,"about_ca_system_score_codex":0.00007042562,"about_ca_system_score_gemma":0.000021585842,"threshold_uncertainty_score":0.9998591},"labels":[],"label_agreement":null},{"id":"W2749840989","doi":"10.1038/s41598-017-10432-9","title":"Mutational heterogeneity in non-serous ovarian cancers","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Physicians' Services Incorporated Foundation; Ovarian Cancer Research Foundation; Moffitt Cancer Center","keywords":"Serous fluid; KRAS; Clear cell; Ovarian cancer; Cancer research; PTEN; Biology; Oncology; Medicine; Pathology; Cancer; Internal medicine; Colorectal cancer; Carcinoma; Genetics; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.025958423233219636,"score_gpt":0.318360277395703,"score_spread":0.2924018541624834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749840989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854755,0.00009317152,0.000026182635,0.0012975157,0.0051740054,0.0003968897,0.000005136898,0.000018055818,0.0075135487],"genre_scores_gemma":[0.9972632,0.0000057878297,0.00059137144,0.0000817549,0.00011225156,0.00007962971,0.00004109831,0.000010912324,0.0018139974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844426,0.000010595717,0.00030740123,0.0006061746,0.0003878207,0.00024376503],"domain_scores_gemma":[0.9983512,0.00001078585,0.00024880134,0.0011461789,0.00009703167,0.00014598278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054815714,0.00010988879,0.00020557956,0.0001065627,0.00040228458,0.0002610879,0.00008544796,0.000049315044,0.00021127715],"category_scores_gemma":[0.00009266437,0.00009435244,0.00008485284,0.000099574616,0.00019095837,0.00015169661,0.00004811328,0.000078661746,0.000032833144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033245666,0.00023539786,0.973306,0.00003732142,0.00006628424,0.007847541,0.00025487063,0.00011000131,0.0010661121,0.00007425821,0.005648738,0.011320205],"study_design_scores_gemma":[0.000840455,0.000045386263,0.9769607,0.000100067235,0.00003307821,0.00046635565,0.000019777148,0.00013470229,0.008540294,0.0009914275,0.011763546,0.00010421547],"about_ca_topic_score_codex":0.0014312142,"about_ca_topic_score_gemma":0.0017794712,"teacher_disagreement_score":0.011787703,"about_ca_system_score_codex":0.00037344205,"about_ca_system_score_gemma":0.0005163157,"threshold_uncertainty_score":0.38475809},"labels":[],"label_agreement":null},{"id":"W2751368634","doi":"10.1158/1055-9965.epi-17-0367","title":"History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Foothills Medical Centre","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; U.S. National Library of Medicine; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Ovarian cancer; Medicine; Oncology; Internal medicine; Association (psychology); Cancer; Gynecology; Psychology","score_opus":0.07283089766475383,"score_gpt":0.34907549599356386,"score_spread":0.27624459832881004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751368634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89052856,0.05227129,0.00007769129,0.043172225,0.007894453,0.0015089806,0.0027943254,0.00003946097,0.0017130271],"genre_scores_gemma":[0.98092186,0.015678981,0.00028456937,0.00046731683,0.00039188008,0.00032969343,0.000292547,0.000024482972,0.0016086452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973561,0.00063361315,0.0009652159,0.00050843554,0.00022260989,0.00031402317],"domain_scores_gemma":[0.99516255,0.0012781036,0.002473852,0.0006461693,0.0003325596,0.000106786814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016959275,0.00023611031,0.0008742331,0.00006090076,0.00016924455,0.000008098839,0.00019541036,0.0002799772,0.00035656206],"category_scores_gemma":[0.0014042888,0.00017937404,0.00021774505,0.000049868366,0.000534108,0.00014077898,0.00009018577,0.00017872821,0.0000014609815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011342712,0.00018859196,0.9334851,0.000073622476,0.0020445783,0.0000013474113,0.00041387806,0.000004207139,0.00017591061,0.00036164452,0.045923855,0.016193008],"study_design_scores_gemma":[0.0057553235,0.0001795932,0.97546214,0.0007473413,0.001149188,3.3190523e-7,0.00007418276,0.00007064525,0.0003127575,0.00083046884,0.0152719775,0.00014604065],"about_ca_topic_score_codex":0.060083915,"about_ca_topic_score_gemma":0.0092326095,"teacher_disagreement_score":0.090393335,"about_ca_system_score_codex":0.0015867418,"about_ca_system_score_gemma":0.0006841667,"threshold_uncertainty_score":0.94617504},"labels":[],"label_agreement":null},{"id":"W2751971240","doi":"","title":"Sustained Intraperitoneal Chemotherapy via an Injectable Depot Delivery System for the Treatment of Ovarian Cancer","year":2012,"lang":"en","type":"dissertation","venue":"TSpace (University of Toronto)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto; Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Ovarian cancer; Intraperitoneal chemotherapy; Depot; Medicine; Chemotherapy; Oncology; Cancer; Internal medicine; Geography","score_opus":0.014106103822054497,"score_gpt":0.27241368849819514,"score_spread":0.2583075846761406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751971240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95815873,0.027099682,0.00036293216,0.001008374,0.0011131049,0.0036795698,0.00026604565,0.000081781785,0.008229752],"genre_scores_gemma":[0.98758876,0.0065532704,0.0008638061,0.000011755372,0.00025773988,0.000029552313,0.00037893315,0.00004224988,0.0042739576],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990143,0.0000338534,0.00015676091,0.00029731024,0.00021899008,0.0002787947],"domain_scores_gemma":[0.9987141,0.000073395495,0.00035031923,0.00043571083,0.0002877974,0.00013868464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007323626,0.00027809583,0.000692849,0.000047247027,0.00017818806,0.000007375597,0.00014898663,0.00024107377,0.0026291837],"category_scores_gemma":[0.0000016932239,0.0002337414,0.00030927366,0.000058800713,0.00005308669,0.00016711639,0.000009727211,0.00005451353,0.0000012910015],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012747229,0.0032290595,0.0053296606,0.0025992116,0.006186697,0.000034388664,0.06753095,0.00002550355,0.0049554603,0.00057644496,0.0004704488,0.8963149],"study_design_scores_gemma":[0.016331794,0.006322488,0.78234005,0.00078315136,0.008273972,0.00001286061,0.1663434,0.000841934,0.010854734,0.0000045047036,0.007306336,0.0005847647],"about_ca_topic_score_codex":0.39924967,"about_ca_topic_score_gemma":0.19321147,"teacher_disagreement_score":0.8957302,"about_ca_system_score_codex":0.0018587883,"about_ca_system_score_gemma":0.0003894994,"threshold_uncertainty_score":0.99828255},"labels":[],"label_agreement":null},{"id":"W2752616940","doi":"10.1002/uog.16002","title":"Outcome of fetal ovarian cysts diagnosed on prenatal ultrasound examination: systematic review and meta‐analysis","year":2016,"lang":"en","type":"review","venue":"Ultrasound in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cyst; Ovarian cyst; Odds ratio; Obstetrics; Meta-analysis; Ultrasound; Ovarian torsion; Pregnancy; Prenatal diagnosis; Gynecology; Fetus; Radiology; Pathology","score_opus":0.048164680955354436,"score_gpt":0.3355923928616392,"score_spread":0.2874277119062848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752616940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000729268,0.9946848,0.000009714198,0.00012497633,0.00024602067,0.003872387,0.00055960036,0.00001849375,0.00041109356],"genre_scores_gemma":[0.0089182295,0.98881996,0.00011255959,0.00029950868,0.000025727773,0.0011029481,0.0002498946,0.000050598803,0.00042057468],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99564946,0.0006934315,0.0019673991,0.0009057488,0.00037948182,0.00040449834],"domain_scores_gemma":[0.9142013,0.08364791,0.0010085144,0.0007924143,0.00014490812,0.00020492068],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010435198,0.00069481396,0.009735267,0.0011499943,0.000066573484,0.000040913408,0.00019394726,0.0005218007,0.00036449483],"category_scores_gemma":[0.028277474,0.00043053116,0.0012339699,0.0015708031,0.00018173299,0.00007905441,0.000062055435,0.00035994564,0.00002070868],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003910245,0.00070613023,0.0013319277,0.8662681,0.09573356,0.00029862634,0.00006210187,2.3035773e-7,6.891919e-8,0.0014561496,0.000033418746,0.034105804],"study_design_scores_gemma":[0.0017190677,0.0007738251,0.0021354493,0.044118058,0.9152883,0.00036223934,0.000025510264,5.1487814e-7,7.7501267e-7,0.00005286973,0.034914322,0.00060901645],"about_ca_topic_score_codex":0.000034323417,"about_ca_topic_score_gemma":0.000043771084,"teacher_disagreement_score":0.82215,"about_ca_system_score_codex":0.00037965595,"about_ca_system_score_gemma":0.00013626243,"threshold_uncertainty_score":0.9998146},"labels":[],"label_agreement":null},{"id":"W2752813594","doi":"10.1016/j.jogc.2017.02.001","title":"Non-Hodgkin Lymphomas in Mature Cystic Teratomas: A Case Report and Review of the Literature","year":2017,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Calgary","funders":"","keywords":"Medicine; Asymptomatic; Pathological; Lymphoma; Cystectomy; Mature Cystic Teratoma; Teratoma; Ovarian Teratoma; Radiology; Surgery; Pathology; Cancer; Internal medicine","score_opus":0.02189391089658981,"score_gpt":0.3074821350937218,"score_spread":0.285588224197132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752813594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044809878,0.99422956,1.00788164e-7,0.00044567368,0.0039044872,0.0006168399,0.00008212425,7.067835e-7,0.00027242617],"genre_scores_gemma":[0.003942856,0.99537253,0.00008280666,0.00034193005,0.000054306398,0.00001731761,0.000011335993,0.000020344434,0.00015655448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799407,0.00010989966,0.0011815566,0.00023580657,0.00028478418,0.00019385832],"domain_scores_gemma":[0.9957768,0.0010748893,0.0021801789,0.00047481697,0.00030888958,0.00018446968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048735624,0.0002965401,0.002372572,0.00025126396,0.000080587866,0.00003333036,0.00015288852,0.00032356157,0.000050865627],"category_scores_gemma":[0.0033988005,0.0001609268,0.00026787742,0.00041526367,0.00007081574,0.00004143101,0.000080160615,0.0006726472,8.021934e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013394192,0.000056707508,0.0023209853,0.046051312,0.0002930378,0.44966963,0.000023030294,3.667606e-8,4.465583e-9,0.0000079654565,0.002834128,0.49874184],"study_design_scores_gemma":[0.0011519747,0.00017507415,0.006897024,0.057163093,0.002152711,0.20010728,0.000010555082,4.2581772e-7,1.4197249e-7,0.000008843283,0.73221153,0.00012135356],"about_ca_topic_score_codex":0.003109684,"about_ca_topic_score_gemma":0.008300936,"teacher_disagreement_score":0.7293774,"about_ca_system_score_codex":0.0012353967,"about_ca_system_score_gemma":0.0063773077,"threshold_uncertainty_score":0.9992556},"labels":[],"label_agreement":null},{"id":"W2752920347","doi":"10.1016/s0140-6736(17)31586-6","title":"The empress of subterfuge: cancer of the fallopian tube presenting with malapropism","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University Health Centre","funders":"McGill University; Johns Hopkins University","keywords":"Medicine; Internal medicine; Thrombotic thrombocytopenic purpura; Stroke (engine); Cardiology; Surgery; Gastroenterology; Radiology; Platelet","score_opus":0.039234491462394175,"score_gpt":0.31601132046972424,"score_spread":0.2767768290073301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752920347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946001,0.00092871784,0.000001532547,0.04350223,0.00021110049,0.00043183882,0.000028886729,0.000007758533,0.008886971],"genre_scores_gemma":[0.9968533,0.00048937974,0.000039252263,0.0001994994,0.00041886236,0.00006938975,6.9287097e-7,0.000011746758,0.0019179075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993049,0.000038172217,0.000137443,0.000114106195,0.00022397425,0.00018138396],"domain_scores_gemma":[0.998226,0.00007335549,0.00024477503,0.0013631985,0.00006928724,0.000023391978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017721948,0.00008626395,0.00026748236,0.0000060538027,0.00029776822,0.00003467836,0.0005016459,0.000024526105,0.00003932793],"category_scores_gemma":[0.00004120478,0.000029628089,0.00006203927,0.000035566725,0.00029382226,0.00003313068,0.00011766203,0.000114910625,0.0000014550881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002313878,0.00006262817,0.9876381,0.000112872665,0.0003141706,0.0000043740306,0.0004906962,0.00001895415,0.00043660402,0.002535343,0.00468937,0.0034654962],"study_design_scores_gemma":[0.0015424035,0.000063318934,0.9696494,0.00028697454,0.00017203149,0.0000049772184,0.000038565177,0.000046277164,0.014288469,0.00018807026,0.013679063,0.000040498006],"about_ca_topic_score_codex":0.0012756225,"about_ca_topic_score_gemma":0.0006354183,"teacher_disagreement_score":0.050852306,"about_ca_system_score_codex":0.000020783098,"about_ca_system_score_gemma":0.00007238627,"threshold_uncertainty_score":0.22902223},"labels":[],"label_agreement":null},{"id":"W2756082032","doi":"10.1097/igc.0000000000001124","title":"Survival Benefit of Adjuvant Radiotherapy","year":2017,"lang":"fr","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Stage (stratigraphy); Internal medicine; Oncology; Radiation therapy; Multivariate analysis; Population; Univariate analysis; Gynecology","score_opus":0.04861966841275897,"score_gpt":0.39249215057113496,"score_spread":0.34387248215837596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756082032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7344556,0.11286221,0.0003158656,0.094871685,0.05036372,0.00027416268,0.00033735228,0.0000066363796,0.006512807],"genre_scores_gemma":[0.9263678,0.06381303,0.0008957288,0.00067159237,0.005235992,0.000011572595,0.0000028478653,0.000018646082,0.0029827591],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776876,0.000059501148,0.0008259686,0.0002038621,0.0008547155,0.00028721808],"domain_scores_gemma":[0.99624723,0.00042648552,0.0015963339,0.00028312954,0.0012066726,0.00024012188],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005226285,0.00020902074,0.00076054607,0.00010854229,0.000091250426,0.00008946394,0.0007899204,0.00017294071,0.011977364],"category_scores_gemma":[0.0005262989,0.00015269713,0.00047216102,0.000035843615,0.0003707246,0.0002566769,0.000099255696,0.0003410845,0.000017589398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001087259,0.0015661736,0.40270635,0.000048585218,0.0033456774,0.0014683299,0.000145556,0.00042696416,0.0005231246,0.0067995344,0.004329667,0.5775528],"study_design_scores_gemma":[0.0058556404,0.0016860667,0.87424284,0.0010412126,0.00038401448,0.00013837467,0.000045236487,0.0001331592,0.001540737,0.0010461825,0.11374741,0.00013911062],"about_ca_topic_score_codex":0.0005379543,"about_ca_topic_score_gemma":0.00021154684,"teacher_disagreement_score":0.5774137,"about_ca_system_score_codex":0.001174762,"about_ca_system_score_gemma":0.000498657,"threshold_uncertainty_score":0.9889258},"labels":[],"label_agreement":null},{"id":"W2756953462","doi":"10.1097/igc.0000000000001132","title":"National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Surgery; Ovarian cancer; Incidence (geometry); Splenectomy; Cancer; Internal medicine","score_opus":0.08102089862001093,"score_gpt":0.4154022105215397,"score_spread":0.33438131190152875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756953462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88626987,0.0027270871,0.00017505359,0.10122992,0.0045883753,0.0003982815,0.00017780981,0.000020187892,0.0044134343],"genre_scores_gemma":[0.9945502,0.001089771,0.00071005215,0.0014472964,0.0014662141,0.00020506285,0.000009803917,0.00001317143,0.00050841004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847126,0.000020126217,0.0005135682,0.00020080424,0.0005898672,0.00020438276],"domain_scores_gemma":[0.9978127,0.0003917138,0.00063585717,0.000097697615,0.0009526485,0.00010937296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042676862,0.00013656444,0.00039473962,0.00032009085,0.00009964064,0.0000980408,0.00027907063,0.000101043326,0.0017541329],"category_scores_gemma":[0.0012685463,0.00009775625,0.00029901494,0.00006069148,0.00007069422,0.00022238429,0.000043114327,0.00017437166,0.000001619548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018499714,0.0010090448,0.6907404,0.000034376866,0.00089499325,0.00043952384,0.00008723389,0.0002774127,0.00022058446,0.0018135768,0.021691833,0.280941],"study_design_scores_gemma":[0.0033206074,0.00018480625,0.9778434,0.00033201152,0.00007807156,0.00007817823,0.000012840429,0.000151914,0.0004326411,0.001671537,0.015788376,0.00010563498],"about_ca_topic_score_codex":0.0001699992,"about_ca_topic_score_gemma":0.0010188364,"teacher_disagreement_score":0.28710294,"about_ca_system_score_codex":0.0009877401,"about_ca_system_score_gemma":0.0009126171,"threshold_uncertainty_score":0.9991584},"labels":[],"label_agreement":null},{"id":"W2759386406","doi":"10.1016/j.ijrobp.2017.06.262","title":"Adjuvant Chemoradiation Therapy for Clear Cell Carcinoma of the Ovary: A Population Based Study of Pelvic Versus Whole Abdominal Radiation Therapy","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adjuvant therapy; Stage (stratigraphy); Radiation therapy; Adjuvant; Population; Internal medicine; Cancer; Surgery; Oncology","score_opus":0.03810706273832932,"score_gpt":0.35096203699634204,"score_spread":0.31285497425801273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759386406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928827,0.0005478701,0.0005009504,0.0026501135,0.002247027,0.0009823804,0.00008657207,0.000007546871,0.00009481308],"genre_scores_gemma":[0.9975186,0.00026310718,0.0006645785,0.0002072192,0.0011657793,0.000047152047,0.000094661904,0.000027782808,0.000011115321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982813,0.00018818058,0.00078250456,0.00022268403,0.00037133822,0.00015398326],"domain_scores_gemma":[0.9954929,0.0003771911,0.002881449,0.00037272286,0.00081030553,0.0000654625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050671946,0.00019182534,0.0005496282,0.00013826982,0.00016090987,0.000027470678,0.00041469873,0.00016039184,0.000027723132],"category_scores_gemma":[0.00019632284,0.00014130979,0.00034061293,0.000091022586,0.00008283038,0.00023603966,0.000028592014,0.00019794593,0.0000017141115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006237111,0.0024708328,0.78694695,0.000012091036,0.0004650687,0.0000033696017,0.00058629573,0.00070708187,0.002579267,0.00030114444,0.00019022143,0.19950058],"study_design_scores_gemma":[0.046010077,0.008388105,0.92632854,0.000031831478,0.0002013575,0.000005399312,0.0001326547,0.0030689146,0.013418085,0.00053010276,0.0017734189,0.00011154128],"about_ca_topic_score_codex":0.00017371212,"about_ca_topic_score_gemma":0.000016841206,"teacher_disagreement_score":0.19938903,"about_ca_system_score_codex":0.00060761144,"about_ca_system_score_gemma":0.0005638739,"threshold_uncertainty_score":0.5762446},"labels":[],"label_agreement":null},{"id":"W2759594088","doi":"10.1097/grf.0000000000000315","title":"Risk-reducing Surgery in Women at Low Lifetime Risk of Developing Ovarian Carcinoma: Opportunistic Salpingectomy","year":2017,"lang":"en","type":"review","venue":"Clinical Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Ovarian cancer; Population; Gynecology; Ovarian carcinoma; General surgery; Surgery; Obstetrics; Intensive care medicine; Cancer; Environmental health; Internal medicine; Pregnancy","score_opus":0.16341967072769473,"score_gpt":0.41090501311759353,"score_spread":0.2474853423898988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759594088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013880979,0.97753817,0.000021446025,0.00015462114,0.005699788,0.0018778214,0.00033630253,0.000052212774,0.0004386888],"genre_scores_gemma":[0.013693861,0.98352367,0.00085771363,0.00016399387,0.00049879315,0.000490623,0.0002875521,0.00015005052,0.00033377187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99055374,0.0016736586,0.004627179,0.0015729101,0.00041797856,0.0011545118],"domain_scores_gemma":[0.9210408,0.07056186,0.0054724016,0.001936715,0.00028893445,0.0006993126],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004631885,0.0008593058,0.008881726,0.0012399935,0.0002510566,0.00003856772,0.00058062875,0.0017717122,0.0003703582],"category_scores_gemma":[0.092370264,0.0007284736,0.0016809148,0.0009576452,0.0004727906,0.00006645521,0.0005955762,0.0018352255,0.00022128224],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00005819025,0.0008269696,0.1894004,0.0070786923,0.0012068388,0.001572057,0.00006384719,7.511419e-7,1.1553785e-8,0.000033487126,0.00090694154,0.7988518],"study_design_scores_gemma":[0.0029426755,0.00060187123,0.21481782,0.009828593,0.004361437,0.000082868966,0.000016452655,0.000015641885,2.9625917e-7,0.00006528268,0.76659364,0.0006734451],"about_ca_topic_score_codex":0.0002957781,"about_ca_topic_score_gemma":0.000054323427,"teacher_disagreement_score":0.7981784,"about_ca_system_score_codex":0.0038274315,"about_ca_system_score_gemma":0.006631981,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W2760451204","doi":"10.1097/grf.0000000000000317","title":"Cost-effectiveness of Ovarian Cancer Prevention Strategies","year":2017,"lang":"en","type":"article","venue":"Clinical Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian cancer; Context (archaeology); BRCA mutation; Cancer prevention; Cancer; Oncology; Disease; Gynecology; Population; Cost effectiveness; Internal medicine; Environmental health; Risk analysis (engineering)","score_opus":0.17917615793864547,"score_gpt":0.480102427560621,"score_spread":0.30092626962197555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760451204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755932,0.0021782317,0.00087324524,0.0016623476,0.0065434533,0.0019805306,0.000043472915,0.000045525005,0.011079991],"genre_scores_gemma":[0.99659413,0.001860622,0.0006468906,0.00012112465,0.00016835632,0.00026417448,0.000019418321,0.000019042953,0.00030626188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982916,0.00026563375,0.0006174975,0.0004050182,0.00016365912,0.00025657986],"domain_scores_gemma":[0.9922136,0.0060412837,0.0005372931,0.00076256384,0.00028304273,0.00016221596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008658478,0.00015293721,0.0007714833,0.000091697315,0.00014132912,0.000038384427,0.00021180799,0.00031539367,0.00036542362],"category_scores_gemma":[0.006674632,0.000127442,0.00028137726,0.0001233382,0.00032815948,0.00012822612,0.00010517016,0.00025818803,0.000034133634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028164717,0.0017384766,0.75281036,0.00020860517,0.00048487904,0.00011190707,0.000023688117,0.000016124202,0.00006999168,0.0066962508,0.00027851315,0.23727955],"study_design_scores_gemma":[0.00655857,0.0016172258,0.97988117,0.00016544033,0.00043776358,0.0000051995885,0.00003885416,0.000035284775,0.000438359,0.0024130712,0.00830175,0.00010728623],"about_ca_topic_score_codex":0.00018095865,"about_ca_topic_score_gemma":0.00012284901,"teacher_disagreement_score":0.23717226,"about_ca_system_score_codex":0.0001989276,"about_ca_system_score_gemma":0.00077010546,"threshold_uncertainty_score":0.79906404},"labels":[],"label_agreement":null},{"id":"W2760857497","doi":"10.1097/grf.0000000000000314","title":"Pathology of Ovarian Cancer: Recent Insights Unveiling Opportunities in Prevention","year":2017,"lang":"en","type":"review","venue":"Clinical Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Serous fluid; Medicine; Fallopian tube; Ovarian cancer; Clear cell; Pathology; Ovarian carcinoma; Carcinogenesis; Serous carcinoma; Epithelium; Ovary; Clear cell carcinoma; Carcinoma; Disease; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.49569660402881016,"score_gpt":0.5177659755338048,"score_spread":0.022069371504994606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760857497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002864471,0.9888642,0.000007732249,0.0005125813,0.0060415003,0.0017209189,0.00006347634,0.000026661586,0.0024764775],"genre_scores_gemma":[0.0003720141,0.99692523,0.00037500446,0.00020443487,0.00034704135,0.0005230723,0.00028332794,0.00006878799,0.00090110174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99430996,0.0009284624,0.0031111494,0.0009191276,0.00024758224,0.00048373107],"domain_scores_gemma":[0.987018,0.008760533,0.0024202226,0.0011996855,0.0003182996,0.00028324293],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010888515,0.000503135,0.0053000194,0.00079907035,0.00008108262,0.000018020193,0.00040772455,0.0016452107,0.00041370944],"category_scores_gemma":[0.009946045,0.00040617725,0.0009856327,0.00047559253,0.00040084252,0.00006405925,0.00023711543,0.0010987598,0.000037222188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002726278,0.0015530336,0.0022142332,0.003927831,0.00052896567,0.0015256386,0.000033517823,5.044928e-7,3.17062e-8,0.0006879302,0.00031873555,0.9891823],"study_design_scores_gemma":[0.0028326923,0.0013826727,0.0039923615,0.0070195426,0.002607826,0.000052668365,0.000023710852,0.0000032905416,5.1254824e-7,0.00036093025,0.9814409,0.00028288775],"about_ca_topic_score_codex":0.000055403176,"about_ca_topic_score_gemma":0.00023539216,"teacher_disagreement_score":0.9888994,"about_ca_system_score_codex":0.0007944421,"about_ca_system_score_gemma":0.0037260482,"threshold_uncertainty_score":0.999839},"labels":[],"label_agreement":null},{"id":"W2761687318","doi":"10.1093/annonc/mdx372.061","title":"A multicentre phase II study of AZD1775 plus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Fallopian tube cancer; Internal medicine; Carboplatin; Ovarian cancer; Clinical endpoint; Fallopian tube; Oncology; Chemotherapy; Gastroenterology; Cancer; Urology; Surgery; Clinical trial; Cisplatin; Adverse effect","score_opus":0.058536181589457136,"score_gpt":0.39402566456565635,"score_spread":0.33548948297619924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761687318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333394,0.00011228496,9.317172e-7,0.0034294936,0.00015917125,0.001555424,0.00015249853,0.000009118441,0.0012471654],"genre_scores_gemma":[0.9983043,0.00022236838,0.0003350706,0.0006014566,0.000105467276,0.00015855058,0.000022569753,0.000027877053,0.00022233985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843514,0.000069297705,0.0005160319,0.00035608475,0.0003142577,0.0003091615],"domain_scores_gemma":[0.9984315,0.00007637282,0.0005422245,0.00054434134,0.00028280725,0.00012276894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016316125,0.0002172435,0.0009452818,0.000111089445,0.0001259531,0.000009385739,0.00018704208,0.00012444207,0.00024395724],"category_scores_gemma":[0.000048154154,0.00014802332,0.000063368294,0.000088903806,0.00015385574,0.00009682965,0.00007619413,0.00014268384,0.0000011441692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085989155,0.053393755,0.6494988,0.00022796956,0.0013837327,0.0004366537,0.009684415,0.00003664624,0.00051756966,0.000041592382,0.0007657684,0.19802395],"study_design_scores_gemma":[0.10019483,0.053834632,0.8393806,0.0002620475,0.00017984744,0.0000019803424,0.00039593404,0.000025096118,0.0009642132,0.0000054232555,0.004613978,0.0001414103],"about_ca_topic_score_codex":0.0038484414,"about_ca_topic_score_gemma":0.006479318,"teacher_disagreement_score":0.19788255,"about_ca_system_score_codex":0.00021172101,"about_ca_system_score_gemma":0.00082457456,"threshold_uncertainty_score":0.60362154},"labels":[],"label_agreement":null},{"id":"W2761972425","doi":"10.1097/pas.0000000000000958","title":"Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract","year":2017,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"KRAS; Mesonephric duct; Genital tract; Biology; Adenocarcinoma; Cancer research; Medicine; Oncology; Mutation; Gene; Genetics; Cancer; Physiology; Kidney","score_opus":0.030011277232359152,"score_gpt":0.3109623122855384,"score_spread":0.28095103505317925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761972425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200326,0.001850509,0.0000064049955,0.0052420488,0.00031719005,0.00027535314,0.000014624697,0.0000031844218,0.00028742672],"genre_scores_gemma":[0.9985302,0.0004872489,0.0006174412,0.00013469315,0.0001650363,0.000012999317,0.0000019680137,0.000014617483,0.000035786463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843794,0.00033354518,0.0006096093,0.00015648376,0.00022790706,0.00023450074],"domain_scores_gemma":[0.99776185,0.00028030982,0.0012645188,0.00047253008,0.00012303532,0.00009778153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066824263,0.00013666417,0.00065580563,0.00009425516,0.00014979494,0.00001439444,0.0003396098,0.000038902363,0.000044218352],"category_scores_gemma":[0.00012385815,0.00007087416,0.00028045045,0.00014608717,0.0006087941,0.000055339286,0.00007527637,0.00040678293,0.0000051252605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010422939,0.00085141294,0.9682041,0.000024754396,0.00020269027,0.0027577998,0.0017062178,0.000069195696,0.0057210648,0.0003115335,0.00008806769,0.019020915],"study_design_scores_gemma":[0.0020295659,0.001202202,0.9911721,0.00009530535,0.00023581344,0.0031983594,0.00062701595,0.000016445865,0.00083545415,0.00021505343,0.00030025525,0.00007243489],"about_ca_topic_score_codex":0.00005173508,"about_ca_topic_score_gemma":0.000007120583,"teacher_disagreement_score":0.02296804,"about_ca_system_score_codex":0.0001167199,"about_ca_system_score_gemma":0.0001870979,"threshold_uncertainty_score":0.28901643},"labels":[],"label_agreement":null},{"id":"W2763475323","doi":"10.1016/j.jogc.2017.07.013","title":"The Practical Side of Opportunistic Salpingectomy","year":2017,"lang":"en","type":"letter","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Salpingectomy; Guideline; Gynecology; Obstetrics and gynaecology; Obstetrics; Population; Fallopian tube; Pregnancy; Ectopic pregnancy","score_opus":0.034900696118986836,"score_gpt":0.2910384035445388,"score_spread":0.256137707425552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763475323","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026803936,0.015331732,0.000007744046,0.95579755,0.020281872,0.00030060078,0.00008564237,0.0000021967476,0.0055122785],"genre_scores_gemma":[0.7035424,0.010328121,0.001020846,0.27829808,0.0022334142,0.000022700217,0.000059056387,0.00010639113,0.004388999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983702,0.000070225244,0.00062505197,0.00015041289,0.00051104004,0.00027311294],"domain_scores_gemma":[0.98989946,0.007481727,0.0015807218,0.00034821624,0.00051989744,0.00016995394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028525182,0.00018591105,0.00075197325,0.00013389482,0.00018392675,0.00003974749,0.00017018612,0.00034720253,0.0001435235],"category_scores_gemma":[0.0080272695,0.00011266988,0.00013440664,0.00007173809,0.00018235685,0.000031935397,0.000048333786,0.0013305774,4.7835914e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006880525,0.000049331247,0.0082257595,0.00012824134,0.000807729,0.05978126,0.000008475196,2.9098794e-7,3.524434e-7,0.00009173306,0.8985369,0.032363046],"study_design_scores_gemma":[0.0014958233,0.0006247615,0.051803067,0.000040681927,0.00097136304,0.00079175434,0.000022525512,0.0000047407084,0.0000054555708,0.00011464488,0.94403255,0.000092658025],"about_ca_topic_score_codex":0.008258968,"about_ca_topic_score_gemma":0.007914427,"teacher_disagreement_score":0.700862,"about_ca_system_score_codex":0.0010209435,"about_ca_system_score_gemma":0.009309609,"threshold_uncertainty_score":0.99834514},"labels":[],"label_agreement":null},{"id":"W2763708507","doi":"10.1016/j.jogc.2017.08.001","title":"Guidelines About Opportunistic Salpingectomy, IVF, and the Practical Side – In Response","year":2017,"lang":"en","type":"letter","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Queen's University; Dalhousie University; Jewish General Hospital","funders":"","keywords":"Medicine; Hydrosalpinx; Salpingectomy; Gynecology; Obstetrics; In vitro fertilisation; Pregnancy; Fallopian tube; Odds ratio; Infertility; Ectopic pregnancy","score_opus":0.05214449943167922,"score_gpt":0.3260546336796415,"score_spread":0.2739101342479623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763708507","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01361067,0.020912504,0.0000036274598,0.9576767,0.006733518,0.00032446408,0.000046218378,0.0000020256641,0.00069024286],"genre_scores_gemma":[0.38234073,0.011471951,0.0010746127,0.6011813,0.001357559,0.000035521352,0.000028137545,0.00007401818,0.002436176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789155,0.00028140534,0.0008309822,0.00023620896,0.0004488273,0.00031100647],"domain_scores_gemma":[0.9852249,0.012723503,0.0010510669,0.00032809936,0.0004860687,0.00018634016],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001170807,0.0002482727,0.0010033587,0.000300523,0.00014308894,0.0000762431,0.00014341046,0.0004235335,0.000118924276],"category_scores_gemma":[0.03172619,0.00015013732,0.0000970202,0.00010270216,0.0002776553,0.00004961036,0.000072459974,0.0016192979,4.4852354e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018951629,0.000044069977,0.013197381,0.00010530734,0.00042023885,0.144883,0.000038767885,0.0000010768767,3.5256517e-7,0.000074297874,0.8208333,0.020212684],"study_design_scores_gemma":[0.0073388857,0.00040204817,0.15329655,0.00009464193,0.00067296025,0.0018003526,0.00004054991,0.00003205229,6.2230515e-7,0.00015424256,0.8360311,0.00013603519],"about_ca_topic_score_codex":0.019762212,"about_ca_topic_score_gemma":0.018234074,"teacher_disagreement_score":0.36873004,"about_ca_system_score_codex":0.0011395043,"about_ca_system_score_gemma":0.007764625,"threshold_uncertainty_score":0.9996806},"labels":[],"label_agreement":null},{"id":"W2763758495","doi":"10.1093/annonc/mdx372.032","title":"ICON7: Ovarian cancer, platinum second-line chemotherapy and overall survival","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bevacizumab; Chemotherapy; Internal medicine; Oncology; Progression-free survival; Cancer; Ovarian cancer; Platinum; Carboplatin; Tumor progression; Surgery; Cisplatin","score_opus":0.11069261496525798,"score_gpt":0.41777760376043144,"score_spread":0.30708498879517343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763758495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89427805,0.001236597,0.000007510443,0.06456562,0.00047747692,0.00028231737,0.0000674489,0.00001471287,0.039070234],"genre_scores_gemma":[0.9888765,0.005061203,0.00034298308,0.0038541146,0.0003909492,0.00003605365,0.000010779661,0.000017825769,0.0014095514],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991689,0.00002791275,0.00023369335,0.00024470422,0.000105622996,0.00021919422],"domain_scores_gemma":[0.99900556,0.00008778727,0.00026087114,0.00039951206,0.00011542748,0.0001308497],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019940964,0.00013338885,0.0005290236,0.000043388343,0.00010446072,0.00001766518,0.00009637846,0.0001357194,0.0012659368],"category_scores_gemma":[0.000044975903,0.00011104952,0.000079388294,0.000019357954,0.0001584088,0.000073128154,0.00004571315,0.00010633738,0.0000064945552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014259893,0.0012690913,0.2618827,0.00015799174,0.001140607,0.00019175406,0.0007141259,0.0000026456344,0.0018477901,0.0063112546,0.020603761,0.7044523],"study_design_scores_gemma":[0.0077490923,0.0025947,0.70654356,0.000075056654,0.00007308275,0.000023115506,0.000023539355,0.000030889634,0.007850537,0.00092483783,0.2739979,0.000113678885],"about_ca_topic_score_codex":0.00097476796,"about_ca_topic_score_gemma":0.0007986237,"teacher_disagreement_score":0.7043386,"about_ca_system_score_codex":0.00003715019,"about_ca_system_score_gemma":0.00023832313,"threshold_uncertainty_score":0.999647},"labels":[],"label_agreement":null},{"id":"W2763851422","doi":"10.1093/annonc/mdx372.021","title":"Gene mutational analyses in 154 ovarian cancer (OC) samples from the ROSiA study of front-line bevacizumab (BEV)-containing therapy for OC","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Progression-free survival; Bevacizumab; Proportional hazards model; Population; Cancer; KRAS; Carboplatin; CDKN2A; Chemotherapy; Colorectal cancer; Confidence interval","score_opus":0.3737642270618406,"score_gpt":0.5146022868673332,"score_spread":0.14083805980549263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763851422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98072785,0.0037705617,0.00006650945,0.013730303,0.00018194753,0.0009831334,0.00033435083,0.0000059365952,0.00019940283],"genre_scores_gemma":[0.99584043,0.0011341698,0.001123156,0.0010430285,0.0003119852,0.00041823788,0.00008506961,0.00001686143,0.000027068361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871445,0.00010351277,0.00049049885,0.00029091956,0.00018828563,0.00021234693],"domain_scores_gemma":[0.99794984,0.0007153044,0.0005283393,0.00047144556,0.00028059777,0.000054455006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033632296,0.00015198167,0.0007020259,0.000076796554,0.00013656986,0.000014537982,0.00022000559,0.00009542654,0.00022204516],"category_scores_gemma":[0.00018487133,0.0001013204,0.00013992602,0.000050455255,0.000111519636,0.000067807756,0.000042235257,0.000094228315,0.0000011693729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006231861,0.0053107925,0.7077032,0.000022702294,0.0031096928,0.000068502435,0.007869242,0.00042751708,0.0025192325,0.00029146412,0.0017212577,0.26472455],"study_design_scores_gemma":[0.015038112,0.0067118728,0.96464723,0.000071588394,0.00027036734,0.0000023648931,0.0014881813,0.00013006761,0.0082412185,0.0007997369,0.002511083,0.00008817445],"about_ca_topic_score_codex":0.03091231,"about_ca_topic_score_gemma":0.021868136,"teacher_disagreement_score":0.26463637,"about_ca_system_score_codex":0.00007923336,"about_ca_system_score_gemma":0.0004432282,"threshold_uncertainty_score":0.9959802},"labels":[],"label_agreement":null},{"id":"W2763936022","doi":"10.1200/jco.2017.35.15_suppl.5522","title":"Phase II clinical and molecular trial of oral ENMD-2076 in clear cell ovarian cancer (CCOC): A study of the Princess Margaret phase II consortium.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Baker Hughes (Canada); University of Toronto; University Health Network","funders":"","keywords":"Medicine; PTEN; Internal medicine; Nausea; Gastroenterology; Cancer; Progression-free survival; Phases of clinical research; ARID1A; Oncology; Chemotherapy; Surgery; Mutation; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.16176038930110476,"score_gpt":0.5318248873649225,"score_spread":0.37006449806381775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763936022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986177,0.00033602325,0.0000061154515,0.009631885,0.0019042095,0.0012085848,0.0000178754,0.0000026677162,0.000715608],"genre_scores_gemma":[0.9971412,0.0011313751,0.0003945649,0.00065020745,0.00056145847,0.000023856914,6.6317193e-7,0.000019260318,0.00007745825],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99393433,0.0010118854,0.0039724354,0.0003400865,0.0004944603,0.0002468068],"domain_scores_gemma":[0.9929519,0.0010044797,0.004666039,0.0006726994,0.00036297823,0.00034187018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004864467,0.00020043709,0.002539257,0.000097493896,0.00014014581,0.000012172729,0.0004276846,0.00039299435,0.00015193335],"category_scores_gemma":[0.0027388243,0.00012269431,0.00057772634,0.00009826564,0.00076663896,0.000101982405,0.00033602273,0.00105468,6.02649e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21961515,0.19819574,0.4000697,0.00006634926,0.0015304238,0.0014414546,0.00067018025,0.000008836396,0.00018723254,0.00015775472,0.0010511536,0.17700602],"study_design_scores_gemma":[0.56471306,0.21616836,0.20494474,0.00021886302,0.0016078367,0.000032094722,0.00022715634,0.00005116506,0.00041773554,0.00012998702,0.011380025,0.00010897505],"about_ca_topic_score_codex":0.00044981673,"about_ca_topic_score_gemma":0.0005058796,"teacher_disagreement_score":0.3450979,"about_ca_system_score_codex":0.000090445355,"about_ca_system_score_gemma":0.0021169123,"threshold_uncertainty_score":0.5003329},"labels":[],"label_agreement":null},{"id":"W2764094032","doi":"10.1093/annonc/mdx372.062","title":"FORWARD I: A phase 3 study to evaluate the safety and efficacy of mirvetuximab soravtansine (IMGN853) versus chemotherapy in adults with folate receptor alpha (FRa)-positive, platinum-resistant epithelial ovarian cancer, primary peritoneal cancer, or primary fallopian tube cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Ovarian cancer; Internal medicine; Oncology; Clinical endpoint; Chemotherapy regimen; Cancer; Phases of clinical research; Topotecan; Chemotherapy; Clinical trial; Adverse effect","score_opus":0.051037166988478856,"score_gpt":0.3993897319209964,"score_spread":0.34835256493251754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764094032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642552,0.0023648934,0.000007691343,0.02762798,0.00044608198,0.0035510357,0.0010561561,0.000017217388,0.00067370647],"genre_scores_gemma":[0.98638266,0.010276532,0.0005736758,0.001548172,0.00032209614,0.0006226657,0.000046942863,0.00006561632,0.00016164662],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971534,0.0002335671,0.0008136733,0.00072721264,0.0005129637,0.00055918365],"domain_scores_gemma":[0.9975414,0.0003945187,0.0005770013,0.00073935813,0.00048934313,0.00025832964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066925824,0.00044175106,0.0015219145,0.00015540306,0.0002647966,0.00002946657,0.00033737908,0.00015654622,0.00025566336],"category_scores_gemma":[0.00010148926,0.00028015111,0.00012457151,0.00024759106,0.0003887633,0.00014118965,0.00013624926,0.00028826453,0.0000013295755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44355953,0.008841163,0.024094116,0.0003179013,0.0028149544,0.00023099835,0.009838225,0.00005064547,0.0039963704,0.000043308406,0.0008591139,0.5053537],"study_design_scores_gemma":[0.15824436,0.058242362,0.76543635,0.0016451877,0.0008045652,0.000012119143,0.00059385854,0.00006831102,0.005463599,0.0000073264077,0.009075747,0.00040622105],"about_ca_topic_score_codex":0.021227816,"about_ca_topic_score_gemma":0.027640752,"teacher_disagreement_score":0.74134225,"about_ca_system_score_codex":0.00061120075,"about_ca_system_score_gemma":0.0021487486,"threshold_uncertainty_score":0.9999651},"labels":[],"label_agreement":null},{"id":"W2764321027","doi":"10.1038/s41467-017-01217-9","title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","year":2017,"lang":"en","type":"article","venue":"Nature Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Fallopian tube; Serous fluid; Serous carcinoma; Pathology; Biology; Ovarian carcinoma; Epithelium; Carcinoma; Serous membrane; Medicine; Anatomy; Ovarian cancer; Cancer; Genetics","score_opus":0.018268154784672516,"score_gpt":0.297172347422208,"score_spread":0.27890419263753546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764321027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98598903,0.0024943405,0.0000379879,0.00971424,0.000057741177,0.00042456962,0.00024776722,0.000036142104,0.0009981751],"genre_scores_gemma":[0.99540377,0.00025008942,0.003527042,0.00030365295,0.000029023808,0.00006740169,0.00033503395,0.000030052734,0.000053919714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998783,0.00012143101,0.0002729245,0.00031616443,0.00028807193,0.0002184266],"domain_scores_gemma":[0.996016,0.00009553193,0.00035189584,0.0030708774,0.0003117396,0.00015394742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016533062,0.00021943763,0.0006448395,0.00021493174,0.00044024317,0.00006926342,0.0005725469,0.0002931577,0.000014950355],"category_scores_gemma":[0.0001294076,0.000175441,0.00013968917,0.00039240814,0.00031470184,0.000089355846,0.00022587027,0.0006026631,0.0000013673447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110577304,0.0006169675,0.9889893,0.000017340813,0.0033475196,0.000029797686,0.00037249146,0.000014330573,0.0008481721,0.00436341,0.000085056636,0.0012050278],"study_design_scores_gemma":[0.0031201388,0.0002952492,0.9867656,0.00006094626,0.0061993743,0.000023045044,0.000060337083,0.0009011821,0.0020988623,0.000060943938,0.00025271391,0.00016161308],"about_ca_topic_score_codex":0.0034675603,"about_ca_topic_score_gemma":0.0059034373,"teacher_disagreement_score":0.009414748,"about_ca_system_score_codex":0.00015673354,"about_ca_system_score_gemma":0.00016881009,"threshold_uncertainty_score":0.71542764},"labels":[],"label_agreement":null},{"id":"W2765609523","doi":"10.1097/grf.0000000000000313","title":"Taking the Tube: From Normal Fallopian Tube Epithelium to Ovarian High-grade Serous Carcinoma","year":2017,"lang":"en","type":"review","venue":"Clinical Obstetrics & Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fallopian tube; Medicine; Serous fluid; Serous carcinoma; Ovarian cancer; Menstruation; Gynecology; Pathology; Cancer; Internal medicine","score_opus":0.18816819473370228,"score_gpt":0.4303865816758063,"score_spread":0.242218386942104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765609523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010870344,0.9725575,0.000055344124,0.0051383865,0.014675667,0.0035168233,0.0005399268,0.00011374897,0.0023155871],"genre_scores_gemma":[0.014569759,0.97397375,0.0014440768,0.0038010199,0.003500904,0.0007338859,0.0005635517,0.00021483161,0.001198213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924717,0.0010177483,0.0028537682,0.0018590708,0.00058617076,0.0012115297],"domain_scores_gemma":[0.9662924,0.027175004,0.0018786255,0.003413662,0.00028260486,0.0009577504],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0012492844,0.0010713966,0.0056996522,0.00042877742,0.0005304467,0.000190972,0.0016433725,0.0020103022,0.0011731347],"category_scores_gemma":[0.019283041,0.00069521874,0.0019221073,0.0007498092,0.00041247494,0.000085323474,0.00085946854,0.002399418,0.0014799698],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034052082,0.0008964308,0.012846044,0.00094856287,0.0014737742,0.0019566943,0.00006290218,9.466029e-7,5.716432e-8,0.0005611563,0.0031237234,0.97809565],"study_design_scores_gemma":[0.0026728637,0.0014106155,0.12302765,0.0020437944,0.005416296,0.00010495448,0.000014973082,0.000006646065,4.8107245e-7,0.00009015473,0.8646379,0.0005736583],"about_ca_topic_score_codex":0.0015365534,"about_ca_topic_score_gemma":0.00056653196,"teacher_disagreement_score":0.977522,"about_ca_system_score_codex":0.0010027719,"about_ca_system_score_gemma":0.0019006648,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W2766164924","doi":"10.1016/j.jogc.2017.06.038","title":"The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; CLIPS; Gynecology; Cost effectiveness; Cancer; Surgery; Internal medicine","score_opus":0.04419160796488647,"score_gpt":0.33323610859212194,"score_spread":0.28904450062723547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766164924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830945,0.012435135,0.000048898924,0.00097249466,0.0026217762,0.00052232697,0.000020387964,3.5722528e-7,0.000284103],"genre_scores_gemma":[0.9992002,0.000602007,0.00006876696,0.000054271757,0.000020210007,0.000036855057,8.4105386e-7,0.000004209373,0.000012617175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993232,0.00007198372,0.00028539324,0.00006151263,0.00014929737,0.00010860207],"domain_scores_gemma":[0.9953531,0.0036917753,0.00057754765,0.00013417681,0.00021186788,0.000031548178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068993395,0.000060919032,0.00028637753,0.00006337531,0.0001445306,0.000014699679,0.00012513866,0.0000433279,0.000005314648],"category_scores_gemma":[0.0015465755,0.00003308136,0.000055976936,0.00006736744,0.000068206595,0.000034199587,0.000015486192,0.000106585445,7.224394e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013227364,0.00014589465,0.85978216,0.00021462352,0.00039349924,0.0001709992,0.00021007407,0.0001376813,0.00006754108,0.0007916421,0.00050369854,0.1374499],"study_design_scores_gemma":[0.0036586078,0.0005380116,0.9914788,0.00009246149,0.00015671775,0.0000075755634,0.00031737314,0.000031851283,0.00029671405,0.0002991542,0.0030937097,0.0000290086],"about_ca_topic_score_codex":0.015968405,"about_ca_topic_score_gemma":0.02447121,"teacher_disagreement_score":0.1374209,"about_ca_system_score_codex":0.0003563093,"about_ca_system_score_gemma":0.0010899991,"threshold_uncertainty_score":0.99332964},"labels":[],"label_agreement":null},{"id":"W2766909368","doi":"10.1002/ijgo.12376","title":"The prognostic value of perioperative, pre‐systemic therapy <scp>CA</scp> 125 levels in patients with high‐grade serous ovarian cancer","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Internal medicine; Univariate analysis; Multivariate analysis; Serous fluid; Perioperative; Oncology; Surgery; Gastroenterology","score_opus":0.018348150026803126,"score_gpt":0.2954184654501982,"score_spread":0.27707031542339505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766909368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921008,0.0021986496,0.00003414002,0.0020906555,0.0027137243,0.0005703684,0.0000610781,0.0000042450606,0.00022638442],"genre_scores_gemma":[0.99733007,0.0015980933,0.00035120797,0.0002194106,0.00017635126,0.00005110998,0.000006691293,0.000022648741,0.00024443597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808353,0.000116015464,0.00066303177,0.0001952419,0.0007053244,0.00023682958],"domain_scores_gemma":[0.9947886,0.002242446,0.0011749009,0.00030030368,0.0013958687,0.00009790952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030954473,0.00018983328,0.0004626984,0.00025501908,0.00015978453,0.00009191674,0.00056321017,0.00011900249,0.00003879776],"category_scores_gemma":[0.0028472454,0.00011207054,0.00011251443,0.00013515337,0.000178251,0.00020349082,0.00006209632,0.00032636448,0.000003075655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017049316,0.0009024113,0.9832407,0.000013508117,0.0010957735,0.00021354153,0.0006044566,0.0003952463,0.00006116987,0.0007143741,0.00011980904,0.012468488],"study_design_scores_gemma":[0.011524909,0.0015801671,0.9830846,0.00031474748,0.00012227493,0.00006943516,0.00010813463,0.000050890823,0.0005956856,0.00006450944,0.0024357925,0.000048827304],"about_ca_topic_score_codex":0.00020006766,"about_ca_topic_score_gemma":0.00010953991,"teacher_disagreement_score":0.012419661,"about_ca_system_score_codex":0.00065437,"about_ca_system_score_gemma":0.00063656754,"threshold_uncertainty_score":0.45701042},"labels":[],"label_agreement":null},{"id":"W2767129025","doi":"10.1016/j.jogc.2017.07.026","title":"Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; Stage (stratigraphy); Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.029105474160922098,"score_gpt":0.2746912620978866,"score_spread":0.24558578793696448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767129025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963356,0.0012020655,0.0000050381204,0.000792514,0.007689245,0.00042350436,0.00014238778,0.0000019373226,0.00010975347],"genre_scores_gemma":[0.9990007,0.00033828567,0.00016061915,0.0001851804,0.00007431158,0.00002668389,0.000015623618,0.000018131792,0.00018040898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987387,0.000030361121,0.00046265475,0.00019351329,0.0002674421,0.00030732816],"domain_scores_gemma":[0.99561596,0.0030823883,0.000616008,0.00015453229,0.0003158992,0.00021523768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015535863,0.0001660631,0.0006038278,0.00020562335,0.00021644485,0.000046339967,0.000097603406,0.000107095235,0.00017720285],"category_scores_gemma":[0.004647614,0.00011985165,0.00008778084,0.00010468834,0.000063220985,0.0001365804,0.000037718262,0.0002067509,8.005297e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008820984,0.0002638516,0.9799394,0.00014185623,0.0002508293,0.0008371283,0.000081213984,0.000012200942,7.013232e-7,0.000016286984,0.00133311,0.017035183],"study_design_scores_gemma":[0.0052579204,0.00082779623,0.9911542,0.000058768346,0.00018478179,0.000007632506,0.00013218372,0.000012020407,0.000027343196,0.000014928007,0.002204954,0.00011749409],"about_ca_topic_score_codex":0.017842604,"about_ca_topic_score_gemma":0.07395501,"teacher_disagreement_score":0.0561124,"about_ca_system_score_codex":0.0028385643,"about_ca_system_score_gemma":0.006605629,"threshold_uncertainty_score":0.999026},"labels":[],"label_agreement":null},{"id":"W2767785601","doi":"10.1634/theoncologist.2017-0297","title":"A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve","year":2017,"lang":"en","type":"review","venue":"The Oncologist","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Quality of life (healthcare); Randomized controlled trial; MEDLINE; Systematic review; Disease; Internal medicine; Physical therapy; Intensive care medicine","score_opus":0.6354246175069749,"score_gpt":0.6413765227387773,"score_spread":0.005951905231802446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767785601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020880796,0.9779684,0.0000107886835,0.0046779807,0.0008013039,0.01584984,0.00019414662,0.000016861968,0.00045977466],"genre_scores_gemma":[0.0005195513,0.9951564,0.000103817554,0.000768381,0.0002196346,0.002892065,0.00005985767,0.000038791088,0.00024151201],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9632074,0.009105986,0.026196964,0.000653298,0.00048054574,0.00035579913],"domain_scores_gemma":[0.9364689,0.0053337645,0.055356808,0.0023109596,0.00026210386,0.00026746807],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.10041934,0.00044783924,0.023949273,0.0001227342,0.00008635579,0.000014827819,0.00048345458,0.00040261235,0.00011725599],"category_scores_gemma":[0.103704125,0.00022611396,0.002155721,0.00035377883,0.00017622547,0.00002660673,0.00015648338,0.00066554267,0.000011195041],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001128901,0.00088230276,0.000044223496,0.66453004,0.0014418932,0.000029717548,0.00005262143,1.038011e-7,7.4181784e-8,0.000064365166,0.00079218164,0.33204958],"study_design_scores_gemma":[0.005192083,0.0012138581,0.00013405994,0.94419307,0.008742192,0.000019004434,0.00003507718,0.0000013994592,3.5348515e-7,0.000014532299,0.04026975,0.00018462876],"about_ca_topic_score_codex":0.009180958,"about_ca_topic_score_gemma":0.00050910277,"teacher_disagreement_score":0.33186495,"about_ca_system_score_codex":0.0010146714,"about_ca_system_score_gemma":0.0064362474,"threshold_uncertainty_score":0.99919635},"labels":[],"label_agreement":null},{"id":"W2768376481","doi":"10.1158/1055-9965.epi-17-0655","title":"Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital","funders":"National Health and Medical Research Council; National Cancer Institute; National Institutes of Health; U.S. Department of Defense; Lon V. Smith Foundation; Kræftens Bekæmpelse; Ovarian Cancer Research Fund; California Breast Cancer Research Program","keywords":"Ovarian cancer; Medicine; Polycystic ovary; Ovary; Oncology; Cancer; Gynecology; Internal medicine; Insulin resistance; Obesity","score_opus":0.05617427452997019,"score_gpt":0.3603510228837166,"score_spread":0.3041767483537464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768376481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8018347,0.14798893,0.0006476691,0.04418304,0.0029247857,0.0015315723,0.00064028415,0.000059200218,0.00018980603],"genre_scores_gemma":[0.91099006,0.08475948,0.0011244853,0.00070284604,0.0004308788,0.0010071659,0.00006230613,0.00004006133,0.00088270765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636096,0.00097616285,0.00097540254,0.0008599175,0.0002666164,0.0005609172],"domain_scores_gemma":[0.9939661,0.0022223587,0.0023143815,0.0010483952,0.0002216393,0.00022712885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024692374,0.00037832255,0.001084267,0.00009861563,0.0006133364,0.00003418477,0.0003275649,0.00041594193,0.0008330823],"category_scores_gemma":[0.002217832,0.00028384363,0.00030367254,0.00014087764,0.00048195192,0.00029300686,0.00013548334,0.00036879614,0.00001114709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009457936,0.0001155754,0.95108247,0.00010348115,0.004426432,0.000015406842,0.00020030692,0.000019222465,0.00030432083,0.00009916473,0.008256067,0.034431778],"study_design_scores_gemma":[0.0025455232,0.00024189918,0.98520947,0.0024795814,0.004163856,0.00001329003,0.00004503555,0.00031984615,0.00024096863,0.002014436,0.002474244,0.00025187145],"about_ca_topic_score_codex":0.1052151,"about_ca_topic_score_gemma":0.00950861,"teacher_disagreement_score":0.10915534,"about_ca_system_score_codex":0.0014591053,"about_ca_system_score_gemma":0.0007029643,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W2768547688","doi":"10.1136/jmedgenet-2017-104926","title":"Paediatric ovarian tumours and their associated cancer susceptibility syndromes","year":2017,"lang":"en","type":"review","venue":"Journal of Medical Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Fondation du cancer des Cèdres; Fondation de l'Hôpital de Montréal pour enfants; Children's Hospital Foundation","keywords":"Pathological; Ovarian cancer; Germline; Biology; Pathology; Genetic predisposition; Germ cell; Cancer; Ovary; Sertoli cell; Cancer research; Medicine; Gene; Genetics; Endocrinology","score_opus":0.11851053827398883,"score_gpt":0.4125210382608319,"score_spread":0.2940104999868431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768547688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075074733,0.9948053,0.000009453111,0.0026667723,0.0011734775,0.00040964145,0.000086288324,0.000008612365,0.00008972003],"genre_scores_gemma":[0.0022458765,0.99563056,0.00011503744,0.0001381247,0.0016550213,0.000017954757,0.000016704586,0.000052820364,0.00012790743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967019,0.00024222492,0.0012158364,0.0003191716,0.0011769354,0.00034393143],"domain_scores_gemma":[0.9962394,0.00042563427,0.0017030492,0.0004635483,0.00026431962,0.0009040165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016846329,0.0004352937,0.0030126318,0.00021481175,0.000102803526,0.00007256937,0.00043185605,0.00076578604,0.00050313177],"category_scores_gemma":[0.0011538847,0.0002494823,0.0007928918,0.00015703759,0.00020463236,0.000033091943,0.00014318855,0.0011514443,0.000005892926],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010661727,0.00037258773,0.0054217116,0.0033049667,0.0013267898,0.0006699325,0.000050736464,1.1759901e-7,3.110658e-8,0.000004316628,0.0037294673,0.9851087],"study_design_scores_gemma":[0.0020493434,0.00074898644,0.010622885,0.023918072,0.0062635583,0.0016254567,0.0000211825,0.000010290358,7.919251e-7,0.000054862176,0.9544346,0.0002499918],"about_ca_topic_score_codex":0.000047618432,"about_ca_topic_score_gemma":0.000062913954,"teacher_disagreement_score":0.9848587,"about_ca_system_score_codex":0.00045688904,"about_ca_system_score_gemma":0.0035851414,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2769010008","doi":"10.1016/j.jpedsurg.2017.10.053","title":"Ovarian torsion in pediatric and adolescent patients: A systematic review","year":2017,"lang":"en","type":"review","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Medicine; Ovarian torsion; Ovary; Systematic review; MEDLINE; Surgery; Internal medicine","score_opus":0.07483957015612365,"score_gpt":0.34591345564962506,"score_spread":0.2710738854935014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769010008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056010438,0.99643934,8.943357e-7,0.00014456197,0.0013185277,0.0019648322,0.000016675438,0.0000069314497,0.000052240823],"genre_scores_gemma":[0.00008638632,0.9954513,0.000042737684,0.00016252568,0.0040511,0.00008633552,0.000021974087,0.00005691666,0.000040778403],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99515533,0.0004079695,0.0030205925,0.00033742853,0.0007163745,0.00036231682],"domain_scores_gemma":[0.99283457,0.0008358763,0.005060855,0.0005780278,0.00033974875,0.00035094807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023468733,0.000503321,0.006552687,0.001281278,0.00007502052,0.00005696305,0.00019019353,0.0002781368,0.000035620607],"category_scores_gemma":[0.0023184514,0.00031993873,0.0013897447,0.0005039162,0.000016937602,0.00016365157,0.00008261534,0.00063526374,0.000023851631],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013082786,0.00059729617,0.03435461,0.87670004,0.00018357101,0.00060714857,0.00000878578,8.22105e-9,1.4946881e-10,8.115311e-7,0.032998208,0.054536447],"study_design_scores_gemma":[0.0010154635,0.00019748697,0.0066909785,0.8475318,0.041253146,0.0003324366,0.0000034547352,1.0924836e-7,6.9367125e-9,0.0000026680038,0.10261366,0.00035881577],"about_ca_topic_score_codex":0.0000065542818,"about_ca_topic_score_gemma":0.0000012733045,"teacher_disagreement_score":0.06961545,"about_ca_system_score_codex":0.00061495363,"about_ca_system_score_gemma":0.0014474157,"threshold_uncertainty_score":0.99992526},"labels":[],"label_agreement":null},{"id":"W2769514698","doi":"10.1038/modpathol.2017.159","title":"Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging","year":2017,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Queen's University","keywords":"Serous carcinoma; Serous fluid; Pathology; Fallopian tube; Cystadenocarcinoma; Ovarian carcinoma; Serous membrane; Stage (stratigraphy); Carcinoma; Medicine; Biology; Adenocarcinoma; Ovarian cancer; Gynecology; Cancer; Internal medicine","score_opus":0.08415963042589442,"score_gpt":0.33764069872669655,"score_spread":0.25348106830080214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769514698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92850506,0.00018545303,0.0031654565,0.06593288,0.000068591864,0.0009312534,0.0010937456,0.000041772117,0.00007581776],"genre_scores_gemma":[0.99407977,0.00004335906,0.0021118573,0.0022569566,0.00015249837,0.00061450317,0.000647242,0.000027268468,0.000066558285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873275,0.00006269742,0.00024456493,0.00059350196,0.0000839642,0.00028250256],"domain_scores_gemma":[0.9984235,0.00014214829,0.000245423,0.00092414767,0.00011133002,0.00015345425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001905198,0.00020469828,0.00025849638,0.0000696437,0.0005348111,0.0000649813,0.00014117098,0.000058103687,0.0000052286964],"category_scores_gemma":[0.00005725703,0.00012853266,0.000052491454,0.00003202777,0.00026548476,0.00005866736,0.000049274142,0.000119489516,0.000002040119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010646622,0.00031727305,0.9821733,0.000059527116,0.000086829226,0.00012736581,0.0003783099,0.00025003526,0.004215847,0.0060093952,0.000114961615,0.0052024885],"study_design_scores_gemma":[0.005264935,0.0007990921,0.9809941,0.000087537,0.00022785399,0.000047407375,0.0000545574,0.0084180515,0.0002711347,0.0033197002,0.000369912,0.00014568999],"about_ca_topic_score_codex":0.00024674766,"about_ca_topic_score_gemma":0.000363799,"teacher_disagreement_score":0.06557472,"about_ca_system_score_codex":0.00019088961,"about_ca_system_score_gemma":0.0002620518,"threshold_uncertainty_score":0.524141},"labels":[],"label_agreement":null},{"id":"W2769931315","doi":"10.1097/ruq.0000000000000334","title":"The Great Mimicker","year":2017,"lang":"en","type":"review","venue":"Ultrasound Quarterly","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Malignancy; Pathology; Pleural effusion; Radiology","score_opus":0.08213232296226544,"score_gpt":0.3814771640967824,"score_spread":0.299344841134517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769931315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000036048716,0.98777777,0.0000031665681,0.00030218362,0.0008743847,0.0011020717,0.00007287134,0.000052172236,0.0098117925],"genre_scores_gemma":[0.000023540186,0.98807085,0.0000628179,0.00007102529,0.000867885,0.0004126139,0.00016057793,0.00007466837,0.010255997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982589,0.0000804149,0.00048668744,0.00048326678,0.00027849307,0.0004122662],"domain_scores_gemma":[0.9969769,0.00074720115,0.00038163963,0.0016513978,0.000059287857,0.00018358785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019968262,0.00047889844,0.0014851128,0.00006285786,0.0005216173,0.0003251713,0.00033349087,0.00026512257,0.00021807496],"category_scores_gemma":[0.000060644372,0.00024412309,0.00091644045,0.00006780235,0.00017422202,0.000058458696,0.000009810616,0.0003678995,0.0012464352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068981653,0.00007100606,0.0000307239,0.0017753283,0.0007202074,0.00008274789,0.00008289691,1.0643223e-9,3.329731e-8,0.00028643614,0.01408389,0.98285985],"study_design_scores_gemma":[0.00043763302,0.0005220888,0.00013536216,0.0065770647,0.0030079745,0.0006599391,0.000024329174,5.046537e-8,1.3203801e-7,0.00009394653,0.9883091,0.00023240231],"about_ca_topic_score_codex":0.00006715675,"about_ca_topic_score_gemma":0.00006454261,"teacher_disagreement_score":0.98262745,"about_ca_system_score_codex":0.00024078082,"about_ca_system_score_gemma":0.0004088631,"threshold_uncertainty_score":0.9995312},"labels":[],"label_agreement":null},{"id":"W2770295769","doi":"10.1016/j.ygyno.2017.11.008","title":"Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; Clovis Oncology","keywords":"Medicine; Internal medicine; Ovarian cancer; Platinum; Adjuvant therapy; Chemotherapy; Oncology; Cancer; Surgery","score_opus":0.07339911402699563,"score_gpt":0.39170845418487565,"score_spread":0.31830934015788004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770295769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88481164,0.00020309322,0.00005062207,0.105604954,0.00073779933,0.0025223973,0.00021118384,0.00004895397,0.005809345],"genre_scores_gemma":[0.9757815,0.0013413876,0.0065693846,0.0016646225,0.000089473164,0.008748309,0.000020857093,0.000016334685,0.005768146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988067,0.00002632139,0.00020378864,0.0004845159,0.00007054463,0.00040809423],"domain_scores_gemma":[0.998438,0.0005309247,0.00019817501,0.0004692412,0.000087458546,0.0002761911],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014120134,0.00020880629,0.0005558676,0.000054285745,0.00067717815,0.000038230748,0.000120340796,0.00012008339,0.0010389439],"category_scores_gemma":[0.00022107114,0.00013367453,0.000043843484,0.000042301133,0.00012539595,0.000062957035,0.000095738425,0.00005906102,0.000033883534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054687716,0.00059555855,0.56330633,0.00002602598,0.00027815666,0.000043560314,0.0007574467,0.0000038420576,0.000009749867,0.0002798422,0.0032646486,0.43088797],"study_design_scores_gemma":[0.0048353043,0.013998627,0.6395499,0.000041477026,0.00013502994,0.000017125287,0.00012304078,0.000008687903,0.000060377748,0.0001574512,0.34095186,0.00012109917],"about_ca_topic_score_codex":0.0004737061,"about_ca_topic_score_gemma":0.016572574,"teacher_disagreement_score":0.43076685,"about_ca_system_score_codex":0.0023181082,"about_ca_system_score_gemma":0.00032827735,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W2770677135","doi":"10.1093/annonc/mdx754","title":"OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Ottawa Hospital; Queen's University","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Debulking; Chemotherapy; Epithelial ovarian cancer; Ovarian cancer; Gynecologic cancer; Gynecologic oncology; Cancer; Oncology; Intraperitoneal chemotherapy; Surgery; Internal medicine","score_opus":0.07607567898418639,"score_gpt":0.4194733978391326,"score_spread":0.34339771885494624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770677135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863145,0.002316204,0.000013725977,0.008465969,0.0011268072,0.0014546447,0.000024983523,0.00001832343,0.00026487024],"genre_scores_gemma":[0.9889079,0.009099349,0.00035696267,0.0007016487,0.00027617897,0.00058971933,0.000006375066,0.000039535447,0.00002236533],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976007,0.00022689332,0.0009255134,0.00051403913,0.0002461964,0.0004866706],"domain_scores_gemma":[0.9975947,0.0008605295,0.0008038621,0.00044869728,0.00014381761,0.0001483586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011164312,0.000334784,0.0024301314,0.0002652581,0.00019268275,0.000024330066,0.00020412714,0.0002307129,0.00029716545],"category_scores_gemma":[0.00029816,0.0002714348,0.000416215,0.00012395895,0.00032810046,0.00013296293,0.00009754844,0.00025589307,4.5396723e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18430343,0.011350661,0.032493137,0.000083956795,0.003771078,0.0004987619,0.00798824,0.00003092939,0.002586669,0.00004157694,0.00014502894,0.75670654],"study_design_scores_gemma":[0.8377859,0.033979397,0.108040355,0.0006911178,0.0010458872,0.000027996382,0.0014854934,0.0005080758,0.013904299,0.00009176467,0.001929061,0.0005106608],"about_ca_topic_score_codex":0.007969723,"about_ca_topic_score_gemma":0.0026565,"teacher_disagreement_score":0.75619584,"about_ca_system_score_codex":0.00022322663,"about_ca_system_score_gemma":0.0005746596,"threshold_uncertainty_score":0.9999738},"labels":[],"label_agreement":null},{"id":"W2774546665","doi":"10.1007/s11136-017-1729-8","title":"Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute for Health and Care Research; National Health and Medical Research Council; Cancer Research UK","keywords":"Medicine; Ovarian cancer; Patient-reported outcome; Adverse effect; Quality of life (healthcare); Internal medicine; Receiver operating characteristic; Stage (stratigraphy); Discriminant validity; Physical therapy; Chemotherapy; Cancer; Oncology; Psychometrics; Clinical psychology","score_opus":0.24913645101639648,"score_gpt":0.44653113897834285,"score_spread":0.19739468796194637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774546665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913682,0.0019684744,0.000003768718,0.0051702517,0.00006003227,0.0012368103,0.00010483044,0.0000036684696,0.00008400837],"genre_scores_gemma":[0.9982781,0.0015127216,0.000059063295,0.000014612257,0.000036202142,0.00005873471,0.0000075563917,0.000021090647,0.000011965494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639523,0.00057796907,0.001154626,0.00034692785,0.0012498166,0.00027541406],"domain_scores_gemma":[0.9965843,0.00030494956,0.0011899072,0.000968065,0.000797288,0.00015547562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581076,0.00020639095,0.0010277352,0.00024880387,0.00008787008,0.00003210116,0.00019106898,0.00012956104,0.000042890417],"category_scores_gemma":[0.00068191177,0.00013661115,0.00020956997,0.00026967647,0.00048478317,0.00019582112,0.00009239842,0.00017526116,1.1548452e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014669697,0.00063046534,0.92526984,0.00078939495,0.001235977,0.0000017892232,0.0046174843,0.000015952763,0.012377356,0.000054186316,0.000016106615,0.05352449],"study_design_scores_gemma":[0.0068768794,0.0010289404,0.950152,0.0023164016,0.00014501395,0.0000025168563,0.0007183107,0.00003748229,0.038551085,0.000065574946,0.000012340246,0.00009349741],"about_ca_topic_score_codex":0.036207844,"about_ca_topic_score_gemma":0.0005735737,"teacher_disagreement_score":0.053430993,"about_ca_system_score_codex":0.00034257284,"about_ca_system_score_gemma":0.000685192,"threshold_uncertainty_score":0.97021013},"labels":[],"label_agreement":null},{"id":"W2775269156","doi":"10.1093/annonc/mdx443","title":"Real-world evidence in the treatment of ovarian cancer","year":2017,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.5808560222584642,"score_gpt":0.5780192370724677,"score_spread":0.0028367851859965043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775269156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006823302,0.9796151,1.196494e-7,0.005927247,0.0002591394,0.0014418839,0.00007684784,0.0000046111036,0.012606813],"genre_scores_gemma":[0.000669781,0.9969254,0.00006614757,0.00018801009,0.0003066865,0.00096216996,0.000025885927,0.000022611908,0.0008332812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809355,0.0002956451,0.00079903536,0.00034407526,0.00020352258,0.00026419025],"domain_scores_gemma":[0.9968854,0.0009051126,0.0010454415,0.0009698182,0.00012554394,0.0000686536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046565707,0.00029875126,0.002928417,0.00025361148,0.000036380192,0.000006819111,0.00029919817,0.00023801012,0.00020417865],"category_scores_gemma":[0.00007312096,0.0001610847,0.00063111103,0.00021633349,0.00017359652,0.00003774609,0.000025502162,0.00014620674,0.000012789476],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007335648,0.0016779377,0.001057549,0.0035168538,0.00068519975,0.00024223422,0.00030886414,2.3065337e-7,9.738025e-8,0.00044713175,0.003021315,0.9889692],"study_design_scores_gemma":[0.00085306755,0.004618047,0.0051916693,0.018190466,0.0018982651,0.000022075039,0.0000117632,2.4819653e-7,0.000008542254,0.000042125976,0.96906507,0.000098653036],"about_ca_topic_score_codex":0.009412463,"about_ca_topic_score_gemma":0.0052511888,"teacher_disagreement_score":0.98887056,"about_ca_system_score_codex":0.0003897016,"about_ca_system_score_gemma":0.0021013552,"threshold_uncertainty_score":0.9971839},"labels":[],"label_agreement":null},{"id":"W2775367434","doi":"10.1016/j.pathol.2017.10.007","title":"Synchronous tumours of the female reproductive tract","year":2017,"lang":"en","type":"review","venue":"Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Female circumcision; Ovarian carcinomas; Carcinoma; Stage (stratigraphy); Metastasis; Ovarian carcinoma; Sex organ; Genital tract; Medicine; Biology; Pathology; Gynecology; Internal medicine; Physiology; Ovarian cancer; Cancer","score_opus":0.10889695242808652,"score_gpt":0.3974957715314442,"score_spread":0.2885988191033577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775367434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015741705,0.99235016,0.0000012171076,0.00037321894,0.0007901212,0.0010062434,0.00007017972,0.000011913281,0.005239544],"genre_scores_gemma":[0.0023006767,0.99602455,0.00009393278,0.000032808242,0.0004306404,0.00021170158,0.000024124487,0.00003464783,0.00084690785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986871,0.00015451491,0.00035778293,0.000501107,0.000111080124,0.00018840494],"domain_scores_gemma":[0.9975357,0.00008784476,0.0006491217,0.0016257565,0.000056293997,0.000045249642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024378755,0.00023731822,0.0017229187,0.000060340695,0.000074315896,0.0000056111726,0.00022387815,0.00021572162,0.00008854074],"category_scores_gemma":[0.00024802503,0.00012868666,0.0005948267,0.000062523126,0.0002328463,0.000015323267,0.00008358498,0.0002945698,0.00006461726],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055397286,0.00035188356,0.0015237826,0.004128835,0.0001419757,0.0005155647,0.000111580826,5.718602e-8,2.70861e-7,0.00010925093,0.00038281505,0.9927285],"study_design_scores_gemma":[0.0003448957,0.0002851954,0.012085406,0.006613432,0.003355168,0.002488497,0.000010682868,4.2416715e-8,0.000015754715,0.00003284352,0.9746492,0.00011890691],"about_ca_topic_score_codex":0.000031406693,"about_ca_topic_score_gemma":0.000004769043,"teacher_disagreement_score":0.99260956,"about_ca_system_score_codex":0.00014633787,"about_ca_system_score_gemma":0.00049472007,"threshold_uncertainty_score":0.52476895},"labels":[],"label_agreement":null},{"id":"W2776186729","doi":"10.3747/co.24.3824","title":"Systemic Therapy for Recurrent Epithelial Ovarian Cancer: A Clinical Practice Guideline","year":2017,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Queen's University; Cancer Care Ontario; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Guideline; Bevacizumab; Olaparib; Ovarian cancer; Oncology; Internal medicine; Clinical trial; Randomized controlled trial; Context (archaeology); Intensive care medicine; Cancer; Gynecology; Chemotherapy; Pathology","score_opus":0.242025014199097,"score_gpt":0.5521467566440835,"score_spread":0.3101217424449865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776186729","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1877085,0.18151838,0.009121728,0.46652785,0.11782785,0.01874104,0.0015715683,0.00048121234,0.016501874],"genre_scores_gemma":[0.7959147,0.14548092,0.023689967,0.00630234,0.0221312,0.005473779,0.00034099596,0.00015166643,0.0005144443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975961,0.00020420838,0.0009514569,0.00061433937,0.00022855113,0.00040533792],"domain_scores_gemma":[0.99671894,0.0005561888,0.0008836977,0.0008972651,0.00066551525,0.0002784027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001458958,0.0002502523,0.00081919093,0.000060911818,0.0003316503,0.000056990153,0.00028052623,0.00021916603,0.00017243095],"category_scores_gemma":[0.001399202,0.00018985276,0.0003414786,0.0000416949,0.0001605418,0.00012668184,0.000082416685,0.00033725225,0.00005680723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003157154,0.0028700174,0.023197541,0.00008639812,0.00042284155,0.00004333244,0.00011287678,9.116323e-7,0.000033064254,0.0012889338,0.07995416,0.88883275],"study_design_scores_gemma":[0.01660822,0.0042931717,0.016604625,0.0003338838,0.00059596734,0.00012354436,0.000056161996,0.00024710636,0.000075633965,0.0001566064,0.9607278,0.00017729065],"about_ca_topic_score_codex":0.00012292466,"about_ca_topic_score_gemma":0.00006654857,"teacher_disagreement_score":0.8886555,"about_ca_system_score_codex":0.00055088993,"about_ca_system_score_gemma":0.001151495,"threshold_uncertainty_score":0.7741971},"labels":[],"label_agreement":null},{"id":"W2781410512","doi":"10.1016/j.jogc.2017.09.018","title":"Examining the Selection Criteria of Neoadjuvant Chemotherapy Patients","year":2017,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"CancerCare Manitoba Foundation; Aeronautical Development Agency; Manitoba Health Research Council; Pfizer Canada; Sanofi; Roche; AstraZeneca Canada; Array BioPharma; AstraZeneca","keywords":"Medicine; Neoadjuvant therapy; Selection (genetic algorithm); Chemotherapy; MEDLINE; Oncology; Internal medicine; Intensive care medicine; Cancer; Artificial intelligence; Breast cancer","score_opus":0.021307558833214304,"score_gpt":0.26474617693230584,"score_spread":0.24343861809909154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781410512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324375,0.0010704703,0.000005429667,0.0012456741,0.0037117775,0.00008853471,0.00000527153,6.6646345e-7,0.0006284262],"genre_scores_gemma":[0.9991009,0.00028317005,0.00017266498,0.0003493061,0.000035071145,0.000001415594,7.074423e-7,0.0000057464804,0.000051010178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993971,0.00001890886,0.00024912355,0.0000664746,0.0001683122,0.00010009519],"domain_scores_gemma":[0.99862385,0.00039118776,0.0005138902,0.00012280825,0.00027634026,0.00007192603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012842043,0.000065205,0.00023962042,0.000055347846,0.00014710579,0.000018881201,0.000079937505,0.00004308325,0.00018551994],"category_scores_gemma":[0.0009049425,0.00003972145,0.000031299754,0.000051214014,0.00004610684,0.000041309806,0.000016312673,0.000112872745,9.122903e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008499967,0.00008235516,0.83181,0.000012455595,0.00012542849,0.0000853501,0.00005199377,0.0000015362425,0.000013903109,0.0000167797,0.0019156091,0.1658761],"study_design_scores_gemma":[0.003147834,0.00083502417,0.98861367,0.000010308855,0.000093261544,0.000017075963,0.00005055169,0.000024417019,0.0002677171,0.000021651886,0.006885216,0.000033248252],"about_ca_topic_score_codex":0.007854188,"about_ca_topic_score_gemma":0.005355427,"teacher_disagreement_score":0.16584286,"about_ca_system_score_codex":0.00034161744,"about_ca_system_score_gemma":0.0005775259,"threshold_uncertainty_score":0.9987526},"labels":[],"label_agreement":null},{"id":"W2782365191","doi":"10.1097/pas.0000000000001016","title":"High-grade Endometrioid Carcinoma of the Ovary","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Calgary Laboratory Services","keywords":"Serous carcinoma; Medicine; Serous fluid; Carcinoma; Univariate analysis; Hazard ratio; Ovarian carcinoma; Oncology; Internal medicine; Population; Pathology; Cancer; Ovarian cancer; Confidence interval; Multivariate analysis","score_opus":0.01811778736518388,"score_gpt":0.2800900606901779,"score_spread":0.261972273324994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782365191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837226,0.0008471567,0.000023467232,0.01434018,0.00040241945,0.00010616225,0.0000072267094,0.0000036930492,0.00054709526],"genre_scores_gemma":[0.99755806,0.00041587435,0.000512553,0.00078007235,0.00066543743,0.0000030162153,4.202163e-7,0.00001181374,0.00005276973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986701,0.00029982819,0.00043288892,0.00011447827,0.00028151556,0.00020121485],"domain_scores_gemma":[0.9982217,0.0004747385,0.0006602835,0.00036040458,0.00018180255,0.00010106802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048474793,0.00011230055,0.0006133317,0.00010733142,0.00006465455,0.0000039527126,0.00023955267,0.000029851777,0.00016182446],"category_scores_gemma":[0.00007758344,0.00004852444,0.00028572718,0.0005262053,0.0014941276,0.00002190015,0.000066981695,0.00026607438,0.000010871591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068013393,0.002692985,0.76866555,0.000040539395,0.0012641185,0.007891907,0.0019984082,0.00002109327,0.010992822,0.0052715917,0.0070499573,0.1873097],"study_design_scores_gemma":[0.0044967383,0.008207847,0.94707847,0.00007434075,0.00044727817,0.013871614,0.00028009992,0.000003612219,0.012638884,0.00063756335,0.01217183,0.000091731796],"about_ca_topic_score_codex":0.00008348091,"about_ca_topic_score_gemma":0.0000021537812,"teacher_disagreement_score":0.18721797,"about_ca_system_score_codex":0.000058616868,"about_ca_system_score_gemma":0.00012698771,"threshold_uncertainty_score":0.5505175},"labels":[],"label_agreement":null},{"id":"W2783240359","doi":"10.1007/s12672-017-0319-0","title":"The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer","year":2018,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Institute of Cancer Research; Canadian Institutes of Health Research","keywords":"Ovarian cancer; Glucocorticoid; Medicine; Adjuvant; Tolerability; Glucocorticoid receptor; Chemotherapy; Oncology; Ex vivo; Pharmacology; In vivo; Cancer; Internal medicine; Cancer research; Biology; Adverse effect","score_opus":0.05219477939617357,"score_gpt":0.3815857450098549,"score_spread":0.32939096561368136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783240359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008014009,0.9959645,6.052461e-7,0.00043446262,0.0004107055,0.0016773216,0.00018569268,0.000009002356,0.00051630614],"genre_scores_gemma":[0.0013000682,0.99468744,0.00001868739,0.00004672504,0.0003751913,0.0023793601,0.000024345283,0.000045744437,0.0011224219],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836296,0.00005576523,0.0005896388,0.00045893446,0.00020171907,0.0003309884],"domain_scores_gemma":[0.9989444,0.00011772877,0.00034156293,0.00042846447,0.000061634964,0.00010618916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010172542,0.00041433016,0.0016739207,0.00009118995,0.000075955584,0.000029263283,0.000094499286,0.00013750396,0.00015755974],"category_scores_gemma":[0.0000060460493,0.00020727579,0.000304758,0.000239112,0.0001380335,0.000031363965,0.00004580222,0.00012222199,0.00001058511],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006419993,0.00014740958,0.0020664067,0.0023453757,0.00073634076,0.000021873435,0.00013459922,8.117511e-7,0.0000013653246,0.0001102467,0.0004545777,0.9939168],"study_design_scores_gemma":[0.0018605567,0.0004902184,0.0037153736,0.0090163825,0.0024072756,0.000014172118,0.000049447834,0.0000073551478,0.00002859981,0.00001636677,0.9821888,0.00020544667],"about_ca_topic_score_codex":0.007380817,"about_ca_topic_score_gemma":0.0036920975,"teacher_disagreement_score":0.99371135,"about_ca_system_score_codex":0.0005562405,"about_ca_system_score_gemma":0.00084251026,"threshold_uncertainty_score":0.99922913},"labels":[],"label_agreement":null},{"id":"W2784104442","doi":"10.1002/ijc.31249","title":"Circulating anti‐Müllerian hormone and breast cancer risk: A study in ten prospective cohorts","year":2018,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; Institute of Cancer Research; National Institutes of Health; Cancer Research UK; National Cancer Institute; Breast Cancer Now; Avon Foundation for Women","keywords":"Medicine; Breast cancer; Prospective cohort study; Anti-Müllerian hormone; Internal medicine; Quartile; Gynecology; Estrogen receptor; Oncology; Odds ratio; Biomarker; Cancer; Case-control study; Obstetrics; Hormone; Confidence interval; Biology","score_opus":0.011188707295488974,"score_gpt":0.3352464654788998,"score_spread":0.3240577581834108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784104442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935663,0.0024109976,0.000013918633,0.002648146,0.00067248265,0.00031397908,0.000052356525,0.0000054682573,0.00031637363],"genre_scores_gemma":[0.9964851,0.0016213694,0.000107264605,0.00017789991,0.0015123812,0.000045531255,7.79917e-7,0.000015234351,0.000034452954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988179,0.000031581632,0.00037867314,0.00017974197,0.00046008377,0.0001319714],"domain_scores_gemma":[0.9987566,0.000030870047,0.0003550998,0.00007798768,0.00068542565,0.000094018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021403669,0.00011788576,0.00030627547,0.00019115067,0.000039539427,0.000042889504,0.00008506486,0.000030426923,0.00023562365],"category_scores_gemma":[0.000030201812,0.00008846239,0.000059028633,0.00012364374,0.000064517575,0.00015251574,0.00003569611,0.00017768555,0.0000017527493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005922763,0.00047914532,0.95022666,0.000003849034,0.0011842034,0.00044986294,0.0012214547,0.000035440447,0.00021504254,0.000013945748,0.00022545237,0.045352664],"study_design_scores_gemma":[0.0057834163,0.00048655533,0.9918091,0.00034874064,0.00023526134,0.00040776163,0.00022983225,0.0001222443,0.00013755941,0.00010474757,0.000252649,0.00008211227],"about_ca_topic_score_codex":0.0022421577,"about_ca_topic_score_gemma":0.001503826,"teacher_disagreement_score":0.04527055,"about_ca_system_score_codex":0.0006028229,"about_ca_system_score_gemma":0.00025819408,"threshold_uncertainty_score":0.36073914},"labels":[],"label_agreement":null},{"id":"W27844308","doi":"10.1007/978-1-62703-547-7_24","title":"Establishment of Primary Cultures from Ovarian Tumor Tissue and Ascites Fluid","year":2013,"lang":"en","type":"article","venue":"Methods in molecular biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Montréal; University Health Network; CancerCare Manitoba; Ontario Institute for Cancer Research","funders":"","keywords":"Trypsinization; Ascites; Cryopreservation; Cell culture; Tumor cells; Primary culture; Isolation (microbiology); Tissue culture; Pathology; Cancer research; Biology; Chemistry; Cell biology; Medicine; Trypsin; Internal medicine; In vitro; Bioinformatics; Embryo; Biochemistry","score_opus":0.01562547678630538,"score_gpt":0.3629785031839258,"score_spread":0.34735302639762045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W27844308","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.776373,0.02288918,0.1882722,0.004947432,0.00041880007,0.0017506145,0.00006107189,0.0000471073,0.0052405596],"genre_scores_gemma":[0.08421574,0.00024318963,0.9139497,0.0012731641,0.00004458007,0.00015369352,0.00006102052,0.000014758144,0.00004414504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879783,0.00035036408,0.00027136266,0.00033218806,0.00006495454,0.00018327092],"domain_scores_gemma":[0.9993257,0.00019380888,0.00007363232,0.00027846044,0.000049407965,0.00007901811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028055013,0.00014296263,0.00046294523,0.0000962014,0.000015264046,0.00001091865,0.000068468464,0.00010309844,0.00029578785],"category_scores_gemma":[0.00015590231,0.00010573986,0.000046177847,0.00012304238,0.00011481679,0.000025844687,0.00007880108,0.00009713129,0.000004948206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031124822,0.00018568768,0.041664105,0.00003744004,0.00012851652,0.000051310675,0.00014625031,0.0000013350349,0.8732915,0.0014746012,0.00021729954,0.08277084],"study_design_scores_gemma":[0.0020710237,0.00060542946,0.22504126,0.00009304027,0.00012969924,0.000024073926,0.00006706867,0.000034246717,0.7516905,0.011633618,0.00845026,0.00015979697],"about_ca_topic_score_codex":0.0016441101,"about_ca_topic_score_gemma":0.000010518949,"teacher_disagreement_score":0.7256775,"about_ca_system_score_codex":0.000057637815,"about_ca_system_score_gemma":0.000045094053,"threshold_uncertainty_score":0.43119463},"labels":[],"label_agreement":null},{"id":"W2786430620","doi":"10.1016/j.ygyno.2018.01.016","title":"Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Serous fluid; Surgical pathology; Serous carcinoma; Fallopian tube; Pathology; Gynecology; General surgery; Radiology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.06401480713532656,"score_gpt":0.374758644771803,"score_spread":0.3107438376364764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786430620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882704,0.0023959205,0.0000087813505,0.0010814759,0.00046496742,0.0005278824,0.00006793193,0.00002522218,0.0071574305],"genre_scores_gemma":[0.9959692,0.0008512739,0.0025512131,0.00023526698,0.00025425325,0.00004727764,0.000025256677,0.000013510518,0.00005278715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796575,0.00056817906,0.00057705055,0.00041999563,0.0001712999,0.00029772217],"domain_scores_gemma":[0.9958338,0.0023351107,0.00089162536,0.0002455523,0.0005731146,0.0001207802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013228036,0.00017405162,0.0009490935,0.00021859624,0.00005287167,0.0000065230142,0.00009444183,0.00033117292,0.0006132786],"category_scores_gemma":[0.0030351193,0.00013239274,0.000056523437,0.0005390478,0.0007772163,0.00007437524,0.0001011883,0.00017886705,0.000010607963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031190175,0.0029714066,0.92028916,0.00019417383,0.00033992223,0.0011536798,0.00041956987,5.173947e-7,0.0031971135,0.0006655524,0.0010497223,0.066600166],"study_design_scores_gemma":[0.008403614,0.0138425045,0.94088686,0.0000384974,0.00026035914,0.0002491644,0.000115668525,0.000015063315,0.004388679,0.00008492044,0.031591207,0.00012344128],"about_ca_topic_score_codex":0.00026254877,"about_ca_topic_score_gemma":0.0007882076,"teacher_disagreement_score":0.066476725,"about_ca_system_score_codex":0.00015397361,"about_ca_system_score_gemma":0.00073345256,"threshold_uncertainty_score":0.67149705},"labels":[],"label_agreement":null},{"id":"W2787335459","doi":"10.1016/j.celrep.2018.01.053","title":"Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry","year":2018,"lang":"en","type":"article","venue":"Cell Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; International Society for the Advancement of Spine Surgery; Ovarian Cancer Research Fund; National Heart, Lung, and Blood Institute; U.S. Department of Defense; National Institutes of Health; National Science Foundation","keywords":"Mass cytometry; Flow cytometry; Serous fluid; Serous ovarian cancer; Cell; Cancer research; Cytometry; Clear cell; Biology; Chemistry; Medicine; Ovarian cancer; Pathology; Molecular biology; Immunology; Phenotype; Genetics; Cancer; Immunohistochemistry; Gene","score_opus":0.01739395874808241,"score_gpt":0.25236741207637464,"score_spread":0.23497345332829223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787335459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745515,0.0011132705,0.0001398159,0.00031252654,0.0013033265,0.0007107881,0.000023163431,0.00012588545,0.021719752],"genre_scores_gemma":[0.99501425,0.000041862917,0.00091274315,0.0006143499,0.00033908713,0.000059053546,0.00015111586,0.00008693521,0.0027806277],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969023,0.00007126814,0.00092490896,0.00088755816,0.0005404685,0.0006734937],"domain_scores_gemma":[0.9978666,0.00008891168,0.0005058646,0.0010319591,0.0001299558,0.00037672961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041544772,0.00040065148,0.00067057466,0.00030461917,0.00012621198,0.000098534176,0.00013687123,0.00020551578,0.0003907009],"category_scores_gemma":[0.000042074054,0.0003835911,0.00015813648,0.0005641846,0.00011624802,0.00013500231,0.00008554958,0.00032401763,0.00015497021],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013427011,0.0045143925,0.7627407,0.00047778097,0.0000819846,0.021199422,0.00054921897,0.000010180638,0.16358526,0.000010550975,0.045874495,0.0008217871],"study_design_scores_gemma":[0.0047855033,0.00077700714,0.08888528,0.00038967773,0.00030357935,0.00054419006,0.00023155635,0.000041688127,0.8820399,0.00019281839,0.021169601,0.0006391969],"about_ca_topic_score_codex":0.0010540541,"about_ca_topic_score_gemma":0.0001289598,"teacher_disagreement_score":0.71845466,"about_ca_system_score_codex":0.00051240594,"about_ca_system_score_gemma":0.00018822307,"threshold_uncertainty_score":0.9998616},"labels":[],"label_agreement":null},{"id":"W2787610894","doi":"10.1016/j.jpedsurg.2017.12.028","title":"The utility of magnetic resonance imaging in the diagnosis and management of pediatric benign ovarian lesions","year":2018,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Magnetic resonance imaging; Radiology; Pathological; Ultrasound; Lesion; Retrospective cohort study; Pathology","score_opus":0.035340242762728284,"score_gpt":0.2862391337633488,"score_spread":0.2508988910006205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787610894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9094406,0.08581968,0.000014794068,0.003251813,0.0004967338,0.00031525496,0.000012011681,0.0000033826707,0.00064573437],"genre_scores_gemma":[0.89709836,0.101114124,0.00028254886,0.00009417331,0.0013654833,0.000020278268,5.501436e-7,0.000009849172,0.000014619959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980612,0.00017437583,0.0008760898,0.00015620336,0.00050201896,0.00023013914],"domain_scores_gemma":[0.9968928,0.0019121503,0.0005720726,0.00032462965,0.0002168692,0.00008144575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020992104,0.00013289257,0.00039859707,0.00028883576,0.000098621895,0.00001843049,0.00015205092,0.000038692153,0.00007939005],"category_scores_gemma":[0.00021592929,0.00007441779,0.0002001202,0.00073640986,0.0001251217,0.00007686062,0.000052676376,0.00016005263,0.0000013580743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013933584,0.00039830923,0.8984337,0.00010908163,0.00002797708,0.00015916779,0.00020947822,2.4271827e-7,7.421724e-7,0.000072731375,0.025165856,0.07528339],"study_design_scores_gemma":[0.0008449083,0.00019479683,0.9941943,0.00008499638,0.0007234731,0.00003633033,0.00032825294,0.000015742371,0.000028934894,0.0001958794,0.0032911967,0.000061183644],"about_ca_topic_score_codex":0.00007011281,"about_ca_topic_score_gemma":0.00001570639,"teacher_disagreement_score":0.09576062,"about_ca_system_score_codex":0.000038866892,"about_ca_system_score_gemma":0.00017435651,"threshold_uncertainty_score":0.30346695},"labels":[],"label_agreement":null},{"id":"W2789365920","doi":"10.1080/09513590.2018.1431215","title":"Case report: an identical twin with Sertoli-Leydig cell tumor","year":2018,"lang":"en","type":"review","venue":"Gynecological Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pacific Centre for Reproductive Medicine; University of British Columbia","funders":"","keywords":"Medicine; Virilization; Context (archaeology); Leydig Cell Tumor; Androgen insensitivity syndrome; Malignancy; Testosterone (patch); Androgen Excess; Androgen; Gynecology; Pathology; Internal medicine; Urology; Leydig cell; Cancer; Hormone; Luteinizing hormone; Polycystic ovary; Androgen receptor; Biology","score_opus":0.07381228219554696,"score_gpt":0.36124447407539456,"score_spread":0.2874321918798476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789365920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003999134,0.98322207,0.000023845403,0.00036724724,0.0008000347,0.0024283598,0.000069597285,0.0003059187,0.008783795],"genre_scores_gemma":[0.0035147031,0.98964214,0.002069472,0.00069469307,0.0008848373,0.0012607803,0.00034721292,0.00011997609,0.001466158],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521405,0.00037585726,0.0012485086,0.0016505365,0.00030241103,0.0012086356],"domain_scores_gemma":[0.996559,0.00065366173,0.0006282036,0.0013438707,0.00017385262,0.0006413947],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001837902,0.00086009427,0.0034749599,0.00023427783,0.000172968,0.000051322757,0.0002788761,0.00055646506,0.0032447185],"category_scores_gemma":[0.00030431105,0.00050622685,0.0006019821,0.00032743104,0.00056532485,0.00007008691,0.00024160004,0.0009196888,0.00096885156],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006480517,0.0016584932,0.00027701198,0.0026094154,0.0004402962,0.8680542,0.000012189483,1.3485153e-7,6.847767e-8,0.000483732,0.0018203837,0.12457927],"study_design_scores_gemma":[0.0013279362,0.0035432894,0.00013491938,0.00053961336,0.0025285587,0.4393122,0.00001582561,0.0000012678643,0.0000041490307,0.000037235124,0.55223346,0.00032155032],"about_ca_topic_score_codex":0.00009048772,"about_ca_topic_score_gemma":0.00014120944,"teacher_disagreement_score":0.5504131,"about_ca_system_score_codex":0.0004986477,"about_ca_system_score_gemma":0.0008173371,"threshold_uncertainty_score":0.999809},"labels":[],"label_agreement":null},{"id":"W2789401347","doi":"10.1016/j.jpag.2018.02.110","title":"Management of Adnexal Masses in Children and Adolescents: Evaluating the Decision Tree System (DTS)","year":2018,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Malignancy; Adnexal mass; Risk stratification; Decision tree; Radiology; Ultrasound; Gynecology; Machine learning; Internal medicine; Computer science","score_opus":0.015543065302513126,"score_gpt":0.30436652167001077,"score_spread":0.2888234563674976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789401347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375325,0.0048795105,0.00012071672,0.00042891808,0.00030498856,0.00038839786,0.000003054922,0.0000037828147,0.00011739463],"genre_scores_gemma":[0.9924942,0.005639108,0.001082296,0.00012307685,0.0006342212,0.0000038092153,7.382409e-7,0.00000971176,0.000012828175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998691,0.00009389683,0.0005859414,0.00017186448,0.0002708983,0.00018636133],"domain_scores_gemma":[0.99906075,0.00014381268,0.00042405404,0.00013445203,0.00013598287,0.000100963065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006623875,0.00012906325,0.0003860277,0.0001926709,0.000059179598,0.00001202128,0.00008563559,0.000072493414,0.000022607559],"category_scores_gemma":[0.00006745842,0.0000785715,0.00006980804,0.00018527001,0.00008302573,0.000051599884,0.00007886944,0.00017275846,0.000002304174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038503399,0.0004082293,0.910486,0.000265568,0.000113490576,0.00006445448,0.000060690625,0.0000040595937,0.0000089127,0.00008470464,0.00065784017,0.08746101],"study_design_scores_gemma":[0.0054902295,0.0017879701,0.99042,0.00069652783,0.0007858372,0.00025736648,0.00030441326,0.00008940526,0.000019483903,0.000037090194,0.0000490825,0.00006261572],"about_ca_topic_score_codex":0.000006327618,"about_ca_topic_score_gemma":0.0000061718997,"teacher_disagreement_score":0.08739839,"about_ca_system_score_codex":0.00012046486,"about_ca_system_score_gemma":0.00008059251,"threshold_uncertainty_score":0.32040527},"labels":[],"label_agreement":null},{"id":"W2789811819","doi":"10.1126/scitranslmed.aap8793","title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","year":2018,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Stand Up To Cancer; National Institutes of Health; Victoria General Hospital Foundation; Novo Nordisk Fonden; Göteborgs Läkaresällskap; National Institute of General Medical Sciences; Novo Nordisk; Swim Across America; Howard Hughes Medical Institute; Swedish Cancer Foundation; Honorable Tina Brozman Foundation; Virginia and D.K. Ludwig Fund for Cancer Research; Gray Foundation; Commonwealth Foundation; John Templeton Foundation; Johns Hopkins University; U.S. Department of Defense","keywords":"Papanicolaou stain; Papanicolaou Test; Medicine; Liquid biopsy; Liquid-based cytology; Gynecology; Oncology; Internal medicine; Cancer; Cervical cancer","score_opus":0.06872096978570788,"score_gpt":0.35093515310869644,"score_spread":0.28221418332298853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789811819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97099227,0.0061498717,0.0017656969,0.01857986,0.000500295,0.00153785,0.00012789213,0.000007963574,0.00033831896],"genre_scores_gemma":[0.99869645,0.00013594456,0.00029394656,0.00023037076,0.0005617556,0.000070638576,0.000002857261,0.0000051452757,0.000002904971],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986486,0.000035180674,0.00023249935,0.00019714661,0.00078582,0.000100741054],"domain_scores_gemma":[0.99766964,0.0014907945,0.00011631953,0.00014982793,0.0005258648,0.000047526602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022962554,0.000076886856,0.00016376327,0.000089951725,0.00019020385,0.000006281655,0.000071545524,0.00002472917,0.00011189516],"category_scores_gemma":[0.0010612629,0.000037905585,0.000025041387,0.00045857514,0.0018570871,0.00006824608,0.0000072489097,0.000039772356,2.5594957e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054994407,0.00019837682,0.027479691,0.00006668748,0.00045054883,2.953821e-7,0.011915444,0.000053853295,0.75720495,0.0031831749,0.000071752605,0.19387576],"study_design_scores_gemma":[0.019648835,0.0124667,0.71878564,0.0006209498,0.00296203,0.0000155075,0.0016112283,0.013828926,0.22414073,0.0021364796,0.0036234385,0.00015950509],"about_ca_topic_score_codex":0.0013727206,"about_ca_topic_score_gemma":0.00068790285,"teacher_disagreement_score":0.691306,"about_ca_system_score_codex":0.000053848766,"about_ca_system_score_gemma":0.00041135593,"threshold_uncertainty_score":0.6842515},"labels":[],"label_agreement":null},{"id":"W2790995136","doi":"10.1089/gyn.2017.0131","title":"Laparoscopic Treatment of Tubal Torsion in Pregnancy","year":2018,"lang":"en","type":"article","venue":"Journal of Gynecologic Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Laparoscopy; Laparotomy; Pregnancy; Surgery; Cosmesis; Salpingectomy; Gestation; Ovarian cyst; Abdominal pain; Lower abdominal pain; Ovarian torsion; Fallopian tube; Obstetrics; Cyst; Ectopic pregnancy","score_opus":0.04650463827540776,"score_gpt":0.31332552500619104,"score_spread":0.2668208867307833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790995136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941404,0.0029852418,0.0000024193605,0.000636619,0.0009744794,0.00015755635,0.0000022529482,0.0000046615123,0.0010963797],"genre_scores_gemma":[0.99654967,0.0026248342,0.00035236392,0.000072788134,0.00024061806,0.000009820681,0.0000014481705,0.000007072752,0.00014137034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989116,0.000058510926,0.0005712836,0.00010923295,0.00017789748,0.00017145209],"domain_scores_gemma":[0.9987429,0.00050824543,0.00037220263,0.00014000024,0.00014816417,0.00008850498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020865774,0.00010936381,0.00065223686,0.00022260548,0.000020280211,0.0000044011513,0.00003596696,0.00007898979,0.0006417619],"category_scores_gemma":[0.000211101,0.000068621586,0.00022544187,0.00018125321,0.000063540545,0.000058969606,0.000009235618,0.000053433007,0.000010933589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024881968,0.00209825,0.9496136,0.000030985233,0.00012239967,0.0005405836,0.00015111524,0.0000016876759,0.0002889334,0.000015756345,0.001702641,0.045185246],"study_design_scores_gemma":[0.0028292947,0.005870352,0.9692756,0.0007403737,0.00013418778,0.00010479078,0.00006636629,0.0000039313495,0.017425315,0.00011786865,0.003367925,0.000064018925],"about_ca_topic_score_codex":0.000024615876,"about_ca_topic_score_gemma":0.000026380347,"teacher_disagreement_score":0.045121226,"about_ca_system_score_codex":0.00039372972,"about_ca_system_score_gemma":0.00030243307,"threshold_uncertainty_score":0.7026843},"labels":[],"label_agreement":null},{"id":"W2791921535","doi":"10.1093/ije/dyx252","title":"Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies","year":2017,"lang":"en","type":"article","venue":"International Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"University of California, Irvine; National Cancer Institute; National Institutes of Health; Medical Research Council; National Engineering College; U.S. Department of Defense; Lon V. Smith Foundation; Assam University, Silchar; University of Southern California; State of Connecticut Department of Public Health","keywords":"Epidemiology; Ethnic group; Ovarian cancer; Medicine; Case-control study; Oncology; Demography; Cancer; Internal medicine; Anthropology; Sociology","score_opus":0.20093729579835604,"score_gpt":0.4751566148426557,"score_spread":0.27421931904429964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791921535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92039394,0.023984084,0.00066476257,0.053514052,0.0009922417,0.00019378861,0.0000983515,0.0000020462255,0.00015674763],"genre_scores_gemma":[0.98912174,0.007888602,0.0006852485,0.0018652244,0.00038248432,0.000026235564,0.000003997446,0.000005440494,0.000021028294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962402,0.0013000795,0.0018362302,0.0002011395,0.00019786948,0.00022447208],"domain_scores_gemma":[0.9845774,0.011070833,0.0032818816,0.00036686356,0.00063526205,0.000067732326],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0060526095,0.0001543885,0.0021497793,0.0005212802,0.000052360265,0.0000026757714,0.0005347785,0.00012331648,0.00014763356],"category_scores_gemma":[0.016062953,0.00008641852,0.0006121856,0.00011907569,0.0004767827,0.00008072328,0.000055997796,0.00028074445,6.921748e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006717836,0.00026166427,0.9530439,0.00001811407,0.021374151,0.00070664147,0.0008222383,0.0003738334,0.000025672203,0.004637627,0.00025271616,0.01781166],"study_design_scores_gemma":[0.0027250913,0.0005495303,0.9855015,0.00021992932,0.004896896,0.00048370232,0.00033969694,0.00068136444,0.000016895576,0.0044114557,0.00011712442,0.000056784676],"about_ca_topic_score_codex":0.0022593988,"about_ca_topic_score_gemma":0.0029768483,"teacher_disagreement_score":0.06872781,"about_ca_system_score_codex":0.00016037963,"about_ca_system_score_gemma":0.00016141978,"threshold_uncertainty_score":0.99222517},"labels":[],"label_agreement":null},{"id":"W2792461576","doi":"10.1177/1066896917752861","title":"Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma","year":2018,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Ontario Institute for Cancer Research","keywords":"Mucinous carcinoma; Immunohistochemistry; Pathology; Medicine; Ovarian carcinoma; Primary (astronomy); Carcinoma; Ovary; Adenocarcinoma; Oncology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.023534357836647205,"score_gpt":0.3026618455483686,"score_spread":0.2791274877117214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792461576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953427,0.00041151777,0.000118848824,0.0023107133,0.0007876324,0.00010052254,0.000028211805,0.000006977759,0.0008929159],"genre_scores_gemma":[0.99734986,0.00052670605,0.00091719726,0.00051902863,0.0005569919,0.0000026221112,0.00007696435,0.0000096941085,0.00004096192],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998733,0.000085530664,0.0006421252,0.0001675651,0.00025544298,0.00011637506],"domain_scores_gemma":[0.99826396,0.00009866004,0.00047045443,0.00011322453,0.00096323603,0.00009048511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018757152,0.00011305526,0.00046734675,0.00016320164,0.000022353473,0.000008527279,0.00011626426,0.0001254935,0.00022302088],"category_scores_gemma":[0.000032823285,0.00008682515,0.0001225837,0.00007654433,0.00033683237,0.000070434005,0.000069297574,0.00018194152,0.0000065806007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063986224,0.0016305197,0.35605752,0.0000468601,0.000498701,0.015040273,0.0005435195,5.341481e-7,0.5856711,0.0009764156,0.00033645102,0.03279944],"study_design_scores_gemma":[0.006586517,0.0021090107,0.9499136,0.00009144702,0.00013587807,0.018698705,0.000023504717,0.000022060458,0.012869484,0.00018300809,0.0092728725,0.000093882074],"about_ca_topic_score_codex":0.0000060790862,"about_ca_topic_score_gemma":1.947609e-7,"teacher_disagreement_score":0.5938561,"about_ca_system_score_codex":0.0001104645,"about_ca_system_score_gemma":0.00010797584,"threshold_uncertainty_score":0.3540627},"labels":[],"label_agreement":null},{"id":"W2794196479","doi":"10.1038/s41416-018-0011-3","title":"Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study","year":2018,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; Public Health Ontario; University of British Columbia; University of Toronto","funders":"Medical Research and Materiel Command; National Cancer Institute; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Rutgers Cancer Institute of New Jersey; Radboud Universiteit; Helse Vest; Cancer Research UK; University College London; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; U.S. Public Health Service; U.S. Department of Defense; Lon V. Smith Foundation; Fred C. and Katherine B. Andersen Foundation; Helsingin ja Uudenmaan Sairaanhoitopiiri; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Mayo Foundation for Medical Education and Research; European Commission; University of Cambridge; Breast Cancer Research Foundation; Oregon Health and Science University; Kræftens Bekæmpelse; Ovarian Cancer Research Fund; National Center for Research Resources; Oak Foundation; Norges Forskningsråd; Kreftforeningen; Minnesota Ovarian Cancer Alliance","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Mendelian inheritance; Internal medicine; Gynecology; Biology; Genetics; Gene","score_opus":0.024505662964782574,"score_gpt":0.328953653169278,"score_spread":0.3044479902044954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794196479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007027808,0.9891979,0.000008378137,0.00012232053,0.00043446783,0.0018450982,0.0011464232,0.00001257137,0.00020502554],"genre_scores_gemma":[0.0074960804,0.9906105,0.00012382363,0.00013711622,0.001002236,0.00034342016,0.0000429039,0.00009552414,0.00014842516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961718,0.0005073917,0.0016248155,0.00040413474,0.0009766737,0.0003151906],"domain_scores_gemma":[0.99352646,0.00021025586,0.0039034917,0.00029861229,0.0017667837,0.0002944183],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008551679,0.00044738286,0.0035784564,0.0002718441,0.000113712405,0.00006931648,0.00021104437,0.00025833258,0.0010866579],"category_scores_gemma":[0.000259015,0.0003399285,0.0008009187,0.0005535759,0.000101893645,0.00012477509,0.000026746537,0.00061662524,0.000003045839],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011176205,0.0017325962,0.012970992,0.002319737,0.019301504,0.0009893936,0.00031708652,0.0000014652226,1.5556303e-7,0.0000013914113,0.008874457,0.9523736],"study_design_scores_gemma":[0.06955528,0.0043196566,0.029348481,0.25397354,0.07482674,0.0015935781,0.00016036205,0.000006791156,0.000022351289,0.000022651644,0.56543106,0.0007395274],"about_ca_topic_score_codex":0.015122756,"about_ca_topic_score_gemma":0.009628198,"teacher_disagreement_score":0.95163405,"about_ca_system_score_codex":0.0011952885,"about_ca_system_score_gemma":0.0029134995,"threshold_uncertainty_score":0.9999053},"labels":[],"label_agreement":null},{"id":"W2794460351","doi":"10.1186/s12885-018-4242-8","title":"Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Ottawa Hospital; University of Manitoba; University of Calgary; Vancouver General Hospital; University of British Columbia; Jewish General Hospital; Ontario Institute for Cancer Research; Université de Sherbrooke; University of Toronto; Centre hospitalier universitaire de Québec; BC Cancer Agency; University of Ottawa; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Terry Fox Research Institute","keywords":"Surgical oncology; Medicine; Ovarian cancer; Cohort; Oncology; Outcome (game theory); Internal medicine; Gynecology; Cohort study; Cancer","score_opus":0.04242073023013328,"score_gpt":0.32991520841292893,"score_spread":0.28749447818279567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794460351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910207,0.0005048569,0.00010488417,0.005599132,0.0013887837,0.0014251864,0.0009769758,0.000013582498,0.0008845257],"genre_scores_gemma":[0.99692273,0.00022547663,0.00034311152,0.0008633996,0.00043546237,0.0004052564,0.000023821602,0.000019957204,0.0007607794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992588,0.000016167347,0.0002137985,0.00020184532,0.00012122301,0.00018815196],"domain_scores_gemma":[0.99930036,0.000039095466,0.00011609907,0.00023343909,0.00017384037,0.00013715074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121911726,0.00010770605,0.00022232758,0.000053203683,0.00010359051,0.0000145851045,0.000054250762,0.00006051966,0.000362676],"category_scores_gemma":[0.00004980724,0.00007440405,0.0000658169,0.00012171211,0.00011173218,0.00002972949,0.0000149974785,0.00003718584,0.000002267139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008437446,0.00002213894,0.9898318,0.000094915136,0.00017945711,5.767535e-7,0.00008942832,4.041137e-7,0.00012225799,0.00019337695,0.003375013,0.0060062385],"study_design_scores_gemma":[0.0011458572,0.00007272194,0.95923567,0.00012549042,0.00041468267,0.0000026621642,0.00001383025,0.0001081704,0.0025012493,0.000018245073,0.036282618,0.00007879873],"about_ca_topic_score_codex":0.116252065,"about_ca_topic_score_gemma":0.1638558,"teacher_disagreement_score":0.04760374,"about_ca_system_score_codex":0.00035223112,"about_ca_system_score_gemma":0.0006260643,"threshold_uncertainty_score":0.8896329},"labels":[],"label_agreement":null},{"id":"W2794902535","doi":"10.1016/j.jmig.2018.03.022","title":"Effect of Pregnancy on the Management and Outcomes of Ovarian Torsion: A Population-Based Matched Cohort Study","year":2018,"lang":"en","type":"article","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Ovarian torsion; Odds ratio; Laparotomy; Confidence interval; Obstetrics; Pregnancy; Population; Cohort study; Cohort; Gynecology; Surgery; Internal medicine","score_opus":0.012841391992518509,"score_gpt":0.287546200263108,"score_spread":0.2747048082705895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794902535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616086,0.00012614891,0.0000044468625,0.0015849753,0.00025159953,0.0013144779,0.000004450308,0.0000028806148,0.0005501405],"genre_scores_gemma":[0.999,0.000057594498,0.0005045532,0.00028104213,0.00005206253,0.000050886683,0.0000016487646,0.000011392407,0.000040819745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857765,0.00024591447,0.00058537704,0.00015375034,0.00029722461,0.00014005014],"domain_scores_gemma":[0.9968993,0.0018558358,0.0006680435,0.00025181644,0.00025897942,0.000066000975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006044163,0.00014816126,0.00072278467,0.00016348992,0.000056267843,0.000005036681,0.000104631006,0.00006231755,0.00027946016],"category_scores_gemma":[0.00044945677,0.00008069252,0.00014082817,0.00010707223,0.00009167661,0.000027063603,0.000039880033,0.00009988534,0.0000031410184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008910892,0.0011280577,0.9930952,0.0001546021,0.0016918678,0.0001675513,0.00032730526,0.0000031289867,0.00011730119,0.00016938419,0.00019974212,0.0020547593],"study_design_scores_gemma":[0.005726432,0.02750994,0.96067816,0.00039144853,0.0012762169,0.000017534312,0.00024838312,0.0000038002024,0.004035672,0.000035825502,0.00002406509,0.000052533924],"about_ca_topic_score_codex":0.00004165258,"about_ca_topic_score_gemma":0.000111375084,"teacher_disagreement_score":0.032417063,"about_ca_system_score_codex":0.00011454527,"about_ca_system_score_gemma":0.00010322562,"threshold_uncertainty_score":0.32905456},"labels":[],"label_agreement":null},{"id":"W2795756220","doi":"10.1016/j.ygyno.2018.03.058","title":"Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"Wellbeing of Women; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Ovarian cancer; Diarrhea; Internal medicine; Adverse effect; Oncology; Chemotherapy; Cancer","score_opus":0.041857910509324955,"score_gpt":0.38598834507433744,"score_spread":0.34413043456501247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795756220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013360701,0.97300994,0.0000026400542,0.000307462,0.001072749,0.0062804455,0.00012535579,0.000036744834,0.005803958],"genre_scores_gemma":[0.0033614514,0.9881149,0.003958787,0.000086938984,0.000099836936,0.0037849937,0.00025492147,0.000054233522,0.00028394518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732566,0.00026208692,0.0008073397,0.00085706497,0.00025235378,0.00049552246],"domain_scores_gemma":[0.998359,0.00035179296,0.00056387164,0.00048462476,0.00006717624,0.00017350126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028352492,0.0005800255,0.0030688867,0.00026957932,0.00006453883,0.000011874475,0.00012676879,0.0004788938,0.00047594743],"category_scores_gemma":[0.000011736907,0.0003598142,0.00031553418,0.00034691373,0.00013450992,0.00004082814,0.00011845271,0.00021483185,0.000019594343],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084264764,0.00303988,0.10170432,0.0046299472,0.0030116043,0.00029709295,0.00005579846,3.5512423e-7,1.7169244e-8,0.00020833999,0.00029271422,0.88667566],"study_design_scores_gemma":[0.008551964,0.010388053,0.1960176,0.007552811,0.005436629,0.0000049253913,0.000030621624,6.1960435e-7,5.089645e-7,0.000014822278,0.77169925,0.00030223],"about_ca_topic_score_codex":0.00018422882,"about_ca_topic_score_gemma":0.000323333,"teacher_disagreement_score":0.88637346,"about_ca_system_score_codex":0.0050241994,"about_ca_system_score_gemma":0.0011096614,"threshold_uncertainty_score":0.9998854},"labels":[],"label_agreement":null},{"id":"W2795906974","doi":"10.1097/igc.0000000000001244","title":"Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; London Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Ovarian cancer; Cohort; Oncology; Cohort study; Cancer; Overall survival; Gynecology; Internal medicine; Obstetrics","score_opus":0.04396397100379561,"score_gpt":0.35094423362071553,"score_spread":0.3069802626169199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795906974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906885,0.00039847073,0.00013907797,0.00476865,0.0017125679,0.00013576463,0.00003694978,0.000010170552,0.002109867],"genre_scores_gemma":[0.9957911,0.00054763793,0.001553033,0.0010555357,0.00069689157,0.00006109792,0.0000016289929,0.000015220416,0.00027785325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983729,0.000037928705,0.0004959001,0.00018514175,0.0006835073,0.00022462093],"domain_scores_gemma":[0.99773335,0.00025238137,0.00053751003,0.00011613982,0.0011937765,0.00016685003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024812482,0.00015840483,0.00055503554,0.00012678663,0.000033228815,0.000018311479,0.00022418582,0.00007321715,0.005435734],"category_scores_gemma":[0.00017971019,0.000093557115,0.00009004123,0.00012650042,0.00017167957,0.00012955834,0.00004794137,0.00017699531,0.0000049810924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025934828,0.00056376157,0.9025561,0.000012960395,0.001963878,0.00057581504,0.00035714818,0.000112289934,0.00075137167,0.00032555358,0.00032571887,0.0898619],"study_design_scores_gemma":[0.00551822,0.0035322958,0.98266244,0.00019719343,0.00013663813,0.00009207116,0.0002455676,0.000011604927,0.0016614281,0.000116734656,0.0057172314,0.00010858948],"about_ca_topic_score_codex":0.00008484246,"about_ca_topic_score_gemma":0.00014887011,"teacher_disagreement_score":0.08975331,"about_ca_system_score_codex":0.00077513786,"about_ca_system_score_gemma":0.0004273485,"threshold_uncertainty_score":0.99547344},"labels":[],"label_agreement":null},{"id":"W2800484708","doi":"10.5505/aot.2018.43255","title":"Secondary, Tertiary and Quaternary Cytoreductive Surgery In Recurrent Epithelial Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"Acta Oncologica Turcica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intertek (Canada)","funders":"","keywords":"Cytoreductive surgery; Epithelial ovarian cancer; Ovarian cancer; Quaternary; Oncology; Medicine; Internal medicine; Cancer; Biology","score_opus":0.030318491427145388,"score_gpt":0.31387147212239014,"score_spread":0.28355298069524476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800484708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756382,0.0011826239,0.0000020175287,0.017973572,0.0008847525,0.0005308724,0.000066176406,0.000052213065,0.0036695502],"genre_scores_gemma":[0.9946399,0.0016813892,0.00043754934,0.0017216314,0.0010246166,0.00027135367,0.000026010432,0.000021313394,0.0001762429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984568,0.000106252315,0.0003405276,0.0005418618,0.00017850439,0.00037609204],"domain_scores_gemma":[0.9990828,0.00025078346,0.00012565574,0.0002701,0.00007290367,0.00019775271],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024911534,0.0002355405,0.00052088965,0.00014202404,0.00009252188,0.000025831152,0.00008185776,0.00016781608,0.0013363452],"category_scores_gemma":[0.00008039781,0.00016907464,0.00009667604,0.00017890587,0.00025230818,0.00010880265,0.00009301648,0.00026194085,0.000031188913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017281545,0.0015859671,0.6128043,0.00007928218,0.0003004103,0.00071121135,0.0013180224,2.03944e-7,0.003190338,0.00009768477,0.022681719,0.3555027],"study_design_scores_gemma":[0.0017993529,0.0010763756,0.942265,0.00023003307,0.00011043067,0.000090554226,0.00008249139,0.0000286423,0.0026200118,0.0002816017,0.051213477,0.00020207482],"about_ca_topic_score_codex":0.0007294092,"about_ca_topic_score_gemma":0.00030108084,"teacher_disagreement_score":0.35530064,"about_ca_system_score_codex":0.00043512826,"about_ca_system_score_gemma":0.00040329286,"threshold_uncertainty_score":0.99957657},"labels":[],"label_agreement":null},{"id":"W2801372365","doi":"10.1111/his.13630","title":"DICER1 hot‐spot mutations in ovarian gynandroblastoma","year":2018,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"Terry Fox Research Institute","keywords":"Hot spot (computer programming); Biology; Medicine; Genetics; Computer science","score_opus":0.016406224748816898,"score_gpt":0.28139573408008417,"score_spread":0.26498950933126725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801372365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94908243,0.00053921074,0.00045502066,0.0042713666,0.00091580744,0.00038297573,0.000014811225,0.00007218903,0.044266194],"genre_scores_gemma":[0.9953941,0.000027227688,0.001746367,0.0011959524,0.0002438312,0.00009337602,0.000022494742,0.000018291474,0.0012583301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991218,0.00004471928,0.00021040317,0.0002965896,0.000088270484,0.00023822393],"domain_scores_gemma":[0.9994864,0.000032070944,0.000051817675,0.0002823831,0.00005765749,0.00008968274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010715135,0.00011331837,0.000248862,0.00019196449,0.00006836351,0.0000046500745,0.000051169332,0.00009590051,0.00080747815],"category_scores_gemma":[0.000049481838,0.00010357386,0.000053365056,0.00020865946,0.00021058811,0.00003529129,0.00002245909,0.00010745123,0.00038384635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014754854,0.0040672473,0.82916087,0.0001457725,0.00006477592,0.012338209,0.012468986,0.000011410526,0.038368292,0.034099728,0.021420006,0.0463792],"study_design_scores_gemma":[0.0023936783,0.00085043645,0.95238334,0.000038263457,0.00007048113,0.0005363629,0.00004582367,0.000028136878,0.00097387587,0.0004519785,0.04212716,0.00010048533],"about_ca_topic_score_codex":0.00017335382,"about_ca_topic_score_gemma":0.0005871757,"teacher_disagreement_score":0.12322243,"about_ca_system_score_codex":0.00026390053,"about_ca_system_score_gemma":0.00013662569,"threshold_uncertainty_score":0.88413197},"labels":[],"label_agreement":null},{"id":"W2801975264","doi":"10.1016/j.jogc.2017.09.023","title":"Recommendation Patterns among Gynaecologists and Radiologists for Adnexal Masses on Ultrasound","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Ultrasound; Radiology; Adnexal mass; Logistic regression; Adnexal Diseases; Specialty; Obstetrics; Laparoscopy; Pathology; Internal medicine","score_opus":0.02026658810883727,"score_gpt":0.26914412153913403,"score_spread":0.24887753343029675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801975264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912047,0.0005115913,0.00012029126,0.0013629026,0.005858964,0.0002631272,0.000058986,0.0000037144357,0.0006157335],"genre_scores_gemma":[0.9978543,0.0005130284,0.00060280395,0.0008226428,0.00012269184,0.000011953695,0.000015963207,0.0000107712185,0.000045853292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991033,0.000040561114,0.00034200048,0.00018151457,0.000119923185,0.0002126922],"domain_scores_gemma":[0.99566394,0.003463609,0.00032380273,0.00008825214,0.00026625837,0.0001941641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023040043,0.00013190159,0.00036159556,0.00014658771,0.00012061734,0.000024393918,0.00004930009,0.000115554416,0.0005668227],"category_scores_gemma":[0.002781306,0.000098919496,0.00004615072,0.00010101403,0.00011376911,0.00005149995,0.000015540309,0.00015318755,3.078234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023836652,0.00010509274,0.90395397,0.000029943247,0.00018177806,0.00026049305,0.000034025154,0.0000016316966,0.0000038321696,0.00010268644,0.0035451953,0.09175749],"study_design_scores_gemma":[0.003361078,0.0037366485,0.9793478,0.000008370836,0.00015575395,0.00009518312,0.00011075604,0.000025041916,0.00014287388,0.00013095055,0.012794513,0.00009099087],"about_ca_topic_score_codex":0.0040266146,"about_ca_topic_score_gemma":0.02659753,"teacher_disagreement_score":0.0916665,"about_ca_system_score_codex":0.00086357974,"about_ca_system_score_gemma":0.0005600772,"threshold_uncertainty_score":0.9911645},"labels":[],"label_agreement":null},{"id":"W2802324884","doi":"10.1093/jnci/djy071","title":"Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage","year":2018,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":556,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Huntsman Cancer Foundation; Calgary Laboratory Services","keywords":"Stage (stratigraphy); Ovarian cancer; Cancer; Disease; Oncology; Epithelial ovarian cancer; Medicine; Pathology; Internal medicine; Cancer research; Biology","score_opus":0.06260176710256106,"score_gpt":0.34906306839670465,"score_spread":0.2864613012941436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802324884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87504816,0.009869252,0.00018157344,0.094977655,0.0132876905,0.0006691542,0.0020477842,0.000019507192,0.003899234],"genre_scores_gemma":[0.9890879,0.0013655,0.00017576055,0.0039747786,0.0034254352,0.000026723932,0.0000065417794,0.000015716083,0.0019216487],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986077,0.000037424372,0.00030397848,0.00016013793,0.0007434746,0.00014727587],"domain_scores_gemma":[0.99844766,0.0000523797,0.00031840225,0.00010471721,0.00079458754,0.00028226958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021793699,0.00013731832,0.0002383939,0.00007539247,0.0001808935,0.000029194889,0.0001389655,0.000046090965,0.0004351233],"category_scores_gemma":[0.00028789474,0.00008710589,0.00012170511,0.00016297634,0.00025807417,0.0002168249,0.00004316313,0.00018336046,0.0000052317887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076058917,0.0014356743,0.46251377,0.0004002147,0.0035976712,0.0002506644,0.0014156455,0.0006946657,0.016559,0.018161943,0.46042418,0.026940659],"study_design_scores_gemma":[0.006177361,0.000338345,0.33649054,0.0005794534,0.00064944563,0.000054419266,0.000021597707,0.000051476152,0.0060032066,0.0012930052,0.6481273,0.00021385924],"about_ca_topic_score_codex":0.0005020301,"about_ca_topic_score_gemma":0.0005721852,"teacher_disagreement_score":0.1877031,"about_ca_system_score_codex":0.0008938555,"about_ca_system_score_gemma":0.0028380305,"threshold_uncertainty_score":0.5034544},"labels":[],"label_agreement":null},{"id":"W2802440228","doi":"10.1097/ogx.0000000000000541","title":"OV21/PETROC: A Randomized Gynecologic Cancer Intergroup Phase II Study of Intraperitoneal Versus Intravenous Chemotherapy Following Neoadjuvant Chemotherapy and Optimal Debulking Surgery in Epithelial Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Oklahoma Health Sciences Center; Jewish General Hospital; McGill University; Huntsman Cancer Institute; National Cancer Research Institute; Centre Hospitalier Universitaire de Québec; University of Oklahoma","keywords":"Medicine; Debulking; Carboplatin; Gynecologic oncology; Chemotherapy; Ovarian cancer; Oncology; Cisplatin; Randomized controlled trial; Stage (stratigraphy); Surgery; Clinical trial; Epithelial ovarian cancer; Internal medicine; Cancer","score_opus":0.04541127379632888,"score_gpt":0.3479840650668713,"score_spread":0.30257279127054243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802440228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165267,0.0028114389,0.00006810821,0.0008334341,0.00200443,0.0023855616,0.000055497774,0.00008198308,0.00010685225],"genre_scores_gemma":[0.9952769,0.0021762762,0.0006136929,0.0006192674,0.00033072042,0.0008567253,0.000030436266,0.00006048218,0.000035475492],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9949621,0.0010492202,0.0013785048,0.0011002905,0.00058324984,0.0009266416],"domain_scores_gemma":[0.98810446,0.01043673,0.00042916604,0.00040322923,0.0002306736,0.00039573552],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017707006,0.0006185392,0.0029344764,0.00040981066,0.00025450997,0.00006088348,0.0002448646,0.00043088564,0.0018111955],"category_scores_gemma":[0.00403417,0.00043965486,0.0005383382,0.00133065,0.00046236147,0.00012214911,0.00017098123,0.0005415002,0.000004711877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15781164,0.022166798,0.35749063,0.000054231456,0.0027468358,0.00068019965,0.0028736156,0.000026241418,0.0007975052,0.00002938574,0.00011867822,0.45520422],"study_design_scores_gemma":[0.32369217,0.0155184455,0.6575621,0.00013990315,0.00044046386,0.000007927818,0.00035707973,0.0007460725,0.0007007105,0.000023179531,0.0003021564,0.0005098192],"about_ca_topic_score_codex":0.006083727,"about_ca_topic_score_gemma":0.002810093,"teacher_disagreement_score":0.45469442,"about_ca_system_score_codex":0.0009137438,"about_ca_system_score_gemma":0.00033354337,"threshold_uncertainty_score":0.9998055},"labels":[],"label_agreement":null},{"id":"W2802459707","doi":"10.1016/j.jogc.2017.09.013","title":"Diagnosis of Ovarian Torsion: Is It Time to Forget About Doppler?","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Ovarian torsion; Medicine; Torsion (gastropod); Ultrasound; Radiology; Surgery","score_opus":0.014111632293736853,"score_gpt":0.2543789658342891,"score_spread":0.24026733354055224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802459707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577159,0.005097942,0.000018894745,0.02475122,0.0062118885,0.00042290322,0.00015089217,0.000003982871,0.005626346],"genre_scores_gemma":[0.99295473,0.00031343702,0.001173891,0.00479887,0.00013023162,0.000009730518,0.0000023043842,0.000012898436,0.0006038766],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987771,0.00002483478,0.0004869965,0.00015128318,0.00031549024,0.00024429147],"domain_scores_gemma":[0.9978391,0.00072047854,0.00030917343,0.0001674684,0.00059151964,0.00037228953],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018226702,0.00012841147,0.00049377,0.00022619948,0.00008388045,0.0000107894675,0.00009565112,0.00009603145,0.0054926034],"category_scores_gemma":[0.0010354071,0.00009915956,0.00008257759,0.00038637305,0.000053211825,0.000037443202,0.00004720399,0.00012594917,0.000011086511],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039597697,0.0003573579,0.34800395,0.00006456024,0.0005753953,0.0014387948,0.00045736012,0.0000026152845,0.000016331933,0.00007057731,0.539202,0.109771475],"study_design_scores_gemma":[0.0032135004,0.002613677,0.54133695,0.00004704019,0.0003299468,0.00011360621,0.00013734546,0.000019844063,0.0011764342,0.0000377604,0.4508488,0.00012512247],"about_ca_topic_score_codex":0.010512129,"about_ca_topic_score_gemma":0.012214317,"teacher_disagreement_score":0.19333297,"about_ca_system_score_codex":0.0007706795,"about_ca_system_score_gemma":0.001389867,"threshold_uncertainty_score":0.99607694},"labels":[],"label_agreement":null},{"id":"W2803327459","doi":"10.1111/aji.12975","title":"Multi‐omics in high‐grade serous ovarian cancer: Biomarkers from genome to the immunome","year":2018,"lang":"en","type":"review","venue":"American Journal of Reproductive Immunology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Ovarian cancer; Omics; Disease; Immunotherapy; Biomarker; Oncology; Serous fluid; Biomarker discovery; Medicine; Ovarian carcinoma; Serous carcinoma; Precision medicine; Immune system; Cancer; Internal medicine; Bioinformatics; Biology; Immunology; Pathology; Proteomics","score_opus":0.03335950687822515,"score_gpt":0.33453169779468556,"score_spread":0.3011721909164604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803327459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0126006175,0.9764775,0.000048159192,0.00708966,0.0021705043,0.0013457265,0.00023786907,0.000015506806,0.000014461186],"genre_scores_gemma":[0.0024640206,0.98956615,0.0053220284,0.00031318996,0.0018635015,0.00021490447,0.00006080569,0.00011712727,0.00007826257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99577457,0.0007492727,0.0015655413,0.0010284042,0.00028925057,0.00059298857],"domain_scores_gemma":[0.99510103,0.0003141689,0.0023638804,0.0016372299,0.00042126118,0.00016243577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000839099,0.0006506754,0.0037914873,0.0007490068,0.00010210845,0.00003538034,0.00077970984,0.00020502058,0.00010132905],"category_scores_gemma":[0.00029944873,0.00041151996,0.00070549164,0.0013620758,0.0008471008,0.00008920581,0.00021099011,0.0010918315,0.000085405925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078300404,0.0006082891,0.0007685461,0.00018615571,0.011267361,0.0004133984,0.0010472238,0.00000727776,0.00010860911,0.0000110854935,0.00028211123,0.9845169],"study_design_scores_gemma":[0.002115628,0.003170171,0.039683096,0.004063365,0.0030803843,0.001439161,0.00059334736,3.9945212e-7,0.00003514712,0.000025130932,0.9453524,0.000441791],"about_ca_topic_score_codex":0.008797707,"about_ca_topic_score_gemma":0.00016324829,"teacher_disagreement_score":0.9840751,"about_ca_system_score_codex":0.002060283,"about_ca_system_score_gemma":0.0014764658,"threshold_uncertainty_score":0.99983364},"labels":[],"label_agreement":null},{"id":"W2803852062","doi":"10.1016/j.ygyno.2018.05.011","title":"Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; Public Health Ontario; London Health Sciences Centre; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Ovarian cancer; Fallopian tube; BRCA mutation; Fallopian tube cancer; Gynecology; Prophylactic Surgery; Incidence (geometry); Oophorectomy; Obstetrics; Breast cancer; Cancer; Oncology; Internal medicine; Hysterectomy; Surgery","score_opus":0.06164547199410488,"score_gpt":0.3512960315957402,"score_spread":0.2896505596016353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803852062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718591,0.00022350503,0.00014403912,0.0048629753,0.00082618283,0.0010973654,0.00002000968,0.00015558988,0.02081122],"genre_scores_gemma":[0.989229,0.00042949244,0.002881387,0.0024271547,0.00076012075,0.0016100317,0.000025895171,0.00003637569,0.0026004987],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99801874,0.00013714831,0.0003491278,0.0006286855,0.0002110994,0.0006551759],"domain_scores_gemma":[0.9985261,0.00035618307,0.00023391364,0.00039957982,0.00020491192,0.00027932558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030416658,0.0002735016,0.0006529062,0.00014280209,0.0002034038,0.000031659303,0.000129339,0.00031713524,0.0127659505],"category_scores_gemma":[0.000095402815,0.00017225627,0.00005524632,0.00040201438,0.00052719435,0.00008985847,0.000054253942,0.00024793492,0.00028117344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067460975,0.0032585473,0.3151225,0.00009134281,0.0014509392,0.011914675,0.006278358,0.000052887335,0.00030629052,0.00091854075,0.031791937,0.62206787],"study_design_scores_gemma":[0.007064946,0.014833756,0.79250914,0.000045009525,0.0001904973,0.0001733844,0.0006836155,0.000029845263,0.00026509995,0.00026107355,0.18373117,0.0002124753],"about_ca_topic_score_codex":0.00051056384,"about_ca_topic_score_gemma":0.005078456,"teacher_disagreement_score":0.62185544,"about_ca_system_score_codex":0.002242492,"about_ca_system_score_gemma":0.0007616546,"threshold_uncertainty_score":0.98813653},"labels":[],"label_agreement":null},{"id":"W2804506739","doi":"10.21037/jlpm.2018.05.01","title":"IL-6 and VEGF-A, novel prognostic biomarkers for ovarian cancer?","year":2018,"lang":"en","type":"article","venue":"Journal of Laboratory and Precision Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ovarian cancer; Epithelial ovarian cancer; Multicellular organism; VEGF receptors; Oncology; Medicine; Cancer; Mechanism (biology); Cancer research; Internal medicine; Overall survival; Biology; Cell","score_opus":0.029688315237845528,"score_gpt":0.33346110480380986,"score_spread":0.3037727895659643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804506739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541642,0.019835249,0.002058769,0.021390386,0.0014601321,0.0007042495,0.00010552694,0.00001341312,0.0002680851],"genre_scores_gemma":[0.9869602,0.0033060098,0.0060436176,0.0014647362,0.0021189419,0.000022386568,0.0000036825654,0.000020575904,0.00005984873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989147,0.000031218326,0.0004443905,0.00018417201,0.00027290484,0.00015257102],"domain_scores_gemma":[0.99814665,0.00039794875,0.0002892623,0.00012782999,0.0007266423,0.0003116687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008161264,0.00014457191,0.0004442241,0.00017059223,0.00010458081,0.000016000222,0.00004967482,0.00008258681,0.00014114357],"category_scores_gemma":[0.00051542174,0.00008902796,0.000039626997,0.00022645853,0.00023025156,0.000110145105,0.000017751865,0.00011668496,8.628003e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010849087,0.0010847524,0.2704972,0.0008438977,0.002463032,0.00029127553,0.0040326826,0.0000014389743,0.07350219,0.0014470938,0.0894163,0.545571],"study_design_scores_gemma":[0.03457197,0.019740071,0.50091696,0.006120701,0.002552296,0.00071725727,0.0008696192,0.0002286206,0.009093065,0.00095868483,0.42388454,0.00034620005],"about_ca_topic_score_codex":0.0000131508605,"about_ca_topic_score_gemma":0.000009444053,"teacher_disagreement_score":0.54522485,"about_ca_system_score_codex":0.000050528153,"about_ca_system_score_gemma":0.00024606942,"threshold_uncertainty_score":0.3630455},"labels":[],"label_agreement":null},{"id":"W2805692138","doi":"10.1016/j.neo.2018.05.005","title":"BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells","year":2018,"lang":"en","type":"article","venue":"Neoplasia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Biology; ISG15; Cancer research; Signal transduction; Internal medicine; Endocrinology; Molecular biology; Gene; Cell biology; Genetics; Medicine","score_opus":0.010349934046879368,"score_gpt":0.25688496127227084,"score_spread":0.24653502722539147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805692138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982835,0.00041384678,0.00011014756,0.00030034347,0.0001268203,0.00038238545,0.000011841,0.000022890781,0.00034820594],"genre_scores_gemma":[0.9986957,0.00011977196,0.00061676645,0.00021591886,0.00021405224,0.000025679654,0.000041507647,0.000018083676,0.000052521154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911994,0.000035532572,0.00020427862,0.00028518672,0.00014863959,0.00020645406],"domain_scores_gemma":[0.9996254,0.000037060418,0.00005203808,0.00012271573,0.000044293974,0.000118490636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101254984,0.00013288188,0.00019653793,0.0001062126,0.00009092895,0.00003783017,0.000018482275,0.000078892575,0.000057789483],"category_scores_gemma":[0.000010901498,0.00012017386,0.00002763807,0.00010204943,0.000060033173,0.00009238387,0.000014353527,0.00007232341,0.000008650968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003112723,0.00031878066,0.7184983,0.00018589693,0.0002061431,0.0002709477,0.0077718375,0.000096082484,0.23759738,0.0011959441,0.0002703707,0.03327704],"study_design_scores_gemma":[0.009387735,0.002105496,0.78093886,0.0002680562,0.00021660842,0.000051622817,0.00046592948,0.00064924656,0.20231497,0.00044488488,0.0028902553,0.00026632176],"about_ca_topic_score_codex":0.00034115592,"about_ca_topic_score_gemma":0.00037120696,"teacher_disagreement_score":0.06244056,"about_ca_system_score_codex":0.00009209665,"about_ca_system_score_gemma":0.000043823853,"threshold_uncertainty_score":0.4900548},"labels":[],"label_agreement":null},{"id":"W2805923253","doi":"10.2217/ebo.11.108","title":"Intraperitoneal chemotherapy: its use in epithelial ovarian cancer","year":2012,"lang":"en","type":"other","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Chemotherapy; Oncology; Gynecologic oncology; Clinical trial; Internal medicine; Metastasis; Intraperitoneal chemotherapy; Cancer; Epithelial ovarian cancer","score_opus":0.029366510710052193,"score_gpt":0.29872515950817136,"score_spread":0.26935864879811916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805923253","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027753236,0.011671208,0.000022283766,0.008952073,0.0025355606,0.002631977,0.0004960947,0.00041713464,0.9704983],"genre_scores_gemma":[0.014527037,0.008425653,0.0016439516,0.0032570432,0.0034184626,0.00044572196,0.000090407244,0.00077594735,0.96741575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869776,0.000025803627,0.00023458416,0.00040497127,0.00022119928,0.00041569117],"domain_scores_gemma":[0.9992699,0.00002501411,0.00009752103,0.00038040584,0.000025215291,0.00020193415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060823233,0.0003612435,0.00062290527,0.00025299782,0.00001400066,0.000028117809,0.00007530757,0.0004058818,0.072155215],"category_scores_gemma":[0.000008222909,0.00027577495,0.00012264324,0.0001631991,0.000035637702,0.000057375277,0.000022159164,0.0002350473,0.00036696595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030684393,0.0017722525,0.08504883,0.0003369226,0.0012429922,0.00022102761,0.00022491373,7.022119e-7,0.00021658232,0.0023938832,0.80742204,0.100813],"study_design_scores_gemma":[0.0039623845,0.00007975063,0.041485745,0.00057617266,0.00018107907,0.000012720441,0.000005974246,0.0000052386335,0.000619699,0.0000040297523,0.9527916,0.00027564907],"about_ca_topic_score_codex":0.011143216,"about_ca_topic_score_gemma":0.0045473548,"teacher_disagreement_score":0.14536951,"about_ca_system_score_codex":0.0002762571,"about_ca_system_score_gemma":0.00020286239,"threshold_uncertainty_score":0.9999694},"labels":[],"label_agreement":null},{"id":"W2807561846","doi":"10.1016/j.ajog.2018.05.019","title":"Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Tubal ligation; Hysterectomy; Fallopian tube; Obstetrics; Perioperative; Gynecologic oncology; Ovarian cancer; Gynecology; Population; Surgery; Pregnancy; Family planning; Ectopic pregnancy; Cancer; Internal medicine","score_opus":0.033186595348750784,"score_gpt":0.3191213225209638,"score_spread":0.285934727172213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807561846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507105,0.0023738553,0.00015162604,0.00082643155,0.00080447964,0.0006907012,0.000053411193,0.0000015506429,0.000026906911],"genre_scores_gemma":[0.99623966,0.0028347909,0.0004570299,0.00025479702,0.0001035679,0.000047339916,0.00000307477,0.000010232244,0.00004953256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998754,0.00011731726,0.0005593724,0.00018200597,0.00020883491,0.0001784471],"domain_scores_gemma":[0.9943272,0.0044358443,0.00066578767,0.0001399439,0.0003246616,0.0001065705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051681616,0.000076308264,0.0005650819,0.000070450245,0.0000914953,0.000028687355,0.00009888274,0.000026010546,0.00010679043],"category_scores_gemma":[0.0027008734,0.000075303455,0.000059124395,0.00038005537,0.0001793973,0.000045978555,0.000028400613,0.00012020946,6.2330024e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006965514,0.00021134487,0.77225727,0.000010087417,0.00026492073,0.00014108009,0.00011407571,0.0000011966997,0.0000062460485,0.0000060295934,0.00037373332,0.22654434],"study_design_scores_gemma":[0.002472097,0.004342953,0.9886633,0.00022562793,0.0004915594,0.00004622431,0.0007612201,0.00004373202,0.000003968747,0.00006537115,0.0028190888,0.00006482427],"about_ca_topic_score_codex":0.72095203,"about_ca_topic_score_gemma":0.85548365,"teacher_disagreement_score":0.22647952,"about_ca_system_score_codex":0.0005894554,"about_ca_system_score_gemma":0.0013911207,"threshold_uncertainty_score":0.32333928},"labels":[],"label_agreement":null},{"id":"W2807683477","doi":"10.1016/j.jogc.2018.03.056","title":"Surgical Management of Adnexal Masses in Children and Adolescents: Evaluating the Decision Tree System (DTS)","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Decision tree; Malignancy; Population; Tree (set theory); Gynecology; Machine learning; Pathology; Environmental health","score_opus":0.014234326333543837,"score_gpt":0.2787427183815588,"score_spread":0.26450839204801496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807683477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914304,0.006388474,0.000007337679,0.00024441665,0.0012944138,0.00020504686,0.000005691696,0.0000010415483,0.00042319155],"genre_scores_gemma":[0.9988501,0.00055240595,0.00047508575,0.00006111203,0.000039642928,0.0000024731623,7.725953e-7,0.0000057622274,0.00001262143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989303,0.000057507936,0.00042776734,0.00011784331,0.00032459767,0.00014197914],"domain_scores_gemma":[0.9987376,0.0006371352,0.00025927083,0.00010671772,0.00016052266,0.000098804325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041682436,0.00008856148,0.00031147507,0.00012787846,0.000055777728,0.000010328299,0.000068845795,0.000050670733,0.00005367826],"category_scores_gemma":[0.00021772867,0.00005356758,0.00003417427,0.00022869716,0.00006308619,0.000026303367,0.00004771206,0.00012921453,1.9329164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033231696,0.000083248175,0.7763711,0.00005954996,0.00016124317,0.00076735177,0.00002448898,0.00000682894,4.8019473e-7,0.00012664669,0.00020265573,0.22216313],"study_design_scores_gemma":[0.005338029,0.00097124086,0.99228996,0.00018580948,0.00022886285,0.00024972303,0.00027339818,0.0001306026,0.000011634503,0.00001788436,0.00025858235,0.00004426052],"about_ca_topic_score_codex":0.0034495315,"about_ca_topic_score_gemma":0.0050575994,"teacher_disagreement_score":0.22211887,"about_ca_system_score_codex":0.0005754235,"about_ca_system_score_gemma":0.0003454193,"threshold_uncertainty_score":0.5214683},"labels":[],"label_agreement":null},{"id":"W2808656778","doi":"10.1038/s41416-018-0036-7","title":"Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Etoposide; Chemotherapy; Debulking; Ovarian cancer; Cisplatin; Internal medicine; Clinical endpoint; Leukopenia; Gastroenterology; Surgery; Phases of clinical research; Chemotherapy regimen; Cancer; Oncology; Randomized controlled trial","score_opus":0.016098204122577453,"score_gpt":0.34985441520265376,"score_spread":0.3337562110800763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808656778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989357,0.008452632,0.0014469604,0.0066995188,0.0009496125,0.0019496621,0.0005032845,0.000009177153,0.00009560397],"genre_scores_gemma":[0.9744036,0.015320102,0.0050324914,0.0012059498,0.0034121098,0.00048285045,0.000014214271,0.00003741581,0.00009125668],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986787,0.000024861372,0.00063977204,0.00019740195,0.00025367358,0.00020557773],"domain_scores_gemma":[0.9986162,0.00011913991,0.0004204631,0.0000998541,0.00051864405,0.00022565594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025132814,0.00014294007,0.0006502811,0.00009339294,0.00008888501,0.00003261164,0.00006369603,0.000073902316,0.0008402949],"category_scores_gemma":[0.00010809249,0.00013857026,0.00018456424,0.00013882174,0.00008614987,0.00011766424,0.0000075347784,0.00011059312,4.3317064e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24873346,0.00057498814,0.00019648958,0.00009230383,0.00045940757,0.000052639687,0.00025184618,0.000020202659,0.0030656185,0.000012703006,0.0056873425,0.740853],"study_design_scores_gemma":[0.84397835,0.011470201,0.0040595937,0.0029489996,0.00071807206,0.00043998682,0.000048079473,0.000097400865,0.052497584,0.00015154114,0.08337251,0.00021769555],"about_ca_topic_score_codex":0.00048074833,"about_ca_topic_score_gemma":0.0012986296,"teacher_disagreement_score":0.7406353,"about_ca_system_score_codex":0.0001726196,"about_ca_system_score_gemma":0.00032039496,"threshold_uncertainty_score":0.9200639},"labels":[],"label_agreement":null},{"id":"W2808946987","doi":"10.1097/md.0000000000010916","title":"A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature","year":2018,"lang":"en","type":"article","venue":"Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Medicine; Ascites; Ovarian tumor; Radiology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.008891222727656169,"score_gpt":0.26028046248485964,"score_spread":0.25138923975720345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808946987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.446128,0.33255434,0.000056761557,0.19275393,0.00045916825,0.004011837,0.00014983665,0.000056275854,0.023829846],"genre_scores_gemma":[0.99084824,0.004306994,0.00037488184,0.0035921454,0.00034849212,0.00006744677,0.000046696612,0.000019106377,0.00039598867],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987866,0.00003636876,0.00043991097,0.0002744939,0.00031847612,0.00014409477],"domain_scores_gemma":[0.99839854,0.00014760469,0.00037528214,0.0005499042,0.0004128165,0.00011582628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036669953,0.00017975907,0.0006365295,0.00006678769,0.00007269494,0.000004661622,0.000058267273,0.00003431101,0.00065941],"category_scores_gemma":[0.00022930227,0.00008279355,0.000056390236,0.0004002988,0.00043406966,0.0000355642,0.000027925853,0.00012342952,0.000002919263],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017838294,0.001716989,0.08260766,0.058426075,0.0013173734,0.5920122,0.015493314,4.6206304e-7,0.0011566395,0.0011353501,0.23397633,0.010373754],"study_design_scores_gemma":[0.02043859,0.023581795,0.038759194,0.22248407,0.00676201,0.33174515,0.0018018051,0.000023799994,0.033034228,0.00038064347,0.3203887,0.0005999873],"about_ca_topic_score_codex":0.00033444742,"about_ca_topic_score_gemma":0.000081248625,"teacher_disagreement_score":0.54472023,"about_ca_system_score_codex":0.000029404855,"about_ca_system_score_gemma":0.00013721581,"threshold_uncertainty_score":0.72200775},"labels":[],"label_agreement":null},{"id":"W2809209390","doi":"10.1016/j.ejogrb.2018.06.036","title":"Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer","year":2018,"lang":"en","type":"article","venue":"European Journal of Obstetrics & Gynecology and Reproductive Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Chemotherapy; Surgery; Ovarian cancer; Retrospective cohort study; Ascites; Cancer; Internal medicine","score_opus":0.0351815230591804,"score_gpt":0.2957284578843015,"score_spread":0.26054693482512115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809209390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844986,0.0073324647,0.00008301679,0.002057161,0.002734166,0.00046450182,0.000025572204,0.0000048538195,0.0027996209],"genre_scores_gemma":[0.99222237,0.005985347,0.0010059429,0.00012074457,0.0005528942,0.000013227102,0.000010711792,0.0000144694195,0.000074294556],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978467,0.00080522604,0.0006113168,0.00039880635,0.00010445364,0.00023345757],"domain_scores_gemma":[0.997843,0.0008478489,0.00060590566,0.00027308724,0.00036733883,0.00006280352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013294512,0.00018581963,0.000553429,0.00034360075,0.00009147745,0.000006850359,0.000084622385,0.00006243021,0.0000557005],"category_scores_gemma":[0.00033527633,0.000112103335,0.00012462153,0.00040974253,0.0004615728,0.00006553519,0.000045680477,0.0002371981,0.000005061572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026202612,0.003255131,0.16747189,0.00015331041,0.004315787,0.0030755291,0.010928889,0.000022669203,0.0017521601,0.0042189797,0.0009595872,0.80122584],"study_design_scores_gemma":[0.0036026724,0.0071938825,0.9658082,0.00019948528,0.0005841383,0.0005048763,0.0023886934,0.000004252004,0.0036010977,0.0003808492,0.015585552,0.00014629246],"about_ca_topic_score_codex":0.000018635119,"about_ca_topic_score_gemma":0.000004864008,"teacher_disagreement_score":0.8010795,"about_ca_system_score_codex":0.00032064738,"about_ca_system_score_gemma":0.00016574102,"threshold_uncertainty_score":0.4571441},"labels":[],"label_agreement":null},{"id":"W2809754893","doi":"10.1038/s41388-018-0377-y","title":"GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Oncogene","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Biology; Ovarian cancer; Estrogen; Estrogen receptor; Cancer research; Carcinogenesis; Cancer; Internal medicine; Endocrinology; Breast cancer; Genetics","score_opus":0.04413994573426509,"score_gpt":0.31402544747008015,"score_spread":0.26988550173581505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809754893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510355,0.0009591091,0.000018233435,0.010679922,0.00039770344,0.00076224504,0.00022158337,0.00006513607,0.0017925258],"genre_scores_gemma":[0.9921068,0.000277046,0.002068953,0.0031012187,0.00080521055,0.0002275359,0.000090127454,0.0000691746,0.0012539658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998165,0.000059728674,0.00030845997,0.00065751205,0.0003453089,0.0004640064],"domain_scores_gemma":[0.9988506,0.000013647582,0.00011979176,0.00058080896,0.00013994297,0.0002952312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014403224,0.00029485123,0.00043221193,0.0001309022,0.00008024968,0.000042501317,0.00015240963,0.00017646937,0.007788796],"category_scores_gemma":[0.0000088764955,0.00024682665,0.00011236748,0.00030010764,0.000090122434,0.00015866615,0.000044600692,0.0001349309,0.00025463713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000685249,0.0020416055,0.23568231,0.00009364612,0.00078038767,0.00028304337,0.005989022,0.0000021753365,0.6630235,0.00010696129,0.03113522,0.06017689],"study_design_scores_gemma":[0.004655256,0.00087008806,0.046814825,0.00035206028,0.00022959178,0.000022533633,0.000078399484,0.00008686005,0.9083117,0.00016452391,0.038114768,0.00029937772],"about_ca_topic_score_codex":0.002754675,"about_ca_topic_score_gemma":0.00038406602,"teacher_disagreement_score":0.24528822,"about_ca_system_score_codex":0.0004331365,"about_ca_system_score_gemma":0.00030524348,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W2810239069","doi":"10.1158/1078-0432.ccr-18-0784","title":"Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Association for Cancer Research","keywords":"Ovarian carcinoma; Serous fluid; Serous carcinoma; Medicine; Carcinoma; Oncology; Ovarian cancer; Pathology; Internal medicine; Cancer","score_opus":0.21726211750262264,"score_gpt":0.5089269287165084,"score_spread":0.2916648112138857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810239069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97585183,0.00085448497,0.0000065665045,0.017226862,0.00047960348,0.00061398523,0.000052045347,0.000026302972,0.004888343],"genre_scores_gemma":[0.99674034,0.00031122915,0.00045134657,0.0008489616,0.00093771424,0.00011045351,0.0000098196815,0.000037296246,0.00055283844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971678,0.00038523035,0.0005529092,0.00058657996,0.0008084634,0.0004989723],"domain_scores_gemma":[0.9971389,0.0009113807,0.000093700204,0.0007884621,0.00070417684,0.0003633661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001283171,0.00015468943,0.0005469069,0.00015800963,0.000101343416,0.00001709349,0.00018312989,0.00019058227,0.00095012895],"category_scores_gemma":[0.00055357267,0.00012008572,0.00018058314,0.0004599147,0.0010032521,0.000013832993,0.00009891967,0.00056827185,0.00021007596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008998574,0.004854999,0.81169283,0.00035763808,0.0011444222,0.0016672108,0.00029284312,0.000010329465,0.0028735125,0.022086013,0.068042964,0.07797863],"study_design_scores_gemma":[0.0082543595,0.009979801,0.8944212,0.00039825513,0.00017900726,0.000018648256,0.00006670218,0.00005377642,0.06428864,0.0017964168,0.02034485,0.00019830912],"about_ca_topic_score_codex":0.0033597632,"about_ca_topic_score_gemma":0.00027925285,"teacher_disagreement_score":0.08272837,"about_ca_system_score_codex":0.0002211974,"about_ca_system_score_gemma":0.00084162975,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W2810500205","doi":"10.1016/j.ygyno.2018.04.226","title":"Investigating the time intervals between primary cytoreductive surgery and initiation of adjuvant chemotherapy in patients with advanced epithelial ovarian cancer who had optimal cytoreduction surgery with bowel resection","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Chemotherapy; Epithelial ovarian cancer; Bowel resection; Ovarian cancer; Adjuvant; Surgery; Adjuvant chemotherapy; Resection; Colorectal cancer; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.019435398314631293,"score_gpt":0.28104337060184525,"score_spread":0.26160797228721394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810500205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952508,0.00011483688,0.000028894898,0.003022155,0.00026661178,0.0010095547,0.00003975719,0.000028709086,0.00023865778],"genre_scores_gemma":[0.9972962,0.00017450782,0.0012025567,0.0005085041,0.00036806785,0.0002952707,0.00009860608,0.000028306917,0.000027969225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823415,0.0002916662,0.0004931782,0.00044159062,0.00022487697,0.00031452044],"domain_scores_gemma":[0.99778277,0.0010424466,0.0005562345,0.00021014235,0.00031971183,0.000088675726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006490452,0.00022855263,0.00082933955,0.00021328877,0.00012520941,0.000012333209,0.00005554962,0.00018791368,0.00009640391],"category_scores_gemma":[0.00022481686,0.00014070176,0.0000588305,0.00036237255,0.00061069406,0.00021085158,0.000034983488,0.00021977823,0.0000026049045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020697375,0.0004644538,0.9091168,0.000056451485,0.0002618957,0.00000822768,0.0010331512,0.000031091873,0.00037081802,0.000008301305,0.0004015157,0.086177535],"study_design_scores_gemma":[0.003640357,0.0051827477,0.98628,0.00032673488,0.00017258764,0.000010797893,0.00017960941,0.000024391344,0.0036871699,0.00005125671,0.0002921879,0.00015213295],"about_ca_topic_score_codex":0.00025152756,"about_ca_topic_score_gemma":0.00015913503,"teacher_disagreement_score":0.0860254,"about_ca_system_score_codex":0.000866977,"about_ca_system_score_gemma":0.00084605126,"threshold_uncertainty_score":0.5737651},"labels":[],"label_agreement":null},{"id":"W2810515890","doi":"10.1186/s13048-018-0428-6","title":"Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model","year":2018,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Cisplatin; Medicine; Ovarian cancer; Reproductive medicine; Internal medicine; Oncology; Cancer research; Urology; Chemotherapy; Gynecology; Cancer; Biology; Pregnancy","score_opus":0.11314853824027979,"score_gpt":0.4560871617709214,"score_spread":0.34293862353064164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810515890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946904,0.0015313925,0.00014755785,0.002319776,0.00006813812,0.0005959278,0.000007954,0.0000059350573,0.00063288753],"genre_scores_gemma":[0.98950315,0.00070432294,0.009166196,0.000032658496,0.0003495842,0.00003195006,0.0000015796136,0.000028057217,0.00018253118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976697,0.00018777166,0.0006103071,0.0002510476,0.0008769377,0.00040421827],"domain_scores_gemma":[0.9981766,0.0003186244,0.00026538686,0.00025562805,0.00066192145,0.0003218352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018848248,0.00014824283,0.00049134,0.0007212457,0.00011163348,0.000053703156,0.0001442167,0.00011749166,0.00017083011],"category_scores_gemma":[0.0006279622,0.00010532507,0.000087848595,0.00055817974,0.00025123887,0.00015914389,0.00009197895,0.0004671386,0.0000023630953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012450443,0.0076518427,0.6431196,0.0011007296,0.0012581843,0.0012168492,0.006464799,0.00019880645,0.12681577,0.003462506,0.0027775965,0.19348294],"study_design_scores_gemma":[0.030760571,0.010146348,0.6998174,0.010947526,0.0004901751,0.00066355267,0.0005965764,0.015742123,0.22719072,0.0022870342,0.0008953938,0.00046257675],"about_ca_topic_score_codex":0.00025786588,"about_ca_topic_score_gemma":0.000099548335,"teacher_disagreement_score":0.19302036,"about_ca_system_score_codex":0.00031068694,"about_ca_system_score_gemma":0.0010376777,"threshold_uncertainty_score":0.42950314},"labels":[],"label_agreement":null},{"id":"W2811253064","doi":"10.1038/s41379-018-0085-8","title":"Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary","year":2018,"lang":"en","type":"erratum","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gynecologic oncology; Center (category theory); Ovary; Gynecology; Medicine; Library science; Pathology; Internal medicine; Computer science; Chemistry","score_opus":0.010062907857929867,"score_gpt":0.2478018072386309,"score_spread":0.23773889938070103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811253064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56247914,0.0056049763,0.0011867465,0.0120565565,0.2025581,0.007465889,0.00054254197,0.00022457902,0.20788145],"genre_scores_gemma":[0.9040737,0.00021832628,0.00036563276,0.0016217943,0.0018009769,0.00043303455,0.0004719359,0.00009757236,0.09091699],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99853194,0.00013150575,0.00039872088,0.00048152034,0.00021904525,0.00023726745],"domain_scores_gemma":[0.9988813,0.000032652515,0.00029091194,0.00058100006,0.00017044516,0.00004368952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011478507,0.00025238947,0.00054640195,0.00014883734,0.00004056364,0.0000061606856,0.00012092264,0.0003785805,0.00013698929],"category_scores_gemma":[0.00004973541,0.00017132396,0.00017041653,0.00014482654,0.00015110562,0.000026233323,0.00006233047,0.00054034195,0.000033754302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032749763,0.0016656219,0.028199673,0.0007862978,0.000108934306,0.0026875476,0.0030931218,0.000009243076,0.00039559975,0.00001344608,0.951637,0.011075977],"study_design_scores_gemma":[0.016208041,0.0067058005,0.8516264,0.006672746,0.0023676285,0.007836931,0.00024187894,0.009776269,0.021047525,0.0035967373,0.07252222,0.0013978047],"about_ca_topic_score_codex":0.0001796379,"about_ca_topic_score_gemma":0.00035171583,"teacher_disagreement_score":0.8791148,"about_ca_system_score_codex":0.00018565092,"about_ca_system_score_gemma":0.00031891788,"threshold_uncertainty_score":0.69863886},"labels":[],"label_agreement":null},{"id":"W2811295596","doi":"10.14740/jcgo.v7i2.488","title":"Ovarian Cancer: Post-Relapse Survival and Prognostic Factors","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Ovarian cancer; Bevacizumab; Stage (stratigraphy); Radiation therapy; Proportional hazards model; Retrospective cohort study; Cancer; Disease; Oncology; Surgery","score_opus":0.062185101077315334,"score_gpt":0.382660287195731,"score_spread":0.32047518611841563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811295596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599654,0.0043844418,0.00002278716,0.0043252246,0.004579005,0.0001749349,0.000011325145,0.0000078138555,0.0004979201],"genre_scores_gemma":[0.9912451,0.006456571,0.00057391287,0.0008316928,0.00073175103,0.0000027628807,0.000001972081,0.000012567726,0.0001437079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983451,0.00014306552,0.0008932097,0.00021022662,0.00019471068,0.00021368843],"domain_scores_gemma":[0.9896636,0.008763874,0.00050550024,0.00012656748,0.0005345304,0.00040592687],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00075097027,0.00014360789,0.00075620745,0.00014849106,0.0000970734,0.000020201993,0.00006507581,0.00028726878,0.00021516652],"category_scores_gemma":[0.01364751,0.00009507128,0.00014996291,0.00020336479,0.00034928235,0.000080460944,0.000047866826,0.00045778844,0.000005458201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024808483,0.00047198957,0.9303942,0.000027090056,0.00035771914,0.00022780412,0.00010780083,2.3322153e-7,0.0000044598887,0.00034600042,0.0005282317,0.06728643],"study_design_scores_gemma":[0.0051308116,0.0061290134,0.96850747,0.00006939335,0.00066980324,0.00009232279,0.00014704639,0.000016385635,0.000036964044,0.00019422312,0.018917646,0.00008889928],"about_ca_topic_score_codex":0.000021345626,"about_ca_topic_score_gemma":0.0000456165,"teacher_disagreement_score":0.06719753,"about_ca_system_score_codex":0.000050500108,"about_ca_system_score_gemma":0.00038598783,"threshold_uncertainty_score":0.994661},"labels":[],"label_agreement":null},{"id":"W2842953797","doi":"10.4158/accr-2017-0197","title":"Co-Existing Graves Disease with Benign Struma Ovarii: A Case Report","year":2018,"lang":"en","type":"article","venue":"AACE Clinical Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Struma ovarii; Thyroid; Ovarian Teratoma; Pathology; Radiology; Calcification; Teratoma; Internal medicine","score_opus":0.09681857902257195,"score_gpt":0.42743022356350163,"score_spread":0.33061164454092967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2842953797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901243,0.0004415304,0.00014679991,0.0014653379,0.0005620458,0.00084867526,0.000026584588,0.00016718108,0.006217585],"genre_scores_gemma":[0.9933326,0.000038815975,0.003322124,0.00073870545,0.0013486872,0.000095922696,0.00008074009,0.00006382792,0.0009785292],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99624217,0.00011000649,0.0015459936,0.0011643174,0.00047451205,0.0004629885],"domain_scores_gemma":[0.9955805,0.00046475104,0.0008129147,0.0015881617,0.00041801744,0.0011356588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001251328,0.00033899854,0.00073826005,0.00007578408,0.00032446976,0.00006358858,0.000030718682,0.00015720444,0.00043853282],"category_scores_gemma":[0.0016800953,0.00024616445,0.00030636942,0.00023682928,0.0005053195,0.00009880704,0.000049731054,0.0003348112,0.00003771642],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035962486,0.00064517773,0.28844082,0.000047119647,0.00026097885,0.7044038,0.000053546144,8.3854945e-7,0.0000014270133,0.00009200236,0.0022228674,0.0034717845],"study_design_scores_gemma":[0.001561967,0.0017186191,0.05109621,0.00026427303,0.0011051788,0.93017167,0.00013154287,0.000051713665,0.0001185239,0.00022528716,0.013269891,0.00028514085],"about_ca_topic_score_codex":0.00093521917,"about_ca_topic_score_gemma":0.00043927284,"teacher_disagreement_score":0.23734461,"about_ca_system_score_codex":0.00012429051,"about_ca_system_score_gemma":0.00075672596,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W2883082836","doi":"10.1097/pgp.0000000000000538","title":"Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Immunohistochemistry; Pathology; Serous fluid; Serous carcinoma; Ovarian carcinoma; Clear cell; Ovary; Medicine; Biology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.015442067877139472,"score_gpt":0.27001902666158584,"score_spread":0.25457695878444636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883082836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987437,0.0006504786,0.00027423556,0.009334532,0.0011054301,0.00017361817,0.00007070658,0.000013394485,0.0009405733],"genre_scores_gemma":[0.9960576,0.00008251345,0.0017148795,0.0009470095,0.00096884026,0.000022326703,0.00004704646,0.000015905303,0.00014385482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983899,0.0000927046,0.0005433801,0.00030349276,0.00042080853,0.00024973863],"domain_scores_gemma":[0.9985501,0.00022601392,0.00029456554,0.00014374226,0.0005850377,0.00020052982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001857247,0.00022305464,0.0004790156,0.00013591304,0.00007952018,0.000031104846,0.00021699783,0.00021451486,0.00094232324],"category_scores_gemma":[0.00010847467,0.00015880888,0.00018312638,0.000052616026,0.00035779097,0.00007185462,0.00006885714,0.00034754377,0.000013329996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025887813,0.0043274346,0.7739364,0.00006969361,0.00054686307,0.01692604,0.0007263872,0.000005636917,0.18540187,0.002720122,0.0034478495,0.00930292],"study_design_scores_gemma":[0.00527027,0.0028013415,0.9596525,0.000033174714,0.00018234107,0.0053665126,0.00008696913,0.000024332523,0.024497418,0.0016077234,0.00032782942,0.00014958454],"about_ca_topic_score_codex":0.000026907288,"about_ca_topic_score_gemma":0.0000070849724,"teacher_disagreement_score":0.18571611,"about_ca_system_score_codex":0.00034026644,"about_ca_system_score_gemma":0.00015528116,"threshold_uncertainty_score":0.999971},"labels":[],"label_agreement":null},{"id":"W2883417695","doi":"10.1373/jalm.2017.025817","title":"Algorithms Used in Ovarian Cancer Detection: A Minireview on Current and Future Applications","year":2018,"lang":"en","type":"article","venue":"The Journal of Applied Laboratory Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Ovarian cancer; Serous fluid; Malignancy; Disease; Medicine; Cancer; Oncology; Algorithm; Stage (stratigraphy); Internal medicine; Asymptomatic; Gynecology; Biology; Computer science","score_opus":0.02273378916698138,"score_gpt":0.3249751197026542,"score_spread":0.3022413305356728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883417695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53607374,0.28719193,0.0018566021,0.15640152,0.005179981,0.0067652753,0.00008962048,0.000083381805,0.006357926],"genre_scores_gemma":[0.9562886,0.03261575,0.0001744831,0.0021825375,0.0085498905,0.0001526702,0.0000019530557,0.000024770894,0.000009379287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988925,0.00005083408,0.00044250846,0.00014232926,0.00032394181,0.00014791822],"domain_scores_gemma":[0.9989544,0.00009797599,0.00029908153,0.0002547677,0.00023196742,0.00016177363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072395924,0.00015897078,0.00044529015,0.00014232751,0.00008854684,0.0000056134495,0.00009074722,0.000053388983,0.00021645793],"category_scores_gemma":[0.000010269316,0.00008405908,0.00002939803,0.0005902278,0.00020501671,0.000030915304,0.000013171624,0.00033825752,0.000007668939],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015799387,0.0007031541,0.0023411284,0.00033852278,0.00032187655,0.000037300953,0.0038781932,0.0000033514743,0.007407681,0.0024873961,0.005407313,0.97549415],"study_design_scores_gemma":[0.008954878,0.0019252485,0.04761768,0.0013851785,0.0010392937,0.000088447916,0.0011855578,0.000015478681,0.0074790632,0.00030595082,0.9298291,0.00017408408],"about_ca_topic_score_codex":0.000016388298,"about_ca_topic_score_gemma":0.000060069797,"teacher_disagreement_score":0.97532004,"about_ca_system_score_codex":0.00015998549,"about_ca_system_score_gemma":0.00019815331,"threshold_uncertainty_score":0.34278297},"labels":[],"label_agreement":null},{"id":"W2883450379","doi":"10.3390/ijms19082184","title":"Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells","year":2018,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates; University of Alberta; Rita and Alex Hillman Foundation; Alberta Cancer Foundation; Li Ka Shing Foundation; Royal Alexandra Hospital Foundation; Ottawa Hospital Research Institute; Children's Health Research Institute; Women and Children's Health Research Institute","keywords":"Carboplatin; Cisplatin; Cancer research; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Ovarian cancer; Biology; Survivin; Phosphorylation; Cell biology; Cell culture; Medicine; Cancer; Internal medicine; Chemotherapy","score_opus":0.012569928057005058,"score_gpt":0.29813265274519135,"score_spread":0.2855627246881863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883450379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940175,0.0009811944,0.0000842876,0.0038913728,0.0002017763,0.00017824586,0.000028590306,0.00000227401,0.00061477994],"genre_scores_gemma":[0.9956612,0.0003654857,0.0030029071,0.00085063634,0.00008851566,0.000010673214,0.0000015696012,0.0000045468587,0.00001444411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986606,0.00006436742,0.0003940563,0.00019224247,0.00055769423,0.00013103773],"domain_scores_gemma":[0.99934155,0.00007048166,0.0002163656,0.00003883637,0.00023939487,0.00009339644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004428438,0.00009386036,0.0002196974,0.00029021566,0.000020655049,0.000029205961,0.00014194223,0.000037524977,0.00006889307],"category_scores_gemma":[0.00005157391,0.00007239992,0.000042037245,0.0002819042,0.00019440918,0.0001280856,0.000048358597,0.000094856594,8.372382e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045313878,0.00063125533,0.045064088,0.000025285233,0.00007728704,0.00048534427,0.00034307755,0.000029911049,0.9500426,0.00022215348,0.0007587242,0.0018671603],"study_design_scores_gemma":[0.0019471113,0.0006211832,0.06936088,0.0006204827,0.00003438658,0.000028848057,0.00005443091,0.000047262278,0.92664975,0.00041792518,0.00013876837,0.00007898754],"about_ca_topic_score_codex":0.0004287068,"about_ca_topic_score_gemma":0.00013174044,"teacher_disagreement_score":0.024296796,"about_ca_system_score_codex":0.00020089897,"about_ca_system_score_gemma":0.00023626884,"threshold_uncertainty_score":0.2952383},"labels":[],"label_agreement":null},{"id":"W2883813435","doi":"10.1158/0008-5472.can-18-0951","title":"A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; National Center for Research Resources; NIHR Cambridge Biomedical Research Centre; Instituto de Salud Carlos III; National Health and Medical Research Council; World Cancer Research Fund; Medical Research Council; Canadian Institutes of Health Research; Health Canada; National Institutes of Health; BC Cancer Foundation; Hebei Medical University; Pomorski Uniwersytet Medyczny W Szczecinie; Mutuelle Générale de l'Education Nationale; Deutsche Krebshilfe; Institut Gustave-Roussy; Norges Forskningsråd; Helse Vest; Japan Society for the Promotion of Science; Hellenic Health Foundation; Ministry of Health, Labour and Welfare; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Associazione Italiana per la Ricerca sul Cancro; Canadian HIV Trials Network, Canadian Institutes of Health Research; Institut National de la Santé et de la Recherche Médicale; Cancerfonden; National Cancer Institute; Peter MacCallum Foundation; University College London; Cancer Institute NSW; European Commission; Fred C. and Katherine B. Andersen Foundation; University of Cambridge; Roswell Park Cancer Institute; National Institute for Health and Care Research; Swedish Cancer Foundation; Ovarian Cancer Australia; U.S. Department of Defense; Cancer Research UK; World Health Organization; Wellcome Trust; Kreftforeningen; Cancer Research Society; Centre International de Recherche sur le Cancer; Ligue Contre le Cancer; Vanderbilt University Medical Center; Deutsches Krebsforschungszentrum; Cancer Council Victoria; Kræftens Bekæmpelse; Mayo Foundation for Medical Education and Research; Radboud Universiteit; Lon V. Smith Foundation; European Social Fund; State of Connecticut Department of Public Health; Korea Health Industry Development Institute; Oregon Health and Science University; Minnesota Ovarian Cancer Alliance; Moffitt Cancer Center; Vanderbilt University; Rutgers Cancer Institute of New Jersey; Cancer Australia; Oak Foundation; NordForsk; Vetenskapsrådet; Georgia Clinical and Translational Science Alliance","keywords":"Transcriptome; Ovarian cancer; Candidate gene; Gene; Biology; Epithelial ovarian cancer; Cancer; Oncology; Genetics; Internal medicine; Bioinformatics; Computational biology; Medicine; Gene expression","score_opus":0.0684549278744645,"score_gpt":0.4351848266239564,"score_spread":0.3667298987494919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883813435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871917,0.0005365193,0.000104183164,0.0050505907,0.0008135839,0.0051741013,0.00088298647,0.00006446231,0.00018192129],"genre_scores_gemma":[0.98187613,0.00069371035,0.000098284436,0.00038653595,0.0018618607,0.011140945,0.000020782703,0.000069498274,0.0038522636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957198,0.0004290752,0.00046593035,0.0009720783,0.0011806412,0.0012324827],"domain_scores_gemma":[0.99667203,0.0004930436,0.00013971778,0.0006973144,0.0013962601,0.00060163374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034948485,0.0002684246,0.0005744062,0.00033365906,0.00059077766,0.00016088308,0.00027309425,0.00015563112,0.0019615768],"category_scores_gemma":[0.00069259165,0.00022997752,0.00015395129,0.0008603363,0.00016174959,0.00015930481,0.00008917466,0.0004049166,0.00012268119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017833237,0.0008064975,0.95369804,0.000097769785,0.000908454,0.000015515621,0.008690793,0.00000892876,0.005443186,0.000009128574,0.010049392,0.018488996],"study_design_scores_gemma":[0.0064551574,0.0026452972,0.94254315,0.00014026802,0.00026510903,2.5060115e-7,0.001564645,0.000019654206,0.013822715,0.00017750854,0.03212971,0.00023652811],"about_ca_topic_score_codex":0.043629564,"about_ca_topic_score_gemma":0.05497668,"teacher_disagreement_score":0.022080317,"about_ca_system_score_codex":0.0061425827,"about_ca_system_score_gemma":0.0010377651,"threshold_uncertainty_score":0.9989508},"labels":[],"label_agreement":null},{"id":"W2883950347","doi":"10.1016/j.jacr.2018.05.022","title":"Patient-Friendly Summary of the ACR Appropriateness Criteria: Ovarian Cancer Screening","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Ovarian cancer; Medicine; Family history; Cancer; Genetic testing; Oncology; Stage (stratigraphy); Gynecology; BRCA mutation; Internal medicine; Obstetrics; Biology","score_opus":0.014082832535997469,"score_gpt":0.2867682177063251,"score_spread":0.27268538517032764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883950347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415786,0.0009521461,0.00013710167,0.012492188,0.0013726753,0.00029739112,0.00013998819,0.000003540512,0.00044709197],"genre_scores_gemma":[0.9952457,0.00028494597,0.0029556,0.00082649844,0.0005458758,0.000010162443,5.3245725e-7,0.000019214178,0.00011149479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983814,0.00029810093,0.0006392707,0.00015251989,0.00030024,0.00022847478],"domain_scores_gemma":[0.9971844,0.00014783138,0.0016711212,0.00047118508,0.00043871152,0.00008678081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029761824,0.00015329223,0.0008243596,0.00010161876,0.000103271,0.0000031900706,0.0003694446,0.000054252894,0.00009883447],"category_scores_gemma":[0.00014777196,0.00007681304,0.00034829005,0.0005123897,0.0010410302,0.00004894247,0.00013304116,0.00021330948,5.173019e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011519813,0.001783156,0.6880734,0.00023212959,0.0061894683,0.00036601326,0.002428924,0.00022840289,0.049346413,0.0016624932,0.1645051,0.07366469],"study_design_scores_gemma":[0.0066445447,0.009639615,0.8999363,0.0012495852,0.0016045604,0.0039516306,0.0022011646,0.00016064402,0.0406452,0.0003786073,0.033320248,0.0002678847],"about_ca_topic_score_codex":0.00036550174,"about_ca_topic_score_gemma":0.00004595423,"teacher_disagreement_score":0.21186292,"about_ca_system_score_codex":0.00013498694,"about_ca_system_score_gemma":0.00047774348,"threshold_uncertainty_score":0.3835719},"labels":[],"label_agreement":null},{"id":"W2884871730","doi":"10.1007/s12307-018-0215-3","title":"Ascites IL-10 Promotes Ovarian Cancer Cell Migration","year":2018,"lang":"en","type":"article","venue":"Cancer Microenvironment","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Institute of Cancer Research","keywords":"Ascites; Ovarian cancer; Serous fluid; Medicine; Cancer research; Chemokine; Cytokine; Cell growth; Cancer; Immunology; Internal medicine; Biology; Inflammation","score_opus":0.013562473382244087,"score_gpt":0.2590323466153384,"score_spread":0.24546987323309433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884871730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616154,0.015986416,0.00011983075,0.014906212,0.0007685428,0.0013822815,0.00027250987,0.00008946411,0.0048593837],"genre_scores_gemma":[0.9771433,0.008428745,0.0012876801,0.0018268982,0.0012506924,0.0008305026,0.00006861135,0.000060120557,0.009103441],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984726,0.000026933794,0.0002753605,0.0005630383,0.000266085,0.0003960041],"domain_scores_gemma":[0.99915767,0.000017268521,0.00012707704,0.00044921314,0.000042371936,0.00020641484],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000074144875,0.00027925754,0.00030403325,0.000043353557,0.00014563474,0.00003534863,0.00009571847,0.0000936666,0.017300107],"category_scores_gemma":[0.000004221406,0.00023388959,0.00011814937,0.00010212962,0.00017185608,0.00010586057,0.000054026154,0.000094023795,0.00043476553],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007504626,0.0029941062,0.276227,0.00039611437,0.0009953852,0.00008483271,0.0031887616,0.00004120437,0.42990166,0.00010856121,0.15905623,0.12625568],"study_design_scores_gemma":[0.0023189993,0.000655841,0.13786732,0.00019586709,0.00038695635,0.000007731169,0.000080163416,0.00007434981,0.41488475,0.000024758814,0.44324648,0.00025680262],"about_ca_topic_score_codex":0.0016584247,"about_ca_topic_score_gemma":0.0010131419,"teacher_disagreement_score":0.28419024,"about_ca_system_score_codex":0.0012250332,"about_ca_system_score_gemma":0.00014169552,"threshold_uncertainty_score":0.98359823},"labels":[],"label_agreement":null},{"id":"W2885095998","doi":"10.1158/1557-3265.ovca17-b46","title":"Abstract B46: DICER1 and FOXL2 mutations correlate with clinicopathologic features of ovarian Sertoli-Leydig cell tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Mutation; Pathology; Sexual differentiation; Cancer research; Internal medicine; Medicine; Genetics; Gene","score_opus":0.15577223194139478,"score_gpt":0.49851166330251695,"score_spread":0.34273943136112217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885095998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97513396,0.0019207756,0.000013426953,0.004455925,0.00027251206,0.00086816686,0.00006622041,0.000038119793,0.017230883],"genre_scores_gemma":[0.9950967,0.0018973902,0.0006729649,0.00039545927,0.0005819034,0.00016865371,0.000020311478,0.00003805758,0.0011285524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972605,0.00022540912,0.0007032824,0.000673441,0.00062911835,0.0005082487],"domain_scores_gemma":[0.99670947,0.0013982432,0.00021067642,0.00055717316,0.0007011089,0.00042331842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017030671,0.00019557607,0.00061523437,0.00016090814,0.00021411122,0.000041495867,0.00016992929,0.00022097601,0.00071671145],"category_scores_gemma":[0.00042766155,0.00013223634,0.00013042535,0.00047694694,0.0016368447,0.00007994519,0.00011495438,0.00093752536,0.00007331173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047897645,0.00246694,0.89962137,0.00045091982,0.0003441662,0.0007540229,0.0007513861,0.0000073770716,0.000326911,0.0007532565,0.010051055,0.079682834],"study_design_scores_gemma":[0.0047550513,0.004562438,0.9853029,0.0005173245,0.00016596072,0.000039405888,0.00023795174,0.000030784955,0.0011263185,0.00038875616,0.002729306,0.0001438017],"about_ca_topic_score_codex":0.0011168625,"about_ca_topic_score_gemma":0.00065866165,"teacher_disagreement_score":0.085681535,"about_ca_system_score_codex":0.00010692409,"about_ca_system_score_gemma":0.00090085197,"threshold_uncertainty_score":0.7847488},"labels":[],"label_agreement":null},{"id":"W2885664910","doi":"10.1007/s00247-018-4073-4","title":"Magnetic resonance imaging of pediatric adnexal masses and mimics","year":2018,"lang":"en","type":"review","venue":"Pediatric Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Adnexal mass; Medicine; Magnetic resonance imaging; Adnexal Diseases; Radiology; Malignancy; Neuroradiology; Virilization; Ultrasound; Presentation (obstetrics); Laparoscopy; Pathology","score_opus":0.02975571937089094,"score_gpt":0.3142236941349306,"score_spread":0.2844679747640397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885664910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047114567,0.9971765,0.0000060094058,0.000093697825,0.00069955294,0.0007971678,0.00012317736,0.00003735598,0.00059537974],"genre_scores_gemma":[0.00016105048,0.9929416,0.00121819,0.00006641579,0.0051278174,0.00014809385,0.00007909187,0.000071646005,0.0001860774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756145,0.00016795598,0.00087703654,0.00075440103,0.00018279745,0.00045633642],"domain_scores_gemma":[0.99805,0.000588598,0.0005181006,0.0005458189,0.00010270629,0.00019479166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025968347,0.0004891487,0.002328281,0.00051858043,0.00005367143,0.000011910688,0.00017733285,0.00034910569,0.00015264843],"category_scores_gemma":[0.00017693198,0.0003804852,0.00035638557,0.00055803824,0.00017964368,0.000036314486,0.00010668487,0.0003235194,0.000051252588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003130482,0.00020643897,0.14792761,0.017168123,0.00009261184,0.00023639848,0.00003941621,4.399309e-8,2.1417224e-8,0.000118955824,0.024819972,0.80935913],"study_design_scores_gemma":[0.0011643999,0.00071836944,0.010004888,0.00051933434,0.009784156,0.0011800851,0.000004575139,0.00000451858,1.2890402e-7,0.000059744776,0.97620785,0.0003519205],"about_ca_topic_score_codex":0.000026660935,"about_ca_topic_score_gemma":0.0000019595575,"teacher_disagreement_score":0.9513879,"about_ca_system_score_codex":0.00013893121,"about_ca_system_score_gemma":0.00066937896,"threshold_uncertainty_score":0.9998647},"labels":[],"label_agreement":null},{"id":"W2885684293","doi":"10.1159/000490664","title":"Correlation between the Length of Ovarian Ligament and Ovarian Torsion: A Prospective Study","year":2018,"lang":"en","type":"article","venue":"Gynecologic and Obstetric Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian torsion; Medicine; Prospective cohort study; Internal medicine; Gynecology; Endocrinology; Surgery","score_opus":0.02553492062690357,"score_gpt":0.2637273549623633,"score_spread":0.23819243433545975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885684293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950601,0.00058893743,0.000101284626,0.0013558894,0.00022478074,0.0015785493,0.0000044433245,0.000025412357,0.0010606233],"genre_scores_gemma":[0.998809,0.00008202262,0.0005408218,0.00020149369,0.00017078206,0.000093922274,0.00000926702,0.0000072819194,0.000085446445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900335,0.00009173755,0.0002853393,0.00028060493,0.00019550794,0.00014345844],"domain_scores_gemma":[0.9989627,0.00041869108,0.00018398679,0.00018153695,0.00015904254,0.00009402597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036212354,0.0001279459,0.00025585422,0.00010532017,0.00025942645,0.000023417075,0.00003211783,0.00008778724,0.00004036389],"category_scores_gemma":[0.00050734973,0.00007909432,0.000027123591,0.00040934506,0.00024261825,0.00007621743,0.000051856678,0.00010526651,0.000005985666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002828428,0.00015619688,0.9810041,0.000018676792,0.00012482668,0.0000053209883,0.0035685825,9.976266e-7,0.000017348755,0.0012349471,0.00009630049,0.01374437],"study_design_scores_gemma":[0.0021700014,0.0033380599,0.9900133,0.00004333039,0.0003711053,0.000007118737,0.0015206425,0.00021344428,0.00049639127,0.0015815996,0.00016695194,0.00007807928],"about_ca_topic_score_codex":0.00013033026,"about_ca_topic_score_gemma":0.000023642246,"teacher_disagreement_score":0.013666291,"about_ca_system_score_codex":0.00013946289,"about_ca_system_score_gemma":0.00007992022,"threshold_uncertainty_score":0.32253727},"labels":[],"label_agreement":null},{"id":"W2886023759","doi":"10.1158/1557-3265.ovca17-b12","title":"Abstract B12: Differences in neoplastic transformation potential between OSE and FTE","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Ovarian cancer; Cancer research; Cell culture; Immortalised cell line; Serous fluid; Biology; In vivo; Transfection; Fallopian tube; Cancer; BRCA mutation; Neoplastic transformation; Mutation; Pathology; Medicine; Carcinogenesis; Genetics; Gene","score_opus":0.2956874030233323,"score_gpt":0.5332519298147181,"score_spread":0.23756452679138584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886023759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908979,0.00051834073,0.00003154125,0.006368244,0.0002025149,0.0004488745,0.000027941527,0.0000150264805,0.0014896068],"genre_scores_gemma":[0.9965527,0.0020042104,0.00004688608,0.00011087306,0.0010828351,0.00009183103,0.000010340421,0.0000117602285,0.000088546476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982545,0.00012531973,0.00046397955,0.00033759893,0.00045930635,0.00035932564],"domain_scores_gemma":[0.9987046,0.0006584566,0.000041228173,0.0001776131,0.0001648786,0.00025318598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011398365,0.00010096759,0.0003436325,0.0001431335,0.000100963036,0.000044455854,0.00008198738,0.00013667214,0.00066908787],"category_scores_gemma":[0.00019203189,0.00007502416,0.00006293707,0.00024516668,0.00046897662,0.00009356591,0.00003816916,0.0005121259,0.00008471013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056330085,0.00025972453,0.7849773,0.000096559765,0.00007339637,0.000038555037,0.00028072562,2.4803862e-7,0.00003743078,0.00007371956,0.00066248357,0.21293655],"study_design_scores_gemma":[0.0029171533,0.0011028172,0.9928127,0.0002741321,0.000044641234,0.0000020999285,0.000071691575,0.00008656357,0.00019965794,0.0004046366,0.0020116654,0.00007223173],"about_ca_topic_score_codex":0.0008599461,"about_ca_topic_score_gemma":0.00067863276,"teacher_disagreement_score":0.21286431,"about_ca_system_score_codex":0.00011577058,"about_ca_system_score_gemma":0.00029154497,"threshold_uncertainty_score":0.7326043},"labels":[],"label_agreement":null},{"id":"W2886495470","doi":"10.12688/f1000research.15663.1","title":"Audit of transvaginal sonography of normal postmenopausal ovaries by sonographers from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","year":2018,"lang":"en","type":"preprint","venue":"F1000Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CReATe Fertility Centre","funders":"Medical Research Council; James Cook University; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Gynecology; Ovarian cancer; Open peer review; Postmenopausal women; Physiology; Cancer; Obstetrics; Plant biology; Internal medicine; Biology","score_opus":0.06462250658612897,"score_gpt":0.37082988167515296,"score_spread":0.30620737508902396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886495470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96878463,0.004280589,0.0011328188,0.006036053,0.0006758675,0.0051536206,0.01305805,0.00004680364,0.00083154364],"genre_scores_gemma":[0.9905835,0.0018528335,0.004317751,0.00010907086,0.00064951635,0.0007945087,0.0015433761,0.00009119368,0.00005824694],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9952074,0.000628324,0.0011179569,0.0007367563,0.0016848894,0.00062465],"domain_scores_gemma":[0.995049,0.00092627975,0.000838277,0.0011177139,0.0018181319,0.00025062435],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010802086,0.0005130306,0.0014056021,0.0007113411,0.00017393993,0.000060195965,0.0007375422,0.00045090565,0.0013386494],"category_scores_gemma":[0.0001376748,0.0003764118,0.00045233316,0.0020105676,0.0018918844,0.00008896049,0.0003875408,0.000986133,0.0000021621959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49318975,0.008205838,0.30806908,0.0026310019,0.037748583,0.00011197037,0.01680322,0.0007913183,0.0118572125,0.0025998647,0.10110266,0.016889473],"study_design_scores_gemma":[0.2642193,0.033398774,0.44969222,0.012349804,0.009763191,0.000009132727,0.005421393,0.0012565892,0.152453,0.0024770151,0.06690631,0.0020532294],"about_ca_topic_score_codex":0.056655116,"about_ca_topic_score_gemma":0.00076476316,"teacher_disagreement_score":0.22897044,"about_ca_system_score_codex":0.00012929013,"about_ca_system_score_gemma":0.0021000337,"threshold_uncertainty_score":0.9998688},"labels":[],"label_agreement":null},{"id":"W2886558446","doi":"10.1002/cjp2.109","title":"Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study","year":2018,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Vancouver General Hospital; University of British Columbia; Royal Alexandra Hospital; BC Cancer Agency; Foothills Medical Centre; University of Calgary","funders":"Medical Research and Materiel Command; Instituto de Salud Carlos III; Cancer Council Tasmania; Cancer Council Victoria; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; National Institutes of Health; Peter MacCallum Foundation; Ministerio de Economía y Competitividad; Canadian Institutes of Health Research; Cancer Institute NSW; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Fred C. and Katherine B. Andersen Foundation; Calgary Laboratory Services; University of Cambridge; University College London; Cancer Research UK; Minnesota Ovarian Cancer Alliance; Huntsman Cancer Foundation; Cancer Council NSW; Ovarian Cancer Australia; National Cancer Institute; Universität Heidelberg; Cancer Research Society; Cancer Council South Australia; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Cancer Australia; Ovarian Cancer Action; VGH and UBC Hospital Foundation; National Center for Research Resources; BC Cancer Foundation; Oak Foundation; Kræftens Bekæmpelse; Mayo Foundation for Medical Education and Research; U.S. Department of Defense","keywords":"Tissue microarray; Ovarian carcinoma; Serous carcinoma; Serous fluid; CDKN2A; Hazard ratio; Immunohistochemistry; Ovarian cancer; Oncology; Cancer research; Medicine; Carcinoma; Survival analysis; Pathology; Internal medicine; Cancer; Confidence interval","score_opus":0.12751558671511637,"score_gpt":0.49262140361273243,"score_spread":0.36510581689761606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886558446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948246,0.00018275969,0.00026128732,0.003599382,0.00019189031,0.0006965266,0.000028058392,0.000009005449,0.00020653111],"genre_scores_gemma":[0.99783987,0.00008553908,0.0011495954,0.00013236621,0.00052116107,0.000026588448,0.000005802371,0.000018725555,0.00022033782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99293584,0.0036728282,0.0013108661,0.0003469339,0.0012328473,0.00050067843],"domain_scores_gemma":[0.9925649,0.0027411897,0.0010403609,0.0007022926,0.00264731,0.0003039492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016821038,0.00017121268,0.0010508146,0.00030704524,0.00033932566,0.00003553791,0.00039080484,0.00019124843,0.00032171718],"category_scores_gemma":[0.0025584223,0.00009280284,0.00020232312,0.0009882138,0.0009782609,0.00012751951,0.00013686647,0.0009942302,0.000018399842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057280175,0.00401907,0.98042613,0.000019062643,0.0016539921,0.00087713293,0.0038186274,0.0000032419737,0.00064261124,0.000022807988,0.00083392765,0.0019553835],"study_design_scores_gemma":[0.0046480545,0.027663201,0.95805484,0.00007463364,0.0027011642,0.00015879606,0.0032979487,0.000024116678,0.0027942576,0.00009324455,0.00040410794,0.00008562705],"about_ca_topic_score_codex":0.0002875641,"about_ca_topic_score_gemma":0.00072506536,"teacher_disagreement_score":0.02364413,"about_ca_system_score_codex":0.0002610476,"about_ca_system_score_gemma":0.00065296545,"threshold_uncertainty_score":0.582987},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2886785709","doi":"10.1158/1557-3265.ovca17-ia19","title":"Abstract IA19: Granulosa cell and other rare ovarian cancers: Genomic-derived diagnostics and emergent management strategies","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Pathognomonic; Cancer; Medicine; Cancer research; Granulosa cell; Ovary; Oncology; Internal medicine; Biology; Disease","score_opus":0.1702701235940406,"score_gpt":0.4768807712659098,"score_spread":0.3066106476718692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886785709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658067,0.00966136,0.000021179287,0.004905078,0.0005279493,0.0013527315,0.0001279399,0.000043947704,0.017553065],"genre_scores_gemma":[0.9511825,0.045364555,0.00050687406,0.0008832828,0.0012030174,0.00034079602,0.000010756634,0.00005139595,0.00045686544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973566,0.00014285096,0.0005559097,0.0007997529,0.0005201165,0.00062480307],"domain_scores_gemma":[0.9980973,0.00048206563,0.00009684852,0.00051710935,0.00026208104,0.00054461503],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000991062,0.00024153026,0.00046582997,0.00013683675,0.0002724482,0.00013905147,0.0001525496,0.0001669975,0.0019904252],"category_scores_gemma":[0.000078306,0.00019571291,0.00009549821,0.00022797067,0.00091332453,0.00008567105,0.00023768278,0.0004948568,0.000077694334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047206236,0.0025342072,0.6392221,0.0023858736,0.0022308365,0.001186972,0.0024014798,0.0000125574625,0.001546624,0.004595212,0.100012034,0.2391515],"study_design_scores_gemma":[0.0059228647,0.00133684,0.85795295,0.00044793574,0.00024099322,0.000006544496,0.0013811014,0.00004533741,0.0008549081,0.00092852156,0.13060212,0.00027989558],"about_ca_topic_score_codex":0.002689187,"about_ca_topic_score_gemma":0.0013857414,"teacher_disagreement_score":0.23887159,"about_ca_system_score_codex":0.00029838382,"about_ca_system_score_gemma":0.00048576028,"threshold_uncertainty_score":0.9989219},"labels":[],"label_agreement":null},{"id":"W2887168129","doi":"10.1158/1557-3265.ovca17-a63","title":"Abstract A63: Estrogen receptor signaling in fallopian tube epithelia of BRCA mutation carriers","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Estrogen receptor; Serous carcinoma; Biology; Cancer research; Carcinogenesis; Fallopian tube; Ovarian cancer; Estrogen; Serous fluid; BRCA mutation; Tissue microarray; Laser capture microdissection; Cancer; Pathology; Medicine; Breast cancer; Gene expression; Genetics; Gene","score_opus":0.20567328374580335,"score_gpt":0.5237894266931445,"score_spread":0.3181161429473412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887168129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919532,0.0009560119,0.0000048971965,0.003335788,0.000343821,0.0006221705,0.00005125765,0.000016648319,0.0027162312],"genre_scores_gemma":[0.9972849,0.000816859,0.00044700655,0.00018407416,0.00086454506,0.00015439477,0.000020557829,0.000028379704,0.00019928788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974705,0.00020784626,0.0007397562,0.00047034124,0.0006596471,0.00045193065],"domain_scores_gemma":[0.9979588,0.00069721136,0.00010940468,0.0003751512,0.0005592079,0.00030023776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022529536,0.00012507025,0.00044033435,0.00019102925,0.00007551989,0.00001924929,0.00015647615,0.00017868204,0.0022017814],"category_scores_gemma":[0.00074157986,0.00010464594,0.00015797053,0.0005182611,0.0005611028,0.00006608896,0.000055329903,0.000555783,0.00012113022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019889064,0.00090630626,0.8739312,0.00023420452,0.00030105803,0.00012675257,0.0008220394,0.00002121286,0.004854185,0.00057787413,0.0046092686,0.11162696],"study_design_scores_gemma":[0.009451234,0.0042574396,0.88786995,0.0017077076,0.00011466974,0.000005632166,0.00084071065,0.00013861779,0.06660668,0.0006618474,0.028051056,0.00029444904],"about_ca_topic_score_codex":0.0035556755,"about_ca_topic_score_gemma":0.0008326901,"teacher_disagreement_score":0.111332506,"about_ca_system_score_codex":0.00039979338,"about_ca_system_score_gemma":0.0010230406,"threshold_uncertainty_score":0.99871033},"labels":[],"label_agreement":null},{"id":"W2887232130","doi":"10.1007/s00428-018-2428-8","title":"Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors","year":2018,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Columbian Hospital","funders":"","keywords":"Anaplastic lymphoma kinase; Leiomyosarcoma; Immunohistochemistry; Fusion gene; Gene rearrangement; Pathology; Smooth Muscle Tumor; Population; Mesenchymal stem cell; Medicine; Biology; Gene","score_opus":0.06426512383666551,"score_gpt":0.4069935013358203,"score_spread":0.3427283774991548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887232130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908726,0.003203191,0.0018888196,0.0006043479,0.000115050534,0.0028181635,0.00008507771,0.00011913256,0.0002935825],"genre_scores_gemma":[0.89489174,0.0004919177,0.10311604,0.00034778594,0.00033671455,0.0005025921,0.00021145886,0.0000692657,0.000032461372],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996005,0.0004507333,0.0010417658,0.001276631,0.0003735455,0.0008523],"domain_scores_gemma":[0.9971703,0.0011294566,0.00044277625,0.00073131267,0.00026851145,0.00025761945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011792671,0.0006116991,0.0012957656,0.00036812207,0.0002014757,0.00003992589,0.0002841509,0.00022233231,0.0000191308],"category_scores_gemma":[0.0012233802,0.00048499258,0.00013041525,0.00052175776,0.0011307317,0.00016655114,0.00039754185,0.0005378726,0.0000020956472],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024093399,0.000639571,0.05689655,0.0006894812,0.0006304937,0.00036795822,0.0013844459,0.000010005265,0.8087434,0.00010881636,0.00007574297,0.1280442],"study_design_scores_gemma":[0.011435146,0.010152908,0.83899564,0.0010594731,0.0007832857,0.00020050524,0.0004245086,0.0029676415,0.1309337,0.0011400024,0.0012315451,0.0006756215],"about_ca_topic_score_codex":0.00054583524,"about_ca_topic_score_gemma":0.000068085144,"teacher_disagreement_score":0.7820991,"about_ca_system_score_codex":0.00011061215,"about_ca_system_score_gemma":0.00017136052,"threshold_uncertainty_score":0.99976015},"labels":[],"label_agreement":null},{"id":"W2887314135","doi":"10.1158/1557-3265.ovca17-a45","title":"Abstract A45: Treatment patterns and outcomes among platinum-refractory/resistant ovarian cancer patients","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Ovarian cancer; Refractory (planetary science); Internal medicine; Fallopian tube cancer; Medical record; Cancer; Proportional hazards model; Stage (stratigraphy); Gynecology","score_opus":0.1824123986265077,"score_gpt":0.5047659988453095,"score_spread":0.3223536002188018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887314135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919746,0.0005486033,0.0000015385324,0.0032416666,0.0006761885,0.001185983,0.00034412698,0.000047665573,0.001979622],"genre_scores_gemma":[0.99227005,0.0039160526,0.000056699548,0.0004350326,0.0012209195,0.00075550604,0.000041189716,0.00006102726,0.0012434919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641037,0.00019019989,0.000791156,0.00092733157,0.0009000093,0.0007809285],"domain_scores_gemma":[0.9969716,0.0008957474,0.00017417595,0.0006406693,0.00059718697,0.00072060956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079396303,0.00032403663,0.00076759595,0.00016588248,0.00031859695,0.00009750702,0.00016497295,0.0002489807,0.0035124586],"category_scores_gemma":[0.00028190683,0.00021993555,0.00022545597,0.0002443539,0.0007046909,0.00012728843,0.00013779209,0.00054472237,0.00010434046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000869026,0.0018046636,0.8979766,0.00006847975,0.00052680157,0.00006489213,0.00022713226,2.2156586e-7,0.000015410407,0.000029556655,0.0026619118,0.09575533],"study_design_scores_gemma":[0.0077637737,0.0036827314,0.9686177,0.00038458093,0.00015939957,5.3885077e-7,0.00006564613,0.000012754199,0.00029604428,0.00005128291,0.01876213,0.00020342327],"about_ca_topic_score_codex":0.023285013,"about_ca_topic_score_gemma":0.014109185,"teacher_disagreement_score":0.09555191,"about_ca_system_score_codex":0.00094628206,"about_ca_system_score_gemma":0.0006229676,"threshold_uncertainty_score":0.9973985},"labels":[],"label_agreement":null},{"id":"W2887491075","doi":"10.1016/j.ygyno.2018.08.016","title":"Histotype classification of ovarian carcinoma: A comparison of approaches","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Huntsman Cancer Foundation; Calgary Laboratory Services","keywords":"Serous fluid; Medicine; Serous carcinoma; Immunohistochemistry; Ovarian carcinoma; Clear cell; Not Otherwise Specified; Pathology; Ovarian cancer; Population; Oncology; Cystadenocarcinoma; Internal medicine; Cancer","score_opus":0.1684320268760851,"score_gpt":0.37261912968287525,"score_spread":0.20418710280679014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887491075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933056,0.00046671455,0.0001698533,0.0028642223,0.0003976502,0.00048750715,0.000008895252,0.000024751842,0.06252439],"genre_scores_gemma":[0.99513596,0.0000127472285,0.0043813316,0.000097557364,0.00011619942,0.00007073968,0.000025113037,0.000008843171,0.00015149331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989185,0.00009231938,0.00044078077,0.00025526749,0.000116329335,0.00017684045],"domain_scores_gemma":[0.99882907,0.00024431292,0.00035142596,0.00031768432,0.00018918052,0.00006835224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022332533,0.00010989984,0.0006110611,0.000101812744,0.000040553892,0.0000014708315,0.00008938367,0.0002170791,0.00068407145],"category_scores_gemma":[0.00016224138,0.00008650786,0.00008738292,0.00018364671,0.0003918188,0.000020883966,0.00003440441,0.00009879571,0.00003532903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046611505,0.0037859832,0.890892,0.00010961717,0.00017084554,0.000013648282,0.0011227283,0.0000022814318,0.00310259,0.013519032,0.0043579726,0.08245715],"study_design_scores_gemma":[0.0022036377,0.008552941,0.96292114,0.000012875367,0.0002789138,0.000012959749,0.00044488066,0.0003988599,0.0061184294,0.00033690792,0.018647403,0.00007106813],"about_ca_topic_score_codex":0.00008250923,"about_ca_topic_score_gemma":0.00019618949,"teacher_disagreement_score":0.082386084,"about_ca_system_score_codex":0.00037853586,"about_ca_system_score_gemma":0.0003723548,"threshold_uncertainty_score":0.74901026},"labels":[],"label_agreement":null},{"id":"W2888117213","doi":"10.1089/gyn.2018.0023","title":"Bilateral Massive Ovarian Edema Due to Chronic Torsion Treated with Conservative Laparoscopic Approach","year":2018,"lang":"en","type":"article","venue":"Journal of Gynecologic Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Surgery; Ovarian torsion; Conservative treatment; Edema; Wedge resection; Lower abdominal pain; Oophorectomy; Laparoscopy; Resection; Hysterectomy","score_opus":0.02870044313980036,"score_gpt":0.27240412458276936,"score_spread":0.243703681442969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888117213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929689,0.00023567659,0.00014765066,0.0037325132,0.00053880934,0.0004285244,0.0000067703363,0.000023782972,0.0019173332],"genre_scores_gemma":[0.99490595,0.00007322637,0.0024211274,0.0014099207,0.00075363973,0.000038264465,0.000009655784,0.000022423337,0.00036580063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983616,0.00013214721,0.0005430077,0.00026748877,0.00033607488,0.00035971042],"domain_scores_gemma":[0.99791425,0.00057941093,0.00047114622,0.00022556422,0.0005038938,0.00030572663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004964868,0.00023491067,0.0009120888,0.00028646103,0.0001133193,0.00003724314,0.000090861904,0.00013266494,0.0007672662],"category_scores_gemma":[0.0002705522,0.00013695566,0.00018882069,0.00043675696,0.00013237873,0.00012731152,0.000032566888,0.00018823164,0.00004375235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023341617,0.0014443772,0.9441456,0.000089023815,0.0011375333,0.0035392374,0.00037014653,0.000044382676,0.00081133767,0.00008009684,0.039630152,0.0063739303],"study_design_scores_gemma":[0.0037921313,0.008825223,0.9674791,0.00054925773,0.0004235744,0.0010588932,0.00017525254,0.000047433816,0.010546364,0.000049051847,0.0068207104,0.00023297433],"about_ca_topic_score_codex":0.000040825867,"about_ca_topic_score_gemma":0.000021838916,"teacher_disagreement_score":0.03280944,"about_ca_system_score_codex":0.0007588114,"about_ca_system_score_gemma":0.0007863587,"threshold_uncertainty_score":0.8401027},"labels":[],"label_agreement":null},{"id":"W2888299515","doi":"10.3390/ijms19092473","title":"rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology","year":2018,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; Women's College Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; European Commission; National Cancer Institute; Cancer Research UK; University of Texas MD Anderson Cancer Center; Roswell Park Cancer Institute; Ovarian Cancer Research Fund; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; American Cancer Society","keywords":"Odds ratio; Expression quantitative trait loci; Internal medicine; Biology; Oncology; Confidence interval; Ovarian cancer; Allele; Genotype; Logistic regression; Thymidylate synthase; Gastroenterology; Gene; Cancer; Medicine; Single-nucleotide polymorphism; Genetics; Fluorouracil","score_opus":0.0492411237081751,"score_gpt":0.35275409044438455,"score_spread":0.3035129667362094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888299515","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02014645,0.97759306,0.00008848239,0.00072361546,0.00045417022,0.00019062553,0.000012263294,8.24632e-7,0.00079050066],"genre_scores_gemma":[0.21743618,0.7816913,0.00067354727,0.00007165922,0.000110122295,0.0000039107267,0.0000021325857,0.00000546498,0.0000056666704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981537,0.00023234182,0.00070794177,0.00017733501,0.0006276557,0.00010106663],"domain_scores_gemma":[0.99787104,0.00021474746,0.0013320994,0.00015035077,0.00038967418,0.000042069423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084590144,0.00013597187,0.0007331576,0.00046941807,0.000024145082,0.00001668029,0.00049907604,0.000086216016,0.000020744796],"category_scores_gemma":[0.00021493608,0.00007554579,0.00028512915,0.00022485376,0.00043638714,0.000050822633,0.00004984861,0.00019225947,7.389497e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018178193,0.0010060924,0.03212914,0.0016177335,0.0020059443,0.0034617246,0.0016660242,0.000009884999,0.000014180781,0.009230097,0.0007086021,0.9479688],"study_design_scores_gemma":[0.008503918,0.012164665,0.06178088,0.047912445,0.0100112595,0.041601554,0.0010754149,0.000075788514,0.00047293413,0.0063665314,0.80924684,0.00078776886],"about_ca_topic_score_codex":0.00023886564,"about_ca_topic_score_gemma":0.000021854012,"teacher_disagreement_score":0.94718105,"about_ca_system_score_codex":0.000107329106,"about_ca_system_score_gemma":0.0005744636,"threshold_uncertainty_score":0.3080668},"labels":[],"label_agreement":null},{"id":"W2888379566","doi":"10.1016/j.jacr.2018.07.004","title":"Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"","keywords":"Lexicon; Terminology; Medicine; Risk stratification; Radiology; Gynecology; Computer science; Natural language processing; Linguistics; Internal medicine","score_opus":0.04171507225198994,"score_gpt":0.32850404018151946,"score_spread":0.2867889679295295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888379566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983052,0.000606055,0.00057360926,0.012233975,0.0013245293,0.0008666793,0.00029845574,0.000012561408,0.0010321285],"genre_scores_gemma":[0.9893282,0.00007455826,0.00876568,0.0006926129,0.0009136574,0.000012185535,0.0000046423443,0.000033387932,0.00017504569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953399,0.00034074817,0.0032436366,0.00036717954,0.0003658207,0.00034275194],"domain_scores_gemma":[0.97878724,0.00080242514,0.018360693,0.0014157994,0.00050499174,0.00012887605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035171965,0.00023688034,0.0015901147,0.000110045665,0.00023044761,0.000013337413,0.00062028517,0.000096873,0.000024802708],"category_scores_gemma":[0.0046812184,0.0001306619,0.00038302073,0.00040719408,0.0010083123,0.00012420354,0.00026693352,0.00032746504,3.0756425e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035133634,0.0005549743,0.89550394,0.0005375684,0.0035886597,0.0004050011,0.0012611607,0.000040815034,0.031931184,0.0029733304,0.055708013,0.00398199],"study_design_scores_gemma":[0.008189653,0.006247823,0.8781673,0.0020898147,0.0032609561,0.06993119,0.007195325,0.0006309857,0.00667156,0.00060475484,0.016613713,0.00039698425],"about_ca_topic_score_codex":0.00022281062,"about_ca_topic_score_gemma":0.00008233781,"teacher_disagreement_score":0.06952618,"about_ca_system_score_codex":0.00019883703,"about_ca_system_score_gemma":0.0007832764,"threshold_uncertainty_score":0.5604194},"labels":[],"label_agreement":null},{"id":"W2888437698","doi":"10.1002/ijgo.12653","title":"Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University Health Network","keywords":"Medicine; Hazard ratio; Epithelial ovarian cancer; Confidence interval; Chemotherapy; Internal medicine; Ovarian cancer; Cytoreductive surgery; Oncology; Retrospective cohort study; Adjuvant; Cohort; Proportional hazards model; Surgery; Ovarian carcinoma; Cancer; Gynecology","score_opus":0.021423141643617184,"score_gpt":0.3415538703454068,"score_spread":0.3201307287017896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888437698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938484,0.00068785826,0.0002162851,0.0014886213,0.0032330349,0.00018427313,0.0001909691,0.0000032543735,0.00014729224],"genre_scores_gemma":[0.9964987,0.000799738,0.0017141125,0.0004055235,0.00052231055,0.000010240794,0.000022182227,0.000016678381,0.000010492894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983451,0.00006730722,0.0008629766,0.00016450264,0.00040886694,0.00015125542],"domain_scores_gemma":[0.9958937,0.0015419528,0.00086225406,0.00012611177,0.0014766366,0.00009935199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002448687,0.00013817467,0.0006534958,0.00081413623,0.0000109759985,0.000006477471,0.00017865545,0.00010405044,0.0005324363],"category_scores_gemma":[0.0014532934,0.00011237422,0.00028324165,0.00036488438,0.00009168399,0.00015843085,0.00003815409,0.00016299146,0.0000035842108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027802272,0.0012584357,0.8392844,0.0000114994145,0.0013603946,0.00015222623,0.0012947959,0.00014550488,0.011153751,0.000029874042,0.00047810917,0.14205076],"study_design_scores_gemma":[0.0044964897,0.0016883254,0.97436756,0.00031031598,0.00009226538,0.000029743116,0.00007964104,0.000023553977,0.018302243,0.00019345632,0.00033917613,0.000077219454],"about_ca_topic_score_codex":0.00038996767,"about_ca_topic_score_gemma":0.000068277855,"teacher_disagreement_score":0.14197354,"about_ca_system_score_codex":0.001516932,"about_ca_system_score_gemma":0.00094011886,"threshold_uncertainty_score":0.5829804},"labels":[],"label_agreement":null},{"id":"W2889751375","doi":"10.1200/jco.2017.35.15_suppl.5547","title":"Mirvetuximab soravtansine (IMGN853), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in platinum-resistant epithelial ovarian cancer (EOC) patients (pts): Activity and safety analyses in phase I pooled expansion cohorts.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Ovarian cancer; Population; Folate receptor; Oncology; Nausea; Phases of clinical research; Dosing; Clinical trial; Cancer; Gastroenterology; Cancer cell","score_opus":0.08919688874973307,"score_gpt":0.4818670002204941,"score_spread":0.39267011147076103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889751375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875269,0.0011010036,0.000034233035,0.009022107,0.0013568351,0.00063034566,0.00013355746,0.000009036857,0.00018596672],"genre_scores_gemma":[0.9916763,0.0056455065,0.0013965215,0.0005058825,0.0006523097,0.000015922958,0.000027107026,0.00003501696,0.000045466062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99471366,0.00075975165,0.0029864016,0.00054860674,0.0005048062,0.00048675996],"domain_scores_gemma":[0.99384695,0.0013438402,0.0035085552,0.00039584484,0.00041540232,0.00048937945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033925045,0.00035349687,0.0029188192,0.00027291547,0.00019871592,0.000056432673,0.00021934419,0.0004132311,0.00019575784],"category_scores_gemma":[0.0029564288,0.00026081936,0.0003779151,0.0001606704,0.00029432453,0.00040769347,0.00013098677,0.0011609787,0.0000046024647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050084107,0.011358494,0.6290061,0.00008865769,0.0010748655,0.0018307039,0.00047706554,0.00003742502,0.018397033,0.000018598714,0.0006270182,0.28699994],"study_design_scores_gemma":[0.07956569,0.008230483,0.9034937,0.0010048581,0.00076068885,0.00001894492,0.000065384425,0.00051652855,0.0016217745,0.000077621095,0.004393981,0.00025033124],"about_ca_topic_score_codex":0.0030094506,"about_ca_topic_score_gemma":0.00292993,"teacher_disagreement_score":0.2867496,"about_ca_system_score_codex":0.0006148386,"about_ca_system_score_gemma":0.0013719514,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W2890218253","doi":"10.1200/jco.2018.36.15_suppl.e17522","title":"Utility of PETCT over conventional imaging in ovarian cancer.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Surgery","score_opus":0.14091089615241048,"score_gpt":0.5202413171159773,"score_spread":0.37933042096356684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890218253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968147,0.00085491576,0.00011165723,0.018303398,0.0021979674,0.00014590527,0.000010622657,0.0000027454507,0.010225785],"genre_scores_gemma":[0.99512,0.00046779026,0.0014259693,0.0014508852,0.0014369944,0.0000027413455,0.0000010487857,0.0000066944353,0.000087867236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974948,0.00020166468,0.0017617369,0.00014096843,0.00025246805,0.00014831679],"domain_scores_gemma":[0.997417,0.0007497841,0.0011175127,0.00013250609,0.00040347036,0.00017973185],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019715065,0.000079828205,0.0009440639,0.00009405456,0.000015482236,0.0000028062925,0.000082366096,0.0001251829,0.003312054],"category_scores_gemma":[0.0008438555,0.000057618534,0.00035065433,0.00011170829,0.0003095612,0.00006918168,0.000029682653,0.00036647904,0.00000786864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019597062,0.0019989219,0.89674956,0.000016998845,0.00018410177,0.00025328636,0.000038208524,5.623612e-7,0.00004774267,0.0004042702,0.006244524,0.092102125],"study_design_scores_gemma":[0.010621936,0.00276739,0.9415233,0.00018859933,0.0002032744,0.000083410705,0.000027361033,0.00011827964,0.00019488578,0.0006476156,0.04358384,0.000040085168],"about_ca_topic_score_codex":0.0002415818,"about_ca_topic_score_gemma":0.00030831384,"teacher_disagreement_score":0.09206204,"about_ca_system_score_codex":0.00012631707,"about_ca_system_score_gemma":0.002043926,"threshold_uncertainty_score":0.99759907},"labels":[],"label_agreement":null},{"id":"W2890272870","doi":"10.1016/j.radcr.2018.08.003","title":"Magnetic resonance imaging findings in ovarian torsion post in vitro fertilization","year":2018,"lang":"en","type":"article","venue":"Radiology Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Ovarian torsion; Medicine; Ovarian hyperstimulation syndrome; Magnetic resonance imaging; Abdominal pain; Infertility; In vitro fertilisation; Nausea; Vomiting; Radiology; Pregnancy; Surgery","score_opus":0.009034841537112634,"score_gpt":0.263414862335951,"score_spread":0.25438002079883837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890272870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226886,0.004483328,0.000019807374,0.0013344297,0.000387487,0.00041135596,0.0000033928184,0.00002452164,0.0010668366],"genre_scores_gemma":[0.9985468,0.000099394434,0.0005341295,0.00048306808,0.00014668345,0.000056160323,0.000042215965,0.000017790237,0.00007379048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866736,0.00006255681,0.00042771906,0.00043874633,0.000089247085,0.0003143754],"domain_scores_gemma":[0.9994028,0.000042111213,0.00008067746,0.00031982578,0.000074607306,0.000079979225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033247832,0.00013551101,0.00029841735,0.00023551607,0.00006089093,0.00000826174,0.00001746052,0.000099412486,0.00016047624],"category_scores_gemma":[0.0001786486,0.00012282023,0.000042655214,0.00027277393,0.00008913701,0.00006665556,0.00002625977,0.00011838842,0.000010309919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003572991,0.00021195196,0.6568593,0.000022979952,0.0000064729056,0.31180477,0.00062351703,0.0000013499802,0.01239032,0.0000385511,0.0003901567,0.017293325],"study_design_scores_gemma":[0.0019014936,0.00046599534,0.77334523,0.00019404286,0.00004512273,0.20931798,0.00011241903,0.00034649644,0.011394138,0.00008800917,0.0026367542,0.00015232901],"about_ca_topic_score_codex":0.0010762302,"about_ca_topic_score_gemma":0.0005030634,"teacher_disagreement_score":0.11648592,"about_ca_system_score_codex":0.00041497115,"about_ca_system_score_gemma":0.00012871748,"threshold_uncertainty_score":0.5008464},"labels":[],"label_agreement":null},{"id":"W2890449437","doi":"10.1200/jco.2017.35.15_suppl.tps5607","title":"FORWARD I (GOG 3011): A randomized phase 3 study to evaluate the safety and efficacy of mirvetuximab soravtansine (IMGN853) versus chemotherapy in adults with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian cancer (EOC), primary peritoneal cancer, or primary fallopian tube cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Topotecan; Oncology; Clinical endpoint; Phases of clinical research; Chemotherapy; Chemotherapy regimen; Carboplatin; Interim analysis; Clinical trial; Adverse effect; Cisplatin","score_opus":0.05741997394984657,"score_gpt":0.44167065880726075,"score_spread":0.3842506848574142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890449437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95767283,0.0024933617,0.000035869645,0.033600915,0.0016176355,0.003918661,0.00027417194,0.000010219573,0.00037632234],"genre_scores_gemma":[0.97503006,0.019124076,0.002053223,0.0018310788,0.0014417447,0.00028345577,0.00001245075,0.000069908616,0.0001540128],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936737,0.0011534104,0.003146297,0.0006365344,0.0008762746,0.0005138165],"domain_scores_gemma":[0.9915175,0.0039053853,0.0026658834,0.00060874585,0.00075888063,0.000543604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004897913,0.0004877857,0.0046651736,0.00016115968,0.00026469462,0.000051877352,0.00044742948,0.0002821246,0.0003198838],"category_scores_gemma":[0.0013977996,0.00025924385,0.0004971585,0.00021116751,0.00068000343,0.00020061116,0.00013299903,0.0009530828,0.0000013527798],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7378252,0.007423805,0.012391726,0.00010019693,0.003912647,0.00045530006,0.0021095492,0.000034743847,0.00023861324,0.000014619691,0.0002646149,0.23522897],"study_design_scores_gemma":[0.5958279,0.043524396,0.35324028,0.001514463,0.0023197487,0.000029739816,0.00021733493,0.000093715375,0.00014742323,0.000007876609,0.0028482117,0.00022895033],"about_ca_topic_score_codex":0.0049217613,"about_ca_topic_score_gemma":0.010095225,"teacher_disagreement_score":0.34084857,"about_ca_system_score_codex":0.0011685812,"about_ca_system_score_gemma":0.005652854,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W2890785873","doi":"10.1200/jco.2017.35.15_suppl.5506","title":"Overall survival results of ICON6: A trial of chemotherapy and cediranib in relapsed ovarian cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Placebo; Clinical endpoint; Chemotherapy; Ovarian cancer; Log-rank test; Oncology; Survival analysis; Surgery; Randomized controlled trial; Cancer; Confidence interval; Pathology","score_opus":0.1606985941140904,"score_gpt":0.49588457906669337,"score_spread":0.335185984952603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890785873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655836,0.00037410064,0.000003453554,0.027587576,0.001819776,0.00029789,0.000017485021,0.0000015729994,0.0043145125],"genre_scores_gemma":[0.9924762,0.005077382,0.0008345465,0.0003985742,0.0010667689,0.0000043764067,7.885091e-7,0.00001072859,0.0001305941],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99669254,0.00023490733,0.0024660255,0.00017726583,0.00028430772,0.00014493628],"domain_scores_gemma":[0.9942279,0.0014837257,0.0035308865,0.0003261328,0.00024682548,0.0001845729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034694476,0.00010986329,0.0018872677,0.00008599367,0.00002533038,0.0000064082237,0.0001546689,0.00031687977,0.000063562264],"category_scores_gemma":[0.0031143161,0.00007676422,0.00032243744,0.00003936306,0.00026606288,0.00006089436,0.000033745582,0.00045989893,4.0296587e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50211215,0.006472278,0.23154226,0.00007469054,0.0010893428,0.00046910316,0.00032325395,0.000006862315,0.00025289351,0.0005598676,0.00195242,0.25514486],"study_design_scores_gemma":[0.3346093,0.018751469,0.6368999,0.00026537175,0.00023233933,0.000018136905,0.000020668731,0.00001648301,0.00022790136,0.00039177563,0.008518252,0.000048440703],"about_ca_topic_score_codex":0.00076272717,"about_ca_topic_score_gemma":0.0004742679,"teacher_disagreement_score":0.40535763,"about_ca_system_score_codex":0.00010307099,"about_ca_system_score_gemma":0.0013842128,"threshold_uncertainty_score":0.37283522},"labels":[],"label_agreement":null},{"id":"W2891080378","doi":"10.1200/jco.2017.35.15_suppl.e17076","title":"Performance of preoperative plasma HE4 and CA-125 levels in predicting ovarian cancer mortality in women with epithelial ovarian cancer (EOC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Cohort; Internal medicine; Receiver operating characteristic; Oncology; Biomarker; Ovarian cancer; Debulking; Cancer; Youden's J statistic","score_opus":0.115120202585895,"score_gpt":0.45080555876250455,"score_spread":0.33568535617660955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891080378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196637,0.00025415848,0.000003396998,0.005671616,0.00063405297,0.00037952315,0.000056271187,0.0000028696868,0.0010317347],"genre_scores_gemma":[0.99537915,0.0026154793,0.0007492811,0.00040482776,0.0006774224,0.00007689624,6.1142276e-7,0.000016666438,0.000079686004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970255,0.00024535184,0.0017770191,0.00029440635,0.00032456446,0.0003331642],"domain_scores_gemma":[0.9966642,0.00056563184,0.0019177329,0.00028804847,0.00027377007,0.00029057972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025343315,0.00019004468,0.0016704546,0.00012256425,0.00008261687,0.00001971142,0.00017915208,0.0002843883,0.00021560292],"category_scores_gemma":[0.0007016494,0.00012630415,0.00009421703,0.00010078386,0.00036374654,0.00029341024,0.00007416623,0.0008384051,8.3025003e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061837304,0.0010270559,0.9173049,0.000085594664,0.0005717124,0.0004020676,0.0012160186,0.00024157103,0.000051189796,0.000022958404,0.000036541303,0.07285671],"study_design_scores_gemma":[0.021192947,0.0076029073,0.9676537,0.0010700154,0.00025730525,0.00006242363,0.00019459898,0.0009065821,0.00025346776,0.00003166125,0.0006628617,0.00011151348],"about_ca_topic_score_codex":0.0037658024,"about_ca_topic_score_gemma":0.010319657,"teacher_disagreement_score":0.0727452,"about_ca_system_score_codex":0.00062323984,"about_ca_system_score_gemma":0.0031947396,"threshold_uncertainty_score":0.57586104},"labels":[],"label_agreement":null},{"id":"W2891144912","doi":"10.1200/jco.2018.36.15_suppl.5561","title":"Tumor molecular profiling to differentiate extreme responses to first-line platinum-based chemotherapy in suboptimally debulked serous ovarian cancer patients.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Institute of Cancer Research; Ontario Institute for Cancer Research; Ottawa Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Carboplatin; Medicine; Serous fluid; Oncology; Internal medicine; Ovarian cancer; Debulking; Chemotherapy; Olaparib; Exome; Exome sequencing; Cancer; Cancer research; Mutation; Cisplatin; Gene; Biology; Genetics","score_opus":0.10834185372273678,"score_gpt":0.43558367804775394,"score_spread":0.32724182432501714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891144912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659946,0.00010556704,0.0007871901,0.03123655,0.0008971814,0.0007534287,0.000014859215,0.000013097258,0.00019754139],"genre_scores_gemma":[0.96122664,0.00007198717,0.019855846,0.01785915,0.00080527505,0.000059856015,0.000004194475,0.00004058945,0.00007648174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648213,0.00028484376,0.002054624,0.00037041417,0.00041843503,0.00038954784],"domain_scores_gemma":[0.99661463,0.0009310312,0.0008606588,0.00026890158,0.00071067765,0.00061409886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001287907,0.00023593147,0.0014026992,0.0002906987,0.000046612848,0.000017083816,0.00019096998,0.00021244194,0.00038301648],"category_scores_gemma":[0.0019314784,0.00017348772,0.00031665657,0.000333425,0.00008404401,0.00005291353,0.00004701421,0.00045722618,0.000030986987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0467356,0.007364717,0.8435741,0.000045359604,0.00048467368,0.0013049503,0.0002626457,0.00033986024,0.0010605706,0.0000337973,0.001371366,0.097422324],"study_design_scores_gemma":[0.025378358,0.032790925,0.9238384,0.0004902425,0.00023886736,0.000020895035,0.000013878496,0.00033994473,0.0055541093,0.00006046788,0.011085807,0.00018811716],"about_ca_topic_score_codex":0.00012594774,"about_ca_topic_score_gemma":0.0006718551,"teacher_disagreement_score":0.09723421,"about_ca_system_score_codex":0.000536127,"about_ca_system_score_gemma":0.0016198673,"threshold_uncertainty_score":0.7074624},"labels":[],"label_agreement":null},{"id":"W2891436279","doi":"10.1200/jco.2017.35.15_suppl.5553","title":"Safety findings from FORWARD II: A Phase 1b study evaluating the folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) mirvetuximab soravtansine (IMGN853) in combination with bevacizumab, carboplatin, pegylated liposomal doxorubicin (PLD), or pembrolizumab in patients (pts) with ovarian cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Bevacizumab; Neutropenia; Internal medicine; Adverse effect; Phases of clinical research; Pembrolizumab; Dosing; Oncology; Gastroenterology; Pharmacology; Chemotherapy; Cancer; Cisplatin; Immunotherapy","score_opus":0.07562984281282185,"score_gpt":0.46037880139180154,"score_spread":0.38474895857897967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891436279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858262,0.0002610609,0.000023418686,0.010562448,0.00088835193,0.0022082187,0.000067691486,0.000016631966,0.00014595992],"genre_scores_gemma":[0.9968699,0.00036994182,0.0015973267,0.0004565425,0.00043060386,0.000063898806,0.000069080714,0.0000667617,0.000075936216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99298954,0.0011494105,0.0034986248,0.0006861717,0.001065741,0.0006105243],"domain_scores_gemma":[0.991873,0.00196825,0.0042034416,0.000595394,0.0010026074,0.00035730575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047760196,0.0004861914,0.0026261515,0.00025063913,0.000535473,0.00009906879,0.00047278134,0.00033767708,0.00021398693],"category_scores_gemma":[0.0027502994,0.00026964277,0.0002539738,0.00035072566,0.0002891232,0.00047870216,0.0001673089,0.0017191482,0.000004636248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12801903,0.022066055,0.76384014,0.00003223738,0.001416623,0.0010186903,0.002986924,0.000110712645,0.00016559793,0.000013006083,0.00019087493,0.080140084],"study_design_scores_gemma":[0.24091443,0.08724163,0.66590035,0.0011327703,0.0011545437,0.000032579028,0.00057460886,0.0023440563,0.000091133144,0.000042557902,0.00031628448,0.00025508547],"about_ca_topic_score_codex":0.004673832,"about_ca_topic_score_gemma":0.009164442,"teacher_disagreement_score":0.1128954,"about_ca_system_score_codex":0.0011876251,"about_ca_system_score_gemma":0.002758173,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W2891822390","doi":"10.1200/jco.2017.35.15_suppl.e17049","title":"Survival outcomes in patients with platinum-resistant (PL-R) ovarian cancer (OC): The Princess Margaret Cancer Centre (PM) experience.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Ovarian cancer; Confidence interval; Oncology; Cancer; Proportional hazards model; Clinical trial; Gynecology; Surgery","score_opus":0.09802903731853926,"score_gpt":0.45625268877028374,"score_spread":0.3582236514517445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891822390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478711,0.00024124702,0.000004394148,0.04736776,0.0025108382,0.00041381034,0.000029124516,0.000004852816,0.0015569032],"genre_scores_gemma":[0.99644935,0.0006730689,0.00033252058,0.0013740045,0.0007469297,0.00003919807,0.0000019542279,0.000021682976,0.00036129713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968845,0.00026336208,0.001575396,0.0002893766,0.0006334207,0.0003539377],"domain_scores_gemma":[0.9955021,0.0009191068,0.002347409,0.00051611295,0.00040724373,0.000307999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011105144,0.0002164467,0.0015603085,0.000059885188,0.00017782237,0.000048142814,0.00043800464,0.00022913962,0.00060937385],"category_scores_gemma":[0.0008873325,0.000104188664,0.0002443371,0.000071984476,0.0003635788,0.00018173442,0.00009961526,0.0007323331,0.0000042392485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004461894,0.0019076335,0.9456387,0.000014454519,0.0005705775,0.00032569995,0.000414776,0.0000119775395,0.000001091339,0.0001450868,0.00072667084,0.04578141],"study_design_scores_gemma":[0.019001804,0.0027542126,0.9495617,0.0002998655,0.0003179074,0.000003875149,0.00020312871,0.000007749741,0.000011838343,0.000047041012,0.027673844,0.0001170406],"about_ca_topic_score_codex":0.0020113934,"about_ca_topic_score_gemma":0.010917185,"teacher_disagreement_score":0.048578274,"about_ca_system_score_codex":0.00048345613,"about_ca_system_score_gemma":0.0017455762,"threshold_uncertainty_score":0.6672216},"labels":[],"label_agreement":null},{"id":"W2892089631","doi":"10.1016/j.jpedsurg.2018.08.058","title":"Ovarian masses in the child and adolescent: An American Pediatric Surgical Association Outcomes and Evidence-Based Practice Committee systematic review","year":2018,"lang":"en","type":"review","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Association (psychology); Family medicine; General surgery; Pediatrics; Psychotherapist","score_opus":0.061463545657581456,"score_gpt":0.36623290563110505,"score_spread":0.3047693599735236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892089631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019765056,0.99115294,0.0000019511863,0.006620089,0.00040036472,0.0015676088,0.000013419684,0.00001036023,0.000035620087],"genre_scores_gemma":[0.0010770629,0.9927455,0.00013166414,0.0019489402,0.0039390866,0.00009317059,0.000011816512,0.000043861513,0.0000088784545],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99248135,0.0032101271,0.0024389268,0.00037684088,0.0011551039,0.00033767207],"domain_scores_gemma":[0.9752096,0.017483918,0.006150819,0.0004872647,0.0003977925,0.00027061193],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010078387,0.0005024441,0.0048797852,0.00079552125,0.00010421032,0.0001455492,0.00020807698,0.00020813172,0.000016753078],"category_scores_gemma":[0.0092699705,0.00027306227,0.0008293962,0.0013273978,0.000049605438,0.00040153266,0.00003886967,0.0008821588,0.0000071833288],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053467236,0.0009522155,0.23132603,0.7347805,0.00052799785,0.00097474625,0.00003703995,6.847958e-8,2.4426472e-10,0.000004596892,0.017592106,0.013751214],"study_design_scores_gemma":[0.0017697505,0.0010102021,0.043930605,0.6875937,0.1169808,0.0033846262,0.00014894304,0.000002085511,1.4026005e-8,0.000005675723,0.14439523,0.0007783756],"about_ca_topic_score_codex":0.000026502215,"about_ca_topic_score_gemma":0.000003286014,"teacher_disagreement_score":0.18739542,"about_ca_system_score_codex":0.0005124882,"about_ca_system_score_gemma":0.0010924293,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W2892187731","doi":"10.1158/1940-6207.capr-18-0009","title":"Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study","year":2018,"lang":"en","type":"article","venue":"Cancer Prevention Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation","keywords":"Ovarian cancer; Fallopian tube; Medicine; Multicenter study; Gynecology; Cancer; Oncology; Internal medicine; Obstetrics; Randomized controlled trial","score_opus":0.09180778565651103,"score_gpt":0.4492406857045393,"score_spread":0.35743290004802825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892187731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017,0.0006173891,0.000063339496,0.0034468723,0.0004228239,0.0046541584,0.00015529411,0.000034394277,0.00043573446],"genre_scores_gemma":[0.97569245,0.0013977347,0.00029603182,0.00015160827,0.00064436236,0.0131514035,0.000021320624,0.000043724933,0.008601377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972414,0.0003626815,0.00038073058,0.0006741237,0.00057266763,0.00076839677],"domain_scores_gemma":[0.99844915,0.0001689562,0.000087302484,0.00051177485,0.0004957547,0.0002870489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013720646,0.00018081653,0.00036947124,0.00034281748,0.00038741456,0.000045833953,0.00016894934,0.000099900826,0.003464412],"category_scores_gemma":[0.00012521338,0.00015408518,0.000104480045,0.0005820924,0.00014386931,0.00009461303,0.00016172395,0.0003056909,0.00007030603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003298382,0.0035372751,0.8355253,0.00016941171,0.00061697746,0.00003598855,0.0052753715,0.000020998237,0.00020651912,0.00017965304,0.009080057,0.14205408],"study_design_scores_gemma":[0.01673632,0.0030098385,0.9393492,0.00050578103,0.00012446301,9.997099e-7,0.0014333891,0.0002837703,0.0010029443,0.00041388042,0.036967497,0.00017191407],"about_ca_topic_score_codex":0.0090095885,"about_ca_topic_score_gemma":0.024013245,"teacher_disagreement_score":0.14188217,"about_ca_system_score_codex":0.0030300096,"about_ca_system_score_gemma":0.0005628901,"threshold_uncertainty_score":0.9975895},"labels":[],"label_agreement":null},{"id":"W2892202359","doi":"10.1200/jco.2018.36.15_suppl.5576","title":"Progression free survival (PFS) as a surrogate endpoint for overall survival (OS) in first-line advanced ovarian cancer (AOC) therapy: A Gynecologic Cancer InterGroup individual (GCIG) patient-level (IPD) analysis of multiple randomized trials.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; BC Cancer Agency","funders":"","keywords":"Medicine; Surrogate endpoint; Clinical endpoint; Progression-free survival; Internal medicine; Randomized controlled trial; Oncology; Clinical trial; Overall survival","score_opus":0.2564612880490028,"score_gpt":0.5040262150334156,"score_spread":0.2475649269844128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892202359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97414875,0.0028216224,0.0006985791,0.013879446,0.0049732593,0.0027611358,0.00052908965,0.000016927124,0.00017116925],"genre_scores_gemma":[0.9799144,0.010216588,0.006344091,0.0013253395,0.0013956251,0.00065725273,0.000056690882,0.000043922897,0.00004608967],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98834884,0.0031233465,0.006438759,0.0006142375,0.0009073398,0.00056745275],"domain_scores_gemma":[0.96334547,0.027404891,0.0068768812,0.00050771283,0.0014044761,0.0004605549],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017477086,0.0004447167,0.008387282,0.00065217965,0.00008704601,0.000024232746,0.00043377632,0.0006628932,0.0014537009],"category_scores_gemma":[0.029900972,0.00027419606,0.0028264537,0.0006751156,0.00049369136,0.00018040382,0.00017336727,0.00077492534,0.00000229072],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4198123,0.0068271514,0.16184084,0.00005516572,0.01503557,0.00014497773,0.0008061733,0.00033678653,0.00008022062,0.00014732638,0.0005277338,0.39438576],"study_design_scores_gemma":[0.5275798,0.024026945,0.42725876,0.00052570883,0.00802683,0.0000073294154,0.00015786856,0.0015145628,0.00058764603,0.0009610742,0.009062725,0.00029075408],"about_ca_topic_score_codex":0.0015546815,"about_ca_topic_score_gemma":0.024752386,"teacher_disagreement_score":0.394095,"about_ca_system_score_codex":0.0006254471,"about_ca_system_score_gemma":0.0023024878,"threshold_uncertainty_score":0.99997103},"labels":[],"label_agreement":null},{"id":"W2892215224","doi":"10.1200/jco.2016.34.15_suppl.5509","title":"Integration of somatic molecular profiling for rare epithelial gynaecologic cancer patients.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; KRAS; Serous fluid; Internal medicine; Oncology; Neuroblastoma RAS viral oncogene homolog; HRAS; Gynecology; Cancer; Pathology","score_opus":0.10776116559958537,"score_gpt":0.46327436090044927,"score_spread":0.3555131953008639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892215224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708457,0.00028223425,0.0018703877,0.008486523,0.0014606393,0.00048683575,0.000027696517,0.0000039882784,0.00029715043],"genre_scores_gemma":[0.9879067,0.00047230805,0.0103745945,0.00070470583,0.0004270688,0.000044737168,0.0000028169336,0.00001058447,0.000056477133],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977995,0.00014357123,0.0016082549,0.00012415607,0.00019117583,0.00013331158],"domain_scores_gemma":[0.99568385,0.0017431072,0.0016048015,0.00010352175,0.00072854833,0.00013618478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009273229,0.000090864545,0.0009536312,0.00006745922,0.000016242719,0.0000022831482,0.000075729215,0.00020783252,0.00018219149],"category_scores_gemma":[0.0037122555,0.000044681772,0.00043610614,0.00005266096,0.00008467462,0.000061292405,0.000015946527,0.00015124834,0.0000032453238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020365147,0.0029983402,0.23663576,0.00007107491,0.0005342507,0.00005628968,0.000041573327,0.0000052564374,0.0044715274,0.00057143107,0.0007048977,0.7518731],"study_design_scores_gemma":[0.04012145,0.051181052,0.8391456,0.0007068085,0.0016580306,0.000022602118,0.000067488545,0.00007709806,0.052763876,0.0039390204,0.010167618,0.00014937186],"about_ca_topic_score_codex":0.0000056622375,"about_ca_topic_score_gemma":0.0000106816315,"teacher_disagreement_score":0.7517237,"about_ca_system_score_codex":0.0002513077,"about_ca_system_score_gemma":0.0010117295,"threshold_uncertainty_score":0.4444185},"labels":[],"label_agreement":null},{"id":"W2893187680","doi":"10.1097/pas.0000000000001160","title":"FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Grading (engineering); Oncology; Ovarian cancer; Internal medicine; Gynecology; Nuclear atypia; Stage (stratigraphy); Atypia; Multivariate analysis; Ovarian carcinoma; Cancer; Pathology; Biology","score_opus":0.028496814193540367,"score_gpt":0.30263581338598805,"score_spread":0.27413899919244766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893187680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909021,0.002024689,0.000038187463,0.0036467665,0.0009560081,0.0001465279,0.000004578042,0.0000068368013,0.0022742755],"genre_scores_gemma":[0.99794984,0.000569095,0.00025008956,0.0001895395,0.0009781887,0.000008193956,0.0000011635727,0.000016577313,0.00003729591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983777,0.00032951304,0.000522927,0.00017802091,0.0002625446,0.0003292979],"domain_scores_gemma":[0.9981163,0.0008204144,0.000473162,0.00026800347,0.00014671484,0.00017541455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075903966,0.00014922443,0.00075361715,0.00030184793,0.00006242069,0.000015424228,0.00017069334,0.000043516706,0.000102956845],"category_scores_gemma":[0.00012070659,0.00008833643,0.00018019332,0.0006947258,0.00058127556,0.00004669398,0.000039059818,0.00033271252,0.000032940843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040610224,0.0024684595,0.6823863,0.00008213606,0.0014862287,0.09112713,0.0041238777,0.00014504745,0.0051942714,0.007971069,0.0031579803,0.16124727],"study_design_scores_gemma":[0.04374293,0.041135192,0.79588604,0.00045321675,0.0009337357,0.04857748,0.0032636153,0.00016146169,0.0018009624,0.00031921762,0.06318611,0.0005400393],"about_ca_topic_score_codex":0.00024964073,"about_ca_topic_score_gemma":0.000009156259,"teacher_disagreement_score":0.16070722,"about_ca_system_score_codex":0.00022283384,"about_ca_system_score_gemma":0.00012576912,"threshold_uncertainty_score":0.3602255},"labels":[],"label_agreement":null},{"id":"W2895100627","doi":"10.5858/arpa.2017-0272-rs","title":"Signet Ring Stromal Cell Tumor: A Legitimate (Benign) Mimic of Krukenberg Tumor","year":2018,"lang":"en","type":"review","venue":"Archives of Pathology & Laboratory Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Krukenberg tumor; Stromal tumor; Stromal cell; Pathology; Signet ring cell; Malignancy; Immunohistochemistry; GiST; Differential diagnosis; Neoplasm; Cancer; Metastasis; Adenocarcinoma; Internal medicine","score_opus":0.026914292171901995,"score_gpt":0.31679959194513485,"score_spread":0.28988529977323285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895100627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005456798,0.9854981,0.000039715058,0.0001254036,0.0005793959,0.0013543285,0.00086834177,0.000059740483,0.0060181986],"genre_scores_gemma":[0.0073735043,0.98768085,0.0028116282,0.00027759487,0.00092257775,0.00024571054,0.0003804135,0.00015462951,0.00015308017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99566287,0.00061824394,0.0017314524,0.00094500784,0.00042755838,0.0006148599],"domain_scores_gemma":[0.9956427,0.0009624687,0.0016338051,0.0012272599,0.00019046712,0.00034329918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005831673,0.00080523436,0.004664143,0.0007193116,0.00007042201,0.000004073544,0.00041623393,0.00020758485,0.00042251145],"category_scores_gemma":[0.0002505145,0.0005841402,0.0005222919,0.0004990436,0.0019244035,0.00005567862,0.0001798284,0.0005760983,0.000043664964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002060112,0.008800128,0.0068616406,0.36533743,0.008199713,0.05084944,0.009231347,0.000006499129,0.01243275,0.0047928807,0.023796927,0.5076311],"study_design_scores_gemma":[0.009058339,0.010978585,0.0019875858,0.086524054,0.014129017,0.0016340395,0.00040085934,0.000015821717,0.0019694087,0.00021943574,0.8720839,0.000998946],"about_ca_topic_score_codex":0.000041671254,"about_ca_topic_score_gemma":0.000012798765,"teacher_disagreement_score":0.848287,"about_ca_system_score_codex":0.000100617865,"about_ca_system_score_gemma":0.0013997538,"threshold_uncertainty_score":0.999661},"labels":[],"label_agreement":null},{"id":"W2895224490","doi":"10.1097/pas.0000000000001153","title":"Uterine Tumor Resembling Ovarian Sex Cord Tumor","year":2018,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; University of Toronto","funders":"National Cancer Institute","keywords":"Immunophenotyping; Endometrial stromal sarcoma; Biology; Pathology; Sarcoma; Ovary; Stromal cell; Cancer research; Medicine; Antigen; Immunology; Endocrinology","score_opus":0.027759390708188444,"score_gpt":0.33766020967784544,"score_spread":0.309900818969657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895224490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818419,0.00025585218,0.00016294248,0.014711314,0.00036065796,0.00012099217,0.0000051158527,0.000016684671,0.0025244993],"genre_scores_gemma":[0.9934588,0.00024407438,0.0018680084,0.0024679455,0.0016837437,0.000005227942,0.0000010382134,0.000024113779,0.00024701297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998387,0.00026946716,0.0005244322,0.00019889792,0.00027838603,0.00034184376],"domain_scores_gemma":[0.99827754,0.00030069164,0.0005952971,0.00035304137,0.00023818323,0.00023526094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007915339,0.00016659316,0.000745226,0.0001370263,0.000106257976,0.000017946486,0.00020918858,0.000021109667,0.00047010835],"category_scores_gemma":[0.00007286582,0.00009280544,0.00021347823,0.0003480528,0.00096068956,0.000045856465,0.000074352254,0.00034919663,0.00006916045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039354138,0.003442062,0.1995609,0.00009091514,0.0018955278,0.20687161,0.0023313444,0.000026219182,0.01095122,0.0045586517,0.013375825,0.5175416],"study_design_scores_gemma":[0.012375379,0.04857283,0.3209583,0.0003582801,0.00075147697,0.21054286,0.0013268073,0.000117798045,0.005293386,0.0014017203,0.39780012,0.000501064],"about_ca_topic_score_codex":0.00006153194,"about_ca_topic_score_gemma":0.000004476147,"teacher_disagreement_score":0.5170405,"about_ca_system_score_codex":0.00008372457,"about_ca_system_score_gemma":0.0001818112,"threshold_uncertainty_score":0.5147357},"labels":[],"label_agreement":null},{"id":"W2896587001","doi":"10.1016/j.jogc.2018.05.031","title":"Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Stage (stratigraphy); Proportional hazards model; Chemotherapy; Ovarian cancer; Internal medicine; Oncology; Retrospective cohort study; Serous fluid; Surgery; Cancer; Confidence interval","score_opus":0.012164089011095839,"score_gpt":0.27053240489542646,"score_spread":0.2583683158843306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896587001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856098,0.004024757,0.0000044988437,0.0038392022,0.0059707654,0.0002856256,0.00008353039,0.0000045701686,0.00017721798],"genre_scores_gemma":[0.9954206,0.00258056,0.0006293418,0.000897739,0.00014563063,0.000021110309,0.000004434709,0.000026480273,0.00027410136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834067,0.00004904914,0.00061537744,0.0002467495,0.0003237924,0.00042439118],"domain_scores_gemma":[0.99759114,0.0010939408,0.00047458045,0.00014795295,0.00035289815,0.00033951353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026597411,0.00022630485,0.0007425425,0.00031423662,0.00009800321,0.000021593776,0.000092302675,0.00013101168,0.002203751],"category_scores_gemma":[0.00061648316,0.00013112814,0.00014390548,0.00041699308,0.00009550625,0.000085565225,0.000032758424,0.00023044825,0.0000010018006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013405693,0.00021260553,0.8333207,0.00003173431,0.00032983872,0.002750301,0.00011267728,0.00004232581,0.00008544683,0.000009923336,0.0013849776,0.16158545],"study_design_scores_gemma":[0.005570345,0.0010559385,0.9673522,0.00004618508,0.000115915056,0.00006520598,0.00005449231,0.0000748319,0.0015538727,0.000016806594,0.023930721,0.00016348339],"about_ca_topic_score_codex":0.039806005,"about_ca_topic_score_gemma":0.16429257,"teacher_disagreement_score":0.16142195,"about_ca_system_score_codex":0.0036748655,"about_ca_system_score_gemma":0.0034680702,"threshold_uncertainty_score":0.99870837},"labels":[],"label_agreement":null},{"id":"W2896823394","doi":"10.1503/cmaj.180499","title":"Diagnosing ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Bloating; Asymptomatic; Medicine; Ovarian cancer; Abdominal pain; Pelvic pain; Pelvic examination; Urinary urgency; Urinary system; Gynecology; Cancer; Internal medicine; Pathology; Surgery; Alternative medicine","score_opus":0.012421586228612514,"score_gpt":0.28474646736907455,"score_spread":0.27232488114046205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896823394","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3685932,0.0019401242,0.00013753073,0.57219535,0.006942583,0.0004157505,0.00006924356,0.000071623894,0.049634594],"genre_scores_gemma":[0.94944394,0.0006805925,0.00028706974,0.0387064,0.009904272,0.000023691304,0.0000061724045,0.000022922146,0.0009249531],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997982,0.00006239912,0.0003093004,0.00016616017,0.0009923012,0.0004877976],"domain_scores_gemma":[0.9970382,0.00009165372,0.00013721752,0.000109043984,0.0005063196,0.0021175998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000690843,0.00011335731,0.00023366917,0.00015376379,0.00033307416,0.000085191394,0.00009282925,0.00026930173,0.02513176],"category_scores_gemma":[0.0007503889,0.00009554766,0.00010479121,0.00024116672,0.000050261733,0.00008466776,0.00000908225,0.0005066245,0.00042399866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011023255,0.000057975092,0.55329144,0.000004927754,0.00026818548,0.0007012013,0.0002078133,2.718214e-7,0.0000052535315,0.0003281416,0.28664503,0.15847877],"study_design_scores_gemma":[0.001586926,0.00013319911,0.32287398,0.00019026463,0.00009189629,0.00037714612,0.00006159876,0.000060507067,0.00008797768,0.0000730173,0.67436874,0.000094743096],"about_ca_topic_score_codex":0.009906826,"about_ca_topic_score_gemma":0.07586355,"teacher_disagreement_score":0.5808507,"about_ca_system_score_codex":0.0024750356,"about_ca_system_score_gemma":0.0049363477,"threshold_uncertainty_score":0.9966863},"labels":[],"label_agreement":null},{"id":"W2897207534","doi":"10.1111/his.13755","title":"Expanding the morphological spectrum of ovarian microcystic stromal tumour","year":2018,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Toronto; McGill University; University Health Network; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Pathology; Ovary; Biology; Medicine; Internal medicine","score_opus":0.02102288348949923,"score_gpt":0.2791579215180241,"score_spread":0.2581350380285249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897207534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866732,0.0005062207,0.00055548566,0.0040384377,0.00051993,0.00022316503,0.000010957924,0.00003313731,0.0074394806],"genre_scores_gemma":[0.99726987,0.000022684751,0.0012653036,0.000545292,0.00042978014,0.000027292812,0.0000064836377,0.000012739219,0.00042056743],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99910456,0.00006605005,0.00022628912,0.00025592843,0.00010355707,0.00024361334],"domain_scores_gemma":[0.9994171,0.00006451788,0.00009878429,0.0003145634,0.000041669464,0.00006334119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017090746,0.00011805367,0.00029941738,0.00006417468,0.000100921134,0.00000433589,0.000100405625,0.00008006225,0.0007959376],"category_scores_gemma":[0.00005338067,0.0000735359,0.000091102134,0.00010820475,0.00043644605,0.00001561244,0.000049234797,0.00012412167,0.00011448801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013511481,0.0015107744,0.2955001,0.00009537468,0.00007784311,0.00587127,0.002503637,0.000002446559,0.65969497,0.017841132,0.0124265645,0.003124721],"study_design_scores_gemma":[0.0016769759,0.0021253494,0.9630704,0.000041064715,0.00020718607,0.0032024353,0.000100189216,0.000009443943,0.02293149,0.0006859784,0.005851292,0.00009818671],"about_ca_topic_score_codex":0.00005437637,"about_ca_topic_score_gemma":0.000018494513,"teacher_disagreement_score":0.6675703,"about_ca_system_score_codex":0.00012422589,"about_ca_system_score_gemma":0.0000685266,"threshold_uncertainty_score":0.87149584},"labels":[],"label_agreement":null},{"id":"W2897586029","doi":"10.21840/siic/154295","title":"Fenocopias de Brugada: Avances en su reconocimiento y abordaje","year":2018,"lang":"es","type":"report","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Humanities; Art","score_opus":0.03749666189444843,"score_gpt":0.3446579170312114,"score_spread":0.30716125513676296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897586029","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031694513,0.05588862,0.00017177945,0.008666644,0.011423342,0.0030707815,0.00036722157,0.00035452194,0.8883626],"genre_scores_gemma":[0.12771924,0.3025946,0.008410152,0.0031297966,0.023820449,0.0011990063,0.0009169852,0.00046784236,0.5317419],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507797,0.00017495644,0.001205886,0.0014570832,0.00093058863,0.001153502],"domain_scores_gemma":[0.9961746,0.0005188871,0.0007082104,0.0013063836,0.00061921036,0.00067272777],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001130275,0.0009665543,0.0018066488,0.00031191797,0.00022131503,0.00022720905,0.0003847868,0.0008828145,0.019488003],"category_scores_gemma":[0.00032937742,0.00076390285,0.0007808344,0.0002978684,0.0002681529,0.00016200276,0.00015401667,0.0005749919,0.002753054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021013571,0.0013802347,0.18824434,0.001843989,0.0053007463,0.0011211273,0.0011361697,0.0000026987084,0.000022413684,0.0015744682,0.6647908,0.13437286],"study_design_scores_gemma":[0.0021448722,0.0013334624,0.072900444,0.0027845863,0.002271173,0.0003129972,0.0003285346,0.000009537362,0.00093883794,0.00024620906,0.9160313,0.0006980647],"about_ca_topic_score_codex":0.009612558,"about_ca_topic_score_gemma":0.001697063,"teacher_disagreement_score":0.35662064,"about_ca_system_score_codex":0.0034252082,"about_ca_system_score_gemma":0.005259207,"threshold_uncertainty_score":0.9994812},"labels":[],"label_agreement":null},{"id":"W2898519404","doi":"10.1186/s12885-018-4970-9","title":"Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stornoway Diamond (Canada); Vancouver General Hospital; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Surgical oncology; Ovarian cancer; Demography; Gynecology; Oncology; Term (time); Population; Gerontology; Internal medicine; Obstetrics; Cancer; Environmental health","score_opus":0.017610938422961266,"score_gpt":0.28326093337655306,"score_spread":0.2656499949535918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898519404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972972,0.00017751787,0.000008654728,0.00014534163,0.00042143732,0.0015205191,0.00029249367,0.00003500119,0.00010182755],"genre_scores_gemma":[0.9959463,0.000019444547,0.000048944497,0.000509558,0.0005608862,0.0022821552,0.000034117715,0.000042426374,0.00055618753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809706,0.00006258153,0.00033773103,0.000547786,0.000491207,0.00046365953],"domain_scores_gemma":[0.9990274,0.000035331606,0.00013866599,0.00040473425,0.00014579446,0.0002481187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014148327,0.00017066396,0.00046427565,0.000042964566,0.00013281578,0.00011176003,0.00009557292,0.000060760685,0.0027673948],"category_scores_gemma":[0.00001495849,0.00021021649,0.000036077672,0.00035386323,0.00006667209,0.000075837066,0.000021430142,0.00012761724,0.0000018898622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001936558,0.00057407614,0.99237263,0.00007908688,0.0002255866,0.0003021192,0.00021264801,0.0000706195,0.0000018533707,3.4977631e-7,0.0003931253,0.005574253],"study_design_scores_gemma":[0.007193659,0.00054100703,0.99103826,0.00046437586,0.00019301803,0.0000036686713,0.00013674301,0.000054552387,0.000015727432,0.0000029539976,0.00011548691,0.00024051606],"about_ca_topic_score_codex":0.99861884,"about_ca_topic_score_gemma":0.99998266,"teacher_disagreement_score":0.007000003,"about_ca_system_score_codex":0.003499162,"about_ca_system_score_gemma":0.0037789273,"threshold_uncertainty_score":0.9981442},"labels":[],"label_agreement":null},{"id":"W2898602366","doi":"10.1093/annonc/mdy285.157","title":"Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant ovarian cancer (PROC): Initial results of an expansion cohort from FORWARD II, a phase Ib study","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Internal medicine; Ovarian cancer; Oncology; Response Evaluation Criteria in Solid Tumors; Adverse effect; Cohort; Interquartile range; Cancer; Phases of clinical research; Immunotherapy; Chemotherapy","score_opus":0.04508941207630825,"score_gpt":0.41096888463374603,"score_spread":0.3658794725574378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898602366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925293,0.00056009594,0.00002295302,0.0026149002,0.00030222986,0.0019764537,0.0010224921,0.000042359086,0.0009292243],"genre_scores_gemma":[0.9962146,0.00030954208,0.0017709055,0.00048149045,0.00041131477,0.00019337978,0.0005067788,0.000061194136,0.000050790688],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962908,0.00035035802,0.0013740477,0.0008800244,0.00051938306,0.00058536266],"domain_scores_gemma":[0.99717927,0.00024341946,0.00089646596,0.00060229347,0.00080878736,0.00026973922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093196804,0.0004189231,0.0015593853,0.00030452246,0.00014322494,0.000015544778,0.00020087289,0.00022170633,0.00030331005],"category_scores_gemma":[0.0001716068,0.0003339402,0.000120240846,0.0004693475,0.00030457677,0.00023823266,0.00010173526,0.000288867,0.0000056871195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42844942,0.07040174,0.12863699,0.00037468597,0.006246426,0.0032142093,0.046514183,0.00007840452,0.13655049,0.00013583049,0.011912601,0.16748501],"study_design_scores_gemma":[0.28145343,0.25851968,0.25983027,0.0028582108,0.0021684663,0.000055740973,0.004963768,0.001777789,0.17194861,0.00033720426,0.014784346,0.0013024877],"about_ca_topic_score_codex":0.018795686,"about_ca_topic_score_gemma":0.011299425,"teacher_disagreement_score":0.18811794,"about_ca_system_score_codex":0.00018815033,"about_ca_system_score_gemma":0.0010623295,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W2898695473","doi":"10.1016/j.jogc.2018.01.028","title":"Treatment Tolerance and Side Effects of Intraperitoneal Carboplatin and Dose-Dense Intravenous Paclitaxel in Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Carboplatin; Chemotherapy; Paclitaxel; Ovarian cancer; Neutropenia; Taxane; Surgery; Internal medicine; Urology; Gastroenterology; Cancer; Cisplatin; Breast cancer","score_opus":0.008553919139020146,"score_gpt":0.24286926350609173,"score_spread":0.23431534436707158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898695473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682953,0.028401373,0.0000019001376,0.0009401154,0.0018661348,0.00023017239,0.000014697129,0.0000012119729,0.00024909756],"genre_scores_gemma":[0.9955091,0.003815994,0.0003167458,0.0002469406,0.00007077126,0.000010714316,7.182796e-7,0.000010364985,0.000018675846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906117,0.000044498374,0.0003816463,0.00016316939,0.00014708276,0.00020244536],"domain_scores_gemma":[0.9983261,0.0010140615,0.000231612,0.00009016483,0.00013386263,0.00020416363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008028372,0.00014639348,0.0005566519,0.00016775346,0.00004758701,0.00001037551,0.000029485987,0.00009291267,0.00002573159],"category_scores_gemma":[0.00034266568,0.000110717374,0.000027595992,0.00018447176,0.00012816695,0.00003422719,0.00001721698,0.00013197133,5.421627e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008749754,0.00033625666,0.52311546,0.00019997664,0.00038351893,0.0054327287,0.00103647,0.000006811122,0.00032886284,0.00013267774,0.000079768804,0.46885997],"study_design_scores_gemma":[0.008325937,0.0036146613,0.9849768,0.000057587557,0.00023671865,0.00020320092,0.00013598714,0.00006542568,0.0011965123,0.000068464506,0.0010251483,0.00009353866],"about_ca_topic_score_codex":0.06944598,"about_ca_topic_score_gemma":0.1000858,"teacher_disagreement_score":0.46876642,"about_ca_system_score_codex":0.0008077458,"about_ca_system_score_gemma":0.0010217802,"threshold_uncertainty_score":0.93675065},"labels":[],"label_agreement":null},{"id":"W2900291138","doi":"10.1016/j.hoc.2018.07.008","title":"Targeting Angiogenesis","year":2018,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Intas Pharmaceuticals","keywords":"Medicine; Angiogenesis; Ovarian cancer; Epithelial ovarian cancer; Gynecologic cancer; Cytotoxic T cell; Adverse effect; Oncology; Perforation; Gastrointestinal perforation; Internal medicine; Cancer; Pharmacology; Cancer research; Biology; Peritonitis","score_opus":0.0650274454269281,"score_gpt":0.40619535786896155,"score_spread":0.3411679124420335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900291138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015921758,0.9959316,0.00005128468,0.00027478475,0.0009395216,0.0013006302,0.00016723348,0.00008482952,0.001090885],"genre_scores_gemma":[0.00007998545,0.9904321,0.007037024,0.0006154133,0.0004839581,0.00041703248,0.0007155137,0.00011156823,0.00010743804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955199,0.0003688513,0.00225577,0.0009797391,0.00024160254,0.0006341555],"domain_scores_gemma":[0.99421984,0.001768566,0.0024120465,0.0009707306,0.00032237553,0.000306471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033184807,0.0006703582,0.006743397,0.00037536537,0.00009806748,0.000005056837,0.0003582687,0.0008924457,0.00039418752],"category_scores_gemma":[0.0005520273,0.0005259438,0.0016218346,0.00069959374,0.00088207494,0.000032312822,0.00021983823,0.0005178662,0.00074200367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068014866,0.0010740509,0.013272945,0.009052831,0.0023089976,0.00053231965,0.000036415222,3.4214565e-7,9.978545e-9,0.00004265721,0.022020353,0.9515911],"study_design_scores_gemma":[0.0008597043,0.0021307892,0.0002432948,0.0033507647,0.006728957,0.0005559301,0.000017729824,0.0000045458246,5.1745286e-7,0.000013809372,0.98575014,0.0003438122],"about_ca_topic_score_codex":0.000019848874,"about_ca_topic_score_gemma":0.000020110247,"teacher_disagreement_score":0.9637298,"about_ca_system_score_codex":0.00026581567,"about_ca_system_score_gemma":0.0021321862,"threshold_uncertainty_score":0.9997192},"labels":[],"label_agreement":null},{"id":"W2900298813","doi":"10.1016/s1470-2045(18)30566-7","title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Medical Research Council; Wellbeing of Women; Mauritius Research Council; Cancer Research UK","keywords":"Debulking; Medicine; Stage (stratigraphy); Chemotherapy; Oncology; Clinical trial; Randomized controlled trial; Surgery; Ovarian cancer; Internal medicine; Gynecologic oncology; Cancer","score_opus":0.1755971065629348,"score_gpt":0.4055934884821742,"score_spread":0.22999638191923938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900298813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778238,0.0036059876,0.00002445971,0.01603197,0.00070825167,0.0006633793,0.00058056344,0.00001958451,0.00054199534],"genre_scores_gemma":[0.992218,0.0030533972,0.0006493392,0.0027722446,0.0008387547,0.000087887944,0.00035739224,0.000017807557,0.000005168142],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976491,0.0006047118,0.0006719351,0.00045329565,0.00027309562,0.0003478675],"domain_scores_gemma":[0.9939649,0.004239971,0.0004915494,0.0011647859,0.00006888839,0.00006991114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024067047,0.00019391597,0.0016695305,0.00013771385,0.00008877761,0.000022554626,0.00037620525,0.00011683715,0.0003839256],"category_scores_gemma":[0.000613143,0.00010623219,0.00012927958,0.0006159989,0.00026485726,0.00006637078,0.00018779491,0.00019603247,0.000004082961],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0135622,0.0004799005,0.2235754,0.000017233688,0.0137559865,0.000077254525,0.005757094,0.000060428825,0.0003757474,0.00018930866,0.008363437,0.733786],"study_design_scores_gemma":[0.01589875,0.0012339127,0.9333803,0.00014546589,0.007151503,0.0000060874036,0.000926195,0.0006279738,0.0008394663,0.00015422201,0.039455365,0.00018074334],"about_ca_topic_score_codex":0.003950125,"about_ca_topic_score_gemma":0.009416049,"teacher_disagreement_score":0.73360527,"about_ca_system_score_codex":0.00028466753,"about_ca_system_score_gemma":0.00045038064,"threshold_uncertainty_score":0.5971434},"labels":[],"label_agreement":null},{"id":"W2900952118","doi":"10.1097/pgp.0000000000000564","title":"Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem","year":2018,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Mucinous carcinoma; Carcinoma; Pathology; Ovarian carcinoma; Mucinous Tumor; Mucinous cystadenocarcinoma; Medicine; Tissue microarray; Ovarian cancer; Ovary; Adenocarcinoma; Cancer; Immunohistochemistry; Oncology; Internal medicine","score_opus":0.07496598113448928,"score_gpt":0.3849746986240931,"score_spread":0.31000871748960385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900952118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014148987,0.9741967,0.000071929666,0.0011428415,0.0044541075,0.0013751865,0.00012976956,0.000047779748,0.004432755],"genre_scores_gemma":[0.0636395,0.92748433,0.0043307724,0.0010058826,0.0028117509,0.00015723049,0.0002539533,0.000087834545,0.00022872788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948973,0.0007591292,0.0021145977,0.0008091126,0.0008493747,0.0005705044],"domain_scores_gemma":[0.99367154,0.0018298287,0.0020455914,0.0004744902,0.0013921866,0.0005863666],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001033357,0.00070232677,0.003315148,0.0011626431,0.00009345791,0.00009350596,0.00095862546,0.00098509,0.0028299422],"category_scores_gemma":[0.0018539837,0.00047215435,0.0014767366,0.0003859616,0.00031431572,0.00016409541,0.00021794255,0.0011255774,0.00034172036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073542324,0.004977649,0.0048633544,0.0009156896,0.00248254,0.07129427,0.00017155518,8.6948256e-7,0.0000060700154,0.0007262556,0.0029983674,0.91082793],"study_design_scores_gemma":[0.01097863,0.0154117,0.012446066,0.0026208232,0.004344726,0.05638746,0.000061078965,0.0000035311475,0.0000209722,0.0019933786,0.89506936,0.0006622725],"about_ca_topic_score_codex":0.00006393795,"about_ca_topic_score_gemma":0.000028976503,"teacher_disagreement_score":0.91016567,"about_ca_system_score_codex":0.0014080447,"about_ca_system_score_gemma":0.0018542493,"threshold_uncertainty_score":0.999773},"labels":[],"label_agreement":null},{"id":"W2901022488","doi":"10.1016/j.ygyno.2018.08.036","title":"Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Princess Margaret Cancer Centre; University Health Network","funders":"Medical Research Council; National Cancer Research Institute; Cancer Research UK; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bevacizumab; Carboplatin; Paclitaxel; Oncology; Ovarian cancer; Internal medicine; Stage (stratigraphy); Outcome (game theory); Chemotherapy; Cancer; Cisplatin","score_opus":0.16791034337082325,"score_gpt":0.45109152124661667,"score_spread":0.28318117787579344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901022488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988223,0.00026480682,0.000054446173,0.0059182514,0.00021576979,0.0033515615,0.00013126238,0.00002149126,0.00016019918],"genre_scores_gemma":[0.9922753,0.0001711079,0.0022919062,0.0021256246,0.00032502552,0.0026379377,0.000010365924,0.00002114321,0.00014157646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982369,0.00024622565,0.0004861714,0.00049167045,0.00017675922,0.00036230066],"domain_scores_gemma":[0.99689233,0.0022157235,0.00023377212,0.00033014768,0.000116229625,0.00021179236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006096359,0.0002388435,0.00087694905,0.00017078397,0.00011992039,0.000023039885,0.00011256961,0.00013723153,0.0001452877],"category_scores_gemma":[0.0011866948,0.0001189776,0.000052984462,0.000283718,0.00026026976,0.00007624238,0.00007059472,0.00013094915,0.0000013392399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15840417,0.0014599485,0.79956967,0.00019577709,0.00039268014,0.0007311909,0.0037562642,0.000025059513,0.00011707985,0.0002794616,0.00056481967,0.034503877],"study_design_scores_gemma":[0.14689894,0.046636246,0.78954583,0.00014242333,0.0013351656,0.000016287167,0.009464586,0.00013362581,0.00016026052,0.000109019835,0.005240151,0.00031747707],"about_ca_topic_score_codex":0.00076561613,"about_ca_topic_score_gemma":0.01690494,"teacher_disagreement_score":0.045176297,"about_ca_system_score_codex":0.0002891439,"about_ca_system_score_gemma":0.000928003,"threshold_uncertainty_score":0.94333535},"labels":[],"label_agreement":null},{"id":"W2901826333","doi":"","title":"Prognosis of patients resected for ovarian metastases of colorectal cancer","year":2010,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Univariate analysis; Colorectal cancer; Hysterectomy; Pathological; Metastasis; Surgery; Stage (stratigraphy); Ovarian cancer; Oncology; Internal medicine; Cancer; Multivariate analysis","score_opus":0.019670315922566423,"score_gpt":0.27452982419449,"score_spread":0.2548595082719236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901826333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98275703,0.001085701,0.0022387642,0.0050329533,0.0003622095,0.0026218349,0.002536046,0.000070208494,0.003295264],"genre_scores_gemma":[0.9480963,0.0005480565,0.048065353,0.000030107452,0.000023086908,0.0009475171,0.001817267,0.00005035307,0.00042197533],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705803,0.00093475776,0.0007032687,0.0006042629,0.00043309628,0.00026657607],"domain_scores_gemma":[0.9918719,0.0010599956,0.0009096113,0.0011052443,0.0048899264,0.00016335436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015828388,0.0002968925,0.0007589231,0.00021774518,0.00010121173,0.00004288728,0.0004177732,0.00031358938,0.00025620588],"category_scores_gemma":[0.0014100384,0.0002734431,0.00038068183,0.00029374205,0.00024408146,0.000048626374,0.0004318872,0.00039012494,0.0000016413072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014730128,0.020255769,0.7267474,0.005792715,0.004110634,0.000007840351,0.010718364,0.00005025858,0.026804494,0.03284881,0.005868995,0.16532172],"study_design_scores_gemma":[0.004098328,0.000010374797,0.28588587,0.0036743772,0.00097439473,0.0000014650254,0.00003919109,0.0010158595,0.6981247,0.00071001885,0.005150615,0.00031480627],"about_ca_topic_score_codex":0.0030609816,"about_ca_topic_score_gemma":0.0028551533,"teacher_disagreement_score":0.6713202,"about_ca_system_score_codex":0.00013160078,"about_ca_system_score_gemma":0.00070411054,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W2903251703","doi":"10.14740/jmc.v9i12.3196","title":"Laparoscopic Management of a Rare Case of Mature Cystic Teratoma With Immature Neural Tissue and Literature Review","year":2018,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian torsion; Mature Cystic Teratoma; Ovarian Teratoma; Adverse effect; Gynecology; General surgery; Teratoma; Surgery; Internal medicine","score_opus":0.011761281056166915,"score_gpt":0.31860068078685005,"score_spread":0.30683939973068314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903251703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7374652,0.25269523,0.000013628219,0.009147891,0.00019007719,0.00033353097,0.00003630734,0.000004925258,0.000113242466],"genre_scores_gemma":[0.967223,0.030196305,0.0013143606,0.00085101294,0.00032779574,0.0000055589203,0.000005724579,0.000012028242,0.000064218635],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99860364,0.00005588216,0.0004665922,0.00012809393,0.00062028394,0.00012552537],"domain_scores_gemma":[0.99881786,0.0000979549,0.0003435488,0.00018607902,0.00029067398,0.00026387285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025012856,0.00014546701,0.00063240214,0.00008013442,0.000027039876,0.000012835556,0.0000756784,0.00010955371,0.00031997016],"category_scores_gemma":[0.000111297086,0.00007828658,0.00007355111,0.00023485134,0.00015483885,0.000063951054,0.00003491756,0.00029217973,6.996125e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027935419,0.0011658684,0.004514338,0.03995094,0.0014643808,0.83100426,0.0009432404,3.82394e-7,0.00011407788,0.00040139136,0.04592854,0.071719036],"study_design_scores_gemma":[0.0112356255,0.013593711,0.017895477,0.22444601,0.0041383365,0.70809466,0.00063126057,0.000024119727,0.0034501113,0.000043513184,0.016207,0.00024020873],"about_ca_topic_score_codex":0.00000879695,"about_ca_topic_score_gemma":0.000010230561,"teacher_disagreement_score":0.22975782,"about_ca_system_score_codex":0.000024937535,"about_ca_system_score_gemma":0.00009384835,"threshold_uncertainty_score":0.3503449},"labels":[],"label_agreement":null},{"id":"W2903693885","doi":"10.1016/j.diii.2018.11.007","title":"Ovarian cancer: An update on imaging in the era of radiomics","year":2018,"lang":"en","type":"review","venue":"Diagnostic and Interventional Imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Radiomics; Radiogenomics; Medicine; Ovarian cancer; Magnetic resonance imaging; Ovarian tumor; Tumor heterogeneity; Radiology; Biopsy; Cancer; Internal medicine","score_opus":0.036758504768422726,"score_gpt":0.37091744735430604,"score_spread":0.3341589425858833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903693885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031311068,0.99617696,0.00005858916,0.0017353045,0.0003602092,0.0007057278,0.00021132121,0.00001250206,0.00042625947],"genre_scores_gemma":[0.010178291,0.9877243,0.00018573194,0.0007067855,0.00042831973,0.00032788207,0.00038534624,0.0000410372,0.00002227875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819875,0.00017016575,0.0006791311,0.0004588945,0.0002514376,0.00024164164],"domain_scores_gemma":[0.99847454,0.00068847154,0.00031708827,0.00035564287,0.000078026416,0.000086203196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004495338,0.0003269869,0.000901676,0.00020311706,0.00006666746,0.00006741339,0.00018780706,0.000054490356,0.00023373429],"category_scores_gemma":[0.0001804175,0.00021626068,0.00042936264,0.00019055465,0.00016581752,0.00012204899,0.000055918186,0.00036386677,0.000017013392],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017973616,0.00070584577,0.007968152,0.0028280907,0.00017706456,0.00015878702,0.00010176715,5.162324e-7,4.2696474e-8,0.0027223811,0.0030511024,0.9822683],"study_design_scores_gemma":[0.0023817387,0.0004276544,0.026344787,0.13225885,0.0028608916,0.00048534977,0.00012794837,0.00020436935,0.0000035013816,0.0008002522,0.83364046,0.00046420176],"about_ca_topic_score_codex":0.00034331623,"about_ca_topic_score_gemma":0.0000268045,"teacher_disagreement_score":0.9818041,"about_ca_system_score_codex":0.0001793375,"about_ca_system_score_gemma":0.00019090569,"threshold_uncertainty_score":0.88188547},"labels":[],"label_agreement":null},{"id":"W2904573490","doi":"10.1016/j.jogc.2018.05.004","title":"Two Cases of Hypercalcemia in Pediatric Ovarian Dysgerminoma","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Dysgerminoma; Parathyroid hormone; Gynecology; Ovary; Internal medicine; Calcium","score_opus":0.01648662420030802,"score_gpt":0.2610465115072021,"score_spread":0.24455988730689407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904573490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924065,0.0048630713,0.0000020419493,0.00049070077,0.0033424678,0.000089780355,0.00001027246,0.0000010868414,0.0019599085],"genre_scores_gemma":[0.9986115,0.00043007004,0.0004896913,0.0002916023,0.00012385694,0.0000016866753,0.0000010281512,0.000007941712,0.000042636162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990013,0.000030551215,0.00047349167,0.00011118829,0.00020233222,0.00018109736],"domain_scores_gemma":[0.99796337,0.0011782978,0.0002925611,0.000108020235,0.00028725713,0.00017050719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148466,0.000097707314,0.0004108915,0.00032970565,0.000031412703,0.0000052774813,0.000060613766,0.000069592956,0.0003690433],"category_scores_gemma":[0.0012769202,0.000077044315,0.00004701837,0.0004280887,0.00005771476,0.00003610554,0.000022581435,0.00015934679,6.1332133e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015046143,0.00016241205,0.9576663,0.000036137,0.00006083396,0.0070045264,0.00005049029,0.0000023339912,0.000005494952,0.00013557544,0.0011015267,0.033759326],"study_design_scores_gemma":[0.004293493,0.0012853554,0.99101347,0.000008288678,0.0001967646,0.00039870525,0.000078354395,0.000013831621,0.00013989239,0.000056684636,0.0024501549,0.00006498649],"about_ca_topic_score_codex":0.023796134,"about_ca_topic_score_gemma":0.058032226,"teacher_disagreement_score":0.034236092,"about_ca_system_score_codex":0.0006858788,"about_ca_system_score_gemma":0.0021753577,"threshold_uncertainty_score":0.9827045},"labels":[],"label_agreement":null},{"id":"W2904882484","doi":"10.1093/jncics/pky061","title":"Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol","year":2018,"lang":"en","type":"article","venue":"JNCI Cancer Spectrum","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Serous carcinoma; Medicine; Salpingectomy; Serous fluid; Gynecology; Population; Fallopian tube; Medical diagnosis; Ovarian cancer; Obstetrics; Pathology; Cancer; Internal medicine; Pregnancy","score_opus":0.05185376780744552,"score_gpt":0.42530461292637406,"score_spread":0.37345084511892856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904882484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729978,0.00011944312,0.000110417226,0.0019713892,0.00087120675,0.022038205,0.00002792706,0.00003270417,0.0018309436],"genre_scores_gemma":[0.9855084,0.000023836146,0.0045381538,0.00044202962,0.0024321866,0.006971441,0.000006821527,0.000033016546,0.00004411806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979142,0.00012775559,0.00085381605,0.00043047755,0.00032922582,0.00034452643],"domain_scores_gemma":[0.9988493,0.00009171809,0.0004042234,0.00038620792,0.00013152148,0.00013707204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044407096,0.0002022913,0.0005428791,0.00012424489,0.000054874425,0.000017045066,0.00008687567,0.00015439013,0.00053444074],"category_scores_gemma":[0.00022822667,0.00017249177,0.000121538935,0.00034562385,0.00010925822,0.00018644739,0.00003673154,0.0002587831,0.00002309603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012268076,0.0008161442,0.9869745,0.00011546781,0.00009224195,0.000110812914,0.00029421778,0.000008845183,0.0002840442,0.00049676874,0.00032954366,0.0092506055],"study_design_scores_gemma":[0.0050306194,0.0016197518,0.98635614,0.00029900193,0.00024159804,0.00006514477,0.000048315927,0.0008088809,0.0028812625,0.00039118514,0.002082123,0.00017595418],"about_ca_topic_score_codex":0.025295671,"about_ca_topic_score_gemma":0.0031549511,"teacher_disagreement_score":0.022140719,"about_ca_system_score_codex":0.0008596607,"about_ca_system_score_gemma":0.000568594,"threshold_uncertainty_score":0.981195},"labels":[],"label_agreement":null},{"id":"W2905030636","doi":"10.14288/1.0372092","title":"Incidence, survival and mortality among women with epithelial ovarian cancer by histotype : a population study in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"cIRcle (University of British Columbia)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Ovarian cancer; Demography; Medicine; Population; Epithelial ovarian cancer; Gynecology; Cancer; Oncology; Environmental health; Internal medicine","score_opus":0.007398924719748577,"score_gpt":0.1990113416238576,"score_spread":0.19161241690410905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905030636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998221,0.00012519228,0.0000043283926,0.00006389094,0.00014736052,0.00073677726,0.0004566172,0.00002259294,0.00022227278],"genre_scores_gemma":[0.99910295,0.000094169234,0.000038776387,0.000044714656,0.00005114054,0.000010556724,0.00003228565,0.00001736116,0.00060806464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855715,0.000072330746,0.00017002084,0.0005027587,0.00040107215,0.00029665572],"domain_scores_gemma":[0.99920964,0.000023364782,0.00013353086,0.00022925028,0.00018734977,0.0002168331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019741357,0.000056905068,0.00044204772,0.000025037716,0.00021827825,0.000117446456,0.000100777535,0.000074290045,0.00036969085],"category_scores_gemma":[0.000014648248,0.00020070052,0.00002497803,0.00031832102,0.0002514867,0.0002055979,0.00005933471,0.000120577344,6.0809083e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045754405,0.00039785609,0.911872,0.000044143897,0.00015414694,0.00071262446,0.00030672605,6.632486e-7,0.000005565395,5.559251e-8,0.0013503253,0.08511013],"study_design_scores_gemma":[0.004672828,0.00070249266,0.9912899,0.0002897463,0.00014901398,0.000031428022,0.0025069811,0.000021943115,1.15196954e-7,0.000015082889,0.0001278372,0.0001926118],"about_ca_topic_score_codex":0.9998488,"about_ca_topic_score_gemma":0.9999943,"teacher_disagreement_score":0.084917516,"about_ca_system_score_codex":0.0010550529,"about_ca_system_score_gemma":0.0005645608,"threshold_uncertainty_score":0.818433},"labels":[],"label_agreement":null},{"id":"W2905490220","doi":"10.1002/ijc.32075","title":"Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium","year":2018,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Institute on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; Instituto de Salud Carlos III; National Health and Medical Research Council; World Cancer Research Fund; National Institutes of Health; Institut Gustave-Roussy; Medical Research Council; Medical Research Council Canada; Mutuelle Générale de l'Education Nationale; U.S. Department of Defense; Associazione Italiana per la Ricerca sul Cancro; NordForsk; Vetenskapsrådet; Cancerfonden; Institut National de la Santé et de la Recherche Médicale; Cancer Research UK; World Health Organization; European Commission; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; National Institute of Environmental Health Sciences; Hellenic Health Foundation; Kræftens Bekæmpelse; Centre International de Recherche sur le Cancer; Cancer Council Victoria; Deutsche Krebshilfe; VicHealth; World Cancer Research Fund International; National Cancer Institute; Office of Dietary Supplements","keywords":"Ovarian cancer; Medicine; Cohort; Oncology; Cancer; Internal medicine; Cohort study; Gynecology; Ovary","score_opus":0.015266440870886645,"score_gpt":0.33459773624314004,"score_spread":0.3193312953722534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905490220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97321403,0.009477427,0.00058743084,0.009790402,0.003787056,0.00027018515,0.0026641218,0.000019178475,0.00019015798],"genre_scores_gemma":[0.9860789,0.0067428453,0.00015684131,0.0023520084,0.0042519197,0.00010761851,0.000083003266,0.000038684193,0.00018814944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725336,0.00014717614,0.0007466671,0.00040298924,0.001153955,0.00029582536],"domain_scores_gemma":[0.996191,0.00020904919,0.0013271633,0.00036439754,0.0016021789,0.00030619773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030725656,0.00030226656,0.0006547266,0.00022183379,0.00016740945,0.00015086544,0.00056269177,0.000095282,0.009576071],"category_scores_gemma":[0.00009444494,0.00018762605,0.00043158766,0.00037662737,0.00023650134,0.0003037932,0.00005623659,0.0003712656,0.000008962367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000747125,0.00028711784,0.9588957,0.0000030337656,0.019210113,0.0001088062,0.0005870442,0.0004120091,0.00038158862,0.000047369107,0.008165739,0.011154399],"study_design_scores_gemma":[0.003000579,0.00020548978,0.94307613,0.00033929164,0.0071991086,0.000016356938,0.000194134,0.0004991848,0.0057762954,0.00012591691,0.039359983,0.00020752868],"about_ca_topic_score_codex":0.07332322,"about_ca_topic_score_gemma":0.01137757,"teacher_disagreement_score":0.061945654,"about_ca_system_score_codex":0.0010728873,"about_ca_system_score_gemma":0.0009410034,"threshold_uncertainty_score":0.9913293},"labels":[],"label_agreement":null},{"id":"W2905520899","doi":"10.1038/s41571-018-0147-3","title":"Advances in prediction for ovarian cancer treatment stratification","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Modalities; Ovarian cancer; Treatment modality; Intensive care medicine; Risk stratification; Consolidation (business); Oncology; Stratification (seeds); Medical physics; Internal medicine; Cancer","score_opus":0.23252689184304717,"score_gpt":0.5767472291325556,"score_spread":0.3442203372895084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905520899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.6871344e-7,0.9832073,0.000037884183,0.0012781208,0.0031095755,0.009691815,0.00027845238,0.000035789242,0.0023605933],"genre_scores_gemma":[0.0000029748576,0.979444,0.002806688,0.00051404786,0.004282672,0.011445659,0.0009966338,0.000059149916,0.00044815365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945431,0.0007572542,0.0029941618,0.0011632863,0.00016617157,0.0003760796],"domain_scores_gemma":[0.99575377,0.0015467681,0.0015749383,0.00072154443,0.000166299,0.00023670799],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016524661,0.0005828697,0.005932171,0.0001833811,0.0000584945,0.0000141459495,0.00016837505,0.0026998285,0.00018526403],"category_scores_gemma":[0.0008447377,0.00035057004,0.0017093478,0.00041134824,0.00013134193,0.000088877416,0.000023137865,0.0010662482,0.00009334558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011213676,0.0015480495,0.00028153212,0.0092552835,0.00028835304,0.000015183704,0.000009592967,6.2734095e-8,1.1644244e-8,0.00039693643,0.006225071,0.9818678],"study_design_scores_gemma":[0.002924736,0.004717539,0.00029485952,0.020573657,0.0054967985,0.0000261841,0.000001878188,0.000004590022,1.8435927e-7,0.00010376706,0.9656397,0.00021611528],"about_ca_topic_score_codex":0.000017213344,"about_ca_topic_score_gemma":0.0005809767,"teacher_disagreement_score":0.98165166,"about_ca_system_score_codex":0.0023589828,"about_ca_system_score_gemma":0.0023710162,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W2905764767","doi":"10.5306/wjco.v9.i8.167","title":"Malignant peritoneal effusion acting as a tumor environment in ovarian cancer progression: Impact and significance","year":2018,"lang":"en","type":"editorial","venue":"World Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ovarian cancer; Medicine; Tumor progression; Peritoneal cavity; Stromal cell; Ascites; Cancer; Context (archaeology); Cancer research; Tumor microenvironment; Disease; Pathology; Tumor cells; Internal medicine; Biology","score_opus":0.045991403625469135,"score_gpt":0.4650959327050907,"score_spread":0.4191045290796216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905764767","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.083711915,0.015092952,0.000010948898,0.018123113,0.87823546,0.0018187657,0.0001022794,0.000018947183,0.002885626],"genre_scores_gemma":[0.090553366,0.023304632,0.0027784703,0.00058215356,0.8813569,0.00013073733,0.000024574068,0.000097616896,0.0011715565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99448705,0.000617588,0.0027668094,0.0006530606,0.000963189,0.0005122853],"domain_scores_gemma":[0.99201614,0.003543225,0.003141588,0.00033579086,0.00025870904,0.0007045789],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033507613,0.0004533,0.0028209307,0.00033499207,0.000085723674,0.000036218582,0.00021746018,0.00079071743,0.0013468555],"category_scores_gemma":[0.0015970044,0.00029756528,0.00058628386,0.00019007863,0.0004005573,0.00009168526,0.00015758518,0.002614575,0.000022310956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013176672,0.0035922548,0.057702653,0.00020865985,0.0010246541,0.009281268,0.00023242256,0.000008854483,0.00008665259,0.000008199468,0.6167544,0.29792333],"study_design_scores_gemma":[0.011579022,0.013825694,0.037807126,0.0033506171,0.00083888124,0.00020067558,0.00004014838,0.0000129352675,0.00006105224,0.00007234149,0.9319584,0.00025312108],"about_ca_topic_score_codex":0.00032705392,"about_ca_topic_score_gemma":0.0004195432,"teacher_disagreement_score":0.315204,"about_ca_system_score_codex":0.0015594404,"about_ca_system_score_gemma":0.0055729626,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W2908365730","doi":"10.1016/j.gore.2018.12.009","title":"Synchronous carcinomas of endometrium and ovary: A pragmatic approach","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Endometrium; Medicine; Ovary; Gynecology; Oncology; Internal medicine","score_opus":0.01783721361690087,"score_gpt":0.2953303634785409,"score_spread":0.27749314986164003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908365730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9229983,0.0017210603,0.00011103942,0.0009015197,0.0005172772,0.0010903329,0.0000056377407,0.00006213138,0.07259271],"genre_scores_gemma":[0.9882606,0.00012548969,0.01054396,0.00038802327,0.00016983206,0.00021602961,0.000026529691,0.000015213876,0.00025430103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837923,0.000092571936,0.0005701959,0.00048008305,0.00016772212,0.0003102055],"domain_scores_gemma":[0.9983575,0.00040023157,0.00045497972,0.00045232268,0.00017273138,0.00016225701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006051788,0.00018204062,0.00077357946,0.00019152735,0.000079434576,0.000006498658,0.000044939694,0.00023778847,0.00040209037],"category_scores_gemma":[0.0006522693,0.00013541496,0.00009116222,0.00029216963,0.0004637293,0.00004145041,0.000087366345,0.00013468415,0.000009384489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013383322,0.0031927263,0.9434387,0.00031634094,0.00062532816,0.004947228,0.0007174511,0.0000019026762,0.0007058022,0.000491629,0.0045675077,0.04086153],"study_design_scores_gemma":[0.0030117265,0.011330961,0.95065206,0.00004375652,0.0008131523,0.010582027,0.00026561663,0.00007815439,0.0017017857,0.0007019348,0.02065027,0.0001685614],"about_ca_topic_score_codex":0.00009450313,"about_ca_topic_score_gemma":0.000025930889,"teacher_disagreement_score":0.07233841,"about_ca_system_score_codex":0.0003190894,"about_ca_system_score_gemma":0.0005178882,"threshold_uncertainty_score":0.5522062},"labels":[],"label_agreement":null},{"id":"W2908583831","doi":"10.1200/jco.2013.31.15_suppl.5517","title":"A multicenter phase II study of bevacizumab (B) and temsirolimus (T) in women with recurrent epithelial ovarian cancer (OC): A study of the Mayo, Chicago, California, New York, Southeast, and Princess Margaret Phase II Consortia.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Temsirolimus; Neutropenia; Internal medicine; Gastroenterology; Adverse effect; Phases of clinical research; Cancer; Hypokalemia; Tolerability; Bevacizumab; Toxicity; Surgery; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.07515892749311999,"score_gpt":0.41698013271736123,"score_spread":0.34182120522424125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908583831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209493,0.0005129868,0.000003853401,0.0047735614,0.0003357815,0.0021762224,0.000052630094,0.0000033697727,0.000046682464],"genre_scores_gemma":[0.9987771,0.00024610516,0.00016703118,0.00032844546,0.00029673334,0.000118222466,6.144035e-7,0.000019916793,0.00004583142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600506,0.00058526953,0.0023120237,0.000340267,0.00045846074,0.00029893444],"domain_scores_gemma":[0.9963693,0.0005717346,0.00199936,0.00031049098,0.00028063636,0.0004684631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012721529,0.00023919402,0.001836238,0.00013854743,0.00007942999,0.000011233904,0.00017387363,0.0001619905,0.00023840883],"category_scores_gemma":[0.0003360866,0.00012792014,0.000109532404,0.00018479626,0.0002611711,0.00007417179,0.0001786318,0.0007023742,7.0892406e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052493926,0.112659276,0.4763863,0.000072021714,0.0019355693,0.00021783168,0.0144370105,0.000012219725,0.000060303748,0.0000053451035,0.0003412488,0.34137893],"study_design_scores_gemma":[0.21908526,0.22112231,0.5453978,0.00042301838,0.0011869986,0.00008189001,0.009963747,0.00010538027,0.00002050538,0.000031766835,0.0024509225,0.0001303751],"about_ca_topic_score_codex":0.0021211754,"about_ca_topic_score_gemma":0.0027330297,"teacher_disagreement_score":0.34124854,"about_ca_system_score_codex":0.00018556566,"about_ca_system_score_gemma":0.0011611726,"threshold_uncertainty_score":0.52164316},"labels":[],"label_agreement":null},{"id":"W2909029412","doi":"10.1136/ijgc-2018-000040","title":"Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Epithelial ovarian cancer; Gynecology; Ovarian cancer; Demography; Cancer; Population; Oncology; Obstetrics; Internal medicine; Environmental health","score_opus":0.011652689490016653,"score_gpt":0.2713113292248358,"score_spread":0.2596586397348192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909029412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678946,0.00040260155,0.0000019727806,0.00096319575,0.0007021342,0.00053224317,0.0005581613,0.0000038590024,0.000046372155],"genre_scores_gemma":[0.9989128,0.00018915789,0.000055933775,0.0003938,0.00011446289,0.00019139679,0.000014006575,0.000016810718,0.00011160015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778116,0.00009534502,0.0007377108,0.00022620753,0.00094019424,0.00021940327],"domain_scores_gemma":[0.9977906,0.00034521997,0.0006788842,0.00011358627,0.0009309501,0.00014080715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026130184,0.00013162181,0.0006895547,0.00009023495,0.000020905118,0.00003607945,0.00021704254,0.00007410357,0.0037273024],"category_scores_gemma":[0.00015354583,0.00012681793,0.00008119281,0.00015479137,0.00003872025,0.000104987164,0.000028556226,0.0002121775,3.086711e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007169898,0.0017202396,0.99117714,0.00003180216,0.00084905676,0.00036538613,0.000111775975,0.001044049,0.000051802654,0.0000030018296,0.00025269567,0.0036760797],"study_design_scores_gemma":[0.0076085827,0.0024732165,0.9882688,0.00048365133,0.00012918517,0.0000102424365,0.00047246975,0.000020975956,0.00015535353,0.000010972597,0.00024481557,0.00012175493],"about_ca_topic_score_codex":0.92527765,"about_ca_topic_score_gemma":0.98039174,"teacher_disagreement_score":0.055114117,"about_ca_system_score_codex":0.0020464833,"about_ca_system_score_gemma":0.0018900232,"threshold_uncertainty_score":0.99718344},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2909128886","doi":"10.1136/ijgc-2018-000087","title":"TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Serous ovarian cancer; Ovarian cancer; DNA sequencing; Serous fluid; Oncology; Bioinformatics; Internal medicine; Computational biology; Cancer; Genetics; Gene; Biology","score_opus":0.24498401400662734,"score_gpt":0.4870466006560772,"score_spread":0.24206258664944985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909128886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995313,0.0006915966,0.000064458975,0.0030427307,0.0005839076,0.00020130667,0.00004292883,0.0000037252275,0.00005637463],"genre_scores_gemma":[0.9959376,0.0014752321,0.0017021403,0.0006686605,0.00016648228,0.0000139013555,0.000011443465,0.000006558013,0.000017973689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984637,0.000054398446,0.0008669867,0.00013479766,0.00036346377,0.00011666025],"domain_scores_gemma":[0.9984431,0.00051106024,0.00057008944,0.00007409956,0.0002909534,0.00011069029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026605508,0.00013172986,0.0005805899,0.00021151762,0.000020517542,0.000038814385,0.000077412464,0.00009832292,0.00035424123],"category_scores_gemma":[0.00019099053,0.00008047307,0.00013845996,0.00010565537,0.00006362181,0.00017551574,0.000027704127,0.00024524424,0.0000017444252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021814306,0.00035997372,0.96800035,0.000016601613,0.0006623636,0.000037095455,0.00027108256,0.0047275755,0.00040968138,0.00012647516,0.00010133472,0.025069293],"study_design_scores_gemma":[0.0037549047,0.0014783372,0.98448104,0.0001823136,0.00019414672,0.00003084274,0.0002284788,0.00907779,0.00033929962,0.00010681971,0.000048578946,0.000077458644],"about_ca_topic_score_codex":0.0008520985,"about_ca_topic_score_gemma":0.00041296036,"teacher_disagreement_score":0.024991835,"about_ca_system_score_codex":0.0005943284,"about_ca_system_score_gemma":0.00029509034,"threshold_uncertainty_score":0.38786933},"labels":[],"label_agreement":null},{"id":"W2910942892","doi":"10.1136/bcr-2018-226454","title":"Hydropic leiomyoma presenting as a rare condition of pseudo-Meigs syndrome: literature review and a case of a pseudo-Meigs syndrome mimicking ovarian carcinoma with elevated CA125","year":2019,"lang":"en","type":"review","venue":"BMJ Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Meigs' syndrome; Pleural effusion; Medicine; Ascites; Ovarian carcinoma; Abdomen; Malignancy; Adnexal mass; Leiomyoma; Differential diagnosis; Uterine leiomyoma; Ovarian cancer; Radiology; Pathology; Cancer; Surgery; Internal medicine","score_opus":0.028594350379622883,"score_gpt":0.33590652453838626,"score_spread":0.3073121741587634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910942892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16814135,0.82249457,0.0000016284285,0.0001108707,0.00017615617,0.0084200865,0.00035984497,0.000057065394,0.00023845636],"genre_scores_gemma":[0.28652784,0.71033835,0.00039936326,0.00007014633,0.00007352679,0.0009063851,0.0011885709,0.00016367428,0.00033214013],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99387974,0.0003751453,0.0028994663,0.0015325762,0.0006779511,0.00063512457],"domain_scores_gemma":[0.99254996,0.00028397367,0.0041109915,0.0020301929,0.00060307066,0.00042181762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000765035,0.0011369962,0.0059685414,0.00064836314,0.00014376675,0.00008417345,0.00009489668,0.0006475088,0.00026091162],"category_scores_gemma":[0.00029014333,0.0008447381,0.00084547634,0.0013378295,0.00016950989,0.0002482968,0.00017491986,0.0007197156,0.000009253649],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024254507,0.00028298746,0.00078762195,0.23690961,0.0016887474,0.7457868,0.00014481429,1.7096427e-7,0.0000019085799,0.000030234629,0.00025314456,0.014089715],"study_design_scores_gemma":[0.0011027375,0.0007796083,0.00025575198,0.24553883,0.016575739,0.7238461,0.00003542605,0.0000052309474,0.000008133592,0.0000109316115,0.011327641,0.00051389076],"about_ca_topic_score_codex":0.0011407249,"about_ca_topic_score_gemma":0.00004944498,"teacher_disagreement_score":0.118386485,"about_ca_system_score_codex":0.0003978518,"about_ca_system_score_gemma":0.0015691794,"threshold_uncertainty_score":0.9994003},"labels":[],"label_agreement":null},{"id":"W29111706","doi":"10.1021/jacs.7b08989","title":"Postmenopausal Ovarian Cysts: Current Management","year":2007,"lang":"en","type":"article","venue":"Journal of the American Chemical Society","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute on Aging; Government of Canada; National Institutes of Health; National Center for Research Resources; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Adnexal mass; Ovarian cancer; Obstetrics and gynaecology; Magnetic resonance imaging; Gynecology; Medical record; Obstetrics; Radiology; General surgery; Cancer; Pregnancy; Internal medicine","score_opus":0.011584504358811157,"score_gpt":0.2977549796651614,"score_spread":0.28617047530635026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29111706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849006,0.00088097,0.0007422462,0.010171364,0.0005432948,0.00024213768,0.0000051285365,0.000016205759,0.002498038],"genre_scores_gemma":[0.98768586,0.000576174,0.00856124,0.002441601,0.0006533881,0.00000275266,0.0000012612428,0.000016763357,0.000060962393],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99867696,0.000016613712,0.00039580034,0.00013688456,0.0005057307,0.00026801456],"domain_scores_gemma":[0.9988995,0.00006442479,0.0004805017,0.00025835168,0.000101191676,0.00019602069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038052263,0.0001365753,0.00034653503,0.000022229058,0.000054412492,0.000014521566,0.0001917085,0.000027251512,0.00003667967],"category_scores_gemma":[0.000020319685,0.000078789526,0.0005204625,0.00033532898,0.00018962257,0.00003543541,0.00009082171,0.00035144424,0.000005526494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020209223,0.0059979022,0.14354104,0.0003196224,0.004710771,0.00047490164,0.0014192028,0.000019142079,0.13809165,0.0012393636,0.16923757,0.53292793],"study_design_scores_gemma":[0.008753529,0.0015777539,0.7269354,0.0008056902,0.0025634693,0.0012470216,0.0016087795,0.00007917853,0.06585876,0.0008195836,0.18926637,0.0004844757],"about_ca_topic_score_codex":0.000012074065,"about_ca_topic_score_gemma":2.8673338e-7,"teacher_disagreement_score":0.58339435,"about_ca_system_score_codex":0.00057306,"about_ca_system_score_gemma":0.000067938985,"threshold_uncertainty_score":0.32129437},"labels":[],"label_agreement":null},{"id":"W2911587956","doi":"10.1136/ijgc-2018-000092","title":"Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Cancer Research UK","keywords":"Medicine; Debulking; Oncology; Internal medicine; Stage (stratigraphy); Serous fluid; Ovarian cancer; Biomarker; Serous carcinoma; Chemotherapy; Progression-free survival; Gynecologic oncology; Ovarian carcinoma; Cancer","score_opus":0.024587047046545067,"score_gpt":0.31904137099560215,"score_spread":0.2944543239490571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911587956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113255,0.00045101778,0.000018288252,0.08570577,0.0012633464,0.0009320057,0.00008513188,0.000030258921,0.00018866376],"genre_scores_gemma":[0.9880409,0.00022000153,0.0011150216,0.009234138,0.00021867127,0.00010069293,0.00002202308,0.000040785864,0.0010077608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966576,0.0004467542,0.0010375865,0.00056053,0.00086086144,0.00043665094],"domain_scores_gemma":[0.99724025,0.00092269044,0.00053855916,0.00033051157,0.00064479973,0.00032316498],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015575102,0.00034982606,0.00076070486,0.000582953,0.000040354123,0.0000641747,0.00047028466,0.00025185553,0.002587164],"category_scores_gemma":[0.001158569,0.00024941645,0.00025498716,0.0004454146,0.00008891519,0.00014231238,0.00007793462,0.00045919523,0.00011146564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32613802,0.003298909,0.5728917,0.000020380909,0.00062157004,0.0127715515,0.0009878259,0.0005834651,0.049229667,0.0001195044,0.0063702455,0.02696717],"study_design_scores_gemma":[0.021934045,0.0052353363,0.9493961,0.00034443525,0.0000618591,0.00073268445,0.000072041024,0.000069182206,0.0022550393,0.00018723785,0.019460386,0.00025167307],"about_ca_topic_score_codex":0.00029896703,"about_ca_topic_score_gemma":0.000074112235,"teacher_disagreement_score":0.3765044,"about_ca_system_score_codex":0.0025008665,"about_ca_system_score_gemma":0.00088446535,"threshold_uncertainty_score":0.9999958},"labels":[],"label_agreement":null},{"id":"W2912551171","doi":"10.1136/jclinpath-2018-205634","title":"Neoadjuvant therapy in gynaecological malignancies: What pathologists need to know","year":2019,"lang":"en","type":"review","venue":"Journal of Clinical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Malignancy; Pathological; Biopsy; Pathological staging; Serous fluid; Pathology; Oncology","score_opus":0.2307786428291473,"score_gpt":0.49561039035750243,"score_spread":0.26483174752835514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912551171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003913719,0.98598206,0.00001768995,0.0029877922,0.005312937,0.0014611746,0.000015895628,0.000013875207,0.00029485344],"genre_scores_gemma":[0.0005345823,0.9931188,0.0013585325,0.0034503986,0.0011467217,0.00008025599,0.000015590154,0.000059833055,0.00023525178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99241924,0.0013838289,0.004522962,0.0006964727,0.00040991988,0.0005675911],"domain_scores_gemma":[0.9932204,0.00302631,0.002255195,0.000703757,0.00030974057,0.00048463172],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037691134,0.0005732096,0.008085235,0.0005161472,0.000024902229,0.000052279738,0.00045883583,0.0014890623,0.0005173635],"category_scores_gemma":[0.0023824533,0.00033073753,0.0023381389,0.00042157847,0.00019380175,0.00013342686,0.0001472235,0.0019827355,0.00040711713],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032542684,0.0017350534,0.004024579,0.0009064578,0.00023287779,0.017592052,0.00005377723,0.0000021454625,4.7482607e-7,0.000038834376,0.002846915,0.9722414],"study_design_scores_gemma":[0.0045218943,0.013219983,0.021631874,0.012328686,0.000882151,0.003486996,0.000058938756,4.4664097e-7,5.524595e-7,0.00008037283,0.94349444,0.00029367328],"about_ca_topic_score_codex":0.0000028674358,"about_ca_topic_score_gemma":0.0000068133763,"teacher_disagreement_score":0.9719477,"about_ca_system_score_codex":0.00034225834,"about_ca_system_score_gemma":0.0014509152,"threshold_uncertainty_score":0.99991447},"labels":[],"label_agreement":null},{"id":"W2914132379","doi":"10.1016/j.ogc.2018.09.001","title":"Current Quality of Gynecologic Cancer Care in North America","year":2019,"lang":"en","type":"review","venue":"Obstetrics and Gynecology Clinics of North America","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Gynecologic cancer; Health care; Quality (philosophy); Family medicine; Clinical Practice; Population; Intensive care medicine; Cancer; Nursing; Environmental health; Ovarian cancer; Internal medicine; Economic growth","score_opus":0.08983824242037766,"score_gpt":0.41425823747553797,"score_spread":0.3244199950551603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914132379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013827202,0.98071367,0.0000026432333,0.00006054287,0.001909054,0.0018628736,0.0013812195,0.00001583048,0.00022699701],"genre_scores_gemma":[0.0072133415,0.9909997,0.0002691941,0.00017919426,0.000059878457,0.00034365582,0.0008401931,0.000055195927,0.000039629223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952818,0.0003670585,0.0024536366,0.0009810553,0.00037269175,0.000543738],"domain_scores_gemma":[0.9821825,0.013399222,0.002850227,0.0008978353,0.00043235198,0.00023785922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019442734,0.00063583674,0.005905146,0.00066892843,0.000045503206,0.000008636807,0.00032442823,0.00041777533,0.0001466869],"category_scores_gemma":[0.003951405,0.0005058486,0.00085452903,0.0019925185,0.00049344485,0.00004416359,0.00025144918,0.000870448,0.000026825095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021929282,0.0007730337,0.30480328,0.015110958,0.00033282812,0.00002441023,0.00010035436,0.000013651531,2.0245516e-9,0.000004899277,0.00010777401,0.6787069],"study_design_scores_gemma":[0.0015516492,0.00197222,0.19228345,0.001306813,0.0017875053,0.0000014249204,0.00006249484,0.000005510893,2.9885307e-8,0.0000027472113,0.80069214,0.00033404355],"about_ca_topic_score_codex":0.00026927522,"about_ca_topic_score_gemma":0.0015630402,"teacher_disagreement_score":0.8005843,"about_ca_system_score_codex":0.0005537281,"about_ca_system_score_gemma":0.001991639,"threshold_uncertainty_score":0.9997393},"labels":[],"label_agreement":null},{"id":"W2914140610","doi":"10.1007/s00404-018-05039-y","title":"Laparoscopy versus open surgery for adnexal masses in pregnancy: a meta-analytic review","year":2019,"lang":"en","type":"review","venue":"Archives of Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Laparoscopy; Adnexal Diseases; Adnexal mass; Pregnancy; Obstetrics; General surgery; Surgery; Gynecology","score_opus":0.3009145756166519,"score_gpt":0.43472514515355903,"score_spread":0.13381056953690712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914140610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000466475,0.9925648,0.0000042468114,0.00026967004,0.0006465044,0.004333974,0.0001772237,0.0000066205425,0.0019923046],"genre_scores_gemma":[0.00003981093,0.99629605,0.0012229278,0.00016773096,0.000020871119,0.0013635616,0.00026614993,0.000039039278,0.00058385276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769586,0.00025032822,0.0009862721,0.00061677303,0.00012055779,0.00033018723],"domain_scores_gemma":[0.9585855,0.040067613,0.0006377508,0.00056233944,0.00003815944,0.000108621374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032845992,0.00039864887,0.006214884,0.00049580156,0.000035950696,0.0000150024525,0.00026619487,0.00021303388,0.00017346186],"category_scores_gemma":[0.0045302366,0.00027484327,0.0012302618,0.00047894186,0.00011827756,0.000059925354,0.000210178,0.00025124976,0.000009081513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007669248,0.0003792666,0.0009303448,0.13564166,0.0068021524,0.00006788443,0.00001913026,1.50152e-7,1.3640941e-8,0.0005545636,0.0012991845,0.854229],"study_design_scores_gemma":[0.0017964343,0.00077837275,0.0003272681,0.042590916,0.06504073,0.000013194447,0.0000053184904,0.0000023611474,0.0000012837709,0.00014422636,0.8890544,0.00024550795],"about_ca_topic_score_codex":0.000014972739,"about_ca_topic_score_gemma":0.000024418157,"teacher_disagreement_score":0.8877552,"about_ca_system_score_codex":0.00007861828,"about_ca_system_score_gemma":0.000998172,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W2914300718","doi":"10.1016/j.jpedsurg.2019.01.027","title":"Management of ovarian lesions diagnosed during infancy","year":2019,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Pediatrics; General surgery; Gynecology","score_opus":0.01828987366241932,"score_gpt":0.2636678515234509,"score_spread":0.24537797786103158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914300718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940464,0.0027930927,0.000011308774,0.000509413,0.0011003518,0.00018832767,0.000004619802,0.000008255128,0.0013382289],"genre_scores_gemma":[0.98749673,0.010210712,0.00062837976,0.00004439595,0.0013078164,0.0000057549346,0.0000020857433,0.000018418319,0.000285683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850786,0.000033094424,0.0007095952,0.00012716884,0.00042781787,0.00019447452],"domain_scores_gemma":[0.998512,0.0003609826,0.00058754283,0.00024085345,0.00014522707,0.00015337332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038093794,0.00012393281,0.0005382921,0.0004366054,0.000025756659,0.000008795729,0.00006629399,0.000056082492,0.00057045254],"category_scores_gemma":[0.00004680827,0.00009603784,0.00039023295,0.0004025148,0.0000108988625,0.0001058619,0.000033260196,0.00014206779,0.00003672153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000189979,0.00058363256,0.9853382,0.0004522761,0.00040433765,0.0016403063,0.00006362794,0.000020627254,0.000038153663,0.000070957234,0.0056744292,0.005523436],"study_design_scores_gemma":[0.0022340312,0.00012843058,0.99492043,0.00028209228,0.0006953689,0.00007176938,0.0000989271,0.0000013324609,0.00037752886,0.0000301487,0.0010721716,0.000087756656],"about_ca_topic_score_codex":0.000011742332,"about_ca_topic_score_gemma":3.8835822e-7,"teacher_disagreement_score":0.009582205,"about_ca_system_score_codex":0.00008004004,"about_ca_system_score_gemma":0.0001821136,"threshold_uncertainty_score":0.62460554},"labels":[],"label_agreement":null},{"id":"W2914512849","doi":"10.1016/s1470-2045(18)30939-2","title":"Conservative management of adnexal masses","year":2019,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Adnexal mass; Scopus; Malignancy; Ovarian cancer; Gynecology; MEDLINE; Cancer; Pathology; Internal medicine","score_opus":0.09741370730472958,"score_gpt":0.3681989465383599,"score_spread":0.2707852392336303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914512849","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013395837,0.0007891747,0.000008690417,0.88699514,0.0007197567,0.0008796121,0.000099594785,0.00002550414,0.10914297],"genre_scores_gemma":[0.0052342545,0.0022659001,0.0016708614,0.9692737,0.004077797,0.00025676822,0.0002473386,0.000043246062,0.016930161],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875027,0.00016519107,0.0002676087,0.00028207432,0.00022136816,0.0003134746],"domain_scores_gemma":[0.99844605,0.00047449605,0.00027661704,0.00070991006,0.00007362873,0.000019294717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022590952,0.00020848784,0.0010704381,0.00004855244,0.000025420699,0.0000054670277,0.00022635609,0.00035985827,0.0005785504],"category_scores_gemma":[0.000009465302,0.00012351108,0.00014073958,0.00009482466,0.00016720471,0.000013033249,0.00009995353,0.0007251043,0.00021447036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020864117,0.00011760244,0.0030599977,0.00092768203,0.0016078633,0.0011982709,0.000096259246,8.6088005e-7,0.0000027025396,0.0009285638,0.98826355,0.003588035],"study_design_scores_gemma":[0.0032281464,0.00087701535,0.012840385,0.00038580867,0.0009914163,0.00006048163,0.000060193277,0.000002428171,0.0000627865,0.00028268291,0.98110497,0.000103679326],"about_ca_topic_score_codex":0.00007484609,"about_ca_topic_score_gemma":0.000009289768,"teacher_disagreement_score":0.0922128,"about_ca_system_score_codex":0.0002851701,"about_ca_system_score_gemma":0.00022464499,"threshold_uncertainty_score":0.63347214},"labels":[],"label_agreement":null},{"id":"W2915560143","doi":"10.1186/s12935-019-0725-1","title":"Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target","year":2019,"lang":"en","type":"article","venue":"Cancer Cell International","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada); BC Cancer Agency; Genome British Columbia; University of British Columbia","funders":"University of British Columbia; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Serous ovarian cancer; Serous fluid; Ovarian cancer; MEK inhibitor; Medicine; Cancer research; EGFR inhibitors; Oncology; Internal medicine; Cancer; Biology; MAPK/ERK pathway; Epidermal growth factor receptor; Signal transduction; Genetics","score_opus":0.009495629598201496,"score_gpt":0.2673511730442593,"score_spread":0.2578555434460578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915560143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92657113,0.021474572,0.00014263297,0.017212491,0.0049229893,0.0013472855,0.0006595453,0.00004860069,0.027620776],"genre_scores_gemma":[0.9889929,0.0022686818,0.0006344096,0.0014506873,0.0003717557,0.00020801317,0.000046758643,0.000034938552,0.005991851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984442,0.000029671266,0.0003885933,0.00042071939,0.0004621477,0.00025463916],"domain_scores_gemma":[0.99926174,0.000034329278,0.00019473635,0.0002626971,0.00015497021,0.000091518865],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000096207674,0.00019805027,0.00034003129,0.00011134949,0.000021274,0.000020335869,0.00017665148,0.000095745905,0.0076275193],"category_scores_gemma":[0.000003904872,0.00018286132,0.00014813131,0.00016289721,0.000051024832,0.00012241819,0.00003840492,0.00015543128,0.00003020821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006726127,0.003029169,0.90606767,0.0013571513,0.0023630331,0.00028273734,0.003148531,0.0016977396,0.031410165,0.0024388111,0.030537149,0.010941725],"study_design_scores_gemma":[0.030239364,0.00071923615,0.6649553,0.0036228867,0.00051567407,0.000018907946,0.00073459704,0.004267996,0.15819885,0.0013910863,0.1343175,0.0010185569],"about_ca_topic_score_codex":0.0022472963,"about_ca_topic_score_gemma":0.0009039885,"teacher_disagreement_score":0.24111232,"about_ca_system_score_codex":0.0010644777,"about_ca_system_score_gemma":0.00040256383,"threshold_uncertainty_score":0.99327964},"labels":[],"label_agreement":null},{"id":"W2917090285","doi":"10.1186/s13048-016-0215-1","title":"Journal of Ovarian Research reviewer acknowledgement 2015","year":2016,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Acknowledgement; Reproductive medicine; Medicine; General surgery; Gynecology; Library science; Family medicine; Biology; Computer science; Pregnancy","score_opus":0.22279295098249122,"score_gpt":0.5033727657236706,"score_spread":0.28057981474117943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917090285","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22446112,0.116294496,0.004742449,0.54871124,0.014850912,0.006234366,0.00011067264,0.000056288358,0.08453845],"genre_scores_gemma":[0.9471202,0.025040822,0.0076864217,0.0002611199,0.008845775,0.000035391906,0.0000018279143,0.00010787142,0.010900563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99102974,0.0015902636,0.0017419336,0.0003289348,0.004303306,0.0010058348],"domain_scores_gemma":[0.97988373,0.0013663644,0.00069222617,0.000800238,0.01624495,0.0010124684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.025818923,0.00024221271,0.0010145939,0.0018341063,0.00025175183,0.00013779863,0.0007534231,0.00020602226,0.0047481307],"category_scores_gemma":[0.0063991775,0.00013248947,0.00051170815,0.0013555991,0.00042206145,0.0004136111,0.00025875293,0.0017304819,0.00046166976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027349163,0.0024953436,0.017065661,0.00033447135,0.0014169369,0.0032979606,0.00057328545,0.0000012721565,0.0052127726,0.0032690198,0.84057987,0.12301849],"study_design_scores_gemma":[0.013803242,0.008455993,0.06401419,0.0068234648,0.00030792825,0.0019184761,0.00046125826,0.0000042481192,0.0059648897,0.0043316106,0.8936924,0.00022232976],"about_ca_topic_score_codex":0.000026080512,"about_ca_topic_score_gemma":0.000011942118,"teacher_disagreement_score":0.7226591,"about_ca_system_score_codex":0.0015523748,"about_ca_system_score_gemma":0.003297836,"threshold_uncertainty_score":0.99616164},"labels":[],"label_agreement":null},{"id":"W2917476978","doi":"10.3390/ijms20040952","title":"High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints","year":2019,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":702,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University Health Centre; McGill University; Rivkin Center for Ovarian Cancer","keywords":"Serous fluid; Ovarian cancer; Serous ovarian cancer; Disease; Cancer; Medicine; Oncology; Bioinformatics; Biology; Internal medicine","score_opus":0.12144623474556941,"score_gpt":0.445201110401075,"score_spread":0.3237548756555056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917476978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029163808,0.99084914,0.00011110308,0.0025634083,0.00296738,0.00031507868,0.000035472505,0.000006381755,0.00023563854],"genre_scores_gemma":[0.011961166,0.98496735,0.0017594278,0.00070725614,0.0005206811,0.000010433488,0.0000032005153,0.000018012004,0.000052497362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967096,0.00020253859,0.0009964434,0.00045788064,0.0014015815,0.00023195152],"domain_scores_gemma":[0.998129,0.00024915626,0.0009979418,0.00016040305,0.0002839811,0.00017951161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014914876,0.00027625402,0.0012477888,0.00044362067,0.000088599314,0.00021281683,0.0007104568,0.00014622741,0.000112915994],"category_scores_gemma":[0.00007438668,0.0001727828,0.0005262034,0.00034382544,0.00070597365,0.00012432272,0.00010394796,0.00039035323,0.00001266904],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024264651,0.00022140039,0.0023980776,0.00034439677,0.0011977653,0.0005612703,0.000024376153,0.000017080729,0.0000023902958,0.0024856848,0.00012089595,0.9926024],"study_design_scores_gemma":[0.0044154148,0.0030633037,0.0035987364,0.028467992,0.004330173,0.0044733095,0.00006442972,0.000058966816,0.000054791923,0.0017217775,0.94917804,0.00057307957],"about_ca_topic_score_codex":0.00007964727,"about_ca_topic_score_gemma":0.0000071263576,"teacher_disagreement_score":0.9920293,"about_ca_system_score_codex":0.00020913385,"about_ca_system_score_gemma":0.0025117593,"threshold_uncertainty_score":0.7045879},"labels":[],"label_agreement":null},{"id":"W2917802131","doi":"10.1016/j.ygyno.2019.02.005","title":"Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Intas Pharmaceuticals; Sociedad Española de Oncología Médica; University of Toronto; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation; Cancer Care Ontario","keywords":"Medicine; KRAS; Neuroblastoma RAS viral oncogene homolog; Clinical trial; Oncology; Internal medicine; Genotype; Ovarian cancer; Serous fluid; Cancer; Colorectal cancer; Gene","score_opus":0.05141778133780034,"score_gpt":0.43007901925180625,"score_spread":0.3786612379140059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917802131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905023,0.000084736384,0.0000013340427,0.00077898375,0.0019655982,0.0038467865,0.00006613122,0.00003840815,0.0027157352],"genre_scores_gemma":[0.9976624,0.00013750879,0.00046861148,0.000837643,0.00009082476,0.0006018543,0.000047637335,0.000025215893,0.00012827425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996953,0.00047213343,0.0011597597,0.0006093987,0.00027467523,0.0005310429],"domain_scores_gemma":[0.99659926,0.0020970197,0.00055906246,0.00044633698,0.00013741126,0.00016090834],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006259227,0.00031918404,0.0016980878,0.00021655779,0.000029708723,0.0000069727107,0.00018151938,0.00054283557,0.001980643],"category_scores_gemma":[0.0014825795,0.00020710929,0.00057896855,0.00022789369,0.00010970019,0.000046674228,0.0000905454,0.0004287493,0.00018046434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008521465,0.010390644,0.96149504,0.000049668153,0.0004610712,0.00016271255,0.00005306638,0.00018311456,0.00014057446,0.00011872856,0.00010907805,0.01831486],"study_design_scores_gemma":[0.09323194,0.055717137,0.8499096,0.0000488339,0.00018633295,0.0000019230818,0.00003036483,0.00005530714,0.00028686496,0.0002239997,0.00014377756,0.00016391935],"about_ca_topic_score_codex":0.00013972218,"about_ca_topic_score_gemma":0.000092737115,"teacher_disagreement_score":0.111585416,"about_ca_system_score_codex":0.0015098635,"about_ca_system_score_gemma":0.0010616273,"threshold_uncertainty_score":0.9989317},"labels":[],"label_agreement":null},{"id":"W2921624236","doi":"10.1097/01.ogx.0000554460.78765.59","title":"Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials","year":2019,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Fallopian tube; Ovary; Randomized controlled trial; Chemotherapy; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.14062922947035988,"score_gpt":0.3509534933213187,"score_spread":0.21032426385095881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921624236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894979,0.006504589,0.00001343536,0.0007667346,0.0007328642,0.0010362798,0.0012937632,0.00002490647,0.00012953582],"genre_scores_gemma":[0.9955749,0.0016627185,0.00036235212,0.00065298215,0.00005248025,0.00006348894,0.0016014609,0.000019951945,0.0000096824215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554384,0.0012355183,0.0011689801,0.00091793336,0.00066442677,0.00046928803],"domain_scores_gemma":[0.9488612,0.04930669,0.00049377565,0.0010072167,0.00011082895,0.00022031598],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002498474,0.00031948843,0.0021386263,0.00027514793,0.0000623784,0.000059343012,0.00038190398,0.0002533034,0.00166817],"category_scores_gemma":[0.01453185,0.00018785661,0.00029478772,0.0022579797,0.00010758148,0.0001105256,0.00029641547,0.00032737412,0.000012953999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001838239,0.0005932664,0.79920036,0.000007178223,0.0031538017,0.000052525887,0.00012281716,0.00010064413,0.00003770997,0.000014922334,0.0003036196,0.19457489],"study_design_scores_gemma":[0.0068567707,0.00070452,0.98820615,0.000051720923,0.0017787224,5.911982e-7,0.00015669242,0.00056622736,0.0000740253,0.000017290085,0.0013784745,0.00020882495],"about_ca_topic_score_codex":0.004849196,"about_ca_topic_score_gemma":0.0022526693,"teacher_disagreement_score":0.19436607,"about_ca_system_score_codex":0.00041358543,"about_ca_system_score_gemma":0.00026134087,"threshold_uncertainty_score":0.99924445},"labels":[],"label_agreement":null},{"id":"W2921658426","doi":"10.1002/cncy.22110","title":"Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Ovarian Cancer Research Alliance; Gray Foundation; Congressionally Directed Medical Research Programs; Johns Hopkins University; U.S. Department of Defense","keywords":"Fallopian tube; Serous carcinoma; Pathology; Serous fluid; Medicine; Immunostaining; Cytopathology; Papanicolaou stain; Serous Cystadenoma; Ovarian cancer; Cytology; Cancer; Immunohistochemistry; Gynecology; Cervical cancer; Internal medicine","score_opus":0.03211854681770394,"score_gpt":0.33166305819455816,"score_spread":0.29954451137685423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921658426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938995,0.0032126305,0.00011014765,0.0010245156,0.0004044528,0.0008492493,0.0002772492,0.00001741782,0.00020480377],"genre_scores_gemma":[0.9971645,0.00057930563,0.0011186461,0.0005568855,0.00014617614,0.00033382437,0.000033987933,0.000027045146,0.000039669787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865997,0.000059654056,0.00043480238,0.00043481714,0.00013481852,0.00027594212],"domain_scores_gemma":[0.99903166,0.00014773983,0.00022791415,0.0003214593,0.00017314627,0.00009807197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001532119,0.00020358543,0.00083674584,0.00012816153,0.000024729556,0.0000060998236,0.00009983404,0.00017061499,0.00018663073],"category_scores_gemma":[0.00007750766,0.00016995583,0.00018457133,0.000143829,0.0001953881,0.000041115058,0.00005865656,0.000100849815,0.0000026368589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000815819,0.00023264594,0.92417854,0.00033616266,0.00018689797,0.00015640543,0.00028672203,0.00003314428,0.06780902,0.00064738444,0.00021376529,0.0051034978],"study_design_scores_gemma":[0.008173168,0.0037984184,0.576258,0.00016442587,0.0009728762,0.00017685088,0.00009154881,0.00007776137,0.40893003,0.00025256985,0.0008851181,0.00021924889],"about_ca_topic_score_codex":0.0006796953,"about_ca_topic_score_gemma":0.00004863116,"teacher_disagreement_score":0.34792054,"about_ca_system_score_codex":0.000096989774,"about_ca_system_score_gemma":0.00018044224,"threshold_uncertainty_score":0.69305974},"labels":[],"label_agreement":null},{"id":"W2922109064","doi":"10.1093/jcag/gwz006.199","title":"A200 UNUSUAL PERIANAL MASS IN A CIRRHOTIC PATIENT: A CASE REPORT","year":2019,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Transjugular intrahepatic portosystemic shunt; Varices; Portal hypertension; Varix; Surgery; Hematochezia; Cirrhosis; Rectum; Esophageal varices; Radiology; Internal medicine; Colonoscopy; Colorectal cancer","score_opus":0.0068277572981075224,"score_gpt":0.22808478802237803,"score_spread":0.2212570307242705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922109064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829197,0.000019392623,0.0000025404368,0.015747905,0.0006789343,0.00019202463,0.00002023862,0.0000011292792,0.00041816666],"genre_scores_gemma":[0.9983464,0.000005896852,0.00012537492,0.0011712717,0.0000726178,0.0000027715405,0.0000024813344,0.000008808782,0.00026438507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986627,0.00015332883,0.00057492155,0.000098894634,0.00025201953,0.00025815333],"domain_scores_gemma":[0.99840444,0.000043633307,0.00096527813,0.00016554311,0.00023687827,0.000184211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005062318,0.000084693915,0.00037962937,0.0002693192,0.000030541665,0.000009140082,0.00007320382,0.00008930043,0.00015818086],"category_scores_gemma":[0.00019406049,0.000063692045,0.00018531151,0.00012434393,0.000020110747,0.000048209084,0.00001070208,0.00024159299,0.0000046871746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001934432,0.00008353005,0.988081,0.00001147007,0.000229418,0.009685295,0.00023851833,0.00009861726,0.000043142958,0.000020270967,0.0012114026,0.00010393538],"study_design_scores_gemma":[0.0044126753,0.0018446981,0.958469,0.00012084168,0.00019888363,0.032768205,0.00016765074,0.00005976736,0.00004948759,0.00004836702,0.0018183558,0.00004208813],"about_ca_topic_score_codex":0.008501806,"about_ca_topic_score_gemma":0.30482897,"teacher_disagreement_score":0.29632714,"about_ca_system_score_codex":0.0024994977,"about_ca_system_score_gemma":0.00070863694,"threshold_uncertainty_score":0.99810064},"labels":[],"label_agreement":null},{"id":"W2922785392","doi":"10.1155/2019/1870834","title":"Primary Peritoneal Cancer Two Decades after a Bilateral Salpingo-Oophorectomy","year":2019,"lang":"en","type":"article","venue":"Case Reports in Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Western University","funders":"","keywords":"Medicine; Omentectomy; Ovarian cancer; Serous fluid; Occult; Surgery; Hysterectomy; Cancer; Radiology; Internal medicine; Pathology","score_opus":0.01027031416224316,"score_gpt":0.2839225381566113,"score_spread":0.2736522239943681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922785392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97979486,0.015361478,8.883729e-7,0.00045703858,0.0020506866,0.0006096442,0.000009919652,0.0000228668,0.0016926363],"genre_scores_gemma":[0.99585503,0.0019800293,0.00029370023,0.00089467916,0.00008998299,0.00028510287,0.000014061561,0.000026362197,0.0005610409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985043,0.000032868862,0.00045103722,0.0005322813,0.00013397886,0.00034554952],"domain_scores_gemma":[0.99832535,0.0009619364,0.00014045363,0.00033447825,0.000076103126,0.00016166735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017140302,0.00018541719,0.0005002276,0.00028600486,0.000037598074,0.000026755315,0.000018763654,0.00016192436,0.00045052884],"category_scores_gemma":[0.0004200666,0.0001578258,0.000077210396,0.0003471891,0.00006673554,0.000058372105,0.00007119129,0.00021283426,0.000008401488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004023499,0.00019562103,0.75327796,0.000113479335,0.000067707864,0.20587464,0.00021493877,0.000011964159,0.000058093865,0.000032781852,0.00007796873,0.040034626],"study_design_scores_gemma":[0.003895335,0.0005632898,0.8650068,0.00014725332,0.00019188893,0.056320194,0.00008542813,0.0001427572,0.0002734348,0.00010428079,0.07294617,0.0003231839],"about_ca_topic_score_codex":0.0004698816,"about_ca_topic_score_gemma":0.00020221647,"teacher_disagreement_score":0.14955443,"about_ca_system_score_codex":0.0005058881,"about_ca_system_score_gemma":0.0002551788,"threshold_uncertainty_score":0.6435949},"labels":[],"label_agreement":null},{"id":"W2924517174","doi":"10.3390/cancers11030416","title":"Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations","year":2019,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Homologous recombination; Cancer research; Olaparib; Germline mutation; DNA repair; Mutation; BRCA2 Protein; PARP inhibitor; Cancer; DNA damage; Biology; Poly ADP ribose polymerase; Genome instability; Germline; Serous fluid; Gene; Medicine; Genetics; Polymerase; DNA; Internal medicine","score_opus":0.11132049899951825,"score_gpt":0.39598786004915665,"score_spread":0.2846673610496384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924517174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014410125,0.9863961,0.000012521594,0.00029781272,0.000575309,0.00196336,0.00097540405,0.000043897504,0.009721201],"genre_scores_gemma":[0.00037711352,0.9933592,0.00020541035,0.000060888626,0.00035947142,0.0029047192,0.00050893065,0.00008645806,0.0021378056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983908,0.000033871864,0.00057890883,0.0005405942,0.00015502871,0.00030077566],"domain_scores_gemma":[0.99833053,0.00012903864,0.00045898295,0.00079211267,0.00011502346,0.00017429452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004262216,0.00041675018,0.001852668,0.00023468515,0.00007098288,0.000016432303,0.00012952213,0.00020286675,0.0007408915],"category_scores_gemma":[0.000013110423,0.0003201571,0.00070182263,0.0005128895,0.00007732201,0.000051720526,0.00002343866,0.00014977764,0.00009604084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000007633957,0.00006791318,0.0004297185,0.006856776,0.0018287472,0.000007182844,0.000107099506,0.00004303413,5.5362756e-7,0.0009838113,0.00072541606,0.9889421],"study_design_scores_gemma":[0.001129135,0.00022198554,0.0005377079,0.010310547,0.008602987,0.000022511047,0.00001858488,0.000004514479,0.000010532307,0.00001873579,0.97889,0.00023273741],"about_ca_topic_score_codex":0.002037043,"about_ca_topic_score_gemma":0.00017778421,"teacher_disagreement_score":0.9887094,"about_ca_system_score_codex":0.0080115935,"about_ca_system_score_gemma":0.0068717073,"threshold_uncertainty_score":0.9999251},"labels":[],"label_agreement":null},{"id":"W2934066533","doi":"10.1097/pas.0000000000001232","title":"DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors","year":2019,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Mutation; Biology; Immunohistochemistry; Internal medicine; Pathology; Cancer research; Medicine; Genetics; Gene","score_opus":0.007280318325974849,"score_gpt":0.26334136058655067,"score_spread":0.2560610422605758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934066533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936744,0.0013717556,0.00001443195,0.003478275,0.0001167954,0.0002381812,0.000004604794,0.000007495634,0.0010940675],"genre_scores_gemma":[0.99715286,0.0014608939,0.00060925947,0.0005902357,0.00007580867,0.0000070670076,0.00000382623,0.000017803324,0.00008223512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853325,0.000308487,0.0004359378,0.00021994741,0.00019648114,0.0003058801],"domain_scores_gemma":[0.9984116,0.0005643954,0.0005872523,0.00019572522,0.00008618823,0.00015486202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005048553,0.00016949594,0.00073980005,0.00014229046,0.000036809903,0.000015143977,0.00008516958,0.00005344132,0.000063780055],"category_scores_gemma":[0.000029073406,0.00008747963,0.00008947827,0.00027164986,0.00040930067,0.00006305986,0.000031518422,0.0005023314,0.000014073821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042173956,0.00044809698,0.95792514,0.000023522336,0.000065378284,0.016823944,0.0011402201,0.00019721987,0.00032814677,0.00021024562,0.000053083353,0.01856761],"study_design_scores_gemma":[0.0060375324,0.008699319,0.9616547,0.00013795197,0.00016351773,0.020863445,0.0014931037,0.000021161055,0.000160691,0.00030853687,0.0003394583,0.00012057554],"about_ca_topic_score_codex":0.000071802715,"about_ca_topic_score_gemma":0.0000116513675,"teacher_disagreement_score":0.018447036,"about_ca_system_score_codex":0.00007075241,"about_ca_system_score_gemma":0.0001362864,"threshold_uncertainty_score":0.3567316},"labels":[],"label_agreement":null},{"id":"W2936025412","doi":"10.1097/pgp.0000000000000429","title":"Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage","year":2017,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Pathology; Serous fluid; Serous carcinoma; Ovarian carcinoma; Disease; Carcinoma; Medicine; Biology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.03187725277443667,"score_gpt":0.32824214594716794,"score_spread":0.2963648931727313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936025412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665777,0.00018641411,0.0028641692,0.028603546,0.00043798145,0.00035378247,0.00085805345,0.000008798509,0.00010957341],"genre_scores_gemma":[0.9969686,0.0001483732,0.0013062364,0.00084844744,0.0002711085,0.00007000992,0.00026528238,0.000010590817,0.00011134765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880457,0.00008211579,0.00046923343,0.00025987797,0.00017182333,0.00021240597],"domain_scores_gemma":[0.99832505,0.0004591952,0.0005119986,0.0002175127,0.00028355446,0.00020266623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038974785,0.00014176543,0.00036426532,0.00010372661,0.000162254,0.0000745609,0.00022951263,0.000119944045,0.00008688577],"category_scores_gemma":[0.0010428897,0.00011038243,0.00012794598,0.000029592438,0.00014423812,0.00017363178,0.00011065061,0.00026058237,0.0000030676122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006409406,0.0008630877,0.9835257,0.000033761648,0.00009805712,0.0025967737,0.000043283213,0.00005945277,0.0010714368,0.0056935297,0.00032709536,0.0050469115],"study_design_scores_gemma":[0.0049359477,0.0006431963,0.9905438,0.0000832595,0.0000852645,0.00020391186,0.000014227835,0.00009186023,0.0001097277,0.0019273789,0.0012659604,0.00009548796],"about_ca_topic_score_codex":0.00004055653,"about_ca_topic_score_gemma":0.000044759643,"teacher_disagreement_score":0.030390922,"about_ca_system_score_codex":0.0004514384,"about_ca_system_score_gemma":0.0001776091,"threshold_uncertainty_score":0.45012647},"labels":[],"label_agreement":null},{"id":"W2937832733","doi":"10.1097/pgp.0000000000000530","title":"Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; University of British Columbia; Alberta Health Services","funders":"National Cancer Institute","keywords":"Serous carcinoma; Serous fluid; Immunohistochemistry; Pathology; Tissue microarray; Population; Medicine; Carcinoma; Clear cell carcinoma; Not Otherwise Specified; Anatomical pathology; Ovarian carcinoma; Clear cell; Ovarian cancer; Cancer; Oncology; Internal medicine","score_opus":0.023491121400145334,"score_gpt":0.2958725733707966,"score_spread":0.2723814519706513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937832733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895439,0.00035257434,0.0018850985,0.0041431063,0.00055504363,0.000108698325,0.000018000825,0.000009027495,0.0033845464],"genre_scores_gemma":[0.98587257,0.00019483802,0.013269476,0.00033785592,0.00025825144,0.000010458663,0.00001174777,0.000007895802,0.000036916874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899644,0.00006338934,0.00046345658,0.00015922893,0.00019401989,0.00012345624],"domain_scores_gemma":[0.99771553,0.00087288494,0.00035188516,0.000102951344,0.00086514035,0.00009161961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001650691,0.000107637796,0.0003258978,0.00016591472,0.00004400089,0.000007297776,0.00012249015,0.00012383689,0.00023327148],"category_scores_gemma":[0.0013923702,0.00007194416,0.00008248037,0.00008783764,0.000537497,0.000058167152,0.000044664746,0.00024454456,0.0000036875208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063496516,0.005278677,0.6927932,0.000036383353,0.0024347766,0.008108118,0.0029786546,0.000037882888,0.10535813,0.03427511,0.003987446,0.13836199],"study_design_scores_gemma":[0.005514782,0.012459739,0.95958424,0.000104404986,0.00041135406,0.011360633,0.0004104044,0.00013241344,0.0036617743,0.0014194464,0.0048051253,0.00013569195],"about_ca_topic_score_codex":0.00001852079,"about_ca_topic_score_gemma":0.000028239128,"teacher_disagreement_score":0.26679105,"about_ca_system_score_codex":0.00018407017,"about_ca_system_score_gemma":0.00017037046,"threshold_uncertainty_score":0.29337978},"labels":[],"label_agreement":null},{"id":"W2937929023","doi":"10.1002/cam4.1996","title":"Evaluation of vitamin D biosynthesis and pathway target genes reveals <i>UGT2A1/2</i> and <i>EGFR</i> polymorphisms associated with epithelial ovarian cancer in African American Women","year":2019,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; NIHR Cambridge Biomedical Research Centre; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; University of North Carolina at Chapel Hill; National Institutes of Health; Norges Forskningsråd; Helse Vest; Ministerio de Economía y Competitividad; Cancer Research UK; University College London; National Institute for Health and Care Research; U.S. Department of Defense; Lon V. Smith Foundation; American Association for Cancer Research; Radboud Universiteit; Canadian Institutes of Health Research; Cancer Institute NSW; Georgia Clinical and Translational Science Alliance; University of Cambridge; American Cancer Society; Moffitt Cancer Center; Minnesota Ovarian Cancer Alliance; Kreftforeningen; National Institute on Minority Health and Health Disparities; Mayo Foundation for Medical Education and Research; Princess Margaret Cancer Foundation; Oregon Health and Science University; Vanderbilt University; American Society of Preventive Oncology; Mayo Clinic; Ovarian Cancer Research Fund; North Carolina Central University; Oak Foundation","keywords":"Calcitriol receptor; CYP24A1; Single-nucleotide polymorphism; SNP; Biology; Vitamin D and neurology; Genotyping; Allele; Odds ratio; Oncology; Genetics; Genotype; Genome-wide association study; 1000 Genomes Project; Internal medicine; Gene; Medicine; Endocrinology","score_opus":0.016457435292787582,"score_gpt":0.2703064647271695,"score_spread":0.2538490294343819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937929023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98210984,0.007933644,0.0000048163743,0.0077107176,0.0001796854,0.0010968022,0.0002523398,0.000022679822,0.0006894997],"genre_scores_gemma":[0.99458885,0.0033933248,0.00012038133,0.00087317865,0.00019804471,0.00060732855,0.000024098337,0.00004539218,0.00014937783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975496,0.00020632338,0.0004446042,0.00055137125,0.0008339192,0.0004142019],"domain_scores_gemma":[0.9985082,0.00021548872,0.00039182958,0.00031718286,0.00031129527,0.00025601307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013026103,0.0003011446,0.0010287426,0.00023951533,0.00004028783,0.000008194773,0.00007127069,0.00008208508,0.00072686275],"category_scores_gemma":[0.00014566348,0.0002099945,0.000032298696,0.0006419969,0.00040982905,0.000079293626,0.00003120112,0.00013911701,0.0000013111537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072111894,0.0002983708,0.7391384,0.00015371526,0.00077718013,0.000027341197,0.004439934,0.00004737888,0.04184528,0.00006506415,0.00019888103,0.21228732],"study_design_scores_gemma":[0.014878333,0.0022138462,0.9646666,0.0024753544,0.0010676439,0.0000124308535,0.0017479169,0.000414244,0.0109006455,0.00012763558,0.0011560912,0.00033923725],"about_ca_topic_score_codex":0.00578493,"about_ca_topic_score_gemma":0.0012093342,"teacher_disagreement_score":0.22552821,"about_ca_system_score_codex":0.00096342363,"about_ca_system_score_gemma":0.0005317723,"threshold_uncertainty_score":0.87451226},"labels":[],"label_agreement":null},{"id":"W2939543377","doi":"10.1038/s41591-019-0422-6","title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","year":2019,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":839,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Organoid; Ovarian cancer; In vivo; Precision medicine; Personalized medicine; Cancer; Cancer research; Biology; Medicine; Computational biology; Pathology; Bioinformatics; Internal medicine; Neuroscience; Genetics","score_opus":0.011933751075103936,"score_gpt":0.32084845407773854,"score_spread":0.3089147030026346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939543377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759109,0.010392409,0.000105923806,0.0101755895,0.0013365345,0.0013131863,0.00006309853,0.000055208428,0.00064715877],"genre_scores_gemma":[0.99122596,0.00040771018,0.0006958518,0.0063248733,0.0008854395,0.00012916901,0.0001419763,0.000035661025,0.00015337569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987584,0.00001296057,0.00024040545,0.0004504304,0.00027046673,0.00026735585],"domain_scores_gemma":[0.9990513,0.00007932803,0.00008734539,0.00037446065,0.00014660737,0.0002609595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015862338,0.00023313318,0.00047588415,0.00010956743,0.000053979515,0.00001232282,0.00008134963,0.00027868059,0.00044575066],"category_scores_gemma":[0.000055036428,0.00014833955,0.000054772467,0.0001236261,0.00007403237,0.00008354442,0.000022371636,0.00035937552,0.0000056779318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045376103,0.0015550947,0.6987327,0.0014240495,0.0018226793,0.00014680844,0.006221129,0.000022043383,0.04672246,0.008913831,0.041887097,0.18801454],"study_design_scores_gemma":[0.035726823,0.0126799615,0.66457653,0.0017380334,0.0016228819,0.00025233754,0.00089474634,0.0010575233,0.09742751,0.00096177764,0.18225497,0.0008069186],"about_ca_topic_score_codex":0.00027666232,"about_ca_topic_score_gemma":0.0003174234,"teacher_disagreement_score":0.18720761,"about_ca_system_score_codex":0.00017665804,"about_ca_system_score_gemma":0.00009209984,"threshold_uncertainty_score":0.6049111},"labels":[],"label_agreement":null},{"id":"W2940145740","doi":"10.1158/1078-0432.ccr-18-3691","title":"Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"Medical Research and Materiel Command; National Health and Medical Research Council","keywords":"Clear cell carcinoma; Oncology; Medicine; Clear cell; Ovarian cancer; Clear-cell adenocarcinoma; Internal medicine; Olaparib; Chemotherapy; Exome sequencing; ARID1A; Exome; Cancer; Serous fluid; Carcinoma; Progression-free survival; Biology; Mutation; Gene","score_opus":0.19237824006158244,"score_gpt":0.4506798602280149,"score_spread":0.25830162016643243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940145740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888229,0.00031446622,0.0000031103827,0.0055099777,0.00025316374,0.0008456105,0.000022354117,0.000014570582,0.00421387],"genre_scores_gemma":[0.997633,0.00018033833,0.00013419286,0.0005956448,0.00011516667,0.00010451727,0.00001727117,0.00003614778,0.0011837379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971217,0.000434277,0.000585188,0.00061150355,0.00081245805,0.00043490395],"domain_scores_gemma":[0.9980399,0.0008499809,0.00014754015,0.00050747825,0.00027328022,0.00018182586],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023705943,0.00014940105,0.00066189363,0.0001277018,0.00004574608,0.000015531772,0.0001720286,0.00019053034,0.0011085168],"category_scores_gemma":[0.00025471588,0.00010960665,0.00019286579,0.000552804,0.00018513938,0.000044324945,0.000044866094,0.0007033712,0.000060605194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031484673,0.0015168643,0.9899474,0.000067226,0.00008040809,0.0001381968,0.00021018319,0.0000020830828,0.0019084534,0.00007803903,0.0008108277,0.0020919002],"study_design_scores_gemma":[0.009322752,0.0029144613,0.9804506,0.00021577961,0.000046878336,8.065663e-7,0.0001216749,0.00009560136,0.004749347,0.000032005715,0.0019326101,0.000117502794],"about_ca_topic_score_codex":0.0007110084,"about_ca_topic_score_gemma":0.00015085924,"teacher_disagreement_score":0.009496771,"about_ca_system_score_codex":0.0005628304,"about_ca_system_score_gemma":0.00070672325,"threshold_uncertainty_score":0.9998046},"labels":[],"label_agreement":null},{"id":"W2942092166","doi":"10.1097/pgp.0000000000000603","title":"Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Fallopian tube; Adenocarcinoma; Medicine; Pathology; Ovary; Hysterectomy; Cervical cancer; Gynecology; Internal medicine; Cancer","score_opus":0.013151174578396532,"score_gpt":0.27055628740547366,"score_spread":0.2574051128270771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942092166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97353476,0.00027350904,0.00012830672,0.024238838,0.0010613288,0.0002542786,0.0000339177,0.000004672923,0.0004703938],"genre_scores_gemma":[0.99522036,0.00006637567,0.0009319254,0.0033543124,0.00031270538,0.00001748692,0.000004477986,0.000008541028,0.0000838166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859935,0.00010040862,0.00049127743,0.00016778364,0.00047866543,0.00016250701],"domain_scores_gemma":[0.9985449,0.00049126375,0.00016814703,0.00014231376,0.00055020244,0.0001031901],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031822702,0.00011265671,0.00040183988,0.00012659447,0.000013052336,0.000015087142,0.00030244785,0.000123765,0.0018801535],"category_scores_gemma":[0.0004109746,0.00006680606,0.00023575369,0.000086419976,0.00010876323,0.00005198864,0.0000772002,0.0002180871,0.00010645277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026169713,0.0008374488,0.98095214,0.000012170587,0.0003713773,0.004875524,0.0010217858,0.00009490252,0.0013423874,0.002172216,0.0006780176,0.0050250427],"study_design_scores_gemma":[0.0018357835,0.002763858,0.9891209,0.00005588173,0.00010937729,0.0010748963,0.00015645396,0.000004294614,0.0007177237,0.00053046946,0.0035681045,0.00006223761],"about_ca_topic_score_codex":0.000026548496,"about_ca_topic_score_gemma":0.00014986628,"teacher_disagreement_score":0.021685604,"about_ca_system_score_codex":0.00012700989,"about_ca_system_score_gemma":0.00021586927,"threshold_uncertainty_score":0.99903226},"labels":[],"label_agreement":null},{"id":"W2942929936","doi":"10.1186/s12885-019-5611-7","title":"Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Université de Sherbrooke","keywords":"Mucin; Cancer research; Downregulation and upregulation; Ascites; Mesothelium; Chemokine; Ovarian cancer; Mesothelial Cell; CCL7; Mucin 2; Proinflammatory cytokine; Medicine; Biology; Pathology; Immunology; Internal medicine; Gene expression; Cancer; Inflammation; CXCL10","score_opus":0.01897863812219446,"score_gpt":0.2945702176792992,"score_spread":0.2755915795571047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942929936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954012,0.0017725073,0.000018747793,0.00015798115,0.0007422336,0.0010194243,0.0005102231,0.000045627345,0.00033205407],"genre_scores_gemma":[0.9971355,0.00060305087,0.0006195765,0.00029179698,0.00049732253,0.00031395684,0.00021002398,0.000054000127,0.00027475282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810606,0.00008865861,0.0003561257,0.0007119281,0.00039556006,0.0003416427],"domain_scores_gemma":[0.99918807,0.00006224749,0.00014748573,0.0003649928,0.00007358689,0.00016364307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009286634,0.00029533426,0.0004603901,0.00008096799,0.000092022616,0.000058439906,0.00008823534,0.00017210135,0.0026210656],"category_scores_gemma":[0.0000072484236,0.00024097794,0.00007434014,0.00010634622,0.000044847922,0.00033359067,0.00006697945,0.00017968877,0.000018336048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004277506,0.00068140245,0.8793251,0.00010000172,0.00006348126,0.000011596451,0.0024277528,0.00033163404,0.113330826,0.000060230817,0.00021179953,0.0030284356],"study_design_scores_gemma":[0.013346811,0.00073121913,0.80851054,0.0010408183,0.00013586131,9.2367134e-7,0.0002726481,0.0006369432,0.1720699,0.0002590481,0.0025763877,0.00041887892],"about_ca_topic_score_codex":0.024589822,"about_ca_topic_score_gemma":0.006029896,"teacher_disagreement_score":0.07081454,"about_ca_system_score_codex":0.0004842537,"about_ca_system_score_gemma":0.0002013635,"threshold_uncertainty_score":0.99829066},"labels":[],"label_agreement":null},{"id":"W2944558421","doi":"10.1002/9780471420194.tnmc84","title":"Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Fallopian tube; Peritoneum; Ovary; Medicine; Physical examination; Gynecology; Radiology; Surgery; Internal medicine","score_opus":0.02066758949708083,"score_gpt":0.28830999945501884,"score_spread":0.26764240995793803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944558421","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022774036,0.011922343,0.0000051003935,0.004422256,0.0006889456,0.0010291343,0.005037345,0.00022131097,0.97439617],"genre_scores_gemma":[0.004163289,0.0028559112,0.004484239,0.0011428914,0.0031183215,0.00007226619,0.004053677,0.00046427094,0.97964513],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988331,0.000016974254,0.00016624464,0.00049964554,0.00021914522,0.00026484567],"domain_scores_gemma":[0.99878263,0.000019893843,0.00015830659,0.0007840028,0.000029893927,0.00022528053],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000040693765,0.0003472563,0.0006956269,0.00014267846,0.00006749171,0.00003534292,0.000114705166,0.00031484276,0.0047279587],"category_scores_gemma":[0.000019432498,0.00028397382,0.00010716629,0.000035196324,0.00012220576,0.000022987475,0.00009017321,0.00024126645,0.000064508225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007427598,0.00054754433,0.023816045,0.00047341554,0.00038060956,0.0007651221,0.000040867166,1.4244579e-8,0.000012543307,0.00010914103,0.93581295,0.03796749],"study_design_scores_gemma":[0.0021760392,0.0002412326,0.2046148,0.00070851884,0.00034265494,0.00010369098,0.0000048960687,0.0000053032954,0.000006483744,0.0000075746375,0.7915859,0.00020286842],"about_ca_topic_score_codex":0.0010094244,"about_ca_topic_score_gemma":0.00069461827,"teacher_disagreement_score":0.18079877,"about_ca_system_score_codex":0.000118042524,"about_ca_system_score_gemma":0.00029006263,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W2945273075","doi":"10.1200/edbk_238755","title":"Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Oncology; Chemotherapy; Maintenance therapy; Internal medicine; Ovarian cancer; Disease; Clinical trial; Adjuvant therapy; Adjuvant; Intensive care medicine; Surgery; Cancer","score_opus":0.14584485210320305,"score_gpt":0.510635520712278,"score_spread":0.36479066860907494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945273075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009445757,0.9674177,0.0000021263493,0.02401636,0.0005048911,0.0017813349,0.00008644893,0.000013662149,0.0052328794],"genre_scores_gemma":[0.00024767,0.97257644,0.003669598,0.013312766,0.00040860494,0.0006192179,0.00015877736,0.00004438227,0.00896252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967903,0.0002566312,0.0015490886,0.00080282125,0.0002289205,0.00037226395],"domain_scores_gemma":[0.9936608,0.0039743194,0.0015612087,0.00042549073,0.00013256312,0.00024563842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005709519,0.00041795455,0.0043500713,0.00006879993,0.000039651874,0.0000062479394,0.00016625682,0.00046486635,0.0006173109],"category_scores_gemma":[0.00020466949,0.00031036767,0.0012431334,0.00026498828,0.0013261441,0.000048570033,0.000053696254,0.0006087187,0.000052431173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006709868,0.0017307771,0.020575041,0.0012795096,0.0014023375,0.0000058298574,0.00015890699,6.151963e-7,3.2766586e-8,0.00012713941,0.042699292,0.93195343],"study_design_scores_gemma":[0.0026505513,0.0023337011,0.07099272,0.001831125,0.0012742459,0.0000235807,0.00014946547,0.0000047159892,1.2269359e-7,0.00007033611,0.92045534,0.00021407205],"about_ca_topic_score_codex":0.00040717347,"about_ca_topic_score_gemma":0.000022665923,"teacher_disagreement_score":0.93173933,"about_ca_system_score_codex":0.0021525633,"about_ca_system_score_gemma":0.010795921,"threshold_uncertainty_score":0.99993485},"labels":[],"label_agreement":null},{"id":"W2945357020","doi":"10.3322/caac.21559","title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","year":2019,"lang":"en","type":"review","venue":"CA A Cancer Journal for Clinicians","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1471,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Ovarian cancer; Medicine; Disease; Precision medicine; Debulking; Oncology; Intensive care medicine; Internal medicine; Chemotherapy; Immunotherapy; Bevacizumab; Bioinformatics; Cancer; Pathology; Biology","score_opus":0.10452180894662583,"score_gpt":0.45157121538374023,"score_spread":0.3470494064371144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945357020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007682952,0.98901427,0.0002000106,0.0023707468,0.00342092,0.00363051,0.0006354287,0.0000049577884,0.00064634066],"genre_scores_gemma":[0.00077465235,0.9958366,0.0002423923,0.00021918843,0.0016450282,0.0007598583,0.000044015884,0.000062021725,0.00041623943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961317,0.00023843959,0.0021885221,0.00042408583,0.00065261236,0.00036461966],"domain_scores_gemma":[0.9962513,0.00075660896,0.001971528,0.00061022793,0.0003037442,0.00010661329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016750548,0.0004162301,0.0029069548,0.0003780961,0.00007879541,0.00001171538,0.00043399804,0.00029645825,0.00032564194],"category_scores_gemma":[0.0001117813,0.00023216054,0.0011085927,0.0005826833,0.00012926219,0.000058265563,0.000042321604,0.0008445125,0.000005288578],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003369075,0.0004463484,0.00029170152,0.015199081,0.0015067921,0.00003830588,0.0003552188,0.000028351982,4.198447e-7,0.0004860689,0.0075947107,0.9737161],"study_design_scores_gemma":[0.004987585,0.0015864488,0.00096048607,0.09442069,0.01011561,0.000081176375,0.00025405004,0.000017601787,0.0000016225661,0.0003349501,0.88705766,0.00018212327],"about_ca_topic_score_codex":0.0008804803,"about_ca_topic_score_gemma":0.00036937612,"teacher_disagreement_score":0.973534,"about_ca_system_score_codex":0.0013241065,"about_ca_system_score_gemma":0.0015934526,"threshold_uncertainty_score":0.9467232},"labels":[],"label_agreement":null},{"id":"W2945550010","doi":"10.1016/j.ygyno.2019.04.679","title":"Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data","year":2019,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK; Barts Charity","keywords":"Medicine; Pathological; Serous fluid; Chemotherapy; Oncology; Internal medicine; Serous carcinoma; Meta-analysis; Ovarian carcinoma; Carcinoma; Gynecology; Ovarian cancer; Cancer","score_opus":0.237294401151195,"score_gpt":0.4067019604507278,"score_spread":0.16940755929953283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945550010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017096873,0.9803337,0.000001917376,0.0026435223,0.00010069149,0.012811051,0.0023296971,0.000032547207,0.000037208323],"genre_scores_gemma":[0.008136713,0.9813886,0.0008808906,0.004365758,0.00001946474,0.0035499462,0.0015148743,0.0000566416,0.0000870572],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99074566,0.0036971122,0.002695832,0.0017298417,0.00052676315,0.00060477824],"domain_scores_gemma":[0.98969716,0.005300171,0.002088055,0.0025577075,0.00014315864,0.0002137483],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032471812,0.0009196351,0.020492075,0.000850764,0.00005050376,0.000026986454,0.0008221682,0.0010499217,0.0012180499],"category_scores_gemma":[0.0018432585,0.000532483,0.0015569115,0.0016446408,0.00022773072,0.00006464027,0.0006699227,0.0007062035,0.00003906908],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017278928,0.003954704,0.0017072161,0.76004153,0.20223328,0.0027726807,0.00036562546,0.0000010630874,1.01984824e-7,0.00007465826,0.001299658,0.027376657],"study_design_scores_gemma":[0.001514439,0.0046820445,0.00911236,0.01139407,0.954191,0.00040227268,0.00004392192,0.000005214034,1.7966036e-7,0.000014641226,0.018205168,0.00043464254],"about_ca_topic_score_codex":0.00007532592,"about_ca_topic_score_gemma":0.0000841161,"teacher_disagreement_score":0.7519578,"about_ca_system_score_codex":0.0007463197,"about_ca_system_score_gemma":0.0013115028,"threshold_uncertainty_score":0.99971265},"labels":[],"label_agreement":null},{"id":"W2945639390","doi":"","title":"Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas","year":2015,"lang":"en","type":"article","venue":"Europe PMC (PubMed Central)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Cancer research; Methylation; Gene; Clear cell; DNA methylation; Biology; Ovarian carcinomas; Oncology; Medicine; Carcinoma; Cancer; Gene expression; Genetics; Ovarian carcinoma","score_opus":0.024880177923661467,"score_gpt":0.2367206965644651,"score_spread":0.21184051864080364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945639390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796695,0.006121434,0.00002152908,0.0018378032,0.00036314718,0.0019405733,0.000016185395,0.00006196993,0.00996782],"genre_scores_gemma":[0.9959052,0.0009538998,0.0016642307,0.0002481322,0.00022757695,0.00021193353,0.00004982578,0.00005682489,0.0006823849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784243,0.00018691746,0.00034510723,0.0005113059,0.0003970817,0.0007171534],"domain_scores_gemma":[0.99868584,0.00012269098,0.000110098656,0.00030125523,0.000094918876,0.0006851824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054603076,0.0002417546,0.00034133892,0.00026717418,0.000039337738,0.00006503376,0.000092309725,0.00008024298,0.00007814396],"category_scores_gemma":[0.00063844747,0.00020792689,0.000054222342,0.0006781907,0.000060381193,0.0001313813,0.000067904904,0.00020759148,0.0000835942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009063449,0.0006093064,0.9739825,0.00010863771,0.00010726236,0.0008049167,0.002472843,0.000013704789,0.000719711,0.00016245742,0.0012127506,0.018899534],"study_design_scores_gemma":[0.0063304626,0.0006527524,0.9607028,0.00006511919,0.00019616849,0.000077993274,0.00017310386,0.00003340483,0.019827165,0.000056234436,0.011680491,0.00020432234],"about_ca_topic_score_codex":0.00018641342,"about_ca_topic_score_gemma":0.000010322064,"teacher_disagreement_score":0.019107454,"about_ca_system_score_codex":0.00032622882,"about_ca_system_score_gemma":0.00027885137,"threshold_uncertainty_score":0.8479012},"labels":[],"label_agreement":null},{"id":"W2946071563","doi":"10.1136/ijgc-00009577-200409001-00385","title":"385 Ovarian Cancer (Eoc): Relapse Outcomes and A Predictive Survival Model","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Ovarian cancer; Internal medicine; Gynecology; Cancer","score_opus":0.033747950500730144,"score_gpt":0.34600672107734676,"score_spread":0.3122587705766166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946071563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9358579,0.0022233604,0.0018744171,0.055948507,0.0021540378,0.00026465798,0.00017606645,0.00002015714,0.0014809349],"genre_scores_gemma":[0.9920142,0.0031497793,0.0016903875,0.0022740366,0.00046939444,0.000063752275,0.000004722419,0.000014720863,0.0003189501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850994,0.00002625217,0.0004437759,0.00021827973,0.0006109346,0.00019079506],"domain_scores_gemma":[0.99870294,0.00013056227,0.0002851938,0.00009059048,0.0005698147,0.00022090653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019300266,0.00017417956,0.00043930364,0.00011906704,0.000046330464,0.000038684153,0.00016089706,0.000117083975,0.0007351821],"category_scores_gemma":[0.00020067253,0.000113083166,0.00019323852,0.00007351226,0.00010018755,0.00016702362,0.00006617873,0.00030007015,0.000004575267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025034042,0.0017898089,0.924078,0.000025973397,0.003653674,0.0015257768,0.0007623082,0.028807381,0.0003317595,0.006017149,0.0018028381,0.028701939],"study_design_scores_gemma":[0.009512871,0.0008511804,0.9805994,0.00022542101,0.00038232998,0.00014603705,0.000067497975,0.0006737486,0.00032159773,0.0049747657,0.0020946213,0.00015054921],"about_ca_topic_score_codex":0.0002562581,"about_ca_topic_score_gemma":0.00018610014,"teacher_disagreement_score":0.056521393,"about_ca_system_score_codex":0.000983116,"about_ca_system_score_gemma":0.0005274742,"threshold_uncertainty_score":0.8049728},"labels":[],"label_agreement":null},{"id":"W2946645287","doi":"10.1136/ijgc-2019-000310","title":"Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Trillium Health Centre; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Debulking; Ascites; Ovarian cancer; Serous fluid; Stage (stratigraphy); Lymph node; Cancer; Surgery; Internal medicine; Urology","score_opus":0.020713627029189784,"score_gpt":0.298504350260105,"score_spread":0.27779072323091525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946645287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932031,0.001478084,0.00019450221,0.003419783,0.0012438374,0.00026381438,0.00007715257,0.0000047231115,0.00011502195],"genre_scores_gemma":[0.99723405,0.0015482266,0.00034535083,0.00048756422,0.00017250045,0.000055900626,0.000020804207,0.00001033425,0.000125249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984994,0.000048400037,0.0005614675,0.00022543929,0.00051482563,0.0001504912],"domain_scores_gemma":[0.9984017,0.00029944303,0.0005695243,0.000089730376,0.00047201436,0.00016756292],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015592185,0.00015060771,0.00048502063,0.00019923937,0.000016516242,0.000018763076,0.000104445025,0.00005842566,0.0011007406],"category_scores_gemma":[0.00019570271,0.00010144348,0.00011341668,0.00012573278,0.00009068125,0.00022563944,0.000044477812,0.0001697738,0.0000018264093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002638234,0.0005354424,0.97501373,0.000062960185,0.00030105872,0.0000985977,0.00007296754,0.00094279245,0.00022219014,0.00012453509,0.000110327885,0.019877149],"study_design_scores_gemma":[0.0037716138,0.0002490315,0.99420017,0.0006902397,0.00013514857,0.0000135889695,0.000043374705,0.0002931908,0.00009648271,0.00014677932,0.0002541628,0.00010623799],"about_ca_topic_score_codex":0.00013981208,"about_ca_topic_score_gemma":0.000048725273,"teacher_disagreement_score":0.019770911,"about_ca_system_score_codex":0.0008181566,"about_ca_system_score_gemma":0.00060249143,"threshold_uncertainty_score":0.99981236},"labels":[],"label_agreement":null},{"id":"W2946854933","doi":"10.1200/jco.2019.37.15_suppl.5513","title":"Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Carboplatin; Internal medicine; Adverse effect; Gemcitabine; Cohort; Toxicity; Oncology; Ovarian cancer; Chemotherapy; Phases of clinical research; Surgery; Cancer; Cisplatin","score_opus":0.12335326585438619,"score_gpt":0.46977216359482143,"score_spread":0.3464188977404352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946854933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966956,0.00010475582,0.0000062170784,0.0066638016,0.00038207657,0.0018219004,0.000012428403,0.000007991946,0.0013312723],"genre_scores_gemma":[0.9931891,0.00013702472,0.0028074896,0.0031011698,0.0003373275,0.000060618295,0.0000062613476,0.000048282876,0.00031272395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965008,0.00035283837,0.001774294,0.0004463926,0.00058336725,0.00034233215],"domain_scores_gemma":[0.99649966,0.0005422273,0.0016240337,0.0004171739,0.0004534007,0.00046351508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001621725,0.00026787232,0.0019684175,0.00012954824,0.000064899774,0.000032933367,0.00036330076,0.00015001428,0.0009053336],"category_scores_gemma":[0.00016416139,0.00015295586,0.0000772754,0.0002740393,0.00009074233,0.00032471106,0.00008458781,0.00077755976,0.000008583864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072814606,0.07295845,0.68213123,0.0000190918,0.0010640324,0.00110193,0.00036264322,0.000027807366,0.00002159901,0.000037218142,0.00068188366,0.16877949],"study_design_scores_gemma":[0.16346198,0.31505314,0.50663596,0.00027560283,0.00035562547,0.000036556943,0.00017085501,0.000028427652,0.000019539102,0.00002388596,0.013801551,0.00013686417],"about_ca_topic_score_codex":0.0005958206,"about_ca_topic_score_gemma":0.0029947977,"teacher_disagreement_score":0.24209468,"about_ca_system_score_codex":0.00053367583,"about_ca_system_score_gemma":0.0025395781,"threshold_uncertainty_score":0.99127686},"labels":[],"label_agreement":null},{"id":"W2946857908","doi":"10.1200/jco.2019.37.15_suppl.tps5604","title":"Phase I (safety assessment) of durvalumab (MEDI4736) with focal sensitizing radiotherapy in platinum resistant ovarian, primary peritoneal or fallopian tube epithelial carcinoma.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Durvalumab; Radioimmunotherapy; Fallopian tube; Tolerability; Response Evaluation Criteria in Solid Tumors; Oncology; Urology; Ovarian carcinoma; Radiation therapy; Internal medicine; Gastroenterology; Ovarian cancer; Chemotherapy; Phases of clinical research; Adverse effect; Immunotherapy; Surgery; Nivolumab; Cancer; Antibody; Immunology","score_opus":0.06220732014825342,"score_gpt":0.4392053871118035,"score_spread":0.3769980669635501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946857908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872631,0.00026180592,0.00033170596,0.0074493657,0.0010196433,0.0006164053,0.000030078025,0.000008216515,0.0030197084],"genre_scores_gemma":[0.97097206,0.00055351673,0.025481958,0.0015581355,0.0011743772,0.0000069272187,0.000011000047,0.000038583712,0.0002034493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950087,0.000647149,0.0029623916,0.0003577585,0.00066252466,0.00036148113],"domain_scores_gemma":[0.99491686,0.0023212654,0.0017027059,0.0003430693,0.00034327846,0.00037282612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030750334,0.00025274762,0.0026977912,0.00020833207,0.000037140413,0.000011384716,0.00015221456,0.00039697337,0.00036259214],"category_scores_gemma":[0.00031716973,0.0001566774,0.0003743279,0.00023448335,0.00022976274,0.00014063819,0.000039125065,0.0010889397,0.000002725463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16504072,0.018259255,0.6716816,0.00035339288,0.0022271043,0.015578183,0.00069645495,0.00018969495,0.00591188,0.000813688,0.0007020974,0.118545964],"study_design_scores_gemma":[0.10523363,0.08454442,0.7901258,0.00054508843,0.0004733333,0.0011440039,0.00024530813,0.00083018054,0.00016034972,0.000027975728,0.01648717,0.00018277054],"about_ca_topic_score_codex":0.00013668544,"about_ca_topic_score_gemma":0.00023108935,"teacher_disagreement_score":0.1184442,"about_ca_system_score_codex":0.0010276088,"about_ca_system_score_gemma":0.0069511835,"threshold_uncertainty_score":0.9986785},"labels":[],"label_agreement":null},{"id":"W2946878839","doi":"10.1200/jco.2019.37.15_suppl.5520","title":"Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-resistant ovarian cancer: Final findings from the FORWARD II study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Adverse effect; Gastroenterology; Nausea; Ovarian cancer; Combination therapy; Cancer; Oncology; Surgery; Chemotherapy","score_opus":0.035629440572361115,"score_gpt":0.3737685522482352,"score_spread":0.33813911167587407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946878839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634696,0.0002950622,0.000012222388,0.011092222,0.00068633485,0.001360252,0.000039038456,0.000008492164,0.0001594372],"genre_scores_gemma":[0.99690807,0.0002713179,0.0015614927,0.0008509911,0.0002175035,0.000030446408,0.00004133473,0.000036955047,0.000081860686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956252,0.0005742121,0.0022581303,0.0004470452,0.00070018845,0.0003952314],"domain_scores_gemma":[0.9956246,0.0016615465,0.0017577484,0.00027535812,0.0004757568,0.00020500411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024769676,0.00029598572,0.0018054704,0.00017189092,0.00009708898,0.000031259693,0.00023271197,0.00022147271,0.00023201441],"category_scores_gemma":[0.00049971906,0.000165749,0.00017289301,0.0003866256,0.00011398703,0.0002412739,0.000072903706,0.0011925687,0.000011521031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03223474,0.008484757,0.9397995,0.000021329193,0.0006857658,0.00035161126,0.0014001911,0.00006419415,0.00004318664,0.00004399261,0.00081990036,0.01605082],"study_design_scores_gemma":[0.091394156,0.048813067,0.8544345,0.00089425547,0.00043377827,0.00000916574,0.00055457937,0.000134641,0.000030186106,0.00008059986,0.0030477825,0.00017327124],"about_ca_topic_score_codex":0.0018191519,"about_ca_topic_score_gemma":0.0043634293,"teacher_disagreement_score":0.085365005,"about_ca_system_score_codex":0.00074296904,"about_ca_system_score_gemma":0.0014793767,"threshold_uncertainty_score":0.6759048},"labels":[],"label_agreement":null},{"id":"W2946909477","doi":"10.1200/jco.2019.37.15_suppl.5580","title":"Clinical outcome of sequential chemotherapy after immune checkpoint inhibitors in advanced ovarian cancer.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Oncology; Ovarian cancer; Cancer; Immunotherapy; Clinical trial","score_opus":0.0830174930603624,"score_gpt":0.4858528766404057,"score_spread":0.40283538358004334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946909477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768226,0.0015601418,0.000016417229,0.015252678,0.004719767,0.00045349795,0.0000063695493,0.000005768843,0.0011627204],"genre_scores_gemma":[0.9894996,0.0032384235,0.0034007952,0.0021804443,0.0013595932,0.00001818422,0.000001657477,0.000028274168,0.00027298473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924699,0.00039032524,0.0061609256,0.0003056803,0.0003884753,0.00028468258],"domain_scores_gemma":[0.9950613,0.0010895217,0.0028696782,0.0003478102,0.0003237831,0.00030791556],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004237926,0.00019901535,0.0028969953,0.00015854904,0.0000099640465,0.0000052758764,0.00016865935,0.00053888,0.0013419844],"category_scores_gemma":[0.00079257134,0.00014029063,0.0013063843,0.0001939096,0.00019304623,0.000118492826,0.00005714247,0.0011705175,0.000030077612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00922108,0.0030769368,0.8002347,0.00005328073,0.00048691005,0.00036087772,0.000065137785,0.00002193134,0.00024249093,0.000032457825,0.0001363031,0.1860679],"study_design_scores_gemma":[0.033234995,0.010827441,0.92694205,0.00042693075,0.00026888007,0.000055366207,0.000052890642,0.000023862667,0.00065906346,0.000113712864,0.027279336,0.000115462775],"about_ca_topic_score_codex":0.00015367419,"about_ca_topic_score_gemma":0.00012114224,"teacher_disagreement_score":0.18595244,"about_ca_system_score_codex":0.0003687374,"about_ca_system_score_gemma":0.0015895707,"threshold_uncertainty_score":0.9995709},"labels":[],"label_agreement":null},{"id":"W2946941944","doi":"10.1200/jco.2019.37.15_suppl.5560","title":"Effect of estrogen and progesterone receptor expression on progression-free and overall survival outcomes in low-grade serous ovarian cancer.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Dalhousie University; Vancouver General Hospital; Centre Hospitalier de l’Université de Montréal; University of Calgary; Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Immunohistochemistry; Internal medicine; Progesterone receptor; Oncology; Ovarian cancer; Estrogen receptor; Tissue microarray; Serous fluid; Proportional hazards model; Gynecology; Progression-free survival; Population; Estrogen; Stage (stratigraphy); Cancer; Breast cancer; Overall survival","score_opus":0.04703348005093867,"score_gpt":0.44751143145926464,"score_spread":0.400477951408326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946941944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892105,0.0009854435,9.3778027e-7,0.008260109,0.0010577478,0.0006225891,0.000009676877,0.000004488224,0.00013793167],"genre_scores_gemma":[0.99688303,0.0013402554,0.0010798565,0.00030131792,0.00029323134,0.000023216884,0.0000017995208,0.000016422715,0.00006084545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974565,0.00054707046,0.0012328553,0.00023884872,0.00033797752,0.00018678364],"domain_scores_gemma":[0.9958919,0.00254561,0.0010005493,0.00022388101,0.00007904249,0.0002589775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018941032,0.00016827851,0.0017706017,0.00009387522,0.000015504236,0.000007445686,0.00009747819,0.00028839317,0.00006436082],"category_scores_gemma":[0.0008389675,0.00009589668,0.00017173467,0.0000560548,0.00010150298,0.00007674215,0.00007983077,0.0005092742,0.000002318294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070148213,0.0016794126,0.8944725,0.0001890568,0.00022233154,0.00013737503,0.000060111597,0.0000048793236,0.00038906588,0.000042339016,0.00024693646,0.09554121],"study_design_scores_gemma":[0.033319414,0.04629689,0.9140266,0.0016641399,0.00021964952,0.0000486614,0.000016872345,0.000016738397,0.0025682037,0.00005913171,0.0016753213,0.000088387635],"about_ca_topic_score_codex":0.000050252038,"about_ca_topic_score_gemma":0.000027059581,"teacher_disagreement_score":0.09545282,"about_ca_system_score_codex":0.00012605432,"about_ca_system_score_gemma":0.0003663758,"threshold_uncertainty_score":0.39105532},"labels":[],"label_agreement":null},{"id":"W2946983074","doi":"10.1200/jco.2019.37.15_suppl.tps5600","title":"ENGOT-OV44/FIRST study: A randomized, double-blind, adaptive, phase III study of platinum-based therapy with dostarlimab (TSR-042) + niraparib versus standard-of-care (SOC) platinum-based therapy as first-line treatment of stage 3/4 non-mucinous epithelial ovarian cancer (OC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Oncology; Internal medicine; Carboplatin; Trabectedin; Pembrolizumab; Bevacizumab; Clinical endpoint; Phases of clinical research; Clinical trial; Chemotherapy; Surgery; Cancer; Immunotherapy; Cisplatin; Soft tissue sarcoma","score_opus":0.12831326470956897,"score_gpt":0.44998987546242525,"score_spread":0.32167661075285625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946983074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984356,0.0022697158,0.00017563681,0.0013892286,0.0012426757,0.009869414,0.0002929424,0.00002009272,0.00038428314],"genre_scores_gemma":[0.9940277,0.0032229272,0.001312036,0.00020585753,0.0005891207,0.00046701473,0.000029774676,0.00009986753,0.000045711153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9910531,0.0010413883,0.0049953703,0.00077569694,0.0015831417,0.00055128825],"domain_scores_gemma":[0.98282397,0.007487229,0.0064595845,0.0009459821,0.0017935748,0.0004896779],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027199276,0.0007758103,0.0077863415,0.0004924153,0.00013233602,0.000021646072,0.000387537,0.0005081332,0.0010350136],"category_scores_gemma":[0.00023778636,0.0004673166,0.0014026122,0.0005247695,0.0004701896,0.00013867511,0.000039279228,0.00077687023,0.0000041643502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7707009,0.07540669,0.07291027,0.00008792191,0.01060023,0.00058899465,0.0059138113,0.0040882053,0.000040920317,0.000018039274,0.000025338586,0.05961869],"study_design_scores_gemma":[0.60615104,0.37862226,0.005393606,0.0003250509,0.002289082,0.0000068682857,0.0031428905,0.00026284147,0.0019269541,0.0000044201497,0.0016412078,0.00023379183],"about_ca_topic_score_codex":0.0031655033,"about_ca_topic_score_gemma":0.0055874554,"teacher_disagreement_score":0.30321556,"about_ca_system_score_codex":0.0010070221,"about_ca_system_score_gemma":0.0067948443,"threshold_uncertainty_score":0.99987817},"labels":[],"label_agreement":null},{"id":"W2947004267","doi":"10.1200/jco.2019.37.15_suppl.5549","title":"How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Prospective cohort study; Internal medicine; Cohort; Ovarian cancer; Cancer; Receiver operating characteristic; Oncology; Gynecology","score_opus":0.07482746390600016,"score_gpt":0.425299448468368,"score_spread":0.35047198456236783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947004267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9130355,0.0014429935,0.00005088556,0.08399258,0.0006121888,0.00068071735,0.000015654485,0.0000031074,0.00016634726],"genre_scores_gemma":[0.99502003,0.0022123442,0.0010748232,0.00076858007,0.0005455323,0.000047623354,0.0000018099416,0.000018695946,0.0003105669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825495,0.00015066874,0.0009146726,0.00019586328,0.00023648281,0.00024735538],"domain_scores_gemma":[0.99404204,0.0040665823,0.0013166183,0.0001774091,0.00026853243,0.0001288456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001390138,0.00014500799,0.0013711812,0.000064058215,0.000024513485,0.00001728698,0.00011785514,0.00014897095,0.0000777739],"category_scores_gemma":[0.00074805407,0.00007651491,0.00015907378,0.00008852358,0.00015849716,0.000109508146,0.000034436245,0.00043406285,0.0000022292438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011466196,0.002339892,0.5139886,0.00019111249,0.0011628781,0.00011023238,0.0008067291,0.00012332306,0.00009558973,0.00010959949,0.0016790365,0.4679268],"study_design_scores_gemma":[0.023279032,0.023491759,0.9195572,0.0012222682,0.0006271629,0.00006531783,0.00061548845,0.0009967966,0.00011338801,0.0003883473,0.029499141,0.00014405743],"about_ca_topic_score_codex":0.000041529456,"about_ca_topic_score_gemma":0.00024385029,"teacher_disagreement_score":0.46778274,"about_ca_system_score_codex":0.00023670931,"about_ca_system_score_gemma":0.0009422598,"threshold_uncertainty_score":0.31201875},"labels":[],"label_agreement":null},{"id":"W2947112132","doi":"10.1200/jco.2019.37.15_suppl.5536","title":"Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the British Columbia (BC) cancer experience.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Cancer; Adjuvant therapy; Population; Lymph node; Dissection (medical); Internal medicine; Cohort; Surgery; Retrospective cohort study; Oncology","score_opus":0.08360401372582288,"score_gpt":0.45040053471250646,"score_spread":0.3667965209866836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947112132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9402634,0.049887415,6.4509084e-7,0.0060997885,0.001442195,0.0005841448,0.00001844736,0.000001802125,0.0017021985],"genre_scores_gemma":[0.6389145,0.35676965,0.00019944523,0.0027536768,0.00020363177,0.00001750925,5.2846576e-7,0.000011510289,0.0011295243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663067,0.00037981436,0.002230886,0.00018769727,0.00039727133,0.00017368334],"domain_scores_gemma":[0.99639606,0.00052354607,0.002288826,0.00028041255,0.00034787497,0.00016326405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015103784,0.00009252683,0.0017367402,0.000025560268,0.000028103344,0.000011001472,0.00022043151,0.0002024211,0.0045893556],"category_scores_gemma":[0.0003441742,0.000069716414,0.00050004444,0.00020177483,0.00014734693,0.000061867715,0.000047489182,0.00052456907,0.0000023871232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076281995,0.0017680462,0.7244207,0.00062892423,0.00012383497,0.0000822208,0.00012530458,0.000008708688,0.00017660193,0.0000037847303,0.009013138,0.26288587],"study_design_scores_gemma":[0.0096905455,0.005524969,0.7689391,0.010177598,0.00014103312,0.000022270075,0.00011043295,0.000009700114,0.00033887135,0.0000183604,0.20496291,0.00006424899],"about_ca_topic_score_codex":0.02077907,"about_ca_topic_score_gemma":0.0070321104,"teacher_disagreement_score":0.30688223,"about_ca_system_score_codex":0.00023561607,"about_ca_system_score_gemma":0.002514385,"threshold_uncertainty_score":0.9963206},"labels":[],"label_agreement":null},{"id":"W2947218961","doi":"10.1200/jco.2019.37.15_suppl.5519","title":"Pembrolizumab with low dose carboplatin for recurrent platinum resistant ovarian, fallopian tube, and primary peritoneal cancer-interim results.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carboplatin; Common Terminology Criteria for Adverse Events; Pembrolizumab; Internal medicine; Ovarian cancer; Tolerability; Neutropenia; Adverse effect; Fallopian tube cancer; Oncology; Topotecan; Bevacizumab; Gastroenterology; Progression-free survival; Surgery; Cancer; Chemotherapy; Immunotherapy; Cisplatin","score_opus":0.07024901414033385,"score_gpt":0.42144278812756775,"score_spread":0.3511937739872339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947218961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97410876,0.00119311,0.00002994603,0.016748847,0.0018294897,0.00090297585,0.000098996534,0.000011993797,0.00507589],"genre_scores_gemma":[0.987903,0.0013877011,0.0071128607,0.0014787283,0.001399733,0.000043672848,0.000018557554,0.000034826462,0.00062090065],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99667615,0.00018231037,0.0020662574,0.0003962666,0.00036339587,0.0003156243],"domain_scores_gemma":[0.9958105,0.0015434634,0.001503424,0.00027417956,0.0004314603,0.00043698848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013933762,0.00022961073,0.0017682277,0.00010086272,0.000050156854,0.000023409713,0.00011956356,0.00031256804,0.000094893134],"category_scores_gemma":[0.0005055175,0.00014700885,0.00028516536,0.00009633034,0.0001535791,0.00010033256,0.000050294537,0.00068169273,0.0000036408053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41154274,0.005391611,0.1503171,0.00083489623,0.0028911226,0.0016193204,0.00071420206,0.000057202546,0.0008306614,0.00082025543,0.01236138,0.4126195],"study_design_scores_gemma":[0.065792404,0.08641828,0.7293237,0.0011836936,0.0008858054,0.00043891015,0.000116527066,0.00019612514,0.0001226203,0.00009937772,0.11519948,0.00022310471],"about_ca_topic_score_codex":0.00008233253,"about_ca_topic_score_gemma":0.00031518305,"teacher_disagreement_score":0.57900655,"about_ca_system_score_codex":0.00049160497,"about_ca_system_score_gemma":0.002746461,"threshold_uncertainty_score":0.5994847},"labels":[],"label_agreement":null},{"id":"W2947257322","doi":"10.1200/jco.2019.37.15_suppl.tps5598","title":"DUO-O: A randomized phase III trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bevacizumab; Olaparib; Oncology; Internal medicine; BRCA mutation; Ovarian cancer; Cancer; PARP inhibitor; Chemotherapy; Maintenance therapy; Surgery","score_opus":0.022389126519296698,"score_gpt":0.3849379027665236,"score_spread":0.3625487762472269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947257322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894393,0.000928908,0.000070761314,0.006509884,0.00071404985,0.0026177245,0.000018178484,0.0000049940386,0.00019155708],"genre_scores_gemma":[0.9914147,0.0063758385,0.00097343134,0.0008937267,0.000096754535,0.00012041492,0.000016253716,0.000027647024,0.00008118678],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99547875,0.000703704,0.00270739,0.00038720018,0.0004240786,0.00029885097],"domain_scores_gemma":[0.9934624,0.0033877685,0.0023704404,0.00019775353,0.00033208466,0.00024956715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003008659,0.0002591682,0.0034528486,0.00021709842,0.00002384363,0.000012995993,0.00010237448,0.0003419089,0.000087074724],"category_scores_gemma":[0.0016461154,0.00017649237,0.00027019586,0.00024381682,0.00026885388,0.00021939033,0.000029230305,0.0006163454,7.7075515e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7922277,0.010837142,0.107107215,0.000053386233,0.00048290912,0.00013251582,0.0003619379,0.000011107532,0.00008213278,0.00015666265,0.0003860937,0.08816121],"study_design_scores_gemma":[0.86008006,0.028042274,0.108967826,0.00054003607,0.00035410057,0.000016911134,0.00007276726,0.0002673594,0.000081711405,0.0003078576,0.0011229133,0.0001461943],"about_ca_topic_score_codex":0.00043389155,"about_ca_topic_score_gemma":0.0006723644,"teacher_disagreement_score":0.08801501,"about_ca_system_score_codex":0.0003780123,"about_ca_system_score_gemma":0.00094003754,"threshold_uncertainty_score":0.71971494},"labels":[],"label_agreement":null},{"id":"W2947277253","doi":"10.1136/ijgc-00009577-200610001-00111","title":"Epigenetic Loss of Brca1 is Common in Highgrade Serous Ovarian Carcinomas, But Not in Other Histopathologic Subtypes of Ovarian Carcinoma","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Ovarian carcinoma; Ovarian carcinomas; Epigenetics; Oncology; Serous carcinoma; Pathology; Carcinoma; Cancer research; Ovarian cancer; Internal medicine; Cancer; Gene; Biology; Genetics","score_opus":0.02348879262082419,"score_gpt":0.29522487750994497,"score_spread":0.27173608488912077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947277253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905015,0.002330676,0.000026623653,0.0053949733,0.00054881815,0.00022071281,0.00012991198,0.000004598962,0.00084217225],"genre_scores_gemma":[0.99799764,0.00027842014,0.0005189585,0.0007875986,0.00023548184,0.000024124594,0.0000067329847,0.000015712865,0.00013530882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977958,0.00011343737,0.0010899382,0.00023941121,0.00052965805,0.00023171857],"domain_scores_gemma":[0.99849594,0.00024069965,0.00068157545,0.00016395855,0.00034119902,0.00007663558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033853223,0.00018918284,0.0007249307,0.00035818506,0.0000140383945,0.000009841945,0.000293707,0.00017267854,0.0011067674],"category_scores_gemma":[0.00007829157,0.0001426024,0.00021377223,0.00020072408,0.00015274329,0.0000676898,0.00005365262,0.00028837976,0.0000022522784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000947957,0.0012754966,0.9889019,0.000034615707,0.000093510615,0.0017710887,0.00017812238,0.00040873908,0.002335333,0.0010227053,0.00017191992,0.0028585924],"study_design_scores_gemma":[0.0048010387,0.0008398968,0.97897255,0.00018242873,0.00008399213,0.00016592571,0.0000393915,0.000057691737,0.012832529,0.0010436665,0.00086593546,0.00011492631],"about_ca_topic_score_codex":0.0076382374,"about_ca_topic_score_gemma":0.002574957,"teacher_disagreement_score":0.010497196,"about_ca_system_score_codex":0.0009500338,"about_ca_system_score_gemma":0.00029018804,"threshold_uncertainty_score":0.99980634},"labels":[],"label_agreement":null},{"id":"W2947454850","doi":"10.1200/jco.2019.37.15_suppl.e14585","title":"Feasibility of a platform trial based on molecular analysis in rare gynecologic cancers.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; KRAS; PTEN; Serous fluid; CDKN2A; Clear cell; Carcinosarcoma; ARID1A; Oncology; Endometrial cancer; Internal medicine; Germ cell tumors; Cancer research; Cancer; PI3K/AKT/mTOR pathway; Carcinoma; Chemotherapy; Colorectal cancer; Biology","score_opus":0.15547059204170982,"score_gpt":0.4855170319560759,"score_spread":0.33004643991436605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947454850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912822,0.000131307,0.00002781913,0.003619116,0.00077107706,0.0005586225,0.000006739563,0.0000027339875,0.0036003883],"genre_scores_gemma":[0.9965234,0.000103083905,0.0011507195,0.00200342,0.00016907667,0.0000086311875,0.0000036013598,0.0000066882844,0.000031395248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967739,0.00030567814,0.0021456596,0.00022947551,0.00037117247,0.00017412653],"domain_scores_gemma":[0.9948423,0.0028517675,0.0015620815,0.00031298053,0.00023176444,0.00019910155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029241988,0.000118850134,0.0022412182,0.00030821707,0.00000803486,0.0000030398928,0.00011952121,0.00033994613,0.0009806614],"category_scores_gemma":[0.0022656263,0.00007799072,0.001118476,0.00045509255,0.00007858141,0.000040005994,0.000018844903,0.00058226875,0.000009028161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11156982,0.006163996,0.8569585,0.000034153847,0.0013070257,0.00077339046,0.000025261157,0.002725198,0.000021598249,0.00008641202,0.00023259592,0.02010206],"study_design_scores_gemma":[0.15446532,0.049262177,0.79163873,0.00008245974,0.0017701156,0.0000063400894,0.000044045704,0.0010627758,0.00010995663,0.00019189995,0.0012932924,0.000072870826],"about_ca_topic_score_codex":0.00008642972,"about_ca_topic_score_gemma":0.0002403634,"teacher_disagreement_score":0.06531974,"about_ca_system_score_codex":0.0008724072,"about_ca_system_score_gemma":0.0028223149,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W2947501186","doi":"10.1200/jco.2019.37.15_suppl.e17105","title":"Clinical outcomes of postoperative intraperitoneal chemotherapy for patients with early-stage high-grade serous ovarian cancer (HGSC) treated at British Columbia cancer agency.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Oncology; Serous fluid; Cohort; Cancer; Surgery","score_opus":0.04794476041468461,"score_gpt":0.41216069356467455,"score_spread":0.36421593314998996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947501186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883546,0.00028744276,0.0000087620965,0.00752922,0.0019738663,0.001388671,0.00030901385,0.000011451795,0.00013693077],"genre_scores_gemma":[0.98630285,0.0029856307,0.002272709,0.004735474,0.00055026246,0.00008844058,0.000024588731,0.00005640167,0.0029836656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995636,0.000313475,0.0027703103,0.0004461508,0.00046377216,0.00037031967],"domain_scores_gemma":[0.9943239,0.0016483506,0.002271451,0.00028697768,0.0010301997,0.00043910058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000917759,0.00023110076,0.0029516849,0.000053666725,0.000070862436,0.000032444874,0.00018717344,0.000529711,0.0021194383],"category_scores_gemma":[0.00030720164,0.00019316621,0.0007557908,0.00015239826,0.00028714098,0.00013331529,0.00003974632,0.0006065953,0.0000057474017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064747897,0.0056334175,0.88797873,0.000038786537,0.0031519146,0.00015096221,0.00012475289,0.000011291838,0.000011737691,0.000007962376,0.004877276,0.09153835],"study_design_scores_gemma":[0.048655294,0.031000145,0.8917635,0.00023942464,0.00084731536,0.000020358488,0.000020385762,0.000011601905,0.000036866306,0.000018067689,0.027212987,0.00017406447],"about_ca_topic_score_codex":0.020587822,"about_ca_topic_score_gemma":0.033586577,"teacher_disagreement_score":0.09136428,"about_ca_system_score_codex":0.00054286816,"about_ca_system_score_gemma":0.0017767097,"threshold_uncertainty_score":0.99879277},"labels":[],"label_agreement":null},{"id":"W2947614825","doi":"10.1200/jco.2019.37.15_suppl.5514","title":"Dose-dense early postoperative intraperitoneal chemotherapy in ovarian cancer: Randomized, phase II trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Ovarian cancer; Debulking; Taxane; Chemotherapy; Internal medicine; Surgery; Cisplatin; Gastroenterology; Cancer; Breast cancer","score_opus":0.07083881081287317,"score_gpt":0.4701139727208219,"score_spread":0.3992751619079487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947614825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9344354,0.0010751188,0.000013224388,0.05776151,0.0030563406,0.0014817939,0.0000057261773,0.0000065898685,0.0021642614],"genre_scores_gemma":[0.983786,0.005142425,0.0011871383,0.007432571,0.0017979678,0.00006179902,0.000002132301,0.000026053707,0.0005639479],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953982,0.00086238654,0.0028316288,0.0002827701,0.00034721868,0.00027779525],"domain_scores_gemma":[0.9952537,0.0024298115,0.0014186302,0.00022774971,0.00031972514,0.00035041198],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041807224,0.0002061985,0.003455271,0.00017069426,0.000036344074,0.000015373276,0.00013922068,0.0004152852,0.0016039163],"category_scores_gemma":[0.0009744927,0.00013224213,0.00084413664,0.00018093284,0.00020088021,0.00013524064,0.000030069737,0.0010019497,0.000032526266],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8283013,0.011022864,0.0067777843,0.000009790212,0.0010872934,0.0007238442,0.0006585882,0.0000072887933,0.00018228701,0.00029869875,0.0012701348,0.1496601],"study_design_scores_gemma":[0.88906056,0.061472762,0.017383497,0.0001634849,0.0004155792,0.00010578232,0.000065667984,0.000050407834,0.0001786852,0.00016271048,0.030825809,0.00011507492],"about_ca_topic_score_codex":0.00031085563,"about_ca_topic_score_gemma":0.000084392865,"teacher_disagreement_score":0.14954503,"about_ca_system_score_codex":0.0003685062,"about_ca_system_score_gemma":0.002532988,"threshold_uncertainty_score":0.99930876},"labels":[],"label_agreement":null},{"id":"W2947885304","doi":"10.1158/1078-0432.ccr-18-3720","title":"Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Government of Canada","keywords":"Epithelial ovarian cancer; Ovarian cancer; Methylation; Biology; DNA methylation; Computational biology; Cancer research; Oncology; Pathology; Cancer; Medicine; Gene; Genetics; Gene expression","score_opus":0.5404776784566071,"score_gpt":0.5762779312042575,"score_spread":0.03580025274765042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947885304","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05998175,0.0033699824,0.0012419552,0.921034,0.0031313638,0.008966281,0.0016717454,0.0000580954,0.00054485037],"genre_scores_gemma":[0.79577965,0.004477116,0.0019270147,0.16773659,0.015892787,0.011041322,0.0016014529,0.00037926305,0.0011648312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321795,0.0013487667,0.001228193,0.0014551368,0.002024455,0.0007255009],"domain_scores_gemma":[0.9889268,0.007079883,0.0005442421,0.0014563213,0.0018125686,0.00018016947],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045732525,0.00039251446,0.0012687355,0.00036369875,0.00010969092,0.00004870432,0.00042227816,0.0012251996,0.0002688152],"category_scores_gemma":[0.0025758753,0.0003229147,0.0007691935,0.00049056724,0.00036623672,0.00006671661,0.00008048839,0.00249394,0.000037444683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020903407,0.002895299,0.27005076,0.01240633,0.003205288,0.00028000603,0.00007034646,0.0012637164,0.013350479,0.0006442745,0.58307064,0.09185944],"study_design_scores_gemma":[0.022872578,0.012915893,0.21567419,0.012998425,0.002872626,0.0000023564403,0.000026379616,0.019528084,0.12834883,0.00053571945,0.5827316,0.0014933072],"about_ca_topic_score_codex":0.0008679556,"about_ca_topic_score_gemma":0.00008704163,"teacher_disagreement_score":0.7532974,"about_ca_system_score_codex":0.0010988604,"about_ca_system_score_gemma":0.0040002135,"threshold_uncertainty_score":0.9999223},"labels":[],"label_agreement":null},{"id":"W2947969924","doi":"10.1200/jco.2019.37.15_suppl.5541","title":"Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Placebo; Internal medicine; Chemotherapy; Oncology; Response Evaluation Criteria in Solid Tumors; Ovarian cancer; Surgery; Progressive disease; Tolerability; Urology; Cancer; Adverse effect; Pathology","score_opus":0.024357977983577105,"score_gpt":0.3886728951364615,"score_spread":0.36431491715288444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947969924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080294,0.000697997,0.000021876862,0.006611269,0.0002883835,0.0014568673,0.000019967003,0.0000039014894,0.000096786185],"genre_scores_gemma":[0.9949151,0.000787116,0.0006446737,0.003339857,0.000142815,0.000109516484,0.000011099558,0.000019829504,0.000029937144],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971263,0.0004242162,0.0014594084,0.00032749848,0.0003347888,0.00032778806],"domain_scores_gemma":[0.99508965,0.003355843,0.0009979084,0.00017152865,0.00014698601,0.00023806073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013252061,0.00020329189,0.0012991843,0.00010659417,0.000023198496,0.000021270498,0.000077996854,0.0001809033,0.00014589787],"category_scores_gemma":[0.0004955505,0.000114398754,0.00012268439,0.00018514073,0.00015626213,0.00012581065,0.000013618246,0.0006389064,0.0000014753223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3305706,0.009753391,0.42814982,0.000026702619,0.00015898078,0.0011498965,0.000438009,0.000057787092,0.0000045860816,0.00002862411,0.00046322422,0.22919837],"study_design_scores_gemma":[0.5045735,0.022558216,0.46514007,0.00024220324,0.000105134575,0.000027883418,0.0000723883,0.0001582283,0.0000062408208,0.000028270731,0.0069987355,0.000089132765],"about_ca_topic_score_codex":0.00020444214,"about_ca_topic_score_gemma":0.00040458792,"teacher_disagreement_score":0.22910923,"about_ca_system_score_codex":0.00027019155,"about_ca_system_score_gemma":0.00089318235,"threshold_uncertainty_score":0.46650457},"labels":[],"label_agreement":null},{"id":"W2948010379","doi":"10.1200/jco.2019.37.15_suppl.e17093","title":"Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis.","year":2019,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University Health Network; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery; Randomized controlled trial; Checklist; Ovarian cancer; Cochrane Library; Meta-analysis; MEDLINE; Chemotherapy; Surgery; Oncology; Internal medicine; Cancer","score_opus":0.33519821354455426,"score_gpt":0.5253226495820315,"score_spread":0.1901244360374772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948010379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032186112,0.9837626,0.000012142335,0.010132685,0.0009839585,0.004555614,0.00018665906,0.000010320861,0.000034159293],"genre_scores_gemma":[0.00017808234,0.99160504,0.000989365,0.0056826607,0.0004890442,0.00066471176,0.000044394306,0.000054205815,0.00029248983],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99067104,0.0017880652,0.0060886606,0.0006629624,0.0004303261,0.00035893495],"domain_scores_gemma":[0.9781321,0.013703938,0.006879344,0.00046211787,0.00035847124,0.00046397216],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.007460947,0.0006519547,0.044477005,0.0003256853,0.00008046465,0.000025172,0.00018062747,0.00089886977,0.00015889372],"category_scores_gemma":[0.002197911,0.00033881894,0.012711001,0.00035820706,0.00018123827,0.00009739296,0.00008637277,0.0008558329,0.0000033452081],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036471803,0.0010025286,0.0010281849,0.36900875,0.5621339,0.00031277232,0.00002183678,2.991737e-7,1.06955945e-7,0.000008273976,0.0012734152,0.06484518],"study_design_scores_gemma":[0.0026217012,0.0021605538,0.0022189014,0.016717343,0.86657536,0.00037107142,0.000005521567,8.8013485e-7,1.8179978e-7,0.000012800838,0.1090659,0.00024978357],"about_ca_topic_score_codex":0.000059426096,"about_ca_topic_score_gemma":0.00003895816,"teacher_disagreement_score":0.3522914,"about_ca_system_score_codex":0.0011466553,"about_ca_system_score_gemma":0.0036708075,"threshold_uncertainty_score":0.99990636},"labels":[],"label_agreement":null},{"id":"W2950867850","doi":"10.7150/thno.30814","title":"Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome","year":2019,"lang":"en","type":"article","venue":"Theranostics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Fundo para o Desenvolvimento das Ciências e da Tecnologia; Universidade de Macau; National Natural Science Foundation of China","keywords":"Estrogen; Estrogen receptor; Cancer research; Ovarian cancer; Internal medicine; Estrogen receptor alpha; Tamoxifen; Signal transduction; Oncology; Medicine; Biology; Endocrinology; Cancer; Breast cancer; Cell biology","score_opus":0.01339562248753621,"score_gpt":0.2728550107180783,"score_spread":0.25945938823054204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950867850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977226,0.000187755,0.000020943715,0.0010724851,0.00021030576,0.0005261644,0.000016782818,0.000034224544,0.00020869414],"genre_scores_gemma":[0.9987084,0.000071331095,0.00036389916,0.00059787405,0.00010195816,0.000021510596,0.000010458819,0.000044802175,0.000079712656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991602,0.000019884103,0.00020023977,0.00024536095,0.00015669766,0.0002176575],"domain_scores_gemma":[0.9995028,0.00011739004,0.000054028882,0.0001806575,0.000047658974,0.00009751018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097462944,0.00014899141,0.00032909337,0.000043721695,0.000016170927,0.000016056312,0.000025450241,0.00008100883,0.000033074833],"category_scores_gemma":[0.000028198196,0.00011864199,0.000045915218,0.00007974282,0.000033424745,0.000038614784,0.000028833161,0.00013685475,0.000013800267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013870889,0.00030552357,0.97186357,0.000057123027,0.000074311145,0.000028286726,0.0002251308,0.000012837324,0.0211079,0.00012369528,0.000022533563,0.0060403566],"study_design_scores_gemma":[0.0049503185,0.0002701441,0.97952557,0.00013615398,0.000112139045,0.0000028236054,0.0000252302,0.00063155714,0.013819841,0.0000414591,0.0003482812,0.00013648547],"about_ca_topic_score_codex":0.00028445193,"about_ca_topic_score_gemma":0.000046837285,"teacher_disagreement_score":0.0076619745,"about_ca_system_score_codex":0.00013918946,"about_ca_system_score_gemma":0.0000653138,"threshold_uncertainty_score":0.48380798},"labels":[],"label_agreement":null},{"id":"W2951611776","doi":"10.1093/ije/dyz113","title":"Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study","year":2019,"lang":"en","type":"article","venue":"International Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Intramural Research Program; National Cancer Institute; National Institute on Aging; Medical Research Council; Health Canada; Cancer Council Western Australia; Ovarian Cancer Research Fund; National Institutes of Health; Novo Nordisk Fonden; California Breast Cancer Research Program; Kræftens Bekæmpelse; Rutgers Cancer Institute of New Jersey; Lon V. Smith Foundation; U.S. Department of Defense","keywords":"Mendelian randomization; Polycystic ovary; Ovarian cancer; Medicine; Ovary; Biology; Genetics; Oncology; Cancer; Gynecology; Internal medicine; Gene; Genotype; Genetic variants","score_opus":0.027837035945928918,"score_gpt":0.3423551092434892,"score_spread":0.3145180732975603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951611776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97624534,0.00088493316,0.0012076992,0.019735243,0.0011863956,0.000496217,0.000049071194,0.000011505601,0.00018357857],"genre_scores_gemma":[0.99606454,0.00080793153,0.001381048,0.0009682149,0.00053542416,0.000018730148,0.00003250854,0.000013753347,0.00017782899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794406,0.00040522614,0.00091939716,0.00020841087,0.00033847147,0.00018440888],"domain_scores_gemma":[0.99703574,0.0014566783,0.00077478593,0.00010983333,0.00046880907,0.00015416424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016652577,0.00012923536,0.000715566,0.0002415703,0.000023107377,0.000012556346,0.000120420475,0.000121977384,0.00036876218],"category_scores_gemma":[0.0013650801,0.00009929755,0.00011616442,0.00008496289,0.000025364574,0.00009040624,0.0000401018,0.00021899136,0.000009554468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011931306,0.0002594785,0.98654526,0.000008739284,0.0038009284,0.00011081357,0.00010066027,0.00012012653,0.00006171013,0.00011812293,0.0007215007,0.00695951],"study_design_scores_gemma":[0.0142756635,0.001417291,0.9805765,0.0001449185,0.00080720475,0.0003435765,0.00003578865,0.0003697433,0.000017548024,0.0006528763,0.0012855345,0.000073331896],"about_ca_topic_score_codex":0.00016847136,"about_ca_topic_score_gemma":0.000012155928,"teacher_disagreement_score":0.019819204,"about_ca_system_score_codex":0.0004745669,"about_ca_system_score_gemma":0.00017558977,"threshold_uncertainty_score":0.40492365},"labels":[],"label_agreement":null},{"id":"W2952644236","doi":"10.1038/s41416-019-0492-8","title":"Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; University of Toronto; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Jonsson Comprehensive Cancer Center; National Center for Advancing Translational Sciences; European Regional Development Fund; Canadian Institutes of Health Research; lékařská fakulta Univerzity Karlovy; Manchester Biomedical Research Centre; University of California, San Francisco; National Institutes of Health; Kerry Group Kuok Foundation; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Medical Research Council; Uppsala Universitet; National Institute of General Medical Sciences; Institut National Du Cancer; Deutsche Krebshilfe; Sahlgrenska Universitetssjukhuset; Associazione Italiana per la Ricerca sul Cancro; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Landspítali Háskólasjúkrahús; Linköpings Universitet; Hungarian Scientific Research Fund; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; Russian Foundation for Basic Research; Cancer Association of South Africa; Ministerstvo Školství, Mládeže a Tělovýchovy; National Breast Cancer Foundation; European Commission; National Institute for Health and Care Research; KWF Kankerbestrijding; Cancer Research UK; Government of Canada; National Cancer Institute; Liga Portuguesa Contra o Cancro; Hospital de Câncer de Barretos; NRG Oncology; Memorial Sloan-Kettering Cancer Center; Fondation du cancer du sein du Québec; Israel Cancer Association; Institut Català de la Salut; University of Pennsylvania; Fundación Mutua Madrileña; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Genome Canada; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; Unicancer; Clalit Health Services; Deutsches Krebsforschungszentrum; American Cancer Society; Fonds Wetenschappelijk Onderzoek; Cancer Center, University of Kansas; Cancerfonden; Ministério da Ciência, Tecnologia e Inovação; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Beth Israel Deaconess Medical Center; Alpha Omega Alpha Honor Medical Society; Georgetown University; Susan G. Komen for the Cure; Instituto de Salud Carlos III; Ohio State University; Cancer Australia; National Health and Medical Research Council; Jewish General Hospital; Fundación Cellex; Fisher Center for Alzheimer's Research Foundation; Istituto Oncologico Veneto; Umeå Universitet; Royal Marsden NHS Foundation Trust; European Social Fund; University of Chicago; Lietuvos Mokslo Taryba","keywords":"Ovarian cancer; Body mass index; Oncology; Medicine; Mendelian inheritance; Mutation; Internal medicine; Cancer; Genetics; Biology; Gynecology; Gene","score_opus":0.007762646086976757,"score_gpt":0.27740165255938026,"score_spread":0.2696390064724035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952644236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864959,0.011970795,0.000024079356,0.0002653511,0.0002531873,0.00071876415,0.00005257149,0.000002635416,0.00021668435],"genre_scores_gemma":[0.98594344,0.013723032,0.00007950977,0.00005511895,0.00008733411,0.000037367347,0.0000024624896,0.000018237937,0.000053526994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984981,0.00011122447,0.000633547,0.00020241016,0.00040542605,0.00014933004],"domain_scores_gemma":[0.99878216,0.00006726259,0.00064940355,0.000104212166,0.0002617738,0.00013518575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004235075,0.00012811674,0.00061722344,0.00020019387,0.000032978107,0.00002527735,0.00004881557,0.00008017864,0.00023423145],"category_scores_gemma":[0.00005141691,0.00012522146,0.00006786621,0.00018035666,0.000057668793,0.0001830612,0.000012692762,0.00021115967,2.1054527e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022840698,0.00032623176,0.91204643,0.00013946537,0.00086317386,0.00017962864,0.0019394362,0.0010864944,0.0006307148,0.000013318177,0.00010260804,0.0803884],"study_design_scores_gemma":[0.04574571,0.0010232561,0.94673127,0.0010666696,0.00059536163,0.0001775936,0.0025946377,0.00039790277,0.0011814848,0.00018446929,0.00018487709,0.000116787414],"about_ca_topic_score_codex":0.025373742,"about_ca_topic_score_gemma":0.0038157986,"teacher_disagreement_score":0.08027161,"about_ca_system_score_codex":0.00025373301,"about_ca_system_score_gemma":0.00033461224,"threshold_uncertainty_score":0.98111635},"labels":[],"label_agreement":null},{"id":"W2953316233","doi":"10.1371/journal.pone.0218621","title":"Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer","year":2019,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Saint-Luc; Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Medicine; Cohort; Ovarian cancer; Oncology; Receiver operating characteristic; Hazard ratio; Internal medicine; Proportional hazards model; Cancer; Multivariate analysis; Debulking; Cohort study; Serous fluid; Confidence interval","score_opus":0.020266234263153035,"score_gpt":0.24620594395061232,"score_spread":0.2259397096874593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953316233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666125,0.00024706483,2.1877042e-7,0.0006038634,0.000053092055,0.0013777848,0.00012130481,0.00001755053,0.00091787265],"genre_scores_gemma":[0.9977163,0.0005276882,0.00037796778,0.00016292788,0.00008163171,0.0009169248,0.0000063686584,0.000030163776,0.00018002804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839747,0.00005598234,0.0003691852,0.00043493748,0.000361714,0.00038070075],"domain_scores_gemma":[0.99929184,0.00006094897,0.0001473569,0.00026751668,0.00010146592,0.00013088746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002580297,0.00021825529,0.0006416955,0.0001344515,0.000032206215,0.000013970201,0.000065903005,0.00006654837,0.0004232883],"category_scores_gemma":[0.000023945575,0.00017337281,0.000018225815,0.0003474091,0.00007680939,0.00016942622,0.000041269348,0.00023904795,0.0000034014379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027580757,0.0011974103,0.98839915,0.0008658194,0.00069387,0.000038792066,0.003181281,0.0002573235,0.0016704495,0.000013588847,0.0000042608026,0.0009200048],"study_design_scores_gemma":[0.0077713756,0.0011230562,0.97351813,0.0035956344,0.00020948074,0.0000036798733,0.0004247576,0.004457232,0.008713363,0.000002931522,0.0000082273555,0.00017215287],"about_ca_topic_score_codex":0.0086047035,"about_ca_topic_score_gemma":0.0046062986,"teacher_disagreement_score":0.014881015,"about_ca_system_score_codex":0.0006131349,"about_ca_system_score_gemma":0.0004994836,"threshold_uncertainty_score":0.9979971},"labels":[],"label_agreement":null},{"id":"W2953647067","doi":"10.1136/ijgc-2019-000287","title":"Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Survival analysis; Log-rank test; Internal medicine; Univariate analysis; Ovarian cancer; Carcinoma; Clear cell carcinoma; Clear cell; Oncology; Cancer; Multivariate analysis; Surgery; Confidence interval","score_opus":0.012837694296677648,"score_gpt":0.2875586852126202,"score_spread":0.27472099091594254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953647067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813086,0.00010295712,0.0000043860337,0.00062342035,0.00043342295,0.00016287457,0.000050078637,0.000001464144,0.00049054006],"genre_scores_gemma":[0.9994896,0.00014161444,0.00007132288,0.00018097094,0.000072741605,0.000004115963,0.000004482001,0.0000063737057,0.000028760021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999037,0.00003383974,0.00027595437,0.00012766379,0.00041913782,0.00010635013],"domain_scores_gemma":[0.99913067,0.00016012926,0.00025526926,0.00006873295,0.00030378142,0.00008144007],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000118166085,0.00009939775,0.00029057116,0.00011161881,0.000006278694,0.000010562921,0.00009560796,0.000048249265,0.001105232],"category_scores_gemma":[0.000032198317,0.00005615787,0.000070837326,0.000052755597,0.000019187706,0.000064923224,0.000023982675,0.00017348875,0.0000032801436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028367292,0.0007528971,0.9893562,0.00001410851,0.00011155209,0.00006939365,0.000053591277,0.00011594286,0.000014122049,0.00006013947,0.00003564263,0.0065796506],"study_design_scores_gemma":[0.0064532612,0.0054343226,0.98741317,0.00021100527,0.000032111104,0.000005938975,0.000024268422,0.000016394893,0.00020542611,0.000023299837,0.0001246137,0.000056204346],"about_ca_topic_score_codex":0.00015383781,"about_ca_topic_score_gemma":0.000032353393,"teacher_disagreement_score":0.006523446,"about_ca_system_score_codex":0.00033419783,"about_ca_system_score_gemma":0.00012637088,"threshold_uncertainty_score":0.9998079},"labels":[],"label_agreement":null},{"id":"W2954005467","doi":"10.1016/j.ygyno.2019.06.021","title":"Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Chemotherapy; Hazard ratio; Lymphadenectomy; Ovarian cancer; Surgery; Cancer; Stage (stratigraphy); Internal medicine; Confidence interval; Retrospective cohort study; Oncology","score_opus":0.019839890127430027,"score_gpt":0.3431664510514473,"score_spread":0.32332656092401724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954005467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449564,0.0006257226,0.00016196634,0.0039644027,0.0008556061,0.0034089086,0.0000813644,0.000039314717,0.006367052],"genre_scores_gemma":[0.99444616,0.0002603594,0.001266915,0.0016342789,0.000052782732,0.0010674073,0.00003066758,0.000024274139,0.0012171514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987561,0.00016128238,0.00026154524,0.00040992626,0.0000993589,0.00031177403],"domain_scores_gemma":[0.9982795,0.0009975284,0.0001644106,0.00027657527,0.00019873446,0.00008325794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041615043,0.00018658704,0.00080360833,0.00007975375,0.000045442706,0.00000475751,0.00008781193,0.00024055055,0.0020107734],"category_scores_gemma":[0.00008638177,0.00013795691,0.00015713487,0.00013328473,0.00008180509,0.000038006332,0.00002681086,0.00011827801,0.00003833798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009162708,0.00623686,0.76092803,0.0017844219,0.0023188489,0.0001666187,0.0013167555,0.00031038793,0.07372972,0.017495785,0.0017190063,0.12483084],"study_design_scores_gemma":[0.022247093,0.018259693,0.8625545,0.00014479514,0.00023332755,0.00001961129,0.00020382399,0.00008788193,0.045326177,0.00039019037,0.05031635,0.00021657151],"about_ca_topic_score_codex":0.00021439396,"about_ca_topic_score_gemma":0.000080682956,"teacher_disagreement_score":0.12461427,"about_ca_system_score_codex":0.0007944004,"about_ca_system_score_gemma":0.00066437206,"threshold_uncertainty_score":0.99890155},"labels":[],"label_agreement":null},{"id":"W2954378910","doi":"10.1007/s10552-019-01199-7","title":"Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women","year":2019,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute; National Heart, Lung, and Blood Institute; Ministerio de Economía y Competitividad; Kaiser Permanente","keywords":"Medicine; Epidemiology; Ovarian cancer; Demography; Incidence (geometry); Cohort; Health equity; Cohort study; Gynecology; Population; Cancer; Oncology; Gerontology; Public health; Internal medicine; Environmental health; Pathology","score_opus":0.07927104082224909,"score_gpt":0.3522955002551661,"score_spread":0.273024459432917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954378910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624478,0.029583497,0.000012193561,0.0031889076,0.00014819621,0.0010323548,0.0032632065,0.000019283096,0.00030452255],"genre_scores_gemma":[0.9876125,0.010282532,0.00023474208,0.0007801265,0.00011477182,0.0007982245,0.00002786409,0.000035974354,0.000113300164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697685,0.00027667542,0.0010241827,0.00080546865,0.0003241537,0.0005926388],"domain_scores_gemma":[0.99606854,0.0012376015,0.0011420213,0.001109669,0.00021075149,0.00023144415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006264932,0.000356466,0.002562709,0.00020045876,0.000029385865,0.000007554858,0.00032969142,0.0000917851,0.0004998168],"category_scores_gemma":[0.0003639823,0.00027846868,0.00008809866,0.00054226146,0.0007883537,0.00011465571,0.0001744499,0.00021506607,0.0000014880977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041687437,0.0004267632,0.9626928,0.00040642655,0.0028130077,0.000028337412,0.0063239415,0.00014813078,0.0043924544,0.000037051694,0.0005907963,0.017971555],"study_design_scores_gemma":[0.018693943,0.0015158091,0.9490169,0.0013096443,0.0008476119,0.000002592836,0.017277084,0.00043850404,0.0012445694,0.0001829944,0.009061013,0.0004092809],"about_ca_topic_score_codex":0.006569986,"about_ca_topic_score_gemma":0.0009279939,"teacher_disagreement_score":0.025164627,"about_ca_system_score_codex":0.0006937932,"about_ca_system_score_gemma":0.00055212487,"threshold_uncertainty_score":0.99996674},"labels":[],"label_agreement":null},{"id":"W2954563397","doi":"10.1158/1538-7445.am2019-3288","title":"Abstract 3288: Ovarian cancer survivors' views of factors that influenced their exceptional survival: A qualitative study","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Focus group; Medicine; Gerontology; Ovarian cancer; Grounded theory; Qualitative research; Cancer; Stage (stratigraphy); Disease; Survivorship curve; Oncology; Internal medicine; Biology","score_opus":0.26761899525592786,"score_gpt":0.5054854896449229,"score_spread":0.23786649438899504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954563397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907567,0.0015303334,0.0000032383957,0.0011172584,0.00046688606,0.0025654254,0.00036395132,0.000033449884,0.0031627624],"genre_scores_gemma":[0.99641716,0.0008910419,0.000020047304,0.00006219021,0.00016835317,0.0010641,0.00004412521,0.00005618458,0.0012767726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961028,0.0005734602,0.00048591156,0.00069391885,0.0015123053,0.0006316099],"domain_scores_gemma":[0.9971553,0.0009474674,0.0001878779,0.00070669,0.00072349055,0.00027918353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019813483,0.00030545314,0.0007927275,0.0003259368,0.00012883158,0.000044149398,0.0002898908,0.0001259969,0.0077826316],"category_scores_gemma":[0.00008085574,0.00021371503,0.0001999545,0.0007268464,0.00023227453,0.00017593394,0.00012346913,0.00057463226,0.000101462174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077793834,0.0015971726,0.92250586,0.00037099584,0.0010104385,0.000018321687,0.06267719,0.000033194483,0.006108632,0.00034310558,0.0009100877,0.0036470608],"study_design_scores_gemma":[0.0035271123,0.00076305255,0.9290724,0.00043795127,0.00006306975,6.415256e-7,0.053849414,0.000003528065,0.008334016,0.00017961107,0.003551052,0.00021815138],"about_ca_topic_score_codex":0.048202336,"about_ca_topic_score_gemma":0.011192152,"teacher_disagreement_score":0.037010185,"about_ca_system_score_codex":0.00075979414,"about_ca_system_score_gemma":0.0010619491,"threshold_uncertainty_score":0.99312437},"labels":[],"label_agreement":null},{"id":"W2954573235","doi":"10.1097/01.ogx.0000458794.60509.a8","title":"Anti-Angiopoietin Therapy With Trebananib for Recurrent Ovarian Cancer (TRINOVA-1)","year":2014,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Adverse effect; Angiogenesis; Vascular endothelial growth factor; Oncology; Internal medicine; Progression-free survival; Cancer; Endometrial cancer; Chemotherapy; Gastroenterology; VEGF receptors","score_opus":0.0637762528799003,"score_gpt":0.3192112720024464,"score_spread":0.2554350191225461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954573235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728182,0.007264227,0.0021223112,0.0080437325,0.0015893672,0.0038706902,0.00032647743,0.00031252837,0.0036524443],"genre_scores_gemma":[0.994141,0.0009179135,0.0019668927,0.0013815984,0.0002552544,0.00064918434,0.00016953684,0.00004355642,0.00047509215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742866,0.00029593613,0.00042902,0.00077567145,0.00040738325,0.00066332694],"domain_scores_gemma":[0.9943469,0.004354111,0.00015768518,0.00042109075,0.00030520436,0.00041496917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005489678,0.00036529297,0.0009017555,0.000117350086,0.00016312696,0.000056308614,0.00017995684,0.00025453375,0.0012080048],"category_scores_gemma":[0.001821032,0.00021270281,0.00025252593,0.00084709114,0.00011169522,0.000046168883,0.000042310432,0.0002516708,0.000053685464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014214304,0.0028166166,0.7095739,0.000034667144,0.00035421926,0.000040605893,0.000030251016,0.000016012547,0.00004477911,0.0011416526,0.0052678003,0.27925807],"study_design_scores_gemma":[0.007667778,0.0060298215,0.88372386,0.00003877385,0.00011022663,0.0000056268314,0.0000068336417,0.00011130817,0.00029161692,0.00007633068,0.10165609,0.0002817233],"about_ca_topic_score_codex":0.0003762061,"about_ca_topic_score_gemma":0.00025390513,"teacher_disagreement_score":0.27897635,"about_ca_system_score_codex":0.00033640146,"about_ca_system_score_gemma":0.00014083918,"threshold_uncertainty_score":0.999705},"labels":[],"label_agreement":null},{"id":"W2954681316","doi":"10.1158/1538-7445.sabcs18-3450","title":"Abstract 3450: Impact of BRCA1 on glucocorticoid signaling in fallopian tube epithelial cells","year":2019,"lang":"en","type":"article","venue":"Molecular and Cellular Biology / Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Fallopian tube; Cancer research; Cell biology; Glucocorticoid; Biology; Medicine; Endocrinology; Anatomy","score_opus":0.008632659302369035,"score_gpt":0.2594533048699348,"score_spread":0.2508206455675657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954681316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958581,0.0023287274,0.000089566194,0.00007726481,0.00013808013,0.0005005585,0.000029752176,0.000007369505,0.0009705959],"genre_scores_gemma":[0.9990855,0.00034744202,0.00023315407,0.00016875629,0.00003518922,0.000009011954,0.000055765366,0.000024239296,0.00004095745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989228,0.000045929097,0.0003011965,0.00035518143,0.000102285645,0.00027255638],"domain_scores_gemma":[0.9994103,0.000039791532,0.00008663015,0.00032923717,0.00003604816,0.0000980476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010555198,0.0001989864,0.0004062327,0.000110569374,0.000013437358,0.0000075798503,0.00006588476,0.00018343287,0.00015025103],"category_scores_gemma":[0.0000066490165,0.00015837344,0.00017659596,0.000094481686,0.000058134756,0.000007678834,0.000032251035,0.00014635421,0.0000426553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012744022,0.00025199272,0.13598557,0.00005823608,0.00016528323,0.00009573147,0.00006404611,0.0010475029,0.85930264,0.00014980334,0.0000036873557,0.0027480626],"study_design_scores_gemma":[0.0025474408,0.0020610767,0.11316885,0.00007656491,0.00008612707,0.0000075537323,0.000022084327,0.00022316798,0.8812955,0.00011292376,0.00024349245,0.00015520626],"about_ca_topic_score_codex":0.00010904529,"about_ca_topic_score_gemma":0.0000054361935,"teacher_disagreement_score":0.02281672,"about_ca_system_score_codex":0.00006162146,"about_ca_system_score_gemma":0.000105778774,"threshold_uncertainty_score":0.6458282},"labels":[],"label_agreement":null},{"id":"W2954976904","doi":"10.1016/j.ygyno.2019.04.053","title":"Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant or refractory epithelial ovarian cancer: Primary and biomarker analysis of the phase III JAVELIN Ovarian 200 trial","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Avelumab; Ovarian cancer; Refractory (planetary science); Doxorubicin; Internal medicine; Oncology; Chemotherapy; Pharmacology; Cancer; Immunotherapy; Nivolumab","score_opus":0.029138449865378058,"score_gpt":0.320123002246093,"score_spread":0.29098455238071497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954976904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897215,0.0003959385,0.000009464505,0.0033539524,0.0010600155,0.00421466,0.00022190603,0.00005643531,0.0009661671],"genre_scores_gemma":[0.9970176,0.00047595412,0.0005506107,0.00045182265,0.00010507641,0.00045603365,0.0003129382,0.000051516163,0.00057841593],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950092,0.0008852073,0.0016346194,0.0010904848,0.00057540595,0.0008051055],"domain_scores_gemma":[0.9956389,0.0021271366,0.0010341689,0.00074589805,0.00023450569,0.00021940496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001102051,0.0005912646,0.0024895181,0.0010339211,0.00013802672,0.000030616673,0.0002950448,0.0007863643,0.0024925282],"category_scores_gemma":[0.00043732006,0.00035607643,0.00020848947,0.0028721641,0.00035037208,0.00017594112,0.00017750141,0.000680912,0.0000106149055],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82948726,0.015091819,0.079622254,0.00018731118,0.005602912,0.0020854285,0.0017517101,0.00037523572,0.027002294,0.00020550836,0.00025215145,0.0383361],"study_design_scores_gemma":[0.40647367,0.028327852,0.5560339,0.00022077606,0.003228305,0.000040037605,0.00043227288,0.0026383924,0.0009994572,0.00001717594,0.0011680799,0.0004200775],"about_ca_topic_score_codex":0.005692434,"about_ca_topic_score_gemma":0.044705052,"teacher_disagreement_score":0.47641164,"about_ca_system_score_codex":0.0024758184,"about_ca_system_score_gemma":0.0024630374,"threshold_uncertainty_score":0.99988914},"labels":[],"label_agreement":null},{"id":"W2955057356","doi":"10.1038/s41379-019-0302-0","title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","year":2019,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Royal Alexandra Hospital; Vancouver General Hospital; University of British Columbia; BC Cancer Agency; Foothills Medical Centre; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Medical Research Council; Universität Heidelberg; Swedish Cancer Foundation; Cancer Research Society; NSW Ministry of Health; University of New South Wales; Ovarian Cancer Action; National Institute for Health and Care Research; Translational Cancer Research Network; National Health and Medical Research Council; Cancer Research UK; National Center for Research Resources; Cancer Institute NSW; Medical Research and Materiel Command; University of Pittsburgh","keywords":"Medicine; CDX2; PAX8; Pathology; Tissue microarray; Mucinous Tumor; Mucinous carcinoma; Immunohistochemistry; Ovarian tumor; Ovarian cancer; Adenocarcinoma; Internal medicine; Cancer; Biology","score_opus":0.008470072828496211,"score_gpt":0.22620158808482055,"score_spread":0.21773151525632434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955057356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959971,0.0013508222,0.0001785783,0.0009474615,0.0001136653,0.00075525104,0.00031537554,0.000011053605,0.00033074885],"genre_scores_gemma":[0.99800825,0.000084545325,0.0014487165,0.0002475632,0.000031756994,0.000029301445,0.00010915016,0.000016204121,0.000024505141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991441,0.000066583605,0.00018959722,0.00035732897,0.00009658025,0.00014584427],"domain_scores_gemma":[0.9992752,0.00033879036,0.00012538588,0.00016324448,0.00004770555,0.000049661565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001482453,0.00013375185,0.00038643007,0.000038376453,0.00006731471,0.000013835084,0.000031164887,0.00007650809,0.000007891808],"category_scores_gemma":[0.00004622423,0.00010092369,0.000047256406,0.000034747954,0.00019375172,0.00003390899,0.00007950984,0.00009595555,4.9747234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056627197,0.000986133,0.551215,0.0006524928,0.0009036364,0.00041655346,0.01354688,0.00000210843,0.38071948,0.0031359943,0.0007193942,0.04203962],"study_design_scores_gemma":[0.005687889,0.00074800156,0.9768736,0.00016492751,0.00034177856,0.00041387265,0.00028570934,0.00063549174,0.013107245,0.0014895778,0.000111582805,0.00014034714],"about_ca_topic_score_codex":0.00017784355,"about_ca_topic_score_gemma":0.000013658793,"teacher_disagreement_score":0.4256586,"about_ca_system_score_codex":0.0000769583,"about_ca_system_score_gemma":0.000039676695,"threshold_uncertainty_score":0.41155484},"labels":[],"label_agreement":null},{"id":"W2956524352","doi":"10.1007/s00247-019-04460-y","title":"Non-visualization of the ovaries on pediatric transabdominal ultrasound with a non-distended bladder: Can adnexal torsion be excluded?","year":2019,"lang":"en","type":"article","venue":"Pediatric Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Ultrasound; Neuroradiology; Ovarian torsion; Adnexal Diseases; Torsion (gastropod); Visualization; Radiology; Anatomy; Gynecology; Surgery; Laparoscopy; Artificial intelligence","score_opus":0.008848107193073256,"score_gpt":0.24293743746788607,"score_spread":0.23408933027481282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956524352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518085,0.00037186084,0.00011062709,0.0009533208,0.0005823214,0.0010738987,0.000048773047,0.000025939426,0.0016524188],"genre_scores_gemma":[0.99696606,0.0010341078,0.00016405548,0.00039955645,0.00095142965,0.00007828076,0.000070627946,0.0000373838,0.00029852008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983062,0.00008880237,0.00040642658,0.00047281463,0.00036384954,0.00036191707],"domain_scores_gemma":[0.9987031,0.00027752068,0.00027326282,0.00050730346,0.00011123139,0.00012753125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018198378,0.00028211597,0.0005866659,0.0002038414,0.00009973624,0.00001164429,0.00016270918,0.00019397608,0.00026022762],"category_scores_gemma":[0.00004965486,0.00017209887,0.00017538817,0.00058971276,0.00010458235,0.000047263246,0.000019600184,0.00020387696,0.000017664688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012637136,0.0005663908,0.99247473,0.00023838055,0.00016383227,0.000023069675,0.000985847,0.00012860245,0.00029249833,0.00044051593,0.0032273666,0.0001950594],"study_design_scores_gemma":[0.007042832,0.003726705,0.9852863,0.00002551727,0.001547351,0.00021784916,0.00013717945,0.00009349784,0.001287401,0.00004289686,0.00034935947,0.00024314158],"about_ca_topic_score_codex":0.00017518517,"about_ca_topic_score_gemma":0.000042280873,"teacher_disagreement_score":0.0071884543,"about_ca_system_score_codex":0.00016096284,"about_ca_system_score_gemma":0.00047022497,"threshold_uncertainty_score":0.70179886},"labels":[],"label_agreement":null},{"id":"W2957449543","doi":"10.3390/ijms20143471","title":"RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line","year":2019,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Alberta Innovates; Rita and Alex Hillman Foundation; Alberta Cancer Foundation; Li Ka Shing Foundation; Royal Alexandra Hospital Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Health Research Institute; Women and Children's Health Research Institute","keywords":"Cancer research; Biology; Cell growth; Stromal cell; Cell culture; Cell cycle; Cyclin E; Transcription factor; Cell biology; Granulosa cell; Cell; Cyclin-dependent kinase; Cyclin; Ovary; Endocrinology; Gene; Genetics","score_opus":0.014317027354090064,"score_gpt":0.29011548247524843,"score_spread":0.27579845512115836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957449543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071425,0.0013483049,0.000057278736,0.0043599466,0.00052738015,0.00020673135,0.000002604993,0.000004315246,0.0027792146],"genre_scores_gemma":[0.9982917,0.00006832565,0.0006410904,0.0007519897,0.00015002236,0.0000049279265,0.0000018059891,0.000007879729,0.00008230353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842286,0.00005338548,0.00036704435,0.00017878086,0.0008144916,0.00016341908],"domain_scores_gemma":[0.99920225,0.000054723932,0.00030371785,0.00012590594,0.000245427,0.000067980145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050168904,0.000111964175,0.00019737684,0.00020063773,0.000048985905,0.00007708291,0.00046955884,0.000022886405,0.00019391671],"category_scores_gemma":[0.000027057558,0.00006710445,0.00014497296,0.00020626621,0.00011316991,0.00011542018,0.000052958618,0.00018508479,0.000030309622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002242059,0.0021526508,0.1917448,0.000057173842,0.00025075424,0.0028127243,0.0016084671,0.0016395306,0.79442453,0.0016463229,0.00026525374,0.0031735587],"study_design_scores_gemma":[0.0074594347,0.0031298278,0.15317656,0.0005790043,0.00015639643,0.0005663717,0.0007823704,0.0006397617,0.82788134,0.0035892872,0.0017420077,0.00029766545],"about_ca_topic_score_codex":0.00007758888,"about_ca_topic_score_gemma":0.000016048349,"teacher_disagreement_score":0.038568255,"about_ca_system_score_codex":0.00010975952,"about_ca_system_score_gemma":0.0002899106,"threshold_uncertainty_score":0.273644},"labels":[],"label_agreement":null},{"id":"W2962795434","doi":"10.1016/j.ajog.2019.07.031","title":"Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses","year":2019,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CReATe Fertility Centre","funders":"Health Technology Assessment Programme; British Gynaecological Cancer Society; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Adnexal mass; Ovarian cancer; Epididymis; Gynecology; Cancer antigen; Ultrasound; Randomized controlled trial; Cancer; Logistic regression; Obstetrics; Radiology; Internal medicine; Andrology","score_opus":0.006658478955513493,"score_gpt":0.2499349065035488,"score_spread":0.2432764275480353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962795434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937707,0.003570544,0.000002450782,0.00203281,0.00026317796,0.00017950701,0.000021813288,0.0000020782975,0.00015687686],"genre_scores_gemma":[0.991873,0.0069749258,0.00063788914,0.00042269955,0.000025380019,0.00002119647,5.951234e-7,0.000014063267,0.000030216741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903107,0.000050144245,0.00035131487,0.0001680648,0.00015746152,0.00024194078],"domain_scores_gemma":[0.99763167,0.0015311793,0.00041304206,0.00011089105,0.00013583578,0.00017739118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016322374,0.00012984958,0.0006862102,0.0003182191,0.000016945096,0.000009983627,0.000050465747,0.0000445991,0.00020781196],"category_scores_gemma":[0.00024113653,0.000091068905,0.000024354084,0.0004623799,0.00016264022,0.00006811826,0.000029751662,0.00016697327,7.397509e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021468994,0.0002742107,0.85089374,0.000041160492,0.0002364743,0.0002315321,0.00044718361,0.000015657432,0.000048169313,0.00008804353,0.000019920806,0.14748919],"study_design_scores_gemma":[0.0045527443,0.014668986,0.9761515,0.00011109567,0.00013111542,0.00014580708,0.0014139173,0.000009309907,0.00011962418,0.00004360246,0.0025588921,0.00009339754],"about_ca_topic_score_codex":0.0001633508,"about_ca_topic_score_gemma":0.000038638056,"teacher_disagreement_score":0.14739579,"about_ca_system_score_codex":0.00021487012,"about_ca_system_score_gemma":0.00025978213,"threshold_uncertainty_score":0.37136823},"labels":[],"label_agreement":null},{"id":"W2963358961","doi":"10.1016/j.jpag.2019.07.005","title":"Preoperative Risk Stratification of Adnexal Masses in the Pediatric and Adolescent Population: Evaluating the Decision Tree System","year":2019,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Risk stratification; Stratification (seeds); Decision tree; Population; Internal medicine; Machine learning; Environmental health; Computer science","score_opus":0.023636800896432716,"score_gpt":0.3119214810907323,"score_spread":0.2882846801942996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963358961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136233,0.006473771,0.00009169247,0.0008713639,0.00034622714,0.00076975697,0.0000062125514,0.0000032351925,0.00007542335],"genre_scores_gemma":[0.9926131,0.0061590415,0.00040335942,0.00011791113,0.0006735814,0.000009778641,0.0000028916895,0.00000847059,0.000011875801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981625,0.00037620382,0.0007364476,0.00019112605,0.00037743352,0.00015630544],"domain_scores_gemma":[0.99783987,0.0009104371,0.0008128138,0.00018069136,0.00018879746,0.000067364825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012613385,0.00014382754,0.0003990761,0.00017804073,0.00008853167,0.000027228047,0.0000999457,0.000094433206,0.000025089246],"category_scores_gemma":[0.00026967836,0.000074676616,0.00008355557,0.00026004954,0.000029776213,0.0000938595,0.000029988138,0.00034019363,0.0000023967775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025644788,0.00038435354,0.9856027,0.00029770096,0.0000320481,0.00001267427,0.0003259356,0.0001462223,0.000011638035,0.00013854771,0.0004733793,0.012318398],"study_design_scores_gemma":[0.0029187005,0.0016236547,0.9922285,0.00012264893,0.0008243192,0.00010755412,0.0013751616,0.0006403944,0.0000074932477,0.000065838954,0.000020005009,0.00006573407],"about_ca_topic_score_codex":0.000012514308,"about_ca_topic_score_gemma":0.00001620637,"teacher_disagreement_score":0.012252664,"about_ca_system_score_codex":0.00012727338,"about_ca_system_score_gemma":0.00018498625,"threshold_uncertainty_score":0.3045224},"labels":[],"label_agreement":null},{"id":"W2964219560","doi":"10.1097/pas.0000000000001328","title":"p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"MSH2; MSH6; Clear cell carcinoma; Medicine; Carcinoma; Ovarian carcinoma; Oncology; PMS2; Lymph node; Univariate analysis; MLH1; Malignancy; Serous carcinoma; Immunohistochemistry; Internal medicine; Pathology; Ovarian cancer; Cancer; DNA mismatch repair; Multivariate analysis","score_opus":0.008506985160140047,"score_gpt":0.24026955580622358,"score_spread":0.23176257064608355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964219560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994607,0.0010093229,0.000002599436,0.006631279,0.000077767676,0.00023621607,0.0000033329645,0.00000795308,0.0020854776],"genre_scores_gemma":[0.998135,0.00027431926,0.00053429144,0.00052457623,0.00012826257,0.0000073646115,7.770711e-7,0.00001542576,0.00037998756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874467,0.0002682252,0.0004018263,0.00016166455,0.00017280156,0.0002508201],"domain_scores_gemma":[0.9990981,0.00015901907,0.00031488045,0.00023490407,0.00006548592,0.00012758188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057063956,0.00012897182,0.0006010804,0.00010668756,0.000030988733,0.000009355492,0.000088787085,0.00004050631,0.00014040554],"category_scores_gemma":[0.000012425535,0.00007651632,0.00014454775,0.00016611603,0.0003144425,0.000048110993,0.000044096298,0.00032521813,0.00002187559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069931694,0.0008799882,0.96151286,0.00012212056,0.00013727596,0.0153493965,0.0029238616,0.000020576785,0.0025244083,0.0015253976,0.00046221563,0.0075487364],"study_design_scores_gemma":[0.006967908,0.00897375,0.9582816,0.00014065208,0.00014011655,0.0115634855,0.0030140001,0.00002512746,0.0013895,0.00033574662,0.00898465,0.00018350082],"about_ca_topic_score_codex":0.00022531368,"about_ca_topic_score_gemma":0.000004345178,"teacher_disagreement_score":0.008522433,"about_ca_system_score_codex":0.00006493374,"about_ca_system_score_gemma":0.00009881652,"threshold_uncertainty_score":0.31202447},"labels":[],"label_agreement":null},{"id":"W2964344648","doi":"10.1158/1078-0432.ccr-19-1797","title":"DNA Methylation as a Robust Classifier of Epithelial Ovarian Cancer","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"Epigenetics; DNA methylation; Methylation; Ovarian cancer; Epithelial ovarian cancer; Biology; Cancer research; DNA; Cancer; Bioinformatics; Genetics; Gene; Gene expression","score_opus":0.3528946916214223,"score_gpt":0.5280786966631082,"score_spread":0.17518400504168596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964344648","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013701889,0.0052445424,0.000020453585,0.96013737,0.0035388872,0.0029633522,0.0008726827,0.000053316897,0.01346749],"genre_scores_gemma":[0.080715604,0.04468127,0.0008377747,0.68721825,0.06984268,0.004940847,0.0012665616,0.0006942105,0.1098028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99257725,0.0010877093,0.001496344,0.0014309306,0.0023659961,0.0010417898],"domain_scores_gemma":[0.9933205,0.0029590237,0.00051096734,0.0014932313,0.0014277166,0.00028851873],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0028754466,0.00047085944,0.001800439,0.00049008656,0.00012346532,0.000064687076,0.00049572345,0.0020104267,0.009719677],"category_scores_gemma":[0.0009454539,0.00036998268,0.0008052554,0.0007515907,0.00070037233,0.00009114698,0.00025619476,0.005774674,0.0006538896],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010754664,0.00042240613,0.014723396,0.0009890763,0.001352618,0.0003872561,0.00007273355,0.000017128192,0.00011170195,0.000088457076,0.93962866,0.041131128],"study_design_scores_gemma":[0.005176482,0.001528402,0.025590032,0.0017732409,0.00069334457,0.000007649442,0.000020554613,0.000062336745,0.0010550178,0.00033768345,0.96340686,0.00034840484],"about_ca_topic_score_codex":0.0063285604,"about_ca_topic_score_gemma":0.0003115593,"teacher_disagreement_score":0.27291915,"about_ca_system_score_codex":0.0011648932,"about_ca_system_score_gemma":0.005538135,"threshold_uncertainty_score":0.9998752},"labels":[],"label_agreement":null},{"id":"W2964857156","doi":"10.1002/jso.25647","title":"Outcome according to residual disease (surgeon's report vs pre‐chemotherapy imaging) in patients with bevacizumab‐treated ovarian cancer: Analysis of the ROSiA study","year":2019,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Roche","keywords":"Medicine; Bevacizumab; Debulking; Internal medicine; Surgery; Carboplatin; Ovarian cancer; Clinical endpoint; Chemotherapy; Oncology; Cancer; Clinical trial; Cisplatin","score_opus":0.012445956584882316,"score_gpt":0.32962755526227916,"score_spread":0.31718159867739687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964857156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889633,0.00008889993,0.0000026017992,0.009564906,0.00027582917,0.00087576435,0.000019534291,0.000005575423,0.00020355628],"genre_scores_gemma":[0.9992016,0.0000522776,0.00007244781,0.00034349496,0.0000822866,0.00002652052,0.0000067086135,0.000019465006,0.0001951889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755454,0.00020453725,0.0010635464,0.00029789444,0.0006227384,0.00025672867],"domain_scores_gemma":[0.9979023,0.0001853459,0.00083192834,0.0004208449,0.00038740627,0.0002721947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006225459,0.0001935046,0.0012844227,0.00044552685,0.000034447294,0.000014207371,0.00016101547,0.00006107939,0.00031510845],"category_scores_gemma":[0.00004933419,0.00010515565,0.0003138837,0.0010447715,0.000045722078,0.00008663469,0.000056237113,0.0002618543,0.0000017590389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011715158,0.0034979873,0.9742773,0.000013127763,0.001801264,0.002327239,0.000270593,0.0008073026,0.00000492143,0.0000058632513,0.00013977561,0.0051394776],"study_design_scores_gemma":[0.013721642,0.0024524692,0.9757525,0.0001137681,0.002635587,0.000046297344,0.00013786666,0.000027758559,0.000015061679,0.0000026643722,0.004991752,0.00010265882],"about_ca_topic_score_codex":0.0006120902,"about_ca_topic_score_gemma":0.00017728249,"teacher_disagreement_score":0.010238278,"about_ca_system_score_codex":0.0007943567,"about_ca_system_score_gemma":0.0005082031,"threshold_uncertainty_score":0.4288123},"labels":[],"label_agreement":null},{"id":"W2965052442","doi":"10.1177/1740774519862528","title":"Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application","year":2019,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; AstraZeneca","keywords":"Placebo; Medicine; Clinical endpoint; Clinical trial; Randomized controlled trial; Medical physics; Oncology; Internal medicine; Alternative medicine; Pathology","score_opus":0.40972810739830384,"score_gpt":0.5655719793965981,"score_spread":0.15584387199829425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965052442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859464,0.000040403593,0.0024616746,0.0009979315,0.00039726673,0.009721965,0.00032897718,0.000015354059,0.00009000282],"genre_scores_gemma":[0.9973,0.0000656731,0.0010607499,0.00006536632,0.0005781961,0.00048706183,0.000374384,0.0000135970095,0.000054918135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711967,0.00081318506,0.0012433651,0.0005511362,0.00015888567,0.000113754795],"domain_scores_gemma":[0.99019694,0.00765768,0.0006283718,0.0012727617,0.00017134532,0.00007288315],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016009133,0.00009104994,0.0006923282,0.000049214916,0.000022009446,0.000023671895,0.00014538286,0.00011480553,0.000053557018],"category_scores_gemma":[0.035790544,0.00005570615,0.00023209794,0.0002288405,0.00002145702,0.000094759795,0.00004781616,0.00007868736,0.0000093715025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11868407,0.0011709038,0.8092144,0.000046912348,0.0003720632,3.1701052e-7,0.000097634256,0.000038695838,0.00040579567,0.0006089755,0.0040878737,0.06527235],"study_design_scores_gemma":[0.049578257,0.0020768452,0.9439382,0.00011924544,0.00026691268,2.9652998e-7,0.00002304308,0.0020936835,0.00008068123,0.00013597767,0.0016231582,0.000063726424],"about_ca_topic_score_codex":0.00007835507,"about_ca_topic_score_gemma":0.000024924826,"teacher_disagreement_score":0.13472377,"about_ca_system_score_codex":0.00016268628,"about_ca_system_score_gemma":0.00020884936,"threshold_uncertainty_score":0.9723314},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"reproducibility","study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch"],"domain":"reproducibility","study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2965579739","doi":"10.1371/journal.pmed.1002893","title":"Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis","year":2019,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; University of Bristol; National Institute for Health and Care Research; University College London; National Cancer Institute; National Institutes of Health; Cancer Research UK","keywords":"Mendelian randomization; Case-control study; Ovarian cancer; Single-nucleotide polymorphism; Genome-wide association study; Oncology; Odds ratio; Risk factor; Observational study; Medicine; Epidemiology; Internal medicine; Gynecology; Biology; Cancer; Genetics; Genotype","score_opus":0.016142347282405944,"score_gpt":0.2794261868077067,"score_spread":0.26328383952530077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965579739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975337,0.0017047459,0.00014085117,0.0057972562,0.00013938648,0.0013831507,0.000039520135,0.000031787527,0.0010099148],"genre_scores_gemma":[0.9974759,0.0015811084,0.00010244922,0.00031799625,0.00023308762,0.00010186725,0.00008426316,0.000025130574,0.00007814891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978097,0.00024033489,0.0007540226,0.00039224842,0.0005383178,0.00026537292],"domain_scores_gemma":[0.99797744,0.00043708333,0.0007288909,0.00060558924,0.00014989931,0.00010111158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007561703,0.0002160484,0.00097215927,0.00037622644,0.000059435453,0.000007279816,0.00009762677,0.00010334777,0.00093941245],"category_scores_gemma":[0.0006280693,0.000117255186,0.00019082201,0.0012283288,0.000082032086,0.00005724434,0.000021909602,0.00030789117,0.000005483463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005365932,0.00024252111,0.9860052,0.000042310177,0.0035388046,0.000015077239,0.0035033305,0.0008197704,0.0011881256,0.000024525327,0.00008247963,0.004001276],"study_design_scores_gemma":[0.021390306,0.0005174541,0.9367627,0.0006339923,0.017026005,0.0000053222766,0.00122313,0.012854711,0.007734018,0.00021067244,0.0014545853,0.00018713855],"about_ca_topic_score_codex":0.017193308,"about_ca_topic_score_gemma":0.000962829,"teacher_disagreement_score":0.049242523,"about_ca_system_score_codex":0.000164813,"about_ca_system_score_gemma":0.00013389841,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W2965977634","doi":"10.1038/s41416-019-0543-1","title":"Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study","year":2019,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Texas MD Anderson Cancer Center; University of Oxford; Kaiser Permanente","keywords":"Medicine; Hazard ratio; Chemotherapy; Internal medicine; Ovarian cancer; Confidence interval; EPIC; Surgery; Oncology; Cancer","score_opus":0.01479247279584464,"score_gpt":0.30574270759039074,"score_spread":0.2909502347945461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965977634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567747,0.03511583,0.000018671915,0.0018536542,0.00082256924,0.0051982165,0.00012203903,0.000008355545,0.00008592264],"genre_scores_gemma":[0.9731511,0.024546776,0.0003587131,0.00052181544,0.00042656474,0.00070188264,0.000004450595,0.00005654781,0.00023213938],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976848,0.00014573254,0.0010603083,0.00030806087,0.00047872885,0.00032236503],"domain_scores_gemma":[0.9979561,0.00026426205,0.000658123,0.00017908393,0.0007907521,0.00015167863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006259537,0.00025937916,0.0018220969,0.00015144335,0.000046899975,0.0000469747,0.00014455126,0.0000992634,0.00065379794],"category_scores_gemma":[0.000060240243,0.00022198829,0.00040172812,0.00014407985,0.000047212303,0.0001826569,0.000008494477,0.00026684956,9.540523e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32629216,0.00399324,0.16104025,0.000066007604,0.003457226,0.00019996637,0.0032393883,0.0010257681,0.006263534,0.000017949193,0.00016894862,0.49423558],"study_design_scores_gemma":[0.5308363,0.0052799587,0.45791948,0.0009585768,0.0002456554,0.000055916986,0.00040085448,0.000052074847,0.003503302,0.000014713608,0.00055261835,0.00018058684],"about_ca_topic_score_codex":0.002788265,"about_ca_topic_score_gemma":0.003902817,"teacher_disagreement_score":0.494055,"about_ca_system_score_codex":0.00031017576,"about_ca_system_score_gemma":0.0006458396,"threshold_uncertainty_score":0.90524197},"labels":[],"label_agreement":null},{"id":"W2966380444","doi":"10.1101/716415","title":"Leveraging biobank-scale rare and common variant analyses to identify <i>ASPHD1</i> as the main driver of reproductive traits in the 16p11.2 locus","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Mendelian randomization; Biology; Genome-wide association study; Copy-number variation; Locus (genetics); Genetics; Phenotype; Biobank; Gene; Single-nucleotide polymorphism; Genome; Genetic variants","score_opus":0.029097239940243047,"score_gpt":0.2963567328594257,"score_spread":0.26725949291918266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966380444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872238,0.0031902592,0.00009965379,0.0063741156,0.00048928865,0.002300846,0.00022478879,0.000053063755,0.000044175005],"genre_scores_gemma":[0.9970122,0.00046862295,0.00054657337,0.0012837318,0.00031455225,0.00028884446,9.096928e-7,0.00007584412,0.000008735125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967523,0.000288908,0.0006561996,0.0012392645,0.00057916786,0.00048416093],"domain_scores_gemma":[0.99704754,0.00022458956,0.0004024381,0.0018816346,0.0002703706,0.00017342276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012865724,0.00052342436,0.00096183515,0.00028687288,0.00012816982,0.00015345168,0.00049076625,0.00027085413,0.0000410313],"category_scores_gemma":[0.0001775931,0.0003449055,0.00020311643,0.0008006004,0.0001685481,0.00009227994,0.00041377405,0.0007303235,0.000028828656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009995725,0.0029376706,0.38843417,0.00250353,0.003682758,0.0022350636,0.005262887,0.0015281579,0.5852279,0.0017491017,0.0052790157,0.0001601596],"study_design_scores_gemma":[0.001254097,0.00017996172,0.92276174,0.0011872158,0.00075790525,7.3905017e-7,0.00014505142,0.000044894317,0.071848415,0.00001309315,0.0014314979,0.0003754126],"about_ca_topic_score_codex":0.0011678191,"about_ca_topic_score_gemma":0.00005184044,"teacher_disagreement_score":0.5343275,"about_ca_system_score_codex":0.00034958264,"about_ca_system_score_gemma":0.00049161405,"threshold_uncertainty_score":0.9999003},"labels":[],"label_agreement":null},{"id":"W2969124354","doi":"10.1136/00009577-201809002-00001","title":"17th Biennial Meeting of the International Gynecologic Cancer Society Kyoto, Japan September 14-16, 2018","year":2018,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Gynecologic cancer; Gynecology; Cancer; Family medicine; Internal medicine; Ovarian cancer","score_opus":0.03149553926749486,"score_gpt":0.3360346258657554,"score_spread":0.3045390865982605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969124354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95172787,0.00093749,0.00006754829,0.021759113,0.010686874,0.00031929868,0.00010539181,0.00001832097,0.014378101],"genre_scores_gemma":[0.9877227,0.0010113902,0.0009890983,0.005134406,0.0032762105,0.00006056263,0.000004980426,0.000019158982,0.0017815187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974002,0.00007022432,0.00081947044,0.00028745545,0.0011390529,0.0002835715],"domain_scores_gemma":[0.9964267,0.00037020794,0.0009880153,0.00018675116,0.0018815531,0.00014679511],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005085295,0.0002239069,0.00046545215,0.000094691015,0.000105483334,0.000048379356,0.0007306134,0.00018712634,0.014347883],"category_scores_gemma":[0.00047266582,0.00012927636,0.000652968,0.00019533669,0.00040580123,0.00015657395,0.00024911543,0.00039233212,0.000028637392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059566123,0.0010850074,0.8024863,0.00002303855,0.0028351645,0.000050210016,0.00039185176,0.00019588572,0.0034646806,0.00044028249,0.1611165,0.027315404],"study_design_scores_gemma":[0.005217094,0.001200047,0.76395005,0.0005036988,0.00045668185,0.00013882933,0.00018233314,0.00027805558,0.013992558,0.0007898276,0.2130603,0.00023050334],"about_ca_topic_score_codex":0.00020431141,"about_ca_topic_score_gemma":0.0004628235,"teacher_disagreement_score":0.051943816,"about_ca_system_score_codex":0.0017172527,"about_ca_system_score_gemma":0.00064406486,"threshold_uncertainty_score":0.98655313},"labels":[],"label_agreement":null},{"id":"W2969375619","doi":"10.1136/ijgc-00009577-200409001-00468","title":"468 Phase I/II Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients (PTS) With Relapsed/Refractory Ovarian, Primary Fallopian, or Primary Peritoneal Cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Ovarian cancer; Fallopian tube; Internal medicine; Oncology; Gynecology; Urology; Cancer","score_opus":0.02566531339371038,"score_gpt":0.3233031724292442,"score_spread":0.29763785903553386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969375619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915707,0.0005592302,0.0000677945,0.004426825,0.0018543955,0.0007467068,0.00011140401,0.000013605204,0.0006493092],"genre_scores_gemma":[0.9945683,0.0016574397,0.0011510389,0.0013080118,0.00085309235,0.000135122,0.00006203461,0.00002804113,0.00023693462],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969775,0.00008071561,0.0011031232,0.0003314076,0.0012253865,0.00028188265],"domain_scores_gemma":[0.99756896,0.00021230291,0.0009349088,0.00016492709,0.00092129025,0.00019763144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030293508,0.00027447916,0.0007838083,0.00029420454,0.0000567736,0.000025912255,0.00025624773,0.00021971377,0.0013256588],"category_scores_gemma":[0.00017603721,0.00017482777,0.00022248067,0.00024358675,0.00013627103,0.0003681804,0.000080405276,0.00051983487,0.0000030959038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46827385,0.040002573,0.30355078,0.00014807543,0.0021212515,0.0015764538,0.00060801284,0.002157582,0.001080047,0.00021237704,0.0014117169,0.17885728],"study_design_scores_gemma":[0.23299265,0.02217642,0.7388538,0.00072096224,0.00025428517,0.000037501617,0.000023157598,0.000008989016,0.00035870142,0.000105256775,0.004269354,0.00019888734],"about_ca_topic_score_codex":0.00034634402,"about_ca_topic_score_gemma":0.00032582338,"teacher_disagreement_score":0.43530306,"about_ca_system_score_codex":0.0035506855,"about_ca_system_score_gemma":0.001883368,"threshold_uncertainty_score":0.99958724},"labels":[],"label_agreement":null},{"id":"W2969706548","doi":"10.1101/740696","title":"Gene networks and expression quantitative trait loci associated with platinum-based chemotherapy response in high-grade serous ovarian cancer","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Queen's University; Canadian Institutes of Health Research; Government of Ontario","keywords":"Expression quantitative trait loci; Ovarian cancer; Biology; Chemotherapy; Gene; Gene expression; Oncology; Ovarian carcinoma; Cancer research; Microarray; Gene expression profiling; Cancer; Internal medicine; Medicine; Genetics; Single-nucleotide polymorphism","score_opus":0.017971821654893604,"score_gpt":0.2525181097586751,"score_spread":0.2345462881037815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969706548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918073,0.002368381,0.0013425645,0.0016399114,0.00032422305,0.001912841,0.00043318715,0.00017002107,0.0000016152399],"genre_scores_gemma":[0.99185467,0.00047047765,0.0058754697,0.0007337781,0.0001586065,0.000695436,0.000005722466,0.00019908587,0.000006738481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685836,0.00035294125,0.00053015386,0.0012174082,0.00044571885,0.0005954363],"domain_scores_gemma":[0.99765235,0.00035472217,0.0005491608,0.00086133933,0.00029474645,0.00028769422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066707627,0.00070360664,0.0011390509,0.00031265424,0.000095606636,0.00011124773,0.00017708576,0.0007173984,0.00007255201],"category_scores_gemma":[0.00011469229,0.00061023206,0.00010941877,0.00054770865,0.00012718647,0.000087722634,0.000088157496,0.0008514081,0.0000034418165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021580974,0.0034265332,0.67284495,0.0009321425,0.0027560082,0.0014525284,0.00026210476,0.047102973,0.24873096,0.00015862705,0.0007206196,0.000031608328],"study_design_scores_gemma":[0.011833287,0.0007434524,0.9051642,0.0035697254,0.00031936663,3.729469e-8,0.00000610935,0.0054624425,0.072102256,8.152504e-7,0.00013611134,0.00066223403],"about_ca_topic_score_codex":0.0005511449,"about_ca_topic_score_gemma":0.000052878488,"teacher_disagreement_score":0.23231924,"about_ca_system_score_codex":0.0011146493,"about_ca_system_score_gemma":0.0013421244,"threshold_uncertainty_score":0.9996349},"labels":[],"label_agreement":null},{"id":"W2970379806","doi":"10.1038/s41467-019-11862-x","title":"The molecular origin and taxonomy of mucinous ovarian carcinoma","year":2019,"lang":"en","type":"article","venue":"Nature Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Medical Research and Materiel Command; Cancer Council Tasmania; National Institutes of Health; BC Cancer Foundation; Université de Montréal; Cancer Council South Australia; Medical Research Council; Peter MacCallum Foundation; Terry Fox Research Institute; Peter MacCallum Cancer Centre; Cancer Council Victoria; Cancer Australia; Australian Cancer Research Foundation; Cancer Council NSW; National Health and Medical Research Council; Minnesota Ovarian Cancer Alliance; VGH and UBC Hospital Foundation; Cancer Institute NSW; Fred C. and Katherine B. Andersen Foundation; National Cancer Institute; Ovarian Cancer Australia; Mayo Foundation for Medical Education and Research","keywords":"Ovary; Ovarian cancer; Ovarian carcinoma; Amplicon; Biology; Pathology; Cancer research; Disease; Oncology; Cancer; Medicine; Gene; Genetics; Polymerase chain reaction","score_opus":0.022189113769553175,"score_gpt":0.2912404914308697,"score_spread":0.26905137766131654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970379806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8018591,0.0923172,0.000033739972,0.04499688,0.0002421456,0.0018688,0.000032777807,0.000040342216,0.058609005],"genre_scores_gemma":[0.99459106,0.0011580453,0.0035522701,0.00036761336,0.0000136892495,0.00009671764,0.00002137494,0.000008622332,0.00019058629],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954844,0.000041945972,0.00012622341,0.0001055185,0.00008945102,0.00008843893],"domain_scores_gemma":[0.9980641,0.00020118823,0.000062548934,0.0015333924,0.00009276291,0.000045988887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009793086,0.00006933923,0.00013466067,0.000031843752,0.00009934968,0.000012548504,0.00022619026,0.00009101373,0.000018823677],"category_scores_gemma":[0.00002903646,0.000046163306,0.00004740513,0.000122014775,0.00008716091,0.00002208792,0.00010875305,0.0003056556,0.000010594591],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004574126,0.00031535907,0.6234925,0.000036526642,0.00025167354,0.000005266991,0.00017845108,0.000001526094,0.0010507244,0.35740033,0.0023111335,0.014910802],"study_design_scores_gemma":[0.0011984003,0.00013191448,0.44743264,0.00004451647,0.00014034238,0.000024097582,0.00011014518,0.00011645237,0.0012419556,0.0001930515,0.54929703,0.000069464324],"about_ca_topic_score_codex":0.00008358825,"about_ca_topic_score_gemma":0.00007486546,"teacher_disagreement_score":0.54698586,"about_ca_system_score_codex":0.00004261054,"about_ca_system_score_gemma":0.00009259813,"threshold_uncertainty_score":0.1882485},"labels":[],"label_agreement":null},{"id":"W2970618655","doi":"10.1097/pas.0000000000001348","title":"Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT)","year":2019,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Vancouver General Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Biology; Fluorescence in situ hybridization; Fusion gene; Gene rearrangement; Ovarian tumor; Genitourinary system; Cancer research; Gene; Genetics; Ovarian cancer; Cancer; Chromosome; Anatomy","score_opus":0.018840514223251788,"score_gpt":0.31502288870595874,"score_spread":0.29618237448270696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970618655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985894,0.00035189968,0.000056509863,0.010963261,0.0003949315,0.00020044313,0.000006334196,0.00001628843,0.0021162916],"genre_scores_gemma":[0.9953442,0.0003336748,0.0011261873,0.0020731564,0.0005663484,0.000006207094,0.000001821072,0.000028652124,0.00051975815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825114,0.00027481976,0.0005597982,0.00022832525,0.0003209472,0.00036496035],"domain_scores_gemma":[0.9981671,0.00038464286,0.0006633209,0.00041337663,0.00014610292,0.00022547222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076165394,0.0001881662,0.00093644095,0.00014576512,0.00005889665,0.000019686175,0.00022282441,0.000024432058,0.0005925763],"category_scores_gemma":[0.000043878856,0.00010676929,0.00027887372,0.0003199283,0.00034720916,0.000056021505,0.00007814674,0.0004669304,0.000121850855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029600399,0.0030175683,0.6520624,0.00016496357,0.0015790672,0.13480961,0.0011566107,0.00023027763,0.019443396,0.0044372072,0.004816418,0.14868204],"study_design_scores_gemma":[0.017725043,0.033738434,0.5340734,0.00044553413,0.0006808014,0.15449508,0.001556994,0.00017732345,0.0029611387,0.0008656049,0.2527016,0.0005790174],"about_ca_topic_score_codex":0.00005531185,"about_ca_topic_score_gemma":0.0000012642191,"teacher_disagreement_score":0.2478852,"about_ca_system_score_codex":0.00010689961,"about_ca_system_score_gemma":0.00018803666,"threshold_uncertainty_score":0.64882946},"labels":[],"label_agreement":null},{"id":"W2973583858","doi":"10.1158/1541-7786.mcr-19-0398","title":"Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Jewish General Hospital; AstraZeneca Canada; Israel Cancer Research Fund","keywords":"Debulking; Serous fluid; Oncology; Chemotherapy; Ovarian cancer; Gene; Gene expression profiling; Cancer; Medicine; Gene expression; Internal medicine; Prognostic variable; Biology; Cancer research; Genetics","score_opus":0.0467967473923134,"score_gpt":0.36648248066375577,"score_spread":0.3196857332714424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973583858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133706,0.0034564438,0.000028261395,0.0027666418,0.00029156235,0.0015629882,0.000023723589,0.000028199132,0.0005051024],"genre_scores_gemma":[0.99736947,0.00064476056,0.0007497938,0.00015562512,0.000041074076,0.00048416213,0.000024252058,0.000057190326,0.00047366414],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997022,0.00020539717,0.0004906816,0.0006137,0.0010553943,0.0006128639],"domain_scores_gemma":[0.99893045,0.00008188599,0.000101004705,0.0005920209,0.00012503218,0.00016960443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014938,0.00023529839,0.00069550105,0.00037141406,0.00005949563,0.000027819384,0.00022752715,0.00017008389,0.0006594603],"category_scores_gemma":[0.000033173128,0.00018474243,0.00018911467,0.0007523162,0.00008867621,0.00006823697,0.00008781662,0.00046550084,0.00002087831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035967526,0.00034435932,0.6976749,0.00019426411,0.0003109562,0.00035545052,0.00067447615,0.00017065361,0.29482597,0.0002475584,0.000119980345,0.0047217896],"study_design_scores_gemma":[0.008627947,0.00061112444,0.31250423,0.0011281245,0.000054263655,0.0000060434236,0.00022860423,0.00018700413,0.6759365,0.0003024388,0.00018226804,0.00023143268],"about_ca_topic_score_codex":0.012715376,"about_ca_topic_score_gemma":0.00015837376,"teacher_disagreement_score":0.38517064,"about_ca_system_score_codex":0.00090672774,"about_ca_system_score_gemma":0.00059911056,"threshold_uncertainty_score":0.99385905},"labels":[],"label_agreement":null},{"id":"W2973731620","doi":"10.1136/ijgc-2019-igcs.1","title":"1 MILO/ENGOT-OV11: Phase-3 study of binimetinib versus physician’s choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; KRAS; Selumetinib; MEK inhibitor; Chemotherapy; Clinical endpoint; Internal medicine; Serous carcinoma; Progression-free survival; Ovarian cancer; Oncology; Gastroenterology; Serous fluid; Surgery; Randomized controlled trial; Cancer; MAPK/ERK pathway; Kinase; Colorectal cancer; Biology","score_opus":0.05509890882951412,"score_gpt":0.3621649320535733,"score_spread":0.3070660232240592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973731620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919788,0.00083908025,8.2025736e-7,0.0035548059,0.0023428455,0.000833623,0.000051795847,0.0000053389554,0.00039287758],"genre_scores_gemma":[0.9976259,0.0007570423,0.000092976334,0.00084789,0.00038043098,0.000054424552,0.000004749637,0.000018934712,0.00021768802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976494,0.0001305388,0.00083085365,0.00027450648,0.0008982707,0.0002164511],"domain_scores_gemma":[0.99796474,0.00055101275,0.0006835032,0.00023334935,0.00046831675,0.000099099816],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022420757,0.00022248074,0.00072399975,0.00015719951,0.00002723938,0.000015115922,0.00046049524,0.00009272068,0.0011493596],"category_scores_gemma":[0.00014110422,0.00011897723,0.00038185838,0.0002615875,0.00008846593,0.00009118776,0.00009032271,0.00036399695,0.000002522429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04249487,0.035992347,0.8450006,0.00022246553,0.004567493,0.00036277002,0.0030731638,0.0007673196,0.005199135,0.000049083006,0.0014944088,0.060776304],"study_design_scores_gemma":[0.03950505,0.017638177,0.93260014,0.00057406374,0.00033359908,0.000038555863,0.0011986417,0.00010529221,0.0025577547,0.0000063241678,0.005275447,0.0001669261],"about_ca_topic_score_codex":0.0003253738,"about_ca_topic_score_gemma":0.0004901157,"teacher_disagreement_score":0.08759953,"about_ca_system_score_codex":0.0010256305,"about_ca_system_score_gemma":0.0005765542,"threshold_uncertainty_score":0.9997637},"labels":[],"label_agreement":null},{"id":"W2974072392","doi":"10.1136/ijgc-2019-igcs.314","title":"314 Patients with ovarian clear cell carcinoma are at high risk of secondary malignancy","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Clear cell carcinoma; Internal medicine; Cohort; Retrospective cohort study; Malignancy; Cancer; Carcinoma; Gastroenterology; Oncology","score_opus":0.006460709447811825,"score_gpt":0.23001274874425345,"score_spread":0.22355203929644163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974072392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950172,0.00049411145,0.000008648939,0.0011839847,0.0010157686,0.00023665083,0.00019614254,0.00000507482,0.00184242],"genre_scores_gemma":[0.9978958,0.00028067193,0.0005151829,0.0005767544,0.00021714554,0.00001143312,0.000014940864,0.000015925343,0.00047216262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850523,0.00004992986,0.0004554451,0.0001930191,0.0006365726,0.00015982201],"domain_scores_gemma":[0.9978206,0.00016685062,0.0008946899,0.00013760038,0.000848657,0.0001315624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011912983,0.0001488237,0.0004271001,0.000105222985,0.000026919754,0.000013062546,0.0001887308,0.00009291063,0.009464364],"category_scores_gemma":[0.000049098107,0.00009169836,0.00017637598,0.000073920884,0.000052113246,0.00009982466,0.00006692953,0.00025267806,0.000035829908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022254826,0.0008218688,0.9900907,0.00003085495,0.00044479533,0.00020522019,0.000051421204,0.00011725025,0.000060889037,0.00008030382,0.0012294711,0.0046417415],"study_design_scores_gemma":[0.0093154535,0.0030171226,0.98146874,0.00015691255,0.00022077655,0.000023396431,0.000032886295,0.000007358205,0.0018948762,0.00008473306,0.003679989,0.00009777595],"about_ca_topic_score_codex":0.0001515094,"about_ca_topic_score_gemma":0.000062159925,"teacher_disagreement_score":0.009428534,"about_ca_system_score_codex":0.0006450539,"about_ca_system_score_gemma":0.00021746667,"threshold_uncertainty_score":0.99144113},"labels":[],"label_agreement":null},{"id":"W2974669716","doi":"10.1136/ijgc-2019-igcs.3","title":"3 Translating endometrial molecular risk stratification to endometrioid ovarian carcinoma: a novel application of precision medicine","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"","keywords":"Endometrial cancer; Oncology; Internal medicine; Medicine; Carcinoma; Ovarian cancer; Ovarian carcinoma; Stage (stratigraphy); Biomarker; Cohort; Risk stratification; Cancer; Biology","score_opus":0.02519755294587055,"score_gpt":0.33477523806144827,"score_spread":0.3095776851155777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974669716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9405933,0.0010229725,0.048238676,0.006788248,0.0011337856,0.0009040851,0.000070039285,0.0000096850845,0.0012392241],"genre_scores_gemma":[0.9913772,0.00022904389,0.007528663,0.00025948184,0.0004955033,0.000054483604,0.000014561729,0.000013112502,0.000027992104],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99769694,0.000059076974,0.0008992667,0.0002582922,0.000939197,0.00014720444],"domain_scores_gemma":[0.997107,0.00068944687,0.0008279459,0.00018170236,0.0010297431,0.00016412113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066690665,0.00014979576,0.00051606464,0.000535413,0.000022290333,0.000015217203,0.00025744212,0.00010672271,0.0011877348],"category_scores_gemma":[0.0011142154,0.00010437551,0.00020911326,0.00044180104,0.000042474545,0.00009801935,0.000029666257,0.00023545441,0.0000133804015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041448865,0.0014560833,0.35712552,0.000049048325,0.0010491393,0.00006486691,0.00049001834,0.0045122597,0.23011751,0.0036369655,0.00017009568,0.3971836],"study_design_scores_gemma":[0.03151681,0.007962695,0.9014655,0.00044946617,0.000818748,0.00015696546,0.00020650991,0.0018623166,0.043877818,0.0012973222,0.010080164,0.0003056944],"about_ca_topic_score_codex":0.00025446806,"about_ca_topic_score_gemma":0.000016276563,"teacher_disagreement_score":0.54433995,"about_ca_system_score_codex":0.00047514017,"about_ca_system_score_gemma":0.00021631524,"threshold_uncertainty_score":0.99972534},"labels":[],"label_agreement":null},{"id":"W2976603966","doi":"10.1016/j.ogc.2019.07.002","title":"The Abnormal Ovary","year":2019,"lang":"en","type":"review","venue":"Obstetrics and Gynecology Clinics of North America","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Ovary; Gynecology; Disease; General surgery; Terminology; Intensive care medicine; Cancer; Pathology; Internal medicine","score_opus":0.048888201747730994,"score_gpt":0.3481346984798489,"score_spread":0.2992464967321179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976603966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091308095,0.9952917,0.000002852243,0.00020276933,0.0019017329,0.0009671375,0.00012651994,0.000014635624,0.0014013253],"genre_scores_gemma":[0.00012059052,0.9981061,0.00024669885,0.00033698385,0.00009120019,0.00009867352,0.00017562344,0.00004453981,0.0007795671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977771,0.00011932863,0.0010324906,0.00048270504,0.00021451552,0.00037387537],"domain_scores_gemma":[0.9758553,0.022083025,0.0009874491,0.0007553202,0.00014881862,0.00017011474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021101974,0.00036823424,0.0023606936,0.00018639959,0.00012876118,0.000020230793,0.00022607135,0.00031678943,0.000042001368],"category_scores_gemma":[0.002633439,0.00022020808,0.0006096217,0.0006384582,0.00037730456,0.000028332626,0.000177796,0.00055984524,0.00009593823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009011582,0.00023905699,0.008014656,0.0028898816,0.0007164437,0.00006620841,0.000008725847,4.3061536e-7,2.691041e-10,0.000056549605,0.001606451,0.98639256],"study_design_scores_gemma":[0.00068585493,0.0014379853,0.0068558087,0.0006098626,0.002825961,0.000027468857,0.0000071685117,0.0000069902835,7.4899615e-9,0.000009879254,0.987351,0.00018199065],"about_ca_topic_score_codex":0.000009913796,"about_ca_topic_score_gemma":0.000011433657,"teacher_disagreement_score":0.9862106,"about_ca_system_score_codex":0.00010774521,"about_ca_system_score_gemma":0.0008203371,"threshold_uncertainty_score":0.8979825},"labels":[],"label_agreement":null},{"id":"W2976696569","doi":"10.1038/s41598-019-50436-1","title":"Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer","year":2019,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Internal medicine; Gelsolin; Ovarian cancer; Proportional hazards model; Oncology; Stage (stratigraphy); Hazard ratio; Multivariate analysis; Survival analysis; Gastroenterology; Cancer; Confidence interval; Biology","score_opus":0.01566269492943216,"score_gpt":0.283215544862325,"score_spread":0.2675528499328928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976696569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935508,0.00059865124,0.000010527191,0.0004985736,0.0027141576,0.0013228761,0.000037605358,0.00007127521,0.00119556],"genre_scores_gemma":[0.9894138,0.000025092146,0.0002854446,0.00007215188,0.000176747,0.00015242303,0.000048511796,0.000029567624,0.009796273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997481,0.0000454979,0.00041704276,0.0010550483,0.0006229098,0.00037848979],"domain_scores_gemma":[0.99833345,0.000046042485,0.0002252177,0.0007822234,0.00015919018,0.00045387223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049287477,0.00021113832,0.0003103085,0.00013252867,0.00025228807,0.00027007237,0.000049112503,0.000068783935,0.0005309355],"category_scores_gemma":[0.00011600607,0.00017111366,0.00007249623,0.00026016324,0.00015161307,0.00022932162,0.00007958394,0.00014528164,0.000024016557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016614464,0.00018989679,0.9822954,0.0002016896,0.00021244367,0.0028995047,0.0019851176,0.0003342518,0.006316704,0.00010736335,0.0011613325,0.004130131],"study_design_scores_gemma":[0.0017199601,0.00022309806,0.97871065,0.00057771686,0.00027960312,0.0001411019,0.000106124295,0.001257647,0.011792962,0.0003012769,0.0046224426,0.00026744104],"about_ca_topic_score_codex":0.00042496744,"about_ca_topic_score_gemma":0.00012147977,"teacher_disagreement_score":0.008600713,"about_ca_system_score_codex":0.00017001868,"about_ca_system_score_gemma":0.0006582868,"threshold_uncertainty_score":0.69778126},"labels":[],"label_agreement":null},{"id":"W2977507283","doi":"10.1002/path.5353","title":"Oncogenic <i>BRAF</i> and <i>KRAS</i> mutations in endosalpingiosis","year":2019,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"KRAS; Serous fluid; Fallopian tube; Serous carcinoma; Pathology; Immunohistochemistry; Cancer research; Medicine; Ovarian cancer; Biology; Cancer; Internal medicine; Gynecology","score_opus":0.010880012827201989,"score_gpt":0.2664128901100983,"score_spread":0.2555328772828963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977507283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014044,0.0025196888,0.000017226064,0.0060175243,0.00017332361,0.00013206637,0.0000023277728,0.0000027343833,0.0009946529],"genre_scores_gemma":[0.9972609,0.001148228,0.00032746783,0.0010893978,0.000068617344,0.0000026324722,7.8490376e-7,0.000007066941,0.00009485715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994337,0.000086442524,0.0002291799,0.00006023693,0.00008472805,0.00010573652],"domain_scores_gemma":[0.999482,0.00018597489,0.00013177458,0.00011363767,0.000042004183,0.000044625198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034896724,0.00006088264,0.00022424174,0.000082228406,0.000018408527,0.000003853221,0.00004720705,0.000037477916,0.00008551383],"category_scores_gemma":[0.000030221376,0.00003588472,0.000052208732,0.00009125147,0.0000457848,0.00003736679,0.000017417904,0.00015613831,0.000033203356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007368739,0.0008805031,0.8914516,0.00007971732,0.00036087655,0.0031022122,0.004896731,0.00014244593,0.077236965,0.0011611016,0.002590761,0.017360209],"study_design_scores_gemma":[0.015376755,0.0041850223,0.92037886,0.00037869433,0.0011018888,0.034096465,0.0014534128,0.00006181168,0.012033962,0.0022833366,0.008456812,0.00019300406],"about_ca_topic_score_codex":0.000015070926,"about_ca_topic_score_gemma":0.000013924948,"teacher_disagreement_score":0.065203,"about_ca_system_score_codex":0.00004428201,"about_ca_system_score_gemma":0.00006972296,"threshold_uncertainty_score":0.14633365},"labels":[],"label_agreement":null},{"id":"W2977559041","doi":"10.1093/biolre/ioz099","title":"Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†","year":2019,"lang":"en","type":"review","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Ovarian cancer; Biology; Computational biology; Disease; Serous ovarian cancer; DNA microarray; Bioinformatics; Transcriptome; Cancer; Cancer research; Gene; Internal medicine; Genetics; Gene expression; Medicine","score_opus":0.1323340814233846,"score_gpt":0.3822794534784576,"score_spread":0.249945372055073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977559041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062738603,0.9963482,0.00018797783,0.0007165062,0.0006975269,0.0012628901,0.000067545494,0.000008468469,0.000083514366],"genre_scores_gemma":[0.005233088,0.9930742,0.0009239922,0.0000031234385,0.00033985995,0.0001354356,0.00012406564,0.000013070055,0.0001531832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887204,0.00012191419,0.00043050075,0.0004182039,0.000072421935,0.00008492033],"domain_scores_gemma":[0.9988444,0.00005558211,0.000497622,0.00042617953,0.00015751674,0.000018695231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003676035,0.00013849174,0.0008651445,0.00012029496,0.00004329092,0.000002003625,0.00004375973,0.00019659736,0.000023696412],"category_scores_gemma":[0.00006606198,0.00008199641,0.00020536393,0.00019460119,0.0003522873,0.00002284205,0.000010863732,0.00013009574,0.0000017489008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019106592,0.00019507695,0.0029411921,0.009581303,0.0010445563,2.306241e-7,0.000061729384,0.0000029784094,0.0002978774,0.043029584,0.00004461356,0.9426098],"study_design_scores_gemma":[0.0023766772,0.0002839374,0.005295546,0.0053347894,0.007901636,0.00016127391,0.000055304958,0.000050375205,0.00019205155,0.0005344502,0.9776235,0.00019044732],"about_ca_topic_score_codex":0.00049103657,"about_ca_topic_score_gemma":0.000005261318,"teacher_disagreement_score":0.9775789,"about_ca_system_score_codex":0.00023260678,"about_ca_system_score_gemma":0.0006645014,"threshold_uncertainty_score":0.33437166},"labels":[],"label_agreement":null},{"id":"W2977799542","doi":"10.1093/annonc/mdz250.036","title":"Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Bevacizumab; Carboplatin; Ovarian cancer; Folate receptor; Antibody-drug conjugate; Conjugate; Oncology; Internal medicine; Phases of clinical research; Antibody; Cancer research; Cancer; Chemotherapy; Monoclonal antibody; Immunology; Cisplatin; Cancer cell","score_opus":0.03156606835158248,"score_gpt":0.37021421649439595,"score_spread":0.33864814814281347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977799542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937049,0.00031333207,0.000002470693,0.0029343707,0.00015272856,0.0020437054,0.0003389098,0.000016399503,0.000493192],"genre_scores_gemma":[0.9983202,0.00019955063,0.00041778374,0.00037681003,0.000045136912,0.000101436526,0.00047973986,0.00003399948,0.000025342624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978403,0.00024325964,0.00068152585,0.0005877037,0.0002997751,0.00034747005],"domain_scores_gemma":[0.99864215,0.00024164203,0.00044314665,0.00025799443,0.0002996368,0.00011541249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045392735,0.0002666835,0.00088911824,0.0002618356,0.00003551198,0.000016175674,0.00007278381,0.00012557198,0.00007783244],"category_scores_gemma":[0.00006998409,0.00020796653,0.000034463625,0.0003543926,0.00008142124,0.00017454886,0.000041683605,0.0002608098,0.0000049517876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032739516,0.012861669,0.90650904,0.000060978506,0.00046424122,0.0002761048,0.0074770018,0.000035062967,0.00038163338,0.000029957058,0.0002862809,0.038878493],"study_design_scores_gemma":[0.18200247,0.033560436,0.7798715,0.0007180741,0.00017510379,0.0000032924793,0.0008804342,0.00033951542,0.0013822728,0.000043443182,0.0007486275,0.0002747786],"about_ca_topic_score_codex":0.014800492,"about_ca_topic_score_gemma":0.0076294355,"teacher_disagreement_score":0.14926295,"about_ca_system_score_codex":0.00018135051,"about_ca_system_score_gemma":0.00040167777,"threshold_uncertainty_score":0.99176},"labels":[],"label_agreement":null},{"id":"W2978649654","doi":"10.1148/radiol.2019190545","title":"Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker","year":2019,"lang":"en","type":"article","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; Addenbrooke's Charitable Trust, Cambridge University Hospitals; Medical Research Council; Cambridge University Hospitals; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; Institute of Cancer Research; University of Cambridge; Cancer Research UK","keywords":"Medicine; Effective diffusion coefficient; Cohort; Interquartile range; Debulking; Prospective cohort study; Confidence interval; Ovarian cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Magnetic resonance imaging; Surgery; Cancer; Radiology; Chemotherapy; Progressive disease","score_opus":0.006958034015787314,"score_gpt":0.27082271871637054,"score_spread":0.2638646847005832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978649654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866153,0.0010662414,0.00006981193,0.008520321,0.0011999509,0.0013388399,0.000048532926,0.00005930825,0.0010816643],"genre_scores_gemma":[0.99481815,0.001529308,0.00037558028,0.0012625355,0.00016062017,0.00033108576,0.00006278301,0.00003823382,0.0014217164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784577,0.00030486475,0.00042259094,0.0006722255,0.0002363992,0.00051817833],"domain_scores_gemma":[0.99870235,0.0003429175,0.00012839022,0.0005594261,0.000059175247,0.00020772837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032283136,0.00028091442,0.0006787208,0.00025482886,0.00006193118,0.000009889038,0.00012568722,0.00021361481,0.0023348657],"category_scores_gemma":[0.00006534837,0.00021511596,0.00013454727,0.0003063107,0.00007710164,0.000035871344,0.00008704775,0.0002497578,0.0003219397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040920354,0.0031405073,0.84319794,0.00012475326,0.0003333533,0.0008560453,0.0015274691,0.0005025983,0.06655505,0.0019827087,0.0030910156,0.03776822],"study_design_scores_gemma":[0.017409842,0.0017569743,0.88584054,0.00033168044,0.00009714465,0.0001760261,0.00011136642,0.0025152203,0.0012098176,0.00010524445,0.09015642,0.00028976088],"about_ca_topic_score_codex":0.00058093126,"about_ca_topic_score_gemma":0.000102516904,"teacher_disagreement_score":0.0870654,"about_ca_system_score_codex":0.0006951042,"about_ca_system_score_gemma":0.00032920006,"threshold_uncertainty_score":0.9985771},"labels":[],"label_agreement":null},{"id":"W2979304263","doi":"10.5114/jhi.2019.87847","title":"Sertoli-Leydig cell tumour (SLCT) – the case of a 15 cm diameter ovarian tumour with negative markers and absent hormonal symptoms","year":2019,"lang":"en","type":"article","venue":"Journal of Health Inequalities","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sertoli cell; Hormone; Leydig cell; Testosterone (patch); Internal medicine; Ovary; Endocrinology; Physiology; Andrology; Biology; Pathology; Medicine; Spermatogenesis; Luteinizing hormone","score_opus":0.020427712749007648,"score_gpt":0.28254760209925656,"score_spread":0.2621198893502489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979304263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797443,0.0034225355,0.00005599452,0.015274807,0.00020640974,0.0005587826,0.000053751482,0.0000064771098,0.00067693356],"genre_scores_gemma":[0.9961492,0.0005150791,0.0010851527,0.0017396143,0.00017976594,0.000014055733,0.0000027487088,0.000027190947,0.00028718656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789053,0.00029012925,0.0009177447,0.00017833845,0.00039564577,0.00032763352],"domain_scores_gemma":[0.9976693,0.0005444547,0.0010449314,0.0002195989,0.00027151976,0.00025023997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010805355,0.00022274443,0.0007787789,0.00015998617,0.00010798624,0.00003415432,0.00008240097,0.00005126347,0.0001368509],"category_scores_gemma":[0.000045007186,0.000119510885,0.00013354389,0.00014028938,0.000113825794,0.0001396506,0.000033521275,0.00031687482,0.0000037840928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023614792,0.0058884094,0.707396,0.015400655,0.0073524434,0.017373398,0.11809779,0.00035753238,0.0013778147,0.018149719,0.03451243,0.050479032],"study_design_scores_gemma":[0.030514425,0.034664825,0.8036802,0.005365828,0.0011995243,0.03080369,0.08260219,0.00039800897,0.004274212,0.0018606248,0.0038579616,0.0007785593],"about_ca_topic_score_codex":0.001662796,"about_ca_topic_score_gemma":0.000127279,"teacher_disagreement_score":0.096284166,"about_ca_system_score_codex":0.00022680218,"about_ca_system_score_gemma":0.00084140187,"threshold_uncertainty_score":0.48735124},"labels":[],"label_agreement":null},{"id":"W2979768168","doi":"10.1136/ijgc-2019-000413","title":"Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Réseau de cancérologie Rossy; Israel Cancer Research Fund","keywords":"Medicine; Laparotomy; Ovarian cancer; Gynecologic oncology; Debulking; Surgery; Chemotherapy; Robotic surgery; Stage (stratigraphy); Cancer; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer","score_opus":0.018935551979156667,"score_gpt":0.3095042097879975,"score_spread":0.2905686578088408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979768168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651773,0.0034898699,0.00014132755,0.027690645,0.002418161,0.00031463164,0.0000073101496,0.0000070600886,0.00075367163],"genre_scores_gemma":[0.9917821,0.0035980938,0.0012657361,0.002514153,0.00041612718,0.00007938117,0.000002347791,0.000013949998,0.0003280769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984303,0.00004278763,0.0005992684,0.00016648232,0.00061127415,0.00014987469],"domain_scores_gemma":[0.99848443,0.00025207,0.00057766313,0.00014661807,0.000458898,0.0000803192],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035882567,0.000141915,0.00042599984,0.00010028892,0.000023787014,0.000026202004,0.00022354351,0.00006638434,0.0044472427],"category_scores_gemma":[0.000023665069,0.00007865141,0.00027829446,0.0001334691,0.00007064423,0.000094794326,0.00006196115,0.00019602444,0.000012238504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014660592,0.00059863715,0.7720749,0.00009723024,0.002987071,0.00058779336,0.00032595574,0.0016397947,0.00030582416,0.00090963294,0.0011822863,0.21782485],"study_design_scores_gemma":[0.0024799777,0.0003217899,0.98733646,0.0008405712,0.0002606119,0.00004813557,0.00013998439,0.00014554086,0.00096980867,0.0007241139,0.0066215517,0.000111441135],"about_ca_topic_score_codex":0.00017571409,"about_ca_topic_score_gemma":0.000050304276,"teacher_disagreement_score":0.2177134,"about_ca_system_score_codex":0.00053312135,"about_ca_system_score_gemma":0.00023113038,"threshold_uncertainty_score":0.9964628},"labels":[],"label_agreement":null},{"id":"W2979808878","doi":"10.1158/1078-0432.ccr-19-0603","title":"Metformin Abrogates Age-Associated Ovarian Fibrosis","year":2019,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Metformin; Ovulation; Fibrosis; Medicine; Ovary; Oncology; Internal medicine; Cohort; Endocrinology; Cancer; Physiology; Diabetes mellitus; Hormone","score_opus":0.321253355543479,"score_gpt":0.5347019113503512,"score_spread":0.21344855580687216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979808878","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005852282,0.005946635,0.0000019950664,0.9647266,0.0024884772,0.0029407144,0.00069486856,0.00016068826,0.017187715],"genre_scores_gemma":[0.020002516,0.016518388,0.00056594244,0.7959498,0.024489827,0.002677923,0.0032421527,0.0005314965,0.13602194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920937,0.0010326301,0.0013220521,0.001627512,0.002295261,0.0016288634],"domain_scores_gemma":[0.9917554,0.0049601346,0.00033498928,0.0016417276,0.0009264054,0.0003813205],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0033771906,0.00056538876,0.001995132,0.0004563566,0.00022341216,0.00019545689,0.0006318538,0.002504857,0.0058529903],"category_scores_gemma":[0.0018173604,0.00044492097,0.0010214247,0.00091256096,0.00062996056,0.00009432427,0.0002922181,0.00821399,0.002078344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032689955,0.00051007775,0.020784581,0.0005079939,0.0016124357,0.0029374268,0.000047403624,6.207917e-7,0.000006267493,0.000021110749,0.9579516,0.015293554],"study_design_scores_gemma":[0.0045112134,0.0017872833,0.026737925,0.001752237,0.0006067947,0.000011655137,0.000019398984,0.000014693637,0.00009711443,0.00025658953,0.96379954,0.0004055673],"about_ca_topic_score_codex":0.003010677,"about_ca_topic_score_gemma":0.00026395786,"teacher_disagreement_score":0.16877681,"about_ca_system_score_codex":0.0017323738,"about_ca_system_score_gemma":0.0024839677,"threshold_uncertainty_score":0.99980026},"labels":[],"label_agreement":null},{"id":"W2980432858","doi":"10.2174/1389450120666191016143836","title":"Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas","year":2019,"lang":"en","type":"review","venue":"Current Drug Targets","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; KRAS; Serous fluid; Oncology; Ovarian cancer; Targeted therapy; Internal medicine; Biomarker; Clinical trial; Immunotherapy; Biomarker discovery; Disease; Olaparib; Bioinformatics; Cancer; Proteomics; Biology; Poly ADP ribose polymerase; Colorectal cancer","score_opus":0.30329226160637957,"score_gpt":0.4495059627430223,"score_spread":0.14621370113664273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980432858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002025132,0.99128604,0.000003299709,0.0000802426,0.0030527764,0.002888859,0.0002838496,0.000026782629,0.00035300598],"genre_scores_gemma":[0.012945373,0.9855214,0.0000314731,0.000007017476,0.00054020644,0.00058329356,0.00027556944,0.00007126896,0.000024435989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669594,0.00042789517,0.0013317629,0.00071443216,0.00036853566,0.000461413],"domain_scores_gemma":[0.99749315,0.00063247775,0.0006195657,0.00094688253,0.00009347397,0.00021442446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007752192,0.0005753876,0.002773622,0.0002963618,0.00003983648,0.00001706976,0.00029146954,0.0001472128,0.00006945863],"category_scores_gemma":[0.00013898945,0.0003182266,0.0018272833,0.00049753516,0.00012359099,0.00010425827,0.00014784785,0.0008053223,0.000073025185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096877986,0.0008549069,0.039914418,0.008823063,0.0024742163,0.00005047163,0.00033654107,0.0000030984552,1.648411e-8,0.00001943293,0.0026819312,0.944745],"study_design_scores_gemma":[0.0030377074,0.0006984359,0.1398895,0.042020235,0.0057583493,0.00003909426,0.00006550885,0.00003493361,0.000001125139,0.000016500428,0.8079627,0.00047590944],"about_ca_topic_score_codex":0.00026301798,"about_ca_topic_score_gemma":0.000016587715,"teacher_disagreement_score":0.9442691,"about_ca_system_score_codex":0.0008281168,"about_ca_system_score_gemma":0.0014479597,"threshold_uncertainty_score":0.999927},"labels":[],"label_agreement":null},{"id":"W2981122073","doi":"","title":"Malignant transformation of mature cystic teratoma of the ovary: 30-year experience of a single tertiary care center.","year":2018,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Adenocarcinoma; Radiation therapy; Surgery; Population; Carcinoma; Radiology; Cancer; Internal medicine","score_opus":0.012481940547103137,"score_gpt":0.22973663964382615,"score_spread":0.21725469909672301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981122073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965567,0.00038365996,0.000024978344,0.00040884456,0.0001724422,0.0007734201,0.000078054385,0.000008570564,0.0015933478],"genre_scores_gemma":[0.99948305,0.000016683372,0.00009989633,0.00007792931,0.000046561625,0.00024080428,0.000008991905,0.000008093726,0.000017966895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992884,0.000024442315,0.00024845047,0.000106531785,0.00019632225,0.00013587513],"domain_scores_gemma":[0.9994535,0.000014875105,0.00011998263,0.00025340292,0.00011515265,0.00004309011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050275517,0.000078311125,0.00018300502,0.000037613372,0.000020879208,0.0000036061322,0.00007644744,0.00004383088,0.00004466482],"category_scores_gemma":[0.000017622151,0.00004751694,0.00008228371,0.00012158086,0.00011380255,0.00005126699,0.000016610129,0.000033976237,0.0000010264594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096098124,0.0024715755,0.7730089,0.002618939,0.00048148158,0.000020211568,0.078255534,0.000003091471,0.02564262,0.0008739647,0.0010460885,0.114616655],"study_design_scores_gemma":[0.0011153894,0.00012515012,0.69194293,0.00023587108,0.00007740257,0.000008872143,0.0008150778,0.0000042867746,0.3051694,0.0000115891,0.0004578047,0.000036245645],"about_ca_topic_score_codex":0.000040293107,"about_ca_topic_score_gemma":0.0000092052915,"teacher_disagreement_score":0.2795268,"about_ca_system_score_codex":0.000055104985,"about_ca_system_score_gemma":0.000029218461,"threshold_uncertainty_score":0.19376846},"labels":[],"label_agreement":null},{"id":"W2982447554","doi":"10.1101/19009712","title":"Computational Modeling of Ovarian Cancer Reveals Optimal Strategies for Therapy and Screening","year":2019,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; Terry Fox Foundation; National Cancer Institute; Princess Margaret Cancer Foundation; U.S. Department of Defense","keywords":"Debulking; Medicine; Ovarian cancer; Stage (stratigraphy); Chemotherapy; Serous carcinoma; Oncology; Clinical significance; Cancer; Internal medicine; Surgery","score_opus":0.08624211527288556,"score_gpt":0.34594236583240334,"score_spread":0.2597002505595178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982447554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88356733,0.00621463,0.10661589,0.0016056807,0.00023993046,0.0012731593,0.00021729681,0.000025205725,0.000240876],"genre_scores_gemma":[0.9426387,0.0011634133,0.055338256,0.00015941107,0.00021409127,0.00028888413,0.00011120097,0.000033897784,0.0000521615],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99887776,0.000024082048,0.00032914456,0.0003987548,0.00020576124,0.00016451384],"domain_scores_gemma":[0.9992062,0.00010556008,0.00017808095,0.00023106243,0.00021162853,0.00006747637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021262033,0.00021016227,0.0005528722,0.0000883782,0.000039083625,0.00003815946,0.00007064495,0.00014521416,0.000053011965],"category_scores_gemma":[0.000010710647,0.00017372184,0.00013696389,0.000041607484,0.000036780828,0.0000433824,0.00006965997,0.000167835,5.721637e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004922727,0.00015166205,0.10669894,0.00093115366,0.0010056342,0.0000060868465,0.00067918433,0.8760329,0.00011042988,0.0025318265,0.00015155107,0.011208398],"study_design_scores_gemma":[0.005055222,0.00037516357,0.1040816,0.0018178284,0.0003674661,0.000007375378,0.00023777511,0.88206655,0.0001573667,0.0052898834,0.00025549717,0.00028830217],"about_ca_topic_score_codex":0.00030054702,"about_ca_topic_score_gemma":0.0000062691433,"teacher_disagreement_score":0.059071355,"about_ca_system_score_codex":0.00004509693,"about_ca_system_score_gemma":0.0004073051,"threshold_uncertainty_score":0.7084171},"labels":[],"label_agreement":null},{"id":"W2982569105","doi":"10.1200/jco.2009.27.15_suppl.e16523","title":"Dysgerminoma of the ovary 35 years on: A single institutional experience","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Dysgerminoma; Etoposide; Stage (stratigraphy); Surgery; Gynecology; Chemotherapy; Internal medicine; Ovary","score_opus":0.18146171759083105,"score_gpt":0.4757151947880696,"score_spread":0.2942534771972386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982569105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768724,0.000281431,0.0000125253355,0.0138182,0.0011092768,0.00009118323,0.0000017092636,0.0000024318376,0.0078108325],"genre_scores_gemma":[0.99207574,0.00013041121,0.001128654,0.0058620977,0.0007044666,0.0000014540424,2.6555418e-7,0.0000029251707,0.000094009796],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99839187,0.00010194942,0.0010174632,0.00009777226,0.00029226468,0.00009865622],"domain_scores_gemma":[0.99833393,0.000508257,0.0007386237,0.00016421001,0.00012024875,0.00013473883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004898213,0.00006424658,0.00057737605,0.00004188146,0.000024454524,0.0000027741362,0.00012197418,0.00013499937,0.000115803516],"category_scores_gemma":[0.000790621,0.000036331305,0.00036278737,0.00009851329,0.00021666048,0.000043879027,0.000017712617,0.0003368157,0.000006574464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003669435,0.014826871,0.17926866,0.000011340012,0.00033267456,0.002087312,0.0004995673,0.000061252074,0.0007232342,0.004950541,0.007995524,0.7855736],"study_design_scores_gemma":[0.0036151232,0.0122301215,0.91625136,0.00014500295,0.00010439075,0.00035545308,0.00003127492,0.000005429756,0.00050796114,0.0004006122,0.06632084,0.000032409764],"about_ca_topic_score_codex":0.0000035994653,"about_ca_topic_score_gemma":0.0000022919987,"teacher_disagreement_score":0.7855412,"about_ca_system_score_codex":0.00014005153,"about_ca_system_score_gemma":0.0010972251,"threshold_uncertainty_score":0.19464304},"labels":[],"label_agreement":null},{"id":"W2983987940","doi":"10.1136/ijgc-2019-esgo.1291","title":"EP1286 Single institution experience with neoadjuvant chemotherapy compared to primary debulking surgery in patients over 75 with high grade ovarian cancer","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Chemotherapy; Internal medicine; Oncology; Stage (stratigraphy); Surgery; Retrospective cohort study; Cancer","score_opus":0.02192791675438917,"score_gpt":0.2889775793463173,"score_spread":0.26704966259192814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983987940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943172,0.00018689281,0.00009931793,0.003758376,0.0010080668,0.0004019317,0.00001696362,0.000010615865,0.00020065793],"genre_scores_gemma":[0.9945235,0.00018932484,0.00077801227,0.0041209883,0.00023026418,0.00008333999,0.00001160794,0.000016500735,0.000046452766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982493,0.000032694847,0.00045086996,0.00027562195,0.0007578203,0.00023372662],"domain_scores_gemma":[0.9987879,0.0001527942,0.00034819214,0.000118370466,0.00043863305,0.00015413311],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012130923,0.00018618457,0.0004984443,0.00020657259,0.00002841715,0.00004421294,0.00016014093,0.00006920778,0.0012613356],"category_scores_gemma":[0.000037502497,0.0001144047,0.00008260505,0.00021468497,0.000058718088,0.00023212415,0.00003061429,0.00019852813,0.000004853178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037128215,0.0012333342,0.97639257,0.000012870561,0.0002645769,0.00023034193,0.0002874019,0.0018008772,0.00034839,0.000049228125,0.0002621673,0.01540543],"study_design_scores_gemma":[0.0072587198,0.0011189093,0.9865826,0.0007890483,0.000041274176,0.000030176925,0.00003393015,0.000021644155,0.0010452173,0.00001682158,0.0029063518,0.00015533928],"about_ca_topic_score_codex":0.0005985365,"about_ca_topic_score_gemma":0.00036171803,"teacher_disagreement_score":0.015250091,"about_ca_system_score_codex":0.0019901358,"about_ca_system_score_gemma":0.00038868017,"threshold_uncertainty_score":0.9996517},"labels":[],"label_agreement":null},{"id":"W2984097645","doi":"10.11606/d.17.2019.tde-04102019-111509","title":"Expressão de BRCA1 e BRCA2 por imuno-histoquímica e prognóstico no câncer de ovário: uma revisão sistemática e meta-análise","year":2019,"lang":"pt","type":"dissertation","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunohistochemistry; Gynecology; Pathology","score_opus":0.038179606710333616,"score_gpt":0.31582850005070345,"score_spread":0.27764889334036985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984097645","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.074498266,0.27842993,0.0030264896,0.014083564,0.016840778,0.038223952,0.0037839697,0.0018169153,0.5692961],"genre_scores_gemma":[0.7053957,0.0065111923,0.006701997,0.0040478897,0.0012775513,0.004005645,0.004199563,0.0006043441,0.2672561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910093,0.00056578714,0.0022939336,0.0025300812,0.0015050962,0.0020958264],"domain_scores_gemma":[0.99248886,0.00092422566,0.0014077785,0.0027339822,0.0011801253,0.0012650392],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0011439216,0.0020691543,0.004305277,0.0004911331,0.000392306,0.00034912775,0.0008656598,0.0014510129,0.049465366],"category_scores_gemma":[0.00085290865,0.0016470088,0.0026490344,0.00053811684,0.00018724176,0.00030043884,0.00015404494,0.0012910122,0.0050710263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014886273,0.028325649,0.058970608,0.057248875,0.18846318,0.0046785353,0.027848119,0.00033506285,0.015671978,0.018505415,0.50457025,0.08049608],"study_design_scores_gemma":[0.028937839,0.007395375,0.046798445,0.016338386,0.32192594,0.00052082684,0.006685767,0.0049185078,0.021482028,0.00027707775,0.5367339,0.007985862],"about_ca_topic_score_codex":0.0026799329,"about_ca_topic_score_gemma":0.00030776637,"teacher_disagreement_score":0.63089746,"about_ca_system_score_codex":0.0023824326,"about_ca_system_score_gemma":0.0037206744,"threshold_uncertainty_score":0.9998453},"labels":[],"label_agreement":null},{"id":"W2985539123","doi":"","title":"Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer.","year":2019,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Ascites; Medicine; Internal medicine; Gastroenterology; Serous fluid; Ovarian cancer; Leptin; Oncology; Cancer","score_opus":0.036727067415110566,"score_gpt":0.2657780376529414,"score_spread":0.22905097023783083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985539123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97719246,0.00037463132,0.000029071552,0.016241373,0.00016300632,0.005335877,0.0005676357,0.000048630063,0.00004730836],"genre_scores_gemma":[0.99160594,0.00018342957,0.0017616391,0.00094542484,0.00014778083,0.0044946056,0.00014362478,0.000045815526,0.00067173067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778366,0.000093827875,0.0005353817,0.0007801939,0.00031227188,0.00049468124],"domain_scores_gemma":[0.9986809,0.0003039027,0.00016207302,0.00030073713,0.000113197115,0.00043921592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034707933,0.00034248887,0.0006687389,0.000143256,0.00007476754,0.00005154365,0.00006075917,0.00012149276,0.000035485216],"category_scores_gemma":[0.00010742009,0.00024642464,0.00005126474,0.00030695918,0.000064493855,0.00010410297,0.000034702283,0.00013351066,0.0000038455337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020039363,0.0020869726,0.9505012,0.00012919633,0.00021148233,0.000029009649,0.00010628229,0.000098494456,8.726314e-7,0.000017827115,0.0003544747,0.044460244],"study_design_scores_gemma":[0.032633435,0.001676976,0.96274555,0.00031817163,0.00026742715,0.0000014860755,0.000013286202,0.00015467817,0.0005023786,0.000007721387,0.0014424535,0.00023645055],"about_ca_topic_score_codex":0.000905528,"about_ca_topic_score_gemma":0.00864838,"teacher_disagreement_score":0.044223793,"about_ca_system_score_codex":0.00038784422,"about_ca_system_score_gemma":0.00016759563,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W2985558334","doi":"10.6004/jnccn.2019.0039","title":"NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Genentech; Puma Biotechnology; Clovis Oncology; Eisai; National Comprehensive Cancer Network; Gilead Sciences; Novartis Pharmaceuticals Corporation; Biogen; Celgene; Bristol-Myers Squibb; AstraZeneca; Genomic Health; Amgen","keywords":"Medicine; Bevacizumab; Ovarian cancer; Chemotherapy; Oncology; Cytoreductive surgery; Internal medicine; Disease; Cancer; Hyperthermic intraperitoneal chemotherapy; Intensive care medicine","score_opus":0.05275035830377755,"score_gpt":0.3485380236263211,"score_spread":0.2957876653225435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985558334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6719925,0.16261746,0.00007225763,0.13287863,0.024518523,0.0016999092,0.0001483098,0.000047140602,0.006025264],"genre_scores_gemma":[0.9547421,0.00995716,0.0014050405,0.0226467,0.008588994,0.000027553173,0.000010991733,0.00004646027,0.0025750182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794525,0.00007375648,0.00057756715,0.0001968521,0.0009916872,0.00021487405],"domain_scores_gemma":[0.99549085,0.00019674734,0.00064694235,0.0001802413,0.0033600016,0.00012522978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013090462,0.00019258811,0.0004536655,0.00009673142,0.00012870903,0.000027837246,0.00023568801,0.00009149441,0.0007602106],"category_scores_gemma":[0.000060741786,0.000117256226,0.00034465297,0.000414644,0.000045713172,0.00013892805,0.000082146944,0.00033328903,0.000042391548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008588617,0.00014398196,0.06013178,0.000057767993,0.0011449028,0.000015353924,0.00009909535,0.086703345,0.0009192406,0.0010723218,0.84547263,0.003380731],"study_design_scores_gemma":[0.0049440865,0.00029056173,0.22477798,0.0016594863,0.00038308016,0.00010191807,0.00005098335,0.0009574787,0.00049859,0.0013520356,0.76480883,0.00017496536],"about_ca_topic_score_codex":0.00009748219,"about_ca_topic_score_gemma":0.000015012395,"teacher_disagreement_score":0.28274956,"about_ca_system_score_codex":0.0008540065,"about_ca_system_score_gemma":0.00089242175,"threshold_uncertainty_score":0.8323774},"labels":[],"label_agreement":null},{"id":"W2985587430","doi":"10.1016/j.ygyno.2019.10.021","title":"Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"Alberta Health Services","keywords":"Medicine; Ovarian cancer; Metastasis; Serous fluid; Pathology; Cancer; Implant; Gene signature; Cancer research; Oncology; Gene; Gene expression; Internal medicine; Biology; Surgery","score_opus":0.06676854889400057,"score_gpt":0.3557926784090974,"score_spread":0.2890241295150968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985587430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771935,0.0008328624,0.000015647132,0.0000844738,0.00042224737,0.0006212132,0.00013654649,0.000022335324,0.00014530755],"genre_scores_gemma":[0.9988038,0.0002968627,0.00042438446,0.00010260268,0.00005913841,0.00011220624,0.00012763392,0.000015500038,0.00005785789],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804133,0.00017908555,0.00057136524,0.00059805956,0.00019082552,0.0004193194],"domain_scores_gemma":[0.9989355,0.00016403545,0.0003534279,0.00036927758,0.00008063261,0.00009710098],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001739516,0.000242373,0.0011524927,0.00043336177,0.000077338875,0.00001363783,0.0001597149,0.00038942552,0.0012882024],"category_scores_gemma":[0.000023358398,0.00018777294,0.00021425856,0.00038854787,0.00007670978,0.00005448199,0.00013521893,0.00025576435,0.00000681184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014649372,0.0004388129,0.4569869,0.000048092665,0.0005159836,0.00012425982,0.000183134,0.00044435033,0.54038453,0.000012388676,0.000010316547,0.00070470513],"study_design_scores_gemma":[0.0023816128,0.0007410051,0.8692863,0.0000996632,0.0013256192,0.00002162474,0.00018837067,0.00042976352,0.12526721,0.000014848836,0.000076881995,0.00016710542],"about_ca_topic_score_codex":0.0013088677,"about_ca_topic_score_gemma":0.0027478912,"teacher_disagreement_score":0.41511735,"about_ca_system_score_codex":0.00095987716,"about_ca_system_score_gemma":0.00025882357,"threshold_uncertainty_score":0.9996247},"labels":[],"label_agreement":null},{"id":"W2989369163","doi":"10.1148/radiol.2019191150","title":"O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee","year":2019,"lang":"en","type":"article","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital; McGill University Health Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Guideline; Risk stratification; Consensus conference; Medical physics; Internal medicine; Pathology","score_opus":0.04135497717400367,"score_gpt":0.3115943998841823,"score_spread":0.27023942271017865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989369163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244065,0.00646255,0.00067571405,0.005366187,0.00062175625,0.001599003,0.00025932328,0.00009346863,0.0024813483],"genre_scores_gemma":[0.9940642,0.0004512653,0.004526377,0.00023881167,0.00026234033,0.000044835662,0.00033043118,0.000015794896,0.00006590538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806577,0.00021363264,0.00083563506,0.0005796504,0.00011901256,0.00018627207],"domain_scores_gemma":[0.9976216,0.00027001614,0.00071837805,0.0012652694,0.000047911806,0.00007682972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001133727,0.00015632011,0.0004622262,0.000032162436,0.00011783963,0.000034544693,0.00012714513,0.000098188684,0.000015440119],"category_scores_gemma":[0.0001027825,0.00010190761,0.000028084634,0.000062523686,0.00008126639,0.000028189292,0.0001370597,0.0001337099,0.000017395927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023914789,0.000086358465,0.94731563,0.000739993,0.0015507448,0.0006025025,0.00029943947,0.00002496995,0.00025003968,0.014871695,0.019873392,0.014146057],"study_design_scores_gemma":[0.004602935,0.00031123374,0.9510591,0.00067928876,0.0016687278,0.0022573422,0.0028719755,0.017503912,0.000033175063,0.000075485725,0.018733086,0.00020371433],"about_ca_topic_score_codex":0.0016812574,"about_ca_topic_score_gemma":0.000099820085,"teacher_disagreement_score":0.017478941,"about_ca_system_score_codex":0.000117060044,"about_ca_system_score_gemma":0.000045869656,"threshold_uncertainty_score":0.41556716},"labels":[],"label_agreement":null},{"id":"W2989612821","doi":"10.1093/annonc/mdz426.039","title":"ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA¬-nonmutated advanced epithelial ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Pembrolizumab; Oncology; Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Internal medicine; Gynecology; Cancer; Immunotherapy; Poly ADP ribose polymerase","score_opus":0.05193308591041664,"score_gpt":0.39148638361326155,"score_spread":0.3395532977028449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989612821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98403114,0.0009679335,0.00016433849,0.008291036,0.00041667168,0.004458982,0.00067363714,0.000023581912,0.0009726661],"genre_scores_gemma":[0.99048835,0.00561025,0.0011387855,0.00054943236,0.00024877663,0.0009078705,0.00015873228,0.000053598105,0.00084421516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99786174,0.00005772226,0.00086322037,0.0004936003,0.0002540431,0.00046965617],"domain_scores_gemma":[0.9975064,0.00033295172,0.0008843308,0.00052401074,0.0005939692,0.00015837178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020039201,0.00034729714,0.0018642485,0.0001571199,0.000038863625,0.0000036124306,0.000129798,0.00020970935,0.000526329],"category_scores_gemma":[0.00003715896,0.00024565784,0.0003261579,0.00023006818,0.00019261088,0.000070308015,0.000016632042,0.00008467046,0.000004394723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5535305,0.01752226,0.0006707468,0.00037925772,0.0027408598,0.00005576623,0.0014735385,0.0005798019,0.0053329975,0.000702762,0.0011557877,0.41585574],"study_design_scores_gemma":[0.72937995,0.11206684,0.0010327719,0.0003332129,0.0005706768,0.000022292745,0.00009932526,0.00041149114,0.07053442,0.00012050816,0.085206866,0.00022161925],"about_ca_topic_score_codex":0.0010756155,"about_ca_topic_score_gemma":0.00046949048,"teacher_disagreement_score":0.4156341,"about_ca_system_score_codex":0.00034796607,"about_ca_system_score_gemma":0.001147995,"threshold_uncertainty_score":0.9999996},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2989990330","doi":"10.1136/ijgc-2019-000832","title":"Low-grade serous ovarian carcinoma: an evolution toward targeted therapy","year":2019,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Serous fluid; Ovarian carcinoma; Serous carcinoma; Medicine; Cystadenocarcinoma; Oncology; Targeted therapy; Internal medicine; Ovarian cancer; Pathology; Cancer research; Cancer","score_opus":0.12250854995067831,"score_gpt":0.4058079041628934,"score_spread":0.2832993542122151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989990330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028249295,0.98980653,0.00007823991,0.0013963267,0.004693934,0.0007587602,0.00014873393,0.000023306357,0.0002692257],"genre_scores_gemma":[0.065729275,0.9305253,0.00031576236,0.0005912335,0.0023668758,0.000110344736,0.000104194856,0.000049141818,0.00020788703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970404,0.00020874453,0.0011032732,0.00042763032,0.00090722216,0.00031272098],"domain_scores_gemma":[0.9971621,0.0002655791,0.0011993027,0.00026218613,0.00082267687,0.00028816762],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031727395,0.00045151988,0.0018843734,0.00034580252,0.000040144267,0.000075463,0.0005654568,0.00047157446,0.002778081],"category_scores_gemma":[0.00012022531,0.00027949817,0.001049565,0.00019781121,0.00006896197,0.0001950662,0.00006667219,0.0007623326,0.000059862683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036157283,0.0017288136,0.0038647132,0.00080819067,0.0025915205,0.001231356,0.00006844409,0.000023641358,0.0000051752945,0.00032400244,0.0017949215,0.98719764],"study_design_scores_gemma":[0.004382107,0.0026812113,0.032863367,0.004168851,0.0016014822,0.00093848025,0.000024800773,0.000017296074,0.000018951469,0.00017302755,0.95275044,0.00037995385],"about_ca_topic_score_codex":0.000119377146,"about_ca_topic_score_gemma":0.00001863204,"teacher_disagreement_score":0.9868177,"about_ca_system_score_codex":0.0031218256,"about_ca_system_score_gemma":0.0019206505,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2990030135","doi":"10.1007/s00261-017-1205-5","title":"Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management","year":2017,"lang":"en","type":"erratum","venue":"Abdominal Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Readability; Selection (genetic algorithm); Hepatology; Medical physics; General surgery; Missing data; Gynecology; Internal medicine; Artificial intelligence; Computer science; Machine learning","score_opus":0.01572376858877359,"score_gpt":0.2851193969402612,"score_spread":0.2693956283514876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990030135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5851366,0.004504837,0.0052943258,0.12629849,0.11996596,0.07342601,0.003317164,0.00064099726,0.08141564],"genre_scores_gemma":[0.6931544,0.0015287466,0.027821053,0.011624583,0.0028858613,0.030034171,0.00275294,0.00041322646,0.22978505],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99669856,0.00011482167,0.00052073604,0.0013742535,0.00037072398,0.0009209149],"domain_scores_gemma":[0.99739057,0.00015777576,0.00057393964,0.00077310443,0.0006664852,0.0004381403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021864235,0.0006899739,0.0014564282,0.00031932152,0.00047663154,0.00008174782,0.00031649965,0.000480803,0.00007084188],"category_scores_gemma":[0.0002704607,0.0005501409,0.00020872382,0.00019420886,0.00012461764,0.000062166175,0.0001644724,0.0005096983,0.000012793515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003176575,0.0004197234,0.089542545,0.0003967308,0.0016734893,0.000115716524,0.00061585824,0.000047326354,0.000005662463,0.00004243574,0.87232757,0.03163636],"study_design_scores_gemma":[0.0041569737,0.008624926,0.54162157,0.0008268523,0.0014462443,0.000028732658,0.00017877265,0.000055466677,0.00008290207,0.000035697332,0.44243717,0.0005046874],"about_ca_topic_score_codex":0.0015635021,"about_ca_topic_score_gemma":0.009113923,"teacher_disagreement_score":0.45207903,"about_ca_system_score_codex":0.0027939146,"about_ca_system_score_gemma":0.00078013056,"threshold_uncertainty_score":0.999695},"labels":[],"label_agreement":null},{"id":"W2990322407","doi":"10.5430/crcp.v6n1p32","title":"Paravaginal female adnexal tumor of probable Wolffian origin mimicking vaginal spindle cell epithelioma on biopsy","year":2019,"lang":"en","type":"article","venue":"Case Reports in Clinical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Biopsy; Epithelioma; Differential diagnosis; Pathology; Carcinoma","score_opus":0.058643923513472654,"score_gpt":0.3795807260641837,"score_spread":0.32093680255071105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990322407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895743,0.00033207118,0.000012770077,0.00043410456,0.0010617467,0.0008458987,0.000012106845,0.000033264896,0.0076937466],"genre_scores_gemma":[0.99637115,0.00005063654,0.0022662678,0.00047699298,0.00019822456,0.00006519579,0.000018691688,0.00003628976,0.000516547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966095,0.00018843105,0.001588113,0.00090762204,0.00024820806,0.00045813646],"domain_scores_gemma":[0.99764425,0.00038730513,0.00068913575,0.00094496773,0.00010771169,0.00022662201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001470388,0.00026568788,0.0010187381,0.000220734,0.00003464965,0.000009918083,0.000060988226,0.00024503723,0.00036875793],"category_scores_gemma":[0.00027356268,0.00021908496,0.00024688753,0.00026935045,0.00022798074,0.0000472478,0.000063840445,0.00053079124,0.00013415595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002556395,0.0017310319,0.6181531,0.00014692187,0.000033314343,0.37719962,0.00005631193,0.000028348726,0.00045404982,0.0001412854,0.00012042134,0.0016799608],"study_design_scores_gemma":[0.008243394,0.008360045,0.6011553,0.0010554753,0.00037385823,0.36241782,0.00023326582,0.000050158615,0.008717315,0.0005902553,0.00825874,0.00054440903],"about_ca_topic_score_codex":0.00009833989,"about_ca_topic_score_gemma":0.000039299775,"teacher_disagreement_score":0.016997822,"about_ca_system_score_codex":0.00014187187,"about_ca_system_score_gemma":0.000422766,"threshold_uncertainty_score":0.8934025},"labels":[],"label_agreement":null},{"id":"W2991408564","doi":"10.1111/his.14039","title":"Histological grading of ovarian mucinous carcinoma – an outcome‐based analysis of traditional and novel systems","year":2019,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; University of Ottawa; Sunnybrook Health Science Centre","funders":"","keywords":"Grading (engineering); Medicine; Univariate analysis; Proportional hazards model; Cohort; Multivariate analysis; Internal medicine; Ovarian carcinoma; Ovarian cancer; Gynecology; Carcinoma; Oncology; Cohort study; Survival analysis; Cancer; Biology","score_opus":0.07603277456831162,"score_gpt":0.28857156514380394,"score_spread":0.21253879057549233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991408564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966804,0.00059364364,0.0008417553,0.00022555304,0.000284841,0.00025041244,0.00011752764,0.000015252547,0.0009906173],"genre_scores_gemma":[0.9982945,0.000004076479,0.0013096759,0.0001316484,0.000030670355,0.000024519562,0.00011882946,0.000010004812,0.00007608302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988792,0.000063270476,0.00042366039,0.00033055784,0.00015615254,0.00014718887],"domain_scores_gemma":[0.9991593,0.00012235143,0.00022322474,0.00033020662,0.00006893668,0.00009602429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019638389,0.00012660939,0.00084798894,0.0003970985,0.000026443258,0.000002522001,0.000056451987,0.00011844695,0.00015885431],"category_scores_gemma":[0.000023786552,0.000106002895,0.00015543003,0.00021048276,0.00014485692,0.000028137956,0.000008772406,0.00008211,0.0000021569833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013665884,0.00096761464,0.9696057,0.00014111327,0.000101195976,0.00011105366,0.00016706837,0.0001319766,0.011878318,0.016597522,0.000022244638,0.00013954585],"study_design_scores_gemma":[0.0021363073,0.0013162843,0.9911923,0.000018212557,0.0016943073,0.00014399286,0.000051844432,0.0029309029,0.00019873456,0.00001988197,0.0002114717,0.00008580749],"about_ca_topic_score_codex":0.00029898933,"about_ca_topic_score_gemma":0.000018062325,"teacher_disagreement_score":0.021586565,"about_ca_system_score_codex":0.00016645221,"about_ca_system_score_gemma":0.000077051714,"threshold_uncertainty_score":0.43226728},"labels":[],"label_agreement":null},{"id":"W2993443964","doi":"10.1158/1557-3265.ovcasymp18-ap11","title":"Abstract AP11: IDENTIFYING FUNCTIONAL NONCODING SOMATIC MUTATIONS IN OVARIAN CANCER","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Somatic cell; Epigenetics; Ovarian cancer; Epigenomics; Germline; Genetics; Transcriptome; Germline mutation; Gene; Cancer research; Cancer; Mutation; DNA methylation; Gene expression","score_opus":0.39906320040213733,"score_gpt":0.5608800758984523,"score_spread":0.16181687549631502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993443964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774169,0.0017887014,0.00003025382,0.010685353,0.0013071665,0.0011681935,0.000033848413,0.000033131422,0.007536482],"genre_scores_gemma":[0.99479216,0.0014329923,0.000178989,0.00039643957,0.0008168516,0.0007632158,0.000030261268,0.000036057325,0.0015530076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702305,0.0001632307,0.00074180955,0.0006162773,0.0008863672,0.0005692438],"domain_scores_gemma":[0.9976285,0.0013000162,0.00010278043,0.0004240408,0.000262521,0.00028213815],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019892019,0.00015195778,0.00046483384,0.0003031413,0.00013413864,0.000076054195,0.0001412002,0.00016716067,0.0120422095],"category_scores_gemma":[0.00028704756,0.0001306737,0.00018914403,0.00059676066,0.0001633288,0.00016635128,0.00009121794,0.001015689,0.00096049585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035093055,0.0007045749,0.970752,0.00034457893,0.00018848422,0.00011128265,0.00019092148,0.00021993676,0.0010154542,0.00047909806,0.003065065,0.022577647],"study_design_scores_gemma":[0.004640637,0.00016985815,0.98931384,0.0009833334,0.000053266293,0.000004201504,0.00022969926,0.00031572592,0.0005101207,0.0006604423,0.0029861925,0.00013269567],"about_ca_topic_score_codex":0.0027589472,"about_ca_topic_score_gemma":0.0014572254,"teacher_disagreement_score":0.022444952,"about_ca_system_score_codex":0.0009055264,"about_ca_system_score_gemma":0.0013722627,"threshold_uncertainty_score":0.9998174},"labels":[],"label_agreement":null},{"id":"W2994272187","doi":"10.15173/sciential.v1i3.2244","title":"Considerations for Chemotherapy Treatment in Platinum Resistant High-Grade Serous Ovarian Cancer","year":2019,"lang":"en","type":"article","venue":"Sciential - McMaster Undergraduate Science Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Ovarian Cancer Coalition","keywords":"Ovarian cancer; Oncology; Disease; Chemotherapy; Serous fluid; Medicine; Internal medicine; Serous ovarian cancer; Cancer; Carboplatin; Cisplatin","score_opus":0.03219672866071982,"score_gpt":0.3124614669611209,"score_spread":0.2802647383004011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994272187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9395045,0.00021530096,0.0003822012,0.05408616,0.0026695048,0.0018096508,0.000055636752,0.000033172222,0.0012438901],"genre_scores_gemma":[0.98754233,0.00017490103,0.00864729,0.00090776826,0.00033235722,0.00009867725,0.000004868447,0.000023114493,0.0022687158],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99708605,0.00004142259,0.00054278487,0.00070741476,0.00083872717,0.00078361627],"domain_scores_gemma":[0.99864906,0.000095512616,0.0002466965,0.0003413053,0.00027459578,0.00039280028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007679698,0.000277238,0.00044936256,0.00053007406,0.0006181508,0.0005547724,0.00019151892,0.00006729181,0.0010064255],"category_scores_gemma":[0.000043830365,0.00020222373,0.00015775584,0.00087911164,0.00034678882,0.0005412095,0.000036659538,0.0001882281,0.00003304169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043858183,0.008547492,0.27785778,0.00027620106,0.0013250172,0.0006964683,0.009634656,0.008051737,0.5115514,0.044009764,0.010334157,0.123329535],"study_design_scores_gemma":[0.1246021,0.016448546,0.5671989,0.0020567896,0.0010700467,0.0019377138,0.0021198287,0.014372861,0.14113593,0.078724034,0.04787791,0.002455378],"about_ca_topic_score_codex":0.0004477528,"about_ca_topic_score_gemma":0.0008226201,"teacher_disagreement_score":0.37041545,"about_ca_system_score_codex":0.001451967,"about_ca_system_score_gemma":0.0021284886,"threshold_uncertainty_score":0.9999068},"labels":[],"label_agreement":null},{"id":"W2995634960","doi":"10.1016/j.ygyno.2019.10.001","title":"Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ipsen; Pfizer UK; Ipsen Fund; Sanofi; AstraZeneca; Janssen Biotech; Astellas Pharma; Roche; Astellas Pharma US; Pfizer","keywords":"Medicine; Chemotherapy; Oncology; Ovarian cancer; Internal medicine; Progression-free survival; Cancer; Gynecology","score_opus":0.019248039451430218,"score_gpt":0.3012838327553,"score_spread":0.2820357933038698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995634960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218243,0.00020715363,0.000015334292,0.0031836168,0.00053135835,0.003451216,0.0000429131,0.000033705903,0.0003522894],"genre_scores_gemma":[0.9979732,0.00076416414,0.0003524253,0.00025631124,0.00011561245,0.00040259867,0.000011571569,0.00003517448,0.00008895067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735683,0.0003386575,0.0007472628,0.00058078073,0.0005129211,0.00046354017],"domain_scores_gemma":[0.9975756,0.00078628404,0.00078982726,0.00045638223,0.00028182357,0.000110120716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011697327,0.00033125043,0.0010864461,0.00014474533,0.00007149389,0.000017763094,0.00017642134,0.00023910032,0.00028324366],"category_scores_gemma":[0.000100229605,0.0001891241,0.00006307378,0.00031528206,0.00017589836,0.00009523369,0.000095106894,0.00030329605,0.0000011117667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010869501,0.0031310036,0.932171,0.00011919148,0.00090610294,0.00006103995,0.009701724,0.00020588585,0.001000571,0.0001266162,0.000037632257,0.04166972],"study_design_scores_gemma":[0.02048635,0.023689326,0.9500549,0.0002518325,0.00016740372,0.000004816073,0.003703249,0.000112368325,0.0010132965,0.00015586916,0.0001731841,0.00018743923],"about_ca_topic_score_codex":0.00097513356,"about_ca_topic_score_gemma":0.0035720808,"teacher_disagreement_score":0.04148228,"about_ca_system_score_codex":0.00080497365,"about_ca_system_score_gemma":0.00060285174,"threshold_uncertainty_score":0.7712257},"labels":[],"label_agreement":null},{"id":"W2995949931","doi":"10.1016/j.ygyno.2019.12.002","title":"EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Clinical endpoint; Placebo; Internal medicine; Discontinuation; Adverse effect; Sorafenib; Gastroenterology; Randomized controlled trial; Combination therapy; Surgery; Hepatocellular carcinoma; Pathology","score_opus":0.024210691035109453,"score_gpt":0.3185982818749869,"score_spread":0.2943875908398774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995949931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96146953,0.00025701706,0.000028803932,0.0039236015,0.00058212935,0.032884203,0.000031623105,0.00007175187,0.00075133593],"genre_scores_gemma":[0.9897475,0.00008971993,0.00040128813,0.0006211041,0.0001514805,0.008035074,0.00025956254,0.00006207663,0.00063214457],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99535596,0.00081015466,0.0014797066,0.00087375095,0.00061773043,0.0008626887],"domain_scores_gemma":[0.9957161,0.0019014518,0.00096425303,0.0006168707,0.0005122972,0.00028901943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013971167,0.00062258187,0.0036207044,0.00043007184,0.00020308916,0.000040655825,0.00025194316,0.0003595087,0.0008571803],"category_scores_gemma":[0.0003699827,0.00032180763,0.00022160301,0.0010276856,0.00026949847,0.00017927226,0.00011964197,0.00048547867,0.000018105831],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92666787,0.02125738,0.04648811,0.00010611339,0.0012496972,0.000100731,0.00086602307,0.0010644168,0.00011934118,0.00007076618,0.00047396854,0.0015355805],"study_design_scores_gemma":[0.9189558,0.06928992,0.006833321,0.00041636892,0.0014396847,0.0000084763005,0.00014475873,0.0008312777,0.0011572022,0.0000145961985,0.0005478012,0.00036081343],"about_ca_topic_score_codex":0.0017844202,"about_ca_topic_score_gemma":0.009149679,"teacher_disagreement_score":0.04803254,"about_ca_system_score_codex":0.0013313907,"about_ca_system_score_gemma":0.0014210186,"threshold_uncertainty_score":0.9999234},"labels":[],"label_agreement":null},{"id":"W2996854366","doi":"10.1007/s00428-019-02728-0","title":"Histotype-specific analysis of acid ceramidase expression in ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Debulking; Medicine; Cancer; Internal medicine; Oncology; Estrogen receptor; Clear cell; Cancer research; Breast cancer; Immunohistochemistry","score_opus":0.05498282313099406,"score_gpt":0.3682652515891977,"score_spread":0.31328242845820364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996854366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9439414,0.029331729,0.0045826593,0.012767574,0.000496162,0.0015723672,0.000429457,0.00023216402,0.006646461],"genre_scores_gemma":[0.98328376,0.0070723514,0.005697353,0.0028752636,0.00037527777,0.00016189097,0.00043015508,0.000054989818,0.000048977807],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958382,0.00043034958,0.0011567777,0.0012763962,0.0005576049,0.0007406712],"domain_scores_gemma":[0.99736917,0.00049747556,0.00049299886,0.000996735,0.00013016096,0.0005134883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052146893,0.0005868144,0.0019324399,0.0005225937,0.00011331672,0.000018254017,0.00046970003,0.000330606,0.0006997574],"category_scores_gemma":[0.00043645405,0.00043021937,0.00060210197,0.0020063617,0.0006482436,0.00012194947,0.0002630864,0.00089515484,0.000041121333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051837666,0.003244121,0.30869594,0.00055684935,0.0058797006,0.002164697,0.0067824763,0.0038332664,0.59039855,0.0043859947,0.006074481,0.06280016],"study_design_scores_gemma":[0.01209102,0.0028999478,0.808525,0.00074427755,0.0065623885,0.000007424836,0.0010052897,0.004584777,0.14586382,0.0014149986,0.015244537,0.0010565036],"about_ca_topic_score_codex":0.00032806318,"about_ca_topic_score_gemma":0.0000660262,"teacher_disagreement_score":0.49982908,"about_ca_system_score_codex":0.00017794898,"about_ca_system_score_gemma":0.00037159692,"threshold_uncertainty_score":0.999815},"labels":[],"label_agreement":null},{"id":"W2996972368","doi":"10.1016/j.ygyno.2019.12.015","title":"Therapeutic options for mucinous ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Cancer Council Tasmania; National Institutes of Health; Cancer Council South Australia; Medical Research Council; Peter MacCallum Foundation; Hudson Institute of Medical Research; Terry Fox Research Institute; BC Cancer Foundation; Cancer Council Victoria; Cancer Australia; Australian Cancer Research Foundation; Australian Government; Cancer Institute NSW; National Cancer Institute; Ovarian Cancer Australia; Peter MacCallum Cancer Centre; Medical Research and Materiel Command; Victorian Cancer Agency; Mayo Foundation for Medical Education and Research; Cancer Council NSW; National Health and Medical Research Council; Minnesota Ovarian Cancer Alliance","keywords":"Medicine; Mucinous carcinoma; Ovarian carcinoma; Oncology; Carcinoma; Ovary; Internal medicine; General surgery; Gynecology; Ovarian cancer; Adenocarcinoma; Cancer","score_opus":0.08267601124765372,"score_gpt":0.33959710976708657,"score_spread":0.25692109851943284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996972368","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4525995,0.004374751,0.005440432,0.47818282,0.0021889966,0.006725585,0.00016695418,0.00061243994,0.049708508],"genre_scores_gemma":[0.97014713,0.00011942925,0.0071129543,0.02108466,0.00041725504,0.00073900976,0.000054426382,0.000021632353,0.00030350577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998831,0.00006621818,0.00025549842,0.0004064536,0.000083147745,0.0003576795],"domain_scores_gemma":[0.9988973,0.00046804166,0.000090286696,0.00021054909,0.000090096386,0.00024373489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012398552,0.00016556606,0.00047782785,0.000045665438,0.00012416265,0.000010786206,0.00009711057,0.00021374912,0.0010826339],"category_scores_gemma":[0.0001660242,0.00012946592,0.00017409257,0.00015154791,0.00007485372,0.00002947505,0.000038088197,0.0001469045,0.00014641254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00225091,0.0058266334,0.25720936,0.00036734168,0.0015912154,0.0015508812,0.0028416244,0.0001337954,0.003379148,0.08673959,0.07651683,0.5615927],"study_design_scores_gemma":[0.009180643,0.015745662,0.3589361,0.0000069986577,0.00072108564,0.000110963025,0.00032676998,0.0007143833,0.00051418704,0.0016636236,0.6118598,0.00021976921],"about_ca_topic_score_codex":0.00002190645,"about_ca_topic_score_gemma":0.00002960929,"teacher_disagreement_score":0.5613729,"about_ca_system_score_codex":0.0003712834,"about_ca_system_score_gemma":0.0004385293,"threshold_uncertainty_score":0.9998305},"labels":[],"label_agreement":null},{"id":"W2997900327","doi":"10.1002/9780471420194.tnmc35.pub2","title":"Ovary","year":2010,"lang":"en","type":"other","venue":"TNM Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Grading (engineering); Pathological; Distant metastasis; Lymph node metastasis; Classification scheme; Lymph node; Stage (stratigraphy); Metastasis; Lymph; Medicine; Pathology; Cancer; Computer science; Biology; Internal medicine; Information retrieval","score_opus":0.01784409182959275,"score_gpt":0.3088672671999022,"score_spread":0.2910231753703095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997900327","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072225914,0.00234758,0.0000049012883,0.0026499892,0.00067909993,0.0003914487,0.0030391978,0.00026646937,0.9905491],"genre_scores_gemma":[0.00013333916,0.0008540519,0.0069657057,0.0013753466,0.0030099845,0.000037217484,0.0035316146,0.00042538418,0.9836674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993465,0.0000055927685,0.00011250349,0.00024441004,0.00014416194,0.00014684875],"domain_scores_gemma":[0.99933076,0.000014914516,0.00007322576,0.00045179378,0.000015817654,0.00011346582],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000018390048,0.00018682037,0.00034750384,0.0001131128,0.000010219373,0.0000050918457,0.000053913314,0.00029243078,0.105167806],"category_scores_gemma":[0.00001345948,0.00014097591,0.000099537014,0.000062900275,0.00003295246,0.0000049859823,0.0000232374,0.0002852511,0.00079116906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000118528305,0.00053670985,0.00042006228,0.00006639208,0.00017961678,0.00016284658,0.000005647578,6.6013515e-9,0.000012992098,0.000061408566,0.9643512,0.034191284],"study_design_scores_gemma":[0.0009741442,0.00011511237,0.0031511982,0.00039871738,0.00023123536,0.000031819265,0.0000023526832,0.0000020570897,0.000026121153,0.00001711945,0.99492985,0.00012029955],"about_ca_topic_score_codex":0.00018784014,"about_ca_topic_score_gemma":0.0004953934,"teacher_disagreement_score":0.10437664,"about_ca_system_score_codex":0.00003329963,"about_ca_system_score_gemma":0.00011938519,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W2998725997","doi":"10.1101/mcs.a004341","title":"Heterogeneous alteration of the ERBB3–MYC axis associated with MEK inhibitor resistance in a <i>KRAS</i>-mutated low-grade serous ovarian cancer patient","year":2019,"lang":"en","type":"article","venue":"Molecular Case Studies","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Princess Margaret Cancer Foundation","keywords":"KRAS; MEK inhibitor; Selumetinib; Neuroblastoma RAS viral oncogene homolog; Medicine; Serous fluid; Ovarian cancer; Cancer research; ERBB3; Oncology; Cancer; Targeted therapy; Metastasis; Internal medicine; Colorectal cancer; MAPK/ERK pathway; Biology; Signal transduction; Epidermal growth factor receptor; Genetics","score_opus":0.0106603113143898,"score_gpt":0.25774661864055,"score_spread":0.2470863073261602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998725997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017465,0.006920959,0.0000076834995,0.0013147042,0.00019119405,0.0011854969,0.00007424919,0.00002182421,0.00010921667],"genre_scores_gemma":[0.9986892,0.00021310188,0.00010474733,0.00054597866,0.000019507932,0.0002914036,0.000016455224,0.000030652303,0.00008899409],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857,0.00012897231,0.0003475183,0.00036349893,0.00033682413,0.00025314328],"domain_scores_gemma":[0.99909097,0.000069640286,0.00020629239,0.00035531196,0.00022629037,0.000051498064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008487795,0.00023031738,0.00046792504,0.00006346363,0.00007855807,0.000013033661,0.000045643308,0.000058568985,0.000014118037],"category_scores_gemma":[0.00007287817,0.00014600501,0.00010669709,0.00040422255,0.00007860373,0.0000361195,0.0000541061,0.000120222525,0.0000023326645],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059888912,0.010356648,0.5933241,0.0039687864,0.025437495,0.13863672,0.07563582,0.020003006,0.11475175,0.00075153355,0.0044615567,0.006683686],"study_design_scores_gemma":[0.031521775,0.004662359,0.07925166,0.012594756,0.0027431617,0.0015185631,0.003814469,0.0005205436,0.8604671,0.00023860073,0.001206756,0.001460272],"about_ca_topic_score_codex":0.00044488642,"about_ca_topic_score_gemma":0.0065943873,"teacher_disagreement_score":0.7457153,"about_ca_system_score_codex":0.00044935127,"about_ca_system_score_gemma":0.0001374912,"threshold_uncertainty_score":0.59539115},"labels":[],"label_agreement":null},{"id":"W2998945641","doi":"10.1001/jamanetworkopen.2019.18939","title":"Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer","year":2020,"lang":"en","type":"review","venue":"JAMA Network Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of British Columbia","funders":"Cancer Research UK","keywords":"Surrogate endpoint; Medicine; Progression-free survival; Ovarian cancer; Oncology; Randomized controlled trial; Internal medicine; Clinical endpoint; Clinical trial; Cancer; Overall survival","score_opus":0.07450528537996831,"score_gpt":0.4127804088594559,"score_spread":0.33827512347948757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998945641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042892498,0.9805657,0.0000087159315,0.0026055663,0.00077233126,0.007132485,0.00093388284,0.000018161742,0.0075342217],"genre_scores_gemma":[0.007140539,0.98762125,0.0019385514,0.000047521884,0.0007179304,0.0016370083,0.00055612426,0.0001181775,0.00022292754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949134,0.00060067285,0.0021458117,0.0008994236,0.00089806406,0.0005426199],"domain_scores_gemma":[0.99533856,0.0008778853,0.001930607,0.001339395,0.00021629513,0.00029724624],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010623621,0.00078982237,0.006358862,0.00017220878,0.0000458498,0.000046310583,0.0007620454,0.00041401363,0.0012951444],"category_scores_gemma":[0.000099123055,0.0005538118,0.000873522,0.0008098369,0.00011616932,0.000117514144,0.0006774218,0.00035180483,0.0000050583544],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008830631,0.0038932369,0.03553358,0.012900345,0.0044222483,0.0005237204,0.00021967648,0.00020219797,3.2901568e-7,0.0024160603,0.0009085201,0.938097],"study_design_scores_gemma":[0.020336682,0.005846222,0.04962017,0.097055666,0.0052894084,0.000026361833,0.000039152867,0.00012841032,0.000016334878,0.00029161907,0.82071453,0.0006354568],"about_ca_topic_score_codex":0.008809819,"about_ca_topic_score_gemma":0.0030248815,"teacher_disagreement_score":0.93746156,"about_ca_system_score_codex":0.0011190503,"about_ca_system_score_gemma":0.0029159908,"threshold_uncertainty_score":0.99969137},"labels":[],"label_agreement":null},{"id":"W2999043970","doi":"10.1016/s0923-7534(20)33538-9","title":"Platinum Combination Chemotherapy Versus Platinum Monotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis of Randomised Trials Using Individual Patient Data (IPD)","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Ovarian cancer; Platinum; Chemotherapy; Meta-analysis; Oncology; Internal medicine; Cancer","score_opus":0.48230475903464526,"score_gpt":0.48457361767615015,"score_spread":0.0022688586415048895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999043970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824509,0.0071038925,0.00014922634,0.004528403,0.0007544619,0.0025240614,0.001765905,0.0000180949,0.0007050447],"genre_scores_gemma":[0.99487364,0.0013909106,0.0020034364,0.00069428154,0.00014866455,0.00017482143,0.0006775674,0.000029273513,0.0000074232385],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959822,0.0009586543,0.0016803374,0.00045976607,0.00050251983,0.00041651388],"domain_scores_gemma":[0.99478316,0.0022405453,0.0018426519,0.0006722156,0.00031176192,0.0001496572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003141665,0.00031804806,0.0035623289,0.0006440678,0.00004519018,0.000010058393,0.0001825989,0.00024912436,0.00068547396],"category_scores_gemma":[0.0004108313,0.00025034026,0.00081766624,0.0008274548,0.00011235544,0.00020108662,0.00007746839,0.00019455396,0.000001377956],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087007545,0.01102951,0.019258197,0.000106523796,0.5135937,0.0000395695,0.019353801,0.0009860388,0.0019285941,0.0005819479,0.0026711207,0.34344348],"study_design_scores_gemma":[0.3556055,0.015299664,0.104683384,0.0002232815,0.4422986,0.000017186321,0.0025544628,0.009676134,0.057114147,0.0002517453,0.011149662,0.0011262432],"about_ca_topic_score_codex":0.0013379364,"about_ca_topic_score_gemma":0.00039802043,"teacher_disagreement_score":0.34231722,"about_ca_system_score_codex":0.00019182067,"about_ca_system_score_gemma":0.0004106026,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2999820772","doi":"10.1016/j.ygyno.2019.12.029","title":"Corrigendum to “Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for reproductive medicine evidence-based review” [Gynecol. Oncol. 155 (2019) 508–514]","year":2020,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CReATe Fertility Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Gynecology; Reproductive medicine; Regret; Hysterectomy; Obstetrics; Fertility preservation; Population; Genetic testing; Fertility; Pregnancy; Family medicine; Oncology; Internal medicine; Surgery","score_opus":0.07727465915859572,"score_gpt":0.3532589585618983,"score_spread":0.2759842994033026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999820772","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09627661,0.24566208,0.00036692052,0.52213174,0.039896347,0.08142646,0.009667503,0.000541288,0.004031055],"genre_scores_gemma":[0.07045066,0.49856207,0.09607442,0.19120586,0.013230099,0.106159315,0.004825935,0.00064851996,0.018843105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98926705,0.0012306363,0.0026601865,0.004382514,0.0006475266,0.0018120572],"domain_scores_gemma":[0.97682303,0.015815714,0.003236413,0.001374164,0.0017299516,0.001020698],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0050539374,0.0015169618,0.006854525,0.0003966564,0.0006935483,0.000027452677,0.00045910396,0.0019824484,0.001244629],"category_scores_gemma":[0.02601759,0.0012656313,0.0010201179,0.001140372,0.0033623315,0.00021349422,0.0006393702,0.001990676,0.000015646494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0028187144,0.0015598367,0.008293745,0.0033432494,0.0023403778,0.00020751164,0.0020190105,0.00003955055,0.00015884775,0.00007531046,0.9494825,0.029661326],"study_design_scores_gemma":[0.015338551,0.08859336,0.096097924,0.0021868474,0.005342181,0.00019617515,0.005261186,0.00043707585,0.00010721883,0.0019426994,0.78304774,0.001449022],"about_ca_topic_score_codex":0.0020047836,"about_ca_topic_score_gemma":0.005044954,"teacher_disagreement_score":0.33092588,"about_ca_system_score_codex":0.015710175,"about_ca_system_score_gemma":0.0114458,"threshold_uncertainty_score":0.99975795},"labels":[],"label_agreement":null},{"id":"W3000219987","doi":"10.1093/biolre/ioaa008","title":"Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis","year":2020,"lang":"en","type":"article","venue":"Biology of Reproduction","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institutes of Health","keywords":"PTEN; CDH1; Biology; Cancer research; Serous fluid; Ovarian cancer; Metastasis; Cancer; Ovary; Pathology; Cadherin; Medicine; PI3K/AKT/mTOR pathway; Endocrinology; Apoptosis; Genetics","score_opus":0.05919150093104882,"score_gpt":0.3148431997916427,"score_spread":0.2556516988605939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000219987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95353293,0.0027270652,0.00014940444,0.04288683,0.00009341467,0.00048821463,0.000023152756,0.000009670974,0.00008932366],"genre_scores_gemma":[0.99605376,0.003032377,0.00060130784,0.0001379678,0.000105119325,0.000031791187,0.000025336818,0.0000054632405,0.0000068625577],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991772,0.00011312335,0.0002728371,0.00027943234,0.0000744598,0.00008292006],"domain_scores_gemma":[0.9995496,0.00004806921,0.00015765782,0.00015120127,0.00006594093,0.000027512046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039042614,0.00009083567,0.0002616649,0.00005864526,0.000032671727,0.000004545321,0.000030762334,0.000076365846,0.000025954152],"category_scores_gemma":[0.00009504605,0.00005618409,0.000027430304,0.0002479379,0.00009806802,0.0001063201,0.000008194575,0.00008574198,3.8262965e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002805447,0.00057930214,0.10432781,0.00070780446,0.00054864987,0.0000047829662,0.019315489,0.00006350313,0.16177806,0.0040369,0.00020860703,0.7056236],"study_design_scores_gemma":[0.00400763,0.0018987971,0.6540908,0.00014583611,0.0004117563,0.000060701946,0.0025229838,0.00019503896,0.3258472,0.00049651804,0.010164103,0.00015858267],"about_ca_topic_score_codex":0.0010509368,"about_ca_topic_score_gemma":0.00006574045,"teacher_disagreement_score":0.7054651,"about_ca_system_score_codex":0.000028899714,"about_ca_system_score_gemma":0.000055202745,"threshold_uncertainty_score":0.22911207},"labels":[],"label_agreement":null},{"id":"W3000267525","doi":"10.1111/aogs.13814","title":"CA‐125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high‐grade ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Acta Obstetricia Et Gynecologica Scandinavica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Israel Cancer Research Fund","keywords":"Medicine; Debulking; Hazard ratio; Chemotherapy; Proportional hazards model; Oncology; Internal medicine; Concordance; Ovarian cancer; Retrospective cohort study; Cancer; Surgery; Confidence interval; Gynecology","score_opus":0.019813882206736064,"score_gpt":0.2664664806226446,"score_spread":0.24665259841590853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000267525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275917,0.00041488724,0.000002786456,0.0052618575,0.00017463832,0.0009883944,0.00025591612,0.000044733188,0.000097601165],"genre_scores_gemma":[0.9982813,0.0007575255,0.0002856157,0.00033906117,0.000036844707,0.00012410976,0.000101720725,0.00004274545,0.000031086274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797547,0.00008180336,0.00053728145,0.0005855893,0.00046747405,0.00035239375],"domain_scores_gemma":[0.99782664,0.0005798528,0.00077096105,0.00025597293,0.00035359015,0.00021298321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009746108,0.00033666656,0.001118522,0.00018918785,0.00010498771,0.000016758773,0.000099094155,0.00017032285,0.00026457332],"category_scores_gemma":[0.00036531084,0.00022657929,0.000104444785,0.0011548563,0.00017979514,0.00019498488,0.00004145769,0.00023104106,5.4409696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017384831,0.0011184706,0.991592,0.00015388225,0.0008122302,0.000038583166,0.00078893575,0.000028471119,0.00080848136,0.000022594162,0.00015289162,0.0027450125],"study_design_scores_gemma":[0.007907385,0.0020483024,0.9784293,0.00028934242,0.00043428966,0.000004204709,0.00025755842,0.00000807263,0.0102771055,0.000009944684,0.000084379564,0.00025007312],"about_ca_topic_score_codex":0.00039832562,"about_ca_topic_score_gemma":0.00003527286,"teacher_disagreement_score":0.013162621,"about_ca_system_score_codex":0.00042870798,"about_ca_system_score_gemma":0.00018588455,"threshold_uncertainty_score":0.92396355},"labels":[],"label_agreement":null},{"id":"W3000562243","doi":"10.1158/0008-5472.can-19-2850","title":"The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Cancer Council Victoria; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; U.S. Department of Defense; World Health Organization; European Commission; National Institute of Environmental Health Sciences; Institut National de la Santé et de la Recherche Médicale; Medical Research Council; Swedish Cancer Foundation; National Institutes of Health; U.S. Department of Health and Human Services; Office of Dietary Supplements; Ligue Contre le Cancer; National Institute for Health and Care Research; National Health and Medical Research Council; American Cancer Society; Cancer Research UK","keywords":"Ovarian cancer; Cancer; Medicine; Cohort; Oncology; Gynecology; Internal medicine","score_opus":0.043778426467996866,"score_gpt":0.38139175511517,"score_spread":0.33761332864717314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000562243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813053,0.0049258834,0.000011559904,0.0101984395,0.00005040893,0.0015388838,0.0015223878,0.000022036262,0.00042509293],"genre_scores_gemma":[0.9890966,0.007237984,0.00009170917,0.0010999113,0.00059853046,0.0016839935,0.0000971401,0.0000542574,0.000039904888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99446666,0.0018841212,0.0006577003,0.0007784971,0.0015736262,0.0006393996],"domain_scores_gemma":[0.9954222,0.0016162683,0.00034672036,0.0015087837,0.00064728525,0.00045875786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022393416,0.0003230761,0.0008277195,0.00013541631,0.0004195352,0.00009814654,0.00083014753,0.0001360918,0.001880748],"category_scores_gemma":[0.0003191974,0.00015569768,0.00021842287,0.0022304298,0.0010412954,0.00017513144,0.00013663397,0.00084188004,0.0000073748774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029696904,0.00056632014,0.9839959,0.000050857794,0.0038680304,0.000061023653,0.0030175743,0.0006929069,0.00020208053,0.0003769343,0.0011732862,0.0030254049],"study_design_scores_gemma":[0.002792045,0.0004151377,0.98610204,0.00024153857,0.003007374,0.0000030076665,0.0030590014,0.0011069328,0.0010149237,0.000104533174,0.0019671742,0.00018630207],"about_ca_topic_score_codex":0.55006504,"about_ca_topic_score_gemma":0.11534305,"teacher_disagreement_score":0.43472198,"about_ca_system_score_codex":0.0004423264,"about_ca_system_score_gemma":0.0023018995,"threshold_uncertainty_score":0.99903166},"labels":[],"label_agreement":null},{"id":"W3000709336","doi":"10.1016/j.ygyno.2019.11.029","title":"Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Western University; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Nova Scotia Health Authority; Dalhousie University; University of British Columbia Hospital","funders":"University of British Columbia; Terry Fox Research Institute; Canadian Institutes of Health Research; Cancer Research Society; Battle Creek Community Foundation","keywords":"Medicine; Oncology; Internal medicine; Serous fluid; Ovarian carcinoma; Hormone receptor; Serous carcinoma; Carcinoma; Gynecology; Cancer research; Ovarian cancer; Cancer","score_opus":0.029883691498491793,"score_gpt":0.2953731901283535,"score_spread":0.2654894986298617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000709336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479523,0.00083355786,0.000012678768,0.048132867,0.00023818425,0.00068959617,0.0000143459865,0.00006839182,0.002058099],"genre_scores_gemma":[0.9901307,0.0003941362,0.0027321319,0.0062533505,0.00012294426,0.00019556966,0.00002494049,0.000017594342,0.00012860671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985931,0.0001283235,0.00033016907,0.00048133795,0.00011798214,0.00034911858],"domain_scores_gemma":[0.999031,0.000373932,0.00010311795,0.00018853912,0.000028144654,0.00027525588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013544517,0.00020465635,0.00069549953,0.00007456442,0.000056599878,0.000010650548,0.00008133561,0.00028245416,0.0004910719],"category_scores_gemma":[0.00026103665,0.00015119104,0.00006862931,0.00016582331,0.00008480674,0.000051810744,0.000110652814,0.0002617875,0.00008656561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040628185,0.0013250341,0.9646984,0.00006390876,0.00007171987,0.0011415702,0.0010493938,0.000006520328,0.0065436927,0.00021187987,0.0062860725,0.018195525],"study_design_scores_gemma":[0.008263004,0.004560413,0.96745837,0.000020338786,0.00007303771,0.000032947388,0.00031886625,0.00006866688,0.0012053036,0.0001037082,0.01773652,0.00015879907],"about_ca_topic_score_codex":0.00008260717,"about_ca_topic_score_gemma":0.00006740418,"teacher_disagreement_score":0.042178445,"about_ca_system_score_codex":0.00036241135,"about_ca_system_score_gemma":0.00017756101,"threshold_uncertainty_score":0.6165392},"labels":[],"label_agreement":null},{"id":"W3001160691","doi":"10.1200/jco.2018.36.15_suppl.5511","title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: Interim results from the phase 2 KEYNOTE-100 study.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Cohort; Ovarian cancer; Interim; Internal medicine; Clinical endpoint; Interim analysis; Oncology; Cancer; Progression-free survival; Topotecan; Chemotherapy; Surgery; Clinical trial; Immunotherapy","score_opus":0.08465868098622457,"score_gpt":0.4704217842886687,"score_spread":0.3857631033024441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001160691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921615,0.00018763535,0.00001751533,0.0058370912,0.00089171523,0.00056401035,0.000092909715,0.0000027490937,0.00024488362],"genre_scores_gemma":[0.99779594,0.00077177066,0.0005146633,0.00036457865,0.00052331,0.000008151686,0.0000040984787,0.000010472384,0.0000070187334],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972817,0.00043620553,0.0015611146,0.00025635053,0.0003031809,0.00016146078],"domain_scores_gemma":[0.99593645,0.0015283718,0.0017007927,0.00026324225,0.00039620002,0.00017496073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012466637,0.00014078402,0.0012211003,0.000060560964,0.000039588627,0.0000063242214,0.00012271457,0.00010958866,0.00007542157],"category_scores_gemma":[0.0010381652,0.00007392848,0.00012083932,0.00013975055,0.0002840863,0.000100600024,0.00006231023,0.0005353609,0.0000011365559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15450248,0.011659334,0.39985833,0.0000060086636,0.0004181894,0.000088751054,0.00042915868,0.0000019319723,0.0000102740705,0.0000045599254,0.0002766206,0.43274438],"study_design_scores_gemma":[0.10477282,0.07038839,0.8191268,0.00035115413,0.000356643,0.000005936726,0.00010313469,0.000015715757,0.00006986406,0.000017344184,0.004734704,0.000057513702],"about_ca_topic_score_codex":0.00041386147,"about_ca_topic_score_gemma":0.0012736195,"teacher_disagreement_score":0.43268687,"about_ca_system_score_codex":0.00022654337,"about_ca_system_score_gemma":0.00088991405,"threshold_uncertainty_score":0.3014716},"labels":[],"label_agreement":null},{"id":"W3002194007","doi":"10.3390/diagnostics10010052","title":"Mucinous Cancer of the Ovary: Overview and Current Status","year":2020,"lang":"en","type":"review","venue":"Diagnostics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Stage (stratigraphy); Ovary; Medicine; Pathological; Ovarian cancer; Disease; Oncology; Ovarian carcinoma; Mucinous carcinoma; Cancer; Chemotherapy; Internal medicine; Pathology; Adenocarcinoma; Biology","score_opus":0.10497821150131967,"score_gpt":0.40336584166973494,"score_spread":0.2983876301684153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002194007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013261789,0.9959899,0.0000012557296,0.0004942159,0.0008779498,0.0014273374,0.001008038,0.000017865206,0.0001701318],"genre_scores_gemma":[0.000047677517,0.9988408,0.000050900555,0.00021321686,0.0003594673,0.00032904497,0.00008228895,0.000055702592,0.000020894817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984927,0.00007738346,0.000494812,0.00037674396,0.0002937655,0.0002645742],"domain_scores_gemma":[0.9982975,0.0005681776,0.0003614037,0.0004800642,0.000076703705,0.00021613373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005256397,0.00037166808,0.0017265796,0.000050218725,0.00004455581,0.000015697282,0.00012147564,0.00013215476,0.00011035098],"category_scores_gemma":[0.0003153684,0.0002140018,0.00040374708,0.0003251922,0.00009279867,0.000016065662,0.00017399194,0.0003648849,0.00001572287],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031807533,0.00020362582,0.004146219,0.026375573,0.00039383577,0.00003979997,0.00005741749,1.4127407e-7,7.455599e-9,0.0004199711,0.006208489,0.96215177],"study_design_scores_gemma":[0.00046741488,0.00011739236,0.0037099866,0.04243588,0.006412624,0.000020200583,0.000003842508,0.000001514278,0.0000014004873,0.000021153026,0.94664294,0.00016564874],"about_ca_topic_score_codex":0.00014754447,"about_ca_topic_score_gemma":0.000023890658,"teacher_disagreement_score":0.96198606,"about_ca_system_score_codex":0.00023295105,"about_ca_system_score_gemma":0.0010452861,"threshold_uncertainty_score":0.87267405},"labels":[],"label_agreement":null},{"id":"W3002742562","doi":"10.1016/j.ygyno.2019.12.033","title":"Low-grade serous ovarian cancer: State of the science","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre; University of British Columbia","funders":"Leonard M. Miller School of Medicine; Cancer Research UK; Sylvester Comprehensive Cancer Center, University of Miami Health Systems","keywords":"Medicine; Serous ovarian cancer; Serous fluid; Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.06310527820407179,"score_gpt":0.38466123059428164,"score_spread":0.32155595239020984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002742562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000205189,0.9870258,0.0000022921402,0.0044919048,0.002060024,0.00248882,0.00016566961,0.00005364518,0.0035066423],"genre_scores_gemma":[0.0016102083,0.9957672,0.00031062364,0.0009055078,0.00022115385,0.00076381874,0.0000151593285,0.00003825904,0.00036810833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709904,0.0002819305,0.00082247815,0.00081256276,0.00039907053,0.0005849277],"domain_scores_gemma":[0.9973152,0.00061338535,0.0009068432,0.00074954965,0.00015378676,0.00026123156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004529823,0.00044775908,0.002906557,0.00016546514,0.0001793403,0.000017279388,0.0007239555,0.00034747046,0.0004576325],"category_scores_gemma":[0.00040522852,0.00024548284,0.000596499,0.0013347885,0.0009155971,0.000039679067,0.00042353087,0.0006745626,0.00008577571],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014189719,0.0005543415,0.00015006089,0.0034351852,0.0003552507,0.00028326162,0.000086043154,0.0000043918935,0.0000031998868,0.00022414114,0.0012226135,0.9936673],"study_design_scores_gemma":[0.001004022,0.0013902261,0.0017465245,0.0024031003,0.002227119,0.0001557594,0.000011897785,0.000006248328,0.000048932834,0.00011399079,0.99068844,0.00020372869],"about_ca_topic_score_codex":0.00013601569,"about_ca_topic_score_gemma":0.00016564273,"teacher_disagreement_score":0.9934636,"about_ca_system_score_codex":0.0027261698,"about_ca_system_score_gemma":0.010801837,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W3003957666","doi":"10.1016/j.ygyno.2019.12.047","title":"Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Partnership Against Cancer; Saskatchewan Cancer Agency; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; Cancer Care Ontario; Alberta Health Services; University of British Columbia; Nova Scotia Health Authority","funders":"Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Department of Health, Government of Western Australia; Public Health Agency; Cancer Society of New Zealand; Cancer Research UK; World Health Organization; Kreftforeningen; Kræftens Bekæmpelse; Cancer Institute NSW; Heart of England NHS Foundation Trust","keywords":"Medicine; Demography; Stage (stratigraphy); Population; Cancer; Internal medicine; Environmental health; Biology","score_opus":0.18216256031331557,"score_gpt":0.36064141489954044,"score_spread":0.17847885458622487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003957666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826463,0.00018317372,0.00009633235,0.014266001,0.00041821436,0.0013683768,0.0000834215,0.00006712766,0.0008710745],"genre_scores_gemma":[0.9958175,0.00013237658,0.0005602989,0.0019673489,0.00011444523,0.0012000677,0.0001004559,0.000021559852,0.00008595495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824005,0.00032097817,0.0004053565,0.0005331604,0.00017144284,0.00032903661],"domain_scores_gemma":[0.9986761,0.00074577506,0.00013454632,0.000186408,0.00003981729,0.00021736008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035835826,0.00020482572,0.00063035364,0.000102925515,0.00009875188,0.00002125327,0.00007704173,0.00012501176,0.0008226908],"category_scores_gemma":[0.00032237972,0.00018093416,0.000050826504,0.00036579097,0.000029246945,0.00009227714,0.00005780302,0.00026245188,0.000010275714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019566577,0.0016922544,0.9876396,0.000034450335,0.00012653809,0.00073099765,0.0011041292,0.0001863974,0.000102144884,0.00024345552,0.0002145429,0.0077298135],"study_design_scores_gemma":[0.0073500895,0.00254762,0.9832579,0.0000123879345,0.00015281781,0.0000010168454,0.00070674357,0.0003764912,0.000020204487,0.000026768803,0.00538894,0.00015902783],"about_ca_topic_score_codex":0.004862784,"about_ca_topic_score_gemma":0.011923356,"teacher_disagreement_score":0.013171214,"about_ca_system_score_codex":0.0007175861,"about_ca_system_score_gemma":0.00032391254,"threshold_uncertainty_score":0.9007887},"labels":[],"label_agreement":null},{"id":"W3004353539","doi":"10.3389/fonc.2019.01570","title":"Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; Institute of Cancer Research; University of Calgary","funders":"China Postdoctoral Science Foundation; Heilongjiang Postdoctoral Science Foundation","keywords":"Gene knockdown; Cancer research; Biomarker; Ovarian cancer; Small interfering RNA; In vivo; Cell; MMP2; Clear cell; Metastasis; Cell culture; Cell growth; Medicine; Cancer; Pathology; Immunohistochemistry; Biology; Internal medicine; Transfection","score_opus":0.013720652912083381,"score_gpt":0.2708580066576459,"score_spread":0.25713735374556257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004353539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736023,0.0015971005,0.00037776664,0.00811879,0.00072505896,0.0006173614,0.00001902219,0.0000151066115,0.014927502],"genre_scores_gemma":[0.98909837,0.00019645934,0.00898761,0.0013523289,0.00017678196,0.000038666938,0.00001970446,0.000021200756,0.00010887745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875194,0.00010954438,0.00037533164,0.00034258162,0.0001619771,0.000258609],"domain_scores_gemma":[0.9994681,0.000030086603,0.00012211195,0.00018847734,0.000029361077,0.00016190435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010570952,0.00013957736,0.00057413965,0.00015706349,0.000016328577,0.0000032937517,0.0001004195,0.00021647828,0.0002881546],"category_scores_gemma":[0.000044612145,0.00012971659,0.00009415454,0.00025311735,0.000064836924,0.000039264014,0.00006771384,0.00023030765,0.000019560743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00783322,0.0031507995,0.8428665,0.00030733284,0.00011467823,0.003081997,0.0040304395,0.00025220914,0.03705823,0.00021027657,0.0664377,0.034656662],"study_design_scores_gemma":[0.056754526,0.018408926,0.68764156,0.0004252541,0.00041098727,0.000109950735,0.0041787373,0.004045307,0.11843688,0.00094697165,0.10801875,0.00062216644],"about_ca_topic_score_codex":0.00046034157,"about_ca_topic_score_gemma":0.00002272804,"teacher_disagreement_score":0.1552249,"about_ca_system_score_codex":0.00044739287,"about_ca_system_score_gemma":0.0004131076,"threshold_uncertainty_score":0.5289689},"labels":[],"label_agreement":null},{"id":"W3004663953","doi":"10.1097/aog.0000000000003702","title":"Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy","year":2020,"lang":"en","type":"review","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Occult; Gynecology; Population; Carcinoma; Obstetrics; General surgery; Surgery; Internal medicine; Pathology","score_opus":0.028116291350953348,"score_gpt":0.3001671593388016,"score_spread":0.2720508679878483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004663953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010435111,0.9944837,0.000004185123,0.00022113336,0.001780302,0.0010649977,0.00020358579,0.000046273664,0.0011522972],"genre_scores_gemma":[0.004952925,0.99309176,0.00042356117,0.000291323,0.00036831928,0.00044682648,0.00013405153,0.00008203983,0.00020921252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767745,0.00015235023,0.00061528874,0.00089174445,0.00019038354,0.00047279947],"domain_scores_gemma":[0.99530333,0.003420623,0.00036239196,0.00043038846,0.00008477053,0.0003985069],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000120933524,0.0005562558,0.0024624583,0.00034105554,0.00010459055,0.000050839702,0.00011589448,0.0005819799,0.00029937626],"category_scores_gemma":[0.0023068504,0.00042190697,0.00050580455,0.0007250494,0.00008467157,0.000030017965,0.00016495357,0.00068249594,0.00017301878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010454873,0.00014669643,0.0070679323,0.004356691,0.0005139725,0.001665119,0.00008387621,5.9132958e-8,2.4962198e-8,0.000056642497,0.0012222492,0.9848763],"study_design_scores_gemma":[0.0012369336,0.00066194765,0.004638419,0.0012482291,0.0042049685,0.00018922705,0.000018286994,0.00000792926,5.5460947e-7,0.000013100169,0.98743266,0.00034773315],"about_ca_topic_score_codex":0.00008396241,"about_ca_topic_score_gemma":0.000008947939,"teacher_disagreement_score":0.9862104,"about_ca_system_score_codex":0.0005642884,"about_ca_system_score_gemma":0.0005909155,"threshold_uncertainty_score":0.9998233},"labels":[],"label_agreement":null},{"id":"W3004779346","doi":"10.1097/ede.0000000000001175","title":"Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Vancouver Coastal Health","funders":"National Institutes of Health; National Cancer Institute; Rutgers Cancer Institute of New Jersey; Ovarian Cancer Research Fund; U.S. Department of Defense","keywords":"Progestin; Estrogen; Medicine; Hormone therapy; Ovarian cancer; Oncology; Estrogen therapy; Hormone; Gynecology; Internal medicine; Cancer; Breast cancer","score_opus":0.15636111545231596,"score_gpt":0.36385186111896367,"score_spread":0.2074907456666477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004779346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58902067,0.073874064,0.0002393237,0.33474487,0.00012459783,0.0007844632,0.000025638263,0.00011094192,0.0010753989],"genre_scores_gemma":[0.9518906,0.010866008,0.005193112,0.030969748,0.00066415913,0.00028877423,0.000023453958,0.000025006673,0.000079126476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892354,0.00012624201,0.00025822094,0.0003696896,0.00004984895,0.00027248202],"domain_scores_gemma":[0.9991318,0.00031597982,0.00008547727,0.00015564515,0.0000277618,0.00028334834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022616684,0.00014565834,0.0005460334,0.00002116818,0.000043441567,0.0000032487949,0.000044368422,0.00010340958,0.00021185317],"category_scores_gemma":[0.000332393,0.00010523724,0.00006389928,0.00008773228,0.00008849671,0.00002261725,0.000029273288,0.0001426993,0.000032301403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087774923,0.00012794824,0.8109381,0.00004262485,0.0005387645,0.00014272233,0.0005936494,0.00003417698,0.00070987013,0.01611116,0.027789244,0.14209396],"study_design_scores_gemma":[0.0061569265,0.0016578981,0.80999565,0.00003541759,0.00013827978,0.00008305729,0.000032725355,0.0010288224,0.0004736929,0.0008582525,0.1793601,0.00017918258],"about_ca_topic_score_codex":0.0004175539,"about_ca_topic_score_gemma":0.000007099702,"teacher_disagreement_score":0.36286992,"about_ca_system_score_codex":0.00006593978,"about_ca_system_score_gemma":0.00013143114,"threshold_uncertainty_score":0.429145},"labels":[],"label_agreement":null},{"id":"W3005887617","doi":"10.1002/ijc.32916","title":"Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?","year":2020,"lang":"en","type":"review","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute; Peter Gilgan Foundation","keywords":"Salpingectomy; Medicine; Fallopian tube; Ovarian cancer; Tubal ligation; Gynecology; BRCA mutation; Obstetrics; Serous fluid; Population; Cancer; Internal medicine; Family planning; Pregnancy","score_opus":0.09929962101225558,"score_gpt":0.44378998465920505,"score_spread":0.34449036364694946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005887617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029150294,0.9780553,0.0010683049,0.016647188,0.0027197897,0.00112755,0.0002630193,0.000005872053,0.00011004615],"genre_scores_gemma":[0.0009498367,0.99341124,0.0006071528,0.00024297311,0.0037969449,0.00047300284,0.000015639656,0.00005308985,0.00045010867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780077,0.000057793215,0.0010068958,0.0002161976,0.00076663075,0.00015172125],"domain_scores_gemma":[0.99668306,0.00026961305,0.0018893629,0.00016364898,0.000887603,0.00010670261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000231595,0.00027679355,0.0013531864,0.00019058406,0.000035858644,0.000043305143,0.00041294307,0.00013626773,0.00061873865],"category_scores_gemma":[0.00009694782,0.00015817453,0.0011362511,0.00017480883,0.000051123596,0.00012787404,0.00004500181,0.00040294847,0.000002639326],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003752542,0.0001686736,0.00009273246,0.005072449,0.006558749,0.000052831354,0.00009067269,0.000026675472,0.0000021651226,0.00036003866,0.0028593813,0.98434037],"study_design_scores_gemma":[0.0019106421,0.0004166442,0.00010054019,0.021784244,0.005748368,0.00010383695,0.00001208728,0.000031815176,0.00005716975,0.00026823845,0.9694449,0.000121521705],"about_ca_topic_score_codex":0.00010427248,"about_ca_topic_score_gemma":0.000033005963,"teacher_disagreement_score":0.98421884,"about_ca_system_score_codex":0.0009486659,"about_ca_system_score_gemma":0.0026671763,"threshold_uncertainty_score":0.6774754},"labels":[],"label_agreement":null},{"id":"W3005947818","doi":"10.1016/j.ajog.2020.02.005","title":"Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada","year":2020,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Menopause; Cohort; Salpingectomy; Cohort study; Obstetrics; Demography; Gynecology; Gerontology; Pregnancy; Internal medicine; Ectopic pregnancy","score_opus":0.017258705939196147,"score_gpt":0.23992030131791373,"score_spread":0.22266159537871758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005947818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766195,0.001009625,0.000014602937,0.00039798138,0.0005119735,0.00027317845,0.00004372921,0.0000054740512,0.00008147811],"genre_scores_gemma":[0.99834764,0.0002797656,0.00038999665,0.00088004605,0.000054748245,0.000007872358,0.00000555516,0.000020223382,0.000014125762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984912,0.000094955365,0.00060964597,0.00023553938,0.00036265122,0.00020599492],"domain_scores_gemma":[0.9964106,0.002176038,0.00073639664,0.00012518713,0.00011926356,0.0004325278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018745665,0.000110155306,0.00095607294,0.000102261394,0.000062944244,0.00004377789,0.000105854415,0.000035161054,0.00008240648],"category_scores_gemma":[0.0021395376,0.00013455653,0.00006421035,0.00061616715,0.00009866258,0.000043723798,0.000049194616,0.00021889765,2.6592053e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019957593,0.0002493127,0.92483604,0.000008615747,0.0011059713,0.0046020723,0.00041914385,8.9760664e-7,0.000017685436,7.6516494e-7,0.00044705183,0.06829248],"study_design_scores_gemma":[0.0026861867,0.009082099,0.9836002,0.000043067314,0.0009793675,0.000036631034,0.0019310437,0.0000047968915,0.000004464101,0.000004347811,0.0015240267,0.000103771315],"about_ca_topic_score_codex":0.4476914,"about_ca_topic_score_gemma":0.12632011,"teacher_disagreement_score":0.32137132,"about_ca_system_score_codex":0.0002703894,"about_ca_system_score_gemma":0.0013061462,"threshold_uncertainty_score":0.8896223},"labels":[],"label_agreement":null},{"id":"W3006968401","doi":"10.1016/j.ygyno.2020.02.023","title":"Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"Barts Charity","keywords":"Medicine; Kingdom; Family medicine; Library science","score_opus":0.19489248194265377,"score_gpt":0.3903486375939709,"score_spread":0.19545615565131716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006968401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010049896,0.96544963,0.000008353986,0.0074363668,0.00035940943,0.021208355,0.004403992,0.000074464006,0.00005446721],"genre_scores_gemma":[0.005019776,0.9672378,0.0022839648,0.013342538,0.0000626864,0.009914576,0.0018113959,0.00011557742,0.00021168796],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98741674,0.00429544,0.0037783193,0.002590647,0.0008504386,0.0010684149],"domain_scores_gemma":[0.9897356,0.0042512813,0.0024147932,0.002566751,0.00026756313,0.000764033],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0037874002,0.0013994516,0.023515379,0.0011803437,0.000108797205,0.000052664203,0.0012369803,0.0013141219,0.0019111055],"category_scores_gemma":[0.004559398,0.0008974672,0.0019115277,0.0032682342,0.00025862228,0.00009124972,0.0011003461,0.0010839414,0.0001096764],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007104913,0.008368114,0.001807795,0.5941531,0.25238496,0.013097655,0.0015086324,0.000003169008,6.969124e-7,0.00012644322,0.020892803,0.10694613],"study_design_scores_gemma":[0.0018241402,0.008628559,0.0093741445,0.00893694,0.8176735,0.00045511217,0.000092996845,0.000009482895,6.236238e-7,0.000014004397,0.15224454,0.00074596767],"about_ca_topic_score_codex":0.00017475909,"about_ca_topic_score_gemma":0.00031133188,"teacher_disagreement_score":0.58521616,"about_ca_system_score_codex":0.0018669227,"about_ca_system_score_gemma":0.002621378,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W3007192988","doi":"10.1136/ijgc-2019-esgo.1007","title":"EP961 Are there opportunities to improve the number of women able to start and tolerate treatment for ovarian cancer? European perspectives from the world ovarian cancer coalition‘s every woman study","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Confidence interval; Cancer; Demography; Ovarian cancer; Family medicine; Quality of life (healthcare); Gynecology; Internal medicine; Nursing","score_opus":0.05866873424555503,"score_gpt":0.34903754494733547,"score_spread":0.29036881070178044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007192988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433054,0.0009109352,0.000020845837,0.051708814,0.0009770053,0.001419194,0.0007814099,0.000008782071,0.0008676465],"genre_scores_gemma":[0.9896127,0.00082669227,0.00017510123,0.004634047,0.0009568076,0.00083533133,0.0000054442835,0.000025814077,0.002928057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827224,0.00017150654,0.0004965555,0.00031754424,0.00045873562,0.00028340964],"domain_scores_gemma":[0.9977478,0.00060243026,0.0004266197,0.00021940743,0.00077459036,0.00022915709],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045833687,0.00023133458,0.00051755784,0.0000759536,0.00010912743,0.00010149321,0.00030016125,0.00003708944,0.0048611383],"category_scores_gemma":[0.000082329236,0.00011717011,0.00015492468,0.00010078752,0.000069804744,0.000113837435,0.000095223564,0.00015656334,0.000007707558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005680414,0.0023818028,0.9198456,0.000026297761,0.0065523298,0.00029868502,0.017012741,0.00079876033,0.0004969774,0.0011610063,0.008262598,0.03748282],"study_design_scores_gemma":[0.0054195113,0.0020886147,0.9254495,0.0002915982,0.00032374467,0.000010680082,0.020186707,0.000022658494,0.00026543852,0.00021199185,0.04556666,0.00016288635],"about_ca_topic_score_codex":0.0033768218,"about_ca_topic_score_gemma":0.003993831,"teacher_disagreement_score":0.04707477,"about_ca_system_score_codex":0.002235595,"about_ca_system_score_gemma":0.00044373597,"threshold_uncertainty_score":0.99604857},"labels":[],"label_agreement":null},{"id":"W3007214813","doi":"10.1136/ijgc-2019-esgo.1282","title":"EP1276 Microinvasive tubal carcinomas: cases of poor outcome despite ‘very early’ diagnosis. A systematic review of the literature","year":2019,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Occult; Incidence (geometry); Data extraction; Breast cancer; Cancer; Gynecology; MEDLINE; Internal medicine; Pathology","score_opus":0.07673757741182304,"score_gpt":0.3880349631889383,"score_spread":0.3112973857771153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007214813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021070302,0.9918282,0.000001056768,0.0013437519,0.0019389067,0.0020444088,0.0006548352,0.0000041533517,0.000077630495],"genre_scores_gemma":[0.010699355,0.98678696,0.0000729691,0.001415846,0.0003845012,0.00032695296,0.000021802329,0.00003181907,0.00025980073],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995322,0.0004080138,0.00269356,0.00029741466,0.0010612885,0.00021770805],"domain_scores_gemma":[0.9912485,0.0021990475,0.0043189134,0.00039929154,0.0017027057,0.0001315605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676114,0.00044868942,0.004452407,0.00024213696,0.000024558556,0.000033670036,0.0008271912,0.00030467284,0.00067934947],"category_scores_gemma":[0.0025095514,0.00021263701,0.0027295158,0.00033787495,0.00012426819,0.000101268146,0.00018405939,0.0006681208,0.0000113131255],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000894634,0.0007304202,0.020740747,0.9467019,0.0054114815,0.0013555619,0.00007219324,0.0000016011527,0.0000013845195,0.00010436679,0.0027607516,0.022030162],"study_design_scores_gemma":[0.0009905074,0.00084520783,0.005718595,0.93457115,0.012285005,0.0017639097,0.000011234819,1.8602019e-7,0.000027195962,0.0000150119195,0.043575462,0.00019654993],"about_ca_topic_score_codex":0.000045540437,"about_ca_topic_score_gemma":0.000013598464,"teacher_disagreement_score":0.040814713,"about_ca_system_score_codex":0.0011313194,"about_ca_system_score_gemma":0.0011076942,"threshold_uncertainty_score":0.8671086},"labels":[],"label_agreement":null},{"id":"W3007328482","doi":"10.1136/ijgc-2019-esgo.950","title":"EP904 Clinical outcomes of post-operative intraperitoneal chemotherapy for patients with early stage high grade serous ovarian cancer treated at british columbia cancer agency","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Chemotherapy; Serous fluid; Oncology; Stage (stratigraphy); Retrospective cohort study; Internal medicine; Paclitaxel; Cancer; Cisplatin","score_opus":0.02086995546776464,"score_gpt":0.3410569255234656,"score_spread":0.32018697005570096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007328482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912782,0.00039857015,0.0000117277095,0.0037011579,0.0017633068,0.0010888794,0.0016858901,0.000013692413,0.000058588485],"genre_scores_gemma":[0.99195427,0.002339291,0.0006396103,0.0022077928,0.00040761527,0.0002512529,0.00006186789,0.000038363323,0.0020999406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975453,0.00007691385,0.0009641348,0.00038550494,0.0007292575,0.00029891482],"domain_scores_gemma":[0.996386,0.0004056804,0.0008493722,0.0001487145,0.0019928722,0.00021734159],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018328342,0.00022646242,0.00096267095,0.00006823848,0.00006621823,0.00008977709,0.00027406984,0.00019628252,0.011602536],"category_scores_gemma":[0.00010311605,0.0001849922,0.00038113765,0.000117453375,0.00014730406,0.00018557857,0.00004848232,0.0002808357,0.000003815869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003093405,0.001984684,0.96118236,0.000026684775,0.0032500278,0.000110758185,0.00014671635,0.00007084715,0.00010405661,0.00001915358,0.001105906,0.028905382],"study_design_scores_gemma":[0.01951383,0.0051881415,0.971213,0.00026174303,0.00032049156,0.0000132866135,0.000021508627,0.000015872758,0.00023578045,0.00003028553,0.0029870383,0.00019901911],"about_ca_topic_score_codex":0.028936125,"about_ca_topic_score_gemma":0.029431023,"teacher_disagreement_score":0.028706362,"about_ca_system_score_codex":0.0011278361,"about_ca_system_score_gemma":0.00055550004,"threshold_uncertainty_score":0.98930097},"labels":[],"label_agreement":null},{"id":"W3007354585","doi":"10.1136/ijgc-2019-esgo.182","title":"P119 An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Organoid; Ovarian cancer; Cancer; In vivo; Cancer research; Medicine; Internal medicine; Oncology; Pathology; Biology; Neuroscience","score_opus":0.031160801266148834,"score_gpt":0.34896937163930436,"score_spread":0.3178085703731555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007354585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896468,0.0013605863,0.00019400858,0.0057716984,0.002298481,0.00040844633,0.000105787054,0.000010635954,0.00020357895],"genre_scores_gemma":[0.9941087,0.000959025,0.0010621407,0.002952141,0.0007104724,0.000077203964,0.00001334889,0.000016130016,0.00010088746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998766,0.000020484156,0.000424639,0.00023385481,0.0003655665,0.00018942099],"domain_scores_gemma":[0.998626,0.0001646793,0.000304237,0.000103733444,0.0005973896,0.00020398191],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017467425,0.00016092915,0.00037511368,0.00010593707,0.000033765027,0.000052630417,0.00017795822,0.000112652604,0.00214589],"category_scores_gemma":[0.000091198526,0.00010650596,0.00015065045,0.000048086316,0.00005090626,0.00019980328,0.000051364306,0.0001894234,0.0000045123165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039605657,0.0013428358,0.7957385,0.00007802717,0.0020372684,0.00019699111,0.00059229357,0.0004315,0.004367517,0.0017259347,0.0024697904,0.18705878],"study_design_scores_gemma":[0.010949853,0.005180266,0.92604643,0.00034053795,0.0003755742,0.00029750552,0.00018689688,0.0005799261,0.013794951,0.001155967,0.04078944,0.00030267233],"about_ca_topic_score_codex":0.00015204151,"about_ca_topic_score_gemma":0.00033801442,"teacher_disagreement_score":0.1867561,"about_ca_system_score_codex":0.0006239996,"about_ca_system_score_gemma":0.0002445473,"threshold_uncertainty_score":0.9987663},"labels":[],"label_agreement":null},{"id":"W3007363914","doi":"10.1016/j.jmir.2020.01.001","title":"The Value of PET-CT in Ovarian Epithelial Carcinoma: A Population-Based Study in British Columbia, Canada","year":2020,"lang":"en","type":"article","venue":"Journal of medical imaging and radiation sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Nuclear Laboratories; BC Cancer Agency","funders":"","keywords":"Value (mathematics); Medicine; Ovarian carcinoma; Oncology; Population; Gynecology; Nuclear medicine; Internal medicine; Ovarian cancer; Cancer; Statistics; Mathematics; Environmental health","score_opus":0.013225250226889472,"score_gpt":0.2841236629501805,"score_spread":0.270898412723291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007363914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536804,0.0013513676,0.00000966748,0.04462194,0.00020389725,0.000114633694,0.0000028517516,9.406026e-7,0.000014286067],"genre_scores_gemma":[0.99891883,0.00012350295,0.000060102488,0.00077067985,0.000119844466,0.0000022456777,5.3337294e-7,0.0000021349558,0.0000021340195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983855,0.000103754974,0.0004180403,0.00010380686,0.0008860781,0.000102849954],"domain_scores_gemma":[0.99926996,0.00031228716,0.00018264864,0.00003595434,0.000043910517,0.00015523756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011853552,0.000037026362,0.0001950985,0.000045185283,0.000088094836,0.00007526836,0.000098407414,0.0000059556282,0.000023976405],"category_scores_gemma":[0.0007368961,0.00003113995,0.000025352414,0.00030866574,0.00007568574,0.00006414493,0.000009916011,0.00013730563,4.647279e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000924009,0.00010095343,0.98145705,0.000008498311,0.0000073125266,0.0006818582,0.00014706458,0.000089167435,0.0000016068072,0.000004997934,0.00034349662,0.017148722],"study_design_scores_gemma":[0.0025731628,0.0001612301,0.9836039,0.00011149417,0.000021351789,0.00012086551,0.0020373566,0.011129068,0.0000042391334,0.000020581614,0.00018749671,0.000029258119],"about_ca_topic_score_codex":0.7312358,"about_ca_topic_score_gemma":0.7105148,"teacher_disagreement_score":0.04523841,"about_ca_system_score_codex":0.00010460321,"about_ca_system_score_gemma":0.0018286115,"threshold_uncertainty_score":0.32438785},"labels":[],"label_agreement":null},{"id":"W3007653724","doi":"10.1117/12.2544475","title":"Endoscopic optical coherence tomography (OCT) and autofluorescence imaging (AFI) of ex vivo fallopian tubes","year":2020,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Optical coherence tomography; Ex vivo; Autofluorescence; Materials science; Tomography; Preclinical imaging; Optical imaging; Optics; Optical tomography; Biomedical engineering; In vivo; Medicine; Physics; Fluorescence; Biology","score_opus":0.01548263655751798,"score_gpt":0.25550859954955224,"score_spread":0.24002596299203427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007653724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95051146,0.0034354334,0.0011171997,0.02167787,0.00012290932,0.0007522971,0.000021545427,0.00014877225,0.022212502],"genre_scores_gemma":[0.9917125,0.00022070445,0.0066929813,0.0012437707,0.00005992027,0.000018204613,0.0000029487085,0.000011036045,0.000037906793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991031,0.00001310671,0.00020677132,0.00030311182,0.00018689343,0.00018699348],"domain_scores_gemma":[0.9994501,0.00006239422,0.00002451812,0.0001661216,0.000048771893,0.00024811938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038025864,0.00013520593,0.00028960122,0.000046016834,0.000026983353,0.000019653022,0.0000611078,0.000030958974,0.00046768435],"category_scores_gemma":[0.000034135326,0.000103592196,0.00006591603,0.00017882776,0.00014119799,0.0000632152,0.000049192608,0.000083876854,0.000010830549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043641794,0.00016946257,0.97027826,0.00018395884,0.00009502237,0.00009023159,0.0003020046,9.3930686e-7,0.013333328,0.003438855,0.00082803454,0.011236283],"study_design_scores_gemma":[0.0040673614,0.0010324168,0.7130552,0.0004632047,0.00031332468,0.000031887434,0.00029265494,0.0010817811,0.27671388,0.00014568098,0.002585834,0.00021677569],"about_ca_topic_score_codex":0.00011830916,"about_ca_topic_score_gemma":0.000009298755,"teacher_disagreement_score":0.26338056,"about_ca_system_score_codex":0.000017883029,"about_ca_system_score_gemma":0.00006470883,"threshold_uncertainty_score":0.51208156},"labels":[],"label_agreement":null},{"id":"W3008908488","doi":"10.1136/ijgc-2019-esgo.1046","title":"EP1002 Secondary cytoreduction surgery for recurrent ovarian cancer – twelve radiological criteria for case selection: preliminary data","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Radiological weapon; Surgery; Radiology; Retrospective cohort study; Greater omentum","score_opus":0.1056103769625253,"score_gpt":0.40958475005376754,"score_spread":0.30397437309124226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008908488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445352,0.0053969,0.002172837,0.026860395,0.01766083,0.0017471384,0.0013637582,0.00003818441,0.0002247876],"genre_scores_gemma":[0.9876249,0.0015812764,0.0042000883,0.0011132666,0.0044592046,0.00045717228,0.00021361519,0.000024894995,0.00032561208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811506,0.00007422719,0.0007311563,0.00045429246,0.00034255386,0.00028272806],"domain_scores_gemma":[0.996851,0.0011478895,0.0005459035,0.00020396191,0.0010680897,0.00018314754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006654088,0.00021616717,0.0006126175,0.00016425249,0.00008460321,0.00005992584,0.00028162458,0.00018962527,0.006451656],"category_scores_gemma":[0.0005077411,0.00015401031,0.00036509737,0.00010129662,0.00006213383,0.00030058026,0.000086744505,0.00028590896,0.000006042306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029315807,0.0027722144,0.09808025,0.0003604224,0.0046039904,0.0021450312,0.00023778065,0.00042947056,0.0011727307,0.0006364492,0.31207332,0.54817253],"study_design_scores_gemma":[0.019644842,0.01576416,0.32307455,0.0010816877,0.002065307,0.020168073,0.00042125786,0.007329316,0.002366833,0.0016815278,0.6055241,0.0008783296],"about_ca_topic_score_codex":0.000059523594,"about_ca_topic_score_gemma":0.000049281865,"teacher_disagreement_score":0.5472942,"about_ca_system_score_codex":0.0009758936,"about_ca_system_score_gemma":0.00078487047,"threshold_uncertainty_score":0.9944566},"labels":[],"label_agreement":null},{"id":"W3008947683","doi":"10.1136/ijgc-2019-esgo.41","title":"Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"","keywords":"Oncology; Stage (stratigraphy); Cohort; Internal medicine; Medicine; Ovarian cancer; Carcinoma; Endometrial cancer; Ovarian carcinoma; Context (archaeology); Cancer; Gynecology; Biology","score_opus":0.01826137168898121,"score_gpt":0.32536187398099586,"score_spread":0.30710050229201463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008947683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.893986,0.0021508858,0.08204611,0.015004806,0.0016161985,0.0031472943,0.00022928833,0.0000199122,0.0017995394],"genre_scores_gemma":[0.9897881,0.0010217158,0.007847608,0.0002973219,0.0003046312,0.00015169258,0.000048598606,0.000013496133,0.00052684976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982275,0.00004516476,0.00069837866,0.0002453953,0.0006433371,0.00014025657],"domain_scores_gemma":[0.9976803,0.00034191806,0.00086482114,0.00020281109,0.0007634196,0.00014670203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003819236,0.00013945627,0.00036686336,0.00028862926,0.00002737497,0.000017943114,0.00024674222,0.00008463882,0.0008768849],"category_scores_gemma":[0.00026285675,0.00009890991,0.00019029732,0.0001960665,0.000043979064,0.00008802609,0.00003270772,0.00015168487,0.000004769721],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032363662,0.0018872555,0.30002844,0.00030210125,0.0025204076,0.000108983535,0.00035246045,0.008647564,0.021920351,0.037732575,0.0030950513,0.62016845],"study_design_scores_gemma":[0.017353049,0.0040432136,0.9182545,0.00045949916,0.00096327986,0.00004084895,0.0002796861,0.0020270366,0.018195655,0.0053222193,0.03281481,0.0002462163],"about_ca_topic_score_codex":0.00033011838,"about_ca_topic_score_gemma":0.00005045039,"teacher_disagreement_score":0.6199222,"about_ca_system_score_codex":0.0006341471,"about_ca_system_score_gemma":0.00027098504,"threshold_uncertainty_score":0.9601275},"labels":[],"label_agreement":null},{"id":"W3009513461","doi":"10.1200/jco.2007.25.18_suppl.5519","title":"CA-125 response as a marker of clinical benefit in patients with recurrent ovarian cancer treated with gemcitabine and sorafenib—A trial of the PMH Phase II Consortium","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Sorafenib; Clinical endpoint; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Surrogate endpoint; Phases of clinical research; Ovarian cancer; Chemotherapy; Progression-free survival; Clinical trial; Cancer; Gastroenterology; Surgery; Hepatocellular carcinoma","score_opus":0.07201841788440105,"score_gpt":0.46034708735349583,"score_spread":0.3883286694690948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009513461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215126,0.00029799962,0.0000052771024,0.0055270656,0.00073711394,0.0009246291,0.00003724364,0.0000027824813,0.00031664156],"genre_scores_gemma":[0.9976878,0.0005181987,0.0007207638,0.0005445067,0.00035424804,0.000013561278,0.0000033237227,0.000019515248,0.00013808854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421996,0.0007457394,0.003908918,0.00029588837,0.0005585796,0.00027092185],"domain_scores_gemma":[0.99132794,0.0037473228,0.003455178,0.00032371248,0.00076813623,0.00037771947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063263085,0.00020903893,0.0022292777,0.00016551488,0.00003951118,0.000004017237,0.00013451398,0.00035528318,0.00018972752],"category_scores_gemma":[0.00281212,0.000104493454,0.00034993445,0.0003400131,0.0005552714,0.00006735137,0.000060258757,0.00080887694,6.458475e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45109487,0.012130012,0.4585902,0.000013274365,0.0005657249,0.00015541619,0.000054147706,0.0000028074608,0.0000042088395,0.00001962062,0.00019433259,0.07717541],"study_design_scores_gemma":[0.2647023,0.103339665,0.62596136,0.00038962232,0.000831249,0.000027514765,0.00003090598,0.000006627627,0.000041341755,0.000018862589,0.004583591,0.00006694485],"about_ca_topic_score_codex":0.00023785798,"about_ca_topic_score_gemma":0.00083652366,"teacher_disagreement_score":0.18639258,"about_ca_system_score_codex":0.00019224668,"about_ca_system_score_gemma":0.0025312041,"threshold_uncertainty_score":0.44902474},"labels":[],"label_agreement":null},{"id":"W3010986187","doi":"10.3390/cancers12030699","title":"The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice","year":2020,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Canada Foundation for Innovation","keywords":"Ovarian cancer; Serous fluid; Ascites; Multicellular organism; Cancer research; Pathology; Biology; Cancer; Ovary; Cancer stem cell; Disease; Medicine; Cell; Internal medicine; Endocrinology","score_opus":0.014357650391017348,"score_gpt":0.2444148975502578,"score_spread":0.23005724715924045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010986187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927951,0.0021256814,0.00005020069,0.0028000493,0.00030968213,0.0017029551,0.00015785948,0.000036158995,0.00002229217],"genre_scores_gemma":[0.9980007,0.00040956744,0.00048500087,0.00055331434,0.00012274379,0.00034776237,0.000021799624,0.000037303114,0.00002183253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847084,0.000059790324,0.0003467611,0.00043761465,0.00030276136,0.00038225012],"domain_scores_gemma":[0.99885726,0.00012624926,0.00018096995,0.00037491278,0.000095779775,0.0003648422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077382305,0.00028275696,0.00043946912,0.000043514534,0.00013142709,0.000029265366,0.00019663344,0.00005716815,0.000058472022],"category_scores_gemma":[0.000032374912,0.00016540538,0.00008414412,0.0003105164,0.00012967907,0.00006375395,0.00004650651,0.00024691242,0.0000018259406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038520895,0.0009843318,0.67906135,0.0023994236,0.002631571,0.005361059,0.031169485,0.070537075,0.13121027,0.0013614132,0.001325628,0.035437476],"study_design_scores_gemma":[0.013172958,0.0028400295,0.56108505,0.0019009744,0.00097033434,0.000054859855,0.0014981609,0.004868272,0.40888035,0.00023974082,0.0036681318,0.00082113687],"about_ca_topic_score_codex":0.011923065,"about_ca_topic_score_gemma":0.0052332887,"teacher_disagreement_score":0.27767012,"about_ca_system_score_codex":0.0009489187,"about_ca_system_score_gemma":0.0007624864,"threshold_uncertainty_score":0.9946566},"labels":[],"label_agreement":null},{"id":"W3011241573","doi":"","title":"Bazo metastásico de un adenocarcinoma de endometrio. Presentación de un caso","year":2020,"lang":"es","type":"article","venue":"Revista Habanera de Ciencias Médicas","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SNC-Lavalin (Canada)","funders":"","keywords":"Medicine; Metastasis; Endometrial cancer; Adenocarcinoma; Radiation therapy; Clear-cell adenocarcinoma; Clear cell carcinoma; Stage (stratigraphy); Chemotherapy; Gynecology; Cancer; General surgery; Surgery; Internal medicine","score_opus":0.030648007515698142,"score_gpt":0.28942349612768303,"score_spread":0.2587754886119849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011241573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83758694,0.13562728,0.0032241032,0.017134197,0.00021193617,0.0016387437,0.00037474104,0.00024676838,0.003955273],"genre_scores_gemma":[0.97055495,0.012336553,0.00573769,0.008829038,0.0017893027,0.00020378586,0.00006411208,0.00016269583,0.00032189745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932788,0.00090708456,0.0010448183,0.0014018778,0.0010970895,0.0022703037],"domain_scores_gemma":[0.99458367,0.0009929544,0.00039407966,0.0010976135,0.00021051269,0.0027211518],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016342513,0.00087182963,0.0015057494,0.00039114497,0.00049556006,0.0006087167,0.0008439396,0.00040377883,0.0024172529],"category_scores_gemma":[0.0026485806,0.0008201399,0.00078933075,0.0022700485,0.00039755506,0.00023789084,0.0003360781,0.0009844814,0.0004545633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033614828,0.0018200196,0.89729345,0.0014570629,0.0020264706,0.014389223,0.0035062516,0.00006583269,0.008129383,0.013103771,0.0143123185,0.043560043],"study_design_scores_gemma":[0.010711989,0.0029863906,0.6452299,0.001395447,0.0068761036,0.004088559,0.0008738557,0.0038464167,0.03754308,0.00019596699,0.284649,0.0016032786],"about_ca_topic_score_codex":0.00055451074,"about_ca_topic_score_gemma":0.0000075557177,"teacher_disagreement_score":0.2703367,"about_ca_system_score_codex":0.002528451,"about_ca_system_score_gemma":0.0030844102,"threshold_uncertainty_score":0.99942493},"labels":[],"label_agreement":null},{"id":"W3011510625","doi":"10.1200/jco.2013.31.15_suppl.5543","title":"Ovarian cancer distribution of histology, stage, and screening performance.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Serous fluid; Cancer; Clear cell; Oncology; Internal medicine; Stage (stratigraphy); Histology; Carcinosarcoma; Clear cell carcinoma; Gynecology; Pathology; Carcinoma","score_opus":0.12283551436261393,"score_gpt":0.4526101980851283,"score_spread":0.3297746837225144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011510625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814368,0.001315564,0.00029321,0.015305374,0.0006083387,0.00015712707,0.000009259668,0.0000033946123,0.00087095244],"genre_scores_gemma":[0.99221796,0.0036832124,0.0027246256,0.0006741642,0.00044517883,0.000009441026,0.0000041113167,0.0000064130227,0.0002348742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982137,0.000109824185,0.0012708514,0.00011231255,0.00015517701,0.00013809756],"domain_scores_gemma":[0.9976209,0.00053367886,0.0011451052,0.00010203235,0.0003728741,0.00022540022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089348224,0.00008199753,0.00092697534,0.00004807782,0.000028048331,0.000003949052,0.000053591986,0.00020690187,0.000522501],"category_scores_gemma":[0.00045410742,0.0000549904,0.0001696151,0.00006617008,0.00020558866,0.00010748872,0.00002832288,0.00038355534,0.000004357174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054680335,0.000509701,0.5822557,0.000035952267,0.0002867339,0.00004073872,0.000024966199,0.000010018763,0.000026502354,0.00016153548,0.004589161,0.41151217],"study_design_scores_gemma":[0.005483728,0.0057290155,0.9156822,0.00012315427,0.00032454092,0.000100590245,0.000041365784,0.0001942293,0.00008889815,0.00004788982,0.072141394,0.00004299771],"about_ca_topic_score_codex":0.00026026767,"about_ca_topic_score_gemma":0.000023977018,"teacher_disagreement_score":0.4114692,"about_ca_system_score_codex":0.00012743882,"about_ca_system_score_gemma":0.00060840714,"threshold_uncertainty_score":0.572102},"labels":[],"label_agreement":null},{"id":"W3012853140","doi":"10.1101/2020.03.19.20038786","title":"Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Sierra Oncology; NuCana; AstraZeneca","keywords":"PTEN; Cancer research; ARID1A; Wnt signaling pathway; Biology; Carcinoma; Internal medicine; Stage (stratigraphy); Gene; Oncology; Mutation; Bioinformatics; PI3K/AKT/mTOR pathway; Medicine; Genetics; Signal transduction","score_opus":0.10276695508232264,"score_gpt":0.37147213769587367,"score_spread":0.26870518261355103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012853140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253214,0.0014433941,0.0013413123,0.008342556,0.0011258816,0.0014813597,0.00016816026,0.00008829039,0.003476918],"genre_scores_gemma":[0.9952266,0.00025145878,0.0030999372,0.00044694231,0.00041779844,0.00016477298,0.00028146344,0.00005296936,0.00005801169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683666,0.00017195652,0.001346991,0.0008413856,0.0005703383,0.00023264196],"domain_scores_gemma":[0.9975,0.00020876974,0.00058075314,0.0011502996,0.0002052444,0.00035493402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052721595,0.0003360225,0.0011639952,0.00019901573,0.000024502893,0.000024616673,0.0002591739,0.0004044824,0.00017340358],"category_scores_gemma":[0.0007584841,0.00029275313,0.0005674867,0.0002980093,0.00010873881,0.000024162116,0.00024027393,0.0007236574,0.00004440003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001494902,0.00067169603,0.9896108,0.0007063616,0.0005997315,0.00035235513,0.00009644245,0.000015559814,0.000853493,0.0014665048,0.00028782312,0.0051897317],"study_design_scores_gemma":[0.0027294972,0.0006397852,0.9835322,0.00021164247,0.0010773856,0.000010862867,0.000016241982,0.00033221915,0.009653784,0.0005129141,0.0010866766,0.00019677782],"about_ca_topic_score_codex":0.00011784882,"about_ca_topic_score_gemma":0.000004682008,"teacher_disagreement_score":0.012694517,"about_ca_system_score_codex":0.00012109727,"about_ca_system_score_gemma":0.0005298689,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W3012991619","doi":"10.2217/cer-2020-0032","title":"Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy","year":2020,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Internal medicine; Serous fluid; Oncology; Cytotoxic T cell; Cancer; Retrospective cohort study","score_opus":0.12655509568559534,"score_gpt":0.4576220673763797,"score_spread":0.33106697169078436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012991619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987909,0.0020511467,0.00016724481,0.007328298,0.00011248306,0.0014246069,0.000040100538,0.000014854049,0.00095224526],"genre_scores_gemma":[0.9972524,0.0013977492,0.0006282472,0.000075417855,0.0004265806,0.00015444028,0.000006258337,0.00003695496,0.000021946105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959904,0.0015154113,0.00055319734,0.00035227326,0.0011777324,0.00041097304],"domain_scores_gemma":[0.9959173,0.001409843,0.00046756756,0.00022311388,0.0015322239,0.00044992616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011385097,0.00026204792,0.0013619342,0.00036630465,0.00014478265,0.000035488683,0.0001758013,0.000064438005,0.00008971953],"category_scores_gemma":[0.00006224576,0.00017401476,0.00017674443,0.0013476863,0.00019333324,0.00013311306,0.000037229252,0.0007712291,0.0000037342422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06998552,0.0052911006,0.8009052,0.0032763972,0.0065383026,0.0012240302,0.011363477,0.003424762,0.03233237,0.003200551,0.0016822711,0.060775984],"study_design_scores_gemma":[0.013152382,0.015758883,0.7780484,0.0052598873,0.00018653355,0.000045337536,0.00049651135,0.00042686498,0.18581635,0.000097056974,0.000500253,0.00021151759],"about_ca_topic_score_codex":0.0022608945,"about_ca_topic_score_gemma":0.00049635296,"teacher_disagreement_score":0.15348399,"about_ca_system_score_codex":0.0014569166,"about_ca_system_score_gemma":0.0011450829,"threshold_uncertainty_score":0.7096116},"labels":[],"label_agreement":null},{"id":"W3013133506","doi":"10.1385/1-59259-071-3:121","title":"Bioactive Interleukin-6 Levels in Serum and Ascites as a Prognostic Factor in Patients with Epithelial Ovarian Cancer","year":2003,"lang":"en","type":"article","venue":"Humana Press eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Ascites; Ovarian cancer; Medicine; Cytokine; Cancer; Chemotherapy; Internal medicine; Thrombocytosis; Interleukin; Gastroenterology; Oncology; Cancer research; Platelet","score_opus":0.03695005111243248,"score_gpt":0.2827043272466073,"score_spread":0.24575427613417483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013133506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267375,0.0005976642,0.0000038519943,0.000050923427,0.000077409335,0.0011912774,0.00008702699,0.000019105633,0.0052989703],"genre_scores_gemma":[0.9989165,0.000033340068,0.00012565876,0.0001476017,0.000028037426,0.0003358642,0.000004689934,0.000027945422,0.0003803601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888486,0.00006251631,0.00020788933,0.00037641305,0.00018703732,0.00028131503],"domain_scores_gemma":[0.9995233,0.000058370064,0.00007374204,0.00018692142,0.00005458811,0.000103071354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054829285,0.00020809077,0.0003130602,0.00014347365,0.000036653975,0.000036292415,0.000047311794,0.00006824789,0.00010870219],"category_scores_gemma":[0.000032131895,0.00015548695,0.000027623211,0.000037778304,0.0000737481,0.000066187495,0.00002620268,0.00016110812,0.0000024546646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003539329,0.00052487286,0.9621643,0.00009755062,0.00021769441,0.000107586806,0.0035475953,0.0000031803759,0.00002289529,0.0024144675,0.000014744856,0.030531218],"study_design_scores_gemma":[0.008278083,0.00066398317,0.9855851,0.0005805634,0.00008390862,0.0000029196167,0.000061927625,0.0000057704938,0.0028139562,0.00015543944,0.0015911626,0.00017717182],"about_ca_topic_score_codex":0.002030431,"about_ca_topic_score_gemma":0.0020750358,"teacher_disagreement_score":0.030354047,"about_ca_system_score_codex":0.00019895128,"about_ca_system_score_gemma":0.00011799553,"threshold_uncertainty_score":0.6340574},"labels":[],"label_agreement":null},{"id":"W3013389901","doi":"10.1155/2020/2134546","title":"Ovarian Mixed Malignant Brenner-Mucinous Tumor with Signet Ring Cells","year":2020,"lang":"en","type":"article","venue":"Case Reports in Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Signet ring cell; Medicine; Pathology; Ovary; Appendix; Stomach; Metastasis; Mucinous carcinoma; Adenocarcinoma; Cancer; Internal medicine; Biology","score_opus":0.01936671753681272,"score_gpt":0.24396647744779054,"score_spread":0.22459975991097783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013389901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401665,0.00047046904,0.00023897365,0.0017939414,0.00036217395,0.0006176822,0.000012595731,0.00007893059,0.0024085876],"genre_scores_gemma":[0.9954346,0.000028839813,0.0026166292,0.0014811938,0.000184997,0.00012240488,0.00002033029,0.00004119425,0.00006982395],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982033,0.00007259074,0.0005121793,0.0006844608,0.00014700774,0.00038045854],"domain_scores_gemma":[0.9989277,0.000055646833,0.00021787925,0.00046841116,0.000056049696,0.0002743143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021876315,0.00022978325,0.00055386376,0.00009144414,0.000050122133,0.000014216791,0.000028289705,0.0000817692,0.00018351378],"category_scores_gemma":[0.000059787668,0.0001755568,0.00007313919,0.00023158698,0.00008292864,0.000038739596,0.00005056902,0.00021067908,0.000020394733],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012010858,0.0003250158,0.03118277,0.000087566346,0.00005224149,0.9623049,0.0005507476,0.00009018726,0.0029582535,0.00008336879,0.00041771715,0.001827131],"study_design_scores_gemma":[0.0031766628,0.0019790835,0.022379903,0.00019362908,0.000317533,0.94121885,0.00038195428,0.00014883702,0.025457462,0.000059476853,0.0043541226,0.00033248222],"about_ca_topic_score_codex":0.00018710596,"about_ca_topic_score_gemma":0.00012007729,"teacher_disagreement_score":0.02249921,"about_ca_system_score_codex":0.00012034861,"about_ca_system_score_gemma":0.00020390551,"threshold_uncertainty_score":0.7158998},"labels":[],"label_agreement":null},{"id":"W3014016523","doi":"10.1097/pgp.0000000000000673","title":"Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Yolk sac; Endometriosis; Pathology; PAX8; Ovary; Clear cell carcinoma; Medicine; Biology; Carcinoma; Internal medicine; Embryo","score_opus":0.022759300754888648,"score_gpt":0.28601598225653996,"score_spread":0.2632566815016513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014016523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96450853,0.00013285183,0.00018015568,0.033495743,0.00047127754,0.0001433865,0.0000073231436,0.000004822791,0.0010559224],"genre_scores_gemma":[0.99274445,0.000045380526,0.0018028953,0.0052186665,0.00016715899,0.00000785886,0.0000013446102,0.0000058453916,0.0000064182395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874943,0.00011872516,0.0005785828,0.00012358066,0.0003065437,0.00012314948],"domain_scores_gemma":[0.998997,0.0002640401,0.0003396543,0.000081577986,0.00022579337,0.000091969065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019256704,0.00009106939,0.00036359942,0.000067121684,0.000013661769,0.000006932895,0.00027494674,0.000068869354,0.00045967603],"category_scores_gemma":[0.0011083648,0.00005193827,0.00019065222,0.00009796429,0.00012428944,0.00004216514,0.000099311445,0.00026831075,0.0000087662675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007950192,0.0012632356,0.960861,0.000019681514,0.00027559735,0.007182653,0.00059174217,0.00007016329,0.023451436,0.001665414,0.0004977309,0.003326289],"study_design_scores_gemma":[0.002666476,0.0011255239,0.9906799,0.000066353845,0.00005628016,0.0013529256,0.00009152031,0.00008770693,0.0023721303,0.0012905233,0.0001642602,0.00004636734],"about_ca_topic_score_codex":0.0000064597643,"about_ca_topic_score_gemma":0.000014975347,"teacher_disagreement_score":0.029818894,"about_ca_system_score_codex":0.00013135128,"about_ca_system_score_gemma":0.00012603484,"threshold_uncertainty_score":0.503313},"labels":[],"label_agreement":null},{"id":"W3014120220","doi":"10.1002/ijc.32999","title":"Serologic markers of <i>Chlamydia trachomatis</i> and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the <scp>EPIC</scp> cohort","year":2020,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"FP7 Ideas: European Research Council; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council Canada; Medical Research Council; Hellenic Health Foundation; Wereld Kanker Onderzoek Fonds; Institut Gustave-Roussy; Deutsche Krebshilfe; Mutuelle Générale de l'Education Nationale; Associazione Italiana per la Ricerca sul Cancro; Deutsches Krebsforschungszentrum; Ligue Contre le Cancer; Cancer Research Foundation in Northern Sweden; NordForsk; Vetenskapsrådet; Cancerfonden; Cancer Research UK; World Health Organization; European Commission; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Institut National de la Santé et de la Recherche Médicale; Kræftens Bekæmpelse; Centre International de Recherche sur le Cancer","keywords":"Chlamydia trachomatis; Mycoplasma genitalium; Serology; Medicine; Population; Chlamydia; Serous fluid; Relative risk; Endometrial cancer; Ovarian cancer; Immunology; Internal medicine; Gynecology; Cancer; Antibody; Confidence interval","score_opus":0.018122802977410434,"score_gpt":0.28716391005110764,"score_spread":0.2690411070736972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014120220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776329,0.0061124275,0.00027000665,0.013718375,0.00046167604,0.000255552,0.0010342797,0.000008537983,0.000506255],"genre_scores_gemma":[0.9877853,0.00800824,0.00019352882,0.0032769518,0.0006457143,0.000029865148,0.000007873254,0.000016384203,0.000036154786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864066,0.00008623094,0.0005311653,0.00019610493,0.00042714516,0.00011869616],"domain_scores_gemma":[0.998401,0.000517716,0.000534879,0.00009387556,0.00030055695,0.00015196772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024756836,0.00014617748,0.0003187945,0.00005516591,0.000046589277,0.00004012866,0.00012664373,0.00007264984,0.00017402142],"category_scores_gemma":[0.00018864116,0.00009491671,0.00010090778,0.000100922385,0.00011089366,0.00010214376,0.00002106966,0.0002725033,9.133323e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055668986,0.00013496174,0.96836317,0.000013457784,0.0031860853,0.000050524835,0.0017035974,0.00020740197,0.00072349934,0.00006173886,0.0025122352,0.02248663],"study_design_scores_gemma":[0.005419736,0.00027467855,0.9759748,0.00020266758,0.0008114424,0.000047730053,0.00016600515,0.00023217054,0.0011734687,0.00020226635,0.015455227,0.000039789982],"about_ca_topic_score_codex":0.0043856264,"about_ca_topic_score_gemma":0.0013846612,"teacher_disagreement_score":0.022446841,"about_ca_system_score_codex":0.00012337179,"about_ca_system_score_gemma":0.00021728793,"threshold_uncertainty_score":0.6629785},"labels":[],"label_agreement":null},{"id":"W3014455410","doi":"10.1016/j.ygyno.2020.06.025","title":"Avelumab in combination with and/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: Results from the phase 3 javelin ovarian 100 trial","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Javelin; Medicine; Avelumab; Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.02442599975128795,"score_gpt":0.30343557135918664,"score_spread":0.2790095716078987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014455410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94656295,0.00012415108,0.000037524158,0.048240546,0.00020707936,0.0044283555,0.00012959848,0.000060398073,0.00020942226],"genre_scores_gemma":[0.98927903,0.00045729714,0.0012856852,0.007667229,0.00021543584,0.00063347066,0.00036477146,0.000046889134,0.000050204904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736005,0.0003455519,0.00068258494,0.0008180339,0.00029663267,0.00049716706],"domain_scores_gemma":[0.99825734,0.0007876989,0.0003558056,0.00032852692,0.00008642999,0.00018420604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044014465,0.00038523824,0.001072865,0.00010208221,0.00010883566,0.000035920417,0.0001706563,0.00031450292,0.00041886838],"category_scores_gemma":[0.00026633823,0.00021679541,0.00007380886,0.00059892697,0.0001297344,0.00010251544,0.000035743065,0.00039422995,0.000007452326],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52891105,0.007704665,0.28625774,0.000019917881,0.0007113917,0.0005343147,0.005785251,0.00003767642,0.000035686757,0.00004043348,0.0005424013,0.16941944],"study_design_scores_gemma":[0.5155744,0.032114137,0.44723877,0.0001092007,0.00021665377,0.0000030552885,0.00015278057,0.0002480997,0.00012612862,0.00005209151,0.003944055,0.00022061125],"about_ca_topic_score_codex":0.0032755095,"about_ca_topic_score_gemma":0.005855232,"teacher_disagreement_score":0.16919883,"about_ca_system_score_codex":0.0008906549,"about_ca_system_score_gemma":0.00083626184,"threshold_uncertainty_score":0.884066},"labels":[],"label_agreement":null},{"id":"W3015982356","doi":"10.1111/1471-0528.16264","title":"Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data","year":2020,"lang":"en","type":"article","venue":"BJOG An International Journal of Obstetrics & Gynaecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Sierra Oncology; NuCana; Nicola Murray Foundation; AstraZeneca","keywords":"Medicine; Debulking; Internal medicine; Serous fluid; Stage (stratigraphy); Gastroenterology; Ovarian cancer; Incidence (geometry); Survival analysis; Overall survival; Prospective cohort study; Oncology; Cancer; Surgery","score_opus":0.06217273671002972,"score_gpt":0.35816879370577503,"score_spread":0.2959960569957453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015982356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627936,0.0004991588,0.00004536901,0.00085576327,0.0013879486,0.00022981215,0.0006315265,0.00000371453,0.000067352616],"genre_scores_gemma":[0.9978407,0.0006125197,0.0009568624,0.00039160714,0.00012367088,0.0000057923303,0.000047645623,0.000011174433,0.000010042318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833083,0.00009428174,0.0008307594,0.00023620864,0.00038530672,0.00012262442],"domain_scores_gemma":[0.9978638,0.0005543682,0.00072511256,0.00014337795,0.0005905419,0.00012278596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020650377,0.00010773374,0.0005355081,0.0003035453,0.000010954416,0.000011547547,0.00035561898,0.00011769849,0.00025378243],"category_scores_gemma":[0.0028816685,0.000090387955,0.00007191498,0.00024953534,0.000058961883,0.00014074838,0.00014548244,0.00026666638,5.6212264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044527597,0.0012465423,0.9719573,0.0000246285,0.00019405641,0.0004777914,0.00047666134,0.000018015293,0.00005588354,0.00017042692,0.0000736324,0.024859749],"study_design_scores_gemma":[0.007764831,0.00240772,0.98904514,0.000030716976,0.000117554904,0.000032378863,0.000082155784,0.000052297222,0.00013910343,0.000052330717,0.00021065239,0.00006509133],"about_ca_topic_score_codex":0.00009075801,"about_ca_topic_score_gemma":0.000042121676,"teacher_disagreement_score":0.024794657,"about_ca_system_score_codex":0.00023817019,"about_ca_system_score_gemma":0.0002514657,"threshold_uncertainty_score":0.36859137},"labels":[],"label_agreement":null},{"id":"W3016400061","doi":"10.1148/radiol.2020200437","title":"Solid Hypoechoic Adnexal Lesions with Acoustic Shadowing Warrant an MRI Recommendation in the O-RADS Risk Stratification and Management System","year":2020,"lang":"en","type":"letter","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Risk stratification; Warrant; Stratification (seeds); Radiology; Medical physics; Internal medicine","score_opus":0.028243440859614204,"score_gpt":0.2918794208376092,"score_spread":0.263635979977995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016400061","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014686676,0.0006397542,0.006814494,0.97241616,0.0005404265,0.0035401296,0.0001492247,0.00013337248,0.0010797608],"genre_scores_gemma":[0.8829227,0.002134156,0.0014481694,0.10908514,0.0016193539,0.00075722026,0.0019388576,0.000053710595,0.00004068101],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820507,0.00044133505,0.00034566477,0.00059046637,0.00015260318,0.00026485414],"domain_scores_gemma":[0.9991383,0.00016865638,0.00020009684,0.0004086278,0.00002483456,0.000059502956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000245996,0.00026469148,0.0005053346,0.00014769203,0.00013312539,0.000037098023,0.00012027573,0.00026215694,0.0000233823],"category_scores_gemma":[0.000010637242,0.00016595605,0.000048697035,0.00014400748,0.000063649,0.000053371015,0.000019215646,0.0007889596,0.000011392387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007732164,0.00075642,0.034787484,0.0052366583,0.0031551872,0.009133901,0.0055187214,0.0004889768,0.00015801178,0.0012382843,0.8705561,0.068197034],"study_design_scores_gemma":[0.01974854,0.012208068,0.4060862,0.00515968,0.01434387,0.006720248,0.008796298,0.022865392,0.00007027478,0.0003942658,0.5013719,0.0022352443],"about_ca_topic_score_codex":0.00015806488,"about_ca_topic_score_gemma":0.00012165237,"teacher_disagreement_score":0.868236,"about_ca_system_score_codex":0.00029197967,"about_ca_system_score_gemma":0.00007612179,"threshold_uncertainty_score":0.6767491},"labels":[],"label_agreement":null},{"id":"W3017921583","doi":"10.1111/his.14123","title":"Somatic tumour testing establishes that bilateral <i>DICER1</i>‐associated ovarian Sertoli–Leydig cell tumours represent independent primary neoplasms","year":2020,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Germline; Germline mutation; Context (archaeology); Somatic cell; Ovary; Metastasis; Pathology; Germ cell; Biology; Medicine; Mutation; Internal medicine; Cancer; Genetics; Gene","score_opus":0.04036553417043684,"score_gpt":0.23669733155395845,"score_spread":0.1963317973835216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017921583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668309,0.0010812436,0.00010709842,0.011649531,0.00075596484,0.0008962612,0.000044425407,0.0004044152,0.01823013],"genre_scores_gemma":[0.9916222,0.00006712965,0.002195562,0.004739303,0.00030640006,0.00014315224,0.00015014334,0.00009029988,0.00068577495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969637,0.00022623503,0.00062319415,0.00095834496,0.0005039389,0.0007246036],"domain_scores_gemma":[0.99817085,0.0002510251,0.00041194534,0.0005182013,0.00014161764,0.00050637603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030245143,0.00044267936,0.0009450025,0.0001561123,0.00020598096,0.00006817355,0.00024325558,0.00024866962,0.00025163594],"category_scores_gemma":[0.0003589745,0.00039995436,0.00021149039,0.0004330306,0.00012526852,0.00018082958,0.00020165446,0.00051864627,0.00019107357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025291747,0.0010512578,0.9579755,0.00035251077,0.000037528443,0.00815182,0.0028165502,0.00009616053,0.022183048,0.00004290736,0.006055531,0.0009842836],"study_design_scores_gemma":[0.0046010823,0.0010100175,0.98456436,0.00019096602,0.00053768023,0.00088637834,0.00020904391,0.00044144137,0.0048801075,0.0001368288,0.0021252928,0.0004167875],"about_ca_topic_score_codex":0.00035213807,"about_ca_topic_score_gemma":0.000044648383,"teacher_disagreement_score":0.026588889,"about_ca_system_score_codex":0.0007258994,"about_ca_system_score_gemma":0.00046056713,"threshold_uncertainty_score":0.9998452},"labels":[],"label_agreement":null},{"id":"W3018715551","doi":"10.25259/jcis_1_2020","title":"Radiographic Features of a Benign Mixed Brenner Tumor and Mucinous Cystadenoma: A Rarely Identified Ovarian Neoplasm on Imaging","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Imaging Science","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mucinous cystadenoma; Medicine; Ovarian tumor; Mucinous Tumor; Cystadenoma; Neoplasm; Pathology; Skin tumor; Radiology; Ovary; Ovarian cancer; Internal medicine; Cancer","score_opus":0.037037131564274926,"score_gpt":0.35313365905508853,"score_spread":0.31609652749081363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018715551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96317196,0.0021269426,0.00026757037,0.0324101,0.0009166351,0.00023530779,0.0000086925,0.000020333526,0.0008424438],"genre_scores_gemma":[0.99216783,0.00018574377,0.003771356,0.0034250135,0.0004134359,0.0000021006067,5.4203747e-7,0.000016143433,0.000017812818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970591,0.00010800125,0.0012111363,0.00046118005,0.0008388203,0.0003217698],"domain_scores_gemma":[0.9972212,0.00056944735,0.0009071248,0.00026710393,0.00037497183,0.0006602003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019418017,0.00018991687,0.0008109534,0.00034684525,0.00013559916,0.00014488853,0.00031321266,0.000030962416,0.000018886281],"category_scores_gemma":[0.0014481354,0.00013555962,0.00035605393,0.00063284574,0.0008764662,0.00037198918,0.00008135147,0.0005527906,0.0000035192413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016903374,0.0012843081,0.8660885,0.00016719615,0.00030106414,0.0040814118,0.0011701352,0.000038488895,0.0087348325,0.00088289,0.008356797,0.10720403],"study_design_scores_gemma":[0.0059779575,0.0008969766,0.98625135,0.0005149951,0.00036693734,0.0014783853,0.0002501765,0.00080164487,0.0022043989,0.00031174,0.0007911239,0.00015431312],"about_ca_topic_score_codex":0.000039572802,"about_ca_topic_score_gemma":0.0000022932684,"teacher_disagreement_score":0.12016284,"about_ca_system_score_codex":0.000045330376,"about_ca_system_score_gemma":0.0005910068,"threshold_uncertainty_score":0.5527961},"labels":[],"label_agreement":null},{"id":"W3018993710","doi":"10.3390/cancers12051090","title":"Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla—Site of Origin of Serous Carcinoma of the Ovary","year":2020,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; University of Miami","keywords":"Fallopian tube; Fimbria; Biology; Ovulation; Ovary; Follicular phase; Ampulla; Ovarian cancer; Serous carcinoma; Transcriptome; Oviduct; Internal medicine; Endocrinology; Medicine; Anatomy; Gene; Cancer; Genetics; Gene expression","score_opus":0.053138699477850514,"score_gpt":0.32120103082179335,"score_spread":0.26806233134394286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018993710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956171,0.0018006227,0.00000751834,0.0010976039,0.00008941828,0.0003524836,0.00016440029,0.0000037410884,0.000867099],"genre_scores_gemma":[0.99943256,0.00013533952,0.000058022146,0.00023864252,0.000036039626,0.000012479737,0.000004900818,0.000010561776,0.00007145003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916637,0.0000526997,0.0003156485,0.00016799752,0.00020104606,0.000096238815],"domain_scores_gemma":[0.99930274,0.000037534963,0.00021810325,0.00027355607,0.000110649096,0.00005740636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004740505,0.00012426598,0.0004640658,0.00003398915,0.000028628814,0.0000020486066,0.0001143339,0.000041527335,0.00005997477],"category_scores_gemma":[0.000019610912,0.00006582278,0.0001899333,0.00033933975,0.00029977725,0.000025017895,0.000026868027,0.00009775851,1.2075182e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024589524,0.000074554184,0.8312447,0.0006724972,0.0008098469,0.000004827227,0.011223957,0.00018005486,0.15268032,0.00082142366,0.0010348681,0.0010070592],"study_design_scores_gemma":[0.002005362,0.0005771281,0.74132043,0.0004812825,0.00070597575,0.0000025683742,0.0011549108,0.00009859204,0.25298285,0.000037219903,0.0005633212,0.00007035745],"about_ca_topic_score_codex":0.0042223595,"about_ca_topic_score_gemma":0.0004421499,"teacher_disagreement_score":0.10030253,"about_ca_system_score_codex":0.00016110034,"about_ca_system_score_gemma":0.00036083377,"threshold_uncertainty_score":0.6382973},"labels":[],"label_agreement":null},{"id":"W3021307559","doi":"10.1002/cjp2.168","title":"Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma","year":2020,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; Alberta Health Services; Foothills Medical Centre; Alberta Cancer Foundation; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Université de Montréal; Alberta Cancer Foundation; Terry Fox Research Institute; Calgary Laboratory Services","keywords":"Serous fluid; Internal medicine; Immunohistochemistry; Ovarian cancer; Serous carcinoma; Ovarian carcinoma; Oncology; Medicine; Biology; Cancer","score_opus":0.32325887744619347,"score_gpt":0.46224931814199943,"score_spread":0.13899044069580596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021307559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9201337,0.00017600179,0.000060663886,0.07906563,0.000067659435,0.00039507044,0.000031196054,0.0000075063963,0.000062563326],"genre_scores_gemma":[0.9970913,0.00046473922,0.00040321285,0.0017507211,0.00015365474,0.000010262556,0.000012048553,0.000019722427,0.00009431859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960434,0.0016200192,0.0009713949,0.0002881985,0.0006887128,0.00038826175],"domain_scores_gemma":[0.99535775,0.003111076,0.00039519477,0.00032967379,0.00044870342,0.00035759504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052506197,0.00015159504,0.00072741625,0.00014351623,0.00013487908,0.00002618639,0.0002441738,0.00023912499,0.00010276591],"category_scores_gemma":[0.0027939717,0.00008450074,0.00008526316,0.00043767903,0.00037132038,0.00008075185,0.00011729406,0.001642865,0.000018247356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038188535,0.0011085332,0.9865071,0.00003492839,0.00016927549,0.0015429033,0.0007443719,0.000009956273,0.0015096037,0.00034461467,0.0027834056,0.0014264414],"study_design_scores_gemma":[0.011738079,0.005745636,0.9799456,0.00026093356,0.0001382152,0.00016856226,0.00023411258,0.00009213609,0.0006123023,0.00090697897,0.00007715675,0.00008026145],"about_ca_topic_score_codex":0.00017907139,"about_ca_topic_score_gemma":0.000026001058,"teacher_disagreement_score":0.077314906,"about_ca_system_score_codex":0.00016461586,"about_ca_system_score_gemma":0.00033003592,"threshold_uncertainty_score":0.7137522},"labels":[],"label_agreement":null},{"id":"W3022180314","doi":"10.1016/j.ygyno.2020.03.034","title":"Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Cochrane Library; Cohort study; Hyperthermic intraperitoneal chemotherapy; Perioperative; Meta-analysis; Internal medicine; Cohort; Surgery; Ovarian cancer; Oncology; Cancer; Cytoreductive surgery","score_opus":0.10950800586543047,"score_gpt":0.3990603436107306,"score_spread":0.28955233774530015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022180314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012645584,0.97262007,0.000010938692,0.013184599,0.00040089272,0.012631056,0.0008313718,0.00010731828,0.00008732604],"genre_scores_gemma":[0.00019205816,0.97270447,0.0009791235,0.0076583424,0.0001420015,0.017483294,0.0004711801,0.000080336555,0.0002892203],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942569,0.0012363407,0.0019891635,0.0015582159,0.00029144424,0.0006678969],"domain_scores_gemma":[0.99101216,0.006253198,0.0015507505,0.00062202895,0.00014251379,0.0004193569],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014748482,0.0011250123,0.028137607,0.0003495553,0.00025791657,0.000039680177,0.00020756926,0.00092795695,0.0005845392],"category_scores_gemma":[0.00088755134,0.00067291,0.005535105,0.0007959626,0.00023393652,0.00007062679,0.00020347214,0.00047006292,0.000010943504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087404274,0.00059911306,0.00038880558,0.49454924,0.44610214,0.00059304154,0.000083183164,2.3763043e-7,6.37868e-7,0.000024467005,0.0011868572,0.056384858],"study_design_scores_gemma":[0.0012255325,0.0010511372,0.0007909756,0.004136175,0.82859135,0.0001867133,0.00001632766,0.0000015156579,8.545726e-7,0.000020844202,0.16347922,0.0004993823],"about_ca_topic_score_codex":0.00015555794,"about_ca_topic_score_gemma":0.00019114427,"teacher_disagreement_score":0.49041307,"about_ca_system_score_codex":0.0032136806,"about_ca_system_score_gemma":0.0016488486,"threshold_uncertainty_score":0.9995722},"labels":[],"label_agreement":null},{"id":"W3022552435","doi":"10.1016/j.jogc.2020.04.008","title":"Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"University of Manitoba","keywords":"Medicine; Serous fluid; Debulking; Chemotherapy; Oncology; Internal medicine; Ovarian cancer; Retrospective cohort study; Cancer; Gynecology","score_opus":0.02122191441034232,"score_gpt":0.27610759065035506,"score_spread":0.25488567624001274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022552435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387333,0.0020613072,0.000083309846,0.056307785,0.0024887358,0.00024679123,0.00003559641,0.0000023814164,0.000040818417],"genre_scores_gemma":[0.98457503,0.00043218047,0.0015943956,0.01322326,0.00007637648,0.000009618044,9.4782604e-7,0.00001611135,0.00007204941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998942,0.000048610927,0.0004089994,0.00016714713,0.00021196167,0.00022125877],"domain_scores_gemma":[0.9984794,0.00065128127,0.00017233385,0.00008872301,0.0001691699,0.00043907485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002019748,0.00013082848,0.00045961567,0.00017272502,0.000034347548,0.000011699862,0.00008077744,0.00008352275,0.00037002837],"category_scores_gemma":[0.0012540959,0.00010497061,0.00004991353,0.000452636,0.000018944333,0.000029710898,0.000022004222,0.00024413413,0.0000012143356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014676988,0.0006411021,0.6582313,0.00007476587,0.0005114904,0.018485278,0.0016873364,0.0007711894,0.001116043,0.000017370665,0.006596829,0.3103996],"study_design_scores_gemma":[0.013290601,0.0015943062,0.9513376,0.000017576707,0.00006811258,0.000031073196,0.00013310355,0.00027067724,0.0005446979,0.0000038033468,0.032601077,0.00010737589],"about_ca_topic_score_codex":0.023287067,"about_ca_topic_score_gemma":0.041128535,"teacher_disagreement_score":0.3102922,"about_ca_system_score_codex":0.0012263895,"about_ca_system_score_gemma":0.0021019957,"threshold_uncertainty_score":0.98321694},"labels":[],"label_agreement":null},{"id":"W3022636907","doi":"10.1101/2020.04.29.20084095","title":"Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Foothills Medical Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; Queen's University; Alberta Health Services; University Health Network","funders":"Medical Research Council","keywords":"Endometrial cancer; Ovarian cancer; Genome-wide association study; Serous fluid; Biology; Cancer; Oncology; Genetic association; Internal medicine; Genetics; Single-nucleotide polymorphism; Gene; Medicine; Genotype","score_opus":0.029189222651567693,"score_gpt":0.3071060812051455,"score_spread":0.2779168585535778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022636907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97692364,0.010556833,0.00004619711,0.0009997506,0.0013755215,0.002926417,0.0070463377,0.000063972715,0.00006130338],"genre_scores_gemma":[0.9450382,0.05176991,0.00011638875,0.0000954614,0.00075167196,0.0016714871,0.000081441176,0.00011489695,0.0003605475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952529,0.00047288576,0.001255607,0.0012361914,0.0012526403,0.0005297619],"domain_scores_gemma":[0.99362123,0.00096209784,0.003589917,0.0007415643,0.0007862879,0.0002989201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008068008,0.00065155013,0.0020145357,0.00039055306,0.00021329099,0.00009172398,0.00029860414,0.000436478,0.0003562481],"category_scores_gemma":[0.001602463,0.00054138585,0.00033438366,0.0008298676,0.00023061327,0.00008280412,0.00030164575,0.0009725263,0.0000016012608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012073575,0.00076976285,0.9755537,0.00031204044,0.012281976,0.000045652705,0.0032201915,0.00455594,0.00019588594,0.0000021413773,0.00024501147,0.0016103694],"study_design_scores_gemma":[0.013513015,0.0010112369,0.9724694,0.0009643289,0.010003063,5.444775e-7,0.00019007291,0.00016608824,0.00087924005,0.000102703816,0.00027368838,0.00042661664],"about_ca_topic_score_codex":0.1289214,"about_ca_topic_score_gemma":0.04396408,"teacher_disagreement_score":0.08495732,"about_ca_system_score_codex":0.0023475222,"about_ca_system_score_gemma":0.0018521562,"threshold_uncertainty_score":0.99970376},"labels":[],"label_agreement":null},{"id":"W3022742848","doi":"10.1016/j.humpath.2020.02.006","title":"Proteomic analysis of transitional cell carcinoma–like variant of tubo-ovarian high-grade serous carcinoma","year":2020,"lang":"en","type":"article","venue":"Human Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Centre for Advancing Health Outcomes; Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Terry Fox Foundation; Cancer Research UK; Memorial Sloan-Kettering Cancer Center","keywords":"Biology; Serous carcinoma; Proteomics; Proteome; Ovarian carcinoma; Serous fluid; Immunohistochemistry; Clear cell carcinoma; Tissue microarray; Cancer research; Pathology; Ovarian cancer; Carcinoma; Cancer; Bioinformatics; Medicine; Immunology; Genetics","score_opus":0.026983444643346274,"score_gpt":0.2547649450757206,"score_spread":0.22778150043237433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022742848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957777,0.00018523424,0.0004418933,0.0019950343,0.00006601882,0.0005420457,0.00034955144,0.00002564947,0.0006168361],"genre_scores_gemma":[0.9970917,0.000008776872,0.0016854068,0.0005694283,0.00012285633,0.000078852565,0.00036273315,0.00002843354,0.000051791354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827284,0.00013072173,0.0005758541,0.00050540885,0.00024762194,0.00026754086],"domain_scores_gemma":[0.9990126,0.000037507743,0.00023857506,0.00041675064,0.00011513295,0.00017945736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012120474,0.0002256674,0.0009780264,0.00029360788,0.000058197398,0.000004483671,0.00012585154,0.00015587125,0.0009478884],"category_scores_gemma":[0.000008234826,0.0002059248,0.00035218566,0.00052443094,0.00015998438,0.000032618726,0.000035871224,0.00017285718,0.000011768882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007832686,0.0030986757,0.65870607,0.0008931284,0.0022947146,0.005681857,0.0072773686,0.00048065672,0.30945483,0.010117093,0.00087266974,0.0003396464],"study_design_scores_gemma":[0.004680154,0.0016295358,0.95454776,0.00002057245,0.0042603356,0.00009149715,0.00008694833,0.00024594076,0.034085676,0.0001350145,0.000051028175,0.00016552025],"about_ca_topic_score_codex":0.000535391,"about_ca_topic_score_gemma":0.000048485563,"teacher_disagreement_score":0.2958417,"about_ca_system_score_codex":0.000074206335,"about_ca_system_score_gemma":0.0001540343,"threshold_uncertainty_score":0.99996537},"labels":[],"label_agreement":null},{"id":"W3023262526","doi":"10.1016/s1701-2163(16)35457-3","title":"In Response","year":2012,"lang":"en","type":"letter","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region; University of Saskatchewan","funders":"","keywords":"Medicine; Gynecology; Tubal ligation; Salpingectomy; Obstetrics and gynaecology; Fallopian tube; Gynecologic oncology; Population; Family medicine; Demographics; Serous fluid; Serous carcinoma; Obstetrics; Ovarian cancer; Oncology; Cancer; Family planning; Pregnancy; Demography; Research methodology; Internal medicine; Environmental health","score_opus":0.015914117424347007,"score_gpt":0.24851262042607955,"score_spread":0.23259850300173254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023262526","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.070101395,0.035200845,7.7189213e-7,0.8691965,0.024495175,0.00020944861,0.000039704293,0.0000016483382,0.0007545628],"genre_scores_gemma":[0.3709649,0.00088748045,0.00021229217,0.6253788,0.000805725,0.0000075115563,0.000010629535,0.000035545043,0.0016971171],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986296,0.000111244946,0.0004907296,0.00012787932,0.00033015956,0.00031038586],"domain_scores_gemma":[0.99580157,0.0033272419,0.00040586633,0.00014532889,0.00016229055,0.00015771129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003113365,0.0001724616,0.0006612158,0.0004678678,0.000024666513,0.00000997905,0.000076332726,0.00044302674,0.00096737675],"category_scores_gemma":[0.0016596754,0.00013386185,0.00007961779,0.00022716209,0.000033945867,0.000041607527,0.000023684406,0.0013485705,0.0000016403084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002114147,0.000061997496,0.057569012,0.00006407886,0.00017515029,0.06897109,0.00002721455,6.304304e-7,4.9143927e-7,0.000003744341,0.8650148,0.008090633],"study_design_scores_gemma":[0.0018864811,0.00034366493,0.27545375,0.000016296173,0.00018821984,0.0003348976,0.000011967522,4.823225e-7,0.0000035822845,0.000016100263,0.72166544,0.00007913612],"about_ca_topic_score_codex":0.012758285,"about_ca_topic_score_gemma":0.008640847,"teacher_disagreement_score":0.3008635,"about_ca_system_score_codex":0.0030794495,"about_ca_system_score_gemma":0.0039790925,"threshold_uncertainty_score":0.9999459},"labels":[],"label_agreement":null},{"id":"W3023744054","doi":"10.1016/s1701-2163(15)30906-3","title":"It Sounded Like a Good Idea at the Time","year":2013,"lang":"en","type":"letter","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.011701665266435138,"score_gpt":0.22277663596473823,"score_spread":0.2110749706983031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023744054","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008118046,0.020114457,0.0000011028168,0.9508456,0.013729994,0.00044104585,0.000082973915,0.000004074006,0.0066627036],"genre_scores_gemma":[0.02159616,0.0013157522,0.00010906275,0.9422395,0.00096824806,0.000026603235,0.00006256871,0.000060632094,0.03362145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808365,0.00008555046,0.0006117564,0.00023098495,0.000596058,0.00039202112],"domain_scores_gemma":[0.9948784,0.0034806058,0.0007543415,0.00031357355,0.00037485745,0.00019823453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017264814,0.000289495,0.00081793894,0.00019517486,0.0001587685,0.0000486361,0.00019142208,0.00050226355,0.006245553],"category_scores_gemma":[0.0006706629,0.00017112237,0.0001885815,0.0002121013,0.000097942655,0.000035549583,0.00008556444,0.0013855912,0.000033788387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027085132,0.000038432674,0.0052417456,0.0000551301,0.00078236003,0.011736754,0.000028015433,0.0000014971112,5.540687e-7,0.0000039984607,0.97426087,0.00784791],"study_design_scores_gemma":[0.0021134575,0.00053691573,0.029380439,0.000022578031,0.0008557328,0.0006503295,0.00002024136,0.0000066335724,0.0000039748784,0.00005129808,0.96620744,0.00015096138],"about_ca_topic_score_codex":0.01516974,"about_ca_topic_score_gemma":0.017851254,"teacher_disagreement_score":0.026958745,"about_ca_system_score_codex":0.0034518638,"about_ca_system_score_gemma":0.0032243172,"threshold_uncertainty_score":0.99614185},"labels":[],"label_agreement":null},{"id":"W3025666123","doi":"10.1016/j.jogc.2020.02.065","title":"Pediatric ovarian torsion: A diagnosis with a twist","year":2020,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ovarian torsion; Ultrasound; Emergency department; Diagnostic accuracy; Radiology; Retrospective cohort study; Laparoscopy; Appendicitis; Gynecology; General surgery; Obstetrics; Surgery","score_opus":0.0135724467075624,"score_gpt":0.21745032891085406,"score_spread":0.20387788220329167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025666123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608033,0.014445977,0.0000338364,0.020461848,0.002949491,0.00025049222,0.000022751377,0.0000065476843,0.0010258121],"genre_scores_gemma":[0.99472547,0.0009867987,0.0008871061,0.0032029299,0.00015596948,0.000008336729,0.0000018181339,0.00001248359,0.00001909718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990241,0.000023751054,0.00030987026,0.00014794877,0.00029392037,0.00020043798],"domain_scores_gemma":[0.9982694,0.0006558459,0.00025768517,0.00008386103,0.00024633363,0.0004869034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000721212,0.00012462155,0.0003961085,0.00010497629,0.000075692435,0.000017622795,0.00006398823,0.00006474753,0.00061668095],"category_scores_gemma":[0.00089970086,0.00008536413,0.0000526441,0.000459145,0.000024660068,0.000043000295,0.000025414984,0.00022390865,0.0000010870992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002091864,0.000129754,0.9598586,0.00006207216,0.0001923436,0.009845348,0.00012551699,0.000010464888,4.213805e-7,0.00008206655,0.012898728,0.016773771],"study_design_scores_gemma":[0.0056456253,0.0029874048,0.9186813,0.00000831186,0.00068427605,0.00019392067,0.00020721984,0.000022275164,0.000033510143,0.000010824987,0.0714002,0.00012510552],"about_ca_topic_score_codex":0.0056902464,"about_ca_topic_score_gemma":0.008055167,"teacher_disagreement_score":0.05850148,"about_ca_system_score_codex":0.0006020903,"about_ca_system_score_gemma":0.0022101959,"threshold_uncertainty_score":0.86019886},"labels":[],"label_agreement":null},{"id":"W3025755455","doi":"10.3390/cancers12051250","title":"A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids","year":2020,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; Western University","funders":"London Health Sciences Foundation; Canadian Institutes of Health Research; Government of Ontario; Ontario Genomics; Genome Canada","keywords":"Spheroid; Fibronectin; Cancer research; Chemistry; Metastasis; Ovarian cancer; Anoikis; Cell biology; Focal adhesion; Biology; Cell; Cell culture; Molecular biology; Phosphorylation; Cancer; Biochemistry; Genetics","score_opus":0.04496317168643211,"score_gpt":0.3067401723616154,"score_spread":0.2617770006751833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025755455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791953,0.001901466,0.00074438704,0.014920199,0.00028523788,0.0023614273,0.00006561947,0.00003528996,0.00049108],"genre_scores_gemma":[0.99155265,0.000108686625,0.007217504,0.00021897083,0.00023497711,0.0005854472,0.000021886226,0.000024297058,0.000035594607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897873,0.000017648377,0.00031337453,0.00036014226,0.00013793101,0.00019217512],"domain_scores_gemma":[0.9995789,0.000026058293,0.00013910278,0.00013752362,0.00006633854,0.000052108222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012330372,0.00012183677,0.00032903987,0.000048939342,0.000021935737,0.0000060980974,0.000038718248,0.000054161024,0.0000869284],"category_scores_gemma":[0.00010868387,0.000115986564,0.00006590592,0.00048286372,0.000026292557,0.0001261403,0.000011864525,0.00008519278,7.8245483e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004672253,0.0008885553,0.22543515,0.0036179377,0.00087833154,0.00001502174,0.051023852,0.08114332,0.34612378,0.0014510653,0.0029875159,0.28176323],"study_design_scores_gemma":[0.018616393,0.0016512335,0.3195451,0.0025080694,0.00055507367,0.000010577766,0.0034644944,0.017355595,0.62559414,0.0006285246,0.009545796,0.0005250163],"about_ca_topic_score_codex":0.004789591,"about_ca_topic_score_gemma":0.0018945548,"teacher_disagreement_score":0.2812382,"about_ca_system_score_codex":0.0014020267,"about_ca_system_score_gemma":0.00052518485,"threshold_uncertainty_score":0.72404605},"labels":[],"label_agreement":null},{"id":"W3025767973","doi":"10.1016/j.jogc.2020.04.014","title":"Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Israel Cancer Research Fund","keywords":"Medicine; Debulking; Ovarian cancer; Serous fluid; Surgery; Chemotherapy; Proportional hazards model; Oncology; Internal medicine; Cancer","score_opus":0.022660980969791373,"score_gpt":0.23997957568110417,"score_spread":0.2173185947113128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025767973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420893,0.0014914529,0.000007521599,0.0017598532,0.0022859217,0.00019678115,0.00002554209,0.0000031752415,0.000020806496],"genre_scores_gemma":[0.99417996,0.0006111684,0.00057808275,0.004505308,0.00007734227,0.0000030191507,0.000007051184,0.000027701186,0.000010334479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985896,0.000056724322,0.00045748323,0.00020064374,0.00041261947,0.00028292768],"domain_scores_gemma":[0.99828345,0.00085965445,0.0003748756,0.00009196544,0.00011696384,0.00027308436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001310114,0.0001743589,0.00069630647,0.00017119343,0.00004703563,0.00002101299,0.00006313735,0.00009432328,0.00036186064],"category_scores_gemma":[0.00029967877,0.00012653777,0.000059368664,0.0003865412,0.000030672833,0.00007849039,0.000022001374,0.00029814412,8.452202e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020599361,0.00019853517,0.9724464,0.000055691282,0.00031278754,0.0051254365,0.00012114128,0.00023279455,0.000010059927,0.0000039558026,0.0010887715,0.020198463],"study_design_scores_gemma":[0.0104766255,0.00053296704,0.9862564,0.00004819844,0.00014974129,0.000012620017,0.00002960597,0.000064318534,0.000027012338,0.0000049261594,0.0022599413,0.00013763967],"about_ca_topic_score_codex":0.03244684,"about_ca_topic_score_gemma":0.022041818,"teacher_disagreement_score":0.020060824,"about_ca_system_score_codex":0.0018645802,"about_ca_system_score_gemma":0.0027403904,"threshold_uncertainty_score":0.99580336},"labels":[],"label_agreement":null},{"id":"W3026787905","doi":"10.1093/jnci/djaa070","title":"<i>BRCA1</i>Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Tasmania; Cancer Council Victoria; Cancer Council South Australia; Cancer Council NSW; National Health and Medical Research Council; Medical Research Council","keywords":"Ovarian cancer; Meta-analysis; Oncology; Methylation; Medicine; Cancer; Internal medicine; DNA methylation; Biology; Genetics; Gene; Gene expression","score_opus":0.4800256938503153,"score_gpt":0.5112946413314446,"score_spread":0.03126894748112935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026787905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014043628,0.98717135,0.000024197767,0.00730859,0.0014639045,0.00085527793,0.0029727046,0.000005674576,0.000057857837],"genre_scores_gemma":[0.0024793416,0.9930246,0.0011543522,0.0017400766,0.0011292906,0.00010661577,0.00029913432,0.000032892727,0.000033717177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950792,0.00048414286,0.002101622,0.0005946211,0.0015437166,0.00019667057],"domain_scores_gemma":[0.9963229,0.00031051686,0.002149449,0.00051294354,0.00044510126,0.00025914787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014728275,0.0004318188,0.0039842115,0.0004942016,0.000095135336,0.000090719645,0.00070765003,0.00026307598,0.00018843051],"category_scores_gemma":[0.00041825016,0.00023045448,0.0021382123,0.0010091522,0.00012162299,0.00053652446,0.00031898275,0.0009615981,0.0000021621818],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008760747,0.0007171851,0.0123720495,0.00069465244,0.37676775,0.0001035366,0.00014619235,0.00024600918,1.0297316e-7,0.00014766432,0.0017799794,0.6069373],"study_design_scores_gemma":[0.0009957354,0.00015533996,0.013053118,0.0005049746,0.37448844,0.00005364581,0.0000040156947,0.00003669682,7.632157e-7,0.00005993167,0.61047006,0.00017729553],"about_ca_topic_score_codex":0.00054412254,"about_ca_topic_score_gemma":0.0022605553,"teacher_disagreement_score":0.6086901,"about_ca_system_score_codex":0.00073570205,"about_ca_system_score_gemma":0.003288547,"threshold_uncertainty_score":0.93976605},"labels":[],"label_agreement":null},{"id":"W3028561328","doi":"10.1186/s13046-020-01557-3","title":"Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; National Natural Science Foundation of China; Natural Science Foundation of Shanghai; Cancer Research Institute","keywords":"Cancer research; Ovarian cancer; Carcinogenesis; Biology; Receptor tyrosine kinase; Cancer; Targeted therapy; MAPK/ERK pathway; Protein kinase B; Signal transduction; Medicine; Genetics","score_opus":0.2251445255156827,"score_gpt":0.5483779181723061,"score_spread":0.3232333926566234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028561328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587726,0.0055981223,0.0000026845157,0.034256525,0.00024915216,0.00045295607,0.000044549844,0.000006509741,0.00061690516],"genre_scores_gemma":[0.9940041,0.0025256851,0.0002512546,0.001449294,0.0015386489,0.000075528464,0.000004319327,0.000028621414,0.00012256295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713624,0.00042215904,0.0009613719,0.00036389809,0.0007614133,0.00035493556],"domain_scores_gemma":[0.9982514,0.00039855202,0.00023032154,0.00014375194,0.00034926966,0.00062674575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012507886,0.00015525128,0.00063279254,0.00016794188,0.00012779499,0.000045446206,0.00012537523,0.00010310333,0.0006916185],"category_scores_gemma":[0.0002353431,0.00012404456,0.0002192386,0.00038528384,0.0003110086,0.00013608337,0.00011078967,0.0010549991,0.000013683582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0129230395,0.0066044684,0.59886265,0.000192514,0.0020750656,0.0055961157,0.014139897,0.000065108994,0.2889642,0.0010486669,0.032464758,0.037063528],"study_design_scores_gemma":[0.038786683,0.01094397,0.57915115,0.0016928401,0.00039968317,0.00017314545,0.0104370015,0.00019616075,0.3411674,0.0003280699,0.016211445,0.0005124578],"about_ca_topic_score_codex":0.0013757902,"about_ca_topic_score_gemma":0.00016999901,"teacher_disagreement_score":0.052203197,"about_ca_system_score_codex":0.0006229215,"about_ca_system_score_gemma":0.00083147956,"threshold_uncertainty_score":0.75727373},"labels":[],"label_agreement":null},{"id":"W3028871862","doi":"10.1200/jco.2020.38.15_suppl.6046","title":"Long-term survival outcomes of intravenous versus intraperitoneal chemotherapy in the treatment of advanced ovarian cancer.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Internal medicine; Serous fluid; Proportional hazards model; Oncology; Surgery; Stage (stratigraphy); Survival analysis; Cancer; Cohort","score_opus":0.14716336983891576,"score_gpt":0.47697489983103486,"score_spread":0.3298115299921191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028871862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453387,0.0012390831,0.000013544905,0.051423613,0.0012029536,0.0003300519,0.00001119668,0.0000029068567,0.00043794228],"genre_scores_gemma":[0.98413247,0.013062585,0.00065227906,0.001354263,0.00076080085,0.000013836799,0.0000022391034,0.000013227099,0.000008276011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720037,0.00027549695,0.0018604399,0.00016618651,0.00032034572,0.00017715443],"domain_scores_gemma":[0.9962297,0.0019626564,0.0012683659,0.00018570747,0.00016460543,0.00018897247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060593593,0.00015568969,0.0019946916,0.000053936852,0.000014525396,0.0000033835154,0.0001719188,0.00018503018,0.00017877635],"category_scores_gemma":[0.00030710647,0.000086023065,0.00052926305,0.00016789442,0.00017740135,0.00004128905,0.000008486731,0.00030239995,0.0000013343431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015863586,0.007022064,0.50033844,0.000033526747,0.0012926543,0.0004913142,0.0015694544,0.000030309335,0.000098496974,0.00009609955,0.00004727585,0.47311682],"study_design_scores_gemma":[0.03960419,0.05479785,0.89957356,0.00005656423,0.00052887545,0.00001935361,0.00028262872,0.0000066366156,0.0005237375,0.00001768371,0.0045299064,0.00005903703],"about_ca_topic_score_codex":0.00011250384,"about_ca_topic_score_gemma":0.00027450212,"teacher_disagreement_score":0.47305778,"about_ca_system_score_codex":0.0002254054,"about_ca_system_score_gemma":0.001052717,"threshold_uncertainty_score":0.35079187},"labels":[],"label_agreement":null},{"id":"W3029117137","doi":"10.1200/jco.2020.38.15_suppl.6004","title":"Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Université de Montréal; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Bevacizumab; Neutropenia; Internal medicine; Adverse effect; Gastroenterology; Ovarian cancer; Nausea; Cancer; Oncology; Surgery; Pharmacology; Chemotherapy","score_opus":0.045248737338270374,"score_gpt":0.3865243554198406,"score_spread":0.3412756180815702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029117137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650293,0.00043365912,0.000084697574,0.03288365,0.00048810273,0.000701974,0.00002027115,0.000013544482,0.00034477326],"genre_scores_gemma":[0.99160206,0.0007804609,0.004370299,0.0027457974,0.000377739,0.000020340101,0.000041685227,0.00004183672,0.000019805067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958568,0.0004582489,0.0023465033,0.0004145048,0.000539207,0.00038469437],"domain_scores_gemma":[0.9956978,0.0012911145,0.0018684895,0.0001525347,0.00054148585,0.00044855478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001285814,0.0002787059,0.0018790897,0.00018230104,0.00004436077,0.000021817721,0.00015191815,0.0002572786,0.00016846841],"category_scores_gemma":[0.0014773699,0.00018867542,0.00017194616,0.00050763245,0.0001344402,0.0002455505,0.000039503524,0.0011756861,0.000013667745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021144312,0.0052403687,0.9250747,0.00008642772,0.00044638128,0.001304005,0.0006963521,0.00025750996,0.000038056995,0.00007195434,0.0014045497,0.04423538],"study_design_scores_gemma":[0.098123915,0.038731758,0.85524476,0.0012452159,0.00044863432,0.00003490555,0.00014524107,0.0006925117,0.00009309555,0.00006833253,0.0049340515,0.0002376135],"about_ca_topic_score_codex":0.0003603386,"about_ca_topic_score_gemma":0.00071435416,"teacher_disagreement_score":0.0769796,"about_ca_system_score_codex":0.0005743287,"about_ca_system_score_gemma":0.0018062876,"threshold_uncertainty_score":0.76939607},"labels":[],"label_agreement":null},{"id":"W3029272205","doi":"10.1016/j.annonc.2020.05.019","title":"Prognostic gene expression signature for high-grade serous ovarian cancer","year":2020,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Alberta Health Services; University of British Columbia; Royal Alexandra Hospital; Foothills Medical Centre; BC Cancer Agency","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Tasmania; Cancer Council NSW; Cancer Council Victoria; Cancer Council South Australia; National Center for Advancing Translational Sciences; Medical Research Council; Oak Foundation; BC Cancer Foundation; U.S. Department of Defense; Eli Lilly and Company; Ignyta; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health; Canada Research Chairs; Canadian Institutes of Health Research; Cancer Institute NSW; Cancer Research UK; University College London; Cancer Australia; Ovarian Cancer Action; Clovis Oncology; National Institute for Health and Care Research; Horizon 2020 Framework Programme; National Health and Medical Research Council; Invitae; AstraZeneca; Carrick Therapeutics; Pfizer; University College London Hospitals NHS Foundation Trust; European Commission","keywords":"Medicine; Serous ovarian cancer; Ovarian cancer; Serous fluid; Gene signature; Oncology; Signature (topology); Internal medicine; Gene; Cancer; Cancer research; Gene expression; Genetics","score_opus":0.1541800533549264,"score_gpt":0.4447541924358067,"score_spread":0.2905741390808803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029272205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015641372,0.9847586,0.000047906608,0.010178891,0.0006666451,0.0032021427,0.00084445474,0.000039170405,0.00024652804],"genre_scores_gemma":[0.0002465762,0.9908541,0.002582614,0.0013616891,0.0011696587,0.0026789892,0.0007410901,0.00009045297,0.0002748488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791354,0.00014037458,0.0007035395,0.0006410614,0.0002080734,0.00039343262],"domain_scores_gemma":[0.9979344,0.0005329111,0.00067983806,0.0003770896,0.00022663266,0.0002491432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015482526,0.00044587385,0.0030633302,0.00013604164,0.00005078113,0.000008644326,0.0001762151,0.00080699945,0.00026841846],"category_scores_gemma":[0.00015108584,0.00031574673,0.00064032734,0.00024634297,0.00006900474,0.000031155105,0.00007650529,0.00039379022,0.000020067755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012462509,0.0007331881,0.000026897113,0.011922665,0.0011087037,0.00026765704,0.00004784521,0.0000010522702,0.000020186622,0.0001659438,0.049351133,0.9362301],"study_design_scores_gemma":[0.0017377982,0.003764599,0.000060576618,0.009718082,0.003448081,0.000061538754,0.000005026069,8.602965e-7,0.00065746735,0.000118724725,0.9801958,0.00023142752],"about_ca_topic_score_codex":0.000090716494,"about_ca_topic_score_gemma":0.000025046966,"teacher_disagreement_score":0.9359987,"about_ca_system_score_codex":0.00019298389,"about_ca_system_score_gemma":0.0019377979,"threshold_uncertainty_score":0.9999295},"labels":[],"label_agreement":null},{"id":"W3030329573","doi":"10.1200/jco.2020.38.15_suppl.6001","title":"A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Clinical endpoint; Interim analysis; Surgery; Ovarian cancer; Chemotherapy; Randomization; Randomized controlled trial; Cancer; Phases of clinical research; Internal medicine","score_opus":0.17649892271946693,"score_gpt":0.4878551666987912,"score_spread":0.31135624397932427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030329573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92712104,0.0021589382,0.000037939084,0.06441731,0.004044873,0.0010108168,0.000029237572,0.0000066654866,0.0011731833],"genre_scores_gemma":[0.9871798,0.0057436037,0.0005229649,0.0025854476,0.0038506018,0.00005753908,0.000007245334,0.00001863103,0.000034123277],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936172,0.001199202,0.004314467,0.00027065258,0.00035897986,0.0002395082],"domain_scores_gemma":[0.99076545,0.0054808008,0.0028050903,0.00014718476,0.00033525898,0.00046624063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004779301,0.0001878171,0.0048035975,0.00016514582,0.000018603323,0.000006592708,0.00011015682,0.00033245253,0.0009346959],"category_scores_gemma":[0.0039467826,0.0001250415,0.0014284004,0.00021019956,0.00028068226,0.00010616017,0.000040177758,0.0010335466,0.000005336317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7804384,0.005371688,0.0022602382,0.000046589128,0.0014190371,0.0007582053,0.0005144517,0.0000043746713,0.000020816013,0.00004880115,0.007775553,0.20134184],"study_design_scores_gemma":[0.9541546,0.013639979,0.0047197784,0.00027902893,0.0012525467,0.000047997568,0.00010188278,0.000054964014,0.0002459353,0.00026308987,0.025134778,0.00010541387],"about_ca_topic_score_codex":0.000088604196,"about_ca_topic_score_gemma":0.000041634972,"teacher_disagreement_score":0.20123643,"about_ca_system_score_codex":0.00027643816,"about_ca_system_score_gemma":0.0050961464,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W3031480296","doi":"10.1200/jco.2020.38.15_suppl.tps6108","title":"DUO-E/GOG-3041/ENGOT-EN10: a randomized phase III trial of first-line carboplatin (carb) and paclitaxel (pac) in combination with durvalumab (durva), followed by maintenance durva with or without olaparib (ola), in patients (pts) with newly diagnosed (nd) advanced or recurrent endometrial cancer (EC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Internal medicine; Oncology; Carboplatin; PARP inhibitor; Cancer; Ovarian cancer; Bevacizumab; Hazard ratio; Atezolizumab; Nivolumab; Chemotherapy; Immunotherapy; Cisplatin; Confidence interval; Poly ADP ribose polymerase","score_opus":0.06261902169067038,"score_gpt":0.4049392146227062,"score_spread":0.34232019293203586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031480296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843171,0.0006880837,0.00034830417,0.008482643,0.00071502244,0.0052452907,0.00008937326,0.00001556893,0.00009857034],"genre_scores_gemma":[0.9904876,0.00499456,0.0028986745,0.0007018198,0.00043012146,0.0003230236,0.000038383874,0.0000632778,0.00006255678],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922135,0.001303215,0.0042229895,0.00070716656,0.0010189763,0.00053417776],"domain_scores_gemma":[0.986479,0.007327891,0.004450523,0.00030510596,0.000770479,0.0006670355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003228339,0.0005401348,0.0059947195,0.00035231776,0.000060190207,0.000025843568,0.00020825602,0.0004709984,0.00010928613],"category_scores_gemma":[0.008067063,0.00028405117,0.00035094356,0.0010203057,0.00048804402,0.0003115465,0.000048655213,0.0014383531,7.689971e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8169047,0.013645922,0.1207487,0.000119536446,0.0011047875,0.000745217,0.0007646606,0.00009774519,0.000010721018,0.000012057553,0.0005025923,0.045343325],"study_design_scores_gemma":[0.8175413,0.16055258,0.01594879,0.0014541934,0.0013831056,0.000030377065,0.00021935656,0.00074829865,0.000047489266,0.000013965026,0.0017724013,0.00028812373],"about_ca_topic_score_codex":0.0007327507,"about_ca_topic_score_gemma":0.008710954,"teacher_disagreement_score":0.14690666,"about_ca_system_score_codex":0.000627544,"about_ca_system_score_gemma":0.0028649808,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W3033247206","doi":"10.1371/journal.pgen.1008808","title":"In vivo modeling of metastatic human high-grade serous ovarian cancer in mice","year":2020,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Indiana University Bloomington; National Institute of Child Health and Human Development; School of Medicine, Indiana University; University of Illinois at Chicago; Breast Cancer Research Foundation; Chungbuk National University; University of Illinois at Urbana-Champaign; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Indiana University Health","keywords":"Ovarian cancer; Biology; Metastasis; Cancer research; Serous fluid; Cancer; Serous carcinoma; Ovarian carcinoma; Ovary; Peritoneal cavity; PTEN; In vivo; Pathology; PI3K/AKT/mTOR pathway; Medicine; Genetics; Signal transduction","score_opus":0.06703386776402094,"score_gpt":0.30938517166511537,"score_spread":0.24235130390109444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033247206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255306,0.0018109551,0.000055480163,0.0049341526,0.000049102855,0.00039623215,0.00004556113,0.0000117574455,0.00014372448],"genre_scores_gemma":[0.9959952,0.0004881272,0.0024538501,0.0008532526,0.00009061232,0.000068487214,0.0000056853055,0.000027223703,0.000017522801],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99899566,0.00002995414,0.00034766947,0.00024237091,0.0001939988,0.00019035069],"domain_scores_gemma":[0.99964476,0.000018188744,0.00006183077,0.00015017978,0.000037768168,0.00008725323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042186188,0.00012966694,0.0003723595,0.00008036912,0.00001355922,0.000006116908,0.00007079344,0.000041718635,0.00020884357],"category_scores_gemma":[0.000012120704,0.00012247429,0.00004145149,0.000254759,0.000017200495,0.00002365764,0.000029978566,0.00011564724,0.0000042263437],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004858219,0.006497721,0.26471677,0.0029424587,0.0016194978,0.0012545212,0.01632319,0.33196807,0.36824986,0.0015996859,0.0011965109,0.0031458961],"study_design_scores_gemma":[0.013040514,0.0011281976,0.01085114,0.00087453757,0.0011094119,0.000008075024,0.0004983192,0.5646589,0.40610892,0.000866953,0.00038822216,0.00046682797],"about_ca_topic_score_codex":0.0008786299,"about_ca_topic_score_gemma":0.0009164977,"teacher_disagreement_score":0.25386563,"about_ca_system_score_codex":0.00011537031,"about_ca_system_score_gemma":0.00008681044,"threshold_uncertainty_score":0.49943566},"labels":[],"label_agreement":null},{"id":"W3033435317","doi":"10.31487/j.aco.2020.02.01","title":"BRCA Tumor Analysis as Molecular Screening for Germline Testing","year":2020,"lang":"en","type":"article","venue":"Annals of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Universidad de Valladolid","keywords":"Germline; Germline mutation; Somatic cell; Adenocarcinoma; Medicine; Prostate cancer; Oncology; Ovarian cancer; Prostate; Mutation; Serous fluid; Cancer research; BRCA mutation; Internal medicine; Cancer; Biology; Genetics; Gene","score_opus":0.5168380050004334,"score_gpt":0.5667588203901553,"score_spread":0.04992081538972193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033435317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7828254,0.000986348,0.0069075376,0.20121023,0.00014764316,0.00079092034,0.0000571315,0.00006384857,0.0070109325],"genre_scores_gemma":[0.92478806,0.0000885749,0.031234512,0.043292385,0.00045216264,0.000047048783,0.000036076388,0.000017191802,0.000043993652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795693,0.0001117715,0.0011199,0.00039620633,0.00017327882,0.0002418892],"domain_scores_gemma":[0.99593014,0.0025282588,0.0005052319,0.00022285651,0.00043139828,0.00038213588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082108617,0.00012749176,0.0013515351,0.000071984876,0.00002971377,0.0000050246367,0.00009661295,0.00013833985,0.00017793216],"category_scores_gemma":[0.0068827625,0.00010566248,0.0007943138,0.0005025116,0.0000985846,0.000027374537,0.000051349813,0.00018270143,0.000018084165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036004134,0.0027168402,0.39161283,0.00019083024,0.009887536,0.0010430192,0.000108971675,0.0006643618,0.0005363664,0.0017172267,0.009672343,0.5782493],"study_design_scores_gemma":[0.017615577,0.05024449,0.6158588,0.00021773641,0.012713293,0.00003273227,0.00012919753,0.018240215,0.010889138,0.0014451942,0.27212352,0.0004901042],"about_ca_topic_score_codex":0.00007149061,"about_ca_topic_score_gemma":0.000008897363,"teacher_disagreement_score":0.57775915,"about_ca_system_score_codex":0.000009712511,"about_ca_system_score_gemma":0.00036360422,"threshold_uncertainty_score":0.8239807},"labels":[],"label_agreement":null},{"id":"W3033876871","doi":"10.1038/s41379-020-0586-0","title":"Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa","year":2020,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Queen's University; Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Calgary; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Terry Fox Research Institute","keywords":"Medicine; Cohort; Tissue microarray; Serous fluid; Serous carcinoma; Ovarian cancer; Oncology; Biomarker; Internal medicine; Cancer; Pathology; Cancer research; Biology","score_opus":0.0195572156738983,"score_gpt":0.25999766333946095,"score_spread":0.24044044766556266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033876871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875085,0.000039702572,0.0010661213,0.010807243,0.00004494351,0.00033484434,0.00016718684,0.000022389006,0.000009104714],"genre_scores_gemma":[0.99617875,0.000012007726,0.001135157,0.0024450237,0.000041596973,0.00005098062,0.000096740776,0.00002144062,0.000018297855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989539,0.00008539543,0.00021377891,0.00038883337,0.00018377457,0.00017431547],"domain_scores_gemma":[0.9995709,0.000026004289,0.00006182148,0.0001400053,0.000049817685,0.00015142835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006100871,0.00015812342,0.00042003152,0.00008391247,0.000026775386,0.000004860525,0.00003582207,0.00011302014,0.000058865917],"category_scores_gemma":[0.000017867796,0.000118614524,0.00003952402,0.00009787566,0.000039280483,0.000056713256,0.000023849978,0.000102468905,0.0000022664315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036288025,0.0023555418,0.593997,0.000152208,0.00013102347,0.0026360238,0.011001794,0.00043396972,0.3803592,0.00006352923,0.00007885374,0.0051620584],"study_design_scores_gemma":[0.005985758,0.004137625,0.9051567,0.000089423054,0.00007442786,0.00006636444,0.000054780354,0.0016539504,0.08256901,0.000075814685,0.000010681885,0.00012546997],"about_ca_topic_score_codex":0.0001681219,"about_ca_topic_score_gemma":0.000060855255,"teacher_disagreement_score":0.3111597,"about_ca_system_score_codex":0.0000572773,"about_ca_system_score_gemma":0.00004336999,"threshold_uncertainty_score":0.48369598},"labels":[],"label_agreement":null},{"id":"W3033970295","doi":"10.14740/jcgo.v9i1-2.630","title":"Primary Fallopian Tube Carcinoma Preoperatively Diagnosed as Cervical Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cervix; Cervical cancer; Stage (stratigraphy); Fallopian tube cancer; Radiology; Surgery; Ovarian cancer; Gynecology; Cancer; Internal medicine","score_opus":0.06966114706460134,"score_gpt":0.3685100551350101,"score_spread":0.29884890807040876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033970295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572021,0.008783948,0.000028554248,0.030587016,0.0014113656,0.00026166285,0.0000111375175,0.000011006722,0.0017032417],"genre_scores_gemma":[0.9671734,0.008855107,0.00076052535,0.022189116,0.0008524651,0.000010698592,0.0000032850874,0.00001687295,0.0001385545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978145,0.00019966712,0.0011823362,0.00028453858,0.00028614685,0.00023283198],"domain_scores_gemma":[0.99212664,0.0062369355,0.0004545319,0.00012373179,0.00033863343,0.00071954605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00040673363,0.00017600424,0.0010544971,0.000082762046,0.00006933906,0.000021235104,0.000120400764,0.00032297496,0.0005122159],"category_scores_gemma":[0.008549841,0.00012378544,0.00029867914,0.00028425333,0.00015974611,0.00010188074,0.000071295246,0.00078433886,0.000020782469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054665195,0.0007061506,0.9222916,0.00008573455,0.00037121802,0.0021976198,0.00026937772,0.000008457728,0.000008421593,0.00024401418,0.0035702642,0.069700494],"study_design_scores_gemma":[0.008398804,0.005504793,0.9277789,0.00005068491,0.00053147296,0.000091841845,0.00008674083,0.00006111867,0.000090799826,0.00006594064,0.057226222,0.00011267611],"about_ca_topic_score_codex":0.0000144787045,"about_ca_topic_score_gemma":0.000010448155,"teacher_disagreement_score":0.06958782,"about_ca_system_score_codex":0.00010750452,"about_ca_system_score_gemma":0.00091254216,"threshold_uncertainty_score":0.9998016},"labels":[],"label_agreement":null},{"id":"W3035508928","doi":"10.1136/ijgc-2019-000983","title":"The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ovarian Cancer Canada","funders":"","keywords":"Medicine; Incidence (geometry); Quality of life (healthcare); Quarter (Canadian coin); Family medicine; Cancer; Gynecology; Demography; Internal medicine; Nursing","score_opus":0.2505835560051818,"score_gpt":0.4073779733004365,"score_spread":0.15679441729525473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035508928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87127244,0.009924197,0.000027866254,0.11702117,0.0009766285,0.00027913143,0.000046864152,0.0000066168773,0.000445097],"genre_scores_gemma":[0.9799466,0.016635064,0.00006571858,0.0026071225,0.00057647156,0.00005278043,0.0000010334512,0.0000074375384,0.0001077842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985446,0.00013226614,0.00053008,0.0001721392,0.00050344574,0.000117476295],"domain_scores_gemma":[0.99828506,0.0005621891,0.00037298008,0.000065496635,0.00046383744,0.00025044277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586877,0.00011174757,0.00037572414,0.000063772924,0.000056529043,0.000048291804,0.0001253463,0.000035639423,0.00022963637],"category_scores_gemma":[0.00037291893,0.000069250375,0.00007327397,0.00003995572,0.000085537766,0.0001063469,0.0001011111,0.0001575267,4.3546177e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006939633,0.0013536061,0.5612837,0.0002571996,0.0048635365,0.000352233,0.004967451,0.00005793891,0.0013396961,0.013301056,0.002505474,0.40277848],"study_design_scores_gemma":[0.002600117,0.0009886153,0.98479646,0.00011304354,0.00013011372,0.0000039379956,0.002708279,0.000013386965,0.0001474781,0.00018110084,0.00823605,0.00008138438],"about_ca_topic_score_codex":0.00023308895,"about_ca_topic_score_gemma":0.0017237648,"teacher_disagreement_score":0.4235128,"about_ca_system_score_codex":0.00018154856,"about_ca_system_score_gemma":0.00020863216,"threshold_uncertainty_score":0.28239483},"labels":[],"label_agreement":null},{"id":"W3035639596","doi":"10.1016/j.jpag.2020.06.002","title":"Recurrent High-grade Ovarian Immature Teratoma with Peritoneal Dissemination","year":2020,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Gynecology","score_opus":0.010660168872259741,"score_gpt":0.2578874440722489,"score_spread":0.24722727519998916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035639596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632101,0.0036343413,0.00028226,0.03211086,0.00044198634,0.00025143882,0.0000115152125,0.000013014189,0.000044470522],"genre_scores_gemma":[0.9927513,0.0028914153,0.0013010406,0.0009607013,0.0020450118,0.000004182759,0.000008441229,0.000014251555,0.000023648328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999067,0.000042992826,0.00033154892,0.0001743203,0.00020865862,0.00017544643],"domain_scores_gemma":[0.9991051,0.00008871751,0.00030032967,0.00006912195,0.00012977577,0.00030694887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085813954,0.00014740502,0.00038412365,0.00009567133,0.00005407524,0.000022305509,0.000051683895,0.00010001135,0.000089484536],"category_scores_gemma":[0.00006999944,0.000096943724,0.00007534644,0.00017498335,0.000032340424,0.00007457427,0.00002099391,0.00033214877,0.000003764155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037527345,0.002852273,0.85354316,0.0007990963,0.00047296513,0.0027483953,0.0012009402,0.000013277176,0.00046328604,0.00043706063,0.080031164,0.053685673],"study_design_scores_gemma":[0.004672159,0.004406739,0.9828859,0.00009757984,0.0009069388,0.00048351748,0.00016355654,0.00005459834,0.00019067826,0.000019013385,0.005986572,0.00013277435],"about_ca_topic_score_codex":0.0000012543279,"about_ca_topic_score_gemma":0.0000017834774,"teacher_disagreement_score":0.12934273,"about_ca_system_score_codex":0.00008489053,"about_ca_system_score_gemma":0.00016265275,"threshold_uncertainty_score":0.39532503},"labels":[],"label_agreement":null},{"id":"W3036427315","doi":"10.1158/1078-0432.ccr-20-0103","title":"Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; BC Cancer Agency; Foothills Medical Centre; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; Alberta Health Services; University of British Columbia","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council Victoria; Horizon 2020 Framework Programme; Peter MacCallum Foundation; BC Cancer Foundation; University College London Hospitals NHS Foundation Trust; Medical Research and Materiel Command; Eisai; Canada Excellence Research Chairs, Government of Canada; Bundesministerium für Bildung und Forschung; Canada Research Chairs; Canadian Institutes of Health Research; Cancer Institute NSW; Cancer Australia; Mayo Clinic; Ovarian Cancer Action; Michael Smith Health Research BC; National Health and Medical Research Council; AstraZeneca; Invitae; Daiichi-Sankyo; MacroGenics; National Institute for Health and Care Research; Clovis Oncology; Cancer Research UK; University College London; Cancer Council NSW; Ovarian Cancer Australia; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Celgene; Carrick Therapeutics; Ignyta; U.S. Department of Defense; Eli Lilly and Company; Cancer Council South Australia; Deutsches Krebsforschungszentrum; Pfizer; European Commission; Breast Cancer Research Foundation; American Oil Chemists' Society; National Center for Advancing Translational Sciences; Medical Research Council; Teva Pharmaceutical Industries; American Cancer Society","keywords":"Serous fluid; Ovarian carcinoma; Serous carcinoma; Oncology; Ovarian cancer; Serous ovarian cancer; Gene expression; Gene expression profiling; Clinical trial; Internal medicine; Gene; Medicine; Bioinformatics; Biology; Cancer; Genetics","score_opus":0.18082035205129865,"score_gpt":0.4301660530588109,"score_spread":0.24934570100751224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036427315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905172,0.0010052855,0.000052842515,0.007383245,0.00010843999,0.0008119141,0.000024572584,0.000008783866,0.000087747074],"genre_scores_gemma":[0.9970385,0.0002517744,0.0021407518,0.00022047159,0.0001589857,0.00012573268,0.000011859754,0.00001791176,0.000034038887],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980475,0.0002437586,0.0005046022,0.00034772579,0.000659147,0.00019726565],"domain_scores_gemma":[0.9988644,0.00018745438,0.00013015707,0.00032815558,0.00027379833,0.00021601674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006464295,0.00009659314,0.000338134,0.00003905433,0.00006228209,0.00000853208,0.0001456256,0.00014215107,0.00012160785],"category_scores_gemma":[0.00031874565,0.00006234417,0.00007581049,0.00030201374,0.00020609814,0.000026938265,0.00019693779,0.00039225243,0.0000034880375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014939719,0.00067553134,0.91968596,0.0005967536,0.00024620446,0.000045023662,0.0010110162,0.000022507305,0.061529543,0.00043838524,0.0014157465,0.012839382],"study_design_scores_gemma":[0.0019686946,0.00042965962,0.43648237,0.00016115088,0.00004930768,0.0000011833818,0.00003337798,0.000023626346,0.5594809,0.000063210835,0.0012630463,0.00004348362],"about_ca_topic_score_codex":0.00030170198,"about_ca_topic_score_gemma":0.000013011731,"teacher_disagreement_score":0.49795136,"about_ca_system_score_codex":0.00008763888,"about_ca_system_score_gemma":0.00074923265,"threshold_uncertainty_score":0.2542321},"labels":[],"label_agreement":null},{"id":"W3036702906","doi":"10.1038/s41416-020-0900-0","title":"Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium","year":2020,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Health Services; Royal Alexandra Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Vancouver General Hospital; University of Calgary; Vancouver Coastal Health","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Tasmania; National Center for Advancing Translational Sciences; Medical Research Council; Peter MacCallum Foundation; National Center for Research Resources; Oak Foundation; BC Cancer Foundation; Canada Research Chairs; Conselho Nacional de Desenvolvimento Científico e Tecnológico; National Institutes of Health; Cancer Institute NSW; National Health and Medical Research Council; American Cancer Society; Academy of Medical Sciences; Calgary Laboratory Services; University of Cambridge; University College London; Cancer Research UK; Michael Smith Health Research BC; Deutsches Krebsforschungszentrum; Cancer Council Victoria; Cancer Australia; Kræftens Bekæmpelse; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Ovarian Cancer Australia","keywords":"Ovarian cancer; PTEN; Pathological; Oncology; Medicine; Pathology; Ovarian tissue; Ovary; Cancer; Internal medicine; Biology; Genetics; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.04998682333486856,"score_gpt":0.3713108150198223,"score_spread":0.32132399168495374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036702906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97701985,0.013121101,0.00008564585,0.008774634,0.00016396327,0.00043558754,0.00035426632,0.000005306024,0.000039640523],"genre_scores_gemma":[0.99190784,0.0060553337,0.00061525917,0.0008653258,0.0004945573,0.000031332725,0.000008351758,0.000011348138,0.000010653835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788916,0.00035520695,0.0009484265,0.000261706,0.00038099795,0.0001645106],"domain_scores_gemma":[0.99847674,0.00034012046,0.00061848725,0.00011733974,0.00023335282,0.00021395674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048166356,0.000121319725,0.00085120945,0.000053391355,0.00006895885,0.000043844324,0.00012381005,0.00009520246,0.00051289046],"category_scores_gemma":[0.00040267076,0.00009067269,0.00020195181,0.000395326,0.00008362809,0.000078438374,0.000054865755,0.000411589,6.816486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027307458,0.00082914106,0.95689785,0.000008003811,0.0012547188,0.0010221845,0.0011918708,0.0000890019,0.00033782315,0.0000025223574,0.0006962692,0.03739753],"study_design_scores_gemma":[0.0068757306,0.00034580205,0.9875217,0.0003380812,0.0028481884,0.00002287441,0.0009439719,0.00011201874,0.00023620247,0.000016741835,0.0006561219,0.00008255189],"about_ca_topic_score_codex":0.006971242,"about_ca_topic_score_gemma":0.0094182985,"teacher_disagreement_score":0.037314977,"about_ca_system_score_codex":0.00009643672,"about_ca_system_score_gemma":0.00024847087,"threshold_uncertainty_score":0.9996414},"labels":[],"label_agreement":null},{"id":"W3037199155","doi":"10.1158/1078-0432.ccr-20-1376","title":"Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ovarian cancer; Chemotherapy; Medicine; Cancer; Oncology; Sensitivity (control systems); Internal medicine; Gynecology; Engineering","score_opus":0.29676594274671286,"score_gpt":0.5097095074310191,"score_spread":0.2129435646843062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037199155","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018006,0.0054394533,0.000012431311,0.9719967,0.000830173,0.0025209242,0.00023082312,0.00004154939,0.0009219461],"genre_scores_gemma":[0.36470908,0.027925443,0.00039631926,0.59335136,0.01022414,0.0022665453,0.00009477427,0.00023426312,0.0007980907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99254024,0.0009558011,0.0013849196,0.0013736488,0.0027953119,0.00095008215],"domain_scores_gemma":[0.9963636,0.0008094094,0.00032089854,0.0009998416,0.0012367532,0.00026954233],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034407212,0.00044263722,0.0018996202,0.00029476307,0.00007117794,0.000031894393,0.00027111094,0.00085895794,0.0011856077],"category_scores_gemma":[0.00080296176,0.0003754653,0.0005367058,0.0008814178,0.0004918959,0.00006126726,0.0001673155,0.005290995,0.00004890666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021623115,0.0007692784,0.09137287,0.0014380381,0.00086726196,0.0025452534,0.000109492474,0.0000101842115,0.00025853925,0.000012719097,0.7721851,0.12826896],"study_design_scores_gemma":[0.010339278,0.001287795,0.17706439,0.0040985527,0.0002188678,0.0000056643516,0.00002182367,0.00006275913,0.001675626,0.00016862185,0.80463094,0.00042568133],"about_ca_topic_score_codex":0.0041380776,"about_ca_topic_score_gemma":0.0015675048,"teacher_disagreement_score":0.37864536,"about_ca_system_score_codex":0.0020518892,"about_ca_system_score_gemma":0.004106551,"threshold_uncertainty_score":0.9998697},"labels":[],"label_agreement":null},{"id":"W3038487399","doi":"10.1158/1078-0432.ccr-20-0219","title":"A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive <i>TP53</i> -mutant Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"Merck; AstraZeneca","keywords":"Carboplatin; Medicine; Tolerability; Internal medicine; Chemotherapy; Oncology; Adverse effect; Ovarian cancer; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Placebo; Clinical endpoint; Hazard ratio; Pemetrexed; Cancer; Progression-free survival; Randomized controlled trial; Surgery; Phases of clinical research; Confidence interval; Cisplatin; Pathology","score_opus":0.20556782163680917,"score_gpt":0.4904681500289786,"score_spread":0.2849003283921694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038487399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643668,0.0017801836,0.00020543934,0.023773499,0.00028263975,0.007965884,0.0006277967,0.000043849646,0.0009538906],"genre_scores_gemma":[0.9893754,0.0025041308,0.00060046493,0.0010916502,0.0009954246,0.005062074,0.000032679454,0.00007124059,0.00026689822],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995133,0.0007627894,0.001323507,0.0010055561,0.0009605706,0.000814587],"domain_scores_gemma":[0.99279225,0.004625434,0.0003819276,0.0004435196,0.0008335452,0.00092330703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037712574,0.00034889954,0.0022072569,0.00013465533,0.00023608565,0.000043783,0.00016167203,0.0002565789,0.00030988484],"category_scores_gemma":[0.0024472582,0.00023741736,0.000304521,0.0006738101,0.0010337714,0.00008975728,0.00018327378,0.0006684265,0.000002922988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94221807,0.0016059588,0.000692351,0.00040167008,0.0019653037,0.000116248164,0.0026088157,0.000007668042,0.0015741043,0.00023213052,0.00180158,0.04677611],"study_design_scores_gemma":[0.9621296,0.025057225,0.00090996746,0.00045318907,0.0006254366,0.000005720431,0.0008411531,0.0024855467,0.0017973825,0.00026204766,0.005140094,0.00029262772],"about_ca_topic_score_codex":0.0016243628,"about_ca_topic_score_gemma":0.00031463002,"teacher_disagreement_score":0.04648348,"about_ca_system_score_codex":0.0005196455,"about_ca_system_score_gemma":0.0025454669,"threshold_uncertainty_score":0.9681599},"labels":[],"label_agreement":null},{"id":"W3040248497","doi":"10.1016/j.ygyno.2020.06.504","title":"Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Surgery; Bowel resection; Dehiscence; Colostomy; Malignancy; Anastomosis; Colectomy; Complication; Wound dehiscence; Odds ratio; Colorectal cancer; Cancer; Internal medicine","score_opus":0.06240470341107937,"score_gpt":0.32827097630297875,"score_spread":0.26586627289189935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040248497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820027,0.00006277666,0.000023359644,0.013441557,0.00012305308,0.0034861218,0.00012500296,0.00012242439,0.0006130294],"genre_scores_gemma":[0.99499667,0.000023266699,0.00027735357,0.0023953223,0.00014350038,0.0013398975,0.0002893935,0.000027000853,0.0005076082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978848,0.00064537895,0.00045134296,0.00056322827,0.00017059012,0.00028465144],"domain_scores_gemma":[0.9961334,0.0024995508,0.00047738923,0.0003819347,0.00036426008,0.00014346711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008982349,0.00020530664,0.0007348068,0.00006465409,0.0002388851,0.000008874962,0.00010242802,0.00019937046,0.00078892405],"category_scores_gemma":[0.0012617464,0.000118793774,0.00012965663,0.00039057844,0.00015217449,0.00007129813,0.000054098222,0.00013349358,0.000024240642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04227995,0.021663021,0.7744728,0.00023181434,0.005563297,0.0006816148,0.009886944,0.000054724343,0.004627809,0.00024241373,0.13443004,0.00586557],"study_design_scores_gemma":[0.007126558,0.026771516,0.9567047,0.000042173793,0.0010770446,0.000028017073,0.0013977136,0.00025211746,0.0023471797,0.00008516635,0.00399241,0.00017541966],"about_ca_topic_score_codex":0.00015348505,"about_ca_topic_score_gemma":0.0009669601,"teacher_disagreement_score":0.18223189,"about_ca_system_score_codex":0.00089985086,"about_ca_system_score_gemma":0.00061550806,"threshold_uncertainty_score":0.8638165},"labels":[],"label_agreement":null},{"id":"W3041613483","doi":"10.1158/0008-5472.can-20-0104","title":"The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Michael Smith Health Research BC","funders":"","keywords":"Biology; Genetics; Transcription factor; Missense mutation; Germline mutation; Point mutation; Somatic cell; Mutation; Molecular biology; Immunoprecipitation; Chromatin immunoprecipitation; Cell biology; Gene; Gene expression; Promoter","score_opus":0.16922309238578007,"score_gpt":0.4280849093084536,"score_spread":0.2588618169226735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041613483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9277264,0.0025025785,0.000038678652,0.06513465,0.00025200844,0.00088391424,0.00003162725,0.000048526454,0.0033815997],"genre_scores_gemma":[0.99527645,0.0025322104,0.00005467756,0.00048806312,0.00070891454,0.00037197606,0.000016076763,0.0000273636,0.0005242843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982163,0.00012183554,0.00018609359,0.0003645721,0.00064236234,0.00046883646],"domain_scores_gemma":[0.9989275,0.00029146936,0.0000404801,0.00027344289,0.00018861129,0.00027854877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051333033,0.00010842019,0.0001710621,0.000056163324,0.00040718593,0.00009760263,0.00015197249,0.000048151946,0.00037593077],"category_scores_gemma":[0.00015366243,0.0000727834,0.000082558836,0.0004856456,0.00014941656,0.00006158717,0.00007116711,0.00038405025,0.00025498445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037822425,0.00067716243,0.097214155,0.0006713451,0.001187654,0.002138679,0.009107076,0.00012353803,0.07324946,0.008754658,0.19925947,0.60383457],"study_design_scores_gemma":[0.009540359,0.003163422,0.1620856,0.00079733826,0.00028255917,0.000055793407,0.005455184,0.0012952496,0.24860923,0.0009265536,0.567141,0.0006477066],"about_ca_topic_score_codex":0.00018101347,"about_ca_topic_score_gemma":0.00008094591,"teacher_disagreement_score":0.60318685,"about_ca_system_score_codex":0.0006006364,"about_ca_system_score_gemma":0.00040106452,"threshold_uncertainty_score":0.41161785},"labels":[],"label_agreement":null},{"id":"W3043539166","doi":"10.1186/s13000-020-01000-3","title":"Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America","year":2020,"lang":"en","type":"article","venue":"Diagnostic Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Red Cross Society; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Ovarian cancer; Medicine; Germ cell tumors; Population; Ovarian carcinoma; Cancer; Ovary; Pathology; H&E stain; Oncology; Immunohistochemistry; Internal medicine","score_opus":0.027010601101359784,"score_gpt":0.2751404902403675,"score_spread":0.24812988913900774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043539166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604529,0.0029608211,0.00062094466,0.033264183,0.00024115396,0.0012444415,0.0008928758,0.00008733838,0.00023531378],"genre_scores_gemma":[0.9927817,0.0010607007,0.0003420459,0.0044417623,0.00021939365,0.00075979106,0.0003612557,0.000026769243,0.0000065650243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983122,0.000099749705,0.00036307538,0.0006059532,0.00016291934,0.00045611963],"domain_scores_gemma":[0.9971667,0.0019297651,0.000107208834,0.00025306916,0.00007493606,0.00046834175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052073006,0.00026021455,0.0006175158,0.0000794684,0.00006864544,0.000024525672,0.00010588296,0.00006469969,0.00016609544],"category_scores_gemma":[0.006091347,0.00023750003,0.00005735987,0.000547896,0.00011129437,0.000059176175,0.00010851739,0.00020532109,0.00016806828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024828862,0.00055668864,0.9599761,0.00010454069,0.00007370364,0.0044986196,0.0030151363,0.00032841443,0.00009777662,0.00017556304,0.0066103707,0.024314819],"study_design_scores_gemma":[0.0024839474,0.0006992892,0.97205937,0.00017822026,0.00022138804,0.000077150646,0.00018153599,0.00026202976,0.00008615691,0.000040937928,0.023473851,0.00023615127],"about_ca_topic_score_codex":0.00038152386,"about_ca_topic_score_gemma":0.00033526088,"teacher_disagreement_score":0.03232879,"about_ca_system_score_codex":0.00016620371,"about_ca_system_score_gemma":0.00015346159,"threshold_uncertainty_score":0.968497},"labels":[],"label_agreement":null},{"id":"W3043953022","doi":"10.1158/1557-3265.ovcasymp18-gmm-047","title":"Abstract GMM-047: GENOMIC CHARACTERIZATION OF ADULT-TYPE GRANULOSA CELL TUMORS: IMPLICATIONS FOR PATHOGENESIS AND TREATMENT OF RECURRENT DISEASE","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Missense mutation; Debulking; Carcinogenesis; Biology; Somatic cell; Disease; Germline mutation; Mutation; Cancer research; Pathogenesis; Internal medicine; Oncology; Ovarian cancer; Medicine; Cancer; Genetics; Gene; Immunology","score_opus":0.1611342047733008,"score_gpt":0.47134396792011934,"score_spread":0.3102097631468186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043953022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992751,0.0014789765,0.0000064345013,0.0025603278,0.0001468909,0.0020770798,0.00090185093,0.00000808711,0.00006937276],"genre_scores_gemma":[0.98324233,0.015426156,0.000102884194,0.00004146861,0.00020086083,0.00055835914,0.00025597546,0.000024315934,0.00014765738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847895,0.00007161757,0.0005830566,0.00042172553,0.00020691914,0.00023772546],"domain_scores_gemma":[0.9979621,0.00047840708,0.00018390201,0.0004686204,0.0006318464,0.00027509613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030941048,0.00012251914,0.00045487133,0.000100897916,0.00004849652,0.000009915691,0.00007671964,0.0000701681,0.0001530082],"category_scores_gemma":[0.00010226595,0.00009487881,0.00017077022,0.0001877818,0.00016481814,0.000036278125,0.000032091964,0.00008258393,0.000011982344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027616075,0.0024859828,0.8575228,0.0006564473,0.00011633502,0.000002518207,0.00008580467,0.0000014637018,0.04319298,0.00019589139,0.00012997379,0.09284821],"study_design_scores_gemma":[0.0034528053,0.0025574383,0.9863905,0.00022818966,0.00014852798,3.9923782e-7,0.000019903424,0.000036006542,0.005170135,0.00008804548,0.0018327059,0.00007535135],"about_ca_topic_score_codex":0.00011351782,"about_ca_topic_score_gemma":0.000017626537,"teacher_disagreement_score":0.12886772,"about_ca_system_score_codex":0.00019036683,"about_ca_system_score_gemma":0.0006195239,"threshold_uncertainty_score":0.38690457},"labels":[],"label_agreement":null},{"id":"W3044304865","doi":"10.23736/s0026-4806.20.06770-1","title":"Gynecological cancers and urinary dysfunction: a comparison between endometrial cancer and other gynecological malignancies","year":2021,"lang":"en","type":"review","venue":"Minerva Medica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Endometrial cancer; Medicine; Urinary system; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.125691395050475,"score_gpt":0.3849694383832157,"score_spread":0.2592780433327407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044304865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021549752,0.99279153,0.0000042632096,0.001352018,0.00079675636,0.0012870975,0.00024829977,0.00006562598,0.0012994123],"genre_scores_gemma":[0.0010192111,0.99340475,0.00037046993,0.00055505265,0.0020303018,0.0012590998,0.00016436627,0.000057223206,0.0011395455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967844,0.0002374523,0.00089025765,0.0010115457,0.00054720824,0.0005291234],"domain_scores_gemma":[0.9968331,0.0017624206,0.00037295124,0.00037167955,0.0000814055,0.0005784485],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042061319,0.0006463564,0.0040822364,0.00022324751,0.00014517849,0.000054819368,0.00012697496,0.0007709195,0.0024341838],"category_scores_gemma":[0.0006428697,0.00041685166,0.0003854808,0.00050076394,0.00041683286,0.000037914237,0.0002246057,0.00065853726,0.00001687427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038610087,0.0003869448,0.027006788,0.004681568,0.0016315094,0.00064523757,0.00006244547,8.85036e-8,2.1297751e-7,0.000055387798,0.012206992,0.9532842],"study_design_scores_gemma":[0.0029402734,0.0014896039,0.006771894,0.009949353,0.0063674143,0.00028170456,0.00005768636,0.000002727846,0.0000011236797,0.0000051258107,0.9717555,0.0003775835],"about_ca_topic_score_codex":0.00034329054,"about_ca_topic_score_gemma":0.000089809306,"teacher_disagreement_score":0.95954853,"about_ca_system_score_codex":0.00075580983,"about_ca_system_score_gemma":0.0011089236,"threshold_uncertainty_score":0.99982834},"labels":[],"label_agreement":null},{"id":"W3044310338","doi":"10.1136/ijgc-2020-001584","title":"Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Laparotomy; Surgery; Chemotherapy; Ovarian cancer; Laparoscopy; Randomized controlled trial; Neoadjuvant therapy; Stage (stratigraphy); Cancer; Internal medicine; Breast cancer","score_opus":0.02612274058956314,"score_gpt":0.3254590829397936,"score_spread":0.29933634235023043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044310338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9060466,0.0016790186,0.00011160033,0.08997176,0.0015242342,0.00012187739,0.0000152548755,0.000014669144,0.0005149439],"genre_scores_gemma":[0.98209196,0.0019011779,0.000711864,0.013025564,0.0021296397,0.000027473843,0.000002916405,0.000010077825,0.00009930018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898213,0.000019780791,0.00032991436,0.00014640002,0.0004013739,0.00012038033],"domain_scores_gemma":[0.9991747,0.00003843096,0.00020697803,0.000054231637,0.00034984856,0.00017581318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006478991,0.000107280044,0.00028910182,0.000044945835,0.000015799478,0.000026911885,0.00012724481,0.000066464294,0.0050945333],"category_scores_gemma":[0.00008729423,0.00007182638,0.00016944189,0.00007168847,0.000045135184,0.00009704732,0.000021488993,0.00018981667,0.000026804168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008093798,0.001477113,0.7050716,0.00004834039,0.002132528,0.0026083207,0.00090838305,0.00030528114,0.008772194,0.000395306,0.030432316,0.2397548],"study_design_scores_gemma":[0.005992368,0.0015769425,0.8668391,0.00012570126,0.00012413869,0.00014245896,0.00004910603,0.000071285234,0.0057676723,0.00019165619,0.11900777,0.000111782654],"about_ca_topic_score_codex":0.000010455933,"about_ca_topic_score_gemma":0.000004492084,"teacher_disagreement_score":0.23964302,"about_ca_system_score_codex":0.00034992624,"about_ca_system_score_gemma":0.00016409678,"threshold_uncertainty_score":0.9958149},"labels":[],"label_agreement":null},{"id":"W3045112382","doi":"10.1158/1557-3265.ovca19-ia05","title":"Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Oncology; Internal medicine; Disease; Serous fluid; Serous carcinoma; Stage (stratigraphy); Cancer; Biology","score_opus":0.25871876786432835,"score_gpt":0.5325381897356704,"score_spread":0.273819421871342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045112382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93968946,0.0018012049,0.000024115232,0.05738089,0.00011554523,0.0005247094,0.00023168729,0.00002017039,0.00021222194],"genre_scores_gemma":[0.9951807,0.0021312062,0.00023895167,0.0015957649,0.0003383069,0.00035743613,0.00004469491,0.000031230993,0.000081703496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961259,0.0005944873,0.0009251903,0.0007402913,0.0011176538,0.00049647916],"domain_scores_gemma":[0.9971716,0.0012954561,0.00014099803,0.00047733547,0.000387486,0.00052713836],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023323225,0.00017587378,0.0009166015,0.00045635825,0.00005180292,0.00002350052,0.00023739254,0.00021373865,0.0044945623],"category_scores_gemma":[0.00087105174,0.00015144733,0.0004168305,0.0026925898,0.0003195485,0.000056722627,0.000118297656,0.0008934033,0.00004223221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021260403,0.0022114168,0.9334934,0.00022771733,0.004337785,0.0011262638,0.0004910185,0.0030673384,0.006417381,0.0005539684,0.0045186803,0.022294626],"study_design_scores_gemma":[0.004405544,0.00088682695,0.989123,0.0001629899,0.0005950709,6.6088404e-7,0.00006691123,0.00047066674,0.0014174844,0.00009596732,0.0026459892,0.00012891293],"about_ca_topic_score_codex":0.005763592,"about_ca_topic_score_gemma":0.0009307276,"teacher_disagreement_score":0.055785123,"about_ca_system_score_codex":0.00047974897,"about_ca_system_score_gemma":0.0014134508,"threshold_uncertainty_score":0.99641544},"labels":[],"label_agreement":null},{"id":"W3045867155","doi":"10.1016/j.jogc.2020.06.008","title":"Directive clinique no 404 : Évaluation initiale et prise en charge des masses ovariennes bénignes","year":2020,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Medicine; Gynecology","score_opus":0.034671786478384335,"score_gpt":0.28324898992940495,"score_spread":0.2485772034510206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045867155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6832255,0.20317838,0.00033580692,0.047099203,0.054838523,0.0009078838,0.00029499776,0.00001597783,0.010103696],"genre_scores_gemma":[0.9771868,0.016768903,0.0020515444,0.00304566,0.0005642473,0.00001460658,0.0000114811855,0.000028405553,0.000328349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777704,0.00045090413,0.0007488452,0.00025980698,0.0003795834,0.00038380627],"domain_scores_gemma":[0.9915195,0.0063103866,0.0006098442,0.000106757514,0.0009054848,0.0005480353],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006935595,0.0002513184,0.00071513915,0.00015428026,0.00014158331,0.000055639735,0.00011020177,0.00023636497,0.0020666632],"category_scores_gemma":[0.01263325,0.00021983756,0.00012234917,0.0004241342,0.00014775182,0.00020050872,0.000056227647,0.0005141961,0.000009609961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096575764,0.0007488819,0.5293683,0.000583357,0.0014585921,0.009983852,0.0046063447,0.00009828276,0.000023347271,0.0017035758,0.012898121,0.4384308],"study_design_scores_gemma":[0.005805291,0.004146073,0.7861871,0.00013603334,0.0012128421,0.00012707156,0.0011156142,0.00042568005,0.00034317147,0.0005804647,0.19962193,0.00029873624],"about_ca_topic_score_codex":0.019878134,"about_ca_topic_score_gemma":0.019343063,"teacher_disagreement_score":0.43813208,"about_ca_system_score_codex":0.0018830773,"about_ca_system_score_gemma":0.0064031375,"threshold_uncertainty_score":0.9992296},"labels":[],"label_agreement":null},{"id":"W3045953996","doi":"10.1016/j.jogc.2020.06.007","title":"Directive clinique no 403 : Évaluation initiale et prise en charge des masses annexielles","year":2020,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Winnipeg","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.038559502355292694,"score_gpt":0.2900048072855834,"score_spread":0.2514453049302907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045953996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57828134,0.30242342,0.00021270645,0.057660285,0.045647316,0.0008635165,0.00030086242,0.000012537921,0.014597991],"genre_scores_gemma":[0.9659781,0.028077336,0.0015832447,0.003429902,0.0004901647,0.000010424555,0.000010076656,0.000025302525,0.0003954604],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99800414,0.00041355568,0.00067167566,0.00022826402,0.00034371944,0.00033862042],"domain_scores_gemma":[0.99255776,0.0055759503,0.00054377876,0.00009446655,0.0007039376,0.0005240867],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059210206,0.00022078658,0.00063365843,0.0001346476,0.00011391169,0.000042116786,0.000096826,0.00021542229,0.0023292897],"category_scores_gemma":[0.010157084,0.00019495055,0.000110578214,0.00034724476,0.000119331715,0.00015419193,0.000048178168,0.00050679076,0.000011061194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075694814,0.00066104106,0.47947684,0.0004393478,0.0012978301,0.0091094375,0.0031021591,0.00009509193,0.000017472164,0.0008918211,0.024298226,0.48053503],"study_design_scores_gemma":[0.005693123,0.0040450827,0.6952586,0.00014391357,0.0010327308,0.00009547513,0.000921023,0.0004528587,0.00034950068,0.00036631207,0.29137966,0.0002617276],"about_ca_topic_score_codex":0.015368266,"about_ca_topic_score_gemma":0.012938154,"teacher_disagreement_score":0.4802733,"about_ca_system_score_codex":0.0018953693,"about_ca_system_score_gemma":0.0062558767,"threshold_uncertainty_score":0.9993777},"labels":[],"label_agreement":null},{"id":"W3045983904","doi":"10.1038/s41379-020-0618-9","title":"Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses","year":2020,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Tasmania; Cancer Council Victoria; Terry Fox Research Institute; Cancer Institute NSW; Canadian Institutes of Health Research; National Institutes of Health; BC Cancer Foundation; Cancer Council South Australia; Université de Montréal; Cancer Australia; National Institute for Health and Care Research; National Health and Medical Research Council; University of Cambridge; Minnesota Ovarian Cancer Alliance; Huntsman Cancer Foundation; Cancer Research UK; Michael Smith Health Research BC; Mayo Foundation for Medical Education and Research; Cancer Council NSW; Ovarian Cancer Australia; Marshfield Clinic Research Foundation; Victorian Cancer Agency; Fred C. and Katherine B. Andersen Foundation; Medical Research Council; Peter MacCallum Foundation; Cancer Research Society; Swedish Cancer Foundation","keywords":"Tissue microarray; Immunohistochemistry; Concordance; Pathology; Medicine; Ovarian cancer; Oncology; Cohort; Anatomical pathology; Internal medicine; Biology; Cancer","score_opus":0.08798721174970824,"score_gpt":0.37658822729790226,"score_spread":0.288601015548194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045983904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92196053,0.0011973971,0.0641861,0.008611066,0.00012869574,0.0020946143,0.0015055706,0.00007737495,0.00023862121],"genre_scores_gemma":[0.99012077,0.00004685206,0.006912462,0.000480821,0.0001050547,0.0012916218,0.00096273207,0.00003102017,0.000048645757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859464,0.000025424859,0.0005898063,0.0004422256,0.00007529589,0.00027257964],"domain_scores_gemma":[0.999063,0.00012438893,0.00023838047,0.0003171357,0.00015735415,0.00009975141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011137535,0.00016460421,0.00048754655,0.00009755062,0.000055139993,0.0000071162285,0.0000676679,0.00013449618,0.000009977336],"category_scores_gemma":[0.00026878843,0.00015512927,0.00015967648,0.00014652366,0.000054494627,0.000047383073,0.00002182805,0.000091384376,0.0000011961323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012057612,0.0007934268,0.08816088,0.00063238776,0.00023237073,0.0000344264,0.001988412,0.00035456204,0.8796536,0.0005021285,0.0003367485,0.026105333],"study_design_scores_gemma":[0.014238025,0.003402559,0.898464,0.00010077315,0.0010843304,0.00010265969,0.0003199819,0.01447992,0.06373363,0.0031428854,0.00063058437,0.00030061262],"about_ca_topic_score_codex":0.00008493496,"about_ca_topic_score_gemma":0.000020853868,"teacher_disagreement_score":0.81591994,"about_ca_system_score_codex":0.00020682366,"about_ca_system_score_gemma":0.00017058269,"threshold_uncertainty_score":0.6325988},"labels":[],"label_agreement":null},{"id":"W3046008757","doi":"10.1016/j.jogc.2020.01.014","title":"Guideline No. 404: Initial Investigation and Management of Benign Ovarian Masses","year":2020,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"","keywords":"Medicine; Guideline; Referral; Fertility preservation; Gynecology; Ovarian cancer; Population; General surgery; Cancer; Family medicine; Fertility; Internal medicine; Pathology","score_opus":0.024810224761230595,"score_gpt":0.2596870271049352,"score_spread":0.2348768023437046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046008757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95739913,0.009967998,0.00016909422,0.024041597,0.004571413,0.00040999695,0.00005044945,0.0000054948932,0.003384799],"genre_scores_gemma":[0.99079955,0.0010694894,0.005807105,0.0022215007,0.00006234795,0.0000020509035,0.0000065140566,0.0000074211816,0.000024051451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990613,0.000024212342,0.0004818223,0.00011088311,0.00021448755,0.00010732681],"domain_scores_gemma":[0.9988091,0.00028418534,0.00030087976,0.00006207322,0.00029307848,0.00025067173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011425642,0.00009033207,0.00031771665,0.000082840335,0.000034079752,0.000009123842,0.000041639294,0.000052865496,0.0001899817],"category_scores_gemma":[0.000490418,0.00007332465,0.000031105723,0.00018637853,0.00004273188,0.000041092942,0.000032037336,0.00011213368,3.349153e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103508915,0.0002830228,0.6694811,0.0011020767,0.0021933753,0.013013251,0.00041087475,0.0001154301,0.000086544365,0.0028929478,0.057352323,0.25296557],"study_design_scores_gemma":[0.008785215,0.0023470102,0.89464164,0.00005436273,0.00086777774,0.000086269014,0.00039509023,0.00032341812,0.0004322856,0.0002540563,0.09165579,0.00015705962],"about_ca_topic_score_codex":0.0028617862,"about_ca_topic_score_gemma":0.0014090791,"teacher_disagreement_score":0.2528085,"about_ca_system_score_codex":0.00021614123,"about_ca_system_score_gemma":0.0006246156,"threshold_uncertainty_score":0.43261835},"labels":[],"label_agreement":null},{"id":"W3046144120","doi":"10.1016/j.jogc.2019.08.044","title":"Guideline No. 403: Initial Investigation and Management of Adnexal Masses","year":2020,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Manitoba Beekeepers' Association","funders":"Royal College of Obstetricians and Gynaecologists","keywords":"Medicine; Guideline; Adnexal mass; Triage; Ovarian cancer; Population; Gynecology; Obstetrics; General surgery; Cancer; Pathology; Internal medicine; Emergency medicine","score_opus":0.0417130968315548,"score_gpt":0.3130181789908445,"score_spread":0.2713050821592897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046144120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017132043,0.99460375,0.000005292936,0.00051948795,0.0036646316,0.00033806878,0.00006261688,0.0000017565511,0.00063306023],"genre_scores_gemma":[0.00091687,0.99642456,0.002117736,0.0003256228,0.00010513631,0.0000083596615,0.000032218588,0.000019151648,0.000050335573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982285,0.000059832484,0.001077981,0.00018345242,0.0003043037,0.0001459122],"domain_scores_gemma":[0.9975269,0.00073622173,0.0010099399,0.000110596186,0.00032820427,0.00028812833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016636365,0.00022408592,0.0014893961,0.00022006285,0.000034895857,0.000012976208,0.00007760946,0.00015882743,0.00015969176],"category_scores_gemma":[0.0006273465,0.00016526443,0.00012823884,0.00029709828,0.000061498526,0.000033012937,0.00006438129,0.00028790405,7.168125e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033428435,0.000045592846,0.001170664,0.007622511,0.0011351465,0.005031422,0.000009565763,4.7551174e-7,2.1344839e-8,0.00011346502,0.0092522185,0.97561556],"study_design_scores_gemma":[0.001607225,0.0006942502,0.0027072725,0.0010447274,0.003281378,0.0001705296,0.000028506935,0.0000046345335,8.175217e-7,0.000024756664,0.9903217,0.00011420565],"about_ca_topic_score_codex":0.0018831628,"about_ca_topic_score_gemma":0.0011753323,"teacher_disagreement_score":0.9810695,"about_ca_system_score_codex":0.0007643624,"about_ca_system_score_gemma":0.002808079,"threshold_uncertainty_score":0.6739288},"labels":[],"label_agreement":null},{"id":"W3047113143","doi":"10.1158/1538-7445.pedca19-a02","title":"Abstract A02: Pediatric ovarian cancer in the United States: Incidence trends over four decades","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Ovarian cancer; Epidemiology; Germ cell tumors; Cancer; Pacific islanders; Demography; Gynecology; Oncology; Internal medicine; Population; Environmental health","score_opus":0.1579987691427776,"score_gpt":0.4452591722806307,"score_spread":0.2872604031378531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047113143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.923866,0.004532908,0.0000052564737,0.06938219,0.00011577804,0.0005531894,0.0001389799,0.00003811368,0.0013676379],"genre_scores_gemma":[0.9800516,0.014240312,0.000026622509,0.0034959796,0.0010755145,0.0008318813,0.00004267741,0.000038320628,0.00019710908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971571,0.00018797159,0.0003247384,0.0005331354,0.0011102952,0.000686754],"domain_scores_gemma":[0.99855876,0.00044468432,0.0000685353,0.00039772768,0.00020397619,0.00032633386],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007439247,0.0002053089,0.0003061999,0.0004945259,0.00015736138,0.00010206667,0.00037431216,0.000109504996,0.003559595],"category_scores_gemma":[0.00014563427,0.0001376095,0.0000927541,0.0034804158,0.000118899334,0.0001229327,0.0000914261,0.0009108845,0.00005899389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010713617,0.00052316574,0.8319461,0.0005409296,0.00023634554,0.0015897144,0.009368455,0.0012811524,0.00057490775,0.00043858425,0.10988064,0.042548656],"study_design_scores_gemma":[0.002802767,0.0003252781,0.9508347,0.00019232299,0.00008963894,0.000006154322,0.00064573064,0.00038025132,0.00044042643,0.000095164214,0.044008236,0.00017934454],"about_ca_topic_score_codex":0.01702917,"about_ca_topic_score_gemma":0.0020647496,"teacher_disagreement_score":0.1188886,"about_ca_system_score_codex":0.000653103,"about_ca_system_score_gemma":0.00079520245,"threshold_uncertainty_score":0.9973513},"labels":[],"label_agreement":null},{"id":"W3047221674","doi":"10.1016/j.jogc.2020.06.025","title":"Sex Cord Tumour with Annular Tubules—An Unusual Case of Abdominal Pain","year":2020,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Differential diagnosis; Histopathology; Pathology; Neoplasm; Cord; Abdominal pain; Surgery","score_opus":0.015389308775802038,"score_gpt":0.24101136483772986,"score_spread":0.2256220560619278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047221674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940827,0.002554698,0.00010548415,0.0022607956,0.00066789996,0.00013315538,0.000026905487,0.000002387241,0.000165959],"genre_scores_gemma":[0.99735,0.00007389924,0.0011038407,0.0013780692,0.00005739162,0.0000016037069,0.0000029718976,0.000013215196,0.000019025516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989504,0.00008593162,0.00039674246,0.00014504678,0.00024236258,0.00017948063],"domain_scores_gemma":[0.99797183,0.0008376635,0.00034008248,0.00009125051,0.00028885933,0.00047028597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002491512,0.00013115072,0.00051795645,0.00010582397,0.000052379357,0.000009842535,0.000060928756,0.000065311564,0.00017954184],"category_scores_gemma":[0.00083506753,0.00009429635,0.000047458474,0.00026253468,0.000057955272,0.00004832608,0.000016796499,0.00022864778,1.7249627e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002625729,0.0004989262,0.43920133,0.00020011816,0.00072024914,0.29588923,0.0004841073,0.000099284945,0.000052538235,0.00015358317,0.00369676,0.2587413],"study_design_scores_gemma":[0.029942418,0.057165485,0.84294015,0.00008254483,0.0023645924,0.020809473,0.008904249,0.0023429722,0.0026716406,0.00006431032,0.032067873,0.00064428744],"about_ca_topic_score_codex":0.014738707,"about_ca_topic_score_gemma":0.02394928,"teacher_disagreement_score":0.40373883,"about_ca_system_score_codex":0.0003746041,"about_ca_system_score_gemma":0.0024598395,"threshold_uncertainty_score":0.9938611},"labels":[],"label_agreement":null},{"id":"W3047413216","doi":"10.1136/ijgc-2020-001838","title":"Management of low-grade serous ovarian neoplasm in the setting of fertility preservation","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Serous fluid; Infertility; Gynecology; Work-up; Fertility; Fertility preservation; General surgery; Biopsy; Internal medicine; Population; Pregnancy","score_opus":0.04379454189632725,"score_gpt":0.3358986830964269,"score_spread":0.29210414120009964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047413216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583775,0.00032580624,0.00016951778,0.03988046,0.0002326041,0.00022130365,0.000015934284,0.0000028606862,0.0007740356],"genre_scores_gemma":[0.99738044,0.00031203558,0.0008686917,0.0012839235,0.000117390315,0.00001867132,0.0000035146086,0.0000039860993,0.000011359092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986648,0.00006638426,0.0005467375,0.0001063338,0.0005264416,0.00008932348],"domain_scores_gemma":[0.9989937,0.0002049965,0.00039960066,0.00007464383,0.0002780728,0.000048964765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003150422,0.00007635874,0.00025107284,0.00004730893,0.00001121972,0.000009322299,0.00024395416,0.000045241413,0.00032985886],"category_scores_gemma":[0.0001332986,0.000045847708,0.00012141607,0.00015206465,0.00003332161,0.00008720609,0.000048026424,0.00016343441,9.625551e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016462074,0.0015545046,0.941485,0.00025453977,0.0009946288,0.0006434803,0.0015494731,0.0022783617,0.0005855277,0.0017091527,0.0006580297,0.046641093],"study_design_scores_gemma":[0.002265738,0.00042005995,0.99398,0.00023920523,0.000088750676,0.000013262503,0.00023838937,0.00037118705,0.0011273903,0.00040290892,0.0008169406,0.00003618406],"about_ca_topic_score_codex":0.0000702614,"about_ca_topic_score_gemma":0.000040661387,"teacher_disagreement_score":0.05249498,"about_ca_system_score_codex":0.00017013105,"about_ca_system_score_gemma":0.00007845157,"threshold_uncertainty_score":0.36117232},"labels":[],"label_agreement":null},{"id":"W3047506451","doi":"10.1101/2020.08.05.20168849","title":"Re-classification of archival Ovarian Carcinoma diagnostics using immunohistologic digital quantification and algorithmic prognosis","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital Notre-Dame","funders":"","keywords":"Computer science; Perspective (graphical); Ovarian carcinoma; Digital pathology; Artificial intelligence; Stain; Biomarker; Random forest; Ground truth; Machine learning; Ovarian cancer; Medicine; Pathology; Cancer; Internal medicine; Staining","score_opus":0.0886484129179279,"score_gpt":0.3139486396994385,"score_spread":0.22530022678151057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047506451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885099,0.002331839,0.002568555,0.0039198096,0.0004080997,0.001393109,0.0002601933,0.00007072947,0.00053774554],"genre_scores_gemma":[0.9924428,0.0009212689,0.005619736,0.000044144683,0.00020299203,0.00018093784,0.00052507216,0.000048402937,0.000014639272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798596,0.00007426248,0.00064392,0.0007516379,0.00032436734,0.0002198488],"domain_scores_gemma":[0.9983375,0.00020808881,0.0005192586,0.000610584,0.00016169429,0.00016286742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015421644,0.0003309835,0.00068592967,0.00016781928,0.00007211594,0.000075090735,0.00015589828,0.00019709894,0.000017995226],"category_scores_gemma":[0.00033038316,0.00030138975,0.00017107176,0.00017527229,0.0002002711,0.000060569637,0.00022980545,0.00038705763,0.000008384753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111691836,0.0006046539,0.9660617,0.00094168604,0.00033742053,0.000088943016,0.0006262755,0.000011767566,0.0033437891,0.00068877,0.00012489763,0.02705839],"study_design_scores_gemma":[0.0008554445,0.00029547256,0.9842484,0.0004907104,0.00078649813,0.000025186282,0.00011795708,0.009441444,0.002481181,0.00070750527,0.00030088617,0.00024933004],"about_ca_topic_score_codex":0.00016254213,"about_ca_topic_score_gemma":0.0000040818545,"teacher_disagreement_score":0.026809061,"about_ca_system_score_codex":0.0001949831,"about_ca_system_score_gemma":0.00030733336,"threshold_uncertainty_score":0.9999438},"labels":[],"label_agreement":null},{"id":"W3047901579","doi":"10.3390/cancers12082222","title":"Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease","year":2020,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Institut Du Cancer de Montréal; Université de Montréal; Canadian Institutes of Health Research; Ovarian Cancer Canada","keywords":"Ovarian cancer; Context (archaeology); Disease; Cancer research; Cell culture; Serous carcinoma; Serous fluid; Malignancy; Cancer; In vivo; Biology; Biomarker; Medicine; Pathology; Internal medicine; Genetics","score_opus":0.03937848391913478,"score_gpt":0.254564843523415,"score_spread":0.21518635960428023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047901579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898762,0.00093518716,0.00058983034,0.006845285,0.00040724795,0.00055932644,0.0005431559,0.000017871313,0.00022590073],"genre_scores_gemma":[0.99726385,0.00081559597,0.00016651378,0.0013439901,0.00029457486,0.00003548203,0.000009125436,0.000017533042,0.000053346615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991173,0.000021322088,0.00022004683,0.00023415653,0.00024270179,0.00016448706],"domain_scores_gemma":[0.9993013,0.000051671526,0.00015316249,0.00029188197,0.0000975568,0.00010442204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005158948,0.00014362411,0.00029969707,0.000012007473,0.00013845418,0.000006822239,0.00019627427,0.000038239268,0.000108445834],"category_scores_gemma":[0.000042725893,0.00008340944,0.00019058539,0.00016648925,0.00010232448,0.000067199966,0.00018604606,0.00011283831,0.0000022376437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006143059,0.000424068,0.6768789,0.0015846969,0.0011860422,0.00002524105,0.014558686,0.1960128,0.100270756,0.0002470806,0.00082500716,0.0018436281],"study_design_scores_gemma":[0.02453842,0.00044198427,0.42993376,0.0014840931,0.0035034765,0.0000025336833,0.0017650414,0.32229075,0.20501505,0.00008184709,0.010247081,0.0006959573],"about_ca_topic_score_codex":0.0069898027,"about_ca_topic_score_gemma":0.00014083351,"teacher_disagreement_score":0.24694519,"about_ca_system_score_codex":0.00028201312,"about_ca_system_score_gemma":0.00054760533,"threshold_uncertainty_score":0.99962276},"labels":[],"label_agreement":null},{"id":"W3047982735","doi":"10.1016/j.pathol.2020.06.008","title":"Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases","year":2020,"lang":"en","type":"review","venue":"Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Medicine; Gynecology; Pathology; Physiology","score_opus":0.10457741295075851,"score_gpt":0.4121737636919088,"score_spread":0.30759635074115027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047982735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013953086,0.99751395,0.00008001837,0.00031459547,0.00005202162,0.00131516,0.0000852201,0.000008876971,0.00049059937],"genre_scores_gemma":[0.007602854,0.99110824,0.0005069865,0.00009148413,0.000043755088,0.00030630236,0.00030903617,0.000027969965,0.0000033666524],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996972,0.00092426396,0.0009754388,0.00047072393,0.00047351042,0.00018401691],"domain_scores_gemma":[0.9983856,0.00016184231,0.0006833211,0.0004834538,0.00021244038,0.00007335149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014052485,0.00028183585,0.0036935944,0.0004771887,0.0000091956335,0.000001880483,0.00009991462,0.00017327227,0.00024232065],"category_scores_gemma":[0.00052798656,0.00023292033,0.00079800386,0.0009345601,0.000047714708,0.000014059524,0.000049663977,0.00020397923,0.0000072763564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010972209,0.00029069348,0.00034930516,0.06259254,0.0020362833,0.0020541314,0.000051908733,0.0000049125624,0.0000015721383,0.00016955972,0.000015273206,0.9324228],"study_design_scores_gemma":[0.0043091024,0.0033448853,0.004510835,0.37585145,0.43415865,0.0027412404,0.000105273306,0.0002633609,0.000053960295,0.00008228653,0.17372914,0.00084982085],"about_ca_topic_score_codex":0.00009310314,"about_ca_topic_score_gemma":0.000026456612,"teacher_disagreement_score":0.93157303,"about_ca_system_score_codex":0.00025515145,"about_ca_system_score_gemma":0.000793263,"threshold_uncertainty_score":0.94982153},"labels":[],"label_agreement":null},{"id":"W3048693593","doi":"10.1136/ijgc-2020-001403","title":"Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Dalhousie University; Vancouver General Hospital; University of Manitoba","funders":"Cancer Council Victoria; Public Health Agency; Cancer Society of New Zealand; Cancer Institute NSW; Cancer Research UK; Scottish Government; World Health Organization; Kreftforeningen; Kræftens Bekæmpelse; Partenariat Canadien Contre Le Cancer; National Cancer Registry Ireland","keywords":"Medicine; Clinical Practice; Ovarian cancer; Cancer; Gynecology; Family medicine; Oncology; Internal medicine","score_opus":0.4470309393113331,"score_gpt":0.5072405154513994,"score_spread":0.06020957614006628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048693593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588631,0.0041069384,0.0000859817,0.03513309,0.0012886764,0.00015564017,0.000107603904,0.0000037862005,0.00025523335],"genre_scores_gemma":[0.9769364,0.019354263,0.0018625109,0.0009625741,0.0008204055,0.00004164686,0.000006022854,0.000007822401,0.000008377555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976519,0.00007399203,0.0014218744,0.00020309401,0.0005428021,0.00010637252],"domain_scores_gemma":[0.99660873,0.00058442046,0.0009814809,0.00006241232,0.0016225432,0.00014043796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019143292,0.00013839577,0.0007562896,0.0001104839,0.000012152416,0.000015489264,0.00018975904,0.00007434372,0.0005280992],"category_scores_gemma":[0.0014895682,0.00009266803,0.00019240624,0.00008044804,0.000059857543,0.00021156955,0.00006451828,0.00019818035,5.5222097e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015352656,0.0006725799,0.8480066,0.000032986823,0.0008279119,0.00014465823,0.0013738039,0.00012957906,0.0000834763,0.00013357244,0.00008648875,0.14697304],"study_design_scores_gemma":[0.0054744557,0.002381148,0.97888106,0.000517488,0.00025953734,0.000020519534,0.0022319,0.00028098255,0.0012917841,0.000016332797,0.008561809,0.000082966166],"about_ca_topic_score_codex":0.0007224944,"about_ca_topic_score_gemma":0.00034014526,"teacher_disagreement_score":0.14689009,"about_ca_system_score_codex":0.00026714953,"about_ca_system_score_gemma":0.00029924756,"threshold_uncertainty_score":0.5782316},"labels":[],"label_agreement":null},{"id":"W3048967410","doi":"10.1200/jco.20.01924","title":"PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline","year":2020,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institutes of Health","keywords":"Olaparib; Medicine; Oncology; Internal medicine; BRCA mutation; Ovarian cancer; Bevacizumab; Guideline; PARP inhibitor; Cancer; Chemotherapy; Pathology; Poly ADP ribose polymerase; Polymerase; Biology; Genetics; Gene","score_opus":0.25277200376666575,"score_gpt":0.5568653200599185,"score_spread":0.30409331629325276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048967410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018432058,0.96751297,0.000011670658,0.025777537,0.0017993473,0.0008371335,0.000020596754,0.0000032152182,0.00401911],"genre_scores_gemma":[0.00016311389,0.99210274,0.0028247403,0.0018555077,0.0028965722,0.00005749221,0.00001017468,0.000028450422,0.00006119369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914028,0.00079923135,0.0067456975,0.00028459114,0.0005492215,0.00021843812],"domain_scores_gemma":[0.9927269,0.0015542532,0.0049132193,0.00034962856,0.00021118569,0.00024479293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004389175,0.0002912022,0.0058440766,0.00016131086,0.000019383777,0.0000074952723,0.00040848795,0.00054293143,0.000180231],"category_scores_gemma":[0.00037739973,0.00014833425,0.0018347042,0.00041767836,0.00013050206,0.000033711556,0.00009421943,0.001501716,0.000014426897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025483867,0.001604311,0.00044447873,0.0031313396,0.00268306,0.003838339,0.00003124482,0.0000018420128,6.1165e-9,0.00031555307,0.026752237,0.96094275],"study_design_scores_gemma":[0.0043337904,0.004237875,0.0014694855,0.014803102,0.008457959,0.00023777688,0.000059896895,0.0000017036672,1.3311552e-7,0.00006632933,0.9662323,0.000099641606],"about_ca_topic_score_codex":0.000075971155,"about_ca_topic_score_gemma":0.000035155983,"teacher_disagreement_score":0.9608431,"about_ca_system_score_codex":0.00045076074,"about_ca_system_score_gemma":0.003254066,"threshold_uncertainty_score":0.6524292},"labels":[],"label_agreement":null},{"id":"W3049523590","doi":"10.1007/s00261-020-02705-1","title":"The follicular ring sign","year":2020,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Hepatology; Sign (mathematics); Internal medicine; Ring (chemistry); General surgery; Gastroenterology","score_opus":0.041390042907035456,"score_gpt":0.3418943740223818,"score_spread":0.30050433111534636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049523590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018017029,0.9941349,0.000042517568,0.0016092833,0.0004545653,0.0008884395,0.000008504925,0.00003242904,0.0028275524],"genre_scores_gemma":[0.00004524247,0.99755585,0.00024613072,0.00027909916,0.0010306218,0.00043320438,0.000038578302,0.000049662856,0.00032159442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984395,0.00020343867,0.0004490614,0.00044431147,0.00012262391,0.0003410642],"domain_scores_gemma":[0.99837184,0.00077506417,0.00020737443,0.00045024595,0.000025691445,0.00016978451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002000648,0.0003446424,0.0018991993,0.000048857743,0.00013817215,0.000019405834,0.00019496494,0.0002577854,0.00009906418],"category_scores_gemma":[0.00013235708,0.00018266418,0.00072900613,0.00015821324,0.00012325414,0.000011384056,0.000060122555,0.00040992833,0.0004330251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003547352,0.000028753244,0.000007683495,0.0013185453,0.0010456017,0.0010868849,0.000017938975,1.0485938e-7,1.45891e-7,0.0013728322,0.0048039365,0.9902821],"study_design_scores_gemma":[0.00054635236,0.00042835443,0.000022130145,0.002006807,0.003432075,0.0022936184,0.000009947142,0.0000047455883,9.855895e-7,0.000049406903,0.99105746,0.00014810442],"about_ca_topic_score_codex":0.000015597418,"about_ca_topic_score_gemma":0.0000030870801,"teacher_disagreement_score":0.990134,"about_ca_system_score_codex":0.00027257617,"about_ca_system_score_gemma":0.00041233067,"threshold_uncertainty_score":0.74488294},"labels":[],"label_agreement":null},{"id":"W3080183262","doi":"10.14740/jcs407","title":"Rare Presentation of a Krukenberg Tumor","year":2020,"lang":"en","type":"article","venue":"Journal of Current Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Krukenberg tumor; Medicine; Metastasectomy; Presentation (obstetrics); Signet ring cell; Surgery; Past medical history; Ovarian cancer; Radiology; Cancer; Metastasis; Internal medicine; Adenocarcinoma","score_opus":0.08271792993272689,"score_gpt":0.33513511504022697,"score_spread":0.2524171851075001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080183262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828931,0.008219214,0.00024254015,0.0072665745,0.0010307892,0.00013555255,0.000012842736,0.000007266098,0.0001920826],"genre_scores_gemma":[0.9983189,0.000757088,0.00009834511,0.00021658961,0.00058563513,0.0000026734351,0.0000054959337,0.000008506323,0.000006747951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895996,0.000042234424,0.0005075078,0.000072443996,0.00032882454,0.000089041605],"domain_scores_gemma":[0.9988671,0.00021070027,0.0004911713,0.00006905367,0.00019361463,0.00016835249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018206045,0.000074353855,0.00040241386,0.00009527173,0.000011446252,0.000006548381,0.000031900636,0.0000151068925,0.00022929665],"category_scores_gemma":[0.00024525684,0.000054480563,0.00029115932,0.00015526704,0.00001766013,0.000095030766,0.000010253137,0.00011632434,0.0000070963442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006819914,0.0007602599,0.82568437,0.0005633931,0.00026677307,0.00034322878,0.00041023176,0.000023073939,0.000707104,0.00006953332,0.11528005,0.055209998],"study_design_scores_gemma":[0.0047994517,0.0010376252,0.8357957,0.0028759562,0.0010752226,0.00044379337,0.0002567394,0.00015932527,0.036374435,0.00014073438,0.11680117,0.00023982149],"about_ca_topic_score_codex":0.0000019245244,"about_ca_topic_score_gemma":2.0452896e-7,"teacher_disagreement_score":0.05497018,"about_ca_system_score_codex":0.00003955111,"about_ca_system_score_gemma":0.00026441258,"threshold_uncertainty_score":0.25106376},"labels":[],"label_agreement":null},{"id":"W3080988574","doi":"10.1200/jco.20.01164","title":"MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Cycle for Survival; Ovarian Cancer Research Fund Alliance; Array BioPharma; Memorial Sloan-Kettering Cancer Center; Pfizer; Ovarian Cancer Research Fund","keywords":"Medicine; Hazard ratio; Chemotherapy; Internal medicine; Clinical endpoint; Oncology; Progression-free survival; KRAS; Serous fluid; Chemotherapy regimen; Surgery; Gastroenterology; Randomized controlled trial; Cancer; Confidence interval","score_opus":0.18735918239603108,"score_gpt":0.4321359889363601,"score_spread":0.24477680654032904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080988574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9098423,0.0017293687,0.0000016314099,0.08438636,0.0023077864,0.0005623753,0.000014547448,0.000008964027,0.0011466272],"genre_scores_gemma":[0.97712904,0.0045208605,0.000881414,0.014920363,0.002346603,0.000018535302,0.000003845775,0.00003852411,0.00014078326],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960539,0.00050940446,0.0022024363,0.0003602712,0.00054570864,0.0003282793],"domain_scores_gemma":[0.9953664,0.0022261892,0.0014244411,0.00033087633,0.00023305861,0.00041903518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008180338,0.0002611388,0.001972653,0.000081528706,0.000043886284,0.000009649157,0.00036308717,0.0003079555,0.00018051676],"category_scores_gemma":[0.0012559528,0.00014074604,0.0010780517,0.00040371792,0.00024525874,0.00007573921,0.00009510497,0.0011144899,0.0000072301605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15220708,0.025963163,0.37741956,0.00081053,0.00469137,0.0019297939,0.0034220426,0.00009508113,0.00084057485,0.000072688104,0.033865113,0.398683],"study_design_scores_gemma":[0.04167304,0.044783384,0.7243214,0.00051002385,0.00089582126,0.00009956567,0.00051024917,0.000114872084,0.00045794068,0.00000658654,0.18643728,0.00018979376],"about_ca_topic_score_codex":0.0000828408,"about_ca_topic_score_gemma":0.00019426268,"teacher_disagreement_score":0.39849323,"about_ca_system_score_codex":0.00050003646,"about_ca_system_score_gemma":0.0028351864,"threshold_uncertainty_score":0.5739457},"labels":[],"label_agreement":null},{"id":"W3081111599","doi":"10.1101/2020.08.21.20178830","title":"Prognostic and theragnostic biomarkers in ovarian clear cell carcinoma","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary","funders":"BC Cancer Foundation; Michael Smith Health Research BC","keywords":"Medicine; Oncology; Stage (stratigraphy); Clear cell carcinoma; Clear cell; Immunohistochemistry; Internal medicine; Overall survival; Biomarker; Ovarian cancer; Cancer research; Cancer; Biology","score_opus":0.02644656492015493,"score_gpt":0.26104349112362,"score_spread":0.2345969262034651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081111599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801921,0.004598066,0.000025869356,0.009877262,0.00038053357,0.0015702852,0.000038905684,0.00005689898,0.003260071],"genre_scores_gemma":[0.9973275,0.0006025108,0.00082376355,0.0005777359,0.00020557732,0.00027305505,0.00006731062,0.0000712155,0.000051349645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980745,0.00010088239,0.0003863728,0.0008501977,0.00025696898,0.0003311099],"domain_scores_gemma":[0.99882156,0.00021011093,0.00012993562,0.00049804,0.000042526786,0.0002978204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018228697,0.00038068995,0.00064052234,0.00017757795,0.000036891655,0.000051965097,0.00013212109,0.0002562771,0.00015791018],"category_scores_gemma":[0.00015093229,0.00032726087,0.00012843989,0.0001989992,0.000079504476,0.000024125684,0.00029120003,0.0005514878,0.000059550446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002433194,0.00037061993,0.99345213,0.00090858166,0.00020359665,0.0016575785,0.0005976015,0.000004576752,0.0002924134,0.00007048102,0.000415275,0.0017838367],"study_design_scores_gemma":[0.0025862176,0.00050007633,0.9930292,0.0005384833,0.0004883142,0.00002793935,0.000069782975,0.00037601576,0.0008781535,0.00039368673,0.0008372757,0.00027487442],"about_ca_topic_score_codex":0.00044855085,"about_ca_topic_score_gemma":0.00004720616,"teacher_disagreement_score":0.017135372,"about_ca_system_score_codex":0.00015966603,"about_ca_system_score_gemma":0.00029403655,"threshold_uncertainty_score":0.9999179},"labels":[],"label_agreement":null},{"id":"W3081580576","doi":"10.1158/1557-3265.ovca19-b15","title":"Abstract B15: BRCA haploinsufficiency promotes gluconeogenesis in fallopian tube epithelial cells","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cancer research; Ovarian cancer; Cancer; Genetics","score_opus":0.27079254864067154,"score_gpt":0.48897631166554273,"score_spread":0.2181837630248712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081580576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534131,0.0019169066,0.000006109102,0.03942097,0.00031579734,0.0012659562,0.00009106971,0.00005932834,0.0035107257],"genre_scores_gemma":[0.99288726,0.0036057758,0.00017577891,0.0015940196,0.0011625375,0.00027670985,0.000012165856,0.000047843063,0.00023794005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962934,0.00024746056,0.0008652663,0.0009155288,0.0009171335,0.000761159],"domain_scores_gemma":[0.99759215,0.00085838855,0.00008287003,0.00045201243,0.00026866252,0.00074593123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016099449,0.00021506802,0.00066202215,0.00014118147,0.000109686545,0.00005858369,0.00030908603,0.00022748458,0.0021543095],"category_scores_gemma":[0.00078303175,0.00017267736,0.0002550141,0.0007959834,0.00035905011,0.00007614446,0.00015805222,0.0010347734,0.0005321616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004597529,0.0077800537,0.6116831,0.0010520766,0.00047237458,0.0025778413,0.0015857812,0.00012163178,0.018671488,0.0004461772,0.014874063,0.33613792],"study_design_scores_gemma":[0.009269932,0.0038486063,0.87707484,0.00046834245,0.00009309068,0.0000054457255,0.00022321944,0.0004674647,0.035843078,0.00016114209,0.07215856,0.00038625786],"about_ca_topic_score_codex":0.001538088,"about_ca_topic_score_gemma":0.00045561194,"teacher_disagreement_score":0.33575168,"about_ca_system_score_codex":0.0003009293,"about_ca_system_score_gemma":0.0013054723,"threshold_uncertainty_score":0.99875784},"labels":[],"label_agreement":null},{"id":"W3081683990","doi":"10.1158/1557-3265.ovca19-a20","title":"Abstract A20: Characterizing chromosome instability in chemonaïve, chemosensitive, and chemoresistant high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chromosome instability; Serous fluid; Cancer research; Cancer; Biology; Fluorescence in situ hybridization; Ovarian cancer; Aneuploidy; Chromosome; Genome instability; Cell; Pathology; Medicine; Genetics; Gene; DNA damage","score_opus":0.21575253268963548,"score_gpt":0.46320195287107513,"score_spread":0.24744942018143964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081683990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91609186,0.0018676664,7.7381327e-7,0.07993469,0.00020655083,0.0011367468,0.00017277093,0.000060246053,0.0005286757],"genre_scores_gemma":[0.9871215,0.0075231674,0.00018020632,0.0033190353,0.0012098172,0.0004687685,0.000044130014,0.00006692472,0.000066448825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569356,0.00022852974,0.0009934066,0.0013263947,0.00087152544,0.0008865789],"domain_scores_gemma":[0.99734104,0.0007271878,0.00016010873,0.0005338264,0.0003304258,0.00090742315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015805577,0.0003388377,0.0010893766,0.00012159556,0.00015421704,0.000088709276,0.00020780027,0.0003179258,0.0010595173],"category_scores_gemma":[0.00067807024,0.00029289804,0.0001755625,0.00083210727,0.0006100566,0.00016898972,0.0002782531,0.001659571,0.00004235258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005737922,0.0027015274,0.84026253,0.0017545945,0.0005416397,0.0018364501,0.0013307787,0.0000053081985,0.045723766,0.00025658813,0.0029862495,0.09686262],"study_design_scores_gemma":[0.006615066,0.00045474825,0.9620413,0.0005606555,0.000065743625,0.0000069682874,0.00015943153,0.000072438845,0.023578905,0.00008823824,0.006081425,0.00027506138],"about_ca_topic_score_codex":0.0047643986,"about_ca_topic_score_gemma":0.001205354,"teacher_disagreement_score":0.121778764,"about_ca_system_score_codex":0.0008114794,"about_ca_system_score_gemma":0.0011297406,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W3081820231","doi":"10.1016/j.semcancer.2020.08.013","title":"New approaches for targeting platinum-resistant ovarian cancer","year":2020,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Clinical trial; Tumor microenvironment; Medicine; Immunotherapy; Disease; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","score_opus":0.11367938200029755,"score_gpt":0.38953412865109566,"score_spread":0.2758547466507981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081820231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003234275,0.99120414,0.00014679012,0.002849759,0.0010971286,0.00278526,0.0009826644,0.0000539542,0.0008770513],"genre_scores_gemma":[0.00002853737,0.9840278,0.00679336,0.00029684458,0.002210159,0.0047553936,0.0007874172,0.00013219033,0.0009682685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695987,0.000112331465,0.00093163585,0.0011809603,0.00013167104,0.00068354484],"domain_scores_gemma":[0.9984016,0.00037961546,0.0005081167,0.00039206195,0.000035544956,0.00028309016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022772238,0.0006941229,0.0030548228,0.0002135995,0.000072472896,0.000021052572,0.00026585563,0.0007081028,0.0007137306],"category_scores_gemma":[0.00009215587,0.0005317335,0.0005133532,0.00048928394,0.00008191918,0.000029511828,0.0001106817,0.0005314262,0.000019035866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016795003,0.00008253923,0.0004165572,0.008440531,0.00077023427,0.00005513235,0.00015800181,0.0000030952988,0.0000034161126,0.0007978698,0.026956942,0.9621477],"study_design_scores_gemma":[0.0015990474,0.0005638615,0.00002964125,0.019390196,0.00180337,0.000015135087,0.00003091566,0.000019469404,0.00001539014,0.00019839083,0.9758767,0.00045787223],"about_ca_topic_score_codex":0.0016364389,"about_ca_topic_score_gemma":0.00049048045,"teacher_disagreement_score":0.9616899,"about_ca_system_score_codex":0.0015206888,"about_ca_system_score_gemma":0.0028720843,"threshold_uncertainty_score":0.9997134},"labels":[],"label_agreement":null},{"id":"W3082378104","doi":"10.1158/1557-3265.ovca19-b30","title":"Abstract B30: The effect of OCP use on the incidence of precancerous p53 lesions in fallopian tube fimbria","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Serous fluid; Fallopian tube; Immunohistochemistry; Serous carcinoma; Cohort; Ovarian cancer; Fimbria; Gynecology; Cancer; Internal medicine; Gastroenterology; Oncology; Biology","score_opus":0.3328179012131451,"score_gpt":0.5237653982364876,"score_spread":0.19094749702334252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082378104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963843,0.0011332274,0.0000010588682,0.032320853,0.00013315158,0.0014467811,0.00005232251,0.000009690813,0.0010599165],"genre_scores_gemma":[0.9956194,0.0026555632,0.000015582678,0.00094387884,0.00028586813,0.00036743394,0.0000032382557,0.000021307938,0.00008773996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685377,0.0007668677,0.00071615144,0.0004273361,0.0008781063,0.00035774166],"domain_scores_gemma":[0.9878123,0.01096115,0.00014199212,0.0006683656,0.00021033597,0.0002058856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029255825,0.00014829123,0.00056802965,0.000060173756,0.00008948768,0.000023290577,0.00041019914,0.00012515923,0.0004621556],"category_scores_gemma":[0.0042171576,0.00007210715,0.00022230818,0.00064648176,0.0006281985,0.00005248573,0.0001672798,0.0011281929,0.000032903492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005306978,0.00055043545,0.9101522,0.00038869306,0.00025929898,0.000095123134,0.000595843,0.00017526101,0.00052611023,0.0006261363,0.01631977,0.065004125],"study_design_scores_gemma":[0.0024369725,0.0039790547,0.9817422,0.0009656304,0.00005947843,8.7460825e-7,0.00007931105,0.00012098465,0.0054497854,0.00005316153,0.005042945,0.000069576265],"about_ca_topic_score_codex":0.004810486,"about_ca_topic_score_gemma":0.0011854103,"teacher_disagreement_score":0.07159,"about_ca_system_score_codex":0.00017951966,"about_ca_system_score_gemma":0.0006433484,"threshold_uncertainty_score":0.7272048},"labels":[],"label_agreement":null},{"id":"W3082625691","doi":"10.1158/1557-3265.ovca19-a03","title":"Abstract A03: PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous fluid; Oncology; Ovarian cancer; Ovarian carcinoma; Subtyping; Serous carcinoma; Internal medicine; Medicine; Serous ovarian cancer; Bioinformatics; Biology; Cancer","score_opus":0.21686505764707673,"score_gpt":0.4494716190603984,"score_spread":0.23260656141332167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082625691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95116645,0.0034836465,0.00021525279,0.04046069,0.00044192869,0.003806869,0.00032687155,0.000024932011,0.00007337027],"genre_scores_gemma":[0.9942526,0.0012770781,0.0021419183,0.000598453,0.00046759399,0.0010816572,0.00005153643,0.000079915044,0.000049198155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99413973,0.0007227518,0.00227433,0.000935911,0.0013001984,0.00062707],"domain_scores_gemma":[0.99311566,0.003627944,0.0007969119,0.0009218239,0.0010797794,0.0004578925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031780496,0.00035865806,0.0013494092,0.00010173655,0.0001892924,0.000038730992,0.0005253224,0.00047989227,0.00021750577],"category_scores_gemma":[0.0016895668,0.00022456051,0.00039858537,0.0006864085,0.001232672,0.0000471959,0.00023373196,0.0012132133,0.0000059657277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014617582,0.0041058823,0.86720216,0.003585176,0.0068314797,0.0002977839,0.0021644763,0.000469784,0.009829302,0.0111045465,0.006641597,0.0731502],"study_design_scores_gemma":[0.010949677,0.0020270166,0.8887587,0.00047569483,0.0009060862,0.0000074011314,0.00031645613,0.00034980098,0.09014885,0.0008136499,0.0049654827,0.0002811457],"about_ca_topic_score_codex":0.005470538,"about_ca_topic_score_gemma":0.00046230765,"teacher_disagreement_score":0.080319546,"about_ca_system_score_codex":0.00016893676,"about_ca_system_score_gemma":0.0028980284,"threshold_uncertainty_score":0.9157312},"labels":[],"label_agreement":null},{"id":"W3083288058","doi":"10.1158/1538-7445.am2020-34","title":"Abstract 34: Predictors of discordance between image-based and manual scoring of immunohistochemical stains in ovarian cancer tissue microarrays","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tissue microarray; Immunohistochemistry; Medicine; Pathology; Stain; Ovarian cancer; Pathological; Cancer; Staining; Internal medicine","score_opus":0.06864075886924989,"score_gpt":0.41343063580473555,"score_spread":0.3447898769354857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083288058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902,0.004478562,0.000029672543,0.0049339053,0.000057697558,0.00074572937,0.00033386826,0.000011115183,0.00038948364],"genre_scores_gemma":[0.9980868,0.0008570794,0.0003899201,0.000048136117,0.00027089077,0.00025512124,0.000025502393,0.00003322685,0.00003330452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981098,0.000057948466,0.00043965917,0.00044031988,0.0005376214,0.0004146295],"domain_scores_gemma":[0.9989847,0.00018211866,0.00010893775,0.00027956255,0.00019371677,0.00025097962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003225986,0.00016410707,0.00052856776,0.00017073295,0.00004440645,0.000014235493,0.00016414808,0.00008622049,0.00027339708],"category_scores_gemma":[0.00009442445,0.00014795223,0.000058809554,0.00048589366,0.00042066074,0.000071679526,0.0000916336,0.000455832,0.0000022942183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007335992,0.00016196488,0.46117783,0.0012135516,0.0001333296,0.000068873625,0.0007175048,0.000019560011,0.53099614,0.000040009738,0.0004928964,0.00424474],"study_design_scores_gemma":[0.002768295,0.00042334976,0.47205687,0.0009743548,0.00005522238,7.3697026e-7,0.0002044689,0.00001317055,0.5226371,0.000011958724,0.0007508495,0.00010357851],"about_ca_topic_score_codex":0.0061494866,"about_ca_topic_score_gemma":0.00015852062,"teacher_disagreement_score":0.010879038,"about_ca_system_score_codex":0.00045396847,"about_ca_system_score_gemma":0.0008619557,"threshold_uncertainty_score":0.92962253},"labels":[],"label_agreement":null},{"id":"W3083732107","doi":"10.1016/j.ygyno.2020.08.032","title":"Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Paclitaxel; Oncology; Epithelial ovarian cancer; Ovarian cancer; Internal medicine; Outcome (game theory); Gynecology; Cancer","score_opus":0.06614972565820502,"score_gpt":0.3667957333078498,"score_spread":0.3006460076496448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083732107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8265181,0.0003145051,0.00006271866,0.16275401,0.0006513238,0.0011191597,0.000098655655,0.000049698527,0.008431786],"genre_scores_gemma":[0.9821826,0.00012222174,0.0038960637,0.013134566,0.00016189997,0.0003208006,0.000009918229,0.000016616663,0.00015529856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983932,0.00011340885,0.0005570156,0.00042477576,0.00014307204,0.00036857516],"domain_scores_gemma":[0.9989395,0.00034232053,0.00014693674,0.00020883455,0.00006542737,0.0002969507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025523145,0.00017851761,0.00079652027,0.00013199172,0.00002469423,0.00000407395,0.00012960681,0.0002211321,0.00195234],"category_scores_gemma":[0.0005164974,0.00014165632,0.00012589428,0.00044452213,0.00008221565,0.000028995557,0.00008862224,0.0001721633,0.00013184658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088835857,0.0009800434,0.8894223,0.000092945294,0.00027533615,0.00059514755,0.00091187475,0.000058633148,0.0023776733,0.00059915375,0.0062216977,0.097576864],"study_design_scores_gemma":[0.0061663026,0.0057200603,0.9024397,0.00003136286,0.00016786355,0.000009749224,0.00033481428,0.000042618227,0.00098616,0.00014441955,0.08379778,0.00015918333],"about_ca_topic_score_codex":0.00090877607,"about_ca_topic_score_gemma":0.0009867391,"teacher_disagreement_score":0.15566447,"about_ca_system_score_codex":0.0006446946,"about_ca_system_score_gemma":0.00038568425,"threshold_uncertainty_score":0.99896},"labels":[],"label_agreement":null},{"id":"W3084670841","doi":"10.1590/1806-9282.66.8.1134","title":"Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety","year":2020,"lang":"en","type":"article","venue":"Revista da Associação Médica Brasileira","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Medicine; Hormone replacement therapy (female-to-male); Breast cancer; Menopause; Prophylactic Surgery; Gynecology; Oophorectomy; Climacteric; Ovarian cancer; Mastectomy; Population; Hormone therapy; Surgical Menopause; Oncology; Cancer; Obstetrics; Surgery; Internal medicine; Hysterectomy","score_opus":0.029897720943665582,"score_gpt":0.26544299047790837,"score_spread":0.2355452695342428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084670841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924536,0.0085463775,0.000018436904,0.0008249798,0.000037833004,0.0010603911,0.00016935621,0.00002261565,0.000074626296],"genre_scores_gemma":[0.9976546,0.0014449283,0.00015895434,0.0003021929,0.000106643194,0.00009023082,0.00020359288,0.000035025107,0.0000037935945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766064,0.0002673123,0.00053222175,0.00043774187,0.00087292556,0.0002291401],"domain_scores_gemma":[0.9986817,0.00016998782,0.000434037,0.00022114019,0.0003251286,0.00016797522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007360976,0.00021945596,0.0006195116,0.00010261671,0.00006749293,0.000047784648,0.000047292433,0.000102873055,0.00016744809],"category_scores_gemma":[0.00024167204,0.00017991946,0.00011565506,0.0004060257,0.00006020673,0.00013828118,0.000025898855,0.00016871163,0.0000048659135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012344577,0.00042795844,0.8927245,0.000062864056,0.0003027462,0.000016629338,0.00048451632,0.00006768341,0.000013242351,0.000014789555,0.00025010225,0.10440047],"study_design_scores_gemma":[0.007880123,0.0005400394,0.990106,0.00038071585,0.00048135707,0.0000021829865,0.000052926076,0.00022966172,0.000045867855,0.0000035638382,0.000113197144,0.00016436302],"about_ca_topic_score_codex":0.000103631624,"about_ca_topic_score_gemma":0.0000067717547,"teacher_disagreement_score":0.1042361,"about_ca_system_score_codex":0.00027790212,"about_ca_system_score_gemma":0.0002786241,"threshold_uncertainty_score":0.73369026},"labels":[],"label_agreement":null},{"id":"W3085355199","doi":"10.1002/jum.15497","title":"Predictive Value of Single or Combined Ultrasound Signs in the Diagnosis of Ovarian Torsion","year":2020,"lang":"en","type":"article","venue":"Journal of Ultrasound in Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"Institute for Clinical Evaluative Sciences","keywords":"Medicine; Ultrasound; Radiology; Differential diagnosis; Ovarian torsion; Likelihood ratios in diagnostic testing; Positive predicative value; Predictive value; Diagnostic accuracy; Pathology; Internal medicine","score_opus":0.040758443491606136,"score_gpt":0.2993324975612629,"score_spread":0.2585740540696568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085355199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789443,0.0016018735,0.00021374694,0.017218856,0.00030164063,0.0006628816,0.00002421664,0.000005518995,0.001026973],"genre_scores_gemma":[0.9948435,0.0024975135,0.00064404437,0.0015045755,0.0004558897,0.000013932525,0.000011402865,0.000019764755,0.000009409859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971183,0.00024839438,0.0013395678,0.00019684434,0.00085441954,0.00024248044],"domain_scores_gemma":[0.9949964,0.0035212368,0.0007847949,0.00024249629,0.00027598796,0.0001790694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001151689,0.00021326818,0.001061617,0.00025393214,0.00003070375,0.0000070483507,0.000254452,0.00011040098,0.0005182548],"category_scores_gemma":[0.0042845896,0.000113953305,0.00015931351,0.0008882561,0.000245129,0.00013054501,0.000017454719,0.00042089575,0.0000010985327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066514425,0.0049890024,0.8728176,0.00049678766,0.0005836336,0.00060323405,0.031102942,0.00030690533,0.067030035,0.00062777114,0.013748603,0.0010420472],"study_design_scores_gemma":[0.03325322,0.073662475,0.8176662,0.0063362657,0.0015841386,0.000805596,0.023384487,0.00006549848,0.037545685,0.0008054865,0.004602665,0.00028830874],"about_ca_topic_score_codex":0.00029820026,"about_ca_topic_score_gemma":0.000053093303,"teacher_disagreement_score":0.06867347,"about_ca_system_score_codex":0.00022142529,"about_ca_system_score_gemma":0.00024755977,"threshold_uncertainty_score":0.56745267},"labels":[],"label_agreement":null},{"id":"W3086574616","doi":"10.1017/cem.2020.436","title":"Just the Facts: Ovarian torsion in the emergency department setting","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Emergency Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Dysuria; Vomiting; Nausea; Medicine; Emergency department; Abdominal pain; Abdomen; Quadrant (abdomen); Vaginal discharge; Ovarian torsion; Vaginal bleeding; Surgery; General surgery; Anesthesia; Internal medicine; Nursing; Urinary system; Pregnancy","score_opus":0.10968819215961342,"score_gpt":0.3467754396940245,"score_spread":0.2370872475344111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086574616","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31166446,0.019005902,0.000106514235,0.64823586,0.008508301,0.0010965703,0.00003021855,0.00001058523,0.0113416],"genre_scores_gemma":[0.9915939,0.0019285325,0.000056214914,0.0035780012,0.0026876323,0.000016907541,0.000014146518,0.000020709045,0.00010395396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978227,0.00014650135,0.0009482052,0.00018836428,0.00046021797,0.00043398852],"domain_scores_gemma":[0.9983451,0.00005452729,0.00032328579,0.00027715153,0.0002127352,0.00078719633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008804666,0.00020449157,0.00037367785,0.00014094096,0.00023911134,0.0000062782156,0.00032540926,0.000062037616,0.0072858185],"category_scores_gemma":[0.0006250986,0.000100277786,0.00016841713,0.00064816396,0.00005767294,0.00008296801,0.000012273407,0.00044053895,0.00002248248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115970346,0.0001164855,0.2786812,0.00011935565,0.00032786466,0.0013074261,0.026657373,0.00004895358,0.00016286124,0.0009894854,0.68569356,0.0057794773],"study_design_scores_gemma":[0.0028276136,0.0020506799,0.40074658,0.00041824084,0.00072426687,0.00013393258,0.012856811,0.000088473666,0.000061878905,0.00021461933,0.5796769,0.00019997606],"about_ca_topic_score_codex":0.005446277,"about_ca_topic_score_gemma":0.017802846,"teacher_disagreement_score":0.67992944,"about_ca_system_score_codex":0.000233093,"about_ca_system_score_gemma":0.00073382497,"threshold_uncertainty_score":0.99362165},"labels":[],"label_agreement":null},{"id":"W3087172083","doi":"10.1007/s10654-020-00682-9","title":"Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies","year":2020,"lang":"en","type":"article","venue":"European Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"Medical Research and Materiel Command; National Center for Research Resources; Cancer Council NSW; Peter MacCallum Cancer Centre; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Ovarian Cancer Research Fund; DOD Peer Reviewed Cancer Research Program; National Cancer Institute; National Institutes of Health; American Cancer Society","keywords":"Offspring; Medicine; Menarche; Odds ratio; Case-control study; Pregnancy; Polycystic ovary; Gynecology; Confidence interval; Logistic regression; Confounding; Obstetrics; Demography; Internal medicine; Physiology; Biology; Genetics","score_opus":0.06360645820604242,"score_gpt":0.3403769407401719,"score_spread":0.27677048253412945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087172083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97219306,0.014953923,0.0029828656,0.009220114,0.00012609948,0.00014259407,0.00017747971,0.0000053382323,0.00019849716],"genre_scores_gemma":[0.98856723,0.005683393,0.0046435003,0.0007434636,0.0003330779,0.0000017447543,0.0000021178603,0.000013128918,0.000012335208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662083,0.0016460215,0.0012652593,0.0001942817,0.0001155479,0.00015808389],"domain_scores_gemma":[0.99573565,0.0020996754,0.0015558609,0.0001246693,0.00030130104,0.00018284161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031428798,0.00013746035,0.0014508825,0.00022162881,0.000040381936,0.0000016596615,0.000070356524,0.000027579015,0.00009244934],"category_scores_gemma":[0.0042935563,0.00009662191,0.0003427673,0.00020383729,0.00015663536,0.000036012938,0.000041482395,0.00020816257,9.605698e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066441955,0.0001313684,0.92363274,0.00007969229,0.034613848,0.0014056426,0.001458266,0.0055445484,0.0005659299,0.00021994193,0.00031213975,0.031371437],"study_design_scores_gemma":[0.0063031213,0.0014453869,0.96239424,0.00013861367,0.022302726,0.00033624703,0.00036935578,0.0053739515,0.000235867,0.000043199165,0.00096885534,0.00008843252],"about_ca_topic_score_codex":0.00012973904,"about_ca_topic_score_gemma":0.00003214621,"teacher_disagreement_score":0.038761478,"about_ca_system_score_codex":0.000047739057,"about_ca_system_score_gemma":0.000068322144,"threshold_uncertainty_score":0.51400983},"labels":[],"label_agreement":null},{"id":"W3088958758","doi":"10.6004/jnccn.2020.7609","title":"Adjuvant Treatment of Early Ovarian Clear Cell Carcinoma: A Population-Based Study of Whole Abdominal Versus Pelvic Nodal Radiotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Medicine; Internal medicine; Radiation therapy; Hazard ratio; Stage (stratigraphy); Population; Oncology; Chemoradiotherapy; Surgery; Confidence interval","score_opus":0.046528856390585134,"score_gpt":0.32332312424064363,"score_spread":0.2767942678500585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088958758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98651576,0.010275324,0.000020242278,0.001510542,0.0011095785,0.00042889683,0.000047813122,0.000003071565,0.00008877035],"genre_scores_gemma":[0.99748707,0.00013947357,0.00094937783,0.00024051384,0.001061861,0.000018242468,0.000008782271,0.000022994363,0.000071661445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979694,0.00018393568,0.00065201253,0.0001876713,0.0008373512,0.0001696684],"domain_scores_gemma":[0.9968025,0.00036805397,0.0008274924,0.000204162,0.00170134,0.0000964621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000836234,0.00018912584,0.0006624254,0.000095540534,0.00009559061,0.0000133079375,0.00011751332,0.000058673606,0.00014911058],"category_scores_gemma":[0.00001983798,0.00013049807,0.00038869708,0.0003913277,0.000036557314,0.00005014557,0.000018858582,0.00014311718,7.551666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013745331,0.0055600265,0.81856805,0.00009892684,0.0021302588,0.00013173628,0.0012556434,0.15108342,0.0015251958,0.00007937741,0.0022048955,0.0036171053],"study_design_scores_gemma":[0.025326999,0.0058835847,0.96381,0.00019219484,0.00079974247,0.000023778925,0.00030052118,0.0007389529,0.0011553764,0.000045244036,0.0016190344,0.0001045355],"about_ca_topic_score_codex":0.00034357942,"about_ca_topic_score_gemma":0.00009071838,"teacher_disagreement_score":0.15034448,"about_ca_system_score_codex":0.0009367832,"about_ca_system_score_gemma":0.0009664122,"threshold_uncertainty_score":0.5321557},"labels":[],"label_agreement":null},{"id":"W3089048329","doi":"10.1016/j.annonc.2020.08.972","title":"833P Mirvetuximab soravtansine (MIRV), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin (CARBO) and bevacizumab (BEV): Final results from a study in patients (pts) with recurrent platinum sensitive ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; McGill University Health Centre","funders":"","keywords":"Medicine; Bevacizumab; Carboplatin; Neutropenia; Internal medicine; Ovarian cancer; Nausea; Gastroenterology; Adverse effect; Tolerability; Pharmacology; Surgery; Cancer; Chemotherapy; Cisplatin","score_opus":0.04605320350170147,"score_gpt":0.3358623265776068,"score_spread":0.28980912307590534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089048329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843574,0.00037228042,0.000007356553,0.012398997,0.00011282688,0.0019735172,0.0005055532,0.000025044603,0.00024700738],"genre_scores_gemma":[0.99745387,0.00030029865,0.00075693557,0.0006800121,0.00007572904,0.000097507334,0.0005849437,0.000040862942,0.000009863676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971381,0.00037486656,0.0008534978,0.00081120926,0.00039857335,0.00042378702],"domain_scores_gemma":[0.9982487,0.00032350738,0.00059277704,0.00021732268,0.0004139708,0.0002037304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041690862,0.00036981227,0.0011195566,0.00020017056,0.000057975696,0.00001939565,0.00007729538,0.00014177713,0.000026228396],"category_scores_gemma":[0.00017269044,0.0002974678,0.00004979118,0.00050908426,0.00011959526,0.00015009346,0.00007016914,0.00041487193,0.0000027225017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07075775,0.009511843,0.82096505,0.00013770805,0.0010185821,0.0010368855,0.032754157,0.00016362674,0.0006668266,0.000038010032,0.0009999282,0.061949614],"study_design_scores_gemma":[0.09655483,0.032512832,0.8638451,0.001029522,0.0002839204,0.000005353715,0.0018247091,0.0015342534,0.0015164897,0.000033190245,0.00047921552,0.0003806002],"about_ca_topic_score_codex":0.0099356705,"about_ca_topic_score_gemma":0.00873548,"teacher_disagreement_score":0.061569013,"about_ca_system_score_codex":0.00025561094,"about_ca_system_score_gemma":0.0004425616,"threshold_uncertainty_score":0.9999477},"labels":[],"label_agreement":null},{"id":"W3090585487","doi":"10.1016/j.gore.2020.100654","title":"Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Ovarian carcinoma; Chemotherapy; Stage (stratigraphy); Internal medicine; Oncology; Cancer research; Ovarian cancer; Cancer","score_opus":0.04087682619968563,"score_gpt":0.32753585837796856,"score_spread":0.2866590321782829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090585487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93977,0.0003378072,0.00046331758,0.048803397,0.00083048956,0.0027227576,0.00006810333,0.00015175728,0.0068524154],"genre_scores_gemma":[0.97572845,0.00009649216,0.0069895037,0.014686105,0.00076261116,0.0008083521,0.00009196627,0.00004717539,0.00078936137],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776506,0.00011231158,0.0006441786,0.0008127428,0.00017549189,0.00049021916],"domain_scores_gemma":[0.99833953,0.000386189,0.00037419915,0.00036414905,0.00018487177,0.0003510489],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040082537,0.0003274547,0.0009314832,0.00005823783,0.00017572632,0.000023089413,0.000093468036,0.00035380787,0.0018193388],"category_scores_gemma":[0.0004330357,0.00024798024,0.00026419683,0.00016460445,0.00016416452,0.0000713878,0.00004826591,0.0002660668,0.000037133635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059135924,0.0052009607,0.51200444,0.00038281461,0.0020757176,0.040214892,0.006064261,0.00009682254,0.030500628,0.0014675285,0.030668387,0.36540994],"study_design_scores_gemma":[0.015922349,0.023564462,0.37730038,0.00003759441,0.0009953057,0.0023628494,0.0010672908,0.0006224947,0.033128504,0.0006641925,0.5436987,0.00063582486],"about_ca_topic_score_codex":0.00005420062,"about_ca_topic_score_gemma":0.000047322756,"teacher_disagreement_score":0.51303035,"about_ca_system_score_codex":0.0005238985,"about_ca_system_score_gemma":0.0010536581,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W3091368850","doi":"10.1158/1078-0432.ccr-20-3331","title":"DNA Methylation Profiling of Premalignant Lesions as a Path to Ovarian Cancer Early Detection","year":2020,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Foundation","keywords":"Serous fluid; DNA methylation; Methylation; Biology; Cancer research; Ovarian cancer; Fallopian tube; Epithelial ovarian cancer; DNA; Pathology; Cancer; Medicine; Genetics; Gene; Gene expression","score_opus":0.2878266441754698,"score_gpt":0.5183152205383363,"score_spread":0.23048857636286652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091368850","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07898599,0.0025129751,0.00018140777,0.91025895,0.0014556021,0.004924997,0.0004694295,0.00009758299,0.0011130861],"genre_scores_gemma":[0.6996944,0.00820954,0.0016056921,0.2568736,0.021906769,0.008039221,0.00025962866,0.00036771936,0.003043412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936775,0.00090181944,0.0013202302,0.0013784758,0.0019068611,0.0008151073],"domain_scores_gemma":[0.99569964,0.0013292119,0.00035358436,0.0008727229,0.0011895181,0.0005552994],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016005771,0.00038791573,0.0012793954,0.00041778642,0.00020355615,0.0000667625,0.00033889202,0.0009259443,0.00083213544],"category_scores_gemma":[0.0014561823,0.00031446503,0.00051908987,0.0011852231,0.00024977257,0.000076510965,0.00026197545,0.003750876,0.00019052006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004198067,0.00085266214,0.02500832,0.0041340943,0.0025925706,0.0024953606,0.00082051323,0.000021446245,0.009131092,0.00011352658,0.68551934,0.26511303],"study_design_scores_gemma":[0.0074242065,0.012113815,0.07871204,0.009313365,0.0019651616,0.000023011833,0.0001225364,0.00019114473,0.092154466,0.0012206945,0.7956838,0.0010757451],"about_ca_topic_score_codex":0.0071321353,"about_ca_topic_score_gemma":0.00030272262,"teacher_disagreement_score":0.65338534,"about_ca_system_score_codex":0.0009846445,"about_ca_system_score_gemma":0.0029653586,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W3091787400","doi":"10.1016/j.ygyno.2020.09.051","title":"Cost-effectiveness of maintenance hormonal therapy in patients with advanced low grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Letrozole; Cost effectiveness; Cost-effectiveness analysis; Quality-adjusted life year; Maintenance therapy; Ovarian cancer; Oncology; Internal medicine; Gynecology; Cancer; Breast cancer; Tamoxifen; Chemotherapy","score_opus":0.03953761207892361,"score_gpt":0.32004834439724095,"score_spread":0.28051073231831736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091787400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924671,0.00037945644,0.000058453672,0.003747047,0.00019516944,0.0024418659,0.000049453392,0.00003403457,0.0006274092],"genre_scores_gemma":[0.99528915,0.0005687331,0.00084198266,0.0021289357,0.00004170717,0.001053585,0.000043365166,0.000021705104,0.000010859767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985107,0.00020332282,0.00029462826,0.00044619563,0.00017746596,0.00036765033],"domain_scores_gemma":[0.9988985,0.00042076368,0.00019071487,0.0001824263,0.00015665968,0.0001509172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016635895,0.0002153406,0.00075554854,0.00006119811,0.000031755404,0.000003679145,0.00010986124,0.00016734308,0.00026925927],"category_scores_gemma":[0.000097457385,0.00014633464,0.00007030782,0.00033531536,0.00013146969,0.000058003217,0.00003605474,0.00022359511,0.000008685774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065513384,0.0026536444,0.8537801,0.0001029026,0.00021392955,0.00019953432,0.00024490422,0.00049289485,0.00028736948,0.00019055711,0.00015418508,0.13512866],"study_design_scores_gemma":[0.02593501,0.015807848,0.9535446,0.00011019793,0.000056447698,0.0000034939485,0.000052594434,0.00003828284,0.0010860555,0.00007180154,0.0031497912,0.00014384398],"about_ca_topic_score_codex":0.000112157104,"about_ca_topic_score_gemma":0.00014386565,"teacher_disagreement_score":0.13498482,"about_ca_system_score_codex":0.0007564496,"about_ca_system_score_gemma":0.0004603791,"threshold_uncertainty_score":0.59673536},"labels":[],"label_agreement":null},{"id":"W3092142993","doi":"10.1186/s13045-020-00971-6","title":"High-throughput approaches for precision medicine in high-grade serous ovarian cancer","year":2020,"lang":"en","type":"review","venue":"Journal of Hematology & Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Precision medicine; Serous carcinoma; Subtyping; Throughput; Personalized medicine; Medicine; Disease; Cancer; Ovarian cancer; Computer science; Oncology; Bioinformatics; Internal medicine; Biology; Pathology","score_opus":0.12953552146891298,"score_gpt":0.41269145702113835,"score_spread":0.2831559355522254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092142993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009525425,0.95721334,0.00038500794,0.03734477,0.002685546,0.0020530564,0.000052904936,0.00001876851,0.00015132134],"genre_scores_gemma":[0.00065254566,0.9858476,0.009601208,0.0008107104,0.0021866658,0.00062880875,0.00008412086,0.0001068471,0.0000815172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950708,0.00052653346,0.0027710912,0.00068360154,0.00036845796,0.0005794734],"domain_scores_gemma":[0.99432266,0.0019848598,0.0026944368,0.00041593311,0.00021671735,0.00036539862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088265305,0.00068396836,0.009411066,0.00068600423,0.00006604496,0.000009630847,0.00039455257,0.0012772124,0.00027338704],"category_scores_gemma":[0.0004407823,0.00043999922,0.0008273776,0.0005149171,0.00025711147,0.00008319887,0.00010198172,0.001318651,0.00001751796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006394631,0.0012612272,0.00023935891,0.00936736,0.0026401912,0.0047135307,0.0002978705,0.000008902469,6.4274224e-7,0.0073408214,0.021959541,0.9515311],"study_design_scores_gemma":[0.0101730395,0.0056681787,0.00014797391,0.015195343,0.0073966077,0.0115532195,0.000076917204,0.0000065693343,0.000008568798,0.001185891,0.9483158,0.00027188775],"about_ca_topic_score_codex":0.00024369576,"about_ca_topic_score_gemma":0.00024015906,"teacher_disagreement_score":0.9512592,"about_ca_system_score_codex":0.00187453,"about_ca_system_score_gemma":0.0031264622,"threshold_uncertainty_score":0.99980515},"labels":[],"label_agreement":null},{"id":"W3092266142","doi":"10.1111/aogs.14023","title":"Carboplatin plus paclitaxel weekly dose‐dense chemotherapy for high‐grade ovarian cancer: A re‐evaluation","year":2020,"lang":"en","type":"article","venue":"Acta Obstetricia Et Gynecologica Scandinavica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Israel Cancer Research Fund","keywords":"Medicine; Carboplatin; Chemotherapy; Cohort; Ovarian cancer; Internal medicine; Stage (stratigraphy); Cancer; Survival analysis; Progression-free survival; Surgery; Oncology; Cisplatin","score_opus":0.06847039361242341,"score_gpt":0.3381578641470285,"score_spread":0.26968747053460507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092266142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73495686,0.0036547468,0.00013977074,0.24684156,0.0013959918,0.0074719694,0.00041787952,0.00038273918,0.0047384594],"genre_scores_gemma":[0.9797203,0.0015171829,0.002610952,0.012844711,0.00048166982,0.0021550127,0.00029331623,0.00008051143,0.00029636722],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966852,0.00019874751,0.0006542043,0.0010293934,0.0007348831,0.0006975826],"domain_scores_gemma":[0.9963744,0.0018429215,0.0004232322,0.0005339887,0.000341159,0.00048424644],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005062325,0.0004975575,0.0009967794,0.0001877047,0.00025834044,0.00010011791,0.0002541317,0.0004038869,0.001909751],"category_scores_gemma":[0.0019386957,0.00040037386,0.00031306007,0.0010693478,0.00008449378,0.00015145622,0.00006941376,0.00037961468,0.000031653773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011322269,0.007949037,0.19787152,0.0014469983,0.006379096,0.00095330575,0.014576623,0.00081807456,0.017025698,0.010816521,0.33211848,0.39872238],"study_design_scores_gemma":[0.049195312,0.008090608,0.84602016,0.00025723726,0.0023283982,0.000021340455,0.0009825286,0.00515485,0.003671194,0.0014483669,0.081718735,0.0011112627],"about_ca_topic_score_codex":0.00059812015,"about_ca_topic_score_gemma":0.00016445291,"teacher_disagreement_score":0.64814866,"about_ca_system_score_codex":0.0015968631,"about_ca_system_score_gemma":0.00085712614,"threshold_uncertainty_score":0.9998448},"labels":[],"label_agreement":null},{"id":"W3092697841","doi":"10.1016/j.eujim.2020.101227","title":"Complementary and alternative medicine status in ovarian cancer guidelines: A systematic review","year":2020,"lang":"en","type":"review","venue":"European Journal of Integrative Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"McMaster University","keywords":"Medicine; Cancer; Ovarian cancer; Alternative medicine; Gynecology; Systematic review; Oncology; Traditional medicine; Internal medicine; MEDLINE; Pathology; Biology","score_opus":0.1518591875724174,"score_gpt":0.4381429165270236,"score_spread":0.2862837289546062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092697841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.2715735e-7,0.9698107,0.0001788473,0.02483695,0.0006020654,0.0028433015,0.000087228036,0.000010518048,0.0016295568],"genre_scores_gemma":[0.000028260516,0.9913798,0.0005928408,0.0057397583,0.001832564,0.000079294216,0.00009661558,0.00011165513,0.00013920268],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9909695,0.0022678454,0.004924708,0.0005493853,0.0009090239,0.0003795302],"domain_scores_gemma":[0.9935228,0.0007310962,0.0036257047,0.0004122041,0.0010522592,0.0006559278],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002971664,0.0009940452,0.0099928435,0.0006815832,0.0000461846,0.000012923932,0.0003796428,0.000052916195,0.00096855435],"category_scores_gemma":[0.0037275117,0.00043481356,0.0004893024,0.0008246406,0.00036685725,0.00009633113,0.000109983965,0.0012586699,0.000019537812],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009582506,0.00013592977,0.00004563597,0.664686,0.004006102,0.009065967,0.0024760945,1.5829816e-7,0.0000012471463,0.0001756569,0.04647727,0.27283406],"study_design_scores_gemma":[0.0028527183,0.002160486,0.000028157343,0.6007707,0.010768753,0.0010051369,0.0006976998,0.000002591827,2.832002e-7,0.000009581451,0.3815314,0.00017251977],"about_ca_topic_score_codex":0.00034182653,"about_ca_topic_score_gemma":0.000056204466,"teacher_disagreement_score":0.3350541,"about_ca_system_score_codex":0.00094267575,"about_ca_system_score_gemma":0.000666017,"threshold_uncertainty_score":0.9999447},"labels":[],"label_agreement":null},{"id":"W3092702599","doi":"10.1093/aje/kwaa223","title":"Prepubertal Internalizing Symptoms and Timing of Puberty Onset in Girls","year":2020,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"National Cancer Institute; National Institutes of Health","keywords":"Menarche; Pubic hair; Hazard ratio; Medicine; Anxiety; Breast development; Proportional hazards model; Confidence interval; Breast cancer; Pediatrics; Internal medicine; Demography; Psychiatry; Cancer; Hormone","score_opus":0.054405648713143365,"score_gpt":0.35056521006169516,"score_spread":0.2961595613485518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092702599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797319,0.0016149816,0.00036481037,0.017891698,0.00006806643,0.0000762033,0.0000035072565,0.0000030764872,0.0002457508],"genre_scores_gemma":[0.9912983,0.0005936534,0.0039618784,0.004020574,0.00010640478,0.0000026773503,0.0000013740403,0.000009381417,0.00000574857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851936,0.00027712088,0.00078779383,0.00015575897,0.00007076596,0.00018918763],"domain_scores_gemma":[0.9977181,0.001199221,0.0007152651,0.000093603405,0.000056453424,0.00021737126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070710183,0.000102127386,0.00096435123,0.00010178669,0.00000943222,0.0000018004716,0.000068372094,0.000033037762,0.00007241304],"category_scores_gemma":[0.0016558623,0.000072764735,0.000117785035,0.00014062074,0.00024251413,0.0000501678,0.00003507125,0.00021637796,0.0000013110401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039801584,0.00007553536,0.9384215,0.00002604767,0.00022174393,0.00011454432,0.0005697202,0.000035558667,0.00012040059,0.00010458378,0.000637691,0.05927465],"study_design_scores_gemma":[0.0022590093,0.0054155737,0.9866172,0.00047423632,0.00020653543,0.0011522982,0.00040435206,0.0006495091,0.0004118297,0.00024048956,0.002066056,0.00010289358],"about_ca_topic_score_codex":0.0003821882,"about_ca_topic_score_gemma":0.000014604414,"teacher_disagreement_score":0.05917176,"about_ca_system_score_codex":0.000060642735,"about_ca_system_score_gemma":0.00008242138,"threshold_uncertainty_score":0.29672596},"labels":[],"label_agreement":null},{"id":"W3094751176","doi":"10.29309/tpmj/2020.27.11.4874","title":"Different types of tumors in perimenopausal women presenting with ovarian masses at A Tertiary Care Hospital.","year":2020,"lang":"en","type":"article","venue":"The Professional Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lachine Hospital","funders":"","keywords":"Medicine; Obstetrics and gynaecology; Family history; Tertiary care; Obstetrics; Obesity; Gynecology; Clinical history; Body mass index; Pregnancy; General surgery; Internal medicine","score_opus":0.010576908092392742,"score_gpt":0.27864867907723556,"score_spread":0.2680717709848428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094751176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521284,0.00087409915,0.000008633419,0.046245128,0.00018958333,0.0002944204,0.0000050671183,0.000010480214,0.00024417433],"genre_scores_gemma":[0.99808395,0.000079825884,0.00013823716,0.0010973198,0.0004348186,0.0000559314,0.0000057643265,0.000018749628,0.00008540542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980985,0.00014096276,0.00035518094,0.00017419903,0.00093729864,0.0002938902],"domain_scores_gemma":[0.999032,0.0001591644,0.00015923477,0.00011719543,0.00007580856,0.00045656067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020288688,0.00014926617,0.000352166,0.000042861255,0.00012305955,0.000011215217,0.00017203462,0.0000659672,0.0013983017],"category_scores_gemma":[0.00015912148,0.00006704312,0.000052441945,0.00011533676,0.00012769073,0.000043804135,0.00016430952,0.00057418906,0.0000067585984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077538943,0.0006940178,0.97629744,0.00023536394,0.00026141573,0.001145503,0.016261112,0.000007811399,0.00041352634,0.000094252995,0.0007550042,0.003059193],"study_design_scores_gemma":[0.00409403,0.0010586308,0.98497504,0.0015867468,0.000097526405,0.00027746274,0.00536024,0.0001359214,0.0017750717,0.00009830711,0.0004222683,0.00011878186],"about_ca_topic_score_codex":0.000011604036,"about_ca_topic_score_gemma":0.0000071150585,"teacher_disagreement_score":0.04595553,"about_ca_system_score_codex":0.00021590525,"about_ca_system_score_gemma":0.0005040455,"threshold_uncertainty_score":0.9995146},"labels":[],"label_agreement":null},{"id":"W3094761089","doi":"10.1055/s-0040-1718221","title":"Safety and efficacy of the anti-PD-1 monoclonal antibody dostarlimab in patients with recurrent or advanced dMMR endometrial cancer","year":2020,"lang":"en","type":"article","venue":"Geburtshilfe und Frauenheilkunde","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Monoclonal antibody; Interim; Endometrial cancer; Medicine; Oncology; Antibody; Monoclonal; Internal medicine; Cancer; Interim analysis; Cancer research; Clinical trial; Immunology; Political science","score_opus":0.018820455719288302,"score_gpt":0.29721890824005687,"score_spread":0.27839845252076856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094761089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900846,0.0030100911,0.000044347988,0.004474025,0.0003464851,0.0015470273,0.00020382545,0.000028077164,0.00026155487],"genre_scores_gemma":[0.9969826,0.0015516096,0.0004968379,0.0006313643,0.00016412225,0.00003794319,0.00006826645,0.000038407878,0.000028845832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979645,0.00007289181,0.0005187292,0.0005534718,0.0005155728,0.00037480335],"domain_scores_gemma":[0.99882674,0.0002152756,0.00024775334,0.00036256944,0.000118704585,0.00022898363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010732714,0.00030905244,0.00070874963,0.00011796495,0.00009251517,0.000024046667,0.0001515664,0.000098598124,0.00022703309],"category_scores_gemma":[0.00018907475,0.00017809319,0.00011334048,0.0008605745,0.00017123796,0.00011240078,0.00011543853,0.00029163118,0.0000037797363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015419563,0.0011905532,0.9489768,0.00014821811,0.0004651537,0.000028063612,0.0006199049,0.00021687533,0.00012947083,0.00014402317,0.0001479504,0.03251343],"study_design_scores_gemma":[0.034256652,0.0019001532,0.95502424,0.00045901953,0.00038256255,0.0000021236904,0.0000520389,0.000077697834,0.0006054407,0.000013790116,0.0070095914,0.00021667524],"about_ca_topic_score_codex":0.00019900066,"about_ca_topic_score_gemma":0.00012854312,"teacher_disagreement_score":0.032296754,"about_ca_system_score_codex":0.00020678264,"about_ca_system_score_gemma":0.0003292916,"threshold_uncertainty_score":0.72624296},"labels":[],"label_agreement":null},{"id":"W3095568771","doi":"10.3390/cancers12113296","title":"Measuring Quality of Life in Ovarian Cancer Clinical Trials—Can We Improve Objectivity and Cross Trial Comparisons?","year":2020,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Quality of life (healthcare); Context (archaeology); Disease; Intensive care medicine; Anxiety; Internal medicine; Psychiatry; Nursing","score_opus":0.5044922696600049,"score_gpt":0.5381287218559131,"score_spread":0.03363645219590816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095568771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013914951,0.98996997,0.000015356662,0.0007018676,0.0024530403,0.0043892628,0.000832328,0.000030216983,0.00021643827],"genre_scores_gemma":[0.012265017,0.98425907,0.00011067887,0.0001538452,0.0019056174,0.0011584657,0.000038790426,0.00007159904,0.00003694035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920654,0.0020916115,0.0037987253,0.0011324079,0.00048605647,0.00042577536],"domain_scores_gemma":[0.99401087,0.002352571,0.0022835345,0.0006246996,0.00011942453,0.0006089065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049645538,0.00061347435,0.009617753,0.00016996593,0.00006129618,0.000052752213,0.0001924222,0.00060109614,0.00010632617],"category_scores_gemma":[0.003484571,0.0004790975,0.001396003,0.00048000005,0.00030505974,0.00006024145,0.000118168435,0.0010661212,0.0000035221128],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011553363,0.00024484794,0.010296256,0.017430296,0.0021702647,0.000031176038,0.00015036034,0.000006967903,6.1652645e-7,0.00006486637,0.0005194591,0.9575315],"study_design_scores_gemma":[0.12017144,0.001376235,0.0069474583,0.02377218,0.0052671763,0.000004855106,0.00008141048,0.00003882089,0.000011203376,0.000030158903,0.8414695,0.0008295342],"about_ca_topic_score_codex":0.008959117,"about_ca_topic_score_gemma":0.0027602953,"teacher_disagreement_score":0.956702,"about_ca_system_score_codex":0.003364451,"about_ca_system_score_gemma":0.012309219,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W3096800089","doi":"10.1158/2159-8290.cd-20-0455","title":"Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Honorable Tina Brozman Foundation; Canadian Institutes of Health Research; V Foundation for Cancer Research","keywords":"Organoid; Biology; Cancer research; Ovarian cancer; KRAS; Immune system; Immunotherapy; Tumor microenvironment; PTEN; CRISPR; Cancer; Immunology; Gene; PI3K/AKT/mTOR pathway; Cell biology; Signal transduction; Genetics; Colorectal cancer","score_opus":0.05253917803458782,"score_gpt":0.3097444191373089,"score_spread":0.2572052411027211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096800089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61750513,0.033675253,0.15429482,0.18241563,0.0021621576,0.0073598973,0.0017290543,0.00024498376,0.0006130441],"genre_scores_gemma":[0.972529,0.003762239,0.00843843,0.009744249,0.0009601369,0.0039949166,0.00019722873,0.00008605954,0.00028774474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871373,0.000007813706,0.00029377293,0.00045624468,0.00018295547,0.00034548287],"domain_scores_gemma":[0.9992683,0.0001244638,0.00010935594,0.00017759092,0.00018556556,0.00013470725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006379219,0.0002389899,0.00040009344,0.0000461878,0.00014088502,0.000085481544,0.00010072142,0.00009543,0.00010493338],"category_scores_gemma":[0.000053097676,0.00019775606,0.0001686972,0.0001800361,0.000046274767,0.00020436547,0.000030345609,0.00006976308,0.0000051221145],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00887732,0.0013288126,0.15665658,0.0065893005,0.007489686,0.000042894546,0.006325438,0.0006604879,0.043577656,0.18553524,0.05984963,0.52306694],"study_design_scores_gemma":[0.053146996,0.004624105,0.29320174,0.0021457702,0.004128044,0.000019507272,0.0010274112,0.00441646,0.26733035,0.011928915,0.35563943,0.0023912631],"about_ca_topic_score_codex":0.00009556613,"about_ca_topic_score_gemma":0.0001245596,"teacher_disagreement_score":0.5206757,"about_ca_system_score_codex":0.0004898931,"about_ca_system_score_gemma":0.0008842009,"threshold_uncertainty_score":0.8064258},"labels":[],"label_agreement":null},{"id":"W3096886743","doi":"10.3390/cells9112408","title":"Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C","year":2020,"lang":"en","type":"article","venue":"Cells","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; Juravinski Cancer Centre; McMaster University; Lawson Health Research Institute","funders":"","keywords":"Clear cell carcinoma; PTEN; Cell culture; Cancer research; Clear cell renal cell carcinoma; PI3K/AKT/mTOR pathway; Biology; Clear cell; Cell; Cancer; Carcinoma; Medicine; Renal cell carcinoma; Cell biology; Genetics; Pathology; Signal transduction","score_opus":0.0157372718533717,"score_gpt":0.22895414487256563,"score_spread":0.21321687301919393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096886743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727756,0.00018409827,0.00046885133,0.0010202499,0.000036626534,0.00041526175,0.00010613992,0.0000174039,0.00047383062],"genre_scores_gemma":[0.9960306,0.000060506227,0.0023824472,0.00031021188,0.000091652,0.0000071447434,0.00017153396,0.00002716886,0.00091867935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990343,0.000054946755,0.00039388603,0.00019745977,0.0001686392,0.00015077369],"domain_scores_gemma":[0.9992345,0.00005390494,0.00023266104,0.00015281675,0.000108190274,0.00021791646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010420364,0.00012166163,0.0002700646,0.000050342063,0.000038752794,0.000013842979,0.00004601143,0.00005036921,0.0005038268],"category_scores_gemma":[0.000012043434,0.00011703025,0.000054673423,0.0001312222,0.000034927834,0.000103078135,0.000029199073,0.00006772936,0.000029619992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013370912,0.0002727106,0.0063517084,0.00040537282,0.00002378174,0.000010050295,0.004845875,0.00004966244,0.984595,0.000054176784,0.0017273964,0.00032717944],"study_design_scores_gemma":[0.0033921117,0.0006301153,0.14483361,0.00003229884,0.00011092603,0.0000018166311,0.00021168243,0.00024675473,0.84578335,0.000018070445,0.0046480657,0.00009120346],"about_ca_topic_score_codex":0.00012704197,"about_ca_topic_score_gemma":0.0000046503365,"teacher_disagreement_score":0.13881165,"about_ca_system_score_codex":0.000057986425,"about_ca_system_score_gemma":0.0002434866,"threshold_uncertainty_score":0.55165505},"labels":[],"label_agreement":null},{"id":"W3097091748","doi":"10.1055/s-0040-1718135","title":"Molecular stratification of clear cell ovarian carcinomas","year":2020,"lang":"de","type":"article","venue":"Geburtshilfe und Frauenheilkunde","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Risk stratification; Personalized medicine; Precision medicine; Oncology; Medicine; Phenotype; Bioinformatics; Somatic cell; Internal medicine; Computational biology; Biology; Pathology; Gene; Genetics","score_opus":0.025226164412056086,"score_gpt":0.260598239581208,"score_spread":0.2353720751691519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097091748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46345606,0.3753386,0.0089799035,0.07897863,0.0040799505,0.00577373,0.0009982247,0.00044603826,0.061948832],"genre_scores_gemma":[0.990538,0.0028676223,0.001790986,0.002892269,0.001251239,0.000055066215,0.00029751522,0.00013591531,0.00017136228],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99597687,0.00020848964,0.0011277028,0.0011243648,0.00082237786,0.0007401916],"domain_scores_gemma":[0.99700874,0.00014526017,0.00058771233,0.001115739,0.00028492796,0.00085761136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024948287,0.0006351365,0.0010411907,0.00016142403,0.00014918562,0.000104264844,0.00039747296,0.00044404468,0.001155099],"category_scores_gemma":[0.00010208389,0.0006442513,0.00046273714,0.0007462403,0.00026263585,0.00015448684,0.00012705024,0.00055901863,0.0010774714],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009595712,0.022125904,0.2527874,0.017320577,0.029630886,0.0071275583,0.046418674,0.007547203,0.1638053,0.25212967,0.09053968,0.10097141],"study_design_scores_gemma":[0.023400465,0.012054036,0.10864545,0.0013147098,0.022655468,0.00001398342,0.0028108219,0.0069177863,0.47124854,0.0032724536,0.34472215,0.0029441454],"about_ca_topic_score_codex":0.00047367378,"about_ca_topic_score_gemma":0.000011211184,"teacher_disagreement_score":0.52708197,"about_ca_system_score_codex":0.00027266276,"about_ca_system_score_gemma":0.0007434918,"threshold_uncertainty_score":0.999758},"labels":[],"label_agreement":null},{"id":"W3098999550","doi":"10.1136/ijgc-2020-igcs.281","title":"327 Venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Incidence (geometry); Ovarian cancer; Chemotherapy; Univariate analysis; Retrospective cohort study; Proportional hazards model; Stage (stratigraphy); Multivariate analysis; Cancer; Oncology","score_opus":0.033376243383823695,"score_gpt":0.3357510797904709,"score_spread":0.3023748364066472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098999550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9258662,0.001114583,0.00022913452,0.06993776,0.0018714549,0.0004933285,0.00007032855,0.000012880986,0.00040434056],"genre_scores_gemma":[0.98488194,0.0016647696,0.00096171576,0.01118952,0.0011590985,0.000086042455,0.000008426575,0.000018853418,0.000029666004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864644,0.000026328547,0.00050002633,0.00020654047,0.00041715428,0.00020351486],"domain_scores_gemma":[0.9987339,0.00015693775,0.00032826842,0.00006090872,0.0005484986,0.00017148939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013313653,0.00014441571,0.00050135824,0.00008105747,0.000026782933,0.000029459372,0.00020626714,0.000096614756,0.001497896],"category_scores_gemma":[0.00024876307,0.00010444748,0.00019389871,0.000106474974,0.000033196397,0.000106386986,0.000030133768,0.00022202497,0.0000040941422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00275069,0.0018872098,0.6496746,0.00003483956,0.0009452652,0.00017445319,0.00080166425,0.00046776587,0.00024685654,0.00027550603,0.0064811,0.33626008],"study_design_scores_gemma":[0.011179256,0.001820372,0.9638063,0.00020323442,0.000093593146,0.00000729264,0.00003033288,0.00014570785,0.0005466633,0.00034223727,0.021711929,0.000113116446],"about_ca_topic_score_codex":0.000085094405,"about_ca_topic_score_gemma":0.00006085993,"teacher_disagreement_score":0.33614695,"about_ca_system_score_codex":0.0007731238,"about_ca_system_score_gemma":0.00029579262,"threshold_uncertainty_score":0.99941486},"labels":[],"label_agreement":null},{"id":"W3099179122","doi":"10.1136/ijgc-2020-igcs.394","title":"454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Université Laval; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Medicine; Lymphadenectomy; Endometrial cancer; Ovarian cancer; Lymph node; Ovarian carcinoma; Carcinoma; Retrospective cohort study; Oncology; General surgery; Internal medicine; Radiology; Cancer","score_opus":0.027959555970759078,"score_gpt":0.3217667415991104,"score_spread":0.29380718562835134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099179122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991863,0.00014342698,0.0000054510815,0.0057025133,0.0006040351,0.0013282155,0.00008074223,0.000011538493,0.00026105926],"genre_scores_gemma":[0.9984885,0.000034501183,0.00007041545,0.0007596287,0.00036842827,0.00022377733,0.000009221341,0.000020054369,0.00002551262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970657,0.0001405755,0.0006754427,0.00043215908,0.0014584039,0.00022770962],"domain_scores_gemma":[0.9983388,0.00016062795,0.0004123297,0.00012535758,0.00066817424,0.0002946808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024595286,0.00023742222,0.0005313421,0.0004642062,0.000025080913,0.000075186945,0.0003732465,0.000051717405,0.0007661426],"category_scores_gemma":[0.0005205764,0.00016088662,0.00011720765,0.00043704844,0.00005480266,0.00021103496,0.000096518714,0.0003886565,0.000007312631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00952744,0.013052614,0.9668134,0.000005062638,0.0006622756,0.0056998814,0.0011710718,0.00016989945,0.0000015526222,0.00004790491,0.00004740592,0.0028014912],"study_design_scores_gemma":[0.030539032,0.010774419,0.9575058,0.00010484523,0.00010545275,0.0000034703053,0.00052844465,0.00003228429,0.0000121401,0.000020060728,0.00023160662,0.00014241306],"about_ca_topic_score_codex":0.0001913423,"about_ca_topic_score_gemma":0.00026398338,"teacher_disagreement_score":0.021011591,"about_ca_system_score_codex":0.0020480137,"about_ca_system_score_gemma":0.00035284407,"threshold_uncertainty_score":0.83887243},"labels":[],"label_agreement":null},{"id":"W3100904250","doi":"10.1136/ijgc-2020-igcs.40","title":"40 Integrated model of patient factors, resectability score and surgical complexity index to predict surgical outcome in debulking surgery for advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Debulking; Medicine; Surgery; Ovarian cancer; Cancer; Internal medicine","score_opus":0.12257249512661651,"score_gpt":0.36861874435782177,"score_spread":0.24604624923120527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100904250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507434,0.0005488252,0.0005436684,0.012407776,0.000466331,0.00054283446,0.00036231527,0.00001192997,0.00004196332],"genre_scores_gemma":[0.9979603,0.00032789007,0.0007241566,0.0006466013,0.00019554308,0.00010302967,0.000020529838,0.000015178138,0.000006747757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755764,0.00009949388,0.0011305739,0.00034244376,0.00060909986,0.00026076974],"domain_scores_gemma":[0.99712074,0.0011872408,0.00044231743,0.00009354521,0.0007808395,0.00037531706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041692922,0.00021741724,0.00091027067,0.00017029405,0.000032246815,0.000022978988,0.00017512073,0.00014014351,0.00048071923],"category_scores_gemma":[0.0010850064,0.00014678731,0.0002864204,0.00021472941,0.00012415322,0.0001229173,0.000102072,0.00035376791,2.6025174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00812211,0.00054150535,0.9658466,0.00006189646,0.00025877438,0.00023908474,0.00027634777,0.0061955377,0.000116152594,0.00020041417,0.00017380543,0.017967783],"study_design_scores_gemma":[0.0072663263,0.001369788,0.9734597,0.00048039458,0.000107259104,0.00004282705,0.00014741435,0.0122633325,0.0012017676,0.0004692565,0.00296764,0.00022427454],"about_ca_topic_score_codex":0.0003381121,"about_ca_topic_score_gemma":0.00031582903,"teacher_disagreement_score":0.01774351,"about_ca_system_score_codex":0.00079113996,"about_ca_system_score_gemma":0.0005042957,"threshold_uncertainty_score":0.59858125},"labels":[],"label_agreement":null},{"id":"W3101563407","doi":"10.1136/ijgc-2020-igcs.320","title":"370 The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Cytoreductive surgery; Chemotherapy; Ovarian cancer; Oncology; Retrospective cohort study; Stage (stratigraphy); Surgery; Serous fluid; Neoadjuvant therapy; Internal medicine; Cancer; Breast cancer","score_opus":0.03406802900001799,"score_gpt":0.32576368770970804,"score_spread":0.29169565870969005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101563407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488738,0.0019242412,0.000021664611,0.047730792,0.00085967884,0.00016352131,0.00021607726,0.000004022921,0.00020615982],"genre_scores_gemma":[0.9910191,0.006008717,0.00023921908,0.0019788775,0.000711326,0.000015110264,0.0000043686655,0.000011824968,0.0000114539025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986359,0.000059468366,0.0004887363,0.00016712432,0.00052518345,0.00012357144],"domain_scores_gemma":[0.9978821,0.00078619045,0.00059838674,0.000084568615,0.000505113,0.00014359226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017284998,0.00013627988,0.0005378853,0.000057471316,0.000022198077,0.000011683547,0.00015572843,0.00006796978,0.0013379401],"category_scores_gemma":[0.0003462328,0.000075576034,0.00020204175,0.00009975858,0.00013343323,0.00007335646,0.00003259987,0.00020748109,0.0000010606207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010608622,0.0009394608,0.8499605,0.000036174726,0.0033614365,0.00021132265,0.001079905,0.00043620018,0.009460072,0.0008063058,0.0033152662,0.11978475],"study_design_scores_gemma":[0.0036756026,0.0010411888,0.97385335,0.0002824347,0.00014352094,0.000009287587,0.0002565129,0.000027313614,0.01823832,0.00028758062,0.0021053886,0.000079473495],"about_ca_topic_score_codex":0.00041575625,"about_ca_topic_score_gemma":0.000052649793,"teacher_disagreement_score":0.123892896,"about_ca_system_score_codex":0.00023307337,"about_ca_system_score_gemma":0.00034594582,"threshold_uncertainty_score":0.99957496},"labels":[],"label_agreement":null},{"id":"W3102113072","doi":"10.1002/ijc.33395","title":"Multiple lines of chemotherapy for patients with high‐grade ovarian cancer: Predictors for response and effect on survival","year":2020,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Chemotherapy; Oncology; Internal medicine; Medicine; Cancer; Overall survival","score_opus":0.01423803261996081,"score_gpt":0.31216809821021746,"score_spread":0.29793006559025664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102113072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978034,0.00043466178,0.00034391627,0.019436838,0.0006954864,0.00055746303,0.0004890188,0.0000046978926,0.000003874414],"genre_scores_gemma":[0.9971033,0.0003360588,0.00082273077,0.00073043467,0.00084979524,0.000102602426,0.000014282017,0.000022350969,0.00001846151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913365,0.000024779529,0.00026493767,0.00012910186,0.00035898536,0.000088548666],"domain_scores_gemma":[0.99847716,0.0005001194,0.00030667792,0.000050234972,0.00056288665,0.00010293043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012951027,0.00011357444,0.00030853102,0.00007183301,0.000018409695,0.000012338271,0.00008030208,0.000036271536,0.000035443067],"category_scores_gemma":[0.00015239239,0.000073850926,0.000103214945,0.000045146433,0.00003161118,0.00005496163,0.0000070972887,0.00006196631,9.307713e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097918466,0.00036632406,0.8724501,0.000088900575,0.0021309578,0.000007257649,0.00027797482,0.00022953318,0.0011343764,0.000049702718,0.00095360895,0.02439281],"study_design_scores_gemma":[0.03991744,0.010256619,0.9113443,0.0005844834,0.00033931024,0.0000024463468,0.000012491113,0.0001937305,0.022200102,0.000026522952,0.015032927,0.00008964499],"about_ca_topic_score_codex":0.00008122306,"about_ca_topic_score_gemma":0.000028929235,"teacher_disagreement_score":0.058001027,"about_ca_system_score_codex":0.00014912058,"about_ca_system_score_gemma":0.00017845431,"threshold_uncertainty_score":0.30115536},"labels":[],"label_agreement":null},{"id":"W3102241214","doi":"10.1136/ijgc-2020-igcs.20","title":"20 Long-term survival outcomes of intravenous vs intraperitoneal chemotherapy in the treatment of advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Internal medicine; Serous fluid; Proportional hazards model; Stage (stratigraphy); Oncology; Retrospective cohort study; Surgery; Cancer; Gastroenterology","score_opus":0.03785718218444149,"score_gpt":0.35207448689682785,"score_spread":0.31421730471238635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102241214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94839907,0.0019311607,0.00003740581,0.04827284,0.0007737018,0.0003256507,0.00007646861,0.0000045139186,0.00017916708],"genre_scores_gemma":[0.98669535,0.010167436,0.0002587056,0.0022920272,0.00048391146,0.000060792107,0.0000067938436,0.000012123928,0.000022838669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828553,0.00007160099,0.00071197894,0.00017549154,0.00058657856,0.00016883702],"domain_scores_gemma":[0.9986045,0.00032526918,0.0005064785,0.00010857375,0.00034847794,0.000106732055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001322735,0.0001800326,0.0007365495,0.00008337433,0.000016740127,0.000013153853,0.00029545944,0.00008417942,0.0015776918],"category_scores_gemma":[0.00006708133,0.00009932938,0.00029178557,0.00014929823,0.0001065162,0.00006919375,0.000016230919,0.00016203262,0.0000011751123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003139028,0.0028049978,0.8470259,0.000027437301,0.0013376646,0.0004546849,0.0018761854,0.0003750374,0.0011856128,0.00018268586,0.00007945451,0.14151134],"study_design_scores_gemma":[0.008558178,0.0044053434,0.98043865,0.00009732883,0.00016930744,0.000026260352,0.00014433487,0.000019028801,0.0036824723,0.000049988477,0.0023245262,0.000084571686],"about_ca_topic_score_codex":0.00018243614,"about_ca_topic_score_gemma":0.000333277,"teacher_disagreement_score":0.14142677,"about_ca_system_score_codex":0.0004962028,"about_ca_system_score_gemma":0.00029901596,"threshold_uncertainty_score":0.999335},"labels":[],"label_agreement":null},{"id":"W3102299777","doi":"10.1136/ijgc-2020-002122","title":"MEK inhibition for low-grade serous ovarian cancer: are we there yet?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Serous fluid; Serous ovarian cancer; Ovarian cancer; Oncology; Disease; Cancer; Internal medicine; Gynecology","score_opus":0.07077248093687619,"score_gpt":0.3541726584955367,"score_spread":0.28340017755866054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102299777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.586086,0.0063053826,0.0010212597,0.4027032,0.0024792347,0.00059656147,0.00035516117,0.000036842994,0.00041637587],"genre_scores_gemma":[0.9810363,0.005958782,0.00082140986,0.009944013,0.0019487282,0.00014699319,0.000013218752,0.00002046488,0.000110093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985827,0.00003440688,0.00047730186,0.00022428056,0.00048687772,0.00019438616],"domain_scores_gemma":[0.9982969,0.00022651882,0.0004934122,0.0000677673,0.0006690259,0.00024633837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011627523,0.00016623421,0.00041329244,0.00006547871,0.00004797496,0.000045933528,0.00016707063,0.00011609221,0.0026555602],"category_scores_gemma":[0.0002033839,0.00011502482,0.0002916975,0.00010366238,0.000048473783,0.00012607992,0.000037906415,0.00024701803,0.000009395572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011859828,0.0048181703,0.39180174,0.00058205053,0.008007932,0.006299888,0.0019989018,0.0053430623,0.008682281,0.0055777184,0.2276268,0.32740164],"study_design_scores_gemma":[0.030697212,0.0056640473,0.54688513,0.002497111,0.0012681235,0.00037437945,0.00070571015,0.0013424102,0.021842757,0.0046343417,0.3834046,0.0006841416],"about_ca_topic_score_codex":0.0000528128,"about_ca_topic_score_gemma":0.00009755586,"teacher_disagreement_score":0.39495033,"about_ca_system_score_codex":0.0006676601,"about_ca_system_score_gemma":0.00031058802,"threshold_uncertainty_score":0.99825615},"labels":[],"label_agreement":null},{"id":"W3102390828","doi":"10.1136/ijgc-2020-igcs.1","title":"1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Javelin; Avelumab; Ovarian cancer; Oncology; Medicine; Chemotherapy; Internal medicine; Biomarker; Cancer; Immunotherapy; Biology; Nivolumab","score_opus":0.0672957544888583,"score_gpt":0.3820117891237232,"score_spread":0.31471603463486486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102390828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95619744,0.00049751025,0.00013657368,0.04192642,0.00030090386,0.000799663,0.00007582315,0.000008485477,0.00005718989],"genre_scores_gemma":[0.9930378,0.0013062344,0.0006514257,0.0044409707,0.00032836653,0.00014698933,0.000040445033,0.000022346363,0.000025392685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982651,0.00010829783,0.0005495332,0.000316081,0.00056396745,0.00019701074],"domain_scores_gemma":[0.99872977,0.000376625,0.00041329305,0.0000972419,0.00024161616,0.00014144351],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014845218,0.00024851874,0.00059830886,0.00012908413,0.000049730083,0.00006832187,0.00017940089,0.0000981389,0.0013668401],"category_scores_gemma":[0.00009862836,0.000119732504,0.00013450104,0.0003079793,0.000077408724,0.00017405223,0.000018141342,0.00021301971,0.0000010056963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19548029,0.003664144,0.6638776,0.0000043256,0.0022743854,0.00047767322,0.0010689868,0.00008477761,0.00009659546,0.000019587234,0.00022177205,0.13272986],"study_design_scores_gemma":[0.2635332,0.008010595,0.7252169,0.00020861294,0.00023456647,0.000005786344,0.0001305123,0.0003524648,0.00030512147,0.000046610203,0.0018205318,0.00013505001],"about_ca_topic_score_codex":0.0018296705,"about_ca_topic_score_gemma":0.001291336,"teacher_disagreement_score":0.13259481,"about_ca_system_score_codex":0.0010046771,"about_ca_system_score_gemma":0.00045018047,"threshold_uncertainty_score":0.99954605},"labels":[],"label_agreement":null},{"id":"W3104873517","doi":"10.1016/j.ejogrb.2020.11.021","title":"A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma","year":2020,"lang":"en","type":"review","venue":"European Journal of Obstetrics & Gynecology and Reproductive Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Serous fluid; Ovarian carcinoma; Medicine; Serous carcinoma; Internal medicine; Hormone receptor; Oncology; Ovarian cancer; Receptor; Hormone; Carcinoma; Cancer; Breast cancer","score_opus":0.06418821554478821,"score_gpt":0.3205640825059292,"score_spread":0.256375866961141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104873517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020545539,0.9968365,0.000016754124,0.0009776118,0.00028034995,0.0015433395,0.00008174527,0.0000053960403,0.00005288452],"genre_scores_gemma":[0.0038255597,0.9950707,0.0006509398,0.00019440071,0.000083305735,0.00004001881,0.000040769417,0.000039956296,0.000054348897],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9925826,0.003783205,0.0024277025,0.0008118453,0.00014906081,0.00024557754],"domain_scores_gemma":[0.99369967,0.00205796,0.00312773,0.0006029765,0.00030837048,0.00020327294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022691672,0.0004846324,0.010941905,0.0011186939,0.00004522009,0.00000888393,0.00021870184,0.00020866006,0.000050429437],"category_scores_gemma":[0.0062770597,0.00027728977,0.0013765077,0.0015850173,0.00022974626,0.000048989667,0.00016632314,0.00071559,0.000005006623],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013014143,0.0013730937,0.0007782938,0.56571877,0.39944002,0.0040321173,0.0008829344,0.0000013190908,0.000034485412,0.0001572885,0.0006067098,0.026844822],"study_design_scores_gemma":[0.0011649051,0.0024915207,0.0017521868,0.012379424,0.9381267,0.000771008,0.00006080792,4.6751316e-7,0.00000667849,0.0000091594775,0.04294244,0.00029471514],"about_ca_topic_score_codex":0.000002765726,"about_ca_topic_score_gemma":5.940952e-7,"teacher_disagreement_score":0.55333936,"about_ca_system_score_codex":0.00017397302,"about_ca_system_score_gemma":0.00021072465,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W3108883225","doi":"10.1016/j.jpag.2020.11.017","title":"Diagnostic Performance of a Sonographic Volume and Solid Vascular Tissue Score (VSVTS) for Preoperative Risk Assessment of Pediatric and Adolescent Adnexal Masses","year":2020,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Adnexal mass; Receiver operating characteristic; Malignancy; Retrospective cohort study; Likelihood ratios in diagnostic testing; Population; Area under the curve; Cohort; Surgery; Internal medicine","score_opus":0.01845983366528844,"score_gpt":0.28481475686571206,"score_spread":0.26635492320042364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108883225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97771,0.018721782,0.0007422654,0.0015726879,0.00021202645,0.0009601863,0.0000652236,0.0000068738673,0.000008923626],"genre_scores_gemma":[0.8733028,0.1237549,0.0017000801,0.00026911404,0.0009142717,0.00002348273,0.0000054352163,0.000021788164,0.000008104528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806637,0.00011883193,0.00087597634,0.0003385807,0.00029566386,0.00030460805],"domain_scores_gemma":[0.9975883,0.0005502815,0.0009515633,0.00013246409,0.0003970496,0.00038036867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039096884,0.00027728933,0.0009977773,0.00028000862,0.000098975266,0.000020000969,0.00008961428,0.0001551049,0.000032670854],"category_scores_gemma":[0.0005117072,0.00021762493,0.00017054378,0.00027555175,0.00012341615,0.0001458396,0.000087943175,0.00036919696,4.9585213e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027252643,0.00092792127,0.9886285,0.0027111052,0.0002895508,0.00003763907,0.00024295916,0.00008745093,0.000047005622,0.00001466776,0.0029353036,0.0038053845],"study_design_scores_gemma":[0.0064543425,0.008299524,0.97901946,0.00017234341,0.0038231767,0.00005096309,0.0001763733,0.0010906311,0.00016210163,0.000019035906,0.00055185694,0.00018018455],"about_ca_topic_score_codex":0.0000049777486,"about_ca_topic_score_gemma":0.0000029641083,"teacher_disagreement_score":0.10503312,"about_ca_system_score_codex":0.00007015604,"about_ca_system_score_gemma":0.0004038095,"threshold_uncertainty_score":0.8874487},"labels":[],"label_agreement":null},{"id":"W3109189658","doi":"10.1016/j.jmig.2020.11.025","title":"Short- and Long-Term Complications of Intraoperative Benign Ovarian Cyst Spillage: A Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Spillage; Meta-analysis; Term (time); Surgery; General surgery; Internal medicine; Waste management","score_opus":0.09204266855853824,"score_gpt":0.3660289064144494,"score_spread":0.27398623785591114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109189658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053379474,0.9930787,0.000030142935,0.0033768872,0.00003658955,0.0030224167,0.0003136909,0.000004601679,0.00008356829],"genre_scores_gemma":[0.002036868,0.995364,0.0008048599,0.0012650462,0.000049198658,0.00034546902,0.00007098231,0.000035856785,0.000027733615],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955164,0.0007408316,0.002762266,0.00046911277,0.00029393152,0.00021744765],"domain_scores_gemma":[0.9932964,0.0024498128,0.0026670825,0.00046887738,0.000771006,0.00034686463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005641472,0.00054746395,0.014611495,0.00050650956,0.00006515007,0.000031724772,0.00023891673,0.00026418743,0.00043194197],"category_scores_gemma":[0.0013014912,0.00033433182,0.00238494,0.0006078078,0.00021068745,0.000073956886,0.00011568745,0.00046643298,0.0000056634804],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013911759,0.00031681158,0.00015102918,0.59512275,0.39917323,0.0011705316,0.00012550691,2.1149292e-7,0.0000019337801,0.00019458827,0.00021828419,0.0035112242],"study_design_scores_gemma":[0.00044719383,0.0014703826,0.00162318,0.029409733,0.95934457,0.003302961,0.000030428899,3.1561297e-7,0.0000017163775,0.0000068988534,0.0041490397,0.00021357706],"about_ca_topic_score_codex":0.0000028696836,"about_ca_topic_score_gemma":0.00007167132,"teacher_disagreement_score":0.565713,"about_ca_system_score_codex":0.0002167638,"about_ca_system_score_gemma":0.0008613664,"threshold_uncertainty_score":0.9999109},"labels":[],"label_agreement":null},{"id":"W3110214443","doi":"10.1101/2020.11.30.20219220","title":"Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Institute of Cancer Research; Public Health Ontario; University of British Columbia; BC Cancer Agency; Alberta Health Services; University of Toronto; University Health Network; Vancouver General Hospital; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec","funders":"","keywords":"Single-nucleotide polymorphism; Logistic regression; Lasso (programming language); Odds ratio; Ovarian cancer; Oncology; Internal medicine; Ancestry-informative marker; SNP; Medicine; Genotype; Statistics; Demography; Biology; Cancer; Genetics; Computer science; Mathematics; Gene","score_opus":0.04964059415981059,"score_gpt":0.2940334132573094,"score_spread":0.24439281909749883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110214443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8710794,0.005556877,0.093794785,0.0033879555,0.0027536908,0.0030827334,0.019846508,0.00016444491,0.00033361823],"genre_scores_gemma":[0.9754896,0.012282609,0.008916426,0.000088343215,0.0017383848,0.0010041225,0.0002927836,0.00008447781,0.000103219776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979495,0.000081952414,0.000606999,0.00074316026,0.00033876038,0.000279672],"domain_scores_gemma":[0.9982376,0.00012202295,0.0006336233,0.0006047418,0.00018978262,0.00021223989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003178391,0.0003418239,0.000800855,0.000119459524,0.00008856232,0.000017787754,0.00015102902,0.00032060887,0.00012747772],"category_scores_gemma":[0.0001035828,0.00029454,0.0005316901,0.00012435055,0.00005129762,0.000028628248,0.00012704273,0.00058075023,0.000009652496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016477564,0.00067196816,0.9299186,0.0017531468,0.004366062,0.000023967617,0.0014115358,0.032817096,0.0007525792,0.00034366018,0.001327647,0.024966009],"study_design_scores_gemma":[0.011850305,0.00140564,0.57521373,0.0020489828,0.013639936,0.000007715023,0.00007248159,0.35929072,0.015113219,0.009180376,0.011515453,0.0006614211],"about_ca_topic_score_codex":0.0029782269,"about_ca_topic_score_gemma":0.00006842211,"teacher_disagreement_score":0.35470483,"about_ca_system_score_codex":0.0002341175,"about_ca_system_score_gemma":0.0004995064,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W3110977585","doi":"10.1136/ijgc-2020-esgo.103","title":"197 Can D-dimers and fibrinogen aid in the diagnosis of ovarian cancer?","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Russian Science Foundation","keywords":"Fibrinogen; Biomarker; Medicine; Internal medicine; Ovarian cancer; Malignancy; Gastroenterology; Prospective cohort study; Oncology; Logistic regression; Debulking; Cancer; Biology","score_opus":0.05399880983272408,"score_gpt":0.3389683208829947,"score_spread":0.28496951105027063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110977585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86923045,0.003254908,0.000006937658,0.1265249,0.00033982308,0.00017133431,0.00006474662,0.0000032470234,0.0004036383],"genre_scores_gemma":[0.98602533,0.006057991,0.00020101781,0.0071961177,0.00043874828,0.000061447565,0.0000025015484,0.0000064554824,0.000010415593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988421,0.000057785233,0.0004074503,0.00013971877,0.0004286757,0.000124249],"domain_scores_gemma":[0.99901515,0.00031485024,0.00027117843,0.000059434573,0.00021937801,0.00012002328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016795573,0.00010511843,0.0003155785,0.00006730945,0.000018608614,0.000018792261,0.00021249345,0.00005923987,0.0011260117],"category_scores_gemma":[0.00020816171,0.00006180315,0.00011963614,0.00013289649,0.00007987394,0.00005639434,0.0000432597,0.00021121681,0.0000010584815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004940739,0.00026653017,0.944655,0.000022878332,0.00047325224,0.00047679368,0.00086865027,0.00021758994,0.00023554884,0.0004030571,0.0026471417,0.04923951],"study_design_scores_gemma":[0.0035328981,0.0009759758,0.97151023,0.00017899416,0.00018052649,0.00006748642,0.00025395953,0.00005547343,0.0023117438,0.00019407766,0.020657271,0.00008136324],"about_ca_topic_score_codex":0.00068535237,"about_ca_topic_score_gemma":0.00036598393,"teacher_disagreement_score":0.119328775,"about_ca_system_score_codex":0.00022955102,"about_ca_system_score_gemma":0.00022854285,"threshold_uncertainty_score":0.9997871},"labels":[],"label_agreement":null},{"id":"W3111315732","doi":"10.3390/cancers12123730","title":"CA125 and Ovarian Cancer: A Comprehensive Review","year":2020,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":622,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Ovarian cancer; Medicine; Oncology; Stage (stratigraphy); Cancer; Biomarker; Malignancy; Internal medicine; Asymptomatic; Gynecology; Biology","score_opus":0.07995013189302502,"score_gpt":0.381761733883036,"score_spread":0.301811601990011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111315732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.1469056e-7,0.9925464,0.000001401618,0.0027977517,0.00045690985,0.0024339177,0.0003067124,0.00006254299,0.0013941557],"genre_scores_gemma":[9.368614e-7,0.9921778,0.00013798235,0.005158606,0.0005848524,0.0014597153,0.00014725105,0.00008703593,0.00024583394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813086,0.00007341563,0.00051610824,0.00073847466,0.00023070502,0.00031044375],"domain_scores_gemma":[0.99862874,0.00008878136,0.00031274388,0.00044495275,0.00008821,0.00043657294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000045699722,0.0005495343,0.0033329907,0.00007662525,0.00006448546,0.000023354862,0.00011304614,0.00018411451,0.0005663976],"category_scores_gemma":[0.000025130605,0.00041391593,0.00048796384,0.0004130058,0.000097706834,0.000033052613,0.000073029885,0.00040500963,0.000076699485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007446625,0.000007501961,0.00000754403,0.14064193,0.0008900005,0.000251968,0.000022230199,1.2529874e-7,2.2675279e-8,0.000056543846,0.040267922,0.8178468],"study_design_scores_gemma":[0.00057999766,0.00012134653,0.000013762936,0.1810868,0.007516836,0.00014710883,0.000005803944,0.0000015230753,1.9632975e-7,0.0000027632996,0.81025577,0.00026808798],"about_ca_topic_score_codex":0.0007497407,"about_ca_topic_score_gemma":0.00002817865,"teacher_disagreement_score":0.8175787,"about_ca_system_score_codex":0.0031438097,"about_ca_system_score_gemma":0.0043492597,"threshold_uncertainty_score":0.99983126},"labels":[],"label_agreement":null},{"id":"W3111709373","doi":"10.1002/ijgo.13542","title":"The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10‐year survival from advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Chemotherapy; Ovarian cancer; Oncology; Surgery; Retrospective cohort study; Internal medicine; Neoadjuvant therapy; Stage (stratigraphy); Cancer; Breast cancer","score_opus":0.02285218992094553,"score_gpt":0.3017376854986549,"score_spread":0.27888549557770936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111709373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728823,0.0034153627,0.000023134467,0.021085102,0.0021766748,0.00011856588,0.000106160864,0.000002953169,0.00018978336],"genre_scores_gemma":[0.9913026,0.007512013,0.00031125773,0.00051918684,0.00031121928,0.000003520065,0.0000056756458,0.000012804283,0.000021733098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877137,0.00005657256,0.00051515753,0.00012823801,0.0004136542,0.000114982955],"domain_scores_gemma":[0.9941244,0.004237606,0.00071388273,0.00009408745,0.000710207,0.00011982971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017383062,0.00011051307,0.0004483494,0.00013352386,0.000026579457,0.000010282118,0.00014465842,0.00007014641,0.00022437349],"category_scores_gemma":[0.0022903734,0.00007347831,0.00015512374,0.00016295188,0.00010903399,0.00006411027,0.000027533362,0.00016760366,0.0000016577384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006815441,0.0010388286,0.74089617,0.000035466554,0.005188712,0.00041659852,0.0015142281,0.00019577923,0.005010054,0.0012404892,0.0045690746,0.23307917],"study_design_scores_gemma":[0.006822978,0.0016599054,0.9565,0.00019805683,0.00021049807,0.000021701058,0.0005630045,0.00004225849,0.02378035,0.00032897203,0.009774702,0.00009759776],"about_ca_topic_score_codex":0.00007259881,"about_ca_topic_score_gemma":0.00001437143,"teacher_disagreement_score":0.23298156,"about_ca_system_score_codex":0.00021104193,"about_ca_system_score_gemma":0.00037937044,"threshold_uncertainty_score":0.29963586},"labels":[],"label_agreement":null},{"id":"W3111826093","doi":"10.1101/2020.12.04.20244046","title":"A Comprehensive Epithelial Tubo-Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors","year":2020,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; European Commission; University College London; Cancer Research UK; Government of Canada; Fondation du cancer du sein du Québec; Canadian Institutes of Health Research; National Institute for Health and Care Research; Genome Canada","keywords":"Epidemiology; Medicine; Oncology; Ovarian cancer; Percentile; Relative risk; Risk assessment; Epithelial ovarian cancer; Population; Internal medicine; Genetic epidemiology; Polygenic risk score; Genetic model; Demography; Gynecology; Cancer; Environmental health; Biology; Statistics; Genetics; Confidence interval; Genotype; Gene; Computer science; Single-nucleotide polymorphism","score_opus":0.06537153310662838,"score_gpt":0.3083089333775914,"score_spread":0.24293740027096303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111826093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265636,0.0029138688,0.0071274936,0.0021600795,0.00069472706,0.0013564548,0.0028062484,0.00018184028,0.00010290666],"genre_scores_gemma":[0.97409964,0.010943056,0.012977635,0.00037504622,0.00087048544,0.00043791058,0.00020889335,0.00006802403,0.000019306177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967393,0.0004283077,0.0008080124,0.0012856243,0.00036135578,0.00037739993],"domain_scores_gemma":[0.99761665,0.0003844883,0.0007958006,0.0005621478,0.00016098162,0.00047991364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027953796,0.0006220855,0.0012971289,0.00011022686,0.00021317237,0.000047267597,0.00014871264,0.00053422427,0.000081487444],"category_scores_gemma":[0.00046707425,0.00045867416,0.00030416079,0.00013317488,0.00018933786,0.000038837214,0.00045494264,0.0014473073,0.000011754854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016470514,0.00014150093,0.96882486,0.00025176353,0.000805372,0.0000803915,0.00053816976,0.02267318,0.00020914826,0.000056221685,0.0002545065,0.006000155],"study_design_scores_gemma":[0.0014522405,0.00031347954,0.7862026,0.00029369805,0.0014810936,0.000010152824,0.000049170554,0.20511475,0.00018977521,0.004424058,0.00019587373,0.0002731069],"about_ca_topic_score_codex":0.0034819425,"about_ca_topic_score_gemma":0.00007844893,"teacher_disagreement_score":0.18262228,"about_ca_system_score_codex":0.00028302576,"about_ca_system_score_gemma":0.00034983695,"threshold_uncertainty_score":0.9997865},"labels":[],"label_agreement":null},{"id":"W3112053888","doi":"10.1097/pgp.0000000000000725","title":"The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting","year":2020,"lang":"en","type":"review","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Session (web analytics); Pathology; Immunohistochemistry; Medicine; Computer science; World Wide Web","score_opus":0.027779698077167157,"score_gpt":0.34355675212700426,"score_spread":0.3157770540498371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112053888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16103595,0.82071763,0.0000047637564,0.0135286655,0.0017485119,0.0011116283,0.00011692005,0.0000140091215,0.0017219263],"genre_scores_gemma":[0.1123226,0.8861454,0.0002695779,0.00057253183,0.00040456848,0.00008590853,0.00001554743,0.000026129273,0.00015772639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629277,0.00035672967,0.0019462932,0.0004067306,0.00068399624,0.00031348853],"domain_scores_gemma":[0.9929358,0.002884317,0.0031232617,0.00022646174,0.0007398153,0.000090339454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001410385,0.00039405358,0.001879497,0.000059160193,0.00016242053,0.000025283935,0.0010345709,0.0006288956,0.00027253333],"category_scores_gemma":[0.0023388774,0.0001636051,0.0014344178,0.00027393704,0.00087405555,0.000054798755,0.00080971495,0.0013890531,0.0000072736952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028953876,0.010281287,0.14827304,0.00780035,0.009369655,0.010181756,0.0031943587,0.00010547296,0.013759825,0.005382107,0.13450311,0.65425366],"study_design_scores_gemma":[0.005861616,0.0036655408,0.15783224,0.012961445,0.0032494343,0.014321474,0.0014967232,0.000042297866,0.00088376715,0.0018564269,0.79714715,0.0006818898],"about_ca_topic_score_codex":0.0000062291647,"about_ca_topic_score_gemma":0.0000038768585,"teacher_disagreement_score":0.662644,"about_ca_system_score_codex":0.0009540351,"about_ca_system_score_gemma":0.00041914033,"threshold_uncertainty_score":0.66716224},"labels":[],"label_agreement":null},{"id":"W3112073541","doi":"10.15574/hw.2019.140.92","title":"Fallopian tubes and ovarian cancer (Literature review)","year":2019,"lang":"en","type":"article","venue":"HEALTH OF WOMAN","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fallopian tube; Ovarian cancer; Serous fluid; Serous carcinoma; Salpingectomy; Medicine; Incidence (geometry); Disease; Gynecology; Cancer; Pathology; Oncology; Internal medicine; Pregnancy; Biology","score_opus":0.01250765449576328,"score_gpt":0.3222496619943438,"score_spread":0.3097420074985805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112073541","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2694647,0.6238794,0.0000013733987,0.10064844,0.0003478962,0.001547919,0.000060470964,0.000033050463,0.0040167538],"genre_scores_gemma":[0.52432525,0.4433459,0.0006569453,0.029896481,0.00015878431,0.00009434697,0.000043993758,0.000023401277,0.0014548593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992142,0.000027524533,0.00023223458,0.00020836382,0.00013660481,0.00018109933],"domain_scores_gemma":[0.9994446,0.000017456565,0.00006323572,0.00025227672,0.000052622367,0.00016979636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012226164,0.00010294736,0.00040618793,0.000035507597,0.00002748822,0.000005387197,0.000030273977,0.000040277315,0.0003354065],"category_scores_gemma":[0.000007751285,0.00007633718,0.00004677092,0.0001293449,0.000018410929,0.000034140707,0.000015527692,0.00009554697,0.000014401384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014407736,0.00041210558,0.78960234,0.036689512,0.00024289943,0.000057007495,0.001172301,5.8317545e-7,0.00010357218,0.004090102,0.09116678,0.076318726],"study_design_scores_gemma":[0.002459927,0.00088780705,0.76884085,0.022518912,0.00007108871,0.000063601045,0.000037454887,0.00001007964,0.00012654772,0.00004135616,0.20482333,0.000119028955],"about_ca_topic_score_codex":0.0002787082,"about_ca_topic_score_gemma":0.000064426546,"teacher_disagreement_score":0.25486058,"about_ca_system_score_codex":0.00008773376,"about_ca_system_score_gemma":0.00019156691,"threshold_uncertainty_score":0.3672466},"labels":[],"label_agreement":null},{"id":"W3112428377","doi":"10.1136/ijgc-2020-esgo.151","title":"557 Peritoneal cancer index (PCI) as a predictor of completeness of cytoreduction at primary and interval debulking surgery in advanced ovarian cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Debulking; Conventional PCI; Hyperthermic intraperitoneal chemotherapy; Ovarian cancer; Surgery; Oncology; Cancer; Internal medicine; Cytoreductive surgery; Myocardial infarction","score_opus":0.041210008967156826,"score_gpt":0.32598918462867055,"score_spread":0.28477917566151373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112428377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148125,0.0050434424,0.000052407344,0.011677857,0.0012663786,0.00022980415,0.00012814111,0.00000777943,0.00011296137],"genre_scores_gemma":[0.9932219,0.0046324087,0.00021855303,0.001178338,0.0006150597,0.00007973874,0.00001027994,0.000017033808,0.00002671399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979423,0.000069256195,0.0009174746,0.0002584189,0.00062350737,0.00018902036],"domain_scores_gemma":[0.9980012,0.0003288975,0.0007972782,0.00007402031,0.000611415,0.00018714675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020293586,0.00018248503,0.00080486474,0.00018131234,0.00002555896,0.000013082566,0.00016218676,0.000116783536,0.0015037677],"category_scores_gemma":[0.0002451944,0.00014076801,0.00021089117,0.00017982625,0.00015982025,0.00017397794,0.00011563612,0.0002591547,5.807679e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054652705,0.00042174303,0.92766476,0.00016445878,0.00061674934,0.00024446065,0.00054741336,0.0009892493,0.008294412,0.0000593463,0.0003921824,0.055139937],"study_design_scores_gemma":[0.0043174126,0.0006697351,0.98619133,0.0009733227,0.000152466,0.000114140916,0.00011989336,0.0003500908,0.0045856927,0.00006164699,0.002338153,0.00012613539],"about_ca_topic_score_codex":0.0009783187,"about_ca_topic_score_gemma":0.0004348143,"teacher_disagreement_score":0.058526535,"about_ca_system_score_codex":0.0011878274,"about_ca_system_score_gemma":0.0006980635,"threshold_uncertainty_score":0.999409},"labels":[],"label_agreement":null},{"id":"W3113056049","doi":"10.18203/2320-1770.ijrcog20205412","title":"Dynamic analysis of serum Ca-125 levels during neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer: a retrospective study","year":2020,"lang":"en","type":"article","venue":"International Journal of Reproduction Contraception Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Ovarian cancer; Proportional hazards model; Oncology; Univariate analysis; Pathological; Cancer; Multivariate analysis","score_opus":0.00914015292188127,"score_gpt":0.27560093614056097,"score_spread":0.2664607832186797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113056049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922656,0.00055783516,0.0001519691,0.0056867627,0.00081461825,0.00041661217,0.000093310526,0.000005579859,0.000007720532],"genre_scores_gemma":[0.99847215,0.0010011917,0.0002671498,0.00011088397,0.00009595645,0.000012018853,0.000008280549,0.0000110385035,0.000021314714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851304,0.00005608913,0.00057657633,0.000334424,0.00040627338,0.00011357996],"domain_scores_gemma":[0.9978897,0.00012713787,0.0006758564,0.00012276447,0.0011021267,0.00008240664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018807137,0.00012598374,0.0005508447,0.0006108722,0.000029625342,0.000015385607,0.00007456171,0.00005599161,0.00022619478],"category_scores_gemma":[0.00080239575,0.000101695456,0.000101621656,0.0007702095,0.00004027733,0.00015071398,0.000018357183,0.00018666888,5.154758e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012812519,0.001072144,0.9055026,0.000009131833,0.0026786805,0.00006042437,0.0009980071,0.0020941528,0.00047804497,0.000011997582,0.0000028448007,0.08581071],"study_design_scores_gemma":[0.016055875,0.0022124837,0.97978973,0.000033345514,0.0006034662,0.000009365486,0.00035236,0.0003947237,0.0002753502,0.000010460528,0.00018200693,0.000080830796],"about_ca_topic_score_codex":0.000038868857,"about_ca_topic_score_gemma":0.000087342836,"teacher_disagreement_score":0.08572988,"about_ca_system_score_codex":0.00056906074,"about_ca_system_score_gemma":0.00010697611,"threshold_uncertainty_score":0.41470203},"labels":[],"label_agreement":null},{"id":"W3114147615","doi":"10.1016/j.ygyno.2021.04.007","title":"The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Meta-analysis; Confidence interval; Cochrane Library; Internal medicine; Serous fluid; Oncology; Radiology","score_opus":0.13709746604118384,"score_gpt":0.42873708932970644,"score_spread":0.2916396232885226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114147615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117624404,0.99156344,0.0000056299123,0.0014237629,0.00013003076,0.005887421,0.0004906507,0.000016811238,0.00036463307],"genre_scores_gemma":[0.0016545049,0.9944464,0.00027862826,0.00058016967,0.000040006762,0.0023368201,0.00017522596,0.000031885527,0.00045636587],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895917,0.005163796,0.0033214372,0.0010021876,0.00035567355,0.0005651615],"domain_scores_gemma":[0.9804012,0.015759733,0.0021714002,0.0010608836,0.00039729523,0.0002094703],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002974901,0.0006753499,0.021110505,0.0002711482,0.00012434919,0.000028733291,0.0003295884,0.0006827529,0.0004345878],"category_scores_gemma":[0.0012440144,0.00034689793,0.003994385,0.001251792,0.00037723628,0.000028970891,0.00035493902,0.0008838702,0.000017302473],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057108038,0.001382763,0.0012253743,0.6928683,0.28166217,0.006818842,0.00013209421,0.0000032617422,1.96362e-8,0.0038073047,0.00014206332,0.011900685],"study_design_scores_gemma":[0.0012131736,0.0014992913,0.0010699121,0.008348802,0.85724443,0.00015958106,0.000107617234,0.0000030952917,1.0005985e-7,0.000016616958,0.13007154,0.00026584166],"about_ca_topic_score_codex":0.00025850607,"about_ca_topic_score_gemma":0.00013944958,"teacher_disagreement_score":0.6845195,"about_ca_system_score_codex":0.00083432125,"about_ca_system_score_gemma":0.0014933709,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W3114683151","doi":"10.1016/j.jmig.2020.12.030","title":"Surgical Technique for Sentinel Lymph Node Sampling in Presumed Early-stage Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Sentinel lymph node; Stage (stratigraphy); Dissection (medical); Indocyanine green; Ovarian cancer; Endometrial cancer; Lymph node; Radiology; Biopsy; Surgery; Cancer; Breast cancer; Pathology; Internal medicine","score_opus":0.05129032665540067,"score_gpt":0.32571584650726126,"score_spread":0.2744255198518606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114683151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97482055,0.0007182237,0.0006334862,0.021962747,0.00025942846,0.000910092,0.00005501331,0.00001442448,0.0006260203],"genre_scores_gemma":[0.9850871,0.00086190127,0.010312969,0.0026559865,0.00065381045,0.0002976211,0.000008886302,0.000039831826,0.000081876584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981687,0.000090063455,0.00083972345,0.00029801094,0.00021269252,0.00039080923],"domain_scores_gemma":[0.9973747,0.0013131717,0.00052803895,0.00013835302,0.00034222126,0.00030349437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032322828,0.00021390933,0.0008157086,0.00019001075,0.00004524844,0.000018880426,0.0001648791,0.00022667096,0.00045463993],"category_scores_gemma":[0.0010176398,0.00017857653,0.00029404627,0.00020318704,0.000068066875,0.00009178615,0.0000575019,0.00031172542,0.000006312198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004007053,0.0009830873,0.9517185,0.00047025192,0.0008448553,0.004296516,0.0008601266,0.00026382325,0.032660376,0.00044062574,0.0015463802,0.0019084195],"study_design_scores_gemma":[0.020107275,0.0016290966,0.9390464,0.00043477074,0.00046871192,0.00040322728,0.00020796264,0.000077242556,0.020071657,0.00014260532,0.017141897,0.00026914047],"about_ca_topic_score_codex":0.000062659026,"about_ca_topic_score_gemma":0.00005100303,"teacher_disagreement_score":0.01930676,"about_ca_system_score_codex":0.00037037753,"about_ca_system_score_gemma":0.0011253258,"threshold_uncertainty_score":0.72821397},"labels":[],"label_agreement":null},{"id":"W3116720339","doi":"10.1136/ijgc-2020-esgo.229","title":"599 Circulating tumour cells in breast and ovarian cancer: size-based isolation and ex vivo expansion","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Ovarian cancer; Cancer research; Circulating tumor cell; Intravasation; Metastasis; Population; Ex vivo; Breast cancer; Biology; Cancer; Cancer cell; Immunology; Medicine; In vivo; Internal medicine","score_opus":0.022826020674859053,"score_gpt":0.29641004577317814,"score_spread":0.2735840250983191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116720339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548778,0.0009558289,0.00019825998,0.04329113,0.00035477913,0.0001576765,0.000041102612,0.000008219226,0.00011520054],"genre_scores_gemma":[0.9938394,0.0009952309,0.00080535567,0.0038519232,0.000469239,0.000015956783,0.0000019414704,0.000010034546,0.000010954225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888796,0.000045136425,0.00040096164,0.00020217165,0.00033250108,0.00013129652],"domain_scores_gemma":[0.99904215,0.00026463956,0.00023068955,0.000037858168,0.00023829924,0.00018637137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014491276,0.00012568152,0.0003009123,0.00007300821,0.000029092407,0.000042038373,0.00007269232,0.00007805215,0.0010614863],"category_scores_gemma":[0.00012640044,0.00009432422,0.00006805028,0.000095036565,0.00004357002,0.00012089598,0.000034970646,0.0002124725,0.0000012055815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012918818,0.0003753583,0.8786811,0.00006159925,0.0002492017,0.0009790873,0.0004363874,0.00289322,0.058680702,0.000104040766,0.0005594581,0.055687957],"study_design_scores_gemma":[0.0053893696,0.00044992872,0.9828739,0.00033397612,0.00009435315,0.000108724744,0.00008051044,0.0068290215,0.0028401546,0.00009088609,0.0007948789,0.000114261034],"about_ca_topic_score_codex":0.00022489816,"about_ca_topic_score_gemma":0.00008199594,"teacher_disagreement_score":0.10419283,"about_ca_system_score_codex":0.00035464866,"about_ca_system_score_gemma":0.0002186154,"threshold_uncertainty_score":0.9998517},"labels":[],"label_agreement":null},{"id":"W311717631","doi":"10.1007/s00262-002-0343-x","title":"A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma","year":2003,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Calicheamicin; Immunoconjugate; Medicine; Ovarian cancer; Internal medicine; Ovarian carcinoma; Gastroenterology; Adverse effect; Oncology; Cytotoxic T cell; Monoclonal antibody; Cancer; Myeloid leukemia; Antibody; Immunology; Chemistry","score_opus":0.01381652151134338,"score_gpt":0.2800756681982798,"score_spread":0.2662591466869364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W311717631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915382,0.0033498346,0.000010680619,0.00036586315,0.0008106229,0.0035609312,0.00010835551,0.00003063292,0.00022484353],"genre_scores_gemma":[0.99815756,0.00047947015,0.00007352063,0.00040040957,0.000038101392,0.00066182954,0.000023402528,0.00008117775,0.0000845333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970991,0.0005093225,0.0008135813,0.0006316702,0.0003594224,0.00058688415],"domain_scores_gemma":[0.99792254,0.000108783715,0.00048003998,0.0011450915,0.00028305774,0.000060494596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026054092,0.0004982949,0.0009736353,0.00022670582,0.0001784643,0.00001906319,0.000260902,0.00019418339,0.00023637962],"category_scores_gemma":[0.00003350484,0.00032977626,0.00018088479,0.00065611297,0.00034991404,0.000105857514,0.000047289086,0.00056590175,0.000011091947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022633355,0.024644354,0.87117606,0.00004671952,0.0037407682,0.000073256575,0.012234239,0.000035395966,0.030985631,0.0003164341,0.000052158888,0.03406165],"study_design_scores_gemma":[0.09680605,0.011394045,0.8538429,0.0003102918,0.0002428059,0.000020144602,0.0010884902,0.000007825891,0.034924958,0.000030947147,0.0009987361,0.00033282168],"about_ca_topic_score_codex":0.001542237,"about_ca_topic_score_gemma":0.00027330217,"teacher_disagreement_score":0.07417269,"about_ca_system_score_codex":0.00076298945,"about_ca_system_score_gemma":0.00053789327,"threshold_uncertainty_score":0.9999154},"labels":[],"label_agreement":null},{"id":"W3118676518","doi":"10.1038/s43018-020-00166-5","title":"Advances in ovarian cancer, from biology to treatment","year":2021,"lang":"en","type":"article","venue":"Nature Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Department of Medicine, University of Toronto; University of Toronto","keywords":"Ovarian cancer; Serous ovarian cancer; Poly ADP ribose polymerase; Biology; Cancer research; DNA damage; DNA repair; Medicine; Serous fluid; Cancer; Computational biology; Bioinformatics; Polymerase; Oncology; Internal medicine; DNA; Genetics","score_opus":0.013911185943450064,"score_gpt":0.3619975744557835,"score_spread":0.3480863885123334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118676518","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3251018,0.59188163,0.00005744917,0.06654437,0.004137294,0.0010199697,0.0010926444,0.000076004864,0.010088803],"genre_scores_gemma":[0.9314426,0.05773916,0.0012465003,0.006642363,0.001050142,0.0009284413,0.00014381624,0.000028828987,0.00077815214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987838,0.000034528548,0.0001905819,0.00056689105,0.00012327483,0.00030090605],"domain_scores_gemma":[0.9992834,0.00006762914,0.00004459893,0.00032584523,0.00010148062,0.00017706466],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000027534046,0.00020707674,0.00043852063,0.00008374552,0.000033795226,0.000012695875,0.000058772497,0.00026125344,0.0020962148],"category_scores_gemma":[0.000030428644,0.00015830906,0.00009460118,0.00040433716,0.000021130802,0.000055511748,0.000026650689,0.0002459152,0.000026423539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033011253,0.00054840837,0.4755449,0.00002769058,0.0002718812,0.00042459145,0.00038959383,0.0000971521,0.0037141242,0.0013261264,0.0022030075,0.5151224],"study_design_scores_gemma":[0.0041239136,0.00024604818,0.2223291,0.00034455553,0.00017109128,0.0000054868365,0.00005646716,0.000008423034,0.0348375,0.00047231754,0.73721457,0.00019052939],"about_ca_topic_score_codex":0.0037852493,"about_ca_topic_score_gemma":0.020387104,"teacher_disagreement_score":0.7350116,"about_ca_system_score_codex":0.001181742,"about_ca_system_score_gemma":0.00059125037,"threshold_uncertainty_score":0.998816},"labels":[],"label_agreement":null},{"id":"W3118976699","doi":"10.1007/s10637-020-01043-9","title":"The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial","year":2021,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Fondation du cancer des Cèdres; Frank McGraw Memorial Chair in Cancer Research","keywords":"Pembrolizumab; Ovary; Medicine; Clinical trial; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.029754829291786605,"score_gpt":0.29047536963805537,"score_spread":0.2607205403462688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118976699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925253,0.00043778514,0.0000016139046,0.005698724,0.00021267166,0.00076341187,0.0002756554,0.000005036373,0.00007982461],"genre_scores_gemma":[0.99880254,0.00006165283,0.0005509371,0.0002339205,0.00010962281,0.000021878486,0.00015768157,0.000009934243,0.0000518404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837345,0.00019707,0.0006400282,0.00026779863,0.00039647036,0.00012520308],"domain_scores_gemma":[0.99854994,0.0005697549,0.00028459958,0.00029728864,0.00014325338,0.00015517368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018999478,0.0001419829,0.00034205092,0.000027694574,0.00011414887,0.000012418399,0.0000620283,0.000048015852,0.00004081915],"category_scores_gemma":[0.00025875488,0.0000804391,0.000094304734,0.00021677457,0.00034768847,0.000050682724,0.00007387556,0.00014892663,6.282526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21154156,0.02728388,0.69013035,0.00023118375,0.0010321547,0.0006987948,0.0085007455,0.000084202125,0.0002890185,0.0022177573,0.0064171124,0.05157324],"study_design_scores_gemma":[0.33129847,0.0064250333,0.6505957,0.001008991,0.000549686,0.0000841639,0.0002926353,0.00003911065,0.0044758776,0.001401625,0.0036191093,0.00020954995],"about_ca_topic_score_codex":0.00025955564,"about_ca_topic_score_gemma":0.00017812039,"teacher_disagreement_score":0.119756915,"about_ca_system_score_codex":0.00007156566,"about_ca_system_score_gemma":0.0009865673,"threshold_uncertainty_score":0.32802114},"labels":[],"label_agreement":null},{"id":"W3119279423","doi":"10.1136/ijgc-2020-esgo.223","title":"596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)","year":2020,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Nintedanib; Medicine; Internal medicine; Chemotherapy; Topotecan; Clinical endpoint; Oncology; Progression-free survival; Ovarian cancer; Phases of clinical research; Gastroenterology; Urology; Cancer; Clinical trial","score_opus":0.03735796590788373,"score_gpt":0.32496898208309755,"score_spread":0.2876110161752138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119279423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476016,0.00022593867,0.000014879053,0.00325246,0.00036904358,0.001190833,0.000056488476,0.000003604229,0.0001266158],"genre_scores_gemma":[0.9983029,0.00008455073,0.00019202048,0.0011975969,0.00013113294,0.000052689862,0.0000030853678,0.000013719532,0.000022322009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978998,0.0001150833,0.00080665,0.00020319645,0.0008290276,0.00014627058],"domain_scores_gemma":[0.99801505,0.00031641606,0.0006529368,0.00012828123,0.0007253221,0.0001619763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019627402,0.00016564367,0.0006694639,0.00017767132,0.000025180256,0.000009285407,0.00034317427,0.00004811556,0.0013274481],"category_scores_gemma":[0.00026923622,0.00008458337,0.00017741074,0.00042954195,0.000050743165,0.000053477626,0.00008663172,0.0002542316,0.000001020145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21509731,0.023187269,0.7364605,0.00004090761,0.00093496713,0.00015428502,0.0031137194,0.00043473835,0.00052601006,0.0000070367732,0.0016882378,0.018355016],"study_design_scores_gemma":[0.18124072,0.033503264,0.7810154,0.00016209779,0.00017190639,0.000004631522,0.00037034886,0.00006176717,0.0022323972,0.000003316357,0.0011439335,0.00009019431],"about_ca_topic_score_codex":0.0000863213,"about_ca_topic_score_gemma":0.000069119036,"teacher_disagreement_score":0.044554915,"about_ca_system_score_codex":0.0003875416,"about_ca_system_score_gemma":0.00027067552,"threshold_uncertainty_score":0.99958545},"labels":[],"label_agreement":null},{"id":"W3120238974","doi":"10.1158/0008-5472.can-20-2222","title":"Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Ovarian Cancer Canada; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Canada Foundation for Innovation","keywords":"KRAS; CDKN2A; Selumetinib; Cancer research; Neuroblastoma RAS viral oncogene homolog; Targeted therapy; MEK inhibitor; Medicine; Synthetic lethality; Cancer; Biology; Mutation; Gene; Internal medicine; Kinase; Genetics; DNA repair; MAPK/ERK pathway","score_opus":0.05249500699688612,"score_gpt":0.36017261681159723,"score_spread":0.3076776098147111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120238974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962274,0.0008627601,0.000078813,0.0019274127,0.0002094483,0.00047841787,0.00018076219,0.0000098199025,0.000025194187],"genre_scores_gemma":[0.99892235,0.0006074161,0.000080679114,0.000037906633,0.00012963459,0.000060885104,0.00006882038,0.000019414008,0.00007288069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982417,0.00037382616,0.00029537943,0.0003740867,0.00046501466,0.000249983],"domain_scores_gemma":[0.9986105,0.00014058842,0.000090123474,0.00034715317,0.00069675257,0.00011488242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000650631,0.0001172995,0.00034853638,0.0001390457,0.00009178867,0.000026453488,0.00003854782,0.000092934184,0.00009499622],"category_scores_gemma":[0.00007819887,0.000106472486,0.0000812133,0.00040953775,0.00031719627,0.000067467794,0.00008139062,0.00017784003,0.0000011709442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039677252,0.0004338469,0.11443757,0.00065867923,0.00027160137,0.00009874905,0.0004917733,0.0000048213897,0.87369764,0.000050083545,0.000020806432,0.009437633],"study_design_scores_gemma":[0.0012493455,0.00008746085,0.46656305,0.00013980037,0.00006445841,0.000018864708,0.00015078516,0.00024709676,0.53137124,0.000031344895,0.000026126567,0.000050452007],"about_ca_topic_score_codex":0.0012570021,"about_ca_topic_score_gemma":0.00026292627,"teacher_disagreement_score":0.35212547,"about_ca_system_score_codex":0.00021373114,"about_ca_system_score_gemma":0.00052324415,"threshold_uncertainty_score":0.4341822},"labels":[],"label_agreement":null},{"id":"W3120699816","doi":"10.1002/cjp2.198","title":"Adult‐type granulosa cell tumor of the ovary: a <scp><i>FOXL2</i></scp>‐centric disease","year":2021,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Canada Research Chairs","keywords":"Missense mutation; Nonsense mutation; Biology; Germline mutation; Mutation; Mutation frequency; Genetics; Granulosa cell; Cancer research; Ovary; Gene","score_opus":0.10800653284159625,"score_gpt":0.4426626189510554,"score_spread":0.3346560861094592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120699816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755552,0.006703764,0.00001093275,0.015530318,0.0007341301,0.00031611542,0.000028518549,0.000004483278,0.0011165529],"genre_scores_gemma":[0.98834914,0.008769213,0.00019386197,0.0015107659,0.00048618784,0.0000060002058,0.0000033088345,0.000018009552,0.0006635108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942717,0.0029308086,0.0010301549,0.00023987037,0.0010531944,0.0004742777],"domain_scores_gemma":[0.98875225,0.007340878,0.00048702225,0.0008681939,0.0020836852,0.00046796555],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0056737866,0.00014010453,0.0006082568,0.00012141064,0.00016256978,0.000014363663,0.00048380715,0.00011371618,0.00014437307],"category_scores_gemma":[0.015080975,0.000068341586,0.00048624183,0.0008656853,0.00078505813,0.000039216982,0.00030768735,0.0016663691,0.00006948926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023007153,0.0066683153,0.8859192,0.0002553981,0.0004911072,0.016378952,0.00061555253,0.000017300043,0.0029523952,0.00060781406,0.07956058,0.0042326325],"study_design_scores_gemma":[0.006370536,0.0027299973,0.9699762,0.0004307408,0.0009246682,0.0014066473,0.00063156645,0.000028099044,0.0072397226,0.0026051288,0.0076035205,0.000053188684],"about_ca_topic_score_codex":0.000010661041,"about_ca_topic_score_gemma":0.0000076141805,"teacher_disagreement_score":0.08405694,"about_ca_system_score_codex":0.00008566117,"about_ca_system_score_gemma":0.0020222499,"threshold_uncertainty_score":0.99321544},"labels":[],"label_agreement":null},{"id":"W3121066036","doi":"10.1016/s1701-2163(16)34255-4","title":"Prise en charge des masses pelviennes/ovariennes : Évaluation initiale et lignes directrices quant à l’orientation des patientes","year":2009,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Winnipeg; Medicine Hat College; University of Fredericton; Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Gynecology","score_opus":0.025719598029722762,"score_gpt":0.279324932388325,"score_spread":0.2536053343586022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121066036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80482537,0.17796549,0.00011375855,0.0029885306,0.012720434,0.00030584904,0.00005347672,0.0000062760446,0.0010208127],"genre_scores_gemma":[0.9696057,0.027240636,0.0021773835,0.000504566,0.00019989046,0.000010311924,0.000022237404,0.00001801175,0.00022125995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975702,0.00034696553,0.0008381134,0.0002634504,0.00048576613,0.0004954914],"domain_scores_gemma":[0.99373925,0.0041246577,0.0007765635,0.00013349265,0.0008626416,0.0003633703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007853659,0.00028608978,0.0006119421,0.000401637,0.00026690977,0.00009733662,0.00010904571,0.00018045498,0.000550927],"category_scores_gemma":[0.0055560926,0.00024225705,0.000114207294,0.0006860998,0.00015981465,0.000423067,0.000024836487,0.00029038367,0.000002642046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029316474,0.0008463639,0.33731604,0.00019416073,0.0002946531,0.0017268832,0.003421681,0.000066201705,0.000024368774,0.0019291099,0.0008427372,0.6533085],"study_design_scores_gemma":[0.0037412262,0.004195256,0.9729581,0.00018515393,0.0009401344,0.00015654437,0.0022306286,0.0002457999,0.0005417781,0.0020207374,0.012539411,0.0002452353],"about_ca_topic_score_codex":0.02493568,"about_ca_topic_score_gemma":0.03503013,"teacher_disagreement_score":0.65306324,"about_ca_system_score_codex":0.0023699657,"about_ca_system_score_gemma":0.0026417747,"threshold_uncertainty_score":0.9878956},"labels":[],"label_agreement":null},{"id":"W3121961838","doi":"10.1016/j.jacr.2020.12.022","title":"Ovarian-Adnexal Reporting Lexicon for MRI: A White Paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"National Institute for Health and Care Research; European Society of Radiology; American College of Radiology","keywords":"Lexicon; Medicine; Radiology; Terminology; Adnexal mass; Computer science; Natural language processing; Linguistics","score_opus":0.046674042462338756,"score_gpt":0.330290794769765,"score_spread":0.2836167523074262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121961838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9301194,0.004769771,0.001282979,0.05821768,0.002566597,0.0012960724,0.0005654071,0.000014256858,0.0011678176],"genre_scores_gemma":[0.98913854,0.00041270364,0.008401136,0.0008681818,0.0006375395,0.00001726074,0.000010008851,0.000036412675,0.00047819255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949417,0.00045679542,0.0034534193,0.00040848588,0.00039813,0.00034146826],"domain_scores_gemma":[0.98044246,0.00070043467,0.016669152,0.0014945724,0.0005574078,0.00013599734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00304878,0.00023901388,0.0018096743,0.00009548614,0.00017897277,0.000018539493,0.0005125708,0.00010293745,0.000030183877],"category_scores_gemma":[0.0041210996,0.00013850453,0.0004376769,0.00048263,0.00052033307,0.0001231561,0.00038895127,0.00040902814,1.7904881e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002386571,0.000929956,0.8536301,0.00073103583,0.005171317,0.0020898217,0.0009693802,0.0007475627,0.023119606,0.0031137061,0.10364853,0.0034623824],"study_design_scores_gemma":[0.013022102,0.0044889236,0.77119106,0.0032194462,0.0051584397,0.114728376,0.010674745,0.0030274035,0.0065628793,0.0010240731,0.06627188,0.00063068315],"about_ca_topic_score_codex":0.00020393587,"about_ca_topic_score_gemma":0.00006806303,"teacher_disagreement_score":0.112638555,"about_ca_system_score_codex":0.0001616524,"about_ca_system_score_gemma":0.0013019881,"threshold_uncertainty_score":0.5648051},"labels":[],"label_agreement":null},{"id":"W3122624214","doi":"10.1016/s0140-6736(20)32554-x","title":"Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Cancer Care Ontario; Kelowna General Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Astellas Pharma; Ontario Institute for Cancer Research; Incyte; Ipsen; Syndax Pharmaceuticals; Clovis Oncology; Astex Pharmaceuticals; Regeneron Pharmaceuticals; U.S. Department of Defense; Princess Margaret Cancer Foundation; Sanofi; GlaxoSmithKline; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Internal medicine; Gemcitabine; Population; Ovarian cancer; Placebo; Clinical trial; Clinical endpoint; Oncology; Cancer; Surgery; Pathology","score_opus":0.0907230657683899,"score_gpt":0.37165497685951604,"score_spread":0.28093191109112614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122624214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8650099,0.0203635,0.00084218406,0.06091801,0.0061339014,0.035158787,0.0022714098,0.00044215933,0.008860118],"genre_scores_gemma":[0.9562565,0.0026616517,0.0018133818,0.0026019386,0.011944717,0.017045956,0.0006802095,0.00016213146,0.0068334765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99675095,0.00020777997,0.00097191625,0.0007209763,0.0005654489,0.00078294484],"domain_scores_gemma":[0.99649096,0.0013791091,0.0004694714,0.001114827,0.00025953964,0.00028612517],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092411553,0.0005056973,0.0022498218,0.00009113362,0.0003324152,0.00013600485,0.00029567743,0.0001846946,0.0017879118],"category_scores_gemma":[0.00046964656,0.00029089666,0.0004973229,0.0003329731,0.0000898232,0.000108725784,0.000077872864,0.00041808694,0.000030602256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9538039,0.0014955768,0.000035788595,0.00020852961,0.001799427,0.00020576155,0.0005933016,0.000053680382,0.0007178134,0.00066863775,0.026787752,0.013629809],"study_design_scores_gemma":[0.89248884,0.0028067788,0.000062589104,0.00041933788,0.0018444734,0.000033720185,0.00015986346,0.0006936805,0.0016278625,0.00011631896,0.09942164,0.00032492055],"about_ca_topic_score_codex":0.00020800799,"about_ca_topic_score_gemma":0.0009814977,"teacher_disagreement_score":0.091246605,"about_ca_system_score_codex":0.00058694807,"about_ca_system_score_gemma":0.0014791854,"threshold_uncertainty_score":0.99995434},"labels":[],"label_agreement":null},{"id":"W3122800113","doi":"10.2139/ssrn.3710743","title":"Oviduct Epithelial Cells Constitute Two Developmentally Distinct Lineages that are Spatially Separated Along the Distal-Proximal Axis","year":2020,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University; McGill University Health Centre","funders":"","keywords":"Oviduct; Biology; Cell biology; Epithelium; Anatomy; Chemistry; Genetics; Endocrinology","score_opus":0.020718234551935208,"score_gpt":0.2652104611491046,"score_spread":0.2444922265971694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122800113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97063124,0.002749748,0.003703072,0.021191202,0.00040633124,0.00068922667,0.00006773795,0.00007928737,0.00048218138],"genre_scores_gemma":[0.995971,0.0013658083,0.00035258147,0.0011865649,0.00085086236,0.000031249016,0.000040835937,0.000041213472,0.00015987053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970069,0.00011264825,0.0004490423,0.0004128854,0.00048304713,0.0015354955],"domain_scores_gemma":[0.99893975,0.00008633933,0.0003243274,0.000225622,0.00012530714,0.00029866162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005539789,0.00035079298,0.00045189293,0.000049957318,0.00041242986,0.00014526324,0.000268331,0.00007181305,0.00019271867],"category_scores_gemma":[0.000071685965,0.0002238969,0.0002334669,0.0002174015,0.00017459446,0.00013460255,0.0000992787,0.0014757884,0.000081010905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003506003,0.0013550809,0.90314376,0.00015892475,0.0059639663,0.0019692604,0.002512338,0.00070361217,0.013050854,0.015268965,0.0016364608,0.05073077],"study_design_scores_gemma":[0.059913922,0.009939347,0.6280798,0.0013463259,0.0056850314,0.009378255,0.0076014823,0.0032310032,0.21853916,0.012903173,0.039713036,0.003669489],"about_ca_topic_score_codex":0.00021621847,"about_ca_topic_score_gemma":0.0022087141,"teacher_disagreement_score":0.275064,"about_ca_system_score_codex":0.0010011444,"about_ca_system_score_gemma":0.004463337,"threshold_uncertainty_score":0.9130251},"labels":[],"label_agreement":null},{"id":"W3124768173","doi":"10.1007/s00330-021-07737-9","title":"Non-contrast MRI can accurately characterize adnexal masses: a retrospective study","year":2021,"lang":"en","type":"article","venue":"European Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"NIHR Cambridge Biomedical Research Centre; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Mark Foundation For Cancer Research","keywords":"Medicine; Neuroradiology; Adnexal mass; Radiology; Confidence interval; Receiver operating characteristic; Malignancy; Contrast (vision); Histopathology; Retrospective cohort study; Magnetic resonance imaging; Repeatability; Likelihood ratios in diagnostic testing; Nuclear medicine; Diagnostic accuracy; Surgery; Pathology; Internal medicine; Statistics; Neurology; Mathematics","score_opus":0.030719551269267193,"score_gpt":0.2867598334390199,"score_spread":0.2560402821697527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124768173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721973,0.0002733363,0.000040090137,0.003797465,0.0006796901,0.0006158421,0.00006709345,0.00007685946,0.022252353],"genre_scores_gemma":[0.9958746,0.0002008202,0.00019994949,0.0014998075,0.00081082946,0.000045904268,0.00011937451,0.000055250424,0.0011934738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981915,0.0003477021,0.00032186054,0.00063666905,0.00013530489,0.00036700827],"domain_scores_gemma":[0.9989852,0.000047469468,0.000110790745,0.0005276564,0.00013554226,0.00019339619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024574288,0.00023719127,0.0005910677,0.00006460746,0.000090197966,0.000034634326,0.00010893565,0.0000472843,0.00065114634],"category_scores_gemma":[0.000088525274,0.00019875297,0.000120445584,0.00019288254,0.000069797774,0.00004383812,0.00008149677,0.00026600066,0.00024658244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002915527,0.0018222947,0.9591243,0.0000224522,0.0011205984,0.02118694,0.0022923714,0.0000016869193,0.004312417,0.00025167823,0.006557622,0.003016087],"study_design_scores_gemma":[0.0048925,0.0017457561,0.98191875,0.000039118768,0.00024010072,0.0008968771,0.000589469,0.0000072076737,0.00049404555,0.0000103697585,0.00899625,0.00016957335],"about_ca_topic_score_codex":0.000049424205,"about_ca_topic_score_gemma":0.00008501566,"teacher_disagreement_score":0.02367732,"about_ca_system_score_codex":0.00023587518,"about_ca_system_score_gemma":0.00020164285,"threshold_uncertainty_score":0.8104911},"labels":[],"label_agreement":null},{"id":"W3128685317","doi":"10.1016/j.ygyno.2021.01.028","title":"The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Meta-analysis; Oncology; Hazard ratio; Cochrane Library; Randomized controlled trial; Progression-free survival; Ovarian cancer; Publication bias; Confidence interval; Chemotherapy; Cancer","score_opus":0.2353284532147614,"score_gpt":0.4281566750376063,"score_spread":0.1928282218228449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128685317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005205927,0.9834729,0.000019744723,0.005413521,0.00006587126,0.010629077,0.00035817438,0.0000064918963,0.000029010527],"genre_scores_gemma":[0.00014633896,0.9815889,0.00059771363,0.0016314615,0.000017590011,0.015729098,0.0001271238,0.000023212413,0.00013856048],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950476,0.0020969452,0.0018017705,0.0005167022,0.00023183497,0.00030514054],"domain_scores_gemma":[0.98771715,0.0091889575,0.0017395689,0.001017602,0.00028315285,0.00005357644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018375702,0.00043232494,0.012579269,0.00013943782,0.00008059175,0.000019545838,0.00031923354,0.00036911963,0.00025153818],"category_scores_gemma":[0.0009852122,0.00017125053,0.0027717217,0.0009182377,0.00015532467,0.000027683669,0.00006393737,0.00036216038,7.1174117e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003881514,0.0009758358,0.000021689133,0.46739915,0.3146928,0.00006969131,0.0002512434,0.000008090628,6.809152e-8,0.000575813,0.0010580716,0.21490873],"study_design_scores_gemma":[0.00082345936,0.000908634,0.000045944187,0.0078505585,0.7805704,0.000035960456,0.000028882863,0.00001403313,2.9160515e-7,0.00007144212,0.20951866,0.00013176346],"about_ca_topic_score_codex":0.0002303071,"about_ca_topic_score_gemma":0.0009542259,"teacher_disagreement_score":0.46587756,"about_ca_system_score_codex":0.00036493776,"about_ca_system_score_gemma":0.0011400111,"threshold_uncertainty_score":0.8598937},"labels":[],"label_agreement":null},{"id":"W3129908491","doi":"10.3390/cancers13050946","title":"Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer","year":2021,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Fondation du cancer des Cèdres","keywords":"Microsatellite instability; Medicine; Oncology; Internal medicine; Ovarian cancer; Germline mutation; Epithelial ovarian cancer; Immunotherapy; Biomarker; Germline; Cancer; Cancer research; Gene; Mutation; Microsatellite; Biology; Allele; Genetics","score_opus":0.030046936659805366,"score_gpt":0.28913261419176955,"score_spread":0.2590856775319642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129908491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953274,0.0017488559,0.00006783558,0.0013623274,0.00025791518,0.00027516022,0.00003231952,0.00001179605,0.00091635634],"genre_scores_gemma":[0.997439,0.0019766805,0.00010256886,0.00007521842,0.000050466242,0.00010625621,0.000048347138,0.000012020736,0.00018941476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991597,0.000030360283,0.00018428417,0.00026103333,0.00021381277,0.00015083498],"domain_scores_gemma":[0.99943715,0.000039338,0.00014567008,0.00015218506,0.00017627077,0.000049398514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014422361,0.000094873234,0.0002305498,0.00007100935,0.000033032364,0.00001264058,0.000028442857,0.000078275334,0.00007107133],"category_scores_gemma":[0.000031343774,0.00008323264,0.000027922737,0.00028014393,0.00003544651,0.000068425164,0.000010553813,0.00009291251,9.1288484e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118067124,0.00010389836,0.9847548,0.00009499689,0.00006813905,0.000038578386,0.0003402646,0.0003371372,0.0010236772,0.0006752677,0.000026998248,0.012418153],"study_design_scores_gemma":[0.0029439384,0.00018351404,0.98475915,0.00026714805,0.00013661332,0.000008492488,0.00007609037,0.00014790206,0.011279058,0.00009693813,0.000015551112,0.000085629945],"about_ca_topic_score_codex":0.0010888224,"about_ca_topic_score_gemma":0.0024516194,"teacher_disagreement_score":0.012332523,"about_ca_system_score_codex":0.0022573906,"about_ca_system_score_gemma":0.0008335291,"threshold_uncertainty_score":0.5902998},"labels":[],"label_agreement":null},{"id":"W3130302511","doi":"10.1016/j.esmoop.2020.100043","title":"Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial","year":2021,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; Canadian Cancer Society; AstraZeneca","keywords":"Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Chemotherapy; Placebo; Ovarian cancer; Maintenance therapy; Progression-free survival; Oncology; Randomized controlled trial; Confidence interval; Surgery; Cancer; Pathology","score_opus":0.033239662900949984,"score_gpt":0.33713862508399317,"score_spread":0.3038989621830432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130302511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97421575,0.000021349113,0.00019470668,0.007243156,0.000361827,0.008305881,0.0011185306,0.00001784013,0.0085209925],"genre_scores_gemma":[0.99181783,0.000056890753,0.0014362335,0.0011519225,0.0003078395,0.002846313,0.0004454161,0.00003889225,0.0018986675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984203,0.00009977456,0.0004986991,0.00046813407,0.00023417732,0.00027890445],"domain_scores_gemma":[0.9987777,0.00034014805,0.00019966798,0.00032053722,0.00020928509,0.00015269987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005451408,0.00019009692,0.0008188608,0.000075857286,0.000045830475,0.000039393755,0.000089612964,0.0000864,0.00072783005],"category_scores_gemma":[0.00015275837,0.00015295463,0.00007955563,0.0002467759,0.000027380791,0.000105264924,0.00003413338,0.00010115981,0.0000023293526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9750944,0.0018156767,0.000098503864,0.00003725372,0.0006987495,0.00015910092,0.0041755727,0.00004271283,0.0009156217,0.0002047052,0.004621334,0.012136382],"study_design_scores_gemma":[0.9560712,0.004163835,0.0063760313,0.000496418,0.00012636613,0.0000055911414,0.00045581165,0.00007513902,0.022716977,0.00009352302,0.009231762,0.00018733049],"about_ca_topic_score_codex":0.002563731,"about_ca_topic_score_gemma":0.0023241777,"teacher_disagreement_score":0.021801354,"about_ca_system_score_codex":0.00038571496,"about_ca_system_score_gemma":0.0006795952,"threshold_uncertainty_score":0.7969228},"labels":[],"label_agreement":null},{"id":"W3131158468","doi":"10.1016/j.jogc.2021.01.020","title":"Two-Port Laparoscopic Removal of Large Ovarian Cystadenoma","year":2021,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cosmesis; Malignancy; Laparotomy; Serous Cystadenoma; Mucinous cystadenoma; Surgery; Laparoscopy; Port (circuit theory); Radiology; Ovary; General surgery; Cyst; Pathology; Internal medicine","score_opus":0.011746463188967108,"score_gpt":0.2567957830145198,"score_spread":0.24504931982555267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131158468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684777,0.019199757,0.000015739846,0.0017675118,0.0056381794,0.00008735703,0.000039837756,0.0000019606393,0.0047719125],"genre_scores_gemma":[0.99693465,0.00043494062,0.0014668491,0.0006855581,0.000052965843,0.0000012912446,0.000006388685,0.000010080925,0.00040728558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988373,0.000039150975,0.0004913186,0.00013328613,0.00028949016,0.00020945306],"domain_scores_gemma":[0.9982888,0.000545442,0.0003499428,0.0001570117,0.0004423284,0.00021647356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016657959,0.000105508014,0.0005302571,0.00012326824,0.00004939699,0.000009250994,0.000055444314,0.000075816584,0.00080283557],"category_scores_gemma":[0.0009665959,0.00008776436,0.00007951717,0.00030916653,0.000030259098,0.00003409527,0.000033880835,0.00019938058,4.207775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023072513,0.00077248976,0.8201999,0.00017685303,0.0010175619,0.13254283,0.00013228031,0.000015527372,0.00016688599,0.0038328494,0.0054847742,0.035634983],"study_design_scores_gemma":[0.010610264,0.0006698466,0.89944744,0.00003076016,0.0004615078,0.0027368516,0.000333573,0.000015651209,0.001351085,0.00014649426,0.084087364,0.000109143475],"about_ca_topic_score_codex":0.0047810944,"about_ca_topic_score_gemma":0.019875914,"teacher_disagreement_score":0.12980598,"about_ca_system_score_codex":0.0006349301,"about_ca_system_score_gemma":0.0041473135,"threshold_uncertainty_score":0.9980088},"labels":[],"label_agreement":null},{"id":"W3132331214","doi":"10.1016/j.ygyno.2021.02.018","title":"Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Prom; Medicine; Clinical trial; Clinical endpoint; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Surgery; Internal medicine","score_opus":0.06518914206641746,"score_gpt":0.3698441545332145,"score_spread":0.30465501246679705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132331214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011612648,0.9733404,0.0000030972685,0.0053603407,0.0011121497,0.007066618,0.000665967,0.00002831891,0.0008104911],"genre_scores_gemma":[0.021266475,0.96824485,0.0011349358,0.0019034148,0.00016662067,0.006325693,0.0008679576,0.00005758472,0.00003246568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898553,0.004576273,0.0037241043,0.00093850004,0.00033364032,0.0005722098],"domain_scores_gemma":[0.978196,0.01737058,0.0033743822,0.00072643236,0.00021917153,0.00011341746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003169931,0.0007249927,0.011110557,0.0002809873,0.000086013635,0.00002829501,0.0003341673,0.00083093083,0.0014884897],"category_scores_gemma":[0.0036028975,0.0004226893,0.0013534288,0.0006225844,0.00023749603,0.00008919143,0.00021637163,0.00078971824,0.00001694854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052699293,0.0013800773,0.0012216847,0.0006819794,0.0015052878,0.00044531102,0.0007396232,0.00004228297,0.0000042991255,0.0023285337,0.00022486679,0.9861561],"study_design_scores_gemma":[0.33591864,0.0034973396,0.010595125,0.07871308,0.008311351,0.00016817286,0.0016966533,0.000029138857,0.00004556698,0.0066303373,0.55315197,0.0012426258],"about_ca_topic_score_codex":0.0028131274,"about_ca_topic_score_gemma":0.008607226,"teacher_disagreement_score":0.9849135,"about_ca_system_score_codex":0.0024699534,"about_ca_system_score_gemma":0.0017200123,"threshold_uncertainty_score":0.9998225},"labels":[],"label_agreement":null},{"id":"W3132348352","doi":"10.1158/1055-9965.epi-20-1355","title":"Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins","year":2021,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Institute on Aging; National Institutes of Health; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Ovarian cancer; Medicine; Medroxyprogesterone acetate; Progestin; Gynecology; Cancer; Relative risk; Case-control study; Obstetrics; Confidence interval; Oncology; Internal medicine; Hormone","score_opus":0.0642455724335246,"score_gpt":0.3511147718902597,"score_spread":0.28686919945673506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132348352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638778,0.029838126,0.000616636,0.0035691115,0.00009138249,0.0018246565,0.00013678348,0.000024588793,0.000020940985],"genre_scores_gemma":[0.99207836,0.0034847131,0.0030277406,0.00015092672,0.000036403784,0.0010907326,0.00003811061,0.00003022375,0.00006277338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964667,0.0013944331,0.0009658795,0.0005650943,0.0002445698,0.0003633017],"domain_scores_gemma":[0.99496233,0.0015093136,0.002118881,0.00054122775,0.0007564476,0.00011180161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018011656,0.00026249443,0.0010476514,0.000092617236,0.00009177284,0.0000055481196,0.00012957679,0.00019919743,0.00008051195],"category_scores_gemma":[0.0030395263,0.00017895635,0.00029462093,0.0005889703,0.00042699208,0.00016505159,0.000066844885,0.00022445312,5.531814e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015347272,0.00048222617,0.9567837,0.0003158473,0.0052105314,0.000010888046,0.00042211128,0.00008687786,0.007919829,0.00006471716,0.00009885901,0.02706965],"study_design_scores_gemma":[0.0027335961,0.0007624953,0.91540664,0.0070567504,0.0029785049,0.000016228943,0.00020642093,0.0006650597,0.06909239,0.0008839823,0.00005192738,0.00014601556],"about_ca_topic_score_codex":0.0072198,"about_ca_topic_score_gemma":0.0029089057,"teacher_disagreement_score":0.06117256,"about_ca_system_score_codex":0.0003625894,"about_ca_system_score_gemma":0.0010864319,"threshold_uncertainty_score":0.9993912},"labels":[],"label_agreement":null},{"id":"W3133006460","doi":"10.1016/j.gore.2021.100729","title":"Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Serous fluid; Medicine; Serous carcinoma; Ovarian cancer; Ovarian carcinoma; Serous ovarian cancer; Immunohistochemistry; Pathology; Ovarian carcinomas; Oncology; Cancer research; Internal medicine; Cancer","score_opus":0.029072390025018567,"score_gpt":0.2955235875264491,"score_spread":0.26645119750143054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133006460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.926585,0.00060511305,0.00001543102,0.058543775,0.0023298033,0.0010797644,0.00008925227,0.00020145383,0.010550391],"genre_scores_gemma":[0.9832093,0.00015857577,0.0075378995,0.0050600995,0.00034740623,0.0005774547,0.00022502124,0.000046634465,0.0028376258],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99660647,0.00034451342,0.00087052153,0.0011414672,0.0002898551,0.00074719987],"domain_scores_gemma":[0.99707574,0.0005678186,0.0005177238,0.0009842905,0.00038860046,0.0004658077],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046515,0.00044381164,0.0011956755,0.0001247768,0.00035782877,0.000045190307,0.00007327828,0.00054230564,0.002263807],"category_scores_gemma":[0.0008922908,0.00037081869,0.00024477986,0.00046797478,0.00026925528,0.000111060326,0.0001849179,0.0004756676,0.00001899996],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008283182,0.0017916509,0.09359445,0.00005610393,0.00061128545,0.8904836,0.0008916216,0.000018425699,0.00021789198,0.0016736323,0.00600031,0.004578177],"study_design_scores_gemma":[0.0037552088,0.003560302,0.23973998,0.000038848328,0.0013534793,0.70351577,0.0017344885,0.000011692101,0.004164424,0.004256282,0.03748461,0.00038489743],"about_ca_topic_score_codex":0.0029476262,"about_ca_topic_score_gemma":0.010730762,"teacher_disagreement_score":0.18696783,"about_ca_system_score_codex":0.0014926065,"about_ca_system_score_gemma":0.0030416592,"threshold_uncertainty_score":0.99987435},"labels":[],"label_agreement":null},{"id":"W3134469437","doi":"10.15252/emmm.202013366","title":"Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer","year":2021,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Science Institute of Singapore, National University of Singapore; Medical Research Council; National Medical Research Council; National Research Foundation Singapore; Ministry of Education - Singapore; Ovarian Cancer Action; National Research Foundation; National University of Singapore; Cancer Research UK","keywords":"Carboplatin; RAD51; ERCC1; Ovarian cancer; Cancer research; Immunohistochemistry; Oncology; Cancer; Biology; Medicine; Internal medicine; DNA repair; Immunology; Chemotherapy; Cisplatin; Gene; Genetics","score_opus":0.015062062152487517,"score_gpt":0.3214592218789447,"score_spread":0.3063971597264572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134469437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8913378,0.054846052,0.0014130474,0.019485127,0.00033357547,0.0006028073,0.00003053908,0.00001766189,0.031933382],"genre_scores_gemma":[0.99236107,0.00060316647,0.0058364472,0.0006808017,0.000044464778,0.000054214306,0.000031668387,0.0000259737,0.00036218073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842477,0.00010772599,0.00049623183,0.00033704285,0.000438675,0.00019558491],"domain_scores_gemma":[0.99894226,0.00012970278,0.00021125203,0.00038873075,0.00023015135,0.000097900935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022624174,0.00016397174,0.00061267306,0.00014900697,0.000017484921,0.000002257881,0.0000618183,0.000051771116,0.0009243381],"category_scores_gemma":[0.00036180386,0.0001315057,0.0000833077,0.0004695789,0.00013359447,0.000039391532,0.000039199807,0.0001369851,0.0000021015471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001079187,0.00050582417,0.07893245,0.00061761483,0.0002570408,0.002857988,0.0028347326,0.000021093276,0.9009097,0.00840343,0.0019017173,0.0016792177],"study_design_scores_gemma":[0.011099553,0.0003833601,0.2551498,0.010411892,0.00034737837,0.00003909543,0.0015033996,0.00008919104,0.7168383,0.0019117865,0.0020279556,0.00019825727],"about_ca_topic_score_codex":0.00054191815,"about_ca_topic_score_gemma":0.00014174015,"teacher_disagreement_score":0.18407139,"about_ca_system_score_codex":0.00010491863,"about_ca_system_score_gemma":0.00030919767,"threshold_uncertainty_score":0.999989},"labels":[],"label_agreement":null},{"id":"W3134672778","doi":"10.1093/jnci/djab037","title":"<i>BRCA1</i>/2 and Endometrial Cancer Risk: Implications for Management","year":2021,"lang":"en","type":"letter","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.08290888713045032,"score_gpt":0.36740616971182416,"score_spread":0.28449728258137386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134672778","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00113711,0.014377661,0.00020011286,0.97165567,0.007854321,0.0011571262,0.0024278676,0.000008521612,0.0011816332],"genre_scores_gemma":[0.017581567,0.069605686,0.0062591555,0.8262505,0.07095103,0.0020765942,0.00030317492,0.00013256438,0.0068397564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980222,0.00004946361,0.00060593477,0.00029762255,0.00080104586,0.00022371655],"domain_scores_gemma":[0.99727446,0.00023175846,0.0009927822,0.00020632932,0.0012072147,0.000087452056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032014403,0.00025110264,0.000551655,0.0002849158,0.00024036656,0.00007161149,0.00024651212,0.0002302103,0.000089670895],"category_scores_gemma":[0.00021468887,0.00016644422,0.00050270045,0.00036984595,0.00010926741,0.00013096568,0.0000806013,0.0008418455,9.954496e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014975581,0.0000904428,0.0057559516,0.00026674088,0.0028135504,0.0000362062,0.00002397602,0.00020278819,0.000017337936,0.0005425005,0.97809124,0.012009529],"study_design_scores_gemma":[0.004769635,0.000088237735,0.034567337,0.00074974634,0.0024964968,0.00017460521,0.0000035463277,0.000005474205,0.0001377905,0.0011696973,0.95568734,0.00015009742],"about_ca_topic_score_codex":0.00012294768,"about_ca_topic_score_gemma":0.00011889905,"teacher_disagreement_score":0.14540517,"about_ca_system_score_codex":0.001462827,"about_ca_system_score_gemma":0.0015384977,"threshold_uncertainty_score":0.67873985},"labels":[],"label_agreement":null},{"id":"W3135098376","doi":"10.1016/j.annonc.2021.02.017","title":"Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Topotecan; Internal medicine; Clinical endpoint; Ovarian cancer; Tolerability; Oncology; Population; Hazard ratio; Chemotherapy; Chemotherapy regimen; Progression-free survival; Cancer; Randomized controlled trial; Surgery; Adverse effect; Confidence interval","score_opus":0.038649593173610164,"score_gpt":0.37204405156171444,"score_spread":0.3333944583881043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135098376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929359,0.00076587754,0.000036842048,0.003058135,0.00014782742,0.0011127249,0.00022305283,0.000005447867,0.0017141985],"genre_scores_gemma":[0.997061,0.0011470523,0.0009282472,0.00037261902,0.000040053514,0.000102069134,0.00029115175,0.000016119358,0.000041652278],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99798495,0.00019395187,0.0009729627,0.00029256238,0.00034246605,0.00021310334],"domain_scores_gemma":[0.9977128,0.0005329628,0.0007425348,0.00034800908,0.0005817176,0.00008200246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047698768,0.00017654794,0.0027164519,0.00034164282,0.000014101871,0.0000025048457,0.000069502035,0.00013530525,0.0004041914],"category_scores_gemma":[0.00012232903,0.00013343585,0.00037953324,0.0009080002,0.00017718524,0.00004094459,0.000020967627,0.00009344493,2.1308199e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9324721,0.014174622,0.004011392,0.00007444015,0.010133531,0.00004464722,0.00038730132,0.000044215016,0.00033881885,0.0001236233,0.00024657944,0.03794874],"study_design_scores_gemma":[0.9512763,0.01614858,0.021343756,0.00011859832,0.0036953501,3.2020154e-7,0.000042772204,0.000054899523,0.0064558485,0.000025400368,0.00073881855,0.0000993323],"about_ca_topic_score_codex":0.0008114397,"about_ca_topic_score_gemma":0.0006573072,"teacher_disagreement_score":0.037849404,"about_ca_system_score_codex":0.00013469365,"about_ca_system_score_gemma":0.00091040594,"threshold_uncertainty_score":0.54413563},"labels":[],"label_agreement":null},{"id":"W3135376158","doi":"10.1016/s1470-2045(21)00006-1","title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Zhongshan Hospital","keywords":"Medicine; Chemotherapy; Ovarian cancer; Internal medicine; Open label; Oncology; Randomized controlled trial; Surgery; Cancer","score_opus":0.061897894713462485,"score_gpt":0.393795617724443,"score_spread":0.3318977230109805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135376158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9035451,0.0019942352,0.000050001498,0.07919727,0.0029808125,0.004727775,0.00019587624,0.00007187986,0.0072370893],"genre_scores_gemma":[0.9624934,0.009334677,0.003350196,0.015844297,0.0035727182,0.0022844677,0.0005442283,0.00012832254,0.0024476987],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975126,0.000540677,0.00054532377,0.0006236055,0.00023373996,0.0005441029],"domain_scores_gemma":[0.9981855,0.00066942204,0.00030344512,0.00056519825,0.00013312695,0.00014329719],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007102063,0.0003222512,0.0013834548,0.0000614211,0.00014343507,0.000054415123,0.000215503,0.00027315403,0.0014963597],"category_scores_gemma":[0.00013719559,0.0002438614,0.00012435605,0.00037641556,0.00014380246,0.000120344375,0.000062781946,0.0005282808,0.000024756413],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81630564,0.006478872,0.00016135059,0.000029431718,0.0014034214,0.00048103445,0.0026573688,0.000006124053,0.015737465,0.00011492157,0.060125865,0.096498534],"study_design_scores_gemma":[0.8795237,0.0028929391,0.0005519262,0.0000926073,0.00033631778,0.000049403207,0.0004764302,0.00018361202,0.020004975,0.000051914234,0.09560299,0.00023319149],"about_ca_topic_score_codex":0.00078592746,"about_ca_topic_score_gemma":0.0009956204,"teacher_disagreement_score":0.096265346,"about_ca_system_score_codex":0.0011535751,"about_ca_system_score_gemma":0.0011970025,"threshold_uncertainty_score":0.9994164},"labels":[],"label_agreement":null},{"id":"W3135570724","doi":"10.3390/curroncol28020107","title":"An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Fallopian tube; Maintenance therapy; Guideline; Population; Oncology; Gynecology; Ovarian cancer; Bevacizumab; Internal medicine; Cancer; Chemotherapy; Pathology","score_opus":0.1344197275071724,"score_gpt":0.46598759871891215,"score_spread":0.33156787121173975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135570724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459373,0.0134849725,0.0011736098,0.01900915,0.01096292,0.0075542224,0.0009788609,0.00016111918,0.00073786586],"genre_scores_gemma":[0.83813244,0.037083868,0.048278015,0.036957063,0.008079582,0.0077934824,0.007601434,0.0002960796,0.015778005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947988,0.00073332625,0.0018888592,0.0012897734,0.0004544632,0.00083479413],"domain_scores_gemma":[0.9948673,0.0013184025,0.00087243004,0.00084787875,0.0014867305,0.00060722354],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011128818,0.0005277374,0.0017196594,0.00010766178,0.0004964872,0.00006420663,0.00023589701,0.00037191738,0.0025389597],"category_scores_gemma":[0.0005680844,0.0003592687,0.00032520466,0.00023567988,0.00016116488,0.00028163183,0.00010926668,0.00095663796,0.0000072163475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.05368072,0.0109006455,0.28070545,0.0009096054,0.00095879426,0.002501792,0.024106937,0.000044595065,0.000082575476,0.00015993853,0.08375999,0.54218894],"study_design_scores_gemma":[0.03559098,0.016084205,0.071168266,0.00064586324,0.00045970356,0.0005286762,0.004633544,0.00009972148,0.000070486436,0.0000037021764,0.8703256,0.00038925526],"about_ca_topic_score_codex":0.09194069,"about_ca_topic_score_gemma":0.7373646,"teacher_disagreement_score":0.7865656,"about_ca_system_score_codex":0.009947096,"about_ca_system_score_gemma":0.04812423,"threshold_uncertainty_score":0.9998859},"labels":[],"label_agreement":null},{"id":"W3135904308","doi":"10.3390/curroncol28020110","title":"Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Serous fluid; Stage (stratigraphy); Medical record; Internal medicine; Cancer; Retrospective cohort study; Performance status; Chemotherapy; Surgery; Oncology","score_opus":0.04084118176830982,"score_gpt":0.35748623429880805,"score_spread":0.31664505253049824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135904308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978049,0.0010032783,0.000007260683,0.015296915,0.0010379863,0.00087256805,0.000038056645,0.000011338095,0.0036836274],"genre_scores_gemma":[0.998191,0.0007192277,0.00026590287,0.0002586952,0.000100883015,0.00026019584,0.000032231226,0.000012484519,0.00015937205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988572,0.00015727834,0.00024935248,0.00025447685,0.0002586213,0.00022304196],"domain_scores_gemma":[0.9992583,0.00008610694,0.00014527938,0.00038455878,0.00008740032,0.000038346974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013272752,0.00012638167,0.00026764823,0.00004508634,0.000058581463,0.0000084044705,0.00012613687,0.000037536578,0.00012515443],"category_scores_gemma":[0.000006246144,0.00006535692,0.000059354126,0.00044290535,0.000059368384,0.000022836259,0.00006751669,0.00020257564,0.000002841522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007173321,0.0019040083,0.76460284,0.00015678385,0.00019215091,0.00011130473,0.0005469487,0.000026317208,0.0000027918604,0.0027241493,0.0011470186,0.22851396],"study_design_scores_gemma":[0.0046129148,0.0003860768,0.957692,0.0005302671,0.000353274,0.0000037192156,0.00027912506,0.0000064425485,0.00012606019,0.000110587476,0.0358321,0.00006743115],"about_ca_topic_score_codex":0.00040202556,"about_ca_topic_score_gemma":0.0029553147,"teacher_disagreement_score":0.22844653,"about_ca_system_score_codex":0.00038764588,"about_ca_system_score_gemma":0.00022110033,"threshold_uncertainty_score":0.2665178},"labels":[],"label_agreement":null},{"id":"W3136463040","doi":"10.1038/s41416-021-01317-w","title":"Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Strong; Government of Canada; CancerCare Manitoba Foundation; Canadian Institutes of Health Research; Cancer Research Society; University of Pennsylvania","keywords":"Cyclin E1; Cyclin D; Cancer research; Ubiquitin ligase; Cyclin B; Cyclin E; Cyclin A; Biology; Cell cycle; Skp1; Cyclin; Cyclin A2; Cell biology; Medicine; Cancer; Ubiquitin; Genetics; Gene","score_opus":0.01569016937950446,"score_gpt":0.28367592865697416,"score_spread":0.2679857592774697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136463040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8983374,0.0999637,0.0000032098396,0.0012382177,0.00014505917,0.00020348867,0.00006960442,0.000003904041,0.000035378685],"genre_scores_gemma":[0.946312,0.052873187,0.00047399913,0.000104105995,0.00014653173,0.000037730297,0.000006025614,0.000018436065,0.000027997989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998463,0.00014742912,0.0006187681,0.00027670807,0.00028782783,0.00020629163],"domain_scores_gemma":[0.9991601,0.000098733064,0.00028246205,0.00013132866,0.0001629332,0.00016445215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002472136,0.00014814398,0.0006620437,0.000118034935,0.000035230176,0.000036165027,0.00005272732,0.00010730956,0.00020103919],"category_scores_gemma":[0.00011101559,0.0001485169,0.00006773012,0.00025963684,0.00011912669,0.0001875336,0.00004908684,0.0002792706,9.210705e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006692677,0.0017665451,0.8390049,0.00073512376,0.00025934778,0.0034828964,0.0009155735,0.00015751213,0.042599145,0.00004605639,0.00024589678,0.110117756],"study_design_scores_gemma":[0.0068714707,0.00019319938,0.89518726,0.0059440495,0.00014915386,0.0005535312,0.00037162966,0.000011746977,0.08980879,0.00042846793,0.00034570688,0.00013498525],"about_ca_topic_score_codex":0.018585518,"about_ca_topic_score_gemma":0.015104417,"teacher_disagreement_score":0.109982766,"about_ca_system_score_codex":0.0003386109,"about_ca_system_score_gemma":0.0005835756,"threshold_uncertainty_score":0.9879498},"labels":[],"label_agreement":null},{"id":"W3136819410","doi":"10.1097/pgp.0000000000000780","title":"Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Clear cell carcinoma; Medicine; Stage (stratigraphy); Clear cell; Oncology; Immunohistochemistry; Internal medicine; Ovarian cancer; Carcinoma; Population; Biomarker; Cancer; Tissue microarray; Cancer research; Pathology; Biology","score_opus":0.016223182239331252,"score_gpt":0.2771422854118113,"score_spread":0.26091910317248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136819410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705894,0.0014953901,0.00008382545,0.008626095,0.00059524033,0.00010106681,0.0000056645918,0.000003650074,0.0020301463],"genre_scores_gemma":[0.99654937,0.00034048178,0.00172986,0.001199831,0.00012614643,0.0000062384934,0.0000058269497,0.0000071924123,0.000035075405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900895,0.00012223514,0.00036816436,0.00017315905,0.00018597512,0.00014150345],"domain_scores_gemma":[0.9989342,0.00048060555,0.0001478214,0.00007206275,0.00026751737,0.00009778483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021764902,0.0000943332,0.0002896335,0.00013279612,0.000016349828,0.000018145822,0.00008527142,0.000108149,0.00049883145],"category_scores_gemma":[0.00063228165,0.000069029156,0.00008820893,0.00008332773,0.00008008647,0.000044196233,0.000054081847,0.00020409281,0.000009840481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050810573,0.0011092194,0.9378997,0.00001158236,0.00016245927,0.04662142,0.00013373283,0.000008448119,0.005851932,0.00044693265,0.00022774287,0.007018712],"study_design_scores_gemma":[0.0038620809,0.0012503656,0.98710716,0.000040902905,0.0000825681,0.0044619897,0.00010689996,0.000023390845,0.0013323851,0.0008812013,0.00078996405,0.000061086095],"about_ca_topic_score_codex":0.00000819042,"about_ca_topic_score_gemma":0.000016429974,"teacher_disagreement_score":0.049207453,"about_ca_system_score_codex":0.0001387213,"about_ca_system_score_gemma":0.0001679752,"threshold_uncertainty_score":0.54618543},"labels":[],"label_agreement":null},{"id":"W3137015334","doi":"10.1016/j.ygyno.2021.03.019","title":"Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary—Clinical significance of BRCA2 gene variants in genomically stable tumors","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Serous fluid; KRAS; Clinical significance; Ovarian cancer; Germline; Medicine; Microsatellite instability; Cancer research; Loss of heterozygosity; Missense mutation; Ovarian carcinoma; Oncology; Cancer; Internal medicine; Mutation; Gene; Biology; Allele; Genetics; Colorectal cancer; Microsatellite","score_opus":0.031531234541806875,"score_gpt":0.33349246076480316,"score_spread":0.30196122622299626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137015334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899068,0.0008053691,0.000032236032,0.00652809,0.000600741,0.0011410872,0.00010575464,0.000016401611,0.0008635099],"genre_scores_gemma":[0.99257153,0.00039531893,0.004999469,0.0014808468,0.0001511507,0.00017053918,0.000065582375,0.000029555129,0.00013600357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497694,0.0009302311,0.0023193725,0.00082929217,0.00034402809,0.00060013856],"domain_scores_gemma":[0.9947184,0.002889613,0.0013167773,0.0006491153,0.00025281706,0.0001733152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012270457,0.00030233333,0.0016610053,0.00014897952,0.00005100001,0.0000074019663,0.0003479042,0.00042240365,0.0006117976],"category_scores_gemma":[0.0024387203,0.00023272754,0.0003047556,0.00073776685,0.00049895764,0.000050775838,0.00023652079,0.00070184836,0.000012939757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008966343,0.008142509,0.9748366,0.00011634097,0.00019907458,0.0069358456,0.00032495146,0.0015684183,0.001686602,0.0005087881,0.0001819008,0.0046023712],"study_design_scores_gemma":[0.009131309,0.003101347,0.9807753,0.00017448743,0.00014268469,0.00027397554,0.0002631156,0.00038753537,0.0038460386,0.0015538777,0.00016094532,0.00018940274],"about_ca_topic_score_codex":0.0005749987,"about_ca_topic_score_gemma":0.0029347385,"teacher_disagreement_score":0.008234674,"about_ca_system_score_codex":0.00080550805,"about_ca_system_score_gemma":0.0047250367,"threshold_uncertainty_score":0.94903535},"labels":[],"label_agreement":null},{"id":"W3137314081","doi":"10.14740/jcgo.v10i1.715","title":"Ovarian Teratoma and N-Methyl-D-Aspartate Receptor Autoimmune Encephalitis: Insights Into Imaging Diagnosis of Teratoma and Timing of Surgery","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian Teratoma; Encephalitis; Teratoma; Autoimmune encephalitis; Pathology; Internal medicine; Immunology","score_opus":0.051407035003287936,"score_gpt":0.35133730829195686,"score_spread":0.29993027328866895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137314081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94553715,0.050913263,0.000018102004,0.0021979155,0.0011549836,0.00010167072,0.000006752264,0.0000047084254,0.00006543356],"genre_scores_gemma":[0.9529343,0.04353969,0.0029936528,0.0003834831,0.000095081916,0.000006279884,0.0000045252245,0.0000131536435,0.000029825083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971964,0.00033925613,0.0017909149,0.00027290537,0.00021366074,0.0001868906],"domain_scores_gemma":[0.9727892,0.025254205,0.0010125615,0.0001759318,0.0005192606,0.00024882902],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0009894841,0.0001707141,0.001398817,0.00027466626,0.000074557014,0.000024453926,0.00005330898,0.0002095055,0.00009897436],"category_scores_gemma":[0.015906807,0.0001339335,0.00024586017,0.00036763516,0.0003243611,0.00016514861,0.000085597254,0.0003735754,5.641592e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013868383,0.000628534,0.8469725,0.00020066471,0.0004542165,0.0008291967,0.00048049595,6.580444e-7,0.00020298833,0.00012584646,0.00036271714,0.14960349],"study_design_scores_gemma":[0.0038300205,0.00081927143,0.9827499,0.0006515092,0.0006043934,0.00024343752,0.00035099202,0.00008023492,0.0042654173,0.0004009061,0.00587856,0.00012537824],"about_ca_topic_score_codex":0.000016667473,"about_ca_topic_score_gemma":0.000008590389,"teacher_disagreement_score":0.14947811,"about_ca_system_score_codex":0.00003648936,"about_ca_system_score_gemma":0.00039175176,"threshold_uncertainty_score":0.99238265},"labels":[],"label_agreement":null},{"id":"W3137640099","doi":"10.1186/s13048-021-00895-w","title":"A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin","year":2021,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cisplatin; Perioperative; Chemotherapy; Cytoreductive surgery; Internal medicine; Oncology; Surgery; Ovarian cancer; Cancer","score_opus":0.08570296951830447,"score_gpt":0.3834348561281198,"score_spread":0.2977318866098153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137640099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928775,0.001251785,0.0003077946,0.004748784,0.00008751503,0.0003270197,0.00008516642,0.000004673644,0.0003097622],"genre_scores_gemma":[0.99505484,0.00078635133,0.0031372092,0.00006479733,0.0001330896,0.0000138355845,0.000016488842,0.00003635332,0.0007570366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970019,0.0003414121,0.000952103,0.00026036645,0.0010925933,0.00035166348],"domain_scores_gemma":[0.9966263,0.0007275987,0.0004908739,0.0003243425,0.0015603105,0.00027053084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016049995,0.00018206795,0.0010221015,0.0004380516,0.0000667501,0.00003334416,0.00017013492,0.00012618791,0.00034535318],"category_scores_gemma":[0.00074476947,0.00013743485,0.00048179773,0.0005723516,0.00025511556,0.00014407301,0.000070320886,0.0005581167,0.0000024509334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009992809,0.008675375,0.032045968,0.00033070295,0.004022974,0.0006935004,0.013900944,0.0003025806,0.89430875,0.00043058148,0.018711105,0.016584707],"study_design_scores_gemma":[0.011138689,0.002283975,0.024210846,0.000975615,0.00020515664,0.00019583036,0.0022290887,0.0011375197,0.95706606,0.00013029357,0.0002565193,0.00017040629],"about_ca_topic_score_codex":0.00008861331,"about_ca_topic_score_gemma":0.000004707589,"teacher_disagreement_score":0.062757306,"about_ca_system_score_codex":0.00032604835,"about_ca_system_score_gemma":0.002315739,"threshold_uncertainty_score":0.56044304},"labels":[],"label_agreement":null},{"id":"W3137940544","doi":"10.14740/jcgo.v10i1.706","title":"Isolated Fallopian Tube Torsion: A Rare Cause of Acute Abdomen in Puerperium","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Acute abdomen; Ovarian torsion; Fallopian tube; Iliac fossa; Torsion (gastropod); Surgery; Abdominal pain; Vomiting; Lower abdominal pain; Abdomen; Radiology","score_opus":0.043785009892454436,"score_gpt":0.3741074904772132,"score_spread":0.33032248058475877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137940544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001896,0.004298352,0.00002470547,0.0035267489,0.0016764044,0.000106945896,0.0000105121435,0.0000033126644,0.00033402882],"genre_scores_gemma":[0.98459154,0.013100332,0.0009494051,0.0009539016,0.00013470129,0.0000020751954,0.000004677626,0.00000908286,0.00025428174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797565,0.0001712075,0.0013217616,0.00017833765,0.00017793934,0.00017513227],"domain_scores_gemma":[0.99535275,0.0033666727,0.0004773989,0.00016985227,0.00040239087,0.00023094678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005247397,0.00011119912,0.0009504167,0.00017188003,0.00002474921,0.0000077605455,0.00006611768,0.00027294783,0.00025530005],"category_scores_gemma":[0.004285908,0.000083159255,0.00022772195,0.00040417368,0.000093533614,0.00007031261,0.000054335058,0.0005136062,0.0000028568732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057141855,0.0017163232,0.95831174,0.000060904884,0.0009959835,0.012624625,0.00014270742,0.000004159928,0.000043915872,0.00015360392,0.0009840624,0.02439053],"study_design_scores_gemma":[0.0117684165,0.004170601,0.9648081,0.00018356953,0.0009304255,0.00088869006,0.00017329185,0.00011025507,0.00048969296,0.00017330358,0.016197888,0.00010575037],"about_ca_topic_score_codex":0.0000030369843,"about_ca_topic_score_gemma":0.0000123031905,"teacher_disagreement_score":0.02428478,"about_ca_system_score_codex":0.00007629134,"about_ca_system_score_gemma":0.0005263743,"threshold_uncertainty_score":0.5130941},"labels":[],"label_agreement":null},{"id":"W3138823977","doi":"10.1016/j.semcancer.2021.03.018","title":"Does the “Devil” originate from the fallopian tubes?","year":2021,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Serous fluid; Ovarian cancer; Fallopian tube; Serous carcinoma; Carcinogenesis; Ovarian carcinoma; Disease; Biology; Histology; Pathology; Medicine; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.05090979548946998,"score_gpt":0.40403755040557493,"score_spread":0.35312775491610493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138823977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000094655814,0.98615235,0.0000011164858,0.00843759,0.0027432614,0.0011345205,0.0005777555,0.000022068456,0.00083670433],"genre_scores_gemma":[0.00007182529,0.99348813,0.00006943278,0.0015969044,0.0014552622,0.0016614008,0.0005410962,0.000053937896,0.0010620095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976559,0.00041540925,0.00056054315,0.00077576196,0.00013917875,0.00045316105],"domain_scores_gemma":[0.9975749,0.0010891696,0.00018079685,0.0010225079,0.000056327073,0.00007629827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028177013,0.0004920569,0.0018720281,0.00006318081,0.000105621606,0.000032146392,0.0004569945,0.0004617856,0.0014443947],"category_scores_gemma":[0.00007631562,0.00016821953,0.00049352855,0.00044283536,0.00027992445,0.00001814208,0.00017878377,0.00077291275,0.000063933054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009657885,0.00008533337,0.0053838366,0.0006837884,0.00075622456,0.00012444933,0.00014640731,2.026569e-7,3.483057e-7,0.00055527093,0.01007861,0.9821759],"study_design_scores_gemma":[0.00041945538,0.00009435364,0.00032706055,0.023340454,0.0014909044,0.000031023123,0.00007486377,7.1261775e-7,0.0000071338345,0.00015437773,0.97384226,0.0002173829],"about_ca_topic_score_codex":0.0031715832,"about_ca_topic_score_gemma":0.002213316,"teacher_disagreement_score":0.9819585,"about_ca_system_score_codex":0.00071201223,"about_ca_system_score_gemma":0.0010892539,"threshold_uncertainty_score":0.99946845},"labels":[],"label_agreement":null},{"id":"W3141735340","doi":"","title":"Medical therapy of advanced malignant epithelial tumours of the ovary","year":2000,"lang":"en","type":"article","venue":"BOA (University of Milano-Bicocca)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Taxane; Regimen; Internal medicine; Oncology; Cisplatin; Paclitaxel; Ovarian cancer; Chemotherapy; Progression-free survival; Clinical trial; Gynecologic oncology; Ovarian carcinoma; Surgery; Cancer; Breast cancer","score_opus":0.010719368217181766,"score_gpt":0.22012161586111012,"score_spread":0.20940224764392834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141735340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98750776,0.0009841783,0.000009458781,0.003911169,0.00008949776,0.0003049186,0.00008762205,0.000013980644,0.0070914063],"genre_scores_gemma":[0.9942968,0.0035535886,0.00052191253,0.00016404559,0.000037667807,5.95194e-7,0.000009486333,0.000010692213,0.0014052377],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989165,0.000055639022,0.00017696791,0.00020075921,0.00048573283,0.00016437125],"domain_scores_gemma":[0.99919754,0.00006253906,0.00015038715,0.0003939544,0.00008155388,0.000114051436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013837138,0.000121707955,0.00040757708,0.000062201216,0.000060658953,0.0000010999803,0.00025480834,0.00010097114,0.00449166],"category_scores_gemma":[0.000012431983,0.00009308725,0.00026382098,0.0001927724,0.00028236813,0.000048241058,0.000045223926,0.000105557694,0.000014039869],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0083748875,0.0068713487,0.39119625,0.0004967957,0.0016029124,0.000625133,0.007072969,0.00010431056,0.05107408,0.0029711064,0.018633185,0.510977],"study_design_scores_gemma":[0.010355557,0.001106304,0.92168206,0.0007403938,0.00024301693,0.000038619277,0.0009853346,0.00006388861,0.030691786,0.00014177203,0.033775818,0.00017544662],"about_ca_topic_score_codex":0.00054351415,"about_ca_topic_score_gemma":0.000081447586,"teacher_disagreement_score":0.5304858,"about_ca_system_score_codex":0.000046586854,"about_ca_system_score_gemma":0.00025704326,"threshold_uncertainty_score":0.99641836},"labels":[],"label_agreement":null},{"id":"W3142914080","doi":"10.1002/cam4.3831","title":"Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"Canada Research Chairs; Princess Margaret Cancer Foundation; Ontario Institute for Cancer Research; AstraZeneca Canada","keywords":"Ovarian cancer; Carboplatin; Medicine; Chemotherapy; Debulking; Paclitaxel; Oncology; Immunohistochemistry; Serous fluid; Exome sequencing; Cancer research; Internal medicine; Cancer; Biology; Mutation; Cisplatin; Gene","score_opus":0.021445477698204898,"score_gpt":0.28754901143673267,"score_spread":0.2661035337385278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142914080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8892951,0.011749316,0.00008258416,0.09668502,0.0010010836,0.0009697499,0.00013620601,0.000052802585,0.000028127619],"genre_scores_gemma":[0.98384696,0.008124536,0.00042996288,0.0048236893,0.0012443962,0.0007665886,0.000101944934,0.00008561578,0.0005763149],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99767756,0.00009223773,0.0006493911,0.0007493334,0.0003144317,0.0005170425],"domain_scores_gemma":[0.9988239,0.00012755873,0.00013889217,0.00044060513,0.00011528835,0.00035377213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023938551,0.00040879555,0.001067567,0.00021192236,0.000102142796,0.00002514342,0.000106598614,0.000111487185,0.0017208445],"category_scores_gemma":[0.00006166111,0.00033237756,0.00008632231,0.00039858307,0.00011382409,0.000070495706,0.000042646265,0.00030825858,0.0000054888606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011250709,0.0006113506,0.07357037,0.00047823405,0.0005458769,0.00094216445,0.004719537,0.000031207197,0.8737055,0.00011887759,0.0003554935,0.03367067],"study_design_scores_gemma":[0.022644939,0.0007181376,0.85054916,0.0018127568,0.00031633963,0.00006980523,0.00021958309,0.00011543416,0.115954995,0.00005028961,0.007217952,0.00033059763],"about_ca_topic_score_codex":0.0023286608,"about_ca_topic_score_gemma":0.00102053,"teacher_disagreement_score":0.7769788,"about_ca_system_score_codex":0.0006535258,"about_ca_system_score_gemma":0.00045172844,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W3146134912","doi":"10.4021/jcs196w","title":"Giant Ovarian Cyst Presenting With Colon Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Current Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Concomitant; Surgery; Ovarian cyst; Abdominal hysterectomy; Ovarian cancer; Hysterectomy; Colorectal cancer; Cyst; General surgery; Radiology; Cancer; Internal medicine","score_opus":0.043899758004082044,"score_gpt":0.313055894625024,"score_spread":0.26915613662094195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146134912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832143,0.006994279,0.000110911955,0.007166285,0.0017233458,0.00030548824,0.000007620215,0.00001334812,0.00046440202],"genre_scores_gemma":[0.99690855,0.0016008687,0.0002263429,0.0001445461,0.0009332424,0.000041130086,0.0000042223473,0.00002045605,0.00012061934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868107,0.000040380386,0.0004817876,0.00012649968,0.0004227858,0.00024746833],"domain_scores_gemma":[0.9985738,0.00017512323,0.00050918746,0.00014477878,0.00036242924,0.00023473063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025257835,0.00013953916,0.00048359035,0.00017509206,0.00004996428,0.000048107002,0.000048360256,0.000035956855,0.00084698875],"category_scores_gemma":[0.000057003428,0.000085862164,0.00020604242,0.00017273767,0.000034256074,0.00021480831,0.0000151801405,0.00023044492,0.000024679863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001998885,0.0007762951,0.84666276,0.00020013582,0.0005061935,0.000347023,0.00014047073,0.000022402404,0.0003931496,0.00004706783,0.08145056,0.06925404],"study_design_scores_gemma":[0.0020152996,0.0002521714,0.9221134,0.0021500313,0.00051315594,0.00074922113,0.000058407746,0.0000754253,0.0015996875,0.00005952627,0.07022739,0.00018628537],"about_ca_topic_score_codex":0.00008831669,"about_ca_topic_score_gemma":0.000009403416,"teacher_disagreement_score":0.07545062,"about_ca_system_score_codex":0.00015692222,"about_ca_system_score_gemma":0.0004765973,"threshold_uncertainty_score":0.92739326},"labels":[],"label_agreement":null},{"id":"W3152748820","doi":"10.1016/j.critrevonc.2021.103324","title":"Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Impact; University of Toronto; Queen's University; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre","funders":"","keywords":"Fallopian tube; Medicine; Stage (stratigraphy); Ovary; Adjuvant therapy; Adjuvant; Gynecology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.08088353931758632,"score_gpt":0.4152486905022938,"score_spread":0.33436515118470744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152748820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002250551,0.96760285,0.0000668017,0.0026060988,0.0011130135,0.027922938,0.0003175821,0.00007434917,0.00027384792],"genre_scores_gemma":[0.00007096428,0.9595333,0.0022772907,0.0047670747,0.00039121968,0.031829413,0.00053533353,0.00020560574,0.0003898157],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98568183,0.0047204006,0.005610498,0.0021437125,0.00044499245,0.0013985534],"domain_scores_gemma":[0.9857623,0.010170788,0.0011749464,0.0017874725,0.00038567957,0.00071881583],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0037278314,0.0016517522,0.026006434,0.0004047282,0.0003180146,0.00005385177,0.000578569,0.001511973,0.00032498073],"category_scores_gemma":[0.010270092,0.0010367471,0.0020302543,0.00068680465,0.0005818217,0.00011063303,0.00039403304,0.0016935938,0.00006787427],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011204847,0.0013288734,0.00004867782,0.77547044,0.0004258274,0.0058171293,0.00012618145,9.535022e-9,4.4730072e-7,0.004409576,0.002882073,0.2093787],"study_design_scores_gemma":[0.0030180418,0.0018633327,0.00000699359,0.4990993,0.006233297,0.009955565,0.000055155535,0.000003673276,6.48335e-7,0.000017541704,0.47921526,0.00053118536],"about_ca_topic_score_codex":0.00003551467,"about_ca_topic_score_gemma":0.0000763039,"teacher_disagreement_score":0.47633317,"about_ca_system_score_codex":0.0017537152,"about_ca_system_score_gemma":0.0040409574,"threshold_uncertainty_score":0.9997843},"labels":[],"label_agreement":null},{"id":"W3153436911","doi":"","title":"Screening and primary and secondary interventions for patients at high risk for ovarian cancer","year":2003,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ovarian cancer; Psychological intervention; Medicine; Oncology; Primary (astronomy); Internal medicine; Cancer; Gynecology; Psychiatry; Physics","score_opus":0.03752347636300222,"score_gpt":0.34950585824070896,"score_spread":0.3119823818777067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153436911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3588481,0.61467415,0.0004658013,0.0130775245,0.00048063815,0.009729368,0.00072006363,0.000036892354,0.0019674816],"genre_scores_gemma":[0.14156774,0.81663746,0.011734919,0.013481039,0.00019314315,0.013426215,0.00019802302,0.00006552607,0.0026959206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915105,0.000108681714,0.00026693594,0.00022098846,0.00004876254,0.00020355881],"domain_scores_gemma":[0.99916446,0.0003350673,0.00017877649,0.00016869324,0.000058412177,0.000094575626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005976941,0.00011821673,0.0005162127,0.0000232901,0.0002180674,0.00000653182,0.000036290694,0.00004949462,0.00027968525],"category_scores_gemma":[0.00008083078,0.00007445873,0.000109519395,0.000053575583,0.0000739376,0.00003181183,0.000030992505,0.000080913676,0.0000018155187],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034693672,0.00052311673,0.041715372,0.009592326,0.0010042235,0.0000029384507,0.00044303975,1.7380016e-7,0.0000030493434,0.0018091946,0.013742978,0.93081665],"study_design_scores_gemma":[0.008015377,0.0022577425,0.10487165,0.0032384405,0.0017128953,0.000022796317,0.00003385729,0.0000022983668,0.0000100716625,0.00062115415,0.87909865,0.000115065784],"about_ca_topic_score_codex":0.000031461357,"about_ca_topic_score_gemma":0.00006038638,"teacher_disagreement_score":0.9307016,"about_ca_system_score_codex":0.00032358538,"about_ca_system_score_gemma":0.00011761516,"threshold_uncertainty_score":0.30623573},"labels":[],"label_agreement":null},{"id":"W3153876288","doi":"10.21203/rs.2.20066/v1","title":"Prognostic Significance of the Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients: A Systematic Review and Meta-analysis of Cohort Studies","year":2020,"lang":"en","type":"review","venue":"Research Square (Research Square)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Shengjing Hospital; China Medical University; China Postdoctoral Science Foundation; Doctoral Start-up Foundation of Liaoning Province; National Natural Science Foundation of China","keywords":"Funnel plot; Publication bias; Medicine; Meta-analysis; Hazard ratio; Internal medicine; Cohort study; Confidence interval; Oncology; Observational study; Cohort","score_opus":0.21391386598982398,"score_gpt":0.4805491490830983,"score_spread":0.26663528309327433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153876288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014828025,0.94875985,0.0000027824121,0.0022446008,0.00003437921,0.045414433,0.0033344321,0.000013265562,0.000047959664],"genre_scores_gemma":[0.023832494,0.9299022,0.000037981965,0.000051562925,0.000063451094,0.045648113,0.00023795936,0.0000852189,0.0001410083],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97945917,0.009736056,0.0027980013,0.001543343,0.0053534308,0.0011099854],"domain_scores_gemma":[0.9805607,0.010387988,0.00090954005,0.0013929405,0.0063064373,0.0004423911],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007988805,0.00080527406,0.012266637,0.0020091105,0.00028667008,0.000078194986,0.0008420672,0.00032913778,0.00041379625],"category_scores_gemma":[0.014366037,0.00044071156,0.0023800826,0.010738221,0.0014151642,0.00014654108,0.0007706966,0.00218374,0.000014060883],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006483613,0.0017784035,0.017525302,0.77575,0.20282866,0.00006739666,0.00048678656,0.000003500198,2.787832e-7,0.00021797743,0.00039233064,0.0008845411],"study_design_scores_gemma":[0.0012217909,0.0015921728,0.016868109,0.3554847,0.62109965,0.000007185683,0.000357486,0.000034383473,0.0000082656725,0.00007775497,0.0028272236,0.00042127684],"about_ca_topic_score_codex":0.0010311987,"about_ca_topic_score_gemma":0.00052499736,"teacher_disagreement_score":0.4202653,"about_ca_system_score_codex":0.0015744072,"about_ca_system_score_gemma":0.003938985,"threshold_uncertainty_score":0.99980444},"labels":[],"label_agreement":null},{"id":"W3154004164","doi":"10.1016/j.critrevonc.2021.103336","title":"Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; University of Toronto; Hamilton Health Sciences; Impact","funders":"Cancer Care Ontario","keywords":"Fallopian tube; Ovary; Consolidation (business); Medicine; Gynecology; Ovarian carcinoma; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.09736373348610841,"score_gpt":0.4254258861202621,"score_spread":0.3280621526341537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154004164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000100258,0.9599208,0.00026361932,0.0028454815,0.0014314186,0.034609307,0.00041183233,0.00009286407,0.00041462918],"genre_scores_gemma":[0.000054633998,0.9372781,0.0031006597,0.0067312643,0.00045616977,0.04908698,0.0007893666,0.00019761865,0.0023052078],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9845762,0.004710425,0.0065755257,0.002124752,0.0004914388,0.0015216068],"domain_scores_gemma":[0.9801324,0.014961563,0.0016559452,0.0020011615,0.00064217893,0.00060672854],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004053446,0.0016573777,0.023867583,0.000409565,0.00033921844,0.00006007284,0.00076633727,0.0016035776,0.0015975777],"category_scores_gemma":[0.021312336,0.0009088663,0.0020453155,0.0010789616,0.000601474,0.00014520058,0.0003026828,0.0016064908,0.00009972876],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000710476,0.001847638,0.000017709719,0.8588281,0.00055919023,0.008725786,0.00013719812,2.2111523e-8,4.1390103e-7,0.0044712825,0.013875089,0.11082709],"study_design_scores_gemma":[0.004282684,0.0021299806,0.0000015594114,0.48275748,0.005087476,0.010650175,0.00008212856,0.00000451078,0.000001110734,0.000011101106,0.49447015,0.0005216439],"about_ca_topic_score_codex":0.000036603178,"about_ca_topic_score_gemma":0.00018592403,"teacher_disagreement_score":0.48059505,"about_ca_system_score_codex":0.002928638,"about_ca_system_score_gemma":0.008486874,"threshold_uncertainty_score":0.99969256},"labels":[],"label_agreement":null},{"id":"W3154235110","doi":"10.24908/iqurcp.10557","title":"Predicting Chemotherapy Treatment Outcomes in Ovarian Cancer Patients Using Gene Expression Analysis","year":2018,"lang":"en","type":"article","venue":"Inquiry Queen s Undergraduate Research Conference Proceedings","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Chemotherapy; Oncology; Disease; Internal medicine; Cancer; Medicine; Bioinformatics; Biology","score_opus":0.12137631272685909,"score_gpt":0.4181007743478397,"score_spread":0.29672446162098065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154235110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856395,0.000065250024,0.00024704123,0.008900948,0.00015158665,0.0013003609,0.000025715084,0.00006798452,0.00067713996],"genre_scores_gemma":[0.99564135,0.0010772211,0.0018168574,0.00013905841,0.00044547633,0.00043824656,0.000032805678,0.00005515064,0.00035384903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961681,0.00008193997,0.00058996823,0.0009984315,0.0011736791,0.0009878825],"domain_scores_gemma":[0.9973546,0.00011595819,0.00019982542,0.00033143963,0.0016102644,0.0003878636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005996911,0.00040220795,0.0008396359,0.0011824624,0.00034145763,0.00021362539,0.00022905089,0.00019634051,0.00020095702],"category_scores_gemma":[0.0001366667,0.00030552162,0.00021243602,0.0019907276,0.00043617468,0.00036595998,0.00013452649,0.00034536637,0.000019650566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003633234,0.0013261492,0.9828191,0.000051722356,0.0010379058,0.000016932763,0.0037117926,0.000004992583,0.006977569,0.00027095317,0.00013660714,0.003282976],"study_design_scores_gemma":[0.009204408,0.0026458746,0.8718797,0.0007801173,0.000696669,0.0000038604253,0.0010873954,0.004707462,0.10646778,0.0016386975,0.0003868287,0.00050120143],"about_ca_topic_score_codex":0.0063839285,"about_ca_topic_score_gemma":0.0003428855,"teacher_disagreement_score":0.110939376,"about_ca_system_score_codex":0.0019764393,"about_ca_system_score_gemma":0.00066789653,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W3154751361","doi":"10.1136/ijgc-2021-002484","title":"Assessment of anastomotic perfusion using indocyanine green fluorescence angiography following bowel resection for gynecologic malignancies: an instructional surgical video","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Indocyanine green; Anastomosis; Perfusion; Bowel resection; Angiography; Radiology; Resection; Surgery","score_opus":0.03778399451916821,"score_gpt":0.3701307345170367,"score_spread":0.3323467399978685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154751361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942458,0.00094424904,0.0007341439,0.0015730581,0.002046907,0.00025267567,0.00005601346,0.000011061413,0.00013603637],"genre_scores_gemma":[0.9806289,0.00047201675,0.017854165,0.00022701586,0.0007018301,0.000035475674,0.00003116599,0.000014425709,0.000034982728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977699,0.000113783215,0.0007557011,0.00030871594,0.00082305144,0.00022883664],"domain_scores_gemma":[0.99718344,0.0004107495,0.0005356677,0.00012966736,0.0015663332,0.00017412985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047360687,0.0001775261,0.0005047453,0.0002910758,0.00009542892,0.00003791491,0.00018845874,0.0001523939,0.0009845027],"category_scores_gemma":[0.00027694012,0.00013508566,0.0007598846,0.0003094387,0.00008918939,0.0002608246,0.000071340524,0.00023580181,3.7772008e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016836585,0.0025722622,0.92235726,0.00008425249,0.0018622013,0.002458909,0.00008987738,0.0025976847,0.022642951,0.0014368127,0.00015676311,0.042057395],"study_design_scores_gemma":[0.006633733,0.0036427013,0.977741,0.00041443505,0.0005156193,0.0009565332,0.00016668683,0.0027527662,0.004956188,0.00064674893,0.0013997097,0.00017390218],"about_ca_topic_score_codex":0.00008916517,"about_ca_topic_score_gemma":0.000112347465,"teacher_disagreement_score":0.05538374,"about_ca_system_score_codex":0.00084383896,"about_ca_system_score_gemma":0.00078192307,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W3156667266","doi":"10.3390/cancers13081925","title":"Fallopian Tube-Derived Tumor Cells Induce Testosterone Secretion from the Ovary, Increasing Epithelial Proliferation and Invasion","year":2021,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Environmental Health Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health","keywords":"Fallopian tube; Ovary; Biology; Serous fluid; Epithelium; Androgen; Cancer research; Internal medicine; Endocrinology; Pathology; Medicine; Hormone; Anatomy","score_opus":0.021923100985664003,"score_gpt":0.24675783131752027,"score_spread":0.22483473033185628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156667266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390477,0.0012833761,0.000059906753,0.0035880327,0.00034360436,0.00043158888,0.00006292564,0.000031079206,0.00029472934],"genre_scores_gemma":[0.9953528,0.0005408866,0.0007749559,0.0025118422,0.00051610405,0.000075278695,0.00016368671,0.00002106863,0.00004338853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905,0.00010195276,0.0001790184,0.0003305739,0.00017963175,0.00015881045],"domain_scores_gemma":[0.9993621,0.00012989304,0.00006963471,0.00024697735,0.00008197056,0.00010942769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011707141,0.00013950549,0.0002018029,0.000022213597,0.00014503209,0.000060697832,0.00003784295,0.000057895377,0.00012074695],"category_scores_gemma":[0.000072803894,0.0001023123,0.000040357598,0.00011828377,0.000058478545,0.00009126565,0.000039729868,0.00013725385,0.000010107564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005323245,0.000089263216,0.11077138,0.00007113608,0.00023528021,0.00019110696,0.0023757902,0.00008182207,0.86515933,0.000099825025,0.0011473418,0.019245403],"study_design_scores_gemma":[0.0042856773,0.00035318438,0.42545107,0.0007382115,0.00037205179,0.00009887912,0.00087640254,0.0008277833,0.5610282,0.00014285045,0.0055879694,0.00023774864],"about_ca_topic_score_codex":0.0018631176,"about_ca_topic_score_gemma":0.000528551,"teacher_disagreement_score":0.31467968,"about_ca_system_score_codex":0.0006672014,"about_ca_system_score_gemma":0.0007402201,"threshold_uncertainty_score":0.41721743},"labels":[],"label_agreement":null},{"id":"W3157842673","doi":"10.1259/bjr.20210157","title":"Ovary: MRI characterisation and O-RADS MRI","year":2021,"lang":"en","type":"review","venue":"British Journal of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Radiology; Cyst; Lesion; Magnetic resonance imaging; Echogenicity; Ultrasound; Pathology","score_opus":0.03096999794232572,"score_gpt":0.32286649170889486,"score_spread":0.2918964937665691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157842673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016351262,0.9979435,0.00005778296,0.0004924254,0.0008634621,0.00026625575,0.000040469455,0.0000064777555,0.00016608664],"genre_scores_gemma":[0.000072007155,0.9972136,0.00074506935,0.00021152098,0.0014736877,0.000018821238,0.00011465324,0.000035319175,0.00011529794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983682,0.00024770002,0.0007900709,0.00025508238,0.00014196441,0.00019699398],"domain_scores_gemma":[0.99868375,0.00012149551,0.0007203864,0.0001497498,0.00014332325,0.00018128961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003402454,0.00021661795,0.002474723,0.00015471329,0.000045449007,0.000046299316,0.00007806318,0.00031506352,0.00022330256],"category_scores_gemma":[0.000084490835,0.00019876852,0.0004735524,0.00011760478,0.00007493822,0.000065055516,0.000030585383,0.0005309868,0.0000063764683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010931079,0.0001122059,0.00015390106,0.001968518,0.00097228645,0.008102334,0.000018909419,9.791765e-8,2.6542696e-7,0.00004939838,0.020953123,0.96765804],"study_design_scores_gemma":[0.0007126391,0.000323727,0.0017203013,0.018093951,0.0016452823,0.33631808,0.000004931628,3.6336274e-7,2.9284035e-7,0.000011870765,0.64107484,0.00009376777],"about_ca_topic_score_codex":0.000021965418,"about_ca_topic_score_gemma":0.000004445931,"teacher_disagreement_score":0.9675643,"about_ca_system_score_codex":0.00023331269,"about_ca_system_score_gemma":0.000538166,"threshold_uncertainty_score":0.81055456},"labels":[],"label_agreement":null},{"id":"W3161147162","doi":"10.1016/j.jogc.2021.04.013","title":"Yolk Sac Tumour of the Ovary in Pregnancy Treated With Surgery and Chemotherapy: A Case Report","year":2021,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Yolk sac; Pregnancy; Gestation; Ovary; Chemotherapy; Concomitant; Obstetrics; Fetus; Gynecology; Adjuvant chemotherapy; Surgery; Cancer; Internal medicine; Embryo","score_opus":0.012966840360604345,"score_gpt":0.22607664223004073,"score_spread":0.2131098018694364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161147162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834884,0.013882536,8.2877636e-7,0.001706622,0.0006248873,0.000101723126,0.000007626344,7.9464166e-7,0.00018662999],"genre_scores_gemma":[0.99863917,0.0008629279,0.00011159285,0.00026582248,0.0000094168245,0.0000030772223,0.000001280665,0.000008168021,0.00009854599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916846,0.00004289537,0.0003863241,0.000116527626,0.00016290022,0.00012290863],"domain_scores_gemma":[0.9983317,0.0008850936,0.00034601553,0.0001254091,0.00021331411,0.00009844754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001191834,0.0000898992,0.00041877732,0.00010223288,0.00003404317,0.0000062744407,0.000022269422,0.00005320523,0.00007592726],"category_scores_gemma":[0.0006104971,0.00005369355,0.0000453567,0.00038916347,0.000043850217,0.00002557921,0.000015002448,0.00015022993,1.18456365e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008247345,0.00011013617,0.6813415,0.000038546295,0.00013192253,0.30428702,0.000035548906,0.0000022953495,0.000006015324,0.000005248568,0.00028096596,0.013752489],"study_design_scores_gemma":[0.0024626155,0.00018564175,0.94814175,0.000103914346,0.0001552447,0.047551747,0.00015847081,0.000005131312,0.00055124686,0.000011850593,0.00062129245,0.000051078696],"about_ca_topic_score_codex":0.014280061,"about_ca_topic_score_gemma":0.041580256,"teacher_disagreement_score":0.2668002,"about_ca_system_score_codex":0.00035522363,"about_ca_system_score_gemma":0.0026332466,"threshold_uncertainty_score":0.99228394},"labels":[],"label_agreement":null},{"id":"W3161486510","doi":"10.1097/01.ogx.0000751592.86339.dc","title":"The World Ovarian Cancer Coalition Every Woman Study: Identifying Challenges and Opportunities to Improve Survival and Quality of Life","year":2021,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Incidence (geometry); Quality of life (healthcare); Cancer; Population; Gynecology; Oncology; Demography; Gerontology; Internal medicine; Environmental health; Nursing","score_opus":0.2743647580168598,"score_gpt":0.3832796960037907,"score_spread":0.10891493798693092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161486510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632615,0.026344806,0.000012008415,0.0076865805,0.00070402096,0.0006915195,0.0001031716,0.00003148712,0.001164951],"genre_scores_gemma":[0.9883113,0.009986725,0.00007197158,0.00056256726,0.00007445735,0.00016498053,0.000018934428,0.000012924356,0.00079611916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970239,0.0011874286,0.00053870253,0.0005163481,0.0004209081,0.00031276076],"domain_scores_gemma":[0.98973876,0.009100337,0.00014485883,0.00030553126,0.00029860478,0.00041190925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014460647,0.00019548326,0.00068236946,0.00007247528,0.00018474497,0.00007325153,0.00007864756,0.000096702686,0.00016829227],"category_scores_gemma":[0.0055281906,0.00012572865,0.00007377984,0.00027827805,0.00013963082,0.000060451497,0.00023108542,0.00019060088,0.0000022472539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004520953,0.0017361029,0.85691,0.00015661909,0.00052228215,0.00013129457,0.0003746556,9.449532e-7,0.00009519649,0.0042130295,0.0002901768,0.1351176],"study_design_scores_gemma":[0.0018471347,0.00062118424,0.99250406,0.000034021137,0.000088862704,9.757231e-7,0.0019308103,0.000004127236,0.000053303855,0.00009710879,0.00267578,0.00014262245],"about_ca_topic_score_codex":0.0010476963,"about_ca_topic_score_gemma":0.011748402,"teacher_disagreement_score":0.13559407,"about_ca_system_score_codex":0.00016187277,"about_ca_system_score_gemma":0.0001759262,"threshold_uncertainty_score":0.66181594},"labels":[],"label_agreement":null},{"id":"W3164144695","doi":"10.1093/carcin/bgab043","title":"Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research","year":2021,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institutes of Health; Medical Research Council; National Institute for Health and Care Research; Centre International de Recherche sur le Cancer; World Health Organization","keywords":"Ovarian cancer; Ovarian carcinoma; Medicine; Cancer; Disease; International agency; Consensus conference; Gynecology; Oncology; Pathology; Internal medicine","score_opus":0.10403782371340327,"score_gpt":0.385067235953584,"score_spread":0.28102941224018074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164144695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7213947,0.05624133,0.000037243466,0.20660175,0.006416865,0.0016082817,0.0007516041,0.00015476454,0.0067934203],"genre_scores_gemma":[0.96129054,0.007296777,0.0031449057,0.002228076,0.0058241123,0.0027419233,0.00044045624,0.000109911096,0.016923297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977376,0.00010476301,0.00038815214,0.000752919,0.0005737555,0.00044283885],"domain_scores_gemma":[0.9974886,0.00018961295,0.000094802286,0.0007014493,0.0012699872,0.00025550163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031421686,0.0002398027,0.0004156599,0.0002216788,0.00036671915,0.000060270315,0.00009158442,0.00015966191,0.0008858493],"category_scores_gemma":[0.00028055065,0.00021390973,0.0002925235,0.00039951978,0.00011531078,0.0000432147,0.00007553633,0.00019472132,0.00001780888],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019218641,0.001893791,0.17521368,0.00037330345,0.002027275,0.013791859,0.003585385,0.000031493546,0.03792502,0.0037714012,0.7003062,0.059158742],"study_design_scores_gemma":[0.001671437,0.00029661338,0.17692457,0.00017775779,0.00016753405,0.0012624473,0.001440844,0.000025424895,0.16490333,0.000062864725,0.6528682,0.00019895067],"about_ca_topic_score_codex":0.0006136396,"about_ca_topic_score_gemma":0.00030897863,"teacher_disagreement_score":0.2398958,"about_ca_system_score_codex":0.0008549368,"about_ca_system_score_gemma":0.00095575454,"threshold_uncertainty_score":0.96994287},"labels":[],"label_agreement":null},{"id":"W3166889753","doi":"10.1158/1557-3265.ovcasymp18-dp-006","title":"Abstract DP-006: THE EFFECT OF AGE AND OCP USE ON THE INCIDENCE OF PRE-CANCEROUS P53 LESIONS AND THE DEVELOPMENT OF HIGH GRADE SEROUS OVARIAN CARCINOMA","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Incidence (geometry); Ovarian cancer; Cohort; Cancer; Hysterectomy; Immunohistochemistry; Gynecology; Internal medicine; Oncology; Pathology","score_opus":0.16101491038278817,"score_gpt":0.45373327138641445,"score_spread":0.29271836100362625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166889753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910452,0.0015939577,0.000001797022,0.004891874,0.00012833452,0.0020915738,0.000033376473,0.000004900656,0.00020902799],"genre_scores_gemma":[0.9977207,0.0015004715,0.00007164371,0.00013983474,0.00008811643,0.00029498004,0.0000033290746,0.00001908753,0.00016180567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704033,0.00072845636,0.00073129905,0.0003899559,0.00080827094,0.00030170663],"domain_scores_gemma":[0.9865381,0.012129487,0.00024666215,0.0007751019,0.00018839198,0.00012227475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044249194,0.00016669172,0.00066291227,0.00006202163,0.00016277499,0.000026271655,0.00029382767,0.00011347033,0.00012603655],"category_scores_gemma":[0.0008763935,0.00006906178,0.00011629294,0.00027223374,0.0013179225,0.000044053108,0.00024478015,0.00066957,0.0000044552103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00832306,0.00044026476,0.93089885,0.0006965299,0.0005794846,0.000034585093,0.002366359,0.00002590762,0.0003995881,0.0021246513,0.00093964516,0.05317108],"study_design_scores_gemma":[0.005059868,0.0016178453,0.98592895,0.0006410466,0.00011401726,0.0000037113464,0.000119816075,0.000027882605,0.0057611833,0.00018254059,0.000478717,0.00006441817],"about_ca_topic_score_codex":0.007940401,"about_ca_topic_score_gemma":0.0013240057,"teacher_disagreement_score":0.05503011,"about_ca_system_score_codex":0.00011241835,"about_ca_system_score_gemma":0.00053766795,"threshold_uncertainty_score":0.9986658},"labels":[],"label_agreement":null},{"id":"W3167584894","doi":"10.1200/jco.2021.39.15_suppl.5574","title":"Phase II trial assessing niraparib with or without dostarlimab (anti-PD-1) in recurrent endometrial carcinoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Cancer Care Ontario; McMaster University; University of Toronto; Royal Victoria Hospital; University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"Conquer Cancer Foundation","keywords":"Medicine; PTEN; Olaparib; Clinical endpoint; Oncology; Internal medicine; Endometrial cancer; Biomarker; Cohort; Serous fluid; Phases of clinical research; Cancer; Clinical trial; Gastroenterology; PI3K/AKT/mTOR pathway; Biology","score_opus":0.2521662109518682,"score_gpt":0.5363523493509751,"score_spread":0.2841861383991069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167584894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98358876,0.0012031836,0.000081669845,0.009270091,0.0039509437,0.00049878703,0.000007207098,0.0000075613893,0.0013917888],"genre_scores_gemma":[0.9879718,0.0009757188,0.0064034504,0.0009787827,0.003489805,0.000017997823,0.000008976367,0.000024453326,0.00012905433],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950426,0.0007515432,0.0029041492,0.0003697176,0.0005784071,0.0003535828],"domain_scores_gemma":[0.9939686,0.0029428336,0.0018070431,0.00028065572,0.00053276593,0.00046808398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030094828,0.00022074125,0.002811896,0.0002815448,0.00006934726,0.00003715898,0.00012230968,0.0003469932,0.0004575256],"category_scores_gemma":[0.004837072,0.00013009734,0.000524321,0.00057036936,0.00015444515,0.00019109737,0.000071251,0.0012364052,0.0000052011205],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38392758,0.052942406,0.15911095,0.000043021762,0.000902686,0.017081594,0.00018466928,0.00000585771,0.00006851301,0.000049465874,0.0017514735,0.3839318],"study_design_scores_gemma":[0.7050112,0.18181226,0.052002706,0.00044905054,0.0014099668,0.0012368144,0.000280535,0.00006115078,0.0003695042,0.000038797338,0.057156786,0.00017126874],"about_ca_topic_score_codex":0.000033399276,"about_ca_topic_score_gemma":0.00020954364,"teacher_disagreement_score":0.3837605,"about_ca_system_score_codex":0.0004765684,"about_ca_system_score_gemma":0.009115296,"threshold_uncertainty_score":0.9965021},"labels":[],"label_agreement":null},{"id":"W3167655766","doi":"10.1200/jco.2021.39.15_suppl.tps5607","title":"Uplift (ENGOT-ov67): A pivotal cohort to evaluate XMT-1536 (upifitamab rilsodotin), a NaPi2b-directed antibody drug conjugate for platinum-resistant ovarian cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital","funders":"Mersana Therapeutics","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Cohort; Bevacizumab; Cancer; Olaparib; Fallopian tube cancer; Chemotherapy","score_opus":0.08863282984229492,"score_gpt":0.4842604555080846,"score_spread":0.3956276256657897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167655766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292513,0.0028239216,0.0004001476,0.058368713,0.004772783,0.001535027,0.00020039413,0.000059464448,0.0025882246],"genre_scores_gemma":[0.9663207,0.0023424767,0.018109415,0.007671632,0.0034982294,0.00018883111,0.00006350296,0.000086737266,0.0017184851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935489,0.00071087666,0.003561905,0.0007062621,0.0007958931,0.00067610573],"domain_scores_gemma":[0.99053574,0.003951038,0.0019327673,0.00050955644,0.0019234989,0.0011474158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0046103788,0.00039744147,0.0031553998,0.00018931346,0.00014716315,0.000048843758,0.00024575743,0.00043690062,0.0008506844],"category_scores_gemma":[0.005826826,0.00030625655,0.0010377595,0.00044228864,0.00016290181,0.00012735724,0.00011543884,0.00095724966,0.000043124695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05150066,0.01589871,0.40174666,0.0005018211,0.01686456,0.012839538,0.0010963922,0.0003517968,0.010835461,0.0018003946,0.1537634,0.3328006],"study_design_scores_gemma":[0.039091207,0.0152706755,0.74933386,0.000978412,0.0042440016,0.0006355584,0.00023286219,0.0007350831,0.0015482361,0.00045230545,0.1870443,0.00043352766],"about_ca_topic_score_codex":0.00025512534,"about_ca_topic_score_gemma":0.00092614815,"teacher_disagreement_score":0.34758717,"about_ca_system_score_codex":0.00071687694,"about_ca_system_score_gemma":0.006271608,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W3168714410","doi":"10.1200/jco.2021.39.15_suppl.tps5601","title":"A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Letrozole; Carboplatin; Internal medicine; Oncology; Aromatase inhibitor; Clinical endpoint; Serous fluid; Serous carcinoma; Taxane; Surgery; Randomized controlled trial; Chemotherapy; Breast cancer; Aromatase; Cancer; Cisplatin; Ovarian cancer","score_opus":0.06425841964498205,"score_gpt":0.4032444483881785,"score_spread":0.3389860287431965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168714410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930043,0.0013085209,0.0000119651595,0.0032799907,0.0010134979,0.0010182182,0.000031297495,0.0000027518486,0.00032945076],"genre_scores_gemma":[0.99629056,0.0014283581,0.0009990849,0.0007751966,0.00032568717,0.000027357448,0.0000057544257,0.000021372063,0.0001266116],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995635,0.0008619484,0.002504964,0.00025874318,0.0004975482,0.00024181402],"domain_scores_gemma":[0.9939373,0.0028703169,0.00224754,0.0003278325,0.00042441208,0.00019258956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017752134,0.00020544256,0.002925424,0.00009738908,0.00004015094,0.0000061772726,0.00013010134,0.00019781095,0.00007885089],"category_scores_gemma":[0.0012625057,0.00010760691,0.000521271,0.00023874316,0.000450274,0.00008439891,0.000074459436,0.00062643696,1.7783235e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9111439,0.013296206,0.05912801,0.000066246845,0.00095729117,0.00050200586,0.00031587228,0.00001738639,0.000074746305,0.000034999623,0.00021328316,0.014250068],"study_design_scores_gemma":[0.8651763,0.036213256,0.09596578,0.00029375535,0.00060699356,0.000031711174,0.00015623565,0.000043229884,0.00035284692,0.000019868181,0.0010494341,0.00009059772],"about_ca_topic_score_codex":0.00014619298,"about_ca_topic_score_gemma":0.00016036812,"teacher_disagreement_score":0.045967594,"about_ca_system_score_codex":0.00024738323,"about_ca_system_score_gemma":0.0023744707,"threshold_uncertainty_score":0.43880823},"labels":[],"label_agreement":null},{"id":"W3169546790","doi":"10.1073/pnas.2026663118","title":"Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening","year":2021,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"National Cancer Institute; Terry Fox Foundation; Princess Margaret Cancer Foundation; Sara Elizabeth O'Brien Trust; Ontario Ministry of Health and Long-Term Care; University of Toronto; Mary Kay Foundation","keywords":"Debulking; Clinical trial; Medicine; Ovarian cancer; Clinical significance; Chemotherapy; Cancer; Minimal residual disease; Intensive care medicine; Oncology; Surgery; Internal medicine","score_opus":0.07990842592245909,"score_gpt":0.3568869417259992,"score_spread":0.27697851580354016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169546790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863345,0.0010285432,0.00041474676,0.008958648,0.000012269393,0.00021897495,0.00006801042,0.0000043801074,0.000660995],"genre_scores_gemma":[0.967203,0.00019160034,0.032367207,0.00015508325,0.000042463616,0.00002001409,0.0000010379753,0.0000033294211,0.000016246611],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990457,0.00000225624,0.000213795,0.00016339732,0.0004939679,0.00008086977],"domain_scores_gemma":[0.9991666,0.000091260365,0.00018407215,0.000004756535,0.0005298987,0.00002337727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000328336,0.000062674255,0.00015899929,0.00006357545,0.00009330259,0.000017951745,0.00009750764,0.000040809187,0.000007829721],"category_scores_gemma":[0.000058792117,0.000042767657,0.000056464785,0.00025396704,0.00023885757,0.00018544425,0.000032786196,0.000054703065,1.5020698e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025635952,0.00031547403,0.070833,0.00046409754,0.00034443868,4.7242917e-8,0.0008714644,0.23145635,0.015438129,0.66975975,0.00016162585,0.010099264],"study_design_scores_gemma":[0.0014246168,0.00013957362,0.10925031,0.00039924882,0.00005688198,0.000014127642,0.0010682913,0.81540936,0.019444508,0.05269825,0.000020198811,0.00007464016],"about_ca_topic_score_codex":0.000021775228,"about_ca_topic_score_gemma":3.791178e-7,"teacher_disagreement_score":0.6170615,"about_ca_system_score_codex":0.000029692323,"about_ca_system_score_gemma":0.00017113278,"threshold_uncertainty_score":0.17440145},"labels":[],"label_agreement":null},{"id":"W3169849224","doi":"10.1016/s1470-2045(21)00216-3","title":"Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eisai; Array BioPharma; Clovis Oncology; Roche; Mersana Therapeutics; Novartis; Merck KGaA; Merck; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Javelin; Ovarian cancer; Avelumab; Medicine; Refractory (planetary science); Chemotherapy; Open label; Oncology; Internal medicine; Cancer; Clinical trial; Immunotherapy; Nivolumab","score_opus":0.09341405805658175,"score_gpt":0.40025337878758066,"score_spread":0.3068393207309989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169849224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683591,0.0005811807,0.000097352044,0.0231225,0.00046889696,0.005679166,0.000094798095,0.00007314442,0.0015238741],"genre_scores_gemma":[0.98761374,0.0013103486,0.0033650782,0.0041762977,0.00056222203,0.0020703154,0.00017093148,0.00011851031,0.0006125389],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961086,0.00077075505,0.00092834386,0.00094222487,0.00049155706,0.00075855624],"domain_scores_gemma":[0.9971265,0.00093628647,0.00046381107,0.0010664089,0.0002047931,0.00020215608],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015881349,0.00052498543,0.0020326036,0.00018651162,0.00018027714,0.00010213998,0.00051512837,0.00027423218,0.00320752],"category_scores_gemma":[0.00014364951,0.00032203313,0.000045201206,0.0009639067,0.0001633264,0.0002523097,0.0001048138,0.00067201495,0.000014231333],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7939706,0.0584125,0.016500423,0.000095199786,0.0017355342,0.004813311,0.007824589,0.00007163743,0.0029418867,0.00038093966,0.0017506492,0.11150275],"study_design_scores_gemma":[0.872629,0.031678014,0.07978816,0.00034016173,0.0003803311,0.00009728161,0.0016961446,0.00088886183,0.0009990536,0.00016034477,0.0108194845,0.0005231928],"about_ca_topic_score_codex":0.0048804544,"about_ca_topic_score_gemma":0.122741364,"teacher_disagreement_score":0.11786091,"about_ca_system_score_codex":0.001559792,"about_ca_system_score_gemma":0.002359773,"threshold_uncertainty_score":0.99992317},"labels":[],"label_agreement":null},{"id":"W3170554531","doi":"10.1200/jco.2021.39.15_suppl.5541","title":"Patient self-reporting of tolerability using PRO-CTCAE: A randomized double-blind placebo controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in women with platinum resistant epithelial ovarian cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Cancer Care Ontario; Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Tolerability; Placebo; Internal medicine; Gemcitabine; Adverse effect; Nausea; Cancer","score_opus":0.1365709277447514,"score_gpt":0.44964866762829697,"score_spread":0.3130777398835456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170554531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913344,0.00017584107,0.00009424189,0.0029933336,0.0004982073,0.004613259,0.000005646968,0.000009524883,0.00027556796],"genre_scores_gemma":[0.9932686,0.00009741341,0.00572695,0.00016856276,0.00027488964,0.00041540182,0.0000049282767,0.000025586405,0.00001767735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98806334,0.0015505684,0.008847902,0.00042981864,0.00069962174,0.00040876947],"domain_scores_gemma":[0.98354775,0.0041322378,0.010745813,0.00027123574,0.0009926163,0.00031032285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01123173,0.0002917868,0.006442153,0.0002610409,0.000072386814,0.00002078355,0.00009125284,0.00028438884,0.00012136553],"category_scores_gemma":[0.0055705192,0.00016840911,0.00030254104,0.0005037966,0.0001931233,0.00015655004,0.00006079027,0.0009147688,1.550381e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9395955,0.025227746,0.019493846,0.00012723212,0.0019195273,0.002393874,0.0016413694,0.0014955085,0.00019095436,0.00004262757,0.0000072094754,0.007864598],"study_design_scores_gemma":[0.9310228,0.05571575,0.005902105,0.0012975212,0.0012188097,0.00016373492,0.000564656,0.003377534,0.00040369216,0.000047573998,0.00012171235,0.0001641097],"about_ca_topic_score_codex":0.00045309527,"about_ca_topic_score_gemma":0.00250921,"teacher_disagreement_score":0.030488007,"about_ca_system_score_codex":0.0015078128,"about_ca_system_score_gemma":0.010413812,"threshold_uncertainty_score":0.9951962},"labels":[],"label_agreement":null},{"id":"W3171688163","doi":"10.1097/md.0000000000026319","title":"Ovarian dysgerminoma with pseudo-Meigs syndrome","year":2021,"lang":"en","type":"article","venue":"Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dysgerminoma; Pleural effusion; Ascites; Meigs' syndrome; Ovarian tumor; Ovary; Differential diagnosis; Radiology; Abdominal mass; Adnexal mass; Carcinoembryonic antigen; Hydrothorax; Pathology; Surgery; Internal medicine; Ovarian cancer","score_opus":0.016521576254422365,"score_gpt":0.2624506971912167,"score_spread":0.24592912093679437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171688163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8425802,0.0033386294,0.00021492441,0.101473056,0.00053191936,0.00050739845,0.000013199047,0.00015268757,0.051187962],"genre_scores_gemma":[0.9890374,0.00018058858,0.001874552,0.0034446765,0.00039361443,0.000063317224,0.0000957378,0.000035706576,0.0048743873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862254,0.000027938622,0.00024266988,0.00041195977,0.00040274748,0.00029212213],"domain_scores_gemma":[0.99888134,0.000069205744,0.0000613092,0.00055522955,0.00014481043,0.00028808572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113833754,0.00020343938,0.0005196064,0.000087014465,0.00006567284,0.0000100790385,0.00005555626,0.000067502966,0.004335766],"category_scores_gemma":[0.000059270435,0.00012885481,0.00005603363,0.0004145619,0.00012352492,0.00004483242,0.000026813726,0.0001546756,0.00013692265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096504274,0.0032583585,0.5677431,0.0009085595,0.0027282725,0.22542974,0.0022795373,0.000004961885,0.0045051174,0.016191108,0.08745645,0.08852974],"study_design_scores_gemma":[0.01323486,0.003332873,0.8585079,0.0014800446,0.0010481921,0.024227923,0.00040455573,0.000028432074,0.0024820263,0.00028091407,0.094689034,0.00028328132],"about_ca_topic_score_codex":0.00011974839,"about_ca_topic_score_gemma":0.000035423374,"teacher_disagreement_score":0.29076475,"about_ca_system_score_codex":0.00012235627,"about_ca_system_score_gemma":0.00025537988,"threshold_uncertainty_score":0.9965744},"labels":[],"label_agreement":null},{"id":"W3171697095","doi":"10.1200/jco.2021.39.15_suppl.5543","title":"The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Oncology; Internal medicine; BRCA mutation; Disease; Perioperative; Serous fluid; Stage (stratigraphy); Minimal residual disease; Ovarian cancer; Surgery; Cancer","score_opus":0.08983597700166294,"score_gpt":0.427390041657983,"score_spread":0.33755406465632004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171697095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633085,0.0019979253,0.000025430287,0.03270051,0.0014197428,0.00010861137,0.0000030262906,0.000003408643,0.0004328058],"genre_scores_gemma":[0.9936364,0.0035411753,0.00073146285,0.0002310592,0.001705339,0.000003266326,0.000007630866,0.000008695656,0.00013495883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975746,0.0005032191,0.0013351117,0.00016487156,0.00022659104,0.00019560134],"domain_scores_gemma":[0.9960437,0.0027257192,0.00062438723,0.00013134234,0.00020302134,0.00027185143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527597,0.000088350986,0.0007870979,0.000053429514,0.000058582635,0.000016985983,0.000034380475,0.00026073074,0.000039794366],"category_scores_gemma":[0.00085507234,0.00005477942,0.00016393172,0.00014623669,0.00012654372,0.00006958094,0.000029553657,0.0007040254,0.0000038076414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067136384,0.0005841951,0.86013615,0.0000063783427,0.00017530411,0.001865248,0.00006619706,0.000014451702,0.000003368956,0.0007429376,0.00051545806,0.13521896],"study_design_scores_gemma":[0.00984575,0.002752921,0.91901547,0.00004109333,0.0003083919,0.0007556876,0.00012444198,0.000028057697,0.000026872684,0.00076868274,0.066287905,0.00004470959],"about_ca_topic_score_codex":0.00013694422,"about_ca_topic_score_gemma":0.00016981013,"teacher_disagreement_score":0.13517426,"about_ca_system_score_codex":0.00028921288,"about_ca_system_score_gemma":0.0014056388,"threshold_uncertainty_score":0.3058679},"labels":[],"label_agreement":null},{"id":"W3172195548","doi":"10.1200/jco.2021.39.15_suppl.5519","title":"Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; KRAS; Internal medicine; Oncology; Logistic regression; Progression-free survival; Proportional hazards model; Vemurafenib; Cancer; Chemotherapy; Metastatic melanoma","score_opus":0.10353998515697357,"score_gpt":0.4774920960452308,"score_spread":0.3739521108882572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172195548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882307,0.0021390445,0.000021664933,0.006825987,0.0021665818,0.00042251052,0.0000917419,0.0000043583577,0.00009741021],"genre_scores_gemma":[0.99465024,0.003466371,0.000814586,0.00043547264,0.00056782225,0.000012250854,0.000015749234,0.000024402148,0.000013076214],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99535674,0.00072324637,0.0027773597,0.0004208804,0.0004892666,0.00023251477],"domain_scores_gemma":[0.9949996,0.0017570612,0.0022277946,0.0003398394,0.0004484014,0.00022732661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011864526,0.00021063171,0.0019307013,0.00016020084,0.000023753188,0.000010114001,0.00014862386,0.00027156615,0.00007387795],"category_scores_gemma":[0.0011799028,0.00017671564,0.0004121885,0.00035646462,0.00016978093,0.00006916654,0.000057091773,0.00055266375,8.3182977e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.115585305,0.099332444,0.083510116,0.00015836212,0.013220326,0.0050589326,0.0027367221,0.00014541528,0.02376584,0.000016956099,0.00229356,0.654176],"study_design_scores_gemma":[0.26239416,0.03274677,0.68302983,0.0007842375,0.0025952193,0.000024130455,0.0015974918,0.00013877371,0.013618339,0.00006590571,0.0027911614,0.00021394998],"about_ca_topic_score_codex":0.0012881408,"about_ca_topic_score_gemma":0.0010017679,"teacher_disagreement_score":0.6539621,"about_ca_system_score_codex":0.0001779406,"about_ca_system_score_gemma":0.0010304108,"threshold_uncertainty_score":0.72062546},"labels":[],"label_agreement":null},{"id":"W3173276073","doi":"10.1016/j.jogc.2020.05.012","title":"Laparoscopic management of a torsioned adnexal mass in the third trimester of pregnancy","year":2021,"lang":"en","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Adnexal mass; Obstetrics; Pregnancy; Gynecology; Third trimester; First trimester; Gestation","score_opus":0.011066190038453957,"score_gpt":0.25394125816625013,"score_spread":0.24287506812779616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173276073","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037215833,0.069638684,0.0000030566155,0.00069558976,0.8898537,0.00052883604,0.00012059492,0.000001129007,0.0019425545],"genre_scores_gemma":[0.92604446,0.033999894,0.0014157372,0.00034193735,0.036186825,0.000061251194,0.00011038413,0.000066732675,0.0017727648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997846,0.00011275905,0.0008677845,0.00017999874,0.0007960316,0.00019739124],"domain_scores_gemma":[0.99557257,0.0027688385,0.0008846109,0.000255583,0.00042705063,0.00009133469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028729832,0.00018862332,0.0009919365,0.00023882536,0.000026319709,0.000010590416,0.00018993508,0.00031025097,0.00012654885],"category_scores_gemma":[0.0008708513,0.00012354704,0.00013991186,0.00039024258,0.000049739363,0.000026832637,0.00004706369,0.0005455252,9.403855e-8],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005868276,0.00093314366,0.042316116,0.0025027283,0.0018725897,0.01857752,0.0002848021,0.000011441206,0.0000035426033,0.0001170727,0.9088723,0.024450041],"study_design_scores_gemma":[0.02823114,0.00432903,0.26374054,0.0030778213,0.0037014447,0.00004362977,0.0016500666,0.0000048424026,0.00022725538,0.00016154358,0.6944563,0.00037642862],"about_ca_topic_score_codex":0.0053405096,"about_ca_topic_score_gemma":0.0058482653,"teacher_disagreement_score":0.88882864,"about_ca_system_score_codex":0.0008481753,"about_ca_system_score_gemma":0.0037800707,"threshold_uncertainty_score":0.8073289},"labels":[],"label_agreement":null},{"id":"W3174128728","doi":"10.1097/01.ogx.0000754400.96078.d7","title":"Fertility Treatment and Cancers—The Eternal Conundrum: A Systematic Review and Meta-analysis","year":2021,"lang":"en","type":"review","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Fertility; Gynecology; Population; Hum; Meta-analysis; Breast cancer; Endometrial cancer; Oncology; Estrogen; Obstetrics; Cancer; Internal medicine; Environmental health","score_opus":0.2589624662524152,"score_gpt":0.4099782607453502,"score_spread":0.151015794492935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174128728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014966135,0.99391276,0.000005319894,0.00054930075,0.00007052784,0.0047557186,0.0005557937,0.000030425967,0.00010518253],"genre_scores_gemma":[0.0008564986,0.99390817,0.00006323671,0.0010178768,0.000015373975,0.002719312,0.0002972502,0.000029180079,0.00109313],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99265903,0.0036864614,0.0015163559,0.0012351172,0.00042728137,0.00047576905],"domain_scores_gemma":[0.98260355,0.015030508,0.0006217933,0.0010168356,0.00021021967,0.000517065],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012165131,0.0008527606,0.015869033,0.00014520223,0.00017357645,0.0001344304,0.00019827567,0.0004167599,0.001660443],"category_scores_gemma":[0.0051892987,0.000350573,0.003480937,0.0018615628,0.00020880676,0.000030512436,0.00019252168,0.00044604682,0.00003238361],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011305776,0.0009369057,0.0017945224,0.4453682,0.5090691,0.0005219991,0.000017288226,2.4320184e-7,2.8939218e-9,0.00004521957,0.0002660342,0.041969217],"study_design_scores_gemma":[0.00038913326,0.00053149235,0.009345981,0.005836795,0.9288947,0.000059321657,0.0000048736633,0.0000022241074,3.044201e-8,0.0000030319611,0.054614622,0.00031776732],"about_ca_topic_score_codex":0.0008892498,"about_ca_topic_score_gemma":0.0004862592,"teacher_disagreement_score":0.4395314,"about_ca_system_score_codex":0.0012851614,"about_ca_system_score_gemma":0.00038566615,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W3175483111","doi":"10.14740/jcgo743","title":"A Case of a Rare Malignant Mixed Ovarian Germ Cell Tumor Masquerading as an Ectopic Pregnancy","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ectopic pregnancy; Germ cell; Gynecology; Pregnancy; Biology","score_opus":0.056722115982244664,"score_gpt":0.36316181313501883,"score_spread":0.3064396971527742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175483111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880868,0.008239572,0.000042954427,0.0008003405,0.0018415708,0.00016899868,0.000009738451,0.0000055743426,0.0008044062],"genre_scores_gemma":[0.9926223,0.0027069189,0.003560597,0.0006139483,0.00021048641,0.000004373453,0.0000032357593,0.000015065863,0.0002630461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975353,0.00034822212,0.0014450355,0.00026781877,0.00018258834,0.00022104688],"domain_scores_gemma":[0.9922569,0.005625314,0.0009748892,0.00027033963,0.00047619845,0.00039635808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067622896,0.00015330264,0.0010247399,0.00015910256,0.00006699346,0.000017556293,0.00007436213,0.00023855388,0.00030822572],"category_scores_gemma":[0.0077470085,0.00011458653,0.00031673632,0.00031053284,0.00009500102,0.000094866,0.000050640363,0.0004850945,0.0000036757915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002990594,0.0042505916,0.634107,0.00036699255,0.0005278366,0.2592353,0.00034205904,0.000005623589,0.00008997249,0.0014521568,0.00025735918,0.09906605],"study_design_scores_gemma":[0.03681574,0.019609062,0.83048207,0.0014827586,0.0033988464,0.08023071,0.0016513435,0.00023990849,0.0098831,0.00320517,0.012514122,0.0004871576],"about_ca_topic_score_codex":0.0000100301695,"about_ca_topic_score_gemma":0.00001991639,"teacher_disagreement_score":0.19637506,"about_ca_system_score_codex":0.00006312703,"about_ca_system_score_gemma":0.0008740787,"threshold_uncertainty_score":0.92744523},"labels":[],"label_agreement":null},{"id":"W3175614148","doi":"10.1016/j.jogc.2020.06.001","title":"Prise en charge laparoscopique d'une torsion de masse annexielle au troisième trimestre de la grossesse","year":2021,"lang":"fr","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.006347828783619052,"score_gpt":0.2566374492095913,"score_spread":0.25028962042597225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175614148","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25785223,0.078086644,0.000033244785,0.0025046582,0.6593465,0.00036546783,0.00030803413,0.0000065948248,0.0014966006],"genre_scores_gemma":[0.7365882,0.055049982,0.0020382502,0.00073063845,0.19687574,0.00005635993,0.0002115877,0.00018239369,0.008266891],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958076,0.00083460874,0.0011371364,0.00048084263,0.00074516,0.0009946392],"domain_scores_gemma":[0.98041433,0.016314665,0.0011359034,0.00033733877,0.00068436493,0.0011133921],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001312397,0.00056436134,0.0016282174,0.00035693328,0.00027011882,0.00012918838,0.0003072597,0.0015772803,0.0011143527],"category_scores_gemma":[0.013992132,0.0005152463,0.00030516676,0.0006235676,0.00017905245,0.00011500518,0.00011906202,0.002084582,0.0000024247522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007539669,0.0013178545,0.13415146,0.0008194772,0.0014219506,0.10917587,0.0007950687,0.00006631846,0.000065663124,0.00032227824,0.73326224,0.018526448],"study_design_scores_gemma":[0.010117093,0.0019081502,0.08826635,0.00041460045,0.0018430296,0.0008186012,0.00064178696,0.000051141204,0.00058926473,0.00009194456,0.89482445,0.00043359748],"about_ca_topic_score_codex":0.14339489,"about_ca_topic_score_gemma":0.028362608,"teacher_disagreement_score":0.47873595,"about_ca_system_score_codex":0.020447476,"about_ca_system_score_gemma":0.072018914,"threshold_uncertainty_score":0.9997988},"labels":[],"label_agreement":null},{"id":"W3176257779","doi":"10.1096/fasebj.2019.33.1_supplement.250.9","title":"Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer","year":2019,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Cohort; Biomarker; Oncology; Receiver operating characteristic; Internal medicine; Ovarian cancer; Hazard ratio; Cancer; Proportional hazards model; Epithelial ovarian cancer; Cohort study; Multivariate analysis; Confidence interval","score_opus":0.012220635158636887,"score_gpt":0.2577295119739019,"score_spread":0.24550887681526504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176257779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971672,0.00034529922,0.0000013223197,0.0010167441,0.00019953414,0.000664938,0.000057763213,0.0000064661626,0.0005406979],"genre_scores_gemma":[0.9985427,0.0006979021,0.00010133608,0.00021148939,0.0001615406,0.00015085514,0.0000014052243,0.000021503498,0.00011121789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985344,0.00011771225,0.00040281468,0.00024172582,0.00032277097,0.00038060397],"domain_scores_gemma":[0.99924374,0.000075361626,0.00023490528,0.00020926968,0.000092711845,0.00014402959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069097325,0.00019662772,0.00044608125,0.00012155211,0.00008481968,0.000030772255,0.00010321548,0.000047534457,0.00045985487],"category_scores_gemma":[0.00001834517,0.000116427625,0.000030415908,0.00029168496,0.00010300403,0.00018262531,0.000036659552,0.00046111943,0.0000019427139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003160257,0.00014749942,0.9850154,0.00012491041,0.00032053664,0.000090324495,0.004627425,0.002132728,0.0013830564,0.000012761058,0.0000137754605,0.002971357],"study_design_scores_gemma":[0.0076013952,0.00086521055,0.9799395,0.0015168157,0.00011689593,0.00015724229,0.0013885181,0.0036885282,0.0045677954,0.0000065760833,0.00002537183,0.0001261254],"about_ca_topic_score_codex":0.0037031136,"about_ca_topic_score_gemma":0.0023784004,"teacher_disagreement_score":0.0050758435,"about_ca_system_score_codex":0.0006190644,"about_ca_system_score_gemma":0.00073093874,"threshold_uncertainty_score":0.5598025},"labels":[],"label_agreement":null},{"id":"W3177171472","doi":"10.1002/ijgo.13813","title":"Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Toxicity; Internal medicine; Oncology; Serous fluid; Adjuvant; Surgery; Cancer","score_opus":0.011613930271225778,"score_gpt":0.2987933300034037,"score_spread":0.28717939973217793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177171472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924878,0.0012122822,0.000028286482,0.005347282,0.00046006127,0.00034800987,0.000028998975,0.0000018928172,0.00008538591],"genre_scores_gemma":[0.9937201,0.0036288225,0.0014544349,0.001078105,0.00007040105,0.000015770749,0.000010369522,0.000011422445,0.000010550356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881774,0.000052863015,0.00046812845,0.00014656332,0.0003803181,0.00013440698],"domain_scores_gemma":[0.997959,0.0007771113,0.00034442495,0.00013091628,0.0007110673,0.00007747475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085870335,0.00012977901,0.00046599773,0.00020946431,0.000017124688,0.0000105499985,0.00013281773,0.000059848946,0.00013754013],"category_scores_gemma":[0.00019314265,0.00008338915,0.0000739244,0.0003038463,0.000068258436,0.000043677457,0.000010228664,0.00009433159,4.0999058e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044839773,0.011620862,0.62733614,0.00002127998,0.0015959069,0.00042473164,0.0053533413,0.00038423866,0.0017102868,0.0001428129,0.00005423053,0.3468722],"study_design_scores_gemma":[0.022369264,0.0054604583,0.9477764,0.00010451494,0.000110677516,0.00006160133,0.00023110838,0.000009465679,0.019998413,0.00003596927,0.0037727938,0.00006932772],"about_ca_topic_score_codex":0.000045325814,"about_ca_topic_score_gemma":0.00006252922,"teacher_disagreement_score":0.34680286,"about_ca_system_score_codex":0.00043695586,"about_ca_system_score_gemma":0.00033099117,"threshold_uncertainty_score":0.34005108},"labels":[],"label_agreement":null},{"id":"W3178182026","doi":"10.1158/1538-7445.am2021-2045","title":"Abstract 2045: Aneuploidy, immunohistochemical overexpression of MSH-2, P53, P21^WAF1/CIP1, P16^INK4A, and correlation to epithelial ovarian carcinoma patient prognosis","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Aneuploidy; Immunohistochemistry; Immunostaining; Biology; Ovarian carcinoma; Carcinoma; Survival analysis; Cancer; Internal medicine; Ovarian cancer; Cancer research; Oncology; Medicine; Gene; Genetics","score_opus":0.04768662578894174,"score_gpt":0.368647710198386,"score_spread":0.32096108440944426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178182026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996615,0.0035155928,0.000010897821,0.0034451536,0.00021176712,0.0010486173,0.0001696133,0.000022002476,0.0016101996],"genre_scores_gemma":[0.9975723,0.0005354792,0.00047807902,0.00015341658,0.00023715195,0.00057500764,0.0000891242,0.000040956937,0.00031849468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743116,0.00010973737,0.00043817319,0.0006243176,0.0009043134,0.0004923097],"domain_scores_gemma":[0.9981023,0.00020772766,0.0000992492,0.0004984338,0.00070825993,0.00038400074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003027497,0.000204705,0.0004164998,0.00019622297,0.00016452823,0.00004263314,0.00010655814,0.00017298882,0.0010896561],"category_scores_gemma":[0.00020779755,0.0001788572,0.00010929677,0.00048673304,0.0001562783,0.00009527576,0.00021480075,0.00045987175,0.000032092623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013265358,0.0010355699,0.11439292,0.0004990368,0.00017157583,0.00019813231,0.0016311706,0.000024865505,0.8301644,0.00017260537,0.011980484,0.038402725],"study_design_scores_gemma":[0.0025068638,0.00066303543,0.4232439,0.0011586475,0.00007588544,0.00003119145,0.00025562505,0.000036160876,0.56457734,0.00007142221,0.007194592,0.00018531864],"about_ca_topic_score_codex":0.0013941103,"about_ca_topic_score_gemma":0.000044007837,"teacher_disagreement_score":0.30885097,"about_ca_system_score_codex":0.0006654841,"about_ca_system_score_gemma":0.00074439053,"threshold_uncertainty_score":0.9998235},"labels":[],"label_agreement":null},{"id":"W3179306134","doi":"10.1016/j.ygyno.2021.07.010","title":"The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Perioperative; Internal medicine; Oncology; Disease; Stage (stratigraphy); Ovarian carcinoma; Ovarian cancer; Surgery; Cancer","score_opus":0.02330149462210738,"score_gpt":0.29998367370456885,"score_spread":0.27668217908246145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179306134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97892755,0.001506697,0.000011128398,0.016418194,0.0007776459,0.0003897981,0.000010714043,0.000031762414,0.0019264828],"genre_scores_gemma":[0.9973282,0.0011191412,0.00044428074,0.00020969805,0.0002959363,0.00010804589,0.00010523456,0.000011153974,0.00037826234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985144,0.00029113956,0.00031603494,0.00037127256,0.00012327645,0.0003838753],"domain_scores_gemma":[0.998327,0.0011470192,0.00010261606,0.00021399696,0.000069262256,0.00014005978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029300104,0.00013915391,0.00040321148,0.000059752685,0.00016321758,0.000022860318,0.000033856046,0.0002716118,0.00017004553],"category_scores_gemma":[0.0001856346,0.00009755044,0.00005008354,0.00023644768,0.00013570358,0.00004538881,0.00006017044,0.00028565963,0.00002064447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009997375,0.0003565581,0.922609,0.000010924599,0.00007374158,0.0014719779,0.00017869273,0.000020406547,0.000022065598,0.003275588,0.00042984425,0.07145126],"study_design_scores_gemma":[0.0047044437,0.0011768059,0.9363783,0.000009072894,0.00014416352,0.00032015343,0.0003164312,0.00004369276,0.00011596681,0.0012004484,0.055503294,0.00008722369],"about_ca_topic_score_codex":0.00043032685,"about_ca_topic_score_gemma":0.001042194,"teacher_disagreement_score":0.07136404,"about_ca_system_score_codex":0.00090415817,"about_ca_system_score_gemma":0.0005161552,"threshold_uncertainty_score":0.39779913},"labels":[],"label_agreement":null},{"id":"W3180494678","doi":"10.1158/1538-7445.am2021-2155","title":"Abstract 2155: BRCAness in HGSC cancer initiation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Laser capture microdissection; Biology; Transcriptome; Ovarian cancer; Cancer research; Luteal phase; Cancer; Follicular phase; Gene; Molecular biology; Oncology; Genetics; Medicine; Gene expression","score_opus":0.17637926582773106,"score_gpt":0.48719499126831317,"score_spread":0.3108157254405821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180494678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559782,0.0104910685,0.0000022661047,0.021303134,0.00031293317,0.0004187881,0.000053662967,0.000022825203,0.011417083],"genre_scores_gemma":[0.988539,0.008037287,0.000034981073,0.00061002246,0.00046247905,0.00096857676,0.00004165703,0.000027611826,0.001278421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821883,0.00007976153,0.00021960522,0.00041075042,0.0006058643,0.00046515846],"domain_scores_gemma":[0.99886996,0.00014166594,0.000031398362,0.00032225627,0.00046421244,0.00017050553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000384549,0.00011117458,0.00024792756,0.00019214173,0.00008051555,0.000047286256,0.00007800787,0.00009245541,0.0057404153],"category_scores_gemma":[0.00009326247,0.00010132494,0.00005728863,0.00081184274,0.00007106815,0.00009657665,0.000053810523,0.00044394436,0.000089389476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005509578,0.0014555213,0.73147315,0.0009113086,0.0003059973,0.0037120131,0.0014389519,0.00022212864,0.02486841,0.0012750975,0.035406828,0.19837965],"study_design_scores_gemma":[0.0029720217,0.00008071348,0.8850209,0.0009371799,0.00003094665,0.00001469453,0.0003472866,0.00002691296,0.06741806,0.00024509925,0.042761397,0.0001447565],"about_ca_topic_score_codex":0.0049666623,"about_ca_topic_score_gemma":0.005645458,"teacher_disagreement_score":0.1982349,"about_ca_system_score_codex":0.0012998857,"about_ca_system_score_gemma":0.0020328008,"threshold_uncertainty_score":0.99516845},"labels":[],"label_agreement":null},{"id":"W3181444527","doi":"10.1158/1538-7445.am2021-878","title":"Abstract 878: Contraceptive use and ovarian cancer risk in <i>BRCA1</i> and <i>BRCA2</i> mutation carriers: A prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Prospective cohort study; Hazard ratio; BRCA mutation; Gynecology; Proportional hazards model; Cancer; Obstetrics; Population; Cohort; Cohort study; Oncology; Confidence interval; Internal medicine; Environmental health","score_opus":0.04850396754944766,"score_gpt":0.38610273117359967,"score_spread":0.337598763624152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181444527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861286,0.008354039,0.000003393111,0.0015612742,0.00011953133,0.0030614943,0.00020399204,0.000023606377,0.0005440534],"genre_scores_gemma":[0.98740107,0.008969321,0.000068529705,0.00014618678,0.00018527314,0.0028988107,0.000017797336,0.000039664388,0.00027334414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997341,0.00027429647,0.0003075198,0.00091113924,0.00065515214,0.0005109168],"domain_scores_gemma":[0.998139,0.0003992282,0.00008339347,0.00035527992,0.00072021125,0.0003028588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087606435,0.00022084346,0.00049959467,0.00018886794,0.00022228781,0.00019147579,0.000055102017,0.000111329544,0.00031853482],"category_scores_gemma":[0.0003474321,0.00019554782,0.000044328768,0.0006470563,0.00024711012,0.00027881638,0.000091340604,0.00071023026,0.000005197859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060805486,0.0006746896,0.9809058,0.000080995494,0.0007014552,0.0011343256,0.0051208716,0.000017063076,0.00079103885,0.000074249794,0.0005310009,0.009360464],"study_design_scores_gemma":[0.008021534,0.00044333917,0.98268217,0.00032912404,0.00022039891,0.000023060966,0.0040732916,0.000026689775,0.0032182492,0.0001507111,0.00063698756,0.0001744322],"about_ca_topic_score_codex":0.030707955,"about_ca_topic_score_gemma":0.026022248,"teacher_disagreement_score":0.009186032,"about_ca_system_score_codex":0.0011489718,"about_ca_system_score_gemma":0.0010067079,"threshold_uncertainty_score":0.9917503},"labels":[],"label_agreement":null},{"id":"W3181740191","doi":"10.14740/wjon1383","title":"Personalized Medicine in Ovarian Cancer: A Perspective From Mexico","year":2021,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Personalized medicine; Ovarian cancer; Perspective (graphical); Precision medicine; Alternative medicine; Family medicine; Reproductive medicine; Internal medicine; Oncology; Cancer; Gynecology; Intensive care medicine; Traditional medicine; Bioinformatics; Pathology","score_opus":0.07804827230428958,"score_gpt":0.43760514403271866,"score_spread":0.3595568717284291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181740191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005142633,0.96742153,0.000010215933,0.020049684,0.0015721148,0.0004999868,0.000049425442,0.00000569998,0.010386225],"genre_scores_gemma":[0.000085509426,0.9940899,0.0008843467,0.000983162,0.0025898607,0.00009647019,0.000039328785,0.00005790384,0.0011735442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674875,0.00056815415,0.0014600502,0.00045191124,0.00043349375,0.00033765388],"domain_scores_gemma":[0.9965475,0.00090881274,0.0014780371,0.0003060319,0.0004471884,0.00031239312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005704558,0.0004523269,0.0059259767,0.0009637458,0.000036912872,0.000011618385,0.0002143584,0.0003230403,0.007810299],"category_scores_gemma":[0.00024542172,0.00030334824,0.0009043562,0.0009203137,0.00019609014,0.000049612136,0.000056545417,0.0013403728,0.000014634479],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00022786765,0.0009008868,0.0005026162,0.000849116,0.003749447,0.011953773,0.001203981,7.7219727e-7,9.5150085e-7,0.0021790438,0.017044451,0.9613871],"study_design_scores_gemma":[0.0073747924,0.0010669879,0.00041155436,0.046280343,0.007091749,0.0012947606,0.0005257014,4.787989e-7,8.785241e-7,0.00018425325,0.9355787,0.00018982713],"about_ca_topic_score_codex":0.0023945684,"about_ca_topic_score_gemma":0.0027428346,"teacher_disagreement_score":0.96119726,"about_ca_system_score_codex":0.006343296,"about_ca_system_score_gemma":0.0058262316,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W3182026103","doi":"10.1097/aog.0000000000004455","title":"Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer","year":2021,"lang":"en","type":"review","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Capsule; Meta-analysis; Stage (stratigraphy); Hazard ratio; Ovary; Internal medicine; Oncology; Surgery; Cancer; Confidence interval","score_opus":0.03751452303336248,"score_gpt":0.32926669736168507,"score_spread":0.29175217432832257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182026103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009400639,0.9943908,0.00000141096,0.00054394704,0.0015580171,0.0011044114,0.000252042,0.000006518794,0.0012027926],"genre_scores_gemma":[0.003792888,0.99386966,0.000103235834,0.0002492782,0.00009226463,0.0003137039,0.00005626019,0.000039926043,0.0014828107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813145,0.0002406668,0.0006028963,0.00052602903,0.00017730727,0.0003216639],"domain_scores_gemma":[0.9975214,0.0013992775,0.00032955813,0.00050787727,0.00012876504,0.00011309886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016029333,0.0003594462,0.0020244378,0.00024580653,0.00006761469,0.000025411533,0.00015404203,0.00058041245,0.0004971123],"category_scores_gemma":[0.0011291133,0.00022147539,0.0003113063,0.0011409953,0.00011983376,0.00002844167,0.00016278429,0.00062762556,0.0000043374207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034433488,0.00044665165,0.0059056836,0.0043674354,0.0007615301,0.000603189,0.00052047963,0.0000023444813,6.090106e-7,0.0046766996,0.00047039066,0.9822416],"study_design_scores_gemma":[0.0013711334,0.0001763955,0.012601293,0.0035742095,0.0011344765,0.000032680666,0.00005618311,0.0000033443446,0.000008519832,0.000016409085,0.9808253,0.00020003381],"about_ca_topic_score_codex":0.0007387729,"about_ca_topic_score_gemma":0.00052635156,"teacher_disagreement_score":0.98204154,"about_ca_system_score_codex":0.0004841166,"about_ca_system_score_gemma":0.0012222338,"threshold_uncertainty_score":0.90315044},"labels":[],"label_agreement":null},{"id":"W3182272247","doi":"10.1158/1538-7445.am2021-3001","title":"Abstract 3001: Multicellular structures of serous ovarian cancer nature isolated from pleural effusions are sufficient to recreate peritoneal carcinomatosis in immunosuppressed mice","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Histopathology; Pleural effusion; Ovarian cancer; Pathology; Ascites; Peritoneal cavity; Pleural cavity; Serous fluid; Abdominal cavity; Peritoneum; Lymph node; Cancer; Internal medicine; Surgery","score_opus":0.0496943983288677,"score_gpt":0.3814572876618752,"score_spread":0.3317628893330075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182272247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732185,0.018669765,0.0000027307537,0.0053362753,0.00047113234,0.0010733308,0.0010295665,0.000029851193,0.00016883311],"genre_scores_gemma":[0.9965113,0.0016033471,0.00033622424,0.00027052464,0.0002486909,0.0005654878,0.00017696735,0.00006387246,0.00022359147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996734,0.00022800257,0.0005254564,0.0008581218,0.00088886236,0.0007655079],"domain_scores_gemma":[0.99752796,0.00032232975,0.00012119653,0.00077835703,0.00086367776,0.00038648365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026951075,0.00030361587,0.0007044462,0.0003346611,0.00018110582,0.00007297796,0.000289489,0.0002944303,0.0023394178],"category_scores_gemma":[0.00018540285,0.00026529253,0.00014475452,0.0012049382,0.00012274315,0.000073831805,0.000228863,0.0012100168,0.000015300902],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032509814,0.0013871252,0.25860742,0.0005127539,0.00068016845,0.0020154805,0.0051728287,0.001455774,0.72182786,0.000058894915,0.0023493106,0.0026813955],"study_design_scores_gemma":[0.0035351843,0.00021371938,0.72479075,0.0012995503,0.000110800735,0.000010070559,0.0013732313,0.00027761725,0.26706463,0.000022217568,0.0010893565,0.00021286508],"about_ca_topic_score_codex":0.06694491,"about_ca_topic_score_gemma":0.010680403,"teacher_disagreement_score":0.46618333,"about_ca_system_score_codex":0.0010162517,"about_ca_system_score_gemma":0.0011365871,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W3184994968","doi":"10.1002/path.5769","title":"A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma","year":2021,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Sierra Oncology; National Medical Research Council; National Research Foundation Singapore; National Research Foundation; NuCana; AstraZeneca; National University Cancer Institute, Singapore; Pfizer","keywords":"Immune system; Ethnic group; Clear cell carcinoma; Medicine; Oncology; Ovarian cancer; Internal medicine; Cancer; Immunology; Political science","score_opus":0.011684659928721777,"score_gpt":0.25448387155565977,"score_spread":0.242799211626938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184994968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949875,0.0044130613,0.00007844712,0.00025120677,0.00007849027,0.000111321446,0.000009778745,0.0000020553773,0.000068160625],"genre_scores_gemma":[0.9974454,0.0002213026,0.0021537966,0.00008768006,0.000016220456,0.0000017377428,0.000011984055,0.000011799442,0.000050099992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987302,0.00031112597,0.0005039036,0.00011386186,0.00019855105,0.00014239432],"domain_scores_gemma":[0.99885637,0.000102723716,0.00046358205,0.00028088936,0.00024247826,0.000053963176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003582919,0.0001053532,0.0005375339,0.00026069354,0.000024839002,0.0000024586095,0.00008943757,0.00010161166,0.00020193396],"category_scores_gemma":[0.000037729005,0.00005802395,0.00017103566,0.000586597,0.00005576251,0.000031187887,0.000036782123,0.00029746746,0.0000011824123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023328187,0.002445447,0.87720174,0.00003128386,0.00099076,0.0022799454,0.0033458185,0.003002609,0.10746641,0.0000069082844,0.00004385106,0.00085242157],"study_design_scores_gemma":[0.0064326525,0.0011392151,0.9446821,0.000068522844,0.0021962428,0.00006447094,0.00021883006,0.00009486682,0.045039393,0.00000699141,0.000006473224,0.000050242063],"about_ca_topic_score_codex":0.000032198754,"about_ca_topic_score_gemma":0.000027640952,"teacher_disagreement_score":0.06748037,"about_ca_system_score_codex":0.00006612612,"about_ca_system_score_gemma":0.000112197304,"threshold_uncertainty_score":0.23661481},"labels":[],"label_agreement":null},{"id":"W3185037356","doi":"10.1016/j.ygyno.2021.07.027","title":"Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic review","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Health Sciences Centre; Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Medicine; Serous fluid; Ovarian cancer; Oncology; MEDLINE; Internal medicine; Systematic review; Population; Randomized controlled trial; Cancer; Gynecology","score_opus":0.04461794821240529,"score_gpt":0.3681142875515476,"score_spread":0.32349633933914235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185037356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021733515,0.9708037,0.000023083281,0.009068696,0.00031990928,0.019069383,0.00017848749,0.000048833328,0.00046619],"genre_scores_gemma":[0.000090377034,0.92149025,0.00058141124,0.008708681,0.00025772522,0.06772236,0.0001883048,0.000081910584,0.0008789552],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.994908,0.0012917226,0.0015037591,0.0009954345,0.00032055963,0.000980576],"domain_scores_gemma":[0.9945821,0.00272326,0.0012472973,0.0010716572,0.0002100866,0.00016558202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021241752,0.0008018956,0.0074459934,0.00014510052,0.000118571246,0.000036013444,0.0005034243,0.00060891925,0.00039514567],"category_scores_gemma":[0.000618079,0.00037707915,0.00054803037,0.0005850829,0.00012465553,0.00003882802,0.00006770824,0.00072817924,0.000030235917],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001241487,0.00182111,0.000021135318,0.58711654,0.0020494931,0.0016390895,0.00040182853,0.0000017968773,1.2602848e-7,0.00012570573,0.008488911,0.39821014],"study_design_scores_gemma":[0.004241678,0.00505662,0.00012805292,0.28979212,0.0043723476,0.0006720779,0.00026349048,0.0000034855084,1.2217383e-7,0.000038900016,0.69505274,0.00037833166],"about_ca_topic_score_codex":0.000060515522,"about_ca_topic_score_gemma":0.00041763452,"teacher_disagreement_score":0.68656385,"about_ca_system_score_codex":0.0035994907,"about_ca_system_score_gemma":0.0030272268,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W3185979054","doi":"10.26443/mjm.v20i1.340","title":"Approach to Gynecological Adnexal Masses","year":2021,"lang":"en","type":"article","venue":"McGill Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Malignancy; Medical diagnosis; Adnexal mass; Differential diagnosis; Gynecology; Radiology; Gynecological Examination; Abscess; Physical examination; Clinical history; Medical history; General surgery; Pathology; Surgery","score_opus":0.06516208766605704,"score_gpt":0.32558692779927484,"score_spread":0.2604248401332178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185979054","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3100873,0.011083686,0.002196122,0.39629146,0.0035432286,0.00083240436,0.00003790847,0.00006990213,0.27585799],"genre_scores_gemma":[0.9644417,0.00074234634,0.012908071,0.019802593,0.0011538118,0.000009051018,0.000008312037,0.000018330651,0.00091579003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985735,0.000058631427,0.0004755963,0.00018155409,0.00050703075,0.00020367635],"domain_scores_gemma":[0.9986522,0.00015457779,0.00014957262,0.00019504548,0.0004051597,0.00044341735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037268622,0.00013580364,0.0006039189,0.00012204449,0.000058618574,0.000005184687,0.00008205246,0.00006910792,0.000985391],"category_scores_gemma":[0.0006790685,0.00008082449,0.00012767669,0.00028857205,0.000050155893,0.000040725357,0.00003599897,0.00023546287,0.000022462958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016198617,0.00810959,0.054284334,0.0004226108,0.0023517504,0.020949155,0.00073300285,0.0001744246,0.014929874,0.013053657,0.68113226,0.2022395],"study_design_scores_gemma":[0.010595843,0.004899535,0.11921419,0.0006499375,0.0008192324,0.0075954073,0.0007200305,0.000015936792,0.0047581187,0.0003313575,0.85024345,0.0001569426],"about_ca_topic_score_codex":0.000006171847,"about_ca_topic_score_gemma":0.0000017021217,"teacher_disagreement_score":0.6543544,"about_ca_system_score_codex":0.00017405931,"about_ca_system_score_gemma":0.00012359729,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W3188131079","doi":"10.1016/s1470-2045(21)00342-9","title":"Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck KGaA; Array BioPharma; Russian Academy of Sciences; Pfizer","keywords":"Avelumab; Javelin; Medicine; Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Open label; Cancer; Immunotherapy; Clinical trial; Pembrolizumab","score_opus":0.05096597704849702,"score_gpt":0.3713370121621499,"score_spread":0.3203710351136529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188131079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704117,0.00033636737,0.00019455921,0.01842793,0.0005784773,0.008290516,0.00031678728,0.000108880675,0.0013347891],"genre_scores_gemma":[0.9780209,0.0016469114,0.005258389,0.007877458,0.0010563824,0.0029869957,0.00072976074,0.00022224676,0.0022009618],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99575037,0.0006984839,0.0007784779,0.001158033,0.0005326753,0.0010819893],"domain_scores_gemma":[0.99716055,0.00032484205,0.0005415187,0.0012766229,0.00036213145,0.0003343266],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008649299,0.00068116386,0.002479112,0.00009814853,0.00022201134,0.00013458387,0.0006133649,0.0003194667,0.0016034958],"category_scores_gemma":[0.000096136275,0.00038181187,0.00008471129,0.0007476641,0.0002919586,0.0002337646,0.000086557564,0.0005572533,0.000018782692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9306635,0.013233154,0.009345897,0.000043655367,0.0017748481,0.00044993457,0.0016377396,0.000008413721,0.00033726933,0.0000670336,0.005162922,0.037275583],"study_design_scores_gemma":[0.93146855,0.032985028,0.00497527,0.0003311785,0.00074431713,0.00005380706,0.00015338951,0.00017228237,0.0016265531,0.000022976803,0.026921159,0.0005454638],"about_ca_topic_score_codex":0.0021902646,"about_ca_topic_score_gemma":0.0071552037,"teacher_disagreement_score":0.036730118,"about_ca_system_score_codex":0.0012693465,"about_ca_system_score_gemma":0.0025279303,"threshold_uncertainty_score":0.9998634},"labels":[],"label_agreement":null},{"id":"W3189636333","doi":"10.21203/rs.3.rs-779341/v1","title":"Impact of Neoadjuvant Chemotherapy on Somatic Mutation Status in High-grade Serous Ovarian Carcinoma","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"University of Toronto; Princess Margaret Cancer Foundation; University Health Network","keywords":"Somatic cell; Chemotherapy; Cisplatin; Oncology; Ovarian carcinoma; Carboplatin; Mutation; Exome sequencing; Germline mutation; Internal medicine; Medicine; Serous carcinoma; Ovarian cancer; Gene; Cancer research; Biology; Cancer; Genetics","score_opus":0.05733183093884633,"score_gpt":0.4132476366290551,"score_spread":0.3559158056902088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189636333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934451,0.0016503064,0.000018047507,0.0018899859,0.00013675896,0.0022379537,0.00020149985,0.000029893594,0.00039046336],"genre_scores_gemma":[0.9963694,0.0013388224,0.0006221069,0.000040147814,0.00017414722,0.00043716235,0.0008605511,0.000077745375,0.00007987595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960942,0.0004794552,0.00056436216,0.0007601504,0.0013208088,0.0007809754],"domain_scores_gemma":[0.9975164,0.00038623714,0.00017781853,0.0011030957,0.0004885015,0.0003279451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006224891,0.00036058668,0.0009518658,0.00080031,0.00005783401,0.00008706087,0.00016311264,0.00034795355,0.00060746144],"category_scores_gemma":[0.00021330453,0.00029166683,0.00037212446,0.00065304554,0.000089810295,0.00005187113,0.000174401,0.0011886008,0.000020183268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013876343,0.006470667,0.9262795,0.0044774394,0.0011236978,0.0038316287,0.0063230195,0.0027069857,0.0009353214,0.0002510536,0.00064753054,0.04556555],"study_design_scores_gemma":[0.0062538655,0.002783369,0.9820536,0.0036797384,0.000058601752,0.000020976933,0.00059595593,0.00076648785,0.0030759647,0.0004936335,0.000021272159,0.00019653613],"about_ca_topic_score_codex":0.023455694,"about_ca_topic_score_gemma":0.0005325828,"teacher_disagreement_score":0.055774126,"about_ca_system_score_codex":0.0028368062,"about_ca_system_score_gemma":0.0026420713,"threshold_uncertainty_score":0.99995357},"labels":[],"label_agreement":null},{"id":"W3190031240","doi":"10.3390/curroncol28040255","title":"Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Univerzita Karlova v Praze","keywords":"Medicine; Colorectal cancer; Oncology; Ovarian cancer; Proportional hazards model; Internal medicine; Rectum; Pathological; Retrospective cohort study; Cancer; Radiology","score_opus":0.11009298200162718,"score_gpt":0.40713349105858015,"score_spread":0.297040509056953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190031240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892125,0.0075103417,0.000011918581,0.0015177984,0.00093009765,0.00036804896,0.00033045333,0.00002017003,0.000098631186],"genre_scores_gemma":[0.9940518,0.0048186528,0.0003440609,0.00015500818,0.00019409692,0.00007818525,0.0003343703,0.00001240543,0.000011412313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986231,0.00018699792,0.00035407973,0.00048583606,0.00010219485,0.00024781396],"domain_scores_gemma":[0.99878055,0.0007351418,0.00010813438,0.00011976203,0.00007186571,0.0001845572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011836943,0.0001904467,0.0006660305,0.000061206156,0.00004928664,0.000022323602,0.00003267169,0.00014247063,0.00061132084],"category_scores_gemma":[0.00044443525,0.00014276261,0.000052002586,0.000089884605,0.0001449398,0.00003915545,0.00008747471,0.00027210882,0.0000047028543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013232169,0.0011600725,0.9676519,0.000039631697,0.00006765724,0.00092501997,0.00034774464,8.914339e-8,0.0005241251,0.00015237166,0.00015500312,0.028844072],"study_design_scores_gemma":[0.003060694,0.0006262963,0.98365897,0.00019388922,0.0004180204,0.000088609384,0.00010934789,0.00003129058,0.0014582691,0.00020137567,0.010020152,0.00013307568],"about_ca_topic_score_codex":0.00008138779,"about_ca_topic_score_gemma":0.00057983486,"teacher_disagreement_score":0.028710997,"about_ca_system_score_codex":0.00017818341,"about_ca_system_score_gemma":0.00033248216,"threshold_uncertainty_score":0.6693534},"labels":[],"label_agreement":null},{"id":"W3190515505","doi":"10.1016/j.jacr.2021.07.012","title":"Clarifying Postcontrast Enhancement Sequences for Implementation and Interpretation of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Risk Stratification and Management System","year":2021,"lang":"en","type":"letter","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Risk stratification; Interpretation (philosophy); Stratification (seeds); Medicine; Medical physics; Computer science; Radiology; Internal medicine; Programming language","score_opus":0.032040305177259566,"score_gpt":0.3317425522270457,"score_spread":0.2997022470497861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190515505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6778519,0.014605382,0.015362882,0.2805454,0.0027188098,0.006316182,0.0024466936,0.0000104288,0.0001422782],"genre_scores_gemma":[0.9904681,0.0028519582,0.0037919485,0.0023418556,0.00039042515,0.000047989543,0.00005816367,0.000016221897,0.00003334982],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9974935,0.00040171368,0.0014202682,0.00029440605,0.00024881226,0.0001413089],"domain_scores_gemma":[0.99086314,0.00031427172,0.008126376,0.00044853194,0.0002159691,0.000031686453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011989936,0.00016528626,0.000880638,0.0000991566,0.00010917528,0.000023259334,0.000190926,0.00008952686,0.0000019738675],"category_scores_gemma":[0.00011517903,0.0000975981,0.00009988259,0.0001302003,0.00024494866,0.00007518447,0.00011631264,0.0003071143,1.5294061e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004306003,0.0005192074,0.37781858,0.031010669,0.03625497,0.0014153637,0.004609068,0.000425468,0.014377464,0.0047974563,0.4050907,0.11937507],"study_design_scores_gemma":[0.023543505,0.014036702,0.6608194,0.027260555,0.043285806,0.04062436,0.10750158,0.022243366,0.006511261,0.0006554746,0.051968135,0.0015498236],"about_ca_topic_score_codex":0.00021023267,"about_ca_topic_score_gemma":0.000035677847,"teacher_disagreement_score":0.35312256,"about_ca_system_score_codex":0.00018205619,"about_ca_system_score_gemma":0.0002067946,"threshold_uncertainty_score":0.3979935},"labels":[],"label_agreement":null},{"id":"W3190950493","doi":"10.1007/s00292-008-1028-9","title":"Ovarialkarzinome","year":2008,"lang":"de","type":"article","venue":"Der Pathologe","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Gynecology","score_opus":0.0402626579590579,"score_gpt":0.26672177404212316,"score_spread":0.22645911608306526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190950493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6514885,0.2828208,0.0004426358,0.012594026,0.013032683,0.0019227542,0.0004450336,0.0003550064,0.0368986],"genre_scores_gemma":[0.97738683,0.012519053,0.0012410474,0.0029176997,0.003162315,0.00011390263,0.00012616998,0.00006483975,0.002468133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789304,0.00011177578,0.00042392043,0.0006397482,0.00032734874,0.0006041696],"domain_scores_gemma":[0.99861914,0.00009718733,0.00013069791,0.00075794215,0.00008952335,0.00030552153],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018925566,0.00035521772,0.0006075941,0.00013076591,0.00023814611,0.00002092578,0.0001363976,0.00027798064,0.0017724063],"category_scores_gemma":[0.00007297868,0.00030856417,0.0002524621,0.00024903292,0.00024055988,0.000067975234,0.00008461661,0.00029659644,0.008702202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044913677,0.0046550306,0.7601638,0.000232364,0.002764378,0.0673261,0.005416818,0.000009817169,0.0007435121,0.0043669655,0.12405545,0.02981661],"study_design_scores_gemma":[0.005741196,0.0009658079,0.6617989,0.00016694092,0.0017148015,0.00068241596,0.00004547784,0.000027718384,0.0016749514,0.00020107711,0.3265376,0.00044313635],"about_ca_topic_score_codex":0.00007532165,"about_ca_topic_score_gemma":0.0000036215304,"teacher_disagreement_score":0.32589835,"about_ca_system_score_codex":0.00021007891,"about_ca_system_score_gemma":0.00030775007,"threshold_uncertainty_score":0.99993664},"labels":[],"label_agreement":null},{"id":"W3192863823","doi":"10.1016/j.jpag.2021.07.011","title":"Surgical Approach to Pediatric Ovarian Growing Teratoma Syndrome: A Case Report","year":2021,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Surgery; Malignant transformation; Teratoma; Surgical oncology; Ovarian cancer; Cancer; Internal medicine; Pathology","score_opus":0.017051366994036657,"score_gpt":0.27293772114154674,"score_spread":0.2558863541475101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192863823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989534,0.0049753655,0.00028178724,0.0032107423,0.00081161247,0.00025036914,0.000006463897,0.000014681851,0.00055363163],"genre_scores_gemma":[0.9910891,0.0020146833,0.0034686204,0.0007561519,0.00237825,0.0000102757285,0.0000071497007,0.000023997107,0.00025175774],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99801534,0.000115885545,0.00082870666,0.00037288238,0.0003039282,0.0003632672],"domain_scores_gemma":[0.998287,0.00021295408,0.00036309366,0.00022648237,0.0003017019,0.00060877565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004726637,0.00021504886,0.00071385055,0.00033587005,0.000108977845,0.000040939514,0.00006187475,0.00017301332,0.00011176972],"category_scores_gemma":[0.00029035777,0.00017207637,0.00023410772,0.000553531,0.000022657443,0.0001172953,0.00008799126,0.000412391,0.000009335288],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009245748,0.0015296389,0.35570258,0.00020447298,0.00012269974,0.6341454,0.00006670315,0.000011079098,0.000004197708,0.00010243459,0.0065954397,0.0014229079],"study_design_scores_gemma":[0.00374727,0.00071632717,0.25781476,0.000024406238,0.001314246,0.7311072,0.00015452382,0.000012264919,0.00001941245,0.000022200611,0.0049095997,0.00015778762],"about_ca_topic_score_codex":0.0000050311887,"about_ca_topic_score_gemma":0.0000016357644,"teacher_disagreement_score":0.097887814,"about_ca_system_score_codex":0.00017205116,"about_ca_system_score_gemma":0.0006584961,"threshold_uncertainty_score":0.70170707},"labels":[],"label_agreement":null},{"id":"W3193536529","doi":"10.2139/ssrn.3386275","title":"Overexpression of IGF2BP3 As a Potential Oncogene in Ovarian Clear Cell Carcinoma","year":2019,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Oncogene; Carcinoma; Cell; Ovarian carcinoma; Medicine; Biology; Pathology; Ovarian cancer; Internal medicine; Cell cycle; Cancer; Genetics","score_opus":0.0044110468932947984,"score_gpt":0.23256193109260176,"score_spread":0.22815088419930696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193536529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913126,0.0029135104,0.000045485616,0.0006961667,0.00016023968,0.00029127052,0.0000030816752,0.0000063339876,0.0045712814],"genre_scores_gemma":[0.99676985,0.0014511914,0.00010348062,0.00010593556,0.0001961388,0.0000053794133,0.0000061039364,0.000028459837,0.0013334651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979407,0.000060721137,0.00034071095,0.00022807861,0.00033516326,0.0010946242],"domain_scores_gemma":[0.99938595,0.000020374639,0.00018052098,0.000238923,0.000062000945,0.00011220099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044929603,0.00015254515,0.0003358343,0.00016525284,0.000037303234,0.000012405656,0.00010673203,0.00010298565,0.0004979916],"category_scores_gemma":[0.000010846647,0.00012283184,0.0001731641,0.00015634652,0.000018602317,0.00008297242,0.000032998767,0.0008933092,0.00009532811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060744025,0.003803191,0.59179515,0.00022507009,0.0005875285,0.00036492076,0.0008236697,0.0002523349,0.34546795,0.027041832,0.00043723814,0.023126697],"study_design_scores_gemma":[0.07211917,0.027816983,0.58360314,0.0014986792,0.00093238865,0.006034774,0.005521833,0.00058351894,0.25552613,0.041111097,0.0041625886,0.0010896937],"about_ca_topic_score_codex":0.000515939,"about_ca_topic_score_gemma":0.00010124391,"teacher_disagreement_score":0.089941815,"about_ca_system_score_codex":0.0010379475,"about_ca_system_score_gemma":0.002375521,"threshold_uncertainty_score":0.5452659},"labels":[],"label_agreement":null},{"id":"W3193750231","doi":"10.1158/1055-9965.epi-21-0296","title":"Weight Gain and the Risk of Ovarian Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers","year":2021,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Women's College Hospital; Shastri Indo-Canadian Institute","keywords":"Ovarian cancer; Medicine; Body mass index; Hazard ratio; Weight gain; Prospective cohort study; Cancer; Oncology; Internal medicine; Gynecology; Risk factor; Anthropometry; Proportional hazards model; BRCA mutation; Weight change; Obstetrics; Obesity; Confidence interval; Weight loss; Body weight","score_opus":0.021483997004265287,"score_gpt":0.32591959763597717,"score_spread":0.3044356006317119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193750231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71127546,0.24013841,0.0009932641,0.044709537,0.0008587897,0.0013430957,0.00013606218,0.000029218481,0.0005161377],"genre_scores_gemma":[0.93201035,0.064874776,0.0011688933,0.0010887268,0.00011679095,0.00049808563,0.000054502056,0.000018993269,0.0001688949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973458,0.0011627668,0.00061244454,0.0005081383,0.000096904434,0.00027393244],"domain_scores_gemma":[0.99825627,0.000855596,0.00040126362,0.00027616904,0.00009746334,0.000113214905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018260648,0.00019292465,0.00068963633,0.00008944194,0.000088953166,0.0000063389143,0.000046864607,0.00017987698,0.00014513596],"category_scores_gemma":[0.00046675524,0.00013691188,0.00014866606,0.0002689898,0.00048458707,0.0000771454,0.000047612066,0.00018774939,7.725912e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009933229,0.00009315089,0.89863944,0.00015433232,0.0014875641,0.000029072587,0.00048063457,0.00006206623,0.0002654264,0.0018677966,0.0014746662,0.09445252],"study_design_scores_gemma":[0.012502977,0.00013451565,0.96786326,0.000720305,0.0013758906,0.000050778322,0.0003227264,0.001193304,0.001685658,0.011847458,0.0021335394,0.00016958338],"about_ca_topic_score_codex":0.0030613123,"about_ca_topic_score_gemma":0.0029326868,"teacher_disagreement_score":0.22073485,"about_ca_system_score_codex":0.00021404761,"about_ca_system_score_gemma":0.00029302968,"threshold_uncertainty_score":0.55831045},"labels":[],"label_agreement":null},{"id":"W3193910473","doi":"10.1016/j.jmig.2021.08.006","title":"Risk Factors Associated with Adnexal Torsion after Hysterectomy","year":2021,"lang":"en","type":"article","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Homewood Research Institute","funders":"National Center for Advancing Translational Sciences; National Institutes of Health","keywords":"Medicine; Hysterectomy; Endometriosis; Odds ratio; Incidence (geometry); Confidence interval; Logistic regression; Retrospective cohort study; Pelvic pain; Abdominal hysterectomy; Laparoscopy; Surgery; Gynecology; Internal medicine","score_opus":0.01877863384881584,"score_gpt":0.2528868218745786,"score_spread":0.23410818802576278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193910473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698246,0.0007466508,0.0000074000454,0.0010045709,0.0004826555,0.00014941828,0.000031552478,0.0000091011,0.00058618974],"genre_scores_gemma":[0.997988,0.00037493726,0.00064036285,0.00055718306,0.00017171609,0.000012453489,0.00001791965,0.000025178537,0.00021223916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984999,0.00021273822,0.00048814234,0.00021823015,0.000301077,0.00027991683],"domain_scores_gemma":[0.99691087,0.0012321423,0.0006492949,0.00017438187,0.00080792233,0.00022540895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017157255,0.00019857501,0.00066337513,0.00013556608,0.00005541622,0.000019921534,0.00007258684,0.00017381016,0.0014910712],"category_scores_gemma":[0.0017526164,0.00013257738,0.00024440672,0.00018274043,0.00007238754,0.000101450525,0.000038776212,0.0003580779,0.000015853815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060106994,0.0011070269,0.98757255,0.000024891138,0.0016787198,0.0044424236,0.00049735646,0.0000056539425,0.0015166509,0.000008935781,0.0018857553,0.00065897405],"study_design_scores_gemma":[0.0054581496,0.005090954,0.96942925,0.00029349746,0.0011052643,0.00036343705,0.00048812453,0.0000015651938,0.016094115,0.000027509235,0.0015195314,0.00012861518],"about_ca_topic_score_codex":0.0000105332,"about_ca_topic_score_gemma":0.00050813425,"teacher_disagreement_score":0.018143304,"about_ca_system_score_codex":0.00046402938,"about_ca_system_score_gemma":0.0011171045,"threshold_uncertainty_score":0.9994217},"labels":[],"label_agreement":null},{"id":"W3194596483","doi":"10.1021/acs.molpharmaceut.1c00401","title":"Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer","year":2021,"lang":"en","type":"article","venue":"Molecular Pharmaceutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Medical Research Future Fund; Tour de Cure","keywords":"Ovarian cancer; Indocyanine green; Medicine; Cancer; Cancer research; In vivo; Cancer cell; Monoclonal antibody; Pathology; Antibody; Internal medicine; Biology; Immunology","score_opus":0.10834929259559145,"score_gpt":0.44908332755490615,"score_spread":0.3407340349593147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194596483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9317416,0.022485135,0.029506415,0.00911951,0.0014189081,0.0050048213,0.00037188487,0.000044110104,0.00030760924],"genre_scores_gemma":[0.9894956,0.0006291768,0.008926575,0.0002015896,0.00009988528,0.0003882045,0.00019505552,0.000024538298,0.000039409155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983704,0.0001367898,0.00057511474,0.000276934,0.00049407553,0.00014666127],"domain_scores_gemma":[0.9980945,0.00005909362,0.00028531355,0.0002541998,0.0012280581,0.00007884405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091183913,0.00010569462,0.00026468694,0.000043574888,0.000027675795,0.000008207662,0.00005124068,0.00007150491,0.00021546303],"category_scores_gemma":[0.00040857072,0.0001029213,0.00016666068,0.00018159329,0.000036648435,0.00002787798,0.000027139258,0.00008154959,0.000002157695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025240093,0.0012708353,0.009151785,0.0007002041,0.0006662959,0.0000058154355,0.0002890583,0.0010288339,0.9191524,0.00049702683,0.000678186,0.06630718],"study_design_scores_gemma":[0.0043164296,0.00009100006,0.0043658367,0.00018748114,0.001827315,0.0000021264686,0.000044684755,0.020362493,0.965394,0.00014581678,0.0031818151,0.00008096606],"about_ca_topic_score_codex":0.000011882116,"about_ca_topic_score_gemma":0.0000024308576,"teacher_disagreement_score":0.066226214,"about_ca_system_score_codex":0.00017113965,"about_ca_system_score_gemma":0.00057829934,"threshold_uncertainty_score":0.4197009},"labels":[],"label_agreement":null},{"id":"W3194607634","doi":"10.1016/s0090-8258(21)01205-1","title":"The effect of lymphadenectomy and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Hazard ratio; Internal medicine; Proportional hazards model; Surgery; Retrospective cohort study; Ovarian cancer; Chemotherapy; Adjuvant therapy; Cancer; Carcinoma; Gastroenterology; Oncology","score_opus":0.015443661846621095,"score_gpt":0.30436872045171476,"score_spread":0.28892505860509365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194607634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855869,0.0048628454,0.000001737251,0.0058182394,0.0003060345,0.0005819448,0.00001027822,0.000013092572,0.002818953],"genre_scores_gemma":[0.99585944,0.0030940268,0.00013664691,0.00047119363,0.000051860028,0.00012820215,0.00000877444,0.000012676728,0.00023718324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985369,0.0004043989,0.00027360316,0.0003633033,0.00013320957,0.0002886116],"domain_scores_gemma":[0.9950348,0.0044727437,0.00011012928,0.0002499472,0.00003466241,0.000097719625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005980404,0.00017512406,0.0006944236,0.00010673377,0.000075171025,0.000012131021,0.000056565943,0.00016882105,0.00013252714],"category_scores_gemma":[0.00054793444,0.00010590411,0.00006326544,0.0002666311,0.0001783743,0.000018719495,0.000057965754,0.00014974912,0.0000026639432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063209893,0.00041284415,0.86633086,0.000059730766,0.0001379749,0.0009669269,0.00014369797,0.0000022012755,0.0007643147,0.00092153717,0.00011061146,0.12951721],"study_design_scores_gemma":[0.01630301,0.008688292,0.94651854,0.000022655022,0.000088797606,0.00009349938,0.00015862328,0.00002311668,0.011369018,0.00009290603,0.016552651,0.000088896195],"about_ca_topic_score_codex":0.00012881674,"about_ca_topic_score_gemma":0.00045780753,"teacher_disagreement_score":0.12942833,"about_ca_system_score_codex":0.0003095728,"about_ca_system_score_gemma":0.0002152815,"threshold_uncertainty_score":0.4318644},"labels":[],"label_agreement":null},{"id":"W3194752933","doi":"10.1503/cmaj.202850","title":"Benign serous cystadenoma presenting with cough and back pain","year":2021,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Emergency department; Chest pain; Dry cough; Vital signs; Physical examination; Back pain; Anesthesia; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.008098482646856276,"score_gpt":0.22601109557851917,"score_spread":0.2179126129316629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194752933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7221951,0.0025350794,0.0002066344,0.2586158,0.0005456172,0.0002903787,0.000039683004,0.000023283645,0.015548476],"genre_scores_gemma":[0.9779163,0.00045754368,0.0009634434,0.016315715,0.0013769378,0.000008890836,0.000024421208,0.000023575272,0.0029131551],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983151,0.00016178482,0.0002308246,0.00017112086,0.00077442935,0.00034675995],"domain_scores_gemma":[0.99782413,0.00018040396,0.000110348934,0.00008813616,0.00034089448,0.0014560787],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008846376,0.00009761623,0.00022053631,0.0000578249,0.0001765641,0.000107154636,0.00004022793,0.00016898812,0.0039483923],"category_scores_gemma":[0.0007556004,0.000078677826,0.000046209687,0.0001608427,0.000023934987,0.000066782726,0.000009101695,0.00043625676,0.0000451746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011660112,0.00006754871,0.87413955,0.000031966905,0.00041317337,0.008484992,0.00033686025,0.0000019698089,0.0000042599513,0.00011322415,0.09283885,0.023555964],"study_design_scores_gemma":[0.0041202456,0.00024284533,0.4486158,0.00035646997,0.00016609616,0.0056128534,0.00077784306,0.00025548827,0.000061611325,0.00007135429,0.5395379,0.00018148051],"about_ca_topic_score_codex":0.0013280073,"about_ca_topic_score_gemma":0.025086006,"teacher_disagreement_score":0.44669908,"about_ca_system_score_codex":0.00077445956,"about_ca_system_score_gemma":0.0033263098,"threshold_uncertainty_score":0.99696213},"labels":[],"label_agreement":null},{"id":"W3194982821","doi":"10.1136/ijgc-2021-002910","title":"Correspondence on \"ESGO/ISUOG/IOTA/ESGE consensus statement on pre-operative diagnosis of ovarian tumors\" by Timmerman et al","year":2021,"lang":"en","type":"letter","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Ultrasonography; Statement (logic); Consensus conference; Gynecology; Ovarian carcinoma; General surgery; Ovarian cancer; Surgery; Internal medicine; Cancer; Law","score_opus":0.03985683519524161,"score_gpt":0.38220260456899674,"score_spread":0.34234576937375516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194982821","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16579157,0.0012694502,0.000011606985,0.8265754,0.0030839604,0.00055207283,0.0014574712,0.000010431291,0.0012480195],"genre_scores_gemma":[0.28468412,0.002976025,0.0002273778,0.7082392,0.0012609108,0.00023199616,0.0002639172,0.000049324943,0.0020671645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542016,0.00041914315,0.0013167305,0.0005685566,0.0019133952,0.00036200281],"domain_scores_gemma":[0.9943397,0.0021202727,0.0014404262,0.0002786962,0.0016302295,0.00019068556],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045018247,0.0004926329,0.0011409007,0.0002853774,0.000051769224,0.000079857105,0.00044433272,0.00035979896,0.010388952],"category_scores_gemma":[0.0007084427,0.00034866497,0.0005019044,0.00014176576,0.00018808487,0.000056220535,0.00010737549,0.001917036,0.00003518564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019412491,0.0015906483,0.007807749,0.000038593676,0.0020565179,0.010517829,0.00017282393,0.00031517973,0.00016093945,0.00012243852,0.9722966,0.00297943],"study_design_scores_gemma":[0.0051261233,0.006507073,0.0428723,0.002725159,0.00039378056,0.00023702644,0.00006293877,0.000036310343,0.003837987,0.000065721826,0.9377546,0.00038102805],"about_ca_topic_score_codex":0.00017677915,"about_ca_topic_score_gemma":0.000051053077,"teacher_disagreement_score":0.11889254,"about_ca_system_score_codex":0.0021125406,"about_ca_system_score_gemma":0.0013275075,"threshold_uncertainty_score":0.9998965},"labels":[],"label_agreement":null},{"id":"W3195469501","doi":"10.1016/j.tranon.2021.101203","title":"Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo","year":2021,"lang":"en","type":"article","venue":"Translational Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Max Rady College of Medicine, University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation","keywords":"Ovarian cancer; Serous fluid; In vivo; Paclitaxel; Cancer research; Medicine; Cancer; Carboplatin; Metastasis; Chemotherapy; Internal medicine; Oncology; Pathology; Biology; Cisplatin","score_opus":0.03282377932314828,"score_gpt":0.3083720805281073,"score_spread":0.275548301204959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195469501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98561174,0.0005450074,0.000044988974,0.012945812,0.000085780055,0.000381198,0.00017315408,0.000007353741,0.000204961],"genre_scores_gemma":[0.99513,0.0002196638,0.0039221547,0.0005200028,0.000059690956,0.000083364575,0.00002203567,0.000016360367,0.000026702188],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988871,0.00007327825,0.0004026144,0.0002903347,0.00014694133,0.00019969401],"domain_scores_gemma":[0.9995603,0.00015091617,0.00007510911,0.00010937023,0.000048502472,0.000055807446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015911488,0.00013502761,0.0005101101,0.00017519956,0.000012832756,0.0000036402496,0.000033318294,0.00015587664,0.00040894834],"category_scores_gemma":[0.00001148797,0.00012808133,0.000045644265,0.00040341623,0.000073113726,0.00004448833,0.0000059383137,0.00018636044,5.888591e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034205704,0.0034896468,0.15845792,0.00012780695,0.00013855603,0.0003593335,0.0016659937,0.0005548871,0.82707566,0.0013509395,0.000013346415,0.0033453607],"study_design_scores_gemma":[0.021251049,0.00021945572,0.87606466,0.00019306212,0.000045903816,0.00003413134,0.00004425763,0.0007198413,0.10017773,0.0003247339,0.0007996613,0.0001255187],"about_ca_topic_score_codex":0.0032634027,"about_ca_topic_score_gemma":0.025105877,"teacher_disagreement_score":0.7268979,"about_ca_system_score_codex":0.0003216603,"about_ca_system_score_gemma":0.00059401843,"threshold_uncertainty_score":0.9926834},"labels":[],"label_agreement":null},{"id":"W3197842459","doi":"10.3390/genes12091386","title":"Expression and Polymorphism of TSLP/TSLP Receptors as Potential Diagnostic Markers of Colorectal Cancer Progression","year":2021,"lang":"en","type":"article","venue":"Genes","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"King Saud University","keywords":"Colorectal cancer; Receptor; Polymorphism (computer science); Cancer research; Immunology; Biology; Medicine; Cancer; Gene; Genetics; Genotype","score_opus":0.008644823159447786,"score_gpt":0.2775299817661496,"score_spread":0.2688851586067018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197842459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96995395,0.028147884,0.000006870951,0.00089950784,0.00045708398,0.00026614123,0.000028756,0.000012079008,0.0002277235],"genre_scores_gemma":[0.99014246,0.008295352,0.0010974016,0.00004629745,0.00010530724,0.00008722424,0.000030780477,0.000016464104,0.0001787272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991191,0.000044039953,0.00021894161,0.00024226181,0.0002329443,0.00014271695],"domain_scores_gemma":[0.99941826,0.000100001664,0.0001245165,0.00014532787,0.0001100339,0.00010184492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056586538,0.00011921912,0.00029207428,0.000050679166,0.00003940364,0.000005980281,0.00003220383,0.00007933841,0.0007722119],"category_scores_gemma":[0.000081976636,0.00009196579,0.000077200166,0.00011773578,0.000088789144,0.00003452562,0.000061678955,0.000048252754,0.0000025008258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087617786,0.00067824684,0.3588748,0.00035260874,0.00027749798,0.00027927,0.00040504054,0.00001515739,0.43509588,0.00003562645,0.0024761853,0.2006335],"study_design_scores_gemma":[0.0017126142,0.00051168504,0.19983909,0.00085501565,0.000236249,0.000052843006,0.00017533718,0.000014479018,0.79515004,0.0000290834,0.001338436,0.00008510641],"about_ca_topic_score_codex":0.00022072444,"about_ca_topic_score_gemma":0.000020852061,"teacher_disagreement_score":0.36005417,"about_ca_system_score_codex":0.000040134284,"about_ca_system_score_gemma":0.0001992965,"threshold_uncertainty_score":0.8455179},"labels":[],"label_agreement":null},{"id":"W3197851066","doi":"10.1016/j.semcancer.2021.09.002","title":"Revisiting platinum-resistant ovarian cancer: Advances in therapy, molecular biomarkers, and clinical outcomes","year":2021,"lang":"en","type":"editorial","venue":"Seminars in Cancer Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ovarian cancer; Medicine; Oncology; Cancer therapy; Internal medicine; Cancer; Bioinformatics; Biology","score_opus":0.01955661420748214,"score_gpt":0.39171337254434274,"score_spread":0.3721567583368606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197851066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035577856,0.63818,0.000004597509,0.0038887004,0.31975573,0.0010596311,0.0008870399,0.00003941653,0.0006069767],"genre_scores_gemma":[0.014177411,0.82817245,0.00094876654,0.000575607,0.15446457,0.0007716951,0.0006540922,0.00010064043,0.00013475107],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.996007,0.00040184063,0.0012061668,0.0014084453,0.000326875,0.00064967334],"domain_scores_gemma":[0.99692607,0.0017050283,0.0004911998,0.000553616,0.00015200149,0.00017209446],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008288944,0.0006028153,0.002020837,0.00029767043,0.0000546364,0.00003270194,0.00020573437,0.0013222175,0.00023975199],"category_scores_gemma":[0.0006345615,0.00049934315,0.00024870766,0.00042687522,0.00028563302,0.0000631306,0.00016065038,0.0010944612,0.000001521373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009004206,0.00025187354,0.5920058,0.00033476242,0.00083825825,0.0009173521,0.00009492425,0.0000031851243,0.00016197193,0.000058765458,0.0475464,0.35688627],"study_design_scores_gemma":[0.008549616,0.00082812994,0.063569784,0.006945263,0.0003284615,0.000006590636,0.00012249887,0.00000984729,0.00016078625,0.00020240116,0.9186404,0.0006362646],"about_ca_topic_score_codex":0.004898861,"about_ca_topic_score_gemma":0.0044227005,"teacher_disagreement_score":0.8710939,"about_ca_system_score_codex":0.00091924047,"about_ca_system_score_gemma":0.0014304118,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W3199444372","doi":"10.29309/tpmj/2012.19.01.1932","title":"EPITHELIAL OVARIAN CANCER;","year":2012,"lang":"en","type":"article","venue":"The Professional Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Family history; Gynecology; Breast cancer; Menarche; Stage (stratigraphy); Population; Pathological; Disease; Internal medicine; Medical record; Obstetrics; Oncology","score_opus":0.03007168393609954,"score_gpt":0.3647532124877553,"score_spread":0.3346815285516557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199444372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5894568,0.008052789,0.00024561773,0.38563848,0.011205677,0.0004544477,0.0000188928,0.00004830901,0.004878982],"genre_scores_gemma":[0.9808476,0.0009144195,0.00031903735,0.008155706,0.008229526,0.000059638813,0.0000034721031,0.000018624614,0.0014519593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978031,0.0001629458,0.0002989184,0.000102625454,0.0011817488,0.0004506658],"domain_scores_gemma":[0.9985138,0.00021228642,0.00011276595,0.00016450329,0.0000822504,0.00091437827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011691875,0.00013136721,0.00022845663,0.000043264354,0.00036086197,0.000015664804,0.00017688956,0.00012287573,0.01123594],"category_scores_gemma":[0.00023500549,0.00005901614,0.00013805657,0.00011445361,0.00012456143,0.00009278948,0.00007685349,0.00090348575,0.00018041562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010488317,0.0030899458,0.34387535,0.00006963032,0.0009768739,0.00045621858,0.0022243576,0.0000021685505,0.00066410296,0.009827695,0.11997319,0.5177916],"study_design_scores_gemma":[0.005397899,0.0002275876,0.80915314,0.0013333986,0.00043260164,0.004537897,0.00036585442,0.00007700621,0.0010851723,0.0013124672,0.17588462,0.00019237326],"about_ca_topic_score_codex":0.000030950916,"about_ca_topic_score_gemma":0.000004713686,"teacher_disagreement_score":0.5175993,"about_ca_system_score_codex":0.00015853238,"about_ca_system_score_gemma":0.0008787284,"threshold_uncertainty_score":0.98966795},"labels":[],"label_agreement":null},{"id":"W3199486036","doi":"10.3390/curroncol28050313","title":"Survival in Advanced Epithelial Ovarian Cancer Associated with Cardiovascular Comorbidities and Type 2 Diabetes Mellitus","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Proportional hazards model; Incidence (geometry); Ovarian cancer; Stage (stratigraphy); Cancer; Disease; Survival analysis; Population; Type 2 diabetes; Endocrinology","score_opus":0.06014955636430375,"score_gpt":0.3442384263888368,"score_spread":0.28408887002453304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199486036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91539687,0.0808403,0.0000055489695,0.0013099703,0.0014423395,0.0002649908,0.000055270993,0.000025931751,0.00065876666],"genre_scores_gemma":[0.982276,0.016974624,0.00010513783,0.00010095184,0.00019987857,0.00013965403,0.000115645504,0.000020786294,0.00006730908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988061,0.00017213954,0.00018570502,0.00034861872,0.00019365188,0.00029377933],"domain_scores_gemma":[0.9992707,0.0001631974,0.000058000027,0.0002183539,0.00018318088,0.000106576226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019148897,0.00015908892,0.0006568101,0.00005780672,0.000043234493,0.000011964234,0.0000344565,0.0000927775,0.00014527571],"category_scores_gemma":[0.00010708616,0.00012886102,0.00008309166,0.0002490314,0.0000964081,0.000041598843,0.00003814068,0.00019916965,0.000004399634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018071831,0.0010057557,0.71917033,0.000109871144,0.0013023762,0.00042876467,0.0004090916,0.000068421614,0.00011124564,0.0003342102,0.00023689511,0.2766423],"study_design_scores_gemma":[0.010361957,0.00084378547,0.821931,0.0005208029,0.0007869322,0.000015570997,0.0002456689,0.000068522764,0.0014582232,0.00010439047,0.16344178,0.00022138104],"about_ca_topic_score_codex":0.000095239724,"about_ca_topic_score_gemma":0.0009798845,"teacher_disagreement_score":0.27642092,"about_ca_system_score_codex":0.00044601262,"about_ca_system_score_gemma":0.0005294335,"threshold_uncertainty_score":0.52548},"labels":[],"label_agreement":null},{"id":"W3200222032","doi":"10.54088/mn73we3","title":"Fertility preservation in ovary pathologies in pediatric patients","year":2021,"lang":"en","type":"article","venue":"Developmental and Adolescent Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Ovarian torsion; Ovarian cyst; Ovary; Etiology; Surgery; Ovarian tumor; Fallopian tube; Prospective cohort study; Ultrasound; Cyst; Radical surgery; Radiology; Ovarian cancer; Pathology; Internal medicine; Cancer","score_opus":0.031914121275490606,"score_gpt":0.2864927459297473,"score_spread":0.2545786246542567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200222032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947523,0.0016071447,0.0000035017233,0.0029821678,0.00009606462,0.00034699604,0.000008389636,0.000013456576,0.00019001885],"genre_scores_gemma":[0.99472255,0.0020665023,0.0009493632,0.0020553137,0.000019457231,0.000025259818,0.00012028058,0.000005718154,0.000035571527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990574,0.000050269613,0.00029012334,0.000262603,0.00013357236,0.00020600006],"domain_scores_gemma":[0.9997584,0.000013504511,0.000042906835,0.00006876826,0.000027204616,0.0000892055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013074826,0.00009377607,0.0002022253,0.00007872684,0.000034673038,0.00000877693,0.000019221146,0.000037405167,0.000016366119],"category_scores_gemma":[0.000029752662,0.000082198036,0.000016616628,0.00023850099,0.000011488594,0.00007229287,0.00005580107,0.000113646674,0.000004367641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005243105,0.0014447395,0.97084475,0.00035834042,0.0000027131778,0.000044070053,0.00034209213,2.9432067e-7,0.000002835659,0.000009606793,0.0003403944,0.026557747],"study_design_scores_gemma":[0.0023701012,0.00008839367,0.996645,0.00023612061,0.0000035068167,0.000003488268,0.00014686039,0.0000064800606,0.00006559156,0.000052359446,0.00031446462,0.000067666726],"about_ca_topic_score_codex":0.00005147741,"about_ca_topic_score_gemma":0.00015625138,"teacher_disagreement_score":0.026490081,"about_ca_system_score_codex":0.0003981973,"about_ca_system_score_gemma":0.00039690244,"threshold_uncertainty_score":0.33519387},"labels":[],"label_agreement":null},{"id":"W3200368844","doi":"10.1097/pas.0000000000001798","title":"Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype","year":2021,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency; University of Calgary","funders":"","keywords":"Immunohistochemistry; Genotype; Phenotype; Carcinoma; Pathology; Ovarian carcinoma; Clear cell; Biology; Medicine; Oncology; Cancer research; Internal medicine; Ovarian cancer; Gene; Cancer; Genetics","score_opus":0.015234206065724008,"score_gpt":0.2688367765235201,"score_spread":0.2536025704577961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200368844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935227,0.0037524065,0.00089776993,0.0012106356,0.00015675991,0.00007627731,0.00003529683,0.000003956548,0.00034419724],"genre_scores_gemma":[0.996244,0.0018258496,0.001666575,0.000053564014,0.00015932754,0.000002865748,0.000017546256,0.000010065723,0.000020220563],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879783,0.00022661265,0.0005450428,0.00013972266,0.00018169366,0.00010911204],"domain_scores_gemma":[0.99823225,0.0004859044,0.00070615334,0.00020836738,0.00029049208,0.00007682354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025333356,0.00010086408,0.0005651072,0.00009044873,0.00003706103,0.0000051478387,0.000067708665,0.000045134962,0.00011393364],"category_scores_gemma":[0.0001440063,0.000064852335,0.00013467751,0.0003058814,0.0004516886,0.000042283198,0.000039238577,0.0002306953,0.0000012973587],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021140847,0.0026139414,0.091065116,0.00010502478,0.0009482211,0.0028676277,0.002884945,0.00008146001,0.7356263,0.0012549566,0.0005534823,0.1408581],"study_design_scores_gemma":[0.007651882,0.0077091544,0.8878747,0.00020683392,0.0014136687,0.0033573266,0.0018997235,0.000184958,0.086908124,0.00080398,0.0018099473,0.00017965837],"about_ca_topic_score_codex":0.00019102741,"about_ca_topic_score_gemma":0.0000029826776,"teacher_disagreement_score":0.7968096,"about_ca_system_score_codex":0.000066045046,"about_ca_system_score_gemma":0.00013853106,"threshold_uncertainty_score":0.26446015},"labels":[],"label_agreement":null},{"id":"W3200484435","doi":"10.1016/j.ctrv.2021.102294","title":"The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research","keywords":"Debulking; Medicine; Tumor Debulking; Oncology; Bevacizumab; Chemotherapy; Ovarian cancer; Internal medicine; Primary tumor; Clinical trial; Surgery; Cancer; Metastasis","score_opus":0.019109934841371513,"score_gpt":0.3121977706038538,"score_spread":0.29308783576248226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200484435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010660207,0.9829121,7.138247e-7,0.0019173376,0.0003067175,0.010621084,0.0001104782,0.0000063165103,0.0030592205],"genre_scores_gemma":[0.0027423112,0.9918033,0.000068487054,0.00025316354,0.000102752085,0.0045034396,0.000048127447,0.000051425173,0.00042698695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958211,0.0009686752,0.00119708,0.00068915245,0.00093011354,0.00039383437],"domain_scores_gemma":[0.99624896,0.00041689834,0.0010954663,0.0019487219,0.000139506,0.00015047172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005142552,0.00065609027,0.0028529926,0.000049729766,0.00019647188,0.000019441315,0.0005725106,0.00012311341,0.000073273426],"category_scores_gemma":[0.00006602884,0.00020104728,0.001057872,0.0011218615,0.00025268068,0.000043295146,0.00034199076,0.00038875433,0.0000054922334],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009240958,0.0007597731,0.014104957,0.0025473798,0.0012325986,0.000049281894,0.00013746602,0.0000021336357,2.5267079e-8,0.00032294248,0.00016562597,0.9805854],"study_design_scores_gemma":[0.0024261062,0.00025804463,0.047315445,0.037841838,0.004046431,0.000015952935,0.000026690339,5.109155e-7,0.000015434658,0.000006973947,0.9078699,0.0001766945],"about_ca_topic_score_codex":0.00030743805,"about_ca_topic_score_gemma":0.0005106437,"teacher_disagreement_score":0.9804087,"about_ca_system_score_codex":0.0018403279,"about_ca_system_score_gemma":0.0010844624,"threshold_uncertainty_score":0.819847},"labels":[],"label_agreement":null},{"id":"W3201119013","doi":"10.4132/jptm.2021.07.28","title":"What’s new in gynecologic pathology 2021: ovary and fallopian tube","year":2021,"lang":"en","type":"article","venue":"Journal of Pathology and Translational Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Fallopian tube; Medicine; Serous fluid; Ovary; Pathology; Female circumcision; Gynecology; Internal medicine","score_opus":0.026112781985329,"score_gpt":0.3001839281253741,"score_spread":0.2740711461400451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201119013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78671193,0.07233185,0.0002921736,0.13909288,0.00087449397,0.00013001707,0.0000036248996,0.0000035602752,0.0005594675],"genre_scores_gemma":[0.9687714,0.02508101,0.0027026958,0.0026284251,0.00057866727,0.0000036267277,0.000018104756,0.000008387952,0.0002077022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890584,0.000111394635,0.0004731642,0.00019945993,0.00016012676,0.0001500222],"domain_scores_gemma":[0.999169,0.00033650262,0.00012199263,0.0000837012,0.0001151793,0.00017361651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038884577,0.00012484448,0.000519746,0.00018389545,0.00003563325,0.000007111146,0.000028335815,0.00015063195,0.000566886],"category_scores_gemma":[0.00013699375,0.00008971642,0.000051475465,0.0001460599,0.0001766113,0.00014395265,0.000010374587,0.0003056439,0.0000015186172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007538588,0.00061467633,0.7205313,0.000115523435,0.00029540632,0.08093052,0.0033787207,0.000024389014,0.003014573,0.00680371,0.0010316381,0.18250568],"study_design_scores_gemma":[0.008781379,0.0012601257,0.9508825,0.0003962554,0.0002690131,0.02505042,0.00042902236,0.0000172249,0.00011610602,0.008733819,0.003987753,0.0000763817],"about_ca_topic_score_codex":0.0000054724114,"about_ca_topic_score_gemma":0.000074881216,"teacher_disagreement_score":0.23035121,"about_ca_system_score_codex":0.000018567831,"about_ca_system_score_gemma":0.0002743686,"threshold_uncertainty_score":0.6207004},"labels":[],"label_agreement":null},{"id":"W3201469468","doi":"10.1200/jco.2020.39.28_suppl.292","title":"Patterns of first-line systemic therapy delivery and adoption of bevacizumab in advanced ovarian cancer in Ontario, Canada.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Princess Margaret Hospital Foundation","keywords":"Medicine; Bevacizumab; Systemic therapy; Internal medicine; Cancer registry; Cohort; Population; Cancer; Oncology; Ovarian cancer; Stage (stratigraphy); Logistic regression; Retrospective cohort study; Chemotherapy; Breast cancer","score_opus":0.06744635450047,"score_gpt":0.3884308034953431,"score_spread":0.3209844489948731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201469468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911945,0.0041235667,0.000012417894,0.0038646988,0.00055590936,0.00015313755,0.0000149751295,6.9721983e-7,0.000080113794],"genre_scores_gemma":[0.9817693,0.01733597,0.00035434024,0.00037876886,0.00010415243,0.0000077091645,0.0000034739908,0.000006978104,0.000039306327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975587,0.00016967776,0.0017966074,0.0001436552,0.00020858557,0.0001227632],"domain_scores_gemma":[0.9976921,0.00072182,0.0010205826,0.0001209023,0.00033040173,0.00011419448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064903736,0.0000912266,0.001240594,0.000083985135,0.000007421238,0.000001504643,0.000049668954,0.00016303026,0.00020161297],"category_scores_gemma":[0.00021715135,0.000069927664,0.00011978591,0.000099829456,0.000027038168,0.000047649883,0.000019938763,0.00041611862,9.165747e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025221226,0.0010835065,0.89035255,0.00009014679,0.00020222605,0.0009252488,0.00016460833,0.00034015803,0.00009074344,0.000017276523,0.000039449973,0.104171984],"study_design_scores_gemma":[0.018378602,0.002904122,0.9742032,0.0013973775,0.00010831193,0.00014862009,0.00020197716,0.00003148422,0.0002487271,0.000026292377,0.002301528,0.000049700833],"about_ca_topic_score_codex":0.5713695,"about_ca_topic_score_gemma":0.98986244,"teacher_disagreement_score":0.4184929,"about_ca_system_score_codex":0.000957581,"about_ca_system_score_gemma":0.0066846246,"threshold_uncertainty_score":0.99894655},"labels":[],"label_agreement":null},{"id":"W3201611853","doi":"10.1136/jitc-2021-003122","title":"Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Ovarian Cancer Academy; Merck Sharp and Dohme; U.S. Department of Defense","keywords":"Carboplatin; Medicine; Ovarian cancer; Pembrolizumab; Fallopian tube cancer; Oncology; Fallopian tube; Internal medicine; Gynecology; Cancer; Chemotherapy; Immunotherapy; Cisplatin","score_opus":0.017180304316084676,"score_gpt":0.3050659985256309,"score_spread":0.2878856942095462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201611853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8404892,0.15335935,0.00014913,0.0033105596,0.0010859338,0.0010544201,0.00035399644,0.000015352187,0.00018204025],"genre_scores_gemma":[0.92470026,0.06763851,0.0044472646,0.00037546598,0.00067456136,0.00069407263,0.00007208242,0.00013457047,0.0012632427],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983259,0.000041133837,0.00060339767,0.0003517916,0.0003191096,0.0003586771],"domain_scores_gemma":[0.9985617,0.00020361143,0.0003962326,0.00022207916,0.0004601433,0.000156237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022791895,0.00030868954,0.0008463828,0.000089732996,0.00025882365,0.00008273354,0.00007115864,0.00011498478,0.00013547046],"category_scores_gemma":[0.000019696694,0.00023271763,0.00018212866,0.00012989444,0.00012820245,0.000120437,0.000022157135,0.0002460689,9.3989534e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11198822,0.0016755296,0.11124402,0.003093885,0.00993054,0.00020031391,0.0039784103,0.00021073257,0.1392294,0.001978509,0.0013173517,0.6151531],"study_design_scores_gemma":[0.090949416,0.010542542,0.8099701,0.005650613,0.0018256134,0.00075058104,0.0008771074,0.0006647842,0.031096295,0.0005936215,0.046142675,0.00093666406],"about_ca_topic_score_codex":0.0003476645,"about_ca_topic_score_gemma":0.00054125796,"teacher_disagreement_score":0.69872606,"about_ca_system_score_codex":0.00036408255,"about_ca_system_score_gemma":0.0010281778,"threshold_uncertainty_score":0.948995},"labels":[],"label_agreement":null},{"id":"W3201941075","doi":"10.14740/jcgo.v10i3.758","title":"Diagnostic Performance of International Ovarian Tumor Analysis Logistic Regression Model LR2 for Adnexal Masses Classification at a Tertiary Gynecology Center in Singapore","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Logistic regression; Population; Malignancy; Receiver operating characteristic; Ovarian cancer; Confidence interval; Adnexal mass; Gynecology; Radiology; Cancer; Internal medicine","score_opus":0.09321938830004368,"score_gpt":0.3947528115570851,"score_spread":0.3015334232570414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201941075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931718,0.0013748375,0.0008456553,0.003016953,0.0012431346,0.00018731816,0.000033814187,0.0000034674208,0.000122982],"genre_scores_gemma":[0.98841333,0.0055747433,0.005042253,0.0006495221,0.00012450402,0.000012318381,0.00005782268,0.000009862643,0.00011563205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976607,0.0001560994,0.001508189,0.00027690458,0.00020894773,0.00018914248],"domain_scores_gemma":[0.9815521,0.016555512,0.0010058538,0.00018166503,0.0005580083,0.0001468093],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008011991,0.00013564755,0.000892591,0.00039778458,0.00005009083,0.000009776821,0.00010285113,0.00024817878,0.00011490148],"category_scores_gemma":[0.027490932,0.00010188249,0.0003367344,0.00039725663,0.00014110912,0.00009114456,0.00007228427,0.00033461256,0.0000011714941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005988489,0.0017521692,0.98016495,0.00009127095,0.0007002148,0.00038064548,0.00007156713,0.0009960833,0.00003222474,0.00013146052,0.00033067528,0.014749873],"study_design_scores_gemma":[0.005988429,0.0010279533,0.94127584,0.00013884848,0.0012698884,0.00010623539,0.000086270535,0.048413265,0.0001239676,0.00018273114,0.0013042889,0.00008231401],"about_ca_topic_score_codex":0.0000019564138,"about_ca_topic_score_gemma":0.000035540394,"teacher_disagreement_score":0.047417182,"about_ca_system_score_codex":0.0002142595,"about_ca_system_score_gemma":0.00042726568,"threshold_uncertainty_score":0.9807009},"labels":[],"label_agreement":null},{"id":"W3203448690","doi":"10.1016/j.annonc.2021.08.1193","title":"751P Survival prognostic and surrogate values of the early modeled CA-125 KELIM in newly diagnosed advanced ovarian cancer: Data from the GCIG meta-analysis group","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Surrogate endpoint; Meta-analysis; Oncology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.19887061607185905,"score_gpt":0.40217141036449183,"score_spread":0.20330079429263279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203448690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94554234,0.02153003,0.000041619005,0.03060499,0.00019025912,0.00067816215,0.0010295624,0.000009251003,0.00037381402],"genre_scores_gemma":[0.9924697,0.005323807,0.000469546,0.001176069,0.0000695576,0.00016354052,0.00022849691,0.000018470771,0.000080795515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974624,0.0006734598,0.0006361485,0.0005876362,0.00034404497,0.00029633442],"domain_scores_gemma":[0.9955393,0.0023999782,0.00038885264,0.001278328,0.00029808635,0.0000954239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007122535,0.00022361566,0.0015953063,0.00008167495,0.00006460689,0.000015897142,0.00037810585,0.00012920026,0.0003916357],"category_scores_gemma":[0.0005683264,0.00012794785,0.00044425856,0.0008198563,0.0002109459,0.00011368059,0.0003228867,0.00020430856,0.0000019276333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095267047,0.0032038018,0.83062804,0.00009563952,0.13143253,0.00041474667,0.0022462895,0.0019543692,0.00052000204,0.0013526737,0.0030400213,0.024159202],"study_design_scores_gemma":[0.004814868,0.00069104607,0.92006624,0.000056471374,0.06840198,0.000003885995,0.00034694673,0.0010872958,0.00081286917,0.0017536685,0.0018146618,0.00015007789],"about_ca_topic_score_codex":0.019617505,"about_ca_topic_score_gemma":0.044101816,"teacher_disagreement_score":0.08943818,"about_ca_system_score_codex":0.000047548834,"about_ca_system_score_gemma":0.00050109206,"threshold_uncertainty_score":0.98691094},"labels":[],"label_agreement":null},{"id":"W3203701277","doi":"10.1016/j.ajog.2021.09.020","title":"Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy","year":2021,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sinai Health System; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Cancer Care Ontario; American College of Surgeons","keywords":"Medicine; Hysterectomy; Interquartile range; Hazard ratio; Ovarian cancer; Gynecology; Oophorectomy; Incidence (geometry); Population; Obstetrics; Cancer; Confidence interval; Surgery; Internal medicine","score_opus":0.011522871115849624,"score_gpt":0.2652532262986562,"score_spread":0.2537303551828066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203701277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990381,0.0077066133,0.000034059904,0.0011278988,0.0005027272,0.0001138638,0.000009914892,0.0000050316266,0.00011888477],"genre_scores_gemma":[0.9779768,0.01979615,0.0013206785,0.000723028,0.00006246283,0.000017395954,0.0000018801671,0.000019120565,0.000082477025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985033,0.00017709775,0.0004758393,0.000298219,0.00018003694,0.00036546687],"domain_scores_gemma":[0.99583095,0.003098206,0.000461923,0.00014951512,0.00017433205,0.00028507362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029476674,0.00017959549,0.00073096156,0.00032999043,0.000087130305,0.00003717014,0.00005919934,0.00006769254,0.00013822809],"category_scores_gemma":[0.0014034825,0.00014855969,0.00006769281,0.00060642674,0.00010673405,0.000088241984,0.00009628052,0.0003018003,0.0000014332485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088577224,0.0001432051,0.90814406,0.000033814053,0.00023940325,0.002171941,0.0012870738,0.00005032098,0.00012696744,0.000050182996,0.000027610633,0.08763684],"study_design_scores_gemma":[0.004710512,0.0019891912,0.98790663,0.00016473174,0.00014187102,0.00091727276,0.00059461815,0.000093440125,0.00025737932,0.00021829222,0.0028445218,0.00016150849],"about_ca_topic_score_codex":0.00029275098,"about_ca_topic_score_gemma":0.0003058718,"teacher_disagreement_score":0.08747534,"about_ca_system_score_codex":0.0009959996,"about_ca_system_score_gemma":0.0005060405,"threshold_uncertainty_score":0.6058088},"labels":[],"label_agreement":null},{"id":"W3206246035","doi":"10.3390/curroncol28050358","title":"Total Colectomy as a Part of Ultra-Radical Surgery for Ovarian Cancer—Short- and Long-Term Outcomes","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Surgery; Adverse effect; Colectomy; Retrospective cohort study; Ovarian cancer; Radical surgery; Cancer; Colorectal cancer; Internal medicine","score_opus":0.1259002270666988,"score_gpt":0.4264200438434172,"score_spread":0.3005198167767184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206246035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97758055,0.012019334,0.00007994304,0.00711647,0.0021577198,0.0006187701,0.00011724418,0.000022867305,0.0002871041],"genre_scores_gemma":[0.9954451,0.002856639,0.000106533815,0.00038644086,0.00036451043,0.0005279496,0.00013927047,0.000019053346,0.00015452871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987949,0.000059269674,0.00036810696,0.00035201287,0.00014590418,0.00027976398],"domain_scores_gemma":[0.998746,0.0006164815,0.00009260193,0.00019714744,0.00014296646,0.0002048457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012693893,0.00016034314,0.0007622926,0.00006746255,0.000046869023,0.000009507586,0.00003246477,0.00011728759,0.0005782621],"category_scores_gemma":[0.00017969984,0.00013404383,0.00020410163,0.000117771786,0.00013153258,0.000029210798,0.000024786335,0.00012065269,0.0000034306813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018912913,0.001459862,0.85413134,0.00032878976,0.00038606752,0.00017491184,0.00008641808,3.4007988e-7,0.00013970527,0.00039767096,0.005577864,0.13712789],"study_design_scores_gemma":[0.003777703,0.000618851,0.90775603,0.0003362107,0.00069266977,0.00024396343,0.00002603765,0.000009154853,0.0033270495,0.000058736037,0.08300202,0.00015155389],"about_ca_topic_score_codex":0.000024063513,"about_ca_topic_score_gemma":0.00012835182,"teacher_disagreement_score":0.13697633,"about_ca_system_score_codex":0.00021822554,"about_ca_system_score_gemma":0.0010366272,"threshold_uncertainty_score":0.6331565},"labels":[],"label_agreement":null},{"id":"W3206338191","doi":"10.1136/ijgc-2021-esgo.360","title":"225 Avelumab alone in platinum-resistant/refractory ovarian cancer: selected biomarker analyses from the JAVELIN Ovarian 200 trial","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Avelumab; Medicine; Ovarian cancer; Internal medicine; Hazard ratio; Oncology; Progression-free survival; Biomarker; Bevacizumab; Cancer; Immunotherapy; Confidence interval; Chemotherapy; Pembrolizumab; Biology","score_opus":0.07675292072476093,"score_gpt":0.38714916161761215,"score_spread":0.3103962408928512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206338191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94704276,0.009098883,0.00014622226,0.03811356,0.0037419354,0.00041157648,0.00038122653,0.000019421765,0.0010443978],"genre_scores_gemma":[0.9912934,0.0032154138,0.0008305954,0.0023431494,0.0017857036,0.00009608663,0.00007404146,0.00002264517,0.00033901454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970184,0.00029365445,0.0010507647,0.00038476064,0.0009373835,0.0003150549],"domain_scores_gemma":[0.9964361,0.0012417817,0.0006276868,0.0002249848,0.0012820889,0.00018736279],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038742452,0.00026392305,0.00071293674,0.0001675624,0.000091410264,0.00010646963,0.00037173915,0.00021474624,0.0137797985],"category_scores_gemma":[0.0011064773,0.00016484907,0.00029568697,0.0005345841,0.00010709456,0.00015035679,0.0000902489,0.0005870101,0.000011670116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16451955,0.010332072,0.4954319,0.000037945018,0.017955301,0.018673277,0.0010833878,0.0011905207,0.052253112,0.00085758534,0.049190484,0.18847486],"study_design_scores_gemma":[0.055580374,0.0006596927,0.9216266,0.00034020844,0.0005218832,0.00007320727,0.00015214231,0.00018598557,0.0022756674,0.0003701227,0.018011387,0.0002026878],"about_ca_topic_score_codex":0.0030413095,"about_ca_topic_score_gemma":0.0053480975,"teacher_disagreement_score":0.42619473,"about_ca_system_score_codex":0.0015144155,"about_ca_system_score_gemma":0.0018310074,"threshold_uncertainty_score":0.98712176},"labels":[],"label_agreement":null},{"id":"W3206381741","doi":"10.1016/j.jmig.2021.09.009","title":"Laparoscopic Technique for Extraction of Large Abdominopelvic Masses","year":2021,"lang":"en","type":"article","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Umbilicus (mollusc); Lithotomy position; Quadrant (abdomen); Surgery; Laparoscopy; Operating table; Abdomen; Cyst; Port (circuit theory); Radiology","score_opus":0.022675657127774997,"score_gpt":0.32927817521984865,"score_spread":0.3066025180920737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206381741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990512,0.0018274162,0.001102426,0.004326143,0.0006832957,0.00054466084,0.000039752344,0.0000054268935,0.0009588893],"genre_scores_gemma":[0.97000384,0.001188367,0.027561778,0.0006758301,0.00022802126,0.000079357145,0.000010596368,0.00001835797,0.00023386952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880326,0.000069987174,0.00061806553,0.00015292081,0.00014946381,0.00020632436],"domain_scores_gemma":[0.9968376,0.0013674301,0.00063141214,0.00015805215,0.00090801297,0.00009747709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002744781,0.00012076076,0.0006590952,0.00015172888,0.00003671927,0.000006728561,0.00006955827,0.00015673994,0.0005843832],"category_scores_gemma":[0.0014374459,0.00010108511,0.00026169003,0.00011871562,0.000044667082,0.00008184995,0.000025320925,0.00016563914,0.0000044253093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093975995,0.003128061,0.07519839,0.00063156406,0.0010980174,0.0016184265,0.00022740854,0.000006369187,0.9000052,0.0011016462,0.013881979,0.0021631632],"study_design_scores_gemma":[0.006785056,0.0045835064,0.10626769,0.00028730836,0.0006415687,0.0013908754,0.0004053963,0.000001676469,0.856167,0.00047392253,0.02290642,0.000089586996],"about_ca_topic_score_codex":0.0000025740846,"about_ca_topic_score_gemma":0.00009328291,"teacher_disagreement_score":0.043838218,"about_ca_system_score_codex":0.00018563488,"about_ca_system_score_gemma":0.0012672689,"threshold_uncertainty_score":0.6398586},"labels":[],"label_agreement":null},{"id":"W3206717762","doi":"10.1016/j.ygyno.2021.09.025","title":"Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"National Center for Advancing Translational Sciences; Stranahan Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Amgen","keywords":"Medicine; Carboplatin; Placebo; Internal medicine; Clinical endpoint; Chemotherapy; Paclitaxel; Neutropenia; Ovarian cancer; Oncology; Multicenter trial; Progression-free survival; Gastroenterology; Surgery; Randomized controlled trial; Cancer; Pathology; Multicenter study; Cisplatin","score_opus":0.030084491948910434,"score_gpt":0.3480903884809034,"score_spread":0.31800589653199296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206717762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675232,0.002221278,0.000018787061,0.004282788,0.004925439,0.009414259,0.0005571422,0.000059537146,0.010997571],"genre_scores_gemma":[0.99055386,0.002015996,0.0020712428,0.00032942518,0.00049221993,0.0036396147,0.00017303933,0.00005123794,0.0006733887],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99269825,0.0018385787,0.0029692568,0.0010545288,0.00058735046,0.00085204956],"domain_scores_gemma":[0.98304534,0.013482195,0.001711466,0.0008474791,0.0005938846,0.00031961134],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002373504,0.000623046,0.0050535095,0.00042694784,0.00012305041,0.00001595417,0.00025671293,0.00074045575,0.0011078225],"category_scores_gemma":[0.014476493,0.000497421,0.0009890881,0.00065488555,0.00046828217,0.00009968191,0.00019713542,0.00062171853,0.00001028168],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94853604,0.016725136,0.000317825,0.000108556575,0.0020527325,0.0018396184,0.0019304162,0.00019080397,0.001949882,0.00035186505,0.00056108,0.02543604],"study_design_scores_gemma":[0.9693875,0.018557217,0.0009262297,0.00020508561,0.0025013203,0.000017997798,0.00071420986,0.00080793997,0.0040666256,0.00015268655,0.002303674,0.00035956458],"about_ca_topic_score_codex":0.003548344,"about_ca_topic_score_gemma":0.008332286,"teacher_disagreement_score":0.025076477,"about_ca_system_score_codex":0.0014295895,"about_ca_system_score_gemma":0.003401231,"threshold_uncertainty_score":0.9998053},"labels":[],"label_agreement":null},{"id":"W3207287416","doi":"10.1158/1078-0432.ccr-21-0158","title":"Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Carboplatin; Chemotherapy; Toxicity; Phases of clinical research; Combination chemotherapy","score_opus":0.247773716913073,"score_gpt":0.5161284923830547,"score_spread":0.26835477546998165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207287416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98660713,0.0005617847,0.0000027160183,0.007190701,0.00017508908,0.0042649903,0.00018288387,0.000041285082,0.0009733993],"genre_scores_gemma":[0.99114126,0.0009945056,0.0011612992,0.0020277433,0.00045517046,0.002192685,0.00014165991,0.0001338727,0.0017517874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939768,0.0007484853,0.0009836869,0.0015798799,0.0017310081,0.000980181],"domain_scores_gemma":[0.9961293,0.0005549563,0.00017340922,0.0012459011,0.0011286152,0.0007678404],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015351317,0.00041877688,0.0012575071,0.00017252461,0.00041868686,0.00021367798,0.0005649185,0.00019676327,0.0023431706],"category_scores_gemma":[0.00018814937,0.00026975363,0.000050017625,0.0013916062,0.00036468983,0.0003322559,0.00041804538,0.0012287188,0.0000078806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09804856,0.07239356,0.7175564,0.00013704243,0.0008830558,0.001962785,0.0007494324,0.000008527328,0.0000712174,0.00003625921,0.0018360944,0.106317036],"study_design_scores_gemma":[0.13317855,0.10026809,0.75388193,0.00085224805,0.00017570393,0.0000061700875,0.00042465792,0.000042730455,0.00016964033,0.000013279204,0.0106133595,0.00037364618],"about_ca_topic_score_codex":0.0056085843,"about_ca_topic_score_gemma":0.035264082,"teacher_disagreement_score":0.10594339,"about_ca_system_score_codex":0.0012058929,"about_ca_system_score_gemma":0.006286513,"threshold_uncertainty_score":0.99997544},"labels":[],"label_agreement":null},{"id":"W3207383745","doi":"10.1093/ije/dyab211","title":"Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)","year":2021,"lang":"en","type":"article","venue":"International Journal of Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Wellcome Trust; World Health Organization","keywords":"Ovarian cancer; Cohort; Medicine; Cohort study; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.047677004168119666,"score_gpt":0.38717812820784725,"score_spread":0.3395011240397276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207383745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49922338,0.017390084,0.0021327736,0.45325896,0.010968213,0.00061507034,0.00013271689,0.000025528638,0.01625327],"genre_scores_gemma":[0.9701109,0.0062104384,0.0027472682,0.017190393,0.002196965,0.00006224298,0.0000464198,0.000017629975,0.0014177395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980602,0.00033359148,0.0008629608,0.00021436854,0.00031164876,0.00021719618],"domain_scores_gemma":[0.99670714,0.0011727851,0.00059015246,0.00022391489,0.0011641226,0.00014187118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015464941,0.00012903185,0.00056357245,0.000078190445,0.00004416572,0.000012894528,0.00021570525,0.00009694931,0.0029402515],"category_scores_gemma":[0.0022086194,0.000077563855,0.00027029656,0.00008918675,0.00014722516,0.00006246443,0.000057638255,0.00034453065,0.000031869506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017707719,0.00018945012,0.9359045,0.0000058093788,0.0028581568,0.0008162193,0.000033615615,0.000057634534,0.0001429149,0.008277676,0.040897645,0.010639304],"study_design_scores_gemma":[0.0013756505,0.000113752125,0.86916715,0.00013065235,0.00040658645,0.0027074227,0.000031637806,0.00007886157,0.0007760081,0.0012879742,0.123859495,0.00006478855],"about_ca_topic_score_codex":0.00020742929,"about_ca_topic_score_gemma":0.000043528842,"teacher_disagreement_score":0.47088754,"about_ca_system_score_codex":0.00032168947,"about_ca_system_score_gemma":0.0007391528,"threshold_uncertainty_score":0.9979712},"labels":[],"label_agreement":null},{"id":"W3208966134","doi":"10.1016/j.ygyno.2021.10.080","title":"Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Meta-analysis; Oncology; Internal medicine; Serous fluid; Progression-free survival; MEDLINE; Randomized controlled trial; Surgery; Overall survival","score_opus":0.1514104611078758,"score_gpt":0.40087005714800295,"score_spread":0.24945959604012716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208966134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028503582,0.98413575,0.00001892734,0.0026101784,0.00051524566,0.011541577,0.0008576288,0.00005606076,0.00026175566],"genre_scores_gemma":[0.000099173354,0.97311,0.00085479196,0.0019343054,0.00014776182,0.021526733,0.0016002742,0.00007426962,0.0006526657],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99325716,0.0018823687,0.0023110176,0.0015866326,0.0002667627,0.00069605507],"domain_scores_gemma":[0.98957837,0.006666793,0.0018544832,0.0011613289,0.0003694856,0.00036955526],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018122903,0.0010312075,0.028736059,0.0005656929,0.00016080648,0.000043211574,0.00021749831,0.000885247,0.0017176146],"category_scores_gemma":[0.00145133,0.0006497461,0.007849718,0.0011564814,0.00015846408,0.000056665256,0.00017400675,0.0006472576,0.000031606938],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009454826,0.0008537181,0.000007172618,0.7168794,0.2493844,0.00071264425,0.000032943048,7.379866e-8,5.086928e-9,0.0001319585,0.004989258,0.026998926],"study_design_scores_gemma":[0.00042562417,0.0008436987,0.000029242981,0.011687531,0.7567037,0.00065992924,0.00003670657,6.082825e-7,1.5510234e-7,0.00002246614,0.22920081,0.00038955547],"about_ca_topic_score_codex":0.000031562813,"about_ca_topic_score_gemma":0.00011815755,"teacher_disagreement_score":0.7051919,"about_ca_system_score_codex":0.0017903945,"about_ca_system_score_gemma":0.0032826266,"threshold_uncertainty_score":0.9995954},"labels":[],"label_agreement":null},{"id":"W3209236449","doi":"10.20944/preprints202110.0434.v1","title":"The Importance of Screening for Early Detection of Ovarian Cancer: Epidemiological Review","year":2021,"lang":"en","type":"article","venue":"Preprints.org","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Epidemiology; Incidence (geometry); Gynecology; Disease; Mortality rate; Malignancy; Population; Cancer; Family history; Internal medicine; Oncology; Environmental health","score_opus":0.188706693453977,"score_gpt":0.4093813755177002,"score_spread":0.2206746820637232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209236449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95292556,0.03536233,0.0008758078,0.008872471,0.00015059108,0.00092781713,0.000020583508,0.000020627158,0.0008442273],"genre_scores_gemma":[0.97551066,0.022841081,0.0006427972,0.0004359494,0.00006784698,0.0003282153,0.0000051871093,0.000008461424,0.00015979624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989667,0.0000764428,0.0004370229,0.0002615029,0.00011814142,0.00014021725],"domain_scores_gemma":[0.99871224,0.00031211143,0.00026295675,0.00044227642,0.00021717303,0.000053231815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007242731,0.00008597881,0.00039609446,0.000011803248,0.000054533884,0.0000013157382,0.00006819026,0.000049394297,0.00022134466],"category_scores_gemma":[0.0009680521,0.00005585567,0.00019553688,0.0001311852,0.000052120125,0.00002310832,0.000055091168,0.00009011372,0.000005168587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010243233,0.00007989299,0.9741992,0.00044788627,0.00019016917,0.0000044175404,0.000026432806,0.0000038575386,0.004586378,0.0004722208,0.000038997903,0.019848134],"study_design_scores_gemma":[0.00060475833,0.00007611561,0.88994896,0.0011148392,0.00021652566,0.0000072309217,0.000014486927,0.000016730024,0.10130272,0.0002449439,0.006409145,0.000043510237],"about_ca_topic_score_codex":0.00015289105,"about_ca_topic_score_gemma":0.00006724853,"teacher_disagreement_score":0.096716344,"about_ca_system_score_codex":0.00004977818,"about_ca_system_score_gemma":0.000091004076,"threshold_uncertainty_score":0.24235687},"labels":[],"label_agreement":null},{"id":"W3210173250","doi":"10.1136/ijgc-2021-igcs.309","title":"EPV238/#131 Impact of lymphadenectomy and intraoperative tumor rupture on survival in early stage mucinous ovarian cancers","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Stage (stratigraphy); Retrospective cohort study; Hazard ratio; Ovarian cancer; Proportional hazards model; Cohort; Internal medicine; Oncology; Surgery; Radiology; Cancer; Confidence interval","score_opus":0.024347158000868986,"score_gpt":0.34816864620338994,"score_spread":0.32382148820252094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210173250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939097,0.001232099,0.000012435058,0.0028611552,0.00070499995,0.00014206755,0.000118644246,0.0000042630086,0.0010146431],"genre_scores_gemma":[0.9973361,0.0012223546,0.00022204164,0.0007217556,0.00032758625,0.000018404977,0.0000058637224,0.000011743107,0.000134183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849623,0.000097710676,0.00049234927,0.00022389184,0.00050088303,0.00018892933],"domain_scores_gemma":[0.998418,0.00032400803,0.00031294255,0.000095822186,0.00068521773,0.00016405447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019993751,0.00017200099,0.000535946,0.00015594861,0.000021806494,0.00003544232,0.000125924,0.00008784995,0.0020104356],"category_scores_gemma":[0.00029727456,0.00011353057,0.00020355705,0.00016284216,0.00008053395,0.00010788449,0.000043435324,0.00028453552,0.0000018486162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020479816,0.0009505244,0.9731948,0.000020247562,0.0013697097,0.0062376135,0.0006460326,0.0019211569,0.001468661,0.0009999404,0.00026533083,0.010878012],"study_design_scores_gemma":[0.0056671016,0.0020304052,0.987325,0.00026197507,0.000074703494,0.00019568624,0.00015110332,0.000061552964,0.0032363168,0.00011947453,0.00077131396,0.00010535748],"about_ca_topic_score_codex":0.0014582311,"about_ca_topic_score_gemma":0.00078964914,"teacher_disagreement_score":0.01413022,"about_ca_system_score_codex":0.001934226,"about_ca_system_score_gemma":0.0013165061,"threshold_uncertainty_score":0.99890184},"labels":[],"label_agreement":null},{"id":"W3210733329","doi":"10.1136/ijgc-2021-igcs.264","title":"EPV193/#344 Systematic review and meta-analysis of the survival impact of secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Oncology; Hazard ratio; Internal medicine; Serous fluid; Progression-free survival; Serous carcinoma; Randomized controlled trial; Overall survival; Ovarian cancer; Cancer; Confidence interval","score_opus":0.08448108011781826,"score_gpt":0.37965533611517965,"score_spread":0.2951742559973614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210733329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76110333,0.21758012,0.00009820428,0.017224254,0.0011696178,0.0012317032,0.0014814857,0.0000044385447,0.000106838714],"genre_scores_gemma":[0.9943809,0.004679314,0.00012900308,0.00055487244,0.00008113769,0.000092398084,0.000016631186,0.0000083287005,0.000057412188],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99786323,0.00025532985,0.0010501243,0.00018679879,0.00051752327,0.00012701782],"domain_scores_gemma":[0.9955327,0.0013164197,0.001256539,0.00019197432,0.0016033227,0.00009906152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006749105,0.00016373003,0.0023441764,0.00014242658,0.000025592242,0.000014562194,0.0001656627,0.000063314605,0.0015505734],"category_scores_gemma":[0.0009807694,0.00008095015,0.002680878,0.00031872926,0.00008093469,0.00006681537,0.0000550834,0.00016365055,2.0591926e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088073564,0.002501447,0.12973368,0.027500238,0.83340716,0.00034081715,0.0003322769,0.00032785904,0.0002465085,0.0006179243,0.0029403383,0.0011710105],"study_design_scores_gemma":[0.0011474933,0.00055563805,0.58711237,0.0019194733,0.40768299,0.0001768785,0.000079963924,0.000037867256,0.00094068726,0.00018340917,0.000046087407,0.00011714396],"about_ca_topic_score_codex":0.00007522659,"about_ca_topic_score_gemma":0.000096257754,"teacher_disagreement_score":0.4573787,"about_ca_system_score_codex":0.00045908685,"about_ca_system_score_gemma":0.0007921078,"threshold_uncertainty_score":0.9993622},"labels":[],"label_agreement":null},{"id":"W3212047343","doi":"10.3389/fendo.2021.772349","title":"Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer","year":2021,"lang":"en","type":"review","venue":"Frontiers in Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Tumor microenvironment; Ovarian cancer; Medicine; Hypoxia (environmental); Carcinogenesis; Tumor hypoxia; Oncology; Endocrine system; Cancer research; Immune system; Immunotherapy; Ovarian tumor; Cancer; Internal medicine; Immunology; Hormone; Radiation therapy","score_opus":0.041290279857022626,"score_gpt":0.3453353291204943,"score_spread":0.3040450492634717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212047343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026483997,0.9904657,0.000044536868,0.0005694531,0.0029029215,0.0027075277,0.00054932537,0.00003325061,0.00007889085],"genre_scores_gemma":[0.0005313764,0.99161434,0.0027633407,0.000312364,0.00042376007,0.0036437553,0.00045387947,0.00010890902,0.00014829573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964191,0.00024403627,0.0009848651,0.0010329819,0.00015300824,0.0011660557],"domain_scores_gemma":[0.9987014,0.00018880487,0.0003604143,0.000527664,0.00006756384,0.00015414742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013272715,0.0006542568,0.00361676,0.00064094196,0.000065202345,0.00003857506,0.00019984554,0.000216734,0.00011486515],"category_scores_gemma":[0.00007655175,0.000562231,0.0004215035,0.00039447375,0.00014893516,0.00008634905,0.00012916578,0.0006440373,0.0000020983941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026134995,0.0003897691,0.02481476,0.0031836212,0.00095831027,0.0011321579,0.000113092916,2.9432812e-7,0.000009175082,0.0001634386,0.00046764046,0.9685064],"study_design_scores_gemma":[0.0071797743,0.00027629352,0.011511556,0.00516281,0.0006028021,0.00037015844,0.0000605925,0.0000061009714,0.0000811264,0.000048610204,0.9742627,0.00043746707],"about_ca_topic_score_codex":0.0015118936,"about_ca_topic_score_gemma":0.00027640545,"teacher_disagreement_score":0.97379506,"about_ca_system_score_codex":0.00097254384,"about_ca_system_score_gemma":0.0009319092,"threshold_uncertainty_score":0.9996829},"labels":[],"label_agreement":null},{"id":"W3212108649","doi":"10.2196/25976","title":"Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database","year":2021,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Serous fluid; Ovarian cancer; Internal medicine; Epidemiology; Oncology; Proportional hazards model; Hazard ratio; Clear cell; Surveillance, Epidemiology, and End Results; Cancer; Survival analysis; Stage (stratigraphy); Population; Disease; Gynecology; Cancer registry; Carcinoma; Confidence interval; Biology","score_opus":0.07347163876520735,"score_gpt":0.3760754921832763,"score_spread":0.30260385341806895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212108649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968896,0.0061458494,0.00006544651,0.022660939,0.00039288064,0.0013548699,0.00037051793,0.00004839788,0.000065118074],"genre_scores_gemma":[0.9952776,0.0017431027,0.00030628045,0.0015923248,0.00018989062,0.00024308423,0.0005855156,0.00002433136,0.000037866765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953067,0.0018024296,0.0009107579,0.00093809696,0.00027454246,0.0007674805],"domain_scores_gemma":[0.99668425,0.0015776306,0.00036992694,0.0006207492,0.0001596439,0.0005878163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033323949,0.00030676933,0.0010452708,0.00012880415,0.000330571,0.00005114795,0.00010319866,0.00013038379,0.000040846506],"category_scores_gemma":[0.001401086,0.0002181003,0.00006642597,0.0005173819,0.00017084046,0.000121152916,0.00008864988,0.00036806177,7.3593793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047538345,0.00053903944,0.9770087,0.00014112609,0.000058118916,0.00013748214,0.00020868599,0.000028504022,0.0000038533854,0.000097199074,0.000048219787,0.021253685],"study_design_scores_gemma":[0.006151265,0.00033621752,0.99143714,0.0000702283,0.0000052459754,0.000024364545,0.00020208313,0.00054011267,7.7281936e-7,0.00001092513,0.0010227449,0.00019889242],"about_ca_topic_score_codex":0.006160779,"about_ca_topic_score_gemma":0.04727555,"teacher_disagreement_score":0.041114774,"about_ca_system_score_codex":0.00040726838,"about_ca_system_score_gemma":0.0011261377,"threshold_uncertainty_score":0.97010916},"labels":[],"label_agreement":null},{"id":"W3212495299","doi":"10.14694/edbk_158927","title":"Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Ovarian cancer; Randomized controlled trial; Oncology; Clinical endpoint; Clinical trial; Stage (stratigraphy); Cancer; Surgery; Internal medicine","score_opus":0.06646668058171958,"score_gpt":0.4597392419738262,"score_spread":0.39327256139210665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212495299","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22028343,0.0009460986,0.0002656694,0.77584827,0.00073078775,0.0010451647,0.00021281796,0.000010833697,0.00065690954],"genre_scores_gemma":[0.84922814,0.067802034,0.017343758,0.0525022,0.003999307,0.0016439371,0.000034299377,0.000045209956,0.0074011055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987063,0.000059614737,0.00062846456,0.0002757312,0.0001619175,0.00016796599],"domain_scores_gemma":[0.9939545,0.004936937,0.0005248354,0.0002758189,0.00019538176,0.00011257529],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025117426,0.0001349884,0.00070162246,0.000014261947,0.00005681872,0.0000017668483,0.00009186822,0.00009104725,0.0010803925],"category_scores_gemma":[0.00006892784,0.000066663546,0.0006840784,0.00007267096,0.0012197401,0.00002209286,0.00000629293,0.000060251816,0.000009539622],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001600593,0.0054080468,0.03581801,0.00001103911,0.0015203216,2.4549226e-7,0.0004584306,0.000002257819,0.0002882536,0.002317376,0.034124058,0.91845137],"study_design_scores_gemma":[0.0058890074,0.007649361,0.29669395,0.00003720835,0.00029547283,0.0000013642459,0.000117742864,0.000013209808,0.0016027977,0.0002570362,0.68737954,0.000063337415],"about_ca_topic_score_codex":0.0002398755,"about_ca_topic_score_gemma":0.000014456732,"teacher_disagreement_score":0.918388,"about_ca_system_score_codex":0.00034742418,"about_ca_system_score_gemma":0.0019769082,"threshold_uncertainty_score":0.99983275},"labels":[],"label_agreement":null},{"id":"W3212610509","doi":"10.1007/s00428-021-03232-0","title":"MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma","year":2021,"lang":"en","type":"article","venue":"Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Royal Alexandra Hospital; University of Alberta; Vancouver General Hospital; University of British Columbia; BC Cancer Agency; Foothills Medical Centre; University of Calgary","funders":"Medical Research and Materiel Command; National Institutes of Health; Translational Cancer Research Network; BC Cancer Foundation; University of New South Wales; Michael Smith Health Research BC; Alberta Precision Laboratories; National Health and Medical Research Council; American Cancer Society; Cancer Research UK; University of Calgary; Sydney West Translational Cancer Research Centre; NSW Ministry of Health; Swedish Cancer Foundation; VGH and UBC Hospital Foundation; National Cancer Institute; KWF Kankerbestrijding; National Center for Research Resources; Cancer Institute NSW","keywords":"Immunohistochemistry; Ovarian carcinoma; Chemotherapy; Serous fluid; Cancer research; Serous carcinoma; Internal medicine; Survival analysis; Messenger RNA; Biology; Ovarian cancer; Oncology; Medicine; Cancer; Gene","score_opus":0.029615238717049113,"score_gpt":0.31263165931809367,"score_spread":0.28301642060104454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212610509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859699,0.00061278185,0.0035184368,0.0049200347,0.00038725196,0.0024924309,0.0007731438,0.0002060072,0.0011199925],"genre_scores_gemma":[0.97888637,0.00015424045,0.012471109,0.0033046328,0.00041596862,0.0005585792,0.0036453945,0.00013528515,0.0004284221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952907,0.0003830712,0.0008014729,0.0015828012,0.00083996204,0.0011019817],"domain_scores_gemma":[0.9959649,0.0012466144,0.0004955645,0.0011432993,0.0007033442,0.00044630055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062524556,0.00083389174,0.0014589846,0.00020303557,0.00037414074,0.00007892945,0.00030408366,0.00040199654,0.00013642774],"category_scores_gemma":[0.0008291006,0.00054052897,0.00028773013,0.00066652056,0.00057648343,0.00019421104,0.0001722359,0.0007605319,0.000021237618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060846237,0.011465212,0.95791376,0.00038685434,0.004976472,0.0010328237,0.0015490709,0.00015207565,0.0036136734,0.0034748702,0.0037504593,0.005600135],"study_design_scores_gemma":[0.02563553,0.0059776995,0.95708764,0.00057166256,0.0022030408,0.00002777438,0.0003523938,0.0005589576,0.004645428,0.0007829896,0.0013801794,0.00077673764],"about_ca_topic_score_codex":0.00014893389,"about_ca_topic_score_gemma":0.00014559245,"teacher_disagreement_score":0.019550905,"about_ca_system_score_codex":0.00022942084,"about_ca_system_score_gemma":0.0010422462,"threshold_uncertainty_score":0.9997046},"labels":[],"label_agreement":null},{"id":"W3212977317","doi":"10.1155/2021/2292907","title":"A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Evidence-based Complementary and Alternative Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Jiangsu Province; Government of Jiangsu Province; China Postdoctoral Science Foundation","keywords":"Medicine; Apatinib; Internal medicine; Meta-analysis; Publication bias; Randomized controlled trial; Funnel plot; Chemotherapy; Oncology; Regimen; Clinical trial; Chemotherapy regimen; Odds ratio; Surgery","score_opus":0.16717911873015764,"score_gpt":0.42736866500413745,"score_spread":0.26018954627397983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212977317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009343083,0.9827382,0.00050364964,0.0028325964,0.00001640226,0.012230095,0.000728058,0.000013211842,0.0000034804561],"genre_scores_gemma":[0.02744557,0.96125865,0.0033659996,0.0014818901,0.000062477375,0.005412144,0.00086079875,0.000076207216,0.000036255522],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958128,0.0005214432,0.0014691029,0.0010216015,0.00086150423,0.00031359977],"domain_scores_gemma":[0.99586344,0.0009757178,0.0016399696,0.0006787715,0.00057722133,0.00026488278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007302777,0.00085838727,0.012063906,0.00034244737,0.00010385306,0.000038284907,0.00013318461,0.00006361477,0.00032717653],"category_scores_gemma":[0.00008296551,0.00042922742,0.0005039561,0.0005945364,0.0004227056,0.00012778997,0.000051815816,0.00020999502,1.2639879e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011286474,0.00049402285,0.07268259,0.7353728,0.18481828,0.00004347329,0.00059662637,3.5791754e-7,5.6949016e-8,0.000044053988,0.00013999997,0.004679088],"study_design_scores_gemma":[0.006778791,0.0076543693,0.0010275686,0.30970028,0.67090756,0.000013106503,0.00010194268,0.000026287984,0.000006734034,0.0000033692725,0.003427817,0.00035215786],"about_ca_topic_score_codex":0.00016913512,"about_ca_topic_score_gemma":0.00008009133,"teacher_disagreement_score":0.4860893,"about_ca_system_score_codex":0.00014434358,"about_ca_system_score_gemma":0.00025777039,"threshold_uncertainty_score":0.99981594},"labels":[],"label_agreement":null},{"id":"W3213382815","doi":"10.1186/s13048-021-00911-z","title":"Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses","year":2021,"lang":"en","type":"review","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nipissing University","funders":"Iran University of Medical Sciences","keywords":"Medicine; Meta-analysis; Ovarian cancer; Systematic review; Gynecology; Cochrane Library; Internal medicine; Cervical cancer; MEDLINE; Oncology; Cancer; Obstetrics","score_opus":0.7193303132213433,"score_gpt":0.5529698211215147,"score_spread":0.16636049209982862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213382815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007378973,0.9939699,0.0000025077698,0.0021814278,0.000056122703,0.003450337,0.0001524421,0.0000067577917,0.00017310528],"genre_scores_gemma":[0.00004716624,0.998308,0.00016451615,0.00057217584,0.00009991277,0.00028705265,0.00014524242,0.00008295157,0.00029295342],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9891701,0.004567797,0.0028842115,0.00054763467,0.0024191905,0.00041108264],"domain_scores_gemma":[0.9904896,0.0016461568,0.0035516848,0.001020414,0.0026869392,0.00060522667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077170236,0.00061656046,0.012565687,0.0007564028,0.000117373376,0.00009067874,0.0003908802,0.00028285786,0.0007567059],"category_scores_gemma":[0.0037324042,0.00030996793,0.0015619069,0.002039687,0.00017521724,0.00015568528,0.000071543494,0.0014347135,0.0000031559784],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010650754,0.0002817293,0.000025116653,0.9541745,0.0396509,0.0002937422,0.00003799799,2.3273205e-7,4.0899351e-7,0.0001321541,0.0023047316,0.0030878033],"study_design_scores_gemma":[0.00044012722,0.0010297361,0.00004432269,0.72247404,0.2652762,0.00019768463,0.000021545968,3.245945e-7,0.000007616926,0.000009462446,0.0103271855,0.00017174472],"about_ca_topic_score_codex":0.00013441463,"about_ca_topic_score_gemma":0.000025046917,"teacher_disagreement_score":0.23170047,"about_ca_system_score_codex":0.00085476716,"about_ca_system_score_gemma":0.0037687998,"threshold_uncertainty_score":0.99993527},"labels":[],"label_agreement":null},{"id":"W3213804188","doi":"10.1016/j.jpag.2021.10.013","title":"Postoperative Ovarian Morphology on Ultrasound after Ovarian Torsion—Effect of Immediate Surgery: A Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Ovary; Ultrasound; Ovarian torsion; Retrospective cohort study; Surgery; Urology; Internal medicine; Radiology","score_opus":0.008258939971112524,"score_gpt":0.26030305722880925,"score_spread":0.2520441172576967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213804188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492526,0.0014915727,0.000017751467,0.0015465475,0.001195328,0.0006739677,0.000028075248,0.000006790106,0.00011468097],"genre_scores_gemma":[0.99560213,0.0026252223,0.00009492404,0.0007270907,0.00081416254,0.00003153905,0.000009752083,0.000023624205,0.00007156819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756664,0.0005722975,0.0007659269,0.0003858296,0.00037294626,0.00033633292],"domain_scores_gemma":[0.9972599,0.0011805312,0.000561192,0.0002447944,0.00050033885,0.0002532506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010214209,0.00027298895,0.0013523216,0.00032252842,0.00008273788,0.000016638141,0.00006174638,0.0001796237,0.000549112],"category_scores_gemma":[0.0011000212,0.00019493766,0.00028271246,0.00034304138,0.000079411526,0.000071321076,0.0000529364,0.00046553754,0.000008483011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018740392,0.0028235798,0.98565656,0.000072838,0.0006575468,0.0037483398,0.00030771835,0.0000023028635,0.00015293938,0.00002883145,0.0041392073,0.00053610717],"study_design_scores_gemma":[0.005609486,0.0077354102,0.98282063,0.00005795082,0.00177729,0.0007096475,0.00023021469,0.0000011256075,0.0007431539,0.000020346693,0.00015484882,0.00013992487],"about_ca_topic_score_codex":0.000021806001,"about_ca_topic_score_gemma":0.00002156508,"teacher_disagreement_score":0.00491183,"about_ca_system_score_codex":0.0003461588,"about_ca_system_score_gemma":0.0004879119,"threshold_uncertainty_score":0.79493266},"labels":[],"label_agreement":null},{"id":"W3214185785","doi":"10.1002/jso.26751","title":"Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Hazard ratio; Internal medicine; Retrospective cohort study; Stage (stratigraphy); Surgery; Ovarian cancer; Cohort; Demographics; Overall survival; Cytoreductive surgery; Cancer; Oncology; Confidence interval","score_opus":0.01688153970874772,"score_gpt":0.31377254591528403,"score_spread":0.2968910062065363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214185785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942164,0.0006186957,0.0000022296808,0.004008401,0.00021913543,0.00017061475,0.000021361033,0.0000032236546,0.0007399616],"genre_scores_gemma":[0.99462926,0.00455681,0.00039427966,0.00014268041,0.00006548345,0.000015966589,0.0000075995704,0.000010885427,0.00017703256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909014,0.000064214924,0.0003247396,0.00016072867,0.00019287122,0.00016728452],"domain_scores_gemma":[0.99919814,0.00019503821,0.00019337086,0.00008367288,0.00014365118,0.000186143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053455587,0.00012778146,0.00065652735,0.00008711672,0.000017471522,0.0000069963644,0.000024618555,0.00008855547,0.00016677866],"category_scores_gemma":[0.000015233087,0.00007437334,0.00009196782,0.00012180736,0.000049873255,0.00006859501,0.000015609852,0.00015442476,8.2337357e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015169627,0.0018998352,0.9460268,0.00000819371,0.00044429416,0.0041983766,0.00037616768,0.00003526371,0.0000052836763,0.0000435756,0.000032731492,0.045412526],"study_design_scores_gemma":[0.022714805,0.007913271,0.9347132,0.000103670725,0.00024723916,0.00017029177,0.00015863252,0.0000030680208,0.00014808055,0.000014804605,0.033749785,0.00006317829],"about_ca_topic_score_codex":0.00006395938,"about_ca_topic_score_gemma":0.00009580456,"teacher_disagreement_score":0.04534935,"about_ca_system_score_codex":0.00082454085,"about_ca_system_score_gemma":0.00041477644,"threshold_uncertainty_score":0.3032857},"labels":[],"label_agreement":null},{"id":"W3214194275","doi":"10.4103/gmit.gmit_24_20","title":"Ovarian Torsion Occurring Nine Days after Ipsilateral Dermoid Cystectomy","year":2021,"lang":"en","type":"article","venue":"Gynecology and Minimally Invasive Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cystectomy; Ovarian torsion; Dermoid cyst; Ovary; Laparoscopy; Oophorectomy; Ultrasound","score_opus":0.015166609293943903,"score_gpt":0.25855325164357185,"score_spread":0.24338664234962795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214194275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783505,0.006306061,0.000010847688,0.0029676373,0.00036441427,0.00038412242,0.000018810664,0.00004444549,0.0020686097],"genre_scores_gemma":[0.9870912,0.002841431,0.0013018494,0.00780523,0.00018668197,0.00020431736,0.000045442586,0.000025471873,0.0004983975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869967,0.00009349988,0.0002521348,0.00046794448,0.00010861247,0.00037815707],"domain_scores_gemma":[0.99907094,0.0002610561,0.00007077944,0.00027957358,0.00014968231,0.0001679773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011579776,0.00023260035,0.00042055247,0.000078006466,0.00014612173,0.000026369631,0.000051458683,0.00019131109,0.0026313104],"category_scores_gemma":[0.000083834435,0.00019226328,0.00011069328,0.00011652856,0.000095250354,0.00008080418,0.00006610029,0.00017133579,0.00004892642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002694646,0.0013496759,0.892396,0.0001544687,0.0013099915,0.0075356727,0.0029181102,0.0000015667077,0.053597994,0.00067390065,0.002189397,0.035178613],"study_design_scores_gemma":[0.010104679,0.0018223639,0.887041,0.00014598241,0.00018295652,0.0006905232,0.00024916683,0.0000055966298,0.070267834,0.00017760867,0.029018646,0.00029365387],"about_ca_topic_score_codex":0.0000282294,"about_ca_topic_score_gemma":0.00026417925,"teacher_disagreement_score":0.03488496,"about_ca_system_score_codex":0.00009854948,"about_ca_system_score_gemma":0.00031397276,"threshold_uncertainty_score":0.9982804},"labels":[],"label_agreement":null},{"id":"W3216314699","doi":"10.1136/ijgc-2021-003153","title":"Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case–control study","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Serous fluid; Ovarian cancer; Gynecology; Serous carcinoma; Tamoxifen; Malignancy; Prophylactic Surgery; Fallopian tube; Lynch syndrome; Germline mutation; Internal medicine; Oncology; Cancer; Gastroenterology; Mutation; Breast cancer; DNA mismatch repair; Colorectal cancer","score_opus":0.023951621384007683,"score_gpt":0.32952558191545545,"score_spread":0.30557396053144775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216314699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917119,0.0016277325,0.00011417418,0.0043272353,0.0013373622,0.00031489957,0.000027560247,0.00001373242,0.00052536547],"genre_scores_gemma":[0.997651,0.00021385278,0.00036999708,0.001125646,0.00043411445,0.000077508805,0.0000030889973,0.000012153203,0.000112654416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980194,0.0002525443,0.000671634,0.00026855417,0.0005639615,0.00022392518],"domain_scores_gemma":[0.99806595,0.0006069289,0.0003295946,0.00010366398,0.0007490823,0.000144784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045471604,0.00017002622,0.00048261433,0.00018306538,0.00005358843,0.00006295052,0.00012000269,0.00010319639,0.0015972941],"category_scores_gemma":[0.0010623187,0.00012414492,0.00019499157,0.0001821298,0.00006837821,0.000160077,0.000043091957,0.0003872009,0.000004415424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013362159,0.002514289,0.6567305,0.00003426621,0.00081411016,0.30401328,0.0012849773,0.0011816337,0.00025829682,0.00026217554,0.00012629484,0.031443983],"study_design_scores_gemma":[0.011376578,0.0026946599,0.9625092,0.00013724537,0.0003611927,0.018856851,0.0026779345,0.00013823046,0.00029407558,0.00037627466,0.00041319226,0.00016457908],"about_ca_topic_score_codex":0.00015287545,"about_ca_topic_score_gemma":0.0010777657,"teacher_disagreement_score":0.3057787,"about_ca_system_score_codex":0.0019813946,"about_ca_system_score_gemma":0.00093703106,"threshold_uncertainty_score":0.9993154},"labels":[],"label_agreement":null},{"id":"W3216784922","doi":"10.1136/jmedgenet-2021-107904","title":"Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"FP7 Health; Medical Research Council; Canadian Institutes of Health Research; Rosetrees Trust; European Commission; University College London; Department of Health and Social Care; Cancer Research UK; Ministère de l'Économie, de la Science et de l'Innovation - Québec; Government of Canada; Fondation du cancer du sein du Québec; Barts Charity; National Institute for Health and Care Research; Genome Canada","keywords":"Epidemiology; Ovarian cancer; Epithelial ovarian cancer; Medicine; Risk assessment; Oncology; Gynecology; Internal medicine; Cancer; Biology; Computer science","score_opus":0.04611423002428986,"score_gpt":0.3215792221976981,"score_spread":0.2754649921734082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216784922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97075105,0.012823355,0.011956324,0.0035311924,0.0005883359,0.00014911889,0.000153413,0.0000118042035,0.000035402412],"genre_scores_gemma":[0.907617,0.06776525,0.022885863,0.0005980212,0.0010804067,0.000006807672,0.000009946251,0.000021753316,0.000014995946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971993,0.0003376371,0.00094218896,0.00028696583,0.0009792653,0.0002546246],"domain_scores_gemma":[0.9974813,0.00048722583,0.0006985025,0.00019963937,0.00041638527,0.0007169689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060143176,0.00022221143,0.0007090699,0.00007477821,0.0001257756,0.000025738305,0.00010712214,0.0003189013,0.00023125707],"category_scores_gemma":[0.0011545231,0.00014885918,0.0002033515,0.00014513615,0.00017715487,0.000035093573,0.000096102005,0.0008537901,0.000001851337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117224794,0.00036600736,0.9230905,0.000059961705,0.00064026203,0.0005907386,0.00027912811,0.011884318,0.00036835103,0.000045349432,0.0008195843,0.06173858],"study_design_scores_gemma":[0.004065567,0.00088006724,0.8798076,0.00033812283,0.0012271452,0.00062775315,0.00019112883,0.10873828,0.0010128841,0.0015822779,0.0013847395,0.00014447048],"about_ca_topic_score_codex":0.00014150649,"about_ca_topic_score_gemma":0.000030886098,"teacher_disagreement_score":0.096853964,"about_ca_system_score_codex":0.0001373904,"about_ca_system_score_gemma":0.00084049016,"threshold_uncertainty_score":0.60703015},"labels":[],"label_agreement":null},{"id":"W3217608827","doi":"10.1007/s00330-021-08390-y","title":"Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group","year":2021,"lang":"en","type":"article","venue":"European Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Medicine; Ovarian cancer; Radiology; Magnetic resonance imaging; Lexicon; Neuroradiology; Ovarian cyst; Interventional radiology; Cancer; Cyst; Internal medicine; Artificial intelligence; Neurology","score_opus":0.03340057859314472,"score_gpt":0.2783944626541941,"score_spread":0.24499388406104938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217608827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65233314,0.3101967,0.0009615287,0.03353863,0.0006380909,0.0014355052,0.00010956125,0.00010729938,0.0006795745],"genre_scores_gemma":[0.9881969,0.0051554306,0.0023813655,0.0033235452,0.0004376895,0.00014557052,0.000052836214,0.000076984885,0.00022965163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974104,0.00048569439,0.00067261804,0.00082266435,0.00012742936,0.00048119077],"domain_scores_gemma":[0.9984395,0.00042458347,0.00042575787,0.00042774333,0.00009080634,0.00019159142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092832296,0.00032577672,0.00056965894,0.00006868413,0.0004651443,0.00014639986,0.00011859766,0.000019711591,0.000040690415],"category_scores_gemma":[0.0001740845,0.0002139835,0.000096411146,0.00025253676,0.000487793,0.00006843986,0.00019172326,0.00023142196,5.957675e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053940085,0.00007366826,0.6518518,0.00013493835,0.00022371249,0.0015660567,0.0009537518,0.0000065186005,0.0005082937,0.00079445273,0.0014135336,0.3419339],"study_design_scores_gemma":[0.008435487,0.00006814369,0.9162503,0.000462322,0.00042895594,0.0011435185,0.0001634492,0.0026725703,0.00007840943,0.00012461864,0.06988922,0.00028302707],"about_ca_topic_score_codex":0.00043164977,"about_ca_topic_score_gemma":0.00012005753,"teacher_disagreement_score":0.34165087,"about_ca_system_score_codex":0.00007059789,"about_ca_system_score_gemma":0.00013602195,"threshold_uncertainty_score":0.87259936},"labels":[],"label_agreement":null},{"id":"W34993257","doi":"10.36469/jheor.2021.29145","title":"近代自然科学与传统学术的现代转型―以章太炎、康有为、梁启超为例","year":2009,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.11727117413093903,"score_gpt":0.4804030909012495,"score_spread":0.3631319167703105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W34993257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8126337,0.008183827,0.000009559057,0.17627119,0.00024513676,0.0003134844,0.000006586895,0.000004368565,0.0023321619],"genre_scores_gemma":[0.96121836,0.032920368,0.0010453358,0.004119691,0.00024210881,0.0000028079512,0.00000173897,0.000011410132,0.0004381847],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984822,0.00008809986,0.0006702561,0.00015481963,0.00020476145,0.00039984914],"domain_scores_gemma":[0.9987596,0.00019673261,0.00023404998,0.00018962528,0.00018554734,0.00043441987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002107692,0.000103242935,0.00060526247,0.00032104494,0.00015991452,0.00005603028,0.00008562494,0.000056757348,0.0000714196],"category_scores_gemma":[0.000078628196,0.00007370973,0.00013092847,0.00009236028,0.000048541715,0.00009810607,0.000024888277,0.0004007434,0.000014346112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039987642,0.00087423465,0.35662583,0.00015589011,0.00032691055,0.00018699071,0.0008659398,0.000023746321,0.00001059031,0.008015893,0.01783697,0.61467713],"study_design_scores_gemma":[0.0034293244,0.003085464,0.87782097,0.00011287362,0.000021613378,0.00028384526,0.0002703559,0.00009203163,0.000038052352,0.002051936,0.11271396,0.00007959269],"about_ca_topic_score_codex":0.00008290867,"about_ca_topic_score_gemma":0.000021856627,"teacher_disagreement_score":0.61459756,"about_ca_system_score_codex":0.00047426132,"about_ca_system_score_gemma":0.000900219,"threshold_uncertainty_score":0.30057955},"labels":[],"label_agreement":null},{"id":"W4200234932","doi":"10.3390/curroncol28060440","title":"Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Epithelial ovarian cancer; Internal medicine; Oncology; Retrospective cohort study; Chemotherapy; Bevacizumab; Progression-free survival; Cancer; Surgery","score_opus":0.07699809203876261,"score_gpt":0.4026530283149445,"score_spread":0.32565493627618186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200234932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389106,0.0005637345,0.000005875886,0.0023440178,0.0005444127,0.0018505919,0.0002918009,0.000013323698,0.0004951983],"genre_scores_gemma":[0.99511087,0.0032616726,0.00037706667,0.0001340317,0.000054629243,0.00062748435,0.00020527965,0.000022353499,0.00020660489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983767,0.00014877194,0.00036213663,0.00059758796,0.00026056566,0.0002542207],"domain_scores_gemma":[0.99846613,0.0003173908,0.00018870686,0.0008515021,0.000081130376,0.00009513947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001151789,0.00024473504,0.00068347546,0.00012758926,0.00005301942,0.000009664177,0.00013415553,0.000028447947,0.000093447285],"category_scores_gemma":[0.000028120052,0.00013905203,0.00004334538,0.0003319797,0.00009580588,0.000049709586,0.00015787168,0.00011967984,0.000003747361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058923016,0.0072514755,0.60340965,0.00003077634,0.00042357866,0.00019800664,0.00032930405,0.00002442395,4.998044e-7,0.00024274571,0.00013378351,0.3873665],"study_design_scores_gemma":[0.025587361,0.0031690705,0.9565637,0.00015673252,0.0007059182,9.549826e-7,0.00038353918,0.000028795053,0.000026005313,0.000037553003,0.013223377,0.00011698954],"about_ca_topic_score_codex":0.000983562,"about_ca_topic_score_gemma":0.030037886,"teacher_disagreement_score":0.38724953,"about_ca_system_score_codex":0.00066718506,"about_ca_system_score_gemma":0.00021667677,"threshold_uncertainty_score":0.9876614},"labels":[],"label_agreement":null},{"id":"W4200326001","doi":"10.36469/jheor.2021.29145","title":"Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data","year":2021,"lang":"en","type":"article","venue":"Journal of health economics and outcomes research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Sunnybrook Hospital; AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Stage (stratigraphy); Cancer; Disease; Internal medicine; Cohort study; Ovarian cancer","score_opus":0.22097682867969046,"score_gpt":0.4915679570257415,"score_spread":0.27059112834605104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200326001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851506,0.0009366689,0.0000027200626,0.011393281,0.00023130025,0.0015228941,0.0006962557,8.657585e-7,0.00006543568],"genre_scores_gemma":[0.98092896,0.01841492,0.00023558235,0.000110665984,0.00015155507,0.00005397777,0.000020234404,0.000016222182,0.000067882764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982012,0.00022005865,0.0006604512,0.00036229246,0.00021607627,0.0003399586],"domain_scores_gemma":[0.9985612,0.00036222316,0.00027435608,0.00027096327,0.0002625802,0.00026869102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017502564,0.00013336485,0.00089067774,0.00016797645,0.00015247635,0.000059055757,0.000075379605,0.00002692113,0.000022041013],"category_scores_gemma":[0.00007951992,0.00010318466,0.000035207013,0.000107415784,0.000027958558,0.00010384928,0.00008801805,0.0002096836,4.9406673e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00026832908,0.00042647767,0.98484707,0.000060478593,0.00048741157,0.00018498268,0.0002797301,0.0000044483213,4.7642123e-7,0.000121373276,0.000098838274,0.013220367],"study_design_scores_gemma":[0.005104769,0.0012555739,0.98945785,0.00012566599,0.00007353657,0.000025935527,0.0029495617,0.00041230491,0.000010707659,0.000021592316,0.0004917294,0.00007075215],"about_ca_topic_score_codex":0.8880298,"about_ca_topic_score_gemma":0.9931806,"teacher_disagreement_score":0.10515078,"about_ca_system_score_codex":0.009969844,"about_ca_system_score_gemma":0.019275539,"threshold_uncertainty_score":0.9938307},"labels":[],"label_agreement":null},{"id":"W4200555614","doi":"10.1136/ijgc-2021-003112","title":"The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Hazard ratio; Lymphadenectomy; Internal medicine; Endometrial cancer; Chemotherapy; Ovarian cancer; Proportional hazards model; Carcinoma; Cancer; Survival analysis; Surgery; Gastroenterology; Oncology; Confidence interval","score_opus":0.024353530339287895,"score_gpt":0.3303531971240088,"score_spread":0.3059996667847209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200555614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845551,0.0047427486,0.0000073523047,0.009766443,0.0004648786,0.0001300772,0.00002878185,0.0000022553972,0.000302318],"genre_scores_gemma":[0.9945198,0.004885263,0.00007073166,0.00022330137,0.00020309498,0.000011322275,0.0000027530048,0.0000069473413,0.00007673485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877244,0.0001512523,0.0003675635,0.00015223099,0.0004208667,0.00013566474],"domain_scores_gemma":[0.9973245,0.0021384384,0.00020260045,0.00007249656,0.0001690689,0.00009286424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004933062,0.00011279801,0.00041384043,0.00009997826,0.000033967845,0.00003251521,0.000086902895,0.00004922664,0.00024744717],"category_scores_gemma":[0.00028039695,0.0000622226,0.00009721652,0.00011004112,0.00010210152,0.00003768061,0.000043187596,0.00023032619,3.1453695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017331346,0.00016250022,0.92750067,0.000018515395,0.00032118236,0.002015158,0.00006807846,0.00003143626,0.00047906517,0.00080579583,0.000053167398,0.06681133],"study_design_scores_gemma":[0.01087118,0.0017562129,0.97183233,0.00012218673,0.000047084653,0.00017597593,0.000057118745,0.00007498851,0.0040322156,0.00008050326,0.010889777,0.00006043506],"about_ca_topic_score_codex":0.00007738837,"about_ca_topic_score_gemma":0.00007139303,"teacher_disagreement_score":0.06675089,"about_ca_system_score_codex":0.00023309774,"about_ca_system_score_gemma":0.00010451695,"threshold_uncertainty_score":0.2709373},"labels":[],"label_agreement":null},{"id":"W4200584211","doi":"10.1016/j.jacr.2021.09.033","title":"Authors’ Response","year":2021,"lang":"en","type":"letter","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Magnetic resonance imaging; Radiology; Adnexal mass; Malignancy; Indeterminate; Ovarian cancer; Adnexal Diseases; Ovarian tumor; Ultrasonography; Cancer; Pathology; Laparoscopy; Internal medicine","score_opus":0.019319320466766866,"score_gpt":0.2858368454736564,"score_spread":0.2665175250068895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200584211","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.096175976,0.0023484842,0.000009541623,0.89929056,0.0015930325,0.00019166857,0.00017294023,0.0000037892967,0.0002140003],"genre_scores_gemma":[0.10899489,0.0020632003,0.00407794,0.8637284,0.008167724,0.00001762459,0.000014039542,0.000110696994,0.0128255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972759,0.0010826746,0.0007626813,0.00020628948,0.0004035249,0.00026892353],"domain_scores_gemma":[0.99572194,0.0009262,0.0022788264,0.00062794704,0.0003546254,0.000090464746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005987576,0.00023858722,0.0017561472,0.0002630269,0.00004513176,0.000004174667,0.0003642822,0.00024939337,0.00016282314],"category_scores_gemma":[0.0005465759,0.00014107938,0.0008741714,0.00044919518,0.0005688153,0.000019023104,0.00007681723,0.0015010472,0.000003228564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019349847,0.00010646802,0.002901304,0.000048796574,0.0013718174,0.008720896,0.00003968098,0.0000047818044,0.00039418432,0.000014642959,0.98401,0.00045249108],"study_design_scores_gemma":[0.0014911509,0.0030421924,0.027671887,0.00043038285,0.0011053582,0.026437612,0.000100527766,0.0000019296651,0.00048445497,0.00007350926,0.93903935,0.00012165076],"about_ca_topic_score_codex":0.00002238151,"about_ca_topic_score_gemma":0.0000020122457,"teacher_disagreement_score":0.044970606,"about_ca_system_score_codex":0.00040622713,"about_ca_system_score_gemma":0.0016292023,"threshold_uncertainty_score":0.65213865},"labels":[],"label_agreement":null},{"id":"W4205397379","doi":"10.1016/j.neo.2021.12.008","title":"RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Neoplasia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bijzonder Onderzoeksfonds UGent; Universiteit Gent; Tel Aviv University; Israel Cancer Research Fund; Israel Science Foundation; Fonds De La Recherche Scientifique - FNRS; Kom op tegen Kanker; Israel Cancer Association; Fonds Wetenschappelijk Onderzoek","keywords":"Liquid biopsy; Ovarian cancer; RNA; RNA extraction; Biopsy; Oncology; Biomarker; Medicine; Internal medicine; microRNA; Cancer research; Biology; Pathology; Computational biology; Cancer; Gene; Genetics","score_opus":0.020023221777977957,"score_gpt":0.2836421762548822,"score_spread":0.26361895447690425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205397379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849918,0.0021686743,0.00004802029,0.0071824486,0.00077789905,0.001290396,0.0018272973,0.000052379623,0.0016611197],"genre_scores_gemma":[0.9918076,0.00019283665,0.002558336,0.00046227573,0.00023814796,0.004356853,0.00018496446,0.000040011608,0.00015898692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877423,0.000033711276,0.00028206618,0.00037119116,0.00028619377,0.00025261406],"domain_scores_gemma":[0.99918747,0.00016808965,0.00014394596,0.00031371412,0.000064521555,0.00012228827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010536689,0.00016545966,0.00036364613,0.00010293932,0.00013055366,0.0000091982665,0.00010635783,0.000055378234,0.0025304838],"category_scores_gemma":[0.00003120565,0.00015073936,0.00019372,0.00024875894,0.000044669287,0.0000388521,0.000070168186,0.00010018406,0.000005647898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011111216,0.0036976724,0.7909887,0.00036430117,0.0041145612,0.00019275764,0.0018875988,0.00008170444,0.011487412,0.001569992,0.09696255,0.07754156],"study_design_scores_gemma":[0.025862878,0.008656152,0.40516654,0.00046300888,0.002800603,0.00008623026,0.001061259,0.00050751446,0.19970573,0.00048290036,0.35442072,0.0007864727],"about_ca_topic_score_codex":0.002165462,"about_ca_topic_score_gemma":0.000085671876,"teacher_disagreement_score":0.38582215,"about_ca_system_score_codex":0.0002843861,"about_ca_system_score_gemma":0.00029680057,"threshold_uncertainty_score":0.9983813},"labels":[],"label_agreement":null},{"id":"W4205449826","doi":"10.3390/cancers14020416","title":"The Evolution of Ovarian Carcinoma Subclassification","year":2022,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Serous carcinoma; Serous fluid; Immunohistochemistry; Clear cell carcinoma; Ovarian carcinoma; Pathology; Clear cell; Biology; Carcinoma; Hematopathology; Ovarian cancer; Molecular pathology; Cancer research; Cancer; Medicine; Gene; Cytogenetics; Genetics","score_opus":0.07048276852676709,"score_gpt":0.33239136700363786,"score_spread":0.26190859847687076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205449826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000043702357,0.9916238,0.000011523759,0.00013662204,0.00069039344,0.0009021894,0.000068156034,0.000016603462,0.006546319],"genre_scores_gemma":[0.0012939221,0.99659526,0.000024568886,0.000016275264,0.00020468181,0.0009658587,0.00013081591,0.0000337649,0.0007348448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881893,0.00008796351,0.00038797295,0.00028060825,0.00025333863,0.00017117591],"domain_scores_gemma":[0.9987598,0.00017093605,0.000376677,0.0005844047,0.000040464165,0.000067711764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017954216,0.00018699134,0.0007182083,0.00008596816,0.00015570638,0.000010201382,0.00014183548,0.00009158408,0.00032231692],"category_scores_gemma":[0.00003567994,0.00011920286,0.00037925,0.00037400433,0.00008173247,0.00001803327,0.000032096283,0.00021302619,0.0000105159515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018995153,0.00001776916,0.00011165717,0.0030772905,0.00028067894,0.000008097945,0.00003272191,0.0000016366283,1.1082498e-7,0.0043533435,0.0031850804,0.98891264],"study_design_scores_gemma":[0.00032055995,0.00013534747,0.0004577275,0.0013087734,0.0016483598,0.000020216416,0.00009539975,0.000008966167,8.183684e-7,0.000023935572,0.9958876,0.00009229631],"about_ca_topic_score_codex":0.0009258928,"about_ca_topic_score_gemma":0.000042726133,"teacher_disagreement_score":0.99270254,"about_ca_system_score_codex":0.014588311,"about_ca_system_score_gemma":0.005245104,"threshold_uncertainty_score":0.9891945},"labels":[],"label_agreement":null},{"id":"W4205664053","doi":"10.1016/j.ygyno.2022.01.003","title":"Impact of care by gynecologic oncologists on primary ovarian cancer survival: A population-based study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Hazard ratio; Proportional hazards model; Ovarian cancer; Multivariate analysis; Internal medicine; Oncology; Population; Gynecology; Cancer; Confidence interval","score_opus":0.037824588554583864,"score_gpt":0.37800112823011855,"score_spread":0.3401765396755347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205664053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856742,0.0007554048,0.0000041050716,0.0021242732,0.001242918,0.0031729545,0.0005673466,0.00014410389,0.006314706],"genre_scores_gemma":[0.993512,0.000053182146,0.00022883178,0.0018613393,0.00010209665,0.0032793547,0.00067597214,0.000046356156,0.00024086535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961581,0.0010008994,0.0007481055,0.0008790958,0.0005722246,0.0006415592],"domain_scores_gemma":[0.99641234,0.0018735072,0.0006131113,0.0006693206,0.00020587716,0.00022587024],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006258389,0.00043797307,0.0014864184,0.00028880194,0.00037934267,0.000012045856,0.00032160868,0.0002739997,0.007999096],"category_scores_gemma":[0.00031934804,0.0003416153,0.00043734428,0.00060375326,0.00009502165,0.00003964955,0.00020811048,0.0005891102,0.000017838232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017116345,0.014402445,0.94654214,0.000059821847,0.000626216,0.00048276928,0.0004335444,0.0038783322,0.00009824856,0.00004820127,0.0049459273,0.026770744],"study_design_scores_gemma":[0.0105599,0.072315715,0.9089148,0.00001199048,0.00049455464,0.000009003101,0.0009007477,0.000044176402,0.000023573017,0.000041981715,0.0064107208,0.0002728353],"about_ca_topic_score_codex":0.0038639659,"about_ca_topic_score_gemma":0.0015984032,"teacher_disagreement_score":0.057913274,"about_ca_system_score_codex":0.012656754,"about_ca_system_score_gemma":0.0022052259,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W4205756350","doi":"10.1038/s41431-021-00987-7","title":"Polygenic risk modeling for prediction of epithelial ovarian cancer risk","year":2022,"lang":"en","type":"article","venue":"European Journal of Human Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; Royal Alexandra Hospital; Public Health Ontario; University of British Columbia; BC Cancer Agency; Alberta Health Services; Centre hospitalier universitaire de Québec; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Medical Research and Materiel Command; European Social Fund; National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; NIHR Cambridge Biomedical Research Centre; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; BC Cancer Foundation; Pomorski Uniwersytet Medyczny W Szczecinie; Mutuelle Générale de l'Education Nationale; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; Deutsche Krebshilfe; Norges Forskningsråd; Associazione Italiana per la Ricerca sul Cancro; National Health and Medical Research Council; Jewish General Hospital; Helse Vest; Ovarian Cancer Research Fund; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Cancerfonden; National Cancer Institute; Peter MacCallum Foundation; University College London; Cancer Institute NSW; European Commission; Ovarian Cancer Action; Roswell Park Cancer Institute; National Institute for Health and Care Research; University of Cambridge; Fred C. and Katherine B. Andersen Foundation; NordForsk; Vetenskapsrådet; Georgia Clinical and Translational Science Alliance; Korea Health Industry Development Institute; Deutsches Krebsforschungszentrum; Vanderbilt University Medical Center; Institut National de la Santé et de la Recherche Médicale; Cancer Council Tasmania; Cedars-Sinai Medical Center; Swedish Cancer Foundation; Ovarian Cancer Australia; Lon V. Smith Foundation; Radboud Universiteit; Ministère du Développement Économique, de l’Innovation et de l’Exportation; U.S. Department of Defense; Cancer Research UK; Memorial Sloan-Kettering Cancer Center; Wellcome Trust; Kreftforeningen; Cancer Research Society; Ligue Contre le Cancer; Breast Cancer Research Foundation; McGill University; Univerzita Karlova v Praze; Mayo Foundation for Medical Education and Research; Cancer Council Victoria; Kræftens Bekæmpelse; University of Pittsburgh; Rutgers Cancer Institute of New Jersey; Hellenic Health Foundation; Ministry of Health, Labour and Welfare; Minnesota Ovarian Cancer Alliance; Moffitt Cancer Center; Vanderbilt University; Cancer Australia; Oak Foundation","keywords":"Logistic regression; Odds ratio; Single-nucleotide polymorphism; Ovarian cancer; Lasso (programming language); Oncology; Internal medicine; Medicine; Biology; Bioinformatics; Genotype; Cancer; Genetics; Computer science; Gene","score_opus":0.036601782850329126,"score_gpt":0.28167102868505633,"score_spread":0.24506924583472722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205756350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98825717,0.004436027,0.0048276754,0.00019753264,0.0006305096,0.00027927515,0.0010536894,0.000009083311,0.0003090229],"genre_scores_gemma":[0.9937754,0.0020828708,0.0029164609,0.000057539008,0.0009931732,0.000009540541,0.000015630263,0.000051106006,0.000098253375],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99843454,0.00028199947,0.0006453913,0.00014733188,0.0003320092,0.00015871103],"domain_scores_gemma":[0.998736,0.000029051302,0.00070744473,0.0002102056,0.0002027293,0.000114572686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008631159,0.000120390796,0.00027919238,0.00013875158,0.00025954508,0.000011357427,0.00013852248,0.000013594613,0.00021384908],"category_scores_gemma":[0.00002982806,0.00010581515,0.00025706989,0.000086383676,0.000027391721,0.00002401346,0.000056364068,0.000283909,0.0000013689921],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035676262,0.003061022,0.37934178,0.00027759842,0.0054144585,0.00043345583,0.008518171,0.39130026,0.027084786,0.00028610142,0.011063867,0.16965088],"study_design_scores_gemma":[0.049704857,0.03761725,0.77245885,0.0006040305,0.0119064795,0.0005849955,0.0017917651,0.06793072,0.010516984,0.001483668,0.044689946,0.000710455],"about_ca_topic_score_codex":0.000028044728,"about_ca_topic_score_gemma":0.000005213771,"teacher_disagreement_score":0.39311707,"about_ca_system_score_codex":0.00014896692,"about_ca_system_score_gemma":0.00014130223,"threshold_uncertainty_score":0.43150166},"labels":[],"label_agreement":null},{"id":"W4205815974","doi":"10.1111/his.14609","title":"Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)","year":2022,"lang":"en","type":"review","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Female circumcision; Key (lock); Cervix; Sex organ; Feature (linguistics); Uterine cervix; Medicine; Pathology; Gynecology; Biology; Cancer; Internal medicine; Carcinoma; Linguistics","score_opus":0.07145911777271087,"score_gpt":0.355303766722292,"score_spread":0.28384464894958117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205815974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021806877,0.95629346,0.00003750446,0.039277345,0.0012476557,0.0023270827,0.00011364911,0.000024295776,0.00046096183],"genre_scores_gemma":[0.0022364305,0.99196917,0.000097536125,0.0017860285,0.0009867423,0.0010106263,0.0013168557,0.000048501326,0.0005480998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979635,0.00066476414,0.0004810627,0.00042836502,0.00024847768,0.00021381964],"domain_scores_gemma":[0.9986439,0.00017511909,0.00046386855,0.0006038802,0.00006304087,0.000050238203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007609376,0.00021557962,0.0009255926,0.00032126263,0.0001384557,0.000008790433,0.00021978718,0.00008254568,0.00041547386],"category_scores_gemma":[0.000175972,0.00013219794,0.00010395959,0.0012519689,0.000057536803,0.000017289838,0.00005918055,0.00035181176,0.000037864094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000370422,0.0007882707,0.001220337,0.0046133148,0.00003221621,0.000171174,0.006570382,0.0000026981827,0.000006778907,0.0034990658,0.087692566,0.89536613],"study_design_scores_gemma":[0.00024089987,0.00043121297,0.026328897,0.00058503717,0.00035633813,0.000256426,0.00023702298,7.9734366e-7,0.0000012400596,0.0000067927,0.9714619,0.000093472096],"about_ca_topic_score_codex":0.000080352525,"about_ca_topic_score_gemma":0.0012000415,"teacher_disagreement_score":0.8952727,"about_ca_system_score_codex":0.0010409317,"about_ca_system_score_gemma":0.00049091753,"threshold_uncertainty_score":0.53908753},"labels":[],"label_agreement":null},{"id":"W4206503271","doi":"10.3390/curroncol29010022","title":"Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Impact; University of Toronto; Queen's University; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre","funders":"","keywords":"Guideline; Systemic therapy; Stage (stratigraphy); Adjuvant therapy; Adjuvant; Primary care; Clinical Practice","score_opus":0.06996030302813078,"score_gpt":0.3854982289330022,"score_spread":0.3155379259048714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206503271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88385785,0.069133565,0.00053640216,0.030503431,0.005825427,0.007728556,0.0013249977,0.00018766824,0.00090213225],"genre_scores_gemma":[0.9659505,0.011768876,0.00566311,0.0063321865,0.0019755356,0.0061306823,0.0010727793,0.00013051863,0.00097584614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968009,0.000557952,0.0008393896,0.00080563035,0.0004152281,0.0005809103],"domain_scores_gemma":[0.99754256,0.0009962335,0.0003937105,0.0004819159,0.0002781717,0.00030743153],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011058082,0.00039287165,0.0010296158,0.00017119915,0.00068702654,0.000027370786,0.0001892936,0.00012347125,0.0004458685],"category_scores_gemma":[0.00029643372,0.00030358785,0.00020190299,0.00021330136,0.00011496443,0.00012369802,0.00029222577,0.0006104856,0.0000054404863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022904946,0.0134598,0.040049646,0.00091876317,0.00094766525,0.0027933856,0.007053221,0.0000933699,0.001983863,0.0011149491,0.08654606,0.8221343],"study_design_scores_gemma":[0.028091267,0.013411406,0.010669374,0.00009773665,0.0005054801,0.0012803602,0.0019880903,0.00068215583,0.0000773841,0.000018159859,0.94285876,0.0003198445],"about_ca_topic_score_codex":0.0002777981,"about_ca_topic_score_gemma":0.00007209214,"teacher_disagreement_score":0.8563127,"about_ca_system_score_codex":0.0013643608,"about_ca_system_score_gemma":0.0017547439,"threshold_uncertainty_score":0.99994165},"labels":[],"label_agreement":null},{"id":"W4206713207","doi":"10.7759/cureus.21365","title":"Primary Transitional Cell Carcinoma of the Endometrium: A Case Report and Review of Literature","year":2022,"lang":"en","type":"article","venue":"Cureus","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba","funders":"","keywords":"Cytokeratin; Pathology; Vimentin; Medicine; Endometrium; Carcinoma; Endometrial cancer; Clear cell carcinoma; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.01217519235331769,"score_gpt":0.24770568502841084,"score_spread":0.23553049267509316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206713207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49561256,0.494944,0.000002356882,0.0033770471,0.00016128697,0.0006066909,0.00035691715,0.0000044165495,0.0049347035],"genre_scores_gemma":[0.99414366,0.004662149,0.00015774588,0.0006747253,0.000033525528,0.000057139707,0.00005850192,0.0000058921773,0.00020666374],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99938536,0.000039217266,0.00020188106,0.00012128419,0.00019725706,0.00005501207],"domain_scores_gemma":[0.9994967,0.000045150486,0.0001108947,0.00024989026,0.000063884014,0.000033453074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015191491,0.000058752827,0.00021074429,0.000027394339,0.0000401537,0.0000016166293,0.000030603896,0.000015698735,0.00029848635],"category_scores_gemma":[0.00002153806,0.000038499038,0.00010111689,0.00025363566,0.000028816654,0.00001559866,0.000034247812,0.00009094828,1.11775734e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008081858,0.009595429,0.34533048,0.09488924,0.0011769389,0.3788199,0.0074367523,0.0000089169935,0.008664756,0.00266956,0.13276944,0.017830396],"study_design_scores_gemma":[0.011140218,0.0026528325,0.36506858,0.008607084,0.0032145467,0.48400536,0.00044397725,0.00000851089,0.018322693,0.00023073933,0.10591279,0.0003926575],"about_ca_topic_score_codex":0.000034993696,"about_ca_topic_score_gemma":0.0000013996716,"teacher_disagreement_score":0.49853107,"about_ca_system_score_codex":0.00007015168,"about_ca_system_score_gemma":0.00014165953,"threshold_uncertainty_score":0.32682163},"labels":[],"label_agreement":null},{"id":"W4206742016","doi":"10.1148/radiol.204371","title":"O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee","year":2022,"lang":"en","type":"review","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Risk stratification; Malignancy; Radiology; Medical diagnosis; Medical physics; Pathology; Internal medicine","score_opus":0.10152885729265039,"score_gpt":0.3922265685918654,"score_spread":0.290697711299215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206742016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023989634,0.9907705,0.0013409109,0.0011054232,0.0015508394,0.00272748,0.0011339156,0.00009598772,0.00125093],"genre_scores_gemma":[0.0005674168,0.98947304,0.0017445871,0.00018756423,0.0016208664,0.0029301967,0.0031849784,0.00008707387,0.00020424537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966784,0.0010304265,0.00094996043,0.0007535437,0.00020871894,0.0003789643],"domain_scores_gemma":[0.99521005,0.0025965674,0.0008096948,0.0012112862,0.00004986884,0.0001225091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078689266,0.00045493268,0.0020373317,0.00009758459,0.00058062124,0.00006074591,0.00039214361,0.00040598083,0.0002623609],"category_scores_gemma":[0.00022626745,0.000283354,0.0007317387,0.00021277861,0.00011334633,0.000045508845,0.00008112542,0.00067109417,0.000037001664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001777305,0.00016934611,0.0005163867,0.0030648492,0.0015537246,0.000047523794,0.000106656196,0.000005161497,5.543065e-7,0.0035222427,0.064559616,0.9264362],"study_design_scores_gemma":[0.0008348659,0.00024151699,0.0009955696,0.0034313304,0.007271991,0.00028225867,0.00024002211,0.000060028757,4.1611858e-7,0.000074532014,0.98633975,0.00022773637],"about_ca_topic_score_codex":0.0005280587,"about_ca_topic_score_gemma":0.000067664325,"teacher_disagreement_score":0.92620844,"about_ca_system_score_codex":0.0011148768,"about_ca_system_score_gemma":0.0009701656,"threshold_uncertainty_score":0.99996185},"labels":[],"label_agreement":null},{"id":"W4206832374","doi":"10.1007/978-3-030-80558-6_3","title":"Par-4 in Chemoresistant Ovarian and Endometrial Cancers","year":2021,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"PTEN; Context (archaeology); Ovarian cancer; Endometrial cancer; Cancer research; PI3K/AKT/mTOR pathway; Medicine; Cancer; Bioinformatics; Oncology; Apoptosis; Biology; Internal medicine; Genetics","score_opus":0.02403561062797519,"score_gpt":0.25999434161713486,"score_spread":0.23595873098915968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206832374","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052797934,0.008934511,0.00000482383,0.002353093,0.0003926994,0.0006265782,0.00006386747,0.000029482744,0.987067],"genre_scores_gemma":[0.09887196,0.015889015,0.00156658,0.0013430765,0.0010937367,0.00011452172,0.00024175091,0.000120052675,0.8807593],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986679,0.000007379787,0.00033688298,0.0005201233,0.00025827374,0.00020943157],"domain_scores_gemma":[0.99925673,0.0000987061,0.00008958258,0.0003304826,0.00005090189,0.0001735961],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009791127,0.00029734033,0.0007694512,0.00024490865,0.000025909269,0.000029281007,0.000037783448,0.00025434664,0.005177934],"category_scores_gemma":[0.000033826196,0.0002458136,0.00013872405,0.00006471784,0.00006487783,0.00002118526,0.00005024883,0.00025179228,0.0000201502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030035588,0.0005723521,0.019086754,0.0013305224,0.0045378874,0.017493222,0.00043265254,0.0000030521494,0.00019124342,0.71246284,0.0421409,0.19874501],"study_design_scores_gemma":[0.020791858,0.00068230956,0.01918602,0.0022582875,0.0011777664,0.00016861389,0.00005463767,0.000008900483,0.0010222325,0.002450518,0.95142454,0.00077433337],"about_ca_topic_score_codex":0.00073973724,"about_ca_topic_score_gemma":0.0013483262,"teacher_disagreement_score":0.90928364,"about_ca_system_score_codex":0.0007014013,"about_ca_system_score_gemma":0.0005914604,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W4207028675","doi":"10.1158/1055-9965.epi-21-1091","title":"Reproductive Factors Do Not Influence Survival with Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research and Materiel Command; National Center for Research Resources; National Cancer Institute; Cancer Council Western Australia; Cancer Research UK; National Institutes of Health; National Health and Medical Research Council; California Breast Cancer Research Program; U.S. Department of Defense","keywords":"Ovarian cancer; Ovarian carcinomas; Ovary; Risk factor; Survival analysis; Proportional hazards model","score_opus":0.0646818429343967,"score_gpt":0.3676601196477506,"score_spread":0.30297827671335387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207028675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627333,0.009257677,0.0002640143,0.023924585,0.0016713447,0.0014242278,0.00018112165,0.00012422404,0.00041946967],"genre_scores_gemma":[0.992477,0.0012110921,0.0009871592,0.0012415989,0.00030813852,0.0025000137,0.00017599364,0.000049463128,0.0010495664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965061,0.0008683207,0.0005904297,0.0011825945,0.0002941869,0.0005583921],"domain_scores_gemma":[0.9980583,0.0003760364,0.0005140182,0.0006914166,0.00015362912,0.00020657352],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015431207,0.00034143263,0.0007920114,0.0001719199,0.00037900673,0.000009585744,0.00017001099,0.00012203906,0.0019329608],"category_scores_gemma":[0.00023683732,0.00027209806,0.00023512819,0.00047361437,0.00025526556,0.00015017597,0.00012888346,0.00037563697,0.000008168903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019737694,0.00030529767,0.9745137,0.000057540292,0.0020138912,0.000034546963,0.0002832967,0.0008737927,0.00041720478,0.00079607643,0.0039397404,0.014791125],"study_design_scores_gemma":[0.0027261823,0.0008897218,0.97584915,0.00020005442,0.0007440745,0.00002943083,0.00037650508,0.00003686253,0.0008118908,0.0009514632,0.017078433,0.0003062357],"about_ca_topic_score_codex":0.0041171485,"about_ca_topic_score_gemma":0.0004346488,"teacher_disagreement_score":0.029743638,"about_ca_system_score_codex":0.0013516312,"about_ca_system_score_gemma":0.00059397286,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W4210303093","doi":"10.1016/j.jpedsurg.2021.12.043","title":"Differentiating congenital ovarian cysts from other abdominal cystic lesions in female infants: A study by the Canadian Consortium for Research in Pediatric Surgery (CanCORPS).","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Centre hospitalier de l'Université Laval; McMaster University; University of Calgary; University of Toronto; Montreal Children's Hospital; Western University; Hospital for Sick Children; Université de Montréal; McMaster Children's Hospital; London Health Sciences Centre; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; University of Ottawa; McGill University Health Centre; Children's Hospital of Eastern Ontario; Children's Hospital of Western Ontario; BC Children's Hospital","funders":"","keywords":"Medicine; Ovarian cyst; Cyst; Prenatal diagnosis; Ovary; Obstetrics; Gestation; Fetus; Pregnancy; Etiology; Gestational age; Cohort; Gynecology; Surgery; Pathology; Internal medicine","score_opus":0.09631060844295432,"score_gpt":0.32231284832534096,"score_spread":0.22600223988238666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210303093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046135,0.0009470634,0.0000025366217,0.0024184128,0.00037626637,0.0046686544,0.0006666265,0.000013256633,0.00044586058],"genre_scores_gemma":[0.97270685,0.00001769278,0.000018108143,0.00025066824,0.00025423372,0.026475098,0.00008488932,0.000038219645,0.00015421046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718374,0.0005346867,0.00046895494,0.0004675764,0.00050480396,0.00084023934],"domain_scores_gemma":[0.99708384,0.0021041147,0.00009671675,0.00036222202,0.00006507917,0.00028801055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021174736,0.00016669025,0.00039620898,0.0005814244,0.00042961238,0.000067155874,0.00016779832,0.00005485691,0.0001997499],"category_scores_gemma":[0.0004663241,0.00013444792,0.00008764874,0.0008197228,0.00005459029,0.000048805483,0.000093416726,0.00046542624,0.00000420732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034632653,0.0010094381,0.9795882,0.000018559378,0.00010790027,0.00023497712,0.0009585637,0.000007010041,0.0000017983392,0.000024728772,0.0025309857,0.015171483],"study_design_scores_gemma":[0.0038714707,0.00011378542,0.99258024,0.000012829348,0.00013526854,0.000007591207,0.0020721394,0.00007647881,0.000008482464,0.000094493415,0.00089604704,0.00013115251],"about_ca_topic_score_codex":0.3939624,"about_ca_topic_score_gemma":0.6757193,"teacher_disagreement_score":0.28175688,"about_ca_system_score_codex":0.0013917309,"about_ca_system_score_gemma":0.0008411692,"threshold_uncertainty_score":0.61007327},"labels":[],"label_agreement":null},{"id":"W4210316197","doi":"10.1136/ijgc-2021-003142","title":"Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"UCLH Biomedical Research Centre; National Health and Medical Research Council; University College London Hospitals NHS Foundation Trust; Cancer Australia; Cancer Research UK; Target Ovarian Cancer; National Institute for Health and Care Research; Australian Government","keywords":"Medicine; Quality of life (healthcare); Ovarian cancer; Internal medicine; Chemotherapy; Cancer; Physical therapy","score_opus":0.046994248915324804,"score_gpt":0.36479880366788614,"score_spread":0.3178045547525613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210316197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515904,0.0052065197,0.000056383742,0.040254,0.0014490775,0.0010708182,0.00027354984,0.000011277008,0.000087932334],"genre_scores_gemma":[0.99198055,0.0031203527,0.00018492214,0.0023563174,0.0008227378,0.0013470314,0.0000073820206,0.00002169465,0.00015898835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758387,0.00014517929,0.0008324886,0.00032949977,0.0008675054,0.00024145261],"domain_scores_gemma":[0.9969538,0.0008848586,0.0010128134,0.00017486924,0.0008139433,0.00015971306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076726207,0.00023225263,0.00070543605,0.00012229664,0.00016340503,0.000040807896,0.00044301397,0.00006159611,0.003516366],"category_scores_gemma":[0.00018594439,0.00013075219,0.00022570153,0.00017022475,0.00013386561,0.00008356995,0.00015437933,0.00037887297,3.2627503e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010008599,0.0020713157,0.833404,0.000048435944,0.004461893,0.000047066915,0.0015441081,0.0021183465,0.00015365171,0.00093668123,0.0012684669,0.14393741],"study_design_scores_gemma":[0.013507121,0.008780019,0.95539856,0.00012085744,0.0004660051,0.00003113257,0.0015227222,0.00015178439,0.00012101402,0.0003211635,0.019386074,0.00019352426],"about_ca_topic_score_codex":0.0012740974,"about_ca_topic_score_gemma":0.0015749505,"teacher_disagreement_score":0.14374389,"about_ca_system_score_codex":0.0012013093,"about_ca_system_score_gemma":0.0005946244,"threshold_uncertainty_score":0.99739456},"labels":[],"label_agreement":null},{"id":"W4210466602","doi":"10.1159/000151878","title":"Gynecologic Cancers","year":2008,"lang":"en","type":"review","venue":"Progress in experimental tumor research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; History; Gynecology","score_opus":0.23118443422697668,"score_gpt":0.5266296784732686,"score_spread":0.2954452442462919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210466602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028926387,0.9892856,2.3037554e-8,0.00007902666,0.00026451415,0.0037745766,0.000020292267,0.000056851088,0.0062298905],"genre_scores_gemma":[0.0036959862,0.9847008,0.00029176002,0.00003536328,0.00029134075,0.010443796,0.00009503639,0.00010862863,0.00033729308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958587,0.00041011325,0.0006539937,0.00097314635,0.0010639979,0.0010400476],"domain_scores_gemma":[0.99848807,0.00028350178,0.00013835225,0.00067439297,0.000091028116,0.00032463053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004021094,0.00049506046,0.0019119796,0.00073663815,0.0001746412,0.00005532441,0.00036795,0.00021805213,0.00082926085],"category_scores_gemma":[0.000057125788,0.00036702046,0.00044342977,0.001061691,0.0007033287,0.000060613434,0.00034067925,0.0012012488,0.0003925418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065046865,0.0017664814,0.0018104914,0.004254751,0.00019996335,0.007456009,0.0001627831,6.344734e-8,1.814363e-7,0.00012413834,0.0037297297,0.98043036],"study_design_scores_gemma":[0.0013061191,0.0011802003,0.00013862159,0.009936289,0.00006121396,0.000614696,0.00015709663,0.0000028274626,0.00014443787,0.0000067168926,0.9861455,0.00030631333],"about_ca_topic_score_codex":0.00013246265,"about_ca_topic_score_gemma":0.000012864879,"teacher_disagreement_score":0.98241574,"about_ca_system_score_codex":0.0061035994,"about_ca_system_score_gemma":0.0019761687,"threshold_uncertainty_score":0.99987817},"labels":[],"label_agreement":null},{"id":"W4210504490","doi":"10.15537/smj.2022.43.2.20210626","title":"Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia","year":2022,"lang":"en","type":"article","venue":"Saudi Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SAIT Polytechnic","funders":"","keywords":"Medicine; Debulking; Serous carcinoma; Stage (stratigraphy); Proportional hazards model; Internal medicine; Serous fluid; Retrospective cohort study; Gynecology; Oncology; Univariate analysis; Epithelial ovarian cancer; Ovarian cancer; Cancer; Multivariate analysis","score_opus":0.026381385282285476,"score_gpt":0.2970206231783752,"score_spread":0.27063923789608973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210504490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991078,0.0008016931,0.00004143102,0.0070458497,0.0004040747,0.00051138666,0.000057247933,0.000008251398,0.000052038915],"genre_scores_gemma":[0.9980055,0.0011407324,0.000034740788,0.00022434762,0.00022152813,0.00025419792,0.000010459999,0.000021323536,0.00008714506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980726,0.00015542236,0.000524442,0.00024150072,0.0006184853,0.00038750045],"domain_scores_gemma":[0.99901366,0.00028545613,0.00018662872,0.00010751223,0.000051170613,0.00035557285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007136086,0.00015769,0.0005420906,0.0002344569,0.000081802056,0.000012087649,0.00009708519,0.000087466324,0.00066032406],"category_scores_gemma":[0.000286625,0.00012037904,0.00007803814,0.00027089388,0.00008398122,0.000048214002,0.00005560598,0.0004924033,3.0193254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991881,0.0006339514,0.96590275,0.000081678576,0.00012916884,0.0007384115,0.0013570124,0.000017615368,0.000059539914,0.00002370821,0.00018844822,0.02987585],"study_design_scores_gemma":[0.011064828,0.001187203,0.98385495,0.00055425183,0.00008046869,0.000302252,0.0006598307,0.00007927293,0.0000889882,0.000187925,0.00182682,0.000113215],"about_ca_topic_score_codex":0.00048622082,"about_ca_topic_score_gemma":0.00061136164,"teacher_disagreement_score":0.029762635,"about_ca_system_score_codex":0.00064925005,"about_ca_system_score_gemma":0.00055983884,"threshold_uncertainty_score":0.7230086},"labels":[],"label_agreement":null},{"id":"W4210762341","doi":"10.1016/j.ygyno.2022.01.019","title":"The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hysterectomy; Subgroup analysis; Serous fluid; Odds ratio; Confidence interval; Stage (stratigraphy); Meta-analysis; Cystectomy; Surgery; Gynecology; Internal medicine; Cancer; Bladder cancer","score_opus":0.083327293528366,"score_gpt":0.4058479429358419,"score_spread":0.32252064940747593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210762341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014465753,0.98743147,4.868735e-7,0.00086187373,0.00004715342,0.010580201,0.00022699339,0.000023635823,0.0006835093],"genre_scores_gemma":[0.0015037816,0.9892089,0.00010370426,0.0008268287,0.000010060156,0.007863767,0.000230946,0.000036731468,0.00021530938],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99392337,0.0023868743,0.001989335,0.0007970872,0.0004186331,0.00048467537],"domain_scores_gemma":[0.98943955,0.007204799,0.002034346,0.0010188638,0.0001439611,0.00015848907],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016158267,0.0007690727,0.018281534,0.00043222145,0.00012640865,0.000019086796,0.00035023177,0.0003365804,0.002052778],"category_scores_gemma":[0.0014703665,0.00028437062,0.0030452134,0.0012614039,0.00017583116,0.000027797421,0.00018748481,0.00070689124,0.000011675221],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022848682,0.008731556,0.010793882,0.3644743,0.5804583,0.0005891131,0.00004709565,0.000009392539,8.568511e-10,0.00017596559,0.00042978342,0.034062155],"study_design_scores_gemma":[0.0021845251,0.01849652,0.020900268,0.0057112686,0.9217686,0.000037196947,0.000019836683,9.08751e-7,4.3973465e-9,0.000014246159,0.030551374,0.00031524626],"about_ca_topic_score_codex":0.00012317623,"about_ca_topic_score_gemma":0.00021018436,"teacher_disagreement_score":0.358763,"about_ca_system_score_codex":0.002146941,"about_ca_system_score_gemma":0.00095703895,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W4210893233","doi":"10.1001/jamanetworkopen.2021.47343","title":"Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention","year":2022,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Tubal ligation; Medicine; Hysterectomy; Ovarian cancer; Salpingectomy; Gynecology; Serous fluid; Fallopian tube; Population; Cohort; Obstetrics; Cancer; Surgery; Internal medicine; Pregnancy; Family planning","score_opus":0.08340959859055654,"score_gpt":0.36411760380163694,"score_spread":0.2807080052110804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210893233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5020424,0.012734922,0.008654913,0.349343,0.013793317,0.036303356,0.0056823455,0.0005969616,0.07084881],"genre_scores_gemma":[0.9716412,0.00018677839,0.0061141597,0.0056362925,0.001160421,0.0069990605,0.0011535934,0.00005607128,0.0070524137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987519,0.00009088748,0.00027352606,0.00038370618,0.00021388395,0.00028609176],"domain_scores_gemma":[0.99909663,0.0001994441,0.00016177482,0.0003648537,0.00004575138,0.00013155042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040427656,0.00015127417,0.0004147094,0.000029276214,0.000333485,0.00011096866,0.0002469703,0.000045351022,0.0064493543],"category_scores_gemma":[0.000029608658,0.00013364317,0.00014394165,0.00015725227,0.000014136143,0.00010434233,0.000316225,0.00014511285,0.00001117225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014650606,0.0007566466,0.61057764,0.000040162522,0.0015421414,0.000096346856,0.00024007678,0.0007972327,0.0000100054585,0.006144049,0.23192309,0.14640754],"study_design_scores_gemma":[0.008299527,0.0004925631,0.60958767,0.00016296223,0.0006271572,0.0000052964797,0.00008681212,0.00088295847,0.0000105828885,0.0039716964,0.37568882,0.00018396848],"about_ca_topic_score_codex":0.0016868344,"about_ca_topic_score_gemma":0.00022821689,"teacher_disagreement_score":0.46959883,"about_ca_system_score_codex":0.0003555873,"about_ca_system_score_gemma":0.00034119945,"threshold_uncertainty_score":0.9944589},"labels":[],"label_agreement":null},{"id":"W4211022054","doi":"10.3390/diagnostics12020458","title":"Low-Grade Serous Carcinoma of the Ovary: The Current Status","year":2022,"lang":"en","type":"review","venue":"Diagnostics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Serous carcinoma; Oncology; Serous fluid; Internal medicine; Chemotherapy; Ovarian carcinoma; Hormonal therapy; Adjuvant therapy; Clinical trial; Ovarian cancer; Cancer","score_opus":0.07120686647244653,"score_gpt":0.3462474343792789,"score_spread":0.2750405679068324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211022054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011178286,0.99357015,0.0000015621773,0.00043291674,0.002158664,0.0022677993,0.0009245414,0.000021565658,0.0005109898],"genre_scores_gemma":[0.0007875778,0.9972225,0.000019298788,0.00018749438,0.0004272051,0.00086690864,0.0003265904,0.00008246588,0.00007995352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764293,0.00025654712,0.0006455673,0.00040387007,0.0006286607,0.00042243552],"domain_scores_gemma":[0.9958486,0.0021200078,0.00050498353,0.0013272603,0.000058833884,0.00014029359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017486092,0.00044677543,0.0013750972,0.00008061331,0.00018292524,0.000022639051,0.000423514,0.000106519496,0.00034404692],"category_scores_gemma":[0.00051336974,0.00021845392,0.0008598055,0.0005623924,0.00014643262,0.000015590778,0.00035167718,0.00089830067,0.0000304857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044343797,0.00078969076,0.0042009996,0.007496801,0.00036438307,0.000076560566,0.00012324858,0.0000018021287,5.4739604e-9,0.00042096098,0.016224338,0.9702968],"study_design_scores_gemma":[0.0004963115,0.00019515003,0.0051573426,0.0066582724,0.0049709976,0.000045514294,0.000023007724,0.0000018329217,0.0000031893223,0.000033346754,0.9822259,0.0001891581],"about_ca_topic_score_codex":0.00011610814,"about_ca_topic_score_gemma":0.000017835793,"teacher_disagreement_score":0.9701076,"about_ca_system_score_codex":0.000523552,"about_ca_system_score_gemma":0.0013473497,"threshold_uncertainty_score":0.89082927},"labels":[],"label_agreement":null},{"id":"W4212983436","doi":"10.1016/b978-008055232-3.60828-1","title":"Ovarian Cancer","year":2007,"lang":"en","type":"book-chapter","venue":"xPharm: The Comprehensive Pharmacology Reference","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Internal medicine","score_opus":0.15711699306573496,"score_gpt":0.39417920830465236,"score_spread":0.2370622152389174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212983436","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020091925,0.037610587,0.000038488914,0.018352536,0.0048613204,0.0032796087,0.0004981217,0.00029052742,0.93305963],"genre_scores_gemma":[0.05237321,0.05412575,0.00043783357,0.04868167,0.004412339,0.0006976637,0.0003774253,0.00033494877,0.83855915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971296,0.000071543196,0.0006337871,0.00097071094,0.00050207984,0.00069223857],"domain_scores_gemma":[0.9972435,0.0004637316,0.00045785104,0.0007246536,0.00072553835,0.00038469036],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015341314,0.0008277062,0.0011553993,0.00023933785,0.00028363155,0.000029974211,0.00047986847,0.00055203895,0.020746818],"category_scores_gemma":[0.0000068124305,0.0005744106,0.00035837275,0.00009677328,0.0005499478,0.000053881937,0.0002876426,0.0016512611,0.0013148818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034782293,0.00076096196,0.0009673665,0.0007457422,0.013531703,0.0041225106,0.00047919346,0.000049299866,0.007362421,0.065323144,0.7121609,0.19101854],"study_design_scores_gemma":[0.0037571453,0.0003110275,0.002762127,0.0003362634,0.003509911,0.00023721518,0.000011636636,0.000026453035,0.0019588387,0.0011899492,0.9853785,0.0005209507],"about_ca_topic_score_codex":0.00012128894,"about_ca_topic_score_gemma":0.000036898276,"teacher_disagreement_score":0.2732176,"about_ca_system_score_codex":0.00056228135,"about_ca_system_score_gemma":0.0005986487,"threshold_uncertainty_score":0.99967074},"labels":[],"label_agreement":null},{"id":"W4213021231","doi":"10.1097/sla.0000000000005409","title":"Treatment and Outcomes of Congenital Ovarian Cysts A Study by the Canadian Consortium for Research in Pediatric Surgery (CanCORPS)","year":2022,"lang":"en","type":"article","venue":"Annals of Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Children's Hospital of Eastern Ontario; Children's Hospital of Western Ontario; University of Toronto; Montreal Children's Hospital; Western University; Hospital for Sick Children; Université de Montréal; London Health Sciences Centre; McMaster Children's Hospital; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; Alberta Children's Hospital; University of Calgary; McGill University","funders":"Canadian Institutes of Health Research; Faculty of Medicine and Health, University of Sydney; McGill University","keywords":"Odds ratio; Ovarian cyst; Cyst; Incidence (geometry); Confidence interval; Pregnancy; Gestational age; Retrospective cohort study; Cohort study","score_opus":0.3331605094228683,"score_gpt":0.41896936267796453,"score_spread":0.08580885325509624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213021231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839253,0.0032057678,9.691258e-8,0.010629921,0.0001795568,0.0013164632,0.00054551085,0.0000050281437,0.00019240139],"genre_scores_gemma":[0.99769413,0.000823091,0.000003921399,0.00021650347,0.00005569291,0.0009923927,0.000048680587,0.000020012456,0.00014555288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981065,0.000281162,0.0005245606,0.00028400967,0.00037882206,0.00042495714],"domain_scores_gemma":[0.9954109,0.0037441093,0.00014915782,0.00031553264,0.00019365785,0.00018664777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021420633,0.0001434979,0.00069059624,0.00065225514,0.0001998663,0.000013840345,0.00006197027,0.00003825415,0.00006786008],"category_scores_gemma":[0.00020469332,0.00010289964,0.00019665243,0.00054746907,0.00010048441,0.000038768958,0.00004067377,0.00011863496,7.6730765e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028543497,0.0014681412,0.9739195,0.000049411276,0.00037305782,0.0001244437,0.00045965382,0.0000016297345,0.0000037866794,0.000060746184,0.018428227,0.004825949],"study_design_scores_gemma":[0.0011765504,0.0006921276,0.9935074,0.000012581795,0.00012893866,0.000014186488,0.0011132692,0.000004587903,0.00016362025,0.000081161896,0.0030137135,0.000091864866],"about_ca_topic_score_codex":0.18971306,"about_ca_topic_score_gemma":0.07644459,"teacher_disagreement_score":0.11326848,"about_ca_system_score_codex":0.000192005,"about_ca_system_score_gemma":0.0015395919,"threshold_uncertainty_score":0.9404079},"labels":[],"label_agreement":null},{"id":"W4213065968","doi":"10.1101/2022.02.19.22271197","title":"Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high grade serous carcinoma","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Tenovus; Sierra Oncology; Cancer Research UK; AstraZeneca","keywords":"Carcinosarcoma; Serous fluid; Medicine; Serous carcinoma; Ovarian cancer; Oncology; Internal medicine; Ovarian carcinoma; Stage (stratigraphy); Chemotherapy; Cancer; Survival rate; Carcinoma; Biology","score_opus":0.036605107235599635,"score_gpt":0.2912658587077149,"score_spread":0.25466075147211525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213065968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714901,0.000677863,0.00023950335,0.016999107,0.0018810341,0.0034815425,0.0032430908,0.00017533041,0.0018124619],"genre_scores_gemma":[0.9907285,0.000075464544,0.003119529,0.0011655209,0.00079526217,0.0022587148,0.00092991575,0.00027333392,0.000653765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935169,0.00027719818,0.0012684575,0.0020559493,0.0017307646,0.0011506843],"domain_scores_gemma":[0.99513376,0.00019150063,0.0007169695,0.0026470036,0.00039854867,0.0009122316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005528188,0.0012362228,0.0026187422,0.00057040254,0.00030586665,0.00010237992,0.0008833576,0.00038821663,0.0043391637],"category_scores_gemma":[0.00005017808,0.0010280282,0.0005658469,0.0009396413,0.00020490923,0.00008353833,0.0012195811,0.0013137952,0.000025717105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018736747,0.0014424967,0.9832995,0.0010686981,0.0020934814,0.0014767296,0.0040072124,0.00015290367,0.0001389943,0.0012208039,0.0018812359,0.001344251],"study_design_scores_gemma":[0.007927829,0.0011156749,0.97897243,0.00089044095,0.0020031296,0.000107167485,0.00033936944,0.00019913446,0.0017291157,0.0004404471,0.005291026,0.0009842356],"about_ca_topic_score_codex":0.08203853,"about_ca_topic_score_gemma":0.0061368314,"teacher_disagreement_score":0.075901695,"about_ca_system_score_codex":0.0014693203,"about_ca_system_score_gemma":0.0017280548,"threshold_uncertainty_score":0.99921703},"labels":[],"label_agreement":null},{"id":"W4213096555","doi":"10.5847/wjem.j.1920-8642.2022.034","title":"A diagnosis with a twist: Ultrasonographic sensitivity and predictors of pediatric ovarian torsion within a large pediatric hospital","year":2022,"lang":"en","type":"article","venue":"World Journal of Emergency Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Ovarian torsion; Pediatric hospital; Ultrasonography; Pediatrics; Pediatric Radiology; Torsion (gastropod); Radiology; General surgery; Surgery","score_opus":0.014598858408978765,"score_gpt":0.26379994657546313,"score_spread":0.24920108816648437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213096555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98022413,0.013153568,0.00004553849,0.0033885632,0.0024196387,0.0005137229,0.000052782525,0.000017855433,0.0001842013],"genre_scores_gemma":[0.9859509,0.011296833,0.00029609987,0.000088299515,0.0021456655,0.000055394914,0.000013625551,0.000038252983,0.00011493925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690413,0.00020579998,0.0011186132,0.00032248045,0.001082566,0.00036641792],"domain_scores_gemma":[0.9975401,0.00019142004,0.0012109504,0.00027617608,0.00037461598,0.00040671322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015017316,0.0002986452,0.0008534479,0.001077689,0.0002254391,0.0000033834363,0.00010429772,0.000044014418,0.0015269492],"category_scores_gemma":[0.00023018112,0.00020648922,0.0002099953,0.0020947587,0.0000688381,0.00012754058,0.00007770967,0.00055084,6.322731e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056366104,0.0016423593,0.97846794,0.00022472432,0.0004431433,0.0004596866,0.0030193005,0.000026397709,0.000045103156,0.000115531446,0.014828156,0.0001640203],"study_design_scores_gemma":[0.008069892,0.009553188,0.97199905,0.00019996207,0.0041783312,0.0002901439,0.0015658124,0.000027274073,0.00007343158,0.00004320798,0.0037516418,0.00024805457],"about_ca_topic_score_codex":0.00015202216,"about_ca_topic_score_gemma":0.00024914966,"teacher_disagreement_score":0.011076515,"about_ca_system_score_codex":0.00013465647,"about_ca_system_score_gemma":0.00025412723,"threshold_uncertainty_score":0.9993858},"labels":[],"label_agreement":null},{"id":"W4213230994","doi":"10.3390/cancers14051122","title":"Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers","year":2022,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Medicine; Angiogenesis; Context (archaeology); Clinical trial; Gynecologic cancer; Drug development; Drug; Oncology; Bioinformatics; Pharmacology; Internal medicine; Cancer; Ovarian cancer; Biology","score_opus":0.07838104421993408,"score_gpt":0.3394532111934222,"score_spread":0.2610721669734881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213230994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018993743,0.9955227,0.000002204161,0.00011775354,0.00050670386,0.0018757893,0.00007402863,0.000019546213,0.0016913774],"genre_scores_gemma":[0.0014632877,0.9929418,0.00028486975,0.0004870414,0.00010599017,0.004327988,0.00015944461,0.000052189444,0.00017740844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777937,0.00021831578,0.00068997254,0.0004907779,0.00043248697,0.00038908713],"domain_scores_gemma":[0.998711,0.00030748805,0.00038724145,0.000490872,0.00002483347,0.00007858509],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046366686,0.00041634505,0.0015425683,0.00022657335,0.00010957299,0.00001170202,0.00034976695,0.00011500429,0.0014794321],"category_scores_gemma":[0.000019813335,0.00025892607,0.00052141806,0.00075528875,0.000083638624,0.000023930514,0.00006232739,0.00032347467,0.000012184874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000027880984,0.00009869968,0.00028200544,0.0051397784,0.0010298026,0.00011488066,0.0017362776,0.00005256983,1.4410341e-7,0.000052562358,0.0019327835,0.9895326],"study_design_scores_gemma":[0.00068443664,0.00014601361,0.00037032634,0.0024723923,0.0011905311,0.000023555358,0.0006498558,0.000002957119,0.0000047907165,0.000010212543,0.9942066,0.00023829998],"about_ca_topic_score_codex":0.00053696294,"about_ca_topic_score_gemma":0.0004642394,"teacher_disagreement_score":0.99227387,"about_ca_system_score_codex":0.011736121,"about_ca_system_score_gemma":0.011348722,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W4213261511","doi":"10.1200/jco.2010.28.18_suppl.lba5012b","title":"PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Interim analysis; Adverse effect; Internal medicine; Ovarian cancer; Oncology; Discontinuation; Randomized controlled trial; Cancer; Urology; Surgery","score_opus":0.07929973743231516,"score_gpt":0.439236840127927,"score_spread":0.35993710269561185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213261511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878769,0.00037264713,0.000009216218,0.007226417,0.0020944197,0.001286075,0.000004809529,0.0000096479935,0.0011198962],"genre_scores_gemma":[0.997334,0.0005487499,0.0010982985,0.00021923649,0.0006563936,0.00007251457,0.0000072021007,0.000021364047,0.000042227904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957768,0.0005357077,0.0026713524,0.0003161475,0.00038694777,0.00031307258],"domain_scores_gemma":[0.9938765,0.0036647706,0.001649378,0.0001836139,0.00026346993,0.0003622631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003709364,0.00022929772,0.002931947,0.0003045217,0.00006546147,0.00002386851,0.00012151624,0.00039392686,0.00014047744],"category_scores_gemma":[0.002309065,0.00015521584,0.00021787005,0.00029287176,0.00026867035,0.00014616358,0.000051660903,0.0014583472,0.0000015507325],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9332918,0.009845278,0.03949058,0.000026586351,0.00069157605,0.0010649526,0.0005099262,0.000033646367,0.00021102799,0.00038263504,0.00013436754,0.014317656],"study_design_scores_gemma":[0.8640987,0.03959788,0.0930128,0.0003488996,0.000720582,0.000085120824,0.00007451824,0.00073482643,0.00014935099,0.0001446953,0.00089873536,0.00013384319],"about_ca_topic_score_codex":0.0008292645,"about_ca_topic_score_gemma":0.020493394,"teacher_disagreement_score":0.06919301,"about_ca_system_score_codex":0.00027118318,"about_ca_system_score_gemma":0.0017758645,"threshold_uncertainty_score":0.9973801},"labels":[],"label_agreement":null},{"id":"W4213415828","doi":"10.1111/tog.12799","title":"Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease","year":2022,"lang":"en","type":"article","venue":"The Obstetrician & Gynaecologist","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Oophorectomy; Medicine; Ovarian cancer; Salpingectomy; Gynecology; Hysterectomy; Family history; Obstetrics; Menopause; Premature Menopause; Breast cancer; Cancer; Internal medicine; Surgery; Pregnancy","score_opus":0.03217774146918913,"score_gpt":0.2785451404517372,"score_spread":0.2463673989825481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213415828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9027996,0.005328023,0.00008922269,0.06709927,0.0026492164,0.009451264,0.0015049315,0.00017728291,0.010901186],"genre_scores_gemma":[0.9837489,0.000041628475,0.0001243429,0.0032442969,0.00008942533,0.001534283,0.00017374246,0.000033114648,0.011010225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845743,0.00020338348,0.00037132978,0.00031624144,0.00035123256,0.00030039565],"domain_scores_gemma":[0.99604917,0.0027857723,0.00028589735,0.00066421984,0.00011382776,0.00010109872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004567173,0.00018657441,0.00036097184,0.000098257646,0.0006769296,0.000022539773,0.00029261428,0.00004010649,0.0054193786],"category_scores_gemma":[0.0008218076,0.000097109936,0.00021309349,0.0006969386,0.00021232055,0.00003133967,0.00020025263,0.00014861194,0.00004653762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017139263,0.0072708046,0.4281657,0.0008363772,0.0035317792,0.0009674339,0.0044464124,0.0014147564,0.00081467046,0.009377055,0.34182605,0.18420969],"study_design_scores_gemma":[0.007690064,0.0024206988,0.7664677,0.000024903875,0.0012752373,0.000033467353,0.0007940804,0.0012094321,0.00084996584,0.0005047485,0.21845266,0.00027706448],"about_ca_topic_score_codex":0.00015051142,"about_ca_topic_score_gemma":0.0000817262,"teacher_disagreement_score":0.33830196,"about_ca_system_score_codex":0.0008377622,"about_ca_system_score_gemma":0.00036962068,"threshold_uncertainty_score":0.9954898},"labels":[],"label_agreement":null},{"id":"W4214565729","doi":"10.3390/curroncol29030125","title":"What Should Be the Topics of a Prospective Study on Ovarian Masses in Children?—Results of a Multicenter Retrospective Study and a Scoping Literature Review","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Uniwersytet Śląski w Katowicach; Uniwersytet Opolski; Uniwersytet Warmińsko-Mazurski w Olsztynie; Uniwersytet Medyczny w Lublinie; Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Pomorski Uniwersytet Medyczny W Szczecinie; Uniwersytet Rzeszowski; Uniwersytet Jana Kochanowskiego w Kielcach; Uniwersytet Łódzki","keywords":"Medicine; Prospective cohort study; Population; Pediatrics; Pathology","score_opus":0.08538555348067006,"score_gpt":0.42763397317740937,"score_spread":0.3422484196967393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214565729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292174,0.054055933,4.949704e-7,0.007236663,0.0005472209,0.008736315,0.00007467008,0.000008836585,0.0001224723],"genre_scores_gemma":[0.98696995,0.011536023,0.000016739536,0.00035661962,0.0000735702,0.0010050222,0.000018200075,0.00001010729,0.000013749991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825466,0.00041322192,0.0004691103,0.00041191973,0.0003002132,0.00015088459],"domain_scores_gemma":[0.9991114,0.00011852733,0.00026554853,0.00034830233,0.000117643,0.000038591894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005452859,0.00016081284,0.00066737615,0.00011415957,0.000067445864,0.000013617648,0.00009923483,0.000032001066,0.000030189176],"category_scores_gemma":[0.00014580942,0.00010563605,0.000068946276,0.00041387192,0.00005845005,0.00006084883,0.00017485797,0.000451624,2.0814616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077523035,0.015636804,0.95401406,0.00036507915,0.0003235837,0.000052006144,0.01767328,0.0000012991625,0.000002175672,0.000085325126,0.00024608575,0.010825048],"study_design_scores_gemma":[0.012094241,0.0120103825,0.9629617,0.0056615006,0.00044078493,0.000021126838,0.0060801604,0.00000579086,0.000017619517,0.00002067416,0.00060715707,0.00007887479],"about_ca_topic_score_codex":0.000043245655,"about_ca_topic_score_gemma":0.00014946237,"teacher_disagreement_score":0.057752572,"about_ca_system_score_codex":0.00040308697,"about_ca_system_score_gemma":0.00012915069,"threshold_uncertainty_score":0.43077132},"labels":[],"label_agreement":null},{"id":"W4214892756","doi":"10.1002/path.5891","title":"Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention","year":2022,"lang":"en","type":"review","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; St. Michael's Hospital","funders":"Brigham and Women's Hospital; National Cancer Institute; Ovarian Cancer Research Alliance; Ovarian Cancer Research Fund; U.S. Department of Defense","keywords":"Peritoneal cavity; Ovarian cancer; Medicine; Biology; Oncology; Cancer; Internal medicine; Surgery","score_opus":0.06471496021455686,"score_gpt":0.3702103346395456,"score_spread":0.30549537442498875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214892756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021596062,0.99513763,0.000012967982,0.0013838933,0.00064952334,0.0005073824,0.00006837288,0.000003119345,0.000077497716],"genre_scores_gemma":[0.00053734594,0.99823594,0.00009631455,0.00014327897,0.00069391564,0.000068051406,0.000015188427,0.000026683416,0.00018327773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827987,0.00073453574,0.00050311117,0.00013641657,0.00017528622,0.00017078323],"domain_scores_gemma":[0.99860376,0.00021277693,0.00076804636,0.00030958513,0.00003768035,0.000068158115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009723118,0.00019932994,0.001019529,0.000075801545,0.000180928,0.0000122235615,0.00020158355,0.00009451589,0.0005555206],"category_scores_gemma":[0.000027081367,0.00008984584,0.00031004797,0.00010107961,0.00013290351,0.000021977918,0.00011501319,0.00074176566,0.0000042286806],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076342185,0.00012579894,0.00016084223,0.00081764517,0.00058456196,0.0006987527,0.0003808881,0.0000025086485,0.000003879973,0.000054837717,0.0010005092,0.99609345],"study_design_scores_gemma":[0.0006568648,0.0006996398,0.0025458417,0.0009746876,0.0067979977,0.020450171,0.000080147765,6.754244e-7,6.234808e-7,0.000052498926,0.9676643,0.000076553755],"about_ca_topic_score_codex":0.00011481084,"about_ca_topic_score_gemma":0.00004549584,"teacher_disagreement_score":0.99601686,"about_ca_system_score_codex":0.00033980454,"about_ca_system_score_gemma":0.0006582174,"threshold_uncertainty_score":0.6082561},"labels":[],"label_agreement":null},{"id":"W4220922564","doi":"10.1007/s00330-022-08644-3","title":"How to improve O-RADS MRI score for rating adnexal masses with cystic component?","year":2022,"lang":"en","type":"article","venue":"European Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Radiology; Magnetic resonance imaging; Malignancy; Adnexal mass; Adnexal Diseases; Neuroradiology; Breast MRI; Effective diffusion coefficient; Logistic regression; Diffusion MRI; Nuclear medicine; Pathology; Internal medicine; Cancer; Breast cancer; Neurology; Laparoscopy; Mammography","score_opus":0.020971026973851788,"score_gpt":0.25001127927311545,"score_spread":0.22904025229926367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220922564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467439,0.001336281,0.011432557,0.029690564,0.0014095135,0.0029296016,0.0002322395,0.00020412651,0.006021218],"genre_scores_gemma":[0.9885751,0.000010714978,0.0073410072,0.0019184973,0.0005582856,0.0002843999,0.000108794186,0.000060681617,0.0011425058],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987566,0.00021340098,0.00016455253,0.00043008596,0.00012218623,0.0003131621],"domain_scores_gemma":[0.9992777,0.00013949824,0.000087040826,0.00030510128,0.000042522723,0.00014815253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002636958,0.00016648626,0.00032671232,0.000080908256,0.00020473998,0.000025604486,0.0001173606,0.000015163201,0.00007245905],"category_scores_gemma":[0.000067499015,0.00012925413,0.000070853705,0.00011258101,0.000046698126,0.000026976702,0.00009640903,0.00015162547,0.000016521388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016624646,0.0040970743,0.38982725,0.0012654717,0.004851893,0.014947286,0.0069596446,0.0068103843,0.09601402,0.023744108,0.31199893,0.122859284],"study_design_scores_gemma":[0.020355722,0.034960896,0.19141762,0.00020422501,0.0009083445,0.0032033215,0.0014410075,0.0008780985,0.0021351548,0.00009536272,0.7435403,0.00085995544],"about_ca_topic_score_codex":0.000009143273,"about_ca_topic_score_gemma":0.0000043804434,"teacher_disagreement_score":0.43154135,"about_ca_system_score_codex":0.00016589553,"about_ca_system_score_gemma":0.00007523455,"threshold_uncertainty_score":0.52708304},"labels":[],"label_agreement":null},{"id":"W4220951488","doi":"10.1097/pas.0000000000001895","title":"Outcome-based Validation of Confluent/Expansile Versus Infiltrative Pattern Assessment and Growth-based Grading in Ovarian Mucinous Carcinoma","year":2022,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Grading (engineering); Medicine; Cohort; Cohort study; Ovarian cancer; Retrospective cohort study; Carcinoma; Ovarian carcinoma; Pathology; Oncology; Cancer; Gynecology; Internal medicine; Radiology; Biology","score_opus":0.036423258584789606,"score_gpt":0.3319882182881727,"score_spread":0.2955649597033831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220951488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346673,0.0001225175,0.0003921274,0.0055057337,0.00017167312,0.00020357531,0.000024509409,0.000004028292,0.00010912444],"genre_scores_gemma":[0.9989595,0.000024255762,0.00038319375,0.0005347775,0.000046117966,0.000028024784,0.000009513141,0.000012998362,0.0000016257137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980694,0.0006569454,0.00059332245,0.00016916519,0.0003207365,0.00019042176],"domain_scores_gemma":[0.99817926,0.00076319097,0.0006803062,0.00017068666,0.00011058187,0.000096005155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007750982,0.00013685756,0.0006683381,0.000225914,0.000076512384,0.000007442107,0.00010565744,0.000021761014,0.00011629807],"category_scores_gemma":[0.000030127647,0.000095184165,0.00013648286,0.00030332175,0.00031971067,0.00003227657,0.000036332163,0.000383144,3.8763093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021492713,0.00053351524,0.98862594,0.000017440143,0.00007966148,0.002246013,0.0004430799,0.0007061824,0.00059165945,0.00017155305,0.00001181511,0.004423854],"study_design_scores_gemma":[0.013734109,0.008687299,0.97301525,0.000035525572,0.0002359168,0.00070247013,0.0011206376,0.00030090575,0.0019175212,0.00005947917,0.00008038642,0.00011049632],"about_ca_topic_score_codex":0.00030213434,"about_ca_topic_score_gemma":0.000004389184,"teacher_disagreement_score":0.015610701,"about_ca_system_score_codex":0.0002725828,"about_ca_system_score_gemma":0.00026700177,"threshold_uncertainty_score":0.38814977},"labels":[],"label_agreement":null},{"id":"W4220984610","doi":"10.3390/curroncol29030172","title":"Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; BRCA mutation; Salpingectomy; Breast cancer; Malignancy; Hysterectomy; Gynecology; Serous fluid; Oncology; Endometrial cancer; Population; Internal medicine; Cancer; Obstetrics; Surgery; Pregnancy","score_opus":0.24320013936310433,"score_gpt":0.46594632752017323,"score_spread":0.2227461881570689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220984610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017312398,0.98898846,0.000029394183,0.0003679954,0.005139805,0.0043445625,0.0005805631,0.00007104585,0.0003050741],"genre_scores_gemma":[0.0001056017,0.98452276,0.0009308797,0.000053485688,0.0006597578,0.011936895,0.001538902,0.00007766173,0.00017407062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968731,0.00047563293,0.0009612124,0.0009064288,0.00018131123,0.0006023585],"domain_scores_gemma":[0.99704164,0.0014966737,0.00070828875,0.0005373384,0.000045874684,0.0001701816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005031506,0.00050932117,0.0027392588,0.00045542908,0.00018010043,0.000015510384,0.00023527365,0.000397976,0.0014101581],"category_scores_gemma":[0.00032273468,0.00041879268,0.0006661635,0.00050511525,0.000066293855,0.000033764132,0.00015756565,0.00096474134,0.000069919275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017260323,0.0028353503,0.00047637246,0.006751021,0.0003177264,0.00013968546,0.0000814391,0.000007292168,2.453031e-8,0.0009594373,0.004233761,0.9841806],"study_design_scores_gemma":[0.002930891,0.0017500834,0.0005212326,0.0036907424,0.0038260014,0.0001301498,0.00004096351,0.000007235347,2.5205628e-7,0.00021542977,0.98656654,0.00032046402],"about_ca_topic_score_codex":0.00010759353,"about_ca_topic_score_gemma":0.00012634524,"teacher_disagreement_score":0.9838602,"about_ca_system_score_codex":0.0038999973,"about_ca_system_score_gemma":0.0016044904,"threshold_uncertainty_score":0.9999238},"labels":[],"label_agreement":null},{"id":"W4220990098","doi":"10.1002/pbc.29650","title":"Comment on: Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents","year":2022,"lang":"en","type":"letter","venue":"Pediatric Blood & Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Stromal cell; MEDLINE; Pathology","score_opus":0.03341159387818354,"score_gpt":0.3015709826844631,"score_spread":0.26815938880627954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220990098","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23299322,0.054990653,6.364902e-7,0.7063304,0.00036772806,0.0026712383,0.002619501,0.000016155433,0.000010475388],"genre_scores_gemma":[0.25036058,0.20616032,0.00008935923,0.53091526,0.0053544096,0.0062418794,0.000738117,0.00009592373,0.000044151406],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99815536,0.00016291368,0.00044701074,0.0005576963,0.000349782,0.0003272477],"domain_scores_gemma":[0.99753237,0.0015743346,0.00031239365,0.00047164113,0.000044213077,0.00006507606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018084358,0.0003665108,0.000594695,0.0000988445,0.00021466773,0.000035323315,0.00018259378,0.00015892081,0.00041533093],"category_scores_gemma":[0.000024868135,0.00022113015,0.00014256795,0.000184591,0.000109694134,0.000017895834,0.0001002242,0.00076139177,5.243531e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019382927,0.00036007853,0.48529023,0.00003339041,0.00048458957,0.0000118078215,0.00027805928,0.0000012439853,1.6141725e-7,0.0000047141716,0.50344115,0.009900756],"study_design_scores_gemma":[0.01018266,0.0013782807,0.5302566,0.00028855292,0.0016048533,0.00001621248,0.00019201501,0.000009280035,0.000035153807,0.00003777287,0.45567834,0.00032022802],"about_ca_topic_score_codex":0.0057803933,"about_ca_topic_score_gemma":0.0001560809,"teacher_disagreement_score":0.17541514,"about_ca_system_score_codex":0.00010908839,"about_ca_system_score_gemma":0.00018777286,"threshold_uncertainty_score":0.9017426},"labels":[],"label_agreement":null},{"id":"W4221121524","doi":"10.1101/2022.03.29.486309","title":"Establishing combination PAC-1 and TRAIL regimens for treating ovarian cancer based on patient-specific pharmacokinetic profiles using <i>in silico</i> clinical trials","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Pharmacokinetics; Oncology; In silico; Ovarian cancer; Cohort; Population; Internal medicine; Clinical trial; Cancer; Pharmacology; Biology","score_opus":0.08318352925570546,"score_gpt":0.3572037391566808,"score_spread":0.2740202099009753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221121524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98502606,0.0030838123,0.00043206435,0.001913658,0.0020319805,0.0059311795,0.0013928049,0.0001686685,0.000019775684],"genre_scores_gemma":[0.9864335,0.0010272554,0.007903631,0.0007341238,0.0007221184,0.0029860514,0.000009257105,0.00018082069,0.0000032416492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99484324,0.00093618134,0.0016043421,0.0014995293,0.0005485729,0.0005681398],"domain_scores_gemma":[0.9958566,0.0015569847,0.0011603079,0.0008019493,0.00029764159,0.00032653566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033413097,0.00063849136,0.0016086672,0.00048529473,0.00025167226,0.00023721028,0.00017836301,0.0003998314,0.00016561235],"category_scores_gemma":[0.00093664473,0.00062717363,0.000371449,0.00049534574,0.00009302879,0.00012871946,0.00015120643,0.0009010822,0.000001114324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009862273,0.016539877,0.6135492,0.007468195,0.0032376186,0.0010481306,0.00043220707,0.012618862,0.32047594,0.0023589297,0.0056926697,0.0067161424],"study_design_scores_gemma":[0.08178409,0.0049721007,0.5199784,0.01371881,0.00592781,2.6301961e-7,0.00013578404,0.14331868,0.19263844,0.000020303094,0.033410113,0.004095197],"about_ca_topic_score_codex":0.00024926572,"about_ca_topic_score_gemma":0.0000056961503,"teacher_disagreement_score":0.13069983,"about_ca_system_score_codex":0.0012076058,"about_ca_system_score_gemma":0.0010655334,"threshold_uncertainty_score":0.99961793},"labels":[],"label_agreement":null},{"id":"W4223430921","doi":"10.1016/j.semcancer.2022.03.027","title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","year":2022,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Radiumhemmets Forskningsfonder; Cancerfonden; Vetenskapsrådet; Kreftforeningen","keywords":"Debulking; Ovarian cancer; Tumor microenvironment; Medicine; Disease; Cancer; Chemotherapy; Oncology; Cancer research; Internal medicine","score_opus":0.025679283941935208,"score_gpt":0.31328528949829854,"score_spread":0.28760600555636334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223430921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011382322,0.98537064,0.0000011080726,0.0001970335,0.0005090168,0.0015376696,0.00080072106,0.000010263369,0.00019120966],"genre_scores_gemma":[0.01119688,0.9864436,0.000052826177,0.0001346903,0.00013749162,0.001787199,0.000111937705,0.00006468709,0.00007071106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782026,0.0001935828,0.00064940186,0.0008190213,0.00014100962,0.00037670135],"domain_scores_gemma":[0.99894,0.00013569761,0.00043700077,0.00034089375,0.000015047969,0.00013137657],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021484635,0.00046427955,0.0021098494,0.0002477446,0.000044354696,0.000006003248,0.00013206663,0.00024781245,0.00045861112],"category_scores_gemma":[0.000018456438,0.0003824874,0.00018294551,0.00021213182,0.00014815638,0.000015496627,0.00021997826,0.00038981513,0.0000023384466],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075695054,0.00023287244,0.001710468,0.021233806,0.0008323644,0.0007113099,0.00015949355,0.000003539871,0.0015026723,0.0006447948,0.00007376793,0.9728192],"study_design_scores_gemma":[0.0020449285,0.0007567973,0.00016810109,0.027070938,0.0025510045,0.0005581437,0.00005087359,0.0000077834065,0.0017311235,0.000068126,0.9645245,0.0004676658],"about_ca_topic_score_codex":0.00069913815,"about_ca_topic_score_gemma":0.000058664024,"teacher_disagreement_score":0.97235155,"about_ca_system_score_codex":0.0009769439,"about_ca_system_score_gemma":0.0005494751,"threshold_uncertainty_score":0.99986273},"labels":[],"label_agreement":null},{"id":"W4223569017","doi":"10.3390/curroncol29040220","title":"Serology-Based Model for Personalized Epithelial Ovarian Cancer Risk Evaluation","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Ovarian cancer; Serology; Epithelial ovarian cancer; Cancer; Computational biology; Bioinformatics; Oncology; Internal medicine; Antibody; Immunology; Biology","score_opus":0.18540727971355095,"score_gpt":0.45442189596990795,"score_spread":0.26901461625635703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223569017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87018174,0.017503439,0.036778957,0.050322592,0.010001486,0.009535216,0.0043612905,0.00021691227,0.0010983929],"genre_scores_gemma":[0.98262614,0.00030864336,0.00212913,0.0012719883,0.00051097,0.012350797,0.0005123147,0.00003247599,0.0002575543],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99848825,0.00025970206,0.0002446896,0.00040663462,0.00031308012,0.00028766616],"domain_scores_gemma":[0.99912316,0.00016314705,0.00019213522,0.00021554803,0.00019632075,0.000109720546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007384175,0.00015166521,0.00037213654,0.00010765947,0.00028276694,0.000005504397,0.00008138671,0.00007165241,0.0020886117],"category_scores_gemma":[0.000084112035,0.00013856203,0.00019304044,0.00011786834,0.00006423617,0.000022015598,0.00004014704,0.00025599726,0.000008396174],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006600809,0.006173101,0.11382285,0.00019378174,0.00073723256,0.000017862485,0.002404112,0.077299856,0.00030354326,0.0037710266,0.041820187,0.7468556],"study_design_scores_gemma":[0.022266857,0.0013802183,0.010100426,0.000016480937,0.0015718465,0.000008283864,0.00007272334,0.69964635,0.00006245094,0.0012127991,0.26352513,0.00013639784],"about_ca_topic_score_codex":0.00007111003,"about_ca_topic_score_gemma":0.00013677344,"teacher_disagreement_score":0.74671924,"about_ca_system_score_codex":0.0016627449,"about_ca_system_score_gemma":0.0019070089,"threshold_uncertainty_score":0.99882364},"labels":[],"label_agreement":null},{"id":"W4223598350","doi":"10.1097/mph.0000000000002464","title":"The Surgical Procedure in the Case of Ovarian Lesion in Neonate","year":2022,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Lesion; Surgery; General surgery","score_opus":0.02778273831382089,"score_gpt":0.34466983045153954,"score_spread":0.31688709213771865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223598350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541743,0.008191209,0.0000034164655,0.03590756,0.0004226361,0.00039370116,0.000004682606,0.0000030519298,0.0008994706],"genre_scores_gemma":[0.99723244,0.0018454462,0.00017407049,0.00033901003,0.000308216,0.00006569934,0.0000014600238,0.000009723296,0.00002391624],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99762046,0.00074432854,0.00095680886,0.000151084,0.00025047993,0.00027681966],"domain_scores_gemma":[0.99738026,0.0015953396,0.00066274597,0.00018956841,0.00009602625,0.000076036675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024598958,0.00012055932,0.00063009246,0.00031853904,0.00013211543,0.0000054834236,0.00022062419,0.00013346865,0.00010452326],"category_scores_gemma":[0.00022635059,0.00006450783,0.00015832116,0.00067599793,0.00008160526,0.000037255635,0.00008385512,0.0008693191,0.0000021669837],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036217906,0.005534207,0.48997048,0.00021016946,0.00021173338,0.4282901,0.0057489285,0.0002414752,0.000013234537,0.013793486,0.022775121,0.029589267],"study_design_scores_gemma":[0.026445705,0.010392226,0.09058637,0.00005387646,0.00092247245,0.7061426,0.016158931,0.00022835922,0.000066717876,0.0033353716,0.14542185,0.00024551232],"about_ca_topic_score_codex":0.00011323385,"about_ca_topic_score_gemma":0.0002479979,"teacher_disagreement_score":0.3993841,"about_ca_system_score_codex":0.0004113953,"about_ca_system_score_gemma":0.001216776,"threshold_uncertainty_score":0.37768072},"labels":[],"label_agreement":null},{"id":"W4223975396","doi":"10.3390/cancers14081954","title":"CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Princess Margaret Cancer Centre; University Health Network","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Medical Research Council; Peter MacCallum Foundation; Cancer Australia; National Health and Medical Research Council; Norges Forskningsråd; Minnesota Ovarian Cancer Alliance; Cancer Research UK; Fred C. and Katherine B. Andersen Foundation; National Cancer Institute; Helse Vest; Ovarian Cancer Australia; Wellcome Trust; Mayo Foundation for Medical Education and Research; National Institutes of Health; Ovarian Cancer Research Fund; Roswell Park Cancer Institute; Génome Québec; Ministry of Health, Labour and Welfare; McGill University; European Commission; U.S. Department of Defense","keywords":"Serous ovarian cancer; Ovarian cancer; Serous fluid; Medicine; Oncology; Internal medicine; Multicenter study; Cancer; Randomized controlled trial","score_opus":0.027641776583382117,"score_gpt":0.29723294286410923,"score_spread":0.2695911662807271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223975396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919078,0.0018726304,0.000105150255,0.0016700805,0.0007792833,0.00075837784,0.0019141387,0.000032242435,0.0009603262],"genre_scores_gemma":[0.9980758,0.00024475018,0.00008381264,0.0004291422,0.00010713341,0.00063031376,0.00007286361,0.000026282054,0.00032991916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998299,0.000106898704,0.00036793965,0.00045085148,0.0004462955,0.00032902326],"domain_scores_gemma":[0.9990993,0.00006907765,0.00022713601,0.00037537547,0.0000858345,0.0001432518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017075747,0.00019478177,0.0006795753,0.00033220532,0.000083131206,0.000007967101,0.00012988108,0.00005124916,0.001913185],"category_scores_gemma":[0.000020978676,0.00018855462,0.0002339667,0.0013475718,0.00006803903,0.0000523608,0.000076411416,0.00024104438,0.000002585065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000589411,0.00031930543,0.9049486,0.00012232747,0.0026730716,0.00020440038,0.002260715,0.08664856,0.00011598093,0.00003779438,0.00079907186,0.0012807483],"study_design_scores_gemma":[0.006095503,0.00030693202,0.977711,0.00018073598,0.0017785032,0.000002957422,0.0028719825,0.008050536,0.0010154891,0.000012371595,0.001776831,0.00019714319],"about_ca_topic_score_codex":0.019291718,"about_ca_topic_score_gemma":0.0075377924,"teacher_disagreement_score":0.07859802,"about_ca_system_score_codex":0.0053586336,"about_ca_system_score_gemma":0.00088020886,"threshold_uncertainty_score":0.9989992},"labels":[],"label_agreement":null},{"id":"W4224209517","doi":"10.1148/radiol.211868","title":"External Validation of O-RADS US Risk Stratification and Management System","year":2022,"lang":"en","type":"article","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Receiver operating characteristic; Risk stratification; Malignancy; Histopathology; Radiology; Retrospective cohort study; Gynecology; Surgery; Internal medicine; Pathology","score_opus":0.012627526010111663,"score_gpt":0.2558905964156848,"score_spread":0.24326307040557313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224209517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960883,0.001180315,0.0009206343,0.00026048417,0.0001635202,0.00031032058,0.000014264032,0.000015010246,0.0010471165],"genre_scores_gemma":[0.9984884,0.0003557186,0.0008713168,0.000028375316,0.000039717404,0.00012561932,0.000021599706,0.0000043853065,0.00006486375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951047,0.00008397162,0.00013543629,0.00013425923,0.000074621654,0.00006124693],"domain_scores_gemma":[0.9997194,0.000017963293,0.00009323897,0.00013355634,0.000011590852,0.000024283261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014297344,0.000043954882,0.00012772514,0.000050184484,0.00005305742,0.000002285322,0.000024079753,0.000015882804,0.00006153187],"category_scores_gemma":[0.0000024366466,0.00003921871,0.000022095044,0.00004806776,0.000019809651,0.000011298723,0.000018934328,0.000043599994,0.0000025457998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028490103,0.00035547107,0.9005042,0.0005623771,0.0004988732,0.00011440201,0.00038456818,0.0007101227,0.0018229038,0.056716338,0.00075003103,0.037295844],"study_design_scores_gemma":[0.0017960488,0.00073886005,0.99170756,0.00004295139,0.00034264187,0.00033126748,0.00027593493,0.00053955027,0.0018335166,0.00019479342,0.0021426915,0.000054195625],"about_ca_topic_score_codex":0.000053531257,"about_ca_topic_score_gemma":0.0000010113367,"teacher_disagreement_score":0.091203384,"about_ca_system_score_codex":0.00012084474,"about_ca_system_score_gemma":0.000012642594,"threshold_uncertainty_score":0.15992926},"labels":[],"label_agreement":null},{"id":"W4225008408","doi":"10.1177/10668969221098083","title":"Metastatic Small Bowel Adenocarcinoma Mimicking a Primary Ovarian Mucinous Tumour – Clinical, Radiologic, Pathologic and Molecular Correlation","year":2022,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Adenocarcinoma; Medicine; Pathology; Immunophenotyping; Ovary; Ovarian carcinoma; Molecular pathology; Ovarian cancer; Internal medicine; Biology; Cancer; Immunology","score_opus":0.037991526284427556,"score_gpt":0.31300945821229803,"score_spread":0.2750179319278705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225008408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820835,0.0048159612,0.0013467727,0.009353048,0.0014261492,0.00022547953,0.000029849205,0.000017290973,0.00070194405],"genre_scores_gemma":[0.9915675,0.0009848479,0.004777485,0.0022071193,0.00033051346,0.000023691084,0.00004530663,0.000017885814,0.00004565437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750733,0.0006010606,0.00092741434,0.00032443088,0.00042964975,0.0002101269],"domain_scores_gemma":[0.9983238,0.00046472257,0.00064874184,0.0001396217,0.00025796625,0.00016512079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013284492,0.000173289,0.00059959386,0.00025882848,0.00008871007,0.000025297953,0.0002167146,0.000082197526,0.00029618424],"category_scores_gemma":[0.00016011219,0.00013782679,0.0003053576,0.00009815116,0.0001507161,0.000065088294,0.00019653008,0.00064214895,0.000005115088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003101532,0.0022916484,0.52504617,0.000030727035,0.0010539936,0.4391389,0.00038876323,0.00071126426,0.0019487357,0.002263726,0.0010852747,0.022939285],"study_design_scores_gemma":[0.015690194,0.0056500966,0.7187844,0.000087836095,0.0007333041,0.24604495,0.00028208733,0.0005488508,0.00011675239,0.0038198913,0.007950169,0.00029145973],"about_ca_topic_score_codex":0.0000097518,"about_ca_topic_score_gemma":7.2744604e-7,"teacher_disagreement_score":0.19373824,"about_ca_system_score_codex":0.0002630819,"about_ca_system_score_gemma":0.00018604075,"threshold_uncertainty_score":0.56204134},"labels":[],"label_agreement":null},{"id":"W4225146161","doi":"10.1155/2022/2084774","title":"Perioperative and Survival Outcomes of Robotic-Assisted Surgery, Comparison with Laparoscopy and Laparotomy, for Ovarian Cancer: A Network Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Chongqing; National Natural Science Foundation of China","keywords":"Medicine; Laparotomy; Laparoscopy; Perioperative; Surgery; Blood loss; Ovarian cancer; Cochrane Library; Incidence (geometry); Blood transfusion; General surgery; Cancer; Internal medicine; Randomized controlled trial","score_opus":0.12197008997568844,"score_gpt":0.39301373721507266,"score_spread":0.27104364723938423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225146161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95673233,0.011167049,0.0009217339,0.029114967,0.00057370175,0.0011122164,0.000119155244,0.000008776815,0.00025004795],"genre_scores_gemma":[0.99244446,0.00028285192,0.0064581432,0.00038427132,0.000089954694,0.00020319724,0.000008772265,0.000014106673,0.000114253984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984322,0.00027295406,0.0006522538,0.0001882841,0.0002628269,0.00019144866],"domain_scores_gemma":[0.9977066,0.0009586925,0.0008208685,0.0001262544,0.00024926235,0.00013833545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007550859,0.00016104469,0.0030541983,0.00019606453,0.00014378448,0.000014940478,0.00005336061,0.000049778166,0.00030269657],"category_scores_gemma":[0.00003815308,0.00010087079,0.0005011719,0.00033645812,0.000105989966,0.000046149296,0.000041471612,0.000192415,5.4473634e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017731297,0.0007246512,0.8581824,0.00003947087,0.13016044,0.00008740206,0.0006078938,0.005321884,0.00002776625,0.00026754866,0.0012184342,0.0015890253],"study_design_scores_gemma":[0.0056632077,0.007068048,0.7173146,0.000014405948,0.25477317,0.00023824499,0.00093886425,0.0005782339,0.00012336163,0.00002947705,0.013099708,0.00015866592],"about_ca_topic_score_codex":0.00027223563,"about_ca_topic_score_gemma":0.0009061376,"teacher_disagreement_score":0.14086774,"about_ca_system_score_codex":0.00020841965,"about_ca_system_score_gemma":0.0005172353,"threshold_uncertainty_score":0.41133916},"labels":[],"label_agreement":null},{"id":"W4225271949","doi":"10.1186/s13048-022-00983-5","title":"Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; Princess Margaret Cancer Foundation; University Health Network","keywords":"Somatic cell; Medicine; Carboplatin; Chemotherapy; Oncology; Cisplatin; Exome sequencing; Ovarian carcinoma; Internal medicine; Germline mutation; Mutation; Serous carcinoma; Ovarian cancer; Gene; Cancer research; Cancer; Biology; Genetics","score_opus":0.06048925555328583,"score_gpt":0.3982550185929287,"score_spread":0.3377657630396429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225271949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936939,0.0003797988,0.000027326843,0.0046692207,0.0001755273,0.00059025316,0.00004013178,0.000005722791,0.00041814],"genre_scores_gemma":[0.9984257,0.00014496874,0.00095140317,0.00010017681,0.00018705719,0.000040171846,0.000015607226,0.00003977213,0.00009514526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99624944,0.00055799924,0.0007727969,0.00023559397,0.0016316662,0.00055251434],"domain_scores_gemma":[0.99824953,0.00037341265,0.00037828003,0.0003838229,0.00032255874,0.00029242353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019643374,0.00017412753,0.0006206204,0.0011990399,0.00013237463,0.000035546007,0.00020625455,0.00006745011,0.0012057661],"category_scores_gemma":[0.00015101764,0.00013402222,0.000264825,0.0010430688,0.00006645178,0.00010738865,0.000059386246,0.0009890012,0.000006920896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01058612,0.010485249,0.8918212,0.0002608595,0.0014362424,0.009532306,0.0069424175,0.0053981235,0.007014608,0.0017721906,0.004794649,0.049956042],"study_design_scores_gemma":[0.014054896,0.011723959,0.96949905,0.00018102925,0.000054934913,0.000596467,0.0006697402,0.00041923343,0.0012694949,0.0011841304,0.00024561986,0.00010142052],"about_ca_topic_score_codex":0.0025898824,"about_ca_topic_score_gemma":0.000030253563,"teacher_disagreement_score":0.07767788,"about_ca_system_score_codex":0.002243641,"about_ca_system_score_gemma":0.0016105822,"threshold_uncertainty_score":0.9997073},"labels":[],"label_agreement":null},{"id":"W4225473893","doi":"","title":"High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival","year":2022,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research and Materiel Command; National Cancer Institute; National Institutes of Health; U.S. Department of Defense; Lon V. Smith Foundation; Rutgers Cancer Institute of New Jersey; California Breast Cancer Research Program","keywords":"Medicine; Aspirin; Ovarian cancer; Proportional hazards model; Internal medicine; Quartile; Oncology; Endometrial cancer; Body mass index; Endometriosis; Confidence interval; Cancer; Gynecology","score_opus":0.0195050206562738,"score_gpt":0.2608337593014934,"score_spread":0.2413287386452196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225473893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877656,0.00034987644,0.00003205959,0.0055344417,0.0004048396,0.0011424494,0.0003327066,0.0002536622,0.003173409],"genre_scores_gemma":[0.99422956,0.0002599283,0.00027771312,0.00033945887,0.000112538655,0.0024949233,0.00051612686,0.000057421625,0.0017123389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792534,0.00021281984,0.00037899494,0.0004648293,0.00066582405,0.00035221383],"domain_scores_gemma":[0.99862474,0.0002994897,0.00028093182,0.00039487568,0.00016130155,0.00023868869],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003368021,0.00026029907,0.00045818556,0.00013897433,0.0004096048,0.00003653288,0.00010950876,0.00008075243,0.016457785],"category_scores_gemma":[0.00013301306,0.00020150446,0.00012045184,0.0007029088,0.00004977174,0.00009087915,0.00006961037,0.00033941172,0.000021802713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004655743,0.00086534483,0.97964096,0.000015905858,0.0019068888,0.00015371952,0.00032296195,0.0019452695,0.000015503734,0.0013247185,0.0043706563,0.008972513],"study_design_scores_gemma":[0.010270967,0.0009144912,0.98227674,0.00013406304,0.0012602775,0.000010710707,0.00013045005,0.00059194304,0.0010500489,0.00020510229,0.0028755707,0.0002796139],"about_ca_topic_score_codex":0.015325196,"about_ca_topic_score_gemma":0.003476717,"teacher_disagreement_score":0.016435983,"about_ca_system_score_codex":0.0009117166,"about_ca_system_score_gemma":0.000523131,"threshold_uncertainty_score":0.99123186},"labels":[],"label_agreement":null},{"id":"W4225551590","doi":"10.1136/ijgc-2021-003319","title":"Interobserver and intraobserver variability of RECIST assessment in ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; Memorial University of Newfoundland; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Radiology; Nuclear medicine; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.03491300503856809,"score_gpt":0.3637118285953803,"score_spread":0.3287988235568122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225551590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826642,0.0007471655,0.000060764836,0.01400948,0.0014363405,0.00020678958,0.00010257135,0.0000036151657,0.00076905126],"genre_scores_gemma":[0.9964831,0.0009985868,0.0011116688,0.0010165452,0.00017716344,0.00011239634,0.000006443974,0.000008541609,0.00008555049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982438,0.00016791328,0.0006688938,0.00020472071,0.0005743329,0.00014033714],"domain_scores_gemma":[0.9987032,0.00030259838,0.00042059008,0.00010614833,0.00036981713,0.00009768415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008299474,0.00011804084,0.00042320887,0.0001417321,0.000032528158,0.000015584881,0.00021535903,0.00005262196,0.0068704556],"category_scores_gemma":[0.00016312471,0.00008968549,0.00013636064,0.00014816425,0.00007675791,0.00009806376,0.00018467828,0.0004568259,2.724293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080239924,0.0010486452,0.96985906,0.0000241601,0.0004631088,0.00031412276,0.00016931178,0.00072219624,0.00054623204,0.0014617715,0.0007004754,0.023888536],"study_design_scores_gemma":[0.0037130176,0.00083882204,0.9847884,0.00010480528,0.000096192445,0.0000794778,0.00009678408,0.00013854596,0.00025703857,0.0009616807,0.0088426825,0.00008250947],"about_ca_topic_score_codex":0.00068552664,"about_ca_topic_score_gemma":0.0002760722,"teacher_disagreement_score":0.023806026,"about_ca_system_score_codex":0.0016390418,"about_ca_system_score_gemma":0.0004865374,"threshold_uncertainty_score":0.9940374},"labels":[],"label_agreement":null},{"id":"W4225724899","doi":"","title":"Reproductive Factors Do Not Influence Survival with Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Western Australia; Cancer Research UK; National Institutes of Health; National Health and Medical Research Council; California Breast Cancer Research Program; U.S. Department of Defense","keywords":"Ovarian cancer; Medicine; Menarche; Fallopian tube cancer; Proportional hazards model; Oncology; Hazard ratio; Gynecology; Cancer; Internal medicine; Confidence interval","score_opus":0.024975126218227423,"score_gpt":0.28623236809524194,"score_spread":0.2612572418770145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225724899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98312443,0.0001731954,0.000014691174,0.0077146525,0.00028377096,0.00045813306,0.000061246225,0.000072954885,0.008096915],"genre_scores_gemma":[0.99554926,0.000039234896,0.00027680604,0.00077323534,0.00012362826,0.00033597669,0.000016021328,0.000022441836,0.0028634022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987219,0.00003785729,0.00013372807,0.0004942598,0.00040613054,0.0002061424],"domain_scores_gemma":[0.9992607,0.00004233834,0.000059706792,0.0004481308,0.00008381871,0.00010526412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000119396165,0.00014376869,0.00023933666,0.000057476715,0.00017129669,0.000017430975,0.00006932281,0.000018642815,0.004189158],"category_scores_gemma":[0.000019770454,0.00009613686,0.000048825572,0.0002823608,0.000044885506,0.000068081055,0.00006882232,0.00016833864,0.000010004364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005613514,0.00043303904,0.9889341,0.000017947443,0.0004201586,0.00012793341,0.0011363891,0.0006656649,0.00030399117,0.0031707636,0.0013100218,0.0029186553],"study_design_scores_gemma":[0.0020144833,0.00076162425,0.96461385,0.0000228484,0.0001757685,0.000024858218,0.0010589983,0.0000057855354,0.0053650234,0.00003880098,0.025752941,0.00016498606],"about_ca_topic_score_codex":0.0043314905,"about_ca_topic_score_gemma":0.00017098674,"teacher_disagreement_score":0.024442919,"about_ca_system_score_codex":0.00037535414,"about_ca_system_score_gemma":0.00025971874,"threshold_uncertainty_score":0.99672115},"labels":[],"label_agreement":null},{"id":"W4226032007","doi":"10.3390/curroncol29040231","title":"New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecologic oncology; Oncology; Internal medicine; Pandemic; Clinical Oncology; Clinical Practice; Cervical cancer; Coronavirus disease 2019 (COVID-19); Gynecology; Family medicine; Disease; Cancer","score_opus":0.23500199568914432,"score_gpt":0.4782000123658334,"score_spread":0.2431980166766891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226032007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008665435,0.994406,0.000008059809,0.00069896365,0.00052972464,0.003871698,0.00028602785,0.000010020401,0.00018085912],"genre_scores_gemma":[0.000014541008,0.99647444,0.0006404711,0.000059625952,0.00010150967,0.00214446,0.00046974755,0.000029073253,0.00006611591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847883,0.00019586772,0.0006088578,0.00039628975,0.00012796845,0.00019218952],"domain_scores_gemma":[0.9984931,0.0007466291,0.00037210304,0.00022174374,0.00003891074,0.00012755806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023638457,0.00026838307,0.002287781,0.00032947684,0.00004407149,0.0000071184063,0.0000729303,0.00012658672,0.00057370204],"category_scores_gemma":[0.00015981901,0.00020544462,0.0002317736,0.00045950673,0.000058739995,0.000025452753,0.000063908934,0.00020294281,0.0000014865839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039505343,0.0008568813,0.00026726926,0.019521566,0.0006663921,0.0000072228736,0.00009401925,7.602083e-9,2.3606855e-8,0.00066634367,0.004355881,0.97352487],"study_design_scores_gemma":[0.008681857,0.0016673075,0.0002168746,0.014095867,0.004335638,0.000021923483,0.000024278896,6.9120193e-7,1.3400098e-7,0.00010267117,0.9707272,0.0001255297],"about_ca_topic_score_codex":0.00014599532,"about_ca_topic_score_gemma":0.00004746983,"teacher_disagreement_score":0.97339934,"about_ca_system_score_codex":0.0008729281,"about_ca_system_score_gemma":0.001338715,"threshold_uncertainty_score":0.83777887},"labels":[],"label_agreement":null},{"id":"W4226059009","doi":"10.2139/ssrn.4082917","title":"Survival Prognostic and Surrogate Values of the Early Modeled Ca-125 Kelim Score in First-Line Treatment of Ovarian Cancer: Results from The Gcig Individual Patient Data Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Meta-analysis; Ovarian cancer; Oncology; Internal medicine; Medicine; Surrogate endpoint; First line; Patient data; Cancer; Computer science","score_opus":0.086785732277448,"score_gpt":0.2998434027716282,"score_spread":0.21305767049418017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226059009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573689,0.031845827,0.00002090148,0.0068062874,0.00010900534,0.0007902166,0.0030326962,0.000005315221,0.000020845164],"genre_scores_gemma":[0.99068743,0.008644302,0.000034097167,0.000051680337,0.00008913795,0.000117414296,0.00029186276,0.000020749212,0.00006333909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966727,0.0004995385,0.00079887087,0.00045522666,0.0008067224,0.0007669681],"domain_scores_gemma":[0.9977797,0.000502688,0.0006343607,0.000901933,0.0001046733,0.00007660907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00143182,0.00025421084,0.0009914188,0.00014404875,0.0002717121,0.00002729168,0.00038672774,0.000044473647,0.00009758301],"category_scores_gemma":[0.000093370356,0.00013170534,0.00048010325,0.00077174115,0.000092122245,0.00007858407,0.00025522342,0.0006282825,3.1055188e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024069538,0.0030062874,0.70601624,0.000015691916,0.25206032,0.000053422405,0.006660154,0.015602957,0.000014378429,0.0010501284,0.000088294044,0.013025146],"study_design_scores_gemma":[0.01705824,0.0065444997,0.63843894,0.00006379721,0.32282415,0.00008778355,0.0031407448,0.0034998576,0.00023738119,0.007314963,0.00045082992,0.00033880983],"about_ca_topic_score_codex":0.030105338,"about_ca_topic_score_gemma":0.06203094,"teacher_disagreement_score":0.070763834,"about_ca_system_score_codex":0.0008059918,"about_ca_system_score_gemma":0.0018939979,"threshold_uncertainty_score":0.9763533},"labels":[],"label_agreement":null},{"id":"W4226541608","doi":"10.1158/1078-0432.ccr-22-0336","title":"Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Genomics; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"University of Toronto; Ontario Institute for Cancer Research","keywords":"Ovarian cancer; Biology; Serous ovarian cancer; Stage (stratigraphy); Serous fluid; Cancer; Genome; Genetics; Gene","score_opus":0.3034459126468498,"score_gpt":0.49461046412122717,"score_spread":0.1911645514743774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226541608","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06254017,0.015556989,0.000003873953,0.90326685,0.0047777765,0.0027718402,0.0048924633,0.0002177529,0.005972271],"genre_scores_gemma":[0.07933813,0.026299015,0.00075145334,0.62988997,0.12680379,0.018967316,0.012620409,0.001303172,0.10402675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893282,0.0009158102,0.0017915145,0.0027021554,0.0032137088,0.0020486244],"domain_scores_gemma":[0.99326265,0.002422309,0.0005139113,0.002118103,0.00094817614,0.0007348495],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0027541486,0.0007975332,0.0021757772,0.00051100453,0.00072129344,0.00048723893,0.0011705521,0.0014355495,0.027070127],"category_scores_gemma":[0.0003691328,0.0006955959,0.00092494296,0.0012843637,0.00069671514,0.00015503702,0.00096986594,0.012647939,0.00044141227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034577174,0.0005954456,0.0678424,0.00040978842,0.0023945468,0.004442037,0.0004409012,0.000029907313,0.000029121189,0.000027178656,0.9116519,0.008679021],"study_design_scores_gemma":[0.0103045115,0.0011364843,0.042730484,0.0007261673,0.00078588014,0.000005351107,0.000043628443,0.000023095801,0.00002187105,0.00033304776,0.9432549,0.00063459034],"about_ca_topic_score_codex":0.06841059,"about_ca_topic_score_gemma":0.0012103363,"teacher_disagreement_score":0.27337688,"about_ca_system_score_codex":0.0027367335,"about_ca_system_score_gemma":0.0039555314,"threshold_uncertainty_score":0.9998608},"labels":[],"label_agreement":null},{"id":"W4229441317","doi":"10.3390/curroncol29050271","title":"Understanding the Experience of Canadian Women Living with Ovarian Cancer through the Every Woman StudyTM","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Manitoba; University of Toronto; Ovarian Cancer Canada","funders":"Ovarian Cancer Canada","keywords":"Medicine; Ovarian cancer; Cancer; Gynecology; Family medicine; Internal medicine","score_opus":0.20569565100591639,"score_gpt":0.38554271613050184,"score_spread":0.17984706512458545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229441317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628067,0.0035431995,0.00016514414,0.021781575,0.0017915841,0.0011849159,0.00005553331,0.000025168036,0.008646168],"genre_scores_gemma":[0.9966445,0.00040106496,0.000023943718,0.001085856,0.00013519518,0.0015607846,0.000003368887,0.000015149199,0.00013015507],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998751,0.00016912134,0.00018867514,0.00024079863,0.00026826683,0.00038216688],"domain_scores_gemma":[0.9991247,0.00026606538,0.00012712728,0.00033072536,0.000039662104,0.00011172907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026438793,0.00012662375,0.00025972226,0.0001053492,0.00056488795,0.000012382156,0.00020335501,0.00002488946,0.0014247472],"category_scores_gemma":[0.000023518409,0.0000682364,0.000044987406,0.00058286317,0.00020951414,0.000043970424,0.00010492127,0.00028742853,0.0000017184375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027374076,0.0014597839,0.58916914,0.000089245426,0.00081716396,0.00013293175,0.36120713,0.00057758664,0.000022057791,0.014835155,0.018993989,0.012422069],"study_design_scores_gemma":[0.002523478,0.0023607388,0.1894374,0.0001980675,0.00029320267,0.00011473923,0.26202884,0.00009561204,0.000023931441,0.00042535205,0.5422784,0.0002202183],"about_ca_topic_score_codex":0.028191345,"about_ca_topic_score_gemma":0.056305103,"teacher_disagreement_score":0.52328444,"about_ca_system_score_codex":0.0038370062,"about_ca_system_score_gemma":0.00131613,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W4229779432","doi":"10.1136/ijgc-00009577-200201000-00014","title":"Use of CA-125 and ultrasound in high-risk women","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ultrasound; Ovarian cancer; Gynecology; BRCA mutation; Population; Retrospective cohort study; Obstetrics; Cancer; Radiology; Internal medicine","score_opus":0.03750988866655887,"score_gpt":0.2948254529117063,"score_spread":0.25731556424514745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229779432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563146,0.0011687559,0.000010136119,0.0024807432,0.00039527603,0.000078285964,0.00004672043,0.0000023958605,0.00018624838],"genre_scores_gemma":[0.98764783,0.010990808,0.0004353096,0.0005547485,0.00016552504,0.000014994416,0.0000012450265,0.0000050873987,0.00018442818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990642,0.00003746219,0.00037498595,0.0001041589,0.00030038194,0.000118813776],"domain_scores_gemma":[0.9987088,0.0006210045,0.00027860375,0.000055848992,0.00023616172,0.00009959763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014458432,0.00008084947,0.00028351697,0.00012130103,0.000011552378,0.000018299388,0.00007684249,0.000060242844,0.0049425387],"category_scores_gemma":[0.0005316702,0.000054658816,0.00006251247,0.00007779308,0.00006626517,0.000112430804,0.00002180493,0.00017414872,0.0000037738798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002100862,0.0006521214,0.94317687,0.0000074349928,0.00036010362,0.0003396046,0.0002606395,0.00017611585,0.00021254308,0.00016663794,0.0015054147,0.052932423],"study_design_scores_gemma":[0.00277762,0.0008069492,0.9860401,0.000088840185,0.00005513168,0.00011213106,0.000046522066,0.000058694124,0.00026770317,0.00035030986,0.009341686,0.00005432006],"about_ca_topic_score_codex":0.00032068777,"about_ca_topic_score_gemma":0.00014812849,"teacher_disagreement_score":0.052878104,"about_ca_system_score_codex":0.0005135603,"about_ca_system_score_gemma":0.00004487914,"threshold_uncertainty_score":0.9959671},"labels":[],"label_agreement":null},{"id":"W4230561859","doi":"10.14740/jmc3196","title":"Laparoscopic Management of a Rare Case of Mature Cystic Teratoma With Immature Neural Tissue and Literature Review","year":2018,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian torsion; Mature Cystic Teratoma; Ovarian Teratoma; Gynecology; General surgery; Teratoma; Surgery","score_opus":0.011761281056166915,"score_gpt":0.31860068078685005,"score_spread":0.30683939973068314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230561859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7374652,0.25269523,0.000013628219,0.009147891,0.00019007719,0.00033353097,0.00003630734,0.000004925258,0.000113242466],"genre_scores_gemma":[0.967223,0.030196305,0.0013143606,0.00085101294,0.00032779574,0.0000055589203,0.000005724579,0.000012028242,0.000064218635],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99860364,0.00005588216,0.0004665922,0.00012809393,0.00062028394,0.00012552537],"domain_scores_gemma":[0.99881786,0.0000979549,0.0003435488,0.00018607902,0.00029067398,0.00026387285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025012856,0.00014546701,0.00063240214,0.00008013442,0.000027039876,0.000012835556,0.0000756784,0.00010955371,0.00031997016],"category_scores_gemma":[0.000111297086,0.00007828658,0.00007355111,0.00023485134,0.00015483885,0.000063951054,0.00003491756,0.00029217973,6.996125e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027935419,0.0011658684,0.004514338,0.03995094,0.0014643808,0.83100426,0.0009432404,3.82394e-7,0.00011407788,0.00040139136,0.04592854,0.071719036],"study_design_scores_gemma":[0.0112356255,0.013593711,0.017895477,0.22444601,0.0041383365,0.70809466,0.00063126057,0.000024119727,0.0034501113,0.000043513184,0.016207,0.00024020873],"about_ca_topic_score_codex":0.00000879695,"about_ca_topic_score_gemma":0.000010230561,"teacher_disagreement_score":0.22975782,"about_ca_system_score_codex":0.000024937535,"about_ca_system_score_gemma":0.00009384835,"threshold_uncertainty_score":0.3503449},"labels":[],"label_agreement":null},{"id":"W4230567452","doi":"10.1002/9781119263906.ch7","title":"GYNAECOLOGICAL TUMOURS","year":2021,"lang":"en","type":"other","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cervix; Gynecology; Vulva; Corpus Uteri; Medicine; Stage (stratigraphy); Ovary; Gestational trophoblastic disease; Vagina; Cancer; Fallopian tube; Pathology; Pregnancy; Anatomy; Internal medicine; Biology; Gestation","score_opus":0.025698559226420448,"score_gpt":0.3002212253966128,"score_spread":0.27452266617019233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230567452","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014609273,0.0041068913,0.0000099415765,0.0018947951,0.00035877473,0.00020704267,0.0000074154295,0.00010939899,0.99329114],"genre_scores_gemma":[0.0017607139,0.0007727965,0.0018699651,0.0012720763,0.0004290075,0.00004972291,0.00011189691,0.00015045621,0.9935834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994608,0.000009188974,0.00007097793,0.0002339594,0.00010757957,0.0001174511],"domain_scores_gemma":[0.99963975,0.000015630078,0.000029516963,0.00021419121,0.000010952422,0.000089944086],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000015279986,0.00012534877,0.0003085915,0.000047566115,0.000007048134,0.000007054317,0.000025309117,0.00017598475,0.39016047],"category_scores_gemma":[0.000011342831,0.00008208227,0.00010375853,0.000051469113,0.000019133262,0.0000015853409,0.000020784613,0.00008542852,0.00036700693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022898425,0.00025536682,0.008015868,0.00004399585,0.00014950619,0.0007784667,0.0000017156672,1.2924277e-8,7.5539486e-7,0.0009691503,0.98446447,0.0053183925],"study_design_scores_gemma":[0.0007110782,0.00012339871,0.039526384,0.00012760212,0.0001562899,0.000030988565,0.000008128708,4.427246e-7,0.0000353041,0.000011468444,0.95918375,0.00008517078],"about_ca_topic_score_codex":0.00010252352,"about_ca_topic_score_gemma":0.00009827126,"teacher_disagreement_score":0.38979346,"about_ca_system_score_codex":0.0000706519,"about_ca_system_score_gemma":0.00010235016,"threshold_uncertainty_score":0.61039704},"labels":[],"label_agreement":null},{"id":"W4231035683","doi":"10.5858/2007-131-979-secoto","title":"Sertoliform Endometrioid Carcinoma of the Ovary: A Potential Diagnostic Pitfall","year":2007,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Hamilton General Hospital","funders":"","keywords":"Ovary; Carcinoma; Pathology; Cytokeratin; Calretinin; Mucin; Stain; Population; Medicine; Biology; Internal medicine; Immunohistochemistry; Staining","score_opus":0.008752622261209379,"score_gpt":0.25562028945271326,"score_spread":0.24686766719150388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231035683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668855,0.005694729,0.0003574275,0.002791835,0.00060455606,0.0005813237,0.00008733803,0.000022041666,0.0031721673],"genre_scores_gemma":[0.9972814,0.0005433418,0.0008515618,0.0008620411,0.00032414813,0.000023155697,0.000023223218,0.000026728801,0.000064400636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981447,0.00012180084,0.0006642349,0.00032691684,0.0003741551,0.00036820082],"domain_scores_gemma":[0.997181,0.0014345525,0.0003543368,0.00068864727,0.0001525445,0.00018891432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048690935,0.0002283356,0.0007164861,0.00037012153,0.000066805405,0.000001280591,0.00022336771,0.00009917434,0.000121460034],"category_scores_gemma":[0.001156612,0.00013943874,0.00016057624,0.0006576929,0.0011980268,0.000034711764,0.00010187827,0.00025898332,0.000004672686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007646684,0.0009444332,0.8820019,0.00031603492,0.00031689455,0.0024775192,0.0028721346,0.0000047289777,0.094526134,0.0024258008,0.0007538219,0.012595956],"study_design_scores_gemma":[0.0054082666,0.001688795,0.94092035,0.00037358576,0.00054663175,0.00028170343,0.00041983346,0.0000072954226,0.048370555,0.00035410532,0.0015280216,0.00010082799],"about_ca_topic_score_codex":0.000103477716,"about_ca_topic_score_gemma":0.00004590492,"teacher_disagreement_score":0.05891851,"about_ca_system_score_codex":0.000044746426,"about_ca_system_score_gemma":0.00031426392,"threshold_uncertainty_score":0.56861466},"labels":[],"label_agreement":null},{"id":"W4231068622","doi":"10.3410/f.1050552.502457","title":"Faculty Opinions recommendation of The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.","year":2006,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Stromal cell; Chemokine; Senescence; Carcinogenesis; Cancer research; Oncogene; Biology; Cell biology; Medicine; Internal medicine; Cancer; Inflammation; Cell cycle","score_opus":0.02114014232064644,"score_gpt":0.3178510317561317,"score_spread":0.2967108894354853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231068622","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028036171,0.0011318111,0.000027291613,0.27249822,0.00046648926,0.0018450739,0.72397184,0.000015634714,0.000015608099],"genre_scores_gemma":[0.0009205683,0.0002989086,0.0007522287,0.0035247097,0.00044184097,0.00024380471,0.99343884,0.000032088526,0.0003469939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99551845,0.00040266837,0.0016488853,0.0006951515,0.0013912653,0.00034358253],"domain_scores_gemma":[0.99247575,0.00020279786,0.0015259132,0.0015276531,0.0039936807,0.00027417907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010872544,0.0005475068,0.001141843,0.00022466299,0.00026538214,0.00007679957,0.0010054313,0.00063872495,0.00017995122],"category_scores_gemma":[0.0022420923,0.00027264428,0.0005888682,0.0022219028,0.0003527579,0.00012949611,0.00048679233,0.00085852505,0.0000068958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004359237,0.0005276456,0.000114238326,0.004680067,0.00029830096,5.33231e-7,0.000088425106,0.0000011921626,0.000065776265,0.000118353,0.99267864,0.0013832432],"study_design_scores_gemma":[0.0012001932,0.00026387678,0.028510433,0.016492281,0.00067954743,0.000063166444,0.000017458802,0.000009657839,0.0011222007,0.0000112102325,0.9514008,0.00022913376],"about_ca_topic_score_codex":0.00033952334,"about_ca_topic_score_gemma":0.00003130062,"teacher_disagreement_score":0.269467,"about_ca_system_score_codex":0.00017291274,"about_ca_system_score_gemma":0.00067160255,"threshold_uncertainty_score":0.9999726},"labels":[],"label_agreement":null},{"id":"W4232401843","doi":"10.1158/1535-7163.targ-09-a9","title":"Abstract A9: Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pazopanib; Topotecan; Ovarian cancer; Medicine; Pharmacology; Paclitaxel; Chemotherapy; Ovarian carcinoma; Cancer; Bevacizumab; Oncology; Cancer research; Internal medicine; Sunitinib","score_opus":0.03545390850934368,"score_gpt":0.3495010082494963,"score_spread":0.31404709974015266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232401843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633308,0.019902276,0.0004578764,0.013490497,0.00015420686,0.0023594634,0.00023031433,0.000020742369,0.000053821823],"genre_scores_gemma":[0.99387217,0.0044121724,0.0002927911,0.0008325763,0.00011310936,0.0003448193,0.000023296176,0.000046990153,0.00006207385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985054,0.000057349127,0.00043691127,0.000342914,0.00028822065,0.00036921876],"domain_scores_gemma":[0.99849254,0.0001724377,0.00032786428,0.0007310784,0.00017125171,0.00010484469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017264085,0.00033700556,0.0006503973,0.00005904455,0.000095759184,0.000022440488,0.00020995422,0.000083961335,0.00010701013],"category_scores_gemma":[0.0000032780354,0.00016257708,0.00074210035,0.00022606636,0.00017070913,0.00003000218,0.000010967908,0.000109143715,8.7885576e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020900363,0.010294785,0.04999933,0.00018674678,0.031620797,0.00007676674,0.0031680122,0.015521766,0.03857106,0.00071078335,0.00063699577,0.8283126],"study_design_scores_gemma":[0.020688862,0.01335834,0.83312565,0.0002808201,0.007784127,0.000010034085,0.00018939182,0.0015127098,0.1183001,0.00019163512,0.0041420134,0.00041628684],"about_ca_topic_score_codex":0.0022602396,"about_ca_topic_score_gemma":0.00052368344,"teacher_disagreement_score":0.8278963,"about_ca_system_score_codex":0.00062494655,"about_ca_system_score_gemma":0.0007116965,"threshold_uncertainty_score":0.6629701},"labels":[],"label_agreement":null},{"id":"W4232807363","doi":"10.1002/14651858.cd011322","title":"Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer","year":2014,"lang":"en","type":"reference-entry","venue":"Cochrane Database of Systematic Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Hormone; Medicine; Oncology; Placebo; Cancer; Internal medicine; Hormone therapy; Ovarian cancer; Endocrinology; Breast cancer; Pathology","score_opus":0.08664724756462114,"score_gpt":0.3588850444642739,"score_spread":0.2722377968996528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232807363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028761395,0.9698741,0.0022614794,0.0006705331,0.001294471,0.01835567,0.0055522528,0.000031879,0.0016720032],"genre_scores_gemma":[0.0017480445,0.9807484,0.0032407192,0.00008498742,0.0013334616,0.0062743467,0.002878066,0.00014230607,0.0035496466],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99307424,0.0006605982,0.0038534503,0.00089818577,0.0009653401,0.0005482159],"domain_scores_gemma":[0.9895698,0.0021919876,0.0042614946,0.0032058505,0.0005219238,0.0002489519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016315668,0.0010074016,0.00727603,0.0002393758,0.00020982305,0.000054471395,0.0004620422,0.0003650758,0.000099618286],"category_scores_gemma":[0.0010301318,0.000534616,0.0015758101,0.0003548415,0.00019926984,0.00008892531,0.00006471074,0.00026175362,0.000040936466],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082607183,0.0017131702,0.000019267865,0.85370547,0.0043182457,0.000046762023,0.00073191134,0.0000030490971,0.0004002394,0.0003674227,0.079209894,0.05865848],"study_design_scores_gemma":[0.0106164,0.0029205007,0.00023045376,0.7232748,0.027758623,0.00011841416,0.00013323087,0.00022579863,0.00056425063,0.000020560328,0.2334624,0.00067452295],"about_ca_topic_score_codex":0.00091279973,"about_ca_topic_score_gemma":0.000052048137,"teacher_disagreement_score":0.1542525,"about_ca_system_score_codex":0.00070462475,"about_ca_system_score_gemma":0.00069454475,"threshold_uncertainty_score":0.99971056},"labels":[],"label_agreement":null},{"id":"W4233339371","doi":"10.1158/1538-7445.am2019-3450","title":"Abstract 3450: Impact of BRCA1 on glucocorticoid signaling in fallopian tube epithelial cells","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Glucocorticoid receptor; Cancer research; Ovarian cancer; Biology; Cell culture; Cancer cell; microRNA; Cancer; Glucocorticoid; Molecular biology; Endocrinology; Gene; Genetics","score_opus":0.06260917361986063,"score_gpt":0.4152076054125848,"score_spread":0.35259843179272415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233339371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901744,0.00049209705,4.781414e-7,0.0005354025,0.00019098633,0.0011220574,0.000064209744,0.000011039564,0.0074093146],"genre_scores_gemma":[0.9983572,0.00053389923,0.000021029331,0.000070580965,0.00018517852,0.00011395941,0.000010581536,0.000035962523,0.00067161274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979217,0.00006819949,0.00032526758,0.00041322166,0.000714333,0.000557289],"domain_scores_gemma":[0.99881625,0.00028024122,0.000063986,0.00047844584,0.0001799465,0.0001811537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005343128,0.00016026267,0.00042663448,0.00033361287,0.000027740612,0.000023450713,0.00014521841,0.00010269153,0.003227747],"category_scores_gemma":[0.000037687416,0.00012133955,0.00018172646,0.00044075688,0.00006776843,0.000059596005,0.000043754368,0.0004927075,0.00044695695],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015665534,0.0008625051,0.27721027,0.0004196837,0.00026385448,0.00014868744,0.00049146864,0.0031996935,0.7023344,0.00022325107,0.0006859702,0.012593641],"study_design_scores_gemma":[0.004427222,0.0018061923,0.61755264,0.0009191149,0.000020618338,0.0000022276065,0.00010439205,0.00009044058,0.37391013,0.000058729816,0.0009723492,0.00013594425],"about_ca_topic_score_codex":0.0053291023,"about_ca_topic_score_gemma":0.00017317165,"teacher_disagreement_score":0.34034237,"about_ca_system_score_codex":0.0011629693,"about_ca_system_score_gemma":0.001017457,"threshold_uncertainty_score":0.99768347},"labels":[],"label_agreement":null},{"id":"W4233576022","doi":"10.1002/9780471420194.tnmc79","title":"Gynaecological Tumours","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gynaecological cancer; Stage (stratigraphy); General surgery; Radiology; Gynecology; Cancer; Internal medicine; Biology","score_opus":0.03727294459624257,"score_gpt":0.3438018851851674,"score_spread":0.3065289405889248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233576022","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008672697,0.0023537145,0.0000031552563,0.0029985502,0.0006069849,0.0004221537,0.0022132448,0.000203442,0.99111205],"genre_scores_gemma":[0.0015161473,0.0013318983,0.0019621782,0.0006800798,0.0018683561,0.00005217534,0.002037934,0.00024573438,0.9903055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922466,0.000010909992,0.00010253214,0.00030606316,0.00015923029,0.0001965743],"domain_scores_gemma":[0.99908185,0.000024849754,0.0001509006,0.0005845829,0.000018445111,0.00013937928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000028378592,0.00021587645,0.0004919775,0.00008206789,0.000032300715,0.000012814555,0.000113556656,0.00026579332,0.07579836],"category_scores_gemma":[0.00006476274,0.00015100907,0.00013138377,0.000024021667,0.000070867776,0.000007065595,0.0000438069,0.00019032878,0.0007102599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012773078,0.0006285913,0.0025627064,0.000045678273,0.00014664316,0.0005839829,0.0000031245756,2.2624961e-8,5.755835e-7,0.00005549469,0.9646239,0.031336498],"study_design_scores_gemma":[0.0012246306,0.0002766185,0.056564167,0.00034925988,0.00026932746,0.00002615464,0.000002269959,0.000002392018,0.000004820026,0.000017636161,0.94113064,0.00013207896],"about_ca_topic_score_codex":0.00011882302,"about_ca_topic_score_gemma":0.00032382316,"teacher_disagreement_score":0.075088106,"about_ca_system_score_codex":0.000096668235,"about_ca_system_score_gemma":0.0001408139,"threshold_uncertainty_score":0.9250465},"labels":[],"label_agreement":null},{"id":"W4234586607","doi":"10.1136/ijgc-00009577-200311001-00003","title":"Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Paclitaxel; Cisplatin; Oncology; Regimen; Cyclophosphamide; Internal medicine; Chemotherapy; Ovarian cancer; Randomized controlled trial; Cancer","score_opus":0.02135910307198088,"score_gpt":0.3313539977105257,"score_spread":0.30999489463854485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234586607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843428,0.0021078603,0.00006955963,0.0073206984,0.0038106688,0.0005739836,0.000057597423,0.0000067629558,0.0017100846],"genre_scores_gemma":[0.99629074,0.0017342047,0.00013128994,0.0009749547,0.00016465508,0.000106555075,0.0000058291293,0.000019501176,0.0005722723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974118,0.00023210712,0.0008837221,0.0002536048,0.00095083995,0.0002679219],"domain_scores_gemma":[0.99739116,0.0007243287,0.00093532016,0.00023957939,0.00060446747,0.00010512054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068251777,0.00022925282,0.00053175393,0.000112391645,0.00006993782,0.00003468343,0.0004080574,0.0001348169,0.002549846],"category_scores_gemma":[0.0006836372,0.00012293865,0.0003198565,0.00028466934,0.000162448,0.00017096897,0.000068707515,0.00046409905,0.0000028446414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010742234,0.0006508138,0.97275215,0.00002200601,0.0005288443,0.00017971858,0.00028075578,0.00034809826,0.000635377,0.0056733503,0.0003595349,0.017495152],"study_design_scores_gemma":[0.01084804,0.00044325396,0.9820131,0.00045711471,0.00016979732,0.000053248248,0.00013290827,0.000037048543,0.0024478363,0.001005499,0.0022612175,0.0001309544],"about_ca_topic_score_codex":0.00023270323,"about_ca_topic_score_gemma":0.0010944527,"teacher_disagreement_score":0.017364196,"about_ca_system_score_codex":0.0009606223,"about_ca_system_score_gemma":0.0005019562,"threshold_uncertainty_score":0.99836195},"labels":[],"label_agreement":null},{"id":"W4235037090","doi":"10.1016/j.ygyno.2020.05.207","title":"Biomarkers of outcome with weekly paclitaxel in platinum-resistant high-grade serous or endometrioid ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Ontario Institute for Cancer Research; Credit Valley Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Paclitaxel; Oncology; Internal medicine; Serous fluid; Ovarian carcinoma; Carcinoma; Ovarian cancer; Chemotherapy; Cancer","score_opus":0.05811571679446622,"score_gpt":0.3125169968771578,"score_spread":0.2544012800826916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235037090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96818423,0.00036646877,0.000040266732,0.026568793,0.00024746088,0.0013006913,0.00009108149,0.00007029416,0.0031306955],"genre_scores_gemma":[0.98885834,0.00007185106,0.008123592,0.0024067108,0.00009088674,0.0002257748,0.000040762625,0.000032499327,0.00014955559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997521,0.00021009355,0.0008192502,0.00062651414,0.0002772009,0.000545974],"domain_scores_gemma":[0.9974319,0.001440698,0.00037059258,0.00035804085,0.00008701688,0.00031178835],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032391018,0.0003243866,0.0013345821,0.00029094703,0.00005270239,0.000009685849,0.0001842248,0.00031537493,0.0011202238],"category_scores_gemma":[0.00079764216,0.00020938368,0.00011090494,0.0010641494,0.00021041445,0.00005585923,0.00008998114,0.00030415674,0.00003767817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065336823,0.0020440773,0.9685014,0.0002448728,0.00056143507,0.0066254498,0.0005995317,0.000029459497,0.0015295256,0.00084570167,0.0013478531,0.0111369975],"study_design_scores_gemma":[0.020479986,0.028734947,0.94018745,0.000040399038,0.00037063358,0.00010471992,0.0008589662,0.000043741184,0.00096021337,0.000077129574,0.007897367,0.00024445282],"about_ca_topic_score_codex":0.001052085,"about_ca_topic_score_gemma":0.0019429228,"teacher_disagreement_score":0.028313968,"about_ca_system_score_codex":0.0008482265,"about_ca_system_score_gemma":0.0006693945,"threshold_uncertainty_score":0.9997929},"labels":[],"label_agreement":null},{"id":"W4235223714","doi":"10.1200/jco.2021.39.15_suppl.5504","title":"Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer: Final analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Internal medicine; Adverse effect; Cancer; Sorafenib; Cohort; Gastroenterology; Oncology; Surgery; Chemotherapy","score_opus":0.04251350568788086,"score_gpt":0.3952454323940415,"score_spread":0.3527319267061606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235223714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872435,0.0007791483,0.00014669674,0.010594561,0.0004784659,0.00040437462,0.000025799445,0.000008894238,0.00031857187],"genre_scores_gemma":[0.9910966,0.0011962424,0.006237398,0.0009919527,0.00022796362,0.000019344765,0.00011957859,0.000031012252,0.00007991333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952275,0.00068082963,0.0025769903,0.00048006757,0.00061908265,0.0004155066],"domain_scores_gemma":[0.9948618,0.0015851617,0.0019834763,0.00024287701,0.0010035308,0.0003231642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018304094,0.00028483284,0.0024456924,0.00043619022,0.000054666863,0.000029981331,0.00013052668,0.00027556982,0.00030279002],"category_scores_gemma":[0.0012918289,0.00019967565,0.00032880766,0.0012434239,0.00013067391,0.00022732743,0.000042143638,0.0011084129,0.0000071051877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010047222,0.008030042,0.94437397,0.0000494759,0.0019576265,0.002682995,0.00027249692,0.00077427103,0.000022591277,0.00007347502,0.000500646,0.0312152],"study_design_scores_gemma":[0.066932894,0.012635397,0.9140017,0.00081576867,0.0021514725,0.000056436456,0.0001149579,0.0006786359,0.000094661424,0.00007994541,0.002229149,0.00020897374],"about_ca_topic_score_codex":0.0005364954,"about_ca_topic_score_gemma":0.0043586837,"teacher_disagreement_score":0.05688567,"about_ca_system_score_codex":0.0007684737,"about_ca_system_score_gemma":0.0028641566,"threshold_uncertainty_score":0.8142536},"labels":[],"label_agreement":null},{"id":"W4235319548","doi":"10.3410/f.14256991.15768136","title":"Faculty Opinions recommendation of Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.","year":2012,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Predictive value; Family medicine; Ovarian cancer; Medicine; Value (mathematics); Psychology; Gynecology; Cancer; Internal medicine; Statistics; Mathematics","score_opus":0.0404473608625955,"score_gpt":0.3925462180676856,"score_spread":0.3520988572050901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235319548","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010023139,0.008793299,0.00038294634,0.10269184,0.00077798456,0.0026879688,0.8846233,0.000019394136,0.000013254084],"genre_scores_gemma":[0.00079594273,0.0017630112,0.0010597451,0.0011700781,0.00030537727,0.0009807713,0.993743,0.000032183423,0.00014986067],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953221,0.00038245332,0.002362883,0.0006096251,0.001036984,0.00028593894],"domain_scores_gemma":[0.988788,0.00022257715,0.0038038213,0.0010427037,0.00584063,0.00030228464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012199329,0.00048571275,0.001644196,0.00029724734,0.00011881198,0.000032966618,0.0004155467,0.0006242802,0.00020882835],"category_scores_gemma":[0.003286727,0.00032180912,0.00056405604,0.0009737108,0.00040277117,0.00027912692,0.00020068168,0.00054932304,0.0000017216007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079347155,0.0017545121,0.0008105147,0.01388485,0.0012206186,1.10219325e-7,0.0001920111,4.7836176e-7,0.0000075051416,0.0003752324,0.97328764,0.0083872015],"study_design_scores_gemma":[0.0020506608,0.00072012295,0.01934501,0.026781086,0.002035039,0.000030635463,0.000017434253,0.000067450695,0.00021400188,0.000017883007,0.9484893,0.00023138768],"about_ca_topic_score_codex":0.00041831663,"about_ca_topic_score_gemma":0.000010227286,"teacher_disagreement_score":0.109119736,"about_ca_system_score_codex":0.00024246129,"about_ca_system_score_gemma":0.000656074,"threshold_uncertainty_score":0.9999234},"labels":[],"label_agreement":null},{"id":"W4237318997","doi":"10.1016/j.jacr.2013.07.017","title":"ACR Appropriateness Criteria Staging and Follow-up of Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ovarian cancer; Radiology; Stage (stratigraphy); Debulking; Cancer; Internal medicine","score_opus":0.014819656084818328,"score_gpt":0.28559942327535065,"score_spread":0.2707797671905323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237318997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98701763,0.0012404607,0.000047549987,0.010674255,0.00058895024,0.0002539344,0.00004695445,0.0000025490506,0.00012772874],"genre_scores_gemma":[0.9962122,0.0009706167,0.002025396,0.0004250496,0.00017645687,0.000014681138,3.9398174e-7,0.000014477077,0.00016074275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989035,0.0001403725,0.00049450976,0.00012207753,0.000165974,0.00017356947],"domain_scores_gemma":[0.99824023,0.00013433641,0.0010124965,0.00023424221,0.00027739524,0.000101278296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022903606,0.00012341593,0.0008642081,0.000116495525,0.00003834694,0.0000039938,0.00016008364,0.00003734613,0.00014519454],"category_scores_gemma":[0.00007860749,0.00007200505,0.00017436797,0.00024225259,0.00040301852,0.000061270344,0.000054403845,0.00013716228,5.2288084e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002792598,0.00063574157,0.8413941,0.00032769446,0.003435422,0.00019497958,0.0013261514,0.000067459834,0.07876015,0.0011458629,0.035624303,0.034295518],"study_design_scores_gemma":[0.0067047006,0.002228611,0.975382,0.00037045343,0.0007311304,0.0018233169,0.0013477507,0.0001385518,0.008385979,0.0006359698,0.0021105586,0.00014101643],"about_ca_topic_score_codex":0.00073460286,"about_ca_topic_score_gemma":0.000013729733,"teacher_disagreement_score":0.13398784,"about_ca_system_score_codex":0.000096553136,"about_ca_system_score_gemma":0.00027908757,"threshold_uncertainty_score":0.2936281},"labels":[],"label_agreement":null},{"id":"W4237319018","doi":"10.1080/00016340500460573","title":"BOOK REVIEW","year":2006,"lang":"fr","type":"article","venue":"Acta Obstetricia Et Gynecologica Scandinavica","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CLARITY; Subject (documents); Gynecology; Library science","score_opus":0.013844514438679574,"score_gpt":0.2906914877558815,"score_spread":0.2768469733172019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237319018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005292053,0.7659606,0.000007565198,0.1233597,0.004943356,0.0017492624,0.00013012448,0.00014520566,0.10317498],"genre_scores_gemma":[0.15392028,0.64647406,0.00032894054,0.09709158,0.0010636986,0.00040810474,0.00024431312,0.00007724835,0.10039176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952373,0.00042803172,0.0010886501,0.0010928677,0.0007084056,0.0014447658],"domain_scores_gemma":[0.99470425,0.003063645,0.0005181462,0.0010059101,0.00024632708,0.00046170797],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00061235134,0.00074030535,0.0014844894,0.00025664398,0.00027815986,0.00010457034,0.00038976042,0.0006201051,0.049049903],"category_scores_gemma":[0.0014485259,0.00061530527,0.0005837365,0.0016045434,0.0002844258,0.00033670774,0.0001957062,0.00076502527,0.002241502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031611045,0.0025110715,0.012253726,0.0016798229,0.00026699487,0.0013809113,0.000021990678,0.000004739694,0.000025558375,0.0035810077,0.9544218,0.023820724],"study_design_scores_gemma":[0.0022473505,0.0012941328,0.16618268,0.0054273675,0.0016681416,0.00012248589,0.000019507694,0.000014656133,0.00011591704,0.00020913382,0.822184,0.0005146114],"about_ca_topic_score_codex":0.0005868898,"about_ca_topic_score_gemma":0.000059323447,"teacher_disagreement_score":0.15392897,"about_ca_system_score_codex":0.0019788505,"about_ca_system_score_gemma":0.0005793009,"threshold_uncertainty_score":0.99962986},"labels":[],"label_agreement":null},{"id":"W4237393521","doi":"10.1016/j.jogc.2019.03.007","title":"Excerpts from World Medical Literature","year":2019,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ovarian cancer; Cohort; Cancer; Obstetrics; Ultrasound; Gynecology; Cohort study; Ascites; Radiology; Surgery; Internal medicine","score_opus":0.00693703128696231,"score_gpt":0.22908943481114372,"score_spread":0.22215240352418142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237393521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550024,0.023730662,0.000002612617,0.005313956,0.012150315,0.00010987255,0.000025644553,0.0000024962249,0.003661989],"genre_scores_gemma":[0.99577034,0.0006643965,0.00026407046,0.0024445932,0.00010036757,0.0000012337754,0.000007897842,0.000008701299,0.0007384243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989358,0.00002636509,0.0003173162,0.00012544871,0.0004360213,0.00015905357],"domain_scores_gemma":[0.9977897,0.0013728567,0.00018533906,0.00012015104,0.00018248001,0.00034946937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011236593,0.00010138193,0.00038923766,0.00016941145,0.00002628529,0.000018225102,0.00007491144,0.0001108312,0.0050124107],"category_scores_gemma":[0.00082733546,0.00007107361,0.0000613578,0.00030048352,0.000020899532,0.000040441566,0.000025460804,0.00036757477,0.0000038117373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013704309,0.00015246213,0.85591537,0.00003640591,0.0003857646,0.012464592,0.00007298296,0.000002957754,0.0000051093016,0.00025309605,0.020109387,0.110588156],"study_design_scores_gemma":[0.0038407592,0.00034176497,0.85406137,0.000052334126,0.00011715122,0.00010254184,0.000034832086,0.000023962537,0.000022405722,0.0001282674,0.14120431,0.00007032437],"about_ca_topic_score_codex":0.007886933,"about_ca_topic_score_gemma":0.03126397,"teacher_disagreement_score":0.12109492,"about_ca_system_score_codex":0.0006469315,"about_ca_system_score_gemma":0.0020152903,"threshold_uncertainty_score":0.99871963},"labels":[],"label_agreement":null},{"id":"W4237961382","doi":"10.1016/s0360-3016(02)03171-1","title":"Consolidative abdomino-pelvic radiotherapy following surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Carboplatin; Chemotherapy; Radiation therapy; Stage (stratigraphy); Ovarian cancer; Paclitaxel; Pelvic cavity; Surgery; Cancer; Radiology; Oncology; Internal medicine; Urology; Cisplatin","score_opus":0.03264334969713428,"score_gpt":0.345788638261055,"score_spread":0.3131452885639207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237961382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9431868,0.008453536,0.010816393,0.03071124,0.005238334,0.00082266354,0.00029896852,0.000042388783,0.00042966113],"genre_scores_gemma":[0.980156,0.0075184503,0.005348756,0.0030804786,0.003654747,0.0000768167,0.000040215895,0.000043791344,0.00008073116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984712,0.00012362411,0.0006737163,0.0002710792,0.00021322259,0.00024712842],"domain_scores_gemma":[0.9973547,0.0011250742,0.0008339069,0.00012369837,0.0004110061,0.0001516211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043467648,0.00023273253,0.0007364535,0.00016844283,0.00008858173,0.0000353647,0.00013539003,0.00020310558,0.00020435125],"category_scores_gemma":[0.00017804452,0.00019751402,0.0004123902,0.00011234459,0.00013551474,0.00020430253,0.000014324621,0.00023361627,0.000004182324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000997588,0.0007651245,0.3702559,0.000018017974,0.0041641206,0.000066625376,0.0015785096,0.000080043734,0.0040962812,0.0030885895,0.0047729407,0.61011624],"study_design_scores_gemma":[0.14549187,0.008453869,0.32646835,0.0010679674,0.0028399022,0.0012010662,0.0005968556,0.023420108,0.03176054,0.021897784,0.43495482,0.0018468729],"about_ca_topic_score_codex":0.000052286632,"about_ca_topic_score_gemma":0.0000060384373,"teacher_disagreement_score":0.6082694,"about_ca_system_score_codex":0.0008553099,"about_ca_system_score_gemma":0.0003651935,"threshold_uncertainty_score":0.8054388},"labels":[],"label_agreement":null},{"id":"W4238100782","doi":"10.1097/igc.0000000000000134","title":"Risk Factors for Ovarian Cancers With and Without Microsatellite Instability","year":2014,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Women's College Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Microsatellite instability; Ovarian cancer; Tubal ligation; Body mass index; Oncology; Population; Internal medicine; Gynecology; Cancer; Microsatellite; Genetics; Family planning; Biology; Gene","score_opus":0.022629015554519207,"score_gpt":0.31516892783707556,"score_spread":0.2925399122825564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238100782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425805,0.00040860067,0.0013144434,0.002829886,0.00054666563,0.00024936386,0.000072942385,0.000008405928,0.00031165124],"genre_scores_gemma":[0.99469537,0.0008631193,0.0033463566,0.00064644904,0.00034130577,0.00003465896,0.0000054845304,0.000010823895,0.000056461722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990444,0.000040200546,0.00030531496,0.00018599721,0.00027768582,0.0001463547],"domain_scores_gemma":[0.99851424,0.00036998338,0.00034082902,0.000080378726,0.0005356592,0.00015893395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027267289,0.0001320817,0.00033164016,0.00006542497,0.000050480932,0.000037335274,0.00010264858,0.000068452835,0.0002628256],"category_scores_gemma":[0.00033535218,0.00007510572,0.00010883106,0.000045634795,0.000114974704,0.00008791064,0.000020454965,0.00016539892,6.372619e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013548932,0.00015853903,0.9624984,0.000013443676,0.0005845092,0.000009047235,0.00013817052,0.00013225572,0.0001315253,0.00028612412,0.00014974934,0.034543324],"study_design_scores_gemma":[0.0046875775,0.0017882098,0.95958436,0.00008468015,0.00025925224,0.0000482622,0.000056831163,0.000120496676,0.0010469621,0.0005127523,0.031713538,0.00009709216],"about_ca_topic_score_codex":0.00028925532,"about_ca_topic_score_gemma":0.00034191273,"teacher_disagreement_score":0.034446232,"about_ca_system_score_codex":0.0005720169,"about_ca_system_score_gemma":0.0002278915,"threshold_uncertainty_score":0.30627224},"labels":[],"label_agreement":null},{"id":"W4238609955","doi":"10.53347/rid-9230","title":"Immature ovarian teratoma","year":2010,"lang":"fr","type":"reference-entry","venue":"Radiopaedia.org","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian Teratoma; Teratoma; Biology; Medicine; Pathology","score_opus":0.01994201238534075,"score_gpt":0.2811749806910419,"score_spread":0.26123296830570114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238609955","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04392896,0.36618596,0.000044620258,0.022987826,0.08782572,0.004057311,0.002664124,0.0005670075,0.47173846],"genre_scores_gemma":[0.20583102,0.33214465,0.0022447002,0.0030326291,0.093901545,0.0011259164,0.004963358,0.00081388815,0.35594228],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931258,0.00025923186,0.0013342011,0.0019401804,0.0012873488,0.002053261],"domain_scores_gemma":[0.9946871,0.00043604916,0.0006952814,0.0022345365,0.00035056617,0.0015965063],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00048400272,0.0017695329,0.0026050496,0.000524742,0.00043331322,0.00020731337,0.0007597376,0.0034691948,0.013727455],"category_scores_gemma":[0.00026143494,0.0015194946,0.001144206,0.0007673389,0.0004572039,0.0002615246,0.0002471823,0.0049742493,0.00657025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015024093,0.0042794086,0.1340371,0.0049350755,0.006150021,0.011548377,0.001928624,0.000005581766,0.0002975271,0.008996498,0.45142466,0.3748947],"study_design_scores_gemma":[0.0050795483,0.0007549219,0.17951512,0.0052262763,0.0028895042,0.0008578699,0.00010480274,0.000030380295,0.0008082522,0.00009724007,0.8035402,0.0010958564],"about_ca_topic_score_codex":0.00048269294,"about_ca_topic_score_gemma":0.00015660025,"teacher_disagreement_score":0.37379888,"about_ca_system_score_codex":0.0016945754,"about_ca_system_score_gemma":0.0027529662,"threshold_uncertainty_score":0.99950504},"labels":[],"label_agreement":null},{"id":"W4238943502","doi":"10.1200/jco.2011.29.18_suppl.lba5006","title":"Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver Coastal Health","funders":"","keywords":"Medicine; Bevacizumab; Interim analysis; Ovarian cancer; Hazard ratio; Carboplatin; Oncology; Internal medicine; Debulking; Chemotherapy; Progression-free survival; Randomized controlled trial; Stage (stratigraphy); Gynecology; Surgery; Cancer; Confidence interval; Cisplatin","score_opus":0.13469147201117654,"score_gpt":0.46080574676548364,"score_spread":0.3261142747543071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238943502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945705,0.00024527014,0.00005729709,0.002424631,0.0004867228,0.0008194478,0.000025615127,0.0000015005917,0.0013690423],"genre_scores_gemma":[0.9966166,0.0019583197,0.0007081963,0.00039614813,0.00022088675,0.00007160793,0.0000031898524,0.000010414075,0.000014626188],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99246716,0.0018167871,0.004797974,0.0002105223,0.00047764136,0.0002299196],"domain_scores_gemma":[0.98823434,0.006582408,0.004304704,0.00033912424,0.0003796745,0.0001597764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009411473,0.00017094596,0.0053397315,0.0004930085,0.000009708348,0.0000031488407,0.00026593087,0.00024502364,0.00039694345],"category_scores_gemma":[0.0027523579,0.00009096101,0.0007854634,0.0006394176,0.0004009593,0.00007498401,0.000034107867,0.0005636938,2.4583605e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92484665,0.014567418,0.019994415,0.000028525077,0.0061055184,0.00046738752,0.003946074,0.000063773325,0.000027381495,0.0002420143,0.00008169643,0.029629176],"study_design_scores_gemma":[0.8218407,0.029531166,0.143292,0.00022952507,0.0038178382,0.000007502187,0.0006411259,0.00008065671,0.0000807825,0.00018350249,0.00022968253,0.000065555956],"about_ca_topic_score_codex":0.0034819792,"about_ca_topic_score_gemma":0.0027821788,"teacher_disagreement_score":0.12329757,"about_ca_system_score_codex":0.00025793523,"about_ca_system_score_gemma":0.0017386681,"threshold_uncertainty_score":0.52637345},"labels":[],"label_agreement":null},{"id":"W4238960738","doi":"10.1515/iupac.88.1399","title":"Teratocarcinoma","year":2017,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Philosophy; Data mining","score_opus":0.02471962620641973,"score_gpt":0.4512089959790612,"score_spread":0.4264893697726415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238960738","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025392883,0.002785994,0.0000035999733,0.0027574352,0.0008811966,0.00063039147,0.9924028,0.000047169633,0.00023750534],"genre_scores_gemma":[0.00033069128,0.0016509492,0.00008523859,0.0008110978,0.0017462915,0.000067360335,0.9945362,0.00004760332,0.00072457397],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769074,0.00002870083,0.00036931311,0.0006040534,0.0009226747,0.00038454117],"domain_scores_gemma":[0.9971419,0.00003640974,0.0002868229,0.0018630271,0.0003665387,0.0003053239],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020963214,0.00047008524,0.0009725105,0.00016703953,0.00018632674,0.000121071156,0.0002706859,0.00036390836,0.0037329108],"category_scores_gemma":[0.00022358901,0.0003667688,0.00030506955,0.0000636311,0.00012860155,0.00005596927,0.00012535059,0.0005062401,0.000013760907],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025650588,0.0007783035,0.00075689045,0.0002949088,0.00045251765,0.0015615394,0.0000063867224,1.221625e-7,6.949161e-7,0.0000037523582,0.9903404,0.0055479906],"study_design_scores_gemma":[0.0031815567,0.0008940377,0.0052386466,0.0009634823,0.0010433317,0.00013340349,0.0000062002136,0.0000017621456,0.000020191766,0.000024848714,0.98818487,0.00030768014],"about_ca_topic_score_codex":0.0003558721,"about_ca_topic_score_gemma":0.0006100408,"teacher_disagreement_score":0.0052403104,"about_ca_system_score_codex":0.00069951016,"about_ca_system_score_gemma":0.0016755017,"threshold_uncertainty_score":0.9998784},"labels":[],"label_agreement":null},{"id":"W4238978858","doi":"10.1002/9780471420194.tnmc30.pub3","title":"Gynaecological Tumours","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine","score_opus":0.03727294459624257,"score_gpt":0.3438018851851674,"score_spread":0.3065289405889248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238978858","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008672697,0.0023537145,0.0000031552563,0.0029985502,0.0006069849,0.0004221537,0.0022132448,0.000203442,0.99111205],"genre_scores_gemma":[0.0015161473,0.0013318983,0.0019621782,0.0006800798,0.0018683561,0.00005217534,0.002037934,0.00024573438,0.9903055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922466,0.000010909992,0.00010253214,0.00030606316,0.00015923029,0.0001965743],"domain_scores_gemma":[0.99908185,0.000024849754,0.0001509006,0.0005845829,0.000018445111,0.00013937928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000028378592,0.00021587645,0.0004919775,0.00008206789,0.000032300715,0.000012814555,0.000113556656,0.00026579332,0.07579836],"category_scores_gemma":[0.00006476274,0.00015100907,0.00013138377,0.000024021667,0.000070867776,0.000007065595,0.0000438069,0.00019032878,0.0007102599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012773078,0.0006285913,0.0025627064,0.000045678273,0.00014664316,0.0005839829,0.0000031245756,2.2624961e-8,5.755835e-7,0.00005549469,0.9646239,0.031336498],"study_design_scores_gemma":[0.0012246306,0.0002766185,0.056564167,0.00034925988,0.00026932746,0.00002615464,0.000002269959,0.000002392018,0.000004820026,0.000017636161,0.94113064,0.00013207896],"about_ca_topic_score_codex":0.00011882302,"about_ca_topic_score_gemma":0.00032382316,"teacher_disagreement_score":0.075088106,"about_ca_system_score_codex":0.000096668235,"about_ca_system_score_gemma":0.0001408139,"threshold_uncertainty_score":0.9250465},"labels":[],"label_agreement":null},{"id":"W4239417395","doi":"10.21203/rs.3.rs-21535/v1","title":"Ovarian Cancer: Diagnostic Accuracy and Tumor Types Distribution in East Africa compared to North America","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ovarian cancer; Distribution (mathematics); Geography; Cancer; Oncology; Medicine; Demography; Internal medicine; Sociology; Mathematics","score_opus":0.08762684597288126,"score_gpt":0.39312249410147304,"score_spread":0.30549564812859176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239417395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87650037,0.01301036,0.00025817426,0.09200479,0.00041818112,0.008887213,0.007565296,0.00018267414,0.001172954],"genre_scores_gemma":[0.9924373,0.0028780785,0.00020255079,0.00019074927,0.0003802904,0.0023248505,0.0014998303,0.000043114007,0.00004321214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969261,0.00025460107,0.00038033276,0.00093644083,0.0008259212,0.000676576],"domain_scores_gemma":[0.9973632,0.0008920812,0.00009725201,0.0005784626,0.0003697466,0.0006992255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020356788,0.0003180323,0.00074259634,0.0002563403,0.00013061555,0.00013954805,0.00022158667,0.00011174868,0.00025491393],"category_scores_gemma":[0.0022461116,0.0002831681,0.000100602985,0.00095049624,0.00012792324,0.000047585167,0.00081246946,0.0011004946,0.0001310819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015324268,0.0016929493,0.8608972,0.0038673314,0.0005391303,0.0027662648,0.0071622394,0.0012051078,0.000048175138,0.00023574504,0.047237843,0.07281563],"study_design_scores_gemma":[0.0016033876,0.000567827,0.9304664,0.002761613,0.000109969245,0.0000065422428,0.0004349267,0.0007351255,0.00004791696,0.00016887908,0.06281595,0.00028143678],"about_ca_topic_score_codex":0.004987202,"about_ca_topic_score_gemma":0.0013020018,"teacher_disagreement_score":0.11593697,"about_ca_system_score_codex":0.0011264065,"about_ca_system_score_gemma":0.0010142718,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W4239556158","doi":"10.3390/curroncol18060003","title":"Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective","year":2011,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Dalhousie University; Hamilton Health Sciences; BC Cancer Agency; Hôtel-Dieu de Québec; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Ottawa Hospital; London Health Sciences Centre; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Perspective (graphical); Ovarian cancer; Corporation; Gynecology; Family medicine; Oncology; Cancer; Internal medicine; Political science; Computer science; Artificial intelligence; Law","score_opus":0.27519082017665064,"score_gpt":0.4811720943517004,"score_spread":0.20598127417504974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239556158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015107785,0.98508894,7.0565017e-7,0.0024893202,0.0034052022,0.004149501,0.00030667995,0.000032884847,0.004525266],"genre_scores_gemma":[0.000007898225,0.99395347,0.00017201644,0.00037542588,0.00040074374,0.0046680938,0.00017664461,0.00007460644,0.00017108936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997032,0.00033851218,0.0007518893,0.0009997407,0.0001906604,0.00068718987],"domain_scores_gemma":[0.9978099,0.000109122455,0.00041520808,0.0007522828,0.00020513886,0.0007083578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032192923,0.0006404366,0.0035869202,0.00038608842,0.00008389932,0.000012160184,0.00029158493,0.00041888334,0.000849604],"category_scores_gemma":[0.00020628021,0.00047547274,0.0003172388,0.00045228587,0.00015067616,0.00005529876,0.00014300575,0.0008106816,0.000036108388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000023399813,0.0005058607,0.0007136556,0.016492257,0.00026436054,0.00026361342,0.00035835322,3.4194858e-9,6.8660073e-9,0.0008870657,0.010510733,0.9699807],"study_design_scores_gemma":[0.0018877368,0.00047008527,0.00066866697,0.07952608,0.0022777147,0.00015153729,0.00009089941,3.1802045e-7,5.4874686e-8,0.00006010775,0.91449755,0.00036925648],"about_ca_topic_score_codex":0.034559224,"about_ca_topic_score_gemma":0.12222317,"teacher_disagreement_score":0.9696114,"about_ca_system_score_codex":0.0050700335,"about_ca_system_score_gemma":0.006195114,"threshold_uncertainty_score":0.9997697},"labels":[],"label_agreement":null},{"id":"W4240257889","doi":"10.1016/j.jpag.2018.03.010","title":"Adnexal Torsion","year":2018,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian torsion; Torsion (gastropod); Fallopian tube; Presentation (obstetrics); Gynecology; Adnexal Diseases; General surgery; Surgery; Laparoscopy","score_opus":0.016021009622223567,"score_gpt":0.28198811911423965,"score_spread":0.2659671094920161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240257889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925208,0.0026436308,0.00010670986,0.002820907,0.001089441,0.00010251422,0.0000015555162,0.000006157671,0.00070825673],"genre_scores_gemma":[0.98979616,0.0039656963,0.0006848193,0.0011364373,0.0042451066,8.4800087e-7,6.5645844e-7,0.0000074164736,0.00016288151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931675,0.000026797123,0.00027715522,0.00010103875,0.00012759777,0.00015064813],"domain_scores_gemma":[0.99931526,0.00006299,0.0002008127,0.000072632494,0.00016844984,0.000179843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015348302,0.00008308229,0.0002523609,0.000126935,0.000049713148,0.00000723431,0.000036969974,0.0000768353,0.0003142278],"category_scores_gemma":[0.00009354573,0.00005773328,0.000077956465,0.00009285778,0.000054303306,0.00004499304,0.00002432875,0.00014121969,0.000024946743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028753883,0.00076887244,0.8908296,0.00006642597,0.00007650281,0.00023293341,0.00007752141,2.2929564e-7,0.000093214134,0.0001404112,0.08778756,0.01963918],"study_design_scores_gemma":[0.0034760335,0.0035405008,0.9521761,0.000033597982,0.0005329687,0.0004126256,0.00004842557,0.00000944738,0.00026205817,0.000092524875,0.039343964,0.00007176384],"about_ca_topic_score_codex":0.0000013928939,"about_ca_topic_score_gemma":0.0000016592421,"teacher_disagreement_score":0.061346482,"about_ca_system_score_codex":0.00007496473,"about_ca_system_score_gemma":0.00014989958,"threshold_uncertainty_score":0.3440574},"labels":[],"label_agreement":null},{"id":"W4240268607","doi":"10.21203/rs.2.20417/v2","title":"WITHDRAWN: Outcomes in patients with early stage uterine clear cell carcinoma treated with chemotherapy and radiotherapy: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Confidence interval; Internal medicine; Radiation therapy; Oncology; Odds ratio; Chemotherapy; Adjuvant; Carcinoma; Meta-analysis; Adjuvant therapy; Surgery","score_opus":0.06411978836562855,"score_gpt":0.38563306390421837,"score_spread":0.3215132755385898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240268607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016412479,0.98599535,0.0000023861962,0.00065701833,0.0000020236484,0.01130652,0.0003253548,0.000025412746,0.000044672932],"genre_scores_gemma":[0.0050972495,0.9911114,0.00020418027,0.00019140483,0.00001145731,0.002018965,0.0001417912,0.0001349634,0.0010885872],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99583685,0.0008398813,0.0007771599,0.0009975599,0.0010491413,0.0004994068],"domain_scores_gemma":[0.9977319,0.00029937754,0.00035576575,0.00095148693,0.0002636732,0.0003977581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005865967,0.0007268515,0.009810233,0.000683225,0.00008237979,0.00013167047,0.0001637218,0.00015257762,0.0003131061],"category_scores_gemma":[0.000029826258,0.00034829314,0.00067449774,0.0019776418,0.00014434275,0.00008698275,0.000059663136,0.00055554905,0.0000071589297],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021594325,0.00052783336,0.057393953,0.8461252,0.093131885,0.00037566735,0.00016727643,9.4860454e-8,7.1261894e-9,0.0000048534207,0.000024650055,0.0020326786],"study_design_scores_gemma":[0.008336123,0.011649459,0.049115688,0.08268649,0.81488764,0.000024692967,0.000060819122,0.0000051918614,7.7674366e-7,4.271353e-7,0.032378983,0.00085368496],"about_ca_topic_score_codex":0.0005398494,"about_ca_topic_score_gemma":0.000079183286,"teacher_disagreement_score":0.7634387,"about_ca_system_score_codex":0.0003912899,"about_ca_system_score_gemma":0.00026708422,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W4240434425","doi":"10.1002/14651858.cd010931","title":"Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility","year":2014,"lang":"en","type":"reference-entry","venue":"Cochrane Database of Systematic Reviews","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane","funders":"","keywords":"Ovary; Medicine; Endometrial cancer; Gynecology; Cancer; Stimulation; Obstetrics; Oncology; Internal medicine","score_opus":0.064939691135996,"score_gpt":0.3560157727677518,"score_spread":0.2910760816317558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240434425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028746042,0.908951,0.0007068934,0.00007539551,0.00064730586,0.038256157,0.019509656,0.000040192455,0.0030673526],"genre_scores_gemma":[0.06416243,0.916738,0.0021264374,0.000042047242,0.00040290246,0.012515059,0.002970327,0.00011076727,0.00093203713],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933388,0.0009526589,0.0037189634,0.0007574982,0.0007773284,0.00045472657],"domain_scores_gemma":[0.9906356,0.002879993,0.003970743,0.0018425897,0.0004639712,0.00020714369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043987525,0.0006815321,0.008069162,0.0004886446,0.000041214495,0.000015942098,0.0002766822,0.00023826493,0.00031983235],"category_scores_gemma":[0.0037577003,0.0003973948,0.0005448132,0.00070810225,0.00009551246,0.00007856148,0.00006232073,0.00031663058,0.000009682747],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016112115,0.00060523616,0.0053582797,0.97809196,0.0013195158,0.000012100982,0.0003587195,0.000007892282,0.0000073060082,0.000013440129,0.003799288,0.008815082],"study_design_scores_gemma":[0.01370046,0.0012643554,0.0011060468,0.9728459,0.0073499093,0.000011401821,0.00012791959,0.00027902605,0.00017942005,0.0000071183244,0.002709442,0.0004190039],"about_ca_topic_score_codex":0.0012699572,"about_ca_topic_score_gemma":0.00011904901,"teacher_disagreement_score":0.03541639,"about_ca_system_score_codex":0.00065642595,"about_ca_system_score_gemma":0.0004941309,"threshold_uncertainty_score":0.99984777},"labels":[],"label_agreement":null},{"id":"W4240662635","doi":"10.1016/j.ygyno.2020.05.189","title":"Appendectomy at time of surgery for ovarian malignancy: An ACS-NSQIP propensity score-stratified analysis","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Propensity score matching; Gynecologic oncology; General surgery; Surgery; Complication; Internal medicine","score_opus":0.12877906336633343,"score_gpt":0.3203669317582048,"score_spread":0.19158786839187136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240662635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828343,0.00016913576,0.00018962429,0.011260063,0.00017670366,0.0017263688,0.00013144112,0.000097801,0.003414612],"genre_scores_gemma":[0.99346054,0.00004761879,0.0022757554,0.0026716643,0.0001617474,0.000322935,0.00046545017,0.00002257726,0.0005717121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978233,0.00021049516,0.0006314841,0.00070680963,0.00018953551,0.00043837822],"domain_scores_gemma":[0.9976674,0.0009498797,0.0003997923,0.00043612244,0.00021004405,0.00033677527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000517809,0.00025848034,0.001618864,0.0001663077,0.00011462288,0.000011703242,0.00014655878,0.00032129136,0.0024777218],"category_scores_gemma":[0.00045193257,0.0002021817,0.0004403507,0.0006333117,0.00014317299,0.00007367088,0.00009383489,0.0001285391,0.00010163069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034215774,0.003247161,0.9443596,0.00036361872,0.004765828,0.0007771886,0.000800122,0.00008680494,0.0060005602,0.00076502346,0.017870938,0.017541546],"study_design_scores_gemma":[0.005273882,0.0059356852,0.94734424,0.00003035781,0.0055990065,0.000028712151,0.00008256004,0.000445406,0.013118992,0.00029545062,0.021457138,0.00038858133],"about_ca_topic_score_codex":0.000049232007,"about_ca_topic_score_gemma":0.00043806914,"teacher_disagreement_score":0.017152965,"about_ca_system_score_codex":0.00041725003,"about_ca_system_score_gemma":0.0006907489,"threshold_uncertainty_score":0.9984341},"labels":[],"label_agreement":null},{"id":"W4240938809","doi":"10.1200/jco.2004.22.14_suppl.5053","title":"Epithelial ovarian cancer (EOC) without macroscopic residual tumour: Long-term, population-based outcomes","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Stage (stratigraphy); Radiation therapy; Incidence (geometry); Internal medicine; Chemotherapy; Population; Ovarian cancer; Oncology; Disease; Gynecology; Surgery; Cancer","score_opus":0.09649344784847107,"score_gpt":0.48111578164589974,"score_spread":0.38462233379742866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240938809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94381183,0.00040518647,0.00020915273,0.05227623,0.0026900084,0.00029505367,0.000022903281,0.000017136665,0.00027247937],"genre_scores_gemma":[0.98564684,0.00030390816,0.0053280876,0.0061198007,0.0023597728,0.000017798453,0.00001147662,0.00003025559,0.00018207886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649346,0.00022851951,0.002186893,0.00027569674,0.00050161796,0.0003137893],"domain_scores_gemma":[0.99654096,0.00087069365,0.0015363209,0.00025273152,0.0003193799,0.00047990412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012001469,0.00021792957,0.0017603283,0.00014088019,0.0000748228,0.000021179074,0.00015988656,0.00036237674,0.0004782835],"category_scores_gemma":[0.0009897898,0.00014521775,0.0005958663,0.0001206436,0.00012619713,0.0001008491,0.000028622122,0.0007427089,0.000034444445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016472318,0.0021833193,0.9682707,0.00003301669,0.0005661675,0.0011403448,0.000033195505,0.0002659213,0.000051154326,0.00015471944,0.00029083915,0.025363376],"study_design_scores_gemma":[0.02656056,0.005355563,0.9645245,0.00032602914,0.00092906377,0.000103960396,0.000007759963,0.0000056353647,0.00035567372,0.00035247378,0.0013527826,0.00012599297],"about_ca_topic_score_codex":0.0006692632,"about_ca_topic_score_gemma":0.0011101923,"teacher_disagreement_score":0.04615643,"about_ca_system_score_codex":0.0007157301,"about_ca_system_score_gemma":0.0038990113,"threshold_uncertainty_score":0.69166785},"labels":[],"label_agreement":null},{"id":"W4241557552","doi":"10.1007/978-1-59259-995-0_66","title":"External Radiation Therapy of Follicular Carcinoma","year":2006,"lang":"en","type":"book-chapter","venue":"Humana Press eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Radioactive iodine; Radical surgery; Thyroid carcinoma; Thyroid cancer; External beam radiotherapy; Follicular phase; Disease; Adjuvant therapy; Follicular carcinoma; Adjuvant; Surgery; Oncology; Radiology; Internal medicine; Thyroid; Cancer; Brachytherapy; Papillary carcinoma","score_opus":0.05387718026002849,"score_gpt":0.2713265991530753,"score_spread":0.21744941889304678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241557552","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019988036,0.06990484,0.000030923533,0.000023110226,0.00018379829,0.0009086915,0.000055962486,0.00003936453,0.9268545],"genre_scores_gemma":[0.28340474,0.005651793,0.00017352503,0.00022242128,0.0012046192,0.00014278847,0.00016990573,0.00015399323,0.7088762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875647,0.00001169937,0.0003704134,0.00034134812,0.00035840302,0.00016164703],"domain_scores_gemma":[0.9989996,0.000022994178,0.00029410413,0.00052196893,0.00008605534,0.00007527344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005192797,0.00030221458,0.0005456797,0.000111690155,0.000041104446,0.000016538022,0.00009094091,0.00022073687,0.00023739999],"category_scores_gemma":[0.000001205541,0.00025832112,0.00031720047,0.0000027260153,0.00007172699,0.000016295273,0.000025201041,0.00016388892,0.000008219553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004346317,0.00029818946,0.0007057947,0.0004594175,0.0016973973,0.00074750575,0.00042441313,0.000012892444,0.000186488,0.28943178,0.023651972,0.6819495],"study_design_scores_gemma":[0.0042651244,0.0005990026,0.010623547,0.00057796465,0.00056761206,0.000022559712,9.655041e-7,0.000012407118,0.0067197145,0.0024943152,0.9737938,0.00032296372],"about_ca_topic_score_codex":0.00068775,"about_ca_topic_score_gemma":0.000015393976,"teacher_disagreement_score":0.95014185,"about_ca_system_score_codex":0.00011913583,"about_ca_system_score_gemma":0.00007605477,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W4241697530","doi":"10.1007/0-387-21605-7_19","title":"Ovary","year":2002,"lang":"es","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ovarian cancer; Disease; Medicine; Cancer; Ovary; Carcinogenesis; Natural history; Pathology; Oncology; Bioinformatics; Gynecology; Biology; Internal medicine","score_opus":0.03791601044266532,"score_gpt":0.2631061383816658,"score_spread":0.22519012793900048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241697530","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004685852,0.009028768,0.000014872001,0.00448534,0.00082490704,0.00059932313,0.000074575844,0.000095953925,0.9848294],"genre_scores_gemma":[0.04647638,0.03877208,0.0005379542,0.0026569904,0.0018226029,0.00004135345,0.00008848744,0.0001269737,0.9094772],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.998192,0.000008529135,0.00042751356,0.0006263411,0.00040587012,0.00033974968],"domain_scores_gemma":[0.99864334,0.00009716632,0.00014526602,0.0007377958,0.000082977844,0.00029344822],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060310245,0.00054874166,0.00077186903,0.0001563781,0.00007484086,0.000038834274,0.00010371993,0.00042792785,0.14768663],"category_scores_gemma":[0.000007992597,0.00042351332,0.00039703574,0.000026433629,0.00010236684,0.00003946947,0.00006500352,0.0003343092,0.017515527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006149598,0.0005026355,0.0056003355,0.00028969927,0.0023055437,0.0017674292,0.000060219103,6.150616e-7,0.000004234177,0.77023935,0.09554225,0.12362621],"study_design_scores_gemma":[0.0019945072,0.0006896412,0.0073768636,0.0013597364,0.0015235088,0.000075852535,0.000007776794,0.000018140374,0.00010510867,0.0012669886,0.98513335,0.0004485366],"about_ca_topic_score_codex":0.000081254875,"about_ca_topic_score_gemma":0.000006664015,"teacher_disagreement_score":0.8895911,"about_ca_system_score_codex":0.00024105837,"about_ca_system_score_gemma":0.00006910976,"threshold_uncertainty_score":0.99982166},"labels":[],"label_agreement":null},{"id":"W4242354015","doi":"10.1097/aog.0000000000001078","title":"In Reply","year":2015,"lang":"en","type":"letter","venue":"Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Columbia university; Obstetrics and gynaecology; University hospital; Medicine; Family medicine; Sociology; Media studies; Pregnancy","score_opus":0.029960406986623406,"score_gpt":0.28231591017629665,"score_spread":0.25235550318967326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242354015","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023474614,0.0108951265,6.4335177e-7,0.9702821,0.0025922493,0.00039778848,0.000029096245,0.000017033297,0.013438528],"genre_scores_gemma":[0.0037600175,0.0025735856,0.00019204302,0.98125845,0.00089049037,0.00008947556,0.00015549283,0.00003691876,0.011043546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885124,0.00004065672,0.00024389137,0.00040624308,0.00016116479,0.00029681582],"domain_scores_gemma":[0.9974629,0.0019631025,0.00008971209,0.00031485021,0.00008480254,0.000084591535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116445895,0.00018894172,0.00055736775,0.00035435264,0.00001786493,0.000014393881,0.00005145895,0.0006230773,0.0002504045],"category_scores_gemma":[0.0018446713,0.00015806218,0.00005584675,0.00026903208,0.00004940977,0.000022986549,0.00005060782,0.00077703374,0.000071218485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045378997,0.00007713554,0.0083733555,0.00008512687,0.000057613837,0.008340675,0.00004049651,1.209861e-7,2.2583245e-7,0.000053302698,0.97372544,0.009242],"study_design_scores_gemma":[0.0020285053,0.00047249548,0.0055274707,0.000032347765,0.000119739816,0.00009006949,0.0000075066923,0.0000050787658,0.0000028036607,0.00050317205,0.99107724,0.0001335578],"about_ca_topic_score_codex":0.00009539922,"about_ca_topic_score_gemma":0.000015343983,"teacher_disagreement_score":0.017351843,"about_ca_system_score_codex":0.00040549255,"about_ca_system_score_gemma":0.00025265076,"threshold_uncertainty_score":0.64455885},"labels":[],"label_agreement":null},{"id":"W4242977731","doi":"10.1016/j.jogc.2019.04.007","title":"La littérature médicale mondiale","year":2019,"lang":"fr","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital; McGill University","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.0072666894049006284,"score_gpt":0.2258064775116933,"score_spread":0.21853978810679267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242977731","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2956559,0.62884104,0.0000037146567,0.0068406076,0.057110567,0.00019533263,0.000064678,0.0000020241516,0.0112861525],"genre_scores_gemma":[0.9609342,0.028958708,0.0002520736,0.0012293911,0.0002863124,0.0000021120109,0.0000038214735,0.000021053029,0.008312312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998418,0.00013118931,0.00050442,0.00018556563,0.00037150094,0.0003893651],"domain_scores_gemma":[0.99604636,0.0026340445,0.00039480158,0.00017536187,0.00025508855,0.0004943161],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031922397,0.00019145306,0.0006263124,0.00016748765,0.000054432046,0.00003257212,0.00011424765,0.00036673385,0.0043215565],"category_scores_gemma":[0.001062966,0.00015804202,0.00011624942,0.00041242823,0.00010052705,0.00007258818,0.000042911543,0.00073817105,0.00001662446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000095173855,0.0003550056,0.40992746,0.00023890082,0.0005958492,0.014037557,0.00011117305,0.00004078974,0.0000045793927,0.0018017853,0.024374267,0.5485031],"study_design_scores_gemma":[0.0041584163,0.0010090532,0.37036228,0.00007443879,0.0004132644,0.00034901866,0.00042375876,0.000033510474,0.000027503911,0.0001092225,0.6229161,0.00012341993],"about_ca_topic_score_codex":0.011210383,"about_ca_topic_score_gemma":0.009018031,"teacher_disagreement_score":0.6652783,"about_ca_system_score_codex":0.0021362551,"about_ca_system_score_gemma":0.0045944266,"threshold_uncertainty_score":0.99658865},"labels":[],"label_agreement":null},{"id":"W4243026494","doi":"10.1371/annotation/856f0890-9d85-4719-8e54-c27530ac94f4","title":"Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation","keywords":"Type (biology); Computational biology; Ovarian cancer; Bioinformatics; Biology; Computer science; Cancer; Genetics","score_opus":0.27053070341775143,"score_gpt":0.35106971518630736,"score_spread":0.08053901176855593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243026494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7691077,0.053428773,0.0017057742,0.044903524,0.0069624973,0.015250244,0.00021011262,0.000663304,0.10776806],"genre_scores_gemma":[0.9375825,0.012544582,0.006120005,0.0003395141,0.0023933477,0.0014988846,0.00011053161,0.00010100915,0.039309654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813193,0.00004680531,0.0002827718,0.0005037701,0.00055172946,0.00048296328],"domain_scores_gemma":[0.9976815,0.00021642137,0.000060949926,0.00055667735,0.0012416737,0.00024277075],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022881592,0.00018880129,0.00039379724,0.00016651806,0.00018584359,0.00007393605,0.00011780846,0.00014102965,0.0041803657],"category_scores_gemma":[0.00003086556,0.00016209463,0.000077819874,0.0005297339,0.00006745708,0.00013413775,0.000043445616,0.0003257591,0.0010162817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017073237,0.013710043,0.0035976663,0.00055733375,0.0010777188,0.000041367628,0.00093036174,0.00030067356,0.042137764,0.0024349384,0.9085969,0.024907913],"study_design_scores_gemma":[0.022565514,0.011014115,0.02073395,0.003763302,0.0013643968,0.000026042662,0.00091482745,0.036304396,0.4466781,0.007515211,0.4474391,0.0016810369],"about_ca_topic_score_codex":0.00036812224,"about_ca_topic_score_gemma":0.00003493796,"teacher_disagreement_score":0.46115777,"about_ca_system_score_codex":0.00042673235,"about_ca_system_score_gemma":0.00021348416,"threshold_uncertainty_score":0.9997615},"labels":[],"label_agreement":null},{"id":"W4243329694","doi":"10.1136/ijgc-00009577-200311001-00016","title":"Translational research in ovarian cancer: a must","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Ovarian cancer; Disease; Medicine; Cancer; Translational research; Stage (stratigraphy); Bioinformatics; Epithelial ovarian cancer; Oncology; Internal medicine; Pathology; Biology","score_opus":0.13220467592093235,"score_gpt":0.45401756965117324,"score_spread":0.3218128937302409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243329694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9009684,0.006832042,0.00016300035,0.07140905,0.0028845407,0.00044408688,0.000052801955,0.000010206502,0.017235924],"genre_scores_gemma":[0.99480945,0.0025430168,0.0008967792,0.00092272775,0.00051195506,0.000079786194,0.00000280073,0.000010169457,0.00022330307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801856,0.00014932046,0.0004896441,0.0001855782,0.0009122834,0.0002446407],"domain_scores_gemma":[0.9983694,0.00040643362,0.00014899865,0.00007830806,0.0008444931,0.00015237341],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008226136,0.00010693862,0.0002872296,0.0003409177,0.000038374084,0.0000320211,0.00017750998,0.00010679959,0.0069778566],"category_scores_gemma":[0.00024926002,0.000077136276,0.00014924278,0.00028334046,0.00008837326,0.000112735,0.000016144724,0.0004903673,0.000012274552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010951762,0.0018658827,0.907485,0.000021858037,0.00066074834,0.0022430099,0.00031150482,0.0009940014,0.0007961221,0.017546738,0.003955411,0.06302452],"study_design_scores_gemma":[0.0071905153,0.0005989729,0.8749802,0.00033510476,0.00006252154,0.00025363103,0.00010935989,0.000049224767,0.0014330809,0.0050193914,0.10984476,0.00012319567],"about_ca_topic_score_codex":0.00020784713,"about_ca_topic_score_gemma":0.00034491412,"teacher_disagreement_score":0.10588935,"about_ca_system_score_codex":0.00092900835,"about_ca_system_score_gemma":0.0009166053,"threshold_uncertainty_score":0.9939299},"labels":[],"label_agreement":null},{"id":"W4243560739","doi":"10.1007/978-3-319-18257-5_43","title":"Epithelial Ovarian Cancer","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Disease; Cancer; Epithelial ovarian cancer; Regimen; Gynecology; Internal medicine; Population; Germ cell tumors; Chemotherapy","score_opus":0.06128268706595723,"score_gpt":0.31302678761864,"score_spread":0.25174410055268276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243560739","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008547009,0.004613373,0.000014285145,0.0057347114,0.0007271548,0.00048577355,0.00020767719,0.00008845491,0.98812],"genre_scores_gemma":[0.001568343,0.0018279512,0.0004862317,0.0012792241,0.0017485406,0.00006916357,0.00010527866,0.000089767105,0.9928255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880856,0.0000036278063,0.00023535665,0.0003937992,0.00036462152,0.00019404144],"domain_scores_gemma":[0.99898624,0.00001756651,0.00009438863,0.000439824,0.00017316098,0.00028881608],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006894467,0.00031628492,0.0005524986,0.00009022103,0.000027871558,0.000015741656,0.00006227416,0.00030368095,0.029871045],"category_scores_gemma":[0.000005729131,0.00023060657,0.00019685828,0.000014692295,0.00004805693,0.000022651793,0.00003976765,0.00022591009,0.001334964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020628428,0.00013541135,0.00030174237,0.00010707387,0.0015034981,0.0005922132,0.000067200475,0.0000016842139,0.000012342296,0.400323,0.45841563,0.13833392],"study_design_scores_gemma":[0.0020877838,0.0002446558,0.00032170874,0.00035777732,0.0008054946,0.000033168995,0.0000024215612,0.0000030358435,0.000077537814,0.0062724142,0.98955965,0.00023433004],"about_ca_topic_score_codex":0.00044671528,"about_ca_topic_score_gemma":0.00017190984,"teacher_disagreement_score":0.531144,"about_ca_system_score_codex":0.0004914548,"about_ca_system_score_gemma":0.0006634417,"threshold_uncertainty_score":0.99944264},"labels":[],"label_agreement":null},{"id":"W4243806301","doi":"10.1016/j.jogc.2018.01.016","title":"RETIRED: No. 230-Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses","year":2018,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Gynecology; Library science; Referral; Web site; General surgery; Family medicine; The Internet; World Wide Web","score_opus":0.07882344038558455,"score_gpt":0.3623972188429463,"score_spread":0.28357377845736176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243806301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949879,0.01354743,0.00024553912,0.009340506,0.01831498,0.0011725666,0.00009139531,0.0000052926803,0.0074033253],"genre_scores_gemma":[0.9895327,0.00061568996,0.008936787,0.0005560983,0.00018274972,0.000011405534,0.000007791972,0.000009857676,0.00014689661],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988598,0.000030125748,0.0005056825,0.000134322,0.00032140064,0.00014864084],"domain_scores_gemma":[0.99680406,0.00043597165,0.00035675179,0.00010545476,0.002170721,0.00012702384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044227115,0.00010231168,0.0003304243,0.00013378689,0.00006815555,0.000011467185,0.000047295103,0.00006997954,0.00028379148],"category_scores_gemma":[0.0015003062,0.000079202146,0.000044915087,0.00013067579,0.00006163718,0.000042153006,0.000025037705,0.000068979076,3.0654988e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021167313,0.0003293969,0.103258625,0.00056054845,0.0017390426,0.0009079065,0.00014596239,0.000011358608,0.000028022121,0.0017834506,0.06738072,0.82364327],"study_design_scores_gemma":[0.017712628,0.005325872,0.8331133,0.00012145757,0.0022472953,0.00012222124,0.0006002229,0.0011868068,0.00031069218,0.00083561754,0.13821557,0.00020828535],"about_ca_topic_score_codex":0.0026612664,"about_ca_topic_score_gemma":0.005464891,"teacher_disagreement_score":0.823435,"about_ca_system_score_codex":0.00044595476,"about_ca_system_score_gemma":0.0009173823,"threshold_uncertainty_score":0.40230566},"labels":[],"label_agreement":null},{"id":"W4243816917","doi":"10.1136/ijgc-00009577-200211000-00002","title":"Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian cancer; Carcinogenesis; Malignancy; Epithelial ovarian cancer; Bioinformatics; Oncology; Pathology; Cancer; Internal medicine; Biology","score_opus":0.07699829495805706,"score_gpt":0.3103954422065072,"score_spread":0.23339714724845018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243816917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880008,0.006733388,0.0000044298517,0.004330536,0.00036054803,0.0002595466,0.0000065148934,0.0000034233763,0.00030080014],"genre_scores_gemma":[0.9984403,0.0006976855,0.00024872398,0.0002134547,0.00023080701,0.00011571546,0.0000011754896,0.000008534331,0.00004356424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886066,0.00005046506,0.00040422252,0.00017182455,0.00035213443,0.00016066806],"domain_scores_gemma":[0.99955004,0.000057082394,0.00016284175,0.000051510404,0.00008185041,0.00009664589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017210943,0.000114817776,0.0002760918,0.00017651531,0.000013666069,0.00001577251,0.00011608173,0.00007811861,0.0005760609],"category_scores_gemma":[0.000035630008,0.00008132642,0.00007333964,0.00009082773,0.00005671772,0.00011426731,0.000040561466,0.0001747845,0.0000032108778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021787248,0.0014651109,0.979819,0.000009018883,0.00012986694,0.00037776944,0.00058470055,0.000073494455,0.0002871767,0.00012732793,0.000027720607,0.016880957],"study_design_scores_gemma":[0.0052091833,0.00072689203,0.9918907,0.00019284461,0.000024998304,0.00011334632,0.00007592318,0.00014922158,0.0010924686,0.00014845934,0.0002964317,0.00007947588],"about_ca_topic_score_codex":0.00014203214,"about_ca_topic_score_gemma":0.000103049846,"teacher_disagreement_score":0.016801482,"about_ca_system_score_codex":0.0005257832,"about_ca_system_score_gemma":0.000047679805,"threshold_uncertainty_score":0.6307463},"labels":[],"label_agreement":null},{"id":"W4244188942","doi":"10.5430/jbgc.v4n4p22","title":"Struma ovarii","year":2014,"lang":"en","type":"article","venue":"Journal of Biomedical Graphics and Computing","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Struma ovarii; Medicine; Ovarian tumor; Metastasis; Radiology; Gynecology; Thyroid; Pathology; General surgery; Ovarian cancer; Internal medicine; Cancer","score_opus":0.009897530351165505,"score_gpt":0.2623550019297956,"score_spread":0.2524574715786301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244188942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738377,0.0013313998,0.015266365,0.008569764,0.00047382017,0.00006289979,0.0000011536694,0.000011403139,0.0004455159],"genre_scores_gemma":[0.99527687,0.00024698183,0.0029319867,0.0009362683,0.0005944284,1.7935767e-7,0.0000011539042,0.0000064154265,0.0000057233665],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991135,0.00002651996,0.0003325263,0.00009338542,0.0003009917,0.00013307629],"domain_scores_gemma":[0.99926835,0.00012053461,0.00018238029,0.000075923956,0.00008625418,0.00026656088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000500156,0.00007771975,0.00026968445,0.00015252308,0.00006421209,0.00002246338,0.000044788132,0.0000624022,0.000019473817],"category_scores_gemma":[0.000066237924,0.000051888765,0.000105255844,0.0001761669,0.00010079742,0.000022417495,0.000029147475,0.00020959745,5.6948346e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001690901,0.0009772027,0.14588527,0.00021822078,0.0006790569,0.00031590345,0.00033976385,0.0000035423895,0.0005231985,0.032828365,0.004466135,0.8135942],"study_design_scores_gemma":[0.014641967,0.009598285,0.73685193,0.0022875485,0.00088745676,0.0043827356,0.00022784932,0.035064116,0.0004761156,0.01207278,0.18308213,0.0004271161],"about_ca_topic_score_codex":0.000006445296,"about_ca_topic_score_gemma":4.4928163e-7,"teacher_disagreement_score":0.81316715,"about_ca_system_score_codex":0.000014557746,"about_ca_system_score_gemma":0.000049478338,"threshold_uncertainty_score":0.21159624},"labels":[],"label_agreement":null},{"id":"W4244556826","doi":"10.21203/rs.2.13812/v4","title":"Defining the short-term disease recurrence after Loop Electrosurgical Excision Procedure (LEEP)","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Loop electrosurgical excision procedure; Term (time); Medicine; Surgery; Electrosurgery; Loop (graph theory); Physics; Internal medicine; Mathematics; Cancer; Colposcopy","score_opus":0.06030654928905887,"score_gpt":0.40796510953535897,"score_spread":0.3476585602463001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244556826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7259356,0.13164338,0.00025212052,0.12255954,0.000830874,0.012167124,0.00096444396,0.00041778112,0.0052291565],"genre_scores_gemma":[0.989986,0.0050151288,0.00009313404,0.00029684955,0.0007299541,0.0031366134,0.0004252307,0.00007326004,0.00024381641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950258,0.00040295057,0.0004145693,0.0012800661,0.0019971598,0.0008794432],"domain_scores_gemma":[0.9968391,0.00050060684,0.00006646176,0.0012089015,0.00050940353,0.0008755462],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00082819903,0.000414431,0.0005673143,0.00018524705,0.00026636687,0.00025982902,0.00043523303,0.00027896467,0.0006339603],"category_scores_gemma":[0.00077572506,0.00025946344,0.00039873234,0.00052410894,0.00023445704,0.000054161363,0.0011396683,0.0027784174,0.00028317625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008084841,0.0022813398,0.81942606,0.0085670585,0.0007478513,0.009269208,0.0014948238,0.000040623858,0.000059465052,0.003305284,0.029178735,0.11754469],"study_design_scores_gemma":[0.0013777692,0.0011989725,0.97024316,0.009217552,0.00039564684,0.000044078603,0.00013737686,0.0010542275,0.00033249796,0.002273188,0.013214117,0.0005114027],"about_ca_topic_score_codex":0.00003583885,"about_ca_topic_score_gemma":0.000022180238,"teacher_disagreement_score":0.26405045,"about_ca_system_score_codex":0.0005715062,"about_ca_system_score_gemma":0.0019381258,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W4244997416","doi":"10.1016/s1701-2163(16)30315-2","title":"Exercise in Pregnancy and the Postpartum Period","year":2003,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diagnostic odds ratio; Likelihood ratios in diagnostic testing; Biomarker; Cochrane Library; Receiver operating characteristic; Meta-analysis; Odds ratio; Malignancy; Internal medicine; Gynecology; Obstetrics","score_opus":0.009496404506582158,"score_gpt":0.2237325058875626,"score_spread":0.21423610138098045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244997416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78312296,0.20555834,0.0000018296057,0.0052353013,0.0035252715,0.00031443321,0.0000044071858,0.0000012146508,0.002236245],"genre_scores_gemma":[0.9918085,0.0076912227,0.000117345255,0.0002562875,0.0000054206835,0.000005980971,2.8446345e-7,0.000005012091,0.000109986475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993637,0.000043308857,0.00024863303,0.000080527105,0.00012960206,0.00013421779],"domain_scores_gemma":[0.99894893,0.00064710464,0.00013085846,0.00007641098,0.00008392565,0.00011276469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015399209,0.0000753282,0.0003072447,0.00008901409,0.00004704086,0.000012611427,0.00003128131,0.000045279718,0.00013502449],"category_scores_gemma":[0.0009843025,0.000044251,0.000030168203,0.00015754986,0.00006486927,0.000026364436,0.000010213348,0.00016502166,1.4273013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043380707,0.00022442774,0.83745396,0.00010336556,0.00017084756,0.007994519,0.00048289518,0.000008148738,0.0000012886214,0.0038557693,0.0013520484,0.14830934],"study_design_scores_gemma":[0.01365781,0.00033235588,0.9726976,0.00012722025,0.00021681964,0.00032673072,0.00045067896,0.000014733162,0.0000306634,0.00035722417,0.011710392,0.00007774436],"about_ca_topic_score_codex":0.0037059116,"about_ca_topic_score_gemma":0.0101435175,"teacher_disagreement_score":0.20868552,"about_ca_system_score_codex":0.00032048198,"about_ca_system_score_gemma":0.0009508629,"threshold_uncertainty_score":0.5660321},"labels":[],"label_agreement":null},{"id":"W4244998371","doi":"10.22541/au.160563829.98625075/v1","title":"The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: a systematic review and meta-analysis.","year":2020,"lang":"en","type":"review","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Meta-analysis; Confidence interval; Cochrane Library; Oncology; Serous fluid; Internal medicine; Radiology","score_opus":0.12540954754563358,"score_gpt":0.3967028188843975,"score_spread":0.2712932713387639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244998371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000057578436,0.99084383,0.000019746709,0.001557528,0.000031459043,0.006614055,0.00064029323,0.00001793802,0.00026938113],"genre_scores_gemma":[0.00088287046,0.9969769,0.00017949358,0.00042112664,0.00003832966,0.0009268513,0.000102900776,0.00004184702,0.00042968435],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99316925,0.0018131826,0.0032764815,0.0008334281,0.00054616854,0.0003614974],"domain_scores_gemma":[0.99322987,0.003795729,0.001457519,0.0009956763,0.0002520963,0.00026912574],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0015253437,0.0006776125,0.018380648,0.00018744273,0.00007377538,0.00004675734,0.00026977347,0.00022178999,0.00017673099],"category_scores_gemma":[0.0002781799,0.0003132344,0.004603024,0.0012127724,0.00016680684,0.000035539273,0.00020954436,0.0006030002,0.000021405109],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029505669,0.00018110072,0.00018935159,0.7956365,0.1988672,0.00077896053,0.00006149173,4.001602e-7,3.439207e-9,0.0028731537,0.00005183017,0.0013305481],"study_design_scores_gemma":[0.00081117044,0.00032563155,0.00021001675,0.02710175,0.9039335,0.000044139968,0.00004260905,0.000009154461,1.1898389e-7,0.000006355108,0.06727472,0.00024083203],"about_ca_topic_score_codex":0.00053402403,"about_ca_topic_score_gemma":0.000030728224,"teacher_disagreement_score":0.7685347,"about_ca_system_score_codex":0.00020732552,"about_ca_system_score_gemma":0.0005040543,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W4246186221","doi":"10.21203/rs.3.rs-21535/v2","title":"Ovarian Cancer: Diagnostic accuracy and tumor types distribution in East Africa compared to North America","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ovarian cancer; Distribution (mathematics); Cancer; Oncology; Medicine; Geography; Internal medicine; Mathematics","score_opus":0.08762684597288126,"score_gpt":0.39312249410147304,"score_spread":0.30549564812859176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246186221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87650037,0.01301036,0.00025817426,0.09200479,0.00041818112,0.008887213,0.007565296,0.00018267414,0.001172954],"genre_scores_gemma":[0.9924373,0.0028780785,0.00020255079,0.00019074927,0.0003802904,0.0023248505,0.0014998303,0.000043114007,0.00004321214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969261,0.00025460107,0.00038033276,0.00093644083,0.0008259212,0.000676576],"domain_scores_gemma":[0.9973632,0.0008920812,0.00009725201,0.0005784626,0.0003697466,0.0006992255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020356788,0.0003180323,0.00074259634,0.0002563403,0.00013061555,0.00013954805,0.00022158667,0.00011174868,0.00025491393],"category_scores_gemma":[0.0022461116,0.0002831681,0.000100602985,0.00095049624,0.00012792324,0.000047585167,0.00081246946,0.0011004946,0.0001310819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015324268,0.0016929493,0.8608972,0.0038673314,0.0005391303,0.0027662648,0.0071622394,0.0012051078,0.000048175138,0.00023574504,0.047237843,0.07281563],"study_design_scores_gemma":[0.0016033876,0.000567827,0.9304664,0.002761613,0.000109969245,0.0000065422428,0.0004349267,0.0007351255,0.00004791696,0.00016887908,0.06281595,0.00028143678],"about_ca_topic_score_codex":0.004987202,"about_ca_topic_score_gemma":0.0013020018,"teacher_disagreement_score":0.11593697,"about_ca_system_score_codex":0.0011264065,"about_ca_system_score_gemma":0.0010142718,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W4247202882","doi":"10.1016/j.ygyno.2020.05.131","title":"Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Epithelial ovarian cancer; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal chemotherapy; Ovarian cancer; Perioperative; Meta-analysis; Chemotherapy; Oncology; Randomized controlled trial; Internal medicine; Surgery; Cancer","score_opus":0.10950800586543047,"score_gpt":0.3990603436107306,"score_spread":0.28955233774530015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247202882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012645584,0.97262007,0.000010938692,0.013184599,0.00040089272,0.012631056,0.0008313718,0.00010731828,0.00008732604],"genre_scores_gemma":[0.00019205816,0.97270447,0.0009791235,0.0076583424,0.0001420015,0.017483294,0.0004711801,0.000080336555,0.0002892203],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942569,0.0012363407,0.0019891635,0.0015582159,0.00029144424,0.0006678969],"domain_scores_gemma":[0.99101216,0.006253198,0.0015507505,0.00062202895,0.00014251379,0.0004193569],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014748482,0.0011250123,0.028137607,0.0003495553,0.00025791657,0.000039680177,0.00020756926,0.00092795695,0.0005845392],"category_scores_gemma":[0.00088755134,0.00067291,0.005535105,0.0007959626,0.00023393652,0.00007062679,0.00020347214,0.00047006292,0.000010943504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087404274,0.00059911306,0.00038880558,0.49454924,0.44610214,0.00059304154,0.000083183164,2.3763043e-7,6.37868e-7,0.000024467005,0.0011868572,0.056384858],"study_design_scores_gemma":[0.0012255325,0.0010511372,0.0007909756,0.004136175,0.82859135,0.0001867133,0.00001632766,0.0000015156579,8.545726e-7,0.000020844202,0.16347922,0.0004993823],"about_ca_topic_score_codex":0.00015555794,"about_ca_topic_score_gemma":0.00019114427,"teacher_disagreement_score":0.49041307,"about_ca_system_score_codex":0.0032136806,"about_ca_system_score_gemma":0.0016488486,"threshold_uncertainty_score":0.9995722},"labels":[],"label_agreement":null},{"id":"W4247326642","doi":"10.14694/edbook_am.2013.33.e205","title":"Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Oncology; Radiation therapy; Chemotherapy; Clear cell; Internal medicine; Serous ovarian cancer; Disease; Cancer; Stage (stratigraphy); Carcinoma; Biology","score_opus":0.09268229458801586,"score_gpt":0.4807174761154469,"score_spread":0.38803518152743105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247326642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004161904,0.9824018,0.000021532649,0.013043746,0.00035250862,0.0025273738,0.00031377282,0.000005464832,0.0009175974],"genre_scores_gemma":[0.0007880837,0.9871486,0.0057594413,0.0007482162,0.0023240354,0.0017425516,0.00021595247,0.000034628618,0.0012384868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971004,0.0002213257,0.0018821241,0.00038332853,0.0002154368,0.00019735919],"domain_scores_gemma":[0.9885093,0.007047744,0.0035398148,0.00038527668,0.00039983448,0.000118012955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061003864,0.00027215978,0.0032010288,0.000036372523,0.00005905394,0.0000033839656,0.00016842749,0.0002636599,0.00036597913],"category_scores_gemma":[0.00025804885,0.00016688458,0.0020884157,0.00017363954,0.00083360355,0.000033329852,0.00002832422,0.0002091256,0.000007733981],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006433647,0.00090485404,0.0036508252,0.0013655598,0.0023656823,1.0091979e-7,0.0002661664,0.0000012385043,0.000002076776,0.0004070149,0.0027601412,0.988212],"study_design_scores_gemma":[0.0013001736,0.0018656551,0.009413314,0.0017881859,0.004251082,0.0000036734748,0.00024514602,0.000015059936,0.00003625675,0.00010037137,0.98086435,0.0001167372],"about_ca_topic_score_codex":0.0013097548,"about_ca_topic_score_gemma":0.000006556031,"teacher_disagreement_score":0.9880953,"about_ca_system_score_codex":0.000571821,"about_ca_system_score_gemma":0.008044954,"threshold_uncertainty_score":0.9975785},"labels":[],"label_agreement":null},{"id":"W4247607096","doi":"10.1200/edbk_158675","title":"Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Serous fluid; Clear cell; Fallopian tube; Endometriosis; Cancer research; Epithelial ovarian cancer; Serous carcinoma; Epithelium; Pathogenesis; Cancer; Ovarian carcinoma; Medicine; Biology; Oncology; Pathology; Carcinoma; Internal medicine; Gynecology","score_opus":0.16389491489976998,"score_gpt":0.5241776539659408,"score_spread":0.36028273906617087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247607096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006811644,0.85689,0.00007392342,0.13573858,0.0005572667,0.00272368,0.00027475468,0.000008275433,0.003726709],"genre_scores_gemma":[0.00010664888,0.97900605,0.0025281832,0.009701199,0.0019465518,0.004241624,0.0001450396,0.000034933324,0.002289777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968496,0.0003300268,0.0016324869,0.00058590376,0.00027689664,0.0003250996],"domain_scores_gemma":[0.99188936,0.0061366884,0.0013128333,0.00046513637,0.000052192132,0.00014379367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011787916,0.00031733979,0.0025940037,0.000049428192,0.000061839004,0.000008423105,0.00032404496,0.00029328986,0.0006858178],"category_scores_gemma":[0.00005350457,0.00017842684,0.0018299735,0.00021029517,0.0009092966,0.000036297428,0.000039750783,0.000405758,0.00003771401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007149016,0.0016962091,0.00035427973,0.0017528546,0.0017571426,0.0000032151922,0.00013040735,4.0178747e-7,3.3003071e-9,0.022079682,0.036143202,0.93601114],"study_design_scores_gemma":[0.0018660525,0.0010905782,0.013849329,0.0027943002,0.0021984777,0.000006823621,0.000093055045,7.579046e-7,2.6352508e-8,0.00290123,0.97503364,0.0001657113],"about_ca_topic_score_codex":0.00016859769,"about_ca_topic_score_gemma":0.000024159837,"teacher_disagreement_score":0.93889046,"about_ca_system_score_codex":0.0006121129,"about_ca_system_score_gemma":0.006161565,"threshold_uncertainty_score":0.99947256},"labels":[],"label_agreement":null},{"id":"W4247723575","doi":"10.1016/j.jpag.2015.02.016","title":"Evolution in the Management of Pediatric and Adolescent Ovarian Torsion as a Result of Quality Improvement Measures","year":2015,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Ovarian torsion; Quality assurance; Quality management; Gynecology; Surgery; Operations management; Pathology; Management system","score_opus":0.035261494291493244,"score_gpt":0.3081523110539876,"score_spread":0.2728908167624944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247723575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862666,0.009804281,0.0001864097,0.002517957,0.00038839935,0.0006203358,0.000008105633,0.0000035059973,0.00020438174],"genre_scores_gemma":[0.9845052,0.0142683815,0.000339895,0.00030478198,0.0005419799,0.000008112493,0.0000020188043,0.00000860376,0.000021031708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978208,0.00021212749,0.00097301515,0.0002063281,0.0005490394,0.00023869619],"domain_scores_gemma":[0.9983678,0.00011192544,0.00083702535,0.0001918472,0.00031063193,0.00018079867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018179329,0.00016572564,0.0005244898,0.0002943115,0.000040869116,0.000008818465,0.0001086083,0.000112588794,0.000009298729],"category_scores_gemma":[0.00015598458,0.00010841159,0.000108553926,0.00030056643,0.000057013796,0.000067178386,0.000079807236,0.00024790165,0.0000010146334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015453428,0.0034879798,0.97313076,0.0013984804,0.00018171096,0.00015549758,0.00070936896,0.000026485199,0.00008095642,0.0009900619,0.005700448,0.012592908],"study_design_scores_gemma":[0.008408873,0.0025500304,0.98489106,0.00011626077,0.0011272626,0.000048076072,0.0017871908,0.000011148754,0.00006323091,0.0004082222,0.000490344,0.000098283825],"about_ca_topic_score_codex":0.00006859959,"about_ca_topic_score_gemma":0.00001769615,"teacher_disagreement_score":0.012494624,"about_ca_system_score_codex":0.0002753713,"about_ca_system_score_gemma":0.00027630012,"threshold_uncertainty_score":0.44208962},"labels":[],"label_agreement":null},{"id":"W4247761110","doi":"10.1097/00004347-200307000-00021","title":"The Author Replies","year":2003,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Germline mutation; Dysplasia; Germline; Medicine; Pathology; Gynecology; Biology; Mutation; Genetics","score_opus":0.028039035420887152,"score_gpt":0.33681851283801423,"score_spread":0.3087794774171271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247761110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250734,0.0018112133,0.0004556553,0.048692055,0.0043286546,0.00015224797,0.0000042017655,0.00001453367,0.019468058],"genre_scores_gemma":[0.9956477,0.00048706995,0.001700969,0.0013865893,0.00020460357,0.000008009173,9.297057e-7,0.0000047687486,0.0005593413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990501,0.00011138784,0.00036416505,0.00009977725,0.00024599637,0.00012860696],"domain_scores_gemma":[0.99859625,0.0006178591,0.0002300878,0.000105318955,0.00037460463,0.00007585532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057882245,0.00007165523,0.00018777855,0.00005317611,0.00006113554,0.000023331435,0.00015196526,0.00007392245,0.00046120063],"category_scores_gemma":[0.0020228208,0.000035945064,0.00015143129,0.00004227597,0.00012374888,0.000033230506,0.000023030076,0.00019630913,0.000032755346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001539499,0.0028235095,0.44435543,0.00000798974,0.001806979,0.027117234,0.00035395133,0.000060351063,0.002853465,0.33338815,0.043069486,0.14262396],"study_design_scores_gemma":[0.002955424,0.002231636,0.52061045,0.000027344833,0.000117773874,0.010252764,0.0001849978,0.0000058611936,0.0017622496,0.02286774,0.43889514,0.00008861387],"about_ca_topic_score_codex":9.264988e-7,"about_ca_topic_score_gemma":0.0000035696412,"teacher_disagreement_score":0.39582565,"about_ca_system_score_codex":0.00013340902,"about_ca_system_score_gemma":0.00011075177,"threshold_uncertainty_score":0.50498235},"labels":[],"label_agreement":null},{"id":"W4247804289","doi":"10.1210/jc.86.10.5075","title":"Expression and Antiproliferative Effect of a Second Form of Gonadotropin-Releasing Hormone in Normal and Neoplastic Ovarian Surface Epithelial Cells","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovary; Biology; Ovarian cancer; Carcinogenesis; Epithelium; Endocrinology; Gonadotropin-releasing hormone; Internal medicine; Ovarian carcinomas; Gonadotropin; Cell growth; Cell culture; Hormone; Cancer research; Ovarian carcinoma; Cancer; Luteinizing hormone; Medicine","score_opus":0.019825747143384496,"score_gpt":0.32508139333346653,"score_spread":0.30525564619008205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247804289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039894,0.008087023,0.00007352654,0.0007933345,0.00027031256,0.00028616117,0.000011760332,0.0000028625025,0.00007608595],"genre_scores_gemma":[0.981105,0.017867984,0.0006380342,0.00010839555,0.00024411427,0.0000019016423,6.1982803e-7,0.000012346842,0.000021569529],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99758774,0.0005671252,0.0012271745,0.00015589714,0.00020103964,0.00026103665],"domain_scores_gemma":[0.9966999,0.0020859535,0.0007782296,0.0001771642,0.000120486,0.00013822896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077994034,0.00017983769,0.0013545884,0.000113225215,0.000041172767,0.0000052745604,0.00009677188,0.00011149085,0.000039695504],"category_scores_gemma":[0.0003317992,0.00010018149,0.00015731915,0.000113762486,0.0003785838,0.00010800284,0.00007295979,0.00053552515,8.577362e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049112324,0.0019523668,0.41488266,0.00034910132,0.0017508009,0.0009303642,0.002797086,0.00015692918,0.4551461,0.00082158425,0.0002349636,0.0718657],"study_design_scores_gemma":[0.01765274,0.0034067016,0.9035673,0.00020266607,0.00074574066,0.000948084,0.00007483655,0.00007018125,0.07229165,0.00022982687,0.00072909327,0.00008114729],"about_ca_topic_score_codex":0.00006273564,"about_ca_topic_score_gemma":0.000015579573,"teacher_disagreement_score":0.48868465,"about_ca_system_score_codex":0.000012970961,"about_ca_system_score_gemma":0.00011072272,"threshold_uncertainty_score":0.40852824},"labels":[],"label_agreement":null},{"id":"W4248365924","doi":"10.3747/co.20.1731","title":"Preventing ovarian cancer by salpingectomy","year":2013,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Salpingectomy; Ovarian carcinoma; Gynecology; Cancer; Oncology; Pathology; Internal medicine; Pregnancy; Biology","score_opus":0.07615453757165407,"score_gpt":0.41022365386876913,"score_spread":0.33406911629711505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248365924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90388864,0.033780906,0.00027074714,0.03434205,0.0046240524,0.0023477317,0.000043638196,0.00021324708,0.020488959],"genre_scores_gemma":[0.9939689,0.0017304709,0.000541931,0.0006803788,0.0006807759,0.0012832241,0.000061771665,0.000027944365,0.0010245858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989866,0.00004697926,0.0002293718,0.00029611998,0.00012309846,0.00031784616],"domain_scores_gemma":[0.9993772,0.000060112256,0.000100275305,0.00019563343,0.00009168529,0.00017511233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007891624,0.00014176343,0.00031495732,0.000051959556,0.000060516046,0.000018108098,0.00006512443,0.000084634434,0.0038456118],"category_scores_gemma":[0.000027616723,0.000114980394,0.00008694024,0.00011676907,0.00004559596,0.00006781744,0.00004295034,0.00018367205,0.00033450255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017001998,0.0009852684,0.1803416,0.00008017192,0.00013505579,0.000009178583,0.0001534078,5.127798e-7,0.0005419642,0.00019092935,0.19860236,0.61894256],"study_design_scores_gemma":[0.003149025,0.00035867427,0.12022586,0.00017406017,0.00020652002,0.000018838513,0.00004032743,0.0001035447,0.00089419086,0.00017462778,0.8745177,0.00013667459],"about_ca_topic_score_codex":0.00032793748,"about_ca_topic_score_gemma":0.000028826205,"teacher_disagreement_score":0.6759153,"about_ca_system_score_codex":0.0004327475,"about_ca_system_score_gemma":0.0002094178,"threshold_uncertainty_score":0.997065},"labels":[],"label_agreement":null},{"id":"W4248522163","doi":"10.1097/ogx.0000000000000980","title":"Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study","year":2021,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Refractory (planetary science); Oncology; Internal medicine; Avelumab; Carboplatin; Cancer; Cisplatin; Immunotherapy; Pembrolizumab","score_opus":0.10124830981634338,"score_gpt":0.3735059806470571,"score_spread":0.2722576708307137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248522163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899624,0.0008346771,0.0001305637,0.0018356575,0.00050820253,0.005982809,0.00019585705,0.000097057855,0.0004527777],"genre_scores_gemma":[0.99273163,0.00065221015,0.0027130179,0.0012661627,0.00010810548,0.0014110367,0.00048281354,0.00011275841,0.00052229385],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9933227,0.0014973385,0.0014936371,0.0016787351,0.0010056891,0.0010019324],"domain_scores_gemma":[0.99019456,0.0074279145,0.00045781548,0.0008916972,0.00043222457,0.0005957952],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017266957,0.0007810747,0.0022736753,0.00033952718,0.00021369892,0.00024234591,0.0005236254,0.00052054116,0.009130217],"category_scores_gemma":[0.003692886,0.0005047664,0.0000849429,0.003256135,0.00015791196,0.00035864746,0.00016590807,0.0008783272,0.000025674773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42618117,0.14880712,0.28442267,0.00006318269,0.0011851361,0.008520592,0.00087464805,0.000058139998,0.00064149575,0.00008068488,0.00045533365,0.12870981],"study_design_scores_gemma":[0.3990312,0.022341609,0.5761259,0.000109276814,0.00012356298,0.000011852839,0.00026165327,0.0005642423,0.00017938582,0.000029111128,0.0007154112,0.0005067824],"about_ca_topic_score_codex":0.006717526,"about_ca_topic_score_gemma":0.074216016,"teacher_disagreement_score":0.29170325,"about_ca_system_score_codex":0.0020100533,"about_ca_system_score_gemma":0.0014210114,"threshold_uncertainty_score":0.9998968},"labels":[],"label_agreement":null},{"id":"W4249020907","doi":"10.1158/1055-9965.epi-16-0088","title":"Hormone Contraception before the First Birth and Ovarian Cancer Risk","year":2016,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Odds ratio; Tubal ligation; Gynecology; Obstetrics; Confidence interval; Population; Breastfeeding; Logistic regression; Relative risk; Family planning; Case-control study; Ovarian cancer; Demography; Cancer; Internal medicine; Pediatrics; Environmental health","score_opus":0.02926714764803065,"score_gpt":0.3301631332938892,"score_spread":0.3008959856458585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249020907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65276426,0.08718797,0.0040735463,0.25210708,0.0012572805,0.0020191157,0.00023064353,0.00013730243,0.00022281746],"genre_scores_gemma":[0.9505298,0.044825394,0.000476134,0.0014082532,0.00055438187,0.0011681783,0.000024098625,0.000030107116,0.000983654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980432,0.0003581572,0.0004982155,0.00056877814,0.000107146436,0.0004245005],"domain_scores_gemma":[0.99850863,0.00042624655,0.0004223373,0.00039461718,0.000084967076,0.00016317835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012407927,0.00025079155,0.0005011724,0.000080182566,0.00027182192,0.000008809871,0.00008749814,0.00022282128,0.0004993421],"category_scores_gemma":[0.0002509759,0.00012916888,0.00019855352,0.00014237515,0.0003830977,0.0001237704,0.000046581812,0.00014084316,0.000025049723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039531765,0.000068478155,0.68680996,0.000027242015,0.0008663225,0.0000036417512,0.00007873736,0.0000015442639,0.00015957821,0.00051636336,0.012376003,0.29869682],"study_design_scores_gemma":[0.0039159656,0.0004253846,0.93537474,0.00043352772,0.00070341036,0.00001806526,0.000033196546,0.00008268102,0.0000952297,0.0048251795,0.053961337,0.00013129543],"about_ca_topic_score_codex":0.001801038,"about_ca_topic_score_gemma":0.004024803,"teacher_disagreement_score":0.2985655,"about_ca_system_score_codex":0.0004327492,"about_ca_system_score_gemma":0.000116068884,"threshold_uncertainty_score":0.5467446},"labels":[],"label_agreement":null},{"id":"W4249231641","doi":"10.14740/jmc2617w","title":"Micropapillary Serous Borderline Ovarian Tumor in Early Pregnancy: Is Conservative Surgery Still a Viable Option?","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Serous fluid; Omentectomy; Pregnancy; Ovarian tumor; Laparotomy; Malignancy; Stage (stratigraphy); Gynecology; Surgery; Obstetrics; Ovarian cancer; Hysterectomy; Cancer; Pathology; Internal medicine","score_opus":0.03298990671752797,"score_gpt":0.30247176985343244,"score_spread":0.2694818631359045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249231641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94442964,0.007170078,0.00016977756,0.047516774,0.00038221027,0.00021155147,0.000035842233,0.000011934149,0.000072191135],"genre_scores_gemma":[0.9915143,0.0042105587,0.000606025,0.0030337763,0.00040975964,0.000015552085,0.0000023305788,0.0000229895,0.0001847066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976347,0.00011568157,0.0008087411,0.00020251986,0.00093911967,0.00029920842],"domain_scores_gemma":[0.9974476,0.0012258489,0.00037715238,0.00018837994,0.0002945273,0.00046645288],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006624199,0.00017996709,0.00068926875,0.00022128962,0.000030905667,0.00001903378,0.000107689346,0.00012225105,0.0013557309],"category_scores_gemma":[0.0014381628,0.00010221738,0.00020039624,0.00024420896,0.00012832209,0.0001652348,0.0000360497,0.00026980747,0.000024253819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016293597,0.002499135,0.82611376,0.0002533286,0.0005825649,0.087954514,0.00057261565,7.44186e-7,0.00034896994,0.000280783,0.027664665,0.05209958],"study_design_scores_gemma":[0.022313407,0.004543183,0.8472185,0.03343347,0.000622849,0.025708493,0.00034624522,0.00003863384,0.0077143456,0.00086833356,0.056666896,0.0005256138],"about_ca_topic_score_codex":0.000312425,"about_ca_topic_score_gemma":0.000054134445,"teacher_disagreement_score":0.06224602,"about_ca_system_score_codex":0.00023184817,"about_ca_system_score_gemma":0.0012894438,"threshold_uncertainty_score":0.99955714},"labels":[],"label_agreement":null},{"id":"W4249260600","doi":"10.1038/sj/bjc/6692196","title":"True","year":2001,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Malignancy; Cancer; Stage (stratigraphy); Epithelial ovarian cancer; Gynecology; Cytoreductive surgery; Multivariate analysis; Surgery; General surgery; Internal medicine","score_opus":0.016977546098720382,"score_gpt":0.3110622925530365,"score_spread":0.29408474645431615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249260600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1638099,0.7986739,0.00007041575,0.01934573,0.009308364,0.00013609447,0.00006000126,0.000005976127,0.0085895695],"genre_scores_gemma":[0.43346965,0.53571117,0.00036177947,0.001454057,0.009076863,0.00001145599,0.0000015963607,0.000034957517,0.019878484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983487,0.00006590991,0.0005872819,0.00015574339,0.0004263665,0.00041599126],"domain_scores_gemma":[0.99868965,0.00006539004,0.0003590261,0.00012189815,0.00036740044,0.00039660462],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028847466,0.00015091516,0.00050671643,0.000075076525,0.00007228449,0.00009220135,0.000116002426,0.0001238347,0.013994917],"category_scores_gemma":[0.00006764312,0.00016898365,0.00030856737,0.0002214298,0.00010750039,0.0002264115,0.000017579832,0.0004022996,0.000080300546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001518521,0.0005522832,0.05289582,0.00008453623,0.0007000967,0.019290188,0.00008474144,0.000072896335,0.00003067568,0.00014442891,0.084143296,0.8418492],"study_design_scores_gemma":[0.0042261076,0.00047597417,0.18978012,0.0067928075,0.00086157053,0.016702812,0.000080741665,0.000014977428,0.00028251062,0.00019979294,0.7804522,0.00013038128],"about_ca_topic_score_codex":0.0026511438,"about_ca_topic_score_gemma":0.0014348637,"teacher_disagreement_score":0.8417188,"about_ca_system_score_codex":0.0007090435,"about_ca_system_score_gemma":0.00072410936,"threshold_uncertainty_score":0.9869064},"labels":[],"label_agreement":null},{"id":"W4249354813","doi":"10.1097/ogx.0000000000000189","title":"Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy","year":2015,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Salpingectomy; Hysterectomy; Gynecology; Obstetrics; Ovarian cancer; Fallopian tube; Cohort; Population; Cohort study; Surgery; Cancer; Pregnancy; Internal medicine; Environmental health","score_opus":0.16182438518417708,"score_gpt":0.3672337965366987,"score_spread":0.2054094113525216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249354813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206215,0.0030447177,0.00002918,0.00036098866,0.00023697436,0.00058666756,0.00011206028,0.000049475297,0.003517784],"genre_scores_gemma":[0.99825424,0.0005588431,0.00031939428,0.00020423978,0.00006341879,0.00008035582,0.00018274678,0.000016779466,0.00031995663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812216,0.00034217568,0.00039526142,0.00046203507,0.00037011932,0.00030824717],"domain_scores_gemma":[0.9973947,0.0011381621,0.0001505772,0.00024706853,0.00032455308,0.0007449726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004989272,0.0002020806,0.00055872113,0.00009147625,0.000050458042,0.000032986132,0.000090024245,0.00022183552,0.00062385463],"category_scores_gemma":[0.0028816517,0.00014690384,0.00006928761,0.00047073193,0.00010584649,0.0000904344,0.0000640936,0.00017222691,0.000020094856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038810083,0.0022076308,0.7957816,0.000034431378,0.000152997,0.00011687059,0.000041920935,0.000031708416,0.000020652304,0.0043326137,0.00045918362,0.19643225],"study_design_scores_gemma":[0.0031939745,0.0044262,0.9904051,0.00005105407,0.00014668949,0.000015311143,0.00004818676,0.00012804488,0.00006148055,0.00065258966,0.000712965,0.00015840074],"about_ca_topic_score_codex":0.0019487332,"about_ca_topic_score_gemma":0.0005555134,"teacher_disagreement_score":0.19627385,"about_ca_system_score_codex":0.00035788657,"about_ca_system_score_gemma":0.0003573082,"threshold_uncertainty_score":0.6830771},"labels":[],"label_agreement":null},{"id":"W4250292140","doi":"10.21203/rs.2.13812/v3","title":"Defining the short-term disease recurrence after Loop Electrosurgical Excision Procedure (LEEP)","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Loop electrosurgical excision procedure; Term (time); Medicine; Surgery; Loop (graph theory); Electrosurgery; Disease; Mathematics; Physics; Internal medicine; Cancer; Colposcopy; Combinatorics","score_opus":0.06030654928905887,"score_gpt":0.40796510953535897,"score_spread":0.3476585602463001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250292140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7259356,0.13164338,0.00025212052,0.12255954,0.000830874,0.012167124,0.00096444396,0.00041778112,0.0052291565],"genre_scores_gemma":[0.989986,0.0050151288,0.00009313404,0.00029684955,0.0007299541,0.0031366134,0.0004252307,0.00007326004,0.00024381641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950258,0.00040295057,0.0004145693,0.0012800661,0.0019971598,0.0008794432],"domain_scores_gemma":[0.9968391,0.00050060684,0.00006646176,0.0012089015,0.00050940353,0.0008755462],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00082819903,0.000414431,0.0005673143,0.00018524705,0.00026636687,0.00025982902,0.00043523303,0.00027896467,0.0006339603],"category_scores_gemma":[0.00077572506,0.00025946344,0.00039873234,0.00052410894,0.00023445704,0.000054161363,0.0011396683,0.0027784174,0.00028317625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008084841,0.0022813398,0.81942606,0.0085670585,0.0007478513,0.009269208,0.0014948238,0.000040623858,0.000059465052,0.003305284,0.029178735,0.11754469],"study_design_scores_gemma":[0.0013777692,0.0011989725,0.97024316,0.009217552,0.00039564684,0.000044078603,0.00013737686,0.0010542275,0.00033249796,0.002273188,0.013214117,0.0005114027],"about_ca_topic_score_codex":0.00003583885,"about_ca_topic_score_gemma":0.000022180238,"teacher_disagreement_score":0.26405045,"about_ca_system_score_codex":0.0005715062,"about_ca_system_score_gemma":0.0019381258,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W4250431719","doi":"10.1210/en.142.2.580","title":"Estradiol Regulates Gonadotropin-Releasing Hormone (GnRH) and its Receptor Gene Expression and Antagonizes the Growth Inhibitory Effects of GnRH in Human Ovarian Surface Epithelial and Ovarian Cancer Cells","year":2001,"lang":"en","type":"article","venue":"Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Endocrinology; Estrogen receptor; Autocrine signalling; Estrogen; GNRHR; Biology; Messenger RNA; Gonadotropin-releasing hormone; Receptor; Estrogen receptor alpha; Hormone; Luteinizing hormone; Gene; Cancer; Medicine; Breast cancer","score_opus":0.0105805501004838,"score_gpt":0.2507197622623348,"score_spread":0.24013921216185097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250431719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97170407,0.025374962,0.000006453929,0.0019087876,0.00023973081,0.00065788755,0.000022455386,0.000025606485,0.000060061637],"genre_scores_gemma":[0.97132254,0.027663393,0.00052239036,0.00010335063,0.00022544964,0.000052188647,0.000009332848,0.000029229112,0.00007210895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985383,0.00016150792,0.00031405385,0.00045894185,0.00012705721,0.00040012912],"domain_scores_gemma":[0.9992638,0.00022321803,0.00013325438,0.00021088118,0.00004524996,0.00012354937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006579002,0.00025151364,0.00050255907,0.000105689425,0.00014606795,0.000018486588,0.000065242064,0.00012009549,0.000028351164],"category_scores_gemma":[0.000031966334,0.00018310091,0.000037523976,0.00012372891,0.0002397571,0.00008244104,0.00009071307,0.00022497885,0.0000012133268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032157393,0.00017224778,0.05280069,0.00015368724,0.00010844133,0.00021548873,0.00064603164,0.000005457422,0.941295,0.00060484273,0.00015396228,0.0035225428],"study_design_scores_gemma":[0.004750413,0.00048258522,0.40723994,0.0002503276,0.00010239532,0.00017286638,0.000059659273,0.000022864033,0.5863458,0.00011402498,0.00032582038,0.00013329076],"about_ca_topic_score_codex":0.0012397516,"about_ca_topic_score_gemma":0.000051456875,"teacher_disagreement_score":0.35494924,"about_ca_system_score_codex":0.00008325283,"about_ca_system_score_gemma":0.00005561831,"threshold_uncertainty_score":0.74666387},"labels":[],"label_agreement":null},{"id":"W4250609003","doi":"10.1038/modpathol.2018.11","title":"USCAP 2018 Abstracts: Gynecologic and Obstetric Pathology (1127–1316)","year":2018,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Pathology; Gynecology; Medical physics","score_opus":0.02584234786166811,"score_gpt":0.278506852480803,"score_spread":0.25266450461913487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250609003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795404,0.0035915237,0.00043466722,0.0027394523,0.00090456574,0.00044057242,0.000028616536,0.00011462876,0.012205537],"genre_scores_gemma":[0.9927639,0.0006734246,0.0022541143,0.0028071208,0.00036607627,0.000099510136,0.000027430919,0.00003526095,0.0009731884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818903,0.00009268782,0.00036890406,0.0006989462,0.00013703802,0.0005133802],"domain_scores_gemma":[0.9988133,0.00020878032,0.00013797003,0.00053402776,0.00011304843,0.00019290492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023253483,0.0002579086,0.0005252238,0.00020114408,0.00011785619,0.000017991466,0.000094637464,0.00034005076,0.0004500234],"category_scores_gemma":[0.00022718581,0.0002084696,0.00008259608,0.0001637781,0.0004560052,0.000062256564,0.000105124716,0.00021415316,0.0004636492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074680644,0.0037660883,0.5338109,0.0002839226,0.0005520378,0.02338661,0.0044292235,0.00002152017,0.02157321,0.0028563715,0.0191438,0.3894295],"study_design_scores_gemma":[0.0043795574,0.003936043,0.9632238,0.000037767088,0.0003174667,0.0034228673,0.00008391808,0.0002943118,0.0019206563,0.0049294485,0.017119454,0.00033471535],"about_ca_topic_score_codex":0.00002937585,"about_ca_topic_score_gemma":0.000065156084,"teacher_disagreement_score":0.42941287,"about_ca_system_score_codex":0.00012921456,"about_ca_system_score_gemma":0.00008562624,"threshold_uncertainty_score":0.85011435},"labels":[],"label_agreement":null},{"id":"W4250741825","doi":"10.21203/rs.2.21098/v1","title":"Gene networks and expression quantitative trait loci associated with platinum-based chemotherapy response in high-grade serous ovarian cancer","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Queen's University; Government of Ontario","keywords":"Expression quantitative trait loci; Ovarian cancer; Biology; Chemotherapy; Gene; Gene expression; Ovarian carcinoma; Oncology; Cancer research; Microarray; Gene expression profiling; Cancer; Bioinformatics; Internal medicine; Medicine; Genetics; Single-nucleotide polymorphism","score_opus":0.07707808367475773,"score_gpt":0.3911993458306174,"score_spread":0.31412126215585967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250741825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703892,0.0033299078,0.00064181513,0.021798402,0.0000740368,0.003083392,0.0005425964,0.00009396983,0.000046683763],"genre_scores_gemma":[0.9938605,0.0010719924,0.002210297,0.0003889469,0.00017754508,0.00138408,0.000698031,0.00012354448,0.00008510428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953109,0.0012718262,0.00042277825,0.0011283979,0.0011239074,0.00074220775],"domain_scores_gemma":[0.99707407,0.0013601009,0.00020478576,0.00054621283,0.00038932796,0.00042552437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013290815,0.00046028954,0.00095090317,0.0003979174,0.00015994393,0.00011984944,0.00018616377,0.00055233756,0.0002238303],"category_scores_gemma":[0.00037636224,0.00036038403,0.00011383824,0.0007767287,0.0002237236,0.00005269534,0.00018222026,0.0019267296,0.0000029683495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21022008,0.009351032,0.56936896,0.004731981,0.005112831,0.01193728,0.017741999,0.12313854,0.010620097,0.0004800337,0.013292721,0.024004456],"study_design_scores_gemma":[0.018958727,0.0041386895,0.94168717,0.009091531,0.00013130509,0.0000050741533,0.00045363442,0.019406704,0.0050943615,0.0002632159,0.00026619624,0.00050340634],"about_ca_topic_score_codex":0.0027388849,"about_ca_topic_score_gemma":0.0008584208,"teacher_disagreement_score":0.3723182,"about_ca_system_score_codex":0.0013997292,"about_ca_system_score_gemma":0.0016243997,"threshold_uncertainty_score":0.9998848},"labels":[],"label_agreement":null},{"id":"W4250977751","doi":"10.14740/jcgo345w","title":"Effectiveness and Safety of Cytoreduction Surgery in Advanced Ovarian Cancer: Initial Experience at a University General Hospital","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; General surgery; Surgery; Oncology; Cancer; Internal medicine","score_opus":0.04891741309517386,"score_gpt":0.3659703418220997,"score_spread":0.3170529287269258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250977751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494916,0.0021595303,0.000021941823,0.000506799,0.0021601936,0.0001416687,0.000006718796,0.0000023541568,0.0000516559],"genre_scores_gemma":[0.99306357,0.006399466,0.0003475804,0.000043199838,0.00012222065,0.000001617853,0.0000012630696,0.000004568073,0.000016518754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987627,0.00024036014,0.00058508274,0.00015872598,0.0001337066,0.00011938449],"domain_scores_gemma":[0.9946685,0.0043791,0.00044097498,0.000069708236,0.00022690733,0.00021483385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081811857,0.00008482879,0.0006639958,0.00015835142,0.000032387135,0.0000028260959,0.00003514647,0.00016964354,0.000013971304],"category_scores_gemma":[0.00391716,0.00007034516,0.000101808444,0.00023523561,0.0002022055,0.0001202407,0.000043968586,0.00021585151,2.4106635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026228107,0.0005186183,0.9426137,0.000039366423,0.00009521609,0.0004267832,0.00027420558,0.000035246503,0.000014137126,0.00006944475,0.000056792243,0.053233653],"study_design_scores_gemma":[0.008342083,0.0017983146,0.9869012,0.0001087237,0.000116616065,0.00006825392,0.00027410654,0.000023151228,0.00027087782,0.000052432253,0.0019798437,0.000064358006],"about_ca_topic_score_codex":0.000035829155,"about_ca_topic_score_gemma":0.000018776529,"teacher_disagreement_score":0.053169295,"about_ca_system_score_codex":0.00026329496,"about_ca_system_score_gemma":0.00042279836,"threshold_uncertainty_score":0.46894893},"labels":[],"label_agreement":null},{"id":"W4252916816","doi":"10.1515/iupac.84.1064","title":"Primary Lymphoid Follicle","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Immunology; Medicine; Immune system; Philosophy; Linguistics","score_opus":0.01385461825732773,"score_gpt":0.3946974939372482,"score_spread":0.3808428756799204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252916816","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001895851,0.003911219,0.00001815932,0.0038977428,0.00076727476,0.000599466,0.99014175,0.000079277146,0.00039553185],"genre_scores_gemma":[0.00003908036,0.0064309607,0.000109038076,0.0022057707,0.0017509906,0.00007210296,0.9881972,0.00006188158,0.0011329704],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726754,0.000040638854,0.0004595316,0.00064441067,0.0011259363,0.0004619594],"domain_scores_gemma":[0.99789464,0.000087887325,0.00021171678,0.0011447528,0.00032907558,0.00033192057],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002506022,0.000480542,0.0009798491,0.00018164802,0.00008249703,0.00003601948,0.0001887751,0.0003522674,0.0055980436],"category_scores_gemma":[0.00012686271,0.00032260726,0.0003298139,0.0001646263,0.00010482053,0.00005772845,0.00012190822,0.00024792837,0.00001554888],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045209,0.0010400322,0.00034205086,0.0003164648,0.00053613476,0.00055829633,0.0000049031732,8.809028e-8,0.000009376763,0.000006548336,0.9767736,0.019960366],"study_design_scores_gemma":[0.005907197,0.0007581067,0.0010884717,0.0011763598,0.0008182657,0.00015206612,0.0000047023727,3.4290457e-7,0.00007304483,0.00004328812,0.98964506,0.0003330819],"about_ca_topic_score_codex":0.0001920123,"about_ca_topic_score_gemma":0.00017068541,"teacher_disagreement_score":0.019627284,"about_ca_system_score_codex":0.0021155034,"about_ca_system_score_gemma":0.0022439866,"threshold_uncertainty_score":0.9999226},"labels":[],"label_agreement":null},{"id":"W4253021856","doi":"10.1200/jco.2015.33.15_suppl.tps5610","title":"The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; MEK inhibitor; Internal medicine; Oncology; Clinical endpoint; KRAS; Chemotherapy; Cancer; MAPK/ERK pathway; Clinical trial; Kinase; Colorectal cancer","score_opus":0.14725233005346622,"score_gpt":0.44779431299604044,"score_spread":0.3005419829425742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253021856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984977,0.00071156677,8.104359e-7,0.0063519464,0.0018772878,0.0059586777,0.000036630954,0.0000056362724,0.00008042131],"genre_scores_gemma":[0.9972367,0.000615611,0.00037016065,0.0007903467,0.0005068048,0.00035347452,0.000007255213,0.000050584425,0.00006905028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9917612,0.0023816964,0.0036225545,0.0005337983,0.0012702848,0.00043047144],"domain_scores_gemma":[0.99062526,0.0044180946,0.0031103005,0.0005786696,0.00092146435,0.0003461803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003969006,0.00042495245,0.0033142911,0.00021275546,0.00010532534,0.000034117773,0.0007448902,0.00022506634,0.000019966437],"category_scores_gemma":[0.0019132311,0.00020301093,0.00039057713,0.0007398577,0.0004254093,0.00019037792,0.00022853528,0.0010726153,8.46379e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52754605,0.13817796,0.29182348,0.00007756432,0.0023935693,0.00017117013,0.004540236,0.00009228248,0.000008014165,0.0000047550466,0.00049252075,0.034672383],"study_design_scores_gemma":[0.5543047,0.06642856,0.37353975,0.0005271553,0.0008730307,0.00000952611,0.0031207576,0.00011713155,0.000022741673,0.0000035339629,0.00090059516,0.00015251065],"about_ca_topic_score_codex":0.0018713202,"about_ca_topic_score_gemma":0.0073372433,"teacher_disagreement_score":0.08171628,"about_ca_system_score_codex":0.0011574025,"about_ca_system_score_gemma":0.0050078644,"threshold_uncertainty_score":0.8883736},"labels":[],"label_agreement":null},{"id":"W4253179252","doi":"10.1136/ijgc-00009577-200602001-00008","title":"A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Debulking; Carboplatin; Chemotherapy; Ovarian cancer; Surgery; Stage (stratigraphy); Retrospective cohort study; Internal medicine; Oncology; Subgroup analysis; Cancer; Confidence interval; Cisplatin","score_opus":0.02393308602563269,"score_gpt":0.33291612833109313,"score_spread":0.3089830423054604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253179252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893527,0.0013751542,0.00020691204,0.006288112,0.0017511131,0.00018524424,0.000118653596,0.0000092490245,0.0007128723],"genre_scores_gemma":[0.9973993,0.00084499735,0.00066529773,0.0005628223,0.00033385036,0.00006058176,0.000022740043,0.000013358624,0.000097108124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797356,0.00005103076,0.0008300071,0.00024348895,0.00068998145,0.00021193927],"domain_scores_gemma":[0.9978065,0.00047819392,0.0007580497,0.00012522556,0.0007446673,0.00008737522],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028011546,0.00017885983,0.00088065385,0.0005942615,0.00001964479,0.00001716122,0.00015978001,0.00011189691,0.0041958624],"category_scores_gemma":[0.0001936049,0.00013190559,0.0005348457,0.00047028836,0.00007374401,0.00009474648,0.000018125693,0.00022556144,0.0000014529257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005323487,0.0009618891,0.94256556,0.0000092900345,0.0030236004,0.0003314993,0.00007337581,0.014879247,0.00055554433,0.00018812681,0.0009143463,0.031174056],"study_design_scores_gemma":[0.009369658,0.00048206572,0.9846714,0.0001787295,0.00068386726,0.0000045867423,0.000035605495,0.0009192468,0.0019394231,0.00011417467,0.0014806696,0.000120586155],"about_ca_topic_score_codex":0.001179893,"about_ca_topic_score_gemma":0.0029694345,"teacher_disagreement_score":0.04210585,"about_ca_system_score_codex":0.0020358488,"about_ca_system_score_gemma":0.00056717696,"threshold_uncertainty_score":0.9967144},"labels":[],"label_agreement":null},{"id":"W4253471023","doi":"10.21203/rs.2.13812/v1","title":"Defining the short-term disease recurrence after Loop Electrosurgical Excision Procedure (LEEP)","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Loop electrosurgical excision procedure; Term (time); Surgery; Loop (graph theory); Medicine; Electrosurgery; Physics; Mathematics; Internal medicine; Cancer; Colposcopy; Combinatorics","score_opus":0.04484358910434212,"score_gpt":0.4008404039854405,"score_spread":0.3559968148810984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253471023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87695926,0.08911212,0.0001094578,0.019346658,0.0007579776,0.00858781,0.00049083726,0.00017062078,0.0044652284],"genre_scores_gemma":[0.9895481,0.0055292016,0.000057037618,0.00015863965,0.000536428,0.0027539867,0.0004016585,0.00007447498,0.00094050815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493015,0.00039979565,0.000408608,0.0012374498,0.002041849,0.0009821656],"domain_scores_gemma":[0.9964264,0.00061029376,0.000073227406,0.0016816108,0.0006146915,0.0005937983],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011874385,0.00042051685,0.0005783769,0.00025769323,0.00022804794,0.0002547706,0.00043976697,0.0003350626,0.000733903],"category_scores_gemma":[0.00051594916,0.00025675318,0.00040150632,0.0004146197,0.00021516027,0.00006298493,0.0010349781,0.002581026,0.0004891591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036222213,0.0014562776,0.91960454,0.0047943434,0.00036763985,0.001984341,0.00052485213,0.000073635536,0.000016743688,0.0012047823,0.011883946,0.054466683],"study_design_scores_gemma":[0.0012466292,0.00088335964,0.975557,0.009902669,0.00027787956,0.00003842768,0.00009475816,0.00088084384,0.00019112087,0.0008297033,0.009673698,0.0004238536],"about_ca_topic_score_codex":0.00004356206,"about_ca_topic_score_gemma":0.000023597744,"teacher_disagreement_score":0.11258877,"about_ca_system_score_codex":0.0006934706,"about_ca_system_score_gemma":0.0020952278,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W4253546705","doi":"10.1136/ijgc-00009577-200605000-00005","title":"Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Hazard ratio; Chemotherapy; Neoadjuvant therapy; Oncology; Internal medicine; Proportional hazards model; Stage (stratigraphy); Surgery; Cancer; Confidence interval; Breast cancer","score_opus":0.01255594879096513,"score_gpt":0.28171305097797655,"score_spread":0.26915710218701144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253546705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957059,0.00079531345,0.000021725054,0.0026398532,0.00021432224,0.00033395353,0.00003922865,0.0000064451924,0.0002432722],"genre_scores_gemma":[0.9983171,0.00054852036,0.00043455002,0.0003213364,0.0002184873,0.000082292485,0.00000738579,0.00001584623,0.000054445067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842954,0.00004658425,0.00061795977,0.0002306053,0.00047652543,0.00019877],"domain_scores_gemma":[0.9985416,0.00024181207,0.00048197436,0.00006667674,0.00057060306,0.000097346456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014672769,0.00017775994,0.0005117711,0.00015840503,0.000020487392,0.00002730057,0.00013157823,0.00006892382,0.00055223366],"category_scores_gemma":[0.000059921673,0.0001118291,0.00010641409,0.00016319808,0.00012438188,0.00010426955,0.000026998372,0.00019974713,5.458016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021957888,0.0013936838,0.97948784,0.00002175963,0.00027381277,0.00067391427,0.00005823036,0.000140342,0.0004596901,0.00008250698,0.00013077733,0.015081647],"study_design_scores_gemma":[0.009650681,0.0015929856,0.98304015,0.000627174,0.000119138764,0.000087132394,0.00001542714,0.00007986286,0.0036872155,0.00009539834,0.0008888836,0.000115940515],"about_ca_topic_score_codex":0.0014211348,"about_ca_topic_score_gemma":0.0005113457,"teacher_disagreement_score":0.0149657065,"about_ca_system_score_codex":0.0005358619,"about_ca_system_score_gemma":0.00021011173,"threshold_uncertainty_score":0.6046571},"labels":[],"label_agreement":null},{"id":"W4253783644","doi":"10.1515/iupac.88.0791","title":"Fallopian Tube","year":2017,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Data mining; Philosophy","score_opus":0.02361122666999418,"score_gpt":0.4497467291446504,"score_spread":0.42613550247465626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253783644","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010317342,0.0022787675,0.000004809263,0.0039003193,0.0011037453,0.0006017673,0.9913975,0.0000585146,0.0005513949],"genre_scores_gemma":[0.00010785962,0.0037922806,0.000106978165,0.00088128156,0.001859545,0.00005399875,0.99170655,0.00005415561,0.0014373547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974212,0.000030790663,0.00040123204,0.00064663636,0.0010627271,0.00043738086],"domain_scores_gemma":[0.9970086,0.000040760002,0.0002841966,0.0019264488,0.00038478657,0.00035521327],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024822628,0.0005071929,0.0010525937,0.00017356443,0.00019859843,0.00011099753,0.00032168138,0.00042814764,0.0044652326],"category_scores_gemma":[0.00030957616,0.00040051577,0.00033386063,0.00007276115,0.00014499808,0.000059543607,0.00013884538,0.0005757749,0.000014706258],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023214404,0.0008297748,0.0003382622,0.000319118,0.0005953046,0.0011484257,0.0000075974312,3.7252752e-7,5.280066e-7,0.0000084085095,0.9895019,0.007018196],"study_design_scores_gemma":[0.0033367558,0.000797099,0.0029102743,0.0011382456,0.0011293509,0.00009149071,0.000008840286,0.0000020876691,0.000011506428,0.00003159649,0.99019784,0.00034488924],"about_ca_topic_score_codex":0.00062134676,"about_ca_topic_score_gemma":0.0018372766,"teacher_disagreement_score":0.0066733067,"about_ca_system_score_codex":0.00080691854,"about_ca_system_score_gemma":0.0017779445,"threshold_uncertainty_score":0.9998447},"labels":[],"label_agreement":null},{"id":"W4254092576","doi":"10.21203/rs.2.20417/v1","title":"WITHDRAWN: Outcomes in patients with early stage uterine clear cell carcinoma treated with chemotherapy and radiotherapy: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"School of Medicine, Shanghai Jiao Tong University; Shanghai Jiao Tong University; Science and Technology Commission of Shanghai Municipality; National Natural Science Foundation of China","keywords":"Medicine; Odds ratio; Internal medicine; Stage (stratigraphy); Confidence interval; Meta-analysis; Radiation therapy; Oncology; Surgery","score_opus":0.06411978836562855,"score_gpt":0.38563306390421837,"score_spread":0.3215132755385898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254092576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016412479,0.98599535,0.0000023861962,0.00065701833,0.0000020236484,0.01130652,0.0003253548,0.000025412746,0.000044672932],"genre_scores_gemma":[0.0050972495,0.9911114,0.00020418027,0.00019140483,0.00001145731,0.002018965,0.0001417912,0.0001349634,0.0010885872],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99583685,0.0008398813,0.0007771599,0.0009975599,0.0010491413,0.0004994068],"domain_scores_gemma":[0.9977319,0.00029937754,0.00035576575,0.00095148693,0.0002636732,0.0003977581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005865967,0.0007268515,0.009810233,0.000683225,0.00008237979,0.00013167047,0.0001637218,0.00015257762,0.0003131061],"category_scores_gemma":[0.000029826258,0.00034829314,0.00067449774,0.0019776418,0.00014434275,0.00008698275,0.000059663136,0.00055554905,0.0000071589297],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021594325,0.00052783336,0.057393953,0.8461252,0.093131885,0.00037566735,0.00016727643,9.4860454e-8,7.1261894e-9,0.0000048534207,0.000024650055,0.0020326786],"study_design_scores_gemma":[0.008336123,0.011649459,0.049115688,0.08268649,0.81488764,0.000024692967,0.000060819122,0.0000051918614,7.7674366e-7,4.271353e-7,0.032378983,0.00085368496],"about_ca_topic_score_codex":0.0005398494,"about_ca_topic_score_gemma":0.000079183286,"teacher_disagreement_score":0.7634387,"about_ca_system_score_codex":0.0003912899,"about_ca_system_score_gemma":0.00026708422,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W4254120630","doi":"10.1136/ijgc-00009577-200201000-00019","title":"Postoperative chemotherapy in advanced ovarian granulosa cell tumors","year":2002,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Univariate analysis; Chemotherapy; Stage (stratigraphy); Hysterectomy; Radiation therapy; Surgery; Retrospective cohort study; Population; Internal medicine; Gynecology; Multivariate analysis","score_opus":0.020721134848475244,"score_gpt":0.3043143164714355,"score_spread":0.2835931816229602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254120630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579582,0.0020962448,0.000036903013,0.033891007,0.0007702827,0.00020251842,0.000013522262,0.000008805012,0.005022488],"genre_scores_gemma":[0.9912415,0.002377668,0.00091042224,0.0047066887,0.00026754264,0.000029482202,0.0000019566858,0.000010956073,0.00045376417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998793,0.000037819565,0.00044013813,0.00016419114,0.0003977115,0.00016712546],"domain_scores_gemma":[0.9991248,0.00010312904,0.00023006264,0.00007568,0.00034841217,0.0001179146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001215285,0.0001332642,0.00033355813,0.00014881756,0.000021470667,0.000023299652,0.0001670081,0.00007156761,0.0069835573],"category_scores_gemma":[0.000082780716,0.0000917591,0.00015511212,0.00012128722,0.00004656638,0.00012742075,0.000019633582,0.00026341726,0.000022422406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028197228,0.00633656,0.66251135,0.000026378426,0.00073124067,0.006601582,0.0015535756,0.0011360548,0.005021937,0.0010917372,0.007919707,0.30425018],"study_design_scores_gemma":[0.015606657,0.0021732207,0.9458051,0.0002943772,0.000055461234,0.0002710041,0.00014397434,0.00027671302,0.006680863,0.00041524845,0.028081207,0.00019617836],"about_ca_topic_score_codex":0.000036546873,"about_ca_topic_score_gemma":0.00004179497,"teacher_disagreement_score":0.304054,"about_ca_system_score_codex":0.0006677096,"about_ca_system_score_gemma":0.00008739284,"threshold_uncertainty_score":0.9939242},"labels":[],"label_agreement":null},{"id":"W4254388271","doi":"10.21203/rs.2.13812/v2","title":"Defining the short-term disease recurrence after Loop Electrosurgical Excision Procedure (LEEP)","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Loop electrosurgical excision procedure; Term (time); Loop (graph theory); Surgery; Medicine; Disease; Control theory (sociology); Computer science; Mathematics; Physics; Internal medicine; Cancer; Artificial intelligence; Control (management); Combinatorics","score_opus":0.04484358910434212,"score_gpt":0.4008404039854405,"score_spread":0.3559968148810984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254388271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87695926,0.08911212,0.0001094578,0.019346658,0.0007579776,0.00858781,0.00049083726,0.00017062078,0.0044652284],"genre_scores_gemma":[0.9895481,0.0055292016,0.000057037618,0.00015863965,0.000536428,0.0027539867,0.0004016585,0.00007447498,0.00094050815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493015,0.00039979565,0.000408608,0.0012374498,0.002041849,0.0009821656],"domain_scores_gemma":[0.9964264,0.00061029376,0.000073227406,0.0016816108,0.0006146915,0.0005937983],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011874385,0.00042051685,0.0005783769,0.00025769323,0.00022804794,0.0002547706,0.00043976697,0.0003350626,0.000733903],"category_scores_gemma":[0.00051594916,0.00025675318,0.00040150632,0.0004146197,0.00021516027,0.00006298493,0.0010349781,0.002581026,0.0004891591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036222213,0.0014562776,0.91960454,0.0047943434,0.00036763985,0.001984341,0.00052485213,0.000073635536,0.000016743688,0.0012047823,0.011883946,0.054466683],"study_design_scores_gemma":[0.0012466292,0.00088335964,0.975557,0.009902669,0.00027787956,0.00003842768,0.00009475816,0.00088084384,0.00019112087,0.0008297033,0.009673698,0.0004238536],"about_ca_topic_score_codex":0.00004356206,"about_ca_topic_score_gemma":0.000023597744,"teacher_disagreement_score":0.11258877,"about_ca_system_score_codex":0.0006934706,"about_ca_system_score_gemma":0.0020952278,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W4254426880","doi":"10.1002/cjp2.2018.4.issue-4","title":"Association of p16 expression with prognosis varies across ovarian carcinoma histotypes:an Ovarian Tumor Tissue Analysis consortium study","year":2018,"lang":"en","type":"paratext","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research and Materiel Command; Instituto de Salud Carlos III; Cancer Council Tasmania; Cancer Council Victoria; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; National Institutes of Health; Peter MacCallum Foundation; Ministerio de Economía y Competitividad; Canadian Institutes of Health Research; Cancer Institute NSW; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Fred C. and Katherine B. Andersen Foundation; Calgary Laboratory Services; University of Cambridge; University College London; Cancer Research UK; Minnesota Ovarian Cancer Alliance; Huntsman Cancer Foundation; Cancer Council NSW; Ovarian Cancer Australia; National Cancer Institute; Universität Heidelberg; Cancer Research Society; Cancer Council South Australia; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Cancer Australia; Ovarian Cancer Action; VGH and UBC Hospital Foundation; BC Cancer Foundation; Oak Foundation; Kræftens Bekæmpelse; Mayo Foundation for Medical Education and Research; U.S. Department of Defense","keywords":"Tissue microarray; Ovarian carcinoma; Hazard ratio; CDKN2A; Immunohistochemistry; Ovarian cancer; Serous carcinoma; Serous fluid; Cancer research; Oncology; Medicine; Pathology; Biology; Internal medicine; Cancer; Confidence interval","score_opus":0.12788371760400136,"score_gpt":0.4948079301032415,"score_spread":0.3669242124992401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254426880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906394,0.0012433036,0.000217021,0.00329288,0.0010369609,0.0017553957,0.00027353637,0.000009466871,0.0015320596],"genre_scores_gemma":[0.988986,0.000769061,0.0007634287,0.00013493905,0.0014335485,0.00008065677,0.000078546,0.000056671033,0.007697143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98617166,0.007515993,0.0025539699,0.00069267704,0.0022294596,0.0008362167],"domain_scores_gemma":[0.9860297,0.004857092,0.0030054664,0.0012854154,0.0043380717,0.00048425922],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022390649,0.0004227282,0.002727224,0.0006709169,0.00044189527,0.00007415497,0.00083046086,0.0007256172,0.0021773456],"category_scores_gemma":[0.0027988586,0.00023474824,0.0005138929,0.0013015567,0.0013058081,0.00012954941,0.00030019882,0.00295355,0.00022492147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012059637,0.008226584,0.9007852,0.00015636295,0.007992922,0.0022480553,0.0037624135,0.000016452406,0.00020862871,0.000007732863,0.062977694,0.0015582769],"study_design_scores_gemma":[0.009421977,0.049529582,0.91101694,0.0005409713,0.013081156,0.00039339584,0.0032748892,0.000016788332,0.0014897073,0.000054938966,0.010849511,0.0003301638],"about_ca_topic_score_codex":0.00050564826,"about_ca_topic_score_gemma":0.00067853794,"teacher_disagreement_score":0.052128185,"about_ca_system_score_codex":0.0006431602,"about_ca_system_score_gemma":0.0021123672,"threshold_uncertainty_score":0.9993467},"labels":[],"label_agreement":null},{"id":"W4254612279","doi":"10.1503/cmaj.180020","title":"Adnexal torsion","year":2018,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Adnexal Diseases; Torsion (gastropod); Adnexal mass; Medicine; Ovarian cyst; Fallopian tube; Cyst; Follicular Cyst; Surgery; Laparoscopy; Gynecology","score_opus":0.008368986136589462,"score_gpt":0.2592903561889899,"score_spread":0.2509213700524004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254612279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64527154,0.00059163256,0.00009142577,0.25902233,0.005120269,0.00028636778,0.000028618173,0.0000540223,0.08953379],"genre_scores_gemma":[0.9680944,0.00013957595,0.00026539914,0.023127116,0.0070131896,0.000004411612,0.0000069933394,0.000012578383,0.0013363252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983583,0.00004701621,0.00022438858,0.00011521675,0.00091700756,0.0003380512],"domain_scores_gemma":[0.99746984,0.00003970275,0.000087234686,0.000084509265,0.00038432702,0.0019344098],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006167292,0.00007749078,0.00015599231,0.00011312215,0.00022046457,0.000043829725,0.000067263725,0.00022872462,0.020280976],"category_scores_gemma":[0.0006200417,0.00006244976,0.00008440556,0.00014943368,0.000033603774,0.00005767921,0.0000068025133,0.0003814441,0.0009461248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016301436,0.00006488989,0.31300873,0.0000035641033,0.00015932533,0.000677083,0.0001542719,4.9928673e-8,0.000007625555,0.00039655587,0.60664225,0.07886935],"study_design_scores_gemma":[0.001332593,0.0002572462,0.20288941,0.000081315324,0.000047175985,0.0005467083,0.00006389341,0.000043628697,0.00008759462,0.000056125693,0.7945303,0.00006402822],"about_ca_topic_score_codex":0.0017033484,"about_ca_topic_score_gemma":0.017245274,"teacher_disagreement_score":0.32282287,"about_ca_system_score_codex":0.0016590934,"about_ca_system_score_gemma":0.0030095978,"threshold_uncertainty_score":0.99983174},"labels":[],"label_agreement":null},{"id":"W4254649859","doi":"10.1158/1538-7445.am2015-lb-307","title":"Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Serous fluid; Oncology; Internal medicine; Serous carcinoma; Ovarian carcinoma; Cancer; Adjuvant; Stage (stratigraphy); Surgery; Biology","score_opus":0.2839295482176014,"score_gpt":0.4612088933759195,"score_spread":0.1772793451583181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254649859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690568,0.0047197086,0.012264618,0.011751973,0.000050722596,0.0010995565,0.00024912128,0.000019433277,0.00078808866],"genre_scores_gemma":[0.99383074,0.00031041823,0.005022445,0.00007688339,0.00014782701,0.00044845522,0.00009442794,0.000022340755,0.000046456335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990413,0.000023387307,0.0001866589,0.0002482723,0.00026501258,0.00023537947],"domain_scores_gemma":[0.99866205,0.00015997398,0.00003952395,0.00019032384,0.00075892475,0.0001892234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043877217,0.000083246436,0.00018687904,0.00012968223,0.00010888989,0.0000255402,0.00006899062,0.000051172476,0.000021544229],"category_scores_gemma":[0.000037893897,0.00007205594,0.00004499541,0.00017173102,0.00007735044,0.00005639252,0.000029334666,0.00012907796,0.0000011841929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024155176,0.00085804204,0.5351252,0.00048285406,0.0007561056,0.000016508622,0.0021137653,0.057563175,0.0012712241,0.019132141,0.004094092,0.3761714],"study_design_scores_gemma":[0.013475027,0.0011295448,0.61637795,0.00035143938,0.00007955224,0.000029389414,0.0009481275,0.3510709,0.0006376582,0.014315229,0.0013309177,0.00025424745],"about_ca_topic_score_codex":0.001751778,"about_ca_topic_score_gemma":0.00011041368,"teacher_disagreement_score":0.37591717,"about_ca_system_score_codex":0.0002608251,"about_ca_system_score_gemma":0.00058708875,"threshold_uncertainty_score":0.29383558},"labels":[],"label_agreement":null},{"id":"W4254864182","doi":"10.1200/jco.2003.99.240","title":"CORRESPONDENCE","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.20731131467138803,"score_gpt":0.5269878382272908,"score_spread":0.31967652355590276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254864182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.871415,0.0021346826,0.00037318983,0.019632239,0.005107861,0.00017026227,0.0000011581188,0.000008315639,0.10115729],"genre_scores_gemma":[0.98595536,0.0009220378,0.0067650075,0.0042219805,0.0005819551,0.0000016784961,1.7584195e-7,0.000006662885,0.0015451226],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981689,0.00025487816,0.001167281,0.00009183397,0.00020222206,0.000114882685],"domain_scores_gemma":[0.9971215,0.0014895023,0.00073498074,0.00012302892,0.0002377482,0.0002932065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021501319,0.000060834092,0.0007773381,0.000050753308,0.000015776766,0.000003592048,0.000054593747,0.00016345107,0.0011695296],"category_scores_gemma":[0.004186368,0.000038586117,0.00033188946,0.00007936034,0.000078500016,0.000043066575,0.0000074871464,0.00041673463,0.00010313623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002853117,0.005078537,0.55599254,0.0000150494025,0.00059199234,0.004354922,0.000059990874,0.000008148346,0.000053272088,0.0062715225,0.07581508,0.34890583],"study_design_scores_gemma":[0.005853102,0.009724839,0.27459875,0.00004478384,0.00024080454,0.00090666977,0.000029618892,0.0000034843897,0.00014241185,0.0006309853,0.7077904,0.00003415433],"about_ca_topic_score_codex":0.0000024135873,"about_ca_topic_score_gemma":0.0000035061983,"teacher_disagreement_score":0.6319753,"about_ca_system_score_codex":0.00010518014,"about_ca_system_score_gemma":0.0018321058,"threshold_uncertainty_score":0.9997435},"labels":[],"label_agreement":null},{"id":"W4255252333","doi":"10.1016/j.ygyno.2021.01.032","title":"Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"","keywords":"Medicine; Kingdom; Family medicine; Library science","score_opus":0.2013144971495261,"score_gpt":0.3988083380898772,"score_spread":0.1974938409403511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255252333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016504923,0.9724942,0.0000074637546,0.0039415667,0.00043291703,0.017612418,0.003749361,0.000056145353,0.00005542545],"genre_scores_gemma":[0.0035333664,0.971502,0.0024201397,0.00947577,0.00005268597,0.009944176,0.0025718154,0.00010669159,0.00039332657],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9863838,0.005200485,0.0038085624,0.0026186279,0.00086622016,0.0011223231],"domain_scores_gemma":[0.9885884,0.004974038,0.0023156248,0.0031058213,0.00038356296,0.0006325408],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004807206,0.0013653743,0.024193296,0.0013093873,0.000116176045,0.000060819504,0.0010977057,0.0014301728,0.0028892732],"category_scores_gemma":[0.0049670734,0.0008875496,0.0020917328,0.0033673246,0.000254232,0.000090590365,0.0011315298,0.0010295075,0.00006328871],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038682873,0.011701362,0.0021402186,0.5700643,0.28226718,0.014924947,0.0012246314,0.000004254342,6.474431e-7,0.0001652145,0.021174194,0.09594623],"study_design_scores_gemma":[0.0018029215,0.0061725453,0.010546805,0.014139507,0.86530083,0.0006558884,0.00013018394,0.00000552332,8.4215446e-7,0.0000104868695,0.10044884,0.0007856227],"about_ca_topic_score_codex":0.00020305262,"about_ca_topic_score_gemma":0.00045422703,"teacher_disagreement_score":0.5830336,"about_ca_system_score_codex":0.0019754602,"about_ca_system_score_gemma":0.0031166445,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W4255520268","doi":"10.1200/jco.2004.22.14_suppl.5043","title":"Is neoadjuvant chemotherapy a realistic alternative to primary surgery for women with advanced ovarian cancer?","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Chemotherapy; Stage (stratigraphy); Oncology; Internal medicine; Paclitaxel; Cancer; Surgery; Cisplatin","score_opus":0.10342443646081402,"score_gpt":0.46166550706924525,"score_spread":0.35824107060843124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255520268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8055684,0.00051267206,0.0030238098,0.1873137,0.0014412729,0.0008965619,0.000051404146,0.000013893157,0.0011783033],"genre_scores_gemma":[0.93329954,0.0028409977,0.021743754,0.039677773,0.0019495933,0.00019603547,0.0000037513364,0.00004141246,0.00024711533],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976055,0.00007245163,0.0014120921,0.00027092657,0.0003077225,0.0003313284],"domain_scores_gemma":[0.9959622,0.0015645371,0.0011813863,0.00019807299,0.000500516,0.0005932728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013005651,0.00017293134,0.0017667343,0.00012151332,0.000037620706,0.000009550434,0.00010677884,0.00015940511,0.00012558317],"category_scores_gemma":[0.00057010335,0.00011028655,0.00032044345,0.00015717495,0.0000870257,0.0000784745,0.000016285583,0.00032493024,0.000004841091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041704047,0.003334652,0.022122668,0.00009020779,0.0019728139,0.0010116189,0.0009978879,0.00046351142,0.000063558335,0.00022209357,0.006963057,0.9210539],"study_design_scores_gemma":[0.04929297,0.053313326,0.66582596,0.00096190505,0.000528234,0.00034051406,0.00018921492,0.000012396613,0.0004848657,0.0029996224,0.22579582,0.0002551545],"about_ca_topic_score_codex":0.00010868209,"about_ca_topic_score_gemma":0.000069186564,"teacher_disagreement_score":0.9207987,"about_ca_system_score_codex":0.0014471109,"about_ca_system_score_gemma":0.0042901537,"threshold_uncertainty_score":0.7610549},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4255632355","doi":"10.1097/pas.0b013e31819b372d","title":"Author's Reply","year":2009,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Philosophy","score_opus":0.019318848874453683,"score_gpt":0.3151636511695068,"score_spread":0.2958448022950531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255632355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8478989,0.0006989247,0.000055741508,0.14892097,0.00013496328,0.00006221335,0.000001191856,0.0000097132,0.0022173827],"genre_scores_gemma":[0.992357,0.00045649122,0.0008294224,0.0057241386,0.00041698923,0.0000012562568,5.37737e-7,0.000006637057,0.00020748415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99901694,0.00015423248,0.0003455171,0.00010815725,0.00018956672,0.00018559833],"domain_scores_gemma":[0.99896187,0.00017035237,0.00038409975,0.00023392594,0.00010088493,0.00014889667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049740355,0.00009413382,0.0004955212,0.00006777625,0.000042813448,0.0000072055345,0.000107201486,0.000019674844,0.00010260345],"category_scores_gemma":[0.00004102218,0.000048016813,0.00020538016,0.00020112969,0.0002734907,0.000026455979,0.000011845871,0.00026233788,0.000022727685],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043741073,0.0013644176,0.026284639,0.0000055349083,0.000316938,0.038812157,0.0007501425,0.00003226785,0.0011300994,0.004030107,0.019607978,0.90329164],"study_design_scores_gemma":[0.00458293,0.02058355,0.6482182,0.00010223088,0.0005116345,0.075337,0.00040173522,0.000011380707,0.0006160037,0.0035207605,0.24593294,0.00018159345],"about_ca_topic_score_codex":0.0000065058903,"about_ca_topic_score_gemma":1.7941171e-7,"teacher_disagreement_score":0.90311,"about_ca_system_score_codex":0.000051380695,"about_ca_system_score_gemma":0.00007410647,"threshold_uncertainty_score":0.19580689},"labels":[],"label_agreement":null},{"id":"W4256490443","doi":"10.3410/f.718450222.793496236","title":"Faculty Opinions recommendation of LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).","year":2014,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Computational biology; Pathology; Medicine; Internal medicine","score_opus":0.022204517535673693,"score_gpt":0.3318903950596629,"score_spread":0.3096858775239892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256490443","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014736749,0.0015538639,0.000020219108,0.15529887,0.0004048544,0.0021704785,0.84047586,0.000022620741,0.000038503415],"genre_scores_gemma":[0.00049802585,0.0007761491,0.0010547609,0.0050332025,0.00024667184,0.0005727396,0.99147534,0.00004352377,0.00029957344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948032,0.000411012,0.0017950545,0.0008258748,0.0017734525,0.00039142562],"domain_scores_gemma":[0.98915684,0.0006336813,0.002455012,0.0018634963,0.005529166,0.0003618017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001074658,0.00069446414,0.0017764824,0.000363939,0.00015240745,0.00006456446,0.0007893302,0.00045082087,0.0006505674],"category_scores_gemma":[0.0061298236,0.0004020364,0.00084897835,0.0013582668,0.00045381652,0.00021366573,0.00031674074,0.0009577929,0.000028254055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013542782,0.0020921838,0.00028764,0.0109361,0.00080603943,0.000001989384,0.000079620004,1.9576093e-7,0.0000032355993,0.0000405909,0.9823466,0.0032704016],"study_design_scores_gemma":[0.002487755,0.0006478779,0.051966377,0.027457038,0.0010670833,0.00011066401,0.000019124736,0.000014762811,0.000110857094,0.0000068629442,0.91579014,0.0003214847],"about_ca_topic_score_codex":0.00023209242,"about_ca_topic_score_gemma":0.000010491169,"teacher_disagreement_score":0.1509995,"about_ca_system_score_codex":0.00021850798,"about_ca_system_score_gemma":0.00089449435,"threshold_uncertainty_score":0.9998432},"labels":[],"label_agreement":null},{"id":"W4280566139","doi":"10.1016/j.jogc.2022.02.051","title":"Predictive Value of Perioperative CA-125 and Ultrasound in Early Ovarian and Fallopian Tube Cancers","year":2022,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Serous fluid; Predictive value; Serous carcinoma; Fallopian tube; Ovarian cancer; Perioperative; Ovarian carcinoma; Gynecology; Ultrasound; Oncology; Obstetrics; Radiology; Internal medicine; Cancer","score_opus":0.007213439514536771,"score_gpt":0.2223016583641962,"score_spread":0.21508821884965942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280566139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882019,0.008772471,0.000003276001,0.00069926045,0.001314157,0.0002013649,0.00010730276,8.922784e-7,0.000699334],"genre_scores_gemma":[0.9984755,0.0009551448,0.00013954774,0.00031350998,0.000015637275,0.000012486171,0.0000030001756,0.000008330701,0.000076847566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990148,0.0000793769,0.00034324918,0.00015600018,0.00024159516,0.0001649779],"domain_scores_gemma":[0.9983966,0.0010315506,0.0002050722,0.000070589296,0.00012149676,0.00017472223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018402954,0.000112214926,0.0004213518,0.00020848983,0.00010955717,0.000011999049,0.00004539773,0.000048730548,0.00020291063],"category_scores_gemma":[0.00052728417,0.00009614158,0.00002684184,0.00028384518,0.00009225777,0.000051960007,0.000042276508,0.00030718074,1.8153383e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000374186,0.00009544953,0.9871356,0.000034768484,0.000307914,0.0016488946,0.0018571188,0.00031530287,0.000019637588,0.0005291858,0.00020200029,0.00781675],"study_design_scores_gemma":[0.004725872,0.0021388242,0.9858267,0.000011730678,0.00015128353,0.00022074267,0.0020847414,0.00012747532,0.00002963853,0.00003768107,0.0045675505,0.00007780287],"about_ca_topic_score_codex":0.10715576,"about_ca_topic_score_gemma":0.059340402,"teacher_disagreement_score":0.04781536,"about_ca_system_score_codex":0.0018116999,"about_ca_system_score_gemma":0.002372989,"threshold_uncertainty_score":0.9578242},"labels":[],"label_agreement":null},{"id":"W4280587697","doi":"10.1016/j.jogc.2022.02.049","title":"Standard Versus Extended Neoadjuvant Chemotherapy: A Canadian Tertiary Centre Cohort Study of Ovarian Cancer Care Amidst the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Chemotherapy; Perioperative; Cohort; Debulking; Internal medicine; Retrospective cohort study; Neoadjuvant therapy; Surgery; Oncology; Cancer; Ovarian cancer; Breast cancer","score_opus":0.01836281563405092,"score_gpt":0.27537958036382437,"score_spread":0.2570167647297735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280587697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729864,0.012450045,0.0000013596282,0.006969219,0.0061784047,0.0008141328,0.00034179844,0.0000044689627,0.00025416882],"genre_scores_gemma":[0.9964672,0.0006055473,0.000019106777,0.002739134,0.000039952207,0.000038776987,0.00001035819,0.000018491175,0.00006145174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982486,0.00015203205,0.0004815761,0.00021248667,0.00059318426,0.00031213294],"domain_scores_gemma":[0.9976559,0.0008605303,0.0004077287,0.00023689166,0.00028925005,0.0005496697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000320546,0.0001683325,0.0005370517,0.00023695131,0.00037203616,0.000014491489,0.00018006022,0.000057993562,0.0018160592],"category_scores_gemma":[0.00046783226,0.00011966084,0.00007803409,0.00039890426,0.0000594825,0.000025252799,0.00005057842,0.00042573112,7.633317e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00013880136,0.00017342549,0.9567492,0.0000282889,0.0009309154,0.0028758363,0.0018459375,0.00027771422,9.81933e-7,0.000016675463,0.0054797614,0.031482458],"study_design_scores_gemma":[0.014292787,0.0017481049,0.8888063,0.000004147236,0.0006161337,0.00009275966,0.013403735,0.000013503609,0.0000036417507,0.0000087442295,0.08090111,0.000109076216],"about_ca_topic_score_codex":0.8193635,"about_ca_topic_score_gemma":0.9593438,"teacher_disagreement_score":0.13998032,"about_ca_system_score_codex":0.012521794,"about_ca_system_score_gemma":0.014227686,"threshold_uncertainty_score":0.9990964},"labels":[],"label_agreement":null},{"id":"W4281561154","doi":"10.1038/s41416-022-01844-0","title":"Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ontario Institute for Cancer Research; Cancer Care Ontario","funders":"Medical Research Council; Cancer Research UK","keywords":"Medicine; Referral; Benchmarking; Cancer; General partnership; Family medicine; Ovarian cancer; Internal medicine","score_opus":0.0191230772184172,"score_gpt":0.3031562460684541,"score_spread":0.2840331688500369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281561154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8734452,0.054541435,0.00008618161,0.064108856,0.004238364,0.0007302844,0.0022439472,0.000017065378,0.00058864185],"genre_scores_gemma":[0.97518724,0.017823862,0.000306532,0.0024335627,0.002398264,0.00096421543,0.00006646635,0.000033341308,0.00078650727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838763,0.00006335346,0.0005475557,0.0002649038,0.00051625556,0.00022030363],"domain_scores_gemma":[0.99856985,0.00068032695,0.00032170783,0.000092331284,0.00023132982,0.00010442841],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048586517,0.00014881084,0.00034401505,0.00013073235,0.00018597877,0.00014515931,0.00027156825,0.000044844837,0.008527371],"category_scores_gemma":[0.00021197108,0.00013711404,0.00016291748,0.0001552856,0.000059957318,0.00019649639,0.00012122825,0.00042043693,9.4681474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006476544,0.00032407683,0.7337521,0.000020835021,0.0013913028,0.00031813115,0.0010809334,0.00165133,0.00020893842,0.000106027204,0.058472972,0.20202571],"study_design_scores_gemma":[0.006420145,0.00023720946,0.7970349,0.0018576366,0.0004750719,0.00037671532,0.00019380094,0.0014758913,0.00021237327,0.0003536093,0.19117136,0.00019124537],"about_ca_topic_score_codex":0.007116893,"about_ca_topic_score_gemma":0.0046099266,"teacher_disagreement_score":0.20183447,"about_ca_system_score_codex":0.0010323412,"about_ca_system_score_gemma":0.00042692974,"threshold_uncertainty_score":0.9994948},"labels":[],"label_agreement":null},{"id":"W4281632563","doi":"10.1186/s13053-022-00227-z","title":"Beyond the pill: contraception and the prevention of hereditary ovarian cancer","year":2022,"lang":"en","type":"review","venue":"Hereditary Cancer in Clinical Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Peter Gilgan Foundation; Canada Research Chairs","keywords":"Medicine; Ovarian cancer; Pill; Gynecology; Population; Family planning; Cancer; Hormonal contraception; Obstetrics; Oncology; Internal medicine; Environmental health; Pharmacology; Research methodology","score_opus":0.12658735088645365,"score_gpt":0.47452507511653685,"score_spread":0.3479377242300832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281632563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033003846,0.96994865,0.000004752355,0.018241743,0.0038494875,0.0035689173,0.00035993112,0.000023154687,0.00397036],"genre_scores_gemma":[0.00037693995,0.9898886,0.00017915477,0.002230609,0.0033961313,0.0033022237,0.00012515952,0.00007775517,0.0004234384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99311477,0.002649995,0.0022898894,0.00082109106,0.00077136856,0.00035290435],"domain_scores_gemma":[0.98298126,0.014042201,0.0017797379,0.0009050692,0.00014698002,0.00014475983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005086196,0.00047842576,0.0024312777,0.00009775401,0.00019752854,0.000034519147,0.00033590652,0.0004011062,0.0028500338],"category_scores_gemma":[0.0019175251,0.00026089285,0.000848337,0.0005425609,0.00061316893,0.00028424984,0.00023361151,0.0022931586,0.000009816585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012579986,0.000837745,0.00020659379,0.0031310106,0.0019405074,0.00022968838,0.00012967548,0.00000882102,1.0921475e-8,0.0006621019,0.017436525,0.9741593],"study_design_scores_gemma":[0.0056771827,0.0005166144,0.0018034822,0.0048445296,0.010579565,0.00028894877,0.0004104108,0.000024536625,8.013307e-8,0.00044710515,0.97516954,0.00023801955],"about_ca_topic_score_codex":0.00463149,"about_ca_topic_score_gemma":0.0010929923,"teacher_disagreement_score":0.9739213,"about_ca_system_score_codex":0.0005708294,"about_ca_system_score_gemma":0.0019939672,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W4281647552","doi":"10.1200/jco.2022.40.16_suppl.5514","title":"A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Institutes of Health","keywords":"Medicine; Mesothelin; Bevacizumab; Internal medicine; Ovarian cancer; Paclitaxel; Oncology; Refractory (planetary science); Gastroenterology; Progression-free survival; Cancer; Chemotherapy","score_opus":0.16389731666071916,"score_gpt":0.49170786806166683,"score_spread":0.32781055140094767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281647552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783312,0.0019774977,0.000007776701,0.015353778,0.0013370283,0.002540955,0.00006554291,0.000009207816,0.0003770251],"genre_scores_gemma":[0.9942433,0.0018978632,0.0008658736,0.00092256424,0.0007878465,0.00026553165,0.000006388388,0.000035563724,0.00097503455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9903006,0.0027592345,0.005317916,0.00044185782,0.00083396706,0.00034644848],"domain_scores_gemma":[0.987649,0.007441778,0.0037930047,0.00036289977,0.00033800534,0.00041528474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008716464,0.00029963267,0.0050499113,0.0003754232,0.0001461379,0.00001205432,0.00020924713,0.00025068264,0.0022728366],"category_scores_gemma":[0.0045043053,0.00017883057,0.000464662,0.00043858335,0.00025098652,0.00011443933,0.00017848448,0.0013557489,9.3259587e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8596101,0.043967593,0.0013348015,0.00004724928,0.0018760723,0.0047895107,0.0013729573,0.000021979053,0.000051537016,0.000034645927,0.0028723078,0.08402128],"study_design_scores_gemma":[0.73873216,0.2245489,0.007689854,0.00014250613,0.0019040207,0.00021407625,0.001890795,0.000072814095,0.0000058509745,0.000097191085,0.024566852,0.00013495797],"about_ca_topic_score_codex":0.00087030046,"about_ca_topic_score_gemma":0.0019132595,"teacher_disagreement_score":0.18058132,"about_ca_system_score_codex":0.000768725,"about_ca_system_score_gemma":0.0050051226,"threshold_uncertainty_score":0.9986392},"labels":[],"label_agreement":null},{"id":"W4281671615","doi":"10.1200/jco.2022.40.16_suppl.tps5615","title":"ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"KRAS; Medicine; MEK inhibitor; Neuroblastoma RAS viral oncogene homolog; Ovarian cancer; Serous fluid; Cancer; Cancer research; Selumetinib; Internal medicine; MAPK/ERK pathway; Kinase; Oncology; Biology","score_opus":0.0909682580429039,"score_gpt":0.456641226699635,"score_spread":0.36567296865673105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281671615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98622227,0.0011065346,0.00000830431,0.010484033,0.0010683676,0.0010022915,0.00001565757,0.0000064632814,0.0000860993],"genre_scores_gemma":[0.9972524,0.0011513627,0.00038612858,0.000678901,0.00032001853,0.00014018398,0.000008246333,0.000026042588,0.000036706326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951667,0.0010468229,0.0024987827,0.00037368145,0.00061602006,0.0002979835],"domain_scores_gemma":[0.9958139,0.0015726268,0.0018747695,0.00022285941,0.00022719057,0.0002886595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002853267,0.00022059392,0.0018754102,0.0003653522,0.00006200099,0.0000105081335,0.00013583788,0.00019162048,0.00019043355],"category_scores_gemma":[0.00046480584,0.00016949736,0.00016085811,0.00043395907,0.00012382603,0.00012128479,0.00009847312,0.0015543173,0.0000010572172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030146249,0.08160508,0.7333102,0.0000836484,0.00068004424,0.0026227778,0.0029465782,0.00028870945,0.00005847725,0.000053160886,0.0012670972,0.14693798],"study_design_scores_gemma":[0.14318909,0.096555665,0.75038177,0.00034852038,0.00059654145,0.00026040603,0.0020763713,0.00020756801,0.00007930594,0.000110299414,0.0060157673,0.00017868775],"about_ca_topic_score_codex":0.00092690653,"about_ca_topic_score_gemma":0.0045079603,"teacher_disagreement_score":0.14675929,"about_ca_system_score_codex":0.00080309185,"about_ca_system_score_gemma":0.0017121057,"threshold_uncertainty_score":0.6911902},"labels":[],"label_agreement":null},{"id":"W4281673889","doi":"10.3390/curroncol29060321","title":"Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Cancer research; Estrogen receptor; PI3K/AKT/mTOR pathway; Medicine; Serous fluid; Carcinogenesis; Immunohistochemistry; Estrogen; Cell growth; Internal medicine; Oncology; Biology; Signal transduction; Cancer; Cell biology; Breast cancer","score_opus":0.04979938805192295,"score_gpt":0.36628554354356346,"score_spread":0.3164861554916405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281673889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926068,0.004606168,0.000010275451,0.00057619286,0.00048862665,0.0012945295,0.0001081232,0.000040680505,0.000268586],"genre_scores_gemma":[0.9988827,0.00011531609,0.0002559514,0.000042675445,0.0001398648,0.00033414597,0.00017348747,0.00003772593,0.000018113262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979205,0.00034873607,0.0005113994,0.0004911678,0.0002511363,0.00047703896],"domain_scores_gemma":[0.9990175,0.00013440014,0.00027942882,0.00028009218,0.000108112385,0.00018049401],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002362441,0.00029603392,0.00072773057,0.00026805996,0.00010497195,0.000010708176,0.00013382854,0.00012241598,0.00030639174],"category_scores_gemma":[0.000019065747,0.00025607148,0.00026054535,0.0006443437,0.00007882962,0.00005277386,0.000058978138,0.00050590094,0.000008671574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076693753,0.015874673,0.5406193,0.00034964416,0.00085159065,0.00037299911,0.0038891702,0.0005948518,0.3303757,0.00016052596,0.00045758713,0.09878456],"study_design_scores_gemma":[0.030867102,0.019112855,0.63220125,0.00024379007,0.0012106007,0.0008521317,0.0013034604,0.002805755,0.30647787,0.00049083517,0.0036300614,0.00080429367],"about_ca_topic_score_codex":0.0005571324,"about_ca_topic_score_gemma":0.000026002166,"teacher_disagreement_score":0.09798027,"about_ca_system_score_codex":0.0019788453,"about_ca_system_score_gemma":0.0020440714,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W4281685079","doi":"10.1200/jco.2022.40.16_suppl.tps5617","title":"ENGOT-ov65/KEYNOTE-B96: Phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Pembrolizumab; Internal medicine; Paclitaxel; Oncology; Chemotherapy; Placebo; Response Evaluation Criteria in Solid Tumors; Surgery; Phases of clinical research; Cancer; Immunotherapy; Pathology","score_opus":0.21759925675284236,"score_gpt":0.5038330728052243,"score_spread":0.2862338160523819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281685079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050976,0.0016921324,0.00039250212,0.008080707,0.0032760827,0.005042533,0.00018453239,0.000014514371,0.0008072294],"genre_scores_gemma":[0.99344563,0.00047869512,0.0028966544,0.0002734949,0.0014004995,0.0012760415,0.00003705782,0.000045234006,0.00014669105],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931496,0.0010650823,0.0037201517,0.0004894498,0.0011690726,0.0004066615],"domain_scores_gemma":[0.9866385,0.00786265,0.0038897544,0.00037698477,0.00074275007,0.00048934534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005280703,0.0003390431,0.0037042766,0.00027323267,0.00022570623,0.000018264207,0.0002925922,0.00021340771,0.00082694704],"category_scores_gemma":[0.0011692275,0.00023283927,0.00086602755,0.0002817382,0.00025992916,0.00010904258,0.00011866681,0.0011794177,0.0000018422312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.933998,0.020559529,0.0006357044,0.0000747529,0.0056288186,0.0005343914,0.00075313734,0.0020523348,0.000008085603,0.0008923259,0.0019903807,0.03287254],"study_design_scores_gemma":[0.838577,0.13849416,0.0014651266,0.00012743918,0.0046708332,0.00014100014,0.0013483497,0.0005851721,0.0000151578915,0.00010327171,0.014286779,0.00018573175],"about_ca_topic_score_codex":0.00020323343,"about_ca_topic_score_gemma":0.0003823726,"teacher_disagreement_score":0.11793463,"about_ca_system_score_codex":0.0014872064,"about_ca_system_score_gemma":0.0056030652,"threshold_uncertainty_score":0.9939597},"labels":[],"label_agreement":null},{"id":"W4281733446","doi":"10.1200/jco.2022.40.16_suppl.5555","title":"Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bevacizumab; Topotecan; Internal medicine; Paclitaxel; Hazard ratio; Oncology; Ovarian cancer; Chemotherapy; Proportional hazards model; Doxorubicin; Progression-free survival; Cancer; Confidence interval","score_opus":0.07656022916424912,"score_gpt":0.4320033288684329,"score_spread":0.35544309970418375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281733446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404479,0.00011283961,0.0000045182483,0.054798055,0.00045445093,0.00041528512,0.000021576152,0.0000141641,0.0037311797],"genre_scores_gemma":[0.99365807,0.00033080988,0.0010547264,0.0037064862,0.00018519262,0.0000685039,0.0000088822935,0.0000344146,0.0009529102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668026,0.00045997225,0.0016933089,0.00025136556,0.000622713,0.0002923749],"domain_scores_gemma":[0.99555457,0.0018440314,0.0019011038,0.00021724345,0.00022116846,0.0002618949],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019263724,0.00019534252,0.0019861052,0.00020547307,0.00008460706,0.000009896142,0.00015858638,0.00012050527,0.0009197507],"category_scores_gemma":[0.0003075822,0.00011750281,0.00022103827,0.00047520507,0.00011875227,0.000060501614,0.00003763168,0.0010972186,0.0000013093195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036891725,0.005839912,0.93172956,0.000010403898,0.0019327361,0.0031790466,0.00018782676,0.00019766808,0.000009963254,0.00038341508,0.0019509328,0.0176868],"study_design_scores_gemma":[0.05466381,0.044422828,0.8870868,0.00015648543,0.00046941158,0.000055084583,0.00013894729,0.000038193804,0.000013787461,0.00012384525,0.012709321,0.000121494966],"about_ca_topic_score_codex":0.00072587247,"about_ca_topic_score_gemma":0.008928548,"teacher_disagreement_score":0.053210143,"about_ca_system_score_codex":0.0016269444,"about_ca_system_score_gemma":0.003347527,"threshold_uncertainty_score":0.99999356},"labels":[],"label_agreement":null},{"id":"W4281845656","doi":"10.1200/jco.2022.40.16_suppl.tps5609","title":"ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients (pts) with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Pembrolizumab; Ovarian cancer; Internal medicine; Oncology; Tolerability; Carboplatin; Chemotherapy; Fallopian tube; Bevacizumab; Cancer; Phases of clinical research; Gastroenterology; Cisplatin; Immunotherapy; Surgery; Adverse effect","score_opus":0.06303458392730951,"score_gpt":0.4184054387971796,"score_spread":0.3553708548698701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281845656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958964,0.00005591305,0.0000063119705,0.0022582756,0.00051421963,0.0010427587,0.000043037962,0.0000042269107,0.00017883511],"genre_scores_gemma":[0.9983154,0.00010491141,0.0007036611,0.00052772515,0.00015681524,0.00010590575,0.000016332853,0.000026992413,0.000042260926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633104,0.0005201927,0.0018930786,0.0002990076,0.0007084752,0.00024819636],"domain_scores_gemma":[0.9972208,0.000684362,0.0014611166,0.000208982,0.0002509402,0.00017376513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093186676,0.00019480915,0.0014314104,0.0002061546,0.000049671962,0.0000081522885,0.0001561722,0.0001130012,0.00030450287],"category_scores_gemma":[0.00016605495,0.0001268194,0.00010598492,0.00032308765,0.0001075069,0.00010234424,0.000050494247,0.0008032251,4.5161397e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3568713,0.05916352,0.53716296,0.000036389734,0.0005494269,0.0014546908,0.00095086923,0.0002409607,0.000021190379,0.00000938753,0.0001075694,0.043431763],"study_design_scores_gemma":[0.27112433,0.14503966,0.58099955,0.00011429961,0.00023289205,0.00001797778,0.0005892174,0.00011166765,0.000014886943,0.0000026086993,0.0016713175,0.000081568316],"about_ca_topic_score_codex":0.0007236442,"about_ca_topic_score_gemma":0.0035725066,"teacher_disagreement_score":0.08587615,"about_ca_system_score_codex":0.0013380373,"about_ca_system_score_gemma":0.0021548318,"threshold_uncertainty_score":0.5171545},"labels":[],"label_agreement":null},{"id":"W4281856738","doi":"10.1200/jco.2022.40.16_suppl.5579","title":"Pharmacokinetic and pharmacodynamic analysis of adavosertib in advanced ovarian cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Princess Margaret Cancer Centre; Ottawa Hospital; Kelowna General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Cmax; Pharmacokinetics; Pharmacodynamics; Internal medicine; Ovarian cancer; Placebo; Gastroenterology; Cancer; Urology; Oncology; Pharmacology; Pathology","score_opus":0.0873480001659174,"score_gpt":0.5068061762553691,"score_spread":0.4194581760894517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281856738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854864,0.0033760092,0.00001551249,0.009529022,0.00071969896,0.00017146477,0.000023650076,0.000002820832,0.000675443],"genre_scores_gemma":[0.9921958,0.0051570144,0.0007070356,0.00167718,0.00014856245,0.000024156643,0.0000037462182,0.000009478575,0.00007704848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972112,0.0003689588,0.0017812256,0.0001807861,0.00030140168,0.00015639224],"domain_scores_gemma":[0.9973733,0.0008893285,0.0012869835,0.000112018235,0.00013166097,0.00020671412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015335323,0.00009955854,0.001575334,0.00042017957,0.000028146686,0.0000019331865,0.0001035787,0.000066621295,0.0012274694],"category_scores_gemma":[0.00021488247,0.00007943008,0.00039459017,0.0007031558,0.0000817822,0.00004889517,0.00006847623,0.00063522864,3.8308704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046482584,0.0027617423,0.51168835,0.000024995015,0.0036646787,0.00072234974,0.00013338169,0.00517316,0.00072821695,0.000050332565,0.00028984057,0.4701147],"study_design_scores_gemma":[0.018948212,0.006412125,0.9382149,0.00003704349,0.0064818193,0.00006699726,0.00012904286,0.004518803,0.00009856697,0.00005395793,0.024965014,0.00007351434],"about_ca_topic_score_codex":0.0001516056,"about_ca_topic_score_gemma":0.0001556218,"teacher_disagreement_score":0.4700412,"about_ca_system_score_codex":0.00032064962,"about_ca_system_score_gemma":0.00090985076,"threshold_uncertainty_score":0.9996855},"labels":[],"label_agreement":null},{"id":"W4282938858","doi":"10.1158/1538-7445.am2022-5886","title":"Abstract 5886: Pre-treatment adiposity measured by computed tomography and survival of women with high-grade serous ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Serous fluid; Body mass index; Ovarian cancer; Internal medicine; Population; Proportional hazards model; Ascites; Oncology; Cancer; Confidence interval","score_opus":0.04544216654781944,"score_gpt":0.3415544304261457,"score_spread":0.29611226387832623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282938858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874556,0.007203092,0.0000054790257,0.0029659516,0.00016267123,0.0012776916,0.00072784297,0.000043395412,0.00015827602],"genre_scores_gemma":[0.9955125,0.0010826297,0.000095141004,0.00008326677,0.000120072546,0.0027431427,0.000066517576,0.000046946723,0.0002497914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691933,0.00023235798,0.00026501945,0.0006128463,0.0012245089,0.00074591587],"domain_scores_gemma":[0.9985553,0.00015482733,0.00010356491,0.00046503238,0.00027868175,0.00044258073],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065438583,0.00024632324,0.00058649475,0.00024298979,0.0003718271,0.00003848599,0.00016522944,0.00006445582,0.0010893525],"category_scores_gemma":[0.0000084015965,0.0001909821,0.00006441602,0.00083668303,0.00025188128,0.00006112175,0.000124374,0.00040892418,0.0000012472784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010072686,0.005555713,0.8909495,0.00074251735,0.0058230925,0.00045711565,0.0053428537,0.00063675095,0.031393792,0.0003050434,0.009288329,0.039432615],"study_design_scores_gemma":[0.009536867,0.004522488,0.9509409,0.00020379633,0.00023722215,0.000019413521,0.00047769118,0.000021768325,0.020803768,0.00006326863,0.012908583,0.00026421715],"about_ca_topic_score_codex":0.033859733,"about_ca_topic_score_gemma":0.0020935268,"teacher_disagreement_score":0.059991427,"about_ca_system_score_codex":0.0028705343,"about_ca_system_score_gemma":0.000956502,"threshold_uncertainty_score":0.9998238},"labels":[],"label_agreement":null},{"id":"W4282964062","doi":"10.1158/1538-7445.am2022-775","title":"Abstract 775: Evaluation of Erb-B2 expression from archival tumor tissue in early stage epithelial ovarian carcinoma patient prognosis","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Gastroenterology; Regimen; Cancer; Population; Chemotherapy; Oncology; Pathology; Biology","score_opus":0.10595877025289831,"score_gpt":0.40456598914017233,"score_spread":0.29860721888727404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338657,0.0011057355,0.0000023910561,0.00096093235,0.0002408488,0.002266121,0.00086064433,0.000015414258,0.0011613258],"genre_scores_gemma":[0.9952376,0.000065306296,0.00016846498,0.000043190004,0.0002052875,0.0040430604,0.00011900854,0.000039763134,0.00007833861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954025,0.0005915326,0.00044729604,0.0005749888,0.0025042272,0.00047941328],"domain_scores_gemma":[0.99864227,0.00021698148,0.00013694631,0.0004773218,0.00033828037,0.00018821296],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014348506,0.00016499888,0.0003545576,0.0003753242,0.00018219638,0.000027494836,0.0001958607,0.000038972947,0.004319883],"category_scores_gemma":[0.000113566784,0.00014832368,0.00008063391,0.00049495924,0.00010006858,0.00008516351,0.00023973192,0.0006153623,0.000017344551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036794918,0.0032967753,0.52396315,0.00028057164,0.00018997178,0.0005913546,0.010281152,0.0012861773,0.27000886,0.0001293853,0.0021428212,0.18415025],"study_design_scores_gemma":[0.0038496754,0.00092575105,0.7527178,0.00024903042,0.000055586755,0.0000018779333,0.000618277,0.0001737668,0.2387354,0.00017908594,0.0023773855,0.00011639133],"about_ca_topic_score_codex":0.025989564,"about_ca_topic_score_gemma":0.00037757595,"teacher_disagreement_score":0.2287546,"about_ca_system_score_codex":0.0014605614,"about_ca_system_score_gemma":0.0013365021,"threshold_uncertainty_score":0.9965903},"labels":[],"label_agreement":null},{"id":"W4282964309","doi":"10.1158/1538-7445.am2022-5906","title":"Abstract 5906: Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Population; Cancer registry; Cancer; Ovarian cancer; Internal medicine; National Death Index; Oncology; Proportional hazards model; Cohort; Disease; Gynecology; Cohort study; Hazard ratio; Confidence interval; Environmental health","score_opus":0.08812359254121675,"score_gpt":0.40248729101678404,"score_spread":0.3143636984755673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282964309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933489,0.0011803573,0.000004816631,0.0009682119,0.0007471842,0.0026231548,0.00086839206,0.00007742183,0.00018157644],"genre_scores_gemma":[0.9944603,0.00062783645,0.000019721236,0.00005433578,0.00041579126,0.0040620025,0.0001311836,0.000058905604,0.00016994735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953817,0.0011826331,0.00048913644,0.00091200694,0.0013027206,0.0007317682],"domain_scores_gemma":[0.99742204,0.0012509959,0.00018314579,0.000554952,0.00023958237,0.00034929533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035208124,0.00031607776,0.00076303276,0.0003163345,0.0009941902,0.00006966248,0.00020749182,0.00009593917,0.0034851914],"category_scores_gemma":[0.00046726008,0.00024488207,0.00014172777,0.0007384371,0.00020495722,0.000096811455,0.00014962182,0.0010474188,0.00000433907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046222223,0.00075605226,0.9936797,0.00006191731,0.0005029599,0.00007612171,0.0006787628,0.0014380601,0.00005677307,0.00003322731,0.0002581839,0.001996032],"study_design_scores_gemma":[0.0024570387,0.0007848134,0.99376357,0.00004936392,0.00020061903,9.39731e-7,0.0015523551,0.00014043385,0.00015908865,0.00008793655,0.0005745487,0.00022930551],"about_ca_topic_score_codex":0.56747955,"about_ca_topic_score_gemma":0.043113966,"teacher_disagreement_score":0.5243656,"about_ca_system_score_codex":0.0015897319,"about_ca_system_score_gemma":0.00072177895,"threshold_uncertainty_score":0.9986002},"labels":[],"label_agreement":null},{"id":"W4282967861","doi":"10.1002/cso2.1035","title":"Establishing combination PAC‐1 and TRAIL regimens for treating ovarian cancer based on patient‐specific pharmacokinetic profiles using <i>in silico</i> clinical trials","year":2022,"lang":"en","type":"article","venue":"Computational and Systems Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Cohort; Oncology; In silico; Ovarian cancer; Pharmacokinetics; Population; Internal medicine; Cancer; Clinical trial; Pharmacology; Biology","score_opus":0.16695808948775775,"score_gpt":0.4390449401187414,"score_spread":0.27208685063098365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282967861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773223,0.0023553753,0.001327568,0.004258833,0.0010791215,0.002659556,0.00027774504,0.000025260204,0.0002843184],"genre_scores_gemma":[0.99634343,0.00005169415,0.0015974824,0.0006362049,0.00024698587,0.0009099447,0.00017061592,0.00001678928,0.000026869546],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99759924,0.0008940532,0.00075750175,0.00037534392,0.00020954582,0.00016431861],"domain_scores_gemma":[0.9958632,0.0035267044,0.00035474994,0.00006791572,0.00009512595,0.00009229253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017192175,0.00013313894,0.00063284027,0.00015613243,0.00021794898,0.000039054692,0.000029289404,0.000064800464,0.00003045431],"category_scores_gemma":[0.00015167631,0.0001157729,0.000074985015,0.00013893927,0.000046727546,0.00004607978,0.00002271769,0.00015056654,2.1425133e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004981504,0.00482333,0.1550843,0.0007078026,0.00051330135,0.00024655892,0.0023998502,0.31630182,0.0009241636,0.008893342,0.0061264327,0.4989976],"study_design_scores_gemma":[0.023571195,0.0038004045,0.033808704,0.00027518105,0.0002442735,0.00009128158,0.0008718295,0.92283225,0.000029633124,0.00039019034,0.013889073,0.0001959606],"about_ca_topic_score_codex":0.00015475789,"about_ca_topic_score_gemma":0.000008461003,"teacher_disagreement_score":0.6065304,"about_ca_system_score_codex":0.00040476825,"about_ca_system_score_gemma":0.00030681767,"threshold_uncertainty_score":0.4721082},"labels":[],"label_agreement":null},{"id":"W4282974382","doi":"10.1097/mph.0000000000002496","title":"A Report of a Case With Pediatric Ovarian Steroid Cell Tumor, Not Otherwise Specified, Found With Precocious Puberty","year":2022,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Precocious puberty; Ovarian tumor; Ovary; Ascites; Metastasis; Chemotherapy; Malignancy; Ovarian cancer; Teratoma; Radiology; Internal medicine; Hormone; Cancer","score_opus":0.021930106796925843,"score_gpt":0.28369612141354833,"score_spread":0.26176601461662247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282974382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887608,0.0031606022,0.00029124724,0.0031516019,0.00068065024,0.00087360304,0.000038646274,0.000026456742,0.0030163547],"genre_scores_gemma":[0.98807186,0.00044369182,0.009183263,0.00050793553,0.0012516043,0.00012599606,0.000007774087,0.000074068004,0.00033379078],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9961657,0.00037405963,0.0016586852,0.0005043642,0.00073728565,0.000559898],"domain_scores_gemma":[0.9945321,0.00063299836,0.0033312603,0.0005586148,0.00050608866,0.00043894252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011662563,0.00038440267,0.0017313987,0.00076154014,0.00019192469,0.000015125161,0.00024241816,0.00018343554,0.00078161195],"category_scores_gemma":[0.00009783701,0.00026423336,0.00028618184,0.0009195737,0.00013423877,0.00013173383,0.00012873617,0.0009743484,0.000009395112],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069234283,0.005338018,0.4056728,0.00045221802,0.0007194455,0.56539714,0.0014908185,0.00012694551,0.00002098136,0.000119568205,0.012942633,0.0007960122],"study_design_scores_gemma":[0.02061968,0.024334775,0.014189595,0.000018530664,0.0060000583,0.9121649,0.001933596,0.000018715871,0.000265409,0.00007028282,0.020004481,0.00037994035],"about_ca_topic_score_codex":0.00014072623,"about_ca_topic_score_gemma":0.00016530846,"teacher_disagreement_score":0.39148322,"about_ca_system_score_codex":0.0009299684,"about_ca_system_score_gemma":0.0038209837,"threshold_uncertainty_score":0.999981},"labels":[],"label_agreement":null},{"id":"W4282975240","doi":"10.1158/1538-7445.am2022-2248","title":"Abstract 2248: Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian cancer; Debulking; Tubal ligation; Oncology; Body mass index; Gynecology; Fallopian tube cancer; Fallopian tube; Odds ratio; Breast cancer; Internal medicine; Cancer; Population; Family planning","score_opus":0.07651840889275054,"score_gpt":0.34002138268189935,"score_spread":0.26350297378914883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897946,0.004018622,3.5539986e-7,0.0042703273,0.00035368226,0.00078370207,0.0013006128,0.000050353938,0.00024290367],"genre_scores_gemma":[0.9927161,0.00086171244,0.000004268194,0.00026616754,0.00044550947,0.0034581684,0.0008114971,0.000074111165,0.0013624647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966191,0.00021178731,0.00025796154,0.0006291648,0.0016173258,0.00066467165],"domain_scores_gemma":[0.9987429,0.00024839537,0.00009351596,0.00040998225,0.000065617336,0.00043960885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005725565,0.00022736478,0.00035203225,0.00028214089,0.0004828833,0.00004976043,0.00011345137,0.000057383004,0.010758999],"category_scores_gemma":[0.000041179672,0.0001866107,0.00011906422,0.00043963833,0.00022338373,0.00014355071,0.00013956742,0.00067892065,0.000011761296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028916497,0.0012584523,0.9689362,0.00009700924,0.00059107423,0.0006737127,0.00042684763,0.00012369182,0.0017943459,0.0000075317485,0.018930156,0.004269329],"study_design_scores_gemma":[0.00136506,0.00019011136,0.98788947,0.00018958886,0.00015686858,0.0000026951125,0.00033021602,0.0000021172589,0.0012892792,0.000016023652,0.008364888,0.00020367219],"about_ca_topic_score_codex":0.0012105308,"about_ca_topic_score_gemma":0.00013690826,"teacher_disagreement_score":0.01895328,"about_ca_system_score_codex":0.005218579,"about_ca_system_score_gemma":0.0017433224,"threshold_uncertainty_score":0.9986002},"labels":[],"label_agreement":null},{"id":"W4282975377","doi":"10.1158/1538-7445.am2022-3476","title":"Abstract 3476: Mechanistic evaluation of VS-6766 (dual RAF/MEK inhibitor) and defactinib (FAK inhibitor) in low-grade serous ovarian cancer models with correlations to clinical response","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"","keywords":"MEK inhibitor; Ovarian cancer; KRAS; Cancer research; Serous fluid; Cell culture; Cancer; Medicine; MAPK/ERK pathway; Biology; Signal transduction; Pathology; Internal medicine; Cell biology; Genetics","score_opus":0.1960953692630206,"score_gpt":0.4668614546880892,"score_spread":0.27076608542506864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282975377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831636,0.0012240644,0.000057197052,0.0068922094,0.00043210803,0.0025411532,0.00030022243,0.000024855735,0.00021182452],"genre_scores_gemma":[0.9952485,0.00033210302,0.0002526943,0.0002058871,0.0003027567,0.0033908733,0.000040523613,0.000058088433,0.00016857502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947713,0.0010713359,0.0007006192,0.00076660933,0.0021282537,0.0005618535],"domain_scores_gemma":[0.9972205,0.0010211426,0.0001624191,0.0004986421,0.0007105941,0.000386676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005942033,0.00022651243,0.0005363563,0.0005670338,0.00030423253,0.000042986198,0.00013118403,0.00012413634,0.0009109367],"category_scores_gemma":[0.00044136107,0.00020416995,0.000076415825,0.0011369437,0.00017369146,0.00014676394,0.00019629418,0.000995066,0.000008764538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14015728,0.011483923,0.39115116,0.0013073013,0.0020440777,0.0015633699,0.019149773,0.28676164,0.020336054,0.0034720232,0.02098074,0.101592645],"study_design_scores_gemma":[0.032591797,0.007470272,0.9224839,0.0023197557,0.0007218187,0.00008904085,0.003239476,0.018180238,0.0077826735,0.0018223729,0.0025545848,0.0007440182],"about_ca_topic_score_codex":0.0044731996,"about_ca_topic_score_gemma":0.0026554642,"teacher_disagreement_score":0.5313328,"about_ca_system_score_codex":0.0021580874,"about_ca_system_score_gemma":0.004437429,"threshold_uncertainty_score":0.9974118},"labels":[],"label_agreement":null},{"id":"W4283018691","doi":"10.1038/s41416-022-01840-4","title":"Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Partnership Against Cancer; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Ovarian cancer; Medicine; Germline mutation; Oncology; Serous fluid; Internal medicine; Cancer; Germline; BRCA mutation; Survival rate; Serous carcinoma; Stage (stratigraphy); Mutation; Gynecology; Biology; Genetics; Gene","score_opus":0.01579432277681403,"score_gpt":0.31718922269611755,"score_spread":0.3013948999193035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283018691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989206,0.008335873,0.000006476384,0.00047577848,0.0005763145,0.0003930954,0.00095731736,0.0000042531465,0.000044847184],"genre_scores_gemma":[0.99602586,0.0032589808,0.00005767408,0.00009139031,0.00031942583,0.00014370464,0.000030058956,0.000036624897,0.000036274847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998135,0.00010113894,0.00061689864,0.00021581972,0.00064787647,0.00028326598],"domain_scores_gemma":[0.9989397,0.000054801134,0.00048123318,0.000121657715,0.00027021562,0.00013239893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002031372,0.00016780333,0.00057543034,0.00028833933,0.00007630914,0.000024456845,0.00011594231,0.00004190154,0.001261847],"category_scores_gemma":[0.000017826862,0.00015463067,0.00016745085,0.00045193982,0.00005376601,0.00013227265,0.000030411686,0.00039016886,2.4251784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019169523,0.001335752,0.83916944,0.000042978445,0.0003772881,0.00059054623,0.00021461214,0.017249638,0.00007692687,0.0000027872738,0.000051668696,0.13897139],"study_design_scores_gemma":[0.013221856,0.001579844,0.9826438,0.0017796543,0.00022587043,0.00007010268,0.000031225394,0.000027845203,0.00019776258,0.000008190987,0.000072692266,0.00014116736],"about_ca_topic_score_codex":0.023094371,"about_ca_topic_score_gemma":0.021736596,"teacher_disagreement_score":0.14347433,"about_ca_system_score_codex":0.0019168544,"about_ca_system_score_gemma":0.001246024,"threshold_uncertainty_score":0.99965113},"labels":[],"label_agreement":null},{"id":"W4283072502","doi":"10.1016/j.annonc.2022.04.062","title":"44TiP ENGOT-ov65/KEYNOTE-B96: Phase III, randomized, double-blind study of pembrolizumab vs placebo + paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Pembrolizumab; Bevacizumab; Ovarian cancer; Paclitaxel; Oncology; Placebo; Internal medicine; Double blind; Chemotherapy; Cancer; Immunotherapy; Pathology","score_opus":0.1193212526315547,"score_gpt":0.42760210415333655,"score_spread":0.30828085152178186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283072502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97664183,0.001956057,0.00018352548,0.0088891,0.00046366954,0.009201745,0.00086958735,0.00003204626,0.0017624425],"genre_scores_gemma":[0.98830986,0.000386229,0.00073409674,0.00046756028,0.0002443542,0.009273883,0.00022886247,0.000048765425,0.00030638222],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99654216,0.0003995827,0.0011958119,0.0006440525,0.00072453887,0.0004938588],"domain_scores_gemma":[0.99666876,0.0010936467,0.0009850812,0.0004984785,0.0005347175,0.00021929527],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013514805,0.00036753385,0.0020590257,0.00032539002,0.00024203156,0.00001166252,0.00021494707,0.00012441234,0.0013101257],"category_scores_gemma":[0.000094422954,0.0002884982,0.0003360911,0.00034175103,0.00021536121,0.00007840529,0.00012408268,0.00032682225,0.000001615005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94948643,0.016770799,0.00047668055,0.00017392007,0.0032293592,0.000109486275,0.0028744359,0.0009056841,0.00010110325,0.0025836653,0.004969219,0.01831919],"study_design_scores_gemma":[0.9177528,0.056857258,0.0008028808,0.00013121798,0.0016245415,0.000051327977,0.0016321947,0.0003336928,0.00067035534,0.00022899969,0.019647023,0.0002677355],"about_ca_topic_score_codex":0.0011747996,"about_ca_topic_score_gemma":0.00065997755,"teacher_disagreement_score":0.04008646,"about_ca_system_score_codex":0.00040822997,"about_ca_system_score_gemma":0.0014683193,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W4283262281","doi":"10.3390/curroncol29070351","title":"Isolated Peritoneal Metastasis of Prostate Cancer Presenting with Massive Ascites: A Case Report","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Metastasis; Ascites; Prostate; Cancer; Pathology; Radiology; Urology; Internal medicine","score_opus":0.07574164010284985,"score_gpt":0.4035357058318054,"score_spread":0.3277940657289556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283262281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98998046,0.0045062224,0.000029633602,0.0029593287,0.000738525,0.0009787504,0.00019467542,0.000035354155,0.00057703373],"genre_scores_gemma":[0.9975689,0.00021395442,0.0003742123,0.000057400288,0.00010854268,0.0013106621,0.00009499008,0.000023614986,0.0002477474],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985895,0.00012001073,0.00037880812,0.00037820474,0.00026299045,0.0002704995],"domain_scores_gemma":[0.9989575,0.00007768288,0.00038241968,0.00027149447,0.00019393602,0.000116925425],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019967709,0.00015283133,0.00048336148,0.00011910473,0.00015401874,0.000006815133,0.000053398926,0.000030546318,0.0010714195],"category_scores_gemma":[0.00003238538,0.00011866804,0.000097919095,0.00033012452,0.00009654664,0.000042114487,0.00011984392,0.00026946765,0.0000016702577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016296754,0.0047774594,0.60582936,0.00044858974,0.0018490949,0.2571657,0.0051647956,0.00042202524,0.00015768166,0.000117961725,0.0062965266,0.1161411],"study_design_scores_gemma":[0.021896765,0.014175567,0.033837143,0.00039961806,0.0058867345,0.21307851,0.008019198,0.00400732,0.003011852,0.00007843363,0.69480765,0.0008012075],"about_ca_topic_score_codex":0.00042023032,"about_ca_topic_score_gemma":0.00014402965,"teacher_disagreement_score":0.68851113,"about_ca_system_score_codex":0.0005419612,"about_ca_system_score_gemma":0.00076519797,"threshold_uncertainty_score":0.99984175},"labels":[],"label_agreement":null},{"id":"W4283400085","doi":"10.14740/wjon1454","title":"Abdominopelvic Lymphatic Drainage Area Irradiation for Consolidative Radiotherapy of Advanced Ovarian Carcinoma: Analysis of Clinical Application Efficacy and Dosimetric Verification","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology of the People's Republic of China","keywords":"Medicine; Radiation therapy; Perforation; Lymphatic system; Overall survival; Radiology; Nuclear medicine; Surgery; Pathology","score_opus":0.03880240784225041,"score_gpt":0.3850638230383826,"score_spread":0.3462614151961322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283400085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98521036,0.0035102512,0.0063864775,0.0030249495,0.0002650797,0.0011465304,0.000057015906,0.000004676135,0.00039465405],"genre_scores_gemma":[0.9930315,0.00037244338,0.0061674807,0.00017583159,0.00007931791,0.000086249136,0.00004175868,0.000010774786,0.000034634828],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981654,0.00024237356,0.001090176,0.00019113014,0.00020325127,0.00010764103],"domain_scores_gemma":[0.9961568,0.001427202,0.0018610398,0.00020034453,0.00026533296,0.00008927558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011093871,0.000098951736,0.0010016728,0.0010276407,0.0000613,0.000003586416,0.000086083375,0.000046350535,0.000086632324],"category_scores_gemma":[0.00019667772,0.00008765068,0.00024922864,0.001329263,0.00012456547,0.00005354773,0.000015593921,0.0001137364,1.2958306e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010392786,0.0049074874,0.29424986,0.00012551402,0.006751839,0.000026649348,0.0018027951,0.0034006187,0.005184524,0.0051438,0.0004358928,0.6675782],"study_design_scores_gemma":[0.019363854,0.005271926,0.95677984,0.000018595108,0.0045644366,0.0000335029,0.00027778742,0.004798136,0.0005038059,0.00013315908,0.008177768,0.00007718295],"about_ca_topic_score_codex":0.000030062058,"about_ca_topic_score_gemma":0.000017346088,"teacher_disagreement_score":0.66750103,"about_ca_system_score_codex":0.00045313162,"about_ca_system_score_gemma":0.00039931238,"threshold_uncertainty_score":0.35742912},"labels":[],"label_agreement":null},{"id":"W4283658663","doi":"10.1007/s00261-022-03580-8","title":"Interobserver agreement between eight observers using IOTA simple rules and O-RADS lexicon descriptors for adnexal masses","year":2022,"lang":"en","type":"article","venue":"Abdominal Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Kappa; Cohen's kappa; Intraclass correlation; Feature (linguistics); Nuclear medicine; Adnexal Diseases; Radiology; Benignity; Mathematics; Statistics; Malignancy; Laparoscopy; Pathology","score_opus":0.08136000295139578,"score_gpt":0.32152156156369693,"score_spread":0.24016155861230115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283658663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482554,0.0017471734,0.00039530557,0.0017123582,0.00040872174,0.000650328,0.0001554527,0.000015796873,0.00008929906],"genre_scores_gemma":[0.99341017,0.00008243343,0.0050606388,0.0006071667,0.00033228914,0.00020334244,0.00016078271,0.000029111647,0.000114058916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985638,0.00011976595,0.00033033002,0.00045302775,0.00014594763,0.00038712387],"domain_scores_gemma":[0.9992069,0.00022674947,0.00012682583,0.000244476,0.000039430855,0.0001556166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027571336,0.00021711313,0.00054782705,0.00010749842,0.00026134393,0.000017275512,0.000112069385,0.00007383227,0.00041752373],"category_scores_gemma":[0.000047309568,0.00019468597,0.00015318485,0.000081716404,0.00011928238,0.000046844154,0.00014471369,0.00015763644,0.0000038226835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013358153,0.00032846822,0.9653615,0.00018436587,0.001181047,0.00018310607,0.00060451956,0.00008974032,0.0033689616,0.0021365958,0.0071801376,0.01804578],"study_design_scores_gemma":[0.017623167,0.010920402,0.8051571,0.00015543198,0.0029170038,0.0010468564,0.0021962905,0.0020212862,0.00486029,0.0030261085,0.14924784,0.00082821364],"about_ca_topic_score_codex":0.00039100292,"about_ca_topic_score_gemma":0.000043964443,"teacher_disagreement_score":0.16020435,"about_ca_system_score_codex":0.00053762423,"about_ca_system_score_gemma":0.00016134373,"threshold_uncertainty_score":0.7939064},"labels":[],"label_agreement":null},{"id":"W4283694626","doi":"10.1136/ijgc-2022-003560","title":"Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Fertility; Stage (stratigraphy); Retrospective cohort study; Exact test; Fertility preservation; Cancer; Cohort; Gynecology; Surgery; Internal medicine; Population","score_opus":0.052920230981355634,"score_gpt":0.35536453279962466,"score_spread":0.30244430181826903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283694626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719787,0.010092663,0.00013167909,0.014085688,0.0027025514,0.00052945403,0.00032489403,0.000017467193,0.00013687034],"genre_scores_gemma":[0.99359596,0.0018090442,0.00052987796,0.0023721128,0.00021282422,0.0008527148,0.000009622134,0.000018149853,0.0005997099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998055,0.00008660406,0.00064194936,0.0002921942,0.00064379367,0.00028048502],"domain_scores_gemma":[0.9974263,0.001424456,0.00046579086,0.0001129155,0.00039044753,0.00018009683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044146992,0.00019346784,0.00062988687,0.00028753557,0.00011527118,0.00005219515,0.00019452603,0.00007424517,0.0054075],"category_scores_gemma":[0.0005756865,0.00013690529,0.00037660435,0.00015862443,0.00007391671,0.00014199394,0.000160041,0.00033702084,0.0000010596057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012519556,0.0009880528,0.94394326,0.000052698084,0.00091983867,0.00067894644,0.00010562265,0.00024062423,0.00007393256,0.00013672859,0.0005582664,0.051050074],"study_design_scores_gemma":[0.00436637,0.0006699828,0.97531974,0.00020056359,0.00020957761,0.000040574145,0.000079651196,0.00006284365,0.00026112882,0.0003084275,0.018334838,0.00014629008],"about_ca_topic_score_codex":0.00013025002,"about_ca_topic_score_gemma":0.00010905641,"teacher_disagreement_score":0.050903782,"about_ca_system_score_codex":0.0014633705,"about_ca_system_score_gemma":0.00048235772,"threshold_uncertainty_score":0.9955017},"labels":[],"label_agreement":null},{"id":"W4283730162","doi":"10.1016/j.jogc.2022.06.005","title":"Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian Carcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; MUTYH; MSH6; BRCA mutation; Population; Serous fluid; Germline mutation; Oncology; Lynch syndrome; Olaparib; Carcinoma; Ovarian cancer; Cancer; Internal medicine; Cancer research; Gynecology; Mutation; Colorectal cancer; Genetics; Biology; DNA mismatch repair; Gene; Polymerase","score_opus":0.008397716764316474,"score_gpt":0.21895904131707566,"score_spread":0.2105613245527592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283730162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373823,0.003233909,0.0000024881926,0.0017550647,0.00091273047,0.00020786347,0.00009302571,9.4017514e-7,0.000055742643],"genre_scores_gemma":[0.99921477,0.00013927539,0.0002457671,0.0003114471,0.000020821339,0.00002237859,0.000022380696,0.000010300741,0.0000128511465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989631,0.0000651536,0.00040239547,0.000142362,0.0002464344,0.00018051817],"domain_scores_gemma":[0.99867064,0.0005806763,0.00030723738,0.00008127388,0.00014218531,0.00021796438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019200175,0.00010762262,0.00037722074,0.0004933016,0.00009463169,0.000010481163,0.000045416375,0.000048128728,0.00035741294],"category_scores_gemma":[0.00036092004,0.00009042039,0.000029138288,0.0004329048,0.000032066382,0.00005078913,0.000018587794,0.0002120831,4.920421e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017435797,0.00012755117,0.9502686,0.000038190065,0.000093953495,0.003745792,0.00019548852,0.00025280312,0.000002435179,0.000049504157,0.00015870878,0.045049526],"study_design_scores_gemma":[0.004685809,0.0013610552,0.9922557,0.000014754358,0.00014377644,0.00024306006,0.0002451551,0.00019470292,0.000065323926,0.00007227847,0.00063843717,0.000079939244],"about_ca_topic_score_codex":0.72866523,"about_ca_topic_score_gemma":0.8361765,"teacher_disagreement_score":0.10751126,"about_ca_system_score_codex":0.0016557405,"about_ca_system_score_gemma":0.0020365536,"threshold_uncertainty_score":0.4329704},"labels":[],"label_agreement":null},{"id":"W4283758123","doi":"10.1038/s41698-022-00288-2","title":"Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression","year":2022,"lang":"en","type":"article","venue":"npj Precision Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Peter MacCallum Foundation; Peter MacCallum Cancer Centre; Medical Research Council; Ovarian Cancer Canada; Terry Fox Research Institute; Cancer Australia; Australian Cancer Research Foundation","keywords":"Cancer research; Ovarian carcinoma; Serous fluid; Serous ovarian cancer; Hormone receptor; Biology; Internal medicine; Oncology; Ovarian cancer; Medicine; Cancer","score_opus":0.021001860241061564,"score_gpt":0.29862967762453047,"score_spread":0.2776278173834689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283758123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260014,0.00020690096,0.0017434766,0.0030686457,0.0008154434,0.001027492,0.00009511221,0.00003945331,0.00040330685],"genre_scores_gemma":[0.9959515,0.00008606954,0.0020794151,0.0005422565,0.00012370643,0.0005689478,0.00032219265,0.0000342716,0.00029163784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829644,0.00021230009,0.0004935096,0.00042875405,0.00034297328,0.00022603446],"domain_scores_gemma":[0.99895644,0.000108279484,0.00023922225,0.00042929137,0.000116458104,0.00015030128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027403538,0.00016143499,0.00043709145,0.0002840047,0.00021988923,0.000018417293,0.00015548785,0.00010397699,0.00069973036],"category_scores_gemma":[0.00007144101,0.00015636142,0.000113156966,0.0003586897,0.000026835496,0.000088635745,0.00027561732,0.00018488202,0.000041054253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005385431,0.000702164,0.0053727217,0.000019001489,0.00005280858,0.000055271914,0.0010653983,0.00017851157,0.97479,0.00010190565,0.0015207953,0.015602911],"study_design_scores_gemma":[0.005444478,0.00429533,0.38012478,0.00012636658,0.00024011915,0.000115393224,0.0011817662,0.00033730612,0.5719206,0.00015526629,0.03572058,0.000338046],"about_ca_topic_score_codex":0.000058587513,"about_ca_topic_score_gemma":0.00000545489,"teacher_disagreement_score":0.4028694,"about_ca_system_score_codex":0.0006795068,"about_ca_system_score_gemma":0.00025692474,"threshold_uncertainty_score":0.7661557},"labels":[],"label_agreement":null},{"id":"W4283771201","doi":"10.1016/s1470-2045(22)00343-6","title":"Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations – Authors' reply","year":2022,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Trabectedin; Topotecan; Oncology; Medicine; Ovarian cancer; Internal medicine; Regimen; Olaparib; BRCA mutation; Chemotherapy; Cancer; Pathology; Sarcoma; Biology","score_opus":0.06730842307923487,"score_gpt":0.3634795755095666,"score_spread":0.29617115243033176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283771201","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068302493,0.0028725017,0.00006255325,0.9888244,0.001418087,0.0020514354,0.0008598718,0.000074052594,0.0031540692],"genre_scores_gemma":[0.0024564022,0.0021398722,0.0034469208,0.96253073,0.012569951,0.009348849,0.0017194632,0.0001276889,0.0056601344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980159,0.0002358038,0.0003190272,0.00063678774,0.00026041697,0.00053208304],"domain_scores_gemma":[0.99813765,0.0006557402,0.00032037855,0.0006909961,0.00010818815,0.00008702045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044904303,0.0003237994,0.001046948,0.00009826804,0.00031203486,0.000034750214,0.00020403805,0.00031004648,0.0010888627],"category_scores_gemma":[0.000056552737,0.00020130067,0.000118319294,0.00016960251,0.00021265024,0.000027481407,0.000085435975,0.0013941567,0.0000075200514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011430971,0.00013932891,0.0008738954,0.0002826117,0.00093956233,0.00038374853,0.000802925,0.0000073387246,0.0000021346684,0.000632994,0.9760125,0.018779831],"study_design_scores_gemma":[0.0056705736,0.0036171312,0.0035872306,0.00014721126,0.0017306192,0.00035455415,0.00008406093,0.00003540452,0.000008308764,0.0006732978,0.9838658,0.00022580054],"about_ca_topic_score_codex":0.0005374949,"about_ca_topic_score_gemma":0.00045326175,"teacher_disagreement_score":0.026293686,"about_ca_system_score_codex":0.00088847,"about_ca_system_score_gemma":0.0009263632,"threshold_uncertainty_score":0.9998243},"labels":[],"label_agreement":null},{"id":"W4283803086","doi":"10.53350/pjmhs22166198","title":"Frequency and Type of Ovarian Tumors in Gynecological Women presenting to DHQ Teaching Hospital Gujranwala","year":2022,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Continental (Canada)","funders":"","keywords":"Medicine; Incidence (geometry); Ovarian cancer; Abdomen; Laparotomy; Ovarian tumor; Acute abdomen; Obstetrics; Gynecology; Obstetrics and gynaecology; Ovary; Cancer; Radiology; Internal medicine; Pregnancy","score_opus":0.01633216337237768,"score_gpt":0.28387373474469585,"score_spread":0.26754157137231815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283803086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840914,0.00006936157,0.0000049988453,0.0032642921,0.000110752306,0.0004152016,0.00000539498,0.000020607173,0.012018],"genre_scores_gemma":[0.99696916,0.000006958504,0.001940968,0.0004534886,0.000036739642,0.0001510943,0.0000050864624,0.000009823481,0.00042670296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991063,0.0000583752,0.00021323487,0.00023524424,0.00016727496,0.00021958546],"domain_scores_gemma":[0.9995953,0.00008925021,0.000042319054,0.00014195118,0.0000233261,0.0001078593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003114072,0.00008653295,0.00024320018,0.00010014865,0.00007154393,0.000008801611,0.00005567661,0.000022809025,0.0014703473],"category_scores_gemma":[0.00018804349,0.00007077718,0.000026185075,0.00017295442,0.000017518818,0.000033875047,0.0001438509,0.00017644564,0.0000022177285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031575837,0.00067397684,0.9899273,0.000025199808,0.000045465393,0.0001366979,0.002757168,0.000018853127,0.00034156608,0.0029734944,0.00057173934,0.0024969848],"study_design_scores_gemma":[0.0013662083,0.0014734203,0.9933179,0.000023243161,0.000016678643,0.000016423952,0.0020061086,0.00004837342,0.0001290765,0.0003948351,0.0011139459,0.00009381214],"about_ca_topic_score_codex":0.00046138777,"about_ca_topic_score_gemma":0.000018574929,"teacher_disagreement_score":0.0128777465,"about_ca_system_score_codex":0.00023225453,"about_ca_system_score_gemma":0.000064590626,"threshold_uncertainty_score":0.99944246},"labels":[],"label_agreement":null},{"id":"W4284899938","doi":"10.3390/cancers14143318","title":"The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer","year":2022,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Chemotherapy; Ovarian cancer; Serous fluid; Cancer research; Medicine; Cancer; Oncology; Ovarian carcinoma; Immune system; Internal medicine; Immunology","score_opus":0.08036947369605997,"score_gpt":0.3722030446012104,"score_spread":0.29183357090515044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284899938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076844895,0.99127173,0.000025389669,0.00046332626,0.0015423733,0.0040559317,0.002352293,0.000013160957,0.00019896973],"genre_scores_gemma":[0.00027889587,0.9917347,0.0000711295,0.00009183548,0.0010191827,0.0052993265,0.00013429833,0.00009695801,0.0012736616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798524,0.0000558106,0.0007640627,0.00044132464,0.00039980852,0.00035372804],"domain_scores_gemma":[0.99780464,0.00036461407,0.0008310832,0.00082247343,0.00008472641,0.000092451475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019602054,0.00044598235,0.0015789415,0.00007811916,0.00038870377,0.00001908877,0.00033087432,0.00012725254,0.0007377723],"category_scores_gemma":[0.000012503347,0.00022231368,0.0013478528,0.00024753067,0.00022080062,0.00001554773,0.000031077252,0.00013474577,7.929783e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039356152,0.00041085336,0.000007606679,0.002901327,0.0051391902,0.0000052403634,0.0002451896,0.0000633363,0.00002664257,0.00034240563,0.002052041,0.9884126],"study_design_scores_gemma":[0.0046073096,0.0014325086,0.00008915806,0.001848098,0.006530517,0.0000048892935,0.00011541817,0.000022106258,0.00008743623,0.0000067298834,0.9850802,0.0001756678],"about_ca_topic_score_codex":0.0030161028,"about_ca_topic_score_gemma":0.0003451105,"teacher_disagreement_score":0.98823696,"about_ca_system_score_codex":0.0044463547,"about_ca_system_score_gemma":0.0026298584,"threshold_uncertainty_score":0.9993754},"labels":[],"label_agreement":null},{"id":"W4284992290","doi":"10.1016/j.ygyno.2022.06.026","title":"Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Cytoreductive surgery; Triage; Ovarian cancer; Retrospective cohort study; Surgery; Internal medicine; Cancer; Oncology; Emergency medicine","score_opus":0.07508663882871011,"score_gpt":0.350768034106301,"score_spread":0.27568139527759083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284992290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406874,0.00032872605,0.000012808938,0.001893814,0.00026992973,0.0017502337,0.0011954084,0.00003768642,0.00044264048],"genre_scores_gemma":[0.9968107,0.00021359,0.0013335035,0.00012443068,0.000022183829,0.0012841503,0.00014679607,0.000012030877,0.000052632116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980048,0.0003392478,0.0005788061,0.00058419944,0.00019035945,0.00030258173],"domain_scores_gemma":[0.9988789,0.0004570461,0.00016501307,0.00022615386,0.00007839083,0.0001945018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030404446,0.00022828931,0.00078544725,0.00017456867,0.00012776867,0.0000051026173,0.000059709182,0.000118366406,0.00029777596],"category_scores_gemma":[0.00018734756,0.0001678612,0.000060956387,0.00021892237,0.00021267342,0.00004590318,0.0001688996,0.00021959991,2.9421247e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019805438,0.0019561406,0.96724206,0.000028639717,0.00013308178,0.00008776307,0.001824046,0.0036959841,0.00021798264,0.0003241324,0.00012108398,0.022388548],"study_design_scores_gemma":[0.0067536435,0.015863968,0.9669644,0.00002192594,0.00014723478,0.000038665483,0.0019430631,0.0033861839,0.0003508706,0.00041336223,0.0039774454,0.0001391971],"about_ca_topic_score_codex":0.0027456416,"about_ca_topic_score_gemma":0.0031344364,"teacher_disagreement_score":0.02224935,"about_ca_system_score_codex":0.0032795796,"about_ca_system_score_gemma":0.0004890065,"threshold_uncertainty_score":0.85759866},"labels":[],"label_agreement":null},{"id":"W4285314687","doi":"10.37897/rmj.2021.s6.13","title":"Application of the new classification criteria in ovarian pathology (IOTA – O-RADS)","year":2021,"lang":"en","type":"article","venue":"Romanian Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adnexal mass; Medicine; Risk stratification; Radiology; Ovarian cancer; Gynecology; Cancer; Internal medicine","score_opus":0.017552971816157597,"score_gpt":0.3083978256005994,"score_spread":0.2908448537844418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285314687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66899353,0.0025640954,0.011706747,0.30996346,0.0014760185,0.00056705583,0.000009146163,0.0000186719,0.004701246],"genre_scores_gemma":[0.99625,0.0003273886,0.0011345071,0.0016029218,0.0005531621,0.000010328582,0.0000062598556,0.000011307895,0.00010413377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985783,0.00014755363,0.00043538556,0.00018795236,0.0004827927,0.0001679822],"domain_scores_gemma":[0.99912065,0.000046645357,0.00015737014,0.00031189498,0.000087667075,0.00027578566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003690885,0.00008911242,0.00024626474,0.000058926515,0.000050733972,0.000015994065,0.00014000144,0.00014509821,0.0009683923],"category_scores_gemma":[0.00030887878,0.000059583424,0.00010169704,0.00027117907,0.00006162638,0.000029234554,0.000040660405,0.000374264,0.00001623054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022792503,0.0023689247,0.5156238,0.00014943923,0.00024690136,0.003096675,0.0013646464,0.000003426664,0.06269918,0.02022844,0.016264958,0.37772566],"study_design_scores_gemma":[0.0023981412,0.00008989218,0.97859657,0.00032010127,0.00008131801,0.0029685337,0.000100601,0.0004011453,0.0018353283,0.0010268216,0.012124898,0.000056649355],"about_ca_topic_score_codex":0.000035286168,"about_ca_topic_score_gemma":0.00012524088,"teacher_disagreement_score":0.46297273,"about_ca_system_score_codex":0.00014912178,"about_ca_system_score_gemma":0.0009782532,"threshold_uncertainty_score":0.99994487},"labels":[],"label_agreement":null},{"id":"W4285394562","doi":"10.1177/08465371221108057","title":"The Ovarian/Adnexal Reporting and Data System for Ultrasound: From Standardized Terminology to Optimal Risk Assessment and Management","year":2022,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Terminology; Lexicon; Risk stratification; Malignancy; Radiology; Ovarian cancer; Ovarian tumor; Medical physics; Gynecology; Artificial intelligence; Cancer; Computer science; Pathology; Internal medicine; Linguistics","score_opus":0.03347242965157082,"score_gpt":0.3297998804394985,"score_spread":0.29632745078792766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285394562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96086025,0.0018240941,0.003413136,0.024372827,0.0015260746,0.0018514363,0.0052778684,0.00002698403,0.0008473108],"genre_scores_gemma":[0.9863921,0.00086139946,0.011886393,0.00027334774,0.0001954302,0.0000970687,0.00015476577,0.000012633547,0.00012689683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829584,0.00023077353,0.00064394437,0.00028642864,0.00024600778,0.000297025],"domain_scores_gemma":[0.9973681,0.0005917597,0.0013329895,0.00030493052,0.000115054194,0.00028718723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034097612,0.000105962245,0.0003608926,0.000109009896,0.0008706197,0.00009623993,0.00015677925,0.000052806787,0.000020469797],"category_scores_gemma":[0.00087990816,0.000082448634,0.000053533728,0.00007375182,0.000035891768,0.000050154275,0.000085452746,0.00023121761,1.9926175e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025832508,0.00003830626,0.92113113,0.000038887276,0.002163436,0.00033642567,0.00038975486,0.00018137928,0.000033752665,0.0013897076,0.04485147,0.029187398],"study_design_scores_gemma":[0.0036906844,0.00051092607,0.8985945,0.00004714889,0.0006447997,0.0006921061,0.002130851,0.00042008335,0.0000085649945,0.00012578726,0.093019575,0.000114987684],"about_ca_topic_score_codex":0.003738159,"about_ca_topic_score_gemma":0.005607209,"teacher_disagreement_score":0.048168104,"about_ca_system_score_codex":0.0033092578,"about_ca_system_score_gemma":0.0006082639,"threshold_uncertainty_score":0.8653594},"labels":[],"label_agreement":null},{"id":"W4285741645","doi":"10.3389/fendo.2022.886533","title":"The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination","year":2022,"lang":"en","type":"review","venue":"Frontiers in Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Ovarian Cancer Canada","keywords":"Ovarian cancer; Debulking; Medicine; Metastasis; Cancer research; Tumor microenvironment; Primary tumor; Peritoneal cavity; Cancer; Oncology; Pathology; Internal medicine; Surgery","score_opus":0.025225512790859966,"score_gpt":0.33110601996430594,"score_spread":0.30588050717344595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285741645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044559914,0.99319243,0.00003454278,0.0009410702,0.0036425316,0.0013218991,0.00027064502,0.00002695054,0.0005253957],"genre_scores_gemma":[0.00020818156,0.9961191,0.0001877798,0.000033903252,0.00022680157,0.0025215023,0.00010283458,0.00004977397,0.00055011857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981784,0.00024525105,0.00049799524,0.0004922401,0.00014717082,0.00043894644],"domain_scores_gemma":[0.99911094,0.00025963632,0.00019145716,0.0003540669,0.000012563845,0.00007133192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014137641,0.00031536122,0.00134919,0.00025149612,0.00017129855,0.000021545125,0.00016777268,0.00014600325,0.00014999342],"category_scores_gemma":[0.000031355557,0.00021033948,0.0002286562,0.0002123818,0.00008645071,0.000026294312,0.00005816138,0.0004984634,0.000004333569],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003668817,0.000061130224,0.0005168589,0.0021207747,0.00046821556,0.000115727285,0.00009156506,3.2006375e-7,8.2263945e-8,0.00046864396,0.003951283,0.9921687],"study_design_scores_gemma":[0.00086581317,0.00012246867,0.00023936419,0.001868602,0.0011475731,0.00021827672,0.00010508437,0.000009387704,0.0000023459231,0.00006120799,0.9951938,0.00016610655],"about_ca_topic_score_codex":0.000102898885,"about_ca_topic_score_gemma":0.00015572191,"teacher_disagreement_score":0.9920026,"about_ca_system_score_codex":0.0009200154,"about_ca_system_score_gemma":0.00030859004,"threshold_uncertainty_score":0.8577395},"labels":[],"label_agreement":null},{"id":"W4286295495","doi":"10.1200/jco.2022.40.16_suppl.5546","title":"Validation of the integrated prediction model algorithm for outcome of cytoreduction in advanced ovarian cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Retrospective cohort study; Ovarian cancer; Cohort; Triage; Stage (stratigraphy); Surgery; Oncology; Youden's J statistic; Cancer; Internal medicine; Algorithm; Predictive value; Emergency medicine","score_opus":0.13366408298817567,"score_gpt":0.4752023374431294,"score_spread":0.3415382544549537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286295495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98311085,0.00019590645,0.0045691105,0.008504653,0.0028219724,0.00056883733,0.00013010214,0.000003353282,0.000095233125],"genre_scores_gemma":[0.9871511,0.00020944113,0.012013035,0.0002143939,0.00024227606,0.00006861249,0.000008825683,0.000008675486,0.000083626706],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745387,0.00022547724,0.001863957,0.000111413334,0.00025756255,0.00008772641],"domain_scores_gemma":[0.9972373,0.00039728658,0.0018402276,0.000121419434,0.00034847943,0.00005528711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017308944,0.00006768434,0.0007536065,0.0000997818,0.000031962663,0.0000011654615,0.00009095733,0.000102934675,0.000055328517],"category_scores_gemma":[0.00056349084,0.000043756427,0.00032835337,0.00020528212,0.00006216603,0.00006271165,0.000028584305,0.0004164858,6.798793e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041948804,0.004083213,0.28173876,0.00005153558,0.0004419956,0.000010309208,0.00026113287,0.058258917,0.0011793486,0.00023757799,0.00097283814,0.6485695],"study_design_scores_gemma":[0.041464828,0.02555688,0.79538554,0.00029213098,0.0015717063,0.00011847266,0.0009456213,0.11435754,0.006524117,0.0020589347,0.0115935085,0.00013072498],"about_ca_topic_score_codex":0.000086575856,"about_ca_topic_score_gemma":0.000023399369,"teacher_disagreement_score":0.64843875,"about_ca_system_score_codex":0.0005578874,"about_ca_system_score_gemma":0.0012976482,"threshold_uncertainty_score":0.23019722},"labels":[],"label_agreement":null},{"id":"W4286297240","doi":"10.1200/jco.2022.40.16_suppl.5574","title":"Integrated safety summary of single-agent mirvetuximab soravtansine in patients with folate receptor α (FRα)-positive recurrent ovarian cancer: Phase 1 and 3 clinical trials.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"ImmunoGen","keywords":"Medicine; Tolerability; Ovarian cancer; Internal medicine; Adverse effect; Gastroenterology; Population; Oncology; Phases of clinical research; Folate receptor; Nausea; Cancer; Toxicity; Surgery; Cancer cell","score_opus":0.14832471963709895,"score_gpt":0.47356855325880187,"score_spread":0.32524383362170295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286297240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380876,0.0019333084,0.0000669126,0.009802078,0.0026405074,0.0009483528,0.0005801033,0.0000066438665,0.00021333556],"genre_scores_gemma":[0.99093395,0.0042862636,0.002852966,0.001144411,0.00053034385,0.00002635686,0.00014217787,0.000032840235,0.0000506605],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9893515,0.0038080153,0.005605984,0.00039467358,0.00056523154,0.00027455887],"domain_scores_gemma":[0.99014056,0.004391043,0.0040992266,0.00022285998,0.00066143845,0.00048485494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010824381,0.00024364555,0.0035019459,0.00023064224,0.00006521302,0.000008935927,0.00014296411,0.00027045462,0.00066740107],"category_scores_gemma":[0.0032487686,0.00016094148,0.0005781211,0.00036769517,0.0002638223,0.000096480355,0.00010748395,0.0015855149,0.000001127932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103110895,0.028567629,0.2984393,0.000022258115,0.0015429475,0.00028823785,0.000117625175,0.000009969842,0.00001684524,0.00003048302,0.0030507478,0.56480306],"study_design_scores_gemma":[0.15101252,0.16448773,0.5971072,0.00072325976,0.0020707096,0.00004334395,0.00017090118,0.00009161213,0.00004519637,0.000059771595,0.08398429,0.00020348566],"about_ca_topic_score_codex":0.00015881733,"about_ca_topic_score_gemma":0.00018176076,"teacher_disagreement_score":0.5645996,"about_ca_system_score_codex":0.0009759481,"about_ca_system_score_gemma":0.0024986558,"threshold_uncertainty_score":0.73075736},"labels":[],"label_agreement":null},{"id":"W4287657580","doi":"","title":"Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Serous fluid; Serous ovarian cancer; Carcinogenesis; Oncology; Medicine; Ovarian cancer; Cancer research; Internal medicine; Cancer","score_opus":0.31379636898399116,"score_gpt":0.4961776702299561,"score_spread":0.18238130124596497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287657580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.848287,0.1265688,0.0060184146,0.013323486,0.0012740723,0.0019665472,0.00018742168,0.000099959085,0.0022743389],"genre_scores_gemma":[0.98810595,0.009724461,0.00032718215,0.0012889239,0.00036607316,0.00003827345,0.000021892702,0.00008475338,0.000042460382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972469,0.00019586716,0.0008323599,0.0005197812,0.0007945068,0.00041054768],"domain_scores_gemma":[0.9980983,0.00012198557,0.0006969665,0.0004458575,0.0001903379,0.00044654214],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039483482,0.00037087634,0.0011515811,0.00037105384,0.00015462792,0.00028801276,0.000877015,0.00013430443,0.008819288],"category_scores_gemma":[0.00004864235,0.00030691133,0.00033444012,0.0007773741,0.00012458973,0.0005992066,0.0003198427,0.00028637383,0.000012863733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002139619,0.0017598736,0.80243146,0.0006378185,0.00468619,0.00075964944,0.0020164018,0.0006343426,0.15260339,0.001408012,0.01262909,0.018294187],"study_design_scores_gemma":[0.004887375,0.00016436115,0.9068505,0.00060588407,0.0015628629,0.00005574228,0.0006996622,0.00012773546,0.07608173,0.0064624506,0.0020169728,0.00048468675],"about_ca_topic_score_codex":0.0010027259,"about_ca_topic_score_gemma":0.00003449306,"teacher_disagreement_score":0.13981901,"about_ca_system_score_codex":0.00028583308,"about_ca_system_score_gemma":0.00028000725,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W4287730147","doi":"10.1016/s1470-2045(22)00139-5","title":"Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Genentech; National Institutes of Health; Mereo BioPharma; Medac; PharmaMar; Eisai; Seagen; Verastem Oncology; Pfizer; NuCana; Incyte; National Medical Research Council; Karyopharm Therapeutics; Kissei; National Institute for Health and Care Research; Clovis Oncology; Nippon Shinyaku; AstraZeneca; Novocure; Mersana Therapeutics; Amgen; Deciphera Pharmaceuticals; Medical Research Council; Teva Pharmaceutical Industries; Fuji Pharma; GlaxoSmithKline; European Commission; PTC Therapeutics; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Consensus conference; Concordance; Ovarian cancer; Medicine; Clinical trial; Deliberation; Gynecologic cancer; Family medicine; Clinical research; MEDLINE; Gynecology; Cancer; Oncology; Internal medicine; Political science","score_opus":0.5870445998710079,"score_gpt":0.5953735657196614,"score_spread":0.008328965848653502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287730147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007887182,0.8329444,5.600161e-7,0.15630409,0.003107541,0.0022600766,0.000786947,0.000031692576,0.004485809],"genre_scores_gemma":[0.00018081856,0.9813614,0.00017370813,0.0050683967,0.0037396483,0.008494414,0.0003614031,0.000057337664,0.00056286075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98995477,0.0069399374,0.0011990351,0.00081188336,0.00034144323,0.0007529315],"domain_scores_gemma":[0.9768097,0.021169715,0.0005195374,0.0012945407,0.000082034436,0.00012449632],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0057005757,0.00036711787,0.0030553974,0.00014928695,0.00038661205,0.000034034994,0.00092409155,0.00047749272,0.010508802],"category_scores_gemma":[0.0005772085,0.0001867897,0.0004683809,0.0008622064,0.00054618565,0.000015440963,0.000623845,0.0038432004,0.00012906721],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014392649,0.00047822032,0.0031024832,0.00036075866,0.00084116985,0.00023482641,0.00019518526,0.0000010683666,2.7114426e-8,0.00068939023,0.15361488,0.84033805],"study_design_scores_gemma":[0.0025380778,0.0006218094,0.0036876067,0.0029108606,0.0013260287,0.000047640868,0.0002540234,0.0000053711337,5.9786146e-8,0.00048069295,0.987957,0.00017082159],"about_ca_topic_score_codex":0.011027712,"about_ca_topic_score_gemma":0.021056864,"teacher_disagreement_score":0.8401672,"about_ca_system_score_codex":0.0035705776,"about_ca_system_score_gemma":0.0041753594,"threshold_uncertainty_score":0.998455},"labels":[],"label_agreement":null},{"id":"W4288039477","doi":"10.3390/curroncol29080419","title":"High-Volume Hospitals’ Ovarian Cancer Care—Less Individual Approach or Better Treatment Results?","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Internal medicine; Overall survival; Oncology; Intervention (counseling); General surgery","score_opus":0.11668617356908349,"score_gpt":0.3815896924653017,"score_spread":0.2649035188962182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288039477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93731934,0.017037045,0.00006809998,0.024074163,0.008970459,0.0031475672,0.0038572403,0.0002184232,0.005307636],"genre_scores_gemma":[0.9854411,0.001294223,0.0015313731,0.00083854434,0.0016025971,0.0057110107,0.0022916833,0.00006348169,0.0012260053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997451,0.0002206988,0.0005002261,0.0008146407,0.00045744205,0.0005559976],"domain_scores_gemma":[0.9987726,0.00009365666,0.0002350542,0.0005482561,0.00009690865,0.00025348412],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018136765,0.00035818986,0.00076564716,0.0001796119,0.0003234362,0.000029283301,0.00021054606,0.000120011384,0.001259382],"category_scores_gemma":[0.000020086129,0.00026708847,0.00020222802,0.00032482206,0.00010573935,0.00005403035,0.00022420834,0.00038972727,0.00004062367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015735717,0.0060127815,0.103593625,0.00013400095,0.0009923396,0.0004224892,0.0064981985,0.00015360217,0.000006079918,0.00037590807,0.05608396,0.8241534],"study_design_scores_gemma":[0.017913755,0.0062604547,0.16361102,0.00004308862,0.0011852344,0.00009289675,0.0024034565,0.00005287341,0.00007226321,0.000029412553,0.8080117,0.00032384714],"about_ca_topic_score_codex":0.0007770462,"about_ca_topic_score_gemma":0.000120782744,"teacher_disagreement_score":0.8238296,"about_ca_system_score_codex":0.0037167326,"about_ca_system_score_gemma":0.001103091,"threshold_uncertainty_score":0.9999781},"labels":[],"label_agreement":null},{"id":"W4289223086","doi":"10.1016/j.respe.2022.06.147","title":"281 - L'adiposité chez l'enfant et le risque de cancer épithélial de l'ovaire","year":2022,"lang":"fr","type":"article","venue":"Revue d Épidémiologie et de Santé Publique","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Gynecology; Medicine; Art; Humanities","score_opus":0.025630668707532618,"score_gpt":0.34009019102445187,"score_spread":0.31445952231691926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289223086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58166796,0.13690901,0.0024781544,0.2487969,0.0058263205,0.0023562089,0.0020021785,0.0005166411,0.019446654],"genre_scores_gemma":[0.92571616,0.03667978,0.0032722005,0.023031596,0.0029293816,0.0032351804,0.0002997455,0.0001822024,0.0046537374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917776,0.0034276869,0.0009195167,0.0012518382,0.0003738623,0.0022494877],"domain_scores_gemma":[0.99621665,0.0012521477,0.0005003067,0.0010489329,0.00017589278,0.000806068],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0049803797,0.00076384994,0.0013163526,0.00032324958,0.0005253038,0.00016488288,0.00074197736,0.0006597412,0.0031195725],"category_scores_gemma":[0.0011307339,0.00079131365,0.00066744804,0.00078409165,0.00027250033,0.0003519799,0.00062918087,0.0022112723,0.00005045257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009006196,0.0041930745,0.67945874,0.001243601,0.0025692305,0.0050878217,0.0053742714,0.019680241,0.0033260307,0.11455109,0.10848164,0.055133626],"study_design_scores_gemma":[0.005618133,0.0021729947,0.5821028,0.0013333545,0.0013453237,0.0022612116,0.0012783892,0.004599696,0.005912876,0.0037976617,0.38833043,0.0012471677],"about_ca_topic_score_codex":0.01858108,"about_ca_topic_score_gemma":0.0018766614,"teacher_disagreement_score":0.34404823,"about_ca_system_score_codex":0.010185585,"about_ca_system_score_gemma":0.016143976,"threshold_uncertainty_score":0.9994538},"labels":[],"label_agreement":null},{"id":"W4289525812","doi":"10.1016/j.ygyno.2022.07.020","title":"Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Subtyping; Logistic regression; Serous fluid; Ovarian cancer; Disease; Stage (stratigraphy); Internal medicine; Oncology; Multivariate analysis; Radiology; Serous ovarian cancer; Predictive value of tests; Cancer","score_opus":0.020715232957499198,"score_gpt":0.3221683117156931,"score_spread":0.3014530787581939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289525812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95644456,0.000809897,0.000032534557,0.036781903,0.0006319549,0.0038745012,0.000008814382,0.000059171878,0.001356684],"genre_scores_gemma":[0.9861267,0.000022101463,0.0013215196,0.0040247864,0.00012730582,0.008308925,0.000011366804,0.000025786054,0.000031465133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973807,0.0007456057,0.00037509596,0.00067258114,0.00034996012,0.0004760615],"domain_scores_gemma":[0.998719,0.00042327147,0.0001255166,0.0005166002,0.000082513565,0.00013310235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013642437,0.00021754405,0.0005224941,0.00015485543,0.00036177662,0.00001812305,0.00025204942,0.000035272467,0.00063285703],"category_scores_gemma":[0.00013984014,0.00014041121,0.00004382996,0.0007505501,0.00008891438,0.000037471193,0.0003729779,0.00062307215,0.0000053572385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017679479,0.0054181274,0.96532166,0.000020865573,0.00018409218,0.0018251897,0.003915206,0.0013323226,0.0006749668,0.00034244897,0.00027103993,0.018926136],"study_design_scores_gemma":[0.009689567,0.040854827,0.9220558,0.000021020189,0.00027380636,0.000081312,0.016929857,0.00020523608,0.00022108734,0.00034504288,0.009102836,0.0002196472],"about_ca_topic_score_codex":0.002108157,"about_ca_topic_score_gemma":0.0075839725,"teacher_disagreement_score":0.043265894,"about_ca_system_score_codex":0.0025317664,"about_ca_system_score_gemma":0.0009474748,"threshold_uncertainty_score":0.69293404},"labels":[],"label_agreement":null},{"id":"W4289745769","doi":"10.1016/j.jogc.2022.07.003","title":"Spontaneous Resolution of Prolapsed Fallopian Tube After Outpatient Loop Electrosurgical Excision Under Local Anaesthesia","year":2022,"lang":"en","type":"letter","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Loop electrosurgical excision procedure; Surgery; Electrosurgery; Anesthesia; General anaesthesia; Internal medicine","score_opus":0.009879462911643785,"score_gpt":0.2187358590303194,"score_spread":0.2088563961186756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289745769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7287023,0.037260078,0.00012661701,0.21825598,0.01359613,0.0012958696,0.00019849742,0.00001175075,0.00055274955],"genre_scores_gemma":[0.9281821,0.0008368822,0.00015632558,0.07006602,0.00019986952,0.00002797385,0.00007241843,0.00004563348,0.00041277354],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971521,0.00018947944,0.0009345723,0.00032030072,0.0009786974,0.000424875],"domain_scores_gemma":[0.9974279,0.00095448346,0.00077667396,0.000258456,0.00037378355,0.0002086928],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002389711,0.00031024957,0.001044833,0.00046737847,0.00008192231,0.000015592841,0.0001440054,0.0005331523,0.0014085572],"category_scores_gemma":[0.00032394638,0.00024554698,0.00022287988,0.0003525643,0.00010189317,0.000033349625,0.000060761115,0.0017443674,4.7138465e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006858751,0.00083276414,0.029921116,0.00046029984,0.0013902929,0.5389685,0.00012344786,0.0003996108,0.0000022993406,0.000055670236,0.36468887,0.06247126],"study_design_scores_gemma":[0.006051499,0.01095088,0.13594185,0.0000736834,0.0011568354,0.0053478484,0.00010104545,0.00012136949,0.0000141673345,0.00008997924,0.8397791,0.00037177576],"about_ca_topic_score_codex":0.007811382,"about_ca_topic_score_gemma":0.008655455,"teacher_disagreement_score":0.53362066,"about_ca_system_score_codex":0.005131565,"about_ca_system_score_gemma":0.0037717782,"threshold_uncertainty_score":0.9999997},"labels":[],"label_agreement":null},{"id":"W4289783227","doi":"10.1007/s11701-022-01447-0","title":"Impact of robotic surgery on patient flow and resource use intensity in ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Journal of Robotic Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep Saint-Jean-sur-Richelieu; McGill University; Jewish General Hospital","funders":"Réseau de cancérologie Rossy; Israel Cancer Research Fund","keywords":"Medicine; Robotic surgery; Ovarian cancer; Laparotomy; Surgery; Logistic regression; Cancer; General surgery; Internal medicine","score_opus":0.04519938269854891,"score_gpt":0.28460959394549923,"score_spread":0.23941021124695033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289783227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547446,0.001423014,0.000026956923,0.0019207774,0.00094458467,0.00017188056,0.000013061039,0.0000051398642,0.000020105914],"genre_scores_gemma":[0.998633,0.0005375909,0.00017388472,0.00044969362,0.00012455108,0.000012501312,0.000007539104,0.000028134386,0.000033049193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978562,0.0001914847,0.0008902236,0.00021170026,0.00055383757,0.00029655025],"domain_scores_gemma":[0.9970577,0.0016229078,0.0006612884,0.00025506652,0.00017230763,0.00023074982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084122876,0.00020193386,0.0011660022,0.00070033723,0.00006634473,0.000019931971,0.000049244456,0.00005265951,0.00032175987],"category_scores_gemma":[0.00039643014,0.00015484232,0.0005350783,0.00043843215,0.000049821247,0.00011085789,0.00006187069,0.00041669334,8.2648364e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014964181,0.0010515933,0.8521487,0.000046685887,0.0004576374,0.0012643167,0.00034884774,0.11920619,0.000048294787,0.000002976389,0.014616191,0.00931213],"study_design_scores_gemma":[0.00090729975,0.0007761236,0.99523914,0.00076714635,0.00025082022,0.0006755988,0.00016239047,0.0006825391,0.000109778695,0.000013718117,0.00027982224,0.00013562187],"about_ca_topic_score_codex":0.0009905646,"about_ca_topic_score_gemma":0.00002650702,"teacher_disagreement_score":0.14309043,"about_ca_system_score_codex":0.0008849852,"about_ca_system_score_gemma":0.00068593497,"threshold_uncertainty_score":0.63142866},"labels":[],"label_agreement":null},{"id":"W4290839585","doi":"10.1097/md.0000000000029607","title":"Synchronous surgery and immediate reconstruction of double primary cancers of the ovary and breast","year":2022,"lang":"en","type":"article","venue":"Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Continental (Canada)","funders":"","keywords":"Medicine; Breast cancer; Ovary; Breast reconstruction; Surgery; Ovarian cancer; Biopsy; Primary tumor; Radiology; Cancer; Internal medicine; Metastasis","score_opus":0.01275756177000675,"score_gpt":0.22809645520329905,"score_spread":0.2153388934332923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290839585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98282313,0.0067468,0.0000021424971,0.008701481,0.00051165535,0.00027581083,0.000034598903,0.0000072461758,0.0008971214],"genre_scores_gemma":[0.99801654,0.0014200722,0.000034999142,0.00028753062,0.00011569465,0.00004026335,0.000013327814,0.000008780864,0.00006281693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925524,0.0000320425,0.00024469243,0.00015175395,0.0002194814,0.00009677628],"domain_scores_gemma":[0.9994634,0.00010776797,0.00015727252,0.00017861315,0.00003498611,0.00005797828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002536959,0.00008072839,0.00035848332,0.00008000655,0.000064906286,9.4872246e-7,0.000028537686,0.00001983615,0.00026413472],"category_scores_gemma":[0.000011460321,0.000051019968,0.00003665879,0.00017680362,0.00028100284,0.000023393524,0.00005747646,0.00009445765,1.0569911e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007574741,0.0001227016,0.8233362,0.0005149005,0.00024558214,0.000024086801,0.000786569,0.000008419166,0.0020312208,0.00010306424,0.0039398624,0.16812994],"study_design_scores_gemma":[0.0041597337,0.00039037087,0.9902746,0.0004240483,0.0003422042,0.0011997098,0.00055215484,0.000023580724,0.0011206297,0.000059291622,0.0013915836,0.00006210791],"about_ca_topic_score_codex":0.0014810463,"about_ca_topic_score_gemma":0.000021888307,"teacher_disagreement_score":0.16806783,"about_ca_system_score_codex":0.00016396341,"about_ca_system_score_gemma":0.00022429584,"threshold_uncertainty_score":0.28920898},"labels":[],"label_agreement":null},{"id":"W4290975632","doi":"10.1158/1078-0432.ccr-22-1623","title":"Taking the Road Less Traveled: Following Molecular Trail Markers","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Scope (computer science); Medicine; Targeted therapy; Cancer; Internal medicine","score_opus":0.2958377884899446,"score_gpt":0.5160971397425603,"score_spread":0.22025935125261575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290975632","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027014209,0.010430254,0.000007160705,0.9411117,0.002345304,0.0021962114,0.00013165684,0.00006290128,0.016700616],"genre_scores_gemma":[0.22899142,0.005141457,0.000107271895,0.73685026,0.011880336,0.005332218,0.00038285714,0.00036010108,0.010954073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913162,0.0019834035,0.0010196517,0.0013736886,0.003004624,0.0013024154],"domain_scores_gemma":[0.9952087,0.0024930453,0.00028538288,0.0015043474,0.0002306739,0.0002778463],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005233734,0.0004411711,0.0011735809,0.00025481777,0.0005854573,0.00015938217,0.0009093252,0.00078620925,0.0103436215],"category_scores_gemma":[0.00081227167,0.00030416198,0.0014533715,0.00080197107,0.00051578187,0.000046269743,0.00043014932,0.0105090765,0.0000769602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041281493,0.00020498357,0.003654856,0.00021150385,0.001624681,0.008297182,0.000097312484,0.0000044540907,0.0000067104706,0.00002253206,0.80678636,0.17867662],"study_design_scores_gemma":[0.0029135183,0.0010230901,0.02224173,0.0005734667,0.00068765355,0.000025416663,0.00023647975,0.000027491751,0.000031029296,0.0000992147,0.97181594,0.00032496854],"about_ca_topic_score_codex":0.003592885,"about_ca_topic_score_gemma":0.00013916157,"teacher_disagreement_score":0.20426142,"about_ca_system_score_codex":0.0012907019,"about_ca_system_score_gemma":0.0023010038,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W4291214311","doi":"10.1007/s42399-022-01265-3","title":"Study Design Solutions for Adjuvant and Maintenance Therapy in Cancer: Ovarian Cancer as an Example","year":2022,"lang":"en","type":"article","venue":"SN Comprehensive Clinical Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Cancer Care Ontario; McMaster University; Queen's University; Impact; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Guideline; Soundness; Maintenance therapy; Adjuvant therapy; Ovarian cancer; Research design; Cancer; Oncology; Medical physics; Internal medicine; Chemotherapy; Computer science; Pathology","score_opus":0.3352415838719477,"score_gpt":0.4577303692073915,"score_spread":0.12248878533544383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291214311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93680465,0.016314121,0.0005913363,0.036913913,0.0019341365,0.007103445,0.00011310283,0.000082950675,0.00014234275],"genre_scores_gemma":[0.9756054,0.008142242,0.00061457604,0.009771504,0.0007572069,0.004817891,0.000044263117,0.000049841314,0.00019703036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678075,0.0005326496,0.00084831886,0.0008972448,0.000394987,0.00054601964],"domain_scores_gemma":[0.9969872,0.0015916,0.0002173374,0.000534387,0.00030806867,0.0003614036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011092887,0.00029005308,0.0010789895,0.00015552109,0.0003582311,0.000010328756,0.00016055975,0.000071795,0.0008540985],"category_scores_gemma":[0.00018370063,0.00021857939,0.000104766645,0.00037190053,0.00028633143,0.000058955444,0.00013681145,0.0004636021,0.0000022952615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008374755,0.011369687,0.5291836,0.00010124551,0.0014495042,0.0007737156,0.0071397796,0.0007511726,0.00035379123,0.0021762599,0.029104209,0.40922228],"study_design_scores_gemma":[0.048200354,0.034186944,0.8423379,0.00032729283,0.00050052564,0.000058073958,0.00794592,0.0012581522,0.000019491701,0.0019246113,0.06289819,0.0003425596],"about_ca_topic_score_codex":0.012956583,"about_ca_topic_score_gemma":0.0010988655,"teacher_disagreement_score":0.40887973,"about_ca_system_score_codex":0.00031701493,"about_ca_system_score_gemma":0.0004815008,"threshold_uncertainty_score":0.9936162},"labels":[],"label_agreement":null},{"id":"W4291744034","doi":"10.3390/curroncol29080454","title":"Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Oncology; Randomized controlled trial; Ovarian cancer; Stage (stratigraphy); Observational study; Chemotherapy; Cancer; Adjuvant; Gynecology","score_opus":0.31016724738366863,"score_gpt":0.47465705029887517,"score_spread":0.16448980291520654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291744034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000289544,0.990922,0.0000043809373,0.000595637,0.0010443709,0.0020501807,0.0044977027,0.00001779558,0.0005784316],"genre_scores_gemma":[0.00030078198,0.99498826,0.00005060807,0.00014097264,0.0001847845,0.002792986,0.00091404136,0.000079397156,0.00054815196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610597,0.00047025277,0.001421364,0.0009515457,0.00058523926,0.00046565564],"domain_scores_gemma":[0.9972778,0.00040815765,0.0012143945,0.0007961782,0.00013212876,0.00017132342],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050272176,0.0006702384,0.008529877,0.00073094614,0.000051348063,0.000010919242,0.00032380826,0.00032381513,0.035876766],"category_scores_gemma":[0.000030962165,0.00046533547,0.004217905,0.0013910393,0.00008484625,0.00003340598,0.00014811859,0.0006978109,0.000017507324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101349215,0.0042520645,0.006454157,0.0043023564,0.11981046,0.000042651325,0.00037175274,0.0000038130754,2.2889687e-8,0.0001352728,0.0004071305,0.864119],"study_design_scores_gemma":[0.002558291,0.0006136162,0.0021939734,0.00032296748,0.24697885,0.0000013614629,0.000023283952,0.0000047368253,7.9894966e-7,0.000011721926,0.74704534,0.00024505556],"about_ca_topic_score_codex":0.0009655687,"about_ca_topic_score_gemma":0.0011099748,"teacher_disagreement_score":0.8638739,"about_ca_system_score_codex":0.0017461252,"about_ca_system_score_gemma":0.0012507832,"threshold_uncertainty_score":0.9997798},"labels":[],"label_agreement":null},{"id":"W4292295080","doi":"10.7759/cureus.28086","title":"A Rare Case of Low-Grade Serous Cystadenocarcinoma of the Ovary in a Seventeen-Year-Old Woman","year":2022,"lang":"en","type":"article","venue":"Cureus","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Serous fluid; Serous cystadenocarcinoma; Ovary; Mucinous cystadenocarcinoma; Malignancy; Cystadenocarcinoma; Serous Cystadenoma; Germ cell tumors; Population; Gynecology; Ovarian cancer; Epithelial ovarian cancer; Neoplasm; Cancer; Pathology; Internal medicine; Chemotherapy","score_opus":0.017914789582415293,"score_gpt":0.262351096328156,"score_spread":0.2444363067457407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292295080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408835,0.0032556357,9.638367e-7,0.0012761313,0.00015251971,0.0004970634,0.00012515807,0.000010178835,0.0005940105],"genre_scores_gemma":[0.9991378,0.000049908427,0.000069621245,0.0002705273,0.000038422048,0.00011889559,0.0000108834,0.000017846083,0.00028609982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909586,0.000079716454,0.00025963617,0.00018906425,0.00021602686,0.00015966968],"domain_scores_gemma":[0.99928397,0.000042707437,0.000115834424,0.00047716007,0.000028192966,0.000052107956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111346526,0.0001052137,0.00027238295,0.000057666817,0.0000512001,0.0000025940835,0.00011472826,0.000032499007,0.00037481336],"category_scores_gemma":[0.000018467646,0.000078328885,0.00012780265,0.00031775903,0.000043691573,0.000023865834,0.00014648114,0.00016695663,0.0000016301806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037942972,0.0030085817,0.97294754,0.00044966093,0.00028824687,0.009266465,0.004946035,0.00012542166,0.0008686323,0.0013671382,0.0051595545,0.0011932994],"study_design_scores_gemma":[0.011048887,0.0019436355,0.9602358,0.0005546144,0.0004106018,0.006530838,0.0058438783,0.00015895764,0.00907969,0.00043116076,0.0034895523,0.00027239087],"about_ca_topic_score_codex":0.0012299827,"about_ca_topic_score_gemma":0.00037689312,"teacher_disagreement_score":0.012711742,"about_ca_system_score_codex":0.00024143573,"about_ca_system_score_gemma":0.00013167367,"threshold_uncertainty_score":0.41039437},"labels":[],"label_agreement":null},{"id":"W4292640845","doi":"10.1016/j.ctarc.2022.100625","title":"Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Survival analysis; Ovarian cancer; Population; Log-rank test; Cohort; Cancer; Oncology; Gynecology; Gastroenterology; Surgery","score_opus":0.22223543453226452,"score_gpt":0.4443921806036002,"score_spread":0.22215674607133568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292640845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938241,0.0027971098,6.365313e-7,0.0014786695,0.000036295492,0.0009935003,0.00071139005,0.0000062443846,0.00015200458],"genre_scores_gemma":[0.9922946,0.0024111965,0.00003278768,0.000011237497,0.000012670144,0.00478267,0.00038254168,0.000014162102,0.00005811341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832326,0.0004797699,0.00033029678,0.00021220955,0.00042388623,0.00023057843],"domain_scores_gemma":[0.99770665,0.0008847096,0.00013368987,0.00093899784,0.0002498776,0.00008606547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038875887,0.0001246167,0.00041311124,0.0005803748,0.00036565273,0.0000146546245,0.00023717106,0.000015123948,0.0005909813],"category_scores_gemma":[0.000064908854,0.00008107361,0.00018807244,0.0020882033,0.0001545875,0.00006186765,0.0001695697,0.00017085765,2.6315277e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024983348,0.0018536021,0.9863167,0.000026503682,0.0015744279,0.0000018953074,0.00095185195,0.0032119153,0.00002602821,0.00013861395,0.00002767459,0.005620975],"study_design_scores_gemma":[0.0024734023,0.0006912733,0.9927273,0.00008744912,0.00090575696,1.4826038e-7,0.0003032657,0.0024682889,0.000057423378,0.000018230086,0.00020460966,0.00006284442],"about_ca_topic_score_codex":0.10746698,"about_ca_topic_score_gemma":0.009686841,"teacher_disagreement_score":0.09778014,"about_ca_system_score_codex":0.0015823147,"about_ca_system_score_gemma":0.00063019205,"threshold_uncertainty_score":0.8984765},"labels":[],"label_agreement":null},{"id":"W4292693911","doi":"10.3390/curroncol29080472","title":"Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sinai Health System; University Health Network; Surrey Memorial Hospital; University of Toronto","funders":"Institut canadien d'information sur la santé; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Systemic therapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Cancer; Bioinformatics; Biology","score_opus":0.0627296741402954,"score_gpt":0.361590919261042,"score_spread":0.2988612451207466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292693911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905977,0.0059493887,0.00000559465,0.0014541647,0.0011057011,0.0007151418,0.000114913644,0.000008581932,0.00004878535],"genre_scores_gemma":[0.9942324,0.004734501,0.00002599647,0.00012480885,0.00004175136,0.00073201687,0.000027029702,0.0000125187125,0.000068952686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998895,0.00009226658,0.00038331433,0.0002820343,0.00014115465,0.00020622244],"domain_scores_gemma":[0.99949044,0.00012059282,0.00013534627,0.00016575548,0.000031759435,0.00005608828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015981885,0.00013992716,0.00057884946,0.00017198634,0.000034194847,0.0000024629815,0.000067217006,0.000048247566,0.00066764833],"category_scores_gemma":[0.000009462287,0.00011826494,0.000059919523,0.00010315383,0.000021587752,0.000030345285,0.00007396353,0.0002951516,9.580114e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005179177,0.0014011443,0.8790217,0.000079858546,0.000061308434,0.000078205034,0.0016359753,0.00020986234,0.00006594155,0.000038109963,0.000014870083,0.11687513],"study_design_scores_gemma":[0.01354632,0.0012404334,0.96796936,0.00025717745,0.000043256237,0.00002523389,0.00026290677,0.00006399262,0.0000769333,0.000031338957,0.016383924,0.00009911891],"about_ca_topic_score_codex":0.03554577,"about_ca_topic_score_gemma":0.2803777,"teacher_disagreement_score":0.2448319,"about_ca_system_score_codex":0.0017551394,"about_ca_system_score_gemma":0.00041199944,"threshold_uncertainty_score":0.97087663},"labels":[],"label_agreement":null},{"id":"W4293559767","doi":"10.1016/j.ygyno.2022.08.006","title":"Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre","funders":"Universitat Autònoma de Barcelona; Universitat de Barcelona; Eisai; Regeneron Pharmaceuticals; Princess Margaret Cancer Foundation; AstraZeneca; National Cancer Institute; Novocure; U.S. Department of Defense","keywords":"Medicine; Gemcitabine; Placebo; Tolerability; Internal medicine; Adverse effect; Common Terminology Criteria for Adverse Events; Brief Pain Inventory; Surgery; Physical therapy; Cancer","score_opus":0.0519709187733715,"score_gpt":0.32940325350043226,"score_spread":0.27743233472706075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293559767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781633,0.0000387457,0.000010672913,0.0003715683,0.00032952247,0.02063481,0.000021271531,0.000042596654,0.00038752682],"genre_scores_gemma":[0.99164164,0.000003763773,0.0019742786,0.00008825386,0.000034367396,0.00609196,0.00010977297,0.00003589692,0.000020093214],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992644,0.0017184586,0.0035680144,0.0008263151,0.0006172274,0.0006259721],"domain_scores_gemma":[0.9934737,0.002304986,0.0034361084,0.00041983614,0.00023580431,0.00012954885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043287394,0.0004340014,0.003757785,0.00068347127,0.0002100021,0.000014538662,0.00013978615,0.00022168763,0.0003438386],"category_scores_gemma":[0.0017739364,0.00027056647,0.00014105806,0.00087017985,0.00015277676,0.00013476743,0.0001913419,0.0006990952,3.9900902e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76217294,0.030486746,0.20033193,0.000095198506,0.00028228876,0.0008261149,0.0023685675,0.0018181487,0.000046435205,0.000033771736,0.0000036154777,0.001534249],"study_design_scores_gemma":[0.8613225,0.07252816,0.060181126,0.0001375544,0.00044972714,0.000019743085,0.00076634175,0.004186121,0.00006922282,0.00002139112,0.000052088202,0.00026600325],"about_ca_topic_score_codex":0.0016665909,"about_ca_topic_score_gemma":0.009424105,"teacher_disagreement_score":0.1401508,"about_ca_system_score_codex":0.004680276,"about_ca_system_score_gemma":0.003095775,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W4293569084","doi":"10.1097/pas.0000000000001954","title":"Ovarian Signet-ring Stromal Tumor","year":2022,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; McGill University; University Health Network","funders":"","keywords":"Pathology; Signet ring cell; Stromal cell; Immunohistochemistry; Population; Stroma; Neoplasm; Stromal tumor; Nuclear atypia; Biology; Medicine; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.014662042956809243,"score_gpt":0.2731693508929241,"score_spread":0.25850730793611487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293569084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98429847,0.0005323321,0.000047998597,0.013210804,0.00024954087,0.000098579985,0.000008870494,0.000010446965,0.0015429666],"genre_scores_gemma":[0.99751693,0.000091512935,0.00059400836,0.001324236,0.00035987797,0.00001524798,0.0000015318147,0.00001624589,0.00008042761],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854046,0.0003759629,0.00037411205,0.00013974898,0.0003204884,0.00024922594],"domain_scores_gemma":[0.99885666,0.00025727076,0.00046691223,0.00021495754,0.000058847494,0.00014533813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006602985,0.00011219558,0.0005302077,0.00009786248,0.00016315746,0.0000087507915,0.00018216501,0.000009773807,0.0009082393],"category_scores_gemma":[0.00002127856,0.00006862663,0.000219111,0.00026450888,0.00028717183,0.000026612692,0.00010501556,0.0004820263,0.000010213853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021928634,0.0055874935,0.28682888,0.000044456105,0.0021107283,0.3123666,0.0037242363,0.00302754,0.008073365,0.012583742,0.007936414,0.33578792],"study_design_scores_gemma":[0.015095291,0.04006446,0.48367494,0.00007861676,0.0011336697,0.27364504,0.0050511854,0.00016615611,0.0006051792,0.0014283964,0.17858633,0.00047070606],"about_ca_topic_score_codex":0.00003057143,"about_ca_topic_score_gemma":5.800385e-7,"teacher_disagreement_score":0.33531722,"about_ca_system_score_codex":0.00014133388,"about_ca_system_score_gemma":0.00014466752,"threshold_uncertainty_score":0.9944583},"labels":[],"label_agreement":null},{"id":"W4293662930","doi":"10.1002/path.6006","title":"The proteome of clear cell ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Canada's Michael Smith Genome Sciences Centre; Calgary Laboratory Services; BC Cancer Agency; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Cancer Institute; BC Cancer Foundation; Ovarian Cancer Canada; Terry Fox Research Institute; Canada Research Chairs; VGH and UBC Hospital Foundation","keywords":"Proteome; Ovarian carcinoma; Carcinoma; Computational biology; Biology; Pathology; Cancer research; Medicine; Oncology; Ovarian cancer; Bioinformatics; Internal medicine; Cancer","score_opus":0.013783770696141603,"score_gpt":0.24874270808881968,"score_spread":0.2349589373926781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293662930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838388,0.0021389844,0.000029246541,0.0119122695,0.0003398827,0.00023426948,0.0000069988387,0.000002424983,0.0014971307],"genre_scores_gemma":[0.9987861,0.000204279,0.00019437386,0.00033626793,0.00013977247,0.000011588721,4.862133e-7,0.000009692176,0.0003174421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899995,0.00030853393,0.00029703646,0.000052541585,0.00021234906,0.00012960134],"domain_scores_gemma":[0.9991349,0.00015773883,0.0003500216,0.00023925408,0.00007690615,0.00004119963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010268791,0.000061325314,0.00020845763,0.0000454087,0.0001789467,0.0000030453555,0.00017619504,0.000020642314,0.00021180774],"category_scores_gemma":[0.00002768404,0.00002940392,0.00010307289,0.0000982408,0.00009394723,0.000013679411,0.000074368734,0.00029981014,0.0000043975506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03696108,0.010343873,0.3968934,0.00052002334,0.0025411386,0.029054059,0.050980758,0.0019269807,0.29226676,0.017019473,0.086325884,0.075166576],"study_design_scores_gemma":[0.01380772,0.028331703,0.7691969,0.00006419635,0.0018127945,0.03217442,0.0074151373,0.00007791261,0.043567296,0.003946957,0.09937265,0.00023228706],"about_ca_topic_score_codex":0.000024625058,"about_ca_topic_score_gemma":0.0000030598087,"teacher_disagreement_score":0.37230352,"about_ca_system_score_codex":0.00007468073,"about_ca_system_score_gemma":0.00015174816,"threshold_uncertainty_score":0.23191461},"labels":[],"label_agreement":null},{"id":"W4293825639","doi":"10.21203/rs.3.rs-1933628/v1","title":"Clear Cell Carcinoma of Uterine Cervix: A Clinicopathologic Review and Molecular Characterization","year":2022,"lang":"en","type":"review","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Uterine cervix; Carcinoma; Cervix; Characterization (materials science); Medicine; Gynecology; Pathology; Internal medicine; Cancer; Materials science; Nanotechnology","score_opus":0.14858530208177,"score_gpt":0.46715603634661346,"score_spread":0.31857073426484345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293825639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003634984,0.9947057,0.0000015130277,0.00040023163,0.000050653318,0.0033102473,0.00042019953,0.000017781455,0.00073019817],"genre_scores_gemma":[0.0005903511,0.99645704,0.000065615124,0.00015755593,0.00007233763,0.0010237925,0.0010944989,0.00006988972,0.0004689127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967957,0.00088627054,0.00068656687,0.000611,0.0006597064,0.00036074946],"domain_scores_gemma":[0.99833286,0.00023607918,0.00028886972,0.0007737222,0.0001757816,0.00019266663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011988551,0.00029146243,0.001973468,0.0003213314,0.000085775544,0.00001857017,0.00017617288,0.00016012866,0.0026578747],"category_scores_gemma":[0.00016885395,0.0002219235,0.00040199285,0.0007508513,0.00009537102,0.000033941356,0.00038620972,0.000698152,0.000041082716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021109474,0.00040677248,0.00023682692,0.39374983,0.00006695417,0.0006566165,0.00002196834,5.9525167e-9,0.000008099196,0.00004398135,0.00031141602,0.6044764],"study_design_scores_gemma":[0.00046445683,0.0020304988,0.0013610511,0.024416903,0.0009521951,0.00011098177,0.000010826909,6.462771e-7,0.000010938765,0.0000036396827,0.97049046,0.00014741247],"about_ca_topic_score_codex":0.000023717426,"about_ca_topic_score_gemma":4.5361068e-7,"teacher_disagreement_score":0.970179,"about_ca_system_score_codex":0.00025846285,"about_ca_system_score_gemma":0.0005163507,"threshold_uncertainty_score":0.9982538},"labels":[],"label_agreement":null},{"id":"W4295066612","doi":"10.1245/s10434-022-12459-3","title":"Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium","year":2022,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Sierra Oncology; Berlin Institute of Health; Eisai; NuCana; Clovis Oncology; PharmaMar; Alexander von Humboldt-Stiftung; European Commission; Pfizer; Teva Pharmaceutical Industries; Eli Lilly and Company; AstraZeneca; Medac; Charité – Universitätsmedizin Berlin","keywords":"Medicine; Surgical oncology; BRCA mutation; Ovarian cancer; Oncology; Internal medicine; Retrospective cohort study; Cancer; Serous fluid; Gynecology; General surgery","score_opus":0.05228259216727282,"score_gpt":0.38912198155527716,"score_spread":0.33683938938800434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295066612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874363,0.001454637,0.0000039470433,0.0074805464,0.00028827993,0.0022249816,0.0009238129,0.0000133482345,0.00017413298],"genre_scores_gemma":[0.9959936,0.0026574957,0.000008396696,0.000206223,0.000047082078,0.0009412558,0.000106438696,0.000027738302,0.000011741523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996609,0.00091536087,0.0008627791,0.00058747845,0.0006080945,0.00041730542],"domain_scores_gemma":[0.99794894,0.0006966019,0.0006250511,0.00022608347,0.00035793692,0.00014537816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076504046,0.0003079894,0.0010661914,0.00017660542,0.00012049972,0.000015258027,0.000086063716,0.00008656699,0.00014511669],"category_scores_gemma":[0.000025403266,0.0002076233,0.00011622305,0.00047694476,0.00020138035,0.00010441937,0.00012153671,0.00047927594,1.5812174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009820087,0.0080559235,0.88564855,0.000039433,0.00075008423,0.00053040916,0.0048027784,0.00033071754,0.000053986663,0.00021623197,0.00020512115,0.08954669],"study_design_scores_gemma":[0.013517896,0.013202508,0.97029823,0.000073941046,0.00009793326,0.000036942834,0.001322136,0.00043736442,0.000142939,0.000050272338,0.0006277648,0.00019206553],"about_ca_topic_score_codex":0.0086827,"about_ca_topic_score_gemma":0.00057557,"teacher_disagreement_score":0.08935463,"about_ca_system_score_codex":0.00087022776,"about_ca_system_score_gemma":0.00032509307,"threshold_uncertainty_score":0.99791855},"labels":[],"label_agreement":null},{"id":"W4295226684","doi":"10.1016/s0090-8258(22)01548-7","title":"ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa, a novel engineered cytokine, in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (326)","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Tolerability; Ovarian cancer; Carboplatin; Chemotherapy; Fallopian tube; Bevacizumab; Cancer; Immunotherapy; Cisplatin; Surgery; Adverse effect","score_opus":0.01954682296436472,"score_gpt":0.2973953425600409,"score_spread":0.2778485195956762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295226684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949939,0.00003014876,0.000017411121,0.0008060804,0.00030258173,0.0032932747,0.00029454677,0.000030527342,0.00023147967],"genre_scores_gemma":[0.9961483,0.000019858291,0.0010221503,0.0003682431,0.000037268346,0.0020916758,0.00020339522,0.000040374234,0.000068732224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771315,0.00018263808,0.0006138285,0.00058802764,0.00045403183,0.00044831162],"domain_scores_gemma":[0.9987999,0.00033334264,0.0003172238,0.00032372613,0.00012356586,0.000102250604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022238164,0.00031973672,0.00089619064,0.00029203246,0.000088603854,0.00000992592,0.00016099829,0.00012588297,0.0007556815],"category_scores_gemma":[0.000055394576,0.00023280672,0.000043352156,0.00056540297,0.000088590896,0.000076024895,0.0000845005,0.0004015972,0.0000010191675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21595345,0.091589734,0.6720445,0.00011753514,0.00069304963,0.0011487489,0.003538321,0.0021716661,0.00075882074,0.000062269915,0.00012822202,0.011793668],"study_design_scores_gemma":[0.24782048,0.061791893,0.6874438,0.000039546958,0.00016669395,0.000007492632,0.0008619707,0.00042322034,0.00006816097,0.0000012923161,0.0011889107,0.00018655937],"about_ca_topic_score_codex":0.0015015437,"about_ca_topic_score_gemma":0.009160836,"teacher_disagreement_score":0.031867016,"about_ca_system_score_codex":0.002985352,"about_ca_system_score_gemma":0.0009170695,"threshold_uncertainty_score":0.9493582},"labels":[],"label_agreement":null},{"id":"W4295226840","doi":"10.1016/s0090-8258(22)01519-0","title":"FLORA-5: A phase III double blind placebo controlled multicenter clinical study of front-line chemo-immunotherapy (paclitaxel and carboplatin +/- oregovomab) in patients with advanced epithelial ovarian cancer (GOG-3035) (298)","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Oncology; Internal medicine; Placebo; Phases of clinical research; Immunotherapy; Ovarian cancer; Front line; Double blind; Clinical trial; Cancer; Chemotherapy; Pathology; Cisplatin","score_opus":0.03521650387064424,"score_gpt":0.37107032392555556,"score_spread":0.3358538200549113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295226840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888214,0.0005690329,0.000010359567,0.0010100396,0.00071763195,0.008363954,0.00013628295,0.00003688638,0.00033440397],"genre_scores_gemma":[0.993572,0.00019964203,0.0007893025,0.0008330006,0.00011164044,0.0041997535,0.00007380203,0.00004246887,0.00017839133],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963764,0.0005742798,0.0012954468,0.00082423916,0.00041039282,0.0005192656],"domain_scores_gemma":[0.997502,0.000948561,0.00075300067,0.00042233357,0.00019329679,0.000180775],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009895187,0.00038959325,0.0020828645,0.00021223076,0.00017099133,0.000011889663,0.00017984366,0.00021178626,0.0014482099],"category_scores_gemma":[0.00014590888,0.00028374366,0.00013120112,0.00027339187,0.00019465694,0.00007449964,0.00016900826,0.00059507485,0.0000032601847],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40723014,0.04091571,0.4923152,0.000024497249,0.0013217361,0.00021719407,0.002086195,0.00037124753,0.00009939515,0.00001578661,0.00012964247,0.05527326],"study_design_scores_gemma":[0.67576283,0.05303828,0.26637596,0.00002587719,0.00054497836,0.0000046475993,0.0015866681,0.0004732252,0.000043073986,0.000012177714,0.0019067682,0.00022554556],"about_ca_topic_score_codex":0.0010831903,"about_ca_topic_score_gemma":0.0030232414,"teacher_disagreement_score":0.26853266,"about_ca_system_score_codex":0.0009298911,"about_ca_system_score_gemma":0.00058572565,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W4295279694","doi":"10.1158/1078-0432.ccr-22-2365","title":"Multi-omics Uncovering Different Faces of Clear Cell Ovarian Cancer","year":2022,"lang":"en","type":"letter","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Histopathology; Transcriptome; Omics; Cancer; Bioinformatics; Medicine; Computational biology; Biology; Oncology; Pathology; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.29137582988529676,"score_gpt":0.5071514451621641,"score_spread":0.2157756152768674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295279694","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15714885,0.018902972,0.000014179764,0.8093775,0.004965855,0.003948943,0.0029687625,0.0001103692,0.0025625855],"genre_scores_gemma":[0.30470318,0.1834592,0.0012033287,0.42239153,0.028127417,0.009429453,0.001607366,0.001046625,0.048031904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323916,0.0008361027,0.0013649716,0.0013776375,0.002086653,0.0010954872],"domain_scores_gemma":[0.99572486,0.0017016558,0.0004412279,0.0012895418,0.00049000466,0.00035270784],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001438277,0.00050133694,0.0017369471,0.0003687279,0.00024208403,0.00006393846,0.0006754154,0.0009242793,0.010904157],"category_scores_gemma":[0.00024390129,0.00040533362,0.0007536298,0.0005269486,0.00054138905,0.000051606425,0.0007762808,0.007277746,0.000054741562],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014576567,0.001466942,0.06623958,0.0020602194,0.0010759267,0.00083691033,0.00015521569,0.00008857042,0.0000951159,0.0000065552595,0.9142271,0.012290175],"study_design_scores_gemma":[0.0058848197,0.0021051823,0.03490962,0.00071956636,0.00048724347,0.000003828765,0.00008936404,0.000099059136,0.00095009344,0.000035201836,0.95432067,0.00039533785],"about_ca_topic_score_codex":0.0067549446,"about_ca_topic_score_gemma":0.00044215602,"teacher_disagreement_score":0.38698596,"about_ca_system_score_codex":0.0018686856,"about_ca_system_score_gemma":0.002102565,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W4295290032","doi":"10.1016/j.jogc.2022.08.018","title":"Outcome and Management of Serous Tubal Intraepithelial Carcinoma Following Opportunistic Salpingectomy: Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Salpingectomy; Fallopian tube; Serous carcinoma; Serous fluid; BRCA mutation; Guideline; Ovarian cancer; Ovarian carcinoma; Meta-analysis; Gynecology; Serous Cystadenoma; Internal medicine; Oncology; Cancer; Pathology; Pregnancy","score_opus":0.09266453789341558,"score_gpt":0.3277398530096884,"score_spread":0.2350753151162728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295290032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010823188,0.9971734,0.0000035968767,0.00022365594,0.0009723062,0.0012741453,0.00016523102,0.0000020216908,0.00007740161],"genre_scores_gemma":[0.007344748,0.99184597,0.0001811906,0.0003492808,0.000008269144,0.00009395362,0.000021896341,0.00002638926,0.00012828062],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966848,0.00027708663,0.0019781936,0.00031958672,0.00050714146,0.0002331979],"domain_scores_gemma":[0.99545795,0.001984597,0.0018304568,0.00031541882,0.000107431886,0.00030413087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008256913,0.00039691926,0.009015695,0.00054709136,0.00009296091,0.00002231675,0.00014514818,0.00011576024,0.000446602],"category_scores_gemma":[0.0006278228,0.0002584696,0.0012170838,0.00076904235,0.00004175115,0.00003107823,0.00013529013,0.0003791304,1.0591888e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001116478,0.00008289033,0.0017699747,0.69684863,0.25810137,0.012093991,0.00001316402,3.875679e-7,1.0696692e-9,0.00008810521,0.000108516,0.030891854],"study_design_scores_gemma":[0.0007437869,0.00035011952,0.0012972162,0.0023718274,0.9609135,0.00039041782,0.00005159354,0.0000016809456,8.689846e-9,0.0000037050706,0.03369018,0.00018600165],"about_ca_topic_score_codex":0.0022060769,"about_ca_topic_score_gemma":0.0014681612,"teacher_disagreement_score":0.7028121,"about_ca_system_score_codex":0.0011458114,"about_ca_system_score_gemma":0.00110223,"threshold_uncertainty_score":0.99998677},"labels":[],"label_agreement":null},{"id":"W4295757593","doi":"10.1002/cncy.22642","title":"Cytohistologic immunohistochemical correlation of epithelial tubo‐ovarian neoplasms: Can cell blocks substitute for tissue?","year":2022,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Serous fluid; Medicine; Immunohistochemistry; Pathology; Clear cell; Serous carcinoma; Ascites; Surgical pathology; Ovary; PAX8; Ovarian cancer; Cancer; Internal medicine; Biology","score_opus":0.015650608715196457,"score_gpt":0.2818805677973196,"score_spread":0.26622995908212316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295757593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832208,0.0050544073,0.0017649727,0.0032263922,0.0023769955,0.0014576314,0.0009671701,0.0000724152,0.0018591868],"genre_scores_gemma":[0.9940264,0.00014794333,0.0016841984,0.00056445884,0.0002258681,0.0016899189,0.00026732613,0.000034592485,0.001359284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984862,0.0000702529,0.0004268134,0.00047733172,0.0001945694,0.00034480987],"domain_scores_gemma":[0.99901074,0.000115014926,0.0002583682,0.00039476372,0.00011859849,0.00010249742],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018596015,0.00021026382,0.0005756316,0.00013088927,0.00020210465,0.000004350932,0.00015124524,0.0001336133,0.0009609632],"category_scores_gemma":[0.000043207863,0.00020783917,0.00015878526,0.00019754277,0.00017381126,0.000024532208,0.00008400237,0.00026391447,0.0000056093454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007237221,0.0027567034,0.15541004,0.00065576355,0.00045299073,0.0013948762,0.0049444577,0.0041368343,0.75349295,0.0062712007,0.018586025,0.044660933],"study_design_scores_gemma":[0.03561978,0.01059847,0.08869699,0.00016869552,0.0032156527,0.0024449578,0.0007111364,0.0011828054,0.4911983,0.0021123195,0.3626716,0.0013792607],"about_ca_topic_score_codex":0.0003926889,"about_ca_topic_score_gemma":0.0000571616,"teacher_disagreement_score":0.3440856,"about_ca_system_score_codex":0.0008747686,"about_ca_system_score_gemma":0.00052942836,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W4295817295","doi":"10.1016/j.annonc.2022.07.663","title":"535P Long term quality of life after chemotherapy among nonepithelial ovarian cancer survivors: The case-control vivrovaire rare tumours study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; PharmaMar; European Society for Medical Oncology; Eisai; Seagen; F. Hoffmann-La Roche; Incyte; Astellas Pharma; Novocure; Springworks Therapeutics; Regeneron Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; American Society of Clinical Oncology; EMD Serono; Centre Léon Bérard; Mersana Therapeutics; Deciphera Pharmaceuticals; Institut Bergonié; Sociedad Española de Oncología Médica; Clovis Oncology; Takeda Oncology; Amgen","keywords":"Medicine; Anxiety; Quality of life (healthcare); Depression (economics); Ovarian cancer; Internal medicine; Chemotherapy; Germ cell tumors; Cog; Etoposide; Oncology; Cancer; Pediatrics; Psychiatry","score_opus":0.05797858506159117,"score_gpt":0.3837561868422294,"score_spread":0.32577760178063825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295817295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772501,0.001515611,0.000010515686,0.018569926,0.00040268767,0.0015361748,0.00037338622,0.000019292049,0.0003223207],"genre_scores_gemma":[0.99414325,0.00019419525,0.000016297663,0.0040572523,0.00029412497,0.0011219063,0.000009231065,0.000034031145,0.00012972616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739844,0.0008031177,0.0007200991,0.0003819761,0.00036308318,0.00033329963],"domain_scores_gemma":[0.9980875,0.0004468049,0.0005324903,0.0005737834,0.00021532393,0.00014405129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013095654,0.00022427895,0.0009537647,0.0001042762,0.00015816152,0.000008156401,0.00019423974,0.00008758853,0.002067854],"category_scores_gemma":[0.000072723284,0.00015955916,0.0002837722,0.0002488484,0.00021412215,0.000057361685,0.00009325581,0.00028794172,0.0000022358488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037648021,0.0040764227,0.9509754,0.00006985695,0.0013304339,0.001396764,0.0039310567,0.0000508957,0.000055895416,0.000030073112,0.00085258204,0.03346583],"study_design_scores_gemma":[0.008799567,0.004706364,0.98238564,0.000030360014,0.00032281235,0.00008238242,0.0023726881,0.000014137535,0.00028292811,0.000023216824,0.00084186235,0.00013806326],"about_ca_topic_score_codex":0.021252496,"about_ca_topic_score_gemma":0.01910972,"teacher_disagreement_score":0.033327766,"about_ca_system_score_codex":0.00014415837,"about_ca_system_score_gemma":0.00049532304,"threshold_uncertainty_score":0.9988444},"labels":[],"label_agreement":null},{"id":"W4296012068","doi":"10.1016/j.annonc.2022.07.660","title":"532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Oncology; Randomized controlled trial; Gynecology; Internal medicine; Cancer","score_opus":0.10741498964121081,"score_gpt":0.4599319288843317,"score_spread":0.3525169392431209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296012068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132515,0.000997151,0.000012863586,0.0136515,0.00015506022,0.0031022804,0.00009008815,0.0000095636615,0.00065635337],"genre_scores_gemma":[0.9968604,0.00040451527,0.00015264307,0.0012768724,0.00002157644,0.0012029455,0.000034028428,0.000022984954,0.000024051044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997006,0.0006477418,0.0010606963,0.00036524716,0.0006151072,0.00030522578],"domain_scores_gemma":[0.9978685,0.0006631728,0.000721913,0.00045536988,0.0002287741,0.00006230248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014657547,0.00024105712,0.00198825,0.00033361497,0.00005970416,0.000006178661,0.00015499152,0.00006431577,0.00051389425],"category_scores_gemma":[0.0001235404,0.00014586392,0.0002387314,0.000710307,0.00016433501,0.00005138099,0.00004694016,0.00024441056,2.699466e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80280924,0.02248552,0.128284,0.000043869342,0.0048948242,0.00097480114,0.01199625,0.00034744033,0.00018169759,0.00013083634,0.0008868444,0.02696465],"study_design_scores_gemma":[0.9087656,0.03826972,0.038824722,0.000057490273,0.0011024353,0.000017682256,0.007546319,0.000044284447,0.0025903783,0.00009779991,0.002496012,0.00018756854],"about_ca_topic_score_codex":0.0058397125,"about_ca_topic_score_gemma":0.003446248,"teacher_disagreement_score":0.10595632,"about_ca_system_score_codex":0.00023887829,"about_ca_system_score_gemma":0.00072502793,"threshold_uncertainty_score":0.8827937},"labels":[],"label_agreement":null},{"id":"W4296342630","doi":"10.1097/ogx.0000000000001075","title":"Symptom Burden and Quality of Life With Chemotherapy for Recurrent Ovarian Cancer: The Gynecologic Cancer InterGroup-Symptom Benefit Study","year":2022,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Ovarian cancer; Context (archaeology); Disease; Chemotherapy; Oncology; Gynecologic cancer; Cancer; Internal medicine; Gynecology","score_opus":0.07523513385193907,"score_gpt":0.34544031932990255,"score_spread":0.27020518547796346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296342630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292124,0.0060456763,0.000032224394,0.006324794,0.0005662969,0.0033822393,0.0005574403,0.000056036864,0.00011402357],"genre_scores_gemma":[0.99310935,0.00089919334,0.00014346861,0.0012005218,0.00014111653,0.004182296,0.00006581598,0.000033957243,0.000224289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996465,0.0007637637,0.0007626547,0.00083100435,0.000652866,0.00052469515],"domain_scores_gemma":[0.9895276,0.008983615,0.00041645797,0.00048160407,0.00028346034,0.00030729215],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013300843,0.00036980642,0.0011439257,0.000099700046,0.00040954782,0.00004245871,0.00034080519,0.00012703886,0.002143784],"category_scores_gemma":[0.001879152,0.0002052542,0.00019342775,0.00091649906,0.00019395023,0.000042303145,0.00027704737,0.00043937986,0.0000017276878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028132075,0.0028323429,0.91107196,0.000052948784,0.00084778696,0.000011125172,0.00044420714,0.00014785254,0.000013367644,0.0003301375,0.00043062522,0.08100447],"study_design_scores_gemma":[0.0093816575,0.01116193,0.9719522,0.000019504061,0.0002459581,0.0000020659238,0.00069745013,0.00013562947,0.000013862668,0.000070599264,0.006054669,0.00026446916],"about_ca_topic_score_codex":0.0050788894,"about_ca_topic_score_gemma":0.0031445152,"teacher_disagreement_score":0.08074,"about_ca_system_score_codex":0.0008198431,"about_ca_system_score_gemma":0.00027946456,"threshold_uncertainty_score":0.9987684},"labels":[],"label_agreement":null},{"id":"W4296476217","doi":"10.1097/pcr.0000000000000524","title":"Carcinomas With Concurrent Involvement of the Endometrium and Uterine Adnexa—Implications for Pathological Diagnosis and Clinical Management in Current Practice","year":2022,"lang":"en","type":"article","venue":"AJSP Review and Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Endometrium; Serous fluid; Serous carcinoma; Pathological; Medicine; Gynecology; Carcinoma; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Biology; Ovarian cancer","score_opus":0.08126433566317388,"score_gpt":0.4086129343242388,"score_spread":0.3273485986610649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296476217","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12405632,0.8474656,0.000033312135,0.022535974,0.00026161742,0.005385889,0.000052133273,0.000009212347,0.00019997555],"genre_scores_gemma":[0.7630355,0.23317659,0.00038336127,0.0009565893,0.000018755143,0.0023830652,0.000017542878,0.000006340687,0.000022276361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998756,0.000101517384,0.00054061005,0.00035314,0.00013663647,0.00011207491],"domain_scores_gemma":[0.99901175,0.0002387858,0.00033247512,0.00028100345,0.00005646315,0.000079503145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007539154,0.00011014552,0.0004170832,0.000042266634,0.00008142019,0.000007054269,0.00002946595,0.000015778356,0.000015723595],"category_scores_gemma":[0.00012938093,0.00006162138,0.000063287174,0.0001850815,0.00008837846,0.00002764958,0.00018240183,0.00011711312,4.157924e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009231783,0.0009147726,0.90153855,0.0015666737,0.0001143154,0.00008407057,0.000032383137,1.8298098e-7,6.1499657e-7,0.00068294647,0.00081206707,0.094244175],"study_design_scores_gemma":[0.0011613768,0.00073705404,0.81991583,0.0005088056,0.0011155889,0.00045413323,0.00004637788,4.106274e-7,0.0000046212544,0.000050539853,0.17594375,0.000061499624],"about_ca_topic_score_codex":0.000018727662,"about_ca_topic_score_gemma":0.0000071490736,"teacher_disagreement_score":0.63897914,"about_ca_system_score_codex":0.000047232723,"about_ca_system_score_gemma":0.000040915136,"threshold_uncertainty_score":0.2512847},"labels":[],"label_agreement":null},{"id":"W4296862298","doi":"10.4329/wjr.v14.i9.319","title":"Reliability of ultrasound ovarian-adnexal reporting and data system amongst less experienced readers before and after training","year":2022,"lang":"en","type":"article","venue":"World Journal of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Risk stratification; Kappa; Cohen's kappa; Cohort; Radiology; Retrospective cohort study; Receiver operating characteristic; Medical physics; Surgery; Internal medicine; Machine learning; Computer science","score_opus":0.04546193255595647,"score_gpt":0.3094738475735017,"score_spread":0.26401191501754523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296862298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651885,0.0017200477,0.00008655281,0.00092516886,0.00035045962,0.00017040815,0.000030127969,0.000007103292,0.0001912763],"genre_scores_gemma":[0.9975375,0.00007430852,0.0020251637,0.00010857222,0.00017081802,0.00001901489,0.000011757011,0.000011982683,0.00004086823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981181,0.00016228268,0.0010441523,0.00029199116,0.00019598493,0.0001875014],"domain_scores_gemma":[0.99790484,0.00023983719,0.0012718436,0.0003803334,0.000071578506,0.00013157031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016549493,0.0001181515,0.0006712725,0.00014717378,0.0001008121,0.000010309485,0.00011918249,0.000037060276,0.000059025126],"category_scores_gemma":[0.00040099595,0.00009133914,0.00006174501,0.00014880458,0.00023974464,0.00010938868,0.00010705351,0.00026664528,4.5572907e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086181145,0.00011766048,0.97738737,0.00018620263,0.00027435762,0.0014342741,0.01047121,0.000031111515,0.00070228614,0.00026141916,0.0006860575,0.007586233],"study_design_scores_gemma":[0.003449549,0.0017140313,0.92204124,0.00036339223,0.00046343278,0.034303434,0.034623615,0.00013353482,0.00010788938,0.00011628489,0.002543682,0.00013993039],"about_ca_topic_score_codex":0.00006069109,"about_ca_topic_score_gemma":0.00006266698,"teacher_disagreement_score":0.055346154,"about_ca_system_score_codex":0.00015455864,"about_ca_system_score_gemma":0.0001680154,"threshold_uncertainty_score":0.37247023},"labels":[],"label_agreement":null},{"id":"W4296906762","doi":"10.1016/j.ygyno.2022.08.020","title":"Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; BRCA mutation; Ovarian cancer; Germline mutation; Oncology; Internal medicine; Germline; Cancer; Serous fluid; Mutation; Gynecology; Genetics","score_opus":0.035754253583514875,"score_gpt":0.3307548590159046,"score_spread":0.29500060543238976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296906762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.908316,0.0003739256,0.0006375986,0.08121616,0.00392155,0.0033010426,0.00096318265,0.0001674878,0.001103062],"genre_scores_gemma":[0.9831894,0.000060275645,0.0023130905,0.007901194,0.0004739299,0.004568176,0.00035494147,0.00005041336,0.0010885958],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99769324,0.00024617187,0.00046811087,0.0007441551,0.0002710879,0.0005772156],"domain_scores_gemma":[0.99693346,0.0018467392,0.0003710114,0.00029808228,0.00027060136,0.00028013292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049437804,0.00028704124,0.0008668135,0.0002703176,0.0004592714,0.000015961165,0.00009356637,0.0002094883,0.0010917814],"category_scores_gemma":[0.0006314663,0.00026936329,0.00024789255,0.0004547232,0.00010966805,0.00006141294,0.00012095382,0.00032527174,0.000018126455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012741534,0.0061195,0.29249683,0.00039130758,0.0043777316,0.010150462,0.012502433,0.025059557,0.0014665955,0.003934053,0.40365854,0.22710145],"study_design_scores_gemma":[0.009841347,0.007925126,0.76147616,0.00006835874,0.0011214879,0.0005693912,0.012528837,0.0006050825,0.000986737,0.0008845257,0.20329979,0.00069313566],"about_ca_topic_score_codex":0.00046950765,"about_ca_topic_score_gemma":0.00075756974,"teacher_disagreement_score":0.46897936,"about_ca_system_score_codex":0.0042109312,"about_ca_system_score_gemma":0.0016188537,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W4297504261","doi":"10.3390/curroncol29100563","title":"Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cervical cancer; General surgery; Ovarian cancer; Cancer; Surgery; Gynecology; Internal medicine","score_opus":0.2028009117816738,"score_gpt":0.4786642497298286,"score_spread":0.27586333794815476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297504261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011336298,0.9850099,0.00006109328,0.00049463013,0.0010306875,0.012673421,0.0003307413,0.000033245477,0.0003651565],"genre_scores_gemma":[0.000020937048,0.9610093,0.00034247857,0.00007300435,0.00015268357,0.03787419,0.0003824886,0.000055297853,0.00008961697],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630606,0.00043931423,0.0014799151,0.0008333846,0.0005024663,0.00043885852],"domain_scores_gemma":[0.99755305,0.00037912113,0.0009817112,0.0007437344,0.00011501782,0.00022736618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049572764,0.0005625568,0.0058609317,0.00018103515,0.00008089078,0.000007997235,0.0003941649,0.0001652867,0.00046084812],"category_scores_gemma":[0.00003944687,0.00036308114,0.00089171954,0.00059401256,0.00007065275,0.000030073397,0.00007920924,0.00042973913,0.000007589573],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007724022,0.00088503305,0.000014758136,0.62354434,0.000678394,0.0001693533,0.00008017825,8.891939e-8,1.143128e-9,0.0003651577,0.0005817952,0.3736037],"study_design_scores_gemma":[0.0014672421,0.00089983636,0.0000028725622,0.3952787,0.015907906,0.00019382584,0.00005770547,0.0000016121619,8.393268e-8,0.0000023817279,0.5859983,0.00018956537],"about_ca_topic_score_codex":0.000012557415,"about_ca_topic_score_gemma":0.000012071796,"teacher_disagreement_score":0.5854165,"about_ca_system_score_codex":0.0011922484,"about_ca_system_score_gemma":0.0009856956,"threshold_uncertainty_score":0.9998821},"labels":[],"label_agreement":null},{"id":"W4297811976","doi":"10.5001/omj.2023.40","title":"Mucinous Adenocarcinoma and Carcinoid Tumor Arising Within an Ovarian Mature Cystic Teratoma: A Case Report","year":2022,"lang":"en","type":"article","venue":"Oman Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Medicine; Omentectomy; Laparotomy; Adenocarcinoma; Mature Cystic Teratoma; Cyst; Teratoma; Ovarian cyst; Pathology; Ovarian Teratoma; Ovarian tumor; General surgery; Radiology; Ovarian cancer; Internal medicine; Hysterectomy; Cancer","score_opus":0.013448699790776519,"score_gpt":0.274094266931702,"score_spread":0.2606455671409255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297811976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896765,0.002605471,0.00012568323,0.006042088,0.00085439504,0.0003002632,0.000017764174,0.000055205,0.00032264242],"genre_scores_gemma":[0.9939824,0.000020122076,0.0021518704,0.0024218096,0.0011699465,0.000045311677,0.000030554118,0.000049981398,0.00012802864],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.996802,0.0002766053,0.0006909136,0.000506556,0.0012781892,0.00044576853],"domain_scores_gemma":[0.9976377,0.000085930056,0.00030660664,0.00041943198,0.00009113628,0.0014591839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013325098,0.00026607505,0.0005140428,0.0002053961,0.0008574181,0.00013204204,0.00013906846,0.00010449601,0.0016537815],"category_scores_gemma":[0.0002737937,0.00020923308,0.00012327751,0.00023185177,0.00012178824,0.00012397519,0.00014805072,0.0015769599,0.0000045498773],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002534706,0.0005731724,0.09050795,0.00005176118,0.00017148888,0.90054554,0.0018706975,0.0000059421577,0.000053950986,0.00012714649,0.001966951,0.0038719212],"study_design_scores_gemma":[0.003546691,0.0012414089,0.14360839,0.00013453081,0.0004022524,0.84752333,0.0014431574,0.00072739745,0.000047870817,0.00016900203,0.00097435236,0.00018160098],"about_ca_topic_score_codex":0.0003099553,"about_ca_topic_score_gemma":0.00009571097,"teacher_disagreement_score":0.05310045,"about_ca_system_score_codex":0.00037889535,"about_ca_system_score_gemma":0.000999612,"threshold_uncertainty_score":0.9992588},"labels":[],"label_agreement":null},{"id":"W4297826886","doi":"10.1007/s11912-022-01316-x","title":"Small Cell and Other Rare Histologic Types of Cervical Cancer","year":2022,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; PTEN; ARID1A; KRAS; Carcinosarcoma; Cancer; Oncology; Adenocarcinoma; Cervix; Cancer research; Cervical cancer; Internal medicine; Carcinoma; Mutation; Colorectal cancer; PI3K/AKT/mTOR pathway; Biology; Signal transduction","score_opus":0.20683909857946894,"score_gpt":0.4224995027986672,"score_spread":0.21566040421919827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297826886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014522421,0.9914011,8.7991873e-7,0.00010609015,0.0022038477,0.0010013578,0.000066275796,0.000026703228,0.0050485157],"genre_scores_gemma":[0.00012721702,0.9980133,0.000072637005,0.00008768388,0.00022943591,0.00091976055,0.000114178445,0.000042260883,0.0003934894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808794,0.00014363503,0.00079133373,0.00059189025,0.00016158355,0.00022359221],"domain_scores_gemma":[0.9982456,0.00018098527,0.0009656601,0.00042518252,0.000043232674,0.00013932641],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020297318,0.00032159153,0.0021848,0.00013505395,0.000048585815,0.000003936746,0.00006733551,0.0002775038,0.0033608477],"category_scores_gemma":[0.00003802702,0.00022960817,0.00036070813,0.00015178398,0.000116746836,0.000009152536,0.00013806006,0.00045514267,0.0000060489633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010736674,0.0009336353,0.012183702,0.016005702,0.00027446708,0.0013937437,0.00006326192,1.8929022e-7,6.426943e-8,0.000023732617,0.004491333,0.96461946],"study_design_scores_gemma":[0.00036933663,0.00040562602,0.0003539364,0.0026198237,0.0040848404,0.0014746008,0.00000862054,2.8800125e-7,0.0000011039818,0.000020329533,0.990516,0.00014548365],"about_ca_topic_score_codex":0.000081092345,"about_ca_topic_score_gemma":0.000034173157,"teacher_disagreement_score":0.9860247,"about_ca_system_score_codex":0.0007513121,"about_ca_system_score_gemma":0.0015720575,"threshold_uncertainty_score":0.9975502},"labels":[],"label_agreement":null},{"id":"W4300188683","doi":"","title":"Erratum: Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.","year":2011,"lang":"en","type":"review","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Ovarian cancer; Progression-free survival; Medicine; Oncology; Overall survival; Internal medicine; Cancer; Computer science; Artificial intelligence","score_opus":0.11963305585852399,"score_gpt":0.345388190380962,"score_spread":0.22575513452243803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300188683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001076519,0.9742802,2.0888339e-7,0.0029700445,0.0010762593,0.008480128,0.00027827805,0.000049690774,0.012864138],"genre_scores_gemma":[0.00003840258,0.95962316,0.00011614365,0.000829487,0.0002837963,0.037624154,0.00010064502,0.000116519135,0.001267698],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675584,0.00019359264,0.00071639766,0.0010656428,0.00029562094,0.0009729047],"domain_scores_gemma":[0.9973667,0.00006172879,0.00033317393,0.0010269675,0.00015396754,0.0010574167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004512345,0.00071177783,0.0030340648,0.0003998628,0.000094604584,0.00003620495,0.00032487273,0.00035703948,0.0002690204],"category_scores_gemma":[0.00024702324,0.0005259834,0.00033632817,0.00064690446,0.00010028427,0.000097861746,0.000112286965,0.00058678404,0.000013087096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001806364,0.00016443314,0.0005674451,0.013932919,0.000400298,0.00030805165,0.00014002505,3.6892585e-9,2.266388e-9,0.00045101056,0.011384481,0.97263324],"study_design_scores_gemma":[0.0014171512,0.00006261159,0.0135547435,0.04024555,0.0021498885,0.000116102354,0.000049090497,7.6270176e-8,1.0323744e-7,0.00007016918,0.9418545,0.00048005162],"about_ca_topic_score_codex":0.103786364,"about_ca_topic_score_gemma":0.13660319,"teacher_disagreement_score":0.9721532,"about_ca_system_score_codex":0.0026270351,"about_ca_system_score_gemma":0.0020523183,"threshold_uncertainty_score":0.9997192},"labels":[],"label_agreement":null},{"id":"W4300334777","doi":"10.2174/2211555204666160202003118","title":"Updates on the Role of FDG-PET/CT in Gynecological Malignancies","year":2015,"lang":"en","type":"article","venue":"Current molecular imaging","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Radiology; Endometrial cancer; Cervical cancer; Ovarian cancer; Effective diffusion coefficient; PET-CT; Positron emission tomography; Cancer; Magnetic resonance imaging; Internal medicine","score_opus":0.026091810463468645,"score_gpt":0.2935285709964614,"score_spread":0.26743676053299276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300334777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097926,0.00939361,0.00003226999,0.0047658887,0.00020103462,0.00033816256,0.000005966357,0.000021796868,0.0042619957],"genre_scores_gemma":[0.99924517,0.000092038725,0.00012472777,0.0004246873,0.000024855126,0.000059624857,0.000012262746,0.000010821972,0.000005804343],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916106,0.000055030865,0.00017785082,0.00019683994,0.00021871662,0.00019049777],"domain_scores_gemma":[0.999499,0.000062832434,0.000056568668,0.00024705593,0.0000571115,0.000077425604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018493108,0.000118025884,0.0001972033,0.000065784036,0.000018844254,0.0000145747945,0.000084608495,0.000004199912,0.000058536945],"category_scores_gemma":[0.00015245816,0.00007326882,0.00007726043,0.00014084058,0.000064888416,0.000027964243,0.000049140053,0.00012456668,0.000032744996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079978985,0.0017535288,0.8885339,0.000058172096,0.00009209973,0.0015915411,0.0002993365,0.000092894865,0.0042823288,0.025720794,0.0038637375,0.0736317],"study_design_scores_gemma":[0.010575417,0.0010128317,0.26277208,0.0023891844,0.0005404784,0.0006727295,0.0028504839,0.004655491,0.48402798,0.018114828,0.2115175,0.00087098376],"about_ca_topic_score_codex":0.000024020186,"about_ca_topic_score_gemma":0.0000018895607,"teacher_disagreement_score":0.6257618,"about_ca_system_score_codex":0.00010593156,"about_ca_system_score_gemma":0.00008473669,"threshold_uncertainty_score":0.2987816},"labels":[],"label_agreement":null},{"id":"W4302027542","doi":"10.1158/1535-7163.mct-22-0004","title":"NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition","year":2022,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Oncode Institute; Janet D. Cottrelle Foundation; BC Cancer Foundation; China Scholarship Council; Ovarian Cancer Canada; VGH and UBC Hospital Foundation","keywords":"Trametinib; MEK inhibitor; Cancer research; KRAS; Gene knockdown; Selumetinib; Synthetic lethality; MAPK/ERK pathway; Medicine; Downregulation and upregulation; Ovarian cancer; Serous fluid; Cell culture; Biology; Cancer; Internal medicine; Mutant; Gene; Signal transduction; Genetics; Colorectal cancer","score_opus":0.03380773318638299,"score_gpt":0.30289646492390804,"score_spread":0.26908873173752507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302027542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669748,0.0035791406,0.00089364307,0.026924718,0.00036128628,0.0009773071,0.0001266855,0.000040439558,0.00012196068],"genre_scores_gemma":[0.98280734,0.00019209499,0.00042058696,0.015591743,0.00008462465,0.0007052892,0.00001777235,0.00005843678,0.00012209652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816996,0.000274267,0.00030720924,0.00034011752,0.000594528,0.00031392573],"domain_scores_gemma":[0.99903643,0.00010416655,0.00013654135,0.0004951389,0.00011548405,0.00011225904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039036834,0.00020563367,0.0002988667,0.00011633999,0.00022176983,0.000020427866,0.00014484374,0.000049603088,0.00024886653],"category_scores_gemma":[0.000011964272,0.00016679012,0.00016442516,0.0006132202,0.000056626046,0.00002439483,0.000069707814,0.0002486124,0.0000043887267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00447791,0.00048700845,0.0019409267,0.00008980441,0.0011311768,0.0003333817,0.0051817438,0.029596314,0.94081473,0.0005143597,0.00050459424,0.014928062],"study_design_scores_gemma":[0.0037672033,0.0016359984,0.007848971,0.0002359748,0.0008357655,0.00005454577,0.0009994004,0.00046247753,0.9477003,0.00019370217,0.035925854,0.00033976865],"about_ca_topic_score_codex":0.0005864534,"about_ca_topic_score_gemma":0.000061129525,"teacher_disagreement_score":0.03542126,"about_ca_system_score_codex":0.0010548658,"about_ca_system_score_gemma":0.0006485788,"threshold_uncertainty_score":0.6801504},"labels":[],"label_agreement":null},{"id":"W4304758122","doi":"10.1158/1078-0432.ccr-22-1206","title":"Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; BC Cancer Agency; Foothills Medical Centre; Alberta Health Services; University of British Columbia; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"National Cancer Institute; Cancer Council Tasmania; Cancer Council South Australia; BC Cancer Foundation; National Center for Advancing Translational Sciences; Medical Research Council; Peter MacCallum Foundation; Medical Research and Materiel Command; NSW Ministry of Health; Cancer Council Victoria; University of New South Wales; Canadian Institutes of Health Research; Cancer Institute NSW; Ovarian Cancer Research Fund; Cancer Australia; University of Cambridge; University of Pittsburgh; Calgary Laboratory Services; Ovarian Cancer Action; Michael Smith Health Research BC; Faculty of Medicine and Health, University of Sydney; Translational Cancer Research Network; Korea Health Industry Development Institute; National Institute for Health and Care Research; Cancer Council NSW; Ovarian Cancer Australia; National Institutes of Health; U.S. Department of Defense; National Health and Medical Research Council; Cancer Research UK; National Science Foundation","keywords":"Gene expression profiling; Ovarian cancer; Oncology; Gene expression; Cancer research; Biology; Pathology; Medicine; Internal medicine; Gene; Cancer; Genetics","score_opus":0.09656373803480299,"score_gpt":0.427403472762598,"score_spread":0.330839734727795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304758122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968296,0.00035812432,0.0000122661195,0.0014508275,0.000059406568,0.0008882737,0.00007101982,0.000025833777,0.00030461533],"genre_scores_gemma":[0.99746203,0.00006197998,0.0015098948,0.00012379329,0.000054556644,0.00031183285,0.000029904497,0.000037428035,0.00040857008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969073,0.00043522698,0.0005705315,0.0006212853,0.0010089366,0.0004567395],"domain_scores_gemma":[0.997789,0.0009554508,0.00022921574,0.00032898545,0.00039202734,0.00030531903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017653074,0.00019531975,0.0007020615,0.00016503279,0.0003176524,0.000028642047,0.000117172196,0.00004328504,0.00035119423],"category_scores_gemma":[0.0005140964,0.00013147602,0.00007862233,0.00034779625,0.0006550135,0.00007149236,0.00033473835,0.00083081593,0.0000012770408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004943172,0.0009200989,0.9914396,0.0001052807,0.00021549029,0.00039869163,0.00015124699,0.00006362352,0.0002666242,0.000016383365,0.00075360003,0.000726206],"study_design_scores_gemma":[0.0060609393,0.005597627,0.9836394,0.001152901,0.00013234834,0.0000831347,0.0015971727,0.00019777086,0.0013231427,0.000023214181,0.000048488797,0.00014383833],"about_ca_topic_score_codex":0.00057134987,"about_ca_topic_score_gemma":0.00018927372,"teacher_disagreement_score":0.0078001595,"about_ca_system_score_codex":0.00024945659,"about_ca_system_score_gemma":0.000620258,"threshold_uncertainty_score":0.53614366},"labels":[],"label_agreement":null},{"id":"W4304810067","doi":"10.3389/fonc.2022.1025475","title":"18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Prospective cohort study; Histopathology; PET-CT; Stage (stratigraphy); Cancer; Radiology; Nuclear medicine; Pathology; Positron emission tomography; Internal medicine","score_opus":0.016971027798274713,"score_gpt":0.3094944653582246,"score_spread":0.2925234375599499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304810067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981981,0.0015155328,0.000033714812,0.0063346936,0.0045401766,0.0034577288,0.00010883796,0.0000614057,0.0019669544],"genre_scores_gemma":[0.98857,0.00035308127,0.003759644,0.00067364,0.00019646707,0.005841479,0.000026724107,0.000044592776,0.00053438335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976155,0.0003613814,0.00046700926,0.0007154428,0.0003191245,0.00052153104],"domain_scores_gemma":[0.9992255,0.00008907864,0.00016049505,0.00036653058,0.000036144018,0.00012228155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040268345,0.00025615425,0.00089947507,0.0004224759,0.0001388528,0.000008836648,0.00019334549,0.0000122593465,0.00045631695],"category_scores_gemma":[0.00004826951,0.0002517262,0.000065365995,0.0006823134,0.00008742647,0.00006588088,0.00015299763,0.0006253976,0.000007090483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038021326,0.013608893,0.9336676,0.000021241976,0.0003324278,0.014137829,0.0013652791,0.0008171256,0.000045575824,0.00033381765,0.0053979754,0.026470104],"study_design_scores_gemma":[0.045332234,0.030896125,0.86742026,0.000054085016,0.00026346583,0.00038857144,0.0073167095,0.00020670895,0.0001261378,0.0016531197,0.045971025,0.00037155277],"about_ca_topic_score_codex":0.005658909,"about_ca_topic_score_gemma":0.0053859437,"teacher_disagreement_score":0.06624734,"about_ca_system_score_codex":0.006161413,"about_ca_system_score_gemma":0.0008449655,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W4306252904","doi":"10.1016/j.gore.2022.101076","title":"Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Endometriosis; Endometrium; Oncology; Disease; Pathology; Cancer research; Internal medicine","score_opus":0.03375426272095772,"score_gpt":0.30785139990731775,"score_spread":0.27409713718636003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306252904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821729,0.0018218714,0.000057543002,0.0042976364,0.0028130277,0.0037380296,0.0006070565,0.00030924333,0.004182688],"genre_scores_gemma":[0.97600883,0.00005222121,0.01047613,0.0059890826,0.00027097348,0.0044192136,0.0024314467,0.00006236826,0.0002897023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995173,0.00051519857,0.0011882284,0.001517923,0.0007090105,0.00089668884],"domain_scores_gemma":[0.9952615,0.0021798352,0.0009982628,0.0008407315,0.00021942452,0.00050028076],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012054289,0.00049708574,0.0014502335,0.00046048933,0.0006755272,0.00004065627,0.00021215087,0.0002471143,0.0026659528],"category_scores_gemma":[0.0026650052,0.00046080843,0.00030201612,0.00094940036,0.00014485337,0.00007390424,0.00044873726,0.00064963836,0.000018108372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034636035,0.0021543226,0.87358445,0.00007711283,0.0010549268,0.07820003,0.0013724607,0.0026852514,0.0014632611,0.00004543707,0.0048594074,0.03415697],"study_design_scores_gemma":[0.0071040713,0.0136302365,0.9156469,0.000041059247,0.0021890216,0.004023977,0.0024651885,0.00012709935,0.0030784188,0.0006098887,0.050276514,0.0008075859],"about_ca_topic_score_codex":0.005361682,"about_ca_topic_score_gemma":0.0035571333,"teacher_disagreement_score":0.07417605,"about_ca_system_score_codex":0.012247911,"about_ca_system_score_gemma":0.002295276,"threshold_uncertainty_score":0.99978435},"labels":[],"label_agreement":null},{"id":"W4306362613","doi":"10.1177/08465371221121738","title":"Ovarian-Adnexal Reporting and Data System for Magnetic Resonance Imaging (O-RADS MRI): Genesis and Future Directions","year":2022,"lang":"en","type":"review","venue":"Canadian Association of Radiologists Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Magnetic resonance imaging; Risk stratification; Radiology; Ultrasound; Adnexal Diseases; Medical physics; Internal medicine","score_opus":0.056082124454917316,"score_gpt":0.3344214866906268,"score_spread":0.2783393622357095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306362613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018117926,0.9943135,0.000017003544,0.0020840794,0.0011493131,0.0007392822,0.0013552876,0.00001814035,0.0003053016],"genre_scores_gemma":[0.00012274412,0.9961022,0.0013795161,0.00007765334,0.0015260552,0.00010997512,0.00038166437,0.00004403853,0.0002561288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973055,0.0002528493,0.001300788,0.00051625504,0.00023426425,0.00039032614],"domain_scores_gemma":[0.9956644,0.0003617015,0.0029793882,0.00043378634,0.00014047824,0.0004202151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023704392,0.00027724385,0.0014800109,0.00036387064,0.00050932483,0.000095797026,0.00018153976,0.00022464716,0.000059879567],"category_scores_gemma":[0.0011939917,0.00024289351,0.00022181812,0.0002478711,0.000046881523,0.00009186529,0.000056063793,0.00045498845,4.4345052e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071238483,0.000014724258,0.015008016,0.0019731722,0.00028504094,0.00025071416,0.0000534564,1.85094e-7,4.47725e-8,0.000120199526,0.012698843,0.96958846],"study_design_scores_gemma":[0.0007205602,0.000105098035,0.013539785,0.0019030487,0.002116393,0.004897982,0.00014293646,0.0000385471,3.810043e-8,0.000006657179,0.97634816,0.00018076645],"about_ca_topic_score_codex":0.0030512055,"about_ca_topic_score_gemma":0.0033769244,"teacher_disagreement_score":0.96940774,"about_ca_system_score_codex":0.003941094,"about_ca_system_score_gemma":0.002362508,"threshold_uncertainty_score":0.9998826},"labels":[],"label_agreement":null},{"id":"W4306661079","doi":"10.1200/jco.22.01207","title":"Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Cancer Center, University of Colorado; Walter Reed National Military Medical Center; SUNY Downstate Medical Center; Cancer Institute, University of Pittsburgh; University of Oklahoma Health Sciences Center; Medical Center, University of Pittsburgh; University of Texas MD Anderson Cancer Center; EMD Serono; Saitama Medical University; Clovis Oncology; Seoul National University Hospital; Case Western Reserve University; Celldex Therapeutics; Exelixis; Regeneron Pharmaceuticals; Ludwig Institute for Cancer Research; Astellas Pharma; University of Oklahoma; Eisai; Virginia Commonwealth University; Barbara Ann Karmanos Cancer Institute; Stryker; AstraZeneca; Genentech; University of Cincinnati; Pennsylvania State University; GlaxoSmithKline; Stony Brook University; University of Pittsburgh; University of Minnesota; Roswell Park Cancer Institute; Cleveland Clinic Foundation; Brody School of Medicine; Bristol-Myers Squibb; York University; Moffitt Cancer Center; Cleveland Clinic; Array BioPharma; Ohio State University; Wake Forest University; NRG Oncology; Memorial Sloan-Kettering Cancer Center; Rush University; Amgen; University of Pennsylvania; University of North Carolina at Chapel Hill; Wayne State University; PharmaMar; Northwestern University; Seoul National University; Yale University; Sanofi; Edwards Lifesciences; Pfizer","keywords":"Medicine; Bevacizumab; Internal medicine; Hazard ratio; Oncology; Ovarian cancer; Carboplatin; Progression-free survival; Placebo; Clinical endpoint; Cancer; Chemotherapy; Randomized controlled trial; Pathology; Cisplatin; Confidence interval","score_opus":0.06551143553526073,"score_gpt":0.3779583636623471,"score_spread":0.31244692812708635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306661079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94917953,0.000102328755,0.000008771676,0.049244925,0.00045543964,0.00090440543,0.00005027402,0.0000024433705,0.000051888637],"genre_scores_gemma":[0.9973988,0.000069222755,0.00002281514,0.0020243418,0.00035289195,0.0001070424,0.000007251364,0.000012943566,0.0000046989276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960394,0.0011658246,0.0017071215,0.00021484935,0.0007238454,0.00014896796],"domain_scores_gemma":[0.9894258,0.006948952,0.0027227376,0.0004976964,0.0003644167,0.000040427578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005448709,0.0001438321,0.00071555143,0.00005802078,0.00024012392,0.00001598528,0.0003460703,0.000054389868,0.00011446149],"category_scores_gemma":[0.00082272297,0.00005433662,0.00021640373,0.0003365103,0.00015668197,0.00006303819,0.000095944844,0.0007674904,7.254267e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004824868,0.008522588,0.8767222,0.000013119565,0.00079598336,0.000057976966,0.012605872,0.0013502274,0.000050153594,0.00015505095,0.00038109877,0.09452086],"study_design_scores_gemma":[0.0054659047,0.0054932036,0.9779226,0.00007779993,0.0004968519,0.000009283891,0.008257152,0.00013114458,0.0010691414,0.00014670174,0.000876621,0.000053551717],"about_ca_topic_score_codex":0.0006673694,"about_ca_topic_score_gemma":0.000834699,"teacher_disagreement_score":0.10120044,"about_ca_system_score_codex":0.00033257037,"about_ca_system_score_gemma":0.000434046,"threshold_uncertainty_score":0.33344066},"labels":[],"label_agreement":null},{"id":"W4307953076","doi":"10.1016/j.ygyno.2022.10.009","title":"Corrigendum to “Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes” [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36–45]","year":2022,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; McMaster University; Alberta Health Services; Juravinski Cancer Centre; University of Calgary; Impact; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Hamilton Health Sciences; Dalhousie University","funders":"","keywords":"Medicine; Regret; Gynecologic oncology; Serous carcinoma; Serous fluid; Oncology; Internal medicine; Clinical Practice; Family medicine; Cancer; Ovarian cancer; Statistics","score_opus":0.0244785991403295,"score_gpt":0.3157471784248316,"score_spread":0.29126857928450206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307953076","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027568473,0.122362554,0.000008058595,0.56350523,0.15266287,0.02452631,0.0060973503,0.00038916006,0.102880016],"genre_scores_gemma":[0.12550263,0.28394943,0.0042310255,0.4387128,0.0021926134,0.012869086,0.0063557513,0.00055507186,0.12563157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909125,0.0018983763,0.0022342734,0.0022049514,0.00085356523,0.0018963453],"domain_scores_gemma":[0.99198806,0.0019323073,0.0020652777,0.001595055,0.0007397911,0.0016795135],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0013187444,0.0013636366,0.004716137,0.00067623524,0.0004445032,0.000042640026,0.000758821,0.0020676935,0.019214017],"category_scores_gemma":[0.004863638,0.0011528411,0.0006642542,0.00068973197,0.0003341369,0.00014256852,0.0009792902,0.00286835,0.0003921447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002420983,0.0034033153,0.054061558,0.0032426948,0.0010967389,0.01065937,0.00086941174,0.0000033138494,0.0000028000873,0.000014739972,0.8720566,0.054347366],"study_design_scores_gemma":[0.0029433272,0.016014371,0.21514562,0.0010786154,0.0024720228,0.0005569944,0.001320053,0.000014046352,0.0000049813198,0.000008062104,0.75972456,0.0007173312],"about_ca_topic_score_codex":0.050516177,"about_ca_topic_score_gemma":0.15998492,"teacher_disagreement_score":0.16158688,"about_ca_system_score_codex":0.010685661,"about_ca_system_score_gemma":0.0072531253,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W4308027634","doi":"10.1016/j.ygyno.2022.10.014","title":"Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; Bevacizumab; Progression-free survival; Chemotherapy; Stage (stratigraphy); Serous fluid; Cohort; Oncology; Retrospective cohort study; Cancer; Gastroenterology","score_opus":0.015959832280266983,"score_gpt":0.2872009373481282,"score_spread":0.2712411050678612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308027634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899271,0.0000903551,0.0000017029689,0.0066983956,0.00044440938,0.002485399,0.00019786826,0.000016060454,0.00013869215],"genre_scores_gemma":[0.9966916,0.000035364876,0.00043489822,0.0006228288,0.00001976215,0.0019564368,0.000041700307,0.000016639397,0.0001807854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982767,0.00042665392,0.00039240907,0.00034520132,0.00030199066,0.00025700757],"domain_scores_gemma":[0.99873984,0.00037806455,0.00030934642,0.00038413625,0.000104341176,0.00008426513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023673465,0.00017199543,0.00056137244,0.00014610177,0.00008152528,0.0000021351555,0.00011701029,0.000079011515,0.0006595674],"category_scores_gemma":[0.00014897132,0.000104748266,0.00007461339,0.00046914612,0.00007304732,0.000027871432,0.00011379234,0.00012846362,0.0000026408445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130570475,0.005641895,0.95145744,0.000023879633,0.00021824395,0.000095492156,0.001412925,0.005048727,0.0007633907,0.00012672877,0.00015296908,0.022001268],"study_design_scores_gemma":[0.015273528,0.035374902,0.9418411,0.000047833273,0.00020628393,0.000008155536,0.00023162166,0.000005964337,0.00347819,0.00008859646,0.0033559995,0.00008779824],"about_ca_topic_score_codex":0.0010916891,"about_ca_topic_score_gemma":0.00050920626,"teacher_disagreement_score":0.029733006,"about_ca_system_score_codex":0.0025515012,"about_ca_system_score_gemma":0.0010415055,"threshold_uncertainty_score":0.72218007},"labels":[],"label_agreement":null},{"id":"W4308639157","doi":"10.1002/jso.27137","title":"Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Recursive partitioning; Ascites; Cohort; Algorithm; Surgery; Ovarian cancer; Stage (stratigraphy); Internal medicine; Cancer","score_opus":0.055544700236169434,"score_gpt":0.36308331376702646,"score_spread":0.30753861353085704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308639157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874329,0.003260449,0.00015986816,0.0067884126,0.0011639757,0.00036608326,0.00006319834,0.000008833351,0.0007562969],"genre_scores_gemma":[0.9881255,0.0013033118,0.00957056,0.00040521554,0.0003944366,0.00005068424,0.000010066113,0.000027515158,0.000112724745],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978283,0.00031755504,0.0009650299,0.00019202016,0.00043567692,0.00026142705],"domain_scores_gemma":[0.99835783,0.000546404,0.0006304053,0.00010016467,0.00015506441,0.0002101281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010076051,0.0001411191,0.0012061314,0.00044516267,0.0000616145,0.0000035687353,0.00008356009,0.00007028712,0.0006613447],"category_scores_gemma":[0.00006692969,0.00011480037,0.0002689325,0.0004831095,0.00004891754,0.00007623316,0.00010466562,0.00067413726,6.813902e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004211598,0.0020906385,0.7291962,0.00007061241,0.00041747038,0.007875968,0.0005018342,0.009565631,0.0007753954,0.000034763023,0.00021202824,0.24504785],"study_design_scores_gemma":[0.02380286,0.0108387815,0.46548867,0.0006202558,0.0008284921,0.008619754,0.0009591516,0.0020978693,0.0007989954,0.00010175956,0.48540938,0.00043402213],"about_ca_topic_score_codex":0.0004254144,"about_ca_topic_score_gemma":0.000023020606,"teacher_disagreement_score":0.48519737,"about_ca_system_score_codex":0.002510279,"about_ca_system_score_gemma":0.0010054054,"threshold_uncertainty_score":0.724126},"labels":[],"label_agreement":null},{"id":"W4309205382","doi":"10.1016/j.ygyno.2022.10.018","title":"Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research and Materiel Command; Wellcome Trust; National Center for Advancing Translational Sciences; Peter MacCallum Foundation; Medical Research Council; Ovarian Cancer Australia; National Cancer Institute; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Australia; Cancer Research UK; Roswell Park Cancer Institute","keywords":"Medicine; Ovarian cancer; Tubal ligation; Odds ratio; Disease; Body mass index; Gynecology; Debulking; Logistic regression; Breast cancer; Oncology; Obstetrics; Internal medicine; Cancer; Population; Family planning","score_opus":0.029169754675463226,"score_gpt":0.2865152862184236,"score_spread":0.25734553154296036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309205382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037194,0.0016641023,0.0000013067141,0.0060000364,0.00056134386,0.0005998538,0.0003574984,0.000070087255,0.00037382083],"genre_scores_gemma":[0.9949171,0.00012947987,0.000074110954,0.0023169655,0.00015315412,0.0015256795,0.00022894572,0.00003072655,0.0006238594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981144,0.00031640506,0.00024408674,0.0005692864,0.0002888814,0.0004669496],"domain_scores_gemma":[0.99842733,0.0008619396,0.00018248758,0.00016534764,0.00006835891,0.00029454872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002918051,0.0002457488,0.0006237232,0.00012713729,0.00034680075,0.000019355239,0.000058560643,0.000110217225,0.0027735864],"category_scores_gemma":[0.00022074624,0.00018958154,0.000089060886,0.000208512,0.00022370562,0.00006990905,0.00015809937,0.0003527308,0.0000026734995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086368603,0.0011456304,0.9888844,0.00003365369,0.00043684195,0.0016527161,0.00087325973,0.000010797054,0.000034481254,0.00001754013,0.002129196,0.0039177993],"study_design_scores_gemma":[0.0022086434,0.0015301107,0.9909974,0.00004204346,0.00058187556,0.000026327238,0.0006326122,0.000009030915,0.000021041422,0.000037456906,0.0037113875,0.00020211209],"about_ca_topic_score_codex":0.00023415918,"about_ca_topic_score_gemma":0.0003022283,"teacher_disagreement_score":0.004545128,"about_ca_system_score_codex":0.0025428487,"about_ca_system_score_gemma":0.0018417761,"threshold_uncertainty_score":0.998138},"labels":[],"label_agreement":null},{"id":"W4309855336","doi":"10.3390/curroncol29120712","title":"Highly Differentiated Follicular Carcinoma of Ovarian Origin: A Systematic Review of the Literature","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Systematic review; Thyroidectomy; Disease; Ovarian carcinoma; Follicular carcinoma; Follicular phase; Carcinoma; Thyroid carcinoma; General surgery; MEDLINE; Internal medicine; Surgery; Thyroid; Ovarian cancer; Cancer; Papillary carcinoma","score_opus":0.11617252923679731,"score_gpt":0.40801744900253883,"score_spread":0.2918449197657415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309855336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017335977,0.9911152,0.0000012713542,0.00025258196,0.0021520136,0.0058464003,0.00033230917,0.000014869333,0.00026802646],"genre_scores_gemma":[0.00012342994,0.9968587,0.0000160357,0.00008691492,0.00013475763,0.0019506755,0.00066344265,0.000046009125,0.00012002704],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960053,0.0011555336,0.0016406815,0.00046231665,0.000480119,0.00025604936],"domain_scores_gemma":[0.9962129,0.00035486996,0.0018846578,0.0012602535,0.00018058435,0.0001067242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041854,0.0004834542,0.005963164,0.00018740172,0.000055226665,0.000006926775,0.00043477592,0.00025289934,0.0005198971],"category_scores_gemma":[0.00024684455,0.00025118413,0.0018324493,0.0009970064,0.00008105741,0.000017649689,0.00021920678,0.00067931146,0.000008041057],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007703376,0.0009404864,0.000094762465,0.9340898,0.0010887206,0.000055556466,0.00007814105,9.3023464e-9,5.3387936e-8,0.0005582853,0.001798151,0.061288375],"study_design_scores_gemma":[0.0004883377,0.00025120837,0.000037574457,0.482013,0.014915484,0.00013135932,0.000003770511,2.9613975e-7,5.50089e-7,0.0000054828292,0.50206155,0.00009138385],"about_ca_topic_score_codex":0.000009615095,"about_ca_topic_score_gemma":0.000001959734,"teacher_disagreement_score":0.5002634,"about_ca_system_score_codex":0.0008381058,"about_ca_system_score_gemma":0.0013101868,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W4310493943","doi":"10.1038/s41588-022-01230-9","title":"The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"Cancer Council Tasmania; Cancer Council South Australia; Medical Research Council; Medical Research and Materiel Command; Genentech; Uniscientia Foundation; BC Cancer Foundation; Swiss Cancer Research Foundation; Cancer Council Victoria; Eisai; Cancer Australia; Cancer Council NSW; National Health and Medical Research Council; Cancer Research UK; Clovis Oncology; Peter MacCallum Cancer Centre; BeiGene; Genome British Columbia; Cancer Institute NSW; National Cancer Institute; Ovarian Cancer Australia; AstraZeneca; Eli Lilly and Company","keywords":"Biology; Ovarian cancer; Somatic cell; Transcriptome; Serous fluid; Immune system; Germline; DNA methylation; Phenotype; Survival analysis; Cancer; Gene; Genetics; Bioinformatics; Oncology; Internal medicine; Gene expression; Medicine","score_opus":0.008226354714891852,"score_gpt":0.25872593173459696,"score_spread":0.2504995770197051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310493943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115596,0.085879885,0.0000028551747,0.001559082,0.0004978513,0.00028191722,0.00011435863,0.0000067565397,0.000097689124],"genre_scores_gemma":[0.9920452,0.0072786217,0.00019135313,0.00012379883,0.00010597862,0.00004696021,0.000030229046,0.000020514017,0.00015730497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991718,0.000041540086,0.00022109738,0.00017382631,0.00024193426,0.00014982483],"domain_scores_gemma":[0.99935126,0.00006862401,0.0001403989,0.00033254124,0.00005860641,0.000048593367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012931644,0.00010969084,0.00025650003,0.000044920707,0.00010795678,0.000006839057,0.000113926246,0.000087002794,0.0001167486],"category_scores_gemma":[0.000007046764,0.00007744768,0.00006111397,0.00015085955,0.00005899267,0.0000063391494,0.00011140511,0.00028457952,3.3661198e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024475687,0.00027749807,0.96590155,0.00012982204,0.000541469,0.000038523423,0.00043544007,0.00022382523,0.0031415527,0.00033882985,0.00045614046,0.028270606],"study_design_scores_gemma":[0.001664835,0.00033324803,0.9869411,0.000026119493,0.0002546579,0.000029403922,0.000067254376,0.000027957944,0.00889874,0.00007182916,0.0016144901,0.00007033739],"about_ca_topic_score_codex":0.00035241997,"about_ca_topic_score_gemma":0.00041231903,"teacher_disagreement_score":0.080485635,"about_ca_system_score_codex":0.00006318584,"about_ca_system_score_gemma":0.00012306107,"threshold_uncertainty_score":0.31582248},"labels":[],"label_agreement":null},{"id":"W4310815716","doi":"10.1016/j.ygyno.2022.11.019","title":"Clinical commentary: Extra-uterine high-grade serous carcinoma: two pathways, two preventions?","year":2022,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Serous carcinoma; Serous fluid; Carcinoma; Gynecology; Oncology; Internal medicine; Cancer; Ovarian cancer","score_opus":0.04897207960213712,"score_gpt":0.39348844030266655,"score_spread":0.34451636070052943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310815716","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04383843,0.0024608588,0.000016054808,0.013264368,0.9323225,0.002927955,0.0020131338,0.0003178579,0.0028388342],"genre_scores_gemma":[0.09802254,0.0054604607,0.0055515654,0.007253319,0.8608835,0.004563795,0.013588345,0.00023306537,0.004443449],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928949,0.0016222603,0.0017830036,0.0017812642,0.00084899913,0.0010695818],"domain_scores_gemma":[0.9910035,0.0058553163,0.0010235932,0.001365726,0.00022471414,0.000527161],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016983974,0.0008714376,0.0028854948,0.00028037585,0.0004259318,0.00004318447,0.000641527,0.0013846015,0.013025147],"category_scores_gemma":[0.00062293065,0.0007725548,0.0008738883,0.00033824675,0.00037178246,0.00007944384,0.00086596375,0.0030611658,0.00021531903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045751335,0.007943136,0.015330377,0.00016288625,0.0011041961,0.0054110372,0.00007581246,0.000011077081,0.0000064197084,0.00022608506,0.9363608,0.032910667],"study_design_scores_gemma":[0.0228606,0.016667943,0.01703302,0.00005568617,0.0020871595,0.00012252176,0.00010868989,0.000010702562,0.000007723425,0.0007708461,0.9397021,0.00057302974],"about_ca_topic_score_codex":0.0022412443,"about_ca_topic_score_gemma":0.0022467528,"teacher_disagreement_score":0.07143905,"about_ca_system_score_codex":0.0047707334,"about_ca_system_score_gemma":0.0025286293,"threshold_uncertainty_score":0.9999118},"labels":[],"label_agreement":null},{"id":"W4311015584","doi":"10.3390/curroncol29120735","title":"Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Referral; Genetic testing; Genetic counseling; Cancer registry; Population; Ovarian cancer; Family history; Family medicine; Cohort; Cancer; Serous fluid; Gynecology; Internal medicine; Genetics; Environmental health","score_opus":0.13158544185956483,"score_gpt":0.38219379888045196,"score_spread":0.25060835702088713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311015584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688736,0.022067739,0.000028368788,0.0066330885,0.0014181263,0.000748443,0.00004722917,0.000030928393,0.00015243629],"genre_scores_gemma":[0.9946599,0.0030155543,0.0003892032,0.0008167052,0.00042008213,0.00054097833,0.00009535023,0.000019721114,0.000042486867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869496,0.0001972529,0.0002848344,0.0003302716,0.00022640928,0.00026626274],"domain_scores_gemma":[0.9993619,0.00017342952,0.00012657512,0.00022756704,0.00004603709,0.000064520405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024660616,0.00014420807,0.00028127653,0.000094153795,0.00020862976,0.000017613089,0.00010320317,0.000049999566,0.00018036157],"category_scores_gemma":[0.00001735872,0.00011160481,0.000031143074,0.0002892067,0.000040677103,0.000026431944,0.000028102706,0.00034479715,0.000005864382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007449691,0.0011067663,0.8518968,0.000064617845,0.000056520166,0.00016719755,0.0010569543,0.0006902594,0.000020265948,0.00059955684,0.016129365,0.12813716],"study_design_scores_gemma":[0.0027225066,0.00071414735,0.8192587,0.00005465721,0.00018519266,0.00020185915,0.00024827072,0.00040992736,0.0000034806621,0.0008009031,0.17528185,0.000118503034],"about_ca_topic_score_codex":0.005035088,"about_ca_topic_score_gemma":0.0026880745,"teacher_disagreement_score":0.1591525,"about_ca_system_score_codex":0.000613149,"about_ca_system_score_gemma":0.00016620412,"threshold_uncertainty_score":0.76115805},"labels":[],"label_agreement":null},{"id":"W4311929040","doi":"10.1002/ijc.34403","title":"Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A <scp>SurvMark</scp>‐2 study","year":2022,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Canadian Centre for Applied Research in Cancer Control; University of Manitoba; Nova Scotia Cancer Centre; Toronto Public Health; Cancer Care Nova Scotia; Public Health Ontario; Alberta Cancer Foundation; University of Calgary","funders":"Queen's University; Department of Health, Northern Ireland; Public Health Agency; Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Cancer Society of New Zealand; Kreftforeningen; Cancer Research UK; Queen's University Belfast; University of Glasgow; Public Health Wales; Cancer Institute NSW; World Health Organization; Kræftens Bekæmpelse","keywords":"Epithelial ovarian cancer; Incidence (geometry); Ovarian cancer; Oncology; Medicine; Cancer; Internal medicine; Gynecology; Biology","score_opus":0.020114235150374745,"score_gpt":0.33795581609788855,"score_spread":0.3178415809475138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311929040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882383,0.005017849,0.000057685636,0.0026168704,0.0026930124,0.00024275732,0.00015984353,0.000006677631,0.00038147488],"genre_scores_gemma":[0.99683183,0.001439334,0.0001600806,0.00033849644,0.0009138278,0.00007812608,0.000002988525,0.000021666408,0.00021364016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976748,0.00011926627,0.00060037646,0.00020566014,0.0012164172,0.00018347037],"domain_scores_gemma":[0.9982238,0.00027387048,0.00068224705,0.00012513496,0.0005736797,0.00012130992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007511499,0.0001474308,0.00041920788,0.00023260422,0.00008026466,0.000031250293,0.00026161197,0.000028981283,0.0005725457],"category_scores_gemma":[0.00013729243,0.00012486825,0.00013507226,0.00014543129,0.000053429954,0.00014057111,0.00017074968,0.0003315863,0.0000012650688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044757573,0.00077977777,0.9659173,0.000020660442,0.0020855756,0.00039959795,0.002245757,0.0005031916,0.00087601744,0.00023761956,0.0011145611,0.025372352],"study_design_scores_gemma":[0.0074367938,0.0010970002,0.97285545,0.00024635598,0.00052647694,0.00022370077,0.002149386,0.00010310557,0.0010081516,0.00026532527,0.014011676,0.00007655279],"about_ca_topic_score_codex":0.0026210665,"about_ca_topic_score_gemma":0.0006461459,"teacher_disagreement_score":0.0252958,"about_ca_system_score_codex":0.0006001927,"about_ca_system_score_gemma":0.00070280366,"threshold_uncertainty_score":0.6268974},"labels":[],"label_agreement":null},{"id":"W4312070075","doi":"10.1158/2767-9764.crc-22-0410","title":"Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Rogel Cancer Center, University of Michigan","keywords":"Pacific islanders; Incidence (geometry); Medicine; Ovarian cancer; Demography; Epidemiology; Ethnic group; Serous fluid; Confidence interval; Cancer; Gynecology; Oncology; Internal medicine; Population; Environmental health","score_opus":0.1301284505922743,"score_gpt":0.45416079050489827,"score_spread":0.324032339912624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312070075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6447507,0.09495132,0.000010245745,0.25545406,0.000070400056,0.0010500334,0.0011984289,0.000028140968,0.0024866536],"genre_scores_gemma":[0.94802475,0.048297457,0.00011305038,0.0006658917,0.000015471218,0.00192157,0.0003363761,0.0000147558,0.0006106565],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978801,0.0008450823,0.0002472775,0.00021197528,0.00055596366,0.0002596228],"domain_scores_gemma":[0.9975715,0.00074103626,0.00008177951,0.0013352197,0.00018693568,0.00008348172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013014368,0.00009328502,0.00021124103,0.0003795194,0.00048171036,0.000019282697,0.0006878676,0.000030847492,0.0006066374],"category_scores_gemma":[0.00007647499,0.00007341604,0.000038848884,0.001971095,0.00045949922,0.000054300424,0.0005030426,0.0007518603,0.0000014016664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097354065,0.003935843,0.44681278,0.0002310192,0.00054829364,0.000034574943,0.03234438,0.0009105873,0.0027836135,0.012409656,0.38916606,0.10984968],"study_design_scores_gemma":[0.0022916647,0.00053279864,0.30160943,0.00018479227,0.000099214914,0.000010383235,0.0029425414,0.0014993413,0.00028049597,0.0004968873,0.68989897,0.00015348395],"about_ca_topic_score_codex":0.11678311,"about_ca_topic_score_gemma":0.009633819,"teacher_disagreement_score":0.30327404,"about_ca_system_score_codex":0.0008351509,"about_ca_system_score_gemma":0.00044794945,"threshold_uncertainty_score":0.8890983},"labels":[],"label_agreement":null},{"id":"W4312076170","doi":"10.4274/nts.galenos.2022.0020","title":"F-18 FDG PET/CT Imaging in Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"Nuclear Medicine Seminars","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stantec (Canada)","funders":"","keywords":"Ovarian cancer; Medicine; Positron emission tomography; Nuclear medicine; Cancer; Internal medicine","score_opus":0.017904780890150438,"score_gpt":0.2988117544999261,"score_spread":0.2809069736097756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312076170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74985534,0.011640782,0.0000037558243,0.14573534,0.0020995017,0.0012362741,0.000057697333,0.00020825396,0.089163035],"genre_scores_gemma":[0.9892214,0.00088383694,0.0002311196,0.0075368197,0.0003470741,0.00016055787,0.00003417601,0.00007530124,0.0015097165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981752,0.00007115032,0.0003402067,0.00046034876,0.00054874725,0.00040435372],"domain_scores_gemma":[0.9991894,0.00006576682,0.00009979884,0.0004066904,0.000035808876,0.00020253197],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037187725,0.00021578018,0.00044526075,0.00027537777,0.00018293926,0.000008841,0.00014887682,0.0000070381266,0.027953763],"category_scores_gemma":[0.00005532377,0.00018897034,0.00008433658,0.000499573,0.00011052756,0.000058063695,0.0001284181,0.00041922423,0.000047711914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057528546,0.0010941455,0.31855243,0.00014860263,0.00018850522,0.029483313,0.003325573,0.000115946495,0.002723101,0.0014407585,0.5449845,0.097367845],"study_design_scores_gemma":[0.009856742,0.00096693996,0.1499609,0.000952482,0.00036372122,0.003999417,0.0069219014,0.0007377052,0.00015382298,0.0001576024,0.82557154,0.00035723698],"about_ca_topic_score_codex":0.0025215412,"about_ca_topic_score_gemma":0.000045744844,"teacher_disagreement_score":0.28058702,"about_ca_system_score_codex":0.00079589844,"about_ca_system_score_gemma":0.00014121602,"threshold_uncertainty_score":0.97293484},"labels":[],"label_agreement":null},{"id":"W4312139306","doi":"10.1136/ijgc-2022-igcs.534","title":"TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Clinical endpoint; Internal medicine; Oncology; Tolerability; Carboplatin; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Gastroenterology; Clinical trial; Immunotherapy; Cisplatin; Adverse effect","score_opus":0.02582260374654257,"score_gpt":0.33403609801599854,"score_spread":0.308213494269456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494106,0.00022828917,0.000011254805,0.0018013859,0.0015809587,0.0008198372,0.00042900254,0.000009198595,0.00017904666],"genre_scores_gemma":[0.99792707,0.00017818558,0.00027677172,0.0007981924,0.0003439362,0.0002713861,0.00003596513,0.000028982551,0.00013950057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996983,0.00013517197,0.000886465,0.0003416521,0.001367302,0.00028644069],"domain_scores_gemma":[0.9981813,0.00026772302,0.0006836503,0.00017464411,0.00053428364,0.00015844352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021371536,0.00025856597,0.0006904748,0.0002164207,0.000081629354,0.000030533272,0.0003625096,0.000070002825,0.006194993],"category_scores_gemma":[0.000089913745,0.00017247774,0.00013523489,0.0002162877,0.00008237497,0.00013724617,0.00012240476,0.00047844514,0.0000010990334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29313055,0.02061616,0.64669794,0.00004197189,0.002446391,0.001931976,0.0014411347,0.003678844,0.00034289339,0.000032315864,0.0007105944,0.02892926],"study_design_scores_gemma":[0.14383453,0.017514229,0.83287865,0.00013282611,0.00024210833,0.000017380811,0.0004584396,0.00016619112,0.00015514258,0.0000059306867,0.004414982,0.0001795594],"about_ca_topic_score_codex":0.00082459766,"about_ca_topic_score_gemma":0.0011531652,"teacher_disagreement_score":0.18618074,"about_ca_system_score_codex":0.0032980002,"about_ca_system_score_gemma":0.000982088,"threshold_uncertainty_score":0.9947135},"labels":[],"label_agreement":null},{"id":"W4312139428","doi":"10.1136/ijgc-2022-igcs.16","title":"O014/#415 Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: an NRG oncology study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Clinical endpoint; Oncology; Phases of clinical research; Adverse effect; Cancer; Clinical trial; Immunotherapy","score_opus":0.04543722970944045,"score_gpt":0.3907274243883293,"score_spread":0.34529019467888883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337494,0.0007659682,0.000001276997,0.0034870158,0.0013891713,0.0005857499,0.00007320848,0.0000018931802,0.00032078646],"genre_scores_gemma":[0.9990491,0.0002708971,0.000055215743,0.00031184364,0.00019638006,0.00007077798,0.0000031549996,0.000007727688,0.000034872835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980813,0.00030077194,0.0006818587,0.00017015744,0.0006404778,0.00012539767],"domain_scores_gemma":[0.99866164,0.00022480881,0.0006468386,0.0001175258,0.0002629652,0.000086218046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054055086,0.00010901229,0.00046813203,0.00015170596,0.00005596227,0.0000055771397,0.00026686137,0.00005064819,0.001215126],"category_scores_gemma":[0.00011882725,0.00006904946,0.00014532635,0.00013598194,0.00008747297,0.000058558355,0.00021949135,0.00040137445,1.8627279e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28407508,0.08713402,0.46212617,0.000041184085,0.0007925787,0.0014793419,0.004484127,0.0005704428,0.0011423139,0.00042189905,0.0019930096,0.15573981],"study_design_scores_gemma":[0.23822057,0.14737734,0.6003667,0.000052679454,0.00035374358,0.00016070215,0.0019171849,0.0001822834,0.001109276,0.00030371945,0.009830028,0.00012575538],"about_ca_topic_score_codex":0.00018193031,"about_ca_topic_score_gemma":0.00014015294,"teacher_disagreement_score":0.15561406,"about_ca_system_score_codex":0.000855185,"about_ca_system_score_gemma":0.0005423262,"threshold_uncertainty_score":0.9996979},"labels":[],"label_agreement":null},{"id":"W4312139480","doi":"10.1136/ijgc-2022-igcs.335","title":"EP244/#718 Poly-(ADP-ribose)-glycohydrolase localizes to the cytoplasm following neoadjuvant chemotherapy in ovarian serous carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Cancer research; Ovarian cancer; Biology; Tissue microarray; Cytoplasm; Cancer; Serous fluid; Molecular biology; Pathology; Immunohistochemistry; Medicine; Immunology; Cell biology","score_opus":0.01747602531681466,"score_gpt":0.3127252415776656,"score_spread":0.295249216260851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88607377,0.0020728784,0.0001635162,0.10721459,0.0035208494,0.0003766687,0.00006435004,0.000011504441,0.00050186075],"genre_scores_gemma":[0.98737633,0.00020609265,0.00035878213,0.010612901,0.0009806086,0.00017168875,0.000007086256,0.000021670987,0.00026482213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777097,0.00013040997,0.0005836131,0.00026444037,0.0009542652,0.00029630217],"domain_scores_gemma":[0.99894696,0.00028385356,0.00026142295,0.00017283286,0.00014401051,0.00019088824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000531493,0.00019129491,0.0004311524,0.00023219777,0.00012518532,0.00005054016,0.00048054822,0.00006321118,0.00441157],"category_scores_gemma":[0.00012357035,0.00012358543,0.0003331088,0.0002460189,0.000035695164,0.000088244975,0.00016047616,0.00047619172,0.000017141565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006446302,0.0026090813,0.796755,0.000014267938,0.001953727,0.01578037,0.0019231036,0.019125622,0.0015746555,0.001134499,0.022718474,0.12996486],"study_design_scores_gemma":[0.013579603,0.0033104464,0.70579845,0.00013447068,0.00021073013,0.0011251374,0.00048787077,0.0007843725,0.002278938,0.0005757544,0.271398,0.00031623009],"about_ca_topic_score_codex":0.0006765462,"about_ca_topic_score_gemma":0.00034389866,"teacher_disagreement_score":0.24867952,"about_ca_system_score_codex":0.0022485852,"about_ca_system_score_gemma":0.00047729825,"threshold_uncertainty_score":0.9964985},"labels":[],"label_agreement":null},{"id":"W4312139511","doi":"10.1136/ijgc-2022-igcs.13","title":"O011/#496 Mirvetuximab soravtansine and bevacizumab in folate receptor αlpha-positive ovarian cancer: efficacy in patients with and without prior bevacizumab","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Nausea; Bevacizumab; Adverse effect; Ovarian cancer; Clinical endpoint; Oncology; Gastroenterology; Cancer; Clinical trial; Chemotherapy","score_opus":0.011953853926783935,"score_gpt":0.2915304767041746,"score_spread":0.27957662277739065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898121,0.001857453,0.0000075371413,0.0070079453,0.000485209,0.00053913856,0.00017220348,0.0000074812892,0.00011094511],"genre_scores_gemma":[0.99723893,0.0008702957,0.0005361464,0.0010192567,0.00013087387,0.00011295486,0.000020719655,0.000020937401,0.000049867067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980635,0.0001202372,0.0005522396,0.00033967616,0.0006714332,0.0002528886],"domain_scores_gemma":[0.99883765,0.00018577954,0.00037657763,0.00008914186,0.00034716993,0.00016369847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027583382,0.00021615833,0.00054813176,0.00029532818,0.00007798023,0.00004270371,0.00015580162,0.000075333315,0.0011924967],"category_scores_gemma":[0.000104354134,0.00015758978,0.00006775466,0.00020971523,0.00009371637,0.00017035166,0.00013144901,0.0005287275,9.836892e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008932625,0.0019519839,0.9101563,0.000012423781,0.00045678424,0.00031227825,0.0004908543,0.00019086171,0.00004232235,0.000112868154,0.00014364932,0.07719703],"study_design_scores_gemma":[0.031209048,0.003405827,0.96245456,0.00026398269,0.00012609358,0.00008183755,0.00007784943,0.00006295494,0.00007938626,0.000087432345,0.0019819376,0.00016911096],"about_ca_topic_score_codex":0.00047347337,"about_ca_topic_score_gemma":0.00061671535,"teacher_disagreement_score":0.07702792,"about_ca_system_score_codex":0.0017783883,"about_ca_system_score_gemma":0.00036533544,"threshold_uncertainty_score":0.9997206},"labels":[],"label_agreement":null},{"id":"W4312139625","doi":"10.1136/ijgc-2022-igcs.32","title":"O030/#339 Primary cytoreductive surgery leads to improved survival in patients with advanced ovarian cancer with brca germline or somatic mutation","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Germline; BRCA mutation; Oncology; Cohort; Internal medicine; Ovarian cancer; Germline mutation; Retrospective cohort study; Cancer; Somatic cell; Population; Chemotherapy; Surgery; Mutation; Genetics; Biology","score_opus":0.016571957150046463,"score_gpt":0.2942076407295227,"score_spread":0.27763568357947627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899617,0.0002038301,0.000109385306,0.007599966,0.0012459911,0.00062987674,0.00013296871,0.000013351134,0.00010296093],"genre_scores_gemma":[0.99572307,0.000104964456,0.0013347096,0.0018332903,0.0003002678,0.00048414464,0.00005141195,0.000028568133,0.00013957046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766976,0.000107711276,0.00062675605,0.00031511427,0.0010121508,0.00026853074],"domain_scores_gemma":[0.9979227,0.00041297052,0.000569672,0.00012073328,0.0007948478,0.00017907267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003112051,0.0002175699,0.0006185997,0.00032558202,0.00007273979,0.00003048586,0.00019314089,0.000048772446,0.0023097203],"category_scores_gemma":[0.00016724116,0.00013279999,0.00011371896,0.0003750556,0.00005406081,0.00021586813,0.00007523643,0.00035758232,0.0000018120714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024859121,0.0024261924,0.9040172,0.000036245736,0.0008793486,0.0011367776,0.00035131906,0.009245594,0.00021922619,0.000029444236,0.00038057365,0.056418937],"study_design_scores_gemma":[0.009418361,0.003928991,0.98456365,0.00024210544,0.00015239572,0.000077744524,0.00014520726,0.000050181214,0.0002045281,0.000029097808,0.0009993674,0.0001883745],"about_ca_topic_score_codex":0.00018475212,"about_ca_topic_score_gemma":0.00050477555,"teacher_disagreement_score":0.080546424,"about_ca_system_score_codex":0.0032200248,"about_ca_system_score_gemma":0.0012792944,"threshold_uncertainty_score":0.99860233},"labels":[],"label_agreement":null},{"id":"W4312139660","doi":"10.1136/ijgc-2022-igcs.428","title":"EP338/#105 Epidemiological profile and clinico-pathological features of pediatric gynecological cancers at moi teaching &amp; referral hospital, Kenya","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Germ cell tumors; Chemotherapy; Internal medicine; Gynecologic oncology; Stage (stratigraphy); Referral; Oncology; Gynecology","score_opus":0.05279364372803519,"score_gpt":0.3754760172361449,"score_spread":0.3226823735081097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781019,0.00436611,0.000029031355,0.01282927,0.0021874085,0.0004637841,0.00019862647,0.00003171531,0.0017921259],"genre_scores_gemma":[0.9876635,0.004387634,0.0032490562,0.0025770841,0.0011582664,0.00020982951,0.00004182211,0.000020468191,0.00069230946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961154,0.00056519185,0.0012802327,0.00055680895,0.0010397972,0.0004425544],"domain_scores_gemma":[0.9958718,0.0019300893,0.0012127183,0.00020542924,0.00044111555,0.00033887313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016025858,0.00033710862,0.0011084337,0.00022321446,0.00025766046,0.000028000393,0.00050900853,0.0002681054,0.00863611],"category_scores_gemma":[0.0028512306,0.00021721341,0.0005240464,0.00016634438,0.00029499247,0.000117139294,0.0006452147,0.0014078065,0.000008019927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022924938,0.0020248538,0.93076307,0.00002975819,0.00062380434,0.0011700396,0.00022005709,0.0005592599,0.00026078132,0.0012966787,0.038405724,0.022353498],"study_design_scores_gemma":[0.0036462804,0.007006782,0.9581398,0.00003515677,0.0003644703,0.0006521503,0.00015756323,0.00003485736,0.00006783989,0.00084471906,0.028792938,0.00025744762],"about_ca_topic_score_codex":0.0000854817,"about_ca_topic_score_gemma":0.000049913095,"teacher_disagreement_score":0.027376745,"about_ca_system_score_codex":0.0021469018,"about_ca_system_score_gemma":0.0004171821,"threshold_uncertainty_score":0.9922701},"labels":[],"label_agreement":null},{"id":"W4312139665","doi":"10.1136/ijgc-2022-igcs.337","title":"EP246/#636 The efficacy of mek inhibitors (MEKI) in the treatment of low-grade serous ovarian cancer (LGSC): a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sinai Health System; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; MEDLINE; Oncology; Clinical trial; Retrospective cohort study","score_opus":0.0808161628935687,"score_gpt":0.4060114342737805,"score_spread":0.3251952713802118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000587357,0.98961484,0.0000019433794,0.004732969,0.0014607045,0.0032217924,0.00023246475,0.0000048321417,0.00014311883],"genre_scores_gemma":[0.0045841313,0.9919971,0.000033809065,0.0008683543,0.0005543218,0.0018193632,0.00002814455,0.00003138723,0.000083341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99443734,0.0008972712,0.0026733042,0.0003123751,0.0014240904,0.00025559808],"domain_scores_gemma":[0.9922504,0.003519408,0.003339341,0.0004323076,0.00035970213,0.0000988575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011307183,0.00045917538,0.0036041937,0.00025654002,0.000053685904,0.000026131189,0.0009240296,0.00016679766,0.0023777874],"category_scores_gemma":[0.000649605,0.0001909252,0.0017581838,0.0005244565,0.00014251492,0.00005461899,0.00007529137,0.00056359294,0.0000033516103],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050697604,0.011430748,0.0010585353,0.33372486,0.015078685,0.0023893341,0.0012254196,0.00012627072,0.0000015272543,0.0006744668,0.004113116,0.6296701],"study_design_scores_gemma":[0.0043131458,0.0026544603,0.001821205,0.38906604,0.013968976,0.0006826287,0.00014950178,0.000004115313,0.0000086580285,0.000052205207,0.5870023,0.0002767932],"about_ca_topic_score_codex":0.0003461365,"about_ca_topic_score_gemma":0.00015303119,"teacher_disagreement_score":0.6293933,"about_ca_system_score_codex":0.0026737123,"about_ca_system_score_gemma":0.001282394,"threshold_uncertainty_score":0.9985342},"labels":[],"label_agreement":null},{"id":"W4312139697","doi":"10.1136/ijgc-2022-igcs.99","title":"EP008/#378 Comparative genomic analysis of ovarian clear cell carcinoma patients with and without a second primary malignancy","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Sinai Health System; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Exome sequencing; Germline mutation; Germline; Exome; Somatic cell; Mutation; Malignancy; Clear cell carcinoma; Biology; Cancer research; Genetics; Oncology; Medicine; Cancer; Gene","score_opus":0.01899243943221456,"score_gpt":0.27941193840184797,"score_spread":0.2604194989696334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967769,0.0008546763,0.000021653954,0.00050938036,0.00022581803,0.00020434149,0.00024401482,0.000003174351,0.0011600418],"genre_scores_gemma":[0.9982989,0.00007368712,0.0006096435,0.00073094585,0.00006663268,0.000034434044,0.000035207548,0.000008637719,0.00014195367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986121,0.00007448082,0.00043777842,0.0001921259,0.0005576917,0.00012579998],"domain_scores_gemma":[0.99865186,0.00011455102,0.0005798635,0.000090447946,0.000452812,0.00011049028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014302945,0.0001291343,0.0005760871,0.00027553982,0.000056636152,0.000015722342,0.00015452244,0.00003389123,0.0049394914],"category_scores_gemma":[0.000010488074,0.00008903217,0.00016460649,0.00021378305,0.00007689923,0.00007094638,0.000099582605,0.00021617598,8.811374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024314632,0.0010202667,0.9908799,0.000014204475,0.0027499634,0.00010499432,0.00040534482,0.00064634584,0.00020424814,0.00007225019,0.0003073134,0.0011637113],"study_design_scores_gemma":[0.005469063,0.002640924,0.988087,0.000019153897,0.0013249079,0.00002498457,0.00012742379,0.000086723325,0.00023805832,0.000024656842,0.0018676252,0.00008946157],"about_ca_topic_score_codex":0.00006035666,"about_ca_topic_score_gemma":0.000056708082,"teacher_disagreement_score":0.0049386104,"about_ca_system_score_codex":0.00067009416,"about_ca_system_score_gemma":0.0002510144,"threshold_uncertainty_score":0.99597013},"labels":[],"label_agreement":null},{"id":"W4312139819","doi":"10.1136/ijgc-2022-igcs.369","title":"EP278/#101 Applications of machine learning in ovarian cancer: a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Machine learning; Artificial intelligence; Support vector machine; Logistic regression; Computer science; Ovarian cancer; Medicine; Artificial neural network; Internal medicine; Oncology; Cancer","score_opus":0.06121618485942105,"score_gpt":0.40301123788233745,"score_spread":0.3417950530229164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312139819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033937915,0.99511975,0.000031521904,0.0016169203,0.0005977288,0.0019624487,0.00018859336,0.000008584141,0.0004710787],"genre_scores_gemma":[0.00021136057,0.9951278,0.000143049,0.00064124505,0.00031652354,0.0031150207,0.000068507696,0.000032022315,0.00034445184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99604934,0.00036624793,0.0021845961,0.0002914478,0.0009100395,0.00019832818],"domain_scores_gemma":[0.9954682,0.00096069847,0.0028118521,0.00021461018,0.0004108708,0.00013376516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087355555,0.00032015896,0.0034720611,0.0004325346,0.00003896936,0.000017967599,0.0005896571,0.00015619639,0.009381119],"category_scores_gemma":[0.00068167795,0.00020790685,0.0009718549,0.00049396657,0.0000510732,0.000060263137,0.00014289602,0.0010058444,0.00000862393],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006307403,0.001021953,0.0012524942,0.43141827,0.0034036525,0.00063168065,0.000035579378,0.00004575657,3.1300027e-7,0.00031806354,0.0005947776,0.5612144],"study_design_scores_gemma":[0.0008681063,0.00031089725,0.00014118366,0.28810027,0.0044274875,0.00033982145,0.000010127587,0.000006083231,5.4655385e-7,0.000034711105,0.7056138,0.00014700499],"about_ca_topic_score_codex":0.00022730484,"about_ca_topic_score_gemma":0.00009096329,"teacher_disagreement_score":0.705019,"about_ca_system_score_codex":0.0024313284,"about_ca_system_score_gemma":0.001319764,"threshold_uncertainty_score":0.99152446},"labels":[],"label_agreement":null},{"id":"W4312173002","doi":"10.3390/cancers15010073","title":"Identifying Borderline Ovarian Tumor Recurrence Using Routine Ultrasound Follow-Up","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Ultrasound; Malignancy; Retrospective cohort study; Fertility preservation; Surgery; Population; Ovarian tumor; Fertility; Radiology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.04625413862088732,"score_gpt":0.31915134566015446,"score_spread":0.2728972070392671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312173002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845845,0.0043233056,0.0011294911,0.0013193927,0.0045921155,0.000929441,0.00020671872,0.00014334377,0.0027716933],"genre_scores_gemma":[0.995484,0.00014490861,0.001783889,0.0011961261,0.00034006944,0.00019185583,0.0000854525,0.00004207767,0.0007316228],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838555,0.00005620765,0.00029398774,0.00046788214,0.00041006104,0.00038630306],"domain_scores_gemma":[0.9991457,0.00006676105,0.00015020308,0.00038913765,0.00006970774,0.00017852189],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023060845,0.00019988017,0.00033827533,0.000112829024,0.00040452732,0.000041285566,0.00013104267,0.000025973948,0.0022356594],"category_scores_gemma":[0.000068560694,0.0002023728,0.00014652079,0.00051570334,0.000054635417,0.00009031432,0.000081015336,0.00027450226,0.000014013355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005064112,0.0014252103,0.72627825,0.0012880194,0.00422923,0.004752349,0.014062245,0.026779408,0.023679435,0.008029531,0.084502354,0.099909864],"study_design_scores_gemma":[0.07383522,0.0050939247,0.22346462,0.0025402992,0.005797657,0.0047584786,0.016930068,0.019035975,0.026697671,0.0022482262,0.6154368,0.004161079],"about_ca_topic_score_codex":0.0019937977,"about_ca_topic_score_gemma":0.00011068412,"teacher_disagreement_score":0.5309344,"about_ca_system_score_codex":0.0042000995,"about_ca_system_score_gemma":0.0012336607,"threshold_uncertainty_score":0.9996226},"labels":[],"label_agreement":null},{"id":"W4312210137","doi":"10.1002/cncr.34582","title":"CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; University of British Columbia; BC Cancer Agency; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; Instituto de Salud Carlos III; Medical Research and Materiel Command; Ministerio de Economía y Competitividad; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Cancer Council Tasmania; National Institutes of Health; Cancer Council Victoria; Cancer Australia; Cancer Council NSW; National Health and Medical Research Council; Cancer Research UK; Cancer Council South Australia; Cancer Research Society; Peter MacCallum Foundation; Medical Research Council; European Regional Development Fund; Alberta Precision Laboratories; National Institute for Health and Care Research; National Cancer Institute; Ovarian Cancer Australia","keywords":"Medicine; Ovarian carcinoma; Serous fluid; Serous carcinoma; Ovary; Ovarian tissue; Oncology; Ovarian cancer; Ovarian tissue cryopreservation; Internal medicine; Gynecology; Cancer; Fertility; Population","score_opus":0.01579486111370843,"score_gpt":0.2752748940586683,"score_spread":0.25948003294495986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312210137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997191,0.00038813078,0.000017861683,0.00046463354,0.00022926013,0.0010362982,0.0005116205,0.000029803574,0.00013140557],"genre_scores_gemma":[0.998676,0.000010577306,0.00016006378,0.00019560318,0.00009855156,0.00048708255,0.0001729406,0.000038443017,0.00016072129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812925,0.00015595095,0.00032872628,0.00057278725,0.0005348412,0.00027846138],"domain_scores_gemma":[0.998843,0.000042606523,0.00019463374,0.00054837845,0.00014798915,0.00022336436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001614605,0.00023645224,0.0007077344,0.0002156125,0.000178996,0.000021161155,0.00010869402,0.00002883506,0.0013068995],"category_scores_gemma":[0.000007746218,0.00019242919,0.00006475337,0.00078157685,0.00008012815,0.000076112156,0.00008803299,0.00016618302,0.0000012116726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058736425,0.0027193837,0.9916009,0.000038573395,0.0018680049,0.00017935861,0.001092157,0.00021261802,0.000021336871,0.00011695624,0.00010159663,0.0014617562],"study_design_scores_gemma":[0.008725339,0.0030852803,0.98212546,0.000012812627,0.0038009859,0.000004841367,0.0010029245,0.000051169834,0.00018425782,0.000009573791,0.00079863874,0.00019871334],"about_ca_topic_score_codex":0.008413122,"about_ca_topic_score_gemma":0.0021608234,"teacher_disagreement_score":0.0094754305,"about_ca_system_score_codex":0.0003008347,"about_ca_system_score_gemma":0.00024223585,"threshold_uncertainty_score":0.999606},"labels":[],"label_agreement":null},{"id":"W4312462526","doi":"10.1136/ijgc-2022-esgo.538","title":"2022-RA-657-ESGO ENGOT-ov65/KEYNOTE-B96: phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bevacizumab; Pembrolizumab; Clinical endpoint; Ovarian cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Placebo; Oncology; Progression-free survival; Paclitaxel; Phases of clinical research; Cancer; Surgery; Clinical trial; Chemotherapy; Pathology; Immunotherapy","score_opus":0.07586500025897046,"score_gpt":0.39868658035641974,"score_spread":0.32282158009744927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312462526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814531,0.0029444755,0.0005273296,0.006117123,0.0036237722,0.0038737087,0.0009807044,0.000020384334,0.00045936505],"genre_scores_gemma":[0.9933491,0.0006437053,0.0008113366,0.00029493342,0.0009614417,0.0035501083,0.00009432361,0.000040140847,0.0002549221],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954395,0.00028331627,0.0013940441,0.00051271793,0.0019826314,0.0003877814],"domain_scores_gemma":[0.995003,0.0017225697,0.0014893094,0.00024084985,0.001271002,0.00027328383],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010887627,0.00038680754,0.0013520656,0.0003667439,0.00023018717,0.000059436647,0.0004977332,0.00010759677,0.0068084016],"category_scores_gemma":[0.0003286525,0.00026739112,0.00048288394,0.00026770897,0.00016477602,0.00017276325,0.00017158865,0.0006479648,0.0000018167257],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9605726,0.006712001,0.0011845361,0.000047962985,0.006014692,0.00045339594,0.0007703722,0.010368254,0.00010779998,0.001379264,0.0018687999,0.0105203185],"study_design_scores_gemma":[0.9637077,0.020120911,0.003473811,0.00020366334,0.0019716995,0.00012430218,0.0011752407,0.001104498,0.00018009718,0.00018739422,0.0074326615,0.0003180225],"about_ca_topic_score_codex":0.0003737828,"about_ca_topic_score_gemma":0.00062534853,"teacher_disagreement_score":0.0134089105,"about_ca_system_score_codex":0.0033452068,"about_ca_system_score_gemma":0.0015801688,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W4312533640","doi":"10.1136/ijgc-2022-esgo.585","title":"2022-RA-893-ESGO Is ethnicity a risk factor for differential outcomes in mucinous ovarian cancer? experience from a UK gynaecological oncology centre","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Ulm; Leids Universitair Medisch Centrum; Rijksuniversiteit Groningen; Barts Health NHS Trust; Universitätsklinikum Heidelberg; Universiteit Leiden; McGill University; Jewish General Hospital; University of Ottawa; Université Laval","keywords":"Ethnic group; Ovarian cancer; Medicine; Stage (stratigraphy); Population; Cancer; Gynecology; Internal medicine; Oncology; Biology","score_opus":0.04532582613489729,"score_gpt":0.37525337181455215,"score_spread":0.3299275456796549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312533640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97222316,0.0009646285,0.00019159858,0.018272236,0.0046838066,0.00063095795,0.0028897633,0.000016097198,0.00012774924],"genre_scores_gemma":[0.99238396,0.0014607895,0.000806058,0.0038463657,0.00062435825,0.0005965461,0.000024995834,0.000018864304,0.000238062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707144,0.00024163359,0.00091075286,0.0004918673,0.0008675032,0.00041679776],"domain_scores_gemma":[0.9970595,0.0013122295,0.00080171996,0.00016881691,0.00040992038,0.00024781094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023254698,0.0002813567,0.00091567467,0.00019743263,0.00015288636,0.00003855095,0.0005410012,0.0001967107,0.07895712],"category_scores_gemma":[0.0005719516,0.00019930076,0.00048978574,0.00015728043,0.00010685085,0.0000894714,0.0002654422,0.00083358225,0.000004301227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026932412,0.0028637706,0.8868903,0.0000063193747,0.0011150136,0.0009935026,0.00218584,0.00027068157,0.00037876295,0.00011785131,0.0016013669,0.100883335],"study_design_scores_gemma":[0.009947749,0.0020265405,0.9697722,0.000030113331,0.00022535607,0.000036574336,0.0006192214,0.00041827784,0.0004267511,0.0006011993,0.015686931,0.00020903746],"about_ca_topic_score_codex":0.0019004513,"about_ca_topic_score_gemma":0.0018959468,"teacher_disagreement_score":0.100674294,"about_ca_system_score_codex":0.004182177,"about_ca_system_score_gemma":0.0007095324,"threshold_uncertainty_score":0.9996406},"labels":[],"label_agreement":null},{"id":"W4312654940","doi":"10.1136/ijgc-2022-esgo.546","title":"2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Internal medicine; Oncology; Chemotherapy; Tolerability; Fallopian tube; Carboplatin; Cancer; Bevacizumab; Gastroenterology; Immunotherapy; Cisplatin; Gynecology; Adverse effect","score_opus":0.02393015304150537,"score_gpt":0.32948489967474714,"score_spread":0.3055547466332418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312654940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403745,0.00035430098,0.000016233766,0.0019485801,0.0018116147,0.0010040455,0.00062293635,0.000012135367,0.00019267494],"genre_scores_gemma":[0.9973714,0.00031831127,0.0002902162,0.00090616464,0.00048163504,0.00036450234,0.000057065747,0.000038687915,0.00017202483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962633,0.00018564037,0.0010703232,0.0004406773,0.0016778595,0.00036216463],"domain_scores_gemma":[0.9978407,0.00030260443,0.0008215219,0.00022968653,0.0006029016,0.00020258641],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002889009,0.00032968944,0.0008343617,0.00026283562,0.00010829141,0.0000402744,0.0004561094,0.000093174145,0.008382718],"category_scores_gemma":[0.00011205842,0.00022568888,0.00016924221,0.00027493175,0.0001006893,0.0001719391,0.00016070301,0.00064000185,0.0000016473157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28044236,0.02379455,0.6477968,0.000063971245,0.0033421495,0.002135772,0.001960216,0.0044251163,0.00072337623,0.000050413044,0.0011797716,0.034085512],"study_design_scores_gemma":[0.15458627,0.017962204,0.8194781,0.00016501153,0.00032502177,0.00002493089,0.0006330714,0.0002570909,0.0002600109,0.00000782883,0.006043255,0.0002571972],"about_ca_topic_score_codex":0.0010188055,"about_ca_topic_score_gemma":0.0017555427,"teacher_disagreement_score":0.1716813,"about_ca_system_score_codex":0.003715269,"about_ca_system_score_gemma":0.0011208236,"threshold_uncertainty_score":0.9925237},"labels":[],"label_agreement":null},{"id":"W4312678234","doi":"10.22514/ejgo.2022.064","title":"Low-grade serous carcinoma with solid growth pattern: an unusual architecture and potential pitfall","year":2022,"lang":"en","type":"article","venue":"European Journal of Gynaecological Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.016254988535325036,"score_gpt":0.26192881256737377,"score_spread":0.24567382403204874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312678234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893032,0.00024156467,0.0006019002,0.0070587755,0.0004683842,0.0002533117,0.000015660573,0.000022446162,0.0020347661],"genre_scores_gemma":[0.9948479,0.00006512442,0.0012569046,0.003221147,0.00049288536,0.000010229751,0.0000120090635,0.000036753256,0.000057052373],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972578,0.0012065765,0.0004994206,0.00032569165,0.00035815535,0.00035231115],"domain_scores_gemma":[0.99873143,0.00014267572,0.00040732126,0.00016389618,0.00012733077,0.00042733504],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000669711,0.00022576765,0.0006301917,0.00015224941,0.0002151216,0.000025649117,0.00021688556,0.000050737617,0.0009390338],"category_scores_gemma":[0.00004663063,0.00014511975,0.00012984556,0.00013447461,0.00018410276,0.0000580304,0.00019049672,0.00087966264,0.000006644189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004852263,0.010977986,0.27870506,0.000093815936,0.0010198186,0.27085176,0.0021929953,0.0015016809,0.0012818966,0.0002027994,0.002442343,0.4258776],"study_design_scores_gemma":[0.009214846,0.07572353,0.8910301,0.000011826321,0.00037496688,0.017273024,0.00039846133,0.000037342925,0.00014105997,0.00006987832,0.005545965,0.00017901094],"about_ca_topic_score_codex":0.0000072865796,"about_ca_topic_score_gemma":0.000009436034,"teacher_disagreement_score":0.612325,"about_ca_system_score_codex":0.00036792332,"about_ca_system_score_gemma":0.00025563568,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W4312842410","doi":"10.1136/ijgc-2022-esgo.645","title":"2022-RA-1127-ESGO The efficacy of MEK inhibitors in the treatment of low-grade serous ovarian cancers: a systematic review","year":2022,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Trametinib; Randomized controlled trial; Selumetinib; Internal medicine; MEDLINE; Oncology; Meta-analysis; Cancer; Kinase; MAPK/ERK pathway; KRAS","score_opus":0.07253093457225157,"score_gpt":0.3944759572621893,"score_spread":0.32194502268993774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312842410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036460534,0.99161375,0.0000017976203,0.0031092695,0.0013941714,0.0031177318,0.00020174115,0.0000042660618,0.00019265516],"genre_scores_gemma":[0.0035447408,0.99365723,0.000030906755,0.00079400145,0.0005191697,0.0013213434,0.0000349304,0.000027980195,0.00006972141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945871,0.0008836488,0.0025486525,0.00030242043,0.0014361918,0.00024196],"domain_scores_gemma":[0.99257463,0.0033641248,0.0031895458,0.00045075134,0.0003275505,0.0000934029],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011754634,0.00043007144,0.003409294,0.0002568626,0.000046423622,0.000025283869,0.0009394366,0.00015245301,0.001964907],"category_scores_gemma":[0.0007173805,0.00018117859,0.0016373568,0.0005510772,0.00013838329,0.0000555153,0.000072410985,0.00055326417,0.0000031911015],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004981332,0.0095474785,0.00067989994,0.3725769,0.015531224,0.0029585408,0.0014320358,0.00012893307,0.0000014010175,0.0005831004,0.005898199,0.5901642],"study_design_scores_gemma":[0.003607177,0.003206462,0.0007855508,0.36854056,0.011824959,0.0008043171,0.00023516415,0.0000042409442,0.000006981461,0.00004712429,0.6106839,0.0002535334],"about_ca_topic_score_codex":0.00033296,"about_ca_topic_score_gemma":0.00017827073,"teacher_disagreement_score":0.60478574,"about_ca_system_score_codex":0.003815005,"about_ca_system_score_gemma":0.0015839463,"threshold_uncertainty_score":0.99894744},"labels":[],"label_agreement":null},{"id":"W4312887979","doi":"10.1136/ijgc-2022-esgo.624","title":"2022-RA-1068-ESGO Canadian practice patterns of primary treatment in advanced (stage III-IV) low grade serous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Dalhousie University; University of Toronto; Centre Hospitalier de l’Université de Montréal; McGill University; Impact; University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Regimen; Internal medicine; Oncology; Chemotherapy; Serous fluid; Ovarian carcinoma; Stage (stratigraphy); Ovarian cancer; Gynecology; Family medicine; Cancer","score_opus":0.023235797728728524,"score_gpt":0.3125554198190113,"score_spread":0.2893196220902828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312887979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97699594,0.0017110412,0.000021377225,0.017022459,0.0015466097,0.0004933279,0.00044656667,0.0000071847385,0.0017554604],"genre_scores_gemma":[0.9937387,0.0013185855,0.0004320082,0.0032906898,0.00028052076,0.00019838457,0.000055786393,0.00002051947,0.00066477514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765193,0.00016725824,0.00074806326,0.00028763153,0.0008242796,0.00032080428],"domain_scores_gemma":[0.9980669,0.00041374576,0.0006347442,0.00018090593,0.0004067597,0.00029691574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034985365,0.00021257656,0.0005779865,0.00038866722,0.00007661388,0.000022095457,0.00031279252,0.000078745004,0.005120445],"category_scores_gemma":[0.00015969899,0.0001686712,0.00023128376,0.00021049427,0.00003957691,0.00018942024,0.000086411485,0.00042272577,0.000002696034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032899843,0.0043568783,0.9134234,0.0000433088,0.0012750407,0.014805734,0.0009769929,0.004661754,0.0007267585,0.00066083035,0.000959639,0.05481966],"study_design_scores_gemma":[0.011443579,0.0033931863,0.9174624,0.00010655617,0.00021799715,0.00056730304,0.0008734316,0.00008191729,0.00074217253,0.0000654085,0.064856894,0.00018913283],"about_ca_topic_score_codex":0.056688357,"about_ca_topic_score_gemma":0.04367622,"teacher_disagreement_score":0.06389725,"about_ca_system_score_codex":0.008271382,"about_ca_system_score_gemma":0.0022313239,"threshold_uncertainty_score":0.995789},"labels":[],"label_agreement":null},{"id":"W4312920160","doi":"10.53350/pjmhs22168878","title":"Efficacy of Doppler Ultrasound in Detection of Ovarian Malignancy","year":2022,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Medicine; Radiology; Malignancy; Ultrasound; Gold standard (test); Laparotomy; Adnexal mass; Histopathology; Surgery; Pathology","score_opus":0.01411552837056233,"score_gpt":0.2607699199850233,"score_spread":0.24665439161446098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312920160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263823,0.00022930346,0.000084995285,0.00032142218,0.00010538667,0.000330678,0.000013093631,0.000011210292,0.0062656594],"genre_scores_gemma":[0.99919623,0.000039632334,0.00035975134,0.0000675332,0.000018536888,0.000036834193,0.000009832889,0.000007639477,0.0002639951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938774,0.000027915834,0.00021585375,0.00012438874,0.00015931742,0.00008476255],"domain_scores_gemma":[0.99961436,0.00010140956,0.00006419533,0.00017207743,0.000020876862,0.000027061607],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010486255,0.000055865195,0.00018263841,0.00009937445,0.00001929082,0.0000012280548,0.00003079259,0.000018052358,0.002189988],"category_scores_gemma":[0.000026125581,0.00004786923,0.00005959436,0.00025162144,0.000016097645,0.00001620171,0.000019498597,0.000061624974,0.0000025773722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020368013,0.007989515,0.76048005,0.00027017234,0.0004899038,0.00012394699,0.0019322627,0.00052185345,0.15266624,0.00853066,0.0012260522,0.06373257],"study_design_scores_gemma":[0.0056474446,0.0008309711,0.8756496,0.00004081307,0.00008031208,0.000054201035,0.00023840296,0.000022167762,0.11484997,0.0001206282,0.0024048614,0.000060647228],"about_ca_topic_score_codex":0.00081831927,"about_ca_topic_score_gemma":0.00007462003,"teacher_disagreement_score":0.115169555,"about_ca_system_score_codex":0.000102287,"about_ca_system_score_gemma":0.000050685823,"threshold_uncertainty_score":0.99872214},"labels":[],"label_agreement":null},{"id":"W4312995735","doi":"10.26443/mjm.v20i2.340","title":"Approach to Gynecological Adnexal Masses","year":2022,"lang":"en","type":"article","venue":"McGill Journal of Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Malignancy; Medical diagnosis; Differential diagnosis; Adnexal mass; Gynecology; Radiology; Gynecological Examination; Physical examination; Abscess; Clinical history; Medical history; General surgery; Pathology; Surgery","score_opus":0.06025174985353477,"score_gpt":0.3132175678922322,"score_spread":0.25296581803869744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312995735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43475363,0.006096306,0.0009166855,0.36054146,0.004690987,0.0017222668,0.000097799086,0.00009201364,0.19108887],"genre_scores_gemma":[0.97800034,0.00013893169,0.0033370557,0.017264707,0.00064213754,0.000036615485,0.0000068918193,0.00001674693,0.00055658846],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833924,0.000086179214,0.00046210777,0.00016630882,0.00073973596,0.00020642886],"domain_scores_gemma":[0.99900687,0.00013469349,0.00019634994,0.00017110951,0.00013254293,0.00035842956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068223255,0.00012848312,0.00053024053,0.00021763732,0.00016735558,0.0000029810406,0.00014522957,0.000030652296,0.0022162036],"category_scores_gemma":[0.0002477946,0.0000801033,0.00011690997,0.00030758753,0.000045565463,0.000031890846,0.000081588005,0.00035965774,0.000009709141],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027548948,0.006405769,0.032575186,0.00014703923,0.0012234419,0.0049758283,0.00089102535,0.0010603414,0.0028087867,0.00786851,0.8383965,0.10089268],"study_design_scores_gemma":[0.007786467,0.01103545,0.04612888,0.0000915173,0.00043644253,0.004014892,0.000996206,0.000026294301,0.00021506808,0.00020914835,0.9289499,0.000109731984],"about_ca_topic_score_codex":0.000014105791,"about_ca_topic_score_gemma":5.644533e-7,"teacher_disagreement_score":0.5432467,"about_ca_system_score_codex":0.00037144436,"about_ca_system_score_gemma":0.000076919,"threshold_uncertainty_score":0.9986959},"labels":[],"label_agreement":null},{"id":"W4313022548","doi":"10.1136/ijgc-2022-esgo.586","title":"2022-RA-894-ESGO Endometrioid ovarian carcinoma – real world evidence from a large transatlantic team initiative: First results of the LEOPARD study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Ontario Institute for Cancer Research; Jewish General Hospital; University of Ottawa; Université Laval","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian carcinoma; Cohort; Lymph node; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.05574767353281292,"score_gpt":0.3420120527129563,"score_spread":0.2862643791801434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313022548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795374,0.0014667718,0.000025548125,0.01433981,0.0021033697,0.0006079182,0.0006950782,0.0000091401635,0.0012149386],"genre_scores_gemma":[0.9972955,0.0008390577,0.00011141894,0.0007737767,0.0005781124,0.0001371435,0.000012601148,0.000013886372,0.00023852629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966816,0.0003416485,0.0009449401,0.00031331182,0.0014861489,0.00023235523],"domain_scores_gemma":[0.9963931,0.0018866351,0.00083845475,0.000251275,0.0005031211,0.0001274525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008849151,0.00018885564,0.0005602322,0.00028024346,0.00016843405,0.000030631385,0.0006651569,0.00004550038,0.004227513],"category_scores_gemma":[0.0008679853,0.000118554104,0.00035618793,0.00055285665,0.00007812217,0.00013202283,0.00022764973,0.00062012346,0.0000031808754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004335602,0.0035217393,0.97995806,0.000009888946,0.0011579054,0.00084235996,0.0015891225,0.00030765895,0.00017475786,0.00007714218,0.005635437,0.0023903418],"study_design_scores_gemma":[0.010523499,0.0025314225,0.97229147,0.00019174787,0.00042750695,0.000052198873,0.00068080786,0.000063214175,0.0005488042,0.00010056515,0.012477895,0.00011087378],"about_ca_topic_score_codex":0.0020662386,"about_ca_topic_score_gemma":0.003764277,"teacher_disagreement_score":0.017758051,"about_ca_system_score_codex":0.0013289854,"about_ca_system_score_gemma":0.0006384065,"threshold_uncertainty_score":0.99668276},"labels":[],"label_agreement":null},{"id":"W4313038059","doi":"10.1136/ijgc-2022-esgo.539","title":"2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Interquartile range; Adverse effect; Ovarian cancer; Gastroenterology; Population; Phases of clinical research; Progression-free survival; Cancer; Oncology; Clinical trial; Surgery; Chemotherapy","score_opus":0.09066084088177515,"score_gpt":0.3777070812159118,"score_spread":0.2870462403341366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313038059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915622,0.0009970298,0.00026907932,0.0019156557,0.0010304801,0.0008922881,0.003293733,0.000012636639,0.000026920166],"genre_scores_gemma":[0.99567443,0.00185637,0.0006555634,0.00031375367,0.00044651967,0.00021023762,0.00075775455,0.00003133254,0.00005404562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967507,0.00034993616,0.0013331416,0.00045701134,0.00088498736,0.00022418944],"domain_scores_gemma":[0.99610764,0.0006843459,0.0018720167,0.00015373505,0.0009425236,0.00023972655],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059687934,0.00031559923,0.0011534226,0.00018146644,0.00010386251,0.000045544148,0.00016234026,0.00009769414,0.0039428123],"category_scores_gemma":[0.00016228341,0.00019212611,0.00020866755,0.00018665433,0.00011119687,0.0001674326,0.000070062044,0.00029912018,8.466661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030081145,0.010255758,0.4860829,0.000007682639,0.0055287024,0.00026997647,0.00021873474,0.000044922737,0.0038477844,0.000028278586,0.000060545884,0.46357355],"study_design_scores_gemma":[0.04115526,0.03405109,0.9181394,0.00039925735,0.0017678554,0.000024964771,0.000060347455,0.00018751263,0.0024964698,0.000038723818,0.0014601131,0.00021901038],"about_ca_topic_score_codex":0.00031468534,"about_ca_topic_score_gemma":0.0003263977,"teacher_disagreement_score":0.46335456,"about_ca_system_score_codex":0.0017081592,"about_ca_system_score_gemma":0.0003621472,"threshold_uncertainty_score":0.99696773},"labels":[],"label_agreement":null},{"id":"W4313312361","doi":"10.1097/pas.0000000000002010","title":"Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs","year":2022,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; University of British Columbia; University Health Network","funders":"","keywords":"Biology; Pathology; Stromal cell; Neoplasm; Context (archaeology); Cancer research; Genetics; Medicine","score_opus":0.015651976624205047,"score_gpt":0.24613803857086577,"score_spread":0.23048606194666071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313312361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932968,0.00057552947,0.000020042567,0.0052725235,0.00016405026,0.00047483153,0.00007392148,0.00003071977,0.00009155993],"genre_scores_gemma":[0.99803656,0.00041004622,0.00005420215,0.0011324453,0.000078236975,0.000043298744,0.000023587372,0.000057467663,0.00016417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966777,0.0009417252,0.0006872044,0.0005350754,0.0006059936,0.0005523099],"domain_scores_gemma":[0.9974129,0.00040442328,0.0010268294,0.000382521,0.00024597553,0.00052730646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042854308,0.00040785852,0.0014038831,0.00023895843,0.00032134927,0.00005590853,0.00021968354,0.000045283326,0.0002214498],"category_scores_gemma":[0.00006186023,0.0002386299,0.0001546545,0.0005748458,0.00038486073,0.000052669504,0.00028838,0.0007130866,0.000004761146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07718932,0.013935533,0.7379569,0.00019702985,0.004915577,0.10658328,0.0064056325,0.0012768365,0.033395875,0.00027214384,0.0018364444,0.016035443],"study_design_scores_gemma":[0.007226452,0.008971034,0.97216624,0.00017533597,0.0008620435,0.008003999,0.0009457208,0.0004153157,0.00068272365,0.00008670511,0.00014455947,0.0003198516],"about_ca_topic_score_codex":0.00008342704,"about_ca_topic_score_gemma":0.000021089152,"teacher_disagreement_score":0.23420937,"about_ca_system_score_codex":0.00021004745,"about_ca_system_score_gemma":0.00013501888,"threshold_uncertainty_score":0.97310454},"labels":[],"label_agreement":null},{"id":"W4313431903","doi":"10.4049/jimmunol.208.supp.179.04","title":"Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia","year":2022,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Occupational Cancer Research Centre","funders":"","keywords":"Ovarian cancer; Immune system; Ovarian carcinoma; FOXP3; Oncology; Serous fluid; Internal medicine; Medicine; Serous carcinoma; Ovarian tumor; Tumor microenvironment; Cancer research; Cancer; Immunology","score_opus":0.0213970650060529,"score_gpt":0.29950670360273185,"score_spread":0.2781096385966789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313431903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97186667,0.015823038,0.0014440985,0.0090270275,0.0007601308,0.0006700369,0.00033866457,0.00001995535,0.000050389794],"genre_scores_gemma":[0.99558616,0.00032646809,0.003253821,0.00031215601,0.00016944135,0.00009057724,0.00009958207,0.000042100848,0.00011970003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99571806,0.0011256316,0.0016389126,0.00038305973,0.0006250743,0.0005092517],"domain_scores_gemma":[0.99555016,0.0008968681,0.0018800022,0.0012224731,0.00033464536,0.00011586465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016432602,0.00040247923,0.0019358731,0.00068757695,0.00065212307,0.000026583766,0.0008676947,0.00010829506,0.0016099099],"category_scores_gemma":[0.00011388315,0.00023056689,0.0010792682,0.002053182,0.0003620268,0.00010333208,0.00048101085,0.0010420245,0.0000048451275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026083824,0.0016232565,0.89866734,0.000017271092,0.059427053,0.00059639994,0.00398006,0.005549381,0.025983984,0.0002848187,0.000043501994,0.0012185656],"study_design_scores_gemma":[0.0061587365,0.0009838773,0.9474379,0.000027209895,0.03571146,0.00027702187,0.0040203603,0.0017041283,0.003253885,0.00006986653,0.00015038413,0.00020518845],"about_ca_topic_score_codex":0.017458718,"about_ca_topic_score_gemma":0.0010292305,"teacher_disagreement_score":0.048770554,"about_ca_system_score_codex":0.0005067395,"about_ca_system_score_gemma":0.00052717485,"threshold_uncertainty_score":0.99930274},"labels":[],"label_agreement":null},{"id":"W4313449393","doi":"10.12775/jehs.2023.13.02.030","title":"Ovarian sclerosing stromal tumor - benign neoplasm of the young. A case study with literature review","year":2023,"lang":"en","type":"article","venue":"Journal of Education Health and Sport","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Louisiana-Pacific (Canada)","funders":"","keywords":"Medicine; Immunophenotyping; Stromal cell; Ovary; Ovarian tumor; Pathology; Neoplasm; Abdominal pain; Pelvic pain; Ovarian cancer; Radiology; Internal medicine; Cancer","score_opus":0.023068983425111607,"score_gpt":0.33990481902111996,"score_spread":0.31683583559600836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313449393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686181,0.019706493,7.057669e-7,0.0106262285,0.00037566415,0.000605347,0.0000043756136,0.000003478943,0.000059585687],"genre_scores_gemma":[0.9892585,0.008405692,0.00024639693,0.0017341098,0.00020871744,0.000014290233,0.0000049668274,0.000008076149,0.00011923144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909025,0.000032256492,0.0004429826,0.000095658994,0.00022721665,0.00011161964],"domain_scores_gemma":[0.99886656,0.000017623708,0.00049833086,0.00015989746,0.00023107215,0.00022651748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004693295,0.00008002278,0.0003279004,0.00009370025,0.00009851805,0.000015343885,0.000032470627,0.00001538011,0.000011503317],"category_scores_gemma":[0.00002779444,0.000043038333,0.000054879503,0.00042647397,0.000017176912,0.000064953354,0.0000073757637,0.00016112633,3.881455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014064893,0.0010607882,0.9739866,0.001565012,0.00008739995,0.0012123936,0.004099406,0.0000012578827,0.0000018209034,0.000055983008,0.0063014026,0.011487245],"study_design_scores_gemma":[0.0014687385,0.0024244376,0.94220626,0.012842683,0.0002497041,0.030363128,0.0073211202,0.0000024559833,0.0000043004543,0.000008046238,0.003057794,0.00005132715],"about_ca_topic_score_codex":0.00019459694,"about_ca_topic_score_gemma":0.00005992671,"teacher_disagreement_score":0.031780377,"about_ca_system_score_codex":0.000079118945,"about_ca_system_score_gemma":0.002363207,"threshold_uncertainty_score":0.4192228},"labels":[],"label_agreement":null},{"id":"W4313816417","doi":"10.1158/1538-7755.disp22-a083","title":"Abstract A083: Higher incidence of rare ovarian tumors in West Africa","year":2023,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Ovarian cancer; Retrospective cohort study; Demographics; Cohort; Demography; Cancer; Gynecology; Internal medicine","score_opus":0.08128701981932286,"score_gpt":0.37598111807753404,"score_spread":0.2946940982582112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313816417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400712,0.016905496,0.00010435431,0.03454184,0.0019239524,0.001701947,0.00008609925,0.0002275638,0.0044375337],"genre_scores_gemma":[0.9955042,0.0018166044,0.00072812254,0.00033256845,0.00015893897,0.00044894373,0.00013576196,0.00002678332,0.0008480513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977057,0.00027290243,0.00085872423,0.00054075103,0.00014413206,0.00047779796],"domain_scores_gemma":[0.9983994,0.00056222605,0.00040757537,0.00039371854,0.00009368305,0.00014342456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015161391,0.00021996991,0.00072931725,0.0003346106,0.00004633375,0.00000340613,0.00012685733,0.00022941419,0.0012351241],"category_scores_gemma":[0.00038033864,0.0001937349,0.000233594,0.0007196551,0.0001700451,0.0001076707,0.00005903798,0.00018199929,0.00009997131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004381758,0.00025166335,0.94447243,0.00025629372,0.00043796125,0.00013654534,0.00013851852,0.00007302919,0.001008645,0.0007187412,0.025563475,0.0265045],"study_design_scores_gemma":[0.0017821558,0.0001935963,0.98828316,0.0012262753,0.00013648598,0.0000071072936,0.00006718217,0.00008091119,0.00027595318,0.0037962294,0.00400286,0.00014806556],"about_ca_topic_score_codex":0.0012910565,"about_ca_topic_score_gemma":0.00044086616,"teacher_disagreement_score":0.055433016,"about_ca_system_score_codex":0.00038237826,"about_ca_system_score_gemma":0.0002622407,"threshold_uncertainty_score":0.9996779},"labels":[],"label_agreement":null},{"id":"W4315853286","doi":"10.3390/curroncol30010083","title":"Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Positron emission tomography; Magnetic resonance imaging; Radiology; Medical physics","score_opus":0.18100555359074535,"score_gpt":0.47459355183730295,"score_spread":0.29358799824655757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315853286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011856614,0.9882576,3.2873015e-7,0.0027693876,0.0049499646,0.003244226,0.0002713571,0.00003560711,0.00045967873],"genre_scores_gemma":[0.000004544739,0.99706453,0.000017529184,0.0004307153,0.00042262266,0.0014166825,0.0005052304,0.00004785746,0.00009026866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648154,0.0006722134,0.0012773534,0.00072922534,0.00038418776,0.00045548705],"domain_scores_gemma":[0.9974804,0.0006054654,0.000768676,0.0008590603,0.00014578356,0.00014062754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062814663,0.00055768265,0.0034991843,0.0002490714,0.00004246518,0.0000104803585,0.00040779304,0.0002756455,0.00035088125],"category_scores_gemma":[0.00043344262,0.0002899122,0.0011274768,0.0012558919,0.00012886348,0.000021208423,0.00026157958,0.0014220733,0.00033547776],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008758983,0.0013274678,0.00020789678,0.18846555,0.0001152099,0.00013380506,0.000020108777,8.9231214e-8,5.945838e-9,0.00078482257,0.051634055,0.7573022],"study_design_scores_gemma":[0.0005081034,0.00032622518,0.00048960134,0.36626604,0.0010665357,0.00006722558,0.00000161375,3.2311297e-7,1.2339156e-7,0.000036790436,0.6311022,0.00013520398],"about_ca_topic_score_codex":0.0000015203767,"about_ca_topic_score_gemma":0.0000122104475,"teacher_disagreement_score":0.75716704,"about_ca_system_score_codex":0.0012214328,"about_ca_system_score_gemma":0.0013262837,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W4317780970","doi":"10.1093/jnci/djad011","title":"Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto; University of Calgary; Foothills Medical Centre; Canada's Michael Smith Genome Sciences Centre","funders":"Medical Research and Materiel Command; National Cancer Institute; Cancer Council Victoria; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Peter MacCallum Foundation; Ministry of Health, Labour and Welfare; Rutgers Cancer Institute of New Jersey; Radboud Universiteit; Ovarian Cancer Research Fund; Cancer Australia; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; U.S. Department of Defense; State of Connecticut Department of Public Health; Lon V. Smith Foundation; Fred C. and Katherine B. Andersen Foundation; University College London; Ovarian Cancer Australia; Deutsches Krebsforschungszentrum; University of Pittsburgh; Friedrich-Alexander-Universität Erlangen-Nürnberg; Mayo Foundation for Medical Education and Research; Minnesota Ovarian Cancer Alliance; Health Canada; California Breast Cancer Research Program; National Health and Medical Research Council; AstraZeneca; Pfizer; National Science Foundation; Oak Foundation","keywords":"Medicine; Serous fluid; Ovulation; Confidence interval; Odds ratio; Ovarian cancer; Gynecology; Oncology; Obstetrics; Demography; Internal medicine; Cancer; Hormone","score_opus":0.02633153458771026,"score_gpt":0.3258877327330272,"score_spread":0.2995561981453169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317780970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913511,0.0012702218,0.000033623346,0.00523324,0.0010734064,0.00018671896,0.0006465167,0.000010120587,0.00019504699],"genre_scores_gemma":[0.9953077,0.0026224535,0.0004788636,0.00034594836,0.000910153,0.000024778845,0.000010427779,0.000010946663,0.00028876303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982481,0.00005589944,0.0004635955,0.00014701972,0.0009577822,0.00012757989],"domain_scores_gemma":[0.998368,0.000112991656,0.0006231253,0.00010151031,0.00068946934,0.00010488458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053353375,0.000114311035,0.00036773575,0.00044733443,0.0000989879,0.000015402646,0.0001320658,0.00006409766,0.00016424879],"category_scores_gemma":[0.00025339515,0.00007923072,0.0003299592,0.0010155649,0.00012701949,0.00014312287,0.00004960457,0.00021029374,0.0000036062136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005797117,0.00030067796,0.9036659,0.0000673942,0.014862329,0.00004338375,0.00060536555,0.051296335,0.0013857356,0.001591333,0.0067811017,0.018820733],"study_design_scores_gemma":[0.002765928,0.000063870495,0.98068875,0.00015186121,0.0036319501,0.000022189159,0.000013971567,0.0016490576,0.00078774453,0.0003770995,0.009771815,0.00007577327],"about_ca_topic_score_codex":0.0007060264,"about_ca_topic_score_gemma":0.0003449069,"teacher_disagreement_score":0.077022836,"about_ca_system_score_codex":0.00041917147,"about_ca_system_score_gemma":0.0010747735,"threshold_uncertainty_score":0.3230935},"labels":[],"label_agreement":null},{"id":"W4317814864","doi":"10.3389/fonc.2023.1090092","title":"Predictors of residual disease after debulking surgery in advanced stage ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Dana-Farber/Harvard Cancer Center; Centers for Disease Control and Prevention; National Cancer Institute; National Institutes of Health; Rivkin Center for Ovarian Cancer; U.S. Department of Defense","keywords":"Debulking; Ovarian cancer; Medicine; Stage (stratigraphy); Disease; Oncology; Internal medicine; Surgery; Cancer; Biology","score_opus":0.018737248567315568,"score_gpt":0.3120523727473868,"score_spread":0.2933151241800712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317814864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989788,0.0031002827,0.00002219442,0.0037339188,0.0023044029,0.00047335963,0.00010263776,0.00004124335,0.0004339912],"genre_scores_gemma":[0.9956045,0.0016618505,0.0008706746,0.00033133622,0.00015552402,0.00067133666,0.000051069113,0.000026698102,0.0006269831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863416,0.00009815975,0.00040672897,0.00032519342,0.00017303109,0.00036271077],"domain_scores_gemma":[0.99930197,0.00018582902,0.00010384057,0.0002359573,0.000030444005,0.0001419747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029152175,0.00013679273,0.00057095557,0.00054859614,0.000015287802,0.0000031567306,0.000058333335,0.00011572148,0.0001544025],"category_scores_gemma":[0.00014707449,0.0001274465,0.00008144519,0.00058512285,0.00008619467,0.00006173884,0.00004272182,0.0001545364,0.00000456565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017801134,0.0003013536,0.95200247,0.0001278216,0.00008334376,0.001788264,0.00046917488,0.0003389939,0.000013435558,0.000018357725,0.017553,0.025523666],"study_design_scores_gemma":[0.002566802,0.00014661414,0.9702351,0.00026323213,0.00007600396,0.0000010683219,0.00024232607,0.00014695524,0.000108950044,0.000097906304,0.026016004,0.0000990386],"about_ca_topic_score_codex":0.00034737572,"about_ca_topic_score_gemma":0.00071113993,"teacher_disagreement_score":0.025424628,"about_ca_system_score_codex":0.00078837306,"about_ca_system_score_gemma":0.0007727876,"threshold_uncertainty_score":0.51971173},"labels":[],"label_agreement":null},{"id":"W4317830112","doi":"10.1186/s13048-022-01084-z","title":"Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jiangsu Provincial Commission of Health and Family Planning","keywords":"Medicine; Meta-analysis; Cochrane Library; Publication bias; Ovarian cancer; Funnel plot; Odds ratio; Ovulation induction; Gynecology; Incidence (geometry); MEDLINE; Obstetrics; Oncology; Internal medicine; Ovulation; Cancer","score_opus":0.38505145522609757,"score_gpt":0.5199378613101243,"score_spread":0.13488640608402674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317830112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011436588,0.9930024,0.000012736376,0.0036833452,0.00008680114,0.0030366662,0.00009612544,0.000017377557,0.000053109594],"genre_scores_gemma":[0.0001502836,0.9974412,0.00031942013,0.000106347354,0.0002559991,0.00037124736,0.00013330445,0.000074805874,0.0011474106],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99348116,0.0021419006,0.0020591794,0.0005683817,0.0013558316,0.00039353155],"domain_scores_gemma":[0.99581367,0.0004360787,0.0014765714,0.0007301277,0.0010123529,0.0005311745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007873787,0.00044448566,0.008425384,0.0021080028,0.00020150325,0.00021953964,0.00023007963,0.000231514,0.00063607446],"category_scores_gemma":[0.0002756983,0.000265485,0.0014276432,0.003160922,0.000102187725,0.0002912853,0.00010646282,0.0012425269,0.000015849655],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002571255,0.00020312294,0.000024817919,0.665964,0.32055712,0.00037240083,0.00011916953,0.0000014671064,1.9312222e-7,0.00026028516,0.0026513939,0.009820308],"study_design_scores_gemma":[0.0004907018,0.00023672536,0.00018496416,0.057409428,0.9174729,0.00063436304,0.00005340517,0.000012346709,3.5880086e-7,0.00008670201,0.023211759,0.0002063405],"about_ca_topic_score_codex":0.00048077008,"about_ca_topic_score_gemma":0.00010583726,"teacher_disagreement_score":0.6085546,"about_ca_system_score_codex":0.00052310916,"about_ca_system_score_gemma":0.0009409763,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W4318262272","doi":"10.1016/j.ygyno.2023.01.021","title":"Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute; Mayo Foundation for Medical Education and Research; Amgen; Mayo Clinic","keywords":"Medicine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Internal medicine; Adverse effect; Progression-free survival; Phases of clinical research; Gastroenterology; Confidence interval; Oncology; Surgery; Clinical trial; Chemotherapy","score_opus":0.04460680893063991,"score_gpt":0.36164281846651397,"score_spread":0.3170360095358741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318262272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402696,0.000056622077,4.0870174e-7,0.00087442674,0.00027914174,0.003964837,0.00027507122,0.000010092361,0.00051242433],"genre_scores_gemma":[0.99936086,0.00013314112,0.00013218692,0.0000811358,0.000014298253,0.0001802094,0.000037439928,0.000011870628,0.00004883147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981279,0.0003054015,0.0007315077,0.00038343063,0.00021453075,0.00023726035],"domain_scores_gemma":[0.9977626,0.00098553,0.00062395167,0.00033623617,0.000228674,0.00006300726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042938645,0.00017422932,0.00085021823,0.00013366922,0.00007428872,0.000003007065,0.00015455071,0.00011234293,0.0000464793],"category_scores_gemma":[0.00053137017,0.00010427391,0.000027875838,0.00055582926,0.00017533338,0.000038003,0.00032925667,0.00017891274,0.0000010204797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081186235,0.124045126,0.5734696,0.00016253078,0.0012129715,0.00017401921,0.01586481,0.00013773804,0.00029317226,0.000083538995,0.001022141,0.20234813],"study_design_scores_gemma":[0.18413469,0.04946476,0.76413524,0.00020621414,0.00030078046,0.00000112053,0.0010382459,0.00006445695,0.0002544193,0.0000066304365,0.00031934463,0.000074093216],"about_ca_topic_score_codex":0.00082355476,"about_ca_topic_score_gemma":0.003386549,"teacher_disagreement_score":0.20227404,"about_ca_system_score_codex":0.00033242296,"about_ca_system_score_gemma":0.0003565612,"threshold_uncertainty_score":0.42521665},"labels":[],"label_agreement":null},{"id":"W4319216343","doi":"10.1016/j.ygyno.2023.01.020","title":"Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"ImmunoGen","keywords":"Medicine; Bevacizumab; Internal medicine; Ovarian cancer; Gastroenterology; Regimen; Oncology; Nausea; Adverse effect; Cancer; Surgery; Chemotherapy","score_opus":0.010506058466405052,"score_gpt":0.28449790342106374,"score_spread":0.27399184495465867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319216343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941256,0.0002550337,0.000008758574,0.0030793983,0.0001813291,0.0016730397,0.00009245417,0.00005932657,0.0005250697],"genre_scores_gemma":[0.99741036,0.00050386565,0.0012315284,0.00019057773,0.00002248673,0.0001445178,0.00038392795,0.00003403615,0.00007868059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977777,0.00022184242,0.000662021,0.0005750849,0.00026007363,0.0005032875],"domain_scores_gemma":[0.9983889,0.00071237684,0.00038609715,0.00021947932,0.00017797148,0.000115205024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005504336,0.00028864888,0.0009531622,0.0003471849,0.0000819299,0.000011996697,0.00008647607,0.00019979116,0.0001799864],"category_scores_gemma":[0.00020104501,0.00020859073,0.000037554004,0.000841703,0.00017323116,0.000102124206,0.00006554179,0.00028619848,0.0000095587175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011310193,0.0027719382,0.9580286,0.0001548031,0.00024858268,0.0003108954,0.0011561142,0.00021537961,0.00041750263,0.00039690713,0.00025458206,0.024734464],"study_design_scores_gemma":[0.050458256,0.007872648,0.9389738,0.00034007785,0.00014121854,0.000003295699,0.00021934955,0.000244099,0.00016226686,0.00006819199,0.0012996327,0.00021715787],"about_ca_topic_score_codex":0.0009656074,"about_ca_topic_score_gemma":0.0036598365,"teacher_disagreement_score":0.039148062,"about_ca_system_score_codex":0.0008465936,"about_ca_system_score_gemma":0.0004624431,"threshold_uncertainty_score":0.8506083},"labels":[],"label_agreement":null},{"id":"W4321378595","doi":"10.1016/j.omto.2023.02.006","title":"Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies","year":2023,"lang":"en","type":"review","venue":"Molecular Therapy — Oncolytics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; University of Science and Technology of China; American Cancer Society","keywords":"Receptor tyrosine kinase; Cancer research; Medicine; Ovarian cancer; Targeted therapy; Cancer; Metastasis; Context (archaeology); Cabozantinib; Biology; Bioinformatics; Internal medicine; Receptor","score_opus":0.0893979594266115,"score_gpt":0.41769948961889636,"score_spread":0.32830153019228486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321378595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008699361,0.983776,0.000083923216,0.00034322633,0.0017698042,0.0051114587,0.00018070008,0.000028171851,0.0000073708998],"genre_scores_gemma":[0.0046384665,0.9915804,0.00078447186,0.00005799398,0.0010698322,0.0010654784,0.0006423938,0.00014017076,0.000020791773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967863,0.0004529915,0.0013711636,0.0005704091,0.0005461171,0.00027300234],"domain_scores_gemma":[0.99810654,0.00029603828,0.00074638985,0.00034724755,0.00040389106,0.000099908524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018420235,0.00041053744,0.0018523637,0.00020533685,0.000064913576,0.000037620244,0.000108856635,0.00044846747,0.000041737854],"category_scores_gemma":[0.00018525247,0.00034566954,0.00047920406,0.00036307878,0.00010357652,0.000036794896,0.000043256154,0.0002355851,0.0000029398227],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033312515,0.0007369033,0.0004122607,0.0033966813,0.0016244868,0.00001598092,0.00012224134,0.00008115721,0.00023019375,0.00033939574,0.0006465151,0.9920611],"study_design_scores_gemma":[0.044453662,0.003914179,0.0021767225,0.029341744,0.0113844825,0.000016700375,0.00010790746,0.0020507788,0.0007237604,0.002192496,0.9022806,0.0013569175],"about_ca_topic_score_codex":0.000084392814,"about_ca_topic_score_gemma":0.000009463141,"teacher_disagreement_score":0.9907041,"about_ca_system_score_codex":0.0006296787,"about_ca_system_score_gemma":0.0014078565,"threshold_uncertainty_score":0.9998995},"labels":[],"label_agreement":null},{"id":"W4321485201","doi":"10.1017/9781108975780.085","title":"Adnexal Mass in Pregnancy","year":2023,"lang":"en","type":"book-chapter","venue":"Cambridge University Press eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Obstetrics; Gestation; Pregnancy; Gynecology; Adnexal mass; Second trimester","score_opus":0.03723853394360061,"score_gpt":0.2287038323584323,"score_spread":0.1914652984148317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321485201","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009254131,0.00043483044,0.00001662536,0.000100634265,0.0002979885,0.0008236074,0.00027857829,0.00016185515,0.9977933],"genre_scores_gemma":[0.0015924529,0.0010093913,0.00008009626,0.000058715563,0.000120325916,0.000005104707,0.00011568128,0.00008044239,0.9969378],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986441,0.000016912609,0.00019663034,0.000571037,0.00027186685,0.00029945117],"domain_scores_gemma":[0.99900043,0.00005760619,0.00012293804,0.00054627704,0.00007747134,0.00019528758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000044523415,0.00034669155,0.0005636493,0.00029256387,0.000055830817,0.000016184053,0.00016733796,0.00036779672,0.000017403561],"category_scores_gemma":[0.0000065833756,0.0003823604,0.0002460937,0.000014749424,0.000102485,0.000037605478,0.0001420849,0.0004350143,0.00009138801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026845513,0.00006421614,0.0003358496,0.0004373375,0.0005518393,0.013757682,0.000056956585,0.0000022782538,0.000015435084,0.943359,0.03409674,0.007054205],"study_design_scores_gemma":[0.0042959107,0.00025675748,0.0020223996,0.004528634,0.00079606764,0.000027829945,0.000028035945,0.00002214454,0.00020407744,0.000029683582,0.98728883,0.00049960945],"about_ca_topic_score_codex":0.00020584837,"about_ca_topic_score_gemma":0.000011970428,"teacher_disagreement_score":0.9531921,"about_ca_system_score_codex":0.000550565,"about_ca_system_score_gemma":0.00022042045,"threshold_uncertainty_score":0.99986285},"labels":[],"label_agreement":null},{"id":"W4321610537","doi":"10.1148/rg.220079","title":"O-RADS US Risk Stratification and Management System: Case-based Learning Approach for Daily Practice","year":2023,"lang":"en","type":"article","venue":"Radiographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Risk stratification; Referral; Library science; Gynecology; Family medicine; Internal medicine","score_opus":0.023946959290820594,"score_gpt":0.2889809859174235,"score_spread":0.2650340266266029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321610537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70461357,0.013586228,0.23598899,0.008776593,0.0010999382,0.016235266,0.0002639828,0.0025687383,0.016866714],"genre_scores_gemma":[0.9645877,0.0022711647,0.031996455,0.000086275846,0.00009389189,0.0006821054,0.00017622484,0.000030297715,0.000075914155],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989763,0.00008026984,0.00020108803,0.00035173586,0.00019294428,0.00019764357],"domain_scores_gemma":[0.99921954,0.00018707341,0.00014391993,0.00026343865,0.00008194962,0.0001041011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006059935,0.0001342776,0.00019385676,0.0003097056,0.00025783782,0.000059111866,0.000032596883,0.00007237679,0.0000010501533],"category_scores_gemma":[0.000049010752,0.00011973868,0.00010060012,0.00072667736,0.000040698058,0.00006694868,0.000010047937,0.00013238449,0.0000028113109],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015620502,0.002557268,0.7370245,0.020176029,0.0067673065,0.0063197976,0.001769645,0.017222974,0.00010178216,0.073250495,0.013128289,0.12011985],"study_design_scores_gemma":[0.022782387,0.0034810987,0.32296693,0.001148121,0.014562103,0.0031132554,0.010683985,0.44795182,0.00027856653,0.00013314355,0.17180319,0.0010953911],"about_ca_topic_score_codex":0.00013137322,"about_ca_topic_score_gemma":0.000008318035,"teacher_disagreement_score":0.43072885,"about_ca_system_score_codex":0.0000696406,"about_ca_system_score_gemma":0.000029471457,"threshold_uncertainty_score":0.48828018},"labels":[],"label_agreement":null},{"id":"W4322012021","doi":"10.1016/j.esmoop.2023.100830","title":"50P Can we learn from failures? A systematic review and metanalysis of phase III trials in platinum resistant ovarian cancer","year":2023,"lang":"en","type":"review","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Ovarian cancer; Internal medicine; Oncology; Population; Biomarker; Chemotherapy; Clinical trial; Meta-analysis; Progression-free survival; Cancer","score_opus":0.18683416395359573,"score_gpt":0.45734650762827594,"score_spread":0.27051234367468024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322012021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032250493,0.9823906,0.0000019173992,0.0029664955,0.00009428487,0.01258039,0.0016678497,0.00001854213,0.0002766923],"genre_scores_gemma":[0.000044978926,0.9911455,0.00021759972,0.0001742174,0.00009392695,0.005836802,0.0005957592,0.00009099921,0.0018002501],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929269,0.0018306907,0.0036585208,0.00083719165,0.00044150752,0.00030521685],"domain_scores_gemma":[0.99430937,0.001691057,0.0025636265,0.0011314165,0.000094728035,0.00020983117],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042129275,0.00060459954,0.017417,0.00039106872,0.000055511755,0.00010475571,0.0004673226,0.00024539186,0.0013993509],"category_scores_gemma":[0.0013975417,0.0003808998,0.00084903673,0.0011539472,0.0000471369,0.000073390634,0.00026662785,0.00034601137,0.00002770076],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011405478,0.00029918557,0.000010101714,0.92040044,0.01576568,0.00032781917,0.00019697442,2.1492758e-7,2.2145335e-7,0.00014609763,0.0023495904,0.060389604],"study_design_scores_gemma":[0.0045013446,0.00014873895,0.000011184342,0.71865433,0.113357306,0.0000070149713,0.000057431997,0.000001889594,0.0000012337053,0.000048607224,0.16294287,0.00026804395],"about_ca_topic_score_codex":0.06417259,"about_ca_topic_score_gemma":0.025036426,"teacher_disagreement_score":0.20174612,"about_ca_system_score_codex":0.00050598825,"about_ca_system_score_gemma":0.0011252541,"threshold_uncertainty_score":0.9998643},"labels":[],"label_agreement":null},{"id":"W4322615483","doi":"10.14740/jocmr4853","title":"Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Medicine Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Japan Science and Technology Agency; Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development","keywords":"Medicine; Histopathology; Ovarian carcinoma; Oncology; Ovarian cancer; Pathology; Gynecology; Internal medicine; Cancer","score_opus":0.6092276785698535,"score_gpt":0.6724324154051929,"score_spread":0.06320473683533945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322615483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018430098,0.9752286,0.0044033155,0.012764109,0.002546414,0.004662209,0.00005803527,0.000017737242,0.00013526404],"genre_scores_gemma":[0.00011571128,0.9790993,0.00989433,0.00048834167,0.009426184,0.00051278033,0.00005274344,0.0001766939,0.00023397086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9879764,0.0033118636,0.0057515353,0.00093695935,0.0012128208,0.000810447],"domain_scores_gemma":[0.83787143,0.15623705,0.0019892754,0.0007515756,0.0020059834,0.0011446904],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.050449286,0.0004918738,0.0076117488,0.0009894769,0.00015840428,0.000050611958,0.00052785856,0.0010811398,0.000042924737],"category_scores_gemma":[0.1213142,0.00029361853,0.0023029104,0.0006636076,0.0007377988,0.000079268895,0.0001602808,0.0031384462,0.0000068707654],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088554877,0.0007115941,0.0023217502,0.008827126,0.0013092026,0.001627178,0.000039340677,1.6739514e-7,2.61969e-7,0.0005316941,0.022049282,0.96169686],"study_design_scores_gemma":[0.013252457,0.022309178,0.0035203632,0.02355847,0.004747769,0.00075077236,0.00004796267,0.000029933184,8.489742e-7,0.0021082046,0.929461,0.00021301441],"about_ca_topic_score_codex":0.00004237678,"about_ca_topic_score_gemma":0.0000059847125,"teacher_disagreement_score":0.96148384,"about_ca_system_score_codex":0.00027949805,"about_ca_system_score_gemma":0.0033847631,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W4322721579","doi":"10.1016/j.jogc.2022.12.012","title":"Isolated Fallopian Tube Torsion Associated with Tubal Pregnancy","year":2023,"lang":"en","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Pregnancy; Gynecology; Obstetrics","score_opus":0.009094014456602724,"score_gpt":0.2326969921572904,"score_spread":0.22360297770068768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322721579","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010643049,0.007963809,0.0000040480368,0.00042432046,0.9800948,0.00026717683,0.00026093383,0.000014237885,0.0003276259],"genre_scores_gemma":[0.75138986,0.016763212,0.00033956696,0.00052424555,0.21934992,0.00007006101,0.0014086146,0.00047618893,0.009678357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976045,0.00007098551,0.0006604173,0.00029796295,0.000956597,0.00040952285],"domain_scores_gemma":[0.99237,0.005080183,0.0008717071,0.00019358133,0.00108809,0.00039645485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018762487,0.00033274,0.0010665118,0.0003384492,0.000113430615,0.000037069254,0.0001418627,0.0006450672,0.00020987232],"category_scores_gemma":[0.008250185,0.00023895245,0.00011958419,0.00051489443,0.000052612195,0.00005115888,0.00004877089,0.0010981532,0.0000013229389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000028972072,0.00020484641,0.017651126,0.000113701746,0.0015857595,0.022808943,0.000029308985,0.000007458683,2.4306843e-7,0.0000053727676,0.94364655,0.013917704],"study_design_scores_gemma":[0.013404791,0.007428734,0.1041783,0.0010685427,0.0025429477,0.00006248074,0.00007557792,0.00006377836,0.0000071168165,0.000024821158,0.87065786,0.00048502834],"about_ca_topic_score_codex":0.014369406,"about_ca_topic_score_gemma":0.07446049,"teacher_disagreement_score":0.76074487,"about_ca_system_score_codex":0.0040514623,"about_ca_system_score_gemma":0.008902823,"threshold_uncertainty_score":0.99977183},"labels":[],"label_agreement":null},{"id":"W4322722656","doi":"10.1007/978-3-319-28845-1_5679-1","title":"Tumor-Like Lesions and Endometriosis, Pathology of the Peritoneum","year":2023,"lang":"en","type":"book-chapter","venue":"Encyclopedia of pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Endometriosis; Peritoneum; Pathology; Medicine","score_opus":0.019565164953141725,"score_gpt":0.2575886282099197,"score_spread":0.23802346325677795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322722656","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10162837,0.020339763,0.000012733545,0.005541192,0.0058918297,0.0025809754,0.0013699881,0.00013567813,0.8624995],"genre_scores_gemma":[0.20921546,0.14028445,0.0015860397,0.0013726522,0.0011043147,0.0003302105,0.00020712982,0.00039658046,0.64550316],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.998263,0.00006432592,0.0006217932,0.0005215664,0.00026561928,0.00026367806],"domain_scores_gemma":[0.9980128,0.00055479613,0.00046685827,0.0007385641,0.00012155822,0.000105441744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020787427,0.0003395056,0.0011047088,0.00033684928,0.00005972469,0.000002524174,0.00016850003,0.00039745282,0.00027604445],"category_scores_gemma":[0.00027599253,0.0002394234,0.00031271973,0.00011156331,0.0006118781,0.000017529052,0.00027605306,0.00042318887,0.000037432426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010475222,0.0028477465,0.16771238,0.0053095464,0.0037295693,0.042398892,0.007082324,0.000009548443,0.0066460995,0.46179682,0.06925604,0.2321635],"study_design_scores_gemma":[0.0054386635,0.0033009513,0.31769317,0.0017058025,0.003436623,0.0047569936,0.00019050145,0.000002433483,0.00091320125,0.012200199,0.64953995,0.00082153623],"about_ca_topic_score_codex":0.000029424735,"about_ca_topic_score_gemma":0.000051661307,"teacher_disagreement_score":0.5802839,"about_ca_system_score_codex":0.000051147363,"about_ca_system_score_gemma":0.000248897,"threshold_uncertainty_score":0.9763403},"labels":[],"label_agreement":null},{"id":"W4324056382","doi":"10.3390/curroncol30030250","title":"A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Nomogram; Medicine; Lymphadenectomy; Stage (stratigraphy); Receiver operating characteristic; Oncology; Lymph node; Univariate analysis; Ovarian cancer; Radiology; Multivariate analysis; McNemar's test; Internal medicine; Metastasis; Cancer","score_opus":0.060162323865509536,"score_gpt":0.3612953040326461,"score_spread":0.3011329801671366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324056382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474144,0.0002226491,0.00009194238,0.0006063811,0.00073470024,0.0014357131,0.0020863574,0.000012465951,0.00006835204],"genre_scores_gemma":[0.9983803,0.00032356975,0.00023641514,0.000019737823,0.00007385185,0.00085140066,0.00008589934,0.00001197327,0.000016868687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991321,0.000095786425,0.00027042735,0.00019474172,0.00015037938,0.00015658673],"domain_scores_gemma":[0.9992614,0.00012129674,0.00021101277,0.00018223705,0.00018636363,0.000037718615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016193253,0.00010177061,0.0003481897,0.0000964643,0.000034027278,0.0000018461471,0.000057938716,0.00005372605,0.000033225933],"category_scores_gemma":[0.000071073024,0.00005810183,0.00009439049,0.0003494378,0.00008754789,0.000026953092,0.000030443567,0.000079125726,0.0000012376216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070775795,0.0014381337,0.93822014,0.00011621615,0.000309207,5.2492277e-7,0.000706178,0.00023006317,0.000011368058,0.00006299654,0.00033407315,0.057863332],"study_design_scores_gemma":[0.010740019,0.0011556318,0.9827539,0.00022438659,0.0006714626,3.4191098e-7,0.00007496901,0.00042023126,0.0007079162,0.000037726055,0.003171383,0.00004203862],"about_ca_topic_score_codex":0.00025617573,"about_ca_topic_score_gemma":0.0002090059,"teacher_disagreement_score":0.057821292,"about_ca_system_score_codex":0.0002672273,"about_ca_system_score_gemma":0.0003317154,"threshold_uncertainty_score":0.23693238},"labels":[],"label_agreement":null},{"id":"W4324098920","doi":"10.1136/ijgc-2023-004327","title":"Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Oncology; Ovary; Mucinous Tumor; Gynecology; Internal medicine; General surgery; Cancer","score_opus":0.0299935915704022,"score_gpt":0.37075725853071123,"score_spread":0.340763666960309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324098920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954044,0.00031428583,0.0000054943634,0.0025304966,0.00074653595,0.00018679487,0.000106193474,0.000009562654,0.00069623225],"genre_scores_gemma":[0.99797493,0.0010663511,0.00007439716,0.00040205396,0.0003133838,0.000027352991,0.000005813409,0.000012296307,0.00012338984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986055,0.000067812325,0.00044486768,0.00019382393,0.00048620056,0.00020178076],"domain_scores_gemma":[0.9987863,0.00034983302,0.00028202528,0.00008021018,0.00035475788,0.00014693277],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002547194,0.00016008716,0.0004672085,0.00029135603,0.000022278571,0.000025598942,0.0001425555,0.00008066454,0.0009998152],"category_scores_gemma":[0.0002414813,0.000102326194,0.00017925858,0.00024137918,0.00008198918,0.00009502184,0.000040380815,0.00024282212,0.0000055093765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017799297,0.00041324907,0.9798663,0.000013708974,0.0008590859,0.0024383985,0.00058784924,0.0032849533,0.0004922229,0.00048719975,0.0005283071,0.009248749],"study_design_scores_gemma":[0.004738113,0.00232556,0.9910929,0.00020097088,0.000048571856,0.000060473107,0.00010769393,0.00014889333,0.0005285011,0.00010759959,0.0005500759,0.00009060261],"about_ca_topic_score_codex":0.0015174452,"about_ca_topic_score_gemma":0.00041357556,"teacher_disagreement_score":0.011226598,"about_ca_system_score_codex":0.0015629455,"about_ca_system_score_gemma":0.00063323934,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4327683165","doi":"10.1177/08465371231162630","title":"Response to Editorial Entitled: Ovarian-Adnexal Reporting and Data System for Ultrasound: A Framework for Improvement","year":2023,"lang":"en","type":"editorial","venue":"Canadian Association of Radiologists Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Medical physics; Gynecology; Radiology","score_opus":0.03315011266960225,"score_gpt":0.3481560002999195,"score_spread":0.3150058876303172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327683165","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006236432,0.00017646494,0.001992419,0.0039781504,0.98025906,0.0017130357,0.011194775,0.00003825316,0.000024193974],"genre_scores_gemma":[0.002597139,0.0001883562,0.01070287,0.000104499166,0.9831204,0.000288782,0.002017753,0.00009554529,0.00088468567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960797,0.00018810082,0.0016012456,0.0006684451,0.0007772068,0.000685325],"domain_scores_gemma":[0.98238033,0.01068649,0.0039957482,0.000677345,0.0013875052,0.0008725997],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011496823,0.0003176553,0.0011230704,0.000427887,0.00036322116,0.00020461944,0.00033820738,0.0013314543,0.000015825459],"category_scores_gemma":[0.15353578,0.00029741105,0.00025844495,0.00018469189,0.0000312734,0.000082564795,0.00005269927,0.0008277292,0.000004464603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011793834,0.000028628809,0.0010598727,0.0002966882,0.0011243396,0.00006240844,0.00013470418,0.000004647457,0.000053854295,0.000076840275,0.99510735,0.0008713096],"study_design_scores_gemma":[0.0034120383,0.0014241162,0.0013461454,0.0009872458,0.00087922387,0.00003478218,0.00020855869,0.000015536361,0.00002149049,0.00017430868,0.99124014,0.00025643824],"about_ca_topic_score_codex":0.005105145,"about_ca_topic_score_gemma":0.009678792,"teacher_disagreement_score":0.14203896,"about_ca_system_score_codex":0.008031341,"about_ca_system_score_gemma":0.0064752437,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W4327729516","doi":"10.3390/cancers15061823","title":"CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Cancer Research UK","keywords":"Medicine; Ovarian cancer; Brier score; Oncology; Internal medicine; Meta-analysis; Cancer; Survival analysis; Chemotherapy; Statistics","score_opus":0.04855735870681628,"score_gpt":0.314826276943266,"score_spread":0.2662689182364497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327729516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731053,0.0005872167,0.0010190185,0.014102453,0.0005697488,0.0024548487,0.005939345,0.0002638489,0.0019582286],"genre_scores_gemma":[0.9918089,0.0002551779,0.0007419293,0.003168515,0.00009960467,0.0022307176,0.0007963571,0.0000771063,0.00082169863],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9969311,0.00009273202,0.00039816188,0.0011208376,0.00072215096,0.000735056],"domain_scores_gemma":[0.99730146,0.00031720425,0.00013596383,0.0016670241,0.000099569195,0.00047878758],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040150216,0.00040421344,0.0013470212,0.0006225189,0.000074887525,0.000055161665,0.0003744386,0.00009767798,0.0012150352],"category_scores_gemma":[0.000088015964,0.0003087525,0.00023352784,0.002927682,0.000054244985,0.00016181005,0.000093848,0.00023574085,0.00004508313],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004750773,0.00025494854,0.11065356,0.0001044909,0.059567884,0.0010255817,0.00091069745,0.8065299,0.000013419335,0.00021415172,0.006737042,0.009237581],"study_design_scores_gemma":[0.018152526,0.0022909462,0.7863031,0.00019771328,0.060741294,0.0000011596361,0.0004923568,0.124585286,0.00003610603,0.00006361485,0.00628488,0.0008510196],"about_ca_topic_score_codex":0.019879954,"about_ca_topic_score_gemma":0.036207665,"teacher_disagreement_score":0.6819446,"about_ca_system_score_codex":0.0058704987,"about_ca_system_score_gemma":0.0015532478,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W4353029051","doi":"10.1002/cjp2.311","title":"p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study","year":2023,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Canada's Michael Smith Genome Sciences Centre; Vancouver General Hospital; University of British Columbia; BC Cancer Agency; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"Cilag; Medical Research and Materiel Command; National Center for Advancing Translational Sciences; Institute of Cancer Research; Breast Cancer Now; University College London; Cancer Institute NSW; Peter MacCallum Foundation; National Cancer Institute; Instituto de Salud Carlos III; Cancer Council Tasmania; University of Calgary; Cancer Council Victoria; Medical Research Council; AstraZeneca; Genentech; National Institutes of Health; UCLH Biomedical Research Centre; Eisai; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Canadian Institutes of Health Research; Swedish Cancer Foundation; Ovarian Cancer Australia; Ipsen; Cancer Australia; National Institute for Health and Care Research; BeiGene; VGH and UBC Hospital Foundation; Minnesota Ovarian Cancer Alliance; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; U.S. Department of Defense; Cancer Research UK; Cancer Council NSW; American Cancer Society; Cancer Council South Australia; Pomorski Uniwersytet Medyczny W Szczecinie; Deutsches Krebsforschungszentrum; Fred C. and Katherine B. Andersen Foundation; University of Cambridge; University of Pittsburgh; Mayo Foundation for Medical Education and Research; National Health and Medical Research Council; National Center for Research Resources; BC Cancer Foundation; Oak Foundation; European Regional Development Fund; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Cancer Research Society; NIHR Cambridge Biomedical Research Centre; Sydney West Translational Cancer Research Centre","keywords":"Serous carcinoma; Ovarian carcinoma; Tissue microarray; Hazard ratio; Immunohistochemistry; Clear cell carcinoma; Serous fluid; Carcinoma; Oncology; Internal medicine; Ovarian cancer; Medicine; Confidence interval; Pathology; Cancer; Biology","score_opus":0.2840315585752345,"score_gpt":0.5422257977343068,"score_spread":0.2581942391590723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353029051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881468,0.00032157562,0.000038786075,0.010160244,0.0003392866,0.0005662052,0.000018217477,0.0000193553,0.0003895559],"genre_scores_gemma":[0.9981309,0.0006114384,0.00016058137,0.00023935609,0.00051890675,0.00001648149,0.000007870017,0.000021089902,0.00029338276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921875,0.004790033,0.0011736178,0.00038059524,0.00092930224,0.00053895725],"domain_scores_gemma":[0.9929481,0.004656639,0.00030839237,0.00080201786,0.0007378868,0.0005469723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026466563,0.00016537371,0.0010343168,0.000723631,0.00026767526,0.000045442466,0.00036687352,0.00013923636,0.0002660729],"category_scores_gemma":[0.0026721978,0.00009724886,0.00021591257,0.001698149,0.00068377936,0.000077567245,0.0002377449,0.0013581004,0.000086890075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013043673,0.0016817404,0.97475755,0.000013608911,0.0013686924,0.012219052,0.0010362748,0.000009241487,0.00014918085,0.00016614095,0.0011459696,0.0061481902],"study_design_scores_gemma":[0.004146937,0.008655879,0.98028845,0.000018637335,0.0020573519,0.00055991113,0.0029417467,0.000102524544,0.000051577554,0.00039993727,0.00069596834,0.00008110446],"about_ca_topic_score_codex":0.00023400129,"about_ca_topic_score_gemma":0.0003066807,"teacher_disagreement_score":0.023794366,"about_ca_system_score_codex":0.00007150289,"about_ca_system_score_gemma":0.00046384815,"threshold_uncertainty_score":0.91728354},"labels":[],"label_agreement":null},{"id":"W4360828019","doi":"10.21203/rs.3.rs-2658142/v1","title":"Gain-of-function p53 R175H blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"London Health Sciences Foundation","keywords":"Biology; Spheroid; Apoptosis; Ovarian carcinoma; Missense mutation; Cancer research; Mutant; Cell biology; Ovarian cancer; Cell culture; Gene; Mutation; Genetics; Cancer","score_opus":0.12404222029993067,"score_gpt":0.3825083522441972,"score_spread":0.25846613194426654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360828019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824936,0.0010007075,0.00037934864,0.0043343487,0.00033750894,0.0037305525,0.00070606114,0.00009108779,0.0011710507],"genre_scores_gemma":[0.99434716,0.0007557557,0.0011249421,0.00002125651,0.00022649752,0.0014119827,0.00040050602,0.00010535373,0.0016065798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955122,0.00033880761,0.00079611724,0.0009855957,0.0016171905,0.0007500925],"domain_scores_gemma":[0.9969324,0.00044815431,0.00024250954,0.00135542,0.0007427681,0.00027876347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012974708,0.00038128468,0.0010876926,0.001306978,0.000059359223,0.00003293902,0.00032377418,0.0005869847,0.00011992821],"category_scores_gemma":[0.00033011902,0.00034732584,0.00034792442,0.0009553013,0.00017448906,0.000048828628,0.0006817722,0.0014485389,0.000030503916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0090587735,0.016607719,0.7415694,0.046416342,0.0044976445,0.00065324124,0.011934185,0.08962837,0.010060826,0.009666709,0.034727503,0.025179287],"study_design_scores_gemma":[0.023349408,0.009512133,0.7006219,0.031839095,0.0016243715,0.000019003897,0.0027441373,0.10413428,0.0894411,0.03455326,0.0004844236,0.0016768868],"about_ca_topic_score_codex":0.011377979,"about_ca_topic_score_gemma":0.0005914071,"teacher_disagreement_score":0.07938027,"about_ca_system_score_codex":0.0009498645,"about_ca_system_score_gemma":0.0014800993,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W4361253891","doi":"10.1158/0008-5472.22364942","title":"Supplementary Figure 1 from Cytogenetic Instability in Ovarian Epithelial Cells from Women at Risk of Ovarian Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ovarian cancer; Epithelial ovarian cancer; Gynecology; Oncology; Medicine; Internal medicine; Cancer; Obstetrics","score_opus":0.02870534405939028,"score_gpt":0.2856673523504752,"score_spread":0.2569620082910849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361253891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8972479,0.00052030693,0.000050573988,0.0026683449,0.0015350613,0.0020006758,0.09557343,0.00005731833,0.00034636675],"genre_scores_gemma":[0.98236084,0.003956436,0.0034294077,0.0003880981,0.0007032985,0.0015552732,0.006753575,0.000115995776,0.0007370745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955448,0.0002905056,0.001234301,0.0016150987,0.0006498532,0.0006654501],"domain_scores_gemma":[0.9968337,0.00043794612,0.0005121046,0.0017453769,0.000105106774,0.000365783],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043737082,0.00067195523,0.0015947866,0.0002456446,0.00006627323,0.000030804094,0.0003652403,0.0005750615,0.06481004],"category_scores_gemma":[0.000046211044,0.0005835226,0.0003845084,0.0002648506,0.00011963762,0.00003125537,0.0010819497,0.0007769821,0.00012612356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001303771,0.0011807587,0.9784971,0.0003035216,0.00267213,0.00018852124,0.003529097,0.0007744738,0.0037980026,0.000014886147,0.00368057,0.0040572076],"study_design_scores_gemma":[0.008027136,0.00025181507,0.9182023,0.00062216056,0.0011403802,4.051168e-7,0.00044320803,0.00015360134,0.060757462,0.004213156,0.0056729238,0.0005154976],"about_ca_topic_score_codex":0.48249474,"about_ca_topic_score_gemma":0.09967547,"teacher_disagreement_score":0.38281927,"about_ca_system_score_codex":0.0031611999,"about_ca_system_score_gemma":0.0009226411,"threshold_uncertainty_score":0.9996616},"labels":[],"label_agreement":null},{"id":"W4361809387","doi":"10.1158/0008-5472.c.6513021.v1","title":"Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada; Canada's Michael Smith Genome Sciences Centre; London Health Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"KRAS; Cancer research; CDKN2A; Selumetinib; Neuroblastoma RAS viral oncogene homolog; MEK inhibitor; Targeted therapy; Synthetic lethality; Medicine; Biology; Cancer; Mutation; Gene; Kinase; Internal medicine; MAPK/ERK pathway; Genetics; Mutant","score_opus":0.06591477514916318,"score_gpt":0.308639348551596,"score_spread":0.24272457340243286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361809387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862736,0.0001515608,0.001688603,0.0012820743,0.0010137568,0.0011007821,0.008416362,0.00006388217,0.000009379909],"genre_scores_gemma":[0.990328,0.00033001284,0.00075045624,0.000049429214,0.0002198,0.00003125512,0.008200995,0.00004746306,0.000042547068],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997552,0.00023537262,0.00071097095,0.00094540714,0.00036419483,0.00019205349],"domain_scores_gemma":[0.997519,0.00020640783,0.00047899105,0.001487188,0.00019986447,0.000108512715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005120473,0.00033250471,0.0008793054,0.00016812935,0.000049443264,0.00004365662,0.00014505735,0.00031709918,0.00005441171],"category_scores_gemma":[0.00006863796,0.0002920788,0.0001421471,0.0001387496,0.00020606551,0.0000891882,0.0008102918,0.00023972665,0.000003388624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013029776,0.001835225,0.38315478,0.0028281363,0.004167296,0.0001725609,0.00085688825,0.00004455674,0.5979931,0.00003234831,0.000105769344,0.0075063547],"study_design_scores_gemma":[0.0018985558,0.00007417862,0.8794947,0.00042455606,0.0010877793,0.000008686298,0.00012415864,0.011575149,0.10493368,0.00017343287,0.0000071072573,0.00019799477],"about_ca_topic_score_codex":0.008520759,"about_ca_topic_score_gemma":0.0009787873,"teacher_disagreement_score":0.49633995,"about_ca_system_score_codex":0.000112941176,"about_ca_system_score_gemma":0.00024962873,"threshold_uncertainty_score":0.99995315},"labels":[],"label_agreement":null},{"id":"W4361809445","doi":"10.1158/0008-5472.22428444.v1","title":"Supplementary Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Vulnerability (computing); Serous fluid; Ovarian carcinoma; Medicine; Cancer research; Internal medicine; Computer science; Ovarian cancer; Cancer; Computer security","score_opus":0.057003988377590055,"score_gpt":0.30717730555378003,"score_spread":0.25017331717618996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361809445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619177,0.00009612988,0.0009640427,0.0020486875,0.00095926435,0.0013226017,0.03264702,0.000040788836,0.0000037852192],"genre_scores_gemma":[0.9605022,0.00032664964,0.001039627,0.000077138284,0.00022353463,0.000039713825,0.037719045,0.000047800684,0.000024263107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973625,0.0002487157,0.0007912111,0.000980182,0.00040042854,0.00021697092],"domain_scores_gemma":[0.99762046,0.00019561565,0.00046240594,0.0014460664,0.00016266252,0.000112782596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053204934,0.000355049,0.0008668549,0.00017989521,0.00005543692,0.00004076935,0.00015628128,0.0002530262,0.0002396223],"category_scores_gemma":[0.000035909037,0.0003188359,0.00014516966,0.00012936287,0.00019528807,0.000082531,0.0009909798,0.00023354743,0.0000018810972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012406236,0.0016959467,0.5729319,0.002333146,0.004276105,0.00016161408,0.00082338566,0.000026323694,0.41157854,0.000017748966,0.0002489336,0.0046657743],"study_design_scores_gemma":[0.0025591182,0.00010009387,0.84494543,0.00036065502,0.0014024916,0.000008935849,0.000233116,0.0075762835,0.14243202,0.00014887689,0.000014747533,0.00021822478],"about_ca_topic_score_codex":0.025521807,"about_ca_topic_score_gemma":0.0025012956,"teacher_disagreement_score":0.27201357,"about_ca_system_score_codex":0.00014067005,"about_ca_system_score_gemma":0.0002418436,"threshold_uncertainty_score":0.9999264},"labels":[],"label_agreement":null},{"id":"W4361809507","doi":"10.1158/0008-5472.22428444","title":"Supplementary Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Vulnerability (computing); Serous fluid; Ovarian carcinoma; Medicine; Cancer research; Internal medicine; Computer science; Ovarian cancer; Cancer; Computer security","score_opus":0.057003988377590055,"score_gpt":0.30717730555378003,"score_spread":0.25017331717618996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361809507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619177,0.00009612988,0.0009640427,0.0020486875,0.00095926435,0.0013226017,0.03264702,0.000040788836,0.0000037852192],"genre_scores_gemma":[0.9605022,0.00032664964,0.001039627,0.000077138284,0.00022353463,0.000039713825,0.037719045,0.000047800684,0.000024263107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973625,0.0002487157,0.0007912111,0.000980182,0.00040042854,0.00021697092],"domain_scores_gemma":[0.99762046,0.00019561565,0.00046240594,0.0014460664,0.00016266252,0.000112782596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053204934,0.000355049,0.0008668549,0.00017989521,0.00005543692,0.00004076935,0.00015628128,0.0002530262,0.0002396223],"category_scores_gemma":[0.000035909037,0.0003188359,0.00014516966,0.00012936287,0.00019528807,0.000082531,0.0009909798,0.00023354743,0.0000018810972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012406236,0.0016959467,0.5729319,0.002333146,0.004276105,0.00016161408,0.00082338566,0.000026323694,0.41157854,0.000017748966,0.0002489336,0.0046657743],"study_design_scores_gemma":[0.0025591182,0.00010009387,0.84494543,0.00036065502,0.0014024916,0.000008935849,0.000233116,0.0075762835,0.14243202,0.00014887689,0.000014747533,0.00021822478],"about_ca_topic_score_codex":0.025521807,"about_ca_topic_score_gemma":0.0025012956,"teacher_disagreement_score":0.27201357,"about_ca_system_score_codex":0.00014067005,"about_ca_system_score_gemma":0.0002418436,"threshold_uncertainty_score":0.9999264},"labels":[],"label_agreement":null},{"id":"W4361809511","doi":"10.1158/0008-5472.c.6513021","title":"Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada; Canada's Michael Smith Genome Sciences Centre; London Health Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"KRAS; Cancer research; CDKN2A; Selumetinib; Neuroblastoma RAS viral oncogene homolog; Targeted therapy; MEK inhibitor; Synthetic lethality; Medicine; Biology; Cancer; Mutation; Gene; Internal medicine; Kinase; MAPK/ERK pathway; Genetics; Mutant","score_opus":0.06591477514916318,"score_gpt":0.308639348551596,"score_spread":0.24272457340243286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361809511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862736,0.0001515608,0.001688603,0.0012820743,0.0010137568,0.0011007821,0.008416362,0.00006388217,0.000009379909],"genre_scores_gemma":[0.990328,0.00033001284,0.00075045624,0.000049429214,0.0002198,0.00003125512,0.008200995,0.00004746306,0.000042547068],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997552,0.00023537262,0.00071097095,0.00094540714,0.00036419483,0.00019205349],"domain_scores_gemma":[0.997519,0.00020640783,0.00047899105,0.001487188,0.00019986447,0.000108512715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005120473,0.00033250471,0.0008793054,0.00016812935,0.000049443264,0.00004365662,0.00014505735,0.00031709918,0.00005441171],"category_scores_gemma":[0.00006863796,0.0002920788,0.0001421471,0.0001387496,0.00020606551,0.0000891882,0.0008102918,0.00023972665,0.000003388624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013029776,0.001835225,0.38315478,0.0028281363,0.004167296,0.0001725609,0.00085688825,0.00004455674,0.5979931,0.00003234831,0.000105769344,0.0075063547],"study_design_scores_gemma":[0.0018985558,0.00007417862,0.8794947,0.00042455606,0.0010877793,0.000008686298,0.00012415864,0.011575149,0.10493368,0.00017343287,0.0000071072573,0.00019799477],"about_ca_topic_score_codex":0.008520759,"about_ca_topic_score_gemma":0.0009787873,"teacher_disagreement_score":0.49633995,"about_ca_system_score_codex":0.000112941176,"about_ca_system_score_gemma":0.00024962873,"threshold_uncertainty_score":0.99995315},"labels":[],"label_agreement":null},{"id":"W4361813639","doi":"10.1158/1078-0432.c.6530816","title":"Data from Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Carboplatin; Internal medicine; Neutropenia; Fallopian tube cancer; Gemcitabine; Gastroenterology; Ovarian cancer; Chemotherapy; Fallopian tube; Phases of clinical research; Anemia; Surgery; Cancer; Cisplatin","score_opus":0.13226527224639792,"score_gpt":0.37547645895670845,"score_spread":0.24321118671031053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361813639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97851306,0.00016243574,0.000037833852,0.0028701096,0.00036884792,0.010061319,0.0069467085,0.0002273894,0.00081228325],"genre_scores_gemma":[0.96409225,0.00039683084,0.011540139,0.0019028021,0.00044240657,0.0025555582,0.016781328,0.0004126721,0.0018759809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410146,0.00017048103,0.0009840119,0.0028219607,0.001215217,0.0007068588],"domain_scores_gemma":[0.99476045,0.00014768665,0.00045560955,0.0038890487,0.0002603674,0.00048682696],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035746035,0.0010399014,0.0019489184,0.0002500168,0.00023971485,0.00033338522,0.001616329,0.00031008723,0.0016087765],"category_scores_gemma":[0.000026465219,0.00065241376,0.00003369949,0.000516514,0.000103944185,0.00045987187,0.002342752,0.0008580758,0.000012119174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11315636,0.11809198,0.71308076,0.00040377135,0.0068979813,0.0024985543,0.0027795366,0.00008434255,0.00004525106,0.000024924244,0.007227747,0.03570879],"study_design_scores_gemma":[0.14901651,0.051613584,0.7901077,0.00224535,0.0013210054,0.0000033600545,0.00054881827,0.00047484357,0.000040215546,0.00002493348,0.0035308886,0.0010727595],"about_ca_topic_score_codex":0.052332014,"about_ca_topic_score_gemma":0.1332705,"teacher_disagreement_score":0.080938496,"about_ca_system_score_codex":0.0010737884,"about_ca_system_score_gemma":0.0028054586,"threshold_uncertainty_score":0.9995927},"labels":[],"label_agreement":null},{"id":"W4361814273","doi":"10.1158/1078-0432.c.6530816.v1","title":"Data from Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Carboplatin; Internal medicine; Neutropenia; Gastroenterology; Gemcitabine; Fallopian tube cancer; Ovarian cancer; Chemotherapy; Fallopian tube; Phases of clinical research; Anemia; Surgery; Cancer; Cisplatin","score_opus":0.13226527224639792,"score_gpt":0.37547645895670845,"score_spread":0.24321118671031053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361814273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97851306,0.00016243574,0.000037833852,0.0028701096,0.00036884792,0.010061319,0.0069467085,0.0002273894,0.00081228325],"genre_scores_gemma":[0.96409225,0.00039683084,0.011540139,0.0019028021,0.00044240657,0.0025555582,0.016781328,0.0004126721,0.0018759809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410146,0.00017048103,0.0009840119,0.0028219607,0.001215217,0.0007068588],"domain_scores_gemma":[0.99476045,0.00014768665,0.00045560955,0.0038890487,0.0002603674,0.00048682696],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035746035,0.0010399014,0.0019489184,0.0002500168,0.00023971485,0.00033338522,0.001616329,0.00031008723,0.0016087765],"category_scores_gemma":[0.000026465219,0.00065241376,0.00003369949,0.000516514,0.000103944185,0.00045987187,0.002342752,0.0008580758,0.000012119174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11315636,0.11809198,0.71308076,0.00040377135,0.0068979813,0.0024985543,0.0027795366,0.00008434255,0.00004525106,0.000024924244,0.007227747,0.03570879],"study_design_scores_gemma":[0.14901651,0.051613584,0.7901077,0.00224535,0.0013210054,0.0000033600545,0.00054881827,0.00047484357,0.000040215546,0.00002493348,0.0035308886,0.0010727595],"about_ca_topic_score_codex":0.052332014,"about_ca_topic_score_gemma":0.1332705,"teacher_disagreement_score":0.080938496,"about_ca_system_score_codex":0.0010737884,"about_ca_system_score_gemma":0.0028054586,"threshold_uncertainty_score":0.9995927},"labels":[],"label_agreement":null},{"id":"W4361816411","doi":"10.1158/1055-9965.c.6515776","title":"Data from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Health and Medical Research Council; National Cancer Institute; Fred C. and Katherine B. Andersen Foundation; Ovarian Cancer Research Fund","keywords":"Single-nucleotide polymorphism; Medicine; Internal medicine; Biology; Gene; Genotype; Genetics","score_opus":0.23513086182118786,"score_gpt":0.44059068486074965,"score_spread":0.20545982303956178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361816411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94386685,0.0010457706,0.0010319569,0.0060766153,0.0023241173,0.0027430202,0.037928287,0.00016676202,0.0048166336],"genre_scores_gemma":[0.98721915,0.003286278,0.0032407716,0.00020187242,0.00030114938,0.00042027707,0.004987875,0.00005585085,0.00028677133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729496,0.00007352885,0.00070482504,0.0011086602,0.00054916,0.00026886957],"domain_scores_gemma":[0.99705344,0.00014045618,0.00028404218,0.0022601844,0.000107664775,0.0001541995],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024172435,0.0003457407,0.0010408292,0.00016057742,0.0000166796,0.000028135992,0.00045847057,0.00028543553,0.0025651655],"category_scores_gemma":[0.000045941266,0.00028015664,0.0001442797,0.00017981144,0.000043512104,0.00006377599,0.0014382856,0.00051799964,0.000019700683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003067478,0.00059660996,0.9940968,0.0004730816,0.0014004012,0.00015561853,0.00006877054,0.000026743106,0.000060224662,0.00031128444,0.0022416431,0.0005381191],"study_design_scores_gemma":[0.001837878,0.00005049067,0.9917499,0.0012675475,0.0005603173,3.703175e-7,0.000029552073,0.0023954788,0.00071020826,0.0009262281,0.0002540177,0.00021802964],"about_ca_topic_score_codex":0.21493547,"about_ca_topic_score_gemma":0.035977695,"teacher_disagreement_score":0.17895778,"about_ca_system_score_codex":0.00064825633,"about_ca_system_score_gemma":0.0014372868,"threshold_uncertainty_score":0.9999651},"labels":[],"label_agreement":null},{"id":"W4361817857","doi":"10.1158/1078-0432.c.6519236.v1","title":"Data from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Sunitinib; STAT3; Cancer research; Medicine; Angiogenesis; Serous fluid; Ovarian cancer; Immunohistochemistry; Cancer; Internal medicine; Biology; Signal transduction","score_opus":0.13524894382744748,"score_gpt":0.35590677350655764,"score_spread":0.22065782967911016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361817857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314246,0.0068045603,0.00013267135,0.053759564,0.0008583055,0.0020496498,0.0046239547,0.000115729774,0.00023093318],"genre_scores_gemma":[0.989574,0.0019641086,0.0013823229,0.00349995,0.0007811859,0.0005379769,0.00068396446,0.0001284103,0.0014480392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722576,0.00034592152,0.00048606913,0.0011580084,0.000386731,0.00039749453],"domain_scores_gemma":[0.99677676,0.0009855214,0.00012967689,0.0018043431,0.00007834594,0.00022535064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009843323,0.000401839,0.0006086812,0.00025427903,0.00011191936,0.00013161922,0.00045062526,0.0002573225,0.000795513],"category_scores_gemma":[0.00008025211,0.00027654512,0.00010701488,0.00036574897,0.000054454984,0.000037392696,0.0012742969,0.00043944066,0.000121502635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07346986,0.0066591217,0.4407792,0.002967124,0.014385844,0.0082458565,0.04259196,0.009988852,0.06403309,0.00044470277,0.1930303,0.14340407],"study_design_scores_gemma":[0.009252207,0.0009083279,0.83929205,0.0038986963,0.0031175571,0.0000139315525,0.0045386516,0.0021337892,0.022850689,0.0008011432,0.11167353,0.0015194427],"about_ca_topic_score_codex":0.022674076,"about_ca_topic_score_gemma":0.008418947,"teacher_disagreement_score":0.3985128,"about_ca_system_score_codex":0.00027651293,"about_ca_system_score_gemma":0.0006329187,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4361888704","doi":"10.1158/1078-0432.22474871","title":"Supplementary material and tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive &lt;i&gt;TP53&lt;/i&gt;-mutant Ovarian Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Carboplatin; Paclitaxel; Biomarker; Mutant; Internal medicine; Oncology; Chemistry; Medicine; Cancer; Biochemistry; Cisplatin; Gene; Chemotherapy","score_opus":0.025850519914720635,"score_gpt":0.29497182852410403,"score_spread":0.2691213086093834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361888704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9320682,0.00073848123,0.0004448557,0.0025335737,0.0013070721,0.012353678,0.050211247,0.00009761954,0.0002452399],"genre_scores_gemma":[0.97433734,0.00208556,0.0064278436,0.00019163048,0.00088948436,0.008255478,0.0069903955,0.00017968651,0.0006425816],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951206,0.00031324086,0.0015701532,0.0015409426,0.0006640987,0.00079096336],"domain_scores_gemma":[0.9961165,0.0014509792,0.000947067,0.00072235405,0.00029444793,0.0004686543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011282748,0.0010079733,0.0038023205,0.00034283384,0.00022235545,0.00012501642,0.00014361055,0.0004844098,0.0015796712],"category_scores_gemma":[0.00018363218,0.00072382885,0.00029988837,0.00020530191,0.00042792404,0.0000938803,0.0005756699,0.00026311775,7.6179913e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95126325,0.0013572581,0.00012175536,0.00083943235,0.010477154,0.00021657652,0.004409327,0.000020129715,0.023704704,0.00037181284,0.0020680905,0.0051505095],"study_design_scores_gemma":[0.97081256,0.0058790827,0.0007142157,0.001327945,0.00512966,0.00001934371,0.0009717765,0.0021397253,0.0086949775,0.0015873199,0.0018619496,0.0008614417],"about_ca_topic_score_codex":0.013406897,"about_ca_topic_score_gemma":0.0060820957,"teacher_disagreement_score":0.04322085,"about_ca_system_score_codex":0.0007668202,"about_ca_system_score_gemma":0.0012004203,"threshold_uncertainty_score":0.99952126},"labels":[],"label_agreement":null},{"id":"W4361934972","doi":"10.1158/1078-0432.22471739.v1","title":"Table S 1-6 and Figures S1-3 from Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Table (database); Cohort; Gynecologic cancer; Cancer; Oncology; Randomized controlled trial; Internal medicine; Family medicine; Gynecology; Ovarian cancer; Database","score_opus":0.04137316477920835,"score_gpt":0.29938443892710864,"score_spread":0.2580112741479003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361934972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886188,0.0011345109,0.0000012744267,0.00029450963,0.00052399235,0.008576775,0.00075617176,0.000016591344,0.000077370496],"genre_scores_gemma":[0.9971016,0.0008845641,0.00014379917,0.00007537155,0.000058086887,0.0014215923,0.0001700391,0.000037585833,0.00010733703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726236,0.0002738282,0.00091230066,0.00070180494,0.00053562474,0.0003140912],"domain_scores_gemma":[0.99791205,0.00052013027,0.0006792788,0.00056385156,0.00016839356,0.0001562961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005858563,0.00036406092,0.0016568131,0.0002688258,0.000096677,0.000032287615,0.00013840052,0.00025884216,0.00017000972],"category_scores_gemma":[0.00030189563,0.00021028171,0.000095943826,0.0002917449,0.00009712498,0.00005152955,0.00021647708,0.00029371094,5.04494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010274376,0.0012499485,0.9813275,0.00021791966,0.0009390948,0.000020573158,0.0013048731,0.0004147974,0.000015136993,0.000015071817,0.00016559834,0.004055139],"study_design_scores_gemma":[0.09021751,0.0025337718,0.90370256,0.0014501767,0.00091133494,2.0439111e-7,0.00069106143,0.000035759404,0.000093280374,0.00012499132,0.00005285989,0.00018646779],"about_ca_topic_score_codex":0.6238442,"about_ca_topic_score_gemma":0.7688499,"teacher_disagreement_score":0.14500573,"about_ca_system_score_codex":0.00044300198,"about_ca_system_score_gemma":0.0009923534,"threshold_uncertainty_score":0.8575039},"labels":[],"label_agreement":null},{"id":"W4361937547","doi":"10.1158/1078-0432.22474871.v1","title":"Supplementary material and tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive &lt;i&gt;TP53&lt;/i&gt;-mutant Ovarian Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Carboplatin; Paclitaxel; Biomarker; Mutant; Internal medicine; Oncology; Chemistry; Medicine; Cancer; Biochemistry; Cisplatin; Gene; Chemotherapy","score_opus":0.025850519914720635,"score_gpt":0.29497182852410403,"score_spread":0.2691213086093834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361937547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9320682,0.00073848123,0.0004448557,0.0025335737,0.0013070721,0.012353678,0.050211247,0.00009761954,0.0002452399],"genre_scores_gemma":[0.97433734,0.00208556,0.0064278436,0.00019163048,0.00088948436,0.008255478,0.0069903955,0.00017968651,0.0006425816],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951206,0.00031324086,0.0015701532,0.0015409426,0.0006640987,0.00079096336],"domain_scores_gemma":[0.9961165,0.0014509792,0.000947067,0.00072235405,0.00029444793,0.0004686543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011282748,0.0010079733,0.0038023205,0.00034283384,0.00022235545,0.00012501642,0.00014361055,0.0004844098,0.0015796712],"category_scores_gemma":[0.00018363218,0.00072382885,0.00029988837,0.00020530191,0.00042792404,0.0000938803,0.0005756699,0.00026311775,7.6179913e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95126325,0.0013572581,0.00012175536,0.00083943235,0.010477154,0.00021657652,0.004409327,0.000020129715,0.023704704,0.00037181284,0.0020680905,0.0051505095],"study_design_scores_gemma":[0.97081256,0.0058790827,0.0007142157,0.001327945,0.00512966,0.00001934371,0.0009717765,0.0021397253,0.0086949775,0.0015873199,0.0018619496,0.0008614417],"about_ca_topic_score_codex":0.013406897,"about_ca_topic_score_gemma":0.0060820957,"teacher_disagreement_score":0.04322085,"about_ca_system_score_codex":0.0007668202,"about_ca_system_score_gemma":0.0012004203,"threshold_uncertainty_score":0.99952126},"labels":[],"label_agreement":null},{"id":"W4361942741","doi":"10.1158/1078-0432.c.6516894","title":"Data from Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from &lt;i&gt;BRCA&lt;/i&gt; Mutation Carriers Resemble High-Grade Serous Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Institute of Gender and Health; U.S. Department of Defense","keywords":"Luteal phase; Biology; Follicular phase; Molecular biology; SERCA; Andrology; Endocrinology; Medicine","score_opus":0.06862157541772346,"score_gpt":0.32416206473922465,"score_spread":0.2555404893215012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361942741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94485676,0.0037481647,0.0013115199,0.0031011081,0.002195569,0.002620777,0.041354835,0.00035624817,0.0004550251],"genre_scores_gemma":[0.90461475,0.0012878808,0.020046735,0.00014343549,0.0013821309,0.00059300975,0.07010594,0.00020661518,0.0016194838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99421775,0.00029630584,0.0012672681,0.0023494419,0.001215716,0.0006535014],"domain_scores_gemma":[0.9940609,0.00042460635,0.0006819723,0.0039870017,0.00029520338,0.000550363],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037977082,0.0008494997,0.0016095068,0.0003791729,0.00016467916,0.000098104436,0.0009681283,0.0008308825,0.0009470007],"category_scores_gemma":[0.00017643238,0.00071265496,0.00031905485,0.00029114223,0.00016215193,0.00021780557,0.0017240548,0.00066959317,0.00010978668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033564102,0.0057835937,0.03505581,0.0016330468,0.0063976017,0.003766778,0.0047688107,0.00109868,0.7432415,0.00047809773,0.18470588,0.009713772],"study_design_scores_gemma":[0.028241972,0.0014169761,0.18183802,0.0037004845,0.004896689,0.000023327144,0.0007772791,0.0070653814,0.75630414,0.0028704884,0.011132185,0.001733046],"about_ca_topic_score_codex":0.019180013,"about_ca_topic_score_gemma":0.003447009,"teacher_disagreement_score":0.1735737,"about_ca_system_score_codex":0.00057411846,"about_ca_system_score_gemma":0.0010691878,"threshold_uncertainty_score":0.99996626},"labels":[],"label_agreement":null},{"id":"W4361943506","doi":"10.1158/1078-0432.c.6519236","title":"Data from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Sunitinib; STAT3; Cancer research; Medicine; Angiogenesis; Serous fluid; Ovarian cancer; Cancer; Internal medicine; Biology; Apoptosis","score_opus":0.13524894382744748,"score_gpt":0.35590677350655764,"score_spread":0.22065782967911016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361943506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314246,0.0068045603,0.00013267135,0.053759564,0.0008583055,0.0020496498,0.0046239547,0.000115729774,0.00023093318],"genre_scores_gemma":[0.989574,0.0019641086,0.0013823229,0.00349995,0.0007811859,0.0005379769,0.00068396446,0.0001284103,0.0014480392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722576,0.00034592152,0.00048606913,0.0011580084,0.000386731,0.00039749453],"domain_scores_gemma":[0.99677676,0.0009855214,0.00012967689,0.0018043431,0.00007834594,0.00022535064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009843323,0.000401839,0.0006086812,0.00025427903,0.00011191936,0.00013161922,0.00045062526,0.0002573225,0.000795513],"category_scores_gemma":[0.00008025211,0.00027654512,0.00010701488,0.00036574897,0.000054454984,0.000037392696,0.0012742969,0.00043944066,0.000121502635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07346986,0.0066591217,0.4407792,0.002967124,0.014385844,0.0082458565,0.04259196,0.009988852,0.06403309,0.00044470277,0.1930303,0.14340407],"study_design_scores_gemma":[0.009252207,0.0009083279,0.83929205,0.0038986963,0.0031175571,0.0000139315525,0.0045386516,0.0021337892,0.022850689,0.0008011432,0.11167353,0.0015194427],"about_ca_topic_score_codex":0.022674076,"about_ca_topic_score_gemma":0.008418947,"teacher_disagreement_score":0.3985128,"about_ca_system_score_codex":0.00027651293,"about_ca_system_score_gemma":0.0006329187,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4361943620","doi":"10.1158/1078-0432.c.6518829","title":"Data from A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Confidence interval; Ovarian cancer; Medicine; Chemotherapy; Hazard ratio; Internal medicine; Oncology; Receiver operating characteristic; Cancer; Ovary","score_opus":0.22581017300773662,"score_gpt":0.4051140192405798,"score_spread":0.1793038462328432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361943620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6941132,0.012237778,0.0029988787,0.2120361,0.002670196,0.020331455,0.0546659,0.00084970496,0.00009680049],"genre_scores_gemma":[0.7175186,0.039869893,0.12712273,0.012576955,0.0027406854,0.08585208,0.009395901,0.00061402115,0.0043091187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636525,0.00009216577,0.00056277425,0.0020710216,0.0003981368,0.000510634],"domain_scores_gemma":[0.9951593,0.0018623531,0.00019270941,0.0021154557,0.00017618046,0.0004939623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006531347,0.0005714272,0.0010716462,0.0004629181,0.000096885036,0.00017947791,0.00050158723,0.00043381934,0.00053632254],"category_scores_gemma":[0.0008099049,0.0004711702,0.00017214028,0.00046035132,0.00005297856,0.000063658306,0.0011239785,0.00034434817,0.000061433006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008853475,0.0020150323,0.44176802,0.0007082723,0.0040828935,0.00012304806,0.0008721781,0.00004314167,0.00013886961,0.00003243346,0.40098596,0.1403767],"study_design_scores_gemma":[0.0084843505,0.00061599293,0.8101795,0.0015590022,0.0014031501,0.000003420683,0.00010429751,0.0019107673,0.0015832576,0.00036248978,0.17313416,0.00065961963],"about_ca_topic_score_codex":0.011243769,"about_ca_topic_score_gemma":0.0018447742,"teacher_disagreement_score":0.36841148,"about_ca_system_score_codex":0.00043061955,"about_ca_system_score_gemma":0.00072022463,"threshold_uncertainty_score":0.999774},"labels":[],"label_agreement":null},{"id":"W4361943644","doi":"10.1158/1078-0432.c.6519431","title":"Data from Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Cancer Research UK","keywords":"Debulking; Ovarian cancer; Cancer research; Serous fluid; Biology; Chemotherapy; Oncology; Cancer; Medicine; Internal medicine","score_opus":0.1064721234545958,"score_gpt":0.36273487368774393,"score_spread":0.25626275023314815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361943644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681493,0.00027620184,0.010513237,0.0036629983,0.00029994047,0.004475356,0.012419515,0.00018214375,0.0000212848],"genre_scores_gemma":[0.8106673,0.00020481822,0.16096313,0.0018450822,0.00081495056,0.0027717073,0.021492913,0.00027150149,0.0009686046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956834,0.00027179407,0.0009725127,0.001868725,0.00079038594,0.00041322687],"domain_scores_gemma":[0.9960611,0.00018450433,0.0007171423,0.0024019289,0.00026896578,0.00036637622],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009719986,0.000585128,0.0015987213,0.0009655947,0.00010956798,0.00006645065,0.0004999939,0.00036245733,0.0020456112],"category_scores_gemma":[0.00013944144,0.0005171868,0.0003386103,0.0011773685,0.000070436545,0.00017970224,0.00047784182,0.00050245714,0.00001983516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021433445,0.0020621473,0.0050840485,0.00031514646,0.013412637,0.00012684641,0.00070209993,0.019902265,0.92813027,0.00000483767,0.00034965406,0.008476621],"study_design_scores_gemma":[0.0294407,0.0021502243,0.17322896,0.0064492775,0.020791627,0.00000821399,0.00072171545,0.016894037,0.7447441,0.00045148912,0.0028494247,0.002270213],"about_ca_topic_score_codex":0.007613766,"about_ca_topic_score_gemma":0.00050546374,"teacher_disagreement_score":0.18338613,"about_ca_system_score_codex":0.0011244996,"about_ca_system_score_gemma":0.002532273,"threshold_uncertainty_score":0.99972796},"labels":[],"label_agreement":null},{"id":"W4361948337","doi":"10.1158/1055-9965.c.6515776.v1","title":"Data from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Health and Medical Research Council; National Cancer Institute; Fred C. and Katherine B. Andersen Foundation; Ovarian Cancer Research Fund","keywords":"Single-nucleotide polymorphism; Medicine; Internal medicine; Biology; Gene; Genetics; Genotype","score_opus":0.23513086182118786,"score_gpt":0.44059068486074965,"score_spread":0.20545982303956178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361948337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94386685,0.0010457706,0.0010319569,0.0060766153,0.0023241173,0.0027430202,0.037928287,0.00016676202,0.0048166336],"genre_scores_gemma":[0.98721915,0.003286278,0.0032407716,0.00020187242,0.00030114938,0.00042027707,0.004987875,0.00005585085,0.00028677133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729496,0.00007352885,0.00070482504,0.0011086602,0.00054916,0.00026886957],"domain_scores_gemma":[0.99705344,0.00014045618,0.00028404218,0.0022601844,0.000107664775,0.0001541995],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024172435,0.0003457407,0.0010408292,0.00016057742,0.0000166796,0.000028135992,0.00045847057,0.00028543553,0.0025651655],"category_scores_gemma":[0.000045941266,0.00028015664,0.0001442797,0.00017981144,0.000043512104,0.00006377599,0.0014382856,0.00051799964,0.000019700683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003067478,0.00059660996,0.9940968,0.0004730816,0.0014004012,0.00015561853,0.00006877054,0.000026743106,0.000060224662,0.00031128444,0.0022416431,0.0005381191],"study_design_scores_gemma":[0.001837878,0.00005049067,0.9917499,0.0012675475,0.0005603173,3.703175e-7,0.000029552073,0.0023954788,0.00071020826,0.0009262281,0.0002540177,0.00021802964],"about_ca_topic_score_codex":0.21493547,"about_ca_topic_score_gemma":0.035977695,"teacher_disagreement_score":0.17895778,"about_ca_system_score_codex":0.00064825633,"about_ca_system_score_gemma":0.0014372868,"threshold_uncertainty_score":0.9999651},"labels":[],"label_agreement":null},{"id":"W4361948368","doi":"10.1158/1055-9965.c.6516379.v1","title":"Data from Common Variation in Nemo-Like Kinase Is Associated with Risk of Ovarian Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Alberta Health Services","funders":"","keywords":"Single-nucleotide polymorphism; Ovarian cancer; Serous fluid; Kinase; Internal medicine; Medicine; Biology; Cancer; Endocrinology; Gene; Genotype; Genetics","score_opus":0.07771073212227869,"score_gpt":0.3353968975788392,"score_spread":0.25768616545656053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361948368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94425637,0.0012481044,0.00061559014,0.009489275,0.001380756,0.0024882539,0.03832793,0.00023568836,0.0019580617],"genre_scores_gemma":[0.98454875,0.0024621864,0.0015964266,0.00052921154,0.00018690753,0.00025191176,0.009466203,0.00007796302,0.00088045426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976963,0.00013514474,0.0005577259,0.0009112594,0.0004578107,0.00024179697],"domain_scores_gemma":[0.9970318,0.0003098029,0.00057908765,0.001839691,0.00013091139,0.00010869151],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039601777,0.0003226382,0.0009304147,0.00018210759,0.000033181488,0.000032515516,0.00032096865,0.00036111067,0.0012425045],"category_scores_gemma":[0.0001028971,0.00024968287,0.00008317518,0.00032957204,0.00003772136,0.00006533677,0.00060273346,0.0005635076,0.000025750689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004246131,0.0012456673,0.970089,0.00014320304,0.0038416965,0.00021457845,0.00087050715,0.0005400068,0.000021878297,0.00005192394,0.01938586,0.003171065],"study_design_scores_gemma":[0.0046943454,0.0001377038,0.9823031,0.002047437,0.002085675,4.6550102e-7,0.000053567535,0.00693071,0.00014182855,0.00080376567,0.00056650717,0.0002349312],"about_ca_topic_score_codex":0.27661344,"about_ca_topic_score_gemma":0.1160739,"teacher_disagreement_score":0.16053955,"about_ca_system_score_codex":0.00058314105,"about_ca_system_score_gemma":0.00064419373,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W4361949564","doi":"10.1158/1078-0432.c.6518829.v1","title":"Data from A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Confidence interval; Ovarian cancer; Medicine; Hazard ratio; Chemotherapy; Internal medicine; Oncology; Receiver operating characteristic; Cancer; Ovary; Odds ratio","score_opus":0.22581017300773662,"score_gpt":0.4051140192405798,"score_spread":0.1793038462328432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361949564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6941132,0.012237778,0.0029988787,0.2120361,0.002670196,0.020331455,0.0546659,0.00084970496,0.00009680049],"genre_scores_gemma":[0.7175186,0.039869893,0.12712273,0.012576955,0.0027406854,0.08585208,0.009395901,0.00061402115,0.0043091187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636525,0.00009216577,0.00056277425,0.0020710216,0.0003981368,0.000510634],"domain_scores_gemma":[0.9951593,0.0018623531,0.00019270941,0.0021154557,0.00017618046,0.0004939623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006531347,0.0005714272,0.0010716462,0.0004629181,0.000096885036,0.00017947791,0.00050158723,0.00043381934,0.00053632254],"category_scores_gemma":[0.0008099049,0.0004711702,0.00017214028,0.00046035132,0.00005297856,0.000063658306,0.0011239785,0.00034434817,0.000061433006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008853475,0.0020150323,0.44176802,0.0007082723,0.0040828935,0.00012304806,0.0008721781,0.00004314167,0.00013886961,0.00003243346,0.40098596,0.1403767],"study_design_scores_gemma":[0.0084843505,0.00061599293,0.8101795,0.0015590022,0.0014031501,0.000003420683,0.00010429751,0.0019107673,0.0015832576,0.00036248978,0.17313416,0.00065961963],"about_ca_topic_score_codex":0.011243769,"about_ca_topic_score_gemma":0.0018447742,"teacher_disagreement_score":0.36841148,"about_ca_system_score_codex":0.00043061955,"about_ca_system_score_gemma":0.00072022463,"threshold_uncertainty_score":0.999774},"labels":[],"label_agreement":null},{"id":"W4361953786","doi":"10.1158/1078-0432.c.6528887.v1","title":"Data from Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Government of Ontario; Cancer Research Society","keywords":"Subtyping; Serous fluid; Concordance; Ovarian carcinoma; Medicine; Oncology; Internal medicine; Cancer research; Ovarian cancer; Computer science; Cancer","score_opus":0.1013287301405116,"score_gpt":0.32511420843893035,"score_spread":0.22378547829841877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361953786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96684825,0.0011384193,0.00016793908,0.018022578,0.0014355913,0.0011791337,0.0082211215,0.0002141101,0.002772874],"genre_scores_gemma":[0.98567104,0.0002078336,0.0058935243,0.0005345245,0.00027422863,0.00006185894,0.006532694,0.000087919165,0.00073639594],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975651,0.000076686,0.00048745648,0.0011375387,0.00046534784,0.0002678914],"domain_scores_gemma":[0.99595475,0.00027669442,0.0002224864,0.0032725295,0.00009623026,0.00017729322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014357943,0.00038707413,0.0009194383,0.00015648139,0.000027258835,0.00002676534,0.00042141555,0.00033720402,0.000510739],"category_scores_gemma":[0.00008635041,0.0003173207,0.00015970283,0.00012405319,0.00007750391,0.000010975423,0.0009174166,0.00041705574,0.0002168548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042152843,0.010969683,0.39891353,0.0038878657,0.026299603,0.031919215,0.00097039645,0.002316597,0.0049106064,0.041406397,0.45810398,0.016086845],"study_design_scores_gemma":[0.008530106,0.0010001994,0.92846954,0.0018070294,0.0039558853,0.000032750162,0.00016151078,0.0012065971,0.03954722,0.009641337,0.004805951,0.00084190135],"about_ca_topic_score_codex":0.032635413,"about_ca_topic_score_gemma":0.000922943,"teacher_disagreement_score":0.529556,"about_ca_system_score_codex":0.00015713942,"about_ca_system_score_gemma":0.00047047847,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W4361959103","doi":"10.1158/1078-0432.c.6532782","title":"Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Hazard ratio; Internal medicine; Medicine; Gastroenterology; Stage (stratigraphy); Confidence interval; Oncology; Biology","score_opus":0.051132161928810614,"score_gpt":0.30378746905587356,"score_spread":0.25265530712706297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361959103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955374,0.00017166011,0.00054793165,0.0005932062,0.000120661665,0.0012466963,0.0013703787,0.00014186956,0.00027021702],"genre_scores_gemma":[0.96427774,0.000045354715,0.032087453,0.00006774023,0.000054425593,0.000078373145,0.002785842,0.00008753615,0.000515506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712366,0.000091144386,0.0006323919,0.0012237035,0.0005738312,0.00035528585],"domain_scores_gemma":[0.99747765,0.00036715812,0.00058741984,0.0011099234,0.00022047079,0.00023738615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003365297,0.0005383949,0.0012829452,0.00018529697,0.00009456958,0.00007036303,0.00022055066,0.0001376182,0.00012720875],"category_scores_gemma":[0.00022924229,0.00034469925,0.00007059997,0.00012589086,0.00023943526,0.00012402513,0.0011418432,0.00051382784,0.0000041224666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011629243,0.00048669294,0.994854,0.000285155,0.0009546335,0.0005862425,0.00017471371,0.000113340204,0.00029642682,0.0000053958697,0.0010134359,0.00006708782],"study_design_scores_gemma":[0.004150367,0.00072630943,0.97905225,0.009451578,0.0011174815,0.00007060715,0.0014801419,0.001550012,0.0020093166,0.000040443283,0.0000036414901,0.00034784226],"about_ca_topic_score_codex":0.0024247514,"about_ca_topic_score_gemma":0.0011501787,"teacher_disagreement_score":0.031539522,"about_ca_system_score_codex":0.00012389357,"about_ca_system_score_gemma":0.00033796128,"threshold_uncertainty_score":0.9999005},"labels":[],"label_agreement":null},{"id":"W4362402981","doi":"10.1158/1078-0432.22467282","title":"NACT Supplementary Methods - revised from Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Moncton; University Health Network; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Oncology; Chemotherapy; Immunotherapy; Tumor-infiltrating lymphocytes; Ovarian cancer; Medicine; Lymphocyte; Internal medicine; Cancer","score_opus":0.06149064331767302,"score_gpt":0.3900493489486612,"score_spread":0.3285587056309882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362402981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.881058,0.0017206968,0.03855918,0.030281244,0.0003211869,0.00791313,0.039941184,0.00010602221,0.00009940371],"genre_scores_gemma":[0.83135104,0.0020801867,0.15864614,0.00056593097,0.0002007479,0.003680806,0.0031658038,0.00018380929,0.00012556021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966517,0.00025022373,0.0015145132,0.0009367534,0.00027263287,0.00037416784],"domain_scores_gemma":[0.9955021,0.0016254407,0.0010768787,0.0014443977,0.0002441598,0.00010699777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012843534,0.0005012495,0.0014722504,0.0002745143,0.000054284552,0.00002475057,0.00029825052,0.00016995931,0.00044293172],"category_scores_gemma":[0.00011174954,0.0003811417,0.00034222615,0.00028061026,0.000085019135,0.000035839952,0.00011151246,0.00025076666,5.013985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08488173,0.001408932,0.73023653,0.0012596265,0.0044574705,0.000037179725,0.0020804163,0.00034944274,0.02636634,0.00028583707,0.0006730202,0.14796345],"study_design_scores_gemma":[0.022686675,0.00093058136,0.9315086,0.0036901573,0.00041644508,0.0000041769176,0.00017854305,0.00040857831,0.03787636,0.001155476,0.0007971364,0.00034728835],"about_ca_topic_score_codex":0.057202484,"about_ca_topic_score_gemma":0.009201137,"teacher_disagreement_score":0.20127204,"about_ca_system_score_codex":0.0008307918,"about_ca_system_score_gemma":0.001366388,"threshold_uncertainty_score":0.99986404},"labels":[],"label_agreement":null},{"id":"W4362406550","doi":"10.1158/1078-0432.22471739","title":"Table S 1-6 and Figures S1-3 from Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Oncology; Table (database); Internal medicine; Gynecologic cancer; Cancer; Family medicine; Database; Ovarian cancer","score_opus":0.04137316477920835,"score_gpt":0.29938443892710864,"score_spread":0.2580112741479003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362406550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886188,0.0011345109,0.0000012744267,0.00029450963,0.00052399235,0.008576775,0.00075617176,0.000016591344,0.000077370496],"genre_scores_gemma":[0.9971016,0.0008845641,0.00014379917,0.00007537155,0.000058086887,0.0014215923,0.0001700391,0.000037585833,0.00010733703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726236,0.0002738282,0.00091230066,0.00070180494,0.00053562474,0.0003140912],"domain_scores_gemma":[0.99791205,0.00052013027,0.0006792788,0.00056385156,0.00016839356,0.0001562961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005858563,0.00036406092,0.0016568131,0.0002688258,0.000096677,0.000032287615,0.00013840052,0.00025884216,0.00017000972],"category_scores_gemma":[0.00030189563,0.00021028171,0.000095943826,0.0002917449,0.00009712498,0.00005152955,0.00021647708,0.00029371094,5.04494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010274376,0.0012499485,0.9813275,0.00021791966,0.0009390948,0.000020573158,0.0013048731,0.0004147974,0.000015136993,0.000015071817,0.00016559834,0.004055139],"study_design_scores_gemma":[0.09021751,0.0025337718,0.90370256,0.0014501767,0.00091133494,2.0439111e-7,0.00069106143,0.000035759404,0.000093280374,0.00012499132,0.00005285989,0.00018646779],"about_ca_topic_score_codex":0.6238442,"about_ca_topic_score_gemma":0.7688499,"teacher_disagreement_score":0.14500573,"about_ca_system_score_codex":0.00044300198,"about_ca_system_score_gemma":0.0009923534,"threshold_uncertainty_score":0.8575039},"labels":[],"label_agreement":null},{"id":"W4362541435","doi":"10.1158/1538-7445.am2023-6499","title":"Abstract 6499: Towards a combined immunohistochemistry-based subtyping of ovarian endometrioid carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Immunohistochemistry; Medicine; Tissue microarray; Hazard ratio; Oncology; Population; Stage (stratigraphy); PTEN; Pathology; Subtyping; Internal medicine; Ovarian carcinoma; Carcinoma; Cancer; Ovarian cancer; Biology; Confidence interval","score_opus":0.10543866130781597,"score_gpt":0.42253028598887005,"score_spread":0.31709162468105406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362541435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668784,0.0021501463,0.0000073698884,0.0041732746,0.00019463952,0.00073354895,0.00012703941,0.00008395003,0.005842183],"genre_scores_gemma":[0.9977683,0.00040473178,0.000109742294,0.00006885245,0.00017364489,0.0005928866,0.00012094457,0.000045182547,0.00071573706],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99760264,0.000054448636,0.0003578424,0.00043348252,0.0009247026,0.0006268947],"domain_scores_gemma":[0.9981657,0.00032920818,0.00008553181,0.00065698224,0.0005175317,0.00024502666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090656977,0.00017302272,0.00043896536,0.0006091081,0.00014365769,0.000029795627,0.00022223157,0.000119781296,0.0014003984],"category_scores_gemma":[0.0003319013,0.00015620796,0.00018053949,0.00209307,0.00021967947,0.00004165869,0.0000881579,0.00042568005,0.00008777724],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042173597,0.0013745412,0.12213082,0.0033863015,0.00080127653,0.00112114,0.00085434876,0.00010442226,0.78153193,0.00059962535,0.02923017,0.054648053],"study_design_scores_gemma":[0.007558469,0.00057835307,0.49559978,0.00061665283,0.000070333794,0.0000053307494,0.00018107968,0.000121252255,0.49054217,0.00009063352,0.0044545042,0.00018142605],"about_ca_topic_score_codex":0.003909773,"about_ca_topic_score_gemma":0.000020252794,"teacher_disagreement_score":0.37346897,"about_ca_system_score_codex":0.00088169164,"about_ca_system_score_gemma":0.0019601244,"threshold_uncertainty_score":0.99951243},"labels":[],"label_agreement":null},{"id":"W4362550449","doi":"10.1136/ijgc-2022-004202","title":"Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Stage (stratigraphy); Ovarian cancer; Chemotherapy; Internal medicine; Oncology; Surgery; Cytoreductive surgery; Neoadjuvant therapy; Cancer; Breast cancer","score_opus":0.05024807923466793,"score_gpt":0.3719066315430669,"score_spread":0.32165855230839896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362550449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835725,0.00018131957,0.002932505,0.005415377,0.0022756322,0.00042494733,0.00035172512,0.000009958873,0.000051303407],"genre_scores_gemma":[0.9961915,0.0006316342,0.0025146783,0.00012288602,0.00021850034,0.00013618253,0.000021755643,0.000009429889,0.00015343771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986181,0.000034085617,0.0006943799,0.00012686219,0.00041673586,0.000109784196],"domain_scores_gemma":[0.99829316,0.00013769309,0.0005703867,0.00008001634,0.00087835174,0.000040385446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031104565,0.00009402011,0.0003064156,0.00019518679,0.000019641542,0.0000063774055,0.00015161674,0.0000865607,0.0001541101],"category_scores_gemma":[0.0002564287,0.000057495836,0.00019971085,0.00028723135,0.000053152966,0.000115914154,0.000027829154,0.00015124306,4.2371505e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001296745,0.0009016376,0.5454694,0.00006679743,0.0007679365,0.000018295777,0.0003511567,0.15319912,0.0148095125,0.00049415295,0.0012925229,0.28133273],"study_design_scores_gemma":[0.006574879,0.00066703995,0.8920142,0.00047268876,0.0002347506,0.00001761289,0.00017562679,0.061130602,0.036395926,0.0013450885,0.0008827007,0.00008887471],"about_ca_topic_score_codex":0.00012298701,"about_ca_topic_score_gemma":0.000050344748,"teacher_disagreement_score":0.3465448,"about_ca_system_score_codex":0.00070597196,"about_ca_system_score_gemma":0.0002996805,"threshold_uncertainty_score":0.23446122},"labels":[],"label_agreement":null},{"id":"W4362567547","doi":"10.1158/1940-6207.c.6544857","title":"Data from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Biomarker; Medicine; Oncology; Internal medicine; Cancer; Population; Colorectal cancer; Prostate cancer; Asymptomatic; Prostate; Lung cancer; Gastroenterology; Biology","score_opus":0.11935404915448869,"score_gpt":0.36525837162135233,"score_spread":0.24590432246686364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362567547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95263296,0.0070970883,0.00011491031,0.0136698,0.004388125,0.0075615076,0.01126081,0.00034712895,0.002927694],"genre_scores_gemma":[0.94618404,0.02945039,0.005415859,0.00065650954,0.0023337007,0.0041856207,0.0073711127,0.00026873095,0.0041340254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954222,0.00011554601,0.00095620734,0.0021608935,0.00060544134,0.0007397517],"domain_scores_gemma":[0.99725974,0.00021890595,0.0003777904,0.001674881,0.00012078909,0.0003479048],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006017958,0.00074398523,0.0013338571,0.00040180862,0.00013941216,0.00021382773,0.00048376338,0.0004714635,0.0029129602],"category_scores_gemma":[0.00006803638,0.0006267849,0.00012942129,0.00046670396,0.00014543593,0.00023548643,0.0019169444,0.0009017695,0.000035377983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039052658,0.0009840286,0.87008375,0.0008946073,0.004548066,0.00075488864,0.0008209026,0.0002314715,0.00015435326,0.000060897677,0.050710816,0.031703535],"study_design_scores_gemma":[0.05939989,0.0002921852,0.90413344,0.0033224812,0.0011855335,0.000007688585,0.000108004744,0.016897803,0.00024377836,0.00006934832,0.013594371,0.00074547256],"about_ca_topic_score_codex":0.06261896,"about_ca_topic_score_gemma":0.02832957,"teacher_disagreement_score":0.037116446,"about_ca_system_score_codex":0.0007581367,"about_ca_system_score_gemma":0.0013257382,"threshold_uncertainty_score":0.99961835},"labels":[],"label_agreement":null},{"id":"W4362594902","doi":"10.1158/1538-7445.am2023-79","title":"Abstract 79: Study of tumor microenvironment of ovarian clear cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"Tumor microenvironment; Medicine; CD8; Immunotherapy; Carboplatin; Tissue microarray; Immune system; Cancer research; Chemotherapy; Oncology; Cancer; Internal medicine; Immunology; Cisplatin","score_opus":0.0914925713484444,"score_gpt":0.38798600666972943,"score_spread":0.296493435321285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362594902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954667,0.00066874793,2.0722132e-7,0.00072640274,0.00008699102,0.0010788114,0.00005329069,0.000015412974,0.0019034427],"genre_scores_gemma":[0.9984793,0.00035597806,0.00002647506,0.000024481564,0.00010344986,0.00027991371,0.000009446994,0.000034055316,0.0006868935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805266,0.00007579983,0.00033107557,0.0003539814,0.00078871835,0.00039777928],"domain_scores_gemma":[0.99896634,0.00011878637,0.00008322875,0.0005473734,0.00012463558,0.00015966191],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005524917,0.000118397766,0.00034885452,0.00027768392,0.000066145534,0.000008353358,0.00015403677,0.00003964143,0.0010677831],"category_scores_gemma":[0.000020984511,0.00009961847,0.00008037294,0.00057601416,0.00012689254,0.000028895425,0.00012845136,0.0002484371,0.000120825236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016222333,0.0068214824,0.8066522,0.0013737237,0.0003650762,0.00090966665,0.0047151065,0.00014102554,0.15149063,0.000055468085,0.019043498,0.0068099126],"study_design_scores_gemma":[0.0035444328,0.0020170477,0.87217855,0.00011134709,0.000059461596,0.0000018584557,0.0025774639,0.000008132592,0.11747336,0.000013969198,0.0019463075,0.00006804647],"about_ca_topic_score_codex":0.003868706,"about_ca_topic_score_gemma":0.000118467615,"teacher_disagreement_score":0.065526396,"about_ca_system_score_codex":0.0003101771,"about_ca_system_score_gemma":0.00027769033,"threshold_uncertainty_score":0.9998454},"labels":[],"label_agreement":null},{"id":"W4362595523","doi":"10.1158/1538-7445.am2023-4248","title":"Abstract 4248: Epithelial ovarian cancer causes cardiac dysfunction and myofilament dysregulation","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; York University; University of New Brunswick; University of Guelph","funders":"","keywords":"Medicine; Ovarian cancer; Myofilament; Cancer; Internal medicine; Cardiac function curve; Endocrinology; Ascites; Cardiology; Pathology; Heart failure; Myocyte","score_opus":0.09961862735893834,"score_gpt":0.41390991680022876,"score_spread":0.3142912894412904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362595523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981382,0.0030622804,0.000004009762,0.011745594,0.0008830166,0.0009905384,0.00020026667,0.000121231235,0.0016110308],"genre_scores_gemma":[0.9855854,0.009458844,0.000027651062,0.000115705676,0.0011865188,0.0013236976,0.000078465964,0.0000443809,0.0021793353],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99786806,0.000078597,0.00022282904,0.00051233097,0.0007753776,0.0005428312],"domain_scores_gemma":[0.9989344,0.00015092608,0.000047689962,0.00033650702,0.0002760308,0.00025446585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000655094,0.00016728879,0.0002958927,0.00032131065,0.00026833598,0.00008041181,0.00006137934,0.00011405958,0.0010258633],"category_scores_gemma":[0.000050762344,0.00014045244,0.00007962299,0.00071070326,0.00014049344,0.00011647214,0.000058822734,0.0002949033,0.00016640767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013511406,0.00039519102,0.3567087,0.00092978217,0.0013980735,0.00027190277,0.0018390644,0.00040468172,0.17890653,0.0017974561,0.09337998,0.3626175],"study_design_scores_gemma":[0.0017852152,0.00020149277,0.92407274,0.000341697,0.0001067576,0.0000025460943,0.00024712732,0.000071130155,0.029156107,0.00019425827,0.04367319,0.00014776165],"about_ca_topic_score_codex":0.00541921,"about_ca_topic_score_gemma":0.0003850685,"teacher_disagreement_score":0.56736404,"about_ca_system_score_codex":0.00083605736,"about_ca_system_score_gemma":0.0005072994,"threshold_uncertainty_score":0.99988735},"labels":[],"label_agreement":null},{"id":"W4362601724","doi":"10.1186/s12935-023-02910-0","title":"High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model","year":2023,"lang":"en","type":"article","venue":"Cancer Cell International","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alpha Cancer Technologies","funders":"","keywords":"Colorectal cancer; Alpha (finance); Conjugate; Medicine; Cancer research; Alpha-fetoprotein; Alpha-2 adrenergic receptor; Receptor; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.022690578234097494,"score_gpt":0.2971315900330064,"score_spread":0.2744410117989089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362601724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915618,0.0009909609,0.00040587044,0.0028099078,0.0015791588,0.0010650756,0.00058812293,0.00007761799,0.00092153094],"genre_scores_gemma":[0.9939822,0.0018271859,0.0014127471,0.00027940574,0.00044582007,0.0011554509,0.00014223371,0.00006836529,0.0006865712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997603,0.00003591521,0.00056870235,0.00066336256,0.00064361823,0.00048542226],"domain_scores_gemma":[0.9988635,0.00007884163,0.0003749562,0.00021775263,0.00029960784,0.00016533035],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027825797,0.00034558494,0.00061369553,0.00026161634,0.00007183349,0.00002977318,0.00023035168,0.00012893998,0.0016253244],"category_scores_gemma":[0.000042375017,0.00033000472,0.0002015164,0.00038752143,0.00012983505,0.0002436273,0.00012337649,0.00029818696,0.00002949461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014752053,0.002141254,0.08330912,0.00040088565,0.00076633156,0.00020140075,0.0010630676,0.03513003,0.8572464,0.00067506783,0.0052820477,0.01230916],"study_design_scores_gemma":[0.007356162,0.0002441278,0.0356071,0.0007143771,0.00013388635,0.0000075375,0.00012766405,0.0670384,0.8854573,0.00008817955,0.0027929903,0.00043231153],"about_ca_topic_score_codex":0.011044022,"about_ca_topic_score_gemma":0.0012442953,"teacher_disagreement_score":0.047702022,"about_ca_system_score_codex":0.0012802632,"about_ca_system_score_gemma":0.0006397734,"threshold_uncertainty_score":0.9999152},"labels":[],"label_agreement":null},{"id":"W4362634433","doi":"10.3390/curroncol30040307","title":"Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"KRAS; Medicine; Ovarian cancer; Mucinous carcinoma; Mucinous Tumor; Mucinous cystadenoma; Genetic heterogeneity; Pathology; Tumor heterogeneity; Oncology; Cancer; Adenocarcinoma; Cancer research; Ovary; Internal medicine; Colorectal cancer; Biology; Gene; Genetics; Phenotype","score_opus":0.22887270751488037,"score_gpt":0.392083498068895,"score_spread":0.1632107905540146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362634433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950168,0.0015882839,0.0000053159306,0.001488324,0.0005959692,0.00074235525,0.0000057445864,0.000051406623,0.000505779],"genre_scores_gemma":[0.9991535,0.00043158978,0.000058763795,0.00008241343,0.000096784155,0.00010894086,0.000010587374,0.0000072602415,0.000050187013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895525,0.00011204492,0.00018462457,0.00036937647,0.00012204645,0.00025667663],"domain_scores_gemma":[0.99951684,0.000104159466,0.00004382269,0.00017581254,0.000027887347,0.00013148549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013261035,0.000120634664,0.00036642753,0.00016863701,0.00009207024,0.0000048293114,0.00006077933,0.000044860946,0.00008598997],"category_scores_gemma":[0.000043732645,0.00009981783,0.000028062288,0.00024701917,0.00007226897,0.00001607379,0.00028428878,0.00017061539,0.00005829418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020941354,0.004275869,0.96041626,0.000030014804,0.000042818934,0.001967564,0.0012488349,0.0000016622025,0.000019167777,0.000058292717,0.0011269345,0.030603142],"study_design_scores_gemma":[0.0058607254,0.008896301,0.97996604,0.000019028903,0.00015859294,0.00006842759,0.00035309282,0.00005476504,0.0000026037578,0.000102182494,0.0044349735,0.00008325173],"about_ca_topic_score_codex":0.0003559321,"about_ca_topic_score_gemma":0.00049031246,"teacher_disagreement_score":0.03051989,"about_ca_system_score_codex":0.00042517425,"about_ca_system_score_gemma":0.00010482715,"threshold_uncertainty_score":0.4070453},"labels":[],"label_agreement":null},{"id":"W4362658873","doi":"10.1016/j.jcpo.2023.100421","title":"Real-world outcomes associated with use of front-line bevacizumab in ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Cancer Policy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"Queen's University","keywords":"Bevacizumab; Ovarian cancer; Medicine; Front line; Oncology; Intensive care medicine; Cancer; Internal medicine; Gynecology; Political science; Chemotherapy","score_opus":0.05700860424702941,"score_gpt":0.384054083392304,"score_spread":0.3270454791452746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362658873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657171,0.00059439504,0.000004906351,0.032129776,0.0003179622,0.00030735857,0.00018462187,0.00002127328,0.0007226163],"genre_scores_gemma":[0.98986423,0.005029979,0.0001956012,0.00080936245,0.0005348367,0.000048026726,0.000009398572,0.00004340369,0.003465154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818087,0.000056533245,0.0007175968,0.000165165,0.0005267563,0.00035308508],"domain_scores_gemma":[0.9983582,0.00019465406,0.0007043382,0.00022297063,0.00032556316,0.0001942953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023999202,0.00020162563,0.0008779056,0.00089590746,0.000029947758,0.00001977467,0.000093482144,0.00007529164,0.00026639746],"category_scores_gemma":[0.0001801591,0.00013550215,0.00018653017,0.0011332826,0.00005656707,0.00017468579,0.00002704107,0.00026243992,0.000003991911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073634036,0.00037334635,0.9815606,0.000056874276,0.001280709,0.00031055533,0.0006023642,0.001408838,0.000183106,0.0002578021,0.0059143333,0.0073151533],"study_design_scores_gemma":[0.007962108,0.00048317385,0.98474866,0.001244879,0.0004222679,0.000008762258,0.00004118147,0.00007221756,0.0010850675,0.00010005839,0.0037106224,0.000120975914],"about_ca_topic_score_codex":0.048480533,"about_ca_topic_score_gemma":0.047549274,"teacher_disagreement_score":0.031320415,"about_ca_system_score_codex":0.0015645828,"about_ca_system_score_gemma":0.0018558541,"threshold_uncertainty_score":0.96983045},"labels":[],"label_agreement":null},{"id":"W4365459983","doi":"10.1016/j.jogc.2023.04.005","title":"Giant Mucinous Borderline Ovarian Tumor Presenting Alongside Perforated Peptic Ulcers","year":2023,"lang":"en","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Mucinous Tumor; Medicine; Peptic; Ovarian tumor; Ovary; Ovarian cancer; Internal medicine; General surgery; Peptic ulcer; Cancer; Pancreas","score_opus":0.010596150025789357,"score_gpt":0.24849123210679308,"score_spread":0.2378950820810037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365459983","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017504644,0.0059214886,0.0000041854246,0.0013136652,0.97428226,0.00036090804,0.00020477716,0.000017358652,0.0003907182],"genre_scores_gemma":[0.54064506,0.0060375687,0.0016886486,0.0009351411,0.4443004,0.00007522388,0.00073875586,0.000487122,0.0050920667],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99657154,0.00009383385,0.0011403699,0.00043587317,0.0011220525,0.00063630374],"domain_scores_gemma":[0.989101,0.007331838,0.0013040629,0.00031835225,0.0013614703,0.0005832678],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005107327,0.00043962017,0.0013905338,0.0005907287,0.000192907,0.00007880347,0.00021905998,0.00053203665,0.0004329654],"category_scores_gemma":[0.01665322,0.0003598753,0.00020615417,0.0007162526,0.00008088367,0.00006583278,0.00009655683,0.0015335592,0.000004520489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023373717,0.00016912253,0.0070069465,0.00033178975,0.0012485083,0.06565721,0.00006596012,0.00006363781,0.0000011348446,0.0000062263775,0.9149809,0.010445196],"study_design_scores_gemma":[0.008960245,0.0017612523,0.09265598,0.00017086435,0.00230145,0.0003315305,0.0003107566,0.00037191296,0.000013938563,0.00003342232,0.8926097,0.0004789287],"about_ca_topic_score_codex":0.05918832,"about_ca_topic_score_gemma":0.077351734,"teacher_disagreement_score":0.52998185,"about_ca_system_score_codex":0.003290797,"about_ca_system_score_gemma":0.014176664,"threshold_uncertainty_score":0.9998853},"labels":[],"label_agreement":null},{"id":"W4366827238","doi":"10.1101/2023.04.21.23288934","title":"Hormone Receptor Expression and Disease Prognosis in High-Grade Serous Ovarian Cancer","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; National Institutes of Health; Sylvester Comprehensive Cancer Center, University of Miami Health Systems","keywords":"Ovarian cancer; Cancer research; Transcriptome; Biology; Signal transduction; Oncology; Internal medicine; Cancer; Medicine; Gene expression; Gene","score_opus":0.03837770802732813,"score_gpt":0.30015615928063766,"score_spread":0.2617784512533095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366827238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612214,0.008066434,0.000015386218,0.027570073,0.000949103,0.0016324783,0.0003236163,0.00018579952,0.00003573488],"genre_scores_gemma":[0.98013705,0.01351531,0.0011292958,0.00026560607,0.0005419792,0.0034098604,0.0002685066,0.00010669635,0.0006257143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976779,0.00009553652,0.0004245399,0.0010014635,0.00040301427,0.00039753414],"domain_scores_gemma":[0.99852693,0.00008172329,0.00016835486,0.00057300983,0.000058788628,0.00059120456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021185768,0.00041539068,0.00069513224,0.0002474399,0.00006173653,0.000057045272,0.00013637225,0.00027175734,0.00015373202],"category_scores_gemma":[0.00011822305,0.00033939123,0.00012696267,0.00024011487,0.000067529174,0.000048373277,0.0004106997,0.00053655484,0.00004331472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037246093,0.0007281767,0.9821899,0.0007192057,0.0002094805,0.0006632627,0.00035324384,0.00003974577,0.0012007364,0.0000626847,0.008662553,0.0047985637],"study_design_scores_gemma":[0.0029507596,0.00012953329,0.98924327,0.0026572666,0.0003752859,0.0000026243408,0.000027979859,0.000096395874,0.0015431147,0.0006920705,0.0019552195,0.00032649524],"about_ca_topic_score_codex":0.0018817936,"about_ca_topic_score_gemma":0.00018420583,"teacher_disagreement_score":0.027304467,"about_ca_system_score_codex":0.00033669063,"about_ca_system_score_gemma":0.00039172752,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W4367323333","doi":"10.21203/rs.3.rs-2840508/v1","title":"Temporal and disease-site specific transcriptional and phenotypic changes in response to neoadjuvant chemotherapy in high-grade serous ovarian cancers","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transcriptome; Biology; Ovarian cancer; Genome instability; RAD51; Serous fluid; Phenotype; Chemotherapy; Ovary; Cancer research; Homologous recombination; Pathology; DNA damage; Medicine; Cancer; Gene; DNA; Genetics; Gene expression","score_opus":0.08138692263707871,"score_gpt":0.36983601525803145,"score_spread":0.28844909262095275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367323333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89375645,0.0062998,0.000008879379,0.09643067,0.00018199795,0.0026176104,0.0006351366,0.000048826823,0.000020634418],"genre_scores_gemma":[0.98676246,0.009871984,0.00044800807,0.0003169964,0.00032246808,0.0012874567,0.00027461187,0.000085164866,0.0006308365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661195,0.0004540668,0.0003248758,0.001086887,0.00083904323,0.0006831682],"domain_scores_gemma":[0.9982672,0.0003178047,0.000045401634,0.00053681957,0.00011193802,0.00072084455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013980399,0.0003369359,0.000623435,0.001175491,0.00008872829,0.000114416594,0.00012912636,0.00022145097,0.00015491138],"category_scores_gemma":[0.00011294087,0.0003123381,0.00006613804,0.00062855636,0.00015340636,0.000036998037,0.00019980456,0.0009118424,0.00002161834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034536876,0.0011382597,0.90823275,0.0029335776,0.00025877764,0.005137559,0.009996252,0.00048326826,0.0021933909,0.0008423611,0.005469548,0.028777385],"study_design_scores_gemma":[0.005529719,0.0006160762,0.98037183,0.0030350287,0.00002080275,0.0000064582664,0.0003960625,0.0001267134,0.000052434378,0.0012830079,0.008306083,0.00025577433],"about_ca_topic_score_codex":0.008987461,"about_ca_topic_score_gemma":0.014864787,"teacher_disagreement_score":0.096113674,"about_ca_system_score_codex":0.0016105486,"about_ca_system_score_gemma":0.00101138,"threshold_uncertainty_score":0.9999329},"labels":[],"label_agreement":null},{"id":"W4372050320","doi":"10.3802/jgo.2023.34.s1.tip04","title":"Oregovomab and non-platinum chemotherapy in PARP inhibitor resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: a multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6)","year":2023,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ovarian cancer; Fallopian tube; Medicine; Fallopian tube cancer; Chemotherapy; Platinum; Oncology; Internal medicine; Gynecology; Cancer; Biology","score_opus":0.02628319096867636,"score_gpt":0.31878767543099756,"score_spread":0.2925044844623212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372050320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865747,0.00015592585,0.000029946588,0.0024102454,0.0009528015,0.0077359523,0.0011954185,0.00016720046,0.0007777724],"genre_scores_gemma":[0.9871367,0.00070293166,0.0027237567,0.0014052764,0.000794832,0.0031887281,0.0011522789,0.0001642084,0.0027312776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960194,0.00008160574,0.0010957278,0.0012317344,0.0006251824,0.00094630785],"domain_scores_gemma":[0.9981974,0.0003493878,0.00028613172,0.0005663875,0.00016984798,0.00043089248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032732188,0.0006948924,0.0012196819,0.00034322657,0.00024891595,0.00014569594,0.00013916513,0.00024036116,0.00044763496],"category_scores_gemma":[0.00011694811,0.0005099042,0.0002204758,0.0006035611,0.00011664368,0.00023973688,0.000092904935,0.00024117497,0.000013527186],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5941047,0.031270266,0.24078031,0.0011568054,0.002998176,0.0012154456,0.0058814753,0.000019631087,0.0112228915,0.00016660402,0.010509901,0.100673765],"study_design_scores_gemma":[0.7582172,0.023145197,0.16750997,0.001652575,0.0010488029,0.000017319335,0.00033387812,0.0025095218,0.030506065,0.000041802403,0.013757058,0.001260603],"about_ca_topic_score_codex":0.0032974354,"about_ca_topic_score_gemma":0.0038164721,"teacher_disagreement_score":0.16411246,"about_ca_system_score_codex":0.0013216416,"about_ca_system_score_gemma":0.00049644907,"threshold_uncertainty_score":0.99973524},"labels":[],"label_agreement":null},{"id":"W4372050383","doi":"10.3802/jgo.2023.34.s1.tip05","title":"Phase 1b/2, single arm study to evaluate the safety and activity of oregovomab and bevacizumab, paclitaxel, carboplatin BRCA-wild type platinum sensitive recurrent epithelial ovarian cancer (KCSG GY20-10/KM-21)","year":2023,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Paclitaxel; Bevacizumab; Ovarian cancer; Oncology; Medicine; Epithelial ovarian cancer; Internal medicine; Cancer; Cancer research; Chemotherapy; Cisplatin","score_opus":0.045813319772719734,"score_gpt":0.3510739981633067,"score_spread":0.30526067839058696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372050383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892561,0.0002598245,0.000025444662,0.0060521094,0.00036765702,0.0022474774,0.00040708057,0.00007214783,0.0013121618],"genre_scores_gemma":[0.9982791,0.00027108123,0.00012654778,0.00020781295,0.00020679906,0.0000999119,0.000034744164,0.000040403833,0.0007336189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99777687,0.00024070803,0.00041538643,0.0006540901,0.0005214602,0.00039149838],"domain_scores_gemma":[0.9983788,0.00047867742,0.00014021917,0.00047885836,0.00026291382,0.00026051883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006978967,0.00034571686,0.00068156567,0.00013852018,0.00020868449,0.000043193544,0.00006845369,0.00007745743,0.00026959286],"category_scores_gemma":[0.00021597081,0.00022459259,0.00007854678,0.00059851067,0.00012405988,0.00008070962,0.00017457335,0.00020196372,0.000022713637],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033728905,0.036438245,0.026629947,0.0003916351,0.0048696613,0.0005914163,0.038917642,0.00013856187,0.02288606,0.00060993386,0.007960908,0.82683706],"study_design_scores_gemma":[0.1130209,0.062314916,0.7061407,0.0012046951,0.004919603,0.00012774584,0.01170348,0.006344836,0.083237074,0.00030426035,0.009180461,0.0015013177],"about_ca_topic_score_codex":0.002297316,"about_ca_topic_score_gemma":0.0022204171,"teacher_disagreement_score":0.82533574,"about_ca_system_score_codex":0.00028239557,"about_ca_system_score_gemma":0.00023906985,"threshold_uncertainty_score":0.91586196},"labels":[],"label_agreement":null},{"id":"W4375948862","doi":"10.1148/radiol.223281","title":"Adnexal Lesion Imaging: Past, Present, and Future","year":2023,"lang":"en","type":"review","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Ovarian cancer; Radiology; Adnexal Diseases; Adnexal mass; Modality (human–computer interaction); Lesion; Cancer; Surgery; Laparoscopy; Internal medicine","score_opus":0.07942863989461559,"score_gpt":0.3832059903674659,"score_spread":0.3037773504728503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375948862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035181686,0.9929838,0.0000023717596,0.004317602,0.00080846495,0.00073229417,0.000046598005,0.00008142632,0.0010239023],"genre_scores_gemma":[0.0000025641805,0.98874056,0.000085003085,0.00012778469,0.0095700305,0.00020953166,0.00030303255,0.00006178106,0.0008997131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987038,0.00011842799,0.00030837444,0.00050621165,0.0000862635,0.00027694707],"domain_scores_gemma":[0.9991693,0.00017180874,0.00013291399,0.00035641665,0.00002115295,0.00014843213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010618475,0.00030513687,0.0015602442,0.00015408889,0.000045957207,0.000011165391,0.00007213545,0.000275773,0.00010589431],"category_scores_gemma":[0.0000071528884,0.0002027474,0.00025236246,0.00014707867,0.0000771621,0.000017158656,0.00007056471,0.0002833295,0.00015633284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007679262,0.000040275692,0.00031451607,0.004956704,0.00034392465,0.00048359047,0.000015045303,1.4478562e-8,3.9184382e-8,0.00022391493,0.09667037,0.8969439],"study_design_scores_gemma":[0.00055810023,0.00013799263,0.0009024587,0.0026551825,0.0015855948,0.001763595,0.000009017167,0.0000019277495,7.947268e-8,0.000037750036,0.9922023,0.0001460191],"about_ca_topic_score_codex":0.000016474032,"about_ca_topic_score_gemma":0.0000011521977,"teacher_disagreement_score":0.8967979,"about_ca_system_score_codex":0.0001254076,"about_ca_system_score_gemma":0.00016552577,"threshold_uncertainty_score":0.8267799},"labels":[],"label_agreement":null},{"id":"W4376289035","doi":"10.1016/j.ygyno.2023.05.003","title":"Safety of fertility sparing management in invasive mucinous ovarian carcinoma","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"Sunnybrook Research Institute","keywords":"Medicine; Fertility; Hazard ratio; Fertility preservation; Radical surgery; Surgery; Retrospective cohort study; Hysterectomy; Proportional hazards model; Stage (stratigraphy); Cancer; Internal medicine; Confidence interval; Population","score_opus":0.040373967114337286,"score_gpt":0.3130041463989331,"score_spread":0.2726301792845958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376289035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93641734,0.00012672204,0.000009376354,0.0033386347,0.00041161623,0.0010386568,0.000011236528,0.00007940755,0.05856703],"genre_scores_gemma":[0.9972683,0.00041658143,0.000993467,0.000508257,0.000035217996,0.00026141637,0.0000424643,0.000013413698,0.00046083867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983146,0.00013094963,0.0005089789,0.00044829043,0.00015317797,0.00044400737],"domain_scores_gemma":[0.99874914,0.00055603916,0.00013850429,0.00039506765,0.000053644613,0.0001075853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052597804,0.00016879383,0.00064459967,0.00029149943,0.000051511317,0.0000038235607,0.00012293445,0.00019638373,0.00055528356],"category_scores_gemma":[0.00018686254,0.00014383667,0.000107385466,0.0006019966,0.000096868716,0.000032155785,0.0001919357,0.00017487745,0.00014729361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006222116,0.0012395947,0.9163818,0.0002166061,0.00023522662,0.0035316367,0.00047982033,0.00012934463,0.00012565385,0.0021675862,0.0008754548,0.07399511],"study_design_scores_gemma":[0.005148897,0.0014520854,0.9865479,0.000039373663,0.0001438653,0.000019372017,0.0005209888,0.00008252946,0.000506401,0.0008925752,0.0045411326,0.000104862556],"about_ca_topic_score_codex":0.00033399856,"about_ca_topic_score_gemma":0.0011955777,"teacher_disagreement_score":0.07389025,"about_ca_system_score_codex":0.0010104756,"about_ca_system_score_gemma":0.00027744914,"threshold_uncertainty_score":0.6079966},"labels":[],"label_agreement":null},{"id":"W4379281331","doi":"10.1200/jco.2023.41.16_suppl.5578","title":"Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Olaparib; Chemotherapy; Oncology; Progression-free survival; Cancer; Ovarian cancer; Retrospective cohort study; Poly ADP ribose polymerase","score_opus":0.11437305139472029,"score_gpt":0.47365586000055415,"score_spread":0.35928280860583384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78942126,0.00015489034,0.000018092805,0.20752262,0.00233823,0.00037392942,0.000031642183,0.000015959955,0.0001233899],"genre_scores_gemma":[0.98219866,0.0007320355,0.0020758193,0.0129285,0.0018161886,0.000054344393,0.000006500597,0.000031283995,0.00015665064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99611294,0.0006648496,0.0021418054,0.00028703563,0.00044005873,0.00035329768],"domain_scores_gemma":[0.9952326,0.0027901845,0.00083806826,0.00023361249,0.00034107186,0.00056450756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050433064,0.00017964277,0.0013480271,0.00036680233,0.00003256846,0.000011957034,0.00014425653,0.00031203282,0.00037925263],"category_scores_gemma":[0.0028695373,0.00013046451,0.00044109323,0.00052077044,0.00008057155,0.000049060567,0.000031663923,0.000696442,0.00008925569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13088194,0.0043535805,0.1605008,0.000042175212,0.0004683095,0.0051567615,0.00056434976,0.00039726493,0.0030213844,0.000059586808,0.025216283,0.6693376],"study_design_scores_gemma":[0.024502097,0.02253259,0.7678568,0.0004417111,0.000117182586,0.000041425938,0.000069611146,0.00009546747,0.0010709217,0.00008067136,0.18307054,0.00012099818],"about_ca_topic_score_codex":0.00014762618,"about_ca_topic_score_gemma":0.00041837536,"teacher_disagreement_score":0.6692166,"about_ca_system_score_codex":0.00085872767,"about_ca_system_score_gemma":0.004977326,"threshold_uncertainty_score":0.88295627},"labels":[],"label_agreement":null},{"id":"W4379281948","doi":"10.1200/jco.2023.41.16_suppl.tps5617","title":"CRI-CCTG-0003/IND.240: An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Immunotherapy; Internal medicine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Biomarker; Ovarian cancer; Progression-free survival; Clinical trial; Cancer; Phases of clinical research; Chemotherapy","score_opus":0.19965416869474437,"score_gpt":0.5005382425116133,"score_spread":0.3008840738168689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379281948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818761,0.00047544183,0.000009554126,0.014257889,0.0022224593,0.00071111077,0.000018472,0.00003824328,0.0003907554],"genre_scores_gemma":[0.99361384,0.0016371337,0.00089020294,0.0017978038,0.0016169212,0.00007738133,0.000009032756,0.000053276708,0.0003044172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99508065,0.00037536316,0.0030045067,0.0004134914,0.0006335176,0.0004924687],"domain_scores_gemma":[0.9960663,0.0013958327,0.0014066066,0.00041504347,0.0002629859,0.00045327013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034619556,0.00028062824,0.00211021,0.00036021945,0.00008432123,0.000029126353,0.00028329482,0.00043050904,0.0005068373],"category_scores_gemma":[0.00046129798,0.00019770584,0.00034845347,0.00057813054,0.000115878254,0.00022472169,0.000057703455,0.001212539,0.000041359475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013754744,0.017817145,0.73326415,0.00004045965,0.001745153,0.010302645,0.0019850184,0.00016753639,0.00024779068,0.00047863484,0.0043071387,0.21588956],"study_design_scores_gemma":[0.03231283,0.03184121,0.9154345,0.00015826039,0.00038037286,0.000115886825,0.0008773879,0.000055900317,0.00006180488,0.0011839664,0.017399052,0.00017887444],"about_ca_topic_score_codex":0.0015054676,"about_ca_topic_score_gemma":0.003241185,"teacher_disagreement_score":0.21571068,"about_ca_system_score_codex":0.0007137456,"about_ca_system_score_gemma":0.0021492047,"threshold_uncertainty_score":0.806221},"labels":[],"label_agreement":null},{"id":"W4379334626","doi":"10.1200/jco.2023.41.16_suppl.5567","title":"Proactive assessment of patient reported outcomes in patients with ovarian cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Observational study; MEDLINE; Ovarian cancer; Quartile; Cancer; Quality of life (healthcare); Clinical trial; Internal medicine; Confidence interval","score_opus":0.1074612622490358,"score_gpt":0.49483671187199757,"score_spread":0.3873754496229618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379334626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070144,0.000025286216,0.000006958461,0.0069538387,0.0007068553,0.00044569565,0.000007610641,0.0000061727687,0.0011461705],"genre_scores_gemma":[0.9972884,0.00018049667,0.0018824874,0.00045001294,0.00009902716,0.000029591389,0.0000049684722,0.000012688194,0.00005231054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968313,0.00019125482,0.0021413756,0.0001751967,0.00048696538,0.0001739301],"domain_scores_gemma":[0.9960327,0.0008083468,0.0022883078,0.00017895234,0.0005062518,0.00018541278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010710483,0.00011311368,0.0014534022,0.00018439721,0.000014327187,0.0000028912361,0.00006199276,0.00015577082,0.00007701338],"category_scores_gemma":[0.00068929396,0.00006541501,0.0002351993,0.00030092016,0.00008016649,0.0000650047,0.000031777807,0.00045059298,0.0000015197351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019474664,0.0053922613,0.9133261,0.000016364193,0.0012826141,0.0005621041,0.00009517583,0.00006494783,0.0000011718391,0.000052155563,0.00045254536,0.07680713],"study_design_scores_gemma":[0.017010959,0.02039179,0.9597726,0.0001628208,0.0004295046,0.00000886358,0.00008574689,0.00002224633,0.000020645346,0.00006194036,0.0019760712,0.000056812143],"about_ca_topic_score_codex":0.00011226567,"about_ca_topic_score_gemma":0.000081945436,"teacher_disagreement_score":0.07675031,"about_ca_system_score_codex":0.00040306442,"about_ca_system_score_gemma":0.0022941027,"threshold_uncertainty_score":0.40696394},"labels":[],"label_agreement":null},{"id":"W4380149657","doi":"10.1016/j.jval.2023.03.1016","title":"EPH134 Accurately Counting Cancer Patients: An Epidemiologic Model to Estimate the Prevalence of Epithelial Ovarian Cancer (EOC) While Accounting for Cure","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Disease; Epithelial ovarian cancer; Ovarian cancer; Cancer; Internal medicine; Estimation; Oncology; Cure rate","score_opus":0.1665433368578929,"score_gpt":0.43834770719090455,"score_spread":0.27180437033301164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737645,0.0012304685,0.00034673003,0.020161578,0.00053469156,0.002792838,0.001051999,0.00008013062,0.0000370636],"genre_scores_gemma":[0.98965013,0.002582011,0.0030831832,0.0025175428,0.00029784057,0.0016856762,0.000048517108,0.00004536344,0.00008975329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758023,0.00015505766,0.0007785381,0.0005287305,0.0002975708,0.00065985706],"domain_scores_gemma":[0.9982304,0.0005580644,0.0004224686,0.00038175928,0.0002395885,0.00016774161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019028548,0.00022139652,0.00055844156,0.00013841351,0.00020002411,0.000020262938,0.00020783303,0.0000937663,0.000042213323],"category_scores_gemma":[0.00048072092,0.0001520361,0.000091963426,0.00057147146,0.00004355032,0.00015054105,0.00006655146,0.00018901502,0.0000066015473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002396629,0.00031014808,0.58494955,0.0026573404,0.000057307712,0.0000024115577,0.0022304666,0.38798395,0.00006597887,0.0010712482,0.0020428984,0.018389054],"study_design_scores_gemma":[0.0023016229,0.00070787634,0.5304053,0.0023034825,0.000108121545,0.0000010704305,0.00010832248,0.46123412,0.00020008805,0.0010446307,0.001378301,0.00020708721],"about_ca_topic_score_codex":0.015853852,"about_ca_topic_score_gemma":0.00067111175,"teacher_disagreement_score":0.073250175,"about_ca_system_score_codex":0.0005437314,"about_ca_system_score_gemma":0.0008908316,"threshold_uncertainty_score":0.99069965},"labels":[],"label_agreement":null},{"id":"W4380417914","doi":"","title":"Advanced epithelial ovarian carcinoma. Impact of primary optimal debulking surgery. Alexis Vautrin Institute Experience.","year":2010,"lang":"en","type":"preprint","venue":"INRIA a CCSD electronic archive server","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Debulking; Medicine; Ovarian carcinoma; Epithelial ovarian carcinoma; Primary (astronomy); General surgery; Surgery; Oncology; Ovarian cancer; Internal medicine; Cancer; Physics","score_opus":0.019051768200641313,"score_gpt":0.2903930497167827,"score_spread":0.2713412815161414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380417914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251205,0.0019417536,0.00082231854,0.0004053518,0.0010502291,0.001748435,0.00036760044,0.000120871504,0.001031399],"genre_scores_gemma":[0.9929978,0.0011800805,0.0029963525,0.00016117372,0.0007013978,0.00059458107,0.0011142042,0.00013817391,0.0001162259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99523157,0.00017443179,0.0011134346,0.0013669909,0.0006879778,0.0014256238],"domain_scores_gemma":[0.9966594,0.00030741625,0.0007713694,0.0016201938,0.00020596724,0.00043563708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044185392,0.00094308326,0.0019893015,0.00051631796,0.00016006235,0.00005537343,0.0005239773,0.00052103464,0.00054750446],"category_scores_gemma":[0.00011241887,0.00080959435,0.0015472757,0.0003117897,0.00037387654,0.00023587876,0.0007236154,0.00219066,0.00002421838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02365057,0.009235389,0.6530424,0.0047570765,0.017108133,0.0027332527,0.01913603,0.016692031,0.07147788,0.018322203,0.0030688127,0.16077624],"study_design_scores_gemma":[0.008830623,0.0020880648,0.953617,0.0018939896,0.0013763828,0.00036040824,0.00005808904,0.0010716907,0.016454982,0.0031247262,0.009509587,0.0016144705],"about_ca_topic_score_codex":0.0036332114,"about_ca_topic_score_gemma":0.0016321624,"teacher_disagreement_score":0.3005746,"about_ca_system_score_codex":0.0017828279,"about_ca_system_score_gemma":0.007268986,"threshold_uncertainty_score":0.9994355},"labels":[],"label_agreement":null},{"id":"W4380841691","doi":"10.1148/rg.220142","title":"Practical Tips for Reporting Adnexal Lesions Using O-RADS MRI","year":2023,"lang":"en","type":"article","venue":"Radiographics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Risk stratification; Lexicon; Radiology; Malignancy; Medical physics; Natural language processing; Pathology; Internal medicine; Computer science","score_opus":0.22279068632932272,"score_gpt":0.4443816914280132,"score_spread":0.22159100509869048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380841691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239164,0.0012370928,0.023571871,0.043688916,0.0019225604,0.0026643826,0.000094886236,0.00090315973,0.0020007144],"genre_scores_gemma":[0.9639088,0.0008378103,0.033813763,0.00040517066,0.00059932534,0.00012961816,0.00008188683,0.000054620534,0.00016902198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985263,0.000023225417,0.0005299013,0.00032467247,0.00025158984,0.00034431106],"domain_scores_gemma":[0.99881154,0.0002497391,0.00032091592,0.00032661977,0.00010397818,0.00018719719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005981395,0.00013697505,0.00030796416,0.0003116188,0.00020607973,0.000030044848,0.000035116245,0.00011437275,0.000019642384],"category_scores_gemma":[0.00065296335,0.00011789472,0.00032109316,0.0009861201,0.000059865135,0.00006824429,0.000024574074,0.00016285163,0.000009724824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032281337,0.0011315666,0.8086849,0.0005254377,0.0015464333,0.002364279,0.0005110422,0.00016388329,0.0012911487,0.0255261,0.14403068,0.013901752],"study_design_scores_gemma":[0.011460894,0.0023342138,0.5087597,0.0015892073,0.00485963,0.004105948,0.0011725243,0.06556577,0.0032219908,0.004105892,0.3916003,0.0012239321],"about_ca_topic_score_codex":0.000042524553,"about_ca_topic_score_gemma":0.000011369679,"teacher_disagreement_score":0.29992518,"about_ca_system_score_codex":0.0000715234,"about_ca_system_score_gemma":0.00022413334,"threshold_uncertainty_score":0.48076072},"labels":[],"label_agreement":null},{"id":"W4381046780","doi":"10.1186/s12885-023-11041-8","title":"Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Shiraz University; Shiraz University of Medical Sciences","keywords":"Medicine; Ovarian cancer; Meta-analysis; MEDLINE; Mortality rate; Internal medicine; Oncology; Cohort study; Survival rate; Surgical oncology; Cancer; Systematic review; Gynecology","score_opus":0.18334734652797868,"score_gpt":0.42894030892250784,"score_spread":0.24559296239452916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381046780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.3816469e-7,0.9915699,0.0000069205444,0.00089183333,0.00013519822,0.0053031286,0.0018745112,0.000029164525,0.00018912341],"genre_scores_gemma":[0.000007944957,0.98556346,0.000036320533,0.0003608013,0.000072951814,0.011012511,0.00008089253,0.00008732323,0.0027777916],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99611145,0.000569389,0.0018277725,0.00075871526,0.00038508148,0.0003475873],"domain_scores_gemma":[0.99710864,0.00047408676,0.0011746528,0.0009060184,0.00017102665,0.0001655941],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012253226,0.0006341294,0.015741052,0.00054510654,0.00003231728,0.000030282796,0.00017557295,0.00022357487,0.002230136],"category_scores_gemma":[0.00013501792,0.00039356737,0.002536905,0.0022363428,0.00007041332,0.00004670821,0.00006922772,0.00024266783,0.00003099131],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000649575,0.000044912922,0.00010821062,0.80968374,0.18881913,0.00003192118,0.000039613147,0.000002261498,2.3958335e-9,0.00011573949,0.00029208936,0.0008558612],"study_design_scores_gemma":[0.0003601734,0.000026277103,0.000116079755,0.18825622,0.7641443,0.0000046286646,0.000013467981,0.0000021869425,8.7005894e-8,0.0000048639004,0.04683416,0.00023752238],"about_ca_topic_score_codex":0.00505967,"about_ca_topic_score_gemma":0.016544893,"teacher_disagreement_score":0.62142754,"about_ca_system_score_codex":0.00065450306,"about_ca_system_score_gemma":0.0014986579,"threshold_uncertainty_score":0.99985164},"labels":[],"label_agreement":null},{"id":"W4381804753","doi":"10.3389/fonc.2023.1238537","title":"Editorial: The role of imaging in gynecological malignancies","year":2023,"lang":"en","type":"editorial","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Gynecologic oncology; Oncology; Medical physics; Gynecology; General surgery; Internal medicine","score_opus":0.007344908329847249,"score_gpt":0.29133879449223316,"score_spread":0.2839938861623859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381804753","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019868222,0.0033462853,0.0000064123064,0.0016656064,0.991928,0.00058842584,0.00007624999,0.00003452679,0.0021558504],"genre_scores_gemma":[0.0011665465,0.0034697647,0.0006443003,0.00006426624,0.9936741,0.0004993333,0.00014106177,0.000050245468,0.00029038187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977327,0.00021779249,0.0006184904,0.00046732108,0.0004984412,0.00046525267],"domain_scores_gemma":[0.9969143,0.0022221224,0.00027558234,0.00037888734,0.00014271688,0.00006637063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086546456,0.00026435382,0.0011602056,0.00033502793,0.00003165662,0.000010264436,0.00028219298,0.0010141878,0.000042851047],"category_scores_gemma":[0.0022375826,0.00018316584,0.00016432608,0.00037677994,0.0002575225,0.00003075666,0.00014164766,0.0009921474,0.000016762828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023079575,0.00037366364,0.05846248,0.000049210423,0.00008010253,0.00017742508,0.00026845554,0.0000075526195,0.000005905057,0.000035836074,0.9238377,0.01647087],"study_design_scores_gemma":[0.0026367502,0.0005385177,0.0064399284,0.00021934313,0.00014317036,0.0000015159816,0.00080231106,0.000028253684,0.00002333772,0.0014108238,0.9876186,0.00013739345],"about_ca_topic_score_codex":0.00061032164,"about_ca_topic_score_gemma":0.00049448793,"teacher_disagreement_score":0.06378095,"about_ca_system_score_codex":0.0016933865,"about_ca_system_score_gemma":0.0014194016,"threshold_uncertainty_score":0.7822345},"labels":[],"label_agreement":null},{"id":"W4382344222","doi":"10.1503/cjs.017020","title":"Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Medical Research and Materiel Command; David Geffen School of Medicine, University of California, Los Angeles; National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Environmental Health Sciences; Radboud Institute for Health Sciences; National Health and Medical Research Council; Medical Research Council; Instituto de Salud Carlos III; Knight Cancer Institute, Oregon Health and Science University; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh; School of Medicine, Stanford University; National Institutes of Health; National Cancer Institute; Cancer Institute NSW; Peter MacCallum Foundation; Rutgers Cancer Institute of New Jersey; NSW Ministry of Health; Medizinischen Hochschule Hannover; QIMR Berghofer Medical Research Institute; University of Sydney; Norges Forskningsråd; Ministry of Health, Labour and Welfare; Universitetet i Bergen; Kræftens Bekæmpelse; Rigshospitalet; Ovarian Cancer Research Fund; Ministerio de Economía y Competitividad; Bundesministerium für Bildung und Forschung; Ovarian Cancer Action; University of Southampton; U.S. Department of Defense; Cancer Research UK; University of Cambridge; Fred C. and Katherine B. Andersen Foundation; University of California, Irvine; Kreftforeningen; Cancer Research Society; Missouri Department of Health and Senior Services; Minnesota Ovarian Cancer Alliance; Moffitt Cancer Center; Deutsches Krebsforschungszentrum; Roswell Park Cancer Institute; National Institute for Health and Care Research; Harvard T.H. Chan School of Public Health; University of Pittsburgh; Lon V. Smith Foundation; Radboud Universiteit; University of Pennsylvania; Mayo Foundation for Medical Education and Research; Oregon Health and Science University; Ovarian Cancer Australia; Brigham and Women's Hospital; State of New Jersey Department of Health; AstraZeneca; Cancer Australia; Radboud Universitair Medisch Centrum; Helse Vest; Magee-Womens Research Institute","keywords":"Medicine; Ovarian carcinoma; Oncology; Internal medicine; Serous fluid; Serous carcinoma; Survival analysis; Carcinoma; Gynecology; Ovarian cancer; Cancer","score_opus":0.051247136494099926,"score_gpt":0.3123344344058336,"score_spread":0.2610872979117337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382344222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721855,0.000025385996,0.000006922474,0.0012263549,0.0012809205,0.00014779581,0.00004395889,0.0000093704675,0.00004074305],"genre_scores_gemma":[0.9992609,0.00001996301,0.00024165689,0.0002048049,0.00013362573,0.0000035000976,0.000087046676,0.000022987282,0.000025487143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981777,0.0001562019,0.0006953061,0.00023771709,0.00035448838,0.00037859107],"domain_scores_gemma":[0.997752,0.00066147326,0.0003173376,0.00022654569,0.00020932216,0.0008332974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000857446,0.000164154,0.0007957421,0.0013746889,0.000056869532,0.000054312728,0.00010934551,0.00008289138,0.00008354303],"category_scores_gemma":[0.0003800981,0.00012696398,0.00038186953,0.00090779236,0.000053808326,0.00020799883,0.0000087003555,0.00027277597,0.000005984788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001489099,0.00027482168,0.990834,0.000011512242,0.0015066077,0.002111427,0.00023568068,0.00036402998,1.4352662e-7,0.0000031267473,0.00012736797,0.0043824045],"study_design_scores_gemma":[0.0027994984,0.00015082204,0.9956583,0.00011202089,0.0005929762,0.00000987925,0.00029534305,0.00016625515,0.0000032732328,0.000002794981,0.00008862555,0.00012024417],"about_ca_topic_score_codex":0.007422447,"about_ca_topic_score_gemma":0.040161964,"teacher_disagreement_score":0.032739516,"about_ca_system_score_codex":0.00042080187,"about_ca_system_score_gemma":0.00093041797,"threshold_uncertainty_score":0.99918723},"labels":[],"label_agreement":null},{"id":"W4382985671","doi":"10.1186/s12885-023-11095-8","title":"Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression","year":2023,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Surgical oncology; Concomitant; Oncology; Medicine; Ovarian cancer; Incidence (geometry); Internal medicine; Clear cell carcinoma; Gene; Cohort; Stage (stratigraphy); Cancer research; Cancer; Biology; Genetics","score_opus":0.03186897425439684,"score_gpt":0.3028527014451125,"score_spread":0.2709837271907157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382985671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952832,0.0011653553,0.000013005358,0.0017699618,0.00024623578,0.0004658619,0.00027878847,0.000041220777,0.0007364128],"genre_scores_gemma":[0.9967636,0.00026658567,0.001140345,0.0001015074,0.00032842366,0.00015405125,0.00008244352,0.000021770544,0.0011412929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920833,0.000026586604,0.00019494853,0.00024332703,0.00016868996,0.0001580877],"domain_scores_gemma":[0.99948347,0.000089981666,0.000068619105,0.0001864196,0.000060200586,0.000111336834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084025065,0.00010868815,0.00025311386,0.00009146128,0.0000630518,0.00001869185,0.000038442784,0.00006034448,0.00026083886],"category_scores_gemma":[0.000013231492,0.00008865255,0.000041917443,0.00017311783,0.000024385601,0.000028309823,0.000042910782,0.000056957433,0.000040780375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003738136,0.000069567526,0.9871214,0.00012124216,0.000046479538,0.000011209933,0.0014872822,0.000056651766,0.0026721847,0.0000937659,0.006044177,0.0019022174],"study_design_scores_gemma":[0.0018779157,0.00022396739,0.98673624,0.000142833,0.00012886226,5.549469e-7,0.00020355494,0.00019283246,0.0017796787,0.000034579858,0.008589857,0.00008912172],"about_ca_topic_score_codex":0.0019683293,"about_ca_topic_score_gemma":0.0021585082,"teacher_disagreement_score":0.0025456804,"about_ca_system_score_codex":0.000080439786,"about_ca_system_score_gemma":0.00022151586,"threshold_uncertainty_score":0.3615146},"labels":[],"label_agreement":null},{"id":"W4383197776","doi":"10.1097/pgp.0000000000000967","title":"TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Mucinous carcinoma; Immunohistochemistry; Ovarian carcinoma; Pathology; Mucinous Tumor; Ovarian tumor; Oncology; Internal medicine; Ovarian cancer; Adenocarcinoma; Cancer","score_opus":0.021489409363399235,"score_gpt":0.3069011955583041,"score_spread":0.28541178619490487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383197776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842089,0.0002824678,0.00011098884,0.013220173,0.0010252497,0.00023397351,0.000045159708,0.0000144924015,0.0008586228],"genre_scores_gemma":[0.9975191,0.00027465826,0.00034846892,0.0012527363,0.00046949877,0.000032715594,0.00006294098,0.000010810289,0.000029082883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812406,0.00022753056,0.00075145456,0.00021922862,0.00046561126,0.00021209383],"domain_scores_gemma":[0.9963201,0.002681275,0.00043214258,0.0001696747,0.00031585648,0.00008094291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058230996,0.00014784327,0.000467624,0.00027852395,0.000033892953,0.000015425912,0.00031591536,0.00013248775,0.00057142397],"category_scores_gemma":[0.003209771,0.000090814065,0.00019598992,0.00025622122,0.00012615918,0.00005734929,0.00007097415,0.00035712853,0.00005387828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009091647,0.0021650868,0.9268623,0.0000118486705,0.00023739849,0.04475499,0.0010274377,0.00024868638,0.0007547136,0.0014803228,0.0011938277,0.02035422],"study_design_scores_gemma":[0.0037616396,0.0024882688,0.98553586,0.00007628376,0.00011681574,0.0019762556,0.00036844614,0.00009699432,0.00021467423,0.004141042,0.0011495668,0.000074169104],"about_ca_topic_score_codex":0.00037834293,"about_ca_topic_score_gemma":0.00014838953,"teacher_disagreement_score":0.058673542,"about_ca_system_score_codex":0.00019732346,"about_ca_system_score_gemma":0.00017291732,"threshold_uncertainty_score":0.6256692},"labels":[],"label_agreement":null},{"id":"W4384401131","doi":"10.1038/s41598-023-38609-5","title":"Gain-of-function p53R175H blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma","year":2023,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada; Western University","funders":"Canadian Institutes of Health Research; London Health Sciences Foundation","keywords":"Ovarian carcinoma; Serous fluid; Function (biology); Serous ovarian cancer; Apoptosis; Computer science; Cancer research; Oncology; Medicine; Internal medicine; Biology; Ovarian cancer; Cell biology; Cancer; Genetics","score_opus":0.03160980174961162,"score_gpt":0.26784503714568525,"score_spread":0.23623523539607363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384401131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995438,0.000098702265,0.00012163298,0.00062159065,0.0021267987,0.0006546255,0.000014750499,0.000058052414,0.0008658475],"genre_scores_gemma":[0.9961701,0.000010589693,0.0006648168,0.000020243746,0.000044487613,0.00011415348,0.00010727864,0.000021355709,0.0028469663],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771595,0.000029936617,0.00069836277,0.00066751597,0.0005811574,0.00030707227],"domain_scores_gemma":[0.9984605,0.000038174836,0.00034332872,0.000868418,0.00016852711,0.000121095894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008222096,0.00015674936,0.00042176765,0.0005095721,0.000068031964,0.000025990763,0.00006451217,0.00009647638,0.000079165264],"category_scores_gemma":[0.000084568564,0.00013578696,0.00014487302,0.0012854211,0.00013233305,0.00007753325,0.000054588632,0.00009938995,0.000010386268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049524114,0.0036475754,0.7513341,0.0010468939,0.00049897935,0.0012344139,0.0050772303,0.020735092,0.14966424,0.0012849353,0.053152993,0.011828348],"study_design_scores_gemma":[0.0049558706,0.0009925808,0.3286748,0.0012405731,0.00085299346,0.00018645533,0.00054226565,0.029160462,0.61044043,0.020679154,0.0016926995,0.00058170035],"about_ca_topic_score_codex":0.0005582239,"about_ca_topic_score_gemma":0.000076140306,"teacher_disagreement_score":0.4607762,"about_ca_system_score_codex":0.00013359748,"about_ca_system_score_gemma":0.00036679662,"threshold_uncertainty_score":0.55372316},"labels":[],"label_agreement":null},{"id":"W4385076102","doi":"10.1016/j.aace.2023.07.003","title":"The Use of Ovarian Vein Sampling to Lateralize a Virilizing Leydig Cell Ovarian Tumor","year":2023,"lang":"en","type":"article","venue":"AACE Clinical Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"Endocrine Society","keywords":"Medicine; Ovarian vein; Internal medicine; Ovary; Endocrinology","score_opus":0.22009952304993863,"score_gpt":0.4173050060493286,"score_spread":0.19720548299938995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385076102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887995,0.00025828145,0.0000984861,0.008156037,0.0011435543,0.00095988886,0.00002091491,0.00014712209,0.00041619994],"genre_scores_gemma":[0.99239403,0.0002428597,0.0040377593,0.0013912935,0.0003581787,0.00010209421,0.000025095174,0.000057049296,0.001391659],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967977,0.0001463974,0.0015488087,0.00066168513,0.00037910658,0.00046632777],"domain_scores_gemma":[0.99571,0.0020075138,0.0004694418,0.0011786399,0.000189916,0.00044448642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017134137,0.00023221166,0.0006352404,0.00009956034,0.00021754831,0.00009070881,0.00005671551,0.00012549959,0.00008042996],"category_scores_gemma":[0.0019754372,0.00016070841,0.00037713314,0.0005701397,0.00009891103,0.00008949852,0.0001668444,0.00028929932,0.000078867466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009679179,0.0015273616,0.31416544,0.00026386915,0.00073128595,0.60995114,0.00082090375,0.00057237665,0.000653841,0.0004935609,0.04328762,0.02656468],"study_design_scores_gemma":[0.0036614318,0.0019109767,0.30278006,0.0008386613,0.0010153028,0.038179886,0.00037379307,0.00067607395,0.0019234495,0.0005272078,0.64750284,0.00061030366],"about_ca_topic_score_codex":0.0012776752,"about_ca_topic_score_gemma":0.0002452943,"teacher_disagreement_score":0.6042152,"about_ca_system_score_codex":0.0000890977,"about_ca_system_score_gemma":0.00027758672,"threshold_uncertainty_score":0.6553499},"labels":[],"label_agreement":null},{"id":"W4385282934","doi":"10.1007/978-3-319-28845-1_5617-1","title":"Mixed Epithelial and Mesenchymal Tumors, Pathology of the cervix","year":2022,"lang":"en","type":"book-chapter","venue":"Encyclopedia of pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pathology; Cervix; Mesenchymal stem cell; Medicine; Cancer; Internal medicine","score_opus":0.016313812665710373,"score_gpt":0.23685298851885123,"score_spread":0.22053917585314087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385282934","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.120940164,0.008743595,0.0000066203515,0.0033935132,0.0026890181,0.0013912638,0.0013128932,0.000037269314,0.86148566],"genre_scores_gemma":[0.48174205,0.05302927,0.0031548138,0.0015769218,0.00207483,0.0004812832,0.00054083794,0.000425147,0.45697483],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814284,0.000118357726,0.0006475949,0.00052823836,0.0003081311,0.0002548248],"domain_scores_gemma":[0.9983332,0.00019512809,0.0005723438,0.0007218661,0.00008698379,0.00009047929],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025041262,0.000347261,0.0011000071,0.00016519747,0.00006854936,0.0000018467541,0.0001991747,0.00034577344,0.0023567278],"category_scores_gemma":[0.00008453628,0.00025086288,0.0003047491,0.000050091272,0.00055986235,0.00002088983,0.00038146848,0.00050653017,0.000011277266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012873356,0.0016845261,0.07606573,0.0021061138,0.0017362107,0.020465925,0.0054483777,0.000010973687,0.0033376438,0.75424945,0.01834552,0.11526218],"study_design_scores_gemma":[0.0048450665,0.0035145814,0.16049856,0.0004449679,0.0021300826,0.0045070387,0.00012513253,0.0000024171375,0.0010728327,0.015862076,0.806384,0.0006132346],"about_ca_topic_score_codex":0.000049455455,"about_ca_topic_score_gemma":0.00004725305,"teacher_disagreement_score":0.7880385,"about_ca_system_score_codex":0.000075856464,"about_ca_system_score_gemma":0.00032002275,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W4385319809","doi":"10.3410/f.742405258.793599823","title":"Faculty Opinions recommendation of Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer.","year":2023,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"MAPK/ERK pathway; Term (time); Baseline (sea); Ovarian cancer; Signature (topology); Cancer research; Oncology; Cancer; Internal medicine; Computer science; Computational biology; Medicine; Information retrieval; Biology; Cell biology; Physics; Mathematics; Signal transduction","score_opus":0.07174095260681765,"score_gpt":0.4062263297586208,"score_spread":0.33448537715180315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385319809","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017654711,0.0023718402,0.00018028842,0.16219611,0.00056793686,0.0038456782,0.83079946,0.000015699012,0.0000053099416],"genre_scores_gemma":[0.00030900605,0.0011724337,0.0009569149,0.0007122841,0.00022284244,0.0018872423,0.9945195,0.000031985943,0.00018783088],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955713,0.0005370044,0.0014108198,0.0006869342,0.0015335246,0.00026040108],"domain_scores_gemma":[0.9911346,0.00033568966,0.0012599454,0.00081967097,0.0062440564,0.00020606814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027404733,0.0004361644,0.0011865338,0.000497716,0.00012666479,0.00003958523,0.00035186828,0.0006482973,0.00030679986],"category_scores_gemma":[0.0038459157,0.00030208658,0.0005506556,0.0016486449,0.00020448143,0.00023976473,0.000106496984,0.00061679713,0.000003254165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014700476,0.0011163316,0.00009182658,0.009699188,0.000424934,2.6675937e-7,0.00009304787,0.000012854938,0.000024017774,0.00012309192,0.9780807,0.010186773],"study_design_scores_gemma":[0.0077005103,0.00025834577,0.11146719,0.020847775,0.0014807499,0.000011823236,0.000014729258,0.0005137213,0.00010471765,0.000043642664,0.857268,0.00028881023],"about_ca_topic_score_codex":0.0002364085,"about_ca_topic_score_gemma":0.00014024727,"teacher_disagreement_score":0.16371998,"about_ca_system_score_codex":0.00032582605,"about_ca_system_score_gemma":0.0014054542,"threshold_uncertainty_score":0.99994314},"labels":[],"label_agreement":null},{"id":"W4385356133","doi":"","title":"Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Ovarian carcinoma; Oncology; Medicine; Internal medicine; Carcinoma; Ovarian cancer; Cancer; Epidermal growth factor receptor","score_opus":0.15409346391559245,"score_gpt":0.500629811613015,"score_spread":0.3465363476974226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385356133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727395,0.022473197,0.000004602278,0.0007226953,0.00016105914,0.0019587467,0.000053461492,0.00000567028,0.0018810538],"genre_scores_gemma":[0.9878782,0.0112438435,0.00024645604,0.00008916355,0.0000836907,0.00027483332,0.000012694409,0.0000252603,0.00014585974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981143,0.00015376616,0.00073933275,0.00030495416,0.000437777,0.00024985452],"domain_scores_gemma":[0.9984483,0.00017822225,0.0005879188,0.00039432524,0.00024710075,0.00014412029],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003061848,0.00024085927,0.00085347134,0.00035700132,0.000062622814,0.00011482422,0.00048602783,0.000072408424,0.0046143266],"category_scores_gemma":[0.00004906377,0.00015264592,0.00016046583,0.0004539867,0.00008629651,0.0005626271,0.00010957843,0.00011780034,0.0000051922425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060766394,0.0031119913,0.8777585,0.00023610378,0.00042529037,0.00010016522,0.0011843832,0.00003943942,0.050701857,0.00014528495,0.0022430052,0.0634463],"study_design_scores_gemma":[0.0037068028,0.00026066497,0.93862444,0.0003328831,0.00023248068,0.000023024666,0.0002468708,0.000060744784,0.055357598,0.00034415105,0.0006870945,0.00012322531],"about_ca_topic_score_codex":0.0025456431,"about_ca_topic_score_gemma":0.000057262583,"teacher_disagreement_score":0.06332307,"about_ca_system_score_codex":0.000098163844,"about_ca_system_score_gemma":0.00014501155,"threshold_uncertainty_score":0.9962956},"labels":[],"label_agreement":null},{"id":"W4385476635","doi":"10.1177/11795549231187264","title":"Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer","year":2023,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Medicine; Monoclonal antibody; Oncology; Cancer; Chemotherapy; Cytotoxic T cell; Internal medicine; Drug resistance; Antibody; Immunology; Cancer research; Biology; In vitro","score_opus":0.3221679591626192,"score_gpt":0.5417869366401211,"score_spread":0.21961897747750192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385476635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051512077,0.9714669,0.0000060138304,0.010853077,0.0046221195,0.002936721,0.00007813714,0.0001890252,0.009796497],"genre_scores_gemma":[0.000060948558,0.98881286,0.00027859732,0.0020271528,0.005194285,0.0011805549,0.00046123532,0.00021782826,0.0017665178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99131674,0.0009913791,0.0045971065,0.0016625766,0.00060310954,0.00082912017],"domain_scores_gemma":[0.9906905,0.0058458336,0.0012859115,0.0011849515,0.00022160764,0.0007711525],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014434243,0.0009907277,0.009890564,0.00091615086,0.00008722658,0.000013544563,0.0004123811,0.0020628318,0.0016354644],"category_scores_gemma":[0.001937984,0.00060887216,0.00080768485,0.0016280055,0.00083521084,0.000053834374,0.00019621338,0.0023747396,0.000596886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032386274,0.001581389,0.00014268969,0.0074382364,0.001280229,0.007816833,0.00014943734,2.8234098e-7,4.2642856e-7,0.00093221915,0.018437585,0.96189684],"study_design_scores_gemma":[0.009946292,0.005300754,0.0013330503,0.04843403,0.0053335503,0.00012710562,0.000041592284,0.000008451903,2.2991311e-7,0.00044705372,0.9285605,0.0004673932],"about_ca_topic_score_codex":0.0011500621,"about_ca_topic_score_gemma":0.0031543276,"teacher_disagreement_score":0.9614294,"about_ca_system_score_codex":0.001813004,"about_ca_system_score_gemma":0.0042611673,"threshold_uncertainty_score":0.9999268},"labels":[],"label_agreement":null},{"id":"W4385530448","doi":"10.55418/9781933477282","title":"Tumors of the Ovary and Fallopian Tube","year":2023,"lang":"en","type":"book","venue":"American Registry of PathologyArlington, Virginia eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Fallopian tube; Ovary; Terminology; Gynecology; Ovarian cancer; Pathology; Medicine; Differential diagnosis; Biology; Cancer; Internal medicine; Philosophy; Linguistics","score_opus":0.012754614003198519,"score_gpt":0.26159818272809615,"score_spread":0.24884356872489763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385530448","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48326322,0.0021790476,0.000024114472,0.0026675193,0.0011536662,0.002487163,0.0010024217,0.0002717939,0.50695103],"genre_scores_gemma":[0.4031557,0.0008929438,0.0018921763,0.0011255475,0.00053650007,0.00015857874,0.00012329285,0.00029824802,0.591817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760336,0.00008145161,0.0008097213,0.0007104681,0.00042416813,0.00037082285],"domain_scores_gemma":[0.9967164,0.00024594722,0.0013282639,0.0013909913,0.00015344043,0.0001649832],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00025503873,0.00049407576,0.0015775816,0.00019792363,0.00008268888,0.000008882353,0.00035079764,0.0003018823,0.000019443709],"category_scores_gemma":[0.00010506237,0.00036930677,0.0004310047,0.000119575336,0.0034372273,0.000013451202,0.00025920785,0.0006231532,0.000009218629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029900777,0.0019800004,0.4367365,0.012768889,0.0110306535,0.009463802,0.012708582,0.000037482194,0.010747673,0.05297069,0.12581629,0.32274938],"study_design_scores_gemma":[0.0099900095,0.008994923,0.66435844,0.015085993,0.0075950273,0.002783742,0.0021591757,0.000049577342,0.008272631,0.010330149,0.26771018,0.002670133],"about_ca_topic_score_codex":0.00026200913,"about_ca_topic_score_gemma":0.000055219538,"teacher_disagreement_score":0.32007924,"about_ca_system_score_codex":0.00014123507,"about_ca_system_score_gemma":0.0011382172,"threshold_uncertainty_score":0.9998759},"labels":[],"label_agreement":null},{"id":"W4385607045","doi":"10.1136/ijgc-2023-004373","title":"Moderately differentiated Sertoli–Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Sertoli cell; Leydig cell; Stromal cell; Hormone; Neoplasm; Internal medicine; Oncology; Pathology; Luteinizing hormone; Spermatogenesis","score_opus":0.026765430232276895,"score_gpt":0.294180692498527,"score_spread":0.2674152622662501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385607045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242675,0.0005054187,0.000056923564,0.0050657117,0.00066469004,0.00019555904,0.00006674896,0.000065755135,0.0009524138],"genre_scores_gemma":[0.9972206,0.0010350181,0.000107248525,0.00065926387,0.00019426069,0.000047510268,0.0000616534,0.000028434251,0.00064601435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798596,0.00006647051,0.0005293444,0.00024519162,0.00084727607,0.00032574122],"domain_scores_gemma":[0.99804634,0.00040000447,0.0005146973,0.00008923755,0.00072083913,0.00022886251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023435861,0.00021776726,0.0005073251,0.0002279368,0.00007649914,0.000082575956,0.0002315258,0.00013417729,0.0008274703],"category_scores_gemma":[0.00023748272,0.00013926277,0.00020476062,0.00031204292,0.000059316797,0.00013912577,0.00006934925,0.00038608242,0.000039938568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007809788,0.006200864,0.84154296,0.000110991605,0.011120978,0.060610723,0.0012685424,0.009123835,0.013526458,0.00031590767,0.030233813,0.01813515],"study_design_scores_gemma":[0.006119618,0.001603392,0.9871285,0.00035452723,0.00031782754,0.00047603666,0.000093603834,0.0014470726,0.0011888728,0.00018858329,0.0008987303,0.00018321104],"about_ca_topic_score_codex":0.00005543436,"about_ca_topic_score_gemma":0.00005489993,"teacher_disagreement_score":0.14558558,"about_ca_system_score_codex":0.00075227255,"about_ca_system_score_gemma":0.00031641335,"threshold_uncertainty_score":0.90602195},"labels":[],"label_agreement":null},{"id":"W4385752321","doi":"10.1001/jamanetworkopen.2023.27198","title":"Salpingectomy and the Risk of Ovarian Cancer in Ontario","year":2023,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Women's College Hospital; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Salpingectomy; Tubal ligation; Fallopian tube; Ovarian cancer; Gynecology; Hysterectomy; Hazard ratio; Obstetrics; Population; Proportional hazards model; Surgery; Family planning; Cancer; Pregnancy; Ectopic pregnancy; Internal medicine; Confidence interval","score_opus":0.02477259277430605,"score_gpt":0.2936103529349412,"score_spread":0.26883776016063515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385752321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635221,0.0016697751,0.0000034048571,0.01780751,0.00024410288,0.0014064509,0.000013263292,0.0000175576,0.015315876],"genre_scores_gemma":[0.994856,0.002499655,0.00021086827,0.00052956445,0.00018281076,0.0002988184,0.000009214653,0.000012692247,0.0014003838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992266,0.00009621364,0.0001963725,0.00018491603,0.000107822736,0.00018804632],"domain_scores_gemma":[0.99934816,0.00024120574,0.00009439329,0.00024254534,0.00002420196,0.000049509745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008115985,0.0000869375,0.0003266496,0.000032444274,0.0000566776,0.000047224366,0.000121210556,0.000049656734,0.0003936211],"category_scores_gemma":[0.000030409268,0.00005188774,0.00004371112,0.000334023,0.00006039597,0.00005850935,0.00017997062,0.00018850312,0.000011606607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007662318,0.00003867431,0.9687218,0.000011808054,0.00023977469,0.000029947985,0.0011132489,0.00060070766,5.675555e-7,0.001659727,0.008894645,0.017922886],"study_design_scores_gemma":[0.009074455,0.00006158912,0.96911013,0.00038356893,0.00016140303,0.0000027940755,0.00005689993,0.00049179455,0.00000879572,0.0012099474,0.019385658,0.000052972176],"about_ca_topic_score_codex":0.3338933,"about_ca_topic_score_gemma":0.41331246,"teacher_disagreement_score":0.07941918,"about_ca_system_score_codex":0.00012679046,"about_ca_system_score_gemma":0.00021117959,"threshold_uncertainty_score":0.67054236},"labels":[],"label_agreement":null},{"id":"W4385778900","doi":"10.1136/ijgc-2023-004627","title":"Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Lymph node; Stage (stratigraphy); Ovary; Proportional hazards model; Oncology; Adenocarcinoma; Carcinoma; Cohort; Internal medicine; Endometrial cancer; Gynecology; Cancer; Gastroenterology","score_opus":0.03490518763349605,"score_gpt":0.30928954666474623,"score_spread":0.2743843590312502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385778900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946426,0.0014917975,0.000046714264,0.002797547,0.00052371016,0.00013732674,0.000114701754,0.0000024209849,0.00024315299],"genre_scores_gemma":[0.9968003,0.0024535388,0.00029060667,0.00022120606,0.00014084305,0.000011742884,0.0000037865464,0.0000051674383,0.00007280242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988799,0.00003857326,0.00049217115,0.00008503721,0.000427332,0.00007695821],"domain_scores_gemma":[0.99855155,0.00042295427,0.00044713085,0.00009118795,0.00043908565,0.0000480989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012320728,0.000070191076,0.0003033603,0.00016628277,0.000014133933,0.000004549376,0.00014756441,0.000042725136,0.00037662752],"category_scores_gemma":[0.0001998624,0.000041070125,0.0001571717,0.00016270053,0.000069466674,0.00003699664,0.000075893164,0.00009980189,5.5203697e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001578547,0.00027844397,0.97506106,0.000055768563,0.0004394375,0.00007824366,0.000114749055,0.00019949545,0.0062758685,0.00017617822,0.00040291352,0.016759964],"study_design_scores_gemma":[0.0016176387,0.000519229,0.9844283,0.00018432483,0.00013671692,0.000065923545,0.000028976805,0.000027748343,0.012239245,0.00017078311,0.00055010314,0.000031032105],"about_ca_topic_score_codex":0.00010133486,"about_ca_topic_score_gemma":0.000031877367,"teacher_disagreement_score":0.01672893,"about_ca_system_score_codex":0.00013656101,"about_ca_system_score_gemma":0.00020430108,"threshold_uncertainty_score":0.41238073},"labels":[],"label_agreement":null},{"id":"W4385827803","doi":"10.1158/1078-0432.ccr-23-0621","title":"Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Pfizer","keywords":"Medicine; Neuroblastoma RAS viral oncogene homolog; KRAS; Internal medicine; Oncology; Progression-free survival; Confidence interval; MEK inhibitor; Proportional hazards model; Ovarian cancer; Selumetinib; Chemotherapy; Logistic regression; Cancer; MAPK/ERK pathway; Biology; Colorectal cancer; Signal transduction","score_opus":0.2301253681193695,"score_gpt":0.5375087817184303,"score_spread":0.3073834135990608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865959,0.0021531484,0.000001252057,0.008022388,0.0007501561,0.0019134337,0.00045848853,0.000022842614,0.00008237636],"genre_scores_gemma":[0.99276423,0.006027874,0.000020638816,0.00016277574,0.00044604798,0.0004358144,0.00006461416,0.000043416516,0.00003459762],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99563754,0.00085033843,0.0010867637,0.0008417861,0.0010758027,0.00050775206],"domain_scores_gemma":[0.99615556,0.0022183897,0.00027267612,0.0008157976,0.00031776636,0.0002197878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022920875,0.00022607193,0.0007587345,0.00023409071,0.00009725504,0.00003257097,0.00033460214,0.00014978828,0.00007873183],"category_scores_gemma":[0.0006372171,0.00016645427,0.00018851228,0.0015872993,0.00046657957,0.000052209718,0.00018814049,0.00063830795,0.000007225126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1127178,0.028456172,0.21595816,0.00049348123,0.0076321033,0.0005853588,0.006554817,0.00016812408,0.021653466,0.000044252905,0.020320443,0.58541584],"study_design_scores_gemma":[0.105770975,0.005902905,0.8709866,0.00095501455,0.00041151152,3.3903262e-7,0.00225669,0.0005582059,0.01106676,0.00008155414,0.0017764728,0.00023298667],"about_ca_topic_score_codex":0.025933616,"about_ca_topic_score_gemma":0.0036889706,"teacher_disagreement_score":0.6550284,"about_ca_system_score_codex":0.00018512392,"about_ca_system_score_gemma":0.0004781715,"threshold_uncertainty_score":0.9805528},"labels":[],"label_agreement":null},{"id":"W4385850019","doi":"","title":"Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study","year":2008,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Gemcitabine; Medicine; Oncology; Ovarian cancer; Internal medicine; Cancer; Chemotherapy; Cisplatin","score_opus":0.2688802621021617,"score_gpt":0.5584200265949629,"score_spread":0.2895397644928012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385850019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96766716,0.022339646,0.00008583081,0.0009635693,0.00084319204,0.005998047,0.000102260994,0.00004606591,0.0019542407],"genre_scores_gemma":[0.975898,0.020968622,0.00021951535,0.00023391335,0.00031095374,0.0019744446,0.00002753608,0.00006694515,0.00030005205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973751,0.00015205571,0.0007851048,0.00060244044,0.00071824406,0.00036708222],"domain_scores_gemma":[0.9976151,0.00023889616,0.000701505,0.0004719482,0.0007150507,0.00025752131],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006460572,0.00037070768,0.001025097,0.0005094392,0.00036548256,0.00026251443,0.0006454698,0.00008820468,0.0024413483],"category_scores_gemma":[0.00013181005,0.00029949268,0.0002507897,0.00078756874,0.00008741347,0.0007438943,0.00017281741,0.00028128913,0.00000424614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023249057,0.005407459,0.9312407,0.000060218474,0.0011677828,0.000076939665,0.0012617866,0.000021287995,0.0013634434,0.00014570406,0.011633429,0.045296356],"study_design_scores_gemma":[0.011548212,0.0005942784,0.9753808,0.0003629799,0.000300119,0.00002221498,0.00013593599,0.000063241496,0.0065773493,0.0012292172,0.0034828053,0.00030288822],"about_ca_topic_score_codex":0.002113766,"about_ca_topic_score_gemma":0.00020182137,"teacher_disagreement_score":0.044993468,"about_ca_system_score_codex":0.0005523637,"about_ca_system_score_gemma":0.0004690064,"threshold_uncertainty_score":0.9999457},"labels":[],"label_agreement":null},{"id":"W4385949246","doi":"10.1136/ijgc-2023-004610","title":"Low-grade serous ovarian cancer: expert consensus report on the state of the science","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"National Cancer Institute; Cancer Research UK; Verastem Oncology","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Disease; Ovarian cancer; Intensive care medicine; Consensus conference; Clinical trial; Translational research; Internal medicine; Oncology; Gynecology; Cancer; Pathology","score_opus":0.05335657227922008,"score_gpt":0.3657755046738609,"score_spread":0.3124189323946408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385949246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9004229,0.00031906224,0.0000042612633,0.09554114,0.0028035138,0.00021238027,0.000038321647,0.000011121502,0.0006473316],"genre_scores_gemma":[0.9947893,0.0012658435,0.000052995478,0.002928215,0.0003796736,0.000050816958,9.1309147e-7,0.000008669764,0.00052359886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789834,0.0000555527,0.0005093611,0.00019068003,0.0011397693,0.00020629384],"domain_scores_gemma":[0.99778605,0.00052192813,0.00056205405,0.00021525969,0.00081257964,0.0001021335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006755515,0.00011689644,0.00025444446,0.000118104705,0.00010467744,0.00003345174,0.000473649,0.000038607774,0.0006435476],"category_scores_gemma":[0.0007833724,0.000052334904,0.0001948092,0.00041969673,0.00041886882,0.000041565443,0.00010525323,0.00025984508,0.0000073787523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041096946,0.0045949924,0.4466495,0.00007953106,0.0051956507,0.01879942,0.003349452,0.021534642,0.047154695,0.008512559,0.1315786,0.30844128],"study_design_scores_gemma":[0.0020807208,0.0005718254,0.93157345,0.00047844966,0.00008642721,0.00058110006,0.00012579428,0.00025091175,0.048000734,0.001359546,0.014778691,0.00011237624],"about_ca_topic_score_codex":0.00028929775,"about_ca_topic_score_gemma":0.000086503074,"teacher_disagreement_score":0.48492393,"about_ca_system_score_codex":0.00071225455,"about_ca_system_score_gemma":0.0010432109,"threshold_uncertainty_score":0.70463955},"labels":[],"label_agreement":null},{"id":"W4385968528","doi":"10.1007/s00280-023-04575-y","title":"Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations","year":2023,"lang":"en","type":"review","venue":"Cancer Chemotherapy and Pharmacology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"College of Physicians and Surgeons of Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Fallopian tube; Cancer; Chemotherapy; Carboplatin; Monoclonal antibody; Pharmacology; Gynecology; Antibody; Cisplatin; Immunology","score_opus":0.20744257282584447,"score_gpt":0.48335285051586097,"score_spread":0.2759102776900165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385968528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015455195,0.98123527,0.000002039174,0.01273167,0.002417879,0.0027999938,0.00028015464,0.000108490254,0.0002699749],"genre_scores_gemma":[0.00019388417,0.9769572,0.000054860044,0.014906542,0.0020739525,0.0052480283,0.00012487182,0.00014396627,0.00029666466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972378,0.00028230235,0.0007159093,0.0009882216,0.00020508538,0.0005706569],"domain_scores_gemma":[0.998649,0.00051240594,0.00027305537,0.00022663357,0.00007241187,0.00026651908],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021427576,0.000722027,0.0022309122,0.00036726164,0.00014042853,0.00003567795,0.00011700872,0.0005743435,0.0074309567],"category_scores_gemma":[0.000008920116,0.00054071005,0.0003399921,0.0004935655,0.00018869103,0.00005408364,0.000036537655,0.0007772098,0.000038120255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006255909,0.0011258402,0.0000710606,0.0017043863,0.0026169769,0.00028256013,0.0003456916,0.000006055586,0.00025443383,0.00015237181,0.06179673,0.9310183],"study_design_scores_gemma":[0.010939265,0.00051041413,0.00013701343,0.003955697,0.00042314484,0.00005322131,0.00000952293,0.000020478352,0.000801687,0.00008278603,0.9825881,0.00047867143],"about_ca_topic_score_codex":0.00033209397,"about_ca_topic_score_gemma":0.000046020232,"teacher_disagreement_score":0.9305396,"about_ca_system_score_codex":0.0007170043,"about_ca_system_score_gemma":0.0010433947,"threshold_uncertainty_score":0.9997044},"labels":[],"label_agreement":null},{"id":"W4386242967","doi":"10.1016/j.modpat.2023.100321","title":"DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas","year":2023,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grail; Friedberg Charitable Foundation; Cycle for Survival; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation","keywords":"Epigenetics; DNA methylation; Biology; Ovarian carcinoma; Ovarian cancer; Cancer research; Ovary; Methylation; Endometrial cancer; Carcinoma; Pathology; Oncology; Medicine; Cancer; DNA; Gene; Genetics; Gene expression","score_opus":0.022680247187508683,"score_gpt":0.2770520130189587,"score_spread":0.25437176583145005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386242967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206465,0.0034228032,0.0014501744,0.0010049792,0.00036226667,0.00052036677,0.00006504178,0.00008389404,0.0010258286],"genre_scores_gemma":[0.9980916,0.00040796888,0.0009144953,0.00009903221,0.00017725916,0.00005940836,0.00008237777,0.000023671608,0.00014423308],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988633,0.000085954416,0.0002664201,0.00036118212,0.00017959354,0.00024356494],"domain_scores_gemma":[0.9990952,0.00035670513,0.000104993385,0.000281331,0.00006756546,0.00009417725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003148108,0.00014504768,0.0004715838,0.00061672664,0.00004612843,0.000007177066,0.000047333415,0.00018847948,0.00007208801],"category_scores_gemma":[0.00028377838,0.00012378361,0.00009228646,0.0006487027,0.00008162824,0.000038646664,0.00005568017,0.00014045998,0.000020010055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017099265,0.0009876034,0.1923988,0.0004873475,0.00090190425,0.00396473,0.0052105715,0.00021839913,0.3134457,0.004165457,0.001187199,0.47532237],"study_design_scores_gemma":[0.021250105,0.0031908124,0.8962368,0.000087106986,0.0008205451,0.0005731067,0.00014684352,0.0022799282,0.06811412,0.004869257,0.0020692847,0.00036213276],"about_ca_topic_score_codex":0.000045936085,"about_ca_topic_score_gemma":0.0000087281705,"teacher_disagreement_score":0.703838,"about_ca_system_score_codex":0.000071320734,"about_ca_system_score_gemma":0.00007799975,"threshold_uncertainty_score":0.5047749},"labels":[],"label_agreement":null},{"id":"W4386417675","doi":"10.3390/curroncol30090592","title":"Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Credit Valley Hospital; Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Oncology; Randomized controlled trial; Clinical trial; Serous fluid; Ovarian cancer; Systematic review; MEDLINE; Adverse effect; Meta-analysis; Cancer; Chemotherapy","score_opus":0.35107363076362935,"score_gpt":0.5286067609017061,"score_spread":0.17753313013807676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386417675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.9837255e-7,0.97029316,0.000016186916,0.0013622631,0.0032437802,0.023830185,0.00094677,0.00019571121,0.00011154318],"genre_scores_gemma":[5.154759e-7,0.93097883,0.00009066625,0.00019213966,0.0009902786,0.06515875,0.0013808325,0.0001811287,0.0010268666],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562246,0.0004000609,0.0018724552,0.001063534,0.00031281312,0.0007286665],"domain_scores_gemma":[0.99625,0.00091280695,0.0011968275,0.0010812131,0.0001821827,0.0003770065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041773808,0.0009786288,0.009819669,0.00029340634,0.00012352152,0.000026985566,0.00027687734,0.00046369265,0.0001422602],"category_scores_gemma":[0.0002243547,0.0006307514,0.0020969836,0.00056867715,0.00006253627,0.000031582073,0.00007774103,0.00034828816,0.00048966653],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011927258,0.0008971265,0.0000018662023,0.56157887,0.0019567555,0.0000962349,0.000029819472,5.2877787e-8,3.8805896e-9,0.00009920498,0.00617139,0.42915672],"study_design_scores_gemma":[0.0017161678,0.00091080274,7.1325456e-7,0.4519293,0.03607123,0.00015154757,0.0000050115973,0.0000031539412,1.16203175e-7,0.000011446213,0.5089671,0.00023341578],"about_ca_topic_score_codex":0.00006508378,"about_ca_topic_score_gemma":0.000112802554,"teacher_disagreement_score":0.5027957,"about_ca_system_score_codex":0.006618912,"about_ca_system_score_gemma":0.0032058978,"threshold_uncertainty_score":0.99961436},"labels":[],"label_agreement":null},{"id":"W4386467333","doi":"10.1080/13697137.2023.2249813","title":"Lack of evidence that progesterone in ovulatory cycles causes breast cancer","year":2023,"lang":"en","type":"article","venue":"Climacteric","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Medicine; Progestin; Cancer; Oncology; Hormone; Gynecology; Internal medicine; Physiology; Obstetrics; Endocrinology","score_opus":0.3022412503298394,"score_gpt":0.4221199309021227,"score_spread":0.11987868057228329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386467333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937362,0.0014160718,4.5585153e-7,0.004194788,0.00016281013,0.00031512353,0.00004724356,0.000054909095,0.00007240321],"genre_scores_gemma":[0.994205,0.0050492403,0.000028229855,0.0002592966,0.000076726785,0.00017093988,0.0000114709055,0.000020628482,0.00017849811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913967,0.00002678926,0.00020160903,0.00023341276,0.0001749776,0.00022354748],"domain_scores_gemma":[0.99945414,0.000081459664,0.00010828533,0.00024397872,0.000038281276,0.00007387059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010368858,0.00011698102,0.00029965167,0.0001312572,0.000017582033,0.000009353986,0.00005767965,0.000046894475,0.00024939017],"category_scores_gemma":[0.00001824434,0.00008376226,0.000056882716,0.00039130976,0.00006177188,0.00010523526,0.000046188128,0.00007188984,0.00006455909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098006705,0.00017296235,0.9766237,0.00028818843,0.00005073068,0.000096202886,0.00023205965,0.0000055935166,0.0030888382,0.000009474663,0.00047227996,0.01886192],"study_design_scores_gemma":[0.00077272864,0.00010045178,0.9943288,0.0013035574,0.00007360352,0.000023153612,0.00007097051,0.000020251024,0.0027177327,0.000011989019,0.00049707346,0.00007970807],"about_ca_topic_score_codex":0.000301012,"about_ca_topic_score_gemma":0.00013010496,"teacher_disagreement_score":0.018782211,"about_ca_system_score_codex":0.00016116329,"about_ca_system_score_gemma":0.0001151655,"threshold_uncertainty_score":0.34157258},"labels":[],"label_agreement":null},{"id":"W4386624292","doi":"10.1148/radiol.230685","title":"O-RADS US v2022: An Update from the American College of Radiology’s Ovarian-Adnexal Reporting and Data System US Committee","year":2023,"lang":"en","type":"review","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Benignity; Lexicon; Risk stratification; Malignancy; Concordance; Radiology; Breast imaging; Terminology; BI-RADS; Serous fluid; Artificial intelligence; Mammography; Pathology; Internal medicine; Computer science; Linguistics; Cancer; Breast cancer","score_opus":0.12439120607718163,"score_gpt":0.3923833785801189,"score_spread":0.2679921725029373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386624292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005799903,0.9842043,0.00001723795,0.0008576468,0.0010744999,0.0016014975,0.0061948206,0.00013496277,0.00011516146],"genre_scores_gemma":[0.0045729983,0.9882148,0.0009408407,0.00035537122,0.0012490314,0.00022042266,0.0042745364,0.000121952355,0.000050070583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943474,0.0012752941,0.002297752,0.001345028,0.00021056298,0.00052395015],"domain_scores_gemma":[0.99127984,0.0015107631,0.0037880475,0.003132164,0.00006615341,0.00022305721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017435859,0.0005906208,0.005335584,0.00016778483,0.0001586523,0.000016122178,0.0007892105,0.0003889772,0.000033059365],"category_scores_gemma":[0.0006201175,0.0003706464,0.00031117137,0.00050464034,0.0006682296,0.0000547377,0.0005113823,0.00065047253,0.000028930064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005983656,0.00073592813,0.12567884,0.029844899,0.025183292,0.019450389,0.00033934132,0.0000071793047,0.000008931898,0.007650894,0.12456077,0.6659412],"study_design_scores_gemma":[0.0014217654,0.0008908575,0.032464333,0.008440112,0.008097038,0.011638282,0.00022925292,0.0001403692,5.5145006e-7,0.000035462504,0.9361978,0.00044415705],"about_ca_topic_score_codex":0.002548121,"about_ca_topic_score_gemma":0.00030480826,"teacher_disagreement_score":0.81163704,"about_ca_system_score_codex":0.00031601996,"about_ca_system_score_gemma":0.000704315,"threshold_uncertainty_score":0.99987453},"labels":[],"label_agreement":null},{"id":"W4386947996","doi":"10.1016/j.ygyno.2023.06.126","title":"Utilizing the KELIM score and the chemo-response score to predict chemosensitivity in ovarian cancer (1212)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Oncology; Ovarian cancer; Cohort; Serous carcinoma; Chemotherapy; Progression-free survival; Stage (stratigraphy); Cancer; Gynecologic oncology; Serous fluid; Retrospective cohort study","score_opus":0.04989889377759566,"score_gpt":0.33870280247662016,"score_spread":0.2888039086990245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.841586,0.00040518882,0.0000032118742,0.15277904,0.00051149103,0.0016632442,0.000023792267,0.000081707076,0.0029463046],"genre_scores_gemma":[0.98776513,0.0007518845,0.000087877735,0.009460506,0.00021163796,0.0011853672,0.000010693536,0.000022362112,0.00050455524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978248,0.0005444203,0.00033521943,0.0005237994,0.00020286067,0.0005688839],"domain_scores_gemma":[0.9956805,0.0035326106,0.000107258136,0.0004518813,0.00007159885,0.00015613779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023244848,0.00023821283,0.0006395294,0.00014068396,0.00022806936,0.00002633522,0.00013911007,0.0002277964,0.00025378322],"category_scores_gemma":[0.0014553702,0.00012586465,0.000098811186,0.0007604171,0.0004240598,0.00003867008,0.00027019728,0.00039186678,0.00008553871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016529987,0.0011714988,0.70114416,0.00014731697,0.00066175463,0.0042024595,0.007490368,0.00029658308,0.0033061174,0.0035520806,0.035691593,0.22580607],"study_design_scores_gemma":[0.0075379563,0.0009734224,0.9675111,0.00008213075,0.00017295241,0.00011324362,0.0010110835,0.00035939197,0.0006297493,0.00040144983,0.02107451,0.00013301731],"about_ca_topic_score_codex":0.0006361592,"about_ca_topic_score_gemma":0.0024925033,"teacher_disagreement_score":0.26636693,"about_ca_system_score_codex":0.0007180879,"about_ca_system_score_gemma":0.0005835547,"threshold_uncertainty_score":0.51326114},"labels":[],"label_agreement":null},{"id":"W4386948038","doi":"10.1016/j.ygyno.2023.06.114","title":"Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer (1198)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cytoreductive surgery; Stage (stratigraphy); Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Disease; Surgery; Cancer","score_opus":0.030866287699798746,"score_gpt":0.3337528490146308,"score_spread":0.30288656131483205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887357,0.00012902616,0.0000046170144,0.004838284,0.0013194955,0.0011511075,0.000054348617,0.00014195126,0.0036255117],"genre_scores_gemma":[0.9962086,0.00022324314,0.00025898806,0.0014272055,0.00020477475,0.00082778314,0.00016029738,0.000046087465,0.0006429848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779594,0.00016474517,0.0004058902,0.0006004575,0.00028617293,0.00074679084],"domain_scores_gemma":[0.9984159,0.0008437127,0.00017552862,0.0002987531,0.000097936776,0.000168183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044077958,0.00028319456,0.0009202817,0.00035803678,0.000112748174,0.000017338114,0.00010062487,0.00027360403,0.0016418544],"category_scores_gemma":[0.00018878993,0.00021168712,0.00015072526,0.0008634525,0.00010031957,0.000120162964,0.000059871534,0.000292081,0.000080356534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001325817,0.0014567905,0.94876194,0.00003254665,0.00041190616,0.001419941,0.0004667292,0.00011228068,0.000027310638,0.000096330026,0.00331531,0.042573124],"study_design_scores_gemma":[0.011902401,0.0024599626,0.97035897,0.00008324076,0.000112597096,0.0000038342914,0.00031635063,0.000035586778,0.00021020751,0.000107559856,0.014178757,0.00023054687],"about_ca_topic_score_codex":0.0008377902,"about_ca_topic_score_gemma":0.0010449269,"teacher_disagreement_score":0.042342577,"about_ca_system_score_codex":0.0016327818,"about_ca_system_score_gemma":0.0011482905,"threshold_uncertainty_score":0.9992708},"labels":[],"label_agreement":null},{"id":"W4386948292","doi":"10.1016/j.ygyno.2023.06.161","title":"Open-label, phase 2, randomized controlled multicenter study comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in participants with homologous recombination deficient stage III/IV ovarian cancer: Trial in progress (1252)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Taxane; Medicine; Oncology; Chemotherapy; Ovarian cancer; Internal medicine; Randomized controlled trial; Neoadjuvant therapy; Homologous recombination; Cancer; Breast cancer; Biology","score_opus":0.11680953418393418,"score_gpt":0.4368824457352764,"score_spread":0.3200729115513422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95996517,0.0003677466,0.000003257475,0.003549421,0.0014239756,0.033094324,0.000020669198,0.00013173553,0.0014437212],"genre_scores_gemma":[0.96277255,0.0006233044,0.00029029732,0.00025065514,0.000078639285,0.035281677,0.0001304704,0.000046215722,0.00052619126],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99451154,0.0013631465,0.0015473716,0.0010917996,0.00038821722,0.001097946],"domain_scores_gemma":[0.9957661,0.0025212732,0.0008293585,0.00050615304,0.0001350624,0.00024204518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027085375,0.00058065436,0.0042630965,0.0005377715,0.000169764,0.000099330624,0.00030807004,0.00029402462,0.0006049077],"category_scores_gemma":[0.00040110838,0.00038133012,0.00015548118,0.0008146611,0.00023784938,0.00013230428,0.00015451017,0.00035469036,0.000043414348],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85694253,0.056736544,0.04252549,0.000019646488,0.0016640234,0.0032154704,0.0038103536,0.0006119923,0.000020013082,0.00012714726,0.000074498086,0.03425231],"study_design_scores_gemma":[0.9185515,0.056824747,0.012769048,0.00010180398,0.00097080524,0.0000073488695,0.0023801907,0.0074873134,0.00009049266,0.000027359261,0.00045954634,0.00032981255],"about_ca_topic_score_codex":0.004504871,"about_ca_topic_score_gemma":0.017810527,"teacher_disagreement_score":0.061609015,"about_ca_system_score_codex":0.003384249,"about_ca_system_score_gemma":0.0011273507,"threshold_uncertainty_score":0.99986386},"labels":[],"label_agreement":null},{"id":"W4386948431","doi":"10.1016/j.ygyno.2023.06.210","title":"ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (1307)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Hamilton Health Sciences","funders":"","keywords":"Medicine; Fallopian tube; Pembrolizumab; Ovarian cancer; Chemotherapy; Oncology; Epithelial ovarian cancer; Gynecology; Fallopian tube cancer; Internal medicine; Cancer; Immunotherapy","score_opus":0.02552190575230495,"score_gpt":0.328918895938515,"score_spread":0.30339699018621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504745,0.000023209,0.0000027190126,0.0011216248,0.00029948485,0.0029219817,0.00008838145,0.000049679966,0.0004454682],"genre_scores_gemma":[0.9978682,0.00006945215,0.00037156485,0.00029048254,0.000044824214,0.0010287226,0.00016875495,0.000036318193,0.00012172987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780256,0.00019784574,0.00058053224,0.00057206576,0.00036571204,0.0004812984],"domain_scores_gemma":[0.9987461,0.0004141462,0.0002798204,0.0003138513,0.00013867341,0.0001074363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002275444,0.0002968255,0.0008673366,0.00030722594,0.000058545873,0.00001175109,0.00012864196,0.0001941262,0.00039092597],"category_scores_gemma":[0.00007310854,0.00019848508,0.00003818259,0.00070551434,0.00012652228,0.00008732982,0.00005356753,0.00027043745,0.000007910673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10817488,0.028455175,0.83257914,0.000106134365,0.00038499062,0.0012912664,0.0025593427,0.00021129021,0.000110925364,0.000026840124,0.00015615637,0.025943844],"study_design_scores_gemma":[0.20072295,0.048386272,0.7487305,0.00009043936,0.00014213544,0.0000024364924,0.0008871233,0.00018648758,0.00006337508,0.0000046535374,0.00062119524,0.0001624537],"about_ca_topic_score_codex":0.0012571388,"about_ca_topic_score_gemma":0.018776566,"teacher_disagreement_score":0.09254807,"about_ca_system_score_codex":0.0016879869,"about_ca_system_score_gemma":0.0007434365,"threshold_uncertainty_score":0.9991282},"labels":[],"label_agreement":null},{"id":"W4386948541","doi":"10.1016/j.ygyno.2023.06.512","title":"ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma (039)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Serous fluid; Internal medicine; Oncology; Chemotherapy; Phases of clinical research; Carcinoma","score_opus":0.18872423698836044,"score_gpt":0.45938250563496513,"score_spread":0.2706582686466047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828349,0.00055804255,0.000007967794,0.007157592,0.00075667806,0.0077130464,0.00009004426,0.00007245873,0.0008092689],"genre_scores_gemma":[0.9949689,0.00044352037,0.00095554395,0.0006022374,0.00012299903,0.0017264914,0.000096476324,0.00003781237,0.001046036],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974224,0.00034510036,0.0007112305,0.000745367,0.00020638526,0.0005694944],"domain_scores_gemma":[0.9963412,0.002383219,0.00035234937,0.00053183583,0.00017680302,0.00021455443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058644445,0.00038580253,0.0010754488,0.00012915704,0.00034274868,0.0000669648,0.00025229275,0.00016447727,0.00034795757],"category_scores_gemma":[0.00044495324,0.00021727323,0.00014026192,0.00031559408,0.00017659248,0.000095112126,0.0003362568,0.00015128724,0.00002034315],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0259934,0.13805372,0.03863842,0.00026194725,0.0028670225,0.0019864943,0.006026027,0.00003550761,0.0011141615,0.00007485326,0.0025922991,0.78235614],"study_design_scores_gemma":[0.20365997,0.44795287,0.22094496,0.00018855669,0.0035452303,0.00021223768,0.01145592,0.0016400006,0.00068040384,0.00003423512,0.109208494,0.00047712738],"about_ca_topic_score_codex":0.00022755074,"about_ca_topic_score_gemma":0.0006967414,"teacher_disagreement_score":0.781879,"about_ca_system_score_codex":0.0012805149,"about_ca_system_score_gemma":0.0005629451,"threshold_uncertainty_score":0.8860145},"labels":[],"label_agreement":null},{"id":"W4386954022","doi":"10.1016/j.ygyno.2023.06.150","title":"ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Paclitaxel; Medicine; Ovarian cancer; Oncology; Internal medicine; Chemotherapy; Population; Phases of clinical research; Cancer; Refractory (planetary science); Biology","score_opus":0.0391776564910209,"score_gpt":0.3837468036909214,"score_spread":0.3445691471999005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386954022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98249876,0.0014747065,0.0000060201846,0.0048649884,0.0020505923,0.0037214968,0.00031011918,0.00026166305,0.0048116343],"genre_scores_gemma":[0.9914109,0.0018968057,0.0008154929,0.00076981937,0.0003337052,0.002696072,0.00012131554,0.00008625571,0.0018696417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994584,0.00056842354,0.0015730701,0.0013709408,0.00060790236,0.0012956654],"domain_scores_gemma":[0.99566257,0.0019397296,0.0007149625,0.0010127069,0.00026078877,0.00040923126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012716451,0.0006594048,0.0021180338,0.00066103565,0.00020877898,0.000024074196,0.00038665914,0.0006169717,0.0011771686],"category_scores_gemma":[0.0009980799,0.00054885587,0.0002413888,0.001627249,0.00023735358,0.00013669675,0.00027623205,0.00075384014,0.00019747594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016335122,0.054602243,0.6380989,0.00085531943,0.002697017,0.018724361,0.015047425,0.0016686547,0.012238588,0.0028268485,0.03108501,0.20582053],"study_design_scores_gemma":[0.07133682,0.056064926,0.7582866,0.0003436715,0.00093867554,0.000074287105,0.00991327,0.00040432965,0.0007549719,0.0009049237,0.10013029,0.00084722036],"about_ca_topic_score_codex":0.0023631225,"about_ca_topic_score_gemma":0.009723563,"teacher_disagreement_score":0.20497331,"about_ca_system_score_codex":0.0023339337,"about_ca_system_score_gemma":0.0012226364,"threshold_uncertainty_score":0.9997359},"labels":[],"label_agreement":null},{"id":"W4387061861","doi":"10.1016/j.ejca.2023.113350","title":"European trends in ovarian cancer mortality, 1990–2020 and predictions to 2025","year":2023,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Ovarian cancer; Demography; Mortality rate; Population; Medicine; Cancer; Developed country; Environmental health; Internal medicine","score_opus":0.045705239180212215,"score_gpt":0.35132625847268467,"score_spread":0.30562101929247243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387061861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8853706,0.0062164003,0.00009709296,0.0518202,0.002003256,0.000305625,0.00016464034,0.000073979914,0.053948186],"genre_scores_gemma":[0.98891544,0.0048395977,0.00014611418,0.0011748635,0.001411774,0.000012424997,0.0000073378383,0.00005851025,0.0034339111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998401,0.00022571241,0.00052343577,0.0002463442,0.00033775708,0.00026578637],"domain_scores_gemma":[0.9991144,0.000026722717,0.00017547482,0.00020544312,0.00011685898,0.00036108482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000745633,0.00016983779,0.00033598757,0.0004377384,0.000060919923,0.000042908152,0.00011893699,0.000016648799,0.0006893551],"category_scores_gemma":[0.000034905646,0.00013747014,0.00011367798,0.0009087211,0.00003941991,0.00009506623,0.000082848754,0.00025693642,0.00006264945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025492124,0.00022423088,0.5376982,0.00005546749,0.0007160255,0.005462146,0.0018670952,0.001647102,0.000673997,0.0000656549,0.16473266,0.28660247],"study_design_scores_gemma":[0.0023797313,0.00036362238,0.86391,0.000493413,0.00024344136,0.000052556392,0.000072920506,0.000037645936,0.00007994105,0.0000067391957,0.13225602,0.00010397332],"about_ca_topic_score_codex":0.00028438616,"about_ca_topic_score_gemma":0.00044012413,"teacher_disagreement_score":0.32621178,"about_ca_system_score_codex":0.00019631388,"about_ca_system_score_gemma":0.00011856015,"threshold_uncertainty_score":0.75479543},"labels":[],"label_agreement":null},{"id":"W4387132218","doi":"10.1158/1055-9965.24212463.v1","title":"Supplementary Material from Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies","year":2023,"lang":"en","type":"review","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Table (database); Systematic review; Cochrane Library; Funnel plot; Oncology; Relative risk; Internal medicine; MEDLINE; Confidence interval; Publication bias; Computer science; Data mining","score_opus":0.09168976678185763,"score_gpt":0.38132547794170363,"score_spread":0.289635711159846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387132218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003402136,0.9668705,7.646941e-7,0.00013738603,0.000022537004,0.0053494587,0.027262414,0.000009282325,0.000007466825],"genre_scores_gemma":[0.00013711218,0.9946224,0.00019745108,0.00003768496,0.000019237104,0.0029345285,0.0018463685,0.000037869868,0.00016732585],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99639094,0.00051962945,0.0019488132,0.00038660373,0.0006085986,0.00014544587],"domain_scores_gemma":[0.9947724,0.000881022,0.0034572505,0.0005415153,0.00029811196,0.000049712165],"candidate_categories":["metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010004363,0.0004269499,0.01849608,0.0002436629,0.000020682835,0.0000060353254,0.000084684056,0.00009326405,0.0011149894],"category_scores_gemma":[0.000072830255,0.00020534878,0.00093176257,0.00074882555,0.000046840672,0.0000232123,0.00004149832,0.00007684543,5.475195e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001973818,0.00010088478,0.0007849119,0.37906727,0.61941725,0.000002685062,0.000045824123,1.7624022e-7,3.0173987e-7,0.0000030344781,0.00037869578,0.00017924678],"study_design_scores_gemma":[0.0005784955,0.000624831,0.000391995,0.05300515,0.94472367,7.816604e-7,0.00005273983,4.402869e-7,0.0000126471505,0.0000031929428,0.0004739102,0.00013216413],"about_ca_topic_score_codex":0.008814604,"about_ca_topic_score_gemma":0.0007472712,"teacher_disagreement_score":0.3260621,"about_ca_system_score_codex":0.00030986324,"about_ca_system_score_gemma":0.00016258656,"threshold_uncertainty_score":0.9997981},"labels":[],"label_agreement":null},{"id":"W4387132392","doi":"10.1158/1055-9965.24212463","title":"Supplementary Material from Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies","year":2023,"lang":"en","type":"review","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Table (database); Funnel plot; Cochrane Library; Systematic review; Cohort; Oncology; Internal medicine; MEDLINE; Publication bias; Computer science; Data mining; Biology","score_opus":0.09168976678185763,"score_gpt":0.38132547794170363,"score_spread":0.289635711159846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387132392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003402136,0.9668705,7.646941e-7,0.00013738603,0.000022537004,0.0053494587,0.027262414,0.000009282325,0.000007466825],"genre_scores_gemma":[0.00013711218,0.9946224,0.00019745108,0.00003768496,0.000019237104,0.0029345285,0.0018463685,0.000037869868,0.00016732585],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99639094,0.00051962945,0.0019488132,0.00038660373,0.0006085986,0.00014544587],"domain_scores_gemma":[0.9947724,0.000881022,0.0034572505,0.0005415153,0.00029811196,0.000049712165],"candidate_categories":["metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010004363,0.0004269499,0.01849608,0.0002436629,0.000020682835,0.0000060353254,0.000084684056,0.00009326405,0.0011149894],"category_scores_gemma":[0.000072830255,0.00020534878,0.00093176257,0.00074882555,0.000046840672,0.0000232123,0.00004149832,0.00007684543,5.475195e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001973818,0.00010088478,0.0007849119,0.37906727,0.61941725,0.000002685062,0.000045824123,1.7624022e-7,3.0173987e-7,0.0000030344781,0.00037869578,0.00017924678],"study_design_scores_gemma":[0.0005784955,0.000624831,0.000391995,0.05300515,0.94472367,7.816604e-7,0.00005273983,4.402869e-7,0.0000126471505,0.0000031929428,0.0004739102,0.00013216413],"about_ca_topic_score_codex":0.008814604,"about_ca_topic_score_gemma":0.0007472712,"teacher_disagreement_score":0.3260621,"about_ca_system_score_codex":0.00030986324,"about_ca_system_score_gemma":0.00016258656,"threshold_uncertainty_score":0.9997981},"labels":[],"label_agreement":null},{"id":"W4387135422","doi":"10.1136/ijgc-2023-esgo.44","title":"#1015 Mirvetuximab soravtansine demonstrates longer overall survival and progression-free survival by prior lines of therapy vs chemotherapy in platinum-resistant ovarian cancer and high folate receptor alpha expression in the MIRASOL trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Progression-free survival; Hazard ratio; Medicine; Internal medicine; Clinical endpoint; Oncology; Topotecan; Population; Ovarian cancer; Adverse effect; Paclitaxel; Confidence interval; Chemotherapy; Cancer; Randomized controlled trial","score_opus":0.03363870962360981,"score_gpt":0.34231345501011756,"score_spread":0.30867474538650774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717878,0.005030516,0.000008088039,0.02143392,0.0008797452,0.0006670815,0.00014989663,0.000009812454,0.000033122036],"genre_scores_gemma":[0.9788376,0.019670915,0.00044816337,0.0003985082,0.00042708998,0.00012487888,0.000020032332,0.000019572726,0.00005321932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977719,0.00018657176,0.0007625061,0.0002808221,0.0007610768,0.00023708843],"domain_scores_gemma":[0.99812245,0.0008853404,0.0004771781,0.00013375882,0.00028414058,0.00009710307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084842095,0.0002267048,0.0006183758,0.00017677726,0.00004189242,0.000056335928,0.00027026408,0.00016230704,0.0004427579],"category_scores_gemma":[0.00026366435,0.0001272515,0.000096882184,0.00021661664,0.00013566253,0.00013992909,0.00006128058,0.00031700812,5.069254e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19411898,0.004292681,0.48126855,0.00009127293,0.0011771512,0.000720721,0.0015646138,0.00006501468,0.05449816,0.00036610957,0.008097455,0.2537393],"study_design_scores_gemma":[0.10503162,0.0036618987,0.88013947,0.000835109,0.00005805477,0.000018482508,0.00019444726,0.000115671886,0.005665933,0.0009098366,0.0031572105,0.00021226027],"about_ca_topic_score_codex":0.00038636336,"about_ca_topic_score_gemma":0.00050428166,"teacher_disagreement_score":0.39887092,"about_ca_system_score_codex":0.00019362112,"about_ca_system_score_gemma":0.00022891942,"threshold_uncertainty_score":0.51891655},"labels":[],"label_agreement":null},{"id":"W4387135460","doi":"10.1136/ijgc-2023-esgo.49","title":"#71 Integrated multi-omic and clinicopathological analysis of high-grade serous ovarian cancer in BRCA1/2 mutated patients with poor survival: identification of predictive biomarkers for personalized treatment","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Oncology; Ovarian cancer; Serous fluid; Medicine; Internal medicine; Cancer; Germline; Cancer research; BRCA mutation; Serous carcinoma; Survival analysis; Biology; Gene; Genetics","score_opus":0.04083059711996549,"score_gpt":0.3617334189412684,"score_spread":0.3209028218213029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943578,0.00032110812,0.00049761287,0.0022474322,0.00044371185,0.0006203357,0.0014949507,0.000012653472,0.000004387483],"genre_scores_gemma":[0.9972447,0.0016242373,0.00052105845,0.0000807021,0.000045397555,0.00019343062,0.00021403222,0.000013659195,0.00006277834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979986,0.00012565462,0.0009564638,0.0003027114,0.00044151768,0.00017503196],"domain_scores_gemma":[0.99725735,0.00052812084,0.00092326454,0.000092629685,0.001096616,0.00010200532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041618958,0.0001868533,0.0008489029,0.00061361725,0.000024882762,0.00001529542,0.00013309343,0.00012878672,0.0002325857],"category_scores_gemma":[0.00031204338,0.00011463682,0.0002522093,0.0007208064,0.00018340896,0.000082214174,0.000026271478,0.00011262585,4.1110994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006533748,0.0020726505,0.96615905,0.000023580833,0.0059432723,0.00008694814,0.0003225967,0.002669296,0.00070437655,0.00006313233,0.000054811662,0.015366547],"study_design_scores_gemma":[0.015901769,0.0023310203,0.9738594,0.00014863769,0.0021541698,0.0000038071873,0.00022369227,0.0041420325,0.0010111138,0.00004240936,0.00008605158,0.000095897645],"about_ca_topic_score_codex":0.0009078903,"about_ca_topic_score_gemma":0.0009380087,"teacher_disagreement_score":0.015270649,"about_ca_system_score_codex":0.000835773,"about_ca_system_score_gemma":0.0002731188,"threshold_uncertainty_score":0.46747538},"labels":[],"label_agreement":null},{"id":"W4387135564","doi":"10.1136/ijgc-2023-esgo.23","title":"#236 Laparoscopic cytoreduction after neoadjuvant chemotherapy (LANCE): feasibility phase of a randomized trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Surgery; Laparotomy; Laparoscopic surgery; Stage (stratigraphy); Neoadjuvant therapy; Chemotherapy; Laparoscopy; Cancer; Internal medicine; Breast cancer","score_opus":0.04837968530107541,"score_gpt":0.40947463827845,"score_spread":0.3610949529773746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98592037,0.0007805904,0.000051895764,0.009246699,0.0030467836,0.00071073667,0.000043090862,0.000018384137,0.00018145844],"genre_scores_gemma":[0.9950543,0.002476763,0.0002569007,0.0005881165,0.0012119364,0.00018294368,0.000010465184,0.000010514846,0.0002080409],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981134,0.00011153335,0.0008210234,0.00018279605,0.0006157848,0.00015549712],"domain_scores_gemma":[0.9982853,0.00031929577,0.0005657542,0.00011540224,0.0006031225,0.00011115931],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072063674,0.00013608155,0.0008784864,0.00016824125,0.000018738661,0.000019312365,0.00014092987,0.000095280564,0.0028024865],"category_scores_gemma":[0.0005480602,0.000085624364,0.0005204173,0.00016298336,0.00015094875,0.00009242937,0.000026071164,0.00017860079,0.000010404016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9505258,0.0022975085,0.015376309,0.000023663802,0.0013462261,0.0003013331,0.00020448398,0.000055662364,0.0013673464,0.00011537139,0.002277142,0.026109142],"study_design_scores_gemma":[0.90709054,0.0023336157,0.08282234,0.00018302324,0.00029082788,0.000042353935,0.000037587644,0.00010674082,0.0034441717,0.0009664277,0.0025917962,0.00009054581],"about_ca_topic_score_codex":0.000032684144,"about_ca_topic_score_gemma":0.0000100041625,"teacher_disagreement_score":0.06744603,"about_ca_system_score_codex":0.0004758322,"about_ca_system_score_gemma":0.0002871965,"threshold_uncertainty_score":0.9981091},"labels":[],"label_agreement":null},{"id":"W4387135691","doi":"10.1136/ijgc-2023-esgo.879","title":"#487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hamilton Health Sciences","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Oncology; Internal medicine; Tolerability; Fallopian tube; Carboplatin; Chemotherapy; Bevacizumab; Phases of clinical research; Cancer; Immunotherapy; Cisplatin; Surgery; Adverse effect","score_opus":0.026223513900528708,"score_gpt":0.3356447379003544,"score_spread":0.3094212239998257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387135691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632484,0.000070589194,0.000012577622,0.0018358285,0.0005823234,0.00091118884,0.00014097978,0.000013847999,0.00010779951],"genre_scores_gemma":[0.9986599,0.00027443565,0.00023680177,0.00030073244,0.00018029225,0.00020719407,0.000043008557,0.000028546556,0.00006905593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739,0.000100618076,0.00081203453,0.00032980737,0.0010732189,0.00029432256],"domain_scores_gemma":[0.9982778,0.0002975448,0.0005413041,0.00014667322,0.0006079222,0.00012875903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023316973,0.0002552862,0.00063886575,0.00036409253,0.000035546615,0.000034952143,0.0002354503,0.000104231156,0.0008325203],"category_scores_gemma":[0.00010300451,0.00015867258,0.00007661713,0.00041789413,0.000085194224,0.00019314063,0.000048425667,0.00035445095,0.0000020978546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12663622,0.012233863,0.8353639,0.000044088792,0.00096181827,0.0013034015,0.0011137257,0.0013317516,0.00022148601,0.000031654836,0.00014499958,0.020613076],"study_design_scores_gemma":[0.14024286,0.012931121,0.8448494,0.00040451394,0.00012545113,0.000006942639,0.0003116875,0.00028211376,0.00021472652,0.00000840384,0.0004707594,0.00015199154],"about_ca_topic_score_codex":0.0009712123,"about_ca_topic_score_gemma":0.0047754035,"teacher_disagreement_score":0.020461084,"about_ca_system_score_codex":0.0016194114,"about_ca_system_score_gemma":0.00058003236,"threshold_uncertainty_score":0.91155136},"labels":[],"label_agreement":null},{"id":"W4387136062","doi":"10.1136/ijgc-2023-esgo.524","title":"#141 Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Olaparib; Chemotherapy; Oncology; Progression-free survival; Population; Retrospective cohort study; Cancer; Poly ADP ribose polymerase; Biology","score_opus":0.033715588662758846,"score_gpt":0.3599319659043354,"score_spread":0.32621637724157654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387136062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88633144,0.00032525155,0.000037505615,0.11009557,0.0025519012,0.00036353045,0.00018428633,0.000025284344,0.00008524187],"genre_scores_gemma":[0.9903168,0.0007287308,0.00050970813,0.006957685,0.001046366,0.00020104273,0.00001511092,0.000024077019,0.00020046828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978047,0.00012774677,0.0006862813,0.00028476145,0.00078156573,0.00031496337],"domain_scores_gemma":[0.9981218,0.0005209289,0.00029278462,0.00012866576,0.0006692936,0.00026650357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007007337,0.00020407999,0.00044336347,0.0004759187,0.00003518724,0.000044015764,0.00025523957,0.00012395132,0.0030901073],"category_scores_gemma":[0.0005844303,0.00014715064,0.0002330268,0.00040669402,0.000049865586,0.000081451326,0.000048064892,0.00032762034,0.000054785203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079269834,0.0030586838,0.43784732,0.000057502166,0.0013989989,0.0075518466,0.001454224,0.008272737,0.04433384,0.0002756747,0.024049515,0.39242983],"study_design_scores_gemma":[0.00968265,0.0022172164,0.9331019,0.0005784121,0.0000544922,0.000035398672,0.000069657166,0.00020431883,0.0076230676,0.00013026664,0.046120845,0.00018179254],"about_ca_topic_score_codex":0.00027933053,"about_ca_topic_score_gemma":0.00054638344,"teacher_disagreement_score":0.49525458,"about_ca_system_score_codex":0.0021006924,"about_ca_system_score_gemma":0.0010789166,"threshold_uncertainty_score":0.9978212},"labels":[],"label_agreement":null},{"id":"W4387253827","doi":"10.1038/s41571-023-00819-1","title":"Heterogeneity and treatment landscape of ovarian carcinoma","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian carcinoma; Malignancy; Ovarian cancer; Medicine; Carcinoma; Targeted therapy; Disease; Genetic heterogeneity; Tumor microenvironment; Cancer research; Oncology; Cancer; Bioinformatics; Internal medicine; Biology; Gene; Genetics; Phenotype","score_opus":0.27561281465262794,"score_gpt":0.5323425707244082,"score_spread":0.2567297560717802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387253827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053251686,0.99350935,6.163838e-7,0.00059816707,0.000982009,0.0034216414,0.00012727374,0.000039057748,0.0012686484],"genre_scores_gemma":[0.000034836274,0.9964943,0.0007794192,0.0003300772,0.001114443,0.0006097639,0.00023038538,0.00007614773,0.00033062705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946122,0.0010815341,0.0027866862,0.00097653456,0.00019414954,0.00034889055],"domain_scores_gemma":[0.9948998,0.0022119153,0.0014679267,0.0009220928,0.00008873896,0.00040952495],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015174765,0.0006325307,0.010108457,0.00018902427,0.000040935476,0.0000085882375,0.0001656518,0.002650639,0.000093157054],"category_scores_gemma":[0.0007900005,0.00035814682,0.0023336967,0.00042844546,0.00017139775,0.00002016685,0.00012944278,0.0012854212,0.00018897699],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049690385,0.00093204685,0.0032806806,0.016184226,0.0012607191,0.00030662402,0.000006575929,4.4317217e-9,1.0839292e-8,0.00014756556,0.003669336,0.9741625],"study_design_scores_gemma":[0.0023030443,0.004016319,0.003603918,0.012639025,0.010727521,0.00020020001,0.0000016277219,6.518103e-7,2.1993775e-7,0.000010639628,0.9662778,0.00021907486],"about_ca_topic_score_codex":0.000021777954,"about_ca_topic_score_gemma":0.00014076676,"teacher_disagreement_score":0.9739435,"about_ca_system_score_codex":0.00040579448,"about_ca_system_score_gemma":0.0012958483,"threshold_uncertainty_score":0.99988705},"labels":[],"label_agreement":null},{"id":"W4387380008","doi":"10.1210/jendso/bvad114.1675","title":"SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome","year":2023,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Endometrial cancer; Medicine; Polycystic ovary; Gynecology; Cancer; Meta-analysis; Family medicine; Internal medicine; Insulin resistance","score_opus":0.020731913127347252,"score_gpt":0.28846259446892303,"score_spread":0.2677306813415758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387380008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908174,0.0009011332,0.0000032299556,0.008548387,0.0009567138,0.00023989574,0.0000661543,0.000018114291,0.00018463674],"genre_scores_gemma":[0.99720603,0.0010491594,0.00013635296,0.00015267864,0.0005493462,0.000011550651,0.000004008024,0.000026039143,0.000864855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876153,0.000048588372,0.000452474,0.00012145232,0.00037265153,0.00024330977],"domain_scores_gemma":[0.99867773,0.0003071277,0.0005945872,0.00021396704,0.00010548144,0.00010109792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029475684,0.00014198806,0.0005439546,0.00008581844,0.000065525805,0.000011984983,0.00016424115,0.000039664363,0.00020399252],"category_scores_gemma":[0.00012107559,0.000080517595,0.0006111966,0.00045810427,0.000082266335,0.00006584937,0.00006265548,0.00026095205,0.000007492901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005649272,0.0018079954,0.57845634,0.00054951094,0.042665888,0.0025378398,0.004498533,0.013145008,0.0063370587,0.00027933624,0.33454025,0.009532959],"study_design_scores_gemma":[0.028724812,0.0026293476,0.9447339,0.0018243768,0.0037253173,0.0020517576,0.0009059603,0.00058099837,0.006997206,0.00026225168,0.0072559225,0.00030814018],"about_ca_topic_score_codex":0.00026290477,"about_ca_topic_score_gemma":0.000012772501,"teacher_disagreement_score":0.36627758,"about_ca_system_score_codex":0.00059451966,"about_ca_system_score_gemma":0.0005015417,"threshold_uncertainty_score":0.32834122},"labels":[],"label_agreement":null},{"id":"W4387563786","doi":"10.1097/coc.0000000000001049","title":"Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre; University Health Network; University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; Lakeridge Health","funders":"","keywords":"Medicine; Internal medicine; KRAS; Serous fluid; MEDLINE; Randomized controlled trial; Oncology; Ovarian cancer; Clinical trial; Meta-analysis; Cancer; Colorectal cancer","score_opus":0.2085496925214123,"score_gpt":0.5294789099811842,"score_spread":0.3209292174597719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018208924,0.9911436,0.000008013835,0.0033173864,0.0022978245,0.0010181023,0.00011842498,0.000021126774,0.00025466073],"genre_scores_gemma":[0.0009982266,0.9944541,0.0014469393,0.00016639211,0.0025008528,0.0001569779,0.000023764676,0.00010702008,0.00014574823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934776,0.00084745226,0.00419199,0.0005122267,0.0005432849,0.00042748472],"domain_scores_gemma":[0.98814434,0.002979029,0.0073498194,0.00047268573,0.00037758658,0.0006765159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007415771,0.0005746187,0.010054695,0.0003665442,0.000035509274,0.000009233568,0.0002262171,0.00035939986,0.00010120787],"category_scores_gemma":[0.00024309212,0.00031401782,0.0021651543,0.0008030756,0.0007617134,0.000039490038,0.000041492454,0.00081312354,0.0000205472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010741891,0.0043239715,0.0018468973,0.0014873209,0.0071150837,0.0023503685,0.00009082648,0.0000044155317,3.3905476e-8,0.000017479184,0.00085428316,0.98083514],"study_design_scores_gemma":[0.0059302375,0.07641748,0.0011605707,0.014410799,0.013414873,0.0009383509,0.00009949619,0.0000022088009,0.0000012099243,0.000007890423,0.88737786,0.00023899574],"about_ca_topic_score_codex":0.0004088713,"about_ca_topic_score_gemma":0.0001535466,"teacher_disagreement_score":0.9805961,"about_ca_system_score_codex":0.0013090369,"about_ca_system_score_gemma":0.007188916,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W4387825090","doi":"10.1016/j.annonc.2023.09.1970","title":"792P Prognostic role of the modeled CA-125 KELIM in early FIGO stage I and II ovarian cancers (OC): A GCIG individual-patient data meta-analysis","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Serous fluid; Stage (stratigraphy); Multivariate analysis; Univariate analysis; Chemotherapy; Oncology; Gynecology; Gastroenterology","score_opus":0.22912457981258644,"score_gpt":0.3989477167335811,"score_spread":0.16982313692099466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387825090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835366,0.0030988636,0.0000026846851,0.010511066,0.00006195698,0.0008248735,0.0012608279,0.000019032237,0.00068412174],"genre_scores_gemma":[0.99797463,0.0006121003,0.00017433867,0.0006781891,0.000022859635,0.0001954998,0.00016986899,0.000018781893,0.00015371185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815404,0.000188779,0.0005599009,0.00044025003,0.0003488122,0.000308241],"domain_scores_gemma":[0.9982513,0.00029863653,0.0003474529,0.00085951725,0.00014071297,0.000102357226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005784633,0.0001752211,0.0011619466,0.0003383945,0.00005043835,0.00000792017,0.00026917303,0.00012314826,0.0001502361],"category_scores_gemma":[0.00017396147,0.00011577949,0.0002982733,0.0011945724,0.0001300756,0.00008005265,0.000442052,0.00015129632,0.000003015186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090688403,0.0039859125,0.6471854,0.0003084279,0.26492915,0.00032332196,0.018634506,0.007973579,0.0002861838,0.0014305046,0.01515267,0.03888351],"study_design_scores_gemma":[0.0035969925,0.0053285286,0.85933954,0.000055948083,0.10052113,0.0000069769144,0.0010631268,0.0048772544,0.001378047,0.00052139733,0.023060828,0.0002502049],"about_ca_topic_score_codex":0.0069405157,"about_ca_topic_score_gemma":0.0064167026,"teacher_disagreement_score":0.2121542,"about_ca_system_score_codex":0.00006396837,"about_ca_system_score_gemma":0.00055077166,"threshold_uncertainty_score":0.99967235},"labels":[],"label_agreement":null},{"id":"W4387934508","doi":"10.1136/ijgc-2023-004745","title":"Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous fluid; Cytoreductive surgery; Stage (stratigraphy); Adjuvant; Chemotherapy; Adjuvant chemotherapy; Ovarian carcinoma; Oncology; Overall survival; Serous carcinoma; Surgery; Internal medicine; Ovarian cancer; Cancer","score_opus":0.026704651296443983,"score_gpt":0.3154612162167232,"score_spread":0.2887565649202792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387934508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964735,0.0001724637,0.000010678809,0.0019630194,0.0007339796,0.0002776311,0.00016938857,0.000008511114,0.00019082565],"genre_scores_gemma":[0.9989158,0.00034693794,0.000072641735,0.0003363941,0.00019805743,0.000024055036,0.000027987802,0.00001988953,0.000058228055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814206,0.00007456433,0.0005175683,0.00017804008,0.0008890397,0.0001987206],"domain_scores_gemma":[0.9975817,0.0009249195,0.00065398024,0.00014305103,0.00060022646,0.00009612349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029440434,0.0001801055,0.00060371513,0.00016849028,0.000030494495,0.0000126704535,0.00019271401,0.00006570713,0.00052827434],"category_scores_gemma":[0.00018942765,0.0000917234,0.00052933046,0.00019736122,0.00008757158,0.00011774282,0.000033819768,0.00020898684,0.0000017051618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003655181,0.0012063642,0.9827187,0.000020260399,0.001902969,0.0002518403,0.00017454698,0.001135584,0.00041152685,0.000119575765,0.000728424,0.007675046],"study_design_scores_gemma":[0.004145623,0.0019376824,0.99218625,0.00026210476,0.000094511095,0.000005481988,0.00004801658,0.000016669192,0.0009639355,0.00008059654,0.00017098118,0.00008817295],"about_ca_topic_score_codex":0.00010894676,"about_ca_topic_score_gemma":0.0000114145205,"teacher_disagreement_score":0.009467543,"about_ca_system_score_codex":0.00088505005,"about_ca_system_score_gemma":0.0005286289,"threshold_uncertainty_score":0.5784233},"labels":[],"label_agreement":null},{"id":"W4388207766","doi":"10.1016/j.jmig.2023.08.022","title":"Comparison of O-RADS 2022 and Simple Rules Ultrasound Classifications to Predict Adnexal Malignancy","year":2023,"lang":"en","type":"article","venue":"Journal of Minimally Invasive Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Malignancy; Radiology; BI-RADS; Gynecology; Internal medicine; Cancer","score_opus":0.043418716609817457,"score_gpt":0.34421227525964526,"score_spread":0.3007935586498278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388207766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275553,0.0009168426,0.000026154092,0.005058738,0.00029166992,0.0003145912,0.00008647515,0.0000128209085,0.00053717504],"genre_scores_gemma":[0.9967523,0.0011859115,0.0013381544,0.00035792356,0.00016634459,0.00003380983,0.00002799224,0.000018166575,0.00011937917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984491,0.00008339983,0.00076425576,0.00019689006,0.00025743234,0.00024895425],"domain_scores_gemma":[0.9969721,0.0017238661,0.0004975054,0.0001921572,0.00036772512,0.0002466887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027024423,0.0001442577,0.00067306304,0.0003600278,0.00007023576,0.000011917745,0.00012391072,0.00011512667,0.00034063187],"category_scores_gemma":[0.0015449256,0.00012000149,0.0001359951,0.00029483167,0.00011914835,0.00006331172,0.000052972013,0.00018840151,0.000039299975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029274728,0.0008718958,0.894111,0.00013347321,0.0006169402,0.00025397952,0.0013636381,0.000044114513,0.040349767,0.0006718246,0.056421846,0.0048687696],"study_design_scores_gemma":[0.0020807127,0.0049631316,0.9738031,0.00014546743,0.00039128208,0.00023999938,0.0014348252,0.000015934032,0.0078519,0.00033608908,0.008644158,0.00009342602],"about_ca_topic_score_codex":0.0000108995755,"about_ca_topic_score_gemma":0.00013248115,"teacher_disagreement_score":0.07969207,"about_ca_system_score_codex":0.00013347589,"about_ca_system_score_gemma":0.0005163403,"threshold_uncertainty_score":0.48935187},"labels":[],"label_agreement":null},{"id":"W4388284020","doi":"10.1016/j.canlet.2023.216469","title":"Metronomic chemotherapy in ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Letters","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Medicine; Chemotherapy; Clinical trial; Angiogenesis; Oncology; Epithelial ovarian cancer; Cancer; Translational research; Bioinformatics; Internal medicine; Biology; Pathology","score_opus":0.023954558734101405,"score_gpt":0.3149997078958131,"score_spread":0.2910451491617117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388284020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85484695,0.0010384662,0.000022872575,0.1424175,0.0006222433,0.00037680625,0.000025938294,0.00008323378,0.0005659707],"genre_scores_gemma":[0.97258145,0.0026333919,0.00015156732,0.02247097,0.00056703243,0.0008694547,0.000021087577,0.00004734857,0.0006576853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990102,0.000015405976,0.00017492502,0.00032581203,0.00013193849,0.00034169925],"domain_scores_gemma":[0.9995794,0.00002802347,0.00004393977,0.00024053856,0.000013381122,0.00009468383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008598601,0.00014886691,0.00027587454,0.00020400435,0.00002986694,0.000015368641,0.000070196096,0.000046453806,0.0010701605],"category_scores_gemma":[0.0000041574954,0.00013289857,0.00008804681,0.00051153015,0.000037921247,0.00005259092,0.000015700401,0.00011874499,0.00015707636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022483256,0.00013223743,0.77144307,0.00008832953,0.000417247,0.00022076404,0.0007190551,0.00083169795,0.022016035,0.00012006959,0.14323671,0.060549967],"study_design_scores_gemma":[0.005003244,0.000042088166,0.9097549,0.0001953225,0.00007305243,0.000002385937,0.000036071535,0.00019093322,0.007394671,0.000018857285,0.077110074,0.0001784103],"about_ca_topic_score_codex":0.0018502023,"about_ca_topic_score_gemma":0.0003162997,"teacher_disagreement_score":0.13831183,"about_ca_system_score_codex":0.0008305622,"about_ca_system_score_gemma":0.0001446618,"threshold_uncertainty_score":0.999843},"labels":[],"label_agreement":null},{"id":"W4388294328","doi":"10.1136/ijgc-2023-004774","title":"Low-grade serous ovarian carcinoma: a brief overview of the histopathologic features and differential diagnosis","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Differential diagnosis; Carcinoma; Ovarian carcinomas; Ovarian cancer; Ovary; Oncology; Gynecology; Pathology; Internal medicine; Cancer","score_opus":0.04661172194320745,"score_gpt":0.331772037629931,"score_spread":0.28516031568672356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388294328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97567147,0.0039542257,0.000006900377,0.018371161,0.0015750725,0.00018201095,0.00005662815,0.0000116088095,0.00017090938],"genre_scores_gemma":[0.99238515,0.0057521323,0.000067857996,0.001137891,0.00038785225,0.000051646122,0.0000039506135,0.000009437554,0.00020407766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987044,0.00007568149,0.00039050865,0.00016960167,0.00050350657,0.00015632658],"domain_scores_gemma":[0.9988647,0.0002879389,0.00035203394,0.00011974442,0.00027890064,0.00009669153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001566131,0.00013443248,0.0003751771,0.00010521353,0.000048073824,0.000023810502,0.00023706169,0.00009800205,0.0007038824],"category_scores_gemma":[0.0002617111,0.00007326918,0.00025440985,0.000170077,0.00013011588,0.000053817817,0.00013607545,0.00023913202,0.000002317993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031435167,0.00074147404,0.9563559,0.00006903167,0.0004102857,0.00092445896,0.0002170697,0.000044837077,0.00084650225,0.0012539469,0.009083742,0.029738361],"study_design_scores_gemma":[0.0022529908,0.00044378458,0.9903256,0.00021821767,0.00021011915,0.00032211147,0.000028146771,0.0000148954705,0.0019922338,0.0005643955,0.003558428,0.0000690279],"about_ca_topic_score_codex":0.00011435698,"about_ca_topic_score_gemma":0.00007150237,"teacher_disagreement_score":0.033969708,"about_ca_system_score_codex":0.0003019348,"about_ca_system_score_gemma":0.00014678082,"threshold_uncertainty_score":0.77070194},"labels":[],"label_agreement":null},{"id":"W4388488241","doi":"10.1158/1078-0432.ccr-23-2365","title":"Methodical Manipulation of the TME in Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Bevacizumab; Tumor microenvironment; Chemotherapy; Medicine; Cancer; Cancer research; Oncology; Biology; Internal medicine","score_opus":0.5819015776579184,"score_gpt":0.6383872710847307,"score_spread":0.05648569342681231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388488241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94317037,0.0011963805,0.0000114642135,0.05123031,0.00075904233,0.0010607088,0.00003514712,0.000028450822,0.0025081523],"genre_scores_gemma":[0.994383,0.0029686268,0.00011695604,0.00033746625,0.00046026305,0.00049378397,0.000006293807,0.000021304819,0.0012123398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972408,0.000620569,0.00057091546,0.0003808539,0.00079026195,0.00039663116],"domain_scores_gemma":[0.99790967,0.0011638975,0.00007372185,0.00048673808,0.00021116108,0.0001548368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034790009,0.00009096004,0.00037533793,0.00017588255,0.000075857424,0.0000121596995,0.00019377365,0.00015819632,0.0008956364],"category_scores_gemma":[0.00088026375,0.000057425415,0.00018007823,0.0016281869,0.0003086816,0.000033687127,0.00017570108,0.0006957787,0.000056674602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003604318,0.00031281673,0.9391942,0.000096735545,0.000087195986,0.00003859063,0.00012335171,0.000082473896,0.00025235038,0.0012985568,0.009217665,0.04893561],"study_design_scores_gemma":[0.0022516544,0.00017181771,0.9846754,0.00036231067,0.000039967505,9.800709e-7,0.000050128463,0.00046944869,0.0012020854,0.0010351713,0.009687319,0.000053689702],"about_ca_topic_score_codex":0.0043319846,"about_ca_topic_score_gemma":0.0016789809,"teacher_disagreement_score":0.05121262,"about_ca_system_score_codex":0.0003270465,"about_ca_system_score_gemma":0.0008733838,"threshold_uncertainty_score":0.98065907},"labels":[],"label_agreement":null},{"id":"W4388495132","doi":"10.1136/ijgc-2023-igcs.103","title":"PR063/#79  Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Serous carcinoma; Population; Cohort; Serous fluid; Retrospective cohort study; BRCA mutation; Gynecology; Internal medicine; Ovarian cancer; Oncology; Cancer","score_opus":0.030236286863281663,"score_gpt":0.3562752845719344,"score_spread":0.32603899770865274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929297,0.000114807866,0.00003623615,0.004601928,0.0018851946,0.00019006614,0.00009401692,0.000023096925,0.00012494261],"genre_scores_gemma":[0.99771905,0.00049144967,0.00026185546,0.0006091592,0.00070941175,0.000032677795,0.0000354827,0.000014345106,0.00012658486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983324,0.00009374782,0.0005663822,0.00020260217,0.00058876595,0.00021610309],"domain_scores_gemma":[0.99882454,0.00027683369,0.00032135416,0.00010319452,0.00031782014,0.00015627818],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034102617,0.0001489137,0.00039657604,0.00027916674,0.000037509533,0.00004262529,0.00019190444,0.00011117758,0.0010748749],"category_scores_gemma":[0.00039442707,0.00010265119,0.00017037739,0.00017894538,0.000033386357,0.00018920471,0.000046638932,0.00032113705,0.00002941075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044242706,0.000516165,0.9579789,0.0000057114885,0.00018776326,0.0012969378,0.00014949904,0.002050347,0.000067961475,0.00012696769,0.00029460518,0.03688271],"study_design_scores_gemma":[0.0034561178,0.0009892893,0.9928374,0.00005236516,0.00008582698,0.00006503484,0.000048563707,0.0008725967,0.00012031201,0.0008024586,0.00057078846,0.000099213015],"about_ca_topic_score_codex":0.00063678995,"about_ca_topic_score_gemma":0.00077669654,"teacher_disagreement_score":0.036783494,"about_ca_system_score_codex":0.0008826253,"about_ca_system_score_gemma":0.00016455282,"threshold_uncertainty_score":0.9998383},"labels":[],"label_agreement":null},{"id":"W4388495151","doi":"10.1136/ijgc-2023-igcs.349","title":"EP280/#231  Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Olaparib; Progression-free survival; Cancer; Retrospective cohort study; Poly ADP ribose polymerase; Biology","score_opus":0.03373060143368868,"score_gpt":0.3597673841096987,"score_spread":0.32603678267601005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88749415,0.00034422748,0.00003631134,0.10872152,0.0026876826,0.00039852195,0.00019971258,0.000027046115,0.00009081945],"genre_scores_gemma":[0.99008703,0.0007731859,0.000572526,0.0069485954,0.0011369002,0.0002258143,0.000017210676,0.000026357944,0.00021239724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976548,0.00013985456,0.0007308096,0.00030699378,0.00082748395,0.00034004328],"domain_scores_gemma":[0.998003,0.0005724745,0.00031643827,0.00013971639,0.0006795551,0.00028879897],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074279425,0.00022032676,0.00047483484,0.00049945404,0.00003866212,0.000047601672,0.0002725595,0.00013458345,0.0033290123],"category_scores_gemma":[0.000608365,0.00015983988,0.00024652178,0.00042873304,0.00005434526,0.000086803826,0.00005196606,0.00034941908,0.000060133094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08054865,0.0032694729,0.4210136,0.000061986015,0.0015703099,0.008026858,0.001546617,0.009294522,0.04505659,0.00031397777,0.024331579,0.40496585],"study_design_scores_gemma":[0.0102294395,0.0022853194,0.9291148,0.00058514305,0.00006149375,0.00003831408,0.000067759065,0.00021178115,0.008156683,0.00015677039,0.048891913,0.00020054427],"about_ca_topic_score_codex":0.00030838215,"about_ca_topic_score_gemma":0.00056741823,"teacher_disagreement_score":0.5081013,"about_ca_system_score_codex":0.0021846134,"about_ca_system_score_gemma":0.0011588268,"threshold_uncertainty_score":0.9975821},"labels":[],"label_agreement":null},{"id":"W4388495382","doi":"10.1136/ijgc-2023-igcs.409","title":"EP354/#665  Histopathologic and oncological characteristics of ovarian borderline tumours with positive peritoneal cytology: a case series","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Serous fluid; Cytology; Retrospective cohort study; Adjuvant therapy; Stage (stratigraphy); Biopsy; Cohort; Internal medicine; Radiology; Gastroenterology; Pathology; Cancer","score_opus":0.020949409875915457,"score_gpt":0.3236738171394997,"score_spread":0.30272440726358424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810315,0.00041779238,0.000056513007,0.017260117,0.0005861747,0.000198657,0.0001546943,0.000021889875,0.00027265496],"genre_scores_gemma":[0.99570847,0.0013315075,0.001628366,0.0007239209,0.0003590159,0.000037732298,0.00002152697,0.000012091543,0.00017739799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858123,0.000082855666,0.0005376717,0.0002242367,0.00036581693,0.00020821622],"domain_scores_gemma":[0.9981619,0.00034384246,0.00048861123,0.000084319596,0.00075862615,0.00016270057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028661845,0.00017797737,0.0006153889,0.00017647311,0.000060066726,0.000022357179,0.00012131212,0.00014169162,0.0005006667],"category_scores_gemma":[0.00031354447,0.00010975606,0.00011904648,0.00016569268,0.00034428324,0.00010314359,0.000079078774,0.00029870533,0.0000034579718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058526723,0.0012091803,0.77435976,0.000046724497,0.00077206234,0.17082034,0.0005350785,0.000045097353,0.0010364633,0.0015993038,0.0007388307,0.042984515],"study_design_scores_gemma":[0.0031547875,0.0059435596,0.9468024,0.00015005833,0.00029588887,0.04063405,0.0003051445,0.00004708542,0.00037855894,0.00023221504,0.0019289139,0.0001273878],"about_ca_topic_score_codex":0.000051343093,"about_ca_topic_score_gemma":0.00008184866,"teacher_disagreement_score":0.17244262,"about_ca_system_score_codex":0.00036191262,"about_ca_system_score_gemma":0.00029258363,"threshold_uncertainty_score":0.54819494},"labels":[],"label_agreement":null},{"id":"W4388495465","doi":"10.1136/ijgc-2023-igcs.14","title":"PO014/#364  Laparoscopic cytoreduction after neoadjuvant chemotherapy (LANCE): feasibility phase of a randomized trial","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Surgery; Laparotomy; Stage (stratigraphy); Laparoscopic surgery; Neoadjuvant therapy; Laparoscopy; Cancer; Internal medicine; Breast cancer","score_opus":0.04728695400374413,"score_gpt":0.4086763127666668,"score_spread":0.3613893587629227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388495465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843342,0.0008466101,0.00005299979,0.010616573,0.0031317566,0.0007511198,0.00004869524,0.000019998228,0.00019804954],"genre_scores_gemma":[0.99486065,0.0025237286,0.00026827247,0.00063694915,0.0012623613,0.00018775064,0.000011989509,0.000011747401,0.00023652773],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979837,0.00012187048,0.000870085,0.00019910885,0.00065547694,0.00016973914],"domain_scores_gemma":[0.9981709,0.00033877784,0.00060358667,0.00012512688,0.0006402894,0.00012132826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075875974,0.00014876778,0.00093191187,0.00018204552,0.000020824464,0.000021469765,0.00015252986,0.00010327789,0.0025589392],"category_scores_gemma":[0.00057434815,0.000094311334,0.00055322546,0.0001738834,0.00015880122,0.000098861805,0.000028827935,0.00019401753,0.000011760715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9461084,0.0024767576,0.019822773,0.000025817299,0.0014776238,0.0003401583,0.00020537933,0.00005958217,0.001299624,0.00012711994,0.002563048,0.025493717],"study_design_scores_gemma":[0.8976821,0.0024404123,0.09225177,0.00019352564,0.0003170843,0.000048426176,0.000038505623,0.00010765876,0.0031224876,0.0010381893,0.0026601972,0.00009968524],"about_ca_topic_score_codex":0.00004366772,"about_ca_topic_score_gemma":0.000013872603,"teacher_disagreement_score":0.072429,"about_ca_system_score_codex":0.0005106233,"about_ca_system_score_gemma":0.000305641,"threshold_uncertainty_score":0.9983529},"labels":[],"label_agreement":null},{"id":"W4388562165","doi":"10.1101/2023.11.09.23298321","title":"Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Alberta Health Services; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"Medical Research and Materiel Command; National Center for Advancing Translational Sciences; BC Cancer Foundation; Cancer Institute NSW; National Cancer Institute; University College London; National Health and Medical Research Council; University of Cambridge; Cancer Research UK; Michael Smith Health Research BC; National Institute for Health and Care Research; National Institutes of Health; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Oak Foundation; Medical Research Council; Swedish Cancer Foundation; European Commission; Cedars-Sinai Medical Center; Marshfield Clinic Research Foundation","keywords":"Ovarian cancer; Ovarian carcinoma; Serous fluid; Germline; Serous carcinoma; Biology; Cancer research; Oncology; Cancer; Internal medicine; Medicine; Gene; Genetics","score_opus":0.03971792290788793,"score_gpt":0.29640537097641373,"score_spread":0.2566874480685258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388562165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98495567,0.007249269,0.00007574894,0.0041234074,0.0016465016,0.0015101669,0.00021073793,0.00017667035,0.000051816125],"genre_scores_gemma":[0.99451387,0.004197822,0.000082320956,0.000107350825,0.00021595748,0.00045248616,0.0001583437,0.00007782526,0.000194013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607825,0.00048468154,0.00074229046,0.0014797545,0.00052941364,0.0006856365],"domain_scores_gemma":[0.9979071,0.0005776718,0.00023990589,0.00084856246,0.00009529516,0.00033149228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093641825,0.0006460054,0.0012286614,0.00031922897,0.00010806859,0.00011368586,0.00024850378,0.0005433837,0.000055101955],"category_scores_gemma":[0.0002921162,0.0005365324,0.00014022479,0.00030028174,0.00040152465,0.00005639677,0.0008360295,0.001014776,0.000025117039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009990887,0.0007566463,0.98677486,0.00061517075,0.00018981304,0.0032001669,0.0007564054,0.000009034935,0.0014099998,0.00021028824,0.000029710569,0.005048791],"study_design_scores_gemma":[0.0062531102,0.0009579743,0.9887002,0.0011668795,0.00028096006,0.000118860975,0.0000609022,0.000045343255,0.0017681738,0.00016958751,0.000049698647,0.0004283043],"about_ca_topic_score_codex":0.0005731675,"about_ca_topic_score_gemma":0.00026700407,"teacher_disagreement_score":0.009558199,"about_ca_system_score_codex":0.00035969188,"about_ca_system_score_gemma":0.00038053596,"threshold_uncertainty_score":0.9997086},"labels":[],"label_agreement":null},{"id":"W4388939913","doi":"10.12688/f1000research.140640.1","title":"Discovery and preliminary validation of a new panel of personalized ovarian cancer biomarkers for individualized detection of recurrence","year":2023,"lang":"en","type":"preprint","venue":"F1000Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Open peer review; Plant biology; Personalized medicine; Medicine; Ovarian cancer; Cancer; Computational biology; Biomarker; Molecular biomarkers; Biomarker discovery; Oncology; Physiology; Bioinformatics; Internal medicine; Biology; Gene; Genetics; Proteomics","score_opus":0.17673314453885602,"score_gpt":0.40975169472631867,"score_spread":0.23301855018746265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388939913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809997,0.0063978327,0.0028615636,0.0021728966,0.000480991,0.004555402,0.002407751,0.000034163473,0.00008969037],"genre_scores_gemma":[0.9891792,0.006073517,0.0022706639,0.0000074022496,0.00012569374,0.0009202399,0.0004129516,0.00005141389,0.0009588953],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99790925,0.00013297635,0.00055581145,0.0004941205,0.00067100755,0.00023683652],"domain_scores_gemma":[0.998131,0.0005286915,0.0004244078,0.00041639578,0.0003821297,0.000117400974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076246087,0.00020167559,0.00070314354,0.0004607991,0.000036553338,0.000021582062,0.0001513903,0.00023343363,0.000059852817],"category_scores_gemma":[0.00042119232,0.00017865431,0.00022049058,0.00034953645,0.00022390287,0.00007283549,0.0003085932,0.00022080792,6.8434315e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047427975,0.0028914087,0.27557534,0.052061897,0.012798299,0.000044375825,0.014057778,0.00025878873,0.11403754,0.0010433301,0.0104396595,0.46936363],"study_design_scores_gemma":[0.012985529,0.0031985166,0.5635508,0.007731552,0.0018160035,0.000008414546,0.00076623244,0.0011451067,0.40438923,0.003286245,0.0007766561,0.00034571034],"about_ca_topic_score_codex":0.0068529677,"about_ca_topic_score_gemma":0.00007090195,"teacher_disagreement_score":0.46901792,"about_ca_system_score_codex":0.0001647382,"about_ca_system_score_gemma":0.001215174,"threshold_uncertainty_score":0.9997605},"labels":[],"label_agreement":null},{"id":"W4388979087","doi":"10.23736/s2724-606x.23.05391-5","title":"Gynecologic oncology top-cited articles: an international analysis","year":2023,"lang":"en","type":"article","venue":"Minerva Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Subspecialty; Gynecologic oncology; Obstetrics and gynaecology; Medicine; Gynecology; Obstetrics; Family medicine; Library science; Oncology; Pregnancy","score_opus":0.04218200524399773,"score_gpt":0.3318545002556497,"score_spread":0.289672495011652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388979087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889987,0.00039410667,0.0000348926,0.005678114,0.0010787437,0.00023650983,0.000030110605,0.00011963182,0.0034292028],"genre_scores_gemma":[0.9943734,0.001470454,0.0007446546,0.0015827978,0.000095681455,0.00009565501,0.00024183748,0.000014616285,0.0013809124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860114,0.000073951145,0.00032590958,0.00046900718,0.00017128357,0.00035870093],"domain_scores_gemma":[0.996581,0.002608279,0.000101274425,0.00030856332,0.0001598635,0.0002410295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025532657,0.00016094171,0.00048764292,0.0010869014,0.00008657275,0.000033757555,0.00011369466,0.00021636745,0.0008936866],"category_scores_gemma":[0.002306842,0.00013272524,0.00013414129,0.0026583963,0.00007057975,0.00008995895,0.00009781708,0.00013519719,0.00011599151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034247918,0.00076673477,0.78838915,0.000011545225,0.001220861,0.0009812616,0.00032911025,0.000120987,0.00020205393,0.0015798323,0.001309869,0.20505437],"study_design_scores_gemma":[0.0024193125,0.0014363409,0.8901048,0.0000037050138,0.0009646088,0.000029095141,0.00035959182,0.012125299,0.00007974935,0.00021750561,0.09211502,0.00014501068],"about_ca_topic_score_codex":0.000081365615,"about_ca_topic_score_gemma":0.00019272225,"teacher_disagreement_score":0.20490937,"about_ca_system_score_codex":0.00027877258,"about_ca_system_score_gemma":0.0000932337,"threshold_uncertainty_score":0.97852415},"labels":[{"model":"gemma","categories":["bibliometrics"],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["bibliometrics"],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4389084470","doi":"10.3390/curroncol30120739","title":"Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Mitacs","keywords":"Medicine; Salpingectomy; Ovarian cancer; Serous carcinoma; Fallopian tube; Tubal ligation; Gynecology; Hysterectomy; Population; Serous fluid; Obstetrics; Pregnancy; Cancer; Surgery; Family planning; Internal medicine; Ectopic pregnancy","score_opus":0.43002436732012533,"score_gpt":0.5360804592950618,"score_spread":0.10605609197493643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389084470","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000046285495,0.98822665,0.00002972419,0.0015225316,0.00074468006,0.008049119,0.00087963935,0.000024559931,0.00051848346],"genre_scores_gemma":[0.000008340725,0.9951792,0.00003153693,0.0003919168,0.0002912399,0.002963816,0.0009121346,0.000057215642,0.0001646071],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997737,0.0003904983,0.00089327595,0.000540955,0.00018898965,0.0002492642],"domain_scores_gemma":[0.9960347,0.002348896,0.00085099327,0.00037879162,0.00024740773,0.00013924294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026575036,0.00041627866,0.0026396725,0.00010948571,0.00008918735,0.00001037364,0.00012958511,0.00016740868,0.00029138586],"category_scores_gemma":[0.00019435835,0.00025152107,0.00039239257,0.0003307717,0.00017361048,0.00001781591,0.00007670134,0.00028920162,0.000019372188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016379009,0.00043346835,0.000004518539,0.09768419,0.0010560821,0.000020247886,0.00009947528,4.185528e-7,3.1298768e-8,0.005409355,0.004429698,0.89069873],"study_design_scores_gemma":[0.001988874,0.001673917,0.0001228288,0.11146865,0.0068352544,0.000039563474,0.000038683393,0.0000049071027,1.586479e-7,0.00016638433,0.8774972,0.00016355849],"about_ca_topic_score_codex":0.000018321578,"about_ca_topic_score_gemma":0.000015581876,"teacher_disagreement_score":0.8905352,"about_ca_system_score_codex":0.00045117445,"about_ca_system_score_gemma":0.0020063743,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W4389089882","doi":"10.1186/s13048-023-01313-z","title":"BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy","year":2023,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute; Canadian Institutes of Health Research; Health Canada; Ovarian Cancer Canada; University of Ottawa","keywords":"Olaparib; Medicine; Ovarian cancer; Cancer research; Immune system; Angiogenesis; Tumor microenvironment; Immunotherapy; Combination therapy; Oncology; Cancer; Immunology; Internal medicine; Biology; Gene; Poly ADP ribose polymerase","score_opus":0.11852636703351473,"score_gpt":0.3749950771103623,"score_spread":0.2564687100768476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389089882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98620623,0.0011522027,0.00032019426,0.011274224,0.00018847451,0.0005804315,0.000047625654,0.000016656131,0.00021394448],"genre_scores_gemma":[0.9946064,0.0029946482,0.001016007,0.00017795929,0.00041530156,0.000034927343,0.000008195138,0.000050058487,0.0006965199],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968776,0.00038964264,0.000552526,0.00044827582,0.0010881004,0.0006438432],"domain_scores_gemma":[0.9983356,0.00030431442,0.00014370227,0.0003020275,0.00022030037,0.000694048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018187662,0.00024303672,0.0005206174,0.0007988537,0.00033639357,0.00022506501,0.00018344885,0.00009574591,0.00013819292],"category_scores_gemma":[0.00015871247,0.00017934584,0.00011654105,0.00055267406,0.00015170098,0.00013693672,0.00023064628,0.00051719084,0.000035008376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029536001,0.0050726812,0.20776775,0.00043476216,0.0036564386,0.014639691,0.007814419,0.00056288636,0.59113467,0.0040731793,0.04165762,0.09364987],"study_design_scores_gemma":[0.0069204564,0.0024269542,0.9767288,0.00027697242,0.000109862725,0.00076294114,0.00028158483,0.00091292843,0.007338167,0.0010060025,0.0030279835,0.00020734494],"about_ca_topic_score_codex":0.0000915004,"about_ca_topic_score_gemma":0.000010266838,"teacher_disagreement_score":0.768961,"about_ca_system_score_codex":0.00025868582,"about_ca_system_score_gemma":0.00028303848,"threshold_uncertainty_score":0.7313511},"labels":[],"label_agreement":null},{"id":"W4389203868","doi":"10.3390/curroncol30120741","title":"Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Salpingectomy; Ovarian cancer; Fallopian tube; Etiology; Serous carcinoma; Oncology; Cancer prevention; Population; Gynecology; Cancer; Intensive care medicine; Internal medicine; Bioinformatics; Pregnancy; Environmental health; Biology; Genetics","score_opus":0.1816046730534932,"score_gpt":0.4615805200789528,"score_spread":0.2799758470254596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389203868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98109233,0.000699313,0.0009899879,0.011715915,0.0029787552,0.0020279728,0.00007356136,0.00027992207,0.00014225942],"genre_scores_gemma":[0.99346274,0.00021512456,0.00062934635,0.00011924814,0.0005182606,0.0018163449,0.0028717483,0.000024650617,0.00034252577],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99867946,0.00008601699,0.00033623754,0.00043513154,0.0002256182,0.00023755817],"domain_scores_gemma":[0.99922466,0.00007051874,0.00014328181,0.00028758496,0.0001087768,0.0001651604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017781115,0.00013758488,0.00027153344,0.00017688169,0.00008503923,0.000025475481,0.000072883195,0.00010298938,0.00025278106],"category_scores_gemma":[0.00005434785,0.00012537627,0.000101549114,0.00049470866,0.000015503869,0.000052314328,0.000027874035,0.00010510179,0.00042678343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120923505,0.0008352084,0.3332841,0.00004957545,0.00004695251,0.0000064241053,0.00015063342,0.000066134366,0.00022738363,0.00011638315,0.0044186893,0.6606776],"study_design_scores_gemma":[0.0021605361,0.00059084245,0.8955683,0.00034751245,0.00025534816,8.470826e-7,0.000033449072,0.001134889,0.0006485225,0.00050099724,0.09863891,0.000119863995],"about_ca_topic_score_codex":0.00056277093,"about_ca_topic_score_gemma":0.0005889736,"teacher_disagreement_score":0.66055775,"about_ca_system_score_codex":0.0007081982,"about_ca_system_score_gemma":0.0003030898,"threshold_uncertainty_score":0.548558},"labels":[],"label_agreement":null},{"id":"W4389237137","doi":"10.3390/curroncol30120748","title":"Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Royal Victoria Hospital; Université Laval; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Hyperthermic intraperitoneal chemotherapy; Carboplatin; Serous fluid; Ovarian cancer; Perioperative; Retrospective cohort study; Ovarian carcinoma; Surgery; Internal medicine; Cancer; Chemotherapy; Oncology; Cytoreductive surgery; Cisplatin","score_opus":0.0671545704119185,"score_gpt":0.36923265543293066,"score_spread":0.3020780850210122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389237137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422414,0.0018425802,0.0000059994495,0.010987411,0.001996432,0.0007061126,0.000042849373,0.000111993635,0.00008246058],"genre_scores_gemma":[0.99568063,0.0022758916,0.00018135861,0.0006751843,0.00031178814,0.0006131979,0.00018711136,0.000045392426,0.000029441568],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843496,0.00011874483,0.00037364638,0.0004970044,0.00016433159,0.00041129364],"domain_scores_gemma":[0.9990735,0.00036691094,0.00012472227,0.00022113604,0.000058395777,0.00015530526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018280532,0.0002570035,0.0007942567,0.0002752991,0.000050341256,0.000011519334,0.00006435148,0.00014255037,0.00009953947],"category_scores_gemma":[0.00003106246,0.00022820492,0.00009944722,0.00043724777,0.00015023454,0.00005453988,0.000034600613,0.00028860127,0.000009834001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018824836,0.0018165888,0.41008583,0.00024213814,0.00019682318,0.0002832022,0.0008723944,0.000060829043,0.0026607479,0.00007217098,0.0014720018,0.5803548],"study_design_scores_gemma":[0.011973708,0.0008591542,0.9758239,0.00037045628,0.00011029227,0.000021981894,0.00014929626,0.00060464244,0.0017810178,0.00010383061,0.007953125,0.0002486051],"about_ca_topic_score_codex":0.0003696154,"about_ca_topic_score_gemma":0.00021542168,"teacher_disagreement_score":0.5801062,"about_ca_system_score_codex":0.0010542767,"about_ca_system_score_gemma":0.00073429296,"threshold_uncertainty_score":0.93059266},"labels":[],"label_agreement":null},{"id":"W4389245685","doi":"10.3390/curroncol30120747","title":"Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Medicinska fakulteten, Umeå Universitet","keywords":"Medicine; Positron emission tomography; Magnetic resonance imaging; Ovarian cancer; Bone scintigraphy; Radiology; Work-up; Tamoxifen; Stage (stratigraphy); Cancer; Breast cancer; Internal medicine","score_opus":0.23759960802704425,"score_gpt":0.4389359096436254,"score_spread":0.20133630161658114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389245685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008894255,0.9863314,3.6275358e-7,0.0016264743,0.00029265753,0.0027329063,0.000111638255,0.0000036450642,0.0000066853595],"genre_scores_gemma":[0.015048487,0.9844119,0.000009411523,0.00001618501,0.00004040341,0.00038384052,0.000042776974,0.000024808782,0.00002219095],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976698,0.00057817117,0.0010698917,0.00038839225,0.00014108681,0.00015263802],"domain_scores_gemma":[0.995854,0.0022780595,0.0011566398,0.0005549724,0.00009643331,0.000059881706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004202587,0.0003245243,0.002599715,0.00014101974,0.000025759802,0.0000051952725,0.000070456736,0.00012602755,0.0000045593492],"category_scores_gemma":[0.0004674915,0.00012463517,0.000332185,0.00024556127,0.00046453287,0.000026916165,0.00014907878,0.000200678,8.372932e-8],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057284287,0.00046339526,0.01615344,0.12691125,0.0003447158,0.0014339206,0.0010515696,2.0218936e-8,1.6187853e-7,0.00008129517,0.00002841858,0.8534745],"study_design_scores_gemma":[0.0117778955,0.0015399336,0.035962135,0.79467607,0.020764275,0.019525567,0.00015492135,0.000005535779,0.000007054716,0.00015030157,0.115121156,0.0003151691],"about_ca_topic_score_codex":0.000063674925,"about_ca_topic_score_gemma":0.0001648949,"teacher_disagreement_score":0.85315937,"about_ca_system_score_codex":0.00012363323,"about_ca_system_score_gemma":0.00027031926,"threshold_uncertainty_score":0.5082475},"labels":[],"label_agreement":null},{"id":"W4389513671","doi":"10.1016/j.ypmed.2023.107794","title":"Childhood body fatness and the risk of epithelial ovarian cancer: A population-based case-control study in Montreal, Canada","year":2023,"lang":"en","type":"article","venue":"Preventive Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal; Centre for Advancing Health Outcomes; Université du Québec à Montréal","funders":"Canadian Cancer Society; Cancer Research Society","keywords":"Medicine; Odds ratio; Confidence interval; Case-control study; Logistic regression; Body mass index; Internal medicine; Epithelial ovarian cancer; Oncology; Population; Demography; Cancer; Ovarian cancer; Gynecology; Environmental health","score_opus":0.008783088072741061,"score_gpt":0.2698894795213911,"score_spread":0.26110639144865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389513671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887088,0.0012387749,0.00002599897,0.0068417503,0.00022382574,0.0025424953,0.00030106303,0.000018648589,0.000098653756],"genre_scores_gemma":[0.998694,0.00024398143,0.000007930552,0.00020878391,0.0001844448,0.00051255163,0.00002787081,0.000018348379,0.000102109676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825,0.00038296467,0.00045770948,0.0003133269,0.00036998646,0.0002260143],"domain_scores_gemma":[0.998474,0.00081485003,0.0002259843,0.00029649262,0.000083760315,0.00010491185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085367326,0.00019241608,0.00069889124,0.00014982397,0.000099611796,0.000004599163,0.00006435619,0.000035283363,0.00020922],"category_scores_gemma":[0.0003380359,0.000109939116,0.000059767826,0.00047632828,0.00010080528,0.000024885414,0.000022772681,0.00016920952,8.159574e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059770525,0.00040478766,0.9824556,0.000050027822,0.0006637633,0.00090158265,0.0018927644,0.00022672549,0.0000041284443,0.00003352561,0.00029216206,0.012477195],"study_design_scores_gemma":[0.038342606,0.00042514782,0.95596576,0.000319779,0.0014278432,0.000028184386,0.001412369,0.0017643401,0.00001927991,0.00018725931,0.00002413143,0.00008330607],"about_ca_topic_score_codex":0.9561042,"about_ca_topic_score_gemma":0.92312455,"teacher_disagreement_score":0.037744902,"about_ca_system_score_codex":0.00019063368,"about_ca_system_score_gemma":0.00033570686,"threshold_uncertainty_score":0.44831872},"labels":[],"label_agreement":null},{"id":"W4389954605","doi":"10.1136/ijgc-2023-005109","title":"Highlights from the 24th European Congress on Gynaecological Oncology in Istanbul: an ENYGO-IJGC Fellows compilation","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Gynecologic oncology; Oncology; Internal medicine; Family medicine","score_opus":0.06874968603770203,"score_gpt":0.385044084649317,"score_spread":0.31629439861161496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389954605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509721,0.00018657862,0.000010915985,0.03701351,0.004772629,0.0002462469,0.000092393784,0.000033558514,0.0066720652],"genre_scores_gemma":[0.99341977,0.0011023661,0.0001337831,0.0037174993,0.001172321,0.00003109979,0.00007048522,0.000014888478,0.0003378038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979164,0.0003880208,0.0006374228,0.00026673885,0.0005677755,0.0002236566],"domain_scores_gemma":[0.9976272,0.0013286788,0.0003975675,0.0001475139,0.0003494171,0.00014960793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006597111,0.00016565148,0.0003954013,0.0001452176,0.0000642271,0.000042588075,0.00039775806,0.00012662531,0.0038687554],"category_scores_gemma":[0.00037795695,0.00009068524,0.00016099989,0.00019038533,0.00012596736,0.000106677784,0.00007756811,0.00043823145,0.00011970243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005209342,0.0052841324,0.7593012,0.000009654792,0.0013461593,0.013466017,0.0015215636,0.003985672,0.00113352,0.006922333,0.06062387,0.14119655],"study_design_scores_gemma":[0.003529264,0.0020827132,0.8828381,0.00006988983,0.00006443413,0.000027337292,0.00015569337,0.00026730436,0.00022564396,0.0006950308,0.10995251,0.000092099915],"about_ca_topic_score_codex":0.00009177934,"about_ca_topic_score_gemma":0.0005716629,"teacher_disagreement_score":0.14110446,"about_ca_system_score_codex":0.0011350355,"about_ca_system_score_gemma":0.0002051052,"threshold_uncertainty_score":0.9970418},"labels":[],"label_agreement":null},{"id":"W4389965997","doi":"10.1111/his.15110","title":"Lessons from genomic profiling: towards a molecular‐based classification of ovarian Sertoli–Leydig cell tumour","year":2023,"lang":"en","type":"letter","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Sertoli cell; Profiling (computer programming); Leydig cell; Biology; Computational biology; Gene expression profiling; Pathology; Oncology; Internal medicine; Medicine; Bioinformatics; Hormone; Computer science; Gene; Genetics; Spermatogenesis; Gene expression; Luteinizing hormone","score_opus":0.05427949231309776,"score_gpt":0.3019766905206135,"score_spread":0.24769719820751573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389965997","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07460064,0.0020746433,0.0011137789,0.9089652,0.002283429,0.0017384741,0.001563754,0.00029992018,0.0073601995],"genre_scores_gemma":[0.6720871,0.00026272915,0.011776072,0.29211488,0.0032932067,0.0013783422,0.013613682,0.00053761783,0.0049363775],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99732745,0.00021474007,0.00065365335,0.0009936837,0.00034943945,0.00046102982],"domain_scores_gemma":[0.9980263,0.0001135473,0.0005432411,0.0010465244,0.0001667466,0.00010360345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016383403,0.0004545457,0.0011052933,0.00040580262,0.000058615642,0.000013152782,0.00025690277,0.0010215299,0.00019215616],"category_scores_gemma":[0.000052438743,0.00044237194,0.00037896904,0.00022858473,0.00016591456,0.00001938323,0.00006638385,0.0009927403,0.00027597832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034653957,0.0009883374,0.00739013,0.0015909852,0.00017073978,0.025970941,0.00048284483,0.000026726024,0.32070658,0.00054334354,0.638922,0.0028608642],"study_design_scores_gemma":[0.0076414994,0.0013004736,0.47594795,0.00067434594,0.00383987,0.00023315978,0.00008224225,0.00051461405,0.042757228,0.0008269649,0.46498942,0.0011922345],"about_ca_topic_score_codex":0.0005531658,"about_ca_topic_score_gemma":0.000024886594,"teacher_disagreement_score":0.61685026,"about_ca_system_score_codex":0.0007347505,"about_ca_system_score_gemma":0.0011571985,"threshold_uncertainty_score":0.9998028},"labels":[],"label_agreement":null},{"id":"W4390174532","doi":"10.3390/curroncol31010007","title":"Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Ovarian cancer; Medicine; Oncolytic virus; Bevacizumab; Immune system; Tumor microenvironment; Cancer; Cancer research; Drug resistance; Immunotherapy; Immunology; Bioinformatics; Chemotherapy; Biology; Internal medicine","score_opus":0.23522888724288524,"score_gpt":0.46635183293183385,"score_spread":0.23112294568894862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390174532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84341633,0.0131760035,0.00037860457,0.122253835,0.009516489,0.0019773536,0.000078695746,0.00023038017,0.008972309],"genre_scores_gemma":[0.9926619,0.0050371396,0.00007857114,0.0009058029,0.0005453803,0.0005001228,0.000029724028,0.000019919384,0.00022147171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910605,0.00003949803,0.00020465483,0.00022296043,0.00012855035,0.00029829738],"domain_scores_gemma":[0.9994421,0.00019056535,0.00005811878,0.00021901085,0.000033200115,0.000056990724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022361543,0.00011443308,0.0002495184,0.00011206652,0.000067644185,0.000011482693,0.0000900331,0.00007213042,0.00014514329],"category_scores_gemma":[0.000019798956,0.00007326932,0.00006652191,0.0004586094,0.00005866335,0.000026038892,0.00003869312,0.00022578296,0.000077035074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001386673,0.0011636973,0.35507306,0.000064975546,0.00018614165,0.00008253473,0.0025756166,0.000049129245,0.0016572125,0.0025125565,0.0073543866,0.62914205],"study_design_scores_gemma":[0.0044204993,0.00028559013,0.48150685,0.00015224601,0.00016117777,0.000024206925,0.00047318896,0.0003841357,0.00052635104,0.00018009038,0.5117765,0.00010918913],"about_ca_topic_score_codex":0.0001261631,"about_ca_topic_score_gemma":0.00027922416,"teacher_disagreement_score":0.62903285,"about_ca_system_score_codex":0.0004944513,"about_ca_system_score_gemma":0.00028205916,"threshold_uncertainty_score":0.29878363},"labels":[],"label_agreement":null},{"id":"W4390412490","doi":"10.3390/curroncol31010015","title":"Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Narodowe Centrum Nauki","keywords":"Medicine; Ovarian cancer; Serous fluid; Tumor microenvironment; Epigenetics; Taxane; Debulking; Cancer research; Cancer; Targeted therapy; Oncology; Internal medicine; Gene; Biology; Breast cancer","score_opus":0.5993952584568857,"score_gpt":0.5348020323177636,"score_spread":0.0645932261391221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390412490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015767333,0.9879921,0.000039689578,0.0024366754,0.002844346,0.0030279732,0.0033265788,0.000076611264,0.000098348966],"genre_scores_gemma":[0.0013369977,0.9927719,0.0000996938,0.00007286334,0.0011222305,0.0017371064,0.0025345616,0.00009515574,0.00022944027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963569,0.00033102397,0.0012115651,0.0011836953,0.00040320677,0.00051362434],"domain_scores_gemma":[0.9971422,0.00051623076,0.00059871393,0.0013587431,0.00012340213,0.0002606894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000579625,0.00052374136,0.0032151362,0.00033936012,0.000036033747,0.000021165484,0.0005426209,0.00070093974,0.00012551168],"category_scores_gemma":[0.00012498023,0.00041210736,0.00026903447,0.00080155564,0.00011460855,0.000067568704,0.00026628198,0.0009192567,0.000042134834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012247317,0.0018463235,0.0014244308,0.014125863,0.0008177011,0.00008124251,0.00004774262,0.000009510232,6.1305184e-7,0.00022759572,0.011172794,0.9701237],"study_design_scores_gemma":[0.0029920016,0.0010815345,0.0066751284,0.016850641,0.0036205745,0.000021220701,0.0000283156,0.00008450215,0.0000017758774,0.00008098429,0.96830714,0.00025616444],"about_ca_topic_score_codex":0.00029250825,"about_ca_topic_score_gemma":0.0011569262,"teacher_disagreement_score":0.9698675,"about_ca_system_score_codex":0.0015066044,"about_ca_system_score_gemma":0.002619161,"threshold_uncertainty_score":0.99983305},"labels":[],"label_agreement":null},{"id":"W4390542167","doi":"10.2147/ijwh.s444258","title":"The High Sensitivity of the Multi-Cancer Detection Test ONCOVERYX-F Offers a Promising Platform for Ovarian Cancer Screening","year":2024,"lang":"en","type":"article","venue":"International Journal of Women s Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Ovarian cancer; Stage (stratigraphy); Screening test; Medicine; Oncology; Cancer; Internal medicine; Biology","score_opus":0.03625964206804668,"score_gpt":0.36204684004949494,"score_spread":0.3257871979814483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390542167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92277443,0.002353797,0.012247571,0.05802589,0.0035801434,0.0007608328,0.00021614059,0.000017303144,0.000023868455],"genre_scores_gemma":[0.9961771,0.0011550774,0.00086350145,0.0006877908,0.0008892177,0.00006079834,0.0000015589621,0.00001779152,0.00014717797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868435,0.000043358366,0.00045663497,0.0001241773,0.00047175557,0.00021975327],"domain_scores_gemma":[0.99836093,0.0006165431,0.00042981905,0.0000962467,0.00038812324,0.00010833487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012388891,0.000101842554,0.00024167568,0.00009745214,0.00014402383,0.00006506329,0.00010180368,0.00003589521,0.000019421974],"category_scores_gemma":[0.00018646602,0.00005525585,0.00016810093,0.00012773562,0.000046509194,0.00013459292,0.000026577021,0.0002176193,4.2882345e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020016802,0.0005458586,0.034303304,0.00034652505,0.0028770946,0.00007767984,0.003937422,0.0009788015,0.004088773,0.00068272813,0.0009636945,0.94919646],"study_design_scores_gemma":[0.019624654,0.0037891972,0.7469148,0.013924904,0.0006375959,0.001450848,0.0026053386,0.036570176,0.04130819,0.0015480639,0.1311891,0.00043711826],"about_ca_topic_score_codex":0.0014802353,"about_ca_topic_score_gemma":0.00076853804,"teacher_disagreement_score":0.9487593,"about_ca_system_score_codex":0.0026693835,"about_ca_system_score_gemma":0.001232527,"threshold_uncertainty_score":0.69803447},"labels":[],"label_agreement":null},{"id":"W4390616956","doi":"10.3390/cancers16020254","title":"Prognostic Significance of Preoperative Inflammation Markers on the Long-Term Outcomes in Peritoneal Carcinomatosis from Ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"","keywords":"Peritoneal carcinomatosis; Medicine; Ovarian cancer; Oncology; Inflammation; Internal medicine; Cancer; Pathology; Gastroenterology; Colorectal cancer","score_opus":0.027014094306363184,"score_gpt":0.29487992417844133,"score_spread":0.26786582987207813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390616956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887154,0.0020110605,0.00001829569,0.006376962,0.0005118025,0.0013668363,0.0001818407,0.000038235085,0.0007795679],"genre_scores_gemma":[0.9974452,0.00042970074,0.00006070704,0.00023756151,0.00017719874,0.0014050341,0.00003372992,0.00002871116,0.00018211525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876106,0.00007007045,0.0003095056,0.00037689455,0.00026926308,0.00021322283],"domain_scores_gemma":[0.99913114,0.0003831753,0.000072202696,0.00028445,0.000055625052,0.00007343115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109906294,0.00020310943,0.00035284375,0.000103340986,0.00004542081,0.000042349275,0.00009344508,0.0000689131,0.0005655358],"category_scores_gemma":[0.00005086297,0.00013026047,0.00011052881,0.0002872476,0.000109706954,0.000087026114,0.000018483477,0.00018555958,0.000014373712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022634644,0.000043266675,0.98656493,0.00020086899,0.00048251395,0.00008885327,0.002267016,0.00042592039,0.00069430127,0.00047097026,0.00040899063,0.008126005],"study_design_scores_gemma":[0.00084949983,0.00021428804,0.98415667,0.0014111056,0.00024233028,0.0000013150974,0.00026048595,0.0008270523,0.011748729,0.000034867222,0.00012499357,0.00012865855],"about_ca_topic_score_codex":0.0055619874,"about_ca_topic_score_gemma":0.0018528152,"teacher_disagreement_score":0.011054428,"about_ca_system_score_codex":0.0019259399,"about_ca_system_score_gemma":0.0010301076,"threshold_uncertainty_score":0.8408098},"labels":[],"label_agreement":null},{"id":"W4390637595","doi":"10.1016/j.ajog.2024.01.002","title":"Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors","year":2024,"lang":"en","type":"article","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Morsani College of Medicine; University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; University of South Florida; Genentech; National Institutes of Health; Fondation du cancer des Cèdres; Astellas Pharma; Eisai; Seagen; Mereo BioPharma; NGM Biopharmaceuticals; EQRx; Clovis Oncology; AstraZeneca; Ovarian Cancer Research Alliance; Frank McGraw Memorial Chair in Cancer Research; Mersana Therapeutics; Stryker; Bristol-Myers Squibb; Eli Lilly and Company; Swedish Cancer Foundation; Moffitt Cancer Center; Verastem Oncology; American Cancer Society","keywords":"Medicine; Cytoreductive surgery; Oncology; Internal medicine; Gynecology; Ovarian cancer; Cancer","score_opus":0.014108751803093898,"score_gpt":0.2735755712118252,"score_spread":0.2594668194087313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390637595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873585,0.00531615,0.00000855503,0.002559748,0.0044784956,0.00012653708,0.000014962544,0.000007610597,0.0001294431],"genre_scores_gemma":[0.9937835,0.0054624546,0.00039809613,0.00016038386,0.000137648,0.0000046321397,0.000004222281,0.000018277944,0.000030818712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873406,0.00011529741,0.00049144245,0.00023665036,0.00017661037,0.0002459452],"domain_scores_gemma":[0.995048,0.0042536305,0.0002238905,0.00009856924,0.00016963482,0.00020627539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003101948,0.00017125638,0.0008425567,0.00054429425,0.00003336303,0.000036468282,0.000043204884,0.00005492838,0.000033077475],"category_scores_gemma":[0.0014550635,0.00012684282,0.000112938804,0.00064563606,0.0001890453,0.00007909773,0.000030938278,0.0002908559,0.0000022904915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002506772,0.0004873287,0.7828189,0.00008845029,0.00026301015,0.0025956444,0.000736571,0.000003117382,0.000048865328,0.00039852658,0.00035005156,0.21195887],"study_design_scores_gemma":[0.0022139493,0.004100303,0.98704886,0.00016445918,0.00027878533,0.00030320443,0.001354996,0.000039466784,0.000088754285,0.00024014895,0.0039793937,0.0001876625],"about_ca_topic_score_codex":0.00009707361,"about_ca_topic_score_gemma":0.000020399724,"teacher_disagreement_score":0.2117712,"about_ca_system_score_codex":0.00020358339,"about_ca_system_score_gemma":0.00036133436,"threshold_uncertainty_score":0.51725},"labels":[],"label_agreement":null},{"id":"W4390706040","doi":"10.1038/s41416-023-02560-z","title":"Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Minnesota Ovarian Cancer Alliance; Division of Cancer Prevention, National Cancer Institute; National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Autoantibody; Ovarian cancer; Medicine; Biomarker; Antigen; Stage (stratigraphy); Osteopontin; Oncology; Cancer; Immunology; Internal medicine; Antibody; Biology","score_opus":0.02331385625616697,"score_gpt":0.3370818268723073,"score_spread":0.31376797061614037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84920186,0.1450898,0.0015216675,0.0015282079,0.0012983832,0.0005748796,0.0006554181,0.00002543945,0.00010435866],"genre_scores_gemma":[0.95389426,0.044073705,0.0009868123,0.00013277469,0.0006782468,0.000044032604,0.000010337372,0.000038458013,0.00014139022],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984529,0.00003065634,0.0006414304,0.00025079356,0.00034601963,0.00027821917],"domain_scores_gemma":[0.99898857,0.0000796712,0.00027340656,0.00010548129,0.00039679365,0.00015608984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002742641,0.0001727869,0.0006000088,0.00017609191,0.0001192473,0.000118643606,0.00007218321,0.00006896983,0.00026469782],"category_scores_gemma":[0.000020470012,0.00016675392,0.00023594414,0.0001903317,0.00010593119,0.00016492838,0.000024726542,0.0001876869,7.821053e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061380485,0.00041073546,0.19389646,0.0017005025,0.0034416975,0.00078121235,0.0007524701,0.000047964248,0.041911785,0.0005573324,0.0057494356,0.7501366],"study_design_scores_gemma":[0.003428544,0.0009012341,0.8512043,0.004840892,0.0008484273,0.0009938477,0.00008712703,0.0003324523,0.023266995,0.00017491363,0.11372668,0.000194622],"about_ca_topic_score_codex":0.0062538492,"about_ca_topic_score_gemma":0.0028441083,"teacher_disagreement_score":0.749942,"about_ca_system_score_codex":0.00021168042,"about_ca_system_score_gemma":0.00043282812,"threshold_uncertainty_score":0.9453991},"labels":[],"label_agreement":null},{"id":"W4390800387","doi":"10.1007/978-3-030-97378-0_5617","title":"Mixed Epithelial and Mesenchymal Tumors, Pathology of the cervix","year":2023,"lang":"en","type":"book-chapter","venue":"Encyclopedia of pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cervix; Pathology; Mesenchymal stem cell; Medicine; Internal medicine; Cancer","score_opus":0.022063145774569335,"score_gpt":0.24669641608023687,"score_spread":0.22463327030566754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390800387","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15229808,0.0053825206,0.000014440305,0.004887756,0.004539042,0.0019261821,0.0015527605,0.000102253485,0.82929695],"genre_scores_gemma":[0.21964327,0.038674638,0.0019331982,0.0007310986,0.002001039,0.00022615695,0.00030299256,0.00039828502,0.73608935],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99818546,0.00007983105,0.0006643511,0.00052525144,0.000268922,0.00027621773],"domain_scores_gemma":[0.9983207,0.00025028017,0.00051143824,0.0006988229,0.00012056246,0.000098193574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002484878,0.0003568625,0.0011354001,0.00018527884,0.000044198234,0.0000022270008,0.00017522568,0.0005156815,0.00031166035],"category_scores_gemma":[0.00013110705,0.0002472574,0.00029685497,0.000060747556,0.000625312,0.000017321165,0.00026783682,0.00039595994,0.00004784755],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011362752,0.0012839056,0.09199163,0.0035786282,0.0023526503,0.027635828,0.005690773,0.000008619722,0.0047937213,0.6810263,0.030521316,0.14998035],"study_design_scores_gemma":[0.008973229,0.0048764236,0.6300409,0.0023701862,0.0041872133,0.0049507194,0.00020823193,0.0000074165187,0.0032418307,0.06285364,0.27706876,0.0012214354],"about_ca_topic_score_codex":0.000037668862,"about_ca_topic_score_gemma":0.00008596883,"teacher_disagreement_score":0.61817265,"about_ca_system_score_codex":0.00004435639,"about_ca_system_score_gemma":0.00026834724,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W4390826315","doi":"10.1007/978-3-030-97378-0_5679","title":"Tumor-Like Lesions and Endometriosis, Pathology of the Peritoneum","year":2023,"lang":"en","type":"book-chapter","venue":"Encyclopedia of pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Endometriosis; Peritoneum; Pathology; Medicine","score_opus":0.019565164953141725,"score_gpt":0.2575886282099197,"score_spread":0.23802346325677795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390826315","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10162837,0.020339763,0.000012733545,0.005541192,0.0058918297,0.0025809754,0.0013699881,0.00013567813,0.8624995],"genre_scores_gemma":[0.20921546,0.14028445,0.0015860397,0.0013726522,0.0011043147,0.0003302105,0.00020712982,0.00039658046,0.64550316],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.998263,0.00006432592,0.0006217932,0.0005215664,0.00026561928,0.00026367806],"domain_scores_gemma":[0.9980128,0.00055479613,0.00046685827,0.0007385641,0.00012155822,0.000105441744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020787427,0.0003395056,0.0011047088,0.00033684928,0.00005972469,0.000002524174,0.00016850003,0.00039745282,0.00027604445],"category_scores_gemma":[0.00027599253,0.0002394234,0.00031271973,0.00011156331,0.0006118781,0.000017529052,0.00027605306,0.00042318887,0.000037432426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010475222,0.0028477465,0.16771238,0.0053095464,0.0037295693,0.042398892,0.007082324,0.000009548443,0.0066460995,0.46179682,0.06925604,0.2321635],"study_design_scores_gemma":[0.0054386635,0.0033009513,0.31769317,0.0017058025,0.003436623,0.0047569936,0.00019050145,0.000002433483,0.00091320125,0.012200199,0.64953995,0.00082153623],"about_ca_topic_score_codex":0.000029424735,"about_ca_topic_score_gemma":0.000051661307,"teacher_disagreement_score":0.5802839,"about_ca_system_score_codex":0.000051147363,"about_ca_system_score_gemma":0.000248897,"threshold_uncertainty_score":0.9763403},"labels":[],"label_agreement":null},{"id":"W4391286454","doi":"10.1016/j.ygyno.2024.01.027","title":"Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; Princess Margaret Cancer Centre","funders":"Queen's University; Cancer Care Ontario","keywords":"Medicine; Bevacizumab; Ovarian cancer; Oncology; Chemotherapy; Internal medicine; Gynecology; Cancer","score_opus":0.0225401340826704,"score_gpt":0.32631354091009895,"score_spread":0.30377340682742854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391286454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93553036,0.00036077757,0.000007823361,0.035915345,0.00042430064,0.0014524966,0.00005511205,0.0002939172,0.025959864],"genre_scores_gemma":[0.99184304,0.00036635157,0.00081655814,0.0019293603,0.000065402885,0.0009316117,0.00007276542,0.00005612337,0.003918763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980036,0.0001293307,0.00041282678,0.00063298206,0.00025989415,0.00056136685],"domain_scores_gemma":[0.9982967,0.001014739,0.00014550166,0.00030891073,0.00008508329,0.00014911001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030782295,0.0003515053,0.001009208,0.00029111106,0.00007715951,0.000036407964,0.00011102764,0.00024191912,0.0018465641],"category_scores_gemma":[0.000068644,0.00020901725,0.00007965804,0.0008003788,0.00015315796,0.000068308735,0.000029484987,0.00039336397,0.000030150157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041189156,0.0026202195,0.94665045,0.00010589289,0.002147035,0.006430443,0.0007436223,0.00008128151,0.00013386963,0.005274529,0.0033019753,0.028391793],"study_design_scores_gemma":[0.014790181,0.010607059,0.95905405,0.00033942997,0.00040927698,0.000019754863,0.00011546126,0.00015270444,0.0001242502,0.0003240529,0.013791259,0.00027252088],"about_ca_topic_score_codex":0.0015377483,"about_ca_topic_score_gemma":0.06564481,"teacher_disagreement_score":0.06410706,"about_ca_system_score_codex":0.0032470075,"about_ca_system_score_gemma":0.001351322,"threshold_uncertainty_score":0.9990659},"labels":[],"label_agreement":null},{"id":"W4391387655","doi":"10.22541/au.170670439.90587796/v1","title":"Establishing combination PAC-1 and TRAIL regimens for treating ovarian cancer based on patient-specific pharmacokinetic profiles using in silico clinical trials","year":2024,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Concordia University","funders":"","keywords":"Pharmacokinetics; Medicine; Ovarian cancer; Oncology; Cohort; In silico; Population; Internal medicine; Clinical trial; Cancer; Pharmacology; Biology","score_opus":0.18179134545476686,"score_gpt":0.45236995755504983,"score_spread":0.270578612100283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391387655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96398747,0.005577443,0.0007329388,0.012794801,0.0032384952,0.010419435,0.00085096434,0.0001839352,0.002214537],"genre_scores_gemma":[0.9872377,0.0010171635,0.0077708894,0.0006761771,0.00082392484,0.0018735423,0.00035466635,0.0001029138,0.00014304937],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960019,0.00052933866,0.0015756133,0.0011666656,0.00036501331,0.00036147705],"domain_scores_gemma":[0.9962541,0.0024734265,0.0005378315,0.0003935487,0.00014459125,0.00019650461],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024217288,0.00047200275,0.0014523838,0.0004397981,0.0000799746,0.00024601474,0.000077709454,0.00039006345,0.00021813216],"category_scores_gemma":[0.0006290464,0.00036833822,0.0003942191,0.00022445664,0.00006261875,0.000057641413,0.00011982851,0.0007351511,0.0000019216022],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032835957,0.003906428,0.03594906,0.0035259745,0.0011005631,0.00020259048,0.0014357923,0.004354358,0.0010865179,0.0018794547,0.0076029752,0.9356727],"study_design_scores_gemma":[0.066797666,0.0044013835,0.036336932,0.027605264,0.006419658,0.000018987128,0.00096573675,0.82977,0.013844418,0.0044556535,0.007526628,0.0018576711],"about_ca_topic_score_codex":0.0008704134,"about_ca_topic_score_gemma":0.000097626835,"teacher_disagreement_score":0.933815,"about_ca_system_score_codex":0.0007184897,"about_ca_system_score_gemma":0.00060192554,"threshold_uncertainty_score":0.99987686},"labels":[],"label_agreement":null},{"id":"W4391388574","doi":"10.5489/cuaj.8527","title":"Case – Leydig cell hyperplasia","year":2024,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Leydig cell; Hyperplasia; Medicine; Internal medicine; Luteinizing hormone; Hormone","score_opus":0.014346466554210714,"score_gpt":0.23754277811169575,"score_spread":0.22319631155748504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391388574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86284965,0.004037317,0.000042719832,0.09748834,0.0016822793,0.00024826336,0.00008994428,0.000091833695,0.033469662],"genre_scores_gemma":[0.9932928,0.00016893611,0.00016297628,0.0036508928,0.0007861457,0.000009420263,0.000010131588,0.000012980829,0.0019056875],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990128,0.000055331737,0.00020050125,0.0001763168,0.00019751188,0.00035749286],"domain_scores_gemma":[0.9989027,0.00012448909,0.000051653333,0.00007478489,0.000091110305,0.0007552709],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029988124,0.00010703143,0.00017222883,0.00015265014,0.00018342808,0.00017921634,0.0000387149,0.00016876726,0.0019786744],"category_scores_gemma":[0.00010544601,0.00007931821,0.00015039206,0.00018320007,0.000012465566,0.00006999378,0.0000056013123,0.00045667557,0.00042686702],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025002957,0.00014348661,0.63081557,0.000025887537,0.00038149027,0.11800508,0.0002488634,0.000028328812,0.000047944086,0.001201533,0.22269732,0.026379526],"study_design_scores_gemma":[0.0009868265,0.00049479585,0.10449555,0.000032183347,0.0003334717,0.04754421,0.00007544146,0.00030781765,0.000059636903,0.00048806155,0.84502083,0.00016118296],"about_ca_topic_score_codex":0.00090870843,"about_ca_topic_score_gemma":0.0007771312,"teacher_disagreement_score":0.6223235,"about_ca_system_score_codex":0.0017483532,"about_ca_system_score_gemma":0.0007413946,"threshold_uncertainty_score":0.9989337},"labels":[],"label_agreement":null},{"id":"W4391447886","doi":"10.1016/j.annonc.2023.11.015","title":"ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"PharmaMar; European Society for Medical Oncology; National Institute for Health and Care Research; Novocure; AstraZeneca","keywords":"Medicine; Consensus conference; Voting; Disease; Ovarian cancer; Stage (stratigraphy); Family medicine; MEDLINE; Oncology; Gynecology; Internal medicine; Cancer; Political science","score_opus":0.07204614253490907,"score_gpt":0.4331132394768885,"score_spread":0.36106709694197947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391447886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82322484,0.019367518,0.000046771238,0.15537702,0.0003564098,0.00040151153,0.00021697671,0.000027991222,0.000980988],"genre_scores_gemma":[0.9738629,0.023341341,0.0006798161,0.0018461975,0.000045616252,0.00013123272,0.000030495572,0.000013660956,0.000048773778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989131,0.00013202165,0.0002540614,0.000435678,0.00005095861,0.00021414658],"domain_scores_gemma":[0.9991126,0.00031186757,0.000080139595,0.00016516885,0.00009991621,0.00023031484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015452623,0.00015789169,0.00041969505,0.00013816687,0.000048852875,0.000012828736,0.00003062223,0.00011693929,0.00007866422],"category_scores_gemma":[0.00008922681,0.00013281038,0.00004166291,0.00008641531,0.00033649837,0.000024613553,0.000055368353,0.00015541277,0.0000025321801],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008225567,0.00040662207,0.02057239,0.0002037892,0.00034192647,0.00095561857,0.00044821092,0.0000014047948,0.0015361543,0.06591321,0.002696986,0.9061011],"study_design_scores_gemma":[0.009618791,0.023820704,0.4428294,0.0017386483,0.0011624983,0.00054026634,0.0002819992,0.00039003024,0.004090806,0.037936512,0.47692585,0.00066449214],"about_ca_topic_score_codex":0.00011833426,"about_ca_topic_score_gemma":0.000055376266,"teacher_disagreement_score":0.90543664,"about_ca_system_score_codex":0.00003279884,"about_ca_system_score_gemma":0.00026025163,"threshold_uncertainty_score":0.541585},"labels":[],"label_agreement":null},{"id":"W4391627809","doi":"10.47671/tvg.66.07.2000728","title":"Neoadjuvante chemotherapie of primaire debulking bij het vergevorderde ovariumcarcinoom","year":2010,"lang":"nl","type":"article","venue":"Tijdschrift voor Geneeskunde","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.009724371568782702,"score_gpt":0.2600369019943393,"score_spread":0.2503125304255566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391627809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93766737,0.019882523,0.00043590605,0.0051925764,0.005872783,0.0020561016,0.00031776063,0.00025431247,0.028320694],"genre_scores_gemma":[0.9853756,0.0025743823,0.004632607,0.0013605064,0.0020548718,0.00010893293,0.000116706105,0.000267207,0.0035092088],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9947498,0.000124636,0.0013617425,0.0013492408,0.0010473811,0.0013672281],"domain_scores_gemma":[0.9956898,0.00030563647,0.0007277536,0.002128406,0.0004291033,0.0007193119],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00066754315,0.0010216661,0.0016497223,0.00042822323,0.0002904379,0.00010343525,0.0006273681,0.00084420777,0.010769585],"category_scores_gemma":[0.0001865209,0.0009566518,0.0007013132,0.0007703243,0.00045796382,0.00022258877,0.0002493087,0.0013051353,0.0015577888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023686416,0.008741739,0.35865667,0.0029462315,0.007192131,0.0011171965,0.004623917,0.00016366322,0.39807945,0.0121371,0.031969756,0.1720035],"study_design_scores_gemma":[0.018004585,0.0024677808,0.4707633,0.001530651,0.0027607174,0.0003147267,0.00042466674,0.0013924971,0.24149133,0.00043729527,0.25861835,0.0017940982],"about_ca_topic_score_codex":0.0016307293,"about_ca_topic_score_gemma":0.00061049307,"teacher_disagreement_score":0.2266486,"about_ca_system_score_codex":0.00018224052,"about_ca_system_score_gemma":0.001294511,"threshold_uncertainty_score":0.9992884},"labels":[],"label_agreement":null},{"id":"W4391649405","doi":"10.1016/j.gore.2024.101334","title":"Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Serous carcinoma; Genetic testing; Serous fluid; Cohort; Internal medicine; Population; Cohort study; Gynecology; Oncology; Ovarian cancer; Cancer","score_opus":0.017851812147829625,"score_gpt":0.3270599621669753,"score_spread":0.3092081500191457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391649405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192727,0.00044389226,0.000023341463,0.0017575681,0.0026701277,0.00081333716,0.000022793634,0.00020688766,0.002134759],"genre_scores_gemma":[0.9976797,0.00009930367,0.0007617161,0.00045930085,0.00025912037,0.00023240852,0.0001509769,0.000027627895,0.00032985632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978323,0.0001872089,0.0006867804,0.0007001197,0.00019671973,0.0003968487],"domain_scores_gemma":[0.9987709,0.00039833342,0.00018584498,0.00041755594,0.000052061638,0.00017531155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006179761,0.00024594867,0.0006833985,0.00021923537,0.00008139842,0.00003678458,0.00005291604,0.00036387454,0.0006530607],"category_scores_gemma":[0.0003778299,0.00018382558,0.00014418492,0.00022174914,0.00006217356,0.0001354305,0.00004764125,0.00040213525,0.000047726902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004614225,0.0009016017,0.9014423,0.000035990153,0.00010224358,0.0385089,0.00027357865,0.00012048602,0.00002633739,0.00013081795,0.000314832,0.058096778],"study_design_scores_gemma":[0.0010167127,0.0027134258,0.98866713,0.000029452114,0.00030734163,0.001573549,0.000057466357,0.0004922564,0.000056523168,0.0016986658,0.003240537,0.00014695652],"about_ca_topic_score_codex":0.0013512044,"about_ca_topic_score_gemma":0.002710446,"teacher_disagreement_score":0.08722482,"about_ca_system_score_codex":0.0012910905,"about_ca_system_score_gemma":0.0004347639,"threshold_uncertainty_score":0.749619},"labels":[],"label_agreement":null},{"id":"W4392031017","doi":"10.1136/ijgc-2024-005400","title":"Mirvetuximab soravtansine: an oasis in the desert?","year":2024,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Medicine; Desert (philosophy); Ovarian cancer; Oncology; Internal medicine; Gynecology; Traditional medicine; Cancer; Epistemology","score_opus":0.028342962206979457,"score_gpt":0.3995215446298507,"score_spread":0.3711785824228712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392031017","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019023743,0.00809323,0.00001160085,0.025279542,0.9451665,0.0003476184,0.0003304961,0.000018552762,0.0017287085],"genre_scores_gemma":[0.16775046,0.008764856,0.0003849466,0.0020188545,0.82015944,0.00011252264,0.00014227173,0.00004859759,0.0006180396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969312,0.00013400437,0.00072228425,0.00030322117,0.0016853695,0.0002239242],"domain_scores_gemma":[0.99721307,0.0011072973,0.00037558685,0.00019117727,0.0009880536,0.00012483308],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007288134,0.00026631085,0.000607997,0.00027720258,0.000026151585,0.00015293594,0.00067890825,0.0004995314,0.0012842017],"category_scores_gemma":[0.00091307494,0.00014154223,0.00037353334,0.00018377892,0.000079974576,0.00013276942,0.00006366642,0.0014852001,0.000027698616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006260259,0.001054545,0.0013945963,0.000038305952,0.0007686681,0.005410205,0.00019158174,0.000021531621,0.00000810839,0.00013423472,0.9634511,0.026901098],"study_design_scores_gemma":[0.002546698,0.0014672494,0.017004702,0.000672511,0.000511185,0.00014976313,0.00008145694,0.00002081449,0.000022246086,0.0010112302,0.9763553,0.00015684612],"about_ca_topic_score_codex":0.00028907813,"about_ca_topic_score_gemma":0.00070578454,"teacher_disagreement_score":0.14872672,"about_ca_system_score_codex":0.0013999799,"about_ca_system_score_gemma":0.001225752,"threshold_uncertainty_score":0.9996288},"labels":[],"label_agreement":null},{"id":"W4392096641","doi":"10.1007/978-3-031-39659-5_21","title":"Pathology of Malignancies Metastatic to the Ovary and of Synchronous Ovarian and Endometrial Carcinoma","year":2023,"lang":"en","type":"book-chapter","venue":"Essentials of Diagnostic Gynecological Pathology.","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Ovary; Ovarian carcinoma; Pathology; Medicine; Carcinoma; Cancer research; Ovarian carcinomas; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.03264822163680451,"score_gpt":0.27332332761107087,"score_spread":0.24067510597426636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392096641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564107,0.019664893,0.0002510874,0.0054334155,0.0018163371,0.00547707,0.0023492742,0.00007179284,0.00852544],"genre_scores_gemma":[0.990682,0.005741433,0.0014158285,0.0002559023,0.00014668993,0.00020092407,0.00007822369,0.000057380403,0.0014216019],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9971179,0.00020928247,0.0012116685,0.0007266876,0.00035648447,0.0003780252],"domain_scores_gemma":[0.9842486,0.013926038,0.00078165036,0.0006070007,0.0002494493,0.00018726822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008934021,0.0004689826,0.0022476353,0.00042537856,0.00006961638,0.0000088946545,0.00020406062,0.0004716249,0.00042076135],"category_scores_gemma":[0.008081922,0.0003132659,0.0002938171,0.00015673984,0.0011366683,0.000025921488,0.00043877977,0.00030429778,0.000020385718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004054453,0.007197927,0.21423036,0.01061842,0.0104953395,0.059497062,0.004017546,0.00015431368,0.02078356,0.5415647,0.014479205,0.1129071],"study_design_scores_gemma":[0.0072773113,0.012541397,0.94254214,0.0011918328,0.0066045937,0.001025281,0.00017881981,0.000005569765,0.004484159,0.021832876,0.001684109,0.0006319051],"about_ca_topic_score_codex":0.00007614983,"about_ca_topic_score_gemma":0.00006744761,"teacher_disagreement_score":0.7283118,"about_ca_system_score_codex":0.000042585594,"about_ca_system_score_gemma":0.00018831837,"threshold_uncertainty_score":0.99993193},"labels":[],"label_agreement":null},{"id":"W4392103639","doi":"10.1007/978-3-031-39659-5_30","title":"Staging of Ovarian, Fallopian tube and Primary Peritoneal Carcinoma","year":2023,"lang":"en","type":"book-chapter","venue":"Essentials of Diagnostic Gynecological Pathology.","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Fallopian tube; Medicine; Gynecology","score_opus":0.02576303858987332,"score_gpt":0.2578973568411755,"score_spread":0.23213431825130215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392103639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7655911,0.009313711,0.00008058588,0.005394507,0.0025735202,0.0042510685,0.0014618123,0.0003061101,0.21102758],"genre_scores_gemma":[0.9760012,0.0057440377,0.0012748708,0.00043065476,0.00029807023,0.00013794449,0.00038555867,0.000118283446,0.015609381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970937,0.00008606524,0.0010782719,0.0008683571,0.00043171173,0.00044190433],"domain_scores_gemma":[0.993343,0.0049796975,0.0006022913,0.0005934025,0.00023746298,0.000244163],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004127596,0.0005424823,0.0020324998,0.00027502832,0.00007564193,0.00001352277,0.0001819349,0.00084983464,0.0010210648],"category_scores_gemma":[0.0018761851,0.00045566304,0.00037978505,0.000074481984,0.0008137322,0.000041586492,0.00036209286,0.00047727686,0.000046319168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080689345,0.0037528106,0.6001807,0.0071653062,0.0035138123,0.039098814,0.0007605327,0.000031491494,0.005216216,0.29465994,0.009414065,0.035399422],"study_design_scores_gemma":[0.0032412088,0.0025925061,0.9761148,0.0010401754,0.00208265,0.00020126312,0.000039924063,0.000004830065,0.0011371793,0.010383904,0.0026444027,0.00051717326],"about_ca_topic_score_codex":0.000053990272,"about_ca_topic_score_gemma":0.000023263843,"teacher_disagreement_score":0.3759341,"about_ca_system_score_codex":0.00011173855,"about_ca_system_score_gemma":0.00027626092,"threshold_uncertainty_score":0.9998921},"labels":[],"label_agreement":null},{"id":"W4392116657","doi":"10.1007/978-3-031-39659-5_9","title":"The Role of Cytology in the Management of Ovarian Lesions","year":2023,"lang":"en","type":"book-chapter","venue":"Essentials of Diagnostic Gynecological Pathology.","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"","keywords":"Cytology; Medicine; Pathology","score_opus":0.024646694671956335,"score_gpt":0.28073499923494977,"score_spread":0.2560883045629934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392116657","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15667629,0.026581,0.00008561099,0.022889508,0.0031119743,0.011398692,0.0009918308,0.00015139848,0.7781137],"genre_scores_gemma":[0.97751045,0.017431656,0.00036777873,0.00015100303,0.00007297137,0.00033596222,0.0000831098,0.00004120473,0.0040058633],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99742985,0.0001937459,0.0011554441,0.00046452644,0.00040061964,0.000355837],"domain_scores_gemma":[0.9862714,0.011968933,0.00072713575,0.0008319106,0.0001396751,0.00006095033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009357703,0.00032780803,0.0011965391,0.00016127173,0.000080382044,0.0000056810886,0.00046920538,0.0005332053,0.00042139515],"category_scores_gemma":[0.001172473,0.00018084979,0.000394993,0.00013017809,0.0008717323,0.0000138906735,0.0002764303,0.00039722995,0.000054317625],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016172312,0.0014356667,0.009503373,0.00040030616,0.0011174803,0.0036371,0.0001872942,0.000025719006,0.00014890675,0.9546555,0.0012013327,0.02752554],"study_design_scores_gemma":[0.0033106203,0.0028657815,0.7060203,0.0016592201,0.0033139489,0.00012401945,0.00071232807,0.000005191907,0.0011539359,0.26437548,0.016088212,0.00037099436],"about_ca_topic_score_codex":0.00004115896,"about_ca_topic_score_gemma":0.000114308416,"teacher_disagreement_score":0.82083416,"about_ca_system_score_codex":0.0000476341,"about_ca_system_score_gemma":0.00009623668,"threshold_uncertainty_score":0.73748404},"labels":[],"label_agreement":null},{"id":"W4392180369","doi":"10.1016/j.ygyno.2024.02.025","title":"Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"UCLH Biomedical Research Centre; Medical Research Council; National Health and Medical Research Council; University College London Hospitals NHS Foundation Trust; Department of Health and Social Care; Cancer Australia; Cancer Research UK; National Institute for Health and Care Research; University of Sydney; Australian Government; Target Ovarian Cancer","keywords":"Medicine; Baseline (sea); Ovarian cancer; Oncology; Internal medicine; Overall survival; Cancer; Progression-free survival","score_opus":0.024873493181761516,"score_gpt":0.3204660633406764,"score_spread":0.2955925701589149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392180369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96491987,0.0040402594,0.000008650992,0.024254635,0.00089278043,0.0008472244,0.000068150184,0.000052779687,0.0049156593],"genre_scores_gemma":[0.9958351,0.0018487091,0.00055835344,0.0003782996,0.00016807496,0.00094968034,0.000022147393,0.000018404888,0.00022118421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979801,0.00030589013,0.0005170003,0.000520311,0.00019870161,0.0004779574],"domain_scores_gemma":[0.99821323,0.0012811747,0.000109178385,0.00020801676,0.000061880826,0.00012650354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008718636,0.00022180128,0.000810897,0.00033027428,0.000022179742,0.000012015494,0.00011854833,0.00022810792,0.0024106556],"category_scores_gemma":[0.00015911636,0.00015214198,0.000046967463,0.0005923103,0.00024773736,0.000055124914,0.000049128837,0.0003235023,0.000023338744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035189902,0.0025789486,0.3453874,0.00067782856,0.0007691206,0.010198689,0.0059502767,0.00036798723,0.0016030092,0.004741709,0.0018097443,0.6223963],"study_design_scores_gemma":[0.014105671,0.014885838,0.8641989,0.001675383,0.00033450846,0.00015249435,0.0031856191,0.0007242325,0.0009481544,0.0021650712,0.097053416,0.00057069707],"about_ca_topic_score_codex":0.001747814,"about_ca_topic_score_gemma":0.0077957218,"teacher_disagreement_score":0.6218256,"about_ca_system_score_codex":0.0022313579,"about_ca_system_score_gemma":0.0017535469,"threshold_uncertainty_score":0.9985013},"labels":[],"label_agreement":null},{"id":"W4392240692","doi":"10.3390/cancers16050972","title":"Impact of Pre-Diagnostic Risk Factors on Short- and Long-Term Ovarian Cancer Survival Trajectories: A Longitudinal Observational Study","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Public Health Ontario; Women's College Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Observational study; Ovarian cancer; Term (time); Medicine; Oncology; Cancer; Internal medicine","score_opus":0.10622739974806532,"score_gpt":0.3875193415178152,"score_spread":0.28129194176974986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392240692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938162,0.0034520286,0.000028650238,0.00010776375,0.00089095905,0.0009918793,0.0005808022,0.00005847164,0.000073245516],"genre_scores_gemma":[0.9981344,0.0010381495,0.000012339532,0.0000199054,0.00035330688,0.0002687698,0.00005632513,0.000041673644,0.00007514458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842954,0.000052237312,0.00031175048,0.000532588,0.00039973287,0.0002741571],"domain_scores_gemma":[0.9987005,0.0006411672,0.00006939333,0.00028316292,0.00009569297,0.00021006096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013431432,0.00029580304,0.0004842865,0.00013525381,0.00007818737,0.000050700324,0.00006891336,0.000073526906,0.000651738],"category_scores_gemma":[0.00012011979,0.00021418974,0.00019375351,0.00034682185,0.000094673436,0.00010945223,0.000023100953,0.00021997203,0.000002423336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038919112,0.00028408016,0.99038726,0.00014390174,0.0022145035,0.00014065811,0.0014523488,0.0011023951,0.000019221601,0.00006701531,0.0003220869,0.003477345],"study_design_scores_gemma":[0.0013670259,0.0026967437,0.9937756,0.00051970314,0.0010248594,0.0000054570205,0.00012377587,0.0001583255,0.00009561095,0.00001308483,0.000039932387,0.00017986113],"about_ca_topic_score_codex":0.008680058,"about_ca_topic_score_gemma":0.0017038233,"teacher_disagreement_score":0.0069762347,"about_ca_system_score_codex":0.0023151112,"about_ca_system_score_gemma":0.0014355929,"threshold_uncertainty_score":0.9979212},"labels":[],"label_agreement":null},{"id":"W4392367358","doi":"10.1158/1538-7445.ovarian23-b113","title":"Abstract B113: Associations between risk factors and epithelial ovarian cancer survival by racial and ethnic group: an analysis from the ovarian cancer association consortium","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Epithelial ovarian cancer; Oncology; Ethnic group; Medicine; Internal medicine; Association (psychology); Gynecology; Cancer; Psychology; Political science","score_opus":0.10635256479189263,"score_gpt":0.43005911439091044,"score_spread":0.3237065495990178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392367358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552216,0.013198372,0.00004607664,0.010037907,0.00057759683,0.0007369815,0.019925613,0.00007607013,0.00017980159],"genre_scores_gemma":[0.9801783,0.01597408,0.000024001258,0.000118642165,0.0019557925,0.0005057265,0.0008773544,0.000058185855,0.000307928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960218,0.0006964656,0.0004624371,0.0009247516,0.0011887872,0.0007057553],"domain_scores_gemma":[0.9959774,0.002676574,0.00020240794,0.00041007844,0.00031829177,0.00041522583],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022458206,0.00031732084,0.00070889585,0.00026835213,0.00065647665,0.00043412327,0.00018340709,0.00033628524,0.0011735903],"category_scores_gemma":[0.00038267695,0.0002248073,0.00019320179,0.0013027734,0.0002030042,0.00028481244,0.000098998426,0.0011478107,0.000008820831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079582496,0.00010757053,0.95785785,0.000029866702,0.0055209114,0.000007990762,0.002425482,0.000018213233,0.00068688707,0.000139154,0.0023540496,0.030772453],"study_design_scores_gemma":[0.0014055675,0.00011269848,0.9849081,0.000113832844,0.0034646129,1.2060981e-7,0.000349605,0.00024769723,0.0005814566,0.00026655025,0.008321365,0.00022837],"about_ca_topic_score_codex":0.31242198,"about_ca_topic_score_gemma":0.08953015,"teacher_disagreement_score":0.22289182,"about_ca_system_score_codex":0.0021956617,"about_ca_system_score_gemma":0.00068057154,"threshold_uncertainty_score":0.99973947},"labels":[],"label_agreement":null},{"id":"W4392368462","doi":"10.1158/1538-7445.ovarian23-ia008","title":"Abstract IA008: Rare ovarian cancers: the sequelae of specific interactions between cell contexts mutations and microenvironments","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Biology; Cancer research; Medicine; Cancer; Genetics","score_opus":0.09773548315498548,"score_gpt":0.41163900520571917,"score_spread":0.3139035220507337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392368462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95596015,0.026157532,0.000028715462,0.01105819,0.00033567683,0.0009866677,0.000533587,0.00002787105,0.0049116174],"genre_scores_gemma":[0.9928015,0.0049797585,0.000066628236,0.000054418833,0.00036842565,0.00031791173,0.00004736353,0.000029869969,0.0013341173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986844,0.000065006185,0.00023989387,0.0003466364,0.00037395963,0.00029011353],"domain_scores_gemma":[0.9989767,0.00043471775,0.000038371367,0.00031545165,0.00009066239,0.00014406344],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028712914,0.00012304104,0.00020728503,0.00016898496,0.00018363114,0.00008491189,0.00010320501,0.000049374292,0.0015728706],"category_scores_gemma":[0.000013319648,0.00008581107,0.000076287026,0.00031855237,0.00032652135,0.000105430656,0.00006163922,0.0004780815,0.00007617205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006411326,0.00091822306,0.17203495,0.0029422315,0.0033168066,0.00089068984,0.016222892,0.00013453832,0.14712869,0.0018919589,0.16876319,0.48511472],"study_design_scores_gemma":[0.0020750395,0.00032839613,0.5729543,0.0016424434,0.0002831396,0.000027885015,0.0022373628,0.000025661417,0.0687223,0.0005478678,0.35094854,0.00020705965],"about_ca_topic_score_codex":0.0019726488,"about_ca_topic_score_gemma":0.00024909983,"teacher_disagreement_score":0.48490766,"about_ca_system_score_codex":0.000804828,"about_ca_system_score_gemma":0.00043651572,"threshold_uncertainty_score":0.9993398},"labels":[],"label_agreement":null},{"id":"W4392369444","doi":"10.1158/1538-7445.ovarian23-b004","title":"Abstract B004: Precision medicine opportunities: uniformity across stromal components of ovarian cancer histotype contrasts heterogeneous disease","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Disease; Ovarian cancer; Stromal cell; Cancer; Medicine; Pathology; Oncology; Internal medicine","score_opus":0.20172250818107304,"score_gpt":0.4540773509795154,"score_spread":0.25235484279844234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392369444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95036316,0.03564841,0.00001620415,0.009723887,0.00092630996,0.0010411557,0.0012022072,0.00007688573,0.0010018067],"genre_scores_gemma":[0.98720556,0.009945991,0.000021832,0.00014720717,0.0006625065,0.00047474113,0.00016112142,0.00006275401,0.0013182821],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99665445,0.000103320446,0.0005350557,0.00062896824,0.0013418794,0.00073629635],"domain_scores_gemma":[0.9976864,0.00033904,0.00008293201,0.0005900569,0.0005329365,0.00076866115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008131843,0.0002704192,0.0005684115,0.00025284934,0.00019267871,0.00005348371,0.00023744287,0.00011964171,0.0037510346],"category_scores_gemma":[0.00009110171,0.00020353727,0.00016501872,0.0004107907,0.00057766394,0.00014315164,0.0001202245,0.00051160355,0.000031914053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016487796,0.0035503134,0.10503738,0.011922918,0.0046169874,0.013673678,0.0066223782,0.0007034351,0.04605506,0.0035229605,0.06525975,0.72254735],"study_design_scores_gemma":[0.010121418,0.0022130345,0.7474609,0.015831199,0.0007050279,0.000074647745,0.0007292812,0.0010884424,0.010148033,0.0008836538,0.21005298,0.00069135503],"about_ca_topic_score_codex":0.0084802145,"about_ca_topic_score_gemma":0.00058816717,"teacher_disagreement_score":0.721856,"about_ca_system_score_codex":0.0013525928,"about_ca_system_score_gemma":0.0013740482,"threshold_uncertainty_score":0.9981224},"labels":[],"label_agreement":null},{"id":"W4392369497","doi":"10.1158/1538-7445.ovarian23-a109","title":"Abstract A109: Novel germline genetic variants in pseudogenes associated with overall survival in advanced stage ovarian cancer treated with carboplatin, paclitaxel, and bevacizumab: Results from the ROSiA trial","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Western University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Carboplatin; Paclitaxel; Bevacizumab; Germline; Oncology; Medicine; Ovarian cancer; Internal medicine; Stage (stratigraphy); Cancer; Chemotherapy; Biology; Gene; Genetics; Cisplatin","score_opus":0.08140658505046139,"score_gpt":0.3784360474014882,"score_spread":0.2970294623510268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392369497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98091143,0.009965963,0.0000049047517,0.0038224559,0.00019552396,0.0023356378,0.0023427878,0.00005377894,0.0003675402],"genre_scores_gemma":[0.9939287,0.0033658221,0.00012353895,0.00008530936,0.00037699548,0.0012992838,0.00021036222,0.00009652387,0.0005135054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616736,0.00025044655,0.0006127145,0.0011111157,0.0010218224,0.00083655975],"domain_scores_gemma":[0.9974996,0.0013132937,0.00011931582,0.000581321,0.00024672554,0.00023975699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010558164,0.00039167062,0.0006854222,0.00028486722,0.00013802276,0.00019680239,0.00019006386,0.00019785874,0.00024576136],"category_scores_gemma":[0.00023288207,0.00023829704,0.000060163577,0.0012161748,0.00023051634,0.00016506837,0.000075387165,0.0008886458,0.0000038260605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31279013,0.0034345242,0.5885886,0.0005201176,0.0037738117,0.0075214007,0.006711115,0.004631837,0.02262976,0.00049090496,0.0010509415,0.04785688],"study_design_scores_gemma":[0.09457798,0.0012110363,0.89840245,0.0028407213,0.00014694735,0.0000057320344,0.00022246699,0.0007524139,0.0008823753,0.000032746146,0.00063069625,0.00029443737],"about_ca_topic_score_codex":0.08239107,"about_ca_topic_score_gemma":0.09577314,"teacher_disagreement_score":0.3098139,"about_ca_system_score_codex":0.0014631847,"about_ca_system_score_gemma":0.0016996108,"threshold_uncertainty_score":0.97174716},"labels":[],"label_agreement":null},{"id":"W4392369509","doi":"10.1097/pgp.0000000000000972","title":"HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Immunohistochemistry; MSH2; Pathology; Medicine; Mucinous carcinoma; Clear cell carcinoma; Ovarian carcinoma; MSH6; Ovarian cancer; Malignancy; Oncology; Carcinoma; Cancer; Internal medicine; Colorectal cancer; Adenocarcinoma; DNA mismatch repair","score_opus":0.01362566206386223,"score_gpt":0.32951272941379256,"score_spread":0.31588706734993033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392369509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915604,0.005256857,0.000068551955,0.002369008,0.00034596113,0.00007758989,0.00001748176,0.000005864275,0.0002982708],"genre_scores_gemma":[0.99662334,0.0022366545,0.0007926612,0.00019877563,0.00010423365,0.000009970798,0.0000045368683,0.000005723307,0.00002407749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989259,0.0000528818,0.00045763556,0.00020108388,0.00024800253,0.00011447414],"domain_scores_gemma":[0.9991729,0.00035598682,0.00015346019,0.00006997686,0.00017153153,0.00007613604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002887071,0.00010023535,0.00045299658,0.00035244637,0.0000130554345,0.000018172486,0.00008330595,0.00012063003,0.00033753525],"category_scores_gemma":[0.00024132864,0.00007064452,0.00012858456,0.00017128975,0.00010476711,0.000066475215,0.000074764066,0.000243402,6.734328e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014826093,0.0013828289,0.786689,0.00015546072,0.0040004207,0.010788009,0.0011911927,0.00033192456,0.10973827,0.003250508,0.00026448912,0.08072528],"study_design_scores_gemma":[0.0018711119,0.0006613831,0.99143374,0.00077614957,0.0005411449,0.0006579174,0.00005440493,0.0007742983,0.0021255158,0.0006921935,0.00033387527,0.00007825142],"about_ca_topic_score_codex":0.000121068224,"about_ca_topic_score_gemma":0.000034214518,"teacher_disagreement_score":0.20474474,"about_ca_system_score_codex":0.00034331976,"about_ca_system_score_gemma":0.00013198728,"threshold_uncertainty_score":0.36957744},"labels":[],"label_agreement":null},{"id":"W4392377096","doi":"10.1158/1538-7445.ovarian23-a063","title":"Abstract A063: What can we learn from a retrospective evaluation of HER2, P53 and P16INK4A protein expression in rare ovarian tumors?","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Protein expression; Ovarian cancer; Expression (computer science); Medicine; Cancer research; Oncology; Internal medicine; Biology; Cancer; Genetics; Computer science; Programming language; Gene","score_opus":0.09902015996392277,"score_gpt":0.42399858196376344,"score_spread":0.32497842199984067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392377096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535932,0.03438545,0.0000020614996,0.009327471,0.00013955383,0.0017822216,0.00007211681,0.00002414839,0.0006738052],"genre_scores_gemma":[0.99437654,0.0036917375,0.000082402345,0.000027713417,0.000277802,0.0012420934,0.000036381258,0.000033390716,0.00023192671],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973966,0.00022190464,0.0002669394,0.0005761495,0.0012152984,0.00032311067],"domain_scores_gemma":[0.99888146,0.00013013922,0.000046461864,0.0003238066,0.00046986225,0.00014824669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001306079,0.0001458791,0.0003154842,0.00030274896,0.000066343295,0.00013855612,0.00008081336,0.00011069345,0.0015687476],"category_scores_gemma":[0.00018826274,0.00011594533,0.00005418196,0.00052832835,0.00012071419,0.00024972012,0.0000714653,0.00054890336,0.000012906749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018840218,0.0011299918,0.089397624,0.0022492707,0.0005980323,0.0009918895,0.020321293,0.000086221626,0.29976544,0.0006816521,0.0053791823,0.57751536],"study_design_scores_gemma":[0.004736698,0.0006193375,0.74760246,0.02369305,0.000117396216,0.000006708827,0.003946437,0.0006257247,0.21057546,0.0062868013,0.0015610587,0.00022888476],"about_ca_topic_score_codex":0.00673281,"about_ca_topic_score_gemma":0.002051747,"teacher_disagreement_score":0.6582048,"about_ca_system_score_codex":0.0014694182,"about_ca_system_score_gemma":0.0011491706,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W4392378834","doi":"10.1158/1538-7445.ovarian23-a099","title":"Abstract A099: Preliminary pharmacodynamic characterization in patients with platinum-resistant ovarian cancer treated with nemvaleukin in combination with pembrolizumab","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Ovarian cancer; Medicine; Pharmacodynamics; Cancer; Oncology; Internal medicine; Pharmacokinetics; Immunotherapy","score_opus":0.02656305725333194,"score_gpt":0.3457545401023751,"score_spread":0.3191914828490432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392378834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994904,0.00052831275,0.000011962423,0.0015465018,0.00006122168,0.0021446696,0.00027052045,0.000060431037,0.0004723833],"genre_scores_gemma":[0.9963767,0.0003632594,0.000032527034,0.000047408776,0.00007385141,0.001923321,0.00073853164,0.00008792771,0.00035645167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743974,0.00009763508,0.00031129326,0.0006787787,0.0009071935,0.0005653684],"domain_scores_gemma":[0.9990815,0.00011329276,0.000071160364,0.0002868433,0.00028885598,0.00015834774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026295113,0.0002744861,0.00036041028,0.0007054523,0.000086931635,0.00010592911,0.00010978614,0.00009470033,0.00040925285],"category_scores_gemma":[0.000009912582,0.00018386627,0.000023978742,0.0015736539,0.00012622311,0.00033533853,0.000029249994,0.0005881882,0.000011180378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025470847,0.0014391084,0.94465375,0.00088836753,0.000259613,0.00092437136,0.00073653564,0.00030771285,0.003187327,0.00013402005,0.000112765825,0.021885589],"study_design_scores_gemma":[0.015685,0.0029933576,0.9739967,0.004406404,0.00009555196,0.000005183971,0.000051377137,0.0008686518,0.0013404527,0.000007047716,0.00033094373,0.00021935643],"about_ca_topic_score_codex":0.0041675516,"about_ca_topic_score_gemma":0.0028581622,"teacher_disagreement_score":0.029342929,"about_ca_system_score_codex":0.0024203178,"about_ca_system_score_gemma":0.0011497906,"threshold_uncertainty_score":0.7497849},"labels":[],"label_agreement":null},{"id":"W4392381125","doi":"10.1158/1538-7445.ovarian23-b047","title":"Abstract B047: Development and validation of an improved risk stratification model for ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Risk stratification; Oncology; Stratification (seeds); Medicine; Cancer; Internal medicine; Biology","score_opus":0.141937194678425,"score_gpt":0.4483739181862786,"score_spread":0.30643672350785356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392381125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185765,0.003288823,0.0015915817,0.0013987855,0.00011888076,0.0012711225,0.00022405278,0.0000319747,0.00021711453],"genre_scores_gemma":[0.9927915,0.0012085736,0.0034583937,0.000016302964,0.00016252186,0.001869933,0.00008650088,0.000026827576,0.00037950007],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998826,0.000027267635,0.0002402955,0.00038056067,0.00029469354,0.00023112817],"domain_scores_gemma":[0.99920565,0.00009907452,0.000046290028,0.00021193855,0.0003037794,0.00013326097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069198554,0.00009941469,0.00016332004,0.00015480327,0.000117014075,0.00006954969,0.000056605615,0.000072032664,0.00012445061],"category_scores_gemma":[0.00003310766,0.00008135663,0.000034378463,0.00019317219,0.000060371218,0.0001404799,0.00001702851,0.00017444725,0.0000023271882],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073235796,0.00046128294,0.0043569165,0.002199831,0.0005907767,0.000008303881,0.0045606983,0.0011839854,0.089200936,0.002252902,0.0016534659,0.89279854],"study_design_scores_gemma":[0.0033749864,0.00058188516,0.085541025,0.0011654478,0.00029844372,0.0000031572522,0.00038682699,0.192454,0.7073442,0.0025944244,0.0059526353,0.00030297754],"about_ca_topic_score_codex":0.0011895982,"about_ca_topic_score_gemma":0.00057645043,"teacher_disagreement_score":0.8924956,"about_ca_system_score_codex":0.00041189708,"about_ca_system_score_gemma":0.0014428307,"threshold_uncertainty_score":0.3317627},"labels":[],"label_agreement":null},{"id":"W4392383296","doi":"10.1158/1538-7445.ovarian23-ia016","title":"Abstract IA016: Opportunistic salpingectomy for ovarian cancer prevention","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Medicine; Salpingectomy; Cancer; Gynecology; Oncology; Internal medicine; Biology; Pregnancy; Genetics","score_opus":0.22408348042819576,"score_gpt":0.5060121483599012,"score_spread":0.2819286679317054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52834225,0.14531446,0.0035030406,0.23719421,0.009194682,0.018571306,0.0027846096,0.0012705456,0.053824913],"genre_scores_gemma":[0.9773109,0.004007378,0.00025903955,0.00016492352,0.0014541439,0.005315465,0.000100624624,0.00007330014,0.011314235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803907,0.000039256804,0.00025250774,0.00056364195,0.00053650496,0.0005690262],"domain_scores_gemma":[0.9988058,0.0002561673,0.000029548068,0.0003275179,0.00030588484,0.00027506705],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070787943,0.00016121476,0.00026736362,0.00026989178,0.00019138015,0.00014584753,0.00011199895,0.00010546736,0.0043403944],"category_scores_gemma":[0.00007324712,0.00013187894,0.0001738254,0.0004955902,0.00009832752,0.000108915076,0.000041045314,0.00035965221,0.00011546306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009170619,0.0007049781,0.004660265,0.0050382204,0.0016152011,0.00061972294,0.0005224918,0.000023494917,0.015706293,0.023796974,0.2729471,0.6734482],"study_design_scores_gemma":[0.0033214744,0.00079443934,0.04068408,0.0040518264,0.00042414461,0.000022145561,0.00012253784,0.0004993212,0.009251646,0.004216959,0.9362899,0.0003215424],"about_ca_topic_score_codex":0.0008832483,"about_ca_topic_score_gemma":0.00027194005,"teacher_disagreement_score":0.67312664,"about_ca_system_score_codex":0.0010942504,"about_ca_system_score_gemma":0.0021241086,"threshold_uncertainty_score":0.99656975},"labels":[],"label_agreement":null},{"id":"W4392450437","doi":"10.1038/s41525-024-00395-y","title":"Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease","year":2024,"lang":"en","type":"article","venue":"npj Genomic Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"Medical Research and Materiel Command; National Cancer Institute; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Cancer Institute NSW; Ovarian Cancer Research Fund; Cancer Australia; National Institute for Health and Care Research; National Health and Medical Research Council; Norges Forskningsråd; Moffitt Cancer Center; Minnesota Ovarian Cancer Alliance; Wellcome Trust; Cancer Research UK; National Center for Research Resources; BC Cancer Foundation; Fred C. and Katherine B. Andersen Foundation; Helse Vest; Ovarian Cancer Australia; National Center for Advancing Translational Sciences; Medical Research Council; Cancer Research Society; Mayo Foundation for Medical Education and Research; Ministerio de Economía y Competitividad; University of Pittsburgh; National Institutes of Health; European Commission; U.S. Department of Defense","keywords":"Debulking; Ovarian cancer; Disease; Medicine; Genome-wide association study; Oncology; Gene; Candidate gene; Genetic association; Internal medicine; Biology; Bioinformatics; Cancer; Genetics; Genotype; Single-nucleotide polymorphism","score_opus":0.04311196093886641,"score_gpt":0.339936937273058,"score_spread":0.2968249763341916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392450437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578765,0.031169312,0.0002607462,0.007895793,0.0013179578,0.0008606541,0.00026304406,0.00006713547,0.0002888348],"genre_scores_gemma":[0.98938817,0.0060396716,0.00019358321,0.001014741,0.001224709,0.00020867692,0.0009391355,0.0000625783,0.00092872634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978672,0.00006192583,0.0007146589,0.00049259077,0.0004943446,0.00036923445],"domain_scores_gemma":[0.9973474,0.0015956856,0.00030238615,0.00028806966,0.00021359118,0.00025287044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057803973,0.00024755203,0.00071601314,0.0003532601,0.00010170597,0.000029123767,0.0000804267,0.000087697845,0.0003535325],"category_scores_gemma":[0.00056327577,0.00019510201,0.00021157444,0.00027110727,0.00005104476,0.00007927856,0.000041063737,0.000108337306,0.000009686179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036966204,0.00016779308,0.9697761,0.0018431796,0.0017393242,0.000063990614,0.0003626247,0.00006078522,0.0043870923,0.000024347564,0.013121267,0.008083837],"study_design_scores_gemma":[0.002442101,0.00018225623,0.9839251,0.0015315068,0.0028131702,0.000001233889,0.0000442713,0.00007262616,0.0010353877,0.00018156577,0.0075954706,0.0001752829],"about_ca_topic_score_codex":0.00084423216,"about_ca_topic_score_gemma":0.0001992196,"teacher_disagreement_score":0.031511657,"about_ca_system_score_codex":0.0015528126,"about_ca_system_score_gemma":0.0010579246,"threshold_uncertainty_score":0.79560286},"labels":[],"label_agreement":null},{"id":"W4392459163","doi":"10.3390/curroncol31030100","title":"A Survival Analysis of Patients with Recurrent Epithelial Ovarian Cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Incidence (geometry); Ovarian cancer; Retrospective cohort study; Cancer; Chemotherapy; Oncology","score_opus":0.0625127298069711,"score_gpt":0.39352390043614716,"score_spread":0.33101117062917607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392459163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946065,0.0006544935,0.0001262593,0.00045543571,0.0022993681,0.0011549596,0.00044239964,0.000030289175,0.00023030778],"genre_scores_gemma":[0.99906504,0.000096293275,0.0001583868,0.000030062174,0.000106241205,0.00030194348,0.00020787488,0.000015613932,0.00001851794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983385,0.00014741803,0.000359806,0.0005370981,0.0003983486,0.00021882345],"domain_scores_gemma":[0.9992174,0.000108397275,0.00010262201,0.00024538595,0.00022571607,0.00010046377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023760153,0.00021416614,0.0006995138,0.000642546,0.000038770348,0.0000101119,0.00006435472,0.00007417286,0.00032585225],"category_scores_gemma":[0.00006640441,0.00014453995,0.00013801116,0.0014965462,0.00008985497,0.0000368289,0.000025047835,0.00031192877,0.000011119815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024012688,0.014648385,0.957583,0.000061768675,0.0016143662,0.00011358524,0.0006429306,0.0007462689,0.0000033692781,0.00029607295,0.000097202734,0.02179178],"study_design_scores_gemma":[0.009942665,0.0050427835,0.9715125,0.0003152521,0.002738622,3.7124755e-7,0.00005614687,0.0072407834,0.000007692841,0.0000060372668,0.003009622,0.00012755099],"about_ca_topic_score_codex":0.0002342094,"about_ca_topic_score_gemma":0.002626967,"teacher_disagreement_score":0.021664228,"about_ca_system_score_codex":0.0018927901,"about_ca_system_score_gemma":0.0009549094,"threshold_uncertainty_score":0.58941686},"labels":[],"label_agreement":null},{"id":"W4392459204","doi":"10.3390/curroncol31030102","title":"Ovarian Cancer in the Older Manitoban Population—Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Medicine; Ovarian cancer; Fallopian tube cancer; Cancer; Discontinuation; Population; Internal medicine; Cancer registry; Fallopian tube; Retrospective cohort study; Oncology; Gynecology","score_opus":0.07644238700447238,"score_gpt":0.4165807702011137,"score_spread":0.34013838319664136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392459204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384511,0.028770432,0.000007556171,0.022445446,0.0052206498,0.0044011166,0.00020453143,0.00018358682,0.00031557173],"genre_scores_gemma":[0.9855097,0.006061804,0.000057210666,0.00064745435,0.0005124927,0.006886194,0.00006706165,0.000065454835,0.00019263357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968791,0.00031090173,0.0007746872,0.0009899077,0.00042453775,0.00062087027],"domain_scores_gemma":[0.99868035,0.00033509565,0.00017164215,0.0005479893,0.00007577433,0.00018912352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033017303,0.000586607,0.0010812179,0.0003003259,0.00020692285,0.00011988533,0.00020154948,0.00019879949,0.0005865433],"category_scores_gemma":[0.00001797773,0.00035963577,0.00021538907,0.0005787276,0.000086240456,0.00015943963,0.00007642397,0.00049475627,0.000026390897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007092704,0.0034956755,0.7605511,0.00014956067,0.0009846382,0.00039437524,0.0057383096,0.000029732644,0.0000026914988,0.0007089286,0.0005430857,0.22733098],"study_design_scores_gemma":[0.008517279,0.0009442794,0.9476621,0.0006070486,0.0014150264,0.000037531536,0.001647433,0.000390893,0.0000028875768,0.00014942305,0.038299885,0.00032618298],"about_ca_topic_score_codex":0.035590403,"about_ca_topic_score_gemma":0.10026929,"teacher_disagreement_score":0.2270048,"about_ca_system_score_codex":0.0032827107,"about_ca_system_score_gemma":0.00044986335,"threshold_uncertainty_score":0.99988556},"labels":[],"label_agreement":null},{"id":"W4392482408","doi":"10.1016/j.ygyno.2024.01.045","title":"Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"ImmunoGen","keywords":"Medicine; Bevacizumab; Carboplatin; Conjugate; Ovarian cancer; Antibody-drug conjugate; Folate receptor; Antibody; Oncology; Drug; Pharmacology; Internal medicine; Cancer research; Cancer; Monoclonal antibody; Chemotherapy; Immunology; Cisplatin; Cancer cell","score_opus":0.011109194254551804,"score_gpt":0.31071417876062785,"score_spread":0.29960498450607603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392482408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507046,0.00046076256,0.000011083757,0.0009706086,0.0002505612,0.0026637318,0.000077496814,0.000046262892,0.00044901457],"genre_scores_gemma":[0.9984919,0.00009797952,0.0007334361,0.00013094035,0.000029062365,0.00027830398,0.00016878243,0.000034920347,0.00003469251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978576,0.00027456429,0.000585872,0.00065497146,0.00024701454,0.00037999995],"domain_scores_gemma":[0.9987253,0.0005635756,0.0002377743,0.00017491124,0.00020197008,0.00009646691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040687952,0.0003074231,0.000909577,0.0003633804,0.00005813205,0.000021713327,0.00005513215,0.00016988906,0.000092421484],"category_scores_gemma":[0.00009245308,0.00021958604,0.000031574313,0.00062833476,0.00012908451,0.0001386874,0.000048063805,0.00036998818,0.0000031793638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060483566,0.02790834,0.90965235,0.00022139322,0.00064176944,0.0015829231,0.008938928,0.00008904951,0.00036923832,0.00020338203,0.00017838586,0.04416591],"study_design_scores_gemma":[0.11244503,0.04414733,0.8375854,0.0005834542,0.00040464482,0.000015727013,0.002599346,0.0012685459,0.00034430454,0.000058561185,0.00023445296,0.00031323032],"about_ca_topic_score_codex":0.0020039743,"about_ca_topic_score_gemma":0.007663824,"teacher_disagreement_score":0.10639667,"about_ca_system_score_codex":0.00088614726,"about_ca_system_score_gemma":0.0004741586,"threshold_uncertainty_score":0.89544594},"labels":[],"label_agreement":null},{"id":"W4392634149","doi":"10.1136/ijgc-2024-esgo.795","title":"1150 Does route of chemotherapy administration affect recurrence site or timing in advanced ovarian cancer?","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Chemotherapy; Serous fluid; Internal medicine; Oncology; Cohort; Proportional hazards model; Surgery; Adjuvant; Paclitaxel; Stage (stratigraphy); Cancer","score_opus":0.03576939653080135,"score_gpt":0.39389878387233557,"score_spread":0.3581293873415342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977424,0.0031990085,0.00019218597,0.01600049,0.0024517917,0.0002577198,0.0000958183,0.000014756198,0.00036418866],"genre_scores_gemma":[0.9906291,0.0068076686,0.0011763709,0.0005450117,0.00050752703,0.00006397153,0.0000078614175,0.000012254918,0.00025028156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859804,0.000041614847,0.00055500976,0.0002130151,0.00044053534,0.00015181421],"domain_scores_gemma":[0.99889994,0.00035886434,0.00027552733,0.000078765974,0.00029935298,0.00008756424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025560262,0.00014336547,0.00037091406,0.00018532327,0.00001594959,0.000040730705,0.00015159145,0.000088479945,0.0025674836],"category_scores_gemma":[0.00016771065,0.00008118911,0.00016332537,0.00020464965,0.000050347557,0.00019470125,0.000021992606,0.00025461632,0.0000033338188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052011576,0.0009486478,0.3120643,0.00018019625,0.0009481477,0.0023350818,0.00061992306,0.00065156986,0.0049407114,0.0007530812,0.00090664456,0.67045057],"study_design_scores_gemma":[0.0065088044,0.003513908,0.93777114,0.003951948,0.00023272992,0.00023263325,0.000111019974,0.001052696,0.020900805,0.0006287603,0.024845028,0.0002505197],"about_ca_topic_score_codex":0.00013119979,"about_ca_topic_score_gemma":0.00080182886,"teacher_disagreement_score":0.67020005,"about_ca_system_score_codex":0.000867356,"about_ca_system_score_gemma":0.0007544863,"threshold_uncertainty_score":0.9983443},"labels":[],"label_agreement":null},{"id":"W4392634152","doi":"10.1136/ijgc-2024-esgo.806","title":"1217 The ultrasound features of papillary projections in benign, borderline and malignant ovarian tumours","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Histopathology; Radiology; Ultrasound; Retrospective cohort study; Pathology","score_opus":0.017731592397199358,"score_gpt":0.331546813620879,"score_spread":0.31381522122367966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311987,0.019628813,0.000053719574,0.045759875,0.0015622712,0.0002758522,0.000059974718,0.000010513519,0.0014502723],"genre_scores_gemma":[0.9918977,0.0065816147,0.0002764099,0.00059751683,0.00041602773,0.000027312879,0.000003751376,0.0000074921295,0.00019217332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990299,0.00004279934,0.0003600691,0.0001341808,0.00032598423,0.00010709021],"domain_scores_gemma":[0.999025,0.00049261836,0.00012747986,0.00006313952,0.00023589974,0.000055875193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028055033,0.00009544378,0.00022430929,0.00014528622,0.000026191903,0.000043364897,0.000112871894,0.00006121166,0.0004902964],"category_scores_gemma":[0.00021164805,0.000049495942,0.00011268729,0.00014381974,0.00009329907,0.00007381383,0.000028023118,0.00026945127,9.555228e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014605656,0.0018370916,0.7884981,0.00016847505,0.002756196,0.004320281,0.0017502127,0.00054812245,0.0050741313,0.020746196,0.018396392,0.15444423],"study_design_scores_gemma":[0.0011164603,0.000615827,0.97985256,0.00043288711,0.00015565331,0.00096904114,0.0002073259,0.0000394613,0.0009311979,0.0013299251,0.014287056,0.000062626],"about_ca_topic_score_codex":0.0002179124,"about_ca_topic_score_gemma":0.00034937952,"teacher_disagreement_score":0.19135444,"about_ca_system_score_codex":0.00024269309,"about_ca_system_score_gemma":0.00028284255,"threshold_uncertainty_score":0.53684014},"labels":[],"label_agreement":null},{"id":"W4392634300","doi":"10.1136/ijgc-2024-esgo.650","title":"484 Should patients with advanced stage ovarian cancer and preoperative hyponatremia be excluded from primary debulking surgery?","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Debulking; Hyponatremia; Serous cystadenocarcinoma; Surgery; Stage (stratigraphy); Ascites; Ovarian cancer; Cancer; Internal medicine","score_opus":0.03804027396947504,"score_gpt":0.3253447822723904,"score_spread":0.2873045083029153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97755855,0.007829207,0.000101368474,0.01190582,0.0013446672,0.00028733822,0.00036189237,0.000026759637,0.00058440125],"genre_scores_gemma":[0.9910996,0.0038041428,0.0011414394,0.0029238472,0.0005468337,0.000088955676,0.000052402196,0.000026080863,0.00031673026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821097,0.00004495882,0.00046448558,0.00033177866,0.0007451493,0.00020268357],"domain_scores_gemma":[0.9981093,0.0007936477,0.00023162329,0.00009095999,0.0005894116,0.00018505052],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015549787,0.00022050606,0.00048121496,0.00015358294,0.000050579052,0.00011410315,0.00012924102,0.00010597103,0.002625865],"category_scores_gemma":[0.00012852786,0.00013435245,0.00014823659,0.0001243713,0.000086558895,0.0003209453,0.00006245219,0.00036211414,0.000002279106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021412051,0.0005095722,0.79011273,0.000049414644,0.0022581215,0.001173485,0.0003447269,0.0002258194,0.0002802635,0.00020013006,0.0029960661,0.19970845],"study_design_scores_gemma":[0.0031538748,0.0005397757,0.965228,0.0008701473,0.00030777184,0.000022377404,0.00004302784,0.00007768796,0.0006405203,0.00011755563,0.028824124,0.00017510756],"about_ca_topic_score_codex":0.00024510044,"about_ca_topic_score_gemma":0.00023885736,"teacher_disagreement_score":0.19953334,"about_ca_system_score_codex":0.0011327165,"about_ca_system_score_gemma":0.00065669004,"threshold_uncertainty_score":0.9982859},"labels":[],"label_agreement":null},{"id":"W4392634404","doi":"10.1136/ijgc-2024-esgo.1121","title":"#1350 Tumor treating fields (TTFields) therapy in platinum-resistant ovarian cancer: results from the ENGOT-ov50/GOG-3029/INNOVATE-3 phase 3 study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Paclitaxel; Oncology; Ovarian cancer; Population; Cancer; Chemotherapy; Mesothelioma; Pathology","score_opus":0.05021908909820553,"score_gpt":0.3849673919569026,"score_spread":0.33474830285869706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95580894,0.0046146647,0.00004923042,0.035426874,0.0023815925,0.00050660194,0.0003182047,0.000026075846,0.0008678362],"genre_scores_gemma":[0.9930154,0.0019721088,0.00015216155,0.0026586705,0.0018292491,0.00015193192,0.000018097931,0.000020536505,0.00018182279],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975112,0.00013266371,0.0010189418,0.00037489808,0.0007089214,0.00025337085],"domain_scores_gemma":[0.9973385,0.001611939,0.00035767397,0.00019491701,0.0003888514,0.00010811902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059855037,0.00024282013,0.00048215763,0.00016263733,0.000069992595,0.00015492103,0.0003771476,0.00011290598,0.002813203],"category_scores_gemma":[0.00046014503,0.00013400285,0.00019312275,0.00030320103,0.000056152046,0.0001451491,0.000063407104,0.0007195508,0.000007979251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018781416,0.0067304694,0.22705069,0.000024116787,0.005404931,0.016438145,0.006946855,0.00095741765,0.0023056653,0.0010584784,0.014515413,0.6997864],"study_design_scores_gemma":[0.05315812,0.011093834,0.87429655,0.0019526904,0.0005267372,0.00015098142,0.0023053424,0.0014211074,0.0027652227,0.0019072593,0.049903437,0.0005187449],"about_ca_topic_score_codex":0.0045440407,"about_ca_topic_score_gemma":0.0026478763,"teacher_disagreement_score":0.6992677,"about_ca_system_score_codex":0.00080526754,"about_ca_system_score_gemma":0.0005575004,"threshold_uncertainty_score":0.9980984},"labels":[],"label_agreement":null},{"id":"W4392634440","doi":"10.1136/ijgc-2024-esgo.895","title":"583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Worry; Salpingectomy; Thematic analysis; Gynecology; Obstetrics; Qualitative research; Pregnancy; Anxiety","score_opus":0.034612812250605494,"score_gpt":0.3842941385633512,"score_spread":0.34968132631274573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392634440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926539,0.0031957794,0.000016204542,0.0018363838,0.0012686421,0.00090621726,0.000013208192,0.000015450922,0.00009421955],"genre_scores_gemma":[0.9981224,0.00052934815,0.00013384316,0.00015670934,0.00037196363,0.00064383884,4.865208e-7,0.000015035935,0.00002635682],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9980355,0.00029295954,0.00055815774,0.00028288751,0.0006240997,0.00020641423],"domain_scores_gemma":[0.9971748,0.0020297344,0.00034335107,0.000091374524,0.00022314207,0.00013762823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013589412,0.00017991157,0.0004748996,0.00018571493,0.00008058183,0.00011172903,0.00015573154,0.000063759355,0.0003564759],"category_scores_gemma":[0.000985034,0.000096369935,0.00016713515,0.00018824777,0.00012695913,0.00012068993,0.00006486825,0.00036315646,0.0000013958316],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03372805,0.0030540412,0.03644549,0.00009376617,0.011630876,0.0017938178,0.84062636,0.00004433166,0.0008243005,0.00072890334,0.00067628105,0.07035381],"study_design_scores_gemma":[0.09088406,0.07273203,0.3126966,0.0038016173,0.0019304429,0.0003314697,0.5014728,0.00048439426,0.006557992,0.0031604304,0.004993732,0.00095442974],"about_ca_topic_score_codex":0.00030848305,"about_ca_topic_score_gemma":0.000019710877,"teacher_disagreement_score":0.33915356,"about_ca_system_score_codex":0.0005911021,"about_ca_system_score_gemma":0.0002442524,"threshold_uncertainty_score":0.39298517},"labels":[],"label_agreement":null},{"id":"W4392907412","doi":"10.1016/j.ejogrb.2024.03.019","title":"A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet® device","year":2024,"lang":"en","type":"article","venue":"European Journal of Obstetrics & Gynecology and Reproductive Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northwestern Polytechnic; University of Alberta","funders":"","keywords":"Stage (stratigraphy); Ovarian cancer; Medicine; Cancer; Oncology; Radiology; Internal medicine; Biology","score_opus":0.05773717913927188,"score_gpt":0.3686169306295887,"score_spread":0.3108797514903168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392907412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90744567,0.08873725,0.000030724397,0.0019257412,0.0013145182,0.0002528534,0.000019465808,0.000004931733,0.00026882067],"genre_scores_gemma":[0.99239904,0.0062644603,0.0009568514,0.00005667245,0.00015316783,0.000007498457,0.0000010106044,0.000012181599,0.00014914531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819195,0.0005506086,0.0006541789,0.00037565653,0.000083136576,0.00014446572],"domain_scores_gemma":[0.99809,0.00096364674,0.00046653723,0.00021304982,0.00018886203,0.00007785771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004843265,0.00015469053,0.00073344156,0.00012227173,0.000044356555,0.0000049038727,0.0000664533,0.00007277009,0.000030534302],"category_scores_gemma":[0.0005695021,0.00007340965,0.000117379954,0.00023238917,0.0009040548,0.000036721874,0.000043367094,0.00023529537,7.819721e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011841299,0.00069490814,0.8751226,0.00008942029,0.00087524805,0.00038256173,0.0009914727,0.000016974946,0.00030784868,0.000321152,0.000039835795,0.11997384],"study_design_scores_gemma":[0.0030364308,0.010804912,0.9414335,0.00017516316,0.00061799574,0.00021862866,0.00034725768,0.000007612973,0.00094367284,0.000035279987,0.042299937,0.00007964176],"about_ca_topic_score_codex":0.0000056779827,"about_ca_topic_score_gemma":0.000009749646,"teacher_disagreement_score":0.1198942,"about_ca_system_score_codex":0.00007448698,"about_ca_system_score_gemma":0.00018570878,"threshold_uncertainty_score":0.33310276},"labels":[],"label_agreement":null},{"id":"W4392910987","doi":"10.21203/rs.3.rs-3851249/v1","title":"Reversible downregulation of MYC in a spheroid model of metastatic epithelial ovarian cancer","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"London Health Sciences Foundation","keywords":"Downregulation and upregulation; Spheroid; Ovarian cancer; Epithelial ovarian cancer; Cancer research; Cancer; Oncology; Medicine; Internal medicine; Chemistry; Biology; Gene; Cell culture","score_opus":0.11259272344416311,"score_gpt":0.4279173041829274,"score_spread":0.3153245807387643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392910987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96899915,0.013528328,0.0002640957,0.0060714385,0.00024663046,0.0040507033,0.0022404755,0.000038634735,0.004560517],"genre_scores_gemma":[0.9937416,0.0022285928,0.0022296575,0.000011559539,0.00010799015,0.0005199199,0.00011200871,0.000043465978,0.0010052045],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997303,0.00019297135,0.00054663187,0.0005326304,0.0010672145,0.00035753424],"domain_scores_gemma":[0.9984143,0.0001662831,0.00013621604,0.0006430249,0.0005130986,0.00012708016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010472984,0.00020607491,0.0007262749,0.00065086834,0.000024280225,0.000019756344,0.00015139228,0.00018425925,0.000509583],"category_scores_gemma":[0.00012098936,0.00017268355,0.00023768855,0.0006192897,0.00012606717,0.000032727497,0.00047114052,0.0008443162,0.000014477928],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069783875,0.009243201,0.061436307,0.15989475,0.0070969127,0.0010742163,0.01867263,0.5213956,0.07107937,0.028649757,0.016253233,0.09822561],"study_design_scores_gemma":[0.019169722,0.0032687844,0.17941573,0.09234177,0.0029479708,0.000020115716,0.0024324579,0.4278999,0.1251334,0.14485782,0.001202763,0.001309573],"about_ca_topic_score_codex":0.007037177,"about_ca_topic_score_gemma":0.0013467965,"teacher_disagreement_score":0.11797943,"about_ca_system_score_codex":0.000800657,"about_ca_system_score_gemma":0.002292917,"threshold_uncertainty_score":0.999575},"labels":[],"label_agreement":null},{"id":"W4393153475","doi":"10.1007/s00261-024-04195-x","title":"Diagnostic accuracy of contrast-enhanced CT versus PET/CT for advanced ovarian cancer staging: a comparative systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Meta-analysis; Ovarian cancer; Radiology; PET-CT; Diagnostic accuracy; Stage (stratigraphy); Cancer staging; Nuclear medicine; Cancer; Internal medicine; Positron emission tomography","score_opus":0.13343979887884402,"score_gpt":0.44513949401770064,"score_spread":0.31169969513885665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393153475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001718975,0.98637027,0.00017317999,0.00068557047,0.00028536574,0.0112051675,0.0011341878,0.00003017268,0.000098887744],"genre_scores_gemma":[0.0055937264,0.9752583,0.0005841279,0.00024185741,0.00007405006,0.017619636,0.00030947538,0.000064519365,0.00025434364],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99573374,0.0005795578,0.0019112615,0.0010670822,0.0002341349,0.00047425512],"domain_scores_gemma":[0.9870326,0.010171976,0.0015263732,0.0008043968,0.0002445578,0.00022007925],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0006171073,0.00090411084,0.019670088,0.00039406514,0.000067842266,0.000024990391,0.00023595725,0.00004749968,0.00037442383],"category_scores_gemma":[0.0014566345,0.0005462646,0.003766214,0.00075093604,0.0002062464,0.00006297095,0.00006526961,0.00035983042,0.000020731008],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012974019,0.00010971089,8.457733e-7,0.63524014,0.3590399,0.00044641658,0.00004754959,0.000003574376,2.8696934e-7,0.00034194117,0.0005140669,0.0041258344],"study_design_scores_gemma":[0.001984589,0.0006854512,0.000002446006,0.06038863,0.9194796,0.0007085847,0.00005322949,0.000015410918,0.000006504129,0.000019282268,0.016285956,0.00037032724],"about_ca_topic_score_codex":0.00011876352,"about_ca_topic_score_gemma":0.00008698982,"teacher_disagreement_score":0.5748515,"about_ca_system_score_codex":0.00040649006,"about_ca_system_score_gemma":0.0006147183,"threshold_uncertainty_score":0.9996989},"labels":[],"label_agreement":null},{"id":"W4393279102","doi":"10.1136/ijgc-2023-005065","title":"Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; Serous ovarian cancer; Oncology; Serous fluid; BRCA mutation; Chemotherapy; Internal medicine; Cancer","score_opus":0.013951653045734846,"score_gpt":0.28712731150373744,"score_spread":0.27317565845800257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393279102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915833,0.0008721072,0.00008932726,0.005830004,0.0010039498,0.00029789275,0.00015931364,0.000027109983,0.00013702392],"genre_scores_gemma":[0.99734473,0.00083627366,0.0006665027,0.00048413486,0.000330278,0.00007205788,0.00011087778,0.000029138384,0.00012597955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978602,0.00007400776,0.00054503453,0.0003750903,0.0008852344,0.0002604244],"domain_scores_gemma":[0.99830955,0.00033770266,0.00032566563,0.00012732469,0.00073865143,0.00016112512],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019996107,0.00024766003,0.00083514693,0.00046805892,0.000029676326,0.000067052235,0.00016726494,0.000086856504,0.0022796134],"category_scores_gemma":[0.000034980916,0.00014975478,0.0002245648,0.000728237,0.00010084711,0.00021045677,0.000024089393,0.00032392237,0.0000042279835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009080816,0.001411115,0.94574076,0.000028336119,0.008148549,0.0013275184,0.0001881548,0.005699553,0.00003418413,0.000060544342,0.0006146909,0.027665786],"study_design_scores_gemma":[0.007604304,0.0009498673,0.9881371,0.00042505687,0.0007758019,0.000019610774,0.000054918644,0.000095920885,0.00019638512,0.000045925397,0.0015102903,0.00018482252],"about_ca_topic_score_codex":0.0005396078,"about_ca_topic_score_gemma":0.00057329255,"teacher_disagreement_score":0.042396344,"about_ca_system_score_codex":0.001975671,"about_ca_system_score_gemma":0.00075247855,"threshold_uncertainty_score":0.99863243},"labels":[],"label_agreement":null},{"id":"W4394006826","doi":"10.1016/j.ygyno.2024.03.029","title":"High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Target Ovarian Cancer; Cancer Research UK; Ovarian Cancer Canada; Nicola Murray Foundation","keywords":"Medicine; Trametinib; Dasatinib; Ovarian carcinoma; Serous fluid; Serous carcinoma; Oncology; Internal medicine; Cancer research; Ovarian cancer; Kinase; Cancer; MAPK/ERK pathway; Biology; Receptor; Genetics; Tyrosine kinase","score_opus":0.026357467618951844,"score_gpt":0.3162409133208326,"score_spread":0.28988344570188074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394006826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760851,0.001411866,0.0004222518,0.012504089,0.0012840689,0.0010895462,0.000027512624,0.0002590236,0.006916493],"genre_scores_gemma":[0.9904549,0.00017283892,0.0059036002,0.0014488546,0.00031799733,0.00053589634,0.000092776274,0.0000533318,0.0010197959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973894,0.00022626032,0.00054939254,0.0008904139,0.00028257733,0.00066196476],"domain_scores_gemma":[0.99781317,0.0013749828,0.00012221048,0.00043294881,0.00006762036,0.00018909524],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004622606,0.00037077838,0.0008842151,0.00029180959,0.0001137425,0.0000819385,0.00016582714,0.00036627028,0.0013631661],"category_scores_gemma":[0.00027007324,0.00027006026,0.00013348363,0.0006139639,0.00025592753,0.00012100574,0.000082937964,0.00054766866,0.0002260073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028577019,0.009432913,0.43865085,0.002353026,0.0031877449,0.15464436,0.007395122,0.003029583,0.0014018444,0.07335194,0.013586628,0.2901083],"study_design_scores_gemma":[0.011559727,0.013233091,0.9402819,0.00088404265,0.001199796,0.0014915562,0.0017244437,0.0010231732,0.0019754535,0.0049837744,0.020904,0.0007390011],"about_ca_topic_score_codex":0.0016716782,"about_ca_topic_score_gemma":0.0018233127,"teacher_disagreement_score":0.5016311,"about_ca_system_score_codex":0.0008339061,"about_ca_system_score_gemma":0.00077485223,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W4394128204","doi":"10.6084/m9.figshare.21151959","title":"Additional file 2 of The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review","year":2022,"lang":"en","type":"review","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mesoderm; Medicine; Oncology; Internal medicine; Biology; Genetics; Embryonic stem cell","score_opus":0.14412912842631273,"score_gpt":0.36351821961778,"score_spread":0.2193890911914673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394128204","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.8371573e-9,0.49135187,1.3393335e-9,0.000014665698,0.000028523657,0.0018807284,0.50658476,0.0000049496753,0.00013447099],"genre_scores_gemma":[9.702067e-8,0.506127,0.000020452933,0.00006661232,0.00006080109,0.008700235,0.4847944,0.000021488662,0.00020893235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734044,0.00036167807,0.0014412272,0.00035985917,0.00034911465,0.00014767911],"domain_scores_gemma":[0.99419206,0.0030793021,0.0017800358,0.000755501,0.00008739952,0.00010569605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000075212214,0.00034948613,0.0037832286,0.0000509067,0.00005216356,0.000007933557,0.00015980071,0.00010445288,0.96619534],"category_scores_gemma":[0.0028048195,0.00018663207,0.0011607482,0.00020202064,0.000021838461,0.000013815877,0.00012189166,0.00015294271,0.00015576965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018683218,0.00024335967,2.8669288e-7,0.43641165,0.0004897854,0.000044040673,0.0000032551882,5.530742e-10,2.459151e-10,0.0000016138192,0.52990687,0.032897282],"study_design_scores_gemma":[0.00013879378,0.00019091833,0.00006955433,0.48525414,0.0029881175,0.00013715298,0.0000016955222,3.5616932e-7,3.1985085e-8,3.505729e-7,0.51115084,0.00006805013],"about_ca_topic_score_codex":0.0000024226863,"about_ca_topic_score_gemma":0.0000017393527,"teacher_disagreement_score":0.9660396,"about_ca_system_score_codex":0.00021601493,"about_ca_system_score_gemma":0.0009588754,"threshold_uncertainty_score":0.7610635},"labels":[],"label_agreement":null},{"id":"W4394279743","doi":"10.6084/m9.figshare.21151956","title":"Additional file 1 of The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review","year":2022,"lang":"en","type":"review","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mesoderm; Medicine; Oncology; Internal medicine; Biology; Genetics; Embryonic stem cell","score_opus":0.148816647535805,"score_gpt":0.3642122452212734,"score_spread":0.21539559768546837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394279743","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.8721627e-9,0.49119848,1.3696542e-9,0.000014748088,0.000028365439,0.0018847611,0.50673723,0.0000049525743,0.00013147626],"genre_scores_gemma":[9.8721884e-8,0.5058204,0.000020935633,0.00006665976,0.000059946113,0.008876879,0.48492515,0.000021535745,0.00020839467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734056,0.00036180246,0.0014405717,0.0003601331,0.0003492032,0.00014773433],"domain_scores_gemma":[0.9941473,0.0031244701,0.0017777821,0.00075709,0.000087610526,0.000105727704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007563147,0.000349599,0.0037822917,0.000050940565,0.000052159678,0.000007916109,0.00015989107,0.000104452265,0.96682066],"category_scores_gemma":[0.0028395227,0.00018669403,0.0011609759,0.00020218022,0.000021838767,0.000013806269,0.00012190907,0.00015297848,0.00015747537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018812364,0.00024376776,2.9662826e-7,0.43574488,0.00049043953,0.000042907293,0.0000032567773,5.511284e-10,2.552175e-10,0.0000015876165,0.531391,0.032079965],"study_design_scores_gemma":[0.0001375793,0.00019053124,0.00007057886,0.48547325,0.0029935394,0.00013659055,0.000001710096,3.579371e-7,3.2128586e-8,3.4711502e-7,0.5109274,0.00006806877],"about_ca_topic_score_codex":0.0000023981434,"about_ca_topic_score_gemma":0.0000017289609,"teacher_disagreement_score":0.9666632,"about_ca_system_score_codex":0.00021595212,"about_ca_system_score_gemma":0.00096322416,"threshold_uncertainty_score":0.7613162},"labels":[],"label_agreement":null},{"id":"W4394405408","doi":"10.6084/m9.figshare.22807553","title":"Additional file 2 of Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages","year":2023,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Oncology; Internal medicine; Ovarian tissue; Biology; Medicine; Cancer; Ovary","score_opus":0.026090915904977873,"score_gpt":0.2827099549398609,"score_spread":0.25661903903488303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394405408","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0128886085,0.00009051572,2.6322535e-8,0.000056142315,0.00012759367,0.0011945841,0.9855169,0.0000011492411,0.0001244571],"genre_scores_gemma":[0.000576675,0.00023948424,0.00010102068,0.000015401292,0.00004857724,0.0015733887,0.9956629,0.000032430144,0.0017500744],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978809,0.00006223606,0.0005377646,0.00060340617,0.000627436,0.00028826916],"domain_scores_gemma":[0.99794686,0.0007901418,0.00057245005,0.00043378482,0.00012571814,0.00013102892],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000035151457,0.0004225806,0.001186866,0.00016406014,0.00003812402,0.000033862856,0.00031691862,0.00014291814,0.5118606],"category_scores_gemma":[0.00007416042,0.0002877339,0.000092309434,0.00025639564,0.000086199914,0.00006774386,0.00017663863,0.00017338851,0.000116878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030201144,0.0037050936,0.019623,0.00012698202,0.00094048446,0.000045130764,0.00003243718,0.0000011197158,2.887503e-7,2.6780287e-7,0.9714201,0.0038030492],"study_design_scores_gemma":[0.004562481,0.0013720591,0.5585484,0.0037997335,0.00050688593,9.668413e-7,0.000022651206,5.691834e-7,0.000050481438,0.0000020188825,0.43089852,0.00023526438],"about_ca_topic_score_codex":0.0064682006,"about_ca_topic_score_gemma":0.01424622,"teacher_disagreement_score":0.5405216,"about_ca_system_score_codex":0.00025925745,"about_ca_system_score_gemma":0.0005192207,"threshold_uncertainty_score":0.9999575},"labels":[],"label_agreement":null},{"id":"W4394762553","doi":"10.1016/j.jped.2024.01.006","title":"Key clinical predictors in the diagnosis of ovarian torsion in children","year":2024,"lang":"en","type":"article","venue":"Jornal de Pediatria","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Wuhan University School of Medicine; BC Children's Hospital","keywords":"Medicine; Ovarian torsion; Logistic regression; Ultrasound; Receiver operating characteristic; Retrospective cohort study; Surgery; Radiology; Internal medicine","score_opus":0.022081879416263352,"score_gpt":0.33672187422055194,"score_spread":0.3146399948042886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394762553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906936,0.003506489,0.0000066802795,0.0041510286,0.00042692092,0.00053762493,0.000036362937,0.000021281003,0.0006199995],"genre_scores_gemma":[0.99406755,0.003806976,0.00025971633,0.00029395393,0.0014047931,0.00010700767,0.000020034593,0.000016042397,0.000023911183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849653,0.00016712942,0.00056067464,0.00026161698,0.00027565638,0.0002383842],"domain_scores_gemma":[0.9991318,0.00045960443,0.00006292239,0.0002335742,0.000021045162,0.000091078255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011980822,0.00012324845,0.00031229696,0.00018695269,0.000020239117,0.000025092757,0.00011469384,0.00013594194,0.00017855885],"category_scores_gemma":[0.00021693674,0.000078347,0.00020356421,0.0004302015,0.00003504924,0.000059572045,0.000033789293,0.00036595174,0.000025089714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011193006,0.00056023506,0.98841864,0.00004855738,0.000079208985,0.00014163458,0.00062237505,0.0000068371223,0.0000024556866,0.0005018616,0.006315842,0.0031904501],"study_design_scores_gemma":[0.0020003717,0.00042479782,0.9940088,0.00019377569,0.0002671405,0.000034628567,0.000058638707,0.00009172527,0.0000313576,0.00020670013,0.0026158914,0.00006620431],"about_ca_topic_score_codex":0.000803001,"about_ca_topic_score_gemma":0.00017957184,"teacher_disagreement_score":0.0055901557,"about_ca_system_score_codex":0.00015760973,"about_ca_system_score_gemma":0.00027956915,"threshold_uncertainty_score":0.3194898},"labels":[],"label_agreement":null},{"id":"W4394832497","doi":"10.1016/j.ijrobp.2023.11.025","title":"Moving Toward Personalized Medicine in Gynecologic Cancers","year":2024,"lang":"en","type":"editorial","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Personalized medicine; Gynecologic oncology; Medicine; Gynecologic cancer; Key (lock); Oncology; Medical physics; Internal medicine; Bioinformatics; Cancer; Computer science; Ovarian cancer; Biology","score_opus":0.02439248040924746,"score_gpt":0.360765906171911,"score_spread":0.33637342576266355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394832497","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005400317,0.013751492,0.0005287834,0.01920744,0.9573115,0.00056007213,0.00036422804,0.00006980217,0.0028063576],"genre_scores_gemma":[0.116884656,0.020988299,0.0010213049,0.0014241592,0.85802203,0.00009951423,0.00089980237,0.00011373026,0.0005465211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965337,0.00026392264,0.0014243906,0.0005498045,0.00084822194,0.00037998075],"domain_scores_gemma":[0.99484795,0.0019941179,0.0015548292,0.00021047416,0.001186103,0.00020653883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010332284,0.00047634842,0.0015171351,0.00057092396,0.00004385009,0.000040477073,0.0005233564,0.0011212927,0.0005075026],"category_scores_gemma":[0.0018083472,0.00037311114,0.000482339,0.00031760643,0.00034679414,0.0001710249,0.00010261491,0.0019400639,0.00006469905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085202703,0.00048377708,0.019346314,0.00011719225,0.0027153033,0.0011308233,0.0012917828,0.00022270903,0.00010379944,0.003028635,0.88434565,0.086362],"study_design_scores_gemma":[0.011978107,0.0027915596,0.0018881805,0.0010745175,0.0008913629,0.00010421565,0.0001809704,0.00038523503,0.00005855539,0.0067259693,0.97361624,0.00030507083],"about_ca_topic_score_codex":0.00036540919,"about_ca_topic_score_gemma":0.0000637779,"teacher_disagreement_score":0.11148434,"about_ca_system_score_codex":0.009345724,"about_ca_system_score_gemma":0.0048614363,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W4394837504","doi":"10.3390/surgeries5020023","title":"Opportunistic Salpingectomy at the Time of General Surgery Procedures: A Systematic Review and Narrative Synthesis of Current Knowledge","year":2024,"lang":"en","type":"review","venue":"Surgeries","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; General surgery; Perioperative; Surgery; Laparoscopy; Salpingectomy; Specialty; Family medicine; Pregnancy","score_opus":0.06745952501223319,"score_gpt":0.36418757593604284,"score_spread":0.29672805092380966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394837504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012472909,0.99614197,2.0127905e-7,0.0002126124,0.00023430008,0.0027921852,0.00037281052,0.000024318111,0.00020909969],"genre_scores_gemma":[0.0000880066,0.99601936,0.0000043388777,0.000021823018,0.00007466864,0.0022963788,0.000118887336,0.00006028123,0.0013162409],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99733293,0.00038523655,0.0014282363,0.00039703754,0.00025020164,0.00020635192],"domain_scores_gemma":[0.99588954,0.002373085,0.000914167,0.00054281566,0.0001750029,0.000105380874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000822938,0.00048307888,0.0060611665,0.0001936457,0.00006894378,0.000016370093,0.00008799861,0.00009943668,0.00020667522],"category_scores_gemma":[0.0013914185,0.00023786828,0.0009537701,0.00042352563,0.00028433796,0.000027950793,0.00011367965,0.00015130299,0.00004126045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058287987,0.00010976297,0.000010597021,0.9503465,0.0018033368,0.000023488865,0.00030960765,1.7354723e-9,9.615239e-8,0.00010344858,0.021094855,0.026192471],"study_design_scores_gemma":[0.000030081466,0.000035477435,0.0000025145187,0.7980431,0.035204742,0.00013464391,0.000034725617,2.6951633e-7,0.0000059210743,0.000006626588,0.16633917,0.0001627344],"about_ca_topic_score_codex":0.0000074959094,"about_ca_topic_score_gemma":0.000008925353,"teacher_disagreement_score":0.15230341,"about_ca_system_score_codex":0.00018559366,"about_ca_system_score_gemma":0.0017871597,"threshold_uncertainty_score":0.9699987},"labels":[],"label_agreement":null},{"id":"W4394873733","doi":"10.1002/jcu.23693","title":"Opting for conservative management over surgery for neonatal ovarian cysts","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Ultrasound","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; St Joseph's Health Care; University of Manitoba; Manitoba Health","funders":"","keywords":"Medicine; Cyst; Ovarian torsion; Retrospective cohort study; Cystectomy; Ovarian cyst; Pathological; Receiver operating characteristic; Cohort; Mann–Whitney U test; Surgery; Conservative management; Obstetrics; Radiology; Pathology; Internal medicine","score_opus":0.09511334170074215,"score_gpt":0.4367688180940585,"score_spread":0.34165547639331634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394873733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88263357,0.007998645,0.06373507,0.02657253,0.0127413105,0.0031992388,0.00040115952,0.00009010466,0.0026283618],"genre_scores_gemma":[0.95949197,0.0012272586,0.03352464,0.0016876683,0.0030186956,0.000070166454,0.00002980347,0.00004575128,0.00090405205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978398,0.000048013382,0.0013557817,0.00024620985,0.00027646386,0.0002337507],"domain_scores_gemma":[0.9858967,0.0131226815,0.00038388502,0.00014749265,0.00023751802,0.00021172628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022161254,0.0001516175,0.0007336999,0.000118008626,0.00005799247,0.00008413797,0.00007152514,0.000108102,0.00011205971],"category_scores_gemma":[0.001545974,0.00010785085,0.0010237333,0.00012669277,0.00006467105,0.00014256018,0.00001339296,0.00023334118,0.0000061915293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008763218,0.002188529,0.23306067,0.0031037705,0.014407015,0.0025681627,0.0005074118,0.000038411745,0.000088524415,0.023248686,0.30488777,0.4071378],"study_design_scores_gemma":[0.009252288,0.0022615634,0.29050517,0.002816416,0.0025114485,0.00068341295,0.0002687963,0.00030166158,0.00023960441,0.0051507032,0.68574136,0.0002675824],"about_ca_topic_score_codex":0.000004150711,"about_ca_topic_score_gemma":0.0000031018853,"teacher_disagreement_score":0.40687022,"about_ca_system_score_codex":0.00010504245,"about_ca_system_score_gemma":0.00032782517,"threshold_uncertainty_score":0.439803},"labels":[],"label_agreement":null},{"id":"W4394956806","doi":"10.1097/pas.0000000000002229","title":"Genomic Catastrophe (Chromothripsis and Polyploidy) Correlates With Tumor Distribution in Extrauterine High-grade Serous Carcinoma","year":2024,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ovarian Cancer Research Alliance; Brigham and Women's Hospital; U.S. Department of Defense","keywords":"Serous fluid; Fallopian tube; Serous carcinoma; Pathology; Ovarian cancer; Ovary; Biology; Cancer; Medicine; Internal medicine; Gynecology","score_opus":0.008563897616600554,"score_gpt":0.24309067317892555,"score_spread":0.23452677556232499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394956806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878574,0.004046088,0.0000995371,0.0076916744,0.000121325626,0.00011367612,0.000045951776,0.0000113807555,0.000012973694],"genre_scores_gemma":[0.9981918,0.0011557083,0.0003129697,0.000122010904,0.00016559046,0.000008438808,0.000012924973,0.000018039822,0.000012530484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990146,0.00012699253,0.0003195392,0.0001853228,0.00013002081,0.0002235378],"domain_scores_gemma":[0.9993558,0.00017537078,0.00016851377,0.00014416865,0.000032921438,0.0001232321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022705039,0.00014665778,0.0005140263,0.00008907241,0.000034967437,0.000020974321,0.00007119098,0.00002254528,0.000037096932],"category_scores_gemma":[0.000006824258,0.00007771548,0.00007219322,0.00025749454,0.00047169894,0.00004441316,0.00003108686,0.0003320498,0.0000053980943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005498806,0.0010522703,0.6976642,0.00011938868,0.0006299549,0.17625897,0.0011970825,0.00017863355,0.0058042738,0.0016908322,0.0005027841,0.109402806],"study_design_scores_gemma":[0.0028295354,0.005884825,0.9175846,0.0002116814,0.00033743182,0.07028934,0.000273746,0.0001052114,0.0003368026,0.0001206653,0.001904843,0.00012134511],"about_ca_topic_score_codex":0.00019754782,"about_ca_topic_score_gemma":0.000013135931,"teacher_disagreement_score":0.21992037,"about_ca_system_score_codex":0.00015903753,"about_ca_system_score_gemma":0.00010162417,"threshold_uncertainty_score":0.31691453},"labels":[],"label_agreement":null},{"id":"W4395091858","doi":"10.21037/gpm-23-35","title":"Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecology and Pelvic Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Atezolizumab; Ovarian cancer; Progression-free survival; Oncology; Medicine; Internal medicine; Overall survival; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.011080315923842314,"score_gpt":0.287583435271332,"score_spread":0.2765031193474897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395091858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600725,0.002508302,0.000016649508,0.030243834,0.0030969405,0.0013142074,0.0001779137,0.000075468706,0.002494146],"genre_scores_gemma":[0.99709284,0.000697635,0.00014078537,0.0007948809,0.00043107627,0.00022883697,0.0001041298,0.000027689617,0.0004821433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983071,0.00008350784,0.0003463661,0.00057438784,0.00032160844,0.00036701452],"domain_scores_gemma":[0.99869084,0.00063239527,0.000081141894,0.00029249498,0.00011159912,0.00019152778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028327122,0.00026993972,0.0005884947,0.0001800493,0.00007542946,0.000012226178,0.00006272126,0.00016792191,0.0008256941],"category_scores_gemma":[0.00021525087,0.00014046671,0.000035072575,0.00021438421,0.00026704973,0.00006522899,0.00006118778,0.00036518925,0.000011342426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031169066,0.000617964,0.6344123,0.0005633031,0.00061844423,0.0009635611,0.002535348,0.0000014709872,0.00007342958,0.002020046,0.0019968129,0.35308042],"study_design_scores_gemma":[0.014600112,0.0040264665,0.97457254,0.0016525309,0.00042155918,0.00001628538,0.00019077734,0.00015770721,0.00021179345,0.00031276484,0.0036353904,0.00020207344],"about_ca_topic_score_codex":0.0004150723,"about_ca_topic_score_gemma":0.0015237229,"teacher_disagreement_score":0.35287833,"about_ca_system_score_codex":0.00022632402,"about_ca_system_score_gemma":0.00024466243,"threshold_uncertainty_score":0.9040772},"labels":[],"label_agreement":null},{"id":"W4395697695","doi":"10.1016/j.ajog.2024.03.039","title":"Corrigendum to Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences","year":2024,"lang":"en","type":"erratum","venue":"American Journal of Obstetrics and Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Regret; Medicine; Clinical trial; Perception; Gynecologic oncology; Obstetrics and gynaecology; Family medicine; Gynecology; General surgery; Oncology; Internal medicine; Pregnancy","score_opus":0.03639495514452695,"score_gpt":0.32189176725172247,"score_spread":0.2854968121071955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395697695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758698,0.0077050785,0.0000011067808,0.0018048162,0.012967964,0.0007349206,0.0000916618,0.000008909758,0.0008157404],"genre_scores_gemma":[0.9849634,0.010026693,0.00059305143,0.0005661477,0.00012151692,0.00007758435,0.00006547731,0.00004794133,0.0035381587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739766,0.00018118485,0.0007830672,0.00050994806,0.00063400407,0.0004941613],"domain_scores_gemma":[0.9963601,0.0016279169,0.0005875935,0.0002516186,0.00078844663,0.00038430546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037198953,0.00033267133,0.001297724,0.0017573967,0.000095337266,0.0000731614,0.00012557724,0.00022984573,0.00012501332],"category_scores_gemma":[0.0027791176,0.00021317799,0.00008685692,0.0013859104,0.00046208323,0.000064969114,0.00013449654,0.0013555184,0.00000585809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011851194,0.0003804299,0.7781343,0.000085271786,0.0005224314,0.0007030095,0.0006912227,0.000001913532,2.3807242e-7,0.000010678192,0.08100413,0.13834791],"study_design_scores_gemma":[0.0016305656,0.018708976,0.86197215,0.00038571775,0.0003590027,0.000049139686,0.0019194612,0.000003216346,3.807208e-7,0.00004931228,0.114726216,0.00019584715],"about_ca_topic_score_codex":0.0005188962,"about_ca_topic_score_gemma":0.00051026035,"teacher_disagreement_score":0.13815206,"about_ca_system_score_codex":0.0012075369,"about_ca_system_score_gemma":0.0013803542,"threshold_uncertainty_score":0.8693146},"labels":[],"label_agreement":null},{"id":"W4396684772","doi":"10.1016/j.vhri.2024.100999","title":"Microcosting Analysis of Advanced Ovarian Cancer: Real-World Evidence From the Perspective of a Reference Public Brazilian Hospital","year":2024,"lang":"en","type":"article","venue":"Value in Health Regional Issues","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Perspective (graphical); Ovarian cancer; Medicine; Public hospital; Intensive care medicine; Gynecology; Cancer; Computer science; Internal medicine; Nursing","score_opus":0.09674254361439394,"score_gpt":0.4177799158538517,"score_spread":0.3210373722394578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396684772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63606995,0.14294858,0.000017256145,0.21928234,0.00023028691,0.0008657361,0.00021637914,0.000045512123,0.0003239287],"genre_scores_gemma":[0.9636499,0.033841543,0.0016734439,0.00036116585,0.0001647945,0.0001218881,0.00004131746,0.000017691938,0.00012820432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979439,0.00017575863,0.0006346419,0.0005287973,0.00043487005,0.00028206015],"domain_scores_gemma":[0.9975279,0.0013751336,0.00027771707,0.00041342786,0.00028020592,0.00012564003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004782709,0.00017566692,0.00068007805,0.0004246633,0.00006433632,0.000025428148,0.00017778148,0.000054019223,0.00012839024],"category_scores_gemma":[0.0002222432,0.00012435096,0.0001900299,0.0022612156,0.00014725167,0.00015140549,0.000044236687,0.00023689044,0.0000030078486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040716497,0.0007218617,0.86609715,0.00095129636,0.0036665648,0.00008039934,0.02706491,0.0013635627,0.00044073092,0.0625569,0.0027483606,0.03390109],"study_design_scores_gemma":[0.000574133,0.00044594562,0.9765193,0.008275359,0.00061413844,0.0000015059532,0.0026566633,0.001783326,0.00032872052,0.0014021451,0.0072606085,0.00013818785],"about_ca_topic_score_codex":0.31820476,"about_ca_topic_score_gemma":0.02056061,"teacher_disagreement_score":0.32757998,"about_ca_system_score_codex":0.0009415515,"about_ca_system_score_gemma":0.0011141129,"threshold_uncertainty_score":0.9973116},"labels":[],"label_agreement":null},{"id":"W4396708268","doi":"10.1007/s00404-024-07537-8","title":"Association between BMI and oncologic outcomes in epithelial ovarian cancer: a predictors-matched case-control study","year":2024,"lang":"en","type":"article","venue":"Archives of Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Hebrew University of Jerusalem; Israel Cancer Research Fund","keywords":"Medicine; Epithelial ovarian cancer; Ovarian cancer; Oncology; Case-control study; Internal medicine; Body mass index; Gynecology; Cancer; Association (psychology)","score_opus":0.01607467696466726,"score_gpt":0.29193767489314787,"score_spread":0.2758629979284806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396708268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176097,0.0037180893,0.000023818415,0.0027544107,0.0004381868,0.00083642086,0.00022784394,0.000030256113,0.00021001304],"genre_scores_gemma":[0.99810904,0.0012272133,0.00018441155,0.00009950132,0.00006395199,0.00011596375,0.0000057933657,0.000011426602,0.0001827199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886984,0.00016255541,0.00033496047,0.0003061225,0.00011126391,0.00021523451],"domain_scores_gemma":[0.9885632,0.011119988,0.000097269425,0.00011271701,0.000019231744,0.00008761691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026335006,0.00014448659,0.0005897676,0.00031974816,0.000056026034,0.000015983615,0.00003823213,0.00012679987,0.000030214907],"category_scores_gemma":[0.0010705129,0.000110563604,0.00005999043,0.00022194709,0.00006992979,0.00004846903,0.00004436413,0.00022153022,0.0000013171295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049163147,0.00043979107,0.9248107,0.00009171493,0.001087504,0.0011681294,0.0020890813,0.000003912196,0.000013799343,0.00009696851,0.000018422756,0.07013079],"study_design_scores_gemma":[0.0061400565,0.0015947277,0.98953503,0.00004814661,0.0010995598,0.000026430173,0.00041114909,0.00020658097,0.000025866148,0.00045781804,0.00036890002,0.00008572238],"about_ca_topic_score_codex":0.00033480505,"about_ca_topic_score_gemma":0.0006170279,"teacher_disagreement_score":0.07004507,"about_ca_system_score_codex":0.00015318254,"about_ca_system_score_gemma":0.00013066294,"threshold_uncertainty_score":0.45086527},"labels":[],"label_agreement":null},{"id":"W4396721881","doi":"10.1016/j.ajhg.2024.04.011","title":"Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions","year":2024,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; Public Health Ontario; Princess Margaret Cancer Centre; University of Calgary; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency; Alberta Health Services; Women's College Hospital; Université de Sherbrooke; University of Toronto; University Health Network","funders":"National Cancer Institute; Medical Research Council; University of Texas Health Science Center at San Antonio; National Institutes of Health; Cedars-Sinai Medical Center","keywords":"Ovarian cancer; Genome-wide association study; Single-nucleotide polymorphism; Biology; Epithelial ovarian cancer; Oncology; Cancer; Bioinformatics; Genetics; Internal medicine; Computational biology; Medicine; Genotype; Gene","score_opus":0.11091903454544445,"score_gpt":0.4158223744032229,"score_spread":0.30490333985777845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396721881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90676004,0.009081984,0.075718336,0.0077368165,0.00034892466,0.00028042955,0.000026950902,0.00001359576,0.00003292884],"genre_scores_gemma":[0.987352,0.004399437,0.0069240406,0.0008514998,0.0002578433,0.000022014594,0.0000015045246,0.000029188068,0.00016248167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99885684,0.00014882053,0.0003475954,0.00018710362,0.00028513177,0.00017451505],"domain_scores_gemma":[0.99895746,0.00019906639,0.0002826408,0.00025534086,0.00015970778,0.00014579526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027712598,0.00017100095,0.00032457875,0.00015446606,0.00029133234,0.0001258171,0.00013812105,0.000020442341,0.000052728406],"category_scores_gemma":[0.0000272559,0.000084293206,0.00016856781,0.00034826648,0.00026420417,0.000028665954,0.000053938325,0.0003374469,0.000005456222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015208581,0.0013318603,0.059864372,0.00018851,0.02556186,0.0011480099,0.04902751,0.028641144,0.18300995,0.019543236,0.020358777,0.6098039],"study_design_scores_gemma":[0.0010958423,0.0026328517,0.96988356,0.00043717257,0.0040628365,0.00065042096,0.008393652,0.0025965543,0.002273646,0.0065019424,0.0012428388,0.00022870598],"about_ca_topic_score_codex":0.000288053,"about_ca_topic_score_gemma":0.000169984,"teacher_disagreement_score":0.91001916,"about_ca_system_score_codex":0.00016771899,"about_ca_system_score_gemma":0.0001973174,"threshold_uncertainty_score":0.34373772},"labels":[],"label_agreement":null},{"id":"W4396842244","doi":"10.1016/j.ygyno.2024.04.009","title":"Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Cohort; Serous carcinoma; Ovarian cancer; Retrospective cohort study; Progression-free survival; Confidence interval; Cancer; Overall survival; Serous fluid; Stage (stratigraphy); Oncology","score_opus":0.009540329117824433,"score_gpt":0.2532768980417366,"score_spread":0.24373656892391216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396842244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652697,0.00050861057,0.000009423785,0.00949906,0.0004025554,0.0017020836,0.000031287986,0.000034632172,0.001285353],"genre_scores_gemma":[0.9988152,0.000095809126,0.00013151251,0.00063525606,0.000037931073,0.00018546754,0.000031104137,0.000016638562,0.00005109784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830693,0.0005062117,0.00035854,0.0003802805,0.00018134256,0.00026671408],"domain_scores_gemma":[0.9955811,0.0037746013,0.00018686018,0.0002581312,0.00013584398,0.00006345513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259929,0.00020050937,0.0005069422,0.000096707576,0.000108752974,0.000018061592,0.000072138195,0.00015792775,0.00005905673],"category_scores_gemma":[0.001019485,0.00009847987,0.000062363346,0.00032827677,0.0006363451,0.00006814334,0.000076601,0.00032306754,0.000004271287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012856223,0.00066354603,0.9219494,0.00011621203,0.00024861062,0.00040559957,0.0022158239,0.0000721704,0.0002039583,0.003385709,0.00017248686,0.05771028],"study_design_scores_gemma":[0.011462503,0.0040388945,0.9814932,0.0001867883,0.00030186857,0.000046375637,0.0004673261,0.00070977455,0.0004657544,0.0002556577,0.0004727538,0.00009915365],"about_ca_topic_score_codex":0.00010602113,"about_ca_topic_score_gemma":0.00019038311,"teacher_disagreement_score":0.059543766,"about_ca_system_score_codex":0.00049531605,"about_ca_system_score_gemma":0.0005781259,"threshold_uncertainty_score":0.40158924},"labels":[],"label_agreement":null},{"id":"W4399118757","doi":"10.1371/journal.pone.0298154","title":"The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer","year":2024,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"World Health Organization","keywords":"Observational study; Medicine; Quality of life (healthcare); Family medicine; Developing country; Disease; Gerontology; Demography; Economic growth; Nursing; Pathology","score_opus":0.3827002357821476,"score_gpt":0.375039095182294,"score_spread":0.007661140599853622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399118757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570206,0.00063546386,0.00001264491,0.005368289,0.000046181445,0.03666626,0.00020762692,0.00003099086,0.00001196336],"genre_scores_gemma":[0.89000255,0.00027285964,0.00037805058,0.00014958877,0.00019867174,0.10885134,0.000004913907,0.000024530495,0.00011747327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986283,0.000080107806,0.00031124806,0.00035241453,0.00043271476,0.00019519926],"domain_scores_gemma":[0.9988139,0.00049145933,0.000083527775,0.00017901606,0.00025036413,0.00018171602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086892984,0.00016828663,0.00041575308,0.00007070019,0.00016215212,0.00012357722,0.000042901003,0.000029663624,0.000007444408],"category_scores_gemma":[0.0001182119,0.00011106165,0.000010960142,0.00008792365,0.00006389262,0.00014681323,0.00006620375,0.00006882421,1.6006359e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060641747,0.007825733,0.9375787,0.017423231,0.003770833,0.000025578445,0.0236986,0.000002283368,0.00014258992,0.0015248732,0.000019944917,0.0019234947],"study_design_scores_gemma":[0.0041083097,0.0039586406,0.96557015,0.0016500206,0.0002473735,6.801335e-7,0.023984866,0.000058295387,0.000063864216,0.00001884058,0.00019882592,0.00014014858],"about_ca_topic_score_codex":0.0005298128,"about_ca_topic_score_gemma":0.0036493754,"teacher_disagreement_score":0.072185084,"about_ca_system_score_codex":0.00014037428,"about_ca_system_score_gemma":0.00032869013,"threshold_uncertainty_score":0.45289627},"labels":[],"label_agreement":null},{"id":"W4399121831","doi":"10.1200/jco.2024.42.16_suppl.505","title":"Correlation of serum anti-Müllerian hormone (AMH) levels on identification of premenopausal patients (pts) with hormone receptor positive (HR+), HER2-negative, node-positive breast cancer most likely to benefit from adjuvant chemotherapy in SWOG S1007 (RxPONDER).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Hope Foundation; Breast Cancer Research Foundation; Exact Sciences Corporation","keywords":"Anti-Müllerian hormone; Medicine; Breast cancer; Ovarian reserve; Hormone receptor; Hormone; Internal medicine; Adjuvant; Correlation; Cancer; Gynecology; Receptor; Oncology; Endocrinology; Infertility; Biology","score_opus":0.03407251763736503,"score_gpt":0.37179306735341394,"score_spread":0.3377205497160489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399121831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641217,0.00068485155,0.00032305997,0.009360149,0.0007631752,0.000851986,0.0014196583,0.000009229582,0.00017571232],"genre_scores_gemma":[0.99584657,0.0016204424,0.0011222003,0.0008154323,0.00038511556,0.00002681024,0.00005214154,0.000044201177,0.000087112705],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959855,0.00026872847,0.0024294467,0.00043823855,0.0006327146,0.00024534186],"domain_scores_gemma":[0.9954519,0.0012395548,0.0017774969,0.00022315174,0.0010414633,0.00026638428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007685681,0.00026919987,0.0015396839,0.00029271116,0.000033693905,0.000017229542,0.00014125001,0.00033390944,0.00019799413],"category_scores_gemma":[0.0002312409,0.00019622318,0.00019855218,0.0004898364,0.00015214318,0.00023069652,0.000033266322,0.00060648145,0.00001538134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050785057,0.0150511805,0.3938722,0.00009887376,0.0043003582,0.0002197808,0.0033721647,0.0016459505,0.018139124,0.00016295446,0.0033791317,0.50897324],"study_design_scores_gemma":[0.012885886,0.02233956,0.9567964,0.0015059463,0.00053198513,0.000013879053,0.00015569328,0.00024431077,0.005042906,0.00008683676,0.00023463911,0.00016194039],"about_ca_topic_score_codex":0.0007510755,"about_ca_topic_score_gemma":0.00026574542,"teacher_disagreement_score":0.5629242,"about_ca_system_score_codex":0.00083743624,"about_ca_system_score_gemma":0.0009744318,"threshold_uncertainty_score":0.8001749},"labels":[],"label_agreement":null},{"id":"W4399166567","doi":"10.1136/ijgc-00009577-200609000-00006","title":"Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Intraperitoneal chemotherapy; Epithelial ovarian cancer; Catheter; Cancer; Oncology; Intensive care medicine; Internal medicine; Surgery","score_opus":0.014201608342584682,"score_gpt":0.3331052177308427,"score_spread":0.318903609388258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399166567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8244774,0.0040787263,0.00046073398,0.16114548,0.0044173994,0.00084977667,0.0005734638,0.000026468919,0.003970598],"genre_scores_gemma":[0.9889052,0.0013013126,0.0025105905,0.003911632,0.0028478052,0.00019011048,0.000012045678,0.000021233314,0.00030005784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99868727,0.000020852682,0.0004182414,0.0002213236,0.00036611967,0.00028621772],"domain_scores_gemma":[0.9979914,0.0001457106,0.00027081362,0.000080362675,0.0012806862,0.00023105119],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014000312,0.0001683006,0.0003755172,0.00018116669,0.00006940044,0.000043728232,0.00020351009,0.00011748214,0.0022457303],"category_scores_gemma":[0.00010053854,0.0001243591,0.00028351115,0.00009888007,0.000074662705,0.000108532964,0.000012073791,0.00019717599,0.0000037528885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014678345,0.004108523,0.29278743,0.00005933604,0.006484381,0.0024914534,0.001178425,0.0035153273,0.015387046,0.053587724,0.04579594,0.55992603],"study_design_scores_gemma":[0.022155777,0.0023742602,0.66266423,0.00025861055,0.00038300062,0.0002879394,0.000331446,0.00021006711,0.009666924,0.008909079,0.29236472,0.0003939334],"about_ca_topic_score_codex":0.044059835,"about_ca_topic_score_gemma":0.050112307,"teacher_disagreement_score":0.5595321,"about_ca_system_score_codex":0.0031515951,"about_ca_system_score_gemma":0.0013587371,"threshold_uncertainty_score":0.99866635},"labels":[],"label_agreement":null},{"id":"W4399167420","doi":"10.1136/ijgc-00009577-200511001-00013","title":"Trial design for testing new therapies in ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.1429027847521492,"score_gpt":0.40107506838636586,"score_spread":0.2581722836342166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399167420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912441,0.011126011,0.011940299,0.17622185,0.0058635767,0.002183391,0.000048594302,0.000033153174,0.0013390154],"genre_scores_gemma":[0.9630576,0.0009867277,0.028285043,0.002755726,0.0042935316,0.0001843751,0.0000016441367,0.0000141512755,0.00042122064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987818,0.000038343136,0.00050727883,0.00015287621,0.00033781712,0.00018190262],"domain_scores_gemma":[0.99832606,0.00075434806,0.00030467476,0.000057992962,0.00043381003,0.00012308174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003421051,0.00012228452,0.00032880544,0.00013254308,0.000025335245,0.000035299505,0.00017013303,0.00008543142,0.0017064103],"category_scores_gemma":[0.00056216185,0.00008254789,0.00015422238,0.00010277585,0.000027780054,0.00012390988,0.000018480832,0.00017477733,0.0000033685722],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05773429,0.0016750594,0.10982251,0.000013138976,0.0012289281,0.0002531189,0.0004015304,0.008284495,0.0011891257,0.0007092385,0.01512961,0.80355895],"study_design_scores_gemma":[0.25770617,0.00924149,0.54581076,0.00082513766,0.00048393867,0.00017403274,0.00010048872,0.0015489944,0.004938511,0.004699815,0.17403144,0.00043923617],"about_ca_topic_score_codex":0.00019258195,"about_ca_topic_score_gemma":0.0002139432,"teacher_disagreement_score":0.8031197,"about_ca_system_score_codex":0.0009393092,"about_ca_system_score_gemma":0.00081524247,"threshold_uncertainty_score":0.9992062},"labels":[],"label_agreement":null},{"id":"W4399167576","doi":"10.1136/ijgc-00009577-200601000-00018","title":"Primary malignant mesodermal ovarian sarcomas","year":2006,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Stage (stratigraphy); Adjuvant chemotherapy; Disease; Surgery; Adjuvant; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.01619722178816822,"score_gpt":0.29752697941472117,"score_spread":0.28132975762655293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399167576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92215294,0.005311691,0.0005599008,0.04241262,0.0031027836,0.00027102797,0.00005288464,0.00003258233,0.026103599],"genre_scores_gemma":[0.9920082,0.00053284207,0.0020461492,0.0030178695,0.0015841444,0.000020225536,0.000013136738,0.000011813073,0.00076558394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985039,0.000034150275,0.000504426,0.00015628102,0.00061603193,0.00018516507],"domain_scores_gemma":[0.9988587,0.00013635526,0.0003038835,0.000088651774,0.0004977969,0.000114628776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018038998,0.0001317661,0.00032855073,0.00011747353,0.000033073055,0.000037667112,0.00019186022,0.00008784434,0.0030690124],"category_scores_gemma":[0.000053919623,0.000086440654,0.00024294121,0.00007442542,0.00006117057,0.000110599234,0.00004776379,0.00019941057,0.000020010753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017259457,0.0031754947,0.81062984,0.000032735185,0.001460933,0.0082273055,0.00005954437,0.0005012925,0.0049311253,0.010134121,0.045239884,0.113881774],"study_design_scores_gemma":[0.003463373,0.00049136375,0.9049864,0.000100982936,0.00015057718,0.00063683203,0.000009458923,0.000024852206,0.0018316454,0.0013384233,0.08686634,0.00009976],"about_ca_topic_score_codex":0.00012553895,"about_ca_topic_score_gemma":0.000036035,"teacher_disagreement_score":0.11378202,"about_ca_system_score_codex":0.00075137324,"about_ca_system_score_gemma":0.00031141998,"threshold_uncertainty_score":0.9978423},"labels":[],"label_agreement":null},{"id":"W4399185074","doi":"10.1016/j.jacr.2024.02.017","title":"ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms: 2023 Update","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Appropriateness criteria; Medicine; Intensive care medicine; Radiology","score_opus":0.010928164449378795,"score_gpt":0.3085137446979069,"score_spread":0.2975855802485281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399185074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960212,0.002424063,0.0002911836,0.030841542,0.004404945,0.00043295053,0.00038266237,0.000032890228,0.0009777999],"genre_scores_gemma":[0.9902228,0.002893135,0.0034837853,0.0012030291,0.0012484585,0.000013622711,0.000006194833,0.00004124657,0.0008877358],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978026,0.00030683746,0.0010033927,0.00026862638,0.00031012463,0.00030840075],"domain_scores_gemma":[0.9978114,0.00038781422,0.00082557334,0.00043536304,0.0003640599,0.00017581604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005822484,0.00022059052,0.00120066,0.00019472146,0.00005400878,0.00001565535,0.00038582453,0.000091163194,0.0003250445],"category_scores_gemma":[0.00021169303,0.00012750186,0.0005658471,0.0006358901,0.00056164735,0.00007397154,0.00008145874,0.00044445766,0.000038664522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020907443,0.0022820048,0.08318781,0.0005888356,0.02919426,0.020117322,0.00043552043,0.00014395273,0.06010123,0.0055763163,0.75632435,0.021140981],"study_design_scores_gemma":[0.028671667,0.05772114,0.40039873,0.0046285563,0.018776389,0.08551699,0.0014855606,0.00402624,0.010910463,0.007188575,0.37883627,0.0018394125],"about_ca_topic_score_codex":0.00002247296,"about_ca_topic_score_gemma":0.0000032926266,"teacher_disagreement_score":0.37748805,"about_ca_system_score_codex":0.0002466233,"about_ca_system_score_gemma":0.0007853653,"threshold_uncertainty_score":0.51993746},"labels":[],"label_agreement":null},{"id":"W4399259161","doi":"10.1038/s41591-024-02981-0","title":"Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial","year":2024,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Science and Technology Commission of Shanghai Municipality; National Natural Science Foundation of China","keywords":"Medicine; Ovarian cancer; Randomized controlled trial; Surgery; Oncology; Overall survival; Internal medicine; Cancer","score_opus":0.03782813935188936,"score_gpt":0.3488597428658531,"score_spread":0.31103160351396375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399259161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94060725,0.012497525,0.000030020497,0.025192369,0.016655255,0.001885935,0.00023361355,0.000077196884,0.0028208238],"genre_scores_gemma":[0.9945138,0.0018665475,0.000028387418,0.0006422284,0.0019098449,0.00016127845,0.00030646884,0.00003571416,0.00053574203],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996454,0.00053252414,0.0010871182,0.0005760993,0.0009757819,0.00037445623],"domain_scores_gemma":[0.98780435,0.010971763,0.00031836747,0.0005049776,0.00025315688,0.00014737122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002711959,0.00036033874,0.0028484503,0.00093496806,0.000058709855,0.000016040389,0.00009732856,0.00040623234,0.0010148671],"category_scores_gemma":[0.0034009279,0.00020330529,0.0012433745,0.0023764938,0.0003163024,0.000068823814,0.00003574633,0.0010170516,0.000005705377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9384076,0.00082842016,0.004745297,0.00025655754,0.012695599,0.0009545457,0.0008692606,0.00003942681,0.00023516717,0.0012568042,0.032206997,0.007504339],"study_design_scores_gemma":[0.95018774,0.0005117815,0.018513821,0.002783736,0.018379638,0.00001088538,0.00010779381,0.0023905134,0.0008371577,0.00008006769,0.005886608,0.00031024404],"about_ca_topic_score_codex":0.0019709475,"about_ca_topic_score_gemma":0.00066291325,"teacher_disagreement_score":0.053906526,"about_ca_system_score_codex":0.0004405655,"about_ca_system_score_gemma":0.0009509145,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W4399328295","doi":"10.1136/bcr-2023-259391","title":"Metastatic malignant struma ovarii to the pituitary presenting as a sellar mass and responding to total thyroidectomy with adjuvant radioactive iodine therapy","year":2024,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Struma ovarii; Thyroid; Metastasis; Pathology; Radiology; Internal medicine; Cancer","score_opus":0.023401882004712708,"score_gpt":0.32305417816083015,"score_spread":0.29965229615611744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399328295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98110646,0.004589024,0.00042111406,0.009564068,0.00025393412,0.0031191225,0.000020816578,0.00008563482,0.0008398201],"genre_scores_gemma":[0.9937502,0.00012348621,0.0034713007,0.000591873,0.00024923607,0.00058578706,0.000012959922,0.00005811456,0.0011570549],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979128,0.00009497121,0.0004404023,0.0007078362,0.0004690077,0.00037497358],"domain_scores_gemma":[0.9986477,0.00024230513,0.000112155794,0.0005836095,0.00008535616,0.00032890553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075159763,0.00028777836,0.00044400105,0.00032714926,0.00017534668,0.00015820184,0.000028988807,0.000037653666,0.00011270824],"category_scores_gemma":[0.00010844746,0.00015989791,0.00010076696,0.0007043372,0.00003482669,0.000106201514,0.00006135315,0.00016311624,0.000018359751],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000803345,0.00012969889,0.0028766466,0.00011393175,0.0014046355,0.9715794,0.0034849863,0.0001444368,0.0018752009,0.00019234764,0.0021819896,0.01521339],"study_design_scores_gemma":[0.0015697585,0.0021333396,0.0064663314,0.0011296886,0.00095247035,0.9512622,0.0021012349,0.00042029648,0.013407939,0.00020385282,0.01994693,0.0004059963],"about_ca_topic_score_codex":0.00044136934,"about_ca_topic_score_gemma":0.000036001253,"teacher_disagreement_score":0.02031723,"about_ca_system_score_codex":0.00018720192,"about_ca_system_score_gemma":0.00033108017,"threshold_uncertainty_score":0.6520448},"labels":[],"label_agreement":null},{"id":"W4399367382","doi":"10.1158/1078-0432.ccr-23-3552","title":"Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma","year":2024,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Vancouver General Hospital; Alberta Health Services; University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Foothills Medical Centre; University of Alberta; University of Calgary","funders":"HORIZON EUROPE European Research Council; Medical Research Council; National Center for Advancing Translational Sciences; National Cancer Institute; U.S. Army Medical Research and Development Command; Cancer Institute NSW; Canadian Institutes of Health Research; Janet D. Cottrelle Foundation; Krebsliga Schweiz; Medical Research and Materiel Command; Eisai; Ovarian Cancer Action; AstraZeneca; National Health and Medical Research Council; Cancer Research UK; Swedish Cancer Foundation; Bundesministerium für Bildung und Forschung; Michael Smith Health Research BC; Genentech; Victorian Cancer Agency; Clovis Oncology; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; U.S. Department of Defense","keywords":"Ovarian carcinoma; Ovarian cancer; Biology; Cancer research; Germline; CD8; Transcriptome; Serous carcinoma; Cancer; Immunology; Immune system; Gene expression; Genetics; Gene","score_opus":0.14307757489155112,"score_gpt":0.46852175686945,"score_spread":0.3254441819778989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399367382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946066,0.042440422,0.00001638458,0.009165177,0.00093414047,0.0010808696,0.000096635675,0.000067073444,0.00013328927],"genre_scores_gemma":[0.9833327,0.015316777,0.000026647675,0.00015380837,0.00038025947,0.00042608505,0.000018923784,0.000042798434,0.00030202258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99553376,0.0010273004,0.0007444075,0.0011651752,0.000718437,0.00081091735],"domain_scores_gemma":[0.9959916,0.0028274513,0.000056644494,0.0005119748,0.00018179024,0.00043054673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035667035,0.0002792522,0.00069979025,0.0002972571,0.00014836606,0.00017790157,0.00019451375,0.00028633568,0.00019154523],"category_scores_gemma":[0.0006559868,0.00021657172,0.00010934731,0.00071390317,0.0010105439,0.000115863884,0.0003247067,0.0013373004,0.000034336434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00299538,0.0009380571,0.90515935,0.0006269116,0.00016551426,0.0025904034,0.0004604595,0.000002119651,0.00080672506,0.0007522183,0.00040484458,0.08509804],"study_design_scores_gemma":[0.0060572964,0.0027570263,0.98786485,0.001085654,0.00009273446,0.000058200298,0.000083587205,0.00008407677,0.00083702034,0.00017620852,0.000700816,0.00020252654],"about_ca_topic_score_codex":0.0011354643,"about_ca_topic_score_gemma":0.00064317096,"teacher_disagreement_score":0.084895514,"about_ca_system_score_codex":0.0005244781,"about_ca_system_score_gemma":0.0011384233,"threshold_uncertainty_score":0.8831538},"labels":[],"label_agreement":null},{"id":"W4399380733","doi":"10.1200/jco.2024.42.16_suppl.5523","title":"Precision oncology for rare gynecologic malignancies: Integrating molecular tumor boards and real-time treatment matching.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Precision oncology; Gynecologic cancer; Internal medicine; Oncology; Cancer; Ovarian cancer","score_opus":0.0735403117581049,"score_gpt":0.4580394458673659,"score_spread":0.384499134109261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399380733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96402395,0.0047588297,0.00078665,0.021940062,0.002065381,0.0009082082,0.000029887009,0.00004285329,0.0054441537],"genre_scores_gemma":[0.9351885,0.006499314,0.05352765,0.0022981262,0.0014450852,0.00012674833,0.000013057041,0.00005114628,0.00085038674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967968,0.00035507654,0.0019493247,0.00037823681,0.00022726708,0.0002932811],"domain_scores_gemma":[0.99109983,0.0072563575,0.0007936865,0.00018282718,0.00029447392,0.0003728301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002434073,0.00023460167,0.0018603569,0.00015636657,0.000061792365,0.000035154964,0.00009835985,0.00038054326,0.00021888572],"category_scores_gemma":[0.0019195863,0.00013886989,0.0007087418,0.00011589369,0.00014049087,0.000093763956,0.000049726754,0.00041908503,0.00002109482],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033756527,0.0031787844,0.003970511,0.00017007443,0.0016367468,0.009795956,0.0005307888,0.000019791742,0.0026060059,0.001767061,0.010196461,0.96275216],"study_design_scores_gemma":[0.024116911,0.21801694,0.038075995,0.0016595426,0.004367675,0.0042122686,0.0009112071,0.0013233804,0.0015308678,0.009929983,0.6954587,0.0003965166],"about_ca_topic_score_codex":0.000045265788,"about_ca_topic_score_gemma":0.000032526917,"teacher_disagreement_score":0.9623557,"about_ca_system_score_codex":0.0010279414,"about_ca_system_score_gemma":0.0028105353,"threshold_uncertainty_score":0.56629497},"labels":[],"label_agreement":null},{"id":"W4399380843","doi":"10.1200/jco.2024.42.16_suppl.5506","title":"Phase II randomized multi-centre study of neoadjuvant olaparib in patients with platinum sensitive relapsed high grade serous ovarian cancer: The NEO trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Ottawa Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Medicine; Olaparib; Serous ovarian cancer; Ovarian cancer; Oncology; Internal medicine; Serous fluid; Randomized controlled trial; Cancer","score_opus":0.06979818042501257,"score_gpt":0.43066278141934455,"score_spread":0.360864600994332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399380843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815609,0.00046474548,0.000033059594,0.012540487,0.0025100326,0.0027928187,0.000026272639,0.000010422135,0.00006128839],"genre_scores_gemma":[0.99755555,0.00040150937,0.00064422126,0.0005676349,0.00063262216,0.000048890095,0.0000074007016,0.000027218282,0.000114961134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942926,0.0015994667,0.0029954526,0.00031807704,0.000538509,0.00025588824],"domain_scores_gemma":[0.9923996,0.0050158277,0.0016816829,0.00025598664,0.00041921955,0.00022772176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034375128,0.0002349836,0.0030647635,0.0001559804,0.000060506583,0.00001482193,0.00012522713,0.00024131929,0.00008220831],"category_scores_gemma":[0.0013751476,0.00011315758,0.00047736708,0.0002811862,0.00020916136,0.000089021654,0.000054213455,0.0011118486,0.000002900849],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8113051,0.07200379,0.02500624,0.000027701277,0.0038420928,0.0019527565,0.0030687847,0.00012413667,0.0000028334068,0.000074694784,0.0008600282,0.08173183],"study_design_scores_gemma":[0.8715869,0.06699456,0.05571113,0.0004982719,0.0028511991,0.000022406832,0.00062528154,0.00034375046,0.000016165355,0.000031807504,0.0012202441,0.00009827443],"about_ca_topic_score_codex":0.00078341505,"about_ca_topic_score_gemma":0.0007718022,"teacher_disagreement_score":0.08163356,"about_ca_system_score_codex":0.00033763255,"about_ca_system_score_gemma":0.0015673491,"threshold_uncertainty_score":0.4830491},"labels":[],"label_agreement":null},{"id":"W4399395081","doi":"10.1200/jco.2024.42.16_suppl.5520","title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): A final overall survival analysis of a multicenter, open-label, randomized, phase 3 trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Oncology; Internal medicine; Randomized controlled trial; Overall survival; Surgery; Cancer","score_opus":0.13313307254854903,"score_gpt":0.4930474423542216,"score_spread":0.3599143698056726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399395081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97044516,0.002388833,0.0002939642,0.018954497,0.0052766353,0.0016829714,0.00011672468,0.000013109163,0.00082810107],"genre_scores_gemma":[0.9841288,0.009711037,0.0028316793,0.001565039,0.0011630615,0.000097660915,0.000059495615,0.000045509238,0.0003977152],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994171,0.0011150319,0.0034646671,0.0004721953,0.0004814625,0.00029562553],"domain_scores_gemma":[0.9919295,0.005260039,0.0019204018,0.0002567615,0.0003515936,0.00028173535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00528415,0.00029401586,0.0047185593,0.00046449914,0.000035385583,0.000043176886,0.00019732752,0.00045610624,0.0009484211],"category_scores_gemma":[0.0011118765,0.00021518,0.0011814984,0.0007019751,0.00025787443,0.00023731364,0.000037785936,0.0010074846,0.0000031330849],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8539941,0.013479962,0.0005740667,0.00003357933,0.021373047,0.0005986249,0.0005269148,0.00002186913,0.0006530909,0.00007226146,0.0067208586,0.10195163],"study_design_scores_gemma":[0.95635855,0.0176364,0.0027630345,0.00031916588,0.0077449717,0.000018382649,0.00011527246,0.002841832,0.0005232904,0.000054460033,0.011448463,0.00017619136],"about_ca_topic_score_codex":0.0008826939,"about_ca_topic_score_gemma":0.00039454433,"teacher_disagreement_score":0.102364436,"about_ca_system_score_codex":0.00076105504,"about_ca_system_score_gemma":0.0025695325,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W4399504392","doi":"10.1158/1538-8514.synthleth24-a020","title":"Abstract A020: TP53 mutation and prediction of platinum response in BRCA-mutated ovarian cancer: A prospective case-series analysis","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; BRCA mutation; Medicine; Olaparib; Oncology; Missense mutation; Internal medicine; Germline mutation; Nonsense mutation; PARP inhibitor; Cancer; Germline; Serous fluid; Mutation; Somatic cell; Cancer research; Genetics; Biology; Gene; Poly ADP ribose polymerase","score_opus":0.020173704639477968,"score_gpt":0.3064825006325342,"score_spread":0.2863087959930562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399504392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807271,0.015226858,0.0004852414,0.0022151028,0.00014475969,0.0006261188,0.00036574906,0.00006014846,0.00014896398],"genre_scores_gemma":[0.9975732,0.001525337,0.0002756915,0.00016053447,0.000040375497,0.0003001428,0.0000417896,0.000034896057,0.000048010203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878705,0.00006983776,0.0003410709,0.0003858787,0.00022832667,0.0001878669],"domain_scores_gemma":[0.9994813,0.00005817654,0.00008830024,0.00020480907,0.000103080856,0.00006433331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020086375,0.00019149769,0.00036219365,0.0003693211,0.000042109576,0.000042745134,0.000030709754,0.00010918671,0.00011137458],"category_scores_gemma":[0.000010133209,0.00017094972,0.00011816005,0.0010431706,0.00008051555,0.00008602767,0.00001386427,0.00016826704,0.000001027565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016593011,0.0012240503,0.52732587,0.0015799652,0.026754873,0.044403695,0.027766984,0.013682088,0.15341577,0.0017602978,0.000062051855,0.18543136],"study_design_scores_gemma":[0.0045915465,0.0011837981,0.90369093,0.0008577496,0.008248834,0.0009377836,0.0009164558,0.012770005,0.06455939,0.0005966188,0.0012954215,0.00035143414],"about_ca_topic_score_codex":0.0018517757,"about_ca_topic_score_gemma":0.00096303324,"teacher_disagreement_score":0.3763651,"about_ca_system_score_codex":0.0005050722,"about_ca_system_score_gemma":0.00033314756,"threshold_uncertainty_score":0.6971127},"labels":[],"label_agreement":null},{"id":"W4399508527","doi":"10.1503/cmaj.231763","title":"Opportunistic salpingectomy to decrease the risk of ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sinai Health System; The Canadian Association of Professional Academic Librarians; University of Toronto","funders":"","keywords":"Salpingectomy; Fallopian tube; Ovarian cancer; Medicine; Epithelial ovarian cancer; Lesion; Disease; Stage (stratigraphy); Gynecology; Oncology; Cancer; Internal medicine; Surgery; Biology; Pregnancy","score_opus":0.013699001603803945,"score_gpt":0.2842614538083427,"score_spread":0.2705624522045388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399508527","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17644489,0.006643797,0.00041993108,0.800892,0.004462173,0.0007762553,0.000643419,0.00006006252,0.009657467],"genre_scores_gemma":[0.9802542,0.0015336388,0.00013239808,0.015409136,0.0019515095,0.00004063931,0.0000091617585,0.00002116038,0.00064820645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981783,0.00011371873,0.00034075588,0.00014726145,0.0009065796,0.00031339133],"domain_scores_gemma":[0.99614275,0.0003023494,0.000106726075,0.0001268642,0.00024551438,0.0030758204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012621741,0.000102733495,0.0002199448,0.00016980621,0.0001609205,0.000076715965,0.0001130434,0.00014349555,0.010862105],"category_scores_gemma":[0.0027252878,0.00006518176,0.00014604749,0.00034951698,0.000027502021,0.00003903279,0.000010382457,0.00058299996,0.00008810355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003075067,0.00007872598,0.22966374,0.00005271165,0.0015143594,0.0022779244,0.00075990584,0.000011979772,0.000010654715,0.0026969681,0.43632346,0.32657883],"study_design_scores_gemma":[0.000768326,0.000113883354,0.18086837,0.00059419137,0.0005481524,0.00028485843,0.00013717865,0.00035834353,0.000021775766,0.00019754517,0.81601685,0.00009048781],"about_ca_topic_score_codex":0.019841924,"about_ca_topic_score_gemma":0.045544717,"teacher_disagreement_score":0.8038093,"about_ca_system_score_codex":0.0015237891,"about_ca_system_score_gemma":0.011703126,"threshold_uncertainty_score":0.9938996},"labels":[],"label_agreement":null},{"id":"W4399558331","doi":"10.3389/fendo.2024.1435877","title":"Editorial: Update on epidemiology, endocrinology and treatment of cryptorchidism","year":2024,"lang":"en","type":"editorial","venue":"Frontiers in Endocrinology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidemiology; Medicine; Gynecology; Endocrinology; Internal medicine","score_opus":0.018864153624601143,"score_gpt":0.315510266832683,"score_spread":0.2966461132080819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399558331","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006798895,0.035754465,0.000025702104,0.003288793,0.9576812,0.00089688896,0.0005244575,0.00009692654,0.0010517159],"genre_scores_gemma":[0.0009555548,0.104368426,0.0023359726,0.000118794334,0.8902148,0.00056474283,0.00063384284,0.00011555374,0.00069228903],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957019,0.00035437447,0.001075578,0.001413564,0.00032411958,0.0011304416],"domain_scores_gemma":[0.9970447,0.0014280619,0.00034921546,0.00085231056,0.00011608407,0.0002096715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017766877,0.00077978167,0.0029700738,0.0010293183,0.000045752637,0.000009760207,0.00020072474,0.0012893984,0.000051462073],"category_scores_gemma":[0.0006774627,0.0006275058,0.0003605018,0.00020325244,0.0006518325,0.000034355977,0.00012863427,0.001090754,0.000060751343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010359263,0.000749776,0.009243892,0.00025418238,0.0014091552,0.0007519007,0.000112051166,0.000003994927,0.000003169776,0.0021168042,0.95422316,0.030096006],"study_design_scores_gemma":[0.0058044954,0.005064058,0.0009425066,0.00032293654,0.0008626144,0.000050845116,0.000050781637,0.000010131766,0.00011776258,0.003949967,0.98248315,0.00034076162],"about_ca_topic_score_codex":0.0005551015,"about_ca_topic_score_gemma":0.00007391414,"teacher_disagreement_score":0.06861396,"about_ca_system_score_codex":0.0011063581,"about_ca_system_score_gemma":0.0005514617,"threshold_uncertainty_score":0.99961764},"labels":[],"label_agreement":null},{"id":"W4399601604","doi":"10.1016/j.bbrep.2024.101755","title":"Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression","year":2024,"lang":"en","type":"article","venue":"Biochemistry and Biophysics Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Science North","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia; Ministério da Ciência, Tecnologia e Ensino Superior; Ministerio de Economía y Competitividad","keywords":"Ascites; Ovarian cancer; Context (archaeology); Cancer; Ascitic fluid; Peritoneal cavity; Proteomics; Biology; Disease; Medicine; Internal medicine; Cancer research; Bioinformatics; Biochemistry; Gene; Surgery","score_opus":0.012447373122486899,"score_gpt":0.30316861887441704,"score_spread":0.29072124575193015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399601604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779385,0.018091725,0.0000015352417,0.0025177505,0.00024382191,0.0006066299,0.000047359004,0.00013592497,0.00041680026],"genre_scores_gemma":[0.995156,0.0013558832,0.00023690915,0.000052269752,0.0008932387,0.00071857305,0.000097297256,0.000028066946,0.0014617506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880207,0.000007798579,0.00017438862,0.00057478616,0.00021666219,0.00022429803],"domain_scores_gemma":[0.99930984,0.0000072243643,0.00008257535,0.00030004018,0.000055060016,0.00024524907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057253234,0.00021108787,0.00023089864,0.000037565987,0.000101173115,0.00008636022,0.00002563572,0.00007455005,0.000064746266],"category_scores_gemma":[0.000016839109,0.00015330133,0.00008110129,0.00020644571,0.000063181265,0.00005776823,0.00005011554,0.00011271852,0.0000033581728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001354582,0.00027601363,0.016687216,0.0024447946,0.00027882511,0.0032492375,0.00008004806,2.9729918e-7,0.94538844,0.00006004915,0.00033483483,0.03106482],"study_design_scores_gemma":[0.00029203936,0.00004825902,0.044708766,0.0014585659,0.00034299152,0.00019176079,0.0000085405845,0.000027901553,0.95024407,0.00012380937,0.0023694043,0.0001839117],"about_ca_topic_score_codex":0.000022629265,"about_ca_topic_score_gemma":7.6380564e-7,"teacher_disagreement_score":0.030880908,"about_ca_system_score_codex":0.00007113389,"about_ca_system_score_gemma":0.00028060397,"threshold_uncertainty_score":0.62514466},"labels":[],"label_agreement":null},{"id":"W4399700346","doi":"10.1016/j.jval.2024.03.213","title":"CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Ovarian cancer; Disease; Current (fluid); Epithelial ovarian cancer; Oncology; Internal medicine; Cancer; Engineering","score_opus":0.044646887089065446,"score_gpt":0.38984965393459586,"score_spread":0.3452027668455304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98606527,0.009146445,0.00011909442,0.0020790705,0.00053073006,0.0017740651,0.000244617,0.000022162547,0.000018519531],"genre_scores_gemma":[0.9989052,0.00057154795,0.000044509994,0.00007191708,0.00014363021,0.00018712199,0.00004115513,0.000022836612,0.000012073235],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99858683,0.00010693799,0.0004569433,0.00032751207,0.00031455242,0.00020723054],"domain_scores_gemma":[0.9994291,0.00007314809,0.00006656261,0.00021351587,0.000057946432,0.000159747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017515733,0.00014172494,0.00031670096,0.00022125008,0.000023235463,0.000010289358,0.000042545602,0.000029103638,0.000024645797],"category_scores_gemma":[0.00003164474,0.00011100081,0.000055984987,0.00037529288,0.000014123475,0.000054410106,0.000025264495,0.00014813371,0.0000034433608],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016193966,0.0010630662,0.38981494,0.0006876279,0.00002290447,0.000010756732,0.0050758645,0.5870853,4.2046892e-7,0.000117290816,0.00001139238,0.015948521],"study_design_scores_gemma":[0.0029734427,0.00027824347,0.528721,0.0010255802,0.000040398794,6.1977204e-8,0.00012680475,0.46639842,5.068554e-7,0.00031440606,0.000058943515,0.000062259045],"about_ca_topic_score_codex":0.014503193,"about_ca_topic_score_gemma":0.0005245657,"teacher_disagreement_score":0.13890602,"about_ca_system_score_codex":0.0010859639,"about_ca_system_score_gemma":0.0010915409,"threshold_uncertainty_score":0.9920593},"labels":[],"label_agreement":null},{"id":"W4399804123","doi":"10.1016/j.jpedsurg.2024.06.011","title":"Retrospective Review of Management of Antenatally Diagnosed Ovarian Cysts at the Hospital for Sick Children","year":2024,"lang":"en","type":"article","venue":"Journal of Pediatric Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Mount Sinai Hospital; SickKids Foundation","funders":"","keywords":"Medicine; Sick child; Retrospective cohort study; Gynecology; Pediatrics; General surgery; Obstetrics; Surgery","score_opus":0.012106260761410055,"score_gpt":0.26878167237311124,"score_spread":0.25667541161170115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399804123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58936924,0.39745203,0.000102944774,0.008248232,0.002525362,0.0015216023,0.00022268716,0.000017182769,0.00054074544],"genre_scores_gemma":[0.77177274,0.22579104,0.00027397842,0.00014049002,0.0018286919,0.00003058833,0.000016298098,0.000024084999,0.00012208898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982041,0.000042418058,0.00088120176,0.00017727433,0.00051571964,0.00017925615],"domain_scores_gemma":[0.99803954,0.00063368847,0.0006681121,0.0002506985,0.00031985273,0.000088091445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001112715,0.00015397024,0.0007207391,0.00020759618,0.000032562355,0.000010976412,0.00010154282,0.000045197747,0.00016804201],"category_scores_gemma":[0.00019941389,0.00009023783,0.0007922753,0.0004943775,0.000040591633,0.000083232364,0.00004613136,0.00013235217,0.0000046920745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032540245,0.0010480782,0.53425723,0.013727985,0.0036870965,0.0014154253,0.00017976061,0.0000022865875,0.000007635676,0.00044611382,0.4229726,0.021930385],"study_design_scores_gemma":[0.0015220979,0.0008004145,0.9801743,0.0088892365,0.0047954377,0.00017357979,0.00004500592,0.0000024300318,0.0001970901,0.00011665106,0.0031401496,0.00014361297],"about_ca_topic_score_codex":0.000013612607,"about_ca_topic_score_gemma":9.0863693e-7,"teacher_disagreement_score":0.44591707,"about_ca_system_score_codex":0.00023829102,"about_ca_system_score_gemma":0.00028428808,"threshold_uncertainty_score":0.3679792},"labels":[],"label_agreement":null},{"id":"W4399808650","doi":"10.1016/j.sagf.2024.05.009","title":"Place de l’immunothérapie dans la prise en charge des cancers gynécologiques","year":2024,"lang":"fr","type":"article","venue":"Sages-Femmes","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Gynecology","score_opus":0.0251372088939603,"score_gpt":0.3114571730094194,"score_spread":0.28631996411545907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399808650","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2999061,0.6274441,0.0002943714,0.020482264,0.0040874644,0.00094194035,0.00044759148,0.00045834863,0.04593782],"genre_scores_gemma":[0.8535072,0.09816421,0.0013755525,0.0006138515,0.0018448618,0.000414002,0.000044970202,0.000120396406,0.043914966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972374,0.00044734825,0.00039201562,0.0006512984,0.00027488472,0.0009970936],"domain_scores_gemma":[0.99770904,0.0013760078,0.000074240845,0.00046505095,0.000053657706,0.00032201537],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009141308,0.00048032665,0.0005526155,0.00016037762,0.0001736407,0.00022542488,0.00022181682,0.00040577076,0.0025835957],"category_scores_gemma":[0.00023852993,0.00042204311,0.00031514096,0.00037233433,0.00049134466,0.00023655058,0.000093974435,0.000595737,0.0006056192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039046133,0.0014209722,0.08148578,0.0043684137,0.00517874,0.012762785,0.045715455,0.00019245625,0.002681109,0.040352218,0.17805424,0.62739736],"study_design_scores_gemma":[0.0028931035,0.0016239422,0.15038538,0.007952673,0.002323545,0.00054375443,0.003332037,0.0010649095,0.017139874,0.0019936783,0.80996215,0.0007849587],"about_ca_topic_score_codex":0.0048295897,"about_ca_topic_score_gemma":0.000841133,"teacher_disagreement_score":0.6319079,"about_ca_system_score_codex":0.004857089,"about_ca_system_score_gemma":0.0021243943,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W4399934649","doi":"10.1097/pgp.0000000000001043","title":"Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; University of Calgary","funders":"","keywords":"CDKN2A; KRAS; Serous fluid; Medicine; Serous carcinoma; Neuroblastoma RAS viral oncogene homolog; Oncology; Internal medicine; Ovarian carcinoma; Pathology; Ovarian cancer; Colorectal cancer; Cancer","score_opus":0.01373047738225939,"score_gpt":0.2957409684933034,"score_spread":0.282010491111044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399934649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875106,0.0028281861,0.00016060164,0.007814209,0.001032638,0.00008562724,0.000019292229,0.000010551194,0.0005382792],"genre_scores_gemma":[0.99799454,0.00035971537,0.000981212,0.0004171874,0.00020012759,0.0000047487074,0.000006009416,0.000009443498,0.00002699951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899745,0.000071587994,0.0003929692,0.0001675104,0.00024446996,0.00012602376],"domain_scores_gemma":[0.99921376,0.00024537832,0.00013099087,0.00007264364,0.00023832575,0.000098919394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022849263,0.00010640509,0.0003298468,0.00016359564,0.000014240806,0.000021566097,0.00011013265,0.00011404662,0.0002301562],"category_scores_gemma":[0.00016188878,0.000073712465,0.00015291144,0.000066216446,0.00013842995,0.000054919885,0.00005312129,0.00021600988,0.00000659853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014705396,0.0025213822,0.64895684,0.00022883092,0.0022037018,0.1758408,0.001001904,0.0001405838,0.076052986,0.03034597,0.0011214676,0.060114976],"study_design_scores_gemma":[0.002600979,0.0027227239,0.96637344,0.00018234499,0.00026404878,0.01122226,0.000078955134,0.00021489002,0.011231628,0.0026600447,0.0023341498,0.000114553775],"about_ca_topic_score_codex":0.000016927033,"about_ca_topic_score_gemma":0.0000056207523,"teacher_disagreement_score":0.31741655,"about_ca_system_score_codex":0.00010505335,"about_ca_system_score_gemma":0.00012533984,"threshold_uncertainty_score":0.3005907},"labels":[],"label_agreement":null},{"id":"W4400051599","doi":"10.1097/pas.0000000000002237","title":"Female Adnexal Tumor of Probable Wolffian Origin (Wolffian Tumor)","year":2024,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Mesonephric duct; Pathology; Biology; Cuboidal Cell; Immunohistochemistry; Mesothelioma; Anatomy; Medicine","score_opus":0.021446879802358185,"score_gpt":0.305892767853491,"score_spread":0.2844458880511328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400051599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98598224,0.0027995864,0.000041714207,0.008651743,0.00039798915,0.00018443259,0.000013576234,0.00002297487,0.0019057196],"genre_scores_gemma":[0.9973993,0.0005061828,0.0008315397,0.0005339074,0.0004777609,0.000011897028,0.0000020897276,0.00002923383,0.00020809381],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982334,0.00022319832,0.0006475789,0.0002279026,0.0003310458,0.00033691735],"domain_scores_gemma":[0.998659,0.00035073684,0.00032903612,0.0003005282,0.00014053234,0.00022016444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007348683,0.00019007834,0.00089236425,0.00018274621,0.000048355552,0.000020326494,0.00019788061,0.00002839556,0.000317818],"category_scores_gemma":[0.000042755182,0.00010497894,0.00035082197,0.0005246528,0.00069970515,0.000063750085,0.000047015907,0.0004569488,0.00005169638],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012475905,0.005863355,0.36148036,0.0009547419,0.0039455397,0.32145116,0.0065538543,0.0005304084,0.013877767,0.023338126,0.017276503,0.23225231],"study_design_scores_gemma":[0.013468013,0.039852608,0.1887456,0.0034044487,0.0033496304,0.2273404,0.004919496,0.00020667765,0.013017048,0.002747752,0.50189143,0.0010568891],"about_ca_topic_score_codex":0.000036047728,"about_ca_topic_score_gemma":0.0000054683214,"teacher_disagreement_score":0.48461494,"about_ca_system_score_codex":0.00012516933,"about_ca_system_score_gemma":0.00040666875,"threshold_uncertainty_score":0.4280917},"labels":[],"label_agreement":null},{"id":"W4400127355","doi":"10.1016/b978-0-12-824040-3.00005-4","title":"Diagnostic, prognostic, and therapeutic biomarkers of ovarian cancer","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Ovarian cancer; Medicine; Oncology; Cancer; Internal medicine","score_opus":0.01904712684733547,"score_gpt":0.2723578375371345,"score_spread":0.25331071068979905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400127355","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036486727,0.08172383,6.034667e-7,0.0013974652,0.000558242,0.0016923667,0.00023749971,0.000066964414,0.91395813],"genre_scores_gemma":[0.041613773,0.007742695,0.00020785027,0.0005324927,0.00049573014,0.00043275827,0.000040389277,0.00019857872,0.9487357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982606,0.000012632446,0.00048957503,0.0006184106,0.00034555857,0.00027317938],"domain_scores_gemma":[0.9986859,0.0003253711,0.00019499511,0.00046863887,0.00011509206,0.00021003559],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012130402,0.00049894716,0.0008691281,0.00021361746,0.000044989814,0.000033082553,0.000085889194,0.0003170858,0.0006753579],"category_scores_gemma":[0.000024976936,0.00038770636,0.00027317522,0.000024144105,0.00026319028,0.000013256167,0.00008823595,0.0003201735,0.00006461031],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000728745,0.000047931357,0.0021294993,0.001193621,0.0032303687,0.00034986887,0.00019728321,9.322978e-8,0.000025463238,0.016194772,0.00025098893,0.9763072],"study_design_scores_gemma":[0.0014262083,0.0005056193,0.006620375,0.007581677,0.0064270473,0.0000932898,0.000011654633,0.0000066863627,0.00023429359,0.011553934,0.96509135,0.00044785815],"about_ca_topic_score_codex":0.000011944479,"about_ca_topic_score_gemma":0.000046981044,"teacher_disagreement_score":0.9758594,"about_ca_system_score_codex":0.00016020972,"about_ca_system_score_gemma":0.0003276622,"threshold_uncertainty_score":0.9998575},"labels":[],"label_agreement":null},{"id":"W4400137539","doi":"10.1093/jnci/djae151","title":"Incidence of peritoneal cancer after oophorectomy among <i>BRCA1</i> and <i>BRCA2</i> mutation carriers","year":2024,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canada Research Chairs; Women's College Hospital; Canadian Cancer Society","keywords":"Oophorectomy; Incidence (geometry); Medicine; Ovarian cancer; Gynecology; Cancer; Oncology; Internal medicine; Surgery; Hysterectomy","score_opus":0.018993203291575556,"score_gpt":0.32206850835921436,"score_spread":0.3030753050676388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400137539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96965116,0.020476168,0.000027289603,0.0058495463,0.0031650674,0.00023580065,0.00014114311,0.000008693294,0.00044511133],"genre_scores_gemma":[0.9954486,0.0021419,0.00022939009,0.0008261843,0.0011040389,0.00007498196,0.0000023333896,0.00001527726,0.00015728443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842876,0.000028617,0.00042718646,0.00017018538,0.0008166786,0.00012857461],"domain_scores_gemma":[0.9989125,0.000062512554,0.00024290255,0.00008172071,0.0005878997,0.0001124274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025967896,0.00013974206,0.00027282644,0.00014940617,0.00006981323,0.000043052438,0.00010508948,0.00006772129,0.00011430533],"category_scores_gemma":[0.00007899431,0.00008967692,0.00017956292,0.00034449762,0.00024780422,0.00039691152,0.000036016674,0.0002681432,0.000001067733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002488461,0.0004641978,0.85392755,0.001850296,0.0049257823,0.0009997087,0.007424443,0.009314454,0.0098404875,0.002823129,0.04049845,0.06544302],"study_design_scores_gemma":[0.0031785376,0.00032713742,0.9001262,0.0043842546,0.0012838872,0.00085030595,0.00010939783,0.0008027852,0.02368918,0.00092274824,0.06405396,0.00027156973],"about_ca_topic_score_codex":0.0005631337,"about_ca_topic_score_gemma":0.00053634477,"teacher_disagreement_score":0.06517145,"about_ca_system_score_codex":0.00078404474,"about_ca_system_score_gemma":0.0015609929,"threshold_uncertainty_score":0.36569184},"labels":[],"label_agreement":null},{"id":"W4400262041","doi":"10.3389/fonc.2024.1421828","title":"Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence","year":2024,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Conventional PCI; Internal medicine; Ovarian cancer; Hazard ratio; Oncology; Cochrane Library; Hyperthermic intraperitoneal chemotherapy; Stage (stratigraphy); Meta-analysis; Cancer; Confidence interval; Cytoreductive surgery; Myocardial infarction","score_opus":0.05216305234095468,"score_gpt":0.3725978657579121,"score_spread":0.3204348134169574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400262041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018126932,0.9752306,0.000032333042,0.012537494,0.00034556026,0.011235749,0.0005630385,0.00001963177,0.000017479924],"genre_scores_gemma":[0.0017361151,0.9610983,0.0014935598,0.0018536977,0.000036444966,0.033468045,0.00004554441,0.00006370715,0.00020459763],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99625075,0.0007014729,0.0012360463,0.00095540937,0.0004837896,0.000372547],"domain_scores_gemma":[0.9973381,0.0006217938,0.000847525,0.0008103014,0.00021952439,0.00016270948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006170544,0.0006733468,0.010220235,0.0006713159,0.00005039185,0.000026869557,0.00028504842,0.00025961333,0.00022100001],"category_scores_gemma":[0.0002552354,0.00025829856,0.0010189381,0.0022098916,0.00014752866,0.000050153587,0.000078521625,0.0004853857,0.000003788393],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024357975,0.0007289796,0.006468525,0.8122727,0.14383934,0.0001076406,0.00018817524,0.00006463692,4.597075e-9,0.000013625823,0.0030345113,0.033038255],"study_design_scores_gemma":[0.0005445201,0.00095413416,0.0004488465,0.20667619,0.7686882,0.0000014889299,0.000027384807,0.000037366615,1.7699824e-7,0.0000039100764,0.022350037,0.00026778172],"about_ca_topic_score_codex":0.0008155003,"about_ca_topic_score_gemma":0.0015984467,"teacher_disagreement_score":0.62484884,"about_ca_system_score_codex":0.0015214212,"about_ca_system_score_gemma":0.0011894576,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W4400272727","doi":"10.1200/jco.2024.42.16_suppl.tps5637","title":"Efficacy and safety of luveltamab tazevibulin vs investigator’s choice of chemotherapy in patients with recurrent platinum-resistant ovarian cancer (PROC) expressing folate receptor alpha (FRα): The REFRaME-01 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase 2/3 study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Internal medicine; Oncology; Alpha (finance); Gynecology; Cancer; Surgery","score_opus":0.06098242071726315,"score_gpt":0.42940563252334285,"score_spread":0.36842321180607973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400272727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853594,0.0045662806,0.000021978143,0.008348874,0.0005643707,0.0010260284,0.000050882743,0.000007214506,0.000055026983],"genre_scores_gemma":[0.99486196,0.0025403388,0.0014680314,0.0006339537,0.00040725732,0.000029637351,0.0000059080458,0.000034540026,0.000018400488],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99593234,0.00048903405,0.002442674,0.00039208884,0.0004954368,0.00024843588],"domain_scores_gemma":[0.9947143,0.0028521938,0.0015331948,0.000265746,0.00025960314,0.00037496802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021000255,0.000263429,0.0016878123,0.0001520715,0.000055152137,0.000024722185,0.00014230641,0.00024455393,0.00010810409],"category_scores_gemma":[0.0012808681,0.00014836104,0.00013234251,0.00029004598,0.00035978036,0.00013155329,0.000061342886,0.000921913,5.6947516e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056063578,0.010343651,0.26177034,0.00032224253,0.0020052206,0.00012123217,0.0027043358,0.000014030778,0.00033670955,0.000061106184,0.001570104,0.66468745],"study_design_scores_gemma":[0.08064845,0.04843829,0.8223691,0.0029750646,0.0010321571,0.000011437706,0.00022281462,0.00013055347,0.00018558232,0.000059760838,0.04374736,0.00017941106],"about_ca_topic_score_codex":0.00016817007,"about_ca_topic_score_gemma":0.00012358866,"teacher_disagreement_score":0.66450804,"about_ca_system_score_codex":0.00025311124,"about_ca_system_score_gemma":0.0014684054,"threshold_uncertainty_score":0.60499877},"labels":[],"label_agreement":null},{"id":"W4400380899","doi":"10.1002/2056-4538.12389","title":"Mesonephric‐type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of <scp>PAX2</scp>","year":2024,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Alberta Precision Laboratories","keywords":"Mesonephric duct; Immunohistochemistry; Calretinin; Medicine; GATA3; Hazard ratio; Ovary; Pathology; Stage (stratigraphy); PAX8; Internal medicine; Oncology; Gastroenterology; Gynecology; Biology; Confidence interval","score_opus":0.18211225402677617,"score_gpt":0.48194760287724003,"score_spread":0.29983534885046387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400380899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572624,0.03230646,0.0000091691445,0.0086653875,0.0006710387,0.0005498238,0.000019368463,0.000005808496,0.00051052857],"genre_scores_gemma":[0.98509854,0.013656885,0.00021560943,0.00016495932,0.00033521594,0.0000067265487,6.225397e-7,0.00001659877,0.0005048271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99415773,0.0026027882,0.0015313393,0.00045250624,0.0009209723,0.00033466372],"domain_scores_gemma":[0.967557,0.029532118,0.00040910798,0.0014750692,0.00083301374,0.00019370769],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028196955,0.00013815291,0.000742686,0.00019166741,0.00008673896,0.00001358336,0.00046567625,0.0001856786,0.00004924374],"category_scores_gemma":[0.054541916,0.00006471045,0.00031680547,0.0006828803,0.0015995149,0.000054962165,0.0004318491,0.0015715315,0.000014104151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023115675,0.00066893105,0.985359,0.0005472893,0.00031304592,0.00062381034,0.0005641064,0.0000057185903,0.00046742885,0.00095118367,0.0061418037,0.004126487],"study_design_scores_gemma":[0.0010945132,0.0037674734,0.9868912,0.0006877618,0.000728836,0.001034507,0.00019230456,0.000025766807,0.0013591481,0.0030799725,0.0011121328,0.000026366613],"about_ca_topic_score_codex":0.000021472351,"about_ca_topic_score_gemma":0.0000045838055,"teacher_disagreement_score":0.027836138,"about_ca_system_score_codex":0.000067382054,"about_ca_system_score_gemma":0.00072411273,"threshold_uncertainty_score":0.9772558},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4400521151","doi":"10.1016/j.soi.2024.100079","title":"Incidence of metastatic tumors to ovary (Krukenberg) versus primary ovarian neoplasms associated with colorectal cancer surgery","year":2024,"lang":"en","type":"article","venue":"Surgical Oncology Insight","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Krukenberg tumor; Ovary; Incidence (geometry); Medicine; Ovarian cancer; Colorectal cancer; Oncology; Cancer; Metastasis; Internal medicine","score_opus":0.031626340577768794,"score_gpt":0.31909155371820164,"score_spread":0.28746521314043283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400521151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96479595,0.0047838227,0.000024019304,0.0071561364,0.0015315759,0.0008195842,0.0001238809,0.0001632659,0.020601787],"genre_scores_gemma":[0.9970927,0.00075350347,0.00045522948,0.00061386253,0.00017538248,0.00040067694,0.00011926703,0.00004863925,0.00034069078],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99764633,0.00025843183,0.00058026944,0.0005698483,0.0004892486,0.00045584296],"domain_scores_gemma":[0.99510735,0.003977184,0.00014892341,0.00022504317,0.00018044918,0.00036103898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053402665,0.00030368322,0.001177305,0.00029983238,0.000066113964,0.000022420414,0.000097904296,0.00017809507,0.00085215044],"category_scores_gemma":[0.00015197619,0.00021276328,0.00023799378,0.0011011062,0.00021975141,0.00011924189,0.00007471961,0.0003522142,0.00005198078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056002166,0.01028636,0.29166836,0.0016338824,0.020439487,0.17943004,0.005566494,0.0006025811,0.0023864545,0.009477969,0.04990469,0.3726015],"study_design_scores_gemma":[0.018533055,0.014512787,0.4905394,0.0054726647,0.0053550215,0.0017407729,0.0002167893,0.00056313915,0.010220707,0.00022059621,0.45125222,0.0013728486],"about_ca_topic_score_codex":0.0004669033,"about_ca_topic_score_gemma":0.0007222373,"teacher_disagreement_score":0.40134755,"about_ca_system_score_codex":0.0013797722,"about_ca_system_score_gemma":0.0029030924,"threshold_uncertainty_score":0.93304497},"labels":[],"label_agreement":null},{"id":"W4400799869","doi":"10.1016/j.ajpath.2024.06.010","title":"Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"Japan Society for the Promotion of Science","keywords":"Ovarian cancer; Serous carcinoma; Serous fluid; Subtyping; Proportional hazards model; Oncology; Ovarian carcinoma; Artificial intelligence; Machine learning; Internal medicine; Medicine; Computer science; Cancer","score_opus":0.039125065456323306,"score_gpt":0.3269255110223737,"score_spread":0.2878004455660504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400799869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961304,0.0030902757,0.024003165,0.010347593,0.0009897532,0.00013245642,0.00003103936,0.000027010572,0.00007471792],"genre_scores_gemma":[0.98897403,0.00043350965,0.009471569,0.00061919953,0.00044758862,0.00001408334,0.0000044902627,0.000022922974,0.000012592319],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843323,0.00015569861,0.00068645744,0.0002475666,0.00022744818,0.000249601],"domain_scores_gemma":[0.99892944,0.00020158266,0.00037609754,0.0001920918,0.00015471177,0.00014609242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038668324,0.00016591641,0.0007324737,0.00030007472,0.000031929718,0.000012587476,0.00011203756,0.00007334913,0.0002882594],"category_scores_gemma":[0.00007457893,0.00012042626,0.0002493618,0.00042026886,0.00047462678,0.000042468913,0.00001964781,0.0003432685,0.000010280222],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008702929,0.00092540105,0.019094665,0.00012091895,0.00030626834,0.019695546,0.0008364221,0.0006433035,0.008879909,0.007350344,0.00025699488,0.94101995],"study_design_scores_gemma":[0.0055479547,0.07958613,0.53926504,0.0069562476,0.008968225,0.051919542,0.004037748,0.004574584,0.2378071,0.04376553,0.015260109,0.002311814],"about_ca_topic_score_codex":0.00023079364,"about_ca_topic_score_gemma":0.000022554968,"teacher_disagreement_score":0.9387081,"about_ca_system_score_codex":0.00024635647,"about_ca_system_score_gemma":0.00049523916,"threshold_uncertainty_score":0.49108404},"labels":[],"label_agreement":null},{"id":"W4400878658","doi":"10.1093/jnci/djae145","title":"Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework","year":2024,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute; University of Texas at Austin; University of Texas MD Anderson Cancer Center; Department of Mechanical Engineering, University of Texas at Austin; Duncan Family Institute for Cancer Prevention and Risk Assessment","keywords":"Medicine; Ovarian cancer; Prostate cancer; Colorectal cancer; Oncology; Cancer; Prostate; Internal medicine; Gynecology","score_opus":0.06808608610784095,"score_gpt":0.3851580666834278,"score_spread":0.31707198057558683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400878658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70035416,0.011057612,0.23980732,0.038681768,0.007822308,0.0011321509,0.0008096691,0.000034825684,0.00030020098],"genre_scores_gemma":[0.90922624,0.00009136742,0.08765782,0.0005196014,0.002416274,0.000012657719,0.0000019475676,0.000019117566,0.000055003387],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988048,0.000036837984,0.0003869948,0.0001381504,0.00049982616,0.00013336452],"domain_scores_gemma":[0.9987709,0.00026782491,0.00031222223,0.00006615748,0.0004990774,0.00008383378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069281785,0.00012208663,0.00030589764,0.00013638262,0.00014145122,0.00004760164,0.000050365674,0.00007131433,0.00004843522],"category_scores_gemma":[0.00033378619,0.000081456245,0.00019550906,0.00023765634,0.00008715453,0.00024285993,0.000030802166,0.00025854385,2.6671253e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023856286,0.00070939056,0.07365041,0.0030501098,0.010426128,0.0004991081,0.003603653,0.5537323,0.039547805,0.016743535,0.011993587,0.28365836],"study_design_scores_gemma":[0.0035858557,0.00027388864,0.054766197,0.018764226,0.0023749357,0.0017042778,0.000035900208,0.894912,0.0073188692,0.0072461073,0.0086850505,0.00033270827],"about_ca_topic_score_codex":0.00025011692,"about_ca_topic_score_gemma":0.00006235646,"teacher_disagreement_score":0.3411797,"about_ca_system_score_codex":0.00046162648,"about_ca_system_score_gemma":0.0011694331,"threshold_uncertainty_score":0.33216894},"labels":[],"label_agreement":null},{"id":"W4400937745","doi":"10.1016/b978-0-323-95488-4.00099-1","title":"Ovarian Cancer and the Environment: Rodent Models","year":2024,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Ottawa","funders":"","keywords":"Rodent; Rodent model; Ovarian cancer; Cancer; Biology; Medicine; Internal medicine; Ecology","score_opus":0.018866859681924714,"score_gpt":0.24320345011111533,"score_spread":0.2243365904291906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400937745","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001984988,0.06189235,0.0000026997102,0.0050701336,0.00034788126,0.0012594368,0.00010540596,0.00004274606,0.9312595],"genre_scores_gemma":[0.0052319644,0.014766432,0.000087768734,0.0012158125,0.0005435657,0.000483002,0.000021678528,0.00012338541,0.97752637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984385,0.000011317612,0.00034146916,0.00059958803,0.00037300368,0.00023617278],"domain_scores_gemma":[0.99903905,0.000054318763,0.00011274567,0.0006107526,0.000021038384,0.00016209208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016159528,0.00044098886,0.00067937793,0.000079452155,0.00009348782,0.00006429795,0.000096145304,0.00022431581,0.0007154322],"category_scores_gemma":[0.0000014825135,0.00026146692,0.00029294688,0.0000066045577,0.00029739735,0.000021686146,0.00015047626,0.0004579085,0.00021129135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085922584,0.000014979289,0.0000085629335,0.00018295553,0.0011489189,0.00015323846,0.00040972422,0.000007938003,0.0000011311437,0.1856805,0.00026094812,0.8120452],"study_design_scores_gemma":[0.002345562,0.000068244386,0.000036961257,0.0012228779,0.0026410155,0.000044916036,0.0000062815466,0.00010966311,0.000013938591,0.08373398,0.9095323,0.00024422564],"about_ca_topic_score_codex":0.0000147960045,"about_ca_topic_score_gemma":0.000030107103,"teacher_disagreement_score":0.90927136,"about_ca_system_score_codex":0.00028495447,"about_ca_system_score_gemma":0.000120181874,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W4401065096","doi":"10.1007/s00247-024-05992-8","title":"Abdominal imaging in precocious puberty in girls: can imaging determine onset of puberty?","year":2024,"lang":"en","type":"review","venue":"Pediatric Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Precocious puberty; Medicine; Bone age; Context (archaeology); Central precocious puberty; Delayed puberty; Pubic hair; Secondary sex characteristic; Pediatrics; Neuroradiology; Endocrinology; Hormone; Neurology","score_opus":0.027331224751553782,"score_gpt":0.3381616348523709,"score_spread":0.3108304101008171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401065096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018970553,0.9941735,0.0000031048762,0.00079540006,0.0009537753,0.0013241555,0.00016559724,0.000039299775,0.00064809265],"genre_scores_gemma":[0.011889621,0.98565114,0.0002453403,0.000122060876,0.00096565735,0.0006522172,0.0002243808,0.00010165133,0.00014796156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962401,0.00031862472,0.0015545051,0.0009650777,0.00019558273,0.0007261178],"domain_scores_gemma":[0.9981058,0.0006397971,0.00045968863,0.00057170726,0.000045563054,0.00017741317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060555985,0.00063944154,0.0032976442,0.0016568714,0.000022246748,0.000019490311,0.00025761395,0.00028745085,0.00011007811],"category_scores_gemma":[0.00022328152,0.00047988206,0.00055866304,0.0009556177,0.0001156663,0.000056769637,0.0001278219,0.0008303748,0.00004427788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003686543,0.00025476466,0.1544308,0.013135998,0.00013062934,0.00406239,0.00014854534,0.000001024467,5.924168e-8,0.000010544806,0.0053651263,0.8224232],"study_design_scores_gemma":[0.010577156,0.0007843142,0.068335116,0.021590669,0.028218694,0.027231282,0.00010358985,0.0004872564,0.0000020598593,0.00054813654,0.8395723,0.0025494304],"about_ca_topic_score_codex":0.0013086571,"about_ca_topic_score_gemma":0.0005953533,"teacher_disagreement_score":0.8342072,"about_ca_system_score_codex":0.001136041,"about_ca_system_score_gemma":0.0013162219,"threshold_uncertainty_score":0.9997653},"labels":[],"label_agreement":null},{"id":"W4401171648","doi":"10.1016/j.ejogrb.2024.07.066","title":"Pembrolizumab for metastatic squamous cell carcinoma arising from mature teratoma of the ovary: A letter to the editor","year":2024,"lang":"en","type":"letter","venue":"European Journal of Obstetrics & Gynecology and Reproductive Biology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Ovary; Basal cell; Pembrolizumab; Pathology; Teratoma; Oncology; Gynecology; Internal medicine; Cancer; Immunotherapy","score_opus":0.018314204744152043,"score_gpt":0.25484838741806826,"score_spread":0.2365341826739162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401171648","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11287323,0.037151385,0.00015042619,0.8033233,0.04427011,0.0014553384,0.00050636264,0.0000123921445,0.00025743648],"genre_scores_gemma":[0.81271285,0.00015292993,0.0013774225,0.14212698,0.042683646,0.000028596758,0.00006483189,0.000107318025,0.000745417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968572,0.0010743975,0.0008043358,0.0007116501,0.00019605867,0.0003563119],"domain_scores_gemma":[0.99495435,0.002906656,0.0008779319,0.0007325789,0.00045093152,0.00007754795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008418527,0.00037850594,0.0009374945,0.00033387606,0.00015525315,0.000032933902,0.0003912981,0.0002842517,0.000025796357],"category_scores_gemma":[0.0024016728,0.00018413505,0.00042859933,0.00034613913,0.00028237473,0.000032603337,0.00020837491,0.0019996713,0.000012705308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024939168,0.00015553366,0.0025248302,0.00022415769,0.0007519093,0.0015124284,0.000976029,0.000004039653,0.00040320784,0.000014222851,0.99085414,0.0023300797],"study_design_scores_gemma":[0.0022759037,0.0030515173,0.023369107,0.00011185488,0.0023271507,0.00043066946,0.00010389418,0.000002050183,0.0009788134,0.00023231098,0.96693265,0.00018406978],"about_ca_topic_score_codex":0.0000075875805,"about_ca_topic_score_gemma":0.0000012874407,"teacher_disagreement_score":0.69983965,"about_ca_system_score_codex":0.00018240996,"about_ca_system_score_gemma":0.00026988456,"threshold_uncertainty_score":0.8687689},"labels":[],"label_agreement":null},{"id":"W4401555194","doi":"10.21203/rs.3.rs-4726734/v1","title":"Quantifying Intratumoral Biomarker Heterogeneity in Tubo-ovarian High-grade Serous Carcinoma to Optimize Clinical Translation","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Serous fluid; Ovarian carcinoma; Intraclass correlation; Biomarker; Tissue microarray; Categorical variable; Oncology; Medicine; Internal medicine; Correlation; Ovarian cancer; Pathology; Biology; Immunohistochemistry; Cancer; Computer science; Machine learning; Mathematics","score_opus":0.3276458376452743,"score_gpt":0.5038636452002213,"score_spread":0.17621780755494704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401555194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96801513,0.004340035,0.00010971433,0.021306554,0.0011342361,0.004031403,0.00035549165,0.00013578865,0.00057164533],"genre_scores_gemma":[0.9906144,0.00065016927,0.0060742158,0.00015204572,0.0008225526,0.0009778091,0.00050337357,0.0001282695,0.000077137556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99351585,0.0011293838,0.0011410502,0.0017793133,0.0013769415,0.0010574759],"domain_scores_gemma":[0.99696493,0.000607482,0.00009007421,0.0012676772,0.00033209135,0.0007377574],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034173983,0.00051756605,0.0011659206,0.0011277908,0.0001239601,0.00030275332,0.000340478,0.000745636,0.00020041307],"category_scores_gemma":[0.00026734776,0.00045534558,0.0005103129,0.0011059467,0.00015726952,0.00005919872,0.0008176008,0.003112234,0.00027304064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039643063,0.004083962,0.8247633,0.00839285,0.0013891761,0.0113127,0.0016341165,0.0011918116,0.0005269151,0.0014568152,0.007176086,0.13410798],"study_design_scores_gemma":[0.005424602,0.0013290644,0.9782124,0.0055796714,0.00024323062,0.00006199614,0.0001631539,0.005297297,0.0010018828,0.0010886017,0.001061976,0.00053612224],"about_ca_topic_score_codex":0.004987662,"about_ca_topic_score_gemma":0.002825923,"teacher_disagreement_score":0.15344912,"about_ca_system_score_codex":0.0011840219,"about_ca_system_score_gemma":0.0013758686,"threshold_uncertainty_score":0.99978983},"labels":[],"label_agreement":null},{"id":"W4401576933","doi":"10.3390/curroncol31080344","title":"Does an Autoimmune Disorder Following Ovarian Cancer Diagnosis Affect Prognosis?","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian cancer; Internal medicine; Cancer; Proportional hazards model; Oncology; Stage (stratigraphy); Endometrial cancer; Gynecology","score_opus":0.06393886589435267,"score_gpt":0.42387054235377786,"score_spread":0.3599316764594252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401576933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8520917,0.08832339,0.00015565555,0.03436057,0.020929938,0.0021299084,0.00012152353,0.00068774447,0.0011995207],"genre_scores_gemma":[0.9844164,0.006705281,0.00027920812,0.00028787696,0.0010605591,0.006778316,0.00013019623,0.000068930014,0.0002732025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800646,0.0001377977,0.00035932517,0.0007324291,0.00025848628,0.0005055042],"domain_scores_gemma":[0.99902654,0.00024095313,0.0000638434,0.00037202393,0.00005514738,0.00024150645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025318278,0.0003214698,0.0006128725,0.00019289674,0.00013621464,0.00008776226,0.0001319818,0.00017372081,0.0014493087],"category_scores_gemma":[0.000038711114,0.00019031501,0.00035572774,0.0003902038,0.00007813571,0.00020244278,0.00007518676,0.0003725753,0.00010787889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046042594,0.0019353305,0.43472388,0.00027516854,0.00055623875,0.00028601574,0.000585683,0.000002952844,0.000041646745,0.0004827698,0.005297576,0.5557667],"study_design_scores_gemma":[0.00224681,0.0011367659,0.25967732,0.0009990339,0.0014059532,0.000016114513,0.00010251074,0.00046672413,0.00033479062,0.00016826016,0.73318523,0.0002604959],"about_ca_topic_score_codex":0.00031143992,"about_ca_topic_score_gemma":0.0004357375,"teacher_disagreement_score":0.72788763,"about_ca_system_score_codex":0.0007388114,"about_ca_system_score_gemma":0.0005466002,"threshold_uncertainty_score":0.9994635},"labels":[],"label_agreement":null},{"id":"W4401584469","doi":"10.3390/cancers16162840","title":"Ascites and Serum Interleukin-10 Levels as a Prognostic Tool for Ovarian Cancer Outcomes","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Jewish General Hospital","keywords":"Ascites; Medicine; Ovarian cancer; Gastroenterology; Internal medicine; Hazard ratio; Serous fluid; Cancer antigen; Histology; Cancer; Confidence interval","score_opus":0.03205130045904723,"score_gpt":0.3384198582211433,"score_spread":0.30636855776209604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401584469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.944861,0.019633489,0.00026957603,0.026114317,0.0024024225,0.0028095173,0.00082165457,0.0003067529,0.0027812596],"genre_scores_gemma":[0.98769426,0.00039097163,0.0005767965,0.0015905336,0.00033543477,0.0013956403,0.000016934559,0.000047895424,0.007951547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988959,0.000010733615,0.00020072363,0.00044229106,0.00014939542,0.00030095413],"domain_scores_gemma":[0.999349,0.00021810965,0.000034276967,0.00019212595,0.00006668931,0.00013981671],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000093825816,0.00021213865,0.0003349167,0.00009780638,0.00006705428,0.00010676661,0.000054207212,0.00007241576,0.0011756445],"category_scores_gemma":[0.00008802566,0.00015900568,0.0001311002,0.00015437472,0.00006831951,0.00010474444,0.000027920558,0.000097840064,0.000038313847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004980666,0.0001149581,0.5123223,0.002682528,0.0039623813,0.00041478514,0.002859069,0.00007401586,0.00045777083,0.010253141,0.057977963,0.40838298],"study_design_scores_gemma":[0.0061842725,0.0014363641,0.57896554,0.0030516202,0.0019463502,0.00009187507,0.00034510327,0.0017080051,0.0037167338,0.0017720369,0.40012285,0.0006592545],"about_ca_topic_score_codex":0.00046952927,"about_ca_topic_score_gemma":0.00017893143,"teacher_disagreement_score":0.40772372,"about_ca_system_score_codex":0.0009876932,"about_ca_system_score_gemma":0.0011441562,"threshold_uncertainty_score":0.99973744},"labels":[],"label_agreement":null},{"id":"W4401612362","doi":"10.1016/j.medj.2024.07.022","title":"Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial","year":2024,"lang":"en","type":"article","venue":"Med","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; National Institutes of Health; Fondation du cancer des Cèdres; Eisai; MacroGenics; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; Clovis Oncology; Novocure; Regeneron Pharmaceuticals; National Center for Research Resources; Karyopharm Therapeutics; Merck; GlaxoSmithKline; Amgen; University of Texas MD Anderson Cancer Center; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Oncology; Chemotherapy; Clinical trial; Internal medicine; Cancer; Immunotherapy","score_opus":0.05318943154343298,"score_gpt":0.4073210919774259,"score_spread":0.3541316604339929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401612362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755588,0.00914937,0.00004061984,0.012424386,0.0005532841,0.0011074273,0.0008910977,0.000034223678,0.0002407548],"genre_scores_gemma":[0.9910726,0.00588187,0.001506973,0.00010131283,0.0006379632,0.00022049554,0.00030684157,0.000021743239,0.00025019172],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986055,0.00005113086,0.0006093115,0.00041384873,0.00017816431,0.0001420585],"domain_scores_gemma":[0.99931854,0.00029066493,0.00006372619,0.00019433645,0.000024567267,0.00010814257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001333687,0.00015797239,0.0005692963,0.00008358066,0.000015636202,0.000011103097,0.000028658105,0.00009395913,0.0002669185],"category_scores_gemma":[0.000025960013,0.000116455514,0.00013773057,0.00012738154,0.00006343929,0.000043128697,0.0000036680806,0.00007811461,0.0000028330649],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27870005,0.0036298137,0.005904758,0.000037304268,0.0007284294,0.00021968238,0.0024266692,0.000029462006,0.00020322399,0.00011978813,0.00040891362,0.7075919],"study_design_scores_gemma":[0.84238565,0.004780274,0.104181014,0.00039707116,0.00042302252,0.0000048315096,0.00004194045,0.0039225593,0.0013647304,0.00027734292,0.042072713,0.00014886986],"about_ca_topic_score_codex":0.0012800426,"about_ca_topic_score_gemma":0.00059127045,"teacher_disagreement_score":0.70744306,"about_ca_system_score_codex":0.00014347694,"about_ca_system_score_gemma":0.00042580263,"threshold_uncertainty_score":0.47489178},"labels":[],"label_agreement":null},{"id":"W4401614952","doi":"10.3390/curroncol31080345","title":"Comparison of Weekly Paclitaxel Regimens in Recurrent Platinum-Resistant Ovarian Cancer: A Single Institution Retrospective Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Paclitaxel; Ovarian cancer; Retrospective cohort study; Oncology; Internal medicine; Platinum; Cancer; Biology","score_opus":0.14376785356662974,"score_gpt":0.4572133248618974,"score_spread":0.3134454712952677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401614952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96755725,0.021602662,0.00006582624,0.0026983963,0.0036350735,0.0016685484,0.0001041926,0.00007973127,0.002588306],"genre_scores_gemma":[0.99861306,0.0004653307,0.00012788776,0.000015622696,0.0002679173,0.00039993206,0.000037231064,0.000020311638,0.00005268719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979795,0.00015139446,0.00068576745,0.0005661208,0.0003098468,0.00030734006],"domain_scores_gemma":[0.99917156,0.000105206374,0.00018315892,0.00029446793,0.00012817823,0.00011740856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030828972,0.00022920671,0.0008342435,0.00031013938,0.000050905368,0.000019309813,0.00008159006,0.00011524472,0.00014463322],"category_scores_gemma":[0.00008403103,0.0001937061,0.00010521863,0.00058089715,0.00012046877,0.00007498926,0.000059349855,0.0004321543,0.00001758221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364461,0.016998922,0.8240222,0.0003811811,0.00036488211,0.00022212733,0.0074404385,0.000020339674,0.00062102923,0.0043198615,0.0042836126,0.14048897],"study_design_scores_gemma":[0.006895921,0.0154910805,0.9017515,0.002132454,0.00070418936,0.000014377092,0.002412586,0.00063909416,0.00055659167,0.00031477035,0.06882449,0.0002629514],"about_ca_topic_score_codex":0.00041468427,"about_ca_topic_score_gemma":0.0023721673,"teacher_disagreement_score":0.14022602,"about_ca_system_score_codex":0.0031987058,"about_ca_system_score_gemma":0.00067532616,"threshold_uncertainty_score":0.83645046},"labels":[],"label_agreement":null},{"id":"W4401652168","doi":"10.3389/fonc.2024.1408196","title":"Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes","year":2024,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of Calgary; Saskatchewan Cancer Agency; University of Alberta; University of Saskatchewan; BC Cancer Agency; McGill University Health Centre; Sunnybrook Health Science Centre; University of Toronto; Surrey Memorial Hospital; University of British Columbia","funders":"BC Cancer Foundation; University of Alberta; Women and Children's Health Research Institute; Cancer Research Society; Children's Health Research Institute","keywords":"Carcinogenesis; Oncology; Cancer research; Internal medicine; Medicine; Biology; Pathology; Bioinformatics; Cancer","score_opus":0.015913571928504348,"score_gpt":0.3174318545130261,"score_spread":0.30151828258452174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401652168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97636133,0.012203702,0.001093764,0.00534892,0.0021397658,0.00043920957,0.0001570697,0.000048421956,0.002207823],"genre_scores_gemma":[0.9918166,0.0011967885,0.0062057655,0.00025863742,0.00010100311,0.00008655694,0.000038812894,0.00002495074,0.00027089132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882686,0.00007004459,0.00033260774,0.00034388987,0.00012791374,0.00029867858],"domain_scores_gemma":[0.99938315,0.00019323923,0.000055645778,0.00021202744,0.000030155732,0.00012575153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014053275,0.0001706009,0.0006422106,0.00025927313,0.000023549075,0.0000117230675,0.000053121585,0.00010271199,0.00007340661],"category_scores_gemma":[0.000050594448,0.00013266555,0.000093898794,0.00016692429,0.000088434805,0.00004141268,0.00005289396,0.00012843993,0.0000036598744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009638232,0.00024603447,0.84647,0.00018252255,0.0002702867,0.00054200523,0.00045260997,0.0000016057446,0.000019792074,0.00060220034,0.0025841198,0.14853242],"study_design_scores_gemma":[0.0029102743,0.0006097096,0.9490532,0.0001475901,0.00032137823,0.000045093067,0.00033539845,0.00014463926,0.00017033669,0.00043357807,0.045716763,0.00011199707],"about_ca_topic_score_codex":0.0016618453,"about_ca_topic_score_gemma":0.00089597306,"teacher_disagreement_score":0.14842042,"about_ca_system_score_codex":0.0004411094,"about_ca_system_score_gemma":0.00029365983,"threshold_uncertainty_score":0.5409944},"labels":[],"label_agreement":null},{"id":"W4401786051","doi":"10.1007/978-3-031-39659-5_31","title":"Correction to: The Role of Cytology in the Management of Ovarian Lesions","year":2024,"lang":"en","type":"book-chapter","venue":"Essentials of Diagnostic Gynecological Pathology.","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"","keywords":"Cytology; Medicine; Computer science; Pathology","score_opus":0.016901682459793087,"score_gpt":0.27735309116314605,"score_spread":0.260451408703353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401786051","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08123624,0.021731066,0.00020709902,0.02365316,0.008073041,0.0090485625,0.0005910685,0.00008681218,0.85537297],"genre_scores_gemma":[0.9897364,0.003294159,0.0003167851,0.00032162297,0.00011326393,0.00032190862,0.000060844217,0.000029133053,0.005805887],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9978991,0.00012587877,0.00090462656,0.00048708438,0.00032588159,0.0002574161],"domain_scores_gemma":[0.9933318,0.005438822,0.00039368533,0.0006611258,0.00011519118,0.000059392416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006385059,0.00030306782,0.0009972012,0.00020837242,0.000043441152,0.000006190397,0.00033322637,0.0003766577,0.00087023113],"category_scores_gemma":[0.00077483215,0.0001668246,0.00034555243,0.00015205698,0.0003668545,0.000013024521,0.00023432127,0.000446171,0.00009017774],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030587983,0.0031113958,0.008525803,0.0009263493,0.0018601189,0.0048467023,0.00088896503,0.0002530401,0.0004131075,0.90952057,0.014606659,0.05474142],"study_design_scores_gemma":[0.0033834341,0.00783338,0.6908356,0.006569775,0.009543985,0.00055651617,0.0014688809,0.000036706053,0.0036216185,0.18264432,0.09279081,0.00071495515],"about_ca_topic_score_codex":0.00007590943,"about_ca_topic_score_gemma":0.00018618745,"teacher_disagreement_score":0.90850013,"about_ca_system_score_codex":0.000069273585,"about_ca_system_score_gemma":0.00007648966,"threshold_uncertainty_score":0.9528421},"labels":[],"label_agreement":null},{"id":"W4401831810","doi":"10.20944/preprints202408.1558.v1","title":"Are There Non-invasive Biomarker(s) That Would Facilitate the Detection of Ovarian Torsion? A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Preprints.org","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Medicine; Systematic review; Meta-analysis; Internal medicine; Ovarian torsion; Ovarian cancer; Gastroenterology; Oncology; Bioinformatics; Pathology; MEDLINE; Biology; Cancer; Biochemistry","score_opus":0.3436719181327797,"score_gpt":0.4108472424604617,"score_spread":0.06717532432768203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401831810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037890622,0.99234015,0.000017700699,0.0008341879,0.000076818,0.0061135665,0.00021471971,0.000037638656,0.0003273252],"genre_scores_gemma":[0.017790288,0.97708833,0.000010248465,0.0002106836,0.000018159448,0.0034230952,0.000029708262,0.000046099733,0.001383364],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967253,0.0005763713,0.0011345388,0.00090121874,0.00042816118,0.00023437418],"domain_scores_gemma":[0.9962453,0.00035199456,0.0012866057,0.0018307368,0.00015542508,0.00012990666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013611339,0.00060258806,0.007091996,0.00028484192,0.00009401711,0.000023029888,0.00025088052,0.00031667217,0.00081323367],"category_scores_gemma":[0.00035535946,0.00027863172,0.0038905502,0.000985932,0.00008167519,0.000047037393,0.0002783916,0.00051760994,0.00042057526],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004545473,0.00007605895,0.00033982194,0.73413485,0.26426294,0.00005324663,0.00012430332,7.504183e-8,0.0000010931736,0.0000065872237,0.00002576814,0.000970669],"study_design_scores_gemma":[0.00011378216,0.000026932194,0.0007881164,0.086632304,0.89744675,0.00005764582,0.00011829996,0.0000016446954,0.000024968596,0.000011975251,0.014580485,0.00019709181],"about_ca_topic_score_codex":0.00024198882,"about_ca_topic_score_gemma":0.0001244228,"teacher_disagreement_score":0.6475026,"about_ca_system_score_codex":0.00023047335,"about_ca_system_score_gemma":0.00013951308,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W4401847181","doi":"10.1136/ijgc-2024-005704","title":"Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Gynecologic oncology; Medicine; Novelty; Relevance (law); Oncology; Family medicine; Internal medicine; Gynecology; Political science","score_opus":0.05096300176144875,"score_gpt":0.37081358492742783,"score_spread":0.3198505831659791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401847181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7494859,0.0076717706,0.000029807878,0.20916684,0.014959156,0.0004431278,0.00007073294,0.000030773463,0.018141892],"genre_scores_gemma":[0.9832268,0.0046555907,0.000080322294,0.009434645,0.0018275821,0.000058566922,0.000009998507,0.000016615873,0.0006899214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977074,0.0005042794,0.000720837,0.0002941468,0.0005461554,0.00022716544],"domain_scores_gemma":[0.9970712,0.0021470962,0.00025387926,0.00017323226,0.00024174184,0.00011282519],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089083,0.00020246179,0.00041923442,0.00009938554,0.00006152695,0.00009597213,0.00064226397,0.00011906173,0.00814989],"category_scores_gemma":[0.00041625754,0.000081952414,0.00032548787,0.00014848555,0.00020565878,0.00008076379,0.00014478248,0.0008141129,0.00014831852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002951044,0.0038669677,0.09931245,0.000030018178,0.0038816652,0.025910025,0.002392886,0.0006301588,0.00045583927,0.021145329,0.24435757,0.5950661],"study_design_scores_gemma":[0.0016110329,0.0013411418,0.46366355,0.00026162894,0.00012848654,0.000101817226,0.00011624183,0.00016633945,0.000178189,0.00071140786,0.5316361,0.00008406352],"about_ca_topic_score_codex":0.0001221512,"about_ca_topic_score_gemma":0.0006598554,"teacher_disagreement_score":0.59498197,"about_ca_system_score_codex":0.0012948377,"about_ca_system_score_gemma":0.00029909465,"threshold_uncertainty_score":0.9927568},"labels":[],"label_agreement":null},{"id":"W4402044273","doi":"10.3390/curroncol31090378","title":"Ovarian Mesonephric-like Adenocarcinoma: Its Prevalence in a Japanese High-Volume Cancer Center and a Literature Review on Therapeutic Targets","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Mesonephric duct; Ovarian cancer; Center (category theory); Adenocarcinoma; Gynecology; Oncology; Volume (thermodynamics); Bioinformatics; Internal medicine; Biology","score_opus":0.10376864477001324,"score_gpt":0.4330743453224005,"score_spread":0.3293057005523873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402044273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013299184,0.98890126,1.7754401e-7,0.0027887805,0.0036516176,0.003973571,0.00043650655,0.00005480757,0.00017996995],"genre_scores_gemma":[0.00012519269,0.992626,0.00002051758,0.0010725047,0.00070814346,0.0037903662,0.0004150986,0.000102371785,0.0011397694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638116,0.00048255984,0.00090307405,0.0013135057,0.00032564971,0.0005940751],"domain_scores_gemma":[0.99850404,0.00015470869,0.0003446263,0.00060358347,0.00011431779,0.00027870853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003220116,0.00087406853,0.0032734948,0.00042087218,0.000046546702,0.00005062825,0.00022835903,0.0005345978,0.00054571644],"category_scores_gemma":[0.000041681524,0.00057161384,0.00048157093,0.0007711232,0.00007994773,0.00007024061,0.00015768394,0.0014698504,0.00024052776],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040126928,0.00088840263,0.00045820096,0.2866182,0.00044663873,0.0010527698,0.00037510644,2.1662732e-8,2.2012742e-8,0.00013413241,0.017471487,0.6925149],"study_design_scores_gemma":[0.0010807649,0.0005414679,0.00065231195,0.31744146,0.0051207454,0.000459052,0.0000042227657,0.0000032819137,3.6864957e-8,0.000009086399,0.6744037,0.00028379852],"about_ca_topic_score_codex":0.000012156151,"about_ca_topic_score_gemma":0.00003340843,"teacher_disagreement_score":0.6922311,"about_ca_system_score_codex":0.0014802217,"about_ca_system_score_gemma":0.0008457298,"threshold_uncertainty_score":0.99967355},"labels":[],"label_agreement":null},{"id":"W4402132538","doi":"10.30683/1929-2279.2024.13.03","title":"Antitumor Activity of Dehydroxymethylepoxyquinomicin (DHMEQ) in Monotherapy and Combination with Cisplatin in the SKOV-3 Ovarian Cancer Model","year":2024,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cisplatin; Pharmacology; Cancer research; Combination therapy; Medicine; Cancer; Chemistry; Biology; Internal medicine; Chemotherapy","score_opus":0.059457944534067685,"score_gpt":0.4256233400637891,"score_spread":0.36616539552972144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402132538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696262,0.012842916,0.00007413963,0.016806826,0.000049734357,0.00041774975,0.00001786433,0.0000029934429,0.00016161197],"genre_scores_gemma":[0.9866848,0.012740181,0.00026761377,0.00009812205,0.000080090605,0.00007090086,0.0000011912814,0.000018472057,0.00003864084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845743,0.00017828683,0.00033169883,0.00018268559,0.00061053643,0.00023935946],"domain_scores_gemma":[0.99918026,0.00029641128,0.00011946032,0.00014685752,0.00018932308,0.00006768166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015717549,0.00011575503,0.00036090674,0.00054936775,0.00003653639,0.0000636771,0.00011895506,0.000049831884,0.000054544176],"category_scores_gemma":[0.000030258272,0.00006637581,0.000048822607,0.0006455461,0.00012924876,0.00024479808,0.000020329067,0.0005739825,4.2738728e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009330861,0.0026829198,0.6745951,0.0012999554,0.0012190684,0.001520241,0.010028395,0.010058313,0.0823481,0.0050174645,0.0027568415,0.1991427],"study_design_scores_gemma":[0.015577486,0.0036613464,0.7649642,0.0065304213,0.00025653766,0.00017492964,0.000761124,0.07621633,0.12529956,0.004854225,0.0014099182,0.00029392366],"about_ca_topic_score_codex":0.0031232988,"about_ca_topic_score_gemma":0.002387098,"teacher_disagreement_score":0.19884877,"about_ca_system_score_codex":0.00041598728,"about_ca_system_score_gemma":0.00087378314,"threshold_uncertainty_score":0.47215143},"labels":[],"label_agreement":null},{"id":"W4402283491","doi":"10.1136/ijgc-2024-005753","title":"Anastomotic diversion rates following integration of indocyanine green fluorescence angiography in cytoreductive surgery for ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University","funders":"","keywords":"Medicine; Indocyanine green; Anastomosis; Ovarian cancer; Cytoreductive surgery; Angiography; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.037786488762256994,"score_gpt":0.35242529460028776,"score_spread":0.3146388058380308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402283491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98145765,0.006545703,0.0005400371,0.0079665715,0.003026497,0.00030640877,0.00008853749,0.000011144352,0.000057452933],"genre_scores_gemma":[0.99705,0.0013526258,0.0008140995,0.00016479428,0.00048257556,0.000068234614,0.000015322961,0.000011070084,0.000041265255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870694,0.0000404828,0.0005169648,0.00019353803,0.00039191663,0.00015014842],"domain_scores_gemma":[0.998572,0.0006111458,0.00022628927,0.000055983888,0.00045785782,0.00007674297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033578405,0.00013058186,0.00039861113,0.0005462774,0.000022309981,0.000029425135,0.00012572449,0.00008282189,0.00034097812],"category_scores_gemma":[0.00021168042,0.000090271125,0.0006037234,0.0003496944,0.00005553812,0.00022630801,0.000028488266,0.00017261866,8.86811e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016809345,0.00071170187,0.75171506,0.00011442228,0.0025260784,0.00090593105,0.00065100536,0.00025966117,0.006879826,0.0006512173,0.0027132493,0.23119092],"study_design_scores_gemma":[0.002349429,0.0007817859,0.98049915,0.0024025273,0.00050407933,0.000042589723,0.00021930246,0.0009916861,0.00980767,0.0010135669,0.001240347,0.00014784028],"about_ca_topic_score_codex":0.0006330348,"about_ca_topic_score_gemma":0.00020728231,"teacher_disagreement_score":0.23104309,"about_ca_system_score_codex":0.00067263417,"about_ca_system_score_gemma":0.00036496154,"threshold_uncertainty_score":0.37334713},"labels":[],"label_agreement":null},{"id":"W4402405333","doi":"10.1016/j.jogc.2024.102660","title":"Diagnostic Laparoscopy: Unveiling Primary Fallopian Tube Carcinoma","year":2024,"lang":"en","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Laparoscopy; Fallopian tube; Carcinoma; General surgery; Gynecology; Pathology","score_opus":0.007593273955712979,"score_gpt":0.23644838675108318,"score_spread":0.22885511279537019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402405333","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02135005,0.08018283,0.0000015111816,0.00084181194,0.8957364,0.0002527386,0.0002409657,0.00000772981,0.0013859919],"genre_scores_gemma":[0.5481688,0.017456591,0.0006082815,0.0013623998,0.4289481,0.000049025213,0.0003557326,0.00022910089,0.0028219922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732286,0.000057558384,0.00086794305,0.00038610827,0.0009430883,0.00042244975],"domain_scores_gemma":[0.9853389,0.012761054,0.0005265079,0.00025699215,0.0006286459,0.0004878527],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027425063,0.00039460388,0.0012839653,0.00045426778,0.00009370288,0.00007269216,0.00017939141,0.00068219187,0.00025324005],"category_scores_gemma":[0.009447869,0.0003141905,0.00020712458,0.00037474404,0.00007504816,0.000050273597,0.00009554763,0.001593432,0.0000036341028],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00000967416,0.00012169558,0.028494999,0.0007703623,0.00071214297,0.031005029,0.0000401161,0.000006907579,7.3885155e-7,0.000022384504,0.923255,0.015560946],"study_design_scores_gemma":[0.00247528,0.0011949915,0.045151103,0.0001964441,0.0019552924,0.00010369662,0.0000464156,0.00000730172,0.000016122398,0.000059655948,0.94853455,0.00025915823],"about_ca_topic_score_codex":0.019070886,"about_ca_topic_score_gemma":0.022613302,"teacher_disagreement_score":0.52681875,"about_ca_system_score_codex":0.0054277917,"about_ca_system_score_gemma":0.017149819,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W4402452245","doi":"10.1007/978-981-19-7696-4_68-1","title":"Benign Tumor-Like Lesions of the Ovary","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Ovary; Ovarian tumor; Medicine; Pathology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.0266843671122606,"score_gpt":0.26106975492134904,"score_spread":0.23438538780908844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402452245","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076419994,0.0043799975,0.0000023573118,0.004160289,0.00069216284,0.00045874086,0.000094936426,0.00004299044,0.9900921],"genre_scores_gemma":[0.032389954,0.00057903555,0.00014819103,0.0011399416,0.00024917597,0.000022849652,0.000022984552,0.000057436228,0.96539044],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990907,0.0000033167296,0.0002489331,0.0002776371,0.00027174418,0.00010768137],"domain_scores_gemma":[0.99916726,0.000047202426,0.00007491123,0.00059050776,0.000049481554,0.00007062505],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004214694,0.00021080767,0.00037491467,0.0000691576,0.00003114266,0.0000074435766,0.00008728555,0.000118616736,0.004374667],"category_scores_gemma":[0.0000035508676,0.00011069655,0.00038546618,0.000028313474,0.00007493225,0.00000947983,0.00009856735,0.00024921732,0.0003294331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025517043,0.00010474207,0.00031095612,0.00029826115,0.0008996777,0.00027015863,0.000052454827,8.201664e-7,0.000017816606,0.84025824,0.15310885,0.004652532],"study_design_scores_gemma":[0.00052387425,0.00021123928,0.002171541,0.002075116,0.0016399221,0.00008876259,0.000013492534,0.0000043732375,0.00037833647,0.020314856,0.9724193,0.00015917985],"about_ca_topic_score_codex":0.00005067364,"about_ca_topic_score_gemma":0.000046558118,"teacher_disagreement_score":0.81994337,"about_ca_system_score_codex":0.000103746876,"about_ca_system_score_gemma":0.0002213325,"threshold_uncertainty_score":0.9965355},"labels":[],"label_agreement":null},{"id":"W4402532043","doi":"10.20944/preprints202409.1008.v1","title":"Multimodal Optical Imaging of Ex Vivo Fallopian Tubes to Distinguish Early and Occult Tubo-Ovarian Cancers","year":2024,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vancouver Coastal Health Research Institute","keywords":"Autofluorescence; Ex vivo; Optical coherence tomography; Pathology; Serous fluid; Ovarian cancer; Lesion; Medicine; In vivo; Cancer; Biology; Radiology; Fluorescence; Optics; Internal medicine","score_opus":0.05570838244370478,"score_gpt":0.3499532694869946,"score_spread":0.2942448870432898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402532043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775745,0.0006739963,0.00004759272,0.0037275525,0.0010591882,0.0014415731,0.0002228382,0.00016590492,0.01508682],"genre_scores_gemma":[0.995665,0.00016808526,0.0022078452,0.00028764945,0.0005256107,0.0003247443,0.000037720638,0.00009525713,0.0006881021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661154,0.000055892997,0.0007202058,0.0015780801,0.00051276485,0.0005215175],"domain_scores_gemma":[0.99779487,0.00011112199,0.00012010033,0.0011627068,0.00025138093,0.00055982784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036808752,0.0005605191,0.0009862932,0.00025507965,0.000067372996,0.000064374806,0.00028639336,0.00024920417,0.0005491604],"category_scores_gemma":[0.00037565228,0.00052074314,0.00029815908,0.00019954496,0.00019680198,0.00004182063,0.0021274916,0.0008797693,0.00026524384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022223766,0.00025813855,0.98606616,0.0011952284,0.0008275157,0.00037655042,0.0026327954,0.00014059416,0.0034261444,0.0011883182,0.00016438057,0.0035019375],"study_design_scores_gemma":[0.0013835144,0.00010510821,0.96876585,0.002712633,0.0009026494,0.000045613164,0.00014941655,0.00048694835,0.022430956,0.0005738237,0.0019522298,0.000491241],"about_ca_topic_score_codex":0.0077003194,"about_ca_topic_score_gemma":0.00018330764,"teacher_disagreement_score":0.019004812,"about_ca_system_score_codex":0.00070095295,"about_ca_system_score_gemma":0.00059222645,"threshold_uncertainty_score":0.9997244},"labels":[],"label_agreement":null},{"id":"W4402559844","doi":"10.1016/j.annonc.2024.08.825","title":"764P How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in platinum sensitive recurrent ovarian cancer and long-term outcomes","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Duration (music); Term (time); Ovarian cancer; Oncology; Intensive care medicine; Internal medicine; Cancer","score_opus":0.2136544856485848,"score_gpt":0.42551418100671445,"score_spread":0.21185969535812965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402559844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8321915,0.00036328766,0.0001382923,0.1658111,0.0005265473,0.0005572054,0.0001075554,0.000012709328,0.00029175708],"genre_scores_gemma":[0.99279124,0.0052318973,0.00018156826,0.0013505103,0.00011752557,0.00018449743,0.00007086303,0.00001768193,0.00005421165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866647,0.0002922993,0.00033814073,0.00031346717,0.0002187924,0.00017082023],"domain_scores_gemma":[0.99781126,0.0012989666,0.00028131166,0.00019078386,0.00036242034,0.000055250814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008134551,0.0001582553,0.00034820932,0.00015508424,0.000043499975,0.000033584267,0.000060075523,0.00007468179,0.000046306188],"category_scores_gemma":[0.00025191953,0.00010059476,0.000048838236,0.00021800488,0.00006623125,0.00037489235,0.000024201592,0.00020762206,9.280392e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020823805,0.0014229203,0.7725291,0.000055543387,0.0012448531,0.00022608992,0.0070034075,0.000026606544,0.00007083823,0.00207791,0.0007985108,0.21246181],"study_design_scores_gemma":[0.001723605,0.002362764,0.99045366,0.00059225556,0.00006743856,0.000026653874,0.0003960685,0.00016148963,0.003107857,0.0000361551,0.00097411004,0.00009794467],"about_ca_topic_score_codex":0.00074309757,"about_ca_topic_score_gemma":0.0038076735,"teacher_disagreement_score":0.21792454,"about_ca_system_score_codex":0.00017163175,"about_ca_system_score_gemma":0.00025434914,"threshold_uncertainty_score":0.41021356},"labels":[],"label_agreement":null},{"id":"W4402559856","doi":"10.1016/j.annonc.2024.08.824","title":"763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Oncology; Internal medicine; Poly ADP ribose polymerase; Gynecology; Cancer; Genetics; DNA; Polymerase; Biology","score_opus":0.05025327819796144,"score_gpt":0.41482749380043477,"score_spread":0.36457421560247333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402559856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96981215,0.0017497968,0.000013896534,0.021612564,0.00016849517,0.0021881894,0.00014277275,0.00004735111,0.0042647948],"genre_scores_gemma":[0.9896856,0.00064257695,0.006925896,0.0003058343,0.0002717013,0.0013721886,0.00003282397,0.0000544631,0.00070892274],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99780333,0.00012586627,0.0006444917,0.0005930544,0.0003266971,0.0005065653],"domain_scores_gemma":[0.99859923,0.00018007409,0.0002811785,0.0003935913,0.00030946758,0.00023646865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041187007,0.00030518766,0.0010740767,0.00034195327,0.00006573453,0.000025248744,0.000091754206,0.00012802983,0.00038908786],"category_scores_gemma":[0.000023021286,0.00020870552,0.00008822281,0.0005083677,0.00011355788,0.00010780789,0.000042933876,0.00013654817,0.0000029812197],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4587784,0.026102724,0.0059316023,0.0011570733,0.006129367,0.0046937265,0.01633744,0.00033488477,0.048542093,0.0006045347,0.013867023,0.41752112],"study_design_scores_gemma":[0.29713383,0.49133435,0.073589124,0.0111746015,0.0017051456,0.00007342495,0.0018188828,0.0008559249,0.01803356,0.00011504175,0.10310306,0.0010630427],"about_ca_topic_score_codex":0.0011010589,"about_ca_topic_score_gemma":0.0016257039,"teacher_disagreement_score":0.46523163,"about_ca_system_score_codex":0.0016216475,"about_ca_system_score_gemma":0.0031599407,"threshold_uncertainty_score":0.8510764},"labels":[],"label_agreement":null},{"id":"W4402559885","doi":"10.1016/j.annonc.2024.08.813","title":"752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of Calgary","funders":"National Health and Medical Research Council; Medical Research Council; Marshfield Clinic Research Foundation; BeiGene; Cancer Institute NSW; Ovarian Cancer Australia; National Cancer Institute; National Institutes of Health; Cancer Australia; Medical Research and Materiel Command; Genentech; AstraZeneca","keywords":"Medicine; Ovarian carcinoma; Serous fluid; Internal medicine; Oncology; Serous carcinoma; Carcinoma; Overall survival; Gynecology; Ovarian cancer; Cancer","score_opus":0.06389431438586542,"score_gpt":0.3790001159869204,"score_spread":0.315105801601055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402559885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400085,0.0005815225,0.000009280767,0.004583948,0.0002159572,0.0002719781,0.00006423879,0.000008546359,0.00026367744],"genre_scores_gemma":[0.99903566,0.00019219054,0.0003236881,0.00030482528,0.00006498083,0.000015616846,0.000032371117,0.000013248185,0.00001740303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888957,0.00009222341,0.00043554333,0.00026387512,0.0001732707,0.00014554632],"domain_scores_gemma":[0.99941576,0.00018836255,0.00007805568,0.0001294933,0.000081980346,0.00010633437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002657378,0.000111707806,0.000519932,0.00011472697,0.000009941499,0.0000042515876,0.000032011252,0.00012378627,0.00003485112],"category_scores_gemma":[0.000039274993,0.000082873354,0.000051530726,0.00010925193,0.00021781912,0.000038028025,0.000037773134,0.00013228541,0.0000011107225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004127445,0.000852797,0.9856257,0.00012744476,0.00026425146,0.00017259571,0.000119163,0.0000022331083,0.000009647389,0.0012895975,0.00021867377,0.010905164],"study_design_scores_gemma":[0.0046163592,0.0061782957,0.9876827,0.00010406354,0.00013356996,0.00000993859,0.000024252273,0.000013418842,0.000078959274,0.00019230817,0.00090365973,0.00006249375],"about_ca_topic_score_codex":0.00028612436,"about_ca_topic_score_gemma":0.00007495661,"teacher_disagreement_score":0.010842671,"about_ca_system_score_codex":0.000023993794,"about_ca_system_score_gemma":0.00013695733,"threshold_uncertainty_score":0.33794773},"labels":[],"label_agreement":null},{"id":"W4402559996","doi":"10.1016/j.annonc.2024.08.794","title":"732P Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as a first-line treatment for endometrial cancer (EC): Progression-free survival (PFS) by clinical factors in DUO-E","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Medicine; Durvalumab; Paclitaxel; Olaparib; Carboplatin; Oncology; Endometrial cancer; Internal medicine; Progression-free survival; Cancer; Overall survival; Chemotherapy; Cisplatin; Nivolumab; Immunotherapy","score_opus":0.16801789610162463,"score_gpt":0.4963520012881549,"score_spread":0.3283341051865303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402559996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931711,0.021097695,0.0000244582,0.03519801,0.0036808548,0.0035574434,0.0028637112,0.000113959846,0.0017528383],"genre_scores_gemma":[0.9824683,0.012113848,0.00030782033,0.0004718169,0.00096955517,0.0018346981,0.000597043,0.00009718313,0.0011397391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560994,0.0003524706,0.0015919763,0.0010484799,0.0005897743,0.0008073563],"domain_scores_gemma":[0.9940428,0.0041957977,0.00041184033,0.00067496096,0.00024569355,0.00042888487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012888776,0.00055002095,0.002062645,0.00034857937,0.00010434665,0.000037948146,0.0002625339,0.00061357534,0.000487995],"category_scores_gemma":[0.0016614308,0.00040821516,0.00085753103,0.00061084406,0.00023874432,0.00012248103,0.000110518726,0.00035258126,0.00001945187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014872421,0.015856031,0.26856926,0.00059441663,0.0056888596,0.00065239123,0.0013793581,0.000022068734,0.0006892864,0.00073761545,0.2765678,0.4143705],"study_design_scores_gemma":[0.07140849,0.06543563,0.021765044,0.001006286,0.0015944765,0.000027342188,0.00027287245,0.0003325302,0.012078417,0.0007386147,0.8246292,0.0007110955],"about_ca_topic_score_codex":0.004190495,"about_ca_topic_score_gemma":0.0032610726,"teacher_disagreement_score":0.54806143,"about_ca_system_score_codex":0.00077948614,"about_ca_system_score_gemma":0.0015699887,"threshold_uncertainty_score":0.999837},"labels":[],"label_agreement":null},{"id":"W4402560004","doi":"10.1016/j.annonc.2024.08.781","title":"719MO A phase I/II study of rinatabart sesutecan (Rina-S) in patients with advanced ovarian or endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Medicine; Endometrial cancer; Ovarian cancer; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.07695685094731747,"score_gpt":0.44070883043770515,"score_spread":0.3637519794903877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402560004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994634,0.0007770558,0.0000034120185,0.0016691405,0.0003875959,0.0013619328,0.00012173541,0.000020189884,0.0010249679],"genre_scores_gemma":[0.9986682,0.00037482282,0.00019696972,0.0001801918,0.000092551185,0.00031022565,0.000018819788,0.000022604521,0.00013560647],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985595,0.00007676898,0.0004751679,0.0003553167,0.00027549645,0.00025775534],"domain_scores_gemma":[0.9990579,0.00020839991,0.00015451541,0.00026875452,0.00020944196,0.00010097188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022198877,0.00016940017,0.00073897,0.00043270257,0.000025443316,0.0000043179507,0.00008088026,0.00007633639,0.00044475053],"category_scores_gemma":[0.00009282616,0.00011368769,0.00007006851,0.00078301446,0.000065310436,0.00008909944,0.000057009445,0.00014905579,0.000002766828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029900828,0.04344572,0.13694078,0.00029568194,0.0014575816,0.001132825,0.0026089232,0.0000488802,0.00009405132,0.00022163565,0.0016138792,0.7822392],"study_design_scores_gemma":[0.15178782,0.38320726,0.37579045,0.0010189583,0.00071886246,0.000020028441,0.00080908835,0.000033524113,0.0031149576,0.00004607543,0.083143376,0.0003096203],"about_ca_topic_score_codex":0.0009768246,"about_ca_topic_score_gemma":0.0013581633,"teacher_disagreement_score":0.7819296,"about_ca_system_score_codex":0.00014393395,"about_ca_system_score_gemma":0.0006270753,"threshold_uncertainty_score":0.48697066},"labels":[],"label_agreement":null},{"id":"W4402582419","doi":"10.1503/cmaj.231763-f","title":"Salpingectomie prophylactique pour réduire le risque de cancer de l’ovaire","year":2024,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Gynecology; Medicine","score_opus":0.009071870288510073,"score_gpt":0.28057806600048707,"score_spread":0.271506195711977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402582419","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03951915,0.12152332,0.0004994036,0.81901175,0.009779276,0.00035303962,0.000235268,0.00006854699,0.009010269],"genre_scores_gemma":[0.90833706,0.022295699,0.0004315648,0.025506211,0.025762798,0.0001171709,0.000015424977,0.00011054825,0.017423522],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601465,0.0004695913,0.0005792417,0.0003643124,0.001100806,0.0014714113],"domain_scores_gemma":[0.99453974,0.00040943563,0.00018105273,0.00015213463,0.00035811795,0.0043595363],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024810734,0.0002997921,0.000458026,0.00029789616,0.00039887664,0.000375909,0.00020806864,0.0010403182,0.015669491],"category_scores_gemma":[0.0014876486,0.0002892946,0.0003255576,0.00047326327,0.00008172735,0.00023277744,0.00001842585,0.0023893192,0.00057742035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000016707963,0.00017681115,0.0783562,0.0003047021,0.0014595536,0.014946508,0.0012581333,0.00006926121,0.00002582429,0.003925953,0.56912297,0.33033738],"study_design_scores_gemma":[0.0018838944,0.00016383886,0.05004185,0.004782888,0.0005854216,0.0027943866,0.00055822934,0.005864297,0.00021655933,0.0009975798,0.931787,0.00032403544],"about_ca_topic_score_codex":0.11182325,"about_ca_topic_score_gemma":0.18812451,"teacher_disagreement_score":0.8688179,"about_ca_system_score_codex":0.032066673,"about_ca_system_score_gemma":0.09653916,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W4402641790","doi":"10.3390/curroncol31090417","title":"Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Debulking; Surgery; Complication; Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Stage (stratigraphy); Adjuvant; Pleural effusion; Cancer; Internal medicine","score_opus":0.07135327151306979,"score_gpt":0.39826476088575163,"score_spread":0.32691148937268183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402641790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8815178,0.05062803,0.00040444755,0.061594035,0.0024069657,0.0011450081,0.00013250406,0.000080558355,0.0020906085],"genre_scores_gemma":[0.99372464,0.004716598,0.00007635468,0.00090117013,0.00015944548,0.00032363253,0.000037891772,0.000015925742,0.000044359127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933887,0.0000550545,0.00016802635,0.00024966692,0.000059107188,0.00012925518],"domain_scores_gemma":[0.9990895,0.0005803508,0.00004131404,0.0001508188,0.00005882576,0.00007918435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087974775,0.00012679306,0.0003562505,0.000095838746,0.00003607879,0.0000084012845,0.000026943926,0.00005806574,0.00010898352],"category_scores_gemma":[0.000015499083,0.000084268744,0.00008022897,0.00011145187,0.00006836001,0.000022025639,0.0000129451155,0.00012348432,0.0000114821605],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001183206,0.00071883324,0.026926026,0.0002335674,0.0003363518,0.00002154919,0.0012547633,0.0000018381844,0.0006053038,0.0030919467,0.018829882,0.9478616],"study_design_scores_gemma":[0.0019976276,0.0012134778,0.32033646,0.0013410668,0.00019405365,0.00005530442,0.00006981188,0.00044980767,0.009097335,0.00031746284,0.66476756,0.00016003074],"about_ca_topic_score_codex":0.00005085849,"about_ca_topic_score_gemma":0.0000312007,"teacher_disagreement_score":0.9477016,"about_ca_system_score_codex":0.00025682268,"about_ca_system_score_gemma":0.00029735322,"threshold_uncertainty_score":0.34363794},"labels":[],"label_agreement":null},{"id":"W4402644711","doi":"10.1038/s41597-024-03869-x","title":"High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma","year":2024,"lang":"en","type":"article","venue":"Scientific Data","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Therapeutic Innovation Australia; BC Cancer Foundation; Medical Research Future Fund; Australian Cancer Research Foundation; Australian Government; Ovarian Cancer Canada; Marshfield Clinic Research Foundation; Cancer Research Society; Peter MacCallum Cancer Centre; Victorian Cancer Agency","keywords":"Serous fluid; Ovarian cancer; Serous carcinoma; Ovarian carcinoma; Oncology; Clear cell; Ovary; Clear cell carcinoma; Internal medicine; Medicine; Cancer research; Drug; Cancer; Carcinoma; Pharmacology","score_opus":0.11066439839271523,"score_gpt":0.34568069755072056,"score_spread":0.23501629915800532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402644711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4944007,0.03640459,0.18752372,0.101576164,0.07252186,0.009694164,0.09450474,0.0020651866,0.0013088733],"genre_scores_gemma":[0.95577633,0.00005407144,0.022542847,0.00047220144,0.0007743886,0.000103701714,0.0103906635,0.00007208019,0.009813705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973317,0.000021149373,0.00035163836,0.0013275413,0.000503687,0.0004642828],"domain_scores_gemma":[0.9973109,0.00015800745,0.00006363209,0.0022049272,0.0001135429,0.0001489996],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.00085944525,0.00024284859,0.00031498182,0.00020041464,0.0003780436,0.0010445362,0.00061146764,0.00006845913,0.00013444095],"category_scores_gemma":[0.00004061652,0.00019607475,0.00012227678,0.00057687366,0.00022621786,0.00050178805,0.00037472585,0.00016010564,0.000112874965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021397247,0.0017349978,0.0033407928,0.0018777245,0.0020100346,0.00039747803,0.0030510486,0.000056859768,0.015901089,0.015211971,0.8574594,0.09874461],"study_design_scores_gemma":[0.00502121,0.0002057322,0.019354254,0.0012968442,0.0021404072,0.00014815769,0.0007533636,0.023667088,0.027448874,0.0020161942,0.91726077,0.0006871185],"about_ca_topic_score_codex":0.0003706159,"about_ca_topic_score_gemma":0.00022089352,"teacher_disagreement_score":0.46137565,"about_ca_system_score_codex":0.00011046932,"about_ca_system_score_gemma":0.00033287783,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W4402985285","doi":"10.21873/anticanres.17270","title":"Factors Limiting Ostomy Reversal After Cytoreductive Surgery for Ovarian Cancer: A Retrospective Study","year":2024,"lang":"en","type":"article","venue":"Anticancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cytoreductive surgery; Limiting; Medicine; Retrospective cohort study; Ovarian cancer; Cancer; Surgery; Oncology; Gynecology; General surgery; Internal medicine","score_opus":0.15912845345255552,"score_gpt":0.44885435892550696,"score_spread":0.2897259054729514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402985285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847013,0.0034113536,0.000045009743,0.00677969,0.0008742355,0.00289821,0.00022176815,0.00012090709,0.0009475761],"genre_scores_gemma":[0.9938477,0.0005400841,0.00009647068,0.00008373404,0.0012846086,0.003170314,0.000021493246,0.000085597465,0.0008699892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686563,0.00015093932,0.0003258738,0.0009342992,0.0009071429,0.00081611174],"domain_scores_gemma":[0.997807,0.0009416226,0.000037448095,0.0004279145,0.0005402684,0.00024574733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011688856,0.00026027655,0.0005818724,0.00047923462,0.00024383562,0.00018273783,0.000105503874,0.0000959732,0.0006204168],"category_scores_gemma":[0.0003417132,0.00019705963,0.0002798717,0.0010200692,0.00020738477,0.0001966836,0.00009167564,0.0005450594,0.000034432218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009192091,0.00078796956,0.9687021,0.0003499047,0.0014766526,0.0004875766,0.0040321215,9.494844e-7,0.00009995023,0.00071500416,0.010785671,0.011642899],"study_design_scores_gemma":[0.0013028934,0.0012232232,0.98111445,0.0010176427,0.00040407284,0.000008076343,0.0032577803,0.00011729796,0.0015819086,0.00036050644,0.009353292,0.00025888736],"about_ca_topic_score_codex":0.0023382332,"about_ca_topic_score_gemma":0.000377799,"teacher_disagreement_score":0.012412326,"about_ca_system_score_codex":0.0017633806,"about_ca_system_score_gemma":0.0013918575,"threshold_uncertainty_score":0.8035858},"labels":[],"label_agreement":null},{"id":"W4403097388","doi":"10.1067/j.cpradiol.2024.10.011","title":"Differentiating primary from metastatic ovarian tumors of gastrointestinal origin by CT","year":2024,"lang":"en","type":"article","venue":"Current Problems in Diagnostic Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canada Research Chairs","funders":"","keywords":"Medicine; Radiology; Pathology","score_opus":0.02867650554757486,"score_gpt":0.29879513526773205,"score_spread":0.2701186297201572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92932326,0.059691913,0.0054472946,0.0014239737,0.001650538,0.00144248,0.0004453829,0.0001325638,0.00044258064],"genre_scores_gemma":[0.994503,0.0015060366,0.0024653955,0.000084609805,0.0002051395,0.00039779276,0.00076747756,0.00004381518,0.000026709047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760973,0.00016830821,0.000890295,0.0006471168,0.00022233985,0.00046223085],"domain_scores_gemma":[0.9957358,0.0035463497,0.00017518278,0.000332601,0.0000530792,0.0001569893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002924781,0.00031904862,0.0008341132,0.00023528795,0.00002989518,0.000027556143,0.00015116087,0.000032093838,0.00036094565],"category_scores_gemma":[0.0011519918,0.00025905608,0.00015584228,0.0003260312,0.00016507742,0.00008313703,0.000065073655,0.0004846739,0.00003799411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053926156,0.0018423455,0.9177147,0.0019966268,0.00040789632,0.0010105239,0.00037522256,0.00019776198,0.0016479222,0.002353203,0.01519379,0.057206053],"study_design_scores_gemma":[0.0102216,0.0027073836,0.91992354,0.029730707,0.0018140608,0.0025093334,0.00012060822,0.0041993097,0.0015674855,0.012294094,0.013942006,0.0009698963],"about_ca_topic_score_codex":0.00035502503,"about_ca_topic_score_gemma":0.000022762197,"teacher_disagreement_score":0.06517975,"about_ca_system_score_codex":0.00032480524,"about_ca_system_score_gemma":0.00034015396,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W4403239841","doi":"10.1136/ijgc-2024-005919","title":"GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Verastem Oncology; GOG Foundation; Australia New Zealand Gynaecological Oncology Group; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Ovarian cancer; Serous fluid; Regimen; Oncology; Internal medicine; Discontinuation; KRAS; Tolerability; Clinical trial; Clinical endpoint; Progression-free survival; Adverse effect; Cancer; Chemotherapy; Colorectal cancer","score_opus":0.07159507315498903,"score_gpt":0.40996909379088864,"score_spread":0.3383740206358996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403239841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971975,0.0023251204,0.00006108808,0.0033032645,0.0019969526,0.0022616775,0.00017662307,0.00002547552,0.0001300255],"genre_scores_gemma":[0.996146,0.0007214915,0.0010700679,0.00040982498,0.0006837534,0.00081780454,0.000054506487,0.0000369316,0.000059590606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962154,0.0003443641,0.0013238399,0.00047219085,0.001289384,0.0003548214],"domain_scores_gemma":[0.99598855,0.0015843615,0.00094861945,0.00017938095,0.0009271101,0.00037199364],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070673926,0.00041518293,0.0015147617,0.0003993467,0.000048868766,0.00009279328,0.00024566884,0.00013731243,0.0013813358],"category_scores_gemma":[0.00080806477,0.00023253779,0.00036706525,0.00039853094,0.00022431284,0.00018063557,0.000041847055,0.00046716005,0.0000032361615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82182103,0.0055377614,0.099198274,0.00012323743,0.005641603,0.0005053148,0.0010577618,0.004102197,0.000070461014,0.00013544384,0.00041141527,0.06139552],"study_design_scores_gemma":[0.9137107,0.017249594,0.059902824,0.0025347811,0.0015590248,0.000031648655,0.000072364266,0.0025961015,0.0003975327,0.000094252326,0.0015472568,0.00030388063],"about_ca_topic_score_codex":0.0010283443,"about_ca_topic_score_gemma":0.00081592164,"teacher_disagreement_score":0.091889724,"about_ca_system_score_codex":0.0038604909,"about_ca_system_score_gemma":0.0029332028,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W4403249386","doi":"10.1016/j.ygyno.2024.07.555","title":"Oncologic outcomes among patients undergoing fertility-sparing treatment of atypical hyperplasia and grade one cancer of the endometrium using progestin therapy: Results of a novel, specialized, oncofertility program","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Oncofertility; Progestin; Fertility preservation; Gynecology; Fertility; Endometrial cancer; Oncology; Endometrium; Cancer; Obstetrics; Internal medicine; Hormone; Population","score_opus":0.10908844508021874,"score_gpt":0.3792467151502728,"score_spread":0.27015827007005405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924178,0.0019175541,0.000006730952,0.0013221666,0.00060874753,0.003089362,0.000111770525,0.000057784942,0.00046809218],"genre_scores_gemma":[0.9952804,0.0009479702,0.0031743073,0.00006352205,0.000052439926,0.00040485174,0.000013753582,0.000021706683,0.00004106669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740916,0.00025863503,0.0010174713,0.0005954067,0.000327478,0.00039186314],"domain_scores_gemma":[0.9965453,0.002231146,0.000510617,0.0004076893,0.0001871134,0.00011812161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003897734,0.00031323102,0.0013429354,0.00018963093,0.00008294352,0.000012610851,0.00013671501,0.0003203193,0.00006269394],"category_scores_gemma":[0.0007795,0.00018275654,0.00030110255,0.00060633133,0.0006372459,0.000060142593,0.00012464238,0.00019133992,5.111924e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020741555,0.013275095,0.8741075,0.00024969605,0.00078500225,0.000019360628,0.00052559964,0.000038494367,0.0007311222,0.00007419494,0.000014885719,0.1081049],"study_design_scores_gemma":[0.014350203,0.012512691,0.964293,0.0002710057,0.000693678,0.000008911538,0.00008737904,0.0003338553,0.0060236664,0.00010278986,0.0011964111,0.00012639121],"about_ca_topic_score_codex":0.0011156367,"about_ca_topic_score_gemma":0.001618792,"teacher_disagreement_score":0.10797851,"about_ca_system_score_codex":0.001500841,"about_ca_system_score_gemma":0.0009769244,"threshold_uncertainty_score":0.7452596},"labels":[],"label_agreement":null},{"id":"W4403249608","doi":"10.1016/j.ygyno.2024.07.456","title":"Canadian management of Serous Tubal Intraepithelial Carcinoma (Can-STIC)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; McMaster University; McGill University; University of Calgary; Memorial University of Newfoundland; University of British Columbia; Dalhousie University; St. John’s Health Sciences Centre; University of Toronto; University of Alberta; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Serous carcinoma; Gynecology; Serous fluid; General surgery; Internal medicine; Ovarian cancer; Cancer","score_opus":0.0182200598169985,"score_gpt":0.2972685235601204,"score_spread":0.2790484637431219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8743413,0.0019966913,0.000027953098,0.024306249,0.002488255,0.0010041578,0.00014396374,0.00011624669,0.095575154],"genre_scores_gemma":[0.9950612,0.00039755992,0.001586912,0.0010872476,0.00018297548,0.00017138824,0.000041805884,0.000020267273,0.001450654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986661,0.00005637468,0.00030858038,0.0003876826,0.00013453343,0.00044672846],"domain_scores_gemma":[0.9991684,0.00019096698,0.0000449133,0.00025842988,0.000054724223,0.00028256723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019544063,0.00017558904,0.00043665472,0.00020179198,0.00005391925,0.000013147699,0.000108895896,0.00021168379,0.0018917765],"category_scores_gemma":[0.00002398411,0.00013903173,0.00012102266,0.00024898825,0.00009595452,0.00002305054,0.00005057971,0.00018343597,0.00020355568],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022533558,0.0012290715,0.0983045,0.0010774824,0.001878332,0.033093944,0.00083696755,0.0000432062,0.00017384067,0.049483713,0.031151878,0.7825017],"study_design_scores_gemma":[0.0037109917,0.007272765,0.6260328,0.0001987947,0.0015613877,0.0005366229,0.0006881639,0.000295405,0.00080444425,0.002202367,0.35636804,0.00032819595],"about_ca_topic_score_codex":0.018055974,"about_ca_topic_score_gemma":0.04837334,"teacher_disagreement_score":0.7821735,"about_ca_system_score_codex":0.0021480941,"about_ca_system_score_gemma":0.0011677167,"threshold_uncertainty_score":0.99902064},"labels":[],"label_agreement":null},{"id":"W4403249882","doi":"10.1016/j.ygyno.2024.07.317","title":"3D organoid models for predicting drug response in platinum-sensitive, high-grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Organoid; Serous ovarian cancer; Ovarian cancer; Oncology; Serous fluid; Platinum; Drug response; Internal medicine; Epithelial ovarian cancer; Drug; Cancer; Pharmacology; Neuroscience; Biology","score_opus":0.029603607368928992,"score_gpt":0.3244030361045668,"score_spread":0.2947994287356378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960406,0.0015065983,0.00077620253,0.030590577,0.0021904097,0.0020697587,0.00022719562,0.00029974148,0.0019335098],"genre_scores_gemma":[0.98501873,0.0004048698,0.009327395,0.001952323,0.000429604,0.0015083525,0.00006115533,0.00005594187,0.0012416524],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976369,0.00029508522,0.0005192403,0.00075169187,0.0001700628,0.00062702876],"domain_scores_gemma":[0.9953691,0.00398132,0.00011082166,0.00027697973,0.00010311554,0.00015865701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009344685,0.0002939323,0.0007289506,0.00027636453,0.000116758994,0.000032800133,0.00010218657,0.00036390717,0.00040870777],"category_scores_gemma":[0.00049575156,0.00024013715,0.0001271774,0.0004067471,0.00010033068,0.00012035218,0.00007723092,0.00040074563,0.00003903021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038884368,0.011193005,0.11037993,0.0024319317,0.0050064577,0.035279647,0.029024573,0.045447957,0.017746586,0.03318596,0.07886507,0.5925545],"study_design_scores_gemma":[0.05099506,0.024138598,0.503219,0.0019742113,0.0031607694,0.0012426837,0.003812113,0.18698187,0.0140401,0.020600196,0.18768236,0.0021530318],"about_ca_topic_score_codex":0.00072748424,"about_ca_topic_score_gemma":0.0016782111,"teacher_disagreement_score":0.5904015,"about_ca_system_score_codex":0.0023899938,"about_ca_system_score_gemma":0.0013399239,"threshold_uncertainty_score":0.97925085},"labels":[],"label_agreement":null},{"id":"W4403250150","doi":"10.1016/j.ygyno.2024.07.560","title":"Voices of women with low-grade serous ovarian cancer: Results from a multinational survey","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ovarian Cancer Canada","funders":"","keywords":"Medicine; Multinational corporation; Serous ovarian cancer; Ovarian cancer; Serous fluid; Gynecology; General surgery; Oncology; Cancer; Internal medicine","score_opus":0.027588450933206114,"score_gpt":0.324597553348614,"score_spread":0.2970091024154079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873064,0.0012051656,0.00003284505,0.00709536,0.0006979801,0.00053491583,0.0011238916,0.00009673683,0.0019066834],"genre_scores_gemma":[0.99564064,0.0005068585,0.0019179129,0.0005943782,0.00020488698,0.00043249485,0.00032392485,0.000021042448,0.00035786518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821323,0.00020140175,0.00041761843,0.0005416893,0.00022435535,0.00040167835],"domain_scores_gemma":[0.99669474,0.0025653765,0.00016646321,0.0002520053,0.0001541814,0.00016720567],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006284304,0.00019608694,0.0006036058,0.00012342448,0.000051981602,0.000017791288,0.000111413916,0.0002192224,0.0010794582],"category_scores_gemma":[0.00034926564,0.00013357904,0.000055503602,0.00034006473,0.00015184189,0.00005792069,0.00004922679,0.00021324778,0.00004976492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009380194,0.0065920516,0.6238758,0.00042008076,0.004696655,0.0038041398,0.008071897,0.00063751166,0.0011687858,0.0017225407,0.011744539,0.32788584],"study_design_scores_gemma":[0.00641414,0.003888851,0.9636984,0.00016523732,0.00019120733,0.000025445841,0.00020616276,0.00033693833,0.00048487168,0.0003234572,0.02411696,0.00014836348],"about_ca_topic_score_codex":0.0070397584,"about_ca_topic_score_gemma":0.0089143,"teacher_disagreement_score":0.3398226,"about_ca_system_score_codex":0.0017516833,"about_ca_system_score_gemma":0.0013540875,"threshold_uncertainty_score":0.9998337},"labels":[],"label_agreement":null},{"id":"W4403250423","doi":"10.1016/j.ygyno.2024.07.213","title":"Homologous recombination status in BRCA wild-type patients as a predictor of disease volume and surgical outcome in patients with high-grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Homologous recombination; Oncology; Serous fluid; Ovarian cancer; Internal medicine; Disease; Serous ovarian cancer; Gynecology; Cancer; Genetics; Gene; Biology","score_opus":0.012608136172239277,"score_gpt":0.2913689870168873,"score_spread":0.278760850844648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944361,0.0006592968,6.274129e-7,0.002391649,0.0008137963,0.0012947351,0.00012182211,0.00004453716,0.00023747473],"genre_scores_gemma":[0.99838185,0.00043791358,0.00015747029,0.00024313851,0.000033568293,0.00030185023,0.00022161471,0.00002355493,0.00019901565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812937,0.00018434456,0.00050536846,0.00053153606,0.00023006246,0.00041930744],"domain_scores_gemma":[0.99900335,0.00033004643,0.00013214609,0.00019319728,0.00011870876,0.00022253205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017791464,0.0002206906,0.00064809906,0.0002963193,0.000029415482,0.000013087789,0.00006445202,0.00022868617,0.00046371474],"category_scores_gemma":[0.00018539152,0.00016282217,0.000044909502,0.00045511086,0.00013521478,0.00009469178,0.00006429228,0.00026820533,0.000013502856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016173229,0.0039845435,0.9724797,0.00014684285,0.00011405891,0.00082200347,0.00022876967,0.000036701967,4.448546e-7,0.0002964754,0.00024105943,0.020032078],"study_design_scores_gemma":[0.015096917,0.009656502,0.971257,0.00013220475,0.00020701443,0.000004280731,0.000023317001,0.000082907936,0.00000263991,0.00041744875,0.0029730918,0.00014667978],"about_ca_topic_score_codex":0.0016198215,"about_ca_topic_score_gemma":0.0011413067,"teacher_disagreement_score":0.019885397,"about_ca_system_score_codex":0.001471008,"about_ca_system_score_gemma":0.00064587034,"threshold_uncertainty_score":0.6639696},"labels":[],"label_agreement":null},{"id":"W4403250649","doi":"10.1016/j.ygyno.2024.07.419","title":"A phase III, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of therapy among patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-OV81/NCRI/RAMP 301","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Serous fluid; Serous ovarian cancer; Ovarian cancer; Oncology; Cancer; Internal medicine","score_opus":0.06630499522620008,"score_gpt":0.39115386280972236,"score_spread":0.32484886758352227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817229,0.002630261,0.000053312004,0.0020921533,0.002041256,0.010255378,0.00011090767,0.0002507359,0.0008430903],"genre_scores_gemma":[0.9900292,0.0007304452,0.002058117,0.00085380336,0.00046164068,0.0054210094,0.0002613222,0.00008619423,0.00009825238],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946764,0.0011751018,0.0013691108,0.0011483142,0.0008028234,0.00082823914],"domain_scores_gemma":[0.99303365,0.004379905,0.0009542006,0.00059859257,0.00046780708,0.0005658209],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015252552,0.00070020126,0.0030345942,0.0003539226,0.00020310683,0.00007199656,0.0002670129,0.00041248646,0.0010215603],"category_scores_gemma":[0.001146609,0.00043401666,0.00035490326,0.0008602329,0.0008026722,0.00016680564,0.00007900724,0.0007383116,0.000013784126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8202446,0.009900764,0.031934507,0.00033688283,0.00422106,0.0003168996,0.0024729562,0.0003575388,0.00008953689,0.00014099946,0.0017125685,0.12827168],"study_design_scores_gemma":[0.93075895,0.040084094,0.017141776,0.00072242355,0.0021970957,0.000015469557,0.00020874203,0.0023869905,0.0003281198,0.00007658994,0.005595184,0.00048455896],"about_ca_topic_score_codex":0.0014068948,"about_ca_topic_score_gemma":0.0011653836,"teacher_disagreement_score":0.12778711,"about_ca_system_score_codex":0.0016767186,"about_ca_system_score_gemma":0.0037960182,"threshold_uncertainty_score":0.99989164},"labels":[],"label_agreement":null},{"id":"W4403250889","doi":"10.1016/j.ygyno.2024.07.276","title":"Serum CA-125 levels in the context of ProMisE molecular classification provide preoperative prognostic information that can direct endometrial cancer management","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Context (archaeology); Cancer; Oncology; Internal medicine; Gynecology; General surgery","score_opus":0.049055402284770414,"score_gpt":0.33718740100633887,"score_spread":0.28813199872156847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393789,0.0019221002,0.000072441304,0.02842043,0.0010141765,0.008964642,0.00023802687,0.00007751636,0.019911742],"genre_scores_gemma":[0.99336207,0.00045856452,0.00024639646,0.0013752085,0.000050476432,0.0042931987,0.000068946734,0.0000094054085,0.00013570875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985171,0.0002759335,0.000425662,0.00027981235,0.00024169637,0.0002597847],"domain_scores_gemma":[0.9987511,0.00072525966,0.00015638581,0.00022639555,0.000091260816,0.000049587914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057230523,0.00017485983,0.00040882893,0.0002672249,0.000047544127,0.000036749618,0.00012623407,0.00014526657,0.00024817305],"category_scores_gemma":[0.00029087212,0.000107656946,0.00008887187,0.0005431838,0.000097606746,0.00013852565,0.000043246026,0.00019254444,0.000024137707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062627415,0.001939687,0.1814249,0.00131953,0.0013198353,0.0009239164,0.012005955,0.00014415728,0.00048285176,0.014767679,0.0053934287,0.77965176],"study_design_scores_gemma":[0.0069030924,0.0035950274,0.92552125,0.0003217044,0.0008671346,0.000031390744,0.004613788,0.00075035664,0.004061778,0.00028111233,0.052844357,0.00020902742],"about_ca_topic_score_codex":0.00032486554,"about_ca_topic_score_gemma":0.0009120505,"teacher_disagreement_score":0.7794428,"about_ca_system_score_codex":0.0011271236,"about_ca_system_score_gemma":0.000638356,"threshold_uncertainty_score":0.43901226},"labels":[],"label_agreement":null},{"id":"W4403250910","doi":"10.1016/j.ygyno.2024.07.130","title":"Developing ovarian cancer innovative diversion criteria (OV-Divert) to decrease the rate of diverting ileostomy among patients undergoing cytoreductive surgery for gynecologic malignancy","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ileostomy; Cytoreductive surgery; Ovarian cancer; Malignancy; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.04810546689178408,"score_gpt":0.34653049072758635,"score_spread":0.29842502383580227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98191786,0.0005648329,0.00071428466,0.010092151,0.0029589487,0.002718355,0.00018569261,0.00011147297,0.0007364101],"genre_scores_gemma":[0.99162966,0.00034177923,0.0028523274,0.0032421637,0.00021089497,0.0014364625,0.00011688066,0.000036573027,0.00013328418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973108,0.00032813897,0.00072890095,0.0007794991,0.0001919205,0.00066075206],"domain_scores_gemma":[0.9921181,0.0062265685,0.000365314,0.00028116273,0.0007657389,0.00024307941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009211665,0.00037013486,0.00088455237,0.00034807142,0.00039799107,0.00004555023,0.0002092092,0.0002852329,0.0007868612],"category_scores_gemma":[0.0041179946,0.0002496289,0.00022870496,0.0010201609,0.00023288208,0.00019382154,0.00033362856,0.00023406508,0.000025800431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010450743,0.00096135825,0.8439669,0.00066198886,0.0013363132,0.00040076015,0.0030830936,0.00006205498,0.000443164,0.0037939784,0.021591792,0.1226535],"study_design_scores_gemma":[0.002591434,0.002585476,0.9749643,0.00080579624,0.0005676599,0.000008697719,0.0013426914,0.00013774545,0.0027836196,0.0014418083,0.012394961,0.00037580525],"about_ca_topic_score_codex":0.00043142997,"about_ca_topic_score_gemma":0.00039926803,"teacher_disagreement_score":0.13099737,"about_ca_system_score_codex":0.0024322858,"about_ca_system_score_gemma":0.0026516863,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W4403250934","doi":"10.1016/j.ygyno.2024.07.109","title":"Final overall survival data from a randomized, open-label, phase II study of relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel among patients with recurrent platinum-resistant ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Paclitaxel; Open label; Glucocorticoid receptor; Nab-paclitaxel; Oncology; Ovarian cancer; Internal medicine; Glucocorticoid; Cancer research; Chemotherapy; Randomized controlled trial; Cancer","score_opus":0.05512589460480387,"score_gpt":0.358533714032534,"score_spread":0.3034078194277301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852724,0.00058460777,0.000041763906,0.00065651676,0.0009258195,0.007861301,0.0007507556,0.000048645572,0.00060332735],"genre_scores_gemma":[0.9956136,0.00017204492,0.0010375516,0.00008688984,0.000065165616,0.0018138908,0.0010122522,0.000042309486,0.00015634738],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99638987,0.0007049516,0.00085406966,0.0011583575,0.00046852673,0.000424249],"domain_scores_gemma":[0.99688274,0.0015438215,0.0004964175,0.0006712418,0.0002668091,0.00013894947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008217037,0.0003924708,0.0017690426,0.00021997721,0.00010962235,0.000048585265,0.0003638901,0.00021176126,0.00052602065],"category_scores_gemma":[0.00034535516,0.0002563853,0.000040633044,0.0005542436,0.00017793367,0.00031392905,0.00037779164,0.00047432136,0.000008332486],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4045271,0.08864464,0.4661288,0.00018343246,0.004497692,0.0007147022,0.0041456944,0.00011899861,0.00013449354,0.00071535516,0.0024792675,0.027709834],"study_design_scores_gemma":[0.55083627,0.07819556,0.36447063,0.0005371227,0.001413498,0.0000023930845,0.0004188365,0.0028442994,0.000021818854,0.00019691107,0.0007598914,0.00030277096],"about_ca_topic_score_codex":0.0067790486,"about_ca_topic_score_gemma":0.018731551,"teacher_disagreement_score":0.14630918,"about_ca_system_score_codex":0.0016063853,"about_ca_system_score_gemma":0.0012676166,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W4403251483","doi":"10.1016/j.ygyno.2024.07.022","title":"Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interim; Ovarian cancer; Oncology; Internal medicine; Gynecology; Interim analysis; Cancer; Clinical trial","score_opus":0.023837470427492412,"score_gpt":0.34583760093827504,"score_spread":0.32200013051078263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918366,0.0017377428,0.000016974867,0.005970968,0.0008510342,0.0011834531,0.00017003455,0.00007239546,0.0008137413],"genre_scores_gemma":[0.9964926,0.0006703901,0.0011132233,0.000664541,0.00004855553,0.00032587806,0.0005910388,0.000029035044,0.00006473095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981173,0.00015765929,0.00036898267,0.0007903402,0.00015560366,0.00041007515],"domain_scores_gemma":[0.9987666,0.0005125294,0.00008614215,0.00043839574,0.00006722849,0.00012911498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029618613,0.00024402454,0.000593513,0.00022529873,0.000036091096,0.000028051452,0.00017054155,0.00022286564,0.00074318075],"category_scores_gemma":[0.00017671795,0.00016462692,0.000025838473,0.00041439,0.00011334103,0.0001848183,0.00025652442,0.00033051218,0.000018595618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011548874,0.0012498344,0.598029,0.000055644752,0.00010108745,0.0012774849,0.00030080558,0.000022004031,0.000031253934,0.00016562467,0.0004517568,0.39716062],"study_design_scores_gemma":[0.0133545315,0.004681996,0.9689965,0.0003564183,0.00011561691,0.0000081707185,0.00017113706,0.00070881995,0.000013826141,0.00013127147,0.011274664,0.00018699563],"about_ca_topic_score_codex":0.00048444158,"about_ca_topic_score_gemma":0.008140183,"teacher_disagreement_score":0.39697364,"about_ca_system_score_codex":0.0007922609,"about_ca_system_score_gemma":0.0004986417,"threshold_uncertainty_score":0.8137308},"labels":[],"label_agreement":null},{"id":"W4403276721","doi":"10.1136/ijgc-2024-005883","title":"Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Observational study; Checklist; Interquartile range; Systematic review; MEDLINE; Ovarian cancer; Meta-analysis; Internal medicine; Cancer","score_opus":0.17106095717308906,"score_gpt":0.5313054002840988,"score_spread":0.3602444431110097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403276721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038928553,0.98971695,0.0000023678306,0.0044028964,0.0018798595,0.0034889956,0.000101496655,0.0000040537593,0.000014109121],"genre_scores_gemma":[0.001829273,0.9933685,0.00023128983,0.0004072856,0.00022155982,0.0038495392,0.000007875373,0.000020725369,0.00006394928],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965564,0.0001815833,0.0022599387,0.0003299827,0.0005134591,0.00015864168],"domain_scores_gemma":[0.995866,0.000820614,0.0021002723,0.00012471412,0.0010228957,0.00006549294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007077756,0.00034235386,0.0043635587,0.00037516677,0.000014885427,0.0000150101205,0.00012852841,0.00016625751,0.000035372646],"category_scores_gemma":[0.00096466346,0.00017596793,0.00055351044,0.00022699701,0.000055636738,0.00007884771,0.000079791054,0.0004717038,2.4638484e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011117913,0.0010035504,0.0033304202,0.8422372,0.03378906,0.00096086896,0.00048322734,0.000007921675,2.6737018e-7,0.00018951195,0.0010741863,0.11681262],"study_design_scores_gemma":[0.0025127262,0.0013940149,0.0058216485,0.9249117,0.032502312,0.00029830285,0.0008535124,0.000005348717,0.000001619092,0.00018865257,0.031213215,0.00029697115],"about_ca_topic_score_codex":0.000044785575,"about_ca_topic_score_gemma":0.00034558194,"teacher_disagreement_score":0.116515644,"about_ca_system_score_codex":0.004355283,"about_ca_system_score_gemma":0.00090863043,"threshold_uncertainty_score":0.99946684},"labels":[],"label_agreement":null},{"id":"W4403328419","doi":"10.1055/s-0044-1790706","title":"LEOPARD trial – Lymphadenectomy in Endometrioid Ovarian carcinoma PAtients with eaRly stage Disease","year":2024,"lang":"de","type":"article","venue":"Geburtshilfe und Frauenheilkunde","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Ontario Institute for Cancer Research; Jewish General Hospital; Université Laval","funders":"","keywords":"Stage (stratigraphy); Medicine; Lymphadenectomy; Disease; Ovary; Oncology; Carcinoma; Internal medicine; Gynecology; Cancer; Biology","score_opus":0.014542012895872375,"score_gpt":0.26555901150560746,"score_spread":0.2510169986097351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403328419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85549194,0.12717372,0.00014370205,0.0022174355,0.0064592157,0.0049645132,0.0012185801,0.00026035454,0.0020705578],"genre_scores_gemma":[0.98985493,0.0024486296,0.00022936572,0.0005459381,0.0031325903,0.00072200474,0.00068897463,0.00029048955,0.002087091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99270046,0.00035387027,0.0013183274,0.0021717153,0.0017119397,0.0017436848],"domain_scores_gemma":[0.9956731,0.0008079876,0.0002765096,0.0015358476,0.00021685878,0.0014896912],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00057333766,0.0012292214,0.0015055238,0.0016128204,0.00024927908,0.0008233004,0.00046587488,0.0004438597,0.0014524853],"category_scores_gemma":[0.0002571616,0.0010217904,0.00055150484,0.002641468,0.0003267007,0.0005898482,0.00020557673,0.0008598943,0.0013468503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052704718,0.0051079593,0.9063154,0.0011067897,0.003759283,0.008221182,0.0015659283,0.00008780741,0.00000244593,0.0038233022,0.0019490538,0.015356121],"study_design_scores_gemma":[0.14465486,0.00421325,0.7164611,0.0017652005,0.0045230114,0.0000022295262,0.00007925386,0.00021095749,0.00006263901,0.00028660384,0.12666152,0.0010793348],"about_ca_topic_score_codex":0.0029447114,"about_ca_topic_score_gemma":0.00028780208,"teacher_disagreement_score":0.18985428,"about_ca_system_score_codex":0.0024886846,"about_ca_system_score_gemma":0.0025267692,"threshold_uncertainty_score":0.99946034},"labels":[],"label_agreement":null},{"id":"W4403533428","doi":"10.1136/ijgc-2024-igcs.82","title":"PR040/#437  Impact of hormone therapy use on survival outcomes of ovarian cancer in British Columbia","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Hormone therapy; Oncology; Ovarian cancer; Medicine; Overall survival; Internal medicine; Computer science; Breast cancer","score_opus":0.04559295242723059,"score_gpt":0.3772053781750264,"score_spread":0.3316124257477958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403533428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075526,0.0047142105,0.000009548874,0.0024298197,0.0013076004,0.00021187562,0.00035686942,0.000007884473,0.00020693814],"genre_scores_gemma":[0.9867949,0.012240571,0.00010380676,0.00025097278,0.00026297278,0.00003388317,0.0000049708015,0.000016168162,0.00029175475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982655,0.00006065544,0.00068146014,0.00018612843,0.0006398802,0.00016637858],"domain_scores_gemma":[0.9984483,0.00055488886,0.0003057087,0.00009446203,0.0004935615,0.0001030436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027103454,0.00012194849,0.00061724824,0.00015028284,0.000012983305,0.00009344307,0.00018018215,0.00010580517,0.004186867],"category_scores_gemma":[0.00020371862,0.00010291625,0.00043235486,0.00018348265,0.00007985427,0.0001526466,0.000028427079,0.00027600618,0.0000018623194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006355986,0.001074882,0.93551064,0.000011832052,0.0016811967,0.0008746244,0.000076793534,0.00041874504,0.000500911,0.00007286721,0.0032534676,0.055888455],"study_design_scores_gemma":[0.003832601,0.001958563,0.9917279,0.00042770352,0.00008259535,0.000047590976,0.000018604027,0.000060112347,0.00015821897,0.00020465777,0.0013957378,0.000085722204],"about_ca_topic_score_codex":0.03486857,"about_ca_topic_score_gemma":0.019468807,"teacher_disagreement_score":0.056217268,"about_ca_system_score_codex":0.0010160111,"about_ca_system_score_gemma":0.0006187996,"threshold_uncertainty_score":0.99842334},"labels":[],"label_agreement":null},{"id":"W4403537554","doi":"10.1016/j.esmoop.2024.103910","title":"173P NRF2 levels in high grade serous ovarian cancer: Characterization and treatment","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Serous ovarian cancer; Serous fluid; Cancer; Oncology; Ovarian cancer; Medicine; Internal medicine","score_opus":0.05150485959038524,"score_gpt":0.335412370547508,"score_spread":0.28390751095712274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403537554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705919,0.0006963009,0.000035512738,0.025598837,0.00046345624,0.0013501701,0.00018506186,0.000052645708,0.0010260905],"genre_scores_gemma":[0.99352586,0.0017275134,0.0002511745,0.0004670772,0.0002073296,0.00051862665,0.0001841699,0.000027021755,0.0030912156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991756,0.00002912971,0.00017208376,0.00035526537,0.00009561403,0.00017230223],"domain_scores_gemma":[0.99964994,0.000028725935,0.000027252934,0.00018683942,0.000014145548,0.00009307487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081075734,0.00015022706,0.0002838249,0.000083614956,0.000043021195,0.0001578648,0.00006191611,0.000059016627,0.0005488681],"category_scores_gemma":[0.0000040859195,0.0001138203,0.000029278115,0.00018660421,0.0000181355,0.00017767788,0.00005324383,0.00006556472,0.000036308797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019704043,0.00091188814,0.33320606,0.00015409615,0.0006955384,0.0013826495,0.002574025,0.000009068846,0.001185501,0.008161532,0.00088565977,0.650637],"study_design_scores_gemma":[0.0027462754,0.0003356742,0.93126833,0.00041707623,0.00014752534,0.000031492542,0.000021818718,0.00013119294,0.0021943783,0.00011691475,0.06247379,0.00011550218],"about_ca_topic_score_codex":0.017245332,"about_ca_topic_score_gemma":0.0023955202,"teacher_disagreement_score":0.65052146,"about_ca_system_score_codex":0.00043282728,"about_ca_system_score_gemma":0.00019580261,"threshold_uncertainty_score":0.98929894},"labels":[],"label_agreement":null},{"id":"W4403592517","doi":"10.1016/j.fertnstert.2024.08.069","title":"DIRECT EFFECT OF CCR2 RECEPTOR ON FOLLICLE ACTIVATION","year":2024,"lang":"en","type":"article","venue":"Fertility and Sterility","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Follicle; Internal medicine; Chemistry; Endocrinology; Cell biology; Biology; Medicine","score_opus":0.015463945932282659,"score_gpt":0.2915248739716723,"score_spread":0.27606092803938964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403592517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942355,0.0004155838,0.000015614618,0.00074619014,0.00015981957,0.00025671124,0.00004362355,0.000051903142,0.004075026],"genre_scores_gemma":[0.9996021,0.00002773704,0.000023804325,0.00005578614,0.000031897795,0.000037199185,0.000018219336,0.0000061251635,0.00019716378],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99929184,0.0000795027,0.00014802016,0.00026603887,0.00012180605,0.00009278746],"domain_scores_gemma":[0.9994651,0.00021612996,0.000018152748,0.00021926027,0.000019307741,0.000062048406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028621737,0.00009796329,0.00026120184,0.000029940176,0.00003093227,0.000015685977,0.000018087152,0.00005195419,0.000182071],"category_scores_gemma":[0.00006660994,0.00006661142,0.00008153361,0.0000937874,0.000045077348,0.000055784563,0.000015509488,0.00006626817,0.000014356233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084029734,0.0013652432,0.20029914,0.0052918997,0.000639014,0.000019631538,0.0013264784,0.0000018009094,0.022650067,0.000102641076,0.001458162,0.6828162],"study_design_scores_gemma":[0.00058315595,0.0012580067,0.8579861,0.0002736432,0.00006170757,5.101762e-7,0.0000063065904,0.00007991286,0.13584036,0.000028882969,0.0038393035,0.00004214781],"about_ca_topic_score_codex":0.000107112566,"about_ca_topic_score_gemma":0.0000058382916,"teacher_disagreement_score":0.68277407,"about_ca_system_score_codex":0.000077297875,"about_ca_system_score_gemma":0.000025142366,"threshold_uncertainty_score":0.2716335},"labels":[],"label_agreement":null},{"id":"W4403697884","doi":"10.1002/2056-4538.70006","title":"Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (<scp>STIC</scp>) in fallopian tubes","year":2024,"lang":"en","type":"article","venue":"The Journal of Pathology Clinical Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"KWF Kankerbestrijding","keywords":"Fallopian tube; Serous carcinoma; Serous fluid; Medicine; Gynecology; Artificial intelligence; Radiology; Pathology; Internal medicine; Computer science; Ovarian cancer; Cancer","score_opus":0.17688190241318397,"score_gpt":0.5038268321640054,"score_spread":0.3269449297508214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403697884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687595,0.004606357,0.00006523304,0.007015391,0.00031269508,0.0003740219,0.000011813086,0.000007556625,0.0007309666],"genre_scores_gemma":[0.9961037,0.0031830429,0.00009728871,0.00012833526,0.00039290488,0.000026938778,0.0000013208697,0.000021271335,0.000045204026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916358,0.005289463,0.0013724478,0.00028723653,0.00089847523,0.0005166025],"domain_scores_gemma":[0.9612201,0.037344716,0.00031139783,0.0004922799,0.0004752991,0.00015623627],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01902213,0.00020110213,0.0008317142,0.00025805383,0.00018023192,0.00005401151,0.00058125064,0.0002476612,0.00007725382],"category_scores_gemma":[0.016349707,0.00007905132,0.00054911064,0.0006530607,0.0015358202,0.000082507984,0.00016905405,0.0035002937,0.000014866787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005430922,0.0012226633,0.9585694,0.000069521426,0.00024362479,0.0038398462,0.0018823007,0.00027418177,0.0009875143,0.0006449258,0.0010148383,0.030708069],"study_design_scores_gemma":[0.0011356518,0.006630358,0.9867906,0.0006061989,0.00020529589,0.00074086164,0.0015032664,0.0005213483,0.00075798045,0.0008577029,0.00021007784,0.000040681265],"about_ca_topic_score_codex":0.00010839648,"about_ca_topic_score_gemma":0.000034794466,"teacher_disagreement_score":0.032055255,"about_ca_system_score_codex":0.0003446455,"about_ca_system_score_gemma":0.0006669311,"threshold_uncertainty_score":0.99879867},"labels":[],"label_agreement":null},{"id":"W4403894098","doi":"10.3390/ijms252111664","title":"Are There Non-Invasive Biomarker(s) That Would Facilitate the Detection of Ovarian Torsion? A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Wellcome Trust; Academy of Medical Sciences; British Society for Gynaecological Endoscopy","keywords":"Meta-analysis; Biomarker; Ovarian torsion; Systematic review; Medicine; Bioinformatics; Computational biology; Internal medicine; Biology; Pathology; MEDLINE; Biochemistry","score_opus":0.1350643879471326,"score_gpt":0.38631640043986376,"score_spread":0.25125201249273116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403894098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002573479,0.9958442,0.00037005288,0.0025703467,0.00020885027,0.00082743785,0.000075506294,0.0000031393063,0.00007472832],"genre_scores_gemma":[0.015848497,0.98349065,0.00011739872,0.00034743405,0.000023215363,0.00008292917,0.0000029508217,0.000010381117,0.00007653026],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972028,0.0002884437,0.0009814146,0.00028232316,0.0011292907,0.00011574003],"domain_scores_gemma":[0.9968791,0.00022659518,0.0020978656,0.00024788574,0.00047082454,0.00007771628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001552267,0.0002698024,0.0029201317,0.00056610536,0.000060197977,0.00011321101,0.00049376703,0.00010495119,0.00007148531],"category_scores_gemma":[0.00026077463,0.00011262648,0.0028103883,0.0007592152,0.00016578117,0.00008883956,0.000094068535,0.0002860942,0.000005925992],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001330695,0.000161361,0.000019057383,0.36826974,0.61912477,0.0013555277,0.00021217851,0.0000051523384,0.0000134963975,0.00010825335,0.00014463971,0.010572513],"study_design_scores_gemma":[0.0001251096,0.00014986299,0.000023530016,0.07168496,0.9224234,0.0008227955,0.00021407407,0.000011550351,0.000035941506,0.0000644151,0.0043266173,0.00011772418],"about_ca_topic_score_codex":0.000045741403,"about_ca_topic_score_gemma":0.0000276908,"teacher_disagreement_score":0.30329865,"about_ca_system_score_codex":0.00013532027,"about_ca_system_score_gemma":0.00028779558,"threshold_uncertainty_score":0.45927748},"labels":[],"label_agreement":null},{"id":"W4404092194","doi":"10.1016/j.prp.2024.155714","title":"Micropapillary pattern in serous borderline ovarian tumor and the risk of extraovarian localization of low-grade serous carcinoma (‘invasive implants’): A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Pathology - Research and Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Serous fluid; Serous carcinoma; Meta-analysis; Medicine; Ovarian carcinoma; Pathology; Oncology; Radiology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.11869125256450547,"score_gpt":0.4267659585955217,"score_spread":0.3080747060310162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404092194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010821367,0.9917488,0.00008716846,0.0024656062,0.00002539728,0.0048504598,0.0006563344,0.0000071931627,0.000050836752],"genre_scores_gemma":[0.009359146,0.988968,0.0001752419,0.00031677287,0.000026798927,0.0009155714,0.00013587461,0.000042405616,0.00006020219],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98946345,0.007472262,0.0014511598,0.00078424555,0.00045181238,0.000377099],"domain_scores_gemma":[0.98981833,0.0077499896,0.0010509508,0.0008120315,0.0004071564,0.00016155986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00819211,0.00044679077,0.006394372,0.00067354366,0.00010726102,0.000053436714,0.00016097177,0.0002318274,0.00004094554],"category_scores_gemma":[0.0036624528,0.00021669346,0.00055349973,0.0013463594,0.0005495215,0.0000955836,0.00022901915,0.00094176363,0.000004319026],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018210165,0.00037068746,0.00043066236,0.92108524,0.07052815,0.0032801358,0.0006169779,3.5036686e-7,6.28843e-7,0.00011567218,0.00007591827,0.003313497],"study_design_scores_gemma":[0.0014609583,0.0006259036,0.00016066903,0.035300072,0.9509476,0.008633764,0.0003422735,0.000033591707,0.000003149126,0.00012122119,0.0021483197,0.00022249197],"about_ca_topic_score_codex":0.0018523555,"about_ca_topic_score_gemma":0.0006414391,"teacher_disagreement_score":0.88578516,"about_ca_system_score_codex":0.00007333582,"about_ca_system_score_gemma":0.00040888236,"threshold_uncertainty_score":0.8836503},"labels":[],"label_agreement":null},{"id":"W4404092794","doi":"10.7759/cureus.73171","title":"Oral Metronomic Therapy: An Effective Palliative Treatment Option for Epithelial Ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"Cureus","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Ovarian cancer; Internal medicine; Oncology; Epithelial ovarian cancer; Cancer; Chemotherapy; Serous fluid; Surgery","score_opus":0.05502031614750914,"score_gpt":0.3842572724126604,"score_spread":0.32923695626515126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404092794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587454,0.025509879,0.0032794126,0.0038765818,0.0022750653,0.0047156373,0.00076139066,0.00025391293,0.00058272574],"genre_scores_gemma":[0.9907793,0.0027616622,0.0013303512,0.00015876962,0.0010165519,0.0034396558,0.00013639788,0.000046936755,0.00033041704],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990899,0.00004133217,0.00014050011,0.00041773636,0.00008858884,0.0002219696],"domain_scores_gemma":[0.9994769,0.000105854,0.0000341048,0.00021285629,0.000050032828,0.00012026161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091858994,0.00021023404,0.0003017753,0.00005788012,0.00006955224,0.000053566408,0.000040950148,0.00007700616,0.00029324257],"category_scores_gemma":[0.0000069049343,0.00014295882,0.00018657859,0.00009141314,0.000028469873,0.0001165049,0.000007019972,0.0000556435,0.000034921228],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012979121,0.0013852211,0.008667241,0.000074951415,0.0034583148,0.000046420675,0.0023377917,0.00007656983,0.0024643638,0.007930583,0.0006679387,0.97159266],"study_design_scores_gemma":[0.029234458,0.023866504,0.53098345,0.00064733543,0.0034523068,0.0000171064,0.00045239917,0.009348657,0.07283628,0.0052033556,0.32306477,0.0008933714],"about_ca_topic_score_codex":0.0013541888,"about_ca_topic_score_gemma":0.00036189673,"teacher_disagreement_score":0.9706993,"about_ca_system_score_codex":0.0015300998,"about_ca_system_score_gemma":0.0001829708,"threshold_uncertainty_score":0.5829691},"labels":[],"label_agreement":null},{"id":"W4404163473","doi":"10.5603/gpl.95221","title":"A case of a patient at reproductive age with BRCA2 and CHEK2 mutations and multiple uterine fibroids","year":2024,"lang":"en","type":"article","venue":"Ginekologia Polska","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Uterine fibroids; Gynecology; Obstetrics","score_opus":0.015480683784854008,"score_gpt":0.2758480606318957,"score_spread":0.2603673768470417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404163473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491274,0.0022608757,0.000022393097,0.001850509,0.00005667187,0.00041739663,0.00009907018,0.000049755297,0.00033060744],"genre_scores_gemma":[0.9969307,0.00011848733,0.0023636294,0.00006517254,0.000048199377,0.000055250475,0.000030732095,0.000014558749,0.00037326248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993023,0.000015116447,0.00013806068,0.0003541445,0.00006689169,0.00012347008],"domain_scores_gemma":[0.9995547,0.000085614265,0.0000346834,0.00021230179,0.000035011944,0.00007767765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004397807,0.00011969184,0.00021063178,0.00007090609,0.000042627293,0.0000137068455,0.000012223248,0.00003729073,0.00004807011],"category_scores_gemma":[0.000043298267,0.000080209924,0.000026198917,0.00012566682,0.00015514554,0.000040949493,0.000050697472,0.00006531431,0.000002928833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029631702,0.0023529541,0.5916894,0.0046496596,0.004132755,0.16157371,0.037728593,0.00016273337,0.019238256,0.0072155152,0.008545269,0.15974794],"study_design_scores_gemma":[0.01554378,0.020230722,0.74334335,0.002003567,0.0023772374,0.10644263,0.0037628969,0.0019061463,0.07303714,0.0012146699,0.028992096,0.0011457489],"about_ca_topic_score_codex":0.00035581828,"about_ca_topic_score_gemma":0.00011152567,"teacher_disagreement_score":0.1586022,"about_ca_system_score_codex":0.00006406478,"about_ca_system_score_gemma":0.000035511443,"threshold_uncertainty_score":0.3270866},"labels":[],"label_agreement":null},{"id":"W4404197733","doi":"10.1016/j.gore.2024.101541","title":"Malignant struma ovarii in pregnancy: A case report","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Clinical Oncology Group; McMaster University; University of British Columbia","funders":"Hamilton Health Sciences","keywords":"Medicine; Struma ovarii; Pregnancy; Gynecology; Obstetrics; Ovary; Internal medicine","score_opus":0.028819184266085634,"score_gpt":0.34118831886743806,"score_spread":0.3123691346013524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404197733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9334701,0.008171599,0.000032485164,0.007107724,0.0033143347,0.0016954322,0.000011179548,0.00036164964,0.04583552],"genre_scores_gemma":[0.9938553,0.00030156254,0.0015218293,0.00045685619,0.00015156037,0.00081167434,0.000060632094,0.000033785895,0.0028067764],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9971628,0.00009473234,0.0010088775,0.0009976228,0.00020639464,0.000529581],"domain_scores_gemma":[0.9984567,0.00034483048,0.00023657536,0.00068397453,0.000074501135,0.00020338356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007507854,0.00027740552,0.0007330245,0.00026486837,0.00007570985,0.000034184224,0.000045117118,0.0004085465,0.0014175341],"category_scores_gemma":[0.00039372203,0.00020839054,0.00019609237,0.0004320593,0.00011620832,0.000093070434,0.000089870024,0.00039301882,0.000059886403],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002098699,0.00078492047,0.11559458,0.000119023374,0.0001845733,0.8282118,0.00019873712,0.0000075852436,0.000037283397,0.00039265322,0.0033937572,0.0510541],"study_design_scores_gemma":[0.00088060746,0.0016699005,0.078384966,0.0004960161,0.0003380604,0.84720546,0.00013243248,0.00007244781,0.00027518207,0.0017556305,0.068608135,0.00018115056],"about_ca_topic_score_codex":0.00042173674,"about_ca_topic_score_gemma":0.0010262688,"teacher_disagreement_score":0.06521438,"about_ca_system_score_codex":0.0012835964,"about_ca_system_score_gemma":0.0014858559,"threshold_uncertainty_score":0.9994953},"labels":[],"label_agreement":null},{"id":"W4404223151","doi":"10.1097/pap.0000000000000473","title":"Diagnosis and Risk Stratification of Ovarian Mucinous Neoplasms: Pattern of Invasion, Immunohistochemistry, and Molecular Diagnostics","year":2024,"lang":"en","type":"review","venue":"Advances in Anatomic Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mucinous carcinoma; Pathology; Immunohistochemistry; Medicine; Risk stratification; Mucinous Tumor; Oncology; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.016158162119848673,"score_gpt":0.3434171264071341,"score_spread":0.32725896428728546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404223151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013925869,0.9845734,0.00009041214,0.00003997806,0.00017471505,0.0007558321,0.00032103245,0.0000123799055,0.000106347725],"genre_scores_gemma":[0.04299687,0.95586264,0.00053357147,0.000019214523,0.000024353834,0.00038340266,0.00013710732,0.000038667076,0.000004145225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810976,0.0001290243,0.0008548401,0.0005965503,0.0001244052,0.00018543814],"domain_scores_gemma":[0.9983548,0.00047214178,0.0005754957,0.00046988376,0.000055816432,0.00007189902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020370125,0.00034609958,0.001631013,0.00025244028,0.000019876075,0.0000070848646,0.00010069106,0.0003118208,0.0000134714055],"category_scores_gemma":[0.00022458597,0.00028566315,0.00015026395,0.00023690218,0.0002981318,0.00004547014,0.000090398826,0.00034336338,0.0000023808072],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011253587,0.00021155602,0.010624399,0.01775569,0.00020637641,0.00048165958,0.00016716555,7.5705293e-7,0.000017812366,0.00029410972,0.000033954006,0.9701953],"study_design_scores_gemma":[0.013032893,0.0045745685,0.01630709,0.22901462,0.054750357,0.006602099,0.0009090291,0.00016541584,0.006154167,0.013875032,0.65085244,0.0037622722],"about_ca_topic_score_codex":0.0001713297,"about_ca_topic_score_gemma":0.000059558137,"teacher_disagreement_score":0.966433,"about_ca_system_score_codex":0.00012369512,"about_ca_system_score_gemma":0.00020190683,"threshold_uncertainty_score":0.9999595},"labels":[],"label_agreement":null},{"id":"W4404386194","doi":"10.1016/j.jogc.2024.102714","title":"Innovative 3-Dimensional Imaging in Preoperative Evaluation for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer—A Pilot Study","year":2024,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; Surgery; Medical physics; Radiology; General surgery; Cancer; Internal medicine","score_opus":0.038370261603775616,"score_gpt":0.3179799782391341,"score_spread":0.2796097166353585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404386194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667008,0.021745225,0.000005353343,0.002085019,0.008379974,0.00093101204,0.000058861482,0.0000019872634,0.00009176846],"genre_scores_gemma":[0.9993063,0.00012586232,0.0001105037,0.00020747603,0.00006152684,0.00014878104,0.000012898017,0.000012309859,0.000014341343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985378,0.00012641933,0.00058768754,0.00023508276,0.00031747145,0.00019554248],"domain_scores_gemma":[0.99642307,0.002532795,0.00018269173,0.000062323365,0.0007150637,0.00008404966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009331206,0.0001374392,0.00044496777,0.00068521575,0.000043734948,0.000024489802,0.000034865552,0.000030296622,0.00020965116],"category_scores_gemma":[0.0014726353,0.0001105256,0.000032386542,0.00083604234,0.000029861802,0.00012333285,0.000019187382,0.00032328145,1.04504885e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00011496206,0.00095650495,0.70554775,0.000074752,0.00034232947,0.0024457206,0.0009212747,0.0002060086,0.000010951555,0.000093435905,0.0028074665,0.28647885],"study_design_scores_gemma":[0.004655329,0.0017346914,0.99038714,0.00010897095,0.00016051989,0.000034012006,0.0010450898,0.0010334814,0.00003971759,0.00016458172,0.0005350584,0.00010140605],"about_ca_topic_score_codex":0.02138825,"about_ca_topic_score_gemma":0.10666384,"teacher_disagreement_score":0.28637746,"about_ca_system_score_codex":0.004811076,"about_ca_system_score_gemma":0.011160462,"threshold_uncertainty_score":0.99900925},"labels":[],"label_agreement":null},{"id":"W4404587126","doi":"10.1001/jamanetworkopen.2024.46325","title":"Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Fondazione Internazionale Menarini; Myriad Genetics; AstraZeneca; GlaxoSmithKline; U.S. Department of Defense","keywords":"Medicine; Laparotomy; Ovarian cancer; Randomized controlled trial; Surgery; Population; Stage (stratigraphy); Laparoscopic surgery; Gynecologic oncology; Laparoscopy; Cancer; Oncology; Internal medicine","score_opus":0.016609546925270793,"score_gpt":0.3085810337549158,"score_spread":0.291971486829645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404587126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9236942,0.008796205,0.00002444157,0.061456636,0.0028787716,0.0014877537,0.000051054772,0.00008491545,0.0015260112],"genre_scores_gemma":[0.9859943,0.0031319878,0.0011171626,0.002629806,0.003945548,0.0011413174,0.000045141387,0.000058480615,0.0019362491],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985638,0.000064375854,0.00029532184,0.00050182594,0.00019049412,0.00038413162],"domain_scores_gemma":[0.9994399,0.000038009955,0.00004455115,0.00032552204,0.000025779473,0.00012626298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027738174,0.00021329673,0.00042138484,0.00007717806,0.000048453367,0.00028715507,0.00015141827,0.00014347103,0.0018853274],"category_scores_gemma":[0.0000053913463,0.00016808666,0.00008294408,0.00043996572,0.000037127604,0.00024635575,0.000076754404,0.0002687102,0.00010794567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042714053,0.0012522737,0.39968473,0.00035226726,0.001380186,0.0019415326,0.0023145413,0.0014866848,0.00080518716,0.0064377906,0.12799005,0.45208335],"study_design_scores_gemma":[0.006550047,0.00026197633,0.82865083,0.002147526,0.00015557295,0.000026807542,0.00002869105,0.00052798254,0.0009392029,0.0011186355,0.15937145,0.00022130087],"about_ca_topic_score_codex":0.0037788209,"about_ca_topic_score_gemma":0.00072842545,"teacher_disagreement_score":0.45186207,"about_ca_system_score_codex":0.0004642378,"about_ca_system_score_gemma":0.00026552376,"threshold_uncertainty_score":0.9990271},"labels":[],"label_agreement":null},{"id":"W4404601811","doi":"10.21037/gpm-24-25","title":"Minimally invasive cytoreduction for advanced-stage ovarian cancer—a narrative review","year":2024,"lang":"en","type":"article","venue":"Gynecology and Pelvic Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Intuitive Surgical; Israel Cancer Research Fund","keywords":"Stage (stratigraphy); Ovarian cancer; Medicine; Narrative; Oncology; Cancer; General surgery; Gynecology; Internal medicine; Biology; Literature; Art","score_opus":0.026604610580570263,"score_gpt":0.35194739841607675,"score_spread":0.32534278783550646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404601811","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13666506,0.5676422,0.0001442785,0.2820793,0.0041872957,0.0036384368,0.00013633563,0.00016193664,0.0053451154],"genre_scores_gemma":[0.6329196,0.33174774,0.0011908343,0.017777195,0.001870695,0.0026205068,0.0003625801,0.000057324076,0.011453538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872833,0.000049640807,0.00033985908,0.0004952428,0.0001259191,0.00026099195],"domain_scores_gemma":[0.99860615,0.0008123052,0.00008455567,0.00018913923,0.00012986134,0.00017798645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031204917,0.000217922,0.0006113461,0.000108182234,0.00012538562,0.000007070973,0.000045252033,0.00012290214,0.0025850786],"category_scores_gemma":[0.000501327,0.0001524757,0.00007905748,0.00020309829,0.00021059938,0.00007894053,0.0000180368,0.00017789548,0.000015515412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012167663,0.0004396541,0.006195398,0.029280469,0.002606357,0.0009464726,0.01312206,0.000008100656,0.0050971387,0.0128147295,0.45823982,0.47003302],"study_design_scores_gemma":[0.008702918,0.006385297,0.022056885,0.017290814,0.0028325352,0.00030903486,0.0023169508,0.00010371126,0.0013845271,0.0011651495,0.9370587,0.00039351653],"about_ca_topic_score_codex":0.000064260224,"about_ca_topic_score_gemma":0.00028823473,"teacher_disagreement_score":0.49625453,"about_ca_system_score_codex":0.00017869758,"about_ca_system_score_gemma":0.00045144558,"threshold_uncertainty_score":0.9983267},"labels":[],"label_agreement":null},{"id":"W4404603639","doi":"10.1097/01.ogx.0001095044.05860.8b","title":"Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Fertility; Stage (stratigraphy); Context (archaeology); Gynecology; Ovarian cancer; Epithelial ovarian cancer; Disease; Fertility preservation; Cancer; Oncology; Internal medicine; Population","score_opus":0.10288963952239744,"score_gpt":0.35024409955259617,"score_spread":0.24735446003019873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404603639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642482,0.016296567,0.002065565,0.005212353,0.005711351,0.002234365,0.0016520908,0.000636388,0.0019431278],"genre_scores_gemma":[0.9949835,0.00040163967,0.00056165224,0.0006422658,0.00024532632,0.00064357754,0.00018960828,0.000043640277,0.002288803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973579,0.00023366905,0.00054141274,0.00083193387,0.00036079253,0.0006743059],"domain_scores_gemma":[0.98341197,0.015631994,0.000059950395,0.00032375887,0.00015711211,0.0004152162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009050681,0.00030483134,0.00079103746,0.00017583637,0.00014237541,0.00013555297,0.000118882155,0.0002966039,0.0027466167],"category_scores_gemma":[0.006047651,0.00020804125,0.00045435174,0.00091368164,0.00008835342,0.000085560896,0.00008149538,0.00033284602,0.00014229534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050559285,0.0011240173,0.8177775,0.00033550852,0.00048538717,0.00047287252,0.00003984336,0.00002350638,0.00010829559,0.00097302755,0.006038496,0.17211594],"study_design_scores_gemma":[0.0009757094,0.00036262677,0.9221982,0.00008590353,0.00014419631,0.0000025460554,0.000008607833,0.00073556515,0.00027707894,0.0001426077,0.07483597,0.00023103265],"about_ca_topic_score_codex":0.00088473875,"about_ca_topic_score_gemma":0.00026218206,"teacher_disagreement_score":0.17188491,"about_ca_system_score_codex":0.0006989834,"about_ca_system_score_gemma":0.0003767768,"threshold_uncertainty_score":0.998165},"labels":[],"label_agreement":null},{"id":"W4404921686","doi":"10.47723/adx1xa66","title":"Diagnostic Performance of Cytocolposcopy versus Biopsy for Premalignant and Malignant Lesions in a Women's Hospital Dysplasia Clinic","year":2024,"lang":"en","type":"article","venue":"AL-Kindy College Medical Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Dysplasia; Biopsy; Dermatology; Pathology","score_opus":0.01628168106396809,"score_gpt":0.31106140721576436,"score_spread":0.29477972615179626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404921686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838757,0.0029059944,0.000066798246,0.0097416,0.0015630999,0.0015329623,0.00010394058,0.000021625638,0.00018826807],"genre_scores_gemma":[0.99194163,0.005831224,0.00070456316,0.0002798395,0.00038861347,0.00069252704,0.0000082114475,0.000036914076,0.000116453484],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99747145,0.0000624314,0.0008104598,0.00039363105,0.0007230194,0.0005389803],"domain_scores_gemma":[0.99712414,0.0017980834,0.00014100385,0.00019385105,0.00010019954,0.0006427134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000974111,0.00024667985,0.0006194928,0.00029603965,0.00011563426,0.00004054314,0.00013965309,0.00018501842,0.0007635837],"category_scores_gemma":[0.0008303972,0.00017354537,0.00016051247,0.00039639632,0.00019451123,0.00012516735,0.00006600624,0.00047646608,0.00001708233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035142638,0.018338801,0.32830527,0.008723282,0.008028245,0.06598285,0.012680528,0.00003413916,0.0015236108,0.008617219,0.11337609,0.39924735],"study_design_scores_gemma":[0.13291414,0.09572914,0.54981285,0.068982534,0.0033587047,0.013485931,0.00797563,0.012354789,0.0053886157,0.0011619183,0.10653334,0.0023023968],"about_ca_topic_score_codex":0.000012429918,"about_ca_topic_score_gemma":0.000010316516,"teacher_disagreement_score":0.39694494,"about_ca_system_score_codex":0.00037282388,"about_ca_system_score_gemma":0.0013625247,"threshold_uncertainty_score":0.8360706},"labels":[],"label_agreement":null},{"id":"W4405407747","doi":"10.1172/jci184790","title":"Immune-molecular interactions in high-grade serous ovarian cancer distinguish long-term survivors","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Ovarian Cancer Canada","keywords":"Serous ovarian cancer; Ovarian cancer; Term (time); Immune system; Serous fluid; Medicine; Cancer; Biology; Oncology; Bioinformatics; Cancer research; Internal medicine; Immunology; Physics","score_opus":0.07930643492989356,"score_gpt":0.4239870536736384,"score_spread":0.3446806187437449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405407747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749943,0.0022884351,0.00029412622,0.018584523,0.0034523655,0.00018654008,0.000007850498,0.000022911629,0.00016894733],"genre_scores_gemma":[0.99615496,0.00076862355,0.0010291236,0.00065780245,0.0011526525,0.000017070597,0.00001935135,0.000025260502,0.00017514532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997667,0.00018166118,0.0014654205,0.00021681633,0.00031026476,0.00015885138],"domain_scores_gemma":[0.99848306,0.0004886967,0.000426041,0.00017202378,0.00018353152,0.00024663494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090887013,0.00014022947,0.0005211802,0.00019820781,0.000030505516,0.00007637593,0.00008253714,0.00009511927,0.00014246805],"category_scores_gemma":[0.00072188576,0.000109303975,0.00029559538,0.000352653,0.00009855539,0.00020028697,0.00002168509,0.00070212263,0.000014747058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012406953,0.0004599724,0.9664414,0.00016269092,0.0004819508,0.0016468716,0.0002328092,0.00012678592,0.00084151176,0.0011896152,0.00074590056,0.0275464],"study_design_scores_gemma":[0.0017941219,0.00033857467,0.98994833,0.0025780401,0.00042904407,0.00013961298,0.000020535028,0.00030613944,0.0016545149,0.0015395994,0.0011484303,0.00010305607],"about_ca_topic_score_codex":0.00082563027,"about_ca_topic_score_gemma":0.0006800233,"teacher_disagreement_score":0.027443344,"about_ca_system_score_codex":0.00024568604,"about_ca_system_score_gemma":0.00053806027,"threshold_uncertainty_score":0.4457287},"labels":[],"label_agreement":null},{"id":"W4405528389","doi":"10.3390/curroncol31120592","title":"Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"State Government of Victoria; Ovarian Cancer Research Foundation","keywords":"Precision medicine; Medicine; Ovarian cancer; Disease; Alternative medicine; Profiling (computer programming); Bioinformatics; Data science; Cancer; Pathology; Computer science; Internal medicine; Biology","score_opus":0.6301109415763657,"score_gpt":0.5821191710105472,"score_spread":0.04799177056581849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405528389","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025133475,0.9875386,0.00007307682,0.0038488186,0.0035554296,0.0036401416,0.00014656564,0.000055811903,0.001139094],"genre_scores_gemma":[0.000013867599,0.9920232,0.0005745555,0.00005573819,0.002400192,0.0042415857,0.00051631744,0.00009492667,0.000079558355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968558,0.00017417302,0.0011074528,0.0010020633,0.0002444303,0.00061609974],"domain_scores_gemma":[0.9980399,0.00081854855,0.00041845464,0.0003940132,0.00015676608,0.0001722947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000519796,0.0005699537,0.0032273866,0.0005985005,0.000065059794,0.000013545972,0.0001643666,0.00036213,0.00022960578],"category_scores_gemma":[0.000091178765,0.00038545657,0.00049913523,0.00033378377,0.00007473265,0.000034667733,0.00018989538,0.00066400605,0.000027351973],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041506868,0.00027565114,0.00005519056,0.038932323,0.0006061254,0.000080911705,0.0002829087,2.371013e-7,8.654237e-8,0.00068755174,0.0092282565,0.94980925],"study_design_scores_gemma":[0.0028467102,0.0008069108,0.00015406392,0.09283952,0.005730519,0.00007190721,0.00014022409,0.000027500355,1.7843774e-7,0.00011799985,0.89702106,0.00024344272],"about_ca_topic_score_codex":0.000062648505,"about_ca_topic_score_gemma":0.00036113756,"teacher_disagreement_score":0.9495658,"about_ca_system_score_codex":0.0012173455,"about_ca_system_score_gemma":0.00072628475,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W4405616616","doi":"10.3802/jgo.2025.36.e51","title":"Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Research Foundation of Korea; Medical Research Council; PharmaMar; Eisai; Amgen; National University of Singapore; National Research Foundation; Chugai Pharmaceutical; Seagen; MacroGenics; Sierra Oncology; Incyte; BeiGene; Clovis Oncology; AstraZeneca; Novocure; Ministry of Science and ICT, South Korea; Kimberly-Clark; Regeneron Pharmaceuticals; Mersana Therapeutics; National Medical Research Council; Karyopharm Therapeutics; Sanofi; GlaxoSmithKline","keywords":"Medicine; Bevacizumab; Chemotherapy; Oncology; Internal medicine; Carcinoma; Phases of clinical research","score_opus":0.03196311436663559,"score_gpt":0.3535288015074919,"score_spread":0.3215656871408563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405616616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886238,0.00180299,0.00003568188,0.0032833936,0.0016211953,0.0026560784,0.000016637256,0.000029242796,0.0019309713],"genre_scores_gemma":[0.9959693,0.0010551091,0.0019844892,0.00028552866,0.00028595264,0.00019480857,0.000009318312,0.00004575661,0.00016972721],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99573666,0.0006689004,0.0018703697,0.00056864735,0.00057641714,0.00057898276],"domain_scores_gemma":[0.9934542,0.0045686592,0.0010107994,0.00035471085,0.00032849138,0.00028312296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019660585,0.00047531814,0.0030440462,0.00056769897,0.00010519535,0.000029614184,0.0002742818,0.00039025018,0.002129412],"category_scores_gemma":[0.0006031982,0.00026637092,0.00041972133,0.00065069285,0.00026084043,0.00014539709,0.00010518055,0.0010098331,0.00001519803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77415216,0.07127146,0.0058044577,0.00025390607,0.001912549,0.01706167,0.005304331,0.000114401504,0.0005331011,0.000049525403,0.002326395,0.12121605],"study_design_scores_gemma":[0.64240843,0.33044332,0.017075835,0.00014370221,0.0016041294,0.00041053575,0.0028246925,0.000510876,0.0006758289,0.000052105548,0.0035888262,0.00026170994],"about_ca_topic_score_codex":0.00008710583,"about_ca_topic_score_gemma":0.0005067054,"teacher_disagreement_score":0.25917187,"about_ca_system_score_codex":0.0017411418,"about_ca_system_score_gemma":0.0014813766,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W4405628491","doi":"10.1007/s00261-024-04751-5","title":"Size threshold as a risk for malignant transformation in typical ovarian dermoid lesions: a scoping review","year":2024,"lang":"en","type":"review","venue":"Abdominal Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dermoid cyst; Malignancy; Malignant transformation; Radiology; Retrospective cohort study; Cochrane Library; Meta-analysis; Internal medicine; Pathology","score_opus":0.06024996845436088,"score_gpt":0.40662961829561917,"score_spread":0.3463796498412583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405628491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014742637,0.98959976,0.00014847609,0.0016715185,0.0003866496,0.0075671985,0.000084479034,0.000039829618,0.00048735944],"genre_scores_gemma":[0.00013911135,0.9926295,0.00097145804,0.00075992214,0.00034527451,0.0048132227,0.00019564034,0.0000704247,0.00007540983],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99709666,0.00030179613,0.00129211,0.00069361966,0.00015120007,0.00046463928],"domain_scores_gemma":[0.99795085,0.0011266787,0.00029434753,0.0004216706,0.00004595517,0.00016047177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090411835,0.00051114656,0.0032593678,0.0002292734,0.000075360775,0.000018924502,0.00014780271,0.0004926295,0.0002425725],"category_scores_gemma":[0.0005337165,0.0003406535,0.0009537051,0.00034582333,0.000066939516,0.00004740654,0.00003005372,0.00066165277,0.00022387922],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022264302,0.00014124502,0.000009345668,0.21385965,0.00048257975,0.00038843378,0.00008117763,2.3357981e-7,2.0657487e-7,0.0025770562,0.0015218917,0.7807155],"study_design_scores_gemma":[0.0017278669,0.00085116667,0.000029540597,0.6459158,0.011311209,0.0030500235,0.000016567259,0.000018974526,0.0000011570178,0.00073492515,0.33602163,0.00032110387],"about_ca_topic_score_codex":0.000050778155,"about_ca_topic_score_gemma":0.00006657587,"teacher_disagreement_score":0.78039443,"about_ca_system_score_codex":0.00044933308,"about_ca_system_score_gemma":0.0011916722,"threshold_uncertainty_score":0.9999046},"labels":[],"label_agreement":null},{"id":"W4405640528","doi":"10.1158/2159-8290.cd-24-1366","title":"Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ludwig Center at Harvard; Gray Foundation; Prairie Improvement Network; U.S. Department of Defense; Division of Cancer Prevention, National Cancer Institute; Honorable Tina Brozman Foundation; Canary Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","keywords":"Immune system; Serous fluid; Cancer research; Biology; Tumor microenvironment; Fallopian tube; Carcinogenesis; Ovarian carcinoma; Ovarian cancer; Cancer; Immunology; Pathology; Medicine","score_opus":0.01399184001921556,"score_gpt":0.27047649311285465,"score_spread":0.2564846530936391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405640528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98064196,0.01114785,0.00058630557,0.005196468,0.00086056656,0.00127921,0.00016654561,0.000048827977,0.000072290415],"genre_scores_gemma":[0.9949444,0.00128991,0.0019089334,0.00032410008,0.000413639,0.00043269675,0.000084045125,0.00006555651,0.0005367552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980496,0.000052159186,0.0004244718,0.00077744137,0.00026276216,0.00043354018],"domain_scores_gemma":[0.9993293,0.00005145796,0.000048207457,0.0003589468,0.000015394497,0.00019665716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014694636,0.0003054252,0.0004634197,0.00017747788,0.00007058971,0.0001242928,0.00007826413,0.00011718944,0.000057143323],"category_scores_gemma":[0.000014433189,0.000255737,0.00009755231,0.00018352523,0.000037583766,0.00025600832,0.00012264817,0.00025772484,0.000009568064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017633962,0.0009616094,0.69814014,0.0022815762,0.0005437499,0.0012202254,0.0053056832,0.0086375885,0.214123,0.00094574265,0.00092729775,0.06514999],"study_design_scores_gemma":[0.0045906533,0.00047837847,0.90026045,0.0052317083,0.00040497852,0.00005866406,0.0003380972,0.008352373,0.0776193,0.00021523867,0.001852948,0.00059723615],"about_ca_topic_score_codex":0.005993471,"about_ca_topic_score_gemma":0.0004683296,"teacher_disagreement_score":0.20212027,"about_ca_system_score_codex":0.0008515933,"about_ca_system_score_gemma":0.00019578746,"threshold_uncertainty_score":0.9999895},"labels":[],"label_agreement":null},{"id":"W4405802125","doi":"10.1016/j.critrevonc.2024.104603","title":"The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Immunohistochemistry; Serous fluid; Pathology; Serous carcinoma; Ovarian carcinoma; Medicine; Biology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.06427543056132641,"score_gpt":0.42297873160860705,"score_spread":0.35870330104728065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405802125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035779685,0.98103595,0.0000056107283,0.013383873,0.0004976481,0.004329877,0.000055383527,0.00003631171,0.00061954715],"genre_scores_gemma":[0.0015696592,0.9919366,0.00094226346,0.0020377876,0.00008260088,0.0032019892,0.00010139092,0.00007811143,0.00004958819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941344,0.0013601001,0.0022729975,0.0012078697,0.00028686205,0.0007377357],"domain_scores_gemma":[0.9937107,0.004278476,0.00042255144,0.0011938331,0.000104792096,0.0002896495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010081177,0.00088607863,0.0077069686,0.00018980306,0.0000953393,0.000021722099,0.00043654747,0.0011640092,0.00007086202],"category_scores_gemma":[0.0059432564,0.00047391493,0.0010485844,0.00051915605,0.0011944956,0.000021473987,0.0003276446,0.0019305542,0.00013941994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077603974,0.0013067245,0.00002708746,0.16263421,0.00037049133,0.008088229,0.000028365259,9.227669e-9,0.000007782949,0.061699376,0.03261687,0.73314327],"study_design_scores_gemma":[0.0007775799,0.0009534508,0.000022610782,0.15135813,0.00429681,0.008954928,0.000007886043,7.0043825e-7,0.00001710488,0.0008761131,0.83241946,0.00031524946],"about_ca_topic_score_codex":0.000036159992,"about_ca_topic_score_gemma":0.000015692725,"teacher_disagreement_score":0.79980254,"about_ca_system_score_codex":0.00064918154,"about_ca_system_score_gemma":0.0005541205,"threshold_uncertainty_score":0.99977124},"labels":[],"label_agreement":null},{"id":"W4405911956","doi":"10.1016/j.ygyno.2024.12.010","title":"Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Vancouver Coastal Health Research Institute; Canada Research Chairs; Canadian Cancer Society; Michael Smith Health Research BC; VGH and UBC Hospital Foundation","keywords":"Medicine; Endometrial cancer; Context (archaeology); Cancer; Oncology; Internal medicine; Gynecology","score_opus":0.048338033816177184,"score_gpt":0.3532392348807828,"score_spread":0.3049012010646056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405911956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95439035,0.0018075128,0.00006825333,0.023219088,0.00085147156,0.007643432,0.00017396167,0.00007554015,0.011770408],"genre_scores_gemma":[0.9936367,0.00048207922,0.00024272272,0.001211163,0.000049493025,0.0041968687,0.00005459387,0.000009322184,0.00011701029],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985556,0.0002707201,0.00041506422,0.00027288613,0.00023520461,0.00025051882],"domain_scores_gemma":[0.9987309,0.0007632531,0.00015441341,0.00021695241,0.00008789343,0.00004661572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005700152,0.00017241167,0.00040515195,0.00026652537,0.000048869853,0.000039398492,0.00012429188,0.00014265126,0.00015505374],"category_scores_gemma":[0.00027764787,0.00010504159,0.00008728901,0.00047401883,0.000105376814,0.00014257107,0.00004200918,0.00018339446,0.000013948663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005952376,0.0022477787,0.108846724,0.0011056536,0.0011119371,0.0006345899,0.0132885575,0.000108688764,0.00053174625,0.013932738,0.0026681118,0.85492826],"study_design_scores_gemma":[0.00806035,0.0037337716,0.93782,0.00033306214,0.0007979889,0.00002873793,0.0045785033,0.00067493203,0.0047112536,0.00030561019,0.038752437,0.00020331147],"about_ca_topic_score_codex":0.0003333063,"about_ca_topic_score_gemma":0.000905375,"teacher_disagreement_score":0.85472494,"about_ca_system_score_codex":0.001007155,"about_ca_system_score_gemma":0.0005738653,"threshold_uncertainty_score":0.42834717},"labels":[],"label_agreement":null},{"id":"W4405948803","doi":"10.1016/j.ijgc.2024.100030","title":"Prognostic significance and accuracy of oncologists’ estimates of survival time in recurrent ovarian cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.03854051515351675,"score_gpt":0.37859451134333816,"score_spread":0.3400539961898214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405948803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97269404,0.015390092,0.000098396566,0.009064841,0.0016818212,0.00034621838,0.00011915123,0.000011148942,0.0005942905],"genre_scores_gemma":[0.99314785,0.005412456,0.0009682853,0.000103013,0.00024255499,0.00005895482,0.0000044453564,0.000009907145,0.0000525101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984928,0.000051216328,0.0006763209,0.00019293277,0.0004424878,0.00014425171],"domain_scores_gemma":[0.9975438,0.001473494,0.0003711446,0.000067004476,0.00045517605,0.00008938711],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035436,0.00013547212,0.0005181951,0.00018881733,0.00001040999,0.000022323957,0.00015667047,0.00008684808,0.0014881436],"category_scores_gemma":[0.00085968815,0.000091179616,0.00012852965,0.00017254088,0.00014961208,0.00010701811,0.000052138512,0.00023595466,0.000002427004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014053928,0.00141162,0.7492343,0.00032764516,0.001196287,0.0010765512,0.00035262833,0.0004492686,0.005046385,0.0012529878,0.0011301577,0.23711674],"study_design_scores_gemma":[0.002236335,0.0016056402,0.9846708,0.0020741671,0.00028835706,0.00007371338,0.00004505226,0.0010202541,0.0035874506,0.0012618459,0.0030175005,0.00011887557],"about_ca_topic_score_codex":0.00023490057,"about_ca_topic_score_gemma":0.00012593817,"teacher_disagreement_score":0.23699786,"about_ca_system_score_codex":0.0005155987,"about_ca_system_score_gemma":0.0006561954,"threshold_uncertainty_score":0.99942464},"labels":[],"label_agreement":null},{"id":"W4405962925","doi":"10.1016/j.ijgc.2024.100009","title":"Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer","year":2024,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.11711469803318757,"score_gpt":0.45289664239862987,"score_spread":0.3357819443654423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405962925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057581372,0.98365295,0.000007774717,0.009949865,0.002257623,0.0022834737,0.0016394523,0.000011698335,0.00013959825],"genre_scores_gemma":[0.0012790522,0.9953456,0.00015441132,0.0007279844,0.0011090135,0.00095429324,0.00009088533,0.000049685954,0.0002890823],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99182504,0.0008908066,0.005307542,0.00045752892,0.0012424256,0.00027666296],"domain_scores_gemma":[0.9915461,0.0025506443,0.004682964,0.00029116898,0.0007015635,0.00022757203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002363889,0.0005585364,0.0088115,0.0005411136,0.000020724869,0.000065324784,0.00059534906,0.00036172243,0.0057937778],"category_scores_gemma":[0.0030188928,0.00030481175,0.0019653994,0.00040883216,0.00007688799,0.00007570801,0.00011257549,0.00095002074,0.00001614151],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068304816,0.0012458417,0.000029240608,0.6721714,0.014634517,0.0037553315,0.00013761042,0.000004397765,0.000006071886,0.0003830294,0.006810238,0.30013928],"study_design_scores_gemma":[0.004110223,0.0005351895,0.000018291465,0.7451826,0.017925212,0.00009350276,0.0000232107,0.000004102093,0.000003824339,0.00020797979,0.23169062,0.00020525284],"about_ca_topic_score_codex":0.0011043902,"about_ca_topic_score_gemma":0.0007942652,"teacher_disagreement_score":0.299934,"about_ca_system_score_codex":0.0029351013,"about_ca_system_score_gemma":0.0027091356,"threshold_uncertainty_score":0.9999404},"labels":[],"label_agreement":null},{"id":"W4406117382","doi":"10.58931/cwht.2024.1315","title":"Imaging Considerations for Adnexal Masses","year":2024,"lang":"en","type":"article","venue":"Canadian Women s Health Today","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Adnexal mass; Medicine; Medical physics; Radiology","score_opus":0.032133013006872664,"score_gpt":0.32726774321030067,"score_spread":0.295134730203428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406117382","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041220114,0.022836879,0.00037448542,0.9083498,0.00335324,0.0038223125,0.0020043002,0.00035475026,0.017684104],"genre_scores_gemma":[0.96925634,0.00014786929,0.0015408263,0.02601268,0.00039130723,0.0006491911,0.000060221664,0.000034788136,0.0019067808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988526,0.000019631701,0.00020292036,0.00027159907,0.00008251488,0.00057069416],"domain_scores_gemma":[0.99851155,0.00018410097,0.000019969846,0.00017786353,0.000050494167,0.0010559945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023534505,0.00011073535,0.00020872266,0.00021891268,0.00022631287,0.00008733951,0.000022860635,0.0000345314,0.0012282911],"category_scores_gemma":[0.00006628001,0.000101783575,0.000054828604,0.00013208248,0.000026929727,0.0000617505,0.0000038978783,0.000100669604,0.000081809914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024121502,0.00008027013,0.009627693,0.0011772573,0.00026911063,0.00064893154,0.006076293,0.000006380689,0.000013241918,0.06681476,0.8318348,0.083427124],"study_design_scores_gemma":[0.00069800735,0.00021177006,0.0044788923,0.00023982549,0.0000301292,0.00009891929,0.00051167136,0.00027776146,0.000028003284,0.003597281,0.9897151,0.00011265782],"about_ca_topic_score_codex":0.020394411,"about_ca_topic_score_gemma":0.050731253,"teacher_disagreement_score":0.9280362,"about_ca_system_score_codex":0.002510857,"about_ca_system_score_gemma":0.006865701,"threshold_uncertainty_score":0.99968475},"labels":[],"label_agreement":null},{"id":"W4406149029","doi":"10.29063/ajrh2024/v28i12.12","title":"Surgery for giant ovarian cysts in Guyana using single-port laparoscopy: a retrospective case series analysis","year":2024,"lang":"en","type":"article","venue":"African Journal of Reproductive Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Medicine; Laparoscopy; Surgery; Laparotomy; Port (circuit theory); Invasive surgery; Fertility; Ovarian cyst; General surgery; Cyst; Population","score_opus":0.057610033916650344,"score_gpt":0.349872612768116,"score_spread":0.29226257885146567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406149029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487157,0.012181654,0.0031434721,0.033317007,0.001246583,0.0010584011,0.00014333447,0.000040043626,0.00015379718],"genre_scores_gemma":[0.989838,0.00034167696,0.008744963,0.00014779187,0.0007821687,0.000023508179,0.000008941528,0.00003985038,0.0000731148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743503,0.00016391651,0.0009866952,0.0006438011,0.00034592603,0.00042464447],"domain_scores_gemma":[0.9980082,0.00020660035,0.0005902195,0.00042247472,0.0004776896,0.00029479567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023596997,0.00022811562,0.0012916438,0.0011946954,0.000118176096,0.000056833844,0.000050650142,0.000056087694,0.000031195956],"category_scores_gemma":[0.00047798784,0.00018287546,0.00049895706,0.0022140276,0.0000998192,0.00028504082,0.000018429313,0.00030452336,8.944684e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061200866,0.0046021948,0.7527799,0.002418392,0.02080575,0.10106783,0.026809076,0.00090783474,0.002070221,0.0032979927,0.007900991,0.07121971],"study_design_scores_gemma":[0.008173559,0.02626714,0.5906656,0.009489796,0.020945212,0.26580507,0.033334427,0.0033214234,0.012602903,0.0071452404,0.019987851,0.0022618137],"about_ca_topic_score_codex":0.00094098545,"about_ca_topic_score_gemma":0.0003300801,"teacher_disagreement_score":0.16473722,"about_ca_system_score_codex":0.0024012933,"about_ca_system_score_gemma":0.001933859,"threshold_uncertainty_score":0.7457445},"labels":[],"label_agreement":null},{"id":"W4406215254","doi":"10.1158/2767-9764.crc-24-0566","title":"Evaluating Ovarian Cancer Risk–Reducing Salpingectomy Acceptance: A Survey","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Salpingectomy; Ovarian cancer; Medicine; Population; Gynecology; Demography; Obstetrics; Incidence (geometry); Risk assessment; Cancer; Oncology; Environmental health; Internal medicine; Pregnancy; Biology","score_opus":0.36091268936756304,"score_gpt":0.5806585139827994,"score_spread":0.2197458246152364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406215254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6737976,0.16246909,0.00053051644,0.10171184,0.0010816719,0.005893144,0.0012599294,0.00038491466,0.052871324],"genre_scores_gemma":[0.9464641,0.04222533,0.0034971,0.00038232724,0.0001474526,0.0047428734,0.0001231052,0.00003934537,0.002378329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620444,0.0014836229,0.00044732186,0.00054896326,0.0006834594,0.00063219276],"domain_scores_gemma":[0.9932791,0.00180482,0.00013651,0.0030709847,0.0014892648,0.00021932035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036843256,0.00020069067,0.0004062938,0.00044361246,0.0012969866,0.00014281162,0.0009309355,0.00011611568,0.0009825851],"category_scores_gemma":[0.0016825347,0.00018660317,0.00012403174,0.0022779668,0.00041364483,0.00013580479,0.0006774563,0.0011847223,0.00004509896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000289876,0.00075440423,0.5879011,0.00018294496,0.0010330573,0.0000046515092,0.0010465141,0.00025789207,0.0011256748,0.0029763447,0.029385243,0.37504226],"study_design_scores_gemma":[0.0029506201,0.00015110773,0.9492837,0.0016757768,0.00028635995,0.000001848159,0.0002823384,0.0038432966,0.0012460704,0.0006695698,0.039404247,0.00020506256],"about_ca_topic_score_codex":0.06086401,"about_ca_topic_score_gemma":0.018213946,"teacher_disagreement_score":0.3748372,"about_ca_system_score_codex":0.0019613078,"about_ca_system_score_gemma":0.0034770994,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W4406229872","doi":"10.1177/08465371241301335","title":"Implementation of O-RADS Ultrasound Reporting System: A Quality Improvement Initiative","year":2025,"lang":"en","type":"article","venue":"Canadian Association of Radiologists Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sinai Health System; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Audit; BI-RADS; Prospective cohort study; Radiology; Ultrasound; Cohen's kappa; Cancer; Surgery; Internal medicine; Breast cancer; Mammography","score_opus":0.034214843126525396,"score_gpt":0.3640811518708331,"score_spread":0.3298663087443077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406229872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916405,0.00038977587,0.00043482002,0.0037056701,0.00057919975,0.0004562419,0.00012754614,0.000012495868,0.0051301764],"genre_scores_gemma":[0.9989078,0.00011993833,0.00037941837,0.00032208566,0.00009164168,0.000017845829,0.000029100907,0.000005606783,0.00012652918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977713,0.00014953101,0.0014565869,0.00014358242,0.0002416191,0.00023733318],"domain_scores_gemma":[0.99545133,0.00019238157,0.0034700471,0.00013803627,0.0005792693,0.00016892573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00211735,0.00010169489,0.00048051198,0.0002659722,0.00010843404,0.000018929482,0.00005852991,0.000101893645,0.00005941142],"category_scores_gemma":[0.0013953075,0.00009110927,0.00016822085,0.00022506305,0.000032611675,0.0000632086,0.0000063102702,0.00015976907,8.9179156e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021128655,0.000048692564,0.9837979,0.0001452413,0.0007645868,0.000026713584,0.00032601424,0.000008090752,0.0007896007,0.0025267138,0.004388094,0.007157231],"study_design_scores_gemma":[0.0023273928,0.00028144894,0.9888264,0.00023887806,0.00025287163,0.000053447875,0.003090101,0.000004806506,0.0039422493,0.00013607001,0.0007791073,0.00006720803],"about_ca_topic_score_codex":0.023417369,"about_ca_topic_score_gemma":0.031268,"teacher_disagreement_score":0.009743759,"about_ca_system_score_codex":0.0056481184,"about_ca_system_score_gemma":0.0023277586,"threshold_uncertainty_score":0.998169},"labels":[],"label_agreement":null},{"id":"W4406320384","doi":"10.1016/j.ijgc.2025.101635","title":"Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Janet D. Cottrelle Foundation; BC Cancer Foundation; Victoria General Hospital Foundation; University of British Columbia; VGH and UBC Hospital Foundation","keywords":"Medicine; Fallopian tube; Gynecology; Reduction (mathematics); Obstetrics; Tube (container)","score_opus":0.022909444462998283,"score_gpt":0.33842010651214793,"score_spread":0.3155106620491496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406320384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821616,0.0002683156,0.000019122788,0.016440876,0.0003414065,0.00019943787,0.000029662855,0.0000036420763,0.0005359467],"genre_scores_gemma":[0.9972893,0.00018477948,0.000113227215,0.0020219223,0.00014840547,0.000027495746,0.0000028108518,0.0000040041846,0.00020803102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895346,0.000091123264,0.0002911346,0.00011764471,0.0004397727,0.00010687072],"domain_scores_gemma":[0.998188,0.00082880486,0.00025988862,0.00006274282,0.000627224,0.00003329834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019100233,0.00009877299,0.00032099674,0.00008320497,0.000019734873,0.000025478383,0.00015118529,0.000073856616,0.00028396246],"category_scores_gemma":[0.00058422924,0.00005053289,0.00013616448,0.00018373872,0.00010180477,0.00010418952,0.000017003618,0.00030424996,4.71556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011343679,0.011928018,0.8708887,0.000037433714,0.008553362,0.0019348754,0.0048749135,0.002329258,0.0049407324,0.010255159,0.022018123,0.05089575],"study_design_scores_gemma":[0.004381772,0.0011466121,0.98944384,0.00036288748,0.00024170996,0.000029441864,0.0002772894,0.00008304049,0.0014356895,0.00077455153,0.0017665431,0.000056643217],"about_ca_topic_score_codex":0.00012447279,"about_ca_topic_score_gemma":0.00017707082,"teacher_disagreement_score":0.11855513,"about_ca_system_score_codex":0.00048115317,"about_ca_system_score_gemma":0.00025176705,"threshold_uncertainty_score":0.310919},"labels":[],"label_agreement":null},{"id":"W4406394407","doi":"10.1016/s0246-1064(19)30180-x","title":"10.1016/s0246-1064(19)30180-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.00931696244088072,"score_gpt":0.2123362447059976,"score_spread":0.20301928226511687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406394407","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034786452,0.00033491247,4.2309577e-7,0.003605424,0.000002440876,0.00035069548,0.000023245926,0.00011021556,0.9952248],"genre_scores_gemma":[0.000821745,0.0000035624068,0.00020241957,0.00034044258,0.00029199646,0.000078089135,0.000033335265,0.000029597702,0.9981988],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990995,0.000017012266,0.00016179448,0.00027291017,0.00019296879,0.00025584007],"domain_scores_gemma":[0.9992295,0.000037753947,0.000020360942,0.0003631974,0.000034623754,0.00031455967],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006951086,0.0001493172,0.00024239268,0.000062500796,0.00005345447,0.00002162294,0.00007141202,0.000057286816,0.9987789],"category_scores_gemma":[0.000019274448,0.00012469603,0.000088469256,0.0001699458,0.000023094257,0.000037685,0.000018110066,0.000079982885,0.9949969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012667562,0.00019398499,0.000004133108,0.000009052118,0.00005026167,0.000051272316,0.000013859132,0.000008959049,0.0000051510415,8.5554007e-7,0.641044,0.35849175],"study_design_scores_gemma":[0.001246042,0.0005567324,0.0010743603,0.000061443105,0.00012867304,0.000034094403,9.987494e-7,0.00003093204,0.0001332618,0.0000071247446,0.9965985,0.00012787509],"about_ca_topic_score_codex":0.00007007835,"about_ca_topic_score_gemma":3.6327688e-7,"teacher_disagreement_score":0.35836387,"about_ca_system_score_codex":0.00012808685,"about_ca_system_score_gemma":0.00007351243,"threshold_uncertainty_score":0.5084956},"labels":[],"label_agreement":null},{"id":"W4406405159","doi":"10.1016/j.ijgc.2025.101640","title":"Factors influencing surgeons’ decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytoreductive surgery; Ovarian cancer; General surgery; Ileostomy; Surgery; Cancer; Internal medicine","score_opus":0.05877032026354865,"score_gpt":0.3753638135145411,"score_spread":0.31659349325099245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406405159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003977,0.001141689,0.00036429663,0.007075471,0.00090674456,0.00025523233,0.00008248951,0.0000071088443,0.00012717808],"genre_scores_gemma":[0.9978181,0.00082046667,0.0002534065,0.00085606484,0.00008847567,0.000105737454,0.000010950807,0.0000067251053,0.000040076615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987975,0.000039533534,0.00055539765,0.00018601958,0.00025587407,0.00016572067],"domain_scores_gemma":[0.9962966,0.0024429644,0.00035503707,0.000058233658,0.00076357345,0.0000835864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033781966,0.00012369694,0.0004132002,0.00031517196,0.000068973466,0.000035188226,0.00010433644,0.00009577244,0.00017124524],"category_scores_gemma":[0.0016010691,0.00008854107,0.00016950881,0.0001939881,0.000054421565,0.00012113719,0.000049019538,0.00017692296,2.8101192e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028004733,0.0002829429,0.97184694,0.000009514956,0.00049781747,0.000024104127,0.0001428359,0.00016145213,0.00021269872,0.00028956044,0.0012628207,0.024989262],"study_design_scores_gemma":[0.0017742852,0.000078435325,0.99382436,0.00066830846,0.00011937642,0.000004903338,0.00015038702,0.000083205916,0.000522548,0.000980526,0.0017192086,0.00007445684],"about_ca_topic_score_codex":0.0005017222,"about_ca_topic_score_gemma":0.0005969147,"teacher_disagreement_score":0.024914805,"about_ca_system_score_codex":0.0013637568,"about_ca_system_score_gemma":0.00051529304,"threshold_uncertainty_score":0.36106},"labels":[],"label_agreement":null},{"id":"W4406424597","doi":"10.1016/s0029-7437(09)70201-0","title":"10.1016/s0029-7437(09)70201-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Biomarker; Computer science; Chemistry; Internal medicine; Medicine; Biochemistry","score_opus":0.008887220947021834,"score_gpt":0.20921204496118645,"score_spread":0.20032482401416463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406424597","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080370245,0.00027103012,3.079276e-7,0.0028655448,4.5292757e-7,0.00034504652,0.000020728648,0.00011764612,0.99557555],"genre_scores_gemma":[0.0006218156,0.0000029676964,0.00023466602,0.00018989864,0.00027957736,0.00007160454,0.000031207685,0.000029705414,0.99853855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991244,0.000015933796,0.00015867638,0.000263137,0.0001868674,0.00025096917],"domain_scores_gemma":[0.99930024,0.00003181924,0.000020707404,0.0003622347,0.000037163245,0.0002478585],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006446177,0.00014765997,0.00024237076,0.00005577491,0.000048824426,0.000020653437,0.00007130244,0.000057030964,0.9990098],"category_scores_gemma":[0.000013007729,0.00012281028,0.0000873156,0.00014818857,0.00002183321,0.000041227257,0.000017710548,0.00007912339,0.996892],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011598368,0.00019119435,0.0000031898435,0.000007399713,0.000060152066,0.000029527206,0.000012378009,0.0000052818714,0.000008266919,0.0000011548974,0.6475085,0.35205698],"study_design_scores_gemma":[0.0012042501,0.00057656923,0.0010413183,0.000064226864,0.00012572104,0.000028852546,7.7010907e-7,0.000026029466,0.0002260974,0.0000047147246,0.99657476,0.00012669121],"about_ca_topic_score_codex":0.000049653754,"about_ca_topic_score_gemma":2.992135e-7,"teacher_disagreement_score":0.3519303,"about_ca_system_score_codex":0.00010271946,"about_ca_system_score_gemma":0.000053761567,"threshold_uncertainty_score":0.5008058},"labels":[],"label_agreement":null},{"id":"W4406430430","doi":"10.1016/s0029-7437(05)70582-6","title":"10.1016/s0029-7437(05)70582-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer; Medicine; Oncology; Risk analysis (engineering); Internal medicine","score_opus":0.008878614346318276,"score_gpt":0.2098401691046477,"score_spread":0.2009615547583294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406430430","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086318003,0.00024343937,3.091591e-7,0.0031789492,5.532583e-7,0.0003472813,0.000020882835,0.000121753765,0.99522364],"genre_scores_gemma":[0.0008416299,0.0000027485974,0.0002503567,0.00028932453,0.00027433076,0.000073391944,0.00003219205,0.000030000987,0.998206],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909985,0.000016807482,0.00016440729,0.00026919547,0.00018986712,0.00025984508],"domain_scores_gemma":[0.999292,0.00003440147,0.000020946502,0.00036565965,0.00003642161,0.00025053925],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006734323,0.00015111828,0.00024998936,0.00005932478,0.000050311734,0.000020856301,0.00007145379,0.000057344474,0.99883085],"category_scores_gemma":[0.000014520187,0.00012618148,0.00009167811,0.00016509333,0.000021934418,0.000041231637,0.000017628108,0.00008063256,0.99526566],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011325881,0.00020623284,0.0000028752625,0.000007939085,0.000062353196,0.0000409688,0.000012578263,0.000006731331,0.000007811691,0.00000134024,0.67334396,0.32619393],"study_design_scores_gemma":[0.0012369815,0.0006489732,0.001007991,0.000069217815,0.00012722156,0.0000391158,7.918216e-7,0.000030396668,0.00022953638,0.0000050820317,0.9964761,0.00012860374],"about_ca_topic_score_codex":0.000052985048,"about_ca_topic_score_gemma":3.37859e-7,"teacher_disagreement_score":0.32606533,"about_ca_system_score_codex":0.00011109045,"about_ca_system_score_gemma":0.000055458033,"threshold_uncertainty_score":0.5145531},"labels":[],"label_agreement":null},{"id":"W4406441536","doi":"10.1016/s0029-7437(06)72390-4","title":"10.1016/s0029-7437(06)72390-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Medicine; Oncology; Cancer; Internal medicine","score_opus":0.008813368323648393,"score_gpt":0.20942683617582697,"score_spread":0.20061346785217857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406441536","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010360985,0.00027130326,3.031506e-7,0.0028020893,2.3035446e-7,0.00034950412,0.00002079328,0.00012243654,0.99539727],"genre_scores_gemma":[0.000936042,0.000002836872,0.00023020749,0.00024457902,0.00027516592,0.00007563483,0.000039629493,0.00003037271,0.99816555],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910325,0.000016325954,0.00016297432,0.0002688961,0.000191847,0.00025672282],"domain_scores_gemma":[0.999297,0.000033296248,0.000020694944,0.00036448354,0.000037497528,0.0002470309],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006533809,0.00015080062,0.00024768437,0.000059439273,0.000050351046,0.000021349368,0.00007168278,0.000057615533,0.99877626],"category_scores_gemma":[0.000013823467,0.00012629852,0.00009084013,0.00016677962,0.00002193609,0.00004123332,0.000017952421,0.000081208156,0.9967159],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010404859,0.00022672393,0.0000050608605,0.000008771983,0.00006972941,0.00003352815,0.000014619883,0.000006871514,0.000008901747,0.000001405146,0.7802692,0.21925116],"study_design_scores_gemma":[0.0012151197,0.0005153025,0.0011936694,0.00006904674,0.00012918301,0.000030387355,8.1433615e-7,0.000027984315,0.00021295763,0.000005036992,0.9964712,0.0001292718],"about_ca_topic_score_codex":0.000043209555,"about_ca_topic_score_gemma":2.6366686e-7,"teacher_disagreement_score":0.21912189,"about_ca_system_score_codex":0.000110771674,"about_ca_system_score_gemma":0.000056518777,"threshold_uncertainty_score":0.51503044},"labels":[],"label_agreement":null},{"id":"W4406451468","doi":"10.1016/s1241-8218(95)34439-3","title":"10.1016/s1241-8218(95)34439-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Nuclear medicine","score_opus":0.007179816125981596,"score_gpt":0.19884436613360873,"score_spread":0.19166455000762714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406451468","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010787175,0.00041329928,2.398109e-7,0.0029877655,0.000002400013,0.00035169462,0.000017968556,0.00010493509,0.995043],"genre_scores_gemma":[0.0008961818,0.000004390442,0.00022607636,0.0002639851,0.00026360922,0.0000762939,0.000028588478,0.000029995246,0.9982109],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910975,0.000016371607,0.00016039106,0.00026683148,0.00019225721,0.00025442752],"domain_scores_gemma":[0.9993044,0.000031917756,0.000020616204,0.00036030932,0.00003750959,0.00024523534],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006461852,0.00014994395,0.00024520126,0.000046113615,0.000049744318,0.000021186974,0.000070585724,0.00005650249,0.9986126],"category_scores_gemma":[0.0000132021205,0.00012445076,0.00008608963,0.00016308723,0.000022092361,0.000041006464,0.000017135071,0.00008024584,0.9952187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013623032,0.00021529819,0.000004162811,0.000008235338,0.000065647844,0.000047916146,0.000012191301,0.000006420156,0.000010036358,0.0000012788989,0.4464073,0.55308527],"study_design_scores_gemma":[0.0012437945,0.000619908,0.0011771424,0.0000691132,0.00013061105,0.000026764208,7.718535e-7,0.000031386066,0.00024565414,0.0000045843576,0.99632174,0.00012855574],"about_ca_topic_score_codex":0.00005683069,"about_ca_topic_score_gemma":2.8413731e-7,"teacher_disagreement_score":0.55295676,"about_ca_system_score_codex":0.00010659134,"about_ca_system_score_gemma":0.000058111338,"threshold_uncertainty_score":0.50749546},"labels":[],"label_agreement":null},{"id":"W4406455651","doi":"10.1016/s0084-3873(13)00221-6","title":"10.1016/s0084-3873(13)00221-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecologic oncology; Oncology; Ovarian cancer; Internal medicine; Cytokine; Epithelial ovarian cancer; Gynecology; Cancer","score_opus":0.006954563113933136,"score_gpt":0.1965535784856897,"score_spread":0.18959901537175655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406455651","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015693028,0.00027860558,2.3609849e-7,0.0028180012,0.0000021481264,0.00034566625,0.000021250578,0.00010356844,0.99486125],"genre_scores_gemma":[0.00071694324,0.0000028679776,0.00016627523,0.00015051628,0.00027232512,0.00007769497,0.00003223039,0.000030343466,0.99855083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991027,0.00001668472,0.0001627419,0.00026743324,0.0001953653,0.0002550468],"domain_scores_gemma":[0.99930066,0.00003240393,0.000020788073,0.00036368688,0.00003689882,0.00024558353],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006414041,0.00014980455,0.00024584687,0.00006037887,0.000052364507,0.000021182344,0.00007188126,0.00005627542,0.9989454],"category_scores_gemma":[0.000013356877,0.00012576248,0.00008971109,0.00016988267,0.000022508239,0.000041403207,0.00001813727,0.000081905746,0.9951503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012966359,0.00022230574,0.000004605952,0.000008297799,0.00006669657,0.00004829042,0.00001627335,0.000008428186,0.000010357206,0.0000010136104,0.33589,0.66359407],"study_design_scores_gemma":[0.0012500987,0.00059359754,0.001253972,0.00006370571,0.00012431444,0.000032202202,8.7568463e-7,0.000030845273,0.0002585607,0.0000047689414,0.9962584,0.00012870372],"about_ca_topic_score_codex":0.00006688247,"about_ca_topic_score_gemma":4.5872716e-7,"teacher_disagreement_score":0.6634654,"about_ca_system_score_codex":0.00010738679,"about_ca_system_score_gemma":0.000057458747,"threshold_uncertainty_score":0.5128445},"labels":[],"label_agreement":null},{"id":"W4406470674","doi":"10.1016/s2211-0666(20)30006-2","title":"10.1016/s2211-0666(20)30006-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0068297249859800456,"score_gpt":0.19790271723811464,"score_spread":0.1910729922521346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406470674","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009385347,0.000332008,2.1576909e-7,0.0034343477,0.0000023622342,0.00034905697,0.000028432076,0.00010667219,0.9948084],"genre_scores_gemma":[0.0008928914,0.000002106099,0.0001667329,0.00027219937,0.00028368138,0.000076645454,0.000045863737,0.000030785122,0.9982291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909097,0.000016824873,0.00016451656,0.0002711891,0.00019472906,0.00026178567],"domain_scores_gemma":[0.99929434,0.000032286636,0.000020709032,0.00036765676,0.000037887632,0.0002471017],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006461364,0.00015226484,0.0002483854,0.000060582614,0.000050855877,0.000021482276,0.00007246965,0.000058233574,0.99856466],"category_scores_gemma":[0.00001172997,0.00012750122,0.00009054129,0.00016694202,0.000022560684,0.000041664218,0.000017635824,0.000082015715,0.99526453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014665973,0.0002258065,0.0000042657557,0.000008718944,0.0000691444,0.000050494622,0.0000136869285,0.000009517834,0.000010776431,0.0000011659404,0.46187586,0.53758395],"study_design_scores_gemma":[0.0015791184,0.00057121675,0.00091801694,0.000067231646,0.00012962455,0.00003136851,7.587802e-7,0.000028246664,0.0002510151,0.0000047833073,0.996288,0.00013060484],"about_ca_topic_score_codex":0.00004483654,"about_ca_topic_score_gemma":4.517375e-7,"teacher_disagreement_score":0.5374533,"about_ca_system_score_codex":0.00011204864,"about_ca_system_score_gemma":0.000061369195,"threshold_uncertainty_score":0.5199349},"labels":[],"label_agreement":null},{"id":"W4406479468","doi":"10.1016/s0029-7437(06)71595-6","title":"10.1016/s0029-7437(06)71595-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cancer detection; Cancer; Medical physics; Medicine; Computer science; Internal medicine","score_opus":0.00880963185643456,"score_gpt":0.20949919032049713,"score_spread":0.20068955846406256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406479468","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001056103,0.00026782166,3.2433124e-7,0.002639773,2.4274811e-7,0.0003509329,0.00002075606,0.00012111488,0.99554294],"genre_scores_gemma":[0.0008703848,0.0000029079013,0.00024833946,0.000245846,0.00027488757,0.00007606606,0.00003935791,0.000030305859,0.9982119],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910545,0.000016367669,0.0001625275,0.0002682684,0.0001913414,0.00025605792],"domain_scores_gemma":[0.9992989,0.000033444103,0.00002065692,0.0003629616,0.000037418296,0.00024666922],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006531409,0.00015058414,0.00024648072,0.00005916234,0.000050470688,0.000021100886,0.00007143964,0.000058284717,0.9988693],"category_scores_gemma":[0.000013745785,0.00012614482,0.00009072049,0.00016580061,0.000022375802,0.000041088424,0.000017838365,0.000082259554,0.99696064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010134292,0.00022445318,0.000004675454,0.000008749451,0.00006927974,0.00003354094,0.000014744424,0.0000066791977,0.000009120622,0.0000013659907,0.76897395,0.2305521],"study_design_scores_gemma":[0.001216952,0.00051263534,0.0012179991,0.0000682103,0.00012809898,0.000029296561,8.6179625e-7,0.000028929622,0.00021759597,0.0000050063045,0.99644536,0.00012908118],"about_ca_topic_score_codex":0.00004173773,"about_ca_topic_score_gemma":2.3139637e-7,"teacher_disagreement_score":0.23042303,"about_ca_system_score_codex":0.00011133544,"about_ca_system_score_gemma":0.000056103043,"threshold_uncertainty_score":0.51440364},"labels":[],"label_agreement":null},{"id":"W4406506955","doi":"10.1016/s0246-1064(20)55470-4","title":"10.1016/s0246-1064(20)55470-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.007813865839426216,"score_gpt":0.2046993541970357,"score_spread":0.19688548835760947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406506955","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044511483,0.00032866845,2.6617008e-7,0.0034236957,0.0000024940646,0.0003464348,0.000025209563,0.00010720806,0.9953209],"genre_scores_gemma":[0.0006925863,0.0000028367945,0.0002073795,0.00025182805,0.0002943193,0.00007617719,0.00003905879,0.000030874362,0.9984049],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990881,0.000016528624,0.00016421264,0.00027308858,0.00019504718,0.0002630016],"domain_scores_gemma":[0.9992827,0.000034669116,0.000020455576,0.0003680877,0.00003764955,0.00025643062],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006649752,0.00015238668,0.00024790992,0.00006115463,0.000050206392,0.000021834623,0.000072360286,0.000058324946,0.99874586],"category_scores_gemma":[0.0000130681265,0.00012731254,0.0000910103,0.00016910624,0.00002270567,0.00004101937,0.000018078515,0.000083989326,0.9954958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012155536,0.00020437506,0.0000029708826,0.000008371403,0.00006355903,0.00004821898,0.000014325186,0.000007973431,0.000011868318,5.956702e-7,0.6199299,0.37958625],"study_design_scores_gemma":[0.0012454755,0.00057026476,0.000690759,0.00007287658,0.00013273506,0.00003167484,8.903182e-7,0.000028338463,0.00025897802,0.0000053709823,0.99683213,0.00013048024],"about_ca_topic_score_codex":0.000045723114,"about_ca_topic_score_gemma":4.5016358e-7,"teacher_disagreement_score":0.37945578,"about_ca_system_score_codex":0.000113101145,"about_ca_system_score_gemma":0.00006319008,"threshold_uncertainty_score":0.5191655},"labels":[],"label_agreement":null},{"id":"W4406507110","doi":"10.1016/s0246-1064(21)44049-1","title":"10.1016/s0246-1064(21)44049-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pith; Biology; Horticulture","score_opus":0.00791915229894611,"score_gpt":0.20491483695688859,"score_spread":0.19699568465794248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406507110","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047327954,0.00042453033,2.839506e-7,0.0028109334,0.0000025707773,0.0003490751,0.000021277323,0.00010761471,0.99581045],"genre_scores_gemma":[0.00084652234,0.0000033258696,0.00021543552,0.0002369952,0.0002934476,0.000076450415,0.00003115565,0.00003094825,0.99826574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908286,0.000016640544,0.00016474002,0.00027452677,0.00019737131,0.0002638761],"domain_scores_gemma":[0.99927855,0.000034655866,0.00002038257,0.00037211645,0.00003725992,0.00025706127],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000064734995,0.00015283405,0.00025096626,0.000060698352,0.00004912057,0.00002184465,0.000072637864,0.00005830614,0.99862796],"category_scores_gemma":[0.00001421136,0.00012766609,0.000094920506,0.00016826588,0.000022479626,0.00004117472,0.000018346269,0.00008344742,0.9953432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012268516,0.00020362898,0.0000028623854,0.000008206099,0.00006767178,0.000047583424,0.000013389973,0.0000067208657,0.000008566321,5.384289e-7,0.6117856,0.38773254],"study_design_scores_gemma":[0.0012380863,0.0005765119,0.000997594,0.00007359067,0.00014043268,0.000032144617,9.344269e-7,0.000025980748,0.0002680709,0.0000049315136,0.9965109,0.00013082569],"about_ca_topic_score_codex":0.00005523101,"about_ca_topic_score_gemma":3.3417632e-7,"teacher_disagreement_score":0.38760173,"about_ca_system_score_codex":0.00011418059,"about_ca_system_score_gemma":0.00006119381,"threshold_uncertainty_score":0.52060723},"labels":[],"label_agreement":null},{"id":"W4406508021","doi":"10.1016/s0246-1064(20)42541-1","title":"10.1016/s0246-1064(20)42541-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Art; Humanities; Philosophy","score_opus":0.0077569801371474775,"score_gpt":0.20431224188574792,"score_spread":0.19655526174860044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406508021","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044117245,0.00031503759,2.6479088e-7,0.0034508314,0.0000025112333,0.00034748478,0.000026345197,0.00010732372,0.99530905],"genre_scores_gemma":[0.0006825682,0.0000028662055,0.00021307927,0.00025524848,0.00029134733,0.00007645041,0.00004000289,0.000030907093,0.99840754],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990868,0.000016253178,0.00016444662,0.000273652,0.0001954695,0.0002633632],"domain_scores_gemma":[0.99928355,0.000033927903,0.000020481748,0.0003682151,0.00003794165,0.00025590401],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006513569,0.00015252682,0.00024842093,0.000061075385,0.00004979928,0.000021715192,0.000072457195,0.000058309717,0.99869543],"category_scores_gemma":[0.000012810539,0.00012744433,0.00009039194,0.00016961033,0.000022390836,0.00004150033,0.000018125556,0.00008330078,0.99516904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012174693,0.00020486982,0.0000028316595,0.000008224309,0.00006375774,0.000046917976,0.000013098524,0.000008027057,0.000011958508,5.632336e-7,0.61650115,0.38301682],"study_design_scores_gemma":[0.0012533354,0.00057685515,0.00062876573,0.000073065334,0.00013317095,0.000031108702,9.307093e-7,0.000029179157,0.00026859876,0.0000052127484,0.99686915,0.00013063241],"about_ca_topic_score_codex":0.000039659906,"about_ca_topic_score_gemma":4.1338507e-7,"teacher_disagreement_score":0.3828862,"about_ca_system_score_codex":0.00011296273,"about_ca_system_score_gemma":0.00006352031,"threshold_uncertainty_score":0.5197029},"labels":[],"label_agreement":null},{"id":"W4406517589","doi":"10.1016/s0029-7437(09)70421-5","title":"10.1016/s0029-7437(09)70421-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Internal medicine; Computer science","score_opus":0.008852116735990144,"score_gpt":0.2095605275163569,"score_spread":0.20070841078036675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406517589","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010016257,0.00029046444,3.1546827e-7,0.0026502477,4.7230336e-7,0.0003484861,0.00002115458,0.00012195769,0.9955653],"genre_scores_gemma":[0.0007451212,0.000003067592,0.00022804098,0.00018563106,0.000275924,0.000075930795,0.000030079056,0.000029444744,0.99842674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991031,0.000016324164,0.00016225192,0.00026834675,0.0001920965,0.0002578668],"domain_scores_gemma":[0.99929565,0.000032684526,0.000020545429,0.00036608608,0.000037626975,0.00024741233],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006531058,0.00015041449,0.0002459097,0.00005835773,0.000051371888,0.000021038735,0.00007189572,0.000057504247,0.9988088],"category_scores_gemma":[0.000013934706,0.00012593236,0.00009056261,0.00016541292,0.000022865326,0.000041145155,0.00001803136,0.000081011094,0.9960346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119129145,0.00020842634,0.000003547326,0.000007835012,0.00006412029,0.000034248,0.000013121132,0.0000062171275,0.000008693418,0.0000012656947,0.6257362,0.3737972],"study_design_scores_gemma":[0.0012280041,0.0005897341,0.0010314087,0.0000678966,0.00013247722,0.000031665128,8.223313e-7,0.000026620031,0.00026670648,0.000004783353,0.99649096,0.00012895204],"about_ca_topic_score_codex":0.000050393126,"about_ca_topic_score_gemma":3.6286562e-7,"teacher_disagreement_score":0.37366825,"about_ca_system_score_codex":0.00011354431,"about_ca_system_score_gemma":0.00005849894,"threshold_uncertainty_score":0.5135373},"labels":[],"label_agreement":null},{"id":"W4406518878","doi":"10.1016/s0029-7437(12)70152-0","title":"10.1016/s0029-7437(12)70152-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Torsion (gastropod); Medicine; Anatomy","score_opus":0.009533803807012322,"score_gpt":0.20830369613133165,"score_spread":0.19876989232431932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406518878","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007110557,0.00024067842,2.9177338e-7,0.0026003027,4.8322875e-7,0.00035264395,0.000019351373,0.00012240415,0.9959528],"genre_scores_gemma":[0.00076833676,0.000002937467,0.0002252034,0.000246086,0.00027736305,0.00007538988,0.000031749812,0.000030666233,0.9983423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909437,0.000016537388,0.0001641504,0.00027028972,0.00019564753,0.0002590282],"domain_scores_gemma":[0.99929386,0.000032816217,0.000020837046,0.0003669508,0.000033000764,0.00025256118],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006661515,0.00015214448,0.00024894046,0.000059543923,0.000050074428,0.000021794518,0.00007206602,0.000057475077,0.9989497],"category_scores_gemma":[0.000013716881,0.0001274716,0.00008968272,0.00013101136,0.000022098315,0.000041921085,0.00001812572,0.00008135921,0.9955034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013176144,0.00020805896,0.000004160011,0.000008019555,0.00006485798,0.000035104422,0.000013774748,0.0000064736237,0.000007968373,0.0000010604754,0.67267907,0.3268397],"study_design_scores_gemma":[0.0012518197,0.0006230174,0.0011810308,0.000067551184,0.00013007471,0.00003080544,7.8900763e-7,0.000028023394,0.0002191054,0.0000048455845,0.9963325,0.00013042359],"about_ca_topic_score_codex":0.000051586292,"about_ca_topic_score_gemma":4.7246215e-7,"teacher_disagreement_score":0.32670927,"about_ca_system_score_codex":0.00011244681,"about_ca_system_score_gemma":0.000056881978,"threshold_uncertainty_score":0.51981413},"labels":[],"label_agreement":null},{"id":"W4406520115","doi":"10.1016/s0029-7437(07)70365-8","title":"10.1016/s0029-7437(07)70365-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.008883153088260187,"score_gpt":0.20993597832631966,"score_spread":0.20105282523805948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406520115","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009528502,0.00026973127,2.922259e-7,0.0027439522,4.7402844e-7,0.00035181502,0.00002024913,0.000122054094,0.9955386],"genre_scores_gemma":[0.000891658,0.00000289079,0.00023576865,0.00024038304,0.00027732848,0.000077343204,0.00003066302,0.000030312189,0.99821365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991037,0.0000163449,0.00016280994,0.00026890516,0.00019151863,0.00025671],"domain_scores_gemma":[0.99929535,0.000033248798,0.000020658068,0.00036602275,0.00003747577,0.0002472182],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006551783,0.00015061938,0.0002468526,0.00005590569,0.000050398212,0.000021214964,0.00007160649,0.000057475125,0.99927205],"category_scores_gemma":[0.000013905448,0.00012611781,0.00009078254,0.00014850318,0.0000220093,0.00004123812,0.000017899096,0.000081122125,0.99751127],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012524029,0.00021451639,0.0000034358347,0.000008329892,0.00006584876,0.000037072925,0.0000134954225,0.000006604638,0.000007764057,0.0000012669227,0.6761591,0.3233573],"study_design_scores_gemma":[0.0012168628,0.0005790866,0.0010292892,0.00006835274,0.00012916313,0.000032246364,7.948468e-7,0.000027306076,0.00021306144,0.000005186234,0.9965695,0.00012914873],"about_ca_topic_score_codex":0.000049418522,"about_ca_topic_score_gemma":2.915342e-7,"teacher_disagreement_score":0.32322818,"about_ca_system_score_codex":0.00011060058,"about_ca_system_score_gemma":0.000056087185,"threshold_uncertainty_score":0.5142935},"labels":[],"label_agreement":null},{"id":"W4406527222","doi":"10.3390/cells14020133","title":"Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis","year":2025,"lang":"en","type":"article","venue":"Cells","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada; Western University","funders":"Canadian Institutes of Health Research; London Health Sciences Foundation","keywords":"Organoid; Spheroid; Biology; Cancer research; Cell biology; Metastasis; Cancer cell; Ovarian cancer; Targeted therapy; Kinase; Phenotype; Cancer; Cell culture; Genetics; Gene","score_opus":0.014920989420238824,"score_gpt":0.290053938488101,"score_spread":0.2751329490678622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406527222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790388,0.0075084176,0.0056762397,0.0035420968,0.0006429562,0.0006473193,0.00007551341,0.00006683277,0.002801856],"genre_scores_gemma":[0.9919224,0.00290643,0.0027384015,0.0012191414,0.00014606856,0.00020384057,0.000011930475,0.000021495058,0.00083034066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987673,0.00003383403,0.00031059628,0.00042924972,0.00015737447,0.00030163507],"domain_scores_gemma":[0.99949116,0.000063391075,0.00008436638,0.00022958008,0.000055829005,0.000075674085],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012514865,0.00019458433,0.00048286575,0.00017779693,0.000082512175,0.00003692963,0.000062838226,0.000091958886,0.0012293427],"category_scores_gemma":[0.000008426512,0.00016854926,0.00010625574,0.00096447516,0.00003070354,0.000089779496,0.000048844817,0.00014346659,0.0000098303735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003265051,0.0011634497,0.31382397,0.0010309977,0.0073997225,0.00051411527,0.0069239084,0.0042619323,0.5724516,0.0067350757,0.00137575,0.08399302],"study_design_scores_gemma":[0.0047958735,0.00009861392,0.033269264,0.0009116969,0.0033378694,0.000001986613,0.0007846368,0.0008054394,0.9514375,0.0016215708,0.0025978955,0.0003376676],"about_ca_topic_score_codex":0.004468627,"about_ca_topic_score_gemma":0.0012396014,"teacher_disagreement_score":0.3789859,"about_ca_system_score_codex":0.00027464362,"about_ca_system_score_gemma":0.00019929142,"threshold_uncertainty_score":0.9996837},"labels":[],"label_agreement":null},{"id":"W4406547759","doi":"10.1016/j.yobg.2013.05.274","title":"10.1016/j.yobg.2013.05.274","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Gynecology; Ovarian cancer; Epithelial ovarian cancer; Oncology; Cancer; Internal medicine","score_opus":0.007829471756014712,"score_gpt":0.20258716658197637,"score_spread":0.19475769482596167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406547759","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011696032,0.00029361784,1.9820341e-7,0.0053905146,0.0000028160857,0.0003346325,0.0000183163,0.00009642726,0.9926939],"genre_scores_gemma":[0.000912719,0.000004114382,0.00019386185,0.0002960865,0.0002589055,0.00006830161,0.000028911765,0.000027869877,0.99820924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917126,0.000014765004,0.00014928075,0.00024710523,0.00017761557,0.00023996142],"domain_scores_gemma":[0.9993396,0.000029670307,0.000019282508,0.00034493132,0.000035397155,0.00023113603],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000059117745,0.00013948105,0.00022958187,0.0000549898,0.000046308956,0.000019286148,0.00006633478,0.000053592765,0.9982704],"category_scores_gemma":[0.000010114516,0.00011529674,0.000082285835,0.00014352972,0.000020505518,0.00003991533,0.00001655555,0.00007295846,0.99456006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009829349,0.00017382907,0.0000023201821,0.0000052409223,0.000053932938,0.000042238233,0.000011291753,0.000006420462,0.0000063239554,0.0000010200297,0.49040446,0.5091946],"study_design_scores_gemma":[0.0011702161,0.00060182536,0.0009435657,0.00006205759,0.00011236269,0.00003308547,7.248739e-7,0.000029397923,0.00019112795,0.0000035154603,0.9967335,0.000118634925],"about_ca_topic_score_codex":0.00009300135,"about_ca_topic_score_gemma":5.212456e-7,"teacher_disagreement_score":0.509076,"about_ca_system_score_codex":0.000094477065,"about_ca_system_score_gemma":0.00004898743,"threshold_uncertainty_score":0.47016644},"labels":[],"label_agreement":null},{"id":"W4406547808","doi":"10.1016/j.yobg.2013.05.175","title":"10.1016/j.yobg.2013.05.175","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Malignancy; Adnexal mass; Radiology; Pathology","score_opus":0.007855502553692524,"score_gpt":0.20262920248075567,"score_spread":0.19477369992706314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406547808","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007279418,0.00033366415,2.7431128e-7,0.005662235,0.0000028448083,0.00033434582,0.00001831176,0.00009545784,0.9928249],"genre_scores_gemma":[0.0005682527,0.000004353303,0.00023267046,0.00033167313,0.00025945494,0.00006831446,0.000028911174,0.000027881893,0.9984785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991732,0.000014709483,0.00014905735,0.0002468723,0.00017645356,0.00023969417],"domain_scores_gemma":[0.9993405,0.000029486982,0.000019269522,0.00034468205,0.000035190147,0.00023087465],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000058777587,0.00013936815,0.00022920362,0.000054855824,0.000045861354,0.000019247296,0.000066213455,0.00005352735,0.99827135],"category_scores_gemma":[0.000010010015,0.00011525258,0.000082215585,0.0001432791,0.00002046145,0.00003981961,0.000016454687,0.00007272684,0.994557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009669669,0.00017370233,0.0000024274134,0.0000064477053,0.000053803575,0.000041101583,0.00001093344,0.000006160282,0.0000064157302,8.269215e-7,0.5144817,0.48511976],"study_design_scores_gemma":[0.0011715628,0.0006052359,0.000986895,0.00006127504,0.0001159871,0.000034505763,6.914009e-7,0.000028167919,0.00019335699,0.0000039866586,0.9966798,0.000118561475],"about_ca_topic_score_codex":0.000073684685,"about_ca_topic_score_gemma":5.243942e-7,"teacher_disagreement_score":0.4850012,"about_ca_system_score_codex":0.000094104296,"about_ca_system_score_gemma":0.00004895964,"threshold_uncertainty_score":0.46998638},"labels":[],"label_agreement":null},{"id":"W4406547834","doi":"10.1016/j.yobg.2013.05.217","title":"10.1016/j.yobg.2013.05.217","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Fallopian tube; Gynecology; Series (stratigraphy); Prospective cohort study; Obstetrics; Salpingectomy; Surgery; Pregnancy","score_opus":0.007978819100292626,"score_gpt":0.20353579071410044,"score_spread":0.1955569716138078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406547834","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063927675,0.00028341837,2.1545185e-7,0.0052526444,0.000004383282,0.0003206106,0.000014092202,0.000093641866,0.9933917],"genre_scores_gemma":[0.0008239711,0.000004062652,0.00015709052,0.00028255416,0.00026589475,0.00006589248,0.000028243903,0.000027586793,0.9983447],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991766,0.000014503904,0.00014778809,0.0002461869,0.00017595415,0.00023895132],"domain_scores_gemma":[0.9993287,0.000032986096,0.000019538687,0.00035383413,0.000035109253,0.00022988352],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000573468,0.00013906354,0.00022876088,0.00005396933,0.00004739393,0.000020003521,0.00006815188,0.00005347974,0.9982682],"category_scores_gemma":[0.000011862262,0.00011505989,0.00008220313,0.00013652319,0.00002066865,0.000040498522,0.000016810764,0.00007529982,0.9945821],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008854995,0.00015949339,0.0000021574397,0.0000048800234,0.000049838807,0.000039838178,0.000010239077,0.0000073374677,0.0000049009036,6.498307e-7,0.5429935,0.45663863],"study_design_scores_gemma":[0.0011093975,0.0005904275,0.0009565821,0.000066583154,0.000114953866,0.00003558945,6.863326e-7,0.00004673905,0.00020471182,0.0000032366768,0.99675274,0.00011838305],"about_ca_topic_score_codex":0.000091617665,"about_ca_topic_score_gemma":5.427101e-7,"teacher_disagreement_score":0.45652023,"about_ca_system_score_codex":0.000092965674,"about_ca_system_score_gemma":0.00005118087,"threshold_uncertainty_score":0.4692006},"labels":[],"label_agreement":null},{"id":"W4406574810","doi":"10.1016/s1634-6939(20)30332-x","title":"10.1016/s1634-6939(20)30332-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.006927081474680204,"score_gpt":0.1983377263701253,"score_spread":0.1914106448954451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406574810","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008855381,0.00028125008,2.6520183e-7,0.0036061213,0.0000024428555,0.0003486581,0.00002419973,0.00010629684,0.99474525],"genre_scores_gemma":[0.0008409689,0.0000023658422,0.00020707153,0.00027427447,0.00028244327,0.00007551116,0.00003930184,0.000030424482,0.9982476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990953,0.000016652395,0.00016321152,0.00027018535,0.00019397939,0.00026062722],"domain_scores_gemma":[0.9992912,0.000032883207,0.000020681868,0.00036699907,0.000038098315,0.00025012696],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000065501205,0.00015120233,0.00024817718,0.000059899125,0.000050651306,0.000021091106,0.000072059374,0.000057823556,0.99855024],"category_scores_gemma":[0.000012661232,0.0001264905,0.00009009567,0.00016800033,0.000022647871,0.000041402516,0.000017828082,0.00007865498,0.9947022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013940057,0.00022088164,0.0000038199832,0.000008748543,0.00006951449,0.000051571926,0.000013302888,0.000008925555,0.000013000837,0.0000010648131,0.45479763,0.54467213],"study_design_scores_gemma":[0.0012567698,0.0005800844,0.00081075536,0.00006762846,0.00013189383,0.000031534666,7.4751495e-7,0.000029330336,0.00026275063,0.000004983346,0.99669397,0.00012957629],"about_ca_topic_score_codex":0.000044597244,"about_ca_topic_score_gemma":4.2239816e-7,"teacher_disagreement_score":0.54454255,"about_ca_system_score_codex":0.000111565096,"about_ca_system_score_gemma":0.00006104355,"threshold_uncertainty_score":0.5158133},"labels":[],"label_agreement":null},{"id":"W4406575185","doi":"10.1016/s1558-0164(11)70312-1","title":"10.1016/s1558-0164(11)70312-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics; Precocious puberty; Endocrinology; Hormone","score_opus":0.007165557388107065,"score_gpt":0.1988658430944152,"score_spread":0.19170028570630815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406575185","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016737408,0.00022402577,2.8323674e-7,0.0031665002,0.000002581046,0.00034775434,0.000020252663,0.00010602934,0.99445885],"genre_scores_gemma":[0.0012521993,0.0000023675013,0.00022968676,0.00025080997,0.00027644477,0.00007349692,0.00003120898,0.000030664087,0.9978531],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909896,0.000016946207,0.00016323452,0.00027035235,0.00019433994,0.00025615082],"domain_scores_gemma":[0.999297,0.000035123714,0.000021132419,0.0003688553,0.000036953617,0.00024092742],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006773208,0.00015074052,0.00024681972,0.000059210568,0.0000506654,0.000021243386,0.000073478295,0.000057475238,0.99859506],"category_scores_gemma":[0.000014359545,0.0001257168,0.000090705726,0.00016016554,0.000022596478,0.000039904964,0.000018430797,0.00006987485,0.99795914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013689604,0.00029610083,0.0000024738717,0.000011998847,0.00007400432,0.000067068715,0.000018943309,0.000009949291,0.0000112833495,0.0000022927939,0.77295244,0.22641654],"study_design_scores_gemma":[0.0012054858,0.0004800485,0.0013854632,0.000068723944,0.00012588955,0.000030278923,8.7207144e-7,0.00002485589,0.0002583002,0.0000045929223,0.9962858,0.00012970675],"about_ca_topic_score_codex":0.000067969064,"about_ca_topic_score_gemma":5.992965e-7,"teacher_disagreement_score":0.22628684,"about_ca_system_score_codex":0.00011130779,"about_ca_system_score_gemma":0.000056938527,"threshold_uncertainty_score":0.51265824},"labels":[],"label_agreement":null},{"id":"W4406575269","doi":"10.1016/s1558-0164(11)70111-0","title":"10.1016/s1558-0164(11)70111-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ovarian reserve; Internal medicine; Biology; Genetics; Pregnancy","score_opus":0.0072087531112215416,"score_gpt":0.1984980810804794,"score_spread":0.19128932796925785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406575269","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001726776,0.00023080678,2.7694472e-7,0.0029985323,0.0000024154838,0.00034685267,0.000018833316,0.0001058859,0.9945696],"genre_scores_gemma":[0.0012224098,0.0000025683478,0.00022213167,0.00024710217,0.0002690744,0.00007431676,0.000030582574,0.00003065062,0.99790114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910223,0.000016774973,0.00016370114,0.0002698001,0.00019234057,0.00025514193],"domain_scores_gemma":[0.99929607,0.000035394394,0.000021202324,0.00036775446,0.00003674857,0.00024284981],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000067151625,0.00015046432,0.00024593092,0.00005918991,0.00005024084,0.000020744726,0.00007343727,0.000056602894,0.99872583],"category_scores_gemma":[0.000013507537,0.00012555391,0.00009053379,0.00015490361,0.000022811133,0.00003976461,0.000018331291,0.00006962349,0.99814636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014198358,0.0003008499,0.0000024703427,0.000011987236,0.00007515247,0.00006784523,0.000019264853,0.000009955729,0.000010604402,0.00000228313,0.79517674,0.20418084],"study_design_scores_gemma":[0.0011753228,0.0004925992,0.0014653063,0.00006723892,0.00012649273,0.000030519746,8.379196e-7,0.000024708372,0.00025207418,0.0000046549576,0.9962307,0.00012952967],"about_ca_topic_score_codex":0.000070345275,"about_ca_topic_score_gemma":6.370493e-7,"teacher_disagreement_score":0.2040513,"about_ca_system_score_codex":0.0001085312,"about_ca_system_score_gemma":0.000056574896,"threshold_uncertainty_score":0.51199394},"labels":[],"label_agreement":null},{"id":"W4406595391","doi":"10.1136/bcr-2024-262137","title":"Unusual recurrence in advanced ovarian cancer after interval cytoreductive surgery and HIPEC","year":2025,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Medicine; Ovarian cancer; Ascites; Malignancy; Ovarian carcinoma; Cancer; Metastasis; Epithelial ovarian cancer; Cytoreductive surgery; Surgery; Oncology; Internal medicine","score_opus":0.02179602066456381,"score_gpt":0.34703640479298065,"score_spread":0.3252403841284168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406595391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088794,0.0039068055,0.000019182682,0.0023936594,0.00096584845,0.00073051546,0.0000124248145,0.000026181506,0.0010574138],"genre_scores_gemma":[0.9976549,0.00034154233,0.0002494248,0.00029524518,0.00012111487,0.0009239864,0.0000101893875,0.00001301455,0.00039057867],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9986151,0.000042663818,0.00048452071,0.00049271795,0.00013646916,0.00022851497],"domain_scores_gemma":[0.99921924,0.00011399399,0.00014184992,0.0003281896,0.000085186,0.00011156265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028536338,0.00017187072,0.00042851173,0.00019949191,0.00003381421,0.000019692452,0.00001080612,0.00007427762,0.000115129624],"category_scores_gemma":[0.00017516877,0.00014888034,0.00008521805,0.0002901395,0.00006568539,0.00009870847,0.000047384434,0.00013709864,0.0000016380277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037256017,0.00022105772,0.4192995,0.00014111916,0.00011742077,0.44470018,0.0002925618,0.0000027870701,0.000019797602,0.000042974643,0.00088758813,0.13390242],"study_design_scores_gemma":[0.0013261029,0.00010660958,0.8803919,0.002715254,0.00025454158,0.10708157,0.00035005613,0.000025105732,0.0016159433,0.00032473129,0.005541833,0.0002663422],"about_ca_topic_score_codex":0.0013469232,"about_ca_topic_score_gemma":0.0008393894,"teacher_disagreement_score":0.46109238,"about_ca_system_score_codex":0.0003450384,"about_ca_system_score_gemma":0.0005566246,"threshold_uncertainty_score":0.6071164},"labels":[],"label_agreement":null},{"id":"W4406595910","doi":"10.1038/s41598-024-82206-z","title":"Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation","year":2025,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Université de Montréal; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Terry Fox Research Institute; Ovarian Cancer Canada","keywords":"Serous fluid; Biomarker; Ovarian carcinoma; Translation (biology); Oncology; Biomarker discovery; Pathology; Medicine; Ovarian cancer; Computer science; Internal medicine; Biology; Cancer; Proteomics; Gene; Messenger RNA","score_opus":0.1043273474139226,"score_gpt":0.38420769382135855,"score_spread":0.279880346407436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406595910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500234,0.00037564963,0.000555107,0.0048442413,0.0073890877,0.0010575585,0.0000063254856,0.00006349232,0.0007061819],"genre_scores_gemma":[0.9916803,0.000009259463,0.007397442,0.00030703226,0.00008354866,0.00009454501,0.00009713995,0.000017588436,0.00031312945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679005,0.00013261005,0.0010889181,0.0011769312,0.00040171744,0.00040979945],"domain_scores_gemma":[0.9984317,0.00008389425,0.00016238543,0.0009586825,0.00011445122,0.0002488769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019392861,0.00021538232,0.0005184654,0.00043512447,0.0001610773,0.00018601322,0.0000888635,0.0001389703,0.00007578551],"category_scores_gemma":[0.0001338041,0.00018901633,0.00019844309,0.001178533,0.0001310235,0.00011758727,0.00005162501,0.00018946621,0.000018506293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021403625,0.00084425637,0.95839065,0.000079845675,0.000107188695,0.0030858472,0.00015936099,0.00014677303,0.002622058,0.00016073888,0.0051012,0.029088022],"study_design_scores_gemma":[0.002415102,0.00013237499,0.98144466,0.00031693303,0.00014845454,0.00018666896,0.00003510456,0.0007060331,0.00945055,0.0004893807,0.004479587,0.00019515543],"about_ca_topic_score_codex":0.00056445337,"about_ca_topic_score_gemma":0.0009375252,"teacher_disagreement_score":0.028892867,"about_ca_system_score_codex":0.00022697744,"about_ca_system_score_gemma":0.00046513154,"threshold_uncertainty_score":0.77078617},"labels":[],"label_agreement":null},{"id":"W4406648873","doi":"10.1016/b978-2-294-73990-3.00010-3","title":"10.1016/b978-2-294-73990-3.00010-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine","score_opus":0.011328261838930848,"score_gpt":0.20002604726882894,"score_spread":0.1886977854298981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406648873","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.1800255e-7,0.0013307986,1.7028987e-7,0.0014307402,0.000008872118,0.00089904753,0.0002136788,0.000166936,0.9959489],"genre_scores_gemma":[0.0000037721281,0.000014276921,0.00012209603,0.00028385152,0.0010195669,0.00009305805,0.0003364699,0.00017958524,0.99794734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980842,0.000010911162,0.00040358407,0.00066741597,0.00044689956,0.0003869818],"domain_scores_gemma":[0.998448,0.00006355452,0.00011523596,0.00083911506,0.00009098882,0.00044311924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007901199,0.00055574847,0.0008486252,0.00023760933,0.00006886494,0.000038902,0.00016356123,0.00038685295,0.9989649],"category_scores_gemma":[0.000010828994,0.0004976569,0.00033986653,0.000050718732,0.00006088943,0.000038268354,0.00006485294,0.0003537083,0.9964201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002005736,0.00011438076,1.0074418e-7,0.00003580069,0.00037537195,0.00025051605,0.000008098669,0.0000016763402,9.554227e-7,0.00008600444,0.418214,0.5807125],"study_design_scores_gemma":[0.0012823805,0.00088884623,0.00001617408,0.00064874254,0.00079122843,0.00007776117,2.0186062e-7,0.0000030943595,0.00002263644,0.00016908548,0.99565595,0.00044388173],"about_ca_topic_score_codex":0.000036690057,"about_ca_topic_score_gemma":6.201569e-7,"teacher_disagreement_score":0.5802686,"about_ca_system_score_codex":0.0003553212,"about_ca_system_score_gemma":0.00021428918,"threshold_uncertainty_score":0.9997475},"labels":[],"label_agreement":null},{"id":"W4406650836","doi":"10.1016/b978-2-294-72762-7.00014-3","title":"10.1016/b978-2-294-72762-7.00014-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.01122417578790652,"score_gpt":0.19976106647123218,"score_spread":0.18853689068332566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406650836","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.0337187e-7,0.0013269596,1.806726e-7,0.0014074084,0.000008303892,0.0008700563,0.000204747,0.00016766237,0.99601376],"genre_scores_gemma":[0.000003870145,0.000014800782,0.00013556803,0.00027663098,0.0010165214,0.00009187218,0.0003136255,0.00017721856,0.99796987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981014,0.000011241028,0.00039888718,0.0006620394,0.00044499768,0.00038143602],"domain_scores_gemma":[0.99846673,0.00006413562,0.00011418365,0.0008279501,0.00009043676,0.0004365514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008075181,0.00054791523,0.00084039976,0.0002211061,0.000068055044,0.000038315502,0.00015981105,0.00037796525,0.99904674],"category_scores_gemma":[0.0000106598745,0.0004909062,0.00033879452,0.000043021748,0.000059448626,0.000036495647,0.00006287752,0.00034967688,0.99724185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020026213,0.000110504894,9.8926634e-8,0.000035911227,0.00036875016,0.0002282441,0.000008476902,0.0000017613282,7.6072376e-7,0.000078083336,0.40039265,0.5985745],"study_design_scores_gemma":[0.0012576302,0.0008893105,0.000017197619,0.0006733476,0.00078417,0.00007591497,2.1877212e-7,0.0000032912417,0.00001996246,0.00015642992,0.99568516,0.00043739384],"about_ca_topic_score_codex":0.000035590736,"about_ca_topic_score_gemma":4.7883253e-7,"teacher_disagreement_score":0.59813714,"about_ca_system_score_codex":0.00036232438,"about_ca_system_score_gemma":0.00021509771,"threshold_uncertainty_score":0.99975425},"labels":[],"label_agreement":null},{"id":"W4406651419","doi":"10.1016/b978-1-4160-2973-1.50022-3","title":"10.1016/b978-1-4160-2973-1.50022-3","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sex organ; Medicine; Biology; Botany","score_opus":0.011564154494761465,"score_gpt":0.19929358626479923,"score_spread":0.18772943177003776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406651419","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.333426e-7,0.0015164107,1.520544e-7,0.0013305397,0.000008727869,0.00086723187,0.00019964878,0.00016028182,0.99591625],"genre_scores_gemma":[0.0000034572329,0.000015418012,0.000112962734,0.00027782243,0.0009255411,0.00009053787,0.00031833354,0.00017359259,0.99808234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981225,0.000010585748,0.00039531256,0.00065562216,0.00044078173,0.00037516694],"domain_scores_gemma":[0.9984851,0.00006475283,0.00011457109,0.0008200062,0.00009035459,0.00042521954],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000080001104,0.0005416461,0.00083160633,0.00023611906,0.000067822104,0.00003731505,0.0001591409,0.00037085655,0.99897224],"category_scores_gemma":[0.000011426093,0.0004872771,0.0003414368,0.00004996249,0.00005837353,0.000037349484,0.00006746294,0.00034844293,0.996335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018509821,0.00010137084,8.4342766e-8,0.0000341591,0.00034988922,0.00021716629,0.000007541413,0.000001613709,7.1231455e-7,0.000081853315,0.5657117,0.4333088],"study_design_scores_gemma":[0.0012682294,0.0009080508,0.000017355758,0.0006198482,0.00079775124,0.00007292876,2.048537e-7,0.000003031089,0.000021150847,0.00013086543,0.99572617,0.00043443384],"about_ca_topic_score_codex":0.00003224409,"about_ca_topic_score_gemma":6.5735065e-7,"teacher_disagreement_score":0.43287438,"about_ca_system_score_codex":0.00035313846,"about_ca_system_score_gemma":0.00019732445,"threshold_uncertainty_score":0.9997579},"labels":[],"label_agreement":null},{"id":"W4406663538","doi":"10.1016/b978-0-323-62453-4.00091-2","title":"10.1016/b978-0-323-62453-4.00091-2","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.01142523046448755,"score_gpt":0.20004784522535127,"score_spread":0.18862261476086373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406663538","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.344097e-7,0.0013675357,1.4962718e-7,0.0015285828,0.000008272074,0.00087999215,0.00020365122,0.00017707841,0.99583393],"genre_scores_gemma":[0.0000034403033,0.000013596384,0.00011986916,0.00027936595,0.0008844743,0.000089327135,0.0003191148,0.0001775486,0.9981133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809617,0.000010692406,0.00040131362,0.00066505483,0.0004454406,0.0003813341],"domain_scores_gemma":[0.9984636,0.000064556836,0.00011441521,0.0008406048,0.000092168906,0.0004246758],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007800193,0.0005517258,0.00084271305,0.00023923082,0.000066498236,0.000038851922,0.00016204336,0.00037669198,0.9988378],"category_scores_gemma":[0.000011361102,0.000493664,0.00034351318,0.000050392606,0.000059239093,0.00003773505,0.000065853514,0.00034402704,0.996439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021080051,0.00010137282,7.387493e-8,0.000038105307,0.00039489765,0.00026228992,0.000008010413,0.000002082028,9.684676e-7,0.00011494828,0.35092288,0.64794356],"study_design_scores_gemma":[0.0011980333,0.00090644293,0.000015190094,0.00067624706,0.0008173184,0.00007632617,1.7444513e-7,0.0000031255706,0.00002417399,0.00014186972,0.99570096,0.00044016977],"about_ca_topic_score_codex":0.000034956498,"about_ca_topic_score_gemma":5.8711754e-7,"teacher_disagreement_score":0.64750344,"about_ca_system_score_codex":0.00033687937,"about_ca_system_score_gemma":0.00020118832,"threshold_uncertainty_score":0.9997515},"labels":[],"label_agreement":null},{"id":"W4406665590","doi":"10.1158/1078-0432.ccr-24-3128","title":"Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Medicine; Internal medicine; Bevacizumab; Neutropenia; Ovarian cancer; Clinical endpoint; Paclitaxel; Oncology; Refractory (planetary science); Progression-free survival; Phases of clinical research; Mesothelin; Gastroenterology; Urology; Cancer; Randomized controlled trial; Chemotherapy","score_opus":0.18897456220348152,"score_gpt":0.5220860365257134,"score_spread":0.33311147432223187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406665590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686331,0.0038361687,0.000016331915,0.015580615,0.00062222197,0.0099796625,0.0002142127,0.000056174707,0.0010615193],"genre_scores_gemma":[0.98512423,0.0034983899,0.00023458617,0.00033206082,0.0005855256,0.0047151763,0.000042792955,0.00007549408,0.005391718],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.990809,0.0024406624,0.0026027462,0.0013911005,0.001762224,0.0009942681],"domain_scores_gemma":[0.9911183,0.0057710693,0.000496217,0.0013158186,0.00083765516,0.00046090205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0063351225,0.0005106815,0.0032994922,0.0007865762,0.0003020207,0.000063436884,0.00046520395,0.00036913864,0.0017638778],"category_scores_gemma":[0.0017922815,0.00032748436,0.00031976134,0.0020910704,0.0009390449,0.00014442299,0.00026386237,0.0016955513,0.000008560126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9214471,0.029825335,0.007055563,0.00032517614,0.0022394191,0.00063196797,0.0007264138,0.000024842157,0.000102998674,0.0003319067,0.006295257,0.03099403],"study_design_scores_gemma":[0.9303441,0.03971202,0.019664649,0.0016788921,0.0010536298,0.0000024371275,0.0011023583,0.00009179823,0.00024467177,0.00026888083,0.0055285506,0.00030801483],"about_ca_topic_score_codex":0.02695289,"about_ca_topic_score_gemma":0.024310894,"teacher_disagreement_score":0.030686013,"about_ca_system_score_codex":0.0012598075,"about_ca_system_score_gemma":0.0055416287,"threshold_uncertainty_score":0.99991775},"labels":[],"label_agreement":null},{"id":"W4406680746","doi":"10.3390/cancers17030336","title":"Predicting Response to Treatment and Survival in Advanced Ovarian Cancer Using Machine Learning and Radiomics: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Machine learning; Radiomics; Medicine; Artificial intelligence; Random forest; Lasso (programming language); Oncology; Internal medicine; Algorithm; Computer science","score_opus":0.03805136123654316,"score_gpt":0.37156316032968645,"score_spread":0.33351179909314327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406680746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004935495,0.99251276,0.000005752172,0.00026325425,0.00027413605,0.0061952733,0.00015052945,0.000038154656,0.00006661557],"genre_scores_gemma":[0.00009259532,0.9960157,0.00035718447,0.00019416687,0.00007751373,0.0026512402,0.000035414592,0.00006576911,0.0005103919],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972066,0.00056789716,0.0008880718,0.0007867356,0.00017348802,0.00037719856],"domain_scores_gemma":[0.9982633,0.0006704548,0.00038669808,0.00036348568,0.0000497486,0.0002662962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066092197,0.00059507776,0.004127597,0.00039293166,0.00010347774,0.000037707516,0.000073071096,0.00015722081,0.000025328114],"category_scores_gemma":[0.0004894989,0.00044617325,0.00022930172,0.0006278209,0.00003847194,0.0000485701,0.000071763156,0.00028468008,0.0000013728624],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002199048,0.000023030772,0.0012259127,0.8123468,0.0008207116,0.00011998306,0.00019835855,0.000036490546,0.0000011972783,0.0000058829455,0.0000056673007,0.18499607],"study_design_scores_gemma":[0.0019613418,0.00035048678,0.00003563972,0.89992106,0.00881515,0.000087204164,0.00005982229,0.00018648052,9.1855446e-7,6.7885895e-7,0.08826358,0.00031762727],"about_ca_topic_score_codex":0.0024043622,"about_ca_topic_score_gemma":0.00072624977,"teacher_disagreement_score":0.18467845,"about_ca_system_score_codex":0.009209498,"about_ca_system_score_gemma":0.0027643626,"threshold_uncertainty_score":0.999799},"labels":[],"label_agreement":null},{"id":"W4406771807","doi":"10.1016/j.ijgc.2025.101662","title":"High-grade serous ovarian cancer—bridging the gap between epidemiology and prevention with biology","year":2025,"lang":"en","type":"editorial","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bridging (networking); Serous ovarian cancer; Ovarian cancer; Epidemiology; Serous fluid; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.04748571791150178,"score_gpt":0.39473500308847126,"score_spread":0.34724928517696946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406771807","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0409461,0.02220536,0.0021690233,0.12650587,0.80531365,0.0010825187,0.0013641566,0.000043960317,0.00036934984],"genre_scores_gemma":[0.21327603,0.031765703,0.0020010218,0.002161284,0.7488651,0.00033482202,0.00031505025,0.000044032495,0.0012369158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974703,0.0003519458,0.00091164495,0.0004262293,0.0005096046,0.00033023144],"domain_scores_gemma":[0.9933172,0.0041260486,0.0012536005,0.00017772666,0.0009667546,0.00015865605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092388416,0.0003349546,0.0011959058,0.00020714095,0.0000999334,0.000039657014,0.00041440842,0.0006287235,0.0004878049],"category_scores_gemma":[0.0015004392,0.00017685797,0.0002504115,0.00012635296,0.0002573632,0.0000734149,0.00013525398,0.0012269247,0.0000017615279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012477906,0.00029200115,0.13389187,0.00010214986,0.007225264,0.0003339598,0.00005635598,0.00015561309,0.0000137099405,0.0014450592,0.7293136,0.1259226],"study_design_scores_gemma":[0.007247542,0.002860867,0.17571525,0.001856975,0.0027072027,0.00008904431,0.000025784224,0.000016653168,0.0000697097,0.0067813583,0.8023193,0.00031031633],"about_ca_topic_score_codex":0.001342437,"about_ca_topic_score_gemma":0.00048216386,"teacher_disagreement_score":0.17232992,"about_ca_system_score_codex":0.0011534579,"about_ca_system_score_gemma":0.0015059226,"threshold_uncertainty_score":0.72120583},"labels":[],"label_agreement":null},{"id":"W4406864256","doi":"10.3390/curroncol32020065","title":"Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ministero della Salute","keywords":"Medicine; Episiotomy; Radiation therapy; Anus; Endometriosis; Lymph node; Wide local excision; Vagina; Surgery; Gynecology; Internal medicine; Pregnancy","score_opus":0.08276980521686797,"score_gpt":0.4314573021673435,"score_spread":0.3486874969504755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406864256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.1734635e-7,0.9867824,0.0000013102282,0.00059762585,0.0021640735,0.008180092,0.00019681043,0.000020892348,0.0020560196],"genre_scores_gemma":[0.0000017757303,0.9961517,0.00004696975,0.00039457582,0.00024992033,0.0021043746,0.0003450305,0.000028959459,0.00067668984],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967347,0.00084752793,0.0013214067,0.00051350344,0.00031861136,0.00026427308],"domain_scores_gemma":[0.9966891,0.0007073729,0.0010118198,0.0012461899,0.00023792156,0.000107589556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000443271,0.0004927687,0.00573524,0.00019230873,0.00004928862,0.000010927294,0.00033900284,0.0003717628,0.00006162669],"category_scores_gemma":[0.0003205417,0.00024698614,0.0015832088,0.00095173717,0.000092574744,0.000021972923,0.00024090167,0.00069664384,0.000038693004],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027892863,0.00033168175,0.00008117771,0.6521103,0.00029648235,0.000041818887,0.000027869566,6.3624546e-9,1.15934915e-8,0.00007821137,0.014531699,0.33249798],"study_design_scores_gemma":[0.00029810172,0.00009007508,0.000043102144,0.49653494,0.009576556,0.000153548,8.122355e-7,1.1469949e-7,7.436918e-8,0.0000026278356,0.49322188,0.00007816825],"about_ca_topic_score_codex":0.000001862593,"about_ca_topic_score_gemma":0.0000023136195,"teacher_disagreement_score":0.47869018,"about_ca_system_score_codex":0.0011314738,"about_ca_system_score_gemma":0.0025565394,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W4406893812","doi":"10.1016/j.ijgc.2025.101664","title":"Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Cytoreductive surgery; Ovarian cancer; Oncology; Interval (graph theory); Gynecology; Internal medicine; Cancer","score_opus":0.04534175409149385,"score_gpt":0.36289113864890743,"score_spread":0.31754938455741355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406893812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013453155,0.96229124,0.000025259054,0.0019654515,0.017234014,0.0019290022,0.0021047494,0.000025361165,0.0009717439],"genre_scores_gemma":[0.0051868604,0.9908178,0.00026582746,0.0004920029,0.0021567966,0.0004201445,0.00015872282,0.000048995473,0.00045284056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964777,0.00017701059,0.0014048599,0.00052130927,0.0010330983,0.00038599415],"domain_scores_gemma":[0.99560535,0.001558121,0.001322164,0.00021040314,0.0010851942,0.00021878837],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031778746,0.0005682673,0.0027895654,0.0007101242,0.000043672066,0.000065332635,0.0004936395,0.00040118862,0.0025632363],"category_scores_gemma":[0.00048434848,0.0003171309,0.00089912553,0.00041859018,0.0001355384,0.00019956038,0.000160337,0.000922456,0.000010369019],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.013603956,0.0016560272,0.019983452,0.0017248521,0.004503112,0.0016351915,0.000055255005,0.000017339438,1.6721052e-7,0.000016966205,0.0025888463,0.9542148],"study_design_scores_gemma":[0.01987628,0.0031522748,0.21104988,0.06166149,0.004277155,0.00009182974,0.000032492248,0.0000016770839,0.000008730615,0.000022584652,0.6991166,0.0007090279],"about_ca_topic_score_codex":0.00018647901,"about_ca_topic_score_gemma":0.00024180069,"teacher_disagreement_score":0.9535058,"about_ca_system_score_codex":0.005359381,"about_ca_system_score_gemma":0.0061369156,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null},{"id":"W4406996337","doi":"10.1158/2767-9764.c.7650169","title":"Data from Evaluating Ovarian Cancer Risk–Reducing Salpingectomy Acceptance: A Survey","year":2025,"lang":"en","type":"preprint","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Salpingectomy; Medicine; Oncology; Cancer; Internal medicine; Biology; Pregnancy","score_opus":0.19257317670892776,"score_gpt":0.4449364883090863,"score_spread":0.2523633116001585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406996337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7316482,0.05303249,0.0070496597,0.0099331625,0.014463196,0.00870228,0.12829459,0.0011072137,0.04576922],"genre_scores_gemma":[0.90516,0.012508434,0.047820672,0.001494662,0.002848495,0.0012825324,0.023626318,0.00013964607,0.0051192143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99520504,0.00048274544,0.0008233694,0.002268897,0.00070449786,0.0005154379],"domain_scores_gemma":[0.9938303,0.0009101418,0.0005619572,0.00407711,0.0003745227,0.00024591957],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016070873,0.0006361398,0.0012834076,0.00019840927,0.00018730757,0.00020041724,0.00089680374,0.00046917432,0.007490466],"category_scores_gemma":[0.0010300622,0.0005434298,0.00020949684,0.00035429906,0.000054797263,0.0001167551,0.00271261,0.0012521065,0.00006413379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004088371,0.00057209056,0.75666946,0.0004629828,0.004800265,0.000050160714,0.00040469767,0.0009323026,0.000027584627,0.000029523198,0.056950014,0.17869209],"study_design_scores_gemma":[0.003901675,0.00008454413,0.9607699,0.004005174,0.0034223865,0.0000017012559,0.00007042569,0.023066798,0.0002825287,0.00034020122,0.003490009,0.0005646592],"about_ca_topic_score_codex":0.25346446,"about_ca_topic_score_gemma":0.029959682,"teacher_disagreement_score":0.22350478,"about_ca_system_score_codex":0.0009122653,"about_ca_system_score_gemma":0.0034938368,"threshold_uncertainty_score":0.99970174},"labels":[],"label_agreement":null},{"id":"W4407032258","doi":"10.21873/anticanres.17453","title":"Use of Indocyanine Green Fluorescence Angiography to Assess Bowel Anastomosis in Ovarian Cancer Surgery","year":2025,"lang":"en","type":"article","venue":"Anticancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Indocyanine green; Medicine; Anastomosis; Angiography; Ovarian cancer; Surgery; Cancer; Radiology; Internal medicine","score_opus":0.18983847441096957,"score_gpt":0.4353838013619376,"score_spread":0.24554532695096803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407032258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217095,0.0021478855,0.0001052825,0.022505267,0.0002692053,0.0014846248,0.000101366226,0.000031189105,0.001184224],"genre_scores_gemma":[0.9951808,0.0022702862,0.0008853159,0.000616074,0.00008492948,0.0004942159,0.000011351404,0.000024993347,0.00043202538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731106,0.00018742644,0.0004678055,0.0005674686,0.0007783336,0.00068790343],"domain_scores_gemma":[0.9977516,0.0008165359,0.00005345398,0.0006362147,0.0005167303,0.00022550032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008762049,0.00018338641,0.00058786303,0.0018584338,0.00008049692,0.000048423666,0.0001873994,0.00010151317,0.0002654224],"category_scores_gemma":[0.00022623535,0.00016164471,0.00023504822,0.004693002,0.00021282831,0.00014719575,0.0001648734,0.00034270677,0.0000121212515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056721177,0.000563554,0.94806015,0.0002701779,0.00033056433,0.00013599126,0.00014095915,0.000021217702,0.0021231943,0.00079689035,0.012237348,0.03475271],"study_design_scores_gemma":[0.00088860316,0.00014339246,0.9743882,0.0017201391,0.0000832686,0.0000017746935,0.00006774367,0.00010935893,0.017923744,0.00007987316,0.0044644317,0.00012947847],"about_ca_topic_score_codex":0.048956037,"about_ca_topic_score_gemma":0.0041425764,"teacher_disagreement_score":0.044813458,"about_ca_system_score_codex":0.00038904676,"about_ca_system_score_gemma":0.0010389289,"threshold_uncertainty_score":0.9573771},"labels":[],"label_agreement":null},{"id":"W4407164311","doi":"10.1016/j.ajcnut.2025.02.004","title":"Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Nutrition","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. Army Medical Research and Development Command; Congressionally Directed Medical Research Programs; National Health and Medical Research Council; Medical Research Council; Peter MacCallum Foundation; National Cancer Institute; Ovarian Cancer Australia; Memorial Sloan-Kettering Cancer Center; Cancer Council Victoria; Rutgers Cancer Institute of New Jersey; Medical Research and Materiel Command; VicHealth; Kræftens Bekæmpelse; Ovarian Cancer Research Fund; U.S. Department of Defense","keywords":"Ovarian cancer; Oncology; Medicine; Cancer; Internal medicine; Gynecology","score_opus":0.02152815098117932,"score_gpt":0.36581791413737574,"score_spread":0.3442897631561964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407164311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263583,0.005197517,0.00021460373,0.067031845,0.0005179552,0.00028777757,0.00031262578,0.0000070261885,0.000072368],"genre_scores_gemma":[0.96889216,0.027228408,0.000709552,0.0023359281,0.0006215284,0.0001596215,0.000015447407,0.000010289646,0.000027046524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973628,0.00046237005,0.0013220606,0.0002562437,0.0004132431,0.00018326564],"domain_scores_gemma":[0.9949638,0.0026444073,0.0014732017,0.0002320467,0.00052677013,0.00015973677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009499217,0.0001570125,0.0013107281,0.00016847126,0.000055391767,0.00003306414,0.00010086239,0.00010403387,0.00026822012],"category_scores_gemma":[0.00063929544,0.00010731189,0.0006154605,0.0009195121,0.00022509464,0.0000838303,0.00003164116,0.00034872742,7.479947e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036377783,0.0010485313,0.9337516,0.000026415113,0.0094045,0.00002278806,0.00010417096,0.000007046196,0.000011698262,0.00004652583,0.0015651423,0.0503738],"study_design_scores_gemma":[0.0060437215,0.0010689348,0.97230804,0.00071555335,0.0147904055,0.0000011799817,0.0002769126,0.000052957217,0.00011091544,0.00030609407,0.00423671,0.000088586494],"about_ca_topic_score_codex":0.0054474883,"about_ca_topic_score_gemma":0.00135926,"teacher_disagreement_score":0.06469592,"about_ca_system_score_codex":0.00022640201,"about_ca_system_score_gemma":0.00033601947,"threshold_uncertainty_score":0.8235009},"labels":[],"label_agreement":null},{"id":"W4407620181","doi":"10.1016/j.ijgc.2024.100651","title":"Risk Factors For Endometrial Cancer Among Women With A BRCA1 Or BRCA2 Mutation","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Gynecology; Mutation; Internal medicine; Obstetrics; Cancer; Genetics; Gene","score_opus":0.026821197326251402,"score_gpt":0.3517105001342434,"score_spread":0.324889302807992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407620181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160683,0.00052779843,0.0011731217,0.0037423957,0.0019733035,0.00047469375,0.00015469236,0.000013750971,0.000333426],"genre_scores_gemma":[0.9954575,0.0012278404,0.00064548204,0.0007320387,0.00063936354,0.00037662318,0.0000073888364,0.0000117772415,0.00090200105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863464,0.00004087589,0.0004599145,0.00020313887,0.0004467025,0.00021470968],"domain_scores_gemma":[0.9972753,0.0011319815,0.00050255813,0.00007642299,0.00087783346,0.00013593624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024568464,0.0001588317,0.00042915283,0.00028762844,0.000062294646,0.000053876327,0.00017453595,0.00009815704,0.0024326998],"category_scores_gemma":[0.0009915914,0.00008558584,0.0001569841,0.00024314999,0.0000801996,0.00013577583,0.000026169888,0.00020961073,0.0000011125279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01473131,0.00079009356,0.8792166,0.000032918655,0.0045115785,0.00030462915,0.00048498355,0.0012050907,0.00007025383,0.00019931879,0.0033178357,0.09513535],"study_design_scores_gemma":[0.014659925,0.003070721,0.9586764,0.00026714822,0.00052693253,0.000025139841,0.00029179198,0.000101398,0.0013593079,0.0003877952,0.020509962,0.00012349665],"about_ca_topic_score_codex":0.00030052132,"about_ca_topic_score_gemma":0.00044976873,"teacher_disagreement_score":0.09501185,"about_ca_system_score_codex":0.0018376829,"about_ca_system_score_gemma":0.000760479,"threshold_uncertainty_score":0.9984792},"labels":[],"label_agreement":null},{"id":"W4407622128","doi":"10.1016/j.ijgc.2024.100319","title":"ATHENA-MONO Post-Progression Survival Data Update In Patients With Newly Diagnosed Advanced Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.01982819557555372,"score_gpt":0.35010076076022595,"score_spread":0.33027256518467224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974197,0.0016846466,0.00016036232,0.020438178,0.0023260943,0.00042748917,0.0002541688,0.00001432216,0.00049775746],"genre_scores_gemma":[0.993578,0.0016604101,0.001466895,0.0027816908,0.0002157452,0.000071756025,0.000112996466,0.000015161369,0.00009730707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998061,0.000070113005,0.00057417125,0.00035635184,0.00069054664,0.00024783038],"domain_scores_gemma":[0.9978978,0.0003177757,0.0003967618,0.00028053104,0.00097094604,0.00013617618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002515081,0.00020342242,0.00047685477,0.00022743802,0.00004169832,0.000048322196,0.00054754416,0.00010655437,0.0015391428],"category_scores_gemma":[0.00037157166,0.00012607746,0.000091814945,0.00023347935,0.0000727209,0.00030617314,0.0001993842,0.00033850098,0.000005189126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004805075,0.0014386298,0.80409217,0.000015091292,0.00064405455,0.00043023267,0.000036120706,0.0004544369,0.000021654992,0.0004806389,0.001459361,0.18612255],"study_design_scores_gemma":[0.021105573,0.00079068425,0.9656333,0.0007783868,0.00017176304,0.000004405439,0.000030302013,0.00008826867,0.0000762679,0.00027754714,0.010913464,0.00013005773],"about_ca_topic_score_codex":0.00023549535,"about_ca_topic_score_gemma":0.000855616,"teacher_disagreement_score":0.1859925,"about_ca_system_score_codex":0.0009049409,"about_ca_system_score_gemma":0.0006964326,"threshold_uncertainty_score":0.9993736},"labels":[],"label_agreement":null},{"id":"W4407622270","doi":"10.1016/j.ijgc.2024.100411","title":"Does The Molecular Profile Of Ovarian Tumors Influence The Response To Radiotherapy? An In Vitro Study On Behalf Of Multicenter Italian Trials In Ovarian Cancer (MITO) Group","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Radiation therapy; In vitro; Multicenter study; Gynecology; Cancer; Randomized controlled trial; Genetics","score_opus":0.026010581732868906,"score_gpt":0.38487876437098323,"score_spread":0.3588681826381143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96488684,0.00037591447,0.00004236963,0.03249176,0.00075504824,0.0013192608,0.000076840464,0.0000028660102,0.000049108843],"genre_scores_gemma":[0.9958423,0.000121360994,0.00030214482,0.0031834773,0.00013144115,0.00036614743,0.0000016720143,0.000010509105,0.000040993975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966585,0.0010717236,0.0012305377,0.00024070915,0.0006154683,0.00018307868],"domain_scores_gemma":[0.996977,0.0016171557,0.00061597704,0.0002463632,0.00046785266,0.00007567878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028335599,0.00017389221,0.000727568,0.0003534194,0.000028106428,0.000030009292,0.0005057519,0.00007485012,0.00039120964],"category_scores_gemma":[0.0018222911,0.00007441504,0.0002072943,0.000355215,0.000100985555,0.00009139429,0.00005994962,0.0003197799,5.077449e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0647513,0.007638772,0.71142334,0.000032827975,0.0017937698,0.0008612516,0.0039051895,0.003576894,0.17474854,0.0006055717,0.00019677379,0.030465776],"study_design_scores_gemma":[0.00740617,0.001896331,0.96018255,0.00049973076,0.00012684341,0.000004719255,0.00084585766,0.000064506865,0.028216539,0.000117790085,0.0005618409,0.00007715238],"about_ca_topic_score_codex":0.0015989289,"about_ca_topic_score_gemma":0.0010331081,"teacher_disagreement_score":0.24875918,"about_ca_system_score_codex":0.000818196,"about_ca_system_score_gemma":0.00039018632,"threshold_uncertainty_score":0.42834714},"labels":[],"label_agreement":null},{"id":"W4407622456","doi":"10.1016/j.ijgc.2024.100344","title":"Integrated Gene Expression Meta-Analysis And Risk Stratification In High-Grade Serous Ovarian Cancer: Identifying Functional Genes And Survival Predictors","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ovarian cancer; Serous ovarian cancer; Serous fluid; Meta-analysis; Oncology; Risk stratification; Gene; Internal medicine; Bioinformatics; Cancer; Genetics; Biology","score_opus":0.06573290604936621,"score_gpt":0.34312447972683385,"score_spread":0.27739157367746764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407622456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97772056,0.011764049,0.003992959,0.005203918,0.0009233537,0.00019681705,0.00014656849,0.000011020131,0.000040735085],"genre_scores_gemma":[0.9844233,0.013216921,0.0017273529,0.00019547748,0.0001699702,0.0000992314,0.00003354798,0.000006828518,0.00012741493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831533,0.00015869775,0.00062123657,0.000307303,0.00046030714,0.00013711836],"domain_scores_gemma":[0.9985531,0.00034124026,0.0004236091,0.00009814845,0.00047676841,0.000107113134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043429717,0.00017407163,0.0006835857,0.00047294333,0.00006671957,0.00008273025,0.000111312256,0.00012095817,0.0010450939],"category_scores_gemma":[0.00014446383,0.00011401266,0.00026957784,0.00037733596,0.00007594954,0.00016201593,0.000052871685,0.00028601772,4.2450694e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004633983,0.00034607283,0.9389147,0.000014501755,0.041877687,0.0000897599,0.00006671378,0.001555587,0.0033643187,0.00034026787,0.00013733565,0.012829653],"study_design_scores_gemma":[0.0021696081,0.00010595944,0.9654,0.00004235305,0.02521484,0.0000144532905,0.000083020794,0.0003016872,0.0056212475,0.00063120615,0.00032617923,0.000089444904],"about_ca_topic_score_codex":0.0018674905,"about_ca_topic_score_gemma":0.0025398154,"teacher_disagreement_score":0.026485298,"about_ca_system_score_codex":0.00045471848,"about_ca_system_score_gemma":0.00024393032,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W4407645875","doi":"10.1016/j.ijgc.2024.100092","title":"Effect Of Crossover-Surgery At The Subsequent Relapse On The Survival Of Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Prespecified And Post-Hoc Analyses Of The SOC-1 Randomized Phase 3 Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Post-hoc analysis; Ovarian cancer; Randomized controlled trial; Post hoc; Oncology; Internal medicine; Crossover study; Surgery; Cancer; Alternative medicine; Placebo","score_opus":0.031121597202661264,"score_gpt":0.3583909555542078,"score_spread":0.3272693583515465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407645875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922753,0.00079049764,0.0000113601045,0.006867493,0.001310563,0.0012000211,0.0002603129,0.000002477794,0.00032971526],"genre_scores_gemma":[0.99844754,0.00072241237,0.000010584842,0.00042075245,0.00013349867,0.00009279313,0.000007777595,0.0000082430815,0.00015640155],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971619,0.0007892029,0.0008860876,0.00017711076,0.0008548987,0.00013076172],"domain_scores_gemma":[0.98633397,0.0109493695,0.0014212439,0.00019505585,0.0010521957,0.000048148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013501907,0.00018602762,0.0009943434,0.00009701692,0.00008222955,0.000017576736,0.00021094446,0.000087653,0.00048836175],"category_scores_gemma":[0.0021840753,0.00006685832,0.0005331327,0.00018213215,0.0005693949,0.000047409292,0.00008517093,0.00026481913,2.3047922e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9438081,0.0009933003,0.042323533,0.00003527668,0.00448103,0.0000269969,0.00018829387,0.00027154712,0.00069643377,0.00066531944,0.00082353636,0.0056866407],"study_design_scores_gemma":[0.60957175,0.006145688,0.33071333,0.0010324722,0.002310736,0.000006806701,0.000074112,0.00004731405,0.049469687,0.00015984956,0.00035062074,0.0001176133],"about_ca_topic_score_codex":0.00024490163,"about_ca_topic_score_gemma":0.00012241001,"teacher_disagreement_score":0.33423632,"about_ca_system_score_codex":0.00042639006,"about_ca_system_score_gemma":0.00043203705,"threshold_uncertainty_score":0.5347219},"labels":[],"label_agreement":null},{"id":"W4407762450","doi":"10.1200/go-24-00313","title":"Socioeconomic Burden of Ovarian Cancer in 11 Countries","year":2025,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"World Health Organization","keywords":"Socioeconomic status; Ovarian cancer; Medicine; Cancer; Oncology; Gynecology; Environmental health; Internal medicine","score_opus":0.010917374597488684,"score_gpt":0.34868457090745114,"score_spread":0.33776719630996244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87661827,0.003043999,0.000014904137,0.06380618,0.0009346245,0.00046630422,0.00013998631,0.000023240056,0.05495249],"genre_scores_gemma":[0.9964947,0.00073983934,0.00020946555,0.0018230547,0.000117979245,0.00009631777,0.0000068032173,0.0000041726767,0.00050768204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923795,0.000031159063,0.00028515662,0.00020020748,0.000056029407,0.00018952209],"domain_scores_gemma":[0.99959487,0.000065988825,0.00008422682,0.00015842308,0.000050730596,0.000045744833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099120974,0.00009722583,0.00045477366,0.000058681177,0.000018793819,0.000004172137,0.00006510781,0.00014922823,0.00080103957],"category_scores_gemma":[0.000014719352,0.00008715126,0.00006818451,0.00011999035,0.000101344805,0.000025538811,0.000038029997,0.00006463806,0.000034506724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030049586,0.00029562443,0.91597867,0.00008446211,0.00024233281,0.00008332478,0.0001638115,0.00009669853,0.000025679436,0.041279197,0.012668911,0.028780805],"study_design_scores_gemma":[0.005084043,0.00030847325,0.68261176,0.00012033829,0.00018797653,0.000008551721,0.00018005751,0.00005690856,0.0001617363,0.0011607233,0.310051,0.00006841381],"about_ca_topic_score_codex":0.0072646416,"about_ca_topic_score_gemma":0.006330318,"teacher_disagreement_score":0.2973821,"about_ca_system_score_codex":0.0020767779,"about_ca_system_score_gemma":0.001265018,"threshold_uncertainty_score":0.9993461},"labels":[],"label_agreement":null},{"id":"W4407762903","doi":"10.1016/j.ijgc.2025.101710","title":"Challenges in Surgical Randomized Controlled Trials (RCTS) in Gynaecologic Oncology: Insights from a European Network of Young Gynae Oncologists (ENYGO) Study","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada","funders":"","keywords":"Medicine; Randomized controlled trial; Gynecology; Internal medicine","score_opus":0.0863220818077003,"score_gpt":0.4116204164029794,"score_spread":0.3252983345952791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407762903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9279546,0.026919642,0.000013804259,0.008440966,0.0040365215,0.0023880226,0.000012087824,0.000014057483,0.030220298],"genre_scores_gemma":[0.9804492,0.017733095,0.00025309096,0.00046120986,0.00058887445,0.00038900884,0.0000059996037,0.000011823095,0.00010772772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99003065,0.0051050754,0.0035157425,0.00041006194,0.00065304997,0.00028539638],"domain_scores_gemma":[0.9777408,0.019321442,0.0019474812,0.00017427892,0.0006977395,0.000118254706],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008507405,0.00030858495,0.005535332,0.000474918,0.000027901779,0.000028121372,0.0004424615,0.00025190666,0.0013511727],"category_scores_gemma":[0.010315873,0.00017293991,0.0009913313,0.00029110129,0.00020757597,0.00009285312,0.00015399422,0.00062894117,0.0000044438257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34685865,0.014713793,0.43594718,0.000026103073,0.0089267595,0.01826683,0.0010873814,0.0024654001,0.000038065482,0.003042048,0.00058143085,0.16804633],"study_design_scores_gemma":[0.37763798,0.0016222331,0.6152703,0.00030949918,0.00072352035,0.000022067905,0.00042626748,0.00009645946,0.000015789286,0.0021494594,0.0016196248,0.00010678165],"about_ca_topic_score_codex":0.00033002056,"about_ca_topic_score_gemma":0.003639293,"teacher_disagreement_score":0.17932314,"about_ca_system_score_codex":0.002085056,"about_ca_system_score_gemma":0.00085978606,"threshold_uncertainty_score":0.9995617},"labels":[],"label_agreement":null},{"id":"W4407964309","doi":"10.1158/1055-9965.epi-24-1143","title":"Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes","year":2025,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Center for Research Resources; National Health and Medical Research Council; National Institutes of Health","keywords":"Ovarian cancer; Oncology; Medicine; Serous fluid; Internal medicine; Family history; Cancer; Menarche; Bioinformatics; Biology","score_opus":0.044793291659764145,"score_gpt":0.35715367321172087,"score_spread":0.3123603815519567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407964309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529777,0.018061286,0.010246288,0.015779505,0.00094938686,0.0011638777,0.0006336497,0.000100740035,0.000087561064],"genre_scores_gemma":[0.9869905,0.005950776,0.0033101605,0.0009969197,0.00010950634,0.0007640614,0.00092533673,0.00002969874,0.0009230196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682325,0.000839553,0.0009356132,0.00074375625,0.00014775917,0.00051007996],"domain_scores_gemma":[0.9973209,0.0010346884,0.00086148706,0.00046594252,0.00016216654,0.00015483082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010108224,0.0003597542,0.0011852313,0.00019297782,0.00015589625,0.000005619678,0.00015101886,0.00040714204,0.0003391533],"category_scores_gemma":[0.00035656945,0.00025713744,0.0002788514,0.00033363572,0.00013105325,0.00010248765,0.000056169873,0.00022783193,0.000002586775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003158181,0.0003933956,0.9734814,0.00013174067,0.001960989,0.0000037864177,0.000047664736,0.00008582148,0.0048516663,0.0004334256,0.013993086,0.004301191],"study_design_scores_gemma":[0.002671868,0.00034177658,0.9701138,0.0010298688,0.0010306102,0.0000019514168,0.00006230595,0.000037186113,0.021580052,0.001782547,0.0011388871,0.00020910506],"about_ca_topic_score_codex":0.008733622,"about_ca_topic_score_gemma":0.00094420626,"teacher_disagreement_score":0.034012813,"about_ca_system_score_codex":0.00077690324,"about_ca_system_score_gemma":0.00034938697,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W4407985436","doi":"10.1007/978-981-19-7696-4_69-1","title":"Normal Structure and Function, Inflammatory and Other Miscellaneous Lesions of the Ovary","year":2024,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Ovary; Function (biology); Medicine; Pathology; Biology; Internal medicine; Cell biology","score_opus":0.010217611058572789,"score_gpt":0.21221277852042025,"score_spread":0.20199516746184745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407985436","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0094853155,0.013020628,7.852128e-7,0.0011879586,0.00038635806,0.0004909267,0.0001829212,0.00003313677,0.975212],"genre_scores_gemma":[0.12280042,0.0006759466,0.000050129598,0.0007391731,0.0002696113,0.0000054688967,0.000010725018,0.000049881848,0.87539864],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994414,0.0000033451784,0.00015528811,0.00020421053,0.00012615588,0.000069607944],"domain_scores_gemma":[0.99960774,0.000029381265,0.000053167754,0.00022358494,0.000026807007,0.00005929282],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000020745667,0.00017054818,0.00022192425,0.0000420008,0.00003642335,0.000010193163,0.000024484936,0.00017041562,0.002842601],"category_scores_gemma":[0.0000017072516,0.000091761314,0.000066708235,0.00000821396,0.000104929604,0.0000044255785,0.000055252123,0.00017883992,0.000011098532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005004416,0.000103899765,0.046548743,0.00366585,0.0049510356,0.0005085823,0.00068253954,0.0000072464286,0.00035246395,0.7432901,0.15237486,0.047014188],"study_design_scores_gemma":[0.00066755613,0.00021129577,0.013233701,0.0007403714,0.0013262571,0.00035159677,0.000018028562,0.0000048888687,0.00020435195,0.0085341735,0.9745568,0.00015096518],"about_ca_topic_score_codex":0.000040802344,"about_ca_topic_score_gemma":0.00015071327,"teacher_disagreement_score":0.82218194,"about_ca_system_score_codex":0.00002285906,"about_ca_system_score_gemma":0.000064742206,"threshold_uncertainty_score":0.9980689},"labels":[],"label_agreement":null},{"id":"W4408047011","doi":"10.1016/j.jpag.2025.01.157","title":"124. Trends in pediatric benign ovarian surgery and risk of subsequent ovarian surgery: an Ontario population-based study","year":2025,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Institute of Health Services and Policy Research; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Gynecology; General surgery; Ovarian tissue; Obstetrics; Ovary; Internal medicine","score_opus":0.021309366938118753,"score_gpt":0.27847984100758183,"score_spread":0.2571704740694631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408047011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625206,0.001804311,0.000039177492,0.0008342851,0.0006838567,0.0003191631,0.000013800526,0.000008724666,0.000044618686],"genre_scores_gemma":[0.99646896,0.002549979,0.00018853869,0.000224416,0.00045599046,0.000010812688,0.000022086919,0.000017011736,0.000062218525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736506,0.00037697438,0.0012822974,0.00035614215,0.0002885477,0.0003309572],"domain_scores_gemma":[0.9973116,0.0011235123,0.0008961353,0.00023659774,0.00017233867,0.00025983114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013720342,0.0002623063,0.0011678191,0.0019737117,0.000085800835,0.000024951634,0.00007396638,0.0001849645,0.00012738576],"category_scores_gemma":[0.00027654585,0.00021843225,0.00017805718,0.0007862958,0.000029039264,0.000120367,0.000032854943,0.00044248023,4.2379736e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005417161,0.003710203,0.98349535,0.00015069717,0.00018721004,0.00029980426,0.00016532512,0.000056478868,9.772098e-7,0.000032639946,0.0012282613,0.010131337],"study_design_scores_gemma":[0.004319041,0.0010508385,0.9918152,0.00004940201,0.0022429375,0.000021882583,0.000103107915,0.0000270161,0.00000325808,0.00006745886,0.00014895917,0.00015087318],"about_ca_topic_score_codex":0.0046695895,"about_ca_topic_score_gemma":0.01609941,"teacher_disagreement_score":0.011429819,"about_ca_system_score_codex":0.0004227954,"about_ca_system_score_gemma":0.0011882224,"threshold_uncertainty_score":0.8983848},"labels":[],"label_agreement":null},{"id":"W4408047094","doi":"10.1016/j.jpag.2025.01.120","title":"87. Para-Tubal Cysts and Their Associations with Adnexal Torsion and Obesity","year":2025,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Gynecology; Torsion (gastropod); Adnexal Diseases; General surgery; Surgery; Laparoscopy","score_opus":0.010901269234836773,"score_gpt":0.2599624644126021,"score_spread":0.24906119517776534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408047094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890724,0.00635929,0.00012356779,0.0039064023,0.00019364104,0.00015933404,0.000008827435,0.0000052144096,0.00017135053],"genre_scores_gemma":[0.9900523,0.00865438,0.00022487601,0.0006186248,0.0003328677,0.000002143443,0.0000020631812,0.0000047463914,0.00010800073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993602,0.000047476897,0.00023395797,0.00013416554,0.00008329935,0.0001409018],"domain_scores_gemma":[0.99931467,0.00019605122,0.000192934,0.00005777836,0.00010247546,0.00013607634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001742567,0.00011125508,0.00034362052,0.00013072237,0.00009836035,0.00001672533,0.00002468471,0.000092157046,0.000013600961],"category_scores_gemma":[0.00007618679,0.00006989553,0.00003975936,0.00011067571,0.00004682269,0.00005495243,0.000026853259,0.00018685873,4.870478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001274602,0.0004333565,0.99015516,0.00008555092,0.00012523444,0.000057377863,0.00010800993,6.804639e-7,0.000022556746,0.00012315702,0.0041690962,0.0045923684],"study_design_scores_gemma":[0.0034893313,0.0009486968,0.9928909,0.0000610145,0.00055621704,0.000117421114,0.000119551296,0.000011496616,0.00005259944,0.0001223088,0.0015706377,0.00005984323],"about_ca_topic_score_codex":0.0000062641498,"about_ca_topic_score_gemma":0.000017524568,"teacher_disagreement_score":0.0045325253,"about_ca_system_score_codex":0.00009740096,"about_ca_system_score_gemma":0.00018665928,"threshold_uncertainty_score":0.28502566},"labels":[],"label_agreement":null},{"id":"W4408161913","doi":"10.1002/path.6407","title":"Cellular origins of mucinous ovarian carcinoma","year":2025,"lang":"en","type":"review","venue":"The Journal of Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"National Health and Medical Research Council; Peter MacCallum Foundation","keywords":"Mucinous carcinoma; Ovarian carcinoma; Pathology; Ovary; Carcinoma; Medicine; Oncology; Ovarian cancer; Adenocarcinoma; Internal medicine; Cancer","score_opus":0.0393556631260376,"score_gpt":0.33682893445357276,"score_spread":0.29747327132753515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408161913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050012505,0.9965878,0.00010852485,0.00038514726,0.00083477807,0.00042177367,0.000035944315,0.000004083246,0.0011218239],"genre_scores_gemma":[0.0035804852,0.99518466,0.00033743406,0.000102367296,0.00045311986,0.00000858758,0.000009670481,0.000024100327,0.00029958005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980271,0.0004323518,0.0009896049,0.00013961097,0.0002082241,0.00020313392],"domain_scores_gemma":[0.99760985,0.00043167433,0.0011561755,0.0005268291,0.0001887098,0.00008676065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072917633,0.0002653416,0.0023972283,0.00031571466,0.000038226004,0.0000039172737,0.000283908,0.00024657117,0.00013508294],"category_scores_gemma":[0.000086968386,0.0001363144,0.00072821963,0.00025988897,0.00010956359,0.000016898672,0.00006106199,0.00055481226,0.000013957455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015573695,0.0007678213,0.00041979968,0.02048328,0.0016560998,0.010115676,0.0004149377,0.0000015084719,0.000022862849,0.003036913,0.0022432404,0.9606821],"study_design_scores_gemma":[0.0013212739,0.0013515551,0.0003029552,0.01177573,0.014210532,0.010332904,0.000033202716,3.3175607e-7,0.000065223554,0.00010584249,0.9603824,0.00011803009],"about_ca_topic_score_codex":0.000046930847,"about_ca_topic_score_gemma":0.0000037586774,"teacher_disagreement_score":0.9605641,"about_ca_system_score_codex":0.00035725808,"about_ca_system_score_gemma":0.0013820293,"threshold_uncertainty_score":0.555874},"labels":[],"label_agreement":null},{"id":"W4408211669","doi":"10.1016/j.gore.2025.101716","title":"The challenge of managing isolated STIC lesions: A single-center experience","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Single Center; Medical physics; Surgery","score_opus":0.03183235960294617,"score_gpt":0.3327745025223365,"score_spread":0.3009421429193903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408211669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78494084,0.008090748,0.0002802761,0.046745252,0.0035317491,0.0022804148,0.0000042150305,0.0001814701,0.15394506],"genre_scores_gemma":[0.99619806,0.001126291,0.00029178726,0.00081625365,0.000030109148,0.00036396965,0.0000071182885,0.000008092676,0.0011583229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984554,0.00008984849,0.0006187429,0.00039594728,0.0001314973,0.00030858576],"domain_scores_gemma":[0.99818724,0.0007257211,0.00034059555,0.0005465715,0.00013118173,0.00006868055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003592309,0.00015148135,0.00044795164,0.00008980089,0.00019661647,0.000010872878,0.000089414396,0.00016851012,0.00019993512],"category_scores_gemma":[0.0005648749,0.00009407594,0.00011766537,0.00023189327,0.00024309903,0.000033732078,0.00011550193,0.00016639984,0.0000058025557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047473953,0.008521597,0.48923558,0.00022128936,0.001084262,0.014050329,0.0016964505,0.000026718355,0.0006798461,0.0043476764,0.010140172,0.4695213],"study_design_scores_gemma":[0.0072371103,0.011784628,0.40958974,0.0009558281,0.0012190295,0.002423942,0.0033138655,0.0003594306,0.0016071846,0.016474104,0.54458433,0.00045081077],"about_ca_topic_score_codex":0.00002674982,"about_ca_topic_score_gemma":0.00010140352,"teacher_disagreement_score":0.53444415,"about_ca_system_score_codex":0.00045394158,"about_ca_system_score_gemma":0.0003254117,"threshold_uncertainty_score":0.38363057},"labels":[],"label_agreement":null},{"id":"W4408343606","doi":"10.14309/crj.0000000000001643","title":"Early-Onset Colorectal Cancer: When to Include Cowden Syndrome in Your Differential Diagnosis","year":2025,"lang":"en","type":"article","venue":"ACG Case Reports Journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cowden syndrome; Differential diagnosis; Colorectal cancer; Cancer; Oncology; PTEN; Internal medicine; Pathology; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.018627111583449762,"score_gpt":0.3177244321883248,"score_spread":0.29909732060487504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408343606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864895,0.0014395397,0.00002936408,0.007354095,0.0013749781,0.0006715279,0.000033367,0.00003231924,0.00041588765],"genre_scores_gemma":[0.99736935,0.00068842206,0.00021864523,0.00058336643,0.0002473538,0.00041866448,0.000010103822,0.000029426124,0.00043468215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778813,0.00007482007,0.00082555047,0.00043285542,0.00041178102,0.0004668892],"domain_scores_gemma":[0.9987078,0.000107272484,0.00026325104,0.00032281468,0.0001530603,0.00044583564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032447925,0.00026913668,0.0006309315,0.0004743577,0.0002046629,0.00012429449,0.000065784785,0.00013577084,0.0009813785],"category_scores_gemma":[0.0001706238,0.0002238826,0.00021236425,0.000368538,0.000040911447,0.00012234261,0.00013050801,0.0004721819,0.000011768013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013239545,0.00041157057,0.6045351,0.000027042985,0.00032532096,0.37969124,0.00038535945,0.00001051645,0.000045372886,0.000005447813,0.0070528174,0.007377843],"study_design_scores_gemma":[0.0016909789,0.0004348672,0.7102295,0.0007860806,0.0004302445,0.28143725,0.00009354332,0.000007156442,0.0011506522,0.00018408007,0.003384671,0.00017093697],"about_ca_topic_score_codex":0.003125246,"about_ca_topic_score_gemma":0.0012960183,"teacher_disagreement_score":0.105694465,"about_ca_system_score_codex":0.00098628,"about_ca_system_score_gemma":0.00065030996,"threshold_uncertainty_score":0.9999319},"labels":[],"label_agreement":null},{"id":"W4408678810","doi":"10.3802/jgo.2025.36.e74","title":"FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Positive Living North; Spinal Cord Injury BC; University of Northern British Columbia; University of Calgary; University of British Columbia","funders":"National Cancer Institute; Janet D. Cottrelle Foundation; BC Cancer Foundation; Ovarian Cancer Canada; Alberta Precision Laboratories; VGH and UBC Hospital Foundation; Cancer Research Society","keywords":"Medicine; Ovarian carcinoma; Carcinoma; Oncology; Serous carcinoma; Serous fluid; Internal medicine; Cancer research; Ovarian cancer; Gynecology; Cancer","score_opus":0.013680263308538075,"score_gpt":0.3049934721474857,"score_spread":0.2913132088389476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408678810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718464,0.0054194,0.00021940283,0.005049488,0.00051882584,0.00067667424,0.00003102705,0.000014145401,0.00088640075],"genre_scores_gemma":[0.9966771,0.00022280678,0.0016465632,0.0011758091,0.00007672019,0.000053687356,0.000010663223,0.000028801323,0.000107844375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713385,0.00047284935,0.0011311992,0.00044167147,0.00029218924,0.0005282203],"domain_scores_gemma":[0.9976782,0.00068209035,0.00077384023,0.00037842532,0.0002739378,0.00021350267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072728645,0.00036082946,0.0013531428,0.0003997847,0.00010803157,0.000022599166,0.000248304,0.0004813517,0.00017257563],"category_scores_gemma":[0.00022153658,0.000275864,0.0002197869,0.00033958428,0.00019071186,0.00010270065,0.00013590812,0.0005972503,0.0000018531109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027350932,0.0018651695,0.9444644,0.00036889562,0.00030421224,0.0066332566,0.0015870073,0.000036812467,0.036694016,0.0011342093,0.00020584874,0.0039711203],"study_design_scores_gemma":[0.009805447,0.007975565,0.9461514,0.00031150976,0.00035358092,0.0004455468,0.00096077373,0.000054763765,0.030162022,0.0020253265,0.0015439875,0.00021008043],"about_ca_topic_score_codex":0.0007105964,"about_ca_topic_score_gemma":0.00056844513,"teacher_disagreement_score":0.009492469,"about_ca_system_score_codex":0.0011989981,"about_ca_system_score_gemma":0.0013221219,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4408695657","doi":"10.1158/1078-0432.ccr-24-3905","title":"Precision Endocrine Therapy in Endometrial Cancer: Has Its Time Finally Come?","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Endometrial cancer; Endocrine system; Medicine; Cancer; Cancer therapy; Oncology; Gynecology; Internal medicine; Hormone","score_opus":0.34561102202869826,"score_gpt":0.5738653788999695,"score_spread":0.2282543568712712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408695657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88171,0.03773068,0.0000064300216,0.067144126,0.0013749052,0.0029725027,0.00010520711,0.000062810526,0.008893357],"genre_scores_gemma":[0.9187543,0.066558294,0.0000855648,0.0011354438,0.0010384344,0.001457748,0.00002118625,0.000032754542,0.010916307],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960029,0.0006027937,0.00091924064,0.00081014057,0.00094328565,0.00072161347],"domain_scores_gemma":[0.994818,0.003637301,0.00008597081,0.0006099823,0.0005644585,0.00028432687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027954208,0.00021476044,0.00087832054,0.0006827613,0.00015927879,0.00008778135,0.0003461166,0.00019273952,0.0047525642],"category_scores_gemma":[0.0018270018,0.00016444357,0.00026391257,0.0020272408,0.0003075385,0.00007995454,0.00021745876,0.0011437502,0.0002467051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009127783,0.0021490436,0.36694193,0.00009443149,0.00037068033,0.00023876908,0.000053404437,0.000019311723,0.00047253893,0.00023347464,0.06634783,0.55395085],"study_design_scores_gemma":[0.031037774,0.0031049675,0.52299064,0.001251512,0.00007033074,0.0000032041703,0.000015895543,0.00025207168,0.005168168,0.0005476739,0.43535498,0.00020279366],"about_ca_topic_score_codex":0.0019280093,"about_ca_topic_score_gemma":0.00063955534,"teacher_disagreement_score":0.553748,"about_ca_system_score_codex":0.00086190645,"about_ca_system_score_gemma":0.0026196989,"threshold_uncertainty_score":0.9961572},"labels":[],"label_agreement":null},{"id":"W4408776708","doi":"10.1016/j.labinv.2024.103202","title":"968 An Integrated Morphological and Immunohistochemical Approach to Distinguish Ovarian Mucinous Carcinoma from Metastatic Pancreatic Adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Immunohistochemistry; Pathology; Adenocarcinoma; Mucinous carcinoma; Ovarian carcinoma; Metastatic adenocarcinoma; Medicine; Ovary; Oncology; Ovarian cancer; Internal medicine; Cancer","score_opus":0.02196565091466899,"score_gpt":0.26786863008992295,"score_spread":0.24590297917525397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408776708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474335,0.0013785991,0.00089483126,0.0010788068,0.00014099527,0.00080432167,0.00016509989,0.00012300328,0.0006710176],"genre_scores_gemma":[0.96607643,0.000009306491,0.029972257,0.002638335,0.000095408686,0.000295523,0.0008208655,0.00002443006,0.00006743536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982881,0.00018455033,0.00039506922,0.0006691214,0.00020967556,0.00025350085],"domain_scores_gemma":[0.99868435,0.0001087934,0.00009463206,0.0005029622,0.00023458466,0.00037470087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018695834,0.00027987207,0.00049367285,0.00014777415,0.0001318447,0.00007614789,0.000106359745,0.00013197966,0.000042568434],"category_scores_gemma":[0.00038876545,0.00023634691,0.000043921642,0.0006867744,0.00019106825,0.00010835194,0.000049822724,0.00023739305,0.000012739806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004001972,0.00090865773,0.93309706,0.0002224708,0.0004304109,0.00025268787,0.0025147777,0.000018014896,0.050699636,0.006158681,0.002919053,0.0023783175],"study_design_scores_gemma":[0.002387254,0.00045774225,0.9803719,0.00020949091,0.0008292876,0.000025669166,0.0006605352,0.0011406979,0.01167212,0.0012176823,0.0007508287,0.00027677868],"about_ca_topic_score_codex":0.0010998046,"about_ca_topic_score_gemma":0.000017879687,"teacher_disagreement_score":0.04727482,"about_ca_system_score_codex":0.0003433907,"about_ca_system_score_gemma":0.00040579398,"threshold_uncertainty_score":0.9637947},"labels":[],"label_agreement":null},{"id":"W4408780557","doi":"10.1016/j.ygyno.2025.03.022","title":"Comparative efficacy and safety of low-dose versus high-dose bevacizumab in ovarian cancer: An indirect treatment comparison","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Bevacizumab; Ovarian cancer; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.10881160243309326,"score_gpt":0.4425460591949762,"score_spread":0.33373445676188296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408780557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009567298,0.9791642,0.000001295246,0.0004109711,0.0014437472,0.0054094866,0.00042367724,0.00005606179,0.0035232555],"genre_scores_gemma":[0.032852963,0.9634785,0.0005817847,0.00006850964,0.00014577442,0.0019095971,0.0006974876,0.00003374575,0.00023164625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955283,0.0010046954,0.0015035493,0.0011446777,0.00020616862,0.00061261136],"domain_scores_gemma":[0.9939455,0.004064312,0.00092405564,0.0006827456,0.00010511842,0.00027826475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035033515,0.0008474689,0.007603603,0.00059776474,0.000113570946,0.000016399948,0.00024006094,0.0009887277,0.0004936354],"category_scores_gemma":[0.0001646606,0.0006212147,0.00035604037,0.00069893216,0.0003014103,0.00005810628,0.00015734031,0.0005680705,0.000021684864],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032401467,0.007343355,0.0011809734,0.00424443,0.0021435823,0.00040948766,0.0006492084,0.000028156637,5.501102e-7,0.0003405616,0.00032269864,0.9800969],"study_design_scores_gemma":[0.06007533,0.030796403,0.060407933,0.0096467985,0.010176882,0.000045190973,0.00029571884,0.000021733957,0.000025006786,0.000037226502,0.8276941,0.0007776812],"about_ca_topic_score_codex":0.0012792612,"about_ca_topic_score_gemma":0.007188273,"teacher_disagreement_score":0.97931916,"about_ca_system_score_codex":0.005704416,"about_ca_system_score_gemma":0.0041775056,"threshold_uncertainty_score":0.9996239},"labels":[],"label_agreement":null},{"id":"W4408795799","doi":"10.1016/j.labinv.2024.103267","title":"1033 Endometrial Carcinoma with Isolated Fallopian Tube Involvement, Characterization of an Uncommon Finding","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Canadian Electricity Association","funders":"","keywords":"Fallopian tube; Carcinoma; Gynecology; Medicine; Pathology","score_opus":0.017431171268582898,"score_gpt":0.258292160837139,"score_spread":0.24086098956855612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408795799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981197,0.000033435135,0.00013672229,0.00040677586,0.00019429145,0.0008315156,0.000057988203,0.000053096774,0.00016648855],"genre_scores_gemma":[0.9983522,0.000006655933,0.00033753982,0.00046625867,0.000081024016,0.000089087276,0.0006017292,0.000016094898,0.000049351354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897087,0.00010552375,0.0003213036,0.0002679617,0.00020650685,0.00012784876],"domain_scores_gemma":[0.99912745,0.00003116315,0.00018104899,0.00030278452,0.0002545852,0.00010299904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017380127,0.00014589852,0.00026932984,0.0003269522,0.00007378485,0.00002889354,0.000055178676,0.000065441964,0.000031933083],"category_scores_gemma":[0.00004415621,0.00012472311,0.000024332605,0.0011741766,0.000057792215,0.00024938013,0.000014658364,0.000093094735,0.000002208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033385403,0.00039185825,0.8954941,0.00011054271,0.0001542085,0.000020307556,0.00074061594,0.000009996575,0.10078969,0.00094307424,0.000027140582,0.0009845911],"study_design_scores_gemma":[0.0057315817,0.0018832921,0.7777027,0.0002574965,0.00030748177,0.0000011382532,0.00023416828,0.00053749885,0.21265778,0.000072933864,0.0004918499,0.00012209167],"about_ca_topic_score_codex":0.00013302661,"about_ca_topic_score_gemma":0.00012389808,"teacher_disagreement_score":0.11779144,"about_ca_system_score_codex":0.00018189536,"about_ca_system_score_gemma":0.00042168205,"threshold_uncertainty_score":0.5086061},"labels":[],"label_agreement":null},{"id":"W4408795896","doi":"10.1016/j.labinv.2024.103357","title":"1123 Molecular Characterization of Ovarian Steroid Cell Tumours Reveals a Subset with Somatic and Germline Mutations in VHL","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; University Health Network; Health Sciences Centre; McGill University","funders":"","keywords":"Somatic cell; Germline; Germline mutation; Biology; Mutation; Genetics; Cancer research; Gene","score_opus":0.005951014052475518,"score_gpt":0.2304063604824483,"score_spread":0.22445534642997278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408795896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672127,0.00014893545,0.0003052336,0.0020411925,0.00003530279,0.000553794,0.00006528039,0.000020914027,0.00010806007],"genre_scores_gemma":[0.9971147,0.000026571086,0.0016508934,0.00071638974,0.000013195055,0.00010466875,0.00032018853,0.000012320036,0.000041036896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921316,0.00007457981,0.00029130458,0.00019422117,0.00012759479,0.000099138255],"domain_scores_gemma":[0.9994196,0.000030581512,0.00015283507,0.00017781169,0.00015141456,0.00006771433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001248761,0.000112208,0.00022418302,0.00019450199,0.000028805354,0.000017238694,0.000026142505,0.00005654521,0.000010222285],"category_scores_gemma":[0.000033431184,0.00010001092,0.000013921516,0.0006561394,0.00007522897,0.00012282035,0.000008789152,0.00006982822,0.0000017123323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038663227,0.00014962154,0.5438867,0.00043532866,0.00003103006,0.000022520258,0.0007039089,0.000022297747,0.45295534,0.0015649324,0.000018950408,0.00017069446],"study_design_scores_gemma":[0.0018365872,0.00013535516,0.80531186,0.0005450447,0.00015959209,0.0000017555782,0.000087673194,0.00020542527,0.19109496,0.0005225694,0.000027515252,0.0000716426],"about_ca_topic_score_codex":0.000027496431,"about_ca_topic_score_gemma":0.000028225859,"teacher_disagreement_score":0.26186037,"about_ca_system_score_codex":0.00007617777,"about_ca_system_score_gemma":0.00026726496,"threshold_uncertainty_score":0.4078327},"labels":[],"label_agreement":null},{"id":"W4408796148","doi":"10.1016/j.labinv.2024.103336","title":"1102 Intraoperative Consultation of 342 Consecutive Ovarian Specimens – Correlation of Gross Pathology, Frozen and Permanent Section Diagnosis","year":2025,"lang":"en","type":"article","venue":"Laboratory Investigation","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gross examination; Frozen section procedure; Medicine; Section (typography); Pathology","score_opus":0.009839548014680762,"score_gpt":0.26036926236939706,"score_spread":0.25052971435471627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408796148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547637,0.0005129807,0.00031911148,0.0017701389,0.00031863715,0.0006999172,0.0001837467,0.000024995812,0.00069413014],"genre_scores_gemma":[0.9980896,0.00029276384,0.00079252204,0.00040017226,0.000050844246,0.00013202375,0.00019313623,0.000008957494,0.000039972732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897194,0.00015223994,0.0003921687,0.00025060115,0.0001381704,0.000094870615],"domain_scores_gemma":[0.9987265,0.000227675,0.00025677343,0.00015082362,0.00057434296,0.00006391548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018720451,0.00013364502,0.00029783623,0.0001713762,0.00007182637,0.000011080865,0.000023496394,0.00013722191,0.000032837812],"category_scores_gemma":[0.00026018784,0.00012699778,0.000030386864,0.0004561456,0.0003719222,0.00013940291,0.000016091479,0.000114757786,0.0000021522346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021845459,0.00028034963,0.9102546,0.00026162094,0.00028990352,0.000014535017,0.007133556,0.000102748876,0.04862433,0.030248543,0.0011864037,0.0013849537],"study_design_scores_gemma":[0.0025304973,0.00036987552,0.81611276,0.0003703206,0.0003331302,0.0000050536655,0.0010846431,0.00033973204,0.17751835,0.00088016497,0.0003644764,0.00009097026],"about_ca_topic_score_codex":0.00013000071,"about_ca_topic_score_gemma":0.00006165683,"teacher_disagreement_score":0.12889402,"about_ca_system_score_codex":0.00016054865,"about_ca_system_score_gemma":0.00031119262,"threshold_uncertainty_score":0.51788193},"labels":[],"label_agreement":null},{"id":"W4409039093","doi":"10.1111/his.15452","title":"Molecular and immunohistochemical characterization of <i>ERBB2</i> activating mutations in low‐grade serous ovarian carcinoma","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Brigham and Women's Hospital","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Serous fluid; Immunohistochemistry; Oncology; Internal medicine; Serous carcinoma; Missense mutation; Medicine; Exon; Cohort; Cancer research; Ovarian cancer; Mutation; Biology; Cancer; Gene; Genetics; Colorectal cancer","score_opus":0.007126421877545721,"score_gpt":0.25480724494869433,"score_spread":0.2476808230711486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409039093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960755,0.00048785438,0.00060521427,0.0014766515,0.000107065614,0.00024865335,0.0000088262805,0.000014264247,0.0009759518],"genre_scores_gemma":[0.99873316,0.00002379248,0.0006149174,0.00037868318,0.000012115865,0.00007214784,0.0000747172,0.000009124887,0.00008134787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99933296,0.000040940704,0.00024067327,0.0002115333,0.00005487316,0.000119031734],"domain_scores_gemma":[0.99965036,0.0000333407,0.00007662775,0.0001720274,0.000038833252,0.000028802882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006121465,0.00009057202,0.0002550767,0.00015902243,0.00002941456,0.0000029679618,0.0000312493,0.00008582532,0.000011394658],"category_scores_gemma":[0.00004264706,0.00009396639,0.000033967994,0.00019091775,0.000086981374,0.000027924012,0.00002530533,0.000101433536,9.820106e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063047126,0.0002515278,0.110855475,0.00012045033,0.000007209754,0.00018947262,0.00053185545,0.0000025172399,0.8836913,0.0018916008,0.000008271688,0.0023872338],"study_design_scores_gemma":[0.001767491,0.00010645837,0.89734834,0.0001487591,0.00006632463,0.00008135672,0.000036408226,0.000087091474,0.09982307,0.00015004753,0.00031728353,0.000067339395],"about_ca_topic_score_codex":0.00008413403,"about_ca_topic_score_gemma":0.0000048157094,"teacher_disagreement_score":0.7864929,"about_ca_system_score_codex":0.0001800361,"about_ca_system_score_gemma":0.00010106935,"threshold_uncertainty_score":0.3831838},"labels":[],"label_agreement":null},{"id":"W4409062435","doi":"10.1148/radiol.241554","title":"Accuracy of Large Language Model–based Automatic Calculation of Ovarian-Adnexal Reporting and Data System MRI Scores from Pelvic MRI Reports","year":2025,"lang":"en","type":"article","venue":"Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Toronto General Hospital; Women's College Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Adnexal Diseases; Feature (linguistics); Radiology; Adnexal mass; Natural language processing; Artificial intelligence; Medical physics; Computer science; Linguistics; Laparoscopy","score_opus":0.025298816379937052,"score_gpt":0.3452238032290642,"score_spread":0.3199249868491272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409062435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812284,0.0030420944,0.013828327,0.0006120574,0.00018985862,0.00050470623,0.00013562184,0.000052367894,0.00040656238],"genre_scores_gemma":[0.99108124,0.000029733243,0.00806588,0.000091339694,0.000052278705,0.000022587265,0.0006129411,0.000010905686,0.000033092405],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99812096,0.000085234904,0.0010910806,0.00041985832,0.00012460086,0.00015828117],"domain_scores_gemma":[0.99732584,0.00032585763,0.0012044723,0.0010296683,0.000065070075,0.000049073395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063464744,0.00012459375,0.00066976546,0.00011976406,0.00003469351,0.0000057016355,0.000076474396,0.00011532773,0.00003116341],"category_scores_gemma":[0.0007559757,0.0001021498,0.000058262685,0.00012792848,0.0000521275,0.0000586899,0.000086099906,0.00008054775,6.1926147e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023642484,0.00054618507,0.9671429,0.0023515827,0.0012129836,0.0018811944,0.0013295528,0.0022666522,0.0075714244,0.0026795196,0.0033557669,0.009425814],"study_design_scores_gemma":[0.0026203638,0.00012860663,0.3539271,0.0013080769,0.0008785733,0.00028130074,0.00027060823,0.636779,0.0035034902,0.00011134116,0.00007893043,0.00011257927],"about_ca_topic_score_codex":0.0007876236,"about_ca_topic_score_gemma":0.00005414645,"teacher_disagreement_score":0.63451236,"about_ca_system_score_codex":0.00008677228,"about_ca_system_score_gemma":0.0003153613,"threshold_uncertainty_score":0.4165548},"labels":[],"label_agreement":null},{"id":"W4409097319","doi":"10.1016/s1470-2045(25)00021-x","title":"Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"ImmunoGen; AbbVie","keywords":"Open label; Medicine; Oncology; Folate receptor; Chemotherapy; Internal medicine; Ovarian cancer; Randomized controlled trial; Cancer; Cancer cell","score_opus":0.08608806022690466,"score_gpt":0.41194481523072124,"score_spread":0.3258567550038166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409097319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601817,0.00047399473,0.0000148601775,0.024134578,0.0019346641,0.01164951,0.00032431868,0.000042318003,0.0012440654],"genre_scores_gemma":[0.98901033,0.00024374164,0.0016242001,0.004788558,0.00064723723,0.00309106,0.0003782202,0.000055684293,0.00016095232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99648297,0.0009552793,0.0009571952,0.0006233043,0.00045369976,0.0005275515],"domain_scores_gemma":[0.9957123,0.002464092,0.00069669966,0.0008163046,0.00021753884,0.00009305574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011909512,0.00039516366,0.0016471518,0.00007723802,0.0002654848,0.00009039522,0.00039737276,0.00019548943,0.00045367476],"category_scores_gemma":[0.00054976606,0.000204935,0.00010665625,0.000459827,0.000159406,0.00009533576,0.000101942984,0.00046498477,0.000006830719],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8952398,0.0054583247,0.005704466,0.00000933011,0.0024052528,0.000033649074,0.000799714,0.0000039077177,0.00019632085,0.00007569796,0.0027080404,0.08736555],"study_design_scores_gemma":[0.9429347,0.028024765,0.022240741,0.0002808024,0.001170714,6.1273266e-7,0.00009668646,0.00007611971,0.00022554693,0.000083204686,0.004657351,0.00020873976],"about_ca_topic_score_codex":0.0028748868,"about_ca_topic_score_gemma":0.0014713194,"teacher_disagreement_score":0.08715681,"about_ca_system_score_codex":0.00085862103,"about_ca_system_score_gemma":0.0012380612,"threshold_uncertainty_score":0.8357007},"labels":[],"label_agreement":null},{"id":"W4409272854","doi":"10.1016/j.jcpo.2025.100582","title":"Challenges and opportunities in ovarian cancer care: A qualitative study of clinician perspectives from 24 low- and middle-income countries","year":2025,"lang":"en","type":"article","venue":"Journal of Cancer Policy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Ovarian Cancer Canada","funders":"World Health Organization","keywords":"Qualitative research; Low and middle income countries; Medicine; Ovarian cancer; Economic growth; Cancer; Political science; Developing country; Economics; Sociology; Internal medicine; Social science","score_opus":0.08856799409279993,"score_gpt":0.4321558296182707,"score_spread":0.3435878355254708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409272854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75727457,0.21808302,5.3130367e-7,0.023415996,0.0001744737,0.00025449728,0.0000793473,0.0000028828586,0.00071467395],"genre_scores_gemma":[0.8337995,0.16529903,0.00004356912,0.0003688706,0.0003479695,0.00004420038,5.4444683e-7,0.000010797992,0.00008557426],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99863833,0.00015931824,0.000589603,0.00020320973,0.00024667702,0.00016284375],"domain_scores_gemma":[0.99869424,0.00029190106,0.0003997816,0.00014267759,0.00035720997,0.00011416658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025834283,0.00017134273,0.0007499954,0.00047306795,0.00004060302,0.000020441594,0.000065164735,0.00006775281,0.000029459783],"category_scores_gemma":[0.000067961555,0.00013413183,0.00006456171,0.00013679605,0.00016612414,0.00012450662,0.000040342537,0.00019656186,9.394552e-8],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016097331,0.0008103442,0.10731154,0.0009705378,0.0021799323,0.00014488205,0.8551166,0.000006484348,0.000012410404,0.0073148543,0.000070533046,0.024452139],"study_design_scores_gemma":[0.0072525414,0.0011076444,0.53220075,0.004348915,0.00045876132,0.00000491282,0.45269153,0.0000015473065,0.0001134222,0.00087682484,0.0008460367,0.000097134915],"about_ca_topic_score_codex":0.017043343,"about_ca_topic_score_gemma":0.01549687,"teacher_disagreement_score":0.4248892,"about_ca_system_score_codex":0.00050916243,"about_ca_system_score_gemma":0.0012735474,"threshold_uncertainty_score":0.98950225},"labels":[],"label_agreement":null},{"id":"W4409333378","doi":"10.3390/curroncol32040218","title":"A Rare Case of Non-Hodgkin B-Cell Lymphoma Following Invasive Lobular Carcinoma of the Breast: A Case Report","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Lymphoma; Axillary Lymphadenopathy; Radiology; Biopsy; Splenectomy; Axillary lymph nodes; Axillary Lymph Node Dissection; Lymph node; Mastectomy; Metastasis; Fine-needle aspiration; Cancer; Pathology; Internal medicine; Sentinel lymph node; Spleen","score_opus":0.0363307586382627,"score_gpt":0.3581851793905705,"score_spread":0.3218544207523078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409333378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092734,0.0034353125,0.000041308387,0.0010204426,0.0015526656,0.0007989215,0.00005920977,0.00000976238,0.0021550092],"genre_scores_gemma":[0.9993124,0.000048551552,0.0001559131,0.0000977058,0.00008331997,0.0001188142,0.00001630228,0.000013156933,0.00015383241],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99864143,0.00010491385,0.0005562937,0.00033822798,0.0001378357,0.00022130153],"domain_scores_gemma":[0.99852544,0.00023729344,0.00033088517,0.00063033623,0.00018446909,0.000091570975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020790244,0.0001784094,0.00062590226,0.00012912898,0.000075182215,0.0000039458287,0.000094430376,0.00012136018,0.00004265373],"category_scores_gemma":[0.000116207695,0.00012639437,0.0003730215,0.00035967148,0.000113603695,0.000027450284,0.00014627994,0.000118154254,0.0000025978147],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001893693,0.0040664896,0.48915267,0.00080104824,0.0003710625,0.43648073,0.0010282367,0.0000040331147,0.0004156364,0.00011217823,0.0044544684,0.06292407],"study_design_scores_gemma":[0.032751102,0.0019299162,0.15417182,0.0020899,0.0047131744,0.74262947,0.0027054853,0.0002242681,0.041711852,0.00015330133,0.016553413,0.00036628215],"about_ca_topic_score_codex":0.00081694726,"about_ca_topic_score_gemma":0.00038078448,"teacher_disagreement_score":0.33498085,"about_ca_system_score_codex":0.00046742897,"about_ca_system_score_gemma":0.001608012,"threshold_uncertainty_score":0.5154213},"labels":[],"label_agreement":null},{"id":"W4409349447","doi":"10.1002/ijgo.70147","title":"Development and implementation of a novel metric score (<scp>SciMet</scp>) for scientific publications","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gynecologic oncology; Sample size determination; Impact factor; Cervical cancer; Citation; Oncology; Psychological intervention; Internal medicine; Ovarian cancer; Bevacizumab; MEDLINE; Clinical trial; Metric (unit); Gynecology; Medical physics; Cancer; Statistics","score_opus":0.08979055478377759,"score_gpt":0.40829544084936353,"score_spread":0.3185048860655859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409349447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014809228,0.9910248,0.001580841,0.00035795016,0.003973549,0.0011136866,0.00028292713,0.00000794603,0.0001773967],"genre_scores_gemma":[0.0008277849,0.9729281,0.024669258,0.00008476873,0.00015785957,0.00020359996,0.00035875375,0.00002531434,0.0007445554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739003,0.000037111804,0.0014843434,0.00031268655,0.0005717349,0.00020409255],"domain_scores_gemma":[0.98932165,0.006125626,0.0018966073,0.00018437838,0.002341499,0.00013025777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006777012,0.00024176386,0.0011589639,0.003936841,0.000091419046,0.00009394125,0.0003737324,0.00020291799,0.000029479088],"category_scores_gemma":[0.0055872165,0.00019543419,0.0004235437,0.0014640903,0.0000907039,0.0001310098,0.000118604075,0.00022780405,0.0000020928896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042323854,0.00067984546,0.0021704496,0.0023373696,0.0024152927,0.000016994058,0.00013414104,0.0000010734087,0.0000018625849,0.0020500822,0.0031137534,0.9870749],"study_design_scores_gemma":[0.0026563092,0.00023940306,0.0031210454,0.0022419286,0.002152975,0.00016613844,0.00013860458,0.0000037410912,0.00007857654,0.000034631856,0.9891046,0.00006203148],"about_ca_topic_score_codex":0.0000035207643,"about_ca_topic_score_gemma":0.000015180182,"teacher_disagreement_score":0.98701286,"about_ca_system_score_codex":0.0010238445,"about_ca_system_score_gemma":0.004057423,"threshold_uncertainty_score":0.7969575},"labels":[],"label_agreement":null},{"id":"W4409376552","doi":"10.18295/2075-0528.2750","title":"Steroid Cell Tumor","year":2008,"lang":"en","type":"article","venue":"Sultan Qaboos University medical journal","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pathology","score_opus":0.012929347899666682,"score_gpt":0.2153089839239882,"score_spread":0.20237963602432152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409376552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647972,0.0005755771,0.00033858034,0.007228116,0.00040751597,0.00015324712,0.000012668449,0.000051213392,0.026435873],"genre_scores_gemma":[0.99237627,0.0017498118,0.0006734208,0.0012394994,0.00047333658,2.2321488e-7,0.000005578388,0.00001258315,0.0034692727],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984458,0.00006595434,0.00018752048,0.00018912276,0.00081511185,0.00029650677],"domain_scores_gemma":[0.99846965,0.000077187855,0.00010111153,0.00015819566,0.00015215631,0.001041708],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017423286,0.00013219746,0.0002787979,0.00017078676,0.0003121679,0.000010338276,0.00016632024,0.00008764265,0.003102724],"category_scores_gemma":[0.000093275536,0.00010988848,0.0001643649,0.0002580235,0.00017151011,0.000109656976,0.00004961105,0.0005261976,0.00016080176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003148243,0.00514187,0.42424795,0.00017594335,0.00096025574,0.287963,0.0030965172,0.000009358987,0.0010619672,0.0007251699,0.24012192,0.0333478],"study_design_scores_gemma":[0.03381295,0.0019904666,0.29067054,0.0004929123,0.000575763,0.02338783,0.0017926235,0.00014024855,0.0027511448,0.000050895906,0.6438055,0.00052914146],"about_ca_topic_score_codex":0.000031213684,"about_ca_topic_score_gemma":0.000010937206,"teacher_disagreement_score":0.40368354,"about_ca_system_score_codex":0.00032270912,"about_ca_system_score_gemma":0.00093828625,"threshold_uncertainty_score":0.9978086},"labels":[],"label_agreement":null},{"id":"W4409412811","doi":"10.1158/1078-0432.ccr-24-1845","title":"A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer – Baseline Findings for CA125","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; School of Public Health, Imperial College London; Instituto de Salud Carlos III; World Cancer Research Fund; Medical Research Council; Centers for Disease Control and Prevention; Institut Gustave-Roussy; Deutsche Krebshilfe; Vetenskapsrådet; Ministero della Salute; Cancerfonden; Congressionally Directed Medical Research Programs; ZonMw; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Mutuelle Générale de l'Education Nationale; U.S. Department of Defense; Associazione Italiana per la Ricerca sul Cancro; Imperial College London; Deutsches Krebsforschungszentrum; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; European Commission; Compagnia di San Paolo; Cancer Research UK; World Health Organization; Universitetet i Tromsø; NIHR Imperial Biomedical Research Centre; Centre International de Recherche sur le Cancer; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Biomarker; Prospective cohort study; Medicine; Ovarian cancer; Oncology; Cancer; Stage (stratigraphy); Internal medicine; Malignancy; Biomarker discovery; Disease; Biology; Proteomics","score_opus":0.14954379900309872,"score_gpt":0.5181273117367589,"score_spread":0.36858351273366013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409412811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96374345,0.0011609488,0.009135074,0.009278109,0.0006630618,0.015398057,0.00055232213,0.000015418176,0.00005355137],"genre_scores_gemma":[0.9788737,0.0005918222,0.00023163583,0.00014883035,0.00037209628,0.018475784,0.00001238278,0.000021780304,0.0012719173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821436,0.00015223629,0.00052744074,0.0005251452,0.00027484368,0.000305952],"domain_scores_gemma":[0.99243486,0.006201122,0.00010317985,0.00028784023,0.0008936695,0.00007934604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037359106,0.00012430434,0.00041220413,0.00012496416,0.00029195577,0.00006330167,0.00009803275,0.00010145877,0.000023608452],"category_scores_gemma":[0.0019628478,0.00008334102,0.00018432288,0.00032937378,0.0002502852,0.00008792494,0.000055281842,0.00021534582,2.369196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027310591,0.0013302177,0.8809884,0.0006884661,0.0017359112,0.0000014216769,0.00035925733,0.000017905159,0.00035778512,0.0007409332,0.0048091775,0.081659906],"study_design_scores_gemma":[0.020779539,0.0077733854,0.9484029,0.00041861102,0.0012825753,5.687211e-7,0.00090003724,0.0011226251,0.012564018,0.0012806681,0.005336832,0.0001382414],"about_ca_topic_score_codex":0.0020195434,"about_ca_topic_score_gemma":0.00143595,"teacher_disagreement_score":0.08152166,"about_ca_system_score_codex":0.00032503236,"about_ca_system_score_gemma":0.0008226552,"threshold_uncertainty_score":0.33985484},"labels":[],"label_agreement":null},{"id":"W4409482809","doi":"10.1016/j.canep.2025.102814","title":"Trajectories of body fatness in adulthood and the risk of ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canada Research Chairs; McGill University","keywords":"Medicine; Ovarian cancer; Cancer; Oncology; Internal medicine","score_opus":0.02513234491858495,"score_gpt":0.35872619360412494,"score_spread":0.33359384868554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409482809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8692501,0.0946108,0.00031440926,0.033095155,0.0008779022,0.0008482245,0.00016338099,0.0000130959,0.00082692615],"genre_scores_gemma":[0.9726349,0.025551112,0.00022941384,0.0009054247,0.00008800121,0.00047289865,0.0000045319575,0.000007571676,0.00010613271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849147,0.0004194232,0.000565643,0.00026359654,0.00005161871,0.00020824601],"domain_scores_gemma":[0.997588,0.0017203615,0.00027729344,0.00028116952,0.000090906586,0.00004231352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008604971,0.00013185329,0.0009973334,0.00009298196,0.000030301082,0.0000010345597,0.00007667434,0.000115547446,0.00009362397],"category_scores_gemma":[0.00072780065,0.000078349796,0.00010342872,0.00023625717,0.00048386608,0.000020075844,0.000036158377,0.00017409204,3.032291e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009115227,0.00008573924,0.9569886,0.000291875,0.00045979602,0.0000021595295,0.0005055512,0.00010911476,0.00003631539,0.026803983,0.0008823416,0.012923043],"study_design_scores_gemma":[0.0067823287,0.00010096915,0.9826766,0.00054850243,0.0004876158,0.0000015416729,0.00017266504,0.00022401751,0.0009758979,0.005814462,0.0021564274,0.000058952286],"about_ca_topic_score_codex":0.017661491,"about_ca_topic_score_gemma":0.0022796297,"teacher_disagreement_score":0.10338481,"about_ca_system_score_codex":0.000114280294,"about_ca_system_score_gemma":0.00030503105,"threshold_uncertainty_score":0.98888},"labels":[],"label_agreement":null},{"id":"W4409533154","doi":"10.21203/rs.3.rs-6185721/v1","title":"CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"In vivo; Epithelial ovarian cancer; In vitro; Ovarian cancer; Cancer research; Oncology; Cancer; Chemistry; Biology; Medicine; Internal medicine; Biotechnology; Biochemistry","score_opus":0.03202471948759193,"score_gpt":0.3858134122896033,"score_spread":0.35378869280201136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409533154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849411,0.0034125478,0.0000026390107,0.005792575,0.00012985292,0.0024150752,0.0015443593,0.000012052801,0.0017497485],"genre_scores_gemma":[0.99312675,0.00563894,0.00018647416,0.00003502691,0.00008811365,0.0007077192,0.000037567133,0.000015766564,0.00016362383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974894,0.0003235778,0.00043826792,0.00075576827,0.00054484204,0.0004481685],"domain_scores_gemma":[0.99861556,0.0004137601,0.000068625246,0.0004878442,0.00022416197,0.00019006581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011587001,0.00022173775,0.0007449897,0.0006603686,0.000036920115,0.000028250552,0.00009853544,0.00029690724,0.00023931147],"category_scores_gemma":[0.0002852332,0.0001933385,0.00007306962,0.00039746767,0.00023849795,0.00003715024,0.00058271765,0.00092567585,4.9044723e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014844175,0.0008377831,0.97265065,0.009063347,0.00013480603,0.00034900603,0.0012166579,0.00001117741,0.0024293761,0.00024763157,0.00018833905,0.011386798],"study_design_scores_gemma":[0.003715646,0.00024000161,0.95408255,0.0037951744,0.00006374833,0.0000053432427,0.00022820552,0.00017635,0.03497355,0.0021381527,0.00040064487,0.00018061558],"about_ca_topic_score_codex":0.029652692,"about_ca_topic_score_gemma":0.0037921404,"teacher_disagreement_score":0.032544177,"about_ca_system_score_codex":0.0005417727,"about_ca_system_score_gemma":0.0014163275,"threshold_uncertainty_score":0.9768089},"labels":[],"label_agreement":null},{"id":"W4409631461","doi":"10.1158/1538-7445.am2025-2317","title":"Abstract 2317: Historical trends in age of menarche and implications for breast cancer risk in the US population","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Menarche; Breast cancer; Medicine; Cancer; Demography; Population; Gynecology; Oncology; Internal medicine; Environmental health","score_opus":0.11787977937258698,"score_gpt":0.47164908341716233,"score_spread":0.35376930404457535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9565124,0.004621281,0.000007662362,0.03689773,0.0000568913,0.0006624962,0.00026093086,0.000004746388,0.0009758592],"genre_scores_gemma":[0.99532586,0.0024594916,0.00004089294,0.00008071698,0.000068236564,0.0016558315,0.000030913816,0.00000735655,0.0003306877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991091,0.00007129356,0.0002083049,0.0002240553,0.00017143931,0.00021583955],"domain_scores_gemma":[0.99932986,0.000271277,0.000037419988,0.0002278178,0.00009177842,0.00004184333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000593216,0.00006741119,0.00018819078,0.00036953553,0.00006788687,0.0000120541345,0.00008338773,0.000055171495,0.00006619186],"category_scores_gemma":[0.000042880132,0.00004673369,0.000040573937,0.0007488121,0.000055905726,0.00003252349,0.000022823728,0.0002361512,2.3114617e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022836556,0.00024217517,0.7877025,0.000101126316,0.00003522752,0.000003505714,0.00034105213,0.00002797872,0.0004467798,0.00089899293,0.0035003817,0.20647193],"study_design_scores_gemma":[0.0015090203,0.000058391295,0.99201405,0.00016478774,0.000032374144,0.0000011614047,0.00004654838,0.000022074084,0.00007439742,0.00087965553,0.0051628123,0.000034738085],"about_ca_topic_score_codex":0.04341818,"about_ca_topic_score_gemma":0.01682486,"teacher_disagreement_score":0.20643719,"about_ca_system_score_codex":0.001588354,"about_ca_system_score_gemma":0.00019332548,"threshold_uncertainty_score":0.9629518},"labels":[],"label_agreement":null},{"id":"W4409633477","doi":"10.1158/1538-7445.am2025-1689","title":"Abstract 1689: Targeting PARP to enhance sensitivity to MEK inhibitors in low-grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; PARP inhibitor; Serous ovarian cancer; Serous fluid; Medicine; Cancer; Cancer research; Oncology; Poly ADP ribose polymerase; Internal medicine; Biology; Genetics; Polymerase; DNA","score_opus":0.043004986751201096,"score_gpt":0.43150662798386413,"score_spread":0.38850164123266306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474872,0.001887306,0.000057928977,0.04562694,0.0006339616,0.0018799021,0.00009434942,0.000056728004,0.002275682],"genre_scores_gemma":[0.99297994,0.0006912988,0.00033552438,0.0020504522,0.00061798765,0.0018743939,0.000012150497,0.000045201796,0.0013930624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99657065,0.00019027754,0.00044615343,0.00092948147,0.0007842211,0.0010792478],"domain_scores_gemma":[0.9981472,0.00036508043,0.000048030484,0.0005304706,0.00039512277,0.00051413587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001468297,0.00027097762,0.00053023186,0.0006354893,0.00019748733,0.00008603564,0.00016209843,0.00013100573,0.00040570737],"category_scores_gemma":[0.00037844456,0.00025050846,0.00009768436,0.0020993634,0.000081743536,0.00010106442,0.00020951105,0.0007446482,0.0001125605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002297118,0.0020064637,0.22408931,0.0017666395,0.0005991772,0.002307415,0.004417014,0.0044970443,0.24886304,0.00039623198,0.20495088,0.30380964],"study_design_scores_gemma":[0.0019486905,0.00025701293,0.48489526,0.005296849,0.00005087252,0.0000035286039,0.0004996926,0.000071391616,0.46038014,0.00010284388,0.0460794,0.00041432545],"about_ca_topic_score_codex":0.027935302,"about_ca_topic_score_gemma":0.016780332,"teacher_disagreement_score":0.30339533,"about_ca_system_score_codex":0.0026306633,"about_ca_system_score_gemma":0.0014229451,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W4409689781","doi":"10.1158/1538-7445.am2025-989","title":"Abstract 989: Vitamin D and the modifying effect of body mass index on ovarian cancer recurrence","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Cancer; Body mass index; Ovarian cancer; Oncology; Vitamin; Internal medicine; Vitamin D and neurology; Physiology; Endocrinology; Gynecology","score_opus":0.04625962051515442,"score_gpt":0.42589001499825707,"score_spread":0.37963039448310265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96271056,0.009654341,0.000023906045,0.013921129,0.000387202,0.0018524188,0.00005840773,0.000020790842,0.011371219],"genre_scores_gemma":[0.9922848,0.0053839493,0.000012467013,0.00017379156,0.00014036044,0.0013149761,0.000003694553,0.000015894184,0.0006701125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982154,0.00021889286,0.00023057968,0.00039969105,0.00055366306,0.00038178687],"domain_scores_gemma":[0.9980365,0.001166086,0.000059295882,0.00044828723,0.00018187037,0.00010792952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013668938,0.0001602372,0.00041436564,0.00022463388,0.00017571222,0.000043198157,0.00016371648,0.00009224986,0.00024537125],"category_scores_gemma":[0.00021395518,0.00009433785,0.00008182672,0.0005394998,0.0004069337,0.000043885393,0.00007581403,0.00056838506,0.000007044202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015519282,0.0004545429,0.5423718,0.0036747926,0.0015609442,0.00013610352,0.0007378557,0.00022791592,0.012283068,0.01159107,0.018292276,0.39315036],"study_design_scores_gemma":[0.023759233,0.0010774056,0.85826355,0.006298979,0.00031022725,0.000004151263,0.00015085877,0.0007193854,0.1011729,0.0010354628,0.0069691148,0.0002387215],"about_ca_topic_score_codex":0.005463498,"about_ca_topic_score_gemma":0.00016236067,"teacher_disagreement_score":0.39291164,"about_ca_system_score_codex":0.00044342852,"about_ca_system_score_gemma":0.0005089001,"threshold_uncertainty_score":0.8259211},"labels":[],"label_agreement":null},{"id":"W4409742164","doi":"10.1016/j.ygyno.2025.04.583","title":"Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Sunnybrook Health Science Centre","funders":"National Institutes of Health; Wellcome Trust; Howard Hughes Medical Institute","keywords":"Medicine; Mesonephric duct; Female circumcision; Adenocarcinoma; Genital tract; Gynecology; Pathology; Internal medicine; Physiology; Cancer; Kidney","score_opus":0.1344649058981779,"score_gpt":0.42915876991963814,"score_spread":0.29469386402146025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409742164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002652083,0.988164,0.000006595397,0.0014656017,0.0025685,0.0032167654,0.00021776218,0.000051871084,0.0016568361],"genre_scores_gemma":[0.0056248354,0.98798305,0.0009277616,0.0029907618,0.00016137188,0.0013572185,0.0000653429,0.00004189989,0.00084773835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957807,0.0007217493,0.0017154792,0.0009700324,0.00026726341,0.0005447582],"domain_scores_gemma":[0.98977053,0.007796764,0.0011209879,0.0010155896,0.00012667471,0.00016944874],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008891917,0.0007016244,0.004770802,0.00018928223,0.00014484467,0.000017605116,0.00048017214,0.001713692,0.00023224235],"category_scores_gemma":[0.0007648582,0.00037373378,0.0015127667,0.0004403661,0.0006162117,0.000030983738,0.00049631007,0.0011124724,0.000024582941],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001744629,0.0031416107,0.29220542,0.0029030081,0.0009452753,0.00030836565,0.00003429445,8.285983e-8,5.2501406e-8,0.00038944295,0.00080379285,0.69925123],"study_design_scores_gemma":[0.0020392,0.0019801508,0.33831486,0.0010915551,0.008166995,0.0003314209,0.00003901522,4.6985485e-7,3.6144235e-7,0.00005885384,0.6477507,0.00022644964],"about_ca_topic_score_codex":0.000022405848,"about_ca_topic_score_gemma":0.0000548402,"teacher_disagreement_score":0.69902474,"about_ca_system_score_codex":0.00056512654,"about_ca_system_score_gemma":0.0021682088,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W4410004207","doi":"10.3390/curroncol32050263","title":"Risk Factors for Recurrence in Serous Borderline Ovarian Tumors and Early-Stage Low-Grade Serous Ovarian Carcinoma","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Nomogram; Serous fluid; Logistic regression; Stage (stratigraphy); Proportional hazards model; Serous carcinoma; Oncology; Internal medicine; Retrospective cohort study; Ovarian carcinoma; Ovarian cancer; Cancer","score_opus":0.05482795935366161,"score_gpt":0.3716661685338299,"score_spread":0.31683820918016825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410004207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886941,0.0035408605,0.000615975,0.0028172338,0.0018195577,0.0018319072,0.0002115943,0.00006215961,0.0004066498],"genre_scores_gemma":[0.99703664,0.00096529984,0.0008052752,0.0001811853,0.0001932111,0.00044690608,0.00011377132,0.000029847723,0.00022783829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777055,0.00015398771,0.00059092196,0.0007529706,0.00015262411,0.0005789262],"domain_scores_gemma":[0.9984769,0.0004928104,0.00022022572,0.00041742664,0.00016223306,0.00023035875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003206939,0.00036058243,0.00084047613,0.00035664276,0.0001423837,0.000035547204,0.00013370038,0.0002238506,0.000046545716],"category_scores_gemma":[0.00036384186,0.0003158921,0.00013844763,0.00045258182,0.00014920092,0.00008980753,0.000098262346,0.00048645557,0.000005106097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030183737,0.0015071465,0.92434114,0.00034152088,0.00010854852,0.00008893951,0.0009276278,0.000011210796,0.000014608468,0.0017117033,0.0008998759,0.06974583],"study_design_scores_gemma":[0.009250714,0.0014499183,0.92661256,0.00036585992,0.00030931624,0.000015745454,0.00041059282,0.0005502444,0.00027073972,0.0005004847,0.06001114,0.00025266883],"about_ca_topic_score_codex":0.0017026222,"about_ca_topic_score_gemma":0.0010616645,"teacher_disagreement_score":0.06949316,"about_ca_system_score_codex":0.000622226,"about_ca_system_score_gemma":0.00058962684,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W4410004353","doi":"10.3390/onco5020020","title":"A Regional Experience of Adult Granulosa Cell Tumours: A Retrospective Analysis","year":2025,"lang":"en","type":"article","venue":"Onco","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Granulosa cell; Medicine; Internal medicine; Ovary","score_opus":0.010003076970139914,"score_gpt":0.29270157884176445,"score_spread":0.28269850187162454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410004353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96248394,0.00053125323,0.0002746387,0.0030276165,0.00008116683,0.00021048606,0.00002195286,0.000023251378,0.033345714],"genre_scores_gemma":[0.996785,0.00016664153,0.0008139892,0.0004976998,0.00003584078,0.000063250314,0.00001428274,0.000004314543,0.0016190197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992928,0.000014252384,0.00016430106,0.00023140882,0.00018599312,0.00011128042],"domain_scores_gemma":[0.9994185,0.000032962536,0.00006933399,0.0002676667,0.00015807989,0.000053461044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003278826,0.000085789936,0.0003185927,0.00016419985,0.000029636309,0.0000055867276,0.000050737028,0.000037432175,0.00018087667],"category_scores_gemma":[0.000023811379,0.00006924959,0.00019856062,0.0007947209,0.0000617082,0.000025696736,0.00001684892,0.000059626287,0.00000711604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102940554,0.000602748,0.9901362,0.000034714547,0.00039603518,0.000036360638,0.0011229778,0.0000039742886,0.00033829137,0.0028524802,0.0035969582,0.00077633106],"study_design_scores_gemma":[0.0017823947,0.00025895648,0.9789606,0.00014331404,0.001432415,0.0000023867199,0.00057954807,0.00008561675,0.01480899,0.00027808148,0.0015966347,0.000071099385],"about_ca_topic_score_codex":0.00046643702,"about_ca_topic_score_gemma":0.000107082444,"teacher_disagreement_score":0.03430104,"about_ca_system_score_codex":0.00017697437,"about_ca_system_score_gemma":0.00011523508,"threshold_uncertainty_score":0.28239164},"labels":[],"label_agreement":null},{"id":"W4410361253","doi":"10.1016/j.jogc.2025.102921","title":"Giant Tumor in Menopausal Woman's Abdomen","year":2025,"lang":"en","type":"editorial","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Abdomen; Radiology; Gynecology; General surgery","score_opus":0.006183197223285809,"score_gpt":0.24248002353872697,"score_spread":0.23629682631544116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410361253","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006160577,0.021411678,0.0000012831222,0.0012375627,0.9687069,0.00025306392,0.0001500985,0.000002832212,0.0020760163],"genre_scores_gemma":[0.49359632,0.024631731,0.0022945476,0.0051916144,0.4629472,0.00015363516,0.0003290377,0.00025330437,0.010602612],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978057,0.00006189949,0.0008230241,0.0002702879,0.0006780476,0.0003610249],"domain_scores_gemma":[0.9935421,0.004867893,0.0006307621,0.00019700377,0.00048267553,0.00027961977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031285468,0.00028184036,0.0011787824,0.0006548269,0.00005147408,0.00002707755,0.00015887315,0.00039953447,0.00031998695],"category_scores_gemma":[0.0053549735,0.00022746644,0.000060509377,0.00043302667,0.000047083216,0.00003682584,0.00006611359,0.0011493403,6.166976e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000022757513,0.00020285968,0.005151189,0.00022479995,0.00044521934,0.030266682,0.00002295624,0.0000052844107,0.0000010691199,0.000024293153,0.946144,0.01748893],"study_design_scores_gemma":[0.006172371,0.00157729,0.04800576,0.00012787888,0.0005155415,0.000042120886,0.000060890212,0.0000049921982,0.0000067786086,0.00005349828,0.9432562,0.0001766727],"about_ca_topic_score_codex":0.03473074,"about_ca_topic_score_gemma":0.084046334,"teacher_disagreement_score":0.5057597,"about_ca_system_score_codex":0.0055670957,"about_ca_system_score_gemma":0.016453387,"threshold_uncertainty_score":0.99825037},"labels":[],"label_agreement":null},{"id":"W4410813910","doi":"10.1200/jco.2025.43.16_suppl.5516","title":"A phase I/II study of the safety and efficacy of intraperitoneal IMNN-001 in combination with neoadjuvant chemotherapy (NACT) of paclitaxel and carboplatin in patients newly diagnosed with advanced epithelial ovarian cancer (EOC): Updated survival analysis from OVATION-2 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Chemotherapy; Oncology; Internal medicine; Phases of clinical research; Ovary; Cisplatin","score_opus":0.024846257108481203,"score_gpt":0.39380533045977456,"score_spread":0.36895907335129335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410813910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967115,0.00010948936,0.000024498142,0.0017052712,0.00020083805,0.0011607019,0.00005953077,0.0000015839031,0.000026596967],"genre_scores_gemma":[0.99878085,0.00056741555,0.00043611522,0.00012318895,0.00004290148,0.000017102335,0.000019518835,0.000008906707,0.000003982393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661255,0.00050543656,0.0021797458,0.00024018547,0.0003409417,0.00012112865],"domain_scores_gemma":[0.9955693,0.0017983407,0.0019435828,0.00020904734,0.0004022082,0.000077529665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011188327,0.00015325863,0.001960837,0.00029927987,0.000026384925,0.000003697557,0.00008862821,0.00014853198,0.000025078774],"category_scores_gemma":[0.0004905983,0.00008885818,0.00011679941,0.00086290913,0.0001853418,0.00007001219,0.000031820582,0.00035264733,1.2142299e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1772445,0.033862747,0.65403897,0.000013390863,0.0020221192,0.000019306402,0.0008882568,0.00019361527,0.00006514172,0.00001764333,0.0000049764794,0.13162933],"study_design_scores_gemma":[0.34920463,0.037604112,0.6113087,0.0001792799,0.00108875,3.2883239e-7,0.00029157943,0.00013510621,0.00009078382,0.000015165606,0.000038235787,0.00004332191],"about_ca_topic_score_codex":0.003670489,"about_ca_topic_score_gemma":0.008208274,"teacher_disagreement_score":0.17196013,"about_ca_system_score_codex":0.00015542492,"about_ca_system_score_gemma":0.00080649497,"threshold_uncertainty_score":0.5548706},"labels":[],"label_agreement":null},{"id":"W4410814172","doi":"10.1200/jco.2025.43.16_suppl.e17565","title":"Healthcare resource use in the management of advanced epithelial ovarian cancer in Canada.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Jewish General Hospital; ABB (Canada)","funders":"AbbVie Canada","keywords":"Medicine; Health care; Ovarian cancer; Epithelial ovarian cancer; Oncology; Cancer; Gynecology; Internal medicine; Cancer research; Economic growth","score_opus":0.08806862542293935,"score_gpt":0.46020819613853825,"score_spread":0.3721395707155989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410814172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84935606,0.0016949946,0.000008593204,0.14544438,0.00094213744,0.000408502,0.0000164694,0.000001207124,0.002127668],"genre_scores_gemma":[0.9869505,0.0032288576,0.0010166442,0.008495427,0.0001439927,0.000020342199,9.198973e-7,0.000005175674,0.00013814551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972705,0.00040696072,0.0017323772,0.00013963204,0.0002710039,0.00017951737],"domain_scores_gemma":[0.9975406,0.0013686924,0.00067887234,0.00020165082,0.000116169125,0.000093999435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016401077,0.00008595298,0.00090341584,0.00010948229,0.000014352388,0.0000031005075,0.00015727947,0.00010613191,0.000039242917],"category_scores_gemma":[0.00023907422,0.00005251525,0.00013975751,0.0002945954,0.00004829768,0.00003654478,0.000032862954,0.0005732647,3.3335044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029601832,0.0009992846,0.53785485,0.0001167633,0.00034155062,0.0019019472,0.00012317592,0.00033595998,0.0000023796006,0.0014012352,0.002665283,0.4512974],"study_design_scores_gemma":[0.008886947,0.0010334661,0.872261,0.00076772156,0.00016823727,0.000013055654,0.00068164006,0.000015108808,0.000012945308,0.00017585598,0.11595124,0.000032785367],"about_ca_topic_score_codex":0.27688086,"about_ca_topic_score_gemma":0.82284766,"teacher_disagreement_score":0.5459668,"about_ca_system_score_codex":0.0010774374,"about_ca_system_score_gemma":0.0056124195,"threshold_uncertainty_score":0.9956191},"labels":[],"label_agreement":null},{"id":"W4410846411","doi":"10.63838/001c.137824","title":"A comprehensive guide to MMR testing in gynecological and gastrointestinal cancers","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Medical Specialties","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Gastrointestinal tract; Gynecology; Oncology; Internal medicine","score_opus":0.029588254260721637,"score_gpt":0.3232325956543141,"score_spread":0.29364434139359247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410846411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9148444,0.0026457605,0.00015729133,0.07138352,0.0006803925,0.00030223242,0.000009771997,0.000006987309,0.0099696675],"genre_scores_gemma":[0.9857615,0.00016088427,0.005912166,0.007183274,0.0007043675,0.000010495439,0.0000010555797,0.000008992755,0.00025722384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987393,0.000040802533,0.00044083153,0.00014323683,0.00032141287,0.00031442512],"domain_scores_gemma":[0.9980286,0.00040946194,0.000074292686,0.00007732147,0.00020037899,0.0012099805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030980608,0.00011434767,0.00040176677,0.00036556076,0.0000666674,0.000031721844,0.00011817256,0.0000673165,0.00059528137],"category_scores_gemma":[0.002651705,0.00008987003,0.000048980048,0.00032184375,0.00018023951,0.000030410769,0.000023521969,0.000342958,0.0000036815202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009293384,0.000051702034,0.85990703,0.0000765412,0.00006756844,0.005896884,0.00029255642,0.0000418301,0.00001579743,0.0013384823,0.0507053,0.08151338],"study_design_scores_gemma":[0.002188992,0.00079715875,0.8516718,0.0022363178,0.000048779504,0.0010460982,0.000802801,0.00005108635,0.000020435677,0.00020004895,0.14085811,0.00007833202],"about_ca_topic_score_codex":0.020405902,"about_ca_topic_score_gemma":0.110890485,"teacher_disagreement_score":0.09048458,"about_ca_system_score_codex":0.0010730707,"about_ca_system_score_gemma":0.006233784,"threshold_uncertainty_score":0.99939996},"labels":[],"label_agreement":null},{"id":"W4410912460","doi":"10.1016/j.ijgc.2025.101952","title":"Erratum to ‘Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101664]","year":2025,"lang":"en","type":"erratum","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Cytoreductive surgery; Ovarian cancer; Cancer; Interval (graph theory); Gynecology; Oncology; General surgery; Internal medicine","score_opus":0.022011221980292556,"score_gpt":0.3203235331637252,"score_spread":0.29831231118343265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410912460","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42222682,0.007219292,0.00025250507,0.07047944,0.4798053,0.0030719596,0.008030337,0.00007181881,0.008842551],"genre_scores_gemma":[0.7685013,0.038406827,0.0030396853,0.01714837,0.07194408,0.0013569181,0.0012327891,0.00039788286,0.09797217],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9918842,0.00031625517,0.0027728698,0.00093595026,0.0032363182,0.00085444207],"domain_scores_gemma":[0.9884181,0.0011396911,0.003028707,0.00035909918,0.0063845734,0.0006698465],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084297714,0.0009930963,0.0029146103,0.0016535426,0.00010808735,0.00023183507,0.0017309521,0.0010300914,0.0154699925],"category_scores_gemma":[0.0018661054,0.00065630506,0.0011187453,0.00066437724,0.00031565758,0.00050772954,0.000498566,0.0028279747,0.000026957678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.05994023,0.0034972257,0.13899262,0.00014255382,0.008281054,0.0049621416,0.00036393505,0.0007162178,0.000027345368,0.0000131624765,0.7141596,0.068903916],"study_design_scores_gemma":[0.018342137,0.0050971773,0.6337252,0.0051076286,0.0012211376,0.00009564747,0.00015634984,0.000028243256,0.00011331683,0.00005094083,0.33537266,0.000689558],"about_ca_topic_score_codex":0.0011109154,"about_ca_topic_score_gemma":0.0017695173,"teacher_disagreement_score":0.4947326,"about_ca_system_score_codex":0.011232323,"about_ca_system_score_gemma":0.011378527,"threshold_uncertainty_score":0.99958885},"labels":[],"label_agreement":null},{"id":"W4410954797","doi":"10.1016/s0140-6736(25)01040-2","title":"Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Australia New Zealand Gynaecological Oncology Group","keywords":"Medicine; Internal medicine; Paclitaxel; Oncology; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Ovarian cancer; Bevacizumab; Chemotherapy; Gynecologic oncology; Progressive disease; Cancer","score_opus":0.03345300559954077,"score_gpt":0.3406242686957676,"score_spread":0.30717126309622683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410954797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131585,0.0012916696,0.00001062261,0.0065128016,0.0003195716,0.0062256637,0.00017971337,0.00002911793,0.004114961],"genre_scores_gemma":[0.9952122,0.000408717,0.00032060582,0.0016011732,0.00036498418,0.001248093,0.000055144454,0.000022116397,0.00076696265],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848855,0.0001796704,0.00039556477,0.00038598792,0.00022412527,0.00032613057],"domain_scores_gemma":[0.9988272,0.0002643268,0.00015311825,0.00057609315,0.00007383634,0.00010538615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005925147,0.00022574574,0.0011419277,0.000072384806,0.00013328028,0.00010979959,0.00021798049,0.00007035554,0.00010713344],"category_scores_gemma":[0.00009742848,0.0001195463,0.000026820819,0.00021593609,0.00008630244,0.00010142006,0.000068797635,0.00020028341,0.000002857318],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9491857,0.0028305121,0.034835882,0.000049241746,0.0005218943,0.000037052654,0.00029820122,0.0000036982306,0.00005736046,0.0018503332,0.0050425264,0.0052875825],"study_design_scores_gemma":[0.9447174,0.0037799354,0.045651525,0.00039475565,0.0004877886,9.807839e-7,0.000047131405,0.000105902924,0.000035376634,0.000275837,0.0043665497,0.00013678521],"about_ca_topic_score_codex":0.00089222175,"about_ca_topic_score_gemma":0.0006510797,"teacher_disagreement_score":0.013896325,"about_ca_system_score_codex":0.00016322659,"about_ca_system_score_gemma":0.00024812142,"threshold_uncertainty_score":0.48749563},"labels":[],"label_agreement":null},{"id":"W4411025709","doi":"10.1200/jco.2025.43.17_suppl.lba5506","title":"FIRST/ENGOT-OV44: A phase 3 clinical trial of dostarlimab (dost) and niraparib (nira) in first-line (1L) advanced ovarian cancer (aOC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ovarian cancer; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.14722634429479448,"score_gpt":0.5387418993511217,"score_spread":0.39151555505632724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411025709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92588806,0.0042003025,0.00013874941,0.06278236,0.0044160914,0.0010612934,0.00003584702,0.000012076132,0.001465218],"genre_scores_gemma":[0.96296865,0.028444193,0.0035215504,0.0031725045,0.001558443,0.00006197641,0.0000054132456,0.000024500494,0.00024275272],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99252665,0.0005242003,0.0056653,0.0004924259,0.0004033633,0.0003880467],"domain_scores_gemma":[0.9896538,0.0065163993,0.002457232,0.00041831064,0.00047792407,0.00047631943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004603331,0.0002872674,0.0034778109,0.00032929133,0.00006145539,0.000013358304,0.00022493715,0.0007218797,0.0002564498],"category_scores_gemma":[0.005974112,0.00021313001,0.0008089081,0.00042415707,0.00042438888,0.0001430286,0.00011811209,0.001420172,0.0000039687866],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2552202,0.022360882,0.15998185,0.00017847081,0.0014840282,0.00090348657,0.000119486926,0.000087077984,0.000014029452,0.0004772472,0.0044170762,0.55475616],"study_design_scores_gemma":[0.5100984,0.04830107,0.2222376,0.0010531176,0.0014204658,0.00004977587,0.00006630303,0.00026874756,0.000067116736,0.0008008714,0.21546428,0.00017222817],"about_ca_topic_score_codex":0.00023588882,"about_ca_topic_score_gemma":0.001913104,"teacher_disagreement_score":0.55458397,"about_ca_system_score_codex":0.00036264336,"about_ca_system_score_gemma":0.0033104613,"threshold_uncertainty_score":0.869119},"labels":[],"label_agreement":null},{"id":"W4411049391","doi":"10.1016/j.ygyno.2025.05.013","title":"Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Calgary; Alberta Health Services; University of British Columbia; Alberta Health; BC Cancer Agency; Foothills Medical Centre","funders":"Medical Research and Materiel Command; European Social Fund; National Center for Advancing Translational Sciences; National Cancer Institute; Cancer Research UK Cambridge Institute, University of Cambridge; Instituto de Salud Carlos III; National Health and Medical Research Council; National Institutes of Health; Peter MacCallum Foundation; National Center for Research Resources; BC Cancer Foundation; Deutsches Krebsforschungszentrum; Pomorski Uniwersytet Medyczny W Szczecinie; European Regional Development Fund; Swedish Cancer Foundation; Bundesministerium für Bildung und Forschung; Canadian Institutes of Health Research; Cancer Institute NSW; Ministry of Higher Education, Malaysia; Fred C. and Katherine B. Andersen Foundation; VGH and UBC Hospital Foundation; Ministerio de Ciencia, Innovación y Universidades; U.S. Department of Defense; Universitätsbund Erlangen-Nürnberg; Ministerio de Economía y Competitividad; University of Cambridge; University of Pittsburgh; Mayo Foundation for Medical Education and Research; Kræftens Bekæmpelse; Cancer Research UK; American Cancer Society; Minnesota Ovarian Cancer Alliance; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Ovarian Cancer Research Fund; Ovarian Cancer Australia; European Commission","keywords":"Medicine; Oncology; Internal medicine; Estrogen receptor; Ovarian cancer; Odds ratio; Proportional hazards model; Cancer; Endocrinology; Gynecology; Breast cancer","score_opus":0.015697954783322778,"score_gpt":0.32793359437747827,"score_spread":0.3122356395941555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411049391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97789705,0.0023450134,0.0009989755,0.013345161,0.0010970103,0.0016828743,0.0006258237,0.00018347603,0.0018245911],"genre_scores_gemma":[0.98749495,0.0016647343,0.0037864237,0.0034633777,0.0003547657,0.0014077312,0.00017454183,0.000037515903,0.0016159822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497294,0.0010159198,0.0010547068,0.0016098575,0.00041938626,0.00092718797],"domain_scores_gemma":[0.9958395,0.0014747164,0.00086546066,0.0007158891,0.00042174305,0.0006827248],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001581268,0.00059326034,0.002484884,0.0012013844,0.0005668451,0.0001513953,0.00020319918,0.000500058,0.0022234542],"category_scores_gemma":[0.0010069044,0.0005157989,0.00029350785,0.0030705302,0.00017081473,0.00019819863,0.0002743033,0.00054786564,0.000016169795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007080472,0.00076893496,0.9505009,0.000042930893,0.01348136,0.00024470285,0.0005116686,0.00035643918,0.0033693414,0.0002437263,0.0021304549,0.027641496],"study_design_scores_gemma":[0.0056912615,0.0013182479,0.9359797,0.000043823704,0.033782102,0.000009566748,0.0013803851,0.00075095455,0.0015932806,0.000120734505,0.018817646,0.0005122645],"about_ca_topic_score_codex":0.008982564,"about_ca_topic_score_gemma":0.012371819,"teacher_disagreement_score":0.027129231,"about_ca_system_score_codex":0.0024353757,"about_ca_system_score_gemma":0.0010135707,"threshold_uncertainty_score":0.99972934},"labels":[],"label_agreement":null},{"id":"W4411132246","doi":"10.1007/978-981-97-4822-8_69","title":"Normal Structure and Function, Inflammatory and Other Miscellaneous Lesions of the Ovary","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Ovary; Function (biology); Pathology; Medicine; Biology; Internal medicine; Cell biology","score_opus":0.008717359823323261,"score_gpt":0.2101422919989588,"score_spread":0.20142493217563556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411132246","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053367247,0.0055875154,0.0000025649947,0.0010080575,0.00024730823,0.00052568404,0.00015501253,0.000020989899,0.98711616],"genre_scores_gemma":[0.07018996,0.0007048397,0.00010688541,0.0014251418,0.00015886418,0.000005957025,0.0000132574905,0.000026706053,0.9273684],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947023,0.000005622223,0.00015932071,0.00018554689,0.000111295,0.000067980734],"domain_scores_gemma":[0.9995467,0.000043813227,0.00007142805,0.00025059088,0.000037891736,0.000049562397],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00002034631,0.00016194898,0.00024223213,0.00004391203,0.000049451643,0.000006353831,0.000028407418,0.00017675184,0.0021989734],"category_scores_gemma":[0.0000036484369,0.00009181273,0.000059947786,0.0000085528545,0.00009806834,0.0000042238344,0.000055089415,0.00014687487,0.000002161305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077273673,0.00015067238,0.14834705,0.002834148,0.0043950174,0.00019103213,0.00040002595,0.0000068984327,0.00023319623,0.44446465,0.27955773,0.118646845],"study_design_scores_gemma":[0.0012379191,0.0001898379,0.041667115,0.0007592918,0.0011513069,0.00012732926,0.000015045971,0.0000038993203,0.00027240545,0.0029763263,0.9514457,0.0001538518],"about_ca_topic_score_codex":0.000053730382,"about_ca_topic_score_gemma":0.00017320224,"teacher_disagreement_score":0.67188793,"about_ca_system_score_codex":0.000022314645,"about_ca_system_score_gemma":0.000107042826,"threshold_uncertainty_score":0.99871314},"labels":[],"label_agreement":null},{"id":"W4411132263","doi":"10.1007/978-981-97-4822-8_68","title":"Benign Tumor-Like Lesions of the Ovary","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Ovary; Medicine; Pathology; Internal medicine","score_opus":0.02177520645250627,"score_gpt":0.2580599801610548,"score_spread":0.23628477370854853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411132263","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040217692,0.0016689794,0.000010195248,0.0035916963,0.00042685328,0.000522739,0.0000818166,0.000026131704,0.99363136],"genre_scores_gemma":[0.014702406,0.0005584372,0.0003369257,0.0022964939,0.00012155981,0.000023254055,0.00002717721,0.000024982653,0.98190874],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000006178713,0.00025667882,0.00024758687,0.00023394254,0.00010467898],"domain_scores_gemma":[0.9990088,0.00007611293,0.00010660514,0.00067669986,0.00007483309,0.00005698092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004118584,0.00019816535,0.00041623495,0.000072939896,0.000044884186,0.0000042302177,0.000104248255,0.0001239041,0.0032213235],"category_scores_gemma":[0.000008816353,0.00011076934,0.00033920986,0.000029726072,0.00006912068,0.000008962734,0.000098248696,0.00019698829,0.000046499794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049733015,0.00018939658,0.0014501775,0.00025425394,0.00090469513,0.00009716879,0.000032097436,8.949265e-7,0.000012596483,0.63086134,0.3497865,0.016361171],"study_design_scores_gemma":[0.0011164994,0.00018934182,0.00880077,0.0021789127,0.00141106,0.000026879321,0.00001107882,0.0000034034626,0.0005432288,0.0058793565,0.9796736,0.00016587217],"about_ca_topic_score_codex":0.000070300164,"about_ca_topic_score_gemma":0.000054886674,"teacher_disagreement_score":0.6298871,"about_ca_system_score_codex":0.00010081719,"about_ca_system_score_gemma":0.00040391667,"threshold_uncertainty_score":0.99768984},"labels":[],"label_agreement":null},{"id":"W4411135651","doi":"10.1016/j.esmoop.2025.105125","title":"Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation Medicine; Bayer Yakuhin; MSD K.K.; Chugai Pharmaceutical; Pfizer Japan; EMD Serono; AstraZeneca; Genentech; Council of Scientific and Industrial Research, India; Sierra Oncology; Sanofi K.K.; INCLIVA Instituto de Investigación Sanitaria; Exelixis; International Atomic Energy Agency; PharmaMar; Daiichi Sankyo Europe; Takeda Oncology; European Society for Medical Oncology; Novocure; Seoul National University; Indian Council of Medical Research; Intas Pharmaceuticals; Seagen; European SocieTy for Radiotherapy and Oncology; Glenmark Pharmaceuticals; The Wellcome Trust DBT India Alliance; Seoul National University Hospital; MacroGenics; Sociedad Española de Oncología Médica; BeiGene; Actuate Therapeutics; Ribon Therapeutics; Sysmex Corporation; Mersana Therapeutics; Amgen; Astellas Pharma; Deciphera Pharmaceuticals; Clovis Oncology; Natera; Regeneron Pharmaceuticals; Boehringer Ingelheim Japan; Gilead Sciences; Taiho Pharmaceutical; EQRx; F. Hoffmann-La Roche; Servier; Eisai; FibroGen; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb; American Society of Clinical Oncology; Hellenic Society of Medical Oncology; Sanofi; Pfizer; Celgene","keywords":"Guideline; Reimbursement; Medicine; Family medicine; China; Political science; Health care; Pathology","score_opus":0.030895119361079686,"score_gpt":0.37895786669597414,"score_spread":0.34806274733489445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411135651","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24326946,0.0059562456,0.024660708,0.56086475,0.0058535812,0.06452526,0.0017661875,0.00022068842,0.092883125],"genre_scores_gemma":[0.8808282,0.0034900547,0.09897867,0.010982304,0.00023989017,0.0024826387,0.00021630233,0.000060789374,0.0027211236],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984342,0.00007568696,0.0006342866,0.00041657023,0.00023778158,0.00020148748],"domain_scores_gemma":[0.99804187,0.0007255762,0.00028733947,0.0005291925,0.00033430159,0.00008174606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007028862,0.0001806599,0.0004459712,0.00004156962,0.00013047263,0.000050962142,0.00023773682,0.00007899224,0.00013686021],"category_scores_gemma":[0.00017335979,0.00010670702,0.000077275996,0.0002085364,0.00008746005,0.00013166058,0.0002023685,0.00013148847,0.0000029184143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013933662,0.0035364055,0.285173,0.0002496154,0.0077813887,0.00010298196,0.00025980748,0.000052206055,9.993838e-7,0.014044613,0.099671416,0.5751939],"study_design_scores_gemma":[0.0207923,0.0006604188,0.5936188,0.00038851943,0.002038368,7.460461e-7,0.00020128791,0.00010397935,0.00004214995,0.00008373644,0.38198128,0.00008842259],"about_ca_topic_score_codex":0.0040057637,"about_ca_topic_score_gemma":0.00061421073,"teacher_disagreement_score":0.63755876,"about_ca_system_score_codex":0.00008245608,"about_ca_system_score_gemma":0.00024335388,"threshold_uncertainty_score":0.6055543},"labels":[],"label_agreement":null},{"id":"W4411223168","doi":"10.1016/j.ijgc.2025.101959","title":"Erratum to ‘Factors influencing surgeons’ decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101640]","year":2025,"lang":"en","type":"erratum","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; General surgery; Cytoreductive surgery; Ovarian cancer; Gynecology; Cancer; Internal medicine","score_opus":0.03772306682926509,"score_gpt":0.36327811029964974,"score_spread":0.32555504347038466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411223168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7310294,0.017516041,0.0011042475,0.09400099,0.14731593,0.0027538617,0.004153845,0.000055297398,0.0020703794],"genre_scores_gemma":[0.9559955,0.022752587,0.0012454472,0.004514131,0.005484723,0.0006359247,0.00028508616,0.00008905334,0.008997523],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99438745,0.00021728541,0.0024858075,0.00067511824,0.001629472,0.0006048858],"domain_scores_gemma":[0.987414,0.003172381,0.002860554,0.00020991484,0.005869847,0.00047328157],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012003821,0.00060960144,0.001989081,0.001440245,0.00016482442,0.0002032705,0.0008882111,0.0007995006,0.002577148],"category_scores_gemma":[0.006640906,0.0004674391,0.00082729576,0.0005358953,0.00017413795,0.00039167213,0.00033313988,0.0015606512,0.0000033108718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015147672,0.0010127901,0.4582284,0.000056652458,0.0034486207,0.0003616211,0.00043783063,0.0009874984,0.00007808675,0.000044510696,0.5028542,0.030974954],"study_design_scores_gemma":[0.0034276473,0.00056821224,0.8275738,0.0041309455,0.00070655526,0.00005497839,0.00025616869,0.00011115963,0.000102966835,0.00054786383,0.16212937,0.00039037137],"about_ca_topic_score_codex":0.0020204762,"about_ca_topic_score_gemma":0.002954492,"teacher_disagreement_score":0.36934534,"about_ca_system_score_codex":0.0069995006,"about_ca_system_score_gemma":0.0045112018,"threshold_uncertainty_score":0.99977773},"labels":[],"label_agreement":null},{"id":"W4411580660","doi":"10.3390/cancers17132119","title":"Trends in the Incidence of Ovarian Cancer Among Premenopausal and Postmenopausal Women in the United States, 2001 to 2021","year":2025,"lang":"en","type":"article","venue":"Cancers","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Texas Medical Branch; Cancer Prevention and Research Institute of Texas","keywords":"Postmenopausal women; Incidence (geometry); Medicine; Gynecology; Ovarian cancer; Cancer; Obstetrics; Internal medicine","score_opus":0.01659097164656581,"score_gpt":0.3064397431358166,"score_spread":0.2898487714892508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411580660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853422,0.0011593178,0.0000052190917,0.010065092,0.000114591414,0.0005633729,0.000051943076,0.000005309605,0.0026929583],"genre_scores_gemma":[0.9935924,0.0011234164,0.000044007065,0.0039993194,0.000046905596,0.0007554656,0.00003286032,0.000009045367,0.00039657927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987186,0.00012306431,0.00026785134,0.00027278138,0.00023015468,0.0003875216],"domain_scores_gemma":[0.99932283,0.00015025568,0.000062596264,0.00033074,0.000050633455,0.00008293157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005641028,0.00015106646,0.00027949136,0.0003826651,0.00004371137,0.000024999448,0.0001756506,0.0000492075,0.0002445128],"category_scores_gemma":[0.000038570393,0.00009200748,0.000018218414,0.0018339559,0.00010283799,0.000052864572,0.00003896458,0.00017792796,9.146157e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011050315,0.00035615085,0.8756543,0.00016986714,0.00035359713,0.00024406069,0.048743185,0.004483371,0.00043459143,0.001139202,0.023032894,0.04428377],"study_design_scores_gemma":[0.002273219,0.0006723468,0.9759574,0.00043333886,0.0000920359,0.0000036542665,0.004347166,0.0002516356,0.0001364642,0.0001238504,0.015605063,0.00010384509],"about_ca_topic_score_codex":0.04484074,"about_ca_topic_score_gemma":0.018529346,"teacher_disagreement_score":0.1003031,"about_ca_system_score_codex":0.0018408586,"about_ca_system_score_gemma":0.0005568366,"threshold_uncertainty_score":0.99937993},"labels":[],"label_agreement":null},{"id":"W4411624557","doi":"10.3390/immuno5030023","title":"Integrative Transcriptomic Meta-Analysis Reveals Risk Signatures and Immune Infiltration Patterns in High-Grade Serous Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Immuno","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Serous fluid; Ovarian cancer; Transcriptome; Immune system; Infiltration (HVAC); Serous ovarian cancer; Oncology; Medicine; Biology; Pathology; Internal medicine; Cancer; Immunology; Gene; Gene expression; Physics; Genetics","score_opus":0.021054954142398156,"score_gpt":0.3065212374710856,"score_spread":0.28546628332868745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411624557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9348627,0.05483117,0.0009053341,0.007505042,0.00022228505,0.00090563897,0.00036105292,0.00004253083,0.00036425158],"genre_scores_gemma":[0.9939649,0.0038128728,0.0003065684,0.00058183155,0.000025586969,0.0004386222,0.000108124805,0.000014318947,0.00074717816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857074,0.00019072148,0.00047175802,0.00039688766,0.00015765497,0.00021225165],"domain_scores_gemma":[0.9992148,0.00013586161,0.0001445894,0.00038656034,0.00007275645,0.00004539928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002531662,0.0002586385,0.0010969738,0.0004045419,0.00007840361,0.000052853597,0.00008347626,0.00013176184,0.00046804236],"category_scores_gemma":[0.000027973396,0.00018120371,0.0004657715,0.00071476854,0.00004482559,0.000107300206,0.000018455561,0.00033284852,0.0000025759757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093342585,0.0013613573,0.5470267,0.00023713824,0.40344933,0.00012843458,0.0059243394,0.0008012763,0.017495694,0.0044379663,0.00073599664,0.017468363],"study_design_scores_gemma":[0.002649378,0.00012444373,0.8786319,0.00008116003,0.10801878,0.0000017548956,0.00024418067,0.000075371456,0.009120496,0.00069436646,0.00020484148,0.00015333647],"about_ca_topic_score_codex":0.028476993,"about_ca_topic_score_gemma":0.0076380414,"teacher_disagreement_score":0.33160523,"about_ca_system_score_codex":0.0002316806,"about_ca_system_score_gemma":0.00010040562,"threshold_uncertainty_score":0.9779925},"labels":[],"label_agreement":null},{"id":"W4411642994","doi":"10.1016/j.esmoop.2025.105252","title":"126TiP REJOICE-Ovarian02: A phase Ib/II study of raludotatug deruxtecan (R-DXd) with other anticancer agents in participants (pts) with relapsed ovarian cancer (OC) after platinum-based chemotherapy","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Ovarian cancer; Chemotherapy; Medicine; Internal medicine; Oncology; Platinum; Cancer; Chemistry","score_opus":0.050804593430607815,"score_gpt":0.38529900125410677,"score_spread":0.33449440782349893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411642994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876344,0.00015779331,0.00014737867,0.004112077,0.00012715491,0.0049628993,0.00007453483,0.00003934513,0.0027443666],"genre_scores_gemma":[0.9897025,0.000035960893,0.0021199125,0.0033104932,0.00005515234,0.0030654722,0.000017797376,0.00008878268,0.0016039232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716896,0.00016698419,0.0006541358,0.00087834225,0.00050033676,0.0006312469],"domain_scores_gemma":[0.99826556,0.000095725874,0.000286666,0.0009878948,0.00015518583,0.00020897042],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042695118,0.00046113713,0.0010635298,0.00026885435,0.00012674912,0.00007767914,0.00034235272,0.00011931974,0.002266335],"category_scores_gemma":[0.000024506964,0.00032321372,0.00007324802,0.0010078601,0.00013129222,0.00018936372,0.000107083564,0.00027687455,0.0000081071385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026552804,0.013278262,0.93719023,0.00015176901,0.0018454021,0.00043290964,0.0039540823,0.00023457133,0.00010033157,0.000098296,0.00090572215,0.015255591],"study_design_scores_gemma":[0.11915448,0.0059510954,0.8592055,0.0025612295,0.0009791023,0.000004657637,0.00064667827,0.00037468996,0.003339531,0.000039715815,0.0073152357,0.00042811487],"about_ca_topic_score_codex":0.027538445,"about_ca_topic_score_gemma":0.037520118,"teacher_disagreement_score":0.09260168,"about_ca_system_score_codex":0.00042321102,"about_ca_system_score_gemma":0.0011316562,"threshold_uncertainty_score":0.999922},"labels":[],"label_agreement":null},{"id":"W4411643018","doi":"10.1016/j.esmoop.2025.105199","title":"69O Novel regimens for persistent/recurrent rare epithelial ovarian carcinomas (EOCs) selected according to biomarker status: ENGOT-GYN2/GOG-3051/BOUQUET phase II study results","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"Daiichi Sankyo Europe; Defence and Security Accelerator; Takeda Oncology; Genentech; PharmaMar; European Society for Medical Oncology; Eisai; AbbVie; European Commission; Seagen; Merck; Mersana Therapeutics; Amgen; Deciphera Pharmaceuticals; AstraZeneca; Novocure; Regeneron Pharmaceuticals; Sociedad Española de Oncología Médica; Eisai Canada; BeiGene; Clovis Oncology; Pfizer; Incyte; F. Hoffmann-La Roche; Myriad Genetics; Bristol-Myers Squibb; American Society of Clinical Oncology; Vifor Pharma","keywords":"Oncology; Ovarian carcinomas; Biomarker; Ovarian cancer; Internal medicine; Medicine; Phases of clinical research; Epithelial ovarian cancer; Ovarian carcinoma; Biology; Cancer; Toxicity","score_opus":0.06490799290462351,"score_gpt":0.3777180111971781,"score_spread":0.3128100182925546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496871,0.0004531968,0.00063538074,0.017107192,0.0018474282,0.017254328,0.003943006,0.00018050721,0.008891815],"genre_scores_gemma":[0.98862094,0.000036292695,0.003116735,0.0008547226,0.00024428236,0.0019458409,0.00091012235,0.00006783294,0.0042032306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966494,0.00012426254,0.0007580927,0.0012425444,0.00038084638,0.0008448771],"domain_scores_gemma":[0.9975654,0.00026607572,0.00020936584,0.0010079136,0.00048988377,0.00046138835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006838613,0.0004967403,0.00090217433,0.0003816178,0.00060283893,0.00024101538,0.00049187714,0.0001433642,0.0001453068],"category_scores_gemma":[0.0005414166,0.00043124234,0.00027577693,0.0010430749,0.000042643194,0.00021064325,0.00050271983,0.00023840023,0.000028295568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10970753,0.08227001,0.11705568,0.0008365827,0.020127786,0.0008515329,0.043773104,0.00008677586,0.011593086,0.0038624925,0.3043375,0.3054979],"study_design_scores_gemma":[0.19000283,0.028388869,0.24375363,0.0016439089,0.0042620557,0.000038632825,0.014215448,0.00067687547,0.008704289,0.00007192466,0.5068661,0.0013754385],"about_ca_topic_score_codex":0.0051888577,"about_ca_topic_score_gemma":0.0014183805,"teacher_disagreement_score":0.30412248,"about_ca_system_score_codex":0.00085730234,"about_ca_system_score_gemma":0.00097327126,"threshold_uncertainty_score":0.9998139},"labels":[],"label_agreement":null},{"id":"W4411643311","doi":"10.1016/j.esmoop.2025.105200","title":"71O Profiling antibody-drug conjugate (ADC) target expression in high-grade serous ovarian cancer (HGSOC): Opportunities for targeted treatment strategies","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Defence and Security Accelerator; Takeda Oncology; Genentech; BeiGene; Eisai Canada; PharmaMar; European Society for Medical Oncology; Eisai; European Commission; Seagen; AstraZeneca; Novocure; Regeneron Pharmaceuticals; Amgen; Deciphera Pharmaceuticals; Sociedad Española de Oncología Médica; Clovis Oncology; Pfizer; Incyte; F. Hoffmann-La Roche; Mersana Therapeutics; Myriad Genetics; Bristol-Myers Squibb; American Society of Clinical Oncology; Vifor Pharma","keywords":"Serous ovarian cancer; Antibody-drug conjugate; Serous fluid; Ovarian cancer; Medicine; Conjugate; Cancer research; Drug; Antibody; Targeted therapy; Oncology; Monoclonal antibody; Internal medicine; Cancer; Immunology; Pharmacology","score_opus":0.0628592540817787,"score_gpt":0.3691242001253307,"score_spread":0.30626494604355203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411643311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204941,0.0046040607,0.00048484147,0.04121086,0.0018280477,0.012412721,0.0010312379,0.0002402421,0.017693913],"genre_scores_gemma":[0.9760842,0.0019972979,0.0090730805,0.00094798784,0.00016412354,0.0035258536,0.0010414142,0.00005245517,0.0071135927],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817,0.00009581371,0.0004840578,0.00060278614,0.00017686884,0.0004704529],"domain_scores_gemma":[0.99903196,0.00012443858,0.00015231283,0.0004425742,0.00010471221,0.00014397781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023891623,0.00036816875,0.0007675387,0.00018953926,0.00019856617,0.00021645623,0.00024150465,0.00012437695,0.0003360886],"category_scores_gemma":[0.000019288731,0.00028429404,0.000120839046,0.0002181027,0.00006635005,0.00034819974,0.00012755573,0.00013207697,0.0000053704325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012541202,0.016758861,0.61486995,0.004116853,0.0076067047,0.0038474826,0.011832578,0.0039795125,0.04207664,0.15578695,0.061232146,0.06535116],"study_design_scores_gemma":[0.051356636,0.0020574182,0.18450627,0.0055792457,0.0012066648,0.00001806046,0.012913467,0.0011332178,0.5802096,0.011198768,0.14850648,0.0013141448],"about_ca_topic_score_codex":0.014268233,"about_ca_topic_score_gemma":0.0020023196,"teacher_disagreement_score":0.53813297,"about_ca_system_score_codex":0.00056149205,"about_ca_system_score_gemma":0.0013252875,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W4411696784","doi":"10.1002/ijgo.70336","title":"Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); McGill University Health Centre","funders":"","keywords":"Medicine; Chemotherapy; Hazard ratio; Serous fluid; Internal medicine; Stage (stratigraphy); Confidence interval; Ovarian cancer; Surgery; Gastroenterology; Retrospective cohort study; Cancer","score_opus":0.014436570996852567,"score_gpt":0.3342746765366211,"score_spread":0.3198381055397685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411696784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87006813,0.008871799,0.0044690645,0.100550376,0.01456508,0.0006510139,0.000068311114,0.00003100059,0.0007252052],"genre_scores_gemma":[0.97866446,0.003839879,0.010918653,0.0051854616,0.0008769308,0.000055202298,0.000015380743,0.000020547634,0.0004235049],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986892,0.00002975844,0.00059587776,0.00019152599,0.00028513986,0.0002085332],"domain_scores_gemma":[0.9967985,0.0015447682,0.00042745483,0.000123691,0.0010174612,0.00008811467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020111381,0.00015033087,0.00043610073,0.00042959154,0.00006033153,0.00003540138,0.00023663437,0.00012852,0.00018003648],"category_scores_gemma":[0.0011575199,0.00012932517,0.00022038457,0.00028318746,0.000045853387,0.000106264815,0.000029051096,0.0002321727,0.000002203545],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009703962,0.0008188176,0.11866185,0.00008857476,0.003143796,0.00048684192,0.0001901948,0.00034316574,0.0021665413,0.0066657998,0.0037582624,0.86270577],"study_design_scores_gemma":[0.049380474,0.0019497119,0.5042331,0.0012545737,0.0012535077,0.0004846448,0.0003535226,0.00052111695,0.025376556,0.0036581736,0.41109324,0.0004413637],"about_ca_topic_score_codex":0.0000237327,"about_ca_topic_score_gemma":0.000007473708,"teacher_disagreement_score":0.8622644,"about_ca_system_score_codex":0.00094186375,"about_ca_system_score_gemma":0.0005054668,"threshold_uncertainty_score":0.5273727},"labels":[],"label_agreement":null},{"id":"W4411973463","doi":"10.37762/jgmds.12-3.699","title":"Borderline Ovarian Tumors And Fertility-Preserving Surgery - A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Journal of Gandhara Medical and Dental Science","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fertility; Medicine; General surgery; Gynecology; Population","score_opus":0.02800249855474137,"score_gpt":0.36156099508791795,"score_spread":0.3335584965331766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411973463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011305586,0.99711794,0.00001415759,0.00146153,0.0003315055,0.0007796585,0.0000076428005,0.0000065825902,0.00016791928],"genre_scores_gemma":[0.00034170243,0.9981572,0.000076649296,0.0011573052,0.00013213407,0.000028872071,0.0000036616404,0.000008847271,0.00009359645],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961661,0.00016184118,0.0015799723,0.0003584849,0.0014461365,0.00028747323],"domain_scores_gemma":[0.9969632,0.00089292205,0.00078461325,0.00027777266,0.00021971481,0.00086175883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003775151,0.00028877813,0.003599318,0.00034033714,0.00014085318,0.00009021812,0.00031505083,0.0001286529,0.00015408399],"category_scores_gemma":[0.005922527,0.00015388943,0.00042698422,0.00081392896,0.00040948862,0.00018239494,0.00025497773,0.0004740132,0.0000027849612],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000133545855,0.00015172105,0.00028716057,0.85010076,0.00014327948,0.0010683474,0.000009264303,1.6982976e-9,7.671358e-8,0.000017764418,0.0007769084,0.14743134],"study_design_scores_gemma":[0.00037961605,0.00014165134,0.0005928706,0.97472596,0.0034575053,0.0064730095,0.000016533197,0.000006423056,5.4560945e-7,0.000022229333,0.014053089,0.00013054861],"about_ca_topic_score_codex":0.00001772043,"about_ca_topic_score_gemma":0.00000514176,"teacher_disagreement_score":0.1473008,"about_ca_system_score_codex":0.00017068327,"about_ca_system_score_gemma":0.0025300102,"threshold_uncertainty_score":0.70902455},"labels":[],"label_agreement":null},{"id":"W4412091448","doi":"10.3390/curroncol32070390","title":"Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ovarian cancer; Cancer antigen; Chemotherapy; Oncology; Cancer; Internal medicine; Antigen; Immunology","score_opus":0.22051785501909463,"score_gpt":0.5546698384561396,"score_spread":0.334151983437045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412091448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911125,0.012441558,0.00027866723,0.0017059231,0.0010712616,0.0017436924,0.0036232541,0.000006132936,0.000018236648],"genre_scores_gemma":[0.97508603,0.022692354,0.00081836845,0.0002092691,0.00018751984,0.0005818426,0.00039896448,0.000010424582,0.0000152198845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783623,0.00016227036,0.0012722402,0.00048202623,0.00011435698,0.00013285797],"domain_scores_gemma":[0.99706215,0.001526895,0.0006723429,0.00051437045,0.00015298052,0.00007126178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005044945,0.00018249893,0.0015683646,0.00012954576,0.00003381821,0.000005472876,0.00010975852,0.00015257177,0.00014275972],"category_scores_gemma":[0.00013625299,0.00011321915,0.0002635616,0.00022879116,0.00032714603,0.000067213,0.00005704315,0.00012254863,5.127102e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049539175,0.0032557903,0.56605804,0.000056875448,0.007943621,0.0000014383279,0.0006828656,0.0000019923693,0.000011503571,0.000026688987,0.0001253533,0.37229663],"study_design_scores_gemma":[0.20458892,0.0041034655,0.7687753,0.00016909235,0.010976747,1.9415725e-7,0.00028416386,0.0008327041,0.00021456128,0.00006772756,0.009892205,0.000094948395],"about_ca_topic_score_codex":0.0013336464,"about_ca_topic_score_gemma":0.0070290547,"teacher_disagreement_score":0.37220168,"about_ca_system_score_codex":0.0001216967,"about_ca_system_score_gemma":0.0010354621,"threshold_uncertainty_score":0.4616943},"labels":[],"label_agreement":null},{"id":"W4412168452","doi":"10.1097/og9.0000000000000097","title":"Opportunistic Salpingectomy at the Time of Cesarean Delivery","year":2025,"lang":"en","type":"article","venue":"O&G Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Cesarean delivery; Salpingectomy; Obstetrics; Medicine; Pregnancy; Biology","score_opus":0.02829765412791604,"score_gpt":0.31418833446780003,"score_spread":0.285890680339884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412168452","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33100474,0.0018170372,0.000021325366,0.031038558,0.0002654135,0.0019705496,0.000113320755,0.000033510285,0.63373554],"genre_scores_gemma":[0.9487748,0.0002002461,0.0001411499,0.001953219,0.000032446074,0.00007192345,0.00006058871,0.000009589905,0.04875601],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949354,0.000023704191,0.00013808739,0.00015035812,0.00009437849,0.00009995087],"domain_scores_gemma":[0.9993978,0.00009876769,0.00005045651,0.000363169,0.000045868615,0.000043916774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012564282,0.00007302703,0.00020501527,0.00002879846,0.00006849464,0.000021383185,0.0001730569,0.000026547976,0.0019512218],"category_scores_gemma":[0.000018859408,0.000044826116,0.000052459185,0.000114295435,0.000049206807,0.000029968789,0.00024784723,0.000041036386,0.00015079456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097514427,0.0012975681,0.16180795,0.00030736864,0.0021862974,0.0002932994,0.00062431913,0.000008289279,0.0037960846,0.011879297,0.6994361,0.117388226],"study_design_scores_gemma":[0.0071950527,0.00062944007,0.35547736,0.0012492551,0.0017463266,0.00003243371,0.0001987835,0.00016650205,0.018118957,0.0007162265,0.6142279,0.00024175207],"about_ca_topic_score_codex":0.00044067137,"about_ca_topic_score_gemma":0.000060075243,"teacher_disagreement_score":0.6177701,"about_ca_system_score_codex":0.00010934656,"about_ca_system_score_gemma":0.00019724037,"threshold_uncertainty_score":0.99896115},"labels":[],"label_agreement":null},{"id":"W4412523369","doi":"10.1038/s41417-025-00941-5","title":"Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Gene Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Chemistry; U.S. Department of Health and Human Services; National Cancer Institute; RIKEN; Ottawa Hospital Research Institute; University of Wisconsin-Madison","keywords":"Ovarian cancer; Carboplatin; Cisplatin; Biology; Cancer research; Gene expression profiling; Gene expression; Cell culture; Ovarian carcinoma; Cancer; Oncology; Gene; Chemotherapy; Medicine; Genetics","score_opus":0.013458655035499836,"score_gpt":0.2887042849017254,"score_spread":0.2752456298662256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412523369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.867176,0.12917513,0.00002030091,0.0026131421,0.00022926691,0.0005893084,0.000050306247,0.000026943855,0.000119627024],"genre_scores_gemma":[0.9451506,0.05127069,0.00046312693,0.0017395023,0.0001116449,0.00042062436,0.000008498825,0.000028904946,0.0008063695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987121,0.00013271734,0.00024707612,0.00046977398,0.00015335587,0.00028494716],"domain_scores_gemma":[0.9993531,0.00013282322,0.000086970205,0.00025199968,0.00006053726,0.000114558214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017300696,0.00023450672,0.00039044375,0.00018227787,0.00009217639,0.00003207294,0.000060226164,0.00016651103,0.00021750829],"category_scores_gemma":[0.000017815459,0.00019231204,0.00004444541,0.0002934257,0.00006200208,0.000037744434,0.000037980666,0.00017780217,7.299285e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006590524,0.00042285744,0.3603588,0.000071473885,0.0003516509,0.00014395911,0.0013020175,0.00026622773,0.557475,0.000015306387,0.0046054684,0.06839675],"study_design_scores_gemma":[0.007875779,0.0002170812,0.7086759,0.00029453926,0.00006557105,0.0000018758262,0.000029877134,0.0000592344,0.2802541,0.00009046135,0.0022871315,0.00014846137],"about_ca_topic_score_codex":0.0006813718,"about_ca_topic_score_gemma":0.00017620977,"teacher_disagreement_score":0.3483171,"about_ca_system_score_codex":0.00035922928,"about_ca_system_score_gemma":0.00038355836,"threshold_uncertainty_score":0.78422576},"labels":[],"label_agreement":null},{"id":"W4412551337","doi":"10.21203/rs.3.rs-6925656/v1","title":"Immune phenotype in high- versus low-NRF2 high grade serous ovarian cancer and the impact on prognosis","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University of Texas MD Anderson Cancer Center; BC Cancer Agency; Rowan University; Ovarian Cancer Research Alliance; Michael Smith Health Research BC; Cancer Research Institute","keywords":"Serous fluid; Serous ovarian cancer; Phenotype; Ovarian cancer; Immune system; Oncology; Medicine; Internal medicine; Cancer; Biology; Immunology; Gene; Genetics","score_opus":0.056047839873924005,"score_gpt":0.4133201258834911,"score_spread":0.35727228600956706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412551337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357482,0.013069646,0.0000022405638,0.041510813,0.00089277106,0.0060118213,0.00073886453,0.00007521499,0.0019503975],"genre_scores_gemma":[0.98376423,0.011113187,0.000098242876,0.000096076896,0.00047282182,0.0035857474,0.000244634,0.000052722982,0.00057233416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599254,0.0006133338,0.00046681406,0.0009737431,0.0010950601,0.0008584994],"domain_scores_gemma":[0.9967642,0.0013202324,0.00012435003,0.0011727687,0.00036439428,0.0002540845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013209952,0.0004905506,0.0010508639,0.0005708027,0.00022203694,0.00018343478,0.00036322782,0.000411169,0.00037207076],"category_scores_gemma":[0.00031980724,0.00029059322,0.00028564042,0.00077639177,0.00033351753,0.000044734898,0.0007607764,0.0022174786,0.000029884424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.108271874,0.0154553745,0.5026944,0.016873442,0.016125284,0.003028464,0.009850485,0.008194078,0.00009812787,0.06303815,0.025240635,0.23112968],"study_design_scores_gemma":[0.028471569,0.0014540665,0.95753664,0.0076675606,0.00035292382,0.0000028525478,0.0002551564,0.00040964028,0.00056887936,0.0023755708,0.00055048545,0.0003546742],"about_ca_topic_score_codex":0.09733456,"about_ca_topic_score_gemma":0.0014157727,"teacher_disagreement_score":0.4548422,"about_ca_system_score_codex":0.0020274885,"about_ca_system_score_gemma":0.0016711868,"threshold_uncertainty_score":0.99995464},"labels":[],"label_agreement":null},{"id":"W4412581556","doi":"10.1016/j.ygyno.2025.06.016","title":"Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"ImmunoGen; AbbVie","keywords":"Medicine; Pembrolizumab; Ovarian cancer; Conjugate; Folate receptor; Antibody; Drug; Antibody-drug conjugate; Oncology; Internal medicine; Monoclonal antibody; Cancer research; Cancer; Pharmacology; Immunology; Immunotherapy; Cancer cell","score_opus":0.006874718684096245,"score_gpt":0.27977110662065596,"score_spread":0.27289638793655974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412581556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922928,0.0006090045,0.000030935207,0.0033003534,0.00019053648,0.0017439672,0.00005643362,0.000030999297,0.0017449586],"genre_scores_gemma":[0.9971055,0.0004051043,0.0016628599,0.0003706546,0.000014416737,0.00013007264,0.00017388668,0.00002173602,0.000115785835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790376,0.00022942794,0.0006806233,0.00056255114,0.00019735005,0.00042625994],"domain_scores_gemma":[0.9984753,0.00065018516,0.00035757245,0.00022469727,0.00020494884,0.00008727763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003991478,0.0002895909,0.00099862,0.0003316323,0.00007867598,0.000012626209,0.000089545494,0.00020762288,0.00015330658],"category_scores_gemma":[0.0001839131,0.00020939439,0.00003768411,0.00061498734,0.0001908541,0.00009234514,0.00006198866,0.0003021089,0.0000021792032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017509002,0.003957396,0.95371664,0.00019348293,0.00029694528,0.00013209501,0.00058088265,0.00011794273,0.00031663539,0.0013339807,0.00018795657,0.02165707],"study_design_scores_gemma":[0.065836385,0.006054968,0.9250446,0.0005402259,0.00020109197,0.000002270108,0.00013151883,0.00014716567,0.00020023494,0.000099547535,0.0015530126,0.00018900451],"about_ca_topic_score_codex":0.0011839339,"about_ca_topic_score_gemma":0.004109395,"teacher_disagreement_score":0.048327383,"about_ca_system_score_codex":0.0010555548,"about_ca_system_score_gemma":0.00071274396,"threshold_uncertainty_score":0.8538856},"labels":[],"label_agreement":null},{"id":"W4412662535","doi":"10.14740/wjon2595","title":"Development and Validation of KN-DIOC: A Novel Preoperative Diagnostic Index Using Ultrasound, Complete Blood Count, and Cancer Antigen 125 for Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer antigen; Ovarian cancer; Cancer; Transvaginal ultrasound; Ultrasound; Oncology; Internal medicine; Radiology","score_opus":0.04619707355402653,"score_gpt":0.35515393131786926,"score_spread":0.30895685776384274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412662535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854848,0.008769093,0.002269729,0.002215137,0.00038736672,0.00062981324,0.000065113025,0.000003186071,0.00017580076],"genre_scores_gemma":[0.98357546,0.0030236049,0.012580189,0.00048047976,0.00014919769,0.00007426365,0.000005674589,0.000011530356,0.00009962476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896455,0.000037564023,0.0005229489,0.00017323748,0.00013488461,0.00016681857],"domain_scores_gemma":[0.9983298,0.00072934455,0.00041035603,0.00007294031,0.0003694195,0.000088108056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028176064,0.00014064425,0.00057033694,0.00024397232,0.00010043973,0.000017686463,0.000046432775,0.000064412394,0.00004957061],"category_scores_gemma":[0.00012841984,0.00011358686,0.000049099875,0.0001892852,0.00009705022,0.00007391694,0.000025470335,0.00012999219,8.120923e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071124616,0.0008622346,0.95290846,0.00028382844,0.0023002839,0.00003780575,0.0017058396,0.00038074623,0.011263821,0.00071949133,0.00040162128,0.028424643],"study_design_scores_gemma":[0.017614318,0.0009963296,0.88423157,0.0018586898,0.002069159,0.0002645694,0.0003363278,0.0001778936,0.022086233,0.00011975995,0.07005726,0.00018787195],"about_ca_topic_score_codex":0.00026887454,"about_ca_topic_score_gemma":0.001263809,"teacher_disagreement_score":0.069655634,"about_ca_system_score_codex":0.00042266634,"about_ca_system_score_gemma":0.0014724946,"threshold_uncertainty_score":0.46319377},"labels":[],"label_agreement":null},{"id":"W4412694569","doi":"10.3390/curroncol32080422","title":"The -124C&gt;T Mutation of the TERT Promoter Indicates Favorable Prognosis in Ovarian Clear Cell Carcinoma: A Single Institutional Study in China","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sanger sequencing; Medicine; Cancer research; ARID1A; Mutation; Tissue microarray; Exon; Oncology; Clear cell; Clear cell carcinoma; Immunohistochemistry; SNP; Proportional hazards model; Carcinoma; Internal medicine; Single-nucleotide polymorphism; Gene; Biology; Genetics; Genotype","score_opus":0.04176157569822255,"score_gpt":0.3432823010662997,"score_spread":0.30152072536807717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412694569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965967,0.001102942,0.0000080338405,0.004684863,0.000590587,0.0018928986,0.000005942657,0.000007268775,0.0020478123],"genre_scores_gemma":[0.999267,0.000030608775,0.0000454911,0.000038765498,0.000036981153,0.0005074632,0.000010853706,0.0000063297634,0.000056520486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880624,0.00020124463,0.00037812485,0.000252178,0.00015864825,0.00020355744],"domain_scores_gemma":[0.99948996,0.00010947185,0.0001300726,0.00019173516,0.00004890896,0.000029836274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033954947,0.00011876901,0.00026433135,0.00015666093,0.000105841085,0.000013343866,0.00013746246,0.00006902303,0.000016937982],"category_scores_gemma":[0.00007236825,0.00006933036,0.000059434646,0.0005035393,0.00014073671,0.000040758867,0.00008961223,0.00024588066,0.0000039754113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018900823,0.010070284,0.9650646,0.00009017416,0.00003481641,0.000035945824,0.0020278848,0.000018787752,0.00012608148,0.00039994414,0.00022771515,0.021714775],"study_design_scores_gemma":[0.004850118,0.0012543598,0.987357,0.00016054382,0.00010146081,0.000007478417,0.00037723343,0.00011857831,0.0020986246,0.00021731823,0.0034034646,0.000053797787],"about_ca_topic_score_codex":0.00023923532,"about_ca_topic_score_gemma":0.0008083307,"teacher_disagreement_score":0.022292439,"about_ca_system_score_codex":0.0006344179,"about_ca_system_score_gemma":0.00064249255,"threshold_uncertainty_score":0.28272098},"labels":[],"label_agreement":null},{"id":"W4412726056","doi":"10.1002/jso.70055","title":"Surgery in Ovarian Cancer—Brazilian Society of Surgical Oncology Consensus","year":2025,"lang":"en","type":"review","venue":"Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Consensus conference; Ovarian cancer; General surgery; Cytoreductive surgery; Chemotherapy; Multidisciplinary approach; Multidisciplinary team; Epithelial ovarian cancer; Oncology; Cancer; Internal medicine; Surgery; Nursing","score_opus":0.07230938992704508,"score_gpt":0.4187224895047202,"score_spread":0.3464130995776751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412726056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081645696,0.9708285,0.0000017335811,0.017048499,0.0020037882,0.00072934484,0.000104893246,0.000010392669,0.009191251],"genre_scores_gemma":[0.00017165311,0.99708116,0.00055983657,0.00024696544,0.0011829763,0.00009314911,0.000036254267,0.000045926063,0.00058209366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99318546,0.001177988,0.0038872228,0.0005352689,0.0005491988,0.00066488667],"domain_scores_gemma":[0.9861681,0.009617909,0.0028604162,0.000385013,0.0004736951,0.0004948811],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002345013,0.00061562593,0.010000849,0.0007506427,0.00005023395,0.000011340161,0.00028131442,0.0017629052,0.0010928181],"category_scores_gemma":[0.00009807588,0.00042957708,0.00378355,0.0010655818,0.00045143813,0.00004246328,0.00013629404,0.0019369499,0.000011185371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008582523,0.0026319842,0.0008141159,0.010081059,0.0021514813,0.025049033,0.000057982852,0.000003745275,2.631946e-7,0.00032938478,0.042589784,0.91543293],"study_design_scores_gemma":[0.006001049,0.0015008266,0.00012254137,0.022980591,0.003305448,0.009284672,0.000044443666,0.0000016572045,0.0000029221972,0.00004714814,0.9564438,0.00026491904],"about_ca_topic_score_codex":0.00021328172,"about_ca_topic_score_gemma":0.00009716707,"teacher_disagreement_score":0.915168,"about_ca_system_score_codex":0.0036264583,"about_ca_system_score_gemma":0.0184238,"threshold_uncertainty_score":0.9998203},"labels":[],"label_agreement":null},{"id":"W4412755721","doi":"10.3390/curroncol32080429","title":"Synchronous Ovarian Sertoli–Leydig Cell and Clear Cell Papillary Renal Cell Tumors: A Rare Case Without Mutations in Cancer-Associated Genes","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gene; Cell; Clear cell; Cancer research; Leydig cell; Sertoli cell; Ovarian cancer; Pathology; Internal medicine; Biology; Cancer; Hormone; Genetics; Spermatogenesis; Carcinoma; Luteinizing hormone","score_opus":0.037254185991886964,"score_gpt":0.35894048341928175,"score_spread":0.3216862974273948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412755721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678179,0.023865711,0.000025094401,0.0018750721,0.00071806717,0.00096759875,0.00012056064,0.000063561245,0.0045464537],"genre_scores_gemma":[0.99469686,0.0035778203,0.00026248096,0.0002821096,0.00014516484,0.00038202974,0.00012292166,0.000029648194,0.000500941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982222,0.00018694345,0.00046399885,0.0005502544,0.00013121364,0.00044539018],"domain_scores_gemma":[0.9990375,0.00018450123,0.00019068667,0.00026284918,0.0001237165,0.00020071767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001516608,0.00028136582,0.0006392108,0.00026248582,0.00015718146,0.000027377824,0.00007875051,0.00020015174,0.00017282853],"category_scores_gemma":[0.000028151171,0.00026085897,0.00009223405,0.00040765357,0.00010940673,0.000060305658,0.00008596049,0.00036249266,0.000017979806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008089917,0.012877454,0.7947183,0.0019730343,0.00033830028,0.014942599,0.004837935,0.00026149323,0.0017065328,0.00014650708,0.011138096,0.15625076],"study_design_scores_gemma":[0.10691985,0.013222104,0.48811224,0.005752081,0.0068254876,0.002991766,0.009362563,0.009017142,0.038828347,0.00088415435,0.31523213,0.002852139],"about_ca_topic_score_codex":0.001349701,"about_ca_topic_score_gemma":0.0025740073,"teacher_disagreement_score":0.30660605,"about_ca_system_score_codex":0.0011677094,"about_ca_system_score_gemma":0.0012475627,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W4413270518","doi":"10.1016/j.jogc.2025.103071","title":"Evaluation of the Performance of the IOTA ADNEX Model in Discriminating Adnexal Masses Preoperatively: An Ambispective Study","year":2025,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Traditional medicine","score_opus":0.02824851986705434,"score_gpt":0.3002415737014345,"score_spread":0.27199305383438016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628747,0.0010510687,0.0000020072764,0.0004913142,0.0011452965,0.0004379455,0.0000075915486,3.0932452e-7,0.0005770111],"genre_scores_gemma":[0.99976146,0.000038574628,0.00006266329,0.000078573714,0.0000056885874,0.000010137998,1.989711e-7,0.0000034457007,0.000039227092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876666,0.00019096074,0.00038077807,0.00009497308,0.00047693352,0.00008971821],"domain_scores_gemma":[0.9984171,0.00039619813,0.00033420196,0.0001440958,0.00067741744,0.00003097953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066696154,0.0000760474,0.0002705168,0.000108630265,0.000069535236,0.000005329643,0.00011044081,0.000035530167,0.000022204895],"category_scores_gemma":[0.0015542328,0.00004075864,0.00003746334,0.00039597577,0.00005033183,0.000044116132,0.000047872334,0.00018619315,6.4423613e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009908427,0.00055286137,0.97134686,0.00003324592,0.00017374221,0.000010203287,0.00109657,0.007811807,0.00002996735,0.00009540931,0.000042111842,0.018797299],"study_design_scores_gemma":[0.0029358624,0.0006342243,0.9671265,0.000045302513,0.0005253157,0.000002800283,0.0025406734,0.025564546,0.0005165172,0.00007108236,0.000006443506,0.000030758307],"about_ca_topic_score_codex":0.008406032,"about_ca_topic_score_gemma":0.07896546,"teacher_disagreement_score":0.07055943,"about_ca_system_score_codex":0.0011739939,"about_ca_system_score_gemma":0.003849829,"threshold_uncertainty_score":0.9981971},"labels":[],"label_agreement":null},{"id":"W4413279030","doi":"10.24124/2025/30534","title":"Ovarian torsion: Factors impacting diagnosis","year":2025,"lang":"en","type":"dissertation","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Toronto","funders":"","keywords":"Ovarian torsion; Torsion (gastropod); Medicine; Pathology; Anatomy","score_opus":0.02574113244783227,"score_gpt":0.32367766423914873,"score_spread":0.29793653179131646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413279030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53347266,0.002566439,0.000008963722,0.0018991188,0.0038336797,0.0014897605,0.00008271625,0.00028432842,0.45636234],"genre_scores_gemma":[0.9145685,0.0013229761,0.00052387983,0.000424099,0.00041002975,0.0003974087,0.0034126241,0.000059406924,0.07888108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984896,0.000020579391,0.00035202404,0.00049404707,0.00030778098,0.00033597252],"domain_scores_gemma":[0.9989266,0.00015644523,0.00015060198,0.0004193449,0.0001479556,0.00019904267],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007041169,0.00038869207,0.0006315609,0.0002469581,0.00016892227,0.000055187928,0.00008154462,0.00037792104,0.005181747],"category_scores_gemma":[0.00013744789,0.00028862304,0.00035593694,0.0002700141,0.0000064537485,0.00005826114,0.000019022536,0.00029479092,0.000058917347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005886272,0.0021350305,0.7060549,0.0024077594,0.003688507,0.00035066248,0.0036802576,0.0000022462186,0.000086900975,0.004398057,0.153174,0.12343303],"study_design_scores_gemma":[0.0034624778,0.00075140916,0.8439568,0.004149023,0.0037324838,0.0000093992885,0.007387413,0.00001307747,0.04109998,0.00015968522,0.09441813,0.0008600736],"about_ca_topic_score_codex":0.0019452962,"about_ca_topic_score_gemma":0.0011311577,"teacher_disagreement_score":0.38109583,"about_ca_system_score_codex":0.00045737284,"about_ca_system_score_gemma":0.0005222914,"threshold_uncertainty_score":0.9999566},"labels":[],"label_agreement":null},{"id":"W4413774700","doi":"10.1200/po-24-00505","title":"Therapeutic Outcomes and Biomarker Potential of <i>CDKL3</i> of Neoadjuvant Chemotherapy in Patients With Stage IIIC Versus Stage IV Epithelial Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Stage (stratigraphy); Oncology; Medicine; Chemotherapy; Epithelial ovarian cancer; Internal medicine; Ovarian cancer; Biomarker; Neoadjuvant therapy; Cancer research; Cancer; Breast cancer; Biology","score_opus":0.017229505671301132,"score_gpt":0.3313117407260863,"score_spread":0.31408223505478516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413774700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447125,0.0006264871,0.0001856081,0.0022412846,0.00057557813,0.0009445271,0.00012315519,0.000011643775,0.00082044833],"genre_scores_gemma":[0.99753463,0.00062746066,0.00061190705,0.0004962522,0.000017286518,0.000070693604,0.000016062846,0.000018909734,0.00060680247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858195,0.00010065921,0.00048805733,0.0003474995,0.00026290803,0.00021895632],"domain_scores_gemma":[0.9989443,0.0002821783,0.00024718887,0.00032291588,0.00013686575,0.00006656053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020979016,0.00019649173,0.0007468164,0.00024865588,0.00002918225,0.0000059577696,0.000091147755,0.00016778633,0.00035731384],"category_scores_gemma":[0.000027249693,0.00013220028,0.00008367183,0.00025723624,0.00014159459,0.000050959483,0.00005621527,0.00012327984,0.0000014220102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018078467,0.0017677539,0.6668163,0.00007809312,0.0006110499,0.000021440823,0.00023250715,0.000026530724,0.001040398,0.00021680766,0.00010874848,0.31100193],"study_design_scores_gemma":[0.048058927,0.0027055528,0.93888766,0.00015609729,0.00020331967,4.7156615e-7,0.000073964824,0.000070138725,0.0019320768,0.000053082123,0.00775907,0.00009966147],"about_ca_topic_score_codex":0.0006037057,"about_ca_topic_score_gemma":0.00033224656,"teacher_disagreement_score":0.31090227,"about_ca_system_score_codex":0.0002620783,"about_ca_system_score_gemma":0.00039267266,"threshold_uncertainty_score":0.53909713},"labels":[],"label_agreement":null},{"id":"W4414006879","doi":"10.1016/j.bulcan.2025.04.016","title":"Ovarian mature teratomas: Differences in management and outcomes in adolescents cared for by gynecologic and pediatric surgeons","year":2025,"lang":"en","type":"article","venue":"Bulletin du Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Gynecology; Intensive care medicine; Pediatrics","score_opus":0.007447683583624054,"score_gpt":0.2496508107231424,"score_spread":0.24220312713951836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414006879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970464,0.010296709,0.000011652604,0.017174406,0.00025935695,0.0013360205,0.00008150312,0.000021109148,0.0003552249],"genre_scores_gemma":[0.99020916,0.0062298914,0.00017178775,0.0011456739,0.00002427673,0.00096679386,0.000010208739,0.000009414232,0.0012327723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990989,0.000027885653,0.00020994399,0.00035214855,0.00008487779,0.00022624641],"domain_scores_gemma":[0.9996763,0.00008588286,0.000043694494,0.000116980125,0.000021245005,0.000055900167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094388524,0.00016090108,0.00036444826,0.00016646237,0.0000413524,0.000030199693,0.00004463305,0.00008662903,0.00010044672],"category_scores_gemma":[0.00002758681,0.00012401986,0.000034490302,0.00015285228,0.000025614949,0.000012392973,0.000052045052,0.00008809287,0.0000012360534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111236826,0.0002844278,0.9780457,0.00057781965,0.000061639585,0.000039083567,0.00007702126,4.516687e-7,0.0000011331227,0.00014741687,0.016222727,0.004431352],"study_design_scores_gemma":[0.0051098918,0.00006741524,0.9805049,0.00037198846,0.00013623101,9.982232e-7,0.000100685946,0.000010833074,0.000009023059,0.000066605215,0.013516108,0.00010533536],"about_ca_topic_score_codex":0.0005866058,"about_ca_topic_score_gemma":0.0005501949,"teacher_disagreement_score":0.019745164,"about_ca_system_score_codex":0.0001518849,"about_ca_system_score_gemma":0.000038743223,"threshold_uncertainty_score":0.5057383},"labels":[],"label_agreement":null},{"id":"W4414090869","doi":"10.3390/curroncol32090504","title":"Ten-Year Real-World Outcomes and Clinicopathologic Predictors of Recurrence in Adult Granulosa Cell Tumors: A Turkish Single-Center Experience","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Ege Üniversitesi","keywords":"Proportional hazards model; Disease; Multivariate analysis; Stage (stratigraphy); Retrospective cohort study; Univariate analysis; Cohort; Granulosa cell; Adjuvant therapy","score_opus":0.06474453284894321,"score_gpt":0.3917794801240175,"score_spread":0.32703494727507426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414090869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973936,0.0010200731,0.000009585404,0.0010611373,0.001494908,0.0007112301,0.00004217804,0.00003384772,0.0058876984],"genre_scores_gemma":[0.9969409,0.0019947714,0.0003334063,0.00023849944,0.000063445776,0.0002403754,0.000025999616,0.000009583551,0.00015298404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982372,0.00014290173,0.0006566541,0.00050431216,0.000152859,0.00030607558],"domain_scores_gemma":[0.99893385,0.00030383433,0.00021386932,0.00031094725,0.0001265623,0.00011093382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002018459,0.0002128479,0.00073359295,0.0002989274,0.000032067855,0.000009143289,0.00012000558,0.00010677198,0.000048040692],"category_scores_gemma":[0.00020995225,0.00016626329,0.00010372925,0.000394127,0.0002778368,0.000056611498,0.000114145485,0.00027318014,0.000005405264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020514996,0.003451084,0.9727988,0.00023148759,0.000019560648,0.00006283476,0.00081520353,3.3105934e-7,0.000041197098,0.0003072788,0.0010412729,0.021025775],"study_design_scores_gemma":[0.0067108585,0.0012707807,0.9825714,0.0009253332,0.00010632313,0.000009582005,0.00045183251,0.000017596069,0.0006272778,0.00012478215,0.007052122,0.00013207592],"about_ca_topic_score_codex":0.00007541917,"about_ca_topic_score_gemma":0.00027031847,"teacher_disagreement_score":0.020893699,"about_ca_system_score_codex":0.000306398,"about_ca_system_score_gemma":0.00022081882,"threshold_uncertainty_score":0.678002},"labels":[],"label_agreement":null},{"id":"W4414130786","doi":"10.1016/j.canep.2025.102903","title":"Chemotherapy use in ovarian cancer patients diagnosed 2012–2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study","year":2025,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Cancer Care Nova Scotia; CancerCare Manitoba; Cancer Care Ontario; Canadian Partnership Against Cancer","funders":"Cancer Council Victoria; Public Health Agency; Cancer Society of New Zealand; Cancer Institute NSW; Cancer Research UK; Public Health Wales; Kreftforeningen; Kræftens Bekæmpelse; Department of Health, Government of Western Australia; Partenariat Canadien Contre Le Cancer; National Cancer Registry Ireland","keywords":"Benchmarking; Chemotherapy; General partnership; Ovarian cancer; Cancer; Work (physics)","score_opus":0.08398817691433631,"score_gpt":0.39926390868035083,"score_spread":0.31527573176601453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414130786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979681,0.0015384997,0.00000890946,0.015773604,0.0013200847,0.0015037715,0.00011443838,0.0000085016,0.000051184477],"genre_scores_gemma":[0.9868938,0.0008837207,0.00006579729,0.008948279,0.0002753476,0.0023470288,0.00012518623,0.000019185265,0.00044167953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973402,0.0005578301,0.00074601645,0.0006876522,0.00018411977,0.00048416745],"domain_scores_gemma":[0.9976066,0.0014586333,0.00027623278,0.00039920228,0.000119206205,0.00014015843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008059259,0.00029440178,0.00082635134,0.0002092846,0.000088422006,0.000021764194,0.00019666507,0.00015057319,0.00081294746],"category_scores_gemma":[0.00033866276,0.00021731887,0.00006657752,0.00027167078,0.00010354224,0.00014215859,0.000036964793,0.00035191877,6.860737e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087819045,0.00041725297,0.98711944,0.000030290736,0.00024529733,0.00002616591,0.00036847792,0.0023026345,0.0000014609686,0.00029585476,0.0037984878,0.0045164586],"study_design_scores_gemma":[0.014566881,0.00011016254,0.98142755,0.00034329022,0.000120342804,2.7716618e-7,0.00006249513,0.0008407388,0.00000959501,0.00014411853,0.0021948467,0.0001797127],"about_ca_topic_score_codex":0.95524913,"about_ca_topic_score_gemma":0.98560286,"teacher_disagreement_score":0.030353695,"about_ca_system_score_codex":0.0020509837,"about_ca_system_score_gemma":0.00097029726,"threshold_uncertainty_score":0.89012045},"labels":[],"label_agreement":null},{"id":"W4414136639","doi":"10.21037/gs-2025-208","title":"The development and validation of a tumor-specific death predictive nomogram in patients with ovarian cancer: a cohort study","year":2025,"lang":"en","type":"article","venue":"Gland Surgery","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nomogram; Cohort study; Ovarian cancer; Cohort; Prognostic model; Retrospective cohort study; MEDLINE","score_opus":0.012331683681547858,"score_gpt":0.24367726132705497,"score_spread":0.23134557764550712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414136639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794006,0.00039141637,0.000019918401,0.00014751097,0.00011195054,0.0010568951,0.000010359943,0.000008989806,0.00031290963],"genre_scores_gemma":[0.9992845,0.00012325284,0.000055153225,0.000023178143,0.000013146882,0.00043052374,0.00002768277,0.0000058812516,0.000036650174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991768,0.000043417665,0.00026076427,0.00019971696,0.00019040584,0.00012887706],"domain_scores_gemma":[0.99945605,0.00019975107,0.00007359693,0.00014947416,0.0000844457,0.00003669186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030619095,0.00009701508,0.00027540754,0.00010421746,0.00007180097,0.00001722521,0.000022695318,0.000019093064,0.000006938689],"category_scores_gemma":[0.000016706355,0.000056387904,0.000021028545,0.00021758922,0.000025436446,0.000027751043,0.000017797052,0.000053532014,3.0888634e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070648483,0.00075609324,0.98057556,0.000022271264,0.0003081444,0.000012082564,0.00041562683,0.000003575719,1.7438072e-7,0.00001930847,0.00015548657,0.017025178],"study_design_scores_gemma":[0.0024447925,0.00014929887,0.9955398,0.00022346326,0.00008396114,4.679557e-7,0.00014263473,0.0000048741867,0.00011167583,0.000008187383,0.0012396475,0.000051211457],"about_ca_topic_score_codex":0.00026938217,"about_ca_topic_score_gemma":0.00025488556,"teacher_disagreement_score":0.016973967,"about_ca_system_score_codex":0.00013956951,"about_ca_system_score_gemma":0.00026035312,"threshold_uncertainty_score":0.2299432},"labels":[],"label_agreement":null},{"id":"W4414349338","doi":"10.1158/1538-7445.ovarian25-b045","title":"Abstract B045: Evaluating the effectiveness of opportunistic salpingectomy (OS) for the prevention of epithelial ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Saskatchewan; University of Ottawa; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Ovarian cancer; Salpingectomy; Fallopian tube; Population; Cohort; Epithelial ovarian cancer; Pathological","score_opus":0.18868059161593437,"score_gpt":0.5167021843933567,"score_spread":0.3280215927774223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414349338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97116625,0.009699777,0.001018924,0.007128874,0.0007973429,0.007033977,0.0003291453,0.000019077466,0.002806633],"genre_scores_gemma":[0.99415237,0.0010253948,0.000068704256,0.00004280303,0.00019488904,0.003971921,0.000012389676,0.000018194223,0.0005133186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818516,0.00037127352,0.00031977298,0.0002772217,0.0005495697,0.00029702505],"domain_scores_gemma":[0.9948353,0.003768934,0.00012693957,0.00046275923,0.00075590005,0.00005016571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048134904,0.00011424974,0.00032103335,0.00011862783,0.00022816026,0.000019510577,0.00021798981,0.000064054395,0.00035211138],"category_scores_gemma":[0.0006441221,0.000063558386,0.00016517848,0.00046728365,0.00026174015,0.000034177992,0.00006954949,0.0002498134,0.0000014239936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013948422,0.0012187252,0.035000227,0.00999933,0.0038788845,0.0000107204805,0.0007545784,0.0009186742,0.27828568,0.026835112,0.0034124204,0.62573725],"study_design_scores_gemma":[0.008809728,0.001466119,0.7642882,0.0072510764,0.0011163994,0.0000019202223,0.00036928063,0.0010741,0.20546074,0.0055846563,0.004431814,0.00014597355],"about_ca_topic_score_codex":0.0029761887,"about_ca_topic_score_gemma":0.0002851092,"teacher_disagreement_score":0.729288,"about_ca_system_score_codex":0.00041267817,"about_ca_system_score_gemma":0.0021557324,"threshold_uncertainty_score":0.44991267},"labels":[],"label_agreement":null},{"id":"W4414355153","doi":"10.1111/his.70002","title":"A 5‐marker immunohistochemical panel of <scp>CK17</scp> , <scp>MEP1A</scp> , <scp>PAX8</scp> , <scp>SMAD4</scp> , and <scp>CDX2</scp> to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Histopathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Ovarian Cancer Research Alliance","keywords":"Immunohistochemistry; Pancreatic ductal adenocarcinoma; Adenocarcinoma; Mucinous carcinoma; Metastatic adenocarcinoma; Pancreatic carcinoma; Metastasis","score_opus":0.01887571482713555,"score_gpt":0.2576507059002718,"score_spread":0.23877499107313624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414355153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92236453,0.044373773,0.00079038483,0.00046835883,0.0027853125,0.0036656472,0.0012222294,0.0005512545,0.023778507],"genre_scores_gemma":[0.9653621,0.0009349299,0.008373065,0.002431758,0.0011056277,0.0017249141,0.0013383637,0.00051969045,0.018209567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98550826,0.0012901108,0.0035789683,0.004369086,0.0016778208,0.0035757592],"domain_scores_gemma":[0.97870684,0.012775802,0.0017735304,0.0037544137,0.0010881551,0.0019012785],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015849202,0.0026759212,0.0054029734,0.0018243385,0.00094109506,0.00025404705,0.0015503545,0.0014375779,0.00008275338],"category_scores_gemma":[0.020562984,0.002690069,0.0013386175,0.0022227573,0.0017693542,0.00039685803,0.0013129995,0.002106914,0.0003799342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012268338,0.005333065,0.69063103,0.002545138,0.0025486648,0.013905953,0.030428005,0.000038079495,0.063449524,0.003343059,0.18586873,0.0017860429],"study_design_scores_gemma":[0.011921359,0.0026807045,0.8566239,0.0011667883,0.007724891,0.0029927858,0.009068096,0.00029894622,0.009527586,0.001834475,0.09590946,0.00025100182],"about_ca_topic_score_codex":0.002944849,"about_ca_topic_score_gemma":0.0002585715,"teacher_disagreement_score":0.16599286,"about_ca_system_score_codex":0.0021488457,"about_ca_system_score_gemma":0.0016689581,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W4414385450","doi":"10.7759/cureus.92910","title":"Human Epidermal Growth Factor Receptor 2 (HER2/Neu)-Positive Ovarian High-Grade Serous Carcinoma Metastasizing to the Breast: A Case Report","year":2025,"lang":"en","type":"article","venue":"Cureus","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Breast cancer; Serous fluid; Human Epidermal Growth Factor Receptor 2; Epidermal growth factor receptor; Ovarian carcinoma; Axillary Lymphadenopathy; Breast carcinoma; Metastasis; Biopsy; Ovarian cancer","score_opus":0.024033990766939132,"score_gpt":0.302114438585083,"score_spread":0.2780804478181439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414385450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93823117,0.0013195028,0.00039169542,0.052789167,0.0011147921,0.0019982764,0.00059809705,0.00016383854,0.0033934687],"genre_scores_gemma":[0.99425244,0.000013459192,0.0012587006,0.0022498076,0.00057681755,0.0002885702,0.000110001965,0.000044541208,0.0012056805],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.997901,0.00014497449,0.00049787964,0.00068094925,0.00029005937,0.00048510008],"domain_scores_gemma":[0.9983572,0.00013261357,0.00015386126,0.00084863935,0.00021100049,0.00029670805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024573682,0.00035456498,0.0005452586,0.00011860234,0.00042219713,0.000083122715,0.0001679355,0.00011841757,0.00050032826],"category_scores_gemma":[0.000105567684,0.0002474095,0.00021934793,0.00042873167,0.000063961874,0.000108557484,0.00013981038,0.00028276132,0.000060589588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007996565,0.0053404556,0.29230422,0.000593664,0.010028283,0.40790606,0.009446093,0.000035155754,0.0045977132,0.040738657,0.19032492,0.037885148],"study_design_scores_gemma":[0.004571796,0.0009394625,0.89539343,0.00042872745,0.002232613,0.06248746,0.000913074,0.000016803915,0.016725289,0.0003753206,0.015288731,0.00062731106],"about_ca_topic_score_codex":0.011203528,"about_ca_topic_score_gemma":0.0011119227,"teacher_disagreement_score":0.6030892,"about_ca_system_score_codex":0.0005907027,"about_ca_system_score_gemma":0.00024897838,"threshold_uncertainty_score":0.9999978},"labels":[],"label_agreement":null},{"id":"W4414465163","doi":"10.1158/2326-6074.cimm25-a004","title":"Abstract A004: Modulating chromatin remodeling as a strategy to reverse immune evasion in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Immune system; Chromatin remodeling; Antigen presentation; Immunotherapy; Chromatin; Immunogenicity; Ovarian cancer; Immune checkpoint; Downregulation and upregulation","score_opus":0.09923062220342622,"score_gpt":0.4569732006418941,"score_spread":0.3577425784384679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477167,0.020092271,0.000026874528,0.020627236,0.00046991976,0.0015440566,0.000020952983,0.000051541356,0.009450459],"genre_scores_gemma":[0.9912883,0.003971721,0.00037729292,0.0006723236,0.00014487919,0.0013876663,0.000018821804,0.000038935894,0.0021000823],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970659,0.00019296538,0.0006290274,0.00075818534,0.00043149455,0.00092242355],"domain_scores_gemma":[0.99834806,0.00024125737,0.00008296857,0.0007454722,0.00044317622,0.00013904869],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011204653,0.00025593757,0.0006011943,0.0008401695,0.00026313777,0.000054162807,0.00028498023,0.00028949245,0.0013808386],"category_scores_gemma":[0.0003096067,0.0002374823,0.000110764915,0.001477603,0.00015353496,0.00012190349,0.00024014355,0.0010534653,0.00013029607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032186094,0.0009488717,0.048619807,0.00063891214,0.0010629809,0.0005266978,0.0018509503,0.007169139,0.50938034,0.0022848507,0.0045733443,0.41972548],"study_design_scores_gemma":[0.009543951,0.0010014636,0.91347873,0.00761502,0.000121534445,0.000029231483,0.0018002415,0.00195319,0.054002795,0.0017697948,0.008218539,0.00046551984],"about_ca_topic_score_codex":0.040764287,"about_ca_topic_score_gemma":0.002044579,"teacher_disagreement_score":0.8648589,"about_ca_system_score_codex":0.0022171529,"about_ca_system_score_gemma":0.002174556,"threshold_uncertainty_score":0.99953204},"labels":[],"label_agreement":null},{"id":"W4414479100","doi":"10.3390/curroncol32100532","title":"A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Adverse effect; Adjuvant; Ovarian cancer; Stimulation; Confidence interval; Antibody; Immunization; Chemotherapy","score_opus":0.03508177806928625,"score_gpt":0.36661655616516287,"score_spread":0.3315347780958766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414479100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958581,0.0008896684,0.00008984225,0.0002370728,0.00026103333,0.0024470056,0.000044935216,0.000023441267,0.00014891944],"genre_scores_gemma":[0.998888,0.00010374769,0.0003027902,0.00002481402,0.000025221883,0.0004282199,0.0001878447,0.000020528147,0.000018833773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998558,0.00012309749,0.00039749942,0.00043206548,0.00026867093,0.00022070762],"domain_scores_gemma":[0.999023,0.00008934588,0.00027902654,0.00027158944,0.00025905733,0.00007794824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109330525,0.00024466938,0.0006111036,0.00031359433,0.000074420626,0.000013515951,0.000060656792,0.00007383005,0.00005779003],"category_scores_gemma":[0.000016766957,0.00016125609,0.000017049413,0.00062561186,0.0000898318,0.00008605746,0.000037598544,0.00019303917,5.9556317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012396137,0.017420538,0.82601494,0.0001457799,0.00040049807,0.000012455289,0.0020071296,0.00012640054,0.000018147493,0.000052013074,0.00010716935,0.1412988],"study_design_scores_gemma":[0.073379725,0.026276594,0.89593107,0.0011966939,0.00064916274,0.0000015680426,0.00045352062,0.00021412435,0.00009920353,0.000005630262,0.0016228538,0.00016987875],"about_ca_topic_score_codex":0.00025680425,"about_ca_topic_score_gemma":0.0023441617,"teacher_disagreement_score":0.14112893,"about_ca_system_score_codex":0.0006805661,"about_ca_system_score_gemma":0.00048112703,"threshold_uncertainty_score":0.65758324},"labels":[],"label_agreement":null},{"id":"W4414572134","doi":"10.1016/j.gore.2025.101960","title":"Tamoxifen for nodal recurrence of serous borderline ovarian tumour − a case report","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology Reports","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"NODAL; Tamoxifen; Serous fluid; Hormonal therapy; Serous ovarian cancer; Hormone","score_opus":0.02297283510597649,"score_gpt":0.35623473902868785,"score_spread":0.3332619039227114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414572134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95288146,0.0010748489,0.0014270262,0.013117077,0.003263336,0.0035354611,0.00005417027,0.00015697294,0.024489626],"genre_scores_gemma":[0.9824535,0.0000681553,0.013161981,0.0009436731,0.00013238711,0.0009299803,0.00013067939,0.000017774313,0.0021618688],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9973396,0.00007962506,0.0012429594,0.0007566269,0.00015604234,0.0004251107],"domain_scores_gemma":[0.9970867,0.00069781474,0.00086512824,0.0007095826,0.0004891129,0.00015167569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010795139,0.00026036802,0.0010202158,0.00018606693,0.00015304665,0.000009719933,0.00007421391,0.0003709555,0.00023436984],"category_scores_gemma":[0.0021773071,0.0002139623,0.00025545995,0.00036403863,0.00017100031,0.00004928395,0.00009277219,0.00022086297,0.0000029739276],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035564965,0.0031750945,0.20198943,0.00033197706,0.0006627942,0.7195155,0.00016353349,0.000024819596,0.00030810217,0.0008890736,0.021554459,0.051029574],"study_design_scores_gemma":[0.0072524953,0.0074193743,0.23970976,0.0002772023,0.0022728695,0.527704,0.00035227998,0.00015241212,0.0042543383,0.006612873,0.20359635,0.00039601116],"about_ca_topic_score_codex":0.00034184876,"about_ca_topic_score_gemma":0.00055578403,"teacher_disagreement_score":0.19181146,"about_ca_system_score_codex":0.0005317311,"about_ca_system_score_gemma":0.0019956382,"threshold_uncertainty_score":0.87251294},"labels":[],"label_agreement":null},{"id":"W4414649692","doi":"10.1016/j.ygyno.2025.04.507","title":"Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: Results from the dose-optimization stage of the REFRαME-O1 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase II/III study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Ovarian cancer; Stage (stratigraphy); Clinical trial; Phases of clinical research; Folate receptor; Cancer; Tumor stage","score_opus":0.016031749350944445,"score_gpt":0.306201884038879,"score_spread":0.29017013468793457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899583,0.0006262612,0.000027274124,0.004091117,0.000290336,0.0034829215,0.00077007536,0.000014179295,0.00073952216],"genre_scores_gemma":[0.99804366,0.0005387778,0.0005924818,0.0002905813,0.000029220117,0.00021159158,0.00011931807,0.000012113707,0.00016226912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767864,0.00041112024,0.0008548352,0.0005488126,0.0002472418,0.00025937735],"domain_scores_gemma":[0.99703336,0.0016322001,0.0005917183,0.00051988836,0.00015525658,0.00006758239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058307295,0.0002534429,0.0007934063,0.00009475236,0.00018841327,0.00000995761,0.00016652238,0.00017907713,0.00013180778],"category_scores_gemma":[0.0005313349,0.00013604488,0.000038309005,0.00043306552,0.000261797,0.000041911506,0.00022257373,0.00029202033,2.3288068e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07748959,0.027738946,0.62160224,0.00014874896,0.0016392835,0.00006396997,0.010276047,0.003069034,0.00013897949,0.0006036971,0.0011575195,0.25607195],"study_design_scores_gemma":[0.09254346,0.012934887,0.8873702,0.00025566595,0.0005388171,4.834927e-7,0.0008177033,0.00028445167,0.0000634814,0.000027978978,0.0050425646,0.00012028913],"about_ca_topic_score_codex":0.0015664119,"about_ca_topic_score_gemma":0.003997779,"teacher_disagreement_score":0.265768,"about_ca_system_score_codex":0.00047584766,"about_ca_system_score_gemma":0.0004985303,"threshold_uncertainty_score":0.55477494},"labels":[],"label_agreement":null},{"id":"W4414649761","doi":"10.1016/j.ygyno.2025.04.300","title":"Comparative efficacy and safety of low-dose versus high-dose bevacizumab in ovarian cancer: A systematic literature review and indirect treatment comparison","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; AstraZeneca (Canada)","funders":"","keywords":"Bevacizumab; Systematic review; Ovarian cancer; Randomized controlled trial; Meta-analysis; Clinical trial","score_opus":0.034633791414051165,"score_gpt":0.37185822400243446,"score_spread":0.3372244325883833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56672966,0.415178,0.0000032011644,0.008121514,0.00059401215,0.0064964625,0.000096222946,0.000038648013,0.0027422588],"genre_scores_gemma":[0.8930014,0.104869,0.00037143962,0.00053019373,0.000021668377,0.00097527896,0.000050070597,0.000008010697,0.00017293378],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99785846,0.00046671805,0.0007834055,0.0004971987,0.00010410536,0.0002901174],"domain_scores_gemma":[0.99734783,0.00178534,0.00033891495,0.00031288993,0.0000995981,0.00011544668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031655308,0.00031491925,0.0026905772,0.00022100883,0.00007379884,0.000013765912,0.000076933764,0.0002474455,0.00009133083],"category_scores_gemma":[0.00021504502,0.00021814425,0.00007982137,0.00052426534,0.00015751686,0.00004356364,0.00007361179,0.00021806038,0.000003935803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042196922,0.03854269,0.26504582,0.41685104,0.01850456,0.0037209655,0.02371734,0.00023055615,0.00053014397,0.014610586,0.009470637,0.16657871],"study_design_scores_gemma":[0.07127259,0.013550616,0.8502612,0.054157134,0.0060246545,0.00006830276,0.00056578027,0.00010372594,0.0004085793,0.00010064564,0.003120777,0.0003659603],"about_ca_topic_score_codex":0.0001867927,"about_ca_topic_score_gemma":0.001497877,"teacher_disagreement_score":0.5852154,"about_ca_system_score_codex":0.0014135323,"about_ca_system_score_gemma":0.00048556525,"threshold_uncertainty_score":0.8895664},"labels":[],"label_agreement":null},{"id":"W4414740646","doi":"10.1093/clinchem/hvaf086.746","title":"B-361 Method Validation of Human Chorionic Gonadotropin (hCG) and a-Fetoprotein (AFP) in Cerebrospinal Fluid (CSF)","year":2025,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Human chorionic gonadotropin; Cerebrospinal fluid; Yolk sac; Gonadotropin; Germ cell tumors; Cerebral Spinal Fluid; Serum concentration","score_opus":0.03212601437981625,"score_gpt":0.4258286998861846,"score_spread":0.39370268550636833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414740646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049413,0.0008469973,0.000097781645,0.002293109,0.000096412856,0.00027845195,0.00000973338,0.000019371311,0.0058640307],"genre_scores_gemma":[0.9963843,0.00022632563,0.001672926,0.0001898184,0.00019642463,0.000055687717,0.000045736928,0.000010291356,0.0012184589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861956,0.00005055871,0.0006634733,0.0003844429,0.00012791037,0.00015403295],"domain_scores_gemma":[0.99920064,0.00017316203,0.00012460432,0.00033436395,0.00006958409,0.00009767042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039642572,0.00013205926,0.00046977296,0.00003233162,0.000034019875,0.000011771144,0.000070611095,0.00020120684,0.00025342603],"category_scores_gemma":[0.00025438017,0.00011988288,0.0001253357,0.00014582413,0.00010682645,0.000028981336,0.00006163336,0.0002624189,0.0000040411287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006582217,0.002225757,0.8849964,0.0017509166,0.00035616776,0.000053708856,0.00004469919,0.000006237775,0.06508515,0.0014791342,0.0019711894,0.041372426],"study_design_scores_gemma":[0.0068277186,0.00042764333,0.5062422,0.0009487563,0.00023632222,0.000009437346,0.00003899157,0.000065958695,0.4792043,0.0022357143,0.0035964379,0.00016652094],"about_ca_topic_score_codex":0.00006505517,"about_ca_topic_score_gemma":0.0000045111474,"teacher_disagreement_score":0.41411915,"about_ca_system_score_codex":0.000113841386,"about_ca_system_score_gemma":0.00016810867,"threshold_uncertainty_score":0.4888682},"labels":[],"label_agreement":null},{"id":"W4414838451","doi":"10.1002/1878-0261.70136","title":"Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel","year":2025,"lang":"en","type":"article","venue":"Molecular Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute of Health Services and Policy Research; Université Laval; Princess Margaret Cancer Centre; University of Toronto","funders":"University of Toronto","keywords":"Germline; Germline mutation; Genetic testing; Somatic cell; Ovarian cancer; DNA sequencing; Epithelial ovarian cancer; Cancer","score_opus":0.1615341997833778,"score_gpt":0.3633893186915093,"score_spread":0.20185511890813151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414838451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993027,0.0008910684,0.0037955064,0.00092584075,0.0001080322,0.0008159668,0.000008676405,0.000034799075,0.0003931511],"genre_scores_gemma":[0.9723563,0.000018935252,0.026377931,0.00086366636,0.00012559221,0.00019923552,0.000022752069,0.000021230964,0.000014357021],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998771,0.00012627958,0.00029170717,0.00044819101,0.00011082541,0.0002519973],"domain_scores_gemma":[0.9994396,0.00004752063,0.00011790134,0.0001835051,0.00012403565,0.00008745332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017570307,0.00017627579,0.00046500756,0.00015436069,0.00009467948,0.000030150753,0.00003905221,0.00008877755,0.000014342205],"category_scores_gemma":[0.000057197816,0.00015329102,0.000025551182,0.00035920154,0.000070305876,0.00006742112,0.00003166464,0.00016820508,5.0544566e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004394703,0.0006157496,0.2889358,0.00007712822,0.00023477698,0.0018703768,0.00088665617,0.0071502426,0.6557925,0.0002768884,0.000015169021,0.043705232],"study_design_scores_gemma":[0.0191498,0.0050482387,0.2903463,0.0008548437,0.001170589,0.0006128143,0.00073686143,0.39213258,0.2886374,0.00028664368,0.00047453327,0.0005493895],"about_ca_topic_score_codex":0.004853473,"about_ca_topic_score_gemma":0.002349845,"teacher_disagreement_score":0.38498235,"about_ca_system_score_codex":0.001698419,"about_ca_system_score_gemma":0.001327793,"threshold_uncertainty_score":0.7337032},"labels":[],"label_agreement":null},{"id":"W4414893408","doi":"10.1200/op.2025.21.10_suppl.217","title":"Assessing disparities in real-world overall survival (rwOS) among sociodemographic groups in advanced ovarian cancer (aOC): The impact of biomarker testing and first-line (1L) maintenance therapies (mtx).","year":2025,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Biomarker; Socioeconomic status; Cohort; Proportional hazards model; Hazard ratio; Cohort study; Ovarian cancer; Logistic regression; Observational study","score_opus":0.052147760711954344,"score_gpt":0.41238378952906557,"score_spread":0.36023602881711125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414893408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634851,0.002848934,0.00003792413,0.026234511,0.0002889782,0.0007774866,0.00001526065,0.000031140957,0.006280665],"genre_scores_gemma":[0.99104244,0.0061528836,0.0015218388,0.0007650634,0.000050211354,0.0002868462,0.000007328045,0.000024250008,0.00014917184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978462,0.0004866424,0.0005992747,0.00044331243,0.0001834588,0.00044114754],"domain_scores_gemma":[0.992334,0.006585327,0.00049689086,0.00033105558,0.00018442722,0.00006830451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013631539,0.00027651354,0.00074368156,0.00034951387,0.00016119432,0.000060135033,0.00012397791,0.00016987388,0.000032610722],"category_scores_gemma":[0.0012801297,0.00018824059,0.000113906266,0.0010054332,0.00038896623,0.00064401404,0.000100293815,0.00056541857,4.2498368e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009921204,0.00075473555,0.9696825,0.00010895491,0.00053170294,0.00022685798,0.0005119669,0.00035490014,0.00013522111,0.001229859,0.00018866337,0.025282528],"study_design_scores_gemma":[0.005959337,0.00038918311,0.9881008,0.0009209088,0.0002727821,0.00002667881,0.0008476129,0.0015025171,0.000014272445,0.0011439411,0.0006685612,0.00015339802],"about_ca_topic_score_codex":0.06967515,"about_ca_topic_score_gemma":0.048019744,"teacher_disagreement_score":0.027557306,"about_ca_system_score_codex":0.0011715045,"about_ca_system_score_gemma":0.0007321434,"threshold_uncertainty_score":0.9693514},"labels":[],"label_agreement":null},{"id":"W4414999257","doi":"10.1016/j.neo.2025.101237","title":"RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells","year":2025,"lang":"en","type":"article","venue":"Neoplasia","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Follicular fluid; Proinflammatory cytokine; Mutation; Germline mutation; Granulosa cell; Follicular phase; Fallopian tube cancer; Cytokine","score_opus":0.004913740910251187,"score_gpt":0.2272030329449873,"score_spread":0.22228929203473613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414999257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719256,0.0016072191,0.0000075061025,0.00026303498,0.00006842692,0.00065231184,0.000018215198,0.000015332302,0.00017538208],"genre_scores_gemma":[0.9993879,0.00016409204,0.0001700628,0.00013149825,0.000023481343,0.00006209327,0.000014129014,0.000013479338,0.00003322752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990202,0.00006769725,0.0003237671,0.00028401474,0.0001370693,0.00016721833],"domain_scores_gemma":[0.9995684,0.00007261887,0.00007383053,0.00014566124,0.000048994174,0.00009050462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001953229,0.00014968176,0.00036891227,0.0002495911,0.000032609663,0.000014341355,0.00002877489,0.000109205226,0.000017572478],"category_scores_gemma":[0.00005942463,0.00014185222,0.000039883358,0.00022752077,0.000063777305,0.00006669028,0.000022375852,0.000120594064,9.3836445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052352546,0.00019126554,0.8936446,0.0006594687,0.0001580389,0.0006428911,0.0019140098,0.00020813567,0.09823545,0.00036039652,0.000041445204,0.0034208158],"study_design_scores_gemma":[0.010050483,0.00017346052,0.8654849,0.00096976885,0.0001731942,0.000023710505,0.0008687774,0.0008704776,0.12074298,0.00010436715,0.0003849928,0.00015289903],"about_ca_topic_score_codex":0.00060926983,"about_ca_topic_score_gemma":0.0005612342,"teacher_disagreement_score":0.02815966,"about_ca_system_score_codex":0.00015194659,"about_ca_system_score_gemma":0.00023508852,"threshold_uncertainty_score":0.5784565},"labels":[],"label_agreement":null},{"id":"W4415000166","doi":"10.1016/j.ijgc.2025.102709","title":"Bridging historical evidence and contemporary strategies in the adjuvant treatment of early-stage epithelial ovarian cancer","year":2025,"lang":"en","type":"review","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Epithelial ovarian cancer; Adjuvant; Adjuvant therapy; Disease; Ovarian cancer; Epithelial ovarian carcinoma; Stage (stratigraphy)","score_opus":0.15135005815310243,"score_gpt":0.4292500234011852,"score_spread":0.27789996524808275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415000166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028466724,0.9907413,0.000025646887,0.0039498815,0.0013143105,0.00063959614,0.00015190142,0.000004749649,0.0003259088],"genre_scores_gemma":[0.08564735,0.91288453,0.00007213967,0.00018614622,0.00064135884,0.00023164146,0.000005874163,0.000011573382,0.00031936998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975938,0.0002402137,0.0011171985,0.00028694724,0.00058422127,0.00017761935],"domain_scores_gemma":[0.9971079,0.0013473738,0.00097435893,0.00015891211,0.00032044356,0.00009101406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036443103,0.0003175104,0.0017309809,0.00029224646,0.000031354743,0.000057872512,0.0003362559,0.00019691973,0.00029874605],"category_scores_gemma":[0.00020818549,0.00016341177,0.0005378525,0.00018789875,0.000095969335,0.00014994566,0.000052527725,0.00035596098,8.924799e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003955211,0.00082950335,0.011954225,0.0013734279,0.0012140932,0.0016463592,0.00027837342,0.000014816028,0.0000013474455,0.00040605266,0.0005985833,0.9812877],"study_design_scores_gemma":[0.0034364813,0.002797257,0.059503093,0.034413315,0.0018992728,0.00019497666,0.00010307634,0.000008975553,0.000007542359,0.00011537782,0.89726424,0.00025637238],"about_ca_topic_score_codex":0.002530101,"about_ca_topic_score_gemma":0.00028951175,"teacher_disagreement_score":0.9810313,"about_ca_system_score_codex":0.003204464,"about_ca_system_score_gemma":0.002958974,"threshold_uncertainty_score":0.8379562},"labels":[],"label_agreement":null},{"id":"W4415014589","doi":"10.1016/j.jogc.2025.103145","title":"Para-Tubal Cysts and Their Associations With Adnexal Torsion and Obesity","year":2025,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Adnexal Diseases; Obesity; Torsion (gastropod); Adnexal mass; Cyst; Ovarian torsion","score_opus":0.009095929314807544,"score_gpt":0.23149887000026428,"score_spread":0.22240294068545674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415014589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673594,0.008881075,0.00001823158,0.002428442,0.0010711063,0.00010053376,0.000021103999,0.0000017198779,0.00074185117],"genre_scores_gemma":[0.9984678,0.0006819701,0.0001788441,0.0005292741,0.00001595265,0.0000017409778,0.000002228117,0.000003419103,0.00011877274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994798,0.000024769497,0.00017967352,0.00009886257,0.00010198807,0.00011490713],"domain_scores_gemma":[0.9987521,0.0007699162,0.00013998925,0.00005478766,0.00014856053,0.00013460648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102436024,0.00008503721,0.0002833209,0.00010570165,0.00010804048,0.000016750499,0.00002293886,0.00006526067,0.000027314469],"category_scores_gemma":[0.0003667407,0.00005483118,0.000018718662,0.00016166616,0.000038413033,0.000034826346,0.000017258499,0.00014398008,4.088046e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000864715,0.000087295346,0.9736832,0.000024827936,0.00024945603,0.00041975803,0.00006107927,0.0000014946029,0.0000045938714,0.00025849557,0.0016249008,0.023576295],"study_design_scores_gemma":[0.0026611867,0.00053331844,0.9899607,0.000017765715,0.00018161457,0.00006150732,0.00015938222,0.000018269271,0.00006519769,0.00009436815,0.006199163,0.000047530833],"about_ca_topic_score_codex":0.0050550927,"about_ca_topic_score_gemma":0.02310657,"teacher_disagreement_score":0.023528764,"about_ca_system_score_codex":0.00057237135,"about_ca_system_score_gemma":0.0010079719,"threshold_uncertainty_score":0.9947192},"labels":[],"label_agreement":null},{"id":"W4415099668","doi":"10.1016/j.ijgc.2025.102719","title":"Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Université Claude Bernard Lyon 1; Hospices Civils de Lyon","keywords":"Ovarian cancer; Adjuvant; Gynecologic cancer; Stage (stratigraphy); Cancer; Epithelial ovarian cancer; Adjuvant therapy","score_opus":0.139126315380412,"score_gpt":0.3962642136323559,"score_spread":0.2571378982519439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415099668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96035475,0.0066722417,0.001517057,0.026715584,0.0025877396,0.0008098459,0.0012291305,0.00001798785,0.00009569565],"genre_scores_gemma":[0.98965937,0.0032553244,0.0012385367,0.0049179844,0.00024482777,0.00035663144,0.00004373739,0.000019620033,0.0002639513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960304,0.00046213847,0.0014157322,0.00066605996,0.0009953253,0.0004303252],"domain_scores_gemma":[0.9960849,0.0009496837,0.0012082993,0.00048891024,0.0010778704,0.00019031475],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015146884,0.00037211616,0.0012615378,0.00094260194,0.00023534529,0.00020289115,0.00091025216,0.00020076743,0.0039910143],"category_scores_gemma":[0.0010051822,0.00022610903,0.00069755956,0.001317337,0.0001473624,0.00039052696,0.0007636558,0.00075804745,0.0000034802376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023205802,0.0019617095,0.6841423,0.000049725862,0.21477894,0.0016413976,0.002233119,0.04554886,0.00048965425,0.002529524,0.0031729273,0.04113125],"study_design_scores_gemma":[0.0040394845,0.00080868957,0.8986634,0.00025375068,0.08852484,0.00002056785,0.00050776737,0.0016848856,0.00082100503,0.00066537113,0.0036651175,0.00034511852],"about_ca_topic_score_codex":0.0117981415,"about_ca_topic_score_gemma":0.020491922,"teacher_disagreement_score":0.2145211,"about_ca_system_score_codex":0.0021685977,"about_ca_system_score_gemma":0.0009192709,"threshold_uncertainty_score":0.99738157},"labels":[],"label_agreement":null},{"id":"W4415287810","doi":"10.1177/10732748251388704","title":"Variations in Ovarian Cancer Survival Rates: Investigating Equity and Prognostic Factors Throughout Nova Scotia","year":2025,"lang":"en","type":"article","venue":"Cancer Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"Ovarian Cancer Canada","keywords":"Socioeconomic status; Nova scotia; Cancer survival; Equity (law); Survival analysis; Ovarian cancer; Health equity; Cancer registry; Overall survival","score_opus":0.06796689028514367,"score_gpt":0.391136457264862,"score_spread":0.3231695669797183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415287810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92605704,0.0141209895,0.002989579,0.04374823,0.0028354924,0.003610214,0.00044051604,0.00013379229,0.0060641323],"genre_scores_gemma":[0.9964193,0.0002701558,0.00015037335,0.00238402,0.00019785881,0.0003795603,0.000022822709,0.00002272343,0.00015314533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984779,0.000077478704,0.000384192,0.0004628805,0.00020857103,0.00038898995],"domain_scores_gemma":[0.9990009,0.00034925446,0.000116605865,0.00024679556,0.00013028044,0.00015614841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022255877,0.00025054443,0.00055860874,0.0001398023,0.00009733104,0.000075797034,0.00009096926,0.00011350474,0.00027100116],"category_scores_gemma":[0.00027866545,0.00021041169,0.00006966694,0.00047909963,0.00011246769,0.00012366081,0.0000807707,0.00023303916,0.00000472765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054780205,0.00013917591,0.98800194,0.00015896183,0.00037529107,0.000011805752,0.00046700911,0.000103723665,0.0007367523,0.004090111,0.0002813417,0.0055791056],"study_design_scores_gemma":[0.008035372,0.00007992814,0.9869836,0.00084703544,0.0005607727,0.000001002368,0.00012616138,0.0010952671,0.0007047466,0.0008590333,0.00052570365,0.00018139891],"about_ca_topic_score_codex":0.017576734,"about_ca_topic_score_gemma":0.014620028,"teacher_disagreement_score":0.070362285,"about_ca_system_score_codex":0.00058795,"about_ca_system_score_gemma":0.0010866618,"threshold_uncertainty_score":0.98896533},"labels":[],"label_agreement":null},{"id":"W4415341740","doi":"10.14740/jmc5173","title":"Fetal Ovarian Cysts in Prenatal Imaging: Diagnostic Challenges and Management Options","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Asymptomatic; Fetus; Pregnancy; Gestation; Prenatal diagnosis; Ovarian torsion; Ultrasound; Cyst","score_opus":0.022860663182181436,"score_gpt":0.31724339462926654,"score_spread":0.2943827314470851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415341740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48343486,0.23897722,0.00026033403,0.26742756,0.0012243561,0.00067557796,0.000012805251,0.000026230062,0.007961035],"genre_scores_gemma":[0.92837024,0.07031529,0.00047728006,0.00057884824,0.00016890072,0.000017741047,0.0000020037135,0.000005940019,0.000063732725],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99880624,0.000046022167,0.00036086133,0.0001359893,0.0005026527,0.00014825811],"domain_scores_gemma":[0.9989918,0.00054809515,0.00008175862,0.00010940634,0.00004758308,0.00022138262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042211276,0.000100773985,0.00028954732,0.00025833212,0.00002752137,0.00001677124,0.00007610741,0.000054146694,0.000121799414],"category_scores_gemma":[0.000684047,0.00007291487,0.000072270755,0.000103498955,0.00007479875,0.00006879198,0.00006504926,0.00021865097,0.0000024173405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003407209,0.0024732864,0.0732866,0.0009330803,0.00068472454,0.083750635,0.00037153056,0.0000065854133,0.0000027242,0.020744512,0.0074379737,0.80996764],"study_design_scores_gemma":[0.008669018,0.0005182055,0.9581376,0.005967509,0.0005692812,0.006421474,0.0008082195,0.00012324152,0.000054039905,0.0008228788,0.017800331,0.000108248256],"about_ca_topic_score_codex":0.000029440926,"about_ca_topic_score_gemma":0.000060052782,"teacher_disagreement_score":0.884851,"about_ca_system_score_codex":0.00010718368,"about_ca_system_score_gemma":0.00015238073,"threshold_uncertainty_score":0.2973382},"labels":[],"label_agreement":null},{"id":"W4415444339","doi":"10.1158/1535-7163.targ-25-a055","title":"Abstract A055: Treatment and tumor heterogeneity – Effects of competition, variable response to treatment, and finite resources","year":2025,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Competition (biology); Population; Genotype; Phenotype; Tumor progression; Genetic heterogeneity; Immune system","score_opus":0.015398708554844598,"score_gpt":0.29802094633967297,"score_spread":0.28262223778482837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415444339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97889197,0.017163606,0.00035221732,0.0022639139,0.00009444713,0.00085594394,0.00007828273,0.000026866013,0.00027276084],"genre_scores_gemma":[0.9941713,0.0025266653,0.0006924302,0.0020358288,0.000023952676,0.0003026709,0.000009184564,0.000023633173,0.00021431706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990403,0.000084038766,0.00021416064,0.0003557749,0.000098580684,0.00020716473],"domain_scores_gemma":[0.99915016,0.00025843273,0.00006932057,0.0003320126,0.00006523445,0.00012485849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007949691,0.00024432532,0.00042206145,0.000130634,0.00007787919,0.000028661736,0.000039106966,0.000060690385,0.000020000298],"category_scores_gemma":[0.000014174239,0.00019159957,0.00007734502,0.00019738225,0.00007435454,0.000021039523,0.00002573037,0.000043629236,0.0000015121806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010844066,0.0038503339,0.14382735,0.0013009369,0.008296473,0.0005260204,0.0030108418,0.00052957644,0.6900039,0.001808963,0.00006728315,0.13593428],"study_design_scores_gemma":[0.0104105845,0.004337683,0.2657197,0.0009415097,0.002114061,0.000017397659,0.00006771319,0.00008266817,0.6117785,0.0002437338,0.10399776,0.00028867577],"about_ca_topic_score_codex":0.000469403,"about_ca_topic_score_gemma":0.000059761554,"teacher_disagreement_score":0.1356456,"about_ca_system_score_codex":0.0003237681,"about_ca_system_score_gemma":0.0001710659,"threshold_uncertainty_score":0.7813204},"labels":[],"label_agreement":null},{"id":"W4415450567","doi":"10.1210/jendso/bvaf149.2244","title":"SAT-326 Three Cases of Malignant Struma Ovarii with Papillary Thyroid Carcinoma in Hamilton, Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Struma ovarii; Ovarian Teratoma; Thyroid carcinoma; Thyroid; Lymph node; Thyroglobulin; Cystectomy; Thyroidectomy; Papillary carcinoma","score_opus":0.008791146933580579,"score_gpt":0.2269911082759576,"score_spread":0.218199961342377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415450567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895196,0.0023630557,0.000008220943,0.006879101,0.0003286875,0.00024920472,0.000019379499,0.0000027965707,0.00062996894],"genre_scores_gemma":[0.99741083,0.0002715418,0.00061571127,0.0010183464,0.00008516254,0.00000625761,0.0000023941989,0.000012192917,0.00057756505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986505,0.0000339066,0.0005000461,0.00014250954,0.0004288468,0.0002442068],"domain_scores_gemma":[0.99895257,0.00012039439,0.00032860908,0.00033480098,0.00018249023,0.00008116399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013968571,0.00017178484,0.0005002464,0.000041332332,0.00006812213,0.0000097219645,0.00017476102,0.000031914606,0.000084290245],"category_scores_gemma":[0.000025192903,0.00009457874,0.0003002951,0.00026367026,0.0000694184,0.00005015757,0.00006270952,0.00036313594,1.6031738e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027219564,0.00024745916,0.9644023,0.00010847076,0.0006887715,0.0009270562,0.00046868803,0.0001415435,0.00020907928,0.0001264871,0.03187863,0.00052927283],"study_design_scores_gemma":[0.004389588,0.000593571,0.9785778,0.0006986847,0.00044646105,0.00096010225,0.00066511193,0.000019550851,0.0063117803,0.0000997277,0.0071463813,0.000091247166],"about_ca_topic_score_codex":0.7137117,"about_ca_topic_score_gemma":0.91335785,"teacher_disagreement_score":0.19964613,"about_ca_system_score_codex":0.0013512226,"about_ca_system_score_gemma":0.0035172172,"threshold_uncertainty_score":0.6239392},"labels":[],"label_agreement":null},{"id":"W4415490144","doi":"10.14740/jcgo1522","title":"A Challenging Case of Malignant Struma Ovarii With Concurrent Papillary Thyroid Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Gynecology and Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Struma ovarii; Ovarian Teratoma; Thyroid; Papillary thyroid cancer; Differential diagnosis; Follicular thyroid cancer; Thyroidectomy; Papillary carcinoma","score_opus":0.04478992235505323,"score_gpt":0.39748615591503916,"score_spread":0.3526962335599859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415490144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95219994,0.041494727,0.00018658878,0.0035638805,0.0018335695,0.00019991923,0.000011353847,0.000004764188,0.00050524756],"genre_scores_gemma":[0.9673508,0.03134362,0.00044381875,0.0006410813,0.00011953608,0.000005850026,8.2153224e-7,0.0000074577874,0.00008704095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832207,0.00010535314,0.0010731149,0.00017902096,0.00014469391,0.00017573287],"domain_scores_gemma":[0.9938528,0.00480776,0.0006603135,0.00014554965,0.00036063464,0.00017294273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060818874,0.00013056205,0.00089058466,0.00020403441,0.000058463338,0.000006904533,0.0000583484,0.00019504555,0.00007394713],"category_scores_gemma":[0.0018234246,0.00008173017,0.00017732517,0.0002857655,0.00016835234,0.000044136847,0.00004123846,0.0004408376,5.3083863e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005415057,0.0013480054,0.64097506,0.00031191597,0.0015668628,0.010167019,0.00012799549,0.000042682612,0.0000085235115,0.0024663194,0.0009742551,0.34146985],"study_design_scores_gemma":[0.032305993,0.015202795,0.910324,0.0020141634,0.004104432,0.0044926926,0.0010814819,0.0004353549,0.00066778663,0.0005390293,0.028528152,0.00030412487],"about_ca_topic_score_codex":0.000017349743,"about_ca_topic_score_gemma":0.000030067407,"teacher_disagreement_score":0.34116572,"about_ca_system_score_codex":0.00007367076,"about_ca_system_score_gemma":0.0005811805,"threshold_uncertainty_score":0.33328596},"labels":[],"label_agreement":null},{"id":"W4415716099","doi":"10.1016/j.ygyno.2025.10.022","title":"Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatment","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Intraperitoneal chemotherapy; Serous fluid; Serous ovarian cancer; Ovarian cancer; Chemotherapy; Stage (stratigraphy)","score_opus":0.038980384936559566,"score_gpt":0.3299974935088963,"score_spread":0.2910171085723367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415716099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871409,0.0027941014,0.000058422826,0.0036269922,0.0030452204,0.0014931913,0.000056243,0.00006317085,0.0017217534],"genre_scores_gemma":[0.99006027,0.0065505574,0.0015168434,0.00016172112,0.00008107835,0.0012058422,0.0000421729,0.000015373442,0.00036614967],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980068,0.0001876362,0.0006354778,0.00056521804,0.00013384888,0.00047098676],"domain_scores_gemma":[0.9984632,0.0007024166,0.00026981765,0.00036243116,0.00010333822,0.00009876531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022554705,0.00028352268,0.00095048593,0.00026384773,0.000095467745,0.0000114238055,0.0001311561,0.00032543315,0.00029003323],"category_scores_gemma":[0.00019542177,0.00023846979,0.00012477327,0.00050833495,0.00012598626,0.00007599768,0.000052151787,0.00022895048,0.000007771287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044779247,0.0061855265,0.45738408,0.00074463367,0.000999612,0.00097343436,0.0019856882,0.0018301213,0.0021639506,0.0026383484,0.00030536752,0.5203113],"study_design_scores_gemma":[0.031907123,0.016182125,0.93050224,0.0011167815,0.00081378873,0.000058674992,0.001694926,0.0003021339,0.0027488638,0.0002663759,0.014024321,0.00038264142],"about_ca_topic_score_codex":0.0039267717,"about_ca_topic_score_gemma":0.01818954,"teacher_disagreement_score":0.5199287,"about_ca_system_score_codex":0.0056861797,"about_ca_system_score_gemma":0.0008965431,"threshold_uncertainty_score":0.99972594},"labels":[],"label_agreement":null},{"id":"W4415727035","doi":"10.1016/j.ijgc.2025.102771","title":"Improving ovarian cancer risk assessment using a machine learning model developed on data from the Prostate Lung Colorectal Ovarian Cancer Screening Trial","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute; National Institutes of Health; University of Texas MD Anderson Cancer Center; Duncan Family Institute for Cancer Prevention and Risk Assessment","keywords":"Ovarian cancer; Risk assessment; Incidence (geometry); Colorectal cancer; Prostate cancer; Epithelial ovarian cancer","score_opus":0.07505002470963278,"score_gpt":0.4011571425097286,"score_spread":0.3261071178000958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415727035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94890994,0.0035161907,0.017906975,0.02254553,0.0040295264,0.0012321778,0.0014313995,0.00003998588,0.00038827574],"genre_scores_gemma":[0.9804821,0.0031300844,0.011853727,0.002529748,0.0014274522,0.00021057314,0.00009853693,0.000032654145,0.00023513801],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969747,0.00026547594,0.00091112877,0.0005545762,0.0009282852,0.0003657997],"domain_scores_gemma":[0.9968094,0.0009246327,0.0010655153,0.00028954912,0.0007532458,0.00015762424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096458587,0.00032631055,0.00062530325,0.00017200438,0.00033361965,0.00021629763,0.00077571615,0.00016396926,0.0012649411],"category_scores_gemma":[0.0008318915,0.00020176973,0.00021864595,0.0002564095,0.00009214518,0.00029739787,0.00042368146,0.0011970208,0.0000012714884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04156009,0.0010210456,0.68976307,0.000026854237,0.0066677295,0.00039529055,0.00032376853,0.0921587,0.0012145058,0.00032333197,0.0020846867,0.16446093],"study_design_scores_gemma":[0.048339892,0.00066004216,0.32974598,0.0010432581,0.0016978012,0.00001720814,0.0000976669,0.6132948,0.00037100218,0.000285145,0.0041461764,0.0003010674],"about_ca_topic_score_codex":0.010948019,"about_ca_topic_score_gemma":0.002992719,"teacher_disagreement_score":0.52113605,"about_ca_system_score_codex":0.002319341,"about_ca_system_score_gemma":0.002788341,"threshold_uncertainty_score":0.99964803},"labels":[],"label_agreement":null},{"id":"W4415764619","doi":"10.1158/1078-0432.ccr-25-2851","title":"Biomarkers in High-Grade Serous Ovarian Cancer: Context Is Everything","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Context (archaeology); Serous fluid; Serous ovarian cancer; Biomarker; Serous carcinoma; Ovarian carcinoma; Carcinoma","score_opus":0.19691061443441976,"score_gpt":0.531483358529785,"score_spread":0.33457274409536525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415764619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200042,0.01660373,0.000016284455,0.15637514,0.0015629608,0.0015542773,0.00010163124,0.000065126325,0.003716619],"genre_scores_gemma":[0.9762792,0.012831429,0.00015675617,0.0065762103,0.00047250805,0.000927185,0.000012793198,0.000034576646,0.002709329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620724,0.0004651216,0.0008612361,0.00092609285,0.00072849443,0.000811843],"domain_scores_gemma":[0.99717015,0.0013378519,0.000086014734,0.00071339903,0.00034485786,0.00034775367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024005317,0.00022407368,0.0007576574,0.0004363754,0.00017431246,0.00007415004,0.00029807255,0.00031271635,0.0015049932],"category_scores_gemma":[0.00049416744,0.00018959268,0.00023376467,0.0014668225,0.00040342833,0.00009317578,0.00021185176,0.0012254931,0.00008170796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012376822,0.00087278447,0.71241,0.0002044241,0.00087469316,0.0002497795,0.000216398,0.0000053703097,0.000049394035,0.001125768,0.0761524,0.20660134],"study_design_scores_gemma":[0.013211847,0.0005444736,0.8594415,0.0022082624,0.00017803113,0.0000036381573,0.00036072294,0.00016061979,0.0014556554,0.0014471574,0.12074991,0.000238142],"about_ca_topic_score_codex":0.038921468,"about_ca_topic_score_gemma":0.007672528,"teacher_disagreement_score":0.2063632,"about_ca_system_score_codex":0.0014327383,"about_ca_system_score_gemma":0.0023812358,"threshold_uncertainty_score":0.99940777},"labels":[],"label_agreement":null},{"id":"W4415769740","doi":"10.1016/j.ygyno.2025.10.027","title":"Experiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Future Fund; State Government of Victoria; Hudson Institute","keywords":"Radiation therapy; Granulosa cell; MEDLINE; Cell; Chemotherapy","score_opus":0.0198184208580872,"score_gpt":0.3038408724828228,"score_spread":0.2840224516247356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415769740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860337,0.005312189,0.000052276093,0.0035857763,0.000910391,0.0016059141,0.000055527038,0.000009505414,0.0024347354],"genre_scores_gemma":[0.99613154,0.0006452102,0.0012327653,0.0008918057,0.00005290758,0.00078794,0.000010608342,0.0000072621765,0.0002399638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884534,0.00017413455,0.00045103353,0.00025396503,0.00011230661,0.00016324056],"domain_scores_gemma":[0.99678934,0.0022734494,0.0003762765,0.0004412463,0.00008829269,0.000031372627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098057506,0.00016015119,0.0007541079,0.0000481227,0.00007369095,0.0000025595655,0.0002027368,0.000110922956,0.00016472631],"category_scores_gemma":[0.000073182295,0.00007331071,0.0002932806,0.00020327873,0.0004018629,0.000015726513,0.000030188952,0.00003768908,5.6639846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0088690445,0.03682439,0.5305436,0.0008071089,0.0070817154,0.00010630807,0.13063763,0.00018257718,0.053002384,0.0115713095,0.017979406,0.20239447],"study_design_scores_gemma":[0.02461064,0.027199835,0.47320366,0.00018432307,0.0019172444,0.000006583652,0.024104817,0.00016053408,0.2965471,0.0025921944,0.14922243,0.00025060782],"about_ca_topic_score_codex":0.0004575732,"about_ca_topic_score_gemma":0.00040233287,"teacher_disagreement_score":0.24354474,"about_ca_system_score_codex":0.0003064591,"about_ca_system_score_gemma":0.00048008063,"threshold_uncertainty_score":0.2989524},"labels":[],"label_agreement":null},{"id":"W4415785825","doi":"10.71104/jsogp.v15i4.940","title":"K167 as a Prognostic Indicator in Serous Types of Ovarian Malignancies","year":2025,"lang":"","type":"article","venue":"Journal of The Society of Obstetricians and Gynaecologists of Pakistan","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pontifical Institute of Mediaeval Studies","funders":"","keywords":"Serous fluid; Immunohistochemistry; H&E stain; Serous carcinoma; Cohort; Ovarian carcinoma; Cohort study; Carcinoma","score_opus":0.010414354580741246,"score_gpt":0.29194143823622976,"score_spread":0.2815270836554885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415785825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92724437,0.062233575,0.00005004963,0.005426249,0.0023981656,0.0009962381,0.00010015421,0.0000042525808,0.0015469242],"genre_scores_gemma":[0.990545,0.007312464,0.0012964227,0.00030219156,0.000052381354,0.0000078603925,0.0000011590134,0.000017882758,0.00046467618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964165,0.00019941769,0.0020700502,0.00028029043,0.00064011005,0.0003936099],"domain_scores_gemma":[0.99437904,0.0016591377,0.0028170922,0.00042507672,0.0005945975,0.00012502291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010974406,0.00033048933,0.0015344303,0.0003454347,0.00011111556,0.00002491126,0.00049931963,0.00037501068,0.00014023785],"category_scores_gemma":[0.0014111345,0.00022415533,0.0010878019,0.0014923465,0.00095548073,0.00010072114,0.00019664812,0.00052992994,6.529235e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000341797,0.0036141963,0.96082616,0.003149035,0.003276239,0.00010466654,0.0050353627,0.00013005327,0.00052150065,0.0034376313,0.0019741426,0.017589241],"study_design_scores_gemma":[0.0057408065,0.0027229928,0.97348315,0.0024266473,0.0019408875,0.000026624326,0.00855659,0.00004100813,0.0026199613,0.0013195176,0.0009577371,0.00016407484],"about_ca_topic_score_codex":0.0003919181,"about_ca_topic_score_gemma":0.000067844,"teacher_disagreement_score":0.063300565,"about_ca_system_score_codex":0.0005972092,"about_ca_system_score_gemma":0.001684034,"threshold_uncertainty_score":0.91407895},"labels":[],"label_agreement":null},{"id":"W4415941783","doi":"10.1016/j.annonc.2025.08.1767","title":"1131P Upgrading the performance of ECOG performance status in recurrent ovarian cancer (ECOG+)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"UCLH Biomedical Research Centre; Cancer Research UK; National Institute for Health and Care Research; Target Ovarian Cancer","keywords":"Ovarian cancer; Performance status; Karnofsky Performance Status; MEDLINE","score_opus":0.061236882447625346,"score_gpt":0.3932023316732281,"score_spread":0.3319654492256028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415941783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969165,0.0038905602,0.0000018819111,0.013635204,0.0005064073,0.0004012181,0.000021947391,0.0000084430985,0.012369337],"genre_scores_gemma":[0.9747313,0.023429407,0.00012741469,0.0011921254,0.00006567658,0.00014572659,0.000008085514,0.000008790641,0.00029144165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872965,0.00006461739,0.0004937858,0.00022118965,0.00014197126,0.00034879002],"domain_scores_gemma":[0.99907184,0.00018716912,0.00021869337,0.00029638095,0.00016589103,0.00006001149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039582877,0.00013701752,0.00050834264,0.00019326956,0.000050460276,0.0000038298763,0.00012453864,0.000099616715,0.00018215165],"category_scores_gemma":[0.000049358834,0.000095707954,0.00009309221,0.00041509522,0.0001377476,0.00006575531,0.000056078028,0.00020393741,0.0000052781243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006021843,0.00068414095,0.552421,0.00032600865,0.0002147762,0.000008632724,0.00060747407,0.00013261392,0.000116323565,0.000730237,0.0042054555,0.43995118],"study_design_scores_gemma":[0.0027635784,0.0028468377,0.8793767,0.0007823374,0.0001132791,0.000005355718,0.00012616935,0.00096543174,0.011969268,0.00006537536,0.100895956,0.000089707435],"about_ca_topic_score_codex":0.00055348413,"about_ca_topic_score_gemma":0.00041616624,"teacher_disagreement_score":0.43986148,"about_ca_system_score_codex":0.0001767518,"about_ca_system_score_gemma":0.0007855779,"threshold_uncertainty_score":0.39028573},"labels":[],"label_agreement":null},{"id":"W4415942832","doi":"10.1016/j.jogc.2025.103170","title":"Beyond AJCC Staging: A Socioeconomic-Clinical Nomogram for Predicting 10-Year Survival in Epithelial Ovarian Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Epithelial ovarian cancer; Nomogram; Cancer; Ovarian cancer; Overall survival","score_opus":0.01907932730062446,"score_gpt":0.30612846144624856,"score_spread":0.2870491341456241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652329,0.0044809766,0.000062674735,0.007908787,0.018730786,0.0004786949,0.00015542819,0.000004117145,0.0029456404],"genre_scores_gemma":[0.9966892,0.0005850848,0.00073780696,0.0012143358,0.0001696132,0.00002614195,0.000005555265,0.000013593861,0.00055866915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985328,0.00005685387,0.00078273186,0.00021382408,0.00013050166,0.00028329404],"domain_scores_gemma":[0.9962052,0.0029102874,0.00035382548,0.00011273742,0.00023411354,0.0001838501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005957172,0.00013653545,0.0006402457,0.00024651422,0.0000789651,0.000023334056,0.00009110099,0.00015186305,0.00044984717],"category_scores_gemma":[0.0012705358,0.00011821529,0.00012804073,0.00018145252,0.00005743804,0.00004486054,0.000035132223,0.00031748673,4.354291e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005576779,0.00019489293,0.9126653,0.000056243047,0.00045393512,0.00026387337,0.00003934317,0.0000382452,0.0000011839029,0.00038149205,0.004035026,0.081814684],"study_design_scores_gemma":[0.013444486,0.0006513022,0.9377365,0.000031456195,0.00035407988,0.0000049219952,0.0003160661,0.0002561142,0.00001989971,0.00033892586,0.04673666,0.00010955487],"about_ca_topic_score_codex":0.013123314,"about_ca_topic_score_gemma":0.05490611,"teacher_disagreement_score":0.08170513,"about_ca_system_score_codex":0.0016498726,"about_ca_system_score_gemma":0.0047294833,"threshold_uncertainty_score":0.9934484},"labels":[],"label_agreement":null},{"id":"W4415978426","doi":"10.1016/j.ygyno.2025.10.028","title":"Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Center for Clinical and Translational Science, Mayo Clinic; Mayo Clinic","keywords":"Salpingectomy; Ovarian cancer; Serous fluid; Serous ovarian cancer; Fallopian tube; Reduction (mathematics)","score_opus":0.1425214410840193,"score_gpt":0.3961736908832295,"score_spread":0.2536522497992102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415978426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6452771,0.00198342,0.00149432,0.28896847,0.007858834,0.0034382984,0.0001445497,0.0006339158,0.050201103],"genre_scores_gemma":[0.96741176,0.0013174035,0.004195382,0.01900409,0.0002792548,0.0012878219,0.00008772135,0.000033705823,0.006382847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976265,0.00018595265,0.00057166535,0.00071709807,0.00020004768,0.00069875584],"domain_scores_gemma":[0.99809146,0.0006257905,0.00018428013,0.00052986847,0.00018302348,0.00038557142],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037749432,0.0003548216,0.0009561017,0.00037600793,0.00025243594,0.00003489007,0.00022172324,0.00035728505,0.0017593519],"category_scores_gemma":[0.00023458032,0.00030519467,0.00014465803,0.00038233644,0.00015992913,0.000061759456,0.00017275916,0.0003273442,0.00011738886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009913291,0.0041304687,0.112251505,0.00055016787,0.0020611547,0.0069782943,0.00067567674,0.00013955592,0.0041637854,0.050121404,0.12572704,0.6922096],"study_design_scores_gemma":[0.00571293,0.003200826,0.32283336,0.00028321688,0.0011967222,0.00016108282,0.000566905,0.00009974776,0.0014248037,0.0017490581,0.66229486,0.0004764455],"about_ca_topic_score_codex":0.0011700427,"about_ca_topic_score_gemma":0.0022065735,"teacher_disagreement_score":0.6917332,"about_ca_system_score_codex":0.0019150253,"about_ca_system_score_gemma":0.0020662865,"threshold_uncertainty_score":0.99994004},"labels":[],"label_agreement":null},{"id":"W4416018865","doi":"10.1016/j.ijgc.2025.102265","title":"ASSOCIATION OF KELIM INDEX WITH PERITONEAL CANCER INDEX AND CHEMOTHERAPY RESPONSE SCORE IN OVARIAN CANCER PATIENTS UNDERGOING INTERVAL CYTOREDUCTIVE SURGERY- FROM INDEX TO IMPACT","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Ovarian cancer; Index (typography); Chemotherapy; Interval (graph theory); Epithelial ovarian cancer","score_opus":0.015026622035676843,"score_gpt":0.32853083127767924,"score_spread":0.3135042092420024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813703,0.00058913865,0.00012426576,0.0164144,0.0009390114,0.00032867922,0.0001820873,0.0000057509906,0.000046389265],"genre_scores_gemma":[0.99671185,0.0010842297,0.000077851364,0.0016139344,0.0002807014,0.000101170364,0.000007899427,0.000016929762,0.00010541697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797875,0.00014200523,0.0006618913,0.00029356487,0.00068164343,0.00024213167],"domain_scores_gemma":[0.997052,0.0010220071,0.00065103365,0.00009336234,0.0010278678,0.00015373666],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038953673,0.00022202599,0.000671293,0.00047191835,0.000033616892,0.000046881934,0.00016206138,0.00017810226,0.0009176615],"category_scores_gemma":[0.00050571637,0.00015591586,0.00016613548,0.00034051164,0.000065982305,0.00018199114,0.00006270449,0.00035133926,4.593605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022173503,0.0006912194,0.95492715,0.000016244801,0.001997334,0.00006439537,0.00051956414,0.0012101625,0.00020597252,0.000007120619,0.0011508312,0.017036494],"study_design_scores_gemma":[0.007161473,0.00084050413,0.98884743,0.0013343194,0.00012650652,0.0000043237587,0.00013948574,0.000114065515,0.0007625128,0.00012913863,0.0004052128,0.00013500736],"about_ca_topic_score_codex":0.0051970296,"about_ca_topic_score_gemma":0.0057256934,"teacher_disagreement_score":0.03392029,"about_ca_system_score_codex":0.0048751617,"about_ca_system_score_gemma":0.0016707814,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W4416018954","doi":"10.1016/j.ijgc.2025.102488","title":"REAL-WORLD TREATMENT PATTERNS OF PATIENTS WITH ADVANCED PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN CANCER WITHIN THE UNITED STATES: AN ANALYSIS OF SECONDARY DATA","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; MEDLINE; Epithelial ovarian cancer; Cancer; Ovary","score_opus":0.02697586960240581,"score_gpt":0.3421523388154213,"score_spread":0.31517646921301545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416018954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946924,0.0001670676,0.0001323325,0.0018459853,0.00024917707,0.00031553465,0.0024217453,0.0000052760106,0.00017051988],"genre_scores_gemma":[0.99697536,0.001277273,0.00050134485,0.0005360182,0.000054054326,0.000030134765,0.00053685164,0.000009725203,0.00007924433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982482,0.00010533416,0.00073598145,0.00027899435,0.00049653393,0.00013493284],"domain_scores_gemma":[0.99703544,0.00057589635,0.0009368272,0.0002980325,0.0010569346,0.000096861186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021691999,0.00019206092,0.00065916264,0.00046154935,0.00004839511,0.00002300935,0.00026599184,0.00005537016,0.0004958539],"category_scores_gemma":[0.000075476484,0.00010092927,0.000097728014,0.00048215035,0.00013460766,0.00014983746,0.00008786228,0.00017401461,9.30319e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048407447,0.0010646703,0.9504981,0.000024498117,0.011275621,0.000102715734,0.00065115513,0.008571427,0.000061901424,0.0004984223,0.00006317951,0.02234755],"study_design_scores_gemma":[0.0054563265,0.0018219425,0.9853756,0.00032653369,0.002914773,0.0000019134698,0.0005412598,0.002158539,0.0006931828,0.000053071355,0.00056584604,0.00009103111],"about_ca_topic_score_codex":0.0065935287,"about_ca_topic_score_gemma":0.021885866,"teacher_disagreement_score":0.034877468,"about_ca_system_score_codex":0.0006423175,"about_ca_system_score_gemma":0.00048374967,"threshold_uncertainty_score":0.9967487},"labels":[],"label_agreement":null},{"id":"W4416019034","doi":"10.1016/j.ijgc.2025.102498","title":"REVISITING INTRAPERITONEAL CHEMOTHERAPY IN ADVANCED HIGH-GRADE SEROUS OVARIAN CANCER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); McGill University Health Centre","funders":"","keywords":"Serous ovarian cancer; Intraperitoneal chemotherapy; Ovarian cancer; Chemotherapy; Serous fluid; MEDLINE","score_opus":0.016372235080735133,"score_gpt":0.35169512344338855,"score_spread":0.3353228883626534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9146388,0.0039623585,0.00012664108,0.07794395,0.002159836,0.00023214731,0.000019738764,0.000015041694,0.00090145797],"genre_scores_gemma":[0.98340917,0.0070369346,0.0016663036,0.0066902093,0.00083477807,0.000084013445,0.0000042108,0.000011937301,0.00026243564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99848926,0.00004867721,0.00061881234,0.00022640635,0.00039395332,0.0002228865],"domain_scores_gemma":[0.9988756,0.00021532526,0.00029660223,0.00010053656,0.0004150812,0.00009683171],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022304851,0.00016472282,0.00047723047,0.00022948728,0.000033065615,0.000039383744,0.00023372044,0.000117253054,0.0018833635],"category_scores_gemma":[0.00014952788,0.0001219172,0.00016652943,0.00024419412,0.000053768686,0.00012361747,0.000040375257,0.0003676848,0.0000028295467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016300525,0.00078131014,0.4332016,0.000040531333,0.0009332603,0.0009419874,0.00012253018,0.0009913845,0.0023063836,0.0023139743,0.0011352965,0.55560166],"study_design_scores_gemma":[0.008971695,0.00030792062,0.9594345,0.00091864215,0.000103620616,0.000058612513,0.0000665062,0.00009807335,0.0033634014,0.0008695402,0.025678342,0.00012913681],"about_ca_topic_score_codex":0.00034076982,"about_ca_topic_score_gemma":0.00016142223,"teacher_disagreement_score":0.55547255,"about_ca_system_score_codex":0.0014104857,"about_ca_system_score_gemma":0.00046081436,"threshold_uncertainty_score":0.99902904},"labels":[],"label_agreement":null},{"id":"W4416019380","doi":"10.1016/j.ijgc.2025.102201","title":"COMPARATIVE EVALUATION OF GA 68 FAPI-PET SCAN OVER CONVENTIONAL IMAGING FOR PERITONEAL CARCINOMATOSIS DETECTION IN OVARIAN CARCINOMA: A PROSPECTIVE MULTIMODAL IMAGING STUDY","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Peritoneal carcinomatosis; Ovarian cancer; Multimodal therapy; Prospective cohort study; Computed tomography; Ultrasound imaging","score_opus":0.0355565687670968,"score_gpt":0.3973486590170488,"score_spread":0.361792090249952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362415,0.0008622368,0.0006362971,0.0015415534,0.0014302724,0.0013868547,0.000062499785,0.0000061854716,0.00044997447],"genre_scores_gemma":[0.998592,0.00001885127,0.0004347059,0.00015806961,0.00027507584,0.00048017153,0.000010473872,0.000008729156,0.000021919193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786776,0.00015592271,0.0007307799,0.00028595654,0.0007831831,0.00017637163],"domain_scores_gemma":[0.99691623,0.00029953363,0.00047295628,0.00008969756,0.0021554087,0.00006618442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008101154,0.00017185738,0.0005188575,0.00041654982,0.00006045347,0.000036061938,0.00014780804,0.000036713875,0.0004840188],"category_scores_gemma":[0.00024527038,0.00013993189,0.00023561415,0.0002038024,0.00008960858,0.0001878031,0.000048923812,0.00021440285,7.0901604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018233998,0.002012376,0.9837618,0.00002153746,0.0006490312,0.00007430059,0.00057265046,0.0005635695,0.0013875705,0.00017518771,0.00016060115,0.008798015],"study_design_scores_gemma":[0.01718134,0.0005244883,0.9600327,0.0001791212,0.0005335341,0.000054054355,0.0013102408,0.01569749,0.0038445098,0.0004653326,0.000077381505,0.00009982339],"about_ca_topic_score_codex":0.0007714204,"about_ca_topic_score_gemma":0.000669261,"teacher_disagreement_score":0.023729078,"about_ca_system_score_codex":0.002653123,"about_ca_system_score_gemma":0.00076119177,"threshold_uncertainty_score":0.69378245},"labels":[],"label_agreement":null},{"id":"W4416056360","doi":"10.33667/2078-5631-2025-26-14-20","title":"Treatment results for patients with low grade ovarian cancer","year":2025,"lang":"","type":"article","venue":"Medical alphabet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Debulking; Clinical endpoint; Conventional PCI; Ovarian cancer; Medical record; Stage (stratigraphy); Retrospective cohort study; Overall survival","score_opus":0.011730591157347007,"score_gpt":0.30016037228263615,"score_spread":0.28842978112528916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416056360","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39219442,0.032659803,0.0023917765,0.49288,0.01945337,0.026084976,0.012050878,0.00047353283,0.021811249],"genre_scores_gemma":[0.9761172,0.0050587063,0.0006694539,0.004122874,0.001338966,0.003356805,0.0009113915,0.000080315505,0.008344276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500453,0.00011946097,0.0010874498,0.0013616597,0.001281816,0.0011450751],"domain_scores_gemma":[0.99657124,0.0008422705,0.00027101432,0.0009033294,0.00033861343,0.0010735004],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030464242,0.00077455305,0.0013100392,0.00022744821,0.00033014768,0.00007285373,0.00030585504,0.0004934444,0.0014082293],"category_scores_gemma":[0.0004661891,0.0005036006,0.00035630187,0.0006386458,0.00036500528,0.00009278006,0.00008565281,0.0003166943,0.000060866158],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009962151,0.021096455,0.429836,0.00090039585,0.006630261,0.00028908334,0.0006390053,0.00001168909,0.0000016614839,0.0018869328,0.08262318,0.44612318],"study_design_scores_gemma":[0.14944266,0.010817714,0.36550406,0.005677138,0.0044107493,0.0000035902644,0.000067837325,0.00078201183,0.00065691915,0.00021622743,0.4617898,0.0006313145],"about_ca_topic_score_codex":0.0011367018,"about_ca_topic_score_gemma":0.0005604534,"teacher_disagreement_score":0.5839228,"about_ca_system_score_codex":0.0016718195,"about_ca_system_score_gemma":0.0029616642,"threshold_uncertainty_score":0.99974155},"labels":[],"label_agreement":null},{"id":"W4416357438","doi":"10.9734/ijrrgy/2025/v8i1143","title":"Incidental Ovarian Mass Leading to the Diagnosis of Krukenberg Tumor in a Young Woman Presenting with Bowel Obstruction","year":2025,"lang":"","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Bowel obstruction; Krukenberg tumor; Ovary; Adenocarcinoma; Ovarian tumor; Differential diagnosis","score_opus":0.011782587128611379,"score_gpt":0.27191776457966416,"score_spread":0.2601351774510528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416357438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644523,0.0010326785,0.00070907833,0.010801134,0.0012708319,0.002583229,0.000026178093,0.00003925675,0.019085284],"genre_scores_gemma":[0.9936456,0.00024915006,0.0014082055,0.000663864,0.00026470344,0.00095173024,0.000010499872,0.000045177294,0.0027610809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664944,0.00020258673,0.0009994137,0.0008314363,0.00059369433,0.0007234005],"domain_scores_gemma":[0.9981529,0.0004136674,0.0003086402,0.00076774333,0.00016073996,0.00019632069],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065328274,0.00046381936,0.00077971123,0.00057320896,0.0002523618,0.0001354755,0.00030886146,0.000115184164,0.0005499654],"category_scores_gemma":[0.0002336346,0.0003191775,0.00018563753,0.0017276896,0.00014240036,0.0002523907,0.00021462851,0.00038481934,0.000036889858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004465911,0.00068105035,0.9851149,0.00035441862,0.00072342507,0.00021818634,0.0029292987,0.0005039374,0.00018079908,0.0022335928,0.0017573572,0.0048564738],"study_design_scores_gemma":[0.004661486,0.0005332241,0.9657643,0.0030687049,0.000868574,0.00005623557,0.0068014436,0.001016158,0.015923833,0.00014611236,0.00084181456,0.000318152],"about_ca_topic_score_codex":0.01002898,"about_ca_topic_score_gemma":0.011503208,"teacher_disagreement_score":0.02919326,"about_ca_system_score_codex":0.0010541127,"about_ca_system_score_gemma":0.0003868154,"threshold_uncertainty_score":0.99992603},"labels":[],"label_agreement":null},{"id":"W4416379749","doi":"10.1016/j.csda.2025.108305","title":"A semi-parametric approach to receiver operating characteristic analysis with semi-continuous biomarker","year":2025,"lang":"en","type":"article","venue":"Computational Statistics & Data Analysis","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Science Foundation of Fujian Province; Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China","keywords":"Receiver operating characteristic; Estimator; Biomarker; Confidence interval; Youden's J statistic; Classifier (UML); Inference; Coverage probability","score_opus":0.032349528775994,"score_gpt":0.3250317895115824,"score_spread":0.2926822607355884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416379749","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020630049,0.00019116125,0.97030413,0.0005053366,0.000046981855,0.00045650388,0.006782225,0.000046225094,0.0010374088],"genre_scores_gemma":[0.695292,0.000035024048,0.26519665,0.00065363664,0.000037183054,0.000069329784,0.03822059,0.000016449943,0.00047913354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733394,0.00010318726,0.0005996157,0.0010579684,0.0005939567,0.00031130208],"domain_scores_gemma":[0.9974315,0.00058704335,0.0002007362,0.0010200527,0.00052858057,0.00023207432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034801403,0.0003025644,0.0009989459,0.0019036881,0.00021343779,0.00022615366,0.00029834494,0.00006699208,0.00021893723],"category_scores_gemma":[0.00031976224,0.00025062432,0.00016576884,0.010480204,0.00006823231,0.00011574399,0.00020389268,0.00014424851,0.000032571064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021475802,0.0014258188,0.68481976,0.00014623368,0.0721315,0.00014226865,0.00017334789,0.20110238,0.0000093514345,0.0028211044,0.015265452,0.021748036],"study_design_scores_gemma":[0.0005916975,0.000054220924,0.52548563,0.000025601692,0.028903982,0.0000038622616,0.000026183383,0.44381866,0.0000020642635,0.00007502529,0.0008529649,0.00016009106],"about_ca_topic_score_codex":0.000889505,"about_ca_topic_score_gemma":0.000138011,"teacher_disagreement_score":0.70510745,"about_ca_system_score_codex":0.00025654072,"about_ca_system_score_gemma":0.00029135103,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W4416387758","doi":"10.1016/j.annonc.2025.09.049","title":"LBA3 Pembrolizumab vs placebo plus weekly paclitaxel ± bevacizumab in platinum-resistant recurrent ovarian cancer: Results from the randomized double-blind phase III ENGOT-ov65/KEYNOTE-B96 study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Southwest Medical University; University of Science and Technology of China; Tongji Medical College, Huazhong University of Science and Technology; Fourth Military Medical University; Hebei Medical University; Tongji University; Huazhong University of Science and Technology; Chongqing University; Jiangsu Hengrui Medicine","keywords":"Pembrolizumab; Bevacizumab; Placebo; Phases of clinical research; Paclitaxel; Randomized controlled trial","score_opus":0.09908739646318673,"score_gpt":0.4280868963601682,"score_spread":0.3289994998969815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416387758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8975099,0.006212549,0.000052270098,0.07225075,0.0012426643,0.008914852,0.0008114492,0.00006143387,0.012944169],"genre_scores_gemma":[0.99186695,0.002876158,0.0001588466,0.0015967656,0.0003419124,0.0022465037,0.00022727986,0.000036085,0.00064952264],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946224,0.0011157128,0.002049359,0.0009830181,0.00054473226,0.0006847854],"domain_scores_gemma":[0.9932608,0.0042225923,0.0008303084,0.0010777939,0.00039186573,0.00021662586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002480731,0.00052118255,0.0026681714,0.00036582668,0.00018870419,0.000043503012,0.00042257467,0.0003436947,0.00027933187],"category_scores_gemma":[0.00075711077,0.0003583596,0.0003996521,0.0006906716,0.00031512228,0.00010097244,0.00019925302,0.00066163955,0.000013357483],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9133827,0.006778352,0.0007867706,0.000055385666,0.0023848,0.0003175355,0.0059200963,0.00009540514,0.00004384231,0.0015477691,0.0125847785,0.056102548],"study_design_scores_gemma":[0.9536353,0.007280668,0.008112081,0.0007108157,0.0013777239,0.0000042511815,0.0016364068,0.0003229311,0.0005231981,0.0007066121,0.025404925,0.00028508512],"about_ca_topic_score_codex":0.021305159,"about_ca_topic_score_gemma":0.013227576,"teacher_disagreement_score":0.094357066,"about_ca_system_score_codex":0.00075946876,"about_ca_system_score_gemma":0.002420601,"threshold_uncertainty_score":0.9998868},"labels":[],"label_agreement":null},{"id":"W4416446162","doi":"10.1016/j.crad.2025.107180","title":"Ultrasound Ovarian-Adnexal Reporting and Data System (O-RADS) and modified ultrasound simple rules comparison in evaluation of surgically proven adnexal masses","year":2025,"lang":"en","type":"article","venue":"Clinical Radiology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ultrasound; Malignancy; Simple (philosophy); Diagnostic accuracy; Ultrasonography; Patient data","score_opus":0.1928551944199995,"score_gpt":0.4780068391646862,"score_spread":0.28515164474468674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416446162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929349,0.0032324938,0.00023920076,0.00059284235,0.00029210746,0.00091988913,0.00005630059,0.000029712883,0.0017025841],"genre_scores_gemma":[0.9976731,0.000550742,0.0010893852,0.00011530253,0.0001419498,0.000058159396,0.0003383381,0.00001259656,0.000020423553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957261,0.0006586975,0.002293513,0.00081528386,0.00023878446,0.0002676299],"domain_scores_gemma":[0.99356455,0.0044606193,0.00091209146,0.00076304947,0.00016821167,0.00013150659],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006076875,0.00019213608,0.0012598616,0.00011300389,0.000058802354,0.000026073001,0.00014671369,0.00030058762,0.00002246559],"category_scores_gemma":[0.011201055,0.0001566633,0.00007174547,0.00015908545,0.00032990891,0.00007849709,0.0001259028,0.00030336212,0.0000013550628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040964608,0.0004567854,0.98302126,0.0002471277,0.0003210082,0.000047472036,0.000065819164,0.000044166292,0.00016893502,0.0038246794,0.000716826,0.010676257],"study_design_scores_gemma":[0.0059729256,0.0004415875,0.9819048,0.0003708868,0.0007841011,0.00029210545,0.00025507552,0.0081244605,0.00005682503,0.0011014921,0.0005720686,0.00012368542],"about_ca_topic_score_codex":0.00028631472,"about_ca_topic_score_gemma":0.00019297983,"teacher_disagreement_score":0.010552571,"about_ca_system_score_codex":0.00013096558,"about_ca_system_score_gemma":0.0004939026,"threshold_uncertainty_score":0.997128},"labels":[],"label_agreement":null},{"id":"W4416597636","doi":"10.1002/jso.70142","title":"Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High‐Grade Serous Ovarian Cancer: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of Surgical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network; Public Health Ontario; University of Toronto","funders":"University of Toronto","keywords":"Retrospective cohort study; Stage (stratigraphy); Disease; Serous fluid; Overall survival; Residual","score_opus":0.02651185553943936,"score_gpt":0.3713110294539885,"score_spread":0.3447991739145491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416597636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307865,0.0012627768,8.3586497e-7,0.0031556105,0.0003350351,0.00076361565,0.00005127642,0.000005018197,0.0013471782],"genre_scores_gemma":[0.9937281,0.0052521448,0.000043949094,0.000041153588,0.00014460186,0.00006097304,0.0000029654643,0.000011271976,0.00071486033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980405,0.00029230333,0.0007863189,0.00028841355,0.00032878687,0.00026366106],"domain_scores_gemma":[0.9986659,0.0003161988,0.00040077613,0.00017921763,0.00017502344,0.00026282805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047317616,0.00019960443,0.0013619096,0.00024630787,0.000043199645,0.000012526109,0.00007131155,0.00011438522,0.00013050575],"category_scores_gemma":[0.000040636885,0.00013825209,0.000122062214,0.00025290984,0.000112658265,0.000062727304,0.00004306366,0.00023784515,9.305385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049568214,0.0062390952,0.95461905,0.00003856322,0.0007328531,0.019514946,0.00021894768,0.000033125405,0.0000115765515,0.00072911265,0.000040432875,0.0128655],"study_design_scores_gemma":[0.019718813,0.011705159,0.96361995,0.00015368908,0.00089850504,0.00014777033,0.00046327815,0.000014361147,0.00008293182,0.00021902821,0.0028895664,0.0000869266],"about_ca_topic_score_codex":0.0032032297,"about_ca_topic_score_gemma":0.0021182816,"teacher_disagreement_score":0.019367177,"about_ca_system_score_codex":0.0014925795,"about_ca_system_score_gemma":0.0015213579,"threshold_uncertainty_score":0.56377566},"labels":[],"label_agreement":null},{"id":"W4416624684","doi":"10.1016/j.freeradbiomed.2025.11.027","title":"Mutant p53 disrupts antioxidant defense in fallopian tube epithelium via GSTAs suppression: A pathway to serous tubal carcinogenesis","year":2025,"lang":"en","type":"article","venue":"Free Radical Biology and Medicine","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Congressionally Directed Medical Research Programs; Division of Loan Repayment; National Cancer Institute; National Institutes of Health; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; University of Miami; Foundation for Women's Cancer; Chan Zuckerberg Initiative; U.S. Department of Defense","keywords":"Fallopian tube; Serous fluid; Carcinogenesis; Neoplastic transformation; Epithelium; DNA damage; Genome instability; Malignant transformation; Ovary","score_opus":0.012202058889346333,"score_gpt":0.29730648595574566,"score_spread":0.2851044270663993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416624684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9333319,0.008358817,0.00061477645,0.054078624,0.00080286246,0.0008445152,0.00009457654,0.000058086003,0.0018158384],"genre_scores_gemma":[0.99195474,0.001082697,0.000351907,0.005835016,0.00031277767,0.00012322939,0.000063098516,0.000016053571,0.0002604724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805564,0.00014976396,0.00049366575,0.0006395204,0.00016346331,0.00049792865],"domain_scores_gemma":[0.99866486,0.00026179734,0.000051811134,0.0005116919,0.000054291828,0.0004555469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003366633,0.00029787287,0.00082411803,0.00029058265,0.00010601968,0.0000050370554,0.00014708022,0.0002866101,0.00024393406],"category_scores_gemma":[0.00036073264,0.00018976514,0.000078968114,0.00042948584,0.00042736594,0.00002447244,0.00013638289,0.00027138216,0.000012059968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002141238,0.0011535212,0.7956055,0.00033490997,0.00048725758,0.0027578345,0.0010277801,0.0000025350855,0.064246304,0.015241281,0.0060008788,0.111000985],"study_design_scores_gemma":[0.014718054,0.00354267,0.88026315,0.001619463,0.0004595125,0.00047592592,0.0002225264,0.000095577525,0.012280522,0.0032978863,0.08267497,0.00034974737],"about_ca_topic_score_codex":0.0008743701,"about_ca_topic_score_gemma":0.0005050564,"teacher_disagreement_score":0.11065124,"about_ca_system_score_codex":0.0001291918,"about_ca_system_score_gemma":0.00017716276,"threshold_uncertainty_score":0.77383983},"labels":[],"label_agreement":null},{"id":"W4416786712","doi":"10.1016/j.jpag.2025.11.011","title":"Laparoscopy Versus Laparotomy for Surgical Management of Ovarian Dermoid Cysts in Children: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Pediatric and Adolescent Gynecology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; Alberta Health Services; Mount Sinai Hospital; Smiths Detection (Canada); University of Toronto","funders":"","keywords":"Laparotomy; Laparoscopy; Dermoid cyst; Ovarian cyst; Ovarian Teratoma; Peritonitis","score_opus":0.023175719298021286,"score_gpt":0.3258827218351327,"score_spread":0.30270700253711147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416786712","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35674998,0.6269434,0.00028078057,0.008905818,0.0002740196,0.0065133227,0.000055242996,0.000009832619,0.00026759118],"genre_scores_gemma":[0.924357,0.07394752,0.000826604,0.00055651146,0.000056034147,0.00013288592,0.000005217197,0.000007389924,0.000110865934],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9984747,0.00011715494,0.00090328563,0.00019358877,0.00014254452,0.00016873116],"domain_scores_gemma":[0.9987969,0.00032420448,0.0005154713,0.00015519858,0.000110900706,0.00009737194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059417816,0.00015692056,0.002198623,0.0003962704,0.000027411672,0.000008177631,0.00006897365,0.00007499955,0.000043812302],"category_scores_gemma":[0.00007115936,0.00010433941,0.0005177691,0.00048552197,0.000031220916,0.00003280502,0.000039269944,0.00012059819,3.8583664e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010903664,0.0024003147,0.50716424,0.27000567,0.21411794,0.00036628972,0.000041174266,0.000015837682,8.0726926e-7,0.0019103201,0.0027352103,0.00015178969],"study_design_scores_gemma":[0.008619023,0.0005618505,0.17763956,0.0010035379,0.8118702,0.00006197453,0.000032157983,0.000008658796,0.000008497837,0.000042826003,0.00006032303,0.000091350885],"about_ca_topic_score_codex":0.000003827037,"about_ca_topic_score_gemma":0.000004475944,"teacher_disagreement_score":0.5977523,"about_ca_system_score_codex":0.00007542173,"about_ca_system_score_gemma":0.000079018806,"threshold_uncertainty_score":0.42548376},"labels":[],"label_agreement":null},{"id":"W4417059717","doi":"10.1016/b978-0-443-15940-4.00019-1","title":"Oophoropexy","year":2025,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Incidence (geometry); Fertility; Natural history; Clinical Practice","score_opus":0.015586132568245663,"score_gpt":0.26180016113630455,"score_spread":0.24621402856805888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417059717","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005350123,0.006136181,6.6782803e-7,0.0007877958,0.0005327388,0.0007930093,0.000055847722,0.0000782928,0.9916101],"genre_scores_gemma":[0.00030916135,0.0009882514,0.00035922424,0.001999034,0.0005287972,0.0000867903,0.00006172079,0.000069360474,0.99559766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986857,0.0000072974076,0.00033094976,0.00048399696,0.00027113344,0.00022088029],"domain_scores_gemma":[0.9988798,0.0000416473,0.0001130086,0.00070875493,0.00009916857,0.00015763038],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006732045,0.0003883681,0.0007064121,0.00015166913,0.000058910126,0.000022824877,0.00009858381,0.00030063177,0.001546296],"category_scores_gemma":[0.000008842785,0.00031859233,0.00036531058,0.000010101971,0.000071321956,0.000009746241,0.00008075906,0.00035494624,0.0006116409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037427304,0.000026490337,0.00003441777,0.00019639109,0.00055484107,0.00032896904,0.000028393166,2.5191225e-8,0.0000023651917,0.014641574,0.009649354,0.97449976],"study_design_scores_gemma":[0.0009392248,0.00017578476,0.0001255427,0.0019401753,0.0010116698,0.000029920917,0.0000013919365,5.542947e-7,0.000072705494,0.0026207867,0.99284583,0.00023643779],"about_ca_topic_score_codex":9.300316e-7,"about_ca_topic_score_gemma":0.000009319609,"teacher_disagreement_score":0.98319644,"about_ca_system_score_codex":0.00027140608,"about_ca_system_score_gemma":0.00041675073,"threshold_uncertainty_score":0.9999266},"labels":[],"label_agreement":null},{"id":"W4417201296","doi":"10.1158/1557-3265.earlyonsetca25-b019","title":"Abstract B019: Lifestyle and reproductive factors and early-onset invasive epithelial ovarian cancer risk","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre; Université de Montréal; McGill University","funders":"","keywords":"Ovarian cancer; Odds ratio; Logistic regression; Body mass index; Risk factor; Population; Epithelial ovarian cancer; Serous fluid","score_opus":0.12782186633567866,"score_gpt":0.48470631159900196,"score_spread":0.3568844452633233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753756,0.007900985,0.000002014481,0.01356954,0.0005597231,0.0010662074,0.00031557368,0.00003500111,0.0011753339],"genre_scores_gemma":[0.96020466,0.037161186,0.00007882337,0.0003264415,0.0007717751,0.000404367,0.000008938435,0.000029155548,0.0010146459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684966,0.00036739075,0.00058592344,0.0011605463,0.0004906112,0.00054590125],"domain_scores_gemma":[0.99564224,0.0026764765,0.00013445328,0.00064189767,0.00044793598,0.00045701335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020691284,0.00024119265,0.00066791027,0.00022212631,0.00033095456,0.000095204734,0.00013530636,0.00024769036,0.0004336284],"category_scores_gemma":[0.0029805226,0.00017837304,0.00013592243,0.00046460892,0.00086171814,0.00010906407,0.00024741606,0.0012477635,0.00001684245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094008207,0.00034204,0.9569706,0.00014548615,0.0005884803,0.000058721762,0.0003787293,0.0000010465884,0.000059520888,0.00012172983,0.006583724,0.033809856],"study_design_scores_gemma":[0.0033412739,0.00056282966,0.9813069,0.00053181825,0.00023289352,0.0000026283424,0.00021545656,0.0000033529402,0.002160873,0.00095275824,0.010539958,0.000149273],"about_ca_topic_score_codex":0.022945937,"about_ca_topic_score_gemma":0.0024538247,"teacher_disagreement_score":0.033660583,"about_ca_system_score_codex":0.00029814185,"about_ca_system_score_gemma":0.0014988171,"threshold_uncertainty_score":0.9835603},"labels":[],"label_agreement":null},{"id":"W44774962","doi":"10.1016/s1701-2163(16)30596-5","title":"Ovarian Thecoma Associated with a Large Quantity of Ascites and Elevated Serum CA 125 and CA 15-3","year":2002,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Meigs' syndrome; Medicine; Ascites; Cancer antigen; Ovarian cancer; Adnexal mass; Pathology; Tumor marker; CA19-9; Cancer; Internal medicine; Gynecology; Pancreatic cancer","score_opus":0.012611778586209205,"score_gpt":0.2177889353178351,"score_spread":0.2051771567316259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W44774962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882273,0.009418835,0.000004837767,0.0012508843,0.00059310073,0.00013062797,0.00010630338,0.0000023020948,0.0002658074],"genre_scores_gemma":[0.9983818,0.0010089895,0.00012890111,0.00033580355,0.000011770183,0.0000016706774,0.000004069005,0.000010151529,0.00011682179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990136,0.000052457384,0.000340475,0.00013984056,0.0002282897,0.00022531881],"domain_scores_gemma":[0.99802524,0.0010132049,0.0003748349,0.00009314021,0.00027424138,0.00021934045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020312986,0.0001347128,0.00050817855,0.00016573405,0.00009211638,0.00001752709,0.000040571147,0.00010312548,0.0006023763],"category_scores_gemma":[0.0010143731,0.000094981886,0.00003028373,0.00032265266,0.00006683154,0.000056387657,0.000024377785,0.00020406072,1.7054545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009980918,0.00026772663,0.9903545,0.000043052492,0.00059548166,0.0015725568,0.00010549672,0.0000021361764,0.000010059363,0.00010924102,0.0018859464,0.0050438554],"study_design_scores_gemma":[0.0061817574,0.0013524086,0.9881926,0.000033299075,0.00036415446,0.00014092315,0.00014433757,0.0002770057,0.00004729609,0.00002821964,0.003146079,0.00009193042],"about_ca_topic_score_codex":0.010202715,"about_ca_topic_score_gemma":0.087204315,"teacher_disagreement_score":0.0770016,"about_ca_system_score_codex":0.00034080082,"about_ca_system_score_gemma":0.00042371877,"threshold_uncertainty_score":0.99638844},"labels":[],"label_agreement":null},{"id":"W564668927","doi":"10.1200/jco.2009.27.15_suppl.5512","title":"Predictors for optimal cytoreduction following neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; Debulking; Internal medicine; Chemotherapy; Oncology; Stage (stratigraphy); Epithelial ovarian carcinoma; Epithelial ovarian cancer; Ovarian carcinoma; Multivariate analysis; Cancer; Surgery; Gastroenterology","score_opus":0.06119754401351552,"score_gpt":0.43756990917775684,"score_spread":0.37637236516424133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W564668927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701237,0.00042168927,0.0005188425,0.025425265,0.0025917424,0.00045748084,0.000004380589,0.000009204034,0.00044768403],"genre_scores_gemma":[0.9731068,0.00034427588,0.022186646,0.0019349342,0.0023227467,0.000012926433,0.0000038342932,0.000015694746,0.00007212783],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974385,0.000117858646,0.0017296929,0.0002237437,0.00023217947,0.00025803837],"domain_scores_gemma":[0.9980139,0.000577785,0.00083262223,0.00014934708,0.00015678344,0.00026952816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015805981,0.00014597579,0.0012847396,0.00013893054,0.000032627773,0.000007734396,0.000094670555,0.00029749295,0.000046776968],"category_scores_gemma":[0.00075938215,0.000107004096,0.0007433734,0.00011918937,0.000045036246,0.00013259213,0.0000074153886,0.0004495596,0.0000020860173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014777586,0.0043155346,0.18175024,0.000013337201,0.00045797357,0.00080722634,0.0002856847,0.00023583502,0.0008289595,0.00024285814,0.0013867011,0.7948981],"study_design_scores_gemma":[0.040191635,0.033126287,0.88938016,0.00012776774,0.00036314916,0.00017119931,0.00010626486,0.00018322609,0.0007078475,0.00042994256,0.035110172,0.000102345024],"about_ca_topic_score_codex":0.000011012751,"about_ca_topic_score_gemma":0.000007444345,"teacher_disagreement_score":0.79479575,"about_ca_system_score_codex":0.0003902281,"about_ca_system_score_gemma":0.0011005739,"threshold_uncertainty_score":0.43635005},"labels":[],"label_agreement":null},{"id":"W59885241","doi":"10.1007/978-1-4757-3587-1_7","title":"Normal Ovarian Surface Epithelium","year":2002,"lang":"en","type":"review","venue":"Ovarian cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Germinal epithelium; Ovary; Mesothelium; Ovarian cancer; Epithelium; Biology; Stromal cell; Pathology; Cancer research; Cancer; Anatomy; Endocrinology; Medicine; Peritoneum; Spermatogenesis","score_opus":0.06068186222172276,"score_gpt":0.3450413897547842,"score_spread":0.28435952753306143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W59885241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016103826,0.96411026,0.000030981322,0.001495899,0.0018839082,0.001885611,0.0006544227,0.00017835751,0.029758947],"genre_scores_gemma":[0.000022606566,0.9736814,0.0012422628,0.0006115547,0.002280409,0.00070874736,0.00026863633,0.00028012192,0.020904265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960134,0.00016338614,0.0010228328,0.0012446672,0.00061952986,0.00093619083],"domain_scores_gemma":[0.9971804,0.00014689125,0.00054062274,0.0014105559,0.00014842679,0.0005730827],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025023264,0.0010771236,0.0033747717,0.00023823083,0.00018023544,0.00011492412,0.00035701774,0.00077272445,0.016960261],"category_scores_gemma":[0.00002896992,0.0008364076,0.0012638628,0.00079372857,0.00011025321,0.00012601116,0.00013175872,0.00087886,0.0019318048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027875276,0.00039140618,0.00012205181,0.009221367,0.001880355,0.0005441125,0.00006940331,0.000004010172,2.6406988e-7,0.00062519766,0.029903606,0.95721036],"study_design_scores_gemma":[0.0018250825,0.00017936177,0.0001646277,0.01711448,0.0064260243,0.0003280635,0.0000052340547,0.000009380191,0.0000040577147,0.000014107271,0.9731842,0.0007453791],"about_ca_topic_score_codex":0.0007531984,"about_ca_topic_score_gemma":0.000061138126,"teacher_disagreement_score":0.95646495,"about_ca_system_score_codex":0.0013728489,"about_ca_system_score_gemma":0.0013643621,"threshold_uncertainty_score":0.99940866},"labels":[],"label_agreement":null},{"id":"W614208957","doi":"","title":"Gynecologic Cancer: Controversies in Management","year":2004,"lang":"en","type":"book","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gynecologic cancer; Cancer; Medicine; History; Internal medicine; Ovarian cancer","score_opus":0.011989188093651224,"score_gpt":0.27230730869452896,"score_spread":0.2603181206008777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W614208957","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046795863,0.004128542,0.000004640856,0.005115816,0.00032823806,0.0011438866,0.000028081284,0.000040215622,0.98916376],"genre_scores_gemma":[0.0028466752,0.0094842715,0.0003116444,0.0026858507,0.00013071859,0.00032580967,0.00006183948,0.000028246486,0.98412496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989667,0.000006132451,0.0002241905,0.00036946867,0.00019824048,0.00023525387],"domain_scores_gemma":[0.99948585,0.00007488404,0.00007424258,0.00026256198,0.000025675827,0.000076759374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000046472334,0.00024267237,0.00054235134,0.00017036055,0.00001879355,0.000011556083,0.000062704756,0.00018661265,0.0053551905],"category_scores_gemma":[0.0000059080066,0.00018746518,0.00013593733,0.00005078807,0.00004169623,0.000013608598,0.000044898352,0.0001724455,0.00016609929],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032602611,0.0013415263,0.0109269135,0.0023717897,0.0030935823,0.007557121,0.00020548094,0.00019807067,7.3296286e-7,0.163926,0.74190897,0.068143755],"study_design_scores_gemma":[0.0071522486,0.00034550022,0.015821164,0.0012931952,0.000669232,0.000006912703,0.00003081998,0.000002057534,0.000012182483,0.0037895197,0.9706562,0.00022094391],"about_ca_topic_score_codex":0.00030102744,"about_ca_topic_score_gemma":0.0007671412,"teacher_disagreement_score":0.22874723,"about_ca_system_score_codex":0.0059924903,"about_ca_system_score_gemma":0.00098339,"threshold_uncertainty_score":0.99782336},"labels":[],"label_agreement":null},{"id":"W65525566","doi":"","title":"Low-grade endometrioid carcinoma of the ovary associated with undifferentiated carcinoma: case report and review of the literature.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"","keywords":"Carcinoma; Serous carcinoma; Ovarian carcinoma; Ovary; Endometrium; Pathological; Clear cell carcinoma; Serous fluid; Medicine; Pathology; Oncology; Cancer; Internal medicine; Ovarian cancer","score_opus":0.016105365370907943,"score_gpt":0.22132033009288204,"score_spread":0.2052149647219741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W65525566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739629,0.021917164,0.0000012097172,0.001737558,0.00016128868,0.001605228,0.00004768423,0.000010974896,0.0005560073],"genre_scores_gemma":[0.99813706,0.0007222685,0.000010187343,0.0003911805,0.000042291522,0.00038813657,0.000027431875,0.000018494296,0.0002629678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986065,0.00018446044,0.00039743233,0.00025109237,0.00033614252,0.00022437613],"domain_scores_gemma":[0.9983952,0.00019799455,0.00044869518,0.0006744562,0.00018192512,0.00010169867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047405425,0.00016765941,0.00050555967,0.00006841738,0.000062712745,0.000011170354,0.00009368933,0.00006797041,0.000010249457],"category_scores_gemma":[0.00071431696,0.00007688067,0.00016021974,0.0007754049,0.00012465389,0.000030827734,0.0000703872,0.00016342159,1.3063504e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053767017,0.00053628907,0.98836523,0.0024028176,0.00041993588,0.0019305984,0.00017777683,1.5762078e-7,0.000022982074,0.00007175227,0.0008892829,0.0051294346],"study_design_scores_gemma":[0.002310645,0.00009017898,0.9842985,0.0026929541,0.00086712866,0.0044950508,0.000009992099,0.0000030891858,0.0049396115,0.000016509932,0.00020026216,0.000076042175],"about_ca_topic_score_codex":0.00014228554,"about_ca_topic_score_gemma":0.000062392864,"teacher_disagreement_score":0.024174158,"about_ca_system_score_codex":0.00010291319,"about_ca_system_score_gemma":0.00008080981,"threshold_uncertainty_score":0.31351027},"labels":[],"label_agreement":null},{"id":"W6901941729","doi":"10.6084/m9.figshare.16986789.v1","title":"Additional file 1 of Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nipissing University","funders":"","keywords":"MEDLINE; Systematic review; Disease; Identification (biology)","score_opus":0.34593128026194464,"score_gpt":0.3757785661242733,"score_spread":0.029847285862328654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901941729","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008256522,0.122887366,1.0181165e-8,0.00038936,0.000002171128,0.00056821125,0.875853,0.000007823259,0.0002837806],"genre_scores_gemma":[0.00089257373,0.004130061,0.00006868784,0.0021393213,0.000010285318,0.002116983,0.99033356,0.000014029847,0.0002944934],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989196,0.00014364261,0.00037855172,0.00019669688,0.0002893952,0.00007213362],"domain_scores_gemma":[0.9978987,0.0007544811,0.00052053656,0.00026907338,0.00047048726,0.000086719294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044396857,0.00013663805,0.001203108,0.000029766627,0.000021389682,0.000005855378,0.00003788824,0.00003725748,0.95908034],"category_scores_gemma":[0.004292248,0.00008238373,0.00016602907,0.00027830605,0.000009037632,0.0000452993,0.000012095779,0.000057089215,0.000017858829],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.4188925e-7,0.000064058106,0.0000076016822,0.3035056,0.0024249314,0.000006007705,0.0000077634,3.034853e-7,8.4467763e-7,0.0000019880692,0.6939709,0.00000901756],"study_design_scores_gemma":[0.00020225902,0.00018442365,0.0040836516,0.95971537,0.029786332,0.0000054117245,0.000009970966,0.0000030800645,0.00045985458,0.0000030921785,0.005457231,0.00008930957],"about_ca_topic_score_codex":0.000014925588,"about_ca_topic_score_gemma":0.000033321347,"teacher_disagreement_score":0.9590625,"about_ca_system_score_codex":0.000060868522,"about_ca_system_score_gemma":0.00029813006,"threshold_uncertainty_score":0.51385313},"labels":[],"label_agreement":null},{"id":"W6901994820","doi":"10.6084/m9.figshare.14978281.v1","title":"Additional file 1 of The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jadad scale; Cohort; Randomized controlled trial; Funnel plot; Life table; Publication bias; Cohort study; Subgroup analysis","score_opus":0.10112106178380537,"score_gpt":0.3251930714850564,"score_spread":0.22407200970125102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901994820","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004585939,0.035414997,6.869599e-8,0.0015032185,0.0000067019378,0.0005657168,0.96235263,0.0000026798537,0.00010810709],"genre_scores_gemma":[0.04375211,0.0013621812,0.00018177083,0.0012880864,0.00003604458,0.008772547,0.94409007,0.000022904389,0.0004942911],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999086,0.00010850459,0.00039515426,0.00018936058,0.00015669379,0.00006428031],"domain_scores_gemma":[0.9982506,0.0009537846,0.00032603837,0.00025173815,0.00018300784,0.000034831297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006182358,0.000097847704,0.0013226809,0.000052439867,0.00001800806,0.0000052206133,0.000033866876,0.000029409812,0.8713897],"category_scores_gemma":[0.00064284995,0.000062004816,0.00034151884,0.00039085874,0.000012742549,0.000028098617,0.000028244773,0.000063477004,0.0000036968106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012343059,0.0001606572,0.00037081883,0.10350869,0.025359116,0.0000054964735,0.000083559,0.0000012262952,8.4899716e-7,0.000011486889,0.8703198,0.00016599265],"study_design_scores_gemma":[0.0013702605,0.00007446242,0.66620815,0.09705368,0.20570748,0.00005608049,0.00017071725,0.00008215559,0.0001852628,0.000035292993,0.028702978,0.00035348043],"about_ca_topic_score_codex":0.000030722502,"about_ca_topic_score_gemma":0.00011350863,"teacher_disagreement_score":0.871386,"about_ca_system_score_codex":0.00007380413,"about_ca_system_score_gemma":0.00024730052,"threshold_uncertainty_score":0.2528483},"labels":[],"label_agreement":null},{"id":"W6902116547","doi":"10.6084/m9.figshare.12667568","title":"Additional file 1 of Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Table (database); Diagnostic accuracy; Distribution (mathematics); Population; Data file","score_opus":0.037873165258758654,"score_gpt":0.2574579512508132,"score_spread":0.21958478599205455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902116547","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046229103,0.00017876083,4.2540654e-7,0.0018305044,0.000007728723,0.0003443576,0.9967936,0.000018214074,0.00036410487],"genre_scores_gemma":[0.2671773,0.0000056762724,0.00010880959,0.0004877575,0.00009041536,0.0016150102,0.73049396,0.000007779227,0.0000132847645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993655,0.0000132956,0.00015267948,0.00020551946,0.00012838712,0.00013462392],"domain_scores_gemma":[0.9986656,0.00090952095,0.00007883683,0.00009058448,0.00007612454,0.00017937404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000029884677,0.00009962152,0.00022420828,0.000025302434,0.000025105805,0.000010838955,0.000046705136,0.000019081966,0.9318805],"category_scores_gemma":[0.0037643055,0.00009077762,0.000034059412,0.00030218594,0.000007782497,0.000041371863,0.000046703335,0.00006828663,0.00051762036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005370783,0.000100109086,0.0011058649,0.00010465511,0.000028146966,0.000053714448,0.00019701879,0.000029342698,0.0000010022289,9.139825e-7,0.99375486,0.004570639],"study_design_scores_gemma":[0.000410673,0.00012882255,0.3292592,0.0016452738,0.00001742994,0.000002375489,0.00004045413,0.00017969306,0.000013118001,0.0000011445597,0.6682354,0.00006642396],"about_ca_topic_score_codex":0.000040695315,"about_ca_topic_score_gemma":0.000084178486,"teacher_disagreement_score":0.93136287,"about_ca_system_score_codex":0.00007614993,"about_ca_system_score_gemma":0.00015468597,"threshold_uncertainty_score":0.6653135},"labels":[],"label_agreement":null},{"id":"W6906412123","doi":"10.17605/osf.io/pbhs7","title":"Quality of life of ovarian cancer patients treated with combined platinum taxane chemotherapy: protocol for a systematic review","year":2021,"lang":"en","type":"other","venue":"OSF Preprints (OSF Preprints)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Observational study; Systematic review; Protocol (science); Ovarian cancer; Randomized controlled trial; Taxane; Data extraction","score_opus":0.02855097774174179,"score_gpt":0.3302726783350484,"score_spread":0.3017217005933066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6906412123","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052864506,0.00008686674,0.000152204,0.0004657088,0.0000814464,0.5053717,0.0005844634,0.00012702527,0.49260196],"genre_scores_gemma":[0.0013746385,0.0004896794,0.0014013225,0.00036383243,0.00006245249,0.5409355,0.0002847501,0.00040845588,0.45467934],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9951478,0.00055023486,0.0016808315,0.0016016123,0.00069137604,0.000328109],"domain_scores_gemma":[0.9925071,0.00033906696,0.0028770359,0.003441973,0.00059236074,0.00024247215],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015204386,0.0006022069,0.003341091,0.00016372894,0.000035129735,0.00001684668,0.00039874073,0.00035384696,0.314942],"category_scores_gemma":[0.0014805994,0.0004657576,0.0004906549,0.00032290022,0.00012962097,0.000031907675,0.00018354491,0.00022551065,0.002550388],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002145033,0.0049914806,0.10285805,0.7855347,0.0059640734,0.00000886799,0.00019516975,0.0000039984484,0.00009391369,0.00016099404,0.09728072,0.0007629925],"study_design_scores_gemma":[0.04440562,0.00013712984,0.043488063,0.86122143,0.004272974,0.000009689212,0.000052291878,0.000027822585,0.004828244,0.0000541442,0.040284082,0.0012184915],"about_ca_topic_score_codex":0.0017195868,"about_ca_topic_score_gemma":0.00023847209,"teacher_disagreement_score":0.3123916,"about_ca_system_score_codex":0.00032725403,"about_ca_system_score_gemma":0.00080149836,"threshold_uncertainty_score":0.9997794},"labels":[],"label_agreement":null},{"id":"W6920289989","doi":"10.6068/dp15b05f63ce34","title":"TREND: National Center for Education Statistics. Fall Enrollment - Postsecondary Education: Full-Time Undergraduate Students | State: Illinois | Gender: All Gender | Race: All Races/Ethnicities, 2001 - 2015. Data-Planet™ Statistical Datasets by Conquest Systems, Inc. Dataset-ID: 017-005-003","year":2017,"lang":"en","type":"other","venue":"Data Planet","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statistics education; Postsecondary education; Vocational education; Quarter (Canadian coin); Higher education; Liberal arts education; Community college; Center (category theory)","score_opus":0.04686278820268334,"score_gpt":0.36506515966626507,"score_spread":0.3182023714635817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920289989","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.55872e-7,0.011823558,0.00007427051,0.00034071534,0.002614753,0.0033332137,0.97891575,0.00010481373,0.0027922587],"genre_scores_gemma":[0.000011194305,0.011970666,0.0031483425,0.0029005362,0.0013405682,0.0004196633,0.96425563,0.00041467368,0.015538749],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936488,0.00032605228,0.0011589121,0.002171039,0.0017023715,0.0009927851],"domain_scores_gemma":[0.99284333,0.0005208457,0.0013036007,0.0044423994,0.00005697823,0.00083282345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008235657,0.0011048442,0.0013396232,0.00033286714,0.00024001804,0.0006180888,0.0023158228,0.000493045,0.012283902],"category_scores_gemma":[0.00005039808,0.0010314647,0.000008820956,0.000036950554,0.00024580827,0.0005414454,0.0009478168,0.00058410724,0.0018786413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004258774,0.0036957362,0.00011424063,0.0012563003,0.0037996885,0.00013346299,0.000019894547,0.0000031181132,0.0000032586847,0.00017531117,0.9872631,0.0031100507],"study_design_scores_gemma":[0.0045845546,0.00034379357,0.00011194319,0.0001332106,0.0020092041,0.00030498693,0.00006830226,0.0003876004,1.5087153e-7,0.00001628936,0.99113554,0.00090440916],"about_ca_topic_score_codex":0.036550257,"about_ca_topic_score_gemma":0.007511905,"teacher_disagreement_score":0.029038353,"about_ca_system_score_codex":0.00056927087,"about_ca_system_score_gemma":0.0033298314,"threshold_uncertainty_score":0.9992136},"labels":[],"label_agreement":null},{"id":"W6920382916","doi":"10.60692/p7v7k-fqz51","title":"The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Observational study; Quality of life (healthcare); Disease; Ovarian cancer; MEDLINE; Developing country; Developed country","score_opus":0.27733403800113837,"score_gpt":0.3436164350665748,"score_spread":0.06628239706543643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920382916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663643,0.000043202213,0.00034578933,0.0008644012,0.00014959347,0.03179221,0.0003647449,0.0000514251,0.000024329265],"genre_scores_gemma":[0.9307741,0.0000041513126,0.00009582082,0.000093140574,0.00010262667,0.068871275,0.0000058132487,0.000012213912,0.00004085842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986184,0.000078045436,0.0005536492,0.00020673135,0.00036686755,0.00017627006],"domain_scores_gemma":[0.99907136,0.000096190524,0.00017742011,0.00018262128,0.0003138831,0.00015853134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011565312,0.00017649108,0.00035452328,0.0001326298,0.00019036008,0.00028626437,0.000042821754,0.000036167403,0.0000022566676],"category_scores_gemma":[0.0000366452,0.0001079708,0.0000142362705,0.0000983567,0.00003635136,0.00043175754,0.00005477322,0.00004759999,7.3143065e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021050524,0.000057856014,0.8172302,0.013847844,0.000544064,0.0000037546613,0.16485891,0.000009044124,3.4455215e-7,0.0006028256,0.000006566477,0.0007335245],"study_design_scores_gemma":[0.003362324,0.0011228266,0.81387293,0.0011037419,0.00006573862,0.0000034320678,0.1799261,0.00017360855,0.000005533999,4.4964983e-7,0.0002553926,0.000107940505],"about_ca_topic_score_codex":0.00015926718,"about_ca_topic_score_gemma":0.00011919551,"teacher_disagreement_score":0.037079066,"about_ca_system_score_codex":0.00019026839,"about_ca_system_score_gemma":0.00022805094,"threshold_uncertainty_score":0.44029215},"labels":[],"label_agreement":null},{"id":"W6920543020","doi":"10.60692/9fbzz-h8t81","title":"MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum","year":2020,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemotherapy; Clinical endpoint; Progression-free survival; Serous fluid; Overall survival; Chemotherapy regimen; Interim analysis; Randomized controlled trial","score_opus":0.06215989570715908,"score_gpt":0.25172684515831967,"score_spread":0.1895669494511606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920543020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310607,0.00006786816,0.000018983106,0.0027098542,0.0006905973,0.0015898654,0.00013267552,0.000083863735,0.001600221],"genre_scores_gemma":[0.99755245,0.0000068811355,0.00012493531,0.0017641254,0.00024066116,0.0001698577,0.00003577524,0.000025179737,0.000080129204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805415,0.000086982225,0.0007815462,0.00027055197,0.0005021848,0.00030460092],"domain_scores_gemma":[0.99883324,0.000031891377,0.00036584007,0.0004813823,0.00012495473,0.00016271934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012943301,0.00030466044,0.00059721456,0.0001266808,0.00008250849,0.00004957111,0.00020930277,0.00011468658,0.00003915482],"category_scores_gemma":[0.000026128353,0.0001778916,0.00027558717,0.0005484974,0.00005277246,0.0002325939,0.00006989845,0.0001848499,0.000059627877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018253379,0.00033117094,0.6897579,0.01106288,0.001558222,0.00006197333,0.26698387,0.00028226525,0.00006997541,0.0000716612,0.0018301171,0.0097365985],"study_design_scores_gemma":[0.030643255,0.0028634928,0.9233073,0.0026546929,0.00050143426,0.000055584078,0.024518488,0.0023949004,0.0041248547,9.5150675e-8,0.008378747,0.00055715366],"about_ca_topic_score_codex":0.00007882429,"about_ca_topic_score_gemma":0.0000053508693,"teacher_disagreement_score":0.24246538,"about_ca_system_score_codex":0.00048132698,"about_ca_system_score_gemma":0.0002644209,"threshold_uncertainty_score":0.7254209},"labels":[],"label_agreement":null},{"id":"W6920562297","doi":"10.6084/m9.figshare.22598687","title":"Additional file 3 of Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovulation induction; Table (database); Cohort; Drug; Quality (philosophy); Ovulation","score_opus":0.08064173167437573,"score_gpt":0.31900183202877863,"score_spread":0.23836010035440292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920562297","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024347328,0.0049597914,4.7287024e-8,0.0007171363,0.0000034423836,0.000585882,0.9935882,0.00003127131,0.000089889705],"genre_scores_gemma":[0.0059710816,0.00013159843,0.00007486627,0.0002732391,0.000022730546,0.0033849129,0.9891348,0.000008986161,0.0009977893],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9993039,0.00005152278,0.00022733764,0.0001957916,0.00015060225,0.00007085053],"domain_scores_gemma":[0.9992796,0.00017189031,0.00017553203,0.00017904173,0.00012550798,0.000068426365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000042969292,0.00009329945,0.0007122556,0.00012088176,0.000039274848,0.000012562308,0.00002205691,0.000033537086,0.97838765],"category_scores_gemma":[0.00021469843,0.00006754219,0.00013982166,0.0005656894,0.000004706529,0.00009306981,0.000017717262,0.000040957777,0.000110703964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016428222,0.000021723296,0.000005727773,0.021211183,0.013839695,0.0000037293232,0.000023880646,0.0000035649384,3.4103212e-7,0.000002526371,0.96485287,0.000033094388],"study_design_scores_gemma":[0.0007452065,0.00016465966,0.06868216,0.0412842,0.7826576,0.000036865607,0.000107586675,0.001227087,0.000053344615,0.00004759724,0.10461695,0.00037670392],"about_ca_topic_score_codex":0.000041784,"about_ca_topic_score_gemma":0.00005000775,"teacher_disagreement_score":0.97827697,"about_ca_system_score_codex":0.000028700611,"about_ca_system_score_gemma":0.00004298299,"threshold_uncertainty_score":0.27542904},"labels":[],"label_agreement":null},{"id":"W6920649231","doi":"10.6084/m9.figshare.11979111","title":"Additional file 1 of Lipid profile and risk of ovarian tumours: a meta-analysis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lipid profile; Comparability; Funnel plot; Table (database); Triglyceride; Selection (genetic algorithm); Cholesterol","score_opus":0.07339700485369718,"score_gpt":0.2718061034760006,"score_spread":0.1984090986223034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920649231","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022623566,0.00030981164,2.732082e-7,0.00049645524,0.0000018692111,0.00019415095,0.99642533,0.000011630872,0.0025378626],"genre_scores_gemma":[0.02033057,0.0000057997436,0.0018746656,0.00020000925,0.00009228019,0.0010407852,0.9761173,0.000010282939,0.00032830413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993137,0.000028067332,0.00019503915,0.00019923496,0.00018319378,0.000080736834],"domain_scores_gemma":[0.99886686,0.0005325368,0.00020864225,0.00015202064,0.00012576456,0.00011419618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000013759032,0.00009604616,0.0005792264,0.00005684122,0.000018588806,0.0000052715254,0.000041162955,0.000038772156,0.99855083],"category_scores_gemma":[0.0011595889,0.000071188806,0.00047523156,0.00032869467,0.000008738687,0.00003219916,0.000035487257,0.000064565655,0.00028333085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002073167,0.000086294865,0.00016275414,0.00013218056,0.029921023,0.000008690628,0.000055182336,0.0000034762595,0.0000010205871,0.0000023774223,0.96938676,0.00021953537],"study_design_scores_gemma":[0.00066236156,0.00044851034,0.08581202,0.000277787,0.077973016,0.0000045487654,0.000044308978,0.0004038546,0.0006332879,0.0000070408614,0.8336123,0.00012092576],"about_ca_topic_score_codex":0.000015734948,"about_ca_topic_score_gemma":0.000007228314,"teacher_disagreement_score":0.9982675,"about_ca_system_score_codex":0.000010242812,"about_ca_system_score_gemma":0.00008840816,"threshold_uncertainty_score":0.36417395},"labels":[],"label_agreement":null},{"id":"W6920721125","doi":"10.6084/m9.figshare.14978281","title":"Additional file 1 of The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jadad scale; Cohort; Randomized controlled trial; Funnel plot; Life table; Publication bias; Cohort study; Subgroup analysis","score_opus":0.10112106178380537,"score_gpt":0.3251930714850564,"score_spread":0.22407200970125102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920721125","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004585939,0.035414997,6.869599e-8,0.0015032185,0.0000067019378,0.0005657168,0.96235263,0.0000026798537,0.00010810709],"genre_scores_gemma":[0.04375211,0.0013621812,0.00018177083,0.0012880864,0.00003604458,0.008772547,0.94409007,0.000022904389,0.0004942911],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999086,0.00010850459,0.00039515426,0.00018936058,0.00015669379,0.00006428031],"domain_scores_gemma":[0.9982506,0.0009537846,0.00032603837,0.00025173815,0.00018300784,0.000034831297],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006182358,0.000097847704,0.0013226809,0.000052439867,0.00001800806,0.0000052206133,0.000033866876,0.000029409812,0.8713897],"category_scores_gemma":[0.00064284995,0.000062004816,0.00034151884,0.00039085874,0.000012742549,0.000028098617,0.000028244773,0.000063477004,0.0000036968106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012343059,0.0001606572,0.00037081883,0.10350869,0.025359116,0.0000054964735,0.000083559,0.0000012262952,8.4899716e-7,0.000011486889,0.8703198,0.00016599265],"study_design_scores_gemma":[0.0013702605,0.00007446242,0.66620815,0.09705368,0.20570748,0.00005608049,0.00017071725,0.00008215559,0.0001852628,0.000035292993,0.028702978,0.00035348043],"about_ca_topic_score_codex":0.000030722502,"about_ca_topic_score_gemma":0.00011350863,"teacher_disagreement_score":0.871386,"about_ca_system_score_codex":0.00007380413,"about_ca_system_score_gemma":0.00024730052,"threshold_uncertainty_score":0.2528483},"labels":[],"label_agreement":null},{"id":"W6920756957","doi":"10.6084/m9.figshare.19695689","title":"Additional file 2 of Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chemotherapy; Mutation; Somatic cell; Ovarian carcinoma; Germline mutation; Serous fluid; Carcinoma","score_opus":0.02157750657597172,"score_gpt":0.2711119931025418,"score_spread":0.2495344865265701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920756957","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047732525,0.000046696485,3.128796e-8,0.00011453347,0.000012817597,0.0003485197,0.9513384,0.000010932438,0.00039553162],"genre_scores_gemma":[0.49149698,6.695456e-7,0.00011078677,0.00006542011,0.000021968173,0.00081565557,0.5074296,0.000011201334,0.000047719714],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991481,0.000036482277,0.00022288813,0.00016055722,0.00027540576,0.00015661881],"domain_scores_gemma":[0.9991156,0.00041752,0.0001767289,0.00018214104,0.000046763304,0.00006126531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000014616957,0.000108302615,0.00025403642,0.00013165991,0.000029224893,0.0000037268971,0.000048394842,0.00003044251,0.9864226],"category_scores_gemma":[0.00017712773,0.00009519583,0.000114667986,0.00022719613,0.0000047818908,0.00003089136,0.000020772337,0.00010176186,0.00007895729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001259178,0.0007187041,0.000847342,0.00011110809,0.000081501974,0.00010021353,0.00025840526,0.00036850595,0.000015742551,0.0000045476363,0.9934961,0.003871882],"study_design_scores_gemma":[0.0032370081,0.0019206594,0.97071284,0.0013121208,0.000017384735,0.000027958886,0.00008883397,0.0004519353,0.000425597,0.000057943147,0.021653147,0.00009458572],"about_ca_topic_score_codex":0.0003059506,"about_ca_topic_score_gemma":0.000018423936,"teacher_disagreement_score":0.9863437,"about_ca_system_score_codex":0.00042995112,"about_ca_system_score_gemma":0.0003705293,"threshold_uncertainty_score":0.38819733},"labels":[],"label_agreement":null},{"id":"W6920842070","doi":"10.6084/m9.figshare.22606205.v1","title":"Additional file 1 of The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Disease; Ovarian cancer; Serous ovarian cancer; Mifepristone; Antibody; Serous fluid; Table (database); Ovary","score_opus":0.04297948579879099,"score_gpt":0.28178886410076887,"score_spread":0.23880937830197788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920842070","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042940117,0.00021579713,5.9021946e-8,0.0018897149,0.000046398105,0.0005217394,0.99294436,0.000033380926,0.00005451267],"genre_scores_gemma":[0.18378954,0.000014859973,0.00014732017,0.00019480442,0.00010185551,0.004012759,0.811312,0.000019504712,0.0004073364],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905264,0.00004228373,0.00017455008,0.00020773424,0.00036628178,0.00015650774],"domain_scores_gemma":[0.9989861,0.00032663348,0.00021070418,0.00024434974,0.00011706608,0.000115108785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000019892805,0.00012414844,0.00023020408,0.000048071055,0.00006209552,0.0000065015147,0.000060674316,0.000038217517,0.9012046],"category_scores_gemma":[0.0002842337,0.00008512374,0.00009810129,0.00033288842,0.000027484908,0.00003848074,0.000054779433,0.00008278184,0.00018294167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025337138,0.00025752632,0.000049279737,0.00053100486,0.00009120325,0.000029489696,0.000061205625,0.0000069319335,0.00019506855,0.0000029749451,0.9973198,0.0014301542],"study_design_scores_gemma":[0.0024717636,0.0002926939,0.26462147,0.029435685,0.00041569798,0.000010955017,0.000078284196,0.00014298587,0.07629982,0.00013759703,0.6257856,0.00030744055],"about_ca_topic_score_codex":0.00011760961,"about_ca_topic_score_gemma":0.0000926175,"teacher_disagreement_score":0.9010216,"about_ca_system_score_codex":0.000081008984,"about_ca_system_score_gemma":0.0001843013,"threshold_uncertainty_score":0.34712455},"labels":[],"label_agreement":null},{"id":"W6920877040","doi":"10.6084/m9.figshare.12299846.v1","title":"Additional file 3 of Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genotype; Gene; Expression quantitative trait loci; Serous ovarian cancer; Ovarian cancer; Gene expression; Adjuvant chemotherapy; Trait","score_opus":0.036014446556749825,"score_gpt":0.26992586341624336,"score_spread":0.23391141685949354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920877040","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008235986,0.0003920376,0.000002054682,0.0014451962,0.0000053609897,0.00033756165,0.9895178,0.000023209417,0.00004080152],"genre_scores_gemma":[0.24703223,0.000016351447,0.0010383079,0.0010822976,0.000076508295,0.0012524921,0.7494028,0.000031311152,0.000067676294],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99918497,0.00006786136,0.00016389573,0.00025507645,0.00017368676,0.00015450644],"domain_scores_gemma":[0.99873275,0.0008396164,0.00014116685,0.000087149616,0.00008243837,0.00011685487],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00002125381,0.00013902558,0.00030622273,0.000036829704,0.00002929434,0.000009250312,0.000040696188,0.000089780966,0.86188763],"category_scores_gemma":[0.00050550455,0.00010822692,0.000036964702,0.00022591524,0.000013601295,0.000050249313,0.0000141434575,0.00012939991,0.000013875779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019698185,0.0001857279,0.0001776043,0.00004256414,0.000120493765,0.00011190607,0.00041220096,0.0003189403,0.00008228943,0.0000010085266,0.99569166,0.0008858072],"study_design_scores_gemma":[0.007846489,0.001957771,0.89954025,0.011681973,0.000051778647,0.000008387942,0.00014851091,0.003166351,0.0015440936,0.000005919611,0.07379398,0.00025452615],"about_ca_topic_score_codex":0.000034836343,"about_ca_topic_score_gemma":0.00005436906,"teacher_disagreement_score":0.92189765,"about_ca_system_score_codex":0.000100031226,"about_ca_system_score_gemma":0.00018841152,"threshold_uncertainty_score":0.44133657},"labels":[],"label_agreement":null},{"id":"W6920986934","doi":"10.6084/m9.figshare.7257455","title":"Additional file 1: of Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cause of death; Population; Table (database); Mortality rate; Epidemiology","score_opus":0.018645706157373685,"score_gpt":0.2520846032640139,"score_spread":0.2334388971066402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920986934","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45105803,0.0000046099144,9.074947e-9,0.000010612905,0.000012908134,0.00039307761,0.5484237,0.0000079586525,0.000089065834],"genre_scores_gemma":[0.59369266,9.762253e-8,0.000014468561,0.00008928684,0.00010987634,0.0032250953,0.40270707,0.0000115604,0.0001498837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989065,0.000028088902,0.00022230293,0.00027726684,0.0003490809,0.00021677259],"domain_scores_gemma":[0.99915886,0.00017795245,0.000137796,0.00021665578,0.00017965489,0.00012910122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018624398,0.0000937303,0.00027100943,0.00002766153,0.00006388641,0.000039168317,0.000065487824,0.000041723084,0.9871056],"category_scores_gemma":[0.00018806935,0.000120638484,0.000025538578,0.00020860416,0.000012522605,0.00005068717,0.000018119796,0.000077902994,0.00001937258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018562725,0.00026461447,0.55208915,0.00005171424,0.000071284754,0.00021932488,0.00002377861,0.0000025312195,3.159325e-8,6.3499557e-9,0.44609287,0.0011661059],"study_design_scores_gemma":[0.001824599,0.00046325495,0.9898738,0.0038740342,0.000028219947,0.0000038333837,0.000041937677,0.00001883364,0.0000030298702,7.041739e-7,0.0037493776,0.00011833189],"about_ca_topic_score_codex":0.916329,"about_ca_topic_score_gemma":0.9990296,"teacher_disagreement_score":0.98708624,"about_ca_system_score_codex":0.0007324362,"about_ca_system_score_gemma":0.0017819408,"threshold_uncertainty_score":0.49194947},"labels":[],"label_agreement":null},{"id":"W6925035344","doi":"10.16577/j.issn.1001-1560.2025.0071","title":"Study on the Structural Optimization of Diffuser Guide Vanes for LNG High-Pressure Pump Expander","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Petro-Canada","funders":"","keywords":"Impeller; Diffuser (optics); Fillet (mechanics); Inlet; Stress (linguistics); Bending; Reliability (semiconductor); Stress concentration","score_opus":0.2036410753896091,"score_gpt":0.5555244620578785,"score_spread":0.35188338666826946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6925035344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847206,0.006269661,0.0006096705,0.0023494873,0.0007912631,0.002907312,0.00008383209,0.00002246179,0.0022457526],"genre_scores_gemma":[0.99644077,0.0013711754,0.0002927684,0.0005265864,0.00013458738,0.000246511,0.00001774866,0.00003254092,0.00093732425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998088,0.00013878226,0.0007120614,0.0003561442,0.00048266965,0.0002223249],"domain_scores_gemma":[0.99780357,0.00059793424,0.000519956,0.0005806428,0.0004057089,0.00009220769],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053427386,0.0002592486,0.00075705256,0.00035752403,0.00021054156,0.00028976315,0.0008126659,0.000074858006,0.002839306],"category_scores_gemma":[0.0002677225,0.00015951479,0.0001825635,0.00047041278,0.00006774474,0.00041530508,0.0002720499,0.00017321203,9.916391e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012394917,0.0017835712,0.92014503,0.00026261437,0.0032424012,0.000026809372,0.00056462287,0.012351247,0.0038876522,0.0013459055,0.049430426,0.005720243],"study_design_scores_gemma":[0.003675289,0.000107802785,0.9679416,0.000664703,0.0011105267,0.0000028214247,0.00052413566,0.00027262914,0.021347148,0.0012348946,0.0029439281,0.00017454711],"about_ca_topic_score_codex":0.00059956743,"about_ca_topic_score_gemma":0.000040405088,"teacher_disagreement_score":0.047796555,"about_ca_system_score_codex":0.000087717905,"about_ca_system_score_gemma":0.00014770213,"threshold_uncertainty_score":0.9980722},"labels":[],"label_agreement":null},{"id":"W6930674117","doi":"10.5281/zenodo.15218019","title":"FIGURES 121–126 in Revision of the western Nearctic species of Empis subgenus Enoplempis (Diptera: Empididae)","year":2025,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Femur; Tibia; Hindlimb; Subgenus; Lower limb","score_opus":0.03002854098848064,"score_gpt":0.27152944710095844,"score_spread":0.2415009061124778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930674117","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004111833,0.0026676806,0.00006281318,0.0027922466,0.00025008965,0.0016807081,0.0008463631,0.00020894605,0.9873793],"genre_scores_gemma":[0.4694295,0.0051096384,0.00018342074,0.0003575,0.00033448442,2.073939e-7,0.0010932432,0.003908361,0.51958364],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981988,0.00027293342,0.00041986085,0.00039802614,0.0004668492,0.00024353406],"domain_scores_gemma":[0.99851584,0.00003887717,0.00029025387,0.00080438505,0.00027167957,0.00007893861],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002955766,0.00021365889,0.00047946908,0.0004179217,0.00019347899,0.00007530049,0.0005624113,0.00014005021,0.02562331],"category_scores_gemma":[0.00036103325,0.00016551817,0.00014165672,0.0006293461,0.00022573395,0.000037578287,0.000664812,0.00027982285,0.0005792536],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001183573,0.00048521825,0.0015583843,0.0014631064,0.0002460095,0.00002732465,0.00096682174,0.000004389822,0.00026428464,0.0005297989,0.9487209,0.045615442],"study_design_scores_gemma":[0.0010433741,0.00027015593,0.018110406,0.0023189182,0.00010979384,0.000015010535,0.00009256261,0.0000036546346,0.00073841744,0.000013861034,0.9771691,0.000114737064],"about_ca_topic_score_codex":0.00033688082,"about_ca_topic_score_gemma":0.0000130998305,"teacher_disagreement_score":0.46779567,"about_ca_system_score_codex":0.00019465017,"about_ca_system_score_gemma":0.000029087052,"threshold_uncertainty_score":0.9752674},"labels":[],"label_agreement":null},{"id":"W6930796534","doi":"10.5281/zenodo.15218150","title":"FIGURES 355–358 in Revision of the western Nearctic species of Empis subgenus Enoplempis (Diptera: Empididae)","year":2025,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Subgenus; Nearctic ecozone; Dorsum; Head (geology); Taxonomy (biology)","score_opus":0.029990137388925395,"score_gpt":0.27178109234262654,"score_spread":0.24179095495370115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930796534","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040581967,0.00261518,0.000063717154,0.0027557304,0.00024928048,0.0016790762,0.00084059197,0.00020842582,0.9875298],"genre_scores_gemma":[0.46260217,0.0049920077,0.0001854896,0.0003565204,0.00032978758,2.0410229e-7,0.0010872739,0.003889895,0.5265567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819875,0.0002723028,0.0004199031,0.000398306,0.0004670185,0.0002437003],"domain_scores_gemma":[0.9985153,0.000038900744,0.00029031982,0.00080469024,0.00027183478,0.00007895498],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002943011,0.0002133685,0.00048040797,0.0004188733,0.00019376882,0.00007534856,0.0005628645,0.00014020815,0.026180936],"category_scores_gemma":[0.0003600899,0.00016561919,0.00014168248,0.0006362392,0.00022625185,0.000037610873,0.0006724011,0.00028006913,0.00058124925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013671165,0.00048790756,0.0014038408,0.001481992,0.00024720395,0.00002748292,0.00092330214,0.0000043547047,0.00024418376,0.00054111466,0.9483764,0.046125494],"study_design_scores_gemma":[0.0010403462,0.00027131222,0.020567814,0.002308582,0.000109519926,0.000015116326,0.0000852781,0.000003651023,0.0007451071,0.000014311711,0.9747244,0.00011457722],"about_ca_topic_score_codex":0.00035273598,"about_ca_topic_score_gemma":0.000014047403,"teacher_disagreement_score":0.46097314,"about_ca_system_score_codex":0.00019860426,"about_ca_system_score_gemma":0.000028949076,"threshold_uncertainty_score":0.9747093},"labels":[],"label_agreement":null},{"id":"W6938997763","doi":"10.60692/5ngbv-c2217","title":"Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis","year":2019,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mendelian randomization; Ovarian cancer; Observational study; Single-nucleotide polymorphism; Confounding; Case-control study; Epithelial ovarian cancer; Odds ratio; Risk factor","score_opus":0.016520232406038105,"score_gpt":0.23765565001168426,"score_spread":0.22113541760564615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6938997763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515706,0.000024451816,0.002054819,0.00016737808,0.00014618065,0.001348606,0.00018446708,0.000047502384,0.00086955674],"genre_scores_gemma":[0.9995469,0.0000064733454,0.00008362898,0.00008069816,0.000046909547,0.00013484902,0.00006739497,0.000010189025,0.00002298052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981145,0.00017961023,0.00097127847,0.00017902718,0.00035655402,0.00019898622],"domain_scores_gemma":[0.9980578,0.000035446363,0.0011748608,0.0004974295,0.00017756998,0.000056881305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070414506,0.00017539412,0.0005679701,0.00045617795,0.00007396218,0.000054346518,0.00007592041,0.000109246015,0.00008354067],"category_scores_gemma":[0.000053598582,0.000103802,0.00022821438,0.0008415412,0.000018214592,0.00026212132,0.000020076355,0.00014469493,0.000033277043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029599585,0.0000064642504,0.9530329,0.00008908632,0.0011621977,0.0000013783545,0.03977571,0.0048397505,0.0000021380008,0.000015935815,0.000005425206,0.00077300996],"study_design_scores_gemma":[0.008041055,0.00006735721,0.9545499,0.0002234203,0.0024915691,0.0000063831153,0.009336137,0.02362363,0.0013124973,0.000001691322,0.00021725698,0.00012909825],"about_ca_topic_score_codex":0.0024532762,"about_ca_topic_score_gemma":0.000019068562,"teacher_disagreement_score":0.030439574,"about_ca_system_score_codex":0.00023698347,"about_ca_system_score_gemma":0.00009508227,"threshold_uncertainty_score":0.42329225},"labels":[],"label_agreement":null},{"id":"W6939397034","doi":"10.6084/m9.figshare.11979111.v1","title":"Additional file 1 of Lipid profile and risk of ovarian tumours: a meta-analysis","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lipid profile; Comparability; Funnel plot; Table (database); Triglyceride; Selection (genetic algorithm); Cholesterol","score_opus":0.07339700485369718,"score_gpt":0.2718061034760006,"score_spread":0.1984090986223034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939397034","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022623566,0.00030981164,2.732082e-7,0.00049645524,0.0000018692111,0.00019415095,0.99642533,0.000011630872,0.0025378626],"genre_scores_gemma":[0.02033057,0.0000057997436,0.0018746656,0.00020000925,0.00009228019,0.0010407852,0.9761173,0.000010282939,0.00032830413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993137,0.000028067332,0.00019503915,0.00019923496,0.00018319378,0.000080736834],"domain_scores_gemma":[0.99886686,0.0005325368,0.00020864225,0.00015202064,0.00012576456,0.00011419618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000013759032,0.00009604616,0.0005792264,0.00005684122,0.000018588806,0.0000052715254,0.000041162955,0.000038772156,0.99855083],"category_scores_gemma":[0.0011595889,0.000071188806,0.00047523156,0.00032869467,0.000008738687,0.00003219916,0.000035487257,0.000064565655,0.00028333085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002073167,0.000086294865,0.00016275414,0.00013218056,0.029921023,0.000008690628,0.000055182336,0.0000034762595,0.0000010205871,0.0000023774223,0.96938676,0.00021953537],"study_design_scores_gemma":[0.00066236156,0.00044851034,0.08581202,0.000277787,0.077973016,0.0000045487654,0.000044308978,0.0004038546,0.0006332879,0.0000070408614,0.8336123,0.00012092576],"about_ca_topic_score_codex":0.000015734948,"about_ca_topic_score_gemma":0.000007228314,"teacher_disagreement_score":0.9982675,"about_ca_system_score_codex":0.000010242812,"about_ca_system_score_gemma":0.00008840816,"threshold_uncertainty_score":0.36417395},"labels":[],"label_agreement":null},{"id":"W6939433636","doi":"10.6084/m9.figshare.12667568.v1","title":"Additional file 1 of Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Table (database); Diagnostic accuracy; Distribution (mathematics); Population; Data file","score_opus":0.037873165258758654,"score_gpt":0.2574579512508132,"score_spread":0.21958478599205455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939433636","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046229103,0.00017876083,4.2540654e-7,0.0018305044,0.000007728723,0.0003443576,0.9967936,0.000018214074,0.00036410487],"genre_scores_gemma":[0.2671773,0.0000056762724,0.00010880959,0.0004877575,0.00009041536,0.0016150102,0.73049396,0.000007779227,0.0000132847645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993655,0.0000132956,0.00015267948,0.00020551946,0.00012838712,0.00013462392],"domain_scores_gemma":[0.9986656,0.00090952095,0.00007883683,0.00009058448,0.00007612454,0.00017937404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000029884677,0.00009962152,0.00022420828,0.000025302434,0.000025105805,0.000010838955,0.000046705136,0.000019081966,0.9318805],"category_scores_gemma":[0.0037643055,0.00009077762,0.000034059412,0.00030218594,0.000007782497,0.000041371863,0.000046703335,0.00006828663,0.00051762036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005370783,0.000100109086,0.0011058649,0.00010465511,0.000028146966,0.000053714448,0.00019701879,0.000029342698,0.0000010022289,9.139825e-7,0.99375486,0.004570639],"study_design_scores_gemma":[0.000410673,0.00012882255,0.3292592,0.0016452738,0.00001742994,0.000002375489,0.00004045413,0.00017969306,0.000013118001,0.0000011445597,0.6682354,0.00006642396],"about_ca_topic_score_codex":0.000040695315,"about_ca_topic_score_gemma":0.000084178486,"teacher_disagreement_score":0.93136287,"about_ca_system_score_codex":0.00007614993,"about_ca_system_score_gemma":0.00015468597,"threshold_uncertainty_score":0.6653135},"labels":[],"label_agreement":null},{"id":"W6939451094","doi":"10.60692/89883-kv560","title":"The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"Observational study; Quality of life (healthcare); Disease; Ovarian cancer; MEDLINE; Developing country; Developed country","score_opus":0.27733403800113837,"score_gpt":0.3436164350665748,"score_spread":0.06628239706543643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939451094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663643,0.000043202213,0.00034578933,0.0008644012,0.00014959347,0.03179221,0.0003647449,0.0000514251,0.000024329265],"genre_scores_gemma":[0.9307741,0.0000041513126,0.00009582082,0.000093140574,0.00010262667,0.068871275,0.0000058132487,0.000012213912,0.00004085842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986184,0.000078045436,0.0005536492,0.00020673135,0.00036686755,0.00017627006],"domain_scores_gemma":[0.99907136,0.000096190524,0.00017742011,0.00018262128,0.0003138831,0.00015853134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011565312,0.00017649108,0.00035452328,0.0001326298,0.00019036008,0.00028626437,0.000042821754,0.000036167403,0.0000022566676],"category_scores_gemma":[0.0000366452,0.0001079708,0.0000142362705,0.0000983567,0.00003635136,0.00043175754,0.00005477322,0.00004759999,7.3143065e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021050524,0.000057856014,0.8172302,0.013847844,0.000544064,0.0000037546613,0.16485891,0.000009044124,3.4455215e-7,0.0006028256,0.000006566477,0.0007335245],"study_design_scores_gemma":[0.003362324,0.0011228266,0.81387293,0.0011037419,0.00006573862,0.0000034320678,0.1799261,0.00017360855,0.000005533999,4.4964983e-7,0.0002553926,0.000107940505],"about_ca_topic_score_codex":0.00015926718,"about_ca_topic_score_gemma":0.00011919551,"teacher_disagreement_score":0.037079066,"about_ca_system_score_codex":0.00019026839,"about_ca_system_score_gemma":0.00022805094,"threshold_uncertainty_score":0.44029215},"labels":[],"label_agreement":null},{"id":"W6939759925","doi":"10.6084/m9.figshare.7257491","title":"Additional file 3: of Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Cause of death; Disease; Epidemiology; Mortality rate; Table (database)","score_opus":0.01824999128838944,"score_gpt":0.2524264179865425,"score_spread":0.23417642669815303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939759925","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45104495,0.0000046101604,9.083175e-9,0.000010515251,0.000012907724,0.00039317438,0.5484364,0.000007955551,0.0000894648],"genre_scores_gemma":[0.5935896,9.750818e-8,0.0000144598225,0.00008922063,0.00010969767,0.0032238245,0.40281162,0.0000115545,0.00014994794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890643,0.000028089413,0.00022231505,0.00027728223,0.00034908523,0.00021677435],"domain_scores_gemma":[0.99915874,0.00017794724,0.00013780504,0.00021675286,0.00017966713,0.00012910254],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018620574,0.00009373277,0.00027103466,0.000027660322,0.00006389654,0.000039166538,0.00006551489,0.000041722964,0.98709923],"category_scores_gemma":[0.00018814004,0.000120640085,0.000025538846,0.00020854828,0.000012523817,0.000050687548,0.000018126817,0.00007790388,0.000019380568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018500794,0.00026466086,0.55292386,0.000051812378,0.00007129634,0.00021827823,0.000023783183,0.0000025316476,3.1466584e-8,6.502128e-9,0.44527212,0.0011531273],"study_design_scores_gemma":[0.0018227068,0.00046383264,0.9898707,0.0038923547,0.000028224533,0.0000038765957,0.000041976404,0.000018690916,0.0000030571562,6.98936e-7,0.0037355481,0.00011832807],"about_ca_topic_score_codex":0.91601354,"about_ca_topic_score_gemma":0.9990409,"teacher_disagreement_score":0.98707986,"about_ca_system_score_codex":0.0007279417,"about_ca_system_score_gemma":0.0017818247,"threshold_uncertainty_score":0.49195597},"labels":[],"label_agreement":null},{"id":"W6939874389","doi":"10.6084/m9.figshare.7257470","title":"Additional file 2: of Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cause of death; Population; Epidemiology; Disease; Mortality rate","score_opus":0.018077605569343916,"score_gpt":0.25220730782631334,"score_spread":0.23412970225696944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939874389","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45144233,0.0000045909187,8.963996e-9,0.000010589659,0.000012885423,0.0003923105,0.5480415,0.000007945415,0.00008782132],"genre_scores_gemma":[0.5952576,9.7660745e-8,0.000014353044,0.00008925468,0.00010925864,0.0031928474,0.40117612,0.000011571141,0.000148939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890697,0.000028084645,0.00022219881,0.00027716154,0.0003488581,0.00021669838],"domain_scores_gemma":[0.99915266,0.00018447792,0.00013770035,0.00021655792,0.00017955643,0.00012906204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018619805,0.00009371198,0.00027089624,0.000027662334,0.00006388545,0.00003915954,0.000065467706,0.000041708736,0.9874557],"category_scores_gemma":[0.00019758908,0.000120617115,0.000025529685,0.00020856938,0.0000125216875,0.000050684517,0.0000181135,0.00007789302,0.00001929189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001861407,0.00026435065,0.55468476,0.000050875755,0.00007164113,0.00022058998,0.000023892228,0.000002508239,3.1667597e-8,6.3121752e-9,0.44344243,0.0012202788],"study_design_scores_gemma":[0.0018211742,0.00046002644,0.9899423,0.004034933,0.000028205728,0.00000391474,0.000041677922,0.000018624969,0.0000031328473,7.0285876e-7,0.0035270022,0.00011832195],"about_ca_topic_score_codex":0.9138229,"about_ca_topic_score_gemma":0.9990225,"teacher_disagreement_score":0.9874364,"about_ca_system_score_codex":0.000727257,"about_ca_system_score_gemma":0.0017811446,"threshold_uncertainty_score":0.4918623},"labels":[],"label_agreement":null},{"id":"W6940027675","doi":"10.6084/m9.figshare.26601520","title":"Additional file 8 of Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Clear cell; Genome; Ovary; Genotype; Ovarian cancer; Genomics","score_opus":0.02269999677368812,"score_gpt":0.26037513618587727,"score_spread":0.23767513941218915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6940027675","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010410458,0.000520611,1.1437942e-7,0.00028838433,0.000028148099,0.00025380022,0.98646873,0.00001923238,0.0020105198],"genre_scores_gemma":[0.3113279,0.0000031069671,0.000951348,0.000031850315,0.00016820629,0.00032996552,0.68666,0.000012910699,0.00051470596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999421,0.000014619054,0.00016425227,0.00017602397,0.00014171291,0.00008236732],"domain_scores_gemma":[0.99914074,0.0005460292,0.000052233616,0.00011327342,0.00007702439,0.00007071535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000012771768,0.0000834168,0.00017600223,0.000066374174,0.000029932893,0.000018996632,0.00003153757,0.00005609495,0.9241429],"category_scores_gemma":[0.00011493844,0.00006854871,0.00004495026,0.00007694186,0.0000064321807,0.00003440091,0.000036043642,0.00006011899,0.00038499624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048595502,0.00005732397,0.00038923993,0.000281084,0.000037772475,0.00001899904,0.00028660687,0.0000014988898,0.00009737482,0.000009664296,0.99795413,0.0008176888],"study_design_scores_gemma":[0.00042259504,0.00030982567,0.38545266,0.003937793,0.00004997203,0.000002296632,0.000059111015,0.00015129273,0.00041361453,0.000018361035,0.60910875,0.00007373522],"about_ca_topic_score_codex":0.000033687487,"about_ca_topic_score_gemma":0.000042527878,"teacher_disagreement_score":0.9237579,"about_ca_system_score_codex":0.000030265322,"about_ca_system_score_gemma":0.00018574552,"threshold_uncertainty_score":0.49484763},"labels":[],"label_agreement":null},{"id":"W6950038938","doi":"10.5281/zenodo.6038064","title":"Signiphora bennetti Molin 2017, n. sp.","year":2017,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Seta; Scutellum; Wing; Scape; Occiput; Dorsum","score_opus":0.06389580261721348,"score_gpt":0.29890068501016076,"score_spread":0.23500488239294728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6950038938","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12926254,0.00071171706,0.00086377806,0.02055284,0.00061897206,0.0016508042,0.0004251632,0.0011505119,0.8447637],"genre_scores_gemma":[0.99454826,0.00032823812,0.0003676639,0.0003012207,0.00033974732,8.4851315e-8,0.00062549225,0.0008837129,0.002605567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872714,0.000074742136,0.00018225067,0.00038948725,0.00030596304,0.00032039807],"domain_scores_gemma":[0.9982852,0.000012532026,0.00012630089,0.00097569876,0.000342753,0.00025756733],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032275106,0.0001381886,0.00019074934,0.000107284606,0.0027267998,0.000759809,0.0005930401,0.00006352783,0.01417793],"category_scores_gemma":[0.0003797869,0.00012919302,0.00007558784,0.00009681361,0.0001613596,0.00019061741,0.00061421253,0.00019044377,0.011590661],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019503091,0.00057295535,0.00028027024,0.00008851342,0.00020151635,0.00025805156,0.00044711892,0.000008805788,0.0023594818,0.0036850318,0.752987,0.23891622],"study_design_scores_gemma":[0.0015528712,0.00038886824,0.030372867,0.000071792434,0.00006449993,0.00016644577,0.00006631885,0.00008123314,0.0011612385,0.0001401731,0.96579653,0.00013714684],"about_ca_topic_score_codex":0.00005235208,"about_ca_topic_score_gemma":5.8254284e-7,"teacher_disagreement_score":0.86528575,"about_ca_system_score_codex":0.00017154508,"about_ca_system_score_gemma":0.0000068508866,"threshold_uncertainty_score":0.9985715},"labels":[],"label_agreement":null},{"id":"W69518242","doi":"10.1016/s1701-2163(16)30464-9","title":"Granulosa Cell Tumour: A Recurrence 40 Years After Initial Diagnosis","year":2005,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Fonds Léon Fredericq; Chung Hua University; Fonds De La Recherche Scientifique - FNRS","keywords":"Medicine; Gynecology; Granulosa cell; Ovary; Internal medicine","score_opus":0.010918691917179053,"score_gpt":0.241241691888757,"score_spread":0.23032299997157793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W69518242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97414666,0.018182749,0.000004620167,0.0024571987,0.0040788385,0.00013088483,0.00003727613,0.0000028184727,0.0009589253],"genre_scores_gemma":[0.99614626,0.0015907402,0.00066658296,0.0013734087,0.00013236869,0.000016735088,0.0000023273644,0.000011243467,0.0000603579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989239,0.00003335145,0.00038439332,0.00014362158,0.00028222497,0.00023248258],"domain_scores_gemma":[0.9983734,0.0008282371,0.00022803404,0.00010346761,0.00017579975,0.0002910564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011929299,0.000125419,0.00035376605,0.0001796004,0.00004171716,0.000018374916,0.00006950669,0.00008379091,0.0010352653],"category_scores_gemma":[0.00047893435,0.000104749575,0.00008072495,0.00021992238,0.000044157667,0.00006591369,0.000026309579,0.00027447115,0.000003771531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038978993,0.0005034066,0.60828346,0.000049832877,0.00015101081,0.0121123325,0.0001589338,0.00001486597,0.0000029662704,0.000024037745,0.01623966,0.3624205],"study_design_scores_gemma":[0.0033590924,0.0006880053,0.8917648,0.000019193696,0.00024314056,0.00012421398,0.00005194089,0.000011061754,0.0002682704,0.000027568316,0.10333075,0.00011192838],"about_ca_topic_score_codex":0.004017637,"about_ca_topic_score_gemma":0.016215898,"teacher_disagreement_score":0.36230856,"about_ca_system_score_codex":0.0009031603,"about_ca_system_score_gemma":0.0013243788,"threshold_uncertainty_score":0.9998779},"labels":[],"label_agreement":null},{"id":"W6957907892","doi":"10.60692/31hwt-m4386","title":"MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum","year":2020,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemotherapy; Clinical endpoint; Progression-free survival; Serous fluid; Overall survival; Chemotherapy regimen; Interim analysis; Randomized controlled trial","score_opus":0.06215989570715908,"score_gpt":0.25172684515831967,"score_spread":0.1895669494511606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957907892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310607,0.00006786816,0.000018983106,0.0027098542,0.0006905973,0.0015898654,0.00013267552,0.000083863735,0.001600221],"genre_scores_gemma":[0.99755245,0.0000068811355,0.00012493531,0.0017641254,0.00024066116,0.0001698577,0.00003577524,0.000025179737,0.000080129204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805415,0.000086982225,0.0007815462,0.00027055197,0.0005021848,0.00030460092],"domain_scores_gemma":[0.99883324,0.000031891377,0.00036584007,0.0004813823,0.00012495473,0.00016271934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012943301,0.00030466044,0.00059721456,0.0001266808,0.00008250849,0.00004957111,0.00020930277,0.00011468658,0.00003915482],"category_scores_gemma":[0.000026128353,0.0001778916,0.00027558717,0.0005484974,0.00005277246,0.0002325939,0.00006989845,0.0001848499,0.000059627877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018253379,0.00033117094,0.6897579,0.01106288,0.001558222,0.00006197333,0.26698387,0.00028226525,0.00006997541,0.0000716612,0.0018301171,0.0097365985],"study_design_scores_gemma":[0.030643255,0.0028634928,0.9233073,0.0026546929,0.00050143426,0.000055584078,0.024518488,0.0023949004,0.0041248547,9.5150675e-8,0.008378747,0.00055715366],"about_ca_topic_score_codex":0.00007882429,"about_ca_topic_score_gemma":0.0000053508693,"teacher_disagreement_score":0.24246538,"about_ca_system_score_codex":0.00048132698,"about_ca_system_score_gemma":0.0002644209,"threshold_uncertainty_score":0.7254209},"labels":[],"label_agreement":null},{"id":"W6958481313","doi":"10.6084/m9.figshare.22601816.v1","title":"Additional file 2 of Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Peripheral blood; DNA methylation; Methylation; Table (database); Disease","score_opus":0.03357838426583077,"score_gpt":0.28208296615290934,"score_spread":0.24850458188707858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958481313","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019384897,0.002013844,2.4640608e-8,0.00039610977,0.000013586924,0.00146762,0.99517286,0.000026879163,0.0007152491],"genre_scores_gemma":[0.027653294,0.00016383591,0.00017945915,0.0003548378,0.00006610964,0.035969272,0.93531466,0.000030193836,0.00026834465],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99878865,0.00007504621,0.00040911368,0.00021118794,0.00037458714,0.000141415],"domain_scores_gemma":[0.99808353,0.0010798764,0.0002797147,0.00035639183,0.00014515221,0.00005533639],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005674813,0.00013730982,0.0005506169,0.00013745442,0.000018781757,0.00000633182,0.00010422551,0.00006354377,0.9398618],"category_scores_gemma":[0.001978236,0.000110858375,0.00015297963,0.0005400015,0.0000061085475,0.000042675296,0.0000289505,0.000077434015,0.00020416216],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001484218,0.0003007641,0.0002425068,0.11870038,0.00006723294,0.000027726379,0.000035224755,0.000017156848,0.0000030087115,0.000001984961,0.8805048,0.00008437423],"study_design_scores_gemma":[0.0016442713,0.00048412645,0.05106184,0.9387649,0.0003630061,0.0000013124524,0.000015952546,0.00030009772,0.0014011184,0.000008248386,0.0058154794,0.00013960937],"about_ca_topic_score_codex":0.000055998615,"about_ca_topic_score_gemma":0.000033496704,"teacher_disagreement_score":0.93965757,"about_ca_system_score_codex":0.000090759335,"about_ca_system_score_gemma":0.00024661227,"threshold_uncertainty_score":0.45206735},"labels":[],"label_agreement":null},{"id":"W6958654276","doi":"10.6084/m9.figshare.7257455.v1","title":"Additional file 1: of Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cause of death; Population; Table (database); Mortality rate; Epidemiology","score_opus":0.018645706157373685,"score_gpt":0.2520846032640139,"score_spread":0.2334388971066402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958654276","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45105803,0.0000046099144,9.074947e-9,0.000010612905,0.000012908134,0.00039307761,0.5484237,0.0000079586525,0.000089065834],"genre_scores_gemma":[0.59369266,9.762253e-8,0.000014468561,0.00008928684,0.00010987634,0.0032250953,0.40270707,0.0000115604,0.0001498837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989065,0.000028088902,0.00022230293,0.00027726684,0.0003490809,0.00021677259],"domain_scores_gemma":[0.99915886,0.00017795245,0.000137796,0.00021665578,0.00017965489,0.00012910122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018624398,0.0000937303,0.00027100943,0.00002766153,0.00006388641,0.000039168317,0.000065487824,0.000041723084,0.9871056],"category_scores_gemma":[0.00018806935,0.000120638484,0.000025538578,0.00020860416,0.000012522605,0.00005068717,0.000018119796,0.000077902994,0.00001937258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018562725,0.00026461447,0.55208915,0.00005171424,0.000071284754,0.00021932488,0.00002377861,0.0000025312195,3.159325e-8,6.3499557e-9,0.44609287,0.0011661059],"study_design_scores_gemma":[0.001824599,0.00046325495,0.9898738,0.0038740342,0.000028219947,0.0000038333837,0.000041937677,0.00001883364,0.0000030298702,7.041739e-7,0.0037493776,0.00011833189],"about_ca_topic_score_codex":0.916329,"about_ca_topic_score_gemma":0.9990296,"teacher_disagreement_score":0.98708624,"about_ca_system_score_codex":0.0007324362,"about_ca_system_score_gemma":0.0017819408,"threshold_uncertainty_score":0.49194947},"labels":[],"label_agreement":null},{"id":"W6958836367","doi":"10.6084/m9.figshare.c.6261333.v1","title":"Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study","year":2022,"lang":"en","type":"other","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dehydration; Osmolyte; Cohort; Cohort study; Hypernatremia; Hyponatremia; Diarrhea; Rhabdomyolysis","score_opus":0.014254249854199019,"score_gpt":0.2739880491546196,"score_spread":0.25973379930042056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958836367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6786505,0.003555822,0.0000010292054,0.000990894,0.00038809015,0.023256142,0.28507483,0.0006682301,0.0074144783],"genre_scores_gemma":[0.9144906,0.000017690138,0.00000375137,0.00029207606,0.00026427725,0.0026749084,0.06310039,0.00022984897,0.018926451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868935,0.000059509166,0.00015831401,0.0005266587,0.00042173988,0.00014439845],"domain_scores_gemma":[0.9991554,0.000046189874,0.00025932654,0.0003357468,0.000071681905,0.0001316349],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003442973,0.00025214782,0.00045582204,0.00011637761,0.000040832572,0.000018509912,0.000050018505,0.000095264804,0.25334966],"category_scores_gemma":[0.0002928164,0.00019466893,0.00005356122,0.00017126634,0.000014739033,0.000037399237,0.000067159584,0.00015214705,0.000043749213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014949849,0.0021152997,0.75484294,0.0006467183,0.0016127083,0.00019059304,0.0008499358,6.0147664e-7,0.0000035044118,4.737798e-8,0.2393759,0.00021227641],"study_design_scores_gemma":[0.003378918,0.0014047365,0.9846181,0.002986924,0.0013262291,0.000014176529,0.000044705936,0.000010084826,0.00007569691,4.1534085e-7,0.005931684,0.00020829552],"about_ca_topic_score_codex":0.000024784415,"about_ca_topic_score_gemma":0.00029363285,"teacher_disagreement_score":0.2533059,"about_ca_system_score_codex":0.00033933687,"about_ca_system_score_gemma":0.00021283331,"threshold_uncertainty_score":0.79383683},"labels":[],"label_agreement":null},{"id":"W6966782368","doi":"10.48336/8knd-my23","title":"Exploring opportunistic salpingectomy as a preventive strategy for ovarian cancer: uptake in Newfoundland and Labrador, Canada","year":2025,"lang":"en","type":"article","venue":"Memorial University Research Repository (Memorial University)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Tubal ligation; Salpingectomy; Hysterectomy; Serous fluid; Serous carcinoma; Ovarian cancer; Retrospective cohort study; Fallopian tube","score_opus":0.08341815776493738,"score_gpt":0.3070951566055927,"score_spread":0.22367699884065534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6966782368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531952,0.00018922068,0.000078168676,0.0018443603,0.004424604,0.002310276,0.00013659922,0.00006667725,0.03775487],"genre_scores_gemma":[0.96936625,0.0008783877,0.00013364543,0.000030453502,0.0012244389,0.00001172549,0.000041426098,0.000023657069,0.028290011],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973974,0.0003354244,0.00024929145,0.00081392715,0.0005360265,0.0006679035],"domain_scores_gemma":[0.99810565,0.0004899999,0.00009922512,0.00038948483,0.00048152637,0.00043413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043576382,0.000272417,0.0005586018,0.0009230142,0.00078265497,0.000096949334,0.0003262033,0.0001615786,0.000039610055],"category_scores_gemma":[0.00014783973,0.00031979513,0.00012460793,0.0013469816,0.00023074872,0.00044032405,0.00025745304,0.0004862608,0.0000014593763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.10221375,0.0044791605,0.22782929,0.003965654,0.0077966065,0.07408669,0.004607381,0.00070221326,0.007952779,0.4474172,0.032358184,0.08659108],"study_design_scores_gemma":[0.051087536,0.0026268414,0.13405769,0.0018961468,0.0015391345,0.000074767675,0.013486658,0.00051889924,0.00206699,0.00086916244,0.79071903,0.0010571317],"about_ca_topic_score_codex":0.75588405,"about_ca_topic_score_gemma":0.5808011,"teacher_disagreement_score":0.75836086,"about_ca_system_score_codex":0.005612591,"about_ca_system_score_gemma":0.0087803975,"threshold_uncertainty_score":0.99992543},"labels":[],"label_agreement":null},{"id":"W6967913613","doi":"10.5281/zenodo.12783485","title":"Nexalyn: Ingredients, & Side Effects: Read This Before You Buy!","year":2024,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Energy (signal processing); Face (sociological concept); Work (physics); Quality (philosophy); Centrality; Constraint (computer-aided design); Sexual relationship; Sexual medicine","score_opus":0.02119091676314341,"score_gpt":0.26996397228143243,"score_spread":0.24877305551828902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6967913613","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013067434,0.0013421077,0.000013586858,0.002485606,0.0008394781,0.0013970716,0.9491839,0.0008598177,0.043747745],"genre_scores_gemma":[0.0006903792,0.0013823729,0.00007069261,0.000571356,0.000993348,5.3577935e-7,0.9906248,0.0020362616,0.0036302553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703604,0.00022046613,0.00044175732,0.0009680082,0.0007614808,0.0005722748],"domain_scores_gemma":[0.99770325,0.00004291794,0.0001754082,0.0012258791,0.00045254335,0.00039998878],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00046748604,0.00043239872,0.00053881685,0.0005236521,0.001012302,0.00079591165,0.00077664456,0.00028916416,0.023932105],"category_scores_gemma":[0.0007092517,0.00038496614,0.00020541436,0.0007284698,0.00017657489,0.000132685,0.0014377782,0.0009218344,0.099699885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009312683,0.00039426555,0.0000022323557,0.0013167935,0.00049598987,0.00068026496,0.00022826105,8.5607354e-7,0.000016630658,0.00011471483,0.9370274,0.059629474],"study_design_scores_gemma":[0.0011451275,0.0011946436,0.00026183884,0.0010577979,0.0006923501,0.00035149846,0.000045897385,0.000012022555,0.000044240263,0.000069424976,0.99484175,0.00028338877],"about_ca_topic_score_codex":0.00015814477,"about_ca_topic_score_gemma":0.0000030134206,"teacher_disagreement_score":0.07576778,"about_ca_system_score_codex":0.0007647573,"about_ca_system_score_gemma":0.00002411881,"threshold_uncertainty_score":0.9998602},"labels":[],"label_agreement":null},{"id":"W6976565507","doi":"10.6084/m9.figshare.16986789","title":"Additional file 1 of Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nipissing University","funders":"","keywords":"MEDLINE; Systematic review; Disease; Identification (biology)","score_opus":0.34593128026194464,"score_gpt":0.3757785661242733,"score_spread":0.029847285862328654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976565507","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008256522,0.122887366,1.0181165e-8,0.00038936,0.000002171128,0.00056821125,0.875853,0.000007823259,0.0002837806],"genre_scores_gemma":[0.00089257373,0.004130061,0.00006868784,0.0021393213,0.000010285318,0.002116983,0.99033356,0.000014029847,0.0002944934],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989196,0.00014364261,0.00037855172,0.00019669688,0.0002893952,0.00007213362],"domain_scores_gemma":[0.9978987,0.0007544811,0.00052053656,0.00026907338,0.00047048726,0.000086719294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044396857,0.00013663805,0.001203108,0.000029766627,0.000021389682,0.000005855378,0.00003788824,0.00003725748,0.95908034],"category_scores_gemma":[0.004292248,0.00008238373,0.00016602907,0.00027830605,0.000009037632,0.0000452993,0.000012095779,0.000057089215,0.000017858829],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.4188925e-7,0.000064058106,0.0000076016822,0.3035056,0.0024249314,0.000006007705,0.0000077634,3.034853e-7,8.4467763e-7,0.0000019880692,0.6939709,0.00000901756],"study_design_scores_gemma":[0.00020225902,0.00018442365,0.0040836516,0.95971537,0.029786332,0.0000054117245,0.000009970966,0.0000030800645,0.00045985458,0.0000030921785,0.005457231,0.00008930957],"about_ca_topic_score_codex":0.000014925588,"about_ca_topic_score_gemma":0.000033321347,"teacher_disagreement_score":0.9590625,"about_ca_system_score_codex":0.000060868522,"about_ca_system_score_gemma":0.00029813006,"threshold_uncertainty_score":0.51385313},"labels":[],"label_agreement":null},{"id":"W6976629542","doi":"10.60692/66kjd-q7h13","title":"Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis","year":2019,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mendelian randomization; Ovarian cancer; Observational study; Single-nucleotide polymorphism; Confounding; Case-control study; Epithelial ovarian cancer; Odds ratio; Risk factor","score_opus":0.016520232406038105,"score_gpt":0.23765565001168426,"score_spread":0.22113541760564615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976629542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515706,0.000024451816,0.002054819,0.00016737808,0.00014618065,0.001348606,0.00018446708,0.000047502384,0.00086955674],"genre_scores_gemma":[0.9995469,0.0000064733454,0.00008362898,0.00008069816,0.000046909547,0.00013484902,0.00006739497,0.000010189025,0.00002298052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981145,0.00017961023,0.00097127847,0.00017902718,0.00035655402,0.00019898622],"domain_scores_gemma":[0.9980578,0.000035446363,0.0011748608,0.0004974295,0.00017756998,0.000056881305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070414506,0.00017539412,0.0005679701,0.00045617795,0.00007396218,0.000054346518,0.00007592041,0.000109246015,0.00008354067],"category_scores_gemma":[0.000053598582,0.000103802,0.00022821438,0.0008415412,0.000018214592,0.00026212132,0.000020076355,0.00014469493,0.000033277043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029599585,0.0000064642504,0.9530329,0.00008908632,0.0011621977,0.0000013783545,0.03977571,0.0048397505,0.0000021380008,0.000015935815,0.000005425206,0.00077300996],"study_design_scores_gemma":[0.008041055,0.00006735721,0.9545499,0.0002234203,0.0024915691,0.0000063831153,0.009336137,0.02362363,0.0013124973,0.000001691322,0.00021725698,0.00012909825],"about_ca_topic_score_codex":0.0024532762,"about_ca_topic_score_gemma":0.000019068562,"teacher_disagreement_score":0.030439574,"about_ca_system_score_codex":0.00023698347,"about_ca_system_score_gemma":0.00009508227,"threshold_uncertainty_score":0.42329225},"labels":[],"label_agreement":null},{"id":"W6976759186","doi":"10.6084/m9.figshare.22606205","title":"Additional file 1 of The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Disease; Ovarian cancer; Serous ovarian cancer; Mifepristone; Antibody; Serous fluid; Table (database); Ovary","score_opus":0.04297948579879099,"score_gpt":0.28178886410076887,"score_spread":0.23880937830197788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976759186","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042940117,0.00021579713,5.9021946e-8,0.0018897149,0.000046398105,0.0005217394,0.99294436,0.000033380926,0.00005451267],"genre_scores_gemma":[0.18378954,0.000014859973,0.00014732017,0.00019480442,0.00010185551,0.004012759,0.811312,0.000019504712,0.0004073364],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905264,0.00004228373,0.00017455008,0.00020773424,0.00036628178,0.00015650774],"domain_scores_gemma":[0.9989861,0.00032663348,0.00021070418,0.00024434974,0.00011706608,0.000115108785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000019892805,0.00012414844,0.00023020408,0.000048071055,0.00006209552,0.0000065015147,0.000060674316,0.000038217517,0.9012046],"category_scores_gemma":[0.0002842337,0.00008512374,0.00009810129,0.00033288842,0.000027484908,0.00003848074,0.000054779433,0.00008278184,0.00018294167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025337138,0.00025752632,0.000049279737,0.00053100486,0.00009120325,0.000029489696,0.000061205625,0.0000069319335,0.00019506855,0.0000029749451,0.9973198,0.0014301542],"study_design_scores_gemma":[0.0024717636,0.0002926939,0.26462147,0.029435685,0.00041569798,0.000010955017,0.000078284196,0.00014298587,0.07629982,0.00013759703,0.6257856,0.00030744055],"about_ca_topic_score_codex":0.00011760961,"about_ca_topic_score_gemma":0.0000926175,"teacher_disagreement_score":0.9010216,"about_ca_system_score_codex":0.000081008984,"about_ca_system_score_gemma":0.0001843013,"threshold_uncertainty_score":0.34712455},"labels":[],"label_agreement":null},{"id":"W6976965550","doi":"10.6084/m9.figshare.19695689.v1","title":"Additional file 2 of Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chemotherapy; Mutation; Somatic cell; Ovarian carcinoma; Germline mutation; Serous fluid; Carcinoma","score_opus":0.02157750657597172,"score_gpt":0.2711119931025418,"score_spread":0.2495344865265701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976965550","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047732525,0.000046696485,3.128796e-8,0.00011453347,0.000012817597,0.0003485197,0.9513384,0.000010932438,0.00039553162],"genre_scores_gemma":[0.49149698,6.695456e-7,0.00011078677,0.00006542011,0.000021968173,0.00081565557,0.5074296,0.000011201334,0.000047719714],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991481,0.000036482277,0.00022288813,0.00016055722,0.00027540576,0.00015661881],"domain_scores_gemma":[0.9991156,0.00041752,0.0001767289,0.00018214104,0.000046763304,0.00006126531],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000014616957,0.000108302615,0.00025403642,0.00013165991,0.000029224893,0.0000037268971,0.000048394842,0.00003044251,0.9864226],"category_scores_gemma":[0.00017712773,0.00009519583,0.000114667986,0.00022719613,0.0000047818908,0.00003089136,0.000020772337,0.00010176186,0.00007895729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001259178,0.0007187041,0.000847342,0.00011110809,0.000081501974,0.00010021353,0.00025840526,0.00036850595,0.000015742551,0.0000045476363,0.9934961,0.003871882],"study_design_scores_gemma":[0.0032370081,0.0019206594,0.97071284,0.0013121208,0.000017384735,0.000027958886,0.00008883397,0.0004519353,0.000425597,0.000057943147,0.021653147,0.00009458572],"about_ca_topic_score_codex":0.0003059506,"about_ca_topic_score_gemma":0.000018423936,"teacher_disagreement_score":0.9863437,"about_ca_system_score_codex":0.00042995112,"about_ca_system_score_gemma":0.0003705293,"threshold_uncertainty_score":0.38819733},"labels":[],"label_agreement":null},{"id":"W6977122916","doi":"10.6084/m9.figshare.22601816","title":"Additional file 2 of Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Peripheral blood; DNA methylation; Methylation; Table (database); Disease","score_opus":0.03357838426583077,"score_gpt":0.28208296615290934,"score_spread":0.24850458188707858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977122916","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019384897,0.002013844,2.4640608e-8,0.00039610977,0.000013586924,0.00146762,0.99517286,0.000026879163,0.0007152491],"genre_scores_gemma":[0.027653294,0.00016383591,0.00017945915,0.0003548378,0.00006610964,0.035969272,0.93531466,0.000030193836,0.00026834465],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99878865,0.00007504621,0.00040911368,0.00021118794,0.00037458714,0.000141415],"domain_scores_gemma":[0.99808353,0.0010798764,0.0002797147,0.00035639183,0.00014515221,0.00005533639],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005674813,0.00013730982,0.0005506169,0.00013745442,0.000018781757,0.00000633182,0.00010422551,0.00006354377,0.9398618],"category_scores_gemma":[0.001978236,0.000110858375,0.00015297963,0.0005400015,0.0000061085475,0.000042675296,0.0000289505,0.000077434015,0.00020416216],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001484218,0.0003007641,0.0002425068,0.11870038,0.00006723294,0.000027726379,0.000035224755,0.000017156848,0.0000030087115,0.000001984961,0.8805048,0.00008437423],"study_design_scores_gemma":[0.0016442713,0.00048412645,0.05106184,0.9387649,0.0003630061,0.0000013124524,0.000015952546,0.00030009772,0.0014011184,0.000008248386,0.0058154794,0.00013960937],"about_ca_topic_score_codex":0.000055998615,"about_ca_topic_score_gemma":0.000033496704,"teacher_disagreement_score":0.93965757,"about_ca_system_score_codex":0.000090759335,"about_ca_system_score_gemma":0.00024661227,"threshold_uncertainty_score":0.45206735},"labels":[],"label_agreement":null},{"id":"W6977141128","doi":"10.6084/m9.figshare.19695686","title":"Additional file 1 of Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chemotherapy; Mutation; Somatic cell; Ovarian carcinoma; Germline mutation; Serous fluid","score_opus":0.02238169531954877,"score_gpt":0.271694769859722,"score_spread":0.24931307454017326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977141128","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0480369,0.000045897705,3.200181e-8,0.000115112176,0.000012733116,0.0003490204,0.95104337,0.0000109303,0.00038603172],"genre_scores_gemma":[0.4923508,6.5067707e-7,0.00011331499,0.00006535233,0.000021607333,0.000831728,0.5065578,0.000011206993,0.00004750688],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991479,0.000036495396,0.00022278231,0.0001606849,0.00027547884,0.00015668002],"domain_scores_gemma":[0.999109,0.00042386464,0.00017646718,0.0001825124,0.00004687377,0.00006127482],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000014702017,0.000108339125,0.0002539705,0.00013175132,0.000029222625,0.0000037183427,0.000048423408,0.000030442323,0.98669],"category_scores_gemma":[0.00017942191,0.000095228825,0.000114691495,0.00022738344,0.000004781961,0.000030868938,0.000020775435,0.0001017867,0.00007986001],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012648209,0.0007180078,0.00087560824,0.00010990615,0.00008139411,0.00009725856,0.00025783523,0.0003661569,0.000016320198,0.000004458461,0.9935908,0.0037558144],"study_design_scores_gemma":[0.0031978332,0.0019108158,0.9716876,0.0013229041,0.000017365313,0.000027755195,0.0000893606,0.00045290528,0.00042629935,0.00005717373,0.020715645,0.00009432728],"about_ca_topic_score_codex":0.0003027172,"about_ca_topic_score_gemma":0.000018309061,"teacher_disagreement_score":0.9866102,"about_ca_system_score_codex":0.00042982068,"about_ca_system_score_gemma":0.0003722845,"threshold_uncertainty_score":0.38833186},"labels":[],"label_agreement":null},{"id":"W6977844494","doi":"10.6084/m9.figshare.26601520.v1","title":"Additional file 8 of Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Clear cell; Genome; Ovary; Genotype; Ovarian cancer; Genomics","score_opus":0.02269999677368812,"score_gpt":0.26037513618587727,"score_spread":0.23767513941218915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977844494","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010410458,0.000520611,1.1437942e-7,0.00028838433,0.000028148099,0.00025380022,0.98646873,0.00001923238,0.0020105198],"genre_scores_gemma":[0.3113279,0.0000031069671,0.000951348,0.000031850315,0.00016820629,0.00032996552,0.68666,0.000012910699,0.00051470596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999421,0.000014619054,0.00016425227,0.00017602397,0.00014171291,0.00008236732],"domain_scores_gemma":[0.99914074,0.0005460292,0.000052233616,0.00011327342,0.00007702439,0.00007071535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000012771768,0.0000834168,0.00017600223,0.000066374174,0.000029932893,0.000018996632,0.00003153757,0.00005609495,0.9241429],"category_scores_gemma":[0.00011493844,0.00006854871,0.00004495026,0.00007694186,0.0000064321807,0.00003440091,0.000036043642,0.00006011899,0.00038499624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048595502,0.00005732397,0.00038923993,0.000281084,0.000037772475,0.00001899904,0.00028660687,0.0000014988898,0.00009737482,0.000009664296,0.99795413,0.0008176888],"study_design_scores_gemma":[0.00042259504,0.00030982567,0.38545266,0.003937793,0.00004997203,0.000002296632,0.000059111015,0.00015129273,0.00041361453,0.000018361035,0.60910875,0.00007373522],"about_ca_topic_score_codex":0.000033687487,"about_ca_topic_score_gemma":0.000042527878,"teacher_disagreement_score":0.9237579,"about_ca_system_score_codex":0.000030265322,"about_ca_system_score_gemma":0.00018574552,"threshold_uncertainty_score":0.49484763},"labels":[],"label_agreement":null},{"id":"W6979975464","doi":"","title":"Anxiety and depression among participants in an early ovarian cancer diagnosis program","year":2014,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anxiety; Depression (economics); Ovarian cancer; Beck Depression Inventory; Disease; Test (biology); Stage (stratigraphy)","score_opus":0.025349063874429333,"score_gpt":0.306931265717031,"score_spread":0.2815822018426017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6979975464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885457,0.001168973,1.7405249e-8,0.000039549133,0.00081007375,0.002466871,0.00048508626,0.00023229141,0.0062514017],"genre_scores_gemma":[0.9855499,0.0028725646,0.00038945358,0.00021350825,0.00013929051,0.00907458,0.00084082445,0.00022945445,0.0006904099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995425,0.00031649615,0.0008909166,0.0016327682,0.00071646017,0.0010183528],"domain_scores_gemma":[0.9972938,0.00013722376,0.00047797093,0.0008856513,0.00030215873,0.0009032375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053577725,0.0008518782,0.0012132962,0.00039234574,0.00047096075,0.00014366204,0.0002502835,0.00096574606,0.00033485758],"category_scores_gemma":[0.0002811125,0.0007793736,0.000246248,0.00050263637,0.00007809703,0.000646461,0.00008420079,0.0012015783,0.00003530093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003790997,0.0011560617,0.54445535,0.0003704464,0.00022470228,0.000119080025,0.000029278432,0.0000042770384,0.0002919864,0.00039567775,0.000008790565,0.45256525],"study_design_scores_gemma":[0.0040802313,0.0006824295,0.9673582,0.0028446738,0.0010163152,0.00000620502,0.00011056111,0.000054896787,0.015129984,0.00048360086,0.0074381647,0.0007947873],"about_ca_topic_score_codex":0.005581053,"about_ca_topic_score_gemma":0.029622275,"teacher_disagreement_score":0.45177045,"about_ca_system_score_codex":0.0007629213,"about_ca_system_score_gemma":0.0000946923,"threshold_uncertainty_score":0.9994657},"labels":[],"label_agreement":null},{"id":"W6980076268","doi":"","title":"Assigning site of origin in non-uterine high-grade serous cancers: Bridging the gap between research and clinical practice","year":2016,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Fallopian tube; Clinical Practice; Serous fluid; Serous carcinoma; Clinical research; Ovarian cancer","score_opus":0.08725571883566315,"score_gpt":0.41344291944948935,"score_spread":0.3261872006138262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6980076268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98642,0.000780472,4.7855167e-7,0.00079828553,0.0007223635,0.0014817198,0.0008646248,0.00004741663,0.008884676],"genre_scores_gemma":[0.9918578,0.003824682,0.00092031,0.00019827607,0.00043955114,0.00025061815,0.00040931592,0.00015624597,0.0019431777],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9944712,0.0008219253,0.00141338,0.0012184071,0.0012626847,0.00081239623],"domain_scores_gemma":[0.99382615,0.0033166313,0.00080184714,0.0009426783,0.00073912484,0.0003735683],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004283657,0.00056360476,0.0013143254,0.0005042738,0.00054904923,0.00007315414,0.00032728587,0.0006470418,0.00008130532],"category_scores_gemma":[0.001748941,0.00040588595,0.00022669502,0.0007638271,0.0001976299,0.0005155897,0.00017603826,0.0024300371,0.00005625103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035538848,0.0019801168,0.122475564,0.00240912,0.0036472103,0.0018207885,0.00014289995,0.000010151819,0.010413821,0.009895185,0.0001307609,0.8435205],"study_design_scores_gemma":[0.014515306,0.0038938522,0.84689695,0.012436102,0.002233324,0.00013350212,0.00090021326,0.000023561377,0.033866804,0.0035321177,0.08021099,0.0013572723],"about_ca_topic_score_codex":0.008447595,"about_ca_topic_score_gemma":0.002884749,"teacher_disagreement_score":0.8421632,"about_ca_system_score_codex":0.0016647984,"about_ca_system_score_gemma":0.00033118,"threshold_uncertainty_score":0.9998714},"labels":[],"label_agreement":null},{"id":"W6991030624","doi":"","title":"Expression analysis of the 3p25.3-ptelomere genes in epithelial ovarian cancer","year":2008,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; McGill University Health Centre; McGill University","keywords":"Loss of heterozygosity; Ovarian cancer; Gene; Microarray analysis techniques; Microarray; Gene expression; Context (archaeology); Epithelial ovarian cancer; Gene expression profiling","score_opus":0.019500492851195612,"score_gpt":0.2761363170813868,"score_spread":0.2566358242301912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6991030624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784933,0.0030048925,2.9619969e-8,0.000098305645,0.0011721973,0.0010464505,0.002443106,0.00005254199,0.013689174],"genre_scores_gemma":[0.9867824,0.0069698878,0.00020696408,0.00022078285,0.000103653205,0.0005030151,0.0009043773,0.00013510593,0.0041738283],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959081,0.00028463945,0.0011287002,0.0010778301,0.0010391653,0.0005615687],"domain_scores_gemma":[0.9971727,0.00016175103,0.0008365214,0.0012127169,0.00036720655,0.00024906624],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000327356,0.00070779223,0.0016264765,0.0009609823,0.00046919755,0.000021097527,0.00045353506,0.0007513141,0.0010112283],"category_scores_gemma":[0.00017797032,0.0005220049,0.0010822804,0.0022804178,0.000078504025,0.00019622852,0.00010360274,0.0009817525,0.000027448796],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044488763,0.004816434,0.11058285,0.002017768,0.017387614,0.0008163519,0.00027813486,0.0013857826,0.21487728,0.00937636,0.00008956232,0.633923],"study_design_scores_gemma":[0.00392536,0.00023875374,0.52778053,0.002456323,0.0077818357,0.0000148691925,0.0002638779,0.000036535734,0.4287647,0.00043184296,0.027497642,0.0008077113],"about_ca_topic_score_codex":0.0034525127,"about_ca_topic_score_gemma":0.013674413,"teacher_disagreement_score":0.6331153,"about_ca_system_score_codex":0.0011276613,"about_ca_system_score_gemma":0.0002554817,"threshold_uncertainty_score":0.999902},"labels":[],"label_agreement":null},{"id":"W7001086364","doi":"","title":"Improved decision making from clinical trial evidence in an era of personalised oncology","year":2021,"lang":"en","type":"dissertation","venue":"The Sydney eScholarship Repository (The University of Sydney)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regorafenib; Clinical trial; Surrogate endpoint; Clinical endpoint; Colorectal cancer; Nomogram; Randomized controlled trial; Progression-free survival","score_opus":0.07357152189109867,"score_gpt":0.36543159425312727,"score_spread":0.2918600723620286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001086364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273235,0.002761328,0.000012768055,0.0004962055,0.001779138,0.001186211,0.00002584817,0.000020016914,0.0009861619],"genre_scores_gemma":[0.99660224,0.0009930492,0.0010920257,0.00014587137,0.00040004932,0.0000060867246,0.00016138314,0.000035745987,0.0005635691],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9960431,0.0013959317,0.0009219392,0.0007407644,0.0006391397,0.00025914083],"domain_scores_gemma":[0.99451166,0.0024265153,0.0011630586,0.0012153076,0.00050671725,0.00017674881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015725002,0.0003303623,0.0011906744,0.0001338868,0.00028351168,0.00004085117,0.0007473975,0.00072327204,0.00023689622],"category_scores_gemma":[0.0009301096,0.00024996116,0.00067458005,0.00033342553,0.00029036662,0.00026640444,0.00011325966,0.0017161695,0.000005856466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5526062,0.010286185,0.12954745,0.0012204128,0.004862259,0.0035888152,0.04230446,0.000048255453,0.038049098,0.00038798407,0.0011384387,0.21596043],"study_design_scores_gemma":[0.062615514,0.0066626836,0.86328006,0.019825233,0.0067474716,0.00005408424,0.030807905,0.00036265957,0.0066249166,0.00040343203,0.0018727896,0.00074326777],"about_ca_topic_score_codex":0.0016644106,"about_ca_topic_score_gemma":0.0016978878,"teacher_disagreement_score":0.7337326,"about_ca_system_score_codex":0.0005928633,"about_ca_system_score_gemma":0.0019709824,"threshold_uncertainty_score":0.9999953},"labels":[],"label_agreement":null},{"id":"W7001345819","doi":"","title":"James Laughlin 203056 (Canada 306343)","year":2017,"lang":"en","type":"other","venue":"OhioLink ETD Center (Ohio Library and Information Network)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tonnage; Yankee; Marine transportation; Minor (academic)","score_opus":0.008347559990926925,"score_gpt":0.21055125103568179,"score_spread":0.20220369104475486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7001345819","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056786944,0.0044220574,0.000027468983,0.0048658634,0.0013158141,0.00064733747,0.00047763286,0.00017805611,0.9880601],"genre_scores_gemma":[0.0067389826,0.06838775,0.0012698261,0.027135327,0.0064308937,0.00018133534,0.009706281,0.00043538582,0.87971425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985693,0.000034855704,0.00042189937,0.00026776703,0.0002713041,0.00043484982],"domain_scores_gemma":[0.9985012,0.000035211655,0.00051330146,0.0006256013,0.000016881737,0.0003078286],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005333075,0.00041713385,0.0005922301,0.00013955576,0.00016178297,0.00020686195,0.00019302822,0.0003383867,0.004766894],"category_scores_gemma":[0.0000071386467,0.0003513132,0.0001244673,0.0000919413,0.0000688934,0.0018223516,0.00014267644,0.0003301346,0.000079586396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078412,0.000043534204,0.0012180596,0.0003260896,0.0002681027,0.000027651884,0.000020954174,0.0000055668825,1.9926366e-8,0.034677036,0.9449003,0.018434294],"study_design_scores_gemma":[0.0020095638,0.000089089735,0.0028327534,0.0021990116,0.000116071955,0.00003319726,0.0000028268469,0.00009371515,0.0000069820726,0.00004938205,0.9922509,0.00031647622],"about_ca_topic_score_codex":0.00015052124,"about_ca_topic_score_gemma":0.0013418886,"teacher_disagreement_score":0.108345866,"about_ca_system_score_codex":0.000040999286,"about_ca_system_score_gemma":0.0004490424,"threshold_uncertainty_score":0.9998939},"labels":[],"label_agreement":null},{"id":"W7002159308","doi":"","title":"The national team has its chances against Spain, because it finished first in a group where there was the second world, Belgium, and Croatia, runner-up, said Lekjaa in an interview with news website Médias24. \"I think all the ingredients are there to go as far as possible.\" Returning to the qualification for the Round of 16 at the expense of Canada (2-1), Lekjaa stressed that his feeling was similar to that of all Moroccans, \"pride and hono...","year":2022,"lang":"en","type":"other","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Group (periodic table); Work (physics); Interview; Agency (philosophy); Class (philosophy); Focus group","score_opus":0.05759063220507613,"score_gpt":0.2916911846435948,"score_spread":0.23410055243851866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7002159308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6546294,0.067923665,0.00003246967,0.24932085,0.00058282574,0.015290401,0.0016723403,0.000047890997,0.01050016],"genre_scores_gemma":[0.9123263,0.010725677,0.00013479008,0.022845862,0.00028062784,0.0027693724,0.00020805783,0.0003429382,0.050366394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995768,0.00069746276,0.0008795672,0.00084354205,0.0011943639,0.0006170735],"domain_scores_gemma":[0.9944438,0.0027490077,0.0011349984,0.0012363091,0.00023990928,0.00019600237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023097554,0.0007129489,0.00094818935,0.00022750197,0.00070938445,0.00022326401,0.0010751314,0.0001575564,0.00087999104],"category_scores_gemma":[0.0003028342,0.00028912813,0.00015759529,0.0006171468,0.0002639757,0.0001756839,0.00046638786,0.0005281544,0.00000202654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00447531,0.00096552365,0.08618381,0.0018223083,0.0047978624,0.00003372469,0.10436785,0.003228292,0.00028415018,0.0011624962,0.7799372,0.0127414465],"study_design_scores_gemma":[0.0035006138,0.001028374,0.032165203,0.0041911383,0.0005174467,0.00001858086,0.11345184,0.00031702977,0.0008731658,0.000053599357,0.84326017,0.0006228238],"about_ca_topic_score_codex":0.120751515,"about_ca_topic_score_gemma":0.98092234,"teacher_disagreement_score":0.8601708,"about_ca_system_score_codex":0.000814177,"about_ca_system_score_gemma":0.00060294714,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W7010254696","doi":"","title":"Hakukoneoptimointi verkkojournalismissa : MTV Lifestylen artikkelien optimointi ja sen vaikutukset artikkelien näkyvyyteen","year":2018,"lang":"fi","type":"other","venue":"Theseus (Ammattikorkeakoulujen)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Corporation; Adobe; Quarter (Canadian coin)","score_opus":0.02197738980196731,"score_gpt":0.277257504409622,"score_spread":0.2552801146076547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7010254696","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008914642,0.004561554,0.0005111337,0.005791679,0.0046788575,0.004102465,0.00097497745,0.00094735203,0.96951735],"genre_scores_gemma":[0.037847947,0.0076751946,0.005635866,0.002128404,0.011906731,0.00057414017,0.00080552854,0.0022614314,0.93116474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98459756,0.0011659863,0.003404108,0.0038316469,0.0029238733,0.004076795],"domain_scores_gemma":[0.98734456,0.0008902317,0.0027622606,0.005224705,0.0009404557,0.002837771],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.002644947,0.0036715188,0.0046301065,0.0014935305,0.00094712083,0.0008680813,0.0023977146,0.0025408678,0.114039645],"category_scores_gemma":[0.0006327547,0.003249674,0.0020742877,0.0014921428,0.0014987498,0.0006234801,0.0012188898,0.0023454179,0.14810684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002866285,0.007146325,0.009702748,0.0026443463,0.018744642,0.005531464,0.0050970237,0.0003556494,0.0007491392,0.0028267496,0.0983739,0.84596175],"study_design_scores_gemma":[0.007969113,0.0027694597,0.0050065117,0.006678615,0.0049847886,0.0009411385,0.0005981617,0.00071795646,0.001439876,0.00092515623,0.9649179,0.0030513066],"about_ca_topic_score_codex":0.0019892587,"about_ca_topic_score_gemma":0.0003086283,"teacher_disagreement_score":0.866544,"about_ca_system_score_codex":0.0019577427,"about_ca_system_score_gemma":0.0016803644,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W7011239237","doi":"","title":"Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer.","year":2003,"lang":"en","type":"article","venue":"Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regimen; Chemotherapy; Paclitaxel; Chemotherapy regimen; Randomized controlled trial; Ovarian cancer; Gynecologic oncology","score_opus":0.010219623418634544,"score_gpt":0.23218369399525896,"score_spread":0.2219640705766244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7011239237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97907263,0.003007398,0.0017747331,0.003731035,0.0007947346,0.0016816517,0.00021405533,0.0001338549,0.009589903],"genre_scores_gemma":[0.992103,0.002836511,0.00069610996,0.0005760032,0.000086274544,0.00003841884,0.00010844478,0.00007842613,0.0034768244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634427,0.00049504964,0.00061279663,0.0008421498,0.000718324,0.0009874245],"domain_scores_gemma":[0.9972653,0.00040913068,0.00060848467,0.0010807487,0.0002240547,0.00041229592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005551653,0.0006520851,0.000840217,0.0003929924,0.0008577305,0.00008433718,0.00086435187,0.00047301067,0.00072136265],"category_scores_gemma":[0.0001361879,0.0005569427,0.0005578114,0.0016762154,0.0005288204,0.0008104291,0.00032935815,0.0007646325,0.000022207643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005090651,0.0013467066,0.8511189,0.00039138258,0.00096493005,0.0015093291,0.011186884,0.0035952018,0.0022226418,0.106975414,0.0032180327,0.012379906],"study_design_scores_gemma":[0.036433306,0.00038020933,0.93166316,0.0013052045,0.00087772484,0.0003030418,0.00881806,0.0011938128,0.004402182,0.0007362064,0.013153345,0.0007337428],"about_ca_topic_score_codex":0.0020387457,"about_ca_topic_score_gemma":0.0025029106,"teacher_disagreement_score":0.10623921,"about_ca_system_score_codex":0.0020225127,"about_ca_system_score_gemma":0.0017234394,"threshold_uncertainty_score":0.9996882},"labels":[],"label_agreement":null},{"id":"W7014684516","doi":"","title":"Reclassifying non-epithelial ovarian cancer, one family at a time","year":2016,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"MEDLINE; Population; Identification (biology); Pregnancy","score_opus":0.024975005956447242,"score_gpt":0.26984406146716594,"score_spread":0.2448690555107187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7014684516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74819154,0.0016383022,1.4883503e-7,0.00045825623,0.0029676007,0.0020859775,0.005348401,0.00037223462,0.23893754],"genre_scores_gemma":[0.81119573,0.0061586867,0.0010753545,0.0014536099,0.00089563907,0.0017690931,0.0029437423,0.0007412481,0.17376691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398744,0.00020352904,0.0012148059,0.00198481,0.0013676378,0.0012417478],"domain_scores_gemma":[0.99603456,0.00026207755,0.00087238324,0.0013927022,0.00056952157,0.0008687413],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00057558273,0.0012775612,0.0018660972,0.0005503156,0.0013298132,0.00008367951,0.0004819234,0.0013272923,0.0036048924],"category_scores_gemma":[0.00024385579,0.0011160236,0.0008185524,0.00054928294,0.000085802094,0.00041663038,0.00017751152,0.0012714784,0.0037150264],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033982052,0.0014541375,0.0005534055,0.0011892819,0.0034194204,0.00072879944,0.000026634036,0.0000023818916,0.42701143,0.004011032,0.0003443323,0.5578609],"study_design_scores_gemma":[0.021411844,0.0017835363,0.067818195,0.015292723,0.006099081,0.00013076364,0.00012388673,0.00002157434,0.4149992,0.0038597498,0.46475905,0.0037004133],"about_ca_topic_score_codex":0.0012007222,"about_ca_topic_score_gemma":0.0012123162,"teacher_disagreement_score":0.55416054,"about_ca_system_score_codex":0.0051793405,"about_ca_system_score_gemma":0.00040797525,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W7020263875","doi":"","title":"La relation entre la qualité de l'alimentation et la récidive chez les survivantes du cancer de l'ovaire","year":2023,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Colonic disease; Breast cancer; Medical screening","score_opus":0.009294529257970047,"score_gpt":0.23866183886329165,"score_spread":0.2293673096053216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7020263875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533322,0.019607507,0.00030290073,0.0017174416,0.0012382839,0.0006259547,0.00029417613,0.00019723902,0.022684315],"genre_scores_gemma":[0.95874244,0.0141688315,0.00038702268,0.00014760549,0.00042089776,0.00018487114,0.0017589685,0.00008266045,0.02410668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963517,0.0011947209,0.00050389336,0.00070696214,0.00069700455,0.0005456809],"domain_scores_gemma":[0.9973756,0.0011481573,0.0005302043,0.00029348495,0.00026743178,0.0003851077],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008533477,0.00055560033,0.000546288,0.00032741902,0.0027249502,0.00010651375,0.00021281147,0.000851858,0.00017140266],"category_scores_gemma":[0.000151799,0.0006260319,0.00039519733,0.00041217572,0.00030423785,0.00032668182,0.000090711226,0.0006493203,0.00007967832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011407909,0.00072875037,0.76771677,0.0006617956,0.002040525,0.0063004736,0.14015177,0.005312193,0.005486208,0.0502135,0.0008502338,0.019396966],"study_design_scores_gemma":[0.0031543989,0.00013765921,0.8884009,0.0025737144,0.0020829127,0.0005776781,0.07871025,0.0013947783,0.0060337773,0.00025636642,0.016150678,0.0005268811],"about_ca_topic_score_codex":0.16952318,"about_ca_topic_score_gemma":0.028469486,"teacher_disagreement_score":0.14105369,"about_ca_system_score_codex":0.012285257,"about_ca_system_score_gemma":0.0045934413,"threshold_uncertainty_score":0.9996191},"labels":[],"label_agreement":null},{"id":"W7028180648","doi":"","title":"Economic integration of developing countries and regionalism in Latin America and the Caribbean : prospects for a free trade area of the Americas","year":2000,"lang":"en","type":"other","venue":"Library and Archives Canada (Government of Canada)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Latin Americans; Economic integration; Developing country; Regionalism (politics); Regional integration; International free trade agreement; Free trade; Equity (law); Negotiation","score_opus":0.0055505299557451855,"score_gpt":0.17092582725543362,"score_spread":0.16537529729968845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7028180648","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07941206,0.015010952,0.00008709663,0.20763654,0.00034465676,0.0055945264,0.0061334446,0.000017662442,0.68576306],"genre_scores_gemma":[0.9713814,0.00848815,0.0018462139,0.002580136,0.00007626882,0.000105679115,0.000030813728,0.00008486327,0.015406435],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991963,0.000027479136,0.00021964672,0.00015503881,0.00030385444,0.00009768331],"domain_scores_gemma":[0.9993173,0.00022774607,0.0002511641,0.00016069328,2.6870708e-7,0.00004285369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000006843992,0.00013607583,0.0003854634,0.000022998936,0.000034654222,0.00000558998,0.000073200914,0.000024529245,0.000020117148],"category_scores_gemma":[0.0000027529206,0.00008330684,0.000025407388,0.000033715907,0.00027640138,0.000028419185,0.00003631759,0.00005983064,1.5871598e-10],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072147297,0.00018054381,0.19391792,0.0042334995,0.002167673,0.00005784014,0.004317533,0.00004066985,0.00051226193,0.56059074,0.16132154,0.06544504],"study_design_scores_gemma":[0.008150504,0.00035780692,0.37971172,0.0041938014,0.00041393092,0.000020460422,0.003158387,0.0007062003,0.009626435,0.0033677304,0.5898537,0.000439304],"about_ca_topic_score_codex":0.015002138,"about_ca_topic_score_gemma":0.10375177,"teacher_disagreement_score":0.8919694,"about_ca_system_score_codex":0.000013955985,"about_ca_system_score_gemma":0.001105217,"threshold_uncertainty_score":0.99155706},"labels":[],"label_agreement":null},{"id":"W7030417462","doi":"","title":"A new prognostic index model using meta-analysis in early-stage epithelial ovarian cancer","year":2014,"lang":"en","type":"article","venue":"YUHSpace (Yonsei University Medical Library)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jadad scale; Ovarian cancer; Proportional hazards model; Stage (stratigraphy); Epithelial ovarian cancer; Adjuvant chemotherapy; Chemotherapy; Cancer","score_opus":0.04223685504910358,"score_gpt":0.2690246077334166,"score_spread":0.226787752684313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7030417462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78098273,0.001077807,0.10927749,0.09736946,0.00024865812,0.0014826508,0.00025557828,0.00037725788,0.008928369],"genre_scores_gemma":[0.9682062,0.00020031058,0.010278619,0.001494736,0.00016053465,0.000006333467,0.000034002056,0.000041649328,0.019577576],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975998,0.00021860699,0.00027441248,0.00064238836,0.00077566673,0.0004891248],"domain_scores_gemma":[0.99810636,0.00021844446,0.0001390287,0.00049998675,0.00003556688,0.0010006097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022149789,0.00031440123,0.0011562094,0.0006535664,0.00010977705,0.000042359246,0.00029279548,0.00029378087,0.005300756],"category_scores_gemma":[0.00011206526,0.00027018288,0.00075794954,0.0015683343,0.0001234725,0.00043167296,0.00019513519,0.00043863934,0.000022591326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011572395,0.0012365454,0.8873159,0.00015303312,0.0694843,0.0029027637,0.0013790273,0.017497396,0.000029197114,0.008659506,0.0072416617,0.0029433798],"study_design_scores_gemma":[0.013955763,0.000518401,0.33988482,0.00021531864,0.19386601,0.000024497527,0.0002983122,0.41154,0.00023943484,0.0005090098,0.037873875,0.0010745508],"about_ca_topic_score_codex":0.009811571,"about_ca_topic_score_gemma":0.0011394237,"teacher_disagreement_score":0.5474311,"about_ca_system_score_codex":0.0001960193,"about_ca_system_score_gemma":0.0016312918,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W7042736659","doi":"","title":"Physical and functional evidence in support of candidate chromosome 3p tumour suppressor genes implicated in epithelial ovarian cancer","year":2008,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; McGill University Health Centre; Natural Sciences and Engineering Research Council of Canada; Institute of Cancer Research; Institut Du Cancer de Montréal; McGill University","keywords":"Loss of heterozygosity; Chromosome; Gene; Ovarian cancer; Tumor suppressor gene; Suppressor; Candidate gene; Mutation; Chromosomal translocation","score_opus":0.03051861084688032,"score_gpt":0.29019515868536483,"score_spread":0.2596765478384845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7042736659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926231,0.0015593354,2.0236024e-8,0.00019408141,0.00049892074,0.0011391353,0.0026026338,0.000046661007,0.0013361265],"genre_scores_gemma":[0.9909458,0.005782803,0.000066950226,0.00019139962,0.00014145502,0.000826883,0.0011476214,0.0001245688,0.0007725185],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99627376,0.00017477265,0.0009700711,0.0012054848,0.0007418916,0.00063400285],"domain_scores_gemma":[0.9981483,0.00023973268,0.0004834466,0.00051568606,0.00029038475,0.00032245534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031440202,0.0006799123,0.0013723292,0.00055476563,0.00019713439,0.000023134571,0.00019680604,0.00047928633,0.00040263662],"category_scores_gemma":[0.00019588866,0.00064630073,0.00025631173,0.000654554,0.00010443944,0.00041193687,0.00007944145,0.0009384861,0.00003019963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069904136,0.004144906,0.047724497,0.0027698416,0.0012709168,0.0022298843,0.00020223505,0.00014184754,0.85727656,0.0049522733,0.00009058907,0.07220604],"study_design_scores_gemma":[0.005970509,0.0006286952,0.6269618,0.002072554,0.00053781015,0.00014585105,0.00006639279,0.000026002072,0.358812,0.0006974377,0.0033588868,0.0007220178],"about_ca_topic_score_codex":0.0069077634,"about_ca_topic_score_gemma":0.009724857,"teacher_disagreement_score":0.57923734,"about_ca_system_score_codex":0.0010586019,"about_ca_system_score_gemma":0.00042183453,"threshold_uncertainty_score":0.9997053},"labels":[],"label_agreement":null},{"id":"W7067637771","doi":"","title":"Modelo 3D y ortofotografía de la autovía 407 en Ontario, Canadá entre PK 24+600 y PK 26+000 a partir de un vuelo con dron","year":2021,"lang":"es","type":"dissertation","venue":"Gredos (University of Salamanca)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Work (physics)","score_opus":0.007147017121560508,"score_gpt":0.21554939369997053,"score_spread":0.20840237657841001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7067637771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069315,0.0014419197,0.00025586633,0.001530634,0.00055587175,0.001101695,0.0002887206,0.00012397573,0.004008141],"genre_scores_gemma":[0.97972375,0.0028981639,0.0026692247,0.00017991329,0.0001948634,0.000019830677,0.0018252674,0.00011813101,0.012370879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963474,0.00039237455,0.0004644069,0.0010898409,0.0007255688,0.0009803833],"domain_scores_gemma":[0.9972784,0.00030006332,0.00061343476,0.0007810931,0.00036391243,0.0006631224],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038634642,0.00075736106,0.0013707492,0.0004426229,0.00052111177,0.00009169726,0.00046525625,0.0010366617,0.0056804023],"category_scores_gemma":[0.000042493466,0.0009669043,0.0005884036,0.00050604215,0.00033430263,0.0002318382,0.00013125555,0.0009264475,0.00007230301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020675194,0.0029516465,0.7458262,0.00268715,0.006809363,0.011803216,0.18023139,0.0009467103,0.0019884256,0.001891025,0.011896077,0.03090126],"study_design_scores_gemma":[0.00878159,0.0007174682,0.90801597,0.0036201456,0.006525957,0.00013084014,0.03170643,0.0032894353,0.0018385097,0.0002297901,0.0340212,0.0011226876],"about_ca_topic_score_codex":0.37211967,"about_ca_topic_score_gemma":0.47977194,"teacher_disagreement_score":0.16218974,"about_ca_system_score_codex":0.003785485,"about_ca_system_score_gemma":0.005333518,"threshold_uncertainty_score":0.9992781},"labels":[],"label_agreement":null},{"id":"W7088478615","doi":"10.6084/m9.figshare.30335026.v1","title":"Additional file 1 of Distinct maternal DNA methylation associations with gestational age at early and late-mid term pregnancy in a low- and middle-income country: evaluation of biological, genetic, and psychosocial contributors","year":2025,"lang":"en","type":"dataset","venue":"Figshare","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Carleton University; BC Children's Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Pregnancy; Psychosocial; DNA methylation; Term (time); Gestational age; Gestation","score_opus":0.03523606366739661,"score_gpt":0.2951530188950488,"score_spread":0.2599169552276522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7088478615","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016587831,0.0005729676,3.2037676e-8,0.000024136512,0.00001589161,0.00073185965,0.9820342,0.000004798096,0.000028255336],"genre_scores_gemma":[0.0057283933,0.00009380856,0.000079112826,0.000013815962,0.000045380202,0.0012619254,0.9927413,0.00000600679,0.00003026911],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99879235,0.00008910837,0.00032566328,0.0002901389,0.0003846839,0.000118055934],"domain_scores_gemma":[0.99814755,0.000968659,0.00044917563,0.00011042885,0.0002695025,0.00005467528],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005582827,0.00017507034,0.00039173831,0.00011529264,0.000056475277,0.000024001336,0.0000385998,0.00020435998,0.31804505],"category_scores_gemma":[0.00093973917,0.00014320422,0.000030253406,0.00012345839,0.00004079937,0.000044343735,0.000049151917,0.00010410436,0.0000031035968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009413367,0.0001481752,0.009104451,0.00087994867,0.0002129248,0.00001921605,0.000034463872,0.0000012197961,0.0000012332576,9.628449e-7,0.98898077,0.00052252744],"study_design_scores_gemma":[0.0021388254,0.0002489318,0.940178,0.024995042,0.00022037969,0.000004134306,0.00000272766,0.00001619764,0.000008263189,0.000033334316,0.032042418,0.00011173954],"about_ca_topic_score_codex":0.00006965934,"about_ca_topic_score_gemma":0.00043752638,"teacher_disagreement_score":0.9569383,"about_ca_system_score_codex":0.00019562464,"about_ca_system_score_gemma":0.00025313543,"threshold_uncertainty_score":0.6825783},"labels":[],"label_agreement":null},{"id":"W7096774044","doi":"","title":"© 1999 Cancer Research Campaign Article no. bjoc.1999.0665 Ovarian cancer histology-specific incidence trends in","year":2013,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Histology; Cohort; Ovarian cancer; Etiology; Cohort study; Cancer","score_opus":0.06644005598012458,"score_gpt":0.37339112215478176,"score_spread":0.3069510661746572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096774044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90702474,0.0137545895,0.000038222235,0.03547495,0.000987287,0.001275718,0.000034213615,0.00015182138,0.041258458],"genre_scores_gemma":[0.9766167,0.002878165,0.000885564,0.0012698307,0.0005048794,0.0021746573,0.000016622706,0.000047801845,0.015605805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695224,0.00017013476,0.0005065611,0.00078264845,0.00063370634,0.0009547352],"domain_scores_gemma":[0.99821943,0.00018701947,0.00008014819,0.0007217783,0.0003903632,0.00040126237],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004835742,0.0002804096,0.00053816306,0.0005448863,0.00015600547,0.000068183406,0.00021768802,0.00019564485,0.03920562],"category_scores_gemma":[0.000052315252,0.00021926682,0.000113595976,0.001227378,0.00025693554,0.00024968438,0.00010570165,0.0005460663,0.0016591934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028976452,0.0010501924,0.4514466,0.000053542884,0.00015498158,0.0002792392,0.0012086127,0.000036264635,0.0056461836,0.0016427429,0.41124022,0.12695166],"study_design_scores_gemma":[0.0039721965,0.00042150446,0.8748245,0.00027008285,0.000053141834,0.000023630739,0.0002894856,0.00038918387,0.003494023,0.0003177073,0.115635045,0.0003094617],"about_ca_topic_score_codex":0.10758911,"about_ca_topic_score_gemma":0.016834743,"teacher_disagreement_score":0.42337793,"about_ca_system_score_codex":0.0018633513,"about_ca_system_score_gemma":0.00036914917,"threshold_uncertainty_score":0.99911815},"labels":[],"label_agreement":null},{"id":"W7097823054","doi":"","title":"GYNAECOLOGY Short-Term Morbidity and Long-Term Recurrence Rate of Ovarian Dermoid Cysts Treated by Laparoscopy Versus Laparotomy","year":2015,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Laparotomy; Laparoscopy; Dermoid cyst; Concomitant; Retrospective cohort study; Medical record; Oophorectomy","score_opus":0.053121049432652404,"score_gpt":0.33050985516471615,"score_spread":0.27738880573206376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097823054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814464,0.00078494987,0.000032616987,0.000586094,0.0005803807,0.00086652767,0.00006970448,0.000065000844,0.008870089],"genre_scores_gemma":[0.9983677,0.00045955935,0.00027843405,0.00013016415,0.000065601016,0.00015475933,0.00016421852,0.000023100054,0.00035645763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856323,0.00009744017,0.00035282088,0.0004744765,0.00017476101,0.00033726633],"domain_scores_gemma":[0.998765,0.00015447233,0.000102761674,0.00040481437,0.00016263452,0.00041030205],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020474018,0.00026310261,0.00058336084,0.00008233048,0.000046070523,0.0000225081,0.000095254596,0.00016000273,0.0009136671],"category_scores_gemma":[0.00007769112,0.00020997805,0.00006873162,0.00017846384,0.00017235389,0.00010272861,0.00006472804,0.00013142188,0.000027004146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010990609,0.0008244717,0.972975,0.00009745396,0.00035743698,0.00026224364,0.0001484847,5.2781263e-7,0.0008214935,0.00016675852,0.0073137437,0.01593329],"study_design_scores_gemma":[0.009087063,0.0020537756,0.9439458,0.000040008028,0.00042743172,0.00004027449,0.000025008889,0.00003073125,0.04365273,0.00002675498,0.00045211887,0.00021830082],"about_ca_topic_score_codex":0.00037107657,"about_ca_topic_score_gemma":0.00023841424,"teacher_disagreement_score":0.042831235,"about_ca_system_score_codex":0.00021371021,"about_ca_system_score_gemma":0.00020089987,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W7097879357","doi":"","title":"PRINCIPAL AUTHORS","year":2015,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Principal (computer security); Permission; Subject (documents); Clinical Oncology; Executive board; Executive summary; Executive committee","score_opus":0.08867928574627429,"score_gpt":0.3396116134577088,"score_spread":0.2509323277114345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097879357","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32978165,0.00044045455,0.00021513116,0.016434,0.00047381225,0.00029697394,0.0000019030582,0.00014706001,0.65220904],"genre_scores_gemma":[0.982932,0.0000067748397,0.0026265818,0.0006571609,0.000113418406,0.000015677368,0.00000357629,0.0000053027247,0.0136395395],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967164,0.000004473536,0.00005574046,0.0000848304,0.000104541825,0.0000788049],"domain_scores_gemma":[0.99964523,0.0000053852573,0.000008392659,0.00011811907,0.00003208708,0.00019079447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058601094,0.00003964286,0.000074944495,0.00001772346,0.000008069056,0.0000052427495,0.000014155418,0.000021388825,0.00040604037],"category_scores_gemma":[0.000017862654,0.0000260173,0.00002517992,0.000044016946,0.000009194825,0.000016584989,0.000010580565,0.000027768127,0.0003612446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017829567,0.0010116798,0.60686135,0.000025412282,0.00022886306,0.0003651032,0.00070882204,0.000009561895,0.000043279673,0.08171262,0.2585455,0.05030953],"study_design_scores_gemma":[0.0043863025,0.00075192767,0.28692624,0.00002963346,0.00012100466,0.00007440334,0.00017967998,0.00013456351,0.003753705,0.0006267217,0.7029075,0.00010832384],"about_ca_topic_score_codex":0.00005659202,"about_ca_topic_score_gemma":0.000008645806,"teacher_disagreement_score":0.6531503,"about_ca_system_score_codex":0.000068114554,"about_ca_system_score_gemma":0.00008651177,"threshold_uncertainty_score":0.4643189},"labels":[],"label_agreement":null},{"id":"W7098736865","doi":"","title":"Comment Government Administered Workplace Surveys and Industrial Relations in Canada","year":2013,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Industrial relations; Work (physics); Field (mathematics)","score_opus":0.03254548366145038,"score_gpt":0.24065344993627524,"score_spread":0.20810796627482486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7098736865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86928564,0.00013142273,0.000045479177,0.11217226,0.00019137791,0.0009761665,0.000027823537,0.000010482166,0.017159374],"genre_scores_gemma":[0.9962785,0.00002548018,0.00020207408,0.0015732254,0.000031271207,0.000103196195,0.000011639109,0.0000058975575,0.001768714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992976,0.00007529091,0.00016638394,0.00013614369,0.0001964696,0.00012806333],"domain_scores_gemma":[0.999567,0.00013379786,0.000030067627,0.00012876517,0.000012146086,0.00012824949],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015822297,0.0000762724,0.00014464247,0.000012256412,0.000023424998,0.000014325502,0.000019008608,0.00003268873,0.0025715076],"category_scores_gemma":[0.00002318521,0.00005948743,0.000012221455,0.00006712171,0.000009467488,0.000030448158,0.00002320512,0.00008353868,0.000020743248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009309636,0.000101901955,0.9178401,0.0000032048365,0.000034730187,0.000014637354,0.000028155528,0.0000016760787,0.0000019102456,0.0001326057,0.06643742,0.015394311],"study_design_scores_gemma":[0.0031883596,0.00011953019,0.97658926,0.000055513763,0.00002506465,0.0000040308037,0.0003394348,0.0001239347,0.00007930839,0.000015051266,0.019392395,0.000068127265],"about_ca_topic_score_codex":0.8739922,"about_ca_topic_score_gemma":0.9042854,"teacher_disagreement_score":0.12699288,"about_ca_system_score_codex":0.0013142996,"about_ca_system_score_gemma":0.00044492955,"threshold_uncertainty_score":0.99834025},"labels":[],"label_agreement":null},{"id":"W7100548936","doi":"","title":"Record Content","year":2015,"lang":"en","type":"article","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"German; Patent application; Content analysis; Bibliometrics","score_opus":0.2342827488160609,"score_gpt":0.3246364583067043,"score_spread":0.09035370949064339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7100548936","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46725672,0.00058124214,0.00028099323,0.026760574,0.0005694638,0.00034788606,0.0000021189114,0.00011282564,0.50408816],"genre_scores_gemma":[0.980592,0.000032663087,0.0028446843,0.0019726802,0.00010658315,0.00002116488,0.0000037001691,0.0000050476365,0.014421494],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972504,0.0000035663866,0.000057854835,0.00007441566,0.00007517811,0.00006395568],"domain_scores_gemma":[0.99969393,0.0000068705563,0.000009205561,0.00010634176,0.000047761685,0.00013587093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000363188,0.000035641882,0.0000812593,0.00001312132,0.0000057972566,0.000004359799,0.000011047352,0.000014231907,0.000402571],"category_scores_gemma":[0.000014941952,0.000022504279,0.000026396987,0.000028620012,0.0000071887794,0.000015068514,0.000006661402,0.000019410389,0.0003756783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016405761,0.0005462309,0.575901,0.00001015762,0.00014329143,0.0001472092,0.00014413994,3.5796975e-7,0.00008114192,0.008979747,0.25669232,0.15719037],"study_design_scores_gemma":[0.006717101,0.0013137036,0.22426426,0.000045068882,0.00012073299,0.00005555746,0.00038703956,0.000051764393,0.003544226,0.000387147,0.76301134,0.00010205036],"about_ca_topic_score_codex":0.00024875609,"about_ca_topic_score_gemma":0.00002611369,"teacher_disagreement_score":0.5133353,"about_ca_system_score_codex":0.000067944755,"about_ca_system_score_gemma":0.000050278417,"threshold_uncertainty_score":0.48287097},"labels":[],"label_agreement":null},{"id":"W7104249371","doi":"10.71781/717","title":"Inflammation, médicaments anti-inflammatoires et risque de cancer de l’ovaire","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Breast cancer; Tumor necrosis factor α; Risk factor; Genetic inheritance","score_opus":0.0062068452525496235,"score_gpt":0.21989359324147079,"score_spread":0.21368674798892115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104249371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8978977,0.0702696,0.00010335822,0.004318426,0.0025130499,0.0010273595,0.00035889866,0.00016303732,0.02334856],"genre_scores_gemma":[0.9167267,0.018393254,0.0007885815,0.00056634936,0.0010092242,0.0006092565,0.001616552,0.00010664351,0.060183406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605197,0.0004020787,0.00068320456,0.00088170264,0.0010598369,0.00092122273],"domain_scores_gemma":[0.9975111,0.00019863897,0.0007084459,0.00055733253,0.00032072238,0.00070376287],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043980323,0.0006999435,0.0007572407,0.0004371806,0.0068745967,0.00009846129,0.00042091197,0.0005566449,0.0012507532],"category_scores_gemma":[0.00010281741,0.00082535145,0.00051517406,0.00048928906,0.00025493358,0.0004110332,0.00021297208,0.00084207446,0.000077098746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0016252755,0.0011951415,0.77562803,0.001212992,0.0039887875,0.016208475,0.078490734,0.03249967,0.017247168,0.043717843,0.005924881,0.022261022],"study_design_scores_gemma":[0.005206823,0.00031392474,0.64110196,0.0021707665,0.00293901,0.0012522492,0.030054878,0.0032373106,0.032654315,0.00021906228,0.27982828,0.0010214323],"about_ca_topic_score_codex":0.14452726,"about_ca_topic_score_gemma":0.015178069,"teacher_disagreement_score":0.2739034,"about_ca_system_score_codex":0.04039249,"about_ca_system_score_gemma":0.011969418,"threshold_uncertainty_score":0.9996622},"labels":[],"label_agreement":null},{"id":"W7104254663","doi":"10.71781/720","title":"La relation entre la qualité de l'alimentation et la récidive chez les survivantes du cancer de l'ovaire","year":2023,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Colonic disease; Breast cancer; Medical screening","score_opus":0.009294529257970047,"score_gpt":0.23866183886329165,"score_spread":0.2293673096053216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104254663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533322,0.019607507,0.00030290073,0.0017174416,0.0012382839,0.0006259547,0.00029417613,0.00019723902,0.022684315],"genre_scores_gemma":[0.95874244,0.0141688315,0.00038702268,0.00014760549,0.00042089776,0.00018487114,0.0017589685,0.00008266045,0.02410668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963517,0.0011947209,0.00050389336,0.00070696214,0.00069700455,0.0005456809],"domain_scores_gemma":[0.9973756,0.0011481573,0.0005302043,0.00029348495,0.00026743178,0.0003851077],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008533477,0.00055560033,0.000546288,0.00032741902,0.0027249502,0.00010651375,0.00021281147,0.000851858,0.00017140266],"category_scores_gemma":[0.000151799,0.0006260319,0.00039519733,0.00041217572,0.00030423785,0.00032668182,0.000090711226,0.0006493203,0.00007967832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011407909,0.00072875037,0.76771677,0.0006617956,0.002040525,0.0063004736,0.14015177,0.005312193,0.005486208,0.0502135,0.0008502338,0.019396966],"study_design_scores_gemma":[0.0031543989,0.00013765921,0.8884009,0.0025737144,0.0020829127,0.0005776781,0.07871025,0.0013947783,0.0060337773,0.00025636642,0.016150678,0.0005268811],"about_ca_topic_score_codex":0.16952318,"about_ca_topic_score_gemma":0.028469486,"teacher_disagreement_score":0.14105369,"about_ca_system_score_codex":0.012285257,"about_ca_system_score_gemma":0.0045934413,"threshold_uncertainty_score":0.9996191},"labels":[],"label_agreement":null},{"id":"W7104274347","doi":"10.71781/993","title":"Cigarette smoking and the risk of ovarian cancer among women in Quebec : a population-based case-control study","year":2022,"lang":"en","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer; Risk factor; Cigarette smoking","score_opus":0.004132630554923221,"score_gpt":0.1969797907451347,"score_spread":0.19284716019021148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104274347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888511,0.007717061,0.000004964876,0.00020129264,0.00035140896,0.001405176,0.0001799394,0.000024814059,0.0012642707],"genre_scores_gemma":[0.9951439,0.00014549642,0.000016995928,0.000052309857,0.000057422996,0.00054218515,0.00012401899,0.000024763183,0.0038929102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802816,0.0003177589,0.00040012648,0.00044777812,0.00053622806,0.00026993192],"domain_scores_gemma":[0.9986303,0.0002782746,0.00050303584,0.000332614,0.00010797055,0.00014780383],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0004745694,0.00028152435,0.0006202405,0.00031720457,0.0020184314,0.000026537711,0.000110558685,0.00015736176,0.00019402415],"category_scores_gemma":[0.000056164845,0.00023851213,0.00018567168,0.0002986725,0.00009011884,0.00009772503,0.000039149596,0.00044577045,2.1086014e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003751318,0.0003377451,0.93422824,0.00009733469,0.0017780331,0.006098821,0.045065273,0.0029687495,0.000006820899,0.00038987419,0.0000143630505,0.0052634445],"study_design_scores_gemma":[0.012034445,0.00015335082,0.940829,0.00019447925,0.002292942,0.00012301962,0.043113668,0.00084348227,0.000026617918,0.00002736902,0.00017552529,0.00018615065],"about_ca_topic_score_codex":0.85386896,"about_ca_topic_score_gemma":0.60199505,"teacher_disagreement_score":0.2518739,"about_ca_system_score_codex":0.008905284,"about_ca_system_score_gemma":0.0015299103,"threshold_uncertainty_score":0.9992808},"labels":[],"label_agreement":null},{"id":"W7112825566","doi":"","title":"Медичний інститут Сумського державного університету","year":2019,"lang":"ru","type":"article","venue":"The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Serous fluid; Fallopian tube; Disease; Ovarian cancer; Incidence (geometry); Serous carcinoma; Salpingectomy; Cancer; Ovarian carcinoma","score_opus":0.05997434975476801,"score_gpt":0.34096821809646755,"score_spread":0.28099386834169954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7112825566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8619801,0.0052223494,0.000046615838,0.047873154,0.005702204,0.0022242703,0.0014507595,0.00018118651,0.07531939],"genre_scores_gemma":[0.6719403,0.0007707688,0.00031255203,0.00024860617,0.0005305337,0.000004833006,0.00030238117,0.000040136267,0.32584986],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.993059,0.00047799558,0.0009023834,0.0015598375,0.002994159,0.001006653],"domain_scores_gemma":[0.9948416,0.0007114874,0.00074778206,0.0013596982,0.0019233451,0.0004160881],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015744021,0.00073648256,0.0012211268,0.0006778122,0.00091660535,0.00027262245,0.0016445807,0.0004605834,0.014157056],"category_scores_gemma":[0.00036389736,0.0005843068,0.0006838778,0.0013548424,0.002387997,0.00085281685,0.0009233583,0.00071558537,0.002889318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077452883,0.0084887175,0.12419703,0.0023323637,0.0051486255,0.00082153926,0.033662844,0.001430686,0.007661203,0.65143776,0.14318213,0.013891806],"study_design_scores_gemma":[0.0052149747,0.0019933747,0.059401177,0.0004926133,0.0008201817,0.0000943128,0.019882211,0.00058454263,0.0021946842,0.0030148155,0.9054132,0.0008938888],"about_ca_topic_score_codex":0.0010070851,"about_ca_topic_score_gemma":0.00044066383,"teacher_disagreement_score":0.7622311,"about_ca_system_score_codex":0.0009333512,"about_ca_system_score_gemma":0.0018126064,"threshold_uncertainty_score":0.99966085},"labels":[],"label_agreement":null},{"id":"W7113898291","doi":"10.1158/1557-3265.earlyonsetca25-a010","title":"Abstract A010: Are We Delaying Ovarian Cancer Diagnosis in Young Women?: Sensitivity of CA-125 Thresholds for Early-Onset Ovarian cancer in Large Cohort","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cohort; Gynecologic oncology; Referral; Cancer; Serous fluid; Cohort study","score_opus":0.13548399230222435,"score_gpt":0.4943773748922086,"score_spread":0.35889338258998427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113898291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97181696,0.0056187413,0.00003264926,0.015275313,0.0009621303,0.0032484308,0.0023613889,0.000033387532,0.00065098674],"genre_scores_gemma":[0.95800734,0.02446203,0.00008797887,0.0006004522,0.00045620062,0.015806152,0.000037338134,0.00006894946,0.0004735517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938404,0.0006301279,0.0016015358,0.0013388952,0.00097231136,0.0016167435],"domain_scores_gemma":[0.99420035,0.0034028783,0.00030487464,0.0008900383,0.00074966246,0.00045222393],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008093723,0.00041536946,0.0016268983,0.00075773435,0.00021175593,0.0000791942,0.00030645748,0.00056702795,0.0016890767],"category_scores_gemma":[0.0012054943,0.0003805568,0.00036065903,0.0019127424,0.00035345022,0.00018147918,0.00027642655,0.0016749857,0.000009486632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026985768,0.0020978916,0.96293473,0.00091744785,0.00066577905,0.00028432006,0.00074098824,0.00012740814,0.00003853728,0.00012776595,0.006661244,0.022705304],"study_design_scores_gemma":[0.010264806,0.00030826684,0.9798968,0.004208969,0.00015188409,0.0000022691588,0.00063564355,0.000466193,0.00048774268,0.0004147785,0.0028632022,0.00029947632],"about_ca_topic_score_codex":0.06966707,"about_ca_topic_score_gemma":0.23339225,"teacher_disagreement_score":0.16372518,"about_ca_system_score_codex":0.0032519717,"about_ca_system_score_gemma":0.0030258666,"threshold_uncertainty_score":0.99986464},"labels":[],"label_agreement":null},{"id":"W7113904464","doi":"10.1158/1557-3265.earlyonsetca25-b018","title":"Abstract B018: Early-onset ovarian cancer in U.S. veterans: A National Cancer Database study","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Logistic regression; Cancer; Cohort; Retrospective cohort study; Cohort study; Fallopian tube","score_opus":0.30878318328812354,"score_gpt":0.5968792021292982,"score_spread":0.2880960188411747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113904464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96594363,0.006425502,0.0000036055021,0.019454397,0.0011299565,0.0023984546,0.00090182526,0.000045392964,0.0036972149],"genre_scores_gemma":[0.9837543,0.007444333,0.000057007004,0.0014565929,0.0008527871,0.004822231,0.000041285253,0.000039693794,0.001531807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505067,0.00047681958,0.0010588621,0.0011395415,0.0014720424,0.000802075],"domain_scores_gemma":[0.99650085,0.0014976623,0.00010533511,0.00070990645,0.00082208414,0.00036416177],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037686648,0.00027741192,0.0007419385,0.00056021847,0.00020247816,0.00010123709,0.00037844037,0.00021169479,0.0043967003],"category_scores_gemma":[0.0007502257,0.00023425372,0.00019865949,0.0014766625,0.0003242349,0.00016935274,0.00023688645,0.0016062631,0.000086651926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021436196,0.0038646185,0.914067,0.00017996444,0.0006062477,0.0003103758,0.00029687854,0.000034066627,0.00004135628,0.000119716125,0.02401365,0.054322563],"study_design_scores_gemma":[0.010304693,0.00051944883,0.9691618,0.0013513337,0.00012251697,0.0000012284283,0.00019931718,0.00007468573,0.00010949612,0.00021815124,0.017748168,0.00018912842],"about_ca_topic_score_codex":0.054622274,"about_ca_topic_score_gemma":0.03349156,"teacher_disagreement_score":0.055094887,"about_ca_system_score_codex":0.0016534677,"about_ca_system_score_gemma":0.005152362,"threshold_uncertainty_score":0.9965134},"labels":[],"label_agreement":null},{"id":"W7116899690","doi":"10.1002/ijgo.70676","title":"Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecology & Obstetrics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Eisai Canada; Eisai; AstraZeneca","keywords":"Clinical trial; Phases of clinical research; Phase (matter); Ovary; Chemotherapy","score_opus":0.020025301149796143,"score_gpt":0.35528553731661405,"score_spread":0.3352602361668179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116899690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565774,0.0002746544,0.000114343384,0.0012672362,0.0019217497,0.00037280656,0.00019824982,0.0000025426393,0.00019069418],"genre_scores_gemma":[0.99808794,0.0010294397,0.00067355455,0.00008257224,0.00007208761,0.0000046700343,0.000016434307,0.0000070079996,0.000026264084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997871,0.00012747804,0.0012744938,0.00019465615,0.00041210576,0.00012029448],"domain_scores_gemma":[0.99565315,0.0021413642,0.0011613667,0.0001418703,0.0008319023,0.00007034193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005079256,0.00012370726,0.00069475523,0.00050990743,0.00001978818,0.000008024363,0.00013768833,0.0001235789,0.000030240637],"category_scores_gemma":[0.0027128581,0.00009294302,0.0001015618,0.00030380735,0.000120741046,0.00009549172,0.0000552771,0.00027106985,1.9650898e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29956353,0.0071401107,0.50887394,0.000046226032,0.0009996064,0.00026208532,0.00011363904,0.000051158513,0.00021472333,0.0001513253,0.00011081062,0.18247284],"study_design_scores_gemma":[0.22007713,0.007937097,0.7694484,0.00039662607,0.00019681778,0.000005168732,0.000020188556,0.000049258542,0.0007727306,0.000024512226,0.0010166906,0.000055362703],"about_ca_topic_score_codex":0.000080068,"about_ca_topic_score_gemma":0.00007840753,"teacher_disagreement_score":0.26057446,"about_ca_system_score_codex":0.00042925583,"about_ca_system_score_gemma":0.0007496026,"threshold_uncertainty_score":0.37901062},"labels":[],"label_agreement":null},{"id":"W7116956731","doi":"10.1016/j.annonc.2025.10.1041","title":"604MO Prognostic value of progression free status at 6 months on overall survival (OS) in platinum resistant ovarian cancer (PROC): Landmark analysis from the GCIG Symptom Benefit Study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"UCLH Biomedical Research Centre; Cancer Research UK; National Institute for Health and Care Research; Target Ovarian Cancer","keywords":"Surrogate endpoint; Progression-free survival; Overall survival; Ovarian cancer; Immunotherapy; Clinical trial; Survival analysis","score_opus":0.0382349403986068,"score_gpt":0.381974377686269,"score_spread":0.3437394372876622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116956731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832229,0.0023770833,0.0000036020422,0.009183351,0.00021784376,0.0015431622,0.0004442445,0.000015944657,0.0029918905],"genre_scores_gemma":[0.9978796,0.00067291816,0.00012756712,0.00055836426,0.000072228875,0.00039161387,0.000096189266,0.000016366339,0.00018515407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976411,0.00029748413,0.0007197739,0.0005037329,0.00045243613,0.00038547677],"domain_scores_gemma":[0.9971278,0.0014202361,0.00039960904,0.00073311053,0.000220517,0.000098741286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005525852,0.00023878508,0.001067767,0.00027458408,0.00007504221,0.000009960098,0.00022284762,0.00016433388,0.00023314497],"category_scores_gemma":[0.000300354,0.00015497302,0.00019027718,0.00073399825,0.00009062204,0.000034539396,0.00017955116,0.00020236873,0.0000020592963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053769024,0.0043467376,0.9614405,0.00005451131,0.003726463,0.00010374261,0.0012255945,0.000580739,0.000114295624,0.00097461423,0.0018619834,0.02019392],"study_design_scores_gemma":[0.0073217605,0.005048604,0.98090446,0.00048771707,0.0018585008,2.7575663e-7,0.0003311584,0.00024746463,0.00056930655,0.00070529745,0.0024127385,0.00011270278],"about_ca_topic_score_codex":0.018363656,"about_ca_topic_score_gemma":0.04077611,"teacher_disagreement_score":0.022412457,"about_ca_system_score_codex":0.0003382355,"about_ca_system_score_gemma":0.0004725499,"threshold_uncertainty_score":0.9881731},"labels":[],"label_agreement":null},{"id":"W7117487322","doi":"10.9734/bpi/msup/v3/6768","title":"Ovarian Mass Leading to the Diagnosis of Krukenberg Tumour: A Case Report","year":2025,"lang":"en","type":"book-chapter","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"","keywords":"Ovary; Exploratory laparotomy; Ascites; Abdomen; Ovarian cancer; Malignancy; Krukenberg tumor; Abdominal mass","score_opus":0.030488041204006347,"score_gpt":0.29512580842072195,"score_spread":0.2646377672167156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117487322","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012915107,0.0011983811,0.00038781867,0.020304352,0.0006024943,0.0015782845,0.00014736282,0.00006782925,0.9755843],"genre_scores_gemma":[0.06965477,0.00056857814,0.0022254174,0.0020909447,0.000491654,0.00041969414,0.000077269644,0.00007512883,0.9243966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979889,0.000018425846,0.00072002626,0.000620967,0.0003890927,0.0002626126],"domain_scores_gemma":[0.9978662,0.00033179807,0.00028246446,0.0011023922,0.00021025709,0.00020687222],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003511007,0.00041220378,0.00090099307,0.00025553151,0.000096271484,0.000027439053,0.00013276808,0.00024172239,0.0028865894],"category_scores_gemma":[0.00013401487,0.00026575313,0.00042788818,0.000097048745,0.000055423065,0.000025724019,0.0001120416,0.0003016487,0.00014456276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015499722,0.00027900535,0.0035879125,0.0005664028,0.0030691973,0.31822,0.00031006,0.000013119409,0.000012420244,0.19589382,0.42995617,0.047936916],"study_design_scores_gemma":[0.0012111152,0.00049271696,0.0004089068,0.0026560859,0.0031008348,0.019286416,0.00007299246,0.0000097809225,0.0013951543,0.0013084691,0.96962595,0.00043155227],"about_ca_topic_score_codex":0.00093019824,"about_ca_topic_score_gemma":0.0006408899,"teacher_disagreement_score":0.5396698,"about_ca_system_score_codex":0.00033811672,"about_ca_system_score_gemma":0.00033636088,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W7117654101","doi":"10.3390/curroncol33010021","title":"A Novel Approach to Reducing Chemoresistance in Advanced Ovarian Cancer: The Effect of Itraconazole—A Single-Institution Randomized Placebo-Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Tanta University","keywords":"Itraconazole; Carboplatin; Chemotherapy; Placebo; Paclitaxel; Randomized controlled trial; Ovarian cancer; Clinical endpoint","score_opus":0.03631568203333857,"score_gpt":0.37417154829135235,"score_spread":0.3378558662580138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117654101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93301195,0.009244685,0.0065903957,0.0062969723,0.0053686844,0.02379312,0.000021980926,0.000055854587,0.0156163415],"genre_scores_gemma":[0.98897845,0.00027206124,0.0007699733,0.00012261742,0.00024352159,0.009492832,0.000017587334,0.000011525905,0.00009145826],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99796724,0.00036902874,0.0007367058,0.00043715927,0.00019143363,0.0002984073],"domain_scores_gemma":[0.9979288,0.0013039894,0.0002808843,0.00032347837,0.000085993386,0.00007688379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012987735,0.00024093121,0.0017968374,0.00021632771,0.000068883164,0.00001098952,0.00013659579,0.00012206961,0.000017861454],"category_scores_gemma":[0.0009085311,0.00014739417,0.000281641,0.00041962616,0.00015642014,0.000040077924,0.000043365126,0.00027223813,0.000002002059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9060325,0.002093814,0.0005871268,0.00025171932,0.0003500677,0.0000036663964,0.00031447376,0.0009143698,0.0012015785,0.0013081442,0.00024738206,0.08669513],"study_design_scores_gemma":[0.9875867,0.0010550229,0.0010137816,0.0006621849,0.00078721775,0.0000041836065,0.000043898577,0.0009962554,0.0036110254,0.000020265135,0.004109791,0.00010968952],"about_ca_topic_score_codex":0.00015981244,"about_ca_topic_score_gemma":0.00010303538,"teacher_disagreement_score":0.08658544,"about_ca_system_score_codex":0.0011475908,"about_ca_system_score_gemma":0.00071873405,"threshold_uncertainty_score":0.601056},"labels":[],"label_agreement":null},{"id":"W7117718600","doi":"10.3390/curroncol33010017","title":"Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival Perspective","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Survivorship curve; Ovarian cancer; Overall survival; Survival analysis; Stage (stratigraphy); Disease; Perspective (graphical); Precision medicine","score_opus":0.0738404441498533,"score_gpt":0.4449961751253135,"score_spread":0.3711557309754602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117718600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7734285,0.020302307,0.0012799957,0.07407442,0.017367465,0.002525704,0.00044847385,0.00022259871,0.11035051],"genre_scores_gemma":[0.9972294,0.0010074469,0.00027203668,0.00020926655,0.0004071247,0.00053127814,0.00010118665,0.00001545983,0.00022678151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984924,0.00014021544,0.0003240747,0.00048927806,0.00018395128,0.0003700505],"domain_scores_gemma":[0.9990573,0.0003329878,0.000095169955,0.00020050729,0.0002010703,0.00011295379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022899188,0.00019520275,0.0005600011,0.00023892599,0.0000889221,0.000011945597,0.00008933105,0.00011616729,0.00040697615],"category_scores_gemma":[0.00016832771,0.00018468061,0.000116518495,0.00046076177,0.00011046137,0.000059249338,0.00006493085,0.00038044513,0.00002142332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069226895,0.002889679,0.6435299,0.000116035386,0.00038615815,0.00017003201,0.00087986526,0.00006443883,0.000108451,0.20565087,0.0021441772,0.14336812],"study_design_scores_gemma":[0.012985241,0.0006603782,0.84098995,0.0004378842,0.00026698803,0.000009204886,0.0020488747,0.00015079798,0.00014018768,0.0052453447,0.1368403,0.00022486196],"about_ca_topic_score_codex":0.0004486406,"about_ca_topic_score_gemma":0.0019615195,"teacher_disagreement_score":0.2238009,"about_ca_system_score_codex":0.0024674153,"about_ca_system_score_gemma":0.0013402897,"threshold_uncertainty_score":0.7531057},"labels":[],"label_agreement":null},{"id":"W7126578698","doi":"","title":"Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes","year":2022,"lang":"en","type":"article","venue":"UWA Profiles and Research Repository (University of Western Australia)","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services; University of British Columbia","funders":"","keywords":"Gene expression profiling; Gene expression; Gene; Transcriptome; Tumor suppressor gene; Ovarian cancer","score_opus":0.04415046880132019,"score_gpt":0.2974986889327968,"score_spread":0.2533482201314766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7126578698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881244,0.000078532146,0.000013108236,0.00029980045,0.000019244664,0.00061532477,0.000042765747,0.000016156988,0.00010263674],"genre_scores_gemma":[0.9953863,0.00001365104,0.001855709,0.0000045969514,0.000011087241,0.000006521334,0.000024279649,0.000014260641,0.0026835813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835116,0.00018858773,0.00018372945,0.00038853602,0.0006102276,0.00027775878],"domain_scores_gemma":[0.9990687,0.000111974405,0.0002106502,0.00019709217,0.00022542325,0.00018619449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035498972,0.00015505214,0.00042676082,0.00017782782,0.000466462,0.000024027087,0.0000877131,0.000036973073,0.000038366466],"category_scores_gemma":[0.000018591705,0.00012586406,0.000043990654,0.00016333612,0.00057803397,0.00013658743,0.0002621543,0.00030869705,2.6879601e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017525492,0.00040161255,0.98341143,0.00027986005,0.00018802579,0.00097100873,0.00083719514,0.000020882137,0.0119521,0.000013433047,0.00010941336,0.00006250027],"study_design_scores_gemma":[0.0028520534,0.0030827082,0.9586124,0.0010682074,0.00013968209,0.0004327149,0.013533828,0.00006702651,0.020074554,0.0000041463363,0.0000087565895,0.00012393676],"about_ca_topic_score_codex":0.0010669216,"about_ca_topic_score_gemma":0.000030019719,"teacher_disagreement_score":0.024799032,"about_ca_system_score_codex":0.000099844714,"about_ca_system_score_gemma":0.00012599252,"threshold_uncertainty_score":0.51325876},"labels":[],"label_agreement":null},{"id":"W7132902704","doi":"","title":"Evaluating Novel Biomarkers for Ovarian Cancer Diagnosis","year":2023,"lang":"","type":"dissertation","venue":"TSpace","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ovarian cancer; Biomarker; Stage (stratigraphy); Multivariate analysis; Cancer; Epithelial ovarian cancer; Multivariate statistics","score_opus":0.1436006362063734,"score_gpt":0.4830159946915988,"score_spread":0.3394153584852254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132902704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7664321,0.06311587,0.0015133695,0.06251751,0.054750033,0.035806723,0.005168661,0.0012376346,0.009458067],"genre_scores_gemma":[0.52014333,0.0540844,0.023901343,0.002321111,0.011317319,0.19921683,0.016165778,0.0023887476,0.17046112],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99452996,0.00009499256,0.0010958678,0.0018719422,0.0010936927,0.0013135424],"domain_scores_gemma":[0.99485457,0.0017864612,0.0009979248,0.0009782527,0.0008232525,0.00055952615],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010651614,0.001142058,0.0015637105,0.0005403953,0.0006234592,0.0001775127,0.00033254022,0.0008198887,0.0041746227],"category_scores_gemma":[0.0010825491,0.0011258665,0.00089559547,0.0011407179,0.000089999005,0.000105782914,0.000069019145,0.0004570227,0.00034621888],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006691724,0.0048129973,0.05628524,0.012052692,0.028591303,0.00016658017,0.052764684,0.00081687473,0.0081792055,0.0013439142,0.117241405,0.7110534],"study_design_scores_gemma":[0.082357496,0.00986347,0.53723913,0.045459118,0.055716697,0.00002483878,0.07974827,0.02789712,0.052838642,0.00045985208,0.10186661,0.00652876],"about_ca_topic_score_codex":0.013701421,"about_ca_topic_score_gemma":0.0030801217,"teacher_disagreement_score":0.70452464,"about_ca_system_score_codex":0.0015865202,"about_ca_system_score_gemma":0.0022514628,"threshold_uncertainty_score":0.99911916},"labels":[],"label_agreement":null},{"id":"W7132906211","doi":"","title":"Characterizing the Epigenetic Landscape of ETMRs","year":2020,"lang":"","type":"dissertation","venue":"TSpace","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Brain Tumour Research","keywords":"Epigenetics; Disease; Affect (linguistics); Epigenesis; DNA methylation","score_opus":0.025862455589576887,"score_gpt":0.3301596184670246,"score_spread":0.3042971628774477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132906211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86686724,0.040202282,0.000035473364,0.03883172,0.0031852373,0.0026029397,0.00006177165,0.000055714856,0.04815762],"genre_scores_gemma":[0.98314184,0.0103484485,0.00008195825,0.0006231141,0.0006807218,0.00014340604,0.00053880946,0.00007761,0.0043641008],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9979679,0.000102238235,0.0005549858,0.0005321925,0.00048293712,0.00035976895],"domain_scores_gemma":[0.9981677,0.00023037643,0.0006351683,0.0006113061,0.00015205856,0.00020340816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001588498,0.00044609897,0.000874114,0.00008016098,0.00013543434,0.000037729413,0.00023517858,0.0002438476,0.003226312],"category_scores_gemma":[0.00009841768,0.00030725045,0.000335423,0.00032098134,0.00006520157,0.00002783678,0.000038908696,0.00042873435,0.00032308386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005114573,0.0035523914,0.11628413,0.0128455525,0.011869841,0.0007720465,0.54919916,0.00005643065,0.10238069,0.0037530917,0.012333009,0.18183908],"study_design_scores_gemma":[0.005641373,0.0028014912,0.6560228,0.005364571,0.007187319,0.000021075319,0.06539063,0.00053529575,0.17369033,0.000045818,0.082373954,0.0009253737],"about_ca_topic_score_codex":0.0002589644,"about_ca_topic_score_gemma":0.000039053724,"teacher_disagreement_score":0.53973866,"about_ca_system_score_codex":0.00007881447,"about_ca_system_score_gemma":0.00047267912,"threshold_uncertainty_score":0.99993795},"labels":[],"label_agreement":null},{"id":"W7133046231","doi":"","title":"First-line Systemic Therapy with Bevacizumab in Advanced Epithelial Ovarian Cancer","year":2022,"lang":"","type":"dissertation","venue":"TSpace","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BC Cancer Agency; University of Toronto; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Bevacizumab; Systemic therapy; Epithelial ovarian cancer; Ovarian cancer; Monoclonal antibody; Angiogenesis; Clinical trial; Targeted therapy","score_opus":0.019366317827349582,"score_gpt":0.3438444118420864,"score_spread":0.3244780940147368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133046231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9028162,0.07934508,0.000042151965,0.0050372654,0.0035329296,0.0060113994,0.00033388348,0.00011393262,0.0027671633],"genre_scores_gemma":[0.8950757,0.081603706,0.00019898746,0.0003423844,0.0007186901,0.0065641403,0.0011161839,0.00028447417,0.014095765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948004,0.0002429102,0.001023345,0.0016906635,0.0011851168,0.0010575673],"domain_scores_gemma":[0.9969907,0.0002617447,0.00092777226,0.0011789221,0.0002819198,0.00035898053],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035871757,0.0012217084,0.0019274163,0.0005435003,0.00043414568,0.00007542304,0.0003979117,0.00044211198,0.014238891],"category_scores_gemma":[0.00004263565,0.0010235218,0.00031572205,0.0012185,0.00007769144,0.00014438156,0.000055235807,0.0012199784,0.000081595266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11697406,0.013161444,0.117609985,0.011259544,0.010157794,0.0071776365,0.2242524,0.069638014,0.0040711816,0.0017494095,0.00084672245,0.42310178],"study_design_scores_gemma":[0.25788337,0.033241075,0.34876168,0.06621063,0.0065898984,0.0006545948,0.12673698,0.0028423811,0.016954647,0.0001964178,0.13211194,0.00781639],"about_ca_topic_score_codex":0.017107425,"about_ca_topic_score_gemma":0.017319653,"teacher_disagreement_score":0.4152854,"about_ca_system_score_codex":0.0033776937,"about_ca_system_score_gemma":0.0023345435,"threshold_uncertainty_score":0.9992215},"labels":[],"label_agreement":null},{"id":"W7161760183","doi":"10.82308/53649","title":"Regional Variation in Ovarian Cancer Treatment in Ontario","year":2018,"lang":"en","type":"dissertation","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian cancer; Cancer; Neoplasm staging; Epithelial ovarian cancer","score_opus":0.03293339083619669,"score_gpt":0.31390703303304146,"score_spread":0.2809736421968448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161760183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91928446,0.00070008694,0.0000039674137,0.0019327739,0.0011687169,0.001799943,0.000016205531,0.000030694322,0.07506313],"genre_scores_gemma":[0.7869917,0.001449339,0.0017636645,0.0006796145,0.00063443056,0.0028373224,0.003688349,0.00009316753,0.20186241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851364,0.000024866398,0.0004159447,0.00053565047,0.00024978464,0.0002600944],"domain_scores_gemma":[0.9993954,0.000028059021,0.00013295948,0.00027758,0.00007737587,0.00008864595],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007708993,0.0003130647,0.0005399102,0.00035952695,0.00002621157,0.000019155841,0.000047502283,0.00032598287,0.0058899727],"category_scores_gemma":[0.0000062629942,0.00025126975,0.000117240954,0.00020274041,0.000010969852,0.000056656423,0.0000045618135,0.00019719143,0.000069189555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002916966,0.0050157835,0.9351975,0.00019572295,0.00092780404,0.00051020226,0.021628775,0.00002044831,0.0002325699,0.0026446579,0.0056248046,0.025084818],"study_design_scores_gemma":[0.005099738,0.0004773845,0.9715058,0.00067849585,0.00022438046,0.0000046031864,0.00015459076,0.00001679524,0.00031699645,0.00022607188,0.021093924,0.00020117749],"about_ca_topic_score_codex":0.7648585,"about_ca_topic_score_gemma":0.98960453,"teacher_disagreement_score":0.22474605,"about_ca_system_score_codex":0.0060643437,"about_ca_system_score_gemma":0.002424452,"threshold_uncertainty_score":0.999994},"labels":[],"label_agreement":null},{"id":"W7162066758","doi":"10.82308/3773","title":"Bevacizumab and conventional chemotherapy for the treatment of epithelial ovarian cancer: a systematic review of the literature, best evidence synthesis and metanalysis","year":2024,"lang":"en","type":"dissertation","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bevacizumab; Tolerability; Randomized controlled trial; Chemotherapy; Standard of care; Clinical trial; Ovarian cancer; Meta-analysis","score_opus":0.021791774662749126,"score_gpt":0.3309669785158401,"score_spread":0.309175203853091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7162066758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068283966,0.98173517,0.000008162577,0.0057146326,0.00023274032,0.004773307,0.0006032706,0.000006923903,0.00009739173],"genre_scores_gemma":[0.08882782,0.89877,0.00019346316,0.00020756577,0.00009559218,0.0060895844,0.00008396105,0.000034938443,0.005697071],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985062,0.00007933398,0.00064375467,0.0003384669,0.00032726728,0.000104963605],"domain_scores_gemma":[0.99778795,0.0009847783,0.00045631753,0.0004441327,0.0002818014,0.000045020177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028353272,0.00028798907,0.0013882943,0.000084161446,0.00006873,0.000035175344,0.000090316564,0.000104499355,0.00018692488],"category_scores_gemma":[0.00015063463,0.00011947536,0.00064019667,0.000273284,0.000058466452,0.000031901178,0.0000071342597,0.000060764814,6.9478097e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041014608,0.00047850763,0.00028958096,0.96928483,0.015690845,0.000004325146,0.0014436793,2.8237622e-7,0.00009075104,0.0013794551,0.00036422795,0.01056334],"study_design_scores_gemma":[0.0015237594,0.0006726697,0.00230903,0.8691503,0.115202606,0.000025893169,0.00048133443,0.00010632465,0.009479602,0.00016683561,0.0006969789,0.00018466389],"about_ca_topic_score_codex":0.0004129606,"about_ca_topic_score_gemma":0.0003028076,"teacher_disagreement_score":0.10013456,"about_ca_system_score_codex":0.00014233742,"about_ca_system_score_gemma":0.00024070627,"threshold_uncertainty_score":0.48720637},"labels":[],"label_agreement":null},{"id":"W7162074622","doi":"10.82308/27718","title":"Predictors of outcome patterns in infants diagnosed with congenital ovarian cysts","year":2023,"lang":"en","type":"dissertation","venue":"","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ovarian torsion; Retrospective cohort study; Asymptomatic; Incidence (geometry); Cohort; Cyst; Ovarian cyst","score_opus":0.01818169522428628,"score_gpt":0.2960841815745021,"score_spread":0.27790248635021586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7162074622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911709,0.00010147093,0.0000017181453,0.000096952725,0.000788206,0.0010768721,0.0001977688,0.000078037054,0.0064881146],"genre_scores_gemma":[0.9897327,0.00019489872,0.00006329307,0.00006243787,0.00012079573,0.00034596457,0.0024061333,0.00008796743,0.0069858464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982219,0.000023948061,0.00061175844,0.00042647315,0.00044466197,0.0002712947],"domain_scores_gemma":[0.9990137,0.00013850989,0.00022680975,0.00037544424,0.000112149515,0.00013335912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000931306,0.00033255955,0.0008116742,0.00038106932,0.000017374414,0.000013779693,0.00008786934,0.0002620399,0.0004805279],"category_scores_gemma":[0.000056571498,0.00023901544,0.00013102555,0.00031835173,0.000020961275,0.000048689162,0.000014086478,0.00023550329,0.000041726587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005205945,0.00044604533,0.99371225,0.0004349948,0.0008822791,0.000924033,0.0012276092,0.000002291075,0.000010570625,0.000044911332,0.0003015557,0.0014928766],"study_design_scores_gemma":[0.005254671,0.0006401862,0.99051076,0.0009290301,0.0005873957,0.00000706793,0.0012718086,0.0000057605407,0.00049700984,0.000004984873,0.00008355599,0.0002077723],"about_ca_topic_score_codex":0.0054417937,"about_ca_topic_score_gemma":0.03991765,"teacher_disagreement_score":0.03447586,"about_ca_system_score_codex":0.00015259808,"about_ca_system_score_gemma":0.00022729537,"threshold_uncertainty_score":0.97760135},"labels":[],"label_agreement":null},{"id":"W74270104","doi":"","title":"Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role?","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Ovarian cancer; Chemotherapy; Pelvic examination; Physical examination; Surgery; Cancer; Gynecology; Internal medicine","score_opus":0.046978954962958695,"score_gpt":0.2764035623154732,"score_spread":0.2294246073525145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W74270104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662066,0.0019322945,0.00030625475,0.023541696,0.00040424228,0.0035694214,0.00008460498,0.00014275726,0.003812089],"genre_scores_gemma":[0.9821155,0.0011164185,0.0004965622,0.0012152782,0.000907938,0.008738245,0.000070111426,0.00005134288,0.0052885977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986079,0.000020964717,0.00027900844,0.00038582215,0.00025414577,0.0004521577],"domain_scores_gemma":[0.9992694,0.000055126355,0.00010853248,0.00027595047,0.000094562216,0.0001963791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019301788,0.00020661314,0.00035736556,0.00010676556,0.00014238806,0.0000169788,0.00007334609,0.00010492901,0.00023225011],"category_scores_gemma":[0.000046884692,0.00017712527,0.00012995124,0.00012519225,0.000034236105,0.00008725269,0.000015443567,0.000103191014,0.000009033302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020960749,0.002367666,0.35592926,0.00034337223,0.0013490481,0.00015822987,0.003768397,0.00010542312,0.00057122856,0.0002498459,0.007151044,0.6259104],"study_design_scores_gemma":[0.01142626,0.00010928379,0.96611756,0.00004260227,0.00016154145,0.00004494642,0.000045499382,0.00021642295,0.010420784,0.000034134726,0.01120885,0.00017213021],"about_ca_topic_score_codex":0.00029733265,"about_ca_topic_score_gemma":0.00016274357,"teacher_disagreement_score":0.62573826,"about_ca_system_score_codex":0.000479148,"about_ca_system_score_gemma":0.000078051205,"threshold_uncertainty_score":0.7222959},"labels":[],"label_agreement":null},{"id":"W7720014","doi":"","title":"Prognostic factors for women with Stage 1 ovarian cancer with or without adhesions.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Stage (stratigraphy); Internal medicine; Proportional hazards model; Oncology; Cancer; Cohort; Adjuvant therapy; Gynecology; Population; Survival analysis","score_opus":0.030912837085338832,"score_gpt":0.25900505299826154,"score_spread":0.22809221591292272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7720014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908545,0.00016752414,0.00016359331,0.0014794644,0.00009022445,0.005077022,0.0001467261,0.00011620072,0.0019047479],"genre_scores_gemma":[0.9528874,0.000021635331,0.0008295301,0.00021553037,0.00020197296,0.03264083,0.0000398012,0.00005932522,0.013103979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855506,0.000014015429,0.00017852719,0.00038356712,0.00025995992,0.00060887967],"domain_scores_gemma":[0.99916065,0.0001192027,0.00010354225,0.0002654124,0.00009930352,0.00025191274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009291903,0.00023739459,0.00038881655,0.00007966512,0.000095774914,0.00004270985,0.00005900915,0.000056657027,0.00015633565],"category_scores_gemma":[0.00003062236,0.00012173267,0.000036204165,0.00022282256,0.00006270407,0.000081960345,0.000011468049,0.000077793346,0.0000027501862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028970449,0.00052591704,0.9794379,0.00016485028,0.00034475443,0.00005705289,0.00021843087,0.000019277531,0.000004320797,0.000117459495,0.0009240269,0.015288969],"study_design_scores_gemma":[0.006534474,0.00091279607,0.9635915,0.00008599727,0.0003180735,0.000011179974,0.00024517436,0.0000122377905,0.0006458632,0.00001929965,0.027422732,0.00020064793],"about_ca_topic_score_codex":0.0007109239,"about_ca_topic_score_gemma":0.0014428843,"teacher_disagreement_score":0.0379671,"about_ca_system_score_codex":0.00042295147,"about_ca_system_score_gemma":0.00027580725,"threshold_uncertainty_score":0.4964114},"labels":[],"label_agreement":null},{"id":"W785196269","doi":"10.1097/pas.0000000000000476","title":"Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers","year":2015,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institute for Health and Care Research","keywords":"Serous carcinoma; Serous fluid; Pathology; Carcinoma; Immunohistochemistry; Ovarian carcinoma; Anatomical pathology; H&E stain; Medicine; Not Otherwise Specified; Cystadenocarcinoma; Ovarian cancer; Cancer; Biology; Internal medicine","score_opus":0.02062045733845763,"score_gpt":0.27940105478811134,"score_spread":0.2587805974496537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W785196269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920769,0.0006841141,0.00012105118,0.0065184394,0.00020283768,0.000084410516,0.000017627703,0.0000041798057,0.0002904731],"genre_scores_gemma":[0.99742484,0.0008025801,0.0011023473,0.00047921375,0.00015945516,0.0000033472024,0.0000018111924,0.000010834458,0.000015581714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988796,0.00023184609,0.00040276346,0.00011676914,0.00019929511,0.00016972635],"domain_scores_gemma":[0.99868196,0.00014709774,0.0005943049,0.00017995558,0.0001883882,0.00020830793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005643974,0.000113820664,0.0006951982,0.00007132081,0.000020180862,0.0000049406763,0.00009715408,0.000035669098,0.000026697431],"category_scores_gemma":[0.000079853584,0.000064056425,0.00011492019,0.00014936896,0.00072504353,0.000020921292,0.000038783674,0.00020066818,0.000003024448],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018533798,0.001681178,0.31295595,0.00008133959,0.0018198035,0.077933274,0.0027871926,0.00011604486,0.024627881,0.0060284473,0.0018980987,0.55153704],"study_design_scores_gemma":[0.018427245,0.027722575,0.859487,0.00025871085,0.0018223794,0.06334394,0.00150685,0.000082237726,0.0069500124,0.0034370483,0.016506828,0.00045518475],"about_ca_topic_score_codex":0.00006255399,"about_ca_topic_score_gemma":7.851638e-7,"teacher_disagreement_score":0.55108184,"about_ca_system_score_codex":0.000082568615,"about_ca_system_score_gemma":0.00020685524,"threshold_uncertainty_score":0.2671453},"labels":[],"label_agreement":null},{"id":"W80040234","doi":"","title":"Emerging concepts in epithelial ovarian cancer: highlights of the 4th Canadian conference on ovarian cancer research.","year":2009,"lang":"en","type":"other","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Epithelial ovarian cancer; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.05459029102858957,"score_gpt":0.33311114284377724,"score_spread":0.27852085181518765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W80040234","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024813975,0.0057889395,0.0000010031329,0.07834527,0.0027308112,0.0069151353,0.0016066611,0.000087153756,0.90204364],"genre_scores_gemma":[0.74584347,0.007021078,0.000039765928,0.0014366762,0.0016273061,0.0059380196,0.000048340407,0.0003262514,0.23771912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966137,0.00025839446,0.00044165296,0.0007372226,0.0008171056,0.0011319139],"domain_scores_gemma":[0.9980583,0.00007144783,0.00026963683,0.0008913969,0.00015606776,0.00055315555],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004847184,0.00042505818,0.0008320047,0.0008164903,0.00011612664,0.000038713184,0.00043853637,0.00042747965,0.0027638972],"category_scores_gemma":[0.00007378981,0.00029689746,0.00016809843,0.0007592685,0.00025056975,0.000031625,0.000052810166,0.000724735,0.00002184237],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037893094,0.0006512643,0.019277891,0.0003628268,0.001048439,0.00042695255,0.0011235116,0.000024506162,0.000024533128,0.028844865,0.550819,0.39701733],"study_design_scores_gemma":[0.0029119335,0.00007321767,0.33782429,0.0018318235,0.00015869144,0.000003279485,0.00004129113,0.0000052746013,0.00045702312,0.00020406318,0.65621233,0.00027680598],"about_ca_topic_score_codex":0.74996585,"about_ca_topic_score_gemma":0.8232747,"teacher_disagreement_score":0.74336207,"about_ca_system_score_codex":0.0019538617,"about_ca_system_score_gemma":0.0025416948,"threshold_uncertainty_score":0.9999483},"labels":[],"label_agreement":null},{"id":"W879794327","doi":"10.1007/s10552-015-0626-0","title":"Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies","year":2015,"lang":"en","type":"article","venue":"Cancer Causes & Control","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Multivitamin; Medicine; Relative risk; Vitamin; Cohort study; Confidence interval; Cohort; Prospective cohort study; Physiology; Population; Ovarian cancer; Cancer; Internal medicine; Proportional hazards model; Lower risk; Gynecology; Environmental health","score_opus":0.023614907767101668,"score_gpt":0.31489444300163955,"score_spread":0.29127953523453787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W879794327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8975047,0.10043794,0.000012678838,0.0010497919,0.000052011117,0.0005809563,0.00029771615,0.0000036434915,0.000060584418],"genre_scores_gemma":[0.966353,0.033174347,0.000023730641,0.00013001458,0.000030372528,0.00023086314,0.0000021981068,0.00000942186,0.000046032223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989662,0.00009813149,0.0003975206,0.00023366047,0.00017215186,0.00013232401],"domain_scores_gemma":[0.9987907,0.00033082537,0.00031061732,0.0002185835,0.00026390853,0.00008540693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042027576,0.0001467091,0.0011488637,0.00017884515,0.000021739097,0.0000058645887,0.000035443303,0.000048753558,0.00003443166],"category_scores_gemma":[0.00015614918,0.000089761335,0.00008360651,0.00033571242,0.00040212105,0.000042501862,0.000034228455,0.00007281171,6.719362e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015015,0.00007969076,0.96737033,0.00010901446,0.019481497,0.000007440495,0.0025602572,0.00011309349,0.0001925696,0.00023729404,0.00006420692,0.008283117],"study_design_scores_gemma":[0.01790286,0.00030336538,0.95156616,0.0002245601,0.027456805,0.0000018538436,0.00076662103,0.0010345703,0.00040783588,0.0001222647,0.00013350365,0.000079598605],"about_ca_topic_score_codex":0.011658078,"about_ca_topic_score_gemma":0.012537682,"teacher_disagreement_score":0.06884834,"about_ca_system_score_codex":0.00009595811,"about_ca_system_score_gemma":0.00015637388,"threshold_uncertainty_score":0.99492335},"labels":[],"label_agreement":null},{"id":"W94397604","doi":"10.1016/s1701-2163(16)30489-3","title":"Ovarian Teratoma Diagnosis and Management: Case Presentations","year":2004,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Saudi Aramco","keywords":"Medicine; Laparotomy; Laparoscopy; Malignancy; Germ cell tumors; Asymptomatic; Teratoma; Ovary; Immature teratoma; Gynecology; Surgery; General surgery; Pathology; Internal medicine","score_opus":0.01433988428501926,"score_gpt":0.25481353030468973,"score_spread":0.24047364601967047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W94397604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814756,0.009169479,0.000038817772,0.0050981455,0.0024628527,0.0002651312,0.000021591093,0.0000034453847,0.0014649439],"genre_scores_gemma":[0.995564,0.0022931932,0.0014565671,0.00057647465,0.00002572066,0.000015311945,0.0000019106217,0.000008049932,0.000058811125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930257,0.000016217859,0.00026738545,0.00011631034,0.000150996,0.0001465046],"domain_scores_gemma":[0.9989943,0.00043291436,0.00014241072,0.00008687675,0.000109886445,0.0002336262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006760968,0.00009429136,0.00023149268,0.00018077531,0.000108405424,0.000026417472,0.000030271285,0.000048035035,0.00014333807],"category_scores_gemma":[0.00021234341,0.000076124095,0.000033287284,0.00021216774,0.000037417918,0.00005753053,0.000025615213,0.000118275064,3.5376496e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007203852,0.000349958,0.63075775,0.00011629703,0.00074739585,0.22634697,0.00017942808,0.000046943223,6.2576333e-7,0.0033202237,0.0033881976,0.134739],"study_design_scores_gemma":[0.007493009,0.00056226505,0.9612692,0.000020155308,0.0005909228,0.0061031934,0.00036620052,0.0000072220323,0.00004982955,0.00038605343,0.02305124,0.000100706915],"about_ca_topic_score_codex":0.015079533,"about_ca_topic_score_gemma":0.029955067,"teacher_disagreement_score":0.33051145,"about_ca_system_score_codex":0.0004775305,"about_ca_system_score_gemma":0.00045701728,"threshold_uncertainty_score":0.99147916},"labels":[],"label_agreement":null},{"id":"W952878123","doi":"","title":"Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"PTEN; Serous fluid; Medicine; Ovarian cancer; Tissue microarray; Hazard ratio; Immunohistochemistry; Oncology; Internal medicine; Cancer research; Cancer; Biology; Apoptosis; PI3K/AKT/mTOR pathway; Confidence interval","score_opus":0.03013343799208482,"score_gpt":0.2740929047574157,"score_spread":0.2439594667653309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W952878123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843773,0.0026096608,0.0000075696153,0.0024501556,0.0001358673,0.0022364073,0.000012584619,0.000023795028,0.008146622],"genre_scores_gemma":[0.9895972,0.000027757887,0.00028161085,0.00008195307,0.000095680625,0.009265583,0.000011905972,0.000016916076,0.0006213867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990137,0.0000228971,0.0002613152,0.00021103723,0.0002256115,0.0002654317],"domain_scores_gemma":[0.9993606,0.000020265927,0.00009314103,0.00026122574,0.00008188536,0.00018285766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022857093,0.00011557799,0.00027799964,0.00006414301,0.000010638097,0.0000066402645,0.00007074205,0.0000707348,0.000026480408],"category_scores_gemma":[0.00019970967,0.00009995183,0.000050906714,0.00022596668,0.00004934433,0.00003881392,0.000029413299,0.00010907668,0.000003942274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072937517,0.0018984345,0.8960634,0.00054082007,0.00031494984,0.00021089165,0.00073469727,0.00004327589,0.0035746323,0.0011259002,0.0016371289,0.09312649],"study_design_scores_gemma":[0.004341355,0.00008892233,0.95917857,0.00021382059,0.00010310935,0.000012544017,0.000052900243,0.000016888502,0.034569677,0.00024145519,0.0010663646,0.000114408474],"about_ca_topic_score_codex":0.0011023515,"about_ca_topic_score_gemma":0.000016024223,"teacher_disagreement_score":0.09301208,"about_ca_system_score_codex":0.00047975234,"about_ca_system_score_gemma":0.00030622745,"threshold_uncertainty_score":0.40759173},"labels":[],"label_agreement":null},{"id":"W956724268","doi":"10.1016/s0246-1064(13)54713-x","title":"10.1016/s0246-1064(13)54713-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Philosophy","score_opus":0.007828246092088032,"score_gpt":0.20414758301649183,"score_spread":0.1963193369244038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W956724268","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007324739,0.00031921794,2.5367677e-7,0.0032888257,0.0000032946027,0.00034263052,0.000020315618,0.00010588355,0.9951871],"genre_scores_gemma":[0.0009635218,0.000003416397,0.00019156831,0.0002658199,0.0002956497,0.00007517962,0.000031018262,0.000030497236,0.9981433],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991018,0.0000159763,0.00016229285,0.00026986966,0.00019330108,0.00025675417],"domain_scores_gemma":[0.9992972,0.000032881413,0.000020229581,0.00036321292,0.000036117362,0.00025038357],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006301655,0.00015064017,0.00024581474,0.000059924514,0.00004876871,0.000021572248,0.00007127998,0.000057408855,0.99867404],"category_scores_gemma":[0.0000134616075,0.00012573489,0.00009085149,0.00016618265,0.00002178918,0.000040778454,0.000017992403,0.00008509941,0.9952963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011989832,0.0001973964,0.0000038670973,0.000008066085,0.00006196827,0.00004465399,0.000013671823,0.000008005068,0.000008265456,5.016925e-7,0.6320835,0.3674502],"study_design_scores_gemma":[0.0012425869,0.00055953354,0.0010870864,0.0000726549,0.00013133754,0.000029269191,9.3953133e-7,0.000032826163,0.00024051842,0.0000048487923,0.99646956,0.0001288633],"about_ca_topic_score_codex":0.00007469645,"about_ca_topic_score_gemma":5.592994e-7,"teacher_disagreement_score":0.36732134,"about_ca_system_score_codex":0.0001058892,"about_ca_system_score_gemma":0.000059263977,"threshold_uncertainty_score":0.512732},"labels":[],"label_agreement":null}]}